id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
143117700|NCT00316914|515974138|FG000|Overall Study|Withdrawal by Subject|5|||
143117701|NCT00316914|515974139|FG001|Overall Study|Withdrawal by Subject|3|||
143117702|NCT00316914|515974138|FG000|Overall Study|Adverse Event|8|||
143117703|NCT00316914|515974139|FG001|Overall Study|Adverse Event|7|||
143117704|NCT00316914|515974138|FG000|Overall Study|Other Problems|6|||
143117705|NCT00316914|515974139|FG001|Overall Study|Other Problems|11|||
143117706|NCT00316914|515974138|FG000|Overall Study|Missing end of treatment documentation|14|||
143117707|NCT00316914|515974139|FG001|Overall Study|Missing end of treatment documentation|15|||
143117708|NCT01675154|515974140|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
143117709|NCT01675154|515974141|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
143117710|NCT01675154|515974142|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
143117711|NCT01675154|515974143|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
143117712|NCT00616603|515974144|FG000|Overall Study|Physician Decision|2|||
143117713|NCT00616603|515974145|FG001|Overall Study|Physician Decision|0|||
143117714|NCT00616603|515974146|FG002|Overall Study|Physician Decision|2|||
143117715|NCT00766467|515974156|FG000|Overall Study|Withdrawal by Subject|7|||
143117716|NCT00766467|515974157|FG001|Overall Study|Withdrawal by Subject|2|||
143117717|NCT00766467|515974156|FG000|Overall Study|Adverse Event|1|||
143117718|NCT00766467|515974157|FG001|Overall Study|Adverse Event|1|||
143117719|NCT00766467|515974156|FG000|Overall Study|Protocol Violation|2|||
143117720|NCT00766467|515974157|FG001|Overall Study|Protocol Violation|4|||
143117721|NCT00766467|515974156|FG000|Overall Study|Tumor Progression on Study|0|||
143117722|NCT00766467|515974157|FG001|Overall Study|Tumor Progression on Study|1|||
143117723|NCT00766467|515974156|FG000|Overall Study|Physician Decision|1|||
143117724|NCT00766467|515974157|FG001|Overall Study|Physician Decision|0|||
143117725|NCT01420679|515974166|FG000|Overall Study|Disease Progression|3|||
143117726|NCT01420679|515974167|FG001|Overall Study|Disease Progression|2|||
143117727|NCT01420679|515974166|FG000|Overall Study|Adverse Event|4|||
143117728|NCT01420679|515974167|FG001|Overall Study|Adverse Event|0|||
143117729|NCT01420679|515974166|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
143117730|NCT01420679|515974167|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
143117731|NCT01420679|515974166|FG000|Overall Study|Patient Decision|1|||
143117732|NCT01420679|515974167|FG001|Overall Study|Patient Decision|0|||
143117733|NCT01420679|515974166|FG000|Overall Study|Investigator Decision|1|||
143117734|NCT01420679|515974167|FG001|Overall Study|Investigator Decision|2|||
143004292|NCT01302366|515554680|FG000|Overall Study|patient choice or noncompliance|5|||
143004293|NCT00467051|515554681|FG000|Overall Study|Adverse Event|2|||
143004294|NCT01740297|515554682|FG000|Overall Study|Withdrawal by Subject|4|||
143004295|NCT01740297|515554683|FG001|Overall Study|Withdrawal by Subject|16|||
143004296|NCT01740297|515554684|FG002|Overall Study|Withdrawal by Subject|17|||
143117735|NCT01420679|515974166|FG000|Overall Study|Sponsor Decision|3|||
143117736|NCT01420679|515974167|FG001|Overall Study|Sponsor Decision|3|||
143117737|NCT01420679|515974166|FG000|Overall Study|Other|1|||
143117738|NCT01420679|515974167|FG001|Overall Study|Other|0|||
143117739|NCT00943670|515974168|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
143117740|NCT00943670|515974168|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
143117741|NCT00943670|515974168|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
143117742|NCT00943670|515974168|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
143117743|NCT00943670|515974168|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
143117744|NCT00943670|515974168|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
143117745|NCT00943670|515974168|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
143117746|NCT00943670|515974168|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
143117747|NCT00943670|515974168|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
143117748|NCT00943670|515974168|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
143117749|NCT04472026|515974169|FG000|Overall Study|Lost to Follow-up|5|||
143117750|NCT01777295|515974170|FG000|Overall Study|Withdrawal by Subject|2|||
143117751|NCT01777295|515974171|FG001|Overall Study|Withdrawal by Subject|2|||
143117752|NCT01777295|515974170|FG000|Overall Study|Pregnancy|0|||
143117753|NCT01777295|515974171|FG001|Overall Study|Pregnancy|1|||
143117754|NCT01777295|515974170|FG000|Overall Study|Personal problem|1|||
143117755|NCT01777295|515974171|FG001|Overall Study|Personal problem|0|||
143117756|NCT01777295|515974170|FG000|Overall Study|Investigator call for AEs check|1|||
143117757|NCT01777295|515974171|FG001|Overall Study|Investigator call for AEs check|0|||
143117758|NCT03114657|515974173|FG000|Overall Study|Adverse Event|9|||
143117759|NCT03114657|515974174|FG001|Overall Study|Adverse Event|6|||
143117760|NCT03114657|515974173|FG000|Overall Study|Death|4|||
143117761|NCT03114657|515974174|FG001|Overall Study|Death|0|||
143117762|NCT03114657|515974173|FG000|Overall Study|Multiple Reasons|1|||
143117763|NCT03114657|515974174|FG001|Overall Study|Multiple Reasons|2|||
143117764|NCT03114657|515974173|FG000|Overall Study|Physician Decision|2|||
143117765|NCT03114657|515974174|FG001|Overall Study|Physician Decision|2|||
143117766|NCT03114657|515974173|FG000|Overall Study|Study Terminated By Sponsor|355|||
143117767|NCT03114657|515974174|FG001|Overall Study|Study Terminated By Sponsor|374|||
143117768|NCT03114657|515974173|FG000|Overall Study|Symptomatic Deterioration|0|||
143343276|NCT02202434|516802479|FG000|Overall Study|Death|70|||
143343277|NCT02202434|516802480|FG001|Overall Study|Death|39|||
143117769|NCT03114657|515974174|FG001|Overall Study|Symptomatic Deterioration|1|||
143117770|NCT03114657|515974173|FG000|Overall Study|Withdrawal by Subject|28|||
143117771|NCT03114657|515974174|FG001|Overall Study|Withdrawal by Subject|22|||
143117772|NCT01179737|515974175|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
143117773|NCT01179737|515974176|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
143117774|NCT01179737|515974177|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
143117775|NCT01179737|515974178|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
143117776|NCT01179737|515974175|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
143117777|NCT01179737|515974176|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
143117778|NCT01179737|515974177|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
143117779|NCT01179737|515974178|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
143117780|NCT01179737|515974175|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
143117781|NCT01179737|515974176|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
143117782|NCT01179737|515974177|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
143117783|NCT01179737|515974178|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
143117784|NCT01179737|515974175|FG000|Cohort 1 & Cohort 2|Death|0|||
143117785|NCT01179737|515974176|FG001|Cohort 1 & Cohort 2|Death|0|||
143117786|NCT01179737|515974177|FG002|Cohort 1 & Cohort 2|Death|1|||
143117787|NCT01179737|515974178|FG003|Cohort 1 & Cohort 2|Death|0|||
143117788|NCT01179737|515974175|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
143117789|NCT01179737|515974176|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
143117790|NCT01179737|515974177|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
143117791|NCT01179737|515974178|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
143117792|NCT01179737|515974175|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
143117793|NCT01179737|515974176|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
143117794|NCT01179737|515974177|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
143117795|NCT01179737|515974178|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
143117796|NCT01179737|515974175|FG000|Extension|The study was terminated|3|||
143117797|NCT01179737|515974176|FG001|Extension|The study was terminated|0|||
143117798|NCT01179737|515974177|FG002|Extension|The study was terminated|0|||
143117799|NCT01179737|515974178|FG003|Extension|The study was terminated|0|||
143117800|NCT00115037|515974179|FG000|Phase1|Lost to Follow-up|16|||
143117801|NCT00115037|515974180|FG001|Phase1|Lost to Follow-up|23|||
143117802|NCT00115037|515974181|FG002|Phase1|Lost to Follow-up|0|||
143117803|NCT00115037|515974182|FG003|Phase1|Lost to Follow-up|0|||
143117804|NCT00115037|515974183|FG004|Phase1|Lost to Follow-up|0|||
143117805|NCT00115037|515974184|FG005|Phase1|Lost to Follow-up|0|||
143117806|NCT00115037|515974179|FG000|Phase1|Withdrawal by Subject|9|||
143117807|NCT00115037|515974180|FG001|Phase1|Withdrawal by Subject|4|||
143117808|NCT00115037|515974181|FG002|Phase1|Withdrawal by Subject|0|||
143117809|NCT00115037|515974182|FG003|Phase1|Withdrawal by Subject|0|||
143117810|NCT00115037|515974183|FG004|Phase1|Withdrawal by Subject|0|||
143117811|NCT00115037|515974184|FG005|Phase1|Withdrawal by Subject|0|||
143117812|NCT00115037|515974179|FG000|Phase2|Death|0|||
143117813|NCT00115037|515974180|FG001|Phase2|Death|0|||
143117814|NCT00115037|515974181|FG002|Phase2|Death|1|||
143117815|NCT00115037|515974182|FG003|Phase2|Death|0|||
143117816|NCT00115037|515974183|FG004|Phase2|Death|0|||
143117817|NCT00115037|515974184|FG005|Phase2|Death|1|||
143117818|NCT00115037|515974179|FG000|Phase2|Withdrawal by Subject|0|||
143117819|NCT00115037|515974180|FG001|Phase2|Withdrawal by Subject|0|||
143117820|NCT00115037|515974181|FG002|Phase2|Withdrawal by Subject|2|||
143117821|NCT00115037|515974182|FG003|Phase2|Withdrawal by Subject|1|||
143117822|NCT00115037|515974183|FG004|Phase2|Withdrawal by Subject|2|||
143117823|NCT00115037|515974184|FG005|Phase2|Withdrawal by Subject|1|||
143117824|NCT00115037|515974179|FG000|Phase2|Lost to Follow-up|0|||
143117825|NCT00115037|515974180|FG001|Phase2|Lost to Follow-up|0|||
143117826|NCT00115037|515974181|FG002|Phase2|Lost to Follow-up|12|||
143117827|NCT00115037|515974182|FG003|Phase2|Lost to Follow-up|14|||
143117828|NCT00115037|515974183|FG004|Phase2|Lost to Follow-up|4|||
143117829|NCT00115037|515974184|FG005|Phase2|Lost to Follow-up|10|||
143117830|NCT01546038|515974185|FG000|Overall Study|Death|15|||
143117831|NCT01546038|515974186|FG001|Overall Study|Death|6|||
143117832|NCT01546038|515974187|FG002|Overall Study|Death|4|||
143117833|NCT01546038|515974188|FG003|Overall Study|Death|2|||
143117834|NCT01546038|515974189|FG004|Overall Study|Death|9|||
143117835|NCT01546038|515974190|FG005|Overall Study|Death|3|||
143117836|NCT01546038|515974191|FG006|Overall Study|Death|46|||
143117837|NCT01546038|515974192|FG007|Overall Study|Death|76|||
143117838|NCT01546038|515974193|FG008|Overall Study|Death|39|||
143117839|NCT01546038|515974185|FG000|Overall Study|Lost to Follow-up|0|||
143117840|NCT01546038|515974186|FG001|Overall Study|Lost to Follow-up|0|||
143117841|NCT01546038|515974187|FG002|Overall Study|Lost to Follow-up|0|||
143117842|NCT01546038|515974188|FG003|Overall Study|Lost to Follow-up|0|||
143117843|NCT01546038|515974189|FG004|Overall Study|Lost to Follow-up|1|||
143117844|NCT01546038|515974190|FG005|Overall Study|Lost to Follow-up|0|||
143117845|NCT01546038|515974191|FG006|Overall Study|Lost to Follow-up|2|||
143117846|NCT01546038|515974192|FG007|Overall Study|Lost to Follow-up|1|||
143117847|NCT01546038|515974193|FG008|Overall Study|Lost to Follow-up|0|||
143117848|NCT01546038|515974185|FG000|Overall Study|Withdrawal by Subject|1|||
143117849|NCT01546038|515974186|FG001|Overall Study|Withdrawal by Subject|0|||
143117850|NCT01546038|515974187|FG002|Overall Study|Withdrawal by Subject|0|||
143117851|NCT01546038|515974188|FG003|Overall Study|Withdrawal by Subject|1|||
143117852|NCT01546038|515974189|FG004|Overall Study|Withdrawal by Subject|0|||
143117853|NCT01546038|515974190|FG005|Overall Study|Withdrawal by Subject|1|||
143117854|NCT01546038|515974191|FG006|Overall Study|Withdrawal by Subject|3|||
143117855|NCT01546038|515974192|FG007|Overall Study|Withdrawal by Subject|3|||
143117856|NCT01546038|515974193|FG008|Overall Study|Withdrawal by Subject|1|||
143117857|NCT01546038|515974185|FG000|Overall Study|: Randomized, not treated|0|||
143343278|NCT02202434|516802481|FG002|Overall Study|Death|13|||
143343279|NCT02202434|516802482|FG003|Overall Study|Death|27|||
143343280|NCT02202434|516802479|FG000|Overall Study|Lost to Follow-up|1|||
143343281|NCT02202434|516802480|FG001|Overall Study|Lost to Follow-up|1|||
143343282|NCT02202434|516802481|FG002|Overall Study|Lost to Follow-up|1|||
143343283|NCT02202434|516802482|FG003|Overall Study|Lost to Follow-up|0|||
143343284|NCT02202434|516802479|FG000|Overall Study|Physician Decision|2|||
143343285|NCT02202434|516802480|FG001|Overall Study|Physician Decision|3|||
143343286|NCT02202434|516802481|FG002|Overall Study|Physician Decision|0|||
143343287|NCT02202434|516802482|FG003|Overall Study|Physician Decision|0|||
143343288|NCT02202434|516802479|FG000|Overall Study|Withdrawal by Subject|13|||
143343289|NCT02202434|516802480|FG001|Overall Study|Withdrawal by Subject|14|||
143343290|NCT02202434|516802481|FG002|Overall Study|Withdrawal by Subject|1|||
143343291|NCT02202434|516802482|FG003|Overall Study|Withdrawal by Subject|4|||
143343292|NCT02202434|516802479|FG000|Overall Study|Completed Study|1|||
143343293|NCT02202434|516802480|FG001|Overall Study|Completed Study|0|||
143343294|NCT02202434|516802481|FG002|Overall Study|Completed Study|0|||
143343295|NCT02202434|516802482|FG003|Overall Study|Completed Study|0|||
143343296|NCT02202434|516802479|FG000|Overall Study|Visit Missed|21|||
143343297|NCT02202434|516802480|FG001|Overall Study|Visit Missed|12|||
143343298|NCT02202434|516802481|FG002|Overall Study|Visit Missed|0|||
143343299|NCT02202434|516802482|FG003|Overall Study|Visit Missed|5|||
143343300|NCT02202434|516802479|FG000|Overall Study|Other|1|||
143343301|NCT02202434|516802480|FG001|Overall Study|Other|0|||
143343302|NCT02202434|516802481|FG002|Overall Study|Other|0|||
143343303|NCT02202434|516802482|FG003|Overall Study|Other|1|||
143343304|NCT03237858|516802483|FG000|Overall Study|Death|19|||
143343305|NCT03237858|516802483|FG000|Overall Study|Withdrawal by Subject|37|||
143343306|NCT01862991|516802484|FG000|Overall Study|Lost to Follow-up|2|||
143343307|NCT01862991|516802485|FG001|Overall Study|Lost to Follow-up|1|||
143343308|NCT01862991|516802486|FG002|Overall Study|Lost to Follow-up|1|||
143343309|NCT01862991|516802484|FG000|Overall Study|Protocol Violation|1|||
143343310|NCT01862991|516802485|FG001|Overall Study|Protocol Violation|0|||
143343311|NCT01862991|516802486|FG002|Overall Study|Protocol Violation|0|||
143343312|NCT04858802|516802487|FG000|Overall Study|Lost to Follow-up|1|||
143343313|NCT04858802|516802488|FG001|Overall Study|Lost to Follow-up|1|||
143343314|NCT04858802|516802487|FG000|Overall Study|Withdrawal by Subject|1|||
143343315|NCT04858802|516802488|FG001|Overall Study|Withdrawal by Subject|1|||
143343316|NCT02026232|516802489|FG000|Overall Study|incomplete visit/missing data|3|||
143343317|NCT02026232|516802490|FG001|Overall Study|incomplete visit/missing data|2|||
143343318|NCT01966003|516802491|FG000|Overall Study|Death|43|||
143343319|NCT01966003|516802492|FG001|Overall Study|Death|36|||
143343320|NCT01966003|516802491|FG000|Overall Study|Protocol Violation|6|||
143343321|NCT01966003|516802492|FG001|Overall Study|Protocol Violation|4|||
143343322|NCT01966003|516802491|FG000|Overall Study|Lost to Follow-up|4|||
143343323|NCT01966003|516802492|FG001|Overall Study|Lost to Follow-up|3|||
143343324|NCT01966003|516802491|FG000|Overall Study|Physician Decision|12|||
143343325|NCT01966003|516802492|FG001|Overall Study|Physician Decision|13|||
143343326|NCT01966003|516802491|FG000|Overall Study|Withdrawal by Subject|29|||
143343327|NCT01966003|516802492|FG001|Overall Study|Withdrawal by Subject|19|||
143343328|NCT01966003|516802491|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
143343329|NCT01966003|516802492|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
143343330|NCT01966003|516802491|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
143343331|NCT01966003|516802492|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
143343332|NCT01966003|516802491|FG000|Overall Study|Other|1|||
143343333|NCT01966003|516802492|FG001|Overall Study|Other|1|||
143343334|NCT00185640|516802495|FG000|Overall Study|Not Eligible|4|||
143343335|NCT00185640|516802495|FG000|Overall Study|Withdrawal by Subject|3|||
143343336|NCT00185640|516802495|FG000|Overall Study|Death|138|||
143343337|NCT00058422|516802496|FG000|Overall Study|Not treated|2|||
143343338|NCT04887948|516802502|FG000|Overall Study|Death|1|||
143343339|NCT04887948|516802503|FG001|Overall Study|Death|0|||
143343340|NCT04887948|516802504|FG002|Overall Study|Death|0|||
143343341|NCT04887948|516802502|FG000|Overall Study|Lost to Follow-up|1|||
143343342|NCT04887948|516802503|FG001|Overall Study|Lost to Follow-up|0|||
143343343|NCT04887948|516802504|FG002|Overall Study|Lost to Follow-up|3|||
143343344|NCT04887948|516802502|FG000|Overall Study|Physician Decision|0|||
143343345|NCT04887948|516802503|FG001|Overall Study|Physician Decision|4|||
143343346|NCT04887948|516802504|FG002|Overall Study|Physician Decision|1|||
143117858|NCT01546038|515974186|FG001|Overall Study|: Randomized, not treated|0|||
143343347|NCT04887948|516802502|FG000|Overall Study|Protocol Violation|1|||
143343348|NCT04887948|516802503|FG001|Overall Study|Protocol Violation|1|||
143343349|NCT04887948|516802504|FG002|Overall Study|Protocol Violation|0|||
143343350|NCT04887948|516802502|FG000|Overall Study|Withdrawal by Subject|0|||
143343351|NCT04887948|516802503|FG001|Overall Study|Withdrawal by Subject|6|||
143343352|NCT04887948|516802504|FG002|Overall Study|Withdrawal by Subject|1|||
143343353|NCT04887948|516802502|FG000|Overall Study|No longer met eligibility criteria|1|||
143343354|NCT04887948|516802503|FG001|Overall Study|No longer met eligibility criteria|2|||
143343355|NCT04887948|516802504|FG002|Overall Study|No longer met eligibility criteria|1|||
143343356|NCT04887948|516802502|FG000|Overall Study|Other|2|||
143343357|NCT04887948|516802503|FG001|Overall Study|Other|1|||
143343358|NCT04887948|516802504|FG002|Overall Study|Other|1|||
143343359|NCT00787319|516802505|FG000|Overall Study|Lost to Follow-up|2|||
143343360|NCT00787319|516802505|FG000|Overall Study|Withdrawal by Subject|15|||
143343361|NCT00787319|516802505|FG000|Overall Study|Adverse Event|3|||
143343362|NCT00787319|516802505|FG000|Overall Study|Objective progression or relapse|30|||
143343363|NCT00787319|516802505|FG000|Overall Study|Lack of Efficacy|1|||
143343364|NCT00787319|516802505|FG000|Overall Study|Budget exhausted/exceeded|1|||
143343365|NCT00787319|516802505|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
143343366|NCT00787319|516802505|FG000|Overall Study|No health insurance reimbursement|2|||
143343367|NCT00787319|516802505|FG000|Overall Study|Stabilized disease findings|3|||
143343368|NCT00787319|516802505|FG000|Overall Study|Inactive disease|5|||
143343369|NCT02312856|516802506|FG000|Overall Study|Death|1|||
143343370|NCT02312856|516802506|FG000|Overall Study|Lost to Follow-up|3|||
143343371|NCT01932294|516802507|FG000|Overall Study|Death|43|||
143343372|NCT01932294|516802507|FG000|Overall Study|Lost to Follow-up|8|||
143343373|NCT01932294|516802507|FG000|Overall Study|VAD Implantation|20|||
143343374|NCT01932294|516802507|FG000|Overall Study|Heart Transplantation|16|||
143343375|NCT01932294|516802507|FG000|Overall Study|Transferred to other hospitals|12|||
143343376|NCT04415151|516802508|FG000|Overall Study|Death|1|||
143343377|NCT04415151|516802509|FG001|Overall Study|Death|1|||
143343378|NCT04415151|516802508|FG000|Overall Study|Withdrawal by Subject|1|||
143343379|NCT04415151|516802509|FG001|Overall Study|Withdrawal by Subject|0|||
143343380|NCT01473381|516802515|FG000|Overall Study|Adverse Event|8|||
143343381|NCT01473381|516802516|FG001|Overall Study|Adverse Event|20|||
143343382|NCT01473381|516802517|FG002|Overall Study|Adverse Event|25|||
143343383|NCT01473381|516802518|FG003|Overall Study|Adverse Event|17|||
143343384|NCT01473381|516802515|FG000|Overall Study|Insufficient Therapeutic Response|10|||
143343385|NCT01473381|516802516|FG001|Overall Study|Insufficient Therapeutic Response|1|||
143343386|NCT01473381|516802517|FG002|Overall Study|Insufficient Therapeutic Response|2|||
143343387|NCT01473381|516802518|FG003|Overall Study|Insufficient Therapeutic Response|3|||
143343388|NCT01473381|516802515|FG000|Overall Study|Protocol Violation|17|||
143343389|NCT01473381|516802516|FG001|Overall Study|Protocol Violation|23|||
143343390|NCT01473381|516802517|FG002|Overall Study|Protocol Violation|19|||
143343391|NCT01473381|516802518|FG003|Overall Study|Protocol Violation|17|||
143230262|NCT02741128|516393179|FG000|Overall Study|Protocol Violation|4|||
143230263|NCT02741128|516393180|FG001|Overall Study|Protocol Violation|1|||
143230264|NCT02741128|516393179|FG000|Overall Study|Withdrawal by Subject|2|||
143230265|NCT02741128|516393180|FG001|Overall Study|Withdrawal by Subject|0|||
143230266|NCT02741128|516393179|FG000|Overall Study|Lost to Follow-up|1|||
143230267|NCT02741128|516393180|FG001|Overall Study|Lost to Follow-up|0|||
143230268|NCT01419769|516393181|FG000|Overall Study|Did not receive the AXIOS stent|3|||
143230269|NCT01419769|516393181|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
143230270|NCT01959503|516393182|FG000|Overall Study|Death|2|||
143230271|NCT01959503|516393183|FG001|Overall Study|Death|1|||
143230272|NCT01959503|516393182|FG000|Overall Study|Randomized but not treated|1|||
143230273|NCT01959503|516393183|FG001|Overall Study|Randomized but not treated|1|||
143230274|NCT03224130|516393185|FG000|Overall Study|consent issue|0|||
143230275|NCT03224130|516393186|FG001|Overall Study|consent issue|1|||
143230276|NCT04124939|516393189|FG000|Overall Study|Lost to Follow-up|1|||
143230277|NCT04124939|516393190|FG001|Overall Study|Lost to Follow-up|3|||
143230278|NCT02250326|516393194|FG000|Treatment|Death|1|||
143230279|NCT02250326|516393195|FG001|Treatment|Death|13|||
143230280|NCT02250326|516393196|FG002|Treatment|Death|2|||
143230281|NCT02250326|516393194|FG000|Treatment|Adverse Event|8|||
143230282|NCT02250326|516393195|FG001|Treatment|Adverse Event|8|||
143230283|NCT02250326|516393196|FG002|Treatment|Adverse Event|9|||
143230284|NCT02250326|516393194|FG000|Treatment|Progressive Disease|42|||
143230285|NCT02250326|516393195|FG001|Treatment|Progressive Disease|40|||
143230286|NCT02250326|516393196|FG002|Treatment|Progressive Disease|47|||
143230287|NCT02250326|516393194|FG000|Treatment|Symptomatic Deterioration|9|||
143230288|NCT02250326|516393195|FG001|Treatment|Symptomatic Deterioration|4|||
143230289|NCT02250326|516393196|FG002|Treatment|Symptomatic Deterioration|10|||
143343392|NCT01473381|516802515|FG000|Overall Study|Withdrawal of Consent|20|||
143343393|NCT01473381|516802516|FG001|Overall Study|Withdrawal of Consent|21|||
143343394|NCT01473381|516802517|FG002|Overall Study|Withdrawal of Consent|20|||
143343395|NCT01473381|516802518|FG003|Overall Study|Withdrawal of Consent|26|||
143343396|NCT01473381|516802515|FG000|Overall Study|Lost to Follow-up|25|||
143343397|NCT01473381|516802516|FG001|Overall Study|Lost to Follow-up|28|||
143230290|NCT02250326|516393194|FG000|Treatment|Withdrawal by Subject|11|||
143230291|NCT02250326|516393195|FG001|Treatment|Withdrawal by Subject|6|||
143343398|NCT01473381|516802517|FG002|Overall Study|Lost to Follow-up|35|||
143343399|NCT01473381|516802518|FG003|Overall Study|Lost to Follow-up|23|||
143343400|NCT01473381|516802515|FG000|Overall Study|Other Reasons|0|||
143343401|NCT01473381|516802516|FG001|Overall Study|Other Reasons|0|||
143343402|NCT01473381|516802517|FG002|Overall Study|Other Reasons|1|||
143343403|NCT01473381|516802518|FG003|Overall Study|Other Reasons|3|||
143343404|NCT00539643|516802519|FG000|Overall Study|Adverse Event|1|||
143343405|NCT00539643|516802520|FG001|Overall Study|Adverse Event|0|||
143343406|NCT00539643|516802519|FG000|Overall Study|Death|2|||
143343407|NCT00539643|516802520|FG001|Overall Study|Death|1|||
143343408|NCT00539643|516802519|FG000|Overall Study|Physician Decision|3|||
143343409|NCT00539643|516802520|FG001|Overall Study|Physician Decision|1|||
143343410|NCT00539643|516802519|FG000|Overall Study|Withdrawal by Subject|0|||
143343411|NCT00539643|516802520|FG001|Overall Study|Withdrawal by Subject|1|||
143343412|NCT00985985|516802526|FG000|Overall Study|Adverse Event|4|||
143343413|NCT00985985|516802527|FG001|Overall Study|Adverse Event|2|||
143343414|NCT00985985|516802528|FG002|Overall Study|Adverse Event|2|||
143343415|NCT00985985|516802529|FG003|Overall Study|Adverse Event|2|||
143343416|NCT00985985|516802526|FG000|Overall Study|Lost to Follow-up|4|||
143343417|NCT00985985|516802527|FG001|Overall Study|Lost to Follow-up|11|||
143343418|NCT00985985|516802528|FG002|Overall Study|Lost to Follow-up|2|||
143343419|NCT00985985|516802529|FG003|Overall Study|Lost to Follow-up|3|||
143343420|NCT00985985|516802526|FG000|Overall Study|Protocol Violation|1|||
143343421|NCT00985985|516802527|FG001|Overall Study|Protocol Violation|2|||
143343422|NCT00985985|516802528|FG002|Overall Study|Protocol Violation|0|||
143343423|NCT00985985|516802529|FG003|Overall Study|Protocol Violation|1|||
143343424|NCT00985985|516802526|FG000|Overall Study|Lack of Efficacy|5|||
143343425|NCT00985985|516802527|FG001|Overall Study|Lack of Efficacy|6|||
143343426|NCT00985985|516802528|FG002|Overall Study|Lack of Efficacy|1|||
143343427|NCT00985985|516802529|FG003|Overall Study|Lack of Efficacy|3|||
143343428|NCT00985985|516802526|FG000|Overall Study|Withdrawal by Subject|4|||
143343429|NCT00985985|516802527|FG001|Overall Study|Withdrawal by Subject|2|||
143343430|NCT00985985|516802528|FG002|Overall Study|Withdrawal by Subject|2|||
143343431|NCT00985985|516802529|FG003|Overall Study|Withdrawal by Subject|2|||
143343432|NCT00985985|516802526|FG000|Overall Study|Other Reason|6|||
143343433|NCT00985985|516802527|FG001|Overall Study|Other Reason|1|||
143343434|NCT00985985|516802528|FG002|Overall Study|Other Reason|4|||
143343435|NCT00985985|516802529|FG003|Overall Study|Other Reason|2|||
143343436|NCT02255357|516802532|FG000|Overall Study|Physician Decision|10|||
143343437|NCT02255357|516802533|FG001|Overall Study|Physician Decision|24|||
143343438|NCT00509236|516802534|FG000|Overall Study|Adverse Event|7|||
143343439|NCT00509236|516802535|FG001|Overall Study|Adverse Event|9|||
143343440|NCT00509236|516802534|FG000|Overall Study|Withdrawal by Subject|5|||
143343441|NCT00509236|516802535|FG001|Overall Study|Withdrawal by Subject|10|||
143343442|NCT00509236|516802534|FG000|Overall Study|Protocol Violation|3|||
143343443|NCT00509236|516802535|FG001|Overall Study|Protocol Violation|0|||
143343444|NCT00509236|516802534|FG000|Overall Study|Excluded Medication|1|||
143343445|NCT00509236|516802535|FG001|Overall Study|Excluded Medication|1|||
143343446|NCT00509236|516802534|FG000|Overall Study|Scheduled Kidney Transplant|1|||
143343447|NCT00509236|516802535|FG001|Overall Study|Scheduled Kidney Transplant|0|||
143343448|NCT00927355|516802536|FG000|Overall Study|Adverse Event|1|||
143343449|NCT00927355|516802537|FG001|Overall Study|Adverse Event|1|||
143343450|NCT01572389|516802538|FG000|Overall Study|Death|1|||
143343451|NCT01572389|516802539|FG001|Overall Study|Death|3|||
143343452|NCT01572389|516802538|FG000|Overall Study|Withdrawal by Subject|14|||
143343453|NCT01572389|516802539|FG001|Overall Study|Withdrawal by Subject|2|||
143343454|NCT01572389|516802538|FG000|Overall Study|Lost to Follow-up|25|||
143230292|NCT02250326|516393196|FG002|Treatment|Withdrawal by Subject|4|||
143230293|NCT02250326|516393194|FG000|Treatment|Other reasons|8|||
143230294|NCT02250326|516393195|FG001|Treatment|Other reasons|7|||
143230295|NCT02250326|516393196|FG002|Treatment|Other reasons|7|||
143230296|NCT02250326|516393194|FG000|Extension Period|Progressive Disease|0|||
143230297|NCT02250326|516393195|FG001|Extension Period|Progressive Disease|2|||
143230298|NCT02250326|516393196|FG002|Extension Period|Progressive Disease|0|||
143230299|NCT02250326|516393194|FG000|Extension Period|Withdrawal by Subject|0|||
143230300|NCT02250326|516393195|FG001|Extension Period|Withdrawal by Subject|1|||
143230301|NCT02250326|516393196|FG002|Extension Period|Withdrawal by Subject|0|||
143230302|NCT02250326|516393194|FG000|Extension Period|Withdrawal by investigator|0|||
143230303|NCT02250326|516393195|FG001|Extension Period|Withdrawal by investigator|1|||
143230304|NCT02250326|516393196|FG002|Extension Period|Withdrawal by investigator|0|||
143230305|NCT04516746|516393199|FG000|Overall Study|Randomized but not Treated|51|||
143230306|NCT04516746|516393200|FG001|Overall Study|Randomized but not Treated|19|||
143230307|NCT04516746|516393199|FG000|Overall Study|Adverse Event|0|||
143230308|NCT04516746|516393200|FG001|Overall Study|Adverse Event|1|||
143230309|NCT04516746|516393199|FG000|Overall Study|Death|62|||
143230310|NCT04516746|516393200|FG001|Overall Study|Death|32|||
143230311|NCT04516746|516393199|FG000|Overall Study|Lost to Follow-up|3431|||
143343455|NCT01572389|516802539|FG001|Overall Study|Lost to Follow-up|14|||
143343456|NCT01572389|516802538|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
143368923|NCT02001623|516894565|FG007|Overall Study|Disease Progression|3|||
143230312|NCT04516746|516393200|FG001|Overall Study|Lost to Follow-up|1831|||
143343457|NCT01572389|516802539|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
143343458|NCT02424591|516802540|FG000|Overall Study|Protocol Violation|2|||
143343459|NCT02424591|516802541|FG001|Overall Study|Protocol Violation|3|||
143343460|NCT00954733|516802550|FG000|Overall Study|blood gas machine did not work|1|||
143343461|NCT03579290|516802551|FG000|Overall Study|Lost to Follow-up|9|||
143343462|NCT04581200|516802552|FG000|Overall Study|Lost to Follow-up|6|||
143343463|NCT04581200|516802553|FG001|Overall Study|Lost to Follow-up|5|||
143343464|NCT02914314|516802556|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
143343465|NCT02914314|516802557|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
143343466|NCT02914314|516802558|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
143230313|NCT04516746|516393199|FG000|Overall Study|Withdrawal by Subject|1946|||
143230314|NCT04516746|516393200|FG001|Overall Study|Withdrawal by Subject|1696|||
143230315|NCT04516746|516393199|FG000|Overall Study|Physician Decision|10|||
143230316|NCT04516746|516393200|FG001|Overall Study|Physician Decision|8|||
143230317|NCT04516746|516393199|FG000|Overall Study|Other|35|||
143230318|NCT04516746|516393200|FG001|Overall Study|Other|16|||
143230319|NCT01751061|516393201|FG000|Overall Study|Death|1|||
143230320|NCT01751061|516393202|FG001|Overall Study|Death|0|||
143230321|NCT01751061|516393201|FG000|Overall Study|patient death|5|||
143230322|NCT01751061|516393202|FG001|Overall Study|patient death|0|||
143230323|NCT01751061|516393201|FG000|Overall Study|Lost to Follow-up|40|||
143230324|NCT01751061|516393202|FG001|Overall Study|Lost to Follow-up|25|||
143230325|NCT01751061|516393201|FG000|Overall Study|patient regained decisional capacity|4|||
143230326|NCT01751061|516393202|FG001|Overall Study|patient regained decisional capacity|8|||
143230327|NCT01751061|516393201|FG000|Overall Study|Withdrawal by Subject|4|||
143230328|NCT01751061|516393202|FG001|Overall Study|Withdrawal by Subject|1|||
143230329|NCT01751061|516393201|FG000|Overall Study|Physician Decision|2|||
143343467|NCT02914314|516802559|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
143343468|NCT02914314|516802556|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
143343469|NCT02914314|516802557|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
143343470|NCT02914314|516802558|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
143343471|NCT02914314|516802559|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
143343472|NCT02914314|516802556|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
143343473|NCT02914314|516802557|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
143343474|NCT02914314|516802558|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
143343475|NCT02914314|516802559|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
143343476|NCT02914314|516802556|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
143343477|NCT02914314|516802557|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
143343478|NCT02914314|516802558|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
143343479|NCT02914314|516802559|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
143343480|NCT02914314|516802556|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
143230330|NCT01751061|516393202|FG001|Overall Study|Physician Decision|0|||
143230331|NCT02153086|516393204|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
143343481|NCT02914314|516802557|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
143343482|NCT02914314|516802558|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
143343483|NCT02914314|516802559|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
143343484|NCT01859793|516802562|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
143343485|NCT01859793|516802563|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
143343486|NCT01859793|516802562|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
143343487|NCT01859793|516802563|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
143343488|NCT01859793|516802562|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
143343489|NCT01859793|516802563|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
143343490|NCT01859793|516802562|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
143343491|NCT01859793|516802563|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
143343492|NCT01597505|516802572|FG000|Overall Study|Physician Decision|5|||
143343493|NCT01597505|516802573|FG001|Overall Study|Physician Decision|0|||
143343494|NCT01597505|516802572|FG000|Overall Study|Adverse Event|19|||
143343495|NCT01597505|516802573|FG001|Overall Study|Adverse Event|7|||
143343496|NCT01597505|516802572|FG000|Overall Study|Lost to Follow-up|4|||
143343497|NCT01597505|516802573|FG001|Overall Study|Lost to Follow-up|2|||
143343498|NCT01597505|516802572|FG000|Overall Study|Withdrawal by Subject|10|||
143343499|NCT01597505|516802573|FG001|Overall Study|Withdrawal by Subject|18|||
143343500|NCT01597505|516802572|FG000|Overall Study|Other|5|||
143343501|NCT01597505|516802573|FG001|Overall Study|Other|6|||
143343502|NCT01597505|516802572|FG000|Overall Study|Missing|1|||
143456241|NCT00432666|517215795|FG000|Main Period|Adverse Event|1|||
143230332|NCT02153086|516393204|FG000|Overall Study|Other|2|||
143343503|NCT01597505|516802573|FG001|Overall Study|Missing|0|||
143343504|NCT05375955|516802574|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
143343505|NCT05375955|516802575|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
143343506|NCT05375955|516802576|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
143343507|NCT05375955|516802577|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
143230333|NCT00446849|516393205|FG000|Acute Phase|Lack of Efficacy|64|||
143343508|NCT05375955|516802578|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
143343509|NCT05375955|516802579|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
143343510|NCT05375955|516802580|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
143343511|NCT05375955|516802574|FG000|Treatment (12 Weeks)|Physician Decision|4|||
143343512|NCT05375955|516802575|FG001|Treatment (12 Weeks)|Physician Decision|1|||
143343513|NCT05375955|516802576|FG002|Treatment (12 Weeks)|Physician Decision|3|||
143343514|NCT05375955|516802577|FG003|Treatment (12 Weeks)|Physician Decision|0|||
143343515|NCT05375955|516802578|FG004|Treatment (12 Weeks)|Physician Decision|0|||
143343516|NCT05375955|516802579|FG005|Treatment (12 Weeks)|Physician Decision|1|||
143343517|NCT05375955|516802580|FG006|Treatment (12 Weeks)|Physician Decision|0|||
143343518|NCT05375955|516802574|FG000|Treatment (12 Weeks)|Other|0|||
143343519|NCT05375955|516802575|FG001|Treatment (12 Weeks)|Other|1|||
143343520|NCT05375955|516802576|FG002|Treatment (12 Weeks)|Other|0|||
143343521|NCT05375955|516802577|FG003|Treatment (12 Weeks)|Other|0|||
143343522|NCT05375955|516802578|FG004|Treatment (12 Weeks)|Other|0|||
143343523|NCT05375955|516802579|FG005|Treatment (12 Weeks)|Other|0|||
143343524|NCT05375955|516802580|FG006|Treatment (12 Weeks)|Other|0|||
143343525|NCT05375955|516802574|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
143343526|NCT05375955|516802575|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
143343527|NCT05375955|516802576|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
143343528|NCT05375955|516802577|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
143343529|NCT05375955|516802578|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
143343530|NCT05375955|516802579|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
143343531|NCT05375955|516802580|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
143343532|NCT05375955|516802574|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
143343533|NCT05375955|516802575|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
143343534|NCT05375955|516802576|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
143343535|NCT05375955|516802577|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
143343536|NCT05375955|516802578|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
143343537|NCT05375955|516802579|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
143343538|NCT05375955|516802580|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
143343539|NCT05375955|516802574|FG000|Treatment (12 Weeks)|Pregnancy|0|||
143343540|NCT05375955|516802575|FG001|Treatment (12 Weeks)|Pregnancy|0|||
143343541|NCT05375955|516802576|FG002|Treatment (12 Weeks)|Pregnancy|1|||
143343542|NCT05375955|516802577|FG003|Treatment (12 Weeks)|Pregnancy|0|||
143343543|NCT05375955|516802578|FG004|Treatment (12 Weeks)|Pregnancy|0|||
143343544|NCT05375955|516802579|FG005|Treatment (12 Weeks)|Pregnancy|0|||
143343545|NCT05375955|516802580|FG006|Treatment (12 Weeks)|Pregnancy|0|||
143343546|NCT05375955|516802574|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
143343547|NCT05375955|516802575|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
143343548|NCT05375955|516802576|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
143343549|NCT05375955|516802577|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
143343550|NCT05375955|516802578|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
143343551|NCT05375955|516802579|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
143343552|NCT05375955|516802580|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
143343553|NCT05375955|516802574|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
143343554|NCT05375955|516802575|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
143343555|NCT05375955|516802576|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
143343556|NCT05375955|516802577|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
143343557|NCT05375955|516802578|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
143343558|NCT05375955|516802579|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
143343559|NCT05375955|516802580|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
143343560|NCT05375955|516802574|FG000|Follow-up (up to 5 Weeks)|Other|0|||
143343561|NCT05375955|516802575|FG001|Follow-up (up to 5 Weeks)|Other|1|||
143343562|NCT05375955|516802576|FG002|Follow-up (up to 5 Weeks)|Other|0|||
143343563|NCT05375955|516802577|FG003|Follow-up (up to 5 Weeks)|Other|0|||
143343564|NCT05375955|516802578|FG004|Follow-up (up to 5 Weeks)|Other|0|||
143343565|NCT05375955|516802579|FG005|Follow-up (up to 5 Weeks)|Other|0|||
143343566|NCT05375955|516802580|FG006|Follow-up (up to 5 Weeks)|Other|0|||
143343567|NCT05375955|516802574|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
143343568|NCT05375955|516802575|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
143343569|NCT05375955|516802576|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
143343570|NCT05375955|516802577|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
143343571|NCT05375955|516802578|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
143343572|NCT05375955|516802579|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
143343573|NCT05375955|516802580|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
143343574|NCT05375955|516802574|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
143343575|NCT05375955|516802575|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
143343576|NCT05375955|516802576|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
143343577|NCT05375955|516802577|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
143343578|NCT05375955|516802578|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
143343579|NCT05375955|516802579|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
143004297|NCT01740297|515554682|FG000|Overall Study|Death|8|||
143343580|NCT05375955|516802580|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
143343581|NCT05454410|516802581|FG000|Overall Study|Withdrawal by Subject|0|||
143343582|NCT05454410|516802582|FG001|Overall Study|Withdrawal by Subject|0|||
143343583|NCT05454410|516802583|FG002|Overall Study|Withdrawal by Subject|1|||
143343584|NCT05454410|516802584|FG003|Overall Study|Withdrawal by Subject|1|||
143343585|NCT05004688|516802585|FG000|Overall Study|Protocol Violation|7|||
143343586|NCT05004688|516802585|FG000|Overall Study|Physician Decision|2|||
143343587|NCT05004688|516802585|FG000|Overall Study|Withdrawal by Subject|2|||
143343588|NCT00895622|516802586|FG000|Overall Study|Protocol Violation|5|||
143343589|NCT00895622|516802587|FG001|Overall Study|Protocol Violation|4|||
143343590|NCT00895622|516802588|FG002|Overall Study|Protocol Violation|4|||
143343591|NCT03879408|516802589|FG000|Overall Study|Lost to Follow-up|0|||
143343592|NCT03879408|516802590|FG001|Overall Study|Lost to Follow-up|3|||
143343593|NCT03879408|516802591|FG002|Overall Study|Lost to Follow-up|2|||
143343594|NCT03879408|516802592|FG003|Overall Study|Lost to Follow-up|1|||
143343595|NCT03879408|516802593|FG004|Overall Study|Lost to Follow-up|0|||
143343596|NCT03879408|516802589|FG000|Overall Study|Withdrawal by Subject|2|||
143343597|NCT03879408|516802590|FG001|Overall Study|Withdrawal by Subject|1|||
143343598|NCT03879408|516802591|FG002|Overall Study|Withdrawal by Subject|1|||
143343599|NCT03879408|516802592|FG003|Overall Study|Withdrawal by Subject|0|||
143343600|NCT03879408|516802593|FG004|Overall Study|Withdrawal by Subject|1|||
143343601|NCT05158296|516802599|FG000|Overall Study|Sponsor Decision|2|||
143343602|NCT05158296|516802600|FG001|Overall Study|Sponsor Decision|3|||
143343603|NCT05158296|516802601|FG002|Overall Study|Sponsor Decision|2|||
143343604|NCT02010632|516802605|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
143343605|NCT02010632|516802606|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
143343606|NCT00652938|516802610|FG000|Overall Study|Adverse Event|1|||
143343607|NCT00652938|516802611|FG001|Overall Study|Adverse Event|0|||
143343608|NCT00652938|516802612|FG002|Overall Study|Adverse Event|2|||
143343609|NCT00652938|516802610|FG000|Overall Study|Withdrawal by Subject|0|||
143343610|NCT00652938|516802611|FG001|Overall Study|Withdrawal by Subject|6|||
143343611|NCT00652938|516802612|FG002|Overall Study|Withdrawal by Subject|1|||
143343612|NCT00652938|516802610|FG000|Overall Study|Lost to Follow-up|0|||
143343613|NCT00652938|516802611|FG001|Overall Study|Lost to Follow-up|0|||
143343614|NCT00652938|516802612|FG002|Overall Study|Lost to Follow-up|2|||
143343615|NCT00652938|516802610|FG000|Overall Study|fear of blood sampling|0|||
143343616|NCT00652938|516802611|FG001|Overall Study|fear of blood sampling|1|||
143343617|NCT00652938|516802612|FG002|Overall Study|fear of blood sampling|0|||
143343618|NCT01412801|516802613|FG000|Overall Study|Death|0|||
143343619|NCT01412801|516802614|FG001|Overall Study|Death|1|||
143343620|NCT01412801|516802615|FG002|Overall Study|Death|0|||
143343621|NCT01412801|516802616|FG003|Overall Study|Death|4|||
143343622|NCT01412801|516802617|FG004|Overall Study|Death|2|||
143343623|NCT01412801|516802618|FG005|Overall Study|Death|2|||
143343624|NCT01412801|516802613|FG000|Overall Study|Lost to Follow-up|1|||
143343625|NCT01412801|516802614|FG001|Overall Study|Lost to Follow-up|2|||
143343626|NCT01412801|516802615|FG002|Overall Study|Lost to Follow-up|4|||
143343627|NCT01412801|516802616|FG003|Overall Study|Lost to Follow-up|0|||
143343628|NCT01412801|516802617|FG004|Overall Study|Lost to Follow-up|1|||
143343629|NCT01412801|516802618|FG005|Overall Study|Lost to Follow-up|1|||
143343630|NCT01412801|516802613|FG000|Overall Study|Withdrawal by Subject|3|||
143343631|NCT01412801|516802614|FG001|Overall Study|Withdrawal by Subject|2|||
143343632|NCT01412801|516802615|FG002|Overall Study|Withdrawal by Subject|1|||
143343633|NCT01412801|516802616|FG003|Overall Study|Withdrawal by Subject|0|||
143343634|NCT01412801|516802617|FG004|Overall Study|Withdrawal by Subject|0|||
143343635|NCT01412801|516802618|FG005|Overall Study|Withdrawal by Subject|0|||
143343636|NCT01412801|516802613|FG000|Overall Study|Relocated to another area|0|||
143343637|NCT01412801|516802614|FG001|Overall Study|Relocated to another area|0|||
143343638|NCT01412801|516802615|FG002|Overall Study|Relocated to another area|2|||
143343639|NCT01412801|516802616|FG003|Overall Study|Relocated to another area|0|||
143343640|NCT01412801|516802617|FG004|Overall Study|Relocated to another area|0|||
143343641|NCT01412801|516802618|FG005|Overall Study|Relocated to another area|0|||
143343642|NCT02272725|516802619|FG000|Overall Study|equipment malfunction|2|||
143343643|NCT02272725|516802620|FG001|Overall Study|equipment malfunction|0|||
143368924|NCT02001623|516894566|FG008|Overall Study|Disease Progression|7|||
143368925|NCT02001623|516894567|FG009|Overall Study|Disease Progression|40|||
143368926|NCT02001623|516894568|FG010|Overall Study|Disease Progression|5|||
143368927|NCT02001623|516894569|FG011|Overall Study|Disease Progression|9|||
143368928|NCT02001623|516894570|FG012|Overall Study|Disease Progression|9|||
143368929|NCT02001623|516894571|FG013|Overall Study|Disease Progression|20|||
143368930|NCT02001623|516894572|FG014|Overall Study|Disease Progression|9|||
143368931|NCT02001623|516894558|FG000|Overall Study|Physician Decision|0|||
143368932|NCT02001623|516894559|FG001|Overall Study|Physician Decision|0|||
143368933|NCT02001623|516894560|FG002|Overall Study|Physician Decision|0|||
143368934|NCT02001623|516894561|FG003|Overall Study|Physician Decision|0|||
143368935|NCT02001623|516894562|FG004|Overall Study|Physician Decision|0|||
143368936|NCT02001623|516894563|FG005|Overall Study|Physician Decision|0|||
143368937|NCT02001623|516894564|FG006|Overall Study|Physician Decision|0|||
143368938|NCT02001623|516894565|FG007|Overall Study|Physician Decision|0|||
143343644|NCT00975221|516804716|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
143343645|NCT00975221|516804717|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
143343646|NCT00975221|516804716|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
143343647|NCT00975221|516804717|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
143343648|NCT00975221|516804716|FG000|Titration Phase (Weeks 1-12)|Other|0|||
143343649|NCT00975221|516804717|FG001|Titration Phase (Weeks 1-12)|Other|1|||
143343650|NCT00975221|516804716|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
143343651|NCT00975221|516804717|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
143343652|NCT00975221|516804716|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
143343653|NCT00975221|516804717|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
143343654|NCT00975221|516804716|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
143343655|NCT00975221|516804717|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
143343656|NCT03610737|516804722|FG000|Overall Study|Withdrawal by Subject|1|||
143343657|NCT03610737|516804723|FG001|Overall Study|Withdrawal by Subject|5|||
143343658|NCT03610737|516804722|FG000|Overall Study|Death|1|||
143343659|NCT03610737|516804723|FG001|Overall Study|Death|0|||
143343660|NCT03610737|516804722|FG000|Overall Study|Not treated|5|||
143343661|NCT03610737|516804723|FG001|Overall Study|Not treated|2|||
143343662|NCT03610737|516804722|FG000|Overall Study|Missed Visit|1|||
143343663|NCT03610737|516804723|FG001|Overall Study|Missed Visit|2|||
143343664|NCT02013388|516804728|FG000|Overall Study|work emergency|1|||
143343665|NCT02013388|516804729|FG001|Overall Study|work emergency|0|||
143343666|NCT02013388|516804730|FG002|Overall Study|work emergency|0|||
143343667|NCT02013388|516804731|FG003|Overall Study|work emergency|0|||
143343668|NCT02013388|516804732|FG004|Overall Study|work emergency|1|||
143343669|NCT02013388|516804733|FG005|Overall Study|work emergency|0|||
143343670|NCT02013388|516804734|FG006|Overall Study|work emergency|0|||
143343671|NCT02013388|516804735|FG007|Overall Study|work emergency|0|||
143343672|NCT03243422|516804736|FG000|Overall Study|Death|20|||
143343673|NCT03243422|516804737|FG001|Overall Study|Death|21|||
143343674|NCT03243422|516804736|FG000|Overall Study|Lost to Follow-up|9|||
143343675|NCT03243422|516804737|FG001|Overall Study|Lost to Follow-up|21|||
143343676|NCT03243422|516804736|FG000|Overall Study|Withdrawal by Subject|22|||
143343677|NCT03243422|516804737|FG001|Overall Study|Withdrawal by Subject|8|||
143343678|NCT00215540|516804741|FG000|Overall Study|Withdrew from study medication|1|||
143343679|NCT00215540|516804742|FG001|Overall Study|Withdrew from study medication|0|||
143343680|NCT00215540|516804743|FG002|Overall Study|Withdrew from study medication|0|||
143343681|NCT03145766|516804744|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
143343682|NCT03145766|516804745|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
143343683|NCT03145766|516804746|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
143343684|NCT03145766|516804747|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
143343685|NCT03145766|516804748|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
143343686|NCT03145766|516804744|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
143343687|NCT03145766|516804745|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
143343688|NCT03145766|516804746|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
143343689|NCT03145766|516804747|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
143343690|NCT03145766|516804748|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
143343691|NCT03145766|516804744|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
143343692|NCT03145766|516804745|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
143343693|NCT03145766|516804746|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
143343694|NCT03145766|516804747|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
143343695|NCT03145766|516804748|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
143343696|NCT03145766|516804744|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
143343697|NCT03145766|516804745|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
143343698|NCT03145766|516804746|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
143343699|NCT03145766|516804747|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
143343700|NCT03145766|516804748|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
143343701|NCT03145766|516804744|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
143343702|NCT03145766|516804745|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
143343703|NCT03145766|516804746|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
143343704|NCT03145766|516804747|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
143343705|NCT03145766|516804748|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
143343706|NCT03145766|516804744|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
143343707|NCT03145766|516804745|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
143343708|NCT03145766|516804746|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
143343709|NCT03145766|516804747|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
143343710|NCT03145766|516804748|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
143004298|NCT01740297|515554683|FG001|Overall Study|Death|46|||
143343711|NCT03145766|516804744|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
143343712|NCT03145766|516804745|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
143343713|NCT03145766|516804746|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
143343714|NCT03145766|516804747|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
143343715|NCT03145766|516804748|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
143343716|NCT02801669|516804750|FG000|Overall Study|Death|66|||
143343717|NCT02801669|516804751|FG001|Overall Study|Death|69|||
143343718|NCT02801669|516804750|FG000|Overall Study|Withdrawal by Subject|81|||
143343719|NCT02801669|516804751|FG001|Overall Study|Withdrawal by Subject|77|||
143343720|NCT02801669|516804750|FG000|Overall Study|Other|4|||
143343721|NCT02801669|516804751|FG001|Overall Study|Other|6|||
143343722|NCT00674570|516804752|FG000|Overall Study|Withdrawal by Subject|0|||
143343723|NCT00674570|516804753|FG001|Overall Study|Withdrawal by Subject|2|||
143343724|NCT00674570|516804754|FG002|Overall Study|Withdrawal by Subject|0|||
143343725|NCT04461795|516804755|FG000|Overall Study|Lost to Follow-up|2|||
143343726|NCT04461795|516804755|FG000|Overall Study|Withdrawal by Subject|2|||
143343727|NCT04461795|516804755|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
143343728|NCT00615264|516804756|FG000|Overall Study|Withdrawal by Subject|17|||
143343729|NCT00615264|516804757|FG001|Overall Study|Withdrawal by Subject|19|||
143343730|NCT00615264|516804756|FG000|Overall Study|Lost to Follow-up|6|||
143343731|NCT00615264|516804757|FG001|Overall Study|Lost to Follow-up|13|||
143343732|NCT00615264|516804756|FG000|Overall Study|Adverse Event|8|||
143343733|NCT00615264|516804757|FG001|Overall Study|Adverse Event|5|||
143343734|NCT00615264|516804756|FG000|Overall Study|Death|1|||
143343735|NCT00615264|516804757|FG001|Overall Study|Death|1|||
143343736|NCT00615264|516804756|FG000|Overall Study|Protocol Violation|11|||
143343737|NCT00615264|516804757|FG001|Overall Study|Protocol Violation|7|||
143343738|NCT00615264|516804756|FG000|Overall Study|Not defined|7|||
143343739|NCT00615264|516804757|FG001|Overall Study|Not defined|4|||
143343740|NCT00615264|516804756|FG000|Overall Study|Dermal Hypersensitivity|0|||
143343741|NCT00615264|516804757|FG001|Overall Study|Dermal Hypersensitivity|3|||
143343742|NCT00638235|516804764|FG000|Overall Study|Lost to Follow-up|31|||
143343743|NCT00638235|516804765|FG001|Overall Study|Lost to Follow-up|3|||
143343744|NCT00638235|516804766|FG002|Overall Study|Lost to Follow-up|18|||
143343745|NCT00638235|516804767|FG003|Overall Study|Lost to Follow-up|10|||
143343746|NCT00638235|516804768|FG004|Overall Study|Lost to Follow-up|13|||
143343747|NCT00638235|516804769|FG005|Overall Study|Lost to Follow-up|26|||
143343748|NCT00638235|516804770|FG006|Overall Study|Lost to Follow-up|0|||
143343749|NCT00638235|516804771|FG007|Overall Study|Lost to Follow-up|1|||
143343750|NCT00638235|516804772|FG008|Overall Study|Lost to Follow-up|18|||
143343751|NCT03587142|516804773|FG000|Overall Study|Lost to Follow-up|5|||
143343752|NCT03587142|516804774|FG001|Overall Study|Lost to Follow-up|3|||
143343753|NCT03587142|516804773|FG000|Overall Study|Did not complete the f4 visit|3|||
143343754|NCT03587142|516804774|FG001|Overall Study|Did not complete the f4 visit|7|||
143343755|NCT03673462|516804775|FG000|Overall Study|Adverse Event|11|||
143343756|NCT03673462|516804776|FG001|Overall Study|Adverse Event|1|||
143343757|NCT03673462|516804775|FG000|Overall Study|Protocol Violation|25|||
143343758|NCT03673462|516804776|FG001|Overall Study|Protocol Violation|11|||
143343759|NCT03673462|516804775|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
143343760|NCT03673462|516804776|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
143343761|NCT03673462|516804775|FG000|Overall Study|Lost to Follow-up|102|||
143343762|NCT03673462|516804776|FG001|Overall Study|Lost to Follow-up|19|||
143343763|NCT01800201|516804777|FG000|Overall Study|Withdrawal by Subject|2|||
143343764|NCT01800201|516804778|FG001|Overall Study|Withdrawal by Subject|0|||
143343765|NCT01800201|516804777|FG000|Overall Study|patient privacy concerns|1|||
143343766|NCT01800201|516804778|FG001|Overall Study|patient privacy concerns|1|||
143343767|NCT01800201|516804777|FG000|Overall Study|did not want to use device|0|||
143343768|NCT01800201|516804778|FG001|Overall Study|did not want to use device|1|||
143343769|NCT01800201|516804777|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
143343770|NCT01800201|516804778|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
143343771|NCT05061537|516804784|FG000|Treatment Phase|Progressive disease|0|||
143343772|NCT05061537|516804785|FG001|Treatment Phase|Progressive disease|1|||
143343773|NCT05061537|516804786|FG002|Treatment Phase|Progressive disease|2|||
143343774|NCT05061537|516804787|FG003|Treatment Phase|Progressive disease|0|||
143343775|NCT05061537|516804788|FG004|Treatment Phase|Progressive disease|0|||
143343776|NCT05061537|516804784|FG000|Treatment Phase|Adverse Event|0|||
143343777|NCT05061537|516804785|FG001|Treatment Phase|Adverse Event|0|||
143004299|NCT01740297|515554684|FG002|Overall Study|Death|40|||
143343778|NCT05061537|516804786|FG002|Treatment Phase|Adverse Event|2|||
143343779|NCT05061537|516804787|FG003|Treatment Phase|Adverse Event|0|||
143343780|NCT05061537|516804788|FG004|Treatment Phase|Adverse Event|0|||
143343781|NCT05061537|516804784|FG000|Treatment Phase|Global deterioration of health status|0|||
143343782|NCT05061537|516804785|FG001|Treatment Phase|Global deterioration of health status|1|||
143343783|NCT05061537|516804786|FG002|Treatment Phase|Global deterioration of health status|0|||
143343784|NCT05061537|516804787|FG003|Treatment Phase|Global deterioration of health status|0|||
143004300|NCT01740297|515554682|FG000|Overall Study|Lost to Follow-up|1|||
143343785|NCT05061537|516804788|FG004|Treatment Phase|Global deterioration of health status|0|||
143343786|NCT05061537|516804784|FG000|Follow up|Other|2|||
143343787|NCT05061537|516804785|FG001|Follow up|Other|0|||
143343788|NCT05061537|516804786|FG002|Follow up|Other|2|||
143343789|NCT05061537|516804787|FG003|Follow up|Other|0|||
143343790|NCT05061537|516804788|FG004|Follow up|Other|0|||
143343791|NCT05061537|516804784|FG000|Follow up|Study terminated by sponsor|0|||
143343792|NCT05061537|516804785|FG001|Follow up|Study terminated by sponsor|0|||
143343793|NCT05061537|516804786|FG002|Follow up|Study terminated by sponsor|2|||
143343794|NCT05061537|516804787|FG003|Follow up|Study terminated by sponsor|0|||
143343795|NCT05061537|516804788|FG004|Follow up|Study terminated by sponsor|0|||
143343796|NCT05061537|516804784|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
143343797|NCT05061537|516804785|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
143343798|NCT05061537|516804786|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
143343799|NCT05061537|516804787|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
143343800|NCT05061537|516804788|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
143343801|NCT05061537|516804784|FG000|Long-term Follow-up|Death|0|||
143343802|NCT05061537|516804785|FG001|Long-term Follow-up|Death|1|||
143343803|NCT05061537|516804786|FG002|Long-term Follow-up|Death|0|||
143343804|NCT05061537|516804787|FG003|Long-term Follow-up|Death|0|||
143343805|NCT05061537|516804788|FG004|Long-term Follow-up|Death|0|||
143343806|NCT04503096|516804791|FG000|Overall Study|Withdrawal by Subject|3|||
143343807|NCT02343003|516804792|FG000|Overall Study|Withdrawal by Subject|9|||
143343808|NCT02343003|516804793|FG001|Overall Study|Withdrawal by Subject|4|||
143343809|NCT02343003|516804792|FG000|Overall Study|Lost to Follow-up|5|||
143343810|NCT02343003|516804793|FG001|Overall Study|Lost to Follow-up|1|||
143343811|NCT02343003|516804792|FG000|Overall Study|Protocol Violation|1|||
143343812|NCT02343003|516804793|FG001|Overall Study|Protocol Violation|0|||
143343813|NCT02343003|516804792|FG000|Overall Study|Death|0|||
143343814|NCT02343003|516804793|FG001|Overall Study|Death|1|||
143343815|NCT02343003|516804792|FG000|Overall Study|exclusion criteria met|1|||
143343816|NCT02343003|516804793|FG001|Overall Study|exclusion criteria met|1|||
143343817|NCT02343003|516804792|FG000|Overall Study|terminated by sponsor|2|||
143343818|NCT02343003|516804793|FG001|Overall Study|terminated by sponsor|0|||
143343819|NCT02281760|516804794|FG000|Overall Study|Withdrawal by Subject|1|||
143343820|NCT02635724|516804795|FG000|Overall Study|Withdrawal by Subject|0|||
143343821|NCT02635724|516804796|FG001|Overall Study|Withdrawal by Subject|1|||
143343822|NCT02635724|516804797|FG002|Overall Study|Withdrawal by Subject|0|||
143343823|NCT01576367|516804802|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
143343824|NCT01576367|516804802|FG000|Overall Study|Moved to commercial use after 6 months|1|||
143343825|NCT00770432|516804805|FG000|Overall Study|Other|4|||
143343826|NCT00770432|516804806|FG001|Overall Study|Other|6|||
143343827|NCT00770432|516804805|FG000|Overall Study|Non-compliance|0|||
143343828|NCT00770432|516804806|FG001|Overall Study|Non-compliance|1|||
143343829|NCT00312702|516804807|FG000|Immunization Phase|Lost to Follow-up|0|||
143343830|NCT00312702|516804808|FG001|Immunization Phase|Lost to Follow-up|1|||
143343831|NCT00312702|516804809|FG002|Immunization Phase|Lost to Follow-up|0|||
143343832|NCT03528174|516804814|FG000|Overall Study|Adverse Event|1|||
143343833|NCT03528174|516804814|FG000|Overall Study|sensors dislodged|1|||
143343834|NCT00979602|516804819|FG000|Overall Study|Serious Adverse Event|5|||
143343835|NCT00979602|516804820|FG001|Overall Study|Serious Adverse Event|3|||
143343836|NCT00979602|516804819|FG000|Overall Study|Protocol Violation|3|||
143343837|NCT00979602|516804820|FG001|Overall Study|Protocol Violation|0|||
143343838|NCT00979602|516804819|FG000|Overall Study|Withdrawal by Subject|31|||
143343839|NCT00979602|516804820|FG001|Overall Study|Withdrawal by Subject|25|||
143343840|NCT00979602|516804819|FG000|Overall Study|Lost to Follow-up|100|||
143343841|NCT00979602|516804820|FG001|Overall Study|Lost to Follow-up|96|||
143343842|NCT00979602|516804819|FG000|Overall Study|Migrated/moved from study area|3|||
143343843|NCT00979602|516804820|FG001|Overall Study|Migrated/moved from study area|6|||
143343844|NCT00979602|516804819|FG000|Overall Study|Others|3|||
143343845|NCT00979602|516804820|FG001|Overall Study|Others|3|||
143343846|NCT02712398|516804821|FG000|Overall Study|Withdrawal by Subject|6|||
143343847|NCT02712398|516804821|FG000|Overall Study|Lost to Follow-up|6|||
143343848|NCT02712398|516804821|FG000|Overall Study|Sponsor Decision|1|||
143343849|NCT02712398|516804821|FG000|Overall Study|Physician Decision|1|||
143343850|NCT02712398|516804821|FG000|Overall Study|Death|2|||
143343851|NCT02712398|516804821|FG000|Overall Study|Re-operation|21|||
143343852|NCT04146896|516804831|FG000|Overall Study|Adverse Event|5|||
143343853|NCT04146896|516804832|FG001|Overall Study|Adverse Event|8|||
143343854|NCT04146896|516804831|FG000|Overall Study|Lack of Efficacy|3|||
143343855|NCT04146896|516804832|FG001|Overall Study|Lack of Efficacy|2|||
143343856|NCT04146896|516804831|FG000|Overall Study|Lost to Follow-up|0|||
143343857|NCT04146896|516804832|FG001|Overall Study|Lost to Follow-up|1|||
143343858|NCT04146896|516804831|FG000|Overall Study|Non-compliance|5|||
143343859|NCT04146896|516804832|FG001|Overall Study|Non-compliance|4|||
143343860|NCT04146896|516804831|FG000|Overall Study|Withdrawal by Subject|3|||
143343861|NCT04146896|516804832|FG001|Overall Study|Withdrawal by Subject|5|||
143343862|NCT04146896|516804831|FG000|Overall Study|Randomized in error|1|||
143343863|NCT04146896|516804832|FG001|Overall Study|Randomized in error|2|||
143343864|NCT04296890|516804834|FG000|Overall Study|Withdrawal by Subject|1|||
143343865|NCT04296890|516804834|FG000|Overall Study|Death|62|||
143343866|NCT04296890|516804834|FG000|Overall Study|Lost to Follow-up|3|||
143343867|NCT04296890|516804834|FG000|Overall Study|Other than specified|2|||
143343868|NCT03787680|516804835|FG000|Overall Study|Physician Decision|2|||
143343869|NCT03787680|516804836|FG001|Overall Study|Physician Decision|3|||
143343870|NCT03787680|516804835|FG000|Overall Study|Adverse Event|7|||
143343871|NCT03787680|516804836|FG001|Overall Study|Adverse Event|3|||
143343872|NCT03787680|516804835|FG000|Overall Study|Withdrawal by Subject|2|||
143343873|NCT03787680|516804836|FG001|Overall Study|Withdrawal by Subject|1|||
143343874|NCT03724396|516804839|FG000|Overall Study|Lost to Follow-up|1|||
143343875|NCT03724396|516804840|FG001|Overall Study|Lost to Follow-up|1|||
143343876|NCT03724396|516804839|FG000|Overall Study|Withdrawal by Subject|1|||
143343877|NCT03724396|516804840|FG001|Overall Study|Withdrawal by Subject|0|||
143343878|NCT01490125|516804841|FG000|Period I|Adverse Event|4|||
143343879|NCT01490125|516804842|FG001|Period I|Adverse Event|1|||
143343880|NCT01490125|516804843|FG002|Period I|Adverse Event|1|||
143343881|NCT01490125|516804844|FG003|Period I|Adverse Event|3|||
143343882|NCT01490125|516804845|FG004|Period I|Adverse Event|2|||
143343883|NCT01490125|516804846|FG005|Period I|Adverse Event|4|||
143343884|NCT01490125|516804841|FG000|Period I|Protocol Violation|1|||
143343885|NCT01490125|516804842|FG001|Period I|Protocol Violation|1|||
143343886|NCT01490125|516804843|FG002|Period I|Protocol Violation|1|||
143343887|NCT01490125|516804844|FG003|Period I|Protocol Violation|1|||
143343888|NCT01490125|516804845|FG004|Period I|Protocol Violation|0|||
143343889|NCT01490125|516804846|FG005|Period I|Protocol Violation|0|||
143343890|NCT01490125|516804841|FG000|Period I|Withdrawal by Subject|1|||
143343891|NCT01490125|516804842|FG001|Period I|Withdrawal by Subject|3|||
143343892|NCT01490125|516804843|FG002|Period I|Withdrawal by Subject|2|||
143343893|NCT01490125|516804844|FG003|Period I|Withdrawal by Subject|1|||
143343894|NCT01490125|516804845|FG004|Period I|Withdrawal by Subject|2|||
143343895|NCT01490125|516804846|FG005|Period I|Withdrawal by Subject|1|||
143343896|NCT01490125|516804841|FG000|Period II|Adverse Event|2|||
143343897|NCT01490125|516804842|FG001|Period II|Adverse Event|3|||
143343898|NCT01490125|516804843|FG002|Period II|Adverse Event|2|||
143343899|NCT01490125|516804844|FG003|Period II|Adverse Event|2|||
143343900|NCT01490125|516804845|FG004|Period II|Adverse Event|4|||
143343901|NCT01490125|516804846|FG005|Period II|Adverse Event|2|||
143343902|NCT01490125|516804841|FG000|Period II|Protocol Violation|0|||
143343903|NCT01490125|516804842|FG001|Period II|Protocol Violation|0|||
143343904|NCT01490125|516804843|FG002|Period II|Protocol Violation|1|||
143343905|NCT01490125|516804844|FG003|Period II|Protocol Violation|1|||
143343906|NCT01490125|516804845|FG004|Period II|Protocol Violation|0|||
143343907|NCT01490125|516804846|FG005|Period II|Protocol Violation|0|||
143343908|NCT01490125|516804841|FG000|Period II|Lost to Follow-up|0|||
143343909|NCT01490125|516804842|FG001|Period II|Lost to Follow-up|1|||
143343910|NCT01490125|516804843|FG002|Period II|Lost to Follow-up|0|||
143343911|NCT01490125|516804844|FG003|Period II|Lost to Follow-up|0|||
143343912|NCT01490125|516804845|FG004|Period II|Lost to Follow-up|0|||
143343913|NCT01490125|516804846|FG005|Period II|Lost to Follow-up|0|||
143343914|NCT01490125|516804841|FG000|Period II|Withdrawal by Subject|1|||
143343915|NCT01490125|516804842|FG001|Period II|Withdrawal by Subject|0|||
143343916|NCT01490125|516804843|FG002|Period II|Withdrawal by Subject|0|||
143343917|NCT01490125|516804844|FG003|Period II|Withdrawal by Subject|0|||
143343918|NCT01490125|516804845|FG004|Period II|Withdrawal by Subject|0|||
143343919|NCT01490125|516804846|FG005|Period II|Withdrawal by Subject|0|||
143343920|NCT01490125|516804841|FG000|Period III|Adverse Event|3|||
143343921|NCT01490125|516804842|FG001|Period III|Adverse Event|1|||
143343922|NCT01490125|516804843|FG002|Period III|Adverse Event|0|||
143343923|NCT01490125|516804844|FG003|Period III|Adverse Event|1|||
143343924|NCT01490125|516804845|FG004|Period III|Adverse Event|0|||
143343925|NCT01490125|516804846|FG005|Period III|Adverse Event|0|||
143343926|NCT01490125|516804841|FG000|Period III|Death|0|||
143343927|NCT01490125|516804842|FG001|Period III|Death|0|||
143343928|NCT01490125|516804843|FG002|Period III|Death|0|||
143343929|NCT01490125|516804844|FG003|Period III|Death|1|||
143343930|NCT01490125|516804845|FG004|Period III|Death|0|||
143343931|NCT01490125|516804846|FG005|Period III|Death|0|||
143343932|NCT01490125|516804841|FG000|Period III|Lack of Efficacy|0|||
143343933|NCT01490125|516804842|FG001|Period III|Lack of Efficacy|0|||
143343934|NCT01490125|516804843|FG002|Period III|Lack of Efficacy|0|||
143343935|NCT01490125|516804844|FG003|Period III|Lack of Efficacy|0|||
143343936|NCT01490125|516804845|FG004|Period III|Lack of Efficacy|1|||
143343937|NCT01490125|516804846|FG005|Period III|Lack of Efficacy|0|||
143343938|NCT02237508|516804847|FG000|Overall Study|Withdrawal by Subject|0|||
143343939|NCT02237508|516804848|FG001|Overall Study|Withdrawal by Subject|2|||
143343940|NCT02237508|516804849|FG002|Overall Study|Withdrawal by Subject|0|||
143343941|NCT02237508|516804850|FG003|Overall Study|Withdrawal by Subject|1|||
143343942|NCT02237508|516804851|FG004|Overall Study|Withdrawal by Subject|0|||
143343943|NCT02237508|516804852|FG005|Overall Study|Withdrawal by Subject|1|||
143343944|NCT02237508|516804853|FG006|Overall Study|Withdrawal by Subject|1|||
143343945|NCT02237508|516804854|FG007|Overall Study|Withdrawal by Subject|0|||
143368939|NCT02001623|516894566|FG008|Overall Study|Physician Decision|3|||
143456242|NCT00432666|517215796|FG001|Main Period|Adverse Event|1|||
143343946|NCT02237508|516804855|FG008|Overall Study|Withdrawal by Subject|1|||
143343947|NCT02237508|516804856|FG009|Overall Study|Withdrawal by Subject|0|||
143343948|NCT02237508|516804847|FG000|Overall Study|Physician Decision|0|||
143343949|NCT02237508|516804848|FG001|Overall Study|Physician Decision|1|||
143343950|NCT02237508|516804849|FG002|Overall Study|Physician Decision|0|||
143343951|NCT02237508|516804850|FG003|Overall Study|Physician Decision|0|||
143343952|NCT02237508|516804851|FG004|Overall Study|Physician Decision|0|||
143343953|NCT02237508|516804852|FG005|Overall Study|Physician Decision|0|||
143343954|NCT02237508|516804853|FG006|Overall Study|Physician Decision|0|||
143343955|NCT02237508|516804854|FG007|Overall Study|Physician Decision|0|||
143343956|NCT02237508|516804855|FG008|Overall Study|Physician Decision|0|||
143343957|NCT02237508|516804856|FG009|Overall Study|Physician Decision|0|||
143343958|NCT02237508|516804847|FG000|Overall Study|Protocol Violation|0|||
143343959|NCT02237508|516804848|FG001|Overall Study|Protocol Violation|0|||
143343960|NCT02237508|516804849|FG002|Overall Study|Protocol Violation|1|||
143343961|NCT02237508|516804850|FG003|Overall Study|Protocol Violation|0|||
143343962|NCT02237508|516804851|FG004|Overall Study|Protocol Violation|0|||
143343963|NCT02237508|516804852|FG005|Overall Study|Protocol Violation|0|||
143343964|NCT02237508|516804853|FG006|Overall Study|Protocol Violation|0|||
143343965|NCT02237508|516804854|FG007|Overall Study|Protocol Violation|0|||
143343966|NCT02237508|516804855|FG008|Overall Study|Protocol Violation|0|||
143343967|NCT02237508|516804856|FG009|Overall Study|Protocol Violation|0|||
143343968|NCT04000594|516804857|FG000|Overall Study|Withdrawal by Subject|1|||
143343969|NCT04000594|516804858|FG001|Overall Study|Withdrawal by Subject|0|||
143343970|NCT04000594|516804859|FG002|Overall Study|Withdrawal by Subject|0|||
143343971|NCT05807919|516804860|FG000|Overall Study|Received antibiotics - excluded|0|||
143343972|NCT05807919|516804861|FG001|Overall Study|Received antibiotics - excluded|1|||
143343973|NCT05807919|516804860|FG000|Overall Study|Withdrawal by Subject|0|||
143343974|NCT05807919|516804861|FG001|Overall Study|Withdrawal by Subject|3|||
143343975|NCT05807919|516804860|FG000|Overall Study|Adverse Event|1|||
143343976|NCT05807919|516804861|FG001|Overall Study|Adverse Event|1|||
143343977|NCT01905046|516804862|FG000|Months 13-24|Withdrawal by Subject|10|||
143343978|NCT01905046|516804863|FG001|Months 13-24|Withdrawal by Subject|10|||
143343979|NCT01905046|516804862|FG000|Months 13-24|Adverse Event|3|||
143343980|NCT01905046|516804863|FG001|Months 13-24|Adverse Event|2|||
143343981|NCT01905046|516804862|FG000|Months 13-24|Protocol Violation|3|||
143343982|NCT01905046|516804863|FG001|Months 13-24|Protocol Violation|3|||
143343983|NCT01905046|516804862|FG000|Months 13-24|Physician Decision|1|||
143343984|NCT01905046|516804863|FG001|Months 13-24|Physician Decision|0|||
143343985|NCT00733980|516804872|FG000|Overall Study|Adverse Event|5|||
143343986|NCT00733980|516804873|FG001|Overall Study|Adverse Event|2|||
143343987|NCT00733980|516804872|FG000|Overall Study|Lack of Efficacy|0|||
143343988|NCT00733980|516804873|FG001|Overall Study|Lack of Efficacy|1|||
143343989|NCT00733980|516804872|FG000|Overall Study|Protocol Violation|2|||
143343990|NCT00733980|516804873|FG001|Overall Study|Protocol Violation|1|||
143343991|NCT00733980|516804872|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
143343992|NCT00733980|516804873|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
143343993|NCT00733980|516804872|FG000|Overall Study|Lost to Follow-up|6|||
143343994|NCT00733980|516804873|FG001|Overall Study|Lost to Follow-up|11|||
143343995|NCT00733980|516804872|FG000|Overall Study|Physician Decision|2|||
143343996|NCT00733980|516804873|FG001|Overall Study|Physician Decision|3|||
143343997|NCT00733980|516804872|FG000|Overall Study|Withdrawal by Subject|6|||
143343998|NCT00733980|516804873|FG001|Overall Study|Withdrawal by Subject|2|||
143343999|NCT01552954|516804875|FG000|Overall Study|Adverse Event|1|||
143344000|NCT01552954|516804876|FG001|Overall Study|Adverse Event|2|||
143344001|NCT01552954|516804875|FG000|Overall Study|Lost to Follow-up|1|||
143344002|NCT01552954|516804876|FG001|Overall Study|Lost to Follow-up|1|||
143344003|NCT01552954|516804875|FG000|Overall Study|Withdrawal by Subject|1|||
143344004|NCT01552954|516804876|FG001|Overall Study|Withdrawal by Subject|1|||
143344005|NCT01552954|516804875|FG000|Overall Study|Protocol Violation|1|||
143344006|NCT01552954|516804876|FG001|Overall Study|Protocol Violation|2|||
143344007|NCT01552954|516804875|FG000|Overall Study|diagnosed DM|1|||
143344008|NCT01552954|516804876|FG001|Overall Study|diagnosed DM|0|||
143344009|NCT00779779|516804877|FG000|Overall Study|Adverse Event|1|||
143344010|NCT00779779|516804877|FG000|Overall Study|Protocol Violation|14|||
143344011|NCT00779779|516804877|FG000|Overall Study|Withdrawal by Subject|4|||
143344012|NCT00779779|516804877|FG000|Overall Study|Lost to Follow-up|5|||
143344013|NCT02404389|516804878|FG000|Overall Study|Adverse Event|1|||
143344014|NCT02404389|516804879|FG001|Overall Study|Adverse Event|0|||
143344015|NCT02404389|516804880|FG002|Overall Study|Adverse Event|1|||
143344016|NCT02404389|516804881|FG003|Overall Study|Adverse Event|0|||
143344017|NCT02404389|516804882|FG004|Overall Study|Adverse Event|2|||
143344018|NCT02404389|516804878|FG000|Overall Study|Subject/guardian decision|1|||
143344019|NCT02404389|516804879|FG001|Overall Study|Subject/guardian decision|0|||
143344020|NCT02404389|516804880|FG002|Overall Study|Subject/guardian decision|0|||
143344021|NCT02404389|516804881|FG003|Overall Study|Subject/guardian decision|1|||
143344022|NCT02404389|516804882|FG004|Overall Study|Subject/guardian decision|1|||
143344023|NCT03300570|516804883|FG000|Overall Study|Adverse Event|0|||
143344024|NCT03300570|516804884|FG001|Overall Study|Adverse Event|1|||
143344025|NCT03300570|516804883|FG000|Overall Study|Withdrawal by Subject|1|||
143344026|NCT03300570|516804884|FG001|Overall Study|Withdrawal by Subject|0|||
143344027|NCT03300570|516804883|FG000|Overall Study|Inadequate bowel prep|1|||
143344028|NCT03300570|516804884|FG001|Overall Study|Inadequate bowel prep|0|||
143344029|NCT00117156|516804885|FG000|Overall Study|Adverse Event|9|||
143344030|NCT00117156|516804885|FG000|Overall Study|Physician Decision|1|||
143344031|NCT00117156|516804885|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
143344032|NCT04043962|516804886|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
143344033|NCT04043962|516804886|FG000|Post-Treatment|Withdrawal by Subject|5|||
143344034|NCT04043962|516804886|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
143344035|NCT01987817|516804887|FG000|Overall Study|Adverse Event|4|||
143344036|NCT01987817|516804888|FG001|Overall Study|Adverse Event|0|||
143344037|NCT01987817|516804887|FG000|Overall Study|Withdrawal by Subject|1|||
143344038|NCT01987817|516804888|FG001|Overall Study|Withdrawal by Subject|1|||
143344039|NCT01987817|516804887|FG000|Overall Study|Physician Decision|1|||
143344040|NCT01987817|516804888|FG001|Overall Study|Physician Decision|0|||
143344041|NCT01576718|516804889|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
143344042|NCT01576718|516804890|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
143344043|NCT01576718|516804891|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
143344044|NCT01576718|516804892|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
143344045|NCT01576718|516804893|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
143344046|NCT01576718|516804894|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
143344047|NCT01576718|516804895|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
143344048|NCT01576718|516804889|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
143344049|NCT01576718|516804890|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
143344050|NCT01576718|516804891|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
143344051|NCT01576718|516804892|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
143344052|NCT01576718|516804893|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
143344053|NCT01576718|516804894|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
143344054|NCT01576718|516804895|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
143344055|NCT01576718|516804889|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
143344056|NCT01576718|516804890|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
143344057|NCT01576718|516804891|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
143344058|NCT01576718|516804892|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
143344059|NCT01576718|516804893|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
143344060|NCT01576718|516804894|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
143344061|NCT01576718|516804895|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
143344062|NCT01576718|516804889|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
143344063|NCT01576718|516804890|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
143344064|NCT01576718|516804891|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
143344065|NCT01576718|516804892|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
143344066|NCT01576718|516804893|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
143344067|NCT01576718|516804894|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
143344068|NCT01576718|516804895|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
143344069|NCT01576718|516804889|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
143344070|NCT01576718|516804890|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
143344071|NCT01576718|516804891|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
143344072|NCT01576718|516804892|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
143344073|NCT01576718|516804893|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
143344074|NCT01576718|516804894|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
143344075|NCT01576718|516804895|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
143344076|NCT01576718|516804889|FG000|Treatment Period|Adverse Event|0|||
143344077|NCT01576718|516804890|FG001|Treatment Period|Adverse Event|1|||
143344078|NCT01576718|516804891|FG002|Treatment Period|Adverse Event|1|||
143344079|NCT01576718|516804892|FG003|Treatment Period|Adverse Event|1|||
143344080|NCT01576718|516804893|FG004|Treatment Period|Adverse Event|1|||
143344081|NCT01576718|516804894|FG005|Treatment Period|Adverse Event|1|||
143344082|NCT01576718|516804895|FG006|Treatment Period|Adverse Event|0|||
143344083|NCT01576718|516804889|FG000|Treatment Period|Withdrawal by Subject|0|||
143344084|NCT01576718|516804890|FG001|Treatment Period|Withdrawal by Subject|1|||
143344085|NCT01576718|516804891|FG002|Treatment Period|Withdrawal by Subject|1|||
143344086|NCT01576718|516804892|FG003|Treatment Period|Withdrawal by Subject|0|||
143456243|NCT00432666|517215795|FG000|Main Period|Consent Withdrawn|1|||
143344087|NCT01576718|516804893|FG004|Treatment Period|Withdrawal by Subject|2|||
143344088|NCT01576718|516804894|FG005|Treatment Period|Withdrawal by Subject|4|||
143344089|NCT01576718|516804895|FG006|Treatment Period|Withdrawal by Subject|2|||
143004301|NCT01740297|515554683|FG001|Overall Study|Lost to Follow-up|2|||
143344090|NCT01576718|516804889|FG000|Treatment Period|Physician Decision|0|||
143344091|NCT01576718|516804890|FG001|Treatment Period|Physician Decision|1|||
143344092|NCT01576718|516804891|FG002|Treatment Period|Physician Decision|1|||
143344093|NCT01576718|516804892|FG003|Treatment Period|Physician Decision|1|||
143344094|NCT01576718|516804893|FG004|Treatment Period|Physician Decision|1|||
143344095|NCT01576718|516804894|FG005|Treatment Period|Physician Decision|0|||
143344096|NCT01576718|516804895|FG006|Treatment Period|Physician Decision|0|||
143344097|NCT01576718|516804889|FG000|Treatment Period|Protocol Violation|0|||
143344098|NCT01576718|516804890|FG001|Treatment Period|Protocol Violation|5|||
143344099|NCT01576718|516804891|FG002|Treatment Period|Protocol Violation|4|||
143344100|NCT01576718|516804892|FG003|Treatment Period|Protocol Violation|10|||
143344101|NCT01576718|516804893|FG004|Treatment Period|Protocol Violation|6|||
143344102|NCT01576718|516804894|FG005|Treatment Period|Protocol Violation|8|||
143344103|NCT01576718|516804895|FG006|Treatment Period|Protocol Violation|12|||
143344104|NCT01576718|516804889|FG000|Treatment Period|Sponsor request|0|||
143344105|NCT01576718|516804890|FG001|Treatment Period|Sponsor request|1|||
143344106|NCT01576718|516804891|FG002|Treatment Period|Sponsor request|0|||
143344107|NCT01576718|516804892|FG003|Treatment Period|Sponsor request|0|||
143344108|NCT01576718|516804893|FG004|Treatment Period|Sponsor request|0|||
143344109|NCT01576718|516804894|FG005|Treatment Period|Sponsor request|1|||
143344110|NCT01576718|516804895|FG006|Treatment Period|Sponsor request|0|||
143344111|NCT01576718|516804889|FG000|Treatment Period|Met stopping criteria|0|||
143344112|NCT01576718|516804890|FG001|Treatment Period|Met stopping criteria|16|||
143344113|NCT01576718|516804891|FG002|Treatment Period|Met stopping criteria|13|||
143344114|NCT01576718|516804892|FG003|Treatment Period|Met stopping criteria|19|||
143344115|NCT01576718|516804893|FG004|Treatment Period|Met stopping criteria|16|||
143344116|NCT01576718|516804894|FG005|Treatment Period|Met stopping criteria|33|||
143344117|NCT01576718|516804895|FG006|Treatment Period|Met stopping criteria|15|||
143344118|NCT01576718|516804889|FG000|Treatment Period|Lost to Follow-up|0|||
143344119|NCT01576718|516804890|FG001|Treatment Period|Lost to Follow-up|0|||
143344120|NCT01576718|516804891|FG002|Treatment Period|Lost to Follow-up|0|||
143344121|NCT01576718|516804892|FG003|Treatment Period|Lost to Follow-up|0|||
143344122|NCT01576718|516804893|FG004|Treatment Period|Lost to Follow-up|1|||
143344123|NCT01576718|516804894|FG005|Treatment Period|Lost to Follow-up|0|||
143344124|NCT01576718|516804895|FG006|Treatment Period|Lost to Follow-up|0|||
143344125|NCT01576718|516804889|FG000|Treatment Period|Noncompliance to study medication|0|||
143344126|NCT01576718|516804890|FG001|Treatment Period|Noncompliance to study medication|0|||
143344127|NCT01576718|516804891|FG002|Treatment Period|Noncompliance to study medication|0|||
143344128|NCT01576718|516804892|FG003|Treatment Period|Noncompliance to study medication|0|||
143344129|NCT01576718|516804893|FG004|Treatment Period|Noncompliance to study medication|0|||
143344130|NCT01576718|516804894|FG005|Treatment Period|Noncompliance to study medication|1|||
143344131|NCT01576718|516804895|FG006|Treatment Period|Noncompliance to study medication|1|||
143344132|NCT04631705|516804896|FG000|Overall Study|Withdrawal by Subject|0|||
143344133|NCT04631705|516804897|FG001|Overall Study|Withdrawal by Subject|0|||
143344134|NCT04631705|516804898|FG002|Overall Study|Withdrawal by Subject|0|||
143344135|NCT04631705|516804899|FG003|Overall Study|Withdrawal by Subject|0|||
143344136|NCT04631705|516804900|FG004|Overall Study|Withdrawal by Subject|0|||
143344137|NCT04631705|516804901|FG005|Overall Study|Withdrawal by Subject|0|||
143344138|NCT04631705|516804902|FG006|Overall Study|Withdrawal by Subject|1|||
143344139|NCT04631705|516804903|FG007|Overall Study|Withdrawal by Subject|0|||
143344140|NCT04631705|516804904|FG008|Overall Study|Withdrawal by Subject|0|||
143344141|NCT02392611|516806601|FG000|Overall Study|Adverse Event|0|||
143344142|NCT02392611|516806602|FG001|Overall Study|Adverse Event|0|||
143344143|NCT02392611|516806603|FG002|Overall Study|Adverse Event|0|||
143344144|NCT02392611|516806604|FG003|Overall Study|Adverse Event|1|||
143344145|NCT02392611|516806605|FG004|Overall Study|Adverse Event|0|||
143344146|NCT02392611|516806606|FG005|Overall Study|Adverse Event|0|||
143344147|NCT02392611|516806607|FG006|Overall Study|Adverse Event|0|||
143344148|NCT02392611|516806608|FG007|Overall Study|Adverse Event|0|||
143344149|NCT02392611|516806609|FG008|Overall Study|Adverse Event|0|||
143344150|NCT02392611|516806601|FG000|Overall Study|Progressive disease|0|||
143344151|NCT02392611|516806602|FG001|Overall Study|Progressive disease|0|||
143344152|NCT02392611|516806603|FG002|Overall Study|Progressive disease|0|||
143344153|NCT02392611|516806604|FG003|Overall Study|Progressive disease|2|||
143344154|NCT02392611|516806605|FG004|Overall Study|Progressive disease|1|||
143344155|NCT02392611|516806606|FG005|Overall Study|Progressive disease|0|||
143344156|NCT02392611|516806607|FG006|Overall Study|Progressive disease|0|||
143344157|NCT02392611|516806608|FG007|Overall Study|Progressive disease|0|||
143344158|NCT02392611|516806609|FG008|Overall Study|Progressive disease|0|||
143344159|NCT02392611|516806601|FG000|Overall Study|Death|1|||
143344160|NCT02392611|516806602|FG001|Overall Study|Death|0|||
143344161|NCT02392611|516806603|FG002|Overall Study|Death|0|||
143344162|NCT02392611|516806604|FG003|Overall Study|Death|0|||
143344163|NCT02392611|516806605|FG004|Overall Study|Death|0|||
143344164|NCT02392611|516806606|FG005|Overall Study|Death|1|||
143344165|NCT02392611|516806607|FG006|Overall Study|Death|0|||
143344166|NCT02392611|516806608|FG007|Overall Study|Death|0|||
143456244|NCT00432666|517215796|FG001|Main Period|Consent Withdrawn|0|||
143456245|NCT00432666|517215795|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
143456246|NCT00432666|517215796|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
143456247|NCT00432666|517215795|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
143456248|NCT00432666|517215796|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
143456249|NCT00432666|517215795|FG000|Open-Label Extension Period|Adverse Event|5|||
143456250|NCT00432666|517215796|FG001|Open-Label Extension Period|Adverse Event|0|||
143456251|NCT00432666|517215795|FG000|Open-Label Extension Period|Consent withdrawn|10|||
143456252|NCT00432666|517215796|FG001|Open-Label Extension Period|Consent withdrawn|0|||
143456253|NCT00432666|517215795|FG000|Open-Label Extension Period|Physician Decision|3|||
143456254|NCT00432666|517215796|FG001|Open-Label Extension Period|Physician Decision|0|||
143456255|NCT00978627|517215797|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
143456256|NCT00978627|517215798|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
143456257|NCT00978627|517215797|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
143456258|NCT00978627|517215798|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
143456259|NCT00978627|517215797|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
143456260|NCT00978627|517215798|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
143456261|NCT00978627|517215797|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
143456262|NCT00978627|517215798|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
143456263|NCT00978627|517215797|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
143456264|NCT00978627|517215798|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
143456265|NCT00978627|517215797|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
143456266|NCT00978627|517215798|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
143456267|NCT00978627|517215797|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
143456268|NCT00978627|517215798|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
143456269|NCT00978627|517215797|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
143456270|NCT00978627|517215798|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
143456271|NCT00978627|517215797|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
143456272|NCT00978627|517215798|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
143344167|NCT02392611|516806609|FG008|Overall Study|Death|0|||
143344168|NCT02392611|516806601|FG000|Overall Study|Withdrawal by Subject|0|||
143344169|NCT02392611|516806602|FG001|Overall Study|Withdrawal by Subject|0|||
143344170|NCT02392611|516806603|FG002|Overall Study|Withdrawal by Subject|0|||
143344171|NCT02392611|516806604|FG003|Overall Study|Withdrawal by Subject|1|||
143344172|NCT02392611|516806605|FG004|Overall Study|Withdrawal by Subject|0|||
143344173|NCT02392611|516806606|FG005|Overall Study|Withdrawal by Subject|0|||
143344174|NCT02392611|516806607|FG006|Overall Study|Withdrawal by Subject|0|||
143344175|NCT02392611|516806608|FG007|Overall Study|Withdrawal by Subject|0|||
143344176|NCT02392611|516806609|FG008|Overall Study|Withdrawal by Subject|0|||
143344177|NCT02392611|516806601|FG000|Overall Study|Lost to Follow-up|0|||
143344178|NCT02392611|516806602|FG001|Overall Study|Lost to Follow-up|0|||
143344179|NCT02392611|516806603|FG002|Overall Study|Lost to Follow-up|0|||
143344180|NCT02392611|516806604|FG003|Overall Study|Lost to Follow-up|0|||
143344181|NCT02392611|516806605|FG004|Overall Study|Lost to Follow-up|0|||
143344182|NCT02392611|516806606|FG005|Overall Study|Lost to Follow-up|0|||
143344183|NCT02392611|516806607|FG006|Overall Study|Lost to Follow-up|1|||
143344184|NCT02392611|516806608|FG007|Overall Study|Lost to Follow-up|0|||
143344185|NCT02392611|516806609|FG008|Overall Study|Lost to Follow-up|0|||
143344186|NCT02392611|516806601|FG000|Overall Study|Enrolled, not treated|0|||
143344187|NCT02392611|516806602|FG001|Overall Study|Enrolled, not treated|0|||
143344188|NCT02392611|516806603|FG002|Overall Study|Enrolled, not treated|0|||
143344189|NCT02392611|516806604|FG003|Overall Study|Enrolled, not treated|2|||
143344190|NCT02392611|516806605|FG004|Overall Study|Enrolled, not treated|0|||
143344191|NCT02392611|516806606|FG005|Overall Study|Enrolled, not treated|0|||
143344192|NCT02392611|516806607|FG006|Overall Study|Enrolled, not treated|0|||
143344193|NCT02392611|516806608|FG007|Overall Study|Enrolled, not treated|0|||
143344194|NCT02392611|516806609|FG008|Overall Study|Enrolled, not treated|0|||
143344195|NCT00369681|516806611|FG000|Overall Study|Death|1|||
143344196|NCT00605319|516806613|FG000|Overall Study|Adverse Event|6|||
143344197|NCT02991482|516806614|FG000|Overall Study|Disease progression|56|||
143344198|NCT02991482|516806615|FG001|Overall Study|Disease progression|47|||
143004302|NCT01740297|515554684|FG002|Overall Study|Lost to Follow-up|4|||
143344199|NCT02991482|516806614|FG000|Overall Study|Death|4|||
143344200|NCT02991482|516806615|FG001|Overall Study|Death|4|||
143344201|NCT02991482|516806614|FG000|Overall Study|Adverse Event|1|||
143344202|NCT02991482|516806615|FG001|Overall Study|Adverse Event|6|||
143344203|NCT02991482|516806614|FG000|Overall Study|Patient decision|1|||
143344204|NCT02991482|516806615|FG001|Overall Study|Patient decision|1|||
143344205|NCT02991482|516806614|FG000|Overall Study|Physician Decision|0|||
143344206|NCT02991482|516806615|FG001|Overall Study|Physician Decision|6|||
143344207|NCT02991482|516806614|FG000|Overall Study|Clinical deterioration|1|||
143344208|NCT02991482|516806615|FG001|Overall Study|Clinical deterioration|0|||
143344209|NCT02991482|516806614|FG000|Overall Study|Patient feeling too unwell|1|||
143344210|NCT02991482|516806615|FG001|Overall Study|Patient feeling too unwell|0|||
143344211|NCT02991482|516806614|FG000|Overall Study|Worsening of performance status|0|||
143344212|NCT02991482|516806615|FG001|Overall Study|Worsening of performance status|1|||
143344213|NCT02991482|516806614|FG000|Overall Study|Death prior to study drug initiation|1|||
143344214|NCT02991482|516806615|FG001|Overall Study|Death prior to study drug initiation|0|||
143344215|NCT02991482|516806614|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
143344216|NCT02991482|516806615|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
143344217|NCT02110732|516806617|FG000|Overall Study|Physician Decision|5|||
143344218|NCT02110732|516806618|FG001|Overall Study|Physician Decision|2|||
143344219|NCT02110732|516806617|FG000|Overall Study|Lost to Follow-up|1|||
143344220|NCT02110732|516806618|FG001|Overall Study|Lost to Follow-up|1|||
143344221|NCT00633932|516806619|FG000|Overall Study|Adverse Event|1|||
143344222|NCT00633932|516806620|FG001|Overall Study|Adverse Event|3|||
143344223|NCT00633932|516806621|FG002|Overall Study|Adverse Event|4|||
143344224|NCT00633932|516806619|FG000|Overall Study|Withdrawal by Subject|3|||
143344225|NCT00633932|516806620|FG001|Overall Study|Withdrawal by Subject|9|||
143344226|NCT00633932|516806621|FG002|Overall Study|Withdrawal by Subject|1|||
143344227|NCT00633932|516806619|FG000|Overall Study|Lost to Follow-up|1|||
143344228|NCT00633932|516806620|FG001|Overall Study|Lost to Follow-up|0|||
143344229|NCT00633932|516806621|FG002|Overall Study|Lost to Follow-up|2|||
143344230|NCT00633932|516806619|FG000|Overall Study|Protocol Violation|5|||
143344231|NCT00633932|516806620|FG001|Overall Study|Protocol Violation|2|||
143344232|NCT00633932|516806621|FG002|Overall Study|Protocol Violation|3|||
143344233|NCT00633932|516806619|FG000|Overall Study|Physician Decision|0|||
143344234|NCT00633932|516806620|FG001|Overall Study|Physician Decision|0|||
143344235|NCT00633932|516806621|FG002|Overall Study|Physician Decision|1|||
143344236|NCT00633932|516806619|FG000|Overall Study|Doctor's judgement|1|||
143344237|NCT00633932|516806620|FG001|Overall Study|Doctor's judgement|0|||
143344238|NCT00633932|516806621|FG002|Overall Study|Doctor's judgement|0|||
143344239|NCT00633932|516806619|FG000|Overall Study|Moved Away|1|||
143344240|NCT00633932|516806620|FG001|Overall Study|Moved Away|0|||
143344241|NCT00633932|516806621|FG002|Overall Study|Moved Away|0|||
143344242|NCT00482274|516806622|FG000|Overall Study|Adverse Event|1|||
143344243|NCT04836858|516806623|FG000|Overall Study|Adverse Event|0|||
143344244|NCT04836858|516806624|FG001|Overall Study|Adverse Event|0|||
143344245|NCT04836858|516806625|FG002|Overall Study|Adverse Event|0|||
143344246|NCT04836858|516806626|FG003|Overall Study|Adverse Event|1|||
143344247|NCT04836858|516806623|FG000|Overall Study|Lost to Follow-up|1|||
143344248|NCT04836858|516806624|FG001|Overall Study|Lost to Follow-up|0|||
143344249|NCT04836858|516806625|FG002|Overall Study|Lost to Follow-up|0|||
143344250|NCT04836858|516806626|FG003|Overall Study|Lost to Follow-up|0|||
143344251|NCT04836858|516806623|FG000|Overall Study|Subject/Guardian decision|3|||
143344252|NCT04836858|516806624|FG001|Overall Study|Subject/Guardian decision|0|||
143344253|NCT04836858|516806625|FG002|Overall Study|Subject/Guardian decision|0|||
143344254|NCT04836858|516806626|FG003|Overall Study|Subject/Guardian decision|1|||
143456273|NCT00565851|517215799|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
143456274|NCT00565851|517215800|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
143456275|NCT00565851|517215801|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
143456276|NCT00565851|517215802|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
143456277|NCT00565851|517215803|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
143456278|NCT00565851|517215804|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
143456279|NCT00565851|517215805|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
143456280|NCT00565851|517215806|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
143456281|NCT00565851|517215799|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
143456282|NCT00565851|517215800|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
143456283|NCT00565851|517215801|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
143456284|NCT00565851|517215802|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
143344255|NCT04836858|516806623|FG000|Overall Study|Randomized but not treated|4|||
143344256|NCT04836858|516806624|FG001|Overall Study|Randomized but not treated|0|||
143344257|NCT04836858|516806625|FG002|Overall Study|Randomized but not treated|0|||
143344258|NCT04836858|516806626|FG003|Overall Study|Randomized but not treated|0|||
143344259|NCT02228395|516806631|FG000|First Intervention Period|No longer willing to participate|1|||
143344260|NCT02228395|516806632|FG001|First Intervention Period|No longer willing to participate|0|||
143344261|NCT02228395|516806633|FG002|First Intervention Period|No longer willing to participate|0|||
143344262|NCT02228395|516806631|FG000|First Intervention Period|Unable to comply with study dates|0|||
143344263|NCT02228395|516806632|FG001|First Intervention Period|Unable to comply with study dates|1|||
143344264|NCT02228395|516806633|FG002|First Intervention Period|Unable to comply with study dates|1|||
143344265|NCT02569437|516806634|FG000|Overall Study|Lost to Follow-up|12|||
143344266|NCT02569437|516806635|FG001|Overall Study|Lost to Follow-up|14|||
143344267|NCT01641926|516806636|FG000|Overall Study|Adverse Event|5|||
143344268|NCT01641926|516806637|FG001|Overall Study|Adverse Event|2|||
143344269|NCT01641926|516806638|FG002|Overall Study|Adverse Event|3|||
143344270|NCT01641926|516806639|FG003|Overall Study|Adverse Event|1|||
143344271|NCT01641926|516806636|FG000|Overall Study|Lost to Follow-up|2|||
143344272|NCT01641926|516806637|FG001|Overall Study|Lost to Follow-up|2|||
143344273|NCT01641926|516806638|FG002|Overall Study|Lost to Follow-up|1|||
143344274|NCT01641926|516806639|FG003|Overall Study|Lost to Follow-up|0|||
143344275|NCT01641926|516806636|FG000|Overall Study|Physician Decision|6|||
143344276|NCT01641926|516806637|FG001|Overall Study|Physician Decision|5|||
143344277|NCT01641926|516806638|FG002|Overall Study|Physician Decision|0|||
143344278|NCT01641926|516806639|FG003|Overall Study|Physician Decision|1|||
143344279|NCT01641926|516806636|FG000|Overall Study|Protocol Violation|1|||
143344280|NCT01641926|516806637|FG001|Overall Study|Protocol Violation|0|||
143344281|NCT01641926|516806638|FG002|Overall Study|Protocol Violation|0|||
143344282|NCT01641926|516806639|FG003|Overall Study|Protocol Violation|1|||
143344283|NCT01641926|516806636|FG000|Overall Study|Withdrawal by Subject|13|||
143344284|NCT01641926|516806637|FG001|Overall Study|Withdrawal by Subject|5|||
143344285|NCT01641926|516806638|FG002|Overall Study|Withdrawal by Subject|6|||
143344286|NCT01641926|516806639|FG003|Overall Study|Withdrawal by Subject|1|||
143344287|NCT01641926|516806636|FG000|Overall Study|Not Treated|1|||
143344288|NCT01641926|516806637|FG001|Overall Study|Not Treated|1|||
143344289|NCT01641926|516806638|FG002|Overall Study|Not Treated|1|||
143344290|NCT01641926|516806639|FG003|Overall Study|Not Treated|0|||
143344291|NCT01287520|516806640|FG000|Overall Study|Adverse Event|2|||
143344292|NCT01287520|516806641|FG001|Overall Study|Adverse Event|2|||
143344293|NCT01287520|516806642|FG002|Overall Study|Adverse Event|2|||
143344294|NCT01287520|516806643|FG003|Overall Study|Adverse Event|1|||
143344295|NCT01287520|516806644|FG004|Overall Study|Adverse Event|1|||
143344296|NCT01287520|516806645|FG005|Overall Study|Adverse Event|2|||
143344297|NCT01287520|516806646|FG006|Overall Study|Adverse Event|0|||
143344298|NCT01287520|516806647|FG007|Overall Study|Adverse Event|2|||
143344299|NCT01287520|516806648|FG008|Overall Study|Adverse Event|0|||
143344300|NCT01287520|516806640|FG000|Overall Study|Physician Decision|1|||
143344301|NCT01287520|516806641|FG001|Overall Study|Physician Decision|1|||
143344302|NCT01287520|516806642|FG002|Overall Study|Physician Decision|2|||
143344303|NCT01287520|516806643|FG003|Overall Study|Physician Decision|0|||
143344304|NCT01287520|516806644|FG004|Overall Study|Physician Decision|1|||
143344305|NCT01287520|516806645|FG005|Overall Study|Physician Decision|1|||
143344306|NCT01287520|516806646|FG006|Overall Study|Physician Decision|0|||
143344307|NCT01287520|516806647|FG007|Overall Study|Physician Decision|1|||
143344308|NCT01287520|516806648|FG008|Overall Study|Physician Decision|0|||
143344309|NCT01287520|516806640|FG000|Overall Study|Progressive disease|0|||
143344310|NCT01287520|516806641|FG001|Overall Study|Progressive disease|4|||
143344311|NCT01287520|516806642|FG002|Overall Study|Progressive disease|1|||
143344312|NCT01287520|516806643|FG003|Overall Study|Progressive disease|6|||
143344313|NCT01287520|516806644|FG004|Overall Study|Progressive disease|1|||
143344314|NCT01287520|516806645|FG005|Overall Study|Progressive disease|0|||
143344315|NCT01287520|516806646|FG006|Overall Study|Progressive disease|2|||
143344316|NCT01287520|516806647|FG007|Overall Study|Progressive disease|2|||
143344317|NCT01287520|516806648|FG008|Overall Study|Progressive disease|4|||
143344318|NCT01287520|516806640|FG000|Overall Study|Withdrawal by Subject|0|||
143344319|NCT01287520|516806641|FG001|Overall Study|Withdrawal by Subject|0|||
143344320|NCT01287520|516806642|FG002|Overall Study|Withdrawal by Subject|0|||
143344321|NCT01287520|516806643|FG003|Overall Study|Withdrawal by Subject|0|||
143344322|NCT01287520|516806644|FG004|Overall Study|Withdrawal by Subject|0|||
143344323|NCT01287520|516806645|FG005|Overall Study|Withdrawal by Subject|1|||
143344324|NCT01287520|516806646|FG006|Overall Study|Withdrawal by Subject|0|||
143344325|NCT01287520|516806647|FG007|Overall Study|Withdrawal by Subject|0|||
143344326|NCT01287520|516806648|FG008|Overall Study|Withdrawal by Subject|1|||
143344327|NCT02768662|516806649|FG000|Overall Study|Adverse Event|1|||
143344328|NCT02768662|516806649|FG000|Overall Study|Lost to Follow-up|4|||
143344329|NCT02768662|516806649|FG000|Overall Study|Withdrawal by Subject|3|||
143456285|NCT00565851|517215803|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
143456286|NCT00565851|517215804|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
143456287|NCT00565851|517215805|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
143456288|NCT00565851|517215806|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
143456289|NCT00055601|517215807|FG000|Overall Study|Protocol Violation|1|||
143456290|NCT00055601|517215808|FG001|Overall Study|Protocol Violation|1|||
143456291|NCT00055601|517215807|FG000|Overall Study|No protocol treatment received|1|||
143344330|NCT02768662|516806649|FG000|Overall Study|Study terminated by Sponsor|78|||
143344331|NCT00708435|516806650|FG000|Overall Study|Death / Serious Adverse Event|10|||
143344332|NCT00708435|516806651|FG001|Overall Study|Death / Serious Adverse Event|5|||
143344333|NCT00708435|516806650|FG000|Overall Study|Lost to Follow-up|9|||
143344334|NCT00708435|516806651|FG001|Overall Study|Lost to Follow-up|4|||
143344335|NCT00708435|516806650|FG000|Overall Study|Withdrawal by Subject|3|||
143344336|NCT00708435|516806651|FG001|Overall Study|Withdrawal by Subject|7|||
143344337|NCT00708435|516806650|FG000|Overall Study|Adverse Event|1|||
143344338|NCT00708435|516806651|FG001|Overall Study|Adverse Event|0|||
143344339|NCT00708435|516806650|FG000|Overall Study|Protocol Violation|0|||
143344340|NCT00708435|516806651|FG001|Overall Study|Protocol Violation|1|||
143344341|NCT00708435|516806650|FG000|Overall Study|Intervention by primary care physician|1|||
143344342|NCT00708435|516806651|FG001|Overall Study|Intervention by primary care physician|0|||
143344343|NCT00708435|516806650|FG000|Overall Study|Refused hospitalization|1|||
143344344|NCT00708435|516806651|FG001|Overall Study|Refused hospitalization|0|||
143456292|NCT00055601|517215808|FG001|Overall Study|No protocol treatment received|1|||
143456293|NCT00275262|517215815|FG000|Overall Study|Adverse Event|2|||
143456294|NCT00275262|517215816|FG001|Overall Study|Adverse Event|0|||
143456295|NCT00275262|517215815|FG000|Overall Study|Disease progression|2|||
143456296|NCT00275262|517215816|FG001|Overall Study|Disease progression|5|||
143456297|NCT00275262|517215815|FG000|Overall Study|Lost to Follow-up|0|||
143456298|NCT00275262|517215816|FG001|Overall Study|Lost to Follow-up|2|||
143456299|NCT00275262|517215815|FG000|Overall Study|Protocol Violation|0|||
143456300|NCT00275262|517215816|FG001|Overall Study|Protocol Violation|2|||
143456301|NCT00275262|517215815|FG000|Overall Study|Death|1|||
143456302|NCT00275262|517215816|FG001|Overall Study|Death|0|||
143456303|NCT00275262|517215815|FG000|Overall Study|Started Chemotherapy|1|||
143456304|NCT00275262|517215816|FG001|Overall Study|Started Chemotherapy|0|||
143456305|NCT02217332|517215819|FG000|Overall Study|Adverse Event|3|||
143456306|NCT02217332|517215819|FG000|Overall Study|Dose interruption >1 month|1|||
143456307|NCT02217332|517215819|FG000|Overall Study|Protocol Violation (eligibility)|1|||
143456308|NCT02217332|517215819|FG000|Overall Study|Withdrawal by Subject|1|||
143456309|NCT02217332|517215819|FG000|Overall Study|Lost to Follow-up|1|||
143456310|NCT02233543|517215820|FG000|Period 1|Withdrawal by Subject|1|||
143344345|NCT01453348|516806654|FG000|Overall Study|Death|0|||
143344346|NCT01453348|516806655|FG001|Overall Study|Death|0|||
143344347|NCT01453348|516806656|FG002|Overall Study|Death|1|||
143344348|NCT01453348|516806654|FG000|Overall Study|Withdrawal by Subject|0|||
143344349|NCT01453348|516806655|FG001|Overall Study|Withdrawal by Subject|1|||
143344350|NCT01453348|516806656|FG002|Overall Study|Withdrawal by Subject|0|||
143344351|NCT01453348|516806654|FG000|Overall Study|Protocol Violation|1|||
143344352|NCT01453348|516806655|FG001|Overall Study|Protocol Violation|0|||
143344353|NCT01453348|516806656|FG002|Overall Study|Protocol Violation|0|||
143344354|NCT00988221|516806657|FG000|Part I|Adverse Event|0|||
143344355|NCT00988221|516806658|FG001|Part I|Adverse Event|1|||
143344356|NCT00988221|516806659|FG002|Part I|Adverse Event|2|||
143344357|NCT00988221|516806660|FG003|Part I|Adverse Event|0|||
143344358|NCT00988221|516806657|FG000|Part I|Insufficient Therapeutic Response|4|||
143344359|NCT00988221|516806658|FG001|Part I|Insufficient Therapeutic Response|6|||
143344360|NCT00988221|516806659|FG002|Part I|Insufficient Therapeutic Response|5|||
143344361|NCT00988221|516806660|FG003|Part I|Insufficient Therapeutic Response|0|||
143344362|NCT00988221|516806657|FG000|Part I|Refused Treatment|0|||
143344363|NCT00988221|516806658|FG001|Part I|Refused Treatment|2|||
143344364|NCT00988221|516806659|FG002|Part I|Refused Treatment|1|||
143344365|NCT00988221|516806660|FG003|Part I|Refused Treatment|0|||
143344366|NCT00988221|516806657|FG000|Part I|Lost to Follow-up|0|||
143344367|NCT00988221|516806658|FG001|Part I|Lost to Follow-up|1|||
143344368|NCT00988221|516806659|FG002|Part I|Lost to Follow-up|0|||
143344369|NCT00988221|516806660|FG003|Part I|Lost to Follow-up|0|||
143344370|NCT00988221|516806657|FG000|Part II|Adverse Event|1|||
143344371|NCT00988221|516806658|FG001|Part II|Adverse Event|0|||
143344372|NCT00988221|516806659|FG002|Part II|Adverse Event|0|||
143344373|NCT00988221|516806660|FG003|Part II|Adverse Event|1|||
143344374|NCT00988221|516806657|FG000|Part II|Withdrawal by Subject|0|||
143344375|NCT00988221|516806658|FG001|Part II|Withdrawal by Subject|0|||
143344376|NCT00988221|516806659|FG002|Part II|Withdrawal by Subject|2|||
143344377|NCT00988221|516806660|FG003|Part II|Withdrawal by Subject|2|||
143344378|NCT00988221|516806657|FG000|Part II|Reason not Specified|0|||
143344379|NCT00988221|516806658|FG001|Part II|Reason not Specified|0|||
143344380|NCT00988221|516806659|FG002|Part II|Reason not Specified|1|||
143344381|NCT00988221|516806660|FG003|Part II|Reason not Specified|0|||
143344382|NCT00988221|516806657|FG000|Part III|Adverse Event|1|||
143344383|NCT00988221|516806658|FG001|Part III|Adverse Event|0|||
143344384|NCT00988221|516806659|FG002|Part III|Adverse Event|1|||
143344385|NCT00988221|516806660|FG003|Part III|Adverse Event|0|||
143344386|NCT00988221|516806657|FG000|Part III|Insufficient Therapeutic Response|0|||
143344387|NCT00988221|516806658|FG001|Part III|Insufficient Therapeutic Response|1|||
143344388|NCT00988221|516806659|FG002|Part III|Insufficient Therapeutic Response|1|||
143344389|NCT00988221|516806660|FG003|Part III|Insufficient Therapeutic Response|0|||
143344390|NCT00988221|516806657|FG000|Part III|Refused Treatment|0|||
143344391|NCT00988221|516806658|FG001|Part III|Refused Treatment|0|||
143344392|NCT00988221|516806659|FG002|Part III|Refused Treatment|1|||
143344393|NCT00988221|516806660|FG003|Part III|Refused Treatment|0|||
143344394|NCT02756832|516806667|FG000|Overall Study|Lost for Observation after Baseline|6|||
143344395|NCT02756832|516806667|FG000|Overall Study|Lost for Observation|13|||
143344396|NCT02756832|516806667|FG000|Overall Study|Patient's Unwillingness|12|||
143344397|NCT02756832|516806667|FG000|Overall Study|Insufficient Efficacy|2|||
143344398|NCT02756832|516806667|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
143344399|NCT02756832|516806667|FG000|Overall Study|Reason not Specified|9|||
143344400|NCT02756832|516806667|FG000|Overall Study|Protocol Deviation|10|||
143344401|NCT04359771|516806668|FG000|Overall Study|Lack of Efficacy|2|||
143344402|NCT04359771|516806669|FG001|Overall Study|Lack of Efficacy|2|||
143344403|NCT03592277|516806672|FG000|Overall Study|Withdrawal by Subject|6|||
143344404|NCT03592277|516806673|FG001|Overall Study|Withdrawal by Subject|8|||
143344405|NCT01346514|516806674|FG000|Overall Study|Lost to Follow-up|19|||
143456311|NCT02233543|517215821|FG001|Period 1|Withdrawal by Subject|0|||
143344406|NCT01346514|516806675|FG001|Overall Study|Lost to Follow-up|30|||
143344407|NCT01346514|516806674|FG000|Overall Study|Withdrawal by Subject|7|||
143344408|NCT01346514|516806675|FG001|Overall Study|Withdrawal by Subject|3|||
143344409|NCT01346514|516806674|FG000|Overall Study|Death|3|||
143344410|NCT01346514|516806675|FG001|Overall Study|Death|4|||
143344411|NCT00909480|516806676|FG000|Overall Study|Adverse Event|5|||
143344412|NCT00909480|516806677|FG001|Overall Study|Adverse Event|3|||
143344413|NCT00909480|516806676|FG000|Overall Study|Protocol Violation|6|||
143344414|NCT00909480|516806677|FG001|Overall Study|Protocol Violation|8|||
143344415|NCT00909480|516806676|FG000|Overall Study|Withdrawal criteria|9|||
143456312|NCT02233543|517215820|FG000|Period 1|Participants required other treatment.|2|||
143456313|NCT02233543|517215821|FG001|Period 1|Participants required other treatment.|3|||
143456314|NCT02233543|517215820|FG000|Period 2|Adverse Event|1|||
143456315|NCT02233543|517215821|FG001|Period 2|Adverse Event|0|||
143456316|NCT02233543|517215820|FG000|Period 2|Participant required other treatment.|0|||
143456317|NCT02233543|517215821|FG001|Period 2|Participant required other treatment.|1|||
143456318|NCT02233543|517215820|FG000|Period 2|COPD exacerbation|1|||
143456319|NCT02233543|517215821|FG001|Period 2|COPD exacerbation|0|||
143456320|NCT00603304|517215822|FG000|Overall Study|Lost to Follow-up|5|||
143456321|NCT00603304|517215823|FG001|Overall Study|Lost to Follow-up|7|||
143456322|NCT00603304|517215822|FG000|Overall Study|Withdrawal by Subject|8|||
143456323|NCT00603304|517215823|FG001|Overall Study|Withdrawal by Subject|5|||
143456324|NCT00603304|517215822|FG000|Overall Study|Protocol Violation|1|||
143456325|NCT00603304|517215823|FG001|Overall Study|Protocol Violation|0|||
143344416|NCT00909480|516806677|FG001|Overall Study|Withdrawal criteria|11|||
143344417|NCT00909480|516806676|FG000|Overall Study|Unclassified|18|||
143344418|NCT00909480|516806677|FG001|Overall Study|Unclassified|19|||
143344419|NCT03002038|516806682|FG000|Overall Study|Adverse Event|3|||
143344420|NCT03002038|516806683|FG001|Overall Study|Adverse Event|1|||
143456326|NCT00603304|517215822|FG000|Overall Study|Adverse Event|4|||
143456327|NCT00603304|517215823|FG001|Overall Study|Adverse Event|2|||
143456328|NCT00603304|517215822|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
143456329|NCT00603304|517215823|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
143456330|NCT00603304|517215822|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
143456331|NCT00603304|517215823|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
143456332|NCT00603304|517215822|FG000|Overall Study|Exclusionary Medication|2|||
143456333|NCT00603304|517215823|FG001|Overall Study|Exclusionary Medication|3|||
143456334|NCT00603304|517215822|FG000|Overall Study|Non-Compliant|0|||
143456335|NCT00603304|517215823|FG001|Overall Study|Non-Compliant|1|||
143344421|NCT03002038|516806682|FG000|Overall Study|Withdrawal by Subject|8|||
143344422|NCT03002038|516806683|FG001|Overall Study|Withdrawal by Subject|4|||
143344423|NCT03002038|516806682|FG000|Overall Study|Immigration to another region|0|||
143344424|NCT03002038|516806683|FG001|Overall Study|Immigration to another region|2|||
143344425|NCT02002182|516806693|FG000|Overall Study|Withdraw from study|3|||
143344426|NCT02002182|516806694|FG001|Overall Study|Withdraw from study|1|||
143344427|NCT02002182|516806693|FG000|Overall Study|Health Reasons|1|||
143344428|NCT02002182|516806694|FG001|Overall Study|Health Reasons|0|||
143344429|NCT02002182|516806693|FG000|Overall Study|Death|1|||
143344430|NCT02002182|516806694|FG001|Overall Study|Death|0|||
143344431|NCT04772053|516806697|FG000|Overall Study|Physician Decision|2|||
143344432|NCT04772053|516806697|FG000|Overall Study|Withdrawal by Subject|3|||
143344433|NCT04772053|516806697|FG000|Overall Study|Study Terminated by Sponsor|1|||
143344434|NCT02118337|516806698|FG000|Overall Study|Other|1|||
143344435|NCT02118337|516806699|FG001|Overall Study|Other|0|||
143344436|NCT02118337|516806700|FG002|Overall Study|Other|0|||
143344437|NCT02118337|516806701|FG003|Overall Study|Other|0|||
143344438|NCT02118337|516806702|FG004|Overall Study|Other|2|||
143344439|NCT02118337|516806703|FG005|Overall Study|Other|3|||
143344440|NCT02118337|516806704|FG006|Overall Study|Other|1|||
143344441|NCT02118337|516806705|FG007|Overall Study|Other|28|||
143344442|NCT02118337|516806706|FG008|Overall Study|Other|15|||
143344443|NCT02118337|516806698|FG000|Overall Study|Lost to Follow-up|0|||
143344444|NCT02118337|516806699|FG001|Overall Study|Lost to Follow-up|0|||
143344445|NCT02118337|516806700|FG002|Overall Study|Lost to Follow-up|0|||
143344446|NCT02118337|516806701|FG003|Overall Study|Lost to Follow-up|0|||
143344447|NCT02118337|516806702|FG004|Overall Study|Lost to Follow-up|0|||
143344448|NCT02118337|516806703|FG005|Overall Study|Lost to Follow-up|0|||
143344449|NCT02118337|516806704|FG006|Overall Study|Lost to Follow-up|0|||
143344450|NCT02118337|516806705|FG007|Overall Study|Lost to Follow-up|1|||
143344451|NCT02118337|516806706|FG008|Overall Study|Lost to Follow-up|0|||
143344452|NCT02118337|516806698|FG000|Overall Study|Withdrawal by Subject|1|||
143344453|NCT02118337|516806699|FG001|Overall Study|Withdrawal by Subject|3|||
143344454|NCT02118337|516806700|FG002|Overall Study|Withdrawal by Subject|2|||
143344455|NCT02118337|516806701|FG003|Overall Study|Withdrawal by Subject|1|||
143344456|NCT02118337|516806702|FG004|Overall Study|Withdrawal by Subject|2|||
143344457|NCT02118337|516806703|FG005|Overall Study|Withdrawal by Subject|2|||
143344458|NCT02118337|516806704|FG006|Overall Study|Withdrawal by Subject|1|||
143344459|NCT02118337|516806705|FG007|Overall Study|Withdrawal by Subject|4|||
143456336|NCT00603304|517215822|FG000|Overall Study|Moved Away|0|||
143456337|NCT00603304|517215823|FG001|Overall Study|Moved Away|2|||
143456338|NCT00603304|517215822|FG000|Overall Study|Other|2|||
143456339|NCT00603304|517215823|FG001|Overall Study|Other|0|||
143456340|NCT00603304|517215822|FG000|Overall Study|Patient Decision|2|||
143344460|NCT02118337|516806706|FG008|Overall Study|Withdrawal by Subject|2|||
143344461|NCT02118337|516806698|FG000|Overall Study|Death|2|||
143456341|NCT00603304|517215823|FG001|Overall Study|Patient Decision|0|||
143456342|NCT01076192|517215824|FG000|Overall Study|Other|197|||
143456343|NCT01034176|517215825|FG000|Overall Study|Physician Decision|2|||
143456344|NCT01034176|517215826|FG001|Overall Study|Physician Decision|0|||
143456345|NCT01034176|517215825|FG000|Overall Study|Withdrawal by Subject|0|||
143456346|NCT01034176|517215826|FG001|Overall Study|Withdrawal by Subject|1|||
143456347|NCT01034176|517215825|FG000|Overall Study|Lost to Follow-up|0|||
143456348|NCT01034176|517215826|FG001|Overall Study|Lost to Follow-up|1|||
143456349|NCT05087979|517215829|FG000|Overall Study|Converted to general anesthesia|1|||
143456350|NCT05087979|517215830|FG001|Overall Study|Converted to general anesthesia|0|||
143456351|NCT00616902|517215831|FG000|Overall Study|Termination of study|6|||
143456352|NCT00616902|517215832|FG001|Overall Study|Termination of study|6|||
143456353|NCT02680002|517215834|FG000|Overall Study|Lost to Follow-up|5|||
143456354|NCT02680002|517215835|FG001|Overall Study|Lost to Follow-up|1|||
143456355|NCT02680002|517215836|FG002|Overall Study|Lost to Follow-up|4|||
143456356|NCT02680002|517215837|FG003|Overall Study|Lost to Follow-up|2|||
143456357|NCT02680002|517215838|FG004|Overall Study|Lost to Follow-up|0|||
143456358|NCT02680002|517215839|FG005|Overall Study|Lost to Follow-up|2|||
143456359|NCT02680002|517215834|FG000|Overall Study|Physician Decision|5|||
143456360|NCT02680002|517215835|FG001|Overall Study|Physician Decision|1|||
143456361|NCT02680002|517215836|FG002|Overall Study|Physician Decision|1|||
143456362|NCT02680002|517215837|FG003|Overall Study|Physician Decision|1|||
143456363|NCT02680002|517215838|FG004|Overall Study|Physician Decision|1|||
143456364|NCT02680002|517215839|FG005|Overall Study|Physician Decision|1|||
143456365|NCT02680002|517215834|FG000|Overall Study|Protocol Violation|1|||
143456366|NCT02680002|517215835|FG001|Overall Study|Protocol Violation|0|||
143456367|NCT02680002|517215836|FG002|Overall Study|Protocol Violation|1|||
143456368|NCT02680002|517215837|FG003|Overall Study|Protocol Violation|0|||
143456369|NCT02680002|517215838|FG004|Overall Study|Protocol Violation|1|||
143456370|NCT02680002|517215839|FG005|Overall Study|Protocol Violation|2|||
143456371|NCT02680002|517215834|FG000|Overall Study|Withdrawal by Subject|0|||
143456372|NCT02680002|517215835|FG001|Overall Study|Withdrawal by Subject|0|||
143456373|NCT02680002|517215836|FG002|Overall Study|Withdrawal by Subject|1|||
143456374|NCT02680002|517215837|FG003|Overall Study|Withdrawal by Subject|0|||
143456375|NCT02680002|517215838|FG004|Overall Study|Withdrawal by Subject|2|||
143456376|NCT02680002|517215839|FG005|Overall Study|Withdrawal by Subject|2|||
143456377|NCT02680002|517215834|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
143456378|NCT02680002|517215835|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
143456379|NCT02680002|517215836|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
143456380|NCT02680002|517215837|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
143456381|NCT02680002|517215838|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
143456382|NCT02680002|517215839|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
143456383|NCT02680002|517215834|FG000|Overall Study|Other|0|||
143004303|NCT03323034|515554685|FG000|Overall Study|Lack of Efficacy|5|||
143004304|NCT03323034|515554686|FG001|Overall Study|Lack of Efficacy|5|||
143004305|NCT03323034|515554687|FG002|Overall Study|Lack of Efficacy|6|||
143004306|NCT03323034|515554688|FG003|Overall Study|Lack of Efficacy|5|||
143004307|NCT03323034|515554689|FG004|Overall Study|Lack of Efficacy|5|||
143456384|NCT02680002|517215835|FG001|Overall Study|Other|1|||
143456385|NCT02680002|517215836|FG002|Overall Study|Other|0|||
143456386|NCT02680002|517215837|FG003|Overall Study|Other|0|||
143456387|NCT02680002|517215838|FG004|Overall Study|Other|1|||
143456388|NCT02680002|517215839|FG005|Overall Study|Other|0|||
143456389|NCT02680002|517215834|FG000|Overall Study|Adverse Event|0|||
143456390|NCT02680002|517215835|FG001|Overall Study|Adverse Event|0|||
143456391|NCT02680002|517215836|FG002|Overall Study|Adverse Event|0|||
143456392|NCT02680002|517215837|FG003|Overall Study|Adverse Event|0|||
143456393|NCT02680002|517215838|FG004|Overall Study|Adverse Event|1|||
143456394|NCT02680002|517215839|FG005|Overall Study|Adverse Event|2|||
143456395|NCT00705679|517215840|FG000|Overall Study|Adverse Event|1|||
143456396|NCT00705679|517215841|FG001|Overall Study|Adverse Event|1|||
143004308|NCT03323034|515554685|FG000|Overall Study|Physician Decision|0|||
143004309|NCT03323034|515554686|FG001|Overall Study|Physician Decision|0|||
143004310|NCT03323034|515554687|FG002|Overall Study|Physician Decision|0|||
143344462|NCT02118337|516806699|FG001|Overall Study|Death|2|||
143344463|NCT02118337|516806700|FG002|Overall Study|Death|1|||
143344464|NCT02118337|516806701|FG003|Overall Study|Death|2|||
143344465|NCT02118337|516806702|FG004|Overall Study|Death|5|||
143344466|NCT02118337|516806703|FG005|Overall Study|Death|1|||
143344467|NCT02118337|516806704|FG006|Overall Study|Death|2|||
143456397|NCT00705679|517215842|FG002|Overall Study|Adverse Event|0|||
143456398|NCT00705679|517215843|FG003|Overall Study|Adverse Event|0|||
143456399|NCT00705679|517215844|FG004|Overall Study|Adverse Event|0|||
143456400|NCT00705679|517215840|FG000|Overall Study|Death|0|||
143456401|NCT00705679|517215841|FG001|Overall Study|Death|0|||
143456402|NCT00705679|517215842|FG002|Overall Study|Death|3|||
143456403|NCT00705679|517215843|FG003|Overall Study|Death|2|||
143456404|NCT00705679|517215844|FG004|Overall Study|Death|1|||
143456405|NCT00705679|517215840|FG000|Overall Study|Lost to Follow-up|32|||
143456406|NCT00705679|517215841|FG001|Overall Study|Lost to Follow-up|60|||
143456407|NCT00705679|517215842|FG002|Overall Study|Lost to Follow-up|44|||
143456408|NCT00705679|517215843|FG003|Overall Study|Lost to Follow-up|30|||
143456409|NCT00705679|517215844|FG004|Overall Study|Lost to Follow-up|35|||
143456410|NCT00705679|517215840|FG000|Overall Study|Physician Decision|0|||
143456411|NCT00705679|517215841|FG001|Overall Study|Physician Decision|1|||
143456412|NCT00705679|517215842|FG002|Overall Study|Physician Decision|0|||
143456413|NCT00705679|517215843|FG003|Overall Study|Physician Decision|1|||
143456414|NCT00705679|517215844|FG004|Overall Study|Physician Decision|0|||
143456415|NCT00705679|517215840|FG000|Overall Study|Withdrawal by Subject|32|||
143456416|NCT00705679|517215841|FG001|Overall Study|Withdrawal by Subject|77|||
143456417|NCT00705679|517215842|FG002|Overall Study|Withdrawal by Subject|68|||
143456418|NCT00705679|517215843|FG003|Overall Study|Withdrawal by Subject|47|||
143456419|NCT00705679|517215844|FG004|Overall Study|Withdrawal by Subject|33|||
143456420|NCT03730480|517215847|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
143456421|NCT01248780|517215848|FG000|Overall Study|Lack of Efficacy|2|||
143456422|NCT01248780|517215849|FG001|Overall Study|Lack of Efficacy|0|||
143456423|NCT01248780|517215848|FG000|Overall Study|Lost to Follow-up|0|||
143456424|NCT01248780|517215849|FG001|Overall Study|Lost to Follow-up|1|||
143456425|NCT01248780|517215848|FG000|Overall Study|Death|0|||
143456426|NCT01248780|517215849|FG001|Overall Study|Death|1|||
143456427|NCT01248780|517215848|FG000|Overall Study|Adverse Event|2|||
143456428|NCT01248780|517215849|FG001|Overall Study|Adverse Event|7|||
143456429|NCT01248780|517215848|FG000|Overall Study|Protocol Violation|1|||
143456430|NCT01248780|517215849|FG001|Overall Study|Protocol Violation|1|||
143456431|NCT01248780|517215848|FG000|Overall Study|Withdrawal by Subject|4|||
143456432|NCT01248780|517215849|FG001|Overall Study|Withdrawal by Subject|4|||
143456433|NCT01248780|517215848|FG000|Overall Study|Not treated|0|||
143456434|NCT01248780|517215849|FG001|Overall Study|Not treated|1|||
143456435|NCT04097301|517215850|FG000|Overall Study|Death|1|||
143456436|NCT04097301|517215850|FG000|Overall Study|Withdrawal by Subject|1|||
143456437|NCT04097301|517215850|FG000|Overall Study|Screening Failure|5|||
143456438|NCT01227577|517215851|FG000|Overall Study|Protocol deviation|3|||
143456439|NCT01227577|517215851|FG000|Overall Study|Death|3|||
143456440|NCT01227577|517215851|FG000|Overall Study|Administrative problems|2|||
143456441|NCT01227577|517215851|FG000|Overall Study|Lost to Follow-up|1|||
143456442|NCT01227577|517215851|FG000|Overall Study|Withdrawal by Subject|4|||
143456443|NCT01227577|517215851|FG000|Overall Study|Lack of Efficacy|5|||
143456444|NCT01227577|517215851|FG000|Overall Study|Adverse Event|17|||
143456445|NCT02480153|517215852|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
143456446|NCT02480153|517215853|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
143456447|NCT02480153|517215854|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
143456448|NCT02480153|517215852|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
143456449|NCT02480153|517215853|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
143456450|NCT02480153|517215854|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
143456451|NCT02480153|517215852|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
143456452|NCT02480153|517215853|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
143456453|NCT02480153|517215854|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
143456454|NCT02480153|517215852|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
143456455|NCT02480153|517215853|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
143456456|NCT02480153|517215854|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
143456457|NCT02480153|517215852|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
143456458|NCT02480153|517215853|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
143456459|NCT02480153|517215854|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
143456460|NCT02480153|517215852|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
143456461|NCT02480153|517215853|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
143456462|NCT02480153|517215854|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
143456463|NCT02480153|517215852|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
143456464|NCT02480153|517215853|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
143456465|NCT02480153|517215854|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
143456466|NCT02480153|517215852|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
143456467|NCT02480153|517215853|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
143456468|NCT02480153|517215854|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
143456469|NCT02480153|517215852|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
143456470|NCT02480153|517215853|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
143456471|NCT02480153|517215854|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
143456472|NCT02480153|517215852|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
143456473|NCT02480153|517215853|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
143456474|NCT02480153|517215854|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
143456475|NCT02480153|517215852|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
143456476|NCT02480153|517215853|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
143456477|NCT02480153|517215854|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
143456478|NCT02480153|517215852|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
143456479|NCT02480153|517215853|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
143456480|NCT02480153|517215854|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
143456481|NCT02480153|517215852|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
143456482|NCT02480153|517215853|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
143456483|NCT02480153|517215854|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
143456484|NCT02480153|517215852|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
143456485|NCT02480153|517215853|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
143456486|NCT02480153|517215854|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
143456487|NCT02480153|517215852|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
143456488|NCT02480153|517215853|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
143456489|NCT02480153|517215854|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
143456490|NCT02480153|517215852|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
143456491|NCT02480153|517215853|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
143456492|NCT02480153|517215854|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
143456493|NCT02480153|517215852|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
143456494|NCT02480153|517215853|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
143456495|NCT02480153|517215854|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
143456496|NCT02480153|517215852|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
143456497|NCT02480153|517215853|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
143456498|NCT02480153|517215854|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
143456499|NCT03241225|517215855|FG000|Overall Study|Lost to Follow-up|2|||
143456500|NCT03241225|517215856|FG001|Overall Study|Lost to Follow-up|1|||
143456501|NCT03241225|517215855|FG000|Overall Study|Protocol Violation|4|||
143456502|NCT03241225|517215856|FG001|Overall Study|Protocol Violation|1|||
143456503|NCT03241225|517215855|FG000|Overall Study|Withdrawal by Subject|1|||
143456504|NCT03241225|517215856|FG001|Overall Study|Withdrawal by Subject|0|||
143456505|NCT00852540|517215857|FG000|Overall Study|Adverse Event|10|||
143004311|NCT03323034|515554688|FG003|Overall Study|Physician Decision|0|||
143004312|NCT03323034|515554689|FG004|Overall Study|Physician Decision|1|||
143004313|NCT03323034|515554685|FG000|Overall Study|Withdrawal by Subject|1|||
143004314|NCT03323034|515554686|FG001|Overall Study|Withdrawal by Subject|1|||
143004315|NCT03323034|515554687|FG002|Overall Study|Withdrawal by Subject|0|||
143004316|NCT03323034|515554688|FG003|Overall Study|Withdrawal by Subject|1|||
143004317|NCT03323034|515554689|FG004|Overall Study|Withdrawal by Subject|0|||
143456506|NCT00852540|517215858|FG001|Overall Study|Adverse Event|3|||
143456507|NCT00852540|517215857|FG000|Overall Study|Lack of Efficacy|15|||
143456508|NCT00852540|517215858|FG001|Overall Study|Lack of Efficacy|3|||
143456509|NCT00852540|517215857|FG000|Overall Study|Protocol Violation|1|||
143456510|NCT00852540|517215858|FG001|Overall Study|Protocol Violation|2|||
143456511|NCT00852540|517215857|FG000|Overall Study|Lost to Follow-up|2|||
143456512|NCT00852540|517215858|FG001|Overall Study|Lost to Follow-up|3|||
143456513|NCT00852540|517215857|FG000|Overall Study|Investigator Discretion|2|||
143456514|NCT00852540|517215858|FG001|Overall Study|Investigator Discretion|3|||
143456515|NCT00852540|517215857|FG000|Overall Study|Withdrawal by Subject|3|||
143456516|NCT00852540|517215858|FG001|Overall Study|Withdrawal by Subject|1|||
143456517|NCT00852540|517215857|FG000|Overall Study|Did Not Receive Study Drug|3|||
143456518|NCT00852540|517215858|FG001|Overall Study|Did Not Receive Study Drug|3|||
143456519|NCT01119105|517215859|FG000|Overall Study|Withdrawal by Subject|1|||
143456520|NCT01119105|517215860|FG001|Overall Study|Withdrawal by Subject|1|||
143456521|NCT01119105|517215861|FG002|Overall Study|Withdrawal by Subject|1|||
143456522|NCT01119105|517215859|FG000|Overall Study|Lost to Follow-up|0|||
143456523|NCT01119105|517215860|FG001|Overall Study|Lost to Follow-up|2|||
143456524|NCT01119105|517215861|FG002|Overall Study|Lost to Follow-up|5|||
143456525|NCT01119105|517215859|FG000|Overall Study|Adverse Event|1|||
143456526|NCT01119105|517215860|FG001|Overall Study|Adverse Event|0|||
143456527|NCT01119105|517215861|FG002|Overall Study|Adverse Event|1|||
143456528|NCT01119105|517215859|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
143456529|NCT01119105|517215860|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
143456530|NCT01119105|517215861|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
143456531|NCT01119105|517215859|FG000|Overall Study|Other|1|||
143456532|NCT01119105|517215860|FG001|Overall Study|Other|1|||
143456533|NCT01119105|517215861|FG002|Overall Study|Other|0|||
143456534|NCT01639495|517215862|FG000|Overall Study|Lost to Follow-up|6|||
143456535|NCT01639495|517215862|FG000|Overall Study|Consented but didn't have study catheter|4|||
143456536|NCT01639495|517215862|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
143456537|NCT01639495|517215862|FG000|Overall Study|No radiofrequency energy applied|2|||
143456538|NCT04214600|517215865|FG000|Overall Study|Lost to Follow-up|9|||
143456539|NCT04214600|517215866|FG001|Overall Study|Lost to Follow-up|14|||
143456540|NCT01635920|517215873|FG000|Overall Study|Adverse Event|1|||
143456541|NCT01635920|517215874|FG001|Overall Study|Adverse Event|0|||
143456542|NCT01635920|517215873|FG000|Overall Study|Lost to Follow-up|0|||
143456543|NCT01635920|517215874|FG001|Overall Study|Lost to Follow-up|1|||
143456544|NCT01635920|517215873|FG000|Overall Study|Subject decision|2|||
143456545|NCT01635920|517215874|FG001|Overall Study|Subject decision|0|||
143456546|NCT01813929|517215876|FG000|Overall Study|Withdrawal by Subject|0|||
143456547|NCT01813929|517215877|FG001|Overall Study|Withdrawal by Subject|1|||
143456548|NCT00007345|517215878|FG000|Overall Study|Refused further treatment|0|||
143456549|NCT00007345|517215879|FG001|Overall Study|Refused further treatment|7|||
143456550|NCT00007345|517215878|FG000|Overall Study|Switched to alternative treatment|0|||
143456551|NCT00007345|517215879|FG001|Overall Study|Switched to alternative treatment|3|||
143456552|NCT00007345|517215878|FG000|Overall Study|Intercurrent illness|1|||
143456553|NCT00007345|517215879|FG001|Overall Study|Intercurrent illness|0|||
143456554|NCT00007345|517215878|FG000|Overall Study|Death on study|1|||
143456555|NCT00007345|517215879|FG001|Overall Study|Death on study|1|||
143456556|NCT04433585|517215880|FG000|Overall Study|Withdrawal by Subject|15|||
143456557|NCT04433585|517215881|FG001|Overall Study|Withdrawal by Subject|3|||
143456558|NCT04433585|517215882|FG002|Overall Study|Withdrawal by Subject|15|||
143456559|NCT04433585|517215883|FG003|Overall Study|Withdrawal by Subject|6|||
143456560|NCT04433585|517215880|FG000|Overall Study|Adverse Event|10|||
143456561|NCT04433585|517215881|FG001|Overall Study|Adverse Event|4|||
143456562|NCT04433585|517215882|FG002|Overall Study|Adverse Event|1|||
143456563|NCT04433585|517215883|FG003|Overall Study|Adverse Event|0|||
143456564|NCT04433585|517215880|FG000|Overall Study|Due to the conflict in Ukraine|2|||
143456565|NCT04433585|517215881|FG001|Overall Study|Due to the conflict in Ukraine|1|||
143456566|NCT04433585|517215882|FG002|Overall Study|Due to the conflict in Ukraine|1|||
143456567|NCT04433585|517215883|FG003|Overall Study|Due to the conflict in Ukraine|2|||
143456568|NCT04433585|517215880|FG000|Overall Study|Physician Decision|1|||
143456569|NCT04433585|517215881|FG001|Overall Study|Physician Decision|2|||
143456570|NCT04433585|517215882|FG002|Overall Study|Physician Decision|0|||
143456571|NCT04433585|517215883|FG003|Overall Study|Physician Decision|0|||
143456572|NCT04433585|517215880|FG000|Overall Study|Lost to Follow-up|1|||
143456573|NCT04433585|517215881|FG001|Overall Study|Lost to Follow-up|1|||
143456574|NCT04433585|517215882|FG002|Overall Study|Lost to Follow-up|1|||
143456575|NCT04433585|517215883|FG003|Overall Study|Lost to Follow-up|0|||
143456576|NCT04433585|517215880|FG000|Overall Study|Lack of Efficacy|0|||
143456577|NCT04433585|517215881|FG001|Overall Study|Lack of Efficacy|1|||
143456578|NCT04433585|517215882|FG002|Overall Study|Lack of Efficacy|1|||
143456579|NCT04433585|517215883|FG003|Overall Study|Lack of Efficacy|1|||
143456580|NCT04433585|517215880|FG000|Overall Study|Death|0|||
143456581|NCT04433585|517215881|FG001|Overall Study|Death|1|||
143456582|NCT04433585|517215882|FG002|Overall Study|Death|0|||
143456583|NCT04433585|517215883|FG003|Overall Study|Death|0|||
143456584|NCT02342743|517215884|FG000|Baseline Period|Withdrawal by Subject|3|||
143456585|NCT02342743|517215884|FG000|Baseline Period|Lost to Follow-up|2|||
143456586|NCT02342743|517215884|FG000|Baseline Period|Change in prophylactic medication|3|||
143456587|NCT02342743|517215884|FG000|Baseline Period|Screening failure regarding baseline|7|||
143456588|NCT02342743|517215884|FG000|Treatment Period|Withdrawal by Subject|2|||
143456589|NCT02342743|517215884|FG000|Treatment Period|Lost to Follow-up|8|||
143456590|NCT02342743|517215884|FG000|Treatment Period|Change in prophylactic medication|1|||
143456591|NCT00686725|517215885|FG000|Overall Study|Adverse Event|1|||
143456592|NCT00686725|517215886|FG001|Overall Study|Adverse Event|1|||
143456593|NCT00686725|517215885|FG000|Overall Study|Progressive Disease|17|||
143456594|NCT00686725|517215886|FG001|Overall Study|Progressive Disease|23|||
143456595|NCT00686725|517215885|FG000|Overall Study|Lost to Follow-up|7|||
143456596|NCT00686725|517215886|FG001|Overall Study|Lost to Follow-up|5|||
143456597|NCT00686725|517215885|FG000|Overall Study|Death|6|||
143456598|NCT00686725|517215886|FG001|Overall Study|Death|3|||
143456599|NCT00686725|517215885|FG000|Overall Study|Withdrawal by Subject|13|||
143456600|NCT00686725|517215886|FG001|Overall Study|Withdrawal by Subject|4|||
143456601|NCT00686725|517215885|FG000|Overall Study|Protocol Violation|1|||
143456602|NCT00686725|517215886|FG001|Overall Study|Protocol Violation|3|||
143456603|NCT00686725|517215885|FG000|Overall Study|Other|1|||
143230334|NCT00446849|516393205|FG000|Acute Phase|Protocol Violation|10|||
143456604|NCT00686725|517215886|FG001|Overall Study|Other|3|||
143456605|NCT00092495|517215887|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
143456606|NCT00092495|517215888|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
143456607|NCT00092495|517215889|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
143456608|NCT00092495|517215890|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
143456609|NCT00092495|517215891|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
143456610|NCT00092495|517215887|FG000|Base Study Vaccination Period|Extended|0|||
143456611|NCT00092495|517215888|FG001|Base Study Vaccination Period|Extended|0|||
143456612|NCT00092495|517215889|FG002|Base Study Vaccination Period|Extended|0|||
143456613|NCT00092495|517215890|FG003|Base Study Vaccination Period|Extended|1|||
143456614|NCT00092495|517215891|FG004|Base Study Vaccination Period|Extended|0|||
143456615|NCT00092495|517215887|FG000|Base Study Vaccination Period|*Clinical AE|1|||
143456616|NCT00092495|517215888|FG001|Base Study Vaccination Period|*Clinical AE|0|||
143456617|NCT00092495|517215889|FG002|Base Study Vaccination Period|*Clinical AE|1|||
143456618|NCT00092495|517215890|FG003|Base Study Vaccination Period|*Clinical AE|2|||
143456619|NCT00092495|517215891|FG004|Base Study Vaccination Period|*Clinical AE|0|||
143456620|NCT00092495|517215887|FG000|Base Study Vaccination Period|*Other reasons|1|||
143456621|NCT00092495|517215888|FG001|Base Study Vaccination Period|*Other reasons|0|||
143456622|NCT00092495|517215889|FG002|Base Study Vaccination Period|*Other reasons|0|||
143456623|NCT00092495|517215890|FG003|Base Study Vaccination Period|*Other reasons|1|||
143456624|NCT00092495|517215891|FG004|Base Study Vaccination Period|*Other reasons|0|||
143456625|NCT00092495|517215887|FG000|Base Study Vaccination Period|*Pregnancy|0|||
143456626|NCT00092495|517215888|FG001|Base Study Vaccination Period|*Pregnancy|2|||
143456627|NCT00092495|517215889|FG002|Base Study Vaccination Period|*Pregnancy|5|||
143456628|NCT00092495|517215890|FG003|Base Study Vaccination Period|*Pregnancy|7|||
143456629|NCT00092495|517215891|FG004|Base Study Vaccination Period|*Pregnancy|0|||
143456630|NCT00092495|517215887|FG000|Base Study Vaccination Period|Adverse Event|1|||
143456631|NCT00092495|517215888|FG001|Base Study Vaccination Period|Adverse Event|0|||
143456632|NCT00092495|517215889|FG002|Base Study Vaccination Period|Adverse Event|0|||
143456633|NCT00092495|517215890|FG003|Base Study Vaccination Period|Adverse Event|3|||
143456634|NCT00092495|517215891|FG004|Base Study Vaccination Period|Adverse Event|0|||
143456635|NCT00092495|517215887|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
143456636|NCT00092495|517215888|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
143456637|NCT00092495|517215889|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
143456638|NCT00092495|517215890|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
143456639|NCT00092495|517215891|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
143456640|NCT00092495|517215887|FG000|Base Study Vaccination Period|Moved|3|||
143456641|NCT00092495|517215888|FG001|Base Study Vaccination Period|Moved|1|||
143456642|NCT00092495|517215889|FG002|Base Study Vaccination Period|Moved|2|||
143456643|NCT00092495|517215890|FG003|Base Study Vaccination Period|Moved|2|||
143456644|NCT00092495|517215891|FG004|Base Study Vaccination Period|Moved|0|||
143456645|NCT00092495|517215887|FG000|Base Study Vaccination Period|Other|1|||
143456646|NCT00092495|517215888|FG001|Base Study Vaccination Period|Other|1|||
143456647|NCT00092495|517215889|FG002|Base Study Vaccination Period|Other|0|||
143456648|NCT00092495|517215890|FG003|Base Study Vaccination Period|Other|2|||
143456649|NCT00092495|517215891|FG004|Base Study Vaccination Period|Other|0|||
143456650|NCT00092495|517215887|FG000|Base Study Vaccination Period|Pregnancy|2|||
143456651|NCT00092495|517215888|FG001|Base Study Vaccination Period|Pregnancy|0|||
143456652|NCT00092495|517215889|FG002|Base Study Vaccination Period|Pregnancy|0|||
143456653|NCT00092495|517215890|FG003|Base Study Vaccination Period|Pregnancy|0|||
143456654|NCT00092495|517215891|FG004|Base Study Vaccination Period|Pregnancy|0|||
143456655|NCT00092495|517215887|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
143456656|NCT00092495|517215888|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
143456657|NCT00092495|517215889|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
143456658|NCT00092495|517215890|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
143456659|NCT00092495|517215891|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
143456660|NCT00092495|517215887|FG000|Base Study Vaccination Period|Protocol Violation|1|||
143456661|NCT00092495|517215888|FG001|Base Study Vaccination Period|Protocol Violation|0|||
143456662|NCT00092495|517215889|FG002|Base Study Vaccination Period|Protocol Violation|0|||
143456663|NCT00092495|517215890|FG003|Base Study Vaccination Period|Protocol Violation|0|||
143456664|NCT00092495|517215891|FG004|Base Study Vaccination Period|Protocol Violation|0|||
143456665|NCT00092495|517215887|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
143456666|NCT00092495|517215888|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
143456667|NCT00092495|517215889|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
143456668|NCT00092495|517215890|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
143456669|NCT00092495|517215891|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
143456670|NCT00092495|517215887|FG000|Base Study Follow-up Period|Extended|0|||
143456671|NCT00092495|517215888|FG001|Base Study Follow-up Period|Extended|0|||
143456672|NCT00092495|517215889|FG002|Base Study Follow-up Period|Extended|1|||
143456673|NCT00092495|517215890|FG003|Base Study Follow-up Period|Extended|2|||
143456674|NCT00092495|517215891|FG004|Base Study Follow-up Period|Extended|0|||
143456675|NCT00092495|517215887|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
143456676|NCT00092495|517215888|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
143456677|NCT00092495|517215889|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
143456678|NCT00092495|517215890|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
143456679|NCT00092495|517215891|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
143456680|NCT00092495|517215887|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
143456681|NCT00092495|517215888|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
143456682|NCT00092495|517215889|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
143456683|NCT00092495|517215890|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
143456684|NCT00092495|517215891|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
143456685|NCT00938470|517215896|FG000|Overall Study|Disease Progression|3|||
143456686|NCT00938470|517215897|FG001|Overall Study|Disease Progression|0|||
143456687|NCT00938470|517215896|FG000|Overall Study|Alternate Treatment|1|||
143456688|NCT00938470|517215897|FG001|Overall Study|Alternate Treatment|0|||
143456689|NCT00938470|517215896|FG000|Overall Study|Death|3|||
143456690|NCT00938470|517215897|FG001|Overall Study|Death|2|||
143456691|NCT00938470|517215896|FG000|Overall Study|Other Reason|0|||
143456692|NCT00938470|517215897|FG001|Overall Study|Other Reason|1|||
143456693|NCT01346475|517215899|FG000|First Intervention|Lost to Follow-up|4|||
143456694|NCT01346475|517215900|FG001|First Intervention|Lost to Follow-up|3|||
143456695|NCT01552603|517215901|FG000|Overall Study|Physician Decision|1|||
143456696|NCT00618618|517215902|FG000|Overall Study|Patient Request|0|||
143456697|NCT00618618|517215903|FG001|Overall Study|Patient Request|0|||
143456698|NCT00618618|517215904|FG002|Overall Study|Patient Request|2|||
143456699|NCT00618618|517215905|FG003|Overall Study|Patient Request|0|||
143456700|NCT00618618|517215902|FG000|Overall Study|Inability to Complete Study Procedures|0|||
143456701|NCT00618618|517215903|FG001|Overall Study|Inability to Complete Study Procedures|1|||
143456702|NCT00618618|517215904|FG002|Overall Study|Inability to Complete Study Procedures|0|||
143456703|NCT00618618|517215905|FG003|Overall Study|Inability to Complete Study Procedures|0|||
143456704|NCT00618618|517215902|FG000|Overall Study|Lost to Follow-up|3|||
143456705|NCT00618618|517215903|FG001|Overall Study|Lost to Follow-up|0|||
143456706|NCT00618618|517215904|FG002|Overall Study|Lost to Follow-up|0|||
143456707|NCT00618618|517215905|FG003|Overall Study|Lost to Follow-up|1|||
143456708|NCT00618618|517215902|FG000|Overall Study|Non-compliance|1|||
143456709|NCT00618618|517215903|FG001|Overall Study|Non-compliance|1|||
143456710|NCT00618618|517215904|FG002|Overall Study|Non-compliance|0|||
143456711|NCT00618618|517215905|FG003|Overall Study|Non-compliance|0|||
143456712|NCT00618618|517215902|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
143456713|NCT00618618|517215903|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
143456714|NCT00618618|517215904|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
143456715|NCT00618618|517215905|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
143456716|NCT00618618|517215902|FG000|Overall Study|Death|0|||
143456717|NCT00618618|517215903|FG001|Overall Study|Death|1|||
143456718|NCT00618618|517215904|FG002|Overall Study|Death|0|||
143456719|NCT00618618|517215905|FG003|Overall Study|Death|0|||
143456720|NCT04797650|517215908|FG000|Overall Study|Reason Not Specified|5|||
143456721|NCT04797650|517215909|FG001|Overall Study|Reason Not Specified|12|||
143456722|NCT04797650|517215910|FG002|Overall Study|Reason Not Specified|5|||
143456723|NCT04797650|517215908|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
143456724|NCT04797650|517215909|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
143456725|NCT04797650|517215910|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
143456726|NCT04797650|517215908|FG000|Overall Study|Lack of Efficacy|1|||
143456727|NCT04797650|517215909|FG001|Overall Study|Lack of Efficacy|0|||
143456728|NCT04797650|517215910|FG002|Overall Study|Lack of Efficacy|1|||
143456729|NCT04797650|517215908|FG000|Overall Study|Non-compliance with Study Drug|0|||
143456730|NCT04797650|517215909|FG001|Overall Study|Non-compliance with Study Drug|0|||
143456731|NCT04797650|517215910|FG002|Overall Study|Non-compliance with Study Drug|2|||
143456732|NCT04797650|517215908|FG000|Overall Study|Lost to Follow-up|4|||
143456733|NCT04797650|517215909|FG001|Overall Study|Lost to Follow-up|6|||
143456734|NCT04797650|517215910|FG002|Overall Study|Lost to Follow-up|1|||
143456735|NCT01183234|517215913|FG000|First Intervention|Adverse Event|1|||
143456736|NCT01183234|517215914|FG001|First Intervention|Adverse Event|0|||
143456737|NCT00473265|517215915|FG000|Overall Study|Unrelated adverse event|5|||
143456738|NCT00473265|517215915|FG000|Overall Study|Off treatment early|15|||
143456739|NCT00309959|517215916|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
143456740|NCT02947087|517215917|FG000|Overall Study|Withdrawal by Subject|3|||
143456741|NCT02947087|517215918|FG001|Overall Study|Withdrawal by Subject|2|||
143456742|NCT00768079|517215923|FG000|Overall Study|Lost to Follow-up|2|||
143456743|NCT00768079|517215924|FG001|Overall Study|Lost to Follow-up|0|||
143456744|NCT00768079|517215925|FG002|Overall Study|Lost to Follow-up|4|||
143456745|NCT00768079|517215923|FG000|Overall Study|Participant incarcerated|0|||
143456746|NCT00768079|517215924|FG001|Overall Study|Participant incarcerated|1|||
143456747|NCT00768079|517215925|FG002|Overall Study|Participant incarcerated|0|||
143004318|NCT02815540|515554693|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
143004319|NCT02222246|515554694|FG000|Overall Study|No Emergency Department Visits|27|||
143004320|NCT02222246|515554695|FG001|Overall Study|No Emergency Department Visits|26|||
143004321|NCT02222246|515554694|FG000|Overall Study|Physician Decision|0|||
143004322|NCT02222246|515554695|FG001|Overall Study|Physician Decision|1|||
143004323|NCT04887922|515554703|FG000|1st Randomization|Decided not to have surgery|0|||
143456748|NCT03212989|517215927|FG000|Overall Study|Physician Decision|8|||
143456749|NCT01844687|517215928|FG000|Visit 1|Protocol Violation|3|||
143004324|NCT04887922|515554704|FG001|1st Randomization|Decided not to have surgery|1|||
143004325|NCT04887922|515554705|FG002|1st Randomization|Decided not to have surgery|0|||
143456750|NCT01844687|517215928|FG000|Visit 1|Lost to Follow-up|5|||
143456751|NCT01844687|517215928|FG000|Visit 2|Withdrawal by Subject|1|||
143456752|NCT01844687|517215928|FG000|Visit 2|Protocol Violation|1|||
143456753|NCT01844687|517215928|FG000|Visit 3|Lost to Follow-up|1|||
143456754|NCT01844687|517215928|FG000|Visit 3|Withdrawal by Subject|3|||
143456755|NCT01844687|517215928|FG000|Visit 3|child care problems|1|||
143456756|NCT01844687|517215928|FG000|Visit 4|Pregnancy|1|||
143456757|NCT01844687|517215928|FG000|Visit 4|Lost to Follow-up|1|||
143456758|NCT01844687|517215928|FG000|Visit 4|Withdrawal by Subject|2|||
143456759|NCT02057523|517215931|FG000|Overall Study|Withdrawal by Subject|1|||
143456760|NCT02057523|517215931|FG000|Overall Study|Lack of Efficacy|1|||
143456761|NCT01871805|517215936|FG000|Phase I|Death|7|||
143456762|NCT01871805|517215937|FG001|Phase I|Death|4|||
143456763|NCT01871805|517215938|FG002|Phase I|Death|6|||
143456764|NCT01871805|517215939|FG003|Phase I|Death|2|||
143456765|NCT01871805|517215940|FG004|Phase I|Death|9|||
143456766|NCT01871805|517215941|FG005|Phase I|Death|0|||
143456767|NCT01871805|517215936|FG000|Phase I|Alive in Survival Follow-up|0|||
143456768|NCT01871805|517215937|FG001|Phase I|Alive in Survival Follow-up|2|||
143456769|NCT01871805|517215938|FG002|Phase I|Alive in Survival Follow-up|4|||
143456770|NCT01871805|517215939|FG003|Phase I|Alive in Survival Follow-up|5|||
143456771|NCT01871805|517215940|FG004|Phase I|Alive in Survival Follow-up|4|||
143456772|NCT01871805|517215941|FG005|Phase I|Alive in Survival Follow-up|0|||
143456773|NCT01871805|517215936|FG000|Phase I|Lost to Follow-up|0|||
143456774|NCT01871805|517215937|FG001|Phase I|Lost to Follow-up|1|||
143456775|NCT01871805|517215938|FG002|Phase I|Lost to Follow-up|3|||
143456776|NCT01871805|517215939|FG003|Phase I|Lost to Follow-up|0|||
143456777|NCT01871805|517215940|FG004|Phase I|Lost to Follow-up|0|||
143456778|NCT01871805|517215941|FG005|Phase I|Lost to Follow-up|0|||
143456779|NCT01871805|517215936|FG000|Phase II|Death|0|||
143456780|NCT01871805|517215937|FG001|Phase II|Death|0|||
143456781|NCT01871805|517215938|FG002|Phase II|Death|0|||
143456782|NCT01871805|517215939|FG003|Phase II|Death|0|||
143456783|NCT01871805|517215940|FG004|Phase II|Death|0|||
143456784|NCT01871805|517215941|FG005|Phase II|Death|45|||
143456785|NCT01871805|517215936|FG000|Phase II|Alive in Survival Follow-up|0|||
143456786|NCT01871805|517215937|FG001|Phase II|Alive in Survival Follow-up|0|||
143456787|NCT01871805|517215938|FG002|Phase II|Alive in Survival Follow-up|0|||
143456788|NCT01871805|517215939|FG003|Phase II|Alive in Survival Follow-up|0|||
143456789|NCT01871805|517215940|FG004|Phase II|Alive in Survival Follow-up|0|||
143456790|NCT01871805|517215941|FG005|Phase II|Alive in Survival Follow-up|29|||
143456791|NCT01871805|517215936|FG000|Phase II|Lost to Follow-up|0|||
143456792|NCT01871805|517215937|FG001|Phase II|Lost to Follow-up|0|||
143456793|NCT01871805|517215938|FG002|Phase II|Lost to Follow-up|0|||
143456794|NCT01871805|517215939|FG003|Phase II|Lost to Follow-up|0|||
143456795|NCT01871805|517215940|FG004|Phase II|Lost to Follow-up|0|||
143456796|NCT01871805|517215941|FG005|Phase II|Lost to Follow-up|13|||
143456797|NCT00635427|517215942|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
143456798|NCT00635427|517215943|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
143456799|NCT00635427|517215944|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
143456800|NCT00635427|517215945|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
143456801|NCT00635427|517215946|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
143456802|NCT00635427|517215942|FG000|Overall Study|Death|0|||
143456803|NCT00635427|517215943|FG001|Overall Study|Death|0|||
143456804|NCT00635427|517215944|FG002|Overall Study|Death|0|||
143004326|NCT04887922|515554706|FG003|1st Randomization|Decided not to have surgery|0|||
143004327|NCT04887922|515554707|FG004|1st Randomization|Decided not to have surgery|0|||
143004328|NCT00953017|515554708|FG000|Overall Study|DId not show up for colonoscopy|4|||
143456805|NCT00635427|517215945|FG003|Overall Study|Death|1|||
143456806|NCT00635427|517215946|FG004|Overall Study|Death|0|||
143456807|NCT00635427|517215942|FG000|Overall Study|Termination Of Study By Sponsor|12|||
143456808|NCT00635427|517215943|FG001|Overall Study|Termination Of Study By Sponsor|6|||
143456809|NCT00635427|517215944|FG002|Overall Study|Termination Of Study By Sponsor|10|||
143456810|NCT00635427|517215945|FG003|Overall Study|Termination Of Study By Sponsor|6|||
143456811|NCT00635427|517215946|FG004|Overall Study|Termination Of Study By Sponsor|6|||
143456812|NCT00635427|517215942|FG000|Overall Study|Withdrawal Of Consent|0|||
143456813|NCT00635427|517215943|FG001|Overall Study|Withdrawal Of Consent|0|||
143456814|NCT00635427|517215944|FG002|Overall Study|Withdrawal Of Consent|0|||
143456815|NCT00635427|517215945|FG003|Overall Study|Withdrawal Of Consent|2|||
143456816|NCT00635427|517215946|FG004|Overall Study|Withdrawal Of Consent|2|||
143456817|NCT00564889|517215947|FG000|Overall Study|Death|7|||
143456818|NCT00564889|517215947|FG000|Overall Study|Adverse Event|12|||
143456819|NCT00564889|517215947|FG000|Overall Study|Alternative treatment|3|||
143456820|NCT00564889|517215947|FG000|Overall Study|Disease progression|3|||
143456821|NCT00564889|517215947|FG000|Overall Study|Other, not specified|4|||
143456822|NCT01021215|517215948|FG000|Overall Study|Lost to Follow-up|3|||
143456823|NCT01021215|517215949|FG001|Overall Study|Lost to Follow-up|0|||
143230335|NCT00446849|516393205|FG000|Acute Phase|Consent withdrawn|4|||
143456824|NCT04058366|517217441|FG000|Overall Study|Adverse Event|14|||
143456825|NCT04058366|517217441|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
143456826|NCT04058366|517217441|FG000|Overall Study|Commercial drug is available for participants|6|||
143004329|NCT00953017|515554709|FG001|Overall Study|DId not show up for colonoscopy|4|||
143004330|NCT00953017|515554710|FG002|Overall Study|DId not show up for colonoscopy|5|||
143004331|NCT00953017|515554711|FG003|Overall Study|DId not show up for colonoscopy|4|||
143004332|NCT00953017|515554708|FG000|Overall Study|Incomplete data|1|||
143004333|NCT00953017|515554709|FG001|Overall Study|Incomplete data|1|||
143004334|NCT00953017|515554710|FG002|Overall Study|Incomplete data|0|||
143004335|NCT00953017|515554711|FG003|Overall Study|Incomplete data|0|||
143004336|NCT00953017|515554708|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
143004337|NCT00953017|515554709|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
143004338|NCT00953017|515554710|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
143004339|NCT00953017|515554711|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
143004340|NCT00953017|515554708|FG000|Overall Study|Brown stool prior to procedure|0|||
143004341|NCT00953017|515554709|FG001|Overall Study|Brown stool prior to procedure|0|||
143456827|NCT04058366|517217441|FG000|Overall Study|Death|1|||
143456828|NCT04058366|517217441|FG000|Overall Study|Other non-compliance|2|||
143456829|NCT04058366|517217441|FG000|Overall Study|Other|6|||
143456830|NCT01589237|517217451|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
143004342|NCT00953017|515554710|FG002|Overall Study|Brown stool prior to procedure|1|||
143004343|NCT00953017|515554711|FG003|Overall Study|Brown stool prior to procedure|0|||
143004344|NCT00449761|515554713|FG000|Overall Study|Disease progression|12|||
143004345|NCT00449761|515554713|FG000|Overall Study|Death|5|||
143004346|NCT00449761|515554713|FG000|Overall Study|New cancer therapy|1|||
143004347|NCT00054639|515554714|FG000|Overall Study|Lack of Efficacy|1|||
143004348|NCT00054639|515554714|FG000|Overall Study|Physician Decision|1|||
143004349|NCT01548573|515554717|FG000|Overall Study|Death|3|||
143004350|NCT01548573|515554717|FG000|Overall Study|Withdrawal by Subject|2|||
143004351|NCT01366846|515554718|FG000|Overall Study|Withdrawal by Subject|2|||
143004352|NCT01366846|515554719|FG001|Overall Study|Withdrawal by Subject|0|||
143004353|NCT01366846|515554720|FG002|Overall Study|Withdrawal by Subject|0|||
143004354|NCT01366846|515554721|FG003|Overall Study|Withdrawal by Subject|0|||
143004355|NCT01366846|515554718|FG000|Overall Study|Communication Difficulties|1|||
143004356|NCT01366846|515554719|FG001|Overall Study|Communication Difficulties|4|||
143004357|NCT01366846|515554720|FG002|Overall Study|Communication Difficulties|0|||
143004358|NCT01366846|515554721|FG003|Overall Study|Communication Difficulties|1|||
143004359|NCT01366846|515554718|FG000|Overall Study|Scheduling Conflicts|0|||
143004360|NCT01366846|515554719|FG001|Overall Study|Scheduling Conflicts|0|||
143004361|NCT01366846|515554720|FG002|Overall Study|Scheduling Conflicts|1|||
143004362|NCT01366846|515554721|FG003|Overall Study|Scheduling Conflicts|0|||
143004363|NCT00558831|515554727|FG000|Overall Study|Lost to Follow-up|1|||
143004364|NCT00447265|515554728|FG000|Overall Study|Physician Decision|1|||
143004365|NCT00447265|515554729|FG001|Overall Study|Physician Decision|0|||
143004366|NCT02204449|515554732|FG000|Overall Study|Lost to Follow-up|7|||
143004367|NCT02204449|515554733|FG001|Overall Study|Lost to Follow-up|9|||
143004368|NCT02204449|515554732|FG000|Overall Study|Death|0|||
143004369|NCT02204449|515554733|FG001|Overall Study|Death|1|||
143004370|NCT02204449|515554732|FG000|Overall Study|Withdrawal by Subject|0|||
143004371|NCT02204449|515554733|FG001|Overall Study|Withdrawal by Subject|1|||
143004372|NCT02506101|515554738|FG000|Overall Study|Transportation issues|1|||
143456831|NCT01589237|517217452|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
143456832|NCT01589237|517217453|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
143456833|NCT01589237|517217454|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
143456834|NCT01589237|517217451|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
143456835|NCT01589237|517217452|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
143456836|NCT01589237|517217453|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
143456837|NCT01589237|517217454|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
143456838|NCT01589237|517217451|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
143456839|NCT01589237|517217452|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
143456840|NCT01589237|517217453|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
143456841|NCT01589237|517217454|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
143456842|NCT01589237|517217451|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
143456843|NCT01589237|517217452|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
143456844|NCT01589237|517217453|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
143456845|NCT01589237|517217454|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
143456846|NCT00910689|517217457|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
143456847|NCT00910689|517217458|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
143456848|NCT00910689|517217459|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
143004373|NCT02506101|515554739|FG001|Overall Study|Transportation issues|0|||
143004374|NCT02506101|515554738|FG000|Overall Study|No enrollment and staff unavailability|1|||
143456849|NCT00910689|517217460|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
143456850|NCT00910689|517217457|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
143456851|NCT00910689|517217458|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
143456852|NCT00910689|517217459|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
143456853|NCT00910689|517217460|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
143456854|NCT00910689|517217457|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
143456855|NCT00910689|517217458|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
143456856|NCT00910689|517217459|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
143456857|NCT00910689|517217460|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
143456858|NCT00910689|517217457|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
143456859|NCT00910689|517217458|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
143456860|NCT00910689|517217459|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
143456861|NCT00910689|517217460|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
143456862|NCT00910689|517217457|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
143456863|NCT00910689|517217458|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
143456864|NCT00910689|517217459|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
143456865|NCT00910689|517217460|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
143456866|NCT00910689|517217457|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
143456867|NCT00910689|517217458|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
143456868|NCT00910689|517217459|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
143456869|NCT00910689|517217460|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
143456870|NCT00910689|517217457|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
143456871|NCT00910689|517217458|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
143456872|NCT00910689|517217459|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
143456873|NCT00910689|517217460|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
143456874|NCT00910689|517217457|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
143456875|NCT00910689|517217458|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
143456876|NCT00910689|517217459|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
143456877|NCT00910689|517217460|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
143456878|NCT00910689|517217457|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
143456879|NCT00910689|517217458|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
143456880|NCT00910689|517217459|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
143456881|NCT00910689|517217460|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
143456882|NCT00910689|517217457|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
143456883|NCT00910689|517217458|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
143456884|NCT00910689|517217459|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
143456885|NCT00910689|517217460|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
143456886|NCT00910689|517217457|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
143456887|NCT00910689|517217458|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
143456888|NCT00910689|517217459|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
143456889|NCT00910689|517217460|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
143456890|NCT00910689|517217457|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
143456891|NCT00910689|517217458|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
143456892|NCT00910689|517217459|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
143456893|NCT00910689|517217460|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
143456894|NCT00910689|517217457|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
143456895|NCT00910689|517217458|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
143456896|NCT00910689|517217459|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
143456897|NCT00910689|517217460|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
143456898|NCT00910689|517217457|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
143456899|NCT00910689|517217458|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
143456900|NCT00910689|517217459|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
143456901|NCT00910689|517217460|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
143456902|NCT00910689|517217457|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
143456903|NCT00910689|517217458|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
143456904|NCT00910689|517217459|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
143456905|NCT00910689|517217460|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
143456906|NCT00910689|517217457|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
143456907|NCT00910689|517217458|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
143456908|NCT00910689|517217459|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
143456909|NCT00910689|517217460|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
143456910|NCT00910689|517217457|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
143456911|NCT00910689|517217458|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
143456912|NCT00910689|517217459|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
143456913|NCT00910689|517217460|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
143456914|NCT00910689|517217457|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
143456915|NCT00910689|517217458|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
143456916|NCT00910689|517217459|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
143230336|NCT00446849|516393205|FG000|Acute Phase|Lost to Follow-up|2|||
143456917|NCT00910689|517217460|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
143456918|NCT00910689|517217457|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
143456919|NCT00910689|517217458|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
143456920|NCT00910689|517217459|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
143456921|NCT00910689|517217460|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
143456922|NCT00910689|517217457|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
143456923|NCT00910689|517217458|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
143456924|NCT00910689|517217459|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
143456925|NCT00910689|517217460|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
143456926|NCT00910689|517217457|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
143456927|NCT00910689|517217458|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
143456928|NCT00910689|517217459|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
143456929|NCT00910689|517217460|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
143456930|NCT03207009|517217461|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
143456931|NCT00645801|517217462|FG000|Overall Study|unclear if patient took all the medication.|1|||
143456932|NCT00645801|517217463|FG001|Overall Study|unclear if patient took all the medication.|0|||
143456933|NCT00645801|517217462|FG000|Overall Study|Lost to Follow-up|19|||
143456934|NCT00645801|517217463|FG001|Overall Study|Lost to Follow-up|15|||
143456935|NCT00203476|517217464|FG000|Overall Study|Lost to Follow-up|1|||
143456936|NCT00203476|517217465|FG001|Overall Study|Lost to Follow-up|0|||
143456937|NCT00203476|517217466|FG002|Overall Study|Lost to Follow-up|0|||
143456938|NCT00203476|517217464|FG000|Overall Study|Withdrawal by Subject|0|||
143456939|NCT00203476|517217465|FG001|Overall Study|Withdrawal by Subject|1|||
143456940|NCT00203476|517217466|FG002|Overall Study|Withdrawal by Subject|0|||
143456941|NCT00512317|517217468|FG000|Overall Study|Insufficient clinical response|36|||
143456942|NCT00512317|517217468|FG000|Overall Study|Withdrawal by Subject|23|||
143456943|NCT00512317|517217468|FG000|Overall Study|Sponsor closure of study|21|||
143456944|NCT00512317|517217468|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
143456945|NCT00512317|517217468|FG000|Overall Study|Adverse Event|13|||
143456946|NCT00512317|517217468|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
143456947|NCT00512317|517217468|FG000|Overall Study|Lost to Follow-up|2|||
143456948|NCT00512317|517217468|FG000|Overall Study|Other|2|||
143456949|NCT00107120|517217469|FG000|Overall Study|Adverse Event|4|||
143456950|NCT00107120|517217470|FG001|Overall Study|Adverse Event|1|||
143456951|NCT00107120|517217469|FG000|Overall Study|Lack of Efficacy|5|||
143456952|NCT00107120|517217470|FG001|Overall Study|Lack of Efficacy|5|||
143456953|NCT00107120|517217469|FG000|Overall Study|Protocol Violation|3|||
143456954|NCT00107120|517217470|FG001|Overall Study|Protocol Violation|0|||
143456955|NCT00107120|517217469|FG000|Overall Study|Withdrawal by Subject|8|||
143456956|NCT00107120|517217470|FG001|Overall Study|Withdrawal by Subject|9|||
143456957|NCT00107120|517217469|FG000|Overall Study|Lost to Follow-up|8|||
143456958|NCT00107120|517217470|FG001|Overall Study|Lost to Follow-up|6|||
143456959|NCT00107120|517217469|FG000|Overall Study|Pregnancy|0|||
143456960|NCT00107120|517217470|FG001|Overall Study|Pregnancy|1|||
143456961|NCT00107120|517217469|FG000|Overall Study|moving away from site|1|||
143456962|NCT00107120|517217470|FG001|Overall Study|moving away from site|1|||
143456963|NCT00107120|517217469|FG000|Overall Study|death of parent|0|||
143456964|NCT00107120|517217470|FG001|Overall Study|death of parent|1|||
143456965|NCT02074553|517217471|FG000|Intervention Period 1|Family Emergency|0|||
143456966|NCT02074553|517217472|FG001|Intervention Period 1|Family Emergency|0|||
143456967|NCT02074553|517217473|FG002|Intervention Period 1|Family Emergency|0|||
143456968|NCT02074553|517217474|FG003|Intervention Period 1|Family Emergency|1|||
143456969|NCT02074553|517217475|FG004|Intervention Period 1|Family Emergency|0|||
143456970|NCT02074553|517217476|FG005|Intervention Period 1|Family Emergency|0|||
143456971|NCT02074553|517217477|FG006|Intervention Period 1|Family Emergency|0|||
143456972|NCT02074553|517217478|FG007|Intervention Period 1|Family Emergency|0|||
143456973|NCT02074553|517217471|FG000|Washout Period 1|Adverse Event|1|||
143456974|NCT02074553|517217472|FG001|Washout Period 1|Adverse Event|0|||
143456975|NCT02074553|517217473|FG002|Washout Period 1|Adverse Event|0|||
143456976|NCT02074553|517217474|FG003|Washout Period 1|Adverse Event|0|||
143456977|NCT02074553|517217475|FG004|Washout Period 1|Adverse Event|0|||
143456978|NCT02074553|517217476|FG005|Washout Period 1|Adverse Event|0|||
143456979|NCT02074553|517217477|FG006|Washout Period 1|Adverse Event|0|||
143456980|NCT02074553|517217478|FG007|Washout Period 1|Adverse Event|0|||
143456981|NCT02074553|517217471|FG000|Washout Period 1|Physician Decision|0|||
143456982|NCT02074553|517217472|FG001|Washout Period 1|Physician Decision|0|||
143456983|NCT02074553|517217473|FG002|Washout Period 1|Physician Decision|0|||
143456984|NCT02074553|517217474|FG003|Washout Period 1|Physician Decision|1|||
143456985|NCT02074553|517217475|FG004|Washout Period 1|Physician Decision|0|||
143456986|NCT02074553|517217476|FG005|Washout Period 1|Physician Decision|0|||
143456987|NCT02074553|517217477|FG006|Washout Period 1|Physician Decision|0|||
143456988|NCT02074553|517217478|FG007|Washout Period 1|Physician Decision|0|||
143456989|NCT02074553|517217471|FG000|Washout Period 1|Other|0|||
143456990|NCT02074553|517217472|FG001|Washout Period 1|Other|0|||
143456991|NCT02074553|517217473|FG002|Washout Period 1|Other|0|||
143456992|NCT02074553|517217474|FG003|Washout Period 1|Other|0|||
143456993|NCT02074553|517217475|FG004|Washout Period 1|Other|0|||
143456994|NCT02074553|517217476|FG005|Washout Period 1|Other|1|||
143456995|NCT02074553|517217477|FG006|Washout Period 1|Other|0|||
143456996|NCT02074553|517217478|FG007|Washout Period 1|Other|0|||
143456997|NCT02074553|517217471|FG000|Washout Period 2|Adverse Event|0|||
143456998|NCT02074553|517217472|FG001|Washout Period 2|Adverse Event|0|||
143456999|NCT02074553|517217473|FG002|Washout Period 2|Adverse Event|0|||
143457000|NCT02074553|517217474|FG003|Washout Period 2|Adverse Event|0|||
143457001|NCT02074553|517217475|FG004|Washout Period 2|Adverse Event|0|||
143457002|NCT02074553|517217476|FG005|Washout Period 2|Adverse Event|0|||
143457003|NCT02074553|517217477|FG006|Washout Period 2|Adverse Event|1|||
143457004|NCT02074553|517217478|FG007|Washout Period 2|Adverse Event|0|||
143457005|NCT02074553|517217471|FG000|Washout Period 2|Physician Decision|0|||
143457006|NCT02074553|517217472|FG001|Washout Period 2|Physician Decision|0|||
143457007|NCT02074553|517217473|FG002|Washout Period 2|Physician Decision|0|||
143457008|NCT02074553|517217474|FG003|Washout Period 2|Physician Decision|0|||
143457009|NCT02074553|517217475|FG004|Washout Period 2|Physician Decision|0|||
143457010|NCT02074553|517217476|FG005|Washout Period 2|Physician Decision|1|||
143457011|NCT02074553|517217477|FG006|Washout Period 2|Physician Decision|0|||
143457012|NCT02074553|517217478|FG007|Washout Period 2|Physician Decision|0|||
143457013|NCT02074553|517217471|FG000|Washout Period 2|Lost to Follow-up|0|||
143457014|NCT02074553|517217472|FG001|Washout Period 2|Lost to Follow-up|0|||
143457015|NCT02074553|517217473|FG002|Washout Period 2|Lost to Follow-up|1|||
143457016|NCT02074553|517217474|FG003|Washout Period 2|Lost to Follow-up|0|||
143457017|NCT02074553|517217475|FG004|Washout Period 2|Lost to Follow-up|0|||
143457018|NCT02074553|517217476|FG005|Washout Period 2|Lost to Follow-up|0|||
143457019|NCT02074553|517217477|FG006|Washout Period 2|Lost to Follow-up|0|||
143457020|NCT02074553|517217478|FG007|Washout Period 2|Lost to Follow-up|0|||
143457021|NCT02074553|517217471|FG000|Washout Period 3|Physician Decision|0|||
143457022|NCT02074553|517217472|FG001|Washout Period 3|Physician Decision|0|||
143457023|NCT02074553|517217473|FG002|Washout Period 3|Physician Decision|0|||
143457024|NCT02074553|517217474|FG003|Washout Period 3|Physician Decision|0|||
143457025|NCT02074553|517217475|FG004|Washout Period 3|Physician Decision|0|||
143457026|NCT02074553|517217476|FG005|Washout Period 3|Physician Decision|0|||
143457027|NCT02074553|517217477|FG006|Washout Period 3|Physician Decision|0|||
143457028|NCT02074553|517217478|FG007|Washout Period 3|Physician Decision|1|||
143457029|NCT00194987|517217479|FG000|Overall Study|Withdrawal by Subject|0|||
143457030|NCT00194987|517217480|FG001|Overall Study|Withdrawal by Subject|3|||
143457031|NCT04875676|517217481|FG000|Overall Study|Lost to Follow-up|1|||
143457032|NCT04875676|517217482|FG001|Overall Study|Lost to Follow-up|0|||
143457033|NCT04875676|517217483|FG002|Overall Study|Lost to Follow-up|0|||
143457034|NCT01970345|517217486|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
143457035|NCT01970345|517217487|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
143457036|NCT01970345|517217486|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
143457037|NCT01970345|517217487|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
143457038|NCT04289051|517217494|FG000|Overall Study|Lost to Follow-up|0|||
143457039|NCT04289051|517217495|FG001|Overall Study|Lost to Follow-up|0|||
143457040|NCT04289051|517217496|FG002|Overall Study|Lost to Follow-up|2|||
143457041|NCT00657020|517217497|FG000|PERIOD 1|Adverse Event|0|||
143457042|NCT00657020|517217498|FG001|PERIOD 1|Adverse Event|1|||
143457043|NCT02937454|517217505|FG000|Overall Study|Adverse Event|0|||
143457044|NCT02937454|517217506|FG001|Overall Study|Adverse Event|1|||
143457045|NCT02937454|517217505|FG000|Overall Study|Death|98|||
143457046|NCT02937454|517217506|FG001|Overall Study|Death|95|||
143457047|NCT02937454|517217505|FG000|Overall Study|Lost to Follow-up|1|||
143457048|NCT02937454|517217506|FG001|Overall Study|Lost to Follow-up|1|||
143457049|NCT02937454|517217505|FG000|Overall Study|Physician Decision|0|||
143457050|NCT02937454|517217506|FG001|Overall Study|Physician Decision|1|||
143457051|NCT02937454|517217505|FG000|Overall Study|Protocol Violation|6|||
143457052|NCT02937454|517217506|FG001|Overall Study|Protocol Violation|10|||
143457053|NCT02937454|517217505|FG000|Overall Study|Withdrawal by Subject|27|||
143457054|NCT02937454|517217506|FG001|Overall Study|Withdrawal by Subject|15|||
143457055|NCT02937454|517217505|FG000|Overall Study|Other|8|||
143457056|NCT02937454|517217506|FG001|Overall Study|Other|5|||
143457057|NCT01156792|517217507|FG000|Overall Study|Adverse Event|1|||
143457058|NCT01156792|517217507|FG000|Overall Study|Lack of Efficacy|36|||
143457059|NCT01156792|517217507|FG000|Overall Study|Protocol Violation|6|||
143457060|NCT01156792|517217507|FG000|Overall Study|Lost to Follow-up|3|||
143230337|NCT00446849|516393205|FG000|Acute Phase|Physician Decision|1|||
143457061|NCT01156792|517217507|FG000|Overall Study|Physician Decision|3|||
143457062|NCT01156792|517217507|FG000|Overall Study|Withdrawal by Subject|9|||
143457063|NCT01156792|517217507|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
143457064|NCT01097707|517217508|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
143457065|NCT01097707|517217509|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
143457066|NCT01097707|517217510|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
143457067|NCT01097707|517217511|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
143457068|NCT01097707|517217512|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
143457069|NCT01097707|517217508|FG000|Overall Study|Adverse Event|4|||
143457070|NCT01097707|517217509|FG001|Overall Study|Adverse Event|2|||
143457071|NCT01097707|517217510|FG002|Overall Study|Adverse Event|3|||
143457072|NCT01097707|517217511|FG003|Overall Study|Adverse Event|1|||
143457073|NCT01097707|517217512|FG004|Overall Study|Adverse Event|3|||
143457074|NCT01097707|517217508|FG000|Overall Study|Entry Criteria Not Met|2|||
143457075|NCT01097707|517217509|FG001|Overall Study|Entry Criteria Not Met|1|||
143457076|NCT01097707|517217510|FG002|Overall Study|Entry Criteria Not Met|1|||
143457077|NCT01097707|517217511|FG003|Overall Study|Entry Criteria Not Met|0|||
143457078|NCT01097707|517217512|FG004|Overall Study|Entry Criteria Not Met|1|||
143457079|NCT01097707|517217508|FG000|Overall Study|Lack of Efficacy|1|||
143457080|NCT01097707|517217509|FG001|Overall Study|Lack of Efficacy|0|||
143457081|NCT01097707|517217510|FG002|Overall Study|Lack of Efficacy|0|||
143457082|NCT01097707|517217511|FG003|Overall Study|Lack of Efficacy|1|||
143457083|NCT01097707|517217512|FG004|Overall Study|Lack of Efficacy|0|||
143457084|NCT01097707|517217508|FG000|Overall Study|Lost to Follow-up|1|||
143457085|NCT01097707|517217509|FG001|Overall Study|Lost to Follow-up|1|||
143457086|NCT01097707|517217510|FG002|Overall Study|Lost to Follow-up|2|||
143457087|NCT01097707|517217511|FG003|Overall Study|Lost to Follow-up|0|||
143457088|NCT01097707|517217512|FG004|Overall Study|Lost to Follow-up|3|||
143457089|NCT01097707|517217508|FG000|Overall Study|Protocol Violation|2|||
143457090|NCT01097707|517217509|FG001|Overall Study|Protocol Violation|2|||
143457091|NCT01097707|517217510|FG002|Overall Study|Protocol Violation|3|||
143457092|NCT01097707|517217511|FG003|Overall Study|Protocol Violation|2|||
143457093|NCT01097707|517217512|FG004|Overall Study|Protocol Violation|2|||
143457094|NCT01097707|517217508|FG000|Overall Study|Sponsor Decision|31|||
143457095|NCT01097707|517217509|FG001|Overall Study|Sponsor Decision|31|||
143457096|NCT01097707|517217510|FG002|Overall Study|Sponsor Decision|34|||
143457097|NCT01097707|517217511|FG003|Overall Study|Sponsor Decision|35|||
143457098|NCT01097707|517217512|FG004|Overall Study|Sponsor Decision|36|||
143457099|NCT01097707|517217508|FG000|Overall Study|Withdrawal by Subject|3|||
143457100|NCT01097707|517217509|FG001|Overall Study|Withdrawal by Subject|6|||
143457101|NCT01097707|517217510|FG002|Overall Study|Withdrawal by Subject|1|||
143457102|NCT01097707|517217511|FG003|Overall Study|Withdrawal by Subject|4|||
143457103|NCT01097707|517217512|FG004|Overall Study|Withdrawal by Subject|3|||
143457104|NCT01097707|517217508|FG000|Overall Study|Reason unknown|0|||
143457105|NCT01097707|517217509|FG001|Overall Study|Reason unknown|0|||
143457106|NCT01097707|517217510|FG002|Overall Study|Reason unknown|0|||
143457107|NCT01097707|517217511|FG003|Overall Study|Reason unknown|0|||
143457108|NCT01097707|517217512|FG004|Overall Study|Reason unknown|1|||
143457109|NCT01236534|517217516|FG000|Overall Study|Adverse Event|3|||
143457110|NCT01236534|517217517|FG001|Overall Study|Adverse Event|0|||
143457111|NCT01014143|517217524|FG000|Second Intervention|Lost to Follow-up|2|||
143457112|NCT01014143|517217525|FG001|Second Intervention|Lost to Follow-up|0|||
143457113|NCT01014143|517217526|FG002|Second Intervention|Lost to Follow-up|0|||
143457114|NCT01801735|517217531|FG000|Overall Study|Adverse Event|79|||
143457115|NCT01801735|517217531|FG000|Overall Study|Lack of Efficacy|28|||
143457116|NCT01801735|517217531|FG000|Overall Study|Withdrawal by Subject|27|||
143457117|NCT01801735|517217531|FG000|Overall Study|Protocol Violation|25|||
143457118|NCT01801735|517217531|FG000|Overall Study|Lost to Follow-up|15|||
143457119|NCT01801735|517217531|FG000|Overall Study|Non-compliance with Trial Drug|13|||
143457120|NCT01801735|517217531|FG000|Overall Study|Physician Decision|3|||
143457121|NCT01801735|517217531|FG000|Overall Study|Death|1|||
143457122|NCT01801735|517217531|FG000|Overall Study|Other, including site closure|19|||
143457123|NCT02533531|517217538|FG000|Overall Study|Device did not turn on|1|||
143457124|NCT01942590|517217539|FG000|Overall Study|Withdrawal by Subject|0|||
143457125|NCT01942590|517217540|FG001|Overall Study|Withdrawal by Subject|1|||
143457126|NCT01942590|517217539|FG000|Overall Study|Adverse Event|1|||
143457127|NCT01942590|517217540|FG001|Overall Study|Adverse Event|0|||
143457128|NCT01226095|517217541|FG000|Overall Study|Poor compliance|1|||
143457129|NCT01285609|517217542|FG000|Randomized|Progressive Disease|41|||
143457130|NCT01285609|517217543|FG001|Randomized|Progressive Disease|61|||
143457131|NCT01285609|517217542|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
143457132|NCT01285609|517217543|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
143457133|NCT01285609|517217542|FG000|Randomized|Study Drug Toxicity|13|||
143457134|NCT01285609|517217543|FG001|Randomized|Study Drug Toxicity|14|||
143457135|NCT01285609|517217542|FG000|Randomized|Death|5|||
143457136|NCT01285609|517217543|FG001|Randomized|Death|7|||
143457137|NCT01285609|517217542|FG000|Randomized|Withdrawal by Subject|8|||
143457138|NCT01285609|517217543|FG001|Randomized|Withdrawal by Subject|11|||
143457139|NCT01285609|517217542|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
143457140|NCT01285609|517217543|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
143457141|NCT01285609|517217542|FG000|Randomized|Undisclosed Reasons|1|||
143457142|NCT01285609|517217543|FG001|Randomized|Undisclosed Reasons|0|||
143457143|NCT01285609|517217542|FG000|Randomized|Randomized but not Treated|4|||
143457144|NCT01285609|517217543|FG001|Randomized|Randomized but not Treated|4|||
143457145|NCT01285609|517217542|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
143457146|NCT01285609|517217543|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
143457147|NCT01285609|517217542|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
143457148|NCT01285609|517217543|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
143457149|NCT01285609|517217542|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
143457150|NCT01285609|517217543|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
143457151|NCT01285609|517217542|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
143457152|NCT01285609|517217543|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
143457153|NCT01285609|517217542|FG000|Treated With Blinded Therapy|Death|11|||
143457154|NCT01285609|517217543|FG001|Treated With Blinded Therapy|Death|3|||
143457155|NCT01285609|517217542|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
143457156|NCT01285609|517217543|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
143457157|NCT01285609|517217542|FG000|Treated With Blinded Therapy|Not Reported|0|||
143457158|NCT01285609|517217543|FG001|Treated With Blinded Therapy|Not Reported|2|||
143457159|NCT01285609|517217542|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
143457160|NCT01285609|517217543|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
143457161|NCT01285609|517217542|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
143457162|NCT01285609|517217543|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
143457163|NCT01285609|517217542|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
143457164|NCT01285609|517217543|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
143457165|NCT01285609|517217542|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
143457166|NCT01285609|517217543|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
143457167|NCT01285609|517217542|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
143457168|NCT01285609|517217543|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
143457169|NCT01285609|517217542|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
143457170|NCT01285609|517217543|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
143457171|NCT01285609|517217542|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
143457172|NCT01285609|517217543|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
143457173|NCT01285609|517217542|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
143457174|NCT01285609|517217543|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
143457175|NCT01285609|517217542|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
143457176|NCT01285609|517217543|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
143457177|NCT01285609|517217542|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
143457178|NCT01285609|517217543|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
143457179|NCT04822597|517217544|FG000|Overall Study|Withdrawal by Subject|0|||
143457180|NCT04822597|517217545|FG001|Overall Study|Withdrawal by Subject|1|||
143457181|NCT04822597|517217546|FG002|Overall Study|Withdrawal by Subject|1|||
143457182|NCT04822597|517217547|FG003|Overall Study|Withdrawal by Subject|0|||
143457183|NCT04822597|517217544|FG000|Overall Study|Physician Decision|0|||
143457184|NCT04822597|517217545|FG001|Overall Study|Physician Decision|0|||
143457185|NCT04822597|517217546|FG002|Overall Study|Physician Decision|1|||
143457186|NCT04822597|517217547|FG003|Overall Study|Physician Decision|1|||
143457187|NCT04822597|517217544|FG000|Overall Study|Subject withdrawn after enrollment|0|||
143457188|NCT04822597|517217545|FG001|Overall Study|Subject withdrawn after enrollment|1|||
143457189|NCT04822597|517217546|FG002|Overall Study|Subject withdrawn after enrollment|0|||
143457190|NCT04822597|517217547|FG003|Overall Study|Subject withdrawn after enrollment|1|||
143457191|NCT04822597|517217544|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
143457192|NCT04822597|517217545|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
143457193|NCT04822597|517217546|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
143004375|NCT02506101|515554739|FG001|Overall Study|No enrollment and staff unavailability|0|||
143004376|NCT01308476|515554740|FG000|Overall Study|Lost to Follow-up|2|||
143004377|NCT01308476|515554741|FG001|Overall Study|Lost to Follow-up|2|||
143004378|NCT01308476|515554740|FG000|Overall Study|Other|1|||
143004379|NCT01308476|515554741|FG001|Overall Study|Other|0|||
143004380|NCT03246152|515554745|FG000|Overall Study|Lost to Follow-up|2|||
143457194|NCT04822597|517217547|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
143457195|NCT00911768|517217553|FG000|Overall Study|Protocol Violation|5|||
143457196|NCT00911768|517217554|FG001|Overall Study|Protocol Violation|4|||
143457197|NCT00911768|517217553|FG000|Overall Study|Withdrawal by Subject|1|||
143457198|NCT00911768|517217554|FG001|Overall Study|Withdrawal by Subject|0|||
143457199|NCT00515853|517217556|FG000|Overall Study|Lost to Follow-up|9|||
143457200|NCT00515853|517217557|FG001|Overall Study|Lost to Follow-up|13|||
143457201|NCT00515853|517217556|FG000|Overall Study|Withdrawal by Subject|6|||
143457202|NCT00515853|517217557|FG001|Overall Study|Withdrawal by Subject|4|||
143457203|NCT02631577|517217558|FG000|Overall Study|Death|1|||
143457204|NCT02631577|517217559|FG001|Overall Study|Death|7|||
143457205|NCT02631577|517217558|FG000|Overall Study|Withdrawal by Subject|0|||
143457206|NCT02631577|517217559|FG001|Overall Study|Withdrawal by Subject|3|||
143457207|NCT00979134|517217560|FG000|Overall Study|Disease progression|18|||
143004381|NCT03246152|515554745|FG000|Overall Study|Protocol Violation|1|||
143004382|NCT01243762|515554746|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
143230338|NCT00446849|516393205|FG000|Acute Phase|noncompliance|1|||
143457208|NCT00979134|517217561|FG001|Overall Study|Disease progression|2|||
143457209|NCT00979134|517217562|FG002|Overall Study|Disease progression|5|||
143457210|NCT00979134|517217560|FG000|Overall Study|Adverse Event|0|||
143457211|NCT00979134|517217561|FG001|Overall Study|Adverse Event|0|||
143457212|NCT00979134|517217562|FG002|Overall Study|Adverse Event|2|||
143457213|NCT00979134|517217560|FG000|Overall Study|Withdrawal by Subject|1|||
143457214|NCT00979134|517217561|FG001|Overall Study|Withdrawal by Subject|1|||
143457215|NCT00979134|517217562|FG002|Overall Study|Withdrawal by Subject|2|||
143457216|NCT00979134|517217560|FG000|Overall Study|Lost to Follow-up|2|||
143457217|NCT00979134|517217561|FG001|Overall Study|Lost to Follow-up|2|||
143457218|NCT00979134|517217562|FG002|Overall Study|Lost to Follow-up|0|||
143457219|NCT00979134|517217560|FG000|Overall Study|Death|4|||
143457220|NCT00979134|517217561|FG001|Overall Study|Death|0|||
143457221|NCT00979134|517217562|FG002|Overall Study|Death|26|||
143457222|NCT00979134|517217560|FG000|Overall Study|Other|8|||
143457223|NCT00979134|517217561|FG001|Overall Study|Other|1|||
143457224|NCT00979134|517217562|FG002|Overall Study|Other|5|||
143457225|NCT00867308|517217563|FG000|Overall Study|Death|1|||
143457226|NCT00867308|517217564|FG001|Overall Study|Death|0|||
143457227|NCT00867308|517217563|FG000|Overall Study|Adverse Event|1|||
143457228|NCT00867308|517217564|FG001|Overall Study|Adverse Event|4|||
143457229|NCT00867308|517217563|FG000|Overall Study|Lack of Efficacy|6|||
143457230|NCT00867308|517217564|FG001|Overall Study|Lack of Efficacy|12|||
143457231|NCT00867308|517217563|FG000|Overall Study|Withdrawal by Subject|1|||
143457232|NCT00867308|517217564|FG001|Overall Study|Withdrawal by Subject|2|||
143457233|NCT00604825|517217565|FG000|Overall Study|Adverse Event|2|||
143457234|NCT00604825|517217566|FG001|Overall Study|Adverse Event|6|||
143457235|NCT00604825|517217567|FG002|Overall Study|Adverse Event|7|||
143457236|NCT00604825|517217568|FG003|Overall Study|Adverse Event|4|||
143457237|NCT00604825|517217565|FG000|Overall Study|Lost to Follow-up|0|||
143457238|NCT00604825|517217566|FG001|Overall Study|Lost to Follow-up|3|||
143457239|NCT00604825|517217567|FG002|Overall Study|Lost to Follow-up|1|||
143457240|NCT00604825|517217568|FG003|Overall Study|Lost to Follow-up|0|||
143457241|NCT00604825|517217565|FG000|Overall Study|Protocol Violation|0|||
143457242|NCT00604825|517217566|FG001|Overall Study|Protocol Violation|1|||
143457243|NCT00604825|517217567|FG002|Overall Study|Protocol Violation|0|||
143457244|NCT00604825|517217568|FG003|Overall Study|Protocol Violation|0|||
143457245|NCT00604825|517217565|FG000|Overall Study|Withdrawal by Subject|4|||
143457246|NCT00604825|517217566|FG001|Overall Study|Withdrawal by Subject|3|||
143457247|NCT00604825|517217567|FG002|Overall Study|Withdrawal by Subject|5|||
143457248|NCT00604825|517217568|FG003|Overall Study|Withdrawal by Subject|5|||
143457249|NCT00604825|517217565|FG000|Overall Study|Lack of Efficacy|3|||
143457250|NCT00604825|517217566|FG001|Overall Study|Lack of Efficacy|2|||
143457251|NCT00604825|517217567|FG002|Overall Study|Lack of Efficacy|1|||
143457252|NCT00604825|517217568|FG003|Overall Study|Lack of Efficacy|0|||
143004383|NCT01243762|515554747|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
143004384|NCT01243762|515554748|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
143004385|NCT01243762|515554749|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
143004386|NCT01243762|515554750|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
143004387|NCT01243762|515554751|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
143004388|NCT01243762|515554752|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
143004389|NCT01243762|515554746|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
143004390|NCT01243762|515554747|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
143004391|NCT01243762|515554748|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
143004392|NCT01243762|515554749|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
143004393|NCT01243762|515554750|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
143004394|NCT01243762|515554751|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
143457253|NCT00604825|517217565|FG000|Overall Study|Did not meet eligibility criteria|0|||
143457254|NCT00604825|517217566|FG001|Overall Study|Did not meet eligibility criteria|0|||
143457255|NCT00604825|517217567|FG002|Overall Study|Did not meet eligibility criteria|2|||
143457256|NCT00604825|517217568|FG003|Overall Study|Did not meet eligibility criteria|0|||
143457257|NCT00604825|517217565|FG000|Overall Study|Physician Decision|0|||
143004395|NCT01243762|515554752|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
143004396|NCT01243762|515554746|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
143004397|NCT01243762|515554747|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
143004398|NCT01243762|515554748|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
143004399|NCT01243762|515554749|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
143004400|NCT01243762|515554750|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
143004401|NCT01243762|515554751|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
143457258|NCT00604825|517217566|FG001|Overall Study|Physician Decision|0|||
143457259|NCT00604825|517217567|FG002|Overall Study|Physician Decision|0|||
143457260|NCT00604825|517217568|FG003|Overall Study|Physician Decision|1|||
143457261|NCT00604825|517217565|FG000|Overall Study|Exclusion criterion met|0|||
143457262|NCT00604825|517217566|FG001|Overall Study|Exclusion criterion met|0|||
143457263|NCT00604825|517217567|FG002|Overall Study|Exclusion criterion met|0|||
143457264|NCT00604825|517217568|FG003|Overall Study|Exclusion criterion met|1|||
143457265|NCT05593445|517217569|FG000|12-Week DBVC Period|Adverse Event|1|||
143004402|NCT01243762|515554752|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
143457266|NCT05593445|517217570|FG001|12-Week DBVC Period|Adverse Event|0|||
143457267|NCT05593445|517217571|FG002|12-Week DBVC Period|Adverse Event|0|||
143457268|NCT05593445|517217572|FG003|12-Week DBVC Period|Adverse Event|0|||
143457269|NCT05593445|517217569|FG000|12-Week DBVC Period|Physician Decision|0|||
143457270|NCT05593445|517217570|FG001|12-Week DBVC Period|Physician Decision|1|||
143457271|NCT05593445|517217571|FG002|12-Week DBVC Period|Physician Decision|0|||
143457272|NCT05593445|517217572|FG003|12-Week DBVC Period|Physician Decision|0|||
143457273|NCT05593445|517217569|FG000|12-Week DBVC Period|Protocol Violation|0|||
143457274|NCT05593445|517217570|FG001|12-Week DBVC Period|Protocol Violation|1|||
143457275|NCT05593445|517217571|FG002|12-Week DBVC Period|Protocol Violation|0|||
143457276|NCT05593445|517217572|FG003|12-Week DBVC Period|Protocol Violation|0|||
143457277|NCT05593445|517217569|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
143457278|NCT05593445|517217570|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
143457279|NCT05593445|517217571|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
143457280|NCT05593445|517217572|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
143457281|NCT05593445|517217569|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
143457282|NCT05593445|517217570|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
143457283|NCT05593445|517217571|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
143457284|NCT05593445|517217572|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
143457285|NCT05593445|517217569|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
143457286|NCT05593445|517217570|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
143457287|NCT05593445|517217571|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
143457288|NCT05593445|517217572|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
143457289|NCT05593445|517217569|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
143457290|NCT05593445|517217570|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
143457291|NCT05593445|517217571|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
143457292|NCT05593445|517217572|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
143457293|NCT05593445|517217569|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
143457294|NCT05593445|517217570|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
143457295|NCT05593445|517217571|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
143457296|NCT05593445|517217572|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
143457297|NCT03647488|517219249|FG000|Overall Study|Progressive disease|10|||
143457298|NCT03647488|517219250|FG001|Overall Study|Progressive disease|0|||
143457299|NCT03647488|517219251|FG002|Overall Study|Progressive disease|0|||
143457300|NCT03647488|517219249|FG000|Overall Study|Adverse Event|5|||
143457301|NCT03647488|517219250|FG001|Overall Study|Adverse Event|0|||
143457302|NCT03647488|517219251|FG002|Overall Study|Adverse Event|0|||
143457303|NCT03647488|517219249|FG000|Overall Study|Clinical progression|2|||
143457304|NCT03647488|517219250|FG001|Overall Study|Clinical progression|0|||
143457305|NCT03647488|517219251|FG002|Overall Study|Clinical progression|0|||
143457306|NCT03647488|517219249|FG000|Overall Study|Participant refused to take investigational product|1|||
143457307|NCT03647488|517219250|FG001|Overall Study|Participant refused to take investigational product|0|||
143457308|NCT03647488|517219251|FG002|Overall Study|Participant refused to take investigational product|0|||
143457309|NCT00812331|517219252|FG000|Overall Study|Adverse Event|1|||
143457310|NCT00812331|517219253|FG001|Overall Study|Adverse Event|0|||
143457311|NCT00812331|517219254|FG002|Overall Study|Adverse Event|0|||
143457312|NCT00812331|517219255|FG003|Overall Study|Adverse Event|0|||
143457313|NCT00812331|517219256|FG004|Overall Study|Adverse Event|0|||
143457314|NCT01506453|517219257|FG000|Overall Study|Withdrawal prior to treatment|0|||
143457315|NCT01506453|517219258|FG001|Overall Study|Withdrawal prior to treatment|2|||
143457316|NCT03694275|517219259|FG000|Overall Study|Adverse Event|0|||
143457317|NCT03694275|517219260|FG001|Overall Study|Adverse Event|1|||
143457318|NCT03694275|517219259|FG000|Overall Study|Reason not Specified|0|||
143457319|NCT03694275|517219260|FG001|Overall Study|Reason not Specified|1|||
143457320|NCT02502799|517219261|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
143457321|NCT02502799|517219262|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
143457322|NCT02502799|517219263|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
143004403|NCT01243762|515554746|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
143004404|NCT01243762|515554747|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
143004405|NCT01243762|515554748|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
143004406|NCT01243762|515554749|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
143004407|NCT01243762|515554750|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
143004408|NCT01243762|515554751|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
143004409|NCT01243762|515554752|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
143004410|NCT01243762|515554746|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
143004411|NCT01243762|515554747|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
143457323|NCT02502799|517219264|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
143457324|NCT02502799|517219261|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
143457325|NCT02502799|517219262|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
143457326|NCT02502799|517219263|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
143004412|NCT01243762|515554748|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
143004413|NCT01243762|515554749|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
143004414|NCT01243762|515554750|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
143004415|NCT01243762|515554751|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
143004416|NCT01243762|515554752|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
143004417|NCT01243762|515554746|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
143004418|NCT01243762|515554747|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
143004419|NCT01243762|515554748|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
143004420|NCT01243762|515554749|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
143004421|NCT01243762|515554750|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
143004422|NCT01243762|515554751|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
143004423|NCT01243762|515554752|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
143004424|NCT01243762|515554746|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
143004425|NCT01243762|515554747|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
143457327|NCT02502799|517219264|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
143457328|NCT02502799|517219261|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
143457329|NCT02502799|517219262|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
143457330|NCT02502799|517219263|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
143457331|NCT02502799|517219264|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
143457332|NCT02502799|517219261|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
143457333|NCT02502799|517219262|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
143457334|NCT02502799|517219263|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
143004426|NCT01243762|515554748|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
143457335|NCT02502799|517219264|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
143457336|NCT02502799|517219261|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
143457337|NCT02502799|517219262|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
143457338|NCT02502799|517219263|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
143457339|NCT02502799|517219264|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
143457340|NCT00153062|517219268|FG000|Overall Study|Death|360|||
143004427|NCT01243762|515554749|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
143004428|NCT01243762|515554750|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
143004429|NCT01243762|515554751|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
143004430|NCT01243762|515554752|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
143004431|NCT01243762|515554746|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
143004432|NCT01243762|515554747|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
143004433|NCT01243762|515554748|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
143004434|NCT01243762|515554749|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
143004435|NCT01243762|515554750|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
143004436|NCT01243762|515554751|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
143004437|NCT01243762|515554752|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
143004438|NCT00003526|515554753|FG000|Overall Study|Not evaluable|6|||
143004439|NCT04196023|515554754|FG000|Overall Study|Withdrawal by Subject|0|||
143004440|NCT04196023|515554755|FG001|Overall Study|Withdrawal by Subject|1|||
143004441|NCT04196023|515554754|FG000|Overall Study|Adverse Event|3|||
143457341|NCT00153062|517219269|FG001|Overall Study|Death|352|||
143457342|NCT00153062|517219270|FG002|Overall Study|Death|369|||
143457343|NCT00153062|517219271|FG003|Overall Study|Death|365|||
143457344|NCT00153062|517219268|FG000|Overall Study|Withdrawal by Subject|14|||
143457345|NCT00153062|517219269|FG001|Overall Study|Withdrawal by Subject|30|||
143457346|NCT00153062|517219270|FG002|Overall Study|Withdrawal by Subject|27|||
143457347|NCT00153062|517219271|FG003|Overall Study|Withdrawal by Subject|28|||
143457348|NCT00153062|517219268|FG000|Overall Study|Lost to Follow-up|12|||
143457349|NCT00153062|517219269|FG001|Overall Study|Lost to Follow-up|20|||
143457350|NCT00153062|517219270|FG002|Overall Study|Lost to Follow-up|15|||
143457351|NCT00153062|517219271|FG003|Overall Study|Lost to Follow-up|16|||
143457352|NCT00153062|517219268|FG000|Overall Study|Adverse Event|0|||
143457353|NCT00153062|517219269|FG001|Overall Study|Adverse Event|1|||
143457354|NCT00153062|517219270|FG002|Overall Study|Adverse Event|1|||
143457355|NCT00153062|517219271|FG003|Overall Study|Adverse Event|0|||
143457356|NCT00153062|517219268|FG000|Overall Study|Protocol Violation|0|||
143457357|NCT00153062|517219269|FG001|Overall Study|Protocol Violation|2|||
143457358|NCT00153062|517219270|FG002|Overall Study|Protocol Violation|1|||
143457359|NCT00153062|517219271|FG003|Overall Study|Protocol Violation|1|||
143004442|NCT04196023|515554755|FG001|Overall Study|Adverse Event|1|||
143004443|NCT04196023|515554754|FG000|Overall Study|Lost to Follow-up|0|||
143004444|NCT04196023|515554755|FG001|Overall Study|Lost to Follow-up|1|||
143004445|NCT03358407|515554757|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
143004446|NCT03358407|515554758|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
143004447|NCT03358407|515554759|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
143457360|NCT00153062|517219268|FG000|Overall Study|No disposition data available|1|||
143457361|NCT00153062|517219269|FG001|Overall Study|No disposition data available|1|||
143004448|NCT03358407|515554760|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
143004449|NCT03358407|515554761|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
143004450|NCT03358407|515554762|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
143004451|NCT03358407|515554763|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
143004452|NCT03358407|515554764|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
143004453|NCT03358407|515554765|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
143004454|NCT03358407|515554766|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
143004455|NCT03358407|515554757|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
143004456|NCT03358407|515554758|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
143004457|NCT03358407|515554759|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
143004458|NCT03358407|515554760|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
143004459|NCT03358407|515554761|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
143004460|NCT03358407|515554762|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
143004461|NCT03358407|515554763|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
143004462|NCT03358407|515554764|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
143457362|NCT00153062|517219270|FG002|Overall Study|No disposition data available|1|||
143457363|NCT00153062|517219271|FG003|Overall Study|No disposition data available|1|||
143457364|NCT00153062|517219268|FG000|Overall Study|Other|0|||
143457365|NCT00153062|517219269|FG001|Overall Study|Other|0|||
143457366|NCT00153062|517219270|FG002|Overall Study|Other|1|||
143457367|NCT00153062|517219271|FG003|Overall Study|Other|0|||
143457368|NCT02594163|517219282|FG000|Treatment Period|Progressive disease|2|||
143457369|NCT02594163|517219283|FG001|Treatment Period|Progressive disease|3|||
143457370|NCT02594163|517219282|FG000|Treatment Period|Adverse Event|1|||
143457371|NCT02594163|517219283|FG001|Treatment Period|Adverse Event|5|||
143457372|NCT02594163|517219282|FG000|Treatment Period|Physician Decision|1|||
143457373|NCT02594163|517219283|FG001|Treatment Period|Physician Decision|3|||
143457374|NCT02594163|517219282|FG000|Treatment Period|Study termination by sponsor|2|||
143457375|NCT02594163|517219283|FG001|Treatment Period|Study termination by sponsor|1|||
143457376|NCT02594163|517219282|FG000|Treatment Period|Other, Non-AE|1|||
143457377|NCT02594163|517219283|FG001|Treatment Period|Other, Non-AE|0|||
143457378|NCT02594163|517219282|FG000|Follow-up Period|Withdrawal by Subject|0|||
143457379|NCT02594163|517219283|FG001|Follow-up Period|Withdrawal by Subject|1|||
143457380|NCT02594163|517219282|FG000|Follow-up Period|Study Termination by Sponsor|6|||
143457381|NCT02594163|517219283|FG001|Follow-up Period|Study Termination by Sponsor|4|||
143457382|NCT02594163|517219282|FG000|Follow-up Period|Lost to Follow-up|1|||
143457383|NCT02594163|517219283|FG001|Follow-up Period|Lost to Follow-up|0|||
143457384|NCT02594163|517219282|FG000|Follow-up Period|Death|2|||
143457385|NCT02594163|517219283|FG001|Follow-up Period|Death|5|||
143457386|NCT02594163|517219282|FG000|Follow-up Period|Adverse Event|0|||
143457387|NCT02594163|517219283|FG001|Follow-up Period|Adverse Event|1|||
143457388|NCT02594163|517219282|FG000|Follow-up Period|Progressive Disease|2|||
143457389|NCT02594163|517219283|FG001|Follow-up Period|Progressive Disease|0|||
143457390|NCT02594163|517219282|FG000|Follow-up Period|Physician Decision|0|||
143457391|NCT02594163|517219283|FG001|Follow-up Period|Physician Decision|1|||
143457392|NCT00117845|517219284|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
143457393|NCT00932113|517219287|FG000|Overall Study|Lost to Follow-up|1|||
143457394|NCT00932113|517219288|FG001|Overall Study|Lost to Follow-up|0|||
143457395|NCT01403610|517219289|FG000|Overall Study|Withdrawal by Subject|2|||
143457396|NCT01403610|517219290|FG001|Overall Study|Withdrawal by Subject|0|||
143457397|NCT01403610|517219291|FG002|Overall Study|Withdrawal by Subject|0|||
143457398|NCT01403610|517219292|FG003|Overall Study|Withdrawal by Subject|0|||
143457399|NCT01403610|517219289|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
143457400|NCT01403610|517219290|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
143457401|NCT01403610|517219291|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
143457402|NCT01403610|517219292|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
143457403|NCT01190514|517219293|FG000|First Intervention (Period 1)|Adverse Event|1|||
143457404|NCT01190514|517219294|FG001|First Intervention (Period 1)|Adverse Event|0|||
143457405|NCT01190514|517219295|FG002|First Intervention (Period 1)|Adverse Event|0|||
143457406|NCT01190514|517219296|FG003|First Intervention (Period 1)|Adverse Event|0|||
143457407|NCT01190514|517219293|FG000|Third Intervention (Period 3)|Adverse Event|1|||
143457408|NCT01190514|517219294|FG001|Third Intervention (Period 3)|Adverse Event|0|||
143457409|NCT01190514|517219295|FG002|Third Intervention (Period 3)|Adverse Event|0|||
143457410|NCT01190514|517219296|FG003|Third Intervention (Period 3)|Adverse Event|0|||
143457411|NCT00700258|517219298|FG000|Overall Study|Premature discontinuation of documentation|136|||
143457412|NCT00700258|517219298|FG000|Overall Study|Type of study end not documented|1|||
143457413|NCT00700258|517219298|FG000|Overall Study|Lost to Follow-up|81|||
143457414|NCT00700258|517219298|FG000|Overall Study|Premature discontinuation of therapy|1013|||
143457415|NCT01160289|517219299|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
143457416|NCT01160289|517219300|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
143457417|NCT01160289|517219301|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
143004463|NCT03358407|515554765|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
143004464|NCT03358407|515554766|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
143004465|NCT03358407|515554757|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
143004466|NCT03358407|515554758|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
143004467|NCT03358407|515554759|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
143004468|NCT03358407|515554760|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
143004469|NCT03358407|515554761|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
143004470|NCT03358407|515554762|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
143004471|NCT03358407|515554763|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
143004472|NCT03358407|515554764|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
143004473|NCT03358407|515554765|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
143004474|NCT03358407|515554766|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
143004475|NCT03358407|515554757|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
143004476|NCT03358407|515554758|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
143004477|NCT03358407|515554759|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
143004478|NCT03358407|515554760|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
143004479|NCT03358407|515554761|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
143004480|NCT03358407|515554762|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
143004481|NCT03358407|515554763|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
143004482|NCT03358407|515554764|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
143004483|NCT03358407|515554765|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
143004484|NCT03358407|515554766|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
143004485|NCT03358407|515554757|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
143004486|NCT03358407|515554758|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
143004487|NCT03358407|515554759|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
143004488|NCT03358407|515554760|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
143004489|NCT03358407|515554761|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
143004490|NCT03358407|515554762|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
143004491|NCT03358407|515554763|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
143004492|NCT03358407|515554764|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
143004493|NCT03358407|515554765|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
143004494|NCT03358407|515554766|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
143004495|NCT03358407|515554757|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
143004496|NCT03358407|515554758|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
143004497|NCT03358407|515554759|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
143004498|NCT03358407|515554760|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
143004499|NCT03358407|515554761|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
143004500|NCT03358407|515554762|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
143004501|NCT03358407|515554763|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
143004502|NCT03358407|515554764|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
143004503|NCT03358407|515554765|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
143004504|NCT03358407|515554766|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
143004505|NCT03605758|515554767|FG000|Overall Study|Lost to Follow-up|2|||
143004506|NCT03605758|515554768|FG001|Overall Study|Lost to Follow-up|1|||
143004507|NCT03605758|515554767|FG000|Overall Study|Illness|0|||
143004508|NCT03605758|515554768|FG001|Overall Study|Illness|1|||
143004509|NCT03605758|515554767|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
143004510|NCT03605758|515554768|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
143004511|NCT01748162|515554769|FG000|Overall Study|no additional croup episodes to evaluate|2|||
143004512|NCT01748162|515554770|FG001|Overall Study|no additional croup episodes to evaluate|2|||
143004513|NCT01748162|515554769|FG000|Overall Study|participant consented but did not begin|0|||
143004514|NCT01748162|515554770|FG001|Overall Study|participant consented but did not begin|1|||
143004515|NCT01748162|515554769|FG000|Overall Study|reasons not available|3|||
143004516|NCT01748162|515554770|FG001|Overall Study|reasons not available|2|||
143004517|NCT03841331|515554771|FG000|Overall Study|Withdrawal by Subject|4|||
143004518|NCT03841331|515554772|FG001|Overall Study|Withdrawal by Subject|9|||
143004519|NCT03841331|515554771|FG000|Overall Study|Lost to Follow-up|5|||
143004520|NCT03841331|515554772|FG001|Overall Study|Lost to Follow-up|1|||
143004521|NCT01428882|515554773|FG000|Overall Study|Lack of Efficacy|2|||
143004522|NCT01428882|515554774|FG001|Overall Study|Lack of Efficacy|7|||
143004523|NCT01428882|515554773|FG000|Overall Study|Protocol Violation|4|||
143004524|NCT01428882|515554774|FG001|Overall Study|Protocol Violation|3|||
143004525|NCT02219477|515554775|FG000|Overall Study|Adverse Event|0|||
143004526|NCT02219477|515554776|FG001|Overall Study|Adverse Event|1|||
143004527|NCT02219477|515554777|FG002|Overall Study|Adverse Event|1|||
143004528|NCT02219477|515554775|FG000|Overall Study|Withdrawal by Subject|0|||
143004529|NCT02219477|515554776|FG001|Overall Study|Withdrawal by Subject|1|||
143004530|NCT02219477|515554777|FG002|Overall Study|Withdrawal by Subject|0|||
143004531|NCT02304484|515554778|FG000|Overall Study|Death|9|||
143004532|NCT02304484|515554778|FG000|Overall Study|Withdrawal by Subject|14|||
143004533|NCT02304484|515554778|FG000|Overall Study|Lost to Follow-up|2|||
143004534|NCT00752206|515554779|FG000|Overall Study|Disease progression|8|||
143004535|NCT00752206|515554780|FG001|Overall Study|Disease progression|11|||
143004536|NCT00752206|515554779|FG000|Overall Study|Pregnancy|1|||
143004537|NCT00752206|515554780|FG001|Overall Study|Pregnancy|0|||
143004538|NCT01539512|515554781|FG000|Overall Study|Adverse Event|9|||
143004539|NCT01539512|515554782|FG001|Overall Study|Adverse Event|7|||
143004540|NCT01539512|515554781|FG000|Overall Study|Physician Decision|1|||
143004541|NCT01539512|515554782|FG001|Overall Study|Physician Decision|1|||
143004542|NCT01539512|515554781|FG000|Overall Study|Withdrawal by Subject|12|||
143004543|NCT01539512|515554782|FG001|Overall Study|Withdrawal by Subject|5|||
143004544|NCT01539512|515554781|FG000|Overall Study|Richter's Transformation|1|||
143004545|NCT01539512|515554782|FG001|Overall Study|Richter's Transformation|0|||
143004546|NCT02283411|515554785|FG000|Overall Study|Withdrawal by Subject|3|||
143004547|NCT02283411|515554785|FG000|Overall Study|Screen Failed|28|||
143004548|NCT01195662|515554800|FG000|Double Blind Treatment Period|Adverse Event|4|||
143004549|NCT01195662|515554801|FG001|Double Blind Treatment Period|Adverse Event|1|||
143004550|NCT01195662|515554802|FG002|Double Blind Treatment Period|Adverse Event|2|||
143004551|NCT01195662|515554800|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
143004552|NCT01195662|515554801|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
143004553|NCT01195662|515554802|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
143004554|NCT01195662|515554800|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
143004555|NCT01195662|515554801|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
143004556|NCT01195662|515554802|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
143004557|NCT01195662|515554800|FG000|Double Blind Treatment Period|Administrative reason|2|||
143004558|NCT01195662|515554801|FG001|Double Blind Treatment Period|Administrative reason|1|||
143004559|NCT01195662|515554802|FG002|Double Blind Treatment Period|Administrative reason|1|||
143004560|NCT01195662|515554800|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
143004561|NCT01195662|515554801|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
143004562|NCT01195662|515554802|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
143004563|NCT01195662|515554800|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
143004564|NCT01195662|515554801|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
143004565|NCT01195662|515554802|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
143004566|NCT01195662|515554800|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
143004567|NCT01195662|515554801|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
143004568|NCT01195662|515554802|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
143004569|NCT01195662|515554800|FG000|Double Blind Treatment Period|Non-specified|3|||
143004570|NCT01195662|515554801|FG001|Double Blind Treatment Period|Non-specified|0|||
143004571|NCT01195662|515554802|FG002|Double Blind Treatment Period|Non-specified|0|||
143004572|NCT01195662|515554800|FG000|Double Blind Treatment Period|Missing disposition information|0|||
143004573|NCT01195662|515554801|FG001|Double Blind Treatment Period|Missing disposition information|1|||
143004574|NCT01195662|515554802|FG002|Double Blind Treatment Period|Missing disposition information|1|||
143004575|NCT01195662|515554800|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
143004576|NCT01195662|515554801|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
143004577|NCT01195662|515554802|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
143004578|NCT01195662|515554800|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
143004579|NCT01195662|515554801|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
143004580|NCT01195662|515554802|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
143004581|NCT04409262|515554814|FG000|Overall Study|Adverse Event|0|||
143004582|NCT04409262|515554815|FG001|Overall Study|Adverse Event|2|||
143004583|NCT04409262|515554814|FG000|Overall Study|Death|55|||
143004584|NCT04409262|515554815|FG001|Overall Study|Death|97|||
143004585|NCT04409262|515554814|FG000|Overall Study|Lost to Follow-up|12|||
143004586|NCT04409262|515554815|FG001|Overall Study|Lost to Follow-up|23|||
143004587|NCT04409262|515554814|FG000|Overall Study|Lack of Staff|0|||
143004588|NCT04409262|515554815|FG001|Overall Study|Lack of Staff|1|||
143004589|NCT04409262|515554814|FG000|Overall Study|Protocol Violation|3|||
143004590|NCT04409262|515554815|FG001|Overall Study|Protocol Violation|1|||
143004591|NCT04409262|515554814|FG000|Overall Study|Withdrawal by Subject|5|||
143004592|NCT04409262|515554815|FG001|Overall Study|Withdrawal by Subject|10|||
143004593|NCT03205605|515554816|FG000|Overall Study|Withdrawal by Subject|1|||
143004594|NCT02396849|515554817|FG000|Overall Study|Lost to Follow-up|1|||
143004595|NCT02396849|515554818|FG001|Overall Study|Lost to Follow-up|1|||
143004596|NCT02396849|515554817|FG000|Overall Study|Did not tolerate intervention|1|||
143004597|NCT02396849|515554818|FG001|Overall Study|Did not tolerate intervention|1|||
143004598|NCT00945815|515554823|FG000|Overall Study|Death|3|||
143004599|NCT00945815|515554823|FG000|Overall Study|Not protocol specified|1|||
143004600|NCT00945815|515554823|FG000|Overall Study|Ineligible|3|||
143004601|NCT00945815|515554823|FG000|Overall Study|Did not begin protocol therapy|1|||
143004602|NCT01869959|515554824|FG000|Randomization Period|Physician Decision|0|||
143004603|NCT01869959|515554825|FG001|Randomization Period|Physician Decision|0|||
143004604|NCT01869959|515554826|FG002|Randomization Period|Physician Decision|0|||
143004605|NCT01869959|515554827|FG003|Randomization Period|Physician Decision|0|||
143004606|NCT01869959|515554828|FG004|Randomization Period|Physician Decision|1|||
143457418|NCT01160289|517219302|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
143457419|NCT01160289|517219303|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
143457420|NCT01160289|517219304|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
143457421|NCT01160289|517219299|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
143457422|NCT01160289|517219300|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
143457423|NCT01160289|517219301|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
143457424|NCT01160289|517219302|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
143457425|NCT01160289|517219303|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
143457426|NCT01160289|517219304|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
143457427|NCT01160289|517219299|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
143457428|NCT01160289|517219300|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
143457429|NCT01160289|517219301|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
143457430|NCT01160289|517219302|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
143457431|NCT01160289|517219303|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
143457432|NCT01160289|517219304|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
143457433|NCT01160289|517219299|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
143457434|NCT01160289|517219300|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
143457435|NCT01160289|517219301|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
143457436|NCT01160289|517219302|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
143457437|NCT01160289|517219303|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
143457438|NCT01160289|517219304|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
143457439|NCT01160289|517219299|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
143457440|NCT01160289|517219300|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
143457441|NCT01160289|517219301|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
143457442|NCT01160289|517219302|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
143457443|NCT01160289|517219303|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
143457444|NCT01160289|517219304|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
143457445|NCT01160289|517219299|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
143457446|NCT01160289|517219300|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
143457447|NCT01160289|517219301|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
143457448|NCT01160289|517219302|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
143457449|NCT01160289|517219303|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
143457450|NCT01160289|517219304|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
143457451|NCT01160289|517219299|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
143457452|NCT01160289|517219300|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
143457453|NCT01160289|517219301|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
143457454|NCT01160289|517219302|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
143457455|NCT01160289|517219303|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
143457456|NCT01160289|517219304|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
143457457|NCT01160289|517219299|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
143457458|NCT01160289|517219300|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
143457459|NCT01160289|517219301|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
143457460|NCT01160289|517219302|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
143457461|NCT01160289|517219303|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
143457462|NCT01160289|517219304|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
143457463|NCT01160289|517219299|FG000|Post-Randomization Period|Adverse Event|0|||
143457464|NCT01160289|517219300|FG001|Post-Randomization Period|Adverse Event|4|||
143457465|NCT01160289|517219301|FG002|Post-Randomization Period|Adverse Event|4|||
143457466|NCT01160289|517219302|FG003|Post-Randomization Period|Adverse Event|2|||
143457467|NCT01160289|517219303|FG004|Post-Randomization Period|Adverse Event|0|||
143457468|NCT01160289|517219304|FG005|Post-Randomization Period|Adverse Event|0|||
143457469|NCT01160289|517219299|FG000|Post-Randomization Period|Death|0|||
143457470|NCT01160289|517219300|FG001|Post-Randomization Period|Death|0|||
143457471|NCT01160289|517219301|FG002|Post-Randomization Period|Death|0|||
143457472|NCT01160289|517219302|FG003|Post-Randomization Period|Death|1|||
143457473|NCT01160289|517219303|FG004|Post-Randomization Period|Death|0|||
143457474|NCT01160289|517219304|FG005|Post-Randomization Period|Death|0|||
143457475|NCT01160289|517219299|FG000|Post-Randomization Period|Lack of Efficacy|0|||
143457476|NCT01160289|517219300|FG001|Post-Randomization Period|Lack of Efficacy|1|||
143457477|NCT01160289|517219301|FG002|Post-Randomization Period|Lack of Efficacy|0|||
143457478|NCT01160289|517219302|FG003|Post-Randomization Period|Lack of Efficacy|3|||
143457479|NCT01160289|517219303|FG004|Post-Randomization Period|Lack of Efficacy|0|||
143457480|NCT01160289|517219304|FG005|Post-Randomization Period|Lack of Efficacy|0|||
143457481|NCT01160289|517219299|FG000|Post-Randomization Period|Lost to Follow-up|0|||
143457482|NCT01160289|517219300|FG001|Post-Randomization Period|Lost to Follow-up|3|||
143457483|NCT01160289|517219301|FG002|Post-Randomization Period|Lost to Follow-up|2|||
143457484|NCT01160289|517219302|FG003|Post-Randomization Period|Lost to Follow-up|5|||
143457485|NCT01160289|517219303|FG004|Post-Randomization Period|Lost to Follow-up|3|||
143457486|NCT01160289|517219304|FG005|Post-Randomization Period|Lost to Follow-up|4|||
143004607|NCT01869959|515554824|FG000|Treatment Period|Adverse Event|1|||
143004608|NCT01869959|515554825|FG001|Treatment Period|Adverse Event|0|||
143004609|NCT01869959|515554826|FG002|Treatment Period|Adverse Event|3|||
143004610|NCT01869959|515554827|FG003|Treatment Period|Adverse Event|1|||
143004611|NCT01869959|515554828|FG004|Treatment Period|Adverse Event|0|||
143004612|NCT01869959|515554824|FG000|Treatment Period|Sponsor decision|0|||
143004613|NCT01869959|515554825|FG001|Treatment Period|Sponsor decision|1|||
143004614|NCT01869959|515554826|FG002|Treatment Period|Sponsor decision|0|||
143004615|NCT01869959|515554827|FG003|Treatment Period|Sponsor decision|1|||
143004616|NCT01869959|515554828|FG004|Treatment Period|Sponsor decision|0|||
143004617|NCT01869959|515554824|FG000|Treatment Period|Withdrawal by Subject|0|||
143457487|NCT01160289|517219299|FG000|Post-Randomization Period|Physician Decision|0|||
143457488|NCT01160289|517219300|FG001|Post-Randomization Period|Physician Decision|0|||
143457489|NCT01160289|517219301|FG002|Post-Randomization Period|Physician Decision|1|||
143457490|NCT01160289|517219302|FG003|Post-Randomization Period|Physician Decision|0|||
143457491|NCT01160289|517219303|FG004|Post-Randomization Period|Physician Decision|0|||
143457492|NCT01160289|517219304|FG005|Post-Randomization Period|Physician Decision|0|||
143457493|NCT01160289|517219299|FG000|Post-Randomization Period|Protocol Violation|0|||
143457494|NCT01160289|517219300|FG001|Post-Randomization Period|Protocol Violation|4|||
143457495|NCT01160289|517219301|FG002|Post-Randomization Period|Protocol Violation|2|||
143457496|NCT01160289|517219302|FG003|Post-Randomization Period|Protocol Violation|0|||
143457497|NCT01160289|517219303|FG004|Post-Randomization Period|Protocol Violation|1|||
143457498|NCT01160289|517219304|FG005|Post-Randomization Period|Protocol Violation|3|||
143457499|NCT01160289|517219299|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
143457500|NCT01160289|517219300|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
143457501|NCT01160289|517219301|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
143457502|NCT01160289|517219302|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
143457503|NCT01160289|517219303|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
143457504|NCT01160289|517219304|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
143457505|NCT01160289|517219299|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
143457506|NCT01160289|517219300|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
143457507|NCT01160289|517219301|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
143457508|NCT01160289|517219302|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
143457509|NCT01160289|517219303|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
143457510|NCT01160289|517219304|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
143457511|NCT01160289|517219299|FG000|Post-Randomization Period|Sponsor Decision|0|||
143457512|NCT01160289|517219300|FG001|Post-Randomization Period|Sponsor Decision|1|||
143457513|NCT01160289|517219301|FG002|Post-Randomization Period|Sponsor Decision|0|||
143457514|NCT01160289|517219302|FG003|Post-Randomization Period|Sponsor Decision|0|||
143457515|NCT01160289|517219303|FG004|Post-Randomization Period|Sponsor Decision|0|||
143457516|NCT01160289|517219304|FG005|Post-Randomization Period|Sponsor Decision|0|||
143457517|NCT00993668|517219305|FG000|Single-Blind Period|Adverse Event|1|||
143457518|NCT00993668|517219306|FG001|Single-Blind Period|Adverse Event|1|||
143457519|NCT00993668|517219305|FG000|Single-Blind Period|Lack of Efficacy|0|||
143457520|NCT00993668|517219306|FG001|Single-Blind Period|Lack of Efficacy|1|||
143457521|NCT00993668|517219305|FG000|Single-Blind Period|Lost to Follow-up|3|||
143457522|NCT00993668|517219306|FG001|Single-Blind Period|Lost to Follow-up|1|||
143457523|NCT00993668|517219305|FG000|Open-Label Period|Adverse Event|9|||
143457524|NCT00993668|517219306|FG001|Open-Label Period|Adverse Event|8|||
143457525|NCT00993668|517219305|FG000|Open-Label Period|Lack of Efficacy|4|||
143457526|NCT00993668|517219306|FG001|Open-Label Period|Lack of Efficacy|3|||
143457527|NCT00993668|517219305|FG000|Open-Label Period|Withdrawal by Subject|4|||
143457528|NCT00993668|517219306|FG001|Open-Label Period|Withdrawal by Subject|3|||
143457529|NCT00993668|517219305|FG000|Open-Label Period|Lost to Follow-up|6|||
143457530|NCT00993668|517219306|FG001|Open-Label Period|Lost to Follow-up|1|||
143457531|NCT03606668|517219310|FG000|Overall Study|Screen Failure|1|||
143457532|NCT03606668|517219310|FG000|Overall Study|Lost to Follow-up|1|||
143457533|NCT01029652|517219311|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
143457534|NCT01029652|517219312|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
143457535|NCT01029652|517219311|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
143457536|NCT01029652|517219312|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
143457537|NCT01029652|517219311|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
143457538|NCT01029652|517219312|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
143004618|NCT01869959|515554825|FG001|Treatment Period|Withdrawal by Subject|1|||
143004619|NCT01869959|515554826|FG002|Treatment Period|Withdrawal by Subject|0|||
143004620|NCT01869959|515554827|FG003|Treatment Period|Withdrawal by Subject|0|||
143004621|NCT01869959|515554828|FG004|Treatment Period|Withdrawal by Subject|0|||
143004622|NCT01965600|515554829|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
143004623|NCT01965600|515554830|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
143004624|NCT01965600|515554831|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
143004625|NCT01965600|515554832|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
143004626|NCT01965600|515554829|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
143004627|NCT01965600|515554830|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
143004628|NCT01965600|515554831|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
143004629|NCT01965600|515554832|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
143004630|NCT01965600|515554829|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
143004631|NCT01965600|515554830|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
143004632|NCT01965600|515554831|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
143004633|NCT01965600|515554832|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
143004634|NCT01965600|515554829|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
143004635|NCT01965600|515554830|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
143004636|NCT01965600|515554831|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
143004637|NCT01965600|515554832|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
143004638|NCT01965600|515554829|FG000|Second Intervention|Study terminated by Sponsor|0|||
143004639|NCT01965600|515554830|FG001|Second Intervention|Study terminated by Sponsor|0|||
143004640|NCT01965600|515554831|FG002|Second Intervention|Study terminated by Sponsor|2|||
143004641|NCT01965600|515554832|FG003|Second Intervention|Study terminated by Sponsor|2|||
143004642|NCT01078974|515554838|FG000|Overall Study|Adverse Event|3|||
143004643|NCT00422227|515554840|FG000|Overall Study|Adverse Event|3|||
143004644|NCT00422227|515554841|FG001|Overall Study|Adverse Event|8|||
143004645|NCT00422227|515554840|FG000|Overall Study|Lost to Follow-up|1|||
143004646|NCT00422227|515554841|FG001|Overall Study|Lost to Follow-up|3|||
143004647|NCT00422227|515554840|FG000|Overall Study|Withdrawal by Subject|0|||
143004648|NCT00422227|515554841|FG001|Overall Study|Withdrawal by Subject|4|||
143004649|NCT00686894|515554843|FG000|Overall Study|Relapse|2|||
143004650|NCT00686894|515554843|FG000|Overall Study|Protocol Violation|4|||
143004651|NCT01790633|515554844|FG000|Overall Study|Protocol Violation|1|||
143004652|NCT01790633|515554845|FG001|Overall Study|Protocol Violation|2|||
143004653|NCT01790633|515554844|FG000|Overall Study|Did not have serology performed|47|||
143004654|NCT01790633|515554845|FG001|Overall Study|Did not have serology performed|0|||
143004655|NCT01790633|515554844|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
143004656|NCT01790633|515554845|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
143004657|NCT00437294|515556684|FG000|Overall Study|Adverse Event|5|||
143004658|NCT00437294|515556685|FG001|Overall Study|Adverse Event|4|||
143004659|NCT00437294|515556684|FG000|Overall Study|Death|5|||
143004660|NCT00437294|515556685|FG001|Overall Study|Death|2|||
143004661|NCT00437294|515556684|FG000|Overall Study|Physician Decision|0|||
143004662|NCT00437294|515556685|FG001|Overall Study|Physician Decision|3|||
143004663|NCT00437294|515556684|FG000|Overall Study|Withdrawal by Subject|5|||
143004664|NCT00437294|515556685|FG001|Overall Study|Withdrawal by Subject|0|||
143004665|NCT00437294|515556684|FG000|Overall Study|Progressive Disease|19|||
143004666|NCT00437294|515556685|FG001|Overall Study|Progressive Disease|23|||
143004667|NCT00437294|515556684|FG000|Overall Study|Sponsor Decision|8|||
143004668|NCT00437294|515556685|FG001|Overall Study|Sponsor Decision|9|||
143004669|NCT00437294|515556684|FG000|Overall Study|Protocol Violation|0|||
143004670|NCT00437294|515556685|FG001|Overall Study|Protocol Violation|1|||
143004671|NCT00437294|515556684|FG000|Overall Study|Entry criteria not met|1|||
143004672|NCT00437294|515556685|FG001|Overall Study|Entry criteria not met|1|||
143004673|NCT00560573|515556687|FG000|Overall Study|Death|4|||
143004674|NCT00560573|515556688|FG001|Overall Study|Death|1|||
143004675|NCT00560573|515556689|FG002|Overall Study|Death|4|||
143004676|NCT00560573|515556690|FG003|Overall Study|Death|5|||
143004677|NCT00560573|515556691|FG004|Overall Study|Death|1|||
143004678|NCT00560573|515556692|FG005|Overall Study|Death|10|||
143004679|NCT00560573|515556687|FG000|Overall Study|Lost to Follow-up|0|||
143004680|NCT00560573|515556688|FG001|Overall Study|Lost to Follow-up|0|||
143004681|NCT00560573|515556689|FG002|Overall Study|Lost to Follow-up|0|||
143004682|NCT00560573|515556690|FG003|Overall Study|Lost to Follow-up|1|||
143004683|NCT00560573|515556691|FG004|Overall Study|Lost to Follow-up|1|||
143004684|NCT00560573|515556692|FG005|Overall Study|Lost to Follow-up|0|||
143004685|NCT00560573|515556687|FG000|Overall Study|Withdrawal by Subject|0|||
143004686|NCT00560573|515556688|FG001|Overall Study|Withdrawal by Subject|0|||
143004687|NCT00560573|515556689|FG002|Overall Study|Withdrawal by Subject|0|||
143004688|NCT00560573|515556690|FG003|Overall Study|Withdrawal by Subject|1|||
143004689|NCT00560573|515556691|FG004|Overall Study|Withdrawal by Subject|1|||
143004690|NCT00560573|515556692|FG005|Overall Study|Withdrawal by Subject|0|||
143004691|NCT00560573|515556687|FG000|Overall Study|Other|2|||
143004692|NCT00560573|515556688|FG001|Overall Study|Other|2|||
143004693|NCT00560573|515556689|FG002|Overall Study|Other|2|||
143004694|NCT00560573|515556690|FG003|Overall Study|Other|3|||
143004695|NCT00560573|515556691|FG004|Overall Study|Other|3|||
143004696|NCT00560573|515556692|FG005|Overall Study|Other|3|||
143004697|NCT00560573|515556687|FG000|Overall Study|Enrolled, not treated|0|||
143004698|NCT00560573|515556688|FG001|Overall Study|Enrolled, not treated|0|||
143004699|NCT00560573|515556689|FG002|Overall Study|Enrolled, not treated|0|||
143004700|NCT00560573|515556690|FG003|Overall Study|Enrolled, not treated|0|||
143004701|NCT00560573|515556691|FG004|Overall Study|Enrolled, not treated|1|||
143004702|NCT00560573|515556692|FG005|Overall Study|Enrolled, not treated|0|||
143004703|NCT00594568|515556693|FG000|Initial Treatment|Adverse Event|51|||
143004704|NCT00594568|515556694|FG001|Initial Treatment|Adverse Event|121|||
143004705|NCT00594568|515556695|FG002|Initial Treatment|Adverse Event|144|||
143004706|NCT00594568|515556693|FG000|Initial Treatment|Death|6|||
143004707|NCT00594568|515556694|FG001|Initial Treatment|Death|11|||
143004708|NCT00594568|515556695|FG002|Initial Treatment|Death|15|||
143004709|NCT00594568|515556693|FG000|Initial Treatment|Lost to Follow-up|4|||
143004710|NCT00594568|515556694|FG001|Initial Treatment|Lost to Follow-up|1|||
143004711|NCT00594568|515556695|FG002|Initial Treatment|Lost to Follow-up|4|||
143004712|NCT00594568|515556693|FG000|Initial Treatment|Physician Decision|3|||
143004713|NCT00594568|515556694|FG001|Initial Treatment|Physician Decision|2|||
143004714|NCT00594568|515556695|FG002|Initial Treatment|Physician Decision|4|||
143004715|NCT00594568|515556693|FG000|Initial Treatment|Protocol Violation|2|||
143004716|NCT00594568|515556694|FG001|Initial Treatment|Protocol Violation|2|||
143004717|NCT00594568|515556695|FG002|Initial Treatment|Protocol Violation|5|||
143004718|NCT00594568|515556693|FG000|Initial Treatment|Withdrawal by Subject|25|||
143004719|NCT00594568|515556694|FG001|Initial Treatment|Withdrawal by Subject|31|||
143004720|NCT00594568|515556695|FG002|Initial Treatment|Withdrawal by Subject|46|||
143004721|NCT00594568|515556693|FG000|Initial Treatment|Sponsor decision|193|||
143004722|NCT00594568|515556694|FG001|Initial Treatment|Sponsor decision|142|||
143004723|NCT00594568|515556695|FG002|Initial Treatment|Sponsor decision|147|||
143004724|NCT00594568|515556693|FG000|Initial Treatment|Caregiver decision|21|||
143004725|NCT00594568|515556694|FG001|Initial Treatment|Caregiver decision|36|||
143004726|NCT00594568|515556695|FG002|Initial Treatment|Caregiver decision|36|||
143004727|NCT00594568|515556693|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
143004728|NCT00594568|515556694|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
143004729|NCT00594568|515556695|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
143004730|NCT00594568|515556693|FG000|Initial Treatment|Entry criteria exclusion|0|||
143004731|NCT00594568|515556694|FG001|Initial Treatment|Entry criteria exclusion|1|||
143004732|NCT00594568|515556695|FG002|Initial Treatment|Entry criteria exclusion|1|||
143004733|NCT00594568|515556693|FG000|Delayed Start|Death|0|||
143004734|NCT00594568|515556694|FG001|Delayed Start|Death|0|||
143004735|NCT00594568|515556695|FG002|Delayed Start|Death|1|||
143004736|NCT00594568|515556693|FG000|Delayed Start|Adverse Event|12|||
143004737|NCT00594568|515556694|FG001|Delayed Start|Adverse Event|2|||
143004738|NCT00594568|515556695|FG002|Delayed Start|Adverse Event|2|||
143004739|NCT00594568|515556693|FG000|Delayed Start|Withdrawal by Subject|4|||
143004740|NCT00594568|515556694|FG001|Delayed Start|Withdrawal by Subject|3|||
143004741|NCT00594568|515556695|FG002|Delayed Start|Withdrawal by Subject|0|||
143004742|NCT00594568|515556693|FG000|Delayed Start|Physician Decision|0|||
143004743|NCT00594568|515556694|FG001|Delayed Start|Physician Decision|0|||
143004744|NCT00594568|515556695|FG002|Delayed Start|Physician Decision|1|||
143004745|NCT00594568|515556693|FG000|Delayed Start|Lost to Follow-up|0|||
143004746|NCT00594568|515556694|FG001|Delayed Start|Lost to Follow-up|0|||
143004747|NCT00594568|515556695|FG002|Delayed Start|Lost to Follow-up|1|||
143004748|NCT00594568|515556693|FG000|Delayed Start|Caregiver Decision|5|||
143004749|NCT00594568|515556694|FG001|Delayed Start|Caregiver Decision|6|||
143004750|NCT00594568|515556695|FG002|Delayed Start|Caregiver Decision|2|||
143004751|NCT00594568|515556693|FG000|Delayed Start|Sponsor Decision|77|||
143004752|NCT00594568|515556694|FG001|Delayed Start|Sponsor Decision|66|||
143004753|NCT00594568|515556695|FG002|Delayed Start|Sponsor Decision|59|||
143004754|NCT00594568|515556693|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
143004755|NCT00594568|515556694|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
143004756|NCT00594568|515556695|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
143004757|NCT00594568|515556693|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
143004758|NCT00594568|515556694|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
143004759|NCT00594568|515556695|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
143004760|NCT00594568|515556693|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
143004761|NCT00594568|515556694|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
143004762|NCT00594568|515556695|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
143004763|NCT00594568|515556693|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
143004764|NCT00594568|515556694|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
143004765|NCT00594568|515556695|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
143004766|NCT00594568|515556693|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
143004767|NCT00594568|515556694|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
143004768|NCT00594568|515556695|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
143004769|NCT00594568|515556693|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
143004770|NCT00594568|515556694|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
143004771|NCT00594568|515556695|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
143004772|NCT01422876|515556697|FG000|Week 24|Lost to Follow-up|1|||
143004773|NCT01422876|515556698|FG001|Week 24|Lost to Follow-up|1|||
143004774|NCT01422876|515556699|FG002|Week 24|Lost to Follow-up|2|||
143004775|NCT01422876|515556700|FG003|Week 24|Lost to Follow-up|4|||
143004776|NCT01422876|515556701|FG004|Week 24|Lost to Follow-up|2|||
143004777|NCT01422876|515556702|FG005|Week 24|Lost to Follow-up|0|||
143004778|NCT01422876|515556703|FG006|Week 24|Lost to Follow-up|1|||
143004779|NCT01422876|515556704|FG007|Week 24|Lost to Follow-up|3|||
143004780|NCT01422876|515556705|FG008|Week 24|Lost to Follow-up|3|||
143004781|NCT01422876|515556706|FG009|Week 24|Lost to Follow-up|4|||
143004782|NCT01422876|515556697|FG000|Week 24|Consent withdrawn|5|||
143004783|NCT01422876|515556698|FG001|Week 24|Consent withdrawn|1|||
143004784|NCT01422876|515556699|FG002|Week 24|Consent withdrawn|3|||
143004785|NCT01422876|515556700|FG003|Week 24|Consent withdrawn|4|||
143004786|NCT01422876|515556701|FG004|Week 24|Consent withdrawn|5|||
143004787|NCT01422876|515556702|FG005|Week 24|Consent withdrawn|6|||
143004788|NCT01422876|515556703|FG006|Week 24|Consent withdrawn|5|||
143004789|NCT01422876|515556704|FG007|Week 24|Consent withdrawn|4|||
143004790|NCT01422876|515556705|FG008|Week 24|Consent withdrawn|3|||
143004791|NCT01422876|515556706|FG009|Week 24|Consent withdrawn|6|||
143004792|NCT01422876|515556697|FG000|Week 24|Death|0|||
143004793|NCT01422876|515556698|FG001|Week 24|Death|1|||
143004794|NCT01422876|515556699|FG002|Week 24|Death|0|||
143004795|NCT01422876|515556700|FG003|Week 24|Death|0|||
143004796|NCT01422876|515556701|FG004|Week 24|Death|0|||
143004797|NCT01422876|515556702|FG005|Week 24|Death|0|||
143004798|NCT01422876|515556703|FG006|Week 24|Death|0|||
143004799|NCT01422876|515556704|FG007|Week 24|Death|0|||
143004800|NCT01422876|515556705|FG008|Week 24|Death|0|||
143004801|NCT01422876|515556706|FG009|Week 24|Death|0|||
143004802|NCT01422876|515556697|FG000|Week 52|Lost to Follow-up|3|||
143004803|NCT01422876|515556698|FG001|Week 52|Lost to Follow-up|5|||
143004804|NCT01422876|515556699|FG002|Week 52|Lost to Follow-up|7|||
143004805|NCT01422876|515556700|FG003|Week 52|Lost to Follow-up|5|||
143004806|NCT01422876|515556701|FG004|Week 52|Lost to Follow-up|8|||
143004807|NCT01422876|515556702|FG005|Week 52|Lost to Follow-up|5|||
143004808|NCT01422876|515556703|FG006|Week 52|Lost to Follow-up|5|||
143004809|NCT01422876|515556704|FG007|Week 52|Lost to Follow-up|8|||
143004810|NCT01422876|515556705|FG008|Week 52|Lost to Follow-up|7|||
143004811|NCT01422876|515556706|FG009|Week 52|Lost to Follow-up|8|||
143004812|NCT01422876|515556697|FG000|Week 52|Consent withdrawn|9|||
143004813|NCT01422876|515556698|FG001|Week 52|Consent withdrawn|4|||
143004814|NCT01422876|515556699|FG002|Week 52|Consent withdrawn|6|||
143004815|NCT01422876|515556700|FG003|Week 52|Consent withdrawn|12|||
143004816|NCT01422876|515556701|FG004|Week 52|Consent withdrawn|7|||
143004817|NCT01422876|515556702|FG005|Week 52|Consent withdrawn|12|||
143004818|NCT01422876|515556703|FG006|Week 52|Consent withdrawn|10|||
143004819|NCT01422876|515556704|FG007|Week 52|Consent withdrawn|12|||
143004820|NCT01422876|515556705|FG008|Week 52|Consent withdrawn|13|||
143004821|NCT01422876|515556706|FG009|Week 52|Consent withdrawn|9|||
143004822|NCT01422876|515556697|FG000|Week 52|Death|0|||
143004823|NCT01422876|515556698|FG001|Week 52|Death|1|||
143004824|NCT01422876|515556699|FG002|Week 52|Death|0|||
143004825|NCT01422876|515556700|FG003|Week 52|Death|1|||
143004826|NCT01422876|515556701|FG004|Week 52|Death|0|||
143004827|NCT01422876|515556702|FG005|Week 52|Death|0|||
143004828|NCT01422876|515556703|FG006|Week 52|Death|1|||
143004829|NCT01422876|515556704|FG007|Week 52|Death|3|||
143004830|NCT01422876|515556705|FG008|Week 52|Death|1|||
143004831|NCT01422876|515556706|FG009|Week 52|Death|0|||
143004832|NCT00536991|515556707|FG000|Overall Study|Withdrawal by Subject|10|||
143004833|NCT00536991|515556707|FG000|Overall Study|Physician Decision|1|||
143004834|NCT00536991|515556707|FG000|Overall Study|patient ineligible|2|||
143004835|NCT00518531|515556708|FG000|Treatment Period 1|Adverse Event|5|||
143004836|NCT00518531|515556709|FG001|Treatment Period 1|Adverse Event|0|||
143004837|NCT00518531|515556708|FG000|Treatment Period 1|Lost to Follow-up|5|||
143004838|NCT00518531|515556709|FG001|Treatment Period 1|Lost to Follow-up|3|||
143004839|NCT00518531|515556708|FG000|Treatment Period 1|Physician Decision|1|||
143344468|NCT02118337|516806705|FG007|Overall Study|Death|9|||
143004840|NCT00518531|515556709|FG001|Treatment Period 1|Physician Decision|0|||
143004841|NCT00518531|515556708|FG000|Treatment Period 1|Protocol Violation|2|||
143004842|NCT00518531|515556709|FG001|Treatment Period 1|Protocol Violation|0|||
143004843|NCT00518531|515556708|FG000|Treatment Period 1|Withdrawal by Subject|4|||
143004844|NCT00518531|515556709|FG001|Treatment Period 1|Withdrawal by Subject|6|||
143004845|NCT00518531|515556708|FG000|Treatment Period 1|Early crossover|1|||
143004846|NCT00518531|515556709|FG001|Treatment Period 1|Early crossover|3|||
143004847|NCT00518531|515556708|FG000|Treatment Period 2|Withdrawal by Subject|0|||
143004848|NCT00518531|515556709|FG001|Treatment Period 2|Withdrawal by Subject|8|||
143004849|NCT00518531|515556708|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
143004850|NCT00518531|515556709|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
143004851|NCT00518531|515556708|FG000|Treatment Period 2|Adverse Event|1|||
143004852|NCT00518531|515556709|FG001|Treatment Period 2|Adverse Event|7|||
143004853|NCT00518531|515556708|FG000|Treatment Period 2|Protocol-specified criteria|0|||
143004854|NCT00518531|515556709|FG001|Treatment Period 2|Protocol-specified criteria|1|||
143004855|NCT00518531|515556708|FG000|Treatment Period 2|Non-compliance|1|||
143004856|NCT00518531|515556709|FG001|Treatment Period 2|Non-compliance|2|||
143004857|NCT01600755|515556710|FG000|Overall Study|Withdrawal by Subject|6|||
143004858|NCT04621227|515556715|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
143004859|NCT04621227|515556715|FG000|Period 3 (29 Days)|Adverse Event|1|||
143004860|NCT04621227|515556715|FG000|Period 8 (2 Days)|Adverse Event|1|||
143004861|NCT00290511|515556718|FG000|Overall Study|Adverse Event|1|||
143004862|NCT00290511|515556718|FG000|Overall Study|Death|1|||
143004863|NCT00290511|515556718|FG000|Overall Study|Physician Decision|1|||
143004864|NCT00290511|515556718|FG000|Overall Study|Withdrawal by Subject|1|||
143004865|NCT04311411|515556719|FG000|Overall Study|Adverse Event|2|||
143004866|NCT04311411|515556720|FG001|Overall Study|Adverse Event|3|||
143004867|NCT04311411|515556721|FG002|Overall Study|Adverse Event|2|||
143004868|NCT04311411|515556719|FG000|Overall Study|Withdrawal by Subject|3|||
143004869|NCT04311411|515556720|FG001|Overall Study|Withdrawal by Subject|3|||
143004870|NCT04311411|515556721|FG002|Overall Study|Withdrawal by Subject|0|||
143004871|NCT05299359|515556722|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
143004872|NCT05299359|515556723|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
143004873|NCT05299359|515556722|FG000|Main Part: Day 1 up to Day 366|Other|2|||
143004874|NCT05299359|515556723|FG001|Main Part: Day 1 up to Day 366|Other|0|||
143004875|NCT05299359|515556722|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
143004876|NCT05299359|515556723|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
143004877|NCT05299359|515556722|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
143004878|NCT05299359|515556723|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
143004879|NCT05299359|515556722|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
143004880|NCT05299359|515556723|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
143004881|NCT05299359|515556722|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
143004882|NCT05299359|515556723|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
143004883|NCT05299359|515556722|FG000|Extension Part: Day 1 to Day 366|Other|0|||
143004884|NCT05299359|515556723|FG001|Extension Part: Day 1 to Day 366|Other|1|||
143004885|NCT04780776|515556728|FG000|Titration Week 1-5|Lost to Follow-up|2|||
143004886|NCT04780776|515556729|FG001|Titration Week 1-5|Lost to Follow-up|8|||
143004887|NCT04780776|515556728|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
143004888|NCT04780776|515556729|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
143004889|NCT04780776|515556728|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
143004890|NCT04780776|515556729|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
143004891|NCT03113760|515556730|FG000|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|2|||
143004892|NCT03113760|515556731|FG001|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
143004893|NCT03113760|515556732|FG002|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
143004894|NCT03113760|515556733|FG003|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
143004895|NCT03113760|515556730|FG000|Initial 18 Weeks Treatment Phase|Adverse Event|1|||
143004896|NCT03113760|515556731|FG001|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
143004897|NCT03113760|515556732|FG002|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
143004898|NCT03113760|515556733|FG003|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
143004899|NCT03113760|515556730|FG000|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
143004900|NCT03113760|515556731|FG001|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
143004901|NCT03113760|515556732|FG002|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
143004902|NCT03113760|515556733|FG003|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
143004903|NCT02696382|515556734|FG000|Overall Study|Death|7|||
143004904|NCT02696382|515556735|FG001|Overall Study|Death|2|||
143004905|NCT02696382|515556734|FG000|Overall Study|Withdrawal by Subject|5|||
143004906|NCT02696382|515556735|FG001|Overall Study|Withdrawal by Subject|12|||
143004907|NCT02696382|515556734|FG000|Overall Study|Lost to Follow-up|4|||
143004908|NCT02696382|515556735|FG001|Overall Study|Lost to Follow-up|7|||
143004909|NCT00483574|515556736|FG000|Overall Study|Adverse Event|6|||
143004910|NCT00483574|515556737|FG001|Overall Study|Adverse Event|0|||
143004911|NCT00483574|515556736|FG000|Overall Study|Protocol Violation|28|||
143004912|NCT00483574|515556737|FG001|Overall Study|Protocol Violation|9|||
143004913|NCT00483574|515556736|FG000|Overall Study|Lost to Follow-up|16|||
143004914|NCT00483574|515556737|FG001|Overall Study|Lost to Follow-up|4|||
143004915|NCT00483574|515556736|FG000|Overall Study|Withdrawal by Subject|52|||
143004916|NCT00483574|515556737|FG001|Overall Study|Withdrawal by Subject|0|||
143004917|NCT04753606|515556740|FG000|Overall Study|Adverse Event|1|||
143004918|NCT04753606|515556741|FG001|Overall Study|Adverse Event|0|||
143004919|NCT04753606|515556742|FG002|Overall Study|Adverse Event|0|||
143004920|NCT00779857|515556743|FG000|Overall Study|Death|1|||
143004921|NCT00779857|515556743|FG000|Overall Study|Withdrawal by Subject|3|||
143004922|NCT00779857|515556743|FG000|Overall Study|Missed Visit|2|||
143004923|NCT04640168|515556744|FG000|Overall Study|Withdrawal by Subject|8|||
143004924|NCT04640168|515556745|FG001|Overall Study|Withdrawal by Subject|7|||
143004925|NCT04640168|515556744|FG000|Overall Study|Lost to Follow-up|1|||
143004926|NCT04640168|515556745|FG001|Overall Study|Lost to Follow-up|0|||
143004927|NCT04640168|515556744|FG000|Overall Study|Enrolled but not treated|12|||
143004928|NCT04640168|515556745|FG001|Overall Study|Enrolled but not treated|12|||
143004929|NCT00442572|515556753|FG000|Overall Study|Relapse|8|||
143004930|NCT00442572|515556754|FG001|Overall Study|Relapse|1|||
143004931|NCT00442572|515556753|FG000|Overall Study|Lost to Follow-up|0|||
143004932|NCT00442572|515556754|FG001|Overall Study|Lost to Follow-up|1|||
143004933|NCT00442572|515556753|FG000|Overall Study|Withdrawal by Subject|0|||
143004934|NCT00442572|515556754|FG001|Overall Study|Withdrawal by Subject|1|||
143004935|NCT04366258|515556755|FG000|Baseline Assessments|Screen Failure|21|||
143004936|NCT04366258|515556755|FG000|Baseline Assessments|Early Termination|3|||
143004937|NCT02940392|515556758|FG000|Overall Study|Lost to Follow-up|3|||
143004938|NCT02940392|515556758|FG000|Overall Study|Retreatment|3|||
143004939|NCT02940392|515556758|FG000|Overall Study|Death|2|||
143004940|NCT03205046|515556759|FG000|Overall Study|Death|10|||
143004941|NCT03205046|515556760|FG001|Overall Study|Death|6|||
143004942|NCT03205046|515556759|FG000|Overall Study|Withdrawal by Subject|1|||
143004943|NCT03205046|515556760|FG001|Overall Study|Withdrawal by Subject|2|||
143004944|NCT03205046|515556759|FG000|Overall Study|Lost to Follow-up|0|||
143004945|NCT03205046|515556760|FG001|Overall Study|Lost to Follow-up|1|||
143004946|NCT03205046|515556759|FG000|Overall Study|Study terminated by sponsor|2|||
143004947|NCT03205046|515556760|FG001|Overall Study|Study terminated by sponsor|1|||
143004948|NCT01023815|515556761|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
143004949|NCT01023815|515556762|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
143004950|NCT01023815|515556763|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
143004951|NCT01023815|515556764|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
143004952|NCT01023815|515556761|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
143004953|NCT01023815|515556762|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
143004954|NCT01023815|515556763|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
143004955|NCT01023815|515556764|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
143004956|NCT01023815|515556761|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
143004957|NCT01023815|515556762|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
143004958|NCT01023815|515556763|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
143004959|NCT01023815|515556764|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
143004960|NCT01023815|515556761|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
143004961|NCT01023815|515556762|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
143004962|NCT01023815|515556763|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
143004963|NCT01023815|515556764|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
143004964|NCT01023815|515556761|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
143004965|NCT01023815|515556762|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
143004966|NCT01023815|515556763|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
143004967|NCT01023815|515556764|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
143004968|NCT02058849|515556768|FG000|Overall Study|Hospitalization|1|||
143004969|NCT02058849|515556769|FG001|Overall Study|Hospitalization|1|||
143004970|NCT02058849|515556768|FG000|Overall Study|Death|1|||
143004971|NCT02058849|515556769|FG001|Overall Study|Death|0|||
143004972|NCT02058849|515556768|FG000|Overall Study|Lost to Follow-up|1|||
143004973|NCT02058849|515556769|FG001|Overall Study|Lost to Follow-up|0|||
143004974|NCT02058849|515556768|FG000|Overall Study|Withdrawal by Subject|4|||
143004975|NCT02058849|515556769|FG001|Overall Study|Withdrawal by Subject|0|||
143004976|NCT01694849|515556770|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
143004977|NCT01694849|515556771|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
143004978|NCT01694849|515556772|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
143004979|NCT01694849|515556770|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
143004980|NCT01694849|515556771|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
143004981|NCT01694849|515556772|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
143004982|NCT01694849|515556770|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
143004983|NCT01694849|515556771|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
143004984|NCT01694849|515556772|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
143004985|NCT01694849|515556770|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
143004986|NCT01694849|515556771|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
143004987|NCT01694849|515556772|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
143004988|NCT01694849|515556770|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
143004989|NCT01694849|515556771|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
143004990|NCT01694849|515556772|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
143004991|NCT01694849|515556770|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
143004992|NCT01694849|515556771|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
143004993|NCT01694849|515556772|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
143004994|NCT01694849|515556770|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
143004995|NCT01694849|515556771|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
143004996|NCT01694849|515556772|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
143004997|NCT01694849|515556770|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
143004998|NCT01694849|515556771|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
143004999|NCT01694849|515556772|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
143005000|NCT02279888|515556776|FG000|Overall Study|Death|326|||
143005001|NCT02279888|515556776|FG000|Overall Study|Withdrawal by Subject|38|||
143005002|NCT02279888|515556776|FG000|Overall Study|Lost to Follow-up|21|||
143005003|NCT02279888|515556776|FG000|Overall Study|Physician Decision|62|||
143005004|NCT02279888|515556776|FG000|Overall Study|Subject Non-compliance|43|||
143005005|NCT02279888|515556776|FG000|Overall Study|Not implanted|14|||
143005006|NCT02279888|515556776|FG000|Overall Study|Visit not performed|26|||
143005007|NCT04505592|515556777|FG000|Overall Study|Death|2|||
143005008|NCT04505592|515556778|FG001|Overall Study|Death|1|||
143005009|NCT01015118|515556783|FG000|Overall Study|Protocol Violation|5|||
143005010|NCT01015118|515556784|FG001|Overall Study|Protocol Violation|6|||
143005011|NCT01015118|515556783|FG000|Overall Study|Withdrawal by Subject|103|||
143005012|NCT01015118|515556784|FG001|Overall Study|Withdrawal by Subject|27|||
143005013|NCT01015118|515556783|FG000|Overall Study|Other Adverse Event (AE)|141|||
143005014|NCT01015118|515556784|FG001|Overall Study|Other Adverse Event (AE)|33|||
143005015|NCT01015118|515556783|FG000|Overall Study|Worsening or AE of underlying disease|5|||
143005016|NCT01015118|515556784|FG001|Overall Study|Worsening or AE of underlying disease|4|||
143005017|NCT01015118|515556783|FG000|Overall Study|Progressive disease|364|||
143005018|NCT01015118|515556784|FG001|Overall Study|Progressive disease|229|||
143005019|NCT01015118|515556783|FG000|Overall Study|Not treated|9|||
143005020|NCT01015118|515556784|FG001|Overall Study|Not treated|5|||
143005021|NCT01015118|515556783|FG000|Overall Study|Other than stated above|42|||
143005022|NCT01015118|515556784|FG001|Overall Study|Other than stated above|23|||
143005023|NCT01683565|515556789|FG000|Overall Study|Lost to Follow-up|2|||
143005024|NCT01683565|515556790|FG001|Overall Study|Lost to Follow-up|0|||
143005025|NCT01683565|515556789|FG000|Overall Study|Discontinued Intervention|1|||
143005026|NCT01683565|515556790|FG001|Overall Study|Discontinued Intervention|1|||
143005027|NCT04527380|515556791|FG000|Overall Study|Lack of Efficacy|0|||
143005028|NCT04527380|515556792|FG001|Overall Study|Lack of Efficacy|1|||
143005029|NCT04527380|515556791|FG000|Overall Study|Withdrawal by Subject|1|||
143005030|NCT04527380|515556792|FG001|Overall Study|Withdrawal by Subject|0|||
143005031|NCT05437211|515556793|FG000|Overall Study|Patient's decision|1|||
143005032|NCT05437211|515556794|FG001|Overall Study|Patient's decision|1|||
143005033|NCT04410991|515556795|FG000|Overall Study|Poor compliance to protocol|5|||
143005034|NCT04410991|515556796|FG001|Overall Study|Poor compliance to protocol|4|||
143005035|NCT04410991|515556795|FG000|Overall Study|Withdrawal by Subject|59|||
143005036|NCT04410991|515556796|FG001|Overall Study|Withdrawal by Subject|55|||
143005037|NCT04410991|515556795|FG000|Overall Study|Other|10|||
143005038|NCT04410991|515556796|FG001|Overall Study|Other|4|||
143005039|NCT01250418|515556801|FG000|Overall Study|monitor data failure|1|||
143005040|NCT01250418|515556802|FG001|Overall Study|monitor data failure|1|||
143005041|NCT01761565|515556803|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
143005042|NCT05966129|515556806|FG000|Overall Study|Death|1|||
143005043|NCT05966129|515556807|FG001|Overall Study|Death|2|||
143005044|NCT05966129|515556806|FG000|Overall Study|Lost to Follow-up|63|||
143005045|NCT05966129|515556807|FG001|Overall Study|Lost to Follow-up|66|||
143005046|NCT05966129|515556806|FG000|Overall Study|Protocol Violation|1|||
143005047|NCT05966129|515556807|FG001|Overall Study|Protocol Violation|0|||
143005048|NCT05966129|515556806|FG000|Overall Study|Withdrawal by Subject|26|||
143005049|NCT05966129|515556807|FG001|Overall Study|Withdrawal by Subject|25|||
143005050|NCT05966129|515556806|FG000|Overall Study|Surgery not completed|63|||
143005051|NCT05966129|515556807|FG001|Overall Study|Surgery not completed|69|||
143005052|NCT05966129|515556806|FG000|Overall Study|Surgery logistics issue|2|||
143005053|NCT05966129|515556807|FG001|Overall Study|Surgery logistics issue|1|||
143005054|NCT04768881|515556808|FG000|Overall Study|Completed Study Follow-up|0|||
143005055|NCT04768881|515556809|FG001|Overall Study|Completed Study Follow-up|2|||
143005056|NCT04768881|515556808|FG000|Overall Study|Death|3|||
143005057|NCT04768881|515556809|FG001|Overall Study|Death|2|||
143005058|NCT04768881|515556808|FG000|Overall Study|Study Terminated by Sponsor|2|||
143005059|NCT04768881|515556809|FG001|Overall Study|Study Terminated by Sponsor|2|||
143005060|NCT04768881|515556808|FG000|Overall Study|Withdrawal by Subject|2|||
143005061|NCT04768881|515556809|FG001|Overall Study|Withdrawal by Subject|0|||
143005062|NCT04768881|515556808|FG000|Overall Study|Other|2|||
143005063|NCT04768881|515556809|FG001|Overall Study|Other|0|||
143005064|NCT03328325|515556812|FG000|Overall Study|Lost to Follow-up|4|||
143005065|NCT03328325|515556812|FG000|Overall Study|Physician Decision|1|||
143005066|NCT03328325|515556812|FG000|Overall Study|Withdrawal by Subject|3|||
143005067|NCT03328325|515556812|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
143114850|NCT03301740|515962434|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
143114851|NCT03301740|515962435|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
143114852|NCT02847182|515962439|FG000|Overall Study|Withdrawal by Subject|0|||
143114853|NCT02847182|515962440|FG001|Overall Study|Withdrawal by Subject|1|||
143114854|NCT02345889|515962441|FG000|Overall Study|Inadequate Bowel Prep|17|||
143114855|NCT02345889|515962442|FG001|Overall Study|Inadequate Bowel Prep|16|||
143114856|NCT02345889|515962443|FG002|Overall Study|Inadequate Bowel Prep|18|||
143114857|NCT02345889|515962444|FG003|Overall Study|Inadequate Bowel Prep|14|||
143114858|NCT02345889|515962441|FG000|Overall Study|Polyposis identified during procedure|1|||
143259550|NCT02720094|516505771|FG000|Overall Study|Death|4|||
143005068|NCT00509223|515558500|FG000|Overall Study|Lost to Follow-up|1|||
143005069|NCT00509223|515558501|FG001|Overall Study|Lost to Follow-up|1|||
143005070|NCT00509223|515558500|FG000|Overall Study|Adverse Event|1|||
143005071|NCT00509223|515558501|FG001|Overall Study|Adverse Event|1|||
143005072|NCT00509223|515558500|FG000|Overall Study|Withdrawal by Subject|25|||
143005073|NCT00509223|515558501|FG001|Overall Study|Withdrawal by Subject|6|||
143005074|NCT00509223|515558500|FG000|Overall Study|Including: subject change of address|5|||
143005075|NCT00509223|515558501|FG001|Overall Study|Including: subject change of address|2|||
143005076|NCT00509223|515558500|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
143005077|NCT00509223|515558501|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
143005078|NCT01300741|515558514|FG000|Overall Study|Lens deposits|1|||
143005079|NCT01300741|515558514|FG000|Overall Study|Lost to Follow-up|1|||
143005080|NCT01300741|515558514|FG000|Overall Study|Discomfort|1|||
143005081|NCT01473602|515558515|FG000|Overall Study|Adverse Event|1|||
143005082|NCT01473602|515558516|FG001|Overall Study|Adverse Event|2|||
143005083|NCT01473602|515558515|FG000|Overall Study|Death|0|||
143005084|NCT01473602|515558516|FG001|Overall Study|Death|1|||
143005085|NCT01473602|515558515|FG000|Overall Study|Lost to Follow-up|1|||
143005086|NCT01473602|515558516|FG001|Overall Study|Lost to Follow-up|1|||
143005087|NCT01473602|515558515|FG000|Overall Study|Withdrawal by Subject|5|||
143005088|NCT01473602|515558516|FG001|Overall Study|Withdrawal by Subject|4|||
143005089|NCT01473602|515558515|FG000|Overall Study|Physician Decision|1|||
143005090|NCT01473602|515558516|FG001|Overall Study|Physician Decision|0|||
143005091|NCT00726882|515558518|FG000|Overall Study|Withdrawal by Subject|5|||
143005092|NCT00726882|515558518|FG000|Overall Study|Lost to Follow-up|7|||
143005093|NCT00726882|515558518|FG000|Overall Study|Other|10|||
143005094|NCT01339273|515558519|FG000|Overall Study|Lost to Follow-up|8|||
143005095|NCT01339273|515558520|FG001|Overall Study|Lost to Follow-up|8|||
143005096|NCT02526017|515558523|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
143005097|NCT02526017|515558524|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
143005098|NCT02526017|515558525|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
143005099|NCT02526017|515558526|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
143005100|NCT02526017|515558527|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
143005101|NCT02526017|515558528|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
143005102|NCT02526017|515558529|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
143005103|NCT02526017|515558530|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
143005104|NCT02526017|515558531|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
143005105|NCT01728376|515558533|FG000|Overall Study|Adverse Event|1|||
143005106|NCT01728376|515558534|FG001|Overall Study|Adverse Event|1|||
143005107|NCT01728376|515558535|FG002|Overall Study|Adverse Event|1|||
143005108|NCT01728376|515558536|FG003|Overall Study|Adverse Event|1|||
143005109|NCT01728376|515558537|FG004|Overall Study|Adverse Event|1|||
143005110|NCT01728376|515558538|FG005|Overall Study|Adverse Event|0|||
143005111|NCT01728376|515558533|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
143005112|NCT01728376|515558534|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
143005113|NCT01728376|515558535|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
143005114|NCT01728376|515558536|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
143005115|NCT01728376|515558537|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
143005116|NCT01728376|515558538|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
143005117|NCT01728376|515558533|FG000|Overall Study|No relevant bacteria|2|||
143005118|NCT01728376|515558534|FG001|Overall Study|No relevant bacteria|0|||
143005119|NCT01728376|515558535|FG002|Overall Study|No relevant bacteria|0|||
143005120|NCT01728376|515558536|FG003|Overall Study|No relevant bacteria|0|||
143005121|NCT01728376|515558537|FG004|Overall Study|No relevant bacteria|1|||
143005122|NCT01728376|515558538|FG005|Overall Study|No relevant bacteria|1|||
143005123|NCT01728376|515558533|FG000|Overall Study|Did not receive treatment|0|||
143005124|NCT01728376|515558534|FG001|Overall Study|Did not receive treatment|1|||
143005125|NCT01728376|515558535|FG002|Overall Study|Did not receive treatment|0|||
143005126|NCT01728376|515558536|FG003|Overall Study|Did not receive treatment|0|||
143005127|NCT01728376|515558537|FG004|Overall Study|Did not receive treatment|0|||
143005128|NCT01728376|515558538|FG005|Overall Study|Did not receive treatment|0|||
143005129|NCT01728376|515558533|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
143005130|NCT01728376|515558534|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
143005131|NCT01728376|515558535|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
143005132|NCT01728376|515558536|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
143005133|NCT01728376|515558537|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
143005134|NCT01728376|515558538|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
143005135|NCT03557775|515558543|FG000|Overall Study|Withdrawal by Subject|1|||
143005136|NCT03557775|515558544|FG001|Overall Study|Withdrawal by Subject|2|||
143005137|NCT03557775|515558545|FG002|Overall Study|Withdrawal by Subject|4|||
143005138|NCT03557775|515558543|FG000|Overall Study|Physician Decision|0|||
143005139|NCT03557775|515558544|FG001|Overall Study|Physician Decision|1|||
143005140|NCT03557775|515558545|FG002|Overall Study|Physician Decision|0|||
143005141|NCT01725217|515558546|FG000|Overall Study|Withdrawal by Subject|1|||
143005142|NCT01725217|515558547|FG001|Overall Study|Withdrawal by Subject|0|||
143005143|NCT01725217|515558548|FG002|Overall Study|Withdrawal by Subject|0|||
143005144|NCT00276458|515558553|FG000|Overall Study|Adverse Event|0|||
143005145|NCT00276458|515558554|FG001|Overall Study|Adverse Event|2|||
143005146|NCT00276458|515558553|FG000|Overall Study|Lost to Follow-up|2|||
143005147|NCT00276458|515558554|FG001|Overall Study|Lost to Follow-up|2|||
143005148|NCT00276458|515558553|FG000|Overall Study|Protocol Violation|4|||
143005149|NCT00276458|515558554|FG001|Overall Study|Protocol Violation|3|||
143005150|NCT03253809|515558562|FG000|Overall Study|Unable to obtain study related data|14|||
143005151|NCT03992456|515558563|FG000|Overall Study|Withdrawal by Subject|1|||
143005152|NCT03992456|515558564|FG001|Overall Study|Withdrawal by Subject|0|||
143005153|NCT03992456|515558563|FG000|Overall Study|Disease progression|4|||
143005154|NCT03992456|515558564|FG001|Overall Study|Disease progression|5|||
143005155|NCT03992456|515558563|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
143005156|NCT03992456|515558564|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
143005157|NCT00910000|515558565|FG000|Overall Study|Adverse Event|0|||
143005158|NCT00910000|515558566|FG001|Overall Study|Adverse Event|3|||
143005159|NCT00910000|515558567|FG002|Overall Study|Adverse Event|2|||
143005160|NCT00910000|515558568|FG003|Overall Study|Adverse Event|2|||
143005161|NCT00910000|515558569|FG004|Overall Study|Adverse Event|0|||
143005162|NCT00910000|515558570|FG005|Overall Study|Adverse Event|1|||
143005163|NCT00910000|515558565|FG000|Overall Study|Withdrawal by Subject|0|||
143005164|NCT00910000|515558566|FG001|Overall Study|Withdrawal by Subject|0|||
143005165|NCT00910000|515558567|FG002|Overall Study|Withdrawal by Subject|1|||
143005166|NCT00910000|515558568|FG003|Overall Study|Withdrawal by Subject|0|||
143005167|NCT00910000|515558569|FG004|Overall Study|Withdrawal by Subject|1|||
143005168|NCT00910000|515558570|FG005|Overall Study|Withdrawal by Subject|0|||
143005169|NCT01977625|515558571|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
143005170|NCT01977625|515558572|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
143005171|NCT01977625|515558571|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
143005172|NCT01977625|515558572|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
143005173|NCT02594384|515558573|FG000|Overall Study|Disease Progression|3|||
143005174|NCT02594384|515558574|FG001|Overall Study|Disease Progression|7|||
143005175|NCT02594384|515558575|FG002|Overall Study|Disease Progression|0|||
143005176|NCT02594384|515558576|FG003|Overall Study|Disease Progression|2|||
143005177|NCT02594384|515558577|FG004|Overall Study|Disease Progression|2|||
143005178|NCT02594384|515558578|FG005|Overall Study|Disease Progression|12|||
143005179|NCT02594384|515558579|FG006|Overall Study|Disease Progression|5|||
143005180|NCT02594384|515558580|FG007|Overall Study|Disease Progression|5|||
143005181|NCT02594384|515558573|FG000|Overall Study|Adverse Event|0|||
143005182|NCT02594384|515558574|FG001|Overall Study|Adverse Event|1|||
143005183|NCT02594384|515558575|FG002|Overall Study|Adverse Event|4|||
143005184|NCT02594384|515558576|FG003|Overall Study|Adverse Event|1|||
143005185|NCT02594384|515558577|FG004|Overall Study|Adverse Event|0|||
143005186|NCT02594384|515558578|FG005|Overall Study|Adverse Event|6|||
143005187|NCT02594384|515558579|FG006|Overall Study|Adverse Event|1|||
143005188|NCT02594384|515558580|FG007|Overall Study|Adverse Event|1|||
143005189|NCT02594384|515558573|FG000|Overall Study|Withdrawal by Subject|0|||
143005190|NCT02594384|515558574|FG001|Overall Study|Withdrawal by Subject|0|||
143005191|NCT02594384|515558575|FG002|Overall Study|Withdrawal by Subject|0|||
143005192|NCT02594384|515558576|FG003|Overall Study|Withdrawal by Subject|1|||
143005193|NCT02594384|515558577|FG004|Overall Study|Withdrawal by Subject|0|||
143005194|NCT02594384|515558578|FG005|Overall Study|Withdrawal by Subject|0|||
143005195|NCT02594384|515558579|FG006|Overall Study|Withdrawal by Subject|0|||
143005196|NCT02594384|515558580|FG007|Overall Study|Withdrawal by Subject|1|||
143005197|NCT02594384|515558573|FG000|Overall Study|Physician Decision|0|||
143005198|NCT02594384|515558574|FG001|Overall Study|Physician Decision|0|||
143005199|NCT02594384|515558575|FG002|Overall Study|Physician Decision|0|||
143005200|NCT02594384|515558576|FG003|Overall Study|Physician Decision|0|||
143005201|NCT02594384|515558577|FG004|Overall Study|Physician Decision|0|||
143005202|NCT02594384|515558578|FG005|Overall Study|Physician Decision|1|||
143005203|NCT02594384|515558579|FG006|Overall Study|Physician Decision|2|||
143005204|NCT02594384|515558580|FG007|Overall Study|Physician Decision|0|||
143005205|NCT02594384|515558573|FG000|Overall Study|Progressive Leukocytosis|0|||
143005206|NCT02594384|515558574|FG001|Overall Study|Progressive Leukocytosis|0|||
143005207|NCT02594384|515558575|FG002|Overall Study|Progressive Leukocytosis|1|||
143005208|NCT02594384|515558576|FG003|Overall Study|Progressive Leukocytosis|0|||
143005209|NCT02594384|515558577|FG004|Overall Study|Progressive Leukocytosis|0|||
143005210|NCT02594384|515558578|FG005|Overall Study|Progressive Leukocytosis|0|||
143005211|NCT02594384|515558579|FG006|Overall Study|Progressive Leukocytosis|0|||
143005212|NCT02594384|515558580|FG007|Overall Study|Progressive Leukocytosis|0|||
143005213|NCT02594384|515558573|FG000|Overall Study|Lack of Efficacy|0|||
143005214|NCT02594384|515558574|FG001|Overall Study|Lack of Efficacy|0|||
143005215|NCT02594384|515558575|FG002|Overall Study|Lack of Efficacy|0|||
143005216|NCT02594384|515558576|FG003|Overall Study|Lack of Efficacy|0|||
143005217|NCT02594384|515558577|FG004|Overall Study|Lack of Efficacy|1|||
143005218|NCT02594384|515558578|FG005|Overall Study|Lack of Efficacy|0|||
143005219|NCT02594384|515558579|FG006|Overall Study|Lack of Efficacy|0|||
143005220|NCT02594384|515558580|FG007|Overall Study|Lack of Efficacy|0|||
143005221|NCT02594384|515558573|FG000|Overall Study|Substantial noncompliance|0|||
143005222|NCT02594384|515558574|FG001|Overall Study|Substantial noncompliance|0|||
143005223|NCT02594384|515558575|FG002|Overall Study|Substantial noncompliance|0|||
143005224|NCT02594384|515558576|FG003|Overall Study|Substantial noncompliance|0|||
143005225|NCT02594384|515558577|FG004|Overall Study|Substantial noncompliance|0|||
143005226|NCT02594384|515558578|FG005|Overall Study|Substantial noncompliance|0|||
143005227|NCT02594384|515558579|FG006|Overall Study|Substantial noncompliance|1|||
143005228|NCT02594384|515558580|FG007|Overall Study|Substantial noncompliance|0|||
143005229|NCT03919669|515558584|FG000|Overall Study|Withdrawal by Subject|1|||
143005230|NCT03919669|515558585|FG001|Overall Study|Withdrawal by Subject|0|||
143005231|NCT03919669|515558586|FG002|Overall Study|Withdrawal by Subject|0|||
143005232|NCT02319642|515558587|FG000|Overall Study|Adverse Event|2|||
143005233|NCT02319642|515558588|FG001|Overall Study|Adverse Event|4|||
143005234|NCT02319642|515558587|FG000|Overall Study|Lack of Efficacy|1|||
143005235|NCT02319642|515558588|FG001|Overall Study|Lack of Efficacy|1|||
143005236|NCT02319642|515558587|FG000|Overall Study|Withdrawal by Subject|1|||
143005237|NCT02319642|515558588|FG001|Overall Study|Withdrawal by Subject|1|||
143005238|NCT04668066|515558591|FG000|Part 1: Treatment Phase|Adverse Event|0|||
143005239|NCT04668066|515558592|FG001|Part 1: Treatment Phase|Adverse Event|0|||
143005240|NCT04668066|515558593|FG002|Part 1: Treatment Phase|Adverse Event|0|||
143005241|NCT04668066|515558594|FG003|Part 1: Treatment Phase|Adverse Event|0|||
143005242|NCT04668066|515558595|FG004|Part 1: Treatment Phase|Adverse Event|0|||
143005243|NCT04668066|515558596|FG005|Part 1: Treatment Phase|Adverse Event|0|||
143005244|NCT04668066|515558597|FG006|Part 1: Treatment Phase|Adverse Event|0|||
143005245|NCT04668066|515558598|FG007|Part 1: Treatment Phase|Adverse Event|0|||
143005246|NCT04668066|515558599|FG008|Part 1: Treatment Phase|Adverse Event|0|||
143005247|NCT04668066|515558600|FG009|Part 1: Treatment Phase|Adverse Event|0|||
143005248|NCT04668066|515558601|FG010|Part 1: Treatment Phase|Adverse Event|0|||
143005249|NCT04668066|515558602|FG011|Part 1: Treatment Phase|Adverse Event|1|||
143005250|NCT04668066|515558603|FG012|Part 1: Treatment Phase|Adverse Event|1|||
143005251|NCT04668066|515558604|FG013|Part 1: Treatment Phase|Adverse Event|0|||
143005252|NCT04668066|515558605|FG014|Part 1: Treatment Phase|Adverse Event|0|||
143005253|NCT04668066|515558606|FG015|Part 1: Treatment Phase|Adverse Event|0|||
143005254|NCT04668066|515558607|FG016|Part 1: Treatment Phase|Adverse Event|0|||
143005255|NCT04668066|515558608|FG017|Part 1: Treatment Phase|Adverse Event|0|||
143005256|NCT04668066|515558609|FG018|Part 1: Treatment Phase|Adverse Event|0|||
143005257|NCT04668066|515558591|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
143005258|NCT04668066|515558592|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
143005259|NCT04668066|515558593|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
143005260|NCT04668066|515558594|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
143005261|NCT04668066|515558595|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
143005262|NCT04668066|515558596|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
143005263|NCT04668066|515558597|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
143005264|NCT04668066|515558598|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
143005265|NCT04668066|515558599|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
143005266|NCT04668066|515558600|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
143005267|NCT04668066|515558601|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
143005268|NCT04668066|515558602|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
143005269|NCT04668066|515558603|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
143005270|NCT04668066|515558604|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
143005271|NCT04668066|515558605|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
143005272|NCT04668066|515558606|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
143005273|NCT04668066|515558607|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
143005274|NCT04668066|515558608|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
143005275|NCT04668066|515558609|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
143005276|NCT04668066|515558591|FG000|Part 1: Treatment Phase|Other|0|||
143005277|NCT04668066|515558592|FG001|Part 1: Treatment Phase|Other|0|||
143005278|NCT04668066|515558593|FG002|Part 1: Treatment Phase|Other|0|||
143005279|NCT04668066|515558594|FG003|Part 1: Treatment Phase|Other|0|||
143005280|NCT04668066|515558595|FG004|Part 1: Treatment Phase|Other|0|||
143005281|NCT04668066|515558596|FG005|Part 1: Treatment Phase|Other|0|||
143005282|NCT04668066|515558597|FG006|Part 1: Treatment Phase|Other|0|||
143005283|NCT04668066|515558598|FG007|Part 1: Treatment Phase|Other|0|||
143005284|NCT04668066|515558599|FG008|Part 1: Treatment Phase|Other|0|||
143005285|NCT04668066|515558600|FG009|Part 1: Treatment Phase|Other|0|||
143005286|NCT04668066|515558601|FG010|Part 1: Treatment Phase|Other|0|||
143005287|NCT04668066|515558602|FG011|Part 1: Treatment Phase|Other|1|||
143005288|NCT04668066|515558603|FG012|Part 1: Treatment Phase|Other|0|||
143005289|NCT04668066|515558604|FG013|Part 1: Treatment Phase|Other|0|||
143005290|NCT04668066|515558605|FG014|Part 1: Treatment Phase|Other|0|||
143005291|NCT04668066|515558606|FG015|Part 1: Treatment Phase|Other|0|||
143005292|NCT04668066|515558607|FG016|Part 1: Treatment Phase|Other|0|||
143005293|NCT04668066|515558608|FG017|Part 1: Treatment Phase|Other|0|||
143005294|NCT04668066|515558609|FG018|Part 1: Treatment Phase|Other|0|||
143005295|NCT04668066|515558591|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
143005296|NCT04668066|515558592|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
143005297|NCT04668066|515558593|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
143005298|NCT04668066|515558594|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
143005299|NCT04668066|515558595|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
143005300|NCT04668066|515558596|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
143005301|NCT04668066|515558597|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
143005302|NCT04668066|515558598|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
143005303|NCT04668066|515558599|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
143005304|NCT04668066|515558600|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
143005305|NCT04668066|515558601|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
143005306|NCT04668066|515558602|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
143005307|NCT04668066|515558603|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
143005308|NCT04668066|515558604|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
143005309|NCT04668066|515558605|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
143005310|NCT04668066|515558606|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
143005311|NCT04668066|515558607|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
143005312|NCT04668066|515558608|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
143005313|NCT04668066|515558609|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
143005314|NCT04668066|515558591|FG000|Part 1: Follow-Up|Adverse Event|0|||
143005315|NCT04668066|515558592|FG001|Part 1: Follow-Up|Adverse Event|0|||
143005316|NCT04668066|515558593|FG002|Part 1: Follow-Up|Adverse Event|0|||
143005317|NCT04668066|515558594|FG003|Part 1: Follow-Up|Adverse Event|0|||
143005318|NCT04668066|515558595|FG004|Part 1: Follow-Up|Adverse Event|0|||
143005319|NCT04668066|515558596|FG005|Part 1: Follow-Up|Adverse Event|0|||
143005320|NCT04668066|515558597|FG006|Part 1: Follow-Up|Adverse Event|0|||
143005321|NCT04668066|515558598|FG007|Part 1: Follow-Up|Adverse Event|0|||
143005322|NCT04668066|515558599|FG008|Part 1: Follow-Up|Adverse Event|0|||
143005323|NCT04668066|515558600|FG009|Part 1: Follow-Up|Adverse Event|0|||
143005324|NCT04668066|515558601|FG010|Part 1: Follow-Up|Adverse Event|0|||
143005325|NCT04668066|515558602|FG011|Part 1: Follow-Up|Adverse Event|1|||
143005326|NCT04668066|515558603|FG012|Part 1: Follow-Up|Adverse Event|0|||
143005327|NCT04668066|515558604|FG013|Part 1: Follow-Up|Adverse Event|0|||
143005328|NCT04668066|515558605|FG014|Part 1: Follow-Up|Adverse Event|0|||
143005329|NCT04668066|515558606|FG015|Part 1: Follow-Up|Adverse Event|0|||
143005330|NCT04668066|515558607|FG016|Part 1: Follow-Up|Adverse Event|0|||
143005331|NCT04668066|515558608|FG017|Part 1: Follow-Up|Adverse Event|0|||
143005332|NCT04668066|515558609|FG018|Part 1: Follow-Up|Adverse Event|0|||
143005333|NCT04668066|515558591|FG000|Part 1: Follow-Up|Other|0|||
143005334|NCT04668066|515558592|FG001|Part 1: Follow-Up|Other|0|||
143005335|NCT04668066|515558593|FG002|Part 1: Follow-Up|Other|0|||
143005336|NCT04668066|515558594|FG003|Part 1: Follow-Up|Other|0|||
143005337|NCT04668066|515558595|FG004|Part 1: Follow-Up|Other|0|||
143005338|NCT04668066|515558596|FG005|Part 1: Follow-Up|Other|0|||
143005339|NCT04668066|515558597|FG006|Part 1: Follow-Up|Other|0|||
143005340|NCT04668066|515558598|FG007|Part 1: Follow-Up|Other|0|||
143005341|NCT04668066|515558599|FG008|Part 1: Follow-Up|Other|0|||
143005342|NCT04668066|515558600|FG009|Part 1: Follow-Up|Other|0|||
143005343|NCT04668066|515558601|FG010|Part 1: Follow-Up|Other|0|||
143005344|NCT04668066|515558602|FG011|Part 1: Follow-Up|Other|1|||
143005345|NCT04668066|515558603|FG012|Part 1: Follow-Up|Other|1|||
143005346|NCT04668066|515558604|FG013|Part 1: Follow-Up|Other|0|||
143005347|NCT04668066|515558605|FG014|Part 1: Follow-Up|Other|0|||
143005348|NCT04668066|515558606|FG015|Part 1: Follow-Up|Other|0|||
143005349|NCT04668066|515558607|FG016|Part 1: Follow-Up|Other|0|||
143005350|NCT04668066|515558608|FG017|Part 1: Follow-Up|Other|0|||
143005351|NCT04668066|515558609|FG018|Part 1: Follow-Up|Other|0|||
143005352|NCT04668066|515558591|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
143005353|NCT04668066|515558592|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
143005354|NCT04668066|515558593|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
143005355|NCT04668066|515558594|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
143005356|NCT04668066|515558595|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
143005357|NCT04668066|515558596|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
143005358|NCT04668066|515558597|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
143005359|NCT04668066|515558598|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
143005360|NCT04668066|515558599|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
143005361|NCT04668066|515558600|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
143005362|NCT04668066|515558601|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
143005363|NCT04668066|515558602|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
143005364|NCT04668066|515558603|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
143005365|NCT04668066|515558604|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
143005366|NCT04668066|515558605|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
143005367|NCT04668066|515558606|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
143005368|NCT04668066|515558607|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
143005369|NCT04668066|515558608|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
143005370|NCT04668066|515558609|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
143005371|NCT04668066|515558591|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
143005372|NCT04668066|515558592|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
143005373|NCT04668066|515558593|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
143005374|NCT04668066|515558594|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
143005375|NCT04668066|515558595|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
143005376|NCT04668066|515558596|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
143005377|NCT04668066|515558597|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
143005378|NCT04668066|515558598|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
143005379|NCT04668066|515558599|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
143005380|NCT04668066|515558600|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
143005381|NCT04668066|515558601|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
143005382|NCT04668066|515558602|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
143005383|NCT04668066|515558603|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
143005384|NCT04668066|515558604|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
143005385|NCT04668066|515558605|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
143005386|NCT04668066|515558606|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
143005387|NCT04668066|515558607|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
143005388|NCT04668066|515558608|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
143005389|NCT04668066|515558609|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
143005390|NCT04668066|515558591|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
143005391|NCT04668066|515558592|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
143005392|NCT04668066|515558593|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
143005393|NCT04668066|515558594|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
143005394|NCT04668066|515558595|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
143005395|NCT04668066|515558596|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
143005396|NCT04668066|515558597|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
143005397|NCT04668066|515558598|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
143005398|NCT04668066|515558599|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
143005399|NCT04668066|515558600|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
143005400|NCT04668066|515558601|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
143005401|NCT04668066|515558602|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
143005402|NCT04668066|515558603|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
143005403|NCT04668066|515558604|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
143005404|NCT04668066|515558605|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
143005405|NCT04668066|515558606|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
143005406|NCT04668066|515558607|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
143005407|NCT04668066|515558608|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
143005408|NCT04668066|515558609|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
143005409|NCT04668066|515558591|FG000|Part 2: Treatment Phase|Other|0|||
143005410|NCT04668066|515558592|FG001|Part 2: Treatment Phase|Other|0|||
143005411|NCT04668066|515558593|FG002|Part 2: Treatment Phase|Other|0|||
143005412|NCT04668066|515558594|FG003|Part 2: Treatment Phase|Other|0|||
143005413|NCT04668066|515558595|FG004|Part 2: Treatment Phase|Other|0|||
143005414|NCT04668066|515558596|FG005|Part 2: Treatment Phase|Other|0|||
143005415|NCT04668066|515558597|FG006|Part 2: Treatment Phase|Other|0|||
143005416|NCT04668066|515558598|FG007|Part 2: Treatment Phase|Other|0|||
143005417|NCT04668066|515558599|FG008|Part 2: Treatment Phase|Other|0|||
143005418|NCT04668066|515558600|FG009|Part 2: Treatment Phase|Other|0|||
143005419|NCT04668066|515558601|FG010|Part 2: Treatment Phase|Other|0|||
143005420|NCT04668066|515558602|FG011|Part 2: Treatment Phase|Other|0|||
143005421|NCT04668066|515558603|FG012|Part 2: Treatment Phase|Other|0|||
143005422|NCT04668066|515558604|FG013|Part 2: Treatment Phase|Other|0|||
143005423|NCT04668066|515558605|FG014|Part 2: Treatment Phase|Other|0|||
143005424|NCT04668066|515558606|FG015|Part 2: Treatment Phase|Other|0|||
143005425|NCT04668066|515558607|FG016|Part 2: Treatment Phase|Other|0|||
143005426|NCT04668066|515558608|FG017|Part 2: Treatment Phase|Other|0|||
143005427|NCT04668066|515558609|FG018|Part 2: Treatment Phase|Other|1|||
143005428|NCT04668066|515558591|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
143005429|NCT04668066|515558592|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
143005430|NCT04668066|515558593|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
143005431|NCT04668066|515558594|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
143005432|NCT04668066|515558595|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
143005433|NCT04668066|515558596|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
143005434|NCT04668066|515558597|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
143005435|NCT04668066|515558598|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
143005436|NCT04668066|515558599|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
143005437|NCT04668066|515558600|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
143005438|NCT04668066|515558601|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
143005439|NCT04668066|515558602|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
143005440|NCT04668066|515558603|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
143005441|NCT04668066|515558604|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
143005442|NCT04668066|515558605|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
143005443|NCT04668066|515558606|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
143005444|NCT04668066|515558607|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
143005445|NCT04668066|515558608|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
143005446|NCT04668066|515558609|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
143005447|NCT00634933|515558615|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
143005448|NCT00634933|515558616|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
143005449|NCT00634933|515558617|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
143259551|NCT02720094|516505772|FG001|Overall Study|Death|7|||
143005450|NCT00634933|515558618|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
143005451|NCT00634933|515558619|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
143005452|NCT00634933|515558615|FG000|Part A: Baseline to Week 24|Death|1|||
143005453|NCT00634933|515558616|FG001|Part A: Baseline to Week 24|Death|0|||
143005454|NCT00634933|515558617|FG002|Part A: Baseline to Week 24|Death|0|||
143005455|NCT00634933|515558618|FG003|Part A: Baseline to Week 24|Death|0|||
143005456|NCT00634933|515558619|FG004|Part A: Baseline to Week 24|Death|0|||
143005457|NCT00634933|515558615|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
143005458|NCT00634933|515558616|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
143005459|NCT00634933|515558617|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
143005460|NCT00634933|515558618|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
143005461|NCT00634933|515558619|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
143005462|NCT00634933|515558615|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
143005463|NCT00634933|515558616|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
143005464|NCT00634933|515558617|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
143005465|NCT00634933|515558618|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
143005466|NCT00634933|515558619|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
143005467|NCT00634933|515558615|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
143005468|NCT00634933|515558616|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
143005469|NCT00634933|515558617|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
143005470|NCT00634933|515558618|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
143005471|NCT00634933|515558619|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
143005472|NCT00634933|515558615|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
143005473|NCT00634933|515558616|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
143005474|NCT00634933|515558617|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
143005475|NCT00634933|515558618|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
143005476|NCT00634933|515558619|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
143005477|NCT00634933|515558615|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
143005478|NCT00634933|515558616|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
143005479|NCT00634933|515558617|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
143005480|NCT00634933|515558618|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
143005481|NCT00634933|515558619|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
143005482|NCT00634933|515558615|FG000|Part A: Baseline to Week 24|Other|1|||
143005483|NCT00634933|515558616|FG001|Part A: Baseline to Week 24|Other|8|||
143005484|NCT00634933|515558617|FG002|Part A: Baseline to Week 24|Other|5|||
143005485|NCT00634933|515558618|FG003|Part A: Baseline to Week 24|Other|0|||
143005486|NCT00634933|515558619|FG004|Part A: Baseline to Week 24|Other|0|||
143005487|NCT00634933|515558615|FG000|Between Part A and Part B|Physician Decision|0|||
143005488|NCT00634933|515558616|FG001|Between Part A and Part B|Physician Decision|1|||
143005489|NCT00634933|515558617|FG002|Between Part A and Part B|Physician Decision|0|||
143005490|NCT00634933|515558618|FG003|Between Part A and Part B|Physician Decision|0|||
143005491|NCT00634933|515558619|FG004|Between Part A and Part B|Physician Decision|0|||
143005492|NCT00634933|515558615|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
143005493|NCT00634933|515558616|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
143005494|NCT00634933|515558617|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
143005495|NCT00634933|515558618|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
143005496|NCT00634933|515558619|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
143005497|NCT00634933|515558615|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
143005498|NCT00634933|515558616|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
143005499|NCT00634933|515558617|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
143005500|NCT00634933|515558618|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
143005501|NCT00634933|515558619|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
143005502|NCT00634933|515558615|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
143005503|NCT00634933|515558616|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
143005504|NCT00634933|515558617|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
143005505|NCT00634933|515558618|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
143005506|NCT00634933|515558619|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
143005507|NCT00634933|515558615|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
143005508|NCT00634933|515558616|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
143005509|NCT00634933|515558617|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
143005510|NCT00634933|515558618|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
143005511|NCT00634933|515558619|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
143005512|NCT00634933|515558615|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
143005513|NCT00634933|515558616|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
143005514|NCT00634933|515558617|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
143005515|NCT00634933|515558618|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
143005516|NCT00634933|515558619|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
143005517|NCT00634933|515558615|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
143005518|NCT00634933|515558616|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
143005519|NCT00634933|515558617|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
143005520|NCT00634933|515558618|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
143005521|NCT00634933|515558619|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
143005522|NCT00634933|515558615|FG000|Part B: Week 24 to Week 52|Other|0|||
143005523|NCT00634933|515558616|FG001|Part B: Week 24 to Week 52|Other|0|||
143005524|NCT00634933|515558617|FG002|Part B: Week 24 to Week 52|Other|5|||
143005525|NCT00634933|515558618|FG003|Part B: Week 24 to Week 52|Other|0|||
143005526|NCT00634933|515558619|FG004|Part B: Week 24 to Week 52|Other|1|||
143005527|NCT05147311|515558620|FG000|Overall Study|Did not complete survey|2|||
143005528|NCT05147311|515558621|FG001|Overall Study|Did not complete survey|1|||
143005529|NCT05147311|515558620|FG000|Overall Study|Patient too sick|1|||
143005530|NCT05147311|515558621|FG001|Overall Study|Patient too sick|2|||
143005531|NCT05147311|515558620|FG000|Overall Study|Death|0|||
143005532|NCT05147311|515558621|FG001|Overall Study|Death|1|||
143005533|NCT05147311|515558620|FG000|Overall Study|Declined survey|1|||
143005534|NCT05147311|515558621|FG001|Overall Study|Declined survey|0|||
143005535|NCT00596466|515558622|FG000|Overall Study|Lack of Efficacy|5|||
143005536|NCT00596466|515558622|FG000|Overall Study|Adverse Event|4|||
143005537|NCT00596466|515558622|FG000|Overall Study|Withdrawal by Subject|2|||
143005538|NCT00596466|515558622|FG000|Overall Study|Protocol Violation|2|||
143005539|NCT00596466|515558622|FG000|Overall Study|Unpecified|2|||
143005540|NCT00596466|515558622|FG000|Overall Study|Enrolled, not treated|2|||
143005541|NCT00145795|515558623|FG000|Overall Study|Adverse Event|1|||
143005542|NCT00145795|515558624|FG001|Overall Study|Adverse Event|0|||
143005543|NCT01891669|515558625|FG000|Overall Study|Death|0|||
143005544|NCT01891669|515558626|FG001|Overall Study|Death|0|||
143005545|NCT01891669|515558627|FG002|Overall Study|Death|0|||
143005546|NCT01891669|515558628|FG003|Overall Study|Death|0|||
143005547|NCT01891669|515558629|FG004|Overall Study|Death|0|||
143005548|NCT01891669|515558630|FG005|Overall Study|Death|0|||
143005549|NCT01891669|515558631|FG006|Overall Study|Death|0|||
143005550|NCT01891669|515558632|FG007|Overall Study|Death|1|||
143005551|NCT01891669|515558633|FG008|Overall Study|Death|0|||
143005552|NCT01891669|515558634|FG009|Overall Study|Death|1|||
143005553|NCT01891669|515558625|FG000|Overall Study|Withdrawal by Subject|1|||
143005554|NCT01891669|515558626|FG001|Overall Study|Withdrawal by Subject|1|||
143005555|NCT01891669|515558627|FG002|Overall Study|Withdrawal by Subject|0|||
143005556|NCT01891669|515558628|FG003|Overall Study|Withdrawal by Subject|0|||
143005557|NCT01891669|515558629|FG004|Overall Study|Withdrawal by Subject|0|||
143005558|NCT01891669|515558630|FG005|Overall Study|Withdrawal by Subject|0|||
143005559|NCT01891669|515558631|FG006|Overall Study|Withdrawal by Subject|1|||
143005560|NCT01891669|515558632|FG007|Overall Study|Withdrawal by Subject|2|||
143005561|NCT01891669|515558633|FG008|Overall Study|Withdrawal by Subject|1|||
143005562|NCT01891669|515558634|FG009|Overall Study|Withdrawal by Subject|1|||
143005563|NCT01891669|515558625|FG000|Overall Study|Other|1|||
143005564|NCT01891669|515558626|FG001|Overall Study|Other|0|||
143005565|NCT01891669|515558627|FG002|Overall Study|Other|0|||
143005566|NCT01891669|515558628|FG003|Overall Study|Other|0|||
143005567|NCT01891669|515558629|FG004|Overall Study|Other|0|||
143005568|NCT01891669|515558630|FG005|Overall Study|Other|0|||
143005569|NCT01891669|515558631|FG006|Overall Study|Other|0|||
143005570|NCT01891669|515558632|FG007|Overall Study|Other|1|||
143005571|NCT01891669|515558633|FG008|Overall Study|Other|0|||
143005572|NCT01891669|515558634|FG009|Overall Study|Other|0|||
143005573|NCT03480243|515558635|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
143005574|NCT03480243|515558635|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
143005575|NCT04365387|515558636|FG000|Overall Study|Adverse Event|4|||
143005576|NCT04365387|515558637|FG001|Overall Study|Adverse Event|2|||
143005577|NCT04365387|515558636|FG000|Overall Study|Participants request|14|||
143005578|NCT04365387|515558637|FG001|Overall Study|Participants request|14|||
143005579|NCT04365387|515558636|FG000|Overall Study|Lost to Follow-up|8|||
143005580|NCT04365387|515558637|FG001|Overall Study|Lost to Follow-up|5|||
143005581|NCT04365387|515558636|FG000|Overall Study|Protocol deviation|3|||
143005582|NCT04365387|515558637|FG001|Overall Study|Protocol deviation|4|||
143005583|NCT04365387|515558636|FG000|Overall Study|Participant compliance with visit schedule|1|||
143005584|NCT04365387|515558637|FG001|Overall Study|Participant compliance with visit schedule|0|||
143005585|NCT04365387|515558636|FG000|Overall Study|Participant incarcerated|1|||
143005586|NCT04365387|515558637|FG001|Overall Study|Participant incarcerated|0|||
143005587|NCT04365387|515558636|FG000|Overall Study|Participant moved out of town (relocated)|0|||
143005588|NCT04365387|515558637|FG001|Overall Study|Participant moved out of town (relocated)|1|||
143005589|NCT04365387|515558636|FG000|Overall Study|Participant PEF not eligible per sponsor|1|||
143005590|NCT04365387|515558637|FG001|Overall Study|Participant PEF not eligible per sponsor|0|||
143005591|NCT04365387|515558636|FG000|Overall Study|Due to working hours, could not return to other visits|1|||
143005592|NCT04365387|515558637|FG001|Overall Study|Due to working hours, could not return to other visits|0|||
143005593|NCT05770401|515558646|FG000|Overall Study|Lost to Follow-up|5|||
143005594|NCT05770401|515558647|FG001|Overall Study|Lost to Follow-up|4|||
143005595|NCT00402298|515558648|FG000|Overall Study|Withdrawal by Subject|1|||
143005596|NCT00402298|515558649|FG001|Overall Study|Withdrawal by Subject|0|||
143005597|NCT05939388|515558650|FG000|Overall Study|Lost to Follow-up|1|||
143005598|NCT01215968|515558653|FG000|Overall Study|Adverse Event|0|||
143005599|NCT01215968|515558654|FG001|Overall Study|Adverse Event|2|||
143005600|NCT01215968|515558653|FG000|Overall Study|Protocol Violation|2|||
143005601|NCT01215968|515558654|FG001|Overall Study|Protocol Violation|4|||
143005602|NCT01215968|515558653|FG000|Overall Study|Not received study drug|0|||
143005603|NCT01215968|515558654|FG001|Overall Study|Not received study drug|1|||
143005604|NCT05643573|515558655|FG000|Overall Study|Adverse Event|117|||
143005605|NCT05643573|515558656|FG001|Overall Study|Adverse Event|90|||
143005606|NCT05643573|515558655|FG000|Overall Study|Death|53|||
143005607|NCT05643573|515558656|FG001|Overall Study|Death|57|||
143005608|NCT05643573|515558655|FG000|Overall Study|Lost to Follow-up|6|||
143005609|NCT05643573|515558656|FG001|Overall Study|Lost to Follow-up|3|||
143005610|NCT05643573|515558655|FG000|Overall Study|Other|18|||
143005611|NCT05643573|515558656|FG001|Overall Study|Other|15|||
143005612|NCT05643573|515558655|FG000|Overall Study|Outcome event|64|||
143005613|NCT05643573|515558656|FG001|Overall Study|Outcome event|36|||
143005614|NCT05643573|515558655|FG000|Overall Study|Physician Decision|33|||
143005615|NCT05643573|515558656|FG001|Overall Study|Physician Decision|19|||
143005616|NCT05643573|515558655|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
143005617|NCT05643573|515558656|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
143005618|NCT05643573|515558655|FG000|Overall Study|Site terminated by sponsor|10|||
143005619|NCT05643573|515558656|FG001|Overall Study|Site terminated by sponsor|10|||
143005620|NCT05643573|515558655|FG000|Overall Study|Study terminated by sponsor|1|||
143005621|NCT05643573|515558656|FG001|Overall Study|Study terminated by sponsor|0|||
143005622|NCT05643573|515558655|FG000|Overall Study|Withdrawal by Subject|178|||
143005623|NCT05643573|515558656|FG001|Overall Study|Withdrawal by Subject|130|||
143005624|NCT00931515|515558657|FG000|Overall Study|Lost to Follow-up|2|||
143005625|NCT00931515|515558658|FG001|Overall Study|Lost to Follow-up|5|||
143005626|NCT03759340|515558659|FG000|Overall Study|Adverse Event|2|||
143005627|NCT03759340|515558659|FG000|Overall Study|Lost to Follow-up|1|||
143005628|NCT03759340|515558659|FG000|Overall Study|Withdrawal by Subject|15|||
143005629|NCT03759340|515558659|FG000|Overall Study|Study Terminated by Sponsor|38|||
143005630|NCT01119118|515558661|FG000|Overall Study|Adverse Event|1|||
143005631|NCT02711306|515558662|FG000|Overall Study|Withdrawal by Subject|2|||
143005632|NCT02711306|515558663|FG001|Overall Study|Withdrawal by Subject|2|||
143005633|NCT01396434|515558669|FG000|Overall Study|Lost to Follow-up|1|||
143005634|NCT01396434|515558670|FG001|Overall Study|Lost to Follow-up|0|||
143005635|NCT01396434|515558671|FG002|Overall Study|Lost to Follow-up|0|||
143005636|NCT01396434|515558669|FG000|Overall Study|Other|10|||
143005637|NCT01396434|515558670|FG001|Overall Study|Other|0|||
143005638|NCT01396434|515558671|FG002|Overall Study|Other|0|||
143005639|NCT04678557|515558672|FG000|Overall Study|Withdrawal by Subject|1|||
143005640|NCT04678557|515558673|FG001|Overall Study|Withdrawal by Subject|0|||
143005641|NCT04678557|515558672|FG000|Overall Study|Lack of Efficacy|0|||
143005642|NCT04678557|515558673|FG001|Overall Study|Lack of Efficacy|13|||
143005643|NCT04678557|515558672|FG000|Overall Study|Safety Evaluation|0|||
143005644|NCT04678557|515558673|FG001|Overall Study|Safety Evaluation|1|||
143005645|NCT00157157|515558674|FG000|Overall Study|Withdrawal by Subject|6|||
143005646|NCT00157157|515558674|FG000|Overall Study|Physician Decision|1|||
143005647|NCT00157157|515558674|FG000|Overall Study|Lost to Follow-up|1|||
143005648|NCT00157157|515558674|FG000|Overall Study|Enrolled in another study|1|||
143005649|NCT00157157|515558674|FG000|Overall Study|Met exclusion criteria|1|||
143005650|NCT00157157|515558674|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
143005651|NCT02260804|515558680|FG000|Induction Study Period|Protocol Violation|2|||
143005652|NCT02260804|515558681|FG001|Induction Study Period|Protocol Violation|0|||
143005653|NCT02260804|515558680|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
143005654|NCT02260804|515558681|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
143005655|NCT02260804|515558680|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
143005656|NCT02260804|515558681|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
143005657|NCT02260804|515558680|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
143005658|NCT02260804|515558681|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
143005659|NCT02260804|515558680|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
143005660|NCT02260804|515558681|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
143005661|NCT02260804|515558680|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
143005662|NCT02260804|515558681|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
143005663|NCT02260804|515558680|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
143005664|NCT02260804|515558681|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
143005665|NCT02260804|515558680|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
143005666|NCT02260804|515558681|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
143005667|NCT02260804|515558680|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
143005668|NCT02260804|515558681|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
143005669|NCT02260804|515558680|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
143005670|NCT02260804|515558681|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
143005671|NCT02260804|515558680|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
143005672|NCT02260804|515558681|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
143005673|NCT02856282|515560495|FG000|Overall Study|Withdrawal by Subject|1|||
143005674|NCT00057330|515560496|FG000|Overall Study|Adverse Event|9|||
143005675|NCT00057330|515560497|FG001|Overall Study|Adverse Event|12|||
143005676|NCT00057330|515560496|FG000|Overall Study|Death|1|||
143005677|NCT00057330|515560497|FG001|Overall Study|Death|0|||
143005678|NCT00057330|515560496|FG000|Overall Study|Protocol Violation|1|||
143005679|NCT00057330|515560497|FG001|Overall Study|Protocol Violation|1|||
143005680|NCT00057330|515560496|FG000|Overall Study|Withdrawal by Subject|115|||
143005681|NCT00057330|515560497|FG001|Overall Study|Withdrawal by Subject|84|||
143005682|NCT00057330|515560496|FG000|Overall Study|Lost to Follow-up|745|||
143005683|NCT00057330|515560497|FG001|Overall Study|Lost to Follow-up|617|||
143005684|NCT00057330|515560496|FG000|Overall Study|Physician Decision|1|||
143005685|NCT00057330|515560497|FG001|Overall Study|Physician Decision|0|||
143005686|NCT00057330|515560496|FG000|Overall Study|Other|260|||
143005687|NCT00057330|515560497|FG001|Overall Study|Other|206|||
143005688|NCT01976663|515560506|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
143005689|NCT01976663|515560506|FG000|Overall Study|Personal Reasons|6|||
143005690|NCT01976663|515560506|FG000|Overall Study|Withdrawal by Subject|4|||
143005691|NCT01976663|515560506|FG000|Overall Study|Screen Failure|3|||
143005692|NCT01976663|515560506|FG000|Overall Study|Adverse Event|2|||
143005693|NCT01976663|515560506|FG000|Overall Study|Lost to Follow-up|3|||
143005694|NCT04888377|515560507|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
143005695|NCT04888377|515560508|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
143005696|NCT04888377|515560507|FG000|Overall Study|Physician Decision|6|||
143005697|NCT04888377|515560508|FG001|Overall Study|Physician Decision|6|||
143005698|NCT04888377|515560507|FG000|Overall Study|Withdrawal by Subject|7|||
143005699|NCT04888377|515560508|FG001|Overall Study|Withdrawal by Subject|3|||
143005700|NCT05279807|515560509|FG000|Overall Study|Withdrawal by Subject|1|||
143005701|NCT05279807|515560510|FG001|Overall Study|Withdrawal by Subject|0|||
143005702|NCT05279807|515560509|FG000|Overall Study|Adverse Event|0|||
143005703|NCT05279807|515560510|FG001|Overall Study|Adverse Event|1|||
143005704|NCT05279807|515560509|FG000|Overall Study|Laboratory Abnormal Results|1|||
143005705|NCT05279807|515560510|FG001|Overall Study|Laboratory Abnormal Results|0|||
143005706|NCT03985982|515560511|FG000|Double-Blind Phase|Lost to Follow-up|4|||
143005707|NCT03985982|515560512|FG001|Double-Blind Phase|Lost to Follow-up|3|||
143005708|NCT03985982|515560513|FG002|Double-Blind Phase|Lost to Follow-up|0|||
143005709|NCT03985982|515560511|FG000|Double-Blind Phase|Physician Decision|1|||
143005710|NCT03985982|515560512|FG001|Double-Blind Phase|Physician Decision|0|||
143005711|NCT03985982|515560513|FG002|Double-Blind Phase|Physician Decision|0|||
143005712|NCT03985982|515560511|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
143005713|NCT03985982|515560512|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
143005714|NCT03985982|515560513|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
143005715|NCT03985982|515560511|FG000|Double-Blind Phase|COVID-19|1|||
143005716|NCT03985982|515560512|FG001|Double-Blind Phase|COVID-19|0|||
143005717|NCT03985982|515560513|FG002|Double-Blind Phase|COVID-19|0|||
143005718|NCT03985982|515560511|FG000|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|1|||
143005719|NCT03985982|515560512|FG001|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
143005720|NCT03985982|515560513|FG002|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
143005721|NCT03985982|515560511|FG000|Open-Label Phase|Lost to Follow-up|0|||
143005722|NCT03985982|515560512|FG001|Open-Label Phase|Lost to Follow-up|0|||
143005723|NCT03985982|515560513|FG002|Open-Label Phase|Lost to Follow-up|13|||
143005724|NCT03985982|515560511|FG000|Open-Label Phase|Physician Decision|0|||
143005725|NCT03985982|515560512|FG001|Open-Label Phase|Physician Decision|0|||
143005726|NCT03985982|515560513|FG002|Open-Label Phase|Physician Decision|2|||
143005727|NCT03985982|515560511|FG000|Open-Label Phase|Withdrawal by Subject|0|||
143005728|NCT03985982|515560512|FG001|Open-Label Phase|Withdrawal by Subject|0|||
143005729|NCT03985982|515560513|FG002|Open-Label Phase|Withdrawal by Subject|11|||
143005730|NCT03526549|515560515|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
143005731|NCT03526549|515560516|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
143005732|NCT03526549|515560515|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
143005733|NCT03526549|515560516|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
143005734|NCT03526549|515560515|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
143005735|NCT03526549|515560516|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
143005736|NCT03526549|515560515|FG000|Open-label Phase|Adverse Event|4|||
143005737|NCT03526549|515560516|FG001|Open-label Phase|Adverse Event|0|||
143005738|NCT03526549|515560515|FG000|Open-label Phase|Withdrawal by Subject|54|||
143005739|NCT03526549|515560516|FG001|Open-label Phase|Withdrawal by Subject|0|||
143005740|NCT03526549|515560515|FG000|Open-label Phase|Lost to Follow-up|35|||
143005741|NCT03526549|515560516|FG001|Open-label Phase|Lost to Follow-up|0|||
143005742|NCT03526549|515560515|FG000|Open-label Phase|Other than Specified|5|||
143005743|NCT03526549|515560516|FG001|Open-label Phase|Other than Specified|0|||
143005744|NCT00812968|515560519|FG000|Overall Study|Relapse after erythroid response|6|||
143005745|NCT00812968|515560519|FG000|Overall Study|Disease progression|1|||
143005746|NCT00812968|515560519|FG000|Overall Study|No further treatment required|1|||
143005747|NCT00812968|515560519|FG000|Overall Study|Study closed due to marketing approval|3|||
143005748|NCT00494234|515560520|FG000|Overall Study|Withdrawal by Subject|1|||
143005749|NCT00494234|515560521|FG001|Overall Study|Withdrawal by Subject|0|||
143005750|NCT00494234|515560520|FG000|Overall Study|Disease progression|11|||
143005751|NCT00494234|515560521|FG001|Overall Study|Disease progression|8|||
143005752|NCT00494234|515560520|FG000|Overall Study|Death|2|||
143005753|NCT00494234|515560521|FG001|Overall Study|Death|1|||
143005754|NCT00423137|515560522|FG000|Overall Study|Lost to Follow-up|0|||
143005755|NCT00423137|515560523|FG001|Overall Study|Lost to Follow-up|0|||
143005756|NCT00423137|515560524|FG002|Overall Study|Lost to Follow-up|1|||
143005757|NCT00423137|515560525|FG003|Overall Study|Lost to Follow-up|0|||
143005758|NCT00423137|515560522|FG000|Overall Study|Protocol Violation|0|||
143005759|NCT00423137|515560523|FG001|Overall Study|Protocol Violation|0|||
143005760|NCT00423137|515560524|FG002|Overall Study|Protocol Violation|0|||
143005761|NCT00423137|515560525|FG003|Overall Study|Protocol Violation|1|||
143005762|NCT00423137|515560522|FG000|Overall Study|Adverse Event Study disease worse|1|||
143005763|NCT00423137|515560523|FG001|Overall Study|Adverse Event Study disease worse|0|||
143005764|NCT00423137|515560524|FG002|Overall Study|Adverse Event Study disease worse|3|||
143005765|NCT00423137|515560525|FG003|Overall Study|Adverse Event Study disease worse|1|||
143005766|NCT00423137|515560522|FG000|Overall Study|Adverse Event Other|0|||
143005767|NCT00423137|515560523|FG001|Overall Study|Adverse Event Other|0|||
143005768|NCT00423137|515560524|FG002|Overall Study|Adverse Event Other|2|||
143005769|NCT00423137|515560525|FG003|Overall Study|Adverse Event Other|0|||
143005770|NCT04359758|515560536|FG000|Overall Study|Protocol Violation|3|||
143005771|NCT04359758|515560537|FG001|Overall Study|Protocol Violation|2|||
143005772|NCT01207219|515560540|FG000|Overall Study|changed diagnosis during study period|5|||
143005773|NCT01207219|515560541|FG001|Overall Study|changed diagnosis during study period|3|||
143005774|NCT01207219|515560542|FG002|Overall Study|changed diagnosis during study period|1|||
143005775|NCT01207219|515560540|FG000|Overall Study|Lost to Follow-up|6|||
143005776|NCT01207219|515560541|FG001|Overall Study|Lost to Follow-up|8|||
143005777|NCT01207219|515560542|FG002|Overall Study|Lost to Follow-up|6|||
143005778|NCT01012609|515560543|FG000|Overall Study|Withdrawal by Subject|1|||
143005779|NCT01012609|515560544|FG001|Overall Study|Withdrawal by Subject|1|||
143005780|NCT00620776|515560545|FG000|Overall Study|Did not receive treatment|3|||
143005781|NCT00620776|515560546|FG001|Overall Study|Did not receive treatment|5|||
143005782|NCT00620776|515560545|FG000|Overall Study|Adverse Event|2|||
143005783|NCT00620776|515560546|FG001|Overall Study|Adverse Event|3|||
143005784|NCT00620776|515560545|FG000|Overall Study|Lack of Efficacy|2|||
143005785|NCT00620776|515560546|FG001|Overall Study|Lack of Efficacy|1|||
143005786|NCT00620776|515560545|FG000|Overall Study|Lost to Follow-up|2|||
143005787|NCT00620776|515560546|FG001|Overall Study|Lost to Follow-up|5|||
143005788|NCT00620776|515560545|FG000|Overall Study|Withdrawal by Subject|3|||
143005789|NCT00620776|515560546|FG001|Overall Study|Withdrawal by Subject|2|||
143005790|NCT00183170|515560551|FG000|First Intervention|Did not complete study|1|||
143005791|NCT00183170|515560552|FG001|First Intervention|Did not complete study|0|||
143005792|NCT00183170|515560551|FG000|First Intervention|Did not meet targeted BrAC|1|||
143005793|NCT00183170|515560552|FG001|First Intervention|Did not meet targeted BrAC|0|||
143005794|NCT00183170|515560551|FG000|Washout 1 Week|Did not complete study|6|||
143005795|NCT00183170|515560552|FG001|Washout 1 Week|Did not complete study|8|||
143005796|NCT00183170|515560551|FG000|Second Intervention|Did not complete study|1|||
143005797|NCT00183170|515560552|FG001|Second Intervention|Did not complete study|0|||
143005798|NCT00183170|515560551|FG000|Second Intervention|Did not meet targeted BrAC|0|||
143005799|NCT00183170|515560552|FG001|Second Intervention|Did not meet targeted BrAC|2|||
143005800|NCT00924820|515560553|FG000|Overall Study|Death|2|||
143005801|NCT00924820|515560553|FG000|Overall Study|Ineligible, Screen Failure|5|||
143005802|NCT00761969|515560554|FG000|Overall Study|Death|112|||
143005803|NCT00761969|515560555|FG001|Overall Study|Death|47|||
143005804|NCT00761969|515560554|FG000|Overall Study|Lost to Follow-up|88|||
143005805|NCT00761969|515560555|FG001|Overall Study|Lost to Follow-up|93|||
143005806|NCT00585468|515560556|FG000|First Intervention|Withdrawal by Subject|1|||
143005807|NCT00585468|515560557|FG001|First Intervention|Withdrawal by Subject|1|||
143005808|NCT00762073|515560560|FG000|Overall Study|Lack of Efficacy|1|||
143005809|NCT00762073|515560561|FG001|Overall Study|Lack of Efficacy|1|||
143005810|NCT00762073|515560562|FG002|Overall Study|Lack of Efficacy|0|||
143005811|NCT00762073|515560563|FG003|Overall Study|Lack of Efficacy|0|||
143005812|NCT00762073|515560560|FG000|Overall Study|Adverse Event|1|||
143005813|NCT00762073|515560561|FG001|Overall Study|Adverse Event|0|||
143005814|NCT00762073|515560562|FG002|Overall Study|Adverse Event|1|||
143005815|NCT00762073|515560563|FG003|Overall Study|Adverse Event|1|||
143005816|NCT00762073|515560560|FG000|Overall Study|Significant Subject Noncompliance|0|||
143005817|NCT00762073|515560561|FG001|Overall Study|Significant Subject Noncompliance|1|||
143005818|NCT00762073|515560562|FG002|Overall Study|Significant Subject Noncompliance|0|||
143005819|NCT00762073|515560563|FG003|Overall Study|Significant Subject Noncompliance|1|||
143005820|NCT00762073|515560560|FG000|Overall Study|Withdrawal by Subject|1|||
143005821|NCT00762073|515560561|FG001|Overall Study|Withdrawal by Subject|2|||
143005822|NCT00762073|515560562|FG002|Overall Study|Withdrawal by Subject|1|||
143005823|NCT00762073|515560563|FG003|Overall Study|Withdrawal by Subject|1|||
143005824|NCT00762073|515560560|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
143005825|NCT00762073|515560561|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
143005826|NCT00762073|515560562|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
143005827|NCT00762073|515560563|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
143005828|NCT03155269|515560566|FG000|Overall Study|Withdrawal by Subject|4|||
143005829|NCT03155269|515560567|FG001|Overall Study|Withdrawal by Subject|5|||
143005830|NCT03155269|515560566|FG000|Overall Study|Lost to Follow-up|1|||
143005831|NCT03155269|515560567|FG001|Overall Study|Lost to Follow-up|2|||
143005832|NCT04637815|515560568|FG000|Overall Study|Death|1|||
143005833|NCT04637815|515560569|FG001|Overall Study|Death|0|||
143005834|NCT04637815|515560568|FG000|Overall Study|Lost to Follow-up|5|||
143005835|NCT04637815|515560569|FG001|Overall Study|Lost to Follow-up|2|||
143005836|NCT01265875|515560570|FG000|Overall Study|Uncooperative/unreliable|1|||
143005837|NCT04409509|515560571|FG000|Overall Study|Failure to meet randomization requirement|1|||
143005838|NCT04409509|515560572|FG001|Overall Study|Failure to meet randomization requirement|0|||
143005839|NCT04409509|515560571|FG000|Overall Study|Adverse Event|0|||
143005840|NCT04409509|515560572|FG001|Overall Study|Adverse Event|1|||
143005841|NCT04409509|515560571|FG000|Overall Study|Death|11|||
143005842|NCT04409509|515560572|FG001|Overall Study|Death|10|||
143005843|NCT04409509|515560571|FG000|Overall Study|Non-compliance with study drug|0|||
143005844|NCT04409509|515560572|FG001|Overall Study|Non-compliance with study drug|1|||
143005845|NCT04409509|515560571|FG000|Overall Study|Lost to Follow-up|0|||
143005846|NCT04409509|515560572|FG001|Overall Study|Lost to Follow-up|3|||
143005847|NCT04409509|515560571|FG000|Overall Study|Withdrawal by Subject|0|||
143005848|NCT04409509|515560572|FG001|Overall Study|Withdrawal by Subject|3|||
143005849|NCT04409509|515560571|FG000|Overall Study|Randomized by mistake|0|||
143005850|NCT04409509|515560572|FG001|Overall Study|Randomized by mistake|1|||
143005851|NCT04409509|515560571|FG000|Overall Study|Other|1|||
143005852|NCT04409509|515560572|FG001|Overall Study|Other|1|||
143005853|NCT00483119|515560573|FG000|Overall Study|Adverse Event|0|||
143005854|NCT00483119|515560574|FG001|Overall Study|Adverse Event|1|||
143005855|NCT00483119|515560573|FG000|Overall Study|Physician Decision|1|||
143005856|NCT00483119|515560574|FG001|Overall Study|Physician Decision|0|||
143005857|NCT02369874|515560575|FG000|Overall Study|Lost to Follow-up|2|||
143005858|NCT02369874|515560576|FG001|Overall Study|Lost to Follow-up|2|||
143005859|NCT02369874|515560577|FG002|Overall Study|Lost to Follow-up|2|||
143005860|NCT02369874|515560575|FG000|Overall Study|Withdrawal by Subject|7|||
143005861|NCT02369874|515560576|FG001|Overall Study|Withdrawal by Subject|9|||
143005862|NCT02369874|515560577|FG002|Overall Study|Withdrawal by Subject|27|||
143005863|NCT02369874|515560575|FG000|Overall Study|Miscellaneous|1|||
143005864|NCT02369874|515560576|FG001|Overall Study|Miscellaneous|1|||
143005865|NCT02369874|515560577|FG002|Overall Study|Miscellaneous|0|||
143005866|NCT02369874|515560575|FG000|Overall Study|On Treatment/Off Study|34|||
143005867|NCT02369874|515560576|FG001|Overall Study|On Treatment/Off Study|45|||
143005868|NCT02369874|515560577|FG002|Overall Study|On Treatment/Off Study|32|||
143005869|NCT02331680|515560578|FG000|Overall Study|Adverse Event|3|||
143005870|NCT02331680|515560579|FG001|Overall Study|Adverse Event|0|||
143005871|NCT02331680|515560580|FG002|Overall Study|Adverse Event|2|||
143005872|NCT02331680|515560578|FG000|Overall Study|Physician Decision|1|||
143005873|NCT02331680|515560579|FG001|Overall Study|Physician Decision|1|||
143005874|NCT02331680|515560580|FG002|Overall Study|Physician Decision|2|||
143005875|NCT02331680|515560578|FG000|Overall Study|Withdrawal by Subject|0|||
143005876|NCT02331680|515560579|FG001|Overall Study|Withdrawal by Subject|1|||
143005877|NCT02331680|515560580|FG002|Overall Study|Withdrawal by Subject|2|||
143005878|NCT02331680|515560578|FG000|Overall Study|Met withdrawal criteria|2|||
143005879|NCT02331680|515560579|FG001|Overall Study|Met withdrawal criteria|2|||
143005880|NCT02331680|515560580|FG002|Overall Study|Met withdrawal criteria|5|||
143005881|NCT02331680|515560578|FG000|Overall Study|Non-compliance with study drug|0|||
143005882|NCT02331680|515560579|FG001|Overall Study|Non-compliance with study drug|0|||
143005883|NCT02331680|515560580|FG002|Overall Study|Non-compliance with study drug|1|||
143005884|NCT02331680|515560578|FG000|Overall Study|Protocol Violation|0|||
143005885|NCT02331680|515560579|FG001|Overall Study|Protocol Violation|0|||
143005886|NCT02331680|515560580|FG002|Overall Study|Protocol Violation|3|||
143117859|NCT01546038|515974187|FG002|Overall Study|: Randomized, not treated|0|||
143117860|NCT01546038|515974188|FG003|Overall Study|: Randomized, not treated|0|||
143117861|NCT01546038|515974189|FG004|Overall Study|: Randomized, not treated|0|||
143117862|NCT01546038|515974190|FG005|Overall Study|: Randomized, not treated|0|||
143117863|NCT01546038|515974191|FG006|Overall Study|: Randomized, not treated|2|||
143259626|NCT01226121|516505809|FG000|Overall Study|Lost to Follow-up|2|||
143005887|NCT03522506|515560581|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
143005888|NCT03522506|515560582|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
143005889|NCT03522506|515560583|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
143005890|NCT03522506|515560584|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
143005891|NCT03522506|515560581|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
143005892|NCT03522506|515560582|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
143005893|NCT03522506|515560583|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
143005894|NCT03522506|515560584|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
143117864|NCT01546038|515974192|FG007|Overall Study|: Randomized, not treated|4|||
143117865|NCT01546038|515974193|FG008|Overall Study|: Randomized, not treated|3|||
143117866|NCT04245202|515974194|FG000|Overall Study|Lack of Efficacy|10|||
143005895|NCT02388906|515560593|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
143005896|NCT02388906|515560594|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
143005897|NCT02388906|515560593|FG000|Treatment Period|Disease progression|121|||
143005898|NCT02388906|515560594|FG001|Treatment Period|Disease progression|100|||
143005899|NCT02388906|515560593|FG000|Treatment Period|Study drug toxicity|41|||
143005900|NCT02388906|515560594|FG001|Treatment Period|Study drug toxicity|208|||
143005901|NCT02388906|515560593|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
143005902|NCT02388906|515560594|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
143005903|NCT02388906|515560593|FG000|Treatment Period|Participant request to stop treatment|5|||
143005904|NCT02388906|515560594|FG001|Treatment Period|Participant request to stop treatment|9|||
143005905|NCT02388906|515560593|FG000|Treatment Period|Participant withdrew consent|2|||
143005906|NCT02388906|515560594|FG001|Treatment Period|Participant withdrew consent|3|||
143005907|NCT02388906|515560593|FG000|Treatment Period|Poor/non-compliance|0|||
143005908|NCT02388906|515560594|FG001|Treatment Period|Poor/non-compliance|1|||
143005909|NCT02388906|515560593|FG000|Treatment Period|Participant no longer meets study criteria|0|||
143005910|NCT02388906|515560594|FG001|Treatment Period|Participant no longer meets study criteria|1|||
143005911|NCT02388906|515560593|FG000|Treatment Period|Other reasons|3|||
143005912|NCT02388906|515560594|FG001|Treatment Period|Other reasons|3|||
143005913|NCT04784455|515560595|FG000|Overall Study|Death|4|||
143005914|NCT04298229|515560596|FG000|Overall Study|Physician Decision|1|||
143005915|NCT04298229|515560597|FG001|Overall Study|Physician Decision|1|||
143005916|NCT04298229|515560596|FG000|Overall Study|Withdrawal by Subject|1|||
143005917|NCT04298229|515560597|FG001|Overall Study|Withdrawal by Subject|1|||
143005918|NCT04298229|515560596|FG000|Overall Study|Did not receive IV loop diuretics|2|||
143005919|NCT04298229|515560597|FG001|Overall Study|Did not receive IV loop diuretics|0|||
143005920|NCT00262119|515560598|FG000|Overall Study|Lost to Follow-up|38|||
143005921|NCT00262119|515560599|FG001|Overall Study|Lost to Follow-up|51|||
143005922|NCT00262119|515560600|FG002|Overall Study|Lost to Follow-up|42|||
143005923|NCT00262119|515560598|FG000|Overall Study|Death|20|||
143005924|NCT00262119|515560599|FG001|Overall Study|Death|19|||
143005925|NCT00262119|515560600|FG002|Overall Study|Death|16|||
143005926|NCT00859313|515560601|FG000|Overall Study|Lack of Efficacy|2|||
143005927|NCT00859313|515560601|FG000|Overall Study|Adverse Event|1|||
143005928|NCT00859313|515560601|FG000|Overall Study|staff error|1|||
143005929|NCT03901274|515560602|FG000|Overall Study|Lost to Follow-up|120|||
143005930|NCT03901274|515560603|FG001|Overall Study|Lost to Follow-up|124|||
143005931|NCT03901274|515560602|FG000|Overall Study|Withdrawal by Subject|0|||
143005932|NCT03901274|515560603|FG001|Overall Study|Withdrawal by Subject|6|||
143005933|NCT05570604|515560604|FG000|Overall Study|Lost to Follow-up|1|||
143005934|NCT05570604|515560605|FG001|Overall Study|Lost to Follow-up|5|||
143005935|NCT05570604|515560604|FG000|Overall Study|Illness|2|||
143005936|NCT05570604|515560605|FG001|Overall Study|Illness|2|||
143005937|NCT05182840|515560606|FG000|Run-in Period|Not treated|0|||
143005938|NCT05182840|515560607|FG001|Run-in Period|Not treated|1|||
143005939|NCT05182840|515560608|FG002|Run-in Period|Not treated|0|||
143005940|NCT05182840|515560609|FG003|Run-in Period|Not treated|0|||
143005941|NCT05182840|515560610|FG004|Run-in Period|Not treated|0|||
143005942|NCT05182840|515560611|FG005|Run-in Period|Not treated|0|||
143005943|NCT05182840|515560612|FG006|Run-in Period|Not treated|0|||
143005944|NCT05182840|515560613|FG007|Run-in Period|Not treated|0|||
143005945|NCT05182840|515560614|FG008|Run-in Period|Not treated|0|||
143005946|NCT05182840|515560615|FG009|Run-in Period|Not treated|0|||
143005947|NCT05182840|515560606|FG000|Run-in Period|Other reason but not sponsor termination|14|||
143005948|NCT05182840|515560607|FG001|Run-in Period|Other reason but not sponsor termination|18|||
143005949|NCT05182840|515560608|FG002|Run-in Period|Other reason but not sponsor termination|0|||
143005950|NCT05182840|515560609|FG003|Run-in Period|Other reason but not sponsor termination|0|||
143005951|NCT05182840|515560610|FG004|Run-in Period|Other reason but not sponsor termination|0|||
143005952|NCT05182840|515560611|FG005|Run-in Period|Other reason but not sponsor termination|0|||
143005953|NCT05182840|515560612|FG006|Run-in Period|Other reason but not sponsor termination|0|||
143005954|NCT05182840|515560613|FG007|Run-in Period|Other reason but not sponsor termination|0|||
143005955|NCT05182840|515560614|FG008|Run-in Period|Other reason but not sponsor termination|0|||
143005956|NCT05182840|515560615|FG009|Run-in Period|Other reason but not sponsor termination|0|||
143005957|NCT05182840|515560606|FG000|Run-in Period|No reason available|2|||
143005958|NCT05182840|515560607|FG001|Run-in Period|No reason available|2|||
143005959|NCT05182840|515560608|FG002|Run-in Period|No reason available|0|||
143005960|NCT05182840|515560609|FG003|Run-in Period|No reason available|0|||
143005961|NCT05182840|515560610|FG004|Run-in Period|No reason available|0|||
143005962|NCT05182840|515560611|FG005|Run-in Period|No reason available|0|||
143005963|NCT05182840|515560612|FG006|Run-in Period|No reason available|0|||
143005964|NCT05182840|515560613|FG007|Run-in Period|No reason available|0|||
143117867|NCT04245202|515974195|FG001|Overall Study|Lack of Efficacy|1|||
143457539|NCT01029652|517219311|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
143457540|NCT01029652|517219312|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
143005965|NCT05182840|515560614|FG008|Run-in Period|No reason available|0|||
143005966|NCT05182840|515560615|FG009|Run-in Period|No reason available|0|||
143005967|NCT05182840|515560606|FG000|Run-in Period|Burden of study procedures|2|||
143005968|NCT05182840|515560607|FG001|Run-in Period|Burden of study procedures|2|||
143005969|NCT05182840|515560608|FG002|Run-in Period|Burden of study procedures|0|||
143005970|NCT05182840|515560609|FG003|Run-in Period|Burden of study procedures|0|||
143005971|NCT05182840|515560610|FG004|Run-in Period|Burden of study procedures|0|||
143005972|NCT05182840|515560611|FG005|Run-in Period|Burden of study procedures|0|||
143005973|NCT05182840|515560612|FG006|Run-in Period|Burden of study procedures|0|||
143005974|NCT05182840|515560613|FG007|Run-in Period|Burden of study procedures|0|||
143005975|NCT05182840|515560614|FG008|Run-in Period|Burden of study procedures|0|||
143005976|NCT05182840|515560615|FG009|Run-in Period|Burden of study procedures|0|||
143005977|NCT05182840|515560606|FG000|Run-in Period|Change of residence|1|||
143005978|NCT05182840|515560607|FG001|Run-in Period|Change of residence|0|||
143005979|NCT05182840|515560608|FG002|Run-in Period|Change of residence|0|||
143005980|NCT05182840|515560609|FG003|Run-in Period|Change of residence|0|||
143005981|NCT05182840|515560610|FG004|Run-in Period|Change of residence|0|||
143005982|NCT05182840|515560611|FG005|Run-in Period|Change of residence|0|||
143005983|NCT05182840|515560612|FG006|Run-in Period|Change of residence|0|||
143005984|NCT05182840|515560613|FG007|Run-in Period|Change of residence|0|||
143005985|NCT05182840|515560614|FG008|Run-in Period|Change of residence|0|||
143005986|NCT05182840|515560615|FG009|Run-in Period|Change of residence|0|||
143005987|NCT05182840|515560606|FG000|Run-in Period|Adverse Event|5|||
143005988|NCT05182840|515560607|FG001|Run-in Period|Adverse Event|5|||
143005989|NCT05182840|515560608|FG002|Run-in Period|Adverse Event|0|||
143005990|NCT05182840|515560609|FG003|Run-in Period|Adverse Event|0|||
143005991|NCT05182840|515560610|FG004|Run-in Period|Adverse Event|0|||
143005992|NCT05182840|515560611|FG005|Run-in Period|Adverse Event|0|||
143005993|NCT05182840|515560612|FG006|Run-in Period|Adverse Event|0|||
143005994|NCT05182840|515560613|FG007|Run-in Period|Adverse Event|0|||
143005995|NCT05182840|515560614|FG008|Run-in Period|Adverse Event|0|||
143005996|NCT05182840|515560615|FG009|Run-in Period|Adverse Event|0|||
143005997|NCT05182840|515560606|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
143005998|NCT05182840|515560607|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
143005999|NCT05182840|515560608|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
143006000|NCT05182840|515560609|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
143006001|NCT05182840|515560610|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
143006002|NCT05182840|515560611|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
143006003|NCT05182840|515560612|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
143006004|NCT05182840|515560613|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
143006005|NCT05182840|515560614|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
143006006|NCT05182840|515560615|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
143006007|NCT05182840|515560606|FG000|Treatment Period|Reason missing|0|||
143006008|NCT05182840|515560607|FG001|Treatment Period|Reason missing|0|||
143006009|NCT05182840|515560608|FG002|Treatment Period|Reason missing|1|||
143006010|NCT05182840|515560609|FG003|Treatment Period|Reason missing|0|||
143117868|NCT03515629|515974197|FG000|Overall Study|Death|0|||
143117869|NCT03515629|515974198|FG001|Overall Study|Death|1|||
143117870|NCT03515629|515974199|FG002|Overall Study|Death|1|||
143117871|NCT03515629|515974197|FG000|Overall Study|Progressive disease|0|||
143117872|NCT03515629|515974198|FG001|Overall Study|Progressive disease|1|||
143117873|NCT03515629|515974199|FG002|Overall Study|Progressive disease|0|||
143006011|NCT05182840|515560610|FG004|Treatment Period|Reason missing|0|||
143006012|NCT05182840|515560611|FG005|Treatment Period|Reason missing|0|||
143006013|NCT05182840|515560612|FG006|Treatment Period|Reason missing|0|||
143006014|NCT05182840|515560613|FG007|Treatment Period|Reason missing|0|||
143006015|NCT05182840|515560614|FG008|Treatment Period|Reason missing|0|||
143006016|NCT05182840|515560615|FG009|Treatment Period|Reason missing|0|||
143006017|NCT05182840|515560606|FG000|Treatment Period|Other but not sponsor termination|0|||
143006018|NCT05182840|515560607|FG001|Treatment Period|Other but not sponsor termination|0|||
143006019|NCT05182840|515560608|FG002|Treatment Period|Other but not sponsor termination|8|||
143006020|NCT05182840|515560609|FG003|Treatment Period|Other but not sponsor termination|6|||
143006021|NCT05182840|515560610|FG004|Treatment Period|Other but not sponsor termination|6|||
143006022|NCT05182840|515560611|FG005|Treatment Period|Other but not sponsor termination|7|||
143006023|NCT05182840|515560612|FG006|Treatment Period|Other but not sponsor termination|5|||
143006024|NCT05182840|515560613|FG007|Treatment Period|Other but not sponsor termination|8|||
143117874|NCT00424021|515974200|FG000|NCT00046319 Study Period|Adverse Event|1|||
143117875|NCT00424021|515974201|FG001|NCT00046319 Study Period|Adverse Event|0|||
143117876|NCT00424021|515974202|FG002|NCT00046319 Study Period|Adverse Event|1|||
143117877|NCT00424021|515974203|FG003|NCT00046319 Study Period|Adverse Event|1|||
143117878|NCT00424021|515974200|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
143117879|NCT00424021|515974201|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
143117880|NCT00424021|515974202|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
143117881|NCT00424021|515974203|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
143117882|NCT00424021|515974200|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
143117883|NCT00424021|515974201|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
143117884|NCT00424021|515974202|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
143117885|NCT00424021|515974203|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
143117886|NCT00424021|515974200|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
143117887|NCT00424021|515974201|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
143117888|NCT00424021|515974202|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
143117889|NCT00424021|515974203|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
143117890|NCT00424021|515974200|FG000|AMB-220-E Study Period|Adverse Event|1|||
143117891|NCT00424021|515974201|FG001|AMB-220-E Study Period|Adverse Event|1|||
143117892|NCT00424021|515974202|FG002|AMB-220-E Study Period|Adverse Event|3|||
143117893|NCT00424021|515974203|FG003|AMB-220-E Study Period|Adverse Event|7|||
143117894|NCT00424021|515974200|FG000|AMB-220-E Study Period|Death|0|||
143117895|NCT00424021|515974201|FG001|AMB-220-E Study Period|Death|0|||
143117896|NCT00424021|515974202|FG002|AMB-220-E Study Period|Death|1|||
143117897|NCT00424021|515974203|FG003|AMB-220-E Study Period|Death|1|||
143117898|NCT00424021|515974200|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
143117899|NCT00424021|515974201|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
143117900|NCT00424021|515974202|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
143117901|NCT00424021|515974203|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
143117902|NCT00424021|515974200|FG000|AMB-220-E Study Period|Physician Decision|0|||
143117903|NCT00424021|515974201|FG001|AMB-220-E Study Period|Physician Decision|0|||
143117904|NCT00424021|515974202|FG002|AMB-220-E Study Period|Physician Decision|0|||
143117905|NCT00424021|515974203|FG003|AMB-220-E Study Period|Physician Decision|1|||
143117906|NCT00987402|515974204|FG000|Overall Study|Insufficient data entry|86|||
143117907|NCT00987402|515974205|FG001|Overall Study|Insufficient data entry|98|||
143117908|NCT03769194|515974206|FG000|Overall Study|Withdrawal by Subject|0|||
143117909|NCT03769194|515974207|FG001|Overall Study|Withdrawal by Subject|7|||
143117910|NCT03769194|515974208|FG002|Overall Study|Withdrawal by Subject|4|||
143117911|NCT03769194|515974209|FG003|Overall Study|Withdrawal by Subject|1|||
143117912|NCT03769194|515974206|FG000|Overall Study|moved from study area|0|||
143117913|NCT03769194|515974207|FG001|Overall Study|moved from study area|2|||
143117914|NCT03769194|515974208|FG002|Overall Study|moved from study area|1|||
143117915|NCT03769194|515974209|FG003|Overall Study|moved from study area|1|||
143117916|NCT03769194|515974206|FG000|Overall Study|Lost to Follow-up|3|||
143006025|NCT05182840|515560614|FG008|Treatment Period|Other but not sponsor termination|7|||
143006026|NCT05182840|515560615|FG009|Treatment Period|Other but not sponsor termination|2|||
143006027|NCT05182840|515560606|FG000|Treatment Period|Protocol deviation|0|||
143006028|NCT05182840|515560607|FG001|Treatment Period|Protocol deviation|0|||
143006029|NCT05182840|515560608|FG002|Treatment Period|Protocol deviation|0|||
143006030|NCT05182840|515560609|FG003|Treatment Period|Protocol deviation|0|||
143006031|NCT05182840|515560610|FG004|Treatment Period|Protocol deviation|0|||
143117917|NCT03769194|515974207|FG001|Overall Study|Lost to Follow-up|6|||
143117918|NCT03769194|515974208|FG002|Overall Study|Lost to Follow-up|3|||
143117919|NCT03769194|515974209|FG003|Overall Study|Lost to Follow-up|6|||
143117920|NCT03769194|515974206|FG000|Overall Study|other|1|||
143117921|NCT03769194|515974207|FG001|Overall Study|other|3|||
143117922|NCT03769194|515974208|FG002|Overall Study|other|0|||
143117923|NCT03769194|515974209|FG003|Overall Study|other|1|||
143006032|NCT05182840|515560611|FG005|Treatment Period|Protocol deviation|0|||
143006033|NCT05182840|515560612|FG006|Treatment Period|Protocol deviation|0|||
143006034|NCT05182840|515560613|FG007|Treatment Period|Protocol deviation|0|||
143006035|NCT05182840|515560614|FG008|Treatment Period|Protocol deviation|1|||
143006036|NCT05182840|515560615|FG009|Treatment Period|Protocol deviation|0|||
143006037|NCT05182840|515560606|FG000|Treatment Period|No reason available|0|||
143006038|NCT05182840|515560607|FG001|Treatment Period|No reason available|0|||
143006039|NCT05182840|515560608|FG002|Treatment Period|No reason available|0|||
143006040|NCT05182840|515560609|FG003|Treatment Period|No reason available|1|||
143006041|NCT05182840|515560610|FG004|Treatment Period|No reason available|0|||
143006042|NCT05182840|515560611|FG005|Treatment Period|No reason available|2|||
143006043|NCT05182840|515560612|FG006|Treatment Period|No reason available|0|||
143006044|NCT05182840|515560613|FG007|Treatment Period|No reason available|1|||
143006045|NCT05182840|515560614|FG008|Treatment Period|No reason available|0|||
143006046|NCT05182840|515560615|FG009|Treatment Period|No reason available|0|||
143006047|NCT05182840|515560606|FG000|Treatment Period|Burden of study procedures|0|||
143006048|NCT05182840|515560607|FG001|Treatment Period|Burden of study procedures|0|||
143006049|NCT05182840|515560608|FG002|Treatment Period|Burden of study procedures|0|||
143006050|NCT05182840|515560609|FG003|Treatment Period|Burden of study procedures|0|||
143006051|NCT05182840|515560610|FG004|Treatment Period|Burden of study procedures|1|||
143006052|NCT05182840|515560611|FG005|Treatment Period|Burden of study procedures|0|||
143006053|NCT05182840|515560612|FG006|Treatment Period|Burden of study procedures|0|||
143006054|NCT05182840|515560613|FG007|Treatment Period|Burden of study procedures|0|||
143006055|NCT05182840|515560614|FG008|Treatment Period|Burden of study procedures|0|||
143006056|NCT05182840|515560615|FG009|Treatment Period|Burden of study procedures|0|||
143006057|NCT05182840|515560606|FG000|Treatment Period|Change of residence|0|||
143006058|NCT05182840|515560607|FG001|Treatment Period|Change of residence|0|||
143006059|NCT05182840|515560608|FG002|Treatment Period|Change of residence|0|||
143006060|NCT05182840|515560609|FG003|Treatment Period|Change of residence|0|||
143006061|NCT05182840|515560610|FG004|Treatment Period|Change of residence|0|||
143006062|NCT05182840|515560611|FG005|Treatment Period|Change of residence|1|||
143006063|NCT05182840|515560612|FG006|Treatment Period|Change of residence|0|||
143006064|NCT05182840|515560613|FG007|Treatment Period|Change of residence|0|||
143006065|NCT05182840|515560614|FG008|Treatment Period|Change of residence|0|||
143006066|NCT05182840|515560615|FG009|Treatment Period|Change of residence|0|||
143006067|NCT05182840|515560606|FG000|Treatment Period|Adverse Event|0|||
143006068|NCT05182840|515560607|FG001|Treatment Period|Adverse Event|0|||
143006069|NCT05182840|515560608|FG002|Treatment Period|Adverse Event|4|||
143006070|NCT05182840|515560609|FG003|Treatment Period|Adverse Event|16|||
143006071|NCT05182840|515560610|FG004|Treatment Period|Adverse Event|12|||
143006072|NCT05182840|515560611|FG005|Treatment Period|Adverse Event|6|||
143006073|NCT05182840|515560612|FG006|Treatment Period|Adverse Event|4|||
143006074|NCT05182840|515560613|FG007|Treatment Period|Adverse Event|8|||
143006075|NCT05182840|515560614|FG008|Treatment Period|Adverse Event|16|||
143006076|NCT05182840|515560615|FG009|Treatment Period|Adverse Event|5|||
143006077|NCT05182840|515560606|FG000|Treatment Period|Not treated with study drug|0|||
143006078|NCT05182840|515560607|FG001|Treatment Period|Not treated with study drug|0|||
143006079|NCT05182840|515560608|FG002|Treatment Period|Not treated with study drug|0|||
143006080|NCT05182840|515560609|FG003|Treatment Period|Not treated with study drug|1|||
143006081|NCT05182840|515560610|FG004|Treatment Period|Not treated with study drug|0|||
143006082|NCT05182840|515560611|FG005|Treatment Period|Not treated with study drug|0|||
143006083|NCT05182840|515560612|FG006|Treatment Period|Not treated with study drug|1|||
143006084|NCT05182840|515560613|FG007|Treatment Period|Not treated with study drug|1|||
143006085|NCT05182840|515560614|FG008|Treatment Period|Not treated with study drug|0|||
143006086|NCT05182840|515560615|FG009|Treatment Period|Not treated with study drug|0|||
143006087|NCT02161380|515560616|FG000|Overall Study|Lost to Follow-up|0|||
143006088|NCT02161380|515560617|FG001|Overall Study|Lost to Follow-up|1|||
143006089|NCT02161380|515560618|FG002|Overall Study|Lost to Follow-up|0|||
143006090|NCT02161380|515560619|FG003|Overall Study|Lost to Follow-up|0|||
143006091|NCT01958619|515560621|FG000|Overall Study|Protocol Violation|2|||
143006092|NCT01958619|515560622|FG001|Overall Study|Protocol Violation|0|||
143006093|NCT01958619|515560623|FG002|Overall Study|Protocol Violation|1|||
143006094|NCT01958619|515560624|FG003|Overall Study|Protocol Violation|0|||
143006095|NCT04794491|515560627|FG000|Overall Study|Adverse Event|1|||
143006096|NCT04794491|515560627|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
143006097|NCT04794491|515560627|FG000|Overall Study|Noncompliance With Study Intervention|1|||
143006098|NCT04794491|515560627|FG000|Overall Study|Withdrawal by Subject|2|||
143006099|NCT00948896|515560628|FG000|Randomization to 24 Months of Age|Death|1|||
143006100|NCT00948896|515560629|FG001|Randomization to 24 Months of Age|Death|0|||
143006101|NCT00948896|515560630|FG002|Randomization to 24 Months of Age|Death|0|||
143006102|NCT00948896|515560631|FG003|Randomization to 24 Months of Age|Death|0|||
143006103|NCT00948896|515560632|FG004|Randomization to 24 Months of Age|Death|2|||
143006104|NCT00948896|515560633|FG005|Randomization to 24 Months of Age|Death|1|||
143006105|NCT00948896|515560634|FG006|Randomization to 24 Months of Age|Death|2|||
143006106|NCT00948896|515560635|FG007|Randomization to 24 Months of Age|Death|1|||
143006107|NCT00948896|515560628|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
143006108|NCT00948896|515560629|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
143006109|NCT00948896|515560630|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
143006110|NCT00948896|515560631|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
143006111|NCT00948896|515560632|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
143006112|NCT00948896|515560633|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
143006113|NCT00948896|515560634|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
143006114|NCT00948896|515560635|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
143006115|NCT00948896|515560628|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
143006116|NCT00948896|515560629|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
143006117|NCT00948896|515560630|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
143006118|NCT00948896|515560631|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
143006119|NCT00948896|515560632|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
143006120|NCT00948896|515560633|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
143006121|NCT00948896|515560634|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
143006122|NCT00948896|515560635|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
143006123|NCT00948896|515560628|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
143259627|NCT01226121|516505810|FG001|Overall Study|Lost to Follow-up|0|||
143457541|NCT01029652|517219311|FG000|Core Study (0-12 Weeks)|Death|0|||
143006124|NCT00948896|515560629|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
143006125|NCT00948896|515560630|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
143006126|NCT00948896|515560631|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
143006127|NCT00948896|515560632|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
143006128|NCT00948896|515560633|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
143006129|NCT00948896|515560634|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
143006130|NCT00948896|515560635|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
143006131|NCT00948896|515560628|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
143006132|NCT00948896|515560629|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
143006133|NCT00948896|515560630|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
143006134|NCT00948896|515560631|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
143006135|NCT00948896|515560632|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
143006136|NCT00948896|515560633|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
143006137|NCT00948896|515560634|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
143006138|NCT00948896|515560635|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
143006139|NCT00948896|515560628|FG000|24 Months of Age to 36 Months of Age|Death|0|||
143006140|NCT00948896|515560629|FG001|24 Months of Age to 36 Months of Age|Death|2|||
143006141|NCT00948896|515560630|FG002|24 Months of Age to 36 Months of Age|Death|2|||
143006142|NCT00948896|515560631|FG003|24 Months of Age to 36 Months of Age|Death|0|||
143006143|NCT00948896|515560632|FG004|24 Months of Age to 36 Months of Age|Death|0|||
143006144|NCT00948896|515560633|FG005|24 Months of Age to 36 Months of Age|Death|1|||
143006145|NCT00948896|515560634|FG006|24 Months of Age to 36 Months of Age|Death|0|||
143006146|NCT00948896|515560635|FG007|24 Months of Age to 36 Months of Age|Death|0|||
143006147|NCT00948896|515560628|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
143006148|NCT00948896|515560629|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
143006149|NCT00948896|515560630|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
143006150|NCT00948896|515560631|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
143006151|NCT00948896|515560632|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
143006152|NCT00948896|515560633|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
143006153|NCT00948896|515560634|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
143006154|NCT00948896|515560635|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
143006155|NCT00948896|515560628|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
143006156|NCT00948896|515560629|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
143006157|NCT00948896|515560630|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
143006158|NCT00948896|515560631|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
143006159|NCT00948896|515560632|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
143006160|NCT00948896|515560633|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
143006161|NCT00948896|515560634|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
143006162|NCT00948896|515560635|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
143006163|NCT00948896|515560628|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
143006164|NCT00948896|515560629|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
143006165|NCT00948896|515560630|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
143006166|NCT00948896|515560631|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
143006167|NCT00948896|515560632|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
143006168|NCT00948896|515560633|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
143006169|NCT00948896|515560634|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
143006170|NCT00948896|515560635|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
143006171|NCT00948896|515560628|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
143006172|NCT00948896|515560629|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
143006173|NCT00948896|515560630|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
143006174|NCT00948896|515560631|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
143006175|NCT00948896|515560632|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
143006176|NCT00948896|515560633|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
143006177|NCT00948896|515560634|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
143006178|NCT00948896|515560635|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
143006179|NCT03795233|515560636|FG000|Overall Study|Withdrawal by Subject|2|||
143006180|NCT03795233|515560637|FG001|Overall Study|Withdrawal by Subject|1|||
143006181|NCT03795233|515560636|FG000|Overall Study|Lost to Follow-up|1|||
143006182|NCT03795233|515560637|FG001|Overall Study|Lost to Follow-up|0|||
143006183|NCT03795233|515560636|FG000|Overall Study|Death|1|||
143006184|NCT03795233|515560637|FG001|Overall Study|Death|0|||
143006185|NCT05403502|515560638|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
143006186|NCT05403502|515560638|FG000|Humalog Lead-In Period|Physician Decision|2|||
143006187|NCT05403502|515560638|FG000|Humalog Lead-In Period|Protocol Violation|1|||
143006188|NCT05403502|515560638|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
143006189|NCT05403502|515560638|FG000|Lyumjev Treatment Period|Physician Decision|2|||
143006190|NCT01054443|515560639|FG000|Overall Study|Withdrawal by Subject|0|||
143006191|NCT01054443|515560640|FG001|Overall Study|Withdrawal by Subject|0|||
143006192|NCT01054443|515560641|FG002|Overall Study|Withdrawal by Subject|0|||
143006193|NCT01054443|515560642|FG003|Overall Study|Withdrawal by Subject|1|||
143006194|NCT00985114|515560643|FG000|Overall Study|Adverse Event|1|||
143006195|NCT00985114|515560644|FG001|Overall Study|Adverse Event|0|||
143006196|NCT00985114|515560643|FG000|Overall Study|Withdrawal by Subject|0|||
143006197|NCT00985114|515560644|FG001|Overall Study|Withdrawal by Subject|2|||
143006198|NCT02950831|515560645|FG000|Overall Study|Lost to Follow-up|1|||
143006199|NCT02950831|515560645|FG000|Overall Study|Withdrawal by Subject|3|||
143006200|NCT02950831|515560645|FG000|Overall Study|stimulation trail failure|5|||
143006201|NCT03145207|515560651|FG000|Overall Study|volunteer started taking allergy shots|1|||
143006202|NCT03145207|515560651|FG000|Overall Study|baseline blood pressure high|1|||
143006203|NCT00563706|515562908|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
143006204|NCT00563706|515562909|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
143006205|NCT00563706|515562910|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
143006206|NCT00563706|515562911|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
143006207|NCT00563706|515562912|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
143006208|NCT00563706|515562913|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
143006209|NCT00563706|515562914|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
143006210|NCT00563706|515562915|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
143006211|NCT00563706|515562916|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
143006212|NCT00563706|515562908|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
143006213|NCT00563706|515562909|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
143006214|NCT00563706|515562910|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
143006215|NCT00563706|515562911|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
143006216|NCT00563706|515562912|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
143006217|NCT00563706|515562913|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
143006218|NCT00563706|515562914|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
143006219|NCT00563706|515562915|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
143006220|NCT00563706|515562916|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
143006221|NCT00563706|515562908|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
143006222|NCT00563706|515562909|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
143006223|NCT00563706|515562910|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
143006224|NCT00563706|515562911|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
143006225|NCT00563706|515562912|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
143006226|NCT00563706|515562913|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
143006227|NCT00563706|515562914|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
143006228|NCT00563706|515562915|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
143006229|NCT00563706|515562916|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
143006230|NCT00563706|515562908|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
143006231|NCT00563706|515562909|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
143006232|NCT00563706|515562910|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
143006233|NCT00563706|515562911|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
143006234|NCT00563706|515562912|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
143006235|NCT00563706|515562913|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
143006236|NCT00563706|515562914|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
143006237|NCT00563706|515562915|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
143006238|NCT00563706|515562916|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
143006239|NCT00563706|515562908|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
143006240|NCT00563706|515562909|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
143259628|NCT01226121|516505811|FG002|Overall Study|Lost to Follow-up|1|||
143457542|NCT01029652|517219312|FG001|Core Study (0-12 Weeks)|Death|1|||
143457543|NCT01029652|517219311|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
143457544|NCT01029652|517219312|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
143457545|NCT01029652|517219311|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
143457546|NCT01029652|517219312|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
143457547|NCT01029652|517219311|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
143457548|NCT01029652|517219312|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
143457549|NCT01029652|517219311|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
143457550|NCT01029652|517219312|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
143457551|NCT01029652|517219311|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
143457552|NCT01029652|517219312|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
143457553|NCT01029652|517219311|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
143457554|NCT01029652|517219312|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
143457555|NCT01029652|517219311|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
143457556|NCT01029652|517219312|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
143457557|NCT02313233|517219313|FG000|Overall Study|Withdrawal by Subject|1|||
143457558|NCT02313233|517219314|FG001|Overall Study|Withdrawal by Subject|2|||
143457559|NCT02313233|517219313|FG000|Overall Study|Administrative reason|1|||
143457560|NCT02313233|517219314|FG001|Overall Study|Administrative reason|1|||
143457561|NCT02095951|517219315|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
143457562|NCT02095951|517219316|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
143457563|NCT04638920|517219317|FG000|Overall Study|Withdrawal by Subject|5|||
143457564|NCT05383508|517219318|FG000|Overall Study|Withdrawal by Subject|1|||
143457565|NCT05383508|517219319|FG001|Overall Study|Withdrawal by Subject|0|||
143457566|NCT05383508|517219320|FG002|Overall Study|Withdrawal by Subject|1|||
143457567|NCT05383508|517219321|FG003|Overall Study|Withdrawal by Subject|1|||
143457568|NCT05383508|517219322|FG004|Overall Study|Withdrawal by Subject|2|||
143457569|NCT05383508|517219323|FG005|Overall Study|Withdrawal by Subject|0|||
143457570|NCT03775434|517219325|FG000|Overall Study|Adverse Event|2|||
143457571|NCT03775434|517219325|FG000|Overall Study|Withdrawal by Subject|1|||
143457572|NCT01621568|517219326|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
143457573|NCT01621568|517219327|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
143457574|NCT01621568|517219326|FG000|Week 5-6 No Treatment|Death|1|||
143457575|NCT01621568|517219327|FG001|Week 5-6 No Treatment|Death|0|||
143457576|NCT01859988|517219328|FG000|Overall Study|Withdrawal by Subject|6|||
143457577|NCT01859988|517219329|FG001|Overall Study|Withdrawal by Subject|3|||
143457578|NCT01859988|517219330|FG002|Overall Study|Withdrawal by Subject|4|||
143457579|NCT01859988|517219331|FG003|Overall Study|Withdrawal by Subject|3|||
143457580|NCT01859988|517219332|FG004|Overall Study|Withdrawal by Subject|2|||
143457581|NCT01859988|517219333|FG005|Overall Study|Withdrawal by Subject|2|||
143457582|NCT01859988|517219328|FG000|Overall Study|Lack of Efficacy|1|||
143457583|NCT01859988|517219329|FG001|Overall Study|Lack of Efficacy|1|||
143457584|NCT01859988|517219330|FG002|Overall Study|Lack of Efficacy|5|||
143457585|NCT01859988|517219331|FG003|Overall Study|Lack of Efficacy|0|||
143457586|NCT01859988|517219332|FG004|Overall Study|Lack of Efficacy|7|||
143457587|NCT01859988|517219333|FG005|Overall Study|Lack of Efficacy|9|||
143457588|NCT01859988|517219328|FG000|Overall Study|Physician Decision|1|||
143457589|NCT01859988|517219329|FG001|Overall Study|Physician Decision|3|||
143457590|NCT01859988|517219330|FG002|Overall Study|Physician Decision|1|||
143457591|NCT01859988|517219331|FG003|Overall Study|Physician Decision|3|||
143457592|NCT01859988|517219332|FG004|Overall Study|Physician Decision|4|||
143457593|NCT01859988|517219333|FG005|Overall Study|Physician Decision|1|||
143457594|NCT01859988|517219328|FG000|Overall Study|Adverse Event|2|||
143457595|NCT01859988|517219329|FG001|Overall Study|Adverse Event|1|||
143457596|NCT01859988|517219330|FG002|Overall Study|Adverse Event|3|||
143457597|NCT01859988|517219331|FG003|Overall Study|Adverse Event|1|||
143457598|NCT01859988|517219332|FG004|Overall Study|Adverse Event|2|||
143457599|NCT01859988|517219333|FG005|Overall Study|Adverse Event|2|||
143457600|NCT01859988|517219328|FG000|Overall Study|Lost to Follow-up|1|||
143457601|NCT01859988|517219329|FG001|Overall Study|Lost to Follow-up|2|||
143457602|NCT01859988|517219330|FG002|Overall Study|Lost to Follow-up|3|||
143457603|NCT01859988|517219331|FG003|Overall Study|Lost to Follow-up|0|||
143457604|NCT01859988|517219332|FG004|Overall Study|Lost to Follow-up|3|||
143457605|NCT01859988|517219333|FG005|Overall Study|Lost to Follow-up|2|||
143457606|NCT01859988|517219328|FG000|Overall Study|Protocol Violation|0|||
143457607|NCT01859988|517219329|FG001|Overall Study|Protocol Violation|0|||
143457608|NCT01859988|517219330|FG002|Overall Study|Protocol Violation|1|||
143457609|NCT01859988|517219331|FG003|Overall Study|Protocol Violation|0|||
143457610|NCT01859988|517219332|FG004|Overall Study|Protocol Violation|0|||
143457611|NCT01859988|517219333|FG005|Overall Study|Protocol Violation|0|||
143457612|NCT01859988|517219328|FG000|Overall Study|Other than specified above|0|||
143457613|NCT01859988|517219329|FG001|Overall Study|Other than specified above|2|||
143457614|NCT01859988|517219330|FG002|Overall Study|Other than specified above|11|||
143457615|NCT01859988|517219331|FG003|Overall Study|Other than specified above|3|||
143457616|NCT01859988|517219332|FG004|Overall Study|Other than specified above|5|||
143457617|NCT01859988|517219333|FG005|Overall Study|Other than specified above|3|||
143457618|NCT02081417|517219336|FG000|Overall Study|Lost to Follow-up|26|||
143457619|NCT02081417|517219337|FG001|Overall Study|Lost to Follow-up|23|||
143457620|NCT02081417|517219336|FG000|Overall Study|Moved Away|1|||
143457621|NCT02081417|517219337|FG001|Overall Study|Moved Away|2|||
143457622|NCT02081417|517219336|FG000|Overall Study|Incarcerated|2|||
143457623|NCT02081417|517219337|FG001|Overall Study|Incarcerated|2|||
143457624|NCT02081417|517219336|FG000|Overall Study|Death|4|||
143457625|NCT02081417|517219337|FG001|Overall Study|Death|3|||
143457626|NCT02081417|517219336|FG000|Overall Study|Withdrawal by Subject|4|||
143006241|NCT00563706|515562910|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
143457627|NCT02081417|517219337|FG001|Overall Study|Withdrawal by Subject|0|||
143457628|NCT02081417|517219336|FG000|Overall Study|Admitted to Residential Treatment|2|||
143457629|NCT02081417|517219337|FG001|Overall Study|Admitted to Residential Treatment|0|||
143457630|NCT02081417|517219336|FG000|Overall Study|Did not start treatment|17|||
143457631|NCT02081417|517219337|FG001|Overall Study|Did not start treatment|21|||
143457632|NCT01157676|517219341|FG000|Randomization|Death|1|||
143457633|NCT01157676|517219342|FG001|Randomization|Death|1|||
143457634|NCT01157676|517219341|FG000|Randomization|unresectable|2|||
143457635|NCT01157676|517219342|FG001|Randomization|unresectable|3|||
143457636|NCT01157676|517219341|FG000|Randomization|Withdrawal by Subject|17|||
143457637|NCT01157676|517219342|FG001|Randomization|Withdrawal by Subject|13|||
143457638|NCT01157676|517219341|FG000|Randomization|Physician Decision|1|||
143457639|NCT01157676|517219342|FG001|Randomization|Physician Decision|0|||
143457640|NCT01157676|517219341|FG000|Surgery|underwent open cystectomy|0|||
143457641|NCT01157676|517219342|FG001|Surgery|underwent open cystectomy|4|||
143457642|NCT01157676|517219341|FG000|Surgery|converted to open procedure|0|||
143457643|NCT01157676|517219342|FG001|Surgery|converted to open procedure|5|||
143457644|NCT01157676|517219341|FG000|Surgery|underwent robotic cystectomy|1|||
143457645|NCT01157676|517219342|FG001|Surgery|underwent robotic cystectomy|0|||
143457646|NCT00682890|517219343|FG000|Overall Study|Lost to Follow-up|1|||
143457647|NCT00682890|517219344|FG001|Overall Study|Lost to Follow-up|1|||
143457648|NCT00682890|517219343|FG000|Overall Study|subject moved away|0|||
143457649|NCT00682890|517219344|FG001|Overall Study|subject moved away|1|||
143457650|NCT00682890|517219343|FG000|Overall Study|heavy menstrual bleeding|1|||
143457651|NCT00682890|517219344|FG001|Overall Study|heavy menstrual bleeding|0|||
143457652|NCT00938860|517219352|FG000|Overall Study|Adverse Event|2|||
143457653|NCT00938860|517219353|FG001|Overall Study|Adverse Event|1|||
143457654|NCT00938860|517219352|FG000|Overall Study|Abnormal laboratory values|2|||
143457655|NCT00938860|517219353|FG001|Overall Study|Abnormal laboratory values|2|||
143457656|NCT00938860|517219352|FG000|Overall Study|Withdrawal by Subject|11|||
143457657|NCT00938860|517219353|FG001|Overall Study|Withdrawal by Subject|8|||
143457658|NCT00938860|517219352|FG000|Overall Study|Lost to Follow-up|4|||
143457659|NCT00938860|517219353|FG001|Overall Study|Lost to Follow-up|4|||
143457660|NCT00938860|517219352|FG000|Overall Study|Administration problems|2|||
143457661|NCT00938860|517219353|FG001|Overall Study|Administration problems|0|||
143457662|NCT00938860|517219352|FG000|Overall Study|Death|1|||
143457663|NCT00938860|517219353|FG001|Overall Study|Death|1|||
143457664|NCT00938860|517219352|FG000|Overall Study|Protocol Violation|3|||
143457665|NCT00938860|517219353|FG001|Overall Study|Protocol Violation|1|||
143457666|NCT01605019|517219354|FG000|Overall Study|pt did not meet transplant endpoint|3|||
143457667|NCT01605019|517219355|FG001|Overall Study|pt did not meet transplant endpoint|0|||
143457668|NCT00468559|517219356|FG000|Open-label Treatment Phase|Adverse Event|5|||
143457669|NCT00468559|517219357|FG001|Open-label Treatment Phase|Adverse Event|0|||
143457670|NCT00468559|517219358|FG002|Open-label Treatment Phase|Adverse Event|0|||
143457671|NCT00468559|517219356|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
143457672|NCT00468559|517219357|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
143457673|NCT00468559|517219358|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
143457674|NCT00468559|517219356|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
143457675|NCT00468559|517219357|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
143457676|NCT00468559|517219358|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
143457677|NCT00468559|517219356|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
143457678|NCT00468559|517219357|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
143457679|NCT00468559|517219358|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
143457680|NCT00468559|517219356|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
143457681|NCT00468559|517219357|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
143457682|NCT00468559|517219358|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
143457683|NCT00324116|517219359|FG000|Overall Study|Adverse Event|5|||
143457684|NCT00324116|517219359|FG000|Overall Study|Lack of Efficacy|17|||
143457685|NCT00324116|517219359|FG000|Overall Study|Withdrawal by Subject|5|||
143457686|NCT00324116|517219359|FG000|Overall Study|Other|5|||
143457687|NCT01153958|517219360|FG000|Overall Study|Study Terminated|36|||
143457688|NCT01153958|517219361|FG001|Overall Study|Study Terminated|32|||
143457689|NCT02971761|517219363|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
143457690|NCT02624791|517219364|FG000|Overall Study|Withdrawal by Subject|2|||
143457691|NCT02624791|517219365|FG001|Overall Study|Withdrawal by Subject|0|||
143457692|NCT02624791|517219366|FG002|Overall Study|Withdrawal by Subject|0|||
143457693|NCT02624791|517219367|FG003|Overall Study|Withdrawal by Subject|0|||
143457694|NCT02624791|517219368|FG004|Overall Study|Withdrawal by Subject|0|||
143457695|NCT02624791|517219369|FG005|Overall Study|Withdrawal by Subject|0|||
143457696|NCT01034163|517219370|FG000|Overall Study|Treatment completed as per protocol|8|||
143457697|NCT01034163|517219371|FG001|Overall Study|Treatment completed as per protocol|7|||
143457698|NCT01034163|517219370|FG000|Overall Study|Withdrawal by Subject|8|||
143457699|NCT01034163|517219371|FG001|Overall Study|Withdrawal by Subject|2|||
143457700|NCT01034163|517219370|FG000|Overall Study|Protocol deviation|1|||
143457701|NCT01034163|517219371|FG001|Overall Study|Protocol deviation|0|||
143457702|NCT01034163|517219370|FG000|Overall Study|Disease progression|3|||
143457703|NCT01034163|517219371|FG001|Overall Study|Disease progression|4|||
143457704|NCT01034163|517219370|FG000|Overall Study|Adverse Event|6|||
143457705|NCT01034163|517219371|FG001|Overall Study|Adverse Event|0|||
143457706|NCT01034163|517219370|FG000|Overall Study|Administrative problems|0|||
143457707|NCT01034163|517219371|FG001|Overall Study|Administrative problems|1|||
143457708|NCT01034163|517219370|FG000|Overall Study|Abnormal laboratory value|1|||
143457709|NCT01034163|517219371|FG001|Overall Study|Abnormal laboratory value|0|||
143457710|NCT01642251|517219372|FG000|Overall Study|Progressive disease|0|||
143457711|NCT01642251|517219373|FG001|Overall Study|Progressive disease|0|||
143457712|NCT01642251|517219374|FG002|Overall Study|Progressive disease|3|||
143457713|NCT01642251|517219375|FG003|Overall Study|Progressive disease|3|||
143457714|NCT01642251|517219372|FG000|Overall Study|Adverse Event|0|||
143457715|NCT01642251|517219373|FG001|Overall Study|Adverse Event|0|||
143457716|NCT01642251|517219374|FG002|Overall Study|Adverse Event|5|||
143457717|NCT01642251|517219375|FG003|Overall Study|Adverse Event|4|||
143457718|NCT01642251|517219372|FG000|Overall Study|Death|0|||
143457719|NCT01642251|517219373|FG001|Overall Study|Death|0|||
143457720|NCT01642251|517219374|FG002|Overall Study|Death|1|||
143457721|NCT01642251|517219375|FG003|Overall Study|Death|3|||
143457722|NCT01642251|517219372|FG000|Overall Study|Withdrawal by Subject|0|||
143457723|NCT01642251|517219373|FG001|Overall Study|Withdrawal by Subject|0|||
143457724|NCT01642251|517219374|FG002|Overall Study|Withdrawal by Subject|1|||
143457725|NCT01642251|517219375|FG003|Overall Study|Withdrawal by Subject|3|||
143457726|NCT01642251|517219372|FG000|Overall Study|Alternative therapy|0|||
143457727|NCT01642251|517219373|FG001|Overall Study|Alternative therapy|0|||
143457728|NCT01642251|517219374|FG002|Overall Study|Alternative therapy|0|||
143457729|NCT01642251|517219375|FG003|Overall Study|Alternative therapy|2|||
143457730|NCT01642251|517219372|FG000|Overall Study|Other complicating disease|0|||
143457731|NCT01642251|517219373|FG001|Overall Study|Other complicating disease|0|||
143006242|NCT00563706|515562911|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
143006243|NCT00563706|515562912|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
143117924|NCT03597022|515974215|FG000|Overall Study|Premature termination of the study|7|||
143117925|NCT03597022|515974216|FG001|Overall Study|Premature termination of the study|7|||
143117926|NCT03597022|515974217|FG002|Overall Study|Premature termination of the study|8|||
143117927|NCT03597022|515974215|FG000|Overall Study|Serious adverse event|1|||
143006244|NCT00563706|515562913|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
143117928|NCT03597022|515974216|FG001|Overall Study|Serious adverse event|1|||
143117929|NCT03597022|515974217|FG002|Overall Study|Serious adverse event|0|||
143006245|NCT00563706|515562914|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
143006246|NCT00563706|515562915|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
143006247|NCT00563706|515562916|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
143006248|NCT03280628|515562919|FG000|Overall Study|Lost to Follow-up|8|||
143006249|NCT03280628|515562920|FG001|Overall Study|Lost to Follow-up|6|||
143006250|NCT03280628|515562921|FG002|Overall Study|Lost to Follow-up|11|||
143006251|NCT01361308|515562924|FG000|Overall Study|Withdrawal by Subject|9|||
143006252|NCT01361308|515562925|FG001|Overall Study|Withdrawal by Subject|13|||
143006253|NCT01361308|515562924|FG000|Overall Study|Physician Decision|3|||
143006254|NCT01361308|515562925|FG001|Overall Study|Physician Decision|3|||
143006255|NCT01361308|515562924|FG000|Overall Study|Lack of Efficacy|2|||
143006256|NCT01361308|515562925|FG001|Overall Study|Lack of Efficacy|0|||
143006257|NCT01361308|515562924|FG000|Overall Study|Protocol Violation|1|||
143006258|NCT01361308|515562925|FG001|Overall Study|Protocol Violation|0|||
143006259|NCT01361308|515562924|FG000|Overall Study|Lost to Follow-up|5|||
143006260|NCT01361308|515562925|FG001|Overall Study|Lost to Follow-up|4|||
143006261|NCT01361308|515562924|FG000|Overall Study|Adverse Event|8|||
143006262|NCT01361308|515562925|FG001|Overall Study|Adverse Event|4|||
143006263|NCT01361308|515562924|FG000|Overall Study|Eligibility Criteria Not Met|2|||
143006264|NCT01361308|515562925|FG001|Overall Study|Eligibility Criteria Not Met|3|||
143117930|NCT00312572|515974218|FG000|Overall Study|Adverse Event|10|||
143117931|NCT00312572|515974219|FG001|Overall Study|Adverse Event|16|||
143117932|NCT00312572|515974218|FG000|Overall Study|Lost to Follow-up|1|||
143117933|NCT00312572|515974219|FG001|Overall Study|Lost to Follow-up|1|||
143117934|NCT00312572|515974218|FG000|Overall Study|Administrative|4|||
143117935|NCT00312572|515974219|FG001|Overall Study|Administrative|2|||
143117936|NCT00312572|515974218|FG000|Overall Study|Lack of Efficacy|1|||
143457732|NCT01642251|517219374|FG002|Overall Study|Other complicating disease|1|||
143457733|NCT01642251|517219375|FG003|Overall Study|Other complicating disease|0|||
143457734|NCT01642251|517219372|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
143457735|NCT01642251|517219373|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
143457736|NCT01642251|517219374|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
143457737|NCT01642251|517219375|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
143457738|NCT01465347|517219378|FG000|Overall Study|Withdrawal by Subject|1|||
143457739|NCT01465347|517219379|FG001|Overall Study|Withdrawal by Subject|1|||
143457740|NCT01465347|517219378|FG000|Overall Study|Physician Decision|0|||
143457741|NCT01465347|517219379|FG001|Overall Study|Physician Decision|1|||
143006265|NCT01361308|515562924|FG000|Overall Study|Failed C-SSRS|5|||
143006266|NCT01361308|515562925|FG001|Overall Study|Failed C-SSRS|2|||
143006267|NCT01361308|515562924|FG000|Overall Study|Other|0|||
143006268|NCT01361308|515562925|FG001|Overall Study|Other|1|||
143006269|NCT03433482|515562934|FG000|Overall Study|Lost to Follow-up|1|||
143006270|NCT03433482|515562935|FG001|Overall Study|Lost to Follow-up|0|||
143006271|NCT03433482|515562936|FG002|Overall Study|Lost to Follow-up|1|||
143117937|NCT00312572|515974219|FG001|Overall Study|Lack of Efficacy|2|||
143117938|NCT00553358|515974224|FG000|Overall Study|Randomized but did not receive treatment|3|||
143117939|NCT00553358|515974225|FG001|Overall Study|Randomized but did not receive treatment|3|||
143117940|NCT00553358|515974226|FG002|Overall Study|Randomized but did not receive treatment|1|||
143117941|NCT00553358|515974224|FG000|Overall Study|Lost to Follow-up|22|||
143117942|NCT00553358|515974225|FG001|Overall Study|Lost to Follow-up|26|||
143117943|NCT00553358|515974226|FG002|Overall Study|Lost to Follow-up|18|||
143117944|NCT00553358|515974224|FG000|Overall Study|Withdrew completely|23|||
143117945|NCT00553358|515974225|FG001|Overall Study|Withdrew completely|33|||
143117946|NCT00553358|515974226|FG002|Overall Study|Withdrew completely|34|||
143117947|NCT00553358|515974224|FG000|Overall Study|Died during clinical follow-up|25|||
143117948|NCT00553358|515974225|FG001|Overall Study|Died during clinical follow-up|29|||
143117949|NCT00553358|515974226|FG002|Overall Study|Died during clinical follow-up|32|||
143117950|NCT00553358|515974224|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
143117951|NCT00553358|515974225|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
143117952|NCT00553358|515974226|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
143117953|NCT00553358|515974224|FG000|Overall Study|Died after clinical follow-up ended|1|||
143117954|NCT00553358|515974225|FG001|Overall Study|Died after clinical follow-up ended|2|||
143117955|NCT00553358|515974226|FG002|Overall Study|Died after clinical follow-up ended|0|||
143006272|NCT03433482|515562937|FG003|Overall Study|Lost to Follow-up|1|||
143006273|NCT03433482|515562934|FG000|Overall Study|Withdrawal by Subject|0|||
143006274|NCT03433482|515562935|FG001|Overall Study|Withdrawal by Subject|0|||
143006275|NCT03433482|515562936|FG002|Overall Study|Withdrawal by Subject|1|||
143006276|NCT03433482|515562937|FG003|Overall Study|Withdrawal by Subject|0|||
143006277|NCT03433482|515562934|FG000|Overall Study|Unknown reason|0|||
143006278|NCT03433482|515562935|FG001|Overall Study|Unknown reason|0|||
143006279|NCT03433482|515562936|FG002|Overall Study|Unknown reason|2|||
143006280|NCT03433482|515562937|FG003|Overall Study|Unknown reason|0|||
143006281|NCT01519635|515562938|FG000|Overall Study|Withdrawal by Subject|0|||
143006282|NCT01519635|515562939|FG001|Overall Study|Withdrawal by Subject|1|||
143006283|NCT01519635|515562938|FG000|Overall Study|No possibility to put a catheter|1|||
143006284|NCT01519635|515562939|FG001|Overall Study|No possibility to put a catheter|2|||
143006285|NCT02325414|515562940|FG000|Overall Study|Withdrawal by Subject|3|||
143006286|NCT02325414|515562941|FG001|Overall Study|Withdrawal by Subject|1|||
143006287|NCT02325414|515562940|FG000|Overall Study|Lost to Follow-up|5|||
143006288|NCT02325414|515562941|FG001|Overall Study|Lost to Follow-up|5|||
143006289|NCT00347776|515562942|FG000|1.5 Month Follow-up|Death|2|||
143006290|NCT00347776|515562943|FG001|1.5 Month Follow-up|Death|0|||
143006291|NCT00347776|515562944|FG002|1.5 Month Follow-up|Death|0|||
143006292|NCT00347776|515562942|FG000|1.5 Month Follow-up|reached the endpoint|12|||
143006293|NCT00347776|515562943|FG001|1.5 Month Follow-up|reached the endpoint|8|||
143006294|NCT00347776|515562944|FG002|1.5 Month Follow-up|reached the endpoint|12|||
143006295|NCT00347776|515562942|FG000|6 Month Follow-up|Death|2|||
143006296|NCT00347776|515562943|FG001|6 Month Follow-up|Death|1|||
143006297|NCT00347776|515562944|FG002|6 Month Follow-up|Death|3|||
143006298|NCT00347776|515562942|FG000|6 Month Follow-up|reached endpont|20|||
143006299|NCT00347776|515562943|FG001|6 Month Follow-up|reached endpont|12|||
143006300|NCT00347776|515562944|FG002|6 Month Follow-up|reached endpont|15|||
143006301|NCT00347776|515562942|FG000|12 Month Follow-up|Lost to Follow-up|7|||
143006302|NCT00347776|515562943|FG001|12 Month Follow-up|Lost to Follow-up|6|||
143006303|NCT00347776|515562944|FG002|12 Month Follow-up|Lost to Follow-up|6|||
143006304|NCT00347776|515562942|FG000|12 Month Follow-up|Death|3|||
143006305|NCT00347776|515562943|FG001|12 Month Follow-up|Death|4|||
143006306|NCT00347776|515562944|FG002|12 Month Follow-up|Death|4|||
143006307|NCT00347776|515562942|FG000|12 Month Follow-up|Reached endpoint|13|||
143006308|NCT00347776|515562943|FG001|12 Month Follow-up|Reached endpoint|6|||
143006309|NCT00347776|515562944|FG002|12 Month Follow-up|Reached endpoint|9|||
143006310|NCT00968539|515562945|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
143006311|NCT00968539|515562946|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
143006312|NCT00457249|515562947|FG000|Overall Study|Lost to Follow-up|3|||
143006313|NCT00457249|515562948|FG001|Overall Study|Lost to Follow-up|0|||
143006314|NCT00457249|515562947|FG000|Overall Study|Protocol Violation|4|||
143006315|NCT00457249|515562948|FG001|Overall Study|Protocol Violation|1|||
143006316|NCT00457249|515562947|FG000|Overall Study|Withdrawal by Subject|3|||
143006317|NCT00457249|515562948|FG001|Overall Study|Withdrawal by Subject|1|||
143006318|NCT00457249|515562947|FG000|Overall Study|Serious Adverse Events|2|||
143006319|NCT00457249|515562948|FG001|Overall Study|Serious Adverse Events|0|||
143006320|NCT00326118|515562949|FG000|Active Phase|Withdrawal by Subject|4|||
143006321|NCT00326118|515562950|FG001|Active Phase|Withdrawal by Subject|1|||
143006322|NCT00938392|515562951|FG000|Overall Study|Adverse Event|0|||
143006323|NCT00938392|515562952|FG001|Overall Study|Adverse Event|1|||
143006324|NCT00938392|515562951|FG000|Overall Study|Withdrawal by Subject|0|||
143006325|NCT00938392|515562952|FG001|Overall Study|Withdrawal by Subject|1|||
143006326|NCT00938392|515562951|FG000|Overall Study|Lost to Follow-up|2|||
143006327|NCT00938392|515562952|FG001|Overall Study|Lost to Follow-up|2|||
143006328|NCT02916056|515562953|FG000|Overall Study|Adverse Event|6|||
143006329|NCT02916056|515562953|FG000|Overall Study|Lost to Follow-up|1|||
143006330|NCT02916056|515562953|FG000|Overall Study|Other|12|||
143006331|NCT02916056|515562953|FG000|Overall Study|Protocol Violation|1|||
143006332|NCT02916056|515562953|FG000|Overall Study|Withdrawal by Subject|8|||
143006333|NCT02916056|515562953|FG000|Overall Study|Study Terminated by Sponsor|269|||
143006334|NCT00124709|515562954|FG000|Overall Study|Randomized but did not take medication|3|||
143006335|NCT00124709|515562955|FG001|Overall Study|Randomized but did not take medication|1|||
143006336|NCT00124709|515562954|FG000|Overall Study|Adverse Event|3|||
143006337|NCT00124709|515562955|FG001|Overall Study|Adverse Event|0|||
143006338|NCT00124709|515562954|FG000|Overall Study|Lack of Efficacy|5|||
143006339|NCT00124709|515562955|FG001|Overall Study|Lack of Efficacy|10|||
143006340|NCT00124709|515562954|FG000|Overall Study|Protocol Violation|3|||
143006341|NCT00124709|515562955|FG001|Overall Study|Protocol Violation|5|||
143006342|NCT00124709|515562954|FG000|Overall Study|Withdrawal by Subject|127|||
143006343|NCT00124709|515562955|FG001|Overall Study|Withdrawal by Subject|136|||
143006344|NCT00124709|515562954|FG000|Overall Study|Lost to Follow-up|114|||
143006345|NCT00124709|515562955|FG001|Overall Study|Lost to Follow-up|120|||
143006346|NCT00122954|515562956|FG000|Overall Study|Withdrawal by Subject|2|||
143006347|NCT00122954|515562957|FG001|Overall Study|Withdrawal by Subject|2|||
143006348|NCT00122954|515562956|FG000|Overall Study|Protocol Violation|0|||
143006349|NCT00122954|515562957|FG001|Overall Study|Protocol Violation|1|||
143006350|NCT04341727|515562967|FG000|Overall Study|Withdrawal by Subject|0|||
143006351|NCT04341727|515562968|FG001|Overall Study|Withdrawal by Subject|0|||
143006352|NCT04341727|515562969|FG002|Overall Study|Withdrawal by Subject|1|||
143006353|NCT04341727|515562970|FG003|Overall Study|Withdrawal by Subject|0|||
143006354|NCT04341727|515562967|FG000|Overall Study|Lost to Follow-up|0|||
143006355|NCT04341727|515562968|FG001|Overall Study|Lost to Follow-up|0|||
143006356|NCT04341727|515562969|FG002|Overall Study|Lost to Follow-up|0|||
143006357|NCT04341727|515562970|FG003|Overall Study|Lost to Follow-up|1|||
143006358|NCT05993299|515562972|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
143006359|NCT05993299|515562972|FG000|Overall Study|Ongoing|4|||
143006360|NCT05644756|515562973|FG000|Aim 1 Activities (Ethnography)|Withdrawal by Subject|1|||
143006361|NCT05644756|515562973|FG000|Aim 2 Activities (Fidelity to MBC)|Lost to Follow-up|5|||
143006362|NCT03110107|515562974|FG000|Treatment Period|Disease Progression|3|||
143006363|NCT03110107|515562975|FG001|Treatment Period|Disease Progression|9|||
143006364|NCT03110107|515562976|FG002|Treatment Period|Disease Progression|8|||
143006365|NCT03110107|515562977|FG003|Treatment Period|Disease Progression|11|||
143006366|NCT03110107|515562978|FG004|Treatment Period|Disease Progression|8|||
143006367|NCT03110107|515562979|FG005|Treatment Period|Disease Progression|4|||
143006368|NCT03110107|515562980|FG006|Treatment Period|Disease Progression|6|||
143006369|NCT03110107|515562981|FG007|Treatment Period|Disease Progression|7|||
143006370|NCT03110107|515562982|FG008|Treatment Period|Disease Progression|2|||
143006371|NCT03110107|515562983|FG009|Treatment Period|Disease Progression|10|||
143006372|NCT03110107|515562984|FG010|Treatment Period|Disease Progression|5|||
143006373|NCT03110107|515562985|FG011|Treatment Period|Disease Progression|2|||
143006374|NCT03110107|515562986|FG012|Treatment Period|Disease Progression|0|||
143006375|NCT03110107|515562987|FG013|Treatment Period|Disease Progression|5|||
143006376|NCT03110107|515562988|FG014|Treatment Period|Disease Progression|14|||
143006377|NCT03110107|515562989|FG015|Treatment Period|Disease Progression|14|||
143006378|NCT03110107|515562990|FG016|Treatment Period|Disease Progression|4|||
143006379|NCT03110107|515562991|FG017|Treatment Period|Disease Progression|3|||
143006380|NCT03110107|515562992|FG018|Treatment Period|Disease Progression|16|||
143006381|NCT03110107|515562993|FG019|Treatment Period|Disease Progression|14|||
143006382|NCT03110107|515562994|FG020|Treatment Period|Disease Progression|12|||
143006383|NCT03110107|515562995|FG021|Treatment Period|Disease Progression|16|||
143006384|NCT03110107|515562996|FG022|Treatment Period|Disease Progression|18|||
143006385|NCT03110107|515562997|FG023|Treatment Period|Disease Progression|13|||
143006386|NCT03110107|515562998|FG024|Treatment Period|Disease Progression|16|||
143006387|NCT03110107|515562999|FG025|Treatment Period|Disease Progression|31|||
143006388|NCT03110107|515562974|FG000|Treatment Period|Study drug toxicity|1|||
143006389|NCT03110107|515562975|FG001|Treatment Period|Study drug toxicity|0|||
143006390|NCT03110107|515562976|FG002|Treatment Period|Study drug toxicity|1|||
143006391|NCT03110107|515562977|FG003|Treatment Period|Study drug toxicity|2|||
143006392|NCT03110107|515562978|FG004|Treatment Period|Study drug toxicity|0|||
143006393|NCT03110107|515562979|FG005|Treatment Period|Study drug toxicity|3|||
143006394|NCT03110107|515562980|FG006|Treatment Period|Study drug toxicity|1|||
143006395|NCT03110107|515562981|FG007|Treatment Period|Study drug toxicity|1|||
143006396|NCT03110107|515562982|FG008|Treatment Period|Study drug toxicity|3|||
143006397|NCT03110107|515562983|FG009|Treatment Period|Study drug toxicity|2|||
143006398|NCT03110107|515562984|FG010|Treatment Period|Study drug toxicity|0|||
143006399|NCT03110107|515562985|FG011|Treatment Period|Study drug toxicity|2|||
143006400|NCT03110107|515562986|FG012|Treatment Period|Study drug toxicity|0|||
143006401|NCT03110107|515562987|FG013|Treatment Period|Study drug toxicity|0|||
143006402|NCT03110107|515562988|FG014|Treatment Period|Study drug toxicity|2|||
143006403|NCT03110107|515562989|FG015|Treatment Period|Study drug toxicity|3|||
143006404|NCT03110107|515562990|FG016|Treatment Period|Study drug toxicity|3|||
143006405|NCT03110107|515562991|FG017|Treatment Period|Study drug toxicity|3|||
143006406|NCT03110107|515562992|FG018|Treatment Period|Study drug toxicity|1|||
143006407|NCT03110107|515562993|FG019|Treatment Period|Study drug toxicity|2|||
143006408|NCT03110107|515562994|FG020|Treatment Period|Study drug toxicity|2|||
143006409|NCT03110107|515562995|FG021|Treatment Period|Study drug toxicity|0|||
143006410|NCT03110107|515562996|FG022|Treatment Period|Study drug toxicity|2|||
143006411|NCT03110107|515562997|FG023|Treatment Period|Study drug toxicity|6|||
143006412|NCT03110107|515562998|FG024|Treatment Period|Study drug toxicity|7|||
143006413|NCT03110107|515562999|FG025|Treatment Period|Study drug toxicity|6|||
143006414|NCT03110107|515562974|FG000|Treatment Period|Death|0|||
143006415|NCT03110107|515562975|FG001|Treatment Period|Death|0|||
143006416|NCT03110107|515562976|FG002|Treatment Period|Death|0|||
143006417|NCT03110107|515562977|FG003|Treatment Period|Death|0|||
143006418|NCT03110107|515562978|FG004|Treatment Period|Death|0|||
143006419|NCT03110107|515562979|FG005|Treatment Period|Death|0|||
143006420|NCT03110107|515562980|FG006|Treatment Period|Death|0|||
143006421|NCT03110107|515562981|FG007|Treatment Period|Death|0|||
143006422|NCT03110107|515562982|FG008|Treatment Period|Death|0|||
143006423|NCT03110107|515562983|FG009|Treatment Period|Death|0|||
143006424|NCT03110107|515562984|FG010|Treatment Period|Death|0|||
143006425|NCT03110107|515562985|FG011|Treatment Period|Death|0|||
143006426|NCT03110107|515562986|FG012|Treatment Period|Death|1|||
143006427|NCT03110107|515562987|FG013|Treatment Period|Death|0|||
143457742|NCT01465347|517219378|FG000|Overall Study|Admitted to hospice|0|||
143457743|NCT01465347|517219379|FG001|Overall Study|Admitted to hospice|1|||
143457744|NCT02414932|517219380|FG000|Overall Study|Withdrawal by Subject|2|||
143457745|NCT02414932|517219381|FG001|Overall Study|Withdrawal by Subject|3|||
143457746|NCT02414932|517219380|FG000|Overall Study|Adverse Event|1|||
143457747|NCT02414932|517219381|FG001|Overall Study|Adverse Event|0|||
143457748|NCT02996474|517219382|FG000|Overall Study|Physician Decision|5|||
143457749|NCT04493502|517219383|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
143457750|NCT04493502|517219384|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
143457751|NCT04493502|517219383|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
143457752|NCT04493502|517219384|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
143457753|NCT04493502|517219383|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
143457754|NCT04493502|517219384|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
143457755|NCT04493502|517219383|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
143457756|NCT04493502|517219384|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
143457757|NCT04493502|517219383|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
143457758|NCT04493502|517219384|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
143457759|NCT04493502|517219383|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
143457760|NCT04493502|517219384|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
143457761|NCT04493502|517219383|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
143457762|NCT04493502|517219384|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
143457763|NCT04493502|517219383|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
143457764|NCT04493502|517219384|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
143457765|NCT04493502|517219383|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
143457766|NCT04493502|517219384|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
143457767|NCT04493502|517219383|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
143457768|NCT04493502|517219384|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
143457769|NCT04493502|517219383|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
143457770|NCT04493502|517219384|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
143457771|NCT04493502|517219383|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
143457772|NCT04493502|517219384|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
143457773|NCT04493502|517219383|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
143457774|NCT04493502|517219384|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
143457775|NCT00540046|517219385|FG000|Overall Study|Lost to Follow-up|33|||
143457776|NCT00540046|517219386|FG001|Overall Study|Lost to Follow-up|23|||
143457777|NCT02891837|517219387|FG000|Overall Study|Lost to Follow-up|2|||
143457778|NCT02891837|517219388|FG001|Overall Study|Lost to Follow-up|0|||
143006428|NCT03110107|515562988|FG014|Treatment Period|Death|0|||
143117956|NCT00553358|515974224|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
143457779|NCT02891837|517219387|FG000|Overall Study|Withdrawal by Subject|1|||
143457780|NCT02891837|517219388|FG001|Overall Study|Withdrawal by Subject|0|||
143457781|NCT01237587|517219390|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
143457782|NCT01237587|517219391|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
143457783|NCT01237587|517219390|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
143006429|NCT03110107|515562989|FG015|Treatment Period|Death|0|||
143006430|NCT03110107|515562990|FG016|Treatment Period|Death|0|||
143006431|NCT03110107|515562991|FG017|Treatment Period|Death|0|||
143006432|NCT03110107|515562992|FG018|Treatment Period|Death|0|||
143006433|NCT03110107|515562993|FG019|Treatment Period|Death|0|||
143006434|NCT03110107|515562994|FG020|Treatment Period|Death|0|||
143006435|NCT03110107|515562995|FG021|Treatment Period|Death|0|||
143457784|NCT01237587|517219391|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
143457785|NCT01237587|517219390|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
143457786|NCT01237587|517219391|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
143457787|NCT01237587|517219390|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
143457788|NCT01237587|517219391|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
143457789|NCT01237587|517219390|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
143457790|NCT01237587|517219391|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
143457791|NCT01237587|517219390|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
143457792|NCT01237587|517219391|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
143457793|NCT01237587|517219390|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
143457794|NCT01237587|517219391|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
143457795|NCT01237587|517219390|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
143457796|NCT01237587|517219391|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
143457797|NCT01237587|517219390|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
143457798|NCT01237587|517219391|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
143457799|NCT01237587|517219390|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
143457800|NCT01237587|517219391|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
143457801|NCT01237587|517219390|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
143457802|NCT01237587|517219391|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
143457803|NCT01237587|517219390|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
143457804|NCT01237587|517219391|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
143457805|NCT01237587|517219390|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
143457806|NCT01237587|517219391|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
143457807|NCT01237587|517219390|FG000|Taper Phase|Adverse Event|0|||
143457808|NCT01237587|517219391|FG001|Taper Phase|Adverse Event|2|||
143457809|NCT01237587|517219390|FG000|Taper Phase|Protocol Violation|2|||
143457810|NCT01237587|517219391|FG001|Taper Phase|Protocol Violation|0|||
143457811|NCT01237587|517219390|FG000|Taper Phase|Lack of Efficacy|2|||
143457812|NCT01237587|517219391|FG001|Taper Phase|Lack of Efficacy|5|||
143457813|NCT01237587|517219390|FG000|Taper Phase|Parent/Guardian Decision|0|||
143457814|NCT01237587|517219391|FG001|Taper Phase|Parent/Guardian Decision|2|||
143457815|NCT01237587|517219390|FG000|Taper Phase|Sponsor Decision|1|||
143457816|NCT01237587|517219391|FG001|Taper Phase|Sponsor Decision|0|||
143457817|NCT01237587|517219390|FG000|Taper Phase|Withdrawal by Subject|0|||
143457818|NCT01237587|517219391|FG001|Taper Phase|Withdrawal by Subject|1|||
143457819|NCT01103362|517219392|FG000|Overall Study|study terminated|596|||
143457820|NCT02047903|517219393|FG000|Overall Study|Adverse Event|14|||
143457821|NCT02047903|517219393|FG000|Overall Study|Serious adverse event|10|||
143457822|NCT02047903|517219393|FG000|Overall Study|Withdrawal by Subject|16|||
143457823|NCT02047903|517219393|FG000|Overall Study|Lost to Follow-up|4|||
143457824|NCT02047903|517219393|FG000|Overall Study|Reason not listed|6|||
143457825|NCT02047903|517219393|FG000|Overall Study|Not Treated|9|||
143457826|NCT03538301|517219396|FG000|Overall Study|Adverse Event|1|||
143457827|NCT03538301|517219397|FG001|Overall Study|Adverse Event|4|||
143457828|NCT03538301|517219398|FG002|Overall Study|Adverse Event|4|||
143457829|NCT03538301|517219396|FG000|Overall Study|Death|1|||
143457830|NCT03538301|517219397|FG001|Overall Study|Death|1|||
143457831|NCT03538301|517219398|FG002|Overall Study|Death|0|||
143457832|NCT03538301|517219396|FG000|Overall Study|Physician Decision|0|||
143457833|NCT03538301|517219397|FG001|Overall Study|Physician Decision|1|||
143457834|NCT03538301|517219398|FG002|Overall Study|Physician Decision|0|||
143457835|NCT03538301|517219396|FG000|Overall Study|Protocol Violation|0|||
143457836|NCT03538301|517219397|FG001|Overall Study|Protocol Violation|0|||
143457837|NCT03538301|517219398|FG002|Overall Study|Protocol Violation|1|||
143457838|NCT03538301|517219396|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
143457839|NCT03538301|517219397|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
143457840|NCT03538301|517219398|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
143457841|NCT03616977|517219399|FG000|Period 1|Physician Decision|0|||
143457842|NCT03616977|517219400|FG001|Period 1|Physician Decision|1|||
143006436|NCT03110107|515562996|FG022|Treatment Period|Death|0|||
143006437|NCT03110107|515562997|FG023|Treatment Period|Death|0|||
143006438|NCT03110107|515562998|FG024|Treatment Period|Death|0|||
143457843|NCT03616977|517219399|FG000|Period 3|Adverse Event|1|||
143457844|NCT03616977|517219400|FG001|Period 3|Adverse Event|1|||
143457845|NCT02665338|517219401|FG000|Overall Study|Withdrawal by Subject|0|||
143457846|NCT02665338|517219402|FG001|Overall Study|Withdrawal by Subject|1|||
143457847|NCT04617275|517219404|FG000|Treatment Period|Adverse Event|1|||
143457848|NCT04617275|517219405|FG001|Treatment Period|Adverse Event|6|||
143457849|NCT04617275|517219406|FG002|Treatment Period|Adverse Event|4|||
143457850|NCT04617275|517219407|FG003|Treatment Period|Adverse Event|6|||
143457851|NCT04617275|517219408|FG004|Treatment Period|Adverse Event|7|||
143457852|NCT04617275|517219409|FG005|Treatment Period|Adverse Event|8|||
143457853|NCT04617275|517219410|FG006|Treatment Period|Adverse Event|0|||
143006439|NCT03110107|515562999|FG025|Treatment Period|Death|0|||
143457854|NCT04617275|517219411|FG007|Treatment Period|Adverse Event|12|||
143457855|NCT04617275|517219404|FG000|Treatment Period|Lost to Follow-up|0|||
143457856|NCT04617275|517219405|FG001|Treatment Period|Lost to Follow-up|0|||
143457857|NCT04617275|517219406|FG002|Treatment Period|Lost to Follow-up|2|||
143457858|NCT04617275|517219407|FG003|Treatment Period|Lost to Follow-up|0|||
143457859|NCT04617275|517219408|FG004|Treatment Period|Lost to Follow-up|0|||
143006440|NCT03110107|515562974|FG000|Treatment Period|Adverse Event|0|||
143006441|NCT03110107|515562975|FG001|Treatment Period|Adverse Event|0|||
143006442|NCT03110107|515562976|FG002|Treatment Period|Adverse Event|1|||
143006443|NCT03110107|515562977|FG003|Treatment Period|Adverse Event|0|||
143006444|NCT03110107|515562978|FG004|Treatment Period|Adverse Event|0|||
143006445|NCT03110107|515562979|FG005|Treatment Period|Adverse Event|2|||
143457860|NCT04617275|517219409|FG005|Treatment Period|Lost to Follow-up|3|||
143457861|NCT04617275|517219410|FG006|Treatment Period|Lost to Follow-up|0|||
143457862|NCT04617275|517219411|FG007|Treatment Period|Lost to Follow-up|2|||
143457863|NCT04617275|517219404|FG000|Treatment Period|No longer meets eligibility criteria|0|||
143457864|NCT04617275|517219405|FG001|Treatment Period|No longer meets eligibility criteria|0|||
143457865|NCT04617275|517219406|FG002|Treatment Period|No longer meets eligibility criteria|0|||
143457866|NCT04617275|517219407|FG003|Treatment Period|No longer meets eligibility criteria|1|||
143457867|NCT04617275|517219408|FG004|Treatment Period|No longer meets eligibility criteria|0|||
143457868|NCT04617275|517219409|FG005|Treatment Period|No longer meets eligibility criteria|0|||
143457869|NCT04617275|517219410|FG006|Treatment Period|No longer meets eligibility criteria|0|||
143457870|NCT04617275|517219411|FG007|Treatment Period|No longer meets eligibility criteria|0|||
143457871|NCT04617275|517219404|FG000|Treatment Period|Other|0|||
143457872|NCT04617275|517219405|FG001|Treatment Period|Other|1|||
143457873|NCT04617275|517219406|FG002|Treatment Period|Other|0|||
143457874|NCT04617275|517219407|FG003|Treatment Period|Other|0|||
143457875|NCT04617275|517219408|FG004|Treatment Period|Other|0|||
143457876|NCT04617275|517219409|FG005|Treatment Period|Other|0|||
143457877|NCT04617275|517219410|FG006|Treatment Period|Other|0|||
143457878|NCT04617275|517219411|FG007|Treatment Period|Other|0|||
143457879|NCT04617275|517219404|FG000|Treatment Period|Withdrawal by Subject|2|||
143457880|NCT04617275|517219405|FG001|Treatment Period|Withdrawal by Subject|0|||
143457881|NCT04617275|517219406|FG002|Treatment Period|Withdrawal by Subject|0|||
143457882|NCT04617275|517219407|FG003|Treatment Period|Withdrawal by Subject|2|||
143457883|NCT04617275|517219408|FG004|Treatment Period|Withdrawal by Subject|2|||
143457884|NCT04617275|517219409|FG005|Treatment Period|Withdrawal by Subject|0|||
143457885|NCT04617275|517219410|FG006|Treatment Period|Withdrawal by Subject|1|||
143457886|NCT04617275|517219411|FG007|Treatment Period|Withdrawal by Subject|2|||
143457887|NCT04617275|517219404|FG000|Follow-up Period|Adverse Event|1|||
143457888|NCT04617275|517219405|FG001|Follow-up Period|Adverse Event|1|||
143457889|NCT04617275|517219406|FG002|Follow-up Period|Adverse Event|2|||
143457890|NCT04617275|517219407|FG003|Follow-up Period|Adverse Event|3|||
143457891|NCT04617275|517219408|FG004|Follow-up Period|Adverse Event|4|||
143457892|NCT04617275|517219409|FG005|Follow-up Period|Adverse Event|3|||
143457893|NCT04617275|517219410|FG006|Follow-up Period|Adverse Event|0|||
143457894|NCT04617275|517219411|FG007|Follow-up Period|Adverse Event|3|||
143457895|NCT04617275|517219404|FG000|Follow-up Period|Lost to Follow-up|0|||
143457896|NCT04617275|517219405|FG001|Follow-up Period|Lost to Follow-up|1|||
143457897|NCT04617275|517219406|FG002|Follow-up Period|Lost to Follow-up|2|||
143457898|NCT04617275|517219407|FG003|Follow-up Period|Lost to Follow-up|0|||
143457899|NCT04617275|517219408|FG004|Follow-up Period|Lost to Follow-up|0|||
143457900|NCT04617275|517219409|FG005|Follow-up Period|Lost to Follow-up|4|||
143457901|NCT04617275|517219410|FG006|Follow-up Period|Lost to Follow-up|0|||
143457902|NCT04617275|517219411|FG007|Follow-up Period|Lost to Follow-up|3|||
143457903|NCT04617275|517219404|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
143457904|NCT04617275|517219405|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
143457905|NCT04617275|517219406|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
143457906|NCT04617275|517219407|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
143457907|NCT04617275|517219408|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
143457908|NCT04617275|517219409|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
143006446|NCT03110107|515562980|FG006|Treatment Period|Adverse Event|0|||
143006447|NCT03110107|515562981|FG007|Treatment Period|Adverse Event|2|||
143006448|NCT03110107|515562982|FG008|Treatment Period|Adverse Event|0|||
143006449|NCT03110107|515562983|FG009|Treatment Period|Adverse Event|1|||
143006450|NCT03110107|515562984|FG010|Treatment Period|Adverse Event|0|||
143006451|NCT03110107|515562985|FG011|Treatment Period|Adverse Event|0|||
143006452|NCT03110107|515562986|FG012|Treatment Period|Adverse Event|0|||
143006453|NCT03110107|515562987|FG013|Treatment Period|Adverse Event|0|||
143006454|NCT03110107|515562988|FG014|Treatment Period|Adverse Event|0|||
143006455|NCT03110107|515562989|FG015|Treatment Period|Adverse Event|2|||
143006456|NCT03110107|515562990|FG016|Treatment Period|Adverse Event|0|||
143006457|NCT03110107|515562991|FG017|Treatment Period|Adverse Event|1|||
143006458|NCT03110107|515562992|FG018|Treatment Period|Adverse Event|2|||
143006459|NCT03110107|515562993|FG019|Treatment Period|Adverse Event|1|||
143006460|NCT03110107|515562994|FG020|Treatment Period|Adverse Event|4|||
143457909|NCT04617275|517219410|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
143457910|NCT04617275|517219411|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
143457911|NCT04617275|517219404|FG000|Follow-up Period|Other|0|||
143457912|NCT04617275|517219405|FG001|Follow-up Period|Other|1|||
143457913|NCT04617275|517219406|FG002|Follow-up Period|Other|0|||
143457914|NCT04617275|517219407|FG003|Follow-up Period|Other|0|||
143457915|NCT04617275|517219408|FG004|Follow-up Period|Other|0|||
143457916|NCT04617275|517219409|FG005|Follow-up Period|Other|0|||
143457917|NCT04617275|517219410|FG006|Follow-up Period|Other|0|||
143457918|NCT04617275|517219411|FG007|Follow-up Period|Other|0|||
143457919|NCT04617275|517219404|FG000|Follow-up Period|Withdrawal by Subject|2|||
143457920|NCT04617275|517219405|FG001|Follow-up Period|Withdrawal by Subject|0|||
143457921|NCT04617275|517219406|FG002|Follow-up Period|Withdrawal by Subject|0|||
143457922|NCT04617275|517219407|FG003|Follow-up Period|Withdrawal by Subject|2|||
143117957|NCT00553358|515974225|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
143117958|NCT00553358|515974226|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
143117959|NCT01870297|515974231|FG000|Overall Study|Adverse Event|0|||
143117960|NCT01870297|515974232|FG001|Overall Study|Adverse Event|0|||
143117961|NCT01870297|515974233|FG002|Overall Study|Adverse Event|0|||
143117962|NCT01870297|515974234|FG003|Overall Study|Adverse Event|0|||
143117963|NCT01870297|515974235|FG004|Overall Study|Adverse Event|2|||
143117964|NCT01870297|515974236|FG005|Overall Study|Adverse Event|0|||
143117965|NCT01870297|515974237|FG006|Overall Study|Adverse Event|0|||
143117966|NCT01870297|515974231|FG000|Overall Study|Lost to Follow-up|0|||
143117967|NCT01870297|515974232|FG001|Overall Study|Lost to Follow-up|1|||
143117968|NCT01870297|515974233|FG002|Overall Study|Lost to Follow-up|1|||
143117969|NCT01870297|515974234|FG003|Overall Study|Lost to Follow-up|0|||
143117970|NCT01870297|515974235|FG004|Overall Study|Lost to Follow-up|0|||
143117971|NCT01870297|515974236|FG005|Overall Study|Lost to Follow-up|0|||
143117972|NCT01870297|515974237|FG006|Overall Study|Lost to Follow-up|0|||
143117973|NCT01870297|515974231|FG000|Overall Study|Withdrawal by Subject|0|||
143117974|NCT01870297|515974232|FG001|Overall Study|Withdrawal by Subject|0|||
143117975|NCT01870297|515974233|FG002|Overall Study|Withdrawal by Subject|0|||
143117976|NCT01870297|515974234|FG003|Overall Study|Withdrawal by Subject|0|||
143117977|NCT01870297|515974235|FG004|Overall Study|Withdrawal by Subject|1|||
143117978|NCT01870297|515974236|FG005|Overall Study|Withdrawal by Subject|1|||
143117979|NCT01870297|515974237|FG006|Overall Study|Withdrawal by Subject|1|||
143117980|NCT01870297|515974231|FG000|Overall Study|Sponsor Decision|0|||
143117981|NCT01870297|515974232|FG001|Overall Study|Sponsor Decision|6|||
143117982|NCT01870297|515974233|FG002|Overall Study|Sponsor Decision|0|||
143117983|NCT01870297|515974234|FG003|Overall Study|Sponsor Decision|0|||
143117984|NCT01870297|515974235|FG004|Overall Study|Sponsor Decision|0|||
143117985|NCT01870297|515974236|FG005|Overall Study|Sponsor Decision|0|||
143457923|NCT04617275|517219408|FG004|Follow-up Period|Withdrawal by Subject|2|||
143457924|NCT04617275|517219409|FG005|Follow-up Period|Withdrawal by Subject|0|||
143457925|NCT04617275|517219410|FG006|Follow-up Period|Withdrawal by Subject|1|||
143457926|NCT04617275|517219411|FG007|Follow-up Period|Withdrawal by Subject|2|||
143457927|NCT04927884|517219412|FG000|Overall Study|Progressive Disease|2|||
143457928|NCT05917470|517219413|FG000|Overall Study|Progressive Disease|1|||
143457929|NCT05917470|517219414|FG001|Overall Study|Progressive Disease|1|||
143457930|NCT05917470|517219415|FG002|Overall Study|Progressive Disease|2|||
143457931|NCT05917470|517219416|FG003|Overall Study|Progressive Disease|3|||
143457932|NCT05917470|517219417|FG004|Overall Study|Progressive Disease|1|||
143457933|NCT05917470|517219418|FG005|Overall Study|Progressive Disease|1|||
143457934|NCT05917470|517219419|FG006|Overall Study|Progressive Disease|0|||
143457935|NCT05917470|517219420|FG007|Overall Study|Progressive Disease|0|||
143457936|NCT05917470|517219413|FG000|Overall Study|Withdrawal by Subject|0|||
143457937|NCT05917470|517219414|FG001|Overall Study|Withdrawal by Subject|0|||
143457938|NCT05917470|517219415|FG002|Overall Study|Withdrawal by Subject|1|||
143457939|NCT05917470|517219416|FG003|Overall Study|Withdrawal by Subject|0|||
143457940|NCT05917470|517219417|FG004|Overall Study|Withdrawal by Subject|0|||
143457941|NCT05917470|517219418|FG005|Overall Study|Withdrawal by Subject|0|||
143457942|NCT05917470|517219419|FG006|Overall Study|Withdrawal by Subject|0|||
143457943|NCT05917470|517219420|FG007|Overall Study|Withdrawal by Subject|0|||
143457944|NCT05917470|517219413|FG000|Overall Study|Sponsor Decision|0|||
143457945|NCT05917470|517219414|FG001|Overall Study|Sponsor Decision|0|||
143457946|NCT05917470|517219415|FG002|Overall Study|Sponsor Decision|1|||
143457947|NCT05917470|517219416|FG003|Overall Study|Sponsor Decision|0|||
143457948|NCT05917470|517219417|FG004|Overall Study|Sponsor Decision|2|||
143457949|NCT05917470|517219418|FG005|Overall Study|Sponsor Decision|1|||
143457950|NCT05917470|517219419|FG006|Overall Study|Sponsor Decision|3|||
143457951|NCT05917470|517219420|FG007|Overall Study|Sponsor Decision|3|||
143457952|NCT05917470|517219413|FG000|Overall Study|Adverse Event|0|||
143457953|NCT05917470|517219414|FG001|Overall Study|Adverse Event|0|||
143117986|NCT01870297|515974237|FG006|Overall Study|Sponsor Decision|1|||
143117987|NCT03313310|515974238|FG000|Phase 2|Lost to Follow-up|4|||
143117988|NCT03313310|515974239|FG001|Phase 2|Lost to Follow-up|0|||
143117989|NCT03313310|515974238|FG000|Phase 3|Lost to Follow-up|0|||
143457954|NCT05917470|517219415|FG002|Overall Study|Adverse Event|0|||
143117990|NCT03313310|515974239|FG001|Phase 3|Lost to Follow-up|1|||
143117991|NCT03013985|515974240|FG000|Overall Study|Protocol Violation|2|||
143117992|NCT03013985|515974241|FG001|Overall Study|Protocol Violation|2|||
143117993|NCT03013985|515974240|FG000|Overall Study|Withdrawal by Subject|14|||
143117994|NCT03013985|515974241|FG001|Overall Study|Withdrawal by Subject|17|||
143117995|NCT00090987|515974244|FG000|Overall Study|Adverse Event|5|||
143117996|NCT00090987|515974244|FG000|Overall Study|Lack of Efficacy|7|||
143117997|NCT00090987|515974244|FG000|Overall Study|Withdrawal by Subject|3|||
143117998|NCT00090987|515974244|FG000|Overall Study|alternative therapy|1|||
143117999|NCT00090987|515974244|FG000|Overall Study|Non-compliance|4|||
143118000|NCT00090987|515974244|FG000|Overall Study|Incarcerated|1|||
143118001|NCT03578146|515974245|FG000|Overall Study|Did Not Receive Treatment|1|||
143118002|NCT03578146|515974246|FG001|Overall Study|Did Not Receive Treatment|0|||
143118003|NCT03578146|515974247|FG002|Overall Study|Did Not Receive Treatment|0|||
143118004|NCT03578146|515974248|FG003|Overall Study|Did Not Receive Treatment|0|||
143118005|NCT03578146|515974249|FG004|Overall Study|Did Not Receive Treatment|0|||
143118006|NCT03578146|515974250|FG005|Overall Study|Did Not Receive Treatment|2|||
143118007|NCT03578146|515974245|FG000|Overall Study|Lost to Follow-up|0|||
143118008|NCT03578146|515974246|FG001|Overall Study|Lost to Follow-up|1|||
143118009|NCT03578146|515974247|FG002|Overall Study|Lost to Follow-up|1|||
143118010|NCT03578146|515974248|FG003|Overall Study|Lost to Follow-up|0|||
143118011|NCT03578146|515974249|FG004|Overall Study|Lost to Follow-up|0|||
143118012|NCT03578146|515974250|FG005|Overall Study|Lost to Follow-up|1|||
143118013|NCT01717391|515974251|FG000|Overall Study|Withdrawal by Subject|5|||
143118014|NCT01717391|515974251|FG000|Overall Study|Physician Decision|1|||
143457955|NCT05917470|517219416|FG003|Overall Study|Adverse Event|0|||
143457956|NCT05917470|517219417|FG004|Overall Study|Adverse Event|0|||
143457957|NCT05917470|517219418|FG005|Overall Study|Adverse Event|1|||
143457958|NCT05917470|517219419|FG006|Overall Study|Adverse Event|0|||
143457959|NCT05917470|517219420|FG007|Overall Study|Adverse Event|0|||
143457960|NCT01022268|517222701|FG000|Overall Study|Withdrawal by Subject|1|||
143457961|NCT01022268|517222702|FG001|Overall Study|Withdrawal by Subject|0|||
143457962|NCT01022268|517222701|FG000|Overall Study|Withdrawal by Subject|1|||
143457963|NCT01022268|517222702|FG001|Overall Study|Withdrawal by Subject|0|||
143457964|NCT02924428|517222705|FG000|Overall Study|Adverse Event|1|||
143457965|NCT02924428|517222706|FG001|Overall Study|Adverse Event|0|||
143457966|NCT02924428|517222705|FG000|Overall Study|Physician Decision|1|||
143457967|NCT02924428|517222706|FG001|Overall Study|Physician Decision|0|||
143457968|NCT02924428|517222705|FG000|Overall Study|Lost to Follow-up|2|||
143457969|NCT02924428|517222706|FG001|Overall Study|Lost to Follow-up|4|||
143457970|NCT02924428|517222705|FG000|Overall Study|Pregnancy|0|||
143457971|NCT02924428|517222706|FG001|Overall Study|Pregnancy|1|||
143457972|NCT01877837|517222707|FG000|Overall Study|Lost to Follow-up|1|||
143457973|NCT01877837|517222707|FG000|Overall Study|Ineligible|4|||
143457974|NCT01775475|517222713|FG000|Overall Study|Death|3|||
143457975|NCT01775475|517222714|FG001|Overall Study|Death|3|||
143457976|NCT00896051|517222715|FG000|Overall Study|Adverse Event|2|||
143457977|NCT00896051|517222716|FG001|Overall Study|Adverse Event|1|||
143457978|NCT00896051|517222715|FG000|Overall Study|Lost to Follow-up|3|||
143457979|NCT00896051|517222716|FG001|Overall Study|Lost to Follow-up|2|||
143457980|NCT00896051|517222715|FG000|Overall Study|Withdrawal by Subject|3|||
143457981|NCT00896051|517222716|FG001|Overall Study|Withdrawal by Subject|2|||
143457982|NCT00896051|517222715|FG000|Overall Study|Subject noncompliant|1|||
143457983|NCT00896051|517222716|FG001|Overall Study|Subject noncompliant|3|||
143457984|NCT00896051|517222715|FG000|Overall Study|Other|1|||
143457985|NCT00896051|517222716|FG001|Overall Study|Other|1|||
143457986|NCT02935452|517222717|FG000|Overall Study|work and life commintment|3|||
143457987|NCT02935452|517222718|FG001|Overall Study|work and life commintment|1|||
143457988|NCT03103763|517222719|FG000|Overall Study|Death|15|||
143457989|NCT03103763|517222720|FG001|Overall Study|Death|5|||
143457990|NCT03103763|517222721|FG002|Overall Study|Death|5|||
143457991|NCT03103763|517222719|FG000|Overall Study|Withdrawal by Subject|0|||
143457992|NCT03103763|517222720|FG001|Overall Study|Withdrawal by Subject|3|||
143457993|NCT03103763|517222721|FG002|Overall Study|Withdrawal by Subject|2|||
143457994|NCT00618982|517222722|FG000|Overall Study|Adverse Event|23|||
143457995|NCT00618982|517222722|FG000|Overall Study|Withdrawal by Subject|1|||
143457996|NCT00618982|517222722|FG000|Overall Study|Protocol Violation|1|||
143457997|NCT00618982|517222722|FG000|Overall Study|ongoing, still treated with study med.|25|||
143118015|NCT01717391|515974251|FG000|Overall Study|FLT technical failure|3|||
143457998|NCT03310268|517222723|FG000|Overall Study|(Not specified)|1|||
143457999|NCT03310268|517222724|FG001|Overall Study|(Not specified)|5|||
143458000|NCT03310268|517222725|FG002|Overall Study|(Not specified)|0|||
143458001|NCT00717067|517222728|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
143458002|NCT00717067|517222729|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
143458003|NCT00717067|517222730|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
143118016|NCT04769739|515974252|FG000|Overall Study|Colorectal cancer obstruction|2|||
143118017|NCT04769739|515974253|FG001|Overall Study|Colorectal cancer obstruction|0|||
143118018|NCT04769739|515974254|FG002|Overall Study|Colorectal cancer obstruction|0|||
143458004|NCT00717067|517222731|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
143458005|NCT00717067|517222732|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
143458006|NCT00822172|517222735|FG000|Overall Study|Adverse Event|10|||
143458007|NCT00822172|517222736|FG001|Overall Study|Adverse Event|12|||
143458008|NCT00822172|517222735|FG000|Overall Study|Death|1|||
143458009|NCT00822172|517222736|FG001|Overall Study|Death|0|||
143458010|NCT00822172|517222735|FG000|Overall Study|Lost to Follow-up|3|||
143458011|NCT00822172|517222736|FG001|Overall Study|Lost to Follow-up|1|||
143458012|NCT00822172|517222735|FG000|Overall Study|Withdrawal by Subject|1|||
143458013|NCT00822172|517222736|FG001|Overall Study|Withdrawal by Subject|4|||
143458014|NCT00822172|517222735|FG000|Overall Study|site closed|0|||
143118019|NCT04769739|515974255|FG003|Overall Study|Colorectal cancer obstruction|0|||
143118020|NCT04769739|515974252|FG000|Overall Study|Failed cecal intubation|1|||
143118021|NCT04769739|515974253|FG001|Overall Study|Failed cecal intubation|0|||
143118022|NCT04769739|515974254|FG002|Overall Study|Failed cecal intubation|0|||
143118023|NCT04769739|515974255|FG003|Overall Study|Failed cecal intubation|1|||
143118024|NCT04769739|515974252|FG000|Overall Study|Poor bowel preparation|0|||
143118025|NCT04769739|515974253|FG001|Overall Study|Poor bowel preparation|0|||
143118026|NCT04769739|515974254|FG002|Overall Study|Poor bowel preparation|0|||
143118027|NCT04769739|515974255|FG003|Overall Study|Poor bowel preparation|1|||
143118028|NCT01260584|515974256|FG000|Period 1|Protocol Violation|0|||
143118029|NCT01260584|515974257|FG001|Period 1|Protocol Violation|0|||
143118030|NCT01260584|515974258|FG002|Period 1|Protocol Violation|1|||
143118031|NCT01260584|515974259|FG003|Period 1|Protocol Violation|1|||
143118032|NCT01260584|515974256|FG000|Period 1|Adverse Event|0|||
143006461|NCT03110107|515562995|FG021|Treatment Period|Adverse Event|2|||
143006462|NCT03110107|515562996|FG022|Treatment Period|Adverse Event|2|||
143006463|NCT03110107|515562997|FG023|Treatment Period|Adverse Event|2|||
143006464|NCT03110107|515562998|FG024|Treatment Period|Adverse Event|2|||
143458015|NCT00822172|517222736|FG001|Overall Study|site closed|1|||
143458016|NCT00822172|517222735|FG000|Overall Study|Other|0|||
143458017|NCT00822172|517222736|FG001|Overall Study|Other|1|||
143458018|NCT00370331|517222737|FG000|Overall Study|Adverse Event|4|||
143458019|NCT00370331|517222738|FG001|Overall Study|Adverse Event|13|||
143458020|NCT00370331|517222737|FG000|Overall Study|Withdrawal by Subject|2|||
143458021|NCT00370331|517222738|FG001|Overall Study|Withdrawal by Subject|4|||
143458022|NCT00370331|517222737|FG000|Overall Study|Lost to Follow-up|0|||
143458023|NCT00370331|517222738|FG001|Overall Study|Lost to Follow-up|3|||
143458024|NCT00370331|517222737|FG000|Overall Study|Lack of Efficacy|0|||
143458025|NCT00370331|517222738|FG001|Overall Study|Lack of Efficacy|1|||
143458026|NCT00370331|517222737|FG000|Overall Study|Non-compliance|0|||
143006465|NCT03110107|515562999|FG025|Treatment Period|Adverse Event|4|||
143006466|NCT03110107|515562974|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
143006467|NCT03110107|515562975|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
143006468|NCT03110107|515562976|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
143006469|NCT03110107|515562977|FG003|Treatment Period|Participant request to discontinue study treatment|0|||
143006470|NCT03110107|515562978|FG004|Treatment Period|Participant request to discontinue study treatment|0|||
143230339|NCT00446849|516393205|FG000|Maintenance Phase|Lack of Efficacy|40|||
143230340|NCT00446849|516393205|FG000|Maintenance Phase|Protocol Violation|7|||
143458027|NCT00370331|517222738|FG001|Overall Study|Non-compliance|1|||
143458028|NCT00370331|517222737|FG000|Overall Study|Protocol Violation|1|||
143458029|NCT00370331|517222738|FG001|Overall Study|Protocol Violation|1|||
143458030|NCT00545051|517222739|FG000|Overall Study|Adverse Event|7|||
143458031|NCT00545051|517222740|FG001|Overall Study|Adverse Event|3|||
143458032|NCT00545051|517222739|FG000|Overall Study|Death|1|||
143458033|NCT00545051|517222740|FG001|Overall Study|Death|0|||
143458034|NCT00545051|517222739|FG000|Overall Study|Violation of inclusion/exclusion|0|||
143458035|NCT00545051|517222740|FG001|Overall Study|Violation of inclusion/exclusion|2|||
143458036|NCT00545051|517222739|FG000|Overall Study|Protocol Violation|1|||
143458037|NCT00545051|517222740|FG001|Overall Study|Protocol Violation|0|||
143458038|NCT00545051|517222739|FG000|Overall Study|Withdrawal by Subject|0|||
143458039|NCT00545051|517222740|FG001|Overall Study|Withdrawal by Subject|1|||
143458040|NCT00545051|517222739|FG000|Overall Study|Administrative reasons|0|||
143458041|NCT00545051|517222740|FG001|Overall Study|Administrative reasons|1|||
143458042|NCT02630693|517222741|FG000|Overall Study|No receive treatment|0|||
143458043|NCT02630693|517222742|FG001|Overall Study|No receive treatment|1|||
143458044|NCT03271021|517222744|FG000|Overall Study|Adverse Event|3|||
143458045|NCT03271021|517222745|FG001|Overall Study|Adverse Event|2|||
143458046|NCT03271021|517222744|FG000|Overall Study|Withdrawal by Subject|36|||
143458047|NCT03271021|517222745|FG001|Overall Study|Withdrawal by Subject|53|||
143458048|NCT03271021|517222744|FG000|Overall Study|Lost to Follow-up|34|||
143458049|NCT03271021|517222745|FG001|Overall Study|Lost to Follow-up|39|||
143458050|NCT03271021|517222744|FG000|Overall Study|Protocol Violation|6|||
143458051|NCT03271021|517222745|FG001|Overall Study|Protocol Violation|4|||
143118033|NCT01260584|515974257|FG001|Period 1|Adverse Event|0|||
143118034|NCT01260584|515974258|FG002|Period 1|Adverse Event|1|||
143458052|NCT03271021|517222744|FG000|Overall Study|Abnormal Lab Results|1|||
143458053|NCT03271021|517222745|FG001|Overall Study|Abnormal Lab Results|0|||
143458054|NCT03271021|517222744|FG000|Overall Study|Miscellaneous|9|||
143458055|NCT03271021|517222745|FG001|Overall Study|Miscellaneous|8|||
143458056|NCT01474434|517222746|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
143458057|NCT01474434|517222747|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
143458058|NCT01474434|517222748|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
143458059|NCT01474434|517222749|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
143458060|NCT01474434|517222746|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
143458061|NCT01474434|517222747|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
143458062|NCT01474434|517222748|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
143458063|NCT01474434|517222749|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
143458064|NCT01474434|517222746|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
143458065|NCT01474434|517222747|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
143458066|NCT01474434|517222748|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
143458067|NCT01474434|517222749|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
143458068|NCT02207569|517222753|FG000|1-Month|Death|6|||
143458069|NCT02207569|517222753|FG000|1-Month|Withdrawal by Subject|2|||
143458070|NCT02207569|517222753|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
143458071|NCT02207569|517222753|FG000|6-Month|Death|8|||
143458072|NCT02207569|517222753|FG000|6-Month|Withdrawal by Subject|2|||
143458073|NCT02207569|517222753|FG000|12-Month|Death|14|||
143458074|NCT02207569|517222753|FG000|12-Month|Withdrawal by Subject|2|||
143458075|NCT02207569|517222753|FG000|24-Month|Death|23|||
143458076|NCT02207569|517222753|FG000|24-Month|Withdrawal by Subject|3|||
143458077|NCT02207569|517222753|FG000|36-Month|Death|23|||
143458078|NCT02207569|517222753|FG000|36-Month|Withdrawal by Subject|4|||
143458079|NCT02207569|517222753|FG000|48-Month|Death|25|||
143458080|NCT02207569|517222753|FG000|48-Month|Withdrawal by Subject|2|||
143458081|NCT02207569|517222753|FG000|48-Month|Lost to Follow-up|4|||
143458082|NCT02207569|517222753|FG000|60-Month|Death|1|||
143458083|NCT02207569|517222753|FG000|60-Month|Lost to Follow-up|1|||
143458084|NCT02207569|517222753|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
143458085|NCT02207569|517222753|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
143458086|NCT00495586|517222754|FG000|Overall Study|Withdrawal by Subject|4|||
143458087|NCT00495586|517222755|FG001|Overall Study|Withdrawal by Subject|4|||
143458088|NCT02038543|517222756|FG000|Overall Study|Screen Failure|0|||
143458089|NCT02038543|517222757|FG001|Overall Study|Screen Failure|0|||
143458090|NCT02038543|517222758|FG002|Overall Study|Screen Failure|0|||
143458091|NCT02038543|517222759|FG003|Overall Study|Screen Failure|1|||
143458092|NCT02038543|517222756|FG000|Overall Study|Withdrawal by Subject|0|||
143458093|NCT02038543|517222757|FG001|Overall Study|Withdrawal by Subject|0|||
143458094|NCT02038543|517222758|FG002|Overall Study|Withdrawal by Subject|0|||
143458095|NCT02038543|517222759|FG003|Overall Study|Withdrawal by Subject|1|||
143458096|NCT03618823|517222760|FG000|Overall Study|Lost to Follow-up|63|||
143006471|NCT03110107|515562979|FG005|Treatment Period|Participant request to discontinue study treatment|0|||
143006472|NCT03110107|515562980|FG006|Treatment Period|Participant request to discontinue study treatment|0|||
143006473|NCT03110107|515562981|FG007|Treatment Period|Participant request to discontinue study treatment|1|||
143006474|NCT03110107|515562982|FG008|Treatment Period|Participant request to discontinue study treatment|0|||
143006475|NCT03110107|515562983|FG009|Treatment Period|Participant request to discontinue study treatment|0|||
143006476|NCT03110107|515562984|FG010|Treatment Period|Participant request to discontinue study treatment|1|||
143006477|NCT03110107|515562985|FG011|Treatment Period|Participant request to discontinue study treatment|0|||
143006478|NCT03110107|515562986|FG012|Treatment Period|Participant request to discontinue study treatment|0|||
143006479|NCT03110107|515562987|FG013|Treatment Period|Participant request to discontinue study treatment|0|||
143006480|NCT03110107|515562988|FG014|Treatment Period|Participant request to discontinue study treatment|0|||
143006481|NCT03110107|515562989|FG015|Treatment Period|Participant request to discontinue study treatment|0|||
143006482|NCT03110107|515562990|FG016|Treatment Period|Participant request to discontinue study treatment|0|||
143006483|NCT03110107|515562991|FG017|Treatment Period|Participant request to discontinue study treatment|0|||
143006484|NCT03110107|515562992|FG018|Treatment Period|Participant request to discontinue study treatment|0|||
143006485|NCT03110107|515562993|FG019|Treatment Period|Participant request to discontinue study treatment|0|||
143006486|NCT03110107|515562994|FG020|Treatment Period|Participant request to discontinue study treatment|0|||
143006487|NCT03110107|515562995|FG021|Treatment Period|Participant request to discontinue study treatment|0|||
143006488|NCT03110107|515562996|FG022|Treatment Period|Participant request to discontinue study treatment|0|||
143006489|NCT03110107|515562997|FG023|Treatment Period|Participant request to discontinue study treatment|0|||
143006490|NCT03110107|515562998|FG024|Treatment Period|Participant request to discontinue study treatment|3|||
143006491|NCT03110107|515562999|FG025|Treatment Period|Participant request to discontinue study treatment|0|||
143006492|NCT03110107|515562974|FG000|Treatment Period|Participant withdrew consent|0|||
143006493|NCT03110107|515562975|FG001|Treatment Period|Participant withdrew consent|0|||
143458097|NCT03618823|517222761|FG001|Overall Study|Lost to Follow-up|61|||
143458098|NCT02292927|517222762|FG000|Overall Study|Protocol Violation|13|||
143458099|NCT02292927|517222763|FG001|Overall Study|Protocol Violation|7|||
143458100|NCT01656733|517222767|FG000|Overall Study|No permission to collect birth outcomes|0|||
143458101|NCT01656733|517222768|FG001|Overall Study|No permission to collect birth outcomes|1|||
143458102|NCT01656733|517222767|FG000|Overall Study|Delivery at another hospital|0|||
143458103|NCT01656733|517222768|FG001|Overall Study|Delivery at another hospital|2|||
143458104|NCT01656733|517222767|FG000|Overall Study|Spontaneous abortion|0|||
143458105|NCT01656733|517222768|FG001|Overall Study|Spontaneous abortion|1|||
143458106|NCT02595073|517222770|FG000|Overall Study|Progressive Disease|0|||
143458107|NCT02595073|517222771|FG001|Overall Study|Progressive Disease|1|||
143458108|NCT02595073|517222770|FG000|Overall Study|Protocol Violation|2|||
143458109|NCT02595073|517222771|FG001|Overall Study|Protocol Violation|0|||
143458110|NCT02084056|517222777|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
143458111|NCT02084056|517222778|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
143458112|NCT02084056|517222779|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
143458113|NCT02084056|517222780|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
143458114|NCT02084056|517222777|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
143458115|NCT02084056|517222778|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
143458116|NCT02084056|517222779|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
143458117|NCT02084056|517222780|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
143458118|NCT01293487|517222781|FG000|Overall Study|Lost to Follow-up|0|||
143458119|NCT01293487|517222782|FG001|Overall Study|Lost to Follow-up|0|||
143458120|NCT01293487|517222783|FG002|Overall Study|Lost to Follow-up|0|||
143458121|NCT01293487|517222784|FG003|Overall Study|Lost to Follow-up|1|||
143458122|NCT01293487|517222785|FG004|Overall Study|Lost to Follow-up|0|||
143458123|NCT01293487|517222786|FG005|Overall Study|Lost to Follow-up|0|||
143458124|NCT01293487|517222787|FG006|Overall Study|Lost to Follow-up|0|||
143458125|NCT01293487|517222788|FG007|Overall Study|Lost to Follow-up|0|||
143458126|NCT01293487|517222781|FG000|Overall Study|Withdrawal by Subject|0|||
143458127|NCT01293487|517222782|FG001|Overall Study|Withdrawal by Subject|0|||
143458128|NCT01293487|517222783|FG002|Overall Study|Withdrawal by Subject|0|||
143458129|NCT01293487|517222784|FG003|Overall Study|Withdrawal by Subject|0|||
143458130|NCT01293487|517222785|FG004|Overall Study|Withdrawal by Subject|0|||
143458131|NCT01293487|517222786|FG005|Overall Study|Withdrawal by Subject|0|||
143458132|NCT01293487|517222787|FG006|Overall Study|Withdrawal by Subject|0|||
143458133|NCT01293487|517222788|FG007|Overall Study|Withdrawal by Subject|2|||
143458134|NCT01737827|517222790|FG000|Overall Study|Adverse Event|3|||
143458135|NCT01737827|517222791|FG001|Overall Study|Adverse Event|6|||
143458136|NCT01737827|517222792|FG002|Overall Study|Adverse Event|0|||
143458137|NCT01737827|517222790|FG000|Overall Study|Lost to Follow-up|0|||
143458138|NCT01737827|517222791|FG001|Overall Study|Lost to Follow-up|1|||
143458139|NCT01737827|517222792|FG002|Overall Study|Lost to Follow-up|0|||
143458140|NCT01737827|517222790|FG000|Overall Study|Physician Decision|0|||
143458141|NCT01737827|517222791|FG001|Overall Study|Physician Decision|2|||
143458142|NCT01737827|517222792|FG002|Overall Study|Physician Decision|0|||
143458143|NCT01737827|517222790|FG000|Overall Study|Progressive Disease|5|||
143458144|NCT01737827|517222791|FG001|Overall Study|Progressive Disease|16|||
143458145|NCT01737827|517222792|FG002|Overall Study|Progressive Disease|2|||
143458146|NCT01737827|517222790|FG000|Overall Study|Study Terminated by Sponsor|0|||
143458147|NCT01737827|517222791|FG001|Overall Study|Study Terminated by Sponsor|1|||
143458148|NCT01737827|517222792|FG002|Overall Study|Study Terminated by Sponsor|0|||
143458149|NCT01737827|517222790|FG000|Overall Study|Subject/Guardian Decision|0|||
143458150|NCT01737827|517222791|FG001|Overall Study|Subject/Guardian Decision|2|||
143458151|NCT01737827|517222792|FG002|Overall Study|Subject/Guardian Decision|0|||
143458152|NCT01451827|517222793|FG000|Overall Study|Adverse Event|2|||
143458153|NCT01451827|517222794|FG001|Overall Study|Adverse Event|0|||
143458154|NCT01451827|517222795|FG002|Overall Study|Adverse Event|1|||
143458155|NCT01451827|517222796|FG003|Overall Study|Adverse Event|1|||
143458156|NCT01451827|517222793|FG000|Overall Study|Protocol deviation|1|||
143458157|NCT01451827|517222794|FG001|Overall Study|Protocol deviation|0|||
143458158|NCT01451827|517222795|FG002|Overall Study|Protocol deviation|0|||
143458159|NCT01451827|517222796|FG003|Overall Study|Protocol deviation|0|||
143458160|NCT01451827|517222793|FG000|Overall Study|Lost to Follow-up|0|||
143458161|NCT01451827|517222794|FG001|Overall Study|Lost to Follow-up|3|||
143458162|NCT01451827|517222795|FG002|Overall Study|Lost to Follow-up|0|||
143458163|NCT01451827|517222796|FG003|Overall Study|Lost to Follow-up|2|||
143458164|NCT01451827|517222793|FG000|Overall Study|Participant met withdrawal criteria|0|||
143458165|NCT01451827|517222794|FG001|Overall Study|Participant met withdrawal criteria|2|||
143458166|NCT01451827|517222795|FG002|Overall Study|Participant met withdrawal criteria|0|||
143458167|NCT01451827|517222796|FG003|Overall Study|Participant met withdrawal criteria|0|||
143458168|NCT01451827|517222793|FG000|Overall Study|Withdrawal by Subject|0|||
143458169|NCT01451827|517222794|FG001|Overall Study|Withdrawal by Subject|0|||
143458170|NCT01451827|517222795|FG002|Overall Study|Withdrawal by Subject|1|||
143458171|NCT01451827|517222796|FG003|Overall Study|Withdrawal by Subject|1|||
143458172|NCT01964924|517222797|FG000|Trametinib Monotherapy|Progression|19|||
143458173|NCT01964924|517222798|FG001|Trametinib Monotherapy|Progression|0|||
143458174|NCT01528345|517222799|FG000|Overall Study|Adverse Event|10|||
143458175|NCT01528345|517222800|FG001|Overall Study|Adverse Event|1|||
143458176|NCT01528345|517222799|FG000|Overall Study|Death|1|||
143006494|NCT03110107|515562976|FG002|Treatment Period|Participant withdrew consent|1|||
143006495|NCT03110107|515562977|FG003|Treatment Period|Participant withdrew consent|0|||
143006496|NCT03110107|515562978|FG004|Treatment Period|Participant withdrew consent|4|||
143006497|NCT03110107|515562979|FG005|Treatment Period|Participant withdrew consent|3|||
143006498|NCT03110107|515562980|FG006|Treatment Period|Participant withdrew consent|0|||
143006499|NCT03110107|515562981|FG007|Treatment Period|Participant withdrew consent|0|||
143006500|NCT03110107|515562982|FG008|Treatment Period|Participant withdrew consent|0|||
143006501|NCT03110107|515562983|FG009|Treatment Period|Participant withdrew consent|1|||
143006502|NCT03110107|515562984|FG010|Treatment Period|Participant withdrew consent|0|||
143006503|NCT03110107|515562985|FG011|Treatment Period|Participant withdrew consent|0|||
143006504|NCT03110107|515562986|FG012|Treatment Period|Participant withdrew consent|0|||
143006505|NCT03110107|515562987|FG013|Treatment Period|Participant withdrew consent|0|||
143006506|NCT03110107|515562988|FG014|Treatment Period|Participant withdrew consent|0|||
143006507|NCT03110107|515562989|FG015|Treatment Period|Participant withdrew consent|0|||
143006508|NCT03110107|515562990|FG016|Treatment Period|Participant withdrew consent|0|||
143006509|NCT03110107|515562991|FG017|Treatment Period|Participant withdrew consent|0|||
143006510|NCT03110107|515562992|FG018|Treatment Period|Participant withdrew consent|0|||
143006511|NCT03110107|515562993|FG019|Treatment Period|Participant withdrew consent|1|||
143006512|NCT03110107|515562994|FG020|Treatment Period|Participant withdrew consent|0|||
143006513|NCT03110107|515562995|FG021|Treatment Period|Participant withdrew consent|2|||
143006514|NCT03110107|515562996|FG022|Treatment Period|Participant withdrew consent|0|||
143006515|NCT03110107|515562997|FG023|Treatment Period|Participant withdrew consent|0|||
143006516|NCT03110107|515562998|FG024|Treatment Period|Participant withdrew consent|0|||
143006517|NCT03110107|515562999|FG025|Treatment Period|Participant withdrew consent|2|||
143006518|NCT03110107|515562974|FG000|Treatment Period|Participants no longer meets study criteria|0|||
143006519|NCT03110107|515562975|FG001|Treatment Period|Participants no longer meets study criteria|0|||
143006520|NCT03110107|515562976|FG002|Treatment Period|Participants no longer meets study criteria|0|||
143006521|NCT03110107|515562977|FG003|Treatment Period|Participants no longer meets study criteria|0|||
143006522|NCT03110107|515562978|FG004|Treatment Period|Participants no longer meets study criteria|0|||
143006523|NCT03110107|515562979|FG005|Treatment Period|Participants no longer meets study criteria|0|||
143006524|NCT03110107|515562980|FG006|Treatment Period|Participants no longer meets study criteria|0|||
143118035|NCT01260584|515974259|FG003|Period 1|Adverse Event|0|||
143118036|NCT01260584|515974256|FG000|Period 2|Protocol Violation|0|||
143118037|NCT01260584|515974257|FG001|Period 2|Protocol Violation|2|||
143118038|NCT01260584|515974258|FG002|Period 2|Protocol Violation|3|||
143118039|NCT01260584|515974259|FG003|Period 2|Protocol Violation|1|||
143118040|NCT01260584|515974256|FG000|Period 2|Adverse Event|1|||
143118041|NCT01260584|515974257|FG001|Period 2|Adverse Event|0|||
143118042|NCT01260584|515974258|FG002|Period 2|Adverse Event|2|||
143118043|NCT01260584|515974259|FG003|Period 2|Adverse Event|0|||
143118044|NCT01260584|515974256|FG000|Period 2|Withdrawal by Subject|0|||
143118045|NCT01260584|515974257|FG001|Period 2|Withdrawal by Subject|1|||
143118046|NCT01260584|515974258|FG002|Period 2|Withdrawal by Subject|0|||
143118047|NCT01260584|515974259|FG003|Period 2|Withdrawal by Subject|0|||
143118048|NCT02918552|515974261|FG000|Overall Study|Failed Pharmacokinetics|1|||
143118049|NCT02918552|515974262|FG001|Overall Study|Failed Pharmacokinetics|0|||
143118050|NCT02918552|515974261|FG000|Overall Study|Withdrawal by Subject|0|||
143118051|NCT02918552|515974262|FG001|Overall Study|Withdrawal by Subject|1|||
143118052|NCT02918552|515974261|FG000|Overall Study|Lost to Follow-up|0|||
143118053|NCT02918552|515974262|FG001|Overall Study|Lost to Follow-up|1|||
143118054|NCT04395274|515974263|FG000|Overall Study|Lost to Follow-up|20|||
143118055|NCT04395274|515974264|FG001|Overall Study|Lost to Follow-up|11|||
143118056|NCT04395274|515974263|FG000|Overall Study|Withdrawal by Subject|13|||
143118057|NCT04395274|515974264|FG001|Overall Study|Withdrawal by Subject|10|||
143118058|NCT04395274|515974263|FG000|Overall Study|Moved Abroad|0|||
143118059|NCT04395274|515974264|FG001|Overall Study|Moved Abroad|1|||
143118060|NCT00335959|515974265|FG000|Overall Study|Adverse Event|2|||
143118061|NCT00335959|515974265|FG000|Overall Study|Ineligible|1|||
143118062|NCT02450552|515974272|FG000|Overall Study|Withdrawal by Subject|4|||
143118063|NCT02450552|515974273|FG001|Overall Study|Withdrawal by Subject|0|||
143118064|NCT02450552|515974274|FG002|Overall Study|Withdrawal by Subject|4|||
143118065|NCT02450552|515974272|FG000|Overall Study|Physician Decision|1|||
143118066|NCT02450552|515974273|FG001|Overall Study|Physician Decision|0|||
143118067|NCT02450552|515974274|FG002|Overall Study|Physician Decision|1|||
143118068|NCT00824382|515974285|FG000|Overall Study|Adverse Event|4|||
143118069|NCT00824382|515974286|FG001|Overall Study|Adverse Event|1|||
143118070|NCT00824382|515974287|FG002|Overall Study|Adverse Event|1|||
143118071|NCT00824382|515974288|FG003|Overall Study|Adverse Event|4|||
143118072|NCT00824382|515974285|FG000|Overall Study|Protocol Violation|1|||
143118073|NCT00824382|515974286|FG001|Overall Study|Protocol Violation|0|||
143118074|NCT00824382|515974287|FG002|Overall Study|Protocol Violation|0|||
143118075|NCT00824382|515974288|FG003|Overall Study|Protocol Violation|1|||
143118076|NCT00824382|515974285|FG000|Overall Study|Investigator's decision|0|||
143230341|NCT00446849|516393205|FG000|Maintenance Phase|Adverse Event|6|||
143230342|NCT00446849|516393205|FG000|Maintenance Phase|Consent withdrawn|5|||
143118077|NCT00824382|515974286|FG001|Overall Study|Investigator's decision|1|||
143118078|NCT00824382|515974287|FG002|Overall Study|Investigator's decision|2|||
143118079|NCT00824382|515974288|FG003|Overall Study|Investigator's decision|0|||
143118080|NCT03673345|515974289|FG000|Overall Study|Lost to Follow-up|1|||
143118081|NCT03673345|515974290|FG001|Overall Study|Lost to Follow-up|0|||
143118082|NCT03673345|515974291|FG002|Overall Study|Lost to Follow-up|3|||
143118083|NCT03673345|515974292|FG003|Overall Study|Lost to Follow-up|3|||
143118084|NCT03673345|515974293|FG004|Overall Study|Lost to Follow-up|2|||
143118085|NCT03673345|515974294|FG005|Overall Study|Lost to Follow-up|1|||
143118086|NCT03673345|515974295|FG006|Overall Study|Lost to Follow-up|0|||
143118087|NCT03673345|515974296|FG007|Overall Study|Lost to Follow-up|0|||
143118088|NCT03673345|515974289|FG000|Overall Study|Withdrawal by Subject|1|||
143118089|NCT03673345|515974290|FG001|Overall Study|Withdrawal by Subject|0|||
143118090|NCT03673345|515974291|FG002|Overall Study|Withdrawal by Subject|4|||
143118091|NCT03673345|515974292|FG003|Overall Study|Withdrawal by Subject|2|||
143118092|NCT03673345|515974293|FG004|Overall Study|Withdrawal by Subject|0|||
143118093|NCT03673345|515974294|FG005|Overall Study|Withdrawal by Subject|0|||
143118094|NCT03673345|515974295|FG006|Overall Study|Withdrawal by Subject|0|||
143118095|NCT03673345|515974296|FG007|Overall Study|Withdrawal by Subject|0|||
143118096|NCT03673345|515974289|FG000|Overall Study|Physician Decision|0|||
143118097|NCT03673345|515974290|FG001|Overall Study|Physician Decision|0|||
143118098|NCT03673345|515974291|FG002|Overall Study|Physician Decision|2|||
143118099|NCT03673345|515974292|FG003|Overall Study|Physician Decision|0|||
143118100|NCT03673345|515974293|FG004|Overall Study|Physician Decision|0|||
143118101|NCT03673345|515974294|FG005|Overall Study|Physician Decision|0|||
143118102|NCT03673345|515974295|FG006|Overall Study|Physician Decision|0|||
143118103|NCT03673345|515974296|FG007|Overall Study|Physician Decision|0|||
143118104|NCT01362244|515974297|FG000|Overall Study|Adverse Event|3|||
143118105|NCT01362244|515974298|FG001|Overall Study|Adverse Event|5|||
143118106|NCT01362244|515974297|FG000|Overall Study|Lack of Efficacy|5|||
143118107|NCT01362244|515974298|FG001|Overall Study|Lack of Efficacy|11|||
143118108|NCT01362244|515974297|FG000|Overall Study|Lost to Follow-up|0|||
143118109|NCT01362244|515974298|FG001|Overall Study|Lost to Follow-up|2|||
143118110|NCT01362244|515974297|FG000|Overall Study|Protocol Violation|5|||
143118111|NCT01362244|515974298|FG001|Overall Study|Protocol Violation|1|||
143118112|NCT01362244|515974297|FG000|Overall Study|Withdrawal by Subject|2|||
143118113|NCT01362244|515974298|FG001|Overall Study|Withdrawal by Subject|1|||
143118114|NCT01362244|515974297|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
143118115|NCT01362244|515974298|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
143118116|NCT01362244|515974297|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
143118117|NCT01362244|515974298|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
143118118|NCT04102865|515974299|FG000|Overall Study|Adverse Event|4|||
143118119|NCT04102865|515974300|FG001|Overall Study|Adverse Event|0|||
143118120|NCT04102865|515974299|FG000|Overall Study|Lost to Follow-up|1|||
143118121|NCT04102865|515974300|FG001|Overall Study|Lost to Follow-up|0|||
143118122|NCT04102865|515974299|FG000|Overall Study|Withdrawal by Subject|2|||
143118123|NCT04102865|515974300|FG001|Overall Study|Withdrawal by Subject|0|||
143118124|NCT02172040|515974304|FG000|Overall Study|Adverse Event|0|||
143118125|NCT02172040|515974305|FG001|Overall Study|Adverse Event|2|||
143118126|NCT02172040|515974306|FG002|Overall Study|Adverse Event|0|||
143118127|NCT02172040|515974307|FG003|Overall Study|Adverse Event|0|||
143118128|NCT02172040|515974304|FG000|Overall Study|Protocol Violation|0|||
143118129|NCT02172040|515974305|FG001|Overall Study|Protocol Violation|1|||
143118130|NCT02172040|515974306|FG002|Overall Study|Protocol Violation|0|||
143118131|NCT02172040|515974307|FG003|Overall Study|Protocol Violation|0|||
143118132|NCT02172040|515974304|FG000|Overall Study|Withdrawal by Subject|0|||
143118133|NCT02172040|515974305|FG001|Overall Study|Withdrawal by Subject|0|||
143118134|NCT02172040|515974306|FG002|Overall Study|Withdrawal by Subject|1|||
143118135|NCT02172040|515974307|FG003|Overall Study|Withdrawal by Subject|0|||
143118136|NCT02172040|515974304|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
143118137|NCT02172040|515974305|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
143118138|NCT02172040|515974306|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
143118139|NCT02172040|515974307|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
143118140|NCT02172040|515974304|FG000|Overall Study|Family emergency abroad|0|||
143118141|NCT02172040|515974305|FG001|Overall Study|Family emergency abroad|0|||
143118142|NCT02172040|515974306|FG002|Overall Study|Family emergency abroad|0|||
143118143|NCT02172040|515974307|FG003|Overall Study|Family emergency abroad|1|||
143118144|NCT02607306|515974308|FG000|Overall Study|Adverse Event|8|||
143118145|NCT02607306|515974309|FG001|Overall Study|Adverse Event|6|||
143118146|NCT02607306|515974310|FG002|Overall Study|Adverse Event|6|||
143118147|NCT02607306|515974308|FG000|Overall Study|Unclassified|1|||
143118148|NCT02607306|515974309|FG001|Overall Study|Unclassified|4|||
143118149|NCT02607306|515974310|FG002|Overall Study|Unclassified|0|||
143118150|NCT02607306|515974308|FG000|Overall Study|Withdrawal by Subject|8|||
143118151|NCT02607306|515974309|FG001|Overall Study|Withdrawal by Subject|10|||
143118152|NCT02607306|515974310|FG002|Overall Study|Withdrawal by Subject|2|||
143118153|NCT02607306|515974308|FG000|Overall Study|Lack of Efficacy|0|||
143118154|NCT02607306|515974309|FG001|Overall Study|Lack of Efficacy|1|||
143118155|NCT02607306|515974310|FG002|Overall Study|Lack of Efficacy|1|||
143118156|NCT02607306|515974308|FG000|Overall Study|Protocol Violation|4|||
143118157|NCT02607306|515974309|FG001|Overall Study|Protocol Violation|2|||
143118158|NCT02607306|515974310|FG002|Overall Study|Protocol Violation|1|||
143118159|NCT00388297|515976023|FG000|Overall Study|Lost to Follow-up|16|||
143118160|NCT00388297|515976024|FG001|Overall Study|Lost to Follow-up|12|||
143118161|NCT00388297|515976025|FG002|Overall Study|Lost to Follow-up|11|||
143118162|NCT00388297|515976026|FG003|Overall Study|Lost to Follow-up|8|||
143118163|NCT00427999|515976029|FG000|Overall Study|Adverse Event|6|||
143118164|NCT00427999|515976029|FG000|Overall Study|Abnormal laboratory values|1|||
143118165|NCT00427999|515976029|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
143118166|NCT00427999|515976029|FG000|Overall Study|Protocol Violation|2|||
143118167|NCT00427999|515976029|FG000|Overall Study|Withdrawal by Subject|9|||
143118168|NCT00427999|515976029|FG000|Overall Study|Death|1|||
143118169|NCT05323994|515976030|FG000|Overall Study|Protocol Violation|1|||
143118170|NCT03570554|515976031|FG000|Overall Study|Non-compliance with study drug|0|||
143118171|NCT03570554|515976032|FG001|Overall Study|Non-compliance with study drug|0|||
143458177|NCT01528345|517222800|FG001|Overall Study|Death|1|||
143458178|NCT01528345|517222799|FG000|Overall Study|Non-compliance with study treatment|1|||
143458179|NCT01528345|517222800|FG001|Overall Study|Non-compliance with study treatment|0|||
143458180|NCT01528345|517222799|FG000|Overall Study|Progressive Disease|26|||
143458181|NCT01528345|517222800|FG001|Overall Study|Progressive Disease|40|||
143458182|NCT01528345|517222799|FG000|Overall Study|Study Terminated by Sponsor|4|||
143458183|NCT01528345|517222800|FG001|Overall Study|Study Terminated by Sponsor|8|||
143458184|NCT01528345|517222799|FG000|Overall Study|Subject/Guardian Decision|5|||
143458185|NCT01528345|517222800|FG001|Overall Study|Subject/Guardian Decision|0|||
143458186|NCT00528645|517222801|FG000|Overall Study|Adverse Event|3|||
143458187|NCT01445301|517222802|FG000|Overall Study|Adverse Event|15|||
143458188|NCT01445301|517222803|FG001|Overall Study|Adverse Event|25|||
143458189|NCT01445301|517222804|FG002|Overall Study|Adverse Event|4|||
143458190|NCT01445301|517222802|FG000|Overall Study|Lack of Efficacy|0|||
143458191|NCT01445301|517222803|FG001|Overall Study|Lack of Efficacy|1|||
143458192|NCT01445301|517222804|FG002|Overall Study|Lack of Efficacy|0|||
143458193|NCT01445301|517222802|FG000|Overall Study|Protocol Violation|1|||
143458194|NCT01445301|517222803|FG001|Overall Study|Protocol Violation|0|||
143458195|NCT01445301|517222804|FG002|Overall Study|Protocol Violation|0|||
143458196|NCT01445301|517222802|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
143458197|NCT01445301|517222803|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
143458198|NCT01445301|517222804|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
143458199|NCT01445301|517222802|FG000|Overall Study|Physician Decision|0|||
143458200|NCT01445301|517222803|FG001|Overall Study|Physician Decision|2|||
143458201|NCT01445301|517222804|FG002|Overall Study|Physician Decision|0|||
143458202|NCT01445301|517222802|FG000|Overall Study|Withdrawal by Subject|5|||
143458203|NCT01445301|517222803|FG001|Overall Study|Withdrawal by Subject|6|||
143458204|NCT01445301|517222804|FG002|Overall Study|Withdrawal by Subject|4|||
143458205|NCT00752557|517222805|FG000|Overall Study|Withdrawal by Subject|4|||
143458206|NCT00752557|517222806|FG001|Overall Study|Withdrawal by Subject|3|||
143458207|NCT00752557|517222807|FG002|Overall Study|Withdrawal by Subject|3|||
143458208|NCT00752557|517222805|FG000|Overall Study|Unspecified resaons|0|||
143458209|NCT00752557|517222806|FG001|Overall Study|Unspecified resaons|2|||
143458210|NCT00752557|517222807|FG002|Overall Study|Unspecified resaons|2|||
143458211|NCT00752557|517222805|FG000|Overall Study|Lost to Follow-up|1|||
143458212|NCT00752557|517222806|FG001|Overall Study|Lost to Follow-up|0|||
143458213|NCT00752557|517222807|FG002|Overall Study|Lost to Follow-up|1|||
143458214|NCT02150343|517222812|FG000|Overall Study|Adverse Event|2|||
143458215|NCT02150343|517222813|FG001|Overall Study|Adverse Event|0|||
143458216|NCT02150343|517222814|FG002|Overall Study|Adverse Event|1|||
143458217|NCT02150343|517222815|FG003|Overall Study|Adverse Event|1|||
143458218|NCT02150343|517222812|FG000|Overall Study|Withdrawal by Subject|13|||
143458219|NCT02150343|517222813|FG001|Overall Study|Withdrawal by Subject|10|||
143458220|NCT02150343|517222814|FG002|Overall Study|Withdrawal by Subject|9|||
143458221|NCT02150343|517222815|FG003|Overall Study|Withdrawal by Subject|4|||
143458222|NCT02150343|517222812|FG000|Overall Study|Lost to Follow-up|4|||
143458223|NCT02150343|517222813|FG001|Overall Study|Lost to Follow-up|4|||
143458224|NCT02150343|517222814|FG002|Overall Study|Lost to Follow-up|2|||
143458225|NCT02150343|517222815|FG003|Overall Study|Lost to Follow-up|3|||
143458226|NCT02150343|517222812|FG000|Overall Study|Other|2|||
143458227|NCT02150343|517222813|FG001|Overall Study|Other|6|||
143458228|NCT02150343|517222814|FG002|Overall Study|Other|0|||
143458229|NCT02150343|517222815|FG003|Overall Study|Other|2|||
143458230|NCT02729753|517222816|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
143458231|NCT02729753|517222817|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
143458232|NCT00190749|517222818|FG000|Overall Study|Lost to Follow-up|8|||
143458233|NCT00190749|517222819|FG001|Overall Study|Lost to Follow-up|11|||
143458234|NCT00190749|517222818|FG000|Overall Study|Withdrawal by Subject|10|||
143458235|NCT00190749|517222819|FG001|Overall Study|Withdrawal by Subject|6|||
143458236|NCT00190749|517222818|FG000|Overall Study|Protocol Violation|5|||
143458237|NCT00190749|517222819|FG001|Overall Study|Protocol Violation|4|||
143458238|NCT00190749|517222818|FG000|Overall Study|Adverse Event|0|||
143458239|NCT00190749|517222819|FG001|Overall Study|Adverse Event|5|||
143458240|NCT00190749|517222818|FG000|Overall Study|Lack of Efficacy|2|||
143458241|NCT00190749|517222819|FG001|Overall Study|Lack of Efficacy|3|||
143458242|NCT00190749|517222818|FG000|Overall Study|Reason Not Specified|0|||
143458243|NCT00190749|517222819|FG001|Overall Study|Reason Not Specified|2|||
143458244|NCT00190749|517222818|FG000|Overall Study|Sponsor Decision|1|||
143458245|NCT00190749|517222819|FG001|Overall Study|Sponsor Decision|0|||
143458246|NCT01090427|517222820|FG000|After Controlled Period|Death|0|||
143458247|NCT01090427|517222821|FG001|After Controlled Period|Death|0|||
143458248|NCT01090427|517222822|FG002|After Controlled Period|Death|0|||
143458249|NCT01090427|517222823|FG003|After Controlled Period|Death|0|||
143458250|NCT01090427|517222824|FG004|After Controlled Period|Death|0|||
143458251|NCT01090427|517222825|FG005|After Controlled Period|Death|1|||
143458252|NCT01090427|517222826|FG006|After Controlled Period|Death|0|||
143458253|NCT01090427|517222820|FG000|After Controlled Period|Lack of Efficacy|0|||
143458254|NCT01090427|517222821|FG001|After Controlled Period|Lack of Efficacy|0|||
143458255|NCT01090427|517222822|FG002|After Controlled Period|Lack of Efficacy|0|||
143458256|NCT01090427|517222823|FG003|After Controlled Period|Lack of Efficacy|0|||
143458257|NCT01090427|517222824|FG004|After Controlled Period|Lack of Efficacy|0|||
143458258|NCT01090427|517222825|FG005|After Controlled Period|Lack of Efficacy|3|||
143458259|NCT01090427|517222826|FG006|After Controlled Period|Lack of Efficacy|2|||
143458260|NCT01090427|517222820|FG000|After Controlled Period|Adverse Event|0|||
143458261|NCT01090427|517222821|FG001|After Controlled Period|Adverse Event|0|||
143458262|NCT01090427|517222822|FG002|After Controlled Period|Adverse Event|0|||
143458263|NCT01090427|517222823|FG003|After Controlled Period|Adverse Event|2|||
143458264|NCT01090427|517222824|FG004|After Controlled Period|Adverse Event|0|||
143458265|NCT01090427|517222825|FG005|After Controlled Period|Adverse Event|1|||
143458266|NCT01090427|517222826|FG006|After Controlled Period|Adverse Event|0|||
143458267|NCT01154010|517222827|FG000|Overall Study|Lost to Follow-up|0|||
143458268|NCT01154010|517222828|FG001|Overall Study|Lost to Follow-up|1|||
143458269|NCT00439231|517222829|FG000|Overall Study|Lack of Efficacy|28|||
143458270|NCT01605916|517222830|FG000|Overall Study|Adverse Event|1|||
143458271|NCT01605916|517222831|FG001|Overall Study|Adverse Event|0|||
143458272|NCT01605916|517222832|FG002|Overall Study|Adverse Event|0|||
143458273|NCT01605916|517222833|FG003|Overall Study|Adverse Event|1|||
143458274|NCT01605916|517222834|FG004|Overall Study|Adverse Event|0|||
143458275|NCT01605916|517222830|FG000|Overall Study|Lack of Efficacy|2|||
143458276|NCT01605916|517222831|FG001|Overall Study|Lack of Efficacy|3|||
143458277|NCT01605916|517222832|FG002|Overall Study|Lack of Efficacy|3|||
143458278|NCT01605916|517222833|FG003|Overall Study|Lack of Efficacy|5|||
143458279|NCT01605916|517222834|FG004|Overall Study|Lack of Efficacy|4|||
143458280|NCT01605916|517222830|FG000|Overall Study|Withdrawal by Subject|1|||
143458281|NCT01605916|517222831|FG001|Overall Study|Withdrawal by Subject|1|||
143458282|NCT01605916|517222832|FG002|Overall Study|Withdrawal by Subject|0|||
143458283|NCT01605916|517222833|FG003|Overall Study|Withdrawal by Subject|0|||
143458284|NCT01605916|517222834|FG004|Overall Study|Withdrawal by Subject|2|||
143458285|NCT01048671|517222843|FG000|Overall Study|Protocol Violation|0|||
143458286|NCT01048671|517222844|FG001|Overall Study|Protocol Violation|1|||
143458287|NCT01048671|517222845|FG002|Overall Study|Protocol Violation|1|||
143458288|NCT00296400|517222846|FG000|Overall Study|Adverse Event|7|||
143458289|NCT00296400|517222847|FG001|Overall Study|Adverse Event|7|||
143458290|NCT00296400|517222848|FG002|Overall Study|Adverse Event|7|||
143458291|NCT00296400|517222846|FG000|Overall Study|Withdrawal by Subject|5|||
143458292|NCT00296400|517222847|FG001|Overall Study|Withdrawal by Subject|6|||
143458293|NCT00296400|517222848|FG002|Overall Study|Withdrawal by Subject|2|||
143458294|NCT00296400|517222846|FG000|Overall Study|Incorrect enrollment|2|||
143458295|NCT00296400|517222847|FG001|Overall Study|Incorrect enrollment|0|||
143458296|NCT00296400|517222848|FG002|Overall Study|Incorrect enrollment|0|||
143458297|NCT00296400|517222846|FG000|Overall Study|Protocol Violation|1|||
143458298|NCT00296400|517222847|FG001|Overall Study|Protocol Violation|1|||
143458299|NCT00296400|517222848|FG002|Overall Study|Protocol Violation|1|||
143458300|NCT00296400|517222846|FG000|Overall Study|Lost to Follow-up|1|||
143458301|NCT00296400|517222847|FG001|Overall Study|Lost to Follow-up|1|||
143458302|NCT00296400|517222848|FG002|Overall Study|Lost to Follow-up|2|||
143458303|NCT00296400|517222846|FG000|Overall Study|Study specific discontinuation criteria|0|||
143458304|NCT00296400|517222847|FG001|Overall Study|Study specific discontinuation criteria|0|||
143458305|NCT00296400|517222848|FG002|Overall Study|Study specific discontinuation criteria|1|||
143458306|NCT00296400|517222846|FG000|Overall Study|Visit 10 was performed earlier|0|||
143458307|NCT00296400|517222847|FG001|Overall Study|Visit 10 was performed earlier|1|||
143458308|NCT00296400|517222848|FG002|Overall Study|Visit 10 was performed earlier|0|||
143458309|NCT00296400|517222846|FG000|Overall Study|Pregnancy|1|||
143458310|NCT00296400|517222847|FG001|Overall Study|Pregnancy|2|||
143458311|NCT00296400|517222848|FG002|Overall Study|Pregnancy|0|||
143458312|NCT01014533|517222849|FG000|Overall Study|Protocol Violation|3|||
143458313|NCT01014533|517222850|FG001|Overall Study|Protocol Violation|2|||
143458314|NCT01014533|517222849|FG000|Overall Study|Withdrawal by Subject|2|||
143458315|NCT01014533|517222850|FG001|Overall Study|Withdrawal by Subject|0|||
143458316|NCT01014533|517222849|FG000|Overall Study|unable to come to appointment|0|||
143458317|NCT01014533|517222850|FG001|Overall Study|unable to come to appointment|3|||
143458318|NCT00412061|517222855|FG000|Double Blind Phase|Disease Progression|101|||
143458319|NCT00412061|517222856|FG001|Double Blind Phase|Disease Progression|154|||
143458320|NCT00412061|517222855|FG000|Double Blind Phase|Adverse Event|61|||
143458321|NCT00412061|517222856|FG001|Double Blind Phase|Adverse Event|16|||
143458322|NCT00412061|517222855|FG000|Double Blind Phase|Final Primary Analysis|26|||
143458323|NCT00412061|517222856|FG001|Double Blind Phase|Final Primary Analysis|14|||
143458324|NCT00412061|517222855|FG000|Double Blind Phase|Withdrawal by Subject|18|||
143458325|NCT00412061|517222856|FG001|Double Blind Phase|Withdrawal by Subject|20|||
143458326|NCT00412061|517222855|FG000|Double Blind Phase|Death|6|||
143458327|NCT00412061|517222856|FG001|Double Blind Phase|Death|3|||
143458328|NCT00412061|517222855|FG000|Double Blind Phase|Protocol Violation|3|||
143458329|NCT00412061|517222856|FG001|Double Blind Phase|Protocol Violation|4|||
143458330|NCT00412061|517222855|FG000|Double Blind Phase|New Cander Therapy|1|||
143458331|NCT00412061|517222856|FG001|Double Blind Phase|New Cander Therapy|1|||
143458332|NCT00412061|517222855|FG000|Double Blind Phase|Lost to Follow-up|0|||
143458333|NCT00412061|517222856|FG001|Double Blind Phase|Lost to Follow-up|1|||
143458334|NCT00412061|517222855|FG000|Open Label Phase|Disease Progression|0|||
143458335|NCT00412061|517222856|FG001|Open Label Phase|Disease Progression|86|||
143458336|NCT00412061|517222855|FG000|Open Label Phase|Adverse Event|0|||
143458337|NCT00412061|517222856|FG001|Open Label Phase|Adverse Event|46|||
143458338|NCT00412061|517222855|FG000|Open Label Phase|Withdrawal by Subject|0|||
143458339|NCT00412061|517222856|FG001|Open Label Phase|Withdrawal by Subject|15|||
143458340|NCT00412061|517222855|FG000|Open Label Phase|Administrative Problems|0|||
143458341|NCT00412061|517222856|FG001|Open Label Phase|Administrative Problems|13|||
143458342|NCT00412061|517222855|FG000|Open Label Phase|Death|0|||
143458343|NCT00412061|517222856|FG001|Open Label Phase|Death|7|||
143458344|NCT00412061|517222855|FG000|Open Label Phase|Lost to Follow-up|0|||
143458345|NCT00412061|517222856|FG001|Open Label Phase|Lost to Follow-up|2|||
143458346|NCT00412061|517222855|FG000|Open Label Phase|New Cancer Therapy|0|||
143458347|NCT00412061|517222856|FG001|Open Label Phase|New Cancer Therapy|1|||
143458348|NCT02689518|517222858|FG000|Overall Study|Withdrawal by Subject|3|||
143458349|NCT02433340|517222862|FG000|Overall Study|Adverse Event|0|||
143458350|NCT02433340|517222863|FG001|Overall Study|Adverse Event|0|||
143458351|NCT02433340|517222864|FG002|Overall Study|Adverse Event|1|||
143458352|NCT02433340|517222865|FG003|Overall Study|Adverse Event|0|||
143458353|NCT02433340|517222862|FG000|Overall Study|Withdrawal by Subject|1|||
143458354|NCT02433340|517222863|FG001|Overall Study|Withdrawal by Subject|0|||
143458355|NCT02433340|517222864|FG002|Overall Study|Withdrawal by Subject|1|||
143458356|NCT02433340|517222865|FG003|Overall Study|Withdrawal by Subject|2|||
143458357|NCT02433340|517222862|FG000|Overall Study|Lost to Follow-up|0|||
143458358|NCT02433340|517222863|FG001|Overall Study|Lost to Follow-up|1|||
143458359|NCT02433340|517222864|FG002|Overall Study|Lost to Follow-up|0|||
143458360|NCT02433340|517222865|FG003|Overall Study|Lost to Follow-up|0|||
143458361|NCT02433340|517222862|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
143458362|NCT02433340|517222863|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
143458363|NCT02433340|517222864|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
143458364|NCT02433340|517222865|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
143458365|NCT02433340|517222862|FG000|Overall Study|Other|0|||
143458366|NCT02433340|517222863|FG001|Overall Study|Other|1|||
143458367|NCT02433340|517222864|FG002|Overall Study|Other|0|||
143458368|NCT02433340|517222865|FG003|Overall Study|Other|0|||
143458369|NCT01178385|517222866|FG000|Overall Study|Withdrawal by Subject|2|||
143458370|NCT01178385|517222867|FG001|Overall Study|Withdrawal by Subject|0|||
143458371|NCT01688830|517222870|FG000|Overall Study|Lost to Follow-up|0|||
143458372|NCT01688830|517222871|FG001|Overall Study|Lost to Follow-up|0|||
143458373|NCT01688830|517222872|FG002|Overall Study|Lost to Follow-up|0|||
143458374|NCT01688830|517222873|FG003|Overall Study|Lost to Follow-up|0|||
143458375|NCT01688830|517222874|FG004|Overall Study|Lost to Follow-up|0|||
143458376|NCT01688830|517222875|FG005|Overall Study|Lost to Follow-up|0|||
143458377|NCT01688830|517222876|FG006|Overall Study|Lost to Follow-up|0|||
143458378|NCT01688830|517222877|FG007|Overall Study|Lost to Follow-up|0|||
143458379|NCT01688830|517222878|FG008|Overall Study|Lost to Follow-up|0|||
143458380|NCT01688830|517222879|FG009|Overall Study|Lost to Follow-up|0|||
143458381|NCT01688830|517222880|FG010|Overall Study|Lost to Follow-up|1|||
143458382|NCT01688830|517222881|FG011|Overall Study|Lost to Follow-up|0|||
143458383|NCT01688830|517222882|FG012|Overall Study|Lost to Follow-up|0|||
143458384|NCT01688830|517222883|FG013|Overall Study|Lost to Follow-up|0|||
143458385|NCT01688830|517222884|FG014|Overall Study|Lost to Follow-up|0|||
143458386|NCT01688830|517222885|FG015|Overall Study|Lost to Follow-up|0|||
143458387|NCT01688830|517222886|FG016|Overall Study|Lost to Follow-up|0|||
143458388|NCT01688830|517222887|FG017|Overall Study|Lost to Follow-up|0|||
143458389|NCT01688830|517222888|FG018|Overall Study|Lost to Follow-up|0|||
143458390|NCT01688830|517222889|FG019|Overall Study|Lost to Follow-up|0|||
143458391|NCT01688830|517222890|FG020|Overall Study|Lost to Follow-up|0|||
143458392|NCT02679508|517222892|FG000|Healing Phase|Protocol Violation|1|||
143458393|NCT02679508|517222893|FG001|Healing Phase|Protocol Violation|1|||
143458394|NCT02679508|517222892|FG000|Healing Phase|Lost to Follow-up|1|||
143458395|NCT02679508|517222893|FG001|Healing Phase|Lost to Follow-up|0|||
143458396|NCT02679508|517222892|FG000|Maintenance Phase|Adverse Event|12|||
143458397|NCT02679508|517222893|FG001|Maintenance Phase|Adverse Event|2|||
143458398|NCT02679508|517222892|FG000|Maintenance Phase|Lost to Follow-up|0|||
143458399|NCT02679508|517222893|FG001|Maintenance Phase|Lost to Follow-up|1|||
143458400|NCT02679508|517222892|FG000|Maintenance Phase|Withdrawal by Subject|15|||
143458401|NCT02679508|517222893|FG001|Maintenance Phase|Withdrawal by Subject|8|||
143458402|NCT02679508|517222892|FG000|Maintenance Phase|Other|5|||
143458403|NCT02679508|517222893|FG001|Maintenance Phase|Other|4|||
143458404|NCT03143166|517222894|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
143458405|NCT00589121|517222899|FG000|Overall Study|Protocol Violation|2|||
143458406|NCT00589121|517222900|FG001|Overall Study|Protocol Violation|6|||
143458407|NCT00589121|517222899|FG000|Overall Study|No protocol treatment received|0|||
143458408|NCT00589121|517222900|FG001|Overall Study|No protocol treatment received|1|||
143458409|NCT00847808|517222901|FG000|Overall Study|Adverse Event|7|||
143458410|NCT00847808|517222901|FG000|Overall Study|Protocol Violation|1|||
143458411|NCT00847808|517222901|FG000|Overall Study|Lost to Follow-up|1|||
143458412|NCT00847808|517222901|FG000|Overall Study|Withdrawal by Subject|4|||
143458413|NCT00847808|517222901|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
143458414|NCT00847808|517222901|FG000|Overall Study|Participant Took Excluded Medication|1|||
143458415|NCT05326815|517222902|FG000|Overall Study|Withdrawal by Subject|3|||
143458416|NCT05326815|517222902|FG000|Overall Study|Did not complete required labs|6|||
143458417|NCT05326815|517222902|FG000|Overall Study|Screen fail- abnormal labs|5|||
143458418|NCT00925132|517222903|FG000|Overall Study|Withdrawal by Subject|2|||
143458419|NCT00925132|517222904|FG001|Overall Study|Withdrawal by Subject|0|||
143458420|NCT00925132|517222905|FG002|Overall Study|Withdrawal by Subject|0|||
143458421|NCT00925132|517222906|FG003|Overall Study|Withdrawal by Subject|0|||
143458422|NCT00925132|517222907|FG004|Overall Study|Withdrawal by Subject|1|||
143458423|NCT00925132|517222903|FG000|Overall Study|Removed due to disease progression|0|||
143458424|NCT00925132|517222904|FG001|Overall Study|Removed due to disease progression|0|||
143458425|NCT00925132|517222905|FG002|Overall Study|Removed due to disease progression|0|||
143458426|NCT00925132|517222906|FG003|Overall Study|Removed due to disease progression|0|||
143458427|NCT00925132|517222907|FG004|Overall Study|Removed due to disease progression|4|||
143458428|NCT02545933|517222908|FG000|Overall Study|Adverse Event|3|||
143458429|NCT02545933|517222909|FG001|Overall Study|Adverse Event|0|||
143458430|NCT02545933|517222910|FG002|Overall Study|Adverse Event|0|||
143458431|NCT02545933|517222908|FG000|Overall Study|Withdrawal by Subject|2|||
143458432|NCT02545933|517222909|FG001|Overall Study|Withdrawal by Subject|3|||
143458433|NCT02545933|517222910|FG002|Overall Study|Withdrawal by Subject|3|||
143458434|NCT02545933|517222908|FG000|Overall Study|Protocol Violation|1|||
143458435|NCT02545933|517222909|FG001|Overall Study|Protocol Violation|0|||
143458436|NCT02545933|517222910|FG002|Overall Study|Protocol Violation|1|||
143458437|NCT01370590|517222911|FG000|Period 1|Adverse Event|8|||
143458438|NCT01370590|517222912|FG001|Period 1|Adverse Event|4|||
143458439|NCT01370590|517222911|FG000|Period 1|Lost to Follow-up|2|||
143458440|NCT01370590|517222912|FG001|Period 1|Lost to Follow-up|2|||
143458441|NCT01370590|517222911|FG000|Period 1|Protocol Violation|2|||
143458442|NCT01370590|517222912|FG001|Period 1|Protocol Violation|2|||
143458443|NCT01370590|517222911|FG000|Period 1|Withdrawal by Subject|4|||
143458444|NCT01370590|517222912|FG001|Period 1|Withdrawal by Subject|2|||
143458445|NCT01370590|517222911|FG000|Period 1|Could not access randomization system|0|||
143458446|NCT01370590|517222912|FG001|Period 1|Could not access randomization system|1|||
143458447|NCT01370590|517222911|FG000|Crossover Washout Period|Adverse Event|1|||
143458448|NCT01370590|517222912|FG001|Crossover Washout Period|Adverse Event|4|||
143458449|NCT01370590|517222911|FG000|Crossover Washout Period|Lost to Follow-up|2|||
143458450|NCT01370590|517222912|FG001|Crossover Washout Period|Lost to Follow-up|0|||
143458451|NCT01370590|517222911|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
143458452|NCT01370590|517222912|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
143458453|NCT01370590|517222911|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
143458454|NCT01370590|517222912|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
143458455|NCT01370590|517222911|FG000|Period 2|Adverse Event|0|||
143458456|NCT01370590|517222912|FG001|Period 2|Adverse Event|1|||
143458457|NCT01370590|517222911|FG000|Period 2|Withdrawal by Subject|1|||
143458458|NCT01370590|517222912|FG001|Period 2|Withdrawal by Subject|1|||
143458459|NCT05172050|517222913|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
143458460|NCT05172050|517222914|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
143458461|NCT05172050|517222915|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
143458462|NCT05172050|517222913|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
143458463|NCT05172050|517222914|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
143458464|NCT05172050|517222915|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
143458465|NCT05172050|517222913|FG000|Overall Study|Other|2|||
143458466|NCT05172050|517222914|FG001|Overall Study|Other|2|||
143458467|NCT05172050|517222915|FG002|Overall Study|Other|1|||
143458468|NCT05180500|517222916|FG000|Overall Study|Adverse Event|1|||
143458469|NCT05180500|517222917|FG001|Overall Study|Adverse Event|0|||
143458470|NCT05180500|517222916|FG000|Overall Study|Withdrawal by Subject|2|||
143458471|NCT05180500|517222917|FG001|Overall Study|Withdrawal by Subject|0|||
143458472|NCT03992846|517222918|FG000|Overall Study|Adverse Event|8|||
143458473|NCT03992846|517222919|FG001|Overall Study|Adverse Event|6|||
143458474|NCT03992846|517222920|FG002|Overall Study|Adverse Event|3|||
143458475|NCT03992846|517222918|FG000|Overall Study|Lost to Follow-up|0|||
143458476|NCT03992846|517222919|FG001|Overall Study|Lost to Follow-up|1|||
143458477|NCT03992846|517222920|FG002|Overall Study|Lost to Follow-up|1|||
143458478|NCT03992846|517222918|FG000|Overall Study|Pregnancy|2|||
143458479|NCT03992846|517222919|FG001|Overall Study|Pregnancy|0|||
143458480|NCT03992846|517222920|FG002|Overall Study|Pregnancy|1|||
143458481|NCT03992846|517222918|FG000|Overall Study|Protocol Violation|1|||
143458482|NCT03992846|517222919|FG001|Overall Study|Protocol Violation|2|||
143458483|NCT03992846|517222920|FG002|Overall Study|Protocol Violation|0|||
143458484|NCT03992846|517222918|FG000|Overall Study|Withdrawal by Subject|8|||
143458485|NCT03992846|517222919|FG001|Overall Study|Withdrawal by Subject|10|||
143458486|NCT03992846|517222920|FG002|Overall Study|Withdrawal by Subject|20|||
143458487|NCT03992846|517222918|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
143458488|NCT03992846|517222919|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
143458489|NCT03992846|517222920|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
143458490|NCT00734097|517224587|FG000|Screening|Protocol Violation|12|||
143458491|NCT00734097|517224587|FG000|Screening|Withdrawal by Subject|5|||
143458492|NCT00734097|517224587|FG000|Screening|Lost to Follow-up|2|||
143458493|NCT00734097|517224587|FG000|Screening|Unconfirmed pregnancy|1|||
143458494|NCT00734097|517224587|FG000|Open Label|Lost to Follow-up|7|||
143458495|NCT00734097|517224587|FG000|Open Label|Withdrawal by Subject|5|||
143458496|NCT00734097|517224587|FG000|Open Label|Protocol Violation|4|||
143458497|NCT01773291|517224590|FG000|Overall Study|Protocol Violation|1|||
143458498|NCT01773291|517224591|FG001|Overall Study|Protocol Violation|0|||
143458499|NCT01773291|517224592|FG002|Overall Study|Protocol Violation|0|||
143458500|NCT01773291|517224590|FG000|Overall Study|Withdrawal by Subject|0|||
143458501|NCT01773291|517224591|FG001|Overall Study|Withdrawal by Subject|0|||
143458502|NCT01773291|517224592|FG002|Overall Study|Withdrawal by Subject|1|||
143458503|NCT01491672|517224593|FG000|Overall Study|Lost to Follow-up|0|||
143458504|NCT01491672|517224594|FG001|Overall Study|Lost to Follow-up|4|||
143458505|NCT01491672|517224595|FG002|Overall Study|Lost to Follow-up|1|||
143458506|NCT01491672|517224593|FG000|Overall Study|Withdrawal by Subject|6|||
143458507|NCT01491672|517224594|FG001|Overall Study|Withdrawal by Subject|7|||
143458508|NCT01491672|517224595|FG002|Overall Study|Withdrawal by Subject|0|||
143458509|NCT01491672|517224593|FG000|Overall Study|Adverse Event|8|||
143458510|NCT01491672|517224594|FG001|Overall Study|Adverse Event|10|||
143458511|NCT01491672|517224595|FG002|Overall Study|Adverse Event|4|||
143458512|NCT01491672|517224593|FG000|Overall Study|Disease progression|42|||
143458513|NCT01491672|517224594|FG001|Overall Study|Disease progression|34|||
143458514|NCT01491672|517224595|FG002|Overall Study|Disease progression|6|||
143458515|NCT01491672|517224593|FG000|Overall Study|Protocol deviation|0|||
143458516|NCT01491672|517224594|FG001|Overall Study|Protocol deviation|1|||
143458517|NCT01491672|517224595|FG002|Overall Study|Protocol deviation|0|||
143458518|NCT01491672|517224593|FG000|Overall Study|Death|0|||
143458519|NCT01491672|517224594|FG001|Overall Study|Death|4|||
143458520|NCT01491672|517224595|FG002|Overall Study|Death|0|||
143458521|NCT03064035|517224596|FG000|Overall Study|Did not receive allocated intervention|4|||
143458522|NCT03064035|517224597|FG001|Overall Study|Did not receive allocated intervention|2|||
143458523|NCT03064035|517224596|FG000|Overall Study|Lost to Follow-up|1|||
143458524|NCT03064035|517224597|FG001|Overall Study|Lost to Follow-up|1|||
143458525|NCT01874431|517224600|FG000|Overall Study|Physician Decision|0|||
143458526|NCT01874431|517224601|FG001|Overall Study|Physician Decision|0|||
143458527|NCT01874431|517224602|FG002|Overall Study|Physician Decision|1|||
143458528|NCT01874431|517224603|FG003|Overall Study|Physician Decision|0|||
143458529|NCT01874431|517224604|FG004|Overall Study|Physician Decision|0|||
143458530|NCT01874431|517224605|FG005|Overall Study|Physician Decision|0|||
143458531|NCT01874431|517224606|FG006|Overall Study|Physician Decision|0|||
143458532|NCT01874431|517224607|FG007|Overall Study|Physician Decision|0|||
143458533|NCT01874431|517224600|FG000|Overall Study|Adverse Event|5|||
143458534|NCT01874431|517224601|FG001|Overall Study|Adverse Event|4|||
143458535|NCT01874431|517224602|FG002|Overall Study|Adverse Event|6|||
143458536|NCT01874431|517224603|FG003|Overall Study|Adverse Event|5|||
143344469|NCT02118337|516806706|FG008|Overall Study|Death|4|||
143458537|NCT01874431|517224604|FG004|Overall Study|Adverse Event|2|||
143458538|NCT01874431|517224605|FG005|Overall Study|Adverse Event|8|||
143458539|NCT01874431|517224606|FG006|Overall Study|Adverse Event|2|||
143458540|NCT01874431|517224607|FG007|Overall Study|Adverse Event|3|||
143458541|NCT01874431|517224600|FG000|Overall Study|Protocol Violation|1|||
143458542|NCT01874431|517224601|FG001|Overall Study|Protocol Violation|1|||
143458543|NCT01874431|517224602|FG002|Overall Study|Protocol Violation|1|||
143458544|NCT01874431|517224603|FG003|Overall Study|Protocol Violation|0|||
143458545|NCT01874431|517224604|FG004|Overall Study|Protocol Violation|3|||
143458546|NCT01874431|517224605|FG005|Overall Study|Protocol Violation|2|||
143458547|NCT01874431|517224606|FG006|Overall Study|Protocol Violation|1|||
143458548|NCT01874431|517224607|FG007|Overall Study|Protocol Violation|1|||
143458549|NCT01874431|517224600|FG000|Overall Study|Non-compliance|0|||
143458550|NCT01874431|517224601|FG001|Overall Study|Non-compliance|0|||
143458551|NCT01874431|517224602|FG002|Overall Study|Non-compliance|0|||
143458552|NCT01874431|517224603|FG003|Overall Study|Non-compliance|0|||
143458553|NCT01874431|517224604|FG004|Overall Study|Non-compliance|1|||
143458554|NCT01874431|517224605|FG005|Overall Study|Non-compliance|0|||
143458555|NCT01874431|517224606|FG006|Overall Study|Non-compliance|1|||
143458556|NCT01874431|517224607|FG007|Overall Study|Non-compliance|0|||
143458557|NCT01874431|517224600|FG000|Overall Study|Logistical difficulties|0|||
143458558|NCT01874431|517224601|FG001|Overall Study|Logistical difficulties|0|||
143458559|NCT01874431|517224602|FG002|Overall Study|Logistical difficulties|0|||
143458560|NCT01874431|517224603|FG003|Overall Study|Logistical difficulties|0|||
143458561|NCT01874431|517224604|FG004|Overall Study|Logistical difficulties|0|||
143458562|NCT01874431|517224605|FG005|Overall Study|Logistical difficulties|0|||
143458563|NCT01874431|517224606|FG006|Overall Study|Logistical difficulties|1|||
143458564|NCT01874431|517224607|FG007|Overall Study|Logistical difficulties|0|||
143458565|NCT01874431|517224600|FG000|Overall Study|Withdrawal by Subject|0|||
143458566|NCT01874431|517224601|FG001|Overall Study|Withdrawal by Subject|0|||
143458567|NCT01874431|517224602|FG002|Overall Study|Withdrawal by Subject|1|||
143458568|NCT01874431|517224603|FG003|Overall Study|Withdrawal by Subject|2|||
143458569|NCT01874431|517224604|FG004|Overall Study|Withdrawal by Subject|1|||
143458570|NCT01874431|517224605|FG005|Overall Study|Withdrawal by Subject|1|||
143458571|NCT01874431|517224606|FG006|Overall Study|Withdrawal by Subject|3|||
143458572|NCT01874431|517224607|FG007|Overall Study|Withdrawal by Subject|0|||
143458573|NCT01874431|517224600|FG000|Overall Study|Sponsor decision|0|||
143458574|NCT01874431|517224601|FG001|Overall Study|Sponsor decision|0|||
143458575|NCT01874431|517224602|FG002|Overall Study|Sponsor decision|0|||
143458576|NCT01874431|517224603|FG003|Overall Study|Sponsor decision|0|||
143458577|NCT01874431|517224604|FG004|Overall Study|Sponsor decision|1|||
143458578|NCT01874431|517224605|FG005|Overall Study|Sponsor decision|0|||
143458579|NCT01874431|517224606|FG006|Overall Study|Sponsor decision|0|||
143458580|NCT01874431|517224607|FG007|Overall Study|Sponsor decision|0|||
143458581|NCT01874431|517224600|FG000|Overall Study|Lost to Follow-up|0|||
143458582|NCT01874431|517224601|FG001|Overall Study|Lost to Follow-up|0|||
143458583|NCT01874431|517224602|FG002|Overall Study|Lost to Follow-up|1|||
143458584|NCT01874431|517224603|FG003|Overall Study|Lost to Follow-up|0|||
143458585|NCT01874431|517224604|FG004|Overall Study|Lost to Follow-up|0|||
143458586|NCT01874431|517224605|FG005|Overall Study|Lost to Follow-up|0|||
143458587|NCT01874431|517224606|FG006|Overall Study|Lost to Follow-up|0|||
143458588|NCT01874431|517224607|FG007|Overall Study|Lost to Follow-up|0|||
143458589|NCT03038438|517224613|FG000|Overall Study|Death|3|||
143458590|NCT03038438|517224613|FG000|Overall Study|Lost to Follow-up|8|||
143458591|NCT03038438|517224613|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
143458592|NCT03038438|517224613|FG000|Overall Study|Withdrawal by Subject|5|||
143458593|NCT03038438|517224613|FG000|Overall Study|No 36-Month Follow-Up|18|||
143458594|NCT03215810|517224614|FG000|Overall Study|Still responding to nivolumab|1|||
143458595|NCT03215810|517224614|FG000|Overall Study|Insufficient TIL growth|1|||
143458596|NCT03215810|517224614|FG000|Overall Study|Decline in performance status|1|||
143458597|NCT03215810|517224614|FG000|Overall Study|Withdrawal by Subject|1|||
143458598|NCT02647866|517224615|FG000|Overall Study|Adverse Event|0|||
143458599|NCT02647866|517224616|FG001|Overall Study|Adverse Event|0|||
143458600|NCT02647866|517224617|FG002|Overall Study|Adverse Event|2|||
143458601|NCT02647866|517224618|FG003|Overall Study|Adverse Event|2|||
143458602|NCT02647866|517224619|FG004|Overall Study|Adverse Event|1|||
143458603|NCT02647866|517224615|FG000|Overall Study|Disease Worsening|3|||
143458604|NCT02647866|517224616|FG001|Overall Study|Disease Worsening|1|||
143458605|NCT02647866|517224617|FG002|Overall Study|Disease Worsening|0|||
143458606|NCT02647866|517224618|FG003|Overall Study|Disease Worsening|0|||
143458607|NCT02647866|517224619|FG004|Overall Study|Disease Worsening|1|||
143458608|NCT02647866|517224615|FG000|Overall Study|Withdrawal by Subject|1|||
143458609|NCT02647866|517224616|FG001|Overall Study|Withdrawal by Subject|1|||
143458610|NCT02647866|517224617|FG002|Overall Study|Withdrawal by Subject|2|||
143458611|NCT02647866|517224618|FG003|Overall Study|Withdrawal by Subject|4|||
143458612|NCT02647866|517224619|FG004|Overall Study|Withdrawal by Subject|4|||
143458613|NCT02647866|517224615|FG000|Overall Study|Physician Decision|0|||
143458614|NCT02647866|517224616|FG001|Overall Study|Physician Decision|1|||
143458615|NCT02647866|517224617|FG002|Overall Study|Physician Decision|1|||
143458616|NCT02647866|517224618|FG003|Overall Study|Physician Decision|0|||
143458617|NCT02647866|517224619|FG004|Overall Study|Physician Decision|2|||
143458618|NCT02647866|517224615|FG000|Overall Study|Death|0|||
143458619|NCT02647866|517224616|FG001|Overall Study|Death|1|||
143458620|NCT02647866|517224617|FG002|Overall Study|Death|0|||
143458621|NCT02647866|517224618|FG003|Overall Study|Death|0|||
143458622|NCT02647866|517224619|FG004|Overall Study|Death|0|||
143458623|NCT02647866|517224615|FG000|Overall Study|Subject moved to different country|1|||
143458624|NCT02647866|517224616|FG001|Overall Study|Subject moved to different country|0|||
143458625|NCT02647866|517224617|FG002|Overall Study|Subject moved to different country|0|||
143458626|NCT02647866|517224618|FG003|Overall Study|Subject moved to different country|0|||
143458627|NCT02647866|517224619|FG004|Overall Study|Subject moved to different country|0|||
143458628|NCT03406260|517224620|FG000|Period 1|Adverse Event|0|||
143458629|NCT03406260|517224621|FG001|Period 1|Adverse Event|0|||
143458630|NCT03406260|517224622|FG002|Period 1|Adverse Event|0|||
143458631|NCT03406260|517224623|FG003|Period 1|Adverse Event|0|||
143458632|NCT03406260|517224624|FG004|Period 1|Adverse Event|1|||
143458633|NCT03406260|517224625|FG005|Period 1|Adverse Event|0|||
143458634|NCT00523640|517224634|FG000|Overall Study|Death|1|||
143458635|NCT02399254|517224635|FG000|Overall Study|Physician Decision|2|||
143458636|NCT02334423|517224636|FG000|Overall Study|Protocol Violation|10|||
143458637|NCT02334423|517224637|FG001|Overall Study|Protocol Violation|3|||
143458638|NCT02930226|517224638|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
143458639|NCT02930226|517224639|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
143458640|NCT02930226|517224640|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
143458641|NCT02930226|517224641|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
143458642|NCT02930226|517224642|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
143458643|NCT02930226|517224643|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
143458644|NCT00652327|517224644|FG000|Overall Study|Adverse Event|0|||
143458645|NCT00652327|517224645|FG001|Overall Study|Adverse Event|2|||
143458646|NCT00652327|517224644|FG000|Overall Study|Lost to Follow-up|0|||
143458647|NCT00652327|517224645|FG001|Overall Study|Lost to Follow-up|3|||
143458648|NCT01076647|517224646|FG000|Overall Study|Adverse Event|4|||
143458649|NCT01076647|517224647|FG001|Overall Study|Adverse Event|1|||
143458650|NCT01076647|517224646|FG000|Overall Study|Lack of Efficacy|0|||
143458651|NCT01076647|517224647|FG001|Overall Study|Lack of Efficacy|1|||
143458652|NCT01076647|517224646|FG000|Overall Study|Protocol Violation|7|||
143458653|NCT01076647|517224647|FG001|Overall Study|Protocol Violation|9|||
143458654|NCT01076647|517224646|FG000|Overall Study|Withdrawal criteria|2|||
143458655|NCT01076647|517224647|FG001|Overall Study|Withdrawal criteria|2|||
143458656|NCT01076647|517224646|FG000|Overall Study|Unclassified|12|||
143458657|NCT01076647|517224647|FG001|Overall Study|Unclassified|12|||
143458658|NCT00141219|517224655|FG000|Overall Study|Protocol violations|5|||
143458659|NCT00141219|517224656|FG001|Overall Study|Protocol violations|4|||
143458660|NCT00141219|517224655|FG000|Overall Study|Adverse Event|8|||
143458661|NCT00141219|517224656|FG001|Overall Study|Adverse Event|6|||
143458662|NCT00141219|517224655|FG000|Overall Study|Lack of Efficacy|5|||
143458663|NCT00141219|517224656|FG001|Overall Study|Lack of Efficacy|4|||
143458664|NCT00141219|517224655|FG000|Overall Study|Withdrawal by Subject|6|||
143458665|NCT00141219|517224656|FG001|Overall Study|Withdrawal by Subject|2|||
143458666|NCT02224690|517224657|FG000|Overall Study|Adverse Event|8|||
143458667|NCT02224690|517224658|FG001|Overall Study|Adverse Event|1|||
143458668|NCT02224690|517224657|FG000|Overall Study|Met Withdrawal Criteria|4|||
143458669|NCT02224690|517224658|FG001|Overall Study|Met Withdrawal Criteria|0|||
143458670|NCT02224690|517224657|FG000|Overall Study|Use of G-tube|1|||
143458671|NCT02224690|517224658|FG001|Overall Study|Use of G-tube|0|||
143458672|NCT02224690|517224657|FG000|Overall Study|Did not meet eligibility criteria|1|||
143458673|NCT02224690|517224658|FG001|Overall Study|Did not meet eligibility criteria|0|||
143458674|NCT01577745|517224659|FG000|Overall Study|Withdrawal by Subject|0|||
143458675|NCT01577745|517224660|FG001|Overall Study|Withdrawal by Subject|1|||
143458676|NCT01577745|517224661|FG002|Overall Study|Withdrawal by Subject|0|||
143458677|NCT01577745|517224662|FG003|Overall Study|Withdrawal by Subject|3|||
143458678|NCT01577745|517224663|FG004|Overall Study|Withdrawal by Subject|2|||
143458679|NCT01577745|517224664|FG005|Overall Study|Withdrawal by Subject|0|||
143458680|NCT01577745|517224659|FG000|Overall Study|Death|3|||
143458681|NCT01577745|517224660|FG001|Overall Study|Death|2|||
143458682|NCT01577745|517224661|FG002|Overall Study|Death|2|||
143458683|NCT01577745|517224662|FG003|Overall Study|Death|1|||
143458684|NCT01577745|517224663|FG004|Overall Study|Death|1|||
143458685|NCT01577745|517224664|FG005|Overall Study|Death|3|||
143458686|NCT01577745|517224659|FG000|Overall Study|Physician Decision|0|||
143458687|NCT01577745|517224660|FG001|Overall Study|Physician Decision|0|||
143458688|NCT01577745|517224661|FG002|Overall Study|Physician Decision|0|||
143458689|NCT01577745|517224662|FG003|Overall Study|Physician Decision|1|||
143458690|NCT01577745|517224663|FG004|Overall Study|Physician Decision|1|||
143458691|NCT01577745|517224664|FG005|Overall Study|Physician Decision|0|||
143458692|NCT01577745|517224659|FG000|Overall Study|Lost to Follow-up|0|||
143458693|NCT01577745|517224660|FG001|Overall Study|Lost to Follow-up|0|||
143458694|NCT01577745|517224661|FG002|Overall Study|Lost to Follow-up|0|||
143458695|NCT01577745|517224662|FG003|Overall Study|Lost to Follow-up|0|||
143458696|NCT01577745|517224663|FG004|Overall Study|Lost to Follow-up|0|||
143458697|NCT01577745|517224664|FG005|Overall Study|Lost to Follow-up|1|||
143458698|NCT01577745|517224659|FG000|Overall Study|Alternative Therapy|0|||
143458699|NCT01577745|517224660|FG001|Overall Study|Alternative Therapy|0|||
143458700|NCT01577745|517224661|FG002|Overall Study|Alternative Therapy|0|||
143458701|NCT01577745|517224662|FG003|Overall Study|Alternative Therapy|1|||
143458702|NCT01577745|517224663|FG004|Overall Study|Alternative Therapy|1|||
143458703|NCT01577745|517224664|FG005|Overall Study|Alternative Therapy|0|||
143458704|NCT01506609|517224665|FG000|Overall Study|Adverse Event Related to Progression|0|||
143458705|NCT01506609|517224666|FG001|Overall Study|Adverse Event Related to Progression|0|||
143458706|NCT01506609|517224667|FG002|Overall Study|Adverse Event Related to Progression|0|||
143458707|NCT01506609|517224668|FG003|Overall Study|Adverse Event Related to Progression|3|||
143458708|NCT01506609|517224669|FG004|Overall Study|Adverse Event Related to Progression|7|||
143458709|NCT01506609|517224670|FG005|Overall Study|Adverse Event Related to Progression|3|||
143458710|NCT01506609|517224665|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
143458711|NCT01506609|517224666|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
143458712|NCT01506609|517224667|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
143458713|NCT01506609|517224668|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
143458714|NCT01506609|517224669|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
143458715|NCT01506609|517224670|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
143458716|NCT01506609|517224665|FG000|Overall Study|Withdrawal by Subject|0|||
143458717|NCT01506609|517224666|FG001|Overall Study|Withdrawal by Subject|0|||
143458718|NCT01506609|517224667|FG002|Overall Study|Withdrawal by Subject|0|||
143458719|NCT01506609|517224668|FG003|Overall Study|Withdrawal by Subject|9|||
143458720|NCT01506609|517224669|FG004|Overall Study|Withdrawal by Subject|7|||
143458721|NCT01506609|517224670|FG005|Overall Study|Withdrawal by Subject|7|||
143458722|NCT01506609|517224665|FG000|Overall Study|Lost to Follow-up|0|||
143458723|NCT01506609|517224666|FG001|Overall Study|Lost to Follow-up|0|||
143458724|NCT01506609|517224667|FG002|Overall Study|Lost to Follow-up|0|||
143458725|NCT01506609|517224668|FG003|Overall Study|Lost to Follow-up|1|||
143458726|NCT01506609|517224669|FG004|Overall Study|Lost to Follow-up|2|||
143458727|NCT01506609|517224670|FG005|Overall Study|Lost to Follow-up|0|||
143458728|NCT01506609|517224665|FG000|Overall Study|Sponsor Discontinued Study|0|||
143458729|NCT01506609|517224666|FG001|Overall Study|Sponsor Discontinued Study|0|||
143458730|NCT01506609|517224667|FG002|Overall Study|Sponsor Discontinued Study|0|||
143458731|NCT01506609|517224668|FG003|Overall Study|Sponsor Discontinued Study|2|||
143458732|NCT01506609|517224669|FG004|Overall Study|Sponsor Discontinued Study|2|||
143458733|NCT01506609|517224670|FG005|Overall Study|Sponsor Discontinued Study|0|||
143458734|NCT01506609|517224665|FG000|Overall Study|Progressive Disease per Protocol|1|||
143458735|NCT01506609|517224666|FG001|Overall Study|Progressive Disease per Protocol|0|||
143458736|NCT01506609|517224667|FG002|Overall Study|Progressive Disease per Protocol|0|||
143458737|NCT01506609|517224668|FG003|Overall Study|Progressive Disease per Protocol|64|||
143458738|NCT01506609|517224669|FG004|Overall Study|Progressive Disease per Protocol|57|||
143458739|NCT01506609|517224670|FG005|Overall Study|Progressive Disease per Protocol|74|||
143458740|NCT01506609|517224665|FG000|Overall Study|Other, Not Specified|0|||
143458741|NCT01506609|517224666|FG001|Overall Study|Other, Not Specified|0|||
143458742|NCT01506609|517224667|FG002|Overall Study|Other, Not Specified|0|||
143458743|NCT01506609|517224668|FG003|Overall Study|Other, Not Specified|10|||
143458744|NCT01506609|517224669|FG004|Overall Study|Other, Not Specified|7|||
143458745|NCT01506609|517224670|FG005|Overall Study|Other, Not Specified|3|||
143458746|NCT01506609|517224665|FG000|Overall Study|Missing / Unknown Reason|1|||
143458747|NCT01506609|517224666|FG001|Overall Study|Missing / Unknown Reason|0|||
143458748|NCT01506609|517224667|FG002|Overall Study|Missing / Unknown Reason|1|||
143458749|NCT01506609|517224668|FG003|Overall Study|Missing / Unknown Reason|4|||
143458750|NCT01506609|517224669|FG004|Overall Study|Missing / Unknown Reason|4|||
143458751|NCT01506609|517224670|FG005|Overall Study|Missing / Unknown Reason|2|||
143458752|NCT00122460|517224671|FG000|Overall Study|investigational study phase ongoing|7|||
143458753|NCT00122460|517224672|FG001|Overall Study|investigational study phase ongoing|1|||
143458754|NCT00577473|517224675|FG000|Overall Study|Protocol Violation|1|||
143458755|NCT00577473|517224676|FG001|Overall Study|Protocol Violation|4|||
143458756|NCT00577473|517224675|FG000|Overall Study|Adverse Event|8|||
143458757|NCT00577473|517224676|FG001|Overall Study|Adverse Event|5|||
143458758|NCT00577473|517224675|FG000|Overall Study|Withdrawal by Subject|2|||
143458759|NCT00577473|517224676|FG001|Overall Study|Withdrawal by Subject|6|||
143458760|NCT00577473|517224675|FG000|Overall Study|Physician Decision|2|||
143458761|NCT00577473|517224676|FG001|Overall Study|Physician Decision|2|||
143458762|NCT00577473|517224675|FG000|Overall Study|Lack of Efficacy|8|||
143458763|NCT00577473|517224676|FG001|Overall Study|Lack of Efficacy|7|||
143458764|NCT00825916|517224679|FG000|Overall Study|Lost to Follow-up|4|||
143458765|NCT00825916|517224680|FG001|Overall Study|Lost to Follow-up|2|||
143458766|NCT00825916|517224681|FG002|Overall Study|Lost to Follow-up|1|||
143458767|NCT02962960|517224682|FG000|Overall Study|Withdrawal by Subject|1|||
143458768|NCT02962960|517224683|FG001|Overall Study|Withdrawal by Subject|1|||
143458769|NCT02962960|517224684|FG002|Overall Study|Withdrawal by Subject|0|||
143458770|NCT02962960|517224682|FG000|Overall Study|Adverse Event|1|||
143458771|NCT02962960|517224683|FG001|Overall Study|Adverse Event|1|||
143458772|NCT02962960|517224684|FG002|Overall Study|Adverse Event|0|||
143458773|NCT02962960|517224682|FG000|Overall Study|Protocol Violation|1|||
143458774|NCT02962960|517224683|FG001|Overall Study|Protocol Violation|0|||
143458775|NCT02962960|517224684|FG002|Overall Study|Protocol Violation|0|||
143458776|NCT01990560|517224685|FG000|Overall Study|Withdrawal by Subject|1|||
143458777|NCT01324440|517224686|FG000|Overall Study|Subject moved|0|||
143458778|NCT01324440|517224687|FG001|Overall Study|Subject moved|1|||
143458779|NCT02884908|517224688|FG000|Overall Study|Lost to Follow-up|13|||
143458780|NCT02884908|517224689|FG001|Overall Study|Lost to Follow-up|18|||
143458781|NCT02054741|517224690|FG000|Overall Study|Protocol Violation|13|||
143458782|NCT02054741|517224691|FG001|Overall Study|Protocol Violation|2|||
143458783|NCT02054741|517224690|FG000|Overall Study|Withdrawal by Subject|10|||
143458784|NCT02054741|517224691|FG001|Overall Study|Withdrawal by Subject|5|||
143458785|NCT02054741|517224690|FG000|Overall Study|Death|94|||
143458786|NCT02054741|517224691|FG001|Overall Study|Death|90|||
143458787|NCT02054741|517224690|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
143458788|NCT02054741|517224691|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
143458789|NCT02325557|517224700|FG000|Overall Study|Progressive disease|1|||
143458790|NCT02325557|517224701|FG001|Overall Study|Progressive disease|0|||
143458791|NCT02325557|517224702|FG002|Overall Study|Progressive disease|0|||
143458792|NCT02325557|517224703|FG003|Overall Study|Progressive disease|0|||
143458793|NCT02325557|517224700|FG000|Overall Study|Withdrawal by Subject|4|||
143458794|NCT02325557|517224701|FG001|Overall Study|Withdrawal by Subject|0|||
143458795|NCT02325557|517224702|FG002|Overall Study|Withdrawal by Subject|0|||
143458796|NCT02325557|517224703|FG003|Overall Study|Withdrawal by Subject|15|||
143458797|NCT02325557|517224700|FG000|Overall Study|Death|5|||
143458798|NCT02325557|517224701|FG001|Overall Study|Death|1|||
143458799|NCT02325557|517224702|FG002|Overall Study|Death|1|||
143458800|NCT02325557|517224703|FG003|Overall Study|Death|16|||
143458801|NCT02325557|517224700|FG000|Overall Study|Lost to Follow-up|0|||
143458802|NCT02325557|517224701|FG001|Overall Study|Lost to Follow-up|0|||
143458803|NCT02325557|517224702|FG002|Overall Study|Lost to Follow-up|1|||
143458804|NCT02325557|517224703|FG003|Overall Study|Lost to Follow-up|1|||
143458805|NCT02325557|517224700|FG000|Overall Study|Other|0|||
143458806|NCT02325557|517224701|FG001|Overall Study|Other|0|||
143458807|NCT02325557|517224702|FG002|Overall Study|Other|0|||
143458808|NCT02325557|517224703|FG003|Overall Study|Other|5|||
143458809|NCT02344004|517224704|FG000|Overall Study|Adverse Event|11|||
143458810|NCT02344004|517224705|FG001|Overall Study|Adverse Event|1|||
143458811|NCT02344004|517224704|FG000|Overall Study|Death|9|||
143458812|NCT02344004|517224705|FG001|Overall Study|Death|7|||
143458813|NCT02344004|517224704|FG000|Overall Study|Physician Decision|4|||
143458814|NCT02344004|517224705|FG001|Overall Study|Physician Decision|1|||
143458815|NCT02344004|517224704|FG000|Overall Study|Withdrawal by Subject|22|||
143458816|NCT02344004|517224705|FG001|Overall Study|Withdrawal by Subject|5|||
143458817|NCT02344004|517224704|FG000|Overall Study|Rescue Medication|2|||
143458818|NCT02344004|517224705|FG001|Overall Study|Rescue Medication|0|||
143458819|NCT02344004|517224704|FG000|Overall Study|Other Not Specified|12|||
143458820|NCT02344004|517224705|FG001|Overall Study|Other Not Specified|0|||
143458821|NCT02344004|517224704|FG000|Overall Study|Protocol Violation|1|||
143458822|NCT02344004|517224705|FG001|Overall Study|Protocol Violation|0|||
143458823|NCT01502631|517224706|FG000|Overall Study|Adverse Event|5|||
143458824|NCT01502631|517224707|FG001|Overall Study|Adverse Event|8|||
143458825|NCT01502631|517224706|FG000|Overall Study|Lost to Follow-up|2|||
143458826|NCT01502631|517224707|FG001|Overall Study|Lost to Follow-up|2|||
143458827|NCT01502631|517224706|FG000|Overall Study|Participant withdrew consent|2|||
143458828|NCT01502631|517224707|FG001|Overall Study|Participant withdrew consent|4|||
143458829|NCT01502631|517224706|FG000|Overall Study|Participant non-compliant|1|||
143458830|NCT01502631|517224707|FG001|Overall Study|Participant non-compliant|0|||
143458831|NCT01502631|517224706|FG000|Overall Study|Investigator's decision|0|||
143458832|NCT01502631|517224707|FG001|Overall Study|Investigator's decision|1|||
143458833|NCT01502631|517224706|FG000|Overall Study|Other|10|||
143458834|NCT01502631|517224707|FG001|Overall Study|Other|5|||
143458835|NCT01488487|517224708|FG000|Overall Study|Adverse Event|6|||
143458836|NCT01488487|517224708|FG000|Overall Study|Death|1|||
143458837|NCT01488487|517224708|FG000|Overall Study|Withdrawal by Subject|2|||
143458838|NCT00395460|517224710|FG000|Overall Study|Withdrawal by Subject|1|||
143458839|NCT00395460|517224711|FG001|Overall Study|Withdrawal by Subject|0|||
143458840|NCT04223830|517224715|FG000|Overall Study|Lost to Follow-up|9|||
143458841|NCT04223830|517224715|FG000|Overall Study|Adverse Event|1|||
143458842|NCT00862719|517224716|FG000|Overall Study|Disease Progression|5|||
143458843|NCT00862719|517224717|FG001|Overall Study|Disease Progression|0|||
143458844|NCT00862719|517224718|FG002|Overall Study|Disease Progression|1|||
143458845|NCT00862719|517224719|FG003|Overall Study|Disease Progression|0|||
143458846|NCT00862719|517224716|FG000|Overall Study|Death|5|||
143458847|NCT00862719|517224717|FG001|Overall Study|Death|6|||
143458848|NCT00862719|517224718|FG002|Overall Study|Death|1|||
143458849|NCT00862719|517224719|FG003|Overall Study|Death|1|||
143458850|NCT00862719|517224716|FG000|Overall Study|Engraftment failure|0|||
143458851|NCT00862719|517224717|FG001|Overall Study|Engraftment failure|0|||
143458852|NCT00862719|517224718|FG002|Overall Study|Engraftment failure|1|||
143458853|NCT00862719|517224719|FG003|Overall Study|Engraftment failure|0|||
143458854|NCT00862719|517224716|FG000|Overall Study|Veno-Occlusive Disease|0|||
143458855|NCT00862719|517224717|FG001|Overall Study|Veno-Occlusive Disease|0|||
143458856|NCT00862719|517224718|FG002|Overall Study|Veno-Occlusive Disease|1|||
143458857|NCT00862719|517224719|FG003|Overall Study|Veno-Occlusive Disease|0|||
143458858|NCT01806623|517224720|FG000|Overall Study|Withdrawal by Subject|1|||
143259629|NCT04231981|516505812|FG000|Overall Study|Adverse Event|1|||
143458859|NCT01806623|517224720|FG000|Overall Study|Adverse Event|1|||
143458860|NCT01806623|517224720|FG000|Overall Study|Did not meet the inclusion criteria|56|||
143458861|NCT02424734|517224721|FG000|Overall Study|Treatment stopped to be discharged home|2|||
143458862|NCT02424734|517224722|FG001|Overall Study|Treatment stopped to be discharged home|2|||
143458863|NCT02424734|517224723|FG002|Overall Study|Treatment stopped to be discharged home|0|||
143458864|NCT02413333|517224729|FG000|Period 1|Adverse Event|1|||
143458865|NCT02413333|517224730|FG001|Period 1|Adverse Event|0|||
143458866|NCT02413333|517224729|FG000|Period 1|Reason Not Specified|0|||
143458867|NCT02413333|517224730|FG001|Period 1|Reason Not Specified|1|||
143458868|NCT02413333|517224729|FG000|Period 2|Protocol Deviation|1|||
143458869|NCT02413333|517224730|FG001|Period 2|Protocol Deviation|0|||
143458870|NCT00709852|517224731|FG000|Period 1|Adverse Event|2|||
143458871|NCT00709852|517224732|FG001|Period 1|Adverse Event|0|||
143458872|NCT00709852|517224731|FG000|Period 1|Withdrawal by Subject|4|||
143458873|NCT00709852|517224732|FG001|Period 1|Withdrawal by Subject|2|||
143458874|NCT00709852|517224731|FG000|Period 1|Protocol Violation|1|||
143458875|NCT00709852|517224732|FG001|Period 1|Protocol Violation|0|||
143458876|NCT00709852|517224731|FG000|Period 1|Defective scanner|0|||
143458877|NCT00709852|517224732|FG001|Period 1|Defective scanner|1|||
143458878|NCT00709852|517224731|FG000|Period 1|Lost to Follow-up|1|||
143458879|NCT00709852|517224732|FG001|Period 1|Lost to Follow-up|0|||
143458880|NCT00709852|517224731|FG000|Period 2|Protocol Violation|4|||
143458881|NCT00709852|517224732|FG001|Period 2|Protocol Violation|1|||
143458882|NCT00709852|517224731|FG000|Period 2|Adverse Event|1|||
143458883|NCT00709852|517224732|FG001|Period 2|Adverse Event|1|||
143458884|NCT00709852|517224731|FG000|Period 2|Lost to Follow-up|1|||
143458885|NCT00709852|517224732|FG001|Period 2|Lost to Follow-up|0|||
143458886|NCT00709852|517224731|FG000|Period 2|No 72-hour follow-up|3|||
143458887|NCT00709852|517224732|FG001|Period 2|No 72-hour follow-up|0|||
143458888|NCT00185965|517224733|FG000|Overall Study|Adverse Event|0|||
143458889|NCT00185965|517224734|FG001|Overall Study|Adverse Event|1|||
143458890|NCT03814187|517224735|FG000|Overall Study|Sponsor's Administrative Decision|0|||
143458891|NCT03814187|517224736|FG001|Overall Study|Sponsor's Administrative Decision|0|||
143458892|NCT03814187|517224737|FG002|Overall Study|Sponsor's Administrative Decision|272|||
143458893|NCT03814187|517224735|FG000|Overall Study|Death|80|||
143458894|NCT03814187|517224736|FG001|Overall Study|Death|81|||
143458895|NCT03814187|517224737|FG002|Overall Study|Death|4|||
143458896|NCT03814187|517224735|FG000|Overall Study|Withdrew Consent|77|||
143458897|NCT03814187|517224736|FG001|Overall Study|Withdrew Consent|78|||
143458898|NCT03814187|517224737|FG002|Overall Study|Withdrew Consent|2|||
143458899|NCT03814187|517224735|FG000|Overall Study|Lost to Follow-up|47|||
143458900|NCT03814187|517224736|FG001|Overall Study|Lost to Follow-up|52|||
143458901|NCT03814187|517224737|FG002|Overall Study|Lost to Follow-up|1|||
143458902|NCT03814187|517224735|FG000|Overall Study|Adverse Event|22|||
143458903|NCT03814187|517224736|FG001|Overall Study|Adverse Event|23|||
143458904|NCT03814187|517224737|FG002|Overall Study|Adverse Event|0|||
143458905|NCT03814187|517224735|FG000|Overall Study|Physician Decision|7|||
143458906|NCT03814187|517224736|FG001|Overall Study|Physician Decision|4|||
143458907|NCT03814187|517224737|FG002|Overall Study|Physician Decision|2|||
143458908|NCT03814187|517224735|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
143458909|NCT03814187|517224736|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
143458910|NCT03814187|517224737|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
143458911|NCT03814187|517224735|FG000|Overall Study|Other reasons|34|||
143458912|NCT03814187|517224736|FG001|Overall Study|Other reasons|40|||
143458913|NCT03814187|517224737|FG002|Overall Study|Other reasons|2|||
143458914|NCT02009761|517224739|FG000|Overall Study|Adverse Event|4|||
143458915|NCT00825825|517224740|FG000|First Medication Period (14 Days)|Adverse Event|1|||
143458916|NCT00825825|517224741|FG001|First Medication Period (14 Days)|Adverse Event|0|||
143458917|NCT00825825|517224742|FG002|First Medication Period (14 Days)|Adverse Event|0|||
143458918|NCT00825825|517224743|FG003|First Medication Period (14 Days)|Adverse Event|0|||
143458919|NCT00825825|517224744|FG004|First Medication Period (14 Days)|Adverse Event|0|||
143458920|NCT00825825|517224745|FG005|First Medication Period (14 Days)|Adverse Event|1|||
143458921|NCT00825825|517224740|FG000|First Medication Period (14 Days)|Physician Decision|2|||
143458922|NCT00825825|517224741|FG001|First Medication Period (14 Days)|Physician Decision|0|||
143458923|NCT00825825|517224742|FG002|First Medication Period (14 Days)|Physician Decision|1|||
143458924|NCT00825825|517224743|FG003|First Medication Period (14 Days)|Physician Decision|0|||
143458925|NCT00825825|517224744|FG004|First Medication Period (14 Days)|Physician Decision|0|||
143458926|NCT00825825|517224745|FG005|First Medication Period (14 Days)|Physician Decision|1|||
143458927|NCT00825825|517224740|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
143458928|NCT00825825|517224741|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
143458929|NCT00825825|517224742|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
143458930|NCT00825825|517224743|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
143458931|NCT00825825|517224744|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
143458932|NCT00825825|517224745|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
143458933|NCT00825825|517224740|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
143458934|NCT00825825|517224741|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
143458935|NCT00825825|517224742|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
143458936|NCT00825825|517224743|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
143458937|NCT00825825|517224744|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
143458938|NCT00825825|517224745|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
143458939|NCT00825825|517224740|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
143458940|NCT00825825|517224741|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
143458941|NCT00825825|517224742|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
143458942|NCT00825825|517224743|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
143458943|NCT00825825|517224744|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
143458944|NCT00825825|517224745|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
143458945|NCT00825825|517224740|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
143458946|NCT00825825|517224741|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
143458947|NCT00825825|517224742|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
143458948|NCT00825825|517224743|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
143458949|NCT00825825|517224744|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
143458950|NCT00825825|517224745|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
143458951|NCT00825825|517224740|FG000|Third Medication Period (14 Days)|poor data quality|0|||
143458952|NCT00825825|517224741|FG001|Third Medication Period (14 Days)|poor data quality|1|||
143458953|NCT00825825|517224742|FG002|Third Medication Period (14 Days)|poor data quality|0|||
143458954|NCT00825825|517224743|FG003|Third Medication Period (14 Days)|poor data quality|0|||
143458955|NCT00825825|517224744|FG004|Third Medication Period (14 Days)|poor data quality|0|||
143458956|NCT00825825|517224745|FG005|Third Medication Period (14 Days)|poor data quality|0|||
143458957|NCT03265938|517224747|FG000|Overall Study|Withdrawal by Subject|1|||
143458958|NCT03265938|517224747|FG000|Overall Study|Physician Decision|1|||
143458959|NCT03265938|517224747|FG000|Overall Study|friable mass|6|||
143458960|NCT01892540|517224748|FG000|Overall Study|Did not complete PET/MRI|0|||
143458961|NCT01892540|517224749|FG001|Overall Study|Did not complete PET/MRI|0|||
143458962|NCT01892540|517224750|FG002|Overall Study|Did not complete PET/MRI|2|||
143458963|NCT01892540|517224748|FG000|Overall Study|Did not fit in scanner|0|||
143458964|NCT01892540|517224749|FG001|Overall Study|Did not fit in scanner|0|||
143458965|NCT01892540|517224750|FG002|Overall Study|Did not fit in scanner|1|||
143458966|NCT02317432|517224754|FG000|Overall Study|Death|4|||
143458967|NCT02317432|517224755|FG001|Overall Study|Death|1|||
143458968|NCT02317432|517224754|FG000|Overall Study|Lost to Follow-up|0|||
143458969|NCT02317432|517224755|FG001|Overall Study|Lost to Follow-up|5|||
143458970|NCT02317432|517224754|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
143458971|NCT02317432|517224755|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
143458972|NCT00727311|517224760|FG000|Overall Study|Did not receive drug|316|||
143458973|NCT00727311|517224760|FG000|Overall Study|Missing end of therapy data|205|||
143458974|NCT00727311|517224760|FG000|Overall Study|Adverse Event|58|||
143458975|NCT00727311|517224760|FG000|Overall Study|Lack of Efficacy|242|||
143458976|NCT00727311|517224760|FG000|Overall Study|Lost to Follow-up|73|||
143458977|NCT00727311|517224760|FG000|Overall Study|Withdrawal by Subject|77|||
143458978|NCT00727311|517224760|FG000|Overall Study|Other|97|||
143458979|NCT00727311|517224760|FG000|Overall Study|Multiple reasons|39|||
143458980|NCT02359877|517226824|FG000|Overall Study|Withdrawal by Subject|1|||
143458981|NCT02359877|517226825|FG001|Overall Study|Withdrawal by Subject|0|||
143458982|NCT02359877|517226826|FG002|Overall Study|Withdrawal by Subject|0|||
143458983|NCT02359877|517226827|FG003|Overall Study|Withdrawal by Subject|2|||
143458984|NCT02359877|517226824|FG000|Overall Study|Adverse Event|0|||
143458985|NCT02359877|517226825|FG001|Overall Study|Adverse Event|0|||
143458986|NCT02359877|517226826|FG002|Overall Study|Adverse Event|0|||
143458987|NCT02359877|517226827|FG003|Overall Study|Adverse Event|1|||
143458988|NCT01290029|517226831|FG000|Overall Study|Other|2|||
143458989|NCT00189488|517226832|FG000|Overall Study|Ineligibility determined|1|||
143458990|NCT00189488|517226833|FG001|Overall Study|Ineligibility determined|0|||
143458991|NCT00189488|517226832|FG000|Overall Study|Protocol deviation|2|||
143458992|NCT00189488|517226833|FG001|Overall Study|Protocol deviation|1|||
143458993|NCT00189488|517226832|FG000|Overall Study|Adverse Event|2|||
143458994|NCT00189488|517226833|FG001|Overall Study|Adverse Event|1|||
143458995|NCT00189488|517226832|FG000|Overall Study|Withdrawal by Subject|2|||
143458996|NCT00189488|517226833|FG001|Overall Study|Withdrawal by Subject|6|||
143458997|NCT00189488|517226832|FG000|Overall Study|Disease progression|2|||
143458998|NCT00189488|517226833|FG001|Overall Study|Disease progression|4|||
143458999|NCT00189488|517226832|FG000|Overall Study|Administrative Decision|0|||
143459000|NCT00189488|517226833|FG001|Overall Study|Administrative Decision|2|||
143459001|NCT00189488|517226832|FG000|Overall Study|Death|5|||
143459002|NCT00189488|517226833|FG001|Overall Study|Death|8|||
143459003|NCT00189488|517226832|FG000|Overall Study|Other|1|||
143459004|NCT00189488|517226833|FG001|Overall Study|Other|0|||
143459005|NCT02349425|517226834|FG000|Period 1|Adverse Event|1|||
143459006|NCT02349425|517226835|FG001|Period 1|Adverse Event|1|||
143459007|NCT02349425|517226836|FG002|Period 1|Adverse Event|0|||
143459008|NCT02349425|517226837|FG003|Period 1|Adverse Event|0|||
143459009|NCT02349425|517226834|FG000|Period 2|Adverse Event|0|||
143459010|NCT02349425|517226835|FG001|Period 2|Adverse Event|1|||
143459011|NCT02349425|517226836|FG002|Period 2|Adverse Event|1|||
143459012|NCT02349425|517226837|FG003|Period 2|Adverse Event|0|||
143459013|NCT00876928|517226838|FG000|Overall Study|Lost to Follow-up|2|||
143459014|NCT00876928|517226839|FG001|Overall Study|Lost to Follow-up|5|||
143459015|NCT00876928|517226838|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
143459016|NCT00876928|517226839|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
143459017|NCT01111474|517226840|FG000|Overall Study|Lost to Follow-up|12|||
143459018|NCT01143038|517226841|FG000|Overall Study|Withdrawal by Subject|4|||
143459019|NCT01143038|517226841|FG000|Overall Study|Requirement for alternative therapy|5|||
143459020|NCT01143038|517226841|FG000|Overall Study|Adverse Event|3|||
143459021|NCT01143038|517226841|FG000|Overall Study|Lost to Follow-up|2|||
143459022|NCT01143038|517226841|FG000|Overall Study|Protocol Deviation|1|||
143459023|NCT01143038|517226841|FG000|Overall Study|Death|1|||
143459024|NCT02336178|517226842|FG000|Overall Study|Lost to Follow-up|1|||
143459025|NCT02336178|517226842|FG000|Overall Study|Protocol Violation|1|||
143459026|NCT02336178|517226842|FG000|Overall Study|Withdrawal by Subject|1|||
143459027|NCT02336178|517226842|FG000|Overall Study|Other|1|||
143459028|NCT00706433|517226846|FG000|Overall Study|Lost to Follow-up|3|||
143459029|NCT00706433|517226847|FG001|Overall Study|Lost to Follow-up|1|||
143459030|NCT00706433|517226848|FG002|Overall Study|Lost to Follow-up|6|||
143459031|NCT00706433|517226849|FG003|Overall Study|Lost to Follow-up|0|||
143459032|NCT00706433|517226846|FG000|Overall Study|Withdrawal by Subject|1|||
143459033|NCT00706433|517226847|FG001|Overall Study|Withdrawal by Subject|2|||
143459034|NCT00706433|517226848|FG002|Overall Study|Withdrawal by Subject|3|||
143459035|NCT00706433|517226849|FG003|Overall Study|Withdrawal by Subject|1|||
143459036|NCT00706433|517226846|FG000|Overall Study|Adverse Event|0|||
143459037|NCT00706433|517226847|FG001|Overall Study|Adverse Event|0|||
143459038|NCT00706433|517226848|FG002|Overall Study|Adverse Event|1|||
143459039|NCT00706433|517226849|FG003|Overall Study|Adverse Event|0|||
143459040|NCT00706433|517226846|FG000|Overall Study|Protocol Violation|1|||
143118172|NCT03570554|515976033|FG002|Overall Study|Non-compliance with study drug|1|||
143118173|NCT03570554|515976034|FG003|Overall Study|Non-compliance with study drug|0|||
143118174|NCT03570554|515976031|FG000|Overall Study|Adverse Event|0|||
143118175|NCT03570554|515976032|FG001|Overall Study|Adverse Event|0|||
143118176|NCT03570554|515976033|FG002|Overall Study|Adverse Event|0|||
143118177|NCT03570554|515976034|FG003|Overall Study|Adverse Event|1|||
143118178|NCT01917344|515976039|FG000|Overall Study|Withdrawal by Subject|1|||
143118179|NCT01133288|515976042|FG000|Eligibility Assessment|met exclusion criteria|5|||
143459041|NCT00706433|517226847|FG001|Overall Study|Protocol Violation|0|||
143459042|NCT00706433|517226848|FG002|Overall Study|Protocol Violation|0|||
143459043|NCT00706433|517226849|FG003|Overall Study|Protocol Violation|0|||
143459044|NCT00706433|517226846|FG000|Overall Study|new job|0|||
143459045|NCT00706433|517226847|FG001|Overall Study|new job|0|||
143459046|NCT00706433|517226848|FG002|Overall Study|new job|0|||
143459047|NCT00706433|517226849|FG003|Overall Study|new job|1|||
143459048|NCT01236365|517226850|FG000|Overall Study|Lost to Follow-up|0|||
143459049|NCT01236365|517226851|FG001|Overall Study|Lost to Follow-up|2|||
143459050|NCT01236365|517226850|FG000|Overall Study|Moved Out of State|1|||
143459051|NCT01236365|517226851|FG001|Overall Study|Moved Out of State|0|||
143459052|NCT01236365|517226850|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
143459053|NCT01236365|517226851|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
143459054|NCT02090959|517226852|FG000|Overall Study|Withdrawal by Subject|10|||
143459055|NCT02090959|517226852|FG000|Overall Study|Adverse Event|1|||
143459056|NCT02090959|517226852|FG000|Overall Study|Investigator decision|2|||
143459057|NCT02090959|517226852|FG000|Overall Study|Study termination|6|||
143459058|NCT02090959|517226852|FG000|Overall Study|Enrolled but not treated|1|||
143459059|NCT02090959|517226852|FG000|Overall Study|Transfer for compassionate use medicine|4|||
143459060|NCT02090959|517226852|FG000|Overall Study|Move to medical need program|3|||
143459061|NCT02090959|517226852|FG000|Overall Study|Entered in to other study|34|||
143459062|NCT02090959|517226852|FG000|Overall Study|Switched to commercial supply|88|||
143459063|NCT02090959|517226852|FG000|Overall Study|Other than specified|2|||
143459064|NCT02808143|517226855|FG000|Maintenance Phase|Disease recurrence|1|||
143459065|NCT02808143|517226856|FG001|Maintenance Phase|Disease recurrence|3|||
143459066|NCT02808143|517226855|FG000|Maintenance Phase|Disease progression|1|||
143459067|NCT02808143|517226856|FG001|Maintenance Phase|Disease progression|2|||
143459068|NCT02808143|517226855|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
143459069|NCT02808143|517226856|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
143459070|NCT02808143|517226855|FG000|Survival Follow-Up|Disease recurrence|0|||
143459071|NCT02808143|517226856|FG001|Survival Follow-Up|Disease recurrence|2|||
143459072|NCT02808143|517226855|FG000|Survival Follow-Up|Adverse Event|0|||
143459073|NCT02808143|517226856|FG001|Survival Follow-Up|Adverse Event|1|||
143459074|NCT02808143|517226855|FG000|Survival Follow-Up|Death|1|||
143459075|NCT02808143|517226856|FG001|Survival Follow-Up|Death|0|||
143459076|NCT00522873|517226857|FG000|Overall Study|Adverse Event|41|||
143459077|NCT00522873|517226858|FG001|Overall Study|Adverse Event|26|||
143459078|NCT00522873|517226857|FG000|Overall Study|Withdrawal by Subject|20|||
143459079|NCT00522873|517226858|FG001|Overall Study|Withdrawal by Subject|9|||
143459080|NCT00522873|517226857|FG000|Overall Study|Protocol Violation|14|||
143459081|NCT00522873|517226858|FG001|Overall Study|Protocol Violation|4|||
143459082|NCT00522873|517226857|FG000|Overall Study|Lost to Follow-up|11|||
143459083|NCT00522873|517226858|FG001|Overall Study|Lost to Follow-up|3|||
143459084|NCT00522873|517226857|FG000|Overall Study|Personal Reasons|8|||
143459085|NCT00522873|517226858|FG001|Overall Study|Personal Reasons|1|||
143459086|NCT00522873|517226857|FG000|Overall Study|Medication Errors|1|||
143459087|NCT00522873|517226858|FG001|Overall Study|Medication Errors|1|||
143459088|NCT00522873|517226857|FG000|Overall Study|Never Received Medication|1|||
143459089|NCT00522873|517226858|FG001|Overall Study|Never Received Medication|0|||
143459090|NCT02029846|517226859|FG000|Overall Study|n=1 each arm|1|||
143459091|NCT02029846|517226860|FG001|Overall Study|n=1 each arm|1|||
143459092|NCT02966301|517226864|FG000|Overall Study|Death|2|||
143459093|NCT02966301|517226864|FG000|Overall Study|Withdrawal by Subject|1|||
143459094|NCT02518490|517226869|FG000|Overall Study|Withdrawal by Subject|1|||
143459095|NCT02518490|517226870|FG001|Overall Study|Withdrawal by Subject|1|||
143459096|NCT04256629|517226871|FG000|Overall Study|Adverse Event|0|||
143459097|NCT04256629|517226872|FG001|Overall Study|Adverse Event|0|||
143459098|NCT04256629|517226873|FG002|Overall Study|Adverse Event|0|||
143459099|NCT04256629|517226874|FG003|Overall Study|Adverse Event|0|||
143459100|NCT04256629|517226875|FG004|Overall Study|Adverse Event|0|||
143459101|NCT04256629|517226876|FG005|Overall Study|Adverse Event|1|||
143459102|NCT04256629|517226871|FG000|Overall Study|Protocol Violation|0|||
143459103|NCT04256629|517226872|FG001|Overall Study|Protocol Violation|1|||
143459104|NCT04256629|517226873|FG002|Overall Study|Protocol Violation|0|||
143459105|NCT04256629|517226874|FG003|Overall Study|Protocol Violation|0|||
143459106|NCT04256629|517226875|FG004|Overall Study|Protocol Violation|0|||
143459107|NCT04256629|517226876|FG005|Overall Study|Protocol Violation|0|||
143459108|NCT00346632|517226877|FG000|Overall Study|Progressive Disease|2|||
143459109|NCT00346632|517226878|FG001|Overall Study|Progressive Disease|2|||
143459110|NCT00346632|517226879|FG002|Overall Study|Progressive Disease|4|||
143459111|NCT00346632|517226880|FG003|Overall Study|Progressive Disease|3|||
143459112|NCT00346632|517226881|FG004|Overall Study|Progressive Disease|3|||
143459113|NCT00346632|517226882|FG005|Overall Study|Progressive Disease|1|||
143459114|NCT00346632|517226883|FG006|Overall Study|Progressive Disease|2|||
143459115|NCT00346632|517226884|FG007|Overall Study|Progressive Disease|2|||
143459116|NCT00346632|517226885|FG008|Overall Study|Progressive Disease|2|||
143459117|NCT00346632|517226886|FG009|Overall Study|Progressive Disease|2|||
143459118|NCT00346632|517226877|FG000|Overall Study|Adverse Event|0|||
143459119|NCT00346632|517226878|FG001|Overall Study|Adverse Event|0|||
143459120|NCT00346632|517226879|FG002|Overall Study|Adverse Event|0|||
143459121|NCT00346632|517226880|FG003|Overall Study|Adverse Event|0|||
143459122|NCT00346632|517226881|FG004|Overall Study|Adverse Event|1|||
143459123|NCT00346632|517226882|FG005|Overall Study|Adverse Event|1|||
143459124|NCT00346632|517226883|FG006|Overall Study|Adverse Event|1|||
143459125|NCT00346632|517226884|FG007|Overall Study|Adverse Event|0|||
143459126|NCT00346632|517226885|FG008|Overall Study|Adverse Event|0|||
143459127|NCT00346632|517226886|FG009|Overall Study|Adverse Event|0|||
143459128|NCT00346632|517226877|FG000|Overall Study|Death|0|||
143118180|NCT01133288|515976042|FG000|Intervention Allocation|study terminated|2|||
143118181|NCT03209518|515976043|FG000|Overall Study|Case Report Forms Uncollected|1|||
143459129|NCT00346632|517226878|FG001|Overall Study|Death|0|||
143459130|NCT00346632|517226879|FG002|Overall Study|Death|1|||
143459131|NCT00346632|517226880|FG003|Overall Study|Death|0|||
143118182|NCT03209518|515976043|FG000|Overall Study|Protocol Deviation|1|||
143118183|NCT00236899|515976044|FG000|Overall Study|Adverse Event (Study Related)|1|||
143118184|NCT00236899|515976045|FG001|Overall Study|Adverse Event (Study Related)|1|||
143118185|NCT00236899|515976046|FG002|Overall Study|Adverse Event (Study Related)|2|||
143118186|NCT00236899|515976047|FG003|Overall Study|Adverse Event (Study Related)|1|||
143118187|NCT00236899|515976044|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
143118188|NCT00236899|515976045|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
143118189|NCT00236899|515976046|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
143118190|NCT00236899|515976047|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
143118191|NCT00236899|515976044|FG000|Overall Study|Death (Study Disease)|1|||
143118192|NCT00236899|515976045|FG001|Overall Study|Death (Study Disease)|4|||
143118193|NCT00236899|515976046|FG002|Overall Study|Death (Study Disease)|0|||
143118194|NCT00236899|515976047|FG003|Overall Study|Death (Study Disease)|0|||
143118195|NCT00236899|515976044|FG000|Overall Study|Death (Not Study Related)|2|||
143118196|NCT00236899|515976045|FG001|Overall Study|Death (Not Study Related)|0|||
143118197|NCT00236899|515976046|FG002|Overall Study|Death (Not Study Related)|0|||
143118198|NCT00236899|515976047|FG003|Overall Study|Death (Not Study Related)|0|||
143118199|NCT00236899|515976044|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
143459132|NCT00346632|517226881|FG004|Overall Study|Death|0|||
143459133|NCT00346632|517226882|FG005|Overall Study|Death|0|||
143459134|NCT00346632|517226883|FG006|Overall Study|Death|0|||
143459135|NCT00346632|517226884|FG007|Overall Study|Death|0|||
143459136|NCT00346632|517226885|FG008|Overall Study|Death|0|||
143118200|NCT00236899|515976045|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
143118201|NCT00236899|515976046|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
143118202|NCT00236899|515976047|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
143118203|NCT00236899|515976044|FG000|Overall Study|Lost to Follow-up|0|||
143118204|NCT00236899|515976045|FG001|Overall Study|Lost to Follow-up|1|||
143118205|NCT00236899|515976046|FG002|Overall Study|Lost to Follow-up|0|||
143118206|NCT00236899|515976047|FG003|Overall Study|Lost to Follow-up|0|||
143118207|NCT00236899|515976044|FG000|Overall Study|Entry Criteria Exclusion|0|||
143118208|NCT00236899|515976045|FG001|Overall Study|Entry Criteria Exclusion|1|||
143118209|NCT00236899|515976046|FG002|Overall Study|Entry Criteria Exclusion|1|||
143118210|NCT00236899|515976047|FG003|Overall Study|Entry Criteria Exclusion|0|||
143118211|NCT00236899|515976044|FG000|Overall Study|Protocol Violation|1|||
143118212|NCT00236899|515976045|FG001|Overall Study|Protocol Violation|0|||
143118213|NCT00236899|515976046|FG002|Overall Study|Protocol Violation|0|||
143118214|NCT00236899|515976047|FG003|Overall Study|Protocol Violation|0|||
143118215|NCT00236899|515976044|FG000|Overall Study|Withdrawal by Subject|6|||
143118216|NCT00236899|515976045|FG001|Overall Study|Withdrawal by Subject|4|||
143118217|NCT00236899|515976046|FG002|Overall Study|Withdrawal by Subject|5|||
143118218|NCT00236899|515976047|FG003|Overall Study|Withdrawal by Subject|2|||
143118219|NCT00236899|515976044|FG000|Overall Study|Physician Decision|7|||
143118220|NCT00236899|515976045|FG001|Overall Study|Physician Decision|8|||
143118221|NCT00236899|515976046|FG002|Overall Study|Physician Decision|7|||
143118222|NCT00236899|515976047|FG003|Overall Study|Physician Decision|6|||
143118223|NCT00236899|515976044|FG000|Overall Study|Satisfactory Response|2|||
143118224|NCT00236899|515976045|FG001|Overall Study|Satisfactory Response|0|||
143118225|NCT00236899|515976046|FG002|Overall Study|Satisfactory Response|0|||
143118226|NCT00236899|515976047|FG003|Overall Study|Satisfactory Response|1|||
143118227|NCT00236899|515976044|FG000|Overall Study|Lack of Efficacy|18|||
143118228|NCT00236899|515976045|FG001|Overall Study|Lack of Efficacy|18|||
143118229|NCT00236899|515976046|FG002|Overall Study|Lack of Efficacy|25|||
143118230|NCT00236899|515976047|FG003|Overall Study|Lack of Efficacy|23|||
143118231|NCT01285492|515976049|FG000|Overall Study|Adverse Event|11|||
143118232|NCT01285492|515976050|FG001|Overall Study|Adverse Event|0|||
143118233|NCT01285492|515976049|FG000|Overall Study|Protocol Violation|3|||
143118234|NCT01285492|515976050|FG001|Overall Study|Protocol Violation|0|||
143118235|NCT01285492|515976049|FG000|Overall Study|Withdrawal by Subject|2|||
143118236|NCT01285492|515976050|FG001|Overall Study|Withdrawal by Subject|1|||
143118237|NCT01285492|515976049|FG000|Overall Study|Death|1|||
143118238|NCT01285492|515976050|FG001|Overall Study|Death|0|||
143118239|NCT03379792|515976051|FG000|Overall Study|Physician Decision|0|||
143118240|NCT03379792|515976052|FG001|Overall Study|Physician Decision|0|||
143118241|NCT03379792|515976053|FG002|Overall Study|Physician Decision|0|||
143118242|NCT03379792|515976054|FG003|Overall Study|Physician Decision|1|||
143118243|NCT03379792|515976055|FG004|Overall Study|Physician Decision|0|||
143118244|NCT03379792|515976056|FG005|Overall Study|Physician Decision|0|||
143118245|NCT03379792|515976051|FG000|Overall Study|Withdrawal by Subject|0|||
143118246|NCT03379792|515976052|FG001|Overall Study|Withdrawal by Subject|0|||
143118247|NCT03379792|515976053|FG002|Overall Study|Withdrawal by Subject|0|||
143118248|NCT03379792|515976054|FG003|Overall Study|Withdrawal by Subject|0|||
143118249|NCT03379792|515976055|FG004|Overall Study|Withdrawal by Subject|1|||
143118250|NCT03379792|515976056|FG005|Overall Study|Withdrawal by Subject|1|||
143118251|NCT01121536|515976058|FG000|Overall Study|Adverse Event|63|||
143118252|NCT01121536|515976058|FG000|Overall Study|Lack of Efficacy|35|||
143118253|NCT01121536|515976058|FG000|Overall Study|Withdrawal by Subject|65|||
143118254|NCT01121536|515976058|FG000|Overall Study|Protocol Violation|20|||
143118255|NCT01121536|515976058|FG000|Overall Study|Noncompliance with study medication|12|||
143118256|NCT01121536|515976058|FG000|Overall Study|Noncompliance with study procedures|9|||
143118257|NCT01121536|515976058|FG000|Overall Study|Lost to Follow-up|39|||
143118258|NCT01121536|515976058|FG000|Overall Study|Other|118|||
143118259|NCT00306787|515976059|FG000|Overall Study|Discontinued without taking study drug|208|||
143118260|NCT00306787|515976060|FG001|Overall Study|Discontinued without taking study drug|215|||
143118261|NCT00306787|515976059|FG000|Overall Study|Adverse Event|1|||
143118262|NCT00306787|515976060|FG001|Overall Study|Adverse Event|1|||
143118263|NCT00306787|515976059|FG000|Overall Study|Lack of Efficacy|1|||
143118264|NCT00306787|515976060|FG001|Overall Study|Lack of Efficacy|0|||
143118265|NCT00306787|515976059|FG000|Overall Study|Protocol Violation|8|||
143118266|NCT00306787|515976060|FG001|Overall Study|Protocol Violation|10|||
143118267|NCT00306787|515976059|FG000|Overall Study|Withdrawal by Subject|2|||
143118268|NCT00306787|515976060|FG001|Overall Study|Withdrawal by Subject|9|||
143118269|NCT00306787|515976059|FG000|Overall Study|Lost to Follow-up|9|||
143118270|NCT00306787|515976060|FG001|Overall Study|Lost to Follow-up|6|||
143118271|NCT00306787|515976059|FG000|Overall Study|Administrative problems|4|||
143118272|NCT00306787|515976060|FG001|Overall Study|Administrative problems|0|||
143118273|NCT00306787|515976059|FG000|Overall Study|Abnormal laboratory value(s)|1|||
143118274|NCT00306787|515976060|FG001|Overall Study|Abnormal laboratory value(s)|0|||
143118275|NCT01438814|515976061|FG000|Overall Study|Adverse Event|3|||
143118276|NCT01438814|515976062|FG001|Overall Study|Adverse Event|3|||
143118277|NCT01438814|515976061|FG000|Overall Study|Protocol Violation|1|||
143118278|NCT01438814|515976062|FG001|Overall Study|Protocol Violation|2|||
143118279|NCT01438814|515976061|FG000|Overall Study|Lost to Follow-up|4|||
143118280|NCT01438814|515976062|FG001|Overall Study|Lost to Follow-up|3|||
143118281|NCT01438814|515976061|FG000|Overall Study|Withdrawal by Subject|4|||
143118282|NCT01438814|515976062|FG001|Overall Study|Withdrawal by Subject|2|||
143118283|NCT01438814|515976061|FG000|Overall Study|Other|2|||
143118284|NCT01438814|515976062|FG001|Overall Study|Other|4|||
143118285|NCT02273908|515976063|FG000|Overall Study|Adverse Event|16|||
143118286|NCT02273908|515976064|FG001|Overall Study|Adverse Event|0|||
143118287|NCT02273908|515976063|FG000|Overall Study|Lost to Follow-up|10|||
143118288|NCT02273908|515976064|FG001|Overall Study|Lost to Follow-up|1|||
143118289|NCT02273908|515976063|FG000|Overall Study|Did not meet entrance criteria|3|||
143118290|NCT02273908|515976064|FG001|Overall Study|Did not meet entrance criteria|2|||
143118291|NCT02273908|515976063|FG000|Overall Study|Withdrawal by Subject|4|||
143118292|NCT02273908|515976064|FG001|Overall Study|Withdrawal by Subject|2|||
143118293|NCT00369161|515976065|FG000|Overall Study|Adverse Event|15|||
143118294|NCT00369161|515976066|FG001|Overall Study|Adverse Event|13|||
143118295|NCT00369161|515976065|FG000|Overall Study|Abnormal laboratory value|0|||
143118296|NCT00369161|515976066|FG001|Overall Study|Abnormal laboratory value|1|||
143118297|NCT00369161|515976065|FG000|Overall Study|Lack of Efficacy|3|||
143118298|NCT00369161|515976066|FG001|Overall Study|Lack of Efficacy|1|||
143118299|NCT00369161|515976065|FG000|Overall Study|Protocol Violation|0|||
143118300|NCT00369161|515976066|FG001|Overall Study|Protocol Violation|2|||
143118301|NCT00369161|515976065|FG000|Overall Study|Withdrawal by Subject|2|||
143118302|NCT00369161|515976066|FG001|Overall Study|Withdrawal by Subject|3|||
143118303|NCT00369161|515976065|FG000|Overall Study|Death|1|||
143118304|NCT00369161|515976066|FG001|Overall Study|Death|2|||
143118305|NCT00369161|515976065|FG000|Overall Study|Graft loss|4|||
143118306|NCT00369161|515976066|FG001|Overall Study|Graft loss|0|||
143118307|NCT00369161|515976065|FG000|Overall Study|Administrative Problem|2|||
143118308|NCT00369161|515976066|FG001|Overall Study|Administrative Problem|2|||
143118309|NCT04908475|515976067|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
143118310|NCT04908475|515976068|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
143118311|NCT04908475|515976069|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
143118312|NCT04908475|515976070|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
143118313|NCT04908475|515976071|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
143118314|NCT04908475|515976072|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
143118315|NCT04908475|515976067|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
143118316|NCT04908475|515976068|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
143118317|NCT04908475|515976069|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
143118318|NCT04908475|515976070|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
143118319|NCT04908475|515976071|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
143118320|NCT04908475|515976072|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
143118321|NCT04908475|515976067|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
143118322|NCT04908475|515976068|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
143118323|NCT04908475|515976069|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
143118324|NCT04908475|515976070|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
143118325|NCT04908475|515976071|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
143118326|NCT04908475|515976072|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
143118327|NCT04908475|515976067|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
143459137|NCT00346632|517226886|FG009|Overall Study|Death|0|||
143459138|NCT00346632|517226877|FG000|Overall Study|Protocol Violation|0|||
143459139|NCT00346632|517226878|FG001|Overall Study|Protocol Violation|0|||
143459140|NCT00346632|517226879|FG002|Overall Study|Protocol Violation|0|||
143459141|NCT00346632|517226880|FG003|Overall Study|Protocol Violation|0|||
143459142|NCT00346632|517226881|FG004|Overall Study|Protocol Violation|0|||
143459143|NCT00346632|517226882|FG005|Overall Study|Protocol Violation|0|||
143459144|NCT00346632|517226883|FG006|Overall Study|Protocol Violation|1|||
143118328|NCT04908475|515976068|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
143118329|NCT04908475|515976069|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
143118330|NCT04908475|515976070|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
143118331|NCT04908475|515976071|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
143118332|NCT04908475|515976072|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
143118333|NCT04908475|515976067|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
143118334|NCT04908475|515976068|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
143118335|NCT04908475|515976069|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
143118336|NCT04908475|515976070|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
143118337|NCT04908475|515976071|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
143118338|NCT04908475|515976072|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
143118339|NCT04908475|515976067|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
143118340|NCT04908475|515976068|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
143459145|NCT00346632|517226884|FG007|Overall Study|Protocol Violation|0|||
143459146|NCT00346632|517226885|FG008|Overall Study|Protocol Violation|0|||
143459147|NCT00346632|517226886|FG009|Overall Study|Protocol Violation|0|||
143459148|NCT00346632|517226877|FG000|Overall Study|Withdrawal by Subject|0|||
143459149|NCT00346632|517226878|FG001|Overall Study|Withdrawal by Subject|0|||
143459150|NCT00346632|517226879|FG002|Overall Study|Withdrawal by Subject|0|||
143459151|NCT00346632|517226880|FG003|Overall Study|Withdrawal by Subject|0|||
143118341|NCT04908475|515976069|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
143118342|NCT04908475|515976070|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
143118343|NCT04908475|515976071|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
143459152|NCT00346632|517226881|FG004|Overall Study|Withdrawal by Subject|0|||
143459153|NCT00346632|517226882|FG005|Overall Study|Withdrawal by Subject|0|||
143459154|NCT00346632|517226883|FG006|Overall Study|Withdrawal by Subject|1|||
143459155|NCT00346632|517226884|FG007|Overall Study|Withdrawal by Subject|0|||
143459156|NCT00346632|517226885|FG008|Overall Study|Withdrawal by Subject|0|||
143459157|NCT00346632|517226886|FG009|Overall Study|Withdrawal by Subject|0|||
143459158|NCT00346632|517226877|FG000|Overall Study|Switched to alternative treatment|0|||
143459159|NCT00346632|517226878|FG001|Overall Study|Switched to alternative treatment|0|||
143459160|NCT00346632|517226879|FG002|Overall Study|Switched to alternative treatment|1|||
143459161|NCT00346632|517226880|FG003|Overall Study|Switched to alternative treatment|0|||
143459162|NCT00346632|517226881|FG004|Overall Study|Switched to alternative treatment|0|||
143459163|NCT00346632|517226882|FG005|Overall Study|Switched to alternative treatment|0|||
143459164|NCT00346632|517226883|FG006|Overall Study|Switched to alternative treatment|0|||
143459165|NCT00346632|517226884|FG007|Overall Study|Switched to alternative treatment|0|||
143459166|NCT00346632|517226885|FG008|Overall Study|Switched to alternative treatment|0|||
143459167|NCT00346632|517226886|FG009|Overall Study|Switched to alternative treatment|0|||
143459168|NCT00346632|517226877|FG000|Overall Study|Not Stated|1|||
143459169|NCT00346632|517226878|FG001|Overall Study|Not Stated|1|||
143459170|NCT00346632|517226879|FG002|Overall Study|Not Stated|0|||
143459171|NCT00346632|517226880|FG003|Overall Study|Not Stated|0|||
143459172|NCT00346632|517226881|FG004|Overall Study|Not Stated|0|||
143459173|NCT00346632|517226882|FG005|Overall Study|Not Stated|0|||
143459174|NCT00346632|517226883|FG006|Overall Study|Not Stated|0|||
143459175|NCT00346632|517226884|FG007|Overall Study|Not Stated|2|||
143459176|NCT00346632|517226885|FG008|Overall Study|Not Stated|2|||
143459177|NCT00346632|517226886|FG009|Overall Study|Not Stated|1|||
143459178|NCT00477334|517226887|FG000|Overall Study|Discontinued prior to taking study drug|106|||
143459179|NCT00477334|517226888|FG001|Overall Study|Discontinued prior to taking study drug|53|||
143459180|NCT00477334|517226887|FG000|Overall Study|Adverse Event|1|||
143459181|NCT00477334|517226888|FG001|Overall Study|Adverse Event|2|||
143459182|NCT00477334|517226887|FG000|Overall Study|Withdrawal by Subject|2|||
143459183|NCT00477334|517226888|FG001|Overall Study|Withdrawal by Subject|1|||
143459184|NCT00477334|517226887|FG000|Overall Study|Lost to Follow-up|15|||
143459185|NCT00477334|517226888|FG001|Overall Study|Lost to Follow-up|4|||
143459186|NCT00477334|517226887|FG000|Overall Study|Administrative Problems|39|||
143459187|NCT00477334|517226888|FG001|Overall Study|Administrative Problems|15|||
143459188|NCT00477334|517226887|FG000|Overall Study|Protocol Violation|7|||
143459189|NCT00477334|517226888|FG001|Overall Study|Protocol Violation|1|||
143459190|NCT00297232|517226889|FG000|Overall Study|Lack of Efficacy|7|||
143459191|NCT00297232|517226889|FG000|Overall Study|Lost to Follow-up|10|||
143459192|NCT00297232|517226889|FG000|Overall Study|Adverse Event|63|||
143459193|NCT00297232|517226889|FG000|Overall Study|Voluntary Withdrawal|120|||
143459194|NCT00297232|517226889|FG000|Overall Study|Subject was Noncompliant|9|||
143459195|NCT00297232|517226889|FG000|Overall Study|Death|9|||
143118344|NCT04908475|515976072|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
143118345|NCT01739764|515976073|FG000|Overall Study|Adverse Event|0|||
143118346|NCT01739764|515976074|FG001|Overall Study|Adverse Event|3|||
143118347|NCT01739764|515976075|FG002|Overall Study|Adverse Event|4|||
143118348|NCT01739764|515976073|FG000|Overall Study|Death|4|||
143118349|NCT01739764|515976074|FG001|Overall Study|Death|6|||
143118350|NCT01739764|515976075|FG002|Overall Study|Death|38|||
143118351|NCT01739764|515976073|FG000|Overall Study|Lost to Follow-up|0|||
143118352|NCT01739764|515976074|FG001|Overall Study|Lost to Follow-up|0|||
143118353|NCT01739764|515976075|FG002|Overall Study|Lost to Follow-up|5|||
143118354|NCT01739764|515976073|FG000|Overall Study|Non-Compliance|0|||
143118355|NCT01739764|515976074|FG001|Overall Study|Non-Compliance|0|||
143118356|NCT01739764|515976075|FG002|Overall Study|Non-Compliance|1|||
143118357|NCT01739764|515976073|FG000|Overall Study|Multiple Reasons|3|||
143118358|NCT01739764|515976074|FG001|Overall Study|Multiple Reasons|2|||
143118359|NCT01739764|515976075|FG002|Overall Study|Multiple Reasons|3|||
143118360|NCT01739764|515976073|FG000|Overall Study|Physician Decision|2|||
143459196|NCT00297232|517226889|FG000|Overall Study|Anti-natalizumab Positive|8|||
143459197|NCT00297232|517226889|FG000|Overall Study|Switched to Commercial Tysabri|22|||
143459198|NCT00297232|517226889|FG000|Overall Study|Disease Progression|8|||
143459199|NCT00297232|517226889|FG000|Overall Study|Fear of PML|10|||
143459200|NCT00297232|517226889|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
143459201|NCT00297232|517226889|FG000|Overall Study|Miscellaneous|5|||
143118361|NCT01739764|515976074|FG001|Overall Study|Physician Decision|2|||
143118362|NCT01739764|515976075|FG002|Overall Study|Physician Decision|4|||
143118363|NCT01739764|515976073|FG000|Overall Study|Progressive Disease|3|||
143459202|NCT00297232|517226889|FG000|Overall Study|Sponsor Decision|34|||
143118364|NCT01739764|515976074|FG001|Overall Study|Progressive Disease|5|||
143118365|NCT01739764|515976075|FG002|Overall Study|Progressive Disease|16|||
143118366|NCT01739764|515976073|FG000|Overall Study|Protocol Violation|0|||
143118367|NCT01739764|515976074|FG001|Overall Study|Protocol Violation|0|||
143118368|NCT01739764|515976075|FG002|Overall Study|Protocol Violation|2|||
143118369|NCT01739764|515976073|FG000|Overall Study|Study Terminated by Sponsor|8|||
143118370|NCT01739764|515976074|FG001|Overall Study|Study Terminated by Sponsor|13|||
143118371|NCT01739764|515976075|FG002|Overall Study|Study Terminated by Sponsor|26|||
143118372|NCT01739764|515976073|FG000|Overall Study|Withdrawal by Subject|6|||
143118373|NCT01739764|515976074|FG001|Overall Study|Withdrawal by Subject|5|||
143118374|NCT01739764|515976075|FG002|Overall Study|Withdrawal by Subject|27|||
143118375|NCT00337779|515976076|FG000|Overall Study|Withdrawal by Subject|10|||
143118376|NCT00337779|515976077|FG001|Overall Study|Withdrawal by Subject|12|||
143118377|NCT00337779|515976076|FG000|Overall Study|Sponsor decision|1|||
143118378|NCT00337779|515976077|FG001|Overall Study|Sponsor decision|1|||
143118379|NCT00337779|515976076|FG000|Overall Study|Physician Decision|3|||
143118380|NCT00337779|515976077|FG001|Overall Study|Physician Decision|6|||
143118381|NCT00337779|515976076|FG000|Overall Study|Protocol Violation|1|||
143118382|NCT00337779|515976077|FG001|Overall Study|Protocol Violation|1|||
143118383|NCT00337779|515976076|FG000|Overall Study|Lost to Follow-up|6|||
143118384|NCT00337779|515976077|FG001|Overall Study|Lost to Follow-up|5|||
143118385|NCT00337779|515976076|FG000|Overall Study|Adverse Event|28|||
143118386|NCT00337779|515976077|FG001|Overall Study|Adverse Event|51|||
143118387|NCT00337779|515976076|FG000|Overall Study|Pregnancy|3|||
143118388|NCT00337779|515976077|FG001|Overall Study|Pregnancy|2|||
143118389|NCT00337779|515976076|FG000|Overall Study|Death|0|||
143118390|NCT00337779|515976077|FG001|Overall Study|Death|1|||
143118391|NCT00404924|515976078|FG000|Overall Study|Adverse Event|75|||
143118392|NCT00404924|515976079|FG001|Overall Study|Adverse Event|16|||
143118393|NCT00404924|515976078|FG000|Overall Study|Condition under investigation worsened|475|||
143118394|NCT00404924|515976079|FG001|Overall Study|Condition under investigation worsened|264|||
143118395|NCT00404924|515976078|FG000|Overall Study|Lost to Follow-up|1|||
143118396|NCT00404924|515976079|FG001|Overall Study|Lost to Follow-up|1|||
143118397|NCT00404924|515976078|FG000|Overall Study|Withdrawal by Subject|26|||
143118398|NCT00404924|515976079|FG001|Overall Study|Withdrawal by Subject|13|||
143118399|NCT00404924|515976078|FG000|Overall Study|Other|25|||
143118400|NCT00404924|515976079|FG001|Overall Study|Other|11|||
143118401|NCT00404924|515976078|FG000|Overall Study|Randomised but not received treatment|1|||
143118402|NCT00404924|515976079|FG001|Overall Study|Randomised but not received treatment|1|||
143118403|NCT01074255|515976086|FG000|Overall Study|Did not receive EMEND|2|||
143118404|NCT00422422|515976087|FG000|Overall Study|Lack of Efficacy|1|||
143118405|NCT00422422|515976087|FG000|Overall Study|Protocol Violation|1|||
143118406|NCT00422422|515976087|FG000|Overall Study|Withdrawal by Subject|2|||
143118407|NCT00422422|515976087|FG000|Overall Study|SAE, non-fatal|1|||
143118408|NCT00422422|515976087|FG000|Overall Study|AE, non-serious non-fatal|5|||
143459203|NCT00297232|517226889|FG000|Overall Study|Subject Relocated|7|||
143459204|NCT00297232|517226889|FG000|Overall Study|Subject Withdrew Consent|37|||
143459205|NCT00297232|517226889|FG000|Overall Study|Persistently Positive Antibodies|11|||
143459206|NCT00297232|517226889|FG000|Overall Study|Investigator Withdrew From Program|19|||
143459207|NCT00297232|517226889|FG000|Overall Study|Did Not Enroll to Week 264|34|||
143459208|NCT00297232|517226889|FG000|Overall Study|Did Not Enroll to Week 480|17|||
143459209|NCT00297232|517226889|FG000|Overall Study|No data available after Week 264|161|||
143459210|NCT00297232|517226889|FG000|Overall Study|Other|1|||
143459211|NCT00552240|517226894|FG000|Overall Study|Adverse Event|9|||
143459212|NCT00552240|517226895|FG001|Overall Study|Adverse Event|9|||
143459213|NCT00552240|517226894|FG000|Overall Study|Protocol Violation|1|||
143459214|NCT00552240|517226895|FG001|Overall Study|Protocol Violation|1|||
143459215|NCT00552240|517226894|FG000|Overall Study|Lost to Follow-up|5|||
143459216|NCT00552240|517226895|FG001|Overall Study|Lost to Follow-up|6|||
143459217|NCT00552240|517226894|FG000|Overall Study|Withdrawal by Subject|2|||
143459218|NCT00552240|517226895|FG001|Overall Study|Withdrawal by Subject|2|||
143459219|NCT00552240|517226894|FG000|Overall Study|Lack of Efficacy|6|||
143459220|NCT00552240|517226895|FG001|Overall Study|Lack of Efficacy|0|||
143459221|NCT00552240|517226894|FG000|Overall Study|Other|1|||
143459222|NCT00552240|517226895|FG001|Overall Study|Other|0|||
143459223|NCT02319525|517226896|FG000|Overall Study|Withdrawal by Subject|2|||
143459224|NCT02319525|517226897|FG001|Overall Study|Withdrawal by Subject|1|||
143459225|NCT00577577|517226898|FG000|Overall Study|Adverse Event|3|||
143118409|NCT02943785|515976089|FG000|Overall Study|Adverse Event|112|||
143459226|NCT00577577|517226899|FG001|Overall Study|Adverse Event|2|||
143459227|NCT00577577|517226898|FG000|Overall Study|Lost to Follow-up|1|||
143459228|NCT00577577|517226899|FG001|Overall Study|Lost to Follow-up|0|||
143459229|NCT00577577|517226898|FG000|Overall Study|Protocol Violation|0|||
143459230|NCT00577577|517226899|FG001|Overall Study|Protocol Violation|3|||
143459231|NCT00577577|517226898|FG000|Overall Study|Transportation|1|||
143459232|NCT00577577|517226899|FG001|Overall Study|Transportation|0|||
143118410|NCT02943785|515976090|FG001|Overall Study|Adverse Event|97|||
143118411|NCT02943785|515976089|FG000|Overall Study|Withdrawal by Subject|63|||
143118412|NCT02943785|515976090|FG001|Overall Study|Withdrawal by Subject|126|||
143459233|NCT01200589|517226900|FG000|Overall Study|Withdrawal by Subject|13|||
143459234|NCT01200589|517226901|FG001|Overall Study|Withdrawal by Subject|11|||
143459235|NCT01200589|517226900|FG000|Overall Study|Physician Decision|2|||
143459236|NCT01200589|517226901|FG001|Overall Study|Physician Decision|2|||
143459237|NCT01200589|517226900|FG000|Overall Study|Lost to Follow-up|5|||
143459238|NCT01200589|517226901|FG001|Overall Study|Lost to Follow-up|4|||
143459239|NCT01200589|517226900|FG000|Overall Study|Study terminated|170|||
143459240|NCT01200589|517226901|FG001|Overall Study|Study terminated|172|||
143459241|NCT02549196|517226902|FG000|Overall Study|Protocol Violation|0|||
143459242|NCT02549196|517226903|FG001|Overall Study|Protocol Violation|0|||
143459243|NCT02549196|517226904|FG002|Overall Study|Protocol Violation|0|||
143459244|NCT02549196|517226905|FG003|Overall Study|Protocol Violation|1|||
143459245|NCT02549196|517226902|FG000|Overall Study|Withdrawal by Subject|1|||
143459246|NCT02549196|517226903|FG001|Overall Study|Withdrawal by Subject|0|||
143459247|NCT02549196|517226904|FG002|Overall Study|Withdrawal by Subject|1|||
143459248|NCT02549196|517226905|FG003|Overall Study|Withdrawal by Subject|0|||
143459249|NCT01442779|517226906|FG000|Overall Study|Withdrawal by Subject|3|||
143459250|NCT01442779|517226906|FG000|Overall Study|Death|3|||
143459251|NCT01442779|517226906|FG000|Overall Study|Non-compliance|1|||
143459252|NCT00757783|517226910|FG000|Overall Study|Adverse Event|0|||
143459253|NCT00757783|517226911|FG001|Overall Study|Adverse Event|2|||
143459254|NCT00757783|517226910|FG000|Overall Study|Lost to Follow-up|1|||
143459255|NCT00757783|517226911|FG001|Overall Study|Lost to Follow-up|1|||
143459256|NCT00757783|517226910|FG000|Overall Study|Protocol Violation|1|||
143459257|NCT00757783|517226911|FG001|Overall Study|Protocol Violation|0|||
143459258|NCT00757783|517226910|FG000|Overall Study|Withdrawal by Subject|2|||
143459259|NCT00757783|517226911|FG001|Overall Study|Withdrawal by Subject|1|||
143459260|NCT00757783|517226910|FG000|Overall Study|Other|1|||
143459261|NCT00757783|517226911|FG001|Overall Study|Other|2|||
143459262|NCT03683823|517226918|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
143459263|NCT03683823|517226919|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
143459264|NCT03683823|517226918|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
143459265|NCT03683823|517226919|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
143459266|NCT03683823|517226918|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
143459267|NCT03683823|517226919|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
143459268|NCT03965351|517226920|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
143459269|NCT03965351|517226921|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
143459270|NCT03965351|517226920|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
143459271|NCT03965351|517226921|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
143459272|NCT00994682|517226923|FG000|Double Bilnd|Withdrawal by Subject|5|||
143459273|NCT00994682|517226924|FG001|Double Bilnd|Withdrawal by Subject|6|||
143459274|NCT00994682|517226923|FG000|Double Bilnd|Lost to Follow-up|3|||
143459275|NCT00994682|517226924|FG001|Double Bilnd|Lost to Follow-up|3|||
143459276|NCT00994682|517226923|FG000|Double Bilnd|Adverse Event|1|||
143459277|NCT00994682|517226924|FG001|Double Bilnd|Adverse Event|0|||
143459278|NCT00994682|517226923|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
143459279|NCT00994682|517226924|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
143459280|NCT00994682|517226923|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
143459281|NCT00994682|517226924|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
143459282|NCT00994682|517226923|FG000|Pioglitazone Open Label|Physician Decision|6|||
143459283|NCT00994682|517226924|FG001|Pioglitazone Open Label|Physician Decision|1|||
143459284|NCT01323972|517226925|FG000|Overall Study|Withdrawal by Subject|1|||
143459285|NCT01323972|517226926|FG001|Overall Study|Withdrawal by Subject|0|||
143459286|NCT01323972|517226927|FG002|Overall Study|Withdrawal by Subject|1|||
143459287|NCT01323972|517226928|FG003|Overall Study|Withdrawal by Subject|0|||
143459288|NCT01323972|517226925|FG000|Overall Study|Migrated/moved from study area|1|||
143459289|NCT01323972|517226926|FG001|Overall Study|Migrated/moved from study area|2|||
143459290|NCT01323972|517226927|FG002|Overall Study|Migrated/moved from study area|0|||
143459291|NCT01323972|517226928|FG003|Overall Study|Migrated/moved from study area|0|||
143459292|NCT01323972|517226925|FG000|Overall Study|Lost to Follow-up|0|||
143459293|NCT01323972|517226926|FG001|Overall Study|Lost to Follow-up|1|||
143459294|NCT01323972|517226927|FG002|Overall Study|Lost to Follow-up|1|||
143459295|NCT01323972|517226928|FG003|Overall Study|Lost to Follow-up|1|||
143459296|NCT00943111|517226931|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
143459297|NCT00943111|517226932|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
143459298|NCT00943111|517226933|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
143459299|NCT00943111|517226931|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
143459300|NCT00943111|517226932|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
143459301|NCT00943111|517226933|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
143459302|NCT00943111|517226931|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
143459303|NCT00943111|517226932|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
143459304|NCT00943111|517226933|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
143459305|NCT00943111|517226931|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
143459306|NCT00943111|517226932|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
143459307|NCT00943111|517226933|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
143459308|NCT00943111|517226931|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
143459309|NCT00943111|517226932|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
143459310|NCT00943111|517226933|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
143459311|NCT00943111|517226931|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
143459312|NCT00943111|517226932|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
143459313|NCT00943111|517226933|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
143459314|NCT00943111|517226931|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
143459315|NCT00943111|517226932|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
143459316|NCT00943111|517226933|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
143459317|NCT00943111|517226931|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
143459318|NCT00943111|517226932|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
143459319|NCT00943111|517226933|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
143459320|NCT02859324|517226934|FG000|Overall Study|Death|4|||
143459321|NCT02859324|517226935|FG001|Overall Study|Death|6|||
143459322|NCT02859324|517226936|FG002|Overall Study|Death|5|||
143459323|NCT02859324|517226934|FG000|Overall Study|Other reasons|3|||
143459324|NCT02859324|517226935|FG001|Overall Study|Other reasons|3|||
143459325|NCT02859324|517226936|FG002|Overall Study|Other reasons|0|||
143459326|NCT02008877|517226937|FG000|Overall Study|Inevaluable|0|||
143459327|NCT02008877|517226938|FG001|Overall Study|Inevaluable|1|||
143459328|NCT02008877|517226939|FG002|Overall Study|Inevaluable|0|||
143459329|NCT01049217|517226940|FG000|Overall Study|Adverse Event|2|||
143459330|NCT01049217|517226941|FG001|Overall Study|Adverse Event|1|||
143459331|NCT01049217|517226940|FG000|Overall Study|Lack of Efficacy|1|||
143459332|NCT01049217|517226941|FG001|Overall Study|Lack of Efficacy|1|||
143459333|NCT01049217|517226940|FG000|Overall Study|Lost to Follow-up|3|||
143459334|NCT01049217|517226941|FG001|Overall Study|Lost to Follow-up|8|||
143459335|NCT01049217|517226940|FG000|Overall Study|Withdrawal by Subject|4|||
143459336|NCT01049217|517226941|FG001|Overall Study|Withdrawal by Subject|3|||
143459337|NCT01049217|517226940|FG000|Overall Study|Protocol Violation|1|||
143459338|NCT01049217|517226941|FG001|Overall Study|Protocol Violation|3|||
143459339|NCT01049217|517226940|FG000|Overall Study|Pregnancy|1|||
143459340|NCT01049217|517226941|FG001|Overall Study|Pregnancy|0|||
143459341|NCT01049217|517226940|FG000|Overall Study|Study Terminated by Sponsor|43|||
143459342|NCT01049217|517226941|FG001|Overall Study|Study Terminated by Sponsor|43|||
143459343|NCT01049217|517226940|FG000|Overall Study|Other|1|||
143459344|NCT01049217|517226941|FG001|Overall Study|Other|2|||
143459345|NCT01049217|517226940|FG000|Overall Study|Randomized but not Treated|0|||
143459346|NCT01049217|517226941|FG001|Overall Study|Randomized but not Treated|2|||
143459347|NCT01946438|517226942|FG000|Overall Study|Adverse Event|0|||
143459348|NCT01946438|517226943|FG001|Overall Study|Adverse Event|0|||
143459349|NCT01946438|517226944|FG002|Overall Study|Adverse Event|0|||
143459350|NCT01946438|517226945|FG003|Overall Study|Adverse Event|1|||
143459351|NCT01946438|517226942|FG000|Overall Study|Serious Adverse event|1|||
143459352|NCT01946438|517226943|FG001|Overall Study|Serious Adverse event|0|||
143459353|NCT01946438|517226944|FG002|Overall Study|Serious Adverse event|0|||
143459354|NCT01946438|517226945|FG003|Overall Study|Serious Adverse event|0|||
143459355|NCT01946438|517226942|FG000|Overall Study|Protocol Violation|0|||
143459356|NCT01946438|517226943|FG001|Overall Study|Protocol Violation|0|||
143459357|NCT01946438|517226944|FG002|Overall Study|Protocol Violation|1|||
143459358|NCT01946438|517226945|FG003|Overall Study|Protocol Violation|0|||
143459359|NCT01946438|517226942|FG000|Overall Study|Withdrawal by Subject|1|||
143459360|NCT01946438|517226943|FG001|Overall Study|Withdrawal by Subject|0|||
143459361|NCT01946438|517226944|FG002|Overall Study|Withdrawal by Subject|0|||
143459362|NCT01946438|517226945|FG003|Overall Study|Withdrawal by Subject|0|||
143459363|NCT02412371|517226946|FG000|Overall Study|Withdrawal by Subject|0|||
143459364|NCT02412371|517226947|FG001|Overall Study|Withdrawal by Subject|2|||
143459365|NCT02412371|517226948|FG002|Overall Study|Withdrawal by Subject|0|||
143459366|NCT02412371|517226949|FG003|Overall Study|Withdrawal by Subject|1|||
143459367|NCT02412371|517226950|FG004|Overall Study|Withdrawal by Subject|1|||
143459368|NCT02412371|517226951|FG005|Overall Study|Withdrawal by Subject|0|||
143459369|NCT02412371|517226946|FG000|Overall Study|Sponsor Discontinued Study|1|||
143459370|NCT02412371|517226947|FG001|Overall Study|Sponsor Discontinued Study|4|||
143459371|NCT02412371|517226948|FG002|Overall Study|Sponsor Discontinued Study|6|||
143459372|NCT02412371|517226949|FG003|Overall Study|Sponsor Discontinued Study|4|||
143459373|NCT02412371|517226950|FG004|Overall Study|Sponsor Discontinued Study|5|||
143459374|NCT02412371|517226951|FG005|Overall Study|Sponsor Discontinued Study|0|||
143459375|NCT02412371|517226946|FG000|Overall Study|Death|4|||
143459376|NCT02412371|517226947|FG001|Overall Study|Death|2|||
143459377|NCT02412371|517226948|FG002|Overall Study|Death|1|||
143459378|NCT02412371|517226949|FG003|Overall Study|Death|3|||
143459379|NCT02412371|517226950|FG004|Overall Study|Death|5|||
143459380|NCT02412371|517226951|FG005|Overall Study|Death|2|||
143459381|NCT02412371|517226946|FG000|Overall Study|Other|2|||
143459382|NCT02412371|517226947|FG001|Overall Study|Other|1|||
143459383|NCT02412371|517226948|FG002|Overall Study|Other|0|||
143459384|NCT02412371|517226949|FG003|Overall Study|Other|0|||
143459385|NCT02412371|517226950|FG004|Overall Study|Other|1|||
143459386|NCT02412371|517226951|FG005|Overall Study|Other|3|||
143459387|NCT05000931|517226952|FG000|Overall Study|Lost to Follow-up|1|||
143459388|NCT03149549|517226953|FG000|Study Discontinuation--Treatment Period|Death|0|||
143459389|NCT03149549|517226954|FG001|Study Discontinuation--Treatment Period|Death|0|||
143459390|NCT03149549|517226955|FG002|Study Discontinuation--Treatment Period|Death|0|||
143459391|NCT03149549|517226956|FG003|Study Discontinuation--Treatment Period|Death|1|||
143459392|NCT03149549|517226957|FG004|Study Discontinuation--Treatment Period|Death|2|||
143459393|NCT03149549|517226958|FG005|Study Discontinuation--Treatment Period|Death|1|||
143459394|NCT03149549|517226959|FG006|Study Discontinuation--Treatment Period|Death|1|||
143459395|NCT03149549|517226960|FG007|Study Discontinuation--Treatment Period|Death|2|||
143118413|NCT02943785|515976089|FG000|Overall Study|Physician Decision|23|||
143118414|NCT02943785|515976090|FG001|Overall Study|Physician Decision|47|||
143118415|NCT02943785|515976089|FG000|Overall Study|Death|46|||
143118416|NCT02943785|515976090|FG001|Overall Study|Death|46|||
143118417|NCT02943785|515976089|FG000|Overall Study|Lost to Follow-up|1|||
143118418|NCT02943785|515976090|FG001|Overall Study|Lost to Follow-up|0|||
143118419|NCT02943785|515976089|FG000|Overall Study|Other|16|||
143118420|NCT02943785|515976090|FG001|Overall Study|Other|19|||
143118421|NCT02943785|515976089|FG000|Overall Study|Did not receive any study medication|21|||
143118422|NCT02943785|515976090|FG001|Overall Study|Did not receive any study medication|28|||
143118423|NCT03170609|515976091|FG000|Overall Study|Death|0|||
143118424|NCT03170609|515976092|FG001|Overall Study|Death|0|||
143118425|NCT03170609|515976093|FG002|Overall Study|Death|1|||
143118426|NCT03170609|515976094|FG003|Overall Study|Death|0|||
143118427|NCT03170609|515976095|FG004|Overall Study|Death|0|||
143118428|NCT03170609|515976096|FG005|Overall Study|Death|0|||
143118429|NCT03170609|515976097|FG006|Overall Study|Death|0|||
143118430|NCT03170609|515976091|FG000|Overall Study|Withdrawal by Subject|1|||
143118431|NCT03170609|515976092|FG001|Overall Study|Withdrawal by Subject|2|||
143118432|NCT03170609|515976093|FG002|Overall Study|Withdrawal by Subject|0|||
143118433|NCT03170609|515976094|FG003|Overall Study|Withdrawal by Subject|0|||
143118434|NCT03170609|515976095|FG004|Overall Study|Withdrawal by Subject|0|||
143118435|NCT03170609|515976096|FG005|Overall Study|Withdrawal by Subject|0|||
143118436|NCT03170609|515976097|FG006|Overall Study|Withdrawal by Subject|1|||
143118437|NCT03170609|515976091|FG000|Overall Study|Lost to Follow-up|1|||
143118438|NCT03170609|515976092|FG001|Overall Study|Lost to Follow-up|0|||
143118439|NCT03170609|515976093|FG002|Overall Study|Lost to Follow-up|5|||
143118440|NCT03170609|515976094|FG003|Overall Study|Lost to Follow-up|2|||
143118441|NCT03170609|515976095|FG004|Overall Study|Lost to Follow-up|1|||
143118442|NCT03170609|515976096|FG005|Overall Study|Lost to Follow-up|1|||
143118443|NCT03170609|515976097|FG006|Overall Study|Lost to Follow-up|0|||
143118444|NCT03170609|515976091|FG000|Overall Study|Other|1|||
143118445|NCT03170609|515976092|FG001|Overall Study|Other|0|||
143118446|NCT03170609|515976093|FG002|Overall Study|Other|0|||
143118447|NCT03170609|515976094|FG003|Overall Study|Other|0|||
143118448|NCT03170609|515976095|FG004|Overall Study|Other|0|||
143118449|NCT03170609|515976096|FG005|Overall Study|Other|1|||
143118450|NCT03170609|515976097|FG006|Overall Study|Other|0|||
143118451|NCT01281956|515976098|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
143118452|NCT01281956|515976099|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
143118453|NCT01593254|515976105|FG000|Overall Study|Disease progression|2|||
143118454|NCT01593254|515976106|FG001|Overall Study|Disease progression|7|||
143118455|NCT01593254|515976105|FG000|Overall Study|Study drug toxicity|6|||
143118456|NCT01593254|515976106|FG001|Overall Study|Study drug toxicity|20|||
143118457|NCT01593254|515976105|FG000|Overall Study|Death|3|||
143118458|NCT01593254|515976106|FG001|Overall Study|Death|3|||
143118459|NCT01593254|515976105|FG000|Overall Study|AE unrelated to study drug|0|||
143118460|NCT01593254|515976106|FG001|Overall Study|AE unrelated to study drug|1|||
143118461|NCT01593254|515976105|FG000|Overall Study|participant request to discontinue study treatment|1|||
143118462|NCT01593254|515976106|FG001|Overall Study|participant request to discontinue study treatment|3|||
143118463|NCT01593254|515976105|FG000|Overall Study|participant withdrew consent|0|||
143118464|NCT01593254|515976106|FG001|Overall Study|participant withdrew consent|9|||
143118465|NCT01593254|515976105|FG000|Overall Study|lost to follow up|1|||
143118466|NCT01593254|515976106|FG001|Overall Study|lost to follow up|6|||
143118467|NCT01593254|515976105|FG000|Overall Study|maximum clinical benefit|1|||
143118468|NCT01593254|515976106|FG001|Overall Study|maximum clinical benefit|2|||
143118469|NCT01593254|515976105|FG000|Overall Study|Poor/non compliance|1|||
143118470|NCT01593254|515976106|FG001|Overall Study|Poor/non compliance|1|||
143118471|NCT01593254|515976105|FG000|Overall Study|Pregnancy|0|||
143118472|NCT01593254|515976106|FG001|Overall Study|Pregnancy|3|||
143118473|NCT01593254|515976105|FG000|Overall Study|participant no longer meets study criteria|1|||
143118474|NCT01593254|515976106|FG001|Overall Study|participant no longer meets study criteria|1|||
143118475|NCT01593254|515976105|FG000|Overall Study|Admin reason by sponsor|7|||
143459396|NCT03149549|517226961|FG008|Study Discontinuation--Treatment Period|Death|4|||
143459397|NCT03149549|517226962|FG009|Study Discontinuation--Treatment Period|Death|1|||
143118476|NCT01593254|515976106|FG001|Overall Study|Admin reason by sponsor|3|||
143459398|NCT03149549|517226963|FG010|Study Discontinuation--Treatment Period|Death|0|||
143118477|NCT01593254|515976105|FG000|Overall Study|Imatinib treatment failure|2|||
143118478|NCT01593254|515976106|FG001|Overall Study|Imatinib treatment failure|0|||
143118479|NCT01593254|515976105|FG000|Overall Study|Other Reasons|61|||
143118480|NCT01593254|515976106|FG001|Overall Study|Other Reasons|115|||
143118481|NCT03411902|515976109|FG000|Overall Study|Lost to Follow-up|3|||
143118482|NCT03411902|515976110|FG001|Overall Study|Lost to Follow-up|0|||
143118483|NCT00791492|515976111|FG000|Overall Study|Withdrawal by Subject|1|||
143118484|NCT00791492|515976112|FG001|Overall Study|Withdrawal by Subject|2|||
143118485|NCT00791492|515976111|FG000|Overall Study|Liver transplantation|5|||
143118486|NCT00791492|515976112|FG001|Overall Study|Liver transplantation|1|||
143118487|NCT00076999|515976115|FG000|Overall Study|Adverse Event|2|||
143118488|NCT00076999|515976116|FG001|Overall Study|Adverse Event|8|||
143118489|NCT00076999|515976117|FG002|Overall Study|Adverse Event|6|||
143118490|NCT00076999|515976118|FG003|Overall Study|Adverse Event|0|||
143118491|NCT00076999|515976119|FG004|Overall Study|Adverse Event|2|||
143118492|NCT00076999|515976115|FG000|Overall Study|Protocol Violation|0|||
143118493|NCT00076999|515976116|FG001|Overall Study|Protocol Violation|3|||
143118494|NCT00076999|515976117|FG002|Overall Study|Protocol Violation|4|||
143118495|NCT00076999|515976118|FG003|Overall Study|Protocol Violation|0|||
143118496|NCT00076999|515976119|FG004|Overall Study|Protocol Violation|9|||
143118497|NCT00076999|515976115|FG000|Overall Study|Lost to Follow-up|2|||
143118498|NCT00076999|515976116|FG001|Overall Study|Lost to Follow-up|1|||
143118499|NCT00076999|515976117|FG002|Overall Study|Lost to Follow-up|0|||
143118500|NCT00076999|515976118|FG003|Overall Study|Lost to Follow-up|0|||
143118501|NCT00076999|515976119|FG004|Overall Study|Lost to Follow-up|0|||
143118502|NCT00076999|515976115|FG000|Overall Study|Withdrawal by Subject|0|||
143118503|NCT00076999|515976116|FG001|Overall Study|Withdrawal by Subject|4|||
143118504|NCT00076999|515976117|FG002|Overall Study|Withdrawal by Subject|3|||
143118505|NCT00076999|515976118|FG003|Overall Study|Withdrawal by Subject|0|||
143118506|NCT00076999|515976119|FG004|Overall Study|Withdrawal by Subject|1|||
143118507|NCT00076999|515976115|FG000|Overall Study|Other reason (not specified)|8|||
143118508|NCT00076999|515976116|FG001|Overall Study|Other reason (not specified)|8|||
143118509|NCT00076999|515976117|FG002|Overall Study|Other reason (not specified)|4|||
143118510|NCT00076999|515976118|FG003|Overall Study|Other reason (not specified)|1|||
143118511|NCT00076999|515976119|FG004|Overall Study|Other reason (not specified)|13|||
143118512|NCT00990665|515976122|FG000|Overall Study|Unsuccessful Implant|8|||
143118513|NCT00990665|515976122|FG000|Overall Study|Death|29|||
143118514|NCT00990665|515976122|FG000|Overall Study|Heart Transplant|1|||
143118515|NCT00990665|515976122|FG000|Overall Study|Withdrawal by Subject|6|||
143118516|NCT00990665|515976122|FG000|Overall Study|Lost to Follow-up|1|||
143118517|NCT00990665|515976122|FG000|Overall Study|System Explant|3|||
143118518|NCT00270231|515976125|FG000|First Intervention|Lost to Follow-up|1|||
143118519|NCT00270231|515976126|FG001|First Intervention|Lost to Follow-up|1|||
143118520|NCT00270231|515976125|FG000|Washout Period|Lost to Follow-up|1|||
143118521|NCT00270231|515976126|FG001|Washout Period|Lost to Follow-up|0|||
143118522|NCT00270231|515976125|FG000|Second Intervention|Lost to Follow-up|0|||
143118523|NCT00270231|515976126|FG001|Second Intervention|Lost to Follow-up|1|||
143118524|NCT02603562|515976127|FG000|Overall Study|Lost to Follow-up|1|||
143118525|NCT01534208|515976136|FG000|Overall Study|Lost to Follow-up|19|||
143118526|NCT01534208|515976137|FG001|Overall Study|Lost to Follow-up|14|||
143118527|NCT01534208|515976136|FG000|Overall Study|Withdrawal by Subject|6|||
143118528|NCT01534208|515976137|FG001|Overall Study|Withdrawal by Subject|20|||
143118529|NCT01534208|515976136|FG000|Overall Study|Adverse Event|15|||
143118530|NCT01534208|515976137|FG001|Overall Study|Adverse Event|8|||
143118531|NCT01534208|515976136|FG000|Overall Study|Physician Decision|2|||
143118532|NCT01534208|515976137|FG001|Overall Study|Physician Decision|0|||
143118533|NCT01534208|515976136|FG000|Overall Study|Lack of Efficacy|0|||
143118534|NCT01534208|515976137|FG001|Overall Study|Lack of Efficacy|3|||
143118535|NCT01534208|515976136|FG000|Overall Study|Protocol Violation|2|||
143118536|NCT01534208|515976137|FG001|Overall Study|Protocol Violation|2|||
143118537|NCT01534208|515976136|FG000|Overall Study|Sponsor decision|4|||
143118538|NCT01534208|515976137|FG001|Overall Study|Sponsor decision|1|||
143118539|NCT01534208|515976136|FG000|Overall Study|Subject relocation|2|||
143118540|NCT01534208|515976137|FG001|Overall Study|Subject relocation|0|||
143118541|NCT01534208|515976136|FG000|Overall Study|Lab assessment|2|||
143118542|NCT01534208|515976137|FG001|Overall Study|Lab assessment|1|||
143118543|NCT01534208|515976136|FG000|Overall Study|Eligibility error|3|||
143118544|NCT01534208|515976137|FG001|Overall Study|Eligibility error|0|||
143118545|NCT01534208|515976136|FG000|Overall Study|PCP decision|1|||
143118546|NCT01534208|515976137|FG001|Overall Study|PCP decision|0|||
143118547|NCT01534208|515976136|FG000|Overall Study|Needed prohibited meds|1|||
143459399|NCT03149549|517226964|FG011|Study Discontinuation--Treatment Period|Death|0|||
143118548|NCT01534208|515976137|FG001|Overall Study|Needed prohibited meds|0|||
143118549|NCT01904903|515976138|FG000|Overall Study|Withdrawal by Subject|1|||
143118550|NCT00634049|515976143|FG000|Overall Study|Never received study drug|1|||
143118551|NCT00634049|515976143|FG000|Overall Study|Died prior to receiving study drug|1|||
143118552|NCT00634049|515976143|FG000|Overall Study|Screening failure|1|||
143118553|NCT00314132|515976144|FG000|Overall Study|Lost to Follow-up|3|||
143118554|NCT00314132|515976145|FG001|Overall Study|Lost to Follow-up|13|||
143118555|NCT00314132|515976144|FG000|Overall Study|Withdrawal by Subject|3|||
143118556|NCT00314132|515976145|FG001|Overall Study|Withdrawal by Subject|5|||
143118557|NCT00314132|515976144|FG000|Overall Study|Adverse Event|1|||
143118558|NCT00314132|515976145|FG001|Overall Study|Adverse Event|0|||
143118559|NCT00314132|515976144|FG000|Overall Study|Physician Decision|1|||
143118560|NCT00314132|515976145|FG001|Overall Study|Physician Decision|0|||
143118561|NCT02079636|515976150|FG000|Overall Study|Death|2|||
143118562|NCT02079636|515976151|FG001|Overall Study|Death|1|||
143118563|NCT02079636|515976152|FG002|Overall Study|Death|0|||
143118564|NCT02079636|515976153|FG003|Overall Study|Death|5|||
143118565|NCT02079636|515976154|FG004|Overall Study|Death|1|||
143118566|NCT02079636|515976155|FG005|Overall Study|Death|2|||
143118567|NCT02079636|515976156|FG006|Overall Study|Death|1|||
143118568|NCT02079636|515976157|FG007|Overall Study|Death|0|||
143118569|NCT02079636|515976158|FG008|Overall Study|Death|0|||
143118570|NCT02079636|515976159|FG009|Overall Study|Death|0|||
143118571|NCT02079636|515976160|FG010|Overall Study|Death|0|||
143118572|NCT02079636|515976161|FG011|Overall Study|Death|1|||
143118573|NCT02079636|515976162|FG012|Overall Study|Death|1|||
143118574|NCT02079636|515976163|FG013|Overall Study|Death|0|||
143118575|NCT02079636|515976164|FG014|Overall Study|Death|2|||
143118576|NCT02079636|515976150|FG000|Overall Study|Adverse Event|1|||
143118577|NCT02079636|515976151|FG001|Overall Study|Adverse Event|1|||
143118578|NCT02079636|515976152|FG002|Overall Study|Adverse Event|0|||
143118579|NCT02079636|515976153|FG003|Overall Study|Adverse Event|1|||
143118580|NCT02079636|515976154|FG004|Overall Study|Adverse Event|1|||
143118581|NCT02079636|515976155|FG005|Overall Study|Adverse Event|2|||
143118582|NCT02079636|515976156|FG006|Overall Study|Adverse Event|0|||
143118583|NCT02079636|515976157|FG007|Overall Study|Adverse Event|0|||
143118584|NCT02079636|515976158|FG008|Overall Study|Adverse Event|0|||
143118585|NCT02079636|515976159|FG009|Overall Study|Adverse Event|0|||
143118586|NCT02079636|515976160|FG010|Overall Study|Adverse Event|0|||
143118587|NCT02079636|515976161|FG011|Overall Study|Adverse Event|0|||
143118588|NCT02079636|515976162|FG012|Overall Study|Adverse Event|0|||
143118589|NCT02079636|515976163|FG013|Overall Study|Adverse Event|0|||
143118590|NCT02079636|515976164|FG014|Overall Study|Adverse Event|0|||
143118591|NCT02079636|515976150|FG000|Overall Study|Progressive disease|0|||
143118592|NCT02079636|515976151|FG001|Overall Study|Progressive disease|0|||
143118593|NCT02079636|515976152|FG002|Overall Study|Progressive disease|0|||
143118594|NCT02079636|515976153|FG003|Overall Study|Progressive disease|2|||
143118595|NCT02079636|515976154|FG004|Overall Study|Progressive disease|0|||
143118596|NCT02079636|515976155|FG005|Overall Study|Progressive disease|0|||
143118597|NCT02079636|515976156|FG006|Overall Study|Progressive disease|0|||
143118598|NCT02079636|515976157|FG007|Overall Study|Progressive disease|0|||
143118599|NCT02079636|515976158|FG008|Overall Study|Progressive disease|0|||
143118600|NCT02079636|515976159|FG009|Overall Study|Progressive disease|0|||
143118601|NCT02079636|515976160|FG010|Overall Study|Progressive disease|0|||
143118602|NCT02079636|515976161|FG011|Overall Study|Progressive disease|0|||
143118603|NCT02079636|515976162|FG012|Overall Study|Progressive disease|1|||
143118604|NCT02079636|515976163|FG013|Overall Study|Progressive disease|0|||
143118605|NCT02079636|515976164|FG014|Overall Study|Progressive disease|0|||
143118606|NCT02079636|515976150|FG000|Overall Study|Withdrawal by Subject|0|||
143118607|NCT02079636|515976151|FG001|Overall Study|Withdrawal by Subject|0|||
143118608|NCT02079636|515976152|FG002|Overall Study|Withdrawal by Subject|0|||
143118609|NCT02079636|515976153|FG003|Overall Study|Withdrawal by Subject|4|||
143118610|NCT02079636|515976154|FG004|Overall Study|Withdrawal by Subject|0|||
143118611|NCT02079636|515976155|FG005|Overall Study|Withdrawal by Subject|1|||
143118612|NCT02079636|515976156|FG006|Overall Study|Withdrawal by Subject|0|||
143118613|NCT02079636|515976157|FG007|Overall Study|Withdrawal by Subject|0|||
143118614|NCT02079636|515976158|FG008|Overall Study|Withdrawal by Subject|0|||
143118615|NCT02079636|515976159|FG009|Overall Study|Withdrawal by Subject|2|||
143118616|NCT02079636|515976160|FG010|Overall Study|Withdrawal by Subject|1|||
143118617|NCT02079636|515976161|FG011|Overall Study|Withdrawal by Subject|1|||
143118618|NCT02079636|515976162|FG012|Overall Study|Withdrawal by Subject|1|||
143118619|NCT02079636|515976163|FG013|Overall Study|Withdrawal by Subject|0|||
143118620|NCT02079636|515976164|FG014|Overall Study|Withdrawal by Subject|2|||
143118621|NCT02079636|515976150|FG000|Overall Study|Physician Decision|0|||
143118622|NCT02079636|515976151|FG001|Overall Study|Physician Decision|0|||
143118623|NCT02079636|515976152|FG002|Overall Study|Physician Decision|0|||
143118624|NCT02079636|515976153|FG003|Overall Study|Physician Decision|0|||
143118625|NCT02079636|515976154|FG004|Overall Study|Physician Decision|0|||
143118626|NCT02079636|515976155|FG005|Overall Study|Physician Decision|1|||
143118627|NCT02079636|515976156|FG006|Overall Study|Physician Decision|0|||
143118628|NCT02079636|515976157|FG007|Overall Study|Physician Decision|0|||
143118629|NCT02079636|515976158|FG008|Overall Study|Physician Decision|0|||
143118630|NCT02079636|515976159|FG009|Overall Study|Physician Decision|1|||
143118631|NCT02079636|515976160|FG010|Overall Study|Physician Decision|1|||
143118632|NCT02079636|515976161|FG011|Overall Study|Physician Decision|0|||
143118633|NCT02079636|515976162|FG012|Overall Study|Physician Decision|0|||
143118634|NCT02079636|515976163|FG013|Overall Study|Physician Decision|0|||
143118635|NCT02079636|515976164|FG014|Overall Study|Physician Decision|1|||
143118636|NCT02079636|515976150|FG000|Overall Study|Lost to Follow-up|0|||
143118637|NCT02079636|515976151|FG001|Overall Study|Lost to Follow-up|0|||
143118638|NCT02079636|515976152|FG002|Overall Study|Lost to Follow-up|0|||
143118639|NCT02079636|515976153|FG003|Overall Study|Lost to Follow-up|0|||
143118640|NCT02079636|515976154|FG004|Overall Study|Lost to Follow-up|0|||
143118641|NCT02079636|515976155|FG005|Overall Study|Lost to Follow-up|0|||
143118642|NCT02079636|515976156|FG006|Overall Study|Lost to Follow-up|0|||
143118643|NCT02079636|515976157|FG007|Overall Study|Lost to Follow-up|1|||
143118644|NCT02079636|515976158|FG008|Overall Study|Lost to Follow-up|0|||
143118645|NCT02079636|515976159|FG009|Overall Study|Lost to Follow-up|0|||
143118646|NCT02079636|515976160|FG010|Overall Study|Lost to Follow-up|0|||
143118647|NCT02079636|515976161|FG011|Overall Study|Lost to Follow-up|0|||
143118648|NCT02079636|515976162|FG012|Overall Study|Lost to Follow-up|0|||
143118649|NCT02079636|515976163|FG013|Overall Study|Lost to Follow-up|0|||
143118650|NCT02079636|515976164|FG014|Overall Study|Lost to Follow-up|0|||
143118651|NCT00561470|515976165|FG000|Overall Study|Adverse Event|74|||
143118652|NCT00561470|515976166|FG001|Overall Study|Adverse Event|163|||
143118653|NCT00561470|515976165|FG000|Overall Study|Disease progression|437|||
143118654|NCT00561470|515976166|FG001|Overall Study|Disease progression|305|||
143118655|NCT00561470|515976165|FG000|Overall Study|poor compliance to protocol|4|||
143118656|NCT00561470|515976166|FG001|Overall Study|poor compliance to protocol|4|||
143118657|NCT00561470|515976165|FG000|Overall Study|Lost to Follow-up|2|||
143118658|NCT00561470|515976166|FG001|Overall Study|Lost to Follow-up|0|||
143118659|NCT00561470|515976165|FG000|Overall Study|Physician Decision|21|||
143118660|NCT00561470|515976166|FG001|Overall Study|Physician Decision|20|||
143118661|NCT00561470|515976165|FG000|Overall Study|Consent Withdrawn|2|||
143118662|NCT00561470|515976166|FG001|Overall Study|Consent Withdrawn|6|||
143118663|NCT00561470|515976165|FG000|Overall Study|Subject request|43|||
143118664|NCT00561470|515976166|FG001|Overall Study|Subject request|77|||
143118665|NCT00561470|515976165|FG000|Overall Study|Metastatic surgery|10|||
143118666|NCT00561470|515976166|FG001|Overall Study|Metastatic surgery|12|||
143118667|NCT00561470|515976165|FG000|Overall Study|Unauthorized procedure|3|||
143118668|NCT00561470|515976166|FG001|Overall Study|Unauthorized procedure|1|||
143118669|NCT00561470|515976165|FG000|Overall Study|Randomized but not treated|5|||
143118670|NCT00561470|515976166|FG001|Overall Study|Randomized but not treated|5|||
143118671|NCT00561470|515976165|FG000|Overall Study|Missed visit window|1|||
143118672|NCT00561470|515976166|FG001|Overall Study|Missed visit window|4|||
143118673|NCT00561470|515976165|FG000|Overall Study|Planning surgery|1|||
143118674|NCT00561470|515976166|FG001|Overall Study|Planning surgery|1|||
143118675|NCT00561470|515976165|FG000|Overall Study|Ongoing Treatment|11|||
143118676|NCT00561470|515976166|FG001|Overall Study|Ongoing Treatment|14|||
143118677|NCT00721279|515976169|FG000|Overall Study|Lack of Efficacy|6|||
143118678|NCT00721279|515976170|FG001|Overall Study|Lack of Efficacy|3|||
143118679|NCT00721279|515976169|FG000|Overall Study|Tolerability insufficient|5|||
143118680|NCT00721279|515976170|FG001|Overall Study|Tolerability insufficient|2|||
143118681|NCT00721279|515976169|FG000|Overall Study|Withdrawal by Subject|13|||
143118682|NCT00721279|515976170|FG001|Overall Study|Withdrawal by Subject|3|||
143118683|NCT00721279|515976169|FG000|Overall Study|Other|12|||
143118684|NCT00721279|515976170|FG001|Overall Study|Other|16|||
143118685|NCT03467763|515976171|FG000|Overall Study|Lost to Follow-up|1|||
143118686|NCT03467763|515976171|FG000|Overall Study|Protocol Violation|2|||
143118687|NCT01324570|515976179|FG000|Overall Study|Adverse Event|4|||
143118688|NCT01324570|515976180|FG001|Overall Study|Adverse Event|7|||
143118689|NCT01324570|515976179|FG000|Overall Study|Withdrawal by Subject|0|||
143118690|NCT01324570|515976180|FG001|Overall Study|Withdrawal by Subject|3|||
143118691|NCT01324570|515976179|FG000|Overall Study|Lack of Efficacy|0|||
143118692|NCT01324570|515976180|FG001|Overall Study|Lack of Efficacy|1|||
143118693|NCT01324570|515976179|FG000|Overall Study|Confirmed or suspected diversion|0|||
143118694|NCT01324570|515976180|FG001|Overall Study|Confirmed or suspected diversion|1|||
143118695|NCT01324570|515976179|FG000|Overall Study|Administrative|0|||
143118696|NCT01324570|515976180|FG001|Overall Study|Administrative|2|||
143118697|NCT04683939|515976183|FG000|Overall Study|Study termination by the sponsor|0|||
143118698|NCT04683939|515976184|FG001|Overall Study|Study termination by the sponsor|1|||
143118699|NCT04683939|515976185|FG002|Overall Study|Study termination by the sponsor|2|||
143118700|NCT04683939|515976186|FG003|Overall Study|Study termination by the sponsor|2|||
143118701|NCT04683939|515976183|FG000|Overall Study|Death|1|||
143118702|NCT04683939|515976184|FG001|Overall Study|Death|1|||
143118703|NCT04683939|515976185|FG002|Overall Study|Death|2|||
143118704|NCT04683939|515976186|FG003|Overall Study|Death|1|||
143118705|NCT04683939|515976183|FG000|Overall Study|Withdrawal by Subject|1|||
143118706|NCT04683939|515976184|FG001|Overall Study|Withdrawal by Subject|0|||
143118707|NCT04683939|515976185|FG002|Overall Study|Withdrawal by Subject|0|||
143118708|NCT04683939|515976186|FG003|Overall Study|Withdrawal by Subject|0|||
143118709|NCT04683939|515976183|FG000|Overall Study|Physician Decision|1|||
143118710|NCT04683939|515976184|FG001|Overall Study|Physician Decision|0|||
143118711|NCT04683939|515976185|FG002|Overall Study|Physician Decision|0|||
143118712|NCT04683939|515976186|FG003|Overall Study|Physician Decision|0|||
143118713|NCT04683939|515976183|FG000|Overall Study|Lost to Follow-up|0|||
143118714|NCT04683939|515976184|FG001|Overall Study|Lost to Follow-up|1|||
143118715|NCT04683939|515976185|FG002|Overall Study|Lost to Follow-up|0|||
143118716|NCT04683939|515976186|FG003|Overall Study|Lost to Follow-up|0|||
143118717|NCT02824562|515977916|FG000|Overall Study|Lost to Follow-up|3|||
143118718|NCT02824562|515977917|FG001|Overall Study|Lost to Follow-up|4|||
143118719|NCT02824562|515977916|FG000|Overall Study|Death|0|||
143118720|NCT02824562|515977917|FG001|Overall Study|Death|1|||
143118721|NCT03089853|515977918|FG000|Overall Study|Lost to Follow-up|2|||
143118722|NCT03089853|515977919|FG001|Overall Study|Lost to Follow-up|1|||
143118723|NCT00642954|515977920|FG000|Overall Study|Progressive Disease|3|||
143118724|NCT00642954|515977921|FG001|Overall Study|Progressive Disease|3|||
143118725|NCT00642954|515977922|FG002|Overall Study|Progressive Disease|3|||
143118726|NCT00642954|515977923|FG003|Overall Study|Progressive Disease|3|||
143118727|NCT00642954|515977924|FG004|Overall Study|Progressive Disease|9|||
143118728|NCT00642954|515977920|FG000|Overall Study|Withdrawal by Subject|0|||
143118729|NCT00642954|515977921|FG001|Overall Study|Withdrawal by Subject|0|||
143118730|NCT00642954|515977922|FG002|Overall Study|Withdrawal by Subject|0|||
143118731|NCT00642954|515977923|FG003|Overall Study|Withdrawal by Subject|0|||
143118732|NCT00642954|515977924|FG004|Overall Study|Withdrawal by Subject|1|||
143118733|NCT00642954|515977920|FG000|Overall Study|Adverse Event|1|||
143118734|NCT00642954|515977921|FG001|Overall Study|Adverse Event|1|||
143118735|NCT00642954|515977922|FG002|Overall Study|Adverse Event|0|||
143118736|NCT00642954|515977923|FG003|Overall Study|Adverse Event|0|||
143118737|NCT00642954|515977924|FG004|Overall Study|Adverse Event|6|||
143118738|NCT02168777|515977925|FG000|Overall Study|Withdrawal by Subject|1|||
143118739|NCT02168777|515977926|FG001|Overall Study|Withdrawal by Subject|0|||
143118740|NCT02168777|515977927|FG002|Overall Study|Withdrawal by Subject|2|||
143118741|NCT02168777|515977925|FG000|Overall Study|Adverse Event|1|||
143118742|NCT02168777|515977926|FG001|Overall Study|Adverse Event|0|||
143118743|NCT02168777|515977927|FG002|Overall Study|Adverse Event|1|||
143118744|NCT02168777|515977925|FG000|Overall Study|Disease recurrence|0|||
143118745|NCT02168777|515977926|FG001|Overall Study|Disease recurrence|0|||
143118746|NCT02168777|515977927|FG002|Overall Study|Disease recurrence|1|||
143118747|NCT02168777|515977925|FG000|Overall Study|Radiological disease progression|0|||
143118748|NCT02168777|515977926|FG001|Overall Study|Radiological disease progression|5|||
143118749|NCT02168777|515977927|FG002|Overall Study|Radiological disease progression|5|||
143118750|NCT02168777|515977925|FG000|Overall Study|Clinical disease progression|0|||
143118751|NCT02168777|515977926|FG001|Overall Study|Clinical disease progression|1|||
143118752|NCT02168777|515977927|FG002|Overall Study|Clinical disease progression|2|||
143118753|NCT02168777|515977925|FG000|Overall Study|Other reason|0|||
143118754|NCT02168777|515977926|FG001|Overall Study|Other reason|1|||
143118755|NCT02168777|515977927|FG002|Overall Study|Other reason|0|||
143118756|NCT01663857|515977928|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
143118757|NCT01663857|515977929|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
143118758|NCT01663857|515977930|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
143118759|NCT01663857|515977931|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
143118760|NCT01663857|515977928|FG000|Overall Study|Lost to Follow-up|0|||
143118761|NCT01663857|515977929|FG001|Overall Study|Lost to Follow-up|0|||
143118762|NCT01663857|515977930|FG002|Overall Study|Lost to Follow-up|3|||
143118763|NCT01663857|515977931|FG003|Overall Study|Lost to Follow-up|1|||
143118764|NCT01172808|515977932|FG000|Overall Study|Adverse Event|8|||
143118765|NCT01172808|515977933|FG001|Overall Study|Adverse Event|4|||
143118766|NCT01172808|515977934|FG002|Overall Study|Adverse Event|8|||
143118767|NCT01172808|515977935|FG003|Overall Study|Adverse Event|3|||
143118768|NCT01172808|515977932|FG000|Overall Study|Lack of Efficacy|1|||
143118769|NCT01172808|515977933|FG001|Overall Study|Lack of Efficacy|0|||
143118770|NCT01172808|515977934|FG002|Overall Study|Lack of Efficacy|0|||
143118771|NCT01172808|515977935|FG003|Overall Study|Lack of Efficacy|0|||
143118772|NCT01172808|515977932|FG000|Overall Study|Protocol Violation|2|||
143118773|NCT01172808|515977933|FG001|Overall Study|Protocol Violation|2|||
143118774|NCT01172808|515977934|FG002|Overall Study|Protocol Violation|2|||
143118775|NCT01172808|515977935|FG003|Overall Study|Protocol Violation|0|||
143118776|NCT01172808|515977932|FG000|Overall Study|Lost to Follow-up|0|||
143118777|NCT01172808|515977933|FG001|Overall Study|Lost to Follow-up|1|||
143118778|NCT01172808|515977934|FG002|Overall Study|Lost to Follow-up|1|||
143118779|NCT01172808|515977935|FG003|Overall Study|Lost to Follow-up|3|||
143118780|NCT01172808|515977932|FG000|Overall Study|Withdrawal by Subject|4|||
143118781|NCT01172808|515977933|FG001|Overall Study|Withdrawal by Subject|1|||
143118782|NCT01172808|515977934|FG002|Overall Study|Withdrawal by Subject|3|||
143118783|NCT01172808|515977935|FG003|Overall Study|Withdrawal by Subject|2|||
143118784|NCT01172808|515977932|FG000|Overall Study|Other|6|||
143118785|NCT01172808|515977933|FG001|Overall Study|Other|5|||
143118786|NCT01172808|515977934|FG002|Overall Study|Other|9|||
143118787|NCT01172808|515977935|FG003|Overall Study|Other|7|||
143118788|NCT03052920|515977936|FG000|Overall Study|Withdrawal by Subject|1|||
143118789|NCT02578940|515977937|FG000|Overall Study|Screening failure|5|||
143118790|NCT02578940|515977937|FG000|Overall Study|Lost to Follow-up|1|||
143118791|NCT01911793|515977939|FG000|Overall Study|Physician Decision|1|||
143118792|NCT01911793|515977940|FG001|Overall Study|Physician Decision|5|||
143118793|NCT03774394|515977941|FG000|Overall Study|Withdrawal by Subject|2|||
143118794|NCT03774394|515977942|FG001|Overall Study|Withdrawal by Subject|0|||
143118795|NCT02697916|515977943|FG000|Overall Study|Death|357|||
143118796|NCT02697916|515977944|FG001|Overall Study|Death|315|||
143118797|NCT02697916|515977943|FG000|Overall Study|Withdrawal by Subject|221|||
143118798|NCT02697916|515977944|FG001|Overall Study|Withdrawal by Subject|393|||
143118799|NCT00994214|515977945|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
143118800|NCT00994214|515977946|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
143118801|NCT00994214|515977947|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
143118802|NCT00994214|515977948|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
143118803|NCT00994214|515977945|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
143118804|NCT00994214|515977946|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
143118805|NCT00994214|515977947|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
143118806|NCT00994214|515977948|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
143118807|NCT00994214|515977945|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
143118808|NCT00994214|515977946|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
143118809|NCT00994214|515977947|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
143118810|NCT00994214|515977948|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
143118811|NCT00994214|515977945|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
143118812|NCT00994214|515977946|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
143118813|NCT00994214|515977947|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
143118814|NCT00994214|515977948|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
143118815|NCT00994214|515977945|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
143118816|NCT00994214|515977946|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
143118817|NCT00994214|515977947|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
143118818|NCT00994214|515977948|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
143118819|NCT00994214|515977945|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
143118820|NCT00994214|515977946|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
143118821|NCT00994214|515977947|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
143118822|NCT00994214|515977948|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
143118823|NCT03246061|515977949|FG000|Overall Study|Still in follow-up|15|||
143118824|NCT03246061|515977950|FG001|Overall Study|Still in follow-up|21|||
143118825|NCT04710368|515977951|FG000|Overall Study|Withdrawal by Subject|9|||
143118826|NCT04710368|515977951|FG000|Overall Study|Lost to Follow-up|4|||
143118827|NCT04710368|515977951|FG000|Overall Study|Death|2|||
143118828|NCT04710368|515977951|FG000|Overall Study|Patient preference|11|||
143118829|NCT04710368|515977951|FG000|Overall Study|Treatment discontinuation|1|||
143118830|NCT01533688|515977952|FG000|Overall Study|Withdrawal by Subject|5|||
143118831|NCT01533688|515977953|FG001|Overall Study|Withdrawal by Subject|4|||
143118832|NCT01533688|515977954|FG002|Overall Study|Withdrawal by Subject|3|||
143118833|NCT01533688|515977952|FG000|Overall Study|Medically unstable|1|||
143118834|NCT01533688|515977953|FG001|Overall Study|Medically unstable|3|||
143118835|NCT01533688|515977954|FG002|Overall Study|Medically unstable|3|||
143118836|NCT01533688|515977952|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
143118837|NCT01533688|515977953|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
143118838|NCT01533688|515977954|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
143118839|NCT02509078|515977956|FG000|Overall Study|Protocol Violation|1|||
143118840|NCT02509078|515977957|FG001|Overall Study|Protocol Violation|1|||
143118841|NCT00290693|515977958|FG000|Overall Study|Withdrawal by Subject|2|||
143118842|NCT05625477|515977959|FG000|Overall Study|Lost to Follow-up|2|||
143118843|NCT05625477|515977960|FG001|Overall Study|Lost to Follow-up|2|||
143118844|NCT05625477|515977961|FG002|Overall Study|Lost to Follow-up|1|||
143118845|NCT05625477|515977962|FG003|Overall Study|Lost to Follow-up|1|||
143118846|NCT05625477|515977963|FG004|Overall Study|Lost to Follow-up|0|||
143118847|NCT05625477|515977959|FG000|Overall Study|Covid quarantine|1|||
143118848|NCT05625477|515977960|FG001|Overall Study|Covid quarantine|0|||
143118849|NCT05625477|515977961|FG002|Overall Study|Covid quarantine|0|||
143118850|NCT05625477|515977962|FG003|Overall Study|Covid quarantine|0|||
143118851|NCT05625477|515977963|FG004|Overall Study|Covid quarantine|0|||
143118852|NCT02667587|515977974|FG000|Pre-Treatment|Not reported|1|||
143118853|NCT02667587|515977975|FG001|Pre-Treatment|Not reported|0|||
143118854|NCT02667587|515977974|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
143118855|NCT02667587|515977975|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
143118856|NCT02667587|515977974|FG000|Pre-Treatment|Participant withdrew consent|0|||
143118857|NCT02667587|515977975|FG001|Pre-Treatment|Participant withdrew consent|1|||
143118858|NCT02667587|515977974|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
143118859|NCT02667587|515977975|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
143118860|NCT02667587|515977974|FG000|End of Treatment|Disease Progression|193|||
143118861|NCT02667587|515977975|FG001|End of Treatment|Disease Progression|226|||
143118862|NCT02667587|515977974|FG000|End of Treatment|Study Drug Toxicity|75|||
143118863|NCT02667587|515977975|FG001|End of Treatment|Study Drug Toxicity|19|||
143118864|NCT02667587|515977974|FG000|End of Treatment|Death|2|||
143118865|NCT02667587|515977975|FG001|End of Treatment|Death|1|||
143118866|NCT02667587|515977974|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
143118867|NCT02667587|515977975|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
143118868|NCT02667587|515977974|FG000|End of Treatment|participant request to discontinue treatment|33|||
143118869|NCT02667587|515977975|FG001|End of Treatment|participant request to discontinue treatment|35|||
143118870|NCT02667587|515977974|FG000|End of Treatment|participant withdrew consent|5|||
143118871|NCT02667587|515977975|FG001|End of Treatment|participant withdrew consent|6|||
143118872|NCT02667587|515977974|FG000|End of Treatment|Lost to Follow-up|1|||
143118873|NCT02667587|515977975|FG001|End of Treatment|Lost to Follow-up|2|||
143118874|NCT02667587|515977974|FG000|End of Treatment|maximum clinical benefit|4|||
143118875|NCT02667587|515977975|FG001|End of Treatment|maximum clinical benefit|4|||
143118876|NCT02667587|515977974|FG000|End of Treatment|poor or non compliant|0|||
143118877|NCT02667587|515977975|FG001|End of Treatment|poor or non compliant|1|||
143118878|NCT02667587|515977974|FG000|End of Treatment|participant no longer meets study criteria|1|||
143118879|NCT02667587|515977975|FG001|End of Treatment|participant no longer meets study criteria|1|||
143118880|NCT02667587|515977974|FG000|End of Treatment|administrative reason by sponsor|1|||
143118881|NCT02667587|515977975|FG001|End of Treatment|administrative reason by sponsor|29|||
143118882|NCT02667587|515977974|FG000|End of Treatment|other reasonse|21|||
143118883|NCT02667587|515977975|FG001|End of Treatment|other reasonse|10|||
143118884|NCT04105010|515977977|FG000|Overall Study|Death|3|||
143118885|NCT04105010|515977978|FG001|Overall Study|Death|1|||
143118886|NCT04105010|515977979|FG002|Overall Study|Death|1|||
143118887|NCT04105010|515977980|FG003|Overall Study|Death|54|||
143118888|NCT04105010|515977977|FG000|Overall Study|Lost to Follow-up|0|||
143118889|NCT04105010|515977978|FG001|Overall Study|Lost to Follow-up|0|||
143118890|NCT04105010|515977979|FG002|Overall Study|Lost to Follow-up|0|||
143118891|NCT04105010|515977980|FG003|Overall Study|Lost to Follow-up|4|||
143118892|NCT04105010|515977977|FG000|Overall Study|Withdrawal by Subject|8|||
143118893|NCT04105010|515977978|FG001|Overall Study|Withdrawal by Subject|1|||
143118894|NCT04105010|515977979|FG002|Overall Study|Withdrawal by Subject|1|||
143118895|NCT04105010|515977980|FG003|Overall Study|Withdrawal by Subject|4|||
143118896|NCT04105010|515977977|FG000|Overall Study|Other reason|4|||
143118897|NCT04105010|515977978|FG001|Overall Study|Other reason|7|||
143118898|NCT04105010|515977979|FG002|Overall Study|Other reason|0|||
143118899|NCT04105010|515977980|FG003|Overall Study|Other reason|19|||
143118900|NCT03956615|515977982|FG000|Overall Study|No multiple myeloma confirmed|2|||
143118901|NCT03956615|515977982|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
143118902|NCT03956615|515977982|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
143118903|NCT03956615|515977982|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
143118904|NCT00412217|515977983|FG000|Overall Study|Insufficient Data Available|8|||
143118905|NCT00412217|515977984|FG001|Overall Study|Insufficient Data Available|3|||
143118906|NCT00412217|515977983|FG000|Overall Study|Death|5|||
143118907|NCT00412217|515977984|FG001|Overall Study|Death|4|||
143118908|NCT00412217|515977983|FG000|Overall Study|Disease Progression|2|||
143118909|NCT00412217|515977984|FG001|Overall Study|Disease Progression|3|||
143118910|NCT00412217|515977983|FG000|Overall Study|Investigator Decision|1|||
143118911|NCT00412217|515977984|FG001|Overall Study|Investigator Decision|0|||
143118912|NCT00412217|515977983|FG000|Overall Study|Withdrawal by Subject|2|||
143118913|NCT00412217|515977984|FG001|Overall Study|Withdrawal by Subject|0|||
143118914|NCT00412217|515977983|FG000|Overall Study|Lost to Follow-up|1|||
143118915|NCT00412217|515977984|FG001|Overall Study|Lost to Follow-up|4|||
143118916|NCT00412217|515977983|FG000|Overall Study|Study Terminated by Sponsor|26|||
143118917|NCT00412217|515977984|FG001|Overall Study|Study Terminated by Sponsor|33|||
143118918|NCT00412217|515977983|FG000|Overall Study|Other|1|||
143118919|NCT00412217|515977984|FG001|Overall Study|Other|1|||
143118920|NCT01069419|515977985|FG000|Overall Study|Adverse Event|233|||
143118921|NCT01069419|515977985|FG000|Overall Study|Lack of Efficacy|332|||
143118922|NCT01069419|515977985|FG000|Overall Study|Lost to Follow-up|49|||
143118923|NCT01069419|515977985|FG000|Overall Study|Remission of disease|11|||
143118924|NCT01069419|515977985|FG000|Overall Study|Withdrawal by Subject|34|||
143118925|NCT01069419|515977985|FG000|Overall Study|Other Reason|43|||
143118926|NCT01069419|515977985|FG000|Overall Study|Missing termination information|13|||
143118927|NCT01398410|515977986|FG000|Overall Study|Adverse Event|12|||
143118928|NCT01398410|515977987|FG001|Overall Study|Adverse Event|16|||
143118929|NCT01398410|515977986|FG000|Overall Study|Participants Choice|8|||
143118930|NCT01398410|515977987|FG001|Overall Study|Participants Choice|11|||
143118931|NCT01398410|515977986|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
143118932|NCT01398410|515977987|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
143118933|NCT01398410|515977986|FG000|Overall Study|Other|36|||
143118934|NCT01398410|515977987|FG001|Overall Study|Other|29|||
143118935|NCT00717275|515977988|FG000|Overall Study|Premature study termination.|3|||
143118936|NCT01254721|515977989|FG000|Overall Study|Lost to Follow-up|0|||
143118937|NCT01254721|515977990|FG001|Overall Study|Lost to Follow-up|4|||
143118938|NCT01254721|515977989|FG000|Overall Study|Lack of Efficacy|4|||
143118939|NCT01254721|515977990|FG001|Overall Study|Lack of Efficacy|2|||
143118940|NCT01254721|515977989|FG000|Overall Study|Death|0|||
143118941|NCT01254721|515977990|FG001|Overall Study|Death|1|||
143118942|NCT01254721|515977989|FG000|Overall Study|technical problum|1|||
143118943|NCT01254721|515977990|FG001|Overall Study|technical problum|0|||
143118944|NCT01254721|515977989|FG000|Overall Study|Adverse Event|2|||
143118945|NCT01254721|515977990|FG001|Overall Study|Adverse Event|3|||
143118946|NCT01254721|515977989|FG000|Overall Study|Withdrawal by Subject|8|||
143118947|NCT01254721|515977990|FG001|Overall Study|Withdrawal by Subject|11|||
143118948|NCT01254721|515977989|FG000|Overall Study|Wrongly randomization|0|||
143118949|NCT01254721|515977990|FG001|Overall Study|Wrongly randomization|1|||
143118950|NCT00574795|515977998|FG000|Infant Series|Withdrawal by Subject|2|||
143118951|NCT00574795|515977998|FG000|Infant Series|Protocol Violation|2|||
143118952|NCT00574795|515977998|FG000|Infant Series|Adverse Event|1|||
143118953|NCT00574795|515977998|FG000|After Infant Series|Withdrawal by Subject|1|||
143118954|NCT00574795|515977998|FG000|After Infant Series|Adverse Event|2|||
143118955|NCT00574795|515977998|FG000|Toddler Dose|Withdrawal by Subject|1|||
143118956|NCT00672841|515977999|FG000|Overall Study|Comfort care|1|||
143118957|NCT00672841|515978000|FG001|Overall Study|Comfort care|4|||
143118958|NCT00672841|515977999|FG000|Overall Study|icteric specimens|0|||
143118959|NCT00672841|515978000|FG001|Overall Study|icteric specimens|3|||
143118960|NCT00672841|515977999|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
143118961|NCT00672841|515978000|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
143118962|NCT00672841|515977999|FG000|Overall Study|Adverse Event|0|||
143118963|NCT00672841|515978000|FG001|Overall Study|Adverse Event|3|||
143118964|NCT00672841|515977999|FG000|Overall Study|Pregnancy|0|||
143118965|NCT00672841|515978000|FG001|Overall Study|Pregnancy|1|||
143118966|NCT02638259|515978001|FG000|Treatment Period 1|Adverse Event|1|||
143118967|NCT02638259|515978002|FG001|Treatment Period 1|Adverse Event|5|||
143118968|NCT02638259|515978001|FG000|Treatment Period 1|Death|0|||
143118969|NCT02638259|515978002|FG001|Treatment Period 1|Death|1|||
143118970|NCT02638259|515978001|FG000|Treatment Period 1|Lack of Efficacy|0|||
143118971|NCT02638259|515978002|FG001|Treatment Period 1|Lack of Efficacy|1|||
143118972|NCT02638259|515978001|FG000|Treatment Period 1|Protocol Violation|0|||
143118973|NCT02638259|515978002|FG001|Treatment Period 1|Protocol Violation|3|||
143118974|NCT02638259|515978001|FG000|Treatment Period 1|Withdrawal by Subject|4|||
143118975|NCT02638259|515978002|FG001|Treatment Period 1|Withdrawal by Subject|6|||
143118976|NCT02638259|515978001|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
143118977|NCT02638259|515978002|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
143118978|NCT02638259|515978001|FG000|Treatment Period 2|Adverse Event|5|||
143118979|NCT02638259|515978002|FG001|Treatment Period 2|Adverse Event|4|||
143118980|NCT02638259|515978001|FG000|Treatment Period 2|Withdrawal by Subject|1|||
143118981|NCT02638259|515978002|FG001|Treatment Period 2|Withdrawal by Subject|7|||
143118982|NCT04299048|515978004|FG000|Overall Study|Death|1|||
143118983|NCT04299048|515978004|FG000|Overall Study|Global deterioration of health status|2|||
143118984|NCT04299048|515978004|FG000|Overall Study|Enrolled and not treated|1|||
143118985|NCT03677934|515978005|FG000|Overall Study|Adverse Event|1|||
143118986|NCT03677934|515978006|FG001|Overall Study|Adverse Event|1|||
143118987|NCT03677934|515978005|FG000|Overall Study|Death|8|||
143118988|NCT03677934|515978006|FG001|Overall Study|Death|4|||
143118989|NCT03677934|515978005|FG000|Overall Study|Lost to Follow-up|3|||
143118990|NCT03677934|515978006|FG001|Overall Study|Lost to Follow-up|0|||
143118991|NCT03677934|515978005|FG000|Overall Study|Non-Compliance With Study Drug|1|||
143118992|NCT03677934|515978006|FG001|Overall Study|Non-Compliance With Study Drug|0|||
143118993|NCT03677934|515978005|FG000|Overall Study|Physician Decision|0|||
143118994|NCT03677934|515978006|FG001|Overall Study|Physician Decision|1|||
143118995|NCT03677934|515978005|FG000|Overall Study|Withdrawal by Subject|1|||
143118996|NCT03677934|515978006|FG001|Overall Study|Withdrawal by Subject|7|||
143118997|NCT00045734|515978007|FG000|Overall Study|Protocol Violation|1|||
143118998|NCT02069093|515978008|FG000|Overall Study|Disease progression|14|||
143118999|NCT02069093|515978008|FG000|Overall Study|New cancer therapy|1|||
143119000|NCT02069093|515978008|FG000|Overall Study|Death|1|||
143119001|NCT02069093|515978008|FG000|Overall Study|Administrative problems|1|||
143119002|NCT02069093|515978008|FG000|Overall Study|Withdrawal by Subject|2|||
143119003|NCT02069093|515978008|FG000|Overall Study|Abnormal laboratory values|1|||
143119004|NCT02069093|515978008|FG000|Overall Study|Adverse Event|10|||
143119005|NCT00586508|515978009|FG000|Overall Study|Progressive disease|52|||
143119006|NCT00586508|515978010|FG001|Overall Study|Progressive disease|8|||
143119007|NCT00586508|515978009|FG000|Overall Study|Death|0|||
143119008|NCT00586508|515978010|FG001|Overall Study|Death|1|||
143119009|NCT00586508|515978009|FG000|Overall Study|Adverse Event|12|||
143119010|NCT00586508|515978010|FG001|Overall Study|Adverse Event|4|||
143119011|NCT00586508|515978009|FG000|Overall Study|Withdrawal by Subject|4|||
143119012|NCT00586508|515978010|FG001|Overall Study|Withdrawal by Subject|0|||
143119013|NCT03434249|515978013|FG000|Overall Study|Adverse Event|1|||
143119014|NCT03434249|515978014|FG001|Overall Study|Adverse Event|0|||
143119015|NCT03434249|515978013|FG000|Overall Study|Lost to Follow-up|0|||
143119016|NCT03434249|515978014|FG001|Overall Study|Lost to Follow-up|1|||
143119017|NCT03434249|515978013|FG000|Overall Study|Non-compliance of family|2|||
143119018|NCT03434249|515978014|FG001|Overall Study|Non-compliance of family|1|||
143119019|NCT03434249|515978013|FG000|Overall Study|Difficulties in completing daily diary|2|||
143119020|NCT03434249|515978014|FG001|Overall Study|Difficulties in completing daily diary|1|||
143119021|NCT01001598|515978017|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
143119022|NCT01001598|515978017|FG000|Overall Study|Adverse Event|1|||
143119023|NCT05079230|515978022|FG000|Overall Study|Study Terminated by Sponsor|101|||
143119024|NCT05079230|515978023|FG001|Overall Study|Study Terminated by Sponsor|102|||
143119025|NCT05079230|515978022|FG000|Overall Study|Death|72|||
143119026|NCT05079230|515978023|FG001|Overall Study|Death|66|||
143119027|NCT05079230|515978022|FG000|Overall Study|Withdrew Consent|16|||
143119028|NCT05079230|515978023|FG001|Overall Study|Withdrew Consent|18|||
143119029|NCT05079230|515978022|FG000|Overall Study|Lost to Follow-up|0|||
143119030|NCT05079230|515978023|FG001|Overall Study|Lost to Follow-up|3|||
143119031|NCT01524783|515978024|FG000|Blinded Period|Adverse Event|64|||
143119032|NCT01524783|515978025|FG001|Blinded Period|Adverse Event|7|||
143119033|NCT01524783|515978026|FG002|Blinded Period|Adverse Event|0|||
143119034|NCT01524783|515978024|FG000|Blinded Period|Disease Progression|89|||
143119035|NCT01524783|515978025|FG001|Blinded Period|Disease Progression|75|||
143119036|NCT01524783|515978026|FG002|Blinded Period|Disease Progression|0|||
143119037|NCT01524783|515978024|FG000|Blinded Period|Withdrawal by Subject|19|||
143119038|NCT01524783|515978025|FG001|Blinded Period|Withdrawal by Subject|6|||
143119039|NCT01524783|515978026|FG002|Blinded Period|Withdrawal by Subject|0|||
143119040|NCT01524783|515978024|FG000|Blinded Period|Protocol deviation|2|||
143119041|NCT01524783|515978025|FG001|Blinded Period|Protocol deviation|1|||
143119042|NCT01524783|515978026|FG002|Blinded Period|Protocol deviation|0|||
143119043|NCT01524783|515978024|FG000|Blinded Period|Death|5|||
143119044|NCT01524783|515978025|FG001|Blinded Period|Death|2|||
143119045|NCT01524783|515978026|FG002|Blinded Period|Death|0|||
143119046|NCT01524783|515978024|FG000|Open-label Period|Disease progression|13|||
143119047|NCT01524783|515978025|FG001|Open-label Period|Disease progression|0|||
143119048|NCT01524783|515978026|FG002|Open-label Period|Disease progression|2|||
143119049|NCT01524783|515978024|FG000|Open-label Period|Administrative problems|5|||
143119050|NCT01524783|515978025|FG001|Open-label Period|Administrative problems|0|||
143119051|NCT01524783|515978026|FG002|Open-label Period|Administrative problems|2|||
143119052|NCT01524783|515978024|FG000|Open-label Period|Adverse Event|5|||
143119053|NCT01524783|515978025|FG001|Open-label Period|Adverse Event|0|||
143119054|NCT01524783|515978026|FG002|Open-label Period|Adverse Event|1|||
143119055|NCT01524783|515978024|FG000|Open-label Period|Withdrawal by Subject|2|||
143119056|NCT01524783|515978025|FG001|Open-label Period|Withdrawal by Subject|0|||
143119057|NCT01524783|515978026|FG002|Open-label Period|Withdrawal by Subject|1|||
143119058|NCT01524783|515978024|FG000|Open-label Period|Protocol deviation|1|||
143119059|NCT01524783|515978025|FG001|Open-label Period|Protocol deviation|0|||
143119060|NCT01524783|515978026|FG002|Open-label Period|Protocol deviation|0|||
143119061|NCT02054910|515978027|FG000|Overall Study|Lost to Follow-up|4|||
143119062|NCT02054910|515978028|FG001|Overall Study|Lost to Follow-up|1|||
143119063|NCT05153148|515978030|FG000|Overall Study|Adverse Event|1|||
143119064|NCT05153148|515978031|FG001|Overall Study|Adverse Event|0|||
143119065|NCT05153148|515978032|FG002|Overall Study|Adverse Event|3|||
143119066|NCT05153148|515978033|FG003|Overall Study|Adverse Event|5|||
143119067|NCT05153148|515978030|FG000|Overall Study|Lost to Follow-up|1|||
143119068|NCT05153148|515978031|FG001|Overall Study|Lost to Follow-up|1|||
143119069|NCT05153148|515978032|FG002|Overall Study|Lost to Follow-up|2|||
143119070|NCT05153148|515978033|FG003|Overall Study|Lost to Follow-up|0|||
143119071|NCT05153148|515978030|FG000|Overall Study|Withdrawal by Subject|6|||
143119072|NCT05153148|515978031|FG001|Overall Study|Withdrawal by Subject|8|||
143119073|NCT05153148|515978032|FG002|Overall Study|Withdrawal by Subject|6|||
143119074|NCT05153148|515978033|FG003|Overall Study|Withdrawal by Subject|8|||
143119075|NCT05153148|515978030|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
143119076|NCT05153148|515978031|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
143119077|NCT05153148|515978032|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
143119078|NCT05153148|515978033|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
143119079|NCT05153148|515978030|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
143119080|NCT05153148|515978031|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
143119081|NCT05153148|515978032|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
143119082|NCT05153148|515978033|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
143119083|NCT05153148|515978030|FG000|Overall Study|Reason not Specified|1|||
143119084|NCT05153148|515978031|FG001|Overall Study|Reason not Specified|1|||
143119085|NCT05153148|515978032|FG002|Overall Study|Reason not Specified|1|||
143119086|NCT05153148|515978033|FG003|Overall Study|Reason not Specified|1|||
143119087|NCT00232596|515978034|FG000|6-Week Titration Phase|Adverse Event|6|||
143119088|NCT00232596|515978035|FG001|6-Week Titration Phase|Adverse Event|19|||
143119089|NCT00232596|515978034|FG000|6-Week Titration Phase|Failed to Return|2|||
143119090|NCT00232596|515978035|FG001|6-Week Titration Phase|Failed to Return|1|||
143119091|NCT00232596|515978034|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
143119092|NCT00232596|515978035|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
143119093|NCT00232596|515978034|FG000|6-Week Titration Phase|Protocol Violation|1|||
143119094|NCT00232596|515978035|FG001|6-Week Titration Phase|Protocol Violation|3|||
143119095|NCT00232596|515978034|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
143119096|NCT00232596|515978035|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
143119097|NCT00232596|515978034|FG000|6-Week Titration Phase|Other|3|||
143119098|NCT00232596|515978035|FG001|6-Week Titration Phase|Other|3|||
143119099|NCT00232596|515978034|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
143119100|NCT00232596|515978035|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
143119101|NCT00232596|515978034|FG000|12-Week Maintenance Phase|Adverse Event|7|||
143119102|NCT00232596|515978035|FG001|12-Week Maintenance Phase|Adverse Event|22|||
143119103|NCT00232596|515978034|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
143119104|NCT00232596|515978035|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
143119105|NCT00232596|515978034|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
143119106|NCT00232596|515978035|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
143119107|NCT00232596|515978034|FG000|12-Week Maintenance Phase|Other|1|||
143119108|NCT00232596|515978035|FG001|12-Week Maintenance Phase|Other|3|||
143119109|NCT02267135|515978036|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
143119110|NCT02267135|515978037|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
143119111|NCT02267135|515978036|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
143119112|NCT02267135|515978037|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
143119113|NCT02267135|515978036|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
143119114|NCT02267135|515978037|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
143119115|NCT02267135|515978036|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
143119116|NCT02267135|515978037|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
143119117|NCT02267135|515978036|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
143119118|NCT02267135|515978037|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
143119119|NCT03806231|515978038|FG000|Overall Study|Physician Decision|1|||
143119120|NCT03806231|515978039|FG001|Overall Study|Physician Decision|0|||
143119121|NCT03806231|515978038|FG000|Overall Study|Withdrawal by Subject|1|||
143119122|NCT03806231|515978039|FG001|Overall Study|Withdrawal by Subject|0|||
143119123|NCT02919267|515978040|FG000|Overall Study|Protocol Violation|0|||
143119124|NCT02919267|515978041|FG001|Overall Study|Protocol Violation|3|||
143119125|NCT02919267|515978042|FG002|Overall Study|Protocol Violation|3|||
143119126|NCT02919267|515978043|FG003|Overall Study|Protocol Violation|4|||
143119127|NCT00932698|515978046|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
143119128|NCT00932698|515978047|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
143119129|NCT00932698|515978048|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
143119130|NCT00932698|515978049|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
143119131|NCT00932698|515978050|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
143119132|NCT00932698|515978051|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
143119133|NCT00932698|515978052|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
143119134|NCT00932698|515978053|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
143119135|NCT00932698|515978054|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
143119136|NCT00932698|515978055|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
143119137|NCT00932698|515978056|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
143119138|NCT00932698|515978046|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
143119139|NCT00932698|515978047|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
143119140|NCT00932698|515978048|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
143119141|NCT00932698|515978049|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
143119142|NCT00932698|515978050|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
143119143|NCT00932698|515978051|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
143119144|NCT00932698|515978052|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
143119145|NCT00932698|515978053|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
143119146|NCT00932698|515978054|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
143119147|NCT00932698|515978055|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
143119148|NCT00932698|515978056|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
143119149|NCT00932698|515978046|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
143119150|NCT00932698|515978047|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
143119151|NCT00932698|515978048|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
143119152|NCT00932698|515978049|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
143119153|NCT00932698|515978050|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
143119154|NCT00932698|515978051|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
143119155|NCT00932698|515978052|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
143119156|NCT00932698|515978053|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
143119157|NCT00932698|515978054|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
143119158|NCT00932698|515978055|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
143119159|NCT00932698|515978056|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
143119160|NCT00932698|515978046|FG000|Part 1 (Dose Escalation)|Other|0|||
143119161|NCT00932698|515978047|FG001|Part 1 (Dose Escalation)|Other|0|||
143119162|NCT00932698|515978048|FG002|Part 1 (Dose Escalation)|Other|1|||
143119163|NCT00932698|515978049|FG003|Part 1 (Dose Escalation)|Other|0|||
143119164|NCT00932698|515978050|FG004|Part 1 (Dose Escalation)|Other|0|||
143119165|NCT00932698|515978051|FG005|Part 1 (Dose Escalation)|Other|0|||
143119166|NCT00932698|515978052|FG006|Part 1 (Dose Escalation)|Other|1|||
143119167|NCT00932698|515978053|FG007|Part 1 (Dose Escalation)|Other|0|||
143119168|NCT00932698|515978054|FG008|Part 1 (Dose Escalation)|Other|0|||
143119169|NCT00932698|515978055|FG009|Part 1 (Dose Escalation)|Other|0|||
143119170|NCT00932698|515978056|FG010|Part 1 (Dose Escalation)|Other|0|||
143119171|NCT00932698|515978046|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
143119172|NCT00932698|515978047|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
143119173|NCT00932698|515978048|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
143119174|NCT00932698|515978049|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
143119175|NCT00932698|515978050|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
143119176|NCT00932698|515978051|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
143119177|NCT00932698|515978052|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
143119178|NCT00932698|515978053|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
143119179|NCT00932698|515978054|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
143119180|NCT00932698|515978055|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
143119181|NCT00932698|515978056|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
143119182|NCT00932698|515978046|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
143119183|NCT00932698|515978047|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
143119184|NCT00932698|515978048|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
143119185|NCT00932698|515978049|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
143119186|NCT00932698|515978050|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
143119187|NCT00932698|515978051|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
143119188|NCT00932698|515978052|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
143119189|NCT00932698|515978053|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
143119190|NCT00932698|515978054|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
143119191|NCT00932698|515978055|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
143119192|NCT00932698|515978056|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
143119193|NCT00932698|515978046|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
143119194|NCT00932698|515978047|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
143119195|NCT00932698|515978048|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
143119196|NCT00932698|515978049|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
143119197|NCT00932698|515978050|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
143119198|NCT00932698|515978051|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
143119199|NCT00932698|515978052|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
143119200|NCT00932698|515978053|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
143119201|NCT00932698|515978054|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
143119202|NCT00932698|515978055|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
143119203|NCT00932698|515978056|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
143119204|NCT04608344|515978057|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
143119205|NCT04608344|515978058|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
143119206|NCT04608344|515978057|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
143119207|NCT04608344|515978058|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
143119208|NCT00131365|515978059|FG000|Overall Study|Withdrawal by Subject|1|||
143119209|NCT00131365|515978059|FG000|Overall Study|Alternative treatment|3|||
143119210|NCT02073565|515978060|FG000|Cohort A|Withdrawal by Subject|1|||
143119211|NCT02073565|515978061|FG001|Cohort A|Withdrawal by Subject|0|||
143119212|NCT02073565|515978060|FG000|Cohort B|Withdrawal by Subject|1|||
143119213|NCT02073565|515978061|FG001|Cohort B|Withdrawal by Subject|2|||
143119214|NCT02073565|515978060|FG000|Cohort C|Withdrawal by Subject|0|||
143119215|NCT02073565|515978061|FG001|Cohort C|Withdrawal by Subject|2|||
143119216|NCT02073565|515978060|FG000|Cohort C|Lost to Follow-up|0|||
143119217|NCT02073565|515978061|FG001|Cohort C|Lost to Follow-up|2|||
143119218|NCT01554176|515978062|FG000|Treatment Phase|Protocol Violation|1|||
143119219|NCT01554176|515978063|FG001|Treatment Phase|Protocol Violation|2|||
143119220|NCT01554176|515978064|FG002|Treatment Phase|Protocol Violation|0|||
143119221|NCT01554176|515978065|FG003|Treatment Phase|Protocol Violation|0|||
143119222|NCT01554176|515978066|FG004|Treatment Phase|Protocol Violation|0|||
143119223|NCT01554176|515978062|FG000|Treatment Phase|Physician Decision|1|||
143119224|NCT01554176|515978063|FG001|Treatment Phase|Physician Decision|1|||
143119225|NCT01554176|515978064|FG002|Treatment Phase|Physician Decision|0|||
143119226|NCT01554176|515978065|FG003|Treatment Phase|Physician Decision|0|||
143119227|NCT01554176|515978066|FG004|Treatment Phase|Physician Decision|0|||
143119228|NCT01554176|515978062|FG000|Treatment Phase|Lack of Efficacy|0|||
143119229|NCT01554176|515978063|FG001|Treatment Phase|Lack of Efficacy|1|||
143119230|NCT01554176|515978064|FG002|Treatment Phase|Lack of Efficacy|0|||
143119231|NCT01554176|515978065|FG003|Treatment Phase|Lack of Efficacy|0|||
143119232|NCT01554176|515978066|FG004|Treatment Phase|Lack of Efficacy|0|||
143119233|NCT01554176|515978062|FG000|Treatment Phase|Adverse event, non-fatal|1|||
143119234|NCT01554176|515978063|FG001|Treatment Phase|Adverse event, non-fatal|1|||
143119235|NCT01554176|515978064|FG002|Treatment Phase|Adverse event, non-fatal|0|||
143119236|NCT01554176|515978065|FG003|Treatment Phase|Adverse event, non-fatal|0|||
143119237|NCT01554176|515978066|FG004|Treatment Phase|Adverse event, non-fatal|0|||
143119238|NCT01554176|515978062|FG000|Treatment Phase|Non-compliance with study drug|1|||
143119239|NCT01554176|515978063|FG001|Treatment Phase|Non-compliance with study drug|0|||
143119240|NCT01554176|515978064|FG002|Treatment Phase|Non-compliance with study drug|0|||
143119241|NCT01554176|515978065|FG003|Treatment Phase|Non-compliance with study drug|0|||
143119242|NCT01554176|515978066|FG004|Treatment Phase|Non-compliance with study drug|0|||
143119243|NCT01554176|515978062|FG000|Treatment Phase|Withdrawal by Subject|1|||
143119244|NCT01554176|515978063|FG001|Treatment Phase|Withdrawal by Subject|0|||
143119245|NCT01554176|515978064|FG002|Treatment Phase|Withdrawal by Subject|0|||
143119246|NCT01554176|515978065|FG003|Treatment Phase|Withdrawal by Subject|0|||
143119247|NCT01554176|515978066|FG004|Treatment Phase|Withdrawal by Subject|0|||
143119248|NCT01554176|515978062|FG000|Treatment Phase|Lost to Follow-up|3|||
143119249|NCT01554176|515978063|FG001|Treatment Phase|Lost to Follow-up|0|||
143119250|NCT01554176|515978064|FG002|Treatment Phase|Lost to Follow-up|0|||
143119251|NCT01554176|515978065|FG003|Treatment Phase|Lost to Follow-up|0|||
143119252|NCT01554176|515978066|FG004|Treatment Phase|Lost to Follow-up|0|||
143119253|NCT01554176|515978062|FG000|Run-out Phase|Protocol Violation|0|||
143119254|NCT01554176|515978063|FG001|Run-out Phase|Protocol Violation|0|||
143119255|NCT01554176|515978064|FG002|Run-out Phase|Protocol Violation|0|||
143119256|NCT01554176|515978065|FG003|Run-out Phase|Protocol Violation|1|||
143119257|NCT01554176|515978066|FG004|Run-out Phase|Protocol Violation|0|||
143119258|NCT01760447|515979597|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
143119259|NCT01760447|515979598|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
143119260|NCT01760447|515979599|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
143119261|NCT01760447|515979600|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
143119262|NCT01760447|515979597|FG000|Weeks 0-20|Withdrawal by Subject|2|||
143119263|NCT01760447|515979598|FG001|Weeks 0-20|Withdrawal by Subject|0|||
143119264|NCT01760447|515979599|FG002|Weeks 0-20|Withdrawal by Subject|1|||
143119265|NCT01760447|515979600|FG003|Weeks 0-20|Withdrawal by Subject|0|||
143119266|NCT01760447|515979597|FG000|Weeks 0-20|Lost to Follow-up|1|||
143119267|NCT01760447|515979598|FG001|Weeks 0-20|Lost to Follow-up|0|||
143119268|NCT01760447|515979599|FG002|Weeks 0-20|Lost to Follow-up|1|||
143119269|NCT01760447|515979600|FG003|Weeks 0-20|Lost to Follow-up|1|||
143119270|NCT01760447|515979597|FG000|Weeks 0-20|Randomized but not treated|0|||
143119271|NCT01760447|515979598|FG001|Weeks 0-20|Randomized but not treated|0|||
143119272|NCT01760447|515979599|FG002|Weeks 0-20|Randomized but not treated|2|||
143119273|NCT01760447|515979600|FG003|Weeks 0-20|Randomized but not treated|0|||
143119274|NCT01760447|515979597|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
143119275|NCT01760447|515979598|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
143119276|NCT01760447|515979599|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
143119277|NCT01760447|515979600|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
143119278|NCT01760447|515979597|FG000|Weeks 20-54|Withdrawal by Subject|2|||
143119279|NCT01760447|515979598|FG001|Weeks 20-54|Withdrawal by Subject|1|||
143119280|NCT01760447|515979599|FG002|Weeks 20-54|Withdrawal by Subject|1|||
143119281|NCT01760447|515979600|FG003|Weeks 20-54|Withdrawal by Subject|2|||
143119282|NCT01760447|515979597|FG000|Weeks 20-54|Lost to Follow-up|0|||
143119283|NCT01760447|515979598|FG001|Weeks 20-54|Lost to Follow-up|0|||
143119284|NCT01760447|515979599|FG002|Weeks 20-54|Lost to Follow-up|1|||
143119285|NCT01760447|515979600|FG003|Weeks 20-54|Lost to Follow-up|2|||
143119286|NCT04849416|515979603|FG000|Overall Study|Ongoing Treatment|12|||
143119287|NCT04849416|515979604|FG001|Overall Study|Ongoing Treatment|5|||
143119288|NCT04849416|515979605|FG002|Overall Study|Ongoing Treatment|3|||
143119289|NCT04849416|515979603|FG000|Overall Study|On Post-Treatment Follow-up|8|||
143119290|NCT04849416|515979604|FG001|Overall Study|On Post-Treatment Follow-up|9|||
143119291|NCT04849416|515979605|FG002|Overall Study|On Post-Treatment Follow-up|10|||
143119292|NCT04849416|515979603|FG000|Overall Study|Withdrawal by Subject|0|||
143119293|NCT04849416|515979604|FG001|Overall Study|Withdrawal by Subject|0|||
143119294|NCT04849416|515979605|FG002|Overall Study|Withdrawal by Subject|1|||
143119295|NCT04849416|515979603|FG000|Overall Study|Lost to Follow-up|1|||
143119296|NCT04849416|515979604|FG001|Overall Study|Lost to Follow-up|0|||
143119297|NCT04849416|515979605|FG002|Overall Study|Lost to Follow-up|0|||
143119298|NCT01716520|515979606|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
143119299|NCT01716520|515979607|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
143119300|NCT01716520|515979608|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
143119301|NCT01716520|515979609|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
143119302|NCT01716520|515979610|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
143119303|NCT01716520|515979611|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
143119304|NCT01716520|515979606|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
143119305|NCT01716520|515979607|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
143119306|NCT01716520|515979608|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
143119307|NCT01716520|515979609|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
143119308|NCT01716520|515979610|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
143119309|NCT01716520|515979611|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
143119310|NCT01716520|515979606|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
143119311|NCT01716520|515979607|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
143119312|NCT01716520|515979608|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
143119313|NCT01716520|515979609|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
143119314|NCT01716520|515979610|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
143119315|NCT01716520|515979611|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
143119316|NCT01716520|515979606|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
143119317|NCT01716520|515979607|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
143119318|NCT01716520|515979608|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
143119319|NCT01716520|515979609|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
143119320|NCT01716520|515979610|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
143119321|NCT01716520|515979611|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
143119322|NCT01716520|515979606|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
143119323|NCT01716520|515979607|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
143119324|NCT01716520|515979608|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
143119325|NCT01716520|515979609|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
143119326|NCT01716520|515979610|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
143119327|NCT01716520|515979611|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
143119328|NCT01716520|515979606|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
143119329|NCT01716520|515979607|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
143119330|NCT01716520|515979608|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
143119331|NCT01716520|515979609|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
143119332|NCT01716520|515979610|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
143119333|NCT01716520|515979611|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
143119334|NCT01716520|515979606|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
143119335|NCT01716520|515979607|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
143119336|NCT01716520|515979608|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
143119337|NCT01716520|515979609|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
143119338|NCT01716520|515979610|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
143119339|NCT01716520|515979611|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
143119340|NCT01716520|515979606|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
143119341|NCT01716520|515979607|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
143119342|NCT01716520|515979608|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
143119343|NCT01716520|515979609|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
143119344|NCT01716520|515979610|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
143119345|NCT01716520|515979611|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
143119346|NCT01716520|515979606|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
143119347|NCT01716520|515979607|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
143119348|NCT01716520|515979608|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
143119349|NCT01716520|515979609|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
143119350|NCT01716520|515979610|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
143119351|NCT01716520|515979611|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
143119352|NCT01716520|515979606|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
143119353|NCT01716520|515979607|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
143119354|NCT01716520|515979608|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
143119355|NCT01716520|515979609|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
143119356|NCT01716520|515979610|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
143119357|NCT01716520|515979611|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
143119358|NCT01716520|515979606|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
143119359|NCT01716520|515979607|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
143119360|NCT01716520|515979608|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
143119361|NCT01716520|515979609|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
143119362|NCT01716520|515979610|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
143119363|NCT01716520|515979611|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
143119364|NCT01716520|515979606|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
143119365|NCT01716520|515979607|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
143119366|NCT01716520|515979608|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
143119367|NCT01716520|515979609|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
143119368|NCT01716520|515979610|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
143119369|NCT01716520|515979611|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
143119370|NCT01716520|515979606|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
143119371|NCT01716520|515979607|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
143119372|NCT01716520|515979608|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
143119373|NCT01716520|515979609|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
143119374|NCT01716520|515979610|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
143119375|NCT01716520|515979611|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
143119376|NCT01716520|515979606|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
143119377|NCT01716520|515979607|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
143119378|NCT01716520|515979608|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
143119379|NCT01716520|515979609|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
143119380|NCT01716520|515979610|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
143119381|NCT01716520|515979611|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
143119382|NCT01716520|515979606|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
143119383|NCT01716520|515979607|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
143119384|NCT01716520|515979608|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
143119385|NCT01716520|515979609|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
143119386|NCT01716520|515979610|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
143119387|NCT01716520|515979611|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
143119388|NCT00253370|515979612|FG000|Overall Study|Adverse Event|18|||
143119389|NCT00253370|515979612|FG000|Overall Study|Disease progression|13|||
143119390|NCT00253370|515979612|FG000|Overall Study|Death|2|||
143119391|NCT00253370|515979612|FG000|Overall Study|Withdrawal by Subject|6|||
143119392|NCT00253370|515979612|FG000|Overall Study|Non-protocol therapy|1|||
143119393|NCT00253370|515979612|FG000|Overall Study|Physician Decision|1|||
143119394|NCT00253370|515979612|FG000|Overall Study|Protocol Violation|1|||
143119395|NCT00253370|515979612|FG000|Overall Study|Abdominal pain due to disease|1|||
143119396|NCT00004088|515979615|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
143119397|NCT00004088|515979615|FG000|Overall Study|Withdrawal by Subject|1|||
143119398|NCT00004088|515979615|FG000|Overall Study|Protocol Violation|3|||
143119399|NCT00004088|515979615|FG000|Overall Study|Physician Decision|1|||
143119400|NCT05916131|515979622|FG000|Overall Study|Lost to Follow-up|0|||
143119401|NCT05916131|515979623|FG001|Overall Study|Lost to Follow-up|0|||
143119402|NCT05916131|515979624|FG002|Overall Study|Lost to Follow-up|1|||
143119403|NCT05916131|515979625|FG003|Overall Study|Lost to Follow-up|0|||
143119404|NCT02305446|515979632|FG000|Overall Study|Adverse Event|1|||
143119405|NCT01636947|515979633|FG000|Overall Study|Not Treated|2|||
143119406|NCT01636947|515979634|FG001|Overall Study|Not Treated|2|||
143119407|NCT01636947|515979633|FG000|Overall Study|Lost to Follow-up|4|||
143119408|NCT01636947|515979634|FG001|Overall Study|Lost to Follow-up|0|||
143119409|NCT01636947|515979633|FG000|Overall Study|Protocol Violation|1|||
143119410|NCT01636947|515979634|FG001|Overall Study|Protocol Violation|1|||
143119411|NCT01636947|515979633|FG000|Overall Study|Withdrawal by Subject|3|||
143119412|NCT01636947|515979634|FG001|Overall Study|Withdrawal by Subject|3|||
143119413|NCT01636947|515979633|FG000|Overall Study|Adverse Event|1|||
143119414|NCT01636947|515979634|FG001|Overall Study|Adverse Event|1|||
143119415|NCT01636947|515979633|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
143119416|NCT01636947|515979634|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
143119417|NCT01211483|515979640|FG000|Phase 1b|Death|6|||
143119418|NCT01211483|515979641|FG001|Phase 1b|Death|0|||
143119419|NCT01211483|515979642|FG002|Phase 1b|Death|0|||
143119420|NCT01211483|515979643|FG003|Phase 1b|Death|0|||
143119421|NCT01211483|515979640|FG000|Phase 1b|Withdrawal by Subject|1|||
143119422|NCT01211483|515979641|FG001|Phase 1b|Withdrawal by Subject|0|||
143119423|NCT01211483|515979642|FG002|Phase 1b|Withdrawal by Subject|0|||
143119424|NCT01211483|515979643|FG003|Phase 1b|Withdrawal by Subject|0|||
143119425|NCT01211483|515979640|FG000|Phase 2|Lost to Follow-up|0|||
143119426|NCT01211483|515979641|FG001|Phase 2|Lost to Follow-up|1|||
143119427|NCT01211483|515979642|FG002|Phase 2|Lost to Follow-up|1|||
143119428|NCT01211483|515979643|FG003|Phase 2|Lost to Follow-up|2|||
143119429|NCT01211483|515979640|FG000|Phase 2|Death|0|||
143119430|NCT01211483|515979641|FG001|Phase 2|Death|64|||
143119431|NCT01211483|515979642|FG002|Phase 2|Death|53|||
143119432|NCT01211483|515979643|FG003|Phase 2|Death|53|||
143119433|NCT01211483|515979640|FG000|Phase 2|Withdrawal by Subject|0|||
143119434|NCT01211483|515979641|FG001|Phase 2|Withdrawal by Subject|1|||
143119435|NCT01211483|515979642|FG002|Phase 2|Withdrawal by Subject|10|||
143119436|NCT01211483|515979643|FG003|Phase 2|Withdrawal by Subject|5|||
143119437|NCT01211483|515979640|FG000|Phase 2|Study terminated by Sponsor|0|||
143119438|NCT01211483|515979641|FG001|Phase 2|Study terminated by Sponsor|6|||
143119439|NCT01211483|515979642|FG002|Phase 2|Study terminated by Sponsor|8|||
143119440|NCT01211483|515979643|FG003|Phase 2|Study terminated by Sponsor|11|||
143119441|NCT02284568|515979644|FG000|Overall Study|Adverse Event|2|||
143119442|NCT02284568|515979645|FG001|Overall Study|Adverse Event|9|||
143119443|NCT02284568|515979646|FG002|Overall Study|Adverse Event|4|||
143119444|NCT02284568|515979644|FG000|Overall Study|Withdrawal by Subject|22|||
143119445|NCT02284568|515979645|FG001|Overall Study|Withdrawal by Subject|21|||
143119446|NCT02284568|515979646|FG002|Overall Study|Withdrawal by Subject|1|||
143119447|NCT02284568|515979644|FG000|Overall Study|Noncompliance with study drug admin|1|||
143119448|NCT02284568|515979645|FG001|Overall Study|Noncompliance with study drug admin|2|||
143119449|NCT02284568|515979646|FG002|Overall Study|Noncompliance with study drug admin|0|||
143119450|NCT02284568|515979644|FG000|Overall Study|Noncompliance|1|||
143119451|NCT02284568|515979645|FG001|Overall Study|Noncompliance|0|||
143119452|NCT02284568|515979646|FG002|Overall Study|Noncompliance|0|||
143119453|NCT02284568|515979644|FG000|Overall Study|Protocol Violation|0|||
143119454|NCT02284568|515979645|FG001|Overall Study|Protocol Violation|1|||
143119455|NCT02284568|515979646|FG002|Overall Study|Protocol Violation|0|||
143119456|NCT02284568|515979644|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
143119457|NCT02284568|515979645|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
143119458|NCT02284568|515979646|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
143119459|NCT02284568|515979644|FG000|Overall Study|Lost to Follow-up|0|||
143119460|NCT02284568|515979645|FG001|Overall Study|Lost to Follow-up|3|||
143119461|NCT02284568|515979646|FG002|Overall Study|Lost to Follow-up|0|||
143119462|NCT02284568|515979644|FG000|Overall Study|Lack of Efficacy|4|||
143119463|NCT02284568|515979645|FG001|Overall Study|Lack of Efficacy|7|||
143119464|NCT02284568|515979646|FG002|Overall Study|Lack of Efficacy|0|||
143119465|NCT02284568|515979644|FG000|Overall Study|Other|1|||
143119466|NCT02284568|515979645|FG001|Overall Study|Other|2|||
143119467|NCT02284568|515979646|FG002|Overall Study|Other|0|||
143119468|NCT02284568|515979644|FG000|Overall Study|Withdrew before taking study drug|0|||
143119469|NCT02284568|515979645|FG001|Overall Study|Withdrew before taking study drug|1|||
143119470|NCT02284568|515979646|FG002|Overall Study|Withdrew before taking study drug|0|||
143119471|NCT00460265|515979647|FG000|Overall Study|Lost to Follow-up|14|||
143119472|NCT00460265|515979648|FG001|Overall Study|Lost to Follow-up|15|||
143119473|NCT00460265|515979647|FG000|Overall Study|Physician Decision|1|||
143119474|NCT00460265|515979648|FG001|Overall Study|Physician Decision|2|||
143119475|NCT00460265|515979647|FG000|Overall Study|Withdrawal by Subject|10|||
143119476|NCT00460265|515979648|FG001|Overall Study|Withdrawal by Subject|25|||
143119477|NCT00460265|515979647|FG000|Overall Study|Ongoing|60|||
143119478|NCT00460265|515979648|FG001|Overall Study|Ongoing|47|||
143119479|NCT02719353|515979649|FG000|First Intervention|Physician Decision|0|||
143119480|NCT02719353|515979650|FG001|First Intervention|Physician Decision|1|||
143119481|NCT00904839|515979652|FG000|Overall Study|Adverse Event|0|||
143119482|NCT00904839|515979653|FG001|Overall Study|Adverse Event|5|||
143119483|NCT00904839|515979654|FG002|Overall Study|Adverse Event|4|||
143119484|NCT00904839|515979652|FG000|Overall Study|Protocol Violation|0|||
143119485|NCT00904839|515979653|FG001|Overall Study|Protocol Violation|1|||
143119486|NCT00904839|515979654|FG002|Overall Study|Protocol Violation|1|||
143119487|NCT00904839|515979652|FG000|Overall Study|Lost to Follow-up|0|||
143119488|NCT00904839|515979653|FG001|Overall Study|Lost to Follow-up|1|||
143119489|NCT00904839|515979654|FG002|Overall Study|Lost to Follow-up|2|||
143119490|NCT00904839|515979652|FG000|Overall Study|Withdrawal by Subject|0|||
143119491|NCT00904839|515979653|FG001|Overall Study|Withdrawal by Subject|2|||
143119492|NCT00904839|515979654|FG002|Overall Study|Withdrawal by Subject|0|||
143119493|NCT00904839|515979652|FG000|Overall Study|Not treated|1|||
143119494|NCT00904839|515979653|FG001|Overall Study|Not treated|0|||
143119495|NCT00904839|515979654|FG002|Overall Study|Not treated|1|||
143119496|NCT00904839|515979652|FG000|Overall Study|Other than above|0|||
143119497|NCT00904839|515979653|FG001|Overall Study|Other than above|9|||
143119498|NCT00904839|515979654|FG002|Overall Study|Other than above|7|||
143119499|NCT02854605|515979655|FG000|Overall Study|Adverse Event|1|||
143119500|NCT02854605|515979656|FG001|Overall Study|Adverse Event|5|||
143119501|NCT02854605|515979657|FG002|Overall Study|Adverse Event|2|||
143119502|NCT02854605|515979655|FG000|Overall Study|Lost to Follow-up|0|||
143119503|NCT02854605|515979656|FG001|Overall Study|Lost to Follow-up|2|||
143119504|NCT02854605|515979657|FG002|Overall Study|Lost to Follow-up|0|||
143119505|NCT02854605|515979655|FG000|Overall Study|Withdrew Consent|1|||
143119506|NCT02854605|515979656|FG001|Overall Study|Withdrew Consent|0|||
143119507|NCT02854605|515979657|FG002|Overall Study|Withdrew Consent|1|||
143119508|NCT02854605|515979655|FG000|Overall Study|Investigator's Discretion|1|||
143119509|NCT02854605|515979656|FG001|Overall Study|Investigator's Discretion|0|||
143119510|NCT02854605|515979657|FG002|Overall Study|Investigator's Discretion|0|||
143119511|NCT02854605|515979655|FG000|Overall Study|Protocol Violation|0|||
143119512|NCT02854605|515979656|FG001|Overall Study|Protocol Violation|0|||
143119513|NCT02854605|515979657|FG002|Overall Study|Protocol Violation|1|||
143119514|NCT01897571|515979658|FG000|Overall Study|Lost to Follow-up|3|||
143119515|NCT01897571|515979659|FG001|Overall Study|Lost to Follow-up|0|||
143119516|NCT01897571|515979660|FG002|Overall Study|Lost to Follow-up|0|||
143119517|NCT01897571|515979661|FG003|Overall Study|Lost to Follow-up|0|||
143119518|NCT01897571|515979662|FG004|Overall Study|Lost to Follow-up|2|||
143119519|NCT01897571|515979663|FG005|Overall Study|Lost to Follow-up|0|||
143119520|NCT01897571|515979664|FG006|Overall Study|Lost to Follow-up|0|||
143119521|NCT01897571|515979665|FG007|Overall Study|Lost to Follow-up|0|||
143119522|NCT01897571|515979666|FG008|Overall Study|Lost to Follow-up|1|||
143119523|NCT01897571|515979667|FG009|Overall Study|Lost to Follow-up|2|||
143119524|NCT01897571|515979668|FG010|Overall Study|Lost to Follow-up|4|||
143119525|NCT01897571|515979658|FG000|Overall Study|Withdrawal by Subject|0|||
143119526|NCT01897571|515979659|FG001|Overall Study|Withdrawal by Subject|0|||
143119527|NCT01897571|515979660|FG002|Overall Study|Withdrawal by Subject|0|||
143119528|NCT01897571|515979661|FG003|Overall Study|Withdrawal by Subject|0|||
143119529|NCT01897571|515979662|FG004|Overall Study|Withdrawal by Subject|0|||
143119530|NCT01897571|515979663|FG005|Overall Study|Withdrawal by Subject|0|||
143119531|NCT01897571|515979664|FG006|Overall Study|Withdrawal by Subject|0|||
143119532|NCT01897571|515979665|FG007|Overall Study|Withdrawal by Subject|1|||
143119533|NCT01897571|515979666|FG008|Overall Study|Withdrawal by Subject|4|||
143119534|NCT01897571|515979667|FG009|Overall Study|Withdrawal by Subject|3|||
143119535|NCT01897571|515979668|FG010|Overall Study|Withdrawal by Subject|1|||
143119536|NCT01897571|515979658|FG000|Overall Study|Other|1|||
143119537|NCT01897571|515979659|FG001|Overall Study|Other|0|||
143119538|NCT01897571|515979660|FG002|Overall Study|Other|0|||
143119539|NCT01897571|515979661|FG003|Overall Study|Other|3|||
143119540|NCT01897571|515979662|FG004|Overall Study|Other|3|||
143119541|NCT01897571|515979663|FG005|Overall Study|Other|4|||
143119542|NCT01897571|515979664|FG006|Overall Study|Other|7|||
143119543|NCT01897571|515979665|FG007|Overall Study|Other|0|||
143119544|NCT01897571|515979666|FG008|Overall Study|Other|0|||
143119545|NCT01897571|515979667|FG009|Overall Study|Other|0|||
143119546|NCT01897571|515979668|FG010|Overall Study|Other|0|||
143119547|NCT01897571|515979658|FG000|Overall Study|Enrolled in rollover study|0|||
143119548|NCT01897571|515979659|FG001|Overall Study|Enrolled in rollover study|0|||
143119549|NCT01897571|515979660|FG002|Overall Study|Enrolled in rollover study|0|||
143119550|NCT01897571|515979661|FG003|Overall Study|Enrolled in rollover study|0|||
143119551|NCT01897571|515979662|FG004|Overall Study|Enrolled in rollover study|0|||
143119552|NCT01897571|515979663|FG005|Overall Study|Enrolled in rollover study|0|||
143119553|NCT01897571|515979664|FG006|Overall Study|Enrolled in rollover study|0|||
143119554|NCT01897571|515979665|FG007|Overall Study|Enrolled in rollover study|9|||
143119555|NCT01897571|515979666|FG008|Overall Study|Enrolled in rollover study|7|||
143119556|NCT01897571|515979667|FG009|Overall Study|Enrolled in rollover study|9|||
143119557|NCT01897571|515979668|FG010|Overall Study|Enrolled in rollover study|1|||
143119558|NCT01897571|515979658|FG000|Overall Study|Death|2|||
143119559|NCT01897571|515979659|FG001|Overall Study|Death|2|||
143119560|NCT01897571|515979660|FG002|Overall Study|Death|3|||
143119561|NCT01897571|515979661|FG003|Overall Study|Death|6|||
143119562|NCT01897571|515979662|FG004|Overall Study|Death|7|||
143119563|NCT01897571|515979663|FG005|Overall Study|Death|9|||
143119564|NCT01897571|515979664|FG006|Overall Study|Death|5|||
143119565|NCT01897571|515979665|FG007|Overall Study|Death|22|||
143119566|NCT01897571|515979666|FG008|Overall Study|Death|23|||
143119567|NCT01897571|515979667|FG009|Overall Study|Death|129|||
143119568|NCT01897571|515979668|FG010|Overall Study|Death|59|||
143119569|NCT01797094|515979669|FG000|Overall Study|Adverse Event|1|||
143119570|NCT01797094|515979670|FG001|Overall Study|Adverse Event|1|||
143119571|NCT01797094|515979669|FG000|Overall Study|Personal Reasons|4|||
143119572|NCT01797094|515979670|FG001|Overall Study|Personal Reasons|0|||
143119573|NCT01797094|515979669|FG000|Overall Study|Protocol Violation|0|||
143119574|NCT01797094|515979670|FG001|Overall Study|Protocol Violation|1|||
143119575|NCT01797094|515979669|FG000|Overall Study|Other Miscellaneous Reasons|1|||
143119576|NCT01797094|515979670|FG001|Overall Study|Other Miscellaneous Reasons|0|||
143119577|NCT03217968|515979673|FG000|Overall Study|Withdrawal by Subject|4|||
143119578|NCT03217968|515979673|FG000|Overall Study|Lost to Follow-up|1|||
143119579|NCT03217968|515979673|FG000|Overall Study|Protocol Violation|6|||
143119580|NCT05268016|515979674|FG000|Overall Study|Unacceptable toxicity or AE|2|||
143119581|NCT05268016|515979675|FG001|Overall Study|Unacceptable toxicity or AE|2|||
143119582|NCT05268016|515979676|FG002|Overall Study|Unacceptable toxicity or AE|4|||
143119583|NCT05268016|515979677|FG003|Overall Study|Unacceptable toxicity or AE|3|||
143119584|NCT05268016|515979678|FG004|Overall Study|Unacceptable toxicity or AE|1|||
143119585|NCT05268016|515979674|FG000|Overall Study|Withdrawal by Subject|1|||
143119586|NCT05268016|515979675|FG001|Overall Study|Withdrawal by Subject|3|||
143119587|NCT05268016|515979676|FG002|Overall Study|Withdrawal by Subject|2|||
143119588|NCT05268016|515979677|FG003|Overall Study|Withdrawal by Subject|2|||
143119589|NCT05268016|515979678|FG004|Overall Study|Withdrawal by Subject|1|||
143119590|NCT05268016|515979674|FG000|Overall Study|Lost to Follow-up|4|||
143119591|NCT05268016|515979675|FG001|Overall Study|Lost to Follow-up|7|||
143119592|NCT05268016|515979676|FG002|Overall Study|Lost to Follow-up|1|||
143119593|NCT05268016|515979677|FG003|Overall Study|Lost to Follow-up|3|||
143119594|NCT05268016|515979678|FG004|Overall Study|Lost to Follow-up|5|||
143119595|NCT05268016|515979674|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
143119596|NCT05268016|515979675|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
143119597|NCT05268016|515979676|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
143119598|NCT05268016|515979677|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
143119599|NCT05268016|515979678|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
143119600|NCT05268016|515979674|FG000|Overall Study|Lack of Efficacy|0|||
143119601|NCT05268016|515979675|FG001|Overall Study|Lack of Efficacy|0|||
143119602|NCT05268016|515979676|FG002|Overall Study|Lack of Efficacy|0|||
143119603|NCT05268016|515979677|FG003|Overall Study|Lack of Efficacy|0|||
143119604|NCT05268016|515979678|FG004|Overall Study|Lack of Efficacy|4|||
143119605|NCT05268016|515979674|FG000|Overall Study|Physician Decision|0|||
143119606|NCT05268016|515979675|FG001|Overall Study|Physician Decision|0|||
143119607|NCT05268016|515979676|FG002|Overall Study|Physician Decision|0|||
143119608|NCT05268016|515979677|FG003|Overall Study|Physician Decision|1|||
143119609|NCT05268016|515979678|FG004|Overall Study|Physician Decision|0|||
143119610|NCT05268016|515979674|FG000|Overall Study|Other|1|||
143119611|NCT05268016|515979675|FG001|Overall Study|Other|0|||
143119612|NCT05268016|515979676|FG002|Overall Study|Other|1|||
143119613|NCT05268016|515979677|FG003|Overall Study|Other|2|||
143119614|NCT05268016|515979678|FG004|Overall Study|Other|0|||
143119615|NCT00089635|515979679|FG000|Overall Study|Adverse Event|2|||
143119616|NCT00089635|515979679|FG000|Overall Study|Death|17|||
143119617|NCT00089635|515979679|FG000|Overall Study|Disease Progression|12|||
143119618|NCT00089635|515979679|FG000|Overall Study|Lost to Follow-up|3|||
143119619|NCT00089635|515979679|FG000|Overall Study|Withdrawal by Subject|6|||
143119620|NCT00089635|515979679|FG000|Overall Study|Ineligibility determined|1|||
143119621|NCT00089635|515979679|FG000|Overall Study|Other|2|||
143119622|NCT02603107|515979680|FG000|Randomized Phase|Withdrew consent|8|||
143119623|NCT02603107|515979681|FG001|Randomized Phase|Withdrew consent|15|||
143119624|NCT02603107|515979680|FG000|Randomized Phase|Lost to Follow-up|1|||
143119625|NCT02603107|515979681|FG001|Randomized Phase|Lost to Follow-up|3|||
143119626|NCT02603107|515979680|FG000|Randomized Phase|Adverse Event|2|||
143119627|NCT02603107|515979681|FG001|Randomized Phase|Adverse Event|0|||
143119628|NCT02603107|515979680|FG000|Randomized Phase|Death|1|||
143119629|NCT02603107|515979681|FG001|Randomized Phase|Death|1|||
143119630|NCT02603107|515979680|FG000|Randomized Phase|Non-compliance with study drug|1|||
143119631|NCT02603107|515979681|FG001|Randomized Phase|Non-compliance with study drug|1|||
143119632|NCT02603107|515979680|FG000|Randomized Phase|Investigator's discretion|0|||
143119633|NCT02603107|515979681|FG001|Randomized Phase|Investigator's discretion|1|||
143119634|NCT02603107|515979680|FG000|Randomized Phase|Lack of Efficacy|1|||
143119635|NCT02603107|515979681|FG001|Randomized Phase|Lack of Efficacy|0|||
143119636|NCT02603107|515979680|FG000|Randomized Phase|Protocol Violation|1|||
143119637|NCT02603107|515979681|FG001|Randomized Phase|Protocol Violation|0|||
143119638|NCT02603107|515979680|FG000|Optional Extension Phase|Lost to Follow-up|3|||
143119639|NCT02603107|515979681|FG001|Optional Extension Phase|Lost to Follow-up|3|||
143119640|NCT02603107|515979680|FG000|Optional Extension Phase|Withdrew consent|3|||
143119641|NCT02603107|515979681|FG001|Optional Extension Phase|Withdrew consent|2|||
143119642|NCT02603107|515979680|FG000|Optional Extension Phase|Investigator's discretion|2|||
143119643|NCT02603107|515979681|FG001|Optional Extension Phase|Investigator's discretion|2|||
143119644|NCT02603107|515979680|FG000|Optional Extension Phase|Pregnancy|0|||
143119645|NCT02603107|515979681|FG001|Optional Extension Phase|Pregnancy|3|||
143119646|NCT02603107|515979680|FG000|Optional Extension Phase|Adverse Event|0|||
143119647|NCT02603107|515979681|FG001|Optional Extension Phase|Adverse Event|2|||
143119648|NCT02603107|515979680|FG000|Optional Extension Phase|Not treated in extension phase|0|||
143119649|NCT02603107|515979681|FG001|Optional Extension Phase|Not treated in extension phase|1|||
143119650|NCT02603107|515979680|FG000|Optional Extension Phase|Protocol Violation|1|||
143119651|NCT02603107|515979681|FG001|Optional Extension Phase|Protocol Violation|0|||
143119652|NCT00821015|515979684|FG000|Overall Study|Lost to Follow-up|12|||
143119653|NCT01887678|515979687|FG000|Overall Study|Adverse Event|4|||
143119654|NCT01887678|515979688|FG001|Overall Study|Adverse Event|6|||
143119655|NCT01887678|515979687|FG000|Overall Study|Exceeded rescue medication dosage|4|||
143119656|NCT01887678|515979688|FG001|Overall Study|Exceeded rescue medication dosage|5|||
143119657|NCT01887678|515979687|FG000|Overall Study|Withdrawal of consent|3|||
143119658|NCT01887678|515979688|FG001|Overall Study|Withdrawal of consent|4|||
143119659|NCT01887678|515979687|FG000|Overall Study|Lost to Follow-up|4|||
143119660|NCT01887678|515979688|FG001|Overall Study|Lost to Follow-up|2|||
143119661|NCT01887678|515979687|FG000|Overall Study|Deterioration of clinical condition|0|||
143119662|NCT01887678|515979688|FG001|Overall Study|Deterioration of clinical condition|4|||
143119663|NCT01887678|515979687|FG000|Overall Study|Lack of Efficacy|1|||
143119664|NCT01887678|515979688|FG001|Overall Study|Lack of Efficacy|2|||
143119665|NCT01887678|515979687|FG000|Overall Study|Non-compliance|0|||
143119666|NCT01887678|515979688|FG001|Overall Study|Non-compliance|3|||
143119667|NCT01887678|515979687|FG000|Overall Study|Specified|1|||
143119668|NCT01887678|515979688|FG001|Overall Study|Specified|2|||
143119669|NCT00187278|515979695|FG000|Overall Study|Protocol Violation|10|||
143119670|NCT00187278|515979696|FG001|Overall Study|Protocol Violation|13|||
143119671|NCT00090584|515979704|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
143119672|NCT00090584|515979705|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
143119673|NCT00090584|515979704|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
143119674|NCT00090584|515979705|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
143119675|NCT01080391|515979709|FG000|Overall Study|Randomized but not treated|7|||
143119676|NCT01080391|515979710|FG001|Overall Study|Randomized but not treated|4|||
143119677|NCT02117713|515979713|FG000|Week 48|Adverse Event|4|||
143119678|NCT02117713|515979713|FG000|Week 48|Withdrawal by caregiver|2|||
143119679|NCT02117713|515979713|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
143119680|NCT02117713|515979713|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
143119681|NCT02117713|515979713|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
143119682|NCT02117713|515979713|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
143119683|NCT03325894|515979714|FG000|Overall Study|Adverse Event|2|||
143119684|NCT03325894|515979715|FG001|Overall Study|Adverse Event|3|||
143119685|NCT03325894|515979714|FG000|Overall Study|Protocol Violation|1|||
143119686|NCT03325894|515979715|FG001|Overall Study|Protocol Violation|2|||
143119687|NCT03325894|515979714|FG000|Overall Study|Withdrawal by Subject|10|||
143119688|NCT03325894|515979715|FG001|Overall Study|Withdrawal by Subject|6|||
143119689|NCT03325894|515979714|FG000|Overall Study|Lost to Follow-up|4|||
143119690|NCT03325894|515979715|FG001|Overall Study|Lost to Follow-up|9|||
143119691|NCT03325894|515979714|FG000|Overall Study|Lack of Efficacy|8|||
143119692|NCT03325894|515979715|FG001|Overall Study|Lack of Efficacy|14|||
143119693|NCT03325894|515979714|FG000|Overall Study|Study Terminated by Sponsor|38|||
143119694|NCT03325894|515979715|FG001|Overall Study|Study Terminated by Sponsor|43|||
143119695|NCT03325894|515979714|FG000|Overall Study|Other (Not received Treatment)|1|||
143119696|NCT03325894|515979715|FG001|Overall Study|Other (Not received Treatment)|0|||
143119697|NCT02920177|515979716|FG000|Overall Study|Withdrawal by Subject|1|||
143119698|NCT02920177|515979717|FG001|Overall Study|Withdrawal by Subject|1|||
143119699|NCT02920177|515979716|FG000|Overall Study|Physician Decision|1|||
143119700|NCT02920177|515979717|FG001|Overall Study|Physician Decision|0|||
143119701|NCT02920177|515979716|FG000|Overall Study|Lost to Follow-up|0|||
143119702|NCT02920177|515979717|FG001|Overall Study|Lost to Follow-up|1|||
143119703|NCT02240069|515979718|FG000|Overall Study|Withdrawal by Subject|5|||
143119704|NCT02240069|515979719|FG001|Overall Study|Withdrawal by Subject|5|||
143119705|NCT02240069|515979720|FG002|Overall Study|Withdrawal by Subject|2|||
143119706|NCT01876979|515979721|FG000|Overall Study|Physician Decision|2|||
143119707|NCT01876979|515979722|FG001|Overall Study|Physician Decision|3|||
143119708|NCT01096589|515979723|FG000|Overall Study|Adverse Event|2|||
143119709|NCT01096589|515979724|FG001|Overall Study|Adverse Event|1|||
143119710|NCT01096589|515979725|FG002|Overall Study|Adverse Event|2|||
143119711|NCT01096589|515979726|FG003|Overall Study|Adverse Event|1|||
143119712|NCT01096589|515979723|FG000|Overall Study|Withdrawal by Subject|2|||
143119713|NCT01096589|515979724|FG001|Overall Study|Withdrawal by Subject|1|||
143119714|NCT01096589|515979725|FG002|Overall Study|Withdrawal by Subject|1|||
143119715|NCT01096589|515979726|FG003|Overall Study|Withdrawal by Subject|1|||
143119716|NCT01096589|515979723|FG000|Overall Study|Compliance with protocol|0|||
143119717|NCT01096589|515979724|FG001|Overall Study|Compliance with protocol|0|||
143119718|NCT01096589|515979725|FG002|Overall Study|Compliance with protocol|1|||
143119719|NCT01096589|515979726|FG003|Overall Study|Compliance with protocol|0|||
143119720|NCT01096589|515979723|FG000|Overall Study|found treatment exhausting|0|||
143119721|NCT01096589|515979724|FG001|Overall Study|found treatment exhausting|0|||
143119722|NCT01096589|515979725|FG002|Overall Study|found treatment exhausting|0|||
143119723|NCT01096589|515979726|FG003|Overall Study|found treatment exhausting|1|||
143119724|NCT01712334|515979727|FG000|Treatment Period 1|Randomized in Error|0|||
143119725|NCT01712334|515979728|FG001|Treatment Period 1|Randomized in Error|2|||
143119726|NCT01253174|515979729|FG000|Period 1|Randomized but not treated|0|||
143119727|NCT01253174|515979730|FG001|Period 1|Randomized but not treated|1|||
143119728|NCT01253174|515979731|FG002|Period 1|Randomized but not treated|1|||
143119729|NCT01253174|515979732|FG003|Period 1|Randomized but not treated|0|||
143119730|NCT01253174|515979733|FG004|Period 1|Randomized but not treated|1|||
143119731|NCT01253174|515979734|FG005|Period 1|Randomized but not treated|0|||
143119732|NCT01253174|515979729|FG000|Period 2|Adverse Event|0|||
143119733|NCT01253174|515979730|FG001|Period 2|Adverse Event|0|||
143119734|NCT01253174|515979731|FG002|Period 2|Adverse Event|1|||
143119735|NCT01253174|515979732|FG003|Period 2|Adverse Event|0|||
143119736|NCT01253174|515979733|FG004|Period 2|Adverse Event|0|||
143119737|NCT01253174|515979734|FG005|Period 2|Adverse Event|0|||
143119738|NCT01253174|515979729|FG000|Period 3|Withdrawal by Subject|0|||
143119739|NCT01253174|515979730|FG001|Period 3|Withdrawal by Subject|1|||
143119740|NCT01253174|515979731|FG002|Period 3|Withdrawal by Subject|0|||
143119741|NCT01253174|515979732|FG003|Period 3|Withdrawal by Subject|0|||
143119742|NCT01253174|515979733|FG004|Period 3|Withdrawal by Subject|1|||
143119743|NCT01253174|515979734|FG005|Period 3|Withdrawal by Subject|0|||
143119744|NCT01253174|515979729|FG000|Period 3|Pregnancy|0|||
143119745|NCT01253174|515979730|FG001|Period 3|Pregnancy|0|||
143119746|NCT01253174|515979731|FG002|Period 3|Pregnancy|1|||
143119747|NCT01253174|515979732|FG003|Period 3|Pregnancy|0|||
143119748|NCT01253174|515979733|FG004|Period 3|Pregnancy|0|||
143119749|NCT01253174|515979734|FG005|Period 3|Pregnancy|0|||
143119750|NCT00900731|515979735|FG000|Overall Study|Adverse Event|31|||
143119751|NCT00900731|515979736|FG001|Overall Study|Adverse Event|27|||
143119752|NCT00900731|515979735|FG000|Overall Study|Withdrawal by Subject|8|||
143119753|NCT00900731|515979736|FG001|Overall Study|Withdrawal by Subject|7|||
143119754|NCT00900731|515979735|FG000|Overall Study|Protocol Deviation|8|||
143119755|NCT00900731|515979736|FG001|Overall Study|Protocol Deviation|11|||
143119756|NCT00900731|515979735|FG000|Overall Study|Administrative Problems|5|||
143119757|NCT00900731|515979736|FG001|Overall Study|Administrative Problems|4|||
143119758|NCT00900731|515979735|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
143119759|NCT00900731|515979736|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
143119760|NCT00900731|515979735|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
143119761|NCT00900731|515979736|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
143119762|NCT00900731|515979735|FG000|Overall Study|Lost to Follow-up|2|||
143119763|NCT00900731|515979736|FG001|Overall Study|Lost to Follow-up|3|||
143119764|NCT00900731|515979735|FG000|Overall Study|Lack of Efficacy|1|||
143119765|NCT00900731|515979736|FG001|Overall Study|Lack of Efficacy|3|||
143119766|NCT00900731|515979735|FG000|Overall Study|Death|0|||
143119767|NCT00900731|515979736|FG001|Overall Study|Death|2|||
143119768|NCT05249127|515979737|FG000|Overall Study|Protocol Violation|13|||
143119769|NCT05249127|515979737|FG000|Overall Study|Physician Decision|4|||
143119770|NCT05249127|515979737|FG000|Overall Study|Withdrawal by Subject|2|||
143119771|NCT05249127|515979737|FG000|Overall Study|Participant Non-compliance|1|||
143119772|NCT02908074|515979738|FG000|Overall Study|sponsor/ICON decision|0|||
143119773|NCT02908074|515979739|FG001|Overall Study|sponsor/ICON decision|0|||
143119774|NCT02908074|515979740|FG002|Overall Study|sponsor/ICON decision|1|||
143119775|NCT02908074|515979741|FG003|Overall Study|sponsor/ICON decision|0|||
143119776|NCT02908074|515979742|FG004|Overall Study|sponsor/ICON decision|0|||
143119777|NCT02908074|515979743|FG005|Overall Study|sponsor/ICON decision|0|||
143119778|NCT02908074|515979738|FG000|Overall Study|Protocol Violation|0|||
143119779|NCT02908074|515979739|FG001|Overall Study|Protocol Violation|1|||
143119780|NCT02908074|515979740|FG002|Overall Study|Protocol Violation|0|||
143119781|NCT02908074|515979741|FG003|Overall Study|Protocol Violation|0|||
143119782|NCT02908074|515979742|FG004|Overall Study|Protocol Violation|0|||
143119783|NCT02908074|515979743|FG005|Overall Study|Protocol Violation|0|||
143119784|NCT02908074|515979738|FG000|Overall Study|Adverse Event|5|||
143119785|NCT02908074|515979739|FG001|Overall Study|Adverse Event|2|||
143119786|NCT02908074|515979740|FG002|Overall Study|Adverse Event|0|||
143119787|NCT02908074|515979741|FG003|Overall Study|Adverse Event|0|||
143119788|NCT02908074|515979742|FG004|Overall Study|Adverse Event|1|||
143119789|NCT02908074|515979743|FG005|Overall Study|Adverse Event|0|||
143119790|NCT02908074|515979738|FG000|Overall Study|AESI|1|||
143119791|NCT02908074|515979739|FG001|Overall Study|AESI|0|||
143119792|NCT02908074|515979740|FG002|Overall Study|AESI|1|||
143119793|NCT02908074|515979741|FG003|Overall Study|AESI|0|||
143119794|NCT02908074|515979742|FG004|Overall Study|AESI|1|||
143119795|NCT02908074|515979743|FG005|Overall Study|AESI|0|||
143119796|NCT02908074|515979738|FG000|Overall Study|Discontinuation criteria per protocol|0|||
143119797|NCT02908074|515979739|FG001|Overall Study|Discontinuation criteria per protocol|0|||
143119798|NCT02908074|515979740|FG002|Overall Study|Discontinuation criteria per protocol|1|||
143119799|NCT02908074|515979741|FG003|Overall Study|Discontinuation criteria per protocol|0|||
143119800|NCT02908074|515979742|FG004|Overall Study|Discontinuation criteria per protocol|0|||
143119801|NCT02908074|515979743|FG005|Overall Study|Discontinuation criteria per protocol|1|||
143119802|NCT02908074|515979738|FG000|Overall Study|Withdrawal by Subject|3|||
143119803|NCT02908074|515979739|FG001|Overall Study|Withdrawal by Subject|2|||
143119804|NCT02908074|515979740|FG002|Overall Study|Withdrawal by Subject|2|||
143119805|NCT02908074|515979741|FG003|Overall Study|Withdrawal by Subject|2|||
143119806|NCT02908074|515979742|FG004|Overall Study|Withdrawal by Subject|2|||
143119807|NCT02908074|515979743|FG005|Overall Study|Withdrawal by Subject|2|||
143119808|NCT02908074|515979738|FG000|Overall Study|Lost to Follow-up|0|||
143119809|NCT02908074|515979739|FG001|Overall Study|Lost to Follow-up|1|||
143119810|NCT02908074|515979740|FG002|Overall Study|Lost to Follow-up|1|||
143119811|NCT02908074|515979741|FG003|Overall Study|Lost to Follow-up|1|||
143119812|NCT02908074|515979742|FG004|Overall Study|Lost to Follow-up|0|||
143119813|NCT02908074|515979743|FG005|Overall Study|Lost to Follow-up|1|||
143119814|NCT03646305|515979744|FG000|Overall Study|Lost to Follow-up|4|||
143119815|NCT03646305|515979745|FG001|Overall Study|Lost to Follow-up|2|||
143119816|NCT03646305|515979746|FG002|Overall Study|Lost to Follow-up|2|||
143119817|NCT03646305|515979747|FG003|Overall Study|Lost to Follow-up|1|||
143119818|NCT03646305|515979744|FG000|Overall Study|Withdrawal by Subject|1|||
143119819|NCT03646305|515979745|FG001|Overall Study|Withdrawal by Subject|0|||
143119820|NCT03646305|515979746|FG002|Overall Study|Withdrawal by Subject|0|||
143119821|NCT03646305|515979747|FG003|Overall Study|Withdrawal by Subject|1|||
143119822|NCT03417024|515979750|FG000|Overall Study|Study Termination prior to follow-up|11|||
143119823|NCT03417024|515979750|FG000|Overall Study|Physician Decision|2|||
143119824|NCT03053427|515979751|FG000|Overall Study|Adverse Event|4|||
143119825|NCT03053427|515979752|FG001|Overall Study|Adverse Event|4|||
143119826|NCT03053427|515979751|FG000|Overall Study|Lack of Efficacy|1|||
143119827|NCT03053427|515979752|FG001|Overall Study|Lack of Efficacy|3|||
143119828|NCT03053427|515979751|FG000|Overall Study|Lost to Follow-up|2|||
143119829|NCT03053427|515979752|FG001|Overall Study|Lost to Follow-up|2|||
143119830|NCT03053427|515979751|FG000|Overall Study|Worsening of the target disease|0|||
143119831|NCT03053427|515979752|FG001|Overall Study|Worsening of the target disease|1|||
143119832|NCT03053427|515979751|FG000|Overall Study|Protocol Deviation|3|||
143119833|NCT03053427|515979752|FG001|Overall Study|Protocol Deviation|3|||
143119834|NCT03053427|515979751|FG000|Overall Study|Withdrawal by Subject|3|||
143119835|NCT03053427|515979752|FG001|Overall Study|Withdrawal by Subject|2|||
143119836|NCT03053427|515979751|FG000|Overall Study|Miscellaneous|0|||
143119837|NCT03053427|515979752|FG001|Overall Study|Miscellaneous|1|||
143119838|NCT05243563|515981336|FG000|Overall Study|Withdrawal by Subject|1|||
143119839|NCT05243563|515981337|FG001|Overall Study|Withdrawal by Subject|0|||
143119840|NCT05243563|515981336|FG000|Overall Study|Physician Decision|1|||
143119841|NCT05243563|515981337|FG001|Overall Study|Physician Decision|0|||
143119842|NCT00441363|515981338|FG000|Overall Study|Adverse Event|4|||
143119843|NCT00441363|515981339|FG001|Overall Study|Adverse Event|2|||
143119844|NCT00441363|515981338|FG000|Overall Study|Withdrawal by Subject|3|||
143119845|NCT00441363|515981339|FG001|Overall Study|Withdrawal by Subject|4|||
143119846|NCT00441363|515981338|FG000|Overall Study|Physician Decision|6|||
143119847|NCT00441363|515981339|FG001|Overall Study|Physician Decision|7|||
143119848|NCT00441363|515981338|FG000|Overall Study|Lost to Follow-up|2|||
143119849|NCT00441363|515981339|FG001|Overall Study|Lost to Follow-up|2|||
143119850|NCT00441363|515981338|FG000|Overall Study|Other|2|||
143119851|NCT00441363|515981339|FG001|Overall Study|Other|0|||
143119852|NCT02437188|515981342|FG000|Overall Study|Randomized but did not receive surgery|4|||
143119853|NCT02437188|515981343|FG001|Overall Study|Randomized but did not receive surgery|8|||
143119854|NCT02437188|515981342|FG000|Overall Study|Adverse Event|0|||
143119855|NCT02437188|515981343|FG001|Overall Study|Adverse Event|1|||
143119856|NCT04114656|515981344|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
143119857|NCT04114656|515981345|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
143119858|NCT04114656|515981344|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
143119859|NCT04114656|515981345|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
143119860|NCT04114656|515981344|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
143119861|NCT04114656|515981345|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
143119862|NCT04114656|515981344|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
143119863|NCT04114656|515981345|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
143119864|NCT04114656|515981344|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
143119865|NCT04114656|515981345|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
143119866|NCT02474355|515981347|FG000|Overall Study|Other|43|||
143119867|NCT02474355|515981347|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
143119868|NCT02474355|515981347|FG000|Overall Study|Lost to Follow-up|98|||
143119869|NCT02474355|515981347|FG000|Overall Study|Withdrawal by Subject|124|||
143119870|NCT02474355|515981347|FG000|Overall Study|Death|1361|||
143119871|NCT01937715|515981348|FG000|Overall Study|Death|0|||
143119872|NCT01937715|515981349|FG001|Overall Study|Death|0|||
143119873|NCT01937715|515981350|FG002|Overall Study|Death|0|||
143119874|NCT01937715|515981351|FG003|Overall Study|Death|1|||
143119875|NCT01937715|515981352|FG004|Overall Study|Death|0|||
143119876|NCT01937715|515981348|FG000|Overall Study|Withdrawal by Subject|0|||
143119877|NCT01937715|515981349|FG001|Overall Study|Withdrawal by Subject|1|||
143119878|NCT01937715|515981350|FG002|Overall Study|Withdrawal by Subject|0|||
143119879|NCT01937715|515981351|FG003|Overall Study|Withdrawal by Subject|0|||
143119880|NCT01937715|515981352|FG004|Overall Study|Withdrawal by Subject|2|||
143119881|NCT01937715|515981348|FG000|Overall Study|Other|0|||
143119882|NCT01937715|515981349|FG001|Overall Study|Other|0|||
143119883|NCT01937715|515981350|FG002|Overall Study|Other|0|||
143119884|NCT01937715|515981351|FG003|Overall Study|Other|3|||
143119885|NCT01937715|515981352|FG004|Overall Study|Other|0|||
143119886|NCT01698268|515981355|FG000|Overall Study|Physician Decision|2|||
143119887|NCT01698268|515981356|FG001|Overall Study|Physician Decision|1|||
143119888|NCT00298363|515981357|FG000|Overall Study|Lost to Follow-up|0|||
143119889|NCT00298363|515981358|FG001|Overall Study|Lost to Follow-up|0|||
143119890|NCT00298363|515981359|FG002|Overall Study|Lost to Follow-up|1|||
143119891|NCT00298363|515981357|FG000|Overall Study|Physician Decision|4|||
143119892|NCT00298363|515981358|FG001|Overall Study|Physician Decision|1|||
143119893|NCT00298363|515981359|FG002|Overall Study|Physician Decision|0|||
143119894|NCT00298363|515981357|FG000|Overall Study|Protocol Violation|1|||
143119895|NCT00298363|515981358|FG001|Overall Study|Protocol Violation|1|||
143119896|NCT00298363|515981359|FG002|Overall Study|Protocol Violation|0|||
143119897|NCT00298363|515981357|FG000|Overall Study|Withdrawal by Subject|5|||
143119898|NCT00298363|515981358|FG001|Overall Study|Withdrawal by Subject|1|||
143119899|NCT00298363|515981359|FG002|Overall Study|Withdrawal by Subject|3|||
143119900|NCT00298363|515981357|FG000|Overall Study|Adverse Event|5|||
143119901|NCT00298363|515981358|FG001|Overall Study|Adverse Event|2|||
143119902|NCT00298363|515981359|FG002|Overall Study|Adverse Event|2|||
143119903|NCT00298363|515981357|FG000|Overall Study|Lack of Efficacy|2|||
143119904|NCT00298363|515981358|FG001|Overall Study|Lack of Efficacy|3|||
143119905|NCT00298363|515981359|FG002|Overall Study|Lack of Efficacy|0|||
143119906|NCT00153816|515981360|FG000|Overall Study|Death|6|||
143119907|NCT00153816|515981361|FG001|Overall Study|Death|5|||
143119908|NCT00153816|515981362|FG002|Overall Study|Death|4|||
143119909|NCT00153816|515981363|FG003|Overall Study|Death|6|||
143119910|NCT00153816|515981364|FG004|Overall Study|Death|0|||
143119911|NCT00153816|515981365|FG005|Overall Study|Death|2|||
143119912|NCT00153816|515981360|FG000|Overall Study|Lost to Follow-up|7|||
143119913|NCT00153816|515981361|FG001|Overall Study|Lost to Follow-up|8|||
143119914|NCT00153816|515981362|FG002|Overall Study|Lost to Follow-up|5|||
143119915|NCT00153816|515981363|FG003|Overall Study|Lost to Follow-up|8|||
143119916|NCT00153816|515981364|FG004|Overall Study|Lost to Follow-up|7|||
143119917|NCT00153816|515981365|FG005|Overall Study|Lost to Follow-up|9|||
143119918|NCT00153816|515981360|FG000|Overall Study|Withdrawal by Subject|9|||
143119919|NCT00153816|515981361|FG001|Overall Study|Withdrawal by Subject|9|||
143119920|NCT00153816|515981362|FG002|Overall Study|Withdrawal by Subject|9|||
143119921|NCT00153816|515981363|FG003|Overall Study|Withdrawal by Subject|4|||
143119922|NCT00153816|515981364|FG004|Overall Study|Withdrawal by Subject|1|||
143119923|NCT00153816|515981365|FG005|Overall Study|Withdrawal by Subject|5|||
143119924|NCT00153816|515981360|FG000|Overall Study|Follow-up exam not done|8|||
143119925|NCT00153816|515981361|FG001|Overall Study|Follow-up exam not done|7|||
143119926|NCT00153816|515981362|FG002|Overall Study|Follow-up exam not done|11|||
143119927|NCT00153816|515981363|FG003|Overall Study|Follow-up exam not done|10|||
143119928|NCT00153816|515981364|FG004|Overall Study|Follow-up exam not done|8|||
143119929|NCT00153816|515981365|FG005|Overall Study|Follow-up exam not done|9|||
143119930|NCT00153816|515981360|FG000|Overall Study|Follow-up exam done, histology missing|2|||
143119931|NCT00153816|515981361|FG001|Overall Study|Follow-up exam done, histology missing|3|||
143119932|NCT00153816|515981362|FG002|Overall Study|Follow-up exam done, histology missing|3|||
143119933|NCT00153816|515981363|FG003|Overall Study|Follow-up exam done, histology missing|3|||
143119934|NCT00153816|515981364|FG004|Overall Study|Follow-up exam done, histology missing|1|||
143119935|NCT00153816|515981365|FG005|Overall Study|Follow-up exam done, histology missing|2|||
143119936|NCT00568334|515981376|FG000|Overall Study|Withdrawal by Subject|0|||
143119937|NCT00568334|515981377|FG001|Overall Study|Withdrawal by Subject|1|||
143119938|NCT00568334|515981376|FG000|Overall Study|Lost to Follow-up|1|||
143119939|NCT00568334|515981377|FG001|Overall Study|Lost to Follow-up|0|||
143119940|NCT00419159|515981379|FG000|Overall Study|Adverse Event|7|||
143119941|NCT00419159|515981380|FG001|Overall Study|Adverse Event|15|||
143119942|NCT00419159|515981379|FG000|Overall Study|Abnormal laboratory value(s)|0|||
143119943|NCT00419159|515981380|FG001|Overall Study|Abnormal laboratory value(s)|2|||
143119944|NCT00419159|515981379|FG000|Overall Study|Subject's no longer requires study drug|0|||
143119945|NCT00419159|515981380|FG001|Overall Study|Subject's no longer requires study drug|1|||
143119946|NCT00419159|515981379|FG000|Overall Study|Protocol Violation|1|||
143119947|NCT00419159|515981380|FG001|Overall Study|Protocol Violation|0|||
143119948|NCT00419159|515981379|FG000|Overall Study|Withdrawal by Subject|10|||
143119949|NCT00419159|515981380|FG001|Overall Study|Withdrawal by Subject|3|||
143119950|NCT00419159|515981379|FG000|Overall Study|Lost to Follow-up|0|||
143119951|NCT00419159|515981380|FG001|Overall Study|Lost to Follow-up|1|||
143119952|NCT00419159|515981379|FG000|Overall Study|Death|2|||
143119953|NCT00419159|515981380|FG001|Overall Study|Death|2|||
143119954|NCT00419159|515981379|FG000|Overall Study|Disease progression|79|||
143119955|NCT00419159|515981380|FG001|Overall Study|Disease progression|76|||
143119956|NCT01017601|515981383|FG000|Overall Study|Disease Progression|12|||
143119957|NCT01017601|515981384|FG001|Overall Study|Disease Progression|12|||
143119958|NCT01017601|515981383|FG000|Overall Study|Withdrawal by Subject|0|||
143119959|NCT01017601|515981384|FG001|Overall Study|Withdrawal by Subject|1|||
143119960|NCT01857102|515981385|FG000|Period 1|No longer meets Eligibility Criteria|0|||
143119961|NCT01857102|515981386|FG001|Period 1|No longer meets Eligibility Criteria|2|||
143119962|NCT01857102|515981385|FG000|Period 1|Lost to Follow-up|0|||
143119963|NCT01857102|515981386|FG001|Period 1|Lost to Follow-up|3|||
143119964|NCT01857102|515981385|FG000|Period 1|Unsatisfactory Lens Fit|1|||
143119965|NCT01857102|515981386|FG001|Period 1|Unsatisfactory Lens Fit|0|||
143119966|NCT01857102|515981385|FG000|Period 1|Unsatisfactory Visual Response|1|||
143119967|NCT01857102|515981386|FG001|Period 1|Unsatisfactory Visual Response|0|||
143119968|NCT01857102|515981385|FG000|Period 1|Physician Decision|1|||
143119969|NCT01857102|515981386|FG001|Period 1|Physician Decision|0|||
143119970|NCT01857102|515981385|FG000|Period 2|Lens Discomfort|1|||
143119971|NCT01857102|515981386|FG001|Period 2|Lens Discomfort|0|||
143119972|NCT01857102|515981385|FG000|Period 2|Unsatisfactory Lens Fit|1|||
143119973|NCT01857102|515981386|FG001|Period 2|Unsatisfactory Lens Fit|0|||
143119974|NCT02735096|515981389|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
143119975|NCT00379808|515981390|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
143119976|NCT00379808|515981391|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
143119977|NCT01094782|515981394|FG000|Overall Study|Withdrawal by Subject|5|||
143119978|NCT01094782|515981395|FG001|Overall Study|Withdrawal by Subject|5|||
143119979|NCT01094782|515981396|FG002|Overall Study|Withdrawal by Subject|1|||
143119980|NCT01094782|515981397|FG003|Overall Study|Withdrawal by Subject|5|||
143119981|NCT01094782|515981398|FG004|Overall Study|Withdrawal by Subject|5|||
143119982|NCT01094782|515981399|FG005|Overall Study|Withdrawal by Subject|0|||
143119983|NCT01094782|515981394|FG000|Overall Study|Lost to Follow-up|1|||
143119984|NCT01094782|515981395|FG001|Overall Study|Lost to Follow-up|0|||
143119985|NCT01094782|515981396|FG002|Overall Study|Lost to Follow-up|0|||
143119986|NCT01094782|515981397|FG003|Overall Study|Lost to Follow-up|2|||
143119987|NCT01094782|515981398|FG004|Overall Study|Lost to Follow-up|1|||
143119988|NCT01094782|515981399|FG005|Overall Study|Lost to Follow-up|4|||
143119989|NCT01094782|515981394|FG000|Overall Study|Positive Drug Screen|2|||
143119990|NCT01094782|515981395|FG001|Overall Study|Positive Drug Screen|2|||
143119991|NCT01094782|515981396|FG002|Overall Study|Positive Drug Screen|1|||
143119992|NCT01094782|515981397|FG003|Overall Study|Positive Drug Screen|1|||
143119993|NCT01094782|515981398|FG004|Overall Study|Positive Drug Screen|3|||
143119994|NCT01094782|515981399|FG005|Overall Study|Positive Drug Screen|2|||
143119995|NCT01094782|515981394|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
143119996|NCT01094782|515981395|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
143119997|NCT01094782|515981396|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
143119998|NCT01094782|515981397|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
143119999|NCT01094782|515981398|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
143120000|NCT01094782|515981399|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
143120001|NCT01094782|515981394|FG000|Overall Study|Unable to Complete Questionnaires|0|||
143120002|NCT01094782|515981395|FG001|Overall Study|Unable to Complete Questionnaires|1|||
143120003|NCT01094782|515981396|FG002|Overall Study|Unable to Complete Questionnaires|0|||
143120004|NCT01094782|515981397|FG003|Overall Study|Unable to Complete Questionnaires|0|||
143120005|NCT01094782|515981398|FG004|Overall Study|Unable to Complete Questionnaires|0|||
143120006|NCT01094782|515981399|FG005|Overall Study|Unable to Complete Questionnaires|0|||
143120007|NCT01094782|515981394|FG000|Overall Study|Healthy Subject Had Pain|0|||
143120008|NCT01094782|515981395|FG001|Overall Study|Healthy Subject Had Pain|1|||
143120009|NCT01094782|515981396|FG002|Overall Study|Healthy Subject Had Pain|0|||
143120010|NCT01094782|515981397|FG003|Overall Study|Healthy Subject Had Pain|0|||
143120011|NCT01094782|515981398|FG004|Overall Study|Healthy Subject Had Pain|0|||
143120012|NCT01094782|515981399|FG005|Overall Study|Healthy Subject Had Pain|0|||
143120013|NCT01094782|515981394|FG000|Overall Study|Hypertension|0|||
143120014|NCT01094782|515981395|FG001|Overall Study|Hypertension|0|||
143120015|NCT01094782|515981396|FG002|Overall Study|Hypertension|1|||
143120016|NCT01094782|515981397|FG003|Overall Study|Hypertension|0|||
143120017|NCT01094782|515981398|FG004|Overall Study|Hypertension|0|||
143120018|NCT01094782|515981399|FG005|Overall Study|Hypertension|0|||
143120019|NCT01094782|515981394|FG000|Overall Study|Wrong Pain Condition|0|||
143120020|NCT01094782|515981395|FG001|Overall Study|Wrong Pain Condition|0|||
143120021|NCT01094782|515981396|FG002|Overall Study|Wrong Pain Condition|0|||
143120022|NCT01094782|515981397|FG003|Overall Study|Wrong Pain Condition|2|||
143120023|NCT01094782|515981398|FG004|Overall Study|Wrong Pain Condition|1|||
143120024|NCT01094782|515981399|FG005|Overall Study|Wrong Pain Condition|1|||
143120025|NCT01094782|515981394|FG000|Overall Study|Recent Interventional Injection|0|||
143120026|NCT01094782|515981395|FG001|Overall Study|Recent Interventional Injection|0|||
143120027|NCT01094782|515981396|FG002|Overall Study|Recent Interventional Injection|0|||
143120028|NCT01094782|515981397|FG003|Overall Study|Recent Interventional Injection|0|||
143120029|NCT01094782|515981398|FG004|Overall Study|Recent Interventional Injection|0|||
143120030|NCT01094782|515981399|FG005|Overall Study|Recent Interventional Injection|1|||
143120031|NCT01094782|515981394|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
143120032|NCT01094782|515981395|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
143120033|NCT01094782|515981396|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
143120034|NCT01094782|515981397|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
143120035|NCT01094782|515981398|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
143120036|NCT01094782|515981399|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
143120037|NCT01094782|515981394|FG000|Overall Study|Noncompliance With Study Schedule|0|||
143120038|NCT01094782|515981395|FG001|Overall Study|Noncompliance With Study Schedule|0|||
143120039|NCT01094782|515981396|FG002|Overall Study|Noncompliance With Study Schedule|0|||
143120040|NCT01094782|515981397|FG003|Overall Study|Noncompliance With Study Schedule|1|||
143120041|NCT01094782|515981398|FG004|Overall Study|Noncompliance With Study Schedule|0|||
143120042|NCT01094782|515981399|FG005|Overall Study|Noncompliance With Study Schedule|0|||
143120043|NCT00957905|515981401|FG000|Part B|Not Treated|0|||
143120044|NCT00957905|515981402|FG001|Part B|Not Treated|1|||
143120045|NCT00957905|515981401|FG000|Part B|Physician Decision|0|||
143120046|NCT00957905|515981402|FG001|Part B|Physician Decision|1|||
143120047|NCT00957905|515981401|FG000|Part B|Death|0|||
143120048|NCT00957905|515981402|FG001|Part B|Death|1|||
143120049|NCT00957905|515981401|FG000|Part B|Protocol Violation|0|||
143120050|NCT00957905|515981402|FG001|Part B|Protocol Violation|1|||
143120051|NCT02073656|515981419|FG000|Primary Study|Lost to Follow-up|6|||
143120052|NCT02073656|515981419|FG000|Primary Study|Death|1|||
143120053|NCT02073656|515981419|FG000|Primary Study|Withdrew Consent|1|||
143120054|NCT01380691|515981423|FG000|Washout (7 Days)|Protocol Violation|0|||
143120055|NCT01380691|515981424|FG001|Washout (7 Days)|Protocol Violation|0|||
143120056|NCT01380691|515981425|FG002|Washout (7 Days)|Protocol Violation|0|||
143120057|NCT01380691|515981426|FG003|Washout (7 Days)|Protocol Violation|1|||
143120058|NCT01380691|515981423|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
143120059|NCT01380691|515981424|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
143120060|NCT01380691|515981425|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
143120061|NCT01380691|515981426|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
143120062|NCT02536781|515981428|FG000|Overall Study|Lost to Follow-up|2|||
143120063|NCT02536781|515981429|FG001|Overall Study|Lost to Follow-up|0|||
143120064|NCT01048099|515981430|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
143120065|NCT01048099|515981430|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
143120066|NCT01987232|515981431|FG000|Overall Study|Ongoing in Study|0|||
143120067|NCT01987232|515981432|FG001|Overall Study|Ongoing in Study|0|||
143120068|NCT01987232|515981433|FG002|Overall Study|Ongoing in Study|0|||
143120069|NCT01987232|515981434|FG003|Overall Study|Ongoing in Study|1|||
143120070|NCT01987232|515981435|FG004|Overall Study|Ongoing in Study|0|||
143120071|NCT01731470|515981436|FG000|Overall Study|Withdrawal by Subject|1|||
143120072|NCT01731470|515981436|FG000|Overall Study|Did not meet study criteria|1|||
143120073|NCT01952080|515981437|FG000|Overall Study|Withdrawal by Subject|0|||
143120074|NCT01952080|515981438|FG001|Overall Study|Withdrawal by Subject|0|||
143120075|NCT01952080|515981439|FG002|Overall Study|Withdrawal by Subject|0|||
143120076|NCT01952080|515981440|FG003|Overall Study|Withdrawal by Subject|1|||
143120077|NCT01952080|515981437|FG000|Overall Study|Protocol Non-compliance|0|||
143120078|NCT01952080|515981438|FG001|Overall Study|Protocol Non-compliance|1|||
143120079|NCT01952080|515981439|FG002|Overall Study|Protocol Non-compliance|0|||
143120080|NCT01952080|515981440|FG003|Overall Study|Protocol Non-compliance|0|||
143120081|NCT02028169|515981442|FG000|Overall Study|Lost to Follow-up|21|||
143120082|NCT02028169|515981442|FG000|Overall Study|Lack of Efficacy|2|||
143120083|NCT02028169|515981442|FG000|Overall Study|Withdrawal by Subject|2|||
143120084|NCT02028169|515981442|FG000|Overall Study|Adverse Event|1|||
143120085|NCT02028169|515981442|FG000|Overall Study|Cessation of Drug|1|||
143120086|NCT02028169|515981442|FG000|Overall Study|Concomitant Medication Usage|1|||
143120087|NCT02258334|515981445|FG000|Overall Study|Adverse Event|1|||
143120088|NCT02258334|515981446|FG001|Overall Study|Adverse Event|0|||
143120089|NCT02258334|515981447|FG002|Overall Study|Adverse Event|0|||
143120090|NCT02258334|515981448|FG003|Overall Study|Adverse Event|0|||
143120091|NCT01969084|515981449|FG000|Overall Study|Adverse Event|0|||
143120092|NCT01969084|515981450|FG001|Overall Study|Adverse Event|1|||
143120093|NCT04907227|515981455|FG000|Overall Study|Death|12|||
143120094|NCT04907227|515981456|FG001|Overall Study|Death|8|||
143120095|NCT04907227|515981455|FG000|Overall Study|Withdrawal by Subject|2|||
143120096|NCT04907227|515981456|FG001|Overall Study|Withdrawal by Subject|2|||
143120097|NCT04907227|515981455|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
143120098|NCT04907227|515981456|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
143120099|NCT04907227|515981455|FG000|Overall Study|Sponsor Decision|25|||
143120100|NCT04907227|515981456|FG001|Overall Study|Sponsor Decision|30|||
143120101|NCT04907227|515981455|FG000|Overall Study|Physician Decision|1|||
143120102|NCT04907227|515981456|FG001|Overall Study|Physician Decision|0|||
143120103|NCT00106639|515981457|FG000|Overall Study|Adverse Event|3|||
143120104|NCT00106639|515981458|FG001|Overall Study|Adverse Event|4|||
143120105|NCT00106639|515981459|FG002|Overall Study|Adverse Event|1|||
143120106|NCT00106639|515981457|FG000|Overall Study|Protocol Violation|0|||
143120107|NCT00106639|515981458|FG001|Overall Study|Protocol Violation|1|||
143120108|NCT00106639|515981459|FG002|Overall Study|Protocol Violation|0|||
143120109|NCT00106639|515981457|FG000|Overall Study|Withdrawal by Subject|0|||
143120110|NCT00106639|515981458|FG001|Overall Study|Withdrawal by Subject|1|||
143120111|NCT00106639|515981459|FG002|Overall Study|Withdrawal by Subject|0|||
143120112|NCT00106639|515981457|FG000|Overall Study|Participant defaulted|0|||
143120113|NCT00106639|515981458|FG001|Overall Study|Participant defaulted|1|||
143120114|NCT00106639|515981459|FG002|Overall Study|Participant defaulted|1|||
143120115|NCT03723070|515981460|FG000|Overall Study|Lost to Follow-up|2|||
143120116|NCT03723070|515981460|FG000|Overall Study|Physician Decision|1|||
143120117|NCT03723070|515981460|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
143120118|NCT02208050|515981461|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
143120119|NCT02208050|515981462|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
143120120|NCT00477607|515981463|FG000|Overall Study|Lost to Follow-up|7|||
143120121|NCT00477607|515981464|FG001|Overall Study|Lost to Follow-up|7|||
143120122|NCT01732471|515981465|FG000|Overall Study|Withdrawal by Subject|1|||
143120123|NCT00432276|515981466|FG000|Overall Study|Hyperglycemic Rescue|44|||
143120124|NCT00432276|515981467|FG001|Overall Study|Hyperglycemic Rescue|87|||
143120125|NCT00432276|515981466|FG000|Overall Study|Adverse Event|13|||
143120126|NCT00432276|515981467|FG001|Overall Study|Adverse Event|16|||
143120127|NCT00432276|515981466|FG000|Overall Study|Protocol Violation|25|||
143120128|NCT00432276|515981467|FG001|Overall Study|Protocol Violation|20|||
143120129|NCT00432276|515981466|FG000|Overall Study|Lost to Follow-up|6|||
143120130|NCT00432276|515981467|FG001|Overall Study|Lost to Follow-up|2|||
143120131|NCT00432276|515981466|FG000|Overall Study|Withdrawal by Subject|25|||
143120132|NCT00432276|515981467|FG001|Overall Study|Withdrawal by Subject|20|||
143120133|NCT00432276|515981466|FG000|Overall Study|Physician Decision|6|||
143120134|NCT00432276|515981467|FG001|Overall Study|Physician Decision|8|||
143120135|NCT00432276|515981466|FG000|Overall Study|Other|2|||
143120136|NCT00432276|515981467|FG001|Overall Study|Other|3|||
143120137|NCT00655681|515981468|FG000|Overall Study|Lost to Follow-up|1|||
143120138|NCT00655681|515981469|FG001|Overall Study|Lost to Follow-up|1|||
143120139|NCT02429310|515981471|FG000|Overall Study|Lost to Follow-up|1|||
143120140|NCT02429310|515981472|FG001|Overall Study|Lost to Follow-up|2|||
143120141|NCT02429310|515981471|FG000|Overall Study|Protocol Violation|1|||
143120142|NCT02429310|515981472|FG001|Overall Study|Protocol Violation|1|||
143120143|NCT00386425|515981473|FG000|Overall Study|Physician Decision|3|||
143120144|NCT00386425|515981474|FG001|Overall Study|Physician Decision|0|||
143120145|NCT00386425|515981475|FG002|Overall Study|Physician Decision|0|||
143120146|NCT00386425|515981473|FG000|Overall Study|Withdrawal by Subject|0|||
143120147|NCT00386425|515981474|FG001|Overall Study|Withdrawal by Subject|1|||
143120148|NCT00386425|515981475|FG002|Overall Study|Withdrawal by Subject|0|||
143120149|NCT00207727|515981476|FG000|Overall Study|Withdrawal by Subject|0|||
143120150|NCT00207727|515981477|FG001|Overall Study|Withdrawal by Subject|0|||
143120151|NCT00207727|515981478|FG002|Overall Study|Withdrawal by Subject|0|||
143120152|NCT00207727|515981479|FG003|Overall Study|Withdrawal by Subject|0|||
143120153|NCT00207727|515981480|FG004|Overall Study|Withdrawal by Subject|1|||
143120154|NCT00207727|515981476|FG000|Overall Study|Lost to Follow-up|0|||
143120155|NCT00207727|515981477|FG001|Overall Study|Lost to Follow-up|1|||
143120156|NCT00207727|515981478|FG002|Overall Study|Lost to Follow-up|0|||
143120157|NCT00207727|515981479|FG003|Overall Study|Lost to Follow-up|0|||
143120158|NCT00207727|515981480|FG004|Overall Study|Lost to Follow-up|0|||
143120159|NCT00207727|515981476|FG000|Overall Study|Other|38|||
143120160|NCT00207727|515981477|FG001|Overall Study|Other|41|||
143120161|NCT00207727|515981478|FG002|Overall Study|Other|41|||
143120162|NCT00207727|515981479|FG003|Overall Study|Other|37|||
143120163|NCT00207727|515981480|FG004|Overall Study|Other|33|||
143120164|NCT00539032|515981484|FG000|Overall Study|Withdrawal by Subject|2|||
143120165|NCT00539032|515981485|FG001|Overall Study|Withdrawal by Subject|1|||
143120166|NCT02333383|515981486|FG000|Overall Study|Adalimumab discontinuation|21|||
143120167|NCT02333383|515981486|FG000|Overall Study|Lost to Follow-up|15|||
143120168|NCT02333383|515981486|FG000|Overall Study|Withdrawal by Subject|3|||
143120169|NCT02333383|515981486|FG000|Overall Study|Transfer to another hospital|2|||
143120170|NCT00463840|515981487|FG000|Overall Study|Disease progression|7|||
143120171|NCT00463840|515981487|FG000|Overall Study|Withdrawal by Subject|2|||
143120172|NCT00463840|515981487|FG000|Overall Study|Adverse Event|3|||
143120173|NCT01653327|515981488|FG000|Overall Study|Withdrawal by Subject|1|||
143120174|NCT04918355|515981492|FG000|Overall Study|no qualifying health encounter|497|||
143120175|NCT04918355|515981493|FG001|Overall Study|no qualifying health encounter|192|||
143120176|NCT04918355|515981494|FG002|Overall Study|no qualifying health encounter|438|||
143120177|NCT04918355|515981495|FG003|Overall Study|no qualifying health encounter|424|||
143120178|NCT04852276|515981499|FG000|Overall Study|Death|2|||
143120179|NCT04852276|515981500|FG001|Overall Study|Death|0|||
143120180|NCT04852276|515981499|FG000|Overall Study|Lost to Follow-up|15|||
143120181|NCT04852276|515981500|FG001|Overall Study|Lost to Follow-up|9|||
143120182|NCT04852276|515981499|FG000|Overall Study|Withdrawal by Subject|26|||
143120183|NCT04852276|515981500|FG001|Overall Study|Withdrawal by Subject|6|||
143120184|NCT02661061|515982802|FG000|Overall Study|Lack of Efficacy|1|||
143120185|NCT02661061|515982803|FG001|Overall Study|Lack of Efficacy|1|||
143120186|NCT02661061|515982802|FG000|Overall Study|Withdrawal by Subject|1|||
143120187|NCT02661061|515982803|FG001|Overall Study|Withdrawal by Subject|1|||
143120188|NCT01980628|515982806|FG000|Overall Study|Adverse Event|12|||
143120189|NCT01980628|515982806|FG000|Overall Study|Physician Decision|5|||
143120190|NCT01980628|515982806|FG000|Overall Study|Withdrawal by Subject|4|||
143120191|NCT01980628|515982806|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
143120192|NCT02469168|515982816|FG000|Overall Study|Trial closed|1|||
143120193|NCT02469168|515982817|FG001|Overall Study|Trial closed|0|||
143120194|NCT00135356|515982818|FG000|Overall Study|Adverse Event|6|||
143120195|NCT00135356|515982819|FG001|Overall Study|Adverse Event|2|||
143120196|NCT00135356|515982818|FG000|Overall Study|Lack of Efficacy|2|||
143120197|NCT00135356|515982819|FG001|Overall Study|Lack of Efficacy|0|||
143120198|NCT00135356|515982818|FG000|Overall Study|Lost to Follow-up|3|||
143120199|NCT00135356|515982819|FG001|Overall Study|Lost to Follow-up|1|||
143120200|NCT00135356|515982818|FG000|Overall Study|Surgery for abdominal fat|1|||
143120201|NCT00135356|515982819|FG001|Overall Study|Surgery for abdominal fat|0|||
143120202|NCT00135356|515982818|FG000|Overall Study|Change in antiviral regimen|0|||
143120203|NCT00135356|515982819|FG001|Overall Study|Change in antiviral regimen|1|||
143120204|NCT00135356|515982818|FG000|Overall Study|Poor/noncompliance|1|||
143120205|NCT00135356|515982819|FG001|Overall Study|Poor/noncompliance|1|||
143120206|NCT00135356|515982818|FG000|Overall Study|No longer meets study criteria|2|||
143120207|NCT00135356|515982819|FG001|Overall Study|No longer meets study criteria|0|||
143120208|NCT00135356|515982818|FG000|Overall Study|Withdrawal by Subject|2|||
143120209|NCT00135356|515982819|FG001|Overall Study|Withdrawal by Subject|4|||
143120210|NCT02263729|515982820|FG000|Overall Study|Lost to Follow-up|1|||
143120211|NCT02263729|515982821|FG001|Overall Study|Lost to Follow-up|1|||
143120212|NCT04591015|515982822|FG000|Overall Study|Death|6|||
143120213|NCT04591015|515982823|FG001|Overall Study|Death|4|||
143120214|NCT04591015|515982822|FG000|Overall Study|Withdrawal by Subject|6|||
143120215|NCT04591015|515982823|FG001|Overall Study|Withdrawal by Subject|3|||
143120216|NCT04591015|515982822|FG000|Overall Study|Lost to Follow-up|16|||
143120217|NCT04591015|515982823|FG001|Overall Study|Lost to Follow-up|11|||
143120218|NCT02686814|515982824|FG000|Overall Study|Physician Decision|14|||
143120219|NCT02686814|515982824|FG000|Overall Study|Withdrawal by Subject|4|||
143120220|NCT02686814|515982824|FG000|Overall Study|Death|1|||
143120221|NCT03959488|515982827|FG000|Season 1|Other|6|||
143120222|NCT03959488|515982828|FG001|Season 1|Other|7|||
143120223|NCT03959488|515982829|FG002|Season 1|Other|0|||
143120224|NCT03959488|515982830|FG003|Season 1|Other|0|||
143120225|NCT03959488|515982831|FG004|Season 1|Other|0|||
143120226|NCT03959488|515982827|FG000|Season 1|Withdrawal by parent/guardian|43|||
143120227|NCT03959488|515982828|FG001|Season 1|Withdrawal by parent/guardian|28|||
143120228|NCT03959488|515982829|FG002|Season 1|Withdrawal by parent/guardian|0|||
143120229|NCT03959488|515982830|FG003|Season 1|Withdrawal by parent/guardian|0|||
143120230|NCT03959488|515982831|FG004|Season 1|Withdrawal by parent/guardian|0|||
143120231|NCT03959488|515982827|FG000|Season 1|Due to COVID-19 pandemic|2|||
143120232|NCT03959488|515982828|FG001|Season 1|Due to COVID-19 pandemic|3|||
143120233|NCT03959488|515982829|FG002|Season 1|Due to COVID-19 pandemic|0|||
143120234|NCT03959488|515982830|FG003|Season 1|Due to COVID-19 pandemic|0|||
143120235|NCT03959488|515982831|FG004|Season 1|Due to COVID-19 pandemic|0|||
143120236|NCT03959488|515982827|FG000|Season 1|Lost to Follow-up|17|||
143120237|NCT03959488|515982828|FG001|Season 1|Lost to Follow-up|7|||
143120238|NCT03959488|515982829|FG002|Season 1|Lost to Follow-up|0|||
143120239|NCT03959488|515982830|FG003|Season 1|Lost to Follow-up|0|||
143120240|NCT03959488|515982831|FG004|Season 1|Lost to Follow-up|0|||
143120241|NCT03959488|515982827|FG000|Season 1|Death|5|||
143120242|NCT03959488|515982828|FG001|Season 1|Death|1|||
143120243|NCT03959488|515982829|FG002|Season 1|Death|0|||
143120244|NCT03959488|515982830|FG003|Season 1|Death|0|||
143120245|NCT03959488|515982831|FG004|Season 1|Death|0|||
143120246|NCT03959488|515982827|FG000|Season 2|Other|0|||
143120247|NCT03959488|515982828|FG001|Season 2|Other|0|||
143120248|NCT03959488|515982829|FG002|Season 2|Other|2|||
143120249|NCT03959488|515982830|FG003|Season 2|Other|0|||
143120250|NCT03959488|515982831|FG004|Season 2|Other|0|||
143120251|NCT03959488|515982827|FG000|Season 2|Withdrawal by parent/guardian|0|||
143120252|NCT03959488|515982828|FG001|Season 2|Withdrawal by parent/guardian|0|||
143120253|NCT03959488|515982829|FG002|Season 2|Withdrawal by parent/guardian|3|||
143120254|NCT03959488|515982830|FG003|Season 2|Withdrawal by parent/guardian|1|||
143120255|NCT03959488|515982831|FG004|Season 2|Withdrawal by parent/guardian|1|||
143120256|NCT03959488|515982827|FG000|Season 2|Lost to Follow-up|0|||
143120257|NCT03959488|515982828|FG001|Season 2|Lost to Follow-up|0|||
143120258|NCT03959488|515982829|FG002|Season 2|Lost to Follow-up|1|||
143120259|NCT03959488|515982830|FG003|Season 2|Lost to Follow-up|0|||
143120260|NCT03959488|515982831|FG004|Season 2|Lost to Follow-up|1|||
143120261|NCT04767529|515982843|FG000|Overall Study|Adverse Event|0|||
143120262|NCT04767529|515982844|FG001|Overall Study|Adverse Event|4|||
143120263|NCT04767529|515982845|FG002|Overall Study|Adverse Event|3|||
143120264|NCT04767529|515982843|FG000|Overall Study|clinical outcomes endpoint (excluding death)|1|||
143120265|NCT04767529|515982844|FG001|Overall Study|clinical outcomes endpoint (excluding death)|3|||
143120266|NCT04767529|515982845|FG002|Overall Study|clinical outcomes endpoint (excluding death)|3|||
143120267|NCT04767529|515982843|FG000|Overall Study|Required use of a prohibited medication|0|||
143120268|NCT04767529|515982844|FG001|Overall Study|Required use of a prohibited medication|1|||
143120269|NCT04767529|515982845|FG002|Overall Study|Required use of a prohibited medication|0|||
143120270|NCT04767529|515982843|FG000|Overall Study|Withdrawal by Subject|7|||
143120271|NCT04767529|515982844|FG001|Overall Study|Withdrawal by Subject|5|||
143120272|NCT04767529|515982845|FG002|Overall Study|Withdrawal by Subject|4|||
143120273|NCT04767529|515982843|FG000|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|1|||
143120274|NCT04767529|515982844|FG001|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|0|||
143120275|NCT04767529|515982845|FG002|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|3|||
143120276|NCT04767529|515982843|FG000|Overall Study|Lost to Follow-up|0|||
143120277|NCT04767529|515982844|FG001|Overall Study|Lost to Follow-up|2|||
143120278|NCT04767529|515982845|FG002|Overall Study|Lost to Follow-up|3|||
143120279|NCT00715520|515982846|FG000|Overall Study|Screen failure|8|||
143120280|NCT00715520|515982847|FG001|Overall Study|Screen failure|1|||
143120281|NCT00715520|515982848|FG002|Overall Study|Screen failure|1|||
143120282|NCT00715520|515982846|FG000|Overall Study|Withdrawal by Subject|2|||
143120283|NCT00715520|515982847|FG001|Overall Study|Withdrawal by Subject|0|||
143120284|NCT00715520|515982848|FG002|Overall Study|Withdrawal by Subject|1|||
143120285|NCT02290925|515982854|FG000|First Period of Three Months|Lost to Follow-up|2|||
143120286|NCT02290925|515982855|FG001|First Period of Three Months|Lost to Follow-up|1|||
143120287|NCT02290925|515982854|FG000|First Period of Three Months|Death|1|||
143120288|NCT02290925|515982855|FG001|First Period of Three Months|Death|0|||
143120289|NCT02290925|515982854|FG000|First Period of Three Months|Insulin Started|1|||
143120290|NCT02290925|515982855|FG001|First Period of Three Months|Insulin Started|1|||
143120291|NCT02290925|515982854|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
143120292|NCT02290925|515982855|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
143120293|NCT02290925|515982854|FG000|Second Period of 3 Months|insulin started|0|||
143120294|NCT02290925|515982855|FG001|Second Period of 3 Months|insulin started|1|||
143120295|NCT00981058|515982857|FG000|Overall Study|Progressive Disease|38|||
143120296|NCT00981058|515982858|FG001|Overall Study|Progressive Disease|31|||
143120297|NCT00981058|515982857|FG000|Overall Study|Lost to Follow-up|3|||
143120298|NCT00981058|515982858|FG001|Overall Study|Lost to Follow-up|2|||
143120299|NCT00981058|515982857|FG000|Overall Study|Physician Decision|4|||
143120300|NCT00981058|515982858|FG001|Overall Study|Physician Decision|5|||
143120301|NCT00981058|515982857|FG000|Overall Study|Randomization Error|0|||
143120302|NCT00981058|515982858|FG001|Overall Study|Randomization Error|1|||
143120303|NCT00981058|515982857|FG000|Overall Study|Withdrawal by Subject|24|||
143120304|NCT00981058|515982858|FG001|Overall Study|Withdrawal by Subject|22|||
143120305|NCT01955109|515982868|FG000|Overall Study|Adverse Event|2|||
143120306|NCT01955109|515982869|FG001|Overall Study|Adverse Event|0|||
143120307|NCT01955109|515982868|FG000|Overall Study|Participant unwilling to continue|35|||
143120308|NCT01955109|515982869|FG001|Overall Study|Participant unwilling to continue|7|||
143120309|NCT01955109|515982868|FG000|Overall Study|Physician Decision|2|||
143120310|NCT01955109|515982869|FG001|Overall Study|Physician Decision|0|||
143120311|NCT01955109|515982868|FG000|Overall Study|Lost to Follow-up|3|||
143120312|NCT01955109|515982869|FG001|Overall Study|Lost to Follow-up|1|||
143120313|NCT01955109|515982868|FG000|Overall Study|Non-compliance|3|||
143120314|NCT01955109|515982869|FG001|Overall Study|Non-compliance|1|||
143120315|NCT04521114|515982873|FG000|Overall Study|Lost to Follow-up|1|||
143120316|NCT04521114|515982874|FG001|Overall Study|Lost to Follow-up|2|||
143120317|NCT04521114|515982875|FG002|Overall Study|Lost to Follow-up|0|||
143120318|NCT04521114|515982873|FG000|Overall Study|Withdrawal by Subject|1|||
143120319|NCT04521114|515982874|FG001|Overall Study|Withdrawal by Subject|2|||
143120320|NCT04521114|515982875|FG002|Overall Study|Withdrawal by Subject|2|||
143120321|NCT04521114|515982873|FG000|Overall Study|Adverse Event|1|||
143120322|NCT04521114|515982874|FG001|Overall Study|Adverse Event|0|||
143120323|NCT04521114|515982875|FG002|Overall Study|Adverse Event|0|||
143120324|NCT04521114|515982873|FG000|Overall Study|Sponsor Wish|1|||
143120325|NCT04521114|515982874|FG001|Overall Study|Sponsor Wish|0|||
143120326|NCT04521114|515982875|FG002|Overall Study|Sponsor Wish|0|||
143120327|NCT04521114|515982873|FG000|Overall Study|Withdrawal of Consent|2|||
143120328|NCT04521114|515982874|FG001|Overall Study|Withdrawal of Consent|2|||
143120329|NCT04521114|515982875|FG002|Overall Study|Withdrawal of Consent|0|||
143120330|NCT01167634|515982876|FG000|Overall Study|Lost to Follow-up|1|||
143120331|NCT01167634|515982877|FG001|Overall Study|Lost to Follow-up|3|||
143120332|NCT01167634|515982878|FG002|Overall Study|Lost to Follow-up|3|||
143120333|NCT01167634|515982879|FG003|Overall Study|Lost to Follow-up|4|||
143120334|NCT01167634|515982876|FG000|Overall Study|Withdrawal by Subject|1|||
143120335|NCT01167634|515982877|FG001|Overall Study|Withdrawal by Subject|1|||
143120336|NCT01167634|515982878|FG002|Overall Study|Withdrawal by Subject|0|||
143120337|NCT01167634|515982879|FG003|Overall Study|Withdrawal by Subject|0|||
143120338|NCT02614131|515982880|FG000|Overall Study|Withdrawal by Subject|1|||
143120339|NCT02614131|515982881|FG001|Overall Study|Withdrawal by Subject|0|||
143120340|NCT02614131|515982882|FG002|Overall Study|Withdrawal by Subject|0|||
143120341|NCT02614131|515982883|FG003|Overall Study|Withdrawal by Subject|0|||
143120342|NCT02614131|515982884|FG004|Overall Study|Withdrawal by Subject|0|||
143120343|NCT02614131|515982885|FG005|Overall Study|Withdrawal by Subject|0|||
143120344|NCT02614131|515982886|FG006|Overall Study|Withdrawal by Subject|0|||
143120345|NCT02614131|515982880|FG000|Overall Study|Adverse Event|0|||
143120346|NCT02614131|515982881|FG001|Overall Study|Adverse Event|0|||
143120347|NCT02614131|515982882|FG002|Overall Study|Adverse Event|0|||
143120348|NCT02614131|515982883|FG003|Overall Study|Adverse Event|0|||
143120349|NCT02614131|515982884|FG004|Overall Study|Adverse Event|0|||
143120350|NCT02614131|515982885|FG005|Overall Study|Adverse Event|0|||
143120351|NCT02614131|515982886|FG006|Overall Study|Adverse Event|1|||
143120352|NCT02147067|515982894|FG000|Overall Study|Withdrawal by Subject|2|||
143120353|NCT02147067|515982895|FG001|Overall Study|Withdrawal by Subject|2|||
143120354|NCT01490697|515982896|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
143120355|NCT01490697|515982897|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
143120356|NCT02083653|515982899|FG000|Overall Study|Randomized but not Treated|0|||
143120357|NCT02083653|515982900|FG001|Overall Study|Randomized but not Treated|2|||
143120358|NCT02083653|515982901|FG002|Overall Study|Randomized but not Treated|7|||
143120359|NCT02083653|515982899|FG000|Overall Study|Adverse Event|12|||
143120360|NCT02083653|515982900|FG001|Overall Study|Adverse Event|5|||
143120361|NCT02083653|515982901|FG002|Overall Study|Adverse Event|4|||
143120362|NCT02083653|515982899|FG000|Overall Study|Lost to Follow-up|1|||
143120363|NCT02083653|515982900|FG001|Overall Study|Lost to Follow-up|0|||
143120364|NCT02083653|515982901|FG002|Overall Study|Lost to Follow-up|0|||
143120365|NCT02083653|515982899|FG000|Overall Study|Death|2|||
143120366|NCT02083653|515982900|FG001|Overall Study|Death|2|||
143120367|NCT02083653|515982901|FG002|Overall Study|Death|2|||
143120368|NCT02083653|515982899|FG000|Overall Study|Progressive Disease|65|||
143120369|NCT02083653|515982900|FG001|Overall Study|Progressive Disease|73|||
143120370|NCT02083653|515982901|FG002|Overall Study|Progressive Disease|63|||
143120371|NCT02083653|515982899|FG000|Overall Study|Withdrawal by Subject|2|||
143120372|NCT02083653|515982900|FG001|Overall Study|Withdrawal by Subject|1|||
143120373|NCT02083653|515982901|FG002|Overall Study|Withdrawal by Subject|2|||
143120374|NCT02083653|515982899|FG000|Overall Study|Other Events|0|||
143120375|NCT02083653|515982900|FG001|Overall Study|Other Events|2|||
143120376|NCT02083653|515982901|FG002|Overall Study|Other Events|2|||
143120377|NCT02083653|515982899|FG000|Overall Study|Reason Missing|0|||
143120378|NCT02083653|515982900|FG001|Overall Study|Reason Missing|0|||
143120379|NCT02083653|515982901|FG002|Overall Study|Reason Missing|4|||
143120380|NCT03423147|515982902|FG000|Overall Study|Lost to Follow-up|5|||
143120381|NCT03423147|515982903|FG001|Overall Study|Lost to Follow-up|8|||
143120382|NCT03423147|515982902|FG000|Overall Study|Withdrawal by Subject|1|||
143120383|NCT03423147|515982903|FG001|Overall Study|Withdrawal by Subject|0|||
143120384|NCT03423147|515982902|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
143120385|NCT03423147|515982903|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
143120386|NCT03423147|515982902|FG000|Overall Study|Age < 18|1|||
143120387|NCT03423147|515982903|FG001|Overall Study|Age < 18|0|||
143120388|NCT03423147|515982902|FG000|Overall Study|No Trial of Labor|0|||
143120389|NCT03423147|515982903|FG001|Overall Study|No Trial of Labor|1|||
143120390|NCT00508157|515982904|FG000|Overall Study|Adverse Event|0|||
143120391|NCT00508157|515982905|FG001|Overall Study|Adverse Event|1|||
143120392|NCT00508157|515982904|FG000|Overall Study|Subject Withdrew Consent|1|||
143120393|NCT00508157|515982905|FG001|Overall Study|Subject Withdrew Consent|0|||
143120394|NCT00508157|515982904|FG000|Overall Study|Lost to Follow-up|1|||
143120395|NCT00508157|515982905|FG001|Overall Study|Lost to Follow-up|0|||
143120396|NCT00508157|515982904|FG000|Overall Study|Subject no longer met study criteria|0|||
143120397|NCT00508157|515982905|FG001|Overall Study|Subject no longer met study criteria|1|||
143120398|NCT00508157|515982904|FG000|Overall Study|Other known cause|0|||
143120399|NCT00508157|515982905|FG001|Overall Study|Other known cause|1|||
143120400|NCT00862459|515982909|FG000|Overall Study|Lost to Follow-up|1|||
143120401|NCT00862459|515982910|FG001|Overall Study|Lost to Follow-up|2|||
143120402|NCT00862459|515982911|FG002|Overall Study|Lost to Follow-up|2|||
143120403|NCT00862459|515982909|FG000|Overall Study|Protocol Violation|1|||
143120404|NCT00862459|515982910|FG001|Overall Study|Protocol Violation|0|||
143120405|NCT00862459|515982911|FG002|Overall Study|Protocol Violation|0|||
143120406|NCT00862459|515982909|FG000|Overall Study|Withdrawal by Subject|1|||
143120407|NCT00862459|515982910|FG001|Overall Study|Withdrawal by Subject|1|||
143120408|NCT00862459|515982911|FG002|Overall Study|Withdrawal by Subject|3|||
143120409|NCT00862459|515982909|FG000|Overall Study|Adverse Event|0|||
143120410|NCT00862459|515982910|FG001|Overall Study|Adverse Event|1|||
143120411|NCT00862459|515982911|FG002|Overall Study|Adverse Event|0|||
143120412|NCT00862459|515982909|FG000|Overall Study|Personal reasons|1|||
143120413|NCT00862459|515982910|FG001|Overall Study|Personal reasons|0|||
143120414|NCT00862459|515982911|FG002|Overall Study|Personal reasons|0|||
143120415|NCT00862459|515982909|FG000|Overall Study|Operation|1|||
143120416|NCT00862459|515982910|FG001|Overall Study|Operation|1|||
143120417|NCT00862459|515982911|FG002|Overall Study|Operation|0|||
143120418|NCT00862459|515982909|FG000|Overall Study|Intravenous (IV) site problems|1|||
143120419|NCT00862459|515982910|FG001|Overall Study|Intravenous (IV) site problems|0|||
143120420|NCT00862459|515982911|FG002|Overall Study|Intravenous (IV) site problems|1|||
143120421|NCT00862459|515982909|FG000|Overall Study|Unable to hold still for imaging|0|||
143120422|NCT00862459|515982910|FG001|Overall Study|Unable to hold still for imaging|1|||
143120423|NCT00862459|515982911|FG002|Overall Study|Unable to hold still for imaging|0|||
143120424|NCT00862459|515982909|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
143120425|NCT00862459|515982910|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
143120426|NCT00862459|515982911|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
143120427|NCT00862459|515982909|FG000|Overall Study|Administrative problems|0|||
143120428|NCT00862459|515982910|FG001|Overall Study|Administrative problems|1|||
143120429|NCT00862459|515982911|FG002|Overall Study|Administrative problems|0|||
143120430|NCT03564795|515982912|FG000|Overall Study|Withdrawal by Subject|3|||
143120431|NCT03564795|515982912|FG000|Overall Study|Lost to Follow-up|6|||
143120432|NCT03564795|515982912|FG000|Overall Study|Physician Decision|2|||
143120433|NCT01333956|515982919|FG000|Overall Study|Lost to Follow-up|1|||
143120434|NCT01333956|515982920|FG001|Overall Study|Lost to Follow-up|2|||
143120435|NCT01333956|515982921|FG002|Overall Study|Lost to Follow-up|0|||
143120436|NCT01333956|515982922|FG003|Overall Study|Lost to Follow-up|1|||
143120437|NCT01333956|515982919|FG000|Overall Study|Unable to complete study procedure|1|||
143120438|NCT01333956|515982920|FG001|Overall Study|Unable to complete study procedure|0|||
143120439|NCT01333956|515982921|FG002|Overall Study|Unable to complete study procedure|0|||
143120440|NCT01333956|515982922|FG003|Overall Study|Unable to complete study procedure|1|||
143120441|NCT01333956|515982919|FG000|Overall Study|Withdrawal by Subject|0|||
143120442|NCT01333956|515982920|FG001|Overall Study|Withdrawal by Subject|2|||
143120443|NCT01333956|515982921|FG002|Overall Study|Withdrawal by Subject|1|||
143120444|NCT01333956|515982922|FG003|Overall Study|Withdrawal by Subject|0|||
143120445|NCT02134353|515982923|FG000|Overall Study|Adverse Event|10|||
143120446|NCT02134353|515982924|FG001|Overall Study|Adverse Event|6|||
143120447|NCT02134353|515982923|FG000|Overall Study|Lost to Follow-up|1|||
143120448|NCT02134353|515982924|FG001|Overall Study|Lost to Follow-up|1|||
143120449|NCT02134353|515982923|FG000|Overall Study|Lack of Efficacy|2|||
143120450|NCT02134353|515982924|FG001|Overall Study|Lack of Efficacy|1|||
143120451|NCT02134353|515982923|FG000|Overall Study|Withdrawal by Subject|12|||
143120452|NCT02134353|515982924|FG001|Overall Study|Withdrawal by Subject|13|||
143120453|NCT02134353|515982923|FG000|Overall Study|Death|0|||
143120454|NCT02134353|515982924|FG001|Overall Study|Death|1|||
143120455|NCT02134353|515982923|FG000|Overall Study|Pregnancy|0|||
143120456|NCT02134353|515982924|FG001|Overall Study|Pregnancy|1|||
143120457|NCT02134353|515982923|FG000|Overall Study|Relocation|1|||
143120458|NCT02134353|515982924|FG001|Overall Study|Relocation|0|||
143120459|NCT02134353|515982923|FG000|Overall Study|Other - Patient's Choice|0|||
143120460|NCT02134353|515982924|FG001|Overall Study|Other - Patient's Choice|1|||
143120461|NCT00474786|515982927|FG000|Overall Study|Not Meeting Study Criteria|0|||
143120462|NCT00474786|515982928|FG001|Overall Study|Not Meeting Study Criteria|1|||
143120463|NCT00474786|515982927|FG000|Overall Study|Investigator Request|2|||
143120464|NCT00474786|515982928|FG001|Overall Study|Investigator Request|1|||
143120465|NCT00474786|515982927|FG000|Overall Study|Death|189|||
143120466|NCT00474786|515982928|FG001|Overall Study|Death|170|||
143120467|NCT00474786|515982927|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
143120468|NCT00474786|515982928|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
143120469|NCT00474786|515982927|FG000|Overall Study|Lost to Follow-up|4|||
143120470|NCT00474786|515982928|FG001|Overall Study|Lost to Follow-up|7|||
143120471|NCT00474786|515982927|FG000|Overall Study|Protocol Violation|2|||
143120472|NCT00474786|515982928|FG001|Overall Study|Protocol Violation|0|||
143120473|NCT00474786|515982927|FG000|Overall Study|Withdrawal by Subject|15|||
143120474|NCT00474786|515982928|FG001|Overall Study|Withdrawal by Subject|15|||
143120475|NCT00474786|515982927|FG000|Overall Study|Other|5|||
143120476|NCT00474786|515982928|FG001|Overall Study|Other|0|||
143120477|NCT02892513|515982929|FG000|Overall Study|Withdrawal by Subject|0|||
143120478|NCT02892513|515982930|FG001|Overall Study|Withdrawal by Subject|1|||
143120479|NCT03426436|515982931|FG000|Overall Study|Incorrect lead placement|12|||
143120480|NCT03426436|515982931|FG000|Overall Study|Withdrawal by Subject|2|||
143120481|NCT03426436|515982931|FG000|Overall Study|Consent issue|1|||
143120482|NCT03426436|515982931|FG000|Overall Study|ECGs not saved|4|||
143120483|NCT00467961|515982933|FG000|Overall Study|Technical Failures|5|||
143120484|NCT00467961|515982933|FG000|Overall Study|Disease Progression|2|||
143120485|NCT02360475|515982934|FG000|Overall Study|Lost to Follow-up|4|||
143120486|NCT02360475|515982935|FG001|Overall Study|Lost to Follow-up|12|||
143120487|NCT02360475|515982936|FG002|Overall Study|Lost to Follow-up|6|||
143120488|NCT02360475|515982937|FG003|Overall Study|Lost to Follow-up|4|||
143120489|NCT02360475|515982934|FG000|Overall Study|Withdrawal by Subject|0|||
143120490|NCT02360475|515982935|FG001|Overall Study|Withdrawal by Subject|1|||
143120491|NCT02360475|515982936|FG002|Overall Study|Withdrawal by Subject|2|||
143120492|NCT02360475|515982937|FG003|Overall Study|Withdrawal by Subject|0|||
143120493|NCT02360475|515982934|FG000|Overall Study|Migrated/moved from study area|0|||
143120494|NCT02360475|515982935|FG001|Overall Study|Migrated/moved from study area|0|||
143120495|NCT02360475|515982936|FG002|Overall Study|Migrated/moved from study area|0|||
143120496|NCT02360475|515982937|FG003|Overall Study|Migrated/moved from study area|1|||
143120497|NCT00505661|515982938|FG000|Overall Study|Not Eligible|4|||
143120498|NCT02227368|515985529|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
143120499|NCT02227368|515985530|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
143120500|NCT02227368|515985529|FG000|Overall Study|Lost to Follow-up|1|||
143120501|NCT02227368|515985530|FG001|Overall Study|Lost to Follow-up|0|||
143120502|NCT02227368|515985529|FG000|Overall Study|Adverse Event|1|||
143120503|NCT02227368|515985530|FG001|Overall Study|Adverse Event|0|||
143120504|NCT02510820|515985534|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
143120505|NCT02510820|515985535|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
143120506|NCT02510820|515985534|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
143120507|NCT02510820|515985535|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
143120508|NCT03046056|515985536|FG000|Overall Study|Non-responder at Week 10|6|||
143120509|NCT03046056|515985537|FG001|Overall Study|Non-responder at Week 10|6|||
143120510|NCT03046056|515985538|FG002|Overall Study|Non-responder at Week 10|4|||
143120511|NCT03046056|515985536|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
143120512|NCT03046056|515985537|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
143120513|NCT03046056|515985538|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
143120514|NCT03046056|515985536|FG000|Overall Study|Adverse Event|1|||
143120515|NCT03046056|515985537|FG001|Overall Study|Adverse Event|5|||
143120516|NCT03046056|515985538|FG002|Overall Study|Adverse Event|0|||
143120517|NCT03046056|515985536|FG000|Overall Study|Non-compliance With Study Drug|0|||
143120518|NCT03046056|515985537|FG001|Overall Study|Non-compliance With Study Drug|0|||
143120519|NCT03046056|515985538|FG002|Overall Study|Non-compliance With Study Drug|2|||
143120520|NCT03046056|515985536|FG000|Overall Study|Protocol Violation|1|||
143120521|NCT03046056|515985537|FG001|Overall Study|Protocol Violation|1|||
143120522|NCT03046056|515985538|FG002|Overall Study|Protocol Violation|0|||
143120523|NCT03046056|515985536|FG000|Overall Study|Investigator's Discretion|0|||
143120524|NCT03046056|515985537|FG001|Overall Study|Investigator's Discretion|1|||
143120525|NCT03046056|515985538|FG002|Overall Study|Investigator's Discretion|0|||
143120526|NCT03046056|515985536|FG000|Overall Study|Withdrew Consent|1|||
143120527|NCT03046056|515985537|FG001|Overall Study|Withdrew Consent|0|||
143120528|NCT03046056|515985538|FG002|Overall Study|Withdrew Consent|0|||
143120529|NCT02913105|515985539|FG000|Overall Study|Adverse Event|11|||
143120530|NCT02913105|515985540|FG001|Overall Study|Adverse Event|0|||
143120531|NCT02913105|515985541|FG002|Overall Study|Adverse Event|4|||
143120532|NCT02913105|515985539|FG000|Overall Study|Non-Compliance With Study Drug|0|||
143120533|NCT02913105|515985540|FG001|Overall Study|Non-Compliance With Study Drug|0|||
143120534|NCT02913105|515985541|FG002|Overall Study|Non-Compliance With Study Drug|1|||
143120535|NCT02913105|515985539|FG000|Overall Study|Reason Not Specified|3|||
143120536|NCT02913105|515985540|FG001|Overall Study|Reason Not Specified|1|||
143120537|NCT02913105|515985541|FG002|Overall Study|Reason Not Specified|1|||
143120538|NCT02913105|515985539|FG000|Overall Study|Physician Decision|1|||
143120539|NCT02913105|515985540|FG001|Overall Study|Physician Decision|1|||
143120540|NCT02913105|515985541|FG002|Overall Study|Physician Decision|0|||
143120541|NCT02913105|515985539|FG000|Overall Study|Withdrawal by Subject|0|||
143120542|NCT02913105|515985540|FG001|Overall Study|Withdrawal by Subject|3|||
143120543|NCT02913105|515985541|FG002|Overall Study|Withdrawal by Subject|1|||
143120544|NCT01317004|515985542|FG000|Overall Study|Withdrawal by Subject|1|||
143120545|NCT01317004|515985543|FG001|Overall Study|Withdrawal by Subject|4|||
143120546|NCT01317004|515985542|FG000|Overall Study|Protocol Violation|0|||
143120547|NCT01317004|515985543|FG001|Overall Study|Protocol Violation|2|||
143120548|NCT01317004|515985542|FG000|Overall Study|Adverse Event|3|||
143120549|NCT01317004|515985543|FG001|Overall Study|Adverse Event|3|||
143120550|NCT01890759|515985546|FG000|Overall Study|Protocol Violation|0|||
143120551|NCT01890759|515985547|FG001|Overall Study|Protocol Violation|2|||
143120552|NCT01890759|515985546|FG000|Overall Study|Lost to Follow-up|0|||
143120553|NCT01890759|515985547|FG001|Overall Study|Lost to Follow-up|2|||
143120554|NCT01890759|515985546|FG000|Overall Study|Withdrawal by Subject|2|||
143120555|NCT01890759|515985547|FG001|Overall Study|Withdrawal by Subject|8|||
143120556|NCT04494425|515985552|FG000|Overall Study|Death|160|||
143120557|NCT04494425|515985553|FG001|Overall Study|Death|166|||
143120558|NCT04494425|515985552|FG000|Overall Study|Withdrawal by Subject|10|||
143120559|NCT04494425|515985553|FG001|Overall Study|Withdrawal by Subject|40|||
143120560|NCT04494425|515985552|FG000|Overall Study|Other|1|||
143120561|NCT04494425|515985553|FG001|Overall Study|Other|1|||
143120562|NCT04494425|515985552|FG000|Overall Study|Ongoing at the time of PCD|265|||
143120563|NCT04494425|515985553|FG001|Overall Study|Ongoing at the time of PCD|223|||
143120564|NCT04003623|515985554|FG000|Overall Study|Withdrawal by Subject|1|||
143120565|NCT04003623|515985555|FG001|Overall Study|Withdrawal by Subject|0|||
143120566|NCT00703326|515985557|FG000|Overall Study|Lost to Follow-up|47|||
143120567|NCT00703326|515985558|FG001|Overall Study|Lost to Follow-up|18|||
143120568|NCT00703326|515985557|FG000|Overall Study|Withdrawal by Subject|54|||
143120569|NCT00703326|515985558|FG001|Overall Study|Withdrawal by Subject|20|||
143120570|NCT00703326|515985557|FG000|Overall Study|Adverse Event|1|||
143120571|NCT00703326|515985558|FG001|Overall Study|Adverse Event|0|||
143120572|NCT03041467|515985561|FG000|Overall Study|Death|46|||
143120573|NCT03041467|515985562|FG001|Overall Study|Death|39|||
143120574|NCT03041467|515985561|FG000|Overall Study|Withdrawal by Subject|36|||
143120575|NCT03041467|515985562|FG001|Overall Study|Withdrawal by Subject|37|||
143120576|NCT03041467|515985561|FG000|Overall Study|Lost to Follow-up|6|||
143120577|NCT03041467|515985562|FG001|Overall Study|Lost to Follow-up|8|||
143120578|NCT03041467|515985561|FG000|Overall Study|Declined consent for study extension|21|||
143120579|NCT03041467|515985562|FG001|Overall Study|Declined consent for study extension|33|||
143120580|NCT03041467|515985561|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
143120581|NCT03041467|515985562|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
143120582|NCT01190189|515985563|FG000|Overall Study|Lost to Follow-up|4|||
143120583|NCT01190189|515985563|FG000|Overall Study|Withdrawal by Subject|1|||
143120584|NCT01190189|515985563|FG000|Overall Study|Migrated/moved from study area|1|||
143120585|NCT03214679|515985566|FG000|Overall Study|Lost to Follow-up|12|||
143120586|NCT03214679|515985567|FG001|Overall Study|Lost to Follow-up|14|||
143120587|NCT03214679|515985566|FG000|Overall Study|not eligible|2|||
143120588|NCT03214679|515985567|FG001|Overall Study|not eligible|0|||
143120589|NCT05025332|515985572|FG000|Screening|Screen failure|12|||
143120590|NCT05025332|515985572|FG000|Treatment & Follow Up|Protocol Violation|1|||
143120591|NCT05025332|515985572|FG000|Treatment & Follow Up|Adverse Event|4|||
143120592|NCT01306214|515985573|FG000|Overall Study|Death|0|||
143120593|NCT01306214|515985574|FG001|Overall Study|Death|0|||
143120594|NCT01306214|515985575|FG002|Overall Study|Death|1|||
143120595|NCT01306214|515985573|FG000|Overall Study|Lost to Follow-up|3|||
143120596|NCT01306214|515985574|FG001|Overall Study|Lost to Follow-up|5|||
143120597|NCT01306214|515985575|FG002|Overall Study|Lost to Follow-up|4|||
143120598|NCT01306214|515985573|FG000|Overall Study|Withdrawal by Subject|24|||
143120599|NCT01306214|515985574|FG001|Overall Study|Withdrawal by Subject|22|||
143120600|NCT01306214|515985575|FG002|Overall Study|Withdrawal by Subject|16|||
143120601|NCT01306214|515985573|FG000|Overall Study|Not treated|1|||
143120602|NCT01306214|515985574|FG001|Overall Study|Not treated|1|||
143120603|NCT01306214|515985575|FG002|Overall Study|Not treated|1|||
143120604|NCT02907619|515985576|FG000|Overall Study|Study terminated by sponsor|18|||
143120605|NCT02907619|515985577|FG001|Overall Study|Study terminated by sponsor|18|||
143120606|NCT02907619|515985578|FG002|Overall Study|Study terminated by sponsor|19|||
143120607|NCT02907619|515985576|FG000|Overall Study|Death|0|||
143120608|NCT02907619|515985577|FG001|Overall Study|Death|0|||
143120609|NCT02907619|515985578|FG002|Overall Study|Death|1|||
143120610|NCT02907619|515985576|FG000|Overall Study|Withdrawal by Subject|1|||
143120611|NCT02907619|515985577|FG001|Overall Study|Withdrawal by Subject|1|||
143120612|NCT02907619|515985578|FG002|Overall Study|Withdrawal by Subject|0|||
143120613|NCT02907619|515985576|FG000|Overall Study|Other|0|||
143120614|NCT02907619|515985577|FG001|Overall Study|Other|1|||
143120615|NCT02907619|515985578|FG002|Overall Study|Other|0|||
143120616|NCT01375374|515985579|FG000|Overall Study|Adverse Event|1|||
143120617|NCT01908582|515985580|FG000|Period 2|Physician Decision|1|||
143120618|NCT01908582|515985580|FG000|Period 2|Withdrawal by Subject|1|||
143120619|NCT02065518|515985582|FG000|Overall Study|Lost to Follow-up|3|||
143120620|NCT02065518|515985583|FG001|Overall Study|Lost to Follow-up|4|||
143120621|NCT02065518|515985584|FG002|Overall Study|Lost to Follow-up|0|||
143120622|NCT02065518|515985585|FG003|Overall Study|Lost to Follow-up|3|||
143120623|NCT02065518|515985582|FG000|Overall Study|Withdrawal by Subject|3|||
143120624|NCT02065518|515985583|FG001|Overall Study|Withdrawal by Subject|4|||
143120625|NCT02065518|515985584|FG002|Overall Study|Withdrawal by Subject|9|||
143120626|NCT02065518|515985585|FG003|Overall Study|Withdrawal by Subject|2|||
143120627|NCT00564278|515985586|FG000|Overall Study|Lost to Follow-up|35|||
143120628|NCT00564278|515985587|FG001|Overall Study|Lost to Follow-up|33|||
143120629|NCT00564278|515985586|FG000|Overall Study|Physician Decision|1|||
143120630|NCT00564278|515985587|FG001|Overall Study|Physician Decision|2|||
143120631|NCT00564278|515985586|FG000|Overall Study|Withdrawal by Subject|11|||
143120632|NCT00564278|515985587|FG001|Overall Study|Withdrawal by Subject|7|||
143120633|NCT06439095|515985588|FG000|Overall Study|Lost to Follow-up|2|||
143120634|NCT03341936|515985589|FG000|Overall Study|Ineligible|1|||
143120635|NCT03341936|515985589|FG000|Overall Study|Disease Progression|2|||
143120636|NCT03341936|515985589|FG000|Overall Study|Withdrew Consent|4|||
143120637|NCT03341936|515985589|FG000|Overall Study|Non-Compliance|1|||
143120638|NCT03341936|515985589|FG000|Overall Study|Physician Decision|1|||
143120639|NCT03341936|515985589|FG000|Overall Study|Withdrawal by Subject|1|||
143120640|NCT03341936|515985589|FG000|Overall Study|Other|1|||
143459400|NCT03149549|517226965|FG012|Study Discontinuation--Treatment Period|Death|1|||
143120641|NCT02368886|515985590|FG000|Overall Study|Cancel|1|||
143120642|NCT02368886|515985591|FG001|Overall Study|Cancel|1|||
143120643|NCT02368886|515985592|FG002|Overall Study|Cancel|1|||
143120644|NCT02368886|515985593|FG003|Overall Study|Cancel|3|||
143120645|NCT02368886|515985590|FG000|Overall Study|Ineligible|0|||
143120646|NCT02368886|515985591|FG001|Overall Study|Ineligible|0|||
143120647|NCT02368886|515985592|FG002|Overall Study|Ineligible|0|||
143120648|NCT02368886|515985593|FG003|Overall Study|Ineligible|1|||
143120649|NCT03484403|515985598|FG000|Overall Study|Withdrawal by Subject|6|||
143120650|NCT03484403|515985599|FG001|Overall Study|Withdrawal by Subject|4|||
143120651|NCT02131636|515985600|FG000|Overall Study|Personal Reasons|4|||
143120652|NCT02131636|515985601|FG001|Overall Study|Personal Reasons|4|||
143120653|NCT02131636|515985600|FG000|Overall Study|Lost to Follow-up|4|||
143120654|NCT02131636|515985601|FG001|Overall Study|Lost to Follow-up|0|||
143120655|NCT02131636|515985600|FG000|Overall Study|Adverse Event|4|||
143120656|NCT02131636|515985601|FG001|Overall Study|Adverse Event|1|||
143120657|NCT02173379|515985602|FG000|Overall Study|Lost to Follow-up|89|||
143120658|NCT02173379|515985603|FG001|Overall Study|Lost to Follow-up|81|||
143120659|NCT02173379|515985602|FG000|Overall Study|Withdrawal by Subject|24|||
143120660|NCT02173379|515985603|FG001|Overall Study|Withdrawal by Subject|29|||
143120661|NCT02173379|515985602|FG000|Overall Study|Physician Decision|8|||
143120662|NCT02173379|515985603|FG001|Overall Study|Physician Decision|8|||
143120663|NCT02173379|515985602|FG000|Overall Study|Death|75|||
143120664|NCT02173379|515985603|FG001|Overall Study|Death|72|||
143120665|NCT02173379|515985602|FG000|Overall Study|Other Reason|1|||
143120666|NCT02173379|515985603|FG001|Overall Study|Other Reason|0|||
143120667|NCT04278924|515985604|FG000|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
143120668|NCT04278924|515985605|FG001|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
143120669|NCT04278924|515985606|FG002|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
143120670|NCT04278924|515985607|FG003|Double Blind Period (Main Study)|Withdrawal by Subject|2|||
143120671|NCT04278924|515985608|FG004|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
143120672|NCT04278924|515985609|FG005|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
143120673|NCT04278924|515985610|FG006|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
143120674|NCT04278924|515985604|FG000|Double Blind Period (Main Study)|Reason Not Specified|0|||
143120675|NCT04278924|515985605|FG001|Double Blind Period (Main Study)|Reason Not Specified|1|||
143120676|NCT04278924|515985606|FG002|Double Blind Period (Main Study)|Reason Not Specified|0|||
143120677|NCT04278924|515985607|FG003|Double Blind Period (Main Study)|Reason Not Specified|0|||
143120678|NCT04278924|515985608|FG004|Double Blind Period (Main Study)|Reason Not Specified|0|||
143120679|NCT04278924|515985609|FG005|Double Blind Period (Main Study)|Reason Not Specified|0|||
143120680|NCT04278924|515985610|FG006|Double Blind Period (Main Study)|Reason Not Specified|0|||
143120681|NCT06226649|515985611|FG000|Overall Study|Withdrawal by Subject|4|||
143120682|NCT06226649|515985612|FG001|Overall Study|Withdrawal by Subject|1|||
143120683|NCT04847232|515985613|FG000|Overall Study|Death|123|||
143120684|NCT04847232|515985614|FG001|Overall Study|Death|115|||
143120685|NCT04847232|515985613|FG000|Overall Study|Lost to Follow-up|3|||
143120686|NCT04847232|515985614|FG001|Overall Study|Lost to Follow-up|10|||
143120687|NCT04847232|515985613|FG000|Overall Study|Withdrawal by Subject|73|||
143120688|NCT04847232|515985614|FG001|Overall Study|Withdrawal by Subject|101|||
143120689|NCT04847232|515985613|FG000|Overall Study|"Subcategories under Other not reported."|1150|||
143120690|NCT04847232|515985614|FG001|Overall Study|"Subcategories under Other not reported."|1115|||
143120691|NCT02476916|515985619|FG000|Core Period|Adverse Event|2|||
143120692|NCT02476916|515985620|FG001|Core Period|Adverse Event|2|||
143120693|NCT02476916|515985619|FG000|Core Period|Investigator decision|1|||
143120694|NCT02476916|515985620|FG001|Core Period|Investigator decision|1|||
143120695|NCT02476916|515985619|FG000|Core Period|Withdrawal by Subject|3|||
143120696|NCT02476916|515985620|FG001|Core Period|Withdrawal by Subject|0|||
143120697|NCT02476916|515985619|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
143120698|NCT02476916|515985620|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
143120699|NCT02476916|515985619|FG000|Extension Period|On Treatment|12|||
143120700|NCT02476916|515985620|FG001|Extension Period|On Treatment|17|||
143120701|NCT00631163|515985621|FG000|Number of Participants in Year 1|Adverse Event|12|||
143120702|NCT00631163|515985621|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
143120703|NCT00631163|515985621|FG000|Number of Participants in Year 1|Death|6|||
143120704|NCT00631163|515985621|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
143120705|NCT00631163|515985621|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
143120706|NCT00631163|515985621|FG000|Number of Participants in Year 1|Administrative problems|6|||
143120707|NCT00631163|515985621|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
143120708|NCT00631163|515985621|FG000|Number of Participants in Year 2|Adverse Event|1|||
143120709|NCT00631163|515985621|FG000|Number of Participants in Year 2|Protocol Violation|1|||
143120710|NCT00631163|515985621|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
143120711|NCT04122625|515985622|FG000|Part A (up to 2.92 Years)|Death|2|||
143120712|NCT04122625|515985623|FG001|Part A (up to 2.92 Years)|Death|4|||
143120713|NCT04122625|515985624|FG002|Part A (up to 2.92 Years)|Death|0|||
143120714|NCT04122625|515985625|FG003|Part A (up to 2.92 Years)|Death|0|||
143120715|NCT04122625|515985626|FG004|Part A (up to 2.92 Years)|Death|0|||
143120716|NCT04122625|515985627|FG005|Part A (up to 2.92 Years)|Death|0|||
143120717|NCT04122625|515985622|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
143120718|NCT04122625|515985623|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
143120719|NCT04122625|515985624|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
143120720|NCT04122625|515985625|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
143120721|NCT04122625|515985626|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
143120722|NCT04122625|515985627|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
143120723|NCT04122625|515985622|FG000|Part B (up to 2.33 Years)|Death|0|||
143120724|NCT04122625|515985623|FG001|Part B (up to 2.33 Years)|Death|0|||
143120725|NCT04122625|515985624|FG002|Part B (up to 2.33 Years)|Death|5|||
143120726|NCT04122625|515985625|FG003|Part B (up to 2.33 Years)|Death|7|||
143120727|NCT04122625|515985626|FG004|Part B (up to 2.33 Years)|Death|6|||
143120728|NCT04122625|515985627|FG005|Part B (up to 2.33 Years)|Death|7|||
143120729|NCT02697591|515985628|FG000|Overall Study|Lost to Follow-up|0|||
143120730|NCT02697591|515985629|FG001|Overall Study|Lost to Follow-up|0|||
143120731|NCT02697591|515985630|FG002|Overall Study|Lost to Follow-up|0|||
143120732|NCT02697591|515985631|FG003|Overall Study|Lost to Follow-up|0|||
143120733|NCT02697591|515985632|FG004|Overall Study|Lost to Follow-up|0|||
143120734|NCT02697591|515985633|FG005|Overall Study|Lost to Follow-up|1|||
143120735|NCT02697591|515985634|FG006|Overall Study|Lost to Follow-up|1|||
143120736|NCT02697591|515985635|FG007|Overall Study|Lost to Follow-up|0|||
143120737|NCT02697591|515985636|FG008|Overall Study|Lost to Follow-up|0|||
143120738|NCT02697591|515985637|FG009|Overall Study|Lost to Follow-up|1|||
143120739|NCT02697591|515985628|FG000|Overall Study|Withdrawal by Subject|1|||
143120740|NCT02697591|515985629|FG001|Overall Study|Withdrawal by Subject|1|||
143120741|NCT02697591|515985630|FG002|Overall Study|Withdrawal by Subject|2|||
143120742|NCT02697591|515985631|FG003|Overall Study|Withdrawal by Subject|1|||
143120743|NCT02697591|515985632|FG004|Overall Study|Withdrawal by Subject|7|||
143120744|NCT02697591|515985633|FG005|Overall Study|Withdrawal by Subject|6|||
143120745|NCT02697591|515985634|FG006|Overall Study|Withdrawal by Subject|9|||
143120746|NCT02697591|515985635|FG007|Overall Study|Withdrawal by Subject|1|||
143120747|NCT02697591|515985636|FG008|Overall Study|Withdrawal by Subject|6|||
143120748|NCT02697591|515985637|FG009|Overall Study|Withdrawal by Subject|10|||
143120749|NCT02697591|515985628|FG000|Overall Study|Physician Decision|1|||
143120750|NCT02697591|515985629|FG001|Overall Study|Physician Decision|0|||
143120751|NCT02697591|515985630|FG002|Overall Study|Physician Decision|0|||
143120752|NCT02697591|515985631|FG003|Overall Study|Physician Decision|0|||
143120753|NCT02697591|515985632|FG004|Overall Study|Physician Decision|1|||
143344470|NCT05400746|516806707|FG000|Overall Study|Trial terminated early due to IMP availability|0|||
143344471|NCT05400746|516806708|FG001|Overall Study|Trial terminated early due to IMP availability|4|||
143344472|NCT05400746|516806709|FG002|Overall Study|Trial terminated early due to IMP availability|1|||
143344473|NCT04522180|516806710|FG000|Overall Study|Investigator judgement|3|||
143344474|NCT04522180|516806711|FG001|Overall Study|Investigator judgement|4|||
143344475|NCT04522180|516806710|FG000|Overall Study|Voluntary withdrawal|1|||
143344476|NCT04522180|516806711|FG001|Overall Study|Voluntary withdrawal|0|||
143344477|NCT04522180|516806710|FG000|Overall Study|Pregnancy|0|||
143344478|NCT04522180|516806711|FG001|Overall Study|Pregnancy|1|||
143344479|NCT04522180|516806710|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
143120754|NCT02697591|515985633|FG005|Overall Study|Physician Decision|2|||
143120755|NCT02697591|515985634|FG006|Overall Study|Physician Decision|0|||
143120756|NCT02697591|515985635|FG007|Overall Study|Physician Decision|0|||
143120757|NCT02697591|515985636|FG008|Overall Study|Physician Decision|1|||
143120758|NCT02697591|515985637|FG009|Overall Study|Physician Decision|1|||
143120759|NCT02697591|515985628|FG000|Overall Study|Death|2|||
143120760|NCT02697591|515985629|FG001|Overall Study|Death|3|||
143120761|NCT02697591|515985630|FG002|Overall Study|Death|1|||
143344480|NCT04522180|516806711|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
143120762|NCT02697591|515985631|FG003|Overall Study|Death|1|||
143120763|NCT02697591|515985632|FG004|Overall Study|Death|4|||
143120764|NCT02697591|515985633|FG005|Overall Study|Death|5|||
143344481|NCT04522180|516806710|FG000|Overall Study|Reason not specified|8|||
143344482|NCT04522180|516806711|FG001|Overall Study|Reason not specified|5|||
143344483|NCT03635489|516806716|FG000|Overall Study|Death|19|||
143344484|NCT03635489|516806717|FG001|Overall Study|Death|13|||
143344485|NCT03635489|516806716|FG000|Overall Study|Lost to Follow-up|1|||
143344486|NCT03635489|516806717|FG001|Overall Study|Lost to Follow-up|2|||
143344487|NCT03635489|516806716|FG000|Overall Study|Withdrawal by Subject|1|||
143344488|NCT03635489|516806717|FG001|Overall Study|Withdrawal by Subject|2|||
143344489|NCT03635489|516806716|FG000|Overall Study|Study Ended by Sponsor|28|||
143344490|NCT03635489|516806717|FG001|Overall Study|Study Ended by Sponsor|34|||
143344491|NCT00943306|516806720|FG000|Overall Study|Physician Decision|1|||
143344492|NCT00943306|516806720|FG000|Overall Study|Death|1|||
143344493|NCT00943306|516806720|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
143344494|NCT01931735|516806721|FG000|Randomized Phase|Lost to Follow-up|2|||
143344495|NCT01931735|516806722|FG001|Randomized Phase|Lost to Follow-up|2|||
143344496|NCT01931735|516806723|FG002|Randomized Phase|Lost to Follow-up|5|||
143344497|NCT01931735|516806724|FG003|Randomized Phase|Lost to Follow-up|0|||
143344498|NCT01931735|516806721|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
143344499|NCT01931735|516806722|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
143344500|NCT01931735|516806723|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
143344501|NCT01931735|516806724|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
143344502|NCT01931735|516806721|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
143344503|NCT01931735|516806722|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
143344504|NCT01931735|516806723|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
143344505|NCT01931735|516806724|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
143344506|NCT03188120|516806729|FG000|Overall Study|Adverse Event|4|||
143344507|NCT03188120|516806729|FG000|Overall Study|Insufficient Effectiveness|8|||
143344508|NCT03188120|516806729|FG000|Overall Study|Improved|12|||
143344509|NCT03188120|516806729|FG000|Overall Study|Lost to Follow-up|7|||
143344510|NCT03188120|516806729|FG000|Overall Study|Other than specified|3|||
143344511|NCT03188120|516806729|FG000|Overall Study|No visit after the first visit|13|||
143344512|NCT00576732|516806730|FG000|DOUBLE BLIND|Adverse Event|0|||
143344513|NCT00576732|516806731|FG001|DOUBLE BLIND|Adverse Event|0|||
143344514|NCT00576732|516806732|FG002|DOUBLE BLIND|Adverse Event|1|||
143344515|NCT00576732|516806733|FG003|DOUBLE BLIND|Adverse Event|0|||
143344516|NCT00576732|516806734|FG004|DOUBLE BLIND|Adverse Event|0|||
143344517|NCT00576732|516806735|FG005|DOUBLE BLIND|Adverse Event|0|||
143120765|NCT02697591|515985634|FG006|Overall Study|Death|3|||
143120766|NCT02697591|515985635|FG007|Overall Study|Death|1|||
143120767|NCT02697591|515985636|FG008|Overall Study|Death|1|||
143120768|NCT02697591|515985637|FG009|Overall Study|Death|5|||
143120769|NCT02697591|515985628|FG000|Overall Study|Reason not Specified|0|||
143120770|NCT02697591|515985629|FG001|Overall Study|Reason not Specified|0|||
143120771|NCT02697591|515985630|FG002|Overall Study|Reason not Specified|0|||
143120772|NCT02697591|515985631|FG003|Overall Study|Reason not Specified|1|||
143120773|NCT02697591|515985632|FG004|Overall Study|Reason not Specified|1|||
143120774|NCT02697591|515985633|FG005|Overall Study|Reason not Specified|2|||
143120775|NCT02697591|515985634|FG006|Overall Study|Reason not Specified|3|||
143120776|NCT02697591|515985635|FG007|Overall Study|Reason not Specified|1|||
143120777|NCT02697591|515985636|FG008|Overall Study|Reason not Specified|1|||
143120778|NCT02697591|515985637|FG009|Overall Study|Reason not Specified|3|||
143120779|NCT01937884|515985638|FG000|Overall Study|Withdrawal by Subject|1|||
143120780|NCT01937884|515985639|FG001|Overall Study|Withdrawal by Subject|0|||
143120781|NCT02636699|515985640|FG000|Screening Period|Inclusion/Exclusion Failure|0|||
143120782|NCT02636699|515985641|FG001|Screening Period|Inclusion/Exclusion Failure|0|||
143120783|NCT02636699|515985642|FG002|Screening Period|Inclusion/Exclusion Failure|117|||
143120784|NCT02636699|515985640|FG000|Screening Period|Withdrawal by Subject|0|||
143120785|NCT02636699|515985641|FG001|Screening Period|Withdrawal by Subject|0|||
143120786|NCT02636699|515985642|FG002|Screening Period|Withdrawal by Subject|23|||
143120787|NCT02636699|515985640|FG000|Screening Period|Adverse Event|0|||
143120788|NCT02636699|515985641|FG001|Screening Period|Adverse Event|0|||
143120789|NCT02636699|515985642|FG002|Screening Period|Adverse Event|1|||
143120790|NCT02636699|515985640|FG000|Screening Period|Other not specified|0|||
143120791|NCT02636699|515985641|FG001|Screening Period|Other not specified|0|||
143120792|NCT02636699|515985642|FG002|Screening Period|Other not specified|3|||
143120793|NCT02636699|515985640|FG000|Treatment and Follow-up Periods|Adverse Event|4|||
143120794|NCT02636699|515985641|FG001|Treatment and Follow-up Periods|Adverse Event|0|||
143344518|NCT00576732|516806730|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
143344519|NCT00576732|516806731|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
143344520|NCT00576732|516806732|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
143344521|NCT00576732|516806733|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
143344522|NCT00576732|516806734|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
143120795|NCT02636699|515985642|FG002|Treatment and Follow-up Periods|Adverse Event|0|||
143120796|NCT02636699|515985640|FG000|Treatment and Follow-up Periods|Lost to Follow-up|3|||
143120797|NCT02636699|515985641|FG001|Treatment and Follow-up Periods|Lost to Follow-up|3|||
143120798|NCT02636699|515985642|FG002|Treatment and Follow-up Periods|Lost to Follow-up|0|||
143120799|NCT02636699|515985640|FG000|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|2|||
143120800|NCT02636699|515985641|FG001|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
143120801|NCT02636699|515985642|FG002|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
143120802|NCT02636699|515985640|FG000|Treatment and Follow-up Periods|Physician Decision|0|||
143120803|NCT02636699|515985641|FG001|Treatment and Follow-up Periods|Physician Decision|1|||
143344523|NCT00576732|516806735|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
143344524|NCT00576732|516806730|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
143344525|NCT00576732|516806731|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
143344526|NCT00576732|516806732|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
143344527|NCT00576732|516806733|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
143344528|NCT00576732|516806734|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
143344529|NCT00576732|516806735|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
143344530|NCT00576732|516806730|FG000|DOUBLE BLIND|OTHER|0|||
143344531|NCT00576732|516806731|FG001|DOUBLE BLIND|OTHER|2|||
143344532|NCT00576732|516806732|FG002|DOUBLE BLIND|OTHER|1|||
143344533|NCT00576732|516806733|FG003|DOUBLE BLIND|OTHER|0|||
143344534|NCT00576732|516806734|FG004|DOUBLE BLIND|OTHER|0|||
143344535|NCT00576732|516806735|FG005|DOUBLE BLIND|OTHER|0|||
143344536|NCT00576732|516806730|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
143344537|NCT00576732|516806731|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
143344538|NCT00576732|516806732|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
143344539|NCT00576732|516806733|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
143344540|NCT00576732|516806734|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
143344541|NCT00576732|516806735|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
143344542|NCT00576732|516806730|FG000|DOUBLE BLIND|Protocol Violation|1|||
143344543|NCT00576732|516806731|FG001|DOUBLE BLIND|Protocol Violation|0|||
143344544|NCT00576732|516806732|FG002|DOUBLE BLIND|Protocol Violation|0|||
143344545|NCT00576732|516806733|FG003|DOUBLE BLIND|Protocol Violation|0|||
143344546|NCT00576732|516806734|FG004|DOUBLE BLIND|Protocol Violation|0|||
143344547|NCT00576732|516806735|FG005|DOUBLE BLIND|Protocol Violation|0|||
143344548|NCT00576732|516806730|FG000|OPEN LABEL|Adverse Event|0|||
143344549|NCT00576732|516806731|FG001|OPEN LABEL|Adverse Event|0|||
143344550|NCT00576732|516806732|FG002|OPEN LABEL|Adverse Event|0|||
143344551|NCT00576732|516806733|FG003|OPEN LABEL|Adverse Event|4|||
143344552|NCT00576732|516806734|FG004|OPEN LABEL|Adverse Event|0|||
143344553|NCT00576732|516806735|FG005|OPEN LABEL|Adverse Event|1|||
143344554|NCT00576732|516806730|FG000|OPEN LABEL|Lost to Follow-up|0|||
143344555|NCT00576732|516806731|FG001|OPEN LABEL|Lost to Follow-up|0|||
143344556|NCT00576732|516806732|FG002|OPEN LABEL|Lost to Follow-up|0|||
143344557|NCT00576732|516806733|FG003|OPEN LABEL|Lost to Follow-up|2|||
143344558|NCT00576732|516806734|FG004|OPEN LABEL|Lost to Follow-up|1|||
143344559|NCT00576732|516806735|FG005|OPEN LABEL|Lost to Follow-up|1|||
143344560|NCT00576732|516806730|FG000|OPEN LABEL|Withdrawal by Subject|0|||
143344561|NCT00576732|516806731|FG001|OPEN LABEL|Withdrawal by Subject|0|||
143344562|NCT00576732|516806732|FG002|OPEN LABEL|Withdrawal by Subject|0|||
143344563|NCT00576732|516806733|FG003|OPEN LABEL|Withdrawal by Subject|1|||
143344564|NCT00576732|516806734|FG004|OPEN LABEL|Withdrawal by Subject|0|||
143344565|NCT00576732|516806735|FG005|OPEN LABEL|Withdrawal by Subject|1|||
143344566|NCT00576732|516806730|FG000|OPEN LABEL|OTHER|0|||
143344567|NCT00576732|516806731|FG001|OPEN LABEL|OTHER|0|||
143344568|NCT00576732|516806732|FG002|OPEN LABEL|OTHER|0|||
143344569|NCT00576732|516806733|FG003|OPEN LABEL|OTHER|0|||
143344570|NCT00576732|516806734|FG004|OPEN LABEL|OTHER|0|||
143344571|NCT00576732|516806735|FG005|OPEN LABEL|OTHER|2|||
143344572|NCT00576732|516806730|FG000|OPEN LABEL|Lack of Efficacy|0|||
143344573|NCT00576732|516806731|FG001|OPEN LABEL|Lack of Efficacy|0|||
143344574|NCT00576732|516806732|FG002|OPEN LABEL|Lack of Efficacy|0|||
143344575|NCT00576732|516806733|FG003|OPEN LABEL|Lack of Efficacy|2|||
143344576|NCT00576732|516806734|FG004|OPEN LABEL|Lack of Efficacy|2|||
143344577|NCT00576732|516806735|FG005|OPEN LABEL|Lack of Efficacy|3|||
143344578|NCT00576732|516806730|FG000|OPEN LABEL|Protocol Violation|0|||
143344579|NCT00576732|516806731|FG001|OPEN LABEL|Protocol Violation|0|||
143344580|NCT00576732|516806732|FG002|OPEN LABEL|Protocol Violation|0|||
143344581|NCT00576732|516806733|FG003|OPEN LABEL|Protocol Violation|2|||
143344582|NCT00576732|516806734|FG004|OPEN LABEL|Protocol Violation|1|||
143344583|NCT00576732|516806735|FG005|OPEN LABEL|Protocol Violation|0|||
143344584|NCT01235403|516806736|FG000|Overall Study|Adverse Event|14|||
143344585|NCT01235403|516806736|FG000|Overall Study|Lost to Follow-up|2|||
143344586|NCT01235403|516806736|FG000|Overall Study|Withdrawal by Subject|4|||
143344587|NCT01235403|516806736|FG000|Overall Study|Lack of Efficacy|2|||
143344588|NCT01235403|516806736|FG000|Overall Study|Other reasons for premature termination|4|||
143344589|NCT02296190|516806739|FG000|Overall Study|Lost to Follow-up|0|||
143344590|NCT02296190|516806740|FG001|Overall Study|Lost to Follow-up|0|||
143344591|NCT02296190|516806741|FG002|Overall Study|Lost to Follow-up|0|||
143344592|NCT02296190|516806742|FG003|Overall Study|Lost to Follow-up|0|||
143344593|NCT02296190|516806743|FG004|Overall Study|Lost to Follow-up|1|||
143344594|NCT02296190|516806744|FG005|Overall Study|Lost to Follow-up|0|||
143344595|NCT02296190|516806739|FG000|Overall Study|Failure to induce PSVT|6|||
143344596|NCT02296190|516806740|FG001|Overall Study|Failure to induce PSVT|10|||
143344597|NCT02296190|516806741|FG002|Overall Study|Failure to induce PSVT|5|||
143344598|NCT02296190|516806742|FG003|Overall Study|Failure to induce PSVT|13|||
143344599|NCT02296190|516806743|FG004|Overall Study|Failure to induce PSVT|8|||
143344600|NCT02296190|516806744|FG005|Overall Study|Failure to induce PSVT|0|||
143344601|NCT02296190|516806739|FG000|Overall Study|Physician Decision|1|||
143344602|NCT02296190|516806740|FG001|Overall Study|Physician Decision|1|||
143344603|NCT02296190|516806741|FG002|Overall Study|Physician Decision|0|||
143344604|NCT02296190|516806742|FG003|Overall Study|Physician Decision|1|||
143344605|NCT02296190|516806743|FG004|Overall Study|Physician Decision|2|||
143344606|NCT02296190|516806744|FG005|Overall Study|Physician Decision|0|||
143344607|NCT02296190|516806739|FG000|Overall Study|Withdrawal by Subject|0|||
143344608|NCT02296190|516806740|FG001|Overall Study|Withdrawal by Subject|1|||
143344609|NCT02296190|516806741|FG002|Overall Study|Withdrawal by Subject|0|||
143344610|NCT02296190|516806742|FG003|Overall Study|Withdrawal by Subject|0|||
143344611|NCT02296190|516806743|FG004|Overall Study|Withdrawal by Subject|0|||
143344612|NCT02296190|516806744|FG005|Overall Study|Withdrawal by Subject|0|||
143344613|NCT02296190|516806739|FG000|Overall Study|PSVT < 5 minutes|5|||
143344614|NCT02296190|516806740|FG001|Overall Study|PSVT < 5 minutes|6|||
143344615|NCT02296190|516806741|FG002|Overall Study|PSVT < 5 minutes|6|||
143344616|NCT02296190|516806742|FG003|Overall Study|PSVT < 5 minutes|6|||
143344617|NCT02296190|516806743|FG004|Overall Study|PSVT < 5 minutes|5|||
143344618|NCT02296190|516806744|FG005|Overall Study|PSVT < 5 minutes|0|||
143344619|NCT02296190|516806739|FG000|Overall Study|Patient was given Propofol|0|||
143344620|NCT02296190|516806740|FG001|Overall Study|Patient was given Propofol|1|||
143344621|NCT02296190|516806741|FG002|Overall Study|Patient was given Propofol|0|||
143344622|NCT02296190|516806742|FG003|Overall Study|Patient was given Propofol|1|||
143344623|NCT02296190|516806743|FG004|Overall Study|Patient was given Propofol|0|||
143344624|NCT02296190|516806744|FG005|Overall Study|Patient was given Propofol|0|||
143344625|NCT02296190|516806739|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
143344626|NCT02296190|516806740|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
143344627|NCT02296190|516806741|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
143344628|NCT02296190|516806742|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
143344629|NCT02296190|516806743|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
143344630|NCT02296190|516806744|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
143344631|NCT02296190|516806739|FG000|Overall Study|Blood pressure <100 after sedation|0|||
143344632|NCT02296190|516806740|FG001|Overall Study|Blood pressure <100 after sedation|0|||
143344633|NCT02296190|516806741|FG002|Overall Study|Blood pressure <100 after sedation|0|||
143344634|NCT02296190|516806742|FG003|Overall Study|Blood pressure <100 after sedation|1|||
143344635|NCT02296190|516806743|FG004|Overall Study|Blood pressure <100 after sedation|0|||
143344636|NCT02296190|516806744|FG005|Overall Study|Blood pressure <100 after sedation|0|||
143344637|NCT02296190|516806739|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
143344638|NCT02296190|516806740|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
143344639|NCT02296190|516806741|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
143344640|NCT02296190|516806742|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
143120804|NCT02636699|515985642|FG002|Treatment and Follow-up Periods|Physician Decision|0|||
143120805|NCT02636699|515985640|FG000|Treatment and Follow-up Periods|Withdrawal by Subject|13|||
143120806|NCT02636699|515985641|FG001|Treatment and Follow-up Periods|Withdrawal by Subject|6|||
143120807|NCT02636699|515985642|FG002|Treatment and Follow-up Periods|Withdrawal by Subject|0|||
143120808|NCT02636699|515985640|FG000|Treatment and Follow-up Periods|Other|3|||
143120809|NCT02636699|515985641|FG001|Treatment and Follow-up Periods|Other|1|||
143120810|NCT02636699|515985642|FG002|Treatment and Follow-up Periods|Other|0|||
143120811|NCT00530790|515985643|FG000|Overall Study|Adverse Event|2|||
143120812|NCT00530790|515985643|FG000|Overall Study|Withdrawal by Subject|2|||
143120813|NCT00530790|515985643|FG000|Overall Study|Physician Decision|1|||
143120814|NCT00438256|515985646|FG000|Overall Study|Ineligible for Resection|2|||
143120815|NCT00438256|515985647|FG001|Overall Study|Ineligible for Resection|1|||
143120816|NCT00438256|515985648|FG002|Overall Study|Ineligible for Resection|1|||
143120817|NCT00438256|515985649|FG003|Overall Study|Ineligible for Resection|7|||
143120818|NCT00438256|515985646|FG000|Overall Study|Excluded final Diagnosis|0|||
143120819|NCT00438256|515985647|FG001|Overall Study|Excluded final Diagnosis|0|||
143120820|NCT00438256|515985648|FG002|Overall Study|Excluded final Diagnosis|0|||
143120821|NCT00438256|515985649|FG003|Overall Study|Excluded final Diagnosis|2|||
143120822|NCT04776018|515985653|FG000|Overall Study|Death|0|||
143120823|NCT04776018|515985654|FG001|Overall Study|Death|1|||
143120824|NCT04776018|515985655|FG002|Overall Study|Death|4|||
143120825|NCT04776018|515985656|FG003|Overall Study|Death|1|||
143120826|NCT04776018|515985657|FG004|Overall Study|Death|4|||
143120827|NCT04776018|515985658|FG005|Overall Study|Death|0|||
143120828|NCT04776018|515985659|FG006|Overall Study|Death|0|||
143120829|NCT04776018|515985653|FG000|Overall Study|Study terminated by sponsor|2|||
143120830|NCT04776018|515985654|FG001|Overall Study|Study terminated by sponsor|1|||
143120831|NCT04776018|515985655|FG002|Overall Study|Study terminated by sponsor|4|||
143120832|NCT04776018|515985656|FG003|Overall Study|Study terminated by sponsor|0|||
143120833|NCT04776018|515985657|FG004|Overall Study|Study terminated by sponsor|3|||
143344641|NCT02296190|516806743|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
143344642|NCT02296190|516806744|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
143120834|NCT04776018|515985658|FG005|Overall Study|Study terminated by sponsor|0|||
143120835|NCT04776018|515985659|FG006|Overall Study|Study terminated by sponsor|0|||
143120836|NCT04776018|515985653|FG000|Overall Study|Withdrawal by Subject|1|||
143120837|NCT04776018|515985654|FG001|Overall Study|Withdrawal by Subject|0|||
143120838|NCT04776018|515985655|FG002|Overall Study|Withdrawal by Subject|0|||
143120839|NCT04776018|515985656|FG003|Overall Study|Withdrawal by Subject|2|||
143120840|NCT04776018|515985657|FG004|Overall Study|Withdrawal by Subject|1|||
143120841|NCT04776018|515985658|FG005|Overall Study|Withdrawal by Subject|0|||
143120842|NCT04776018|515985659|FG006|Overall Study|Withdrawal by Subject|0|||
143120843|NCT04776018|515985653|FG000|Overall Study|Other|0|||
143120844|NCT04776018|515985654|FG001|Overall Study|Other|1|||
143120845|NCT04776018|515985655|FG002|Overall Study|Other|1|||
143120846|NCT04776018|515985656|FG003|Overall Study|Other|0|||
143120847|NCT04776018|515985657|FG004|Overall Study|Other|0|||
143120848|NCT04776018|515985658|FG005|Overall Study|Other|0|||
143120849|NCT04776018|515985659|FG006|Overall Study|Other|0|||
143120850|NCT04776018|515985653|FG000|Overall Study|Lost to Follow-up|0|||
143120851|NCT04776018|515985654|FG001|Overall Study|Lost to Follow-up|0|||
143120852|NCT04776018|515985655|FG002|Overall Study|Lost to Follow-up|1|||
143120853|NCT04776018|515985656|FG003|Overall Study|Lost to Follow-up|0|||
143120854|NCT04776018|515985657|FG004|Overall Study|Lost to Follow-up|0|||
143120855|NCT04776018|515985658|FG005|Overall Study|Lost to Follow-up|0|||
143120856|NCT04776018|515985659|FG006|Overall Study|Lost to Follow-up|0|||
143120857|NCT00394433|515985660|FG000|Overall Study|Adverse Event|2|||
143120858|NCT00394433|515985660|FG000|Overall Study|Alternative Therapy|1|||
143120859|NCT00594386|515985663|FG000|Overall Study|Major protocol violation|2|||
143120860|NCT00594386|515985663|FG000|Overall Study|Lack of Efficacy|12|||
143120861|NCT00594386|515985663|FG000|Overall Study|Adverse Event|68|||
143120862|NCT00594386|515985663|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
143120863|NCT00594386|515985663|FG000|Overall Study|Subject withdrew consent|35|||
143120864|NCT00594386|515985663|FG000|Overall Study|Study ended per sponsor|115|||
143120865|NCT00594386|515985663|FG000|Overall Study|Lost to Follow-up|6|||
143120866|NCT00594386|515985663|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
143120867|NCT00594386|515985663|FG000|Overall Study|Other: Subject moved to Seattle|1|||
143120868|NCT00594386|515985663|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
143120869|NCT00594386|515985663|FG000|Overall Study|Other: Study terminated per investigator|2|||
143120870|NCT00594386|515985663|FG000|Overall Study|Other: Sponsor closure of study|1|||
143120871|NCT00594386|515985663|FG000|Overall Study|Other: Site terminated participation|1|||
143120872|NCT00594386|515985663|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
143120873|NCT00594386|515985663|FG000|Overall Study|Other: Loss of drivers license|1|||
143120874|NCT03168919|515985664|FG000|Overall Study|Withdrawal by Subject|2|||
143120875|NCT01085136|515985665|FG000|Part A|Other Adverse event|223|||
143120876|NCT01085136|515985666|FG001|Part A|Other Adverse event|0|||
143120877|NCT01085136|515985667|FG002|Part A|Other Adverse event|0|||
143120878|NCT01085136|515985665|FG000|Part A|Protocol Violation|3|||
143120879|NCT01085136|515985666|FG001|Part A|Protocol Violation|0|||
143120880|NCT01085136|515985667|FG002|Part A|Protocol Violation|0|||
143120881|NCT01085136|515985665|FG000|Part A|Lost to Follow-up|3|||
143120882|NCT01085136|515985666|FG001|Part A|Lost to Follow-up|0|||
143120883|NCT01085136|515985667|FG002|Part A|Lost to Follow-up|0|||
143120884|NCT01085136|515985665|FG000|Part A|Refusal to continue trial medication|64|||
143120885|NCT01085136|515985666|FG001|Part A|Refusal to continue trial medication|0|||
143120886|NCT01085136|515985667|FG002|Part A|Refusal to continue trial medication|0|||
143120887|NCT01085136|515985665|FG000|Part A|Other reason not defined above|30|||
143120888|NCT01085136|515985666|FG001|Part A|Other reason not defined above|0|||
143120889|NCT01085136|515985667|FG002|Part A|Other reason not defined above|0|||
143120890|NCT01085136|515985665|FG000|Part B|Other AE|0|||
143120891|NCT01085136|515985666|FG001|Part B|Other AE|29|||
143120892|NCT01085136|515985667|FG002|Part B|Other AE|8|||
143120893|NCT01085136|515985665|FG000|Part B|Refusal to continue trial medication|0|||
143120894|NCT01085136|515985666|FG001|Part B|Refusal to continue trial medication|12|||
143120895|NCT01085136|515985667|FG002|Part B|Refusal to continue trial medication|7|||
143120896|NCT01085136|515985665|FG000|Part B|Not treated|0|||
143120897|NCT01085136|515985666|FG001|Part B|Not treated|4|||
143120898|NCT01085136|515985667|FG002|Part B|Not treated|8|||
143120899|NCT01085136|515985665|FG000|Part B|Other reason not defined above|0|||
143120900|NCT01085136|515985666|FG001|Part B|Other reason not defined above|6|||
143120901|NCT01085136|515985667|FG002|Part B|Other reason not defined above|3|||
143120902|NCT02195427|515985668|FG000|Overall Study|Did not consent to study extension|13|||
143120903|NCT02195427|515985669|FG001|Overall Study|Did not consent to study extension|9|||
143120904|NCT02195427|515985668|FG000|Overall Study|Withdrawal by Subject|4|||
143120905|NCT02195427|515985669|FG001|Overall Study|Withdrawal by Subject|2|||
143120906|NCT02195427|515985668|FG000|Overall Study|Lost to Follow-up|0|||
143120907|NCT02195427|515985669|FG001|Overall Study|Lost to Follow-up|1|||
143120908|NCT02195427|515985668|FG000|Overall Study|Protocol Violation|7|||
143120909|NCT02195427|515985669|FG001|Overall Study|Protocol Violation|14|||
143120910|NCT02195427|515985668|FG000|Overall Study|Conditional re-treatment at W52|2|||
143120911|NCT02195427|515985669|FG001|Overall Study|Conditional re-treatment at W52|1|||
143120912|NCT01210144|515985670|FG000|Overall Study|Lack of ovarian response|1|||
143120913|NCT01210144|515985671|FG001|Overall Study|Lack of ovarian response|0|||
143120914|NCT01210144|515985670|FG000|Overall Study|No fertilization|1|||
143120915|NCT01210144|515985671|FG001|Overall Study|No fertilization|0|||
143120916|NCT01210144|515985670|FG000|Overall Study|No transfer|1|||
143120917|NCT01210144|515985671|FG001|Overall Study|No transfer|0|||
143120918|NCT02678000|515985675|FG000|PART 2|Adverse Event|0|||
143120919|NCT02678000|515985676|FG001|PART 2|Adverse Event|0|||
143120920|NCT02678000|515985677|FG002|PART 2|Adverse Event|2|||
143120921|NCT02678000|515985678|FG003|PART 2|Adverse Event|1|||
143120922|NCT02678000|515985679|FG004|PART 2|Adverse Event|0|||
143120923|NCT02678000|515985675|FG000|PART 2|Withdrawal by Subject|0|||
143120924|NCT02678000|515985676|FG001|PART 2|Withdrawal by Subject|0|||
143120925|NCT02678000|515985677|FG002|PART 2|Withdrawal by Subject|1|||
143120926|NCT02678000|515985678|FG003|PART 2|Withdrawal by Subject|0|||
143120927|NCT02678000|515985679|FG004|PART 2|Withdrawal by Subject|0|||
143120928|NCT03759366|515985681|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
143120929|NCT03759366|515985681|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
143120930|NCT03759366|515985681|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
143120931|NCT03759366|515985681|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
143120932|NCT03759366|515985681|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
143120933|NCT03759366|515985681|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
143120934|NCT03759366|515985681|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
143120935|NCT04226495|515985682|FG000|Overall Study|Withdrawal by Subject|3|||
143120936|NCT04226495|515985683|FG001|Overall Study|Withdrawal by Subject|3|||
143120937|NCT04226495|515985682|FG000|Overall Study|PI discretion|3|||
143120938|NCT04226495|515985683|FG001|Overall Study|PI discretion|4|||
143120939|NCT00435019|515985684|FG000|Overall Study|Adverse Event|1|||
143120940|NCT00435019|515985685|FG001|Overall Study|Adverse Event|0|||
143120941|NCT00435019|515985684|FG000|Overall Study|Lack of Efficacy|1|||
143120942|NCT00435019|515985685|FG001|Overall Study|Lack of Efficacy|2|||
143120943|NCT00435019|515985684|FG000|Overall Study|Protocol Violation|3|||
143120944|NCT00435019|515985685|FG001|Overall Study|Protocol Violation|1|||
143120945|NCT00435019|515985684|FG000|Overall Study|Personal reasons for withdrawal|8|||
143120946|NCT00435019|515985685|FG001|Overall Study|Personal reasons for withdrawal|7|||
143120947|NCT03611582|515985692|FG000|Overall Study|Adverse Event|26|||
143120948|NCT03611582|515985693|FG001|Overall Study|Adverse Event|6|||
143120949|NCT03611582|515985692|FG000|Overall Study|Protocol Violation|0|||
143120950|NCT03611582|515985693|FG001|Overall Study|Protocol Violation|1|||
143120951|NCT03611582|515985692|FG000|Overall Study|Pregnancy|1|||
143120952|NCT03611582|515985693|FG001|Overall Study|Pregnancy|2|||
143120953|NCT03611582|515985692|FG000|Overall Study|Lack of Efficacy|0|||
143120954|NCT03611582|515985693|FG001|Overall Study|Lack of Efficacy|1|||
143120955|NCT03611582|515985692|FG000|Overall Study|At the discretion of the investigator|1|||
143120956|NCT03611582|515985693|FG001|Overall Study|At the discretion of the investigator|0|||
143120957|NCT03611582|515985692|FG000|Overall Study|Safety concern as judged by the investigator|1|||
143120958|NCT03611582|515985693|FG001|Overall Study|Safety concern as judged by the investigator|2|||
143120959|NCT03611582|515985692|FG000|Overall Study|Withdrawal by Subject|4|||
143120960|NCT03611582|515985693|FG001|Overall Study|Withdrawal by Subject|3|||
143120961|NCT03611582|515985692|FG000|Overall Study|Lost to Follow-up|18|||
143120962|NCT03611582|515985693|FG001|Overall Study|Lost to Follow-up|7|||
143120963|NCT03611582|515985692|FG000|Overall Study|other|17|||
143120964|NCT03611582|515985693|FG001|Overall Study|other|16|||
143120965|NCT01783821|515985694|FG000|Overall Study|Screen Failure|1|||
143120966|NCT01783821|515985695|FG001|Overall Study|Screen Failure|1|||
143120967|NCT04459598|515985696|FG000|Overall Study|Adverse Event|1|||
143120968|NCT04459598|515985697|FG001|Overall Study|Adverse Event|1|||
143120969|NCT01907217|515985698|FG000|Overall Study|Withdrawal by Subject|0|||
143120970|NCT01907217|515985699|FG001|Overall Study|Withdrawal by Subject|2|||
143120971|NCT00866333|515985706|FG000|Overall Study|Withdrawal of consent|0|||
143120972|NCT00866333|515985707|FG001|Overall Study|Withdrawal of consent|1|||
143120973|NCT00866333|515985708|FG002|Overall Study|Withdrawal of consent|2|||
143120974|NCT00866333|515985706|FG000|Overall Study|Reason not Specified|3|||
143120975|NCT00866333|515985707|FG001|Overall Study|Reason not Specified|1|||
143120976|NCT00866333|515985708|FG002|Overall Study|Reason not Specified|1|||
143120977|NCT00866333|515985706|FG000|Overall Study|Study Terminated by Sponsor|2|||
143120978|NCT00866333|515985707|FG001|Overall Study|Study Terminated by Sponsor|5|||
143120979|NCT00866333|515985708|FG002|Overall Study|Study Terminated by Sponsor|9|||
143120980|NCT01764659|515985709|FG000|Overall Study|Death|1|||
143120981|NCT01764659|515985709|FG000|Overall Study|Physician Decision|1|||
143120982|NCT01210352|515985710|FG000|Overall Study|Adverse Event|0|||
143120983|NCT01210352|515985711|FG001|Overall Study|Adverse Event|0|||
143120984|NCT01210352|515985712|FG002|Overall Study|Adverse Event|0|||
143120985|NCT01210352|515985713|FG003|Overall Study|Adverse Event|0|||
143120986|NCT01210352|515985714|FG004|Overall Study|Adverse Event|0|||
143120987|NCT01210352|515985715|FG005|Overall Study|Adverse Event|0|||
143120988|NCT01210352|515985716|FG006|Overall Study|Adverse Event|0|||
143120989|NCT01210352|515985717|FG007|Overall Study|Adverse Event|2|||
143120990|NCT01210352|515985718|FG008|Overall Study|Adverse Event|1|||
143120991|NCT01210352|515985710|FG000|Overall Study|Lack of Efficacy|0|||
143120992|NCT01210352|515985711|FG001|Overall Study|Lack of Efficacy|0|||
143120993|NCT01210352|515985712|FG002|Overall Study|Lack of Efficacy|0|||
143120994|NCT01210352|515985713|FG003|Overall Study|Lack of Efficacy|0|||
143120995|NCT01210352|515985714|FG004|Overall Study|Lack of Efficacy|0|||
143120996|NCT01210352|515985715|FG005|Overall Study|Lack of Efficacy|0|||
143120997|NCT01210352|515985716|FG006|Overall Study|Lack of Efficacy|1|||
143120998|NCT01210352|515985717|FG007|Overall Study|Lack of Efficacy|0|||
143120999|NCT01210352|515985718|FG008|Overall Study|Lack of Efficacy|0|||
143121000|NCT01210352|515985710|FG000|Overall Study|Physician Decision|0|||
143121001|NCT01210352|515985711|FG001|Overall Study|Physician Decision|0|||
143121002|NCT01210352|515985712|FG002|Overall Study|Physician Decision|0|||
143121003|NCT01210352|515985713|FG003|Overall Study|Physician Decision|0|||
143344643|NCT02296190|516806739|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
143344644|NCT02296190|516806740|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
143344645|NCT02296190|516806741|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
143344646|NCT02296190|516806742|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
143344647|NCT02296190|516806743|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
143344648|NCT02296190|516806744|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
143344649|NCT02296190|516806739|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
143344650|NCT02296190|516806740|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
143344651|NCT02296190|516806741|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
143344652|NCT02296190|516806742|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
143344653|NCT02296190|516806743|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
143344654|NCT02296190|516806744|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
143344655|NCT02296190|516806739|FG000|Overall Study|Lab result not available in time|1|||
143344656|NCT02296190|516806740|FG001|Overall Study|Lab result not available in time|0|||
143344657|NCT02296190|516806741|FG002|Overall Study|Lab result not available in time|0|||
143344658|NCT02296190|516806742|FG003|Overall Study|Lab result not available in time|0|||
143344659|NCT02296190|516806743|FG004|Overall Study|Lab result not available in time|0|||
143344660|NCT02296190|516806744|FG005|Overall Study|Lab result not available in time|0|||
143344661|NCT02978443|516806745|FG000|Overall Study|Withdrawal by Subject|1|||
143344662|NCT02978443|516806745|FG000|Overall Study|Adverse Event|3|||
143344663|NCT02978443|516806745|FG000|Overall Study|Disease Progression on study|6|||
143344664|NCT02978443|516806745|FG000|Overall Study|Death|1|||
143344665|NCT02978443|516806745|FG000|Overall Study|Physician Decision|1|||
143344666|NCT02978443|516806745|FG000|Overall Study|Switch to alternative therapy|1|||
143344667|NCT02978443|516806745|FG000|Overall Study|Refused further treatment|1|||
143344668|NCT01919970|516806747|FG000|Overall Study|Withdrawal by Subject|3|||
143344669|NCT01919970|516806748|FG001|Overall Study|Withdrawal by Subject|0|||
143344670|NCT02070484|516806749|FG000|Overall Study|Withdrawal by Subject|1|||
143344671|NCT02070484|516806750|FG001|Overall Study|Withdrawal by Subject|0|||
143344672|NCT02839343|516806751|FG000|Overall Study|Withdrawal by Subject|3|||
143344673|NCT02839343|516806752|FG001|Overall Study|Withdrawal by Subject|1|||
143344674|NCT02839343|516806751|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
143344675|NCT02839343|516806752|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
143344676|NCT02839343|516806751|FG000|Overall Study|Adverse Event|1|||
143121004|NCT01210352|515985714|FG004|Overall Study|Physician Decision|0|||
143121005|NCT01210352|515985715|FG005|Overall Study|Physician Decision|0|||
143121006|NCT01210352|515985716|FG006|Overall Study|Physician Decision|0|||
143121007|NCT01210352|515985717|FG007|Overall Study|Physician Decision|1|||
143121008|NCT01210352|515985718|FG008|Overall Study|Physician Decision|2|||
143121009|NCT01210352|515985710|FG000|Overall Study|Withdrawal by Subject|0|||
143344677|NCT02839343|516806752|FG001|Overall Study|Adverse Event|0|||
143344678|NCT03075501|516808667|FG000|Overall Study|Scheduling difficulties|15|||
143344679|NCT03075501|516808668|FG001|Overall Study|Scheduling difficulties|9|||
143344680|NCT00957931|516808671|FG000|Overall Study|Death|4|||
143344681|NCT00857805|516808672|FG000|Overall Study|Withdrawal by Subject|1|||
143344682|NCT00857805|516808673|FG001|Overall Study|Withdrawal by Subject|1|||
143344683|NCT01062763|516808674|FG000|Overall Study|Adverse Event|3|||
143344684|NCT01062763|516808675|FG001|Overall Study|Adverse Event|4|||
143344685|NCT02670538|516808678|FG000|Overall Study|Withdrawal of Consent|8|||
143344686|NCT02670538|516808679|FG001|Overall Study|Withdrawal of Consent|6|||
143121010|NCT01210352|515985711|FG001|Overall Study|Withdrawal by Subject|0|||
143121011|NCT01210352|515985712|FG002|Overall Study|Withdrawal by Subject|1|||
143121012|NCT01210352|515985713|FG003|Overall Study|Withdrawal by Subject|0|||
143121013|NCT01210352|515985714|FG004|Overall Study|Withdrawal by Subject|0|||
143121014|NCT01210352|515985715|FG005|Overall Study|Withdrawal by Subject|0|||
143344687|NCT02670538|516808680|FG002|Overall Study|Withdrawal of Consent|5|||
143121015|NCT01210352|515985716|FG006|Overall Study|Withdrawal by Subject|1|||
143121016|NCT01210352|515985717|FG007|Overall Study|Withdrawal by Subject|0|||
143121017|NCT01210352|515985718|FG008|Overall Study|Withdrawal by Subject|1|||
143121018|NCT01210352|515985710|FG000|Overall Study|Patient Discharged Early|0|||
143121019|NCT01210352|515985711|FG001|Overall Study|Patient Discharged Early|0|||
143121020|NCT01210352|515985712|FG002|Overall Study|Patient Discharged Early|1|||
143121021|NCT01210352|515985713|FG003|Overall Study|Patient Discharged Early|0|||
143121022|NCT01210352|515985714|FG004|Overall Study|Patient Discharged Early|0|||
143121023|NCT01210352|515985715|FG005|Overall Study|Patient Discharged Early|0|||
143121024|NCT01210352|515985716|FG006|Overall Study|Patient Discharged Early|0|||
143121025|NCT01210352|515985717|FG007|Overall Study|Patient Discharged Early|0|||
143121026|NCT01210352|515985718|FG008|Overall Study|Patient Discharged Early|0|||
143121027|NCT01270321|515987193|FG000|Overall Study|Death|3|||
143121028|NCT01270321|515987194|FG001|Overall Study|Death|1|||
143121029|NCT01270321|515987195|FG002|Overall Study|Death|4|||
143121030|NCT01270321|515987193|FG000|Overall Study|Adverse Event|7|||
143121031|NCT01270321|515987194|FG001|Overall Study|Adverse Event|9|||
143121032|NCT01270321|515987195|FG002|Overall Study|Adverse Event|5|||
143121033|NCT01393106|515987201|FG000|Overall Study|Adverse Event|3|||
143121034|NCT01393106|515987201|FG000|Overall Study|Withdrawal by Subject|1|||
143121035|NCT01393106|515987201|FG000|Overall Study|Lack of Efficacy|1|||
143121036|NCT01744483|515987202|FG000|Overall Study|Death|9|||
143121037|NCT01744483|515987203|FG001|Overall Study|Death|4|||
143121038|NCT01744483|515987204|FG002|Overall Study|Death|11|||
143121039|NCT01744483|515987202|FG000|Overall Study|Lost to Follow-up|8|||
143121040|NCT01744483|515987203|FG001|Overall Study|Lost to Follow-up|9|||
143121041|NCT01744483|515987204|FG002|Overall Study|Lost to Follow-up|11|||
143121042|NCT01744483|515987202|FG000|Overall Study|Protocol Violation|1|||
143121043|NCT01744483|515987203|FG001|Overall Study|Protocol Violation|2|||
143121044|NCT01744483|515987204|FG002|Overall Study|Protocol Violation|1|||
143121045|NCT01744483|515987202|FG000|Overall Study|Withdrawal by Subject|4|||
143121046|NCT01744483|515987203|FG001|Overall Study|Withdrawal by Subject|6|||
143121047|NCT01744483|515987204|FG002|Overall Study|Withdrawal by Subject|2|||
143121048|NCT01744483|515987202|FG000|Overall Study|No ICU Admit|5|||
143121049|NCT01744483|515987203|FG001|Overall Study|No ICU Admit|1|||
143121050|NCT01744483|515987204|FG002|Overall Study|No ICU Admit|2|||
143121051|NCT01744483|515987202|FG000|Overall Study|Routed to OSH|2|||
143121052|NCT01744483|515987203|FG001|Overall Study|Routed to OSH|0|||
143121053|NCT01744483|515987204|FG002|Overall Study|Routed to OSH|1|||
143121054|NCT02732015|515987205|FG000|Overall Study|Lost to Follow-up|0|||
143121055|NCT02732015|515987206|FG001|Overall Study|Lost to Follow-up|1|||
143121056|NCT05437640|515987207|FG000|Washout (1 Week)|Adverse Event|1|||
143121057|NCT05437640|515987208|FG001|Washout (1 Week)|Adverse Event|0|||
143121058|NCT04228965|515987211|FG000|Overall Study|Lost to Follow-up|26|||
143121059|NCT04228965|515987212|FG001|Overall Study|Lost to Follow-up|11|||
143121060|NCT04228965|515987211|FG000|Overall Study|Withdrawal by Subject|18|||
143121061|NCT04228965|515987212|FG001|Overall Study|Withdrawal by Subject|5|||
143121062|NCT00734656|515987213|FG000|Lab Session 1|Withdrawal by Subject|2|||
143121063|NCT00734656|515987214|FG001|Lab Session 1|Withdrawal by Subject|0|||
143121064|NCT00734656|515987215|FG002|Lab Session 1|Withdrawal by Subject|0|||
143121065|NCT00734656|515987216|FG003|Lab Session 1|Withdrawal by Subject|0|||
143121066|NCT00734656|515987213|FG000|Washout 1|Withdrawal by Subject|1|||
143121067|NCT00734656|515987214|FG001|Washout 1|Withdrawal by Subject|5|||
143121068|NCT00734656|515987215|FG002|Washout 1|Withdrawal by Subject|2|||
143121069|NCT00734656|515987216|FG003|Washout 1|Withdrawal by Subject|3|||
143121070|NCT00734656|515987213|FG000|Lab Session 2|Withdrawal by Subject|1|||
143121071|NCT00734656|515987214|FG001|Lab Session 2|Withdrawal by Subject|0|||
143121072|NCT00734656|515987215|FG002|Lab Session 2|Withdrawal by Subject|0|||
143121073|NCT00734656|515987216|FG003|Lab Session 2|Withdrawal by Subject|1|||
143121074|NCT00734656|515987213|FG000|Washout 2|Withdrawal by Subject|1|||
143121075|NCT00734656|515987214|FG001|Washout 2|Withdrawal by Subject|1|||
143121076|NCT00734656|515987215|FG002|Washout 2|Withdrawal by Subject|1|||
143121077|NCT00734656|515987216|FG003|Washout 2|Withdrawal by Subject|0|||
143121078|NCT00734656|515987213|FG000|Washout 3|Withdrawal by Subject|1|||
143121079|NCT00734656|515987214|FG001|Washout 3|Withdrawal by Subject|0|||
143121080|NCT00734656|515987215|FG002|Washout 3|Withdrawal by Subject|0|||
143121081|NCT00734656|515987216|FG003|Washout 3|Withdrawal by Subject|1|||
143121082|NCT00734656|515987213|FG000|Lab Session 4|Withdrawal by Subject|0|||
143121083|NCT00734656|515987214|FG001|Lab Session 4|Withdrawal by Subject|0|||
143121084|NCT00734656|515987215|FG002|Lab Session 4|Withdrawal by Subject|0|||
143121085|NCT00734656|515987216|FG003|Lab Session 4|Withdrawal by Subject|1|||
143121086|NCT03915626|515987218|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
143121087|NCT03015194|515987219|FG000|Overall Study|Death|10|||
143121088|NCT03015194|515987219|FG000|Overall Study|Withdrawal by Subject|2|||
143121089|NCT01754766|515987224|FG000|Overall Study|Personal reasons|1|||
143121090|NCT01754766|515987225|FG001|Overall Study|Personal reasons|1|||
143121091|NCT01754766|515987226|FG002|Overall Study|Personal reasons|0|||
143121092|NCT01026818|515987227|FG000|Screening Period|Entry Criteria Not Met|105|||
143121093|NCT01026818|515987228|FG001|Screening Period|Entry Criteria Not Met|0|||
143121094|NCT01026818|515987229|FG002|Screening Period|Entry Criteria Not Met|0|||
143121095|NCT01026818|515987230|FG003|Screening Period|Entry Criteria Not Met|0|||
143121096|NCT01026818|515987227|FG000|Screening Period|Withdrawal by Subject|49|||
143121097|NCT01026818|515987228|FG001|Screening Period|Withdrawal by Subject|0|||
143121098|NCT01026818|515987229|FG002|Screening Period|Withdrawal by Subject|0|||
143121099|NCT01026818|515987230|FG003|Screening Period|Withdrawal by Subject|0|||
143121100|NCT01026818|515987227|FG000|Screening Period|Protocol Deviation|3|||
143121101|NCT01026818|515987228|FG001|Screening Period|Protocol Deviation|0|||
143121102|NCT01026818|515987229|FG002|Screening Period|Protocol Deviation|0|||
143121103|NCT01026818|515987230|FG003|Screening Period|Protocol Deviation|0|||
143121104|NCT01026818|515987227|FG000|Screening Period|Adverse Event|2|||
143121105|NCT01026818|515987228|FG001|Screening Period|Adverse Event|0|||
143121106|NCT01026818|515987229|FG002|Screening Period|Adverse Event|0|||
143121107|NCT01026818|515987230|FG003|Screening Period|Adverse Event|0|||
143121108|NCT01026818|515987227|FG000|Screening Period|Physician Decision|1|||
143121109|NCT01026818|515987228|FG001|Screening Period|Physician Decision|0|||
143121110|NCT01026818|515987229|FG002|Screening Period|Physician Decision|0|||
143121111|NCT01026818|515987230|FG003|Screening Period|Physician Decision|0|||
143121112|NCT01026818|515987227|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
143121113|NCT01026818|515987228|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
143121114|NCT01026818|515987229|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
143121115|NCT01026818|515987230|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
143121116|NCT01026818|515987227|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
143121117|NCT01026818|515987228|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
143121118|NCT01026818|515987229|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
143121119|NCT01026818|515987230|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
143121120|NCT01026818|515987227|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
143121121|NCT01026818|515987228|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
143259630|NCT04231981|516505812|FG000|Overall Study|Death|16|||
143259631|NCT04231981|516505812|FG000|Overall Study|Lost to Follow-up|1|||
143259632|NCT02581943|516505813|FG000|Overall Study|Death|5|||
143259633|NCT02581943|516505814|FG001|Overall Study|Death|2|||
143259634|NCT02581943|516505813|FG000|Overall Study|Disease Progression|12|||
143259635|NCT02581943|516505814|FG001|Overall Study|Disease Progression|15|||
143259636|NCT02581943|516505813|FG000|Overall Study|Withdrawal by Subject|1|||
143259637|NCT02581943|516505814|FG001|Overall Study|Withdrawal by Subject|2|||
143259638|NCT00378079|516505815|FG000|Overall Study|Lost to Follow-up|6|||
143259639|NCT00378079|516505816|FG001|Overall Study|Lost to Follow-up|1|||
143259640|NCT00378079|516505817|FG002|Overall Study|Lost to Follow-up|0|||
143259641|NCT02290431|516505818|FG000|Overall Study|Adverse Event|20|||
143259642|NCT02290431|516505818|FG000|Overall Study|Progressive disease|4|||
143259643|NCT02290431|516505818|FG000|Overall Study|Study terminated by Sponsor|1|||
143259644|NCT02290431|516505818|FG000|Overall Study|Physician Decision|2|||
143259645|NCT00989573|516505827|FG000|Overall Study|Adverse Event|8|||
143259646|NCT00989573|516505828|FG001|Overall Study|Adverse Event|12|||
143259647|NCT00989573|516505829|FG002|Overall Study|Adverse Event|4|||
143259648|NCT00989573|516505827|FG000|Overall Study|Physician Decision|0|||
143259649|NCT00989573|516505828|FG001|Overall Study|Physician Decision|2|||
143259650|NCT00989573|516505829|FG002|Overall Study|Physician Decision|0|||
143259651|NCT00989573|516505827|FG000|Overall Study|Protocol Violation|1|||
143259652|NCT00989573|516505828|FG001|Overall Study|Protocol Violation|1|||
143259653|NCT00989573|516505829|FG002|Overall Study|Protocol Violation|1|||
143259654|NCT00989573|516505827|FG000|Overall Study|Withdrawal by Subject|4|||
143259655|NCT00989573|516505828|FG001|Overall Study|Withdrawal by Subject|7|||
143259656|NCT00989573|516505829|FG002|Overall Study|Withdrawal by Subject|3|||
143259657|NCT00586664|516505832|FG000|Overall Study|Withdrawal by Subject|3|||
143259658|NCT00586664|516505833|FG001|Overall Study|Withdrawal by Subject|7|||
143259659|NCT00586664|516505834|FG002|Overall Study|Withdrawal by Subject|1|||
143259660|NCT00586664|516505832|FG000|Overall Study|Exclusion criteria met|2|||
143259661|NCT00586664|516505833|FG001|Overall Study|Exclusion criteria met|0|||
143259662|NCT00586664|516505834|FG002|Overall Study|Exclusion criteria met|0|||
143259663|NCT01163032|516505835|FG000|Randomization Phase|Withdrawal by Subject|2|||
143259664|NCT01163032|516505836|FG001|Randomization Phase|Withdrawal by Subject|3|||
143259665|NCT01163032|516505837|FG002|Randomization Phase|Withdrawal by Subject|0|||
143259666|NCT01163032|516505835|FG000|Randomization Phase|Adverse Event|3|||
143259667|NCT01163032|516505836|FG001|Randomization Phase|Adverse Event|3|||
143259668|NCT01163032|516505837|FG002|Randomization Phase|Adverse Event|0|||
143259669|NCT01163032|516505835|FG000|Randomization Phase|Protocol Violation|0|||
143259670|NCT01163032|516505836|FG001|Randomization Phase|Protocol Violation|1|||
143259671|NCT01163032|516505837|FG002|Randomization Phase|Protocol Violation|0|||
143259672|NCT01163032|516505835|FG000|Randomization Phase|Various*|5|||
143259673|NCT01163032|516505836|FG001|Randomization Phase|Various*|4|||
143259674|NCT01163032|516505837|FG002|Randomization Phase|Various*|0|||
143259675|NCT01163032|516505835|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
143259676|NCT01163032|516505836|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
143259677|NCT01163032|516505837|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
143259678|NCT01163032|516505835|FG000|Open Label Extension Phase|Adverse Event|0|||
143121122|NCT01026818|515987229|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
143121123|NCT01026818|515987230|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
143121124|NCT01026818|515987227|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
143121125|NCT01026818|515987228|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
143121126|NCT01026818|515987229|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
143121127|NCT01026818|515987230|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
143121128|NCT01026818|515987227|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
143121129|NCT01026818|515987228|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
143121130|NCT01026818|515987229|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
143121131|NCT01026818|515987230|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
143121132|NCT01026818|515987227|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
143121133|NCT01026818|515987228|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
143121134|NCT01026818|515987229|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
143121135|NCT01026818|515987230|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
143121136|NCT01026818|515987227|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
143121137|NCT01026818|515987228|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
143121138|NCT01026818|515987229|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
143121139|NCT01026818|515987230|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
143121140|NCT01026818|515987227|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
143121141|NCT01026818|515987228|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
143121142|NCT01026818|515987229|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
143121143|NCT01026818|515987230|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
143121144|NCT01026818|515987227|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
143121145|NCT01026818|515987228|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
143121146|NCT01026818|515987229|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
143121147|NCT01026818|515987230|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
143121148|NCT01026818|515987227|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
143121149|NCT01026818|515987228|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
143121150|NCT01026818|515987229|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
143344688|NCT02670538|516808678|FG000|Overall Study|Lost to Follow-up|8|||
143344689|NCT02670538|516808679|FG001|Overall Study|Lost to Follow-up|12|||
143344690|NCT02670538|516808680|FG002|Overall Study|Lost to Follow-up|7|||
143344691|NCT02670538|516808678|FG000|Overall Study|Adverse Event|5|||
143344692|NCT02670538|516808679|FG001|Overall Study|Adverse Event|5|||
143344693|NCT02670538|516808680|FG002|Overall Study|Adverse Event|11|||
143344694|NCT02670538|516808678|FG000|Overall Study|Lack of Efficacy|7|||
143121151|NCT01026818|515987230|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
143121152|NCT01026818|515987227|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
143121153|NCT01026818|515987228|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
143121154|NCT01026818|515987229|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
143121155|NCT01026818|515987230|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
143121156|NCT01026818|515987227|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
143121157|NCT01026818|515987228|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
143121158|NCT01026818|515987229|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
143121159|NCT01026818|515987230|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
143121160|NCT01026818|515987227|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
143121161|NCT01026818|515987228|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
143121162|NCT01026818|515987229|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
143121163|NCT01026818|515987230|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
143121164|NCT01026818|515987227|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
143121165|NCT01026818|515987228|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
143121166|NCT01026818|515987229|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
143121167|NCT01026818|515987230|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
143121168|NCT01026818|515987227|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
143121169|NCT01026818|515987228|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
143121170|NCT01026818|515987229|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
143121171|NCT01026818|515987230|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
143121172|NCT01026818|515987227|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
143121173|NCT01026818|515987228|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
143121174|NCT01026818|515987229|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
143121175|NCT01026818|515987230|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
143121176|NCT01026818|515987227|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
143121177|NCT01026818|515987228|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
143121178|NCT01026818|515987229|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
143121179|NCT01026818|515987230|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
143344695|NCT02670538|516808679|FG001|Overall Study|Lack of Efficacy|1|||
143344696|NCT02670538|516808680|FG002|Overall Study|Lack of Efficacy|2|||
143121180|NCT01026818|515987227|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
143121181|NCT01026818|515987228|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
143121182|NCT01026818|515987229|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
143121183|NCT01026818|515987230|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
143121184|NCT01026818|515987227|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
143121185|NCT01026818|515987228|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
143121186|NCT01026818|515987229|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
143121187|NCT01026818|515987230|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
143121188|NCT01548768|515987251|FG000|Overall Study|Withdrawal by Subject|0|||
143121189|NCT01548768|515987252|FG001|Overall Study|Withdrawal by Subject|2|||
143121190|NCT01548768|515987253|FG002|Overall Study|Withdrawal by Subject|1|||
143121191|NCT01548768|515987254|FG003|Overall Study|Withdrawal by Subject|0|||
143121192|NCT01548768|515987251|FG000|Overall Study|Physician Decision|1|||
143121193|NCT01548768|515987252|FG001|Overall Study|Physician Decision|0|||
143121194|NCT01548768|515987253|FG002|Overall Study|Physician Decision|0|||
143121195|NCT01548768|515987254|FG003|Overall Study|Physician Decision|0|||
143121196|NCT01548768|515987251|FG000|Overall Study|Adverse Event|0|||
143121197|NCT01548768|515987252|FG001|Overall Study|Adverse Event|0|||
143121198|NCT01548768|515987253|FG002|Overall Study|Adverse Event|0|||
143121199|NCT01548768|515987254|FG003|Overall Study|Adverse Event|1|||
143121200|NCT01548768|515987251|FG000|Overall Study|Non-Compliance|0|||
143121201|NCT01548768|515987252|FG001|Overall Study|Non-Compliance|0|||
143121202|NCT01548768|515987253|FG002|Overall Study|Non-Compliance|0|||
143121203|NCT01548768|515987254|FG003|Overall Study|Non-Compliance|3|||
143121204|NCT03326518|515987255|FG000|Overall Study|Protocol Violation|1|||
143121205|NCT03326518|515987256|FG001|Overall Study|Protocol Violation|0|||
143121206|NCT03326518|515987257|FG002|Overall Study|Protocol Violation|0|||
143121207|NCT03326518|515987255|FG000|Overall Study|Withdrawal by Subject|1|||
143121208|NCT03326518|515987256|FG001|Overall Study|Withdrawal by Subject|0|||
143121209|NCT03326518|515987257|FG002|Overall Study|Withdrawal by Subject|0|||
143121210|NCT03326518|515987255|FG000|Overall Study|Lost to Follow-up|1|||
143121211|NCT03326518|515987256|FG001|Overall Study|Lost to Follow-up|0|||
143121212|NCT03326518|515987257|FG002|Overall Study|Lost to Follow-up|1|||
143121213|NCT02714036|515987258|FG000|Overall Study|Adverse Event|9|||
143121214|NCT02714036|515987259|FG001|Overall Study|Adverse Event|2|||
143121215|NCT02714036|515987258|FG000|Overall Study|Withdrawal by Subject|3|||
143121216|NCT02714036|515987259|FG001|Overall Study|Withdrawal by Subject|2|||
143121217|NCT01006590|515987260|FG000|Overall Study|Adverse Event|2|||
143121218|NCT01006590|515987261|FG001|Overall Study|Adverse Event|3|||
143121219|NCT01006590|515987260|FG000|Overall Study|Death|1|||
143121220|NCT01006590|515987261|FG001|Overall Study|Death|1|||
143344697|NCT02670538|516808678|FG000|Overall Study|Protocol Violation|3|||
143344698|NCT02670538|516808679|FG001|Overall Study|Protocol Violation|4|||
143344699|NCT02670538|516808680|FG002|Overall Study|Protocol Violation|1|||
143344700|NCT02670538|516808678|FG000|Overall Study|Noncompliance with Study Drug|1|||
143344701|NCT02670538|516808679|FG001|Overall Study|Noncompliance with Study Drug|3|||
143344702|NCT02670538|516808680|FG002|Overall Study|Noncompliance with Study Drug|2|||
143344703|NCT02670538|516808678|FG000|Overall Study|Other Miscellaneous Reasons|0|||
143344704|NCT02670538|516808679|FG001|Overall Study|Other Miscellaneous Reasons|1|||
143344705|NCT02670538|516808680|FG002|Overall Study|Other Miscellaneous Reasons|2|||
143344706|NCT01250119|516808681|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
143344707|NCT01250119|516808682|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
143344708|NCT01250119|516808681|FG000|Diagnostic Phase|Participants Not Tested|44|||
143344709|NCT01250119|516808682|FG001|Diagnostic Phase|Participants Not Tested|0|||
143344710|NCT01250119|516808681|FG000|Treatment Phase|Progressive Disease|0|||
143344711|NCT01250119|516808682|FG001|Treatment Phase|Progressive Disease|32|||
143344712|NCT01250119|516808681|FG000|Treatment Phase|Death|0|||
143344713|NCT01250119|516808682|FG001|Treatment Phase|Death|2|||
143344714|NCT01250119|516808681|FG000|Treatment Phase|Withdrawal by Subject|0|||
143344715|NCT01250119|516808682|FG001|Treatment Phase|Withdrawal by Subject|1|||
143344716|NCT01250119|516808681|FG000|Treatment Phase|Adverse Event|0|||
143344717|NCT01250119|516808682|FG001|Treatment Phase|Adverse Event|2|||
143344718|NCT01250119|516808681|FG000|Treatment Phase|Unknown reason|0|||
143344719|NCT01250119|516808682|FG001|Treatment Phase|Unknown reason|4|||
143344720|NCT02887989|516808683|FG000|Overall Study|Withdrawal by Subject|8|||
143344721|NCT02887989|516808684|FG001|Overall Study|Withdrawal by Subject|11|||
143121221|NCT01006590|515987260|FG000|Overall Study|Lost to Follow-up|1|||
143121222|NCT01006590|515987261|FG001|Overall Study|Lost to Follow-up|1|||
143121223|NCT01006590|515987260|FG000|Overall Study|Protocol Violation|1|||
143121224|NCT01006590|515987261|FG001|Overall Study|Protocol Violation|0|||
143121225|NCT01006590|515987260|FG000|Overall Study|Withdrawal by Subject|4|||
143121226|NCT01006590|515987261|FG001|Overall Study|Withdrawal by Subject|2|||
143121227|NCT01006590|515987260|FG000|Overall Study|Study specific discontinuation criteria|16|||
143121228|NCT01006590|515987261|FG001|Overall Study|Study specific discontinuation criteria|23|||
143121229|NCT01006590|515987260|FG000|Overall Study|Other|3|||
143344722|NCT02887989|516808683|FG000|Overall Study|Death|1|||
143344723|NCT02887989|516808684|FG001|Overall Study|Death|0|||
143344724|NCT02045433|516808693|FG000|Overall Study|Withdrawal by Subject|1|||
143344725|NCT01559454|516808694|FG000|Overall Study|Lost to Follow-up|3|||
143344726|NCT01559454|516808695|FG001|Overall Study|Lost to Follow-up|2|||
143344727|NCT01559454|516808694|FG000|Overall Study|Withdrawal by Subject|0|||
143344728|NCT01559454|516808695|FG001|Overall Study|Withdrawal by Subject|1|||
143344729|NCT01559454|516808694|FG000|Overall Study|Physician Decision|0|||
143344730|NCT01559454|516808695|FG001|Overall Study|Physician Decision|1|||
143344731|NCT01559454|516808694|FG000|Overall Study|Protocol Violation|0|||
143344732|NCT01559454|516808695|FG001|Overall Study|Protocol Violation|1|||
143344733|NCT01559454|516808694|FG000|Overall Study|Lack of Efficacy|0|||
143344734|NCT01559454|516808695|FG001|Overall Study|Lack of Efficacy|1|||
143344735|NCT02207725|516808696|FG000|Overall Study|Did Not Receive Treatment|0|||
143344736|NCT02207725|516808697|FG001|Overall Study|Did Not Receive Treatment|1|||
143344737|NCT02207725|516808698|FG002|Overall Study|Did Not Receive Treatment|1|||
143344738|NCT02207725|516808699|FG003|Overall Study|Did Not Receive Treatment|1|||
143344739|NCT02948959|516808703|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
143344740|NCT02948959|516808704|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
143344741|NCT02948959|516808703|FG000|52 Weeks Treatment Period|Adverse Event|2|||
143344742|NCT02948959|516808704|FG001|52 Weeks Treatment Period|Adverse Event|5|||
143344743|NCT02948959|516808703|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
143344744|NCT02948959|516808704|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
143344745|NCT02948959|516808703|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
143344746|NCT02948959|516808704|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
143344747|NCT02948959|516808703|FG000|52 Weeks Treatment Period|Randomized by error|0|||
143344748|NCT02948959|516808704|FG001|52 Weeks Treatment Period|Randomized by error|5|||
143344749|NCT02948959|516808703|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
143344750|NCT02948959|516808704|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
143344751|NCT02948959|516808703|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
143344752|NCT02948959|516808704|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
143344753|NCT02948959|516808703|FG000|52 Weeks Treatment Period|Change of residence location|0|||
143344754|NCT02948959|516808704|FG001|52 Weeks Treatment Period|Change of residence location|1|||
143344755|NCT02948959|516808703|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
143344756|NCT02948959|516808704|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
143344757|NCT02948959|516808703|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
143344758|NCT02948959|516808704|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
143344759|NCT02948959|516808703|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
143344760|NCT02948959|516808704|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
143344761|NCT02948959|516808703|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
143344762|NCT02948959|516808704|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
143344763|NCT02948959|516808703|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
143344764|NCT02948959|516808704|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
143344765|NCT02948959|516808703|FG000|12 Weeks Follow-up Period|Study site closure|1|||
143344766|NCT02948959|516808704|FG001|12 Weeks Follow-up Period|Study site closure|0|||
143344767|NCT00409786|516808705|FG000|Overall Study|Withdrawal by Subject|3|||
143344768|NCT02341456|516808706|FG000|Overall Study|Disease progression|2|||
143344769|NCT02341456|516808707|FG001|Overall Study|Disease progression|3|||
143344770|NCT02341456|516808708|FG002|Overall Study|Disease progression|1|||
143344771|NCT02341456|516808706|FG000|Overall Study|Death|1|||
143344772|NCT02341456|516808707|FG001|Overall Study|Death|1|||
143344773|NCT02341456|516808708|FG002|Overall Study|Death|1|||
143344774|NCT02341456|516808706|FG000|Overall Study|Withdrawal by Subject|0|||
143344775|NCT02341456|516808707|FG001|Overall Study|Withdrawal by Subject|1|||
143344776|NCT02341456|516808708|FG002|Overall Study|Withdrawal by Subject|1|||
143344777|NCT02341456|516808706|FG000|Overall Study|Moved to local access programme.|0|||
143344778|NCT02341456|516808707|FG001|Overall Study|Moved to local access programme.|1|||
143344779|NCT02341456|516808708|FG002|Overall Study|Moved to local access programme.|1|||
143344780|NCT02341456|516808706|FG000|Overall Study|Physician Decision|1|||
143344781|NCT02341456|516808707|FG001|Overall Study|Physician Decision|0|||
143344782|NCT02341456|516808708|FG002|Overall Study|Physician Decision|0|||
143344783|NCT01077362|516808709|FG000|Overall Study|Lack of Efficacy|13|||
143344784|NCT01077362|516808710|FG001|Overall Study|Lack of Efficacy|8|||
143344785|NCT01077362|516808711|FG002|Overall Study|Lack of Efficacy|10|||
143344786|NCT01077362|516808709|FG000|Overall Study|Lost to Follow-up|1|||
143344787|NCT01077362|516808710|FG001|Overall Study|Lost to Follow-up|0|||
143344788|NCT01077362|516808711|FG002|Overall Study|Lost to Follow-up|3|||
143344789|NCT01077362|516808709|FG000|Overall Study|Adverse Event|12|||
143344790|NCT01077362|516808710|FG001|Overall Study|Adverse Event|7|||
143344791|NCT01077362|516808711|FG002|Overall Study|Adverse Event|4|||
143344792|NCT01077362|516808709|FG000|Overall Study|Withdrawal by Subject|5|||
143344793|NCT01077362|516808710|FG001|Overall Study|Withdrawal by Subject|3|||
143344794|NCT01077362|516808711|FG002|Overall Study|Withdrawal by Subject|5|||
143344795|NCT01077362|516808709|FG000|Overall Study|Other|0|||
143344796|NCT01077362|516808710|FG001|Overall Study|Other|1|||
143344797|NCT01077362|516808711|FG002|Overall Study|Other|2|||
143121230|NCT01006590|515987261|FG001|Overall Study|Other|2|||
143344798|NCT02508532|516808712|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
143344799|NCT02508532|516808713|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
143344800|NCT02508532|516808714|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
143344801|NCT02508532|516808715|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
143121231|NCT03332095|515987262|FG000|Overall Study|Lost to Follow-up|1|||
143121232|NCT03332095|515987263|FG001|Overall Study|Lost to Follow-up|0|||
143121233|NCT03332095|515987262|FG000|Overall Study|Pregnancy|0|||
143344802|NCT02508532|516808716|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
143344803|NCT02508532|516808717|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
143344804|NCT02508532|516808718|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
143344805|NCT02508532|516808719|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
143344806|NCT02508532|516808720|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
143344807|NCT02508532|516808712|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
143344808|NCT02508532|516808713|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
143344809|NCT02508532|516808714|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
143344810|NCT02508532|516808715|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
143344811|NCT02508532|516808716|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
143344812|NCT02508532|516808717|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
143344813|NCT02508532|516808718|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
143344814|NCT02508532|516808719|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
143344815|NCT02508532|516808720|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
143344816|NCT02508532|516808712|FG000|Part 2 - Treatment|Disease Progression|0|||
143344817|NCT02508532|516808713|FG001|Part 2 - Treatment|Disease Progression|0|||
143344818|NCT02508532|516808714|FG002|Part 2 - Treatment|Disease Progression|0|||
143344819|NCT02508532|516808715|FG003|Part 2 - Treatment|Disease Progression|0|||
143344820|NCT02508532|516808716|FG004|Part 2 - Treatment|Disease Progression|0|||
143344821|NCT02508532|516808717|FG005|Part 2 - Treatment|Disease Progression|0|||
143344822|NCT02508532|516808718|FG006|Part 2 - Treatment|Disease Progression|0|||
143344823|NCT02508532|516808719|FG007|Part 2 - Treatment|Disease Progression|0|||
143344824|NCT02508532|516808720|FG008|Part 2 - Treatment|Disease Progression|118|||
143344825|NCT02508532|516808712|FG000|Part 2 - Treatment|Adverse Event|0|||
143344826|NCT02508532|516808713|FG001|Part 2 - Treatment|Adverse Event|0|||
143344827|NCT02508532|516808714|FG002|Part 2 - Treatment|Adverse Event|0|||
143344828|NCT02508532|516808715|FG003|Part 2 - Treatment|Adverse Event|0|||
143344829|NCT02508532|516808716|FG004|Part 2 - Treatment|Adverse Event|0|||
143344830|NCT02508532|516808717|FG005|Part 2 - Treatment|Adverse Event|0|||
143344831|NCT02508532|516808718|FG006|Part 2 - Treatment|Adverse Event|0|||
143344832|NCT02508532|516808719|FG007|Part 2 - Treatment|Adverse Event|0|||
143344833|NCT02508532|516808720|FG008|Part 2 - Treatment|Adverse Event|49|||
143344834|NCT02508532|516808712|FG000|Part 2 - Treatment|Physician Decision|0|||
143344835|NCT02508532|516808713|FG001|Part 2 - Treatment|Physician Decision|0|||
143344836|NCT02508532|516808714|FG002|Part 2 - Treatment|Physician Decision|0|||
143344837|NCT02508532|516808715|FG003|Part 2 - Treatment|Physician Decision|0|||
143344838|NCT02508532|516808716|FG004|Part 2 - Treatment|Physician Decision|0|||
143344839|NCT02508532|516808717|FG005|Part 2 - Treatment|Physician Decision|0|||
143121234|NCT03332095|515987263|FG001|Overall Study|Pregnancy|1|||
143121235|NCT04942210|515987267|FG000|Overall Study|Adverse Event|0|||
143121236|NCT04942210|515987268|FG001|Overall Study|Adverse Event|1|||
143121237|NCT04942210|515987267|FG000|Overall Study|Protocol Deviation|4|||
143121238|NCT04942210|515987268|FG001|Overall Study|Protocol Deviation|1|||
143121239|NCT04942210|515987267|FG000|Overall Study|Withdrawal by Subject|5|||
143121240|NCT04942210|515987268|FG001|Overall Study|Withdrawal by Subject|2|||
143121241|NCT04942210|515987267|FG000|Overall Study|Lost to Follow-up|16|||
143121242|NCT04942210|515987268|FG001|Overall Study|Lost to Follow-up|7|||
143121243|NCT04942210|515987267|FG000|Overall Study|Ongoing at the time of DBL date|60|||
143121244|NCT04942210|515987268|FG001|Overall Study|Ongoing at the time of DBL date|25|||
143121245|NCT04942210|515987267|FG000|Overall Study|Randomized but did not receive vaccination|3|||
143121246|NCT04942210|515987268|FG001|Overall Study|Randomized but did not receive vaccination|0|||
143121247|NCT05697627|515987271|FG000|Overall Study|Adverse Event|1|||
143121248|NCT02570750|515987272|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
143121249|NCT02570750|515987273|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
143121250|NCT02570750|515987272|FG000|Overall Study|Protocol deviation|4|||
143121251|NCT02570750|515987273|FG001|Overall Study|Protocol deviation|2|||
143121252|NCT02570750|515987272|FG000|Overall Study|Withdrawal by Subject|5|||
143344840|NCT02508532|516808718|FG006|Part 2 - Treatment|Physician Decision|0|||
143344841|NCT02508532|516808719|FG007|Part 2 - Treatment|Physician Decision|0|||
143344842|NCT02508532|516808720|FG008|Part 2 - Treatment|Physician Decision|12|||
143121253|NCT02570750|515987273|FG001|Overall Study|Withdrawal by Subject|0|||
143121254|NCT02570750|515987272|FG000|Overall Study|Lost to Follow-up|2|||
143121255|NCT02570750|515987273|FG001|Overall Study|Lost to Follow-up|2|||
143121256|NCT02570750|515987272|FG000|Overall Study|Adverse Event|2|||
143121257|NCT02570750|515987273|FG001|Overall Study|Adverse Event|1|||
143121258|NCT01410240|515987274|FG000|Overall Study|Physician Decision|0|||
143121259|NCT01410240|515987275|FG001|Overall Study|Physician Decision|0|||
143121260|NCT01410240|515987276|FG002|Overall Study|Physician Decision|1|||
143121261|NCT01410240|515987274|FG000|Overall Study|Missed week 6 assessments|1|||
143121262|NCT01410240|515987275|FG001|Overall Study|Missed week 6 assessments|1|||
143121263|NCT01410240|515987276|FG002|Overall Study|Missed week 6 assessments|1|||
143121264|NCT04348500|515987277|FG000|Overall Study|Death|2|||
143121265|NCT04348500|515987278|FG001|Overall Study|Death|2|||
143121266|NCT04348500|515987277|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
143121267|NCT04348500|515987278|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
143121268|NCT02776670|515987279|FG000|Overall Study|Adverse Event|0|||
143121269|NCT02776670|515987280|FG001|Overall Study|Adverse Event|2|||
143121270|NCT02776670|515987279|FG000|Overall Study|Protocol Violation|0|||
143121271|NCT02776670|515987280|FG001|Overall Study|Protocol Violation|2|||
143121272|NCT02776670|515987279|FG000|Overall Study|Withdrawal by Subject|0|||
143121273|NCT02776670|515987280|FG001|Overall Study|Withdrawal by Subject|1|||
143121274|NCT02776670|515987279|FG000|Overall Study|Other - Reason not given|0|||
143121275|NCT02776670|515987280|FG001|Overall Study|Other - Reason not given|1|||
143121276|NCT03699540|515987281|FG000|Overall Study|Lost to Follow-up|1|||
143121277|NCT00624832|515987284|FG000|Overall Study|Adverse Event|0|||
143121278|NCT00624832|515987285|FG001|Overall Study|Adverse Event|1|||
143121279|NCT00624832|515987286|FG002|Overall Study|Adverse Event|0|||
143121280|NCT00624832|515987287|FG003|Overall Study|Adverse Event|1|||
143121281|NCT00624832|515987284|FG000|Overall Study|Abnormal Laboratory Value|2|||
143121282|NCT00624832|515987285|FG001|Overall Study|Abnormal Laboratory Value|0|||
143121283|NCT00624832|515987286|FG002|Overall Study|Abnormal Laboratory Value|0|||
143121284|NCT00624832|515987287|FG003|Overall Study|Abnormal Laboratory Value|0|||
143344843|NCT02508532|516808712|FG000|Part 2 - Treatment|Administrative|0|||
143344844|NCT02508532|516808713|FG001|Part 2 - Treatment|Administrative|0|||
143344845|NCT02508532|516808714|FG002|Part 2 - Treatment|Administrative|0|||
143344846|NCT02508532|516808715|FG003|Part 2 - Treatment|Administrative|0|||
143344847|NCT02508532|516808716|FG004|Part 2 - Treatment|Administrative|0|||
143344848|NCT02508532|516808717|FG005|Part 2 - Treatment|Administrative|0|||
143344849|NCT02508532|516808718|FG006|Part 2 - Treatment|Administrative|0|||
143344850|NCT02508532|516808719|FG007|Part 2 - Treatment|Administrative|0|||
143344851|NCT02508532|516808720|FG008|Part 2 - Treatment|Administrative|3|||
143344852|NCT02508532|516808712|FG000|Part 2 - Treatment|Sponsor Decision|0|||
143344853|NCT02508532|516808713|FG001|Part 2 - Treatment|Sponsor Decision|0|||
143344854|NCT02508532|516808714|FG002|Part 2 - Treatment|Sponsor Decision|0|||
143344855|NCT02508532|516808715|FG003|Part 2 - Treatment|Sponsor Decision|0|||
143344856|NCT02508532|516808716|FG004|Part 2 - Treatment|Sponsor Decision|0|||
143344857|NCT02508532|516808717|FG005|Part 2 - Treatment|Sponsor Decision|0|||
143344858|NCT02508532|516808718|FG006|Part 2 - Treatment|Sponsor Decision|0|||
143344859|NCT02508532|516808719|FG007|Part 2 - Treatment|Sponsor Decision|0|||
143344860|NCT02508532|516808720|FG008|Part 2 - Treatment|Sponsor Decision|28|||
143344861|NCT02508532|516808712|FG000|Part 2 - Treatment|Death|0|||
143344862|NCT02508532|516808713|FG001|Part 2 - Treatment|Death|0|||
143344863|NCT02508532|516808714|FG002|Part 2 - Treatment|Death|0|||
143344864|NCT02508532|516808715|FG003|Part 2 - Treatment|Death|0|||
143344865|NCT02508532|516808716|FG004|Part 2 - Treatment|Death|0|||
143344866|NCT02508532|516808717|FG005|Part 2 - Treatment|Death|0|||
143344867|NCT02508532|516808718|FG006|Part 2 - Treatment|Death|0|||
143344868|NCT02508532|516808719|FG007|Part 2 - Treatment|Death|0|||
143344869|NCT02508532|516808720|FG008|Part 2 - Treatment|Death|1|||
143344870|NCT02508532|516808712|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
143344871|NCT02508532|516808713|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
143344872|NCT02508532|516808714|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
143344873|NCT02508532|516808715|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
143344874|NCT02508532|516808716|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
143344875|NCT02508532|516808717|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
143344876|NCT02508532|516808718|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
143344877|NCT02508532|516808719|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
143344878|NCT02508532|516808720|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
143344879|NCT02508532|516808712|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
143344880|NCT02508532|516808713|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
143121285|NCT01939223|515987288|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
143121286|NCT01939223|515987289|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
143121287|NCT01939223|515987288|FG000|Overall Study|Disease recurrence (radiological)|1|||
143121288|NCT01939223|515987289|FG001|Overall Study|Disease recurrence (radiological)|3|||
143121289|NCT01939223|515987288|FG000|Overall Study|Study stopped by Sponsor|5|||
143121290|NCT01939223|515987289|FG001|Overall Study|Study stopped by Sponsor|7|||
143121291|NCT01939223|515987288|FG000|Overall Study|Withdrawal by Subject|6|||
143121292|NCT01939223|515987289|FG001|Overall Study|Withdrawal by Subject|0|||
143344881|NCT02508532|516808714|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
143344882|NCT02508532|516808715|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
143344883|NCT02508532|516808716|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
143344884|NCT02508532|516808717|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
143121293|NCT00957424|515987292|FG000|Overall Study|Lost to Follow-up|19|||
143121294|NCT00957424|515987292|FG000|Overall Study|Protocol Violation|3|||
143121295|NCT00957424|515987292|FG000|Overall Study|Withdrawal by Subject|1|||
143121296|NCT02700698|515987293|FG000|Overall Study|Withdrawal by Subject|1|||
143121297|NCT02700698|515987294|FG001|Overall Study|Withdrawal by Subject|0|||
143121298|NCT00703118|515987295|FG000|Overall Study|Adverse Event|1|||
143121299|NCT00703118|515987296|FG001|Overall Study|Adverse Event|2|||
143121300|NCT00703118|515987297|FG002|Overall Study|Adverse Event|2|||
143121301|NCT00703118|515987295|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
143121302|NCT00703118|515987296|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
143121303|NCT00703118|515987297|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
143121304|NCT00703118|515987295|FG000|Overall Study|Lost to Follow-up|6|||
143121305|NCT00703118|515987296|FG001|Overall Study|Lost to Follow-up|4|||
143121306|NCT00703118|515987297|FG002|Overall Study|Lost to Follow-up|4|||
143121307|NCT00703118|515987295|FG000|Overall Study|Withdrawal by Subject|8|||
143121308|NCT00703118|515987296|FG001|Overall Study|Withdrawal by Subject|7|||
143121309|NCT00703118|515987297|FG002|Overall Study|Withdrawal by Subject|13|||
143121310|NCT00703118|515987295|FG000|Overall Study|Other|0|||
143121311|NCT00703118|515987296|FG001|Overall Study|Other|0|||
143121312|NCT00703118|515987297|FG002|Overall Study|Other|1|||
143121313|NCT04165135|515987298|FG000|Overall Study|Protocol Violation|10|||
143121314|NCT04165135|515987298|FG000|Overall Study|Participants withdrawal of consent|5|||
143121315|NCT03913104|515987301|FG000|Overall Study|Lost to Follow-up|20|||
143121316|NCT03913104|515987301|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
143121317|NCT03913104|515987301|FG000|Overall Study|Withdrawal by Subject|2|||
143121318|NCT01370616|515987302|FG000|Overall Study|Adverse Event|11|||
143121319|NCT01370616|515987303|FG001|Overall Study|Adverse Event|16|||
143121320|NCT01370616|515987302|FG000|Overall Study|Death|1|||
143121321|NCT01370616|515987303|FG001|Overall Study|Death|0|||
143121322|NCT01370616|515987302|FG000|Overall Study|Lack of Efficacy|6|||
143121323|NCT01370616|515987303|FG001|Overall Study|Lack of Efficacy|2|||
143121324|NCT01370616|515987302|FG000|Overall Study|Lost to Follow-up|0|||
143121325|NCT01370616|515987303|FG001|Overall Study|Lost to Follow-up|3|||
143121326|NCT01370616|515987302|FG000|Overall Study|Physician Decision|6|||
143121327|NCT01370616|515987303|FG001|Overall Study|Physician Decision|6|||
143121328|NCT01370616|515987302|FG000|Overall Study|Progressive Disease|0|||
143121329|NCT01370616|515987303|FG001|Overall Study|Progressive Disease|1|||
143121330|NCT01370616|515987302|FG000|Overall Study|Recovery|1|||
143121331|NCT01370616|515987303|FG001|Overall Study|Recovery|0|||
143121332|NCT01370616|515987302|FG000|Overall Study|Technical Problems|3|||
143121333|NCT01370616|515987303|FG001|Overall Study|Technical Problems|5|||
143121334|NCT01370616|515987302|FG000|Overall Study|Withdrawal by Subject|34|||
143121335|NCT01370616|515987303|FG001|Overall Study|Withdrawal by Subject|34|||
143121336|NCT00803205|515987304|FG000|Overall Study|Adverse Event|7|||
143121337|NCT00803205|515987305|FG001|Overall Study|Adverse Event|2|||
143121338|NCT00803205|515987304|FG000|Overall Study|Lost to Follow-up|1|||
143121339|NCT00803205|515987305|FG001|Overall Study|Lost to Follow-up|0|||
143121340|NCT00803205|515987304|FG000|Overall Study|Withdrawal by Subject|9|||
143121341|NCT00803205|515987305|FG001|Overall Study|Withdrawal by Subject|9|||
143121342|NCT00803205|515987304|FG000|Overall Study|Physician Decision|1|||
143121343|NCT00803205|515987305|FG001|Overall Study|Physician Decision|0|||
143121344|NCT00803205|515987304|FG000|Overall Study|Protocol Violation|1|||
143121345|NCT00803205|515987305|FG001|Overall Study|Protocol Violation|1|||
143121346|NCT00803205|515987304|FG000|Overall Study|Medical Monitor Decision|1|||
143121347|NCT00803205|515987305|FG001|Overall Study|Medical Monitor Decision|0|||
143121348|NCT00803205|515987304|FG000|Overall Study|Acquired a Lung Infection|0|||
143121349|NCT00803205|515987305|FG001|Overall Study|Acquired a Lung Infection|1|||
143121350|NCT00803205|515987304|FG000|Overall Study|Sponsor Decision|0|||
143121351|NCT00803205|515987305|FG001|Overall Study|Sponsor Decision|1|||
143121352|NCT02912455|515987308|FG000|Overall Study|Withdrawal by Subject|0|||
143121353|NCT02912455|515987309|FG001|Overall Study|Withdrawal by Subject|1|||
143121354|NCT02912455|515987308|FG000|Overall Study|Lack of Efficacy|0|||
143121355|NCT02912455|515987309|FG001|Overall Study|Lack of Efficacy|1|||
143121356|NCT02912455|515987308|FG000|Overall Study|Lost to Follow-up|2|||
143121357|NCT02912455|515987309|FG001|Overall Study|Lost to Follow-up|1|||
143121358|NCT03742258|515987312|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
143121359|NCT03742258|515987313|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
143121360|NCT03742258|515987314|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
143121361|NCT03742258|515987312|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
143121362|NCT03742258|515987313|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
143121363|NCT03742258|515987314|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
143121364|NCT03742258|515987312|FG000|Survival Follow-Up|Still in Follow-up|0|||
143121365|NCT03742258|515987313|FG001|Survival Follow-Up|Still in Follow-up|0|||
143121366|NCT03742258|515987314|FG002|Survival Follow-Up|Still in Follow-up|2|||
143121367|NCT00564395|515987323|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
143121368|NCT00564395|515987324|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
143121369|NCT00564395|515987323|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
143121370|NCT00564395|515987324|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
143121371|NCT01625689|515987325|FG000|Overall Study|Migration|2|||
143121372|NCT01625689|515987326|FG001|Overall Study|Migration|1|||
143121373|NCT00358956|515987333|FG000|Overall Study|Adverse Event|3|||
143121374|NCT00358956|515987333|FG000|Overall Study|condition under investigation worsened|4|||
143121375|NCT00358956|515987333|FG000|Overall Study|Withdrawal by Subject|1|||
143121376|NCT00628927|515987334|FG000|Overall Study|Problems performing blood draw|6|||
143121377|NCT00628927|515987335|FG001|Overall Study|Problems performing blood draw|0|||
143121378|NCT00628927|515987334|FG000|Overall Study|Lost to Follow-up|1|||
143121379|NCT00628927|515987335|FG001|Overall Study|Lost to Follow-up|0|||
143121380|NCT00628927|515987334|FG000|Overall Study|Equipment failure|1|||
143121381|NCT00628927|515987335|FG001|Overall Study|Equipment failure|0|||
143121382|NCT00422292|515987336|FG000|Overall Study|Serious adverse events|1|||
143121383|NCT00422292|515987337|FG001|Overall Study|Serious adverse events|4|||
143121384|NCT00422292|515987338|FG002|Overall Study|Serious adverse events|0|||
143121385|NCT00422292|515987339|FG003|Overall Study|Serious adverse events|0|||
143121386|NCT00422292|515987336|FG000|Overall Study|Adverse Event|1|||
143121387|NCT00422292|515987337|FG001|Overall Study|Adverse Event|0|||
143121388|NCT00422292|515987338|FG002|Overall Study|Adverse Event|1|||
143121389|NCT00422292|515987339|FG003|Overall Study|Adverse Event|0|||
143121390|NCT00422292|515987336|FG000|Overall Study|Protocol Violation|4|||
143121391|NCT00422292|515987337|FG001|Overall Study|Protocol Violation|25|||
143121392|NCT00422292|515987338|FG002|Overall Study|Protocol Violation|8|||
143121393|NCT00422292|515987339|FG003|Overall Study|Protocol Violation|5|||
143121394|NCT00422292|515987336|FG000|Overall Study|Lost to Follow-up|6|||
143121395|NCT00422292|515987337|FG001|Overall Study|Lost to Follow-up|12|||
143121396|NCT00422292|515987338|FG002|Overall Study|Lost to Follow-up|6|||
143121397|NCT00422292|515987339|FG003|Overall Study|Lost to Follow-up|6|||
143121398|NCT00422292|515987336|FG000|Overall Study|Withdrawal by Subject|6|||
143121399|NCT00422292|515987337|FG001|Overall Study|Withdrawal by Subject|25|||
143121400|NCT00422292|515987338|FG002|Overall Study|Withdrawal by Subject|7|||
143121401|NCT00422292|515987339|FG003|Overall Study|Withdrawal by Subject|13|||
143121402|NCT02440854|515987340|FG000|Overall Study|Relocation of patient|1|||
143121403|NCT02440854|515987340|FG000|Overall Study|Death|6|||
143121404|NCT02440854|515987340|FG000|Overall Study|Lost to Follow-up|10|||
143121405|NCT02440854|515987340|FG000|Overall Study|Afatinib discontinuation|46|||
143121406|NCT02440854|515987340|FG000|Overall Study|stopped study at earlier timepoint|14|||
143121407|NCT02440854|515987340|FG000|Overall Study|Study medication not received|1|||
143121408|NCT02440854|515987340|FG000|Overall Study|Violation of inclusion criteria|2|||
143121409|NCT01298141|515987341|FG000|Overall Study|Adverse Event|3|||
143121410|NCT01298141|515987341|FG000|Overall Study|Refusal of Required Study Procedures|1|||
143121411|NCT01298141|515987341|FG000|Overall Study|Withdrawal by Subject|6|||
143121412|NCT01298141|515987341|FG000|Overall Study|Termination of Study by the Investigator|5|||
143121413|NCT01298141|515987341|FG000|Overall Study|Other|5|||
143121414|NCT01298141|515987341|FG000|Overall Study|Lost to Follow-up|1|||
143121415|NCT01298141|515987341|FG000|Overall Study|Death|6|||
143121416|NCT01298141|515987341|FG000|Overall Study|Not treated|4|||
143121417|NCT02243046|515987342|FG000|Overall Study|Lost to Follow-up|1|||
143121418|NCT02243046|515987343|FG001|Overall Study|Lost to Follow-up|1|||
143121419|NCT02243046|515987344|FG002|Overall Study|Lost to Follow-up|4|||
143121420|NCT03338569|515987345|FG000|Overall Study|Physician Decision|8|||
143121421|NCT03338569|515987346|FG001|Overall Study|Physician Decision|3|||
143121422|NCT03338569|515987345|FG000|Overall Study|Withdrawal by Subject|0|||
143121423|NCT03338569|515987346|FG001|Overall Study|Withdrawal by Subject|1|||
143121424|NCT03338569|515987345|FG000|Overall Study|Lost to Follow-up|0|||
143121425|NCT03338569|515987346|FG001|Overall Study|Lost to Follow-up|1|||
143121426|NCT04607980|515987347|FG000|Overall Study|Adverse Event|3|||
143121427|NCT04607980|515987348|FG001|Overall Study|Adverse Event|4|||
143121428|NCT04607980|515987347|FG000|Overall Study|Death|0|||
143121429|NCT04607980|515987348|FG001|Overall Study|Death|1|||
143121430|NCT04607980|515987347|FG000|Overall Study|Withdrawal by Subject|2|||
143344885|NCT02508532|516808718|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
143121431|NCT04607980|515987348|FG001|Overall Study|Withdrawal by Subject|5|||
143121432|NCT04607980|515987347|FG000|Overall Study|Lost to Follow-up|4|||
143121433|NCT04607980|515987348|FG001|Overall Study|Lost to Follow-up|8|||
143121434|NCT04607980|515987347|FG000|Overall Study|Protocol Violation|0|||
143121435|NCT04607980|515987348|FG001|Overall Study|Protocol Violation|3|||
143121436|NCT04607980|515987347|FG000|Overall Study|Other|3|||
143121437|NCT04607980|515987348|FG001|Overall Study|Other|0|||
143121438|NCT02669082|515987349|FG000|Overall Study|Adverse Event|1|||
143121439|NCT01854879|515987350|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
143121440|NCT01854879|515987350|FG000|Overall Study|screen fail|3|||
143121441|NCT01854879|515987350|FG000|Overall Study|incomplete data set|1|||
143121442|NCT01687283|515988719|FG000|Overall Study|Adverse Event|11|||
143121443|NCT01687283|515988720|FG001|Overall Study|Adverse Event|4|||
143121444|NCT01687283|515988719|FG000|Overall Study|Lack of Efficacy|3|||
143121445|NCT01687283|515988720|FG001|Overall Study|Lack of Efficacy|1|||
143121446|NCT01687283|515988719|FG000|Overall Study|Protocol Violation|1|||
143121447|NCT01687283|515988720|FG001|Overall Study|Protocol Violation|3|||
143121448|NCT01687283|515988719|FG000|Overall Study|protocol defined stopping criteria|8|||
143121449|NCT01687283|515988720|FG001|Overall Study|protocol defined stopping criteria|10|||
143121450|NCT01687283|515988719|FG000|Overall Study|Lost to Follow-up|1|||
143121451|NCT01687283|515988720|FG001|Overall Study|Lost to Follow-up|1|||
143121452|NCT01687283|515988719|FG000|Overall Study|Investigator discretion|2|||
143121453|NCT01687283|515988720|FG001|Overall Study|Investigator discretion|0|||
143121454|NCT01687283|515988719|FG000|Overall Study|Withdrawal by Subject|9|||
143121455|NCT01687283|515988720|FG001|Overall Study|Withdrawal by Subject|8|||
143121456|NCT01859949|515988724|FG000|Overall Study|Family Matters|0|||
143121457|NCT01859949|515988725|FG001|Overall Study|Family Matters|1|||
143121458|NCT01859949|515988724|FG000|Overall Study|Physician Decision|2|||
143121459|NCT01859949|515988725|FG001|Overall Study|Physician Decision|4|||
143121460|NCT01859949|515988724|FG000|Overall Study|Withdrawal by Subject|11|||
143121461|NCT01859949|515988725|FG001|Overall Study|Withdrawal by Subject|10|||
143121462|NCT01859949|515988724|FG000|Overall Study|Protocol Violation|1|||
143121463|NCT01859949|515988725|FG001|Overall Study|Protocol Violation|1|||
143121464|NCT01859949|515988724|FG000|Overall Study|Adverse Event|0|||
143121465|NCT01859949|515988725|FG001|Overall Study|Adverse Event|1|||
143121466|NCT01344759|515988726|FG000|Overall Study|Patients failed to reach sedation level|0|||
143121467|NCT01344759|515988727|FG001|Overall Study|Patients failed to reach sedation level|2|||
143121468|NCT01153009|515988728|FG000|Overall Study|Adverse Event|4|||
143121469|NCT01153009|515988729|FG001|Overall Study|Adverse Event|14|||
143121470|NCT01153009|515988730|FG002|Overall Study|Adverse Event|14|||
143121471|NCT01153009|515988731|FG003|Overall Study|Adverse Event|10|||
143121472|NCT01153009|515988728|FG000|Overall Study|Lack of Efficacy|9|||
143121473|NCT01153009|515988729|FG001|Overall Study|Lack of Efficacy|0|||
143121474|NCT01153009|515988730|FG002|Overall Study|Lack of Efficacy|2|||
143121475|NCT01153009|515988731|FG003|Overall Study|Lack of Efficacy|1|||
143121476|NCT01153009|515988728|FG000|Overall Study|Noncompliance with Study Medication|1|||
143121477|NCT01153009|515988729|FG001|Overall Study|Noncompliance with Study Medication|3|||
143121478|NCT01153009|515988730|FG002|Overall Study|Noncompliance with Study Medication|4|||
143121479|NCT01153009|515988731|FG003|Overall Study|Noncompliance with Study Medication|1|||
143121480|NCT01153009|515988728|FG000|Overall Study|Protocol Deviations|4|||
143121481|NCT01153009|515988729|FG001|Overall Study|Protocol Deviations|3|||
143121482|NCT01153009|515988730|FG002|Overall Study|Protocol Deviations|3|||
143121483|NCT01153009|515988731|FG003|Overall Study|Protocol Deviations|2|||
143121484|NCT01153009|515988728|FG000|Overall Study|Withdrawal of Consent|5|||
143121485|NCT01153009|515988729|FG001|Overall Study|Withdrawal of Consent|5|||
143121486|NCT01153009|515988730|FG002|Overall Study|Withdrawal of Consent|4|||
143121487|NCT01153009|515988731|FG003|Overall Study|Withdrawal of Consent|6|||
143121488|NCT01153009|515988728|FG000|Overall Study|Lost to Follow-up|8|||
143121489|NCT01153009|515988729|FG001|Overall Study|Lost to Follow-up|8|||
143121490|NCT01153009|515988730|FG002|Overall Study|Lost to Follow-up|11|||
143121491|NCT01153009|515988731|FG003|Overall Study|Lost to Follow-up|15|||
143121492|NCT01153009|515988728|FG000|Overall Study|Other|1|||
143121493|NCT01153009|515988729|FG001|Overall Study|Other|1|||
143121494|NCT01153009|515988730|FG002|Overall Study|Other|3|||
143121495|NCT01153009|515988731|FG003|Overall Study|Other|2|||
143121496|NCT00410072|515988732|FG000|Day 1 to Week 48|Adverse Event|1|||
143121497|NCT00410072|515988733|FG001|Day 1 to Week 48|Adverse Event|2|||
143121498|NCT00410072|515988732|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
143121499|NCT00410072|515988733|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
143121500|NCT00410072|515988732|FG000|Day 1 to Week 48|Other|0|||
143121501|NCT00410072|515988733|FG001|Day 1 to Week 48|Other|1|||
143121502|NCT00410072|515988732|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
143121503|NCT00410072|515988733|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
143121504|NCT00410072|515988732|FG000|Day 1 to Week 48|Pregnancy|0|||
143121505|NCT00410072|515988733|FG001|Day 1 to Week 48|Pregnancy|2|||
143344886|NCT02508532|516808719|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
143344887|NCT02508532|516808720|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
143121506|NCT00410072|515988732|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
143121507|NCT00410072|515988733|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
143121508|NCT00410072|515988732|FG000|After Week 48 to Week 96|Adverse Event|1|||
143344888|NCT02508532|516808712|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
143121509|NCT00410072|515988733|FG001|After Week 48 to Week 96|Adverse Event|2|||
143121510|NCT00410072|515988732|FG000|After Week 48 to Week 96|Death|0|||
143121511|NCT00410072|515988733|FG001|After Week 48 to Week 96|Death|1|||
143121512|NCT00410072|515988732|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
143121513|NCT00410072|515988733|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
143121514|NCT00410072|515988732|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
143121515|NCT00410072|515988733|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
143121516|NCT00410072|515988732|FG000|After Week 48 to Week 96|Other|2|||
143121517|NCT00410072|515988733|FG001|After Week 48 to Week 96|Other|0|||
143121518|NCT00410072|515988732|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
143121519|NCT00410072|515988733|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
143121520|NCT00410072|515988732|FG000|After Week 48 to Week 96|Pregnancy|0|||
143121521|NCT00410072|515988733|FG001|After Week 48 to Week 96|Pregnancy|2|||
143121522|NCT00410072|515988732|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
143121523|NCT00410072|515988733|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
143121524|NCT00433017|515988737|FG000|Overall Study|Adverse Event|5|||
143121525|NCT00433017|515988738|FG001|Overall Study|Adverse Event|3|||
143121526|NCT00433017|515988737|FG000|Overall Study|Withdrawal by Subject|4|||
143121527|NCT00433017|515988738|FG001|Overall Study|Withdrawal by Subject|5|||
143121528|NCT00433017|515988737|FG000|Overall Study|Lost to Follow-up|3|||
143121529|NCT00433017|515988738|FG001|Overall Study|Lost to Follow-up|4|||
143121530|NCT00433017|515988737|FG000|Overall Study|Administrative problems|80|||
143121531|NCT00433017|515988738|FG001|Overall Study|Administrative problems|86|||
143121532|NCT00433017|515988737|FG000|Overall Study|Protocol Violation|1|||
143121533|NCT00433017|515988738|FG001|Overall Study|Protocol Violation|0|||
143121534|NCT00433017|515988737|FG000|Overall Study|Death|2|||
143121535|NCT00433017|515988738|FG001|Overall Study|Death|2|||
143121536|NCT00433017|515988737|FG000|Overall Study|Subject no longer requires study drug|1|||
143121537|NCT00433017|515988738|FG001|Overall Study|Subject no longer requires study drug|1|||
143121538|NCT04575584|515988745|FG000|Overall Study|Death|6|||
143121539|NCT04575584|515988746|FG001|Overall Study|Death|4|||
143121540|NCT04575584|515988747|FG002|Overall Study|Death|6|||
143121541|NCT04575584|515988748|FG003|Overall Study|Death|2|||
143121542|NCT04575584|515988749|FG004|Overall Study|Death|0|||
143121543|NCT04575584|515988750|FG005|Overall Study|Death|0|||
143121544|NCT04575584|515988745|FG000|Overall Study|Lost to Follow-up|1|||
143121545|NCT04575584|515988746|FG001|Overall Study|Lost to Follow-up|1|||
143121546|NCT04575584|515988747|FG002|Overall Study|Lost to Follow-up|1|||
143344889|NCT02508532|516808713|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
143344890|NCT02508532|516808714|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
143344891|NCT02508532|516808715|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
143344892|NCT02508532|516808716|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
143344893|NCT02508532|516808717|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
143344894|NCT02508532|516808718|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
143344895|NCT02508532|516808719|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
143344896|NCT02508532|516808720|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
143344897|NCT02508532|516808712|FG000|Part 1 and Part 2 End of Study|Death|0|||
143344898|NCT02508532|516808713|FG001|Part 1 and Part 2 End of Study|Death|4|||
143344899|NCT02508532|516808714|FG002|Part 1 and Part 2 End of Study|Death|2|||
143344900|NCT02508532|516808715|FG003|Part 1 and Part 2 End of Study|Death|4|||
143344901|NCT02508532|516808716|FG004|Part 1 and Part 2 End of Study|Death|3|||
143344902|NCT02508532|516808717|FG005|Part 1 and Part 2 End of Study|Death|0|||
143344903|NCT02508532|516808718|FG006|Part 1 and Part 2 End of Study|Death|0|||
143344904|NCT02508532|516808719|FG007|Part 1 and Part 2 End of Study|Death|1|||
143344905|NCT02508532|516808720|FG008|Part 1 and Part 2 End of Study|Death|111|||
143344906|NCT02508532|516808712|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
143344907|NCT02508532|516808713|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
143344908|NCT02508532|516808714|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
143344909|NCT02508532|516808715|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
143344910|NCT02508532|516808716|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
143344911|NCT02508532|516808717|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
143344912|NCT02508532|516808718|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
143344913|NCT02508532|516808719|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
143344914|NCT02508532|516808720|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
143344915|NCT02508532|516808712|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
143344916|NCT02508532|516808713|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
143344917|NCT02508532|516808714|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
143344918|NCT02508532|516808715|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
143344919|NCT02508532|516808716|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
143344920|NCT02508532|516808717|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
143344921|NCT02508532|516808718|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
143344922|NCT02508532|516808719|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
143344923|NCT02508532|516808720|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
143344924|NCT02508532|516808712|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
143344925|NCT02508532|516808713|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
143344926|NCT02508532|516808714|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
143344927|NCT02508532|516808715|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
143344928|NCT02508532|516808716|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
143344929|NCT02508532|516808717|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
143344930|NCT02508532|516808718|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
143344931|NCT02508532|516808719|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
143121547|NCT04575584|515988748|FG003|Overall Study|Lost to Follow-up|1|||
143121548|NCT04575584|515988749|FG004|Overall Study|Lost to Follow-up|0|||
143121549|NCT04575584|515988750|FG005|Overall Study|Lost to Follow-up|0|||
143121550|NCT04575584|515988745|FG000|Overall Study|Physician Decision|0|||
143121551|NCT04575584|515988746|FG001|Overall Study|Physician Decision|1|||
143121552|NCT04575584|515988747|FG002|Overall Study|Physician Decision|1|||
143121553|NCT04575584|515988748|FG003|Overall Study|Physician Decision|1|||
143121554|NCT04575584|515988749|FG004|Overall Study|Physician Decision|0|||
143121555|NCT04575584|515988750|FG005|Overall Study|Physician Decision|0|||
143121556|NCT04575584|515988745|FG000|Overall Study|Withdrawal by Subject|7|||
143121557|NCT04575584|515988746|FG001|Overall Study|Withdrawal by Subject|9|||
143121558|NCT04575584|515988747|FG002|Overall Study|Withdrawal by Subject|5|||
143121559|NCT04575584|515988748|FG003|Overall Study|Withdrawal by Subject|3|||
143121560|NCT04575584|515988749|FG004|Overall Study|Withdrawal by Subject|0|||
143121561|NCT04575584|515988750|FG005|Overall Study|Withdrawal by Subject|0|||
143121562|NCT04575584|515988745|FG000|Overall Study|Not recorded|0|||
143121563|NCT04575584|515988746|FG001|Overall Study|Not recorded|0|||
143121564|NCT04575584|515988747|FG002|Overall Study|Not recorded|0|||
143121565|NCT04575584|515988748|FG003|Overall Study|Not recorded|1|||
143121566|NCT04575584|515988749|FG004|Overall Study|Not recorded|0|||
143121567|NCT04575584|515988750|FG005|Overall Study|Not recorded|0|||
143121568|NCT02634801|515988751|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
143121569|NCT02634801|515988752|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
143121570|NCT02634801|515988753|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
143121571|NCT02634801|515988751|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
143121572|NCT02634801|515988752|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
143121573|NCT02634801|515988753|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
143121574|NCT02634801|515988751|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
143121575|NCT02634801|515988752|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
143121576|NCT02634801|515988753|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
143121577|NCT02634801|515988751|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
143121578|NCT02634801|515988752|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
143121579|NCT02634801|515988753|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
143121580|NCT02634801|515988751|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
143121581|NCT02634801|515988752|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
143121582|NCT02634801|515988753|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
143121583|NCT02634801|515988751|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
143121584|NCT02634801|515988752|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
143121585|NCT02634801|515988753|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
143121586|NCT02634801|515988751|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
143121587|NCT02634801|515988752|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
143121588|NCT02634801|515988753|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
143121589|NCT02634801|515988751|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
143121590|NCT02634801|515988752|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
143121591|NCT02634801|515988753|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
143121592|NCT02634801|515988751|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
143121593|NCT02634801|515988752|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
143121594|NCT02634801|515988753|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
143121595|NCT02634801|515988751|FG000|Follow-up Period|Lost to Follow-up|3|||
143121596|NCT02634801|515988752|FG001|Follow-up Period|Lost to Follow-up|1|||
143121597|NCT02634801|515988753|FG002|Follow-up Period|Lost to Follow-up|2|||
143121598|NCT02634801|515988751|FG000|Follow-up Period|Physician Decision|0|||
143121599|NCT02634801|515988752|FG001|Follow-up Period|Physician Decision|0|||
143121600|NCT02634801|515988753|FG002|Follow-up Period|Physician Decision|1|||
143121601|NCT02634801|515988751|FG000|Follow-up Period|Withdrawal by Subject|1|||
143121602|NCT02634801|515988752|FG001|Follow-up Period|Withdrawal by Subject|2|||
143121603|NCT02634801|515988753|FG002|Follow-up Period|Withdrawal by Subject|5|||
143121604|NCT02634801|515988751|FG000|Follow-up Period|Adverse Event|1|||
143121605|NCT02634801|515988752|FG001|Follow-up Period|Adverse Event|5|||
143121606|NCT02634801|515988753|FG002|Follow-up Period|Adverse Event|0|||
143121607|NCT02335346|515988754|FG000|Overall Study|Adverse Event|11|||
143121608|NCT02335346|515988754|FG000|Overall Study|Withdrawal by Subject|1|||
143121609|NCT03594955|515988755|FG000|Overall Study|Adverse Event|1|||
143121610|NCT03594955|515988755|FG000|Overall Study|Progressive disease|5|||
143121611|NCT03594955|515988755|FG000|Overall Study|Sponsor's decision|1|||
143121612|NCT00560703|515988757|FG000|Overall Study|Adverse Event|0|||
143121613|NCT00560703|515988758|FG001|Overall Study|Adverse Event|2|||
143121614|NCT00560703|515988757|FG000|Overall Study|Protocol Violation|0|||
143121615|NCT00560703|515988758|FG001|Overall Study|Protocol Violation|2|||
143121616|NCT00560703|515988757|FG000|Overall Study|Withdrawal by Subject|0|||
143121617|NCT00560703|515988758|FG001|Overall Study|Withdrawal by Subject|1|||
143121618|NCT00560703|515988757|FG000|Overall Study|non-compliance|0|||
143121619|NCT00560703|515988758|FG001|Overall Study|non-compliance|1|||
143121620|NCT05600036|515988760|FG000|Overall Study|Adverse Event|0|||
143121621|NCT05600036|515988761|FG001|Overall Study|Adverse Event|2|||
143121622|NCT05600036|515988762|FG002|Overall Study|Adverse Event|1|||
143121623|NCT05600036|515988763|FG003|Overall Study|Adverse Event|0|||
143121624|NCT05600036|515988764|FG004|Overall Study|Adverse Event|1|||
143121625|NCT05600036|515988765|FG005|Overall Study|Adverse Event|0|||
143344932|NCT02508532|516808720|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
143344933|NCT02508532|516808712|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
143344934|NCT02508532|516808713|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
143344935|NCT02508532|516808714|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
143121626|NCT05600036|515988760|FG000|Overall Study|Lost to Follow-up|0|||
143121627|NCT05600036|515988761|FG001|Overall Study|Lost to Follow-up|2|||
143121628|NCT05600036|515988762|FG002|Overall Study|Lost to Follow-up|1|||
143344936|NCT02508532|516808715|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
143344937|NCT02508532|516808716|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
143344938|NCT02508532|516808717|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
143344939|NCT02508532|516808718|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
143344940|NCT02508532|516808719|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
143344941|NCT02508532|516808720|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
143344942|NCT02508532|516808712|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
143344943|NCT02508532|516808713|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
143344944|NCT02508532|516808714|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
143344945|NCT02508532|516808715|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
143344946|NCT02508532|516808716|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
143344947|NCT02508532|516808717|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
143344948|NCT02508532|516808718|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
143344949|NCT02508532|516808719|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
143344950|NCT02508532|516808720|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
143344951|NCT00301080|516808723|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
143344952|NCT00301080|516808724|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
143344953|NCT00301080|516808725|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
143344954|NCT00301080|516808726|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
143344955|NCT00301080|516808727|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
143344956|NCT03502616|516808728|FG000|Up to Week 16|Withdrawal by Subject|1|||
143344957|NCT03502616|516808729|FG001|Up to Week 16|Withdrawal by Subject|2|||
143344958|NCT03502616|516808728|FG000|Up to Week 16|Lost to Follow-up|0|||
143344959|NCT03502616|516808729|FG001|Up to Week 16|Lost to Follow-up|1|||
143344960|NCT03502616|516808728|FG000|Up to Week 16|Randomized, but not treated|1|||
143344961|NCT03502616|516808729|FG001|Up to Week 16|Randomized, but not treated|0|||
143344962|NCT03502616|516808728|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
143344963|NCT03502616|516808729|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
143344964|NCT03502616|516808728|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
143344965|NCT03502616|516808729|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
143344966|NCT01691521|516808730|FG000|Overall Study|Adverse Event|4|||
143344967|NCT01691521|516808731|FG001|Overall Study|Adverse Event|0|||
143344968|NCT01691521|516808732|FG002|Overall Study|Adverse Event|1|||
143344969|NCT01691521|516808730|FG000|Overall Study|Lack of Efficacy|1|||
143344970|NCT01691521|516808731|FG001|Overall Study|Lack of Efficacy|1|||
143344971|NCT01691521|516808732|FG002|Overall Study|Lack of Efficacy|2|||
143344972|NCT01691521|516808730|FG000|Overall Study|Protocol Violation|0|||
143344973|NCT01691521|516808731|FG001|Overall Study|Protocol Violation|3|||
143344974|NCT01691521|516808732|FG002|Overall Study|Protocol Violation|0|||
143344975|NCT01691521|516808730|FG000|Overall Study|Lost to Follow-up|0|||
143344976|NCT01691521|516808731|FG001|Overall Study|Lost to Follow-up|2|||
143344977|NCT01691521|516808732|FG002|Overall Study|Lost to Follow-up|2|||
143344978|NCT01691521|516808730|FG000|Overall Study|Physician Decision|2|||
143344979|NCT01691521|516808731|FG001|Overall Study|Physician Decision|1|||
143344980|NCT01691521|516808732|FG002|Overall Study|Physician Decision|0|||
143344981|NCT01691521|516808730|FG000|Overall Study|Withdrawal by Subject|5|||
143344982|NCT01691521|516808731|FG001|Overall Study|Withdrawal by Subject|9|||
143344983|NCT01691521|516808732|FG002|Overall Study|Withdrawal by Subject|4|||
143344984|NCT01480596|516808735|FG000|Overall Study|Adverse Event|3|||
143121629|NCT05600036|515988763|FG003|Overall Study|Lost to Follow-up|1|||
143121630|NCT05600036|515988764|FG004|Overall Study|Lost to Follow-up|0|||
143121631|NCT05600036|515988765|FG005|Overall Study|Lost to Follow-up|0|||
143121632|NCT05600036|515988760|FG000|Overall Study|Protocol Violation|0|||
143121633|NCT05600036|515988761|FG001|Overall Study|Protocol Violation|0|||
143121634|NCT05600036|515988762|FG002|Overall Study|Protocol Violation|2|||
143121635|NCT05600036|515988763|FG003|Overall Study|Protocol Violation|0|||
143121636|NCT05600036|515988764|FG004|Overall Study|Protocol Violation|0|||
143121637|NCT05600036|515988765|FG005|Overall Study|Protocol Violation|0|||
143121638|NCT05600036|515988760|FG000|Overall Study|Withdrawal by Subject|0|||
143121639|NCT05600036|515988761|FG001|Overall Study|Withdrawal by Subject|1|||
143121640|NCT05600036|515988762|FG002|Overall Study|Withdrawal by Subject|2|||
143121641|NCT05600036|515988763|FG003|Overall Study|Withdrawal by Subject|0|||
143121642|NCT05600036|515988764|FG004|Overall Study|Withdrawal by Subject|3|||
143121643|NCT05600036|515988765|FG005|Overall Study|Withdrawal by Subject|5|||
143121644|NCT05600036|515988760|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
143121645|NCT05600036|515988761|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
143121646|NCT05600036|515988762|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
143121647|NCT05600036|515988763|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
143121648|NCT05600036|515988764|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
143121649|NCT05600036|515988765|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
143121650|NCT05600036|515988760|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
143121651|NCT05600036|515988761|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
143121652|NCT05600036|515988762|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
143121653|NCT05600036|515988763|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
143121654|NCT05600036|515988764|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
143121655|NCT05600036|515988765|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
143121656|NCT05600036|515988760|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
143121657|NCT05600036|515988761|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
143121658|NCT05600036|515988762|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
143121659|NCT05600036|515988763|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
143121660|NCT05600036|515988764|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
143121661|NCT05600036|515988765|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
143121662|NCT04401202|515988766|FG000|Overall Study|Lost to Follow-up|2|||
143121663|NCT04401202|515988767|FG001|Overall Study|Lost to Follow-up|2|||
143121664|NCT04401202|515988766|FG000|Overall Study|Adverse Event|0|||
143121665|NCT04401202|515988767|FG001|Overall Study|Adverse Event|1|||
143121666|NCT04401202|515988766|FG000|Overall Study|Hospitalized|4|||
143121667|NCT04401202|515988767|FG001|Overall Study|Hospitalized|1|||
143121668|NCT05053035|515988775|FG000|Overall Study|Withdrawal by Subject|1|||
143121669|NCT05053035|515988776|FG001|Overall Study|Withdrawal by Subject|0|||
143121670|NCT02005627|515988780|FG000|Overall Study|Lost to Follow-up|1|||
143121671|NCT02005627|515988781|FG001|Overall Study|Lost to Follow-up|2|||
143121672|NCT02005627|515988780|FG000|Overall Study|Withdrawal by Subject|1|||
143121673|NCT02005627|515988781|FG001|Overall Study|Withdrawal by Subject|2|||
143121674|NCT03003000|515988790|FG000|Overall Study|Adverse Event|1|||
143121675|NCT03003000|515988791|FG001|Overall Study|Adverse Event|2|||
143121676|NCT03003000|515988792|FG002|Overall Study|Adverse Event|3|||
143121677|NCT03003000|515988790|FG000|Overall Study|Lack of Efficacy|1|||
143121678|NCT03003000|515988791|FG001|Overall Study|Lack of Efficacy|0|||
143121679|NCT03003000|515988792|FG002|Overall Study|Lack of Efficacy|0|||
143121680|NCT03003000|515988790|FG000|Overall Study|Non-compliant with protocol|0|||
143121681|NCT03003000|515988791|FG001|Overall Study|Non-compliant with protocol|1|||
143121682|NCT03003000|515988792|FG002|Overall Study|Non-compliant with protocol|1|||
143121683|NCT03003000|515988790|FG000|Overall Study|Refused to continue medication|2|||
143121684|NCT03003000|515988791|FG001|Overall Study|Refused to continue medication|0|||
143121685|NCT03003000|515988792|FG002|Overall Study|Refused to continue medication|0|||
143121686|NCT03003000|515988790|FG000|Overall Study|Other than listed|1|||
143121687|NCT03003000|515988791|FG001|Overall Study|Other than listed|1|||
143121688|NCT03003000|515988792|FG002|Overall Study|Other than listed|1|||
143121689|NCT00048997|515988795|FG000|Overall Study|Protocol Violation|7|||
143121690|NCT00048997|515988796|FG001|Overall Study|Protocol Violation|2|||
143121691|NCT00048997|515988795|FG000|Overall Study|Withdrawal by Subject|6|||
143121692|NCT00048997|515988796|FG001|Overall Study|Withdrawal by Subject|1|||
143121693|NCT00048165|515988797|FG000|Completed 6 Months Study|Administration/Other|8|||
143121694|NCT00048165|515988798|FG001|Completed 6 Months Study|Administration/Other|8|||
143121695|NCT00048165|515988797|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
143121696|NCT00048165|515988798|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
143121697|NCT00048165|515988797|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
143121698|NCT00048165|515988798|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
143121699|NCT00048165|515988797|FG000|Completed 6 Months Study|Death|12|||
143121700|NCT00048165|515988798|FG001|Completed 6 Months Study|Death|6|||
143121701|NCT00048165|515988797|FG000|Completed 6 Months Study|Insufficient therapy|1|||
143121702|NCT00048165|515988798|FG001|Completed 6 Months Study|Insufficient therapy|4|||
143121703|NCT00048165|515988797|FG000|Completed 6 Months Study|Other violation|4|||
143121704|NCT00048165|515988798|FG001|Completed 6 Months Study|Other violation|6|||
143121705|NCT00048165|515988797|FG000|Completed 6 Months Study|Refused treatment|5|||
143121706|NCT00048165|515988798|FG001|Completed 6 Months Study|Refused treatment|5|||
143121707|NCT00048165|515988797|FG000|Completed 6 Months Study|Violation criteria|0|||
143121708|NCT00048165|515988798|FG001|Completed 6 Months Study|Violation criteria|2|||
143121709|NCT00048165|515988797|FG000|Completed 6 Months Study|Did not receive study drug|6|||
143121710|NCT00048165|515988798|FG001|Completed 6 Months Study|Did not receive study drug|6|||
143121711|NCT00048165|515988797|FG000|Completed 12 Months Study|Administration/Other|0|||
143121712|NCT00048165|515988798|FG001|Completed 12 Months Study|Administration/Other|2|||
143121713|NCT00048165|515988797|FG000|Completed 12 Months Study|Death|2|||
143121714|NCT00048165|515988798|FG001|Completed 12 Months Study|Death|1|||
143121715|NCT00048165|515988797|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
143121716|NCT00048165|515988798|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
143121717|NCT02112877|515988799|FG000|Overall Study|Withdrawal by Subject|1|||
143121718|NCT02112877|515988800|FG001|Overall Study|Withdrawal by Subject|7|||
143121719|NCT02112877|515988799|FG000|Overall Study|Visit Missed|1|||
143121720|NCT02112877|515988800|FG001|Overall Study|Visit Missed|6|||
143121721|NCT01693185|515988801|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
143121722|NCT01693185|515988802|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
143121723|NCT01084538|515988811|FG000|Overall Study|Drug not available|30|||
143121724|NCT01084538|515988811|FG000|Overall Study|Adverse Event|9|||
143121725|NCT01084538|515988811|FG000|Overall Study|Kidney transplant|6|||
143121726|NCT01084538|515988811|FG000|Overall Study|Serious Adverse Event|3|||
143121727|NCT01084538|515988811|FG000|Overall Study|Lack of effectiveness|2|||
143121728|NCT01084538|515988811|FG000|Overall Study|Patient noncompliance|2|||
143121729|NCT01084538|515988811|FG000|Overall Study|Hyperphosphatemia|2|||
143121730|NCT01084538|515988811|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
143121731|NCT01084538|515988811|FG000|Overall Study|Change of residence|2|||
143121732|NCT01084538|515988811|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
143121733|NCT01084538|515988811|FG000|Overall Study|Reason unknown|8|||
143121734|NCT01429441|515988812|FG000|Overall Study|Adverse Event|5|||
143121735|NCT01429441|515988813|FG001|Overall Study|Adverse Event|1|||
143121736|NCT01429441|515988812|FG000|Overall Study|Death|0|||
143121737|NCT01429441|515988813|FG001|Overall Study|Death|2|||
143121738|NCT01429441|515988812|FG000|Overall Study|Lost to Follow-up|5|||
143121739|NCT01429441|515988813|FG001|Overall Study|Lost to Follow-up|2|||
143121740|NCT01429441|515988812|FG000|Overall Study|Physician Decision|1|||
143121741|NCT01429441|515988813|FG001|Overall Study|Physician Decision|0|||
143121742|NCT01429441|515988812|FG000|Overall Study|Withdrawal by Subject|27|||
143121743|NCT01429441|515988813|FG001|Overall Study|Withdrawal by Subject|18|||
143121744|NCT00380718|515988820|FG000|Overall Study|Adverse Event|1|||
143121745|NCT00380718|515988820|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
143121746|NCT01706575|515988821|FG000|Overall Study|Participant Withdrew Consent|4|||
143121747|NCT01706575|515988821|FG000|Overall Study|Lost to Follow-up|2|||
143121748|NCT01706575|515988821|FG000|Overall Study|Started but not Treated|6|||
143121749|NCT03084315|515988822|FG000|Overall Study|Lost to Follow-up|8|||
143121750|NCT03084315|515988823|FG001|Overall Study|Lost to Follow-up|7|||
143121751|NCT03084315|515988822|FG000|Overall Study|Withdrawal by Subject|2|||
143121752|NCT03084315|515988823|FG001|Overall Study|Withdrawal by Subject|2|||
143121753|NCT02906033|515988825|FG000|Baseline|Protocol Violation|37|||
143121754|NCT02906033|515988826|FG001|Baseline|Protocol Violation|33|||
143121755|NCT02906033|515988825|FG000|Follow-up|Lost to Follow-up|46|||
143121756|NCT02906033|515988826|FG001|Follow-up|Lost to Follow-up|62|||
143121757|NCT01810783|515988831|FG000|Overall Study|Adverse Event|32|||
143121758|NCT01810783|515988831|FG000|Overall Study|Withdrawal by Subject|22|||
143121759|NCT01810783|515988831|FG000|Overall Study|Lack of Efficacy|12|||
143121760|NCT01810783|515988831|FG000|Overall Study|Lost to Follow-up|10|||
143121761|NCT01810783|515988831|FG000|Overall Study|Protocol Violation|5|||
143121762|NCT01810783|515988831|FG000|Overall Study|Non-compliance with IMP|4|||
143121763|NCT01810783|515988831|FG000|Overall Study|Adminstrative or other reason(s)|23|||
143121764|NCT01810783|515988831|FG000|Overall Study|Enrolled, not treated|1|||
143121765|NCT02655419|515988836|FG000|Overall Study|Enrolled but not treated|1|||
143121766|NCT02655419|515988837|FG001|Overall Study|Enrolled but not treated|5|||
143121767|NCT02655419|515988836|FG000|Overall Study|Withdrawal by Subject|4|||
143121768|NCT02655419|515988837|FG001|Overall Study|Withdrawal by Subject|1|||
143121769|NCT02655419|515988836|FG000|Overall Study|Other|0|||
143121770|NCT02655419|515988837|FG001|Overall Study|Other|1|||
143121771|NCT00094536|515988838|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
143121772|NCT00094536|515988838|FG000|Treatment and Follow-up|Adverse Event|4|||
143121773|NCT00094536|515988838|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
143121774|NCT00094536|515988838|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
143121775|NCT00094536|515988838|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
143121776|NCT00094536|515988838|FG000|Treatment and Follow-up|Subject non-compliance|9|||
143121777|NCT00094536|515988838|FG000|Treatment and Follow-up|Unable to attend visits|1|||
143121778|NCT02071082|515988839|FG000|Overall Study|Enrolled and Never Treated|1|||
143121779|NCT02071082|515988840|FG001|Overall Study|Enrolled and Never Treated|1|||
143121780|NCT02071082|515988839|FG000|Overall Study|Adverse Event|0|||
143121781|NCT02071082|515988840|FG001|Overall Study|Adverse Event|1|||
143121782|NCT02071082|515988839|FG000|Overall Study|Withdrew Consent|0|||
143121783|NCT02071082|515988840|FG001|Overall Study|Withdrew Consent|4|||
143121784|NCT02071082|515988839|FG000|Overall Study|Lost to Follow-up|1|||
143121785|NCT02071082|515988840|FG001|Overall Study|Lost to Follow-up|1|||
143121786|NCT04503668|515988841|FG000|Overall Study|Incomplete data|4|||
143121787|NCT04503668|515988842|FG001|Overall Study|Incomplete data|3|||
143121788|NCT04503668|515988841|FG000|Overall Study|Withdrawal by Subject|1|||
143121789|NCT04503668|515988842|FG001|Overall Study|Withdrawal by Subject|1|||
143121790|NCT04503668|515988841|FG000|Overall Study|Adverse Event|2|||
143121791|NCT04503668|515988842|FG001|Overall Study|Adverse Event|0|||
143121792|NCT03403621|515988843|FG000|Overall Study|Withdrawal by Subject|2|||
143344985|NCT01480596|516808736|FG001|Overall Study|Adverse Event|0|||
143344986|NCT01480596|516808735|FG000|Overall Study|MG exacerbation or change in medication|2|||
143344987|NCT01480596|516808736|FG001|Overall Study|MG exacerbation or change in medication|2|||
143344988|NCT01153269|516808738|FG000|Overall Study|Withdrawal by Subject|1|||
143344989|NCT01153269|516808738|FG000|Overall Study|Antiretroviral therapy break|1|||
143344990|NCT00100932|516808739|FG000|Overall Study|Adverse Event|11|||
143344991|NCT00100932|516808740|FG001|Overall Study|Adverse Event|2|||
143344992|NCT00100932|516808739|FG000|Overall Study|Withdrawal by Subject|6|||
143344993|NCT00100932|516808740|FG001|Overall Study|Withdrawal by Subject|0|||
143121793|NCT03403621|515988844|FG001|Overall Study|Withdrawal by Subject|2|||
143344994|NCT00100932|516808739|FG000|Overall Study|Progressive Disease|44|||
143344995|NCT00100932|516808740|FG001|Overall Study|Progressive Disease|18|||
143344996|NCT00100932|516808739|FG000|Overall Study|Physician Decision|7|||
143344997|NCT00100932|516808740|FG001|Overall Study|Physician Decision|5|||
143344998|NCT00100932|516808739|FG000|Overall Study|Other|5|||
143344999|NCT00100932|516808740|FG001|Overall Study|Other|2|||
143345000|NCT02904902|516808746|FG000|Overall Study|Withdrawal by Subject|1|||
143345001|NCT01725386|516808751|FG000|Overall Study|Death|84|||
143345002|NCT01725386|516808752|FG001|Overall Study|Death|40|||
143345003|NCT01725386|516808751|FG000|Overall Study|Lost to Follow-up|81|||
143345004|NCT01725386|516808752|FG001|Overall Study|Lost to Follow-up|6|||
143345005|NCT01725386|516808751|FG000|Overall Study|Withdrawal by Subject|10|||
143345006|NCT01725386|516808752|FG001|Overall Study|Withdrawal by Subject|0|||
143345007|NCT00879996|516808756|FG000|Overall Study|Lost to Follow-up|7|||
143345008|NCT00879996|516808757|FG001|Overall Study|Lost to Follow-up|6|||
143121794|NCT00395642|515988845|FG000|Overall Study|Death|4|||
143121795|NCT00395642|515988845|FG000|Overall Study|Lost to Follow-up|1|||
143121796|NCT00395642|515988845|FG000|Overall Study|Physician Decision|7|||
143121797|NCT00395642|515988845|FG000|Overall Study|Withdrawal by Subject|1|||
143121798|NCT02012959|515988849|FG000|Treatment Phase A|Adverse Event|2|||
143121799|NCT02012959|515988850|FG001|Treatment Phase A|Adverse Event|0|||
143121800|NCT02012959|515988851|FG002|Treatment Phase A|Adverse Event|0|||
143121801|NCT02012959|515988852|FG003|Treatment Phase A|Adverse Event|0|||
143121802|NCT02012959|515988853|FG004|Treatment Phase A|Adverse Event|0|||
143121803|NCT06010732|515990390|FG000|Crossover Period 1|Protocol Violation|0|||
143121804|NCT06010732|515990391|FG001|Crossover Period 1|Protocol Violation|0|||
143121805|NCT06010732|515990392|FG002|Crossover Period 1|Protocol Violation|1|||
143121806|NCT06010732|515990393|FG003|Crossover Period 1|Protocol Violation|0|||
143121807|NCT06010732|515990394|FG004|Crossover Period 1|Protocol Violation|1|||
143121808|NCT06010732|515990395|FG005|Crossover Period 1|Protocol Violation|0|||
143121809|NCT06010732|515990390|FG000|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
143121810|NCT06010732|515990391|FG001|Washout Between Periods 1 and 2|Withdrawal by Subject|1|||
143121811|NCT06010732|515990392|FG002|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
143121812|NCT06010732|515990393|FG003|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
143121813|NCT06010732|515990394|FG004|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
143121814|NCT06010732|515990395|FG005|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
143121815|NCT06010732|515990390|FG000|Crossover Period 2|Adverse Event|0|||
143121816|NCT06010732|515990391|FG001|Crossover Period 2|Adverse Event|1|||
143121817|NCT06010732|515990392|FG002|Crossover Period 2|Adverse Event|0|||
143121818|NCT06010732|515990393|FG003|Crossover Period 2|Adverse Event|0|||
143121819|NCT06010732|515990394|FG004|Crossover Period 2|Adverse Event|0|||
143121820|NCT06010732|515990395|FG005|Crossover Period 2|Adverse Event|0|||
143121821|NCT06010732|515990390|FG000|Crossover Period 2|broken denture|0|||
143121822|NCT06010732|515990391|FG001|Crossover Period 2|broken denture|0|||
143121823|NCT06010732|515990392|FG002|Crossover Period 2|broken denture|1|||
143121824|NCT06010732|515990393|FG003|Crossover Period 2|broken denture|0|||
143121825|NCT06010732|515990394|FG004|Crossover Period 2|broken denture|0|||
143121826|NCT06010732|515990395|FG005|Crossover Period 2|broken denture|0|||
143121827|NCT02722746|515990398|FG000|Overall Study|Withdrawal by Subject|0|||
143345009|NCT00879996|516808756|FG000|Overall Study|non-compliance|6|||
143345010|NCT00879996|516808757|FG001|Overall Study|non-compliance|4|||
143345011|NCT00879996|516808756|FG000|Overall Study|Physician Decision|1|||
143345012|NCT00879996|516808757|FG001|Overall Study|Physician Decision|2|||
143345013|NCT00879996|516808756|FG000|Overall Study|psychiatric problem|0|||
143345014|NCT00879996|516808757|FG001|Overall Study|psychiatric problem|1|||
143345015|NCT00879996|516808756|FG000|Overall Study|put on parole|1|||
143345016|NCT00879996|516808757|FG001|Overall Study|put on parole|0|||
143345017|NCT01216163|516808758|FG000|Overall Study|Withdrawal by Subject|1|||
143345018|NCT01216163|516808759|FG001|Overall Study|Withdrawal by Subject|1|||
143121828|NCT02722746|515990399|FG001|Overall Study|Withdrawal by Subject|1|||
143121829|NCT02722746|515990400|FG002|Overall Study|Withdrawal by Subject|0|||
143121830|NCT02722746|515990398|FG000|Overall Study|Protocol Violation|8|||
143121831|NCT02722746|515990399|FG001|Overall Study|Protocol Violation|4|||
143121832|NCT02722746|515990400|FG002|Overall Study|Protocol Violation|6|||
143121833|NCT01134263|515990405|FG000|Overall Study|Serious adverse event|2|||
143121834|NCT01134263|515990406|FG001|Overall Study|Serious adverse event|1|||
143345019|NCT01216163|516808760|FG002|Overall Study|Withdrawal by Subject|0|||
143121835|NCT01134263|515990407|FG002|Overall Study|Serious adverse event|1|||
143121836|NCT01134263|515990408|FG003|Overall Study|Serious adverse event|1|||
143121837|NCT01134263|515990409|FG004|Overall Study|Serious adverse event|1|||
143121838|NCT01134263|515990405|FG000|Overall Study|Other adverse event|1|||
143121839|NCT01134263|515990406|FG001|Overall Study|Other adverse event|2|||
143121840|NCT01134263|515990407|FG002|Overall Study|Other adverse event|5|||
143121841|NCT01134263|515990408|FG003|Overall Study|Other adverse event|3|||
143121842|NCT01134263|515990409|FG004|Overall Study|Other adverse event|0|||
143121843|NCT01134263|515990405|FG000|Overall Study|Protocol Violation|8|||
143121844|NCT01134263|515990406|FG001|Overall Study|Protocol Violation|7|||
143121845|NCT01134263|515990407|FG002|Overall Study|Protocol Violation|2|||
143121846|NCT01134263|515990408|FG003|Overall Study|Protocol Violation|4|||
143121847|NCT01134263|515990409|FG004|Overall Study|Protocol Violation|2|||
143121848|NCT01134263|515990405|FG000|Overall Study|Lost to Follow-up|4|||
143121849|NCT01134263|515990406|FG001|Overall Study|Lost to Follow-up|3|||
143121850|NCT01134263|515990407|FG002|Overall Study|Lost to Follow-up|5|||
143121851|NCT01134263|515990408|FG003|Overall Study|Lost to Follow-up|3|||
143121852|NCT01134263|515990409|FG004|Overall Study|Lost to Follow-up|1|||
143121853|NCT01134263|515990405|FG000|Overall Study|Withdrawal by Subject|8|||
143121854|NCT01134263|515990406|FG001|Overall Study|Withdrawal by Subject|6|||
143121855|NCT01134263|515990407|FG002|Overall Study|Withdrawal by Subject|16|||
143121856|NCT01134263|515990408|FG003|Overall Study|Withdrawal by Subject|7|||
143121857|NCT01134263|515990409|FG004|Overall Study|Withdrawal by Subject|5|||
143121858|NCT01134263|515990405|FG000|Overall Study|Enrolled, but not treated|1|||
143121859|NCT01134263|515990406|FG001|Overall Study|Enrolled, but not treated|1|||
143121860|NCT01134263|515990407|FG002|Overall Study|Enrolled, but not treated|0|||
143121861|NCT01134263|515990408|FG003|Overall Study|Enrolled, but not treated|1|||
143121862|NCT01134263|515990409|FG004|Overall Study|Enrolled, but not treated|0|||
143121863|NCT01038752|515990410|FG000|Overall Study|Tumor Progression|2|||
143121864|NCT01038752|515990411|FG001|Overall Study|Tumor Progression|2|||
143121865|NCT01038752|515990410|FG000|Overall Study|Lost to Follow-up|3|||
143121866|NCT01038752|515990411|FG001|Overall Study|Lost to Follow-up|3|||
143121867|NCT01618916|515990424|FG000|Overall Study|Adverse Event|1|||
143121868|NCT01618916|515990425|FG001|Overall Study|Adverse Event|0|||
143121869|NCT01618916|515990426|FG002|Overall Study|Adverse Event|0|||
143121870|NCT01618916|515990427|FG003|Overall Study|Adverse Event|0|||
143121871|NCT01618916|515990428|FG004|Overall Study|Adverse Event|0|||
143121872|NCT01618916|515990429|FG005|Overall Study|Adverse Event|0|||
143121873|NCT01618916|515990424|FG000|Overall Study|Withdrawal by Subject|0|||
143121874|NCT01618916|515990425|FG001|Overall Study|Withdrawal by Subject|1|||
143121875|NCT01618916|515990426|FG002|Overall Study|Withdrawal by Subject|1|||
143121876|NCT01618916|515990427|FG003|Overall Study|Withdrawal by Subject|0|||
143121877|NCT01618916|515990428|FG004|Overall Study|Withdrawal by Subject|1|||
143121878|NCT01618916|515990429|FG005|Overall Study|Withdrawal by Subject|0|||
143121879|NCT01618916|515990424|FG000|Overall Study|Lost to Follow-up|1|||
143121880|NCT01618916|515990425|FG001|Overall Study|Lost to Follow-up|0|||
143121881|NCT01618916|515990426|FG002|Overall Study|Lost to Follow-up|0|||
143121882|NCT01618916|515990427|FG003|Overall Study|Lost to Follow-up|2|||
143121883|NCT01618916|515990428|FG004|Overall Study|Lost to Follow-up|0|||
143121884|NCT01618916|515990429|FG005|Overall Study|Lost to Follow-up|0|||
143121885|NCT01853696|515990430|FG000|Overall Study|Withdrawal by Subject|1|||
143121886|NCT01853696|515990431|FG001|Overall Study|Withdrawal by Subject|1|||
143121887|NCT01853696|515990430|FG000|Overall Study|Lost to Follow-up|5|||
143121888|NCT01853696|515990431|FG001|Overall Study|Lost to Follow-up|4|||
143121889|NCT03004924|515990432|FG000|Overall Study|Adverse Event|6|||
143121890|NCT03004924|515990433|FG001|Overall Study|Adverse Event|5|||
143121891|NCT03004924|515990434|FG002|Overall Study|Adverse Event|10|||
143121892|NCT03004924|515990432|FG000|Overall Study|Protocol Violation|4|||
143121893|NCT03004924|515990433|FG001|Overall Study|Protocol Violation|0|||
143121894|NCT03004924|515990434|FG002|Overall Study|Protocol Violation|1|||
143121895|NCT03004924|515990432|FG000|Overall Study|Withdrawal by Subject|5|||
143345020|NCT00733499|516808762|FG000|Pre-operative|Protocol Violation|0|||
143121896|NCT03004924|515990433|FG001|Overall Study|Withdrawal by Subject|3|||
143121897|NCT03004924|515990434|FG002|Overall Study|Withdrawal by Subject|5|||
143121898|NCT03004924|515990432|FG000|Overall Study|Lost to Follow-up|6|||
143121899|NCT03004924|515990433|FG001|Overall Study|Lost to Follow-up|1|||
143121900|NCT03004924|515990434|FG002|Overall Study|Lost to Follow-up|4|||
143121901|NCT03004924|515990432|FG000|Overall Study|Lack of Efficacy|2|||
143121902|NCT03004924|515990433|FG001|Overall Study|Lack of Efficacy|4|||
143121903|NCT03004924|515990434|FG002|Overall Study|Lack of Efficacy|2|||
143121904|NCT03004924|515990432|FG000|Overall Study|Physician Decision|1|||
143121905|NCT03004924|515990433|FG001|Overall Study|Physician Decision|0|||
143121906|NCT03004924|515990434|FG002|Overall Study|Physician Decision|1|||
143121907|NCT03004924|515990432|FG000|Overall Study|Withdrawal by parent/guardian|1|||
143121908|NCT03004924|515990433|FG001|Overall Study|Withdrawal by parent/guardian|0|||
143121909|NCT03004924|515990434|FG002|Overall Study|Withdrawal by parent/guardian|2|||
143121910|NCT03004924|515990432|FG000|Overall Study|Screen Failure|1|||
143121911|NCT03004924|515990433|FG001|Overall Study|Screen Failure|0|||
143121912|NCT03004924|515990434|FG002|Overall Study|Screen Failure|0|||
143345021|NCT00733499|516808763|FG001|Pre-operative|Protocol Violation|1|||
143345022|NCT00733499|516808762|FG000|3 Months Follow-up|Death|1|||
143345023|NCT00733499|516808763|FG001|3 Months Follow-up|Death|2|||
143345024|NCT00733499|516808762|FG000|6 Months Follow-up|Death|0|||
143345025|NCT00733499|516808763|FG001|6 Months Follow-up|Death|2|||
143345026|NCT00733499|516808762|FG000|6 Months Follow-up|Adverse Event|0|||
143345027|NCT00733499|516808763|FG001|6 Months Follow-up|Adverse Event|1|||
143345028|NCT00733499|516808762|FG000|12 Months Follow-up|Death|2|||
143345029|NCT00733499|516808763|FG001|12 Months Follow-up|Death|1|||
143345030|NCT00733499|516808762|FG000|24 Months Follow-up|Death|0|||
143345031|NCT00733499|516808763|FG001|24 Months Follow-up|Death|1|||
143345032|NCT00733499|516808762|FG000|5 Year Followup|Adverse Event|2|||
143345033|NCT00733499|516808763|FG001|5 Year Followup|Adverse Event|2|||
143345034|NCT00733499|516808762|FG000|5 Year Followup|Non device related AE|0|||
143345035|NCT00733499|516808763|FG001|5 Year Followup|Non device related AE|1|||
143345036|NCT00733499|516808762|FG000|5 Year Followup|Revision of Study Implant|0|||
143345037|NCT00733499|516808763|FG001|5 Year Followup|Revision of Study Implant|1|||
143345038|NCT00733499|516808762|FG000|5 Year Followup|Lost to Follow-up|2|||
143345039|NCT00733499|516808763|FG001|5 Year Followup|Lost to Follow-up|0|||
143345040|NCT00733499|516808762|FG000|5 Year Followup|Death|13|||
143345041|NCT00733499|516808763|FG001|5 Year Followup|Death|19|||
143345042|NCT00733499|516808762|FG000|5 Year Followup|missing, unable to locate|0|||
143345043|NCT00733499|516808763|FG001|5 Year Followup|missing, unable to locate|1|||
143345044|NCT00733499|516808762|FG000|5 Year Followup|Withdrawal by Subject|4|||
143345045|NCT00733499|516808763|FG001|5 Year Followup|Withdrawal by Subject|1|||
143345046|NCT00733499|516808762|FG000|10 Year Followup|Death|9|||
143345047|NCT00733499|516808763|FG001|10 Year Followup|Death|7|||
143345048|NCT00733499|516808762|FG000|10 Year Followup|Adverse Event|3|||
143345049|NCT00733499|516808763|FG001|10 Year Followup|Adverse Event|3|||
143345050|NCT00733499|516808762|FG000|10 Year Followup|Lost to Follow-up|3|||
143345051|NCT00733499|516808763|FG001|10 Year Followup|Lost to Follow-up|2|||
143345052|NCT00733499|516808762|FG000|10 Year Followup|Withdrawal by Subject|5|||
143345053|NCT00733499|516808763|FG001|10 Year Followup|Withdrawal by Subject|5|||
143345054|NCT00733499|516808762|FG000|10 Year Followup|missing, unable to locate|0|||
143345055|NCT00733499|516808763|FG001|10 Year Followup|missing, unable to locate|2|||
143345056|NCT01395823|516808764|FG000|Overall Study|Death|4|||
143345057|NCT01395823|516808765|FG001|Overall Study|Death|4|||
143345058|NCT01395823|516808764|FG000|Overall Study|Physician Decision|3|||
143345059|NCT01395823|516808765|FG001|Overall Study|Physician Decision|1|||
143345060|NCT01395823|516808764|FG000|Overall Study|Lost to Follow-up|1|||
143345061|NCT01395823|516808765|FG001|Overall Study|Lost to Follow-up|0|||
143345062|NCT01395823|516808764|FG000|Overall Study|Transplant|1|||
143345063|NCT01395823|516808765|FG001|Overall Study|Transplant|0|||
143345064|NCT01395823|516808764|FG000|Overall Study|GI symptoms|1|||
143345065|NCT01395823|516808765|FG001|Overall Study|GI symptoms|0|||
143345066|NCT01395823|516808764|FG000|Overall Study|Withdrawal by Subject|5|||
143345067|NCT01395823|516808765|FG001|Overall Study|Withdrawal by Subject|4|||
143345068|NCT02719990|516808766|FG000|Overall Study|Physician Decision|2|||
143345069|NCT02719990|516808766|FG000|Overall Study|Withdrawal by Subject|2|||
143345070|NCT02719990|516808766|FG000|Overall Study|Study Terminated By Sponsor|32|||
143345071|NCT00116272|516808767|FG000|Overall Study|Lost to Follow-up|11|||
143345072|NCT00116272|516808768|FG001|Overall Study|Lost to Follow-up|6|||
143345073|NCT00717314|516808770|FG000|Overall Study|Adverse Event|3|||
143121913|NCT03004924|515990432|FG000|Overall Study|Pregnancy|0|||
143121914|NCT03004924|515990433|FG001|Overall Study|Pregnancy|1|||
143345074|NCT00717314|516808771|FG001|Overall Study|Adverse Event|2|||
143345075|NCT00717314|516808770|FG000|Overall Study|Protocol Violation|1|||
143345076|NCT00717314|516808771|FG001|Overall Study|Protocol Violation|0|||
143345077|NCT00717314|516808770|FG000|Overall Study|Lost to Follow-up|1|||
143345078|NCT00717314|516808771|FG001|Overall Study|Lost to Follow-up|5|||
143345079|NCT00717314|516808770|FG000|Overall Study|Withdrawal by Subject|1|||
143345080|NCT00717314|516808771|FG001|Overall Study|Withdrawal by Subject|3|||
143345081|NCT05076149|516808772|FG000|Overall Study|Adverse Event|3|||
143345082|NCT05076149|516808773|FG001|Overall Study|Adverse Event|9|||
143345083|NCT05076149|516808772|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
143121915|NCT03004924|515990434|FG002|Overall Study|Pregnancy|0|||
143121916|NCT03004924|515990432|FG000|Overall Study|Terminated by Sponsor|0|||
143121917|NCT03004924|515990433|FG001|Overall Study|Terminated by Sponsor|0|||
143121918|NCT03004924|515990434|FG002|Overall Study|Terminated by Sponsor|1|||
143121919|NCT03004924|515990432|FG000|Overall Study|Missed Study Visit|0|||
143121920|NCT03004924|515990433|FG001|Overall Study|Missed Study Visit|0|||
143121921|NCT03004924|515990434|FG002|Overall Study|Missed Study Visit|2|||
143121922|NCT03004924|515990432|FG000|Overall Study|HSV1 Positive|1|||
143121923|NCT03004924|515990433|FG001|Overall Study|HSV1 Positive|0|||
143121924|NCT03004924|515990434|FG002|Overall Study|HSV1 Positive|0|||
143345084|NCT05076149|516808773|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
143345085|NCT05076149|516808772|FG000|Overall Study|Lost to Follow-up|0|||
143121925|NCT04933617|515990449|FG000|Dose Escalation|Early closure of study|0|||
143345086|NCT05076149|516808773|FG001|Overall Study|Lost to Follow-up|1|||
143345087|NCT05076149|516808772|FG000|Overall Study|Commercial drug is available for participant|0|||
143121926|NCT04933617|515990450|FG001|Dose Escalation|Early closure of study|3|||
143121927|NCT04933617|515990451|FG002|Dose Escalation|Early closure of study|0|||
143121928|NCT04933617|515990452|FG003|Dose Escalation|Early closure of study|0|||
143121929|NCT04933617|515990453|FG004|Dose Escalation|Early closure of study|0|||
143121930|NCT02191046|515990463|FG000|Overall Study|low compliance|5|||
143121931|NCT02191046|515990464|FG001|Overall Study|low compliance|1|||
143121932|NCT01964716|515990465|FG000|Overall Study|Withdrawal by Subject|2|||
143121933|NCT01964716|515990466|FG001|Overall Study|Withdrawal by Subject|3|||
143121934|NCT01964716|515990465|FG000|Overall Study|Lost to Follow-up|1|||
143121935|NCT01964716|515990466|FG001|Overall Study|Lost to Follow-up|2|||
143121936|NCT01964716|515990465|FG000|Overall Study|No longer met eligibility criteria|1|||
143121937|NCT01964716|515990466|FG001|Overall Study|No longer met eligibility criteria|1|||
143121938|NCT01964716|515990465|FG000|Overall Study|Death|1|||
143121939|NCT01964716|515990466|FG001|Overall Study|Death|0|||
143121940|NCT03760458|515990467|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
143121941|NCT03760458|515990468|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
143121942|NCT03760458|515990469|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
143121943|NCT03760458|515990470|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
143121944|NCT03760458|515990471|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
143121945|NCT00750919|515990472|FG000|Overall Study|Adverse Event|9|||
143121946|NCT00750919|515990472|FG000|Overall Study|Withdrawal by Subject|1|||
143121947|NCT00750919|515990472|FG000|Overall Study|Lack of Efficacy|8|||
143121948|NCT00750919|515990472|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
143121949|NCT00750919|515990472|FG000|Overall Study|Other|36|||
143121950|NCT01464619|515990473|FG000|Overall Study|Lost to Follow-up|3|||
143121951|NCT01464619|515990474|FG001|Overall Study|Lost to Follow-up|4|||
143121952|NCT00080483|515990481|FG000|Overall Study|Lost to Follow-up|1|||
143121953|NCT00080483|515990482|FG001|Overall Study|Lost to Follow-up|1|||
143121954|NCT00080483|515990481|FG000|Overall Study|Physician Decision|1|||
143121955|NCT00080483|515990482|FG001|Overall Study|Physician Decision|1|||
143121956|NCT01119846|515990485|FG000|Overall Study|Adverse Event|1|||
143121957|NCT01119846|515990486|FG001|Overall Study|Adverse Event|0|||
143121958|NCT01119846|515990487|FG002|Overall Study|Adverse Event|6|||
143121959|NCT01119846|515990485|FG000|Overall Study|Physician Decision|1|||
143121960|NCT01119846|515990486|FG001|Overall Study|Physician Decision|0|||
143121961|NCT01119846|515990487|FG002|Overall Study|Physician Decision|0|||
143121962|NCT01119846|515990485|FG000|Overall Study|Protocol Violation|0|||
143121963|NCT01119846|515990486|FG001|Overall Study|Protocol Violation|0|||
143121964|NCT01119846|515990487|FG002|Overall Study|Protocol Violation|1|||
143121965|NCT01119846|515990485|FG000|Overall Study|Withdrawal by Subject|0|||
143121966|NCT01119846|515990486|FG001|Overall Study|Withdrawal by Subject|0|||
143121967|NCT01119846|515990487|FG002|Overall Study|Withdrawal by Subject|4|||
143121968|NCT02819440|515990488|FG000|Overall Study|Adverse Event|3|||
143121969|NCT02819440|515990489|FG001|Overall Study|Adverse Event|1|||
143121970|NCT02819440|515990488|FG000|Overall Study|Lost to Follow-up|1|||
143121971|NCT02819440|515990489|FG001|Overall Study|Lost to Follow-up|3|||
143121972|NCT02819440|515990488|FG000|Overall Study|Withdrawal by Subject|9|||
143121973|NCT02819440|515990489|FG001|Overall Study|Withdrawal by Subject|8|||
143121974|NCT01404949|515990495|FG000|Overall Study|Not Treated|1|||
143121975|NCT00002525|515990496|FG000|Overall Study|Adverse Event|36|||
143121976|NCT00002525|515990497|FG001|Overall Study|Adverse Event|0|||
143121977|NCT00002525|515990496|FG000|Overall Study|Death|5|||
143121978|NCT00002525|515990497|FG001|Overall Study|Death|0|||
143121979|NCT00002525|515990496|FG000|Overall Study|Withdrawal by Subject|11|||
143121980|NCT00002525|515990497|FG001|Overall Study|Withdrawal by Subject|0|||
143121981|NCT00002525|515990496|FG000|Overall Study|Start non-protocol therapy|1|||
143121982|NCT00002525|515990497|FG001|Overall Study|Start non-protocol therapy|0|||
143121983|NCT00002525|515990496|FG000|Overall Study|Other complicating disease|1|||
143121984|NCT00002525|515990497|FG001|Overall Study|Other complicating disease|0|||
143121985|NCT00002525|515990496|FG000|Overall Study|Duke's A, B1, D disease|92|||
143121986|NCT00002525|515990497|FG001|Overall Study|Duke's A, B1, D disease|0|||
143121987|NCT00002525|515990496|FG000|Overall Study|Error|6|||
143121988|NCT00002525|515990497|FG001|Overall Study|Error|0|||
143121989|NCT00002525|515990496|FG000|Overall Study|Other|26|||
143121990|NCT00002525|515990497|FG001|Overall Study|Other|0|||
143121991|NCT00002525|515990496|FG000|Overall Study|Never start protocol therapy|8|||
143345088|NCT05076149|516808773|FG001|Overall Study|Commercial drug is available for participant|1|||
143345089|NCT05076149|516808772|FG000|Overall Study|Other non compliance|1|||
143121992|NCT00002525|515990497|FG001|Overall Study|Never start protocol therapy|0|||
143121993|NCT03304184|515990498|FG000|Overall Study|Withdrawal by Subject|1|||
143121994|NCT03304184|515990499|FG001|Overall Study|Withdrawal by Subject|2|||
143121995|NCT00435188|515990504|FG000|Overall Study|Death|1|||
143121996|NCT00435188|515990505|FG001|Overall Study|Death|6|||
143121997|NCT00435188|515990504|FG000|Overall Study|Withdrawal by Subject|16|||
143121998|NCT00435188|515990505|FG001|Overall Study|Withdrawal by Subject|11|||
143121999|NCT00435188|515990504|FG000|Overall Study|Lost to Follow-up|5|||
143122000|NCT00435188|515990505|FG001|Overall Study|Lost to Follow-up|6|||
143122001|NCT00575510|515990506|FG000|Overall Study|Lost to Follow-up|4|||
143345090|NCT05076149|516808773|FG001|Overall Study|Other non compliance|1|||
143345091|NCT05076149|516808772|FG000|Overall Study|Physician Decision|0|||
143122002|NCT00575510|515990507|FG001|Overall Study|Lost to Follow-up|6|||
143122003|NCT00575510|515990508|FG002|Overall Study|Lost to Follow-up|9|||
143122004|NCT00575510|515990506|FG000|Overall Study|Withdrawal by Subject|1|||
143122005|NCT00575510|515990507|FG001|Overall Study|Withdrawal by Subject|0|||
143122006|NCT00575510|515990508|FG002|Overall Study|Withdrawal by Subject|0|||
143122007|NCT00575510|515990506|FG000|Overall Study|Clinic Called Patient|7|||
143122008|NCT00575510|515990507|FG001|Overall Study|Clinic Called Patient|7|||
143122009|NCT00575510|515990508|FG002|Overall Study|Clinic Called Patient|7|||
143122010|NCT00575510|515990506|FG000|Overall Study|Pregnancy|0|||
143122011|NCT00575510|515990507|FG001|Overall Study|Pregnancy|0|||
143122012|NCT00575510|515990508|FG002|Overall Study|Pregnancy|1|||
143122013|NCT02651688|515990514|FG000|Overall Study|Non-compliance|0|||
143122014|NCT02651688|515990515|FG001|Overall Study|Non-compliance|0|||
143122015|NCT02651688|515990516|FG002|Overall Study|Non-compliance|1|||
143122016|NCT02651688|515990514|FG000|Overall Study|Principal Investigator (PI) decision|0|||
143122017|NCT02651688|515990515|FG001|Overall Study|Principal Investigator (PI) decision|2|||
143122018|NCT02651688|515990516|FG002|Overall Study|Principal Investigator (PI) decision|0|||
143122019|NCT02651688|515990514|FG000|Overall Study|Lost to Follow-up|1|||
143122020|NCT02651688|515990515|FG001|Overall Study|Lost to Follow-up|3|||
143122021|NCT02651688|515990516|FG002|Overall Study|Lost to Follow-up|0|||
143345092|NCT05076149|516808773|FG001|Overall Study|Physician Decision|1|||
143345093|NCT05076149|516808772|FG000|Overall Study|Other|5|||
143345094|NCT05076149|516808773|FG001|Overall Study|Other|4|||
143345095|NCT00990340|516808775|FG000|First 14-day Treatment|Not Compliant|2|||
143345096|NCT00990340|516808776|FG001|First 14-day Treatment|Not Compliant|1|||
143345097|NCT00990340|516808775|FG000|First 14-day Treatment|Lost to Follow-up|2|||
143345098|NCT00990340|516808776|FG001|First 14-day Treatment|Lost to Follow-up|1|||
143345099|NCT00990340|516808775|FG000|First 14-day Treatment|Protocol Violation|2|||
143345100|NCT00990340|516808776|FG001|First 14-day Treatment|Protocol Violation|2|||
143345101|NCT04615182|516808777|FG000|Overall Study|Re-transplanted|2|||
143345102|NCT04615182|516808777|FG000|Overall Study|Protocol Violation|6|||
143345103|NCT04615182|516808777|FG000|Overall Study|Death|6|||
143345104|NCT04615182|516808777|FG000|Overall Study|Death and protocol violation|1|||
143345105|NCT01874145|516808780|FG000|Core Period|Non-compliance|1|||
143345106|NCT01874145|516808781|FG001|Core Period|Non-compliance|0|||
143345107|NCT01874145|516808780|FG000|Core Period|Protocol Violation|1|||
143345108|NCT01874145|516808781|FG001|Core Period|Protocol Violation|1|||
143345109|NCT01874145|516808780|FG000|Core Period|Physician Decision|1|||
143345110|NCT01874145|516808781|FG001|Core Period|Physician Decision|1|||
143345111|NCT01874145|516808780|FG000|Core Period|Adverse Event|0|||
143345112|NCT01874145|516808781|FG001|Core Period|Adverse Event|1|||
143345113|NCT01874145|516808780|FG000|Core Period|Withdrawal by Subject|0|||
143345114|NCT01874145|516808781|FG001|Core Period|Withdrawal by Subject|4|||
143345115|NCT01874145|516808780|FG000|Extension Period|Adverse Event|3|||
143345116|NCT01874145|516808781|FG001|Extension Period|Adverse Event|2|||
143345117|NCT01874145|516808780|FG000|Extension Period|Withdrawal by Subject|2|||
143345118|NCT01874145|516808781|FG001|Extension Period|Withdrawal by Subject|1|||
143345119|NCT01874145|516808780|FG000|Extension Period|Lost to Follow-up|1|||
143345120|NCT01874145|516808781|FG001|Extension Period|Lost to Follow-up|1|||
143345121|NCT02658630|516808786|FG000|Overall Study|Withdrawal by Subject|4|||
143345122|NCT02130284|516808787|FG000|Overall Study|Withdrawal by Subject|3|||
143345123|NCT02130284|516808787|FG000|Overall Study|Subject Withdrew Consent|1|||
143345124|NCT02130284|516808787|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
143345125|NCT02130284|516808787|FG000|Overall Study|Subject was screened as backup for study|3|||
143345126|NCT02130284|516808787|FG000|Overall Study|Screen Failure|1|||
143345127|NCT01521884|516808788|FG000|Overall Study|Non Responders|10|||
143345128|NCT01521884|516808788|FG000|Overall Study|Adverse Event|5|||
143345129|NCT01521884|516808788|FG000|Overall Study|Pregnancy|1|||
143122022|NCT02651688|515990514|FG000|Overall Study|Withdrawal by Subject|1|||
143122023|NCT02651688|515990515|FG001|Overall Study|Withdrawal by Subject|0|||
143122024|NCT02651688|515990516|FG002|Overall Study|Withdrawal by Subject|2|||
143122025|NCT04527978|515990517|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
143345130|NCT01521884|516808788|FG000|Overall Study|Withdrawal by Subject|1|||
143345131|NCT01521884|516808788|FG000|Overall Study|Physician Decision|2|||
143345132|NCT01521884|516808788|FG000|Overall Study|Protocol Violation|3|||
143345133|NCT01521884|516808788|FG000|Overall Study|Participant non-eligible|1|||
143345134|NCT01521884|516808788|FG000|Overall Study|Lost to Follow-up|4|||
143345135|NCT02821819|516808789|FG000|Overall Study|Protocol Violation|1|||
143345136|NCT00263328|516808793|FG000|Overall Study|Death|0|||
143345137|NCT00263328|516808794|FG001|Overall Study|Death|0|||
143122026|NCT04527978|515990518|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
143122027|NCT00055497|515990519|FG000|Overall Study|Adverse Event|1|||
143122028|NCT00055497|515990520|FG001|Overall Study|Adverse Event|1|||
143345138|NCT00263328|516808795|FG002|Overall Study|Death|1|||
143122029|NCT00055497|515990521|FG002|Overall Study|Adverse Event|1|||
143345139|NCT00263328|516808793|FG000|Overall Study|Lost to Follow-up|1|||
143122030|NCT00055497|515990522|FG003|Overall Study|Adverse Event|28|||
143122031|NCT00055497|515990519|FG000|Overall Study|Withdrawal by Subject|3|||
143122032|NCT00055497|515990520|FG001|Overall Study|Withdrawal by Subject|1|||
143122033|NCT00055497|515990521|FG002|Overall Study|Withdrawal by Subject|1|||
143122034|NCT00055497|515990522|FG003|Overall Study|Withdrawal by Subject|15|||
143122035|NCT00055497|515990519|FG000|Overall Study|Lost to Follow-up|0|||
143122036|NCT00055497|515990520|FG001|Overall Study|Lost to Follow-up|1|||
143122037|NCT00055497|515990521|FG002|Overall Study|Lost to Follow-up|0|||
143122038|NCT00055497|515990522|FG003|Overall Study|Lost to Follow-up|5|||
143122039|NCT00055497|515990519|FG000|Overall Study|Protocol Violation|0|||
143122040|NCT00055497|515990520|FG001|Overall Study|Protocol Violation|0|||
143122041|NCT00055497|515990521|FG002|Overall Study|Protocol Violation|0|||
143122042|NCT00055497|515990522|FG003|Overall Study|Protocol Violation|3|||
143122043|NCT00055497|515990519|FG000|Overall Study|Lack of Efficacy|1|||
143122044|NCT00055497|515990520|FG001|Overall Study|Lack of Efficacy|0|||
143122045|NCT00055497|515990521|FG002|Overall Study|Lack of Efficacy|0|||
143122046|NCT00055497|515990522|FG003|Overall Study|Lack of Efficacy|27|||
143122047|NCT00055497|515990519|FG000|Overall Study|Administrative Reasons|0|||
143122048|NCT00055497|515990520|FG001|Overall Study|Administrative Reasons|0|||
143122049|NCT00055497|515990521|FG002|Overall Study|Administrative Reasons|0|||
143122050|NCT00055497|515990522|FG003|Overall Study|Administrative Reasons|1|||
143122051|NCT00055497|515990519|FG000|Overall Study|Other|0|||
143122052|NCT00055497|515990520|FG001|Overall Study|Other|0|||
143122053|NCT00055497|515990521|FG002|Overall Study|Other|0|||
143122054|NCT00055497|515990522|FG003|Overall Study|Other|11|||
143122055|NCT01900431|515990527|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
143122056|NCT01900431|515990528|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
143122057|NCT01900431|515990529|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
143122058|NCT01900431|515990527|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
143122059|NCT01900431|515990528|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
143459401|NCT03149549|517226953|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
143459402|NCT03149549|517226954|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
143459403|NCT03149549|517226955|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
143122060|NCT01900431|515990529|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
143122061|NCT01900431|515990527|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
143122062|NCT01900431|515990528|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
143122063|NCT01900431|515990529|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
143122064|NCT01900431|515990527|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
143122065|NCT01900431|515990528|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
143122066|NCT01900431|515990529|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
143122067|NCT01900431|515990527|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
143122068|NCT01900431|515990528|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
143122069|NCT01900431|515990529|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
143122070|NCT01900431|515990527|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
143122071|NCT01900431|515990528|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
143122072|NCT01900431|515990529|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
143122073|NCT01900431|515990527|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
143122074|NCT01900431|515990528|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
143122075|NCT01900431|515990529|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
143122076|NCT01900431|515990527|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
143122077|NCT01900431|515990528|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
143122078|NCT01900431|515990529|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
143122079|NCT01900431|515990527|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
143122080|NCT01900431|515990528|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
143122081|NCT01900431|515990529|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
143122082|NCT00659776|515990531|FG000|Overall Study|Withdrawal by Subject|12|||
143122083|NCT00659776|515990532|FG001|Overall Study|Withdrawal by Subject|2|||
143122084|NCT00659776|515990533|FG002|Overall Study|Withdrawal by Subject|0|||
143122085|NCT01421147|515992447|FG000|Treatment Period|Adverse Event|2|||
143122086|NCT01421147|515992448|FG001|Treatment Period|Adverse Event|3|||
143122087|NCT01421147|515992447|FG000|Treatment Period|Lost to Follow-up|2|||
143122088|NCT01421147|515992448|FG001|Treatment Period|Lost to Follow-up|1|||
143122089|NCT01421147|515992447|FG000|Treatment Period|Physician Decision|2|||
143122090|NCT01421147|515992448|FG001|Treatment Period|Physician Decision|2|||
143122091|NCT01421147|515992447|FG000|Treatment Period|Withdrawal by Subject|10|||
143122092|NCT01421147|515992448|FG001|Treatment Period|Withdrawal by Subject|5|||
143122093|NCT01421147|515992447|FG000|Extension Period|Adverse Event|0|||
143122094|NCT01421147|515992448|FG001|Extension Period|Adverse Event|2|||
143122095|NCT01421147|515992447|FG000|Extension Period|Death|0|||
143122096|NCT01421147|515992448|FG001|Extension Period|Death|1|||
143122097|NCT01421147|515992447|FG000|Extension Period|Lost to Follow-up|2|||
143122098|NCT01421147|515992448|FG001|Extension Period|Lost to Follow-up|5|||
143345140|NCT00263328|516808794|FG001|Overall Study|Lost to Follow-up|1|||
143345141|NCT00263328|516808795|FG002|Overall Study|Lost to Follow-up|0|||
143345142|NCT00263328|516808793|FG000|Overall Study|Withdrawal by Subject|3|||
143345143|NCT00263328|516808794|FG001|Overall Study|Withdrawal by Subject|0|||
143345144|NCT00263328|516808795|FG002|Overall Study|Withdrawal by Subject|1|||
143345145|NCT00263328|516808793|FG000|Overall Study|Other|3|||
143345146|NCT00263328|516808794|FG001|Overall Study|Other|0|||
143345147|NCT00263328|516808795|FG002|Overall Study|Other|1|||
143345148|NCT00263328|516808793|FG000|Overall Study|Adverse Event|1|||
143345149|NCT00263328|516808794|FG001|Overall Study|Adverse Event|1|||
143345150|NCT00263328|516808795|FG002|Overall Study|Adverse Event|4|||
143345151|NCT01301274|516808796|FG000|Overall Study|Physician Decision|2|||
143345152|NCT01301274|516808797|FG001|Overall Study|Physician Decision|1|||
143345153|NCT00661661|516808798|FG000|Overall Study|Adverse Event|99|||
143345154|NCT00661661|516808799|FG001|Overall Study|Adverse Event|24|||
143345155|NCT00661661|516808798|FG000|Overall Study|Lack of Efficacy|3|||
143345156|NCT00661661|516808799|FG001|Overall Study|Lack of Efficacy|2|||
143345157|NCT00661661|516808798|FG000|Overall Study|Lost to Follow-up|0|||
143345158|NCT00661661|516808799|FG001|Overall Study|Lost to Follow-up|1|||
143345159|NCT00661661|516808798|FG000|Overall Study|Withdrawal by Subject|15|||
143345160|NCT00661661|516808799|FG001|Overall Study|Withdrawal by Subject|5|||
143345161|NCT00661661|516808798|FG000|Overall Study|Other|22|||
143345162|NCT00661661|516808799|FG001|Overall Study|Other|7|||
143345163|NCT00661661|516808798|FG000|Overall Study|Not assigned treatment|1|||
143345164|NCT00661661|516808799|FG001|Overall Study|Not assigned treatment|0|||
143345165|NCT01893827|516808800|FG000|Overall Study|Lost to Follow-up|19|||
143345166|NCT01893827|516808801|FG001|Overall Study|Lost to Follow-up|26|||
143345167|NCT00399763|516808802|FG000|Overall Study|Lost to Follow-up|2|||
143345168|NCT00399763|516808803|FG001|Overall Study|Lost to Follow-up|3|||
143345169|NCT04182880|516808804|FG000|Overall Study|Pregnancy|1|||
143345170|NCT04182880|516808805|FG001|Overall Study|Pregnancy|0|||
143345171|NCT04512066|516808810|FG000|Double-blind Treatment Period|Adverse Event|6|||
143345172|NCT04512066|516808811|FG001|Double-blind Treatment Period|Adverse Event|4|||
143345173|NCT04512066|516808812|FG002|Double-blind Treatment Period|Adverse Event|5|||
143345174|NCT04512066|516808813|FG003|Double-blind Treatment Period|Adverse Event|1|||
143345175|NCT04512066|516808814|FG004|Double-blind Treatment Period|Adverse Event|0|||
143345176|NCT04512066|516808815|FG005|Double-blind Treatment Period|Adverse Event|0|||
143345177|NCT04512066|516808810|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
143345178|NCT04512066|516808811|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
143345179|NCT04512066|516808812|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
143345180|NCT04512066|516808813|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
143345181|NCT04512066|516808814|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
143345182|NCT04512066|516808815|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
143345183|NCT04512066|516808810|FG000|Double-blind Treatment Period|Physician Decision|1|||
143345184|NCT04512066|516808811|FG001|Double-blind Treatment Period|Physician Decision|0|||
143345185|NCT04512066|516808812|FG002|Double-blind Treatment Period|Physician Decision|1|||
143345186|NCT04512066|516808813|FG003|Double-blind Treatment Period|Physician Decision|0|||
143345187|NCT04512066|516808814|FG004|Double-blind Treatment Period|Physician Decision|0|||
143345188|NCT04512066|516808815|FG005|Double-blind Treatment Period|Physician Decision|0|||
143345189|NCT04512066|516808810|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
143122099|NCT01421147|515992447|FG000|Extension Period|Physician Decision|1|||
143122100|NCT01421147|515992448|FG001|Extension Period|Physician Decision|0|||
143122101|NCT01421147|515992447|FG000|Extension Period|Withdrawal by Subject|5|||
143122102|NCT01421147|515992448|FG001|Extension Period|Withdrawal by Subject|3|||
143122103|NCT03307837|515992449|FG000|Overall Study|Withdrawal by Subject|0|||
143122104|NCT03307837|515992450|FG001|Overall Study|Withdrawal by Subject|0|||
143122105|NCT03307837|515992451|FG002|Overall Study|Withdrawal by Subject|1|||
143122106|NCT03307837|515992452|FG003|Overall Study|Withdrawal by Subject|0|||
143122107|NCT03307837|515992453|FG004|Overall Study|Withdrawal by Subject|0|||
143122108|NCT03307837|515992454|FG005|Overall Study|Withdrawal by Subject|1|||
143122109|NCT03307837|515992449|FG000|Overall Study|Lost to Follow-up|1|||
143122110|NCT03307837|515992450|FG001|Overall Study|Lost to Follow-up|1|||
143122111|NCT03307837|515992451|FG002|Overall Study|Lost to Follow-up|0|||
143122112|NCT03307837|515992452|FG003|Overall Study|Lost to Follow-up|0|||
143122113|NCT03307837|515992453|FG004|Overall Study|Lost to Follow-up|0|||
143122114|NCT03307837|515992454|FG005|Overall Study|Lost to Follow-up|1|||
143122115|NCT00904917|515992456|FG000|Overall Study|Lost to Follow-up|2|||
143122116|NCT00904917|515992457|FG001|Overall Study|Lost to Follow-up|2|||
143122117|NCT00904917|515992458|FG002|Overall Study|Lost to Follow-up|2|||
143122118|NCT00904917|515992459|FG003|Overall Study|Lost to Follow-up|2|||
143122119|NCT00762034|515992460|FG000|Induction Period|Protocol Violation|1|||
143122120|NCT00762034|515992461|FG001|Induction Period|Protocol Violation|2|||
143122121|NCT00762034|515992460|FG000|Induction Period|Entry Criterion Not Met|12|||
143122122|NCT00762034|515992461|FG001|Induction Period|Entry Criterion Not Met|11|||
143122123|NCT00762034|515992460|FG000|Induction Period|Adverse Event|27|||
143122124|NCT00762034|515992461|FG001|Induction Period|Adverse Event|38|||
143122125|NCT00762034|515992460|FG000|Induction Period|Lost to Follow-up|1|||
143122126|NCT00762034|515992461|FG001|Induction Period|Lost to Follow-up|1|||
143122127|NCT00762034|515992460|FG000|Induction Period|Progressive Disease|73|||
143122128|NCT00762034|515992461|FG001|Induction Period|Progressive Disease|55|||
143122129|NCT00762034|515992460|FG000|Induction Period|Physician Decision|21|||
143122130|NCT00762034|515992461|FG001|Induction Period|Physician Decision|20|||
143122131|NCT00762034|515992460|FG000|Induction Period|Withdrawal by Subject|15|||
143122132|NCT00762034|515992461|FG001|Induction Period|Withdrawal by Subject|19|||
143122133|NCT00762034|515992460|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
143122134|NCT00762034|515992461|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
143122135|NCT00762034|515992460|FG000|Induction Period|Deaths Due to Study Disease|9|||
143122136|NCT00762034|515992461|FG001|Induction Period|Deaths Due to Study Disease|9|||
143122137|NCT00762034|515992460|FG000|Maintenance Period|Protocol Violation|1|||
143122138|NCT00762034|515992461|FG001|Maintenance Period|Protocol Violation|3|||
143122139|NCT00762034|515992460|FG000|Maintenance Period|Entry Criterion Not Met|0|||
143122140|NCT00762034|515992461|FG001|Maintenance Period|Entry Criterion Not Met|2|||
143122141|NCT00762034|515992460|FG000|Maintenance Period|Adverse Event|42|||
143122142|NCT00762034|515992461|FG001|Maintenance Period|Adverse Event|26|||
143122143|NCT00762034|515992460|FG000|Maintenance Period|Progressive Disease|186|||
143122144|NCT00762034|515992461|FG001|Maintenance Period|Progressive Disease|224|||
143122145|NCT00762034|515992460|FG000|Maintenance Period|Physician Decision|25|||
143122146|NCT00762034|515992461|FG001|Maintenance Period|Physician Decision|20|||
143122147|NCT00762034|515992460|FG000|Maintenance Period|Withdrawal by Subject|34|||
143122148|NCT00762034|515992461|FG001|Maintenance Period|Withdrawal by Subject|14|||
143122149|NCT00762034|515992460|FG000|Maintenance Period|Death not due to study disease|2|||
143122150|NCT00762034|515992461|FG001|Maintenance Period|Death not due to study disease|5|||
143122151|NCT00762034|515992460|FG000|Maintenance Period|Death due to study disease|3|||
143122152|NCT00762034|515992461|FG001|Maintenance Period|Death due to study disease|3|||
143122153|NCT00762034|515992460|FG000|Maintenance Period|Other|1|||
143122154|NCT00762034|515992461|FG001|Maintenance Period|Other|1|||
143122155|NCT02442206|515992462|FG000|Period 1|Adverse Event|1|||
143122156|NCT02442206|515992463|FG001|Period 1|Adverse Event|1|||
143122157|NCT02442206|515992462|FG000|Period 1|withdrew consent|0|||
143122158|NCT02442206|515992463|FG001|Period 1|withdrew consent|1|||
143122159|NCT02442206|515992462|FG000|Period 1|COPD exacerbation|0|||
143122160|NCT02442206|515992463|FG001|Period 1|COPD exacerbation|1|||
143122161|NCT02442206|515992462|FG000|Period 2|Adverse Event|1|||
143122162|NCT02442206|515992463|FG001|Period 2|Adverse Event|0|||
143122163|NCT01709409|515992468|FG000|Overall Study|Protocol Violation|1|||
143122164|NCT01709409|515992469|FG001|Overall Study|Protocol Violation|0|||
143122165|NCT02412878|515992472|FG000|Overall Study|Withdrawal by Subject|19|||
143122166|NCT02412878|515992473|FG001|Overall Study|Withdrawal by Subject|10|||
143122167|NCT02412878|515992472|FG000|Overall Study|Lost to Follow-up|2|||
143122168|NCT02412878|515992473|FG001|Overall Study|Lost to Follow-up|3|||
143122169|NCT02190721|515992474|FG000|Overall Study|Patient was out of the city|0|||
143122170|NCT02190721|515992475|FG001|Overall Study|Patient was out of the city|1|||
143122171|NCT02190721|515992476|FG002|Overall Study|Patient was out of the city|0|||
143122172|NCT04571385|515992477|FG000|Overall Study|Participant non-compliance|1|||
143122173|NCT04571385|515992478|FG001|Overall Study|Participant non-compliance|0|||
143122174|NCT04571385|515992479|FG002|Overall Study|Participant non-compliance|0|||
143122175|NCT04571385|515992477|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
143122176|NCT04571385|515992478|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
143122177|NCT04571385|515992479|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
143122178|NCT04571385|515992477|FG000|Overall Study|Screen failure|0|||
143122179|NCT04571385|515992478|FG001|Overall Study|Screen failure|0|||
143345190|NCT04512066|516808811|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
143345191|NCT04512066|516808812|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
143345192|NCT04512066|516808813|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
143345193|NCT04512066|516808814|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
143345194|NCT04512066|516808815|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
143345195|NCT04512066|516808810|FG000|Extension Period|Adverse Event|0|||
143345196|NCT04512066|516808811|FG001|Extension Period|Adverse Event|1|||
143345197|NCT04512066|516808812|FG002|Extension Period|Adverse Event|4|||
143345198|NCT04512066|516808813|FG003|Extension Period|Adverse Event|3|||
143345199|NCT04512066|516808814|FG004|Extension Period|Adverse Event|1|||
143345200|NCT04512066|516808815|FG005|Extension Period|Adverse Event|3|||
143345201|NCT04512066|516808810|FG000|Extension Period|Death|0|||
143345202|NCT04512066|516808811|FG001|Extension Period|Death|0|||
143122180|NCT04571385|515992479|FG002|Overall Study|Screen failure|1|||
143345203|NCT04512066|516808812|FG002|Extension Period|Death|0|||
143345204|NCT04512066|516808813|FG003|Extension Period|Death|0|||
143345205|NCT04512066|516808814|FG004|Extension Period|Death|0|||
143345206|NCT04512066|516808815|FG005|Extension Period|Death|1|||
143345207|NCT04512066|516808810|FG000|Extension Period|Lack of Efficacy|0|||
143345208|NCT04512066|516808811|FG001|Extension Period|Lack of Efficacy|4|||
143345209|NCT04512066|516808812|FG002|Extension Period|Lack of Efficacy|4|||
143345210|NCT04512066|516808813|FG003|Extension Period|Lack of Efficacy|1|||
143345211|NCT04512066|516808814|FG004|Extension Period|Lack of Efficacy|3|||
143345212|NCT04512066|516808815|FG005|Extension Period|Lack of Efficacy|3|||
143345213|NCT04512066|516808810|FG000|Extension Period|Lost to Follow-up|0|||
143345214|NCT04512066|516808811|FG001|Extension Period|Lost to Follow-up|1|||
143345215|NCT04512066|516808812|FG002|Extension Period|Lost to Follow-up|5|||
143345216|NCT04512066|516808813|FG003|Extension Period|Lost to Follow-up|2|||
143345217|NCT04512066|516808814|FG004|Extension Period|Lost to Follow-up|3|||
143345218|NCT04512066|516808815|FG005|Extension Period|Lost to Follow-up|2|||
143345219|NCT04512066|516808810|FG000|Extension Period|Non-compliance with study drug|0|||
143345220|NCT04512066|516808811|FG001|Extension Period|Non-compliance with study drug|1|||
143345221|NCT04512066|516808812|FG002|Extension Period|Non-compliance with study drug|0|||
143345222|NCT04512066|516808813|FG003|Extension Period|Non-compliance with study drug|0|||
143345223|NCT04512066|516808814|FG004|Extension Period|Non-compliance with study drug|0|||
143345224|NCT04512066|516808815|FG005|Extension Period|Non-compliance with study drug|1|||
143345225|NCT04512066|516808810|FG000|Extension Period|Other|0|||
143345226|NCT04512066|516808811|FG001|Extension Period|Other|2|||
143459404|NCT03149549|517226956|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
143122181|NCT01212159|515992481|FG000|Overall Study|Withdrawal by Subject|12|||
143122182|NCT01212159|515992482|FG001|Overall Study|Withdrawal by Subject|12|||
143122183|NCT04676152|515992483|FG000|Overall Study|screen fail|9|||
143122184|NCT01928199|515992484|FG000|Overall Study|Lost to Follow-up|2|||
143122185|NCT01928199|515992485|FG001|Overall Study|Lost to Follow-up|1|||
143122186|NCT01928199|515992484|FG000|Overall Study|Withdrawal by Subject|3|||
143122187|NCT01928199|515992485|FG001|Overall Study|Withdrawal by Subject|5|||
143122188|NCT02107313|515992487|FG000|Overall Study|One participant did not do the FED cohor|0|||
143122189|NCT02107313|515992488|FG001|Overall Study|One participant did not do the FED cohor|1|||
143122190|NCT01031004|515992489|FG000|Overall Study|Protocol Violation|0|||
143122191|NCT01031004|515992490|FG001|Overall Study|Protocol Violation|1|||
143122192|NCT01031004|515992489|FG000|Overall Study|Lost to Follow-up|1|||
143122193|NCT01031004|515992490|FG001|Overall Study|Lost to Follow-up|0|||
143122194|NCT01641471|515992491|FG000|Overall Study|Withdrawal by Subject|19|||
143122195|NCT01641471|515992492|FG001|Overall Study|Withdrawal by Subject|19|||
143122196|NCT01641471|515992491|FG000|Overall Study|Lost to Follow-up|2|||
143122197|NCT01641471|515992492|FG001|Overall Study|Lost to Follow-up|4|||
143122198|NCT01641471|515992491|FG000|Overall Study|Protocol Violation|2|||
143122199|NCT01641471|515992492|FG001|Overall Study|Protocol Violation|4|||
143122200|NCT03300050|515992495|FG000|Overall Study|Lost to Follow-up|2|||
143122201|NCT03300050|515992496|FG001|Overall Study|Lost to Follow-up|1|||
143122202|NCT03300050|515992497|FG002|Overall Study|Lost to Follow-up|0|||
143122203|NCT03300050|515992498|FG003|Overall Study|Lost to Follow-up|0|||
143122204|NCT03300050|515992499|FG004|Overall Study|Lost to Follow-up|1|||
143122205|NCT03300050|515992495|FG000|Overall Study|Withdrawal by Subject|1|||
143122206|NCT03300050|515992496|FG001|Overall Study|Withdrawal by Subject|1|||
143122207|NCT03300050|515992497|FG002|Overall Study|Withdrawal by Subject|1|||
143122208|NCT03300050|515992498|FG003|Overall Study|Withdrawal by Subject|0|||
143122209|NCT03300050|515992499|FG004|Overall Study|Withdrawal by Subject|0|||
143122210|NCT03300050|515992495|FG000|Overall Study|Death|0|||
143122211|NCT03300050|515992496|FG001|Overall Study|Death|0|||
143122212|NCT03300050|515992497|FG002|Overall Study|Death|1|||
143122213|NCT03300050|515992498|FG003|Overall Study|Death|0|||
143122214|NCT03300050|515992499|FG004|Overall Study|Death|0|||
143122215|NCT03300050|515992495|FG000|Overall Study|Not Eligible at Randomization|0|||
143122216|NCT03300050|515992496|FG001|Overall Study|Not Eligible at Randomization|0|||
143122217|NCT03300050|515992497|FG002|Overall Study|Not Eligible at Randomization|1|||
143122218|NCT03300050|515992498|FG003|Overall Study|Not Eligible at Randomization|1|||
143122219|NCT03300050|515992499|FG004|Overall Study|Not Eligible at Randomization|0|||
143122220|NCT00482170|515992501|FG000|Overall Study|Adverse Event|5|||
143122221|NCT00482170|515992502|FG001|Overall Study|Adverse Event|14|||
143122222|NCT00482170|515992501|FG000|Overall Study|Withdrawal by Subject|6|||
143122223|NCT00482170|515992502|FG001|Overall Study|Withdrawal by Subject|1|||
143122224|NCT00482170|515992501|FG000|Overall Study|Protocol Violation|2|||
143122225|NCT00482170|515992502|FG001|Overall Study|Protocol Violation|3|||
143122226|NCT00482170|515992501|FG000|Overall Study|Lost to Follow-up|2|||
143122227|NCT00482170|515992502|FG001|Overall Study|Lost to Follow-up|0|||
143122228|NCT00482170|515992501|FG000|Overall Study|Unspecified reason|0|||
143122229|NCT00482170|515992502|FG001|Overall Study|Unspecified reason|2|||
143122230|NCT04379700|515992503|FG000|Overall Study|Withdrawal by Subject|10|||
143122231|NCT04379700|515992503|FG000|Overall Study|Screen Fail|4|||
143122232|NCT04379700|515992503|FG000|Overall Study|Lost to Follow-up|3|||
143122233|NCT00592592|515992504|FG000|Overall Study|Patient found ineligible upon chart review|1|||
143122234|NCT00431067|515992509|FG000|Overall Study|Other Adverse Event|9|||
143122235|NCT00431067|515992509|FG000|Overall Study|Progressive disease|30|||
143122236|NCT00431067|515992509|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
143122237|NCT00548249|515992510|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
143122238|NCT00548249|515992511|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
143122239|NCT00548249|515992512|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
143345227|NCT04512066|516808812|FG002|Extension Period|Other|0|||
143345228|NCT04512066|516808813|FG003|Extension Period|Other|0|||
143122240|NCT00548249|515992513|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
143122241|NCT00548249|515992514|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
143122242|NCT00548249|515992510|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
143122243|NCT00548249|515992511|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
143122244|NCT00548249|515992512|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
143122245|NCT00548249|515992513|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
143122246|NCT00548249|515992514|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
143122247|NCT00548249|515992510|FG000|Overall Study|Protocol Violation|1|||
143122248|NCT00548249|515992511|FG001|Overall Study|Protocol Violation|1|||
143122249|NCT00548249|515992512|FG002|Overall Study|Protocol Violation|4|||
143122250|NCT00548249|515992513|FG003|Overall Study|Protocol Violation|0|||
143122251|NCT00548249|515992514|FG004|Overall Study|Protocol Violation|3|||
143122252|NCT00548249|515992510|FG000|Overall Study|Miscellaneous|2|||
143122253|NCT00548249|515992511|FG001|Overall Study|Miscellaneous|3|||
143122254|NCT00548249|515992512|FG002|Overall Study|Miscellaneous|2|||
143122255|NCT00548249|515992513|FG003|Overall Study|Miscellaneous|0|||
143122256|NCT00548249|515992514|FG004|Overall Study|Miscellaneous|2|||
143122257|NCT00548249|515992510|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
143122258|NCT00548249|515992511|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
143122259|NCT00548249|515992512|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
143122260|NCT00548249|515992513|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
143122261|NCT00548249|515992514|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
143122262|NCT00548249|515992510|FG000|Overall Study|Adverse Event|2|||
143122263|NCT00548249|515992511|FG001|Overall Study|Adverse Event|2|||
143122264|NCT00548249|515992512|FG002|Overall Study|Adverse Event|0|||
143122265|NCT00548249|515992513|FG003|Overall Study|Adverse Event|1|||
143122266|NCT00548249|515992514|FG004|Overall Study|Adverse Event|1|||
143122267|NCT00548249|515992510|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
143122268|NCT00548249|515992511|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
143122269|NCT00548249|515992512|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
143122270|NCT00548249|515992513|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
143122271|NCT00548249|515992514|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
143122272|NCT00548249|515992510|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
143122273|NCT00548249|515992511|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
143122274|NCT00548249|515992512|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
143122275|NCT00548249|515992513|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
143122276|NCT00548249|515992514|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
143122277|NCT00548249|515992510|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
143122278|NCT00548249|515992511|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
143122279|NCT00548249|515992512|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
143122280|NCT00548249|515992513|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
143122281|NCT00548249|515992514|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
143122282|NCT00548249|515992510|FG000|Overall Study|Prolonged hospitalization|0|||
143122283|NCT00548249|515992511|FG001|Overall Study|Prolonged hospitalization|0|||
143122284|NCT00548249|515992512|FG002|Overall Study|Prolonged hospitalization|2|||
143122285|NCT00548249|515992513|FG003|Overall Study|Prolonged hospitalization|1|||
143122286|NCT00548249|515992514|FG004|Overall Study|Prolonged hospitalization|0|||
143122287|NCT00548249|515992510|FG000|Overall Study|Withdrawal by Subject|2|||
143122288|NCT00548249|515992511|FG001|Overall Study|Withdrawal by Subject|0|||
143122289|NCT00548249|515992512|FG002|Overall Study|Withdrawal by Subject|0|||
143122290|NCT00548249|515992513|FG003|Overall Study|Withdrawal by Subject|0|||
143122291|NCT00548249|515992514|FG004|Overall Study|Withdrawal by Subject|0|||
143122292|NCT00548249|515992510|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
143122293|NCT00548249|515992511|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
143122294|NCT00548249|515992512|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
143122295|NCT00548249|515992513|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
143122296|NCT00548249|515992514|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
143122297|NCT00548249|515992510|FG000|Overall Study|Sponsor's request|0|||
143122298|NCT00548249|515992511|FG001|Overall Study|Sponsor's request|0|||
143122299|NCT00548249|515992512|FG002|Overall Study|Sponsor's request|0|||
143122300|NCT00548249|515992513|FG003|Overall Study|Sponsor's request|1|||
143122301|NCT00548249|515992514|FG004|Overall Study|Sponsor's request|0|||
143122302|NCT01606748|515992522|FG000|Overall Study|Adverse Event|1|||
143122303|NCT01606748|515992523|FG001|Overall Study|Adverse Event|0|||
143122304|NCT01606748|515992522|FG000|Overall Study|Progressive Disease|1|||
143122305|NCT01606748|515992523|FG001|Overall Study|Progressive Disease|0|||
143122306|NCT01606748|515992522|FG000|Overall Study|Withdrawal by Subject|1|||
143122307|NCT01606748|515992523|FG001|Overall Study|Withdrawal by Subject|0|||
143122308|NCT00621517|515992527|FG000|Overall Study|Lost to Follow-up|3|||
143122309|NCT00621517|515992528|FG001|Overall Study|Lost to Follow-up|3|||
143122310|NCT00621517|515992527|FG000|Overall Study|Withdrawal by Subject|3|||
143122311|NCT00621517|515992528|FG001|Overall Study|Withdrawal by Subject|4|||
143122312|NCT00621517|515992527|FG000|Overall Study|Adverse Event|1|||
143122313|NCT00621517|515992528|FG001|Overall Study|Adverse Event|0|||
143459405|NCT03149549|517226957|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
143459406|NCT03149549|517226958|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
143459407|NCT03149549|517226959|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
143459408|NCT03149549|517226960|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
143459409|NCT03149549|517226961|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
143459410|NCT03149549|517226962|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
143459411|NCT03149549|517226963|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
143459412|NCT03149549|517226964|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
143459413|NCT03149549|517226965|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
143459414|NCT03149549|517226953|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
143459415|NCT03149549|517226954|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
143459416|NCT03149549|517226955|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
143459417|NCT03149549|517226956|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
143459418|NCT03149549|517226957|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
143459419|NCT03149549|517226958|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
143459420|NCT03149549|517226959|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
143459421|NCT03149549|517226960|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
143459422|NCT03149549|517226961|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
143459423|NCT03149549|517226962|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
143459424|NCT03149549|517226963|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
143459425|NCT03149549|517226964|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
143459426|NCT03149549|517226965|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
143459427|NCT03149549|517226953|FG000|Study Discontinuation--Treatment Period|Other|0|||
143459428|NCT03149549|517226954|FG001|Study Discontinuation--Treatment Period|Other|0|||
143459429|NCT03149549|517226955|FG002|Study Discontinuation--Treatment Period|Other|0|||
143459430|NCT03149549|517226956|FG003|Study Discontinuation--Treatment Period|Other|0|||
143459431|NCT03149549|517226957|FG004|Study Discontinuation--Treatment Period|Other|0|||
143459432|NCT03149549|517226958|FG005|Study Discontinuation--Treatment Period|Other|0|||
143459433|NCT03149549|517226959|FG006|Study Discontinuation--Treatment Period|Other|0|||
143459434|NCT03149549|517226960|FG007|Study Discontinuation--Treatment Period|Other|1|||
143459435|NCT03149549|517226961|FG008|Study Discontinuation--Treatment Period|Other|0|||
143459436|NCT03149549|517226962|FG009|Study Discontinuation--Treatment Period|Other|1|||
143459437|NCT03149549|517226963|FG010|Study Discontinuation--Treatment Period|Other|0|||
143459438|NCT03149549|517226964|FG011|Study Discontinuation--Treatment Period|Other|0|||
143459439|NCT03149549|517226965|FG012|Study Discontinuation--Treatment Period|Other|0|||
143459440|NCT03149549|517226953|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
143459441|NCT03149549|517226954|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
143122314|NCT01863732|515992530|FG000|Overall Study|Adverse Event|2|||
143122315|NCT01863732|515992531|FG001|Overall Study|Adverse Event|0|||
143122316|NCT01863732|515992532|FG002|Overall Study|Adverse Event|3|||
143122317|NCT01863732|515992533|FG003|Overall Study|Adverse Event|3|||
143122318|NCT01863732|515992530|FG000|Overall Study|Lack of Efficacy|1|||
143122319|NCT01863732|515992531|FG001|Overall Study|Lack of Efficacy|0|||
143122320|NCT01863732|515992532|FG002|Overall Study|Lack of Efficacy|2|||
143122321|NCT01863732|515992533|FG003|Overall Study|Lack of Efficacy|1|||
143122322|NCT01863732|515992530|FG000|Overall Study|Lost to Follow-up|2|||
143122323|NCT01863732|515992531|FG001|Overall Study|Lost to Follow-up|2|||
143122324|NCT01863732|515992532|FG002|Overall Study|Lost to Follow-up|1|||
143122325|NCT01863732|515992533|FG003|Overall Study|Lost to Follow-up|1|||
143122326|NCT01863732|515992530|FG000|Overall Study|Physician Decision|1|||
143122327|NCT01863732|515992531|FG001|Overall Study|Physician Decision|0|||
143122328|NCT01863732|515992532|FG002|Overall Study|Physician Decision|1|||
143122329|NCT01863732|515992533|FG003|Overall Study|Physician Decision|0|||
143122330|NCT01863732|515992530|FG000|Overall Study|Pregnancy|0|||
143122331|NCT01863732|515992531|FG001|Overall Study|Pregnancy|0|||
143122332|NCT01863732|515992532|FG002|Overall Study|Pregnancy|0|||
143122333|NCT01863732|515992533|FG003|Overall Study|Pregnancy|1|||
143122334|NCT01863732|515992530|FG000|Overall Study|Technical problems|0|||
143122335|NCT01863732|515992531|FG001|Overall Study|Technical problems|1|||
143122336|NCT01863732|515992532|FG002|Overall Study|Technical problems|1|||
143122337|NCT01863732|515992533|FG003|Overall Study|Technical problems|0|||
143122338|NCT01863732|515992530|FG000|Overall Study|Subject/guardian decision|6|||
143459442|NCT03149549|517226955|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
143122339|NCT01863732|515992531|FG001|Overall Study|Subject/guardian decision|9|||
143122340|NCT01863732|515992532|FG002|Overall Study|Subject/guardian decision|3|||
143122341|NCT01863732|515992533|FG003|Overall Study|Subject/guardian decision|1|||
143122342|NCT01863732|515992530|FG000|Overall Study|Death|1|||
143122343|NCT01863732|515992531|FG001|Overall Study|Death|0|||
143122344|NCT01863732|515992532|FG002|Overall Study|Death|0|||
143122345|NCT01863732|515992533|FG003|Overall Study|Death|1|||
143122346|NCT00394771|515992534|FG000|Overall Study|Did not meet protocol requirements|1|||
143345229|NCT04512066|516808814|FG004|Extension Period|Other|0|||
143345230|NCT04512066|516808815|FG005|Extension Period|Other|0|||
143345231|NCT04512066|516808810|FG000|Extension Period|Physician Decision|0|||
143345232|NCT04512066|516808811|FG001|Extension Period|Physician Decision|2|||
143345233|NCT04512066|516808812|FG002|Extension Period|Physician Decision|0|||
143345234|NCT04512066|516808813|FG003|Extension Period|Physician Decision|1|||
143345235|NCT04512066|516808814|FG004|Extension Period|Physician Decision|1|||
143345236|NCT04512066|516808815|FG005|Extension Period|Physician Decision|0|||
143345237|NCT04512066|516808810|FG000|Extension Period|Withdrawal by Subject|0|||
143345238|NCT04512066|516808811|FG001|Extension Period|Withdrawal by Subject|3|||
143345239|NCT04512066|516808812|FG002|Extension Period|Withdrawal by Subject|7|||
143345240|NCT04512066|516808813|FG003|Extension Period|Withdrawal by Subject|11|||
143345241|NCT04512066|516808814|FG004|Extension Period|Withdrawal by Subject|8|||
143345242|NCT04512066|516808815|FG005|Extension Period|Withdrawal by Subject|4|||
143345243|NCT01119898|516808819|FG000|Overall Study|Adverse Event|4|||
143345244|NCT01119898|516808820|FG001|Overall Study|Adverse Event|5|||
143345245|NCT01119898|516808819|FG000|Overall Study|Withdrawal by Subject|1|||
143345246|NCT01119898|516808820|FG001|Overall Study|Withdrawal by Subject|4|||
143345247|NCT01119898|516808819|FG000|Overall Study|Lack of Efficacy|0|||
143345248|NCT01119898|516808820|FG001|Overall Study|Lack of Efficacy|2|||
143345249|NCT01119898|516808819|FG000|Overall Study|Protocol Violation|1|||
143345250|NCT01119898|516808820|FG001|Overall Study|Protocol Violation|1|||
143345251|NCT01119898|516808819|FG000|Overall Study|Medical procedure|1|||
143345252|NCT01119898|516808820|FG001|Overall Study|Medical procedure|0|||
143345253|NCT01119898|516808819|FG000|Overall Study|Randomized in error did not participate|1|||
143345254|NCT01119898|516808820|FG001|Overall Study|Randomized in error did not participate|0|||
143345255|NCT01806584|516808821|FG000|Overall Study|Adverse Event|2|||
143345256|NCT01806584|516808822|FG001|Overall Study|Adverse Event|1|||
143345257|NCT01806584|516808821|FG000|Overall Study|Death|1|||
143345258|NCT01806584|516808822|FG001|Overall Study|Death|0|||
143345259|NCT01806584|516808821|FG000|Overall Study|Lost to Follow-up|0|||
143345260|NCT01806584|516808822|FG001|Overall Study|Lost to Follow-up|2|||
143345261|NCT01806584|516808821|FG000|Overall Study|Study terminated by sponsor|9|||
143345262|NCT01806584|516808822|FG001|Overall Study|Study terminated by sponsor|14|||
143345263|NCT01806584|516808821|FG000|Overall Study|Withdrawal by Subject|1|||
143345264|NCT01806584|516808822|FG001|Overall Study|Withdrawal by Subject|1|||
143345265|NCT01806584|516808821|FG000|Overall Study|Other unspecified|1|||
143345266|NCT01806584|516808822|FG001|Overall Study|Other unspecified|0|||
143345267|NCT01833143|516808823|FG000|Overall Study|Not Treated|1|||
143345268|NCT02217280|516808824|FG000|Overall Study|Withdrawal by Subject|2|||
143345269|NCT02217280|516808824|FG000|Overall Study|Post-consent sceen fail|2|||
143345270|NCT03995784|516808825|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
143345271|NCT01786330|516808832|FG000|Overall Study|Withdrawal by Subject|0|||
143345272|NCT01786330|516808833|FG001|Overall Study|Withdrawal by Subject|1|||
143345273|NCT01786330|516808832|FG000|Overall Study|Lost to Follow-up|0|||
143345274|NCT01786330|516808833|FG001|Overall Study|Lost to Follow-up|1|||
143345275|NCT01786330|516808832|FG000|Overall Study|Excluded intraoperatively|0|||
143345276|NCT01786330|516808833|FG001|Overall Study|Excluded intraoperatively|1|||
143345277|NCT01786330|516808832|FG000|Overall Study|Protocol Violation|1|||
143345278|NCT01786330|516808833|FG001|Overall Study|Protocol Violation|0|||
143345279|NCT02172625|516808834|FG000|Overall Study|Adverse Event|0|||
143345280|NCT02172625|516808835|FG001|Overall Study|Adverse Event|1|||
143345281|NCT02172625|516808834|FG000|Overall Study|Pregnancy|0|||
143345282|NCT02172625|516808835|FG001|Overall Study|Pregnancy|1|||
143345283|NCT02172625|516808834|FG000|Overall Study|car accident|0|||
143345284|NCT02172625|516808835|FG001|Overall Study|car accident|1|||
143345285|NCT01816763|516810297|FG000|Overall Study|The main reason for an incomplete survey|4|||
143345286|NCT01816763|516810298|FG001|Overall Study|The main reason for an incomplete survey|15|||
143345287|NCT01816763|516810299|FG002|Overall Study|The main reason for an incomplete survey|11|||
143345288|NCT00311155|516810300|FG000|Overall Study|Adverse Event|21|||
143345289|NCT00311155|516810300|FG000|Overall Study|Withdrawal by Subject|17|||
143345290|NCT00311155|516810300|FG000|Overall Study|Did not meet entry criteria|55|||
143345291|NCT00429494|516810302|FG000|Overall Study|Withdrawal by Subject|9|||
143345292|NCT00429494|516810302|FG000|Overall Study|Death|6|||
143345293|NCT00976703|516810303|FG000|Overall Study|Physician Decision|1|||
143345294|NCT00976703|516810304|FG001|Overall Study|Physician Decision|1|||
143345295|NCT00976703|516810303|FG000|Overall Study|ineligible for study|2|||
143345296|NCT00976703|516810304|FG001|Overall Study|ineligible for study|2|||
143345297|NCT02762981|516810313|FG000|Overall Study|Adverse Event|2|||
143345298|NCT02762981|516810314|FG001|Overall Study|Adverse Event|3|||
143345299|NCT02762981|516810315|FG002|Overall Study|Adverse Event|1|||
143459443|NCT03149549|517226956|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
143345300|NCT02762981|516810316|FG003|Overall Study|Adverse Event|1|||
143345301|NCT02762981|516810317|FG004|Overall Study|Adverse Event|3|||
143345302|NCT02762981|516810313|FG000|Overall Study|Physician Decision|0|||
143345303|NCT02762981|516810314|FG001|Overall Study|Physician Decision|1|||
143345304|NCT02762981|516810315|FG002|Overall Study|Physician Decision|0|||
143122347|NCT00394771|515992535|FG001|Overall Study|Did not meet protocol requirements|0|||
143122348|NCT00394771|515992536|FG002|Overall Study|Did not meet protocol requirements|2|||
143122349|NCT00394771|515992537|FG003|Overall Study|Did not meet protocol requirements|0|||
143122350|NCT00394771|515992534|FG000|Overall Study|Protocol Violation|2|||
143122351|NCT00394771|515992535|FG001|Overall Study|Protocol Violation|4|||
143122352|NCT00394771|515992536|FG002|Overall Study|Protocol Violation|9|||
143122353|NCT00394771|515992537|FG003|Overall Study|Protocol Violation|7|||
143122354|NCT00394771|515992534|FG000|Overall Study|Withdrawal by Subject|10|||
143122355|NCT00394771|515992535|FG001|Overall Study|Withdrawal by Subject|6|||
143122356|NCT00394771|515992536|FG002|Overall Study|Withdrawal by Subject|8|||
143122357|NCT00394771|515992537|FG003|Overall Study|Withdrawal by Subject|12|||
143122358|NCT00394771|515992534|FG000|Overall Study|Adverse Event|10|||
143122359|NCT00394771|515992535|FG001|Overall Study|Adverse Event|5|||
143122360|NCT00394771|515992536|FG002|Overall Study|Adverse Event|12|||
143122361|NCT00394771|515992537|FG003|Overall Study|Adverse Event|8|||
143122362|NCT00394771|515992534|FG000|Overall Study|Participant pregnant|0|||
143122363|NCT00394771|515992535|FG001|Overall Study|Participant pregnant|1|||
143122364|NCT00394771|515992536|FG002|Overall Study|Participant pregnant|2|||
143122365|NCT00394771|515992537|FG003|Overall Study|Participant pregnant|2|||
143122366|NCT00394771|515992534|FG000|Overall Study|Lost to Follow-up|15|||
143122367|NCT00394771|515992535|FG001|Overall Study|Lost to Follow-up|15|||
143122368|NCT00394771|515992536|FG002|Overall Study|Lost to Follow-up|13|||
143122369|NCT00394771|515992537|FG003|Overall Study|Lost to Follow-up|10|||
143122370|NCT00394771|515992534|FG000|Overall Study|Other|3|||
143122371|NCT00394771|515992535|FG001|Overall Study|Other|3|||
143122372|NCT00394771|515992536|FG002|Overall Study|Other|1|||
143122373|NCT00394771|515992537|FG003|Overall Study|Other|0|||
143122374|NCT02839876|515992538|FG000|Overall Study|Protocol Violation|10|||
143122375|NCT02839876|515992539|FG001|Overall Study|Protocol Violation|11|||
143122376|NCT03816007|515992540|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
143122377|NCT03816007|515992541|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
143122378|NCT03816007|515992540|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
143122379|NCT03816007|515992541|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
143122380|NCT03816007|515992540|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
143122381|NCT03816007|515992541|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
143122382|NCT01428115|515992542|FG000|Overall Study|Lack of Efficacy|3|||
143122383|NCT01428115|515992542|FG000|Overall Study|Lost to Follow-up|10|||
143122384|NCT01428115|515992542|FG000|Overall Study|Pregnancy|1|||
143122385|NCT01428115|515992542|FG000|Overall Study|Protocol Violation|3|||
143122386|NCT01428115|515992542|FG000|Overall Study|Withdrawal by Subject|4|||
143122387|NCT00494221|515992543|FG000|Overall Study|Death|15|||
143122388|NCT00494221|515992544|FG001|Overall Study|Death|9|||
143122389|NCT00494221|515992545|FG002|Overall Study|Death|14|||
143122390|NCT00494221|515992543|FG000|Overall Study|Withdrawal by Subject|1|||
143122391|NCT00494221|515992544|FG001|Overall Study|Withdrawal by Subject|2|||
143122392|NCT00494221|515992545|FG002|Overall Study|Withdrawal by Subject|0|||
143122393|NCT03755518|515992550|FG000|Overall Study|Lack of Efficacy|10|||
143122394|NCT03755518|515992550|FG000|Overall Study|Adverse Event|7|||
143122395|NCT03755518|515992550|FG000|Overall Study|Study Terminated by Sponsor|5|||
143122396|NCT03755518|515992550|FG000|Overall Study|Death|1|||
143122397|NCT03755518|515992550|FG000|Overall Study|Withdrawal by Subject|3|||
143122398|NCT03755518|515992550|FG000|Overall Study|Progressive Disease|4|||
143122399|NCT03755518|515992550|FG000|Overall Study|Bone Marrow Transplant|4|||
143122400|NCT03755518|515992550|FG000|Overall Study|Physicians Decision|1|||
143122401|NCT03755518|515992550|FG000|Overall Study|Relapse|1|||
143122402|NCT03755518|515992550|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
143122403|NCT03755518|515992550|FG000|Overall Study|Withdrawal by PI|1|||
143122404|NCT03172364|515992551|FG000|Overall Study|Adverse Event|1|||
143122405|NCT03172364|515992552|FG001|Overall Study|Adverse Event|1|||
143122406|NCT03172364|515992551|FG000|Overall Study|Protocol Violation|1|||
143122407|NCT03172364|515992552|FG001|Overall Study|Protocol Violation|0|||
143122408|NCT01714609|515992553|FG000|Overall Study|Protocol Violation|1|||
143122409|NCT01714609|515992554|FG001|Overall Study|Protocol Violation|0|||
143122410|NCT00630747|515992555|FG000|Overall Study|Death|1|||
143122411|NCT00630747|515992555|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
143122412|NCT00630747|515992555|FG000|Overall Study|Returned to country of origin|1|||
143122413|NCT02732327|515992556|FG000|Overall Study|Protocol Violation|0|||
143122414|NCT02732327|515992557|FG001|Overall Study|Protocol Violation|1|||
143122415|NCT02306694|515992558|FG000|Overall Study|Withdrawal by Subject|3|||
143122416|NCT02306694|515992558|FG000|Overall Study|Lost to Follow-up|1|||
143122417|NCT00603382|515992559|FG000|Overall Study|Adverse Event|0|||
143122418|NCT00603382|515992560|FG001|Overall Study|Adverse Event|1|||
143122419|NCT00603382|515992561|FG002|Overall Study|Adverse Event|1|||
143122420|NCT00603382|515992562|FG003|Overall Study|Adverse Event|2|||
143122421|NCT00603382|515992563|FG004|Overall Study|Adverse Event|1|||
143122422|NCT00603382|515992564|FG005|Overall Study|Adverse Event|2|||
143122423|NCT00603382|515992559|FG000|Overall Study|Lack of Efficacy|14|||
143122424|NCT00603382|515992560|FG001|Overall Study|Lack of Efficacy|9|||
143122425|NCT00603382|515992561|FG002|Overall Study|Lack of Efficacy|3|||
143345305|NCT02762981|516810316|FG003|Overall Study|Physician Decision|0|||
143345306|NCT02762981|516810317|FG004|Overall Study|Physician Decision|1|||
143345307|NCT02762981|516810313|FG000|Overall Study|Disease progression|11|||
143345308|NCT02762981|516810314|FG001|Overall Study|Disease progression|23|||
143345309|NCT02762981|516810315|FG002|Overall Study|Disease progression|4|||
143345310|NCT02762981|516810316|FG003|Overall Study|Disease progression|10|||
143345311|NCT02762981|516810317|FG004|Overall Study|Disease progression|1|||
143345312|NCT02762981|516810313|FG000|Overall Study|Enrolled not treated|1|||
143345313|NCT02762981|516810314|FG001|Overall Study|Enrolled not treated|5|||
143345314|NCT02762981|516810315|FG002|Overall Study|Enrolled not treated|0|||
143345315|NCT02762981|516810316|FG003|Overall Study|Enrolled not treated|2|||
143345316|NCT02762981|516810317|FG004|Overall Study|Enrolled not treated|0|||
143345317|NCT02762981|516810313|FG000|Overall Study|Other|2|||
143345318|NCT02762981|516810314|FG001|Overall Study|Other|3|||
143345319|NCT02762981|516810315|FG002|Overall Study|Other|1|||
143345320|NCT02762981|516810316|FG003|Overall Study|Other|0|||
143345321|NCT02762981|516810317|FG004|Overall Study|Other|0|||
143345322|NCT02762981|516810313|FG000|Overall Study|Missing|1|||
143345323|NCT02762981|516810314|FG001|Overall Study|Missing|0|||
143345324|NCT02762981|516810315|FG002|Overall Study|Missing|0|||
143345325|NCT02762981|516810316|FG003|Overall Study|Missing|0|||
143345326|NCT02762981|516810317|FG004|Overall Study|Missing|0|||
143345327|NCT02762981|516810313|FG000|Overall Study|Withdrawal by Subject|0|||
143345328|NCT02762981|516810314|FG001|Overall Study|Withdrawal by Subject|5|||
143345329|NCT02762981|516810315|FG002|Overall Study|Withdrawal by Subject|1|||
143345330|NCT02762981|516810316|FG003|Overall Study|Withdrawal by Subject|3|||
143345331|NCT02762981|516810317|FG004|Overall Study|Withdrawal by Subject|0|||
143345332|NCT01289041|516810318|FG000|Overall Study|Adverse Event|24|||
143345333|NCT01289041|516810318|FG000|Overall Study|Physician Decision|1|||
143345334|NCT01289041|516810318|FG000|Overall Study|Progressive Disease|41|||
143345335|NCT01289041|516810318|FG000|Overall Study|Withdrawal by Subject|3|||
143345336|NCT01289041|516810318|FG000|Overall Study|Death|1|||
143345337|NCT02494921|516810320|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
143345338|NCT02494921|516810321|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
143345339|NCT02494921|516810322|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
143345340|NCT02494921|516810323|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
143345341|NCT02494921|516810324|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
143345342|NCT02494921|516810320|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
143345343|NCT02494921|516810321|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
143345344|NCT02494921|516810322|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
143345345|NCT02494921|516810323|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
143345346|NCT02494921|516810324|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
143345347|NCT02494921|516810320|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
143345348|NCT02494921|516810321|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
143345349|NCT02494921|516810322|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
143345350|NCT02494921|516810323|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
143345351|NCT02494921|516810324|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
143345352|NCT05648357|516810329|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|3|||
143345353|NCT00597714|516810338|FG000|Overall Study|Death|56|||
143345354|NCT00597714|516810339|FG001|Overall Study|Death|46|||
143345355|NCT00597714|516810340|FG002|Overall Study|Death|0|||
143345356|NCT00597714|516810338|FG000|Overall Study|Recipient death|0|||
143345357|NCT00597714|516810339|FG001|Overall Study|Recipient death|0|||
143345358|NCT00597714|516810340|FG002|Overall Study|Recipient death|10|||
143345359|NCT01350141|516810341|FG000|Overall Study|Lost to Follow-up|1|||
143345360|NCT01350141|516810342|FG001|Overall Study|Lost to Follow-up|0|||
143345361|NCT01350141|516810343|FG002|Overall Study|Lost to Follow-up|1|||
143345362|NCT01350141|516810341|FG000|Overall Study|Withdrawal by Subject|1|||
143345363|NCT01350141|516810342|FG001|Overall Study|Withdrawal by Subject|0|||
143345364|NCT01350141|516810343|FG002|Overall Study|Withdrawal by Subject|0|||
143345365|NCT01350141|516810341|FG000|Overall Study|Randomized but not treated|1|||
143345366|NCT01350141|516810342|FG001|Overall Study|Randomized but not treated|0|||
143345367|NCT01350141|516810343|FG002|Overall Study|Randomized but not treated|0|||
143345368|NCT00519896|516810344|FG000|Overall Study|Protocol Violation|1|||
143345369|NCT00519896|516810344|FG000|Overall Study|Adverse Event|1|||
143345370|NCT00810082|516810345|FG000|Overall Study|Lost to Follow-up|0|||
143345371|NCT00810082|516810346|FG001|Overall Study|Lost to Follow-up|4|||
143345372|NCT01588990|516810347|FG000|Phase A|Withdrawal by Subject|5|||
143345373|NCT01588990|516810347|FG000|Phase A|Physician Decision|11|||
143345374|NCT01588990|516810347|FG000|Phase A|Other|14|||
143345375|NCT01588990|516810347|FG000|Phase A|Lost to Follow-up|1|||
143345376|NCT01588990|516810347|FG000|Phase A|Death|5|||
143345377|NCT01588990|516810347|FG000|Phase A|Adverse Event|28|||
143345378|NCT01588990|516810347|FG000|Phase A|Still on therapy at end of study|6|||
143345379|NCT01588990|516810347|FG000|Phase B|Adverse Event|2|||
143345380|NCT01588990|516810347|FG000|Phase B|Still on therapy at end of study|5|||
143345381|NCT01588990|516810347|FG000|Phase B|Withdrawal by Subject|3|||
143345382|NCT01588990|516810347|FG000|Phase B|Physician Decision|4|||
143345383|NCT01588990|516810347|FG000|Phase B|Other|2|||
143368940|NCT02001623|516894567|FG009|Overall Study|Physician Decision|2|||
143122426|NCT00603382|515992562|FG003|Overall Study|Lack of Efficacy|6|||
143122427|NCT00603382|515992563|FG004|Overall Study|Lack of Efficacy|6|||
143122428|NCT00603382|515992564|FG005|Overall Study|Lack of Efficacy|11|||
143122429|NCT00603382|515992559|FG000|Overall Study|Protocol Violation|1|||
143122430|NCT00603382|515992560|FG001|Overall Study|Protocol Violation|0|||
143122431|NCT00603382|515992561|FG002|Overall Study|Protocol Violation|1|||
143345384|NCT02367716|516810352|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
143345385|NCT02917265|516810353|FG000|Overall Study|Physician Decision|1|||
143345386|NCT02917265|516810354|FG001|Overall Study|Physician Decision|0|||
143345387|NCT02917265|516810353|FG000|Overall Study|Withdrawal by Subject|1|||
143345388|NCT02917265|516810354|FG001|Overall Study|Withdrawal by Subject|0|||
143345389|NCT05458024|516810361|FG000|Overall Study|Withdrawal by Subject|1|||
143345390|NCT05458024|516810362|FG001|Overall Study|Withdrawal by Subject|1|||
143345391|NCT05672680|516810363|FG000|Overall Study|Patient Did Not Complete the Form|5|||
143345392|NCT05672680|516810364|FG001|Overall Study|Patient Did Not Complete the Form|4|||
143345393|NCT05672680|516810363|FG000|Overall Study|Procedure Aborted|1|||
143345394|NCT05672680|516810364|FG001|Overall Study|Procedure Aborted|0|||
143345395|NCT01368900|516810365|FG000|Overall Study|Lost to Follow-up|7|||
143345396|NCT02277743|516810366|FG000|Overall Study|Protocol Violation|1|||
143345397|NCT02277743|516810367|FG001|Overall Study|Protocol Violation|1|||
143345398|NCT02277743|516810368|FG002|Overall Study|Protocol Violation|1|||
143345399|NCT02277743|516810366|FG000|Overall Study|Adverse Event|10|||
143345400|NCT02277743|516810367|FG001|Overall Study|Adverse Event|6|||
143345401|NCT02277743|516810368|FG002|Overall Study|Adverse Event|6|||
143345402|NCT02277743|516810366|FG000|Overall Study|Lack of Efficacy|11|||
143345403|NCT02277743|516810367|FG001|Overall Study|Lack of Efficacy|4|||
143345404|NCT02277743|516810368|FG002|Overall Study|Lack of Efficacy|3|||
143345405|NCT02277743|516810366|FG000|Overall Study|Other than specified above|18|||
143345406|NCT02277743|516810367|FG001|Overall Study|Other than specified above|5|||
143345407|NCT02277743|516810368|FG002|Overall Study|Other than specified above|16|||
143345408|NCT01224158|516810372|FG000|Overall Study|Withdrawal by Subject|1|||
143345409|NCT01224158|516810373|FG001|Overall Study|Withdrawal by Subject|0|||
143459444|NCT03149549|517226957|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
143459445|NCT03149549|517226958|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
143459446|NCT03149549|517226959|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
143459447|NCT03149549|517226960|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
143459448|NCT03149549|517226961|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
143459449|NCT03149549|517226962|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
143459450|NCT03149549|517226963|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
143122432|NCT00603382|515992562|FG003|Overall Study|Protocol Violation|2|||
143122433|NCT00603382|515992563|FG004|Overall Study|Protocol Violation|1|||
143122434|NCT00603382|515992564|FG005|Overall Study|Protocol Violation|0|||
143122435|NCT00603382|515992559|FG000|Overall Study|Lost to Follow-up|0|||
143122436|NCT00603382|515992560|FG001|Overall Study|Lost to Follow-up|1|||
143122437|NCT00603382|515992561|FG002|Overall Study|Lost to Follow-up|1|||
143122438|NCT00603382|515992562|FG003|Overall Study|Lost to Follow-up|1|||
143122439|NCT00603382|515992563|FG004|Overall Study|Lost to Follow-up|0|||
143122440|NCT00603382|515992564|FG005|Overall Study|Lost to Follow-up|1|||
143122441|NCT00603382|515992559|FG000|Overall Study|Physician Decision|0|||
143122442|NCT00603382|515992560|FG001|Overall Study|Physician Decision|0|||
143122443|NCT00603382|515992561|FG002|Overall Study|Physician Decision|2|||
143122444|NCT00603382|515992562|FG003|Overall Study|Physician Decision|0|||
143122445|NCT00603382|515992563|FG004|Overall Study|Physician Decision|1|||
143122446|NCT00603382|515992564|FG005|Overall Study|Physician Decision|3|||
143122447|NCT00603382|515992559|FG000|Overall Study|Withdrawal by Subject|3|||
143122448|NCT00603382|515992560|FG001|Overall Study|Withdrawal by Subject|3|||
143122449|NCT00603382|515992561|FG002|Overall Study|Withdrawal by Subject|1|||
143122450|NCT00603382|515992562|FG003|Overall Study|Withdrawal by Subject|1|||
143122451|NCT00603382|515992563|FG004|Overall Study|Withdrawal by Subject|0|||
143122452|NCT00603382|515992564|FG005|Overall Study|Withdrawal by Subject|1|||
143122453|NCT03782974|515992565|FG000|Overall Study|Withdrawal by Subject|7|||
143122454|NCT03782974|515992566|FG001|Overall Study|Withdrawal by Subject|7|||
143122455|NCT03782974|515992565|FG000|Overall Study|Pregnancy|1|||
143122456|NCT03782974|515992566|FG001|Overall Study|Pregnancy|0|||
143122457|NCT00583102|515992567|FG000|Overall Study|Adverse Event|3|||
143122458|NCT01078298|515992571|FG000|Overall Study|Lost to Follow-up|12|||
143122459|NCT01078298|515992572|FG001|Overall Study|Lost to Follow-up|13|||
143122460|NCT01078298|515992571|FG000|Overall Study|Withdrawal by Subject|31|||
143122461|NCT01078298|515992572|FG001|Overall Study|Withdrawal by Subject|33|||
143345410|NCT03976466|516810374|FG000|Overall Study|Lost to Follow-up|1|||
143345411|NCT03976466|516810375|FG001|Overall Study|Lost to Follow-up|3|||
143345412|NCT02055157|516810376|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
143345413|NCT02055157|516810377|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
143345414|NCT02055157|516810378|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
143122462|NCT01078298|515992571|FG000|Overall Study|Protocol Violation|6|||
143122463|NCT01078298|515992572|FG001|Overall Study|Protocol Violation|6|||
143122464|NCT01078298|515992571|FG000|Overall Study|Adverse Event|6|||
143122465|NCT01078298|515992572|FG001|Overall Study|Adverse Event|5|||
143122466|NCT01078298|515992571|FG000|Overall Study|Death|2|||
143122467|NCT01078298|515992572|FG001|Overall Study|Death|0|||
143122468|NCT01078298|515992571|FG000|Overall Study|Did not meet entrance criteria|0|||
143122469|NCT01078298|515992572|FG001|Overall Study|Did not meet entrance criteria|1|||
143122470|NCT01078298|515992571|FG000|Overall Study|Other|24|||
143122471|NCT01078298|515992572|FG001|Overall Study|Other|32|||
143122472|NCT00448812|515992581|FG000|Year 2|Missed visit but remained in study|4|||
143459451|NCT03149549|517226964|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
143459452|NCT03149549|517226965|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
143459453|NCT03149549|517226953|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
143459454|NCT03149549|517226954|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
143459455|NCT03149549|517226955|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
143459456|NCT03149549|517226956|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
143459457|NCT03149549|517226957|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
143459458|NCT03149549|517226958|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
143459459|NCT03149549|517226959|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
143459460|NCT03149549|517226960|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
143459461|NCT03149549|517226961|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
143459462|NCT03149549|517226962|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
143459463|NCT03149549|517226963|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
143459464|NCT03149549|517226964|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
143459465|NCT03149549|517226965|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
143459466|NCT03149549|517226953|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
143459467|NCT03149549|517226954|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
143459468|NCT03149549|517226955|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
143459469|NCT03149549|517226956|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
143459470|NCT03149549|517226957|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
143459471|NCT03149549|517226958|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
143459472|NCT03149549|517226959|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
143459473|NCT03149549|517226960|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
143459474|NCT03149549|517226961|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
143459475|NCT03149549|517226962|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
143459476|NCT03149549|517226963|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
143459477|NCT03149549|517226964|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
143459478|NCT03149549|517226965|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
143459479|NCT03149549|517226953|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
143459480|NCT03149549|517226954|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
143459481|NCT03149549|517226955|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
143459482|NCT03149549|517226956|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
143459483|NCT03149549|517226957|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
143459484|NCT03149549|517226958|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
143459485|NCT03149549|517226959|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
143459486|NCT03149549|517226960|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
143459487|NCT03149549|517226961|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
143459488|NCT03149549|517226962|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
143459489|NCT03149549|517226963|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
143459490|NCT03149549|517226964|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
143459491|NCT03149549|517226965|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
143459492|NCT03149549|517226953|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
143459493|NCT03149549|517226954|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
143459494|NCT03149549|517226955|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
143459495|NCT03149549|517226956|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
143459496|NCT03149549|517226957|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
143459497|NCT03149549|517226958|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
143459498|NCT03149549|517226959|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
143459499|NCT03149549|517226960|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
143459500|NCT03149549|517226961|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
143459501|NCT03149549|517226962|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
143459502|NCT03149549|517226963|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
143459503|NCT03149549|517226964|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
143459504|NCT03149549|517226965|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
143122473|NCT00448812|515992582|FG001|Year 2|Missed visit but remained in study|1|||
143122474|NCT00448812|515992581|FG000|Year 3|Withdrawal by Subject|1|||
143122475|NCT00448812|515992582|FG001|Year 3|Withdrawal by Subject|3|||
143122476|NCT00448812|515992581|FG000|Year 3|Lost to Follow-up|1|||
143122477|NCT00448812|515992582|FG001|Year 3|Lost to Follow-up|0|||
143122478|NCT00448812|515992581|FG000|Year 3|Missed visit but remained in study|2|||
143122479|NCT00448812|515992582|FG001|Year 3|Missed visit but remained in study|0|||
143122480|NCT00448812|515992581|FG000|Year 5|Missed visit but remained in study|1|||
143122481|NCT00448812|515992582|FG001|Year 5|Missed visit but remained in study|0|||
143122482|NCT01471444|515994287|FG000|Overall Study|Physician Decision|3|||
143122483|NCT01471444|515994288|FG001|Overall Study|Physician Decision|2|||
143122484|NCT01471444|515994287|FG000|Overall Study|Withdrawal by Subject|0|||
143122485|NCT01471444|515994288|FG001|Overall Study|Withdrawal by Subject|1|||
143122486|NCT01066663|515994295|FG000|Overall Study|Adverse Event|0|||
143459505|NCT03141905|517226970|FG000|Overall Study|Death|3|||
143459506|NCT03141905|517226971|FG001|Overall Study|Death|2|||
143459507|NCT03141905|517226970|FG000|Overall Study|Withdrawal by Subject|1|||
143459508|NCT03141905|517226971|FG001|Overall Study|Withdrawal by Subject|0|||
143122487|NCT01066663|515994296|FG001|Overall Study|Adverse Event|0|||
143122488|NCT01066663|515994297|FG002|Overall Study|Adverse Event|1|||
143122489|NCT00339833|515994298|FG000|Overall Study|Withdrawal by Subject|1|||
143122490|NCT00339833|515994299|FG001|Overall Study|Withdrawal by Subject|2|||
143122491|NCT00339833|515994298|FG000|Overall Study|toothache|0|||
143122492|NCT00339833|515994299|FG001|Overall Study|toothache|1|||
143122493|NCT00339833|515994298|FG000|Overall Study|indigestion|0|||
143122494|NCT00339833|515994299|FG001|Overall Study|indigestion|1|||
143122495|NCT00339833|515994298|FG000|Overall Study|Chest pain|0|||
143122496|NCT00339833|515994299|FG001|Overall Study|Chest pain|1|||
143122497|NCT00339833|515994298|FG000|Overall Study|minor infection|0|||
143122498|NCT00339833|515994299|FG001|Overall Study|minor infection|1|||
143122499|NCT00339833|515994298|FG000|Overall Study|Poor venous access|2|||
143122500|NCT00339833|515994299|FG001|Overall Study|Poor venous access|2|||
143122501|NCT00339833|515994298|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
143122502|NCT00339833|515994299|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
143122503|NCT00339833|515994298|FG000|Overall Study|Error in data records|1|||
143122504|NCT00339833|515994299|FG001|Overall Study|Error in data records|0|||
143122505|NCT02829047|515994300|FG000|Overall Study|Withdrawal by Subject|1|||
143122506|NCT01597492|515994302|FG000|Overall Study|Withdrawal by Subject|1|||
143122507|NCT01597492|515994303|FG001|Overall Study|Withdrawal by Subject|2|||
143459509|NCT03141905|517226970|FG000|Overall Study|Lost to Follow-up|3|||
143459510|NCT03141905|517226971|FG001|Overall Study|Lost to Follow-up|7|||
143122508|NCT01597492|515994302|FG000|Overall Study|Adverse Event|3|||
143122509|NCT01597492|515994303|FG001|Overall Study|Adverse Event|0|||
143122510|NCT01597492|515994302|FG000|Overall Study|Lost to Follow-up|0|||
143122511|NCT01597492|515994303|FG001|Overall Study|Lost to Follow-up|2|||
143122512|NCT01597492|515994302|FG000|Overall Study|Other Reason|2|||
143122513|NCT01597492|515994303|FG001|Overall Study|Other Reason|0|||
143122514|NCT00496587|515994304|FG000|Overall Study|Adverse Event|2|||
143122515|NCT00496587|515994304|FG000|Overall Study|Progressive Disease|24|||
143122516|NCT00496587|515994304|FG000|Overall Study|Withdrawal by Subject|2|||
143122517|NCT00496587|515994304|FG000|Overall Study|Death|1|||
143122518|NCT00496587|515994304|FG000|Overall Study|Complications unrelated|2|||
143122519|NCT05259917|515994309|FG000|Overall Study|Protocol Violation|0|||
143122520|NCT05259917|515994310|FG001|Overall Study|Protocol Violation|0|||
143122521|NCT05259917|515994311|FG002|Overall Study|Protocol Violation|1|||
143122522|NCT05259917|515994312|FG003|Overall Study|Protocol Violation|0|||
143122523|NCT05259917|515994313|FG004|Overall Study|Protocol Violation|0|||
143122524|NCT05259917|515994314|FG005|Overall Study|Protocol Violation|0|||
143122525|NCT05259917|515994309|FG000|Overall Study|Lost to Follow-up|0|||
143122526|NCT05259917|515994310|FG001|Overall Study|Lost to Follow-up|0|||
143122527|NCT05259917|515994311|FG002|Overall Study|Lost to Follow-up|1|||
143122528|NCT05259917|515994312|FG003|Overall Study|Lost to Follow-up|0|||
143122529|NCT05259917|515994313|FG004|Overall Study|Lost to Follow-up|0|||
143122530|NCT05259917|515994314|FG005|Overall Study|Lost to Follow-up|1|||
143122531|NCT05259917|515994309|FG000|Overall Study|Physician Decision|0|||
143122532|NCT05259917|515994310|FG001|Overall Study|Physician Decision|1|||
143122533|NCT05259917|515994311|FG002|Overall Study|Physician Decision|0|||
143122534|NCT05259917|515994312|FG003|Overall Study|Physician Decision|0|||
143122535|NCT05259917|515994313|FG004|Overall Study|Physician Decision|0|||
143122536|NCT05259917|515994314|FG005|Overall Study|Physician Decision|0|||
143122537|NCT05259917|515994309|FG000|Overall Study|Withdrawal by Subject|0|||
143122538|NCT05259917|515994310|FG001|Overall Study|Withdrawal by Subject|1|||
143122539|NCT05259917|515994311|FG002|Overall Study|Withdrawal by Subject|0|||
143122540|NCT05259917|515994312|FG003|Overall Study|Withdrawal by Subject|0|||
143122541|NCT05259917|515994313|FG004|Overall Study|Withdrawal by Subject|1|||
143122542|NCT05259917|515994314|FG005|Overall Study|Withdrawal by Subject|1|||
143122543|NCT05259917|515994309|FG000|Overall Study|Trial Termination by Sponsor|7|||
143122544|NCT05259917|515994310|FG001|Overall Study|Trial Termination by Sponsor|2|||
143122545|NCT05259917|515994311|FG002|Overall Study|Trial Termination by Sponsor|3|||
143122546|NCT05259917|515994312|FG003|Overall Study|Trial Termination by Sponsor|5|||
143122547|NCT05259917|515994313|FG004|Overall Study|Trial Termination by Sponsor|11|||
143122548|NCT05259917|515994314|FG005|Overall Study|Trial Termination by Sponsor|4|||
143122549|NCT05259917|515994309|FG000|Overall Study|Other|1|||
143122550|NCT05259917|515994310|FG001|Overall Study|Other|0|||
143345415|NCT02055157|516810379|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
143345416|NCT02055157|516810376|FG000|Initial 6 Months|Adverse Event|0|||
143345417|NCT02055157|516810377|FG001|Initial 6 Months|Adverse Event|0|||
143345418|NCT02055157|516810378|FG002|Initial 6 Months|Adverse Event|0|||
143345419|NCT02055157|516810379|FG003|Initial 6 Months|Adverse Event|1|||
143345420|NCT02055157|516810376|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
143345421|NCT02055157|516810377|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
143345422|NCT02055157|516810378|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
143345423|NCT02055157|516810379|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
143345424|NCT02055157|516810376|FG000|18-month Extension|Investigator decision|0|||
143345425|NCT02055157|516810377|FG001|18-month Extension|Investigator decision|1|||
143345426|NCT02055157|516810378|FG002|18-month Extension|Investigator decision|0|||
143345427|NCT02055157|516810379|FG003|18-month Extension|Investigator decision|0|||
143345428|NCT02055157|516810376|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
143345429|NCT02055157|516810377|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
143345430|NCT02055157|516810378|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
143345431|NCT02055157|516810379|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
143345432|NCT02739347|516810382|FG000|Overall Study|Adverse Event|3|||
143345433|NCT02739347|516810383|FG001|Overall Study|Adverse Event|0|||
143345434|NCT02739347|516810382|FG000|Overall Study|Protocol Violation|0|||
143345435|NCT02739347|516810383|FG001|Overall Study|Protocol Violation|1|||
143345436|NCT02739347|516810382|FG000|Overall Study|Lost to Follow-up|0|||
143345437|NCT02739347|516810383|FG001|Overall Study|Lost to Follow-up|2|||
143345438|NCT05096208|516810384|FG000|Overall Study|Lost to Follow-up|3|||
143345439|NCT05096208|516810385|FG001|Overall Study|Lost to Follow-up|5|||
143345440|NCT05096208|516810386|FG002|Overall Study|Lost to Follow-up|5|||
143345441|NCT05096208|516810387|FG003|Overall Study|Lost to Follow-up|2|||
143345442|NCT05096208|516810384|FG000|Overall Study|Withdrawal by Subject|0|||
143345443|NCT05096208|516810385|FG001|Overall Study|Withdrawal by Subject|1|||
143345444|NCT05096208|516810386|FG002|Overall Study|Withdrawal by Subject|2|||
143345445|NCT05096208|516810387|FG003|Overall Study|Withdrawal by Subject|3|||
143345446|NCT05096208|516810384|FG000|Overall Study|No longer met eligibility criteria|1|||
143345447|NCT05096208|516810385|FG001|Overall Study|No longer met eligibility criteria|0|||
143345448|NCT05096208|516810386|FG002|Overall Study|No longer met eligibility criteria|0|||
143345449|NCT05096208|516810387|FG003|Overall Study|No longer met eligibility criteria|0|||
143345450|NCT05096208|516810384|FG000|Overall Study|Other|0|||
143345451|NCT05096208|516810385|FG001|Overall Study|Other|0|||
143345452|NCT05096208|516810386|FG002|Overall Study|Other|1|||
143345453|NCT05096208|516810387|FG003|Overall Study|Other|0|||
143345454|NCT00782496|516810388|FG000|Overall Study|Lost to Follow-up|14|||
143345455|NCT00782496|516810389|FG001|Overall Study|Lost to Follow-up|15|||
143345456|NCT01336621|516810393|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
143345457|NCT01336621|516810393|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
143345458|NCT01336621|516810393|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
143345459|NCT01336621|516810393|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
143345460|NCT01336621|516810393|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
143345461|NCT01336621|516810393|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
143345462|NCT01336621|516810393|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
143345463|NCT01336621|516810393|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
143122551|NCT05259917|515994311|FG002|Overall Study|Other|2|||
143122552|NCT05259917|515994312|FG003|Overall Study|Other|0|||
143122553|NCT05259917|515994313|FG004|Overall Study|Other|0|||
143122554|NCT05259917|515994314|FG005|Overall Study|Other|0|||
143122555|NCT03624569|515994315|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
143122556|NCT03624569|515994316|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
143122557|NCT03624569|515994315|FG000|Second Intervention (2 Weeks)|Protocol Violation|1|||
143122558|NCT03624569|515994316|FG001|Second Intervention (2 Weeks)|Protocol Violation|1|||
143122559|NCT03585712|515994317|FG000|Treatment Period 1|Protocol Violation|1|||
143122560|NCT03585712|515994318|FG001|Treatment Period 1|Protocol Violation|0|||
143345464|NCT01336621|516810393|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
143345465|NCT01336621|516810393|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
143345466|NCT01336621|516810393|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
143345467|NCT01336621|516810393|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
143345468|NCT01336621|516810393|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
143345469|NCT01336621|516810393|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
143345470|NCT01126060|516810396|FG000|Overall Study|Protocol Violation|0|||
143345471|NCT01126060|516810397|FG001|Overall Study|Protocol Violation|2|||
143122561|NCT03585712|515994319|FG002|Treatment Period 1|Protocol Violation|0|||
143122562|NCT03585712|515994317|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
143345472|NCT00402337|516810402|FG000|Overall Study|Adverse Event|0|||
143345473|NCT00402337|516810403|FG001|Overall Study|Adverse Event|2|||
143345474|NCT00402337|516810404|FG002|Overall Study|Adverse Event|2|||
143345475|NCT00402337|516810405|FG003|Overall Study|Adverse Event|3|||
143122563|NCT03585712|515994318|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
143122564|NCT03585712|515994319|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
143122565|NCT03585712|515994317|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
143122566|NCT03585712|515994318|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
143122567|NCT03585712|515994319|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
143122568|NCT03585712|515994317|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
143122569|NCT03585712|515994318|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
143122570|NCT03585712|515994319|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
143122571|NCT03517449|515994320|FG000|Overall Study|Death|184|||
143122572|NCT03517449|515994321|FG001|Overall Study|Death|236|||
143122573|NCT03517449|515994320|FG000|Overall Study|Lost to Follow-up|0|||
143122574|NCT03517449|515994321|FG001|Overall Study|Lost to Follow-up|2|||
143122575|NCT03517449|515994320|FG000|Overall Study|Withdrawal by Subject|7|||
143122576|NCT03517449|515994321|FG001|Overall Study|Withdrawal by Subject|26|||
143122577|NCT03517449|515994320|FG000|Overall Study|Participants Ongoing|220|||
143122578|NCT03517449|515994321|FG001|Overall Study|Participants Ongoing|152|||
143122579|NCT00269477|515994322|FG000|Overall Study|Protocol Violation|5|||
143122580|NCT00269477|515994323|FG001|Overall Study|Protocol Violation|5|||
143122581|NCT00269477|515994324|FG002|Overall Study|Protocol Violation|1|||
143122582|NCT00269477|515994325|FG003|Overall Study|Protocol Violation|0|||
143122583|NCT00269477|515994322|FG000|Overall Study|Missed post-vaccination blood draw|0|||
143122584|NCT00269477|515994323|FG001|Overall Study|Missed post-vaccination blood draw|1|||
143122585|NCT00269477|515994324|FG002|Overall Study|Missed post-vaccination blood draw|0|||
143122586|NCT00269477|515994325|FG003|Overall Study|Missed post-vaccination blood draw|0|||
143122587|NCT00938587|515994326|FG000|Overall Study|Adverse Event|2|||
143122588|NCT00938587|515994327|FG001|Overall Study|Adverse Event|0|||
143122589|NCT00938587|515994328|FG002|Overall Study|Adverse Event|0|||
143122590|NCT00938587|515994329|FG003|Overall Study|Adverse Event|2|||
143122591|NCT00938587|515994326|FG000|Overall Study|Did not meet entrance criteria|0|||
143122592|NCT00938587|515994327|FG001|Overall Study|Did not meet entrance criteria|0|||
143122593|NCT00938587|515994328|FG002|Overall Study|Did not meet entrance criteria|1|||
143122594|NCT00938587|515994329|FG003|Overall Study|Did not meet entrance criteria|0|||
143122595|NCT00938587|515994326|FG000|Overall Study|Withdrawal by Subject|1|||
143122596|NCT00938587|515994327|FG001|Overall Study|Withdrawal by Subject|1|||
143122597|NCT00938587|515994328|FG002|Overall Study|Withdrawal by Subject|0|||
143122598|NCT00938587|515994329|FG003|Overall Study|Withdrawal by Subject|0|||
143122599|NCT00849290|515994330|FG000|Overall Study|Adverse Event|3|||
143122600|NCT00849290|515994330|FG000|Overall Study|Death|14|||
143122601|NCT00849290|515994330|FG000|Overall Study|Withdrawal by Subject|11|||
143122602|NCT00849290|515994330|FG000|Overall Study|Lost to Follow-up|2|||
143122603|NCT00849290|515994330|FG000|Overall Study|Protocol Violation|5|||
143122604|NCT00849290|515994330|FG000|Overall Study|Disease Progression|20|||
143122605|NCT02007278|515994337|FG000|Overall Study|Failure to comply with an eligibility|0|||
143122606|NCT02007278|515994338|FG001|Overall Study|Failure to comply with an eligibility|1|||
143122607|NCT02007278|515994337|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
143122608|NCT02007278|515994338|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
143122609|NCT02007278|515994337|FG000|Overall Study|Incorrect medication administration|1|||
143122610|NCT02007278|515994338|FG001|Overall Study|Incorrect medication administration|0|||
143122611|NCT02007278|515994337|FG000|Overall Study|Mis-randomization|1|||
143122612|NCT02007278|515994338|FG001|Overall Study|Mis-randomization|1|||
143122613|NCT02886884|515994344|FG000|Follow-up|Withdrawal by Subject|0|||
143122614|NCT02886884|515994345|FG001|Follow-up|Withdrawal by Subject|0|||
143122615|NCT02886884|515994346|FG002|Follow-up|Withdrawal by Subject|0|||
143122616|NCT02886884|515994347|FG003|Follow-up|Withdrawal by Subject|1|||
143122617|NCT01915771|515994348|FG000|Day 1|Withdrawal by Subject|1|||
143122618|NCT01915771|515994348|FG000|Day 15|Withdrawal by Subject|1|||
143122619|NCT03420222|515994356|FG000|Overall Study|Withdrawal by Subject|5|||
143122620|NCT03420222|515994357|FG001|Overall Study|Withdrawal by Subject|0|||
143122621|NCT03420222|515994356|FG000|Overall Study|Physician Decision|0|||
143122622|NCT03420222|515994357|FG001|Overall Study|Physician Decision|1|||
143122623|NCT02697734|515994358|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
143122624|NCT02697734|515994359|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
143122625|NCT02697734|515994358|FG000|Core Phase - up to Week 48|Adverse Event|1|||
143122626|NCT02697734|515994359|FG001|Core Phase - up to Week 48|Adverse Event|2|||
143122627|NCT02697734|515994358|FG000|Core Phase - up to Week 48|Physician Decision|1|||
143122628|NCT02697734|515994359|FG001|Core Phase - up to Week 48|Physician Decision|0|||
143122629|NCT02697734|515994358|FG000|Optional Extension Phase|Adverse Event|5|||
143122630|NCT02697734|515994359|FG001|Optional Extension Phase|Adverse Event|1|||
143122631|NCT02697734|515994358|FG000|Optional Extension Phase|Physician Decision|0|||
143122632|NCT02697734|515994359|FG001|Optional Extension Phase|Physician Decision|1|||
143122633|NCT02334384|515994360|FG000|Overall Study|Lost to Follow-up|1|||
143122634|NCT02334384|515994361|FG001|Overall Study|Lost to Follow-up|1|||
143122635|NCT00731731|515994362|FG000|Overall Study|Protocol Violation|0|||
143122636|NCT00731731|515994363|FG001|Overall Study|Protocol Violation|0|||
143122637|NCT00731731|515994364|FG002|Overall Study|Protocol Violation|1|||
143122638|NCT00731731|515994362|FG000|Overall Study|Cancel prior to treatment|0|||
143122639|NCT00731731|515994363|FG001|Overall Study|Cancel prior to treatment|0|||
143122640|NCT00731731|515994364|FG002|Overall Study|Cancel prior to treatment|2|||
143122641|NCT01578499|515994368|FG000|Overall Study|Reason not Specified|0|||
143122642|NCT01578499|515994369|FG001|Overall Study|Reason not Specified|1|||
143122643|NCT01578499|515994368|FG000|Overall Study|Lost to Follow-up|2|||
143122644|NCT01578499|515994369|FG001|Overall Study|Lost to Follow-up|1|||
143122645|NCT01578499|515994368|FG000|Overall Study|Withdrawal by Subject|10|||
143122646|NCT01578499|515994369|FG001|Overall Study|Withdrawal by Subject|16|||
143122647|NCT01578499|515994368|FG000|Overall Study|Death|20|||
143122648|NCT01578499|515994369|FG001|Overall Study|Death|25|||
143122649|NCT01578499|515994368|FG000|Overall Study|Died and End of Study Page not Completed|2|||
143122650|NCT01578499|515994369|FG001|Overall Study|Died and End of Study Page not Completed|0|||
143122651|NCT02670382|515994373|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
143122652|NCT02670382|515994374|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
143122653|NCT03244618|515994377|FG000|Overall Study|Lost to Follow-up|3|||
143122654|NCT03244618|515994378|FG001|Overall Study|Lost to Follow-up|4|||
143122655|NCT03244618|515994377|FG000|Overall Study|Protocol Violation|4|||
143122656|NCT03244618|515994378|FG001|Overall Study|Protocol Violation|3|||
143122657|NCT03244618|515994377|FG000|Overall Study|Withdrawal by Subject|0|||
143122658|NCT03244618|515994378|FG001|Overall Study|Withdrawal by Subject|2|||
143122659|NCT00830518|515994379|FG000|Overall Study|Progressive Disease|18|||
143122660|NCT00830518|515994380|FG001|Overall Study|Progressive Disease|8|||
143122661|NCT00830518|515994379|FG000|Overall Study|Symptomatic Deterioration|4|||
143122662|NCT00830518|515994380|FG001|Overall Study|Symptomatic Deterioration|1|||
143122663|NCT00830518|515994379|FG000|Overall Study|Adverse Event|14|||
143122664|NCT00830518|515994380|FG001|Overall Study|Adverse Event|1|||
143122665|NCT00830518|515994379|FG000|Overall Study|Withdrawal by Patient|2|||
143122666|NCT00830518|515994380|FG001|Overall Study|Withdrawal by Patient|0|||
143122667|NCT00830518|515994379|FG000|Overall Study|Reason not Specified|8|||
143122668|NCT00830518|515994380|FG001|Overall Study|Reason not Specified|1|||
143122669|NCT01778751|515994386|FG000|Overall Study|Lost to Follow-up|1|||
143122670|NCT01778751|515994387|FG001|Overall Study|Lost to Follow-up|0|||
143122671|NCT01778751|515994386|FG000|Overall Study|Withdrawal by Subject|0|||
143122672|NCT01778751|515994387|FG001|Overall Study|Withdrawal by Subject|2|||
143122673|NCT01778751|515994386|FG000|Overall Study|Transfered care|1|||
143122674|NCT01778751|515994387|FG001|Overall Study|Transfered care|0|||
143122675|NCT02791438|515994394|FG000|Treatment Period|Adverse Event|1|||
143122676|NCT02791438|515994395|FG001|Treatment Period|Adverse Event|0|||
143122677|NCT02791438|515994394|FG000|Treatment Period|Withdrawal by Subject|0|||
143122678|NCT02791438|515994395|FG001|Treatment Period|Withdrawal by Subject|1|||
143122679|NCT02791438|515994394|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
143122680|NCT02791438|515994395|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
143122681|NCT01215435|515994396|FG000|Overall Study|Adverse Event|1|||
143122682|NCT01215435|515994397|FG001|Overall Study|Adverse Event|0|||
143122683|NCT01215435|515994396|FG000|Overall Study|Protocol Violation|2|||
143122684|NCT01215435|515994397|FG001|Overall Study|Protocol Violation|0|||
143122685|NCT01215435|515994396|FG000|Overall Study|Withdrawal Criteria|8|||
143122686|NCT01215435|515994397|FG001|Overall Study|Withdrawal Criteria|11|||
143122687|NCT01215435|515994396|FG000|Overall Study|Lost to Follow-up|3|||
143122688|NCT01215435|515994397|FG001|Overall Study|Lost to Follow-up|0|||
143122689|NCT01215435|515994396|FG000|Overall Study|Unclassified|5|||
143122690|NCT01215435|515994397|FG001|Overall Study|Unclassified|5|||
143122691|NCT00586898|515994406|FG000|Overall Study|Adverse Event|1|||
143122692|NCT00586898|515994406|FG000|Overall Study|Patiemt Non-compliance|1|||
143122693|NCT00586898|515994406|FG000|Overall Study|Evaluable for Toxicity Only|5|||
143122694|NCT01156051|515994407|FG000|Overall Study|Lost to Follow-up|1|||
143122695|NCT01156051|515994408|FG001|Overall Study|Lost to Follow-up|0|||
143459511|NCT03141905|517226970|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
143459512|NCT03141905|517226971|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
143122696|NCT01156051|515994407|FG000|Overall Study|patient not compliant with protocol|0|||
143122697|NCT01156051|515994408|FG001|Overall Study|patient not compliant with protocol|1|||
143122698|NCT02620384|515994412|FG000|Overall Study|Adverse Event|2|||
143122699|NCT02620384|515994413|FG001|Overall Study|Adverse Event|1|||
143122700|NCT02620384|515994412|FG000|Overall Study|Discharged prior to 2nd dose|2|||
143122701|NCT02620384|515994413|FG001|Overall Study|Discharged prior to 2nd dose|5|||
143122702|NCT02620384|515994412|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
143122703|NCT02620384|515994413|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
143122704|NCT02101359|515994414|FG000|Overall Study|Not included|23|||
143122705|NCT02101359|515994415|FG001|Overall Study|Not included|13|||
143122706|NCT02101359|515994414|FG000|Overall Study|Withdrawal by Subject|5|||
143122707|NCT02101359|515994415|FG001|Overall Study|Withdrawal by Subject|4|||
143122708|NCT02101359|515994414|FG000|Overall Study|Lost to Follow-up|1|||
143122709|NCT02101359|515994415|FG001|Overall Study|Lost to Follow-up|0|||
143122710|NCT02101359|515994414|FG000|Overall Study|Protocol Violation|0|||
143122711|NCT02101359|515994415|FG001|Overall Study|Protocol Violation|2|||
143122712|NCT00742027|515994423|FG000|Overall Study|Disease Progression|76|||
143122713|NCT00742027|515994423|FG000|Overall Study|New Cancer Therapy|19|||
143122714|NCT00742027|515994423|FG000|Overall Study|Withdrawal by Subject|18|||
143122715|NCT00742027|515994423|FG000|Overall Study|Death|7|||
143122716|NCT00742027|515994423|FG000|Overall Study|Lost to Follow-up|4|||
143122717|NCT00742027|515994423|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
143122718|NCT00742027|515994423|FG000|Overall Study|Missing|2|||
143122719|NCT00742027|515994423|FG000|Overall Study|Administrative Problems|1|||
143122720|NCT01180049|515994424|FG000|Overall Study|Other|9|||
143122721|NCT01180049|515994425|FG001|Overall Study|Other|7|||
143122722|NCT01180049|515994424|FG000|Overall Study|Lost to Follow-up|8|||
143122723|NCT01180049|515994425|FG001|Overall Study|Lost to Follow-up|6|||
143122724|NCT01180049|515994424|FG000|Overall Study|Death|36|||
143122725|NCT01180049|515994425|FG001|Overall Study|Death|35|||
143122726|NCT01738191|515994428|FG000|Overall Study|Withdrawal by Subject|4|||
143122727|NCT01738191|515994429|FG001|Overall Study|Withdrawal by Subject|1|||
143122728|NCT00350779|515994431|FG000|Overall Study|Adverse Event|4|||
143122729|NCT00350779|515994432|FG001|Overall Study|Adverse Event|2|||
143122730|NCT00350779|515994431|FG000|Overall Study|Lack of Efficacy|0|||
143122731|NCT00350779|515994432|FG001|Overall Study|Lack of Efficacy|4|||
143122732|NCT00350779|515994431|FG000|Overall Study|Lost to Follow-up|2|||
143122733|NCT00350779|515994432|FG001|Overall Study|Lost to Follow-up|0|||
143122734|NCT00350779|515994431|FG000|Overall Study|Physician Decision|2|||
143122735|NCT00350779|515994432|FG001|Overall Study|Physician Decision|4|||
143122736|NCT00350779|515994431|FG000|Overall Study|Protocol Violation|3|||
143122737|NCT00350779|515994432|FG001|Overall Study|Protocol Violation|1|||
143122738|NCT00350779|515994431|FG000|Overall Study|Withdrawal by Subject|9|||
143122739|NCT00350779|515994432|FG001|Overall Study|Withdrawal by Subject|8|||
143122740|NCT00350779|515994431|FG000|Overall Study|Patient Moved|2|||
143122741|NCT00350779|515994432|FG001|Overall Study|Patient Moved|1|||
143122742|NCT00350779|515994431|FG000|Overall Study|Non-compliance with study procedures|0|||
143122743|NCT00350779|515994432|FG001|Overall Study|Non-compliance with study procedures|1|||
143122744|NCT03796676|515994433|FG000|Overall Study|Adverse Event|2|||
143122745|NCT03796676|515994434|FG001|Overall Study|Adverse Event|1|||
143122746|NCT03796676|515994435|FG002|Overall Study|Adverse Event|2|||
143122747|NCT03796676|515994433|FG000|Overall Study|Lost to Follow-up|2|||
143122748|NCT03796676|515994434|FG001|Overall Study|Lost to Follow-up|1|||
143122749|NCT03796676|515994435|FG002|Overall Study|Lost to Follow-up|0|||
143122750|NCT03796676|515994433|FG000|Overall Study|Protocol Violation|0|||
143122751|NCT03796676|515994434|FG001|Overall Study|Protocol Violation|0|||
143122752|NCT03796676|515994435|FG002|Overall Study|Protocol Violation|1|||
143122753|NCT03796676|515994433|FG000|Overall Study|Withdrawal by Subject|1|||
143122754|NCT03796676|515994434|FG001|Overall Study|Withdrawal by Subject|1|||
143122755|NCT03796676|515994435|FG002|Overall Study|Withdrawal by Subject|0|||
143122756|NCT03796676|515994433|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
143122757|NCT03796676|515994434|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
143122758|NCT03796676|515994435|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
143122759|NCT00528372|515994436|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
143122760|NCT00528372|515994437|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
143122761|NCT00528372|515994438|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
143122762|NCT00528372|515994439|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
143122763|NCT00528372|515994440|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
143122764|NCT00528372|515994441|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
143122765|NCT00528372|515994442|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
143122766|NCT00528372|515994443|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
143122767|NCT00528372|515994444|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
143122768|NCT00528372|515994436|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
143122769|NCT00528372|515994437|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
143122770|NCT00528372|515994438|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
143122771|NCT00528372|515994439|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
143122772|NCT00528372|515994440|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
143122773|NCT00528372|515994441|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
143122774|NCT00528372|515994442|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
143122775|NCT00528372|515994443|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
143122776|NCT00528372|515994444|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
143122777|NCT00528372|515994436|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
143122778|NCT00528372|515994437|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
143122779|NCT00528372|515994438|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
143122780|NCT00528372|515994439|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
143122781|NCT00528372|515994440|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
143122782|NCT00528372|515994441|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
143122783|NCT00528372|515994442|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
143345476|NCT00402337|516810406|FG004|Overall Study|Adverse Event|2|||
143345477|NCT00402337|516810402|FG000|Overall Study|Noncompliance|0|||
143345478|NCT00402337|516810403|FG001|Overall Study|Noncompliance|0|||
143345479|NCT00402337|516810404|FG002|Overall Study|Noncompliance|0|||
143345480|NCT00402337|516810405|FG003|Overall Study|Noncompliance|0|||
143345481|NCT00402337|516810406|FG004|Overall Study|Noncompliance|2|||
143345482|NCT00402337|516810402|FG000|Overall Study|Withdrawal by Subject|5|||
143345483|NCT00402337|516810403|FG001|Overall Study|Withdrawal by Subject|3|||
143345484|NCT00402337|516810404|FG002|Overall Study|Withdrawal by Subject|1|||
143345485|NCT00402337|516810405|FG003|Overall Study|Withdrawal by Subject|6|||
143345486|NCT00402337|516810406|FG004|Overall Study|Withdrawal by Subject|4|||
143345487|NCT00402337|516810402|FG000|Overall Study|Lost to Follow-up|0|||
143345488|NCT00402337|516810403|FG001|Overall Study|Lost to Follow-up|0|||
143345489|NCT00402337|516810404|FG002|Overall Study|Lost to Follow-up|1|||
143345490|NCT00402337|516810405|FG003|Overall Study|Lost to Follow-up|2|||
143345491|NCT00402337|516810406|FG004|Overall Study|Lost to Follow-up|0|||
143345492|NCT00402337|516810402|FG000|Overall Study|Physician Decision|0|||
143345493|NCT00402337|516810403|FG001|Overall Study|Physician Decision|0|||
143345494|NCT00402337|516810404|FG002|Overall Study|Physician Decision|0|||
143345495|NCT00402337|516810405|FG003|Overall Study|Physician Decision|1|||
143345496|NCT00402337|516810406|FG004|Overall Study|Physician Decision|0|||
143345497|NCT00402337|516810402|FG000|Overall Study|Other Reason|0|||
143345498|NCT00402337|516810403|FG001|Overall Study|Other Reason|1|||
143345499|NCT00402337|516810404|FG002|Overall Study|Other Reason|0|||
143345500|NCT00402337|516810405|FG003|Overall Study|Other Reason|0|||
143345501|NCT00402337|516810406|FG004|Overall Study|Other Reason|0|||
143345502|NCT02178566|516810407|FG000|Overall Study|patient did not complete due to noncompliance|0|||
143345503|NCT02178566|516810408|FG001|Overall Study|patient did not complete due to noncompliance|1|||
143345504|NCT05778526|516810413|FG000|Overall Study|Lost to Follow-up|0|||
143345505|NCT05778526|516810414|FG001|Overall Study|Lost to Follow-up|1|||
143345506|NCT05778526|516810415|FG002|Overall Study|Lost to Follow-up|3|||
143345507|NCT05778526|516810413|FG000|Overall Study|Protocol Violation|0|||
143345508|NCT05778526|516810414|FG001|Overall Study|Protocol Violation|0|||
143345509|NCT05778526|516810415|FG002|Overall Study|Protocol Violation|8|||
143345510|NCT00085202|516810416|FG000|Overall Study|Still on therapy|2|||
143345511|NCT00085202|516810417|FG001|Overall Study|Still on therapy|0|||
143345512|NCT00085202|516810416|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
143345513|NCT00085202|516810417|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
143345514|NCT00085202|516810416|FG000|Overall Study|Excessive toxicity|6|||
143345515|NCT00085202|516810417|FG001|Overall Study|Excessive toxicity|5|||
143345516|NCT00085202|516810416|FG000|Overall Study|Non-specified|3|||
143345517|NCT00085202|516810417|FG001|Overall Study|Non-specified|5|||
143345518|NCT00085202|516810416|FG000|Overall Study|Withdrawal by Subject|2|||
143345519|NCT00085202|516810417|FG001|Overall Study|Withdrawal by Subject|1|||
143345520|NCT00085202|516810416|FG000|Overall Study|Physician Decision|4|||
143345521|NCT00085202|516810417|FG001|Overall Study|Physician Decision|1|||
143345522|NCT00085202|516810416|FG000|Overall Study|Progressive disease|1|||
143345523|NCT00085202|516810417|FG001|Overall Study|Progressive disease|11|||
143345524|NCT01436201|516810420|FG000|Overall Study|Adverse Event|2|||
143345525|NCT01436201|516810420|FG000|Overall Study|Withdrawal by Subject|1|||
143345526|NCT01436201|516810420|FG000|Overall Study|Protocol Violation|1|||
143345527|NCT00110890|516810422|FG000|Overall Study|Adverse Event|30|||
143345528|NCT00110890|516810423|FG001|Overall Study|Adverse Event|7|||
143345529|NCT00110890|516810422|FG000|Overall Study|Death|16|||
143345530|NCT00110890|516810423|FG001|Overall Study|Death|9|||
143345531|NCT00110890|516810422|FG000|Overall Study|Lost to Follow-up|3|||
143345532|NCT00110890|516810423|FG001|Overall Study|Lost to Follow-up|1|||
143345533|NCT00110890|516810422|FG000|Overall Study|Physician Decision|4|||
143345534|NCT00110890|516810423|FG001|Overall Study|Physician Decision|5|||
143345535|NCT00110890|516810422|FG000|Overall Study|Withdrawal by Subject|17|||
143345536|NCT00110890|516810423|FG001|Overall Study|Withdrawal by Subject|5|||
143345537|NCT00110890|516810422|FG000|Overall Study|Protocol Deviation|1|||
143345538|NCT00110890|516810423|FG001|Overall Study|Protocol Deviation|0|||
143345539|NCT00110890|516810422|FG000|Overall Study|Noncompliance|10|||
143345540|NCT00110890|516810423|FG001|Overall Study|Noncompliance|0|||
143345541|NCT00110890|516810422|FG000|Overall Study|Kidney Transplant|16|||
143345542|NCT00110890|516810423|FG001|Overall Study|Kidney Transplant|12|||
143345543|NCT00110890|516810422|FG000|Overall Study|Invest. Product Commercially Available|217|||
143345544|NCT00110890|516810423|FG001|Overall Study|Invest. Product Commercially Available|110|||
143345545|NCT00110890|516810422|FG000|Overall Study|Other|34|||
143345546|NCT00110890|516810423|FG001|Overall Study|Other|23|||
143345547|NCT00110890|516810422|FG000|Overall Study|Ineligibility determined|3|||
143345548|NCT00110890|516810423|FG001|Overall Study|Ineligibility determined|0|||
143345549|NCT00110890|516810422|FG000|Overall Study|Requirement for alternative therapy|0|||
143345550|NCT00110890|516810423|FG001|Overall Study|Requirement for alternative therapy|1|||
143345551|NCT00110890|516810422|FG000|Overall Study|Disease progression|0|||
143345552|NCT00110890|516810423|FG001|Overall Study|Disease progression|1|||
143345553|NCT00110890|516810422|FG000|Overall Study|Parathyroidectomy|0|||
143345554|NCT00110890|516810423|FG001|Overall Study|Parathyroidectomy|1|||
143345555|NCT00110890|516810422|FG000|Overall Study|Did not enter follow-up phase|10|||
143345556|NCT00110890|516810423|FG001|Overall Study|Did not enter follow-up phase|4|||
143345557|NCT01975220|516810424|FG000|Test Period 1|Not treated|0|||
143345558|NCT01975220|516810425|FG001|Test Period 1|Not treated|1|||
143345559|NCT01975220|516810426|FG002|Test Period 1|Not treated|0|||
143345560|NCT01975220|516810427|FG003|Test Period 1|Not treated|0|||
143345561|NCT01975220|516810428|FG004|Test Period 1|Not treated|0|||
143345562|NCT01975220|516810429|FG005|Test Period 1|Not treated|0|||
143345563|NCT03389477|516810438|FG000|Step 1|Withdrawal by Subject|1|||
143345564|NCT03389477|516810439|FG001|Step 1|Withdrawal by Subject|0|||
143345565|NCT03389477|516810438|FG000|Step 2|Withdrawal by Subject|1|||
143345566|NCT03389477|516810439|FG001|Step 2|Withdrawal by Subject|2|||
143345567|NCT03389477|516810438|FG000|Step 2|Disease progression|1|||
143345568|NCT03389477|516810439|FG001|Step 2|Disease progression|0|||
143345569|NCT03389477|516810438|FG000|Step 2|Death|0|||
143345570|NCT03389477|516810439|FG001|Step 2|Death|1|||
143345571|NCT03389477|516810438|FG000|Step 2|Poor performance status and nutrition|0|||
143345572|NCT03389477|516810439|FG001|Step 2|Poor performance status and nutrition|1|||
143345573|NCT03389477|516810438|FG000|Step 3|Withdrawal after 3 cycles|0|||
143345574|NCT03389477|516810439|FG001|Step 3|Withdrawal after 3 cycles|1|||
143345575|NCT03389477|516810438|FG000|Step 3|Still receiving active treatment|4|||
143345576|NCT03389477|516810439|FG001|Step 3|Still receiving active treatment|0|||
143345577|NCT03389477|516810438|FG000|Step 3|Progressive disease after 2 cycles|1|||
143345578|NCT03389477|516810439|FG001|Step 3|Progressive disease after 2 cycles|0|||
143345579|NCT00445679|516810440|FG000|Overall Study|Adverse Event|22|||
143345580|NCT00445679|516810441|FG001|Overall Study|Adverse Event|12|||
143345581|NCT00445679|516810442|FG002|Overall Study|Adverse Event|30|||
143345582|NCT00445679|516810443|FG003|Overall Study|Adverse Event|19|||
143345583|NCT00445679|516810440|FG000|Overall Study|Failed to return|1|||
143345584|NCT00445679|516810441|FG001|Overall Study|Failed to return|3|||
143345585|NCT00445679|516810442|FG002|Overall Study|Failed to return|2|||
143345586|NCT00445679|516810443|FG003|Overall Study|Failed to return|2|||
143345587|NCT00445679|516810440|FG000|Overall Study|Physician Decision|0|||
143345588|NCT00445679|516810441|FG001|Overall Study|Physician Decision|0|||
143345589|NCT00445679|516810442|FG002|Overall Study|Physician Decision|1|||
143345590|NCT00445679|516810443|FG003|Overall Study|Physician Decision|0|||
143345591|NCT00445679|516810440|FG000|Overall Study|Lost to Follow-up|10|||
143345592|NCT00445679|516810441|FG001|Overall Study|Lost to Follow-up|6|||
143345593|NCT00445679|516810442|FG002|Overall Study|Lost to Follow-up|6|||
143345594|NCT00445679|516810443|FG003|Overall Study|Lost to Follow-up|5|||
143345595|NCT00445679|516810440|FG000|Overall Study|Compliance|3|||
143345596|NCT00445679|516810441|FG001|Overall Study|Compliance|2|||
143345597|NCT00445679|516810442|FG002|Overall Study|Compliance|1|||
143345598|NCT00445679|516810443|FG003|Overall Study|Compliance|2|||
143345599|NCT00445679|516810440|FG000|Overall Study|Withdrawal of Informed Consent|0|||
143345600|NCT00445679|516810441|FG001|Overall Study|Withdrawal of Informed Consent|0|||
143345601|NCT00445679|516810442|FG002|Overall Study|Withdrawal of Informed Consent|1|||
143345602|NCT00445679|516810443|FG003|Overall Study|Withdrawal of Informed Consent|0|||
143345603|NCT00445679|516810440|FG000|Overall Study|Protocol Violation|2|||
143345604|NCT00445679|516810441|FG001|Overall Study|Protocol Violation|3|||
143345605|NCT00445679|516810442|FG002|Overall Study|Protocol Violation|3|||
143345606|NCT00445679|516810443|FG003|Overall Study|Protocol Violation|1|||
143345607|NCT00445679|516810440|FG000|Overall Study|Withdrawal by Subject|8|||
143345608|NCT00445679|516810441|FG001|Overall Study|Withdrawal by Subject|14|||
143345609|NCT00445679|516810442|FG002|Overall Study|Withdrawal by Subject|20|||
143345610|NCT00445679|516810443|FG003|Overall Study|Withdrawal by Subject|18|||
143345611|NCT00445679|516810440|FG000|Overall Study|Lack of Efficacy|2|||
143345612|NCT00445679|516810441|FG001|Overall Study|Lack of Efficacy|6|||
143345613|NCT00445679|516810442|FG002|Overall Study|Lack of Efficacy|2|||
143345614|NCT00445679|516810443|FG003|Overall Study|Lack of Efficacy|0|||
143345615|NCT01353222|516810444|FG000|Overall Study|Death|30|||
143345616|NCT01353222|516810445|FG001|Overall Study|Death|30|||
143345617|NCT01353222|516810444|FG000|Overall Study|Withdrawal by Subject|8|||
143345618|NCT01353222|516810445|FG001|Overall Study|Withdrawal by Subject|5|||
143345619|NCT01353222|516810444|FG000|Overall Study|Study Terminated|31|||
143345620|NCT01353222|516810445|FG001|Overall Study|Study Terminated|37|||
143345621|NCT01353222|516810444|FG000|Overall Study|Site closed research department|1|||
143345622|NCT01353222|516810445|FG001|Overall Study|Site closed research department|0|||
143345623|NCT01654601|516810447|FG000|1st Administration|Withdrawal by Subject|2|||
143345624|NCT01654601|516810448|FG001|1st Administration|Withdrawal by Subject|0|||
143345625|NCT01654601|516810447|FG000|1st Administration|Protocol Violation|0|||
143345626|NCT01654601|516810448|FG001|1st Administration|Protocol Violation|2|||
143345627|NCT01654601|516810447|FG000|2nd Administration|Adverse Event|1|||
143345628|NCT01654601|516810448|FG001|2nd Administration|Adverse Event|0|||
143345629|NCT01654601|516810447|FG000|2nd Administration|Protocol Violation|0|||
143345630|NCT01654601|516810448|FG001|2nd Administration|Protocol Violation|1|||
143345631|NCT02636270|516810449|FG000|Overall Study|Adverse Event|1|||
143345632|NCT02636270|516810450|FG001|Overall Study|Adverse Event|0|||
143345633|NCT02636270|516810451|FG002|Overall Study|Adverse Event|0|||
143368941|NCT02001623|516894568|FG010|Overall Study|Physician Decision|3|||
143459513|NCT01775124|517226973|FG000|Core Period|Disease Progression|0|||
143459514|NCT01775124|517226974|FG001|Core Period|Disease Progression|1|||
143122784|NCT00528372|515994443|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
143122785|NCT00528372|515994444|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
143122786|NCT00528372|515994436|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
143122787|NCT00528372|515994437|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
143122788|NCT00528372|515994438|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
143122789|NCT00528372|515994439|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
143122790|NCT00528372|515994440|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
143122791|NCT00528372|515994441|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
143122792|NCT00528372|515994442|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
143122793|NCT00528372|515994443|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
143122794|NCT00528372|515994444|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
143122795|NCT00528372|515994436|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
143122796|NCT00528372|515994437|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
143122797|NCT00528372|515994438|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
143122798|NCT00528372|515994439|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
143122799|NCT00528372|515994440|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
143122800|NCT00528372|515994441|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
143122801|NCT00528372|515994442|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
143122802|NCT00528372|515994443|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
143122803|NCT00528372|515994444|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
143122804|NCT00528372|515994436|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
143122805|NCT00528372|515994437|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
143122806|NCT00528372|515994438|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
143122807|NCT00528372|515994439|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
143122808|NCT00528372|515994440|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
143122809|NCT00528372|515994441|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
143122810|NCT00528372|515994442|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
143122811|NCT00528372|515994443|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
143122812|NCT00528372|515994444|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
143122813|NCT00528372|515994436|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
143122814|NCT00528372|515994437|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
143122815|NCT00528372|515994438|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
143122816|NCT00528372|515994439|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
143122817|NCT00528372|515994440|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
143122818|NCT00528372|515994441|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
143122819|NCT00528372|515994442|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
143122820|NCT00528372|515994443|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
143122821|NCT00528372|515994444|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
143122822|NCT00528372|515994436|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
143122823|NCT00528372|515994437|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
143122824|NCT00528372|515994438|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
143122825|NCT00528372|515994439|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
143122826|NCT00528372|515994440|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
143122827|NCT00528372|515994441|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
143122828|NCT00528372|515994442|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
143122829|NCT00528372|515994443|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
143122830|NCT00528372|515994444|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
143122831|NCT00528372|515994436|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
143122832|NCT00528372|515994437|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
143122833|NCT00528372|515994438|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
143122834|NCT00528372|515994439|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
143122835|NCT00528372|515994440|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
143122836|NCT00528372|515994441|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
143122837|NCT00528372|515994442|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
143122838|NCT00528372|515994443|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
143122839|NCT00528372|515994444|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
143122840|NCT00528372|515994436|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
143122841|NCT00528372|515994437|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
143122842|NCT00528372|515994438|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
143122843|NCT00528372|515994439|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
143122844|NCT00528372|515994440|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
143459515|NCT01775124|517226973|FG000|Core Period|Physician Decision|1|||
143459516|NCT01775124|517226974|FG001|Core Period|Physician Decision|1|||
143459517|NCT01775124|517226973|FG000|Core Period|Death|0|||
143459518|NCT01775124|517226974|FG001|Core Period|Death|1|||
143459519|NCT01775124|517226973|FG000|Core Period|Administrative problems|1|||
143459520|NCT01775124|517226974|FG001|Core Period|Administrative problems|0|||
143459521|NCT01775124|517226973|FG000|Core Period|Withdrawal by Subject|4|||
143459522|NCT01775124|517226974|FG001|Core Period|Withdrawal by Subject|2|||
143459523|NCT01775124|517226973|FG000|Core Period|Adverse Event|5|||
143459524|NCT01775124|517226974|FG001|Core Period|Adverse Event|5|||
143459525|NCT01775124|517226973|FG000|Extension Period|Adverse Event|3|||
143459526|NCT01775124|517226974|FG001|Extension Period|Adverse Event|2|||
143459527|NCT01775124|517226973|FG000|Extension Period|Physician Decision|0|||
143459528|NCT01775124|517226974|FG001|Extension Period|Physician Decision|2|||
143459529|NCT01775124|517226973|FG000|Extension Period|Administrative problems|0|||
143459530|NCT01775124|517226974|FG001|Extension Period|Administrative problems|1|||
143459531|NCT01775124|517226973|FG000|Extension Period|Lost to Follow-up|0|||
143459532|NCT01775124|517226974|FG001|Extension Period|Lost to Follow-up|1|||
143459533|NCT01775124|517226973|FG000|Extension Period|Withdrawal by Subject|9|||
143459534|NCT01775124|517226974|FG001|Extension Period|Withdrawal by Subject|12|||
143459535|NCT00346268|517228770|FG000|Overall Study|Adverse Event|1|||
143459536|NCT00346268|517228771|FG001|Overall Study|Adverse Event|0|||
143459537|NCT00346268|517228770|FG000|Overall Study|Protocol Violation|1|||
143459538|NCT00346268|517228771|FG001|Overall Study|Protocol Violation|0|||
143459539|NCT00346268|517228770|FG000|Overall Study|Participant refused|0|||
143459540|NCT00346268|517228771|FG001|Overall Study|Participant refused|3|||
143459541|NCT02164383|517228772|FG000|Overall Study|Lost to Follow-up|1|||
143459542|NCT02164383|517228773|FG001|Overall Study|Lost to Follow-up|0|||
143459543|NCT00743275|517228774|FG000|Overall Study|Protocol Violation|0|||
143459544|NCT00743275|517228775|FG001|Overall Study|Protocol Violation|1|||
143459545|NCT01672723|517228776|FG000|First Intervention|Adverse Event|3|||
143459546|NCT01672723|517228777|FG001|First Intervention|Adverse Event|0|||
143459547|NCT00484289|517228786|FG000|Long Term Phase|Adverse Event|1|||
143459548|NCT00484289|517228787|FG001|Long Term Phase|Adverse Event|17|||
143459549|NCT00484289|517228788|FG002|Long Term Phase|Adverse Event|5|||
143459550|NCT00484289|517228786|FG000|Long Term Phase|Withdrawal by Subject|0|||
143459551|NCT00484289|517228787|FG001|Long Term Phase|Withdrawal by Subject|7|||
143459552|NCT00484289|517228788|FG002|Long Term Phase|Withdrawal by Subject|6|||
143459553|NCT00484289|517228786|FG000|Long Term Phase|Inadequate response|2|||
143459554|NCT00484289|517228787|FG001|Long Term Phase|Inadequate response|7|||
143459555|NCT00484289|517228788|FG002|Long Term Phase|Inadequate response|4|||
143459556|NCT00484289|517228786|FG000|Long Term Phase|Other Reason|0|||
143459557|NCT00484289|517228787|FG001|Long Term Phase|Other Reason|5|||
143459558|NCT00484289|517228788|FG002|Long Term Phase|Other Reason|1|||
143459559|NCT00484289|517228786|FG000|Post Marketing Phase|Adverse Event|0|||
143459560|NCT00484289|517228787|FG001|Post Marketing Phase|Adverse Event|1|||
143459561|NCT00484289|517228788|FG002|Post Marketing Phase|Adverse Event|0|||
143459562|NCT02831387|517228789|FG000|Overall Study|Withdrawal by Subject|1|||
143459563|NCT02831387|517228790|FG001|Overall Study|Withdrawal by Subject|1|||
143459564|NCT02831387|517228789|FG000|Overall Study|Discontinued due to stock recovery|0|||
143459565|NCT02831387|517228790|FG001|Overall Study|Discontinued due to stock recovery|1|||
143459566|NCT02186223|517228791|FG000|Overall Study|Not eligible for device placement|6|||
143459567|NCT02186223|517228791|FG000|Overall Study|Unable to obtain femoral access|3|||
143459568|NCT02186223|517228791|FG000|Overall Study|Death|3|||
143459569|NCT02186223|517228791|FG000|Overall Study|Device in place less than 48 hours|9|||
143459570|NCT00252733|517228792|FG000|Overall Study|Withdrawal by Subject|73|||
143459571|NCT00252733|517228793|FG001|Overall Study|Withdrawal by Subject|67|||
143459572|NCT00252733|517228792|FG000|Overall Study|Death|7|||
143459573|NCT00252733|517228793|FG001|Overall Study|Death|5|||
143459574|NCT00252733|517228792|FG000|Overall Study|Lost to Follow-up|12|||
143459575|NCT00252733|517228793|FG001|Overall Study|Lost to Follow-up|6|||
143459576|NCT00252733|517228792|FG000|Overall Study|Multiple Reasons|14|||
143459577|NCT00252733|517228793|FG001|Overall Study|Multiple Reasons|14|||
143459578|NCT04101318|517228796|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
143459579|NCT04101318|517228797|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
143459580|NCT04101318|517228796|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
143459581|NCT04101318|517228797|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
143459582|NCT04101318|517228796|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
143459583|NCT04101318|517228797|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
143459584|NCT00558259|517228798|FG000|Overall Study|Adverse Event|50|||
143459585|NCT00558259|517228799|FG001|Overall Study|Adverse Event|81|||
143459586|NCT00558259|517228798|FG000|Overall Study|Protocol Violation|9|||
143459587|NCT00558259|517228799|FG001|Overall Study|Protocol Violation|5|||
143459588|NCT00558259|517228798|FG000|Overall Study|Withdrawal by Subject|12|||
143459589|NCT00558259|517228799|FG001|Overall Study|Withdrawal by Subject|13|||
143459590|NCT02874924|517228800|FG000|Overall Study|Adverse Event|2|||
143459591|NCT02874924|517228801|FG001|Overall Study|Adverse Event|0|||
143459592|NCT02874924|517228802|FG002|Overall Study|Adverse Event|0|||
143459593|NCT02874924|517228800|FG000|Overall Study|Withdrawal by Subject|1|||
143345634|NCT02636270|516810449|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
143345635|NCT02636270|516810450|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
143345636|NCT02636270|516810451|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
143345637|NCT03021668|516810452|FG000|Overall Study|Physician Decision|0|||
143345638|NCT03021668|516810453|FG001|Overall Study|Physician Decision|1|||
143345639|NCT00116844|516810456|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
143345640|NCT00116844|516810457|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
143345641|NCT00116844|516810456|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
143345642|NCT00116844|516810457|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
143345643|NCT00116844|516810456|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
143345644|NCT00116844|516810457|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
143345645|NCT00116844|516810456|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
143345646|NCT00116844|516810457|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
143345647|NCT00116844|516810456|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
143345648|NCT00116844|516810457|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
143345649|NCT00116844|516810456|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
143345650|NCT00116844|516810457|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
143345651|NCT00116844|516810456|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
143345652|NCT00116844|516810457|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
143345653|NCT00116844|516810456|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
143345654|NCT00116844|516810457|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
143345655|NCT00116844|516810456|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
143345656|NCT00116844|516810457|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
143345657|NCT03535337|516810461|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
143345658|NCT03535337|516810462|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
143345659|NCT03535337|516810463|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
143345660|NCT03535337|516810464|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
143345661|NCT03535337|516810465|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
143345662|NCT03535337|516810466|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
143345663|NCT03535337|516810467|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
143345664|NCT03535337|516810468|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
143345665|NCT03535337|516810469|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
143345666|NCT03535337|516810470|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
143345667|NCT00767104|516812538|FG000|Overall Study|Lost to Follow-up|1|||
143345668|NCT00767104|516812539|FG001|Overall Study|Lost to Follow-up|2|||
143345669|NCT00840996|516812540|FG000|Overall Study|Withdrawal by Subject|1|||
143345670|NCT00840996|516812541|FG001|Overall Study|Withdrawal by Subject|0|||
143345671|NCT04022889|516812542|FG000|Stage 1: Period 1|Adverse Event|1|||
143345672|NCT04022889|516812543|FG001|Stage 1: Period 1|Adverse Event|0|||
143345673|NCT04022889|516812544|FG002|Stage 1: Period 1|Adverse Event|0|||
143345674|NCT04022889|516812542|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
143345675|NCT04022889|516812543|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
143345676|NCT04022889|516812544|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
143345677|NCT04022889|516812542|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
143345678|NCT04022889|516812543|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
143345679|NCT04022889|516812544|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
143345680|NCT04022889|516812542|FG000|Stage 2|Screen Failure|0|||
143345681|NCT04022889|516812543|FG001|Stage 2|Screen Failure|0|||
143345682|NCT04022889|516812544|FG002|Stage 2|Screen Failure|3|||
143345683|NCT04022889|516812542|FG000|Stage 2|Ineligible for apheresis donation|0|||
143345684|NCT04022889|516812543|FG001|Stage 2|Ineligible for apheresis donation|0|||
143345685|NCT04022889|516812544|FG002|Stage 2|Ineligible for apheresis donation|2|||
143345686|NCT04022889|516812542|FG000|Stage 2|Adverse Event|0|||
143345687|NCT04022889|516812543|FG001|Stage 2|Adverse Event|0|||
143345688|NCT04022889|516812544|FG002|Stage 2|Adverse Event|2|||
143345689|NCT04022889|516812542|FG000|Stage 2|Protocol Violation|0|||
143345690|NCT04022889|516812543|FG001|Stage 2|Protocol Violation|0|||
143345691|NCT04022889|516812544|FG002|Stage 2|Protocol Violation|1|||
143345692|NCT04022889|516812542|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
143345693|NCT04022889|516812543|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
143459594|NCT02874924|517228801|FG001|Overall Study|Withdrawal by Subject|0|||
143459595|NCT02874924|517228802|FG002|Overall Study|Withdrawal by Subject|0|||
143345694|NCT04022889|516812544|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
143345695|NCT03285295|516812550|FG000|Alinity s HBsAg|Protocol Violation|11|||
143345696|NCT03285295|516812551|FG001|Alinity s HBsAg|Protocol Violation|0|||
143345697|NCT03285295|516812552|FG002|Alinity s HBsAg|Protocol Violation|0|||
143345698|NCT03285295|516812553|FG003|Alinity s HBsAg|Protocol Violation|0|||
143345699|NCT03285295|516812554|FG004|Alinity s HBsAg|Protocol Violation|0|||
143345700|NCT03285295|516812550|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
143459596|NCT03718533|517228805|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
143459597|NCT03718533|517228805|FG000|Overall Study|Protocol deviation|1|||
143345701|NCT03285295|516812551|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
143345702|NCT03285295|516812552|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
143345703|NCT03285295|516812553|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
143345704|NCT03285295|516812554|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
143345705|NCT03285295|516812550|FG000|Alinity s HBsAg|No Results Generated|74|||
143345706|NCT03285295|516812551|FG001|Alinity s HBsAg|No Results Generated|6|||
143345707|NCT03285295|516812552|FG002|Alinity s HBsAg|No Results Generated|0|||
143345708|NCT03285295|516812553|FG003|Alinity s HBsAg|No Results Generated|0|||
143345709|NCT03285295|516812554|FG004|Alinity s HBsAg|No Results Generated|0|||
143345710|NCT03285295|516812550|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
143345711|NCT03285295|516812551|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
143345712|NCT03285295|516812552|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
143345713|NCT03285295|516812553|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
143345714|NCT03285295|516812554|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
143345715|NCT03285295|516812550|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
143345716|NCT03285295|516812551|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
143345717|NCT03285295|516812552|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
143345718|NCT03285295|516812553|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
143345719|NCT03285295|516812554|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
143345720|NCT03285295|516812550|FG000|Alinity s HTLV I/II|No Results Generated|70|||
143345721|NCT03285295|516812551|FG001|Alinity s HTLV I/II|No Results Generated|0|||
143345722|NCT03285295|516812552|FG002|Alinity s HTLV I/II|No Results Generated|0|||
143345723|NCT03285295|516812553|FG003|Alinity s HTLV I/II|No Results Generated|0|||
143345724|NCT03285295|516812554|FG004|Alinity s HTLV I/II|No Results Generated|0|||
143345725|NCT03285295|516812550|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
143345726|NCT03285295|516812551|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
143345727|NCT03285295|516812552|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
143345728|NCT03285295|516812553|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
143345729|NCT03285295|516812554|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
143345730|NCT03285295|516812550|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
143345731|NCT03285295|516812551|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
143345732|NCT03285295|516812552|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
143345733|NCT03285295|516812553|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
143345734|NCT03285295|516812554|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
143345735|NCT03285295|516812550|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
143345736|NCT03285295|516812551|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
143345737|NCT03285295|516812552|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
143345738|NCT03285295|516812553|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
143345739|NCT03285295|516812554|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
143345740|NCT03285295|516812550|FG000|Alinity s Anti-HCV|No Results Generated|71|||
143345741|NCT03285295|516812551|FG001|Alinity s Anti-HCV|No Results Generated|0|||
143345742|NCT03285295|516812552|FG002|Alinity s Anti-HCV|No Results Generated|0|||
143345743|NCT03285295|516812553|FG003|Alinity s Anti-HCV|No Results Generated|0|||
143345744|NCT03285295|516812554|FG004|Alinity s Anti-HCV|No Results Generated|0|||
143345745|NCT03285295|516812550|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
143345746|NCT03285295|516812551|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
143345747|NCT03285295|516812552|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
143345748|NCT03285295|516812553|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
143345749|NCT03285295|516812554|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
143345750|NCT03285295|516812550|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
143345751|NCT03285295|516812551|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
143345752|NCT03285295|516812552|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
143345753|NCT03285295|516812553|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
143345754|NCT03285295|516812554|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
143345755|NCT03285295|516812550|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
143345756|NCT03285295|516812551|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
143345757|NCT03285295|516812552|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
143345758|NCT03285295|516812553|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
143345759|NCT03285295|516812554|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
143368942|NCT02001623|516894569|FG011|Overall Study|Physician Decision|3|||
143368943|NCT02001623|516894570|FG012|Overall Study|Physician Decision|1|||
143368944|NCT02001623|516894571|FG013|Overall Study|Physician Decision|2|||
143122845|NCT00528372|515994441|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
143122846|NCT00528372|515994442|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
143122847|NCT00528372|515994443|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
143122848|NCT00528372|515994444|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
143122849|NCT00528372|515994436|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
143122850|NCT00528372|515994437|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
143122851|NCT00528372|515994438|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
143122852|NCT00528372|515994439|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
143122853|NCT00528372|515994440|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
143459598|NCT03718533|517228805|FG000|Overall Study|Disease progression|1|||
143459599|NCT03718533|517228805|FG000|Overall Study|Relapse|1|||
143122854|NCT00528372|515994441|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
143122855|NCT00528372|515994442|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
143122856|NCT00528372|515994443|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
143122857|NCT00528372|515994444|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
143122858|NCT00528372|515994436|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
143122859|NCT00528372|515994437|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
143122860|NCT00528372|515994438|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
143122861|NCT00528372|515994439|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
143122862|NCT00528372|515994440|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
143122863|NCT00528372|515994441|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
143122864|NCT00528372|515994442|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
143122865|NCT00528372|515994443|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
143122866|NCT00528372|515994444|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
143122867|NCT00528372|515994436|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
143122868|NCT00528372|515994437|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
143122869|NCT00528372|515994438|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
143122870|NCT00528372|515994439|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
143122871|NCT00528372|515994440|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
143122872|NCT00528372|515994441|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
143122873|NCT00528372|515994442|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
143122874|NCT00528372|515994443|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
143122875|NCT00528372|515994444|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
143122876|NCT00528372|515994436|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
143122877|NCT00528372|515994437|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
143122878|NCT00528372|515994438|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
143122879|NCT00528372|515994439|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
143122880|NCT00528372|515994440|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
143122881|NCT00528372|515994441|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
143122882|NCT00528372|515994442|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
143122883|NCT00528372|515994443|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
143122884|NCT00528372|515994444|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
143122885|NCT00528372|515994436|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
143122886|NCT00528372|515994437|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
143122887|NCT00528372|515994438|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
143122888|NCT00528372|515994439|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
143122889|NCT00528372|515994440|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
143122890|NCT00528372|515994441|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
143122891|NCT00528372|515994442|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
143122892|NCT00528372|515994443|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
143122893|NCT00528372|515994444|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
143122894|NCT02432144|515994451|FG000|Overall Study|Participant Non-Compliance|1|||
143122895|NCT01905592|515994452|FG000|Overall Study|Disease Progression|51|||
143122896|NCT01905592|515994453|FG001|Overall Study|Disease Progression|110|||
143122897|NCT01905592|515994452|FG000|Overall Study|Toxicity|1|||
143122898|NCT01905592|515994453|FG001|Overall Study|Toxicity|16|||
143122899|NCT01905592|515994452|FG000|Overall Study|Physician Decision|0|||
143122900|NCT01905592|515994453|FG001|Overall Study|Physician Decision|2|||
143122901|NCT01905592|515994452|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
143122902|NCT01905592|515994453|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
143122903|NCT01905592|515994452|FG000|Overall Study|Protocol Violation|0|||
143122904|NCT01905592|515994453|FG001|Overall Study|Protocol Violation|1|||
143122905|NCT01905592|515994452|FG000|Overall Study|Sponsor's decision|1|||
143122906|NCT01905592|515994453|FG001|Overall Study|Sponsor's decision|1|||
143122907|NCT01905592|515994452|FG000|Overall Study|Not treated|7|||
143122908|NCT01905592|515994453|FG001|Overall Study|Not treated|3|||
143122909|NCT01905592|515994452|FG000|Overall Study|Withdrawal by Subject|10|||
143122910|NCT01905592|515994453|FG001|Overall Study|Withdrawal by Subject|2|||
143122911|NCT01483599|515994455|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
143122912|NCT01483599|515994456|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
143122913|NCT01483599|515994457|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
143122914|NCT01483599|515994458|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
143122915|NCT01483599|515994459|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
143122916|NCT01483599|515994460|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
143459600|NCT03718533|517228805|FG000|Overall Study|Physician Decision|2|||
143459601|NCT03718533|517228805|FG000|Overall Study|Physician Decision and Adverse Event|1|||
143122917|NCT01483599|515994461|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
143122918|NCT01483599|515994462|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
143122919|NCT01483599|515994463|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
143122920|NCT01483599|515994464|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
143122921|NCT01483599|515994465|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
143122922|NCT01483599|515994466|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
143122923|NCT01483599|515994467|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
143122924|NCT01483599|515994468|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
143122925|NCT01483599|515994455|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
143122926|NCT01483599|515994456|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
143122927|NCT01483599|515994457|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
143122928|NCT01483599|515994458|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
143122929|NCT01483599|515994459|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
143122930|NCT01483599|515994460|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
143122931|NCT01483599|515994461|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
143122932|NCT01483599|515994462|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
143122933|NCT01483599|515994463|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
143122934|NCT01483599|515994464|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
143122935|NCT01483599|515994465|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
143122936|NCT01483599|515994466|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
143122937|NCT01483599|515994467|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
143122938|NCT01483599|515994468|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
143122939|NCT01483599|515994455|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
143122940|NCT01483599|515994456|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
143122941|NCT01483599|515994457|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
143122942|NCT01483599|515994458|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
143122943|NCT01483599|515994459|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
143122944|NCT01483599|515994460|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
143122945|NCT01483599|515994461|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
143122946|NCT01483599|515994462|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
143122947|NCT01483599|515994463|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
143122948|NCT01483599|515994464|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
143122949|NCT01483599|515994465|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
143122950|NCT01483599|515994466|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
143122951|NCT01483599|515994467|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
143122952|NCT01483599|515994468|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
143122953|NCT01483599|515994455|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
143122954|NCT01483599|515994456|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
143122955|NCT01483599|515994457|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
143122956|NCT01483599|515994458|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
143122957|NCT01483599|515994459|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
143122958|NCT01483599|515994460|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
143122959|NCT01483599|515994461|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
143122960|NCT01483599|515994462|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
143122961|NCT01483599|515994463|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
143122962|NCT01483599|515994464|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
143122963|NCT01483599|515994465|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
143122964|NCT01483599|515994466|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
143122965|NCT01483599|515994467|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
143122966|NCT01483599|515994468|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
143122967|NCT01483599|515994455|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
143122968|NCT01483599|515994456|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
143122969|NCT01483599|515994457|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
143122970|NCT01483599|515994458|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
143122971|NCT01483599|515994459|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
143122972|NCT01483599|515994460|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
143122973|NCT01483599|515994461|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
143122974|NCT01483599|515994462|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
143122975|NCT01483599|515994463|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
143122976|NCT01483599|515994464|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
143122977|NCT01483599|515994465|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
143122978|NCT01483599|515994466|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
143122979|NCT01483599|515994467|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
143122980|NCT01483599|515994468|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
143122981|NCT01483599|515994455|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
143122982|NCT01483599|515994456|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
143122983|NCT01483599|515994457|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
143345760|NCT03285295|516812550|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
143345761|NCT03285295|516812551|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
143345762|NCT03285295|516812552|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
143345763|NCT03285295|516812553|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
143345764|NCT03285295|516812554|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
143345765|NCT03285295|516812550|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
143345766|NCT03285295|516812551|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
143345767|NCT03285295|516812552|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
143345768|NCT03285295|516812553|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
143345769|NCT03285295|516812554|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
143345770|NCT03285295|516812550|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
143345771|NCT03285295|516812551|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
143345772|NCT03285295|516812552|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
143345773|NCT03285295|516812553|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
143345774|NCT03285295|516812554|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
143345775|NCT03285295|516812550|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
143345776|NCT03285295|516812551|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
143345777|NCT03285295|516812552|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
143345778|NCT03285295|516812553|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
143345779|NCT03285295|516812554|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
143345780|NCT03285295|516812550|FG000|Alinity s Anti-HBc|No Results Generated|70|||
143345781|NCT03285295|516812551|FG001|Alinity s Anti-HBc|No Results Generated|0|||
143345782|NCT03285295|516812552|FG002|Alinity s Anti-HBc|No Results Generated|0|||
143345783|NCT03285295|516812553|FG003|Alinity s Anti-HBc|No Results Generated|0|||
143345784|NCT03285295|516812554|FG004|Alinity s Anti-HBc|No Results Generated|0|||
143345785|NCT03285295|516812550|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
143345786|NCT03285295|516812551|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
143345787|NCT03285295|516812552|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
143345788|NCT03285295|516812553|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
143345789|NCT03285295|516812554|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
143345790|NCT03285295|516812550|FG000|Alinity s Chagas|Protocol Violation|76|||
143345791|NCT03285295|516812551|FG001|Alinity s Chagas|Protocol Violation|0|||
143345792|NCT03285295|516812552|FG002|Alinity s Chagas|Protocol Violation|0|||
143345793|NCT03285295|516812553|FG003|Alinity s Chagas|Protocol Violation|0|||
143345794|NCT03285295|516812554|FG004|Alinity s Chagas|Protocol Violation|0|||
143345795|NCT03285295|516812550|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
143345796|NCT03285295|516812551|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
143345797|NCT03285295|516812552|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
143345798|NCT03285295|516812553|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
143345799|NCT03285295|516812554|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
143345800|NCT03285295|516812550|FG000|Alinity s Chagas|No Results Generated|105|||
143345801|NCT03285295|516812551|FG001|Alinity s Chagas|No Results Generated|0|||
143345802|NCT03285295|516812552|FG002|Alinity s Chagas|No Results Generated|0|||
143345803|NCT03285295|516812553|FG003|Alinity s Chagas|No Results Generated|0|||
143345804|NCT03285295|516812554|FG004|Alinity s Chagas|No Results Generated|0|||
143345805|NCT03285295|516812550|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
143345806|NCT03285295|516812551|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
143345807|NCT03285295|516812552|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
143345808|NCT03285295|516812553|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
143345809|NCT03285295|516812554|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
143345810|NCT04867785|516812556|FG000|Overall Study|Adverse Event|1|||
143345811|NCT04867785|516812557|FG001|Overall Study|Adverse Event|0|||
143345812|NCT04867785|516812558|FG002|Overall Study|Adverse Event|1|||
143345813|NCT04867785|516812559|FG003|Overall Study|Adverse Event|0|||
143345814|NCT04867785|516812560|FG004|Overall Study|Adverse Event|0|||
143345815|NCT04867785|516812561|FG005|Overall Study|Adverse Event|0|||
143345816|NCT04867785|516812562|FG006|Overall Study|Adverse Event|0|||
143345817|NCT04867785|516812563|FG007|Overall Study|Adverse Event|2|||
143345818|NCT04867785|516812556|FG000|Overall Study|Lost to Follow-up|4|||
143345819|NCT04867785|516812557|FG001|Overall Study|Lost to Follow-up|4|||
143345820|NCT04867785|516812558|FG002|Overall Study|Lost to Follow-up|3|||
143345821|NCT04867785|516812559|FG003|Overall Study|Lost to Follow-up|2|||
143345822|NCT04867785|516812560|FG004|Overall Study|Lost to Follow-up|0|||
143459602|NCT01375114|517228808|FG000|Overall Study|Lost to Follow-up|1|||
143459603|NCT01375114|517228809|FG001|Overall Study|Lost to Follow-up|0|||
143459604|NCT01375114|517228810|FG002|Overall Study|Lost to Follow-up|1|||
143345823|NCT04867785|516812561|FG005|Overall Study|Lost to Follow-up|1|||
143345824|NCT04867785|516812562|FG006|Overall Study|Lost to Follow-up|0|||
143345825|NCT04867785|516812563|FG007|Overall Study|Lost to Follow-up|1|||
143345826|NCT04867785|516812556|FG000|Overall Study|Withdrawal by Subject|6|||
143345827|NCT04867785|516812557|FG001|Overall Study|Withdrawal by Subject|2|||
143345828|NCT04867785|516812558|FG002|Overall Study|Withdrawal by Subject|2|||
143345829|NCT04867785|516812559|FG003|Overall Study|Withdrawal by Subject|1|||
143459605|NCT01375114|517228808|FG000|Overall Study|Disease Progression|3|||
143459606|NCT01375114|517228809|FG001|Overall Study|Disease Progression|2|||
143459607|NCT01375114|517228810|FG002|Overall Study|Disease Progression|2|||
143122984|NCT01483599|515994458|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
143122985|NCT01483599|515994459|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
143122986|NCT01483599|515994460|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
143122987|NCT01483599|515994461|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
143122988|NCT01483599|515994462|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
143122989|NCT01483599|515994463|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
143122990|NCT01483599|515994464|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
143122991|NCT01483599|515994465|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
143122992|NCT01483599|515994466|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
143122993|NCT01483599|515994467|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
143122994|NCT01483599|515994468|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
143122995|NCT01483599|515994455|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
143122996|NCT01483599|515994456|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
143122997|NCT01483599|515994457|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
143122998|NCT01483599|515994458|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
143122999|NCT01483599|515994459|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
143123000|NCT01483599|515994460|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
143123001|NCT01483599|515994461|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
143123002|NCT01483599|515994462|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
143123003|NCT01483599|515994463|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
143123004|NCT01483599|515994464|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
143123005|NCT01483599|515994465|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
143123006|NCT01483599|515994466|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
143123007|NCT01483599|515994467|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
143123008|NCT01483599|515994468|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
143123009|NCT01483599|515994455|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
143123010|NCT01483599|515994456|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
143123011|NCT01483599|515994457|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
143123012|NCT01483599|515994458|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
143123013|NCT01483599|515994459|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
143123014|NCT01483599|515994460|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
143123015|NCT01483599|515994461|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
143123016|NCT01483599|515994462|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
143123017|NCT01483599|515994463|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
143123018|NCT01483599|515994464|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
143123019|NCT01483599|515994465|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
143123020|NCT01483599|515994466|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
143123021|NCT01483599|515994467|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
143123022|NCT01483599|515994468|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
143123023|NCT01483599|515994455|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
143123024|NCT01483599|515994456|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
143123025|NCT01483599|515994457|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
143123026|NCT01483599|515994458|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
143123027|NCT01483599|515994459|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
143123028|NCT01483599|515994460|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
143123029|NCT01483599|515994461|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
143123030|NCT01483599|515994462|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
143123031|NCT01483599|515994463|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
143123032|NCT01483599|515994464|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
143123033|NCT01483599|515994465|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
143123034|NCT01483599|515994466|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
143123035|NCT01483599|515994467|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
143123036|NCT01483599|515994468|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
143123037|NCT01483599|515994455|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
143123038|NCT01483599|515994456|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
143123039|NCT01483599|515994457|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
143123040|NCT01483599|515994458|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
143123041|NCT01483599|515994459|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
143123042|NCT01483599|515994460|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
143123043|NCT01483599|515994461|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
143123044|NCT01483599|515994462|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
143123045|NCT01483599|515994463|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
143459608|NCT01375114|517228808|FG000|Overall Study|Patient Changed Mind|0|||
143345830|NCT04867785|516812560|FG004|Overall Study|Withdrawal by Subject|2|||
143345831|NCT04867785|516812561|FG005|Overall Study|Withdrawal by Subject|0|||
143345832|NCT04867785|516812562|FG006|Overall Study|Withdrawal by Subject|2|||
143345833|NCT04867785|516812563|FG007|Overall Study|Withdrawal by Subject|5|||
143345834|NCT04867785|516812556|FG000|Overall Study|Physician Decision|0|||
143345835|NCT04867785|516812557|FG001|Overall Study|Physician Decision|0|||
143345836|NCT04867785|516812558|FG002|Overall Study|Physician Decision|0|||
143345837|NCT04867785|516812559|FG003|Overall Study|Physician Decision|0|||
143345838|NCT04867785|516812560|FG004|Overall Study|Physician Decision|0|||
143345839|NCT04867785|516812561|FG005|Overall Study|Physician Decision|0|||
143345840|NCT04867785|516812562|FG006|Overall Study|Physician Decision|0|||
143345841|NCT04867785|516812563|FG007|Overall Study|Physician Decision|1|||
143345842|NCT04867785|516812556|FG000|Overall Study|Inadvertent Enrollment|0|||
143345843|NCT04867785|516812557|FG001|Overall Study|Inadvertent Enrollment|0|||
143345844|NCT04867785|516812558|FG002|Overall Study|Inadvertent Enrollment|0|||
143345845|NCT04867785|516812559|FG003|Overall Study|Inadvertent Enrollment|1|||
143345846|NCT04867785|516812560|FG004|Overall Study|Inadvertent Enrollment|1|||
143345847|NCT04867785|516812561|FG005|Overall Study|Inadvertent Enrollment|0|||
143345848|NCT04867785|516812562|FG006|Overall Study|Inadvertent Enrollment|0|||
143345849|NCT04867785|516812563|FG007|Overall Study|Inadvertent Enrollment|1|||
143345850|NCT04867785|516812556|FG000|Overall Study|Eligibility Criteria Not Met|0|||
143345851|NCT04867785|516812557|FG001|Overall Study|Eligibility Criteria Not Met|0|||
143345852|NCT04867785|516812558|FG002|Overall Study|Eligibility Criteria Not Met|0|||
143345853|NCT04867785|516812559|FG003|Overall Study|Eligibility Criteria Not Met|0|||
143345854|NCT04867785|516812560|FG004|Overall Study|Eligibility Criteria Not Met|0|||
143345855|NCT04867785|516812561|FG005|Overall Study|Eligibility Criteria Not Met|0|||
143345856|NCT04867785|516812562|FG006|Overall Study|Eligibility Criteria Not Met|0|||
143345857|NCT04867785|516812563|FG007|Overall Study|Eligibility Criteria Not Met|1|||
143345858|NCT02714868|516812569|FG000|Overall Study|Withdrawal by Subject|3|||
143345859|NCT02714868|516812570|FG001|Overall Study|Withdrawal by Subject|0|||
143345860|NCT02714868|516812569|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
143345861|NCT02714868|516812570|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
143345862|NCT02714868|516812569|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
143345863|NCT02714868|516812570|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
143123046|NCT01483599|515994464|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
143123047|NCT01483599|515994465|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
143123048|NCT01483599|515994466|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
143123049|NCT01483599|515994467|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
143123050|NCT01483599|515994468|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
143123051|NCT02109445|515994469|FG000|Overall Study|Symptomatic deterioration|2|||
143123052|NCT02109445|515994469|FG000|Overall Study|Adverse Event|1|||
143123053|NCT00958412|515994470|FG000|Overall Study|Study prematurely terminated|18|||
143123054|NCT00171158|515996025|FG000|Core Study|Death|27|||
143123055|NCT00171158|515996025|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
143123056|NCT00171158|515996025|FG000|Core Study|Protocol Violation|4|||
143123057|NCT00171158|515996025|FG000|Core Study|Administrative problems|1|||
143123058|NCT00171158|515996025|FG000|Core Study|Adverse event, non-fatal|21|||
143123059|NCT00171158|515996025|FG000|Core Study|Consent withdrawn by subject|6|||
143123060|NCT00171158|515996025|FG000|Core Study|No longer required drug (BMT)|14|||
143123061|NCT00171158|515996025|FG000|Core Study|Abnormal Laboratory Values|2|||
143123062|NCT00171158|515996025|FG000|Core Study|Lost to Follow-up|1|||
143123063|NCT00171158|515996025|FG000|E2 Extension|Other|7|||
143123064|NCT03536663|515996029|FG000|Endexo|Protocol Violation|1|||
143123065|NCT00497146|515996031|FG000|Treatment Period|Adverse Event|6|||
143123066|NCT00497146|515996032|FG001|Treatment Period|Adverse Event|2|||
143123067|NCT00497146|515996031|FG000|Treatment Period|Withdrawal by Subject|5|||
143123068|NCT00497146|515996032|FG001|Treatment Period|Withdrawal by Subject|9|||
143123069|NCT00497146|515996031|FG000|Treatment Period|Lost to Follow-up|1|||
143123070|NCT00497146|515996032|FG001|Treatment Period|Lost to Follow-up|3|||
143123071|NCT00497146|515996031|FG000|Treatment Period|Required dialysis|4|||
143123072|NCT00497146|515996032|FG001|Treatment Period|Required dialysis|1|||
143123073|NCT00497146|515996031|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
143123074|NCT00497146|515996032|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
143123075|NCT00497146|515996031|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
143123076|NCT00497146|515996032|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
143123077|NCT00497146|515996031|FG000|Treatment Period|Other Reason|2|||
143123078|NCT00497146|515996032|FG001|Treatment Period|Other Reason|3|||
143123079|NCT00497146|515996031|FG000|Long-term Follow-up Period|Adverse Event|2|||
143123080|NCT00497146|515996032|FG001|Long-term Follow-up Period|Adverse Event|2|||
143123081|NCT00497146|515996031|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
143123082|NCT00497146|515996032|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
143123083|NCT00497146|515996031|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
143123084|NCT00497146|515996032|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
143345864|NCT00255346|516812573|FG000|Overall Study|Adverse Event|1|||
143345865|NCT00255346|516812574|FG001|Overall Study|Adverse Event|0|||
143345866|NCT00255346|516812575|FG002|Overall Study|Adverse Event|0|||
143345867|NCT00255346|516812576|FG003|Overall Study|Adverse Event|0|||
143345868|NCT00255346|516812577|FG004|Overall Study|Adverse Event|0|||
143345869|NCT01616771|516812583|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
143345870|NCT00154310|516812584|FG000|Overall Study|Adverse Event|19|||
143345871|NCT00154310|516812585|FG001|Overall Study|Adverse Event|9|||
143345872|NCT00154310|516812584|FG000|Overall Study|Lack of Efficacy|5|||
143345873|NCT00154310|516812585|FG001|Overall Study|Lack of Efficacy|4|||
143345874|NCT00154310|516812584|FG000|Overall Study|Protocol Violation|4|||
143345875|NCT00154310|516812585|FG001|Overall Study|Protocol Violation|2|||
143345876|NCT00154310|516812584|FG000|Overall Study|Withdrawal by Subject|9|||
143345877|NCT00154310|516812585|FG001|Overall Study|Withdrawal by Subject|3|||
143345878|NCT00154310|516812584|FG000|Overall Study|Lost to Follow-up|0|||
143345879|NCT00154310|516812585|FG001|Overall Study|Lost to Follow-up|8|||
143345880|NCT00154310|516812584|FG000|Overall Study|Administrative problems|0|||
143345881|NCT00154310|516812585|FG001|Overall Study|Administrative problems|1|||
143345882|NCT00154310|516812584|FG000|Overall Study|Death|0|||
143345883|NCT00154310|516812585|FG001|Overall Study|Death|1|||
143345884|NCT04041440|516812586|FG000|Overall Study|Withdrawal by Subject|0|||
143345885|NCT04041440|516812587|FG001|Overall Study|Withdrawal by Subject|1|||
143345886|NCT04041440|516812586|FG000|Overall Study|Lost to Follow-up|0|||
143345887|NCT04041440|516812587|FG001|Overall Study|Lost to Follow-up|1|||
143345888|NCT01054573|516812588|FG000|Overall Study|Adverse Event|1|||
143345889|NCT01054573|516812589|FG001|Overall Study|Adverse Event|0|||
143345890|NCT01054573|516812590|FG002|Overall Study|Adverse Event|1|||
143345891|NCT01054573|516812591|FG003|Overall Study|Adverse Event|1|||
143345892|NCT01054573|516812588|FG000|Overall Study|Lost to Follow-up|0|||
143345893|NCT01054573|516812589|FG001|Overall Study|Lost to Follow-up|2|||
143345894|NCT01054573|516812590|FG002|Overall Study|Lost to Follow-up|0|||
143345895|NCT01054573|516812591|FG003|Overall Study|Lost to Follow-up|0|||
143345896|NCT01054573|516812588|FG000|Overall Study|Withdrawal by Subject|0|||
143345897|NCT01054573|516812589|FG001|Overall Study|Withdrawal by Subject|2|||
143345898|NCT01054573|516812590|FG002|Overall Study|Withdrawal by Subject|2|||
143345899|NCT01054573|516812591|FG003|Overall Study|Withdrawal by Subject|1|||
143345900|NCT01735396|516812594|FG000|Overall Study|not evaluable|1|||
143345901|NCT00423852|516812595|FG000|Overall Study|Removed pior to the high-dose portion|3|||
143345902|NCT00980005|516812596|FG000|Overall Study|Withdrawal by Subject|6|||
143345903|NCT00980005|516812597|FG001|Overall Study|Withdrawal by Subject|17|||
143345904|NCT00980005|516812596|FG000|Overall Study|Lost to Follow-up|37|||
143345905|NCT00980005|516812597|FG001|Overall Study|Lost to Follow-up|43|||
143345906|NCT00980005|516812596|FG000|Overall Study|Other|4|||
143345907|NCT00980005|516812597|FG001|Overall Study|Other|3|||
143345908|NCT00572624|516812598|FG000|Overall Study|Lost to Follow-up|10|||
143345909|NCT00572624|516812599|FG001|Overall Study|Lost to Follow-up|4|||
143345910|NCT00572624|516812598|FG000|Overall Study|Wanted to do a different diet program|1|||
143345911|NCT00572624|516812599|FG001|Overall Study|Wanted to do a different diet program|0|||
143345912|NCT00572624|516812598|FG000|Overall Study|Medication change|1|||
143345913|NCT00572624|516812599|FG001|Overall Study|Medication change|0|||
143345914|NCT00572624|516812598|FG000|Overall Study|Started a new job-- no time for study|1|||
143345915|NCT00572624|516812599|FG001|Overall Study|Started a new job-- no time for study|0|||
143345916|NCT00572624|516812598|FG000|Overall Study|Admitted to being a smoker|1|||
143345917|NCT00572624|516812599|FG001|Overall Study|Admitted to being a smoker|0|||
143345918|NCT00572624|516812598|FG000|Overall Study|Refused to do the stress test|1|||
143345919|NCT00572624|516812599|FG001|Overall Study|Refused to do the stress test|0|||
143345920|NCT00572624|516812598|FG000|Overall Study|Problem with vascular access|1|||
143345921|NCT00572624|516812599|FG001|Overall Study|Problem with vascular access|0|||
143345922|NCT00572624|516812598|FG000|Overall Study|Health issues unrelated to the study|1|||
143345923|NCT00572624|516812599|FG001|Overall Study|Health issues unrelated to the study|0|||
143345924|NCT04599101|516812603|FG000|Overall Study|Lost to Follow-up|5|||
143345925|NCT04599101|516812604|FG001|Overall Study|Lost to Follow-up|5|||
143345926|NCT00098254|516812605|FG000|Overall Study|Adverse Event|2|||
143345927|NCT00098254|516812605|FG000|Overall Study|Death|1|||
143345928|NCT03107377|516812606|FG000|Overall Study|Adverse Event|3|||
143345929|NCT03107377|516812607|FG001|Overall Study|Adverse Event|3|||
143345930|NCT03107377|516812606|FG000|Overall Study|Protocol Violation|9|||
143459609|NCT01375114|517228809|FG001|Overall Study|Patient Changed Mind|0|||
143459610|NCT01375114|517228810|FG002|Overall Study|Patient Changed Mind|2|||
143459611|NCT01375114|517228808|FG000|Overall Study|Pruritus|0|||
143345931|NCT03107377|516812607|FG001|Overall Study|Protocol Violation|12|||
143345932|NCT03107377|516812606|FG000|Overall Study|Physician Decision|3|||
143345933|NCT03107377|516812607|FG001|Overall Study|Physician Decision|6|||
143345934|NCT03107377|516812606|FG000|Overall Study|Pregnancy|7|||
143345935|NCT03107377|516812607|FG001|Overall Study|Pregnancy|7|||
143345936|NCT03107377|516812606|FG000|Overall Study|Withdrawal by Subject|16|||
143345937|NCT03107377|516812607|FG001|Overall Study|Withdrawal by Subject|22|||
143345938|NCT03107377|516812606|FG000|Overall Study|Lost to Follow-up|37|||
143345939|NCT03107377|516812607|FG001|Overall Study|Lost to Follow-up|34|||
143459612|NCT01375114|517228809|FG001|Overall Study|Pruritus|0|||
143345940|NCT03107377|516812606|FG000|Overall Study|Other reason not specified|16|||
143345941|NCT03107377|516812607|FG001|Overall Study|Other reason not specified|15|||
143345942|NCT00211237|516812608|FG000|Baseline|Withdrew|1|||
143345943|NCT00211237|516812609|FG001|Baseline|Withdrew|3|||
143345944|NCT00211237|516812610|FG002|Baseline|Withdrew|0|||
143345945|NCT00211237|516812608|FG000|Baseline|Refused random assignment|1|||
143345946|NCT00211237|516812609|FG001|Baseline|Refused random assignment|0|||
143345947|NCT00211237|516812610|FG002|Baseline|Refused random assignment|0|||
143345948|NCT00211237|516812608|FG000|1 Month|Death|2|||
143345949|NCT00211237|516812609|FG001|1 Month|Death|1|||
143345950|NCT00211237|516812610|FG002|1 Month|Death|0|||
143345951|NCT00211237|516812608|FG000|1 Month|Lost to Follow-up|0|||
143345952|NCT00211237|516812609|FG001|1 Month|Lost to Follow-up|2|||
143345953|NCT00211237|516812610|FG002|1 Month|Lost to Follow-up|0|||
143345954|NCT00211237|516812608|FG000|1 Month|Withdrew|0|||
143345955|NCT00211237|516812609|FG001|1 Month|Withdrew|4|||
143345956|NCT00211237|516812610|FG002|1 Month|Withdrew|0|||
143345957|NCT00211237|516812608|FG000|1 Month|Additional surgery needed|1|||
143345958|NCT00211237|516812609|FG001|1 Month|Additional surgery needed|0|||
143345959|NCT00211237|516812610|FG002|1 Month|Additional surgery needed|0|||
143345960|NCT00211237|516812608|FG000|1 Month|Non-medical problem|0|||
143345961|NCT00211237|516812609|FG001|1 Month|Non-medical problem|2|||
143345962|NCT00211237|516812610|FG002|1 Month|Non-medical problem|0|||
143345963|NCT00211237|516812608|FG000|3 Months|Death|7|||
143345964|NCT00211237|516812609|FG001|3 Months|Death|3|||
143345965|NCT00211237|516812610|FG002|3 Months|Death|0|||
143345966|NCT00211237|516812608|FG000|3 Months|Could not comply with protocol|1|||
143345967|NCT00211237|516812609|FG001|3 Months|Could not comply with protocol|0|||
143345968|NCT00211237|516812610|FG002|3 Months|Could not comply with protocol|0|||
143345969|NCT00211237|516812608|FG000|3 Months|Withdrew|0|||
143345970|NCT00211237|516812609|FG001|3 Months|Withdrew|1|||
143345971|NCT00211237|516812610|FG002|3 Months|Withdrew|0|||
143345972|NCT00211237|516812608|FG000|3 Months|Non-medical problem|0|||
143459613|NCT01375114|517228810|FG002|Overall Study|Pruritus|1|||
143459614|NCT01375114|517228808|FG000|Overall Study|Restlessness|0|||
143123085|NCT00497146|515996031|FG000|Long-term Follow-up Period|Other|0|||
143123086|NCT00497146|515996032|FG001|Long-term Follow-up Period|Other|1|||
143123087|NCT01214668|515996040|FG000|Overall Study|Adverse Event|0|||
143123088|NCT01214668|515996041|FG001|Overall Study|Adverse Event|1|||
143123089|NCT01214668|515996042|FG002|Overall Study|Adverse Event|0|||
143123090|NCT01214668|515996043|FG003|Overall Study|Adverse Event|2|||
143123091|NCT01214668|515996044|FG004|Overall Study|Adverse Event|1|||
143123092|NCT01214668|515996045|FG005|Overall Study|Adverse Event|1|||
143123093|NCT01214668|515996040|FG000|Overall Study|Death|0|||
143123094|NCT01214668|515996041|FG001|Overall Study|Death|0|||
143123095|NCT01214668|515996042|FG002|Overall Study|Death|1|||
143123096|NCT01214668|515996043|FG003|Overall Study|Death|0|||
143123097|NCT01214668|515996044|FG004|Overall Study|Death|0|||
143123098|NCT01214668|515996045|FG005|Overall Study|Death|0|||
143123099|NCT01214668|515996040|FG000|Overall Study|Progressive Disease|4|||
143123100|NCT01214668|515996041|FG001|Overall Study|Progressive Disease|2|||
143123101|NCT01214668|515996042|FG002|Overall Study|Progressive Disease|5|||
143123102|NCT01214668|515996043|FG003|Overall Study|Progressive Disease|4|||
143123103|NCT01214668|515996044|FG004|Overall Study|Progressive Disease|4|||
143123104|NCT01214668|515996045|FG005|Overall Study|Progressive Disease|5|||
143123105|NCT01214668|515996040|FG000|Overall Study|Withdrawal by Subject|0|||
143123106|NCT01214668|515996041|FG001|Overall Study|Withdrawal by Subject|0|||
143123107|NCT01214668|515996042|FG002|Overall Study|Withdrawal by Subject|0|||
143123108|NCT01214668|515996043|FG003|Overall Study|Withdrawal by Subject|0|||
143123109|NCT01214668|515996044|FG004|Overall Study|Withdrawal by Subject|1|||
143123110|NCT01214668|515996045|FG005|Overall Study|Withdrawal by Subject|0|||
143123111|NCT01964989|515996046|FG000|Overall Study|Protocol Violation|3|||
143123112|NCT01964989|515996047|FG001|Overall Study|Protocol Violation|4|||
143123113|NCT01964989|515996046|FG000|Overall Study|Administrative Reason|103|||
143123114|NCT01964989|515996047|FG001|Overall Study|Administrative Reason|95|||
143123115|NCT01964989|515996046|FG000|Overall Study|Adverse Event|0|||
143123116|NCT01964989|515996047|FG001|Overall Study|Adverse Event|1|||
143123117|NCT01964989|515996046|FG000|Overall Study|Death|1|||
143123118|NCT01964989|515996047|FG001|Overall Study|Death|3|||
143123119|NCT01964989|515996046|FG000|Overall Study|Withdrawal by Subject|156|||
143123120|NCT01964989|515996047|FG001|Overall Study|Withdrawal by Subject|160|||
143123121|NCT01964989|515996046|FG000|Overall Study|Lost to Follow-up|254|||
143123122|NCT01964989|515996047|FG001|Overall Study|Lost to Follow-up|232|||
143123123|NCT01964989|515996046|FG000|Overall Study|Other|267|||
143123124|NCT01964989|515996047|FG001|Overall Study|Other|252|||
143345973|NCT00211237|516812609|FG001|3 Months|Non-medical problem|0|||
143345974|NCT00211237|516812610|FG002|3 Months|Non-medical problem|1|||
143345975|NCT00211237|516812608|FG000|6 Months|Death|6|||
143345976|NCT00211237|516812609|FG001|6 Months|Death|0|||
143345977|NCT00211237|516812610|FG002|6 Months|Death|3|||
143345978|NCT00211237|516812608|FG000|6 Months|Lost to Follow-up|2|||
143345979|NCT00211237|516812609|FG001|6 Months|Lost to Follow-up|0|||
143345980|NCT00211237|516812610|FG002|6 Months|Lost to Follow-up|0|||
143459615|NCT01375114|517228809|FG001|Overall Study|Restlessness|0|||
143345981|NCT00211237|516812608|FG000|6 Months|Could not comply with protocol|0|||
143345982|NCT00211237|516812609|FG001|6 Months|Could not comply with protocol|2|||
143345983|NCT00211237|516812610|FG002|6 Months|Could not comply with protocol|0|||
143345984|NCT00211237|516812608|FG000|12 Months|Death|8|||
143459616|NCT01375114|517228810|FG002|Overall Study|Restlessness|1|||
143459617|NCT01375114|517228808|FG000|Overall Study|Diarrhea|0|||
143459618|NCT01375114|517228809|FG001|Overall Study|Diarrhea|0|||
143459619|NCT01375114|517228810|FG002|Overall Study|Diarrhea|1|||
143459620|NCT01375114|517228808|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
143459621|NCT01375114|517228809|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
143459622|NCT01375114|517228810|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
143459623|NCT01375114|517228808|FG000|Overall Study|Nausea|0|||
143459624|NCT01375114|517228809|FG001|Overall Study|Nausea|1|||
143459625|NCT01375114|517228810|FG002|Overall Study|Nausea|0|||
143459626|NCT01375114|517228808|FG000|Overall Study|Increased AST/ALT|0|||
143459627|NCT01375114|517228809|FG001|Overall Study|Increased AST/ALT|1|||
143345985|NCT00211237|516812609|FG001|12 Months|Death|2|||
143345986|NCT00211237|516812610|FG002|12 Months|Death|3|||
143345987|NCT00211237|516812608|FG000|12 Months|Lost to Follow-up|1|||
143345988|NCT00211237|516812609|FG001|12 Months|Lost to Follow-up|0|||
143345989|NCT00211237|516812610|FG002|12 Months|Lost to Follow-up|1|||
143345990|NCT00211237|516812608|FG000|12 Months|Withdrew|0|||
143345991|NCT00211237|516812609|FG001|12 Months|Withdrew|0|||
143345992|NCT00211237|516812610|FG002|12 Months|Withdrew|1|||
143345993|NCT00211237|516812608|FG000|12 Months|unrelated medical problem|0|||
143345994|NCT00211237|516812609|FG001|12 Months|unrelated medical problem|0|||
143345995|NCT00211237|516812610|FG002|12 Months|unrelated medical problem|1|||
143345996|NCT01515189|516812611|FG000|Induction|Disease Progression|109|||
143345997|NCT01515189|516812612|FG001|Induction|Disease Progression|155|||
143345998|NCT01515189|516812611|FG000|Induction|Study drug toxicity|86|||
143345999|NCT01515189|516812612|FG001|Induction|Study drug toxicity|36|||
143346000|NCT01515189|516812611|FG000|Induction|Death|24|||
143346001|NCT01515189|516812612|FG001|Induction|Death|17|||
143346002|NCT01515189|516812611|FG000|Induction|Adverse Event|14|||
143346003|NCT01515189|516812612|FG001|Induction|Adverse Event|9|||
143346004|NCT01515189|516812611|FG000|Induction|Withdrawal by Subject|3|||
143346005|NCT01515189|516812612|FG001|Induction|Withdrawal by Subject|9|||
143346006|NCT01515189|516812611|FG000|Induction|No longer meets study criteria|0|||
143346007|NCT01515189|516812612|FG001|Induction|No longer meets study criteria|2|||
143346008|NCT01515189|516812611|FG000|Induction|Lost to Follow-up|1|||
143346009|NCT01515189|516812612|FG001|Induction|Lost to Follow-up|0|||
143346010|NCT01515189|516812611|FG000|Induction|Other|0|||
143346011|NCT01515189|516812612|FG001|Induction|Other|4|||
143346012|NCT01515189|516812611|FG000|First Re-Induction Phase|Disease progression|6|||
143346013|NCT01515189|516812612|FG001|First Re-Induction Phase|Disease progression|14|||
143346014|NCT01515189|516812611|FG000|First Re-Induction Phase|Study drug toxicity|5|||
143346015|NCT01515189|516812612|FG001|First Re-Induction Phase|Study drug toxicity|0|||
143346016|NCT01515189|516812611|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
143346017|NCT01515189|516812612|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
143346018|NCT01515189|516812611|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
143346019|NCT01515189|516812612|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
143346020|NCT01515189|516812611|FG000|First Re-Induction Phase|Other|1|||
143346021|NCT01515189|516812612|FG001|First Re-Induction Phase|Other|0|||
143346022|NCT01036022|516812628|FG000|Overall Study|Adverse Event|1|||
143346023|NCT01036022|516812629|FG001|Overall Study|Adverse Event|3|||
143346024|NCT01036022|516812630|FG002|Overall Study|Adverse Event|2|||
143346025|NCT01036022|516812631|FG003|Overall Study|Adverse Event|1|||
143346026|NCT01036022|516812632|FG004|Overall Study|Adverse Event|0|||
143346027|NCT01036022|516812633|FG005|Overall Study|Adverse Event|2|||
143346028|NCT01036022|516812628|FG000|Overall Study|Lack of Efficacy|1|||
143346029|NCT01036022|516812629|FG001|Overall Study|Lack of Efficacy|1|||
143346030|NCT01036022|516812630|FG002|Overall Study|Lack of Efficacy|1|||
143346031|NCT01036022|516812631|FG003|Overall Study|Lack of Efficacy|0|||
143346032|NCT01036022|516812632|FG004|Overall Study|Lack of Efficacy|1|||
143346033|NCT01036022|516812633|FG005|Overall Study|Lack of Efficacy|1|||
143346034|NCT01036022|516812628|FG000|Overall Study|Physician Decision|0|||
143346035|NCT01036022|516812629|FG001|Overall Study|Physician Decision|0|||
143346036|NCT01036022|516812630|FG002|Overall Study|Physician Decision|1|||
143346037|NCT01036022|516812631|FG003|Overall Study|Physician Decision|0|||
143346038|NCT01036022|516812632|FG004|Overall Study|Physician Decision|0|||
143346039|NCT01036022|516812633|FG005|Overall Study|Physician Decision|0|||
143346040|NCT01036022|516812628|FG000|Overall Study|Withdrawal by Subject|0|||
143346041|NCT01036022|516812629|FG001|Overall Study|Withdrawal by Subject|0|||
143346042|NCT01036022|516812630|FG002|Overall Study|Withdrawal by Subject|0|||
143346043|NCT01036022|516812631|FG003|Overall Study|Withdrawal by Subject|1|||
143346044|NCT01036022|516812632|FG004|Overall Study|Withdrawal by Subject|2|||
143346045|NCT01036022|516812633|FG005|Overall Study|Withdrawal by Subject|0|||
143346046|NCT02087501|516812634|FG000|Overall Study|Death|7|||
143459628|NCT01375114|517228810|FG002|Overall Study|Increased AST/ALT|0|||
143459629|NCT01375114|517228808|FG000|Overall Study|Vaginal Hemorrhage|0|||
143123125|NCT02769312|515996048|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
143123126|NCT02769312|515996049|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
143123127|NCT02769312|515996048|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
143123128|NCT02769312|515996049|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
143123129|NCT02769312|515996048|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
143123130|NCT02769312|515996049|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
143123131|NCT02769312|515996048|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
143123132|NCT02769312|515996049|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
143123133|NCT02769312|515996048|FG000|Follow-up|Lost to Follow-up|1|||
143123134|NCT02769312|515996049|FG001|Follow-up|Lost to Follow-up|1|||
143123135|NCT02815267|515996050|FG000|Double-Blind Phase|Adverse Event|0|||
143123136|NCT02815267|515996051|FG001|Double-Blind Phase|Adverse Event|3|||
143123137|NCT02815267|515996050|FG000|Double-Blind Phase|Lost to Follow-up|17|||
143123138|NCT02815267|515996051|FG001|Double-Blind Phase|Lost to Follow-up|9|||
143123139|NCT02815267|515996050|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
143123140|NCT02815267|515996051|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
143123141|NCT02815267|515996050|FG000|Double-Blind Phase|Protocol Violation|3|||
143123142|NCT02815267|515996051|FG001|Double-Blind Phase|Protocol Violation|2|||
143123143|NCT02815267|515996050|FG000|Double-Blind Phase|Site withdrawal|1|||
143123144|NCT02815267|515996051|FG001|Double-Blind Phase|Site withdrawal|6|||
143123145|NCT02815267|515996050|FG000|Double-Blind Phase|Received a disallowed medication|1|||
143123146|NCT02815267|515996051|FG001|Double-Blind Phase|Received a disallowed medication|1|||
143123147|NCT02815267|515996050|FG000|Open-Label Phase|Adverse Event|1|||
143123148|NCT02815267|515996051|FG001|Open-Label Phase|Adverse Event|1|||
143123149|NCT02815267|515996050|FG000|Open-Label Phase|Lost to Follow-up|23|||
143123150|NCT02815267|515996051|FG001|Open-Label Phase|Lost to Follow-up|9|||
143123151|NCT02815267|515996050|FG000|Open-Label Phase|Withdrawal by Subject|24|||
143123152|NCT02815267|515996051|FG001|Open-Label Phase|Withdrawal by Subject|13|||
143123153|NCT02815267|515996050|FG000|Open-Label Phase|Protocol Violation|0|||
143123154|NCT02815267|515996051|FG001|Open-Label Phase|Protocol Violation|1|||
143123155|NCT02815267|515996050|FG000|Open-Label Phase|Administrative|21|||
143123156|NCT02815267|515996051|FG001|Open-Label Phase|Administrative|12|||
143123157|NCT02815267|515996050|FG000|Open-Label Phase|Other|2|||
143123158|NCT02815267|515996051|FG001|Open-Label Phase|Other|5|||
143123159|NCT01108237|515996052|FG000|Overall Study|No alignment data|2|||
143123160|NCT01108237|515996053|FG001|Overall Study|No alignment data|15|||
143123161|NCT01108237|515996052|FG000|Overall Study|Did not meet criteria for analysis|7|||
143123162|NCT01108237|515996053|FG001|Overall Study|Did not meet criteria for analysis|0|||
143123163|NCT02178358|515996056|FG000|Overall Study|Withdrawal by Subject|0|||
143123164|NCT02178358|515996057|FG001|Overall Study|Withdrawal by Subject|2|||
143123165|NCT02178358|515996058|FG002|Overall Study|Withdrawal by Subject|2|||
143123166|NCT02178358|515996056|FG000|Overall Study|Lost to Follow-up|1|||
143123167|NCT02178358|515996057|FG001|Overall Study|Lost to Follow-up|0|||
143123168|NCT02178358|515996058|FG002|Overall Study|Lost to Follow-up|0|||
143123169|NCT01090050|515996059|FG000|Overall Study|Lost to Follow-up|0|||
143123170|NCT01090050|515996060|FG001|Overall Study|Lost to Follow-up|1|||
143123171|NCT01090050|515996059|FG000|Overall Study|Lack of Efficacy|1|||
143123172|NCT01090050|515996060|FG001|Overall Study|Lack of Efficacy|5|||
143123173|NCT01090050|515996059|FG000|Overall Study|Physician Decision|0|||
143123174|NCT01090050|515996060|FG001|Overall Study|Physician Decision|1|||
143123175|NCT03539484|515996061|FG000|Overall Study|Death|1|||
143123176|NCT03539484|515996062|FG001|Overall Study|Death|0|||
143123177|NCT03539484|515996063|FG002|Overall Study|Death|0|||
143123178|NCT03539484|515996064|FG003|Overall Study|Death|2|||
143123179|NCT03539484|515996065|FG004|Overall Study|Death|8|||
143123180|NCT03539484|515996066|FG005|Overall Study|Death|3|||
143123181|NCT03539484|515996067|FG006|Overall Study|Death|0|||
143123182|NCT03539484|515996061|FG000|Overall Study|Lost to Follow-up|0|||
143123183|NCT03539484|515996062|FG001|Overall Study|Lost to Follow-up|1|||
143123184|NCT03539484|515996063|FG002|Overall Study|Lost to Follow-up|0|||
143123185|NCT03539484|515996064|FG003|Overall Study|Lost to Follow-up|0|||
143123186|NCT03539484|515996065|FG004|Overall Study|Lost to Follow-up|1|||
143123187|NCT03539484|515996066|FG005|Overall Study|Lost to Follow-up|0|||
143123188|NCT03539484|515996067|FG006|Overall Study|Lost to Follow-up|0|||
143123189|NCT03539484|515996061|FG000|Overall Study|Withdrawal by Subject|0|||
143123190|NCT03539484|515996062|FG001|Overall Study|Withdrawal by Subject|0|||
143123191|NCT03539484|515996063|FG002|Overall Study|Withdrawal by Subject|0|||
143123192|NCT03539484|515996064|FG003|Overall Study|Withdrawal by Subject|0|||
143123193|NCT03539484|515996065|FG004|Overall Study|Withdrawal by Subject|2|||
143123194|NCT03539484|515996066|FG005|Overall Study|Withdrawal by Subject|0|||
143123195|NCT03539484|515996067|FG006|Overall Study|Withdrawal by Subject|1|||
143123196|NCT03539484|515996061|FG000|Overall Study|Study Terminated by Sponsor|0|||
143123197|NCT03539484|515996062|FG001|Overall Study|Study Terminated by Sponsor|0|||
143123198|NCT03539484|515996063|FG002|Overall Study|Study Terminated by Sponsor|1|||
143123199|NCT03539484|515996064|FG003|Overall Study|Study Terminated by Sponsor|1|||
143123200|NCT03539484|515996065|FG004|Overall Study|Study Terminated by Sponsor|2|||
143123201|NCT03539484|515996066|FG005|Overall Study|Study Terminated by Sponsor|2|||
143346047|NCT02087501|516812634|FG000|Overall Study|Open repair of aneurysm|1|||
143346048|NCT02087501|516812634|FG000|Overall Study|Lost to Follow-up|2|||
143346049|NCT00094328|516812635|FG000|Overall Study|Lost to Follow-up|1|||
143346050|NCT03682705|516812636|FG000|Overall Study|Adverse Event|1|||
143346051|NCT03682705|516812637|FG001|Overall Study|Adverse Event|1|||
143346052|NCT03682705|516812638|FG002|Overall Study|Adverse Event|1|||
143346053|NCT03682705|516812639|FG003|Overall Study|Adverse Event|0|||
143346054|NCT03682705|516812640|FG004|Overall Study|Adverse Event|1|||
143346055|NCT03682705|516812641|FG005|Overall Study|Adverse Event|1|||
143346056|NCT03682705|516812636|FG000|Overall Study|Withdrawal by Subject|1|||
143346057|NCT03682705|516812637|FG001|Overall Study|Withdrawal by Subject|3|||
143346058|NCT03682705|516812638|FG002|Overall Study|Withdrawal by Subject|2|||
143346059|NCT03682705|516812639|FG003|Overall Study|Withdrawal by Subject|4|||
143346060|NCT03682705|516812640|FG004|Overall Study|Withdrawal by Subject|0|||
143346061|NCT03682705|516812641|FG005|Overall Study|Withdrawal by Subject|1|||
143346062|NCT03682705|516812636|FG000|Overall Study|Other, not specified|0|||
143346063|NCT03682705|516812637|FG001|Overall Study|Other, not specified|0|||
143346064|NCT03682705|516812638|FG002|Overall Study|Other, not specified|0|||
143346065|NCT03682705|516812639|FG003|Overall Study|Other, not specified|1|||
143346066|NCT03682705|516812640|FG004|Overall Study|Other, not specified|2|||
143346067|NCT03682705|516812641|FG005|Overall Study|Other, not specified|0|||
143459630|NCT01375114|517228809|FG001|Overall Study|Vaginal Hemorrhage|1|||
143459631|NCT01375114|517228810|FG002|Overall Study|Vaginal Hemorrhage|0|||
143459632|NCT01375114|517228808|FG000|Overall Study|Family problem|0|||
143459633|NCT01375114|517228809|FG001|Overall Study|Family problem|1|||
143459634|NCT01375114|517228810|FG002|Overall Study|Family problem|0|||
143459635|NCT01375114|517228808|FG000|Overall Study|Protocol Violation|2|||
143459636|NCT01375114|517228809|FG001|Overall Study|Protocol Violation|0|||
143459637|NCT01375114|517228810|FG002|Overall Study|Protocol Violation|0|||
143459638|NCT01888900|517228816|FG000|Overall Study|failed treatment|0|||
143459639|NCT01888900|517228817|FG001|Overall Study|failed treatment|2|||
143459640|NCT01248065|517228818|FG000|Overall Study|Lost to Follow-up|3|||
143459641|NCT01248065|517228819|FG001|Overall Study|Lost to Follow-up|5|||
143459642|NCT01248065|517228818|FG000|Overall Study|Withdrawal by Subject|14|||
143459643|NCT01248065|517228819|FG001|Overall Study|Withdrawal by Subject|11|||
143459644|NCT01248065|517228818|FG000|Overall Study|Adverse Event|3|||
143459645|NCT01248065|517228819|FG001|Overall Study|Adverse Event|0|||
143459646|NCT01248065|517228818|FG000|Overall Study|Third treatment failure event|3|||
143459647|NCT01248065|517228819|FG001|Overall Study|Third treatment failure event|1|||
143459648|NCT01248065|517228818|FG000|Overall Study|Other|3|||
143459649|NCT01248065|517228819|FG001|Overall Study|Other|5|||
143459650|NCT02781844|517228830|FG000|Treatment Period 1|Adverse Event|0|||
143459651|NCT02781844|517228831|FG001|Treatment Period 1|Adverse Event|0|||
143459652|NCT02781844|517228832|FG002|Treatment Period 1|Adverse Event|0|||
143459653|NCT02781844|517228833|FG003|Treatment Period 1|Adverse Event|0|||
143459654|NCT02781844|517228834|FG004|Treatment Period 1|Adverse Event|0|||
143459655|NCT02781844|517228835|FG005|Treatment Period 1|Adverse Event|1|||
143459656|NCT02781844|517228836|FG006|Treatment Period 1|Adverse Event|0|||
143459657|NCT02781844|517228837|FG007|Treatment Period 1|Adverse Event|0|||
143459658|NCT00321373|517228842|FG000|Overall Study|Adverse Event|0|||
143459659|NCT00321373|517228843|FG001|Overall Study|Adverse Event|0|||
143459660|NCT00321373|517228844|FG002|Overall Study|Adverse Event|1|||
143459661|NCT00321373|517228842|FG000|Overall Study|Lost to Follow-up|1|||
143459662|NCT00321373|517228843|FG001|Overall Study|Lost to Follow-up|0|||
143459663|NCT00321373|517228844|FG002|Overall Study|Lost to Follow-up|1|||
143459664|NCT00321373|517228842|FG000|Overall Study|Withdrawal by Subject|1|||
143459665|NCT00321373|517228843|FG001|Overall Study|Withdrawal by Subject|0|||
143459666|NCT00321373|517228844|FG002|Overall Study|Withdrawal by Subject|0|||
143459667|NCT00321373|517228842|FG000|Overall Study|Other|0|||
143459668|NCT00321373|517228843|FG001|Overall Study|Other|0|||
143459669|NCT00321373|517228844|FG002|Overall Study|Other|1|||
143459670|NCT01774487|517228845|FG000|Overall Study|Did not tolerate taste|4|||
143459671|NCT01774487|517228846|FG001|Overall Study|Did not tolerate taste|4|||
143459672|NCT04275089|517228847|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
143459673|NCT02354508|517228851|FG000|Period 1: Core Phase|Adverse Event|1|||
143459674|NCT02354508|517228852|FG001|Period 1: Core Phase|Adverse Event|1|||
143459675|NCT02354508|517228853|FG002|Period 1: Core Phase|Adverse Event|2|||
143346068|NCT03682705|516812636|FG000|Overall Study|Lost to Follow-up|0|||
143346069|NCT03682705|516812637|FG001|Overall Study|Lost to Follow-up|0|||
143346070|NCT03682705|516812638|FG002|Overall Study|Lost to Follow-up|0|||
143346071|NCT03682705|516812639|FG003|Overall Study|Lost to Follow-up|0|||
143346072|NCT03682705|516812640|FG004|Overall Study|Lost to Follow-up|3|||
143459676|NCT02354508|517228851|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
143459677|NCT02354508|517228852|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
143459678|NCT02354508|517228853|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
143459679|NCT02354508|517228851|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
143459680|NCT02354508|517228852|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
143459681|NCT02354508|517228853|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
143346073|NCT03682705|516812641|FG005|Overall Study|Lost to Follow-up|0|||
143346074|NCT01483937|516812642|FG000|Overall Study|Withdrawal by Subject|4|||
143346075|NCT01483937|516812643|FG001|Overall Study|Withdrawal by Subject|3|||
143346076|NCT02213328|516812644|FG000|Overall Study|Withdrawal by Subject|10|||
143346077|NCT02213328|516812644|FG000|Overall Study|Physician Decision|2|||
143346078|NCT02213328|516812644|FG000|Overall Study|Lost to Follow-up|16|||
143346079|NCT00682643|516812646|FG000|Overall Study|Adverse Event|12|||
143346080|NCT00682643|516812647|FG001|Overall Study|Adverse Event|23|||
143346081|NCT00682643|516812646|FG000|Overall Study|Lack of Efficacy|2|||
143346082|NCT00682643|516812647|FG001|Overall Study|Lack of Efficacy|0|||
143346083|NCT00682643|516812646|FG000|Overall Study|Protocol Violation|38|||
143346084|NCT00682643|516812647|FG001|Overall Study|Protocol Violation|76|||
143346085|NCT00682643|516812646|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
143346086|NCT00682643|516812647|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
143346087|NCT00682643|516812646|FG000|Overall Study|Lost to Follow-up|1|||
143346088|NCT00682643|516812647|FG001|Overall Study|Lost to Follow-up|6|||
143346089|NCT00682643|516812646|FG000|Overall Study|Physician Decision|2|||
143346090|NCT00682643|516812647|FG001|Overall Study|Physician Decision|6|||
143346091|NCT00682643|516812646|FG000|Overall Study|Withdrawal by Subject|19|||
143346092|NCT00682643|516812647|FG001|Overall Study|Withdrawal by Subject|53|||
143346093|NCT00682643|516812646|FG000|Overall Study|Did Not Receive Study Drug|1|||
143346094|NCT00682643|516812647|FG001|Overall Study|Did Not Receive Study Drug|1|||
143346095|NCT01875185|516812648|FG000|Overall Study|study was terminated|52|||
143346096|NCT01875185|516812649|FG001|Overall Study|study was terminated|48|||
143346097|NCT03565068|516812651|FG000|Overall Study|Protocol Violation|0|||
143346098|NCT03565068|516812652|FG001|Overall Study|Protocol Violation|0|||
143346099|NCT03565068|516812653|FG002|Overall Study|Protocol Violation|0|||
143123202|NCT03539484|515996067|FG006|Overall Study|Study Terminated by Sponsor|1|||
143123203|NCT02232061|515996068|FG000|Overall Study|Administrative problems|1|||
143123204|NCT02232061|515996068|FG000|Overall Study|Withdrawal by Subject|1|||
143123205|NCT00571103|515996069|FG000|Overall Study|Withdrawal by Subject|1|||
143123206|NCT00571103|515996069|FG000|Overall Study|Lost to Follow-up|1|||
143123207|NCT00948922|515996071|FG000|Overall Study|Did not start study treatment|2|||
143123208|NCT00948922|515996072|FG001|Overall Study|Did not start study treatment|5|||
143123209|NCT00948922|515996073|FG002|Overall Study|Did not start study treatment|0|||
143123210|NCT00948922|515996071|FG000|Overall Study|Withdrawal by Subject|0|||
143123211|NCT00948922|515996072|FG001|Overall Study|Withdrawal by Subject|2|||
143123212|NCT00948922|515996073|FG002|Overall Study|Withdrawal by Subject|1|||
143123213|NCT00948922|515996071|FG000|Overall Study|Death|3|||
143123214|NCT00948922|515996072|FG001|Overall Study|Death|0|||
143123215|NCT00948922|515996073|FG002|Overall Study|Death|0|||
143123216|NCT00948922|515996071|FG000|Overall Study|Disease progression|0|||
143123217|NCT00948922|515996072|FG001|Overall Study|Disease progression|1|||
143123218|NCT00948922|515996073|FG002|Overall Study|Disease progression|0|||
143123219|NCT00948922|515996071|FG000|Overall Study|Insurance issues|1|||
143123220|NCT00948922|515996072|FG001|Overall Study|Insurance issues|0|||
143123221|NCT00948922|515996073|FG002|Overall Study|Insurance issues|0|||
143123222|NCT00948922|515996071|FG000|Overall Study|Transplant eligibility issues|2|||
143123223|NCT00948922|515996072|FG001|Overall Study|Transplant eligibility issues|3|||
143123224|NCT00948922|515996073|FG002|Overall Study|Transplant eligibility issues|0|||
143123225|NCT00948922|515996071|FG000|Overall Study|Not evaluable at time of analysis|0|||
143123226|NCT00948922|515996072|FG001|Overall Study|Not evaluable at time of analysis|3|||
143123227|NCT00948922|515996073|FG002|Overall Study|Not evaluable at time of analysis|0|||
143123228|NCT02784288|515996074|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
143123229|NCT02757625|515996075|FG000|Overall Study|Investigator's discretion|0|||
143123230|NCT02757625|515996076|FG001|Overall Study|Investigator's discretion|0|||
143123231|NCT02757625|515996077|FG002|Overall Study|Investigator's discretion|1|||
143123232|NCT02757625|515996078|FG003|Overall Study|Investigator's discretion|0|||
143123233|NCT02757625|515996075|FG000|Overall Study|Adverse Event|0|||
143123234|NCT02757625|515996076|FG001|Overall Study|Adverse Event|0|||
143123235|NCT02757625|515996077|FG002|Overall Study|Adverse Event|1|||
143123236|NCT02757625|515996078|FG003|Overall Study|Adverse Event|0|||
143123237|NCT02131233|515996079|FG000|Overall Study|Not Treated|2|||
143123238|NCT02131233|515996080|FG001|Overall Study|Not Treated|3|||
143123239|NCT02131233|515996079|FG000|Overall Study|Adverse Event|7|||
143123240|NCT02131233|515996080|FG001|Overall Study|Adverse Event|6|||
143123241|NCT02131233|515996079|FG000|Overall Study|Death|0|||
143123242|NCT02131233|515996080|FG001|Overall Study|Death|1|||
143123243|NCT02131233|515996079|FG000|Overall Study|Lack of Efficacy|6|||
143123244|NCT02131233|515996080|FG001|Overall Study|Lack of Efficacy|3|||
143346100|NCT03565068|516812654|FG003|Overall Study|Protocol Violation|0|||
143346101|NCT03565068|516812655|FG004|Overall Study|Protocol Violation|1|||
143346102|NCT03565068|516812656|FG005|Overall Study|Protocol Violation|0|||
143346103|NCT03565068|516812657|FG006|Overall Study|Protocol Violation|0|||
143346104|NCT03565068|516812658|FG007|Overall Study|Protocol Violation|1|||
143346105|NCT03565068|516812659|FG008|Overall Study|Protocol Violation|0|||
143346106|NCT03565068|516812651|FG000|Overall Study|Sponsor decision|0|||
143346107|NCT03565068|516812652|FG001|Overall Study|Sponsor decision|0|||
143123245|NCT02131233|515996079|FG000|Overall Study|Lost to Follow-up|14|||
143123246|NCT02131233|515996080|FG001|Overall Study|Lost to Follow-up|13|||
143123247|NCT02131233|515996079|FG000|Overall Study|Non-Compliance With Study Drug|8|||
143123248|NCT02131233|515996080|FG001|Overall Study|Non-Compliance With Study Drug|5|||
143123249|NCT02131233|515996079|FG000|Overall Study|Physician Decision|7|||
143123250|NCT02131233|515996080|FG001|Overall Study|Physician Decision|0|||
143123251|NCT02131233|515996079|FG000|Overall Study|Pregnancy|4|||
143123252|NCT02131233|515996080|FG001|Overall Study|Pregnancy|0|||
143123253|NCT02131233|515996079|FG000|Overall Study|Withdrawal by Subject|18|||
143123254|NCT02131233|515996080|FG001|Overall Study|Withdrawal by Subject|11|||
143123255|NCT00645671|515996081|FG000|Overall Study|Protocol Violation|1|||
143123256|NCT00645671|515996082|FG001|Overall Study|Protocol Violation|0|||
143123257|NCT00645671|515996081|FG000|Overall Study|Withdrawal by Subject|0|||
143123258|NCT00645671|515996082|FG001|Overall Study|Withdrawal by Subject|4|||
143123259|NCT00645671|515996081|FG000|Overall Study|Adverse Event|0|||
143123260|NCT00645671|515996082|FG001|Overall Study|Adverse Event|1|||
143123261|NCT00645671|515996081|FG000|Overall Study|Physician Decision|0|||
143123262|NCT00645671|515996082|FG001|Overall Study|Physician Decision|1|||
143123263|NCT02095197|515996083|FG000|Overall Study|Lost to Follow-up|0|||
143123264|NCT02095197|515996084|FG001|Overall Study|Lost to Follow-up|3|||
143123265|NCT05114564|515996086|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
143123266|NCT05114564|515996087|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
143123267|NCT05114564|515996086|FG000|First Intervention|Adverse Event|0|||
143123268|NCT05114564|515996087|FG001|First Intervention|Adverse Event|1|||
143123269|NCT00493311|515996088|FG000|Overall Study|Need for rescue medication|2|||
143123270|NCT00493311|515996089|FG001|Overall Study|Need for rescue medication|2|||
143123271|NCT02779075|515996090|FG000|Overall Study|Withdrawal by Subject|1|||
143123272|NCT02779075|515996091|FG001|Overall Study|Withdrawal by Subject|3|||
143123273|NCT02779075|515996090|FG000|Overall Study|IV lost during 2nd study|1|||
143123274|NCT02779075|515996091|FG001|Overall Study|IV lost during 2nd study|0|||
143123275|NCT00790556|515996092|FG000|Treatment Period 1|Physician Decision|1|||
143123276|NCT00790556|515996093|FG001|Treatment Period 1|Physician Decision|0|||
143123277|NCT00790556|515996092|FG000|Treatment Period 1|Withdrawal by Subject|1|||
143123278|NCT00790556|515996093|FG001|Treatment Period 1|Withdrawal by Subject|0|||
143123279|NCT00255840|515996094|FG000|Overall Study|Lost to Follow-up|10|||
143123280|NCT00255840|515996095|FG001|Overall Study|Lost to Follow-up|14|||
143123281|NCT00255840|515996094|FG000|Overall Study|Discontinued intervention|53|||
143123282|NCT00255840|515996095|FG001|Overall Study|Discontinued intervention|56|||
143123283|NCT00217581|515996098|FG000|Overall Study|Withdrawal by Subject|1|||
143123284|NCT02087943|515996099|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
143123285|NCT02087943|515996100|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
143123286|NCT02087943|515996101|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
143123287|NCT02087943|515996102|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
143123288|NCT02087943|515996103|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
143123289|NCT02087943|515996099|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
143123290|NCT02087943|515996100|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
143123291|NCT02087943|515996101|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
143123292|NCT02087943|515996102|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
143123293|NCT02087943|515996103|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
143123294|NCT02087943|515996099|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
143123295|NCT02087943|515996100|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
143123296|NCT02087943|515996101|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
143123297|NCT02087943|515996102|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
143123298|NCT02087943|515996103|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
143123299|NCT02087943|515996099|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
143123300|NCT02087943|515996100|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
143123301|NCT02087943|515996101|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
143123302|NCT02087943|515996102|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
143123303|NCT02087943|515996103|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
143123304|NCT02087943|515996099|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
143123305|NCT02087943|515996100|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
143123306|NCT02087943|515996101|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
143123307|NCT02087943|515996102|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
143123308|NCT02087943|515996103|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
143123309|NCT02087943|515996099|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
143123310|NCT02087943|515996100|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
143123311|NCT02087943|515996101|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
143123312|NCT02087943|515996102|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
143123313|NCT02087943|515996103|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
143123314|NCT02087943|515996099|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
143123315|NCT02087943|515996100|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
143123316|NCT02087943|515996101|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
143346108|NCT03565068|516812653|FG002|Overall Study|Sponsor decision|0|||
143346109|NCT03565068|516812654|FG003|Overall Study|Sponsor decision|0|||
143346110|NCT03565068|516812655|FG004|Overall Study|Sponsor decision|1|||
143346111|NCT03565068|516812656|FG005|Overall Study|Sponsor decision|1|||
143346112|NCT03565068|516812657|FG006|Overall Study|Sponsor decision|0|||
143346113|NCT03565068|516812658|FG007|Overall Study|Sponsor decision|0|||
143346114|NCT03565068|516812659|FG008|Overall Study|Sponsor decision|0|||
143346115|NCT03565068|516812651|FG000|Overall Study|Withdrawal by Subject|0|||
143346116|NCT03565068|516812652|FG001|Overall Study|Withdrawal by Subject|0|||
143346117|NCT03565068|516812653|FG002|Overall Study|Withdrawal by Subject|1|||
143346118|NCT03565068|516812654|FG003|Overall Study|Withdrawal by Subject|0|||
143346119|NCT03565068|516812655|FG004|Overall Study|Withdrawal by Subject|2|||
143346120|NCT03565068|516812656|FG005|Overall Study|Withdrawal by Subject|0|||
143346121|NCT03565068|516812657|FG006|Overall Study|Withdrawal by Subject|1|||
143346122|NCT03565068|516812658|FG007|Overall Study|Withdrawal by Subject|5|||
143346123|NCT03565068|516812659|FG008|Overall Study|Withdrawal by Subject|1|||
143346124|NCT03565068|516812651|FG000|Overall Study|Physician Decision|0|||
143346125|NCT03565068|516812652|FG001|Overall Study|Physician Decision|0|||
143346126|NCT03565068|516812653|FG002|Overall Study|Physician Decision|0|||
143346127|NCT03565068|516812654|FG003|Overall Study|Physician Decision|0|||
143346128|NCT03565068|516812655|FG004|Overall Study|Physician Decision|0|||
143346129|NCT03565068|516812656|FG005|Overall Study|Physician Decision|0|||
143346130|NCT03565068|516812657|FG006|Overall Study|Physician Decision|0|||
143346131|NCT03565068|516812658|FG007|Overall Study|Physician Decision|1|||
143346132|NCT03565068|516812659|FG008|Overall Study|Physician Decision|0|||
143346133|NCT03565068|516812651|FG000|Overall Study|Lost to Follow-up|0|||
143346134|NCT03565068|516812652|FG001|Overall Study|Lost to Follow-up|0|||
143346135|NCT03565068|516812653|FG002|Overall Study|Lost to Follow-up|0|||
143346136|NCT03565068|516812654|FG003|Overall Study|Lost to Follow-up|0|||
143346137|NCT03565068|516812655|FG004|Overall Study|Lost to Follow-up|0|||
143346138|NCT03565068|516812656|FG005|Overall Study|Lost to Follow-up|0|||
143346139|NCT03565068|516812657|FG006|Overall Study|Lost to Follow-up|0|||
143346140|NCT03565068|516812658|FG007|Overall Study|Lost to Follow-up|1|||
143346141|NCT03565068|516812659|FG008|Overall Study|Lost to Follow-up|0|||
143346142|NCT03238300|516812660|FG000|Baseline (Before Intervention)|Physician Decision|0|||
143346143|NCT03238300|516812661|FG001|Baseline (Before Intervention)|Physician Decision|1|||
143346144|NCT03238300|516812660|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
143346145|NCT03238300|516812661|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
143346146|NCT03238300|516812660|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
143346147|NCT03238300|516812661|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
143346148|NCT03238300|516812660|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
143346149|NCT03238300|516812661|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
143346150|NCT01435655|516812662|FG000|Overall Study|Death|2|||
143346151|NCT01435655|516812662|FG000|Overall Study|Other|1|||
143346152|NCT01686581|516812663|FG000|Overall Study|Side-effects or Health Problems|15|||
143346153|NCT01686581|516812663|FG000|Overall Study|Lack of Efficacy|90|||
143346154|NCT01686581|516812663|FG000|Overall Study|Participant Concerned about Risks|6|||
143346155|NCT01686581|516812663|FG000|Overall Study|Thinks Injections Too Painful|8|||
143346156|NCT01686581|516812663|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
143346157|NCT01686581|516812663|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
143346158|NCT01686581|516812663|FG000|Overall Study|Thinks it is Inconvenient|17|||
143346159|NCT01686581|516812663|FG000|Overall Study|Other Miscellaneous Reasons|36|||
143346160|NCT01686581|516812663|FG000|Overall Study|Reason Missing|1|||
143346161|NCT01852058|516812664|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
143346162|NCT01852058|516812665|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
143346163|NCT01852058|516812666|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
143346164|NCT01852058|516812667|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
143346165|NCT01852058|516812668|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
143346166|NCT01852058|516812669|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
143346167|NCT01852058|516812670|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
143346168|NCT01852058|516812671|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
143346169|NCT01852058|516812672|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
143346170|NCT01852058|516812673|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
143346171|NCT01852058|516812674|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
143346172|NCT01852058|516812675|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
143346173|NCT01852058|516812664|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
143346174|NCT01852058|516812665|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
143346175|NCT01852058|516812666|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
143346176|NCT01852058|516812667|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
143346177|NCT01852058|516812668|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
143346178|NCT01852058|516812669|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
143346179|NCT01852058|516812670|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
143368945|NCT02001623|516894572|FG014|Overall Study|Physician Decision|1|||
143459682|NCT02354508|517228851|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
143459683|NCT02354508|517228852|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
143459684|NCT02354508|517228853|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
143459685|NCT02354508|517228851|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
143459686|NCT02354508|517228852|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
143459687|NCT02354508|517228853|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
143459688|NCT02354508|517228851|FG000|Period 2: Extension Phase|Physician Decision|5|||
143459689|NCT02354508|517228852|FG001|Period 2: Extension Phase|Physician Decision|0|||
143459690|NCT02354508|517228853|FG002|Period 2: Extension Phase|Physician Decision|1|||
143123317|NCT02087943|515996102|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
143123318|NCT02087943|515996103|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
143123319|NCT02087943|515996099|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
143123320|NCT02087943|515996100|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
143123321|NCT02087943|515996101|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
143123322|NCT02087943|515996102|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
143123323|NCT02087943|515996103|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
143123324|NCT02087943|515996099|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
143123325|NCT02087943|515996100|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
143123326|NCT02087943|515996101|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
143123327|NCT02087943|515996102|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
143123328|NCT02087943|515996103|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
143123329|NCT02087943|515996099|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
143123330|NCT02087943|515996100|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
143123331|NCT02087943|515996101|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
143123332|NCT02087943|515996102|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
143123333|NCT02087943|515996103|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
143123334|NCT00329745|515996111|FG000|Overall Study|Protocol Violation|1|||
143123335|NCT00329745|515996112|FG001|Overall Study|Protocol Violation|0|||
143123336|NCT00329745|515996111|FG000|Overall Study|Withdrawal by Subject|0|||
143123337|NCT00329745|515996112|FG001|Overall Study|Withdrawal by Subject|1|||
143123338|NCT00329745|515996111|FG000|Overall Study|Lost to Follow-up|86|||
143123339|NCT00329745|515996112|FG001|Overall Study|Lost to Follow-up|101|||
143123340|NCT01557517|515996115|FG000|Overall Study|Death|1|||
143123341|NCT01557517|515996116|FG001|Overall Study|Death|0|||
143123342|NCT01557517|515996115|FG000|Overall Study|Refused further treatment|0|||
143123343|NCT01557517|515996116|FG001|Overall Study|Refused further treatment|2|||
143123344|NCT01557517|515996115|FG000|Overall Study|Adverse Event|0|||
143123345|NCT01557517|515996116|FG001|Overall Study|Adverse Event|2|||
143123346|NCT01557517|515996115|FG000|Overall Study|Pt declined before treatment started|1|||
143123347|NCT01557517|515996116|FG001|Overall Study|Pt declined before treatment started|0|||
143123348|NCT00162097|515996117|FG000|Overall Study|Participant no longer met study criteria|0|||
143123349|NCT00162097|515996118|FG001|Overall Study|Participant no longer met study criteria|0|||
143123350|NCT00162097|515996119|FG002|Overall Study|Participant no longer met study criteria|0|||
143123351|NCT00162097|515996120|FG003|Overall Study|Participant no longer met study criteria|1|||
143123352|NCT01204918|515996121|FG000|Overall Study|Withdrawal by Subject|4|||
143123353|NCT01204918|515996122|FG001|Overall Study|Withdrawal by Subject|10|||
143123354|NCT01204918|515996123|FG002|Overall Study|Withdrawal by Subject|5|||
143123355|NCT01280682|515996126|FG000|Overall Study|Lost to Follow-up|0|||
143123356|NCT01280682|515996127|FG001|Overall Study|Lost to Follow-up|6|||
143123357|NCT01280682|515996126|FG000|Overall Study|Withdrawal by Subject|0|||
143123358|NCT01280682|515996127|FG001|Overall Study|Withdrawal by Subject|7|||
143123359|NCT01808222|515996128|FG000|Overall Study|mpMR scan was not performed|1|||
143123360|NCT03230838|515996129|FG000|Overall Study|Withdrawal by Subject|3|||
143123361|NCT03230838|515996130|FG001|Overall Study|Withdrawal by Subject|0|||
143123362|NCT03230838|515996129|FG000|Overall Study|Temperature excursion|1|||
143123363|NCT03230838|515996130|FG001|Overall Study|Temperature excursion|0|||
143123364|NCT02324699|515996131|FG000|Overall Study|study terminated|1|||
143123365|NCT03970200|515996132|FG000|Overall Study|Death|2|||
143123366|NCT03970200|515996133|FG001|Overall Study|Death|2|||
143123367|NCT03970200|515996134|FG002|Overall Study|Death|1|||
143123368|NCT03970200|515996132|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
143123369|NCT03970200|515996133|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
143123370|NCT03970200|515996134|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
143123371|NCT01098162|515996135|FG000|Overall Study|Adverse Event|37|||
143123372|NCT01098162|515996135|FG000|Overall Study|Lack of Efficacy|4|||
143123373|NCT01098162|515996135|FG000|Overall Study|Wish of Patient|7|||
143123374|NCT01098162|515996135|FG000|Overall Study|Lost to Follow-up|9|||
143123375|NCT01098162|515996135|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
143123376|NCT01098162|515996135|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
143123377|NCT01098162|515996135|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
143123378|NCT01098162|515996135|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
143123379|NCT01098162|515996135|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
143123380|NCT01098162|515996135|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
143123381|NCT01098162|515996135|FG000|Overall Study|Other Reason|1|||
143123382|NCT01098162|515996135|FG000|Overall Study|Reason Unknown|26|||
143123383|NCT00625183|515996136|FG000|Overall Study|Disease Progression|1|||
143123384|NCT01605825|515996137|FG000|Overall Study|Adverse Event|4|||
143123385|NCT01605825|515996138|FG001|Overall Study|Adverse Event|2|||
143123386|NCT01605825|515996137|FG000|Overall Study|Withdrawal by Subject|0|||
143123387|NCT01605825|515996138|FG001|Overall Study|Withdrawal by Subject|1|||
143123388|NCT01605825|515996137|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
143123389|NCT01605825|515996138|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
143123390|NCT01605825|515996137|FG000|Overall Study|Non-Compliance with Protocol|3|||
143123391|NCT01605825|515996138|FG001|Overall Study|Non-Compliance with Protocol|0|||
143123392|NCT02279745|515996139|FG000|Overall Study|Adverse Event|7|||
143123393|NCT02279745|515996139|FG000|Overall Study|Death|6|||
143123394|NCT02279745|515996139|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
143123395|NCT02279745|515996139|FG000|Overall Study|Withdrawal by Subject|2|||
143123396|NCT02279745|515996139|FG000|Overall Study|Pregnancy|1|||
143123397|NCT02279745|515996139|FG000|Overall Study|Study Non-compliance|1|||
143123398|NCT02279745|515996139|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
143123399|NCT03469999|515996140|FG000|Overall Study|Lost to Follow-up|2|||
143123400|NCT02155322|515996141|FG000|Overall Study|Adverse Event|1|||
143123401|NCT02155322|515996141|FG000|Overall Study|Physician Decision|1|||
143123402|NCT02155322|515996141|FG000|Overall Study|Relapse/Recurrence|8|||
143123403|NCT02155322|515996141|FG000|Overall Study|Withdrawal by Subject|4|||
143123404|NCT00460746|515996142|FG000|Overall Study|Adverse Event|1|||
143123405|NCT00460746|515996142|FG000|Overall Study|Lost to Follow-up|1|||
143123406|NCT02669667|515996143|FG000|Overall Study|Lost to Follow-up|0|||
143123407|NCT02669667|515996144|FG001|Overall Study|Lost to Follow-up|0|||
143123408|NCT02669667|515996145|FG002|Overall Study|Lost to Follow-up|0|||
143123409|NCT02669667|515996146|FG003|Overall Study|Lost to Follow-up|0|||
143123410|NCT02669667|515996147|FG004|Overall Study|Lost to Follow-up|0|||
143123411|NCT02669667|515996148|FG005|Overall Study|Lost to Follow-up|1|||
143123412|NCT02669667|515996149|FG006|Overall Study|Lost to Follow-up|0|||
143123413|NCT01603394|515996150|FG000|Overall Study|Adverse Event|1|||
143123414|NCT00840034|515996151|FG000|Acute Treatment Phase|Adverse Event|6|||
143123415|NCT00840034|515996152|FG001|Acute Treatment Phase|Adverse Event|8|||
143123416|NCT00840034|515996151|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
143123417|NCT00840034|515996152|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
143123418|NCT00840034|515996151|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
143123419|NCT00840034|515996152|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
143123420|NCT00840034|515996151|FG000|Acute Treatment Phase|Physician Decision|0|||
143123421|NCT00840034|515996152|FG001|Acute Treatment Phase|Physician Decision|1|||
143123422|NCT00840034|515996151|FG000|Acute Treatment Phase|Protocol Violation|2|||
143123423|NCT00840034|515996152|FG001|Acute Treatment Phase|Protocol Violation|4|||
143123424|NCT00840034|515996151|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
143123425|NCT00840034|515996152|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
143123426|NCT00840034|515996151|FG000|Taper Phase|Adverse Event|1|||
143123427|NCT00840034|515996152|FG001|Taper Phase|Adverse Event|0|||
143123428|NCT00840034|515996151|FG000|Taper Phase|Lost to Follow-up|1|||
143123429|NCT00840034|515996152|FG001|Taper Phase|Lost to Follow-up|1|||
143123430|NCT00840034|515996151|FG000|Taper Phase|Withdrawal by Subject|1|||
143123431|NCT00840034|515996152|FG001|Taper Phase|Withdrawal by Subject|1|||
143123432|NCT03383692|515996161|FG000|Overall Study|Progressive disease as per RECIST|3|||
143123433|NCT03383692|515996162|FG001|Overall Study|Progressive disease as per RECIST|3|||
143123434|NCT03383692|515996161|FG000|Overall Study|Clinical progression|0|||
143123435|NCT03383692|515996162|FG001|Overall Study|Clinical progression|1|||
143123436|NCT03383692|515996161|FG000|Overall Study|Adverse Event|3|||
143123437|NCT03383692|515996162|FG001|Overall Study|Adverse Event|0|||
143123438|NCT00793546|515996163|FG000|Overall Study|Death|3|||
143123439|NCT00793546|515996164|FG001|Overall Study|Death|0|||
143123440|NCT00793546|515996163|FG000|Overall Study|Lost to Follow-up|1|||
143123441|NCT00793546|515996164|FG001|Overall Study|Lost to Follow-up|0|||
143123442|NCT00793546|515996163|FG000|Overall Study|Withdrawal by Subject|1|||
143123443|NCT00793546|515996164|FG001|Overall Study|Withdrawal by Subject|1|||
143123444|NCT00793546|515996163|FG000|Overall Study|Study Terminated by Sponsor|8|||
143123445|NCT00793546|515996164|FG001|Overall Study|Study Terminated by Sponsor|27|||
143123446|NCT00793546|515996163|FG000|Overall Study|Other|1|||
143123447|NCT00793546|515996164|FG001|Overall Study|Other|0|||
143123448|NCT00385827|515997776|FG000|Part 1|Adverse Event|1|||
143123449|NCT00385827|515997777|FG001|Part 1|Adverse Event|0|||
143123450|NCT00385827|515997778|FG002|Part 1|Adverse Event|0|||
143123451|NCT00385827|515997776|FG000|Part 1|Death|2|||
143123452|NCT00385827|515997777|FG001|Part 1|Death|0|||
143123453|NCT00385827|515997778|FG002|Part 1|Death|0|||
143123454|NCT00385827|515997776|FG000|Part 1|Lack of Efficacy|5|||
143123455|NCT00385827|515997777|FG001|Part 1|Lack of Efficacy|0|||
143123456|NCT00385827|515997778|FG002|Part 1|Lack of Efficacy|0|||
143123457|NCT00385827|515997776|FG000|Part 1|Other|1|||
143123458|NCT00385827|515997777|FG001|Part 1|Other|0|||
143346180|NCT01852058|516812671|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
143346181|NCT01852058|516812672|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
143346182|NCT01852058|516812673|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
143346183|NCT01852058|516812674|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
143346184|NCT01852058|516812675|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
143346185|NCT01852058|516812664|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
143346186|NCT01852058|516812665|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
143346187|NCT01852058|516812666|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
143346188|NCT01852058|516812667|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
143346189|NCT01852058|516812668|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
143346190|NCT01852058|516812669|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
143346191|NCT01852058|516812670|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
143346192|NCT01852058|516812671|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
143346193|NCT01852058|516812672|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
143346194|NCT01852058|516812673|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
143346195|NCT01852058|516812674|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
143346196|NCT01852058|516812675|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
143346197|NCT01852058|516812664|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
143346198|NCT01852058|516812665|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
143346199|NCT01852058|516812666|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
143346200|NCT01852058|516812667|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
143346201|NCT01852058|516812668|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
143346202|NCT01852058|516812669|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
143346203|NCT01852058|516812670|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
143346204|NCT01852058|516812671|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
143346205|NCT01852058|516812672|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
143346206|NCT01852058|516812673|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
143346207|NCT01852058|516812674|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
143346208|NCT01852058|516812675|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
143346209|NCT01852058|516812664|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
143346210|NCT01852058|516812665|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
143346211|NCT01852058|516812666|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
143346212|NCT01852058|516812667|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
143346213|NCT01852058|516812668|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
143346214|NCT01852058|516812669|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
143346215|NCT01852058|516812670|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
143346216|NCT01852058|516812671|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
143346217|NCT01852058|516812672|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
143346218|NCT01852058|516812673|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
143346219|NCT01852058|516812674|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
143346220|NCT01852058|516812675|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
143346221|NCT01852058|516812664|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
143346222|NCT01852058|516812665|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
143346223|NCT01852058|516812666|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
143346224|NCT01852058|516812667|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
143346225|NCT01852058|516812668|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
143346226|NCT01852058|516812669|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
143346227|NCT01852058|516812670|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
143346228|NCT01852058|516812671|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
143346229|NCT01852058|516812672|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
143346230|NCT01852058|516812673|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
143346231|NCT01852058|516812674|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
143346232|NCT01852058|516812675|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
143346233|NCT01852058|516812664|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
143346234|NCT01852058|516812665|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
143346235|NCT01852058|516812666|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
143346236|NCT01852058|516812667|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
143346237|NCT01852058|516812668|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
143346238|NCT01852058|516812669|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
143346239|NCT01852058|516812670|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
143346240|NCT01852058|516812671|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
143123459|NCT00385827|515997778|FG002|Part 1|Other|0|||
143346241|NCT01852058|516812672|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
143123460|NCT00385827|515997776|FG000|Part 2|Adverse Event|0|||
143123461|NCT00385827|515997777|FG001|Part 2|Adverse Event|6|||
143123462|NCT00385827|515997778|FG002|Part 2|Adverse Event|10|||
143123463|NCT00385827|515997776|FG000|Part 2|Death|0|||
143123464|NCT00385827|515997777|FG001|Part 2|Death|0|||
143123465|NCT00385827|515997778|FG002|Part 2|Death|2|||
143123466|NCT00385827|515997776|FG000|Part 2|Lack of Efficacy|0|||
143123467|NCT00385827|515997777|FG001|Part 2|Lack of Efficacy|14|||
143123468|NCT00385827|515997778|FG002|Part 2|Lack of Efficacy|13|||
143123469|NCT00385827|515997776|FG000|Part 2|Randomized but not treated|0|||
143346242|NCT01852058|516812673|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
143346243|NCT01852058|516812674|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
143346244|NCT01852058|516812675|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
143346245|NCT01852058|516812664|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
143346246|NCT01852058|516812665|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
143346247|NCT01852058|516812666|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
143346248|NCT01852058|516812667|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
143346249|NCT01852058|516812668|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
143346250|NCT01852058|516812669|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
143346251|NCT01852058|516812670|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
143346252|NCT01852058|516812671|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
143346253|NCT01852058|516812672|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
143346254|NCT01852058|516812673|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
143346255|NCT01852058|516812674|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
143346256|NCT01852058|516812675|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
143346257|NCT01852058|516812664|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
143346258|NCT01852058|516812665|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
143346259|NCT01852058|516812666|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
143346260|NCT01852058|516812667|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
143346261|NCT01852058|516812668|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
143346262|NCT01852058|516812669|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
143346263|NCT01852058|516812670|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
143346264|NCT01852058|516812671|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
143346265|NCT01852058|516812672|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
143346266|NCT01852058|516812673|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
143346267|NCT01852058|516812674|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
143346268|NCT01852058|516812675|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
143346269|NCT02613221|516812676|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
143346270|NCT02613221|516812676|FG000|Overall Study|Adverse Event|2|||
143346271|NCT02613221|516812676|FG000|Overall Study|Voluntary Discontinuation|1|||
143346272|NCT02613221|516812676|FG000|Overall Study|Delayed Treatment|1|||
143346273|NCT02613221|516812676|FG000|Overall Study|Enrolled but Not Treated|1|||
143346274|NCT02917941|516812677|FG000|Treatment Period|Adverse Event|11|||
143346275|NCT02917941|516812677|FG000|Treatment Period|Progressive Disease|11|||
143346276|NCT02917941|516812677|FG000|Treatment Period|Reason not Specified|2|||
143346277|NCT02917941|516812677|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
143346278|NCT02917941|516812677|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
143346279|NCT03520400|516812688|FG000|Overall Study|Physician Decision|15|||
143346280|NCT03520400|516812689|FG001|Overall Study|Physician Decision|7|||
143346281|NCT00909428|516812692|FG000|Overall Study|Lost to Follow-up|13|||
143346282|NCT00909428|516812693|FG001|Overall Study|Lost to Follow-up|10|||
143346283|NCT00909428|516812694|FG002|Overall Study|Lost to Follow-up|9|||
143346284|NCT01933880|516812695|FG000|Overall Study|Withdrawal by Subject|5|||
143346285|NCT01933880|516812696|FG001|Overall Study|Withdrawal by Subject|0|||
143346286|NCT01933880|516812695|FG000|Overall Study|Lack of Efficacy|1|||
143346287|NCT01933880|516812696|FG001|Overall Study|Lack of Efficacy|0|||
143346288|NCT01933880|516812695|FG000|Overall Study|Concomitant medication Interference|0|||
143346289|NCT01933880|516812696|FG001|Overall Study|Concomitant medication Interference|1|||
143346290|NCT01933880|516812695|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
143346291|NCT01933880|516812696|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
143346292|NCT01933880|516812695|FG000|Overall Study|Other|4|||
143346293|NCT01933880|516812696|FG001|Overall Study|Other|0|||
143346294|NCT01933880|516812695|FG000|Overall Study|Protocol Violation|1|||
143346295|NCT01933880|516812696|FG001|Overall Study|Protocol Violation|0|||
143346296|NCT03474549|516812697|FG000|Overall Study|Death|31|||
143123470|NCT00385827|515997777|FG001|Part 2|Randomized but not treated|2|||
143123471|NCT00385827|515997778|FG002|Part 2|Randomized but not treated|2|||
143123472|NCT00385827|515997776|FG000|Part 2|Other|0|||
143346297|NCT03474549|516812697|FG000|Overall Study|Lost to Follow-up|4|||
143346298|NCT03474549|516812697|FG000|Overall Study|Withdrawal by Subject|2|||
143346299|NCT00738101|516812698|FG000|Overall Study|Physician Decision|5|||
143346300|NCT00738101|516812698|FG000|Overall Study|Death|1|||
143346301|NCT00738101|516812698|FG000|Overall Study|Repeat enrollment|1|||
143346302|NCT00709059|516812703|FG000|Overall Study|Lost to Follow-up|34|||
143346303|NCT00709059|516812703|FG000|Overall Study|Withdrawal by Subject|19|||
143346304|NCT00709059|516812703|FG000|Overall Study|Physician Decision|7|||
143346305|NCT00709059|516812703|FG000|Overall Study|Disease complication|3|||
143346306|NCT00709059|516812703|FG000|Overall Study|Side effects|20|||
143346307|NCT00709059|516812703|FG000|Overall Study|Serious side effects|11|||
143346308|NCT01396317|516812704|FG000|Overall Study|Adverse Event|1|||
143346309|NCT01396317|516812705|FG001|Overall Study|Adverse Event|0|||
143346310|NCT03315130|516812706|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
143459691|NCT02354508|517228851|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
143459692|NCT02354508|517228852|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
143459693|NCT02354508|517228853|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
143459694|NCT02354508|517228851|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
143459695|NCT02354508|517228852|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
143459696|NCT02354508|517228853|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
143459697|NCT02354508|517228851|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
143459698|NCT02354508|517228852|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
143459699|NCT02354508|517228853|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
143459700|NCT02585232|517228856|FG000|Overall Study|Lost to Follow-up|8|||
143459701|NCT02585232|517228857|FG001|Overall Study|Lost to Follow-up|8|||
143459702|NCT02585232|517228856|FG000|Overall Study|Withdrawal by Subject|4|||
143459703|NCT02585232|517228857|FG001|Overall Study|Withdrawal by Subject|8|||
143459704|NCT02257567|517228859|FG000|Overall Study|Adverse Event|0|||
143459705|NCT02257567|517228860|FG001|Overall Study|Adverse Event|0|||
143459706|NCT02257567|517228861|FG002|Overall Study|Adverse Event|0|||
143459707|NCT02257567|517228862|FG003|Overall Study|Adverse Event|1|||
143459708|NCT02257567|517228863|FG004|Overall Study|Adverse Event|1|||
143459709|NCT02257567|517228864|FG005|Overall Study|Adverse Event|0|||
143459710|NCT02257567|517228865|FG006|Overall Study|Adverse Event|0|||
143459711|NCT02257567|517228866|FG007|Overall Study|Adverse Event|0|||
143459712|NCT02257567|517228867|FG008|Overall Study|Adverse Event|1|||
143459713|NCT02257567|517228868|FG009|Overall Study|Adverse Event|0|||
143459714|NCT02257567|517228869|FG010|Overall Study|Adverse Event|0|||
143459715|NCT02257567|517228859|FG000|Overall Study|Death|2|||
143459716|NCT02257567|517228860|FG001|Overall Study|Death|2|||
143459717|NCT02257567|517228861|FG002|Overall Study|Death|2|||
143459718|NCT02257567|517228862|FG003|Overall Study|Death|4|||
143459719|NCT02257567|517228863|FG004|Overall Study|Death|15|||
143459720|NCT02257567|517228864|FG005|Overall Study|Death|11|||
143459721|NCT02257567|517228865|FG006|Overall Study|Death|26|||
143459722|NCT02257567|517228866|FG007|Overall Study|Death|30|||
143459723|NCT02257567|517228867|FG008|Overall Study|Death|2|||
143459724|NCT02257567|517228868|FG009|Overall Study|Death|18|||
143459725|NCT02257567|517228869|FG010|Overall Study|Death|65|||
143459726|NCT02257567|517228859|FG000|Overall Study|Lost to Follow-up|0|||
143459727|NCT02257567|517228860|FG001|Overall Study|Lost to Follow-up|0|||
143459728|NCT02257567|517228861|FG002|Overall Study|Lost to Follow-up|0|||
143459729|NCT02257567|517228862|FG003|Overall Study|Lost to Follow-up|0|||
143459730|NCT02257567|517228863|FG004|Overall Study|Lost to Follow-up|2|||
143459731|NCT02257567|517228864|FG005|Overall Study|Lost to Follow-up|2|||
143459732|NCT02257567|517228865|FG006|Overall Study|Lost to Follow-up|0|||
143459733|NCT02257567|517228866|FG007|Overall Study|Lost to Follow-up|0|||
143459734|NCT02257567|517228867|FG008|Overall Study|Lost to Follow-up|0|||
143459735|NCT02257567|517228868|FG009|Overall Study|Lost to Follow-up|1|||
143459736|NCT02257567|517228869|FG010|Overall Study|Lost to Follow-up|1|||
143459737|NCT02257567|517228859|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
143459738|NCT02257567|517228860|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
143459739|NCT02257567|517228861|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
143459740|NCT02257567|517228862|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
143123473|NCT00385827|515997777|FG001|Part 2|Other|11|||
143123474|NCT00385827|515997778|FG002|Part 2|Other|21|||
143123475|NCT04227405|515997779|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
143346311|NCT03315130|516812707|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
143346312|NCT03315130|516812708|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
143346313|NCT03315130|516812709|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
143346314|NCT03315130|516812706|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
143459741|NCT02257567|517228863|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
143459742|NCT02257567|517228864|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
143346315|NCT03315130|516812707|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
143459743|NCT02257567|517228865|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
143459744|NCT02257567|517228866|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
143459745|NCT02257567|517228867|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
143459746|NCT02257567|517228868|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
143459747|NCT02257567|517228869|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
143459748|NCT02257567|517228859|FG000|Overall Study|Physician Decision|0|||
143459749|NCT02257567|517228860|FG001|Overall Study|Physician Decision|0|||
143459750|NCT02257567|517228861|FG002|Overall Study|Physician Decision|0|||
143459751|NCT02257567|517228862|FG003|Overall Study|Physician Decision|0|||
143459752|NCT02257567|517228863|FG004|Overall Study|Physician Decision|0|||
143459753|NCT02257567|517228864|FG005|Overall Study|Physician Decision|0|||
143459754|NCT02257567|517228865|FG006|Overall Study|Physician Decision|0|||
143459755|NCT02257567|517228866|FG007|Overall Study|Physician Decision|2|||
143459756|NCT02257567|517228867|FG008|Overall Study|Physician Decision|0|||
143459757|NCT02257567|517228868|FG009|Overall Study|Physician Decision|1|||
143459758|NCT02257567|517228869|FG010|Overall Study|Physician Decision|0|||
143459759|NCT02257567|517228859|FG000|Overall Study|Withdrawal by Subject|0|||
143459760|NCT02257567|517228860|FG001|Overall Study|Withdrawal by Subject|0|||
143459761|NCT02257567|517228861|FG002|Overall Study|Withdrawal by Subject|2|||
143459762|NCT02257567|517228862|FG003|Overall Study|Withdrawal by Subject|0|||
143459763|NCT02257567|517228863|FG004|Overall Study|Withdrawal by Subject|0|||
143459764|NCT02257567|517228864|FG005|Overall Study|Withdrawal by Subject|6|||
143459765|NCT02257567|517228865|FG006|Overall Study|Withdrawal by Subject|6|||
143459766|NCT02257567|517228866|FG007|Overall Study|Withdrawal by Subject|6|||
143459767|NCT02257567|517228867|FG008|Overall Study|Withdrawal by Subject|1|||
143459768|NCT02257567|517228868|FG009|Overall Study|Withdrawal by Subject|1|||
143459769|NCT02257567|517228869|FG010|Overall Study|Withdrawal by Subject|10|||
143459770|NCT00871780|517228872|FG000|Overall Study|Enrolled But Not Treated|6|||
143459771|NCT00871780|517228872|FG000|Overall Study|Withdrawal by Subject|9|||
143459772|NCT00871780|517228872|FG000|Overall Study|Adverse Event|6|||
143459773|NCT00871780|517228872|FG000|Overall Study|Voluntary Discontinuation|4|||
143459774|NCT00871780|517228872|FG000|Overall Study|Death|1|||
143459775|NCT00871780|517228872|FG000|Overall Study|Physician Decision|1|||
143459776|NCT06377488|517228873|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|2|||
143459777|NCT06377488|517228873|FG000|Overall Study|Unsatisfactory Lens Fitting due to Test Article|2|||
143459778|NCT06377488|517228873|FG000|Overall Study|Protocol Violation|1|||
143459779|NCT06377488|517228873|FG000|Overall Study|Lost to Follow-up|1|||
143459780|NCT06377488|517228873|FG000|Overall Study|Incorrect Lens Dispensed|2|||
143459781|NCT03625895|517228874|FG000|Overall Study|Protocol Violation|585|||
143459782|NCT01065844|517228875|FG000|Overall Study|Adverse Event|5|||
143459783|NCT02679573|517228876|FG000|Overall Study|Adverse Event|13|||
143459784|NCT02679573|517228877|FG001|Overall Study|Adverse Event|6|||
143459785|NCT02679573|517228876|FG000|Overall Study|Lack of Efficacy|12|||
143459786|NCT02679573|517228877|FG001|Overall Study|Lack of Efficacy|15|||
143459787|NCT02679573|517228876|FG000|Overall Study|Could not complete required study visits|6|||
143459788|NCT02679573|517228877|FG001|Overall Study|Could not complete required study visits|2|||
143459789|NCT02679573|517228876|FG000|Overall Study|Withdrawal by Subject|2|||
143459790|NCT02679573|517228877|FG001|Overall Study|Withdrawal by Subject|9|||
143459791|NCT02679573|517228876|FG000|Overall Study|Death|2|||
143459792|NCT02679573|517228877|FG001|Overall Study|Death|0|||
143459793|NCT02679573|517228876|FG000|Overall Study|Physician Decision|2|||
143459794|NCT02679573|517228877|FG001|Overall Study|Physician Decision|4|||
143459795|NCT02679573|517228876|FG000|Overall Study|Lost to Follow-up|0|||
143459796|NCT02679573|517228877|FG001|Overall Study|Lost to Follow-up|3|||
143459797|NCT03545503|517228878|FG000|Overall Study|Protocol Violation|14|||
143459798|NCT03545503|517228879|FG001|Overall Study|Protocol Violation|16|||
143459799|NCT01415531|517228880|FG000|Overall Study|Adverse Event|7|||
143459800|NCT01415531|517228881|FG001|Overall Study|Adverse Event|10|||
143459801|NCT01415531|517228880|FG000|Overall Study|Lack of Efficacy|3|||
143459802|NCT01415531|517228881|FG001|Overall Study|Lack of Efficacy|2|||
143459803|NCT01415531|517228880|FG000|Overall Study|Protocol Violation|0|||
143459804|NCT01415531|517228881|FG001|Overall Study|Protocol Violation|1|||
143459805|NCT01415531|517228880|FG000|Overall Study|Withdrawal by Subject|5|||
143459806|NCT01415531|517228881|FG001|Overall Study|Withdrawal by Subject|4|||
143459807|NCT01415531|517228880|FG000|Overall Study|Lost to Follow-up|6|||
143459808|NCT01415531|517228881|FG001|Overall Study|Lost to Follow-up|14|||
143459809|NCT01415531|517228880|FG000|Overall Study|Lack of Compliance|1|||
143459810|NCT01415531|517228881|FG001|Overall Study|Lack of Compliance|4|||
143459811|NCT01415531|517228880|FG000|Overall Study|Other Reasons|3|||
143459812|NCT01415531|517228881|FG001|Overall Study|Other Reasons|2|||
143459813|NCT05753670|517228882|FG000|Overall Study|Withdrawal by Subject|6|||
143459814|NCT05753670|517228883|FG001|Overall Study|Withdrawal by Subject|8|||
143459815|NCT05753670|517228882|FG000|Overall Study|Protocol Violation|3|||
143459816|NCT05753670|517228883|FG001|Overall Study|Protocol Violation|1|||
143459817|NCT00394082|517228884|FG000|Overall Study|Unacceptable toxicity|15|||
143459818|NCT00394082|517228884|FG000|Overall Study|Adverse Event|4|||
143459819|NCT00394082|517228884|FG000|Overall Study|Physician Decision|4|||
143459820|NCT00394082|517228884|FG000|Overall Study|Withdrawal by Subject|2|||
143459821|NCT00394082|517228884|FG000|Overall Study|Other|1|||
143459822|NCT01945060|517228885|FG000|Overall Study|Lost to follow up|1|||
143459823|NCT01945060|517228886|FG001|Overall Study|Lost to follow up|0|||
143459824|NCT01945060|517228885|FG000|Overall Study|Distress related to IV access|0|||
143459825|NCT01945060|517228886|FG001|Overall Study|Distress related to IV access|1|||
143459826|NCT01210664|517228889|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
143459827|NCT01210664|517228890|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
143459828|NCT01210664|517228891|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
143459829|NCT01210664|517228892|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
143459830|NCT01210664|517228889|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
143459831|NCT01210664|517228890|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
143459832|NCT01210664|517228891|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
143459833|NCT01210664|517228892|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
143459834|NCT01210664|517228889|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
143459835|NCT01210664|517228890|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
143459836|NCT01210664|517228891|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
143459837|NCT01210664|517228892|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
143459838|NCT01853644|517228893|FG000|Registration and Treatment Start|Did not start treatment|1|||
143459839|NCT01853644|517228893|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
143459840|NCT01853644|517228893|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
143459841|NCT01853644|517228893|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
143459842|NCT01853644|517228893|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
143459843|NCT01853644|517228893|FG000|Continued Treatment After First Response|Adverse Event|2|||
143459844|NCT01853644|517228893|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
143459845|NCT02891408|517228894|FG000|Overall Study|Lost to Follow-up|0|||
143459846|NCT02891408|517228895|FG001|Overall Study|Lost to Follow-up|0|||
143459847|NCT02891408|517228896|FG002|Overall Study|Lost to Follow-up|1|||
143459848|NCT02891408|517228897|FG003|Overall Study|Lost to Follow-up|0|||
143459849|NCT02891408|517228898|FG004|Overall Study|Lost to Follow-up|0|||
143459850|NCT02891408|517228899|FG005|Overall Study|Lost to Follow-up|0|||
143459851|NCT02891408|517228900|FG006|Overall Study|Lost to Follow-up|0|||
143459852|NCT01054170|517228901|FG000|Overall Study|Protocol Violation|1|||
143459853|NCT01054170|517228902|FG001|Overall Study|Protocol Violation|0|||
143459854|NCT01054170|517228901|FG000|Overall Study|Withdrawal by Subject|3|||
143459855|NCT01054170|517228902|FG001|Overall Study|Withdrawal by Subject|2|||
143459856|NCT01054170|517228901|FG000|Overall Study|Adverse Event|0|||
143459857|NCT01054170|517228902|FG001|Overall Study|Adverse Event|4|||
143459858|NCT02951767|517228903|FG000|Overall Study|Study Terminated By Sponsor|9|||
143459859|NCT02951767|517228903|FG000|Overall Study|Withdrawal by Subject|11|||
143459860|NCT02951767|517228903|FG000|Overall Study|Death|96|||
143459861|NCT02951767|517228903|FG000|Overall Study|Lost to Follow-up|2|||
143459862|NCT02951767|517228903|FG000|Overall Study|Physician Decision|1|||
143459863|NCT00609765|517228906|FG000|Overall Study|Study ended prior to 12 months|1|||
143459864|NCT00950950|517228907|FG000|Overall Study|Adverse Event|1|||
143459865|NCT00950950|517228908|FG001|Overall Study|Adverse Event|0|||
143459866|NCT00950950|517228907|FG000|Overall Study|Withdrawal by Subject|0|||
143459867|NCT00950950|517228908|FG001|Overall Study|Withdrawal by Subject|1|||
143459868|NCT01047293|517228911|FG000|Overall Study|DLT criteria not fulfilled|1|||
143459869|NCT01047293|517228912|FG001|Overall Study|DLT criteria not fulfilled|1|||
143459870|NCT01047293|517228913|FG002|Overall Study|DLT criteria not fulfilled|0|||
143459871|NCT01047293|517228914|FG003|Overall Study|DLT criteria not fulfilled|0|||
143459872|NCT01920854|517228915|FG000|Overall Study|Withdrawal by Subject|1|||
143459873|NCT01920854|517228916|FG001|Overall Study|Withdrawal by Subject|0|||
143459874|NCT01920854|517228917|FG002|Overall Study|Withdrawal by Subject|0|||
143459875|NCT01920854|517228918|FG003|Overall Study|Withdrawal by Subject|0|||
143459876|NCT01920854|517228919|FG004|Overall Study|Withdrawal by Subject|1|||
143459877|NCT01920854|517228920|FG005|Overall Study|Withdrawal by Subject|0|||
143459878|NCT01920854|517228921|FG006|Overall Study|Withdrawal by Subject|1|||
143459879|NCT02372136|517228924|FG000|Overall Study|Death|3|||
143459880|NCT02372136|517228925|FG001|Overall Study|Death|1|||
143459881|NCT00985946|517228926|FG000|Overall Study|Lost to Follow-up|6|||
143459882|NCT00985946|517228926|FG000|Overall Study|Withdrawal by Subject|1|||
143459883|NCT02673515|517228927|FG000|Overall Study|Lack of motivation|2|||
143459884|NCT02673515|517228928|FG001|Overall Study|Lack of motivation|1|||
143459885|NCT01586910|517231098|FG000|Overall Study|Death|4|||
143459886|NCT01586910|517231099|FG001|Overall Study|Death|4|||
143459887|NCT01586910|517231098|FG000|Overall Study|Withdrawal by Subject|6|||
143459888|NCT01586910|517231099|FG001|Overall Study|Withdrawal by Subject|43|||
143459889|NCT01586910|517231098|FG000|Overall Study|Physician withdrew Subject|5|||
143459890|NCT01586910|517231099|FG001|Overall Study|Physician withdrew Subject|24|||
143123476|NCT04227405|515997780|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
143368946|NCT02001623|516894558|FG000|Overall Study|Death|0|||
143368947|NCT02001623|516894559|FG001|Overall Study|Death|1|||
143368948|NCT02001623|516894560|FG002|Overall Study|Death|0|||
143368949|NCT02001623|516894561|FG003|Overall Study|Death|0|||
143368950|NCT02001623|516894562|FG004|Overall Study|Death|0|||
143368951|NCT02001623|516894563|FG005|Overall Study|Death|0|||
143368952|NCT02001623|516894564|FG006|Overall Study|Death|0|||
143368953|NCT02001623|516894565|FG007|Overall Study|Death|0|||
143368954|NCT02001623|516894566|FG008|Overall Study|Death|0|||
143368955|NCT02001623|516894567|FG009|Overall Study|Death|0|||
143368956|NCT02001623|516894568|FG010|Overall Study|Death|0|||
143368957|NCT02001623|516894569|FG011|Overall Study|Death|0|||
143368958|NCT02001623|516894570|FG012|Overall Study|Death|0|||
143368959|NCT02001623|516894571|FG013|Overall Study|Death|0|||
143368960|NCT02001623|516894572|FG014|Overall Study|Death|0|||
143368961|NCT02001623|516894558|FG000|Overall Study|Adverse Event|0|||
143368962|NCT02001623|516894559|FG001|Overall Study|Adverse Event|0|||
143368963|NCT02001623|516894560|FG002|Overall Study|Adverse Event|0|||
143368964|NCT02001623|516894561|FG003|Overall Study|Adverse Event|0|||
143368965|NCT02001623|516894562|FG004|Overall Study|Adverse Event|0|||
143368966|NCT02001623|516894563|FG005|Overall Study|Adverse Event|1|||
143368967|NCT02001623|516894564|FG006|Overall Study|Adverse Event|0|||
143368968|NCT02001623|516894565|FG007|Overall Study|Adverse Event|3|||
143368969|NCT02001623|516894566|FG008|Overall Study|Adverse Event|4|||
143368970|NCT02001623|516894567|FG009|Overall Study|Adverse Event|6|||
143368971|NCT02001623|516894568|FG010|Overall Study|Adverse Event|4|||
143368972|NCT02001623|516894569|FG011|Overall Study|Adverse Event|0|||
143368973|NCT02001623|516894570|FG012|Overall Study|Adverse Event|3|||
143368974|NCT02001623|516894571|FG013|Overall Study|Adverse Event|5|||
143368975|NCT02001623|516894572|FG014|Overall Study|Adverse Event|6|||
143368976|NCT02001623|516894558|FG000|Overall Study|Other - Miscellaneous|0|||
143368977|NCT02001623|516894559|FG001|Overall Study|Other - Miscellaneous|0|||
143368978|NCT02001623|516894560|FG002|Overall Study|Other - Miscellaneous|0|||
143368979|NCT02001623|516894561|FG003|Overall Study|Other - Miscellaneous|0|||
143368980|NCT02001623|516894562|FG004|Overall Study|Other - Miscellaneous|0|||
143368981|NCT02001623|516894563|FG005|Overall Study|Other - Miscellaneous|0|||
143368982|NCT02001623|516894564|FG006|Overall Study|Other - Miscellaneous|0|||
143368983|NCT02001623|516894565|FG007|Overall Study|Other - Miscellaneous|0|||
143368984|NCT02001623|516894566|FG008|Overall Study|Other - Miscellaneous|0|||
143368985|NCT02001623|516894567|FG009|Overall Study|Other - Miscellaneous|1|||
143368986|NCT02001623|516894568|FG010|Overall Study|Other - Miscellaneous|0|||
143368987|NCT02001623|516894569|FG011|Overall Study|Other - Miscellaneous|0|||
143368988|NCT02001623|516894570|FG012|Overall Study|Other - Miscellaneous|0|||
143368989|NCT02001623|516894571|FG013|Overall Study|Other - Miscellaneous|1|||
143368990|NCT02001623|516894572|FG014|Overall Study|Other - Miscellaneous|0|||
143368991|NCT02001623|516894558|FG000|Overall Study|Withdrawal by Subject|1|||
143368992|NCT02001623|516894559|FG001|Overall Study|Withdrawal by Subject|0|||
143368993|NCT02001623|516894560|FG002|Overall Study|Withdrawal by Subject|0|||
143368994|NCT02001623|516894561|FG003|Overall Study|Withdrawal by Subject|0|||
143368995|NCT02001623|516894562|FG004|Overall Study|Withdrawal by Subject|0|||
143368996|NCT02001623|516894563|FG005|Overall Study|Withdrawal by Subject|0|||
143368997|NCT02001623|516894564|FG006|Overall Study|Withdrawal by Subject|0|||
143368998|NCT02001623|516894565|FG007|Overall Study|Withdrawal by Subject|0|||
143368999|NCT02001623|516894566|FG008|Overall Study|Withdrawal by Subject|1|||
143369000|NCT02001623|516894567|FG009|Overall Study|Withdrawal by Subject|3|||
143369001|NCT02001623|516894568|FG010|Overall Study|Withdrawal by Subject|2|||
143369002|NCT02001623|516894569|FG011|Overall Study|Withdrawal by Subject|2|||
143369003|NCT02001623|516894570|FG012|Overall Study|Withdrawal by Subject|1|||
143369004|NCT02001623|516894571|FG013|Overall Study|Withdrawal by Subject|5|||
143369005|NCT02001623|516894572|FG014|Overall Study|Withdrawal by Subject|2|||
143369006|NCT02001623|516894558|FG000|Overall Study|Lost to Follow-up|0|||
143369007|NCT02001623|516894559|FG001|Overall Study|Lost to Follow-up|0|||
143369008|NCT02001623|516894560|FG002|Overall Study|Lost to Follow-up|0|||
143369009|NCT02001623|516894561|FG003|Overall Study|Lost to Follow-up|0|||
143369010|NCT02001623|516894562|FG004|Overall Study|Lost to Follow-up|0|||
143369011|NCT02001623|516894563|FG005|Overall Study|Lost to Follow-up|0|||
143369012|NCT02001623|516894564|FG006|Overall Study|Lost to Follow-up|0|||
143369013|NCT02001623|516894565|FG007|Overall Study|Lost to Follow-up|0|||
143369014|NCT02001623|516894566|FG008|Overall Study|Lost to Follow-up|0|||
143369015|NCT02001623|516894567|FG009|Overall Study|Lost to Follow-up|1|||
143369016|NCT02001623|516894568|FG010|Overall Study|Lost to Follow-up|0|||
143369017|NCT02001623|516894569|FG011|Overall Study|Lost to Follow-up|0|||
143369018|NCT02001623|516894570|FG012|Overall Study|Lost to Follow-up|0|||
143369019|NCT02001623|516894571|FG013|Overall Study|Lost to Follow-up|0|||
143369020|NCT02001623|516894572|FG014|Overall Study|Lost to Follow-up|0|||
143369021|NCT02001623|516894558|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
143459891|NCT00192647|517231100|FG000|Overall Study|Death|1|||
143459892|NCT00192647|517231101|FG001|Overall Study|Death|1|||
143459893|NCT00192647|517231100|FG000|Overall Study|Adverse Event|35|||
143459894|NCT00192647|517231101|FG001|Overall Study|Adverse Event|29|||
143459895|NCT00192647|517231100|FG000|Overall Study|Laboratory Test Abnormality|4|||
143459896|NCT00192647|517231101|FG001|Overall Study|Laboratory Test Abnormality|2|||
143459897|NCT00192647|517231100|FG000|Overall Study|Insufficient Therapeutic Response|53|||
143459898|NCT00192647|517231101|FG001|Overall Study|Insufficient Therapeutic Response|83|||
143459899|NCT00192647|517231100|FG000|Overall Study|Entry Criteria Violation|6|||
143459900|NCT00192647|517231101|FG001|Overall Study|Entry Criteria Violation|6|||
143459901|NCT00192647|517231100|FG000|Overall Study|Protocol Violation|3|||
143459902|NCT00192647|517231101|FG001|Overall Study|Protocol Violation|1|||
143459903|NCT00192647|517231100|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
143459904|NCT00192647|517231101|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
143459905|NCT00192647|517231100|FG000|Overall Study|Failure to Return|11|||
143459906|NCT00192647|517231101|FG001|Overall Study|Failure to Return|13|||
143459907|NCT00192647|517231100|FG000|Overall Study|Other/Administrative|5|||
143459908|NCT00192647|517231101|FG001|Overall Study|Other/Administrative|3|||
143459909|NCT01828073|517231102|FG000|Overall Study|Lost to Follow-up|1|||
143459910|NCT01828073|517231103|FG001|Overall Study|Lost to Follow-up|2|||
143459911|NCT00690443|517231104|FG000|Overall Study|Adverse Event|1|||
143459912|NCT00690443|517231105|FG001|Overall Study|Adverse Event|2|||
143459913|NCT02502097|517231106|FG000|Period 1|Adverse Event|0|||
143459914|NCT02502097|517231107|FG001|Period 1|Adverse Event|0|||
143459915|NCT02502097|517231108|FG002|Period 1|Adverse Event|1|||
143459916|NCT02502097|517231109|FG003|Period 1|Adverse Event|0|||
143459917|NCT02502097|517231106|FG000|Wash Out Period|Adverse Event|0|||
143459918|NCT02502097|517231107|FG001|Wash Out Period|Adverse Event|1|||
143459919|NCT02502097|517231108|FG002|Wash Out Period|Adverse Event|1|||
143459920|NCT02502097|517231109|FG003|Wash Out Period|Adverse Event|1|||
143459921|NCT02502097|517231106|FG000|Period 2|Adverse Event|0|||
143459922|NCT02502097|517231107|FG001|Period 2|Adverse Event|0|||
143459923|NCT02502097|517231108|FG002|Period 2|Adverse Event|1|||
143459924|NCT02502097|517231109|FG003|Period 2|Adverse Event|0|||
143459925|NCT01350336|517231110|FG000|Overall Study|Lost to Follow-up|31|||
143459926|NCT01350336|517231110|FG000|Overall Study|Withdrawal by Subject|14|||
143459927|NCT01350336|517231110|FG000|Overall Study|Physician Decision|8|||
143459928|NCT01350336|517231110|FG000|Overall Study|Death|4|||
143459929|NCT01776541|517231111|FG000|Overall Study|Administrative Reason|6|||
143459930|NCT01776541|517231112|FG001|Overall Study|Administrative Reason|2|||
143459931|NCT01776541|517231111|FG000|Overall Study|Death|4|||
143459932|NCT01776541|517231112|FG001|Overall Study|Death|0|||
143459933|NCT01776541|517231111|FG000|Overall Study|Lost to Follow-up|27|||
143459934|NCT01776541|517231112|FG001|Overall Study|Lost to Follow-up|48|||
143459935|NCT01776541|517231111|FG000|Overall Study|Unclassified|5|||
143459936|NCT01776541|517231112|FG001|Overall Study|Unclassified|4|||
143459937|NCT01776541|517231111|FG000|Overall Study|Protocol Violation|2|||
143459938|NCT01776541|517231112|FG001|Overall Study|Protocol Violation|1|||
143459939|NCT01776541|517231111|FG000|Overall Study|Withdrawal by Subject|12|||
143459940|NCT01776541|517231112|FG001|Overall Study|Withdrawal by Subject|20|||
143459941|NCT01981473|517231113|FG000|Overall Study|Incorrect diagnosis of RA|0|||
143459942|NCT01981473|517231114|FG001|Overall Study|Incorrect diagnosis of RA|0|||
143459943|NCT01981473|517231115|FG002|Overall Study|Incorrect diagnosis of RA|1|||
143459944|NCT01981473|517231113|FG000|Overall Study|Received treatment for < 6 months|0|||
143459945|NCT01981473|517231114|FG001|Overall Study|Received treatment for < 6 months|0|||
143459946|NCT01981473|517231115|FG002|Overall Study|Received treatment for < 6 months|1|||
143459947|NCT01981473|517231113|FG000|Overall Study|Received treatment for >24 months|2|||
143459948|NCT01981473|517231114|FG001|Overall Study|Received treatment for >24 months|0|||
143459949|NCT01981473|517231115|FG002|Overall Study|Received treatment for >24 months|6|||
143459950|NCT00799513|517231118|FG000|Overall Study|Physician Decision|1|||
143459951|NCT00799513|517231118|FG000|Overall Study|Adverse Event|1|||
143459952|NCT05398237|517231119|FG000|Overall Study|Withdrawal by Subject|1|||
143459953|NCT01312857|517231121|FG000|Overall Study|Adverse Event|1|||
143459954|NCT01312857|517231122|FG001|Overall Study|Adverse Event|1|||
143459955|NCT01312857|517231121|FG000|Overall Study|Lost to Follow-up|2|||
143459956|NCT01312857|517231122|FG001|Overall Study|Lost to Follow-up|0|||
143459957|NCT01312857|517231121|FG000|Overall Study|Physician Decision|3|||
143459958|NCT01312857|517231122|FG001|Overall Study|Physician Decision|0|||
143459959|NCT01312857|517231121|FG000|Overall Study|Withdrawal by Subject|2|||
143459960|NCT01312857|517231122|FG001|Overall Study|Withdrawal by Subject|0|||
143459961|NCT00461032|517231123|FG000|Overall Study|Adverse Event|5|||
143459962|NCT00461032|517231124|FG001|Overall Study|Adverse Event|6|||
143459963|NCT00461032|517231123|FG000|Overall Study|Lack of Efficacy|5|||
143459964|NCT00461032|517231124|FG001|Overall Study|Lack of Efficacy|1|||
143459965|NCT00461032|517231123|FG000|Overall Study|Lost to Follow-up|7|||
143459966|NCT00461032|517231124|FG001|Overall Study|Lost to Follow-up|12|||
143459967|NCT00461032|517231123|FG000|Overall Study|Protocol Violation|4|||
143459968|NCT00461032|517231124|FG001|Overall Study|Protocol Violation|4|||
143459969|NCT00461032|517231123|FG000|Overall Study|Withdrawal by Subject|7|||
143459970|NCT00461032|517231124|FG001|Overall Study|Withdrawal by Subject|15|||
143459971|NCT00461032|517231123|FG000|Overall Study|Patient Moved or Relocated|2|||
143459972|NCT00461032|517231124|FG001|Overall Study|Patient Moved or Relocated|1|||
143459973|NCT00461032|517231123|FG000|Overall Study|Other|7|||
143459974|NCT00461032|517231124|FG001|Overall Study|Other|5|||
143459975|NCT04447846|517231125|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
143459976|NCT05767021|517231126|FG000|Overall Study|Adverse Event|2|||
143459977|NCT05767021|517231126|FG000|Overall Study|Protocol Deviation|1|||
143459978|NCT05767021|517231126|FG000|Overall Study|Withdrawal by Subject|1|||
143459979|NCT05767021|517231126|FG000|Overall Study|Physician Decision|1|||
143459980|NCT05767021|517231126|FG000|Overall Study|Lack of Efficacy|11|||
143459981|NCT05767021|517231126|FG000|Overall Study|Assigned Treatment by Mistake|1|||
143459982|NCT02483585|517231127|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
143459983|NCT02483585|517231128|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
143459984|NCT02483585|517231127|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
143459985|NCT02483585|517231128|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
143459986|NCT02483585|517231127|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
143459987|NCT02483585|517231128|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
143459988|NCT02483585|517231127|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
143459989|NCT02483585|517231128|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
143459990|NCT02483585|517231127|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
143459991|NCT02483585|517231128|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
143459992|NCT02483585|517231127|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
143459993|NCT02483585|517231128|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
143459994|NCT02483585|517231127|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
143459995|NCT02483585|517231128|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
143459996|NCT01236339|517231134|FG000|Overall Study|Termination of study by sponsor|11|||
143459997|NCT01236339|517231135|FG001|Overall Study|Termination of study by sponsor|13|||
143459998|NCT01098097|517231136|FG000|Overall Study|Adverse Event|17|||
143459999|NCT01098097|517231136|FG000|Overall Study|Lost to Follow-up|18|||
143460000|NCT01098097|517231136|FG000|Overall Study|Status unknown|16|||
143460001|NCT01098097|517231136|FG000|Overall Study|No reason reported|31|||
143460002|NCT00232544|517231140|FG000|Overall Study|Lost to Follow-up|20|||
143460003|NCT00232544|517231141|FG001|Overall Study|Lost to Follow-up|15|||
143460004|NCT00116753|517231142|FG000|Overall Study|Adverse Event|16|||
143460005|NCT00116753|517231143|FG001|Overall Study|Adverse Event|10|||
143460006|NCT00116753|517231144|FG002|Overall Study|Adverse Event|7|||
143460007|NCT00116753|517231142|FG000|Overall Study|Withdrawal by Subject|11|||
143460008|NCT00116753|517231143|FG001|Overall Study|Withdrawal by Subject|12|||
143460009|NCT00116753|517231144|FG002|Overall Study|Withdrawal by Subject|8|||
143460010|NCT00116753|517231142|FG000|Overall Study|Lost to Follow-up|0|||
143460011|NCT00116753|517231143|FG001|Overall Study|Lost to Follow-up|2|||
143460012|NCT00116753|517231144|FG002|Overall Study|Lost to Follow-up|1|||
143460013|NCT00116753|517231142|FG000|Overall Study|Protocol Violation|0|||
143460014|NCT00116753|517231143|FG001|Overall Study|Protocol Violation|0|||
143460015|NCT00116753|517231144|FG002|Overall Study|Protocol Violation|1|||
143460016|NCT00116753|517231142|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
143460017|NCT00116753|517231143|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
143460018|NCT00116753|517231144|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
143460019|NCT00116753|517231142|FG000|Overall Study|Disease Progression|3|||
143460020|NCT00116753|517231143|FG001|Overall Study|Disease Progression|4|||
143460021|NCT00116753|517231144|FG002|Overall Study|Disease Progression|3|||
143460022|NCT00116753|517231142|FG000|Overall Study|Abnormal Echocardiogram|0|||
143460023|NCT00116753|517231143|FG001|Overall Study|Abnormal Echocardiogram|0|||
143460024|NCT00116753|517231144|FG002|Overall Study|Abnormal Echocardiogram|1|||
143460025|NCT00116753|517231142|FG000|Overall Study|Progressive Parkinson's Disease|1|||
143460026|NCT00116753|517231143|FG001|Overall Study|Progressive Parkinson's Disease|0|||
143460027|NCT00116753|517231144|FG002|Overall Study|Progressive Parkinson's Disease|0|||
143460028|NCT00116753|517231142|FG000|Overall Study|Dosing Error|0|||
143460029|NCT00116753|517231143|FG001|Overall Study|Dosing Error|1|||
143460030|NCT00116753|517231144|FG002|Overall Study|Dosing Error|0|||
143460031|NCT01590082|517231145|FG000|Overall Study|Withdrawal by Subject|1|||
143460032|NCT01590082|517231146|FG001|Overall Study|Withdrawal by Subject|0|||
143460033|NCT01590082|517231145|FG000|Overall Study|Ineligible|1|||
143460034|NCT01590082|517231146|FG001|Overall Study|Ineligible|0|||
143460035|NCT00906945|517231147|FG000|Overall Study|Found to be not eligible|0|||
143460036|NCT00906945|517231148|FG001|Overall Study|Found to be not eligible|0|||
143460037|NCT00906945|517231149|FG002|Overall Study|Found to be not eligible|0|||
143460038|NCT00906945|517231150|FG003|Overall Study|Found to be not eligible|1|||
143460039|NCT00906945|517231151|FG004|Overall Study|Found to be not eligible|1|||
143460040|NCT00906945|517231152|FG005|Overall Study|Found to be not eligible|1|||
143460041|NCT00906945|517231147|FG000|Overall Study|Physician Decision|0|||
143460042|NCT00906945|517231148|FG001|Overall Study|Physician Decision|0|||
143460043|NCT00906945|517231149|FG002|Overall Study|Physician Decision|0|||
143460044|NCT00906945|517231150|FG003|Overall Study|Physician Decision|0|||
143460045|NCT00906945|517231151|FG004|Overall Study|Physician Decision|0|||
143460046|NCT00906945|517231152|FG005|Overall Study|Physician Decision|1|||
143460047|NCT02751320|517231154|FG000|Overall Study|Adverse Event|2|||
143460048|NCT02751320|517231154|FG000|Overall Study|Withdrawal by Subject|1|||
143460049|NCT05249829|517231155|FG000|Overall Study|Participant Relocation|0|||
143460050|NCT05249829|517231156|FG001|Overall Study|Participant Relocation|1|||
143460051|NCT05249829|517231157|FG002|Overall Study|Participant Relocation|2|||
143460052|NCT05249829|517231158|FG003|Overall Study|Participant Relocation|2|||
143460053|NCT05249829|517231155|FG000|Overall Study|Withdrawal by Subject|9|||
143460054|NCT05249829|517231156|FG001|Overall Study|Withdrawal by Subject|17|||
143460055|NCT05249829|517231157|FG002|Overall Study|Withdrawal by Subject|40|||
143460056|NCT05249829|517231158|FG003|Overall Study|Withdrawal by Subject|35|||
143460057|NCT05249829|517231155|FG000|Overall Study|Physician Decision|1|||
143460058|NCT05249829|517231156|FG001|Overall Study|Physician Decision|0|||
143460059|NCT05249829|517231157|FG002|Overall Study|Physician Decision|0|||
143460060|NCT05249829|517231158|FG003|Overall Study|Physician Decision|0|||
143460061|NCT05249829|517231155|FG000|Overall Study|Lost to Follow-up|16|||
143460062|NCT05249829|517231156|FG001|Overall Study|Lost to Follow-up|16|||
143460063|NCT05249829|517231157|FG002|Overall Study|Lost to Follow-up|57|||
143460064|NCT05249829|517231158|FG003|Overall Study|Lost to Follow-up|60|||
143460065|NCT05249829|517231155|FG000|Overall Study|Adverse Event|2|||
143460066|NCT05249829|517231156|FG001|Overall Study|Adverse Event|2|||
143460067|NCT05249829|517231157|FG002|Overall Study|Adverse Event|2|||
143460068|NCT05249829|517231158|FG003|Overall Study|Adverse Event|2|||
143460069|NCT05249829|517231155|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
143460070|NCT05249829|517231156|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
143460071|NCT05249829|517231157|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
143460072|NCT05249829|517231158|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
143460073|NCT05249829|517231155|FG000|Overall Study|Protocol Violation|2|||
143460074|NCT05249829|517231156|FG001|Overall Study|Protocol Violation|0|||
143460075|NCT05249829|517231157|FG002|Overall Study|Protocol Violation|5|||
143460076|NCT05249829|517231158|FG003|Overall Study|Protocol Violation|3|||
143460077|NCT05249829|517231155|FG000|Overall Study|Death|0|||
143460078|NCT05249829|517231156|FG001|Overall Study|Death|1|||
143460079|NCT05249829|517231157|FG002|Overall Study|Death|2|||
143460080|NCT05249829|517231158|FG003|Overall Study|Death|4|||
143460081|NCT00513604|517231159|FG000|Overall Study|Not treated|2|||
143460082|NCT00513604|517231160|FG001|Overall Study|Not treated|0|||
143460083|NCT00513604|517231161|FG002|Overall Study|Not treated|1|||
143460084|NCT00513604|517231162|FG003|Overall Study|Not treated|0|||
143460085|NCT00513604|517231163|FG004|Overall Study|Not treated|0|||
143460086|NCT00513604|517231159|FG000|Overall Study|Death during treatment|0|||
143460087|NCT00513604|517231160|FG001|Overall Study|Death during treatment|3|||
143460088|NCT00513604|517231161|FG002|Overall Study|Death during treatment|2|||
143460089|NCT00513604|517231162|FG003|Overall Study|Death during treatment|0|||
143460090|NCT00513604|517231163|FG004|Overall Study|Death during treatment|0|||
143460091|NCT00196976|517231164|FG000|Primary Study|Migrated from study area|0|||
143460092|NCT00196976|517231165|FG001|Primary Study|Migrated from study area|0|||
143460093|NCT00196976|517231166|FG002|Primary Study|Migrated from study area|0|||
143460094|NCT00196976|517231167|FG003|Primary Study|Migrated from study area|0|||
143460095|NCT00196976|517231168|FG004|Primary Study|Migrated from study area|0|||
143460096|NCT00196976|517231169|FG005|Primary Study|Migrated from study area|0|||
143460097|NCT00196976|517231170|FG006|Primary Study|Migrated from study area|0|||
143460098|NCT00196976|517231171|FG007|Primary Study|Migrated from study area|1|||
143460099|NCT00196976|517231172|FG008|Primary Study|Migrated from study area|0|||
143460100|NCT00196976|517231173|FG009|Primary Study|Migrated from study area|0|||
143460101|NCT00196976|517231174|FG010|Primary Study|Migrated from study area|0|||
143460102|NCT00196976|517231175|FG011|Primary Study|Migrated from study area|0|||
143460103|NCT00196976|517231176|FG012|Primary Study|Migrated from study area|0|||
143460104|NCT00196976|517231177|FG013|Primary Study|Migrated from study area|0|||
143460105|NCT00196976|517231164|FG000|Primary Study|Protocol Violation|0|||
143460106|NCT00196976|517231165|FG001|Primary Study|Protocol Violation|1|||
143460107|NCT00196976|517231166|FG002|Primary Study|Protocol Violation|1|||
143460108|NCT00196976|517231167|FG003|Primary Study|Protocol Violation|0|||
143460109|NCT00196976|517231168|FG004|Primary Study|Protocol Violation|0|||
143460110|NCT00196976|517231169|FG005|Primary Study|Protocol Violation|0|||
143460111|NCT00196976|517231170|FG006|Primary Study|Protocol Violation|0|||
143460112|NCT00196976|517231171|FG007|Primary Study|Protocol Violation|0|||
143460113|NCT00196976|517231172|FG008|Primary Study|Protocol Violation|0|||
143460114|NCT00196976|517231173|FG009|Primary Study|Protocol Violation|0|||
143460115|NCT00196976|517231174|FG010|Primary Study|Protocol Violation|0|||
143460116|NCT00196976|517231175|FG011|Primary Study|Protocol Violation|0|||
143460117|NCT00196976|517231176|FG012|Primary Study|Protocol Violation|0|||
143460118|NCT00196976|517231177|FG013|Primary Study|Protocol Violation|0|||
143460119|NCT00196976|517231164|FG000|Primary Study|Withdrawal by Subject|1|||
143460120|NCT00196976|517231165|FG001|Primary Study|Withdrawal by Subject|0|||
143460121|NCT00196976|517231166|FG002|Primary Study|Withdrawal by Subject|1|||
143460122|NCT00196976|517231167|FG003|Primary Study|Withdrawal by Subject|1|||
143460123|NCT00196976|517231168|FG004|Primary Study|Withdrawal by Subject|2|||
143460124|NCT00196976|517231169|FG005|Primary Study|Withdrawal by Subject|1|||
143460125|NCT00196976|517231170|FG006|Primary Study|Withdrawal by Subject|0|||
143460126|NCT00196976|517231171|FG007|Primary Study|Withdrawal by Subject|0|||
143460127|NCT00196976|517231172|FG008|Primary Study|Withdrawal by Subject|0|||
143460128|NCT00196976|517231173|FG009|Primary Study|Withdrawal by Subject|1|||
143460129|NCT00196976|517231174|FG010|Primary Study|Withdrawal by Subject|0|||
143460130|NCT00196976|517231175|FG011|Primary Study|Withdrawal by Subject|0|||
143460131|NCT00196976|517231176|FG012|Primary Study|Withdrawal by Subject|0|||
143460132|NCT00196976|517231177|FG013|Primary Study|Withdrawal by Subject|0|||
143460133|NCT00196976|517231164|FG000|Primary Study|Lost to Follow-up|0|||
143460134|NCT00196976|517231165|FG001|Primary Study|Lost to Follow-up|0|||
143460135|NCT00196976|517231166|FG002|Primary Study|Lost to Follow-up|0|||
143460136|NCT00196976|517231167|FG003|Primary Study|Lost to Follow-up|0|||
143460137|NCT00196976|517231168|FG004|Primary Study|Lost to Follow-up|1|||
143460138|NCT00196976|517231169|FG005|Primary Study|Lost to Follow-up|1|||
143460139|NCT00196976|517231170|FG006|Primary Study|Lost to Follow-up|0|||
143460140|NCT00196976|517231171|FG007|Primary Study|Lost to Follow-up|2|||
143460141|NCT00196976|517231172|FG008|Primary Study|Lost to Follow-up|0|||
143460142|NCT00196976|517231173|FG009|Primary Study|Lost to Follow-up|0|||
143460143|NCT00196976|517231174|FG010|Primary Study|Lost to Follow-up|0|||
143460144|NCT00196976|517231175|FG011|Primary Study|Lost to Follow-up|0|||
143460145|NCT00196976|517231176|FG012|Primary Study|Lost to Follow-up|0|||
143460146|NCT00196976|517231177|FG013|Primary Study|Lost to Follow-up|0|||
143460147|NCT00196976|517231164|FG000|Primary Study|Other|0|||
143460148|NCT00196976|517231165|FG001|Primary Study|Other|0|||
143460149|NCT00196976|517231166|FG002|Primary Study|Other|2|||
143460150|NCT00196976|517231167|FG003|Primary Study|Other|0|||
143460151|NCT00196976|517231168|FG004|Primary Study|Other|0|||
143460152|NCT00196976|517231169|FG005|Primary Study|Other|0|||
143460153|NCT00196976|517231170|FG006|Primary Study|Other|0|||
143460154|NCT00196976|517231171|FG007|Primary Study|Other|0|||
143460155|NCT00196976|517231172|FG008|Primary Study|Other|0|||
143460156|NCT00196976|517231173|FG009|Primary Study|Other|0|||
143460157|NCT00196976|517231174|FG010|Primary Study|Other|0|||
143460158|NCT00196976|517231175|FG011|Primary Study|Other|0|||
143460159|NCT00196976|517231176|FG012|Primary Study|Other|0|||
143460160|NCT00196976|517231177|FG013|Primary Study|Other|0|||
143460161|NCT00196976|517231164|FG000|Booster Study|Withdrawal by Subject|0|||
143460162|NCT00196976|517231165|FG001|Booster Study|Withdrawal by Subject|0|||
143460163|NCT00196976|517231166|FG002|Booster Study|Withdrawal by Subject|0|||
143460164|NCT00196976|517231167|FG003|Booster Study|Withdrawal by Subject|0|||
143460165|NCT00196976|517231168|FG004|Booster Study|Withdrawal by Subject|0|||
143460166|NCT00196976|517231169|FG005|Booster Study|Withdrawal by Subject|0|||
143460167|NCT00196976|517231170|FG006|Booster Study|Withdrawal by Subject|0|||
143460168|NCT00196976|517231171|FG007|Booster Study|Withdrawal by Subject|0|||
143460169|NCT00196976|517231172|FG008|Booster Study|Withdrawal by Subject|0|||
143460170|NCT00196976|517231173|FG009|Booster Study|Withdrawal by Subject|0|||
143460171|NCT00196976|517231174|FG010|Booster Study|Withdrawal by Subject|1|||
143460172|NCT00196976|517231175|FG011|Booster Study|Withdrawal by Subject|0|||
143460173|NCT00196976|517231176|FG012|Booster Study|Withdrawal by Subject|0|||
143460174|NCT00196976|517231177|FG013|Booster Study|Withdrawal by Subject|0|||
143460175|NCT00196976|517231164|FG000|Booster Study|Lost to Follow-up|0|||
143460176|NCT00196976|517231165|FG001|Booster Study|Lost to Follow-up|0|||
143460177|NCT00196976|517231166|FG002|Booster Study|Lost to Follow-up|0|||
143460178|NCT00196976|517231167|FG003|Booster Study|Lost to Follow-up|0|||
143460179|NCT00196976|517231168|FG004|Booster Study|Lost to Follow-up|0|||
143460180|NCT00196976|517231169|FG005|Booster Study|Lost to Follow-up|0|||
143460181|NCT00196976|517231170|FG006|Booster Study|Lost to Follow-up|0|||
143460182|NCT00196976|517231171|FG007|Booster Study|Lost to Follow-up|0|||
143460183|NCT00196976|517231172|FG008|Booster Study|Lost to Follow-up|0|||
143460184|NCT00196976|517231173|FG009|Booster Study|Lost to Follow-up|0|||
143460185|NCT00196976|517231174|FG010|Booster Study|Lost to Follow-up|1|||
143460186|NCT00196976|517231175|FG011|Booster Study|Lost to Follow-up|2|||
143460187|NCT00196976|517231176|FG012|Booster Study|Lost to Follow-up|0|||
143460188|NCT00196976|517231177|FG013|Booster Study|Lost to Follow-up|0|||
143460189|NCT01535560|517231178|FG000|Overall Study|Adverse Event|12|||
143181142|NCT04951622|516210473|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
143460190|NCT01535560|517231179|FG001|Overall Study|Adverse Event|7|||
143460191|NCT01535560|517231178|FG000|Overall Study|Lost to Follow-up|1|||
143460192|NCT01535560|517231179|FG001|Overall Study|Lost to Follow-up|3|||
143460193|NCT01535560|517231178|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
143460194|NCT01535560|517231179|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
143460195|NCT01535560|517231178|FG000|Overall Study|Treatment Failure|21|||
143346316|NCT03315130|516812708|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
143460196|NCT01535560|517231179|FG001|Overall Study|Treatment Failure|83|||
143460197|NCT01535560|517231178|FG000|Overall Study|Other|0|||
143346317|NCT03315130|516812709|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
143460198|NCT01535560|517231179|FG001|Overall Study|Other|1|||
143460199|NCT01535560|517231178|FG000|Overall Study|Randomized in Error|0|||
143460200|NCT01535560|517231179|FG001|Overall Study|Randomized in Error|1|||
143460201|NCT02842827|517231182|FG000|Overall Study|Adverse Event|0|||
143123477|NCT04227405|515997779|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
143460202|NCT02842827|517231183|FG001|Overall Study|Adverse Event|1|||
143460203|NCT02842827|517231184|FG002|Overall Study|Adverse Event|0|||
143460204|NCT02842827|517231185|FG003|Overall Study|Adverse Event|1|||
143460205|NCT02842827|517231186|FG004|Overall Study|Adverse Event|0|||
143460206|NCT02842827|517231187|FG005|Overall Study|Adverse Event|1|||
143460207|NCT02842827|517231188|FG006|Overall Study|Adverse Event|0|||
143460208|NCT02842827|517231189|FG007|Overall Study|Adverse Event|0|||
143460209|NCT02842827|517231182|FG000|Overall Study|Death|1|||
143460210|NCT02842827|517231183|FG001|Overall Study|Death|0|||
143460211|NCT02842827|517231184|FG002|Overall Study|Death|2|||
143460212|NCT02842827|517231185|FG003|Overall Study|Death|3|||
143460213|NCT02842827|517231186|FG004|Overall Study|Death|2|||
143460214|NCT02842827|517231187|FG005|Overall Study|Death|1|||
143460215|NCT02842827|517231188|FG006|Overall Study|Death|0|||
143460216|NCT02842827|517231189|FG007|Overall Study|Death|4|||
143460217|NCT02842827|517231182|FG000|Overall Study|Physician Decision|1|||
143460218|NCT02842827|517231183|FG001|Overall Study|Physician Decision|3|||
143460219|NCT02842827|517231184|FG002|Overall Study|Physician Decision|0|||
143460220|NCT02842827|517231185|FG003|Overall Study|Physician Decision|0|||
143460221|NCT02842827|517231186|FG004|Overall Study|Physician Decision|1|||
143460222|NCT02842827|517231187|FG005|Overall Study|Physician Decision|4|||
143460223|NCT02842827|517231188|FG006|Overall Study|Physician Decision|2|||
143460224|NCT02842827|517231189|FG007|Overall Study|Physician Decision|1|||
143460225|NCT02842827|517231182|FG000|Overall Study|Protocol Defined Disease Progression|0|||
143460226|NCT02842827|517231183|FG001|Overall Study|Protocol Defined Disease Progression|0|||
143460227|NCT02842827|517231184|FG002|Overall Study|Protocol Defined Disease Progression|0|||
143460228|NCT02842827|517231185|FG003|Overall Study|Protocol Defined Disease Progression|0|||
143460229|NCT02842827|517231186|FG004|Overall Study|Protocol Defined Disease Progression|0|||
143460230|NCT02842827|517231187|FG005|Overall Study|Protocol Defined Disease Progression|1|||
143460231|NCT02842827|517231188|FG006|Overall Study|Protocol Defined Disease Progression|0|||
143460232|NCT02842827|517231189|FG007|Overall Study|Protocol Defined Disease Progression|0|||
143460233|NCT02842827|517231182|FG000|Overall Study|Participant Withdrawal of Consent|1|||
143460234|NCT02842827|517231183|FG001|Overall Study|Participant Withdrawal of Consent|2|||
143460235|NCT02842827|517231184|FG002|Overall Study|Participant Withdrawal of Consent|2|||
143460236|NCT02842827|517231185|FG003|Overall Study|Participant Withdrawal of Consent|2|||
143460237|NCT02842827|517231186|FG004|Overall Study|Participant Withdrawal of Consent|2|||
143460238|NCT02842827|517231187|FG005|Overall Study|Participant Withdrawal of Consent|1|||
143460239|NCT02842827|517231188|FG006|Overall Study|Participant Withdrawal of Consent|2|||
143460240|NCT02842827|517231189|FG007|Overall Study|Participant Withdrawal of Consent|1|||
143460241|NCT02649946|517231195|FG000|Overall Study|Withdrawal by Subject|1|||
143460242|NCT02649946|517231196|FG001|Overall Study|Withdrawal by Subject|1|||
143460243|NCT02649946|517231195|FG000|Overall Study|Death|7|||
143460244|NCT02649946|517231196|FG001|Overall Study|Death|9|||
143460245|NCT02649946|517231195|FG000|Overall Study|Physician Decision|1|||
143460246|NCT02649946|517231196|FG001|Overall Study|Physician Decision|0|||
143460247|NCT02649946|517231195|FG000|Overall Study|Lost to Follow-up|2|||
143460248|NCT02649946|517231196|FG001|Overall Study|Lost to Follow-up|1|||
143460249|NCT02649946|517231195|FG000|Overall Study|Erroneously enrolled|1|||
143460250|NCT02649946|517231196|FG001|Overall Study|Erroneously enrolled|0|||
143460251|NCT02649946|517231195|FG000|Overall Study|Missed 6-month follow-up visit|0|||
143460252|NCT02649946|517231196|FG001|Overall Study|Missed 6-month follow-up visit|4|||
143460253|NCT02054520|517231197|FG000|Overall Study|Adverse Event|1|||
143460254|NCT02054520|517231198|FG001|Overall Study|Adverse Event|4|||
143460255|NCT02054520|517231199|FG002|Overall Study|Adverse Event|2|||
143460256|NCT02054520|517231200|FG003|Overall Study|Adverse Event|1|||
143460257|NCT02054520|517231201|FG004|Overall Study|Adverse Event|1|||
143460258|NCT02054520|517231202|FG005|Overall Study|Adverse Event|0|||
143460259|NCT02054520|517231197|FG000|Overall Study|Lack of Efficacy|7|||
143460260|NCT02054520|517231198|FG001|Overall Study|Lack of Efficacy|0|||
143460261|NCT02054520|517231199|FG002|Overall Study|Lack of Efficacy|2|||
143460262|NCT02054520|517231200|FG003|Overall Study|Lack of Efficacy|1|||
143460263|NCT02054520|517231201|FG004|Overall Study|Lack of Efficacy|3|||
143460264|NCT02054520|517231202|FG005|Overall Study|Lack of Efficacy|2|||
143460265|NCT02054520|517231197|FG000|Overall Study|Withdrawal by Subject|1|||
143460266|NCT02054520|517231198|FG001|Overall Study|Withdrawal by Subject|0|||
143460267|NCT02054520|517231199|FG002|Overall Study|Withdrawal by Subject|0|||
143460268|NCT02054520|517231200|FG003|Overall Study|Withdrawal by Subject|2|||
143460269|NCT02054520|517231201|FG004|Overall Study|Withdrawal by Subject|1|||
143460270|NCT02054520|517231202|FG005|Overall Study|Withdrawal by Subject|0|||
143460271|NCT02054520|517231197|FG000|Overall Study|Physician Decision|0|||
143460272|NCT02054520|517231198|FG001|Overall Study|Physician Decision|1|||
143460273|NCT02054520|517231199|FG002|Overall Study|Physician Decision|0|||
143460274|NCT02054520|517231200|FG003|Overall Study|Physician Decision|1|||
143460275|NCT02054520|517231201|FG004|Overall Study|Physician Decision|0|||
143460276|NCT02054520|517231202|FG005|Overall Study|Physician Decision|1|||
143460277|NCT02054520|517231197|FG000|Overall Study|Study terminated by Sponsor|0|||
143460278|NCT02054520|517231198|FG001|Overall Study|Study terminated by Sponsor|0|||
143460279|NCT02054520|517231199|FG002|Overall Study|Study terminated by Sponsor|2|||
143460280|NCT02054520|517231200|FG003|Overall Study|Study terminated by Sponsor|1|||
143460281|NCT02054520|517231201|FG004|Overall Study|Study terminated by Sponsor|0|||
143460282|NCT02054520|517231202|FG005|Overall Study|Study terminated by Sponsor|0|||
143460283|NCT01272804|517231203|FG000|Overall Study|Adverse Event|1|||
143460284|NCT01272804|517231204|FG001|Overall Study|Adverse Event|0|||
143460285|NCT01272804|517231205|FG002|Overall Study|Adverse Event|0|||
143460286|NCT01272804|517231206|FG003|Overall Study|Adverse Event|0|||
143460287|NCT01272804|517231207|FG004|Overall Study|Adverse Event|2|||
143460288|NCT01272804|517231208|FG005|Overall Study|Adverse Event|1|||
143460289|NCT03801915|517231209|FG000|Overall Study|Screen failure|0|||
143460290|NCT03801915|517231210|FG001|Overall Study|Screen failure|0|||
143460291|NCT03801915|517231211|FG002|Overall Study|Screen failure|1|||
143460292|NCT03801915|517231209|FG000|Overall Study|Ineligible|1|||
143460293|NCT03801915|517231210|FG001|Overall Study|Ineligible|0|||
143460294|NCT03801915|517231211|FG002|Overall Study|Ineligible|0|||
143460295|NCT03801915|517231209|FG000|Overall Study|Physician Decision|2|||
143460296|NCT03801915|517231210|FG001|Overall Study|Physician Decision|1|||
143460297|NCT03801915|517231211|FG002|Overall Study|Physician Decision|0|||
143460298|NCT01211288|517231212|FG000|Overall Study|Lost to Follow-up|1|||
143460299|NCT01211288|517231213|FG001|Overall Study|Lost to Follow-up|1|||
143460300|NCT02471833|517231214|FG000|Overall Study|Lost to Follow-up|1|||
143460301|NCT02471833|517231215|FG001|Overall Study|Lost to Follow-up|0|||
143460302|NCT02471833|517231216|FG002|Overall Study|Lost to Follow-up|0|||
143460303|NCT02471833|517231214|FG000|Overall Study|Withdrawal by Subject|2|||
143460304|NCT02471833|517231215|FG001|Overall Study|Withdrawal by Subject|1|||
143460305|NCT02471833|517231216|FG002|Overall Study|Withdrawal by Subject|5|||
143460306|NCT02232243|517231219|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
143460307|NCT02232243|517231220|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
143460308|NCT02232243|517231221|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
143460309|NCT00490724|517231222|FG000|Period I|Physician Decision|0|||
143460310|NCT00490724|517231223|FG001|Period I|Physician Decision|0|||
143460311|NCT00490724|517231224|FG002|Period I|Physician Decision|1|||
143460312|NCT00490724|517231222|FG000|Period II|Treatment Discontinuation|3|||
143460313|NCT00490724|517231223|FG001|Period II|Treatment Discontinuation|1|||
143460314|NCT00490724|517231224|FG002|Period II|Treatment Discontinuation|3|||
143460315|NCT00928018|517231225|FG000|Overall Study|Withdrawal by Subject|1|||
143460316|NCT00928018|517231226|FG001|Overall Study|Withdrawal by Subject|0|||
143460317|NCT03218397|517231227|FG000|Overall Study|Prior positive blood culture|8|||
143460318|NCT03218397|517231228|FG001|Overall Study|Prior positive blood culture|13|||
143460319|NCT03218397|517231227|FG000|Overall Study|Comfort care|8|||
143460320|NCT03218397|517231228|FG001|Overall Study|Comfort care|5|||
143460321|NCT03218397|517231227|FG000|Overall Study|Comfort care and positive blood culture|1|||
143460322|NCT03218397|517231228|FG001|Overall Study|Comfort care and positive blood culture|0|||
143460323|NCT03218397|517231227|FG000|Overall Study|Comfort care and mixed culture|0|||
143460324|NCT03218397|517231228|FG001|Overall Study|Comfort care and mixed culture|1|||
143460325|NCT03218397|517231227|FG000|Overall Study|Mixed culture|2|||
143460326|NCT03218397|517231228|FG001|Overall Study|Mixed culture|2|||
143460327|NCT03218397|517231227|FG000|Overall Study|Inaccessible hospital records|2|||
143460328|NCT03218397|517231228|FG001|Overall Study|Inaccessible hospital records|5|||
143460329|NCT03218397|517231227|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
143460330|NCT03218397|517231228|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
143460331|NCT03218397|517231227|FG000|Overall Study|Randomized during laboratory off hours|2|||
143460332|NCT03218397|517231228|FG001|Overall Study|Randomized during laboratory off hours|1|||
143460333|NCT01796548|517231229|FG000|Overall Study|Lost to Follow-up|1|||
143460334|NCT01796548|517231229|FG000|Overall Study|Other|2|||
143460335|NCT00126503|517231230|FG000|Overall Study|disease progression|23|||
143460336|NCT00126503|517231231|FG001|Overall Study|disease progression|14|||
143460337|NCT00126503|517231230|FG000|Overall Study|Withdrawal by Subject|0|||
143460338|NCT00126503|517231231|FG001|Overall Study|Withdrawal by Subject|1|||
143460339|NCT00126503|517231230|FG000|Overall Study|alternative therapy|1|||
143460340|NCT00126503|517231231|FG001|Overall Study|alternative therapy|1|||
143460341|NCT00126503|517231230|FG000|Overall Study|other complicating disease|4|||
143460342|NCT00126503|517231231|FG001|Overall Study|other complicating disease|1|||
143460343|NCT00126503|517231230|FG000|Overall Study|Death|3|||
143460344|NCT00126503|517231231|FG001|Overall Study|Death|0|||
143460345|NCT00126503|517231230|FG000|Overall Study|Adverse Event|13|||
143460346|NCT00126503|517231231|FG001|Overall Study|Adverse Event|3|||
143460347|NCT00126503|517231230|FG000|Overall Study|non-compliant|1|||
143460348|NCT00126503|517231231|FG001|Overall Study|non-compliant|0|||
143460349|NCT00126503|517231230|FG000|Overall Study|Physician Decision|2|||
143460350|NCT00126503|517231231|FG001|Overall Study|Physician Decision|1|||
143460351|NCT02457559|517231232|FG000|Overall Study|Progressive Disease|1|||
143460352|NCT02457559|517231233|FG001|Overall Study|Progressive Disease|2|||
143460353|NCT02457559|517231234|FG002|Overall Study|Progressive Disease|3|||
143460354|NCT02457559|517231235|FG003|Overall Study|Progressive Disease|0|||
143460355|NCT02457559|517231236|FG004|Overall Study|Progressive Disease|0|||
143460356|NCT02457559|517231237|FG005|Overall Study|Progressive Disease|2|||
143460357|NCT02457559|517231238|FG006|Overall Study|Progressive Disease|1|||
143460358|NCT02457559|517231239|FG007|Overall Study|Progressive Disease|0|||
143460359|NCT02457559|517231240|FG008|Overall Study|Progressive Disease|1|||
143460360|NCT02457559|517231241|FG009|Overall Study|Progressive Disease|1|||
143460361|NCT02457559|517231242|FG010|Overall Study|Progressive Disease|1|||
143460362|NCT02457559|517231232|FG000|Overall Study|Investigator's Discretion|0|||
143460363|NCT02457559|517231233|FG001|Overall Study|Investigator's Discretion|0|||
143460364|NCT02457559|517231234|FG002|Overall Study|Investigator's Discretion|2|||
143460365|NCT02457559|517231235|FG003|Overall Study|Investigator's Discretion|0|||
143460366|NCT02457559|517231236|FG004|Overall Study|Investigator's Discretion|1|||
143460367|NCT02457559|517231237|FG005|Overall Study|Investigator's Discretion|0|||
143460368|NCT02457559|517231238|FG006|Overall Study|Investigator's Discretion|1|||
143460369|NCT02457559|517231239|FG007|Overall Study|Investigator's Discretion|0|||
143460370|NCT02457559|517231240|FG008|Overall Study|Investigator's Discretion|1|||
143460371|NCT02457559|517231241|FG009|Overall Study|Investigator's Discretion|0|||
143460372|NCT02457559|517231242|FG010|Overall Study|Investigator's Discretion|1|||
143460373|NCT02457559|517231232|FG000|Overall Study|Adverse Event|0|||
143460374|NCT02457559|517231233|FG001|Overall Study|Adverse Event|1|||
143460375|NCT02457559|517231234|FG002|Overall Study|Adverse Event|2|||
143460376|NCT02457559|517231235|FG003|Overall Study|Adverse Event|0|||
143460377|NCT02457559|517231236|FG004|Overall Study|Adverse Event|0|||
143460378|NCT02457559|517231237|FG005|Overall Study|Adverse Event|0|||
143460379|NCT02457559|517231238|FG006|Overall Study|Adverse Event|0|||
143460380|NCT02457559|517231239|FG007|Overall Study|Adverse Event|0|||
143460381|NCT02457559|517231240|FG008|Overall Study|Adverse Event|0|||
143460382|NCT02457559|517231241|FG009|Overall Study|Adverse Event|0|||
143460383|NCT02457559|517231242|FG010|Overall Study|Adverse Event|0|||
143460384|NCT02457559|517231232|FG000|Overall Study|Reason not Specified|1|||
143460385|NCT02457559|517231233|FG001|Overall Study|Reason not Specified|0|||
143460386|NCT02457559|517231234|FG002|Overall Study|Reason not Specified|0|||
143460387|NCT02457559|517231235|FG003|Overall Study|Reason not Specified|0|||
143460388|NCT02457559|517231236|FG004|Overall Study|Reason not Specified|0|||
143460389|NCT02457559|517231237|FG005|Overall Study|Reason not Specified|0|||
143460390|NCT02457559|517231238|FG006|Overall Study|Reason not Specified|0|||
143460391|NCT02457559|517231239|FG007|Overall Study|Reason not Specified|0|||
143460392|NCT02457559|517231240|FG008|Overall Study|Reason not Specified|0|||
143460393|NCT02457559|517231241|FG009|Overall Study|Reason not Specified|2|||
143460394|NCT02457559|517231242|FG010|Overall Study|Reason not Specified|0|||
143460395|NCT02457559|517231232|FG000|Overall Study|Death|0|||
143460396|NCT02457559|517231233|FG001|Overall Study|Death|0|||
143460397|NCT02457559|517231234|FG002|Overall Study|Death|0|||
143460398|NCT02457559|517231235|FG003|Overall Study|Death|0|||
143460399|NCT02457559|517231236|FG004|Overall Study|Death|0|||
143460400|NCT02457559|517231237|FG005|Overall Study|Death|0|||
143460401|NCT02457559|517231238|FG006|Overall Study|Death|0|||
143460402|NCT02457559|517231239|FG007|Overall Study|Death|0|||
143460403|NCT02457559|517231240|FG008|Overall Study|Death|1|||
143460404|NCT02457559|517231241|FG009|Overall Study|Death|1|||
143460405|NCT02457559|517231242|FG010|Overall Study|Death|0|||
143460406|NCT00998335|517231245|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
143460407|NCT00998335|517231246|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
143460408|NCT02374671|517231247|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
143460409|NCT02374671|517231248|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
143460410|NCT02374671|517231249|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
143460411|NCT02374671|517231247|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
143460412|NCT02374671|517231248|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
143460413|NCT02374671|517231249|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
143460414|NCT02374671|517231247|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
143460415|NCT02374671|517231248|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
143460416|NCT02374671|517231249|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
143460417|NCT02374671|517231247|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
143460418|NCT02374671|517231248|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
143460419|NCT02374671|517231249|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
143460420|NCT02374671|517231247|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
143460421|NCT02374671|517231248|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
143460422|NCT02374671|517231249|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
143460423|NCT02495792|517231252|FG000|Overall Study|Lost to Follow-up|5|||
143460424|NCT02495792|517231253|FG001|Overall Study|Lost to Follow-up|9|||
143460425|NCT02495792|517231252|FG000|Overall Study|Protocol Violation|32|||
143460426|NCT02495792|517231253|FG001|Overall Study|Protocol Violation|31|||
143460427|NCT02523599|517231254|FG000|Overall Study|Adverse Event|1|||
143460428|NCT02523599|517231255|FG001|Overall Study|Adverse Event|0|||
143460429|NCT02523599|517231254|FG000|Overall Study|Physician Decision|1|||
143460430|NCT02523599|517231255|FG001|Overall Study|Physician Decision|0|||
143460431|NCT02523599|517231254|FG000|Overall Study|Lost to Follow-up|4|||
143460432|NCT02523599|517231255|FG001|Overall Study|Lost to Follow-up|1|||
143460433|NCT02523599|517231254|FG000|Overall Study|Did not return for Day 30 visit|2|||
143460434|NCT02523599|517231255|FG001|Overall Study|Did not return for Day 30 visit|0|||
143460435|NCT04227704|517231266|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
143460436|NCT04227704|517231267|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
143460437|NCT04227704|517231268|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
143460438|NCT04227704|517231266|FG000|Overall Study|due to C/S being cancelled|1|||
143460439|NCT04227704|517231267|FG001|Overall Study|due to C/S being cancelled|0|||
143460440|NCT04227704|517231268|FG002|Overall Study|due to C/S being cancelled|0|||
143460441|NCT02079610|517232824|FG000|Overall Study|Withdrawal by Subject|1|||
143460442|NCT02079610|517232825|FG001|Overall Study|Withdrawal by Subject|1|||
143460443|NCT01016977|517232833|FG000|Overall Study|Lost to Follow-up|1|||
143460444|NCT01016977|517232834|FG001|Overall Study|Lost to Follow-up|0|||
143460445|NCT01016977|517232833|FG000|Overall Study|Withdrawal by Subject|2|||
143460446|NCT01016977|517232834|FG001|Overall Study|Withdrawal by Subject|2|||
143460447|NCT05081388|517232837|FG000|Overall Study|Adverse Event|1|||
143460448|NCT05081388|517232838|FG001|Overall Study|Adverse Event|0|||
143460449|NCT05081388|517232839|FG002|Overall Study|Adverse Event|0|||
143460450|NCT05081388|517232840|FG003|Overall Study|Adverse Event|0|||
143460451|NCT05081388|517232841|FG004|Overall Study|Adverse Event|0|||
143460452|NCT05081388|517232837|FG000|Overall Study|Lost to Follow-up|0|||
143460453|NCT05081388|517232838|FG001|Overall Study|Lost to Follow-up|1|||
143460454|NCT05081388|517232839|FG002|Overall Study|Lost to Follow-up|0|||
143460455|NCT05081388|517232840|FG003|Overall Study|Lost to Follow-up|0|||
143460456|NCT05081388|517232841|FG004|Overall Study|Lost to Follow-up|0|||
143460457|NCT05081388|517232837|FG000|Overall Study|Subject decision|0|||
143460458|NCT05081388|517232838|FG001|Overall Study|Subject decision|0|||
143460459|NCT05081388|517232839|FG002|Overall Study|Subject decision|0|||
143460460|NCT05081388|517232840|FG003|Overall Study|Subject decision|1|||
143460461|NCT05081388|517232841|FG004|Overall Study|Subject decision|0|||
143460462|NCT04279392|517232842|FG000|Overall Study|Physician Decision|1|||
143460463|NCT04279392|517232843|FG001|Overall Study|Physician Decision|0|||
143460464|NCT01171807|517232844|FG000|Overall Study|Treatment failure|2|||
143460465|NCT01171807|517232845|FG001|Overall Study|Treatment failure|4|||
143460466|NCT01171807|517232844|FG000|Overall Study|Non compliance|1|||
143460467|NCT01171807|517232845|FG001|Overall Study|Non compliance|0|||
143460468|NCT01171807|517232844|FG000|Overall Study|Lost to Follow-up|3|||
143460469|NCT01171807|517232845|FG001|Overall Study|Lost to Follow-up|0|||
143460470|NCT01901341|517232846|FG000|Overall Study|Adverse Event|4|||
143460471|NCT01901341|517232847|FG001|Overall Study|Adverse Event|2|||
143460472|NCT01901341|517232846|FG000|Overall Study|Lack of Efficacy|0|||
143460473|NCT01901341|517232847|FG001|Overall Study|Lack of Efficacy|2|||
143460474|NCT01901341|517232846|FG000|Overall Study|Lost to Follow-up|0|||
143460475|NCT01901341|517232847|FG001|Overall Study|Lost to Follow-up|1|||
143460476|NCT01901341|517232846|FG000|Overall Study|Protocol Violation|2|||
143460477|NCT01901341|517232847|FG001|Overall Study|Protocol Violation|0|||
143460478|NCT01901341|517232846|FG000|Overall Study|Study Terminated by Sponsor|13|||
143460479|NCT01901341|517232847|FG001|Overall Study|Study Terminated by Sponsor|15|||
143460480|NCT01901341|517232846|FG000|Overall Study|Withdrawal by Subject|1|||
143460481|NCT01901341|517232847|FG001|Overall Study|Withdrawal by Subject|1|||
143460482|NCT00156819|517232848|FG000|Overall Study|Lost to Follow-up|1|||
143460483|NCT00156819|517232849|FG001|Overall Study|Lost to Follow-up|1|||
143460484|NCT00156819|517232850|FG002|Overall Study|Lost to Follow-up|3|||
143460485|NCT04964388|517232851|FG000|Overall Study|Lost to Follow-up|3|||
143460486|NCT04964388|517232852|FG001|Overall Study|Lost to Follow-up|2|||
143460487|NCT01689337|517232853|FG000|Overall Study|Study Discontinuation|1|||
143460488|NCT00738582|517232854|FG000|Combination Therapy|Completed Combination Therapy|1|||
143460489|NCT00738582|517232855|FG001|Combination Therapy|Completed Combination Therapy|0|||
143460490|NCT00738582|517232854|FG000|Combination Therapy|Physician Decision|1|||
143460491|NCT00738582|517232855|FG001|Combination Therapy|Physician Decision|0|||
143460492|NCT00738582|517232854|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
143460493|NCT00738582|517232855|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
143460494|NCT00738582|517232854|FG000|Combination Therapy|Other|5|||
143460495|NCT00738582|517232855|FG001|Combination Therapy|Other|0|||
143460496|NCT00738582|517232854|FG000|Combination Therapy|Adverse Event|16|||
143460497|NCT00738582|517232855|FG001|Combination Therapy|Adverse Event|0|||
143460498|NCT00738582|517232854|FG000|Combination Therapy|Progressive Disease|9|||
143460499|NCT00738582|517232855|FG001|Combination Therapy|Progressive Disease|0|||
143460500|NCT00738582|517232854|FG000|Maintenance Therapy|Other|0|||
143346318|NCT03315130|516812706|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
143460501|NCT00738582|517232855|FG001|Maintenance Therapy|Other|2|||
143460502|NCT00738582|517232854|FG000|Maintenance Therapy|Adverse Event|0|||
143460503|NCT00738582|517232855|FG001|Maintenance Therapy|Adverse Event|6|||
143460504|NCT00738582|517232854|FG000|Maintenance Therapy|Progressive Disease|0|||
143460505|NCT00738582|517232855|FG001|Maintenance Therapy|Progressive Disease|47|||
143460506|NCT00738582|517232854|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
143460507|NCT00738582|517232855|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
143460508|NCT00642772|517232856|FG000|Overall Study|Lost to Follow-up|3|||
143460509|NCT00642772|517232856|FG000|Overall Study|Withdrawal by Subject|7|||
143460510|NCT00757588|517232857|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
143460511|NCT00757588|517232858|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
143460512|NCT00757588|517232857|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
143460513|NCT00757588|517232858|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
143460514|NCT00757588|517232857|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
143460515|NCT00757588|517232858|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
143460516|NCT00757588|517232857|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
143460517|NCT00757588|517232858|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
143460518|NCT00757588|517232857|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
143460519|NCT00757588|517232858|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
143460520|NCT00757588|517232857|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
143460521|NCT00757588|517232858|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
143460522|NCT00757588|517232857|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
143460523|NCT00757588|517232858|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
143460524|NCT00757588|517232857|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
143460525|NCT00757588|517232858|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
143460526|NCT00757588|517232857|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
143460527|NCT00757588|517232858|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
143460528|NCT00757588|517232857|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
143460529|NCT00757588|517232858|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
143460530|NCT00757588|517232857|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
143460531|NCT00757588|517232858|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
143460532|NCT00757588|517232857|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
143460533|NCT00757588|517232858|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
143460534|NCT00757588|517232857|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
143460535|NCT00757588|517232858|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
143460536|NCT00757588|517232857|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
143460537|NCT00757588|517232858|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
143460538|NCT00757588|517232857|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
143460539|NCT00757588|517232858|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
143460540|NCT00757588|517232857|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
143460541|NCT00757588|517232858|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
143460542|NCT01052103|517232859|FG000|Overall Study|Adverse Event|10|||
143460543|NCT01052103|517232860|FG001|Overall Study|Adverse Event|6|||
143460544|NCT01052103|517232859|FG000|Overall Study|Entry Criteria Not Met|3|||
143460545|NCT01052103|517232860|FG001|Overall Study|Entry Criteria Not Met|1|||
143460546|NCT01052103|517232859|FG000|Overall Study|Lost to Follow-up|3|||
143460547|NCT01052103|517232860|FG001|Overall Study|Lost to Follow-up|5|||
143460548|NCT01052103|517232859|FG000|Overall Study|Protocol Violation|10|||
143460549|NCT01052103|517232860|FG001|Overall Study|Protocol Violation|4|||
143460550|NCT01052103|517232859|FG000|Overall Study|Scheduling conflict|2|||
143460551|NCT01052103|517232860|FG001|Overall Study|Scheduling conflict|1|||
143460552|NCT01052103|517232859|FG000|Overall Study|Sponsor Decision|2|||
143460553|NCT01052103|517232860|FG001|Overall Study|Sponsor Decision|0|||
143460554|NCT01052103|517232859|FG000|Overall Study|Withdrawal by Subject|3|||
143460555|NCT01052103|517232860|FG001|Overall Study|Withdrawal by Subject|6|||
143460556|NCT01052103|517232859|FG000|Overall Study|Perceived Lack of Efficacy|1|||
143460557|NCT01052103|517232860|FG001|Overall Study|Perceived Lack of Efficacy|0|||
143460558|NCT05062759|517232864|FG000|Overall Study|Death|0|||
143460559|NCT05062759|517232865|FG001|Overall Study|Death|1|||
143460560|NCT05062759|517232864|FG000|Overall Study|Lost to Follow-up|1|||
143460561|NCT05062759|517232865|FG001|Overall Study|Lost to Follow-up|0|||
143460562|NCT00903006|517232866|FG000|Overall Study|Withdrawal by Subject|2|||
143460563|NCT00903006|517232867|FG001|Overall Study|Withdrawal by Subject|0|||
143460564|NCT00903006|517232868|FG002|Overall Study|Withdrawal by Subject|0|||
143460565|NCT00903006|517232869|FG003|Overall Study|Withdrawal by Subject|0|||
143460566|NCT00903006|517232866|FG000|Overall Study|Progressive Disease|0|||
143460567|NCT00903006|517232867|FG001|Overall Study|Progressive Disease|3|||
143460568|NCT00903006|517232868|FG002|Overall Study|Progressive Disease|1|||
143460569|NCT00903006|517232869|FG003|Overall Study|Progressive Disease|0|||
143460570|NCT03405792|517232870|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
143460571|NCT03405792|517232871|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
143460572|NCT03405792|517232870|FG000|Overall Study|o Did not receive pembrolizumab|1|||
143460573|NCT03405792|517232871|FG001|Overall Study|o Did not receive pembrolizumab|0|||
143460574|NCT01383499|517232872|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
143123478|NCT04227405|515997780|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
143123479|NCT04227405|515997779|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
143460575|NCT01383499|517232873|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
143460576|NCT01383499|517232874|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
143460577|NCT01383499|517232875|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
143460578|NCT02572882|517232876|FG000|Overall Study|Withdrawal by Subject|1|||
143460579|NCT02572882|517232876|FG000|Overall Study|Participant received kidney transplant|1|||
143460580|NCT01079663|517232877|FG000|Overall Study|Adverse Event|0|||
143460581|NCT01079663|517232878|FG001|Overall Study|Adverse Event|2|||
143460582|NCT01079663|517232877|FG000|Overall Study|Protocol Violation|0|||
143460583|NCT01079663|517232878|FG001|Overall Study|Protocol Violation|2|||
143460584|NCT03587974|517232882|FG000|Overall Study|caregiver demented, care recipient died|3|||
143460585|NCT03587974|517232883|FG001|Overall Study|caregiver demented, care recipient died|3|||
143460586|NCT03587974|517232882|FG000|Overall Study|Withdrawal by Subject|2|||
143460587|NCT03587974|517232883|FG001|Overall Study|Withdrawal by Subject|1|||
143460588|NCT03536143|517232886|FG000|Overall Study|Early termination, Sponsor decision|1|||
143460589|NCT01878214|517232887|FG000|Overall Study|Withdrawal by Subject|18|||
143460590|NCT01878214|517232888|FG001|Overall Study|Withdrawal by Subject|7|||
143460591|NCT01878214|517232887|FG000|Overall Study|Death|0|||
143460592|NCT01878214|517232888|FG001|Overall Study|Death|1|||
143460593|NCT01878214|517232887|FG000|Overall Study|Lost to Follow-up|35|||
143460594|NCT01878214|517232888|FG001|Overall Study|Lost to Follow-up|36|||
143460595|NCT01590017|517232889|FG000|Overall Study|Adverse Event|1|||
143460596|NCT01590017|517232889|FG000|Overall Study|Withdrawal by Subject|1|||
143460597|NCT01590017|517232889|FG000|Overall Study|Lack of Efficacy|1|||
143460598|NCT01590017|517232889|FG000|Overall Study|Physician Decision|1|||
143460599|NCT02527343|517232890|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
143460600|NCT02527343|517232891|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
143460601|NCT02527343|517232892|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
143460602|NCT02527343|517232893|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
143460603|NCT02527343|517232894|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
143460604|NCT02527343|517232895|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
143460605|NCT02527343|517232890|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
143460606|NCT02527343|517232891|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
143460607|NCT02527343|517232892|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
143460608|NCT02527343|517232893|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
143460609|NCT02527343|517232894|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
143460610|NCT02527343|517232895|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
143460611|NCT02527343|517232890|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
143460612|NCT02527343|517232891|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
143460613|NCT02527343|517232892|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
143460614|NCT02527343|517232893|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
143460615|NCT02527343|517232894|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
143460616|NCT02527343|517232895|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
143460617|NCT02527343|517232890|FG000|RT Period: Weeks 1 to 52|Other|4|||
143460618|NCT02527343|517232891|FG001|RT Period: Weeks 1 to 52|Other|3|||
143460619|NCT02527343|517232892|FG002|RT Period: Weeks 1 to 52|Other|0|||
143460620|NCT02527343|517232893|FG003|RT Period: Weeks 1 to 52|Other|0|||
143460621|NCT02527343|517232894|FG004|RT Period: Weeks 1 to 52|Other|0|||
143460622|NCT02527343|517232895|FG005|RT Period: Weeks 1 to 52|Other|0|||
143460623|NCT02527343|517232890|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
143460624|NCT02527343|517232891|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
143460625|NCT02527343|517232892|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
143460626|NCT02527343|517232893|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
143460627|NCT02527343|517232894|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
143460628|NCT02527343|517232895|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
143460629|NCT02527343|517232890|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
143460630|NCT02527343|517232891|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
143460631|NCT02527343|517232892|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
143460632|NCT02527343|517232893|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
143460633|NCT02527343|517232894|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
143460634|NCT02527343|517232895|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
143460635|NCT02527343|517232890|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
143460636|NCT02527343|517232891|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
143460637|NCT02527343|517232892|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
143460638|NCT02527343|517232893|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
143460639|NCT02527343|517232894|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
143460640|NCT02527343|517232895|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
143460641|NCT02527343|517232890|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
143460642|NCT02527343|517232891|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
143460643|NCT02527343|517232892|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
143181143|NCT04951622|516210474|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
143460644|NCT02527343|517232893|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
143460645|NCT02527343|517232894|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
143460646|NCT02527343|517232895|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
143460647|NCT02527343|517232890|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
143460648|NCT02527343|517232891|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
143460649|NCT02527343|517232892|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
143460650|NCT02527343|517232893|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
143460651|NCT02527343|517232894|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
143460652|NCT02527343|517232895|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
143460653|NCT02527343|517232890|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
143460654|NCT02527343|517232891|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
143460655|NCT02527343|517232892|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
143460656|NCT02527343|517232893|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
143460657|NCT02527343|517232894|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
143460658|NCT02527343|517232895|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
143460659|NCT02527343|517232890|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
143460660|NCT02527343|517232891|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
143460661|NCT02527343|517232892|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
143460662|NCT02527343|517232893|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
143460663|NCT02527343|517232894|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
143460664|NCT02527343|517232895|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
143460665|NCT02527343|517232890|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
143460666|NCT02527343|517232891|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
143460667|NCT02527343|517232892|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
143460668|NCT02527343|517232893|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
143460669|NCT02527343|517232894|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
143460670|NCT02527343|517232895|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
143460671|NCT02527343|517232890|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
143460672|NCT02527343|517232891|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
143460673|NCT02527343|517232892|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
143460674|NCT02527343|517232893|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
143460675|NCT02527343|517232894|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
143460676|NCT02527343|517232895|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
143460677|NCT02581631|517232905|FG000|Overall Study|Disease progression|29|||
143460678|NCT02581631|517232906|FG001|Overall Study|Disease progression|19|||
143460679|NCT02581631|517232907|FG002|Overall Study|Disease progression|13|||
143460680|NCT02581631|517232908|FG003|Overall Study|Disease progression|5|||
143460681|NCT02581631|517232909|FG004|Overall Study|Disease progression|8|||
143460682|NCT02581631|517232905|FG000|Overall Study|Study drug toxicity|4|||
143460683|NCT02581631|517232906|FG001|Overall Study|Study drug toxicity|6|||
143460684|NCT02581631|517232907|FG002|Overall Study|Study drug toxicity|7|||
143460685|NCT02581631|517232908|FG003|Overall Study|Study drug toxicity|0|||
143460686|NCT02581631|517232909|FG004|Overall Study|Study drug toxicity|3|||
143123480|NCT04227405|515997780|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
143123481|NCT04985942|515997781|FG000|Overall Study|Adverse Event|14|||
143460687|NCT02581631|517232905|FG000|Overall Study|AE unrelated to study drug|3|||
143460688|NCT02581631|517232906|FG001|Overall Study|AE unrelated to study drug|1|||
143460689|NCT02581631|517232907|FG002|Overall Study|AE unrelated to study drug|1|||
143460690|NCT02581631|517232908|FG003|Overall Study|AE unrelated to study drug|0|||
143460691|NCT02581631|517232909|FG004|Overall Study|AE unrelated to study drug|2|||
143460692|NCT02581631|517232905|FG000|Overall Study|Request to discontinue|1|||
143460693|NCT02581631|517232906|FG001|Overall Study|Request to discontinue|0|||
143460694|NCT02581631|517232907|FG002|Overall Study|Request to discontinue|3|||
143460695|NCT02581631|517232908|FG003|Overall Study|Request to discontinue|0|||
143460696|NCT02581631|517232909|FG004|Overall Study|Request to discontinue|1|||
143460697|NCT02581631|517232905|FG000|Overall Study|participant withdrew consent|3|||
143460698|NCT02581631|517232906|FG001|Overall Study|participant withdrew consent|0|||
143460699|NCT02581631|517232907|FG002|Overall Study|participant withdrew consent|1|||
143460700|NCT02581631|517232908|FG003|Overall Study|participant withdrew consent|0|||
143460701|NCT02581631|517232909|FG004|Overall Study|participant withdrew consent|0|||
143460702|NCT02581631|517232905|FG000|Overall Study|Maximum clinical benefit|1|||
143460703|NCT02581631|517232906|FG001|Overall Study|Maximum clinical benefit|7|||
143460704|NCT02581631|517232907|FG002|Overall Study|Maximum clinical benefit|1|||
143460705|NCT02581631|517232908|FG003|Overall Study|Maximum clinical benefit|3|||
143460706|NCT02581631|517232909|FG004|Overall Study|Maximum clinical benefit|13|||
143460707|NCT02581631|517232905|FG000|Overall Study|Other Reasons|1|||
143460708|NCT02581631|517232906|FG001|Overall Study|Other Reasons|0|||
143460709|NCT02581631|517232907|FG002|Overall Study|Other Reasons|2|||
143460710|NCT02581631|517232908|FG003|Overall Study|Other Reasons|2|||
143460711|NCT02581631|517232909|FG004|Overall Study|Other Reasons|3|||
143460712|NCT02581631|517232905|FG000|Overall Study|Poor/Non-Compliance|0|||
143460713|NCT02581631|517232906|FG001|Overall Study|Poor/Non-Compliance|0|||
143460714|NCT02581631|517232907|FG002|Overall Study|Poor/Non-Compliance|1|||
143123482|NCT04985942|515997782|FG001|Overall Study|Adverse Event|2|||
143460715|NCT02581631|517232908|FG003|Overall Study|Poor/Non-Compliance|0|||
143460716|NCT02581631|517232909|FG004|Overall Study|Poor/Non-Compliance|0|||
143460717|NCT00986973|517232910|FG000|Overall Study|Withdrawn by study team|1|||
143460718|NCT00598273|517232911|FG000|Overall Study|Adverse Event|4|||
143460719|NCT00598273|517232912|FG001|Overall Study|Adverse Event|5|||
143460720|NCT00598273|517232913|FG002|Overall Study|Adverse Event|2|||
143460721|NCT00598273|517232911|FG000|Overall Study|Death|6|||
143460722|NCT00598273|517232912|FG001|Overall Study|Death|12|||
143460723|NCT00598273|517232913|FG002|Overall Study|Death|8|||
143006525|NCT03110107|515562981|FG007|Treatment Period|Participants no longer meets study criteria|0|||
143006526|NCT03110107|515562982|FG008|Treatment Period|Participants no longer meets study criteria|0|||
143006527|NCT03110107|515562983|FG009|Treatment Period|Participants no longer meets study criteria|0|||
143006528|NCT03110107|515562984|FG010|Treatment Period|Participants no longer meets study criteria|0|||
143006529|NCT03110107|515562985|FG011|Treatment Period|Participants no longer meets study criteria|0|||
143006530|NCT03110107|515562986|FG012|Treatment Period|Participants no longer meets study criteria|0|||
143006531|NCT03110107|515562987|FG013|Treatment Period|Participants no longer meets study criteria|0|||
143006532|NCT03110107|515562988|FG014|Treatment Period|Participants no longer meets study criteria|0|||
143006533|NCT03110107|515562989|FG015|Treatment Period|Participants no longer meets study criteria|0|||
143006534|NCT03110107|515562990|FG016|Treatment Period|Participants no longer meets study criteria|0|||
143006535|NCT03110107|515562991|FG017|Treatment Period|Participants no longer meets study criteria|0|||
143006536|NCT03110107|515562992|FG018|Treatment Period|Participants no longer meets study criteria|0|||
143006537|NCT03110107|515562993|FG019|Treatment Period|Participants no longer meets study criteria|0|||
143006538|NCT03110107|515562994|FG020|Treatment Period|Participants no longer meets study criteria|0|||
143006539|NCT03110107|515562995|FG021|Treatment Period|Participants no longer meets study criteria|0|||
143006540|NCT03110107|515562996|FG022|Treatment Period|Participants no longer meets study criteria|0|||
143006541|NCT03110107|515562997|FG023|Treatment Period|Participants no longer meets study criteria|1|||
143006542|NCT03110107|515562998|FG024|Treatment Period|Participants no longer meets study criteria|0|||
143006543|NCT03110107|515562999|FG025|Treatment Period|Participants no longer meets study criteria|0|||
143006544|NCT03110107|515562974|FG000|Treatment Period|Other Reasons|0|||
143006545|NCT03110107|515562975|FG001|Treatment Period|Other Reasons|0|||
143006546|NCT03110107|515562976|FG002|Treatment Period|Other Reasons|1|||
143006547|NCT03110107|515562977|FG003|Treatment Period|Other Reasons|1|||
143006548|NCT03110107|515562978|FG004|Treatment Period|Other Reasons|0|||
143006549|NCT03110107|515562979|FG005|Treatment Period|Other Reasons|1|||
143006550|NCT03110107|515562980|FG006|Treatment Period|Other Reasons|0|||
143006551|NCT03110107|515562981|FG007|Treatment Period|Other Reasons|0|||
143006552|NCT03110107|515562982|FG008|Treatment Period|Other Reasons|0|||
143006553|NCT03110107|515562983|FG009|Treatment Period|Other Reasons|0|||
143006554|NCT03110107|515562984|FG010|Treatment Period|Other Reasons|0|||
143006555|NCT03110107|515562985|FG011|Treatment Period|Other Reasons|0|||
143006556|NCT03110107|515562986|FG012|Treatment Period|Other Reasons|0|||
143006557|NCT03110107|515562987|FG013|Treatment Period|Other Reasons|0|||
143006558|NCT03110107|515562988|FG014|Treatment Period|Other Reasons|0|||
143006559|NCT03110107|515562989|FG015|Treatment Period|Other Reasons|0|||
143006560|NCT03110107|515562990|FG016|Treatment Period|Other Reasons|0|||
143006561|NCT03110107|515562991|FG017|Treatment Period|Other Reasons|0|||
143006562|NCT03110107|515562992|FG018|Treatment Period|Other Reasons|0|||
143006563|NCT03110107|515562993|FG019|Treatment Period|Other Reasons|0|||
143006564|NCT03110107|515562994|FG020|Treatment Period|Other Reasons|0|||
143006565|NCT03110107|515562995|FG021|Treatment Period|Other Reasons|0|||
143006566|NCT03110107|515562996|FG022|Treatment Period|Other Reasons|0|||
143006567|NCT03110107|515562997|FG023|Treatment Period|Other Reasons|0|||
143006568|NCT03110107|515562998|FG024|Treatment Period|Other Reasons|1|||
143006569|NCT03110107|515562999|FG025|Treatment Period|Other Reasons|0|||
143006570|NCT03927989|515563004|FG000|Overall Study|Withdrawal by Subject|0|||
143006571|NCT03927989|515563005|FG001|Overall Study|Withdrawal by Subject|1|||
143006572|NCT00478933|515563009|FG000|Overall Study|Protocol Violation|22|||
143006573|NCT00478933|515563009|FG000|Overall Study|Informed consent not verified|3|||
143006574|NCT00478933|515563009|FG000|Overall Study|Inadequate data available|53|||
143006575|NCT01298362|515563016|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
143006576|NCT01298362|515563017|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
143006577|NCT01283009|515563018|FG000|Overall Study|Death|83|||
143006578|NCT01283009|515563019|FG001|Overall Study|Death|78|||
143006579|NCT01283009|515563018|FG000|Overall Study|Study ended early|23|||
143006580|NCT01283009|515563019|FG001|Overall Study|Study ended early|26|||
143006581|NCT01283009|515563018|FG000|Overall Study|Withdrawal by Subject|10|||
143123483|NCT04985942|515997781|FG000|Overall Study|Lack of Efficacy|0|||
143123484|NCT04985942|515997782|FG001|Overall Study|Lack of Efficacy|3|||
143006582|NCT01283009|515563019|FG001|Overall Study|Withdrawal by Subject|8|||
143006583|NCT01283009|515563018|FG000|Overall Study|Physician Decision|1|||
143006584|NCT01283009|515563019|FG001|Overall Study|Physician Decision|1|||
143123485|NCT04985942|515997781|FG000|Overall Study|Lost to Follow-up|1|||
143460724|NCT00598273|517232911|FG000|Overall Study|Lost to Follow-up|8|||
143460725|NCT00598273|517232912|FG001|Overall Study|Lost to Follow-up|3|||
143123486|NCT04985942|515997782|FG001|Overall Study|Lost to Follow-up|1|||
143123487|NCT04985942|515997781|FG000|Overall Study|Protocol Violation|1|||
143123488|NCT04985942|515997782|FG001|Overall Study|Protocol Violation|1|||
143123489|NCT04985942|515997781|FG000|Overall Study|Withdrawal by Subject|5|||
143123490|NCT04985942|515997782|FG001|Overall Study|Withdrawal by Subject|4|||
143123491|NCT02757352|515997783|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
143123492|NCT02757352|515997784|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
143123493|NCT02757352|515997785|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
143123494|NCT02757352|515997786|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
143123495|NCT02757352|515997787|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
143123496|NCT02757352|515997788|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
143460726|NCT00598273|517232913|FG002|Overall Study|Lost to Follow-up|5|||
143460727|NCT00598273|517232911|FG000|Overall Study|Physician Decision|0|||
143460728|NCT00598273|517232912|FG001|Overall Study|Physician Decision|0|||
143460729|NCT00598273|517232913|FG002|Overall Study|Physician Decision|1|||
143460730|NCT00598273|517232911|FG000|Overall Study|Withdrawal by Subject|12|||
143460731|NCT00598273|517232912|FG001|Overall Study|Withdrawal by Subject|10|||
143460732|NCT00598273|517232913|FG002|Overall Study|Withdrawal by Subject|10|||
143460733|NCT00598273|517232911|FG000|Overall Study|Noncompliance|3|||
143460734|NCT00598273|517232912|FG001|Overall Study|Noncompliance|2|||
143460735|NCT00598273|517232913|FG002|Overall Study|Noncompliance|3|||
143460736|NCT00598273|517232911|FG000|Overall Study|Relocation|0|||
143460737|NCT00598273|517232912|FG001|Overall Study|Relocation|2|||
143460738|NCT00598273|517232913|FG002|Overall Study|Relocation|4|||
143460739|NCT00598273|517232911|FG000|Overall Study|Renal transplant|1|||
143460740|NCT00598273|517232912|FG001|Overall Study|Renal transplant|0|||
143460741|NCT00598273|517232913|FG002|Overall Study|Renal transplant|1|||
143460742|NCT00598273|517232911|FG000|Overall Study|Site elected to close|1|||
143460743|NCT00598273|517232912|FG001|Overall Study|Site elected to close|0|||
143460744|NCT00598273|517232913|FG002|Overall Study|Site elected to close|0|||
143460745|NCT00598273|517232911|FG000|Overall Study|Started dialysis|6|||
143460746|NCT00598273|517232912|FG001|Overall Study|Started dialysis|4|||
143460747|NCT00598273|517232913|FG002|Overall Study|Started dialysis|5|||
143460748|NCT03426605|517232914|FG000|Overall Study|AML relapse or progression|2|||
143460749|NCT03426605|517232915|FG001|Overall Study|AML relapse or progression|1|||
143460750|NCT03426605|517232916|FG002|Overall Study|AML relapse or progression|2|||
143460751|NCT03426605|517232917|FG003|Overall Study|AML relapse or progression|2|||
143460752|NCT03426605|517232914|FG000|Overall Study|Treatment failure|3|||
143460753|NCT03426605|517232915|FG001|Overall Study|Treatment failure|2|||
143460754|NCT03426605|517232916|FG002|Overall Study|Treatment failure|0|||
143460755|NCT03426605|517232917|FG003|Overall Study|Treatment failure|0|||
143460756|NCT03426605|517232914|FG000|Overall Study|Adverse Event|1|||
143460757|NCT03426605|517232915|FG001|Overall Study|Adverse Event|0|||
143460758|NCT03426605|517232916|FG002|Overall Study|Adverse Event|1|||
143460759|NCT03426605|517232917|FG003|Overall Study|Adverse Event|1|||
143460760|NCT03426605|517232914|FG000|Overall Study|Withdrawal by Subject|0|||
143460761|NCT03426605|517232915|FG001|Overall Study|Withdrawal by Subject|0|||
143460762|NCT03426605|517232916|FG002|Overall Study|Withdrawal by Subject|1|||
143460763|NCT03426605|517232917|FG003|Overall Study|Withdrawal by Subject|1|||
143460764|NCT01815138|517232920|FG000|Overall Study|Withdrawal by Subject|0|||
143460765|NCT01815138|517232921|FG001|Overall Study|Withdrawal by Subject|1|||
143460766|NCT01815138|517232920|FG000|Overall Study|Physician Decision|8|||
143460767|NCT01815138|517232921|FG001|Overall Study|Physician Decision|5|||
143460768|NCT02308020|517232924|FG000|Overall Study|Lost to Follow-up|1|||
143460769|NCT02308020|517232925|FG001|Overall Study|Lost to Follow-up|7|||
143460770|NCT02308020|517232926|FG002|Overall Study|Lost to Follow-up|0|||
143460771|NCT02308020|517232927|FG003|Overall Study|Lost to Follow-up|0|||
143460772|NCT02308020|517232928|FG004|Overall Study|Lost to Follow-up|1|||
143460773|NCT02308020|517232929|FG005|Overall Study|Lost to Follow-up|2|||
143460774|NCT02308020|517232924|FG000|Overall Study|Sponsor Decision|0|||
143460775|NCT02308020|517232925|FG001|Overall Study|Sponsor Decision|8|||
143460776|NCT02308020|517232926|FG002|Overall Study|Sponsor Decision|0|||
143460777|NCT02308020|517232927|FG003|Overall Study|Sponsor Decision|2|||
143460778|NCT02308020|517232928|FG004|Overall Study|Sponsor Decision|2|||
143460779|NCT02308020|517232929|FG005|Overall Study|Sponsor Decision|1|||
143460780|NCT02308020|517232924|FG000|Overall Study|Withdrawal by Subject|3|||
143460781|NCT02308020|517232925|FG001|Overall Study|Withdrawal by Subject|5|||
143460782|NCT02308020|517232926|FG002|Overall Study|Withdrawal by Subject|3|||
143460783|NCT02308020|517232927|FG003|Overall Study|Withdrawal by Subject|2|||
143460784|NCT02308020|517232928|FG004|Overall Study|Withdrawal by Subject|1|||
143460785|NCT02308020|517232929|FG005|Overall Study|Withdrawal by Subject|2|||
143460786|NCT01270971|517232930|FG000|Overall Study|Withdrawal by Subject|24|||
143460787|NCT01270971|517232931|FG001|Overall Study|Withdrawal by Subject|11|||
143460788|NCT01270971|517232930|FG000|Overall Study|Lost to Follow-up|18|||
143460789|NCT01270971|517232931|FG001|Overall Study|Lost to Follow-up|5|||
143460790|NCT01270971|517232930|FG000|Overall Study|Adverse Event|1|||
143460791|NCT01270971|517232931|FG001|Overall Study|Adverse Event|2|||
143460792|NCT01270971|517232930|FG000|Overall Study|Non compliance|2|||
143460793|NCT01270971|517232931|FG001|Overall Study|Non compliance|2|||
143460794|NCT01270971|517232930|FG000|Overall Study|Non-specific|7|||
143460795|NCT01270971|517232931|FG001|Overall Study|Non-specific|3|||
143460796|NCT01588496|517232932|FG000|Overall Study|Withdrawal by Subject|0|||
143460797|NCT01588496|517232933|FG001|Overall Study|Withdrawal by Subject|1|||
143460798|NCT01588496|517232934|FG002|Overall Study|Withdrawal by Subject|0|||
143460799|NCT01551212|517232935|FG000|Overall Study|Graft loss/Retransplantation|0|||
143460800|NCT01551212|517232936|FG001|Overall Study|Graft loss/Retransplantation|1|||
143460801|NCT01551212|517232935|FG000|Overall Study|Administrative problems|1|||
143460802|NCT01551212|517232936|FG001|Overall Study|Administrative problems|2|||
143460803|NCT01551212|517232935|FG000|Overall Study|Lost to Follow-up|0|||
143460804|NCT01551212|517232936|FG001|Overall Study|Lost to Follow-up|1|||
143460805|NCT01551212|517232935|FG000|Overall Study|Protocol Violation|0|||
143460806|NCT01551212|517232936|FG001|Overall Study|Protocol Violation|1|||
143460807|NCT01551212|517232935|FG000|Overall Study|Withdrawal by Subject|0|||
143460808|NCT01551212|517232936|FG001|Overall Study|Withdrawal by Subject|7|||
143460809|NCT01551212|517232935|FG000|Overall Study|Death|2|||
143460810|NCT01551212|517232936|FG001|Overall Study|Death|4|||
143460811|NCT01551212|517232935|FG000|Overall Study|Never Received Study Treatment|2|||
143460812|NCT01551212|517232936|FG001|Overall Study|Never Received Study Treatment|4|||
143460813|NCT05924945|517232937|FG000|Overall Study|Withdrawal by Subject|3|||
143460814|NCT05924945|517232938|FG001|Overall Study|Withdrawal by Subject|4|||
143460815|NCT04217590|517232939|FG000|Overall Study|Other|1|||
143460816|NCT04217590|517232940|FG001|Overall Study|Other|1|||
143460817|NCT04217590|517232939|FG000|Overall Study|Withdrawal by Subject|3|||
143460818|NCT04217590|517232940|FG001|Overall Study|Withdrawal by Subject|1|||
143460819|NCT04217590|517232939|FG000|Overall Study|Death|0|||
143460820|NCT04217590|517232940|FG001|Overall Study|Death|1|||
143460821|NCT02003573|517232944|FG000|Overall Study|Progressive disease|2|||
143460822|NCT02003573|517232945|FG001|Overall Study|Progressive disease|0|||
143460823|NCT02003573|517232946|FG002|Overall Study|Progressive disease|1|||
143460824|NCT02003573|517232944|FG000|Overall Study|Other Adverse event|0|||
143460825|NCT02003573|517232945|FG001|Overall Study|Other Adverse event|1|||
143460826|NCT02003573|517232946|FG002|Overall Study|Other Adverse event|1|||
143460827|NCT02003573|517232944|FG000|Overall Study|Refuse to take trial medication|0|||
143460828|NCT02003573|517232945|FG001|Overall Study|Refuse to take trial medication|1|||
143460829|NCT02003573|517232946|FG002|Overall Study|Refuse to take trial medication|1|||
143460830|NCT02003573|517232944|FG000|Overall Study|Other than specified|1|||
143460831|NCT02003573|517232945|FG001|Overall Study|Other than specified|2|||
143460832|NCT02003573|517232946|FG002|Overall Study|Other than specified|3|||
143460833|NCT05026710|517232949|FG000|Overall Study|No longer met eligibility criteria|3|||
143460834|NCT05026710|517232950|FG001|Overall Study|No longer met eligibility criteria|1|||
143460835|NCT00704405|517232951|FG000|Overall Study (NC Population)|Adverse Event|1|||
143460836|NCT00704405|517232952|FG001|Overall Study (NC Population)|Adverse Event|0|||
143460837|NCT00704405|517232953|FG002|Overall Study (NC Population)|Adverse Event|0|||
143460838|NCT00704405|517232954|FG003|Overall Study (NC Population)|Adverse Event|0|||
143460839|NCT00704405|517232955|FG004|Overall Study (NC Population)|Adverse Event|0|||
143460840|NCT00704405|517232951|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
143460841|NCT00704405|517232952|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
143460842|NCT00704405|517232953|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
143460843|NCT00704405|517232954|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
143460844|NCT00704405|517232955|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
143460845|NCT00704405|517232951|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
143460846|NCT00704405|517232952|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
143460847|NCT00704405|517232953|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
143460848|NCT00704405|517232954|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
143460849|NCT00704405|517232955|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
143460850|NCT00704405|517232951|FG000|Overall Study (NC Population)|Other|0|||
143460851|NCT00704405|517232952|FG001|Overall Study (NC Population)|Other|0|||
143460852|NCT00704405|517232953|FG002|Overall Study (NC Population)|Other|0|||
143460853|NCT00704405|517232954|FG003|Overall Study (NC Population)|Other|0|||
143123497|NCT02757352|515997789|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
143123498|NCT02757352|515997790|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
143123499|NCT02757352|515997791|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
143123500|NCT02757352|515997792|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
143460854|NCT00704405|517232955|FG004|Overall Study (NC Population)|Other|1|||
143460855|NCT00704405|517232951|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
143460856|NCT00704405|517232952|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
143460857|NCT00704405|517232953|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
143460858|NCT00704405|517232954|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
143460859|NCT00704405|517232955|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
143460860|NCT00704405|517232951|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
143460861|NCT00704405|517232952|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
143460862|NCT00704405|517232953|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
143460863|NCT00704405|517232954|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
143460864|NCT00704405|517232955|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
143460865|NCT01395888|517232956|FG000|2-week Run-in Period|Adverse Event|2|||
143460866|NCT01395888|517232957|FG001|2-week Run-in Period|Adverse Event|0|||
143460867|NCT01395888|517232958|FG002|2-week Run-in Period|Adverse Event|0|||
143460868|NCT01395888|517232956|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
143460869|NCT01395888|517232957|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
143460870|NCT01395888|517232958|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
143460871|NCT01395888|517232956|FG000|2-week Run-in Period|Lost to Follow-up|1|||
143460872|NCT01395888|517232957|FG001|2-week Run-in Period|Lost to Follow-up|0|||
143460873|NCT01395888|517232958|FG002|2-week Run-in Period|Lost to Follow-up|0|||
143460874|NCT01395888|517232956|FG000|2-week Run-in Period|Protocol Violation|2|||
143460875|NCT01395888|517232957|FG001|2-week Run-in Period|Protocol Violation|0|||
143460876|NCT01395888|517232958|FG002|2-week Run-in Period|Protocol Violation|0|||
143460877|NCT01395888|517232956|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
143460878|NCT01395888|517232957|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
143460879|NCT01395888|517232958|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
143460880|NCT01395888|517232956|FG000|Treatment Period (TP)|Adverse Event|0|||
143460881|NCT01395888|517232957|FG001|Treatment Period (TP)|Adverse Event|7|||
143460882|NCT01395888|517232958|FG002|Treatment Period (TP)|Adverse Event|6|||
143460883|NCT01395888|517232956|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
143460884|NCT01395888|517232957|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
143460885|NCT01395888|517232958|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
143460886|NCT01395888|517232956|FG000|Treatment Period (TP)|Protocol Violation|0|||
143460887|NCT01395888|517232957|FG001|Treatment Period (TP)|Protocol Violation|1|||
143460888|NCT01395888|517232958|FG002|Treatment Period (TP)|Protocol Violation|5|||
143460889|NCT01395888|517232956|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
143460890|NCT01395888|517232957|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
143460891|NCT01395888|517232958|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
143460892|NCT01395888|517232956|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
143460893|NCT01395888|517232957|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
143460894|NCT01395888|517232958|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
143460895|NCT00903682|517232959|FG000|Overall Study|Adverse Event|6|||
143460896|NCT00903682|517232960|FG001|Overall Study|Adverse Event|13|||
143460897|NCT00903682|517232959|FG000|Overall Study|Lost to Follow-up|1|||
143460898|NCT00903682|517232960|FG001|Overall Study|Lost to Follow-up|0|||
143460899|NCT00903682|517232959|FG000|Overall Study|Withdrawal by Subject|5|||
143460900|NCT00903682|517232960|FG001|Overall Study|Withdrawal by Subject|0|||
143460901|NCT00903682|517232959|FG000|Overall Study|Pregnancy|0|||
143460902|NCT00903682|517232960|FG001|Overall Study|Pregnancy|1|||
143460903|NCT00903682|517232959|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
143460904|NCT00903682|517232960|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
143460905|NCT00903682|517232959|FG000|Overall Study|Subject Non-Compliant|1|||
143460906|NCT00903682|517232960|FG001|Overall Study|Subject Non-Compliant|0|||
143460907|NCT00903682|517232959|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
143460908|NCT00903682|517232960|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
143460909|NCT00903682|517232959|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
143460910|NCT00903682|517232960|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
143460911|NCT03169101|517232961|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
143460912|NCT03169101|517232962|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
143460913|NCT03169101|517232963|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
143460914|NCT03169101|517232964|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
143123501|NCT02757352|515997783|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
143460915|NCT00600886|517232965|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
143460916|NCT00600886|517232966|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
143460917|NCT00600886|517232965|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
143460918|NCT00600886|517232966|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
143460919|NCT00600886|517232965|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
143460920|NCT00600886|517232966|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
143460921|NCT00600886|517232965|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
143460922|NCT00600886|517232966|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
143123502|NCT02757352|515997784|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
143123503|NCT02757352|515997785|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
143123504|NCT02757352|515997786|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
143123505|NCT02757352|515997787|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
143123506|NCT02757352|515997788|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
143123507|NCT02757352|515997789|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
143123508|NCT02757352|515997790|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
143123509|NCT02757352|515997791|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
143006585|NCT01283009|515563018|FG000|Overall Study|Lost to Follow-up|1|||
143006586|NCT01283009|515563019|FG001|Overall Study|Lost to Follow-up|0|||
143006587|NCT01283009|515563018|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
143006588|NCT01283009|515563019|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
143006589|NCT00505765|515563026|FG000|Overall Study|Withdrawal by Subject|1|||
143006590|NCT00505765|515563027|FG001|Overall Study|Withdrawal by Subject|0|||
143123510|NCT02757352|515997792|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
143346319|NCT03315130|516812707|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
143346320|NCT03315130|516812708|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
143346321|NCT03315130|516812709|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
143346322|NCT03315130|516812706|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
143346323|NCT03315130|516812707|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
143346324|NCT03315130|516812708|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
143346325|NCT03315130|516812709|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
143346326|NCT03315130|516812706|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
143346327|NCT03315130|516812707|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
143346328|NCT03315130|516812708|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
143346329|NCT03315130|516812709|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
143346330|NCT03315130|516812706|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
143346331|NCT03315130|516812707|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
143346332|NCT03315130|516812708|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
143346333|NCT03315130|516812709|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
143346334|NCT04398537|516812710|FG000|Overall Study|Physician Decision|10|||
143346335|NCT04398537|516812711|FG001|Overall Study|Physician Decision|15|||
143346336|NCT02089230|516812712|FG000|Overall Study|Death|0|||
143346337|NCT02089230|516812713|FG001|Overall Study|Death|0|||
143346338|NCT02089230|516812714|FG002|Overall Study|Death|2|||
143346339|NCT02089230|516812712|FG000|Overall Study|Seeking Alternative Therapy|0|||
143346340|NCT02089230|516812713|FG001|Overall Study|Seeking Alternative Therapy|0|||
143346341|NCT02089230|516812714|FG002|Overall Study|Seeking Alternative Therapy|4|||
143346342|NCT02764775|516814278|FG000|Overall Study|Death|1|||
143346343|NCT02764775|516814278|FG000|Overall Study|Lost to Follow-up|2|||
143346344|NCT02764775|516814278|FG000|Overall Study|Withdrawal by Subject|3|||
143346345|NCT01992549|516814290|FG000|Overall Study|Lost to Follow-up|2|||
143346346|NCT01992549|516814290|FG000|Overall Study|Serious Adverse Event|1|||
143346347|NCT01992549|516814290|FG000|Overall Study|Product Switch to Extend Half Life|1|||
143346348|NCT01900054|516814293|FG000|Overall Study|Physician Decision|1|||
143346349|NCT01900054|516814293|FG000|Overall Study|Withdrawal by Subject|1|||
143346350|NCT01186328|516814294|FG000|Overall Study|Death|1|||
143346351|NCT01186328|516814295|FG001|Overall Study|Death|0|||
143346352|NCT01186328|516814296|FG002|Overall Study|Death|0|||
143346353|NCT03015116|516814299|FG000|Overall Study|Lost to Follow-up|3|||
143346354|NCT03015116|516814300|FG001|Overall Study|Lost to Follow-up|0|||
143346355|NCT03015116|516814301|FG002|Overall Study|Lost to Follow-up|2|||
143346356|NCT03015116|516814299|FG000|Overall Study|Withdrawal by Subject|3|||
143346357|NCT03015116|516814300|FG001|Overall Study|Withdrawal by Subject|1|||
143346358|NCT03015116|516814301|FG002|Overall Study|Withdrawal by Subject|0|||
143346359|NCT03015116|516814299|FG000|Overall Study|Subject has New Medical Status|1|||
143346360|NCT03015116|516814300|FG001|Overall Study|Subject has New Medical Status|0|||
143346361|NCT03015116|516814301|FG002|Overall Study|Subject has New Medical Status|0|||
143346362|NCT03015116|516814299|FG000|Overall Study|Physician Decision|0|||
143346363|NCT03015116|516814300|FG001|Overall Study|Physician Decision|1|||
143346364|NCT03015116|516814301|FG002|Overall Study|Physician Decision|0|||
143346365|NCT00674323|516814305|FG000|Overall Study|Adverse Event|0|||
143346366|NCT00674323|516814306|FG001|Overall Study|Adverse Event|1|||
143346367|NCT00674323|516814307|FG002|Overall Study|Adverse Event|0|||
143346368|NCT00674323|516814305|FG000|Overall Study|Protocol Violation|1|||
143346369|NCT00674323|516814306|FG001|Overall Study|Protocol Violation|0|||
143346370|NCT00674323|516814307|FG002|Overall Study|Protocol Violation|0|||
143346371|NCT03585296|516814308|FG000|Overall Study|Adverse Event|1|||
143346372|NCT03585296|516814308|FG000|Overall Study|Lost to Follow-up|2|||
143346373|NCT03585296|516814308|FG000|Overall Study|Withdrawal by Subject|2|||
143346374|NCT00462670|516814311|FG000|Overall Study|Adverse Event|3|||
143346375|NCT00462670|516814312|FG001|Overall Study|Adverse Event|5|||
143346376|NCT00462670|516814311|FG000|Overall Study|Lack of Efficacy|1|||
143346377|NCT00462670|516814312|FG001|Overall Study|Lack of Efficacy|0|||
143346378|NCT00462670|516814311|FG000|Overall Study|Protocol Violation|1|||
143346379|NCT00462670|516814312|FG001|Overall Study|Protocol Violation|0|||
143346380|NCT00462670|516814311|FG000|Overall Study|Resolution of signs and symptoms|0|||
143346381|NCT00462670|516814312|FG001|Overall Study|Resolution of signs and symptoms|2|||
143346382|NCT02966002|516814313|FG000|Overall Study|Withdrawal by Subject|2|||
143346383|NCT02966002|516814313|FG000|Overall Study|Adverse Event|1|||
143346384|NCT02966002|516814313|FG000|Overall Study|Lost to Follow-up|1|||
143346385|NCT02291432|516814314|FG000|Overall Study|Withdrawal by Subject|2|||
143346386|NCT00584805|516814315|FG000|Overall Study|No longer at risk of exposure|39|||
143460923|NCT00600886|517232965|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
143460924|NCT00600886|517232966|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
143460925|NCT00600886|517232965|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
143460926|NCT00600886|517232966|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
143460927|NCT00600886|517232965|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
143460928|NCT00600886|517232966|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
143460929|NCT00600886|517232965|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
143460930|NCT00600886|517232966|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
143460931|NCT00600886|517232965|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
143460932|NCT00600886|517232966|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
143460933|NCT00600886|517232965|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
143460934|NCT00600886|517232966|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
143460935|NCT00600886|517232965|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
143460936|NCT00600886|517232966|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
143460937|NCT00600886|517232965|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
143460938|NCT00600886|517232966|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
143460939|NCT00600886|517232965|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
143460940|NCT00600886|517232966|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
143460941|NCT00600886|517232965|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
143460942|NCT00600886|517232966|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
143460943|NCT00600886|517232965|FG000|Extension - Same Treatment (FAS)|Death|1|||
143460944|NCT00600886|517232966|FG001|Extension - Same Treatment (FAS)|Death|1|||
143460945|NCT00600886|517232965|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
143460946|NCT00600886|517232966|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
143460947|NCT00600886|517232965|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
143460948|NCT00600886|517232966|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
143460949|NCT00600886|517232965|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
143460950|NCT00600886|517232966|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
143460951|NCT00600886|517232965|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
143460952|NCT00600886|517232966|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
143460953|NCT00600886|517232965|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
143460954|NCT00600886|517232966|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
143460955|NCT00600886|517232965|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
143460956|NCT00600886|517232966|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
143460957|NCT00600886|517232965|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
143460958|NCT00600886|517232966|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
143460959|NCT00600886|517232965|FG000|Extension - After Crossover (CAS)|Death|1|||
143460960|NCT00600886|517232966|FG001|Extension - After Crossover (CAS)|Death|0|||
143460961|NCT02053792|517232967|FG000|Overall Study|Physician Decision|0|||
143006591|NCT00505765|515563028|FG002|Overall Study|Withdrawal by Subject|0|||
143006592|NCT00505765|515563026|FG000|Overall Study|Adverse Event|1|||
143006593|NCT00505765|515563027|FG001|Overall Study|Adverse Event|2|||
143006594|NCT00505765|515563028|FG002|Overall Study|Adverse Event|0|||
143006595|NCT00505765|515563026|FG000|Overall Study|Noncompliance|0|||
143006596|NCT00505765|515563027|FG001|Overall Study|Noncompliance|1|||
143460962|NCT02053792|517232968|FG001|Overall Study|Physician Decision|1|||
143460963|NCT02053792|517232967|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
143460964|NCT02053792|517232968|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
143460965|NCT02053792|517232967|FG000|Overall Study|Lack of Efficacy|1|||
143460966|NCT02053792|517232968|FG001|Overall Study|Lack of Efficacy|0|||
143460967|NCT02053792|517232967|FG000|Overall Study|Adverse Event|1|||
143460968|NCT02053792|517232968|FG001|Overall Study|Adverse Event|0|||
143460969|NCT02053792|517232967|FG000|Overall Study|Withdrawal by Subject|2|||
143460970|NCT02053792|517232968|FG001|Overall Study|Withdrawal by Subject|2|||
143460971|NCT02053792|517232967|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
143460972|NCT02053792|517232968|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
143460973|NCT02053792|517232967|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
143460974|NCT02053792|517232968|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
143460975|NCT04428151|517232969|FG000|Overall Study|Death|100|||
143460976|NCT04428151|517232970|FG001|Overall Study|Death|86|||
143460977|NCT04428151|517232971|FG002|Overall Study|Death|57|||
143460978|NCT04428151|517232969|FG000|Overall Study|Lost to Follow-up|1|||
143460979|NCT04428151|517232970|FG001|Overall Study|Lost to Follow-up|1|||
143460980|NCT04428151|517232971|FG002|Overall Study|Lost to Follow-up|0|||
143460981|NCT04428151|517232969|FG000|Overall Study|Withdrawal by Subject|2|||
143460982|NCT04428151|517232970|FG001|Overall Study|Withdrawal by Subject|2|||
143006597|NCT00505765|515563028|FG002|Overall Study|Noncompliance|3|||
143006598|NCT02743117|515563029|FG000|Overall Study|Lost to Follow-up|0|||
143006599|NCT02743117|515563030|FG001|Overall Study|Lost to Follow-up|1|||
143123511|NCT02757352|515997783|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
143460983|NCT04428151|517232971|FG002|Overall Study|Withdrawal by Subject|3|||
143460984|NCT04428151|517232969|FG000|Overall Study|Participant Ongoing in Study|41|||
143460985|NCT04428151|517232970|FG001|Overall Study|Participant Ongoing in Study|53|||
143460986|NCT04428151|517232971|FG002|Overall Study|Participant Ongoing in Study|28|||
143460987|NCT04134845|517232975|FG000|Overall Study|withdrawl by PI|12|||
143460988|NCT04134845|517232976|FG001|Overall Study|withdrawl by PI|5|||
143460989|NCT03110224|517232977|FG000|Overall Study|Death|3|||
143460990|NCT03110224|517232977|FG000|Overall Study|Lost to Follow-up|132|||
143460991|NCT03110224|517232977|FG000|Overall Study|Physician Decision|2|||
143460992|NCT03110224|517232977|FG000|Overall Study|Site Closed by Physician|35|||
143460993|NCT03110224|517232977|FG000|Overall Study|Site Closed by Sponsor|202|||
143460994|NCT03110224|517232977|FG000|Overall Study|Withdrawal by Subject|9|||
143460995|NCT05328167|517232978|FG000|Overall Study|Treatment cancelled prior to radioembolization|1|||
143460996|NCT05328167|517232978|FG000|Overall Study|imaging not obtained for primary outcome assessment|1|||
143460997|NCT00112047|517232979|FG000|Randomized Phase|Lost to Follow-up|26|||
143460998|NCT00112047|517232980|FG001|Randomized Phase|Lost to Follow-up|33|||
143460999|NCT00112047|517232979|FG000|Randomized Phase|Adverse Event|10|||
143461000|NCT00112047|517232980|FG001|Randomized Phase|Adverse Event|10|||
143461001|NCT00112047|517232979|FG000|Randomized Phase|Withrawal of consent|10|||
143461002|NCT00112047|517232980|FG001|Randomized Phase|Withrawal of consent|18|||
143461003|NCT00112047|517232979|FG000|Randomized Phase|Sub-optimal virological response|3|||
143461004|NCT00112047|517232980|FG001|Randomized Phase|Sub-optimal virological response|13|||
143461005|NCT00112047|517232979|FG000|Randomized Phase|Noncompliance|8|||
143461006|NCT00112047|517232980|FG001|Randomized Phase|Noncompliance|4|||
143461007|NCT00112047|517232979|FG000|Randomized Phase|Protocol Violation|2|||
143461008|NCT00112047|517232980|FG001|Randomized Phase|Protocol Violation|0|||
143461009|NCT00112047|517232979|FG000|Randomized Phase|Pregnancy|3|||
143461010|NCT00112047|517232980|FG001|Randomized Phase|Pregnancy|1|||
143461011|NCT00112047|517232979|FG000|Randomized Phase|Death|1|||
143461012|NCT00112047|517232980|FG001|Randomized Phase|Death|3|||
143461013|NCT00112047|517232979|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
143461014|NCT00112047|517232980|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
143461015|NCT00112047|517232979|FG000|Randomized Phase|Inability to swallow pills|0|||
143461016|NCT00112047|517232980|FG001|Randomized Phase|Inability to swallow pills|1|||
143461017|NCT00112047|517232979|FG000|Randomized Phase|Incarceration|3|||
143461018|NCT00112047|517232980|FG001|Randomized Phase|Incarceration|2|||
143461019|NCT00112047|517232979|FG000|Randomized Phase|Moved out of State|0|||
143461020|NCT00112047|517232980|FG001|Randomized Phase|Moved out of State|1|||
143461021|NCT00112047|517232979|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
143461022|NCT00112047|517232980|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
143461023|NCT00112047|517232979|FG000|Randomized Phase|High Hepatitis B DNA|0|||
143461024|NCT00112047|517232980|FG001|Randomized Phase|High Hepatitis B DNA|1|||
143461025|NCT00112047|517232979|FG000|Atripla Phase|Adverse Event|2|||
143461026|NCT00112047|517232980|FG001|Atripla Phase|Adverse Event|1|||
143461027|NCT00112047|517232979|FG000|Atripla Phase|Lost to Follow-up|5|||
143461028|NCT00112047|517232980|FG001|Atripla Phase|Lost to Follow-up|7|||
143461029|NCT00112047|517232979|FG000|Atripla Phase|Pregnancy|0|||
143461030|NCT00112047|517232980|FG001|Atripla Phase|Pregnancy|1|||
143461031|NCT00112047|517232979|FG000|Atripla Phase|Death|0|||
143461032|NCT00112047|517232980|FG001|Atripla Phase|Death|2|||
143461033|NCT00112047|517232979|FG000|Atripla Phase|Withdrew consent|7|||
143461034|NCT00112047|517232980|FG001|Atripla Phase|Withdrew consent|7|||
143461035|NCT00112047|517232979|FG000|Atripla Phase|Sub-optimal virological response|0|||
143461036|NCT00112047|517232980|FG001|Atripla Phase|Sub-optimal virological response|1|||
143461037|NCT00112047|517232979|FG000|Atripla Phase|Non-compliance|1|||
143461038|NCT00112047|517232980|FG001|Atripla Phase|Non-compliance|0|||
143123512|NCT02757352|515997784|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
143123513|NCT02757352|515997785|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
143461039|NCT00112047|517232979|FG000|Atripla Phase|Other|3|||
143123514|NCT02757352|515997786|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
143123515|NCT02757352|515997787|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
143461040|NCT00112047|517232980|FG001|Atripla Phase|Other|1|||
143461041|NCT01307579|517232981|FG000|Overall Study|Death|3|||
143461042|NCT01307579|517232982|FG001|Overall Study|Death|6|||
143461043|NCT01307579|517232981|FG000|Overall Study|Physician Decision|26|||
143461044|NCT01307579|517232982|FG001|Overall Study|Physician Decision|29|||
143461045|NCT01307579|517232981|FG000|Overall Study|Withdrawal by Subject|7|||
143461046|NCT01307579|517232982|FG001|Overall Study|Withdrawal by Subject|3|||
143461047|NCT01307579|517232981|FG000|Overall Study|Institutional diagnosis of IFD|21|||
143461048|NCT01307579|517232982|FG001|Overall Study|Institutional diagnosis of IFD|36|||
143461049|NCT01307579|517232981|FG000|Overall Study|Begin conditioning for HSCT|42|||
143461050|NCT01307579|517232982|FG001|Overall Study|Begin conditioning for HSCT|44|||
143461051|NCT01307579|517232981|FG000|Overall Study|Refractory or relapsed AML|38|||
143461052|NCT01307579|517232982|FG001|Overall Study|Refractory or relapsed AML|23|||
143461053|NCT01307579|517232981|FG000|Overall Study|Ineligible|3|||
143461054|NCT01307579|517232982|FG001|Overall Study|Ineligible|4|||
143461055|NCT03727438|517232983|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
143461056|NCT03727438|517232984|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
143461057|NCT03727438|517232983|FG000|Intervention Period|Excluded (health)|1|||
143461058|NCT03727438|517232984|FG001|Intervention Period|Excluded (health)|0|||
143461059|NCT03727438|517232983|FG000|Intervention Period|Withdrawal by Subject|3|||
143461060|NCT03727438|517232984|FG001|Intervention Period|Withdrawal by Subject|1|||
143461061|NCT03727438|517232983|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
143461062|NCT03727438|517232984|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
143461063|NCT03727438|517232983|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
143461064|NCT03727438|517232984|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
143461065|NCT03727438|517232983|FG000|8 Week Assessment|Withdrawal by Subject|6|||
143461066|NCT03727438|517232984|FG001|8 Week Assessment|Withdrawal by Subject|1|||
143461067|NCT03727438|517232983|FG000|6 mo Assessment|did not complete assessment|10|||
143461068|NCT03727438|517232984|FG001|6 mo Assessment|did not complete assessment|11|||
143461069|NCT06729606|517232985|FG000|Overall Study|Adverse Event|0|||
143461070|NCT06729606|517232986|FG001|Overall Study|Adverse Event|2|||
143461071|NCT06729606|517232985|FG000|Overall Study|Death|1|||
143461072|NCT06729606|517232986|FG001|Overall Study|Death|0|||
143461073|NCT06729606|517232985|FG000|Overall Study|Physician Decision|0|||
143461074|NCT06729606|517232986|FG001|Overall Study|Physician Decision|1|||
143461075|NCT06729606|517232985|FG000|Overall Study|Withdrawal by Subject|2|||
143461076|NCT06729606|517232986|FG001|Overall Study|Withdrawal by Subject|4|||
143006600|NCT02743117|515563029|FG000|Overall Study|Other|1|||
143006601|NCT02743117|515563030|FG001|Overall Study|Other|0|||
143006602|NCT01453296|515563032|FG000|Treatment Period 1|Adverse Event|0|||
143006603|NCT01453296|515563033|FG001|Treatment Period 1|Adverse Event|1|||
143006604|NCT01453296|515563032|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
143006605|NCT01453296|515563033|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
143006606|NCT01453296|515563032|FG000|Treatment Period 2|Adverse Event|1|||
143006607|NCT01453296|515563033|FG001|Treatment Period 2|Adverse Event|0|||
143006608|NCT01453296|515563032|FG000|Treatment Period 2|Withdrawal by Subject|1|||
143006609|NCT01453296|515563033|FG001|Treatment Period 2|Withdrawal by Subject|0|||
143006610|NCT01068418|515563040|FG000|Overall Study|Physician Decision|12|||
143006611|NCT00455923|515563047|FG000|Overall Study|Pregnancy|0|||
143006612|NCT00455923|515563048|FG001|Overall Study|Pregnancy|2|||
143006613|NCT00455923|515563047|FG000|Overall Study|Other|3|||
143006614|NCT00455923|515563048|FG001|Overall Study|Other|1|||
143006615|NCT02686749|515563050|FG000|Overall Study|terminated for poor enrollment|2|||
143006616|NCT02686749|515563051|FG001|Overall Study|terminated for poor enrollment|2|||
143006617|NCT00480077|515563056|FG000|Overall Study|Death|19|||
143006618|NCT00480077|515563057|FG001|Overall Study|Death|15|||
143006619|NCT00480077|515563056|FG000|Overall Study|early exit|12|||
143006620|NCT00480077|515563057|FG001|Overall Study|early exit|11|||
143006621|NCT03707145|515563058|FG000|Overall Study|Lost to Follow-up|0|||
143006622|NCT03707145|515563059|FG001|Overall Study|Lost to Follow-up|1|||
143006623|NCT03707145|515563060|FG002|Overall Study|Lost to Follow-up|1|||
143006624|NCT03707145|515563061|FG003|Overall Study|Lost to Follow-up|0|||
143006625|NCT00071006|515563068|FG000|Overall Study|Lack of Efficacy|7|||
143006626|NCT00071006|515563068|FG000|Overall Study|Adverse Event|1|||
143006627|NCT00071006|515563068|FG000|Overall Study|Withdrawal by Subject|1|||
143006628|NCT00071006|515563068|FG000|Overall Study|Other|3|||
143006629|NCT05261126|515563073|FG000|Overall Study|Death|0|||
143006630|NCT05261126|515563074|FG001|Overall Study|Death|0|||
143006631|NCT05261126|515563075|FG002|Overall Study|Death|1|||
143006632|NCT05261126|515563076|FG003|Overall Study|Death|0|||
143006633|NCT05261126|515563077|FG004|Overall Study|Death|0|||
143006634|NCT05261126|515563073|FG000|Overall Study|Lost to Follow-up|0|||
143006635|NCT05261126|515563074|FG001|Overall Study|Lost to Follow-up|0|||
143006636|NCT05261126|515563075|FG002|Overall Study|Lost to Follow-up|0|||
143006637|NCT05261126|515563076|FG003|Overall Study|Lost to Follow-up|0|||
143006638|NCT05261126|515563077|FG004|Overall Study|Lost to Follow-up|1|||
143123516|NCT02757352|515997788|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
143123517|NCT02757352|515997789|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
143123518|NCT02757352|515997790|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
143461077|NCT03570892|517232987|FG000|Overall Study|Death|51|||
143461078|NCT03570892|517232988|FG001|Overall Study|Death|45|||
143461079|NCT03570892|517232987|FG000|Overall Study|Subject decision|5|||
143461080|NCT03570892|517232988|FG001|Overall Study|Subject decision|3|||
143461081|NCT03570892|517232987|FG000|Overall Study|Protocol Violation|1|||
143006639|NCT05261126|515563073|FG000|Overall Study|Physician Decision|1|||
143006640|NCT05261126|515563074|FG001|Overall Study|Physician Decision|0|||
143006641|NCT05261126|515563075|FG002|Overall Study|Physician Decision|0|||
143006642|NCT05261126|515563076|FG003|Overall Study|Physician Decision|0|||
143006643|NCT05261126|515563077|FG004|Overall Study|Physician Decision|0|||
143006644|NCT05261126|515563073|FG000|Overall Study|Screen Failure|0|||
143006645|NCT05261126|515563074|FG001|Overall Study|Screen Failure|0|||
143006646|NCT05261126|515563075|FG002|Overall Study|Screen Failure|0|||
143006647|NCT05261126|515563076|FG003|Overall Study|Screen Failure|0|||
143006648|NCT05261126|515563077|FG004|Overall Study|Screen Failure|1|||
143006649|NCT05261126|515563073|FG000|Overall Study|Withdrawal by Subject|1|||
143006650|NCT05261126|515563074|FG001|Overall Study|Withdrawal by Subject|0|||
143006651|NCT05261126|515563075|FG002|Overall Study|Withdrawal by Subject|1|||
143006652|NCT05261126|515563076|FG003|Overall Study|Withdrawal by Subject|1|||
143006653|NCT05261126|515563077|FG004|Overall Study|Withdrawal by Subject|0|||
143006654|NCT05261126|515563073|FG000|Overall Study|Not Recorded|0|||
143006655|NCT05261126|515563074|FG001|Overall Study|Not Recorded|0|||
143006656|NCT05261126|515563075|FG002|Overall Study|Not Recorded|0|||
143006657|NCT05261126|515563076|FG003|Overall Study|Not Recorded|1|||
143006658|NCT05261126|515563077|FG004|Overall Study|Not Recorded|0|||
143006659|NCT00938366|515563080|FG000|Overall Study|Withdrawal by Subject|1|||
143006660|NCT00938366|515563081|FG001|Overall Study|Withdrawal by Subject|0|||
143006661|NCT01003691|515563084|FG000|Overall Study|Adverse Event|0|||
143006662|NCT01003691|515563085|FG001|Overall Study|Adverse Event|0|||
143006663|NCT01003691|515563086|FG002|Overall Study|Adverse Event|0|||
143006664|NCT01003691|515563087|FG003|Overall Study|Adverse Event|1|||
143006665|NCT02207413|515563092|FG000|Overall Study|Withdrawal by Subject|1|||
143006666|NCT02207413|515563093|FG001|Overall Study|Withdrawal by Subject|0|||
143006667|NCT02207413|515563094|FG002|Overall Study|Withdrawal by Subject|0|||
143006668|NCT02207413|515563095|FG003|Overall Study|Withdrawal by Subject|0|||
143006669|NCT02207413|515563096|FG004|Overall Study|Withdrawal by Subject|3|||
143006670|NCT02207413|515563097|FG005|Overall Study|Withdrawal by Subject|7|||
143006671|NCT02207413|515563092|FG000|Overall Study|Lost to Follow-up|0|||
143006672|NCT02207413|515563093|FG001|Overall Study|Lost to Follow-up|0|||
143006673|NCT02207413|515563094|FG002|Overall Study|Lost to Follow-up|0|||
143006674|NCT02207413|515563095|FG003|Overall Study|Lost to Follow-up|1|||
143006675|NCT02207413|515563096|FG004|Overall Study|Lost to Follow-up|1|||
143006676|NCT02207413|515563097|FG005|Overall Study|Lost to Follow-up|5|||
143006677|NCT02207413|515563092|FG000|Overall Study|Adverse Event|0|||
143006678|NCT02207413|515563093|FG001|Overall Study|Adverse Event|0|||
143006679|NCT02207413|515563094|FG002|Overall Study|Adverse Event|0|||
143006680|NCT02207413|515563095|FG003|Overall Study|Adverse Event|0|||
143006681|NCT02207413|515563096|FG004|Overall Study|Adverse Event|2|||
143006682|NCT02207413|515563097|FG005|Overall Study|Adverse Event|1|||
143006683|NCT02207413|515563092|FG000|Overall Study|Migrated/moved from study area|0|||
143006684|NCT02207413|515563093|FG001|Overall Study|Migrated/moved from study area|0|||
143006685|NCT02207413|515563094|FG002|Overall Study|Migrated/moved from study area|0|||
143006686|NCT02207413|515563095|FG003|Overall Study|Migrated/moved from study area|0|||
143006687|NCT02207413|515563096|FG004|Overall Study|Migrated/moved from study area|1|||
143006688|NCT02207413|515563097|FG005|Overall Study|Migrated/moved from study area|0|||
143006689|NCT03839693|515564211|FG000|Overall Study|Lost to Follow-up|0|||
143006690|NCT03839693|515564212|FG001|Overall Study|Lost to Follow-up|2|||
143006691|NCT03839693|515564213|FG002|Overall Study|Lost to Follow-up|2|||
143006692|NCT03839693|515564211|FG000|Overall Study|Withdrawal by Subject|1|||
143006693|NCT03839693|515564212|FG001|Overall Study|Withdrawal by Subject|0|||
143006694|NCT03839693|515564213|FG002|Overall Study|Withdrawal by Subject|2|||
143006695|NCT03839693|515564211|FG000|Overall Study|subject moved out of the area|1|||
143006696|NCT03839693|515564212|FG001|Overall Study|subject moved out of the area|0|||
143123519|NCT02757352|515997791|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
143123520|NCT02757352|515997792|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
143123521|NCT02757352|515997783|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
143123522|NCT02757352|515997784|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
143123523|NCT02757352|515997785|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
143123524|NCT02757352|515997786|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
143123525|NCT02757352|515997787|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
143123526|NCT02757352|515997788|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
143123527|NCT02757352|515997789|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
143123528|NCT02757352|515997790|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
143006697|NCT03839693|515564213|FG002|Overall Study|subject moved out of the area|0|||
143006698|NCT00700115|515564214|FG000|Overall Study|Withdrawal by Subject|1|||
143006699|NCT00700115|515564215|FG001|Overall Study|Withdrawal by Subject|0|||
143006700|NCT00700115|515564214|FG000|Overall Study|Lost to Follow-up|0|||
143006701|NCT00700115|515564215|FG001|Overall Study|Lost to Follow-up|1|||
143006702|NCT02503215|515564216|FG000|Overall Study|Unable to wear compression stockings|1|||
143006703|NCT02503215|515564216|FG000|Overall Study|Unable to use positive airway pressure|2|||
143006704|NCT02983305|515564217|FG000|Overall Study|incomplete data|2|||
143123529|NCT02757352|515997791|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
143123530|NCT02757352|515997792|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
143346387|NCT00584805|516814315|FG000|Overall Study|Relocation|36|||
143006705|NCT02983305|515564218|FG001|Overall Study|incomplete data|0|||
143006706|NCT00706901|515564219|FG000|Overall Study|Lost to Follow-up|2|||
143006707|NCT00706901|515564220|FG001|Overall Study|Lost to Follow-up|3|||
143006708|NCT00706901|515564221|FG002|Overall Study|Lost to Follow-up|2|||
143006709|NCT00706901|515564219|FG000|Overall Study|Withdrawal by Subject|4|||
143006710|NCT00706901|515564220|FG001|Overall Study|Withdrawal by Subject|2|||
143006711|NCT00706901|515564221|FG002|Overall Study|Withdrawal by Subject|5|||
143006712|NCT00706901|515564219|FG000|Overall Study|In Jail|1|||
143006713|NCT00706901|515564220|FG001|Overall Study|In Jail|0|||
143006714|NCT00706901|515564221|FG002|Overall Study|In Jail|1|||
143006715|NCT00706901|515564219|FG000|Overall Study|Death|1|||
143006716|NCT00706901|515564220|FG001|Overall Study|Death|0|||
143006717|NCT00706901|515564221|FG002|Overall Study|Death|0|||
143006718|NCT00822237|515564222|FG000|Dose 1 Vaccination|Not vaccinated|3|||
143006719|NCT00822237|515564223|FG001|Dose 1 Vaccination|Not vaccinated|0|||
143006720|NCT00822237|515564222|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
143006721|NCT00822237|515564223|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
143006722|NCT00822237|515564222|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
143006723|NCT00822237|515564223|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
143006724|NCT00822237|515564222|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
143006725|NCT00822237|515564223|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
143006726|NCT00822237|515564222|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
143006727|NCT00822237|515564223|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
143006728|NCT05604521|515564224|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
143006729|NCT05604521|515564225|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
143006730|NCT05604521|515564224|FG000|Overall Study|Adverse Event|1|||
143006731|NCT05604521|515564225|FG001|Overall Study|Adverse Event|0|||
143006732|NCT01491737|515564226|FG000|Overall Study|Withdrawal by Subject|20|||
143006733|NCT01491737|515564227|FG001|Overall Study|Withdrawal by Subject|17|||
143006734|NCT01491737|515564226|FG000|Overall Study|Lost to Follow-up|2|||
143006735|NCT01491737|515564227|FG001|Overall Study|Lost to Follow-up|10|||
143006736|NCT01491737|515564226|FG000|Overall Study|Death|63|||
143006737|NCT01491737|515564227|FG001|Overall Study|Death|57|||
143006738|NCT01491737|515564226|FG000|Overall Study|Study Termination by Sponsor|36|||
143006739|NCT01491737|515564227|FG001|Overall Study|Study Termination by Sponsor|36|||
143006740|NCT01491737|515564226|FG000|Overall Study|Reason Not Specified|8|||
143006741|NCT01491737|515564227|FG001|Overall Study|Reason Not Specified|9|||
143006742|NCT01817764|515564228|FG000|Overall Study|Adverse Event|7|||
143006743|NCT01817764|515564229|FG001|Overall Study|Adverse Event|10|||
143006744|NCT01817764|515564228|FG000|Overall Study|Lack of Efficacy|9|||
143006745|NCT01817764|515564229|FG001|Overall Study|Lack of Efficacy|7|||
143006746|NCT01817764|515564228|FG000|Overall Study|Protocol Violation|7|||
143006747|NCT01817764|515564229|FG001|Overall Study|Protocol Violation|5|||
143006748|NCT01817764|515564228|FG000|Overall Study|Lost to Follow-up|1|||
143006749|NCT01817764|515564229|FG001|Overall Study|Lost to Follow-up|4|||
143006750|NCT01817764|515564228|FG000|Overall Study|Withdrawal by Subject|10|||
143006751|NCT01817764|515564229|FG001|Overall Study|Withdrawal by Subject|12|||
143006752|NCT03587116|515564230|FG000|Overall Study|Lost to Follow-up|0|||
143006753|NCT03587116|515564231|FG001|Overall Study|Lost to Follow-up|1|||
143006754|NCT03587116|515564230|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
143006755|NCT03587116|515564231|FG001|Overall Study|No Longer Met Eligibility Criteria|1|||
143006756|NCT03587116|515564230|FG000|Overall Study|Withdrawal by Subject|4|||
143006757|NCT03587116|515564231|FG001|Overall Study|Withdrawal by Subject|0|||
143006758|NCT05981365|515564234|FG000|Period 1|Adverse Event|1|||
143006759|NCT05981365|515564235|FG001|Period 1|Adverse Event|0|||
143006760|NCT02593175|515564238|FG000|Overall Study|Adverse Event|5|||
143006761|NCT02593175|515564238|FG000|Overall Study|Disease progression|4|||
143006762|NCT05027958|515564239|FG000|Overall Study|Lost to Follow-up|1|||
143006763|NCT05027958|515564240|FG001|Overall Study|Lost to Follow-up|1|||
143006764|NCT05027958|515564239|FG000|Overall Study|Non-compliance (missed one or more study visits)|1|||
143006765|NCT05027958|515564240|FG001|Overall Study|Non-compliance (missed one or more study visits)|0|||
143006766|NCT05027958|515564239|FG000|Overall Study|Physician Decision|1|||
143006767|NCT05027958|515564240|FG001|Overall Study|Physician Decision|4|||
143006768|NCT05027958|515564239|FG000|Overall Study|Adverse Event|0|||
143006769|NCT05027958|515564240|FG001|Overall Study|Adverse Event|1|||
143006770|NCT01870921|515564243|FG000|Overall Study|Subject decision|80|||
143006771|NCT01870921|515564243|FG000|Overall Study|Severe non-compliance to protocol|7|||
143006772|NCT01870921|515564243|FG000|Overall Study|Subject Lost to Follow up|2|||
143006773|NCT01870921|515564243|FG000|Overall Study|Other|1|||
143006774|NCT02152982|515564244|FG000|Overall Study|Withdrawal by Subject|17|||
143006775|NCT02152982|515564245|FG001|Overall Study|Withdrawal by Subject|16|||
143006776|NCT02152982|515564244|FG000|Overall Study|Did not start treatment|11|||
143006777|NCT02152982|515564245|FG001|Overall Study|Did not start treatment|5|||
143006778|NCT02152982|515564244|FG000|Overall Study|Disease progression|41|||
143006779|NCT02152982|515564245|FG001|Overall Study|Disease progression|52|||
143006780|NCT02152982|515564244|FG000|Overall Study|Adverse Event|7|||
143006781|NCT02152982|515564245|FG001|Overall Study|Adverse Event|12|||
143006782|NCT02152982|515564244|FG000|Overall Study|Complicating disease|1|||
143006783|NCT02152982|515564245|FG001|Overall Study|Complicating disease|1|||
143006784|NCT02152982|515564244|FG000|Overall Study|Death|0|||
143006785|NCT02152982|515564245|FG001|Overall Study|Death|3|||
143006786|NCT02152982|515564244|FG000|Overall Study|Physician Decision|3|||
143006787|NCT02152982|515564245|FG001|Overall Study|Physician Decision|0|||
143006788|NCT04456998|515564248|FG000|Overall Study|Adverse Event|0|||
143006789|NCT04456998|515564249|FG001|Overall Study|Adverse Event|4|||
143006790|NCT04456998|515564248|FG000|Overall Study|Protocol Deviation|0|||
143006791|NCT04456998|515564249|FG001|Overall Study|Protocol Deviation|1|||
143006792|NCT04456998|515564248|FG000|Overall Study|Withdrawal by Subject|0|||
143006793|NCT04456998|515564249|FG001|Overall Study|Withdrawal by Subject|1|||
143006794|NCT02242942|515564253|FG000|Overall Study|Death|17|||
143006795|NCT02242942|515564254|FG001|Overall Study|Death|20|||
143006796|NCT02242942|515564255|FG002|Overall Study|Death|2|||
143006797|NCT02242942|515564253|FG000|Overall Study|Physician Decision|1|||
143006798|NCT02242942|515564254|FG001|Overall Study|Physician Decision|0|||
143006799|NCT02242942|515564255|FG002|Overall Study|Physician Decision|0|||
143006800|NCT02242942|515564253|FG000|Overall Study|Withdrawal by Subject|8|||
143006801|NCT02242942|515564254|FG001|Overall Study|Withdrawal by Subject|10|||
143006802|NCT02242942|515564255|FG002|Overall Study|Withdrawal by Subject|0|||
143006803|NCT02242942|515564253|FG000|Overall Study|On-going in Study|190|||
143006804|NCT02242942|515564254|FG001|Overall Study|On-going in Study|186|||
143006805|NCT02242942|515564255|FG002|Overall Study|On-going in Study|11|||
143006806|NCT04882085|515564256|FG000|Overall Study|Death|6|||
143006807|NCT04882085|515564257|FG001|Overall Study|Death|9|||
143006808|NCT04882085|515564256|FG000|Overall Study|Withdrawal by Subject|0|||
143006809|NCT04882085|515564257|FG001|Overall Study|Withdrawal by Subject|3|||
143006810|NCT04882085|515564256|FG000|Overall Study|Randomized not treated|1|||
143006811|NCT04882085|515564257|FG001|Overall Study|Randomized not treated|0|||
143006812|NCT00145119|515564262|FG000|Overall Study|Death|45|||
143006813|NCT00098475|515564263|FG000|Step 1|Progressive disease|33|||
143006814|NCT00098475|515564264|FG001|Step 1|Progressive disease|35|||
143006815|NCT00098475|515564265|FG002|Step 1|Progressive disease|2|||
143006816|NCT00098475|515564266|FG003|Step 1|Progressive disease|1|||
143006817|NCT00098475|515564263|FG000|Step 1|Adverse Event|56|||
143006818|NCT00098475|515564264|FG001|Step 1|Adverse Event|37|||
143006819|NCT00098475|515564265|FG002|Step 1|Adverse Event|0|||
143006820|NCT00098475|515564266|FG003|Step 1|Adverse Event|1|||
143006821|NCT00098475|515564263|FG000|Step 1|Death|8|||
143006822|NCT00098475|515564264|FG001|Step 1|Death|5|||
143006823|NCT00098475|515564265|FG002|Step 1|Death|0|||
143006824|NCT00098475|515564266|FG003|Step 1|Death|1|||
143006825|NCT00098475|515564263|FG000|Step 1|Withdrawal by Subject|14|||
143006826|NCT00098475|515564264|FG001|Step 1|Withdrawal by Subject|11|||
143006827|NCT00098475|515564265|FG002|Step 1|Withdrawal by Subject|0|||
143006828|NCT00098475|515564266|FG003|Step 1|Withdrawal by Subject|0|||
143006829|NCT00098475|515564263|FG000|Step 1|Physician Decision|5|||
143006830|NCT00098475|515564264|FG001|Step 1|Physician Decision|2|||
143006831|NCT00098475|515564265|FG002|Step 1|Physician Decision|0|||
143006832|NCT00098475|515564266|FG003|Step 1|Physician Decision|0|||
143006833|NCT00098475|515564263|FG000|Step 1|Alternative therapy|31|||
143006834|NCT00098475|515564264|FG001|Step 1|Alternative therapy|43|||
143006835|NCT00098475|515564265|FG002|Step 1|Alternative therapy|1|||
143006836|NCT00098475|515564266|FG003|Step 1|Alternative therapy|0|||
143006837|NCT00098475|515564263|FG000|Step 1|Other disease|2|||
143006838|NCT00098475|515564264|FG001|Step 1|Other disease|1|||
143006839|NCT00098475|515564265|FG002|Step 1|Other disease|1|||
143006840|NCT00098475|515564266|FG003|Step 1|Other disease|0|||
143006841|NCT00098475|515564263|FG000|Step 1|Never started treatment|0|||
143006842|NCT00098475|515564264|FG001|Step 1|Never started treatment|2|||
143006843|NCT00098475|515564265|FG002|Step 1|Never started treatment|0|||
143006844|NCT00098475|515564266|FG003|Step 1|Never started treatment|0|||
143006845|NCT00098475|515564263|FG000|Step 1|Still on treatment as of this analysis|14|||
143006846|NCT00098475|515564264|FG001|Step 1|Still on treatment as of this analysis|27|||
143006847|NCT00098475|515564265|FG002|Step 1|Still on treatment as of this analysis|0|||
143006848|NCT00098475|515564266|FG003|Step 1|Still on treatment as of this analysis|0|||
143006849|NCT00098475|515564263|FG000|Step 1|Knee surgery|1|||
143006850|NCT00098475|515564264|FG001|Step 1|Knee surgery|0|||
143006851|NCT00098475|515564265|FG002|Step 1|Knee surgery|0|||
143006852|NCT00098475|515564266|FG003|Step 1|Knee surgery|0|||
143006853|NCT00098475|515564263|FG000|Step 1|Complications|1|||
143006854|NCT00098475|515564264|FG001|Step 1|Complications|0|||
143006855|NCT00098475|515564265|FG002|Step 1|Complications|0|||
143006856|NCT00098475|515564266|FG003|Step 1|Complications|0|||
143006857|NCT00098475|515564263|FG000|Step 1|Cannot comply due to other tx|0|||
143006858|NCT00098475|515564264|FG001|Step 1|Cannot comply due to other tx|1|||
143006859|NCT00098475|515564265|FG002|Step 1|Cannot comply due to other tx|0|||
143006860|NCT00098475|515564266|FG003|Step 1|Cannot comply due to other tx|0|||
143006861|NCT00098475|515564263|FG000|Step 1|Both patient and physician's decision|2|||
143006862|NCT00098475|515564264|FG001|Step 1|Both patient and physician's decision|1|||
143006863|NCT00098475|515564265|FG002|Step 1|Both patient and physician's decision|0|||
143006864|NCT00098475|515564266|FG003|Step 1|Both patient and physician's decision|0|||
143006865|NCT00098475|515564263|FG000|Step 1|Incorrect disease assessment|2|||
143006866|NCT00098475|515564264|FG001|Step 1|Incorrect disease assessment|0|||
143006867|NCT00098475|515564265|FG002|Step 1|Incorrect disease assessment|0|||
143006868|NCT00098475|515564266|FG003|Step 1|Incorrect disease assessment|0|||
143006869|NCT00098475|515564263|FG000|Step 1|Off treatment for > specified timeframe|1|||
143006870|NCT00098475|515564264|FG001|Step 1|Off treatment for > specified timeframe|1|||
143006871|NCT00098475|515564265|FG002|Step 1|Off treatment for > specified timeframe|0|||
143006872|NCT00098475|515564266|FG003|Step 1|Off treatment for > specified timeframe|0|||
143006873|NCT00098475|515564263|FG000|Step 1|Declining performance status|0|||
143006874|NCT00098475|515564264|FG001|Step 1|Declining performance status|1|||
143006875|NCT00098475|515564265|FG002|Step 1|Declining performance status|0|||
143006876|NCT00098475|515564266|FG003|Step 1|Declining performance status|0|||
143006877|NCT00098475|515564263|FG000|Step 1|Insurance issue|0|||
143006878|NCT00098475|515564264|FG001|Step 1|Insurance issue|1|||
143006879|NCT00098475|515564265|FG002|Step 1|Insurance issue|0|||
143006880|NCT00098475|515564266|FG003|Step 1|Insurance issue|0|||
143006881|NCT00098475|515564263|FG000|Step 1|Rising paraprotein|0|||
143006882|NCT00098475|515564264|FG001|Step 1|Rising paraprotein|1|||
143006883|NCT00098475|515564265|FG002|Step 1|Rising paraprotein|0|||
143006884|NCT00098475|515564266|FG003|Step 1|Rising paraprotein|0|||
143006885|NCT00098475|515564263|FG000|Step 1|Referred to other physicians|0|||
143006886|NCT00098475|515564264|FG001|Step 1|Referred to other physicians|1|||
143006887|NCT00098475|515564265|FG002|Step 1|Referred to other physicians|0|||
143006888|NCT00098475|515564266|FG003|Step 1|Referred to other physicians|0|||
143006889|NCT00098475|515564263|FG000|Step 1|Criteria to continue treatment not met|0|||
143006890|NCT00098475|515564264|FG001|Step 1|Criteria to continue treatment not met|1|||
143006891|NCT00098475|515564265|FG002|Step 1|Criteria to continue treatment not met|0|||
143006892|NCT00098475|515564266|FG003|Step 1|Criteria to continue treatment not met|0|||
143006893|NCT00098475|515564263|FG000|Step 1|Misinterpretation of lab data|0|||
143006894|NCT00098475|515564264|FG001|Step 1|Misinterpretation of lab data|1|||
143006895|NCT00098475|515564265|FG002|Step 1|Misinterpretation of lab data|0|||
143006896|NCT00098475|515564266|FG003|Step 1|Misinterpretation of lab data|0|||
143006897|NCT00098475|515564263|FG000|Step 1|Patient fell with fracture|1|||
143006898|NCT00098475|515564264|FG001|Step 1|Patient fell with fracture|0|||
143006899|NCT00098475|515564265|FG002|Step 1|Patient fell with fracture|0|||
143006900|NCT00098475|515564266|FG003|Step 1|Patient fell with fracture|0|||
143006901|NCT00098475|515564263|FG000|Step 1|Not documented|0|||
143006902|NCT00098475|515564264|FG001|Step 1|Not documented|1|||
143006903|NCT00098475|515564265|FG002|Step 1|Not documented|0|||
143006904|NCT00098475|515564266|FG003|Step 1|Not documented|0|||
143006905|NCT00098475|515564263|FG000|Step 2|Disease progression|1|||
143006906|NCT00098475|515564264|FG001|Step 2|Disease progression|4|||
143006907|NCT00098475|515564265|FG002|Step 2|Disease progression|0|||
143006908|NCT00098475|515564266|FG003|Step 2|Disease progression|0|||
143006909|NCT00098475|515564263|FG000|Step 2|Adverse Event|2|||
143006910|NCT00098475|515564264|FG001|Step 2|Adverse Event|0|||
143006911|NCT00098475|515564265|FG002|Step 2|Adverse Event|0|||
143006912|NCT00098475|515564266|FG003|Step 2|Adverse Event|0|||
143006913|NCT00098475|515564263|FG000|Step 2|Withdrawal by Subject|0|||
143006914|NCT00098475|515564264|FG001|Step 2|Withdrawal by Subject|2|||
143006915|NCT00098475|515564265|FG002|Step 2|Withdrawal by Subject|0|||
143006916|NCT00098475|515564266|FG003|Step 2|Withdrawal by Subject|0|||
143006917|NCT00098475|515564263|FG000|Step 2|Physician Decision|0|||
143006918|NCT00098475|515564264|FG001|Step 2|Physician Decision|1|||
143006919|NCT00098475|515564265|FG002|Step 2|Physician Decision|0|||
143006920|NCT00098475|515564266|FG003|Step 2|Physician Decision|0|||
143006921|NCT00098475|515564263|FG000|Step 2|Alternative therapy|1|||
143006922|NCT00098475|515564264|FG001|Step 2|Alternative therapy|2|||
143006923|NCT00098475|515564265|FG002|Step 2|Alternative therapy|0|||
143006924|NCT00098475|515564266|FG003|Step 2|Alternative therapy|0|||
143006925|NCT00098475|515564263|FG000|Step 2|Never started treatment|1|||
143006926|NCT00098475|515564264|FG001|Step 2|Never started treatment|1|||
143006927|NCT00098475|515564265|FG002|Step 2|Never started treatment|0|||
143006928|NCT00098475|515564266|FG003|Step 2|Never started treatment|0|||
143006929|NCT05681715|515564267|FG000|Training Period (6-weeks)|Adverse Event|3|||
143006930|NCT05681715|515564268|FG001|Training Period (6-weeks)|Adverse Event|0|||
143006931|NCT05681715|515564269|FG002|Training Period (6-weeks)|Adverse Event|0|||
143006932|NCT05681715|515564267|FG000|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|1|||
143006933|NCT05681715|515564268|FG001|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
143006934|NCT05681715|515564269|FG002|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
143006935|NCT05681715|515564267|FG000|Training Period (6-weeks)|Not Eligible for SA but continued in study|3|||
143006936|NCT05681715|515564268|FG001|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
143006937|NCT05681715|515564269|FG002|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
143006938|NCT05681715|515564267|FG000|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
143006939|NCT05681715|515564268|FG001|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|1|||
143006940|NCT05681715|515564269|FG002|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
143006941|NCT05681715|515564267|FG000|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
143006942|NCT05681715|515564268|FG001|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
143006943|NCT05681715|515564269|FG002|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|1|||
143006944|NCT05681715|515564267|FG000|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
143006945|NCT05681715|515564268|FG001|Self-administration Period 1 (6 Weeks)|Adverse Event|1|||
143006946|NCT05681715|515564269|FG002|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
143006947|NCT05681715|515564267|FG000|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
143006948|NCT05681715|515564268|FG001|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|1|||
143006949|NCT05681715|515564269|FG002|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
143006950|NCT05681715|515564267|FG000|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
143006951|NCT05681715|515564268|FG001|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|2|||
143006952|NCT05681715|515564269|FG002|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
143006953|NCT05455684|515564270|FG000|Overall Study|Withdrawal by Subject|7|||
143006954|NCT05455684|515564271|FG001|Overall Study|Withdrawal by Subject|4|||
143006955|NCT05455684|515564270|FG000|Overall Study|Lost to Follow-up|3|||
143006956|NCT05455684|515564271|FG001|Overall Study|Lost to Follow-up|3|||
143006957|NCT05455684|515564270|FG000|Overall Study|Adverse Event|2|||
143006958|NCT05455684|515564271|FG001|Overall Study|Adverse Event|3|||
143006959|NCT05455684|515564270|FG000|Overall Study|Protocol Violation|1|||
143006960|NCT05455684|515564271|FG001|Overall Study|Protocol Violation|1|||
143006961|NCT05455684|515564270|FG000|Overall Study|Non-Compliant with study drug|0|||
143006962|NCT05455684|515564271|FG001|Overall Study|Non-Compliant with study drug|1|||
143006963|NCT05455684|515564270|FG000|Overall Study|Other|1|||
143006964|NCT05455684|515564271|FG001|Overall Study|Other|2|||
143006965|NCT05455684|515564270|FG000|Overall Study|Randomized but not treated|1|||
143006966|NCT05455684|515564271|FG001|Overall Study|Randomized but not treated|0|||
143006967|NCT05116241|515564272|FG000|Study|Withdrawal by Subject|5|||
143006968|NCT05116241|515564273|FG001|Study|Withdrawal by Subject|2|||
143006969|NCT05116241|515564274|FG002|Study|Withdrawal by Subject|1|||
143006970|NCT05116241|515564272|FG000|Study|Lost to Follow-up|0|||
143006971|NCT05116241|515564273|FG001|Study|Lost to Follow-up|2|||
143006972|NCT05116241|515564274|FG002|Study|Lost to Follow-up|2|||
143006973|NCT05204563|515564275|FG000|Overall Study|Other than Specified|2|||
143006974|NCT05204563|515564276|FG001|Overall Study|Other than Specified|1|||
143006975|NCT05204563|515564275|FG000|Overall Study|Death|18|||
143006976|NCT05204563|515564276|FG001|Overall Study|Death|4|||
143006977|NCT05204563|515564275|FG000|Overall Study|Lost to Follow-up|6|||
143006978|NCT05204563|515564276|FG001|Overall Study|Lost to Follow-up|3|||
143006979|NCT05204563|515564275|FG000|Overall Study|Withdrawal by Subject|12|||
143006980|NCT05204563|515564276|FG001|Overall Study|Withdrawal by Subject|3|||
143006981|NCT05204563|515564275|FG000|Overall Study|Enrolled, Not Treated|1|||
143006982|NCT05204563|515564276|FG001|Overall Study|Enrolled, Not Treated|0|||
143006983|NCT04755283|515564279|FG000|Overall Study|Withdrawal by Subject|14|||
143006984|NCT04755283|515564280|FG001|Overall Study|Withdrawal by Subject|3|||
143006985|NCT04755283|515564281|FG002|Overall Study|Withdrawal by Subject|6|||
143006986|NCT04755283|515564279|FG000|Overall Study|Lost to Follow-up|0|||
143006987|NCT04755283|515564280|FG001|Overall Study|Lost to Follow-up|0|||
143006988|NCT04755283|515564281|FG002|Overall Study|Lost to Follow-up|1|||
143006989|NCT04755283|515564279|FG000|Overall Study|Death|31|||
143006990|NCT04755283|515564280|FG001|Overall Study|Death|36|||
143006991|NCT04755283|515564281|FG002|Overall Study|Death|34|||
143006992|NCT02268214|515564282|FG000|Overall Study|Subject no longer meets study criteria|0|||
143006993|NCT02268214|515564283|FG001|Overall Study|Subject no longer meets study criteria|2|||
143006994|NCT02268214|515564284|FG002|Overall Study|Subject no longer meets study criteria|0|||
143006995|NCT02268214|515564282|FG000|Overall Study|Pregnancy|2|||
143006996|NCT02268214|515564283|FG001|Overall Study|Pregnancy|2|||
143006997|NCT02268214|515564284|FG002|Overall Study|Pregnancy|1|||
143006998|NCT02268214|515564282|FG000|Overall Study|Lost to Follow-up|3|||
143006999|NCT02268214|515564283|FG001|Overall Study|Lost to Follow-up|3|||
143007000|NCT02268214|515564284|FG002|Overall Study|Lost to Follow-up|4|||
143007001|NCT02268214|515564282|FG000|Overall Study|Lack of Efficacy|1|||
143007002|NCT02268214|515564283|FG001|Overall Study|Lack of Efficacy|0|||
143007003|NCT02268214|515564284|FG002|Overall Study|Lack of Efficacy|2|||
143007004|NCT02268214|515564282|FG000|Overall Study|Adverse Event|11|||
143007005|NCT02268214|515564283|FG001|Overall Study|Adverse Event|14|||
143007006|NCT02268214|515564284|FG002|Overall Study|Adverse Event|9|||
143007007|NCT02268214|515564282|FG000|Overall Study|Withdrawal by Subject|4|||
143007008|NCT02268214|515564283|FG001|Overall Study|Withdrawal by Subject|5|||
143007009|NCT02268214|515564284|FG002|Overall Study|Withdrawal by Subject|10|||
143007010|NCT02268214|515564282|FG000|Overall Study|Subject request to discontinue treatment|10|||
143007011|NCT02268214|515564283|FG001|Overall Study|Subject request to discontinue treatment|8|||
143007012|NCT02268214|515564284|FG002|Overall Study|Subject request to discontinue treatment|6|||
143007013|NCT02268214|515564282|FG000|Overall Study|Poor/non-compliance|2|||
143007014|NCT02268214|515564283|FG001|Overall Study|Poor/non-compliance|1|||
143007015|NCT02268214|515564284|FG002|Overall Study|Poor/non-compliance|2|||
143007016|NCT02268214|515564282|FG000|Overall Study|Other reasons|7|||
143007017|NCT02268214|515564283|FG001|Overall Study|Other reasons|3|||
143007018|NCT02268214|515564284|FG002|Overall Study|Other reasons|3|||
143007019|NCT02268214|515564282|FG000|Overall Study|Not entering long-term period|2|||
143007020|NCT02268214|515564283|FG001|Overall Study|Not entering long-term period|3|||
143007021|NCT02268214|515564284|FG002|Overall Study|Not entering long-term period|5|||
143007022|NCT04342390|515564285|FG000|Overall Study|Lost to Follow-up|3|||
143007023|NCT04342390|515564286|FG001|Overall Study|Lost to Follow-up|0|||
143007024|NCT04584294|515564289|FG000|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|3|||
143007025|NCT04584294|515564290|FG001|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|4|||
143007026|NCT04584294|515564289|FG000|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|16|||
143007027|NCT04584294|515564290|FG001|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|18|||
143007028|NCT04584294|515564289|FG000|Enrollment to Post-Visit - PATIENTS|Pregnancy|0|||
143007029|NCT04584294|515564290|FG001|Enrollment to Post-Visit - PATIENTS|Pregnancy|1|||
143007030|NCT04584294|515564289|FG000|3-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
143007031|NCT04584294|515564290|FG001|3-month Follow-up - PATIENTS|Withdrawal by Subject|1|||
143007032|NCT04584294|515564289|FG000|6-month Follow-up - PATIENTS|Withdrawal by Subject|4|||
143007033|NCT04584294|515564290|FG001|6-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
143007034|NCT04584294|515564289|FG000|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|3|||
143007035|NCT04584294|515564290|FG001|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|5|||
143007036|NCT01083121|515564291|FG000|Overall Study|Use of Humira outside the approved label|81|||
143007037|NCT03743571|515564294|FG000|Overall Study|Withdrawal by Subject|1|||
143007038|NCT03743571|515564295|FG001|Overall Study|Withdrawal by Subject|1|||
143007039|NCT03743571|515564294|FG000|Overall Study|Lost to Follow-up|1|||
143007040|NCT03743571|515564295|FG001|Overall Study|Lost to Follow-up|2|||
143007041|NCT00026312|515564296|FG000|Overall Study|Adverse Event|0|||
143007042|NCT00026312|515564297|FG001|Overall Study|Adverse Event|32|||
143007043|NCT00026312|515564296|FG000|Overall Study|Death|1|||
143007044|NCT00026312|515564297|FG001|Overall Study|Death|7|||
143007045|NCT00026312|515564296|FG000|Overall Study|Lack of Efficacy|19|||
143007046|NCT00026312|515564297|FG001|Overall Study|Lack of Efficacy|114|||
143007047|NCT00026312|515564296|FG000|Overall Study|Lost to Follow-up|0|||
143007048|NCT00026312|515564297|FG001|Overall Study|Lost to Follow-up|5|||
143007049|NCT00026312|515564296|FG000|Overall Study|Physician Decision|1|||
143007050|NCT00026312|515564297|FG001|Overall Study|Physician Decision|37|||
143007051|NCT00026312|515564296|FG000|Overall Study|Protocol Violation|0|||
143007052|NCT00026312|515564297|FG001|Overall Study|Protocol Violation|3|||
143007053|NCT00026312|515564296|FG000|Overall Study|Withdrawal by Subject|1|||
143007054|NCT00026312|515564297|FG001|Overall Study|Withdrawal by Subject|6|||
143007055|NCT00026312|515564296|FG000|Overall Study|Ineligible|4|||
143007056|NCT00026312|515564297|FG001|Overall Study|Ineligible|5|||
143007057|NCT00026312|515564296|FG000|Overall Study|Entry onto another COG study|0|||
143007058|NCT00026312|515564297|FG001|Overall Study|Entry onto another COG study|1|||
143007059|NCT00026312|515564296|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
143007060|NCT00026312|515564297|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
143007061|NCT00167414|515564299|FG000|Overall Study|Death|10|||
143007062|NCT04814654|515564303|FG000|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|170|||
143007063|NCT04814654|515564304|FG001|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|167|||
143007064|NCT04814654|515564305|FG002|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|157|||
143007065|NCT01676818|515564309|FG000|Overall Study|Physician Decision|1|||
143007066|NCT01676818|515564309|FG000|Overall Study|Withdrawal by Subject|1|||
143007067|NCT03213704|515564312|FG000|Overall Study|Physician Decision|3|||
143007068|NCT03213704|515564312|FG000|Overall Study|Protocol Violation|1|||
143007069|NCT03213704|515564312|FG000|Overall Study|Progressive disease|4|||
143007070|NCT01646268|515566070|FG000|Overall Study|Adverse Event|6|||
143007071|NCT01646268|515566071|FG001|Overall Study|Adverse Event|7|||
143007072|NCT01646268|515566070|FG000|Overall Study|Lack of Efficacy|1|||
143007073|NCT01646268|515566071|FG001|Overall Study|Lack of Efficacy|3|||
143007074|NCT01646268|515566070|FG000|Overall Study|Protocol Violation|0|||
143007075|NCT01646268|515566071|FG001|Overall Study|Protocol Violation|1|||
143007076|NCT01646268|515566070|FG000|Overall Study|Withdrawal by Subject|2|||
143007077|NCT01646268|515566071|FG001|Overall Study|Withdrawal by Subject|5|||
143007078|NCT01646268|515566070|FG000|Overall Study|Other|2|||
143007079|NCT01646268|515566071|FG001|Overall Study|Other|0|||
143007080|NCT04242446|515566080|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
143007081|NCT04242446|515566081|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
143007082|NCT04242446|515566082|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
143007083|NCT04242446|515566083|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
143007084|NCT04242446|515566084|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
143007085|NCT04242446|515566085|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
143007086|NCT04242446|515566086|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
143007087|NCT04242446|515566080|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
143007088|NCT04242446|515566081|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
143007089|NCT04242446|515566082|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
143007090|NCT04242446|515566083|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
143007091|NCT04242446|515566084|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
143007092|NCT04242446|515566085|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
143007093|NCT04242446|515566086|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
143007094|NCT04242446|515566080|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
143007095|NCT04242446|515566081|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
143007096|NCT04242446|515566082|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
143007097|NCT04242446|515566083|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
143007098|NCT04242446|515566084|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
143007099|NCT04242446|515566085|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
143007100|NCT04242446|515566086|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
143007101|NCT04242446|515566080|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
143007102|NCT04242446|515566081|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
143007103|NCT04242446|515566082|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
143007104|NCT04242446|515566083|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
143007105|NCT04242446|515566084|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
143007106|NCT04242446|515566085|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
143007107|NCT04242446|515566086|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
143007108|NCT04242446|515566080|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
143007109|NCT04242446|515566081|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
143007110|NCT04242446|515566082|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
143007111|NCT04242446|515566083|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
143007112|NCT04242446|515566084|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
143007113|NCT04242446|515566085|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
143007114|NCT04242446|515566086|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
143007115|NCT04242446|515566080|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
143007116|NCT04242446|515566081|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
143007117|NCT04242446|515566082|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
143007118|NCT04242446|515566083|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
143007119|NCT04242446|515566084|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
143007120|NCT04242446|515566085|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
143007121|NCT04242446|515566086|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
143007122|NCT04242446|515566080|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
143007123|NCT04242446|515566081|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
143007124|NCT04242446|515566082|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
143007125|NCT04242446|515566083|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
143007126|NCT04242446|515566084|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
143007127|NCT04242446|515566085|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
143007128|NCT04242446|515566086|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
143007129|NCT04242446|515566080|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
143007130|NCT04242446|515566081|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
143007131|NCT04242446|515566082|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
143007132|NCT04242446|515566083|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
143007133|NCT04242446|515566084|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
143007134|NCT04242446|515566085|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
143007135|NCT04242446|515566086|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
143007136|NCT04242446|515566080|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
143007137|NCT04242446|515566081|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
143007138|NCT04242446|515566082|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
143007139|NCT04242446|515566083|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
143007140|NCT04242446|515566084|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
143007141|NCT04242446|515566085|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
143007142|NCT04242446|515566086|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
143007143|NCT04242446|515566080|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
143007144|NCT04242446|515566081|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
143007145|NCT04242446|515566082|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
143007146|NCT04242446|515566083|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
143007147|NCT04242446|515566084|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
143123531|NCT02757352|515997783|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
143007148|NCT04242446|515566085|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
143007149|NCT04242446|515566086|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
143007150|NCT04242446|515566080|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
143007151|NCT04242446|515566081|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
143007152|NCT04242446|515566082|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
143007153|NCT04242446|515566083|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
143007154|NCT04242446|515566084|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
143007155|NCT04242446|515566085|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
143007156|NCT04242446|515566086|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
143007157|NCT04242446|515566080|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
143007158|NCT04242446|515566081|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
143007159|NCT04242446|515566082|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
143007160|NCT04242446|515566083|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
143007161|NCT04242446|515566084|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
143007162|NCT04242446|515566085|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
143007163|NCT04242446|515566086|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
143007164|NCT04242446|515566080|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
143007165|NCT04242446|515566081|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
143007166|NCT04242446|515566082|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
143007167|NCT04242446|515566083|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
143007168|NCT04242446|515566084|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
143007169|NCT04242446|515566085|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
143007170|NCT04242446|515566086|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
143007171|NCT04242446|515566080|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
143007172|NCT04242446|515566081|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
143007173|NCT04242446|515566082|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
143007174|NCT04242446|515566083|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
143007175|NCT04242446|515566084|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
143007176|NCT04242446|515566085|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
143007177|NCT04242446|515566086|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
143007178|NCT04242446|515566080|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
143007179|NCT04242446|515566081|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
143007180|NCT04242446|515566082|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
143007181|NCT04242446|515566083|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
143007182|NCT04242446|515566084|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
143007183|NCT04242446|515566085|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
143007184|NCT04242446|515566086|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
143007185|NCT04242446|515566080|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
143007186|NCT04242446|515566081|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
143007187|NCT04242446|515566082|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
143007188|NCT04242446|515566083|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
143007189|NCT04242446|515566084|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
143007190|NCT04242446|515566085|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
143007191|NCT04242446|515566086|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
143007192|NCT04242446|515566080|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
143007193|NCT04242446|515566081|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
143007194|NCT04242446|515566082|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
143007195|NCT04242446|515566083|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
143007196|NCT04242446|515566084|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
143007197|NCT04242446|515566085|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
143007198|NCT04242446|515566086|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
143007199|NCT04242446|515566080|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
143007200|NCT04242446|515566081|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
143007201|NCT04242446|515566082|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
143346388|NCT00584805|516814315|FG000|Overall Study|Withdrawal by Subject|18|||
143007202|NCT04242446|515566083|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
143007203|NCT04242446|515566084|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
143007204|NCT04242446|515566085|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
143007205|NCT04242446|515566086|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
143007206|NCT04242446|515566080|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
143007207|NCT04242446|515566081|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
143007208|NCT04242446|515566082|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
143007209|NCT04242446|515566083|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
143007210|NCT04242446|515566084|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
143007211|NCT04242446|515566085|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
143007212|NCT04242446|515566086|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
143007213|NCT04242446|515566080|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
143007214|NCT04242446|515566081|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
143007215|NCT04242446|515566082|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
143007216|NCT04242446|515566083|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
143007217|NCT04242446|515566084|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
143007218|NCT04242446|515566085|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
143007219|NCT04242446|515566086|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
143007220|NCT04242446|515566080|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
143007221|NCT04242446|515566081|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
143007222|NCT04242446|515566082|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
143007223|NCT04242446|515566083|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
143007224|NCT04242446|515566084|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
143007225|NCT04242446|515566085|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
143007226|NCT04242446|515566086|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
143007227|NCT04242446|515566080|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
143007228|NCT04242446|515566081|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
143007229|NCT04242446|515566082|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
143007230|NCT04242446|515566083|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
143007231|NCT04242446|515566084|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
143007232|NCT04242446|515566085|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
143007233|NCT04242446|515566086|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
143007234|NCT04242446|515566080|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
143007235|NCT04242446|515566081|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
143007236|NCT04242446|515566082|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
143007237|NCT04242446|515566083|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
143007238|NCT04242446|515566084|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
143007239|NCT04242446|515566085|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
143007240|NCT04242446|515566086|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
143007241|NCT04242446|515566080|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
143007242|NCT04242446|515566081|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
143007243|NCT04242446|515566082|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
143007244|NCT04242446|515566083|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
143007245|NCT04242446|515566084|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
143007246|NCT04242446|515566085|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
143007247|NCT04242446|515566086|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
143007248|NCT00643006|515566088|FG000|Overall Study|Lost to Follow-up|5|||
143007249|NCT00643006|515566089|FG001|Overall Study|Lost to Follow-up|4|||
143007250|NCT03772574|515566090|FG000|Overall Study|Protocol Violation|2|||
143007251|NCT03772574|515566091|FG001|Overall Study|Protocol Violation|0|||
143007252|NCT03772574|515566092|FG002|Overall Study|Protocol Violation|0|||
143007253|NCT03772574|515566090|FG000|Overall Study|Discomfort|0|||
143007254|NCT03772574|515566091|FG001|Overall Study|Discomfort|5|||
143007255|NCT03772574|515566092|FG002|Overall Study|Discomfort|4|||
143007256|NCT03586427|515566095|FG000|Overall Study|Lost to Follow-up|0|||
143007257|NCT03586427|515566096|FG001|Overall Study|Lost to Follow-up|3|||
143007258|NCT03586427|515566097|FG002|Overall Study|Lost to Follow-up|1|||
143007259|NCT03586427|515566098|FG003|Overall Study|Lost to Follow-up|3|||
143007260|NCT03586427|515566099|FG004|Overall Study|Lost to Follow-up|3|||
143123532|NCT02757352|515997784|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
143007261|NCT03586427|515566095|FG000|Overall Study|Withdrawal by Subject|0|||
143007262|NCT03586427|515566096|FG001|Overall Study|Withdrawal by Subject|1|||
143007263|NCT03586427|515566097|FG002|Overall Study|Withdrawal by Subject|2|||
143007264|NCT03586427|515566098|FG003|Overall Study|Withdrawal by Subject|1|||
143007265|NCT03586427|515566099|FG004|Overall Study|Withdrawal by Subject|1|||
143007266|NCT03586427|515566095|FG000|Overall Study|Adverse Event|0|||
143007267|NCT03586427|515566096|FG001|Overall Study|Adverse Event|0|||
143007268|NCT03586427|515566097|FG002|Overall Study|Adverse Event|1|||
143007269|NCT03586427|515566098|FG003|Overall Study|Adverse Event|0|||
143007270|NCT03586427|515566099|FG004|Overall Study|Adverse Event|0|||
143007271|NCT03586427|515566095|FG000|Overall Study|Protocol Violation|0|||
143007272|NCT03586427|515566096|FG001|Overall Study|Protocol Violation|0|||
143007273|NCT03586427|515566097|FG002|Overall Study|Protocol Violation|1|||
143007274|NCT03586427|515566098|FG003|Overall Study|Protocol Violation|0|||
143007275|NCT03586427|515566099|FG004|Overall Study|Protocol Violation|1|||
143007276|NCT03586427|515566095|FG000|Overall Study|Noncompliance with study drug|0|||
143007277|NCT03586427|515566096|FG001|Overall Study|Noncompliance with study drug|0|||
143007278|NCT03586427|515566097|FG002|Overall Study|Noncompliance with study drug|1|||
143007279|NCT03586427|515566098|FG003|Overall Study|Noncompliance with study drug|0|||
143007280|NCT03586427|515566099|FG004|Overall Study|Noncompliance with study drug|0|||
143007281|NCT03193996|515566102|FG000|Overall Study|Withdrawal by Subject|4|||
143007282|NCT03193996|515566102|FG000|Overall Study|Lost to Follow-up|4|||
143007283|NCT03193996|515566102|FG000|Overall Study|Physician Decision|2|||
143007284|NCT03193996|515566102|FG000|Overall Study|Pregnancy|1|||
143007285|NCT03193996|515566102|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
143007286|NCT03193996|515566102|FG000|Overall Study|Complicating disease|1|||
143007287|NCT00593385|515566105|FG000|Overall Study|Death|14|||
143007288|NCT00593385|515566105|FG000|Overall Study|Lost to Follow-up|17|||
143007289|NCT00593385|515566105|FG000|Overall Study|Withdrawal by Subject|9|||
143007290|NCT01471197|515566106|FG000|Overall Study|Disease Progression|4|||
143007291|NCT01471197|515566107|FG001|Overall Study|Disease Progression|2|||
143007292|NCT01471197|515566106|FG000|Overall Study|Death|1|||
143007293|NCT01471197|515566107|FG001|Overall Study|Death|0|||
143007294|NCT01471197|515566106|FG000|Overall Study|Study Drug Toxicity|1|||
143007295|NCT01471197|515566107|FG001|Overall Study|Study Drug Toxicity|0|||
143007296|NCT00924313|515566110|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
143007297|NCT04983589|515566118|FG000|Overall Study|Withdrawal by Subject|0|||
143007298|NCT04983589|515566119|FG001|Overall Study|Withdrawal by Subject|3|||
143007299|NCT04983589|515566118|FG000|Overall Study|COVID-19 Infection|1|||
143007300|NCT04983589|515566119|FG001|Overall Study|COVID-19 Infection|0|||
143007301|NCT04983589|515566118|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
143007302|NCT04983589|515566119|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
143007303|NCT01353586|515566120|FG000|Overall Study|Procedure terminated prior to ablation|3|||
143007304|NCT01353586|515566121|FG001|Overall Study|Procedure terminated prior to ablation|0|||
143007305|NCT01353586|515566120|FG000|Overall Study|Never had insertion of study catheter|4|||
143007306|NCT01353586|515566121|FG001|Overall Study|Never had insertion of study catheter|1|||
143007307|NCT01353586|515566120|FG000|Overall Study|Neurological exam not done|0|||
143007308|NCT01353586|515566121|FG001|Overall Study|Neurological exam not done|1|||
143007309|NCT00978120|515566124|FG000|Overall Study|Death|0|||
143007310|NCT00978120|515566125|FG001|Overall Study|Death|0|||
143007311|NCT00978120|515566126|FG002|Overall Study|Death|0|||
143007312|NCT00978120|515566127|FG003|Overall Study|Death|1|||
143007313|NCT00978120|515566124|FG000|Overall Study|Lost to Follow-up|0|||
143007314|NCT00978120|515566125|FG001|Overall Study|Lost to Follow-up|0|||
143007315|NCT00978120|515566126|FG002|Overall Study|Lost to Follow-up|3|||
143007316|NCT00978120|515566127|FG003|Overall Study|Lost to Follow-up|0|||
143007317|NCT00978120|515566124|FG000|Overall Study|Withdrawal by Subject|2|||
143007318|NCT00978120|515566125|FG001|Overall Study|Withdrawal by Subject|0|||
143007319|NCT00978120|515566126|FG002|Overall Study|Withdrawal by Subject|0|||
143007320|NCT00978120|515566127|FG003|Overall Study|Withdrawal by Subject|0|||
143007321|NCT00978120|515566124|FG000|Overall Study|Moved out of state|0|||
143007322|NCT00978120|515566125|FG001|Overall Study|Moved out of state|0|||
143007323|NCT00978120|515566126|FG002|Overall Study|Moved out of state|0|||
143007324|NCT00978120|515566127|FG003|Overall Study|Moved out of state|1|||
143007325|NCT00491322|515566128|FG000|Overall Study|Protocol Violation|1|||
143007326|NCT00491322|515566129|FG001|Overall Study|Protocol Violation|0|||
143007327|NCT00491322|515566128|FG000|Overall Study|Pregnancy|0|||
143007328|NCT00491322|515566129|FG001|Overall Study|Pregnancy|1|||
143007329|NCT02060188|515566142|FG000|Overall Study|Disease Progression|36|||
143007330|NCT02060188|515566143|FG001|Overall Study|Disease Progression|42|||
143007331|NCT02060188|515566144|FG002|Overall Study|Disease Progression|8|||
143007332|NCT02060188|515566145|FG003|Overall Study|Disease Progression|5|||
143007333|NCT02060188|515566146|FG004|Overall Study|Disease Progression|6|||
143007334|NCT02060188|515566147|FG005|Overall Study|Disease Progression|3|||
143007335|NCT02060188|515566148|FG006|Overall Study|Disease Progression|23|||
143007336|NCT02060188|515566149|FG007|Overall Study|Disease Progression|20|||
143007337|NCT02060188|515566150|FG008|Overall Study|Disease Progression|43|||
143007338|NCT02060188|515566142|FG000|Overall Study|Study Drug Toxicity|10|||
143007339|NCT02060188|515566143|FG001|Overall Study|Study Drug Toxicity|18|||
143007340|NCT02060188|515566144|FG002|Overall Study|Study Drug Toxicity|7|||
143007341|NCT02060188|515566145|FG003|Overall Study|Study Drug Toxicity|4|||
143007342|NCT02060188|515566146|FG004|Overall Study|Study Drug Toxicity|3|||
143007343|NCT02060188|515566147|FG005|Overall Study|Study Drug Toxicity|0|||
143007344|NCT02060188|515566148|FG006|Overall Study|Study Drug Toxicity|2|||
143007345|NCT02060188|515566149|FG007|Overall Study|Study Drug Toxicity|5|||
143007346|NCT02060188|515566150|FG008|Overall Study|Study Drug Toxicity|0|||
143007347|NCT02060188|515566142|FG000|Overall Study|Adverse event unrelated to study drug|2|||
143007348|NCT02060188|515566143|FG001|Overall Study|Adverse event unrelated to study drug|5|||
143007349|NCT02060188|515566144|FG002|Overall Study|Adverse event unrelated to study drug|6|||
143007350|NCT02060188|515566145|FG003|Overall Study|Adverse event unrelated to study drug|0|||
143007351|NCT02060188|515566146|FG004|Overall Study|Adverse event unrelated to study drug|1|||
143007352|NCT02060188|515566147|FG005|Overall Study|Adverse event unrelated to study drug|0|||
143007353|NCT02060188|515566148|FG006|Overall Study|Adverse event unrelated to study drug|4|||
143007354|NCT02060188|515566149|FG007|Overall Study|Adverse event unrelated to study drug|4|||
143007355|NCT02060188|515566150|FG008|Overall Study|Adverse event unrelated to study drug|1|||
143007356|NCT02060188|515566142|FG000|Overall Study|Participant request to discontinue study treatment|7|||
143007357|NCT02060188|515566143|FG001|Overall Study|Participant request to discontinue study treatment|7|||
143007358|NCT02060188|515566144|FG002|Overall Study|Participant request to discontinue study treatment|4|||
143007359|NCT02060188|515566145|FG003|Overall Study|Participant request to discontinue study treatment|0|||
143007360|NCT02060188|515566146|FG004|Overall Study|Participant request to discontinue study treatment|0|||
143007361|NCT02060188|515566147|FG005|Overall Study|Participant request to discontinue study treatment|0|||
143007362|NCT02060188|515566148|FG006|Overall Study|Participant request to discontinue study treatment|1|||
143007363|NCT02060188|515566149|FG007|Overall Study|Participant request to discontinue study treatment|1|||
143007364|NCT02060188|515566150|FG008|Overall Study|Participant request to discontinue study treatment|0|||
143007365|NCT02060188|515566142|FG000|Overall Study|Participant withdrew consent|3|||
143007366|NCT02060188|515566143|FG001|Overall Study|Participant withdrew consent|0|||
143007367|NCT02060188|515566144|FG002|Overall Study|Participant withdrew consent|0|||
143007368|NCT02060188|515566145|FG003|Overall Study|Participant withdrew consent|0|||
143007369|NCT02060188|515566146|FG004|Overall Study|Participant withdrew consent|0|||
143007370|NCT02060188|515566147|FG005|Overall Study|Participant withdrew consent|0|||
143007371|NCT02060188|515566148|FG006|Overall Study|Participant withdrew consent|0|||
143007372|NCT02060188|515566149|FG007|Overall Study|Participant withdrew consent|0|||
143007373|NCT02060188|515566150|FG008|Overall Study|Participant withdrew consent|0|||
143007374|NCT02060188|515566142|FG000|Overall Study|Maximum clinical benefit|13|||
143007375|NCT02060188|515566143|FG001|Overall Study|Maximum clinical benefit|38|||
143007376|NCT02060188|515566144|FG002|Overall Study|Maximum clinical benefit|19|||
143007377|NCT02060188|515566145|FG003|Overall Study|Maximum clinical benefit|0|||
143007378|NCT02060188|515566146|FG004|Overall Study|Maximum clinical benefit|0|||
143007379|NCT02060188|515566147|FG005|Overall Study|Maximum clinical benefit|0|||
143007380|NCT02060188|515566148|FG006|Overall Study|Maximum clinical benefit|0|||
143007381|NCT02060188|515566149|FG007|Overall Study|Maximum clinical benefit|10|||
143007382|NCT02060188|515566150|FG008|Overall Study|Maximum clinical benefit|0|||
143007383|NCT02060188|515566142|FG000|Overall Study|Other reason|3|||
143007384|NCT02060188|515566143|FG001|Overall Study|Other reason|7|||
143007385|NCT02060188|515566144|FG002|Overall Study|Other reason|0|||
143007386|NCT02060188|515566145|FG003|Overall Study|Other reason|1|||
143007387|NCT02060188|515566146|FG004|Overall Study|Other reason|0|||
143007388|NCT02060188|515566147|FG005|Overall Study|Other reason|0|||
143007389|NCT02060188|515566148|FG006|Overall Study|Other reason|0|||
143007390|NCT02060188|515566149|FG007|Overall Study|Other reason|9|||
143007391|NCT02060188|515566150|FG008|Overall Study|Other reason|0|||
143007392|NCT02060188|515566142|FG000|Overall Study|Death|0|||
143007393|NCT02060188|515566143|FG001|Overall Study|Death|1|||
143007394|NCT02060188|515566144|FG002|Overall Study|Death|0|||
143007395|NCT02060188|515566145|FG003|Overall Study|Death|0|||
143007396|NCT02060188|515566146|FG004|Overall Study|Death|0|||
143007397|NCT02060188|515566147|FG005|Overall Study|Death|0|||
143007398|NCT02060188|515566148|FG006|Overall Study|Death|0|||
143007399|NCT02060188|515566149|FG007|Overall Study|Death|1|||
143007400|NCT02060188|515566150|FG008|Overall Study|Death|0|||
143007401|NCT02060188|515566142|FG000|Overall Study|Administrative reasons by sponsor|0|||
143123533|NCT02757352|515997785|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
143123534|NCT02757352|515997786|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
143123535|NCT02757352|515997787|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
143123536|NCT02757352|515997788|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
143007402|NCT02060188|515566143|FG001|Overall Study|Administrative reasons by sponsor|1|||
143007403|NCT02060188|515566144|FG002|Overall Study|Administrative reasons by sponsor|0|||
143007404|NCT02060188|515566145|FG003|Overall Study|Administrative reasons by sponsor|0|||
143007405|NCT02060188|515566146|FG004|Overall Study|Administrative reasons by sponsor|0|||
143007406|NCT02060188|515566147|FG005|Overall Study|Administrative reasons by sponsor|0|||
143007407|NCT02060188|515566148|FG006|Overall Study|Administrative reasons by sponsor|0|||
143007408|NCT02060188|515566149|FG007|Overall Study|Administrative reasons by sponsor|0|||
143007409|NCT02060188|515566150|FG008|Overall Study|Administrative reasons by sponsor|0|||
143007410|NCT02060188|515566142|FG000|Overall Study|Lost to Follow-up|0|||
143007411|NCT02060188|515566143|FG001|Overall Study|Lost to Follow-up|0|||
143007412|NCT02060188|515566144|FG002|Overall Study|Lost to Follow-up|1|||
143007413|NCT02060188|515566145|FG003|Overall Study|Lost to Follow-up|0|||
143007414|NCT02060188|515566146|FG004|Overall Study|Lost to Follow-up|0|||
143007415|NCT02060188|515566147|FG005|Overall Study|Lost to Follow-up|0|||
143007416|NCT02060188|515566148|FG006|Overall Study|Lost to Follow-up|0|||
143007417|NCT02060188|515566149|FG007|Overall Study|Lost to Follow-up|0|||
143007418|NCT02060188|515566150|FG008|Overall Study|Lost to Follow-up|0|||
143007419|NCT03426995|515566151|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
143007420|NCT03426995|515566152|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
143007421|NCT03426995|515566153|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
143007422|NCT03426995|515566154|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
143007423|NCT03426995|515566155|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
143007424|NCT03426995|515566156|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
143007425|NCT03426995|515566157|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
143007426|NCT03426995|515566158|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
143007427|NCT03426995|515566159|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
143007428|NCT03426995|515566160|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
143007429|NCT03426995|515566161|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
143007430|NCT03426995|515566162|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
143007431|NCT03426995|515566163|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
143007432|NCT03426995|515566164|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
143007433|NCT03426995|515566165|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
143007434|NCT03426995|515566166|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
143007435|NCT03426995|515566167|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
143007436|NCT03426995|515566168|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
143007437|NCT03426995|515566169|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
143007438|NCT03426995|515566151|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
143007439|NCT03426995|515566152|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
143007440|NCT03426995|515566153|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
143007441|NCT03426995|515566154|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
143007442|NCT03426995|515566155|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
143007443|NCT03426995|515566156|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
143007444|NCT03426995|515566157|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
143007445|NCT03426995|515566158|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
143007446|NCT03426995|515566159|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
143007447|NCT03426995|515566160|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
143007448|NCT03426995|515566161|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
143007449|NCT03426995|515566162|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
143007450|NCT03426995|515566163|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
143007451|NCT03426995|515566164|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
143007452|NCT03426995|515566165|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
143007453|NCT03426995|515566166|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
143007454|NCT03426995|515566167|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
143007455|NCT03426995|515566168|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
143007456|NCT03426995|515566169|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
143007457|NCT03426995|515566151|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
143007458|NCT03426995|515566152|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
143007459|NCT03426995|515566153|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
143007460|NCT03426995|515566154|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
143007461|NCT03426995|515566155|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
143007462|NCT03426995|515566156|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
143007463|NCT03426995|515566157|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
143007464|NCT03426995|515566158|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
143007465|NCT03426995|515566159|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
143007466|NCT03426995|515566160|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
143007467|NCT03426995|515566161|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
143007468|NCT03426995|515566162|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
143007469|NCT03426995|515566163|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
143007470|NCT03426995|515566164|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
143123537|NCT02757352|515997789|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
143123538|NCT02757352|515997790|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
143123539|NCT02757352|515997791|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
143007471|NCT03426995|515566165|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
143007472|NCT03426995|515566166|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
143007473|NCT03426995|515566167|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
143007474|NCT03426995|515566168|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
143007475|NCT03426995|515566169|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
143007476|NCT03426995|515566151|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
143007477|NCT03426995|515566152|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
143007478|NCT03426995|515566153|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
143007479|NCT03426995|515566154|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
143007480|NCT03426995|515566155|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
143007481|NCT03426995|515566156|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
143007482|NCT03426995|515566157|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
143007483|NCT03426995|515566158|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
143007484|NCT03426995|515566159|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
143007485|NCT03426995|515566160|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
143007486|NCT03426995|515566161|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
143007487|NCT03426995|515566162|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
143007488|NCT03426995|515566163|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
143007489|NCT03426995|515566164|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
143007490|NCT03426995|515566165|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
143007491|NCT03426995|515566166|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
143007492|NCT03426995|515566167|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
143007493|NCT03426995|515566168|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
143007494|NCT03426995|515566169|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
143007495|NCT03426995|515566151|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
143007496|NCT03426995|515566152|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
143007497|NCT03426995|515566153|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
143007498|NCT03426995|515566154|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
143007499|NCT03426995|515566155|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
143007500|NCT03426995|515566156|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
143007501|NCT03426995|515566157|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
143007502|NCT03426995|515566158|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
143007503|NCT03426995|515566159|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
143007504|NCT03426995|515566160|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
143007505|NCT03426995|515566161|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
143007506|NCT03426995|515566162|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
143007507|NCT03426995|515566163|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
143007508|NCT03426995|515566164|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
143007509|NCT03426995|515566165|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
143007510|NCT03426995|515566166|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
143007511|NCT03426995|515566167|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
143007512|NCT03426995|515566168|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
143007513|NCT03426995|515566169|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
143007514|NCT03426995|515566151|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
143007515|NCT03426995|515566152|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
143007516|NCT03426995|515566153|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
143007517|NCT03426995|515566154|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
143007518|NCT03426995|515566155|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
143007519|NCT03426995|515566156|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
143007520|NCT03426995|515566157|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
143007521|NCT03426995|515566158|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
143007522|NCT03426995|515566159|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
143007523|NCT03426995|515566160|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
143007524|NCT03426995|515566161|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
143007525|NCT03426995|515566162|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
143007526|NCT03426995|515566163|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
143007527|NCT03426995|515566164|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
143007528|NCT03426995|515566165|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
143007529|NCT03426995|515566166|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
143007530|NCT03426995|515566167|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
143007531|NCT03426995|515566168|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
143007532|NCT03426995|515566169|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
143007533|NCT03426995|515566151|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
143123540|NCT02757352|515997792|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
143123541|NCT02757352|515997783|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
143123542|NCT02757352|515997784|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
143007534|NCT03426995|515566152|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
143007535|NCT03426995|515566153|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
143007536|NCT03426995|515566154|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
143007537|NCT03426995|515566155|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
143007538|NCT03426995|515566156|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
143007539|NCT03426995|515566157|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
143007540|NCT03426995|515566158|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
143007541|NCT03426995|515566159|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
143007542|NCT03426995|515566160|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
143007543|NCT03426995|515566161|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
143007544|NCT03426995|515566162|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
143007545|NCT03426995|515566163|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
143007546|NCT03426995|515566164|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
143007547|NCT03426995|515566165|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
143007548|NCT03426995|515566166|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
143007549|NCT03426995|515566167|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
143007550|NCT03426995|515566168|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
143007551|NCT03426995|515566169|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
143007552|NCT02335411|515566170|FG000|Overall Study|Death|223|||
143007553|NCT02335411|515566171|FG001|Overall Study|Death|22|||
143007554|NCT02335411|515566172|FG002|Overall Study|Death|26|||
143007555|NCT02335411|515566170|FG000|Overall Study|Physician Decision|3|||
143007556|NCT02335411|515566171|FG001|Overall Study|Physician Decision|0|||
143007557|NCT02335411|515566172|FG002|Overall Study|Physician Decision|0|||
143007558|NCT02335411|515566170|FG000|Overall Study|Protocol Violation|1|||
143007559|NCT02335411|515566171|FG001|Overall Study|Protocol Violation|0|||
143007560|NCT02335411|515566172|FG002|Overall Study|Protocol Violation|0|||
143007561|NCT02335411|515566170|FG000|Overall Study|Withdrawal by Subject|11|||
143007562|NCT02335411|515566171|FG001|Overall Study|Withdrawal by Subject|0|||
143007563|NCT02335411|515566172|FG002|Overall Study|Withdrawal by Subject|3|||
143007564|NCT02335411|515566170|FG000|Overall Study|Sponsor Decision|12|||
143007565|NCT02335411|515566171|FG001|Overall Study|Sponsor Decision|3|||
143007566|NCT02335411|515566172|FG002|Overall Study|Sponsor Decision|2|||
143007567|NCT02335411|515566170|FG000|Overall Study|Adverse Event|9|||
143007568|NCT02335411|515566171|FG001|Overall Study|Adverse Event|0|||
143007569|NCT02335411|515566172|FG002|Overall Study|Adverse Event|0|||
143007570|NCT04150107|515566176|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
143007571|NCT04150107|515566177|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
143007572|NCT04150107|515566176|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
143007573|NCT04150107|515566177|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
143007574|NCT03075826|515566179|FG000|Overall Study|Withdrawal by Subject|1|||
143007575|NCT03075826|515566179|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
143007576|NCT00650806|515566180|FG000|Overall Study|Adverse Event|0|||
143007577|NCT00650806|515566181|FG001|Overall Study|Adverse Event|5|||
143007578|NCT00650806|515566182|FG002|Overall Study|Adverse Event|3|||
143007579|NCT00650806|515566183|FG003|Overall Study|Adverse Event|4|||
143007580|NCT00650806|515566180|FG000|Overall Study|Lost to Follow-up|7|||
143007581|NCT00650806|515566181|FG001|Overall Study|Lost to Follow-up|6|||
143007582|NCT00650806|515566182|FG002|Overall Study|Lost to Follow-up|11|||
143007583|NCT00650806|515566183|FG003|Overall Study|Lost to Follow-up|10|||
143007584|NCT00650806|515566180|FG000|Overall Study|Protocol Violation|0|||
143007585|NCT00650806|515566181|FG001|Overall Study|Protocol Violation|0|||
143007586|NCT00650806|515566182|FG002|Overall Study|Protocol Violation|0|||
143007587|NCT00650806|515566183|FG003|Overall Study|Protocol Violation|1|||
143007588|NCT00650806|515566180|FG000|Overall Study|Pregnancy|0|||
143007589|NCT00650806|515566181|FG001|Overall Study|Pregnancy|0|||
143007590|NCT00650806|515566182|FG002|Overall Study|Pregnancy|0|||
143007591|NCT00650806|515566183|FG003|Overall Study|Pregnancy|1|||
143007592|NCT00650806|515566180|FG000|Overall Study|Withdrawal by Subject|7|||
143007593|NCT00650806|515566181|FG001|Overall Study|Withdrawal by Subject|5|||
143007594|NCT00650806|515566182|FG002|Overall Study|Withdrawal by Subject|8|||
143007595|NCT00650806|515566183|FG003|Overall Study|Withdrawal by Subject|6|||
143007596|NCT00650806|515566180|FG000|Overall Study|Noncompliance with study drug regimen|1|||
143346389|NCT00584805|516814315|FG000|Overall Study|Non-compliance|1|||
143007597|NCT00650806|515566181|FG001|Overall Study|Noncompliance with study drug regimen|1|||
143007598|NCT00650806|515566182|FG002|Overall Study|Noncompliance with study drug regimen|0|||
143007599|NCT00650806|515566183|FG003|Overall Study|Noncompliance with study drug regimen|0|||
143007600|NCT00650806|515566180|FG000|Overall Study|Study terminated by sponsor|2|||
143007601|NCT00650806|515566181|FG001|Overall Study|Study terminated by sponsor|3|||
143007602|NCT00650806|515566182|FG002|Overall Study|Study terminated by sponsor|5|||
143007603|NCT00650806|515566183|FG003|Overall Study|Study terminated by sponsor|4|||
143007604|NCT00650806|515566180|FG000|Overall Study|Other|1|||
143007605|NCT00650806|515566181|FG001|Overall Study|Other|1|||
143007606|NCT00650806|515566182|FG002|Overall Study|Other|2|||
143007607|NCT00650806|515566183|FG003|Overall Study|Other|0|||
143007608|NCT04221477|515566184|FG000|Overall Study|Adverse Event|1|||
143007609|NCT04221477|515566185|FG001|Overall Study|Adverse Event|1|||
143007610|NCT04221477|515566184|FG000|Overall Study|Death|5|||
143007611|NCT04221477|515566185|FG001|Overall Study|Death|4|||
143007612|NCT04221477|515566184|FG000|Overall Study|Lack of Efficacy|1|||
143007613|NCT04221477|515566185|FG001|Overall Study|Lack of Efficacy|2|||
143007614|NCT04221477|515566184|FG000|Overall Study|Lost to Follow-up|1|||
143007615|NCT04221477|515566185|FG001|Overall Study|Lost to Follow-up|2|||
143007616|NCT04221477|515566184|FG000|Overall Study|Non-compliance with Study Drug|1|||
143007617|NCT04221477|515566185|FG001|Overall Study|Non-compliance with Study Drug|0|||
143007618|NCT04221477|515566184|FG000|Overall Study|Reason not Specified|0|||
143007619|NCT04221477|515566185|FG001|Overall Study|Reason not Specified|5|||
143007620|NCT04221477|515566184|FG000|Overall Study|Physician Decision|0|||
143007621|NCT04221477|515566185|FG001|Overall Study|Physician Decision|6|||
143007622|NCT04221477|515566184|FG000|Overall Study|Withdrawal by Subject|10|||
143007623|NCT04221477|515566185|FG001|Overall Study|Withdrawal by Subject|14|||
143007624|NCT04221477|515566184|FG000|Overall Study|Ongoing in the Study|116|||
143007625|NCT04221477|515566185|FG001|Overall Study|Ongoing in the Study|102|||
143007626|NCT04455620|515566186|FG000|Overall Study|Withdrawal by Subject|0|||
143007627|NCT04455620|515566187|FG001|Overall Study|Withdrawal by Subject|0|||
143007628|NCT04455620|515566188|FG002|Overall Study|Withdrawal by Subject|2|||
143007629|NCT04455620|515566189|FG003|Overall Study|Withdrawal by Subject|0|||
143007630|NCT04455620|515566190|FG004|Overall Study|Withdrawal by Subject|1|||
143007631|NCT04455620|515566186|FG000|Overall Study|Lost to Follow-up|0|||
143007632|NCT04455620|515566187|FG001|Overall Study|Lost to Follow-up|0|||
143007633|NCT04455620|515566188|FG002|Overall Study|Lost to Follow-up|1|||
143007634|NCT04455620|515566189|FG003|Overall Study|Lost to Follow-up|1|||
143007635|NCT04455620|515566190|FG004|Overall Study|Lost to Follow-up|0|||
143007636|NCT04455620|515566186|FG000|Overall Study|Death|1|||
143007637|NCT04455620|515566187|FG001|Overall Study|Death|6|||
143007638|NCT04455620|515566188|FG002|Overall Study|Death|20|||
143007639|NCT04455620|515566189|FG003|Overall Study|Death|1|||
143007640|NCT04455620|515566190|FG004|Overall Study|Death|7|||
143007641|NCT04455620|515566186|FG000|Overall Study|Study Termination|0|||
143007642|NCT04455620|515566187|FG001|Overall Study|Study Termination|2|||
143007643|NCT04455620|515566188|FG002|Overall Study|Study Termination|1|||
143007644|NCT04455620|515566189|FG003|Overall Study|Study Termination|0|||
143007645|NCT04455620|515566190|FG004|Overall Study|Study Termination|6|||
143007646|NCT05012943|515566191|FG000|Overall Study|Adverse Event|2|||
143007647|NCT05012943|515566192|FG001|Overall Study|Adverse Event|1|||
143007648|NCT05012943|515566193|FG002|Overall Study|Adverse Event|0|||
143007649|NCT05012943|515566191|FG000|Overall Study|Withdrawal by Subject|1052|||
143007650|NCT05012943|515566192|FG001|Overall Study|Withdrawal by Subject|1006|||
143007651|NCT05012943|515566193|FG002|Overall Study|Withdrawal by Subject|20|||
143007652|NCT05012943|515566191|FG000|Overall Study|Death|25|||
143007653|NCT05012943|515566192|FG001|Overall Study|Death|17|||
143007654|NCT05012943|515566193|FG002|Overall Study|Death|4|||
143007655|NCT05012943|515566191|FG000|Overall Study|Lost to Follow-up|11|||
143007656|NCT05012943|515566192|FG001|Overall Study|Lost to Follow-up|24|||
143007657|NCT05012943|515566193|FG002|Overall Study|Lost to Follow-up|3|||
143007658|NCT05012943|515566191|FG000|Overall Study|Physician Decision|1|||
143007659|NCT05012943|515566192|FG001|Overall Study|Physician Decision|1|||
143007660|NCT05012943|515566193|FG002|Overall Study|Physician Decision|0|||
143007661|NCT05012943|515566191|FG000|Overall Study|Other than Specified|2|||
143007662|NCT05012943|515566192|FG001|Overall Study|Other than Specified|1|||
143007663|NCT05012943|515566193|FG002|Overall Study|Other than Specified|0|||
143007664|NCT04228107|515566194|FG000|Overall Study|Protocol Violation|1|||
143007665|NCT04228107|515566195|FG001|Overall Study|Protocol Violation|0|||
143007666|NCT04228107|515566194|FG000|Overall Study|Withdrawal by Subject|6|||
143007667|NCT04228107|515566195|FG001|Overall Study|Withdrawal by Subject|0|||
143007668|NCT04228107|515566194|FG000|Overall Study|Lost to Follow-up|18|||
143007669|NCT04228107|515566195|FG001|Overall Study|Lost to Follow-up|0|||
143007670|NCT04228107|515566194|FG000|Overall Study|No controller use data|1|||
143007671|NCT04228107|515566195|FG001|Overall Study|No controller use data|0|||
143007672|NCT04228107|515566194|FG000|Overall Study|No medication data collected|1|||
143007673|NCT04228107|515566195|FG001|Overall Study|No medication data collected|0|||
143007674|NCT00400985|515566196|FG000|Overall Study|Withdrawal by Subject|5|||
143007675|NCT00400985|515566196|FG000|Overall Study|system modification|8|||
143007676|NCT00400985|515566196|FG000|Overall Study|Death|30|||
143007677|NCT00400985|515566196|FG000|Overall Study|Lost to Follow-up|9|||
143007678|NCT00965562|515566197|FG000|Overall Study|Lost to Follow-up|1|||
143007679|NCT00965562|515566198|FG001|Overall Study|Lost to Follow-up|2|||
143007680|NCT00965562|515566199|FG002|Overall Study|Lost to Follow-up|3|||
143007681|NCT00965562|515566197|FG000|Overall Study|Withdrawal by Subject|2|||
143007682|NCT00965562|515566198|FG001|Overall Study|Withdrawal by Subject|2|||
143007683|NCT00965562|515566199|FG002|Overall Study|Withdrawal by Subject|0|||
143007684|NCT03792633|515566200|FG000|Overall Study|Alternative Treatment|17|||
143007685|NCT03792633|515566201|FG001|Overall Study|Alternative Treatment|19|||
143007686|NCT03792633|515566200|FG000|Overall Study|Death|2|||
143461082|NCT03570892|517232988|FG001|Overall Study|Protocol Violation|4|||
143461083|NCT03570892|517232987|FG000|Overall Study|Physician Decision|0|||
143461084|NCT03570892|517232988|FG001|Overall Study|Physician Decision|2|||
143461085|NCT00729378|517234928|FG000|Baseline|Did not complete study measurements|72|||
143461086|NCT00729378|517234929|FG001|Baseline|Did not complete study measurements|33|||
143461087|NCT00729378|517234928|FG000|Baseline|Withdrawal by Subject|66|||
143461088|NCT00729378|517234929|FG001|Baseline|Withdrawal by Subject|59|||
143461089|NCT00729378|517234928|FG000|12-months|Lost to Follow-up|100|||
143461090|NCT00729378|517234929|FG001|12-months|Lost to Follow-up|65|||
143461091|NCT00729378|517234928|FG000|24-months|Lost to Follow-up|72|||
143461092|NCT00729378|517234929|FG001|24-months|Lost to Follow-up|51|||
143461093|NCT00729378|517234928|FG000|36-months|Lost to Follow-up|15|||
143461094|NCT00729378|517234929|FG001|36-months|Lost to Follow-up|6|||
143461095|NCT01328717|517234938|FG000|Overall Study|Adverse Event|1|||
143461096|NCT00031551|517234939|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
143461097|NCT00031551|517234940|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
143461098|NCT01177722|517234943|FG000|Overall Study|Serious Adverse Event|0|||
143461099|NCT01177722|517234944|FG001|Overall Study|Serious Adverse Event|0|||
143461100|NCT01177722|517234945|FG002|Overall Study|Serious Adverse Event|1|||
143461101|NCT01177722|517234946|FG003|Overall Study|Serious Adverse Event|0|||
143461102|NCT01177722|517234943|FG000|Overall Study|Protocol Violation|0|||
143461103|NCT01177722|517234944|FG001|Overall Study|Protocol Violation|0|||
143461104|NCT01177722|517234945|FG002|Overall Study|Protocol Violation|1|||
143461105|NCT01177722|517234946|FG003|Overall Study|Protocol Violation|0|||
143461106|NCT01177722|517234943|FG000|Overall Study|Lost to Follow-up|3|||
143461107|NCT01177722|517234944|FG001|Overall Study|Lost to Follow-up|4|||
143461108|NCT01177722|517234945|FG002|Overall Study|Lost to Follow-up|3|||
143461109|NCT01177722|517234946|FG003|Overall Study|Lost to Follow-up|1|||
143461110|NCT01177722|517234943|FG000|Overall Study|Withdrawal by Subject|10|||
143461111|NCT01177722|517234944|FG001|Overall Study|Withdrawal by Subject|6|||
143461112|NCT01177722|517234945|FG002|Overall Study|Withdrawal by Subject|4|||
143461113|NCT01177722|517234946|FG003|Overall Study|Withdrawal by Subject|6|||
143461114|NCT03057977|517234953|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
143461115|NCT03057977|517234954|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
143461116|NCT03057977|517234953|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
143461117|NCT03057977|517234954|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
143461118|NCT03057977|517234953|FG000|Discontinuation From Treatment|Protocol Violation|6|||
143461119|NCT03057977|517234954|FG001|Discontinuation From Treatment|Protocol Violation|5|||
143461120|NCT03057977|517234953|FG000|Discontinuation From Treatment|Not treated|4|||
143461121|NCT03057977|517234954|FG001|Discontinuation From Treatment|Not treated|0|||
143461122|NCT03057977|517234953|FG000|Discontinuation From Treatment|Adverse Event|343|||
143461123|NCT03057977|517234954|FG001|Discontinuation From Treatment|Adverse Event|337|||
143461124|NCT03057977|517234953|FG000|Discontinuation From Treatment|Reason Unknown|0|||
143461125|NCT03057977|517234954|FG001|Discontinuation From Treatment|Reason Unknown|1|||
143461126|NCT03057977|517234953|FG000|Discontinuation From Treatment|Personal Reasons|1|||
143461127|NCT03057977|517234954|FG001|Discontinuation From Treatment|Personal Reasons|1|||
143461128|NCT03057977|517234953|FG000|Discontinuation From Treatment|Unblinded medication|1|||
143461129|NCT03057977|517234954|FG001|Discontinuation From Treatment|Unblinded medication|0|||
143461130|NCT03057977|517234953|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
143461131|NCT03057977|517234954|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
143461132|NCT03057977|517234953|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
143461133|NCT03057977|517234954|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
143461134|NCT03057977|517234953|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
143461135|NCT03057977|517234954|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
143461136|NCT03057977|517234953|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
143461137|NCT03057977|517234954|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
143461138|NCT03057977|517234953|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
143461139|NCT03057977|517234954|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
143461140|NCT03057977|517234953|FG000|Discontinuation From Treatment|Not attending study visit|3|||
143461141|NCT03057977|517234954|FG001|Discontinuation From Treatment|Not attending study visit|10|||
143461142|NCT03057977|517234953|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
143461143|NCT03057977|517234954|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
143461144|NCT03057977|517234953|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
143461145|NCT03057977|517234954|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
143461146|NCT03057977|517234953|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
143461147|NCT03057977|517234954|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
143461148|NCT03057977|517234953|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
143461149|NCT03057977|517234954|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
143461150|NCT03057977|517234953|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
143461151|NCT03057977|517234954|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
143007687|NCT03792633|515566201|FG001|Overall Study|Death|0|||
143007688|NCT03792633|515566200|FG000|Overall Study|Disease progression|8|||
143007689|NCT03792633|515566201|FG001|Overall Study|Disease progression|9|||
143007690|NCT03792633|515566200|FG000|Overall Study|Lost to Follow-up|1|||
143007691|NCT03792633|515566201|FG001|Overall Study|Lost to Follow-up|1|||
143007692|NCT03792633|515566200|FG000|Overall Study|Screen fail|1|||
143007693|NCT03792633|515566201|FG001|Overall Study|Screen fail|0|||
143007694|NCT03792633|515566200|FG000|Overall Study|Second malignancy|0|||
143007695|NCT03792633|515566201|FG001|Overall Study|Second malignancy|1|||
143007696|NCT05048875|515566203|FG000|Overall Study|Withdrawal by Subject|1|||
143007697|NCT05048875|515566204|FG001|Overall Study|Withdrawal by Subject|0|||
143007698|NCT05048875|515566205|FG002|Overall Study|Withdrawal by Subject|0|||
143007699|NCT05048875|515566206|FG003|Overall Study|Withdrawal by Subject|0|||
143007700|NCT05048875|515566207|FG004|Overall Study|Withdrawal by Subject|0|||
143007701|NCT05048875|515566208|FG005|Overall Study|Withdrawal by Subject|0|||
143007702|NCT05048875|515566209|FG006|Overall Study|Withdrawal by Subject|0|||
143007703|NCT05048875|515566210|FG007|Overall Study|Withdrawal by Subject|0|||
143007704|NCT05048875|515566203|FG000|Overall Study|Adverse Event|0|||
143007705|NCT05048875|515566204|FG001|Overall Study|Adverse Event|0|||
143007706|NCT05048875|515566205|FG002|Overall Study|Adverse Event|0|||
143007707|NCT05048875|515566206|FG003|Overall Study|Adverse Event|1|||
143007708|NCT05048875|515566207|FG004|Overall Study|Adverse Event|0|||
143007709|NCT05048875|515566208|FG005|Overall Study|Adverse Event|0|||
143007710|NCT05048875|515566209|FG006|Overall Study|Adverse Event|0|||
143007711|NCT05048875|515566210|FG007|Overall Study|Adverse Event|0|||
143007712|NCT02951130|515566217|FG000|Overall Study|Protocol Violation|1|||
143007713|NCT02951130|515566218|FG001|Overall Study|Protocol Violation|1|||
143007714|NCT04242498|515566219|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
143007715|NCT04242498|515566220|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
143007716|NCT04242498|515566221|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
143007717|NCT04242498|515566222|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
143007718|NCT04242498|515566223|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
143007719|NCT04242498|515566224|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
143007720|NCT04242498|515566225|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
143007721|NCT04242498|515566219|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
143007722|NCT04242498|515566220|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
143007723|NCT04242498|515566221|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
143007724|NCT04242498|515566222|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
143007725|NCT04242498|515566223|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
143007726|NCT04242498|515566224|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
143007727|NCT04242498|515566225|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
143007728|NCT04242498|515566219|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
143007729|NCT04242498|515566220|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
143007730|NCT04242498|515566221|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
143007731|NCT04242498|515566222|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
143007732|NCT04242498|515566223|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
143007733|NCT04242498|515566224|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
143007734|NCT04242498|515566225|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
143007735|NCT04242498|515566219|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
143007736|NCT04242498|515566220|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
143007737|NCT04242498|515566221|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
143007738|NCT04242498|515566222|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
143007739|NCT04242498|515566223|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
143007740|NCT04242498|515566224|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
143007741|NCT04242498|515566225|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
143007742|NCT04242498|515566219|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
143007743|NCT04242498|515566220|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
143007744|NCT04242498|515566221|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
143007745|NCT04242498|515566222|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
143007746|NCT04242498|515566223|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
143007747|NCT04242498|515566224|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
143007748|NCT04242498|515566225|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
143007749|NCT04242498|515566219|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
143007750|NCT04242498|515566220|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
143007751|NCT04242498|515566221|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
143007752|NCT04242498|515566222|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
143007753|NCT04242498|515566223|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
143007754|NCT04242498|515566224|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
143007755|NCT04242498|515566225|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
143007756|NCT04242498|515566219|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
143007757|NCT04242498|515566220|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
143007758|NCT04242498|515566221|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
143007759|NCT04242498|515566222|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
143007760|NCT04242498|515566223|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
143007761|NCT04242498|515566224|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
143007762|NCT04242498|515566225|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
143007763|NCT04242498|515566219|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
143007764|NCT04242498|515566220|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
143007765|NCT04242498|515566221|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
143007766|NCT04242498|515566222|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
143007767|NCT04242498|515566223|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
143007768|NCT04242498|515566224|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
143007769|NCT04242498|515566225|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
143007770|NCT04242498|515566219|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
143007771|NCT04242498|515566220|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
143007772|NCT04242498|515566221|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
143007773|NCT04242498|515566222|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
143007774|NCT04242498|515566223|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
143007775|NCT04242498|515566224|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
143007776|NCT04242498|515566225|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
143007777|NCT04242498|515566219|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
143007778|NCT04242498|515566220|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
143007779|NCT04242498|515566221|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
143007780|NCT04242498|515566222|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
143007781|NCT04242498|515566223|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
143007782|NCT04242498|515566224|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
143007783|NCT04242498|515566225|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
143007784|NCT04242498|515566219|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
143007785|NCT04242498|515566220|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
143007786|NCT04242498|515566221|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
143007787|NCT04242498|515566222|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
143007788|NCT04242498|515566223|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
143007789|NCT04242498|515566224|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
143007790|NCT04242498|515566225|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
143007791|NCT04242498|515566219|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
143007792|NCT04242498|515566220|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
143007793|NCT04242498|515566221|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
143007794|NCT04242498|515566222|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
143007795|NCT04242498|515566223|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
143007796|NCT04242498|515566224|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
143007797|NCT04242498|515566225|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
143007798|NCT04242498|515566219|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
143007799|NCT04242498|515566220|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
143007800|NCT04242498|515566221|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
143007801|NCT04242498|515566222|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
143007802|NCT04242498|515566223|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
143007803|NCT04242498|515566224|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
143007804|NCT04242498|515566225|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
143007805|NCT04242498|515566219|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
143007806|NCT04242498|515566220|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
143007807|NCT04242498|515566221|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
143007808|NCT04242498|515566222|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
143007809|NCT04242498|515566223|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
143007810|NCT04242498|515566224|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
143007811|NCT04242498|515566225|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
143007812|NCT04242498|515566219|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
143346390|NCT00584805|516814315|FG000|Overall Study|Lost to follow up|3|||
143007813|NCT04242498|515566220|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
143007814|NCT04242498|515566221|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
143007815|NCT04242498|515566222|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
143007816|NCT04242498|515566223|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
143007817|NCT04242498|515566224|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
143007818|NCT04242498|515566225|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
143007819|NCT04242498|515566219|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
143007820|NCT04242498|515566220|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
143007821|NCT04242498|515566221|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
143007822|NCT04242498|515566222|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
143007823|NCT04242498|515566223|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
143007824|NCT04242498|515566224|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
143007825|NCT04242498|515566225|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
143007826|NCT02684162|515566226|FG000|Overall Study|Physician Decision|0|||
143007827|NCT02684162|515566227|FG001|Overall Study|Physician Decision|1|||
143007828|NCT02684162|515566228|FG002|Overall Study|Physician Decision|0|||
143007829|NCT05153629|515566229|FG000|Overall Study|Withdrawal by Subject|0|||
143007830|NCT05153629|515566230|FG001|Overall Study|Withdrawal by Subject|2|||
143007831|NCT00828009|515566235|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
143007832|NCT00828009|515566235|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
143007833|NCT00828009|515566235|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
143007834|NCT00828009|515566235|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
143007835|NCT00828009|515566235|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
143007836|NCT00828009|515566235|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
143007837|NCT00828009|515566235|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
143007838|NCT00828009|515566235|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
143007839|NCT00828009|515566235|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
143007840|NCT00828009|515566235|FG000|Step 2 - Maintenance Therapy|Death|1|||
143007841|NCT00828009|515566235|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
143007842|NCT00828009|515566235|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
143007843|NCT00828009|515566235|FG000|Step 2 - Maintenance Therapy|Other|1|||
143007844|NCT00795886|515566236|FG000|Overall Study|Death|10|||
143007845|NCT04075656|515566244|FG000|Overall Study|Withdrawal by Subject|5|||
143007846|NCT04075656|515566245|FG001|Overall Study|Withdrawal by Subject|5|||
143007847|NCT04478994|515567881|FG000|Overall Study|Withdrawal by Subject|1|||
143007848|NCT04478994|515567882|FG001|Overall Study|Withdrawal by Subject|1|||
143007849|NCT01100073|515567883|FG000|Overall Study|Lack of Efficacy|4|||
143007850|NCT01100073|515567883|FG000|Overall Study|Insufficient Tolerability|21|||
143007851|NCT01100073|515567883|FG000|Overall Study|Withdrawal by Subject|13|||
143007852|NCT01100073|515567883|FG000|Overall Study|Lost to Follow-up|39|||
143007853|NCT01100073|515567883|FG000|Overall Study|Lack of effect + patient's wish|2|||
143007854|NCT01100073|515567883|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
143007855|NCT01100073|515567883|FG000|Overall Study|Other|8|||
143007856|NCT01100073|515567883|FG000|Overall Study|Missing|5|||
143007857|NCT00299546|515567884|FG000|Overall Study|Death|3|||
143007858|NCT00299546|515567885|FG001|Overall Study|Death|2|||
143007859|NCT00299546|515567886|FG002|Overall Study|Death|0|||
143007860|NCT00299546|515567884|FG000|Overall Study|Lost to Follow-up|2|||
143007861|NCT00299546|515567885|FG001|Overall Study|Lost to Follow-up|2|||
143007862|NCT00299546|515567886|FG002|Overall Study|Lost to Follow-up|5|||
143007863|NCT00299546|515567884|FG000|Overall Study|Adverse Event|37|||
143007864|NCT00299546|515567885|FG001|Overall Study|Adverse Event|22|||
143007865|NCT00299546|515567886|FG002|Overall Study|Adverse Event|27|||
143007866|NCT00299546|515567884|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
143007867|NCT00299546|515567885|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
143007868|NCT00299546|515567886|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
143007869|NCT00299546|515567884|FG000|Overall Study|Other|24|||
143007870|NCT00299546|515567885|FG001|Overall Study|Other|26|||
143007871|NCT00299546|515567886|FG002|Overall Study|Other|19|||
143007872|NCT00299546|515567884|FG000|Overall Study|Not treated|0|||
143007873|NCT00299546|515567885|FG001|Overall Study|Not treated|1|||
143007874|NCT00299546|515567886|FG002|Overall Study|Not treated|1|||
143007875|NCT03099265|515567887|FG000|Overall Study|Adverse Event|1|||
143007876|NCT01656850|515567900|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
143007877|NCT01656850|515567901|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
143007878|NCT02674568|515567902|FG000|Overall Study|Withdrawal by Subject|5|||
143007879|NCT02674568|515567902|FG000|Overall Study|Death|303|||
143007880|NCT02674568|515567902|FG000|Overall Study|Physician Decision|2|||
143007881|NCT02674568|515567902|FG000|Overall Study|Lost to Follow-up|9|||
143007882|NCT02674568|515567902|FG000|Overall Study|Other, Not Specified|20|||
143007883|NCT00396318|515567903|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
143007884|NCT01118949|515567904|FG000|Overall Study|Adverse Event|5|||
143007885|NCT01118949|515567904|FG000|Overall Study|Withdrawal by Subject|4|||
143007886|NCT03255226|515567910|FG000|Overall Study|Adverse Event|2|||
143007887|NCT03255226|515567910|FG000|Overall Study|Physician Decision|3|||
143007888|NCT03255226|515567910|FG000|Overall Study|Withdrawal by Subject|1|||
143007889|NCT03255226|515567910|FG000|Overall Study|Serum or blood sodium increased|4|||
143007890|NCT03255226|515567910|FG000|Overall Study|Serum or blood potassium increased|4|||
143007891|NCT00602927|515567911|FG000|Period 1: 13 Days|Protocol Violation|2|||
143007892|NCT00602927|515567912|FG001|Period 1: 13 Days|Protocol Violation|4|||
143007893|NCT00602927|515567911|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
143007894|NCT00602927|515567912|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
143007895|NCT00602927|515567911|FG000|Period 1: 13 Days|Time|1|||
143007896|NCT00602927|515567912|FG001|Period 1: 13 Days|Time|0|||
143007897|NCT00602927|515567911|FG000|Period 1: 13 Days|Claustrophobia|0|||
143007898|NCT00602927|515567912|FG001|Period 1: 13 Days|Claustrophobia|1|||
143007899|NCT00602927|515567911|FG000|Period 2: 14 Days|Protocol Violation|0|||
143007900|NCT00602927|515567912|FG001|Period 2: 14 Days|Protocol Violation|2|||
143007901|NCT00602927|515567911|FG000|Period 3: 13 Days|Protocol Violation|0|||
143007902|NCT00602927|515567912|FG001|Period 3: 13 Days|Protocol Violation|1|||
143007903|NCT00602927|515567911|FG000|Period 3: 13 Days|MRI data quality|2|||
143007904|NCT00602927|515567912|FG001|Period 3: 13 Days|MRI data quality|2|||
143007905|NCT00685763|515567919|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
143007906|NCT00685763|515567919|FG000|Overall Study|Protocol Violation|1|||
143007907|NCT01741259|515567920|FG000|Overall Study|Protocol Violation|6|||
143007908|NCT01741259|515567921|FG001|Overall Study|Protocol Violation|4|||
143007909|NCT01741259|515567920|FG000|Overall Study|Withdrawal by Subject|0|||
143007910|NCT01741259|515567921|FG001|Overall Study|Withdrawal by Subject|2|||
143007911|NCT02074982|515567922|FG000|Overall Study|Adverse Event|15|||
143007912|NCT02074982|515567923|FG001|Overall Study|Adverse Event|7|||
143007913|NCT02074982|515567922|FG000|Overall Study|Lack of Efficacy|6|||
143007914|NCT02074982|515567923|FG001|Overall Study|Lack of Efficacy|1|||
143007915|NCT02074982|515567922|FG000|Overall Study|Lost to Follow-up|9|||
143007916|NCT02074982|515567923|FG001|Overall Study|Lost to Follow-up|10|||
143007917|NCT02074982|515567922|FG000|Overall Study|Non-compliance with study treatment|0|||
143007918|NCT02074982|515567923|FG001|Overall Study|Non-compliance with study treatment|2|||
143007919|NCT02074982|515567922|FG000|Overall Study|Physician Decision|1|||
143007920|NCT02074982|515567923|FG001|Overall Study|Physician Decision|1|||
143007921|NCT02074982|515567922|FG000|Overall Study|Pregnancy|1|||
143007922|NCT02074982|515567923|FG001|Overall Study|Pregnancy|2|||
143007923|NCT02074982|515567922|FG000|Overall Study|Protocol deviation|4|||
143007924|NCT02074982|515567923|FG001|Overall Study|Protocol deviation|3|||
143007925|NCT02074982|515567922|FG000|Overall Study|Technical problems|0|||
143007926|NCT02074982|515567923|FG001|Overall Study|Technical problems|2|||
143007927|NCT02074982|515567922|FG000|Overall Study|Subject/guardian decision|15|||
143007928|NCT02074982|515567923|FG001|Overall Study|Subject/guardian decision|24|||
143007929|NCT02074982|515567922|FG000|Overall Study|Death|0|||
143007930|NCT02074982|515567923|FG001|Overall Study|Death|2|||
143007931|NCT02094573|515567926|FG000|Overall Study|Adverse Event|4|||
143007932|NCT02094573|515567927|FG001|Overall Study|Adverse Event|14|||
143007933|NCT02094573|515567926|FG000|Overall Study|Clinical Progressive Disease|9|||
143007934|NCT02094573|515567927|FG001|Overall Study|Clinical Progressive Disease|13|||
143007935|NCT02094573|515567926|FG000|Overall Study|Death|11|||
143007936|NCT02094573|515567927|FG001|Overall Study|Death|3|||
143007937|NCT02094573|515567926|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
143007938|NCT02094573|515567927|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
143007939|NCT02094573|515567926|FG000|Overall Study|Non-compliance with Study Drug|1|||
143007940|NCT02094573|515567927|FG001|Overall Study|Non-compliance with Study Drug|1|||
143007941|NCT02094573|515567926|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
143007942|NCT02094573|515567927|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
143007943|NCT02094573|515567926|FG000|Overall Study|Physician Decision|4|||
143007944|NCT02094573|515567927|FG001|Overall Study|Physician Decision|4|||
143007945|NCT02094573|515567926|FG000|Overall Study|Site Terminated by Sponsor|10|||
143007946|NCT02094573|515567927|FG001|Overall Study|Site Terminated by Sponsor|17|||
143007947|NCT02094573|515567926|FG000|Overall Study|Withdrawal by Subject|6|||
143007948|NCT02094573|515567927|FG001|Overall Study|Withdrawal by Subject|8|||
143007949|NCT02094573|515567926|FG000|Overall Study|Randomized but not Treated|3|||
143007950|NCT02094573|515567927|FG001|Overall Study|Randomized but not Treated|0|||
143007951|NCT02875340|515567929|FG000|Overall Study|Death|2|||
143007952|NCT02875340|515567929|FG000|Overall Study|Withdrawal by Subject|2|||
143007953|NCT02875340|515567929|FG000|Overall Study|Physician Decision|3|||
143007954|NCT02875340|515567929|FG000|Overall Study|Adverse Event|1|||
143007955|NCT01160770|515567930|FG000|Overall Study|Adverse Event|10|||
143007956|NCT01160770|515567930|FG000|Overall Study|Protocol Violation|2|||
143007957|NCT01160770|515567930|FG000|Overall Study|Subject/parent/caregiver request|33|||
143007958|NCT01160770|515567930|FG000|Overall Study|Physician Decision|1|||
143007959|NCT01160770|515567930|FG000|Overall Study|Lost to Follow-up|7|||
143007960|NCT01160770|515567930|FG000|Overall Study|Study termination or sponsor request|1|||
143007961|NCT01160770|515567930|FG000|Overall Study|Death|9|||
143007962|NCT01160770|515567930|FG000|Overall Study|Lack of Efficacy|15|||
143007963|NCT01160770|515567930|FG000|Overall Study|Other Reasons|1|||
143007964|NCT00526162|515567931|FG000|Overall Study|Device not implanted|3|||
143007965|NCT00348348|515567932|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
143007966|NCT00348348|515567933|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
143007967|NCT00348348|515567932|FG000|Overall Study|Lack of Efficacy|1|||
143007968|NCT00348348|515567933|FG001|Overall Study|Lack of Efficacy|1|||
143007969|NCT00348348|515567932|FG000|Overall Study|Lost to Follow-up|8|||
143007970|NCT00348348|515567933|FG001|Overall Study|Lost to Follow-up|10|||
143007971|NCT00348348|515567932|FG000|Overall Study|Withdrawal by Subject|4|||
143007972|NCT00348348|515567933|FG001|Overall Study|Withdrawal by Subject|1|||
143007973|NCT00348348|515567932|FG000|Overall Study|Other|7|||
143007974|NCT00348348|515567933|FG001|Overall Study|Other|4|||
143007975|NCT00348348|515567932|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
143007976|NCT00348348|515567933|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
143007977|NCT00348348|515567932|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
143007978|NCT00348348|515567933|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
143007979|NCT00348348|515567932|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
143007980|NCT00348348|515567933|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
143007981|NCT00348348|515567932|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
143007982|NCT00348348|515567933|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
143007983|NCT00348348|515567932|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
143007984|NCT00348348|515567933|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
143007985|NCT00348348|515567932|FG000|Overall Study|Adverse event probably related to study|1|||
143007986|NCT00348348|515567933|FG001|Overall Study|Adverse event probably related to study|0|||
143007987|NCT01605370|515567936|FG000|Overall Study|Adverse Event|1|||
143007988|NCT01605370|515567937|FG001|Overall Study|Adverse Event|0|||
143007989|NCT04764669|515567940|FG000|Overall Study|Adverse Event|1|||
143007990|NCT04764669|515567941|FG001|Overall Study|Adverse Event|0|||
143007991|NCT04764669|515567942|FG002|Overall Study|Adverse Event|1|||
143007992|NCT04764669|515567943|FG003|Overall Study|Adverse Event|0|||
143007993|NCT04764669|515567940|FG000|Overall Study|Subject Choice|0|||
143007994|NCT04764669|515567941|FG001|Overall Study|Subject Choice|0|||
143007995|NCT04764669|515567942|FG002|Overall Study|Subject Choice|1|||
143461152|NCT00953407|517234955|FG000|Overall Study|Failed inclusion criteria|1|||
143461153|NCT00953407|517234956|FG001|Overall Study|Failed inclusion criteria|1|||
143461154|NCT00953407|517234957|FG002|Overall Study|Failed inclusion criteria|1|||
143461155|NCT00953407|517234958|FG003|Overall Study|Failed inclusion criteria|1|||
143461156|NCT00953407|517234959|FG004|Overall Study|Failed inclusion criteria|1|||
143461157|NCT00953407|517234955|FG000|Overall Study|Lost to Follow-up|0|||
143461158|NCT00953407|517234956|FG001|Overall Study|Lost to Follow-up|0|||
143461159|NCT00953407|517234957|FG002|Overall Study|Lost to Follow-up|0|||
143461160|NCT00953407|517234958|FG003|Overall Study|Lost to Follow-up|1|||
143461161|NCT00953407|517234959|FG004|Overall Study|Lost to Follow-up|0|||
143461162|NCT01201317|517234960|FG000|Overall Study|Withdrawal by Subject|5|||
143461163|NCT01201317|517234961|FG001|Overall Study|Withdrawal by Subject|0|||
143461164|NCT01201317|517234962|FG002|Overall Study|Withdrawal by Subject|3|||
143461165|NCT01201317|517234960|FG000|Overall Study|Adverse Event|2|||
143461166|NCT01201317|517234961|FG001|Overall Study|Adverse Event|2|||
143461167|NCT01201317|517234962|FG002|Overall Study|Adverse Event|2|||
143461168|NCT01201317|517234960|FG000|Overall Study|Screen failure|1|||
143461169|NCT01201317|517234961|FG001|Overall Study|Screen failure|1|||
143461170|NCT01201317|517234962|FG002|Overall Study|Screen failure|0|||
143461171|NCT01201317|517234960|FG000|Overall Study|Protocol Violation|0|||
143461172|NCT01201317|517234961|FG001|Overall Study|Protocol Violation|1|||
143461173|NCT01201317|517234962|FG002|Overall Study|Protocol Violation|1|||
143461174|NCT01201317|517234960|FG000|Overall Study|Death|0|||
143461175|NCT01201317|517234961|FG001|Overall Study|Death|1|||
143007996|NCT04764669|515567943|FG003|Overall Study|Subject Choice|0|||
143007997|NCT04764669|515567940|FG000|Overall Study|Withdrawal by Subject|2|||
143007998|NCT04764669|515567941|FG001|Overall Study|Withdrawal by Subject|0|||
143007999|NCT04764669|515567942|FG002|Overall Study|Withdrawal by Subject|0|||
143008000|NCT04764669|515567943|FG003|Overall Study|Withdrawal by Subject|0|||
143461176|NCT01201317|517234962|FG002|Overall Study|Death|0|||
143461177|NCT01201317|517234960|FG000|Overall Study|Study-specific withdrawal criteria|0|||
143461178|NCT01201317|517234961|FG001|Overall Study|Study-specific withdrawal criteria|0|||
143461179|NCT01201317|517234962|FG002|Overall Study|Study-specific withdrawal criteria|1|||
143461180|NCT01201317|517234960|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
143461181|NCT01201317|517234961|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
143461182|NCT01201317|517234962|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
143461183|NCT01201317|517234960|FG000|Overall Study|Decrease in renal function|0|||
143461184|NCT01201317|517234961|FG001|Overall Study|Decrease in renal function|1|||
143461185|NCT01201317|517234962|FG002|Overall Study|Decrease in renal function|0|||
143461186|NCT01201317|517234960|FG000|Overall Study|Lack of Efficacy|1|||
143461187|NCT01201317|517234961|FG001|Overall Study|Lack of Efficacy|0|||
143008001|NCT00890409|515567944|FG000|Overall Study|Lost to Follow-up|20|||
143008002|NCT00890409|515567945|FG001|Overall Study|Lost to Follow-up|21|||
143008003|NCT02255422|515567948|FG000|Overall Study|Withdrawal by Subject|0|||
143008004|NCT02255422|515567949|FG001|Overall Study|Withdrawal by Subject|0|||
143008005|NCT02255422|515567950|FG002|Overall Study|Withdrawal by Subject|0|||
143008006|NCT02255422|515567951|FG003|Overall Study|Withdrawal by Subject|0|||
143008007|NCT02255422|515567952|FG004|Overall Study|Withdrawal by Subject|0|||
143008008|NCT02255422|515567953|FG005|Overall Study|Withdrawal by Subject|0|||
143008009|NCT02255422|515567954|FG006|Overall Study|Withdrawal by Subject|2|||
143008010|NCT02255422|515567948|FG000|Overall Study|Lost to Follow-up|0|||
143008011|NCT02255422|515567949|FG001|Overall Study|Lost to Follow-up|0|||
143008012|NCT02255422|515567950|FG002|Overall Study|Lost to Follow-up|1|||
143008013|NCT02255422|515567951|FG003|Overall Study|Lost to Follow-up|0|||
143008014|NCT02255422|515567952|FG004|Overall Study|Lost to Follow-up|0|||
143008015|NCT02255422|515567953|FG005|Overall Study|Lost to Follow-up|0|||
143008016|NCT02255422|515567954|FG006|Overall Study|Lost to Follow-up|0|||
143008017|NCT04411641|515567955|FG000|DB Period|Other|7|||
143008018|NCT04411641|515567956|FG001|DB Period|Other|27|||
143008019|NCT04411641|515567957|FG002|DB Period|Other|0|||
143008020|NCT04411641|515567958|FG003|DB Period|Other|0|||
143008021|NCT04411641|515567955|FG000|DB Period|Withdrawal by Subject|67|||
143008022|NCT04411641|515567956|FG001|DB Period|Withdrawal by Subject|122|||
143008023|NCT04411641|515567957|FG002|DB Period|Withdrawal by Subject|0|||
143008024|NCT04411641|515567958|FG003|DB Period|Withdrawal by Subject|0|||
143008025|NCT04411641|515567955|FG000|DB Period|Progressive disease|76|||
143008026|NCT04411641|515567956|FG001|DB Period|Progressive disease|116|||
143008027|NCT04411641|515567957|FG002|DB Period|Progressive disease|0|||
143008028|NCT04411641|515567958|FG003|DB Period|Progressive disease|0|||
143008029|NCT04411641|515567955|FG000|DB Period|Poor compliance to protocol|1|||
143008030|NCT04411641|515567956|FG001|DB Period|Poor compliance to protocol|5|||
143008031|NCT04411641|515567957|FG002|DB Period|Poor compliance to protocol|0|||
143008032|NCT04411641|515567958|FG003|DB Period|Poor compliance to protocol|0|||
143008033|NCT04411641|515567955|FG000|DB Period|Lack of Efficacy|19|||
143008034|NCT04411641|515567956|FG001|DB Period|Lack of Efficacy|19|||
143008035|NCT04411641|515567957|FG002|DB Period|Lack of Efficacy|0|||
143008036|NCT04411641|515567958|FG003|DB Period|Lack of Efficacy|0|||
143008037|NCT04411641|515567955|FG000|DB Period|Adverse Event|13|||
143008038|NCT04411641|515567956|FG001|DB Period|Adverse Event|29|||
143008039|NCT04411641|515567957|FG002|DB Period|Adverse Event|0|||
143008040|NCT04411641|515567958|FG003|DB Period|Adverse Event|0|||
143008041|NCT04411641|515567955|FG000|DB Period|Randomized and not treated|2|||
143008042|NCT04411641|515567956|FG001|DB Period|Randomized and not treated|2|||
143008043|NCT04411641|515567957|FG002|DB Period|Randomized and not treated|0|||
143008044|NCT04411641|515567958|FG003|DB Period|Randomized and not treated|0|||
143008045|NCT04411641|515567955|FG000|OL|Withdrawal by Subject|0|||
143008046|NCT04411641|515567956|FG001|OL|Withdrawal by Subject|0|||
143008047|NCT04411641|515567957|FG002|OL|Withdrawal by Subject|6|||
143008048|NCT04411641|515567958|FG003|OL|Withdrawal by Subject|17|||
143008049|NCT04411641|515567955|FG000|OL|Progressive disease|0|||
143008050|NCT04411641|515567956|FG001|OL|Progressive disease|0|||
143008051|NCT04411641|515567957|FG002|OL|Progressive disease|1|||
143008052|NCT04411641|515567958|FG003|OL|Progressive disease|2|||
143008053|NCT04411641|515567955|FG000|OL|Poor compliance to protocol|0|||
143008054|NCT04411641|515567956|FG001|OL|Poor compliance to protocol|0|||
143008055|NCT04411641|515567957|FG002|OL|Poor compliance to protocol|1|||
143008056|NCT04411641|515567958|FG003|OL|Poor compliance to protocol|0|||
143008057|NCT04411641|515567955|FG000|OL|Adverse Event|0|||
143008058|NCT04411641|515567956|FG001|OL|Adverse Event|0|||
143008059|NCT04411641|515567957|FG002|OL|Adverse Event|1|||
143008060|NCT04411641|515567958|FG003|OL|Adverse Event|0|||
143008061|NCT04411641|515567955|FG000|OL|Other|0|||
143008062|NCT04411641|515567956|FG001|OL|Other|0|||
143008063|NCT04411641|515567957|FG002|OL|Other|0|||
143008064|NCT04411641|515567958|FG003|OL|Other|6|||
143008065|NCT04410978|515567965|FG000|Overall Study|Poor compliance to protocol|2|||
143008066|NCT04410978|515567966|FG001|Overall Study|Poor compliance to protocol|4|||
143008067|NCT04410978|515567965|FG000|Overall Study|Withdrawal by Subject|64|||
143008068|NCT04410978|515567966|FG001|Overall Study|Withdrawal by Subject|66|||
143008069|NCT04410978|515567965|FG000|Overall Study|Other|6|||
143008070|NCT04410978|515567966|FG001|Overall Study|Other|7|||
143008071|NCT04410978|515567965|FG000|Overall Study|Missing study status|1|||
143346391|NCT00584805|516814315|FG000|Overall Study|Screen failures|2|||
143008072|NCT04410978|515567966|FG001|Overall Study|Missing study status|0|||
143008073|NCT04089566|515567970|FG000|Overall Study|Death|0|||
143008074|NCT04089566|515567971|FG001|Overall Study|Death|6|||
143008075|NCT04089566|515567972|FG002|Overall Study|Death|10|||
143008076|NCT04089566|515567973|FG003|Overall Study|Death|0|||
143008077|NCT04089566|515567974|FG004|Overall Study|Death|0|||
143008078|NCT04089566|515567975|FG005|Overall Study|Death|0|||
143008079|NCT04089566|515567970|FG000|Overall Study|Withdrawal by Parent or Guardian|0|||
143008080|NCT04089566|515567971|FG001|Overall Study|Withdrawal by Parent or Guardian|2|||
143008081|NCT04089566|515567972|FG002|Overall Study|Withdrawal by Parent or Guardian|1|||
143008082|NCT04089566|515567973|FG003|Overall Study|Withdrawal by Parent or Guardian|0|||
143008083|NCT04089566|515567974|FG004|Overall Study|Withdrawal by Parent or Guardian|0|||
143008084|NCT04089566|515567975|FG005|Overall Study|Withdrawal by Parent or Guardian|0|||
143008085|NCT04089566|515567970|FG000|Overall Study|Reason not Specified|0|||
143008086|NCT04089566|515567971|FG001|Overall Study|Reason not Specified|4|||
143008087|NCT04089566|515567972|FG002|Overall Study|Reason not Specified|4|||
143008088|NCT04089566|515567973|FG003|Overall Study|Reason not Specified|1|||
143008089|NCT04089566|515567974|FG004|Overall Study|Reason not Specified|0|||
143008090|NCT04089566|515567975|FG005|Overall Study|Reason not Specified|0|||
143008091|NCT01489865|515567978|FG000|Overall Study|Progression of Disease|4|||
143008092|NCT01489865|515567979|FG001|Overall Study|Progression of Disease|2|||
143008093|NCT01489865|515567980|FG002|Overall Study|Progression of Disease|2|||
143008094|NCT01489865|515567981|FG003|Overall Study|Progression of Disease|3|||
143008095|NCT01489865|515567982|FG004|Overall Study|Progression of Disease|1|||
143008096|NCT01489865|515567983|FG005|Overall Study|Progression of Disease|6|||
143008097|NCT01489865|515567984|FG006|Overall Study|Progression of Disease|3|||
143008098|NCT01489865|515567985|FG007|Overall Study|Progression of Disease|0|||
143008099|NCT01489865|515567986|FG008|Overall Study|Progression of Disease|23|||
143008100|NCT01489865|515567978|FG000|Overall Study|Adverse Event|2|||
143008101|NCT01489865|515567979|FG001|Overall Study|Adverse Event|0|||
143008102|NCT01489865|515567980|FG002|Overall Study|Adverse Event|0|||
143008103|NCT01489865|515567981|FG003|Overall Study|Adverse Event|0|||
143008104|NCT01489865|515567982|FG004|Overall Study|Adverse Event|1|||
143008105|NCT01489865|515567983|FG005|Overall Study|Adverse Event|0|||
143008106|NCT01489865|515567984|FG006|Overall Study|Adverse Event|2|||
143008107|NCT01489865|515567985|FG007|Overall Study|Adverse Event|0|||
143008108|NCT01489865|515567986|FG008|Overall Study|Adverse Event|5|||
143008109|NCT01489865|515567978|FG000|Overall Study|Death|0|||
143008110|NCT01489865|515567979|FG001|Overall Study|Death|1|||
143008111|NCT01489865|515567980|FG002|Overall Study|Death|0|||
143008112|NCT01489865|515567981|FG003|Overall Study|Death|0|||
143008113|NCT01489865|515567982|FG004|Overall Study|Death|1|||
143008114|NCT01489865|515567983|FG005|Overall Study|Death|0|||
143008115|NCT01489865|515567984|FG006|Overall Study|Death|0|||
143008116|NCT01489865|515567985|FG007|Overall Study|Death|0|||
143008117|NCT01489865|515567986|FG008|Overall Study|Death|2|||
143008118|NCT01489865|515567978|FG000|Overall Study|Withdrawal by Subject|0|||
143008119|NCT01489865|515567979|FG001|Overall Study|Withdrawal by Subject|0|||
143008120|NCT01489865|515567980|FG002|Overall Study|Withdrawal by Subject|0|||
143008121|NCT01489865|515567981|FG003|Overall Study|Withdrawal by Subject|0|||
143008122|NCT01489865|515567982|FG004|Overall Study|Withdrawal by Subject|0|||
143008123|NCT01489865|515567983|FG005|Overall Study|Withdrawal by Subject|1|||
143008124|NCT01489865|515567984|FG006|Overall Study|Withdrawal by Subject|1|||
143008125|NCT01489865|515567985|FG007|Overall Study|Withdrawal by Subject|0|||
143008126|NCT01489865|515567986|FG008|Overall Study|Withdrawal by Subject|2|||
143008127|NCT01489865|515567978|FG000|Overall Study|Shifted|0|||
143008128|NCT01489865|515567979|FG001|Overall Study|Shifted|0|||
143008129|NCT01489865|515567980|FG002|Overall Study|Shifted|1|||
143008130|NCT01489865|515567981|FG003|Overall Study|Shifted|0|||
143008131|NCT01489865|515567982|FG004|Overall Study|Shifted|0|||
143008132|NCT01489865|515567983|FG005|Overall Study|Shifted|0|||
143008133|NCT01489865|515567984|FG006|Overall Study|Shifted|0|||
143008134|NCT01489865|515567985|FG007|Overall Study|Shifted|0|||
143008135|NCT01489865|515567986|FG008|Overall Study|Shifted|0|||
143008136|NCT04115488|515567987|FG000|Overall Study|Adverse Event|8|||
143008137|NCT04115488|515567988|FG001|Overall Study|Adverse Event|4|||
143008138|NCT04115488|515567987|FG000|Overall Study|Withdrawal by Subject|3|||
143008139|NCT04115488|515567988|FG001|Overall Study|Withdrawal by Subject|6|||
143008140|NCT04115488|515567987|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
143008141|NCT04115488|515567988|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
143008142|NCT04115488|515567987|FG000|Overall Study|Patient 's location change|1|||
143008143|NCT04115488|515567988|FG001|Overall Study|Patient 's location change|0|||
143008144|NCT04115488|515567987|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
143008145|NCT04115488|515567988|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
143008146|NCT00885677|515567989|FG000|Overall Study|Death|40|||
143008147|NCT00885677|515567990|FG001|Overall Study|Death|34|||
143008148|NCT00885677|515567989|FG000|Overall Study|Lost to Follow-up|15|||
143008149|NCT00885677|515567990|FG001|Overall Study|Lost to Follow-up|13|||
143008150|NCT00885677|515567989|FG000|Overall Study|Protocol Violation|54|||
143008151|NCT00885677|515567990|FG001|Overall Study|Protocol Violation|54|||
143008152|NCT00885677|515567989|FG000|Overall Study|premature study closure|41|||
143008153|NCT00885677|515567990|FG001|Overall Study|premature study closure|44|||
143008154|NCT00885677|515567989|FG000|Overall Study|device/lead revision or replacement|7|||
143008155|NCT00885677|515567990|FG001|Overall Study|device/lead revision or replacement|6|||
143008156|NCT00885677|515567989|FG000|Overall Study|Heart transplantation|1|||
143008157|NCT00885677|515567990|FG001|Overall Study|Heart transplantation|0|||
143008158|NCT00885677|515567989|FG000|Overall Study|Inclusion/exclusion not met|25|||
143008159|NCT00885677|515567990|FG001|Overall Study|Inclusion/exclusion not met|27|||
143008160|NCT00972309|515567991|FG000|Overall Study|Switched to alternative treatment|0|||
143008161|NCT00972309|515567992|FG001|Overall Study|Switched to alternative treatment|2|||
143008162|NCT00972309|515567991|FG000|Overall Study|Refused further treatment|0|||
143008163|NCT00972309|515567992|FG001|Overall Study|Refused further treatment|1|||
143008164|NCT00972309|515567991|FG000|Overall Study|Late determination of ineligibility|0|||
143008165|NCT00972309|515567992|FG001|Overall Study|Late determination of ineligibility|1|||
143008166|NCT00972309|515567991|FG000|Overall Study|Second malignancy|1|||
143008167|NCT00972309|515567992|FG001|Overall Study|Second malignancy|1|||
143008168|NCT00972309|515567991|FG000|Overall Study|Visa issues|0|||
143008169|NCT00972309|515567992|FG001|Overall Study|Visa issues|1|||
143008170|NCT00972309|515567991|FG000|Overall Study|Secondary cancer (SCC)|0|||
143008171|NCT00972309|515567992|FG001|Overall Study|Secondary cancer (SCC)|1|||
143008172|NCT00972309|515567991|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
143008173|NCT00972309|515567992|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
143008174|NCT00972309|515567991|FG000|Overall Study|Lost to Follow-up|1|||
143008175|NCT00972309|515567992|FG001|Overall Study|Lost to Follow-up|1|||
143008176|NCT00972309|515567991|FG000|Overall Study|Disease progression on study|10|||
143008177|NCT00972309|515567992|FG001|Overall Study|Disease progression on study|4|||
143008178|NCT01233284|515568004|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
143008179|NCT01233284|515568005|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
143008180|NCT01233284|515568006|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
143008181|NCT01233284|515568007|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
143008182|NCT01233284|515568008|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
143008183|NCT01233284|515568004|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
143008184|NCT01233284|515568005|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
143008185|NCT01233284|515568006|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
143008186|NCT01233284|515568007|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
143008187|NCT01233284|515568008|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
143008188|NCT01233284|515568004|FG000|Period 1 (4 Weeks)|Other|0|||
143008189|NCT01233284|515568005|FG001|Period 1 (4 Weeks)|Other|0|||
143008190|NCT01233284|515568006|FG002|Period 1 (4 Weeks)|Other|1|||
143008191|NCT01233284|515568007|FG003|Period 1 (4 Weeks)|Other|0|||
143008192|NCT01233284|515568008|FG004|Period 1 (4 Weeks)|Other|0|||
143008193|NCT01233284|515568004|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
143008194|NCT01233284|515568005|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
143008195|NCT01233284|515568006|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
143008196|NCT01233284|515568007|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
143008197|NCT01233284|515568008|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
143008198|NCT01233284|515568004|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
143008199|NCT01233284|515568005|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
143008200|NCT01233284|515568006|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
143008201|NCT01233284|515568007|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
143008202|NCT01233284|515568008|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
143008203|NCT01233284|515568004|FG000|Period 3 (4 Weeks)|Other|0|||
143008204|NCT01233284|515568005|FG001|Period 3 (4 Weeks)|Other|0|||
143008205|NCT01233284|515568006|FG002|Period 3 (4 Weeks)|Other|0|||
143008206|NCT01233284|515568007|FG003|Period 3 (4 Weeks)|Other|1|||
143008207|NCT01233284|515568008|FG004|Period 3 (4 Weeks)|Other|0|||
143008208|NCT01233284|515568004|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
143008209|NCT01233284|515568005|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
143008210|NCT01233284|515568006|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
143008211|NCT01233284|515568007|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
143008212|NCT01233284|515568008|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
143008213|NCT01233284|515568004|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
143008214|NCT01233284|515568005|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
143008215|NCT01233284|515568006|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
143008216|NCT01233284|515568007|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
143008217|NCT01233284|515568008|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
143008218|NCT02756182|515568010|FG000|Overall Study|StudyTechnical Difficulties|4|||
143008219|NCT01593761|515568013|FG000|Overall Study|Lost to Follow-up|1|||
143008220|NCT01593761|515568013|FG000|Overall Study|culture negative for MRSA at baseline|5|||
143008221|NCT01593761|515568013|FG000|Overall Study|positive for hepatitis C virus|1|||
143008222|NCT01593761|515568013|FG000|Overall Study|secondary cellulitis|1|||
143008223|NCT05554471|515568016|FG000|Overall Study|Physician Decision|2|||
143008224|NCT05554471|515568017|FG001|Overall Study|Physician Decision|1|||
143008225|NCT05554471|515568016|FG000|Overall Study|Lost to Follow-up|2|||
143008226|NCT05554471|515568017|FG001|Overall Study|Lost to Follow-up|1|||
143008227|NCT05554471|515568016|FG000|Overall Study|Death|0|||
143008228|NCT05554471|515568017|FG001|Overall Study|Death|1|||
143008229|NCT04880850|515568018|FG000|Overall Study|Death|2|||
143008230|NCT04880850|515568019|FG001|Overall Study|Death|1|||
143008231|NCT04880850|515568018|FG000|Overall Study|Lost to Follow-up|3|||
143008232|NCT04880850|515568019|FG001|Overall Study|Lost to Follow-up|6|||
143008233|NCT04880850|515568018|FG000|Overall Study|Physician Decision|2|||
143008234|NCT04880850|515568019|FG001|Overall Study|Physician Decision|1|||
143008235|NCT04880850|515568018|FG000|Overall Study|Withdrawal by Subject|9|||
143008236|NCT04880850|515568019|FG001|Overall Study|Withdrawal by Subject|10|||
143008237|NCT01875731|515568021|FG000|Overall Study|Fail to obtain lab sample|1|||
143008238|NCT01875731|515568022|FG001|Overall Study|Fail to obtain lab sample|0|||
143008239|NCT02576951|515568023|FG000|Overall Study|Lost to Follow-up|0|||
143008240|NCT02576951|515568024|FG001|Overall Study|Lost to Follow-up|0|||
143008241|NCT02576951|515568025|FG002|Overall Study|Lost to Follow-up|2|||
143008242|NCT02576951|515568026|FG003|Overall Study|Lost to Follow-up|2|||
143008243|NCT02576951|515568023|FG000|Overall Study|Withdrawal by Subject|1|||
143008244|NCT02576951|515568024|FG001|Overall Study|Withdrawal by Subject|0|||
143008245|NCT02576951|515568025|FG002|Overall Study|Withdrawal by Subject|0|||
143008246|NCT02576951|515568026|FG003|Overall Study|Withdrawal by Subject|2|||
143008247|NCT02576951|515568023|FG000|Overall Study|Protocol Violation|0|||
143008248|NCT02576951|515568024|FG001|Overall Study|Protocol Violation|0|||
143008249|NCT02576951|515568025|FG002|Overall Study|Protocol Violation|0|||
143008250|NCT02576951|515568026|FG003|Overall Study|Protocol Violation|1|||
143008251|NCT01340794|515569107|FG000|Overall Study|Withdrawal by Subject|0|||
143008252|NCT01340794|515569108|FG001|Overall Study|Withdrawal by Subject|1|||
143008253|NCT03606109|515569112|FG000|Overall Study|Lost to Follow-up|2|||
143008254|NCT03606109|515569113|FG001|Overall Study|Lost to Follow-up|1|||
143008255|NCT03722849|515569114|FG000|Overall Study|Withdrawal by Subject|1|||
143008256|NCT03722849|515569115|FG001|Overall Study|Withdrawal by Subject|1|||
143008257|NCT03533608|515569116|FG000|Overall Study|Withdrawal by Subject|3|||
143008258|NCT03533608|515569116|FG000|Overall Study|Physician Decision|2|||
143008259|NCT03286426|515569117|FG000|Overall Study|Physician Decision|3|||
143008260|NCT04930536|515569118|FG000|Overall Study|Adverse Event|1|||
143008261|NCT04930536|515569119|FG001|Overall Study|Adverse Event|0|||
143008262|NCT04930536|515569118|FG000|Overall Study|Disease Progression|2|||
143008263|NCT04930536|515569119|FG001|Overall Study|Disease Progression|0|||
143008264|NCT04930536|515569118|FG000|Overall Study|Patient Decision|4|||
143008265|NCT04930536|515569119|FG001|Overall Study|Patient Decision|2|||
143008266|NCT04930536|515569118|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
143008267|NCT04930536|515569119|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
143008268|NCT01432600|515569120|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
143008269|NCT01432600|515569121|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
143008270|NCT01432600|515569122|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
143008271|NCT02411110|515569128|FG000|Treatment Period 1|Adverse Event|4|||
143008272|NCT02411110|515569129|FG001|Treatment Period 1|Adverse Event|2|||
143008273|NCT02411110|515569128|FG000|Treatment Period 1|Lost to Follow-up|1|||
143008274|NCT02411110|515569129|FG001|Treatment Period 1|Lost to Follow-up|0|||
143008275|NCT02411110|515569128|FG000|Treatment Period 1|Personal Reasons|2|||
143008276|NCT02411110|515569129|FG001|Treatment Period 1|Personal Reasons|5|||
143008277|NCT02411110|515569128|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
143008278|NCT02411110|515569129|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
143008279|NCT02411110|515569128|FG000|Treatment Period 2|Adverse Event|1|||
143008280|NCT02411110|515569129|FG001|Treatment Period 2|Adverse Event|0|||
143008281|NCT02411110|515569128|FG000|Treatment Period 2|Lost to Follow-up|0|||
143008282|NCT02411110|515569129|FG001|Treatment Period 2|Lost to Follow-up|2|||
143008283|NCT02411110|515569128|FG000|Treatment Period 2|Personal Reasons|0|||
143008284|NCT02411110|515569129|FG001|Treatment Period 2|Personal Reasons|2|||
143008285|NCT04633434|515569130|FG000|Overall Study|Lost to Follow-up|32|||
143008286|NCT04633434|515569131|FG001|Overall Study|Lost to Follow-up|32|||
143008287|NCT00297882|515569136|FG000|Day 14|Lack of Efficacy|12|||
143008288|NCT00297882|515569137|FG001|Day 14|Lack of Efficacy|49|||
143008289|NCT00297882|515569136|FG000|Day 28|Lost to Follow-up|13|||
143008290|NCT00297882|515569137|FG001|Day 28|Lost to Follow-up|23|||
143008291|NCT00297882|515569136|FG000|Day 28|Lack of Efficacy|3|||
143008292|NCT00297882|515569137|FG001|Day 28|Lack of Efficacy|0|||
143008293|NCT04242264|515569138|FG000|Overall Study|Lost to Follow-up|2|||
143008294|NCT04242264|515569139|FG001|Overall Study|Lost to Follow-up|2|||
143008295|NCT04242264|515569140|FG002|Overall Study|Lost to Follow-up|1|||
143008296|NCT04242264|515569141|FG003|Overall Study|Lost to Follow-up|1|||
143008297|NCT04242264|515569138|FG000|Overall Study|Withdrawal by Subject|1|||
143008298|NCT04242264|515569139|FG001|Overall Study|Withdrawal by Subject|0|||
143008299|NCT04242264|515569140|FG002|Overall Study|Withdrawal by Subject|0|||
143008300|NCT04242264|515569141|FG003|Overall Study|Withdrawal by Subject|0|||
143008301|NCT00848965|515569144|FG000|Overall Study|Adverse Event|1|||
143008302|NCT00848965|515569144|FG000|Overall Study|Withdrawal by Subject|1|||
143008303|NCT01976104|515569149|FG000|Overall Study|Adverse Event|0|||
143008304|NCT01976104|515569150|FG001|Overall Study|Adverse Event|0|||
143008305|NCT01976104|515569151|FG002|Overall Study|Adverse Event|1|||
143008306|NCT01976104|515569152|FG003|Overall Study|Adverse Event|0|||
143008307|NCT01976104|515569149|FG000|Overall Study|Lost to Follow-up|3|||
143008308|NCT01976104|515569150|FG001|Overall Study|Lost to Follow-up|0|||
143008309|NCT01976104|515569151|FG002|Overall Study|Lost to Follow-up|1|||
143008310|NCT01976104|515569152|FG003|Overall Study|Lost to Follow-up|1|||
143008311|NCT01976104|515569149|FG000|Overall Study|Subject Choice|0|||
143008312|NCT01976104|515569150|FG001|Overall Study|Subject Choice|1|||
143008313|NCT01976104|515569151|FG002|Overall Study|Subject Choice|0|||
143008314|NCT01976104|515569152|FG003|Overall Study|Subject Choice|1|||
143008315|NCT01976104|515569149|FG000|Overall Study|Withdrawal by Subject|3|||
143008316|NCT01976104|515569150|FG001|Overall Study|Withdrawal by Subject|0|||
143008317|NCT01976104|515569151|FG002|Overall Study|Withdrawal by Subject|0|||
143008318|NCT01976104|515569152|FG003|Overall Study|Withdrawal by Subject|1|||
143008319|NCT01976104|515569149|FG000|Overall Study|Other|0|||
143008320|NCT01976104|515569150|FG001|Overall Study|Other|1|||
143008321|NCT01976104|515569151|FG002|Overall Study|Other|0|||
143008322|NCT01976104|515569152|FG003|Overall Study|Other|0|||
143008323|NCT01353209|515569153|FG000|Overall Study|Adverse Event|1|||
143008324|NCT01353209|515569154|FG001|Overall Study|Adverse Event|1|||
143008325|NCT05102162|515569159|FG000|Overall Study|Withdrawal by Subject|3|||
143008326|NCT05102162|515569160|FG001|Overall Study|Withdrawal by Subject|0|||
143008327|NCT05102162|515569159|FG000|Overall Study|Baseline cultures negative|4|||
143008328|NCT05102162|515569160|FG001|Overall Study|Baseline cultures negative|2|||
143008329|NCT05102162|515569159|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
143008330|NCT05102162|515569160|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
143008331|NCT05102162|515569159|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
143008332|NCT05102162|515569160|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
143008333|NCT01165424|515569161|FG000|Overall Study|Clinical adverse experiences|1|||
143008334|NCT01165424|515569161|FG000|Overall Study|Laboratory adverse experiences|1|||
143008335|NCT01165424|515569161|FG000|Overall Study|Did not meet entry criteria|1|||
143008336|NCT01165424|515569161|FG000|Overall Study|Participant moved (relocated)|1|||
143008337|NCT02181673|515569162|FG000|Up to Week 24|Adverse Event|2|||
143008338|NCT02181673|515569163|FG001|Up to Week 24|Adverse Event|0|||
143008339|NCT02181673|515569164|FG002|Up to Week 24|Adverse Event|3|||
143008340|NCT02181673|515569162|FG000|Up to Week 24|Death|1|||
143008341|NCT02181673|515569163|FG001|Up to Week 24|Death|0|||
143008342|NCT02181673|515569164|FG002|Up to Week 24|Death|0|||
143008343|NCT02181673|515569162|FG000|Up to Week 24|Lack of Efficacy|1|||
143008344|NCT02181673|515569163|FG001|Up to Week 24|Lack of Efficacy|0|||
143008345|NCT02181673|515569164|FG002|Up to Week 24|Lack of Efficacy|0|||
143008346|NCT02181673|515569162|FG000|Up to Week 24|Lost to Follow-up|1|||
143008347|NCT02181673|515569163|FG001|Up to Week 24|Lost to Follow-up|0|||
143008348|NCT02181673|515569164|FG002|Up to Week 24|Lost to Follow-up|0|||
143008349|NCT02181673|515569162|FG000|Up to Week 24|Physician Decision|0|||
143008350|NCT02181673|515569163|FG001|Up to Week 24|Physician Decision|0|||
143008351|NCT02181673|515569164|FG002|Up to Week 24|Physician Decision|3|||
143008352|NCT02181673|515569162|FG000|Up to Week 24|Withdrawal by Subject|10|||
143008353|NCT02181673|515569163|FG001|Up to Week 24|Withdrawal by Subject|0|||
143008354|NCT02181673|515569164|FG002|Up to Week 24|Withdrawal by Subject|1|||
143008355|NCT02181673|515569162|FG000|Up to Week 24|Other|2|||
143008356|NCT02181673|515569163|FG001|Up to Week 24|Other|0|||
143008357|NCT02181673|515569164|FG002|Up to Week 24|Other|3|||
143008358|NCT02181673|515569162|FG000|Up to Week 24|Randomized not Treated|0|||
143008359|NCT02181673|515569163|FG001|Up to Week 24|Randomized not Treated|0|||
143008360|NCT02181673|515569164|FG002|Up to Week 24|Randomized not Treated|1|||
143008361|NCT02181673|515569162|FG000|Week 24-Week 60|Adverse Event|0|||
143008362|NCT02181673|515569163|FG001|Week 24-Week 60|Adverse Event|4|||
143008363|NCT02181673|515569164|FG002|Week 24-Week 60|Adverse Event|10|||
143008364|NCT02181673|515569162|FG000|Week 24-Week 60|Other|0|||
143008365|NCT02181673|515569163|FG001|Week 24-Week 60|Other|2|||
143008366|NCT02181673|515569164|FG002|Week 24-Week 60|Other|1|||
143008367|NCT02181673|515569162|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
143008368|NCT02181673|515569163|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
143008369|NCT02181673|515569164|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
143008370|NCT02181673|515569162|FG000|Week 24-Week 60|Pregnancy|0|||
143008371|NCT02181673|515569163|FG001|Week 24-Week 60|Pregnancy|0|||
143008372|NCT02181673|515569164|FG002|Week 24-Week 60|Pregnancy|1|||
143008373|NCT02181673|515569162|FG000|Week 24-Week 60|Lack of Efficacy|0|||
143008374|NCT02181673|515569163|FG001|Week 24-Week 60|Lack of Efficacy|0|||
143123543|NCT02757352|515997785|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
143123544|NCT02757352|515997786|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
143123545|NCT02757352|515997787|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
143008375|NCT02181673|515569164|FG002|Week 24-Week 60|Lack of Efficacy|1|||
143008376|NCT02181673|515569162|FG000|Week 24-Week 60|Lost to Follow-up|0|||
143008377|NCT02181673|515569163|FG001|Week 24-Week 60|Lost to Follow-up|0|||
143008378|NCT02181673|515569164|FG002|Week 24-Week 60|Lost to Follow-up|1|||
143008379|NCT02181673|515569162|FG000|Week 24-Week 60|Physician Decision|0|||
143008380|NCT02181673|515569163|FG001|Week 24-Week 60|Physician Decision|0|||
143008381|NCT02181673|515569164|FG002|Week 24-Week 60|Physician Decision|1|||
143008382|NCT00433771|515569165|FG000|Overall Study|screen fail|14|||
143008383|NCT00433771|515569165|FG000|Overall Study|Treated and later found to be ineligible|2|||
143008384|NCT00433771|515569165|FG000|Overall Study|Death|2|||
143008385|NCT00433771|515569165|FG000|Overall Study|Failure to deploy stent|1|||
143008386|NCT02871921|515569168|FG000|Overall Study|Withdrawal by Subject|34|||
143008387|NCT02871921|515569169|FG001|Overall Study|Withdrawal by Subject|27|||
143008388|NCT02871921|515569170|FG002|Overall Study|Withdrawal by Subject|27|||
143008389|NCT02871921|515569171|FG003|Overall Study|Withdrawal by Subject|30|||
143008390|NCT00320801|515569172|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
143008391|NCT00320801|515569173|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
143008392|NCT00320801|515569174|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
143008393|NCT00320801|515569175|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
143008394|NCT00320801|515569172|FG000|Open-label Run-in Period|Adverse Event|33|||
143008395|NCT00320801|515569173|FG001|Open-label Run-in Period|Adverse Event|0|||
143008396|NCT00320801|515569174|FG002|Open-label Run-in Period|Adverse Event|0|||
143008397|NCT00320801|515569175|FG003|Open-label Run-in Period|Adverse Event|0|||
143008398|NCT00320801|515569172|FG000|Open-label Run-in Period|Administrative|10|||
143008399|NCT00320801|515569173|FG001|Open-label Run-in Period|Administrative|0|||
143008400|NCT00320801|515569174|FG002|Open-label Run-in Period|Administrative|0|||
143008401|NCT00320801|515569175|FG003|Open-label Run-in Period|Administrative|0|||
143008402|NCT00320801|515569172|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
143008403|NCT00320801|515569173|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
143008404|NCT00320801|515569174|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
143008405|NCT00320801|515569175|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
143008406|NCT00320801|515569172|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
143008407|NCT00320801|515569173|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
143008408|NCT00320801|515569174|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
143008409|NCT00320801|515569175|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
143008410|NCT00320801|515569172|FG000|Open-label Run-in Period|Did not qualify|1|||
143008411|NCT00320801|515569173|FG001|Open-label Run-in Period|Did not qualify|0|||
143008412|NCT00320801|515569174|FG002|Open-label Run-in Period|Did not qualify|0|||
143008413|NCT00320801|515569175|FG003|Open-label Run-in Period|Did not qualify|0|||
143008414|NCT00320801|515569172|FG000|Double-blind Phase|Withdrawal by Subject|0|||
143008415|NCT00320801|515569173|FG001|Double-blind Phase|Withdrawal by Subject|0|||
143008416|NCT00320801|515569174|FG002|Double-blind Phase|Withdrawal by Subject|1|||
143008417|NCT00320801|515569175|FG003|Double-blind Phase|Withdrawal by Subject|0|||
143008418|NCT00320801|515569172|FG000|Double-blind Phase|Adverse Event|0|||
143008419|NCT00320801|515569173|FG001|Double-blind Phase|Adverse Event|2|||
143008420|NCT00320801|515569174|FG002|Double-blind Phase|Adverse Event|8|||
143008421|NCT00320801|515569175|FG003|Double-blind Phase|Adverse Event|0|||
143008422|NCT00320801|515569172|FG000|Double-blind Phase|Administrative|0|||
143008423|NCT00320801|515569173|FG001|Double-blind Phase|Administrative|0|||
143008424|NCT00320801|515569174|FG002|Double-blind Phase|Administrative|4|||
143008425|NCT00320801|515569175|FG003|Double-blind Phase|Administrative|0|||
143008426|NCT00320801|515569172|FG000|Double-blind Phase|Lack of Efficacy|0|||
143008427|NCT00320801|515569173|FG001|Double-blind Phase|Lack of Efficacy|9|||
143008428|NCT00320801|515569174|FG002|Double-blind Phase|Lack of Efficacy|1|||
143008429|NCT00320801|515569175|FG003|Double-blind Phase|Lack of Efficacy|0|||
143008430|NCT00320801|515569172|FG000|Extension Phase|Withdrawal by Subject|0|||
143008431|NCT00320801|515569173|FG001|Extension Phase|Withdrawal by Subject|0|||
143008432|NCT00320801|515569174|FG002|Extension Phase|Withdrawal by Subject|0|||
143008433|NCT00320801|515569175|FG003|Extension Phase|Withdrawal by Subject|6|||
143008434|NCT00320801|515569172|FG000|Extension Phase|Adverse Event|0|||
143008435|NCT00320801|515569173|FG001|Extension Phase|Adverse Event|0|||
143008436|NCT00320801|515569174|FG002|Extension Phase|Adverse Event|0|||
143008437|NCT00320801|515569175|FG003|Extension Phase|Adverse Event|8|||
143008438|NCT00320801|515569172|FG000|Extension Phase|Administrative|0|||
143008439|NCT00320801|515569173|FG001|Extension Phase|Administrative|0|||
143008440|NCT00320801|515569174|FG002|Extension Phase|Administrative|0|||
143008441|NCT00320801|515569175|FG003|Extension Phase|Administrative|29|||
143008442|NCT00320801|515569172|FG000|Extension Phase|Lack of Efficacy|0|||
143008443|NCT00320801|515569173|FG001|Extension Phase|Lack of Efficacy|0|||
143008444|NCT00320801|515569174|FG002|Extension Phase|Lack of Efficacy|0|||
143008445|NCT00320801|515569175|FG003|Extension Phase|Lack of Efficacy|2|||
143008446|NCT00320801|515569172|FG000|Extension Phase|Lost to Follow-up|0|||
143008447|NCT00320801|515569173|FG001|Extension Phase|Lost to Follow-up|0|||
143008448|NCT00320801|515569174|FG002|Extension Phase|Lost to Follow-up|0|||
143008449|NCT00320801|515569175|FG003|Extension Phase|Lost to Follow-up|3|||
143008450|NCT00625846|515569176|FG000|Overall Study|Withdrawal by Subject|2|||
143008451|NCT00625846|515569177|FG001|Overall Study|Withdrawal by Subject|0|||
143008452|NCT00625846|515569178|FG002|Overall Study|Withdrawal by Subject|1|||
143008453|NCT00625846|515569179|FG003|Overall Study|Withdrawal by Subject|2|||
143008454|NCT00807040|515569180|FG000|Overall Study|Death|24|||
143008455|NCT00807040|515569181|FG001|Overall Study|Death|29|||
143008456|NCT00807040|515569180|FG000|Overall Study|Withdrawal by Subject|8|||
143008457|NCT00807040|515569181|FG001|Overall Study|Withdrawal by Subject|6|||
143008458|NCT00807040|515569180|FG000|Overall Study|Lost to Follow-up|4|||
143008459|NCT00807040|515569181|FG001|Overall Study|Lost to Follow-up|6|||
143008460|NCT02353572|515569182|FG000|Overall Study|Withdrawal by Subject|1|||
143008461|NCT02353572|515569182|FG000|Overall Study|Study terminated|2|||
143008462|NCT00602667|515569184|FG000|Overall Study|Still on Therapy|0|||
143008463|NCT00602667|515569185|FG001|Overall Study|Still on Therapy|2|||
143008464|NCT00602667|515569186|FG002|Overall Study|Still on Therapy|2|||
143008465|NCT00602667|515569184|FG000|Overall Study|Death|0|||
143008466|NCT00602667|515569185|FG001|Overall Study|Death|1|||
143008467|NCT00602667|515569186|FG002|Overall Study|Death|1|||
143008468|NCT00602667|515569184|FG000|Overall Study|Family request|3|||
143008469|NCT00602667|515569185|FG001|Overall Study|Family request|25|||
143008470|NCT00602667|515569186|FG002|Overall Study|Family request|6|||
143008471|NCT00602667|515569184|FG000|Overall Study|Excessive toxicity|1|||
143008472|NCT00602667|515569185|FG001|Overall Study|Excessive toxicity|1|||
143008473|NCT00602667|515569186|FG002|Overall Study|Excessive toxicity|0|||
143008474|NCT00602667|515569184|FG000|Overall Study|Second malignancy|0|||
143008475|NCT00602667|515569185|FG001|Overall Study|Second malignancy|1|||
143008476|NCT00602667|515569186|FG002|Overall Study|Second malignancy|0|||
143008477|NCT00602667|515569184|FG000|Overall Study|Physician Decision|2|||
143008478|NCT00602667|515569185|FG001|Overall Study|Physician Decision|3|||
143008479|NCT00602667|515569186|FG002|Overall Study|Physician Decision|8|||
143008480|NCT00602667|515569184|FG000|Overall Study|Progressive disease|13|||
143008481|NCT00602667|515569185|FG001|Overall Study|Progressive disease|48|||
143008482|NCT00602667|515569186|FG002|Overall Study|Progressive disease|45|||
143008483|NCT00602667|515569184|FG000|Overall Study|Progressive disease prior to therapy|0|||
143008484|NCT00602667|515569185|FG001|Overall Study|Progressive disease prior to therapy|0|||
143008485|NCT00602667|515569186|FG002|Overall Study|Progressive disease prior to therapy|1|||
143008486|NCT00157820|515569208|FG000|Randomized|Physician Decision|4|||
143008487|NCT00157820|515569209|FG001|Randomized|Physician Decision|2|||
143008488|NCT00157820|515569210|FG002|Randomized|Physician Decision|3|||
143008489|NCT00157820|515569208|FG000|Randomized|Withdrawal by Subject|1|||
143008490|NCT00157820|515569209|FG001|Randomized|Withdrawal by Subject|2|||
143008491|NCT00157820|515569210|FG002|Randomized|Withdrawal by Subject|3|||
143008492|NCT00157820|515569208|FG000|Randomized|Protocol Violation|2|||
143008493|NCT00157820|515569209|FG001|Randomized|Protocol Violation|1|||
143008494|NCT00157820|515569210|FG002|Randomized|Protocol Violation|2|||
143008495|NCT00157820|515569208|FG000|1st 8 Month|Death|7|||
143008496|NCT00157820|515569209|FG001|1st 8 Month|Death|8|||
143008497|NCT00157820|515569210|FG002|1st 8 Month|Death|3|||
143008498|NCT00157820|515569208|FG000|1st 8 Month|Lost to Follow-up|1|||
143008499|NCT00157820|515569209|FG001|1st 8 Month|Lost to Follow-up|2|||
143008500|NCT00157820|515569210|FG002|1st 8 Month|Lost to Follow-up|1|||
143008501|NCT00157820|515569208|FG000|1st 8 Month|Premature cross-over|0|||
143008502|NCT00157820|515569209|FG001|1st 8 Month|Premature cross-over|2|||
143008503|NCT00157820|515569210|FG002|1st 8 Month|Premature cross-over|2|||
143008504|NCT00157820|515569208|FG000|2nd 8 Months|Death|3|||
143008505|NCT00157820|515569209|FG001|2nd 8 Months|Death|1|||
143008506|NCT00157820|515569210|FG002|2nd 8 Months|Death|3|||
143008507|NCT00157820|515569208|FG000|2nd 8 Months|Lost to Follow-up|1|||
143008508|NCT00157820|515569209|FG001|2nd 8 Months|Lost to Follow-up|5|||
143008509|NCT00157820|515569210|FG002|2nd 8 Months|Lost to Follow-up|2|||
143008510|NCT00157820|515569208|FG000|2nd 8 Months|Premature cross-over|1|||
143008511|NCT00157820|515569209|FG001|2nd 8 Months|Premature cross-over|7|||
143008512|NCT00157820|515569210|FG002|2nd 8 Months|Premature cross-over|9|||
143008513|NCT00223990|515569211|FG000|Overall Study|Moved from area|2|||
143008514|NCT00223990|515569212|FG001|Overall Study|Moved from area|1|||
143008515|NCT00223990|515569211|FG000|Overall Study|Withdrawal by Subject|4|||
143008516|NCT00223990|515569212|FG001|Overall Study|Withdrawal by Subject|8|||
143008517|NCT00223990|515569211|FG000|Overall Study|Lost to Follow-up|1|||
143008518|NCT00223990|515569212|FG001|Overall Study|Lost to Follow-up|0|||
143008519|NCT01319994|515571109|FG000|Overall Study|Protocol Violation|7|||
143008520|NCT01319994|515571110|FG001|Overall Study|Protocol Violation|6|||
143008521|NCT00698009|515571114|FG000|Overall Study|Withdrawal by Subject|1|||
143008522|NCT00798707|515571120|FG000|Overall Study|Adverse Event|6|||
143008523|NCT00798707|515571121|FG001|Overall Study|Adverse Event|8|||
143008524|NCT00798707|515571122|FG002|Overall Study|Adverse Event|8|||
143008525|NCT00798707|515571120|FG000|Overall Study|Failed to return|2|||
143008526|NCT00798707|515571121|FG001|Overall Study|Failed to return|2|||
143008527|NCT00798707|515571122|FG002|Overall Study|Failed to return|0|||
143008528|NCT00798707|515571120|FG000|Overall Study|Investigator|0|||
143008529|NCT00798707|515571121|FG001|Overall Study|Investigator|1|||
143008530|NCT00798707|515571122|FG002|Overall Study|Investigator|2|||
143008531|NCT00798707|515571120|FG000|Overall Study|Lack of Efficacy|2|||
143008532|NCT00798707|515571121|FG001|Overall Study|Lack of Efficacy|2|||
143008533|NCT00798707|515571122|FG002|Overall Study|Lack of Efficacy|1|||
143008534|NCT00798707|515571120|FG000|Overall Study|Lost to Follow-up|5|||
143008535|NCT00798707|515571121|FG001|Overall Study|Lost to Follow-up|6|||
143008536|NCT00798707|515571122|FG002|Overall Study|Lost to Follow-up|6|||
143008537|NCT00798707|515571120|FG000|Overall Study|Other|0|||
143008538|NCT00798707|515571121|FG001|Overall Study|Other|1|||
143008539|NCT00798707|515571122|FG002|Overall Study|Other|0|||
143008540|NCT00798707|515571120|FG000|Overall Study|Protocol Violation|4|||
143008541|NCT00798707|515571121|FG001|Overall Study|Protocol Violation|0|||
143008542|NCT00798707|515571122|FG002|Overall Study|Protocol Violation|2|||
143008543|NCT00798707|515571120|FG000|Overall Study|Withdrawal by Subject|3|||
143008544|NCT00798707|515571121|FG001|Overall Study|Withdrawal by Subject|8|||
143008545|NCT00798707|515571122|FG002|Overall Study|Withdrawal by Subject|2|||
143008546|NCT00798707|515571120|FG000|Overall Study|Randomized not treated|4|||
143008547|NCT00798707|515571121|FG001|Overall Study|Randomized not treated|5|||
143008548|NCT00798707|515571122|FG002|Overall Study|Randomized not treated|1|||
143008549|NCT02525627|515571125|FG000|Overall Study|Revision|1|||
143008550|NCT02525627|515571126|FG001|Overall Study|Revision|1|||
143008551|NCT02525627|515571125|FG000|Overall Study|Withdrawal by Subject|1|||
143008552|NCT02525627|515571126|FG001|Overall Study|Withdrawal by Subject|2|||
143008553|NCT02525627|515571125|FG000|Overall Study|Death|1|||
143008554|NCT02525627|515571126|FG001|Overall Study|Death|0|||
143008555|NCT02525627|515571125|FG000|Overall Study|Site terminated|11|||
143008556|NCT02525627|515571126|FG001|Overall Study|Site terminated|10|||
143008557|NCT01473589|515571127|FG000|Overall Study|Adverse Event|1|||
143008558|NCT01473589|515571128|FG001|Overall Study|Adverse Event|1|||
143008559|NCT01473589|515571127|FG000|Overall Study|Death|2|||
143008560|NCT01473589|515571128|FG001|Overall Study|Death|0|||
143008561|NCT01473589|515571127|FG000|Overall Study|Lost to Follow-up|2|||
143008562|NCT01473589|515571128|FG001|Overall Study|Lost to Follow-up|2|||
143008563|NCT01473589|515571127|FG000|Overall Study|Protocol Violation|1|||
143008564|NCT01473589|515571128|FG001|Overall Study|Protocol Violation|0|||
143008565|NCT01473589|515571127|FG000|Overall Study|Withdrawal by Subject|5|||
143008566|NCT01473589|515571128|FG001|Overall Study|Withdrawal by Subject|11|||
143008567|NCT01473589|515571127|FG000|Overall Study|Physician Decision|0|||
143008568|NCT01473589|515571128|FG001|Overall Study|Physician Decision|1|||
143008569|NCT01473589|515571127|FG000|Overall Study|Entry criteria not met|0|||
143008570|NCT01473589|515571128|FG001|Overall Study|Entry criteria not met|1|||
143008571|NCT03457727|515571129|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
143008572|NCT03457727|515571130|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
143008573|NCT03457727|515571131|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
143008574|NCT03457727|515571132|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
143008575|NCT00929201|515571133|FG000|Period 1|Withdrawal by Subject|0|||
143008576|NCT00929201|515571134|FG001|Period 1|Withdrawal by Subject|1|||
143008577|NCT01299272|515571138|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
143008578|NCT01299272|515571139|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
143008579|NCT01299272|515571140|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
143008580|NCT01299272|515571141|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
143008581|NCT01299272|515571138|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
143008582|NCT01299272|515571139|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
143008583|NCT01299272|515571140|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
143008584|NCT01299272|515571141|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
143008585|NCT01299272|515571138|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
143008586|NCT01299272|515571139|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
143008587|NCT01299272|515571140|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
143008588|NCT01299272|515571141|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
143008589|NCT01299272|515571138|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
143008590|NCT01299272|515571139|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
143008591|NCT01299272|515571140|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
143008592|NCT01299272|515571141|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
143008593|NCT01299272|515571138|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
143008594|NCT01299272|515571139|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
143008595|NCT01299272|515571140|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
143008596|NCT01299272|515571141|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
143008597|NCT01299272|515571138|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
143008598|NCT01299272|515571139|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
143008599|NCT01299272|515571140|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
143008600|NCT01299272|515571141|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
143008601|NCT01299272|515571138|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
143008602|NCT01299272|515571139|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
143008603|NCT01299272|515571140|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
143008604|NCT01299272|515571141|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
143008605|NCT01299272|515571138|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
143008606|NCT01299272|515571139|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
143008607|NCT01299272|515571140|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
143008608|NCT01299272|515571141|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
143008609|NCT01299272|515571138|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
143008610|NCT01299272|515571139|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
143008611|NCT01299272|515571140|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
143008612|NCT01299272|515571141|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
143008613|NCT01299272|515571138|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
143008614|NCT01299272|515571139|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
143008615|NCT01299272|515571140|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
143008616|NCT01299272|515571141|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
143008617|NCT01299272|515571138|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
143008618|NCT01299272|515571139|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
143008619|NCT01299272|515571140|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
143008620|NCT01299272|515571141|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
143008621|NCT01299272|515571138|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
143008622|NCT01299272|515571139|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
143008623|NCT01299272|515571140|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
143008624|NCT01299272|515571141|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
143008625|NCT01299272|515571138|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
143008626|NCT01299272|515571139|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
143008627|NCT01299272|515571140|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
143008628|NCT01299272|515571141|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
143008629|NCT01299272|515571138|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
143008630|NCT01299272|515571139|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
143008631|NCT01299272|515571140|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
143008632|NCT01299272|515571141|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
143008633|NCT01299272|515571138|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
143008634|NCT01299272|515571139|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
143008635|NCT01299272|515571140|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
143008636|NCT01299272|515571141|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
143008637|NCT01299272|515571138|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
143008638|NCT01299272|515571139|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
143008639|NCT01299272|515571140|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
143008640|NCT01299272|515571141|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
143008641|NCT01299272|515571138|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
143008642|NCT01299272|515571139|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
143008643|NCT01299272|515571140|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
143008644|NCT01299272|515571141|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
143008645|NCT01299272|515571138|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
143008646|NCT01299272|515571139|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
143008647|NCT01299272|515571140|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
143008648|NCT01299272|515571141|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
143008649|NCT01299272|515571138|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
143008650|NCT01299272|515571139|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
143008651|NCT01299272|515571140|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
143008652|NCT01299272|515571141|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
143008653|NCT01299272|515571138|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
143008654|NCT01299272|515571139|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
143008655|NCT01299272|515571140|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
143008656|NCT01299272|515571141|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
143008657|NCT01299272|515571138|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
143008658|NCT01299272|515571139|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
143008659|NCT01299272|515571140|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
143008660|NCT01299272|515571141|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
143008661|NCT01299272|515571138|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
143008662|NCT01299272|515571139|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
143008663|NCT01299272|515571140|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
143008664|NCT01299272|515571141|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
143008665|NCT01299272|515571138|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
143008666|NCT01299272|515571139|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
143008667|NCT01299272|515571140|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
143008668|NCT01299272|515571141|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
143008669|NCT01299272|515571138|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
143008670|NCT01299272|515571139|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
143008671|NCT01299272|515571140|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
143008672|NCT01299272|515571141|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
143008673|NCT01299272|515571138|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
143008674|NCT01299272|515571139|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
143008675|NCT01299272|515571140|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
143008676|NCT01299272|515571141|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
143008677|NCT03514121|515571148|FG000|Overall Study|Withdrawal by Subject|0|||
143008678|NCT03514121|515571149|FG001|Overall Study|Withdrawal by Subject|0|||
143008679|NCT03514121|515571150|FG002|Overall Study|Withdrawal by Subject|0|||
143008680|NCT03514121|515571151|FG003|Overall Study|Withdrawal by Subject|0|||
143008681|NCT03514121|515571152|FG004|Overall Study|Withdrawal by Subject|1|||
143008682|NCT03514121|515571153|FG005|Overall Study|Withdrawal by Subject|2|||
143008683|NCT03514121|515571154|FG006|Overall Study|Withdrawal by Subject|1|||
143008684|NCT03514121|515571155|FG007|Overall Study|Withdrawal by Subject|1|||
143008685|NCT03514121|515571156|FG008|Overall Study|Withdrawal by Subject|7|||
143008686|NCT03514121|515571157|FG009|Overall Study|Withdrawal by Subject|2|||
143008687|NCT03514121|515571148|FG000|Overall Study|Death|0|||
143008688|NCT03514121|515571149|FG001|Overall Study|Death|0|||
143008689|NCT03514121|515571150|FG002|Overall Study|Death|0|||
143008690|NCT03514121|515571151|FG003|Overall Study|Death|0|||
143008691|NCT03514121|515571152|FG004|Overall Study|Death|0|||
143008692|NCT03514121|515571153|FG005|Overall Study|Death|3|||
143008693|NCT03514121|515571154|FG006|Overall Study|Death|2|||
143008694|NCT03514121|515571155|FG007|Overall Study|Death|1|||
143008695|NCT03514121|515571156|FG008|Overall Study|Death|26|||
143008696|NCT03514121|515571157|FG009|Overall Study|Death|3|||
143008697|NCT03514121|515571148|FG000|Overall Study|Lost to Follow-up|0|||
143008698|NCT03514121|515571149|FG001|Overall Study|Lost to Follow-up|0|||
143008699|NCT03514121|515571150|FG002|Overall Study|Lost to Follow-up|1|||
143008700|NCT03514121|515571151|FG003|Overall Study|Lost to Follow-up|0|||
143008701|NCT03514121|515571152|FG004|Overall Study|Lost to Follow-up|0|||
143008702|NCT03514121|515571153|FG005|Overall Study|Lost to Follow-up|0|||
143008703|NCT03514121|515571154|FG006|Overall Study|Lost to Follow-up|0|||
143008704|NCT03514121|515571155|FG007|Overall Study|Lost to Follow-up|0|||
143008705|NCT03514121|515571156|FG008|Overall Study|Lost to Follow-up|1|||
143008706|NCT03514121|515571157|FG009|Overall Study|Lost to Follow-up|0|||
143008707|NCT03514121|515571148|FG000|Overall Study|Adverse Event|0|||
143008708|NCT03514121|515571149|FG001|Overall Study|Adverse Event|0|||
143008709|NCT03514121|515571150|FG002|Overall Study|Adverse Event|0|||
143008710|NCT03514121|515571151|FG003|Overall Study|Adverse Event|0|||
143008711|NCT03514121|515571152|FG004|Overall Study|Adverse Event|0|||
143008712|NCT03514121|515571153|FG005|Overall Study|Adverse Event|0|||
143008713|NCT03514121|515571154|FG006|Overall Study|Adverse Event|1|||
143008714|NCT03514121|515571155|FG007|Overall Study|Adverse Event|0|||
143008715|NCT03514121|515571156|FG008|Overall Study|Adverse Event|0|||
143008716|NCT03514121|515571157|FG009|Overall Study|Adverse Event|0|||
143008717|NCT03514121|515571148|FG000|Overall Study|Other|0|||
143008718|NCT03514121|515571149|FG001|Overall Study|Other|1|||
143008719|NCT03514121|515571150|FG002|Overall Study|Other|1|||
143008720|NCT03514121|515571151|FG003|Overall Study|Other|0|||
143008721|NCT03514121|515571152|FG004|Overall Study|Other|1|||
143008722|NCT03514121|515571153|FG005|Overall Study|Other|2|||
143008723|NCT03514121|515571154|FG006|Overall Study|Other|3|||
143008724|NCT03514121|515571155|FG007|Overall Study|Other|2|||
143008725|NCT03514121|515571156|FG008|Overall Study|Other|7|||
143008726|NCT03514121|515571157|FG009|Overall Study|Other|3|||
143008727|NCT03514121|515571148|FG000|Overall Study|Study termination by Sponsor|0|||
143008728|NCT03514121|515571149|FG001|Overall Study|Study termination by Sponsor|0|||
143008729|NCT03514121|515571150|FG002|Overall Study|Study termination by Sponsor|0|||
143008730|NCT03514121|515571151|FG003|Overall Study|Study termination by Sponsor|0|||
143008731|NCT03514121|515571152|FG004|Overall Study|Study termination by Sponsor|0|||
143008732|NCT03514121|515571153|FG005|Overall Study|Study termination by Sponsor|0|||
143008733|NCT03514121|515571154|FG006|Overall Study|Study termination by Sponsor|0|||
143008734|NCT03514121|515571155|FG007|Overall Study|Study termination by Sponsor|0|||
143008735|NCT03514121|515571156|FG008|Overall Study|Study termination by Sponsor|11|||
143008736|NCT03514121|515571157|FG009|Overall Study|Study termination by Sponsor|3|||
143008737|NCT03514121|515571148|FG000|Overall Study|Investigator decision|0|||
143008738|NCT03514121|515571149|FG001|Overall Study|Investigator decision|0|||
143008739|NCT03514121|515571150|FG002|Overall Study|Investigator decision|0|||
143008740|NCT03514121|515571151|FG003|Overall Study|Investigator decision|0|||
143008741|NCT03514121|515571152|FG004|Overall Study|Investigator decision|0|||
143008742|NCT03514121|515571153|FG005|Overall Study|Investigator decision|0|||
143008743|NCT03514121|515571154|FG006|Overall Study|Investigator decision|0|||
143008744|NCT03514121|515571155|FG007|Overall Study|Investigator decision|0|||
143008745|NCT03514121|515571156|FG008|Overall Study|Investigator decision|1|||
143008746|NCT03514121|515571157|FG009|Overall Study|Investigator decision|0|||
143008747|NCT05553600|515571158|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
143008748|NCT05553600|515571159|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
143008749|NCT05553600|515571160|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
143008750|NCT05553600|515571161|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
143008751|NCT05553600|515571158|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
143123546|NCT02757352|515997788|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
143123547|NCT02757352|515997789|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
143008752|NCT05553600|515571159|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
143008753|NCT05553600|515571160|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
143008754|NCT05553600|515571161|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
143008755|NCT05553600|515571158|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
143008756|NCT05553600|515571159|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
143008757|NCT05553600|515571160|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
143008758|NCT05553600|515571161|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
143008759|NCT05553600|515571158|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
143008760|NCT05553600|515571159|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
143008761|NCT05553600|515571160|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
143008762|NCT05553600|515571161|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
143008763|NCT05553600|515571158|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
143008764|NCT05553600|515571159|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
143008765|NCT05553600|515571160|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
143008766|NCT05553600|515571161|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
143008767|NCT05553600|515571158|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
143008768|NCT05553600|515571159|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
143008769|NCT05553600|515571160|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
143008770|NCT05553600|515571161|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
143008771|NCT05553600|515571158|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
143008772|NCT05553600|515571159|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
143008773|NCT05553600|515571160|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
143008774|NCT05553600|515571161|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
143008775|NCT05553600|515571158|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
143008776|NCT05553600|515571159|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
143008777|NCT05553600|515571160|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
143008778|NCT05553600|515571161|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
143008779|NCT05553600|515571158|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
143008780|NCT05553600|515571159|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
143008781|NCT05553600|515571160|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
143008782|NCT05553600|515571161|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
143008783|NCT05553600|515571158|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
143008784|NCT05553600|515571159|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
143008785|NCT05553600|515571160|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
143008786|NCT05553600|515571161|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
143008787|NCT05553600|515571158|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
143008788|NCT05553600|515571159|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
143008789|NCT05553600|515571160|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
143008790|NCT05553600|515571161|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
143008791|NCT05553600|515571158|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
143008792|NCT05553600|515571159|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
143008793|NCT05553600|515571160|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
143008794|NCT05553600|515571161|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
143008795|NCT03286400|515571162|FG000|Overall Study|Death|10|||
143008796|NCT03286400|515571162|FG000|Overall Study|Lost to Follow-up|10|||
143008797|NCT03286400|515571162|FG000|Overall Study|Physician Decision|1|||
143008798|NCT03286400|515571162|FG000|Overall Study|Scheduling difficulty|4|||
143008799|NCT03576131|515571163|FG000|Overall Study|Investigator decision|0|||
143008800|NCT03576131|515571164|FG001|Overall Study|Investigator decision|0|||
143008801|NCT03576131|515571165|FG002|Overall Study|Investigator decision|0|||
143008802|NCT03576131|515571166|FG003|Overall Study|Investigator decision|1|||
143008803|NCT03576131|515571167|FG004|Overall Study|Investigator decision|0|||
143008804|NCT03576131|515571168|FG005|Overall Study|Investigator decision|1|||
143008805|NCT03576131|515571169|FG006|Overall Study|Investigator decision|0|||
143008806|NCT03576131|515571170|FG007|Overall Study|Investigator decision|0|||
143008807|NCT03576131|515571163|FG000|Overall Study|Withdrawal by Subject|1|||
143008808|NCT03576131|515571164|FG001|Overall Study|Withdrawal by Subject|1|||
143008809|NCT03576131|515571165|FG002|Overall Study|Withdrawal by Subject|0|||
143008810|NCT03576131|515571166|FG003|Overall Study|Withdrawal by Subject|1|||
143008811|NCT03576131|515571167|FG004|Overall Study|Withdrawal by Subject|2|||
143008812|NCT03576131|515571168|FG005|Overall Study|Withdrawal by Subject|3|||
143008813|NCT03576131|515571169|FG006|Overall Study|Withdrawal by Subject|1|||
143008814|NCT03576131|515571170|FG007|Overall Study|Withdrawal by Subject|0|||
143008815|NCT03576131|515571163|FG000|Overall Study|Death|3|||
143008816|NCT03576131|515571164|FG001|Overall Study|Death|3|||
143008817|NCT03576131|515571165|FG002|Overall Study|Death|1|||
143008818|NCT03576131|515571166|FG003|Overall Study|Death|5|||
143008819|NCT03576131|515571167|FG004|Overall Study|Death|4|||
143008820|NCT03576131|515571168|FG005|Overall Study|Death|1|||
143008821|NCT03576131|515571169|FG006|Overall Study|Death|0|||
143008822|NCT03576131|515571170|FG007|Overall Study|Death|1|||
143008823|NCT03576131|515571163|FG000|Overall Study|New anti-cancer treatment|5|||
143008824|NCT03576131|515571164|FG001|Overall Study|New anti-cancer treatment|1|||
143008825|NCT03576131|515571165|FG002|Overall Study|New anti-cancer treatment|2|||
143008826|NCT03576131|515571166|FG003|Overall Study|New anti-cancer treatment|3|||
143008827|NCT03576131|515571167|FG004|Overall Study|New anti-cancer treatment|0|||
143008828|NCT03576131|515571168|FG005|Overall Study|New anti-cancer treatment|0|||
143008829|NCT03576131|515571169|FG006|Overall Study|New anti-cancer treatment|0|||
143461188|NCT01201317|517234962|FG002|Overall Study|Lack of Efficacy|0|||
143461189|NCT01201317|517234960|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
143461190|NCT01201317|517234961|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
143461191|NCT01201317|517234962|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
143461192|NCT02563522|517234964|FG000|Overall Study|Adverse Event|2|||
143461193|NCT02563522|517234965|FG001|Overall Study|Adverse Event|3|||
143461194|NCT02563522|517234964|FG000|Overall Study|Lost to Follow-up|1|||
143461195|NCT02563522|517234965|FG001|Overall Study|Lost to Follow-up|0|||
143461196|NCT02563522|517234964|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
143461197|NCT02563522|517234965|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
143461198|NCT04874415|517234970|FG000|Overall Study|Missing Fitbit data but not lost to follow up|1|||
143461199|NCT04874415|517234971|FG001|Overall Study|Missing Fitbit data but not lost to follow up|1|||
143461200|NCT04874415|517234972|FG002|Overall Study|Missing Fitbit data but not lost to follow up|1|||
143461201|NCT04874415|517234973|FG003|Overall Study|Missing Fitbit data but not lost to follow up|1|||
143461202|NCT04874415|517234974|FG004|Overall Study|Missing Fitbit data but not lost to follow up|1|||
143461203|NCT04874415|517234975|FG005|Overall Study|Missing Fitbit data but not lost to follow up|1|||
143461204|NCT04874415|517234976|FG006|Overall Study|Missing Fitbit data but not lost to follow up|0|||
143461205|NCT04874415|517234977|FG007|Overall Study|Missing Fitbit data but not lost to follow up|1|||
143461206|NCT04874415|517234978|FG008|Overall Study|Missing Fitbit data but not lost to follow up|4|||
143461207|NCT04874415|517234979|FG009|Overall Study|Missing Fitbit data but not lost to follow up|0|||
143461208|NCT04874415|517234980|FG010|Overall Study|Missing Fitbit data but not lost to follow up|1|||
143461209|NCT04874415|517234981|FG011|Overall Study|Missing Fitbit data but not lost to follow up|0|||
143461210|NCT04874415|517234982|FG012|Overall Study|Missing Fitbit data but not lost to follow up|0|||
143461211|NCT04874415|517234983|FG013|Overall Study|Missing Fitbit data but not lost to follow up|1|||
143461212|NCT04874415|517234984|FG014|Overall Study|Missing Fitbit data but not lost to follow up|4|||
143461213|NCT04874415|517234985|FG015|Overall Study|Missing Fitbit data but not lost to follow up|0|||
143461214|NCT04874415|517234970|FG000|Overall Study|Missing Fitbit data and lost to follow up|1|||
143461215|NCT04874415|517234971|FG001|Overall Study|Missing Fitbit data and lost to follow up|0|||
143461216|NCT04874415|517234972|FG002|Overall Study|Missing Fitbit data and lost to follow up|0|||
143461217|NCT04874415|517234973|FG003|Overall Study|Missing Fitbit data and lost to follow up|1|||
143461218|NCT04874415|517234974|FG004|Overall Study|Missing Fitbit data and lost to follow up|0|||
143461219|NCT04874415|517234975|FG005|Overall Study|Missing Fitbit data and lost to follow up|0|||
143461220|NCT04874415|517234976|FG006|Overall Study|Missing Fitbit data and lost to follow up|1|||
143461221|NCT04874415|517234977|FG007|Overall Study|Missing Fitbit data and lost to follow up|1|||
143461222|NCT04874415|517234978|FG008|Overall Study|Missing Fitbit data and lost to follow up|0|||
143461223|NCT04874415|517234979|FG009|Overall Study|Missing Fitbit data and lost to follow up|3|||
143461224|NCT04874415|517234980|FG010|Overall Study|Missing Fitbit data and lost to follow up|1|||
143461225|NCT04874415|517234981|FG011|Overall Study|Missing Fitbit data and lost to follow up|1|||
143461226|NCT04874415|517234982|FG012|Overall Study|Missing Fitbit data and lost to follow up|1|||
143461227|NCT04874415|517234983|FG013|Overall Study|Missing Fitbit data and lost to follow up|0|||
143461228|NCT04874415|517234984|FG014|Overall Study|Missing Fitbit data and lost to follow up|0|||
143461229|NCT04874415|517234985|FG015|Overall Study|Missing Fitbit data and lost to follow up|1|||
143461230|NCT04874415|517234970|FG000|Overall Study|Did not attend final study visit but had Fitbit data|0|||
143461231|NCT04874415|517234971|FG001|Overall Study|Did not attend final study visit but had Fitbit data|0|||
143461232|NCT04874415|517234972|FG002|Overall Study|Did not attend final study visit but had Fitbit data|0|||
143461233|NCT04874415|517234973|FG003|Overall Study|Did not attend final study visit but had Fitbit data|0|||
143461234|NCT04874415|517234974|FG004|Overall Study|Did not attend final study visit but had Fitbit data|1|||
143461235|NCT04874415|517234975|FG005|Overall Study|Did not attend final study visit but had Fitbit data|0|||
143461236|NCT04874415|517234976|FG006|Overall Study|Did not attend final study visit but had Fitbit data|0|||
143461237|NCT04874415|517234977|FG007|Overall Study|Did not attend final study visit but had Fitbit data|0|||
143461238|NCT04874415|517234978|FG008|Overall Study|Did not attend final study visit but had Fitbit data|0|||
143461239|NCT04874415|517234979|FG009|Overall Study|Did not attend final study visit but had Fitbit data|0|||
143461240|NCT04874415|517234980|FG010|Overall Study|Did not attend final study visit but had Fitbit data|0|||
143461241|NCT04874415|517234981|FG011|Overall Study|Did not attend final study visit but had Fitbit data|0|||
143461242|NCT04874415|517234982|FG012|Overall Study|Did not attend final study visit but had Fitbit data|0|||
143461243|NCT04874415|517234983|FG013|Overall Study|Did not attend final study visit but had Fitbit data|0|||
143461244|NCT04874415|517234984|FG014|Overall Study|Did not attend final study visit but had Fitbit data|0|||
143461245|NCT04874415|517234985|FG015|Overall Study|Did not attend final study visit but had Fitbit data|0|||
143461246|NCT00918580|517234986|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
143461247|NCT00918580|517234986|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
143461248|NCT00918580|517234986|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
143461249|NCT00918580|517234986|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
143461250|NCT00918580|517234986|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
143008830|NCT03576131|515571170|FG007|Overall Study|New anti-cancer treatment|0|||
143008831|NCT03576131|515571163|FG000|Overall Study|Unspecified reason|0|||
143008832|NCT03576131|515571164|FG001|Overall Study|Unspecified reason|0|||
143008833|NCT03576131|515571165|FG002|Overall Study|Unspecified reason|1|||
143008834|NCT03576131|515571166|FG003|Overall Study|Unspecified reason|1|||
143008835|NCT03576131|515571167|FG004|Overall Study|Unspecified reason|1|||
143008836|NCT03576131|515571168|FG005|Overall Study|Unspecified reason|1|||
143008837|NCT03576131|515571169|FG006|Overall Study|Unspecified reason|0|||
143008838|NCT03576131|515571170|FG007|Overall Study|Unspecified reason|0|||
143008839|NCT03576131|515571163|FG000|Overall Study|Subject non-compliance|0|||
143008840|NCT03576131|515571164|FG001|Overall Study|Subject non-compliance|0|||
143008841|NCT03576131|515571165|FG002|Overall Study|Subject non-compliance|0|||
143008842|NCT03576131|515571166|FG003|Overall Study|Subject non-compliance|0|||
143008843|NCT03576131|515571167|FG004|Overall Study|Subject non-compliance|0|||
143008844|NCT03576131|515571168|FG005|Overall Study|Subject non-compliance|1|||
143008845|NCT03576131|515571169|FG006|Overall Study|Subject non-compliance|0|||
143008846|NCT03576131|515571170|FG007|Overall Study|Subject non-compliance|0|||
143008847|NCT01317199|515571171|FG000|Dose-escalation Phase 1|Physician Decision|5|||
143008848|NCT01317199|515571172|FG001|Dose-escalation Phase 1|Physician Decision|0|||
143008849|NCT01317199|515571173|FG002|Dose-escalation Phase 1|Physician Decision|0|||
143008850|NCT01317199|515571174|FG003|Dose-escalation Phase 1|Physician Decision|0|||
143008851|NCT01317199|515571171|FG000|Dose-escalation Phase 1|Disease progression|1|||
143008852|NCT01317199|515571172|FG001|Dose-escalation Phase 1|Disease progression|0|||
143008853|NCT01317199|515571173|FG002|Dose-escalation Phase 1|Disease progression|0|||
143008854|NCT01317199|515571174|FG003|Dose-escalation Phase 1|Disease progression|0|||
143008855|NCT01317199|515571171|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
143008856|NCT01317199|515571172|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
143008857|NCT01317199|515571173|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
143008858|NCT01317199|515571174|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
143008859|NCT01317199|515571171|FG000|Randomized Phase 2|Disease progression|0|||
143008860|NCT01317199|515571172|FG001|Randomized Phase 2|Disease progression|3|||
143008861|NCT01317199|515571173|FG002|Randomized Phase 2|Disease progression|7|||
143008862|NCT01317199|515571174|FG003|Randomized Phase 2|Disease progression|5|||
143008863|NCT01317199|515571171|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
143008864|NCT01317199|515571172|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
143008865|NCT01317199|515571173|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
143008866|NCT01317199|515571174|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
143008867|NCT01317199|515571171|FG000|Randomized Phase 2|Adverse Event|0|||
143008868|NCT01317199|515571172|FG001|Randomized Phase 2|Adverse Event|0|||
143008869|NCT01317199|515571173|FG002|Randomized Phase 2|Adverse Event|0|||
143008870|NCT01317199|515571174|FG003|Randomized Phase 2|Adverse Event|1|||
143008871|NCT01317199|515571171|FG000|Randomized Phase 2|Comorbidities|0|||
143008872|NCT01317199|515571172|FG001|Randomized Phase 2|Comorbidities|2|||
143008873|NCT01317199|515571173|FG002|Randomized Phase 2|Comorbidities|2|||
143008874|NCT01317199|515571174|FG003|Randomized Phase 2|Comorbidities|2|||
143008875|NCT01317199|515571171|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
143008876|NCT01317199|515571172|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
143008877|NCT01317199|515571173|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
143008878|NCT01317199|515571174|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
143008879|NCT01317199|515571171|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
143008880|NCT01317199|515571172|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
143008881|NCT01317199|515571173|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
143008882|NCT01317199|515571174|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
143008883|NCT01317199|515571171|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
143008884|NCT01317199|515571172|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
143123548|NCT02757352|515997790|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
143123549|NCT02757352|515997791|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
143461251|NCT00918580|517234986|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
143461252|NCT00918580|517234986|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
143461253|NCT03486457|517234987|FG000|Up to Month 3|Adverse Event|2|||
143461254|NCT03486457|517234988|FG001|Up to Month 3|Adverse Event|5|||
143461255|NCT03486457|517234987|FG000|Up to Month 3|Lack of Efficacy|1|||
143461256|NCT03486457|517234988|FG001|Up to Month 3|Lack of Efficacy|0|||
143461257|NCT03486457|517234987|FG000|Up to Month 3|Withdrawal by Subject|1|||
143461258|NCT03486457|517234988|FG001|Up to Month 3|Withdrawal by Subject|0|||
143461259|NCT03486457|517234987|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
143461260|NCT03486457|517234988|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
143461261|NCT03486457|517234987|FG000|Up to Month 3|Other|1|||
143008885|NCT01317199|515571173|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
143123550|NCT02757352|515997792|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
143461262|NCT03486457|517234988|FG001|Up to Month 3|Other|0|||
143461263|NCT03486457|517234987|FG000|Month 3 to Month 6|Adverse Event|2|||
143461264|NCT03486457|517234988|FG001|Month 3 to Month 6|Adverse Event|0|||
143008886|NCT01317199|515571174|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
143008887|NCT01317199|515571171|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
143008888|NCT01317199|515571172|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
143008889|NCT01317199|515571173|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
143008890|NCT01317199|515571174|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
143008891|NCT00337727|515571177|FG000|Overall Study|Adverse Event|5|||
143008892|NCT00337727|515571178|FG001|Overall Study|Adverse Event|3|||
143008893|NCT00337727|515571177|FG000|Overall Study|Lost to Follow-up|5|||
143008894|NCT00337727|515571178|FG001|Overall Study|Lost to Follow-up|4|||
143008895|NCT00337727|515571177|FG000|Overall Study|Physician Decision|1|||
143008896|NCT00337727|515571178|FG001|Overall Study|Physician Decision|0|||
143008897|NCT00337727|515571177|FG000|Overall Study|Protocol Violation|4|||
143123551|NCT02757352|515997783|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
143123552|NCT02757352|515997784|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
143123553|NCT02757352|515997785|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
143123554|NCT02757352|515997786|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
143123555|NCT02757352|515997787|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
143123556|NCT02757352|515997788|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
143123557|NCT02757352|515997789|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
143123558|NCT02757352|515997790|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
143123559|NCT02757352|515997791|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
143123560|NCT02757352|515997792|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
143123561|NCT02757352|515997783|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
143123562|NCT02757352|515997784|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
143123563|NCT02757352|515997785|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
143123564|NCT02757352|515997786|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
143123565|NCT02757352|515997787|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
143123566|NCT02757352|515997788|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
143123567|NCT02757352|515997789|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
143123568|NCT02757352|515997790|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
143123569|NCT02757352|515997791|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
143123570|NCT02757352|515997792|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
143123571|NCT02757352|515997783|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
143123572|NCT02757352|515997784|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
143123573|NCT02757352|515997785|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
143123574|NCT02757352|515997786|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
143123575|NCT02757352|515997787|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
143123576|NCT02757352|515997788|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
143123577|NCT02757352|515997789|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
143123578|NCT02757352|515997790|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
143123579|NCT02757352|515997791|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
143123580|NCT02757352|515997792|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
143123581|NCT02757352|515997783|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
143123582|NCT02757352|515997784|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
143008898|NCT00337727|515571178|FG001|Overall Study|Protocol Violation|0|||
143008899|NCT00337727|515571177|FG000|Overall Study|Withdrawal by Subject|3|||
143008900|NCT00337727|515571178|FG001|Overall Study|Withdrawal by Subject|5|||
143008901|NCT00943826|515571179|FG000|Concurrent Phase|Adverse Event|50|||
143008902|NCT00943826|515571180|FG001|Concurrent Phase|Adverse Event|27|||
143008903|NCT00943826|515571179|FG000|Concurrent Phase|Withdrew consent|3|||
143008904|NCT00943826|515571180|FG001|Concurrent Phase|Withdrew consent|7|||
143008905|NCT00943826|515571179|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
143008906|NCT00943826|515571180|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
143008907|NCT00943826|515571179|FG000|Concurrent Phase|Administrative reasons|2|||
143008908|NCT00943826|515571180|FG001|Concurrent Phase|Administrative reasons|1|||
143008909|NCT00943826|515571179|FG000|Concurrent Phase|Protocol Violation|1|||
143008910|NCT00943826|515571180|FG001|Concurrent Phase|Protocol Violation|0|||
143008911|NCT00943826|515571179|FG000|Maintenance Phase|Adverse Event|31|||
143008912|NCT00943826|515571180|FG001|Maintenance Phase|Adverse Event|30|||
143008913|NCT00943826|515571179|FG000|Maintenance Phase|Withdrew consent|2|||
143008914|NCT00943826|515571180|FG001|Maintenance Phase|Withdrew consent|4|||
143008915|NCT00943826|515571179|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
143008916|NCT00943826|515571180|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
143008917|NCT00943826|515571179|FG000|Maintenance Phase|Administrative reasons|4|||
143008918|NCT00943826|515571180|FG001|Maintenance Phase|Administrative reasons|1|||
143008919|NCT00943826|515571179|FG000|Maintenance Phase|Failure to return|0|||
143008920|NCT00943826|515571180|FG001|Maintenance Phase|Failure to return|1|||
143008921|NCT00943826|515571179|FG000|Monotherapy Phase|Adverse Event|42|||
143123583|NCT02757352|515997785|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
143123584|NCT02757352|515997786|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
143123585|NCT02757352|515997787|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
143123586|NCT02757352|515997788|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
143123587|NCT02757352|515997789|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
143123588|NCT02757352|515997790|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
143123589|NCT02757352|515997791|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
143123590|NCT02757352|515997792|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
143008922|NCT00943826|515571180|FG001|Monotherapy Phase|Adverse Event|5|||
143008923|NCT00943826|515571179|FG000|Monotherapy Phase|Administrative reasons|11|||
143008924|NCT00943826|515571180|FG001|Monotherapy Phase|Administrative reasons|5|||
143008925|NCT00943826|515571179|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
143008926|NCT00943826|515571180|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
143008927|NCT00943826|515571179|FG000|Monotherapy Phase|Withdrew Consent|2|||
143008928|NCT00943826|515571180|FG001|Monotherapy Phase|Withdrew Consent|3|||
143008929|NCT00943826|515571179|FG000|Monotherapy Phase|Failure to return|2|||
143008930|NCT00943826|515571180|FG001|Monotherapy Phase|Failure to return|1|||
143008931|NCT00943826|515571179|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
143008932|NCT00943826|515571180|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
143008933|NCT00943826|515571179|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
143008934|NCT00943826|515571180|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
143008935|NCT00943826|515571179|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
143008936|NCT00943826|515571180|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
143008937|NCT00943826|515571179|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
143008938|NCT00943826|515571180|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
143008939|NCT00326625|515571181|FG000|Overall Study|Adverse Event|20|||
143008940|NCT00326625|515571182|FG001|Overall Study|Adverse Event|9|||
143008941|NCT00326625|515571181|FG000|Overall Study|Withdrawal by Subject|15|||
143008942|NCT00326625|515571182|FG001|Overall Study|Withdrawal by Subject|12|||
143008943|NCT00326625|515571181|FG000|Overall Study|Death|18|||
143008944|NCT00326625|515571182|FG001|Overall Study|Death|16|||
143008945|NCT00326625|515571181|FG000|Overall Study|Lost to Follow-up|1|||
143008946|NCT00326625|515571182|FG001|Overall Study|Lost to Follow-up|0|||
143008947|NCT00326625|515571181|FG000|Overall Study|prescheduled medical intervention|0|||
143008948|NCT00326625|515571182|FG001|Overall Study|prescheduled medical intervention|1|||
143008949|NCT00669110|515571193|FG000|Overall Study|Adverse Event|4|||
143008950|NCT00669110|515571194|FG001|Overall Study|Adverse Event|3|||
143008951|NCT00669110|515571193|FG000|Overall Study|Caregiver request|3|||
143008952|NCT00669110|515571194|FG001|Overall Study|Caregiver request|2|||
143008953|NCT00669110|515571193|FG000|Overall Study|Physician Decision|0|||
143008954|NCT00669110|515571194|FG001|Overall Study|Physician Decision|1|||
143008955|NCT00669110|515571193|FG000|Overall Study|Lost to Follow-up|1|||
143008956|NCT00669110|515571194|FG001|Overall Study|Lost to Follow-up|0|||
143008957|NCT00669110|515571193|FG000|Overall Study|Protocol Violation|0|||
143008958|NCT00669110|515571194|FG001|Overall Study|Protocol Violation|5|||
143008959|NCT00669110|515571193|FG000|Overall Study|Withdrawal by Subject|0|||
143008960|NCT00669110|515571194|FG001|Overall Study|Withdrawal by Subject|2|||
143008961|NCT05275673|515571200|FG000|Overall Study|Study Termination by Sponsor|2|||
143008962|NCT05275673|515571201|FG001|Overall Study|Study Termination by Sponsor|3|||
143008963|NCT05275673|515571200|FG000|Overall Study|Death|1|||
143008964|NCT05275673|515571201|FG001|Overall Study|Death|0|||
143008965|NCT05275673|515571200|FG000|Overall Study|Withdrawal by Subject|1|||
143008966|NCT05275673|515571201|FG001|Overall Study|Withdrawal by Subject|0|||
143008967|NCT02325739|515571202|FG000|Phase I Part|Adverse Event|1|||
143008968|NCT02325739|515571203|FG001|Phase I Part|Adverse Event|0|||
143008969|NCT02325739|515571204|FG002|Phase I Part|Adverse Event|1|||
143008970|NCT02325739|515571205|FG003|Phase I Part|Adverse Event|2|||
143008971|NCT02325739|515571206|FG004|Phase I Part|Adverse Event|3|||
143008972|NCT02325739|515571207|FG005|Phase I Part|Adverse Event|1|||
143008973|NCT02325739|515571208|FG006|Phase I Part|Adverse Event|0|||
143008974|NCT02325739|515571209|FG007|Phase I Part|Adverse Event|2|||
143008975|NCT02325739|515571210|FG008|Phase I Part|Adverse Event|0|||
143008976|NCT02325739|515571211|FG009|Phase I Part|Adverse Event|0|||
143008977|NCT02325739|515571212|FG010|Phase I Part|Adverse Event|0|||
143008978|NCT02325739|515571202|FG000|Phase I Part|Progressive disease|9|||
143008979|NCT02325739|515571203|FG001|Phase I Part|Progressive disease|6|||
143123591|NCT02757352|515997783|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
143008980|NCT02325739|515571204|FG002|Phase I Part|Progressive disease|3|||
143008981|NCT02325739|515571205|FG003|Phase I Part|Progressive disease|23|||
143008982|NCT02325739|515571206|FG004|Phase I Part|Progressive disease|14|||
143008983|NCT02325739|515571207|FG005|Phase I Part|Progressive disease|6|||
143008984|NCT02325739|515571208|FG006|Phase I Part|Progressive disease|6|||
143123592|NCT02757352|515997784|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
143346392|NCT03097861|516814320|FG000|Overall Study|Adverse Event|3|||
143008985|NCT02325739|515571209|FG007|Phase I Part|Progressive disease|3|||
143123593|NCT02757352|515997785|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
143123594|NCT02757352|515997786|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
143123595|NCT02757352|515997787|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
143123596|NCT02757352|515997788|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
143123597|NCT02757352|515997789|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
143123598|NCT02757352|515997790|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
143123599|NCT02757352|515997791|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
143123600|NCT02757352|515997792|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
143123601|NCT02757352|515997783|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
143123602|NCT02757352|515997784|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
143123603|NCT02757352|515997785|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
143123604|NCT02757352|515997786|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
143123605|NCT02757352|515997787|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
143123606|NCT02757352|515997788|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
143123607|NCT02757352|515997789|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
143123608|NCT02757352|515997790|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
143123609|NCT02757352|515997791|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
143123610|NCT02757352|515997792|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
143123611|NCT02757352|515997783|FG000|Follow-Up Period|Adverse Event|0|||
143123612|NCT02757352|515997784|FG001|Follow-Up Period|Adverse Event|0|||
143123613|NCT02757352|515997785|FG002|Follow-Up Period|Adverse Event|0|||
143123614|NCT02757352|515997786|FG003|Follow-Up Period|Adverse Event|0|||
143123615|NCT02757352|515997787|FG004|Follow-Up Period|Adverse Event|0|||
143123616|NCT02757352|515997788|FG005|Follow-Up Period|Adverse Event|0|||
143123617|NCT02757352|515997789|FG006|Follow-Up Period|Adverse Event|1|||
143123618|NCT02757352|515997790|FG007|Follow-Up Period|Adverse Event|0|||
143123619|NCT02757352|515997791|FG008|Follow-Up Period|Adverse Event|2|||
143123620|NCT02757352|515997792|FG009|Follow-Up Period|Adverse Event|0|||
143123621|NCT02757352|515997783|FG000|Follow-Up Period|Lost to Follow-up|0|||
143123622|NCT02757352|515997784|FG001|Follow-Up Period|Lost to Follow-up|0|||
143123623|NCT02757352|515997785|FG002|Follow-Up Period|Lost to Follow-up|0|||
143123624|NCT02757352|515997786|FG003|Follow-Up Period|Lost to Follow-up|0|||
143123625|NCT02757352|515997787|FG004|Follow-Up Period|Lost to Follow-up|0|||
143123626|NCT02757352|515997788|FG005|Follow-Up Period|Lost to Follow-up|0|||
143123627|NCT02757352|515997789|FG006|Follow-Up Period|Lost to Follow-up|0|||
143123628|NCT02757352|515997790|FG007|Follow-Up Period|Lost to Follow-up|0|||
143123629|NCT02757352|515997791|FG008|Follow-Up Period|Lost to Follow-up|1|||
143123630|NCT02757352|515997792|FG009|Follow-Up Period|Lost to Follow-up|0|||
143123631|NCT02757352|515997783|FG000|Follow-Up Period|Lack of Efficacy|0|||
143123632|NCT02757352|515997784|FG001|Follow-Up Period|Lack of Efficacy|0|||
143123633|NCT02757352|515997785|FG002|Follow-Up Period|Lack of Efficacy|0|||
143008986|NCT02325739|515571210|FG008|Phase I Part|Progressive disease|0|||
143008987|NCT02325739|515571211|FG009|Phase I Part|Progressive disease|0|||
143008988|NCT02325739|515571212|FG010|Phase I Part|Progressive disease|0|||
143008989|NCT02325739|515571202|FG000|Phase I Part|Subject/guardian decision|1|||
143008990|NCT02325739|515571203|FG001|Phase I Part|Subject/guardian decision|0|||
143008991|NCT02325739|515571204|FG002|Phase I Part|Subject/guardian decision|1|||
143008992|NCT02325739|515571205|FG003|Phase I Part|Subject/guardian decision|1|||
143008993|NCT02325739|515571206|FG004|Phase I Part|Subject/guardian decision|0|||
143008994|NCT02325739|515571207|FG005|Phase I Part|Subject/guardian decision|0|||
143008995|NCT02325739|515571208|FG006|Phase I Part|Subject/guardian decision|0|||
143008996|NCT02325739|515571209|FG007|Phase I Part|Subject/guardian decision|1|||
143008997|NCT02325739|515571210|FG008|Phase I Part|Subject/guardian decision|0|||
143008998|NCT02325739|515571211|FG009|Phase I Part|Subject/guardian decision|0|||
143008999|NCT02325739|515571212|FG010|Phase I Part|Subject/guardian decision|0|||
143009000|NCT02325739|515571202|FG000|Phase I Part|Death|0|||
143009001|NCT02325739|515571203|FG001|Phase I Part|Death|0|||
143009002|NCT02325739|515571204|FG002|Phase I Part|Death|0|||
143009003|NCT02325739|515571205|FG003|Phase I Part|Death|0|||
143009004|NCT02325739|515571206|FG004|Phase I Part|Death|2|||
143009005|NCT02325739|515571207|FG005|Phase I Part|Death|0|||
143009006|NCT02325739|515571208|FG006|Phase I Part|Death|0|||
143123634|NCT02757352|515997786|FG003|Follow-Up Period|Lack of Efficacy|0|||
143123635|NCT02757352|515997787|FG004|Follow-Up Period|Lack of Efficacy|0|||
143123636|NCT02757352|515997788|FG005|Follow-Up Period|Lack of Efficacy|0|||
143123637|NCT02757352|515997789|FG006|Follow-Up Period|Lack of Efficacy|0|||
143009007|NCT02325739|515571209|FG007|Phase I Part|Death|0|||
143009008|NCT02325739|515571210|FG008|Phase I Part|Death|0|||
143009009|NCT02325739|515571211|FG009|Phase I Part|Death|0|||
143009010|NCT02325739|515571212|FG010|Phase I Part|Death|0|||
143009011|NCT02325739|515571202|FG000|Phase II Part|Adverse Event|0|||
143009012|NCT02325739|515571203|FG001|Phase II Part|Adverse Event|0|||
143009013|NCT02325739|515571204|FG002|Phase II Part|Adverse Event|0|||
143009014|NCT02325739|515571205|FG003|Phase II Part|Adverse Event|0|||
143009015|NCT02325739|515571206|FG004|Phase II Part|Adverse Event|0|||
143123638|NCT02757352|515997790|FG007|Follow-Up Period|Lack of Efficacy|0|||
143123639|NCT02757352|515997791|FG008|Follow-Up Period|Lack of Efficacy|1|||
143123640|NCT02757352|515997792|FG009|Follow-Up Period|Lack of Efficacy|1|||
143123641|NCT02757352|515997783|FG000|Follow-Up Period|Withdrawal by Subject|0|||
143123642|NCT02757352|515997784|FG001|Follow-Up Period|Withdrawal by Subject|0|||
143123643|NCT02757352|515997785|FG002|Follow-Up Period|Withdrawal by Subject|0|||
143123644|NCT02757352|515997786|FG003|Follow-Up Period|Withdrawal by Subject|0|||
143123645|NCT02757352|515997787|FG004|Follow-Up Period|Withdrawal by Subject|0|||
143123646|NCT02757352|515997788|FG005|Follow-Up Period|Withdrawal by Subject|0|||
143123647|NCT02757352|515997789|FG006|Follow-Up Period|Withdrawal by Subject|0|||
143123648|NCT02757352|515997790|FG007|Follow-Up Period|Withdrawal by Subject|1|||
143123649|NCT02757352|515997791|FG008|Follow-Up Period|Withdrawal by Subject|6|||
143123650|NCT02757352|515997792|FG009|Follow-Up Period|Withdrawal by Subject|2|||
143123651|NCT02155309|515997793|FG000|Overall Study|Protocol Violation|0|||
143123652|NCT02155309|515997794|FG001|Overall Study|Protocol Violation|0|||
143123653|NCT02155309|515997795|FG002|Overall Study|Protocol Violation|1|||
143123654|NCT02113007|515997798|FG000|Overall Study|Progressive disease|2|||
143123655|NCT03252145|515997799|FG000|Overall Study|Withdrawal by Subject|1|||
143123656|NCT03252145|515997800|FG001|Overall Study|Withdrawal by Subject|0|||
143123657|NCT03252145|515997799|FG000|Overall Study|Complicating Disease|1|||
143123658|NCT03252145|515997800|FG001|Overall Study|Complicating Disease|2|||
143123659|NCT03488563|515997801|FG000|Overall Study|Lost to Follow-up|7|||
143123660|NCT03488563|515997802|FG001|Overall Study|Lost to Follow-up|6|||
143123661|NCT03488563|515997803|FG002|Overall Study|Lost to Follow-up|7|||
143123662|NCT03488563|515997801|FG000|Overall Study|Withdrawal by Subject|8|||
143123663|NCT03488563|515997802|FG001|Overall Study|Withdrawal by Subject|7|||
143123664|NCT03488563|515997803|FG002|Overall Study|Withdrawal by Subject|7|||
143123665|NCT03488563|515997801|FG000|Overall Study|Physician Decision|0|||
143123666|NCT03488563|515997802|FG001|Overall Study|Physician Decision|0|||
143123667|NCT03488563|515997803|FG002|Overall Study|Physician Decision|1|||
143123668|NCT03488563|515997801|FG000|Overall Study|Protocol Violation|3|||
143123669|NCT03488563|515997802|FG001|Overall Study|Protocol Violation|2|||
143123670|NCT03488563|515997803|FG002|Overall Study|Protocol Violation|6|||
143123671|NCT03488563|515997801|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
143123672|NCT03488563|515997802|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
143123673|NCT03488563|515997803|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
143123674|NCT03488563|515997801|FG000|Overall Study|Use of prohibited medication|2|||
143123675|NCT03488563|515997802|FG001|Overall Study|Use of prohibited medication|0|||
143123676|NCT03488563|515997803|FG002|Overall Study|Use of prohibited medication|0|||
143123677|NCT03488563|515997801|FG000|Overall Study|Adverse Event|1|||
143123678|NCT03488563|515997802|FG001|Overall Study|Adverse Event|0|||
143123679|NCT03488563|515997803|FG002|Overall Study|Adverse Event|1|||
143123680|NCT03488563|515997801|FG000|Overall Study|Subject returned for ET visit|0|||
143123681|NCT03488563|515997802|FG001|Overall Study|Subject returned for ET visit|1|||
143123682|NCT03488563|515997803|FG002|Overall Study|Subject returned for ET visit|0|||
143123683|NCT03488563|515997801|FG000|Overall Study|Sponsor's decision|0|||
143123684|NCT03488563|515997802|FG001|Overall Study|Sponsor's decision|0|||
143123685|NCT03488563|515997803|FG002|Overall Study|Sponsor's decision|1|||
143123686|NCT00582426|515997817|FG000|Overall Study|Lost to Follow-up|0|||
143123687|NCT00582426|515997818|FG001|Overall Study|Lost to Follow-up|2|||
143123688|NCT00582426|515997817|FG000|Overall Study|Adverse Event|4|||
143123689|NCT00582426|515997818|FG001|Overall Study|Adverse Event|2|||
143123690|NCT00582426|515997817|FG000|Overall Study|Protocol Violation|6|||
143123691|NCT00582426|515997818|FG001|Overall Study|Protocol Violation|2|||
143123692|NCT00582426|515997817|FG000|Overall Study|Death|4|||
143123693|NCT00582426|515997818|FG001|Overall Study|Death|3|||
143123694|NCT00582426|515997817|FG000|Overall Study|Withdrawal by Subject|3|||
143123695|NCT00582426|515997818|FG001|Overall Study|Withdrawal by Subject|2|||
143123696|NCT00582426|515997817|FG000|Overall Study|Disease Progression|2|||
143123697|NCT00582426|515997818|FG001|Overall Study|Disease Progression|2|||
143461265|NCT03486457|517234987|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
143123698|NCT00582426|515997817|FG000|Overall Study|Use of illicit drugs|1|||
143123699|NCT00582426|515997818|FG001|Overall Study|Use of illicit drugs|0|||
143123700|NCT02626000|515997821|FG000|Overall Study|Decision by Sponsor|1|||
143461266|NCT03486457|517234988|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
143461267|NCT03486457|517234987|FG000|Month 3 to Month 6|Pregnancy|0|||
143123701|NCT02626000|515997821|FG000|Overall Study|Death|29|||
143123702|NCT00662311|515997822|FG000|Overall Study|Respiratory Infection|1|||
143123703|NCT00662311|515997823|FG001|Overall Study|Respiratory Infection|0|||
143123704|NCT00662311|515997824|FG002|Overall Study|Respiratory Infection|0|||
143123705|NCT02164318|515997825|FG000|Overall Study|Withdrawal by Subject|0|||
143123706|NCT02164318|515997826|FG001|Overall Study|Withdrawal by Subject|1|||
143123707|NCT02164318|515997827|FG002|Overall Study|Withdrawal by Subject|0|||
143123708|NCT02164318|515997828|FG003|Overall Study|Withdrawal by Subject|1|||
143123709|NCT01467271|515997831|FG000|Overall Study|Death|84|||
143123710|NCT01467271|515997831|FG000|Overall Study|Lost to Follow-up|83|||
143461268|NCT03486457|517234988|FG001|Month 3 to Month 6|Pregnancy|1|||
143009016|NCT02325739|515571207|FG005|Phase II Part|Adverse Event|0|||
143009017|NCT02325739|515571208|FG006|Phase II Part|Adverse Event|0|||
143009018|NCT02325739|515571209|FG007|Phase II Part|Adverse Event|0|||
143009019|NCT02325739|515571210|FG008|Phase II Part|Adverse Event|4|||
143009020|NCT02325739|515571211|FG009|Phase II Part|Adverse Event|5|||
143009021|NCT02325739|515571212|FG010|Phase II Part|Adverse Event|1|||
143009022|NCT02325739|515571202|FG000|Phase II Part|Physician Decision|0|||
143009023|NCT02325739|515571203|FG001|Phase II Part|Physician Decision|0|||
143009024|NCT02325739|515571204|FG002|Phase II Part|Physician Decision|0|||
143009025|NCT02325739|515571205|FG003|Phase II Part|Physician Decision|0|||
143009026|NCT02325739|515571206|FG004|Phase II Part|Physician Decision|0|||
143009027|NCT02325739|515571207|FG005|Phase II Part|Physician Decision|0|||
143009028|NCT02325739|515571208|FG006|Phase II Part|Physician Decision|0|||
143009029|NCT02325739|515571209|FG007|Phase II Part|Physician Decision|0|||
143009030|NCT02325739|515571210|FG008|Phase II Part|Physician Decision|0|||
143009031|NCT02325739|515571211|FG009|Phase II Part|Physician Decision|1|||
143009032|NCT02325739|515571212|FG010|Phase II Part|Physician Decision|0|||
143009033|NCT02325739|515571202|FG000|Phase II Part|Progressive disease|0|||
143009034|NCT02325739|515571203|FG001|Phase II Part|Progressive disease|0|||
143009035|NCT02325739|515571204|FG002|Phase II Part|Progressive disease|0|||
143009036|NCT02325739|515571205|FG003|Phase II Part|Progressive disease|0|||
143009037|NCT02325739|515571206|FG004|Phase II Part|Progressive disease|0|||
143009038|NCT02325739|515571207|FG005|Phase II Part|Progressive disease|0|||
143009039|NCT02325739|515571208|FG006|Phase II Part|Progressive disease|0|||
143009040|NCT02325739|515571209|FG007|Phase II Part|Progressive disease|0|||
143009041|NCT02325739|515571210|FG008|Phase II Part|Progressive disease|22|||
143009042|NCT02325739|515571211|FG009|Phase II Part|Progressive disease|29|||
143009043|NCT02325739|515571212|FG010|Phase II Part|Progressive disease|18|||
143009044|NCT02325739|515571202|FG000|Phase II Part|Subject/guardian decision|0|||
143009045|NCT02325739|515571203|FG001|Phase II Part|Subject/guardian decision|0|||
143009046|NCT02325739|515571204|FG002|Phase II Part|Subject/guardian decision|0|||
143009047|NCT02325739|515571205|FG003|Phase II Part|Subject/guardian decision|0|||
143009048|NCT02325739|515571206|FG004|Phase II Part|Subject/guardian decision|0|||
143009049|NCT02325739|515571207|FG005|Phase II Part|Subject/guardian decision|0|||
143009050|NCT02325739|515571208|FG006|Phase II Part|Subject/guardian decision|0|||
143009051|NCT02325739|515571209|FG007|Phase II Part|Subject/guardian decision|0|||
143009052|NCT02325739|515571210|FG008|Phase II Part|Subject/guardian decision|4|||
143009053|NCT02325739|515571211|FG009|Phase II Part|Subject/guardian decision|1|||
143009054|NCT02325739|515571212|FG010|Phase II Part|Subject/guardian decision|1|||
143009055|NCT00227591|515571213|FG000|Overall Study|Withdrawal by Subject|1|||
143009056|NCT00077766|515571214|FG000|Overall Study|Adverse Event|1|||
143009057|NCT00077766|515571215|FG001|Overall Study|Adverse Event|1|||
143009058|NCT00077766|515571214|FG000|Overall Study|Withdrawal by Subject|4|||
143009059|NCT00077766|515571215|FG001|Overall Study|Withdrawal by Subject|3|||
143009060|NCT00077766|515571214|FG000|Overall Study|Death|12|||
143009061|NCT00077766|515571215|FG001|Overall Study|Death|10|||
143009062|NCT00077766|515571214|FG000|Overall Study|Lost to Follow-up|2|||
143009063|NCT00077766|515571215|FG001|Overall Study|Lost to Follow-up|0|||
143009064|NCT00077766|515571214|FG000|Overall Study|Protocol Violation|1|||
143009065|NCT00077766|515571215|FG001|Overall Study|Protocol Violation|0|||
143009066|NCT00077766|515571214|FG000|Overall Study|Kidney Transplantation|9|||
143009067|NCT00077766|515571215|FG001|Overall Study|Kidney Transplantation|5|||
143009068|NCT00077766|515571214|FG000|Overall Study|Transplantation|5|||
143009069|NCT00077766|515571215|FG001|Overall Study|Transplantation|1|||
143009070|NCT00077766|515571214|FG000|Overall Study|Investigators Discretion|1|||
143009071|NCT00077766|515571215|FG001|Overall Study|Investigators Discretion|0|||
143009072|NCT00077766|515571214|FG000|Overall Study|Participant's decision|1|||
143009073|NCT00077766|515571215|FG001|Overall Study|Participant's decision|0|||
143009074|NCT00077766|515571214|FG000|Overall Study|Dialysis Discontinued|1|||
143009075|NCT00077766|515571215|FG001|Overall Study|Dialysis Discontinued|0|||
143009076|NCT00077766|515571214|FG000|Overall Study|Dialysis|0|||
143009077|NCT00077766|515571215|FG001|Overall Study|Dialysis|1|||
143009078|NCT00077766|515571214|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
143009079|NCT00077766|515571215|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
143009080|NCT00077766|515571214|FG000|Overall Study|Started Nocturnal Dialysis|0|||
143346393|NCT03097861|516814321|FG001|Overall Study|Adverse Event|8|||
143009081|NCT00077766|515571215|FG001|Overall Study|Started Nocturnal Dialysis|1|||
143009082|NCT00077766|515571214|FG000|Overall Study|Stop Dialysis|0|||
143009083|NCT00077766|515571215|FG001|Overall Study|Stop Dialysis|1|||
143009084|NCT00077766|515571214|FG000|Overall Study|Participants Vacation|2|||
143009085|NCT00077766|515571215|FG001|Overall Study|Participants Vacation|1|||
143009086|NCT01886105|515571216|FG000|Overall Study|Lack of Efficacy|3|||
143009087|NCT02057549|515571218|FG000|Overall Study|Lost to Follow-up|1|||
143009088|NCT02057549|515571219|FG001|Overall Study|Lost to Follow-up|0|||
143009089|NCT02057549|515571218|FG000|Overall Study|Physician Decision|1|||
143009090|NCT02057549|515571219|FG001|Overall Study|Physician Decision|0|||
143009091|NCT02057549|515571218|FG000|Overall Study|Withdrawal by Subject|1|||
143009092|NCT02057549|515571219|FG001|Overall Study|Withdrawal by Subject|0|||
143009093|NCT03843775|515571222|FG000|Overall Study|Adverse Event|1|||
143009094|NCT03843775|515571223|FG001|Overall Study|Adverse Event|1|||
143009095|NCT03843775|515571222|FG000|Overall Study|Lack of Efficacy|2|||
143009096|NCT03843775|515571223|FG001|Overall Study|Lack of Efficacy|6|||
143009097|NCT03843775|515571222|FG000|Overall Study|Withdrawal by Subject|0|||
143009098|NCT03843775|515571223|FG001|Overall Study|Withdrawal by Subject|1|||
143009099|NCT00530621|515571224|FG000|Overall Study|Adverse Event|11|||
143009100|NCT00530621|515571225|FG001|Overall Study|Adverse Event|8|||
143009101|NCT00530621|515571224|FG000|Overall Study|Physician Decision|2|||
143009102|NCT00530621|515571225|FG001|Overall Study|Physician Decision|4|||
143009103|NCT00530621|515571224|FG000|Overall Study|Progressive Disease (PD)|47|||
143009104|NCT00530621|515571225|FG001|Overall Study|Progressive Disease (PD)|40|||
143009105|NCT00530621|515571224|FG000|Overall Study|Sponsor Decision|12|||
143009106|NCT00530621|515571225|FG001|Overall Study|Sponsor Decision|15|||
143009107|NCT00530621|515571224|FG000|Overall Study|Subject Decision|4|||
143009108|NCT00530621|515571225|FG001|Overall Study|Subject Decision|7|||
143009109|NCT00530621|515571224|FG000|Overall Study|Death|3|||
143009110|NCT00530621|515571225|FG001|Overall Study|Death|6|||
143009111|NCT00530621|515571224|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
143009112|NCT00530621|515571225|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
143009113|NCT04611152|515571226|FG000|Overall Study|Adverse Event|9|||
143009114|NCT04611152|515571227|FG001|Overall Study|Adverse Event|8|||
143009115|NCT04611152|515571226|FG000|Overall Study|Non-compliance with study schedule|1|||
143009116|NCT04611152|515571227|FG001|Overall Study|Non-compliance with study schedule|3|||
143009117|NCT04611152|515571226|FG000|Overall Study|Withdrawal by Subject|5|||
143009118|NCT04611152|515571227|FG001|Overall Study|Withdrawal by Subject|6|||
143009119|NCT04611152|515571226|FG000|Overall Study|Lost to Follow-up|11|||
143009120|NCT04611152|515571227|FG001|Overall Study|Lost to Follow-up|2|||
143009121|NCT00605839|515571235|FG000|Overall Study|Protocol Violation|1|||
143009122|NCT00605839|515571236|FG001|Overall Study|Protocol Violation|0|||
143009123|NCT00605839|515571237|FG002|Overall Study|Protocol Violation|0|||
143009124|NCT03917654|515571238|FG000|Year 1|Withdrawal by Subject|1|||
143009125|NCT03917654|515571239|FG001|Year 1|Withdrawal by Subject|0|||
143009126|NCT03917654|515571240|FG002|Year 1|Withdrawal by Subject|0|||
143009127|NCT03917654|515571241|FG003|Year 1|Withdrawal by Subject|0|||
143009128|NCT03917654|515571242|FG004|Year 1|Withdrawal by Subject|0|||
143009129|NCT03917654|515571243|FG005|Year 1|Withdrawal by Subject|1|||
143009130|NCT03917654|515571244|FG006|Year 1|Withdrawal by Subject|6|||
143009131|NCT03917654|515571245|FG007|Year 1|Withdrawal by Subject|2|||
143009132|NCT03917654|515571246|FG008|Year 1|Withdrawal by Subject|5|||
143009133|NCT03917654|515571247|FG009|Year 1|Withdrawal by Subject|3|||
143009134|NCT03917654|515571248|FG010|Year 1|Withdrawal by Subject|1|||
143009135|NCT03917654|515571249|FG011|Year 1|Withdrawal by Subject|0|||
143009136|NCT03917654|515571238|FG000|Year 1|Travel|0|||
143009137|NCT03917654|515571239|FG001|Year 1|Travel|1|||
143009138|NCT03917654|515571240|FG002|Year 1|Travel|1|||
143009139|NCT03917654|515571241|FG003|Year 1|Travel|0|||
143009140|NCT03917654|515571242|FG004|Year 1|Travel|4|||
143009141|NCT03917654|515571243|FG005|Year 1|Travel|4|||
143009142|NCT03917654|515571244|FG006|Year 1|Travel|10|||
143009143|NCT03917654|515571245|FG007|Year 1|Travel|8|||
143009144|NCT03917654|515571246|FG008|Year 1|Travel|2|||
143009145|NCT03917654|515571247|FG009|Year 1|Travel|5|||
143009146|NCT03917654|515571248|FG010|Year 1|Travel|3|||
143123711|NCT01467271|515997831|FG000|Overall Study|Retraction of patient's consent|21|||
143123712|NCT01467271|515997831|FG000|Overall Study|Other reason|14|||
143123713|NCT03084302|515997836|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
143123714|NCT03084302|515997836|FG000|Overall Study|No valid objective monitor data|6|||
143123715|NCT01411319|515997837|FG000|Overall Study|Lost to Follow-up|1|||
143123716|NCT00424593|515997853|FG000|Acute Double-Blind Period|Adverse Event|16|||
143009147|NCT03917654|515571249|FG011|Year 1|Travel|3|||
143009148|NCT03917654|515571238|FG000|Year 1|Subject moved away from site|0|||
143009149|NCT03917654|515571239|FG001|Year 1|Subject moved away from site|1|||
143009150|NCT03917654|515571240|FG002|Year 1|Subject moved away from site|0|||
143009151|NCT03917654|515571241|FG003|Year 1|Subject moved away from site|0|||
143009152|NCT03917654|515571242|FG004|Year 1|Subject moved away from site|0|||
143009153|NCT03917654|515571243|FG005|Year 1|Subject moved away from site|0|||
143009154|NCT03917654|515571244|FG006|Year 1|Subject moved away from site|1|||
143009155|NCT03917654|515571245|FG007|Year 1|Subject moved away from site|2|||
143009156|NCT03917654|515571246|FG008|Year 1|Subject moved away from site|1|||
143009157|NCT03917654|515571247|FG009|Year 1|Subject moved away from site|0|||
143009158|NCT03917654|515571248|FG010|Year 1|Subject moved away from site|0|||
143123717|NCT00424593|515997854|FG001|Acute Double-Blind Period|Adverse Event|7|||
143009159|NCT03917654|515571249|FG011|Year 1|Subject moved away from site|3|||
143009160|NCT03917654|515571238|FG000|Year 1|Spouse/Family member request|0|||
143009161|NCT03917654|515571239|FG001|Year 1|Spouse/Family member request|0|||
143009162|NCT03917654|515571240|FG002|Year 1|Spouse/Family member request|1|||
143009163|NCT03917654|515571241|FG003|Year 1|Spouse/Family member request|0|||
143009164|NCT03917654|515571242|FG004|Year 1|Spouse/Family member request|1|||
143009165|NCT03917654|515571243|FG005|Year 1|Spouse/Family member request|0|||
143009166|NCT03917654|515571244|FG006|Year 1|Spouse/Family member request|0|||
143009167|NCT03917654|515571245|FG007|Year 1|Spouse/Family member request|2|||
143009168|NCT03917654|515571246|FG008|Year 1|Spouse/Family member request|0|||
143461269|NCT03486457|517234987|FG000|Month 3 to Month 6|Other|1|||
143461270|NCT03486457|517234988|FG001|Month 3 to Month 6|Other|0|||
143461271|NCT00372229|517234989|FG000|Study Phase|Graft loss|0|||
143461272|NCT00372229|517234990|FG001|Study Phase|Graft loss|3|||
143461273|NCT00372229|517234989|FG000|Study Phase|Protocol Violation|3|||
143461274|NCT00372229|517234990|FG001|Study Phase|Protocol Violation|4|||
143461275|NCT00372229|517234989|FG000|Study Phase|Consent withdrawn|16|||
143461276|NCT00372229|517234990|FG001|Study Phase|Consent withdrawn|14|||
143461277|NCT00372229|517234989|FG000|Study Phase|Refused treatment/did not cooperate|3|||
143461278|NCT00372229|517234990|FG001|Study Phase|Refused treatment/did not cooperate|1|||
143461279|NCT00372229|517234989|FG000|Study Phase|Death|3|||
143461280|NCT00372229|517234990|FG001|Study Phase|Death|2|||
143461281|NCT00372229|517234989|FG000|Study Phase|Reason not specified|3|||
143461282|NCT00372229|517234990|FG001|Study Phase|Reason not specified|2|||
143461283|NCT00372229|517234989|FG000|Study Phase|Lost to Follow-up|3|||
143461284|NCT00372229|517234990|FG001|Study Phase|Lost to Follow-up|3|||
143461285|NCT00372229|517234989|FG000|Follow-Up Phase|Graft loss|8|||
143461286|NCT00372229|517234990|FG001|Follow-Up Phase|Graft loss|7|||
143461287|NCT00372229|517234989|FG000|Follow-Up Phase|Consent withdrawn|13|||
143461288|NCT00372229|517234990|FG001|Follow-Up Phase|Consent withdrawn|19|||
143461289|NCT00372229|517234989|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
143461290|NCT00372229|517234990|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
143461291|NCT00372229|517234989|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
143461292|NCT00372229|517234990|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
143461293|NCT00372229|517234989|FG000|Follow-Up Phase|Death|9|||
143461294|NCT00372229|517234990|FG001|Follow-Up Phase|Death|12|||
143461295|NCT00372229|517234989|FG000|Follow-Up Phase|Administrative|1|||
143461296|NCT00372229|517234990|FG001|Follow-Up Phase|Administrative|0|||
143461297|NCT00372229|517234989|FG000|Follow-Up Phase|Reason not specified|2|||
143461298|NCT00372229|517234990|FG001|Follow-Up Phase|Reason not specified|3|||
143461299|NCT00372229|517234989|FG000|Follow-Up Phase|Lost to Follow-up|12|||
143461300|NCT00372229|517234990|FG001|Follow-Up Phase|Lost to Follow-up|10|||
143461301|NCT00946101|517234991|FG000|Overall Study|Lost to Follow-up|2|||
143461302|NCT00946101|517234992|FG001|Overall Study|Lost to Follow-up|1|||
143461303|NCT00946101|517234991|FG000|Overall Study|Withdrawal of consent|2|||
143461304|NCT00946101|517234992|FG001|Overall Study|Withdrawal of consent|0|||
143461305|NCT00946101|517234991|FG000|Overall Study|Physician Decision|0|||
143461306|NCT00946101|517234992|FG001|Overall Study|Physician Decision|1|||
143461307|NCT01174160|517234993|FG000|Overall Study|Adverse Event|1|||
143461308|NCT01174160|517234994|FG001|Overall Study|Adverse Event|0|||
143461309|NCT01174160|517234993|FG000|Overall Study|Lost to Follow-up|1|||
143461310|NCT01174160|517234994|FG001|Overall Study|Lost to Follow-up|0|||
143461311|NCT01174160|517234993|FG000|Overall Study|Physician Decision|1|||
143461312|NCT01174160|517234994|FG001|Overall Study|Physician Decision|0|||
143461313|NCT01174160|517234993|FG000|Overall Study|Protocol Violation|4|||
143461314|NCT01174160|517234994|FG001|Overall Study|Protocol Violation|6|||
143461315|NCT01174160|517234993|FG000|Overall Study|Withdrawal by Subject|1|||
143461316|NCT01174160|517234994|FG001|Overall Study|Withdrawal by Subject|0|||
143461317|NCT01347762|517234995|FG000|Overall Study|Lost to Follow-up|0|||
143461318|NCT01347762|517234996|FG001|Overall Study|Lost to Follow-up|1|||
143461319|NCT01347762|517234997|FG002|Overall Study|Lost to Follow-up|6|||
143461320|NCT01347762|517234998|FG003|Overall Study|Lost to Follow-up|5|||
143461321|NCT01347762|517234995|FG000|Overall Study|Withdrawal by Subject|4|||
143461322|NCT01347762|517234996|FG001|Overall Study|Withdrawal by Subject|1|||
143461323|NCT01347762|517234997|FG002|Overall Study|Withdrawal by Subject|3|||
143461324|NCT01347762|517234998|FG003|Overall Study|Withdrawal by Subject|3|||
143461325|NCT00093808|517234999|FG000|Overall Study|Cancel participation before receiving tx|1|||
143461326|NCT00093808|517234999|FG000|Overall Study|Protocol Violation|1|||
143461327|NCT00701220|517235000|FG000|Overall Study|Withdrawal by Subject|0|||
143461328|NCT00701220|517235001|FG001|Overall Study|Withdrawal by Subject|2|||
143461329|NCT00701220|517235000|FG000|Overall Study|Protocol Violation|2|||
143461330|NCT00701220|517235001|FG001|Overall Study|Protocol Violation|0|||
143461331|NCT03235284|517235002|FG000|Overall Study|Adverse Event|1|||
143461332|NCT03235284|517235003|FG001|Overall Study|Adverse Event|2|||
143461333|NCT03235284|517235004|FG002|Overall Study|Adverse Event|1|||
143009169|NCT03917654|515571247|FG009|Year 1|Spouse/Family member request|0|||
143461334|NCT00310037|517235005|FG000|Overall Study|Adverse Event|7|||
143461335|NCT00310037|517235006|FG001|Overall Study|Adverse Event|14|||
143461336|NCT00310037|517235005|FG000|Overall Study|Withdrawal by Subject|4|||
143461337|NCT00310037|517235006|FG001|Overall Study|Withdrawal by Subject|3|||
143461338|NCT00310037|517235005|FG000|Overall Study|Progression|6|||
143461339|NCT00310037|517235006|FG001|Overall Study|Progression|0|||
143461340|NCT00310037|517235005|FG000|Overall Study|Non-protocol treatment|1|||
143461341|NCT00310037|517235006|FG001|Overall Study|Non-protocol treatment|0|||
143461342|NCT01382706|517235019|FG000|Overall Study|Adverse Event|1|||
143461343|NCT01382706|517235019|FG000|Overall Study|Withdrawal by Subject|1|||
143461344|NCT05559099|517235020|FG000|Overall Study|Death|5|||
143123718|NCT00424593|515997853|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
143123719|NCT00424593|515997854|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
143123720|NCT00424593|515997853|FG000|Acute Double-Blind Period|Protocol Violation|2|||
143123721|NCT00424593|515997854|FG001|Acute Double-Blind Period|Protocol Violation|2|||
143123722|NCT00424593|515997853|FG000|Acute Double-Blind Period|Physician Decision|1|||
143123723|NCT00424593|515997854|FG001|Acute Double-Blind Period|Physician Decision|2|||
143123724|NCT00424593|515997853|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
143123725|NCT00424593|515997854|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
143123726|NCT00424593|515997853|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
143123727|NCT00424593|515997854|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
143123728|NCT00424593|515997853|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
143123729|NCT00424593|515997854|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
143123730|NCT00424593|515997853|FG000|Dose-Blind Extension Period|Adverse Event|18|||
143123731|NCT00424593|515997854|FG001|Dose-Blind Extension Period|Adverse Event|0|||
143123732|NCT00424593|515997853|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
143123733|NCT00424593|515997854|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
143123734|NCT00424593|515997853|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
143123735|NCT00424593|515997854|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
143123736|NCT00424593|515997853|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
143123737|NCT00424593|515997854|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
143123738|NCT00424593|515997853|FG000|Dose-Blind Extension Period|Physician Decision|3|||
143123739|NCT00424593|515997854|FG001|Dose-Blind Extension Period|Physician Decision|0|||
143123740|NCT02496039|515997855|FG000|Overall Study|Adverse Event|3|||
143123741|NCT02496039|515997855|FG000|Overall Study|Protocol Violation|1|||
143123742|NCT03297021|515997856|FG000|Overall Study|Incomplete/illegible data sheet|4|||
143123743|NCT03297021|515997857|FG001|Overall Study|Incomplete/illegible data sheet|2|||
143123744|NCT03297021|515997858|FG002|Overall Study|Incomplete/illegible data sheet|3|||
143123745|NCT03297021|515997856|FG000|Overall Study|Missing Post-Op Data|1|||
143123746|NCT03297021|515997857|FG001|Overall Study|Missing Post-Op Data|2|||
143123747|NCT03297021|515997858|FG002|Overall Study|Missing Post-Op Data|1|||
143123748|NCT01607346|515997878|FG000|Overall Study|Adverse Event|3|||
143123749|NCT04424914|515997881|FG000|Overall Study|Other|0|||
143123750|NCT04424914|515997882|FG001|Overall Study|Other|0|||
143123751|NCT04424914|515997883|FG002|Overall Study|Other|28|||
143123752|NCT04424914|515997881|FG000|Overall Study|Withdrawal by Subject|3|||
143123753|NCT04424914|515997882|FG001|Overall Study|Withdrawal by Subject|0|||
143123754|NCT04424914|515997883|FG002|Overall Study|Withdrawal by Subject|0|||
143123755|NCT04424914|515997881|FG000|Overall Study|Study terminated by sponsor|23|||
143123756|NCT04424914|515997882|FG001|Overall Study|Study terminated by sponsor|7|||
143123757|NCT04424914|515997883|FG002|Overall Study|Study terminated by sponsor|0|||
143123758|NCT04424914|515997881|FG000|Overall Study|Lost to Follow-up|0|||
143123759|NCT04424914|515997882|FG001|Overall Study|Lost to Follow-up|0|||
143123760|NCT04424914|515997883|FG002|Overall Study|Lost to Follow-up|1|||
143123761|NCT04424914|515997881|FG000|Overall Study|Death|3|||
143123762|NCT04424914|515997882|FG001|Overall Study|Death|1|||
143123763|NCT04424914|515997883|FG002|Overall Study|Death|0|||
143123764|NCT01841567|515997884|FG000|Overall Study|Adverse Event|3|||
143123765|NCT01573754|515997889|FG000|Overall Study|Noncompliance or remission not achieved|3|||
143123766|NCT01573754|515997890|FG001|Overall Study|Noncompliance or remission not achieved|15|||
143123767|NCT00829829|515997891|FG000|Overall Study|Protocol Violation|0|||
143123768|NCT00829829|515997892|FG001|Overall Study|Protocol Violation|3|||
143123769|NCT00829829|515997893|FG002|Overall Study|Protocol Violation|0|||
143123770|NCT00829829|515997891|FG000|Overall Study|Adverse Event|4|||
143123771|NCT00829829|515997892|FG001|Overall Study|Adverse Event|4|||
143123772|NCT00829829|515997893|FG002|Overall Study|Adverse Event|3|||
143123773|NCT00829829|515997891|FG000|Overall Study|Withdrawal by Subject|8|||
143123774|NCT00829829|515997892|FG001|Overall Study|Withdrawal by Subject|4|||
143123775|NCT00829829|515997893|FG002|Overall Study|Withdrawal by Subject|2|||
143123776|NCT00829829|515997891|FG000|Overall Study|Decision by the Sponsor|1|||
143123777|NCT00829829|515997892|FG001|Overall Study|Decision by the Sponsor|0|||
143123778|NCT00829829|515997893|FG002|Overall Study|Decision by the Sponsor|2|||
143123779|NCT00829829|515997891|FG000|Overall Study|Lost to Follow-up|7|||
143123780|NCT00829829|515997892|FG001|Overall Study|Lost to Follow-up|3|||
143123781|NCT00829829|515997893|FG002|Overall Study|Lost to Follow-up|3|||
143123782|NCT00829829|515997891|FG000|Overall Study|Other than specified above|2|||
143009170|NCT03917654|515571248|FG010|Year 1|Spouse/Family member request|0|||
143009171|NCT03917654|515571249|FG011|Year 1|Spouse/Family member request|1|||
143123783|NCT00829829|515997892|FG001|Overall Study|Other than specified above|2|||
143123784|NCT00829829|515997893|FG002|Overall Study|Other than specified above|1|||
143123785|NCT02685072|515997894|FG000|Treatment Period|Lost to Follow-up|12|||
143123786|NCT02685072|515997895|FG001|Treatment Period|Lost to Follow-up|6|||
143123787|NCT02685072|515997894|FG000|Treatment Period|Withdrawal by Subject|1|||
143123788|NCT02685072|515997895|FG001|Treatment Period|Withdrawal by Subject|3|||
143123789|NCT02685072|515997894|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
143123790|NCT02685072|515997895|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
143009172|NCT03917654|515571238|FG000|Year 1|Death|0|||
143009173|NCT03917654|515571239|FG001|Year 1|Death|0|||
143009174|NCT03917654|515571240|FG002|Year 1|Death|0|||
143009175|NCT03917654|515571241|FG003|Year 1|Death|0|||
143009176|NCT03917654|515571242|FG004|Year 1|Death|0|||
143009177|NCT03917654|515571243|FG005|Year 1|Death|0|||
143009178|NCT03917654|515571244|FG006|Year 1|Death|0|||
143009179|NCT03917654|515571245|FG007|Year 1|Death|0|||
143009180|NCT03917654|515571246|FG008|Year 1|Death|1|||
143009181|NCT03917654|515571247|FG009|Year 1|Death|1|||
143009182|NCT03917654|515571248|FG010|Year 1|Death|0|||
143009183|NCT03917654|515571249|FG011|Year 1|Death|0|||
143009184|NCT03917654|515571238|FG000|Year 1|Lost to Follow-up|0|||
143009185|NCT03917654|515571239|FG001|Year 1|Lost to Follow-up|0|||
143009186|NCT03917654|515571240|FG002|Year 1|Lost to Follow-up|0|||
143009187|NCT03917654|515571241|FG003|Year 1|Lost to Follow-up|0|||
143009188|NCT03917654|515571242|FG004|Year 1|Lost to Follow-up|0|||
143009189|NCT03917654|515571243|FG005|Year 1|Lost to Follow-up|0|||
143123791|NCT01994902|515997896|FG000|Test Period 1|Withdrawal by Subject|3|||
143123792|NCT01994902|515997897|FG001|Test Period 1|Withdrawal by Subject|0|||
143009190|NCT03917654|515571244|FG006|Year 1|Lost to Follow-up|2|||
143009191|NCT03917654|515571245|FG007|Year 1|Lost to Follow-up|0|||
143009192|NCT03917654|515571246|FG008|Year 1|Lost to Follow-up|0|||
143009193|NCT03917654|515571247|FG009|Year 1|Lost to Follow-up|0|||
143009194|NCT03917654|515571248|FG010|Year 1|Lost to Follow-up|0|||
143009195|NCT03917654|515571249|FG011|Year 1|Lost to Follow-up|0|||
143009196|NCT03917654|515571238|FG000|Year 1|Missed visits|0|||
143009197|NCT03917654|515571239|FG001|Year 1|Missed visits|0|||
143009198|NCT03917654|515571240|FG002|Year 1|Missed visits|0|||
143009199|NCT03917654|515571241|FG003|Year 1|Missed visits|0|||
143009200|NCT03917654|515571242|FG004|Year 1|Missed visits|0|||
143009201|NCT03917654|515571243|FG005|Year 1|Missed visits|0|||
143009202|NCT03917654|515571244|FG006|Year 1|Missed visits|0|||
143009203|NCT03917654|515571245|FG007|Year 1|Missed visits|0|||
143009204|NCT03917654|515571246|FG008|Year 1|Missed visits|0|||
143009205|NCT03917654|515571247|FG009|Year 1|Missed visits|0|||
143009206|NCT03917654|515571248|FG010|Year 1|Missed visits|1|||
143009207|NCT03917654|515571249|FG011|Year 1|Missed visits|1|||
143009208|NCT03917654|515571238|FG000|Year 1|Pregnancy|0|||
143009209|NCT03917654|515571239|FG001|Year 1|Pregnancy|0|||
143009210|NCT03917654|515571240|FG002|Year 1|Pregnancy|0|||
143009211|NCT03917654|515571241|FG003|Year 1|Pregnancy|0|||
143009212|NCT03917654|515571242|FG004|Year 1|Pregnancy|0|||
143009213|NCT03917654|515571243|FG005|Year 1|Pregnancy|0|||
143009214|NCT03917654|515571244|FG006|Year 1|Pregnancy|0|||
143009215|NCT03917654|515571245|FG007|Year 1|Pregnancy|1|||
143009216|NCT03917654|515571246|FG008|Year 1|Pregnancy|0|||
143009217|NCT03917654|515571247|FG009|Year 1|Pregnancy|1|||
143009218|NCT03917654|515571248|FG010|Year 1|Pregnancy|0|||
143009219|NCT03917654|515571249|FG011|Year 1|Pregnancy|0|||
143009220|NCT03917654|515571238|FG000|Year 2|Travel|1|||
143009221|NCT03917654|515571239|FG001|Year 2|Travel|0|||
143009222|NCT03917654|515571240|FG002|Year 2|Travel|0|||
143009223|NCT03917654|515571241|FG003|Year 2|Travel|0|||
143009224|NCT03917654|515571242|FG004|Year 2|Travel|1|||
143009225|NCT03917654|515571243|FG005|Year 2|Travel|1|||
143009226|NCT03917654|515571244|FG006|Year 2|Travel|2|||
143009227|NCT03917654|515571245|FG007|Year 2|Travel|1|||
143009228|NCT03917654|515571246|FG008|Year 2|Travel|0|||
143009229|NCT03917654|515571247|FG009|Year 2|Travel|1|||
143009230|NCT03917654|515571248|FG010|Year 2|Travel|0|||
143009231|NCT03917654|515571249|FG011|Year 2|Travel|1|||
143009232|NCT03917654|515571238|FG000|Year 2|Married|1|||
143009233|NCT03917654|515571239|FG001|Year 2|Married|0|||
143009234|NCT03917654|515571240|FG002|Year 2|Married|0|||
143009235|NCT03917654|515571241|FG003|Year 2|Married|0|||
143009236|NCT03917654|515571242|FG004|Year 2|Married|0|||
143009237|NCT03917654|515571243|FG005|Year 2|Married|0|||
143123793|NCT01994902|515997896|FG000|Test Period 1|device deficiency with adverse event|0|||
143009238|NCT03917654|515571244|FG006|Year 2|Married|1|||
143009239|NCT03917654|515571245|FG007|Year 2|Married|1|||
143009240|NCT03917654|515571246|FG008|Year 2|Married|0|||
143009241|NCT03917654|515571247|FG009|Year 2|Married|0|||
143009242|NCT03917654|515571248|FG010|Year 2|Married|0|||
143009243|NCT03917654|515571249|FG011|Year 2|Married|0|||
143009244|NCT03917654|515571238|FG000|Year 2|Subject moved away from site|1|||
143009245|NCT03917654|515571239|FG001|Year 2|Subject moved away from site|0|||
143009246|NCT03917654|515571240|FG002|Year 2|Subject moved away from site|0|||
143009247|NCT03917654|515571241|FG003|Year 2|Subject moved away from site|0|||
143009248|NCT03917654|515571242|FG004|Year 2|Subject moved away from site|1|||
143009249|NCT03917654|515571243|FG005|Year 2|Subject moved away from site|0|||
143009250|NCT03917654|515571244|FG006|Year 2|Subject moved away from site|2|||
143009251|NCT03917654|515571245|FG007|Year 2|Subject moved away from site|3|||
143009252|NCT03917654|515571246|FG008|Year 2|Subject moved away from site|0|||
143009253|NCT03917654|515571247|FG009|Year 2|Subject moved away from site|2|||
143009254|NCT03917654|515571248|FG010|Year 2|Subject moved away from site|0|||
143009255|NCT03917654|515571249|FG011|Year 2|Subject moved away from site|1|||
143009256|NCT03917654|515571238|FG000|Year 2|Year 2 Screening failure|0|||
143009257|NCT03917654|515571239|FG001|Year 2|Year 2 Screening failure|1|||
143123794|NCT01994902|515997897|FG001|Test Period 1|device deficiency with adverse event|1|||
143123795|NCT01994902|515997896|FG000|Test Period 1|Adverse Event|2|||
143123796|NCT01994902|515997897|FG001|Test Period 1|Adverse Event|1|||
143123797|NCT01994902|515997896|FG000|Test Period 1|Lack of Efficacy|0|||
143123798|NCT01994902|515997897|FG001|Test Period 1|Lack of Efficacy|1|||
143123799|NCT01994902|515997896|FG000|Test Period 1|bag too small|1|||
143123800|NCT01994902|515997897|FG001|Test Period 1|bag too small|0|||
143123801|NCT01994902|515997896|FG000|Test Period 2|Withdrawal by Subject|0|||
143123802|NCT01994902|515997897|FG001|Test Period 2|Withdrawal by Subject|2|||
143123803|NCT01994902|515997896|FG000|Test Period 2|Lack of Efficacy|0|||
143123804|NCT01994902|515997897|FG001|Test Period 2|Lack of Efficacy|1|||
143123805|NCT01994902|515997896|FG000|Test Period 2|Other|0|||
143123806|NCT01994902|515997897|FG001|Test Period 2|Other|3|||
143123807|NCT02483572|515997898|FG000|Overall Study|Withdrawal by Subject|1|||
143123808|NCT02483572|515997899|FG001|Overall Study|Withdrawal by Subject|0|||
143123809|NCT02483572|515997898|FG000|Overall Study|Lost to Follow-up|1|||
143123810|NCT02483572|515997899|FG001|Overall Study|Lost to Follow-up|0|||
143123811|NCT02483572|515997898|FG000|Overall Study|Physician Decision|0|||
143123812|NCT02483572|515997899|FG001|Overall Study|Physician Decision|1|||
143123813|NCT00248833|515997904|FG000|Overall Study|Adverse Event|2|||
143123814|NCT00248833|515997905|FG001|Overall Study|Adverse Event|0|||
143123815|NCT00248833|515997906|FG002|Overall Study|Adverse Event|0|||
143123816|NCT00248833|515997904|FG000|Overall Study|Withdrawal by Subject|0|||
143123817|NCT00248833|515997905|FG001|Overall Study|Withdrawal by Subject|1|||
143123818|NCT00248833|515997906|FG002|Overall Study|Withdrawal by Subject|1|||
143123819|NCT00248833|515997904|FG000|Overall Study|Lost to Follow-up|1|||
143123820|NCT00248833|515997905|FG001|Overall Study|Lost to Follow-up|1|||
143123821|NCT00248833|515997906|FG002|Overall Study|Lost to Follow-up|1|||
143123822|NCT00248833|515997904|FG000|Overall Study|Other|0|||
143123823|NCT00248833|515997905|FG001|Overall Study|Other|1|||
143123824|NCT00248833|515997906|FG002|Overall Study|Other|0|||
143123825|NCT02774005|515997907|FG000|Overall Study|Adverse Event|8|||
143123826|NCT02774005|515997907|FG000|Overall Study|Withdrawal by Subject|23|||
143123827|NCT02774005|515997907|FG000|Overall Study|Lost to Follow-up|7|||
143123828|NCT02774005|515997907|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
143123829|NCT02774005|515997907|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
143123830|NCT02774005|515997907|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
143123831|NCT02774005|515997907|FG000|Overall Study|Death|1|||
143123832|NCT02774005|515997907|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
143123833|NCT02774005|515997907|FG000|Overall Study|Lack of compliance with study medication|4|||
143123834|NCT02774005|515997907|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
143123835|NCT02774005|515997907|FG000|Overall Study|another study|1|||
143123836|NCT02774005|515997907|FG000|Overall Study|cardiologist imposed travel restriction|1|||
143346394|NCT03097861|516814322|FG002|Overall Study|Adverse Event|4|||
143346395|NCT03097861|516814320|FG000|Overall Study|Investigator Decision|0|||
143346396|NCT03097861|516814321|FG001|Overall Study|Investigator Decision|1|||
143346397|NCT03097861|516814322|FG002|Overall Study|Investigator Decision|0|||
143346398|NCT03097861|516814320|FG000|Overall Study|Lost to Follow-up|0|||
143346399|NCT03097861|516814321|FG001|Overall Study|Lost to Follow-up|7|||
143346400|NCT03097861|516814322|FG002|Overall Study|Lost to Follow-up|1|||
143346401|NCT03097861|516814320|FG000|Overall Study|Withdrawal by Subject|1|||
143346402|NCT03097861|516814321|FG001|Overall Study|Withdrawal by Subject|5|||
143346403|NCT03097861|516814322|FG002|Overall Study|Withdrawal by Subject|3|||
143346404|NCT03097861|516814320|FG000|Overall Study|Reason not provided|3|||
143346405|NCT03097861|516814321|FG001|Overall Study|Reason not provided|1|||
143346406|NCT03097861|516814322|FG002|Overall Study|Reason not provided|1|||
143346407|NCT01785563|516814323|FG000|Overall Study|Physician Decision|10|||
143346408|NCT01785563|516814323|FG000|Overall Study|Withdrawal by Subject|1|||
143346409|NCT01785563|516814323|FG000|Overall Study|Protocol Violation|2|||
143346410|NCT00744328|516814324|FG000|Overall Study|Lost to Follow-up|2|||
143346411|NCT00744328|516814325|FG001|Overall Study|Lost to Follow-up|5|||
143346412|NCT00744328|516814326|FG002|Overall Study|Lost to Follow-up|3|||
143346413|NCT00744328|516814324|FG000|Overall Study|Withdrawal by Subject|5|||
143346414|NCT00744328|516814325|FG001|Overall Study|Withdrawal by Subject|3|||
143346415|NCT00744328|516814326|FG002|Overall Study|Withdrawal by Subject|4|||
143346416|NCT00744328|516814324|FG000|Overall Study|Found ineligible after randomization|0|||
143346417|NCT00744328|516814325|FG001|Overall Study|Found ineligible after randomization|0|||
143346418|NCT00744328|516814326|FG002|Overall Study|Found ineligible after randomization|1|||
143123837|NCT00723697|515997908|FG000|Overall Study|Physician questionnaires not received|2|||
143123838|NCT00723697|515997908|FG000|Overall Study|Missing Informed Consent Form|10|||
143123839|NCT00723697|515997908|FG000|Overall Study|Other exclusion criteria applied|6|||
143123840|NCT01289574|515997909|FG000|Overall Study|Lack of Efficacy|4|||
143123841|NCT01289574|515997910|FG001|Overall Study|Lack of Efficacy|0|||
143123842|NCT01289574|515997911|FG002|Overall Study|Lack of Efficacy|1|||
143123843|NCT01289574|515997909|FG000|Overall Study|Lost to Follow-up|2|||
143123844|NCT01289574|515997910|FG001|Overall Study|Lost to Follow-up|0|||
143123845|NCT01289574|515997911|FG002|Overall Study|Lost to Follow-up|1|||
143123846|NCT01289574|515997909|FG000|Overall Study|Withdrawal by Subject|1|||
143123847|NCT01289574|515997910|FG001|Overall Study|Withdrawal by Subject|1|||
143123848|NCT01289574|515997911|FG002|Overall Study|Withdrawal by Subject|1|||
143123849|NCT01289574|515997909|FG000|Overall Study|Adverse Event|0|||
143123850|NCT01289574|515997910|FG001|Overall Study|Adverse Event|1|||
143123851|NCT01289574|515997911|FG002|Overall Study|Adverse Event|0|||
143123852|NCT01289574|515997909|FG000|Overall Study|Subject wanted alternate treatment|0|||
143123853|NCT01289574|515997910|FG001|Overall Study|Subject wanted alternate treatment|1|||
143123854|NCT01289574|515997911|FG002|Overall Study|Subject wanted alternate treatment|0|||
143123855|NCT00262002|515997912|FG000|Overall Study|Adverse Event|2|||
143123856|NCT00262002|515997913|FG001|Overall Study|Adverse Event|1|||
143123857|NCT00262002|515997914|FG002|Overall Study|Adverse Event|0|||
143123858|NCT00262002|515997915|FG003|Overall Study|Adverse Event|0|||
143123859|NCT00262002|515997916|FG004|Overall Study|Adverse Event|0|||
143123860|NCT00262002|515997917|FG005|Overall Study|Adverse Event|1|||
143123861|NCT00262002|515997918|FG006|Overall Study|Adverse Event|0|||
143123862|NCT00262002|515997912|FG000|Overall Study|Withdrawal by Subject|4|||
143123863|NCT00262002|515997913|FG001|Overall Study|Withdrawal by Subject|2|||
143123864|NCT00262002|515997914|FG002|Overall Study|Withdrawal by Subject|0|||
143123865|NCT00262002|515997915|FG003|Overall Study|Withdrawal by Subject|1|||
143123866|NCT00262002|515997916|FG004|Overall Study|Withdrawal by Subject|2|||
143123867|NCT00262002|515997917|FG005|Overall Study|Withdrawal by Subject|2|||
143123868|NCT00262002|515997918|FG006|Overall Study|Withdrawal by Subject|2|||
143123869|NCT00262002|515997912|FG000|Overall Study|Lost to Follow-up|2|||
143123870|NCT00262002|515997913|FG001|Overall Study|Lost to Follow-up|0|||
143123871|NCT00262002|515997914|FG002|Overall Study|Lost to Follow-up|0|||
143123872|NCT00262002|515997915|FG003|Overall Study|Lost to Follow-up|2|||
143123873|NCT00262002|515997916|FG004|Overall Study|Lost to Follow-up|0|||
143123874|NCT00262002|515997917|FG005|Overall Study|Lost to Follow-up|1|||
143123875|NCT00262002|515997918|FG006|Overall Study|Lost to Follow-up|0|||
143123876|NCT00262002|515997912|FG000|Overall Study|Inapropriate enrollment|0|||
143123877|NCT00262002|515997913|FG001|Overall Study|Inapropriate enrollment|1|||
143123878|NCT00262002|515997914|FG002|Overall Study|Inapropriate enrollment|0|||
143123879|NCT00262002|515997915|FG003|Overall Study|Inapropriate enrollment|0|||
143123880|NCT00262002|515997916|FG004|Overall Study|Inapropriate enrollment|0|||
143123881|NCT00262002|515997917|FG005|Overall Study|Inapropriate enrollment|0|||
143123882|NCT00262002|515997918|FG006|Overall Study|Inapropriate enrollment|0|||
143123883|NCT00262002|515997912|FG000|Overall Study|Protocol Violation|3|||
143123884|NCT00262002|515997913|FG001|Overall Study|Protocol Violation|2|||
143123885|NCT00262002|515997914|FG002|Overall Study|Protocol Violation|0|||
143123886|NCT00262002|515997915|FG003|Overall Study|Protocol Violation|2|||
143123887|NCT00262002|515997916|FG004|Overall Study|Protocol Violation|5|||
143123888|NCT00262002|515997917|FG005|Overall Study|Protocol Violation|3|||
143123889|NCT00262002|515997918|FG006|Overall Study|Protocol Violation|2|||
143123890|NCT00262002|515997912|FG000|Overall Study|Unable to classify|0|||
143123891|NCT00262002|515997913|FG001|Overall Study|Unable to classify|0|||
143123892|NCT00262002|515997914|FG002|Overall Study|Unable to classify|0|||
143123893|NCT00262002|515997915|FG003|Overall Study|Unable to classify|0|||
143123894|NCT00262002|515997916|FG004|Overall Study|Unable to classify|0|||
143123895|NCT00262002|515997917|FG005|Overall Study|Unable to classify|0|||
143123896|NCT00262002|515997918|FG006|Overall Study|Unable to classify|2|||
143123897|NCT03885999|515997919|FG000|Overall Study|Adverse Event|1|||
143123898|NCT02452554|515997920|FG000|Overall Study|Death|2|||
143123899|NCT02452554|515997921|FG001|Overall Study|Death|1|||
143123900|NCT02452554|515997922|FG002|Overall Study|Death|0|||
143123901|NCT02452554|515997923|FG003|Overall Study|Death|0|||
143123902|NCT02452554|515997924|FG004|Overall Study|Death|0|||
143123903|NCT02452554|515997925|FG005|Overall Study|Death|0|||
143123904|NCT02452554|515997920|FG000|Overall Study|Lack of Efficacy|13|||
143123905|NCT02452554|515997921|FG001|Overall Study|Lack of Efficacy|14|||
143123906|NCT02452554|515997922|FG002|Overall Study|Lack of Efficacy|9|||
143123907|NCT02452554|515997923|FG003|Overall Study|Lack of Efficacy|1|||
143123908|NCT02452554|515997924|FG004|Overall Study|Lack of Efficacy|5|||
143123909|NCT02452554|515997925|FG005|Overall Study|Lack of Efficacy|8|||
143123910|NCT02452554|515997920|FG000|Overall Study|Physician Decision|0|||
143123911|NCT02452554|515997921|FG001|Overall Study|Physician Decision|1|||
143123912|NCT02452554|515997922|FG002|Overall Study|Physician Decision|0|||
143123913|NCT02452554|515997923|FG003|Overall Study|Physician Decision|0|||
143123914|NCT02452554|515997924|FG004|Overall Study|Physician Decision|0|||
143123915|NCT02452554|515997925|FG005|Overall Study|Physician Decision|0|||
143123916|NCT02452554|515997920|FG000|Overall Study|Withdrawal by Subject|1|||
143123917|NCT02452554|515997921|FG001|Overall Study|Withdrawal by Subject|0|||
143123918|NCT02452554|515997922|FG002|Overall Study|Withdrawal by Subject|2|||
143123919|NCT02452554|515997923|FG003|Overall Study|Withdrawal by Subject|0|||
143123920|NCT02452554|515997924|FG004|Overall Study|Withdrawal by Subject|0|||
143123921|NCT02452554|515997925|FG005|Overall Study|Withdrawal by Subject|1|||
143123922|NCT02452554|515997920|FG000|Overall Study|Ineligible|0|||
143123923|NCT02452554|515997921|FG001|Overall Study|Ineligible|1|||
143123924|NCT02452554|515997922|FG002|Overall Study|Ineligible|0|||
143123925|NCT02452554|515997923|FG003|Overall Study|Ineligible|0|||
143123926|NCT02452554|515997924|FG004|Overall Study|Ineligible|0|||
143123927|NCT02452554|515997925|FG005|Overall Study|Ineligible|0|||
143123928|NCT02452554|515997920|FG000|Overall Study|Never Received Treatment|1|||
143123929|NCT02452554|515997921|FG001|Overall Study|Never Received Treatment|0|||
143123930|NCT02452554|515997922|FG002|Overall Study|Never Received Treatment|0|||
143123931|NCT02452554|515997923|FG003|Overall Study|Never Received Treatment|0|||
143123932|NCT02452554|515997924|FG004|Overall Study|Never Received Treatment|0|||
143123933|NCT02452554|515997925|FG005|Overall Study|Never Received Treatment|0|||
143123934|NCT01085084|515997926|FG000|Overall Study|Withdrawal by Subject|1|||
143123935|NCT01085084|515997927|FG001|Overall Study|Withdrawal by Subject|0|||
143123936|NCT01085084|515997928|FG002|Overall Study|Withdrawal by Subject|0|||
143123937|NCT01085084|515997926|FG000|Overall Study|Lost to Follow-up|2|||
143123938|NCT01085084|515997927|FG001|Overall Study|Lost to Follow-up|1|||
143123939|NCT01085084|515997928|FG002|Overall Study|Lost to Follow-up|1|||
143123940|NCT01085084|515997926|FG000|Overall Study|Adverse Event|4|||
143123941|NCT01085084|515997927|FG001|Overall Study|Adverse Event|3|||
143123942|NCT01085084|515997928|FG002|Overall Study|Adverse Event|6|||
143123943|NCT01085084|515997926|FG000|Overall Study|Treatment Failure|0|||
143123944|NCT01085084|515997927|FG001|Overall Study|Treatment Failure|1|||
143123945|NCT01085084|515997928|FG002|Overall Study|Treatment Failure|2|||
143123946|NCT02749799|515997929|FG000|Overall Study|Adverse Event|2|||
143123947|NCT02749799|515997929|FG000|Overall Study|Lost to Follow-up|4|||
143123948|NCT02749799|515997929|FG000|Overall Study|Protocol Violation|1|||
143123949|NCT02749799|515997929|FG000|Overall Study|Withdrawal by Subject|1|||
143123950|NCT02669043|515997932|FG000|Overall Study|Didn't meet I/E criteria|4|||
143123951|NCT02636439|515997935|FG000|Overall Study|Adverse Event|2|||
143123952|NCT02636439|515997936|FG001|Overall Study|Adverse Event|2|||
143123953|NCT02636439|515997935|FG000|Overall Study|Lost to Follow-up|1|||
143123954|NCT02636439|515997936|FG001|Overall Study|Lost to Follow-up|0|||
143123955|NCT02636439|515997935|FG000|Overall Study|Non-compliance|1|||
143123956|NCT02636439|515997936|FG001|Overall Study|Non-compliance|1|||
143123957|NCT02636439|515997935|FG000|Overall Study|Personal reasons|2|||
143123958|NCT02636439|515997936|FG001|Overall Study|Personal reasons|0|||
143123959|NCT01299896|515999575|FG000|Overall Study|Withdrawal by Subject|1|||
143123960|NCT01299896|515999576|FG001|Overall Study|Withdrawal by Subject|7|||
143123961|NCT01299896|515999575|FG000|Overall Study|Lost to Follow-up|0|||
143123962|NCT01299896|515999576|FG001|Overall Study|Lost to Follow-up|11|||
143123963|NCT01502956|515999577|FG000|Overall Study|Death|0|||
143123964|NCT01502956|515999578|FG001|Overall Study|Death|2|||
143123965|NCT01502956|515999577|FG000|Overall Study|Lost to Follow-up|14|||
143123966|NCT01502956|515999578|FG001|Overall Study|Lost to Follow-up|11|||
143123967|NCT01502956|515999577|FG000|Overall Study|Physician Decision|2|||
143123968|NCT01502956|515999578|FG001|Overall Study|Physician Decision|3|||
143123969|NCT01502956|515999577|FG000|Overall Study|Withdrawal by Subject|8|||
143123970|NCT01502956|515999578|FG001|Overall Study|Withdrawal by Subject|10|||
143123971|NCT02499263|515999579|FG000|Overall Study|Lost to Follow-up|9|||
143123972|NCT02499263|515999579|FG000|Overall Study|Participant's withdrawal of consent|4|||
143123973|NCT02499263|515999579|FG000|Overall Study|Lack of Efficacy|22|||
143009258|NCT03917654|515571240|FG002|Year 2|Year 2 Screening failure|0|||
143123974|NCT02499263|515999579|FG000|Overall Study|investigator's judgment|12|||
143123975|NCT02499263|515999579|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
143123976|NCT02499263|515999579|FG000|Overall Study|Participant's decision|3|||
143123977|NCT02499263|515999579|FG000|Overall Study|Pregnancy|1|||
143123978|NCT04126317|515999583|FG000|Overall Study|Adverse Event|0|||
143123979|NCT04126317|515999584|FG001|Overall Study|Adverse Event|1|||
143123980|NCT04126317|515999583|FG000|Overall Study|Withdrawal by Subject|4|||
143123981|NCT04126317|515999584|FG001|Overall Study|Withdrawal by Subject|1|||
143123982|NCT02985021|515999587|FG000|Overall Study|Inability to comply with study procedures|1|||
143009259|NCT03917654|515571241|FG003|Year 2|Year 2 Screening failure|0|||
143123983|NCT02734862|515999588|FG000|Part A|Death|3|||
143123984|NCT02734862|515999589|FG001|Part A|Death|4|||
143123985|NCT02734862|515999590|FG002|Part A|Death|6|||
143123986|NCT02734862|515999588|FG000|Part A|Lost to Follow-up|2|||
143123987|NCT02734862|515999589|FG001|Part A|Lost to Follow-up|1|||
143123988|NCT02734862|515999590|FG002|Part A|Lost to Follow-up|1|||
143123989|NCT02734862|515999588|FG000|Part A|Withdrawal by Subject|1|||
143123990|NCT02734862|515999589|FG001|Part A|Withdrawal by Subject|1|||
143123991|NCT02734862|515999590|FG002|Part A|Withdrawal by Subject|2|||
143123992|NCT02734862|515999588|FG000|Part A|Physician Decision|2|||
143346419|NCT02387216|516814331|FG000|Overall Study|Progressive disease|2|||
143123993|NCT02734862|515999589|FG001|Part A|Physician Decision|0|||
143009260|NCT03917654|515571242|FG004|Year 2|Year 2 Screening failure|2|||
143123994|NCT02734862|515999590|FG002|Part A|Physician Decision|1|||
143123995|NCT02734862|515999588|FG000|Part A|Adverse Event|2|||
143123996|NCT02734862|515999589|FG001|Part A|Adverse Event|0|||
143123997|NCT02734862|515999590|FG002|Part A|Adverse Event|1|||
143123998|NCT02734862|515999588|FG000|Part A|Noncompliance|1|||
143123999|NCT02734862|515999589|FG001|Part A|Noncompliance|1|||
143124000|NCT02734862|515999590|FG002|Part A|Noncompliance|0|||
143124001|NCT02734862|515999588|FG000|Part A|Other|1|||
143124002|NCT02734862|515999589|FG001|Part A|Other|1|||
143124003|NCT02734862|515999590|FG002|Part A|Other|3|||
143124004|NCT02734862|515999588|FG000|Part B|Death|8|||
143124005|NCT02734862|515999589|FG001|Part B|Death|3|||
143124006|NCT02734862|515999590|FG002|Part B|Death|5|||
143124007|NCT02734862|515999588|FG000|Part B|Lost to Follow-up|2|||
143124008|NCT02734862|515999589|FG001|Part B|Lost to Follow-up|2|||
143124009|NCT02734862|515999590|FG002|Part B|Lost to Follow-up|0|||
143124010|NCT02734862|515999588|FG000|Part B|Withdrawal by Subject|3|||
143124011|NCT02734862|515999589|FG001|Part B|Withdrawal by Subject|1|||
143124012|NCT02734862|515999590|FG002|Part B|Withdrawal by Subject|0|||
143124013|NCT02734862|515999588|FG000|Part B|Other|0|||
143124014|NCT02734862|515999589|FG001|Part B|Other|1|||
143124015|NCT02734862|515999590|FG002|Part B|Other|0|||
143124016|NCT04854057|515999591|FG000|Overall Study|Adverse Event|0|||
143124017|NCT04854057|515999592|FG001|Overall Study|Adverse Event|1|||
143124018|NCT01951573|515999595|FG000|Washout Period|Adverse Event|0|||
143124019|NCT01951573|515999596|FG001|Washout Period|Adverse Event|1|||
143124020|NCT04399889|515999597|FG000|Overall Study|Death|5|||
143124021|NCT04399889|515999598|FG001|Overall Study|Death|1|||
143124022|NCT04399889|515999599|FG002|Overall Study|Death|1|||
143124023|NCT03077607|515999603|FG000|Period 1 (15 Days)|Adverse Event|1|||
143124024|NCT03077607|515999604|FG001|Period 1 (15 Days)|Adverse Event|0|||
143124025|NCT03077607|515999603|FG000|Period 1 (15 Days)|Death|1|||
143124026|NCT03077607|515999604|FG001|Period 1 (15 Days)|Death|0|||
143124027|NCT03077607|515999603|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
143124028|NCT03077607|515999604|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
143124029|NCT03077607|515999603|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
143124030|NCT03077607|515999604|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
143124031|NCT00460239|515999605|FG000|Overall Study|Physician Decision|0|||
143124032|NCT00460239|515999606|FG001|Overall Study|Physician Decision|1|||
143124033|NCT00460239|515999607|FG002|Overall Study|Physician Decision|0|||
143124034|NCT00460239|515999608|FG003|Overall Study|Physician Decision|0|||
143124035|NCT00460239|515999609|FG004|Overall Study|Physician Decision|0|||
143124036|NCT00460239|515999610|FG005|Overall Study|Physician Decision|2|||
143124037|NCT00460239|515999611|FG006|Overall Study|Physician Decision|0|||
143124038|NCT00460239|515999612|FG007|Overall Study|Physician Decision|0|||
143124039|NCT00460239|515999613|FG008|Overall Study|Physician Decision|0|||
143124040|NCT00460239|515999605|FG000|Overall Study|Withdrawal by Subject|0|||
143124041|NCT00460239|515999606|FG001|Overall Study|Withdrawal by Subject|0|||
143124042|NCT00460239|515999607|FG002|Overall Study|Withdrawal by Subject|0|||
143124043|NCT00460239|515999608|FG003|Overall Study|Withdrawal by Subject|0|||
143124044|NCT00460239|515999609|FG004|Overall Study|Withdrawal by Subject|0|||
143124045|NCT00460239|515999610|FG005|Overall Study|Withdrawal by Subject|1|||
143124046|NCT00460239|515999611|FG006|Overall Study|Withdrawal by Subject|0|||
143124047|NCT00460239|515999612|FG007|Overall Study|Withdrawal by Subject|0|||
143124048|NCT00460239|515999613|FG008|Overall Study|Withdrawal by Subject|0|||
143124049|NCT00760487|515999621|FG000|Overall Study|Unilateral implantation|3|||
143124050|NCT04217317|515999625|FG000|Overall Study|Lack of Efficacy|4|||
143124051|NCT04217317|515999625|FG000|Overall Study|Physician Decision|1|||
143124052|NCT04313400|515999629|FG000|Overall Study|Withdrawal by Subject|0|||
143124053|NCT04313400|515999630|FG001|Overall Study|Withdrawal by Subject|0|||
143124054|NCT04313400|515999631|FG002|Overall Study|Withdrawal by Subject|0|||
143124055|NCT04313400|515999632|FG003|Overall Study|Withdrawal by Subject|0|||
143124056|NCT04313400|515999633|FG004|Overall Study|Withdrawal by Subject|0|||
143124057|NCT04313400|515999634|FG005|Overall Study|Withdrawal by Subject|4|||
143124058|NCT04313400|515999635|FG006|Overall Study|Withdrawal by Subject|1|||
143124059|NCT04313400|515999629|FG000|Overall Study|Adverse Event|0|||
143124060|NCT04313400|515999630|FG001|Overall Study|Adverse Event|0|||
143124061|NCT04313400|515999631|FG002|Overall Study|Adverse Event|0|||
143124062|NCT04313400|515999632|FG003|Overall Study|Adverse Event|0|||
143124063|NCT04313400|515999633|FG004|Overall Study|Adverse Event|0|||
143124064|NCT04313400|515999634|FG005|Overall Study|Adverse Event|1|||
143124065|NCT04313400|515999635|FG006|Overall Study|Adverse Event|0|||
143124066|NCT04313400|515999629|FG000|Overall Study|Lost to Follow-up|0|||
143124067|NCT04313400|515999630|FG001|Overall Study|Lost to Follow-up|0|||
143346420|NCT02387216|516814332|FG001|Overall Study|Progressive disease|0|||
143124068|NCT04313400|515999631|FG002|Overall Study|Lost to Follow-up|0|||
143124069|NCT04313400|515999632|FG003|Overall Study|Lost to Follow-up|0|||
143124070|NCT04313400|515999633|FG004|Overall Study|Lost to Follow-up|0|||
143124071|NCT04313400|515999634|FG005|Overall Study|Lost to Follow-up|1|||
143124072|NCT04313400|515999635|FG006|Overall Study|Lost to Follow-up|0|||
143124073|NCT03224624|515999640|FG000|Overall Study|Lost to Follow-up|9|||
143124074|NCT03224624|515999641|FG001|Overall Study|Lost to Follow-up|4|||
143124075|NCT03224624|515999640|FG000|Overall Study|Death|1|||
143124076|NCT03224624|515999641|FG001|Overall Study|Death|0|||
143124077|NCT01884545|515999642|FG000|Overall Study|Lost to Follow-up|6|||
143124078|NCT01884545|515999643|FG001|Overall Study|Lost to Follow-up|4|||
143124079|NCT01884545|515999644|FG002|Overall Study|Lost to Follow-up|9|||
143124080|NCT01884545|515999645|FG003|Overall Study|Lost to Follow-up|4|||
143124081|NCT01884545|515999642|FG000|Overall Study|Patient withdrawn|7|||
143124082|NCT01884545|515999643|FG001|Overall Study|Patient withdrawn|12|||
143124083|NCT01884545|515999644|FG002|Overall Study|Patient withdrawn|5|||
143124084|NCT01884545|515999645|FG003|Overall Study|Patient withdrawn|5|||
143124085|NCT01884545|515999642|FG000|Overall Study|Non-adherence|0|||
143124086|NCT01884545|515999643|FG001|Overall Study|Non-adherence|2|||
143124087|NCT01884545|515999644|FG002|Overall Study|Non-adherence|0|||
143124088|NCT01884545|515999645|FG003|Overall Study|Non-adherence|0|||
143124089|NCT01424241|515999646|FG000|Overall Study|Withdrawal by Subject|1|||
143124090|NCT01424241|515999646|FG000|Overall Study|Time constraints|2|||
143124091|NCT02782377|515999647|FG000|Overall Study|Physician Decision|5|||
143124092|NCT00303472|515999648|FG000|Treatment Period|Adverse Event|0|||
143124093|NCT00303472|515999649|FG001|Treatment Period|Adverse Event|0|||
143124094|NCT00303472|515999650|FG002|Treatment Period|Adverse Event|0|||
143124095|NCT00303472|515999651|FG003|Treatment Period|Adverse Event|0|||
143124096|NCT00303472|515999652|FG004|Treatment Period|Adverse Event|1|||
143124097|NCT00303472|515999653|FG005|Treatment Period|Adverse Event|0|||
143124098|NCT00303472|515999654|FG006|Treatment Period|Adverse Event|0|||
143124099|NCT00303472|515999648|FG000|Treatment Period|Death|0|||
143124100|NCT00303472|515999649|FG001|Treatment Period|Death|0|||
143124101|NCT00303472|515999650|FG002|Treatment Period|Death|0|||
143124102|NCT00303472|515999651|FG003|Treatment Period|Death|1|||
143124103|NCT00303472|515999652|FG004|Treatment Period|Death|0|||
143124104|NCT00303472|515999653|FG005|Treatment Period|Death|0|||
143124105|NCT00303472|515999654|FG006|Treatment Period|Death|1|||
143124106|NCT00303472|515999648|FG000|Treatment Period|Withdrawal by Subject|0|||
143124107|NCT00303472|515999649|FG001|Treatment Period|Withdrawal by Subject|0|||
143124108|NCT00303472|515999650|FG002|Treatment Period|Withdrawal by Subject|0|||
143124109|NCT00303472|515999651|FG003|Treatment Period|Withdrawal by Subject|1|||
143124110|NCT00303472|515999652|FG004|Treatment Period|Withdrawal by Subject|0|||
143124111|NCT00303472|515999653|FG005|Treatment Period|Withdrawal by Subject|1|||
143124112|NCT00303472|515999654|FG006|Treatment Period|Withdrawal by Subject|0|||
143124113|NCT00303472|515999648|FG000|Treatment Period|Other|0|||
143124114|NCT00303472|515999649|FG001|Treatment Period|Other|0|||
143124115|NCT00303472|515999650|FG002|Treatment Period|Other|0|||
143124116|NCT00303472|515999651|FG003|Treatment Period|Other|0|||
143124117|NCT00303472|515999652|FG004|Treatment Period|Other|1|||
143124118|NCT00303472|515999653|FG005|Treatment Period|Other|0|||
143124119|NCT00303472|515999654|FG006|Treatment Period|Other|1|||
143124120|NCT00303472|515999648|FG000|Treatment Period|Disease Progression (to AML)|0|||
143124121|NCT00303472|515999649|FG001|Treatment Period|Disease Progression (to AML)|0|||
143124122|NCT00303472|515999650|FG002|Treatment Period|Disease Progression (to AML)|0|||
143124123|NCT00303472|515999651|FG003|Treatment Period|Disease Progression (to AML)|0|||
143124124|NCT00303472|515999652|FG004|Treatment Period|Disease Progression (to AML)|1|||
143124125|NCT00303472|515999653|FG005|Treatment Period|Disease Progression (to AML)|0|||
143124126|NCT00303472|515999654|FG006|Treatment Period|Disease Progression (to AML)|0|||
143124127|NCT00303472|515999648|FG000|Treatment Extension (Optional)|Adverse Event|1|||
143124128|NCT00303472|515999649|FG001|Treatment Extension (Optional)|Adverse Event|0|||
143124129|NCT00303472|515999650|FG002|Treatment Extension (Optional)|Adverse Event|1|||
143124130|NCT00303472|515999651|FG003|Treatment Extension (Optional)|Adverse Event|0|||
143124131|NCT00303472|515999652|FG004|Treatment Extension (Optional)|Adverse Event|0|||
143124132|NCT00303472|515999653|FG005|Treatment Extension (Optional)|Adverse Event|0|||
143124133|NCT00303472|515999654|FG006|Treatment Extension (Optional)|Adverse Event|0|||
143124134|NCT00303472|515999648|FG000|Treatment Extension (Optional)|Death|2|||
143124135|NCT00303472|515999649|FG001|Treatment Extension (Optional)|Death|0|||
143124136|NCT00303472|515999650|FG002|Treatment Extension (Optional)|Death|1|||
143124137|NCT00303472|515999651|FG003|Treatment Extension (Optional)|Death|0|||
143124138|NCT00303472|515999652|FG004|Treatment Extension (Optional)|Death|0|||
143124139|NCT00303472|515999653|FG005|Treatment Extension (Optional)|Death|0|||
143124140|NCT00303472|515999654|FG006|Treatment Extension (Optional)|Death|0|||
143124141|NCT00303472|515999648|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
143124142|NCT00303472|515999649|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
143124143|NCT00303472|515999650|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
143124144|NCT00303472|515999651|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
143124145|NCT00303472|515999652|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
143124146|NCT00303472|515999653|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
143124147|NCT00303472|515999654|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
143124148|NCT00303472|515999648|FG000|Treatment Extension (Optional)|Physician Decision|0|||
143124149|NCT00303472|515999649|FG001|Treatment Extension (Optional)|Physician Decision|4|||
143124150|NCT00303472|515999650|FG002|Treatment Extension (Optional)|Physician Decision|2|||
143124151|NCT00303472|515999651|FG003|Treatment Extension (Optional)|Physician Decision|3|||
143124152|NCT00303472|515999652|FG004|Treatment Extension (Optional)|Physician Decision|2|||
143124153|NCT00303472|515999653|FG005|Treatment Extension (Optional)|Physician Decision|0|||
143124154|NCT00303472|515999654|FG006|Treatment Extension (Optional)|Physician Decision|0|||
143124155|NCT00303472|515999648|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
143124156|NCT00303472|515999649|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
143124157|NCT00303472|515999650|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
143124158|NCT00303472|515999651|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
143124159|NCT00303472|515999652|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
143124160|NCT00303472|515999653|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
143124161|NCT00303472|515999654|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
143124162|NCT00303472|515999648|FG000|Treatment Extension (Optional)|Other|0|||
143124163|NCT00303472|515999649|FG001|Treatment Extension (Optional)|Other|2|||
143124164|NCT00303472|515999650|FG002|Treatment Extension (Optional)|Other|4|||
143124165|NCT00303472|515999651|FG003|Treatment Extension (Optional)|Other|2|||
143124166|NCT00303472|515999652|FG004|Treatment Extension (Optional)|Other|1|||
143124167|NCT00303472|515999653|FG005|Treatment Extension (Optional)|Other|0|||
143124168|NCT00303472|515999654|FG006|Treatment Extension (Optional)|Other|0|||
143124169|NCT00303472|515999648|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
143124170|NCT00303472|515999649|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
143124171|NCT00303472|515999650|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
143124172|NCT00303472|515999651|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
143124173|NCT00303472|515999652|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
143124174|NCT00303472|515999653|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
143124175|NCT00303472|515999654|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
143124176|NCT00359294|515999659|FG000|Overall Study|Progressive disease|1|||
143124177|NCT00359294|515999660|FG001|Overall Study|Progressive disease|1|||
143124178|NCT00359294|515999661|FG002|Overall Study|Progressive disease|2|||
143124179|NCT00359294|515999662|FG003|Overall Study|Progressive disease|3|||
143124180|NCT00359294|515999663|FG004|Overall Study|Progressive disease|2|||
143124181|NCT00359294|515999659|FG000|Overall Study|Withdrawal by Subject|0|||
143124182|NCT00359294|515999660|FG001|Overall Study|Withdrawal by Subject|0|||
143124183|NCT00359294|515999661|FG002|Overall Study|Withdrawal by Subject|0|||
143124184|NCT00359294|515999662|FG003|Overall Study|Withdrawal by Subject|0|||
143124185|NCT00359294|515999663|FG004|Overall Study|Withdrawal by Subject|1|||
143124186|NCT00359294|515999659|FG000|Overall Study|Not treated|0|||
143124187|NCT00359294|515999660|FG001|Overall Study|Not treated|0|||
143124188|NCT00359294|515999661|FG002|Overall Study|Not treated|0|||
143124189|NCT00359294|515999662|FG003|Overall Study|Not treated|1|||
143124190|NCT00359294|515999663|FG004|Overall Study|Not treated|0|||
143124191|NCT00359294|515999659|FG000|Overall Study|Physician Decision|0|||
143124192|NCT00359294|515999660|FG001|Overall Study|Physician Decision|0|||
143124193|NCT00359294|515999661|FG002|Overall Study|Physician Decision|1|||
143124194|NCT00359294|515999662|FG003|Overall Study|Physician Decision|0|||
143124195|NCT00359294|515999663|FG004|Overall Study|Physician Decision|0|||
143124196|NCT01658904|515999670|FG000|Overall Study|Principal Investigator discretion|2|||
143124197|NCT01658904|515999671|FG001|Overall Study|Principal Investigator discretion|0|||
143124198|NCT01658904|515999672|FG002|Overall Study|Principal Investigator discretion|0|||
143124199|NCT01146561|515999673|FG000|Overall Study|Withdrawal by Subject|1|||
143124200|NCT01146561|515999673|FG000|Overall Study|Lost to Follow-up|1|||
143124201|NCT04318132|515999674|FG000|Overall Study|Protocol Violation|0|||
143461345|NCT05559099|517235021|FG001|Overall Study|Death|4|||
143124202|NCT04318132|515999675|FG001|Overall Study|Protocol Violation|0|||
143124203|NCT04318132|515999676|FG002|Overall Study|Protocol Violation|3|||
143124204|NCT04318132|515999677|FG003|Overall Study|Protocol Violation|0|||
143124205|NCT00073008|515999678|FG000|Overall Study|Missing|6|||
143124206|NCT00073008|515999679|FG001|Overall Study|Missing|6|||
143124207|NCT00073008|515999678|FG000|Overall Study|Withdrawal by Subject|2|||
143124208|NCT00073008|515999679|FG001|Overall Study|Withdrawal by Subject|2|||
143124209|NCT00073008|515999678|FG000|Overall Study|Lost to Follow-up|1|||
143124210|NCT00073008|515999679|FG001|Overall Study|Lost to Follow-up|3|||
143124211|NCT00073008|515999678|FG000|Overall Study|Death|46|||
143124212|NCT00073008|515999679|FG001|Overall Study|Death|47|||
143124213|NCT00073008|515999678|FG000|Overall Study|"Other selected on Case Report Form"|7|||
143124214|NCT00073008|515999679|FG001|Overall Study|"Other selected on Case Report Form"|5|||
143124215|NCT00636961|515999691|FG000|Period 1|Administrative problems|1|||
143124216|NCT00636961|515999692|FG001|Period 1|Administrative problems|1|||
143124217|NCT00636961|515999691|FG000|Period 2|Adverse Event|1|||
143124218|NCT00636961|515999692|FG001|Period 2|Adverse Event|0|||
143124219|NCT01926197|515999694|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
143124220|NCT01926197|515999695|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
143124221|NCT01926197|515999694|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
143124222|NCT01926197|515999695|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
143124223|NCT03628716|515999696|FG000|Overall Study|Adverse Event|1|||
143124224|NCT03628716|515999697|FG001|Overall Study|Adverse Event|1|||
143124225|NCT03628716|515999696|FG000|Overall Study|Death|1|||
143124226|NCT03628716|515999697|FG001|Overall Study|Death|0|||
143124227|NCT03628716|515999696|FG000|Overall Study|Lack of Efficacy|15|||
143124228|NCT03628716|515999697|FG001|Overall Study|Lack of Efficacy|20|||
143124229|NCT03628716|515999696|FG000|Overall Study|Withdrawal by Subject|1|||
143124230|NCT03628716|515999697|FG001|Overall Study|Withdrawal by Subject|2|||
143124231|NCT03628716|515999696|FG000|Overall Study|Study Terminated by Sponsor|1|||
143124232|NCT03628716|515999697|FG001|Overall Study|Study Terminated by Sponsor|0|||
143124233|NCT00856843|515999698|FG000|Overall Study|Withdrawal by Subject|1|||
143124234|NCT00856843|515999699|FG001|Overall Study|Withdrawal by Subject|5|||
143124235|NCT00856843|515999698|FG000|Overall Study|Lack of Efficacy|1|||
143124236|NCT00856843|515999699|FG001|Overall Study|Lack of Efficacy|0|||
143124237|NCT02179749|515999700|FG000|Overall Study|Adverse Event|0|||
143124238|NCT02179749|515999701|FG001|Overall Study|Adverse Event|0|||
143124239|NCT02179749|515999702|FG002|Overall Study|Adverse Event|1|||
143124240|NCT02179749|515999700|FG000|Overall Study|Withdrawal by Subject|0|||
143124241|NCT02179749|515999701|FG001|Overall Study|Withdrawal by Subject|0|||
143124242|NCT02179749|515999702|FG002|Overall Study|Withdrawal by Subject|1|||
143124243|NCT02756364|515999703|FG000|Overall Study|Site Terminated by Sponsor|24|||
143124244|NCT02756364|515999704|FG001|Overall Study|Site Terminated by Sponsor|30|||
143124245|NCT02756364|515999705|FG002|Overall Study|Site Terminated by Sponsor|21|||
143124246|NCT02756364|515999703|FG000|Overall Study|Death|20|||
143124247|NCT02756364|515999704|FG001|Overall Study|Death|15|||
143124248|NCT02756364|515999705|FG002|Overall Study|Death|18|||
143124249|NCT02756364|515999703|FG000|Overall Study|Withdrawal by Patient|2|||
143124250|NCT02756364|515999704|FG001|Overall Study|Withdrawal by Patient|1|||
143124251|NCT02756364|515999705|FG002|Overall Study|Withdrawal by Patient|8|||
143124252|NCT02756364|515999703|FG000|Overall Study|Lost to Follow-up|0|||
143124253|NCT02756364|515999704|FG001|Overall Study|Lost to Follow-up|1|||
143124254|NCT02756364|515999705|FG002|Overall Study|Lost to Follow-up|1|||
143124255|NCT02223364|515999706|FG000|Overall Study|Protocol Violation|3|||
143124256|NCT02223364|515999707|FG001|Overall Study|Protocol Violation|0|||
143124257|NCT02223364|515999708|FG002|Overall Study|Protocol Violation|3|||
143124258|NCT02223364|515999706|FG000|Overall Study|subject expired before surgery|1|||
143124259|NCT02223364|515999707|FG001|Overall Study|subject expired before surgery|0|||
143124260|NCT02223364|515999708|FG002|Overall Study|subject expired before surgery|0|||
143124261|NCT02223364|515999706|FG000|Overall Study|Physician Decision|1|||
143124262|NCT02223364|515999707|FG001|Overall Study|Physician Decision|0|||
143124263|NCT02223364|515999708|FG002|Overall Study|Physician Decision|0|||
143124264|NCT02984267|515999709|FG000|Overall Study|Protocol Violation|1|||
143124265|NCT02984267|515999710|FG001|Overall Study|Protocol Violation|0|||
143124266|NCT02984267|515999709|FG000|Overall Study|Withdrawal by Subject|0|||
143124267|NCT02984267|515999710|FG001|Overall Study|Withdrawal by Subject|1|||
143124268|NCT02634710|515999711|FG000|Overall Study|Death|4|||
143124269|NCT01249833|515999712|FG000|Overall Study|Lost to Follow-up|0|||
143124270|NCT01249833|515999713|FG001|Overall Study|Lost to Follow-up|1|||
143124271|NCT02427802|515999717|FG000|Overall Study|Adverse Event|11|||
143124272|NCT02427802|515999718|FG001|Overall Study|Adverse Event|3|||
143124273|NCT02427802|515999719|FG002|Overall Study|Adverse Event|7|||
143124274|NCT02427802|515999717|FG000|Overall Study|Death|0|||
143124275|NCT02427802|515999718|FG001|Overall Study|Death|4|||
143124276|NCT02427802|515999719|FG002|Overall Study|Death|1|||
143124277|NCT02427802|515999717|FG000|Overall Study|Lost to Follow-up|13|||
143124278|NCT02427802|515999718|FG001|Overall Study|Lost to Follow-up|8|||
143124279|NCT02427802|515999719|FG002|Overall Study|Lost to Follow-up|8|||
143124280|NCT02427802|515999717|FG000|Overall Study|Physician Decision|4|||
143124281|NCT02427802|515999718|FG001|Overall Study|Physician Decision|2|||
143124282|NCT02427802|515999719|FG002|Overall Study|Physician Decision|4|||
143124283|NCT02427802|515999717|FG000|Overall Study|Withdrawal by Subject|10|||
143124284|NCT02427802|515999718|FG001|Overall Study|Withdrawal by Subject|5|||
143124285|NCT02427802|515999719|FG002|Overall Study|Withdrawal by Subject|11|||
143124286|NCT02427802|515999717|FG000|Overall Study|Protocol Violation|3|||
143124287|NCT02427802|515999718|FG001|Overall Study|Protocol Violation|1|||
143124288|NCT02427802|515999719|FG002|Overall Study|Protocol Violation|1|||
143124289|NCT02427802|515999717|FG000|Overall Study|protocol specific treatment unrelated|18|||
143124290|NCT02427802|515999718|FG001|Overall Study|protocol specific treatment unrelated|11|||
143124291|NCT02427802|515999719|FG002|Overall Study|protocol specific treatment unrelated|11|||
143124292|NCT02070978|515999720|FG000|Overall Study|Adverse Event|6|||
143124293|NCT02070978|515999721|FG001|Overall Study|Adverse Event|2|||
143124294|NCT02070978|515999722|FG002|Overall Study|Adverse Event|0|||
143124295|NCT02070978|515999720|FG000|Overall Study|Lost to Follow-up|1|||
143124296|NCT02070978|515999721|FG001|Overall Study|Lost to Follow-up|3|||
143124297|NCT02070978|515999722|FG002|Overall Study|Lost to Follow-up|4|||
143124298|NCT02070978|515999720|FG000|Overall Study|Withdrawal by Subject|3|||
143124299|NCT02070978|515999721|FG001|Overall Study|Withdrawal by Subject|5|||
143124300|NCT02070978|515999722|FG002|Overall Study|Withdrawal by Subject|3|||
143124301|NCT02070978|515999720|FG000|Overall Study|Protocol Violation|1|||
143124302|NCT02070978|515999721|FG001|Overall Study|Protocol Violation|0|||
143124303|NCT02070978|515999722|FG002|Overall Study|Protocol Violation|3|||
143124304|NCT02070978|515999720|FG000|Overall Study|Lack of Efficacy|0|||
143124305|NCT02070978|515999721|FG001|Overall Study|Lack of Efficacy|1|||
143124306|NCT02070978|515999722|FG002|Overall Study|Lack of Efficacy|0|||
143124307|NCT02070978|515999720|FG000|Overall Study|Death|0|||
143124308|NCT02070978|515999721|FG001|Overall Study|Death|0|||
143124309|NCT02070978|515999722|FG002|Overall Study|Death|2|||
143124310|NCT02070978|515999720|FG000|Overall Study|Un-specified|3|||
143009261|NCT03917654|515571243|FG005|Year 2|Year 2 Screening failure|0|||
143009262|NCT03917654|515571244|FG006|Year 2|Year 2 Screening failure|4|||
143009263|NCT03917654|515571245|FG007|Year 2|Year 2 Screening failure|3|||
143009264|NCT03917654|515571246|FG008|Year 2|Year 2 Screening failure|10|||
143009265|NCT03917654|515571247|FG009|Year 2|Year 2 Screening failure|2|||
143009266|NCT03917654|515571248|FG010|Year 2|Year 2 Screening failure|1|||
143009267|NCT03917654|515571249|FG011|Year 2|Year 2 Screening failure|1|||
143009268|NCT03917654|515571238|FG000|Year 2|Death|0|||
143009269|NCT03917654|515571239|FG001|Year 2|Death|0|||
143009270|NCT03917654|515571240|FG002|Year 2|Death|0|||
143009271|NCT03917654|515571241|FG003|Year 2|Death|0|||
143009272|NCT03917654|515571242|FG004|Year 2|Death|0|||
143009273|NCT03917654|515571243|FG005|Year 2|Death|1|||
143009274|NCT03917654|515571244|FG006|Year 2|Death|0|||
143009275|NCT03917654|515571245|FG007|Year 2|Death|0|||
143009276|NCT03917654|515571246|FG008|Year 2|Death|1|||
143009277|NCT03917654|515571247|FG009|Year 2|Death|1|||
143009278|NCT03917654|515571248|FG010|Year 2|Death|0|||
143009279|NCT03917654|515571249|FG011|Year 2|Death|0|||
143009280|NCT03917654|515571238|FG000|Year 2|Withdrawal by Subject|0|||
143009281|NCT03917654|515571239|FG001|Year 2|Withdrawal by Subject|0|||
143009282|NCT03917654|515571240|FG002|Year 2|Withdrawal by Subject|0|||
143009283|NCT03917654|515571241|FG003|Year 2|Withdrawal by Subject|0|||
143009284|NCT03917654|515571242|FG004|Year 2|Withdrawal by Subject|0|||
143009285|NCT03917654|515571243|FG005|Year 2|Withdrawal by Subject|0|||
143009286|NCT03917654|515571244|FG006|Year 2|Withdrawal by Subject|3|||
143009287|NCT03917654|515571245|FG007|Year 2|Withdrawal by Subject|0|||
143009288|NCT03917654|515571246|FG008|Year 2|Withdrawal by Subject|2|||
143009289|NCT03917654|515571247|FG009|Year 2|Withdrawal by Subject|5|||
143009290|NCT03917654|515571248|FG010|Year 2|Withdrawal by Subject|0|||
143009291|NCT03917654|515571249|FG011|Year 2|Withdrawal by Subject|0|||
143009292|NCT03917654|515571238|FG000|Year 2|Spouse/family member request|0|||
143009293|NCT03917654|515571239|FG001|Year 2|Spouse/family member request|0|||
143009294|NCT03917654|515571240|FG002|Year 2|Spouse/family member request|0|||
143009295|NCT03917654|515571241|FG003|Year 2|Spouse/family member request|0|||
143009296|NCT03917654|515571242|FG004|Year 2|Spouse/family member request|0|||
143009297|NCT03917654|515571243|FG005|Year 2|Spouse/family member request|0|||
143009298|NCT03917654|515571244|FG006|Year 2|Spouse/family member request|1|||
143009299|NCT03917654|515571245|FG007|Year 2|Spouse/family member request|0|||
143009300|NCT03917654|515571246|FG008|Year 2|Spouse/family member request|0|||
143009301|NCT03917654|515571247|FG009|Year 2|Spouse/family member request|0|||
143124311|NCT02070978|515999721|FG001|Overall Study|Un-specified|2|||
143124312|NCT02070978|515999722|FG002|Overall Study|Un-specified|2|||
143124313|NCT02070978|515999720|FG000|Overall Study|Terminated by Sponsor|33|||
143124314|NCT02070978|515999721|FG001|Overall Study|Terminated by Sponsor|40|||
143009302|NCT03917654|515571248|FG010|Year 2|Spouse/family member request|0|||
143009303|NCT03917654|515571249|FG011|Year 2|Spouse/family member request|0|||
143009304|NCT03917654|515571238|FG000|Year 2|Lost to Follow-up|0|||
143009305|NCT03917654|515571239|FG001|Year 2|Lost to Follow-up|0|||
143009306|NCT03917654|515571240|FG002|Year 2|Lost to Follow-up|0|||
143009307|NCT03917654|515571241|FG003|Year 2|Lost to Follow-up|0|||
143009308|NCT03917654|515571242|FG004|Year 2|Lost to Follow-up|0|||
143009309|NCT03917654|515571243|FG005|Year 2|Lost to Follow-up|0|||
143009310|NCT03917654|515571244|FG006|Year 2|Lost to Follow-up|1|||
143009311|NCT03917654|515571245|FG007|Year 2|Lost to Follow-up|0|||
143009312|NCT03917654|515571246|FG008|Year 2|Lost to Follow-up|1|||
143009313|NCT03917654|515571247|FG009|Year 2|Lost to Follow-up|0|||
143009314|NCT03917654|515571248|FG010|Year 2|Lost to Follow-up|0|||
143009315|NCT03917654|515571249|FG011|Year 2|Lost to Follow-up|1|||
143009316|NCT03917654|515571238|FG000|Year 2|Adverse Event|0|||
143009317|NCT03917654|515571239|FG001|Year 2|Adverse Event|0|||
143009318|NCT03917654|515571240|FG002|Year 2|Adverse Event|0|||
143009319|NCT03917654|515571241|FG003|Year 2|Adverse Event|0|||
143009320|NCT03917654|515571242|FG004|Year 2|Adverse Event|0|||
143124315|NCT02070978|515999722|FG002|Overall Study|Terminated by Sponsor|39|||
143124316|NCT03951753|515999723|FG000|Overall Study|Adverse Event|1|||
143009321|NCT03917654|515571243|FG005|Year 2|Adverse Event|0|||
143009322|NCT03917654|515571244|FG006|Year 2|Adverse Event|0|||
143124317|NCT03951753|515999724|FG001|Overall Study|Adverse Event|0|||
143124318|NCT03951753|515999725|FG002|Overall Study|Adverse Event|3|||
143009323|NCT03917654|515571245|FG007|Year 2|Adverse Event|0|||
143009324|NCT03917654|515571246|FG008|Year 2|Adverse Event|0|||
143009325|NCT03917654|515571247|FG009|Year 2|Adverse Event|1|||
143009326|NCT03917654|515571248|FG010|Year 2|Adverse Event|0|||
143009327|NCT03917654|515571249|FG011|Year 2|Adverse Event|0|||
143009328|NCT03179462|515571250|FG000|Overall Study|screening failure|1|||
143009329|NCT03179462|515571251|FG001|Overall Study|screening failure|2|||
143009330|NCT03179462|515571252|FG002|Overall Study|screening failure|0|||
143009331|NCT04636437|515571256|FG000|Overall Study|Eligibility failure discovered after study entry|2|||
143009332|NCT04636437|515571257|FG001|Overall Study|Eligibility failure discovered after study entry|1|||
143009333|NCT04636437|515571258|FG002|Overall Study|Eligibility failure discovered after study entry|0|||
143009334|NCT04636437|515571256|FG000|Overall Study|Started weight loss drug/program|2|||
143009335|NCT04636437|515571257|FG001|Overall Study|Started weight loss drug/program|1|||
143124319|NCT03951753|515999723|FG000|Overall Study|Withdrawal by Subject|3|||
143124320|NCT03951753|515999724|FG001|Overall Study|Withdrawal by Subject|1|||
143124321|NCT03951753|515999725|FG002|Overall Study|Withdrawal by Subject|0|||
143124322|NCT03951753|515999723|FG000|Overall Study|Lost to Follow-up|0|||
143124323|NCT03951753|515999724|FG001|Overall Study|Lost to Follow-up|0|||
143124324|NCT03951753|515999725|FG002|Overall Study|Lost to Follow-up|1|||
143124325|NCT00467558|515999729|FG000|Overall Study|Lost to Follow-up|2|||
143124326|NCT00467558|515999730|FG001|Overall Study|Lost to Follow-up|0|||
143124327|NCT02494401|515999731|FG000|Overall Study|Lost to Follow-up|22|||
143124328|NCT02494401|515999732|FG001|Overall Study|Lost to Follow-up|25|||
143124329|NCT02494401|515999731|FG000|Overall Study|Withdrawal by Subject|3|||
143124330|NCT02494401|515999732|FG001|Overall Study|Withdrawal by Subject|2|||
143124331|NCT05188729|515999737|FG000|Overall Study|Withdrawal by Subject|0|||
143124332|NCT05188729|515999738|FG001|Overall Study|Withdrawal by Subject|0|||
143124333|NCT05188729|515999739|FG002|Overall Study|Withdrawal by Subject|0|||
143124334|NCT05188729|515999740|FG003|Overall Study|Withdrawal by Subject|0|||
143124335|NCT05188729|515999741|FG004|Overall Study|Withdrawal by Subject|0|||
143124336|NCT05188729|515999742|FG005|Overall Study|Withdrawal by Subject|0|||
143124337|NCT05188729|515999743|FG006|Overall Study|Withdrawal by Subject|0|||
143124338|NCT05188729|515999744|FG007|Overall Study|Withdrawal by Subject|0|||
143124339|NCT05188729|515999745|FG008|Overall Study|Withdrawal by Subject|0|||
143124340|NCT05188729|515999746|FG009|Overall Study|Withdrawal by Subject|1|||
143124341|NCT05188729|515999747|FG010|Overall Study|Withdrawal by Subject|0|||
143124342|NCT05188729|515999748|FG011|Overall Study|Withdrawal by Subject|0|||
143124343|NCT05188729|515999749|FG012|Overall Study|Withdrawal by Subject|0|||
143124344|NCT05188729|515999737|FG000|Overall Study|Lost to Follow-up|0|||
143124345|NCT05188729|515999738|FG001|Overall Study|Lost to Follow-up|0|||
143124346|NCT05188729|515999739|FG002|Overall Study|Lost to Follow-up|0|||
143124347|NCT05188729|515999740|FG003|Overall Study|Lost to Follow-up|0|||
143124348|NCT05188729|515999741|FG004|Overall Study|Lost to Follow-up|0|||
143124349|NCT05188729|515999742|FG005|Overall Study|Lost to Follow-up|0|||
143124350|NCT05188729|515999743|FG006|Overall Study|Lost to Follow-up|0|||
143124351|NCT05188729|515999744|FG007|Overall Study|Lost to Follow-up|0|||
143124352|NCT05188729|515999745|FG008|Overall Study|Lost to Follow-up|0|||
143124353|NCT05188729|515999746|FG009|Overall Study|Lost to Follow-up|0|||
143124354|NCT05188729|515999747|FG010|Overall Study|Lost to Follow-up|1|||
143124355|NCT05188729|515999748|FG011|Overall Study|Lost to Follow-up|1|||
143124356|NCT05188729|515999749|FG012|Overall Study|Lost to Follow-up|0|||
143124357|NCT00966355|515999750|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
143124358|NCT00966355|515999751|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
143124359|NCT00966355|515999752|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
143124360|NCT00966355|515999750|FG000|Overall Study|newly diagnosed advanced HCC|11|||
143124361|NCT00966355|515999751|FG001|Overall Study|newly diagnosed advanced HCC|12|||
143124362|NCT00966355|515999752|FG002|Overall Study|newly diagnosed advanced HCC|10|||
143124363|NCT00966355|515999750|FG000|Overall Study|Lost to Follow-up|5|||
143124364|NCT00966355|515999751|FG001|Overall Study|Lost to Follow-up|4|||
143124365|NCT00966355|515999752|FG002|Overall Study|Lost to Follow-up|3|||
143124366|NCT02552888|515999753|FG000|Overall Study|Lost to Follow-up|1|||
143124367|NCT02552888|515999754|FG001|Overall Study|Lost to Follow-up|1|||
143124368|NCT04304508|516001181|FG000|Overall Study|Subject Decision|29|||
143124369|NCT04304508|516001182|FG001|Overall Study|Subject Decision|39|||
143124370|NCT04304508|516001183|FG002|Overall Study|Subject Decision|37|||
143124371|NCT04304508|516001184|FG003|Overall Study|Subject Decision|48|||
143124372|NCT04304508|516001181|FG000|Overall Study|Death|6|||
143124373|NCT04304508|516001182|FG001|Overall Study|Death|1|||
143124374|NCT04304508|516001183|FG002|Overall Study|Death|8|||
143124375|NCT04304508|516001184|FG003|Overall Study|Death|5|||
143124376|NCT04304508|516001181|FG000|Overall Study|Non-compliance With Study Drug|3|||
143124377|NCT04304508|516001182|FG001|Overall Study|Non-compliance With Study Drug|1|||
143124378|NCT04304508|516001183|FG002|Overall Study|Non-compliance With Study Drug|2|||
143124379|NCT04304508|516001184|FG003|Overall Study|Non-compliance With Study Drug|0|||
143124380|NCT04304508|516001181|FG000|Overall Study|Switching To Other Therapy|1|||
143124381|NCT04304508|516001182|FG001|Overall Study|Switching To Other Therapy|1|||
143124382|NCT04304508|516001183|FG002|Overall Study|Switching To Other Therapy|1|||
143124383|NCT04304508|516001184|FG003|Overall Study|Switching To Other Therapy|2|||
143124384|NCT04304508|516001181|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
143124385|NCT04304508|516001182|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
143124386|NCT04304508|516001183|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
143124387|NCT04304508|516001184|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
143124388|NCT04304508|516001181|FG000|Overall Study|Withdrawal by Subject|7|||
143124389|NCT04304508|516001182|FG001|Overall Study|Withdrawal by Subject|5|||
143124390|NCT04304508|516001183|FG002|Overall Study|Withdrawal by Subject|11|||
143124391|NCT04304508|516001184|FG003|Overall Study|Withdrawal by Subject|6|||
143124392|NCT04304508|516001181|FG000|Overall Study|Logistical Difficulties|2|||
143124393|NCT04304508|516001182|FG001|Overall Study|Logistical Difficulties|2|||
143124394|NCT04304508|516001183|FG002|Overall Study|Logistical Difficulties|3|||
143124395|NCT04304508|516001184|FG003|Overall Study|Logistical Difficulties|2|||
143124396|NCT04304508|516001181|FG000|Overall Study|Missing Information|1|||
143124397|NCT04304508|516001182|FG001|Overall Study|Missing Information|2|||
143124398|NCT04304508|516001183|FG002|Overall Study|Missing Information|1|||
143124399|NCT04304508|516001184|FG003|Overall Study|Missing Information|3|||
143124400|NCT04304508|516001181|FG000|Overall Study|Other|7|||
143124401|NCT04304508|516001182|FG001|Overall Study|Other|6|||
143124402|NCT04304508|516001183|FG002|Overall Study|Other|5|||
143124403|NCT04304508|516001184|FG003|Overall Study|Other|4|||
143124404|NCT04304508|516001181|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
143124405|NCT04304508|516001182|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
143124406|NCT04304508|516001183|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
143124407|NCT04304508|516001184|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
143124408|NCT04304508|516001181|FG000|Overall Study|Physician Decision|3|||
143124409|NCT04304508|516001182|FG001|Overall Study|Physician Decision|4|||
143124410|NCT04304508|516001183|FG002|Overall Study|Physician Decision|9|||
143124411|NCT04304508|516001184|FG003|Overall Study|Physician Decision|7|||
143124412|NCT04304508|516001181|FG000|Overall Study|Study drug never administered|10|||
143124413|NCT04304508|516001182|FG001|Overall Study|Study drug never administered|4|||
143124414|NCT04304508|516001183|FG002|Overall Study|Study drug never administered|4|||
143124415|NCT04304508|516001184|FG003|Overall Study|Study drug never administered|4|||
143124416|NCT04304508|516001181|FG000|Overall Study|Adverse Event|49|||
143124417|NCT04304508|516001182|FG001|Overall Study|Adverse Event|50|||
143124418|NCT04304508|516001183|FG002|Overall Study|Adverse Event|51|||
143124419|NCT04304508|516001184|FG003|Overall Study|Adverse Event|56|||
143124420|NCT04304508|516001181|FG000|Overall Study|Lost to Follow-up|1|||
143124421|NCT04304508|516001182|FG001|Overall Study|Lost to Follow-up|5|||
143124422|NCT04304508|516001183|FG002|Overall Study|Lost to Follow-up|2|||
143124423|NCT04304508|516001184|FG003|Overall Study|Lost to Follow-up|3|||
143124424|NCT02688764|516001191|FG000|Overall Study|Adverse Event|3|||
143124425|NCT02688764|516001192|FG001|Overall Study|Adverse Event|3|||
143124426|NCT02688764|516001191|FG000|Overall Study|AE/Kidney transplant|1|||
143124427|NCT02688764|516001192|FG001|Overall Study|AE/Kidney transplant|0|||
143124428|NCT02688764|516001191|FG000|Overall Study|AE/Lack of efficacy|1|||
143124429|NCT02688764|516001192|FG001|Overall Study|AE/Lack of efficacy|0|||
143124430|NCT02688764|516001191|FG000|Overall Study|AE/Non-compl.|1|||
143124431|NCT02688764|516001192|FG001|Overall Study|AE/Non-compl.|0|||
143124432|NCT02688764|516001191|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
143124433|NCT02688764|516001192|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
143124434|NCT02688764|516001191|FG000|Overall Study|AE/Other|0|||
143124435|NCT02688764|516001192|FG001|Overall Study|AE/Other|1|||
143124436|NCT02688764|516001191|FG000|Overall Study|AE/Physician decision|1|||
143124437|NCT02688764|516001192|FG001|Overall Study|AE/Physician decision|0|||
143124438|NCT02688764|516001191|FG000|Overall Study|AE/Withd. parent|3|||
143124439|NCT02688764|516001192|FG001|Overall Study|AE/Withd. parent|0|||
143124440|NCT02688764|516001191|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
143124441|NCT02688764|516001192|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
143124442|NCT02688764|516001191|FG000|Overall Study|AE/Withd. subject|1|||
143124443|NCT02688764|516001192|FG001|Overall Study|AE/Withd. subject|0|||
143124444|NCT02688764|516001191|FG000|Overall Study|Kidney transplant|10|||
143124445|NCT02688764|516001192|FG001|Overall Study|Kidney transplant|4|||
143124446|NCT02688764|516001191|FG000|Overall Study|Lack of Efficacy|3|||
143124447|NCT02688764|516001192|FG001|Overall Study|Lack of Efficacy|2|||
143124448|NCT02688764|516001191|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
143124449|NCT02688764|516001192|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
143124450|NCT02688764|516001191|FG000|Overall Study|Non-compliance with study drug|4|||
143124451|NCT02688764|516001192|FG001|Overall Study|Non-compliance with study drug|0|||
143124452|NCT02688764|516001191|FG000|Overall Study|Non-compl./Physician decision|2|||
143124453|NCT02688764|516001192|FG001|Overall Study|Non-compl./Physician decision|0|||
143124454|NCT02688764|516001191|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
143124455|NCT02688764|516001192|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
143124456|NCT02688764|516001191|FG000|Overall Study|Non-compl./Withd. subject|0|||
143124457|NCT02688764|516001192|FG001|Overall Study|Non-compl./Withd. subject|2|||
143124458|NCT02688764|516001191|FG000|Overall Study|Phosphorus level outside safe range|0|||
143124459|NCT02688764|516001192|FG001|Overall Study|Phosphorus level outside safe range|1|||
143124460|NCT02688764|516001191|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
143124461|NCT02688764|516001192|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
143124462|NCT02688764|516001191|FG000|Overall Study|Study drug taste/Withd. parent|1|||
143124463|NCT02688764|516001192|FG001|Overall Study|Study drug taste/Withd. parent|0|||
143124464|NCT02688764|516001191|FG000|Overall Study|Subject moving out|2|||
143124465|NCT02688764|516001192|FG001|Overall Study|Subject moving out|0|||
143124466|NCT02688764|516001191|FG000|Overall Study|Subject taken off dialysis|1|||
143124467|NCT02688764|516001192|FG001|Overall Study|Subject taken off dialysis|0|||
143124468|NCT02688764|516001191|FG000|Overall Study|Withdrawal by parent|3|||
143124469|NCT02688764|516001192|FG001|Overall Study|Withdrawal by parent|0|||
143124470|NCT00885378|516001193|FG000|Overall Study|Lack of Efficacy|2|||
143124471|NCT00885378|516001194|FG001|Overall Study|Lack of Efficacy|2|||
143124472|NCT00885378|516001193|FG000|Overall Study|Withdrawal by Subject|1|||
143124473|NCT00885378|516001194|FG001|Overall Study|Withdrawal by Subject|2|||
143124474|NCT00885378|516001193|FG000|Overall Study|Lost to Follow-up|1|||
143124475|NCT00885378|516001194|FG001|Overall Study|Lost to Follow-up|2|||
143124476|NCT00885378|516001193|FG000|Overall Study|Poor/Noncompliance|2|||
143124477|NCT00885378|516001194|FG001|Overall Study|Poor/Noncompliance|2|||
143124478|NCT00885378|516001193|FG000|Overall Study|Protocol Violation|2|||
143124479|NCT00885378|516001194|FG001|Overall Study|Protocol Violation|0|||
143124480|NCT04750278|516001195|FG000|Overall Study|Death|9|||
143124481|NCT04750278|516001196|FG001|Overall Study|Death|10|||
143124482|NCT04750278|516001197|FG002|Overall Study|Death|10|||
143124483|NCT04750278|516001195|FG000|Overall Study|Withdrawal by Subject|4|||
143124484|NCT04750278|516001196|FG001|Overall Study|Withdrawal by Subject|1|||
143124485|NCT04750278|516001197|FG002|Overall Study|Withdrawal by Subject|2|||
143124486|NCT04750278|516001195|FG000|Overall Study|Lost to Follow-up|1|||
143124487|NCT04750278|516001196|FG001|Overall Study|Lost to Follow-up|1|||
143124488|NCT04750278|516001197|FG002|Overall Study|Lost to Follow-up|1|||
143124489|NCT04750278|516001195|FG000|Overall Study|Pregnancy|1|||
143124490|NCT04750278|516001196|FG001|Overall Study|Pregnancy|0|||
143124491|NCT04750278|516001197|FG002|Overall Study|Pregnancy|0|||
143124492|NCT04750278|516001195|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
143124493|NCT04750278|516001196|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
143124494|NCT04750278|516001197|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
143124495|NCT04750278|516001195|FG000|Overall Study|Non-compliance|0|||
143124496|NCT04750278|516001196|FG001|Overall Study|Non-compliance|0|||
143124497|NCT04750278|516001197|FG002|Overall Study|Non-compliance|1|||
143124498|NCT04750278|516001195|FG000|Overall Study|Transfer to Outside Facility|0|||
143124499|NCT04750278|516001196|FG001|Overall Study|Transfer to Outside Facility|2|||
143124500|NCT04750278|516001197|FG002|Overall Study|Transfer to Outside Facility|1|||
143124501|NCT04750278|516001195|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
143124502|NCT04750278|516001196|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
143124503|NCT04750278|516001197|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
143124504|NCT04750278|516001195|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
143124505|NCT04750278|516001196|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
143124506|NCT04750278|516001197|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
143124507|NCT01775787|516001198|FG000|First 7-10 Days|Adverse Event|0|||
143124508|NCT01775787|516001199|FG001|First 7-10 Days|Adverse Event|1|||
143124509|NCT01775787|516001198|FG000|First 7-10 Days|family emergency|0|||
143124510|NCT01775787|516001199|FG001|First 7-10 Days|family emergency|1|||
143124511|NCT01775787|516001198|FG000|First 7-10 Days|time commitment|0|||
143124512|NCT01775787|516001199|FG001|First 7-10 Days|time commitment|2|||
143124513|NCT01775787|516001198|FG000|First 7-10 Days|concerns with using IV|1|||
143124514|NCT01775787|516001199|FG001|First 7-10 Days|concerns with using IV|2|||
143124515|NCT01775787|516001198|FG000|Second 7-10 Days|time commitment|0|||
143124516|NCT01775787|516001199|FG001|Second 7-10 Days|time commitment|1|||
143124517|NCT01775787|516001198|FG000|Second 7-10 Days|concerns with using IV|0|||
143124518|NCT01775787|516001199|FG001|Second 7-10 Days|concerns with using IV|1|||
143124519|NCT01616758|516001204|FG000|Overall Study|Adverse Event|1|||
143124520|NCT01616758|516001204|FG000|Overall Study|Withdrawal by Subject|2|||
143124521|NCT01616758|516001204|FG000|Overall Study|Disease progression|18|||
143124522|NCT01616758|516001204|FG000|Overall Study|Study termination by Sponsor|1|||
143124523|NCT03026283|516001205|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
143124524|NCT03026283|516001206|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
143346421|NCT02387216|516814331|FG000|Overall Study|Withdrawal by Subject|3|||
143346422|NCT02387216|516814332|FG001|Overall Study|Withdrawal by Subject|5|||
143346423|NCT02387216|516814331|FG000|Overall Study|Physician Decision|2|||
143346424|NCT02387216|516814332|FG001|Overall Study|Physician Decision|0|||
143346425|NCT02387216|516814331|FG000|Overall Study|Sponsor Decision|28|||
143346426|NCT02387216|516814332|FG001|Overall Study|Sponsor Decision|12|||
143346427|NCT02387216|516814331|FG000|Overall Study|Death|60|||
143346428|NCT02387216|516814332|FG001|Overall Study|Death|23|||
143346429|NCT02387216|516814331|FG000|Overall Study|Other|5|||
143346430|NCT02387216|516814332|FG001|Overall Study|Other|4|||
143346431|NCT02387216|516814331|FG000|Overall Study|Lost to Follow-up|0|||
143346432|NCT02387216|516814332|FG001|Overall Study|Lost to Follow-up|3|||
143346433|NCT04399356|516814333|FG000|Overall Study|Lost to Follow-up|1|||
143346434|NCT04399356|516814334|FG001|Overall Study|Lost to Follow-up|1|||
143346435|NCT04399356|516814333|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
143124525|NCT03026283|516001207|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
143346436|NCT04399356|516814334|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
143346437|NCT04399356|516814333|FG000|Overall Study|Withdrawal by Subject|1|||
143346438|NCT04399356|516814334|FG001|Overall Study|Withdrawal by Subject|0|||
143346439|NCT02306265|516814335|FG000|Overall Study|Withdrawal by Subject|1|||
143346440|NCT02247804|516814336|FG000|Treatment Period 1|Adverse Event|9|||
143346441|NCT02247804|516814337|FG001|Treatment Period 1|Adverse Event|2|||
143009336|NCT04636437|515571258|FG002|Overall Study|Started weight loss drug/program|1|||
143009337|NCT04636437|515571256|FG000|Overall Study|Lost to Follow-up|3|||
143009338|NCT04636437|515571257|FG001|Overall Study|Lost to Follow-up|1|||
143009339|NCT04636437|515571258|FG002|Overall Study|Lost to Follow-up|4|||
143009340|NCT04636437|515571256|FG000|Overall Study|Participant or physician decision|3|||
143009341|NCT04636437|515571257|FG001|Overall Study|Participant or physician decision|1|||
143009342|NCT04636437|515571258|FG002|Overall Study|Participant or physician decision|1|||
143009343|NCT00816166|515571259|FG000|Overall Study|Lost to Follow-up|6|||
143009344|NCT00816166|515571260|FG001|Overall Study|Lost to Follow-up|10|||
143009345|NCT00816166|515571259|FG000|Overall Study|Death|4|||
143009346|NCT00816166|515571260|FG001|Overall Study|Death|2|||
143009347|NCT02851069|515571261|FG000|Overall Study|Failure to Return|3|||
143009348|NCT02851069|515571261|FG000|Overall Study|Other|3|||
143009349|NCT00352664|515571268|FG000|Overall Study|Withdrawal by Subject|7|||
143009350|NCT00352664|515571269|FG001|Overall Study|Withdrawal by Subject|0|||
143009351|NCT01058707|515571272|FG000|Overall Study|Disease Progression|15|||
143009352|NCT01058707|515571273|FG001|Overall Study|Disease Progression|20|||
143009353|NCT01058707|515571274|FG002|Overall Study|Disease Progression|20|||
143009354|NCT01058707|515571275|FG003|Overall Study|Disease Progression|15|||
143009355|NCT01058707|515571276|FG004|Overall Study|Disease Progression|23|||
143009356|NCT01058707|515571277|FG005|Overall Study|Disease Progression|10|||
143009357|NCT01058707|515571278|FG006|Overall Study|Disease Progression|12|||
143009358|NCT01058707|515571272|FG000|Overall Study|Adverse Event|11|||
143009359|NCT01058707|515571273|FG001|Overall Study|Adverse Event|4|||
143009360|NCT01058707|515571274|FG002|Overall Study|Adverse Event|7|||
143009361|NCT01058707|515571275|FG003|Overall Study|Adverse Event|6|||
143009362|NCT01058707|515571276|FG004|Overall Study|Adverse Event|7|||
143009363|NCT01058707|515571277|FG005|Overall Study|Adverse Event|3|||
143009364|NCT01058707|515571278|FG006|Overall Study|Adverse Event|1|||
143009365|NCT01058707|515571272|FG000|Overall Study|Subject Decision|5|||
143009366|NCT01058707|515571273|FG001|Overall Study|Subject Decision|3|||
143009367|NCT01058707|515571274|FG002|Overall Study|Subject Decision|3|||
143009368|NCT01058707|515571275|FG003|Overall Study|Subject Decision|1|||
143009369|NCT01058707|515571276|FG004|Overall Study|Subject Decision|2|||
143009370|NCT01058707|515571277|FG005|Overall Study|Subject Decision|3|||
143009371|NCT01058707|515571278|FG006|Overall Study|Subject Decision|6|||
143009372|NCT01058707|515571272|FG000|Overall Study|Lost to Follow-up|0|||
143009373|NCT01058707|515571273|FG001|Overall Study|Lost to Follow-up|0|||
143009374|NCT01058707|515571274|FG002|Overall Study|Lost to Follow-up|1|||
143009375|NCT01058707|515571275|FG003|Overall Study|Lost to Follow-up|0|||
143009376|NCT01058707|515571276|FG004|Overall Study|Lost to Follow-up|0|||
143009377|NCT01058707|515571277|FG005|Overall Study|Lost to Follow-up|0|||
143009378|NCT01058707|515571278|FG006|Overall Study|Lost to Follow-up|0|||
143009379|NCT01058707|515571272|FG000|Overall Study|Reason Not Specified|0|||
143009380|NCT01058707|515571273|FG001|Overall Study|Reason Not Specified|3|||
143009381|NCT01058707|515571274|FG002|Overall Study|Reason Not Specified|2|||
143009382|NCT01058707|515571275|FG003|Overall Study|Reason Not Specified|0|||
143009383|NCT01058707|515571276|FG004|Overall Study|Reason Not Specified|7|||
143009384|NCT01058707|515571277|FG005|Overall Study|Reason Not Specified|1|||
143009385|NCT01058707|515571278|FG006|Overall Study|Reason Not Specified|7|||
143009386|NCT03417102|515571279|FG000|Overall Study|Adverse Event|0|||
143009387|NCT03417102|515571280|FG001|Overall Study|Adverse Event|1|||
143009388|NCT03417102|515571279|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
143009389|NCT03417102|515571280|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
143009390|NCT03417102|515571279|FG000|Overall Study|Other|0|||
143009391|NCT03417102|515571280|FG001|Overall Study|Other|1|||
143009392|NCT02062385|515571281|FG000|Overall Study|Adverse Event|19|||
143009393|NCT02062385|515571282|FG001|Overall Study|Adverse Event|13|||
143009394|NCT02062385|515571283|FG002|Overall Study|Adverse Event|1|||
143009395|NCT02062385|515571284|FG003|Overall Study|Adverse Event|0|||
143009396|NCT02062385|515571281|FG000|Overall Study|Protocol Violation|1|||
143009397|NCT02062385|515571282|FG001|Overall Study|Protocol Violation|0|||
143009398|NCT02062385|515571283|FG002|Overall Study|Protocol Violation|0|||
143009399|NCT02062385|515571284|FG003|Overall Study|Protocol Violation|0|||
143009400|NCT02062385|515571281|FG000|Overall Study|Incomplete EPI by database lock|2|||
143009401|NCT02062385|515571282|FG001|Overall Study|Incomplete EPI by database lock|0|||
143009402|NCT02062385|515571283|FG002|Overall Study|Incomplete EPI by database lock|0|||
143009403|NCT02062385|515571284|FG003|Overall Study|Incomplete EPI by database lock|0|||
143009404|NCT02062385|515571281|FG000|Overall Study|Moved|10|||
143009405|NCT02062385|515571282|FG001|Overall Study|Moved|11|||
143009406|NCT02062385|515571283|FG002|Overall Study|Moved|1|||
143009407|NCT02062385|515571284|FG003|Overall Study|Moved|0|||
143009408|NCT02062385|515571281|FG000|Overall Study|Withdrawn by parent/guardian|46|||
143009409|NCT02062385|515571282|FG001|Overall Study|Withdrawn by parent/guardian|41|||
143009410|NCT02062385|515571283|FG002|Overall Study|Withdrawn by parent/guardian|9|||
143009411|NCT02062385|515571284|FG003|Overall Study|Withdrawn by parent/guardian|8|||
143009412|NCT02062385|515571281|FG000|Overall Study|Death|0|||
143009413|NCT02062385|515571282|FG001|Overall Study|Death|0|||
143009414|NCT02062385|515571283|FG002|Overall Study|Death|0|||
143346442|NCT02247804|516814338|FG002|Treatment Period 1|Adverse Event|0|||
143346443|NCT02247804|516814336|FG000|Treatment Period 1|Lack of Efficacy|0|||
143346444|NCT02247804|516814337|FG001|Treatment Period 1|Lack of Efficacy|0|||
143346445|NCT02247804|516814338|FG002|Treatment Period 1|Lack of Efficacy|2|||
143346446|NCT02247804|516814336|FG000|Treatment Period 1|Lost to Follow-up|1|||
143346447|NCT02247804|516814337|FG001|Treatment Period 1|Lost to Follow-up|0|||
143346448|NCT02247804|516814338|FG002|Treatment Period 1|Lost to Follow-up|2|||
143346449|NCT02247804|516814336|FG000|Treatment Period 1|Personal Reasons|7|||
143346450|NCT02247804|516814337|FG001|Treatment Period 1|Personal Reasons|1|||
143346451|NCT02247804|516814338|FG002|Treatment Period 1|Personal Reasons|2|||
143346452|NCT02247804|516814336|FG000|Treatment Period 1|Protocol Deviation|0|||
143346453|NCT02247804|516814337|FG001|Treatment Period 1|Protocol Deviation|0|||
143346454|NCT02247804|516814338|FG002|Treatment Period 1|Protocol Deviation|1|||
143346455|NCT02247804|516814336|FG000|Treatment Period 1|Randomized but not Treated|5|||
143346456|NCT02247804|516814337|FG001|Treatment Period 1|Randomized but not Treated|1|||
143346457|NCT02247804|516814338|FG002|Treatment Period 1|Randomized but not Treated|1|||
143346458|NCT02247804|516814336|FG000|Treatment Period 2|Adverse Event|6|||
143346459|NCT02247804|516814337|FG001|Treatment Period 2|Adverse Event|3|||
143346460|NCT02247804|516814338|FG002|Treatment Period 2|Adverse Event|3|||
143346461|NCT02247804|516814336|FG000|Treatment Period 2|Lack of Efficacy|0|||
143346462|NCT02247804|516814337|FG001|Treatment Period 2|Lack of Efficacy|0|||
143346463|NCT02247804|516814338|FG002|Treatment Period 2|Lack of Efficacy|1|||
143346464|NCT02247804|516814336|FG000|Treatment Period 2|Lost to Follow-up|0|||
143346465|NCT02247804|516814337|FG001|Treatment Period 2|Lost to Follow-up|1|||
143346466|NCT02247804|516814338|FG002|Treatment Period 2|Lost to Follow-up|1|||
143346467|NCT02247804|516814336|FG000|Treatment Period 2|Personal Reasons|2|||
143346468|NCT02247804|516814337|FG001|Treatment Period 2|Personal Reasons|1|||
143346469|NCT02247804|516814338|FG002|Treatment Period 2|Personal Reasons|1|||
143346470|NCT02247804|516814336|FG000|Treatment Period 2|Reason not Specified|0|||
143346471|NCT02247804|516814337|FG001|Treatment Period 2|Reason not Specified|0|||
143346472|NCT02247804|516814338|FG002|Treatment Period 2|Reason not Specified|2|||
143346473|NCT02247804|516814336|FG000|Treatment Period 3|Adverse Event|4|||
143346474|NCT02247804|516814337|FG001|Treatment Period 3|Adverse Event|3|||
143346475|NCT02247804|516814338|FG002|Treatment Period 3|Adverse Event|3|||
143346476|NCT02247804|516814336|FG000|Treatment Period 3|Lack of Efficacy|0|||
143346477|NCT02247804|516814337|FG001|Treatment Period 3|Lack of Efficacy|1|||
143346478|NCT02247804|516814338|FG002|Treatment Period 3|Lack of Efficacy|0|||
143346479|NCT02247804|516814336|FG000|Treatment Period 3|Lost to Follow-up|1|||
143346480|NCT02247804|516814337|FG001|Treatment Period 3|Lost to Follow-up|2|||
143346481|NCT02247804|516814338|FG002|Treatment Period 3|Lost to Follow-up|2|||
143346482|NCT02247804|516814336|FG000|Treatment Period 3|Personal Reasons|4|||
143346483|NCT02247804|516814337|FG001|Treatment Period 3|Personal Reasons|3|||
143346484|NCT02247804|516814338|FG002|Treatment Period 3|Personal Reasons|2|||
143346485|NCT02247804|516814336|FG000|Treatment Period 3|Reason not Specified|2|||
143346486|NCT02247804|516814337|FG001|Treatment Period 3|Reason not Specified|1|||
143346487|NCT02247804|516814338|FG002|Treatment Period 3|Reason not Specified|3|||
143346488|NCT03447730|516814343|FG000|Overall Study|Adverse Event|0|||
143346489|NCT03447730|516814344|FG001|Overall Study|Adverse Event|2|||
143346490|NCT03447730|516814345|FG002|Overall Study|Adverse Event|0|||
143346491|NCT01350505|516814349|FG000|Overall Study|Lost to Follow-up|4|||
143346492|NCT04251065|516814350|FG000|Overall Study|Death|2|||
143346493|NCT04251065|516814350|FG000|Overall Study|Lack of Efficacy|3|||
143346494|NCT04251065|516814350|FG000|Overall Study|Death|1|||
143346495|NCT05266963|516814351|FG000|Drug Period A|Withdrawal by Subject|0|||
143346496|NCT05266963|516814352|FG001|Drug Period A|Withdrawal by Subject|1|||
143346497|NCT03812536|516814353|FG000|Overall Study|Protocol Violation|2|||
143346498|NCT03812536|516814354|FG001|Overall Study|Protocol Violation|0|||
143346499|NCT03812536|516814353|FG000|Overall Study|Withdrawal by Subject|1|||
143346500|NCT03812536|516814354|FG001|Overall Study|Withdrawal by Subject|1|||
143346501|NCT00152009|516814355|FG000|Overall Study|Adverse Event|9|||
143346502|NCT00152009|516814356|FG001|Overall Study|Adverse Event|13|||
143346503|NCT00152009|516814357|FG002|Overall Study|Adverse Event|20|||
143346504|NCT00152009|516814358|FG003|Overall Study|Adverse Event|1|||
143346505|NCT00152009|516814355|FG000|Overall Study|Protocol Violation|3|||
143346506|NCT00152009|516814356|FG001|Overall Study|Protocol Violation|0|||
143346507|NCT00152009|516814357|FG002|Overall Study|Protocol Violation|0|||
143346508|NCT00152009|516814358|FG003|Overall Study|Protocol Violation|1|||
143346509|NCT00152009|516814355|FG000|Overall Study|Withdrawal by Subject|2|||
143346510|NCT00152009|516814356|FG001|Overall Study|Withdrawal by Subject|3|||
143346511|NCT00152009|516814357|FG002|Overall Study|Withdrawal by Subject|4|||
143346512|NCT00152009|516814358|FG003|Overall Study|Withdrawal by Subject|9|||
143346513|NCT00152009|516814355|FG000|Overall Study|Lost to Follow-up|2|||
143346514|NCT00152009|516814356|FG001|Overall Study|Lost to Follow-up|4|||
143346515|NCT00152009|516814357|FG002|Overall Study|Lost to Follow-up|3|||
143346516|NCT00152009|516814358|FG003|Overall Study|Lost to Follow-up|3|||
143346517|NCT00152009|516814355|FG000|Overall Study|Lack of Efficacy|8|||
143346518|NCT00152009|516814356|FG001|Overall Study|Lack of Efficacy|6|||
143346519|NCT00152009|516814357|FG002|Overall Study|Lack of Efficacy|7|||
143346520|NCT00152009|516814358|FG003|Overall Study|Lack of Efficacy|15|||
143346521|NCT00152009|516814355|FG000|Overall Study|ECG abnormalities|2|||
143346522|NCT00152009|516814356|FG001|Overall Study|ECG abnormalities|2|||
143346523|NCT00152009|516814357|FG002|Overall Study|ECG abnormalities|2|||
143346524|NCT00152009|516814358|FG003|Overall Study|ECG abnormalities|1|||
143346525|NCT00152009|516814355|FG000|Overall Study|Sponsor's decision|3|||
143346526|NCT00152009|516814356|FG001|Overall Study|Sponsor's decision|3|||
143346527|NCT00152009|516814357|FG002|Overall Study|Sponsor's decision|1|||
143346528|NCT00152009|516814358|FG003|Overall Study|Sponsor's decision|3|||
143346529|NCT04091360|516814359|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
143346530|NCT04091360|516814360|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
143346531|NCT04091360|516814361|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
143346532|NCT04091360|516814362|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
143346533|NCT04091360|516814363|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
143346534|NCT04091360|516814364|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
143346535|NCT04091360|516814365|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
143346536|NCT04091360|516814366|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
143346537|NCT04091360|516814367|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
143346538|NCT04091360|516814368|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
143346539|NCT04091360|516814359|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
143346540|NCT04091360|516814360|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
143346541|NCT04091360|516814361|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
143346542|NCT04091360|516814362|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
143346543|NCT04091360|516814363|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
143346544|NCT04091360|516814364|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
143346545|NCT04091360|516814365|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
143346546|NCT04091360|516814366|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
143346547|NCT04091360|516814367|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
143346548|NCT04091360|516814368|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
143346549|NCT04091360|516814359|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
143346550|NCT04091360|516814360|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
143346551|NCT04091360|516814361|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
143346552|NCT04091360|516814362|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
143346553|NCT04091360|516814363|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
143346554|NCT04091360|516814364|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
143346555|NCT04091360|516814365|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
143346556|NCT04091360|516814366|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
143346557|NCT04091360|516814367|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
143346558|NCT04091360|516814368|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
143346559|NCT02597933|516814371|FG000|Overall Study|Withdrawal by Subject|7|||
143346560|NCT02597933|516814372|FG001|Overall Study|Withdrawal by Subject|5|||
143346561|NCT02597933|516814371|FG000|Overall Study|Protocol Violation|2|||
143346562|NCT02597933|516814372|FG001|Overall Study|Protocol Violation|2|||
143346563|NCT02597933|516814371|FG000|Overall Study|Adverse Event|20|||
143346564|NCT02597933|516814372|FG001|Overall Study|Adverse Event|28|||
143346565|NCT02597933|516814371|FG000|Overall Study|Not treated|2|||
143346566|NCT02597933|516814372|FG001|Overall Study|Not treated|2|||
143346567|NCT02597933|516814371|FG000|Overall Study|Other than stated above|7|||
143346568|NCT02597933|516814372|FG001|Overall Study|Other than stated above|14|||
143346569|NCT04145037|516814373|FG000|Overall Study|Study terminated|2|||
143346570|NCT04145037|516814374|FG001|Overall Study|Study terminated|0|||
143346571|NCT04145037|516814373|FG000|Overall Study|Withdrawal by Subject|1|||
143346572|NCT04145037|516814374|FG001|Overall Study|Withdrawal by Subject|0|||
143346573|NCT04145037|516814373|FG000|Overall Study|Lost to Follow-up|1|||
143346574|NCT04145037|516814374|FG001|Overall Study|Lost to Follow-up|0|||
143346575|NCT00744263|516814379|FG000|Overall Study|Death|3006|||
143346576|NCT00744263|516814380|FG001|Overall Study|Death|3005|||
143346577|NCT00744263|516814379|FG000|Overall Study|Lost to Follow-up|2038|||
143346578|NCT00744263|516814380|FG001|Overall Study|Lost to Follow-up|2135|||
143346579|NCT00744263|516814379|FG000|Overall Study|Withdrawal by Subject|166|||
143346580|NCT00744263|516814380|FG001|Overall Study|Withdrawal by Subject|150|||
143346581|NCT00744263|516814379|FG000|Overall Study|Physician Decision|20|||
143346582|NCT00744263|516814380|FG001|Overall Study|Physician Decision|23|||
143346583|NCT00744263|516814379|FG000|Overall Study|Protocol Violation|3|||
143346584|NCT00744263|516814380|FG001|Overall Study|Protocol Violation|5|||
143346585|NCT00744263|516814379|FG000|Overall Study|Adverse Event|1|||
143346586|NCT00744263|516814380|FG001|Overall Study|Adverse Event|0|||
143346587|NCT00744263|516814379|FG000|Overall Study|Other|2|||
143346588|NCT00744263|516814380|FG001|Overall Study|Other|2|||
143346589|NCT01013792|516814382|FG000|Overall Study|Study suspended|2|||
143346590|NCT01013792|516814383|FG001|Overall Study|Study suspended|1|||
143346591|NCT01013792|516814382|FG000|Overall Study|Adverse Event|0|||
143346592|NCT01013792|516814383|FG001|Overall Study|Adverse Event|3|||
143346593|NCT01013792|516814382|FG000|Overall Study|Lost to Follow-up|0|||
143346594|NCT01013792|516814383|FG001|Overall Study|Lost to Follow-up|1|||
143346595|NCT03500640|516814388|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
143346596|NCT03500640|516814389|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
143346597|NCT03500640|516814390|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
143346598|NCT03500640|516814388|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
143346599|NCT03500640|516814389|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
143346600|NCT03500640|516814390|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
143346601|NCT03500640|516814388|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
143346602|NCT03500640|516814389|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
143346603|NCT03500640|516814390|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
143346604|NCT03500640|516814388|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
143346605|NCT03500640|516814389|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
143346606|NCT03500640|516814390|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
143346607|NCT03500640|516814388|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
143346608|NCT03500640|516814389|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
143346609|NCT03500640|516814390|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
143346610|NCT03500640|516814388|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
143346611|NCT03500640|516814389|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
143346612|NCT03500640|516814390|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
143346613|NCT03500640|516814388|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
143346614|NCT03500640|516814389|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
143346615|NCT03500640|516814390|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
143346616|NCT03500640|516814388|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
143346617|NCT03500640|516814389|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
143346618|NCT03500640|516814390|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
143346619|NCT03500640|516814388|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
143346620|NCT03500640|516814389|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
143346621|NCT03500640|516814390|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
143346622|NCT03500640|516814388|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
143346623|NCT03500640|516814389|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
143346624|NCT03500640|516814390|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
143346625|NCT02954458|516814391|FG000|Overall Study|Adverse Event|0|||
143346626|NCT02954458|516814392|FG001|Overall Study|Adverse Event|0|||
143346627|NCT02954458|516814393|FG002|Overall Study|Adverse Event|0|||
143346628|NCT02954458|516814394|FG003|Overall Study|Adverse Event|1|||
143346629|NCT02954458|516814391|FG000|Overall Study|Withdrawal by Subject|0|||
143346630|NCT02954458|516814392|FG001|Overall Study|Withdrawal by Subject|0|||
143346631|NCT02954458|516814393|FG002|Overall Study|Withdrawal by Subject|0|||
143346632|NCT02954458|516814394|FG003|Overall Study|Withdrawal by Subject|1|||
143346633|NCT02954458|516814391|FG000|Overall Study|Physician Decision|0|||
143346634|NCT02954458|516814392|FG001|Overall Study|Physician Decision|0|||
143346635|NCT02954458|516814393|FG002|Overall Study|Physician Decision|1|||
143346636|NCT02954458|516814394|FG003|Overall Study|Physician Decision|1|||
143346637|NCT02954458|516814391|FG000|Overall Study|Lost to Follow-up|1|||
143346638|NCT02954458|516814392|FG001|Overall Study|Lost to Follow-up|0|||
143346639|NCT02954458|516814393|FG002|Overall Study|Lost to Follow-up|0|||
143346640|NCT02954458|516814394|FG003|Overall Study|Lost to Follow-up|1|||
143346641|NCT02954458|516814391|FG000|Overall Study|Death|0|||
143346642|NCT02954458|516814392|FG001|Overall Study|Death|0|||
143346643|NCT02954458|516814393|FG002|Overall Study|Death|0|||
143346644|NCT02954458|516814394|FG003|Overall Study|Death|1|||
143346645|NCT02954458|516814391|FG000|Overall Study|Other|0|||
143346646|NCT02954458|516814392|FG001|Overall Study|Other|0|||
143346647|NCT02954458|516814393|FG002|Overall Study|Other|0|||
143346648|NCT02954458|516814394|FG003|Overall Study|Other|7|||
143346649|NCT03929562|516814397|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
143346650|NCT03929562|516814398|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
143346651|NCT03929562|516814397|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
143346652|NCT03929562|516814398|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
143009415|NCT02062385|515571284|FG003|Overall Study|Death|1|||
143346653|NCT03929562|516814397|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
143346654|NCT03929562|516814398|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
143346655|NCT01778556|516814399|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
143346656|NCT01778556|516814400|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
143346657|NCT01778556|516814399|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
143346658|NCT01778556|516814400|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
143346659|NCT01778556|516814399|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
143346660|NCT01778556|516814400|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
143009416|NCT02062385|515571281|FG000|Overall Study|Lost to Follow-up|0|||
143346661|NCT01778556|516814399|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
143346662|NCT01778556|516814400|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
143346663|NCT00265330|516814401|FG000|Overall Study|Adverse Event|41|||
143346664|NCT00265330|516814401|FG000|Overall Study|Lost to Follow-up|8|||
143346665|NCT00265330|516814401|FG000|Overall Study|Withdrawal by Subject|34|||
143346666|NCT00265330|516814401|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
143346667|NCT00265330|516814401|FG000|Overall Study|Lack of Efficacy|4|||
143346668|NCT00265330|516814401|FG000|Overall Study|Family Scheduling Conflicts|1|||
143346669|NCT00265330|516814401|FG000|Overall Study|Began Taking Formulary Geodon|1|||
143346670|NCT00265330|516814401|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
143346671|NCT00265330|516814401|FG000|Overall Study|Site Closed by Sponsor|1|||
143346672|NCT00265330|516814401|FG000|Overall Study|Principal Investigators Request|1|||
143346673|NCT00265330|516814401|FG000|Overall Study|Withdrew Consent|1|||
143346674|NCT00265330|516814401|FG000|Overall Study|Protocol Violation|1|||
143346675|NCT03403426|516814408|FG000|Overall Study|Death|1|||
143346676|NCT03403426|516814408|FG000|Overall Study|Lost to Follow-up|2|||
143346677|NCT01657266|516814410|FG000|Overall Study|Lost to Follow-up|2|||
143346678|NCT01657266|516814411|FG001|Overall Study|Lost to Follow-up|2|||
143346679|NCT01657266|516814410|FG000|Overall Study|Adverse Event|2|||
143346680|NCT01657266|516814411|FG001|Overall Study|Adverse Event|3|||
143346681|NCT00736489|516814414|FG000|Period 1|Lost to Follow-up|1|||
143346682|NCT00736489|516814415|FG001|Period 1|Lost to Follow-up|0|||
143346683|NCT00736489|516814416|FG002|Period 1|Lost to Follow-up|0|||
143346684|NCT00736489|516814417|FG003|Period 1|Lost to Follow-up|0|||
143346685|NCT00736489|516814418|FG004|Period 1|Lost to Follow-up|0|||
143346686|NCT00736489|516814419|FG005|Period 1|Lost to Follow-up|0|||
143346687|NCT00736489|516814414|FG000|Period 1|Withdrawal by Subject|0|||
143346688|NCT00736489|516814415|FG001|Period 1|Withdrawal by Subject|0|||
143346689|NCT00736489|516814416|FG002|Period 1|Withdrawal by Subject|0|||
143346690|NCT00736489|516814417|FG003|Period 1|Withdrawal by Subject|0|||
143346691|NCT00736489|516814418|FG004|Period 1|Withdrawal by Subject|0|||
143346692|NCT00736489|516814419|FG005|Period 1|Withdrawal by Subject|1|||
143346693|NCT01125722|516814420|FG000|Overall Study|Withdrawal by Subject|2|||
143346694|NCT01125722|516814421|FG001|Overall Study|Withdrawal by Subject|1|||
143346695|NCT01125722|516814420|FG000|Overall Study|Lost to Follow-up|1|||
143346696|NCT01125722|516814421|FG001|Overall Study|Lost to Follow-up|0|||
143346697|NCT01555164|516814428|FG000|Overall Study|Adverse Event|5|||
143346698|NCT01555164|516814429|FG001|Overall Study|Adverse Event|7|||
143346699|NCT01555164|516814428|FG000|Overall Study|Hyperglycemia|0|||
143346700|NCT01555164|516814429|FG001|Overall Study|Hyperglycemia|1|||
143346701|NCT01555164|516814428|FG000|Overall Study|Investigator's Discretion|2|||
143346702|NCT01555164|516814429|FG001|Overall Study|Investigator's Discretion|2|||
143346703|NCT01555164|516814428|FG000|Overall Study|Lost to Follow-up|4|||
143346704|NCT01555164|516814429|FG001|Overall Study|Lost to Follow-up|3|||
143346705|NCT01555164|516814428|FG000|Overall Study|Protocol Violation|9|||
143346706|NCT01555164|516814429|FG001|Overall Study|Protocol Violation|5|||
143346707|NCT01555164|516814428|FG000|Overall Study|Subject Non-compliance|14|||
143346708|NCT01555164|516814429|FG001|Overall Study|Subject Non-compliance|6|||
143346709|NCT01555164|516814428|FG000|Overall Study|Subject Withdrew Consent|6|||
143346710|NCT01555164|516814429|FG001|Overall Study|Subject Withdrew Consent|11|||
143346711|NCT00524030|516814432|FG000|Overall Study|Lack of Efficacy|10|||
143346712|NCT00524030|516814433|FG001|Overall Study|Lack of Efficacy|24|||
143346713|NCT00524030|516814432|FG000|Overall Study|Lost to Follow-up|0|||
143346714|NCT00524030|516814433|FG001|Overall Study|Lost to Follow-up|2|||
143346715|NCT00524030|516814432|FG000|Overall Study|Withdrawal by Subject|3|||
143346716|NCT00524030|516814433|FG001|Overall Study|Withdrawal by Subject|8|||
143009417|NCT02062385|515571282|FG001|Overall Study|Lost to Follow-up|0|||
143009418|NCT02062385|515571283|FG002|Overall Study|Lost to Follow-up|1|||
143009419|NCT02062385|515571284|FG003|Overall Study|Lost to Follow-up|0|||
143009420|NCT03188991|515571285|FG000|Overall Study|Withdrawal by Subject|0|||
143009421|NCT03188991|515571286|FG001|Overall Study|Withdrawal by Subject|0|||
143009422|NCT03188991|515571287|FG002|Overall Study|Withdrawal by Subject|0|||
143009423|NCT03188991|515571288|FG003|Overall Study|Withdrawal by Subject|1|||
143009424|NCT03222856|515571293|FG000|Overall Study|Adverse Event|6|||
143009425|NCT03222856|515571293|FG000|Overall Study|Death|1|||
143346717|NCT00524030|516814432|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
143346718|NCT00524030|516814433|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
143346719|NCT00524030|516814432|FG000|Overall Study|Protocol Violation|0|||
143346720|NCT00524030|516814433|FG001|Overall Study|Protocol Violation|1|||
143346721|NCT00524030|516814432|FG000|Overall Study|Pregnancy|1|||
143346722|NCT00524030|516814433|FG001|Overall Study|Pregnancy|0|||
143346723|NCT00524030|516814432|FG000|Overall Study|Adverse Event|3|||
143346724|NCT00524030|516814433|FG001|Overall Study|Adverse Event|21|||
143346725|NCT00524030|516814432|FG000|Overall Study|Death|0|||
143346726|NCT00524030|516814433|FG001|Overall Study|Death|1|||
143346727|NCT01590771|516816700|FG000|Overall Study|Other Protocol Specified Criteria|5|||
143346728|NCT01590771|516816701|FG001|Overall Study|Other Protocol Specified Criteria|14|||
143346729|NCT01590771|516816700|FG000|Overall Study|Withdrawal by Subject|8|||
143346730|NCT01590771|516816701|FG001|Overall Study|Withdrawal by Subject|15|||
143346731|NCT01590771|516816700|FG000|Overall Study|Protocol Violation|1|||
143346732|NCT01590771|516816701|FG001|Overall Study|Protocol Violation|2|||
143346733|NCT01590771|516816700|FG000|Overall Study|Lost to Follow-up|1|||
143346734|NCT01590771|516816701|FG001|Overall Study|Lost to Follow-up|1|||
143346735|NCT01590771|516816700|FG000|Overall Study|Lack of Efficacy|1|||
143346736|NCT01590771|516816701|FG001|Overall Study|Lack of Efficacy|0|||
143346737|NCT01590771|516816700|FG000|Overall Study|Adverse Event|3|||
143346738|NCT01590771|516816701|FG001|Overall Study|Adverse Event|7|||
143346739|NCT01785628|516816702|FG000|Overall Study|Lost to Follow-up|2|||
143346740|NCT01785628|516816703|FG001|Overall Study|Lost to Follow-up|3|||
143346741|NCT02200939|516816704|FG000|Overall Study|Participant withdrew consent|0|||
143346742|NCT02200939|516816705|FG001|Overall Study|Participant withdrew consent|1|||
143346743|NCT02200939|516816704|FG000|Overall Study|Lost to Follow-up|2|||
143346744|NCT02200939|516816705|FG001|Overall Study|Lost to Follow-up|9|||
143346745|NCT02200939|516816704|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
143346746|NCT02200939|516816705|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
143346747|NCT02746575|516816706|FG000|Overall Study|Surgery cancelled or time chaned|13|||
143346748|NCT02746575|516816706|FG000|Overall Study|Received epidural|10|||
143346749|NCT02746575|516816706|FG000|Overall Study|Withdrawal by Subject|3|||
143346750|NCT02746575|516816706|FG000|Overall Study|Bradycardia/hypotension|9|||
143346751|NCT02746575|516816706|FG000|Overall Study|Study paused|8|||
143346752|NCT02746575|516816706|FG000|Overall Study|put on beta-blocker|3|||
143346753|NCT02746575|516816706|FG000|Overall Study|type of surgery|1|||
143346754|NCT02746575|516816706|FG000|Overall Study|typ of surgery|1|||
143346755|NCT02746575|516816706|FG000|Overall Study|PI unavailable|1|||
143346756|NCT02746575|516816706|FG000|Overall Study|Unknown history of CVA|1|||
143346757|NCT04567693|516816707|FG000|Overall Study|Death|0|||
143346758|NCT04567693|516816708|FG001|Overall Study|Death|0|||
143346759|NCT04567693|516816709|FG002|Overall Study|Death|2|||
143346760|NCT04567693|516816707|FG000|Overall Study|Lost to Follow-up|1|||
143346761|NCT04567693|516816708|FG001|Overall Study|Lost to Follow-up|0|||
143346762|NCT04567693|516816709|FG002|Overall Study|Lost to Follow-up|2|||
143346763|NCT04567693|516816707|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
143346764|NCT04567693|516816708|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
143346765|NCT04567693|516816709|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
143346766|NCT00976482|516816712|FG000|Overall Study|Death|208|||
143346767|NCT00976482|516816712|FG000|Overall Study|Withdrawal by Subject|45|||
143346768|NCT00976482|516816712|FG000|Overall Study|Center terminated|1|||
143346769|NCT00976482|516816712|FG000|Overall Study|Protocol Violation|5|||
143346770|NCT03722264|516816715|FG000|Overall Study|Physician Decision|3|||
143346771|NCT00720902|516816716|FG000|Overall Study|Withdrawal by Subject|1|||
143346772|NCT00720902|516816717|FG001|Overall Study|Withdrawal by Subject|0|||
143346773|NCT00720902|516816716|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
143346774|NCT00720902|516816717|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
143346775|NCT01486758|516816718|FG000|Overall Study|Lost to Follow-up|0|||
143346776|NCT01486758|516816719|FG001|Overall Study|Lost to Follow-up|1|||
143346777|NCT02959671|516816720|FG000|Overall Study|Adverse Event|2|||
143346778|NCT02959671|516816720|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
143346779|NCT03239873|516816731|FG000|Overall Study|Lost to Follow-up|15|||
143346780|NCT03239873|516816732|FG001|Overall Study|Lost to Follow-up|16|||
143346781|NCT03239873|516816731|FG000|Overall Study|Physician Decision|1|||
143346782|NCT03239873|516816732|FG001|Overall Study|Physician Decision|0|||
143346783|NCT03239873|516816731|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
143346784|NCT03239873|516816732|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
143346785|NCT03239873|516816731|FG000|Overall Study|Withdrawal by Subject|2|||
143346786|NCT03239873|516816732|FG001|Overall Study|Withdrawal by Subject|0|||
143346787|NCT03239873|516816731|FG000|Overall Study|Contraindication to study medication|1|||
143346788|NCT03239873|516816732|FG001|Overall Study|Contraindication to study medication|0|||
143346789|NCT03239873|516816731|FG000|Overall Study|Protocol Violation|1|||
143346790|NCT03239873|516816732|FG001|Overall Study|Protocol Violation|0|||
143346791|NCT01161472|516816734|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
143346792|NCT01161472|516816735|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
143346793|NCT01161472|516816736|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
143346794|NCT01161472|516816737|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
143346795|NCT00798174|516816739|FG000|Overall Study|inability to implant azygos coil|3|||
143346796|NCT00798174|516816740|FG001|Overall Study|inability to implant azygos coil|3|||
143346797|NCT00798174|516816739|FG000|Overall Study|Inability to sedate for DFT testing|1|||
143346798|NCT00798174|516816740|FG001|Overall Study|Inability to sedate for DFT testing|0|||
143346799|NCT01478113|516816745|FG000|Overall Study|Withdrawal by Subject|0|||
143346800|NCT01478113|516816746|FG001|Overall Study|Withdrawal by Subject|1|||
143346801|NCT01478113|516816745|FG000|Overall Study|Physician Decision|1|||
143346802|NCT01478113|516816746|FG001|Overall Study|Physician Decision|0|||
143009426|NCT00464308|515572801|FG000|Overall Study|Adverse Event|22|||
143009427|NCT00464308|515572802|FG001|Overall Study|Adverse Event|27|||
143009428|NCT00464308|515572803|FG002|Overall Study|Adverse Event|16|||
143009429|NCT00464308|515572801|FG000|Overall Study|Lost to Follow-up|29|||
143009430|NCT00464308|515572802|FG001|Overall Study|Lost to Follow-up|19|||
143009431|NCT00464308|515572803|FG002|Overall Study|Lost to Follow-up|20|||
143009432|NCT00464308|515572801|FG000|Overall Study|Patient discontinued and other reasons|17|||
143009433|NCT00464308|515572802|FG001|Overall Study|Patient discontinued and other reasons|17|||
143009434|NCT00464308|515572803|FG002|Overall Study|Patient discontinued and other reasons|23|||
143009435|NCT00464308|515572801|FG000|Overall Study|Physician Decision|1|||
143009436|NCT00464308|515572802|FG001|Overall Study|Physician Decision|0|||
143009437|NCT00464308|515572803|FG002|Overall Study|Physician Decision|0|||
143009438|NCT01513759|515572804|FG000|Overall Study|Protocol Violation|4|||
143009439|NCT01513759|515572804|FG000|Overall Study|Death during catheter placement|1|||
143009440|NCT00826176|515572809|FG000|Overall Study|Lost to Follow-up|1|||
143009441|NCT00826176|515572810|FG001|Overall Study|Lost to Follow-up|0|||
143009442|NCT00826176|515572809|FG000|Overall Study|Subject Withdrew Consent|3|||
143009443|NCT00826176|515572810|FG001|Overall Study|Subject Withdrew Consent|0|||
143009444|NCT00826176|515572809|FG000|Overall Study|Administrative|9|||
143009445|NCT00826176|515572810|FG001|Overall Study|Administrative|0|||
143009446|NCT04484805|515572826|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
143009447|NCT04484805|515572827|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
143009448|NCT04484805|515572826|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
143009449|NCT04484805|515572827|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
143009450|NCT02116309|515572828|FG000|Overall Study|Lost to Follow-up|0|||
143009451|NCT02116309|515572829|FG001|Overall Study|Lost to Follow-up|1|||
143009452|NCT01301625|515572833|FG000|Overall Study|Death|5|||
143009453|NCT01301625|515572833|FG000|Overall Study|Not Due|21|||
143009454|NCT01301625|515572833|FG000|Overall Study|Expected|8|||
143009455|NCT01301625|515572833|FG000|Overall Study|Lost to Follow-up|1|||
143009456|NCT03237325|515572836|FG000|Overall Study|Lost to Follow-up|3|||
143009457|NCT03237325|515572837|FG001|Overall Study|Lost to Follow-up|5|||
143009458|NCT03237325|515572836|FG000|Overall Study|Physician Decision|2|||
143009459|NCT03237325|515572837|FG001|Overall Study|Physician Decision|4|||
143009460|NCT03237325|515572836|FG000|Overall Study|Withdrawal by Subject|9|||
143009461|NCT03237325|515572837|FG001|Overall Study|Withdrawal by Subject|12|||
143009462|NCT03237325|515572836|FG000|Overall Study|Noncompliance with Study Procedures|1|||
143009463|NCT03237325|515572837|FG001|Overall Study|Noncompliance with Study Procedures|1|||
143009464|NCT03237325|515572836|FG000|Overall Study|Termination by Sponsor|0|||
143009465|NCT03237325|515572837|FG001|Overall Study|Termination by Sponsor|1|||
143009466|NCT03237325|515572836|FG000|Overall Study|Reason other than described|0|||
143009467|NCT03237325|515572837|FG001|Overall Study|Reason other than described|2|||
143009468|NCT02684370|515572838|FG000|Part A|Adverse Event|2|||
143009469|NCT02684370|515572839|FG001|Part A|Adverse Event|0|||
143009470|NCT02684370|515572840|FG002|Part A|Adverse Event|1|||
143009471|NCT02684370|515572841|FG003|Part A|Adverse Event|0|||
143009472|NCT02684370|515572842|FG004|Part A|Adverse Event|0|||
143009473|NCT02684370|515572843|FG005|Part A|Adverse Event|0|||
143009474|NCT02684370|515572838|FG000|Part A|Lost to Follow-up|1|||
143009475|NCT02684370|515572839|FG001|Part A|Lost to Follow-up|1|||
143009476|NCT02684370|515572840|FG002|Part A|Lost to Follow-up|0|||
143009477|NCT02684370|515572841|FG003|Part A|Lost to Follow-up|0|||
143009478|NCT02684370|515572842|FG004|Part A|Lost to Follow-up|0|||
143009479|NCT02684370|515572843|FG005|Part A|Lost to Follow-up|0|||
143009480|NCT02684370|515572838|FG000|Part A|Subject Withdrawal|1|||
143009481|NCT02684370|515572839|FG001|Part A|Subject Withdrawal|0|||
143009482|NCT02684370|515572840|FG002|Part A|Subject Withdrawal|3|||
143009483|NCT02684370|515572841|FG003|Part A|Subject Withdrawal|0|||
143009484|NCT02684370|515572842|FG004|Part A|Subject Withdrawal|0|||
143009485|NCT02684370|515572843|FG005|Part A|Subject Withdrawal|0|||
143009486|NCT02684370|515572838|FG000|Part A|Other|0|||
143009487|NCT02684370|515572839|FG001|Part A|Other|0|||
143346803|NCT01454830|516816747|FG000|Overall Study|Withdrawal by Subject|4|||
143009488|NCT02684370|515572840|FG002|Part A|Other|1|||
143346804|NCT01454830|516816748|FG001|Overall Study|Withdrawal by Subject|4|||
143009489|NCT02684370|515572841|FG003|Part A|Other|0|||
143009490|NCT02684370|515572842|FG004|Part A|Other|0|||
143009491|NCT02684370|515572843|FG005|Part A|Other|0|||
143009492|NCT02684370|515572838|FG000|Part B|Adverse Event|0|||
143009493|NCT02684370|515572839|FG001|Part B|Adverse Event|0|||
143009494|NCT02684370|515572840|FG002|Part B|Adverse Event|0|||
143009495|NCT02684370|515572841|FG003|Part B|Adverse Event|0|||
143009496|NCT02684370|515572842|FG004|Part B|Adverse Event|2|||
143009497|NCT02684370|515572843|FG005|Part B|Adverse Event|1|||
143009498|NCT02684370|515572838|FG000|Part B|Lost to Follow-up|0|||
143009499|NCT02684370|515572839|FG001|Part B|Lost to Follow-up|0|||
143009500|NCT02684370|515572840|FG002|Part B|Lost to Follow-up|0|||
143009501|NCT02684370|515572841|FG003|Part B|Lost to Follow-up|1|||
143009502|NCT02684370|515572842|FG004|Part B|Lost to Follow-up|2|||
143461346|NCT05559099|517235020|FG000|Overall Study|Lost to Follow-up|0|||
143009503|NCT02684370|515572843|FG005|Part B|Lost to Follow-up|5|||
143009504|NCT02684370|515572838|FG000|Part B|Subject Withdrawal|0|||
143009505|NCT02684370|515572839|FG001|Part B|Subject Withdrawal|0|||
143009506|NCT02684370|515572840|FG002|Part B|Subject Withdrawal|0|||
143009507|NCT02684370|515572841|FG003|Part B|Subject Withdrawal|1|||
143009508|NCT02684370|515572842|FG004|Part B|Subject Withdrawal|1|||
143009509|NCT02684370|515572843|FG005|Part B|Subject Withdrawal|2|||
143009510|NCT04139642|515572852|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
143009511|NCT04139642|515572853|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
143009512|NCT00138658|515572858|FG000|Overall Study|Adverse Event|23|||
143009513|NCT00138658|515572858|FG000|Overall Study|Death|1|||
143009514|NCT00138658|515572858|FG000|Overall Study|Disease Progression|21|||
143009515|NCT00138658|515572858|FG000|Overall Study|Physician Decision|11|||
143009516|NCT00138658|515572858|FG000|Overall Study|Withdrawal by Subject|5|||
143009517|NCT03733301|515572859|FG000|Overall Study|Screen Fail|1|||
143009518|NCT03733301|515572860|FG001|Overall Study|Screen Fail|0|||
143009519|NCT03733301|515572861|FG002|Overall Study|Screen Fail|0|||
143009520|NCT03733301|515572859|FG000|Overall Study|Non-compliance|1|||
143009521|NCT03733301|515572860|FG001|Overall Study|Non-compliance|0|||
143009522|NCT03733301|515572861|FG002|Overall Study|Non-compliance|0|||
143009523|NCT03733301|515572859|FG000|Overall Study|Lack of Efficacy|2|||
143009524|NCT03733301|515572860|FG001|Overall Study|Lack of Efficacy|3|||
143009525|NCT03733301|515572861|FG002|Overall Study|Lack of Efficacy|0|||
143009526|NCT03733301|515572859|FG000|Overall Study|Adverse Event|0|||
143009527|NCT03733301|515572860|FG001|Overall Study|Adverse Event|1|||
143009528|NCT03733301|515572861|FG002|Overall Study|Adverse Event|3|||
143009529|NCT03733301|515572859|FG000|Overall Study|Withdrawal by Subject|3|||
143009530|NCT03733301|515572860|FG001|Overall Study|Withdrawal by Subject|5|||
143009531|NCT03733301|515572861|FG002|Overall Study|Withdrawal by Subject|1|||
143009532|NCT06067191|515572865|FG000|Overall Study|Withdrawal by Subject|0|||
143009533|NCT06067191|515572866|FG001|Overall Study|Withdrawal by Subject|1|||
143009534|NCT01067339|515572869|FG000|Overall Study|Withdrawal by Subject|6|||
143009535|NCT01067339|515572870|FG001|Overall Study|Withdrawal by Subject|5|||
143009536|NCT00769132|515572872|FG000|Period 1|Adverse Event|1|||
143009537|NCT00769132|515572873|FG001|Period 1|Adverse Event|0|||
143009538|NCT00769132|515572874|FG002|Period 1|Adverse Event|0|||
143009539|NCT00769132|515572875|FG003|Period 1|Adverse Event|1|||
143009540|NCT00769132|515572872|FG000|Period 2|Withdrawal by Subject|0|||
143009541|NCT00769132|515572873|FG001|Period 2|Withdrawal by Subject|0|||
143009542|NCT00769132|515572874|FG002|Period 2|Withdrawal by Subject|0|||
143009543|NCT00769132|515572875|FG003|Period 2|Withdrawal by Subject|1|||
143009544|NCT00769132|515572872|FG000|Period 3|Withdrawal by Subject|1|||
143009545|NCT00769132|515572873|FG001|Period 3|Withdrawal by Subject|0|||
143009546|NCT00769132|515572874|FG002|Period 3|Withdrawal by Subject|0|||
143009547|NCT00769132|515572875|FG003|Period 3|Withdrawal by Subject|0|||
143009548|NCT00769132|515572872|FG000|Period 4|Withdrawal by Subject|0|||
143009549|NCT00769132|515572873|FG001|Period 4|Withdrawal by Subject|1|||
143009550|NCT00769132|515572874|FG002|Period 4|Withdrawal by Subject|0|||
143009551|NCT00769132|515572875|FG003|Period 4|Withdrawal by Subject|0|||
143009552|NCT00877799|515572877|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
143009553|NCT00877799|515572878|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
143009554|NCT00877799|515572879|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
143009555|NCT00877799|515572880|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
143009556|NCT00877799|515572881|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
143009557|NCT00877799|515572877|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
143009558|NCT00877799|515572878|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
143009559|NCT00877799|515572879|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
143009560|NCT00877799|515572880|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
143009561|NCT00877799|515572881|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
143009562|NCT00877799|515572877|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
143009563|NCT00877799|515572878|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
143009564|NCT00877799|515572879|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
143009565|NCT00877799|515572880|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
143009566|NCT00877799|515572881|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
143009567|NCT00877799|515572877|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
143009568|NCT00877799|515572878|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
143009569|NCT00877799|515572879|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
143009570|NCT00877799|515572880|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
143009571|NCT00877799|515572881|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
143009572|NCT00877799|515572877|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
143009573|NCT00877799|515572878|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
143009574|NCT00877799|515572879|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
143009575|NCT00877799|515572880|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
143009576|NCT00877799|515572881|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
143009577|NCT01833897|515572882|FG000|Overall Study|Lack of Efficacy|1|||
143009578|NCT02860039|515572883|FG000|Overall Study|Death|4|||
143009579|NCT02860039|515572884|FG001|Overall Study|Death|0|||
143009580|NCT02860039|515572883|FG000|Overall Study|Lost to Follow-up|2|||
143009581|NCT02860039|515572884|FG001|Overall Study|Lost to Follow-up|2|||
143009582|NCT02860039|515572883|FG000|Overall Study|Protocol Violation|3|||
143009583|NCT02860039|515572884|FG001|Overall Study|Protocol Violation|1|||
143009584|NCT02860039|515572883|FG000|Overall Study|Withdrawal by Subject|1|||
143009585|NCT02860039|515572884|FG001|Overall Study|Withdrawal by Subject|0|||
143009586|NCT02860039|515572883|FG000|Overall Study|Not otherwise eligible|1|||
143009587|NCT02860039|515572884|FG001|Overall Study|Not otherwise eligible|1|||
143009588|NCT00127192|515572885|FG000|Overall Study|Adverse Event|0|||
143009589|NCT00127192|515572886|FG001|Overall Study|Adverse Event|1|||
143009590|NCT00127192|515572887|FG002|Overall Study|Adverse Event|1|||
143009591|NCT00127192|515572888|FG003|Overall Study|Adverse Event|1|||
143009592|NCT00127192|515572889|FG004|Overall Study|Adverse Event|0|||
143009593|NCT00127192|515572885|FG000|Overall Study|Lack of Efficacy|2|||
143009594|NCT00127192|515572886|FG001|Overall Study|Lack of Efficacy|0|||
143009595|NCT00127192|515572887|FG002|Overall Study|Lack of Efficacy|0|||
143009596|NCT00127192|515572888|FG003|Overall Study|Lack of Efficacy|0|||
143009597|NCT00127192|515572889|FG004|Overall Study|Lack of Efficacy|2|||
143009598|NCT00127192|515572885|FG000|Overall Study|Withdrawal by Subject|0|||
143009599|NCT00127192|515572886|FG001|Overall Study|Withdrawal by Subject|0|||
143009600|NCT00127192|515572887|FG002|Overall Study|Withdrawal by Subject|1|||
143009601|NCT00127192|515572888|FG003|Overall Study|Withdrawal by Subject|0|||
143009602|NCT00127192|515572889|FG004|Overall Study|Withdrawal by Subject|3|||
143009603|NCT00127192|515572885|FG000|Overall Study|Adverse event in pre-treatment period|1|||
143009604|NCT00127192|515572886|FG001|Overall Study|Adverse event in pre-treatment period|0|||
143009605|NCT00127192|515572887|FG002|Overall Study|Adverse event in pre-treatment period|0|||
143009606|NCT00127192|515572888|FG003|Overall Study|Adverse event in pre-treatment period|0|||
143009607|NCT00127192|515572889|FG004|Overall Study|Adverse event in pre-treatment period|0|||
143009608|NCT01244516|515572895|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
143009609|NCT01244516|515572896|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
143009610|NCT01244516|515572897|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
143009611|NCT01244516|515572895|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
143009612|NCT01244516|515572896|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
143009613|NCT01244516|515572897|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
143009614|NCT01244516|515572895|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
143009615|NCT01244516|515572896|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
143009616|NCT01244516|515572897|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
143009617|NCT01244516|515572895|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
143009618|NCT01244516|515572896|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
143009619|NCT01244516|515572897|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
143009620|NCT01244516|515572895|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
143009621|NCT01244516|515572896|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
143009622|NCT01244516|515572897|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
143009623|NCT01244516|515572895|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
143009624|NCT01244516|515572896|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
143009625|NCT01244516|515572897|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
143009626|NCT01244516|515572895|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
143009627|NCT01244516|515572896|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
143009628|NCT01244516|515572897|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
143009629|NCT01102972|515572899|FG000|Overall Study|Adverse Event|8|||
143009630|NCT01102972|515572900|FG001|Overall Study|Adverse Event|2|||
143009631|NCT01102972|515572899|FG000|Overall Study|Lack of Efficacy|2|||
143009632|NCT01102972|515572900|FG001|Overall Study|Lack of Efficacy|1|||
143009633|NCT01102972|515572899|FG000|Overall Study|Protocol Violation|1|||
143009634|NCT01102972|515572900|FG001|Overall Study|Protocol Violation|0|||
143009635|NCT01102972|515572899|FG000|Overall Study|Lost to Follow-up|10|||
143009636|NCT01102972|515572900|FG001|Overall Study|Lost to Follow-up|5|||
143009637|NCT01102972|515572899|FG000|Overall Study|Investigator Discretion|2|||
143009638|NCT01102972|515572900|FG001|Overall Study|Investigator Discretion|0|||
143346805|NCT01454830|516816747|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
143346806|NCT01454830|516816748|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
143346807|NCT01454830|516816747|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
143346808|NCT01454830|516816748|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
143346809|NCT01454830|516816747|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
143346810|NCT01454830|516816748|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
143009639|NCT01102972|515572899|FG000|Overall Study|Withdrawal by Subject|6|||
143009640|NCT01102972|515572900|FG001|Overall Study|Withdrawal by Subject|6|||
143009641|NCT01856257|515572904|FG000|Overall Study|Death|2|||
143009642|NCT01856257|515572905|FG001|Overall Study|Death|0|||
143009643|NCT01856257|515572906|FG002|Overall Study|Death|0|||
143346811|NCT01454830|516816747|FG000|Overall Study|Withdrawal - no polysomnography|3|||
143009644|NCT01856257|515572907|FG003|Overall Study|Death|0|||
143009645|NCT01856257|515572904|FG000|Overall Study|Physician Decision|0|||
143009646|NCT01856257|515572905|FG001|Overall Study|Physician Decision|0|||
143009647|NCT01856257|515572906|FG002|Overall Study|Physician Decision|0|||
143009648|NCT01856257|515572907|FG003|Overall Study|Physician Decision|1|||
143009649|NCT01856257|515572904|FG000|Overall Study|Withdrawal by Subject|1|||
143009650|NCT01856257|515572905|FG001|Overall Study|Withdrawal by Subject|1|||
143009651|NCT01856257|515572906|FG002|Overall Study|Withdrawal by Subject|0|||
143009652|NCT01856257|515572907|FG003|Overall Study|Withdrawal by Subject|0|||
143009653|NCT01856257|515572904|FG000|Overall Study|Donor complication|0|||
143009654|NCT01856257|515572905|FG001|Overall Study|Donor complication|0|||
143009655|NCT01856257|515572906|FG002|Overall Study|Donor complication|0|||
143009656|NCT01856257|515572907|FG003|Overall Study|Donor complication|1|||
143009657|NCT03664024|515572908|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
143009658|NCT03664024|515572908|FG000|Overall Study|Lost to Follow-up|2|||
143009659|NCT03664024|515572908|FG000|Overall Study|Withdrawal by Subject|2|||
143009660|NCT03664024|515572908|FG000|Overall Study|Death|80|||
143009661|NCT01157065|515572909|FG000|Overall Study|Death|0|||
143009662|NCT01157065|515572910|FG001|Overall Study|Death|1|||
143009663|NCT01821391|515572913|FG000|Overall Study|Adverse Event|1|||
143009664|NCT01821391|515572914|FG001|Overall Study|Adverse Event|0|||
143009665|NCT02146365|515572915|FG000|Overall Study|Lost to Follow-up|2|||
143009666|NCT02146365|515572916|FG001|Overall Study|Lost to Follow-up|1|||
143009667|NCT02146365|515572917|FG002|Overall Study|Lost to Follow-up|3|||
143009668|NCT02146365|515572918|FG003|Overall Study|Lost to Follow-up|3|||
143009669|NCT02146365|515572919|FG004|Overall Study|Lost to Follow-up|1|||
143009670|NCT02146365|515572920|FG005|Overall Study|Lost to Follow-up|1|||
143009671|NCT02146365|515572921|FG006|Overall Study|Lost to Follow-up|0|||
143009672|NCT02146365|515572922|FG007|Overall Study|Lost to Follow-up|1|||
143009673|NCT02146365|515572915|FG000|Overall Study|Withdrawal by Subject|1|||
143009674|NCT02146365|515572916|FG001|Overall Study|Withdrawal by Subject|2|||
143009675|NCT02146365|515572917|FG002|Overall Study|Withdrawal by Subject|1|||
143009676|NCT02146365|515572918|FG003|Overall Study|Withdrawal by Subject|5|||
143009677|NCT02146365|515572919|FG004|Overall Study|Withdrawal by Subject|1|||
143009678|NCT02146365|515572920|FG005|Overall Study|Withdrawal by Subject|0|||
143009679|NCT02146365|515572921|FG006|Overall Study|Withdrawal by Subject|0|||
143009680|NCT02146365|515572922|FG007|Overall Study|Withdrawal by Subject|0|||
143009681|NCT02146365|515572915|FG000|Overall Study|Unable to Comply with Protocol|0|||
143009682|NCT02146365|515572916|FG001|Overall Study|Unable to Comply with Protocol|1|||
143009683|NCT02146365|515572917|FG002|Overall Study|Unable to Comply with Protocol|1|||
143009684|NCT02146365|515572918|FG003|Overall Study|Unable to Comply with Protocol|0|||
143009685|NCT02146365|515572919|FG004|Overall Study|Unable to Comply with Protocol|0|||
143009686|NCT02146365|515572920|FG005|Overall Study|Unable to Comply with Protocol|0|||
143009687|NCT02146365|515572921|FG006|Overall Study|Unable to Comply with Protocol|0|||
143009688|NCT02146365|515572922|FG007|Overall Study|Unable to Comply with Protocol|0|||
143009689|NCT02146365|515572915|FG000|Overall Study|Other|1|||
143009690|NCT02146365|515572916|FG001|Overall Study|Other|0|||
143009691|NCT02146365|515572917|FG002|Overall Study|Other|2|||
143009692|NCT02146365|515572918|FG003|Overall Study|Other|1|||
143009693|NCT02146365|515572919|FG004|Overall Study|Other|0|||
143009694|NCT02146365|515572920|FG005|Overall Study|Other|0|||
143009695|NCT02146365|515572921|FG006|Overall Study|Other|0|||
143009696|NCT02146365|515572922|FG007|Overall Study|Other|0|||
143009697|NCT01843660|515572923|FG000|Overall Study|Other|30|||
143009698|NCT01977482|515572924|FG000|Overall Study|Adverse Event|0|||
143009699|NCT01977482|515572925|FG001|Overall Study|Adverse Event|1|||
143009700|NCT01977482|515572926|FG002|Overall Study|Adverse Event|1|||
143009701|NCT01977482|515572927|FG003|Overall Study|Adverse Event|0|||
143009702|NCT01977482|515572928|FG004|Overall Study|Adverse Event|2|||
143009703|NCT01977482|515572929|FG005|Overall Study|Adverse Event|0|||
143009704|NCT01977482|515572924|FG000|Overall Study|Lost to Follow-up|1|||
143009705|NCT01977482|515572925|FG001|Overall Study|Lost to Follow-up|0|||
143009706|NCT01977482|515572926|FG002|Overall Study|Lost to Follow-up|0|||
143009707|NCT01977482|515572927|FG003|Overall Study|Lost to Follow-up|0|||
143009708|NCT01977482|515572928|FG004|Overall Study|Lost to Follow-up|0|||
143009709|NCT01977482|515572929|FG005|Overall Study|Lost to Follow-up|0|||
143009710|NCT01977482|515572924|FG000|Overall Study|Physician Decision|0|||
143009711|NCT01977482|515572925|FG001|Overall Study|Physician Decision|1|||
143009712|NCT01977482|515572926|FG002|Overall Study|Physician Decision|0|||
143009713|NCT01977482|515572927|FG003|Overall Study|Physician Decision|0|||
143009714|NCT01977482|515572928|FG004|Overall Study|Physician Decision|0|||
143009715|NCT01977482|515572929|FG005|Overall Study|Physician Decision|0|||
143009716|NCT01977482|515572924|FG000|Overall Study|Protocol Violation|0|||
143009717|NCT01977482|515572925|FG001|Overall Study|Protocol Violation|0|||
143009718|NCT01977482|515572926|FG002|Overall Study|Protocol Violation|1|||
143009719|NCT01977482|515572927|FG003|Overall Study|Protocol Violation|0|||
143009720|NCT01977482|515572928|FG004|Overall Study|Protocol Violation|0|||
143009721|NCT01977482|515572929|FG005|Overall Study|Protocol Violation|0|||
143009722|NCT01977482|515572924|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
143461347|NCT05559099|517235021|FG001|Overall Study|Lost to Follow-up|2|||
143009723|NCT01977482|515572925|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
143009724|NCT01977482|515572926|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
143009725|NCT01977482|515572927|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
143009726|NCT01977482|515572928|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
143009727|NCT01977482|515572929|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
143009728|NCT01977482|515572924|FG000|Overall Study|Withdrawal by Subject|2|||
143009729|NCT01977482|515572925|FG001|Overall Study|Withdrawal by Subject|4|||
143009730|NCT01977482|515572926|FG002|Overall Study|Withdrawal by Subject|1|||
143009731|NCT01977482|515572927|FG003|Overall Study|Withdrawal by Subject|3|||
143009732|NCT01977482|515572928|FG004|Overall Study|Withdrawal by Subject|1|||
143009733|NCT01977482|515572929|FG005|Overall Study|Withdrawal by Subject|5|||
143009734|NCT00209560|515572930|FG000|Overall Study|Lack of Efficacy|1|||
143009735|NCT00209560|515572931|FG001|Overall Study|Lack of Efficacy|0|||
143009736|NCT01721369|515572934|FG000|Overall Study|Not initial etiological diagnosis|12|||
143009737|NCT03505606|515574268|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
143009738|NCT03505606|515574269|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
143009739|NCT03505606|515574270|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
143009740|NCT03505606|515574268|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
143009741|NCT03505606|515574269|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
143009742|NCT03505606|515574270|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
143009743|NCT03505606|515574268|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
143009744|NCT03505606|515574269|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
143009745|NCT03505606|515574270|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
143009746|NCT03505606|515574268|FG000|Overall Study|Poor compliance with refractive correction|0|||
143009747|NCT03505606|515574269|FG001|Overall Study|Poor compliance with refractive correction|0|||
143009748|NCT03505606|515574270|FG002|Overall Study|Poor compliance with refractive correction|1|||
143009749|NCT03505606|515574268|FG000|Overall Study|Insufficient anisometropia|0|||
143009750|NCT03505606|515574269|FG001|Overall Study|Insufficient anisometropia|0|||
143009751|NCT03505606|515574270|FG002|Overall Study|Insufficient anisometropia|2|||
143009752|NCT03505606|515574268|FG000|Overall Study|Ectopia Lentis|0|||
143009753|NCT03505606|515574269|FG001|Overall Study|Ectopia Lentis|0|||
143009754|NCT03505606|515574270|FG002|Overall Study|Ectopia Lentis|1|||
143009755|NCT03505606|515574268|FG000|Overall Study|alternation of amblyopic eye|0|||
143009756|NCT03505606|515574269|FG001|Overall Study|alternation of amblyopic eye|1|||
143009757|NCT03505606|515574270|FG002|Overall Study|alternation of amblyopic eye|0|||
143009758|NCT01392469|515574271|FG000|Overall Study|Adverse Event|2|||
143009759|NCT01392469|515574271|FG000|Overall Study|Withdrawal by Subject|1|||
143009760|NCT01392469|515574271|FG000|Overall Study|Protocol Violation|1|||
143009761|NCT01017731|515574272|FG000|Overall Study|Lost to Follow-up|2|||
143009762|NCT01017731|515574272|FG000|Overall Study|Withdrawal by Subject|3|||
143009763|NCT01017731|515574272|FG000|Overall Study|Physician Decision|2|||
143009764|NCT01017731|515574272|FG000|Overall Study|Adverse Event|1|||
143009765|NCT01035229|515574273|FG000|Overall Study|Adverse Event|61|||
143009766|NCT01035229|515574274|FG001|Overall Study|Adverse Event|14|||
143009767|NCT01035229|515574273|FG000|Overall Study|Withdrawal by Subject|20|||
143009768|NCT01035229|515574274|FG001|Overall Study|Withdrawal by Subject|7|||
143009769|NCT01035229|515574273|FG000|Overall Study|Lost to Follow-up|1|||
143009770|NCT01035229|515574274|FG001|Overall Study|Lost to Follow-up|0|||
143009771|NCT01035229|515574273|FG000|Overall Study|Administrative problems|1|||
143009772|NCT01035229|515574274|FG001|Overall Study|Administrative problems|1|||
143009773|NCT01035229|515574273|FG000|Overall Study|Death|13|||
143009774|NCT01035229|515574274|FG001|Overall Study|Death|5|||
143009775|NCT01035229|515574273|FG000|Overall Study|New cancer therapy|2|||
143009776|NCT01035229|515574274|FG001|Overall Study|New cancer therapy|0|||
143009777|NCT01035229|515574273|FG000|Overall Study|Protocol Violation|0|||
143009778|NCT01035229|515574274|FG001|Overall Study|Protocol Violation|2|||
143009779|NCT01035229|515574273|FG000|Overall Study|Sponsor's decision to end study|3|||
143009780|NCT01035229|515574274|FG001|Overall Study|Sponsor's decision to end study|3|||
143009781|NCT01035229|515574273|FG000|Overall Study|Disease Progression|261|||
143009782|NCT01035229|515574274|FG001|Overall Study|Disease Progression|152|||
143009783|NCT00242567|515574277|FG000|Overall Study|Adverse Event|70|||
143009784|NCT00242567|515574278|FG001|Overall Study|Adverse Event|43|||
143009785|NCT00242567|515574277|FG000|Overall Study|Disease Progression|17|||
143009786|NCT00242567|515574278|FG001|Overall Study|Disease Progression|22|||
143009787|NCT00242567|515574277|FG000|Overall Study|Symptomatic deterioration|9|||
143009788|NCT00242567|515574278|FG001|Overall Study|Symptomatic deterioration|3|||
143009789|NCT00242567|515574277|FG000|Overall Study|Lack of Efficacy|2|||
143009790|NCT00242567|515574278|FG001|Overall Study|Lack of Efficacy|2|||
143009791|NCT00242567|515574277|FG000|Overall Study|Lost to Follow-up|9|||
143009792|NCT00242567|515574278|FG001|Overall Study|Lost to Follow-up|19|||
143009793|NCT00242567|515574277|FG000|Overall Study|Withdrawal by Subject|33|||
143009794|NCT00242567|515574278|FG001|Overall Study|Withdrawal by Subject|28|||
143124526|NCT03026283|516001208|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
143009795|NCT00242567|515574277|FG000|Overall Study|Protocol Violation|12|||
143009796|NCT00242567|515574278|FG001|Overall Study|Protocol Violation|12|||
143346812|NCT01454830|516816748|FG001|Overall Study|Withdrawal - no polysomnography|2|||
143346813|NCT01872910|516816755|FG000|Overall Study|Lost to Follow-up|2|||
143346814|NCT01872910|516816756|FG001|Overall Study|Lost to Follow-up|0|||
143346815|NCT01872910|516816757|FG002|Overall Study|Lost to Follow-up|2|||
143346816|NCT01872910|516816758|FG003|Overall Study|Lost to Follow-up|0|||
143346817|NCT01872910|516816759|FG004|Overall Study|Lost to Follow-up|0|||
143346818|NCT01872910|516816760|FG005|Overall Study|Lost to Follow-up|0|||
143346819|NCT01306201|516816763|FG000|Overall Study|Arrhythmia|4|||
143346820|NCT01306201|516816763|FG000|Overall Study|Files could not be processed|3|||
143346821|NCT01306201|516816763|FG000|Overall Study|Files unreadable|3|||
143009797|NCT00242567|515574277|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
143009798|NCT00242567|515574278|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
143009799|NCT00242567|515574277|FG000|Overall Study|Other|14|||
143009800|NCT00242567|515574278|FG001|Overall Study|Other|9|||
143009801|NCT01721200|515574279|FG000|Overall Study|Lost to Follow-up|3|||
143009802|NCT01721200|515574280|FG001|Overall Study|Lost to Follow-up|5|||
143009803|NCT00630994|515574281|FG000|Overall Study|Adverse Event|1|||
143009804|NCT00630994|515574281|FG000|Overall Study|Disease Progression|1|||
143009805|NCT00630994|515574281|FG000|Overall Study|Lack of Efficacy|1|||
143009806|NCT00630994|515574281|FG000|Overall Study|Other|1|||
143009807|NCT03669640|515574282|FG000|Overall Study|Study Terminated by Sponsor|0|||
143009808|NCT03669640|515574283|FG001|Overall Study|Study Terminated by Sponsor|0|||
143009809|NCT03669640|515574284|FG002|Overall Study|Study Terminated by Sponsor|0|||
143009810|NCT03669640|515574285|FG003|Overall Study|Study Terminated by Sponsor|0|||
143009811|NCT03669640|515574286|FG004|Overall Study|Study Terminated by Sponsor|1|||
143009812|NCT03669640|515574287|FG005|Overall Study|Study Terminated by Sponsor|0|||
143009813|NCT03669640|515574282|FG000|Overall Study|Lost to Follow-up|0|||
143009814|NCT03669640|515574283|FG001|Overall Study|Lost to Follow-up|0|||
143009815|NCT03669640|515574284|FG002|Overall Study|Lost to Follow-up|2|||
143009816|NCT03669640|515574285|FG003|Overall Study|Lost to Follow-up|0|||
143009817|NCT03669640|515574286|FG004|Overall Study|Lost to Follow-up|0|||
143009818|NCT03669640|515574287|FG005|Overall Study|Lost to Follow-up|0|||
143009819|NCT03669640|515574282|FG000|Overall Study|Death|0|||
143009820|NCT03669640|515574283|FG001|Overall Study|Death|0|||
143009821|NCT03669640|515574284|FG002|Overall Study|Death|1|||
143009822|NCT03669640|515574285|FG003|Overall Study|Death|0|||
143009823|NCT03669640|515574286|FG004|Overall Study|Death|0|||
143009824|NCT03669640|515574287|FG005|Overall Study|Death|0|||
143009825|NCT03669640|515574282|FG000|Overall Study|Withdrawal by Subject|1|||
143009826|NCT03669640|515574283|FG001|Overall Study|Withdrawal by Subject|2|||
143009827|NCT03669640|515574284|FG002|Overall Study|Withdrawal by Subject|1|||
143009828|NCT03669640|515574285|FG003|Overall Study|Withdrawal by Subject|0|||
143009829|NCT03669640|515574286|FG004|Overall Study|Withdrawal by Subject|1|||
143009830|NCT03669640|515574287|FG005|Overall Study|Withdrawal by Subject|3|||
143009831|NCT03669640|515574282|FG000|Overall Study|Protocol Violation|1|||
143009832|NCT03669640|515574283|FG001|Overall Study|Protocol Violation|0|||
143009833|NCT03669640|515574284|FG002|Overall Study|Protocol Violation|0|||
143009834|NCT03669640|515574285|FG003|Overall Study|Protocol Violation|0|||
143009835|NCT03669640|515574286|FG004|Overall Study|Protocol Violation|0|||
143009836|NCT03669640|515574287|FG005|Overall Study|Protocol Violation|0|||
143009837|NCT03669640|515574282|FG000|Overall Study|Physician Decision|0|||
143009838|NCT03669640|515574283|FG001|Overall Study|Physician Decision|2|||
143009839|NCT03669640|515574284|FG002|Overall Study|Physician Decision|0|||
143009840|NCT03669640|515574285|FG003|Overall Study|Physician Decision|0|||
143009841|NCT03669640|515574286|FG004|Overall Study|Physician Decision|0|||
143009842|NCT03669640|515574287|FG005|Overall Study|Physician Decision|0|||
143009843|NCT03669640|515574282|FG000|Overall Study|Disease Relapse|1|||
143009844|NCT03669640|515574283|FG001|Overall Study|Disease Relapse|0|||
143009845|NCT03669640|515574284|FG002|Overall Study|Disease Relapse|0|||
143009846|NCT03669640|515574285|FG003|Overall Study|Disease Relapse|0|||
143009847|NCT03669640|515574286|FG004|Overall Study|Disease Relapse|0|||
143009848|NCT03669640|515574287|FG005|Overall Study|Disease Relapse|0|||
143009849|NCT03669640|515574282|FG000|Overall Study|Adverse Event|2|||
143009850|NCT03669640|515574283|FG001|Overall Study|Adverse Event|1|||
143009851|NCT03669640|515574284|FG002|Overall Study|Adverse Event|0|||
143009852|NCT03669640|515574285|FG003|Overall Study|Adverse Event|0|||
143009853|NCT03669640|515574286|FG004|Overall Study|Adverse Event|1|||
143009854|NCT03669640|515574287|FG005|Overall Study|Adverse Event|0|||
143009855|NCT00366678|515574288|FG000|Infant Series|Withdrawal by Subject|8|||
143009856|NCT00366678|515574289|FG001|Infant Series|Withdrawal by Subject|6|||
143009857|NCT00366678|515574290|FG002|Infant Series|Withdrawal by Subject|0|||
143009858|NCT00366678|515574288|FG000|Infant Series|Protocol Violation|4|||
143009859|NCT00366678|515574289|FG001|Infant Series|Protocol Violation|3|||
143009860|NCT00366678|515574290|FG002|Infant Series|Protocol Violation|0|||
143009861|NCT00366678|515574288|FG000|Infant Series|Failed to return|1|||
143009862|NCT00366678|515574289|FG001|Infant Series|Failed to return|1|||
143346822|NCT04702568|516816764|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
143461348|NCT05559099|517235020|FG000|Overall Study|Adverse Event|1|||
143346823|NCT04702568|516816765|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
143346824|NCT04702568|516816764|FG000|Overall Study|Pregnancy|1|||
143346825|NCT04702568|516816765|FG001|Overall Study|Pregnancy|0|||
143346826|NCT04702568|516816764|FG000|Overall Study|Bone marrow transplant|1|||
143346827|NCT04702568|516816765|FG001|Overall Study|Bone marrow transplant|0|||
143346828|NCT04702568|516816764|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
143346829|NCT04702568|516816765|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
143346830|NCT04702568|516816764|FG000|Overall Study|Withdrawal by Subject|0|||
143009863|NCT00366678|515574290|FG002|Infant Series|Failed to return|0|||
143009864|NCT00366678|515574288|FG000|Infant Series|Adverse Event|1|||
143009865|NCT00366678|515574289|FG001|Infant Series|Adverse Event|0|||
143009866|NCT00366678|515574290|FG002|Infant Series|Adverse Event|0|||
143009867|NCT00366678|515574288|FG000|After Infant|Withdrawal by Subject|8|||
143009868|NCT00366678|515574289|FG001|After Infant|Withdrawal by Subject|4|||
143009869|NCT00366678|515574290|FG002|After Infant|Withdrawal by Subject|0|||
143009870|NCT00366678|515574288|FG000|After Infant|Lost to Follow-up|2|||
143009871|NCT00366678|515574289|FG001|After Infant|Lost to Follow-up|1|||
143346831|NCT04702568|516816765|FG001|Overall Study|Withdrawal by Subject|2|||
143346832|NCT00393523|516816766|FG000|Overall Study|Lost to Follow-up|0|||
143346833|NCT00393523|516816767|FG001|Overall Study|Lost to Follow-up|0|||
143346834|NCT00393523|516816768|FG002|Overall Study|Lost to Follow-up|0|||
143009872|NCT00366678|515574290|FG002|After Infant|Lost to Follow-up|0|||
143009873|NCT00366678|515574288|FG000|After Infant|Failed to return|5|||
143009874|NCT00366678|515574289|FG001|After Infant|Failed to return|5|||
143009875|NCT00366678|515574290|FG002|After Infant|Failed to return|0|||
143009876|NCT00366678|515574288|FG000|After Infant|Adverse Event|1|||
143009877|NCT00366678|515574289|FG001|After Infant|Adverse Event|0|||
143009878|NCT00366678|515574290|FG002|After Infant|Adverse Event|0|||
143009879|NCT00366678|515574288|FG000|After Infant|Protocol Violation|1|||
143009880|NCT00366678|515574289|FG001|After Infant|Protocol Violation|0|||
143009881|NCT00366678|515574290|FG002|After Infant|Protocol Violation|0|||
143009882|NCT00366678|515574288|FG000|Toddler Dose|Protocol Violation|2|||
143009883|NCT00366678|515574289|FG001|Toddler Dose|Protocol Violation|1|||
143009884|NCT00366678|515574290|FG002|Toddler Dose|Protocol Violation|0|||
143009885|NCT00366678|515574288|FG000|Toddler Dose|Failed to return|1|||
143009886|NCT00366678|515574289|FG001|Toddler Dose|Failed to return|0|||
143009887|NCT00366678|515574290|FG002|Toddler Dose|Failed to return|0|||
143009888|NCT00366678|515574288|FG000|Toddler Dose|Withdrawal by Subject|1|||
143009889|NCT00366678|515574289|FG001|Toddler Dose|Withdrawal by Subject|0|||
143009890|NCT00366678|515574290|FG002|Toddler Dose|Withdrawal by Subject|0|||
143009891|NCT00366678|515574288|FG000|Toddler Dose|protocol deviation|1|||
143009892|NCT00366678|515574289|FG001|Toddler Dose|protocol deviation|0|||
143009893|NCT00366678|515574290|FG002|Toddler Dose|protocol deviation|0|||
143009894|NCT04292171|515574291|FG000|Overall Study|Pharmacy error|2|||
143009895|NCT04292171|515574292|FG001|Overall Study|Pharmacy error|0|||
143009896|NCT04292171|515574291|FG000|Overall Study|Delivered prior to procedure|0|||
143009897|NCT04292171|515574292|FG001|Overall Study|Delivered prior to procedure|1|||
143009898|NCT03079869|515574299|FG000|Overall Study|Adverse Event|6|||
143009899|NCT03079869|515574300|FG001|Overall Study|Adverse Event|8|||
143009900|NCT03079869|515574299|FG000|Overall Study|Withdrawal by Subject|4|||
143009901|NCT03079869|515574300|FG001|Overall Study|Withdrawal by Subject|1|||
143009902|NCT03079869|515574299|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
143009903|NCT03079869|515574300|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
143009904|NCT00388674|515574302|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
143009905|NCT00388674|515574303|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
143009906|NCT00388674|515574302|FG000|Initial Treatment|Adverse Event|22|||
143009907|NCT00388674|515574303|FG001|Initial Treatment|Adverse Event|87|||
143009908|NCT00388674|515574302|FG000|Initial Treatment|Death|215|||
143009909|NCT00388674|515574303|FG001|Initial Treatment|Death|216|||
143346835|NCT00393523|516816769|FG003|Overall Study|Lost to Follow-up|2|||
143346836|NCT00393523|516816770|FG004|Overall Study|Lost to Follow-up|1|||
143346837|NCT00393523|516816766|FG000|Overall Study|Protocol Violation|6|||
143346838|NCT00393523|516816767|FG001|Overall Study|Protocol Violation|2|||
143346839|NCT00393523|516816768|FG002|Overall Study|Protocol Violation|0|||
143009910|NCT00388674|515574302|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
143009911|NCT00388674|515574303|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
143009912|NCT00388674|515574302|FG000|Initial Treatment|HCC|12|||
143009913|NCT00388674|515574303|FG001|Initial Treatment|HCC|20|||
143009914|NCT00388674|515574302|FG000|Initial Treatment|Lost to Follow-up|526|||
143009915|NCT00388674|515574303|FG001|Initial Treatment|Lost to Follow-up|624|||
143009916|NCT00388674|515574302|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
143009917|NCT00388674|515574303|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
143009918|NCT00388674|515574302|FG000|Initial Treatment|Never Treated with Study Medication|1|||
143009919|NCT00388674|515574303|FG001|Initial Treatment|Never Treated with Study Medication|7|||
143009920|NCT00388674|515574302|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
143346840|NCT00393523|516816769|FG003|Overall Study|Protocol Violation|1|||
143346841|NCT00393523|516816770|FG004|Overall Study|Protocol Violation|0|||
143009921|NCT00388674|515574303|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
143009922|NCT00388674|515574302|FG000|Initial Treatment|Not Defined|125|||
143009923|NCT00388674|515574303|FG001|Initial Treatment|Not Defined|172|||
143009924|NCT00388674|515574302|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
143009925|NCT00388674|515574303|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
143009926|NCT00388674|515574302|FG000|Initial Treatment|Pregnancy|26|||
143009927|NCT00388674|515574303|FG001|Initial Treatment|Pregnancy|16|||
143009928|NCT00388674|515574302|FG000|Initial Treatment|Study Drug Toxicity|5|||
143009929|NCT00388674|515574303|FG001|Initial Treatment|Study Drug Toxicity|92|||
143009930|NCT00388674|515574302|FG000|Initial Treatment|Participant Request|501|||
143009931|NCT00388674|515574303|FG001|Initial Treatment|Participant Request|673|||
143009932|NCT00388674|515574302|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
143009933|NCT00388674|515574303|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
143009934|NCT00388674|515574302|FG000|Initial Treatment|Not Reported|10|||
143009935|NCT00388674|515574303|FG001|Initial Treatment|Not Reported|12|||
143009936|NCT00388674|515574302|FG000|End of Study|Administrative Reason By Sponsor|299|||
143009937|NCT00388674|515574303|FG001|End of Study|Administrative Reason By Sponsor|253|||
143009938|NCT00388674|515574302|FG000|End of Study|Death|239|||
143009939|NCT00388674|515574303|FG001|End of Study|Death|262|||
143009940|NCT00388674|515574302|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
143009941|NCT00388674|515574303|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
143009942|NCT00388674|515574302|FG000|End of Study|HCC|8|||
143009943|NCT00388674|515574303|FG001|End of Study|HCC|7|||
143009944|NCT00388674|515574302|FG000|End of Study|Lost to Follow-up|587|||
143009945|NCT00388674|515574303|FG001|End of Study|Lost to Follow-up|715|||
143009946|NCT00388674|515574302|FG000|End of Study|Malignancy (Non-HCC)|1|||
143009947|NCT00388674|515574303|FG001|End of Study|Malignancy (Non-HCC)|1|||
143009948|NCT00388674|515574302|FG000|End of Study|Non-Study Related Comorbidities|3|||
143009949|NCT00388674|515574303|FG001|End of Study|Non-Study Related Comorbidities|4|||
143009950|NCT00388674|515574302|FG000|End of Study|Not Defined|135|||
143009951|NCT00388674|515574303|FG001|End of Study|Not Defined|214|||
143009952|NCT00388674|515574302|FG000|End of Study|Participant Withdrew Consent|437|||
143009953|NCT00388674|515574303|FG001|End of Study|Participant Withdrew Consent|673|||
143009954|NCT00388674|515574302|FG000|End of Study|No Off-Treatment Status Data|22|||
143009955|NCT00388674|515574303|FG001|End of Study|No Off-Treatment Status Data|30|||
143009956|NCT00388674|515574302|FG000|End of Study|Not Reported|0|||
143009957|NCT00388674|515574303|FG001|End of Study|Not Reported|1|||
143009958|NCT00996632|515574306|FG000|Overall Study|Physician Decision|0|||
143009959|NCT00996632|515574307|FG001|Overall Study|Physician Decision|0|||
143009960|NCT02118896|515574308|FG000|Overall Study|Death|4|||
143009961|NCT02118896|515574309|FG001|Overall Study|Death|0|||
143009962|NCT02118896|515574310|FG002|Overall Study|Death|4|||
143009963|NCT02118896|515574311|FG003|Overall Study|Death|6|||
143009964|NCT02118896|515574312|FG004|Overall Study|Death|3|||
143009965|NCT02118896|515574313|FG005|Overall Study|Death|1|||
143009966|NCT02118896|515574314|FG006|Overall Study|Death|0|||
143009967|NCT02118896|515574315|FG007|Overall Study|Death|0|||
143009968|NCT02118896|515574316|FG008|Overall Study|Death|0|||
143009969|NCT02118896|515574317|FG009|Overall Study|Death|0|||
143009970|NCT02118896|515574308|FG000|Overall Study|Adverse Event|5|||
143009971|NCT02118896|515574309|FG001|Overall Study|Adverse Event|4|||
143009972|NCT02118896|515574310|FG002|Overall Study|Adverse Event|4|||
143009973|NCT02118896|515574311|FG003|Overall Study|Adverse Event|5|||
143009974|NCT02118896|515574312|FG004|Overall Study|Adverse Event|5|||
143009975|NCT02118896|515574313|FG005|Overall Study|Adverse Event|9|||
143009976|NCT02118896|515574314|FG006|Overall Study|Adverse Event|1|||
143009977|NCT02118896|515574315|FG007|Overall Study|Adverse Event|1|||
143009978|NCT02118896|515574316|FG008|Overall Study|Adverse Event|4|||
143009979|NCT02118896|515574317|FG009|Overall Study|Adverse Event|0|||
143009980|NCT02118896|515574308|FG000|Overall Study|Consent withdrawn|2|||
143009981|NCT02118896|515574309|FG001|Overall Study|Consent withdrawn|0|||
143009982|NCT02118896|515574310|FG002|Overall Study|Consent withdrawn|3|||
143009983|NCT02118896|515574311|FG003|Overall Study|Consent withdrawn|4|||
143009984|NCT02118896|515574312|FG004|Overall Study|Consent withdrawn|1|||
143009985|NCT02118896|515574313|FG005|Overall Study|Consent withdrawn|4|||
143009986|NCT02118896|515574314|FG006|Overall Study|Consent withdrawn|0|||
143346842|NCT00393523|516816766|FG000|Overall Study|Withdrawal by Subject|6|||
143346843|NCT00393523|516816767|FG001|Overall Study|Withdrawal by Subject|7|||
143009987|NCT02118896|515574315|FG007|Overall Study|Consent withdrawn|0|||
143009988|NCT02118896|515574316|FG008|Overall Study|Consent withdrawn|0|||
143009989|NCT02118896|515574317|FG009|Overall Study|Consent withdrawn|0|||
143009990|NCT02118896|515574308|FG000|Overall Study|Non-compliance|2|||
143009991|NCT02118896|515574309|FG001|Overall Study|Non-compliance|1|||
143009992|NCT02118896|515574310|FG002|Overall Study|Non-compliance|1|||
143009993|NCT02118896|515574311|FG003|Overall Study|Non-compliance|5|||
143009994|NCT02118896|515574312|FG004|Overall Study|Non-compliance|0|||
143009995|NCT02118896|515574313|FG005|Overall Study|Non-compliance|1|||
143009996|NCT02118896|515574314|FG006|Overall Study|Non-compliance|0|||
143009997|NCT02118896|515574315|FG007|Overall Study|Non-compliance|1|||
143009998|NCT02118896|515574316|FG008|Overall Study|Non-compliance|0|||
143009999|NCT02118896|515574317|FG009|Overall Study|Non-compliance|0|||
143010000|NCT02118896|515574308|FG000|Overall Study|Pregnancy|1|||
143010001|NCT02118896|515574309|FG001|Overall Study|Pregnancy|1|||
143010002|NCT02118896|515574310|FG002|Overall Study|Pregnancy|0|||
143010003|NCT02118896|515574311|FG003|Overall Study|Pregnancy|0|||
143010004|NCT02118896|515574312|FG004|Overall Study|Pregnancy|1|||
143010005|NCT02118896|515574313|FG005|Overall Study|Pregnancy|3|||
143010006|NCT02118896|515574314|FG006|Overall Study|Pregnancy|1|||
143010007|NCT02118896|515574315|FG007|Overall Study|Pregnancy|0|||
143010008|NCT02118896|515574316|FG008|Overall Study|Pregnancy|0|||
143010009|NCT02118896|515574317|FG009|Overall Study|Pregnancy|0|||
143010010|NCT02118896|515574308|FG000|Overall Study|Lost to Follow-up|1|||
143010011|NCT02118896|515574309|FG001|Overall Study|Lost to Follow-up|2|||
143010012|NCT02118896|515574310|FG002|Overall Study|Lost to Follow-up|1|||
143010013|NCT02118896|515574311|FG003|Overall Study|Lost to Follow-up|0|||
143010014|NCT02118896|515574312|FG004|Overall Study|Lost to Follow-up|2|||
143010015|NCT02118896|515574313|FG005|Overall Study|Lost to Follow-up|1|||
143010016|NCT02118896|515574314|FG006|Overall Study|Lost to Follow-up|0|||
143010017|NCT02118896|515574315|FG007|Overall Study|Lost to Follow-up|0|||
143010018|NCT02118896|515574316|FG008|Overall Study|Lost to Follow-up|0|||
143010019|NCT02118896|515574317|FG009|Overall Study|Lost to Follow-up|0|||
143010020|NCT02118896|515574308|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
143010021|NCT02118896|515574309|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
143010022|NCT02118896|515574310|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
143010023|NCT02118896|515574311|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
143010024|NCT02118896|515574312|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
143010025|NCT02118896|515574313|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
143010026|NCT02118896|515574314|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
143010027|NCT02118896|515574315|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
143010028|NCT02118896|515574316|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
143010029|NCT02118896|515574317|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
143010030|NCT02118896|515574308|FG000|Overall Study|Prohibited medication|0|||
143010031|NCT02118896|515574309|FG001|Overall Study|Prohibited medication|0|||
143010032|NCT02118896|515574310|FG002|Overall Study|Prohibited medication|0|||
143010033|NCT02118896|515574311|FG003|Overall Study|Prohibited medication|0|||
143010034|NCT02118896|515574312|FG004|Overall Study|Prohibited medication|1|||
143010035|NCT02118896|515574313|FG005|Overall Study|Prohibited medication|3|||
143010036|NCT02118896|515574314|FG006|Overall Study|Prohibited medication|0|||
143010037|NCT02118896|515574315|FG007|Overall Study|Prohibited medication|0|||
143010038|NCT02118896|515574316|FG008|Overall Study|Prohibited medication|0|||
143010039|NCT02118896|515574317|FG009|Overall Study|Prohibited medication|0|||
143010040|NCT02118896|515574308|FG000|Overall Study|Miscellaneous|1|||
143010041|NCT02118896|515574309|FG001|Overall Study|Miscellaneous|2|||
143010042|NCT02118896|515574310|FG002|Overall Study|Miscellaneous|0|||
143010043|NCT02118896|515574311|FG003|Overall Study|Miscellaneous|2|||
143010044|NCT02118896|515574312|FG004|Overall Study|Miscellaneous|0|||
143010045|NCT02118896|515574313|FG005|Overall Study|Miscellaneous|4|||
143010046|NCT02118896|515574314|FG006|Overall Study|Miscellaneous|0|||
143010047|NCT02118896|515574315|FG007|Overall Study|Miscellaneous|0|||
143010048|NCT02118896|515574316|FG008|Overall Study|Miscellaneous|0|||
143010049|NCT02118896|515574317|FG009|Overall Study|Miscellaneous|0|||
143010050|NCT03292731|515574318|FG000|Overall Study|Protocol Violation|4|||
143010051|NCT03292731|515574319|FG001|Overall Study|Protocol Violation|11|||
143010052|NCT03292731|515574320|FG002|Overall Study|Protocol Violation|1|||
143010053|NCT00471237|515574321|FG000|Overall Study|Adverse Event|6|||
143010054|NCT00471237|515574322|FG001|Overall Study|Adverse Event|5|||
143010055|NCT00471237|515574323|FG002|Overall Study|Adverse Event|4|||
143010056|NCT00471237|515574324|FG003|Overall Study|Adverse Event|8|||
143010057|NCT00471237|515574325|FG004|Overall Study|Adverse Event|7|||
143010058|NCT00471237|515574326|FG005|Overall Study|Adverse Event|5|||
143010059|NCT00471237|515574327|FG006|Overall Study|Adverse Event|0|||
143010060|NCT00471237|515574321|FG000|Overall Study|Lost to Follow-up|1|||
143010061|NCT00471237|515574322|FG001|Overall Study|Lost to Follow-up|1|||
143010062|NCT00471237|515574323|FG002|Overall Study|Lost to Follow-up|0|||
143346844|NCT00393523|516816768|FG002|Overall Study|Withdrawal by Subject|2|||
143346845|NCT00393523|516816769|FG003|Overall Study|Withdrawal by Subject|3|||
143010063|NCT00471237|515574324|FG003|Overall Study|Lost to Follow-up|2|||
143010064|NCT00471237|515574325|FG004|Overall Study|Lost to Follow-up|3|||
143010065|NCT00471237|515574326|FG005|Overall Study|Lost to Follow-up|0|||
143010066|NCT00471237|515574327|FG006|Overall Study|Lost to Follow-up|0|||
143010067|NCT00471237|515574321|FG000|Overall Study|Protocol Violation|3|||
143010068|NCT00471237|515574322|FG001|Overall Study|Protocol Violation|6|||
143010069|NCT00471237|515574323|FG002|Overall Study|Protocol Violation|3|||
143010070|NCT00471237|515574324|FG003|Overall Study|Protocol Violation|2|||
143010071|NCT00471237|515574325|FG004|Overall Study|Protocol Violation|2|||
143010072|NCT00471237|515574326|FG005|Overall Study|Protocol Violation|4|||
143010073|NCT00471237|515574327|FG006|Overall Study|Protocol Violation|1|||
143010074|NCT00471237|515574321|FG000|Overall Study|Withdrawal by Subject|8|||
143010075|NCT00471237|515574322|FG001|Overall Study|Withdrawal by Subject|6|||
143010076|NCT00471237|515574323|FG002|Overall Study|Withdrawal by Subject|5|||
143010077|NCT00471237|515574324|FG003|Overall Study|Withdrawal by Subject|8|||
143010078|NCT00471237|515574325|FG004|Overall Study|Withdrawal by Subject|7|||
143010079|NCT00471237|515574326|FG005|Overall Study|Withdrawal by Subject|4|||
143010080|NCT00471237|515574327|FG006|Overall Study|Withdrawal by Subject|2|||
143010081|NCT00471237|515574321|FG000|Overall Study|Sponsor terminated study|20|||
143010082|NCT00471237|515574322|FG001|Overall Study|Sponsor terminated study|23|||
143010083|NCT00471237|515574323|FG002|Overall Study|Sponsor terminated study|19|||
143010084|NCT00471237|515574324|FG003|Overall Study|Sponsor terminated study|22|||
143010085|NCT00471237|515574325|FG004|Overall Study|Sponsor terminated study|18|||
143010086|NCT00471237|515574326|FG005|Overall Study|Sponsor terminated study|24|||
143010087|NCT00471237|515574327|FG006|Overall Study|Sponsor terminated study|0|||
143010088|NCT00471237|515574321|FG000|Overall Study|Non-compliance|0|||
143010089|NCT00471237|515574322|FG001|Overall Study|Non-compliance|1|||
143010090|NCT00471237|515574323|FG002|Overall Study|Non-compliance|0|||
143010091|NCT00471237|515574324|FG003|Overall Study|Non-compliance|1|||
143010092|NCT00471237|515574325|FG004|Overall Study|Non-compliance|0|||
143010093|NCT00471237|515574326|FG005|Overall Study|Non-compliance|0|||
143010094|NCT00471237|515574327|FG006|Overall Study|Non-compliance|0|||
143010095|NCT00471237|515574321|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
143010096|NCT00471237|515574322|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
143010097|NCT00471237|515574323|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
143010098|NCT00471237|515574324|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
143010099|NCT00471237|515574325|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
143010100|NCT00471237|515574326|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
143010101|NCT00471237|515574327|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
143010102|NCT00471237|515574321|FG000|Overall Study|Early stopping due to non-efficacy|1|||
143010103|NCT00471237|515574322|FG001|Overall Study|Early stopping due to non-efficacy|0|||
143010104|NCT00471237|515574323|FG002|Overall Study|Early stopping due to non-efficacy|0|||
143010105|NCT00471237|515574324|FG003|Overall Study|Early stopping due to non-efficacy|0|||
143010106|NCT00471237|515574325|FG004|Overall Study|Early stopping due to non-efficacy|1|||
143010107|NCT00471237|515574326|FG005|Overall Study|Early stopping due to non-efficacy|0|||
143010108|NCT00471237|515574327|FG006|Overall Study|Early stopping due to non-efficacy|0|||
143010109|NCT00471237|515574321|FG000|Overall Study|Participant planned to travel to abraod|1|||
143010110|NCT00471237|515574322|FG001|Overall Study|Participant planned to travel to abraod|0|||
143010111|NCT00471237|515574323|FG002|Overall Study|Participant planned to travel to abraod|0|||
143010112|NCT00471237|515574324|FG003|Overall Study|Participant planned to travel to abraod|0|||
143010113|NCT00471237|515574325|FG004|Overall Study|Participant planned to travel to abraod|0|||
143010114|NCT00471237|515574326|FG005|Overall Study|Participant planned to travel to abraod|1|||
143010115|NCT00471237|515574327|FG006|Overall Study|Participant planned to travel to abraod|0|||
143010116|NCT00471237|515574321|FG000|Overall Study|High parathyroid hormone|0|||
143010117|NCT00471237|515574322|FG001|Overall Study|High parathyroid hormone|0|||
143010118|NCT00471237|515574323|FG002|Overall Study|High parathyroid hormone|1|||
143010119|NCT00471237|515574324|FG003|Overall Study|High parathyroid hormone|0|||
143010120|NCT00471237|515574325|FG004|Overall Study|High parathyroid hormone|0|||
143010121|NCT00471237|515574326|FG005|Overall Study|High parathyroid hormone|0|||
143010122|NCT00471237|515574327|FG006|Overall Study|High parathyroid hormone|0|||
143010123|NCT00471237|515574321|FG000|Overall Study|Participant lost medication|0|||
143010124|NCT00471237|515574322|FG001|Overall Study|Participant lost medication|0|||
143010125|NCT00471237|515574323|FG002|Overall Study|Participant lost medication|0|||
143010126|NCT00471237|515574324|FG003|Overall Study|Participant lost medication|0|||
143010127|NCT00471237|515574325|FG004|Overall Study|Participant lost medication|1|||
143010128|NCT00471237|515574326|FG005|Overall Study|Participant lost medication|0|||
143010129|NCT00471237|515574327|FG006|Overall Study|Participant lost medication|0|||
143010130|NCT00471237|515574321|FG000|Overall Study|Administration of prohibited medicine|0|||
143010131|NCT00471237|515574322|FG001|Overall Study|Administration of prohibited medicine|0|||
143010132|NCT00471237|515574323|FG002|Overall Study|Administration of prohibited medicine|0|||
143010133|NCT00471237|515574324|FG003|Overall Study|Administration of prohibited medicine|0|||
143010134|NCT00471237|515574325|FG004|Overall Study|Administration of prohibited medicine|1|||
143010135|NCT00471237|515574326|FG005|Overall Study|Administration of prohibited medicine|0|||
143010136|NCT00471237|515574327|FG006|Overall Study|Administration of prohibited medicine|0|||
143010137|NCT00471237|515574321|FG000|Overall Study|Participant shifted residence|0|||
143010138|NCT00471237|515574322|FG001|Overall Study|Participant shifted residence|0|||
143346846|NCT00393523|516816770|FG004|Overall Study|Withdrawal by Subject|0|||
143346847|NCT00393523|516816766|FG000|Overall Study|Difficulties in specimen collection|0|||
143010139|NCT00471237|515574323|FG002|Overall Study|Participant shifted residence|0|||
143010140|NCT00471237|515574324|FG003|Overall Study|Participant shifted residence|0|||
143010141|NCT00471237|515574325|FG004|Overall Study|Participant shifted residence|1|||
143010142|NCT00471237|515574326|FG005|Overall Study|Participant shifted residence|0|||
143010143|NCT00471237|515574327|FG006|Overall Study|Participant shifted residence|0|||
143346848|NCT00393523|516816767|FG001|Overall Study|Difficulties in specimen collection|0|||
143010144|NCT00471237|515574321|FG000|Overall Study|Participant's decision|0|||
143010145|NCT00471237|515574322|FG001|Overall Study|Participant's decision|0|||
143010146|NCT00471237|515574323|FG002|Overall Study|Participant's decision|0|||
143010147|NCT00471237|515574324|FG003|Overall Study|Participant's decision|0|||
143010148|NCT00471237|515574325|FG004|Overall Study|Participant's decision|0|||
143010149|NCT00471237|515574326|FG005|Overall Study|Participant's decision|1|||
143010150|NCT00471237|515574327|FG006|Overall Study|Participant's decision|0|||
143010151|NCT03710824|515574328|FG000|Overall Study|Withdrawal by Subject|1|||
143010152|NCT03710824|515574328|FG000|Overall Study|Lost to Follow-up|3|||
143010153|NCT03710824|515574328|FG000|Overall Study|Adverse Event|25|||
143010154|NCT03710824|515574328|FG000|Overall Study|Treatment discontinuation|2|||
143010155|NCT02329834|515574329|FG000|Overall Study|Physician Decision|1|||
143010156|NCT02329834|515574330|FG001|Overall Study|Physician Decision|0|||
143010157|NCT00539006|515574332|FG000|Pre-treatment|Other|0|||
143010158|NCT00539006|515574333|FG001|Pre-treatment|Other|1|||
143010159|NCT00539006|515574334|FG002|Pre-treatment|Other|0|||
143010160|NCT00539006|515574335|FG003|Pre-treatment|Other|0|||
143010161|NCT00539006|515574332|FG000|Treatment Period 1|Lost to Follow-up|0|||
143010162|NCT00539006|515574333|FG001|Treatment Period 1|Lost to Follow-up|0|||
143010163|NCT00539006|515574334|FG002|Treatment Period 1|Lost to Follow-up|1|||
143010164|NCT00539006|515574335|FG003|Treatment Period 1|Lost to Follow-up|0|||
143010165|NCT00539006|515574332|FG000|Treatment Period 1|Protocol Violation|0|||
143010166|NCT00539006|515574333|FG001|Treatment Period 1|Protocol Violation|0|||
143010167|NCT00539006|515574334|FG002|Treatment Period 1|Protocol Violation|1|||
143010168|NCT00539006|515574335|FG003|Treatment Period 1|Protocol Violation|0|||
143010169|NCT00539006|515574332|FG000|Treatment Period 1|Lack of Efficacy|0|||
143010170|NCT00539006|515574333|FG001|Treatment Period 1|Lack of Efficacy|0|||
143010171|NCT00539006|515574334|FG002|Treatment Period 1|Lack of Efficacy|0|||
143010172|NCT00539006|515574335|FG003|Treatment Period 1|Lack of Efficacy|1|||
143010173|NCT00539006|515574332|FG000|Washout|Adverse Event|2|||
143010174|NCT00539006|515574333|FG001|Washout|Adverse Event|1|||
143010175|NCT00539006|515574334|FG002|Washout|Adverse Event|0|||
143010176|NCT00539006|515574335|FG003|Washout|Adverse Event|0|||
143010177|NCT00539006|515574332|FG000|Washout|Protocol Violation|1|||
143010178|NCT00539006|515574333|FG001|Washout|Protocol Violation|1|||
143010179|NCT00539006|515574334|FG002|Washout|Protocol Violation|0|||
143010180|NCT00539006|515574335|FG003|Washout|Protocol Violation|0|||
143010181|NCT00539006|515574332|FG000|Washout|Withdrawal by Subject|0|||
143010182|NCT00539006|515574333|FG001|Washout|Withdrawal by Subject|2|||
143010183|NCT00539006|515574334|FG002|Washout|Withdrawal by Subject|0|||
143010184|NCT00539006|515574335|FG003|Washout|Withdrawal by Subject|0|||
143010185|NCT00539006|515574332|FG000|Washout|Failed to meet continuation criteria|16|||
143010186|NCT00539006|515574333|FG001|Washout|Failed to meet continuation criteria|5|||
143010187|NCT00539006|515574334|FG002|Washout|Failed to meet continuation criteria|14|||
143010188|NCT00539006|515574335|FG003|Washout|Failed to meet continuation criteria|6|||
143010189|NCT00539006|515574332|FG000|Washout|Other|1|||
143010190|NCT00539006|515574333|FG001|Washout|Other|1|||
143010191|NCT00539006|515574334|FG002|Washout|Other|2|||
143010192|NCT00539006|515574335|FG003|Washout|Other|3|||
143010193|NCT00539006|515574332|FG000|Treatment Period 2|Protocol Violation|1|||
143010194|NCT00539006|515574333|FG001|Treatment Period 2|Protocol Violation|0|||
143010195|NCT00539006|515574334|FG002|Treatment Period 2|Protocol Violation|0|||
143010196|NCT00539006|515574335|FG003|Treatment Period 2|Protocol Violation|0|||
143010197|NCT00539006|515574332|FG000|Treatment Period 2|Other|0|||
143010198|NCT00539006|515574333|FG001|Treatment Period 2|Other|1|||
143010199|NCT00539006|515574334|FG002|Treatment Period 2|Other|0|||
143010200|NCT00539006|515574335|FG003|Treatment Period 2|Other|0|||
143010201|NCT01965431|515574338|FG000|Overall Study|Adverse Event|0|||
143010202|NCT01965431|515574339|FG001|Overall Study|Adverse Event|1|||
143010203|NCT01965431|515574340|FG002|Overall Study|Adverse Event|0|||
143010204|NCT01965431|515574341|FG003|Overall Study|Adverse Event|0|||
143010205|NCT01965431|515574342|FG004|Overall Study|Adverse Event|0|||
143010206|NCT01965431|515574343|FG005|Overall Study|Adverse Event|0|||
143346849|NCT00393523|516816768|FG002|Overall Study|Difficulties in specimen collection|1|||
143346850|NCT00393523|516816769|FG003|Overall Study|Difficulties in specimen collection|0|||
143010207|NCT01965431|515574338|FG000|Overall Study|Other than stated above|6|||
143010208|NCT01965431|515574339|FG001|Overall Study|Other than stated above|5|||
143010209|NCT01965431|515574340|FG002|Overall Study|Other than stated above|6|||
143346851|NCT00393523|516816770|FG004|Overall Study|Difficulties in specimen collection|0|||
143346852|NCT00393523|516816766|FG000|Overall Study|Vaccine supply issue|0|||
143346853|NCT00393523|516816767|FG001|Overall Study|Vaccine supply issue|0|||
143010210|NCT01965431|515574341|FG003|Overall Study|Other than stated above|6|||
143010211|NCT01965431|515574342|FG004|Overall Study|Other than stated above|6|||
143010212|NCT01965431|515574343|FG005|Overall Study|Other than stated above|6|||
143010213|NCT04635631|515574344|FG000|Overall Study|Adverse Event|1|||
143010214|NCT04635631|515574344|FG000|Overall Study|Progressive disease|13|||
143010215|NCT04635631|515574344|FG000|Overall Study|Withdrawal by Subject|1|||
143010216|NCT00577031|515574345|FG000|Overall Study|Adverse Event|52|||
143010217|NCT00577031|515574345|FG000|Overall Study|Progression of disease|93|||
143010218|NCT00577031|515574345|FG000|Overall Study|Protocol Violation|5|||
143010219|NCT00577031|515574345|FG000|Overall Study|Participant withdrew consent|13|||
143010220|NCT00577031|515574345|FG000|Overall Study|Participant non-compliance|5|||
143010221|NCT00577031|515574345|FG000|Overall Study|Need for surgery|17|||
143010222|NCT00577031|515574345|FG000|Overall Study|Medical decision|14|||
143010223|NCT00577031|515574345|FG000|Overall Study|Death|6|||
143010224|NCT02050373|515574346|FG000|Overall Study|Adverse Event|4|||
143010225|NCT02050373|515574347|FG001|Overall Study|Adverse Event|7|||
143010226|NCT02050373|515574346|FG000|Overall Study|Death|3|||
143010227|NCT02050373|515574347|FG001|Overall Study|Death|3|||
143010228|NCT02230332|515574348|FG000|Overall Study|Adverse Event|2|||
143010229|NCT02230332|515574349|FG001|Overall Study|Adverse Event|1|||
143010230|NCT02230332|515574348|FG000|Overall Study|Lost to Follow-up|1|||
143010231|NCT02230332|515574349|FG001|Overall Study|Lost to Follow-up|0|||
143010232|NCT02230332|515574348|FG000|Overall Study|Protocol Violation|1|||
143010233|NCT02230332|515574349|FG001|Overall Study|Protocol Violation|0|||
143010234|NCT04054011|515574350|FG000|Overall Study|COVID|3|||
143010235|NCT00557830|515574351|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
143010236|NCT00557830|515574352|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
143010237|NCT00557830|515574353|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
143010238|NCT00557830|515574351|FG000|Screening Treatment Phase|Adverse Event|2|||
143010239|NCT00557830|515574352|FG001|Screening Treatment Phase|Adverse Event|0|||
143010240|NCT00557830|515574353|FG002|Screening Treatment Phase|Adverse Event|0|||
143010241|NCT00557830|515574351|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
143010242|NCT00557830|515574352|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
143010243|NCT00557830|515574353|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
143010244|NCT00538473|515574357|FG000|Overall Study|Adverse Event|1|||
143010245|NCT00538473|515574358|FG001|Overall Study|Adverse Event|0|||
143010246|NCT01803464|515574359|FG000|Overall Study|Incomplete data|0|||
143010247|NCT01803464|515574360|FG001|Overall Study|Incomplete data|0|||
143010248|NCT01803464|515574361|FG002|Overall Study|Incomplete data|4|||
143010249|NCT01803464|515574362|FG003|Overall Study|Incomplete data|0|||
143010250|NCT01803464|515574359|FG000|Overall Study|Withdrawal by Subject|1|||
143010251|NCT01803464|515574360|FG001|Overall Study|Withdrawal by Subject|0|||
143010252|NCT01803464|515574361|FG002|Overall Study|Withdrawal by Subject|0|||
143010253|NCT01803464|515574362|FG003|Overall Study|Withdrawal by Subject|0|||
143010254|NCT01360021|515574368|FG000|Overall Study|Eligibility criteria + other|2|||
143010255|NCT01360021|515574369|FG001|Overall Study|Eligibility criteria + other|1|||
143010256|NCT01360021|515574370|FG002|Overall Study|Eligibility criteria + other|1|||
143010257|NCT01360021|515574368|FG000|Overall Study|Protocol Violation|0|||
143010258|NCT01360021|515574369|FG001|Overall Study|Protocol Violation|0|||
143010259|NCT01360021|515574370|FG002|Overall Study|Protocol Violation|1|||
143010260|NCT01360021|515574368|FG000|Overall Study|Withdrawal by Subject|4|||
143010261|NCT01360021|515574369|FG001|Overall Study|Withdrawal by Subject|0|||
143010262|NCT01360021|515574370|FG002|Overall Study|Withdrawal by Subject|2|||
143010263|NCT01360021|515574368|FG000|Overall Study|Adverse Event|2|||
143010264|NCT01360021|515574369|FG001|Overall Study|Adverse Event|3|||
143010265|NCT01360021|515574370|FG002|Overall Study|Adverse Event|3|||
143010266|NCT00203892|515574371|FG000|Overall Study|Physician Decision|1|||
143010267|NCT00203892|515574372|FG001|Overall Study|Physician Decision|2|||
143010268|NCT00203892|515574373|FG002|Overall Study|Physician Decision|0|||
143010269|NCT00203892|515574371|FG000|Overall Study|Death|1|||
143010270|NCT00203892|515574372|FG001|Overall Study|Death|0|||
143010271|NCT00203892|515574373|FG002|Overall Study|Death|0|||
143010272|NCT00806416|515574374|FG000|Period 1 - Part I|Adverse Event|0|||
143010273|NCT00806416|515574375|FG001|Period 1 - Part I|Adverse Event|1|||
143010274|NCT00806416|515574376|FG002|Period 1 - Part I|Adverse Event|0|||
143010275|NCT00806416|515574377|FG003|Period 1 - Part I|Adverse Event|0|||
143010276|NCT00806416|515574374|FG000|Period 1 - Part I|Lost to Follow-up|0|||
143010277|NCT00806416|515574375|FG001|Period 1 - Part I|Lost to Follow-up|2|||
143010278|NCT00806416|515574376|FG002|Period 1 - Part I|Lost to Follow-up|0|||
143010279|NCT00806416|515574377|FG003|Period 1 - Part I|Lost to Follow-up|0|||
143010280|NCT00806416|515574374|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
143010281|NCT00806416|515574375|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
143346854|NCT00393523|516816768|FG002|Overall Study|Vaccine supply issue|1|||
143010282|NCT00806416|515574376|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
143010283|NCT00806416|515574377|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
143010284|NCT00806416|515574374|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
143010285|NCT00806416|515574375|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
143010286|NCT00806416|515574376|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
143010287|NCT00806416|515574377|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
143010288|NCT01036594|515574378|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
143010289|NCT01036594|515574379|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
143010290|NCT01036594|515574378|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
143010291|NCT01036594|515574379|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
143346855|NCT00393523|516816769|FG003|Overall Study|Vaccine supply issue|0|||
143010292|NCT01036594|515574378|FG000|Week 12 Evaluation|Adverse Event|5|||
143010293|NCT01036594|515574379|FG001|Week 12 Evaluation|Adverse Event|0|||
143010294|NCT01036594|515574378|FG000|Week 12 Evaluation|Physician Decision|1|||
143010295|NCT01036594|515574379|FG001|Week 12 Evaluation|Physician Decision|0|||
143010296|NCT01036594|515574378|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
143010297|NCT01036594|515574379|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
143010298|NCT01036594|515574378|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
143010299|NCT01036594|515574379|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
143010300|NCT01036594|515574378|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
143010301|NCT01036594|515574379|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
143010302|NCT01036594|515574378|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
143010303|NCT01036594|515574379|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
143010304|NCT01036594|515574378|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
143010305|NCT01036594|515574379|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
143010306|NCT00244881|515574380|FG000|Overall Study|Withdrawal by Subject|3|||
143010307|NCT04935931|515574384|FG000|Overall Study|Withdrawal by Subject|1|||
143010308|NCT00824993|515574391|FG000|Overall Study|Withdrawal by Subject|1|||
143010309|NCT00824993|515574392|FG001|Overall Study|Withdrawal by Subject|1|||
143010310|NCT00824993|515574391|FG000|Overall Study|Malignancy Relapse|9|||
143010311|NCT00824993|515574392|FG001|Overall Study|Malignancy Relapse|10|||
143010312|NCT00824993|515574391|FG000|Overall Study|Rapid Bone Loss|0|||
143010313|NCT00824993|515574392|FG001|Overall Study|Rapid Bone Loss|1|||
143010314|NCT00824993|515574391|FG000|Overall Study|Non-Compliant|2|||
143010315|NCT00824993|515574392|FG001|Overall Study|Non-Compliant|1|||
143010316|NCT00824993|515574391|FG000|Overall Study|Insurance Issue|2|||
143010317|NCT00824993|515574392|FG001|Overall Study|Insurance Issue|1|||
143010318|NCT00824993|515574391|FG000|Overall Study|Death|0|||
143010319|NCT00824993|515574392|FG001|Overall Study|Death|3|||
143010320|NCT02596009|515574398|FG000|Overall Study|Administrative problems|0|||
143010321|NCT02596009|515574399|FG001|Overall Study|Administrative problems|1|||
143010322|NCT02596009|515574400|FG002|Overall Study|Administrative problems|0|||
143010323|NCT02596009|515574401|FG003|Overall Study|Administrative problems|0|||
143010324|NCT02596009|515574402|FG004|Overall Study|Administrative problems|0|||
143010325|NCT02596009|515574403|FG005|Overall Study|Administrative problems|0|||
143010326|NCT00518011|515574404|FG000|Overall Study|Death|1|||
143010327|NCT00518011|515574405|FG001|Overall Study|Death|1|||
143010328|NCT00518011|515574404|FG000|Overall Study|Adverse Event|2|||
143010329|NCT00518011|515574405|FG001|Overall Study|Adverse Event|3|||
143010330|NCT00518011|515574404|FG000|Overall Study|Disease Progression|2|||
143010331|NCT00518011|515574405|FG001|Overall Study|Disease Progression|2|||
143010332|NCT00518011|515574404|FG000|Overall Study|Other Reasons|3|||
143010333|NCT00518011|515574405|FG001|Overall Study|Other Reasons|2|||
143010334|NCT00518011|515574404|FG000|Overall Study|Withdrawal by Subject|1|||
143010335|NCT00518011|515574405|FG001|Overall Study|Withdrawal by Subject|0|||
143010336|NCT03409328|515574406|FG000|Overall Study|Lost to Follow-up|6|||
143010337|NCT03409328|515574407|FG001|Overall Study|Lost to Follow-up|3|||
143010338|NCT02998645|515574408|FG000|Treatment Period 1|Adverse Event|6|||
143010339|NCT02998645|515574408|FG000|Treatment Period 1|Death|5|||
143010340|NCT02998645|515574408|FG000|Treatment Period 1|Technical Problems|4|||
143010341|NCT02998645|515574408|FG000|Treatment Period 1|Lack of Efficacy|2|||
143010342|NCT02998645|515574408|FG000|Treatment Period 1|Progressive disease|1|||
143010343|NCT02998645|515574408|FG000|Treatment Period 1|Subject/guardian decision|1|||
143010344|NCT02998645|515574408|FG000|Treatment Period 2|Lack of Efficacy|5|||
143010345|NCT02998645|515574408|FG000|Treatment Period 2|Adverse Event|2|||
143010346|NCT02998645|515574408|FG000|Treatment Period 2|Progressive disease|2|||
143010347|NCT02998645|515574408|FG000|Treatment Period 2|Physician Decision|1|||
143010348|NCT03930615|515574410|FG000|Overall Study|Death|9|||
143010349|NCT03930615|515574411|FG001|Overall Study|Death|3|||
143010350|NCT03930615|515574410|FG000|Overall Study|Lost to Follow-up|1|||
143010351|NCT03930615|515574411|FG001|Overall Study|Lost to Follow-up|2|||
143010352|NCT03930615|515574410|FG000|Overall Study|Physician Decision|3|||
143010353|NCT03930615|515574411|FG001|Overall Study|Physician Decision|4|||
143010354|NCT03930615|515574410|FG000|Overall Study|Withdrawal by Subject|13|||
143010355|NCT03930615|515574411|FG001|Overall Study|Withdrawal by Subject|2|||
143010356|NCT03930615|515574410|FG000|Overall Study|Not treated|1|||
143010357|NCT03930615|515574411|FG001|Overall Study|Not treated|1|||
143010358|NCT03128931|515574412|FG000|Overall Study|Physician Decision|1|||
143010359|NCT03128931|515574412|FG000|Overall Study|Equipment Issues|3|||
143010360|NCT03539952|515574413|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
143010361|NCT03539952|515574414|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
143010362|NCT03539952|515574413|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
143010363|NCT03539952|515574414|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
143010364|NCT03539952|515574413|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
143010365|NCT03539952|515574414|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
143010366|NCT03539952|515574413|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
143010367|NCT03539952|515574414|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
143461349|NCT05559099|517235021|FG001|Overall Study|Adverse Event|1|||
143010368|NCT03539952|515574413|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
143010369|NCT03539952|515574414|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
143010370|NCT03539952|515574413|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
143010371|NCT03539952|515574414|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
143010372|NCT03539952|515574413|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
143010373|NCT03539952|515574414|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
143010374|NCT02184988|515574415|FG000|Overall Study|Pregnancy|2|||
143010375|NCT02184988|515574415|FG000|Overall Study|Adverse Event|2|||
143010376|NCT02184988|515574415|FG000|Overall Study|moving away/travelling/unable to complet|6|||
143010377|NCT02184988|515574415|FG000|Overall Study|work scheduling issues|4|||
143010378|NCT02184988|515574415|FG000|Overall Study|various other reasons|9|||
143010379|NCT02184988|515574415|FG000|Overall Study|Lost to Follow-up|32|||
143010380|NCT03075215|515574416|FG000|12-Month Primary Endpoint|Death|152|||
143010381|NCT03075215|515574416|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
143010382|NCT03075215|515574416|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
143010383|NCT03075215|515574416|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
143010384|NCT01608321|515574421|FG000|Overall Study|Withdrawal by Subject|1|||
143010385|NCT01608321|515574422|FG001|Overall Study|Withdrawal by Subject|0|||
143010386|NCT00526227|515574423|FG000|Overall Study|Device not implanted|1|||
143010387|NCT00526227|515574423|FG000|Overall Study|Death|1|||
143010388|NCT02087865|515576147|FG000|Overall Study|Withdrawal by Subject|6|||
143010389|NCT02087865|515576148|FG001|Overall Study|Withdrawal by Subject|0|||
143010390|NCT02087865|515576149|FG002|Overall Study|Withdrawal by Subject|1|||
143010391|NCT02087865|515576147|FG000|Overall Study|Lost to Follow-up|0|||
143010392|NCT02087865|515576148|FG001|Overall Study|Lost to Follow-up|0|||
143010393|NCT02087865|515576149|FG002|Overall Study|Lost to Follow-up|1|||
143010394|NCT02087865|515576147|FG000|Overall Study|Drug Non-compliance|0|||
143010395|NCT02087865|515576148|FG001|Overall Study|Drug Non-compliance|2|||
143010396|NCT02087865|515576149|FG002|Overall Study|Drug Non-compliance|0|||
143010397|NCT02087865|515576147|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
143010398|NCT02087865|515576148|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
143010399|NCT02087865|515576149|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
143010400|NCT01808508|515576152|FG000|Overall Study|Lost to Follow-up|1|||
143010401|NCT01808508|515576153|FG001|Overall Study|Lost to Follow-up|0|||
143010402|NCT01808508|515576154|FG002|Overall Study|Lost to Follow-up|0|||
143010403|NCT00648739|515576156|FG000|Overall Study|Adverse Event|1|||
143010404|NCT00648739|515576157|FG001|Overall Study|Adverse Event|0|||
143010405|NCT00648739|515576158|FG002|Overall Study|Adverse Event|1|||
143010406|NCT00648739|515576159|FG003|Overall Study|Adverse Event|2|||
143010407|NCT00648739|515576160|FG004|Overall Study|Adverse Event|1|||
143010408|NCT00648739|515576161|FG005|Overall Study|Adverse Event|0|||
143010409|NCT00648739|515576162|FG006|Overall Study|Adverse Event|0|||
143010410|NCT00648739|515576156|FG000|Overall Study|Withdrawal by Subject|1|||
143010411|NCT00648739|515576157|FG001|Overall Study|Withdrawal by Subject|0|||
143010412|NCT00648739|515576158|FG002|Overall Study|Withdrawal by Subject|1|||
143010413|NCT00648739|515576159|FG003|Overall Study|Withdrawal by Subject|0|||
143010414|NCT00648739|515576160|FG004|Overall Study|Withdrawal by Subject|0|||
143010415|NCT00648739|515576161|FG005|Overall Study|Withdrawal by Subject|2|||
143010416|NCT00648739|515576162|FG006|Overall Study|Withdrawal by Subject|0|||
143010417|NCT00648739|515576156|FG000|Overall Study|Lack of Efficacy|0|||
143010418|NCT00648739|515576157|FG001|Overall Study|Lack of Efficacy|0|||
143010419|NCT00648739|515576158|FG002|Overall Study|Lack of Efficacy|0|||
143010420|NCT00648739|515576159|FG003|Overall Study|Lack of Efficacy|0|||
143010421|NCT00648739|515576160|FG004|Overall Study|Lack of Efficacy|1|||
143010422|NCT00648739|515576161|FG005|Overall Study|Lack of Efficacy|2|||
143010423|NCT00648739|515576162|FG006|Overall Study|Lack of Efficacy|0|||
143010424|NCT00648739|515576156|FG000|Overall Study|Investigator Considered it Advisable|0|||
143010425|NCT00648739|515576157|FG001|Overall Study|Investigator Considered it Advisable|0|||
143010426|NCT00648739|515576158|FG002|Overall Study|Investigator Considered it Advisable|0|||
143010427|NCT00648739|515576159|FG003|Overall Study|Investigator Considered it Advisable|0|||
143010428|NCT00648739|515576160|FG004|Overall Study|Investigator Considered it Advisable|0|||
143010429|NCT00648739|515576161|FG005|Overall Study|Investigator Considered it Advisable|1|||
143461350|NCT04018092|517235022|FG000|Overall Study|Withdrawal by Subject|1|||
143461351|NCT04018092|517235023|FG001|Overall Study|Withdrawal by Subject|1|||
143461352|NCT04018092|517235022|FG000|Overall Study|Withdrawal by Subject|1|||
143010430|NCT00648739|515576162|FG006|Overall Study|Investigator Considered it Advisable|1|||
143010431|NCT00648739|515576156|FG000|Overall Study|Death|0|||
143010432|NCT00648739|515576157|FG001|Overall Study|Death|1|||
143010433|NCT00648739|515576158|FG002|Overall Study|Death|0|||
143010434|NCT00648739|515576159|FG003|Overall Study|Death|0|||
143010435|NCT00648739|515576160|FG004|Overall Study|Death|0|||
143010436|NCT00648739|515576161|FG005|Overall Study|Death|0|||
143010437|NCT00648739|515576162|FG006|Overall Study|Death|0|||
143010438|NCT00648739|515576156|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
143010439|NCT00648739|515576157|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
143010440|NCT00648739|515576158|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
143010441|NCT00648739|515576159|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
143010442|NCT00648739|515576160|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
143010443|NCT00648739|515576161|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
143010444|NCT00648739|515576162|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
143010445|NCT00648739|515576156|FG000|Overall Study|Follow-up Visits Not Completed|0|||
143010446|NCT00648739|515576157|FG001|Overall Study|Follow-up Visits Not Completed|1|||
143010447|NCT00648739|515576158|FG002|Overall Study|Follow-up Visits Not Completed|0|||
143010448|NCT00648739|515576159|FG003|Overall Study|Follow-up Visits Not Completed|0|||
143010449|NCT00648739|515576160|FG004|Overall Study|Follow-up Visits Not Completed|0|||
143010450|NCT00648739|515576161|FG005|Overall Study|Follow-up Visits Not Completed|0|||
143010451|NCT00648739|515576162|FG006|Overall Study|Follow-up Visits Not Completed|0|||
143010452|NCT00564486|515576169|FG000|Overall Study|Adverse Event|0|||
143010453|NCT00564486|515576170|FG001|Overall Study|Adverse Event|1|||
143010454|NCT00564486|515576171|FG002|Overall Study|Adverse Event|0|||
143010455|NCT00564486|515576172|FG003|Overall Study|Adverse Event|0|||
143010456|NCT00564486|515576169|FG000|Overall Study|Withdrawal by Subject|4|||
143010457|NCT00564486|515576170|FG001|Overall Study|Withdrawal by Subject|0|||
143010458|NCT00564486|515576171|FG002|Overall Study|Withdrawal by Subject|0|||
143010459|NCT00564486|515576172|FG003|Overall Study|Withdrawal by Subject|5|||
143010460|NCT00564486|515576169|FG000|Overall Study|Subject refused to have blood drawn|0|||
143010461|NCT00564486|515576170|FG001|Overall Study|Subject refused to have blood drawn|0|||
143010462|NCT00564486|515576171|FG002|Overall Study|Subject refused to have blood drawn|1|||
143010463|NCT00564486|515576172|FG003|Overall Study|Subject refused to have blood drawn|0|||
143010464|NCT00564486|515576169|FG000|Overall Study|Lost to Follow-up|3|||
143010465|NCT00564486|515576170|FG001|Overall Study|Lost to Follow-up|0|||
143346856|NCT00393523|516816770|FG004|Overall Study|Vaccine supply issue|0|||
143346857|NCT02912468|516816772|FG000|Overall Study|Adverse Event|3|||
143346858|NCT02912468|516816773|FG001|Overall Study|Adverse Event|2|||
143346859|NCT02912468|516816772|FG000|Overall Study|Withdrawal by Subject|6|||
143346860|NCT02912468|516816773|FG001|Overall Study|Withdrawal by Subject|2|||
143346861|NCT02912468|516816772|FG000|Overall Study|Randomized and not treated|0|||
143346862|NCT02912468|516816773|FG001|Overall Study|Randomized and not treated|1|||
143346863|NCT00692406|516816776|FG000|Overall Study|PI dropped, bad data|57|||
143346864|NCT00525265|516816779|FG000|Overall Study|Protocol Violation|1|||
143346865|NCT00525265|516816780|FG001|Overall Study|Protocol Violation|0|||
143346866|NCT01913639|516816783|FG000|Overall Study|Not Eligible|3|||
143346867|NCT00130793|516816795|FG000|Overall Study|Lost to Follow-up|1|||
143461353|NCT04018092|517235023|FG001|Overall Study|Withdrawal by Subject|1|||
143461354|NCT04055090|517235024|FG000|Overall Study|screen failure|1|||
143461355|NCT04055090|517235025|FG001|Overall Study|screen failure|0|||
143461356|NCT04055090|517235024|FG000|Overall Study|Withdrawal by Subject|1|||
143461357|NCT04055090|517235025|FG001|Overall Study|Withdrawal by Subject|0|||
143461358|NCT04745026|517235026|FG000|Overall Study|Physician Decision|1|||
143461359|NCT04745026|517235027|FG001|Overall Study|Physician Decision|0|||
143461360|NCT04745026|517235026|FG000|Overall Study|Adverse Event|2|||
143461361|NCT04745026|517235027|FG001|Overall Study|Adverse Event|2|||
143461362|NCT04745026|517235026|FG000|Overall Study|Protocol Violation|1|||
143461363|NCT04745026|517235027|FG001|Overall Study|Protocol Violation|3|||
143461364|NCT04745026|517235026|FG000|Overall Study|Lost to Follow-up|4|||
143461365|NCT04745026|517235027|FG001|Overall Study|Lost to Follow-up|3|||
143461366|NCT04745026|517235026|FG000|Overall Study|Withdrawal by Subject|5|||
143461367|NCT04745026|517235027|FG001|Overall Study|Withdrawal by Subject|5|||
143461368|NCT05478499|517235030|FG000|Placebo Controlled: Week 0 - 16|Adverse Event|4|||
143461369|NCT05478499|517235031|FG001|Placebo Controlled: Week 0 - 16|Adverse Event|2|||
143461370|NCT05478499|517235030|FG000|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|3|||
143461371|NCT05478499|517235031|FG001|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|2|||
143461372|NCT05478499|517235030|FG000|Placebo Controlled: Week 0 - 16|Lack of Efficacy|1|||
143461373|NCT05478499|517235031|FG001|Placebo Controlled: Week 0 - 16|Lack of Efficacy|0|||
143461374|NCT05478499|517235030|FG000|Placebo Controlled: Week 0 - 16|Lost to Follow-up|1|||
143461375|NCT05478499|517235031|FG001|Placebo Controlled: Week 0 - 16|Lost to Follow-up|0|||
143461376|NCT05478499|517235030|FG000|Placebo Controlled: Week 0 - 16|Other reasons|0|||
143010466|NCT00564486|515576171|FG002|Overall Study|Lost to Follow-up|2|||
143346868|NCT00130793|516816796|FG001|Overall Study|Lost to Follow-up|4|||
143346869|NCT00130793|516816795|FG000|Overall Study|Withdrew consent|2|||
143461377|NCT05478499|517235031|FG001|Placebo Controlled: Week 0 - 16|Other reasons|2|||
143461378|NCT05478499|517235030|FG000|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|4|||
143010467|NCT00564486|515576172|FG003|Overall Study|Lost to Follow-up|2|||
143010468|NCT03387423|515576173|FG000|Overall Study|Lost to Follow-up|16|||
143010469|NCT03387423|515576174|FG001|Overall Study|Lost to Follow-up|12|||
143010470|NCT03387423|515576175|FG002|Overall Study|Lost to Follow-up|1|||
143346870|NCT00130793|516816796|FG001|Overall Study|Withdrew consent|0|||
143346871|NCT00453102|516816799|FG000|Overall Study|Withdrawal by Subject|2|||
143461379|NCT05478499|517235031|FG001|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|2|||
143461380|NCT05478499|517235030|FG000|Active Treatment: Week 16 - Week 52|Lack of Efficacy|4|||
143010471|NCT03387423|515576176|FG003|Overall Study|Lost to Follow-up|0|||
143010472|NCT03387423|515576173|FG000|Overall Study|Other|0|||
143010473|NCT03387423|515576174|FG001|Overall Study|Other|3|||
143010474|NCT03387423|515576175|FG002|Overall Study|Other|0|||
143010475|NCT03387423|515576176|FG003|Overall Study|Other|0|||
143010476|NCT03387423|515576173|FG000|Overall Study|Administrative Reason|166|||
143010477|NCT03387423|515576174|FG001|Overall Study|Administrative Reason|89|||
143010478|NCT03387423|515576175|FG002|Overall Study|Administrative Reason|17|||
143010479|NCT03387423|515576176|FG003|Overall Study|Administrative Reason|19|||
143010480|NCT03387423|515576173|FG000|Overall Study|Revocation Consent|76|||
143010481|NCT03387423|515576174|FG001|Overall Study|Revocation Consent|32|||
143010482|NCT03387423|515576175|FG002|Overall Study|Revocation Consent|3|||
143010483|NCT03387423|515576176|FG003|Overall Study|Revocation Consent|5|||
143010484|NCT03862807|515576181|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
143010485|NCT04362761|515576182|FG000|Part A (48 Weeks)|Adverse Event|2|||
143010486|NCT04362761|515576182|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
143010487|NCT04362761|515576182|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
143010488|NCT04362761|515576182|FG000|Part A (48 Weeks)|Other|5|||
143010489|NCT04362761|515576182|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
143010490|NCT04362761|515576182|FG000|Part B (86 Weeks)|Other|4|||
143010491|NCT01819467|515576186|FG000|Overall Study|Physician Decision|20|||
143010492|NCT01819467|515576187|FG001|Overall Study|Physician Decision|9|||
143010493|NCT01607398|515576188|FG000|Overall Study|Adverse Event|0|||
143010494|NCT01607398|515576189|FG001|Overall Study|Adverse Event|2|||
143010495|NCT01607398|515576188|FG000|Overall Study|Severe COPD|2|||
143010496|NCT01607398|515576189|FG001|Overall Study|Severe COPD|0|||
143010497|NCT03926728|515576190|FG000|Overall Study|Withdrawal by Subject|0|||
143010498|NCT03926728|515576191|FG001|Overall Study|Withdrawal by Subject|1|||
143010499|NCT03926728|515576192|FG002|Overall Study|Withdrawal by Subject|1|||
143010500|NCT03926728|515576193|FG003|Overall Study|Withdrawal by Subject|0|||
143010501|NCT03926728|515576194|FG004|Overall Study|Withdrawal by Subject|0|||
143010502|NCT03926728|515576195|FG005|Overall Study|Withdrawal by Subject|1|||
143010503|NCT03926728|515576196|FG006|Overall Study|Withdrawal by Subject|1|||
143010504|NCT03926728|515576197|FG007|Overall Study|Withdrawal by Subject|0|||
143010505|NCT03926728|515576198|FG008|Overall Study|Withdrawal by Subject|0|||
143010506|NCT03926728|515576199|FG009|Overall Study|Withdrawal by Subject|1|||
143010507|NCT03926728|515576200|FG010|Overall Study|Withdrawal by Subject|0|||
143010508|NCT03926728|515576201|FG011|Overall Study|Withdrawal by Subject|0|||
143010509|NCT03993288|515576202|FG000|Overall Study|Lost to Follow-up|2|||
143010510|NCT03993288|515576203|FG001|Overall Study|Lost to Follow-up|1|||
143010511|NCT03993288|515576202|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
143010512|NCT03993288|515576203|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
143010513|NCT03993288|515576202|FG000|Overall Study|wrong randomization|0|||
143010514|NCT03993288|515576203|FG001|Overall Study|wrong randomization|1|||
143010515|NCT03993288|515576202|FG000|Overall Study|improper enrollment|0|||
143010516|NCT03993288|515576203|FG001|Overall Study|improper enrollment|1|||
143010517|NCT03993288|515576202|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
143010518|NCT03993288|515576203|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
143010519|NCT03993288|515576202|FG000|Overall Study|developed SAE|2|||
143010520|NCT03993288|515576203|FG001|Overall Study|developed SAE|0|||
143010521|NCT03993288|515576202|FG000|Overall Study|consent withdrawal|1|||
143010522|NCT03993288|515576203|FG001|Overall Study|consent withdrawal|0|||
143010523|NCT03993288|515576202|FG000|Overall Study|did not follow the treatment schedule|1|||
143010524|NCT03993288|515576203|FG001|Overall Study|did not follow the treatment schedule|0|||
143010525|NCT03993288|515576202|FG000|Overall Study|did not follow the treatment regimen|1|||
143010526|NCT03993288|515576203|FG001|Overall Study|did not follow the treatment regimen|0|||
143010527|NCT03993288|515576202|FG000|Overall Study|Adverse Event|1|||
143010528|NCT03993288|515576203|FG001|Overall Study|Adverse Event|0|||
143346872|NCT04078035|516816800|FG000|Session 2|Lost to Follow-up|3|||
143346873|NCT04078035|516816801|FG001|Session 2|Lost to Follow-up|1|||
143346874|NCT04078035|516816800|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
143346875|NCT04078035|516816801|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
143346876|NCT02100722|516816804|FG000|Overall Study|Withdrawal pre-procedure|4|||
143346877|NCT02100722|516816805|FG001|Overall Study|Withdrawal pre-procedure|9|||
143346878|NCT02100722|516816804|FG000|Overall Study|Withdrawal post-procedure|0|||
143010529|NCT03993288|515576202|FG000|Overall Study|Withdrawal by Subject|1|||
143010530|NCT03993288|515576203|FG001|Overall Study|Withdrawal by Subject|1|||
143010531|NCT00915473|515576204|FG000|Screening|Withdrawal by Subject|1|||
143010532|NCT00915473|515576205|FG001|Screening|Withdrawal by Subject|0|||
143010533|NCT00915473|515576204|FG000|4-week Follow Up|Lost to Follow-up|1|||
143010534|NCT00915473|515576205|FG001|4-week Follow Up|Lost to Follow-up|5|||
143010535|NCT02325401|515576206|FG000|Overall Study|Withdrawal by Subject|0|||
143010536|NCT02325401|515576207|FG001|Overall Study|Withdrawal by Subject|1|||
143010537|NCT02325401|515576208|FG002|Overall Study|Withdrawal by Subject|1|||
143010538|NCT00398632|515576209|FG000|Overall Study|Withdrawal by Subject|1|||
143346879|NCT02100722|516816805|FG001|Overall Study|Withdrawal post-procedure|3|||
143010539|NCT00398632|515576209|FG000|Overall Study|Lack of Efficacy|1|||
143010540|NCT00568776|515576212|FG000|Overall Study|Adverse Event|8|||
143010541|NCT00568776|515576213|FG001|Overall Study|Adverse Event|8|||
143010542|NCT00568776|515576214|FG002|Overall Study|Adverse Event|10|||
143010543|NCT00568776|515576215|FG003|Overall Study|Adverse Event|8|||
143010544|NCT00568776|515576212|FG000|Overall Study|Death|0|||
143010545|NCT00568776|515576213|FG001|Overall Study|Death|1|||
143010546|NCT00568776|515576214|FG002|Overall Study|Death|4|||
143010547|NCT00568776|515576215|FG003|Overall Study|Death|3|||
143010548|NCT00568776|515576212|FG000|Overall Study|Physician Decision|0|||
143010549|NCT00568776|515576213|FG001|Overall Study|Physician Decision|2|||
143010550|NCT00568776|515576214|FG002|Overall Study|Physician Decision|0|||
143010551|NCT00568776|515576215|FG003|Overall Study|Physician Decision|0|||
143010552|NCT00568776|515576212|FG000|Overall Study|Lack of Efficacy|2|||
143010553|NCT00568776|515576213|FG001|Overall Study|Lack of Efficacy|2|||
143010554|NCT00568776|515576214|FG002|Overall Study|Lack of Efficacy|2|||
143010555|NCT00568776|515576215|FG003|Overall Study|Lack of Efficacy|4|||
143010556|NCT00568776|515576212|FG000|Overall Study|Lost to Follow-up|1|||
143010557|NCT00568776|515576213|FG001|Overall Study|Lost to Follow-up|1|||
143010558|NCT00568776|515576214|FG002|Overall Study|Lost to Follow-up|1|||
143010559|NCT00568776|515576215|FG003|Overall Study|Lost to Follow-up|1|||
143010560|NCT00568776|515576212|FG000|Overall Study|Protocol Violation|1|||
143010561|NCT00568776|515576213|FG001|Overall Study|Protocol Violation|0|||
143010562|NCT00568776|515576214|FG002|Overall Study|Protocol Violation|1|||
143010563|NCT00568776|515576215|FG003|Overall Study|Protocol Violation|1|||
143010564|NCT00568776|515576212|FG000|Overall Study|Withdrawal by Subject|13|||
143010565|NCT00568776|515576213|FG001|Overall Study|Withdrawal by Subject|15|||
143010566|NCT00568776|515576214|FG002|Overall Study|Withdrawal by Subject|13|||
143010567|NCT00568776|515576215|FG003|Overall Study|Withdrawal by Subject|7|||
143010568|NCT00568776|515576212|FG000|Overall Study|Loss of Caregiver|0|||
143010569|NCT00568776|515576213|FG001|Overall Study|Loss of Caregiver|2|||
143010570|NCT00568776|515576214|FG002|Overall Study|Loss of Caregiver|1|||
143010571|NCT00568776|515576215|FG003|Overall Study|Loss of Caregiver|2|||
143010572|NCT00568776|515576212|FG000|Overall Study|Sponsor Decision|2|||
143010573|NCT00568776|515576213|FG001|Overall Study|Sponsor Decision|2|||
143010574|NCT00568776|515576214|FG002|Overall Study|Sponsor Decision|41|||
143010575|NCT00568776|515576215|FG003|Overall Study|Sponsor Decision|42|||
143010576|NCT00568776|515576212|FG000|Overall Study|Miscellaeneous|3|||
143010577|NCT00568776|515576213|FG001|Overall Study|Miscellaeneous|3|||
143010578|NCT00568776|515576214|FG002|Overall Study|Miscellaeneous|1|||
143010579|NCT00568776|515576215|FG003|Overall Study|Miscellaeneous|4|||
143010580|NCT01005680|515576216|FG000|Overall Study|Lost to Follow-up|4|||
143010581|NCT01005680|515576217|FG001|Overall Study|Lost to Follow-up|6|||
143010582|NCT01005680|515576216|FG000|Overall Study|Withdrawal by Subject|1|||
143010583|NCT01005680|515576217|FG001|Overall Study|Withdrawal by Subject|4|||
143010584|NCT01005680|515576216|FG000|Overall Study|Physician Decision|1|||
143010585|NCT01005680|515576217|FG001|Overall Study|Physician Decision|1|||
143010586|NCT00578448|515576224|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
143010587|NCT00578448|515576224|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
143010588|NCT00578448|515576224|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
143010589|NCT00578448|515576224|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
143010590|NCT04221373|515576225|FG000|Overall Study|Physician Decision|4|||
143010591|NCT04221373|515576226|FG001|Overall Study|Physician Decision|0|||
143010592|NCT00627094|515576227|FG000|Overall Study|Adverse Event|8|||
143010593|NCT00627094|515576228|FG001|Overall Study|Adverse Event|7|||
143010594|NCT00627094|515576227|FG000|Overall Study|Lost to Follow-up|1|||
143010595|NCT00627094|515576228|FG001|Overall Study|Lost to Follow-up|0|||
143010596|NCT00627094|515576227|FG000|Overall Study|Withdrawal by Subject|1|||
143010597|NCT00627094|515576228|FG001|Overall Study|Withdrawal by Subject|1|||
143010598|NCT00627094|515576227|FG000|Overall Study|ulcer healed|1|||
143010599|NCT00627094|515576228|FG001|Overall Study|ulcer healed|7|||
143010600|NCT00627094|515576227|FG000|Overall Study|Other reason|1|||
143010601|NCT00627094|515576228|FG001|Overall Study|Other reason|0|||
143010602|NCT03159611|515576240|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
143010603|NCT03159611|515576241|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
143010604|NCT03159611|515576240|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
143010605|NCT03159611|515576241|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
143010606|NCT03159611|515576240|FG000|Overall Study|Protocol Violation|7|||
143010607|NCT03159611|515576241|FG001|Overall Study|Protocol Violation|4|||
143010608|NCT03159611|515576240|FG000|Overall Study|Adverse Event|1|||
143010609|NCT03159611|515576241|FG001|Overall Study|Adverse Event|0|||
143010610|NCT03159611|515576240|FG000|Overall Study|Withdrawal by Subject|1|||
143010611|NCT03159611|515576241|FG001|Overall Study|Withdrawal by Subject|1|||
143010612|NCT03159611|515576240|FG000|Overall Study|Non-compliance with protocol requirement|3|||
143010613|NCT03159611|515576241|FG001|Overall Study|Non-compliance with protocol requirement|2|||
143010614|NCT03159611|515576240|FG000|Overall Study|Inability to perform procedures|1|||
143010615|NCT03159611|515576241|FG001|Overall Study|Inability to perform procedures|0|||
143010616|NCT01984229|515576242|FG000|Safety Follow-up Period|Adverse Event|1|||
143010617|NCT01984229|515576243|FG001|Safety Follow-up Period|Adverse Event|1|||
143346880|NCT02100722|516816804|FG000|Overall Study|Lost to Follow-up|2|||
143346881|NCT02100722|516816805|FG001|Overall Study|Lost to Follow-up|2|||
143346882|NCT02100722|516816804|FG000|Overall Study|Continuing on study|751|||
143346883|NCT02100722|516816805|FG001|Overall Study|Continuing on study|729|||
143346884|NCT05644353|516816807|FG000|Overall Study|Physician Decision|1|||
143346885|NCT05644353|516816808|FG001|Overall Study|Physician Decision|0|||
143346886|NCT05644353|516816809|FG002|Overall Study|Physician Decision|0|||
143346887|NCT05644353|516816810|FG003|Overall Study|Physician Decision|0|||
143346888|NCT05644353|516816811|FG004|Overall Study|Physician Decision|0|||
143346889|NCT05644353|516816812|FG005|Overall Study|Physician Decision|0|||
143346890|NCT05644353|516816807|FG000|Overall Study|Protocol Violation|1|||
143346891|NCT05644353|516816808|FG001|Overall Study|Protocol Violation|0|||
143346892|NCT05644353|516816809|FG002|Overall Study|Protocol Violation|0|||
143346893|NCT05644353|516816810|FG003|Overall Study|Protocol Violation|0|||
143346894|NCT05644353|516816811|FG004|Overall Study|Protocol Violation|0|||
143346895|NCT05644353|516816812|FG005|Overall Study|Protocol Violation|0|||
143346896|NCT05644353|516816807|FG000|Overall Study|Withdrawal by Subject|0|||
143346897|NCT05644353|516816808|FG001|Overall Study|Withdrawal by Subject|2|||
143346898|NCT05644353|516816809|FG002|Overall Study|Withdrawal by Subject|0|||
143346899|NCT05644353|516816810|FG003|Overall Study|Withdrawal by Subject|0|||
143346900|NCT05644353|516816811|FG004|Overall Study|Withdrawal by Subject|1|||
143346901|NCT05644353|516816812|FG005|Overall Study|Withdrawal by Subject|0|||
143346902|NCT05644353|516816807|FG000|Overall Study|Lost to Follow-up|0|||
143346903|NCT05644353|516816808|FG001|Overall Study|Lost to Follow-up|0|||
143346904|NCT05644353|516816809|FG002|Overall Study|Lost to Follow-up|1|||
143346905|NCT05644353|516816810|FG003|Overall Study|Lost to Follow-up|0|||
143346906|NCT05644353|516816811|FG004|Overall Study|Lost to Follow-up|0|||
143346907|NCT05644353|516816812|FG005|Overall Study|Lost to Follow-up|0|||
143346908|NCT01650519|516816813|FG000|Overall Study|Withdrawal by Subject|1|||
143346909|NCT01650519|516816814|FG001|Overall Study|Withdrawal by Subject|0|||
143346910|NCT00747123|516816818|FG000|Overall Study|Investigator's request|0|||
143346911|NCT00747123|516816819|FG001|Overall Study|Investigator's request|0|||
143346912|NCT00747123|516816820|FG002|Overall Study|Investigator's request|1|||
143346913|NCT00747123|516816821|FG003|Overall Study|Investigator's request|0|||
143346914|NCT00747123|516816818|FG000|Overall Study|Withdrew consent|0|||
143010618|NCT01984229|515576242|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
143010619|NCT01984229|515576243|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
143010620|NCT02072174|515576244|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
143010621|NCT02072174|515576245|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
143010622|NCT02072174|515576244|FG000|Overall Study|Protocol Violation|16|||
143010623|NCT02072174|515576245|FG001|Overall Study|Protocol Violation|23|||
143010624|NCT02072174|515576244|FG000|Overall Study|Physician Decision|0|||
143010625|NCT02072174|515576245|FG001|Overall Study|Physician Decision|1|||
143010626|NCT02072174|515576244|FG000|Overall Study|Non-compliance with protocol requirement|2|||
143010627|NCT02072174|515576245|FG001|Overall Study|Non-compliance with protocol requirement|0|||
143010628|NCT03644927|515576254|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
143010629|NCT03644927|515576255|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
143010630|NCT00956813|515576256|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
143124527|NCT03026283|516001209|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
143124528|NCT03026283|516001210|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
143124529|NCT03026283|516001211|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
143124530|NCT03026283|516001212|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
143124531|NCT03026283|516001205|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
143124532|NCT03026283|516001206|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
143124533|NCT03026283|516001207|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
143124534|NCT03026283|516001208|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
143124535|NCT03026283|516001209|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
143124536|NCT03026283|516001210|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
143124537|NCT03026283|516001211|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
143124538|NCT03026283|516001212|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
143124539|NCT03026283|516001205|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
143124540|NCT03026283|516001206|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
143124541|NCT03026283|516001207|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
143124542|NCT03026283|516001208|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
143124543|NCT03026283|516001209|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
143124544|NCT03026283|516001210|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
143124545|NCT03026283|516001211|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
143124546|NCT03026283|516001212|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
143124547|NCT03026283|516001205|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
143346915|NCT00747123|516816819|FG001|Overall Study|Withdrew consent|1|||
143346916|NCT00747123|516816820|FG002|Overall Study|Withdrew consent|0|||
143346917|NCT00747123|516816821|FG003|Overall Study|Withdrew consent|0|||
143346918|NCT00747123|516816818|FG000|Overall Study|Adverse Event|0|||
143346919|NCT00747123|516816819|FG001|Overall Study|Adverse Event|1|||
143346920|NCT00747123|516816820|FG002|Overall Study|Adverse Event|0|||
143346921|NCT00747123|516816821|FG003|Overall Study|Adverse Event|1|||
143346922|NCT01279343|516816827|FG000|Overall Study|Did not receive treatment|2|||
143346923|NCT01279343|516816828|FG001|Overall Study|Did not receive treatment|6|||
143010631|NCT00956813|515576257|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
143010632|NCT00956813|515576256|FG000|Flaxseed and Placebo|Ineligible|3|||
143010633|NCT00956813|515576257|FG001|Flaxseed and Placebo|Ineligible|1|||
143010634|NCT04797637|515576258|FG000|Overall Study|Lost to Follow-up|23|||
143010635|NCT04797637|515576259|FG001|Overall Study|Lost to Follow-up|32|||
143010636|NCT04797637|515576258|FG000|Overall Study|Withdrawal by Subject|0|||
143010637|NCT04797637|515576259|FG001|Overall Study|Withdrawal by Subject|1|||
143010638|NCT00358670|515576262|FG000|Overall Study|Adverse Event|26|||
143010639|NCT00358670|515576263|FG001|Overall Study|Adverse Event|29|||
143010640|NCT00358670|515576262|FG000|Overall Study|Lack of Efficacy|20|||
143010641|NCT00358670|515576263|FG001|Overall Study|Lack of Efficacy|23|||
143010642|NCT00358670|515576262|FG000|Overall Study|Protocol Violation|6|||
143010643|NCT00358670|515576263|FG001|Overall Study|Protocol Violation|9|||
143010644|NCT00358670|515576262|FG000|Overall Study|Lost to Follow-up|4|||
143010645|NCT00358670|515576263|FG001|Overall Study|Lost to Follow-up|5|||
143010646|NCT00358670|515576262|FG000|Overall Study|Withdrawal by Subject|13|||
143010647|NCT00358670|515576263|FG001|Overall Study|Withdrawal by Subject|24|||
143010648|NCT00358670|515576262|FG000|Overall Study|Protocol Defined Clinical Event|0|||
143010649|NCT00358670|515576263|FG001|Overall Study|Protocol Defined Clinical Event|1|||
143010650|NCT00358670|515576262|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
143010651|NCT00358670|515576263|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
143010652|NCT00358670|515576262|FG000|Overall Study|Administrative|153|||
143010653|NCT00358670|515576263|FG001|Overall Study|Administrative|125|||
143010654|NCT00905437|515576267|FG000|Overall Study|Adverse Event|3|||
143010655|NCT00905437|515576268|FG001|Overall Study|Adverse Event|2|||
143010656|NCT00905437|515576267|FG000|Overall Study|Lost to Follow-up|0|||
143010657|NCT00905437|515576268|FG001|Overall Study|Lost to Follow-up|1|||
143010658|NCT00905437|515576267|FG000|Overall Study|Withdrawal by Subject|0|||
143010659|NCT00905437|515576268|FG001|Overall Study|Withdrawal by Subject|1|||
143010660|NCT00905437|515576267|FG000|Overall Study|Other|5|||
143010661|NCT00905437|515576268|FG001|Overall Study|Other|6|||
143010662|NCT03252015|515576271|FG000|Overall Study|Withdrawal by Subject|0|||
143010663|NCT03252015|515576272|FG001|Overall Study|Withdrawal by Subject|1|||
143010664|NCT03252015|515576273|FG002|Overall Study|Withdrawal by Subject|1|||
143010665|NCT03252015|515576274|FG003|Overall Study|Withdrawal by Subject|0|||
143010666|NCT03252015|515576271|FG000|Overall Study|Adverse Event|1|||
143010667|NCT03252015|515576272|FG001|Overall Study|Adverse Event|0|||
143010668|NCT03252015|515576273|FG002|Overall Study|Adverse Event|0|||
143010669|NCT03252015|515576274|FG003|Overall Study|Adverse Event|1|||
143010670|NCT04993339|515576275|FG000|Overall Study|Lost to Follow-up|0|||
143010671|NCT04993339|515576276|FG001|Overall Study|Lost to Follow-up|1|||
143010672|NCT04993339|515576275|FG000|Overall Study|no MRI scan|3|||
143010673|NCT04993339|515576276|FG001|Overall Study|no MRI scan|1|||
143010674|NCT01071278|515576277|FG000|Overall Study|Premature Discontinuation|254|||
143010675|NCT01071278|515576277|FG000|Overall Study|Completion Status Unknown|459|||
143010676|NCT00903409|515576278|FG000|Overall Study|Adverse Event|11|||
143010677|NCT00903409|515576279|FG001|Overall Study|Adverse Event|9|||
143010678|NCT00903409|515576278|FG000|Overall Study|Non-compliance with Protocol|1|||
143010679|NCT00903409|515576279|FG001|Overall Study|Non-compliance with Protocol|1|||
143010680|NCT00903409|515576278|FG000|Overall Study|Laboratory Abnormality|2|||
143010681|NCT00903409|515576279|FG001|Overall Study|Laboratory Abnormality|0|||
143010682|NCT00903409|515576278|FG000|Overall Study|Withdrawal by Subject|8|||
143010683|NCT00903409|515576279|FG001|Overall Study|Withdrawal by Subject|8|||
143010684|NCT00903409|515576278|FG000|Overall Study|Other|2|||
143010685|NCT00903409|515576279|FG001|Overall Study|Other|3|||
143010686|NCT00903409|515576278|FG000|Overall Study|Lost to Follow-up|2|||
143010687|NCT00903409|515576279|FG001|Overall Study|Lost to Follow-up|6|||
143010688|NCT00690573|515576295|FG000|Overall Study|Lack of Efficacy|8|||
143010689|NCT00690573|515576295|FG000|Overall Study|Withdrawal by Subject|1|||
143010690|NCT02392377|515576296|FG000|Overall Study|Withdrawal by Subject|0|||
143010691|NCT02392377|515576297|FG001|Overall Study|Withdrawal by Subject|1|||
143010692|NCT01126359|515576300|FG000|First Intervention (20-minutes)|Physician Decision|0|||
143346924|NCT04534114|516816829|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
143346925|NCT04534114|516816830|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
143010693|NCT01126359|515576301|FG001|First Intervention (20-minutes)|Physician Decision|1|||
143010694|NCT00902486|515576302|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
143010695|NCT00902486|515576303|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
143010696|NCT00902486|515576304|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
143010697|NCT00902486|515576305|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
143010698|NCT00902486|515576306|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
143010699|NCT00902486|515576307|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
143010700|NCT00902486|515576302|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
143010701|NCT00902486|515576303|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
143010702|NCT00902486|515576304|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
143010703|NCT00902486|515576305|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
143010704|NCT00902486|515576306|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
143010705|NCT00902486|515576307|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
143010706|NCT00902486|515576302|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
143010707|NCT00902486|515576303|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
143010708|NCT00902486|515576304|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
143010709|NCT00902486|515576305|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
143010710|NCT00902486|515576306|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
143010711|NCT00902486|515576307|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
143010712|NCT00902486|515576302|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
143010713|NCT00902486|515576303|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
143010714|NCT00902486|515576304|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
143010715|NCT00902486|515576305|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
143010716|NCT00902486|515576306|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
143010717|NCT00902486|515576307|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
143010718|NCT00902486|515576302|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
143010719|NCT00902486|515576303|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
143010720|NCT00902486|515576304|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
143010721|NCT00902486|515576305|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
143010722|NCT00902486|515576306|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
143010723|NCT00902486|515576307|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
143010724|NCT00902486|515576302|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
143010725|NCT00902486|515576303|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
143010726|NCT00902486|515576304|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
143010727|NCT00902486|515576305|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
143010728|NCT00902486|515576306|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
143010729|NCT00902486|515576307|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
143010730|NCT00902486|515576302|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
143010731|NCT00902486|515576303|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
143010732|NCT00902486|515576304|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
143010733|NCT00902486|515576305|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
143010734|NCT00902486|515576306|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
143010735|NCT00902486|515576307|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
143010736|NCT00902486|515576302|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
143010737|NCT00902486|515576303|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
143010738|NCT00902486|515576304|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
143010739|NCT00902486|515576305|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
143010740|NCT00902486|515576306|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
143010741|NCT00902486|515576307|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
143010742|NCT00902486|515576302|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
143346926|NCT04534114|516816831|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
143346927|NCT04534114|516816832|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
143346928|NCT04534114|516816829|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
143346929|NCT04534114|516816830|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
143346930|NCT04534114|516816831|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
143346931|NCT04534114|516816832|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
143346932|NCT04534114|516816829|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
143346933|NCT04534114|516816830|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
143346934|NCT04534114|516816831|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
143346935|NCT04534114|516816832|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
143346936|NCT04534114|516816829|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
143346937|NCT04534114|516816830|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
143346938|NCT04534114|516816831|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
143346939|NCT04534114|516816832|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
143010743|NCT00902486|515576303|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
143010744|NCT00902486|515576304|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
143010745|NCT00902486|515576305|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
143346940|NCT04534114|516816829|FG000|Main Treatment Period|Physician Decision|0|||
143346941|NCT04534114|516816830|FG001|Main Treatment Period|Physician Decision|0|||
143346942|NCT04534114|516816831|FG002|Main Treatment Period|Physician Decision|0|||
143010746|NCT00902486|515576306|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
143010747|NCT00902486|515576307|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
143010748|NCT00902486|515576302|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
143010749|NCT00902486|515576303|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
143010750|NCT00902486|515576304|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
143010751|NCT00902486|515576305|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
143010752|NCT00902486|515576306|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
143010753|NCT00902486|515576307|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
143010754|NCT00902486|515576302|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
143010755|NCT00902486|515576303|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
143010756|NCT00902486|515576304|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
143010757|NCT00902486|515576305|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
143010758|NCT00902486|515576306|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
143010759|NCT00902486|515576307|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
143010760|NCT01525407|515576308|FG000|Overall Study|Change in recipient treatment plan|2|||
143010761|NCT01525407|515576309|FG001|Overall Study|Change in recipient treatment plan|2|||
143010762|NCT01525407|515576308|FG000|Overall Study|Withdrawal by Subject|0|||
143010763|NCT01525407|515576309|FG001|Overall Study|Withdrawal by Subject|1|||
143010764|NCT01525407|515576308|FG000|Overall Study|Transplant was delayed|0|||
143010765|NCT01525407|515576309|FG001|Overall Study|Transplant was delayed|1|||
143010766|NCT01525407|515576308|FG000|Overall Study|Delay in Transplant|1|||
143124548|NCT03026283|516001206|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
143124549|NCT03026283|516001207|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
143124550|NCT03026283|516001208|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
143124551|NCT03026283|516001209|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
143124552|NCT03026283|516001210|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
143124553|NCT03026283|516001211|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
143124554|NCT03026283|516001212|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
143124555|NCT03026283|516001205|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
143124556|NCT03026283|516001206|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
143124557|NCT03026283|516001207|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
143124558|NCT03026283|516001208|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
143124559|NCT03026283|516001209|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
143124560|NCT03026283|516001210|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
143124561|NCT03026283|516001211|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
143124562|NCT03026283|516001212|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
143124563|NCT03026283|516001205|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
143124564|NCT03026283|516001206|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
143124565|NCT03026283|516001207|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
143124566|NCT03026283|516001208|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
143124567|NCT03026283|516001209|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
143124568|NCT03026283|516001210|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
143124569|NCT03026283|516001211|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
143124570|NCT03026283|516001212|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
143124571|NCT03026283|516001205|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
143124572|NCT03026283|516001206|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
143124573|NCT03026283|516001207|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
143124574|NCT03026283|516001208|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
143124575|NCT03026283|516001209|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
143124576|NCT03026283|516001210|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
143124577|NCT03026283|516001211|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
143124578|NCT03026283|516001212|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
143124579|NCT03026283|516001205|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
143124580|NCT03026283|516001206|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
143124581|NCT03026283|516001207|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
143124582|NCT03026283|516001208|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
143124583|NCT03026283|516001209|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
143124584|NCT03026283|516001210|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
143124585|NCT03026283|516001211|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
143124586|NCT03026283|516001212|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
143124587|NCT03026283|516001205|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
143124588|NCT03026283|516001206|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
143124589|NCT03026283|516001207|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
143124590|NCT03026283|516001208|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
143010767|NCT01525407|515576309|FG001|Overall Study|Delay in Transplant|0|||
143010768|NCT05378269|515577884|FG000|Overall Study|Protocol Violation|1|||
143346943|NCT04534114|516816832|FG003|Main Treatment Period|Physician Decision|1|||
143346944|NCT04534114|516816829|FG000|Main Treatment Period|Death|1|||
143346945|NCT04534114|516816830|FG001|Main Treatment Period|Death|0|||
143346946|NCT04534114|516816831|FG002|Main Treatment Period|Death|0|||
143346947|NCT04534114|516816832|FG003|Main Treatment Period|Death|1|||
143346948|NCT04534114|516816829|FG000|Main Treatment Period|Other reason|1|||
143346949|NCT04534114|516816830|FG001|Main Treatment Period|Other reason|1|||
143346950|NCT04534114|516816831|FG002|Main Treatment Period|Other reason|0|||
143346951|NCT04534114|516816832|FG003|Main Treatment Period|Other reason|0|||
143346952|NCT04534114|516816829|FG000|Main Treatment Period|Participant decision|1|||
143346953|NCT04534114|516816830|FG001|Main Treatment Period|Participant decision|3|||
143346954|NCT04534114|516816831|FG002|Main Treatment Period|Participant decision|3|||
143010769|NCT05378269|515577885|FG001|Overall Study|Protocol Violation|0|||
143010770|NCT05378269|515577886|FG002|Overall Study|Protocol Violation|2|||
143010771|NCT05378269|515577887|FG003|Overall Study|Protocol Violation|0|||
143010772|NCT05378269|515577888|FG004|Overall Study|Protocol Violation|0|||
143010773|NCT00684645|515577889|FG000|Overall Study|Death|2|||
143010774|NCT00684645|515577889|FG000|Overall Study|Progressive disease|67|||
143010775|NCT00684645|515577889|FG000|Overall Study|Adverse Event|27|||
143010776|NCT00684645|515577889|FG000|Overall Study|Lost to Follow-up|3|||
143010777|NCT00684645|515577889|FG000|Overall Study|Other|15|||
143346955|NCT04534114|516816832|FG003|Main Treatment Period|Participant decision|1|||
143346956|NCT04534114|516816829|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
143010778|NCT03256526|515577898|FG000|Overall Study|Adverse Event|1|||
143346957|NCT04534114|516816830|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
143346958|NCT04534114|516816831|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
143010779|NCT03256526|515577899|FG001|Overall Study|Adverse Event|0|||
143010780|NCT03256526|515577900|FG002|Overall Study|Adverse Event|1|||
143010781|NCT03256526|515577898|FG000|Overall Study|Lost to Follow-up|1|||
143010782|NCT03256526|515577899|FG001|Overall Study|Lost to Follow-up|0|||
143010783|NCT03256526|515577900|FG002|Overall Study|Lost to Follow-up|2|||
143010784|NCT02729545|515577901|FG000|Overall Study|Pregnancy|1|||
143010785|NCT02729545|515577902|FG001|Overall Study|Pregnancy|1|||
143010786|NCT02729545|515577901|FG000|Overall Study|Lost to Follow-up|0|||
143010787|NCT02729545|515577902|FG001|Overall Study|Lost to Follow-up|1|||
143010788|NCT02729545|515577901|FG000|Overall Study|Withdrawal by Subject|2|||
143010789|NCT02729545|515577902|FG001|Overall Study|Withdrawal by Subject|3|||
143010790|NCT03443973|515577905|FG000|Double-blind Treatment Period|Adverse Event|5|||
143010791|NCT03443973|515577906|FG001|Double-blind Treatment Period|Adverse Event|19|||
143010792|NCT03443973|515577907|FG002|Double-blind Treatment Period|Adverse Event|0|||
143010793|NCT03443973|515577908|FG003|Double-blind Treatment Period|Adverse Event|0|||
143010794|NCT03443973|515577905|FG000|Double-blind Treatment Period|Death|5|||
143346959|NCT04534114|516816832|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
143346960|NCT04534114|516816829|FG000|Main Treatment Period|Adverse Event|4|||
143346961|NCT04534114|516816830|FG001|Main Treatment Period|Adverse Event|2|||
143346962|NCT04534114|516816831|FG002|Main Treatment Period|Adverse Event|1|||
143010795|NCT03443973|515577906|FG001|Double-blind Treatment Period|Death|7|||
143010796|NCT03443973|515577907|FG002|Double-blind Treatment Period|Death|0|||
143010797|NCT03443973|515577908|FG003|Double-blind Treatment Period|Death|0|||
143010798|NCT03443973|515577905|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
143010799|NCT03443973|515577906|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
143010800|NCT03443973|515577907|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
143346963|NCT04534114|516816832|FG003|Main Treatment Period|Adverse Event|2|||
143346964|NCT04534114|516816829|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
143346965|NCT04534114|516816830|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
143346966|NCT04534114|516816831|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
143346967|NCT04534114|516816832|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
143346968|NCT04534114|516816829|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
143346969|NCT04534114|516816830|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
143010801|NCT03443973|515577908|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
143010802|NCT03443973|515577905|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
143010803|NCT03443973|515577906|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
143010804|NCT03443973|515577907|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
143010805|NCT03443973|515577908|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
143010806|NCT03443973|515577905|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
143010807|NCT03443973|515577906|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
143010808|NCT03443973|515577907|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
143346970|NCT04534114|516816831|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
143346971|NCT04534114|516816832|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
143346972|NCT04534114|516816829|FG000|Extension Treatment Period|Other reason|0|||
143010809|NCT03443973|515577908|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
143010810|NCT03443973|515577905|FG000|Double-blind Treatment Period|Physician Decision|5|||
143346973|NCT04534114|516816830|FG001|Extension Treatment Period|Other reason|1|||
143346974|NCT04534114|516816831|FG002|Extension Treatment Period|Other reason|0|||
143346975|NCT04534114|516816832|FG003|Extension Treatment Period|Other reason|0|||
143346976|NCT04534114|516816829|FG000|Extension Treatment Period|Death|0|||
143346977|NCT04534114|516816830|FG001|Extension Treatment Period|Death|0|||
143346978|NCT04534114|516816831|FG002|Extension Treatment Period|Death|1|||
143010811|NCT03443973|515577906|FG001|Double-blind Treatment Period|Physician Decision|6|||
143010812|NCT03443973|515577907|FG002|Double-blind Treatment Period|Physician Decision|0|||
143346979|NCT04534114|516816832|FG003|Extension Treatment Period|Death|2|||
143346980|NCT04534114|516816829|FG000|Extension Treatment Period|Adverse Event|0|||
143346981|NCT04534114|516816830|FG001|Extension Treatment Period|Adverse Event|1|||
143346982|NCT04534114|516816831|FG002|Extension Treatment Period|Adverse Event|0|||
143010813|NCT03443973|515577908|FG003|Double-blind Treatment Period|Physician Decision|0|||
143010814|NCT03443973|515577905|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
143010815|NCT03443973|515577906|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
143010816|NCT03443973|515577907|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
143010817|NCT03443973|515577908|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
143010818|NCT03443973|515577905|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
143010819|NCT03443973|515577906|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
143010820|NCT03443973|515577907|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
143010821|NCT03443973|515577908|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
143010822|NCT03443973|515577905|FG000|Open-label Extension Period|Reason Not Specified|0|||
143010823|NCT03443973|515577906|FG001|Open-label Extension Period|Reason Not Specified|0|||
143010824|NCT03443973|515577907|FG002|Open-label Extension Period|Reason Not Specified|3|||
143010825|NCT03443973|515577908|FG003|Open-label Extension Period|Reason Not Specified|0|||
143010826|NCT03443973|515577905|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
143010827|NCT03443973|515577906|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
143010828|NCT03443973|515577907|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
143010829|NCT03443973|515577908|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
143010830|NCT02545868|515577911|FG000|Overall Study|Lack of Efficacy|1|||
143010831|NCT02545868|515577912|FG001|Overall Study|Lack of Efficacy|1|||
143010832|NCT02545868|515577913|FG002|Overall Study|Lack of Efficacy|0|||
143010833|NCT02545868|515577911|FG000|Overall Study|Lost to Follow-up|1|||
143010834|NCT02545868|515577912|FG001|Overall Study|Lost to Follow-up|5|||
143010835|NCT02545868|515577913|FG002|Overall Study|Lost to Follow-up|1|||
143346983|NCT04534114|516816832|FG003|Extension Treatment Period|Adverse Event|1|||
143346984|NCT04534114|516816829|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
143346985|NCT04534114|516816830|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
143346986|NCT04534114|516816831|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
143346987|NCT04534114|516816832|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
143346988|NCT03287414|516816833|FG000|Treatment Epoch|Adverse Event|0|||
143346989|NCT03287414|516816834|FG001|Treatment Epoch|Adverse Event|1|||
143346990|NCT03287414|516816833|FG000|Treatment Epoch|Study terminated by sponsor|2|||
143346991|NCT03287414|516816834|FG001|Treatment Epoch|Study terminated by sponsor|2|||
143346992|NCT03287414|516816833|FG000|Treatment Epoch|Subject/Guardian decision|4|||
143346993|NCT03287414|516816834|FG001|Treatment Epoch|Subject/Guardian decision|0|||
143346994|NCT03287414|516816833|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
143346995|NCT03287414|516816834|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
143346996|NCT03287414|516816833|FG000|Treatment Epoch|Withdrawal by Subject|1|||
143346997|NCT03287414|516816834|FG001|Treatment Epoch|Withdrawal by Subject|0|||
143346998|NCT03287414|516816833|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
143346999|NCT03287414|516816834|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
143347000|NCT03287414|516816833|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
143347001|NCT03287414|516816834|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
143347002|NCT02759185|516816835|FG000|Stage 1|Adverse Event|0|||
143010836|NCT02545868|515577911|FG000|Overall Study|Non-compliance|1|||
143010837|NCT02545868|515577912|FG001|Overall Study|Non-compliance|1|||
143010838|NCT02545868|515577913|FG002|Overall Study|Non-compliance|1|||
143347003|NCT02759185|516816836|FG001|Stage 1|Adverse Event|1|||
143010839|NCT02545868|515577911|FG000|Overall Study|Treatment change|21|||
143010840|NCT02545868|515577912|FG001|Overall Study|Treatment change|19|||
143010841|NCT02545868|515577913|FG002|Overall Study|Treatment change|22|||
143010842|NCT02545868|515577911|FG000|Overall Study|Physician Decision|1|||
143010843|NCT02545868|515577912|FG001|Overall Study|Physician Decision|1|||
143010844|NCT02545868|515577913|FG002|Overall Study|Physician Decision|1|||
143010845|NCT02545868|515577911|FG000|Overall Study|Withdrawal by Subject|6|||
143010846|NCT02545868|515577912|FG001|Overall Study|Withdrawal by Subject|7|||
143347004|NCT02759185|516816837|FG002|Stage 1|Adverse Event|3|||
143347005|NCT02759185|516816838|FG003|Stage 1|Adverse Event|0|||
143347006|NCT02759185|516816839|FG004|Stage 1|Adverse Event|0|||
143347007|NCT02759185|516816840|FG005|Stage 1|Adverse Event|0|||
143347008|NCT02759185|516816841|FG006|Stage 1|Adverse Event|0|||
143347009|NCT02759185|516816835|FG000|Stage 1|Withdrawal by Subject|1|||
143347010|NCT02759185|516816836|FG001|Stage 1|Withdrawal by Subject|0|||
143010847|NCT02545868|515577913|FG002|Overall Study|Withdrawal by Subject|9|||
143010848|NCT01777191|515577914|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
143010849|NCT01777191|515577915|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
143010850|NCT01777191|515577914|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
143010851|NCT01777191|515577915|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
143010852|NCT01777191|515577914|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
143010853|NCT01777191|515577915|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
143010854|NCT01777191|515577914|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
143010855|NCT01777191|515577915|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
143010856|NCT01777191|515577914|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
143010857|NCT01777191|515577915|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
143010858|NCT01777191|515577914|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
143010859|NCT01777191|515577915|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
143010860|NCT01777191|515577914|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
143010861|NCT01777191|515577915|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
143010862|NCT01777191|515577914|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
143010863|NCT01777191|515577915|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
143010864|NCT01777191|515577914|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
143010865|NCT01777191|515577915|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
143010866|NCT01777191|515577914|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
143010867|NCT01777191|515577915|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
143010868|NCT01777191|515577914|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
143010869|NCT01777191|515577915|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
143010870|NCT04465916|515577920|FG000|Overall Study|Withdrawal by Subject|0|||
143010871|NCT04465916|515577921|FG001|Overall Study|Withdrawal by Subject|1|||
143010872|NCT00468312|515577930|FG000|Overall Study|Adverse Event|2|||
143010873|NCT00468312|515577931|FG001|Overall Study|Adverse Event|1|||
143010874|NCT00468312|515577930|FG000|Overall Study|Lack of Efficacy|0|||
143010875|NCT00468312|515577931|FG001|Overall Study|Lack of Efficacy|1|||
143010876|NCT00468312|515577930|FG000|Overall Study|Withdrawal by Subject|0|||
143010877|NCT00468312|515577931|FG001|Overall Study|Withdrawal by Subject|1|||
143010878|NCT00468312|515577930|FG000|Overall Study|Protocol Violation|2|||
143010879|NCT00468312|515577931|FG001|Overall Study|Protocol Violation|1|||
143010880|NCT00468312|515577930|FG000|Overall Study|Did not meet protocol eligibility|0|||
143010881|NCT00468312|515577931|FG001|Overall Study|Did not meet protocol eligibility|1|||
143010882|NCT01260194|515577937|FG000|Overall Study|Withdrawal of Consent|1|||
143010883|NCT00566631|515577939|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
143010884|NCT00566631|515577939|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
143010885|NCT00566631|515577939|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
143010886|NCT00566631|515577939|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
143010887|NCT00566631|515577939|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
143010888|NCT00566631|515577939|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
143010889|NCT00566631|515577939|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
143010890|NCT00566631|515577939|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
143010891|NCT00566631|515577939|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
143010892|NCT00566631|515577939|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
143010893|NCT00566631|515577939|FG000|Part 2: Extension Phase|Adverse Event|11|||
143010894|NCT00566631|515577939|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
143010895|NCT00566631|515577939|FG000|Part 2: Extension Phase|Death|1|||
143010896|NCT00566631|515577939|FG000|Part 2: Extension Phase|Other|5|||
143010897|NCT00592007|515577940|FG000|Overall Study|Withdrawal by Subject|1|||
143010898|NCT00592007|515577940|FG000|Overall Study|patient ineligible (out of lab range)|1|||
143010899|NCT00595127|515577941|FG000|Overall Study|Death|6|||
143010900|NCT00595127|515577941|FG000|Overall Study|Relapsed|3|||
143010901|NCT00595127|515577941|FG000|Overall Study|joined another trial|1|||
143010902|NCT01569074|515577943|FG000|Overall Study|Study stopped|6|||
143010903|NCT01569074|515577944|FG001|Overall Study|Study stopped|6|||
143010904|NCT01569074|515577945|FG002|Overall Study|Study stopped|8|||
143010905|NCT01569074|515577946|FG003|Overall Study|Study stopped|7|||
143010906|NCT01569074|515577947|FG004|Overall Study|Study stopped|7|||
143010907|NCT01569074|515577943|FG000|Overall Study|Study-specific discontinuation criteria|0|||
143010908|NCT01569074|515577944|FG001|Overall Study|Study-specific discontinuation criteria|1|||
143010909|NCT01569074|515577945|FG002|Overall Study|Study-specific discontinuation criteria|0|||
143010910|NCT01569074|515577946|FG003|Overall Study|Study-specific discontinuation criteria|0|||
143010911|NCT01569074|515577947|FG004|Overall Study|Study-specific discontinuation criteria|0|||
143010912|NCT01569074|515577943|FG000|Overall Study|Severe non-compliance to protocol|0|||
143010913|NCT01569074|515577944|FG001|Overall Study|Severe non-compliance to protocol|0|||
143124591|NCT03026283|516001209|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
143124592|NCT03026283|516001210|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
143347011|NCT02759185|516816837|FG002|Stage 1|Withdrawal by Subject|0|||
143010914|NCT01569074|515577945|FG002|Overall Study|Severe non-compliance to protocol|1|||
143010915|NCT01569074|515577946|FG003|Overall Study|Severe non-compliance to protocol|0|||
143010916|NCT01569074|515577947|FG004|Overall Study|Severe non-compliance to protocol|0|||
143010917|NCT01569074|515577943|FG000|Overall Study|eg change in circumstances|0|||
143010918|NCT01569074|515577944|FG001|Overall Study|eg change in circumstances|2|||
143010919|NCT01569074|515577945|FG002|Overall Study|eg change in circumstances|0|||
143010920|NCT01569074|515577946|FG003|Overall Study|eg change in circumstances|1|||
143010921|NCT01569074|515577947|FG004|Overall Study|eg change in circumstances|1|||
143010922|NCT01569074|515577943|FG000|Overall Study|Adverse Event|1|||
143010923|NCT01569074|515577944|FG001|Overall Study|Adverse Event|0|||
143010924|NCT01569074|515577945|FG002|Overall Study|Adverse Event|3|||
143010925|NCT01569074|515577946|FG003|Overall Study|Adverse Event|0|||
143010926|NCT01569074|515577947|FG004|Overall Study|Adverse Event|0|||
143010927|NCT03345485|515577948|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
143010928|NCT03345485|515577949|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
143010929|NCT03345485|515577950|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
143010930|NCT03345485|515577951|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
143010931|NCT03345485|515577952|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
143010932|NCT03345485|515577953|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
143010933|NCT03345485|515577954|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
143010934|NCT03345485|515577955|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
143010935|NCT03345485|515577956|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
143010936|NCT03345485|515577957|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
143010937|NCT03345485|515577958|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
143010938|NCT03345485|515577959|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
143010939|NCT03345485|515577960|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
143010940|NCT01610284|515577961|FG000|Randomization Phase|Adverse Event|1|||
143010941|NCT01610284|515577962|FG001|Randomization Phase|Adverse Event|0|||
143010942|NCT01610284|515577961|FG000|Randomization Phase|Physician Decision|1|||
143010943|NCT01610284|515577962|FG001|Randomization Phase|Physician Decision|1|||
143010944|NCT01610284|515577961|FG000|Randomization Phase|Death|0|||
143010945|NCT01610284|515577962|FG001|Randomization Phase|Death|1|||
143010946|NCT01610284|515577961|FG000|Treatment Phase|Adverse Event|80|||
143010947|NCT01610284|515577962|FG001|Treatment Phase|Adverse Event|12|||
143010948|NCT01610284|515577961|FG000|Treatment Phase|Lost to Follow-up|1|||
143010949|NCT01610284|515577962|FG001|Treatment Phase|Lost to Follow-up|0|||
143010950|NCT01610284|515577961|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
143010951|NCT01610284|515577962|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
143010952|NCT01610284|515577961|FG000|Treatment Phase|Physician Decision|27|||
143010953|NCT01610284|515577962|FG001|Treatment Phase|Physician Decision|24|||
143010954|NCT01610284|515577961|FG000|Treatment Phase|Progressive Disease|377|||
143010955|NCT01610284|515577962|FG001|Treatment Phase|Progressive Disease|486|||
143010956|NCT01610284|515577961|FG000|Treatment Phase|Protocol Deviation|2|||
143010957|NCT01610284|515577962|FG001|Treatment Phase|Protocol Deviation|3|||
143010958|NCT01610284|515577961|FG000|Treatment Phase|Study terminated by Sponsor|18|||
143010959|NCT01610284|515577962|FG001|Treatment Phase|Study terminated by Sponsor|15|||
143010960|NCT01610284|515577961|FG000|Treatment Phase|Subject/Guardian Decision|55|||
143010961|NCT01610284|515577962|FG001|Treatment Phase|Subject/Guardian Decision|23|||
143010962|NCT01610284|515577961|FG000|Treatment Phase|Death|6|||
143010963|NCT01610284|515577962|FG001|Treatment Phase|Death|5|||
143010964|NCT01610284|515577961|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
143010965|NCT01610284|515577962|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
143010966|NCT01610284|515577961|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
143010967|NCT01610284|515577962|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
143010968|NCT01610284|515577961|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
143010969|NCT01610284|515577962|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
143010970|NCT01610284|515577961|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
143010971|NCT01610284|515577962|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
143010972|NCT01610284|515577961|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
143010973|NCT01610284|515577962|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
143010974|NCT01610284|515577961|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
143010975|NCT01610284|515577962|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
143010976|NCT01125358|515577963|FG000|Overall Study|Adverse Event|3|||
143347012|NCT02759185|516816838|FG003|Stage 1|Withdrawal by Subject|0|||
143347013|NCT02759185|516816839|FG004|Stage 1|Withdrawal by Subject|0|||
143010977|NCT01125358|515577964|FG001|Overall Study|Adverse Event|0|||
143010978|NCT01125358|515577965|FG002|Overall Study|Adverse Event|0|||
143010979|NCT01125358|515577966|FG003|Overall Study|Adverse Event|2|||
143010980|NCT01125358|515577963|FG000|Overall Study|Perceived Lack of Efficacy|6|||
143010981|NCT01125358|515577964|FG001|Overall Study|Perceived Lack of Efficacy|3|||
143010982|NCT01125358|515577965|FG002|Overall Study|Perceived Lack of Efficacy|7|||
143010983|NCT01125358|515577966|FG003|Overall Study|Perceived Lack of Efficacy|4|||
143010984|NCT01125358|515577963|FG000|Overall Study|Protocol Violation|1|||
143010985|NCT01125358|515577964|FG001|Overall Study|Protocol Violation|0|||
143010986|NCT01125358|515577965|FG002|Overall Study|Protocol Violation|0|||
143010987|NCT01125358|515577966|FG003|Overall Study|Protocol Violation|0|||
143010988|NCT01125358|515577963|FG000|Overall Study|Sponsor Decision|0|||
143010989|NCT01125358|515577964|FG001|Overall Study|Sponsor Decision|0|||
143010990|NCT01125358|515577965|FG002|Overall Study|Sponsor Decision|1|||
143010991|NCT01125358|515577966|FG003|Overall Study|Sponsor Decision|1|||
143010992|NCT01125358|515577963|FG000|Overall Study|Withdrawal by Subject|2|||
143010993|NCT01125358|515577964|FG001|Overall Study|Withdrawal by Subject|1|||
143010994|NCT01125358|515577965|FG002|Overall Study|Withdrawal by Subject|1|||
143010995|NCT01125358|515577966|FG003|Overall Study|Withdrawal by Subject|1|||
143010996|NCT01060007|515577967|FG000|Overall Study|Withdrawal by Subject|1|||
143010997|NCT01060007|515577967|FG000|Overall Study|Inevaluable for response at surgery|3|||
143010998|NCT05168657|515577968|FG000|Overall Study|Adverse Event|0|||
143010999|NCT05168657|515577969|FG001|Overall Study|Adverse Event|0|||
143011000|NCT05168657|515577970|FG002|Overall Study|Adverse Event|1|||
143011001|NCT05168657|515577971|FG003|Overall Study|Adverse Event|0|||
143011002|NCT05168657|515577972|FG004|Overall Study|Adverse Event|0|||
143011003|NCT05168657|515577973|FG005|Overall Study|Adverse Event|0|||
143011004|NCT05168657|515577974|FG006|Overall Study|Adverse Event|0|||
143011005|NCT05168657|515577975|FG007|Overall Study|Adverse Event|0|||
143011006|NCT01418365|515577980|FG000|First Intervention|Withdrawal by Subject|0|||
143011007|NCT01418365|515577981|FG001|First Intervention|Withdrawal by Subject|1|||
143011008|NCT01418365|515577980|FG000|First Intervention|Non-compliance|1|||
143011009|NCT01418365|515577981|FG001|First Intervention|Non-compliance|0|||
143011010|NCT01418365|515577980|FG000|Second Intervention|Withdrawal by Subject|0|||
143011011|NCT01418365|515577981|FG001|Second Intervention|Withdrawal by Subject|1|||
143011012|NCT03319368|515577982|FG000|Overall Study|Discharge swabs not collected from resident|57|||
143011013|NCT03319368|515577983|FG001|Overall Study|Discharge swabs not collected from resident|46|||
143011014|NCT03701516|515577984|FG000|Period 1|Lost to Follow-up|0|||
143011015|NCT03701516|515577985|FG001|Period 1|Lost to Follow-up|1|||
143011016|NCT03701516|515577984|FG000|Period 1|Adverse Event|0|||
143011017|NCT03701516|515577985|FG001|Period 1|Adverse Event|2|||
143011018|NCT03701516|515577984|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
143011019|NCT03701516|515577985|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
143011020|NCT03701516|515577984|FG000|Period 1|Non Compliance to Protocol|2|||
143011021|NCT03701516|515577985|FG001|Period 1|Non Compliance to Protocol|1|||
143011022|NCT03701516|515577984|FG000|Period 1|Withdrawal by Subject|0|||
143011023|NCT03701516|515577985|FG001|Period 1|Withdrawal by Subject|1|||
143011024|NCT03701516|515577984|FG000|Period 2|failed to meet all eligibility creiteria|1|||
143011025|NCT03701516|515577985|FG001|Period 2|failed to meet all eligibility creiteria|0|||
143011026|NCT03701516|515577984|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
143011027|NCT03701516|515577985|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
143011028|NCT02864953|515577986|FG000|Overall Study|Adverse Event|22|||
143011029|NCT02864953|515577987|FG001|Overall Study|Adverse Event|19|||
143011030|NCT02864953|515577986|FG000|Overall Study|Withdrawal by Subject|1|||
143011031|NCT02864953|515577987|FG001|Overall Study|Withdrawal by Subject|0|||
143011032|NCT02864953|515577986|FG000|Overall Study|Physician Decision|4|||
143011033|NCT02864953|515577987|FG001|Overall Study|Physician Decision|2|||
143011034|NCT02864953|515577986|FG000|Overall Study|Death|3|||
143011035|NCT02864953|515577987|FG001|Overall Study|Death|13|||
143011036|NCT02864953|515577986|FG000|Overall Study|Reason not specified|14|||
143011037|NCT02864953|515577987|FG001|Overall Study|Reason not specified|12|||
143011038|NCT02864953|515577986|FG000|Overall Study|Withdrew Prior to Dosing|9|||
143011039|NCT02864953|515577987|FG001|Overall Study|Withdrew Prior to Dosing|8|||
143011040|NCT00981019|515577988|FG000|Overall Study|Did not respond|65|||
143011041|NCT00981019|515577988|FG000|Overall Study|Did not match target population|94|||
143011042|NCT00981019|515577988|FG000|Overall Study|Inadvertent exclusion|239|||
143011043|NCT00981019|515577988|FG000|Overall Study|Hit the survey after closure|79|||
143011044|NCT05083559|515577989|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
143011045|NCT05083559|515577990|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
143347014|NCT02759185|516816840|FG005|Stage 1|Withdrawal by Subject|0|||
143011046|NCT05083559|515577989|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
143011047|NCT05083559|515577990|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
143011048|NCT05083559|515577989|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
143011049|NCT05083559|515577990|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
143011050|NCT02666768|515577991|FG000|Overall Study|Withdrawal by Subject|4|||
143011051|NCT01023022|515577992|FG000|Overall Study|Death|5|||
143011052|NCT01023022|515577992|FG000|Overall Study|Lost to Follow-up|7|||
143011053|NCT01023022|515577992|FG000|Overall Study|due to technical issues|2|||
143011054|NCT03728257|515577993|FG000|Overall Study|Death|3|||
143011055|NCT03728257|515577994|FG001|Overall Study|Death|0|||
143011056|NCT00621309|515577996|FG000|Overall Study|Withdrawal by Subject|2|||
143011057|NCT00621309|515577997|FG001|Overall Study|Withdrawal by Subject|0|||
143011058|NCT00621309|515577998|FG002|Overall Study|Withdrawal by Subject|1|||
143011059|NCT00621309|515577999|FG003|Overall Study|Withdrawal by Subject|1|||
143011060|NCT00621309|515578000|FG004|Overall Study|Withdrawal by Subject|1|||
143347015|NCT02759185|516816841|FG006|Stage 1|Withdrawal by Subject|0|||
143347016|NCT02759185|516816835|FG000|Stage 2|Adverse Event|0|||
143347017|NCT02759185|516816836|FG001|Stage 2|Adverse Event|0|||
143347018|NCT02759185|516816837|FG002|Stage 2|Adverse Event|0|||
143347019|NCT02759185|516816838|FG003|Stage 2|Adverse Event|0|||
143347020|NCT02759185|516816839|FG004|Stage 2|Adverse Event|1|||
143347021|NCT02759185|516816840|FG005|Stage 2|Adverse Event|2|||
143347022|NCT02759185|516816841|FG006|Stage 2|Adverse Event|0|||
143347023|NCT02759185|516816835|FG000|Stage 2|Withdrawal by Subject|0|||
143347024|NCT02759185|516816836|FG001|Stage 2|Withdrawal by Subject|0|||
143347025|NCT02759185|516816837|FG002|Stage 2|Withdrawal by Subject|0|||
143347026|NCT02759185|516816838|FG003|Stage 2|Withdrawal by Subject|0|||
143347027|NCT02759185|516816839|FG004|Stage 2|Withdrawal by Subject|1|||
143347028|NCT02759185|516816840|FG005|Stage 2|Withdrawal by Subject|1|||
143011061|NCT00621309|515578001|FG005|Overall Study|Withdrawal by Subject|1|||
143011062|NCT01306968|515578004|FG000|Overall Study|Lost to Follow-up|1|||
143011063|NCT01306968|515578005|FG001|Overall Study|Lost to Follow-up|1|||
143011064|NCT01306968|515578006|FG002|Overall Study|Lost to Follow-up|0|||
143011065|NCT01306968|515578007|FG003|Overall Study|Lost to Follow-up|0|||
143011066|NCT01306968|515578004|FG000|Overall Study|Physician Decision|0|||
143011067|NCT01306968|515578005|FG001|Overall Study|Physician Decision|1|||
143011068|NCT01306968|515578006|FG002|Overall Study|Physician Decision|0|||
143011069|NCT01306968|515578007|FG003|Overall Study|Physician Decision|0|||
143011070|NCT01306968|515578004|FG000|Overall Study|Relocated and left active duty|0|||
143011071|NCT01306968|515578005|FG001|Overall Study|Relocated and left active duty|1|||
143011072|NCT01306968|515578006|FG002|Overall Study|Relocated and left active duty|1|||
143011073|NCT01306968|515578007|FG003|Overall Study|Relocated and left active duty|1|||
143011074|NCT01306968|515578004|FG000|Overall Study|Withdrew - time commitment|0|||
143011075|NCT01306968|515578005|FG001|Overall Study|Withdrew - time commitment|0|||
143011076|NCT01306968|515578006|FG002|Overall Study|Withdrew - time commitment|0|||
143011077|NCT01306968|515578007|FG003|Overall Study|Withdrew - time commitment|2|||
143011078|NCT01306968|515578004|FG000|Overall Study|Withdrew over privacy concerns|0|||
143011079|NCT01306968|515578005|FG001|Overall Study|Withdrew over privacy concerns|0|||
143011080|NCT01306968|515578006|FG002|Overall Study|Withdrew over privacy concerns|0|||
143011081|NCT01306968|515578007|FG003|Overall Study|Withdrew over privacy concerns|1|||
143011082|NCT01329562|515578008|FG000|Overall Study|Protocol Violation|5|||
143011083|NCT01329562|515578009|FG001|Overall Study|Protocol Violation|3|||
143011084|NCT01329562|515578008|FG000|Overall Study|Lost to Follow-up|1|||
143011085|NCT01329562|515578009|FG001|Overall Study|Lost to Follow-up|1|||
143011086|NCT01329562|515578008|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
143011087|NCT01329562|515578009|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
143011088|NCT01329562|515578008|FG000|Overall Study|Physician Decision|0|||
143011089|NCT01329562|515578009|FG001|Overall Study|Physician Decision|1|||
143011090|NCT00061568|515578010|FG000|Overall Study|Lost to Follow-up|12|||
143011091|NCT00061568|515578011|FG001|Overall Study|Lost to Follow-up|0|||
143011092|NCT00061568|515578010|FG000|Overall Study|Death|6|||
143011093|NCT00061568|515578011|FG001|Overall Study|Death|0|||
143011094|NCT00061568|515578010|FG000|Overall Study|Withdrawal by Subject|1|||
143011095|NCT00061568|515578011|FG001|Overall Study|Withdrawal by Subject|0|||
143011096|NCT01381068|515578012|FG000|Overall Study|Death|1|||
143347029|NCT02759185|516816841|FG006|Stage 2|Withdrawal by Subject|1|||
143347030|NCT04395183|516816844|FG000|Overall Study|Withdrawal by Subject|1|||
143347031|NCT04395183|516816845|FG001|Overall Study|Withdrawal by Subject|0|||
143347032|NCT04395183|516816846|FG002|Overall Study|Withdrawal by Subject|2|||
143347033|NCT04395183|516816847|FG003|Overall Study|Withdrawal by Subject|2|||
143347034|NCT01008475|516816848|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
143347035|NCT01008475|516816849|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
143347036|NCT01008475|516816850|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
143347037|NCT01008475|516816851|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
143347038|NCT01008475|516816852|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
143347039|NCT01008475|516816853|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
143347040|NCT01008475|516816854|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
143347041|NCT02668016|516816855|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
143347042|NCT02668016|516816855|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
143347043|NCT02668016|516816855|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
143347044|NCT02668016|516816855|FG000|Month 4|Withdrawal due to severe symptoms|1|||
143011097|NCT01381068|515578013|FG001|Overall Study|Death|0|||
143011098|NCT00797316|515578014|FG000|Overall Study|Administrative problems|1|||
143347045|NCT02668016|516816855|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
143011099|NCT00797316|515578015|FG001|Overall Study|Administrative problems|0|||
143011100|NCT00797316|515578014|FG000|Overall Study|Adverse Event|5|||
143011101|NCT00797316|515578015|FG001|Overall Study|Adverse Event|3|||
143011102|NCT00797316|515578014|FG000|Overall Study|Lost to Follow-up|4|||
143011103|NCT00797316|515578015|FG001|Overall Study|Lost to Follow-up|8|||
143011104|NCT00797316|515578014|FG000|Overall Study|Protocol Deviation|1|||
143011105|NCT00797316|515578015|FG001|Overall Study|Protocol Deviation|2|||
143011106|NCT00797316|515578014|FG000|Overall Study|Patient withdrew consent|12|||
143011107|NCT00797316|515578015|FG001|Overall Study|Patient withdrew consent|6|||
143011108|NCT00797316|515578014|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
143011109|NCT00797316|515578015|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
143011110|NCT03239340|515578022|FG000|Overall Study|Other|26|||
143011111|NCT03239340|515578022|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
143011112|NCT03239340|515578022|FG000|Overall Study|Death|40|||
143011113|NCT03239340|515578022|FG000|Overall Study|Lost to Follow-up|2|||
143011114|NCT03239340|515578022|FG000|Overall Study|Physician Decision|16|||
143011115|NCT03239340|515578022|FG000|Overall Study|Withdrawal by Subject|27|||
143011116|NCT03868059|515578029|FG000|Overall Study|Adverse Event|3|||
143011117|NCT03868059|515578029|FG000|Overall Study|Lost to Follow-up|3|||
143011118|NCT03868059|515578029|FG000|Overall Study|Withdrawal by Subject|6|||
143011119|NCT02061293|515578030|FG000|Overall Study|Elevated Blood Pressure|1|||
143011120|NCT02061293|515578031|FG001|Overall Study|Elevated Blood Pressure|1|||
143011121|NCT03205163|515578033|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
143011122|NCT03205163|515578034|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
143011123|NCT02332655|515578035|FG000|Overall Study|Lack of Efficacy|1|||
143011124|NCT01298661|515578036|FG000|Overall Study|Withdrawal by Subject|2|||
143011125|NCT01298661|515578037|FG001|Overall Study|Withdrawal by Subject|0|||
143011126|NCT01298661|515578038|FG002|Overall Study|Withdrawal by Subject|2|||
143011127|NCT04502862|515578039|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
143011128|NCT04502862|515578040|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
143011129|NCT04502862|515578039|FG000|Overall Study|Withdrawal by Subject|1|||
143011130|NCT04502862|515578040|FG001|Overall Study|Withdrawal by Subject|0|||
143011131|NCT04502862|515578039|FG000|Overall Study|Adverse Event|1|||
143011132|NCT04502862|515578040|FG001|Overall Study|Adverse Event|1|||
143011133|NCT03526679|515579551|FG000|Overall Study|still under treatment|2|||
143011134|NCT01325701|515579560|FG000|Overall Study|Adverse Event|12|||
143011135|NCT01325701|515579561|FG001|Overall Study|Adverse Event|0|||
143011136|NCT01325701|515579560|FG000|Overall Study|Protocol Violation|1|||
143011137|NCT01325701|515579561|FG001|Overall Study|Protocol Violation|0|||
143011138|NCT01325701|515579560|FG000|Overall Study|Physician Decision|2|||
143011139|NCT01325701|515579561|FG001|Overall Study|Physician Decision|2|||
143011140|NCT01325701|515579560|FG000|Overall Study|Withdrawal by Subject|2|||
143011141|NCT01325701|515579561|FG001|Overall Study|Withdrawal by Subject|1|||
143011142|NCT01325701|515579560|FG000|Overall Study|Rollerover Extension Study|4|||
143011143|NCT01325701|515579561|FG001|Overall Study|Rollerover Extension Study|0|||
143011144|NCT01179191|515579564|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
143011145|NCT01179191|515579564|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
143011146|NCT01179191|515579564|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
143011147|NCT01179191|515579564|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
143011148|NCT01179191|515579564|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
143011149|NCT01179191|515579564|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
143011150|NCT01179191|515579564|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
143011151|NCT01179191|515579564|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
143011152|NCT01179191|515579564|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
143011153|NCT01179191|515579564|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
143011154|NCT01179191|515579564|FG000|Maintenance Phase (8 Weeks)|Other|66|||
143011155|NCT00572910|515579565|FG000|Overall Study|Adverse Event|1|||
143011156|NCT00572910|515579566|FG001|Overall Study|Adverse Event|2|||
143011157|NCT00572910|515579567|FG002|Overall Study|Adverse Event|0|||
143011158|NCT00572910|515579568|FG003|Overall Study|Adverse Event|2|||
143011159|NCT00572910|515579569|FG004|Overall Study|Adverse Event|0|||
143011160|NCT00572910|515579570|FG005|Overall Study|Adverse Event|0|||
143011161|NCT00572910|515579571|FG006|Overall Study|Adverse Event|4|||
143011162|NCT00572910|515579572|FG007|Overall Study|Adverse Event|2|||
143347046|NCT02668016|516816855|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
143347047|NCT02668016|516816855|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
143347048|NCT02668016|516816855|FG000|Month 6|Withdrawal due to severe symptoms|2|||
143347049|NCT02668016|516816855|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
143011163|NCT00572910|515579573|FG008|Overall Study|Adverse Event|1|||
143011164|NCT00572910|515579574|FG009|Overall Study|Adverse Event|3|||
143011165|NCT00572910|515579575|FG010|Overall Study|Adverse Event|2|||
143011166|NCT00572910|515579565|FG000|Overall Study|Lost to Follow-up|0|||
143011167|NCT00572910|515579566|FG001|Overall Study|Lost to Follow-up|1|||
143011168|NCT00572910|515579567|FG002|Overall Study|Lost to Follow-up|1|||
143011169|NCT00572910|515579568|FG003|Overall Study|Lost to Follow-up|2|||
143011170|NCT00572910|515579569|FG004|Overall Study|Lost to Follow-up|1|||
143011171|NCT00572910|515579570|FG005|Overall Study|Lost to Follow-up|0|||
143011172|NCT00572910|515579571|FG006|Overall Study|Lost to Follow-up|0|||
143011173|NCT00572910|515579572|FG007|Overall Study|Lost to Follow-up|0|||
143011174|NCT00572910|515579573|FG008|Overall Study|Lost to Follow-up|0|||
143011175|NCT00572910|515579574|FG009|Overall Study|Lost to Follow-up|1|||
143011176|NCT00572910|515579575|FG010|Overall Study|Lost to Follow-up|0|||
143011177|NCT00572910|515579565|FG000|Overall Study|Withdrawal by Subject|3|||
143011178|NCT00572910|515579566|FG001|Overall Study|Withdrawal by Subject|0|||
143011179|NCT00572910|515579567|FG002|Overall Study|Withdrawal by Subject|1|||
143011180|NCT00572910|515579568|FG003|Overall Study|Withdrawal by Subject|0|||
143011181|NCT00572910|515579569|FG004|Overall Study|Withdrawal by Subject|1|||
143011182|NCT00572910|515579570|FG005|Overall Study|Withdrawal by Subject|3|||
143011183|NCT00572910|515579571|FG006|Overall Study|Withdrawal by Subject|0|||
143011184|NCT00572910|515579572|FG007|Overall Study|Withdrawal by Subject|2|||
143011185|NCT00572910|515579573|FG008|Overall Study|Withdrawal by Subject|2|||
143011186|NCT00572910|515579574|FG009|Overall Study|Withdrawal by Subject|2|||
143011187|NCT00572910|515579575|FG010|Overall Study|Withdrawal by Subject|1|||
143011188|NCT00916617|515579576|FG000|Overall Study|Adverse Event|3|||
143011189|NCT00916617|515579577|FG001|Overall Study|Adverse Event|2|||
143011190|NCT00916617|515579578|FG002|Overall Study|Adverse Event|6|||
143011191|NCT00916617|515579579|FG003|Overall Study|Adverse Event|3|||
143011192|NCT00916617|515579576|FG000|Overall Study|Withdrawal by Subject|3|||
143011193|NCT00916617|515579577|FG001|Overall Study|Withdrawal by Subject|2|||
143011194|NCT00916617|515579578|FG002|Overall Study|Withdrawal by Subject|0|||
143011195|NCT00916617|515579579|FG003|Overall Study|Withdrawal by Subject|1|||
143011196|NCT00916617|515579576|FG000|Overall Study|Caregiver Request|3|||
143011197|NCT00916617|515579577|FG001|Overall Study|Caregiver Request|2|||
143011198|NCT00916617|515579578|FG002|Overall Study|Caregiver Request|1|||
143011199|NCT00916617|515579579|FG003|Overall Study|Caregiver Request|0|||
143011200|NCT00916617|515579576|FG000|Overall Study|Physician Decision|1|||
143011201|NCT00916617|515579577|FG001|Overall Study|Physician Decision|1|||
143011202|NCT00916617|515579578|FG002|Overall Study|Physician Decision|0|||
143011203|NCT00916617|515579579|FG003|Overall Study|Physician Decision|0|||
143011204|NCT00916617|515579576|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
143011205|NCT00916617|515579577|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
143011206|NCT00916617|515579578|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
143011207|NCT00916617|515579579|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
143011208|NCT00916617|515579576|FG000|Overall Study|Lost to Follow-up|2|||
143011209|NCT00916617|515579577|FG001|Overall Study|Lost to Follow-up|1|||
143011210|NCT00916617|515579578|FG002|Overall Study|Lost to Follow-up|0|||
143011211|NCT00916617|515579579|FG003|Overall Study|Lost to Follow-up|0|||
143011212|NCT00916617|515579576|FG000|Overall Study|Lack of Efficacy|1|||
143011213|NCT00916617|515579577|FG001|Overall Study|Lack of Efficacy|0|||
143011214|NCT00916617|515579578|FG002|Overall Study|Lack of Efficacy|0|||
143011215|NCT00916617|515579579|FG003|Overall Study|Lack of Efficacy|0|||
143011216|NCT00916617|515579576|FG000|Overall Study|Other|2|||
143011217|NCT00916617|515579577|FG001|Overall Study|Other|0|||
143011218|NCT00916617|515579578|FG002|Overall Study|Other|0|||
143011219|NCT00916617|515579579|FG003|Overall Study|Other|2|||
143011220|NCT03387735|515579580|FG000|Overall Study|Lost to Follow-up|4|||
143011221|NCT03387735|515579581|FG001|Overall Study|Lost to Follow-up|8|||
143011222|NCT03387735|515579580|FG000|Overall Study|Death|4|||
143011223|NCT03387735|515579581|FG001|Overall Study|Death|8|||
143011224|NCT03099161|515579582|FG000|Overall Study|Adverse Event|0|||
143011225|NCT03099161|515579583|FG001|Overall Study|Adverse Event|0|||
143011226|NCT03099161|515579584|FG002|Overall Study|Adverse Event|2|||
143011227|NCT03099161|515579582|FG000|Overall Study|Physician Decision|2|||
143011228|NCT03099161|515579583|FG001|Overall Study|Physician Decision|0|||
143011229|NCT03099161|515579584|FG002|Overall Study|Physician Decision|0|||
143011230|NCT03099161|515579582|FG000|Overall Study|Progressive Disease|1|||
143011231|NCT03099161|515579583|FG001|Overall Study|Progressive Disease|4|||
143011232|NCT03099161|515579584|FG002|Overall Study|Progressive Disease|1|||
143011233|NCT02723786|515579587|FG000|Overall Study|Lost to Follow-up|1|||
143011234|NCT03170271|515579596|FG000|Overall Study|Adverse Event|7|||
143011235|NCT03170271|515579597|FG001|Overall Study|Adverse Event|2|||
143011236|NCT03170271|515579596|FG000|Overall Study|Lost to Follow-up|0|||
143011237|NCT03170271|515579597|FG001|Overall Study|Lost to Follow-up|1|||
143011238|NCT03170271|515579596|FG000|Overall Study|Physician Decision|1|||
143011239|NCT03170271|515579597|FG001|Overall Study|Physician Decision|0|||
143011240|NCT03170271|515579596|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
143011241|NCT03170271|515579597|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
143011242|NCT03170271|515579596|FG000|Overall Study|Withdrawal by Subject|17|||
143011243|NCT03170271|515579597|FG001|Overall Study|Withdrawal by Subject|5|||
143011244|NCT03170271|515579596|FG000|Overall Study|Other|2|||
143011245|NCT03170271|515579597|FG001|Overall Study|Other|2|||
143011246|NCT03170271|515579596|FG000|Overall Study|Randomized in error|4|||
143011247|NCT03170271|515579597|FG001|Overall Study|Randomized in error|0|||
143011248|NCT01612780|515579615|FG000|Overall Study|Treatment not completed|1|||
143011249|NCT01612780|515579615|FG000|Overall Study|Withdrawal by Subject|5|||
143011250|NCT03466060|515579616|FG000|Period 1|Test Lens Damage|0|||
143011251|NCT03466060|515579617|FG001|Period 1|Test Lens Damage|2|||
143011252|NCT03466060|515579618|FG002|Period 1|Test Lens Damage|0|||
143011253|NCT03466060|515579619|FG003|Period 1|Test Lens Damage|0|||
143011254|NCT03466060|515579620|FG004|Period 1|Test Lens Damage|0|||
143011255|NCT03466060|515579621|FG005|Period 1|Test Lens Damage|0|||
143011256|NCT03466060|515579616|FG000|Period 1|Withdrawal by Subject|0|||
143011257|NCT03466060|515579617|FG001|Period 1|Withdrawal by Subject|0|||
143347050|NCT02668016|516816855|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
143347051|NCT02668016|516816855|FG000|Month 8|Withdrawal due to severe symptoms|1|||
143347052|NCT02668016|516816855|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
143347053|NCT02668016|516816855|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
143347054|NCT02668016|516816855|FG000|Month 10|Withdrawal due to severe symptoms|1|||
143347055|NCT02668016|516816855|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
143347056|NCT02569710|516816859|FG000|Overall Study|Adverse Event|1|||
143347057|NCT02569710|516816860|FG001|Overall Study|Adverse Event|0|||
143347058|NCT02569710|516816861|FG002|Overall Study|Adverse Event|0|||
143347059|NCT02569710|516816862|FG003|Overall Study|Adverse Event|0|||
143347060|NCT02569710|516816863|FG004|Overall Study|Adverse Event|0|||
143347061|NCT02569710|516816864|FG005|Overall Study|Adverse Event|0|||
143011258|NCT03466060|515579618|FG002|Period 1|Withdrawal by Subject|2|||
143011259|NCT03466060|515579619|FG003|Period 1|Withdrawal by Subject|0|||
143011260|NCT03466060|515579620|FG004|Period 1|Withdrawal by Subject|0|||
143011261|NCT03466060|515579621|FG005|Period 1|Withdrawal by Subject|0|||
143011262|NCT03466060|515579616|FG000|Period 1|Lost to Follow-up|0|||
143011263|NCT03466060|515579617|FG001|Period 1|Lost to Follow-up|0|||
143011264|NCT03466060|515579618|FG002|Period 1|Lost to Follow-up|0|||
143011265|NCT03466060|515579619|FG003|Period 1|Lost to Follow-up|1|||
143011266|NCT03466060|515579620|FG004|Period 1|Lost to Follow-up|0|||
143011267|NCT03466060|515579621|FG005|Period 1|Lost to Follow-up|0|||
143011268|NCT03466060|515579616|FG000|Period 1|Grade 2 Conjunctivitis|0|||
143011269|NCT03466060|515579617|FG001|Period 1|Grade 2 Conjunctivitis|0|||
143011270|NCT03466060|515579618|FG002|Period 1|Grade 2 Conjunctivitis|1|||
143011271|NCT03466060|515579619|FG003|Period 1|Grade 2 Conjunctivitis|0|||
143011272|NCT03466060|515579620|FG004|Period 1|Grade 2 Conjunctivitis|0|||
143011273|NCT03466060|515579621|FG005|Period 1|Grade 2 Conjunctivitis|0|||
143011274|NCT03466060|515579616|FG000|Period 2|Lens Handling Difficulties|0|||
143011275|NCT03466060|515579617|FG001|Period 2|Lens Handling Difficulties|0|||
143011276|NCT03466060|515579618|FG002|Period 2|Lens Handling Difficulties|1|||
143011277|NCT03466060|515579619|FG003|Period 2|Lens Handling Difficulties|0|||
143011278|NCT03466060|515579620|FG004|Period 2|Lens Handling Difficulties|0|||
143011279|NCT03466060|515579621|FG005|Period 2|Lens Handling Difficulties|0|||
143011280|NCT00556166|515579622|FG000|Overall Study|Withdrawal by Subject|1|||
143011281|NCT02985515|515579625|FG000|Olfaction Testing|Lost to Follow-up|0|||
143011282|NCT02985515|515579626|FG001|Olfaction Testing|Lost to Follow-up|5|||
143011283|NCT02985515|515579625|FG000|Olfaction Testing|Protocol Violation|0|||
143011284|NCT02985515|515579626|FG001|Olfaction Testing|Protocol Violation|3|||
143011285|NCT03359473|515579627|FG000|Overall Study|Adverse Event|0|||
143011286|NCT03359473|515579628|FG001|Overall Study|Adverse Event|2|||
143011287|NCT03359473|515579629|FG002|Overall Study|Adverse Event|5|||
143011288|NCT03359473|515579630|FG003|Overall Study|Adverse Event|3|||
143011289|NCT03359473|515579627|FG000|Overall Study|Lost to Follow-up|0|||
143011290|NCT03359473|515579628|FG001|Overall Study|Lost to Follow-up|1|||
143011291|NCT03359473|515579629|FG002|Overall Study|Lost to Follow-up|0|||
143011292|NCT03359473|515579630|FG003|Overall Study|Lost to Follow-up|0|||
143011293|NCT03359473|515579627|FG000|Overall Study|Physician Decision|0|||
143011294|NCT03359473|515579628|FG001|Overall Study|Physician Decision|1|||
143011295|NCT03359473|515579629|FG002|Overall Study|Physician Decision|0|||
143011296|NCT03359473|515579630|FG003|Overall Study|Physician Decision|1|||
143011297|NCT03359473|515579627|FG000|Overall Study|Withdrawal by Subject|1|||
143011298|NCT03359473|515579628|FG001|Overall Study|Withdrawal by Subject|2|||
143011299|NCT03359473|515579629|FG002|Overall Study|Withdrawal by Subject|1|||
143011300|NCT03359473|515579630|FG003|Overall Study|Withdrawal by Subject|0|||
143347062|NCT02569710|516816865|FG006|Overall Study|Adverse Event|0|||
143011301|NCT03359473|515579627|FG000|Overall Study|Protocol-defined stopping criteria|1|||
143347063|NCT02569710|516816866|FG007|Overall Study|Adverse Event|0|||
143011302|NCT03359473|515579628|FG001|Overall Study|Protocol-defined stopping criteria|0|||
143011303|NCT03359473|515579629|FG002|Overall Study|Protocol-defined stopping criteria|0|||
143011304|NCT03359473|515579630|FG003|Overall Study|Protocol-defined stopping criteria|1|||
143347064|NCT02569710|516816867|FG008|Overall Study|Adverse Event|0|||
143011305|NCT05302414|515579631|FG000|Pretest to Posttest|Lost to Follow-up|12|||
143011306|NCT05302414|515579632|FG001|Pretest to Posttest|Lost to Follow-up|8|||
143011307|NCT05302414|515579633|FG002|Pretest to Posttest|Lost to Follow-up|8|||
143011308|NCT05302414|515579631|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
143124593|NCT03026283|516001211|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
143011309|NCT05302414|515579632|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
143011310|NCT05302414|515579633|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
143011311|NCT00742859|515579636|FG000|Overall Study|Adverse Event|5|||
143011312|NCT00742859|515579637|FG001|Overall Study|Adverse Event|6|||
143011313|NCT00742859|515579638|FG002|Overall Study|Adverse Event|3|||
143011314|NCT00742859|515579639|FG003|Overall Study|Adverse Event|1|||
143011315|NCT00742859|515579636|FG000|Overall Study|Death|1|||
143011316|NCT00742859|515579637|FG001|Overall Study|Death|0|||
143011317|NCT00742859|515579638|FG002|Overall Study|Death|0|||
143011318|NCT00742859|515579639|FG003|Overall Study|Death|1|||
143011319|NCT00742859|515579636|FG000|Overall Study|Physician Decision|1|||
143011320|NCT00742859|515579637|FG001|Overall Study|Physician Decision|2|||
143011321|NCT00742859|515579638|FG002|Overall Study|Physician Decision|0|||
143011322|NCT00742859|515579639|FG003|Overall Study|Physician Decision|0|||
143011323|NCT00742859|515579636|FG000|Overall Study|Withdrawal by Subject|4|||
143011324|NCT00742859|515579637|FG001|Overall Study|Withdrawal by Subject|2|||
143011325|NCT00742859|515579638|FG002|Overall Study|Withdrawal by Subject|4|||
143011326|NCT00742859|515579639|FG003|Overall Study|Withdrawal by Subject|1|||
143011327|NCT00742859|515579636|FG000|Overall Study|Endpoint|0|||
143011328|NCT00742859|515579637|FG001|Overall Study|Endpoint|1|||
143011329|NCT00742859|515579638|FG002|Overall Study|Endpoint|1|||
143011330|NCT00742859|515579639|FG003|Overall Study|Endpoint|2|||
143011331|NCT00742859|515579636|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
143011332|NCT00742859|515579637|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
143011333|NCT00742859|515579638|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
143011334|NCT00742859|515579639|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
143011335|NCT00742859|515579636|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
143011336|NCT00742859|515579637|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
143011337|NCT00742859|515579638|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
143011338|NCT00742859|515579639|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
143011339|NCT00742859|515579636|FG000|Overall Study|Sponsor request patient out of town|0|||
143011340|NCT00742859|515579637|FG001|Overall Study|Sponsor request patient out of town|0|||
143011341|NCT00742859|515579638|FG002|Overall Study|Sponsor request patient out of town|1|||
143011342|NCT00742859|515579639|FG003|Overall Study|Sponsor request patient out of town|1|||
143011343|NCT00742859|515579636|FG000|Overall Study|Site error|0|||
143011344|NCT00742859|515579637|FG001|Overall Study|Site error|0|||
143011345|NCT00742859|515579638|FG002|Overall Study|Site error|1|||
143011346|NCT00742859|515579639|FG003|Overall Study|Site error|1|||
143011347|NCT00962013|515579642|FG000|Overall Study|Did not have surgery|1|||
143011348|NCT00962013|515579642|FG000|Overall Study|Death|8|||
143011349|NCT00962013|515579642|FG000|Overall Study|Lost to Follow-up|12|||
143011350|NCT00962013|515579642|FG000|Overall Study|Unable/Unwilling to return|6|||
143011351|NCT00962013|515579642|FG000|Overall Study|Withdrawal by Subject|8|||
143011352|NCT00962013|515579642|FG000|Overall Study|Removal of study device|3|||
143011353|NCT00962013|515579642|FG000|Overall Study|Site Termination|24|||
143011354|NCT00962013|515579642|FG000|Overall Study|No 5 year evaluation|6|||
143011355|NCT00424632|515579647|FG000|Overall Study|Death|0|||
143011356|NCT00424632|515579648|FG001|Overall Study|Death|0|||
143011357|NCT00424632|515579649|FG002|Overall Study|Death|0|||
143011358|NCT00424632|515579650|FG003|Overall Study|Death|0|||
143011359|NCT00424632|515579651|FG004|Overall Study|Death|0|||
143011360|NCT00424632|515579652|FG005|Overall Study|Death|2|||
143011361|NCT00424632|515579653|FG006|Overall Study|Death|0|||
143011362|NCT00424632|515579654|FG007|Overall Study|Death|0|||
143011363|NCT00424632|515579655|FG008|Overall Study|Death|0|||
143011364|NCT00424632|515579656|FG009|Overall Study|Death|0|||
143011365|NCT00424632|515579647|FG000|Overall Study|Adverse Event|0|||
143011366|NCT00424632|515579648|FG001|Overall Study|Adverse Event|0|||
143011367|NCT00424632|515579649|FG002|Overall Study|Adverse Event|0|||
143011368|NCT00424632|515579650|FG003|Overall Study|Adverse Event|0|||
143011369|NCT00424632|515579651|FG004|Overall Study|Adverse Event|0|||
143011370|NCT00424632|515579652|FG005|Overall Study|Adverse Event|0|||
143011371|NCT00424632|515579653|FG006|Overall Study|Adverse Event|0|||
143011372|NCT00424632|515579654|FG007|Overall Study|Adverse Event|0|||
143011373|NCT00424632|515579655|FG008|Overall Study|Adverse Event|3|||
143011374|NCT00424632|515579656|FG009|Overall Study|Adverse Event|2|||
143011375|NCT00424632|515579647|FG000|Overall Study|Global deterioration of health status|0|||
143011376|NCT00424632|515579648|FG001|Overall Study|Global deterioration of health status|0|||
143011377|NCT00424632|515579649|FG002|Overall Study|Global deterioration of health status|0|||
143011378|NCT00424632|515579650|FG003|Overall Study|Global deterioration of health status|1|||
143011379|NCT00424632|515579651|FG004|Overall Study|Global deterioration of health status|1|||
143011380|NCT00424632|515579652|FG005|Overall Study|Global deterioration of health status|0|||
143011381|NCT00424632|515579653|FG006|Overall Study|Global deterioration of health status|0|||
143011382|NCT00424632|515579654|FG007|Overall Study|Global deterioration of health status|0|||
143011383|NCT00424632|515579655|FG008|Overall Study|Global deterioration of health status|0|||
143011384|NCT00424632|515579656|FG009|Overall Study|Global deterioration of health status|0|||
143011385|NCT00424632|515579647|FG000|Overall Study|Objective progression or relapse|1|||
143011386|NCT00424632|515579648|FG001|Overall Study|Objective progression or relapse|1|||
143011387|NCT00424632|515579649|FG002|Overall Study|Objective progression or relapse|1|||
143011388|NCT00424632|515579650|FG003|Overall Study|Objective progression or relapse|2|||
143011389|NCT00424632|515579651|FG004|Overall Study|Objective progression or relapse|2|||
143347065|NCT02569710|516816868|FG009|Overall Study|Adverse Event|0|||
143011390|NCT00424632|515579652|FG005|Overall Study|Objective progression or relapse|13|||
143011391|NCT00424632|515579653|FG006|Overall Study|Objective progression or relapse|7|||
143011392|NCT00424632|515579654|FG007|Overall Study|Objective progression or relapse|3|||
143011393|NCT00424632|515579655|FG008|Overall Study|Objective progression or relapse|12|||
143011394|NCT00424632|515579656|FG009|Overall Study|Objective progression or relapse|4|||
143011395|NCT00424632|515579647|FG000|Overall Study|Other|0|||
143011396|NCT00424632|515579648|FG001|Overall Study|Other|0|||
143011397|NCT00424632|515579649|FG002|Overall Study|Other|0|||
143011398|NCT00424632|515579650|FG003|Overall Study|Other|1|||
143011399|NCT00424632|515579651|FG004|Overall Study|Other|0|||
143011400|NCT00424632|515579652|FG005|Overall Study|Other|0|||
143011401|NCT00424632|515579653|FG006|Overall Study|Other|0|||
143011402|NCT00424632|515579654|FG007|Overall Study|Other|0|||
143011403|NCT00424632|515579655|FG008|Overall Study|Other|1|||
143011404|NCT00424632|515579656|FG009|Overall Study|Other|0|||
143011405|NCT00445458|515579658|FG000|Overall Study|Disease Progression|3|||
143011406|NCT00445458|515579659|FG001|Overall Study|Disease Progression|4|||
143011407|NCT00445458|515579660|FG002|Overall Study|Disease Progression|54|||
143011408|NCT00445458|515579661|FG003|Overall Study|Disease Progression|27|||
143011409|NCT00445458|515579658|FG000|Overall Study|Withdrawal by Subject|0|||
143011410|NCT00445458|515579659|FG001|Overall Study|Withdrawal by Subject|0|||
143011411|NCT00445458|515579660|FG002|Overall Study|Withdrawal by Subject|7|||
143011412|NCT00445458|515579661|FG003|Overall Study|Withdrawal by Subject|0|||
143011413|NCT00445458|515579658|FG000|Overall Study|Adverse Event|0|||
143011414|NCT00445458|515579659|FG001|Overall Study|Adverse Event|0|||
143011415|NCT00445458|515579660|FG002|Overall Study|Adverse Event|3|||
143011416|NCT00445458|515579661|FG003|Overall Study|Adverse Event|0|||
143011417|NCT00445458|515579658|FG000|Overall Study|Death|0|||
143011418|NCT00445458|515579659|FG001|Overall Study|Death|1|||
143011419|NCT00445458|515579660|FG002|Overall Study|Death|2|||
143011420|NCT00445458|515579661|FG003|Overall Study|Death|0|||
143011421|NCT00445458|515579658|FG000|Overall Study|Physician Decision|0|||
143347066|NCT02569710|516816859|FG000|Overall Study|Lost to Follow-up|0|||
143347067|NCT02569710|516816860|FG001|Overall Study|Lost to Follow-up|0|||
143347068|NCT02569710|516816861|FG002|Overall Study|Lost to Follow-up|0|||
143347069|NCT02569710|516816862|FG003|Overall Study|Lost to Follow-up|0|||
143347070|NCT02569710|516816863|FG004|Overall Study|Lost to Follow-up|0|||
143347071|NCT02569710|516816864|FG005|Overall Study|Lost to Follow-up|0|||
143347072|NCT02569710|516816865|FG006|Overall Study|Lost to Follow-up|1|||
143347073|NCT02569710|516816866|FG007|Overall Study|Lost to Follow-up|0|||
143347074|NCT02569710|516816867|FG008|Overall Study|Lost to Follow-up|1|||
143347075|NCT02569710|516816868|FG009|Overall Study|Lost to Follow-up|0|||
143347076|NCT02569710|516816859|FG000|Overall Study|Virologic failure|0|||
143347077|NCT02569710|516816860|FG001|Overall Study|Virologic failure|0|||
143347078|NCT02569710|516816861|FG002|Overall Study|Virologic failure|0|||
143347079|NCT02569710|516816862|FG003|Overall Study|Virologic failure|0|||
143347080|NCT02569710|516816863|FG004|Overall Study|Virologic failure|1|||
143347081|NCT02569710|516816864|FG005|Overall Study|Virologic failure|0|||
143347082|NCT02569710|516816865|FG006|Overall Study|Virologic failure|1|||
143347083|NCT02569710|516816866|FG007|Overall Study|Virologic failure|0|||
143347084|NCT02569710|516816867|FG008|Overall Study|Virologic failure|0|||
143347085|NCT02569710|516816868|FG009|Overall Study|Virologic failure|0|||
143347086|NCT02569710|516816859|FG000|Overall Study|Withdrawal by Subject|0|||
143347087|NCT02569710|516816860|FG001|Overall Study|Withdrawal by Subject|0|||
143347088|NCT02569710|516816861|FG002|Overall Study|Withdrawal by Subject|0|||
143347089|NCT02569710|516816862|FG003|Overall Study|Withdrawal by Subject|0|||
143347090|NCT02569710|516816863|FG004|Overall Study|Withdrawal by Subject|0|||
143347091|NCT02569710|516816864|FG005|Overall Study|Withdrawal by Subject|1|||
143347092|NCT02569710|516816865|FG006|Overall Study|Withdrawal by Subject|0|||
143347093|NCT02569710|516816866|FG007|Overall Study|Withdrawal by Subject|0|||
143347094|NCT02569710|516816867|FG008|Overall Study|Withdrawal by Subject|0|||
143347095|NCT02569710|516816868|FG009|Overall Study|Withdrawal by Subject|0|||
143347096|NCT03573908|516816869|FG000|Treatment Period|Adverse Event|4|||
143347097|NCT03573908|516816870|FG001|Treatment Period|Adverse Event|9|||
143347098|NCT03573908|516816871|FG002|Treatment Period|Adverse Event|0|||
143011422|NCT00445458|515579659|FG001|Overall Study|Physician Decision|0|||
143011423|NCT00445458|515579660|FG002|Overall Study|Physician Decision|1|||
143011424|NCT00445458|515579661|FG003|Overall Study|Physician Decision|1|||
143011425|NCT00445458|515579658|FG000|Overall Study|Surgery|0|||
143011426|NCT00445458|515579659|FG001|Overall Study|Surgery|0|||
143011427|NCT00445458|515579660|FG002|Overall Study|Surgery|1|||
143011428|NCT00445458|515579661|FG003|Overall Study|Surgery|0|||
143011429|NCT01071083|515579667|FG000|Overall Study|Adverse Event|1|||
143011430|NCT01071083|515579668|FG001|Overall Study|Adverse Event|0|||
143011431|NCT01071083|515579669|FG002|Overall Study|Adverse Event|1|||
143011432|NCT01071083|515579670|FG003|Overall Study|Adverse Event|0|||
143011433|NCT01071083|515579671|FG004|Overall Study|Adverse Event|1|||
143347099|NCT03573908|516816872|FG003|Treatment Period|Adverse Event|0|||
143011434|NCT01071083|515579667|FG000|Overall Study|Withdrawal by Subject|3|||
143011435|NCT01071083|515579668|FG001|Overall Study|Withdrawal by Subject|0|||
143347100|NCT03573908|516816873|FG004|Treatment Period|Adverse Event|0|||
143347101|NCT03573908|516816869|FG000|Treatment Period|Protocol Violation|1|||
143347102|NCT03573908|516816870|FG001|Treatment Period|Protocol Violation|0|||
143347103|NCT03573908|516816871|FG002|Treatment Period|Protocol Violation|0|||
143347104|NCT03573908|516816872|FG003|Treatment Period|Protocol Violation|0|||
143347105|NCT03573908|516816873|FG004|Treatment Period|Protocol Violation|0|||
143347106|NCT03573908|516816869|FG000|Treatment Period|Withdrawal by Subject|7|||
143347107|NCT03573908|516816870|FG001|Treatment Period|Withdrawal by Subject|5|||
143347108|NCT03573908|516816871|FG002|Treatment Period|Withdrawal by Subject|0|||
143347109|NCT03573908|516816872|FG003|Treatment Period|Withdrawal by Subject|0|||
143347110|NCT03573908|516816873|FG004|Treatment Period|Withdrawal by Subject|0|||
143347111|NCT03573908|516816869|FG000|Treatment Period|Lost to Follow-up|7|||
143347112|NCT03573908|516816870|FG001|Treatment Period|Lost to Follow-up|6|||
143347113|NCT03573908|516816871|FG002|Treatment Period|Lost to Follow-up|0|||
143347114|NCT03573908|516816872|FG003|Treatment Period|Lost to Follow-up|0|||
143347115|NCT03573908|516816873|FG004|Treatment Period|Lost to Follow-up|0|||
143347116|NCT03573908|516816869|FG000|Treatment Period|Pregnancy|1|||
143347117|NCT03573908|516816870|FG001|Treatment Period|Pregnancy|0|||
143347118|NCT03573908|516816871|FG002|Treatment Period|Pregnancy|0|||
143347119|NCT03573908|516816872|FG003|Treatment Period|Pregnancy|0|||
143347120|NCT03573908|516816873|FG004|Treatment Period|Pregnancy|0|||
143347121|NCT03573908|516816869|FG000|Treatment Period|Other, Not Specified|4|||
143347122|NCT03573908|516816870|FG001|Treatment Period|Other, Not Specified|6|||
143347123|NCT03573908|516816871|FG002|Treatment Period|Other, Not Specified|0|||
143347124|NCT03573908|516816872|FG003|Treatment Period|Other, Not Specified|0|||
143347125|NCT03573908|516816873|FG004|Treatment Period|Other, Not Specified|0|||
143347126|NCT03573908|516816869|FG000|Randomized Withdrawal Period|Adverse Event|0|||
143347127|NCT03573908|516816870|FG001|Randomized Withdrawal Period|Adverse Event|0|||
143347128|NCT03573908|516816871|FG002|Randomized Withdrawal Period|Adverse Event|3|||
143347129|NCT03573908|516816872|FG003|Randomized Withdrawal Period|Adverse Event|0|||
143347130|NCT03573908|516816873|FG004|Randomized Withdrawal Period|Adverse Event|0|||
143347131|NCT03573908|516816869|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
143347132|NCT03573908|516816870|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
143347133|NCT03573908|516816871|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
143347134|NCT03573908|516816872|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
143347135|NCT03573908|516816873|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
143347136|NCT03573908|516816869|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
143011436|NCT01071083|515579669|FG002|Overall Study|Withdrawal by Subject|2|||
143011437|NCT01071083|515579670|FG003|Overall Study|Withdrawal by Subject|0|||
143011438|NCT01071083|515579671|FG004|Overall Study|Withdrawal by Subject|3|||
143011439|NCT01071083|515579667|FG000|Overall Study|Physician Decision|1|||
143011440|NCT01071083|515579668|FG001|Overall Study|Physician Decision|0|||
143011441|NCT01071083|515579669|FG002|Overall Study|Physician Decision|0|||
143011442|NCT01071083|515579670|FG003|Overall Study|Physician Decision|1|||
143011443|NCT01071083|515579671|FG004|Overall Study|Physician Decision|1|||
143011444|NCT01071083|515579667|FG000|Overall Study|Early Rescue|1|||
143011445|NCT01071083|515579668|FG001|Overall Study|Early Rescue|0|||
143011446|NCT01071083|515579669|FG002|Overall Study|Early Rescue|0|||
143011447|NCT01071083|515579670|FG003|Overall Study|Early Rescue|0|||
143011448|NCT01071083|515579671|FG004|Overall Study|Early Rescue|1|||
143011449|NCT01071083|515579667|FG000|Overall Study|Subject Moved|0|||
143011450|NCT01071083|515579668|FG001|Overall Study|Subject Moved|1|||
143011451|NCT01071083|515579669|FG002|Overall Study|Subject Moved|0|||
143011452|NCT01071083|515579670|FG003|Overall Study|Subject Moved|0|||
143011453|NCT01071083|515579671|FG004|Overall Study|Subject Moved|0|||
143011454|NCT01071083|515579667|FG000|Overall Study|Images Not Usable (Motion)|0|||
143011455|NCT01071083|515579668|FG001|Overall Study|Images Not Usable (Motion)|1|||
143011456|NCT01071083|515579669|FG002|Overall Study|Images Not Usable (Motion)|0|||
143011457|NCT01071083|515579670|FG003|Overall Study|Images Not Usable (Motion)|0|||
143011458|NCT01071083|515579671|FG004|Overall Study|Images Not Usable (Motion)|0|||
143011459|NCT01071083|515579667|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
143011460|NCT01071083|515579668|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
143011461|NCT01071083|515579669|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
143011462|NCT01071083|515579670|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
143011463|NCT01071083|515579671|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
143011464|NCT01071083|515579667|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
143011465|NCT01071083|515579668|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
143011466|NCT01071083|515579669|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
143011467|NCT01071083|515579670|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
143011468|NCT01071083|515579671|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
143011469|NCT01071083|515579667|FG000|Overall Study|Subject Refused to Continue|1|||
143011470|NCT01071083|515579668|FG001|Overall Study|Subject Refused to Continue|0|||
143011471|NCT01071083|515579669|FG002|Overall Study|Subject Refused to Continue|0|||
143011472|NCT01071083|515579670|FG003|Overall Study|Subject Refused to Continue|0|||
143011473|NCT01071083|515579671|FG004|Overall Study|Subject Refused to Continue|0|||
143011474|NCT03972709|515579672|FG000|Overall Study|Withdrawal by Subject|18|||
143011475|NCT03972709|515579673|FG001|Overall Study|Withdrawal by Subject|7|||
143011476|NCT03972709|515579674|FG002|Overall Study|Withdrawal by Subject|14|||
143011477|NCT03972709|515579672|FG000|Overall Study|Study Terminated by Sponsor|48|||
143011478|NCT03972709|515579673|FG001|Overall Study|Study Terminated by Sponsor|25|||
143011479|NCT03972709|515579674|FG002|Overall Study|Study Terminated by Sponsor|50|||
143011480|NCT03972709|515579672|FG000|Overall Study|Physician Decision|1|||
143011481|NCT03972709|515579673|FG001|Overall Study|Physician Decision|0|||
143011482|NCT03972709|515579674|FG002|Overall Study|Physician Decision|0|||
143011483|NCT03972709|515579672|FG000|Overall Study|COVID-19|0|||
143011484|NCT03972709|515579673|FG001|Overall Study|COVID-19|1|||
143011485|NCT03972709|515579674|FG002|Overall Study|COVID-19|1|||
143011486|NCT03972709|515579672|FG000|Overall Study|Lost to Follow-up|6|||
143124594|NCT03026283|516001212|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
143124595|NCT01054222|516001217|FG000|Overall Study|Lack of Efficacy|1|||
143124596|NCT01054222|516001217|FG000|Overall Study|Lost to Follow-up|4|||
143124597|NCT01054222|516001217|FG000|Overall Study|Withdrawal by Subject|6|||
143124598|NCT00824655|516001218|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
143124599|NCT00824655|516001219|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
143124600|NCT00824655|516001218|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
143124601|NCT00824655|516001219|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
143124602|NCT03504189|516001220|FG000|Overall Study|Withdrawal by Subject|1|||
143124603|NCT03504189|516001220|FG000|Overall Study|Screening Failure|1|||
143124604|NCT03504189|516001220|FG000|Overall Study|Device Failure|2|||
143124605|NCT03091738|516001221|FG000|Overall Study|Adverse Event|1|||
143124606|NCT03091738|516001221|FG000|Overall Study|Lost to Follow-up|1|||
143124607|NCT00199849|516001223|FG000|Overall Study|Unrelated illness or complication|0|||
143124608|NCT00199849|516001224|FG001|Overall Study|Unrelated illness or complication|1|||
143124609|NCT00199849|516001225|FG002|Overall Study|Unrelated illness or complication|0|||
143124610|NCT00199849|516001223|FG000|Overall Study|Progressive disease requiring intervention|0|||
143124611|NCT00199849|516001224|FG001|Overall Study|Progressive disease requiring intervention|0|||
143124612|NCT00199849|516001225|FG002|Overall Study|Progressive disease requiring intervention|1|||
143124613|NCT00199849|516001223|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
143124614|NCT00199849|516001224|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
143124615|NCT00199849|516001225|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
143124616|NCT04727528|516001226|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
143124617|NCT04727528|516001227|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
143124618|NCT04727528|516001226|FG000|Open-label Period|Randomized who did not receive treatment|1|||
143124619|NCT04727528|516001227|FG001|Open-label Period|Randomized who did not receive treatment|0|||
143124620|NCT04727528|516001226|FG000|Double-blind Treatment Phase|Adverse Event|0|||
143124621|NCT04727528|516001227|FG001|Double-blind Treatment Phase|Adverse Event|1|||
143124622|NCT04727528|516001226|FG000|Double-blind Treatment Phase|Death|0|||
143124623|NCT04727528|516001227|FG001|Double-blind Treatment Phase|Death|1|||
143124624|NCT04727528|516001226|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
143124625|NCT04727528|516001227|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
143124626|NCT04727528|516001226|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
143124627|NCT04727528|516001227|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
143124628|NCT04727528|516001226|FG000|Double-blind Treatment Phase|Physician Decision|0|||
143124629|NCT04727528|516001227|FG001|Double-blind Treatment Phase|Physician Decision|1|||
143124630|NCT04727528|516001226|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
143124631|NCT04727528|516001227|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
143124632|NCT03479008|516001242|FG000|Overall Study|Withdrawal by Subject|3|||
143124633|NCT01796301|516001243|FG000|Overall Study|Withdrawal by Subject|15|||
143124634|NCT01796301|516001244|FG001|Overall Study|Withdrawal by Subject|15|||
143124635|NCT01796301|516001243|FG000|Overall Study|Lost to Follow-up|3|||
143124636|NCT01796301|516001244|FG001|Overall Study|Lost to Follow-up|3|||
143124637|NCT01796301|516001243|FG000|Overall Study|Death|0|||
143124638|NCT01796301|516001244|FG001|Overall Study|Death|1|||
143124639|NCT01796301|516001243|FG000|Overall Study|Decision by Sponsor|0|||
143124640|NCT01796301|516001244|FG001|Overall Study|Decision by Sponsor|1|||
143124641|NCT01704755|516001245|FG000|Overall Study|Adverse Event|4|||
143124642|NCT01704755|516001246|FG001|Overall Study|Adverse Event|1|||
143124643|NCT01704755|516001245|FG000|Overall Study|Lost to Follow-up|3|||
143124644|NCT01704755|516001246|FG001|Overall Study|Lost to Follow-up|4|||
143124645|NCT01704755|516001245|FG000|Overall Study|Withdrew consent|1|||
143124646|NCT01704755|516001246|FG001|Overall Study|Withdrew consent|1|||
143124647|NCT01704755|516001245|FG000|Overall Study|Other (not specified)|3|||
143124648|NCT01704755|516001246|FG001|Overall Study|Other (not specified)|1|||
143124649|NCT01704755|516001245|FG000|Overall Study|Withdrew consent and personal issues|1|||
143124650|NCT01704755|516001246|FG001|Overall Study|Withdrew consent and personal issues|0|||
143011487|NCT03972709|515579673|FG001|Overall Study|Lost to Follow-up|1|||
143011488|NCT03972709|515579674|FG002|Overall Study|Lost to Follow-up|2|||
143011489|NCT03972709|515579672|FG000|Overall Study|Death|5|||
143124651|NCT00667563|516001247|FG000|Overall Study|Protocol Violation|24|||
143124652|NCT00660595|516001250|FG000|Overall Study|Lost to Follow-up|0|||
143124653|NCT00660595|516001251|FG001|Overall Study|Lost to Follow-up|1|||
143124654|NCT00660595|516001250|FG000|Overall Study|Did not consent to participate in study|12|||
143347137|NCT03573908|516816870|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
143011490|NCT03972709|515579673|FG001|Overall Study|Death|1|||
143011491|NCT03972709|515579674|FG002|Overall Study|Death|4|||
143011492|NCT03972709|515579672|FG000|Overall Study|Adverse Event|3|||
143011493|NCT03972709|515579673|FG001|Overall Study|Adverse Event|1|||
143011494|NCT03972709|515579674|FG002|Overall Study|Adverse Event|4|||
143011495|NCT03972709|515579672|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
143011496|NCT03972709|515579673|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
143011497|NCT03972709|515579674|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
143011498|NCT03972709|515579672|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
143011499|NCT03972709|515579673|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
143011500|NCT03972709|515579674|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
143011501|NCT03972709|515579672|FG000|Overall Study|Subject Unable to be Contacted|0|||
143011502|NCT03972709|515579673|FG001|Overall Study|Subject Unable to be Contacted|1|||
143011503|NCT03972709|515579674|FG002|Overall Study|Subject Unable to be Contacted|0|||
143011504|NCT03972709|515579672|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
143011505|NCT03972709|515579673|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
143011506|NCT03972709|515579674|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
143011507|NCT03972709|515579672|FG000|Overall Study|Subject Moved|0|||
143011508|NCT03972709|515579673|FG001|Overall Study|Subject Moved|1|||
143011509|NCT03972709|515579674|FG002|Overall Study|Subject Moved|0|||
143011510|NCT03972709|515579672|FG000|Overall Study|Missed Study Visits|1|||
143011511|NCT03972709|515579673|FG001|Overall Study|Missed Study Visits|0|||
143011512|NCT03972709|515579674|FG002|Overall Study|Missed Study Visits|0|||
143011513|NCT01523301|515579675|FG000|Overall Study|Adverse Event|25|||
143011514|NCT01523301|515579676|FG001|Overall Study|Adverse Event|16|||
143011515|NCT01523301|515579675|FG000|Overall Study|Lack of Efficacy|0|||
143011516|NCT01523301|515579676|FG001|Overall Study|Lack of Efficacy|2|||
143011517|NCT01523301|515579675|FG000|Overall Study|Protocol Violation|3|||
143011518|NCT01523301|515579676|FG001|Overall Study|Protocol Violation|4|||
143011519|NCT01523301|515579675|FG000|Overall Study|Lost to Follow-up|1|||
143011520|NCT01523301|515579676|FG001|Overall Study|Lost to Follow-up|0|||
143011521|NCT01523301|515579675|FG000|Overall Study|Withdrawal by Subject|6|||
143011522|NCT01523301|515579676|FG001|Overall Study|Withdrawal by Subject|8|||
143011523|NCT01523301|515579675|FG000|Overall Study|Other Reason|0|||
143011524|NCT01523301|515579676|FG001|Overall Study|Other Reason|2|||
143011525|NCT01339000|515579677|FG000|Overall Study|study closed due to lack of drug supply|1|||
143011526|NCT01339000|515579678|FG001|Overall Study|study closed due to lack of drug supply|0|||
143011527|NCT00728988|515579681|FG000|Overall Study|Not Treated|2|||
143011528|NCT00728988|515579682|FG001|Overall Study|Not Treated|2|||
143011529|NCT00728988|515579681|FG000|Overall Study|Death|1|||
143011530|NCT00728988|515579682|FG001|Overall Study|Death|1|||
143011531|NCT00728988|515579681|FG000|Overall Study|Adverse Event|3|||
143011532|NCT00728988|515579682|FG001|Overall Study|Adverse Event|2|||
143011533|NCT00728988|515579681|FG000|Overall Study|Other|85|||
143011534|NCT00728988|515579682|FG001|Overall Study|Other|77|||
143011535|NCT00728988|515579681|FG000|Overall Study|Withdrawal by Subject|2|||
143011536|NCT00728988|515579682|FG001|Overall Study|Withdrawal by Subject|6|||
143011537|NCT05674721|515579683|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
143011538|NCT05674721|515579684|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
143011539|NCT05674721|515579683|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
143011540|NCT05674721|515579684|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
143011541|NCT02017535|515579687|FG000|Overall Study|Withdrawal by Subject|1|||
143011542|NCT02017535|515579688|FG001|Overall Study|Withdrawal by Subject|0|||
143011543|NCT02017535|515579689|FG002|Overall Study|Withdrawal by Subject|0|||
143011544|NCT02017535|515579690|FG003|Overall Study|Withdrawal by Subject|0|||
143011545|NCT01393626|515579691|FG000|Overall Study|Adverse Event|2|||
143011546|NCT01393626|515579692|FG001|Overall Study|Adverse Event|1|||
143011547|NCT01393626|515579693|FG002|Overall Study|Adverse Event|5|||
143011548|NCT01393626|515579694|FG003|Overall Study|Adverse Event|0|||
143011549|NCT01393626|515579691|FG000|Overall Study|Did not meet entrance criteria|1|||
143011550|NCT01393626|515579692|FG001|Overall Study|Did not meet entrance criteria|0|||
143124655|NCT00660595|516001251|FG001|Overall Study|Did not consent to participate in study|8|||
143124656|NCT00660595|516001250|FG000|Overall Study|Participant left hospital|1|||
143347138|NCT03573908|516816871|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
143011551|NCT01393626|515579693|FG002|Overall Study|Did not meet entrance criteria|0|||
143011552|NCT01393626|515579694|FG003|Overall Study|Did not meet entrance criteria|0|||
143011553|NCT01393626|515579691|FG000|Overall Study|Lack of Efficacy|6|||
143011554|NCT01393626|515579692|FG001|Overall Study|Lack of Efficacy|6|||
143124657|NCT00660595|516001251|FG001|Overall Study|Participant left hospital|0|||
143124658|NCT00660595|516001250|FG000|Overall Study|Non Specified reasons|5|||
143124659|NCT00660595|516001251|FG001|Overall Study|Non Specified reasons|0|||
143124660|NCT00264290|516001266|FG000|Intervention (8 Weeks)|Adverse Event|1|||
143124661|NCT00264290|516001267|FG001|Intervention (8 Weeks)|Adverse Event|0|||
143124662|NCT04472494|516001268|FG000|Pre-treatment|Other reasons|2|||
143124663|NCT04472494|516001269|FG001|Pre-treatment|Other reasons|0|||
143011555|NCT01393626|515579693|FG002|Overall Study|Lack of Efficacy|4|||
143124664|NCT04472494|516001268|FG000|Treatment|Death|5|||
143124665|NCT04472494|516001269|FG001|Treatment|Death|2|||
143124666|NCT04472494|516001268|FG000|Treatment|Hospital discharge|1|||
143124667|NCT04472494|516001269|FG001|Treatment|Hospital discharge|1|||
143124668|NCT00707980|516001270|FG000|Overall Study|Adverse Event|49|||
143124669|NCT00707980|516001270|FG000|Overall Study|Lack of Efficacy|35|||
143124670|NCT00707980|516001270|FG000|Overall Study|Non-Compliance with Study Drug|28|||
143124671|NCT00707980|516001270|FG000|Overall Study|Protocol Deviations|19|||
143124672|NCT00707980|516001270|FG000|Overall Study|Withdrawal of Consent|81|||
143124673|NCT00707980|516001270|FG000|Overall Study|Lost to Follow-up|59|||
143124674|NCT00707980|516001270|FG000|Overall Study|Other|39|||
143124675|NCT01152996|516001271|FG000|Overall Study|Withdrawal by Subject|142|||
143124676|NCT01152996|516001271|FG000|Overall Study|Adverse Event|115|||
143124677|NCT01152996|516001271|FG000|Overall Study|Lost to Follow-up|112|||
143124678|NCT01152996|516001271|FG000|Overall Study|Lack of Efficacy|68|||
143124679|NCT01152996|516001271|FG000|Overall Study|Noncompliance|41|||
143124680|NCT01152996|516001271|FG000|Overall Study|Other|36|||
143124681|NCT01152996|516001271|FG000|Overall Study|Protocol Violation|22|||
143124682|NCT01152996|516001271|FG000|Overall Study|Elevated liver enzymes|1|||
143124683|NCT01005901|516001273|FG000|Overall Study|Withdrawal by Subject|38|||
143124684|NCT01005901|516001274|FG001|Overall Study|Withdrawal by Subject|14|||
143124685|NCT01005901|516001273|FG000|Overall Study|Adverse Event|30|||
143124686|NCT01005901|516001274|FG001|Overall Study|Adverse Event|16|||
143124687|NCT01005901|516001273|FG000|Overall Study|Administrative problems|21|||
143124688|NCT01005901|516001274|FG001|Overall Study|Administrative problems|13|||
143124689|NCT01005901|516001273|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
143124690|NCT01005901|516001274|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
143124691|NCT01005901|516001273|FG000|Overall Study|Protocol Violation|4|||
143124692|NCT01005901|516001274|FG001|Overall Study|Protocol Violation|3|||
143124693|NCT01005901|516001273|FG000|Overall Study|Death|2|||
143124694|NCT01005901|516001274|FG001|Overall Study|Death|3|||
143124695|NCT01005901|516001273|FG000|Overall Study|Lost to Follow-up|1|||
143124696|NCT01005901|516001274|FG001|Overall Study|Lost to Follow-up|2|||
143124697|NCT01005901|516001273|FG000|Overall Study|Patient's inability to use the device|1|||
143124698|NCT01005901|516001274|FG001|Overall Study|Patient's inability to use the device|1|||
143124699|NCT01005901|516001273|FG000|Overall Study|No longer requires study drug|0|||
143124700|NCT01005901|516001274|FG001|Overall Study|No longer requires study drug|1|||
143124701|NCT01690299|516001278|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
143124702|NCT01690299|516001279|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
143124703|NCT01690299|516001280|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
143124704|NCT01690299|516001281|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
143124705|NCT01690299|516001282|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
143124706|NCT01690299|516001283|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
143124707|NCT01690299|516001278|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
143124708|NCT01690299|516001279|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
143124709|NCT01690299|516001280|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
143124710|NCT01690299|516001281|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
143124711|NCT01690299|516001282|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
143124712|NCT01690299|516001283|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
143124713|NCT01690299|516001278|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
143124714|NCT01690299|516001279|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
143124715|NCT01690299|516001280|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
143124716|NCT01690299|516001281|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
143124717|NCT01690299|516001282|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
143124718|NCT01690299|516001283|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
143124719|NCT01690299|516001278|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
143124720|NCT01690299|516001279|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
143124721|NCT01690299|516001280|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
143124722|NCT01690299|516001281|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
143011556|NCT01393626|515579694|FG003|Overall Study|Lack of Efficacy|1|||
143011557|NCT01393626|515579691|FG000|Overall Study|Lost to Follow-up|1|||
143011558|NCT01393626|515579692|FG001|Overall Study|Lost to Follow-up|1|||
143011559|NCT01393626|515579693|FG002|Overall Study|Lost to Follow-up|1|||
143011560|NCT01393626|515579694|FG003|Overall Study|Lost to Follow-up|0|||
143011561|NCT01393626|515579691|FG000|Overall Study|Withdrawal by Subject|6|||
143011562|NCT01393626|515579692|FG001|Overall Study|Withdrawal by Subject|4|||
143347139|NCT03573908|516816872|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
143347140|NCT03573908|516816873|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
143347141|NCT03573908|516816869|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
143347142|NCT03573908|516816870|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
143347143|NCT03573908|516816871|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
143347144|NCT03573908|516816872|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
143347145|NCT03573908|516816873|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
143347146|NCT04006925|516816874|FG000|Overall Study|Side effects|2|||
143347147|NCT04006925|516816875|FG001|Overall Study|Side effects|0|||
143347148|NCT03443713|516816880|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
143347149|NCT03443713|516816881|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
143347150|NCT03443713|516816882|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
143347151|NCT01672853|516816885|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
143347152|NCT01672853|516816886|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
143347153|NCT01672853|516816887|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
143347154|NCT01672853|516816885|FG000|Overall Study|Pregnancy|0|||
143347155|NCT01672853|516816886|FG001|Overall Study|Pregnancy|1|||
143347156|NCT01672853|516816887|FG002|Overall Study|Pregnancy|0|||
143347157|NCT01672853|516816885|FG000|Overall Study|Investigator's Discretion|1|||
143347158|NCT01672853|516816886|FG001|Overall Study|Investigator's Discretion|0|||
143347159|NCT01672853|516816887|FG002|Overall Study|Investigator's Discretion|0|||
143347160|NCT01672853|516816885|FG000|Overall Study|Withdrew Consent|5|||
143347161|NCT01672853|516816886|FG001|Overall Study|Withdrew Consent|5|||
143347162|NCT01672853|516816887|FG002|Overall Study|Withdrew Consent|5|||
143347163|NCT01672853|516816885|FG000|Overall Study|Adverse Event|4|||
143347164|NCT01672853|516816886|FG001|Overall Study|Adverse Event|6|||
143347165|NCT01672853|516816887|FG002|Overall Study|Adverse Event|8|||
143347166|NCT01672853|516816885|FG000|Overall Study|Lost to Follow-up|0|||
143347167|NCT01672853|516816886|FG001|Overall Study|Lost to Follow-up|1|||
143347168|NCT01672853|516816887|FG002|Overall Study|Lost to Follow-up|0|||
143347169|NCT01672853|516816885|FG000|Overall Study|Randomized but Never Treated|0|||
143347170|NCT01672853|516816886|FG001|Overall Study|Randomized but Never Treated|0|||
143347171|NCT01672853|516816887|FG002|Overall Study|Randomized but Never Treated|1|||
143347172|NCT02969525|516816890|FG000|Double-Blind Period|Adverse Event|0|||
143347173|NCT02969525|516816891|FG001|Double-Blind Period|Adverse Event|0|||
143347174|NCT02969525|516816892|FG002|Double-Blind Period|Adverse Event|1|||
143347175|NCT02969525|516816893|FG003|Double-Blind Period|Adverse Event|1|||
143347176|NCT02969525|516816894|FG004|Double-Blind Period|Adverse Event|0|||
143347177|NCT02969525|516816895|FG005|Double-Blind Period|Adverse Event|0|||
143347178|NCT02969525|516816896|FG006|Double-Blind Period|Adverse Event|0|||
143347179|NCT02969525|516816897|FG007|Double-Blind Period|Adverse Event|0|||
143347180|NCT02969525|516816898|FG008|Double-Blind Period|Adverse Event|0|||
143347181|NCT02969525|516816899|FG009|Double-Blind Period|Adverse Event|0|||
143347182|NCT02969525|516816900|FG010|Double-Blind Period|Adverse Event|0|||
143347183|NCT02969525|516816901|FG011|Double-Blind Period|Adverse Event|0|||
143347184|NCT02969525|516816890|FG000|Double-Blind Period|LOW EGFR|0|||
143347185|NCT02969525|516816891|FG001|Double-Blind Period|LOW EGFR|0|||
143347186|NCT02969525|516816892|FG002|Double-Blind Period|LOW EGFR|0|||
143347187|NCT02969525|516816893|FG003|Double-Blind Period|LOW EGFR|1|||
143347188|NCT02969525|516816894|FG004|Double-Blind Period|LOW EGFR|0|||
143347189|NCT02969525|516816895|FG005|Double-Blind Period|LOW EGFR|0|||
143347190|NCT02969525|516816896|FG006|Double-Blind Period|LOW EGFR|0|||
143347191|NCT02969525|516816897|FG007|Double-Blind Period|LOW EGFR|0|||
143347192|NCT02969525|516816898|FG008|Double-Blind Period|LOW EGFR|0|||
143347193|NCT02969525|516816899|FG009|Double-Blind Period|LOW EGFR|0|||
143347194|NCT02969525|516816900|FG010|Double-Blind Period|LOW EGFR|0|||
143347195|NCT02969525|516816901|FG011|Double-Blind Period|LOW EGFR|0|||
143347196|NCT02969525|516816890|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
143347197|NCT02969525|516816891|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
143347198|NCT02969525|516816892|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
143347199|NCT02969525|516816893|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
143347200|NCT02969525|516816894|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
143011563|NCT01393626|515579693|FG002|Overall Study|Withdrawal by Subject|0|||
143011564|NCT01393626|515579694|FG003|Overall Study|Withdrawal by Subject|0|||
143347201|NCT02969525|516816895|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
143011565|NCT01393626|515579691|FG000|Overall Study|Other|1|||
143347202|NCT02969525|516816896|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
143347203|NCT02969525|516816897|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
143347204|NCT02969525|516816898|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
143011566|NCT01393626|515579692|FG001|Overall Study|Other|0|||
143011567|NCT01393626|515579693|FG002|Overall Study|Other|0|||
143347205|NCT02969525|516816899|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
143011568|NCT01393626|515579694|FG003|Overall Study|Other|0|||
143011569|NCT01393626|515579691|FG000|Overall Study|Protocol Violation|1|||
143347206|NCT02969525|516816900|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
143347207|NCT02969525|516816901|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
143347208|NCT02969525|516816890|FG000|Dose-Blind Period|Adverse Event|0|||
143347209|NCT02969525|516816891|FG001|Dose-Blind Period|Adverse Event|0|||
143347210|NCT02969525|516816892|FG002|Dose-Blind Period|Adverse Event|0|||
143347211|NCT02969525|516816893|FG003|Dose-Blind Period|Adverse Event|0|||
143347212|NCT02969525|516816894|FG004|Dose-Blind Period|Adverse Event|0|||
143347213|NCT02969525|516816895|FG005|Dose-Blind Period|Adverse Event|0|||
143347214|NCT02969525|516816896|FG006|Dose-Blind Period|Adverse Event|0|||
143347215|NCT02969525|516816897|FG007|Dose-Blind Period|Adverse Event|0|||
143347216|NCT02969525|516816898|FG008|Dose-Blind Period|Adverse Event|0|||
143347217|NCT02969525|516816899|FG009|Dose-Blind Period|Adverse Event|1|||
143347218|NCT02969525|516816900|FG010|Dose-Blind Period|Adverse Event|1|||
143347219|NCT02969525|516816901|FG011|Dose-Blind Period|Adverse Event|1|||
143347220|NCT02969525|516816890|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
143347221|NCT02969525|516816891|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
143347222|NCT02969525|516816892|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
143347223|NCT02969525|516816893|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
143347224|NCT02969525|516816894|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
143347225|NCT02969525|516816895|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
143347226|NCT02969525|516816896|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
143347227|NCT02969525|516816897|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
143347228|NCT02969525|516816898|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
143347229|NCT02969525|516816899|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
143347230|NCT02969525|516816900|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
143347231|NCT02969525|516816901|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
143347232|NCT02969525|516816890|FG000|Dose-Blind Period|Non-cooperating patient|0|||
143347233|NCT02969525|516816891|FG001|Dose-Blind Period|Non-cooperating patient|0|||
143347234|NCT02969525|516816892|FG002|Dose-Blind Period|Non-cooperating patient|0|||
143347235|NCT02969525|516816893|FG003|Dose-Blind Period|Non-cooperating patient|0|||
143347236|NCT02969525|516816894|FG004|Dose-Blind Period|Non-cooperating patient|0|||
143347237|NCT02969525|516816895|FG005|Dose-Blind Period|Non-cooperating patient|0|||
143347238|NCT02969525|516816896|FG006|Dose-Blind Period|Non-cooperating patient|0|||
143347239|NCT02969525|516816897|FG007|Dose-Blind Period|Non-cooperating patient|0|||
143347240|NCT02969525|516816898|FG008|Dose-Blind Period|Non-cooperating patient|0|||
143347241|NCT02969525|516816899|FG009|Dose-Blind Period|Non-cooperating patient|0|||
143347242|NCT02969525|516816900|FG010|Dose-Blind Period|Non-cooperating patient|0|||
143347243|NCT02969525|516816901|FG011|Dose-Blind Period|Non-cooperating patient|1|||
143347244|NCT02969525|516816890|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
143347245|NCT02969525|516816891|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
143347246|NCT02969525|516816892|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
143347247|NCT02969525|516816893|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
143347248|NCT02969525|516816894|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
143347249|NCT02969525|516816895|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
143347250|NCT02969525|516816896|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
143347251|NCT02969525|516816897|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
143347252|NCT02969525|516816898|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
143347253|NCT02969525|516816899|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
143347254|NCT02969525|516816900|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
143347255|NCT02969525|516816901|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
143347256|NCT03445065|516816902|FG000|Overall Study|Withdrawal by Subject|3|||
143347257|NCT03445065|516816903|FG001|Overall Study|Withdrawal by Subject|6|||
143347258|NCT03445065|516816904|FG002|Overall Study|Withdrawal by Subject|2|||
143347259|NCT03445065|516816905|FG003|Overall Study|Withdrawal by Subject|2|||
143347260|NCT03445065|516816902|FG000|Overall Study|Other|4|||
143347261|NCT03445065|516816903|FG001|Overall Study|Other|3|||
143347262|NCT03445065|516816904|FG002|Overall Study|Other|3|||
143347263|NCT03445065|516816905|FG003|Overall Study|Other|1|||
143347264|NCT02944656|516816913|FG000|Overall Study|No longer eligible|3|||
143347265|NCT02944656|516816914|FG001|Overall Study|No longer eligible|0|||
143347266|NCT02944656|516816913|FG000|Overall Study|Lost to Follow-up|7|||
143347267|NCT02944656|516816914|FG001|Overall Study|Lost to Follow-up|10|||
143347268|NCT00118898|516816915|FG000|Overall Study|Death|6|||
143347269|NCT00118898|516816916|FG001|Overall Study|Death|11|||
143011570|NCT01393626|515579692|FG001|Overall Study|Protocol Violation|0|||
143011571|NCT01393626|515579693|FG002|Overall Study|Protocol Violation|2|||
143011572|NCT01393626|515579694|FG003|Overall Study|Protocol Violation|0|||
143347270|NCT00118898|516816917|FG002|Overall Study|Death|6|||
143347271|NCT00118898|516816918|FG003|Overall Study|Death|8|||
143347272|NCT00118898|516816915|FG000|Overall Study|Lost to Follow-up|26|||
143347273|NCT00118898|516816916|FG001|Overall Study|Lost to Follow-up|34|||
143347274|NCT00118898|516816917|FG002|Overall Study|Lost to Follow-up|33|||
143347275|NCT00118898|516816918|FG003|Overall Study|Lost to Follow-up|33|||
143347276|NCT00118898|516816915|FG000|Overall Study|Withdrawal by Subject|10|||
143347277|NCT00118898|516816916|FG001|Overall Study|Withdrawal by Subject|5|||
143011573|NCT02341482|515579695|FG000|Overall Study|Adverse Event|1|||
143347278|NCT00118898|516816917|FG002|Overall Study|Withdrawal by Subject|8|||
143347279|NCT00118898|516816918|FG003|Overall Study|Withdrawal by Subject|8|||
143347280|NCT00118898|516816915|FG000|Overall Study|Site Closure|33|||
143347281|NCT00118898|516816916|FG001|Overall Study|Site Closure|31|||
143124723|NCT01690299|516001282|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
143461381|NCT05478499|517235031|FG001|Active Treatment: Week 16 - Week 52|Lack of Efficacy|1|||
143124724|NCT01690299|516001283|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
143124725|NCT01690299|516001278|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
143124726|NCT01690299|516001279|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
143124727|NCT01690299|516001280|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
143124728|NCT01690299|516001281|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
143124729|NCT01690299|516001282|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
143124730|NCT01690299|516001283|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
143124731|NCT01690299|516001278|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
143124732|NCT01690299|516001279|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
143124733|NCT01690299|516001280|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
143124734|NCT01690299|516001281|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
143124735|NCT01690299|516001282|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
143124736|NCT01690299|516001283|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
143124737|NCT01690299|516001278|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
143124738|NCT01690299|516001279|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
143124739|NCT01690299|516001280|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
143124740|NCT01690299|516001281|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
143124741|NCT01690299|516001282|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
143124742|NCT01690299|516001283|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
143124743|NCT01690299|516001278|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
143124744|NCT01690299|516001279|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
143124745|NCT01690299|516001280|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
143124746|NCT01690299|516001281|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
143124747|NCT01690299|516001282|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
143124748|NCT01690299|516001283|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
143124749|NCT01690299|516001278|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
143124750|NCT01690299|516001279|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
143124751|NCT01690299|516001280|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
143124752|NCT01690299|516001281|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
143124753|NCT01690299|516001282|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
143124754|NCT01690299|516001283|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
143124755|NCT01690299|516001278|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
143124756|NCT01690299|516001279|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
143124757|NCT01690299|516001280|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
143124758|NCT01690299|516001281|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
143124759|NCT01690299|516001282|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
143124760|NCT01690299|516001283|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
143124761|NCT03836209|516001284|FG000|Overall Study|Adverse Event|5|||
143124762|NCT03836209|516001285|FG001|Overall Study|Adverse Event|2|||
143124763|NCT03836209|516001284|FG000|Overall Study|Death|4|||
143124764|NCT03836209|516001285|FG001|Overall Study|Death|1|||
143124765|NCT03836209|516001284|FG000|Overall Study|Lack of Efficacy|7|||
143124766|NCT03836209|516001285|FG001|Overall Study|Lack of Efficacy|10|||
143124767|NCT03836209|516001284|FG000|Overall Study|Physician Decision|7|||
143124768|NCT03836209|516001285|FG001|Overall Study|Physician Decision|11|||
143124769|NCT03836209|516001284|FG000|Overall Study|Protocol Violation|0|||
143124770|NCT03836209|516001285|FG001|Overall Study|Protocol Violation|3|||
143124771|NCT03836209|516001284|FG000|Overall Study|Withdrawal by Subject|2|||
143124772|NCT03836209|516001285|FG001|Overall Study|Withdrawal by Subject|10|||
143124773|NCT03836209|516001284|FG000|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|55|||
143124774|NCT03836209|516001285|FG001|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|44|||
143124775|NCT03739710|516001286|FG000|Overall Study|Screen Failed|81|||
143124776|NCT01753115|516001287|FG000|Overall Study|Lost to Follow-up|3|||
143124777|NCT01753115|516001288|FG001|Overall Study|Lost to Follow-up|6|||
143124778|NCT01753115|516001289|FG002|Overall Study|Lost to Follow-up|8|||
143124779|NCT01753115|516001287|FG000|Overall Study|Withdrawal by Subject|6|||
143124780|NCT01753115|516001288|FG001|Overall Study|Withdrawal by Subject|5|||
143124781|NCT01753115|516001289|FG002|Overall Study|Withdrawal by Subject|6|||
143124782|NCT01753115|516001287|FG000|Overall Study|Subject non-compliant|3|||
143124783|NCT01753115|516001288|FG001|Overall Study|Subject non-compliant|3|||
143124784|NCT01753115|516001289|FG002|Overall Study|Subject non-compliant|0|||
143347282|NCT00118898|516816917|FG002|Overall Study|Site Closure|28|||
143347283|NCT00118898|516816918|FG003|Overall Study|Site Closure|37|||
143347284|NCT00118898|516816915|FG000|Overall Study|Severe debilitation|1|||
143347285|NCT00118898|516816916|FG001|Overall Study|Severe debilitation|4|||
143347286|NCT00118898|516816917|FG002|Overall Study|Severe debilitation|6|||
143347287|NCT00118898|516816918|FG003|Overall Study|Severe debilitation|4|||
143347288|NCT00118898|516816915|FG000|Overall Study|Not compliant with requirements|11|||
143347289|NCT00118898|516816916|FG001|Overall Study|Not compliant with requirements|13|||
143347290|NCT00118898|516816917|FG002|Overall Study|Not compliant with requirements|11|||
143347291|NCT00118898|516816918|FG003|Overall Study|Not compliant with requirements|11|||
143347292|NCT00118898|516816915|FG000|Overall Study|Not able to get to clinic|34|||
143347293|NCT00118898|516816916|FG001|Overall Study|Not able to get to clinic|43|||
143347294|NCT00118898|516816917|FG002|Overall Study|Not able to get to clinic|31|||
143347295|NCT00118898|516816918|FG003|Overall Study|Not able to get to clinic|40|||
143347296|NCT02243631|516818091|FG000|Overall Study|no synovial fluid on second aspirate|0|||
143347297|NCT02243631|516818092|FG001|Overall Study|no synovial fluid on second aspirate|1|||
143347298|NCT03462706|516818093|FG000|Overall Study|Polyp was pedunculated|1|||
143347299|NCT03462706|516818094|FG001|Overall Study|Polyp was pedunculated|0|||
143347300|NCT03462706|516818095|FG002|Overall Study|Polyp was pedunculated|1|||
143347301|NCT03462706|516818096|FG003|Overall Study|Polyp was pedunculated|0|||
143347302|NCT03462706|516818093|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
143347303|NCT03462706|516818094|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
143347304|NCT03462706|516818095|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
143347305|NCT03462706|516818096|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
143347306|NCT04105972|516818105|FG000|Overall Study|Adverse Event|2|||
143347307|NCT04105972|516818106|FG001|Overall Study|Adverse Event|1|||
143347308|NCT02254408|516818109|FG000|Overall Study|Randomized But Not Treated|1|||
143347309|NCT02254408|516818110|FG001|Overall Study|Randomized But Not Treated|3|||
143347310|NCT02254408|516818109|FG000|Overall Study|Adverse Event|1|||
143347311|NCT02254408|516818110|FG001|Overall Study|Adverse Event|0|||
143347312|NCT02254408|516818109|FG000|Overall Study|Death|2|||
143347313|NCT02254408|516818110|FG001|Overall Study|Death|3|||
143347314|NCT02254408|516818109|FG000|Overall Study|Investigator's Discretion|0|||
143347315|NCT02254408|516818110|FG001|Overall Study|Investigator's Discretion|1|||
143347316|NCT02254408|516818109|FG000|Overall Study|Withdrawal by Subject|3|||
143347317|NCT02254408|516818110|FG001|Overall Study|Withdrawal by Subject|3|||
143347318|NCT02254408|516818109|FG000|Overall Study|Lost to Follow-up|1|||
143347319|NCT02254408|516818110|FG001|Overall Study|Lost to Follow-up|0|||
143347320|NCT00553202|516818111|FG000|Overall Study|Death|16|||
143347321|NCT00553202|516818111|FG000|Overall Study|Lost to Follow-up|1|||
143347322|NCT00553202|516818111|FG000|Overall Study|Physician Decision|28|||
143347323|NCT00553202|516818111|FG000|Overall Study|Withdrawal by Subject|1|||
143347324|NCT00553202|516818111|FG000|Overall Study|No donor identified|16|||
143347325|NCT00553202|516818111|FG000|Overall Study|Fails to meet organ function|6|||
143347326|NCT02914184|516818116|FG000|Overall Study|Lost to Follow-up|7|||
143347327|NCT02914184|516818117|FG001|Overall Study|Lost to Follow-up|10|||
143347328|NCT02914184|516818118|FG002|Overall Study|Lost to Follow-up|8|||
143347329|NCT02914184|516818119|FG003|Overall Study|Lost to Follow-up|7|||
143347330|NCT02914184|516818116|FG000|Overall Study|Withdrawal by Subject|4|||
143347331|NCT02914184|516818117|FG001|Overall Study|Withdrawal by Subject|2|||
143347332|NCT02914184|516818118|FG002|Overall Study|Withdrawal by Subject|7|||
143347333|NCT02914184|516818119|FG003|Overall Study|Withdrawal by Subject|3|||
143347334|NCT02914184|516818116|FG000|Overall Study|Other|1|||
143347335|NCT02914184|516818117|FG001|Overall Study|Other|0|||
143347336|NCT02914184|516818118|FG002|Overall Study|Other|0|||
143347337|NCT02914184|516818119|FG003|Overall Study|Other|0|||
143347338|NCT02914184|516818116|FG000|Overall Study|Migrated/moved from the study area|2|||
143347339|NCT02914184|516818117|FG001|Overall Study|Migrated/moved from the study area|1|||
143011574|NCT03186794|515579696|FG000|Overall Study|Physician Decision|2|||
143011575|NCT03186794|515579696|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
143011576|NCT03000075|515579702|FG000|Part A|Adverse Event|4|||
143011577|NCT03000075|515579703|FG001|Part A|Adverse Event|0|||
143011578|NCT03000075|515579704|FG002|Part A|Adverse Event|0|||
143011579|NCT03000075|515579705|FG003|Part A|Adverse Event|0|||
143011580|NCT03000075|515579706|FG004|Part A|Adverse Event|0|||
143011581|NCT03000075|515579707|FG005|Part A|Adverse Event|0|||
143347340|NCT02914184|516818118|FG002|Overall Study|Migrated/moved from the study area|2|||
143461382|NCT05478499|517235030|FG000|Active Treatment: Week 16 - Week 52|Adverse Event|4|||
143347341|NCT02914184|516818119|FG003|Overall Study|Migrated/moved from the study area|1|||
143347342|NCT00768430|516818120|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
143347343|NCT00768430|516818121|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
143347344|NCT03093428|516818124|FG000|Overall Study|Not eligible for treatment|2|||
143347345|NCT03093428|516818125|FG001|Overall Study|Not eligible for treatment|1|||
143347346|NCT03093428|516818124|FG000|Overall Study|Progression|14|||
143347347|NCT03093428|516818125|FG001|Overall Study|Progression|4|||
143347348|NCT03093428|516818124|FG000|Overall Study|Death|1|||
143347349|NCT03093428|516818125|FG001|Overall Study|Death|0|||
143011582|NCT03000075|515579708|FG006|Part A|Adverse Event|0|||
143347350|NCT03093428|516818124|FG000|Overall Study|Adverse Event|1|||
143347351|NCT03093428|516818125|FG001|Overall Study|Adverse Event|0|||
143347352|NCT03093428|516818124|FG000|Overall Study|Withdrawal by Subject|1|||
143347353|NCT03093428|516818125|FG001|Overall Study|Withdrawal by Subject|1|||
143347354|NCT00041756|516818126|FG000|Overall Study|Adverse Event|4|||
143347355|NCT00041756|516818127|FG001|Overall Study|Adverse Event|10|||
143347356|NCT00041756|516818128|FG002|Overall Study|Adverse Event|6|||
143347357|NCT00041756|516818129|FG003|Overall Study|Adverse Event|11|||
143347358|NCT00041756|516818130|FG004|Overall Study|Adverse Event|34|||
143347359|NCT00041756|516818126|FG000|Overall Study|Protocol Violation|1|||
143347360|NCT00041756|516818127|FG001|Overall Study|Protocol Violation|1|||
143347361|NCT00041756|516818128|FG002|Overall Study|Protocol Violation|2|||
143347362|NCT00041756|516818129|FG003|Overall Study|Protocol Violation|2|||
143347363|NCT00041756|516818130|FG004|Overall Study|Protocol Violation|1|||
143347364|NCT00041756|516818126|FG000|Overall Study|Withdrawal by Subject|3|||
143347365|NCT00041756|516818127|FG001|Overall Study|Withdrawal by Subject|3|||
143347366|NCT00041756|516818128|FG002|Overall Study|Withdrawal by Subject|4|||
143347367|NCT00041756|516818129|FG003|Overall Study|Withdrawal by Subject|2|||
143347368|NCT00041756|516818130|FG004|Overall Study|Withdrawal by Subject|3|||
143347369|NCT00041756|516818126|FG000|Overall Study|Lost to Follow-up|0|||
143347370|NCT00041756|516818127|FG001|Overall Study|Lost to Follow-up|1|||
143347371|NCT00041756|516818128|FG002|Overall Study|Lost to Follow-up|0|||
143347372|NCT00041756|516818129|FG003|Overall Study|Lost to Follow-up|1|||
143347373|NCT00041756|516818130|FG004|Overall Study|Lost to Follow-up|0|||
143347374|NCT00041756|516818126|FG000|Overall Study|Unable to meet protocol criteria|0|||
143347375|NCT00041756|516818127|FG001|Overall Study|Unable to meet protocol criteria|0|||
143347376|NCT00041756|516818128|FG002|Overall Study|Unable to meet protocol criteria|1|||
143347377|NCT00041756|516818129|FG003|Overall Study|Unable to meet protocol criteria|0|||
143347378|NCT00041756|516818130|FG004|Overall Study|Unable to meet protocol criteria|1|||
143347379|NCT00041756|516818126|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
143347380|NCT00041756|516818127|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
143347381|NCT00041756|516818128|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
143347382|NCT00041756|516818129|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
143347383|NCT00041756|516818130|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
143347384|NCT03980184|516818131|FG000|Overall Study|Dropped out before treatment|2|||
143347385|NCT03980184|516818132|FG001|Overall Study|Dropped out before treatment|2|||
143347386|NCT03980184|516818131|FG000|Overall Study|Lost to Follow-up|11|||
143347387|NCT03980184|516818132|FG001|Overall Study|Lost to Follow-up|13|||
143347388|NCT02002884|516818133|FG000|Main Period (MP)|Other|0|||
143347389|NCT02002884|516818134|FG001|Main Period (MP)|Other|3|||
143347390|NCT02002884|516818135|FG002|Main Period (MP)|Other|3|||
143347391|NCT02002884|516818136|FG003|Main Period (MP)|Other|0|||
143347392|NCT02002884|516818133|FG000|Main Period (MP)|Adverse Event|0|||
143347393|NCT02002884|516818134|FG001|Main Period (MP)|Adverse Event|1|||
143347394|NCT02002884|516818135|FG002|Main Period (MP)|Adverse Event|1|||
143347395|NCT02002884|516818136|FG003|Main Period (MP)|Adverse Event|0|||
143347396|NCT02002884|516818133|FG000|Main Period (MP)|Withdrawal by Subject|6|||
143347397|NCT02002884|516818134|FG001|Main Period (MP)|Withdrawal by Subject|2|||
143347398|NCT02002884|516818135|FG002|Main Period (MP)|Withdrawal by Subject|2|||
143347399|NCT02002884|516818136|FG003|Main Period (MP)|Withdrawal by Subject|0|||
143347400|NCT02002884|516818133|FG000|Main Period (MP)|Lost to Follow-up|0|||
143347401|NCT02002884|516818134|FG001|Main Period (MP)|Lost to Follow-up|0|||
143347402|NCT02002884|516818135|FG002|Main Period (MP)|Lost to Follow-up|2|||
143347403|NCT02002884|516818136|FG003|Main Period (MP)|Lost to Follow-up|0|||
143347404|NCT02002884|516818133|FG000|Open-Label Extension Period (OLEX)|Other|0|||
143347405|NCT02002884|516818134|FG001|Open-Label Extension Period (OLEX)|Other|0|||
143347406|NCT02002884|516818135|FG002|Open-Label Extension Period (OLEX)|Other|0|||
143347407|NCT02002884|516818136|FG003|Open-Label Extension Period (OLEX)|Other|24|||
143347408|NCT02002884|516818133|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
143347409|NCT02002884|516818134|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
143347410|NCT02002884|516818135|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
143347411|NCT02002884|516818136|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
143347412|NCT02002884|516818133|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
143347413|NCT02002884|516818134|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
143347414|NCT02002884|516818135|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
143347415|NCT02002884|516818136|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
143124785|NCT01753115|516001287|FG000|Overall Study|Used excluded drug|0|||
143347416|NCT02002884|516818133|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
143347417|NCT02002884|516818134|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
143347418|NCT02002884|516818135|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
143347419|NCT02002884|516818136|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
143347420|NCT02002884|516818133|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
143347421|NCT02002884|516818134|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
143347422|NCT02002884|516818135|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
143347423|NCT02002884|516818136|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
143347424|NCT02176421|516818137|FG000|Overall Study|Lost to Follow-up|4|||
143347425|NCT02176421|516818137|FG000|Overall Study|Adverse Event|1|||
143347426|NCT02145078|516818140|FG000|Overall Study|Death|1|||
143347427|NCT02145078|516818140|FG000|Overall Study|Reason not given|3|||
143347428|NCT03327402|516818143|FG000|Overall Study|Withdrawal by Subject|1|||
143347429|NCT03327402|516818143|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
143347430|NCT02091739|516818150|FG000|MP: 16 Weeks|Adverse Event|1|||
143347431|NCT02091739|516818151|FG001|MP: 16 Weeks|Adverse Event|1|||
143347432|NCT02091739|516818152|FG002|MP: 16 Weeks|Adverse Event|1|||
143347433|NCT02091739|516818153|FG003|MP: 16 Weeks|Adverse Event|0|||
143347434|NCT02091739|516818154|FG004|MP: 16 Weeks|Adverse Event|0|||
143347435|NCT02091739|516818150|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
143347436|NCT02091739|516818151|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
143347437|NCT02091739|516818152|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
143347438|NCT02091739|516818153|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
143347439|NCT02091739|516818154|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
143347440|NCT02091739|516818150|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
143347441|NCT02091739|516818151|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
143347442|NCT02091739|516818152|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
143347443|NCT02091739|516818153|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
143347444|NCT02091739|516818154|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
143347445|NCT02091739|516818150|FG000|EP: 48 Weeks|Other|0|||
143347446|NCT02091739|516818151|FG001|EP: 48 Weeks|Other|0|||
143347447|NCT02091739|516818152|FG002|EP: 48 Weeks|Other|0|||
143347448|NCT02091739|516818153|FG003|EP: 48 Weeks|Other|1|||
143347449|NCT02091739|516818154|FG004|EP: 48 Weeks|Other|0|||
143347450|NCT02091739|516818150|FG000|EP: 48 Weeks|Death|0|||
143347451|NCT02091739|516818151|FG001|EP: 48 Weeks|Death|0|||
143347452|NCT02091739|516818152|FG002|EP: 48 Weeks|Death|0|||
143347453|NCT02091739|516818153|FG003|EP: 48 Weeks|Death|3|||
143347454|NCT02091739|516818154|FG004|EP: 48 Weeks|Death|2|||
143347455|NCT02091739|516818150|FG000|EP: 48 Weeks|Adverse Event|0|||
143347456|NCT02091739|516818151|FG001|EP: 48 Weeks|Adverse Event|0|||
143347457|NCT02091739|516818152|FG002|EP: 48 Weeks|Adverse Event|0|||
143347458|NCT02091739|516818153|FG003|EP: 48 Weeks|Adverse Event|2|||
143347459|NCT02091739|516818154|FG004|EP: 48 Weeks|Adverse Event|6|||
143347460|NCT02091739|516818150|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
143347461|NCT02091739|516818151|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
143347462|NCT02091739|516818152|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
143347463|NCT02091739|516818153|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
143347464|NCT02091739|516818154|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
143347465|NCT03469349|516818155|FG000|Overall Study|Withdrawal by Subject|1|||
143347466|NCT03469349|516818156|FG001|Overall Study|Withdrawal by Subject|3|||
143347467|NCT03469349|516818155|FG000|Overall Study|Progressive Disease|0|||
143347468|NCT03469349|516818156|FG001|Overall Study|Progressive Disease|1|||
143347469|NCT03469349|516818155|FG000|Overall Study|Lost to Follow-up|2|||
143347470|NCT03469349|516818156|FG001|Overall Study|Lost to Follow-up|2|||
143347471|NCT03469349|516818155|FG000|Overall Study|Adverse Event|2|||
143347472|NCT03469349|516818156|FG001|Overall Study|Adverse Event|4|||
143347473|NCT01834222|516818162|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
143347474|NCT01617005|516818169|FG000|Overall Study|Pregnancy|1|||
143347475|NCT01617005|516818169|FG000|Overall Study|Lack of motivation for treatment|1|||
143347476|NCT01320735|516818170|FG000|Overall Study|Adverse Event|3|||
143347477|NCT01320735|516818170|FG000|Overall Study|Withdrawal by Subject|3|||
143347478|NCT01320735|516818170|FG000|Overall Study|Lost to Follow-up|13|||
143347479|NCT01320735|516818170|FG000|Overall Study|Administrative Reason|6|||
143347480|NCT01320735|516818170|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
143347481|NCT01320735|516818170|FG000|Overall Study|Protocol Violation|1|||
143347482|NCT01320735|516818170|FG000|Overall Study|Other|1|||
143347483|NCT01320735|516818170|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
143347484|NCT01320735|516818170|FG000|Overall Study|Investigator Unable to be Contacted|17|||
143347485|NCT02307513|516818171|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
143011583|NCT03000075|515579702|FG000|Part B|Not dosed due to AE|0|||
143347486|NCT02307513|516818172|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
143347487|NCT02307513|516818171|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
143347488|NCT02307513|516818172|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
143347489|NCT02307513|516818171|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
143347490|NCT02307513|516818172|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
143011584|NCT03000075|515579703|FG001|Part B|Not dosed due to AE|0|||
143347491|NCT02307513|516818171|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
143347492|NCT02307513|516818172|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
143347493|NCT02307513|516818171|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
143347494|NCT02307513|516818172|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
143347495|NCT02307513|516818171|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
143347496|NCT02307513|516818172|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
143347497|NCT02307513|516818171|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
143347498|NCT02307513|516818172|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
143347499|NCT02307513|516818171|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
143347500|NCT02307513|516818172|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
143347501|NCT02307513|516818171|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
143347502|NCT02307513|516818172|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
143347503|NCT02307513|516818171|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
143347504|NCT02307513|516818172|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
143347505|NCT02307513|516818171|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
143347506|NCT02307513|516818172|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
143347507|NCT02307513|516818171|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
143347508|NCT02307513|516818172|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
143347509|NCT02307513|516818171|FG000|Long-term Extension|Physician Decision|1|||
143347510|NCT02307513|516818172|FG001|Long-term Extension|Physician Decision|0|||
143347511|NCT05952297|516818174|FG000|Overall Study|Withdrawal by Subject|1|||
143347512|NCT05952297|516818175|FG001|Overall Study|Withdrawal by Subject|0|||
143347513|NCT01225822|516818176|FG000|Overall Study|Adverse Event|13|||
143347514|NCT01225822|516818177|FG001|Overall Study|Adverse Event|31|||
143347515|NCT01225822|516818178|FG002|Overall Study|Adverse Event|18|||
143347516|NCT01225822|516818179|FG003|Overall Study|Adverse Event|23|||
143347517|NCT01225822|516818180|FG004|Overall Study|Adverse Event|14|||
143347518|NCT01225822|516818176|FG000|Overall Study|Protocol Violation|6|||
143347519|NCT01225822|516818177|FG001|Overall Study|Protocol Violation|8|||
143347520|NCT01225822|516818178|FG002|Overall Study|Protocol Violation|6|||
143347521|NCT01225822|516818179|FG003|Overall Study|Protocol Violation|7|||
143347522|NCT01225822|516818180|FG004|Overall Study|Protocol Violation|4|||
143347523|NCT01225822|516818176|FG000|Overall Study|Lost to Follow-up|0|||
143347524|NCT01225822|516818177|FG001|Overall Study|Lost to Follow-up|0|||
143347525|NCT01225822|516818178|FG002|Overall Study|Lost to Follow-up|0|||
143347526|NCT01225822|516818179|FG003|Overall Study|Lost to Follow-up|1|||
143347527|NCT01225822|516818180|FG004|Overall Study|Lost to Follow-up|0|||
143347528|NCT01225822|516818176|FG000|Overall Study|Withdrawal by Subject|6|||
143347529|NCT01225822|516818177|FG001|Overall Study|Withdrawal by Subject|7|||
143347530|NCT01225822|516818178|FG002|Overall Study|Withdrawal by Subject|7|||
143347531|NCT01225822|516818179|FG003|Overall Study|Withdrawal by Subject|11|||
143347532|NCT01225822|516818180|FG004|Overall Study|Withdrawal by Subject|6|||
143347533|NCT01225822|516818176|FG000|Overall Study|Other|13|||
143347534|NCT01225822|516818177|FG001|Overall Study|Other|10|||
143347535|NCT01225822|516818178|FG002|Overall Study|Other|7|||
143347536|NCT01225822|516818179|FG003|Overall Study|Other|10|||
143347537|NCT01225822|516818180|FG004|Overall Study|Other|7|||
143347538|NCT01290822|516818181|FG000|Overall Study|Withdrawal by Subject|1|||
143347539|NCT01290822|516818181|FG000|Overall Study|Physician Decision|10|||
143347540|NCT02541383|516818182|FG000|Overall Study|Death|50|||
143347541|NCT02541383|516818183|FG001|Overall Study|Death|37|||
143347542|NCT02541383|516818184|FG002|Overall Study|Death|48|||
143347543|NCT02541383|516818185|FG003|Overall Study|Death|41|||
143347544|NCT02541383|516818186|FG004|Overall Study|Death|21|||
143347545|NCT02541383|516818187|FG005|Overall Study|Death|25|||
143347546|NCT02541383|516818182|FG000|Overall Study|Lost to Follow-up|5|||
143347547|NCT02541383|516818183|FG001|Overall Study|Lost to Follow-up|3|||
143347548|NCT02541383|516818184|FG002|Overall Study|Lost to Follow-up|1|||
143347549|NCT02541383|516818185|FG003|Overall Study|Lost to Follow-up|1|||
143347550|NCT02541383|516818186|FG004|Overall Study|Lost to Follow-up|3|||
143347551|NCT02541383|516818187|FG005|Overall Study|Lost to Follow-up|0|||
143347552|NCT02541383|516818182|FG000|Overall Study|Consent withdrawn|5|||
143347553|NCT02541383|516818183|FG001|Overall Study|Consent withdrawn|6|||
143347554|NCT02541383|516818184|FG002|Overall Study|Consent withdrawn|1|||
143347555|NCT02541383|516818185|FG003|Overall Study|Consent withdrawn|1|||
143347556|NCT02541383|516818186|FG004|Overall Study|Consent withdrawn|0|||
143347557|NCT02541383|516818187|FG005|Overall Study|Consent withdrawn|0|||
143347558|NCT02541383|516818182|FG000|Overall Study|Sponsor's decision|1|||
143461383|NCT05478499|517235031|FG001|Active Treatment: Week 16 - Week 52|Adverse Event|0|||
143461384|NCT05478499|517235030|FG000|Active Treatment: Week 16 - Week 52|Lost to Follow-up|1|||
143461385|NCT05478499|517235031|FG001|Active Treatment: Week 16 - Week 52|Lost to Follow-up|2|||
143347559|NCT02541383|516818183|FG001|Overall Study|Sponsor's decision|1|||
143347560|NCT02541383|516818184|FG002|Overall Study|Sponsor's decision|0|||
143347561|NCT02541383|516818185|FG003|Overall Study|Sponsor's decision|0|||
143347562|NCT02541383|516818186|FG004|Overall Study|Sponsor's decision|0|||
143347563|NCT02541383|516818187|FG005|Overall Study|Sponsor's decision|0|||
143347564|NCT02487095|516818192|FG000|Dose Expansion|Unable to scan/restage participant|0|||
143347565|NCT02487095|516818193|FG001|Dose Expansion|Unable to scan/restage participant|0|||
143347566|NCT02487095|516818194|FG002|Dose Expansion|Unable to scan/restage participant|0|||
143347567|NCT02487095|516818195|FG003|Dose Expansion|Unable to scan/restage participant|0|||
143347568|NCT02487095|516818196|FG004|Dose Expansion|Unable to scan/restage participant|1|||
143347569|NCT03108157|516818199|FG000|Overall Study|Protocol Violation|15|||
143461386|NCT05478499|517235030|FG000|Active Treatment: Week 16 - Week 52|Death|1|||
143347570|NCT03108157|516818200|FG001|Overall Study|Protocol Violation|4|||
143347571|NCT01122381|516818205|FG000|Overall Study|study terminated early|0|||
143347572|NCT01122381|516818206|FG001|Overall Study|study terminated early|1|||
143347573|NCT02395133|516818207|FG000|Overall Study|Adverse Event|4|||
143347574|NCT02395133|516818208|FG001|Overall Study|Adverse Event|1|||
143347575|NCT02395133|516818209|FG002|Overall Study|Adverse Event|3|||
143347576|NCT02395133|516818210|FG003|Overall Study|Adverse Event|0|||
143347577|NCT02395133|516818207|FG000|Overall Study|Lack of Efficacy|1|||
143347578|NCT02395133|516818208|FG001|Overall Study|Lack of Efficacy|0|||
143347579|NCT02395133|516818209|FG002|Overall Study|Lack of Efficacy|1|||
143347580|NCT02395133|516818210|FG003|Overall Study|Lack of Efficacy|1|||
143347581|NCT02395133|516818207|FG000|Overall Study|Protocol Violation|1|||
143347582|NCT02395133|516818208|FG001|Overall Study|Protocol Violation|1|||
143347583|NCT02395133|516818209|FG002|Overall Study|Protocol Violation|0|||
143347584|NCT02395133|516818210|FG003|Overall Study|Protocol Violation|3|||
143347585|NCT02395133|516818207|FG000|Overall Study|Lost to Follow-up|0|||
143347586|NCT02395133|516818208|FG001|Overall Study|Lost to Follow-up|1|||
143347587|NCT02395133|516818209|FG002|Overall Study|Lost to Follow-up|1|||
143347588|NCT02395133|516818210|FG003|Overall Study|Lost to Follow-up|0|||
143347589|NCT02395133|516818207|FG000|Overall Study|Pregnancy|0|||
143347590|NCT02395133|516818208|FG001|Overall Study|Pregnancy|0|||
143347591|NCT02395133|516818209|FG002|Overall Study|Pregnancy|3|||
143347592|NCT02395133|516818210|FG003|Overall Study|Pregnancy|0|||
143347593|NCT02395133|516818207|FG000|Overall Study|Consent withdrawn with no reason given|1|||
143347594|NCT02395133|516818208|FG001|Overall Study|Consent withdrawn with no reason given|3|||
143347595|NCT02395133|516818209|FG002|Overall Study|Consent withdrawn with no reason given|0|||
143347596|NCT02395133|516818210|FG003|Overall Study|Consent withdrawn with no reason given|2|||
143347597|NCT02395133|516818207|FG000|Overall Study|Consent withdrawn with personal reason|0|||
143347598|NCT02395133|516818208|FG001|Overall Study|Consent withdrawn with personal reason|1|||
143347599|NCT02395133|516818209|FG002|Overall Study|Consent withdrawn with personal reason|0|||
143347600|NCT02395133|516818210|FG003|Overall Study|Consent withdrawn with personal reason|3|||
143347601|NCT02395133|516818207|FG000|Overall Study|Sponsor decision|2|||
143347602|NCT02395133|516818208|FG001|Overall Study|Sponsor decision|0|||
143347603|NCT02395133|516818209|FG002|Overall Study|Sponsor decision|0|||
143347604|NCT02395133|516818210|FG003|Overall Study|Sponsor decision|1|||
143347605|NCT02395133|516818207|FG000|Overall Study|Other than specified above|5|||
143347606|NCT02395133|516818208|FG001|Overall Study|Other than specified above|2|||
143347607|NCT02395133|516818209|FG002|Overall Study|Other than specified above|2|||
143347608|NCT02395133|516818210|FG003|Overall Study|Other than specified above|4|||
143347609|NCT00962247|516818213|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
143347610|NCT00962247|516818213|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
143347611|NCT00510458|516818216|FG000|Overall Study|5 year not evaluable/missed|21|||
143347612|NCT00510458|516818216|FG000|Overall Study|Death|1|||
143347613|NCT00510458|516818216|FG000|Overall Study|Terminated|14|||
143347614|NCT00510458|516818216|FG000|Overall Study|Lost to Follow-up|6|||
143347615|NCT00510458|516818216|FG000|Overall Study|Withdrawal by Subject|3|||
143347616|NCT00510458|516818216|FG000|Overall Study|Revision|2|||
143347617|NCT00926003|516818218|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
143347618|NCT00926003|516818219|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
143347619|NCT00926003|516818220|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
143347620|NCT00926003|516818218|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
143347621|NCT00926003|516818219|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
143347622|NCT00926003|516818220|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
143347623|NCT05879198|516818223|FG000|Overall Study|Lost to Follow-up|1|||
143347624|NCT01598298|516818224|FG000|Overall Study|Not eligible|5|||
143347625|NCT01598298|516818225|FG001|Overall Study|Not eligible|5|||
143347626|NCT01598298|516818224|FG000|Overall Study|Adverse Event|21|||
143347627|NCT01598298|516818225|FG001|Overall Study|Adverse Event|19|||
143347628|NCT01598298|516818224|FG000|Overall Study|Progression/relapse|0|||
143347629|NCT01598298|516818225|FG001|Overall Study|Progression/relapse|2|||
143347630|NCT01598298|516818224|FG000|Overall Study|Withdrawal by Subject|10|||
143347631|NCT01598298|516818225|FG001|Overall Study|Withdrawal by Subject|15|||
143347632|NCT01598298|516818224|FG000|Overall Study|Other reason (not protocol specified)|4|||
143347633|NCT01598298|516818225|FG001|Overall Study|Other reason (not protocol specified)|0|||
143461387|NCT05478499|517235031|FG001|Active Treatment: Week 16 - Week 52|Death|0|||
143347634|NCT02567825|516819246|FG000|Overall Study|No follow-up post-randomization|5|||
143347635|NCT02567825|516819247|FG001|Overall Study|No follow-up post-randomization|1|||
143347636|NCT02567825|516819246|FG000|Overall Study|Follow-up less than 23 months|16|||
143347637|NCT02567825|516819247|FG001|Overall Study|Follow-up less than 23 months|20|||
143347638|NCT04741802|516819248|FG000|Overall Study|Death|1|||
143347639|NCT04741802|516819248|FG000|Overall Study|Lost to Follow-up|11|||
143347640|NCT01540565|516819249|FG000|Overall Study|Ineligible|2|||
143347641|NCT01678820|516819250|FG000|Overall Study|Study Terminated by Sponsor|45|||
143347642|NCT01678820|516819251|FG001|Overall Study|Study Terminated by Sponsor|43|||
143347643|NCT01678820|516819252|FG002|Overall Study|Study Terminated by Sponsor|43|||
143347644|NCT01678820|516819250|FG000|Overall Study|Withdrawal by Subject|2|||
143347645|NCT01678820|516819251|FG001|Overall Study|Withdrawal by Subject|5|||
143347646|NCT01678820|516819252|FG002|Overall Study|Withdrawal by Subject|2|||
143347647|NCT01678820|516819250|FG000|Overall Study|Protocol Specified Criteria|2|||
143347648|NCT01678820|516819251|FG001|Overall Study|Protocol Specified Criteria|3|||
143347649|NCT01678820|516819252|FG002|Overall Study|Protocol Specified Criteria|1|||
143347650|NCT01678820|516819250|FG000|Overall Study|Adverse Event|2|||
143347651|NCT01678820|516819251|FG001|Overall Study|Adverse Event|2|||
143347652|NCT01678820|516819252|FG002|Overall Study|Adverse Event|2|||
143347653|NCT01678820|516819250|FG000|Overall Study|Lost to Follow-up|7|||
143347654|NCT01678820|516819251|FG001|Overall Study|Lost to Follow-up|2|||
143347655|NCT01678820|516819252|FG002|Overall Study|Lost to Follow-up|2|||
143347656|NCT01678820|516819250|FG000|Overall Study|Non-compliance with study drug|0|||
143347657|NCT01678820|516819251|FG001|Overall Study|Non-compliance with study drug|1|||
143347658|NCT01678820|516819252|FG002|Overall Study|Non-compliance with study drug|0|||
143347659|NCT01678820|516819250|FG000|Overall Study|Physician Decision|0|||
143347660|NCT01678820|516819251|FG001|Overall Study|Physician Decision|0|||
143347661|NCT01678820|516819252|FG002|Overall Study|Physician Decision|1|||
143347662|NCT01678820|516819250|FG000|Overall Study|Protocol Violation|4|||
143347663|NCT01678820|516819251|FG001|Overall Study|Protocol Violation|5|||
143347664|NCT01678820|516819252|FG002|Overall Study|Protocol Violation|4|||
143347665|NCT01678820|516819250|FG000|Overall Study|Not treated with double-blind study drug|0|||
143347666|NCT01678820|516819251|FG001|Overall Study|Not treated with double-blind study drug|2|||
143347667|NCT01678820|516819252|FG002|Overall Study|Not treated with double-blind study drug|2|||
143347668|NCT01381874|516819253|FG000|Overall Study|Lost to Follow-up|1|||
143347669|NCT01381874|516819254|FG001|Overall Study|Lost to Follow-up|1|||
143347670|NCT01381874|516819255|FG002|Overall Study|Lost to Follow-up|0|||
143347671|NCT01381874|516819253|FG000|Overall Study|Withdrawal by Subject|9|||
143347672|NCT01381874|516819254|FG001|Overall Study|Withdrawal by Subject|10|||
143347673|NCT01381874|516819255|FG002|Overall Study|Withdrawal by Subject|9|||
143347674|NCT01381874|516819253|FG000|Overall Study|Other|67|||
143347675|NCT01381874|516819254|FG001|Overall Study|Other|52|||
143347676|NCT01381874|516819255|FG002|Overall Study|Other|67|||
143347677|NCT04488003|516819256|FG000|Assessed for Eligibility|Screen Failure|24|||
143347678|NCT04488003|516819257|FG001|Assessed for Eligibility|Screen Failure|0|||
143347679|NCT04488003|516819258|FG002|Assessed for Eligibility|Screen Failure|0|||
143347680|NCT04488003|516819256|FG000|Assessed for Eligibility|Adverse Event|1|||
143347681|NCT04488003|516819257|FG001|Assessed for Eligibility|Adverse Event|0|||
143347682|NCT04488003|516819258|FG002|Assessed for Eligibility|Adverse Event|0|||
143347683|NCT04488003|516819256|FG000|Assessed for Eligibility|Death|1|||
143347684|NCT04488003|516819257|FG001|Assessed for Eligibility|Death|0|||
143347685|NCT04488003|516819258|FG002|Assessed for Eligibility|Death|0|||
143347686|NCT04488003|516819256|FG000|Assessed for Eligibility|Physician Decision|1|||
143347687|NCT04488003|516819257|FG001|Assessed for Eligibility|Physician Decision|0|||
143347688|NCT04488003|516819258|FG002|Assessed for Eligibility|Physician Decision|0|||
143347689|NCT04488003|516819256|FG000|Allocated to Treatment|Progressive Disease|51|||
143347690|NCT04488003|516819257|FG001|Allocated to Treatment|Progressive Disease|0|||
143347691|NCT04488003|516819258|FG002|Allocated to Treatment|Progressive Disease|0|||
143347692|NCT04488003|516819256|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
143347693|NCT04488003|516819257|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
143347694|NCT04488003|516819258|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
143347695|NCT04488003|516819256|FG000|Allocated to Treatment|Adverse Event|6|||
143347696|NCT04488003|516819257|FG001|Allocated to Treatment|Adverse Event|0|||
143347697|NCT04488003|516819258|FG002|Allocated to Treatment|Adverse Event|0|||
143347698|NCT04488003|516819256|FG000|Allocated to Treatment|Other|5|||
143347699|NCT04488003|516819257|FG001|Allocated to Treatment|Other|0|||
143347700|NCT04488003|516819258|FG002|Allocated to Treatment|Other|0|||
143347701|NCT04488003|516819256|FG000|Allocated to Treatment|Physician Decision|4|||
143347702|NCT04488003|516819257|FG001|Allocated to Treatment|Physician Decision|0|||
143347703|NCT04488003|516819258|FG002|Allocated to Treatment|Physician Decision|0|||
143347704|NCT04488003|516819256|FG000|Allocated to Treatment|Death|4|||
143347705|NCT04488003|516819257|FG001|Allocated to Treatment|Death|0|||
143347706|NCT04488003|516819258|FG002|Allocated to Treatment|Death|0|||
143347707|NCT02086162|516819259|FG000|Overall Study|Withdrawal by Subject|4|||
143347708|NCT02086162|516819260|FG001|Overall Study|Withdrawal by Subject|4|||
143347709|NCT02086162|516819259|FG000|Overall Study|moved|1|||
143347710|NCT02086162|516819260|FG001|Overall Study|moved|1|||
143347711|NCT02086162|516819259|FG000|Overall Study|Lost to Follow-up|4|||
143347712|NCT02086162|516819260|FG001|Overall Study|Lost to Follow-up|2|||
143347713|NCT02086162|516819259|FG000|Overall Study|Death|1|||
143347714|NCT02086162|516819260|FG001|Overall Study|Death|0|||
143347715|NCT01248962|516819261|FG000|Overall Study|Withdrawal by Subject|1|||
143347716|NCT01248962|516819262|FG001|Overall Study|Withdrawal by Subject|1|||
143347717|NCT01248962|516819261|FG000|Overall Study|Adverse Event|2|||
143347718|NCT01248962|516819262|FG001|Overall Study|Adverse Event|1|||
143347719|NCT01248962|516819261|FG000|Overall Study|Complete Response after 4 Cycles|1|||
143347720|NCT01248962|516819262|FG001|Overall Study|Complete Response after 4 Cycles|0|||
143347721|NCT01248962|516819261|FG000|Overall Study|Complete Response after 3 Cycles|0|||
143347722|NCT01248962|516819262|FG001|Overall Study|Complete Response after 3 Cycles|1|||
143347723|NCT01248962|516819261|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
143347724|NCT01248962|516819262|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
143347725|NCT01539863|516819263|FG000|Overall Study|Lost to Follow-up|5|||
143347726|NCT01539863|516819264|FG001|Overall Study|Lost to Follow-up|4|||
143347727|NCT00557622|516819265|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
143347728|NCT00557622|516819266|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
143347729|NCT00557622|516819265|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
143347730|NCT00557622|516819266|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
143347731|NCT00557622|516819265|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
143347732|NCT00557622|516819266|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
143347733|NCT01512745|516819267|FG000|Overall Study|Adverse Event|22|||
143347734|NCT01512745|516819268|FG001|Overall Study|Adverse Event|3|||
143347735|NCT01512745|516819267|FG000|Overall Study|Death|9|||
143347736|NCT01512745|516819268|FG001|Overall Study|Death|13|||
143347737|NCT01512745|516819267|FG000|Overall Study|Withdrawal by Subject|2|||
143347738|NCT01512745|516819268|FG001|Overall Study|Withdrawal by Subject|2|||
143347739|NCT01512745|516819267|FG000|Overall Study|Lost to Follow-up|4|||
143347740|NCT01512745|516819268|FG001|Overall Study|Lost to Follow-up|0|||
143347741|NCT01512745|516819267|FG000|Overall Study|Lack of Efficacy|2|||
143347742|NCT01512745|516819268|FG001|Overall Study|Lack of Efficacy|2|||
143347743|NCT01512745|516819267|FG000|Overall Study|Protocol Violation|1|||
143347744|NCT01512745|516819268|FG001|Overall Study|Protocol Violation|0|||
143347745|NCT05796518|516819271|FG000|Overall Study|Were enrolled but did not complete the intervention|2|||
143347746|NCT02690077|516819272|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
143347747|NCT02690077|516819273|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
143347748|NCT02690077|516819272|FG000|Overall Study|Withdrawal by Subject|0|||
143347749|NCT02690077|516819273|FG001|Overall Study|Withdrawal by Subject|5|||
143347750|NCT02690077|516819272|FG000|Overall Study|Excluded by IRB|0|||
143347751|NCT02690077|516819273|FG001|Overall Study|Excluded by IRB|2|||
143347752|NCT05229653|516819274|FG000|Overall Study|Lost to Follow-up|1|||
143347753|NCT05229653|516819275|FG001|Overall Study|Lost to Follow-up|0|||
143347754|NCT01845974|516819276|FG000|Overall Study|screen failure|1|||
143347755|NCT01845974|516819277|FG001|Overall Study|screen failure|0|||
143347756|NCT02667886|516819278|FG000|Dose Escalation (Part A)|Adverse Event|1|||
143347757|NCT02667886|516819279|FG001|Dose Escalation (Part A)|Adverse Event|3|||
143347758|NCT02667886|516819280|FG002|Dose Escalation (Part A)|Adverse Event|1|||
143347759|NCT02667886|516819281|FG003|Dose Escalation (Part A)|Adverse Event|0|||
143347760|NCT02667886|516819282|FG004|Dose Escalation (Part A)|Adverse Event|0|||
143347761|NCT02667886|516819278|FG000|Dose Escalation (Part A)|Disease Progression|1|||
143347762|NCT02667886|516819279|FG001|Dose Escalation (Part A)|Disease Progression|4|||
143347763|NCT02667886|516819280|FG002|Dose Escalation (Part A)|Disease Progression|3|||
143347764|NCT02667886|516819281|FG003|Dose Escalation (Part A)|Disease Progression|0|||
143347765|NCT02667886|516819282|FG004|Dose Escalation (Part A)|Disease Progression|0|||
143347766|NCT02667886|516819278|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
143347767|NCT02667886|516819279|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
143347768|NCT02667886|516819280|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
143347769|NCT02667886|516819281|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
143347770|NCT02667886|516819282|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
143347771|NCT02667886|516819278|FG000|Dose Expansion (Part B)|Adverse Event|0|||
143347772|NCT02667886|516819279|FG001|Dose Expansion (Part B)|Adverse Event|0|||
143011585|NCT03000075|515579704|FG002|Part B|Not dosed due to AE|0|||
143011586|NCT03000075|515579705|FG003|Part B|Not dosed due to AE|0|||
143011587|NCT03000075|515579706|FG004|Part B|Not dosed due to AE|0|||
143011588|NCT03000075|515579707|FG005|Part B|Not dosed due to AE|2|||
143011589|NCT03000075|515579708|FG006|Part B|Not dosed due to AE|1|||
143011590|NCT03000075|515579702|FG000|Part B|Adverse Event|0|||
143011591|NCT03000075|515579703|FG001|Part B|Adverse Event|0|||
143011592|NCT03000075|515579704|FG002|Part B|Adverse Event|0|||
143011593|NCT03000075|515579705|FG003|Part B|Adverse Event|0|||
143011594|NCT03000075|515579706|FG004|Part B|Adverse Event|1|||
143011595|NCT03000075|515579707|FG005|Part B|Adverse Event|0|||
143011596|NCT03000075|515579708|FG006|Part B|Adverse Event|0|||
143347773|NCT02667886|516819280|FG002|Dose Expansion (Part B)|Adverse Event|0|||
143347774|NCT02667886|516819281|FG003|Dose Expansion (Part B)|Adverse Event|9|||
143347775|NCT02667886|516819282|FG004|Dose Expansion (Part B)|Adverse Event|0|||
143347776|NCT02667886|516819278|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
143011597|NCT00111007|515579709|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
143011598|NCT00111007|515579710|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
143011599|NCT00111007|515579709|FG000|Double-blind (DB) Treatment|Death|5|||
143347777|NCT02667886|516819279|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
143347778|NCT02667886|516819280|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
143011600|NCT00111007|515579710|FG001|Double-blind (DB) Treatment|Death|2|||
143011601|NCT00111007|515579709|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
143011602|NCT00111007|515579710|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
143347779|NCT02667886|516819281|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
143347780|NCT02667886|516819282|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
143347781|NCT02667886|516819278|FG000|Dose Expansion (Part B)|Disease Progression|0|||
143347782|NCT02667886|516819279|FG001|Dose Expansion (Part B)|Disease Progression|0|||
143347783|NCT02667886|516819280|FG002|Dose Expansion (Part B)|Disease Progression|0|||
143347784|NCT02667886|516819281|FG003|Dose Expansion (Part B)|Disease Progression|38|||
143347785|NCT02667886|516819282|FG004|Dose Expansion (Part B)|Disease Progression|0|||
143347786|NCT02667886|516819278|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
143347787|NCT02667886|516819279|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
143347788|NCT02667886|516819280|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
143347789|NCT02667886|516819281|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
143347790|NCT02667886|516819282|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
143347791|NCT02667886|516819278|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
143347792|NCT02667886|516819279|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
143347793|NCT02667886|516819280|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
143347794|NCT02667886|516819281|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
143347795|NCT02667886|516819282|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
143347796|NCT02667886|516819278|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
143347797|NCT02667886|516819279|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
143347798|NCT02667886|516819280|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
143347799|NCT02667886|516819281|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
143347800|NCT02667886|516819282|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
143347801|NCT00594217|516819283|FG000|Overall Study|Withdrawal by Subject|1|||
143347802|NCT00594217|516819284|FG001|Overall Study|Withdrawal by Subject|3|||
143347803|NCT00405639|516819285|FG000|Overall Study|Withdrawal by Subject|1|||
143347804|NCT00405639|516819286|FG001|Overall Study|Withdrawal by Subject|0|||
143347805|NCT00405639|516819285|FG000|Overall Study|Adverse Event|1|||
143347806|NCT00405639|516819286|FG001|Overall Study|Adverse Event|0|||
143347807|NCT00405639|516819285|FG000|Overall Study|Seizure prior to receiving BNP|1|||
143347808|NCT00405639|516819286|FG001|Overall Study|Seizure prior to receiving BNP|0|||
143347809|NCT00612534|516819287|FG000|Overall Study|Adverse Event|0|||
143347810|NCT00612534|516819288|FG001|Overall Study|Adverse Event|4|||
143347811|NCT00612534|516819289|FG002|Overall Study|Adverse Event|2|||
143347812|NCT00612534|516819290|FG003|Overall Study|Adverse Event|1|||
143347813|NCT00612534|516819287|FG000|Overall Study|Lack of Efficacy|13|||
143347814|NCT00612534|516819288|FG001|Overall Study|Lack of Efficacy|12|||
143347815|NCT00612534|516819289|FG002|Overall Study|Lack of Efficacy|5|||
143347816|NCT00612534|516819290|FG003|Overall Study|Lack of Efficacy|16|||
143347817|NCT00612534|516819287|FG000|Overall Study|Other Reason|0|||
143347818|NCT00612534|516819288|FG001|Overall Study|Other Reason|1|||
143347819|NCT00612534|516819289|FG002|Overall Study|Other Reason|0|||
143347820|NCT00612534|516819290|FG003|Overall Study|Other Reason|0|||
143347821|NCT02223754|516819291|FG000|Period 1|Adverse Event|1|||
143347822|NCT02223754|516819292|FG001|Period 1|Adverse Event|0|||
143347823|NCT02223754|516819291|FG000|Period 1|Lost to Follow-up|0|||
143347824|NCT02223754|516819292|FG001|Period 1|Lost to Follow-up|1|||
143347825|NCT02223754|516819291|FG000|Period 1|Protocol Violation|2|||
143347826|NCT02223754|516819292|FG001|Period 1|Protocol Violation|4|||
143347827|NCT02223754|516819291|FG000|Period 1|Withdrawal by Subject|0|||
143347828|NCT02223754|516819292|FG001|Period 1|Withdrawal by Subject|4|||
143347829|NCT02223754|516819291|FG000|Period 1|Test Article No Longer Available|1|||
143347830|NCT02223754|516819292|FG001|Period 1|Test Article No Longer Available|5|||
143347831|NCT02223754|516819291|FG000|Period 1|Unsatisfactory Visual Response|0|||
143347832|NCT02223754|516819292|FG001|Period 1|Unsatisfactory Visual Response|1|||
143347833|NCT02223754|516819291|FG000|Period 2|Adverse Event|0|||
143347834|NCT02223754|516819292|FG001|Period 2|Adverse Event|1|||
143347835|NCT02223754|516819291|FG000|Period 2|Protocol Violation|1|||
143347836|NCT02223754|516819292|FG001|Period 2|Protocol Violation|0|||
143347837|NCT02223754|516819291|FG000|Period 2|Lens Discomfort|1|||
143461388|NCT05478499|517235030|FG000|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|0|||
143461389|NCT05478499|517235031|FG001|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|1|||
143461390|NCT04426851|517235032|FG000|Part 2: Period 2+Washout|Withdrawal by Subject|0|||
143347838|NCT02223754|516819292|FG001|Period 2|Lens Discomfort|1|||
143347839|NCT02223754|516819291|FG000|Period 2|Lost to Follow-up|1|||
143347840|NCT02223754|516819292|FG001|Period 2|Lost to Follow-up|0|||
143347841|NCT02223754|516819291|FG000|Period 2|Test Article No Longer Available|0|||
143347842|NCT02223754|516819292|FG001|Period 2|Test Article No Longer Available|1|||
143347843|NCT01807650|516819301|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
143461391|NCT04426851|517235033|FG001|Part 2: Period 2+Washout|Withdrawal by Subject|1|||
143347844|NCT01807650|516819301|FG000|Overall Study|Adverse Event|5|||
143347845|NCT01807650|516819301|FG000|Overall Study|Other|2|||
143347846|NCT02234063|516819314|FG000|Overall Study|Lost to Follow-up|235|||
143347847|NCT02234063|516819315|FG001|Overall Study|Lost to Follow-up|42|||
143347848|NCT02234063|516819314|FG000|Overall Study|Withdrawal by Subject|20|||
143347849|NCT02234063|516819315|FG001|Overall Study|Withdrawal by Subject|1|||
143347850|NCT02946918|516819318|FG000|Overall Study|Patient unblinded himself|1|||
143347851|NCT02946918|516819319|FG001|Overall Study|Patient unblinded himself|0|||
143347852|NCT02946918|516819318|FG000|Overall Study|Physician Decision|0|||
143347853|NCT02946918|516819319|FG001|Overall Study|Physician Decision|2|||
143347854|NCT02946918|516819318|FG000|Overall Study|Ran out of study medication|0|||
143347855|NCT02946918|516819319|FG001|Overall Study|Ran out of study medication|1|||
143347856|NCT01861522|516819320|FG000|Overall Study|Adverse Event|1|||
143347857|NCT01861522|516819321|FG001|Overall Study|Adverse Event|0|||
143347858|NCT01861522|516819320|FG000|Overall Study|Withdrawal by Subject|2|||
143347859|NCT01861522|516819321|FG001|Overall Study|Withdrawal by Subject|0|||
143347860|NCT02716038|516819322|FG000|Overall Study|Not evaluable|1|||
143347861|NCT02716038|516819322|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
143347862|NCT02716038|516819322|FG000|Overall Study|Unresectable|3|||
143347863|NCT00069784|516819323|FG000|Overall Study|Adverse Event|105|||
143347864|NCT00069784|516819324|FG001|Overall Study|Adverse Event|0|||
143347865|NCT00069784|516819323|FG000|Overall Study|Withdrawal by Subject|1090|||
143347866|NCT00069784|516819324|FG001|Overall Study|Withdrawal by Subject|0|||
143347867|NCT00069784|516819323|FG000|Overall Study|Other|17|||
143347868|NCT00069784|516819324|FG001|Overall Study|Other|0|||
143347869|NCT02669095|516819330|FG000|Overall Study|Adverse Event|1|||
143347870|NCT02669095|516819331|FG001|Overall Study|Adverse Event|0|||
143347871|NCT02669095|516819330|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
143347872|NCT02669095|516819331|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
143347873|NCT02669095|516819330|FG000|Overall Study|Torn Lens|0|||
143347874|NCT02669095|516819331|FG001|Overall Study|Torn Lens|1|||
143347875|NCT02669095|516819330|FG000|Overall Study|Visit 5 assessments not completed|0|||
143347876|NCT02669095|516819331|FG001|Overall Study|Visit 5 assessments not completed|1|||
143347877|NCT00886639|516819334|FG000|Overall Study|acute exacerbation|14|||
143347878|NCT00886639|516819334|FG000|Overall Study|non-compliance|2|||
143347879|NCT01871558|516819335|FG000|Overall Study|Other reason|0|||
143347880|NCT01871558|516819336|FG001|Overall Study|Other reason|1|||
143347881|NCT01871558|516819335|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
143347882|NCT01871558|516819336|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
143347883|NCT01871558|516819335|FG000|Overall Study|Withdrawal by Subject|2|||
143347884|NCT01871558|516819336|FG001|Overall Study|Withdrawal by Subject|0|||
143347885|NCT03203694|516819337|FG000|Overall Study|Withdrawal by Subject|2|||
143347886|NCT03203694|516819338|FG001|Overall Study|Withdrawal by Subject|0|||
143347887|NCT03203694|516819339|FG002|Overall Study|Withdrawal by Subject|0|||
143347888|NCT03203694|516819340|FG003|Overall Study|Withdrawal by Subject|0|||
143347889|NCT03203694|516819341|FG004|Overall Study|Withdrawal by Subject|0|||
143347890|NCT03203694|516819342|FG005|Overall Study|Withdrawal by Subject|0|||
143347891|NCT01709305|516819343|FG000|Phase 1|Clinical Adverse Event|80|||
143347892|NCT01709305|516819344|FG001|Phase 1|Clinical Adverse Event|0|||
143347893|NCT01709305|516819345|FG002|Phase 1|Clinical Adverse Event|0|||
143347894|NCT01709305|516819346|FG003|Phase 1|Clinical Adverse Event|0|||
143347895|NCT01709305|516819347|FG004|Phase 1|Clinical Adverse Event|0|||
143347896|NCT01709305|516819343|FG000|Phase 1|Death|2|||
143347897|NCT01709305|516819344|FG001|Phase 1|Death|0|||
143347898|NCT01709305|516819345|FG002|Phase 1|Death|0|||
143347899|NCT01709305|516819346|FG003|Phase 1|Death|0|||
143011603|NCT00111007|515579709|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
143011604|NCT00111007|515579710|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
143124786|NCT01753115|516001288|FG001|Overall Study|Used excluded drug|1|||
143124787|NCT01753115|516001289|FG002|Overall Study|Used excluded drug|0|||
143124788|NCT02521792|516001292|FG000|Overall Study|Study Terminated|6|||
143124789|NCT00398047|516001293|FG000|Overall Study|all patient progressed before completion|3|||
143124790|NCT01188668|516001294|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
143124791|NCT01188668|516001294|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
143124792|NCT01188668|516001294|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
143124793|NCT00902746|516001295|FG000|Overall Study|Protocol Violation|7|||
143124794|NCT00902746|516001295|FG000|Overall Study|Withdrawal by Subject|16|||
143124795|NCT00902746|516001295|FG000|Overall Study|Adverse Event|8|||
143124796|NCT00902746|516001295|FG000|Overall Study|Lost to Follow-up|3|||
143124797|NCT00902746|516001295|FG000|Overall Study|Physician Decision|2|||
143124798|NCT02937636|516001298|FG000|Overall Study|Other (Not specified)|3|||
143124799|NCT02937636|516001299|FG001|Overall Study|Other (Not specified)|2|||
143124800|NCT00770913|516001300|FG000|Overall Study|Adverse Event|1|||
143124801|NCT00770913|516001301|FG001|Overall Study|Adverse Event|3|||
143347900|NCT01709305|516819347|FG004|Phase 1|Death|0|||
143347901|NCT01709305|516819343|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
143347902|NCT01709305|516819344|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
143347903|NCT01709305|516819345|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
143347904|NCT01709305|516819346|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
143347905|NCT01709305|516819347|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
143347906|NCT01709305|516819343|FG000|Phase 1|Laboratory Adverse Event|16|||
143347907|NCT01709305|516819344|FG001|Phase 1|Laboratory Adverse Event|0|||
143347908|NCT01709305|516819345|FG002|Phase 1|Laboratory Adverse Event|0|||
143347909|NCT01709305|516819346|FG003|Phase 1|Laboratory Adverse Event|0|||
143347910|NCT01709305|516819347|FG004|Phase 1|Laboratory Adverse Event|0|||
143347911|NCT01709305|516819343|FG000|Phase 1|Lost to Follow-up|147|||
143347912|NCT01709305|516819344|FG001|Phase 1|Lost to Follow-up|0|||
143347913|NCT01709305|516819345|FG002|Phase 1|Lost to Follow-up|0|||
143347914|NCT01709305|516819346|FG003|Phase 1|Lost to Follow-up|0|||
143347915|NCT01709305|516819347|FG004|Phase 1|Lost to Follow-up|0|||
143347916|NCT01709305|516819343|FG000|Phase 1|Travel, moving, etc.|30|||
143347917|NCT01709305|516819344|FG001|Phase 1|Travel, moving, etc.|0|||
143347918|NCT01709305|516819345|FG002|Phase 1|Travel, moving, etc.|0|||
143347919|NCT01709305|516819346|FG003|Phase 1|Travel, moving, etc.|0|||
143347920|NCT01709305|516819347|FG004|Phase 1|Travel, moving, etc.|0|||
143347921|NCT01709305|516819343|FG000|Phase 1|Physician Decision|13|||
143124802|NCT00770913|516001302|FG002|Overall Study|Adverse Event|6|||
143347922|NCT01709305|516819344|FG001|Phase 1|Physician Decision|0|||
143347923|NCT01709305|516819345|FG002|Phase 1|Physician Decision|0|||
143347924|NCT01709305|516819346|FG003|Phase 1|Physician Decision|0|||
143347925|NCT01709305|516819347|FG004|Phase 1|Physician Decision|0|||
143347926|NCT01709305|516819343|FG000|Phase 1|Protocol Violation|118|||
143347927|NCT01709305|516819344|FG001|Phase 1|Protocol Violation|0|||
143347928|NCT01709305|516819345|FG002|Phase 1|Protocol Violation|0|||
143347929|NCT01709305|516819346|FG003|Phase 1|Protocol Violation|0|||
143347930|NCT01709305|516819347|FG004|Phase 1|Protocol Violation|0|||
143347931|NCT01709305|516819343|FG000|Phase 1|Withdrawal by Subject|218|||
143347932|NCT01709305|516819344|FG001|Phase 1|Withdrawal by Subject|0|||
143347933|NCT01709305|516819345|FG002|Phase 1|Withdrawal by Subject|0|||
143347934|NCT01709305|516819346|FG003|Phase 1|Withdrawal by Subject|0|||
143347935|NCT01709305|516819347|FG004|Phase 1|Withdrawal by Subject|0|||
143347936|NCT01709305|516819343|FG000|Phase 2|Clinical Adverse Event|0|||
143347937|NCT01709305|516819344|FG001|Phase 2|Clinical Adverse Event|10|||
143347938|NCT01709305|516819345|FG002|Phase 2|Clinical Adverse Event|10|||
143347939|NCT01709305|516819346|FG003|Phase 2|Clinical Adverse Event|6|||
143347940|NCT01709305|516819347|FG004|Phase 2|Clinical Adverse Event|11|||
143347941|NCT01709305|516819343|FG000|Phase 2|Death|0|||
143347942|NCT01709305|516819344|FG001|Phase 2|Death|0|||
143347943|NCT01709305|516819345|FG002|Phase 2|Death|1|||
143347944|NCT01709305|516819346|FG003|Phase 2|Death|0|||
143347945|NCT01709305|516819347|FG004|Phase 2|Death|0|||
143347946|NCT01709305|516819343|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
143347947|NCT01709305|516819344|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
143347948|NCT01709305|516819345|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
143347949|NCT01709305|516819346|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
143347950|NCT01709305|516819347|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
143347951|NCT01709305|516819343|FG000|Phase 2|Laboratory Adverse Event|0|||
143347952|NCT01709305|516819344|FG001|Phase 2|Laboratory Adverse Event|1|||
143347953|NCT01709305|516819345|FG002|Phase 2|Laboratory Adverse Event|0|||
143347954|NCT01709305|516819346|FG003|Phase 2|Laboratory Adverse Event|1|||
143347955|NCT01709305|516819347|FG004|Phase 2|Laboratory Adverse Event|1|||
143347956|NCT01709305|516819343|FG000|Phase 2|Lost to Follow-up|0|||
143347957|NCT01709305|516819344|FG001|Phase 2|Lost to Follow-up|10|||
143347958|NCT01709305|516819345|FG002|Phase 2|Lost to Follow-up|6|||
143347959|NCT01709305|516819346|FG003|Phase 2|Lost to Follow-up|9|||
143347960|NCT01709305|516819347|FG004|Phase 2|Lost to Follow-up|5|||
143347961|NCT01709305|516819343|FG000|Phase 2|Travel, moving, etc.|0|||
143347962|NCT01709305|516819344|FG001|Phase 2|Travel, moving, etc.|2|||
143347963|NCT01709305|516819345|FG002|Phase 2|Travel, moving, etc.|3|||
143347964|NCT01709305|516819346|FG003|Phase 2|Travel, moving, etc.|3|||
143347965|NCT01709305|516819347|FG004|Phase 2|Travel, moving, etc.|5|||
143347966|NCT01709305|516819343|FG000|Phase 2|Physician Decision|0|||
143347967|NCT01709305|516819344|FG001|Phase 2|Physician Decision|2|||
143347968|NCT01709305|516819345|FG002|Phase 2|Physician Decision|0|||
143347969|NCT01709305|516819346|FG003|Phase 2|Physician Decision|1|||
143347970|NCT01709305|516819347|FG004|Phase 2|Physician Decision|2|||
143347971|NCT01709305|516819343|FG000|Phase 2|Protocol Violation|0|||
143347972|NCT01709305|516819344|FG001|Phase 2|Protocol Violation|19|||
143347973|NCT01709305|516819345|FG002|Phase 2|Protocol Violation|19|||
143347974|NCT01709305|516819346|FG003|Phase 2|Protocol Violation|13|||
143347975|NCT01709305|516819347|FG004|Phase 2|Protocol Violation|9|||
143347976|NCT01709305|516819343|FG000|Phase 2|Withdrawal by Subject|0|||
143124803|NCT00770913|516001300|FG000|Overall Study|Refusal to continue participation|6|||
143347977|NCT01709305|516819344|FG001|Phase 2|Withdrawal by Subject|8|||
143347978|NCT01709305|516819345|FG002|Phase 2|Withdrawal by Subject|6|||
143124804|NCT00770913|516001301|FG001|Overall Study|Refusal to continue participation|4|||
143347979|NCT01709305|516819346|FG003|Phase 2|Withdrawal by Subject|15|||
143347980|NCT01709305|516819347|FG004|Phase 2|Withdrawal by Subject|12|||
143347981|NCT01103960|516819350|FG000|Overall Study|Adverse Event|2|||
143347982|NCT01103960|516819351|FG001|Overall Study|Adverse Event|1|||
143347983|NCT01103960|516819350|FG000|Overall Study|Withdrawal by Subject|2|||
143347984|NCT01103960|516819351|FG001|Overall Study|Withdrawal by Subject|1|||
143347985|NCT01103960|516819350|FG000|Overall Study|Other|1|||
143347986|NCT01103960|516819351|FG001|Overall Study|Other|0|||
143347987|NCT01338012|516819357|FG000|Overall Study|Death|4|||
143347988|NCT01338012|516819357|FG000|Overall Study|Study terminated|4|||
143347989|NCT02714205|516819358|FG000|Overall Study|Cannot tolerate medication|1|||
143347990|NCT02714205|516819359|FG001|Overall Study|Cannot tolerate medication|0|||
143347991|NCT02714205|516819358|FG000|Overall Study|Adverse Event|2|||
143347992|NCT02714205|516819359|FG001|Overall Study|Adverse Event|0|||
143347993|NCT02714205|516819358|FG000|Overall Study|Too busy|1|||
143347994|NCT02714205|516819359|FG001|Overall Study|Too busy|0|||
143347995|NCT02714205|516819358|FG000|Overall Study|Incomplete outcome data|0|||
143347996|NCT02714205|516819359|FG001|Overall Study|Incomplete outcome data|1|||
143347997|NCT02073097|516819360|FG000|Overall Study|Adverse Event|0|||
143347998|NCT02073097|516819361|FG001|Overall Study|Adverse Event|0|||
143347999|NCT02073097|516819362|FG002|Overall Study|Adverse Event|0|||
143348000|NCT02073097|516819363|FG003|Overall Study|Adverse Event|0|||
143348001|NCT02073097|516819364|FG004|Overall Study|Adverse Event|0|||
143348002|NCT02073097|516819365|FG005|Overall Study|Adverse Event|0|||
143348003|NCT02073097|516819366|FG006|Overall Study|Adverse Event|0|||
143348004|NCT02073097|516819367|FG007|Overall Study|Adverse Event|2|||
143348005|NCT02073097|516819360|FG000|Overall Study|Withdrawal by Subject|0|||
143348006|NCT02073097|516819361|FG001|Overall Study|Withdrawal by Subject|0|||
143348007|NCT02073097|516819362|FG002|Overall Study|Withdrawal by Subject|0|||
143348008|NCT02073097|516819363|FG003|Overall Study|Withdrawal by Subject|0|||
143348009|NCT02073097|516819364|FG004|Overall Study|Withdrawal by Subject|0|||
143348010|NCT02073097|516819365|FG005|Overall Study|Withdrawal by Subject|0|||
143348011|NCT02073097|516819366|FG006|Overall Study|Withdrawal by Subject|0|||
143348012|NCT02073097|516819367|FG007|Overall Study|Withdrawal by Subject|2|||
143348013|NCT02073097|516819360|FG000|Overall Study|Death|0|||
143348014|NCT02073097|516819361|FG001|Overall Study|Death|0|||
143348015|NCT02073097|516819362|FG002|Overall Study|Death|0|||
143348016|NCT02073097|516819363|FG003|Overall Study|Death|0|||
143348017|NCT02073097|516819364|FG004|Overall Study|Death|0|||
143348018|NCT02073097|516819365|FG005|Overall Study|Death|0|||
143348019|NCT02073097|516819366|FG006|Overall Study|Death|0|||
143348020|NCT02073097|516819367|FG007|Overall Study|Death|1|||
143348021|NCT02073097|516819360|FG000|Overall Study|Physician Decision|0|||
143348022|NCT02073097|516819361|FG001|Overall Study|Physician Decision|0|||
143348023|NCT02073097|516819362|FG002|Overall Study|Physician Decision|0|||
143348024|NCT02073097|516819363|FG003|Overall Study|Physician Decision|0|||
143348025|NCT02073097|516819364|FG004|Overall Study|Physician Decision|0|||
143348026|NCT02073097|516819365|FG005|Overall Study|Physician Decision|0|||
143348027|NCT02073097|516819366|FG006|Overall Study|Physician Decision|0|||
143348028|NCT02073097|516819367|FG007|Overall Study|Physician Decision|1|||
143348029|NCT01167179|516821500|FG000|Overall Study|disease recurrence|4|||
143348030|NCT01167179|516821501|FG001|Overall Study|disease recurrence|4|||
143348031|NCT01167179|516821500|FG000|Overall Study|Death|4|||
143348032|NCT01167179|516821501|FG001|Overall Study|Death|10|||
143348033|NCT01167179|516821500|FG000|Overall Study|Withdrawal by Subject|1|||
143348034|NCT01167179|516821501|FG001|Overall Study|Withdrawal by Subject|2|||
143348035|NCT01167179|516821500|FG000|Overall Study|diverse|6|||
143348036|NCT01167179|516821501|FG001|Overall Study|diverse|5|||
143348037|NCT00663117|516821502|FG000|Overall Study|Lack of Efficacy|1|||
143348038|NCT00663117|516821503|FG001|Overall Study|Lack of Efficacy|0|||
143348039|NCT01158378|516821504|FG000|Overall Study|Death|4|||
143348040|NCT01158378|516821505|FG001|Overall Study|Death|5|||
143348041|NCT01158378|516821504|FG000|Overall Study|Lost to Follow-up|2|||
143348042|NCT01158378|516821505|FG001|Overall Study|Lost to Follow-up|4|||
143348043|NCT01158378|516821504|FG000|Overall Study|Withdrawal by Subject|4|||
143348044|NCT01158378|516821505|FG001|Overall Study|Withdrawal by Subject|0|||
143348045|NCT02769065|516821506|FG000|Overall Study|Voluntary Withdrawal|1|||
143348046|NCT02769065|516821507|FG001|Overall Study|Voluntary Withdrawal|0|||
143348047|NCT02769065|516821508|FG002|Overall Study|Voluntary Withdrawal|0|||
143348048|NCT02769065|516821509|FG003|Overall Study|Voluntary Withdrawal|0|||
143348049|NCT02769065|516821510|FG004|Overall Study|Voluntary Withdrawal|0|||
143348050|NCT02769065|516821511|FG005|Overall Study|Voluntary Withdrawal|0|||
143348051|NCT02769065|516821512|FG006|Overall Study|Voluntary Withdrawal|0|||
143348052|NCT02769065|516821513|FG007|Overall Study|Voluntary Withdrawal|0|||
143348053|NCT02769065|516821514|FG008|Overall Study|Voluntary Withdrawal|0|||
143348054|NCT02769065|516821515|FG009|Overall Study|Voluntary Withdrawal|0|||
143348055|NCT02769065|516821516|FG010|Overall Study|Voluntary Withdrawal|0|||
143348056|NCT02769065|516821517|FG011|Overall Study|Voluntary Withdrawal|0|||
143348057|NCT02769065|516821518|FG012|Overall Study|Voluntary Withdrawal|0|||
143348058|NCT02769065|516821519|FG013|Overall Study|Voluntary Withdrawal|0|||
143348059|NCT02769065|516821520|FG014|Overall Study|Voluntary Withdrawal|0|||
143348060|NCT02769065|516821521|FG015|Overall Study|Voluntary Withdrawal|0|||
143348061|NCT02769065|516821522|FG016|Overall Study|Voluntary Withdrawal|0|||
143348062|NCT02769065|516821523|FG017|Overall Study|Voluntary Withdrawal|0|||
143348063|NCT02769065|516821524|FG018|Overall Study|Voluntary Withdrawal|0|||
143348064|NCT02769065|516821525|FG019|Overall Study|Voluntary Withdrawal|0|||
143348065|NCT02769065|516821526|FG020|Overall Study|Voluntary Withdrawal|0|||
143348066|NCT02769065|516821527|FG021|Overall Study|Voluntary Withdrawal|0|||
143348067|NCT02769065|516821528|FG022|Overall Study|Voluntary Withdrawal|0|||
143124805|NCT00770913|516001302|FG002|Overall Study|Refusal to continue participation|5|||
143124806|NCT00770913|516001300|FG000|Overall Study|Physician Decision|0|||
143124807|NCT00770913|516001301|FG001|Overall Study|Physician Decision|1|||
143124808|NCT00770913|516001302|FG002|Overall Study|Physician Decision|1|||
143124809|NCT00770913|516001300|FG000|Overall Study|Protocol Violation|3|||
143124810|NCT00770913|516001301|FG001|Overall Study|Protocol Violation|0|||
143124811|NCT00770913|516001302|FG002|Overall Study|Protocol Violation|1|||
143124812|NCT00770913|516001300|FG000|Overall Study|Incorrect drug was allocated|1|||
143124813|NCT00770913|516001301|FG001|Overall Study|Incorrect drug was allocated|0|||
143124814|NCT00770913|516001302|FG002|Overall Study|Incorrect drug was allocated|0|||
143124815|NCT02347072|516001305|FG000|Overall Study|Adverse Event|2|||
143124816|NCT02347072|516001305|FG000|Overall Study|Withdrawal by Subject|6|||
143124817|NCT02347072|516001305|FG000|Overall Study|Physician Decision|1|||
143124818|NCT02347072|516001305|FG000|Overall Study|Lost to Follow-up|2|||
143124819|NCT02347072|516001305|FG000|Overall Study|Protocol Violation|1|||
143124820|NCT02347072|516001305|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
143124821|NCT01134393|516001308|FG000|Overall Study|Adverse Event|18|||
143124822|NCT01134393|516001308|FG000|Overall Study|Lack of Efficacy|2|||
143124823|NCT01134393|516001308|FG000|Overall Study|Protocol Violation|12|||
143124824|NCT01134393|516001308|FG000|Overall Study|Lost to Follow-up|3|||
143124825|NCT01134393|516001308|FG000|Overall Study|Withdrawal by Subject|11|||
143124826|NCT01134393|516001308|FG000|Overall Study|Other|6|||
143124827|NCT03762681|516001310|FG000|Part 1|Withdrawal by Subject|0|||
143124828|NCT03762681|516001311|FG001|Part 1|Withdrawal by Subject|0|||
143011605|NCT00111007|515579709|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
143011606|NCT00111007|515579710|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
143011607|NCT00111007|515579709|FG000|Double-blind (DB) Treatment|Relapse|1|||
143011608|NCT00111007|515579710|FG001|Double-blind (DB) Treatment|Relapse|0|||
143011609|NCT00111007|515579709|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
143011610|NCT00111007|515579710|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
143011611|NCT00111007|515579709|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
143011612|NCT00111007|515579710|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
143011613|NCT00111007|515579709|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
143011614|NCT00111007|515579710|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
143011615|NCT00111007|515579709|FG000|Active Follow-up|Adverse Event|1|||
143011616|NCT00111007|515579710|FG001|Active Follow-up|Adverse Event|0|||
143011617|NCT00111007|515579709|FG000|Active Follow-up|Death|2|||
143011618|NCT00111007|515579710|FG001|Active Follow-up|Death|0|||
143011619|NCT00111007|515579709|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
143011620|NCT00111007|515579710|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
143011621|NCT00111007|515579709|FG000|Long Term Follow-up|Death|34|||
143011622|NCT00111007|515579710|FG001|Long Term Follow-up|Death|39|||
143011623|NCT00111007|515579709|FG000|Long Term Follow-up|Lost to Follow-up|1|||
143011624|NCT00111007|515579710|FG001|Long Term Follow-up|Lost to Follow-up|1|||
143011625|NCT00111007|515579709|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
143011626|NCT00111007|515579710|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
143011627|NCT00111007|515579709|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
143011628|NCT00111007|515579710|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
143011629|NCT00111007|515579709|FG000|Long Term Follow-up|Missing|10|||
143011630|NCT00111007|515579710|FG001|Long Term Follow-up|Missing|3|||
143011631|NCT00440193|515579711|FG000|Treatment Period|Adverse Event|74|||
143011632|NCT00440193|515579712|FG001|Treatment Period|Adverse Event|67|||
143011633|NCT00440193|515579711|FG000|Treatment Period|Death|19|||
143011634|NCT00440193|515579712|FG001|Treatment Period|Death|22|||
143011635|NCT00440193|515579711|FG000|Treatment Period|Lack of Efficacy|0|||
143011636|NCT00440193|515579712|FG001|Treatment Period|Lack of Efficacy|1|||
143011637|NCT00440193|515579711|FG000|Treatment Period|Lost to Follow-up|12|||
143011638|NCT00440193|515579712|FG001|Treatment Period|Lost to Follow-up|18|||
143011639|NCT00440193|515579711|FG000|Treatment Period|Physician Decision|3|||
143011640|NCT00440193|515579712|FG001|Treatment Period|Physician Decision|6|||
143011641|NCT00440193|515579711|FG000|Treatment Period|Protocol Violation|16|||
143011642|NCT00440193|515579712|FG001|Treatment Period|Protocol Violation|19|||
143011643|NCT00440193|515579711|FG000|Treatment Period|Withdrawal by Subject|36|||
143011644|NCT00440193|515579712|FG001|Treatment Period|Withdrawal by Subject|77|||
143011645|NCT00440193|515579711|FG000|Treatment Period|Clinical endpoint reached|28|||
143124829|NCT03762681|516001312|FG002|Part 1|Withdrawal by Subject|0|||
143124830|NCT03762681|516001313|FG003|Part 1|Withdrawal by Subject|1|||
143124831|NCT03762681|516001314|FG004|Part 1|Withdrawal by Subject|0|||
143124832|NCT03762681|516001315|FG005|Part 1|Withdrawal by Subject|0|||
143124833|NCT03762681|516001316|FG006|Part 1|Withdrawal by Subject|0|||
143124834|NCT03762681|516001317|FG007|Part 1|Withdrawal by Subject|0|||
143124835|NCT03762681|516001310|FG000|Part 2a|Pandemic Travel Restrictions|0|||
143124836|NCT03762681|516001311|FG001|Part 2a|Pandemic Travel Restrictions|0|||
143011646|NCT00440193|515579712|FG001|Treatment Period|Clinical endpoint reached|25|||
143124837|NCT03762681|516001312|FG002|Part 2a|Pandemic Travel Restrictions|0|||
143348068|NCT02769065|516821529|FG023|Overall Study|Voluntary Withdrawal|0|||
143348069|NCT02769065|516821530|FG024|Overall Study|Voluntary Withdrawal|0|||
143348070|NCT02769065|516821531|FG025|Overall Study|Voluntary Withdrawal|0|||
143348071|NCT02769065|516821532|FG026|Overall Study|Voluntary Withdrawal|0|||
143348072|NCT02769065|516821533|FG027|Overall Study|Voluntary Withdrawal|0|||
143348073|NCT02769065|516821534|FG028|Overall Study|Voluntary Withdrawal|0|||
143348074|NCT02769065|516821535|FG029|Overall Study|Voluntary Withdrawal|0|||
143348075|NCT02769065|516821506|FG000|Overall Study|Reason Not Specified|0|||
143348076|NCT02769065|516821507|FG001|Overall Study|Reason Not Specified|0|||
143348077|NCT02769065|516821508|FG002|Overall Study|Reason Not Specified|0|||
143348078|NCT02769065|516821509|FG003|Overall Study|Reason Not Specified|0|||
143348079|NCT02769065|516821510|FG004|Overall Study|Reason Not Specified|0|||
143348080|NCT02769065|516821511|FG005|Overall Study|Reason Not Specified|0|||
143348081|NCT02769065|516821512|FG006|Overall Study|Reason Not Specified|1|||
143348082|NCT02769065|516821513|FG007|Overall Study|Reason Not Specified|0|||
143348083|NCT02769065|516821514|FG008|Overall Study|Reason Not Specified|0|||
143348084|NCT02769065|516821515|FG009|Overall Study|Reason Not Specified|0|||
143348085|NCT02769065|516821516|FG010|Overall Study|Reason Not Specified|0|||
143348086|NCT02769065|516821517|FG011|Overall Study|Reason Not Specified|0|||
143348087|NCT02769065|516821518|FG012|Overall Study|Reason Not Specified|0|||
143348088|NCT02769065|516821519|FG013|Overall Study|Reason Not Specified|0|||
143348089|NCT02769065|516821520|FG014|Overall Study|Reason Not Specified|0|||
143348090|NCT02769065|516821521|FG015|Overall Study|Reason Not Specified|0|||
143348091|NCT02769065|516821522|FG016|Overall Study|Reason Not Specified|0|||
143348092|NCT02769065|516821523|FG017|Overall Study|Reason Not Specified|0|||
143348093|NCT02769065|516821524|FG018|Overall Study|Reason Not Specified|0|||
143348094|NCT02769065|516821525|FG019|Overall Study|Reason Not Specified|0|||
143348095|NCT02769065|516821526|FG020|Overall Study|Reason Not Specified|0|||
143348096|NCT02769065|516821527|FG021|Overall Study|Reason Not Specified|0|||
143348097|NCT02769065|516821528|FG022|Overall Study|Reason Not Specified|0|||
143348098|NCT02769065|516821529|FG023|Overall Study|Reason Not Specified|0|||
143348099|NCT02769065|516821530|FG024|Overall Study|Reason Not Specified|0|||
143348100|NCT02769065|516821531|FG025|Overall Study|Reason Not Specified|0|||
143348101|NCT02769065|516821532|FG026|Overall Study|Reason Not Specified|0|||
143348102|NCT02769065|516821533|FG027|Overall Study|Reason Not Specified|0|||
143348103|NCT02769065|516821534|FG028|Overall Study|Reason Not Specified|0|||
143348104|NCT02769065|516821535|FG029|Overall Study|Reason Not Specified|0|||
143348105|NCT02769065|516821506|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
143348106|NCT02769065|516821507|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
143348107|NCT02769065|516821508|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
143348108|NCT02769065|516821509|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
143348109|NCT02769065|516821510|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
143348110|NCT02769065|516821511|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
143348111|NCT02769065|516821512|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
143348112|NCT02769065|516821513|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
143348113|NCT02769065|516821514|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
143348114|NCT02769065|516821515|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
143348115|NCT02769065|516821516|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
143348116|NCT02769065|516821517|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
143348117|NCT02769065|516821518|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
143348118|NCT02769065|516821519|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
143348119|NCT02769065|516821520|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
143348120|NCT02769065|516821521|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
143348121|NCT02769065|516821522|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
143348122|NCT02769065|516821523|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
143348123|NCT02769065|516821524|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
143348124|NCT02769065|516821525|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
143348125|NCT02769065|516821526|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
143348126|NCT02769065|516821527|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
143348127|NCT02769065|516821528|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
143348128|NCT02769065|516821529|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
143348129|NCT02769065|516821530|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
143461392|NCT04426851|517235032|FG000|Part 2: Period 2+Washout|Adverse Event|1|||
143348130|NCT02769065|516821531|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
143348131|NCT02769065|516821532|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
143348132|NCT02769065|516821533|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
143348133|NCT02769065|516821534|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
143348134|NCT02769065|516821535|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
143348135|NCT03017235|516821536|FG000|Overall Study|Withdrawal by Subject|4|||
143348136|NCT03017235|516821537|FG001|Overall Study|Withdrawal by Subject|3|||
143348137|NCT03017235|516821536|FG000|Overall Study|Lost to Follow-up|2|||
143348138|NCT03017235|516821537|FG001|Overall Study|Lost to Follow-up|7|||
143348139|NCT03017235|516821536|FG000|Overall Study|Adverse Event|0|||
143348140|NCT03017235|516821537|FG001|Overall Study|Adverse Event|1|||
143348141|NCT03017235|516821536|FG000|Overall Study|Protocol Violation|2|||
143348142|NCT03017235|516821537|FG001|Overall Study|Protocol Violation|1|||
143348143|NCT03017235|516821536|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
143348144|NCT03017235|516821537|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
143348145|NCT04666922|516821541|FG000|Overall Study|Withdrawal by Subject|1|||
143348146|NCT04666922|516821542|FG001|Overall Study|Withdrawal by Subject|0|||
143348147|NCT04666922|516821543|FG002|Overall Study|Withdrawal by Subject|0|||
143348148|NCT04666922|516821544|FG003|Overall Study|Withdrawal by Subject|0|||
143348149|NCT04666922|516821545|FG004|Overall Study|Withdrawal by Subject|0|||
143348150|NCT04666922|516821546|FG005|Overall Study|Withdrawal by Subject|0|||
143348151|NCT04666922|516821547|FG006|Overall Study|Withdrawal by Subject|0|||
143348152|NCT01382940|516821548|FG000|Overall Study|Adverse Event|19|||
143348153|NCT01382940|516821548|FG000|Overall Study|Lost to Follow-up|4|||
143348154|NCT01382940|516821548|FG000|Overall Study|Physician Decision|7|||
143348155|NCT01382940|516821548|FG000|Overall Study|Withdrawal by Subject|23|||
143348156|NCT01382940|516821548|FG000|Overall Study|Protocol Violation|20|||
143348157|NCT03029247|516821552|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
143348158|NCT03029247|516821553|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
143348159|NCT03029247|516821552|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
143348160|NCT03029247|516821553|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
143348161|NCT03029247|516821552|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
143348162|NCT03029247|516821553|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
143348163|NCT03029247|516821552|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
143348164|NCT03029247|516821553|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
143348165|NCT00312858|516821556|FG000|Overall Study|Adverse Event|0|||
143348166|NCT00312858|516821557|FG001|Overall Study|Adverse Event|1|||
143348167|NCT00312858|516821556|FG000|Overall Study|Lost to Follow-up|25|||
143348168|NCT00312858|516821557|FG001|Overall Study|Lost to Follow-up|42|||
143348169|NCT00312858|516821556|FG000|Overall Study|Protocol Violation|3|||
143348170|NCT00312858|516821557|FG001|Overall Study|Protocol Violation|8|||
143348171|NCT00312858|516821556|FG000|Overall Study|Withdraw by Participant|20|||
143348172|NCT00312858|516821557|FG001|Overall Study|Withdraw by Participant|20|||
143348173|NCT00312858|516821556|FG000|Overall Study|Participant Moved|11|||
143348174|NCT00312858|516821557|FG001|Overall Study|Participant Moved|10|||
143348175|NCT00312858|516821556|FG000|Overall Study|Other|9|||
143348176|NCT00312858|516821557|FG001|Overall Study|Other|12|||
143348177|NCT03638635|516821558|FG000|Initial Hospitalization|Study terminated prematurely|0|||
143348178|NCT03638635|516821559|FG001|Initial Hospitalization|Study terminated prematurely|1|||
143348179|NCT03638635|516821558|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
143348180|NCT03638635|516821559|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
143348181|NCT03638635|516821558|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
143348182|NCT03638635|516821559|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
143348183|NCT00802659|516821562|FG000|Overall Study|Physician Decision|0|||
143348184|NCT00802659|516821563|FG001|Overall Study|Physician Decision|1|||
143348185|NCT00802659|516821564|FG002|Overall Study|Physician Decision|0|||
143348186|NCT00802659|516821565|FG003|Overall Study|Physician Decision|0|||
143348187|NCT00603265|516821566|FG000|Overall Study|Adverse Event|2|||
143348188|NCT00603265|516821567|FG001|Overall Study|Adverse Event|11|||
143348189|NCT00603265|516821568|FG002|Overall Study|Adverse Event|1|||
143348190|NCT00603265|516821566|FG000|Overall Study|Withdrawal by Subject|1|||
143348191|NCT00603265|516821567|FG001|Overall Study|Withdrawal by Subject|2|||
143348192|NCT00603265|516821568|FG002|Overall Study|Withdrawal by Subject|1|||
143348193|NCT00603265|516821566|FG000|Overall Study|Lack of Efficacy|3|||
143348194|NCT00603265|516821567|FG001|Overall Study|Lack of Efficacy|0|||
143348195|NCT00603265|516821568|FG002|Overall Study|Lack of Efficacy|3|||
143348196|NCT00603265|516821566|FG000|Overall Study|Lost to Follow-up|0|||
143348197|NCT00603265|516821567|FG001|Overall Study|Lost to Follow-up|1|||
143348198|NCT00603265|516821568|FG002|Overall Study|Lost to Follow-up|0|||
143348199|NCT00603265|516821566|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
143348200|NCT00603265|516821567|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
143348201|NCT00603265|516821568|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
143348202|NCT00603265|516821566|FG000|Overall Study|Participant Left Country, No Responses|0|||
143348203|NCT00603265|516821567|FG001|Overall Study|Participant Left Country, No Responses|1|||
143348204|NCT00603265|516821568|FG002|Overall Study|Participant Left Country, No Responses|0|||
143348205|NCT00603265|516821566|FG000|Overall Study|Protocol Violation|1|||
143348206|NCT00603265|516821567|FG001|Overall Study|Protocol Violation|0|||
143348207|NCT00603265|516821568|FG002|Overall Study|Protocol Violation|0|||
143348208|NCT05340751|516821569|FG000|Overall Study|Physician Decision|3|||
143348209|NCT00067990|516821570|FG000|Overall Study|Death|5|||
143348210|NCT00067990|516821571|FG001|Overall Study|Death|7|||
143348211|NCT00067990|516821570|FG000|Overall Study|ESRD, Non IF/TA|1|||
143348212|NCT00067990|516821571|FG001|Overall Study|ESRD, Non IF/TA|3|||
143348213|NCT00067990|516821570|FG000|Overall Study|Withdrawal by Subject|4|||
143348214|NCT00067990|516821571|FG001|Overall Study|Withdrawal by Subject|12|||
143348215|NCT03377790|516821572|FG000|Overall Study|Withdrawal by Subject|1|||
143348216|NCT03377790|516821573|FG001|Overall Study|Withdrawal by Subject|0|||
143348217|NCT03377790|516821572|FG000|Overall Study|Adverse Event|1|||
143348218|NCT03377790|516821573|FG001|Overall Study|Adverse Event|0|||
143348219|NCT03377790|516821572|FG000|Overall Study|Lost to Follow-up|0|||
143348220|NCT03377790|516821573|FG001|Overall Study|Lost to Follow-up|2|||
143348221|NCT03377790|516821572|FG000|Overall Study|Randomized but not treated|1|||
143348222|NCT03377790|516821573|FG001|Overall Study|Randomized but not treated|0|||
143348223|NCT03377790|516821572|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
143348224|NCT03377790|516821573|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
143348225|NCT03810313|516821581|FG000|Overall Study|Study terminated by sponsor|164|||
143348226|NCT03810313|516821582|FG001|Overall Study|Study terminated by sponsor|159|||
143348227|NCT03810313|516821581|FG000|Overall Study|Subject decision|10|||
143348228|NCT03810313|516821582|FG001|Overall Study|Subject decision|11|||
143348229|NCT03810313|516821581|FG000|Overall Study|Lost to Follow-up|3|||
143348230|NCT03810313|516821582|FG001|Overall Study|Lost to Follow-up|3|||
143348231|NCT03810313|516821581|FG000|Overall Study|Adverse Event|2|||
143348232|NCT03810313|516821582|FG001|Overall Study|Adverse Event|1|||
143348233|NCT03810313|516821581|FG000|Overall Study|Death|2|||
143348234|NCT03810313|516821582|FG001|Overall Study|Death|1|||
143348235|NCT03810313|516821581|FG000|Overall Study|Physician Decision|0|||
143348236|NCT03810313|516821582|FG001|Overall Study|Physician Decision|1|||
143348237|NCT01111838|516821583|FG000|Overall Study|Patient Ineligible|2|||
143348238|NCT01111838|516821583|FG000|Overall Study|Not Treated|3|||
143348239|NCT01111838|516821583|FG000|Overall Study|Clinical deterioration|1|||
143348240|NCT01111838|516821583|FG000|Overall Study|Other Complicating Disease|1|||
143348241|NCT01827254|516821586|FG000|Overall Study|Death|10|||
143348242|NCT01827254|516821586|FG000|Overall Study|Case report form not completed|4|||
143348243|NCT01827254|516821586|FG000|Overall Study|Invalidated centre|3|||
143348244|NCT01827254|516821586|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
143348245|NCT01827254|516821586|FG000|Overall Study|Did not complete re-challenge|1|||
143348246|NCT01827254|516821586|FG000|Overall Study|Disease progression|36|||
143348247|NCT01827254|516821586|FG000|Overall Study|Intolerance to treatment|4|||
143348248|NCT02357810|516821587|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
143348249|NCT02357810|516821587|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
143348250|NCT02357810|516821587|FG000|Reached 12 Weeks Response|Adverse Event|5|||
143348251|NCT02357810|516821587|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
143348252|NCT02357810|516821587|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
143348253|NCT02357810|516821587|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
143348254|NCT02357810|516821587|FG000|Reached 12 Weeks Response|Death|1|||
143348255|NCT02357810|516821587|FG000|Reached 12 Weeks Response|Physician Decision|1|||
143348256|NCT02357810|516821587|FG000|Reached 12 Weeks Response|Other|1|||
143348257|NCT02357810|516821587|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
143348258|NCT02357810|516821587|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
143348259|NCT02357810|516821587|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
143348260|NCT02357810|516821587|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
143348261|NCT02357810|516821587|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
143348262|NCT02357810|516821587|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
143348263|NCT00936221|516821589|FG000|Overall Study|Withdrawal by Subject|1|||
143348264|NCT00936221|516821590|FG001|Overall Study|Withdrawal by Subject|1|||
143348265|NCT03820323|516821591|FG000|Overall Study|Lost to Follow-up|2|||
143348266|NCT03820323|516821592|FG001|Overall Study|Lost to Follow-up|1|||
143348267|NCT03820323|516821591|FG000|Overall Study|Missed 12-month visit|22|||
143348268|NCT03820323|516821592|FG001|Overall Study|Missed 12-month visit|14|||
143348269|NCT03820323|516821591|FG000|Overall Study|Death|2|||
143348270|NCT03820323|516821592|FG001|Overall Study|Death|1|||
143348271|NCT03820323|516821591|FG000|Overall Study|Transferred out|13|||
143348272|NCT03820323|516821592|FG001|Overall Study|Transferred out|11|||
143348273|NCT03820323|516821591|FG000|Overall Study|Terminated|0|||
143011647|NCT00440193|515579711|FG000|Treatment Period|Study terminated by sponsor|102|||
143011648|NCT00440193|515579712|FG001|Treatment Period|Study terminated by sponsor|94|||
143011649|NCT00440193|515579711|FG000|Treatment Period|Protocol driven decision point|2|||
143011650|NCT00440193|515579712|FG001|Treatment Period|Protocol driven decision point|2|||
143011651|NCT00440193|515579711|FG000|Treatment Period|Switch to commercial drug|0|||
143011652|NCT00440193|515579712|FG001|Treatment Period|Switch to commercial drug|2|||
143011653|NCT00440193|515579711|FG000|Treatment Period|Technical problems|1|||
143011654|NCT00440193|515579712|FG001|Treatment Period|Technical problems|1|||
143348274|NCT03820323|516821592|FG001|Overall Study|Terminated|3|||
143348275|NCT03820323|516821591|FG000|Overall Study|Withdrawal by Subject|1|||
143348276|NCT03820323|516821592|FG001|Overall Study|Withdrawal by Subject|6|||
143348277|NCT03151395|516821593|FG000|Overall Study|Adverse Event|2|||
143348278|NCT03151395|516821593|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
143348279|NCT03151395|516821593|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
143011655|NCT00440193|515579711|FG000|Treatment Period|Participant convenience|5|||
143348280|NCT03151395|516821593|FG000|Overall Study|Unspecified reason|4|||
143348281|NCT01107743|516821596|FG000|Overall Study|Protocol Violation|46|||
143348282|NCT00308737|516821597|FG000|Overall Study|Adverse Event|104|||
143348283|NCT00308737|516821598|FG001|Overall Study|Adverse Event|9|||
143348284|NCT00308737|516821599|FG002|Overall Study|Adverse Event|0|||
143348285|NCT00308737|516821597|FG000|Overall Study|Death|4|||
143348286|NCT00308737|516821598|FG001|Overall Study|Death|3|||
143348287|NCT00308737|516821599|FG002|Overall Study|Death|0|||
143348288|NCT00308737|516821597|FG000|Overall Study|Lost to Follow-up|56|||
143348289|NCT00308737|516821598|FG001|Overall Study|Lost to Follow-up|80|||
143348290|NCT00308737|516821599|FG002|Overall Study|Lost to Follow-up|5|||
143348291|NCT00308737|516821597|FG000|Overall Study|Physician Decision|15|||
143348292|NCT00308737|516821598|FG001|Overall Study|Physician Decision|2|||
143348293|NCT00308737|516821599|FG002|Overall Study|Physician Decision|1|||
143348294|NCT00308737|516821597|FG000|Overall Study|Protocol Violation|34|||
143348295|NCT00308737|516821598|FG001|Overall Study|Protocol Violation|9|||
143348296|NCT00308737|516821599|FG002|Overall Study|Protocol Violation|5|||
143348297|NCT00308737|516821597|FG000|Overall Study|Withdrawal by Subject|218|||
143348298|NCT00308737|516821598|FG001|Overall Study|Withdrawal by Subject|166|||
143348299|NCT00308737|516821599|FG002|Overall Study|Withdrawal by Subject|18|||
143348300|NCT00308737|516821597|FG000|Overall Study|Various|32|||
143348301|NCT00308737|516821598|FG001|Overall Study|Various|20|||
143348302|NCT00308737|516821599|FG002|Overall Study|Various|8|||
143348303|NCT00089895|516821602|FG000|Overall Study|Consent Withdrawn|11|||
143348304|NCT00089895|516821603|FG001|Overall Study|Consent Withdrawn|14|||
143348305|NCT00089895|516821602|FG000|Overall Study|Technical reason|7|||
143348306|NCT00089895|516821603|FG001|Overall Study|Technical reason|2|||
143348307|NCT00089895|516821602|FG000|Overall Study|Surgery|0|||
143348308|NCT00089895|516821603|FG001|Overall Study|Surgery|1|||
143348309|NCT00089895|516821602|FG000|Overall Study|Bleeding|0|||
143348310|NCT00089895|516821603|FG001|Overall Study|Bleeding|2|||
143348311|NCT00089895|516821602|FG000|Overall Study|Physician Decision|3|||
143348312|NCT00089895|516821603|FG001|Overall Study|Physician Decision|7|||
143348313|NCT00089895|516821602|FG000|Overall Study|Exclusion criteria met|6|||
143348314|NCT00089895|516821603|FG001|Overall Study|Exclusion criteria met|6|||
143348315|NCT00089895|516821602|FG000|Overall Study|Not otherwise specified|4|||
143348316|NCT00089895|516821603|FG001|Overall Study|Not otherwise specified|8|||
143348317|NCT00089895|516821602|FG000|Overall Study|Missing|4|||
143348318|NCT00089895|516821603|FG001|Overall Study|Missing|2|||
143348319|NCT02494206|516821617|FG000|Overall Study|Adverse Event|1|||
143348320|NCT02494206|516821617|FG000|Overall Study|Disease Progression|1|||
143348321|NCT04986982|516821618|FG000|Overall Study|Withdrawal by Subject|3|||
143348322|NCT04986982|516821619|FG001|Overall Study|Withdrawal by Subject|1|||
143348323|NCT04986982|516821618|FG000|Overall Study|Lack of Efficacy|0|||
143348324|NCT04986982|516821619|FG001|Overall Study|Lack of Efficacy|2|||
143348325|NCT04986982|516821618|FG000|Overall Study|Ineligibility|3|||
143348326|NCT04986982|516821619|FG001|Overall Study|Ineligibility|0|||
143348327|NCT04986982|516821618|FG000|Overall Study|Adverse Event|4|||
143348328|NCT04986982|516821619|FG001|Overall Study|Adverse Event|4|||
143348329|NCT04986982|516821618|FG000|Overall Study|Lost to Follow-up|0|||
143348330|NCT04986982|516821619|FG001|Overall Study|Lost to Follow-up|1|||
143348331|NCT04986982|516821618|FG000|Overall Study|Sponsor's discretion|1|||
143348332|NCT04986982|516821619|FG001|Overall Study|Sponsor's discretion|0|||
143348333|NCT01535274|516821620|FG000|Overall Study|Determined to be ineligible|0|||
143348334|NCT01535274|516821621|FG001|Overall Study|Determined to be ineligible|1|||
143348335|NCT01535274|516821620|FG000|Overall Study|Misallocated to propofol intervention|0|||
143348336|NCT01535274|516821621|FG001|Overall Study|Misallocated to propofol intervention|1|||
143348337|NCT03679767|516821622|FG000|Overall Study|Death|16|||
143348338|NCT03679767|516821623|FG001|Overall Study|Death|11|||
143348339|NCT03679767|516821624|FG002|Overall Study|Death|17|||
143348340|NCT03679767|516821625|FG003|Overall Study|Death|10|||
143348341|NCT03679767|516821622|FG000|Overall Study|Lost to Follow-up|1|||
143348342|NCT03679767|516821623|FG001|Overall Study|Lost to Follow-up|1|||
143348343|NCT03679767|516821624|FG002|Overall Study|Lost to Follow-up|1|||
143348344|NCT03679767|516821625|FG003|Overall Study|Lost to Follow-up|1|||
143348345|NCT03679767|516821622|FG000|Overall Study|Withdrawal by Subject|0|||
143348346|NCT03679767|516821623|FG001|Overall Study|Withdrawal by Subject|0|||
143348347|NCT03679767|516821624|FG002|Overall Study|Withdrawal by Subject|0|||
143348348|NCT03679767|516821625|FG003|Overall Study|Withdrawal by Subject|1|||
143348349|NCT03679767|516821622|FG000|Overall Study|Follow-up Completed|18|||
143348350|NCT03679767|516821623|FG001|Overall Study|Follow-up Completed|11|||
143348351|NCT03679767|516821624|FG002|Overall Study|Follow-up Completed|11|||
143348352|NCT03679767|516821625|FG003|Overall Study|Follow-up Completed|20|||
143348353|NCT03679767|516821622|FG000|Overall Study|Entered Hospice Care|0|||
143348354|NCT03679767|516821623|FG001|Overall Study|Entered Hospice Care|0|||
143348355|NCT03679767|516821624|FG002|Overall Study|Entered Hospice Care|0|||
143348356|NCT03679767|516821625|FG003|Overall Study|Entered Hospice Care|1|||
143348357|NCT03679767|516821622|FG000|Overall Study|Progressive Disease|0|||
143348358|NCT03679767|516821623|FG001|Overall Study|Progressive Disease|0|||
143348359|NCT03679767|516821624|FG002|Overall Study|Progressive Disease|0|||
143348360|NCT03679767|516821625|FG003|Overall Study|Progressive Disease|1|||
143348361|NCT05408468|516821626|FG000|Overall Study|Lost to Follow-up|3|||
143348362|NCT05408468|516821627|FG001|Overall Study|Lost to Follow-up|1|||
143348363|NCT05408468|516821626|FG000|Overall Study|Physician Decision|1|||
143348364|NCT05408468|516821627|FG001|Overall Study|Physician Decision|0|||
143348365|NCT05408468|516821626|FG000|Overall Study|Overwhelmed by clinical situation|3|||
143348366|NCT05408468|516821627|FG001|Overall Study|Overwhelmed by clinical situation|0|||
143348367|NCT05408468|516821626|FG000|Overall Study|Personal illness precluding participation|1|||
143348368|NCT05408468|516821627|FG001|Overall Study|Personal illness precluding participation|0|||
143348369|NCT05408468|516821626|FG000|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
143348370|NCT05408468|516821627|FG001|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
143348371|NCT04186403|516821628|FG000|Overall Study|Adverse Event|1|||
143348372|NCT04186403|516821629|FG001|Overall Study|Adverse Event|8|||
143348373|NCT04186403|516821628|FG000|Overall Study|Lost to Follow-up|7|||
143348374|NCT04186403|516821629|FG001|Overall Study|Lost to Follow-up|3|||
143348375|NCT04186403|516821628|FG000|Overall Study|Physician Decision|1|||
143348376|NCT04186403|516821629|FG001|Overall Study|Physician Decision|0|||
143348377|NCT04186403|516821628|FG000|Overall Study|Withdrawal by Subject|7|||
143348378|NCT04186403|516821629|FG001|Overall Study|Withdrawal by Subject|8|||
143348379|NCT04186403|516821628|FG000|Overall Study|Other: Not Related to Covid-19|3|||
143348380|NCT04186403|516821629|FG001|Overall Study|Other: Not Related to Covid-19|0|||
143348381|NCT01407354|516821633|FG000|First Intervention|Withdrawal by Subject|0|||
143348382|NCT01407354|516821634|FG001|First Intervention|Withdrawal by Subject|2|||
143348383|NCT01407354|516821633|FG000|First Intervention|Adverse Event|1|||
143348384|NCT01407354|516821634|FG001|First Intervention|Adverse Event|0|||
143348385|NCT01407354|516821633|FG000|First Intervention|Physician Decision|1|||
143348386|NCT01407354|516821634|FG001|First Intervention|Physician Decision|0|||
143348387|NCT02204579|516821636|FG000|Overall Study|Screen failures|2|||
143348388|NCT02778399|516821637|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
143348389|NCT02778399|516821638|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
143348390|NCT02778399|516821639|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
143348391|NCT02778399|516821640|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
143348392|NCT02778399|516821641|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
143348393|NCT02778399|516821642|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
143348394|NCT02778399|516821637|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
143348395|NCT02778399|516821638|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
143348396|NCT02778399|516821639|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
143348397|NCT02778399|516821640|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
143348398|NCT02778399|516821641|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
143348399|NCT02778399|516821642|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
143348400|NCT02778399|516821637|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
143348401|NCT02778399|516821638|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
143348402|NCT02778399|516821639|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
143348403|NCT02778399|516821640|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
143348404|NCT02778399|516821641|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
143348405|NCT02778399|516821642|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
143348406|NCT02778399|516821637|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
143348407|NCT02778399|516821638|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
143348408|NCT02778399|516821639|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
143348409|NCT02778399|516821640|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
143348410|NCT02778399|516821641|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
143348411|NCT02778399|516821642|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
143348412|NCT02778399|516821637|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
143348413|NCT02778399|516821638|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
143348414|NCT02778399|516821639|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
143348415|NCT02778399|516821640|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
143348416|NCT02778399|516821641|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
143348417|NCT02778399|516821642|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
143348418|NCT02778399|516821637|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
143348419|NCT02778399|516821638|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
143348420|NCT02778399|516821639|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
143348421|NCT02778399|516821640|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
143348422|NCT02778399|516821641|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
143348423|NCT02778399|516821642|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
143348424|NCT02778399|516821637|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
143348425|NCT02778399|516821638|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
143348426|NCT02778399|516821639|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
143348427|NCT02778399|516821640|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
143011656|NCT00440193|515579712|FG001|Treatment Period|Participant convenience|2|||
143011657|NCT00440193|515579711|FG000|Treatment Period|Participant did not receive treatment|7|||
143348428|NCT02778399|516821641|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
143348429|NCT02778399|516821642|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
143348430|NCT02778399|516821637|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
143348431|NCT02778399|516821638|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
143348432|NCT02778399|516821639|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
143348433|NCT02778399|516821640|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
143348434|NCT02778399|516821641|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
143348435|NCT02778399|516821642|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
143348436|NCT02778399|516821637|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
143348437|NCT02778399|516821638|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
143348438|NCT02778399|516821639|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
143348439|NCT02778399|516821640|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
143348440|NCT02778399|516821641|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
143348441|NCT02778399|516821642|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
143348442|NCT02778399|516821637|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
143348443|NCT02778399|516821638|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
143348444|NCT02778399|516821639|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
143348445|NCT02778399|516821640|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
143348446|NCT02778399|516821641|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
143348447|NCT02778399|516821642|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
143348448|NCT02778399|516821637|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
143348449|NCT02778399|516821638|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
143348450|NCT02778399|516821639|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
143348451|NCT02778399|516821640|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
143348452|NCT02778399|516821641|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
143348453|NCT02778399|516821642|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
143348454|NCT03556358|516821647|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
143348455|NCT03556358|516821648|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
143348456|NCT03556358|516821647|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
143348457|NCT03556358|516821648|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
143348458|NCT03556358|516821647|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
143348459|NCT03556358|516821648|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
143348460|NCT03556358|516821647|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
143348461|NCT03556358|516821648|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
143348462|NCT03556358|516821647|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
143348463|NCT03556358|516821648|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
143348464|NCT03556358|516821647|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
143348465|NCT03556358|516821648|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
143348466|NCT03556358|516821647|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
143348467|NCT03556358|516821648|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
143348468|NCT01351025|516821652|FG000|Week 0 - 20|Lost to Follow-up|2|||
143348469|NCT01351025|516821653|FG001|Week 0 - 20|Lost to Follow-up|1|||
143348470|NCT01351025|516821652|FG000|Week 0 - 20|Withdrawal by Subject|1|||
143348471|NCT01351025|516821653|FG001|Week 0 - 20|Withdrawal by Subject|0|||
143348472|NCT01351025|516821652|FG000|Week 24 - 44|Lost to Follow-up|0|||
143348473|NCT01351025|516821653|FG001|Week 24 - 44|Lost to Follow-up|2|||
143348474|NCT01351025|516821652|FG000|Week 24 - 44|Site closed|0|||
143348475|NCT01351025|516821653|FG001|Week 24 - 44|Site closed|1|||
143348476|NCT01351025|516821652|FG000|Week 24 - 44|unable to get to clinic|1|||
143348477|NCT01351025|516821653|FG001|Week 24 - 44|unable to get to clinic|1|||
143348478|NCT05067933|516821657|FG000|Overall Study|Withdrawal by Subject|2|||
143348479|NCT05067933|516821658|FG001|Overall Study|Withdrawal by Subject|0|||
143348480|NCT05067933|516821659|FG002|Overall Study|Withdrawal by Subject|0|||
143348481|NCT05067933|516821660|FG003|Overall Study|Withdrawal by Subject|0|||
143348482|NCT05067933|516821661|FG004|Overall Study|Withdrawal by Subject|0|||
143348483|NCT05067933|516821662|FG005|Overall Study|Withdrawal by Subject|0|||
143348484|NCT05067933|516821657|FG000|Overall Study|Lost to Follow-up|1|||
143348485|NCT05067933|516821658|FG001|Overall Study|Lost to Follow-up|1|||
143348486|NCT05067933|516821659|FG002|Overall Study|Lost to Follow-up|1|||
143348487|NCT05067933|516821660|FG003|Overall Study|Lost to Follow-up|2|||
143348488|NCT05067933|516821661|FG004|Overall Study|Lost to Follow-up|1|||
143348489|NCT05067933|516821662|FG005|Overall Study|Lost to Follow-up|0|||
143348490|NCT05067933|516821657|FG000|Overall Study|Miscellaneous|1|||
143348491|NCT05067933|516821658|FG001|Overall Study|Miscellaneous|0|||
143348492|NCT05067933|516821659|FG002|Overall Study|Miscellaneous|0|||
143348493|NCT05067933|516821660|FG003|Overall Study|Miscellaneous|0|||
143348494|NCT05067933|516821661|FG004|Overall Study|Miscellaneous|0|||
143348495|NCT05067933|516821662|FG005|Overall Study|Miscellaneous|0|||
143348496|NCT05067933|516821657|FG000|Overall Study|Death|0|||
143348497|NCT05067933|516821658|FG001|Overall Study|Death|0|||
143348498|NCT05067933|516821659|FG002|Overall Study|Death|0|||
143348499|NCT05067933|516821660|FG003|Overall Study|Death|1|||
143348500|NCT05067933|516821661|FG004|Overall Study|Death|0|||
143348501|NCT05067933|516821662|FG005|Overall Study|Death|0|||
143348502|NCT01065350|516821663|FG000|Overall Study|Received incorrect drug allocation|0|||
143348503|NCT01065350|516821664|FG001|Overall Study|Received incorrect drug allocation|1|||
143348504|NCT02875834|516821667|FG000|Open-label Phase|Withdrawal by Subject|3|||
143348505|NCT02875834|516821668|FG001|Open-label Phase|Withdrawal by Subject|0|||
143348506|NCT02875834|516821669|FG002|Open-label Phase|Withdrawal by Subject|0|||
143348507|NCT02875834|516821670|FG003|Open-label Phase|Withdrawal by Subject|0|||
143348508|NCT02875834|516821667|FG000|Open-label Phase|(Not collected)|4|||
143348509|NCT02875834|516821668|FG001|Open-label Phase|(Not collected)|0|||
143348510|NCT02875834|516821669|FG002|Open-label Phase|(Not collected)|0|||
143348511|NCT02875834|516821670|FG003|Open-label Phase|(Not collected)|0|||
143348512|NCT02875834|516821667|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
143348513|NCT02875834|516821668|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
143348514|NCT02875834|516821669|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
143011658|NCT00440193|515579712|FG001|Treatment Period|Participant did not receive treatment|13|||
143011659|NCT00440193|515579711|FG000|Treatment Period|Site closed by investigator|0|||
143011660|NCT00440193|515579712|FG001|Treatment Period|Site closed by investigator|2|||
143348515|NCT02875834|516821670|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
143348516|NCT02875834|516821667|FG000|Randomized Treatment Phase|Protocol Violation|0|||
143348517|NCT02875834|516821668|FG001|Randomized Treatment Phase|Protocol Violation|2|||
143348518|NCT02875834|516821669|FG002|Randomized Treatment Phase|Protocol Violation|0|||
143348519|NCT02875834|516821670|FG003|Randomized Treatment Phase|Protocol Violation|0|||
143348520|NCT02875834|516821667|FG000|Randomized Treatment Phase|(Not collected)|0|||
143348521|NCT02875834|516821668|FG001|Randomized Treatment Phase|(Not collected)|9|||
143348522|NCT02875834|516821669|FG002|Randomized Treatment Phase|(Not collected)|10|||
143348523|NCT02875834|516821670|FG003|Randomized Treatment Phase|(Not collected)|9|||
143348524|NCT02294474|516821671|FG000|Overall Study|Adverse Event|7|||
143348525|NCT02294474|516821672|FG001|Overall Study|Adverse Event|7|||
143348526|NCT02294474|516821671|FG000|Overall Study|Lack of Efficacy|2|||
143348527|NCT02294474|516821672|FG001|Overall Study|Lack of Efficacy|1|||
143348528|NCT02294474|516821671|FG000|Overall Study|Protocol Violation|4|||
143348529|NCT02294474|516821672|FG001|Overall Study|Protocol Violation|2|||
143348530|NCT02294474|516821671|FG000|Overall Study|Other than specified above|12|||
143348531|NCT02294474|516821672|FG001|Overall Study|Other than specified above|12|||
143348532|NCT00539279|516821674|FG000|Treatment|Withdrawal by Subject|10|||
143348533|NCT00539279|516821675|FG001|Treatment|Withdrawal by Subject|8|||
143348534|NCT00539279|516821674|FG000|Treatment|Death|1|||
143348535|NCT00539279|516821675|FG001|Treatment|Death|0|||
143348536|NCT00539279|516821674|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
143348537|NCT00539279|516821675|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
143348538|NCT00539279|516821674|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
143348539|NCT00539279|516821675|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
143348540|NCT03813147|516821676|FG000|Overall Study|Lack of Efficacy|4|||
143348541|NCT03813147|516821677|FG001|Overall Study|Lack of Efficacy|4|||
143348542|NCT03813147|516821676|FG000|Overall Study|Physician Decision|2|||
143348543|NCT03813147|516821677|FG001|Overall Study|Physician Decision|1|||
143348544|NCT01693692|516821678|FG000|Overall Study|Withdrawal by Subject|12|||
143348545|NCT01693692|516821679|FG001|Overall Study|Withdrawal by Subject|10|||
143348546|NCT01693692|516821680|FG002|Overall Study|Withdrawal by Subject|11|||
143348547|NCT01693692|516821678|FG000|Overall Study|Adverse Event|7|||
143348548|NCT01693692|516821679|FG001|Overall Study|Adverse Event|14|||
143348549|NCT01693692|516821680|FG002|Overall Study|Adverse Event|9|||
143011661|NCT00440193|515579711|FG000|Observational Period|Adverse Event|2|||
143011662|NCT00440193|515579712|FG001|Observational Period|Adverse Event|2|||
143011663|NCT00440193|515579711|FG000|Observational Period|Death|15|||
143011664|NCT00440193|515579712|FG001|Observational Period|Death|20|||
143011665|NCT00440193|515579711|FG000|Observational Period|Lost to Follow-up|12|||
143011666|NCT00440193|515579712|FG001|Observational Period|Lost to Follow-up|8|||
143011667|NCT00440193|515579711|FG000|Observational Period|Protocol Violation|1|||
143011668|NCT00440193|515579712|FG001|Observational Period|Protocol Violation|0|||
143348550|NCT01693692|516821678|FG000|Overall Study|Physician Decision|0|||
143348551|NCT01693692|516821679|FG001|Overall Study|Physician Decision|0|||
143348552|NCT01693692|516821680|FG002|Overall Study|Physician Decision|1|||
143348553|NCT01693692|516821678|FG000|Overall Study|Protocol Violation|5|||
143348554|NCT01693692|516821679|FG001|Overall Study|Protocol Violation|4|||
143348555|NCT01693692|516821680|FG002|Overall Study|Protocol Violation|6|||
143348556|NCT01693692|516821678|FG000|Overall Study|Lost to Follow-up|2|||
143348557|NCT01693692|516821679|FG001|Overall Study|Lost to Follow-up|2|||
143348558|NCT01693692|516821680|FG002|Overall Study|Lost to Follow-up|3|||
143348559|NCT01693692|516821678|FG000|Overall Study|Other|4|||
143348560|NCT01693692|516821679|FG001|Overall Study|Other|4|||
143011669|NCT00440193|515579711|FG000|Observational Period|Withdrawal by Subject|11|||
143011670|NCT00440193|515579712|FG001|Observational Period|Withdrawal by Subject|8|||
143348561|NCT01693692|516821680|FG002|Overall Study|Other|6|||
143348562|NCT00437125|516823932|FG000|Overall Study|Adverse Event|12|||
143348563|NCT00437125|516823932|FG000|Overall Study|Death|1|||
143348564|NCT00437125|516823932|FG000|Overall Study|Clinical Relapse|1|||
143348565|NCT00437125|516823932|FG000|Overall Study|Lack of Efficacy|1|||
143348566|NCT00437125|516823932|FG000|Overall Study|Lost to Follow-up|1|||
143348567|NCT00437125|516823932|FG000|Overall Study|Withdrawal by Subject|13|||
143348568|NCT00437125|516823932|FG000|Overall Study|Withdrawal by Caregiver|2|||
143348569|NCT00437125|516823932|FG000|Overall Study|Physician Decision|1|||
143348570|NCT02248961|516823933|FG000|Overall Study|Adverse Event|1|||
143348571|NCT02248961|516823934|FG001|Overall Study|Adverse Event|0|||
143348572|NCT02248961|516823933|FG000|Overall Study|Withdrawal by Subject|1|||
143348573|NCT02248961|516823934|FG001|Overall Study|Withdrawal by Subject|2|||
143348574|NCT02248961|516823933|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
143348575|NCT02248961|516823934|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
143348576|NCT02531295|516823935|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
143348577|NCT02531295|516823936|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
143348578|NCT02531295|516823937|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
143348579|NCT02531295|516823938|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
143348580|NCT02531295|516823939|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
143348581|NCT02531295|516823940|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
143348582|NCT01806740|516823943|FG000|Overall Study|Withdrawal by Subject|4|||
143348583|NCT01806740|516823943|FG000|Overall Study|Physician Decision|1|||
143348584|NCT01806740|516823943|FG000|Overall Study|Patient's refusal of treatment|1|||
143348585|NCT00244374|516823946|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
143348586|NCT00244374|516823947|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
143348587|NCT00244374|516823948|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
143348588|NCT00244374|516823949|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
143348589|NCT00244374|516823950|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
143348590|NCT00244374|516823946|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
143348591|NCT00244374|516823947|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
143348592|NCT00244374|516823948|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
143348593|NCT00244374|516823949|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
143348594|NCT00244374|516823950|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
143348595|NCT00244374|516823946|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
143348596|NCT00244374|516823947|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
143348597|NCT00244374|516823948|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
143011671|NCT00440193|515579711|FG000|Observational Period|Physician Decision|1|||
143011672|NCT00440193|515579712|FG001|Observational Period|Physician Decision|0|||
143011673|NCT00440193|515579711|FG000|Observational Period|Clinical endpoint reached|1|||
143011674|NCT00440193|515579712|FG001|Observational Period|Clinical endpoint reached|0|||
143011675|NCT00440193|515579711|FG000|Observational Period|Participant convenience|2|||
143011676|NCT00440193|515579712|FG001|Observational Period|Participant convenience|0|||
143011677|NCT00834366|515579713|FG000|Treatment Period 1|Adverse Event|1|||
143124838|NCT03762681|516001313|FG003|Part 2a|Pandemic Travel Restrictions|0|||
143124839|NCT03762681|516001314|FG004|Part 2a|Pandemic Travel Restrictions|0|||
143124840|NCT03762681|516001315|FG005|Part 2a|Pandemic Travel Restrictions|0|||
143124841|NCT03762681|516001316|FG006|Part 2a|Pandemic Travel Restrictions|0|||
143124842|NCT03762681|516001317|FG007|Part 2a|Pandemic Travel Restrictions|1|||
143124843|NCT00524680|516001319|FG000|Overall Study|progression|0|||
143124844|NCT00524680|516001320|FG001|Overall Study|progression|0|||
143124845|NCT00524680|516001321|FG002|Overall Study|progression|0|||
143124846|NCT00524680|516001322|FG003|Overall Study|progression|1|||
143124847|NCT00524680|516001319|FG000|Overall Study|Adverse Event|2|||
143124848|NCT00524680|516001320|FG001|Overall Study|Adverse Event|0|||
143124849|NCT00524680|516001321|FG002|Overall Study|Adverse Event|0|||
143124850|NCT00524680|516001322|FG003|Overall Study|Adverse Event|1|||
143124851|NCT00524680|516001319|FG000|Overall Study|Other|0|||
143124852|NCT00524680|516001320|FG001|Overall Study|Other|1|||
143348598|NCT00244374|516823949|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
143011678|NCT00834366|515579714|FG001|Treatment Period 1|Adverse Event|1|||
143348599|NCT00244374|516823950|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
143348600|NCT00244374|516823946|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
143348601|NCT00244374|516823947|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
143348602|NCT00244374|516823948|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
143348603|NCT00244374|516823949|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
143011679|NCT04066894|515579717|FG000|Overall Study|Lack of Efficacy|1|||
143124853|NCT00524680|516001321|FG002|Overall Study|Other|2|||
143124854|NCT00524680|516001322|FG003|Overall Study|Other|3|||
143348604|NCT00244374|516823950|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
143348605|NCT00244374|516823946|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
143348606|NCT00244374|516823947|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
143348607|NCT00244374|516823948|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
143348608|NCT00244374|516823949|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
143348609|NCT00244374|516823950|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
143348610|NCT00244374|516823946|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
143348611|NCT00244374|516823947|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
143348612|NCT00244374|516823948|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
143348613|NCT00244374|516823949|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
143348614|NCT00244374|516823950|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
143348615|NCT00244374|516823946|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
143348616|NCT00244374|516823947|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
143348617|NCT00244374|516823948|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
143348618|NCT00244374|516823949|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
143348619|NCT00244374|516823950|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
143348620|NCT00244374|516823946|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
143348621|NCT00244374|516823947|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
143348622|NCT00244374|516823948|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
143348623|NCT00244374|516823949|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
143348624|NCT00244374|516823950|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
143348625|NCT00244374|516823946|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
143348626|NCT00244374|516823947|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
143348627|NCT00244374|516823948|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
143348628|NCT00244374|516823949|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
143348629|NCT00244374|516823950|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
143348630|NCT02105636|516823954|FG000|Pre-Treatment|Disease Progression|1|||
143348631|NCT02105636|516823955|FG001|Pre-Treatment|Disease Progression|0|||
143348632|NCT02105636|516823954|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
143348633|NCT02105636|516823955|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
143348634|NCT02105636|516823954|FG000|Pre-Treatment|Participant withdrew consent|0|||
143348635|NCT02105636|516823955|FG001|Pre-Treatment|Participant withdrew consent|6|||
143348636|NCT02105636|516823954|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
143348637|NCT02105636|516823955|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
143348638|NCT02105636|516823954|FG000|Treatment|Study Drug Toxicity|14|||
143348639|NCT02105636|516823955|FG001|Treatment|Study Drug Toxicity|10|||
143348640|NCT02105636|516823954|FG000|Treatment|Adverse event unrelated to study drug|19|||
143348641|NCT02105636|516823955|FG001|Treatment|Adverse event unrelated to study drug|3|||
143348642|NCT02105636|516823954|FG000|Treatment|Participant request to discontinue study treatment|8|||
143348643|NCT02105636|516823955|FG001|Treatment|Participant request to discontinue study treatment|6|||
143348644|NCT02105636|516823954|FG000|Treatment|Participant withdrew consent|5|||
143348645|NCT02105636|516823955|FG001|Treatment|Participant withdrew consent|1|||
143348646|NCT02105636|516823954|FG000|Treatment|Lost to Follow-up|1|||
143348647|NCT02105636|516823955|FG001|Treatment|Lost to Follow-up|0|||
143348648|NCT02105636|516823954|FG000|Treatment|Maximum Clinical Benefit|1|||
143348649|NCT02105636|516823955|FG001|Treatment|Maximum Clinical Benefit|3|||
143348650|NCT02105636|516823954|FG000|Treatment|Poor/Non-compliance|0|||
143348651|NCT02105636|516823955|FG001|Treatment|Poor/Non-compliance|1|||
143348652|NCT02105636|516823954|FG000|Treatment|Participant no longer meets study criteria|1|||
143348653|NCT02105636|516823955|FG001|Treatment|Participant no longer meets study criteria|0|||
143348654|NCT02105636|516823954|FG000|Treatment|Other reasons|1|||
143348655|NCT02105636|516823955|FG001|Treatment|Other reasons|0|||
143348656|NCT02105636|516823954|FG000|Treatment|Disease Progression|185|||
143348657|NCT02105636|516823955|FG001|Treatment|Disease Progression|87|||
143348658|NCT02802319|516823957|FG000|Overall Study|Physician Decision|2|||
143348659|NCT02802319|516823958|FG001|Overall Study|Physician Decision|1|||
143348660|NCT02802319|516823957|FG000|Overall Study|Lost to Follow-up|0|||
143348661|NCT02802319|516823958|FG001|Overall Study|Lost to Follow-up|4|||
143348662|NCT04651114|516823959|FG000|Overall Study|Withdrawal by Subject|8|||
143348663|NCT01923896|516823964|FG000|Overall Study|Adverse Event|1|||
143348664|NCT01923896|516823965|FG001|Overall Study|Adverse Event|0|||
143348665|NCT03545113|516823968|FG000|Overall Study|Surgery Cancelled|1|||
143348666|NCT03545113|516823969|FG001|Overall Study|Surgery Cancelled|0|||
143348667|NCT03545113|516823968|FG000|Overall Study|Death|1|||
143011680|NCT04066894|515579717|FG000|Overall Study|Screen Failure|1|||
143011681|NCT02949219|515579718|FG000|Overall Study|Withdrawal by Subject|1|||
143348668|NCT03545113|516823969|FG001|Overall Study|Death|0|||
143348669|NCT03545113|516823968|FG000|Overall Study|Adverse Event|2|||
143348670|NCT03545113|516823969|FG001|Overall Study|Adverse Event|0|||
143348671|NCT03545113|516823968|FG000|Overall Study|Received different surgery|1|||
143348672|NCT03545113|516823969|FG001|Overall Study|Received different surgery|0|||
143348673|NCT00235443|516823970|FG000|Overall Study|Adverse Event|4|||
143348674|NCT00235443|516823971|FG001|Overall Study|Adverse Event|12|||
143348675|NCT00235443|516823972|FG002|Overall Study|Adverse Event|17|||
143348676|NCT00235443|516823973|FG003|Overall Study|Adverse Event|44|||
143348677|NCT00235443|516823974|FG004|Overall Study|Adverse Event|10|||
143348678|NCT00235443|516823975|FG005|Overall Study|Adverse Event|15|||
143348679|NCT00235443|516823970|FG000|Overall Study|Lack of Efficacy|0|||
143348680|NCT00235443|516823971|FG001|Overall Study|Lack of Efficacy|1|||
143348681|NCT00235443|516823972|FG002|Overall Study|Lack of Efficacy|5|||
143348682|NCT00235443|516823973|FG003|Overall Study|Lack of Efficacy|12|||
143348683|NCT00235443|516823974|FG004|Overall Study|Lack of Efficacy|2|||
143348684|NCT00235443|516823975|FG005|Overall Study|Lack of Efficacy|9|||
143348685|NCT00235443|516823970|FG000|Overall Study|Withdrawal by Subject|3|||
143348686|NCT00235443|516823971|FG001|Overall Study|Withdrawal by Subject|9|||
143348687|NCT00235443|516823972|FG002|Overall Study|Withdrawal by Subject|25|||
143348688|NCT00235443|516823973|FG003|Overall Study|Withdrawal by Subject|24|||
143348689|NCT00235443|516823974|FG004|Overall Study|Withdrawal by Subject|10|||
143348690|NCT00235443|516823975|FG005|Overall Study|Withdrawal by Subject|12|||
143348691|NCT00235443|516823970|FG000|Overall Study|Lost to Follow-up|0|||
143348692|NCT00235443|516823971|FG001|Overall Study|Lost to Follow-up|8|||
143348693|NCT00235443|516823972|FG002|Overall Study|Lost to Follow-up|6|||
143348694|NCT00235443|516823973|FG003|Overall Study|Lost to Follow-up|6|||
143348695|NCT00235443|516823974|FG004|Overall Study|Lost to Follow-up|4|||
143348696|NCT00235443|516823975|FG005|Overall Study|Lost to Follow-up|3|||
143348697|NCT00235443|516823970|FG000|Overall Study|Unsatisfactory compliance|0|||
143348698|NCT00235443|516823971|FG001|Overall Study|Unsatisfactory compliance|2|||
143348699|NCT00235443|516823972|FG002|Overall Study|Unsatisfactory compliance|3|||
143348700|NCT00235443|516823973|FG003|Overall Study|Unsatisfactory compliance|4|||
143348701|NCT00235443|516823974|FG004|Overall Study|Unsatisfactory compliance|1|||
143348702|NCT00235443|516823975|FG005|Overall Study|Unsatisfactory compliance|0|||
143348703|NCT00235443|516823970|FG000|Overall Study|Other reasons for premature termination|1|||
143348704|NCT00235443|516823971|FG001|Overall Study|Other reasons for premature termination|6|||
143348705|NCT00235443|516823972|FG002|Overall Study|Other reasons for premature termination|6|||
143348706|NCT00235443|516823973|FG003|Overall Study|Other reasons for premature termination|7|||
143348707|NCT00235443|516823974|FG004|Overall Study|Other reasons for premature termination|3|||
143348708|NCT00235443|516823975|FG005|Overall Study|Other reasons for premature termination|6|||
143348709|NCT02032173|516823976|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
143348710|NCT00474929|516823977|FG000|Overall Study|Withdrawal by Subject|0|||
143348711|NCT00474929|516823978|FG001|Overall Study|Withdrawal by Subject|1|||
143348712|NCT00474929|516823979|FG002|Overall Study|Withdrawal by Subject|0|||
143348713|NCT00474929|516823980|FG003|Overall Study|Withdrawal by Subject|0|||
143348714|NCT00474929|516823981|FG004|Overall Study|Withdrawal by Subject|0|||
143348715|NCT00474929|516823977|FG000|Overall Study|Unrelated medical condition|0|||
143348716|NCT00474929|516823978|FG001|Overall Study|Unrelated medical condition|0|||
143348717|NCT00474929|516823979|FG002|Overall Study|Unrelated medical condition|1|||
143348718|NCT00474929|516823980|FG003|Overall Study|Unrelated medical condition|0|||
143348719|NCT00474929|516823981|FG004|Overall Study|Unrelated medical condition|0|||
143348720|NCT00474929|516823977|FG000|Overall Study|Physician Decision|0|||
143348721|NCT00474929|516823978|FG001|Overall Study|Physician Decision|0|||
143348722|NCT00474929|516823979|FG002|Overall Study|Physician Decision|1|||
143348723|NCT00474929|516823980|FG003|Overall Study|Physician Decision|2|||
143348724|NCT00474929|516823981|FG004|Overall Study|Physician Decision|0|||
143348725|NCT03661996|516823984|FG000|Overall Study|Adverse Event|0|||
143348726|NCT03661996|516823985|FG001|Overall Study|Adverse Event|0|||
143348727|NCT03661996|516823986|FG002|Overall Study|Adverse Event|1|||
143348728|NCT03661996|516823987|FG003|Overall Study|Adverse Event|1|||
143348729|NCT03661996|516823988|FG004|Overall Study|Adverse Event|0|||
143348730|NCT03661996|516823984|FG000|Overall Study|Lost to Follow-up|5|||
143348731|NCT03661996|516823985|FG001|Overall Study|Lost to Follow-up|1|||
143348732|NCT03661996|516823986|FG002|Overall Study|Lost to Follow-up|2|||
143348733|NCT03661996|516823987|FG003|Overall Study|Lost to Follow-up|2|||
143348734|NCT03661996|516823988|FG004|Overall Study|Lost to Follow-up|6|||
143348735|NCT03661996|516823984|FG000|Overall Study|Physician Decision|1|||
143348736|NCT03661996|516823985|FG001|Overall Study|Physician Decision|1|||
143348737|NCT03661996|516823986|FG002|Overall Study|Physician Decision|1|||
143348738|NCT03661996|516823987|FG003|Overall Study|Physician Decision|2|||
143348739|NCT03661996|516823988|FG004|Overall Study|Physician Decision|0|||
143348740|NCT03661996|516823984|FG000|Overall Study|Protocol Violation|0|||
143348741|NCT03661996|516823985|FG001|Overall Study|Protocol Violation|0|||
143348742|NCT03661996|516823986|FG002|Overall Study|Protocol Violation|0|||
143348743|NCT03661996|516823987|FG003|Overall Study|Protocol Violation|0|||
143348744|NCT03661996|516823988|FG004|Overall Study|Protocol Violation|1|||
143348745|NCT03661996|516823984|FG000|Overall Study|Withdrawal by Subject|3|||
143348746|NCT03661996|516823985|FG001|Overall Study|Withdrawal by Subject|5|||
143348747|NCT03661996|516823986|FG002|Overall Study|Withdrawal by Subject|1|||
143348748|NCT03661996|516823987|FG003|Overall Study|Withdrawal by Subject|7|||
143348749|NCT03661996|516823988|FG004|Overall Study|Withdrawal by Subject|7|||
143348750|NCT03661996|516823984|FG000|Overall Study|Sponsors Decision|2|||
143348751|NCT03661996|516823985|FG001|Overall Study|Sponsors Decision|0|||
143348752|NCT03661996|516823986|FG002|Overall Study|Sponsors Decision|0|||
143348753|NCT03661996|516823987|FG003|Overall Study|Sponsors Decision|0|||
143348754|NCT03661996|516823988|FG004|Overall Study|Sponsors Decision|0|||
143348755|NCT03661996|516823984|FG000|Overall Study|Other|1|||
143348756|NCT03661996|516823985|FG001|Overall Study|Other|1|||
143348757|NCT03661996|516823986|FG002|Overall Study|Other|1|||
143348758|NCT03661996|516823987|FG003|Overall Study|Other|1|||
143348759|NCT03661996|516823988|FG004|Overall Study|Other|0|||
143348760|NCT03321513|516823989|FG000|Overall Study|Death|11|||
143348761|NCT03321513|516823990|FG001|Overall Study|Death|5|||
143348762|NCT03321513|516823989|FG000|Overall Study|Withdrawal by Subject|5|||
143348763|NCT03321513|516823990|FG001|Overall Study|Withdrawal by Subject|10|||
143348764|NCT03321513|516823989|FG000|Overall Study|Lost to Follow-up|10|||
143348765|NCT03321513|516823990|FG001|Overall Study|Lost to Follow-up|11|||
143348766|NCT02593305|516823991|FG000|Post 1|Comparison only group. No intervention.|0|||
143348767|NCT02593305|516823992|FG001|Post 1|Comparison only group. No intervention.|0|||
143348768|NCT02593305|516823993|FG002|Post 1|Comparison only group. No intervention.|10|||
143348769|NCT00068380|516823994|FG000|Overall Study|Withdrawal by Subject|3|||
143348770|NCT00068380|516823994|FG000|Overall Study|Adverse Event|2|||
143348771|NCT01976364|516823995|FG000|Main Study (36 Months)|Adverse Event|63|||
143348772|NCT01976364|516823996|FG001|Main Study (36 Months)|Adverse Event|0|||
143348773|NCT01976364|516823997|FG002|Main Study (36 Months)|Adverse Event|0|||
143348774|NCT01976364|516823995|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
143348775|NCT01976364|516823996|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
143348776|NCT01976364|516823997|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
143348777|NCT01976364|516823995|FG000|Main Study (36 Months)|Other|13|||
143348778|NCT01976364|516823996|FG001|Main Study (36 Months)|Other|0|||
143348779|NCT01976364|516823997|FG002|Main Study (36 Months)|Other|0|||
143348780|NCT01976364|516823995|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
143348781|NCT01976364|516823996|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
143348782|NCT01976364|516823997|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
143348783|NCT01976364|516823995|FG000|Main Study (36 Months)|Medication error|1|||
143348784|NCT01976364|516823996|FG001|Main Study (36 Months)|Medication error|0|||
143348785|NCT01976364|516823997|FG002|Main Study (36 Months)|Medication error|0|||
143348786|NCT01976364|516823995|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
143348787|NCT01976364|516823996|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
143348788|NCT01976364|516823997|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
143348789|NCT01976364|516823995|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
143348790|NCT01976364|516823996|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
143348791|NCT01976364|516823997|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
143348792|NCT01976364|516823995|FG000|Main Study (36 Months)|Protocol Violation|13|||
143348793|NCT01976364|516823996|FG001|Main Study (36 Months)|Protocol Violation|0|||
143348794|NCT01976364|516823997|FG002|Main Study (36 Months)|Protocol Violation|0|||
143348795|NCT01976364|516823995|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
143348796|NCT01976364|516823996|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
143348797|NCT01976364|516823997|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
143348798|NCT01976364|516823995|FG000|Main Study (36 Months)|Death|5|||
143348799|NCT01976364|516823996|FG001|Main Study (36 Months)|Death|0|||
143348800|NCT01976364|516823997|FG002|Main Study (36 Months)|Death|0|||
143348801|NCT01976364|516823995|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
143348802|NCT01976364|516823996|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
143348803|NCT01976364|516823997|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
143348804|NCT01976364|516823995|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
143348805|NCT01976364|516823996|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
143348806|NCT01976364|516823997|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
143348807|NCT01976364|516823995|FG000|Sub-study (12 Months)|Protocol Violation|0|||
143348808|NCT01976364|516823996|FG001|Sub-study (12 Months)|Protocol Violation|1|||
143348809|NCT01976364|516823997|FG002|Sub-study (12 Months)|Protocol Violation|1|||
143348810|NCT01976364|516823995|FG000|Sub-study (12 Months)|Adverse Event|0|||
143348811|NCT01976364|516823996|FG001|Sub-study (12 Months)|Adverse Event|4|||
143348812|NCT01976364|516823997|FG002|Sub-study (12 Months)|Adverse Event|3|||
143348813|NCT02757521|516823998|FG000|Overall Study|Adverse Event|1|||
143348814|NCT02757521|516823999|FG001|Overall Study|Adverse Event|0|||
143348815|NCT01190215|516824000|FG000|Up to Month 6|Lost to Follow-up|2|||
143348816|NCT01190215|516824001|FG001|Up to Month 6|Lost to Follow-up|0|||
143348817|NCT00003511|516824002|FG000|Overall Study|Not evaluable|4|||
143348818|NCT01683994|516824025|FG000|Overall Study|Withdrawal by Subject|1|||
143124855|NCT00524680|516001319|FG000|Overall Study|Withdrawal by Subject|1|||
143348819|NCT01683994|516824026|FG001|Overall Study|Withdrawal by Subject|0|||
143348820|NCT01683994|516824027|FG002|Overall Study|Withdrawal by Subject|0|||
143348821|NCT01683994|516824028|FG003|Overall Study|Withdrawal by Subject|1|||
143348822|NCT01683994|516824029|FG004|Overall Study|Withdrawal by Subject|0|||
143348823|NCT01683994|516824025|FG000|Overall Study|Intercurrent illness|0|||
143348824|NCT01683994|516824026|FG001|Overall Study|Intercurrent illness|0|||
143348825|NCT01683994|516824027|FG002|Overall Study|Intercurrent illness|0|||
143348826|NCT01683994|516824028|FG003|Overall Study|Intercurrent illness|2|||
143348827|NCT01683994|516824029|FG004|Overall Study|Intercurrent illness|1|||
143348828|NCT00999661|516824030|FG000|Overall Study|Lost to Follow-up|59|||
143348829|NCT00999661|516824030|FG000|Overall Study|Adverse Event|1|||
143348830|NCT00999661|516824030|FG000|Overall Study|Withdrawal by Subject|1|||
143348831|NCT00999661|516824030|FG000|Overall Study|Not meeting eligibility criteria|9|||
143348832|NCT00917267|516824031|FG000|Overall Study|Adverse Event|15|||
143348833|NCT00917267|516824032|FG001|Overall Study|Adverse Event|36|||
143348834|NCT00917267|516824031|FG000|Overall Study|Physician Decision|2|||
143348835|NCT00917267|516824032|FG001|Overall Study|Physician Decision|4|||
143348836|NCT00917267|516824031|FG000|Overall Study|Protocol Violation|9|||
143348837|NCT00917267|516824032|FG001|Overall Study|Protocol Violation|18|||
143348838|NCT00917267|516824031|FG000|Overall Study|Withdrawal by Subject|5|||
143348839|NCT00917267|516824032|FG001|Overall Study|Withdrawal by Subject|12|||
143348840|NCT00917267|516824031|FG000|Overall Study|Lost to follow up|0|||
143348841|NCT00917267|516824032|FG001|Overall Study|Lost to follow up|2|||
143348842|NCT00917267|516824031|FG000|Overall Study|Entry Criteria Not Met|1|||
143348843|NCT00917267|516824032|FG001|Overall Study|Entry Criteria Not Met|0|||
143348844|NCT00917267|516824031|FG000|Overall Study|Sponsor Decision|5|||
143348845|NCT00917267|516824032|FG001|Overall Study|Sponsor Decision|5|||
143348846|NCT00917267|516824031|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
143348847|NCT00917267|516824032|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
143348848|NCT02960763|516824034|FG000|Step 1|Withdrawal by Subject|10|||
143348849|NCT02960763|516824035|FG001|Step 1|Withdrawal by Subject|8|||
143348850|NCT02960763|516824036|FG002|Step 1|Withdrawal by Subject|13|||
143348851|NCT02960763|516824037|FG003|Step 1|Withdrawal by Subject|0|||
143348852|NCT02960763|516824038|FG004|Step 1|Withdrawal by Subject|0|||
143348853|NCT02960763|516824034|FG000|Step 1|Lost to Follow-up|7|||
143348854|NCT02960763|516824035|FG001|Step 1|Lost to Follow-up|9|||
143348855|NCT02960763|516824036|FG002|Step 1|Lost to Follow-up|12|||
143348856|NCT02960763|516824037|FG003|Step 1|Lost to Follow-up|0|||
143348857|NCT02960763|516824038|FG004|Step 1|Lost to Follow-up|0|||
143348858|NCT02960763|516824034|FG000|Step 1|Death|1|||
143348859|NCT02960763|516824035|FG001|Step 1|Death|1|||
143348860|NCT02960763|516824036|FG002|Step 1|Death|1|||
143348861|NCT02960763|516824037|FG003|Step 1|Death|0|||
143348862|NCT02960763|516824038|FG004|Step 1|Death|0|||
143348863|NCT02960763|516824034|FG000|Step 1|Investigator discretion|1|||
143348864|NCT02960763|516824035|FG001|Step 1|Investigator discretion|0|||
143348865|NCT02960763|516824036|FG002|Step 1|Investigator discretion|1|||
143348866|NCT02960763|516824037|FG003|Step 1|Investigator discretion|0|||
143348867|NCT02960763|516824038|FG004|Step 1|Investigator discretion|0|||
143348868|NCT02960763|516824034|FG000|Step 1|Other|0|||
143348869|NCT02960763|516824035|FG001|Step 1|Other|0|||
143348870|NCT02960763|516824036|FG002|Step 1|Other|1|||
143348871|NCT02960763|516824037|FG003|Step 1|Other|0|||
143348872|NCT02960763|516824038|FG004|Step 1|Other|0|||
143348873|NCT02960763|516824034|FG000|Step 2|Withdrawal by Subject|0|||
143348874|NCT02960763|516824035|FG001|Step 2|Withdrawal by Subject|0|||
143348875|NCT02960763|516824036|FG002|Step 2|Withdrawal by Subject|0|||
143348876|NCT02960763|516824037|FG003|Step 2|Withdrawal by Subject|7|||
143348877|NCT02960763|516824038|FG004|Step 2|Withdrawal by Subject|3|||
143348878|NCT02960763|516824034|FG000|Step 2|Lost to Follow-up|0|||
143348879|NCT02960763|516824035|FG001|Step 2|Lost to Follow-up|0|||
143348880|NCT02960763|516824036|FG002|Step 2|Lost to Follow-up|0|||
143348881|NCT02960763|516824037|FG003|Step 2|Lost to Follow-up|4|||
143348882|NCT02960763|516824038|FG004|Step 2|Lost to Follow-up|1|||
143348883|NCT02960763|516824034|FG000|Step 2|Investigator discretion|0|||
143348884|NCT02960763|516824035|FG001|Step 2|Investigator discretion|0|||
143348885|NCT02960763|516824036|FG002|Step 2|Investigator discretion|0|||
143348886|NCT02960763|516824037|FG003|Step 2|Investigator discretion|0|||
143348887|NCT02960763|516824038|FG004|Step 2|Investigator discretion|1|||
143348888|NCT02318719|516824039|FG000|Double-blind Phase|Adverse Event|7|||
143348889|NCT02318719|516824040|FG001|Double-blind Phase|Adverse Event|6|||
143348890|NCT02318719|516824041|FG002|Double-blind Phase|Adverse Event|12|||
143348891|NCT02318719|516824042|FG003|Double-blind Phase|Adverse Event|4|||
143348892|NCT02318719|516824043|FG004|Double-blind Phase|Adverse Event|0|||
143348893|NCT02318719|516824039|FG000|Double-blind Phase|Lack of Efficacy|5|||
143348894|NCT02318719|516824040|FG001|Double-blind Phase|Lack of Efficacy|0|||
143348895|NCT02318719|516824041|FG002|Double-blind Phase|Lack of Efficacy|1|||
143348896|NCT02318719|516824042|FG003|Double-blind Phase|Lack of Efficacy|1|||
143348897|NCT02318719|516824043|FG004|Double-blind Phase|Lack of Efficacy|0|||
143348898|NCT02318719|516824039|FG000|Double-blind Phase|Protocol Violation|0|||
143348899|NCT02318719|516824040|FG001|Double-blind Phase|Protocol Violation|1|||
143348900|NCT02318719|516824041|FG002|Double-blind Phase|Protocol Violation|3|||
143348901|NCT02318719|516824042|FG003|Double-blind Phase|Protocol Violation|0|||
143348902|NCT02318719|516824043|FG004|Double-blind Phase|Protocol Violation|0|||
143348903|NCT02318719|516824039|FG000|Double-blind Phase|Withdrawal by Subject|25|||
143348904|NCT02318719|516824040|FG001|Double-blind Phase|Withdrawal by Subject|7|||
143348905|NCT02318719|516824041|FG002|Double-blind Phase|Withdrawal by Subject|9|||
143348906|NCT02318719|516824042|FG003|Double-blind Phase|Withdrawal by Subject|10|||
143348907|NCT02318719|516824043|FG004|Double-blind Phase|Withdrawal by Subject|0|||
143348908|NCT02318719|516824039|FG000|Double-blind Phase|Other|1|||
143348909|NCT02318719|516824040|FG001|Double-blind Phase|Other|2|||
143348910|NCT02318719|516824041|FG002|Double-blind Phase|Other|0|||
143348911|NCT02318719|516824042|FG003|Double-blind Phase|Other|0|||
143348912|NCT02318719|516824043|FG004|Double-blind Phase|Other|0|||
143348913|NCT02318719|516824039|FG000|Open-label Extension Phase|Adverse Event|0|||
143348914|NCT02318719|516824040|FG001|Open-label Extension Phase|Adverse Event|0|||
143348915|NCT02318719|516824041|FG002|Open-label Extension Phase|Adverse Event|0|||
143348916|NCT02318719|516824042|FG003|Open-label Extension Phase|Adverse Event|0|||
143348917|NCT02318719|516824043|FG004|Open-label Extension Phase|Adverse Event|15|||
143348918|NCT02318719|516824039|FG000|Open-label Extension Phase|Death|0|||
143348919|NCT02318719|516824040|FG001|Open-label Extension Phase|Death|0|||
143348920|NCT02318719|516824041|FG002|Open-label Extension Phase|Death|0|||
143348921|NCT02318719|516824042|FG003|Open-label Extension Phase|Death|0|||
143348922|NCT02318719|516824043|FG004|Open-label Extension Phase|Death|1|||
143348923|NCT02318719|516824039|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
143348924|NCT02318719|516824040|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
143348925|NCT02318719|516824041|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
143348926|NCT02318719|516824042|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
143348927|NCT02318719|516824043|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
143348928|NCT02318719|516824039|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
143348929|NCT02318719|516824040|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
143348930|NCT02318719|516824041|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
143348931|NCT02318719|516824042|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
143348932|NCT02318719|516824043|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
143348933|NCT02318719|516824039|FG000|Open-label Extension Phase|Other|0|||
143348934|NCT02318719|516824040|FG001|Open-label Extension Phase|Other|0|||
143348935|NCT02318719|516824041|FG002|Open-label Extension Phase|Other|0|||
143348936|NCT02318719|516824042|FG003|Open-label Extension Phase|Other|0|||
143348937|NCT02318719|516824043|FG004|Open-label Extension Phase|Other|7|||
143348938|NCT00432835|516824047|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
143348939|NCT00432835|516824048|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
143348940|NCT00289770|516824049|FG000|Year 15|Withdrawal by Subject|1|||
143348941|NCT00423293|516824050|FG000|Overall Study|Ineligible / No protocol treatment|11|||
143348942|NCT04399551|516824060|FG000|Overall Study|Adverse Event|15|||
143348943|NCT04399551|516824060|FG000|Overall Study|Withdrawal by Subject|6|||
143348944|NCT04399551|516824060|FG000|Overall Study|Physician Decision|3|||
143348945|NCT04399551|516824060|FG000|Overall Study|Lost to Follow-up|2|||
143348946|NCT04399551|516824060|FG000|Overall Study|Protocol Deviation|2|||
143348947|NCT01014975|516824074|FG000|Overall Study|Withdrawal by Subject|1|||
143348948|NCT01014975|516824075|FG001|Overall Study|Withdrawal by Subject|0|||
143348949|NCT01014975|516824076|FG002|Overall Study|Withdrawal by Subject|1|||
143348950|NCT01014975|516824074|FG000|Overall Study|Death|3|||
143348951|NCT01014975|516824075|FG001|Overall Study|Death|3|||
143348952|NCT01014975|516824076|FG002|Overall Study|Death|4|||
143348953|NCT01014975|516824074|FG000|Overall Study|Lost to Follow-up|0|||
143348954|NCT01014975|516824075|FG001|Overall Study|Lost to Follow-up|0|||
143348955|NCT01014975|516824076|FG002|Overall Study|Lost to Follow-up|1|||
143348956|NCT01642602|516824079|FG000|Overall Study|Adverse Event|2|||
143348957|NCT01336634|516824080|FG000|Overall Study|Study closed/terminated|5|||
143348958|NCT01336634|516824081|FG001|Overall Study|Study closed/terminated|6|||
143348959|NCT01336634|516824082|FG002|Overall Study|Study closed/terminated|6|||
143348960|NCT01336634|516824080|FG000|Overall Study|Lost to Follow-up|2|||
143348961|NCT01336634|516824081|FG001|Overall Study|Lost to Follow-up|1|||
143348962|NCT01336634|516824082|FG002|Overall Study|Lost to Follow-up|1|||
143348963|NCT01336634|516824080|FG000|Overall Study|Physician Decision|1|||
143348964|NCT01336634|516824081|FG001|Overall Study|Physician Decision|1|||
143011682|NCT03494816|515579719|FG000|Overall Study|Protocol Violation|2|||
143011683|NCT03494816|515579719|FG000|Overall Study|Physician Decision|2|||
143011684|NCT03494816|515579719|FG000|Overall Study|Did not start trial treatment|1|||
143348965|NCT01336634|516824082|FG002|Overall Study|Physician Decision|0|||
143348966|NCT01336634|516824080|FG000|Overall Study|Withdrawal by Subject|6|||
143348967|NCT01336634|516824081|FG001|Overall Study|Withdrawal by Subject|0|||
143348968|NCT01336634|516824082|FG002|Overall Study|Withdrawal by Subject|2|||
143348969|NCT01112514|516824083|FG000|Overall Study|Lost to Follow-up|1|||
143348970|NCT02961881|516824084|FG000|Overall Study|Adverse Event|1|||
143348971|NCT02961881|516824085|FG001|Overall Study|Adverse Event|2|||
143348972|NCT02961881|516824086|FG002|Overall Study|Adverse Event|2|||
143348973|NCT02961881|516824087|FG003|Overall Study|Adverse Event|0|||
143348974|NCT02961881|516824088|FG004|Overall Study|Adverse Event|1|||
143348975|NCT02961881|516824084|FG000|Overall Study|Participant request|0|||
143348976|NCT02961881|516824085|FG001|Overall Study|Participant request|2|||
143348977|NCT02961881|516824086|FG002|Overall Study|Participant request|0|||
143348978|NCT02961881|516824087|FG003|Overall Study|Participant request|0|||
143348979|NCT02961881|516824088|FG004|Overall Study|Participant request|0|||
143348980|NCT02961881|516824084|FG000|Overall Study|Disease progression|1|||
143348981|NCT02961881|516824085|FG001|Overall Study|Disease progression|0|||
143348982|NCT02961881|516824086|FG002|Overall Study|Disease progression|1|||
143348983|NCT02961881|516824087|FG003|Overall Study|Disease progression|0|||
143348984|NCT02961881|516824088|FG004|Overall Study|Disease progression|0|||
143348985|NCT01118455|516824089|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
143348986|NCT01118455|516824090|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
143348987|NCT01973491|516824091|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
143348988|NCT01973491|516824091|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
143348989|NCT01973491|516824091|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
143348990|NCT00152763|516824092|FG000|Overall Study|Death|4|||
143348991|NCT00152763|516824093|FG001|Overall Study|Death|1|||
143348992|NCT00152763|516824094|FG002|Overall Study|Death|2|||
143348993|NCT00152763|516824095|FG003|Overall Study|Death|1|||
143348994|NCT00152763|516824092|FG000|Overall Study|Lost to Follow-up|6|||
143348995|NCT00152763|516824093|FG001|Overall Study|Lost to Follow-up|4|||
143348996|NCT00152763|516824094|FG002|Overall Study|Lost to Follow-up|2|||
143348997|NCT00152763|516824095|FG003|Overall Study|Lost to Follow-up|13|||
143348998|NCT01993823|516824099|FG000|Overall Study|Requested by the patient|6|||
143348999|NCT01993823|516824100|FG001|Overall Study|Requested by the patient|11|||
143349000|NCT01993823|516824099|FG000|Overall Study|Protocol Violation|0|||
143349001|NCT01993823|516824100|FG001|Overall Study|Protocol Violation|1|||
143349002|NCT01993823|516824099|FG000|Overall Study|Lost to Follow-up|1|||
143349003|NCT01993823|516824100|FG001|Overall Study|Lost to Follow-up|4|||
143349004|NCT05033743|516824103|FG000|Overall Study|Lost to Follow-up|1|||
143349005|NCT05033743|516824103|FG000|Overall Study|Protocol Violation|2|||
143349006|NCT05033743|516824103|FG000|Overall Study|Withdrawal by Subject|1|||
143349007|NCT01619787|516824104|FG000|Overall Study|Lost to Follow-up|5|||
143349008|NCT03066622|516824109|FG000|Overall Study|Lost to Follow-up|24|||
143349009|NCT03066622|516824110|FG001|Overall Study|Lost to Follow-up|25|||
143349010|NCT03066622|516824109|FG000|Overall Study|Withdrawal by Subject|2|||
143349011|NCT03066622|516824110|FG001|Overall Study|Withdrawal by Subject|1|||
143349012|NCT00641719|516824111|FG000|Overall Study|Lack of Efficacy|1|||
143349013|NCT00641719|516824112|FG001|Overall Study|Lack of Efficacy|2|||
143349014|NCT00641719|516824111|FG000|Overall Study|Adverse Event|24|||
143349015|NCT00641719|516824112|FG001|Overall Study|Adverse Event|29|||
143349016|NCT00641719|516824111|FG000|Overall Study|Withdrawal by Subject|4|||
143349017|NCT00641719|516824112|FG001|Overall Study|Withdrawal by Subject|4|||
143349018|NCT00641719|516824111|FG000|Overall Study|Reason Not Specified|1|||
143349019|NCT00641719|516824112|FG001|Overall Study|Reason Not Specified|2|||
143349020|NCT03303469|516824113|FG000|Overall Study|Lost to Follow-up|2|||
143349021|NCT03101241|516824117|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
143349022|NCT03101241|516824118|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
143349023|NCT03101241|516824117|FG000|Overall Study|Participant withdrew consent|3|||
143349024|NCT03101241|516824118|FG001|Overall Study|Participant withdrew consent|1|||
143349025|NCT03101241|516824117|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
143349026|NCT03101241|516824118|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
143349027|NCT03101241|516824117|FG000|Overall Study|Lost to Follow-up|2|||
143349028|NCT03101241|516824118|FG001|Overall Study|Lost to Follow-up|0|||
143349029|NCT03101241|516824117|FG000|Overall Study|Lack of Efficacy|0|||
143349030|NCT03101241|516824118|FG001|Overall Study|Lack of Efficacy|1|||
143349031|NCT03101241|516824117|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
143349032|NCT03101241|516824118|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
143349033|NCT00245856|516824123|FG000|Period Two|Withdrawal by Subject|0|||
143349034|NCT00245856|516824124|FG001|Period Two|Withdrawal by Subject|1|||
143349035|NCT01003184|516824125|FG000|Overall Study|Adverse Event|12|||
143349036|NCT01003184|516824126|FG001|Overall Study|Adverse Event|5|||
143349037|NCT01003184|516824125|FG000|Overall Study|Lost to Follow-up|1|||
143349038|NCT01003184|516824126|FG001|Overall Study|Lost to Follow-up|0|||
143349039|NCT01003184|516824125|FG000|Overall Study|Loss of glucose control|1|||
143461393|NCT04426851|517235033|FG001|Part 2: Period 2+Washout|Adverse Event|0|||
143461394|NCT03256851|517235034|FG000|Overall Study|Withdrawal by Subject|1|||
143349040|NCT01003184|516824126|FG001|Overall Study|Loss of glucose control|1|||
143349041|NCT01003184|516824125|FG000|Overall Study|Protocol Violation|3|||
143349042|NCT01003184|516824126|FG001|Overall Study|Protocol Violation|0|||
143349043|NCT01003184|516824125|FG000|Overall Study|Withdrawal by Subject|1|||
143349044|NCT01003184|516824126|FG001|Overall Study|Withdrawal by Subject|6|||
143349045|NCT01003184|516824125|FG000|Overall Study|Physician Decision|1|||
143349046|NCT01003184|516824126|FG001|Overall Study|Physician Decision|0|||
143349047|NCT02765490|516824127|FG000|Overall Study|Lost to Follow-up|1|||
143349048|NCT02765490|516824128|FG001|Overall Study|Lost to Follow-up|1|||
143349049|NCT02765490|516824127|FG000|Overall Study|Other|0|||
143349050|NCT02765490|516824128|FG001|Overall Study|Other|1|||
143461395|NCT03256851|517235035|FG001|Overall Study|Withdrawal by Subject|0|||
143349051|NCT02765490|516824127|FG000|Overall Study|Death|0|||
143349052|NCT02765490|516824128|FG001|Overall Study|Death|1|||
143349053|NCT04848662|516824129|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
143349054|NCT04848662|516824130|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
143349055|NCT03662997|516824137|FG000|Overall Study|Adverse Event|0|||
143349056|NCT03662997|516824138|FG001|Overall Study|Adverse Event|2|||
143349057|NCT03662997|516824139|FG002|Overall Study|Adverse Event|0|||
143349058|NCT03662997|516824140|FG003|Overall Study|Adverse Event|0|||
143349059|NCT00007475|516824141|FG000|Overall Study|Withdrawal by Subject|1|||
143349060|NCT00007475|516824142|FG001|Overall Study|Withdrawal by Subject|0|||
143349061|NCT00007475|516824143|FG002|Overall Study|Withdrawal by Subject|0|||
143349062|NCT00007475|516824144|FG003|Overall Study|Withdrawal by Subject|0|||
143349063|NCT00007475|516824141|FG000|Overall Study|Adverse Event|3|||
143349064|NCT00007475|516824142|FG001|Overall Study|Adverse Event|0|||
143349065|NCT00007475|516824143|FG002|Overall Study|Adverse Event|0|||
143349066|NCT00007475|516824144|FG003|Overall Study|Adverse Event|0|||
143349067|NCT01719224|516824145|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
143349068|NCT01719224|516824146|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
143349069|NCT03000673|516824147|FG000|Overall Study|Withdrawal by Subject|1|||
143349070|NCT03000673|516824148|FG001|Overall Study|Withdrawal by Subject|0|||
143349071|NCT03000673|516824149|FG002|Overall Study|Withdrawal by Subject|0|||
143349072|NCT03000673|516824150|FG003|Overall Study|Withdrawal by Subject|0|||
143349073|NCT01121484|516824152|FG000|Overall Study|Adverse Event|12|||
143349074|NCT01121484|516824153|FG001|Overall Study|Adverse Event|5|||
143349075|NCT01121484|516824152|FG000|Overall Study|Lack of Efficacy|3|||
143349076|NCT01121484|516824153|FG001|Overall Study|Lack of Efficacy|11|||
143349077|NCT01121484|516824152|FG000|Overall Study|Lost to Follow-up|5|||
143349078|NCT01121484|516824153|FG001|Overall Study|Lost to Follow-up|9|||
143349079|NCT01121484|516824152|FG000|Overall Study|Physician Decision|0|||
143349080|NCT01121484|516824153|FG001|Overall Study|Physician Decision|3|||
143349081|NCT01121484|516824152|FG000|Overall Study|Protocol Violation|1|||
143349082|NCT01121484|516824153|FG001|Overall Study|Protocol Violation|0|||
143349083|NCT01121484|516824152|FG000|Overall Study|Withdrawal by Subject|8|||
143349084|NCT01121484|516824153|FG001|Overall Study|Withdrawal by Subject|7|||
143349085|NCT01121484|516824152|FG000|Overall Study|Discontinuation of study by sponsor|0|||
143349086|NCT01121484|516824153|FG001|Overall Study|Discontinuation of study by sponsor|1|||
143349087|NCT01121484|516824152|FG000|Overall Study|Other|3|||
143349088|NCT01121484|516824153|FG001|Overall Study|Other|3|||
143349089|NCT01121484|516824152|FG000|Overall Study|Randomized, not treated|1|||
143349090|NCT01121484|516824153|FG001|Overall Study|Randomized, not treated|4|||
143349091|NCT00562978|516824154|FG000|Overall Study|Patient had imaging dose only|1|||
143349092|NCT00562978|516824155|FG001|Overall Study|Patient had imaging dose only|11|||
143349093|NCT00152971|516824159|FG000|Overall Study|Adverse Event|12|||
143349094|NCT00152971|516824160|FG001|Overall Study|Adverse Event|10|||
143349095|NCT00152971|516824161|FG002|Overall Study|Adverse Event|9|||
143349096|NCT00152971|516824159|FG000|Overall Study|Protocol Violation|10|||
143349097|NCT00152971|516824160|FG001|Overall Study|Protocol Violation|11|||
143349098|NCT00152971|516824161|FG002|Overall Study|Protocol Violation|8|||
143349099|NCT00152971|516824159|FG000|Overall Study|Lost to Follow-up|17|||
143349100|NCT00152971|516824160|FG001|Overall Study|Lost to Follow-up|14|||
143349101|NCT00152971|516824161|FG002|Overall Study|Lost to Follow-up|13|||
143349102|NCT00152971|516824159|FG000|Overall Study|Withdrawal by Subject|9|||
143349103|NCT00152971|516824160|FG001|Overall Study|Withdrawal by Subject|8|||
143349104|NCT00152971|516824161|FG002|Overall Study|Withdrawal by Subject|14|||
143349105|NCT00152971|516824159|FG000|Overall Study|Other|3|||
143349106|NCT00152971|516824160|FG001|Overall Study|Other|5|||
143349107|NCT00152971|516824161|FG002|Overall Study|Other|5|||
143349108|NCT00152971|516824159|FG000|Treatment|Adverse Event|49|||
143349109|NCT00152971|516824160|FG001|Treatment|Adverse Event|40|||
143349110|NCT00152971|516824161|FG002|Treatment|Adverse Event|54|||
143349111|NCT00152971|516824159|FG000|Treatment|Protocol Violation|8|||
143349112|NCT00152971|516824160|FG001|Treatment|Protocol Violation|6|||
143349113|NCT00152971|516824161|FG002|Treatment|Protocol Violation|10|||
143349114|NCT00152971|516824159|FG000|Treatment|Lost to Follow-up|1|||
143349115|NCT00152971|516824160|FG001|Treatment|Lost to Follow-up|2|||
143349116|NCT00152971|516824161|FG002|Treatment|Lost to Follow-up|1|||
143349117|NCT00152971|516824159|FG000|Treatment|Withdrawal by Subject|4|||
143349118|NCT00152971|516824160|FG001|Treatment|Withdrawal by Subject|4|||
143349119|NCT00152971|516824161|FG002|Treatment|Withdrawal by Subject|5|||
143349120|NCT00152971|516824159|FG000|Treatment|Other|9|||
143349121|NCT00152971|516824160|FG001|Treatment|Other|11|||
143349122|NCT00152971|516824161|FG002|Treatment|Other|10|||
143349123|NCT00675506|516824162|FG000|Overall Study|Lost to Follow-up|1|||
143349124|NCT00675506|516824163|FG001|Overall Study|Lost to Follow-up|5|||
143349125|NCT00675506|516824162|FG000|Overall Study|Lost interest|3|||
143349126|NCT00675506|516824163|FG001|Overall Study|Lost interest|5|||
143349127|NCT00675506|516824162|FG000|Overall Study|Elevated fasting glucose|2|||
143349128|NCT00675506|516824163|FG001|Overall Study|Elevated fasting glucose|1|||
143349129|NCT00675506|516824162|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
143349130|NCT00675506|516824163|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
143349131|NCT00675506|516824162|FG000|Overall Study|Elevated IGF-1|2|||
143349132|NCT00675506|516824163|FG001|Overall Study|Elevated IGF-1|0|||
143349133|NCT00675506|516824162|FG000|Overall Study|Hypersensitivity Reaction|1|||
143349134|NCT00675506|516824163|FG001|Overall Study|Hypersensitivity Reaction|0|||
143349135|NCT00675506|516824162|FG000|Overall Study|Disclosed history of cancer|1|||
143349136|NCT00675506|516824163|FG001|Overall Study|Disclosed history of cancer|0|||
143349137|NCT00675506|516824162|FG000|Overall Study|Declined participation|1|||
143349138|NCT00675506|516824163|FG001|Overall Study|Declined participation|0|||
143349139|NCT00675506|516824162|FG000|Overall Study|Schedule conflict|0|||
143349140|NCT00675506|516824163|FG001|Overall Study|Schedule conflict|1|||
143349141|NCT01003639|516824166|FG000|Overall Study|Lost to Follow-up|6|||
143349142|NCT01003639|516824167|FG001|Overall Study|Lost to Follow-up|9|||
143349143|NCT01003639|516824166|FG000|Overall Study|Withdrawal by Subject|9|||
143349144|NCT01003639|516824167|FG001|Overall Study|Withdrawal by Subject|5|||
143349145|NCT01003639|516824166|FG000|Overall Study|Lack of Efficacy|1|||
143349146|NCT01003639|516824167|FG001|Overall Study|Lack of Efficacy|6|||
143349147|NCT01003639|516824166|FG000|Overall Study|Adverse Event|0|||
143349148|NCT01003639|516824167|FG001|Overall Study|Adverse Event|1|||
143349149|NCT01003639|516824166|FG000|Overall Study|Protocol Violation|0|||
143349150|NCT01003639|516824167|FG001|Overall Study|Protocol Violation|1|||
143349151|NCT01003639|516824166|FG000|Overall Study|Physician Decision|1|||
143349152|NCT01003639|516824167|FG001|Overall Study|Physician Decision|0|||
143349153|NCT00284089|516824168|FG000|Multiple Dose Phase|Adverse Event|1|||
143349154|NCT00284089|516824169|FG001|Multiple Dose Phase|Adverse Event|0|||
143349155|NCT00284089|516824170|FG002|Multiple Dose Phase|Adverse Event|1|||
143349156|NCT00284089|516824171|FG003|Multiple Dose Phase|Adverse Event|1|||
143349157|NCT00284089|516824168|FG000|Multiple Dose Phase|Protocol Violation|0|||
143349158|NCT00284089|516824169|FG001|Multiple Dose Phase|Protocol Violation|0|||
143349159|NCT00284089|516824170|FG002|Multiple Dose Phase|Protocol Violation|1|||
143349160|NCT00284089|516824171|FG003|Multiple Dose Phase|Protocol Violation|0|||
143349161|NCT00284089|516824168|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
143349162|NCT00284089|516824169|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
143349163|NCT00284089|516824170|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
143349164|NCT00284089|516824171|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
143349165|NCT00284089|516824168|FG000|Multiple Dose Phase|Death|0|||
143349166|NCT00284089|516824169|FG001|Multiple Dose Phase|Death|0|||
143349167|NCT00284089|516824170|FG002|Multiple Dose Phase|Death|1|||
143349168|NCT00284089|516824171|FG003|Multiple Dose Phase|Death|1|||
143349169|NCT00284089|516824168|FG000|Extension Phase|Adverse Event|0|||
143349170|NCT00284089|516824169|FG001|Extension Phase|Adverse Event|0|||
143349171|NCT00284089|516824170|FG002|Extension Phase|Adverse Event|2|||
143349172|NCT00284089|516824171|FG003|Extension Phase|Adverse Event|2|||
143349173|NCT00284089|516824168|FG000|Extension Phase|condition no longer requires study drug|2|||
143349174|NCT00284089|516824169|FG001|Extension Phase|condition no longer requires study drug|0|||
143349175|NCT00284089|516824170|FG002|Extension Phase|condition no longer requires study drug|2|||
143349176|NCT00284089|516824171|FG003|Extension Phase|condition no longer requires study drug|7|||
143349177|NCT00284089|516824168|FG000|Extension Phase|Protocol Violation|0|||
143349178|NCT00284089|516824169|FG001|Extension Phase|Protocol Violation|0|||
143349179|NCT00284089|516824170|FG002|Extension Phase|Protocol Violation|1|||
143349180|NCT00284089|516824171|FG003|Extension Phase|Protocol Violation|0|||
143349181|NCT00284089|516824168|FG000|Extension Phase|Withdrawal by Subject|0|||
143349182|NCT00284089|516824169|FG001|Extension Phase|Withdrawal by Subject|0|||
143349183|NCT00284089|516824170|FG002|Extension Phase|Withdrawal by Subject|1|||
143349184|NCT00284089|516824171|FG003|Extension Phase|Withdrawal by Subject|3|||
143349185|NCT04362137|516824172|FG000|Overall Study|Death|9|||
143349186|NCT04362137|516824173|FG001|Overall Study|Death|3|||
143349187|NCT04362137|516824172|FG000|Overall Study|Patient decision|6|||
143349188|NCT04362137|516824173|FG001|Overall Study|Patient decision|3|||
143349189|NCT04362137|516824172|FG000|Overall Study|Adverse Event|1|||
143349190|NCT04362137|516824173|FG001|Overall Study|Adverse Event|0|||
143349191|NCT04362137|516824172|FG000|Overall Study|Lost to Follow-up|1|||
143349192|NCT04362137|516824173|FG001|Overall Study|Lost to Follow-up|0|||
143349193|NCT04362137|516824172|FG000|Overall Study|Protocol deviation|1|||
143349194|NCT04362137|516824173|FG001|Overall Study|Protocol deviation|0|||
143011685|NCT03494816|515579719|FG000|Overall Study|Adverse Event|1|||
143011686|NCT01186744|515581697|FG000|Overall Study|Lack of Efficacy|156|||
143349195|NCT00447954|516824176|FG000|Overall Study|Adverse Event|0|||
143349196|NCT00447954|516824177|FG001|Overall Study|Adverse Event|2|||
143349197|NCT00447954|516824178|FG002|Overall Study|Adverse Event|0|||
143349198|NCT00447954|516824176|FG000|Overall Study|Withdrawal by Subject|0|||
143349199|NCT00447954|516824177|FG001|Overall Study|Withdrawal by Subject|1|||
143349200|NCT00447954|516824178|FG002|Overall Study|Withdrawal by Subject|1|||
143349201|NCT00447954|516824176|FG000|Overall Study|Lost to Follow-up|0|||
143349202|NCT00447954|516824177|FG001|Overall Study|Lost to Follow-up|1|||
143349203|NCT00447954|516824178|FG002|Overall Study|Lost to Follow-up|0|||
143349204|NCT00447954|516824176|FG000|Overall Study|Exclusionary event prior to implant procedure|1|||
143011687|NCT01186744|515581698|FG001|Overall Study|Lack of Efficacy|99|||
143349205|NCT00447954|516824177|FG001|Overall Study|Exclusionary event prior to implant procedure|0|||
143349206|NCT00447954|516824178|FG002|Overall Study|Exclusionary event prior to implant procedure|0|||
143349207|NCT03176238|516824181|FG000|Overall Study|Unacceptable AEs|15|||
143349208|NCT03176238|516824182|FG001|Overall Study|Unacceptable AEs|8|||
143349209|NCT03176238|516824181|FG000|Overall Study|Abnormal lab value(s)|2|||
143349210|NCT03176238|516824182|FG001|Overall Study|Abnormal lab value(s)|0|||
143349211|NCT03176238|516824181|FG000|Overall Study|Inter-current illness|0|||
143349212|NCT03176238|516824182|FG001|Overall Study|Inter-current illness|1|||
143349213|NCT03176238|516824181|FG000|Overall Study|Consent withdrawal|14|||
143349214|NCT03176238|516824182|FG001|Overall Study|Consent withdrawal|2|||
143349215|NCT03176238|516824181|FG000|Overall Study|Lost to Follow-up|3|||
143349216|NCT03176238|516824182|FG001|Overall Study|Lost to Follow-up|0|||
143349217|NCT03176238|516824181|FG000|Overall Study|Administrative problems|1|||
143349218|NCT03176238|516824182|FG001|Overall Study|Administrative problems|0|||
143349219|NCT03176238|516824181|FG000|Overall Study|Death|3|||
143349220|NCT03176238|516824182|FG001|Overall Study|Death|0|||
143349221|NCT03176238|516824181|FG000|Overall Study|Disease Progression|133|||
143349222|NCT03176238|516824182|FG001|Overall Study|Disease Progression|22|||
143349223|NCT03176238|516824181|FG000|Overall Study|Tx duration completed per EAP|0|||
143349224|NCT03176238|516824182|FG001|Overall Study|Tx duration completed per EAP|1|||
143349225|NCT03176238|516824181|FG000|Overall Study|Patient is switched to commercial drug|16|||
143349226|NCT03176238|516824182|FG001|Overall Study|Patient is switched to commercial drug|1|||
143349227|NCT03176238|516824181|FG000|Overall Study|Protocol Violation|1|||
143349228|NCT03176238|516824182|FG001|Overall Study|Protocol Violation|0|||
143349229|NCT03176238|516824181|FG000|Overall Study|Changes in the patient's condition|2|||
143349230|NCT03176238|516824182|FG001|Overall Study|Changes in the patient's condition|1|||
143349231|NCT03176238|516824181|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
143349232|NCT03176238|516824182|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
143349233|NCT00550550|516824183|FG000|Overall Study|Adverse Event|13|||
143349234|NCT00550550|516824184|FG001|Overall Study|Adverse Event|5|||
143349235|NCT00550550|516824183|FG000|Overall Study|Treatment Failure|0|||
143349236|NCT00550550|516824184|FG001|Overall Study|Treatment Failure|1|||
143349237|NCT00550550|516824183|FG000|Overall Study|Lost to Follow-up|4|||
143349238|NCT00550550|516824184|FG001|Overall Study|Lost to Follow-up|0|||
143349239|NCT00550550|516824183|FG000|Overall Study|Withdrawal by Subject|10|||
143349240|NCT00550550|516824184|FG001|Overall Study|Withdrawal by Subject|8|||
143349241|NCT00550550|516824183|FG000|Overall Study|Protocol Violation|5|||
143349242|NCT00550550|516824184|FG001|Overall Study|Protocol Violation|14|||
143349243|NCT00550550|516824183|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
143349244|NCT00550550|516824184|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
143349245|NCT00550550|516824183|FG000|Overall Study|Randomized But Not Treated|1|||
143349246|NCT00550550|516824184|FG001|Overall Study|Randomized But Not Treated|0|||
143349247|NCT00386308|516825540|FG000|Overall Study|Adverse Event|3|||
143349248|NCT00386308|516825541|FG001|Overall Study|Adverse Event|3|||
143349249|NCT00386308|516825540|FG000|Overall Study|Protocol Violation|2|||
143349250|NCT00386308|516825541|FG001|Overall Study|Protocol Violation|5|||
143349251|NCT00386308|516825540|FG000|Overall Study|Lack of Efficacy|0|||
143349252|NCT00386308|516825541|FG001|Overall Study|Lack of Efficacy|2|||
143349253|NCT00386308|516825540|FG000|Overall Study|Lost to Follow-up|10|||
143349254|NCT00386308|516825541|FG001|Overall Study|Lost to Follow-up|6|||
143349255|NCT00386308|516825540|FG000|Overall Study|Withdrawal by Subject|6|||
143349256|NCT00386308|516825541|FG001|Overall Study|Withdrawal by Subject|2|||
143349257|NCT00386308|516825540|FG000|Overall Study|Other Event|8|||
143349258|NCT00386308|516825541|FG001|Overall Study|Other Event|1|||
143349259|NCT02593539|516825542|FG000|Overall Study|Adverse Event|1|||
143349260|NCT01282476|516825543|FG000|Overall Study|Death|11|||
143349261|NCT03518658|516825544|FG000|Overall Study|Other|51|||
143349262|NCT03518658|516825545|FG001|Overall Study|Other|0|||
143349263|NCT00649389|516825546|FG000|Overall Study|Adverse Event|22|||
143349264|NCT00649389|516825547|FG001|Overall Study|Adverse Event|46|||
143349265|NCT00649389|516825548|FG002|Overall Study|Adverse Event|38|||
143349266|NCT00649389|516825549|FG003|Overall Study|Adverse Event|48|||
143349267|NCT00649389|516825546|FG000|Overall Study|Lost to Follow-up|15|||
143349268|NCT00649389|516825547|FG001|Overall Study|Lost to Follow-up|17|||
143349269|NCT00649389|516825548|FG002|Overall Study|Lost to Follow-up|21|||
143349270|NCT00649389|516825549|FG003|Overall Study|Lost to Follow-up|26|||
143349271|NCT00649389|516825546|FG000|Overall Study|Protocol Violation|11|||
143349272|NCT00649389|516825547|FG001|Overall Study|Protocol Violation|13|||
143349273|NCT00649389|516825548|FG002|Overall Study|Protocol Violation|9|||
143349274|NCT00649389|516825549|FG003|Overall Study|Protocol Violation|8|||
143349275|NCT00649389|516825546|FG000|Overall Study|Withdrawal by Subject|20|||
143349276|NCT00649389|516825547|FG001|Overall Study|Withdrawal by Subject|21|||
143349277|NCT00649389|516825548|FG002|Overall Study|Withdrawal by Subject|19|||
143349278|NCT00649389|516825549|FG003|Overall Study|Withdrawal by Subject|23|||
143349279|NCT00649389|516825546|FG000|Overall Study|Other|3|||
143349280|NCT00649389|516825547|FG001|Overall Study|Other|9|||
143349281|NCT00649389|516825548|FG002|Overall Study|Other|1|||
143349282|NCT00649389|516825549|FG003|Overall Study|Other|6|||
143349283|NCT02936037|516825550|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
143349284|NCT02936037|516825551|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
143349285|NCT02936037|516825550|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
143349286|NCT02936037|516825551|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
143349287|NCT02936037|516825550|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
143349288|NCT02936037|516825551|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
143349289|NCT02936037|516825550|FG000|Double-Blind Treatment Period|Death|0|||
143349290|NCT02936037|516825551|FG001|Double-Blind Treatment Period|Death|1|||
143349291|NCT02936037|516825550|FG000|Double-Blind Treatment Period|Adverse Event|11|||
143349292|NCT02936037|516825551|FG001|Double-Blind Treatment Period|Adverse Event|11|||
143349293|NCT02936037|516825550|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
143349294|NCT02936037|516825551|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
143349295|NCT02936037|516825550|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
143349296|NCT02936037|516825551|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
143349297|NCT02936037|516825550|FG000|Open Label Extension|Adverse Event|0|||
143349298|NCT02936037|516825551|FG001|Open Label Extension|Adverse Event|3|||
143349299|NCT02936037|516825550|FG000|Open Label Extension|Other|0|||
143349300|NCT02936037|516825551|FG001|Open Label Extension|Other|3|||
143349301|NCT02936037|516825550|FG000|Open Label Extension|Withdrawal by Subject|0|||
143349302|NCT02936037|516825551|FG001|Open Label Extension|Withdrawal by Subject|4|||
143349303|NCT00453310|516825552|FG000|Overall Study|Progression of Disease|10|||
143349304|NCT01993017|516825562|FG000|Overall Study|Death|23|||
143349305|NCT01993017|516825563|FG001|Overall Study|Death|26|||
143349306|NCT01993017|516825564|FG002|Overall Study|Death|18|||
143349307|NCT01993017|516825562|FG000|Overall Study|Could not be contacted|43|||
143349308|NCT01993017|516825563|FG001|Overall Study|Could not be contacted|42|||
143349309|NCT01993017|516825564|FG002|Overall Study|Could not be contacted|38|||
143349310|NCT01993017|516825562|FG000|Overall Study|Dropped out|19|||
143349311|NCT01993017|516825563|FG001|Overall Study|Dropped out|6|||
143349312|NCT01993017|516825564|FG002|Overall Study|Dropped out|11|||
143349313|NCT01993017|516825562|FG000|Overall Study|Other reasons|17|||
143349314|NCT01993017|516825563|FG001|Overall Study|Other reasons|11|||
143349315|NCT01993017|516825564|FG002|Overall Study|Other reasons|7|||
143349316|NCT01993017|516825562|FG000|Overall Study|Ineligible after randomization|4|||
143349317|NCT01993017|516825563|FG001|Overall Study|Ineligible after randomization|5|||
143349318|NCT01993017|516825564|FG002|Overall Study|Ineligible after randomization|5|||
143349319|NCT01087723|516825568|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
143349320|NCT01087723|516825569|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
143349321|NCT01087723|516825568|FG000|Overall Study|Withdrawal by Subject|10|||
143349322|NCT01087723|516825569|FG001|Overall Study|Withdrawal by Subject|13|||
143349323|NCT01087723|516825568|FG000|Overall Study|Physician Decision|2|||
143349324|NCT01087723|516825569|FG001|Overall Study|Physician Decision|0|||
143349325|NCT01087723|516825568|FG000|Overall Study|Lost to Follow-up|1|||
143349326|NCT01087723|516825569|FG001|Overall Study|Lost to Follow-up|4|||
143349327|NCT01087723|516825568|FG000|Overall Study|Reason Not Specified|1|||
143349328|NCT01087723|516825569|FG001|Overall Study|Reason Not Specified|2|||
143349329|NCT00806624|516825570|FG000|Overall Study|Adverse Event|2|||
143349330|NCT00806624|516825571|FG001|Overall Study|Adverse Event|8|||
143349331|NCT00806624|516825572|FG002|Overall Study|Adverse Event|0|||
143349332|NCT00806624|516825570|FG000|Overall Study|Death|0|||
143349333|NCT00806624|516825571|FG001|Overall Study|Death|1|||
143349334|NCT00806624|516825572|FG002|Overall Study|Death|1|||
143349335|NCT00806624|516825570|FG000|Overall Study|Lost to Follow-up|1|||
143349336|NCT00806624|516825571|FG001|Overall Study|Lost to Follow-up|0|||
143349337|NCT00806624|516825572|FG002|Overall Study|Lost to Follow-up|1|||
143349338|NCT00806624|516825570|FG000|Overall Study|Withdrawal by Subject|6|||
143349339|NCT00806624|516825571|FG001|Overall Study|Withdrawal by Subject|3|||
143349340|NCT00806624|516825572|FG002|Overall Study|Withdrawal by Subject|3|||
143349341|NCT00806624|516825570|FG000|Overall Study|discontinued before start of treatment|0|||
143011688|NCT01186744|515581699|FG002|Overall Study|Lack of Efficacy|0|||
143011689|NCT01186744|515581700|FG003|Overall Study|Lack of Efficacy|2|||
143011690|NCT01186744|515581701|FG004|Overall Study|Lack of Efficacy|2|||
143011691|NCT01186744|515581702|FG005|Overall Study|Lack of Efficacy|5|||
143011692|NCT01186744|515581697|FG000|Overall Study|Protocol Violation|1|||
143011693|NCT01186744|515581698|FG001|Overall Study|Protocol Violation|2|||
143011694|NCT01186744|515581699|FG002|Overall Study|Protocol Violation|0|||
143011695|NCT01186744|515581700|FG003|Overall Study|Protocol Violation|1|||
143011696|NCT01186744|515581701|FG004|Overall Study|Protocol Violation|1|||
143349342|NCT00806624|516825571|FG001|Overall Study|discontinued before start of treatment|0|||
143011697|NCT01186744|515581702|FG005|Overall Study|Protocol Violation|2|||
143349343|NCT00806624|516825572|FG002|Overall Study|discontinued before start of treatment|1|||
143349344|NCT01804673|516825576|FG000|Overall Study|Adverse Event|4|||
143349345|NCT01804673|516825576|FG000|Overall Study|Withdrawal by Subject|1|||
143349346|NCT01804673|516825576|FG000|Overall Study|Lack of Efficacy|9|||
143349347|NCT01804673|516825576|FG000|Overall Study|Change to Oral Therapy|37|||
143349348|NCT01804673|516825576|FG000|Overall Study|No Further Therapy Required|84|||
143461396|NCT02476279|517235040|FG000|Overall Study|Lost to Follow-up|1|||
143349349|NCT01804673|516825576|FG000|Overall Study|Use of Prohibited Medication|1|||
143349350|NCT01804673|516825576|FG000|Overall Study|Other|4|||
143349351|NCT01863043|516825585|FG000|Overall Study|Death|6|||
143349352|NCT01863043|516825586|FG001|Overall Study|Death|1|||
143349353|NCT01863043|516825585|FG000|Overall Study|Withdrawal by Subject|0|||
143349354|NCT01863043|516825586|FG001|Overall Study|Withdrawal by Subject|2|||
143349355|NCT01863043|516825585|FG000|Overall Study|Adverse Event|7|||
143349356|NCT01863043|516825586|FG001|Overall Study|Adverse Event|8|||
143349357|NCT01863043|516825585|FG000|Overall Study|exclusion criteria found after enrollment|0|||
143349358|NCT01863043|516825586|FG001|Overall Study|exclusion criteria found after enrollment|1|||
143349359|NCT00313911|516825587|FG000|Overall Study|Serious adverse event|6|||
143349360|NCT00313911|516825588|FG001|Overall Study|Serious adverse event|1|||
143349361|NCT00313911|516825587|FG000|Overall Study|Adverse Event|2|||
143349362|NCT00313911|516825588|FG001|Overall Study|Adverse Event|3|||
143349363|NCT00313911|516825587|FG000|Overall Study|Protocol Violation|19|||
143349364|NCT00313911|516825588|FG001|Overall Study|Protocol Violation|10|||
143349365|NCT00313911|516825587|FG000|Overall Study|Lost to Follow-up|27|||
143349366|NCT00313911|516825588|FG001|Overall Study|Lost to Follow-up|14|||
143349367|NCT00313911|516825587|FG000|Overall Study|Withdrawal by Subject|39|||
143349368|NCT00313911|516825588|FG001|Overall Study|Withdrawal by Subject|12|||
143349369|NCT00313911|516825587|FG000|Overall Study|Did not meet age criteria|1|||
143349370|NCT00313911|516825588|FG001|Overall Study|Did not meet age criteria|1|||
143349371|NCT01912781|516825591|FG000|Overall Study|Withdrawal by Subject|2|||
143349372|NCT01912781|516825592|FG001|Overall Study|Withdrawal by Subject|0|||
143349373|NCT01987596|516825593|FG000|Overall Study|Physician Decision|1|||
143349374|NCT01987596|516825594|FG001|Overall Study|Physician Decision|0|||
143349375|NCT01987596|516825593|FG000|Overall Study|Progressive Disease; missing all period|0|||
143349376|NCT01987596|516825594|FG001|Overall Study|Progressive Disease; missing all period|1|||
143349377|NCT02632786|516825595|FG000|Overall Study|Adverse Event|2|||
143349378|NCT02632786|516825596|FG001|Overall Study|Adverse Event|1|||
143349379|NCT02632786|516825595|FG000|Overall Study|Death|3|||
143349380|NCT02632786|516825596|FG001|Overall Study|Death|2|||
143349381|NCT02632786|516825595|FG000|Overall Study|Physician Decision|5|||
143349382|NCT02632786|516825596|FG001|Overall Study|Physician Decision|4|||
143349383|NCT02632786|516825595|FG000|Overall Study|Withdrawal by Subject|1|||
143349384|NCT02632786|516825596|FG001|Overall Study|Withdrawal by Subject|0|||
143349385|NCT01928225|516825597|FG000|Overall Study|Pregnancy|1|||
143349386|NCT01928225|516825598|FG001|Overall Study|Pregnancy|0|||
143349387|NCT01928225|516825597|FG000|Overall Study|basaloid cervical cancer|1|||
143349388|NCT01928225|516825598|FG001|Overall Study|basaloid cervical cancer|0|||
143349389|NCT01928225|516825597|FG000|Overall Study|Lost to Follow-up|1|||
143349390|NCT01928225|516825598|FG001|Overall Study|Lost to Follow-up|3|||
143349391|NCT00854295|516825599|FG000|Overall Study|Death|7|||
143349392|NCT00854295|516825600|FG001|Overall Study|Death|0|||
143349393|NCT00854295|516825601|FG002|Overall Study|Death|1|||
143349394|NCT00854295|516825602|FG003|Overall Study|Death|1|||
143349395|NCT00854295|516825599|FG000|Overall Study|Adverse Event|6|||
143349396|NCT00854295|516825600|FG001|Overall Study|Adverse Event|1|||
143349397|NCT00854295|516825601|FG002|Overall Study|Adverse Event|1|||
143349398|NCT00854295|516825602|FG003|Overall Study|Adverse Event|3|||
143349399|NCT00854295|516825599|FG000|Overall Study|Lost to Follow-up|18|||
143349400|NCT00854295|516825600|FG001|Overall Study|Lost to Follow-up|5|||
143349401|NCT00854295|516825601|FG002|Overall Study|Lost to Follow-up|21|||
143349402|NCT00854295|516825602|FG003|Overall Study|Lost to Follow-up|21|||
143349403|NCT00854295|516825599|FG000|Overall Study|Physician Decision|10|||
143349404|NCT00854295|516825600|FG001|Overall Study|Physician Decision|0|||
143349405|NCT00854295|516825601|FG002|Overall Study|Physician Decision|0|||
143349406|NCT00854295|516825602|FG003|Overall Study|Physician Decision|0|||
143349407|NCT00709592|516825603|FG000|Overall Study|Unable to proceed to transplant|0|||
143349408|NCT00709592|516825604|FG001|Overall Study|Unable to proceed to transplant|1|||
143349409|NCT02440594|516825607|FG000|Overall Study|Lost to Follow-up|34|||
143349410|NCT02440594|516825608|FG001|Overall Study|Lost to Follow-up|33|||
143461397|NCT02476279|517235041|FG001|Overall Study|Lost to Follow-up|1|||
143349411|NCT02440594|516825609|FG002|Overall Study|Lost to Follow-up|54|||
143349412|NCT02440594|516825610|FG003|Overall Study|Lost to Follow-up|47|||
143349413|NCT02440594|516825611|FG004|Overall Study|Lost to Follow-up|5|||
143349414|NCT02440594|516825612|FG005|Overall Study|Lost to Follow-up|4|||
143349415|NCT02440594|516825613|FG006|Overall Study|Lost to Follow-up|28|||
143349416|NCT02440594|516825614|FG007|Overall Study|Lost to Follow-up|48|||
143349417|NCT02440594|516825607|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
143349418|NCT02440594|516825608|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
143349419|NCT02440594|516825609|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
143349420|NCT02440594|516825610|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
143349421|NCT02440594|516825611|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
143349422|NCT02440594|516825612|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
143349423|NCT02440594|516825613|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
143349424|NCT02440594|516825614|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
143461398|NCT02208999|517235043|FG000|Overall Study|Lost to Follow-up|1|||
143349425|NCT02440594|516825607|FG000|Overall Study|Withdrawal by Subject|81|||
143349426|NCT02440594|516825608|FG001|Overall Study|Withdrawal by Subject|67|||
143349427|NCT02440594|516825609|FG002|Overall Study|Withdrawal by Subject|59|||
143349428|NCT02440594|516825610|FG003|Overall Study|Withdrawal by Subject|38|||
143349429|NCT02440594|516825611|FG004|Overall Study|Withdrawal by Subject|2|||
143349430|NCT02440594|516825612|FG005|Overall Study|Withdrawal by Subject|2|||
143349431|NCT02440594|516825613|FG006|Overall Study|Withdrawal by Subject|7|||
143349432|NCT02440594|516825614|FG007|Overall Study|Withdrawal by Subject|7|||
143349433|NCT02440594|516825607|FG000|Overall Study|Administratively w/drawn|3|||
143349434|NCT02440594|516825608|FG001|Overall Study|Administratively w/drawn|2|||
143349435|NCT02440594|516825609|FG002|Overall Study|Administratively w/drawn|0|||
143349436|NCT02440594|516825610|FG003|Overall Study|Administratively w/drawn|0|||
143349437|NCT02440594|516825611|FG004|Overall Study|Administratively w/drawn|0|||
143349438|NCT02440594|516825612|FG005|Overall Study|Administratively w/drawn|0|||
143349439|NCT02440594|516825613|FG006|Overall Study|Administratively w/drawn|2|||
143349440|NCT02440594|516825614|FG007|Overall Study|Administratively w/drawn|1|||
143349441|NCT03154359|516825615|FG000|Overall Study|Adverse Event|1|||
143349442|NCT03154359|516825615|FG000|Overall Study|Lack of Efficacy|2|||
143349443|NCT03154359|516825615|FG000|Overall Study|Lost to Follow-up|3|||
143349444|NCT03154359|516825615|FG000|Overall Study|Physician Decision|3|||
143349445|NCT03154359|516825615|FG000|Overall Study|Protocol Violation|4|||
143349446|NCT03154359|516825615|FG000|Overall Study|Withdrawal by Subject|5|||
143349447|NCT03154359|516825615|FG000|Overall Study|Disruption of study due to COVID-19|4|||
143349448|NCT04250337|516825616|FG000|Overall Study|Adverse Event|0|||
143349449|NCT04250337|516825617|FG001|Overall Study|Adverse Event|3|||
143349450|NCT04250337|516825616|FG000|Overall Study|Lack of Efficacy|1|||
143349451|NCT04250337|516825617|FG001|Overall Study|Lack of Efficacy|3|||
143349452|NCT04250337|516825616|FG000|Overall Study|Physician Decision|1|||
143349453|NCT04250337|516825617|FG001|Overall Study|Physician Decision|0|||
143349454|NCT04250337|516825616|FG000|Overall Study|Protocol Deviation|2|||
143349455|NCT04250337|516825617|FG001|Overall Study|Protocol Deviation|2|||
143349456|NCT04250337|516825616|FG000|Overall Study|Withdrawal by Subject|4|||
143349457|NCT04250337|516825617|FG001|Overall Study|Withdrawal by Subject|3|||
143349458|NCT04668989|516825618|FG000|First Intervention|Covid-19 related self-isolation|0|||
143349459|NCT04668989|516825619|FG001|First Intervention|Covid-19 related self-isolation|1|||
143349460|NCT04668989|516825618|FG000|Second Intervention|Adverse Event|0|||
143349461|NCT04668989|516825619|FG001|Second Intervention|Adverse Event|1|||
143349462|NCT01235975|516825623|FG000|Overall Study|Serious Adverse Event|0|||
143349463|NCT01235975|516825624|FG001|Overall Study|Serious Adverse Event|1|||
143349464|NCT01235975|516825623|FG000|Overall Study|Withdrawal by Subject|8|||
143349465|NCT01235975|516825624|FG001|Overall Study|Withdrawal by Subject|2|||
143349466|NCT01235975|516825623|FG000|Overall Study|Migrated/moved from study area|2|||
143349467|NCT01235975|516825624|FG001|Overall Study|Migrated/moved from study area|1|||
143349468|NCT01235975|516825623|FG000|Overall Study|Lost to Follow-up|7|||
143349469|NCT01235975|516825624|FG001|Overall Study|Lost to Follow-up|3|||
143349470|NCT00791921|516825629|FG000|Overall Study|Protocol planed|24|||
143349471|NCT00791921|516825630|FG001|Overall Study|Protocol planed|88|||
143349472|NCT00791921|516825629|FG000|Overall Study|Withdrawal by Subject|1|||
143349473|NCT00791921|516825630|FG001|Overall Study|Withdrawal by Subject|2|||
143349474|NCT00791921|516825629|FG000|Overall Study|Adverse Event|8|||
143349475|NCT00791921|516825630|FG001|Overall Study|Adverse Event|2|||
143349476|NCT00791921|516825629|FG000|Overall Study|Lack of Efficacy|0|||
143349477|NCT00791921|516825630|FG001|Overall Study|Lack of Efficacy|2|||
143349478|NCT00791921|516825629|FG000|Overall Study|Lack of study drug administration|1|||
143349479|NCT00791921|516825630|FG001|Overall Study|Lack of study drug administration|1|||
143349480|NCT00791921|516825629|FG000|Overall Study|Reason other than those above|0|||
143349481|NCT00791921|516825630|FG001|Overall Study|Reason other than those above|1|||
143349482|NCT01592695|516825632|FG000|Overall Study|Lost to Follow-up|8|||
143349483|NCT01592695|516825633|FG001|Overall Study|Lost to Follow-up|4|||
143349484|NCT00422799|516825634|FG000|Overall Study|Withdrawal by Subject|6|||
143349485|NCT00422799|516825634|FG000|Overall Study|Adverse Event|7|||
143349486|NCT01965158|516825635|FG000|Overall Study|Adverse Event|14|||
143349487|NCT01965158|516825636|FG001|Overall Study|Adverse Event|5|||
143349488|NCT01965158|516825635|FG000|Overall Study|Withdrawal by Subject|16|||
143349489|NCT01965158|516825636|FG001|Overall Study|Withdrawal by Subject|24|||
143349490|NCT01965158|516825635|FG000|Overall Study|Lost to Follow-up|7|||
143349491|NCT01965158|516825636|FG001|Overall Study|Lost to Follow-up|5|||
143349492|NCT01965158|516825635|FG000|Overall Study|Protocol Violation|1|||
143349493|NCT01965158|516825636|FG001|Overall Study|Protocol Violation|1|||
143349494|NCT01965158|516825635|FG000|Overall Study|Other - Miscellaneous|3|||
143349495|NCT01965158|516825636|FG001|Overall Study|Other - Miscellaneous|0|||
143349496|NCT00474175|516825637|FG000|Overall Study|Lack of Efficacy|0|||
143349497|NCT00474175|516825638|FG001|Overall Study|Lack of Efficacy|0|||
143349498|NCT00474175|516825639|FG002|Overall Study|Lack of Efficacy|1|||
143349499|NCT00474175|516825637|FG000|Overall Study|Withdrawal by Subject|0|||
143349500|NCT00474175|516825638|FG001|Overall Study|Withdrawal by Subject|1|||
143349501|NCT00474175|516825639|FG002|Overall Study|Withdrawal by Subject|1|||
143349502|NCT00474175|516825637|FG000|Overall Study|Ineligible|1|||
143349503|NCT00474175|516825638|FG001|Overall Study|Ineligible|3|||
143349504|NCT00474175|516825639|FG002|Overall Study|Ineligible|1|||
143349505|NCT00474175|516825637|FG000|Overall Study|Protocol Violation|0|||
143349506|NCT00474175|516825638|FG001|Overall Study|Protocol Violation|2|||
143349507|NCT00474175|516825639|FG002|Overall Study|Protocol Violation|1|||
143349508|NCT00474175|516825637|FG000|Overall Study|Administrative|0|||
143349509|NCT00474175|516825638|FG001|Overall Study|Administrative|1|||
143349510|NCT00474175|516825639|FG002|Overall Study|Administrative|0|||
143349511|NCT03321006|516825645|FG000|Overall Study|Death|1|||
143349512|NCT03321006|516825646|FG001|Overall Study|Death|0|||
143349513|NCT03321006|516825645|FG000|Overall Study|Lack of Efficacy|1|||
143349514|NCT03321006|516825646|FG001|Overall Study|Lack of Efficacy|0|||
143349515|NCT04498247|516825649|FG000|Overall Study|Lost to Follow-up|0|||
143349516|NCT04498247|516825650|FG001|Overall Study|Lost to Follow-up|0|||
143349517|NCT04498247|516825651|FG002|Overall Study|Lost to Follow-up|0|||
143349518|NCT04498247|516825652|FG003|Overall Study|Lost to Follow-up|1|||
143349519|NCT04498247|516825653|FG004|Overall Study|Lost to Follow-up|0|||
143349520|NCT04498247|516825654|FG005|Overall Study|Lost to Follow-up|0|||
143349521|NCT04498247|516825655|FG006|Overall Study|Lost to Follow-up|0|||
143349522|NCT04498247|516825656|FG007|Overall Study|Lost to Follow-up|0|||
143349523|NCT04498247|516825649|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
143349524|NCT04498247|516825650|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
143349525|NCT04498247|516825651|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
143349526|NCT04498247|516825652|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
143349527|NCT04498247|516825653|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
143349528|NCT04498247|516825654|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
143349529|NCT04498247|516825655|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
143349530|NCT04498247|516825656|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
143349531|NCT04498247|516825649|FG000|Overall Study|Withdrawal by Subject|0|||
143349532|NCT04498247|516825650|FG001|Overall Study|Withdrawal by Subject|8|||
143349533|NCT04498247|516825651|FG002|Overall Study|Withdrawal by Subject|0|||
143349534|NCT04498247|516825652|FG003|Overall Study|Withdrawal by Subject|7|||
143349535|NCT04498247|516825653|FG004|Overall Study|Withdrawal by Subject|0|||
143349536|NCT04498247|516825654|FG005|Overall Study|Withdrawal by Subject|0|||
143349537|NCT04498247|516825655|FG006|Overall Study|Withdrawal by Subject|1|||
143349538|NCT04498247|516825656|FG007|Overall Study|Withdrawal by Subject|0|||
143349539|NCT04498247|516825649|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
143349540|NCT04498247|516825650|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
143349541|NCT04498247|516825651|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
143349542|NCT04498247|516825652|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
143349543|NCT04498247|516825653|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
143349544|NCT04498247|516825654|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
143349545|NCT04498247|516825655|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
143349546|NCT04498247|516825656|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
143349547|NCT00192023|516825657|FG000|Period III - Double-Blind|Adverse Event|3|||
143349548|NCT00192023|516825658|FG001|Period III - Double-Blind|Adverse Event|0|||
143349549|NCT00192023|516825657|FG000|Period III - Double-Blind|Physician Decision|2|||
143349550|NCT00192023|516825658|FG001|Period III - Double-Blind|Physician Decision|0|||
143349551|NCT00192023|516825657|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
143349552|NCT00192023|516825658|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
143349553|NCT00192023|516825657|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
143349554|NCT00192023|516825658|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
143349555|NCT00192023|516825657|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
143349556|NCT00192023|516825658|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
143349557|NCT00192023|516825657|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
143349558|NCT00192023|516825658|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
143349559|NCT00192023|516825657|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
143349560|NCT00192023|516825658|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
143349561|NCT00192023|516825657|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
143349562|NCT00192023|516825658|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
143349563|NCT00192023|516825657|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
143349564|NCT00192023|516825658|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
143349565|NCT00192023|516825657|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
143349566|NCT00192023|516825658|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
143349567|NCT00669903|516825659|FG000|Overall Study|Adverse Event|0|||
143349568|NCT00669903|516825660|FG001|Overall Study|Adverse Event|1|||
143349569|NCT00669903|516825661|FG002|Overall Study|Adverse Event|3|||
143349570|NCT00669903|516825662|FG003|Overall Study|Adverse Event|1|||
143349571|NCT00669903|516825659|FG000|Overall Study|Withdrawal by Subject|0|||
143349572|NCT00669903|516825660|FG001|Overall Study|Withdrawal by Subject|2|||
143349573|NCT00669903|516825661|FG002|Overall Study|Withdrawal by Subject|2|||
143349574|NCT00669903|516825662|FG003|Overall Study|Withdrawal by Subject|2|||
143349575|NCT00669903|516825659|FG000|Overall Study|Lost to Follow-up|1|||
143349576|NCT00669903|516825660|FG001|Overall Study|Lost to Follow-up|1|||
143349577|NCT00669903|516825661|FG002|Overall Study|Lost to Follow-up|0|||
143349578|NCT00669903|516825662|FG003|Overall Study|Lost to Follow-up|1|||
143349579|NCT00669903|516825659|FG000|Overall Study|Protocol Violation|0|||
143349580|NCT00669903|516825660|FG001|Overall Study|Protocol Violation|1|||
143349581|NCT00669903|516825661|FG002|Overall Study|Protocol Violation|0|||
143349582|NCT00669903|516825662|FG003|Overall Study|Protocol Violation|0|||
143349583|NCT01737996|516825666|FG000|Overall Study|Adverse Event|0|||
143349584|NCT01737996|516825667|FG001|Overall Study|Adverse Event|1|||
143349585|NCT01737996|516825668|FG002|Overall Study|Adverse Event|1|||
143349586|NCT01737996|516825666|FG000|Overall Study|Withdrawal by Subject|0|||
143349587|NCT01737996|516825667|FG001|Overall Study|Withdrawal by Subject|0|||
143349588|NCT01737996|516825668|FG002|Overall Study|Withdrawal by Subject|1|||
143349589|NCT02340520|516825673|FG000|Overall Study|Lost to Follow-up|1|||
143349590|NCT02340520|516825673|FG000|Overall Study|Patient did not take drug as specified|1|||
143349591|NCT02340520|516825673|FG000|Overall Study|Withdrawal by Subject|1|||
143349592|NCT03311230|516825680|FG000|Overall Study|Withdrawal by Subject|1|||
143349593|NCT03311230|516825681|FG001|Overall Study|Withdrawal by Subject|4|||
143349594|NCT03311230|516825682|FG002|Overall Study|Withdrawal by Subject|2|||
143349595|NCT03311230|516825683|FG003|Overall Study|Withdrawal by Subject|7|||
143349596|NCT03311230|516825680|FG000|Overall Study|Unrelated injury|0|||
143349597|NCT03311230|516825681|FG001|Overall Study|Unrelated injury|1|||
143349598|NCT03311230|516825682|FG002|Overall Study|Unrelated injury|0|||
143349599|NCT03311230|516825683|FG003|Overall Study|Unrelated injury|0|||
143349600|NCT01302938|516825684|FG000|Overall Study|Withdrawal by Subject|1|||
143349601|NCT01302938|516825685|FG001|Overall Study|Withdrawal by Subject|0|||
143349602|NCT01302938|516825684|FG000|Overall Study|Adverse Event|1|||
143349603|NCT01302938|516825685|FG001|Overall Study|Adverse Event|0|||
143349604|NCT00171873|516825686|FG000|Overall Study|Withdrawal by Subject|4|||
143349605|NCT00171873|516825687|FG001|Overall Study|Withdrawal by Subject|2|||
143349606|NCT00171873|516825686|FG000|Overall Study|Adverse Event|5|||
143349607|NCT00171873|516825687|FG001|Overall Study|Adverse Event|0|||
143349608|NCT00171873|516825686|FG000|Overall Study|Switched to Octreotide|0|||
143349609|NCT00171873|516825687|FG001|Overall Study|Switched to Octreotide|1|||
143349610|NCT05200936|516825690|FG000|Overall Study|Withdrawal by Subject|2|||
143349611|NCT05200936|516825691|FG001|Overall Study|Withdrawal by Subject|2|||
143349612|NCT05200936|516825690|FG000|Overall Study|Lost to Follow-up|2|||
143349613|NCT05200936|516825691|FG001|Overall Study|Lost to Follow-up|0|||
143349614|NCT05200936|516825690|FG000|Overall Study|Pregnancy|0|||
143349615|NCT05200936|516825691|FG001|Overall Study|Pregnancy|1|||
143349616|NCT04287868|516825695|FG000|Overall Study|Screening fail|1|||
143349617|NCT04287868|516825696|FG001|Overall Study|Screening fail|0|||
143349618|NCT02906683|516827199|FG000|Overall Study|Adverse Event|0|||
143349619|NCT02906683|516827200|FG001|Overall Study|Adverse Event|1|||
143349620|NCT02906683|516827201|FG002|Overall Study|Adverse Event|0|||
143349621|NCT02906683|516827199|FG000|Overall Study|Physician Decision|0|||
143349622|NCT02906683|516827200|FG001|Overall Study|Physician Decision|1|||
143349623|NCT02906683|516827201|FG002|Overall Study|Physician Decision|1|||
143349624|NCT02906683|516827199|FG000|Overall Study|Withdrawal by Subject|0|||
143349625|NCT02906683|516827200|FG001|Overall Study|Withdrawal by Subject|2|||
143349626|NCT02906683|516827201|FG002|Overall Study|Withdrawal by Subject|1|||
143349627|NCT02906683|516827199|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
143349628|NCT02906683|516827200|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
143349629|NCT02906683|516827201|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
143349630|NCT02906683|516827199|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
143349631|NCT02906683|516827200|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
143349632|NCT02906683|516827201|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
143349633|NCT02781506|516827202|FG000|Overall Study|Adverse Event|5|||
143349634|NCT01340482|516827204|FG000|Overall Study|Adverse Event|2|||
143349635|NCT01340482|516827205|FG001|Overall Study|Adverse Event|0|||
143349636|NCT01340482|516827206|FG002|Overall Study|Adverse Event|0|||
143349637|NCT00077636|516827209|FG000|Overall Study|Refused Treatment|9|||
143349638|NCT00077636|516827210|FG001|Overall Study|Refused Treatment|31|||
143349639|NCT00077636|516827209|FG000|Overall Study|Admin|3|||
143349640|NCT00077636|516827210|FG001|Overall Study|Admin|3|||
143349641|NCT00077636|516827209|FG000|Overall Study|Withdrawal by Subject|2|||
143349642|NCT00077636|516827210|FG001|Overall Study|Withdrawal by Subject|2|||
143349643|NCT00077636|516827209|FG000|Overall Study|Adverse Event|17|||
143349644|NCT00077636|516827210|FG001|Overall Study|Adverse Event|34|||
143349645|NCT00077636|516827209|FG000|Overall Study|Protocol Violation|0|||
143349646|NCT00077636|516827210|FG001|Overall Study|Protocol Violation|2|||
143349647|NCT00077636|516827209|FG000|Overall Study|Lost to Follow-up|10|||
143349648|NCT00077636|516827210|FG001|Overall Study|Lost to Follow-up|18|||
143349649|NCT00077636|516827209|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
143349650|NCT00077636|516827210|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
143349651|NCT00592319|516827211|FG000|Overall Study|Lost to Follow-up|0|||
143349652|NCT00592319|516827212|FG001|Overall Study|Lost to Follow-up|3|||
143349653|NCT01868035|516827214|FG000|Overall Study|Lost to Follow-up|3|||
143349654|NCT01868035|516827214|FG000|Overall Study|Withdrawal by Subject|1|||
143349655|NCT01868035|516827214|FG000|Overall Study|Progressive Disease|2|||
143349656|NCT01868035|516827214|FG000|Overall Study|Non-compliance|1|||
143349657|NCT00569803|516827215|FG000|Overall Study|Lost to Follow-up|1|||
143349658|NCT00569803|516827216|FG001|Overall Study|Lost to Follow-up|0|||
143349659|NCT00569803|516827217|FG002|Overall Study|Lost to Follow-up|0|||
143349660|NCT00569803|516827218|FG003|Overall Study|Lost to Follow-up|0|||
143349661|NCT00569803|516827219|FG004|Overall Study|Lost to Follow-up|0|||
143349662|NCT00569803|516827220|FG005|Overall Study|Lost to Follow-up|0|||
143349663|NCT00569803|516827221|FG006|Overall Study|Lost to Follow-up|0|||
143349664|NCT00569803|516827222|FG007|Overall Study|Lost to Follow-up|0|||
143349665|NCT00569803|516827215|FG000|Overall Study|injection syringe leaked during dosing|0|||
143349666|NCT00569803|516827216|FG001|Overall Study|injection syringe leaked during dosing|0|||
143349667|NCT00569803|516827217|FG002|Overall Study|injection syringe leaked during dosing|0|||
143349668|NCT00569803|516827218|FG003|Overall Study|injection syringe leaked during dosing|1|||
143349669|NCT00569803|516827219|FG004|Overall Study|injection syringe leaked during dosing|0|||
143349670|NCT00569803|516827220|FG005|Overall Study|injection syringe leaked during dosing|0|||
143349671|NCT00569803|516827221|FG006|Overall Study|injection syringe leaked during dosing|0|||
143349672|NCT00569803|516827222|FG007|Overall Study|injection syringe leaked during dosing|0|||
143349673|NCT00569803|516827215|FG000|Overall Study|Withdrawal by Subject|0|||
143349674|NCT00569803|516827216|FG001|Overall Study|Withdrawal by Subject|0|||
143349675|NCT00569803|516827217|FG002|Overall Study|Withdrawal by Subject|0|||
143349676|NCT00569803|516827218|FG003|Overall Study|Withdrawal by Subject|0|||
143349677|NCT00569803|516827219|FG004|Overall Study|Withdrawal by Subject|0|||
143349678|NCT00569803|516827220|FG005|Overall Study|Withdrawal by Subject|0|||
143349679|NCT00569803|516827221|FG006|Overall Study|Withdrawal by Subject|0|||
143349680|NCT00569803|516827222|FG007|Overall Study|Withdrawal by Subject|1|||
143349681|NCT01622348|516827223|FG000|Overall Study|Withdrawal by Subject|1|||
143349682|NCT01622348|516827224|FG001|Overall Study|Withdrawal by Subject|0|||
143349683|NCT01622348|516827225|FG002|Overall Study|Withdrawal by Subject|1|||
143349684|NCT04537897|516827226|FG000|Overall Study|Other than listed|0|||
143349685|NCT04537897|516827227|FG001|Overall Study|Other than listed|0|||
143349686|NCT04537897|516827228|FG002|Overall Study|Other than listed|0|||
143349687|NCT04537897|516827229|FG003|Overall Study|Other than listed|0|||
143349688|NCT04537897|516827230|FG004|Overall Study|Other than listed|0|||
143349689|NCT04537897|516827231|FG005|Overall Study|Other than listed|0|||
143349690|NCT04537897|516827232|FG006|Overall Study|Other than listed|1|||
143349691|NCT04537897|516827233|FG007|Overall Study|Other than listed|0|||
143349692|NCT04537897|516827234|FG008|Overall Study|Other than listed|0|||
143349693|NCT04537897|516827226|FG000|Overall Study|Adverse Event|0|||
143349694|NCT04537897|516827227|FG001|Overall Study|Adverse Event|0|||
143349695|NCT04537897|516827228|FG002|Overall Study|Adverse Event|0|||
143349696|NCT04537897|516827229|FG003|Overall Study|Adverse Event|1|||
143349697|NCT04537897|516827230|FG004|Overall Study|Adverse Event|0|||
143349698|NCT04537897|516827231|FG005|Overall Study|Adverse Event|0|||
143349699|NCT04537897|516827232|FG006|Overall Study|Adverse Event|0|||
143349700|NCT04537897|516827233|FG007|Overall Study|Adverse Event|0|||
143349701|NCT04537897|516827234|FG008|Overall Study|Adverse Event|0|||
143349702|NCT04537897|516827226|FG000|Overall Study|Withdrawal by Subject|0|||
143349703|NCT04537897|516827227|FG001|Overall Study|Withdrawal by Subject|1|||
143349704|NCT04537897|516827228|FG002|Overall Study|Withdrawal by Subject|0|||
143349705|NCT04537897|516827229|FG003|Overall Study|Withdrawal by Subject|0|||
143349706|NCT04537897|516827230|FG004|Overall Study|Withdrawal by Subject|0|||
143349707|NCT04537897|516827231|FG005|Overall Study|Withdrawal by Subject|0|||
143349708|NCT04537897|516827232|FG006|Overall Study|Withdrawal by Subject|0|||
143349709|NCT04537897|516827233|FG007|Overall Study|Withdrawal by Subject|0|||
143349710|NCT04537897|516827234|FG008|Overall Study|Withdrawal by Subject|0|||
143349711|NCT03029780|516827235|FG000|Overall Study|Disease Progression|20|||
143349712|NCT03029780|516827236|FG001|Overall Study|Disease Progression|22|||
143349713|NCT03029780|516827235|FG000|Overall Study|Study Drug Toxicity|15|||
143349714|NCT03029780|516827236|FG001|Overall Study|Study Drug Toxicity|11|||
143349715|NCT03029780|516827235|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
143349716|NCT03029780|516827236|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
143349717|NCT03029780|516827235|FG000|Overall Study|Participant request to discontinue study treatment|4|||
143349718|NCT03029780|516827236|FG001|Overall Study|Participant request to discontinue study treatment|1|||
143349719|NCT03029780|516827235|FG000|Overall Study|Maximum clinical benefit|1|||
143349720|NCT03029780|516827236|FG001|Overall Study|Maximum clinical benefit|0|||
143349721|NCT03029780|516827235|FG000|Overall Study|Participant no longer meets study criteria|0|||
143349722|NCT03029780|516827236|FG001|Overall Study|Participant no longer meets study criteria|1|||
143349723|NCT03029780|516827235|FG000|Overall Study|Other reasons|6|||
143349724|NCT03029780|516827236|FG001|Overall Study|Other reasons|6|||
143349725|NCT03029780|516827235|FG000|Overall Study|Not reported|1|||
143349726|NCT03029780|516827236|FG001|Overall Study|Not reported|1|||
143349727|NCT03029780|516827235|FG000|Overall Study|Death|2|||
143349728|NCT03029780|516827236|FG001|Overall Study|Death|6|||
143349729|NCT00197028|516827237|FG000|Overall Study|Adverse Event|2|||
143349730|NCT00197028|516827238|FG001|Overall Study|Adverse Event|2|||
143349731|NCT00197028|516827237|FG000|Overall Study|Protocol Violation|2|||
143349732|NCT00197028|516827238|FG001|Overall Study|Protocol Violation|1|||
143349733|NCT00197028|516827237|FG000|Overall Study|Withdrawal by Subject|8|||
143349734|NCT00197028|516827238|FG001|Overall Study|Withdrawal by Subject|12|||
143349735|NCT00197028|516827237|FG000|Overall Study|Lost to Follow-up|1|||
143349736|NCT00197028|516827238|FG001|Overall Study|Lost to Follow-up|0|||
143349737|NCT00197028|516827237|FG000|Overall Study|Other|3|||
143349738|NCT00197028|516827238|FG001|Overall Study|Other|6|||
143349739|NCT00885352|516827243|FG000|Overall Study|Adverse Event|2|||
143349740|NCT00885352|516827244|FG001|Overall Study|Adverse Event|3|||
143349741|NCT00885352|516827243|FG000|Overall Study|Lost to Follow-up|2|||
143349742|NCT00885352|516827244|FG001|Overall Study|Lost to Follow-up|2|||
143349743|NCT00885352|516827243|FG000|Overall Study|Physician Decision|0|||
143349744|NCT00885352|516827244|FG001|Overall Study|Physician Decision|3|||
143349745|NCT00885352|516827243|FG000|Overall Study|Protocol Violation|0|||
143349746|NCT00885352|516827244|FG001|Overall Study|Protocol Violation|2|||
143349747|NCT00885352|516827243|FG000|Overall Study|Withdrawal by Subject|1|||
143349748|NCT00885352|516827244|FG001|Overall Study|Withdrawal by Subject|5|||
143349749|NCT00885352|516827243|FG000|Overall Study|Contradiction to study medication|0|||
143349750|NCT00885352|516827244|FG001|Overall Study|Contradiction to study medication|2|||
143349751|NCT00885352|516827243|FG000|Overall Study|Excluded medication|2|||
143349752|NCT00885352|516827244|FG001|Overall Study|Excluded medication|2|||
143349753|NCT00885352|516827243|FG000|Overall Study|Lab abnormalities|1|||
143349754|NCT00885352|516827244|FG001|Overall Study|Lab abnormalities|1|||
143349755|NCT00365378|516827245|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
143349756|NCT00365378|516827246|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
143349757|NCT00365378|516827247|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
143349758|NCT00365378|516827245|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
143349759|NCT00365378|516827246|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
143349760|NCT00365378|516827247|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
143349761|NCT00365378|516827245|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
143349762|NCT00365378|516827246|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
143349763|NCT00365378|516827247|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
143349764|NCT00365378|516827245|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
143349765|NCT00365378|516827246|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
143349766|NCT00365378|516827247|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
143349767|NCT00365378|516827245|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
143349768|NCT00365378|516827246|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
143349769|NCT00365378|516827247|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
143349770|NCT00365378|516827245|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
143349771|NCT00365378|516827246|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
143349772|NCT00365378|516827247|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
143349773|NCT00365378|516827245|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
143349774|NCT00365378|516827246|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
143349775|NCT00365378|516827247|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
143349776|NCT00365378|516827245|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
143349777|NCT00365378|516827246|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
143349778|NCT00365378|516827247|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
143349779|NCT00365378|516827245|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
143349780|NCT00365378|516827246|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
143349781|NCT00365378|516827247|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
143349782|NCT00365378|516827245|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
143349783|NCT00365378|516827246|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
143349784|NCT00365378|516827247|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
143349785|NCT00365378|516827245|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
143349786|NCT00365378|516827246|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
143349787|NCT00365378|516827247|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
143011698|NCT01186744|515581697|FG000|Overall Study|Lost to Follow-up|15|||
143349788|NCT00365378|516827245|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
143349789|NCT00365378|516827246|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
143349790|NCT00365378|516827247|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
143349791|NCT00365378|516827245|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
143349792|NCT00365378|516827246|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
143011699|NCT01186744|515581698|FG001|Overall Study|Lost to Follow-up|16|||
143349793|NCT00365378|516827247|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
143349794|NCT00365378|516827245|FG000|Extension|Adverse Event|0|||
143349795|NCT00365378|516827246|FG001|Extension|Adverse Event|0|||
143349796|NCT00365378|516827247|FG002|Extension|Adverse Event|1|||
143011700|NCT01186744|515581699|FG002|Overall Study|Lost to Follow-up|2|||
143011701|NCT01186744|515581700|FG003|Overall Study|Lost to Follow-up|1|||
143349797|NCT00365378|516827245|FG000|Extension|Moved|0|||
143349798|NCT00365378|516827246|FG001|Extension|Moved|0|||
143349799|NCT00365378|516827247|FG002|Extension|Moved|8|||
143349800|NCT00365378|516827245|FG000|Extension|Lost to Follow-up|0|||
143349801|NCT00365378|516827246|FG001|Extension|Lost to Follow-up|0|||
143349802|NCT00365378|516827247|FG002|Extension|Lost to Follow-up|57|||
143349803|NCT00365378|516827245|FG000|Extension|Protocol Violation|0|||
143349804|NCT00365378|516827246|FG001|Extension|Protocol Violation|0|||
143349805|NCT00365378|516827247|FG002|Extension|Protocol Violation|2|||
143349806|NCT00365378|516827245|FG000|Extension|Withdrawal by Subject|0|||
143349807|NCT00365378|516827246|FG001|Extension|Withdrawal by Subject|0|||
143349808|NCT00365378|516827247|FG002|Extension|Withdrawal by Subject|98|||
143349809|NCT00365378|516827245|FG000|Extension|Other|0|||
143349810|NCT00365378|516827246|FG001|Extension|Other|0|||
143349811|NCT00365378|516827247|FG002|Extension|Other|31|||
143349812|NCT03560258|516827248|FG000|Overall Study|Lost to Follow-up|3|||
143349813|NCT03560258|516827249|FG001|Overall Study|Lost to Follow-up|0|||
143349814|NCT03560258|516827250|FG002|Overall Study|Lost to Follow-up|0|||
143349815|NCT03560258|516827248|FG000|Overall Study|Protocol Violation|0|||
143349816|NCT03560258|516827249|FG001|Overall Study|Protocol Violation|1|||
143349817|NCT03560258|516827250|FG002|Overall Study|Protocol Violation|0|||
143349818|NCT03560258|516827248|FG000|Overall Study|Withdrawal by Subject|0|||
143349819|NCT03560258|516827249|FG001|Overall Study|Withdrawal by Subject|0|||
143349820|NCT03560258|516827250|FG002|Overall Study|Withdrawal by Subject|1|||
143349821|NCT02006121|516827254|FG000|Double Blind Phase|Adverse Event|6|||
143349822|NCT02006121|516827255|FG001|Double Blind Phase|Adverse Event|0|||
143349823|NCT02006121|516827254|FG000|Double Blind Phase|Lack of Efficacy|1|||
143349824|NCT02006121|516827255|FG001|Double Blind Phase|Lack of Efficacy|16|||
143349825|NCT02006121|516827254|FG000|Double Blind Phase|Withdrawal by Subject|3|||
143349826|NCT02006121|516827255|FG001|Double Blind Phase|Withdrawal by Subject|4|||
143349827|NCT02006121|516827254|FG000|Double Blind Phase|Non-compliance with study drug|1|||
143349828|NCT02006121|516827255|FG001|Double Blind Phase|Non-compliance with study drug|3|||
143349829|NCT02006121|516827254|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
143349830|NCT02006121|516827255|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
143349831|NCT02006121|516827254|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
143349832|NCT02006121|516827255|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
143349833|NCT02006121|516827254|FG000|Open Label Phase|Adverse Event|15|||
143349834|NCT02006121|516827255|FG001|Open Label Phase|Adverse Event|0|||
143349835|NCT02006121|516827254|FG000|Open Label Phase|Lack of Efficacy|2|||
143349836|NCT02006121|516827255|FG001|Open Label Phase|Lack of Efficacy|0|||
143349837|NCT02006121|516827254|FG000|Open Label Phase|Protocol Violation|2|||
143349838|NCT02006121|516827255|FG001|Open Label Phase|Protocol Violation|0|||
143349839|NCT02006121|516827254|FG000|Open Label Phase|Withdrawal by Subject|3|||
143349840|NCT02006121|516827255|FG001|Open Label Phase|Withdrawal by Subject|0|||
143349841|NCT02006121|516827254|FG000|Open Label Phase|Non-compliance with study drug|3|||
143349842|NCT02006121|516827255|FG001|Open Label Phase|Non-compliance with study drug|0|||
143349843|NCT00452413|516827258|FG000|Overall Study|Progressive Disease|4|||
143349844|NCT00452413|516827259|FG001|Overall Study|Progressive Disease|11|||
143349845|NCT00452413|516827260|FG002|Overall Study|Progressive Disease|30|||
143349846|NCT00452413|516827258|FG000|Overall Study|Withdrawal by Subject|0|||
143349847|NCT00452413|516827259|FG001|Overall Study|Withdrawal by Subject|1|||
143349848|NCT00452413|516827260|FG002|Overall Study|Withdrawal by Subject|4|||
143349849|NCT00452413|516827258|FG000|Overall Study|Adverse Event|0|||
143349850|NCT00452413|516827259|FG001|Overall Study|Adverse Event|0|||
143349851|NCT00452413|516827260|FG002|Overall Study|Adverse Event|5|||
143349852|NCT00452413|516827258|FG000|Overall Study|Physician Decision|0|||
143349853|NCT00452413|516827259|FG001|Overall Study|Physician Decision|0|||
143349854|NCT00452413|516827260|FG002|Overall Study|Physician Decision|4|||
143349855|NCT00452413|516827258|FG000|Overall Study|Death due to study disease|0|||
143349856|NCT00452413|516827259|FG001|Overall Study|Death due to study disease|0|||
143349857|NCT00452413|516827260|FG002|Overall Study|Death due to study disease|2|||
143349858|NCT00452413|516827258|FG000|Overall Study|Death due to adverse event (AE)|0|||
143349859|NCT00452413|516827259|FG001|Overall Study|Death due to adverse event (AE)|0|||
143349860|NCT00452413|516827260|FG002|Overall Study|Death due to adverse event (AE)|1|||
143349861|NCT00452413|516827258|FG000|Overall Study|On treatment|0|||
143349862|NCT00452413|516827259|FG001|Overall Study|On treatment|0|||
143349863|NCT00452413|516827260|FG002|Overall Study|On treatment|3|||
143349864|NCT02693834|516827267|FG000|Baseline Measurement|Withdrawal by Subject|1|||
143349865|NCT02693834|516827268|FG001|Baseline Measurement|Withdrawal by Subject|0|||
143349866|NCT02693834|516827267|FG000|Baseline Measurement|Adverse Event|1|||
143349867|NCT02693834|516827268|FG001|Baseline Measurement|Adverse Event|0|||
143349868|NCT02693834|516827267|FG000|Week 2 Practice|Adverse Event|0|||
143349869|NCT02693834|516827268|FG001|Week 2 Practice|Adverse Event|1|||
143349870|NCT01468922|516827269|FG000|Overall Study|Screening failure|0|||
143349871|NCT01468922|516827270|FG001|Overall Study|Screening failure|0|||
143349872|NCT01468922|516827271|FG002|Overall Study|Screening failure|0|||
143349873|NCT01468922|516827272|FG003|Overall Study|Screening failure|0|||
143349874|NCT01468922|516827273|FG004|Overall Study|Screening failure|0|||
143349875|NCT01468922|516827274|FG005|Overall Study|Screening failure|0|||
143349876|NCT01468922|516827275|FG006|Overall Study|Screening failure|0|||
143349877|NCT01468922|516827276|FG007|Overall Study|Screening failure|0|||
143349878|NCT01468922|516827277|FG008|Overall Study|Screening failure|1|||
143349879|NCT01468922|516827269|FG000|Overall Study|Per patient choice|1|||
143349880|NCT01468922|516827270|FG001|Overall Study|Per patient choice|0|||
143349881|NCT01468922|516827271|FG002|Overall Study|Per patient choice|0|||
143349882|NCT01468922|516827272|FG003|Overall Study|Per patient choice|0|||
143349883|NCT01468922|516827273|FG004|Overall Study|Per patient choice|0|||
143349884|NCT01468922|516827274|FG005|Overall Study|Per patient choice|0|||
143349885|NCT01468922|516827275|FG006|Overall Study|Per patient choice|0|||
143349886|NCT01468922|516827276|FG007|Overall Study|Per patient choice|0|||
143349887|NCT01468922|516827277|FG008|Overall Study|Per patient choice|0|||
143349888|NCT01468922|516827269|FG000|Overall Study|Switched to alternative treatment|1|||
143349889|NCT01468922|516827270|FG001|Overall Study|Switched to alternative treatment|0|||
143349890|NCT01468922|516827271|FG002|Overall Study|Switched to alternative treatment|0|||
143349891|NCT01468922|516827272|FG003|Overall Study|Switched to alternative treatment|0|||
143349892|NCT01468922|516827273|FG004|Overall Study|Switched to alternative treatment|1|||
143349893|NCT01468922|516827274|FG005|Overall Study|Switched to alternative treatment|0|||
143349894|NCT01468922|516827275|FG006|Overall Study|Switched to alternative treatment|0|||
143349895|NCT01468922|516827276|FG007|Overall Study|Switched to alternative treatment|0|||
143349896|NCT01468922|516827277|FG008|Overall Study|Switched to alternative treatment|0|||
143349897|NCT01468922|516827269|FG000|Overall Study|Enrolled on new protocol|0|||
143349898|NCT01468922|516827270|FG001|Overall Study|Enrolled on new protocol|0|||
143349899|NCT01468922|516827271|FG002|Overall Study|Enrolled on new protocol|0|||
143349900|NCT01468922|516827272|FG003|Overall Study|Enrolled on new protocol|0|||
143349901|NCT01468922|516827273|FG004|Overall Study|Enrolled on new protocol|1|||
143349902|NCT01468922|516827274|FG005|Overall Study|Enrolled on new protocol|0|||
143349903|NCT01468922|516827275|FG006|Overall Study|Enrolled on new protocol|0|||
143349904|NCT01468922|516827276|FG007|Overall Study|Enrolled on new protocol|0|||
143349905|NCT01468922|516827277|FG008|Overall Study|Enrolled on new protocol|0|||
143349906|NCT01468922|516827269|FG000|Overall Study|Adverse Event|0|||
143349907|NCT01468922|516827270|FG001|Overall Study|Adverse Event|0|||
143349908|NCT01468922|516827271|FG002|Overall Study|Adverse Event|0|||
143349909|NCT01468922|516827272|FG003|Overall Study|Adverse Event|0|||
143349910|NCT01468922|516827273|FG004|Overall Study|Adverse Event|0|||
143349911|NCT01468922|516827274|FG005|Overall Study|Adverse Event|0|||
143349912|NCT01468922|516827275|FG006|Overall Study|Adverse Event|0|||
143349913|NCT01468922|516827276|FG007|Overall Study|Adverse Event|1|||
143349914|NCT01468922|516827277|FG008|Overall Study|Adverse Event|0|||
143349915|NCT01468922|516827269|FG000|Overall Study|Infection of blood|0|||
143349916|NCT01468922|516827270|FG001|Overall Study|Infection of blood|0|||
143349917|NCT01468922|516827271|FG002|Overall Study|Infection of blood|0|||
143349918|NCT01468922|516827272|FG003|Overall Study|Infection of blood|0|||
143349919|NCT01468922|516827273|FG004|Overall Study|Infection of blood|0|||
143349920|NCT01468922|516827274|FG005|Overall Study|Infection of blood|0|||
143349921|NCT01468922|516827275|FG006|Overall Study|Infection of blood|0|||
143349922|NCT01468922|516827276|FG007|Overall Study|Infection of blood|1|||
143349923|NCT01468922|516827277|FG008|Overall Study|Infection of blood|0|||
143349924|NCT01468922|516827269|FG000|Overall Study|Patient choice - surgery|0|||
143349925|NCT01468922|516827270|FG001|Overall Study|Patient choice - surgery|0|||
143349926|NCT01468922|516827271|FG002|Overall Study|Patient choice - surgery|0|||
143349927|NCT01468922|516827272|FG003|Overall Study|Patient choice - surgery|0|||
143349928|NCT01468922|516827273|FG004|Overall Study|Patient choice - surgery|0|||
143349929|NCT01468922|516827274|FG005|Overall Study|Patient choice - surgery|0|||
143349930|NCT01468922|516827275|FG006|Overall Study|Patient choice - surgery|0|||
143349931|NCT01468922|516827276|FG007|Overall Study|Patient choice - surgery|1|||
143349932|NCT01468922|516827277|FG008|Overall Study|Patient choice - surgery|0|||
143349933|NCT01468922|516827269|FG000|Overall Study|Refused further treatment|0|||
143349934|NCT01468922|516827270|FG001|Overall Study|Refused further treatment|0|||
143349935|NCT01468922|516827271|FG002|Overall Study|Refused further treatment|0|||
143349936|NCT01468922|516827272|FG003|Overall Study|Refused further treatment|0|||
143349937|NCT01468922|516827273|FG004|Overall Study|Refused further treatment|0|||
143349938|NCT01468922|516827274|FG005|Overall Study|Refused further treatment|0|||
143349939|NCT01468922|516827275|FG006|Overall Study|Refused further treatment|0|||
143349940|NCT01468922|516827276|FG007|Overall Study|Refused further treatment|1|||
143349941|NCT01468922|516827277|FG008|Overall Study|Refused further treatment|0|||
143349942|NCT01923389|516827278|FG000|Overall Study|Protocol Violation|1|||
143349943|NCT01923389|516827279|FG001|Overall Study|Protocol Violation|0|||
143349944|NCT02761629|516827283|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
143349945|NCT02761629|516827284|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
143349946|NCT02761629|516827283|FG000|Overall Study|Insufficient Therapeutic Response|2|||
143349947|NCT02761629|516827284|FG001|Overall Study|Insufficient Therapeutic Response|7|||
143349948|NCT02761629|516827283|FG000|Overall Study|Failure to Return|2|||
143349949|NCT02761629|516827284|FG001|Overall Study|Failure to Return|4|||
143349950|NCT02761629|516827283|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
143349951|NCT02761629|516827284|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
143349952|NCT02761629|516827283|FG000|Overall Study|Protocol Violation|2|||
143349953|NCT02761629|516827284|FG001|Overall Study|Protocol Violation|2|||
143349954|NCT02761629|516827283|FG000|Overall Study|Withdrawal by Subject|0|||
143349955|NCT02761629|516827284|FG001|Overall Study|Withdrawal by Subject|3|||
143349956|NCT02761629|516827283|FG000|Overall Study|Other|0|||
143349957|NCT02761629|516827284|FG001|Overall Study|Other|2|||
143349958|NCT02761629|516827283|FG000|Overall Study|Lost to Follow-up|4|||
143349959|NCT02761629|516827284|FG001|Overall Study|Lost to Follow-up|1|||
143349960|NCT02761629|516827283|FG000|Overall Study|Randomized But Not Treated|8|||
143349961|NCT02761629|516827284|FG001|Overall Study|Randomized But Not Treated|4|||
143349962|NCT01348776|516827285|FG000|Overall Study|Lost to Follow-up|3|||
143349963|NCT03856996|516827293|FG000|Overall Study|Withdrawal by Subject|1|||
143349964|NCT03856996|516827294|FG001|Overall Study|Withdrawal by Subject|0|||
143349965|NCT03856996|516827293|FG000|Overall Study|Lost to Follow-up|0|||
143349966|NCT03856996|516827294|FG001|Overall Study|Lost to Follow-up|1|||
143349967|NCT03856996|516827293|FG000|Overall Study|Adverse Event|1|||
143349968|NCT03856996|516827294|FG001|Overall Study|Adverse Event|1|||
143349969|NCT03856996|516827293|FG000|Overall Study|Other|1|||
143349970|NCT03856996|516827294|FG001|Overall Study|Other|0|||
143349971|NCT01155661|516827300|FG000|Overall Study|Adverse Event|101|||
143349972|NCT01155661|516827300|FG000|Overall Study|Death|1|||
143349973|NCT01155661|516827300|FG000|Overall Study|Lack of Efficacy|32|||
143349974|NCT01155661|516827300|FG000|Overall Study|Lost to Follow-up|22|||
143349975|NCT01155661|516827300|FG000|Overall Study|Physician Decision|3|||
143349976|NCT01155661|516827300|FG000|Overall Study|Protocol Violation|35|||
143349977|NCT01155661|516827300|FG000|Overall Study|Withdrawal by Subject|73|||
143349978|NCT01155661|516827300|FG000|Overall Study|Sponsor Decision|13|||
143011702|NCT01186744|515581701|FG004|Overall Study|Lost to Follow-up|1|||
143011703|NCT01186744|515581702|FG005|Overall Study|Lost to Follow-up|4|||
143011704|NCT01186744|515581697|FG000|Overall Study|Screen failure|1|||
143011705|NCT01186744|515581698|FG001|Overall Study|Screen failure|1|||
143011706|NCT01186744|515581699|FG002|Overall Study|Screen failure|0|||
143011707|NCT01186744|515581700|FG003|Overall Study|Screen failure|1|||
143349979|NCT01396395|516827301|FG000|Overall Study|Withdrawal by Subject|10|||
143349980|NCT01396395|516827302|FG001|Overall Study|Withdrawal by Subject|12|||
143349981|NCT01396395|516827301|FG000|Overall Study|Protocol Violation|3|||
143349982|NCT01396395|516827302|FG001|Overall Study|Protocol Violation|1|||
143349983|NCT01396395|516827301|FG000|Overall Study|Adverse Event|10|||
143349984|NCT01396395|516827302|FG001|Overall Study|Adverse Event|2|||
143349985|NCT01396395|516827301|FG000|Overall Study|Lost to Follow-up|17|||
143349986|NCT01396395|516827302|FG001|Overall Study|Lost to Follow-up|11|||
143349987|NCT01396395|516827301|FG000|Overall Study|Other|0|||
143349988|NCT01396395|516827302|FG001|Overall Study|Other|1|||
143349989|NCT00882921|516827303|FG000|Overall Study|Death|2|||
143349990|NCT00882921|516827303|FG000|Overall Study|Other|3|||
143349991|NCT00882921|516827303|FG000|Overall Study|Lost to Follow-up|2|||
143349992|NCT00882921|516827303|FG000|Overall Study|Termination By Investigator|3|||
143349993|NCT00882921|516827303|FG000|Overall Study|Withdrawal Of Consent|1|||
143349994|NCT01370005|516827304|FG000|Overall Study|Not treated|1|||
143349995|NCT01370005|516827305|FG001|Overall Study|Not treated|0|||
143349996|NCT01370005|516827306|FG002|Overall Study|Not treated|0|||
143349997|NCT01370005|516827304|FG000|Overall Study|Adverse Event|5|||
143349998|NCT01370005|516827305|FG001|Overall Study|Adverse Event|5|||
143349999|NCT01370005|516827306|FG002|Overall Study|Adverse Event|6|||
143350000|NCT01370005|516827304|FG000|Overall Study|Lack of Efficacy|1|||
143350001|NCT01370005|516827305|FG001|Overall Study|Lack of Efficacy|0|||
143350002|NCT01370005|516827306|FG002|Overall Study|Lack of Efficacy|0|||
143350003|NCT01370005|516827304|FG000|Overall Study|Non compliant with protocol|0|||
143350004|NCT01370005|516827305|FG001|Overall Study|Non compliant with protocol|1|||
143350005|NCT01370005|516827306|FG002|Overall Study|Non compliant with protocol|2|||
143350006|NCT01370005|516827304|FG000|Overall Study|Lost to Follow-up|1|||
143350007|NCT01370005|516827305|FG001|Overall Study|Lost to Follow-up|1|||
143350008|NCT01370005|516827306|FG002|Overall Study|Lost to Follow-up|1|||
143011708|NCT01186744|515581701|FG004|Overall Study|Screen failure|0|||
143011709|NCT01186744|515581702|FG005|Overall Study|Screen failure|0|||
143011710|NCT01186744|515581697|FG000|Overall Study|Withdrawal by Subject|14|||
143011711|NCT01186744|515581698|FG001|Overall Study|Withdrawal by Subject|10|||
143124856|NCT00524680|516001320|FG001|Overall Study|Withdrawal by Subject|0|||
143350009|NCT01370005|516827304|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
143350010|NCT01370005|516827305|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
143350011|NCT01370005|516827306|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
143350012|NCT01370005|516827304|FG000|Overall Study|Other reason not defined above|3|||
143350013|NCT01370005|516827305|FG001|Overall Study|Other reason not defined above|0|||
143350014|NCT01370005|516827306|FG002|Overall Study|Other reason not defined above|2|||
143011712|NCT01186744|515581699|FG002|Overall Study|Withdrawal by Subject|2|||
143011713|NCT01186744|515581700|FG003|Overall Study|Withdrawal by Subject|5|||
143011714|NCT01186744|515581701|FG004|Overall Study|Withdrawal by Subject|0|||
143350015|NCT03691948|516827307|FG000|Overall Study|Lost to Follow-up|1|||
143350016|NCT03691948|516827308|FG001|Overall Study|Lost to Follow-up|3|||
143350017|NCT02009696|516827309|FG000|Overall Study|Withdrawal by Subject|2|||
143350018|NCT02120664|516827310|FG000|Overall Study|Withdrawal by Subject|0|||
143350019|NCT02120664|516827311|FG001|Overall Study|Withdrawal by Subject|0|||
143350020|NCT02120664|516827312|FG002|Overall Study|Withdrawal by Subject|0|||
143350021|NCT02120664|516827313|FG003|Overall Study|Withdrawal by Subject|1|||
143350022|NCT02120664|516827314|FG004|Overall Study|Withdrawal by Subject|0|||
143350023|NCT02460263|516827315|FG000|Transition Period|Withdrawal by Subject|1|||
143350024|NCT02460263|516827315|FG000|Transition Period|Death|1|||
143350025|NCT03916744|516827316|FG000|Overall Study|Withdrawal by Subject|0|||
143350026|NCT03916744|516827317|FG001|Overall Study|Withdrawal by Subject|1|||
143350027|NCT03916744|516827318|FG002|Overall Study|Withdrawal by Subject|2|||
143350028|NCT04524598|516827319|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
143350029|NCT04524598|516827320|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
143350030|NCT04524598|516827321|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
143350031|NCT04524598|516827322|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
143350032|NCT04524598|516827323|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
143350033|NCT04524598|516827319|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
143350034|NCT04524598|516827320|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
143350035|NCT04524598|516827321|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
143350036|NCT04524598|516827322|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
143350037|NCT04524598|516827323|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
143350038|NCT04524598|516827319|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
143350039|NCT04524598|516827320|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
143350040|NCT04524598|516827321|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
143350041|NCT04524598|516827322|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
143350042|NCT04524598|516827323|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
143350043|NCT04524598|516827319|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
143350044|NCT04524598|516827320|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
143350045|NCT04524598|516827321|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
143350046|NCT04524598|516827322|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
143350047|NCT04524598|516827323|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
143350048|NCT04524598|516827319|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
143350049|NCT04524598|516827320|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
143350050|NCT04524598|516827321|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
143350051|NCT04524598|516827322|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
143350052|NCT04524598|516827323|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
143350053|NCT04524598|516827319|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
143350054|NCT04524598|516827320|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
143350055|NCT04524598|516827321|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
143350056|NCT04524598|516827322|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
143350057|NCT04524598|516827323|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
143350058|NCT04524598|516827319|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
143350059|NCT04524598|516827320|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
143350060|NCT04524598|516827321|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
143350061|NCT04524598|516827322|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
143350062|NCT04524598|516827323|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
143350063|NCT02301156|516827324|FG000|Overall Study|Adverse Event|13|||
143350064|NCT02301156|516827325|FG001|Overall Study|Adverse Event|14|||
143350065|NCT02301156|516827324|FG000|Overall Study|Death|1|||
143350066|NCT02301156|516827325|FG001|Overall Study|Death|5|||
143350067|NCT02301156|516827324|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
143350068|NCT02301156|516827325|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
143350069|NCT02301156|516827324|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
143350070|NCT02301156|516827325|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
143350071|NCT02301156|516827324|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
143350072|NCT02301156|516827325|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
143350073|NCT02301156|516827324|FG000|Overall Study|Reason not Specified|6|||
143350074|NCT02301156|516827325|FG001|Overall Study|Reason not Specified|3|||
143350075|NCT00591864|516827328|FG000|Overall Study|Incomplete Imaging|5|||
143350076|NCT00118092|516827333|FG000|Overall Study|Withdrawal by Subject|1|||
143350077|NCT00118092|516827333|FG000|Overall Study|Protocol Violation|1|||
143350078|NCT02041923|516827336|FG000|Overall Study|Lost to Follow-up|26|||
143350079|NCT02041923|516827337|FG001|Overall Study|Lost to Follow-up|30|||
143350080|NCT00621296|516827348|FG000|Overall Study|Adverse Event|2|||
143350081|NCT00621296|516827348|FG000|Overall Study|Lack of Efficacy|1|||
143350082|NCT00621296|516827348|FG000|Overall Study|Physician Decision|7|||
143350083|NCT00621296|516827348|FG000|Overall Study|Unmatch Criteria|1|||
143350084|NCT00621296|516827348|FG000|Overall Study|Stopping Criteria|3|||
143350085|NCT01518946|516827355|FG000|Open-label Phase|Other|4|||
143350086|NCT01518946|516827356|FG001|Open-label Phase|Other|0|||
143350087|NCT01518946|516827357|FG002|Open-label Phase|Other|0|||
143350088|NCT01518946|516827355|FG000|Randomized Phase (First Intervention)|Other|0|||
143350089|NCT01518946|516827356|FG001|Randomized Phase (First Intervention)|Other|1|||
143350090|NCT01518946|516827357|FG002|Randomized Phase (First Intervention)|Other|0|||
143350091|NCT00384059|516827358|FG000|Infant Series|Not consented|2|||
143350092|NCT00384059|516827359|FG001|Infant Series|Not consented|6|||
143350093|NCT00384059|516827358|FG000|Infant Series|Withdrawal by Subject|2|||
143350094|NCT00384059|516827359|FG001|Infant Series|Withdrawal by Subject|2|||
143350095|NCT00384059|516827358|FG000|Infant Series|Adverse Event|1|||
143350096|NCT00384059|516827359|FG001|Infant Series|Adverse Event|2|||
143350097|NCT00384059|516827358|FG000|Infant Series|Protocol Violation|1|||
143350098|NCT00384059|516827359|FG001|Infant Series|Protocol Violation|2|||
143350099|NCT00384059|516827358|FG000|Infant Series|Lost to Follow-up|0|||
143350100|NCT00384059|516827359|FG001|Infant Series|Lost to Follow-up|1|||
143350101|NCT00384059|516827358|FG000|After Infant Series|Protocol Violation|2|||
143350102|NCT00384059|516827359|FG001|After Infant Series|Protocol Violation|3|||
143350103|NCT00384059|516827358|FG000|After Infant Series|Withdrawal by Subject|2|||
143350104|NCT00384059|516827359|FG001|After Infant Series|Withdrawal by Subject|2|||
143350105|NCT00384059|516827358|FG000|After Infant Series|Failed to Return|0|||
143350106|NCT00384059|516827359|FG001|After Infant Series|Failed to Return|2|||
143350107|NCT00384059|516827358|FG000|After Infant Series|Adverse Event|0|||
143350108|NCT00384059|516827359|FG001|After Infant Series|Adverse Event|1|||
143350109|NCT00384059|516827358|FG000|After Infant Series|Physician Decision|0|||
143350110|NCT00384059|516827359|FG001|After Infant Series|Physician Decision|1|||
143350111|NCT00384059|516827358|FG000|After Infant Series|Lost to Follow-up|0|||
143350112|NCT00384059|516827359|FG001|After Infant Series|Lost to Follow-up|1|||
143350113|NCT00384059|516827358|FG000|Toddler Dose|Lost to Follow-up|1|||
143350114|NCT00384059|516827359|FG001|Toddler Dose|Lost to Follow-up|1|||
143350115|NCT00384059|516827358|FG000|Toddler Dose|Failed to return|0|||
143350116|NCT00384059|516827359|FG001|Toddler Dose|Failed to return|1|||
143350117|NCT00381641|516827365|FG000|Overall Study|Withdrawal by Subject|0|||
143350118|NCT00381641|516827366|FG001|Overall Study|Withdrawal by Subject|2|||
143350119|NCT04921969|516827367|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
143350120|NCT04921969|516827368|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
143350121|NCT04921969|516827369|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
143350122|NCT04921969|516827370|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
143350123|NCT04921969|516827371|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
143350124|NCT04921969|516827372|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
143350125|NCT04921969|516827373|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
143350126|NCT04921969|516827367|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
143350127|NCT04921969|516827368|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
143350128|NCT04921969|516827369|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
143350129|NCT04921969|516827370|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
143350130|NCT04921969|516827371|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
143350131|NCT04921969|516827372|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
143350132|NCT04921969|516827373|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
143350133|NCT04921969|516827367|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
143350134|NCT04921969|516827368|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
143350135|NCT04921969|516827369|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
143350136|NCT04921969|516827370|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
143350137|NCT04921969|516827371|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
143350138|NCT04921969|516827372|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
143350139|NCT04921969|516827373|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
143350140|NCT04921969|516827367|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
143350141|NCT04921969|516827368|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
143350142|NCT04921969|516827369|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
143350143|NCT04921969|516827370|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
143350144|NCT04921969|516827371|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
143350145|NCT04921969|516827372|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
143350146|NCT04921969|516827373|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
143350147|NCT04921969|516827367|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
143350148|NCT04921969|516827368|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
143350149|NCT04921969|516827369|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
143124857|NCT00524680|516001321|FG002|Overall Study|Withdrawal by Subject|1|||
143350150|NCT04921969|516827370|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
143350151|NCT04921969|516827371|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
143350152|NCT04921969|516827372|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
143350153|NCT04921969|516827373|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
143350154|NCT04921969|516827367|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
143350155|NCT04921969|516827368|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
143350156|NCT04921969|516827369|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
143350157|NCT04921969|516827370|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
143350158|NCT04921969|516827371|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
143350159|NCT04921969|516827372|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
143350160|NCT04921969|516827373|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
143350161|NCT04921969|516827367|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
143350162|NCT04921969|516827368|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
143350163|NCT04921969|516827369|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
143350164|NCT04921969|516827370|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
143350165|NCT04921969|516827371|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
143350166|NCT04921969|516827372|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
143350167|NCT04921969|516827373|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
143350168|NCT04921969|516827367|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
143350169|NCT04921969|516827368|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
143350170|NCT04921969|516827369|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
143350171|NCT04921969|516827370|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
143350172|NCT04921969|516827371|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
143350173|NCT04921969|516827372|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
143350174|NCT04921969|516827373|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
143350175|NCT04921969|516827367|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
143350176|NCT04921969|516827368|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
143350177|NCT04921969|516827369|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
143350178|NCT04921969|516827370|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
143350179|NCT04921969|516827371|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
143350180|NCT04921969|516827372|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
143350181|NCT04921969|516827373|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
143350182|NCT04921969|516827367|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
143350183|NCT04921969|516827368|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
143350184|NCT04921969|516827369|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
143350185|NCT04921969|516827370|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
143350186|NCT04921969|516827371|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
143350187|NCT04921969|516827372|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|18|||
143350188|NCT04921969|516827373|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|9|||
143350189|NCT04921969|516827367|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
143350190|NCT04921969|516827368|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
143350191|NCT04921969|516827369|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
143350192|NCT04921969|516827370|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
143350193|NCT04921969|516827371|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
143350194|NCT04921969|516827372|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
143350195|NCT04921969|516827373|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
143350196|NCT04921969|516827367|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
143350197|NCT04921969|516827368|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
143350198|NCT04921969|516827369|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
143350199|NCT04921969|516827370|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|2|||
143350200|NCT04921969|516827371|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
143350201|NCT04921969|516827372|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|22|||
143350202|NCT04921969|516827373|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
143350203|NCT04921969|516827367|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
143350204|NCT04921969|516827368|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
143350205|NCT04921969|516827369|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
143350206|NCT04921969|516827370|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
143350207|NCT04921969|516827371|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
143350208|NCT04921969|516827372|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
143350209|NCT04921969|516827373|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
143350210|NCT04921969|516827367|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
143350211|NCT04921969|516827368|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
143350212|NCT04921969|516827369|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
143350213|NCT04921969|516827370|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
143350214|NCT04921969|516827371|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
143350215|NCT04921969|516827372|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
143350216|NCT04921969|516827373|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
143350217|NCT04921969|516827367|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
143350218|NCT04921969|516827368|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
143350219|NCT04921969|516827369|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
143350220|NCT04921969|516827370|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
143350221|NCT04921969|516827371|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
143350222|NCT04921969|516827372|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
143350223|NCT04921969|516827373|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
143350224|NCT01811563|516829155|FG000|Overall Study|Lost to Follow-up|5|||
143350225|NCT01811563|516829156|FG001|Overall Study|Lost to Follow-up|2|||
143350226|NCT01811563|516829155|FG000|Overall Study|Incorrect Randomization procedure|0|||
143350227|NCT01811563|516829156|FG001|Overall Study|Incorrect Randomization procedure|1|||
143350228|NCT04424290|516829157|FG000|Overall Study|Not treated|0|||
143350229|NCT04424290|516829158|FG001|Overall Study|Not treated|0|||
143350230|NCT04424290|516829159|FG002|Overall Study|Not treated|1|||
143350231|NCT04424290|516829160|FG003|Overall Study|Not treated|0|||
143350232|NCT04424290|516829161|FG004|Overall Study|Not treated|1|||
143350233|NCT04424290|516829157|FG000|Overall Study|Adverse Event|0|||
143350234|NCT04424290|516829158|FG001|Overall Study|Adverse Event|0|||
143350235|NCT04424290|516829159|FG002|Overall Study|Adverse Event|0|||
143350236|NCT04424290|516829160|FG003|Overall Study|Adverse Event|2|||
143350237|NCT04424290|516829161|FG004|Overall Study|Adverse Event|0|||
143350238|NCT04424290|516829157|FG000|Overall Study|Withdrawal by Subject|0|||
143350239|NCT04424290|516829158|FG001|Overall Study|Withdrawal by Subject|0|||
143350240|NCT04424290|516829159|FG002|Overall Study|Withdrawal by Subject|0|||
143350241|NCT04424290|516829160|FG003|Overall Study|Withdrawal by Subject|0|||
143350242|NCT04424290|516829161|FG004|Overall Study|Withdrawal by Subject|1|||
143350243|NCT04424290|516829157|FG000|Overall Study|Other than listed|0|||
143350244|NCT04424290|516829158|FG001|Overall Study|Other than listed|0|||
143350245|NCT04424290|516829159|FG002|Overall Study|Other than listed|0|||
143350246|NCT04424290|516829160|FG003|Overall Study|Other than listed|1|||
143350247|NCT04424290|516829161|FG004|Overall Study|Other than listed|0|||
143350248|NCT01267825|516829162|FG000|Overall Study|study terminated. no data collected.|1|||
143350249|NCT01267825|516829163|FG001|Overall Study|study terminated. no data collected.|0|||
143350250|NCT02791490|516829164|FG000|Overall Study|Lost to Follow-up|1|||
143350251|NCT02791490|516829165|FG001|Overall Study|Lost to Follow-up|2|||
143350252|NCT02791490|516829164|FG000|Overall Study|Withdrawal by Subject|2|||
143350253|NCT02791490|516829165|FG001|Overall Study|Withdrawal by Subject|6|||
143350254|NCT01017120|516829166|FG000|Overall Study|Adverse Event|9|||
143350255|NCT01017120|516829167|FG001|Overall Study|Adverse Event|0|||
143350256|NCT01017120|516829166|FG000|Overall Study|Lost to Follow-up|13|||
143350257|NCT01017120|516829167|FG001|Overall Study|Lost to Follow-up|11|||
143350258|NCT01017120|516829166|FG000|Overall Study|Lack of Efficacy|1|||
143350259|NCT01017120|516829167|FG001|Overall Study|Lack of Efficacy|0|||
143350260|NCT01017120|516829166|FG000|Overall Study|Withdrawal by Subject|39|||
143350261|NCT01017120|516829167|FG001|Overall Study|Withdrawal by Subject|21|||
143350262|NCT01017120|516829166|FG000|Overall Study|Pregnancy|1|||
143350263|NCT01017120|516829167|FG001|Overall Study|Pregnancy|1|||
143350264|NCT01017120|516829166|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
143350265|NCT01017120|516829167|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
143350266|NCT01017120|516829166|FG000|Overall Study|Relocated Out of Town|0|||
143350267|NCT01017120|516829167|FG001|Overall Study|Relocated Out of Town|2|||
143350268|NCT01017120|516829166|FG000|Overall Study|Protocol Violation|1|||
143350269|NCT01017120|516829167|FG001|Overall Study|Protocol Violation|0|||
143350270|NCT01017120|516829166|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
143350271|NCT01017120|516829167|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
143350272|NCT01912222|516829171|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
143350273|NCT01912222|516829172|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
143350274|NCT01912222|516829173|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
143350275|NCT01912222|516829171|FG000|Part B: Treatment Period|Progressive disease|10|||
143350276|NCT01912222|516829172|FG001|Part B: Treatment Period|Progressive disease|12|||
143350277|NCT01912222|516829173|FG002|Part B: Treatment Period|Progressive disease|15|||
143350278|NCT01912222|516829171|FG000|Part B: Treatment Period|Adverse Event|1|||
143350279|NCT01912222|516829172|FG001|Part B: Treatment Period|Adverse Event|2|||
143350280|NCT01912222|516829173|FG002|Part B: Treatment Period|Adverse Event|3|||
143350281|NCT01912222|516829171|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
143350282|NCT01912222|516829172|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
143350283|NCT01912222|516829173|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
143350284|NCT01024959|516829174|FG000|Overall Study|ineligible|12|||
143350285|NCT01024959|516829174|FG000|Overall Study|results not evaluable|12|||
143350286|NCT01024959|516829174|FG000|Overall Study|missing results required for analysis|17|||
143461399|NCT00319839|517235044|FG000|Overall Study|Adverse Event|5|||
143461400|NCT00319839|517235044|FG000|Overall Study|Withdrawal by Subject|1|||
143461401|NCT04494256|517235045|FG000|Part 1: Double Blinded Period|Adverse Event|1|||
143461402|NCT04494256|517235046|FG001|Part 1: Double Blinded Period|Adverse Event|0|||
143461403|NCT04494256|517235047|FG002|Part 1: Double Blinded Period|Adverse Event|0|||
143461404|NCT04494256|517235048|FG003|Part 1: Double Blinded Period|Adverse Event|0|||
143350287|NCT00451217|516829176|FG000|Overall Study|Lost to Follow-up|0|||
143350288|NCT00451217|516829177|FG001|Overall Study|Lost to Follow-up|1|||
143350289|NCT00451217|516829178|FG002|Overall Study|Lost to Follow-up|1|||
143350290|NCT00451217|516829179|FG003|Overall Study|Lost to Follow-up|1|||
143350291|NCT00451217|516829176|FG000|Overall Study|Withdrawal by Subject|1|||
143350292|NCT00451217|516829177|FG001|Overall Study|Withdrawal by Subject|0|||
143461405|NCT04494256|517235049|FG004|Part 1: Double Blinded Period|Adverse Event|3|||
143461406|NCT04494256|517235050|FG005|Part 1: Double Blinded Period|Adverse Event|0|||
143350293|NCT00451217|516829178|FG002|Overall Study|Withdrawal by Subject|0|||
143350294|NCT00451217|516829179|FG003|Overall Study|Withdrawal by Subject|0|||
143350295|NCT00451217|516829176|FG000|Overall Study|Not Treated|1|||
143350296|NCT00451217|516829177|FG001|Overall Study|Not Treated|1|||
143350297|NCT00451217|516829178|FG002|Overall Study|Not Treated|3|||
143350298|NCT00451217|516829179|FG003|Overall Study|Not Treated|4|||
143350299|NCT01129336|516829180|FG000|Overall Study|Protocol Violation|1|||
143350300|NCT01129336|516829181|FG001|Overall Study|Protocol Violation|0|||
143350301|NCT01129336|516829180|FG000|Overall Study|Disease Progression|1|||
143350302|NCT01129336|516829181|FG001|Overall Study|Disease Progression|4|||
143350303|NCT01129336|516829180|FG000|Overall Study|Lost to Follow-up|1|||
143350304|NCT01129336|516829181|FG001|Overall Study|Lost to Follow-up|0|||
143350305|NCT01129336|516829180|FG000|Overall Study|Withdrawal by Subject|7|||
143350306|NCT01129336|516829181|FG001|Overall Study|Withdrawal by Subject|4|||
143350307|NCT01129336|516829180|FG000|Overall Study|Adverse Event|0|||
143350308|NCT01129336|516829181|FG001|Overall Study|Adverse Event|1|||
143350309|NCT01129336|516829180|FG000|Overall Study|Missing Study Completion Status|2|||
143350310|NCT01129336|516829181|FG001|Overall Study|Missing Study Completion Status|3|||
143350311|NCT01129336|516829180|FG000|Overall Study|Death|0|||
143350312|NCT01129336|516829181|FG001|Overall Study|Death|4|||
143350313|NCT00467142|516829187|FG000|Overall Study|Withdrawal by Subject|1|||
143350314|NCT00467142|516829187|FG000|Overall Study|Adverse Event|1|||
143350315|NCT00467142|516829187|FG000|Overall Study|Protocol Violation|1|||
143350316|NCT00919893|516829188|FG000|Overall Study|Protocol Violation|19|||
143350317|NCT00919893|516829189|FG001|Overall Study|Protocol Violation|9|||
143350318|NCT00178256|516829195|FG000|Overall Study|Adverse Event|2|||
143350319|NCT00178256|516829196|FG001|Overall Study|Adverse Event|0|||
143350320|NCT00178256|516829197|FG002|Overall Study|Adverse Event|0|||
143350321|NCT00178256|516829198|FG003|Overall Study|Adverse Event|0|||
143350322|NCT00178256|516829195|FG000|Overall Study|Death|0|||
143350323|NCT00178256|516829196|FG001|Overall Study|Death|1|||
143350324|NCT00178256|516829197|FG002|Overall Study|Death|0|||
143350325|NCT00178256|516829198|FG003|Overall Study|Death|1|||
143350326|NCT00178256|516829195|FG000|Overall Study|Cancer progression|2|||
143350327|NCT00178256|516829196|FG001|Overall Study|Cancer progression|0|||
143350328|NCT00178256|516829197|FG002|Overall Study|Cancer progression|0|||
143350329|NCT00178256|516829198|FG003|Overall Study|Cancer progression|1|||
143350330|NCT01763788|516829199|FG000|Overall Study|Lost to Follow-up|0|||
143350331|NCT01763788|516829200|FG001|Overall Study|Lost to Follow-up|0|||
143350332|NCT01763788|516829201|FG002|Overall Study|Lost to Follow-up|1|||
143350333|NCT01763788|516829202|FG003|Overall Study|Lost to Follow-up|0|||
143350334|NCT01460160|516829205|FG000|Treatment Phase|Lack of Efficacy|3|||
143350335|NCT01460160|516829205|FG000|Treatment Phase|Study Drug Toxicity|2|||
143350336|NCT01460160|516829205|FG000|Treatment Phase|Adverse Event|8|||
143350337|NCT01460160|516829205|FG000|Treatment Phase|Withdrawal by Subject|4|||
143350338|NCT01460160|516829205|FG000|Treatment Phase|Death|2|||
143350339|NCT01460160|516829205|FG000|Treatment Phase|Other reasons|9|||
143350340|NCT01460160|516829205|FG000|Follow-up Phase|Withdrawal by Subject|4|||
143350341|NCT01460160|516829205|FG000|Follow-up Phase|Death|14|||
143350342|NCT01460160|516829205|FG000|Follow-up Phase|Lost to Follow-up|7|||
143350343|NCT01460160|516829205|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
143350344|NCT01460160|516829205|FG000|Follow-up Phase|Other and not reported reasons|5|||
143350345|NCT03893825|516829206|FG000|Overall Study|Death|2|||
143350346|NCT03893825|516829207|FG001|Overall Study|Death|1|||
143350347|NCT03893825|516829206|FG000|Overall Study|Adverse Event|0|||
143350348|NCT03893825|516829207|FG001|Overall Study|Adverse Event|2|||
143350349|NCT03893825|516829206|FG000|Overall Study|Withdrawal by Subject|19|||
143350350|NCT03893825|516829207|FG001|Overall Study|Withdrawal by Subject|21|||
143350351|NCT03893825|516829206|FG000|Overall Study|Protocol deviation|1|||
143350352|NCT03893825|516829207|FG001|Overall Study|Protocol deviation|0|||
143350353|NCT03893825|516829206|FG000|Overall Study|Lost to Follow-up|10|||
143350354|NCT03893825|516829207|FG001|Overall Study|Lost to Follow-up|10|||
143350355|NCT03893825|516829206|FG000|Overall Study|Other than specified|7|||
143350356|NCT03893825|516829207|FG001|Overall Study|Other than specified|6|||
143350357|NCT04161807|516829208|FG000|Overall Study|Withdrawal by Subject|2|||
143350358|NCT04161807|516829208|FG000|Overall Study|Performed only 1 treatment|2|||
143350359|NCT00708305|516829219|FG000|Period 1|Protocol Violation|1|||
143350360|NCT00708305|516829220|FG001|Period 1|Protocol Violation|0|||
143350361|NCT00708305|516829221|FG002|Period 1|Protocol Violation|1|||
143350362|NCT00708305|516829222|FG003|Period 1|Protocol Violation|0|||
143350363|NCT00708305|516829219|FG000|Period 1|Other Reason|0|||
143350364|NCT00708305|516829220|FG001|Period 1|Other Reason|0|||
143350365|NCT00708305|516829221|FG002|Period 1|Other Reason|0|||
143350366|NCT00708305|516829222|FG003|Period 1|Other Reason|2|||
143350367|NCT00708305|516829219|FG000|Period 2|Lost to Follow-up|0|||
143350368|NCT00708305|516829220|FG001|Period 2|Lost to Follow-up|1|||
143350369|NCT00708305|516829221|FG002|Period 2|Lost to Follow-up|0|||
143350370|NCT00708305|516829222|FG003|Period 2|Lost to Follow-up|0|||
143350371|NCT00708305|516829219|FG000|Period 2|Protocol Violation|0|||
143350372|NCT00708305|516829220|FG001|Period 2|Protocol Violation|1|||
143011715|NCT01186744|515581702|FG005|Overall Study|Withdrawal by Subject|6|||
143011716|NCT01186744|515581697|FG000|Overall Study|Study terminated by Sponsor|1|||
143011717|NCT01186744|515581698|FG001|Overall Study|Study terminated by Sponsor|0|||
143011718|NCT01186744|515581699|FG002|Overall Study|Study terminated by Sponsor|0|||
143011719|NCT01186744|515581700|FG003|Overall Study|Study terminated by Sponsor|0|||
143011720|NCT01186744|515581701|FG004|Overall Study|Study terminated by Sponsor|0|||
143011721|NCT01186744|515581702|FG005|Overall Study|Study terminated by Sponsor|0|||
143011722|NCT01186744|515581697|FG000|Overall Study|Other|9|||
143011723|NCT01186744|515581698|FG001|Overall Study|Other|10|||
143011724|NCT01186744|515581699|FG002|Overall Study|Other|1|||
143350373|NCT00708305|516829221|FG002|Period 2|Protocol Violation|0|||
143011725|NCT01186744|515581700|FG003|Overall Study|Other|2|||
143011726|NCT01186744|515581701|FG004|Overall Study|Other|1|||
143011727|NCT01186744|515581702|FG005|Overall Study|Other|5|||
143011728|NCT01186744|515581697|FG000|Overall Study|Adverse Event|10|||
143011729|NCT01186744|515581698|FG001|Overall Study|Adverse Event|14|||
143011730|NCT01186744|515581699|FG002|Overall Study|Adverse Event|1|||
143011731|NCT01186744|515581700|FG003|Overall Study|Adverse Event|0|||
143011732|NCT01186744|515581701|FG004|Overall Study|Adverse Event|1|||
143011733|NCT01186744|515581702|FG005|Overall Study|Adverse Event|4|||
143011734|NCT01186744|515581697|FG000|Overall Study|Death|1|||
143011735|NCT01186744|515581698|FG001|Overall Study|Death|0|||
143011736|NCT01186744|515581699|FG002|Overall Study|Death|0|||
143011737|NCT01186744|515581700|FG003|Overall Study|Death|0|||
143011738|NCT01186744|515581701|FG004|Overall Study|Death|0|||
143011739|NCT01186744|515581702|FG005|Overall Study|Death|0|||
143011740|NCT01389024|515581705|FG000|Overall Study|Withdrawal by Subject|0|||
143011741|NCT01389024|515581706|FG001|Overall Study|Withdrawal by Subject|1|||
143011742|NCT01389024|515581705|FG000|Overall Study|Lost to Follow-up|1|||
143011743|NCT01389024|515581706|FG001|Overall Study|Lost to Follow-up|0|||
143011744|NCT01956123|515581707|FG000|COS Cycle 2|Protocol Violation|8|||
143011745|NCT01956123|515581708|FG001|COS Cycle 2|Protocol Violation|3|||
143011746|NCT01956123|515581709|FG002|COS Cycle 2|Protocol Violation|0|||
143011747|NCT01956123|515581710|FG003|COS Cycle 2|Protocol Violation|0|||
143011748|NCT01956123|515581707|FG000|COS Cycle 2|Adverse Event|3|||
143011749|NCT01956123|515581708|FG001|COS Cycle 2|Adverse Event|4|||
143011750|NCT01956123|515581709|FG002|COS Cycle 2|Adverse Event|0|||
143011751|NCT01956123|515581710|FG003|COS Cycle 2|Adverse Event|0|||
143011752|NCT01956123|515581707|FG000|COS Cycle 2|Personal Reasons|2|||
143011753|NCT01956123|515581708|FG001|COS Cycle 2|Personal Reasons|0|||
143011754|NCT01956123|515581709|FG002|COS Cycle 2|Personal Reasons|0|||
143011755|NCT01956123|515581710|FG003|COS Cycle 2|Personal Reasons|0|||
143011756|NCT01956123|515581707|FG000|COS Cycle 2|Withdrawal by Subject|1|||
143011757|NCT01956123|515581708|FG001|COS Cycle 2|Withdrawal by Subject|0|||
143011758|NCT01956123|515581709|FG002|COS Cycle 2|Withdrawal by Subject|0|||
143011759|NCT01956123|515581710|FG003|COS Cycle 2|Withdrawal by Subject|0|||
143011760|NCT01956123|515581707|FG000|COS Cycle 3|Protocol Violation|0|||
143011761|NCT01956123|515581708|FG001|COS Cycle 3|Protocol Violation|0|||
143011762|NCT01956123|515581709|FG002|COS Cycle 3|Protocol Violation|2|||
143011763|NCT01956123|515581710|FG003|COS Cycle 3|Protocol Violation|1|||
143011764|NCT01956123|515581707|FG000|COS Cycle 3|Adverse Event|0|||
143011765|NCT01956123|515581708|FG001|COS Cycle 3|Adverse Event|0|||
143011766|NCT01956123|515581709|FG002|COS Cycle 3|Adverse Event|3|||
143011767|NCT01956123|515581710|FG003|COS Cycle 3|Adverse Event|0|||
143011768|NCT01956123|515581707|FG000|COS Cycle 3|Personal Reasons|0|||
143011769|NCT01956123|515581708|FG001|COS Cycle 3|Personal Reasons|0|||
143350374|NCT00708305|516829222|FG003|Period 2|Protocol Violation|0|||
143350375|NCT00708305|516829219|FG000|Period 2|Other Reason|1|||
143350376|NCT00708305|516829220|FG001|Period 2|Other Reason|0|||
143350377|NCT00708305|516829221|FG002|Period 2|Other Reason|0|||
143350378|NCT00708305|516829222|FG003|Period 2|Other Reason|1|||
143350379|NCT00708305|516829219|FG000|Period 3|Protocol Violation|0|||
143350380|NCT00708305|516829220|FG001|Period 3|Protocol Violation|2|||
143350381|NCT00708305|516829221|FG002|Period 3|Protocol Violation|0|||
143350382|NCT00708305|516829222|FG003|Period 3|Protocol Violation|0|||
143350383|NCT00708305|516829219|FG000|Period 3|Other Reason|1|||
143350384|NCT00708305|516829220|FG001|Period 3|Other Reason|0|||
143011770|NCT01956123|515581709|FG002|COS Cycle 3|Personal Reasons|1|||
143011771|NCT01956123|515581710|FG003|COS Cycle 3|Personal Reasons|0|||
143011772|NCT01956123|515581707|FG000|COS Cycle 3|Withdrawal by Subject|0|||
143011773|NCT01956123|515581708|FG001|COS Cycle 3|Withdrawal by Subject|0|||
143011774|NCT01956123|515581709|FG002|COS Cycle 3|Withdrawal by Subject|0|||
143011775|NCT01956123|515581710|FG003|COS Cycle 3|Withdrawal by Subject|1|||
143011776|NCT00267020|515581713|FG000|Overall Study|Adverse Event|22|||
143011777|NCT00267020|515581714|FG001|Overall Study|Adverse Event|5|||
143011778|NCT00267020|515581713|FG000|Overall Study|Death|2|||
143350385|NCT00708305|516829221|FG002|Period 3|Other Reason|0|||
143011779|NCT00267020|515581714|FG001|Overall Study|Death|1|||
143011780|NCT00267020|515581713|FG000|Overall Study|Withdrawal by Subject|17|||
143011781|NCT00267020|515581714|FG001|Overall Study|Withdrawal by Subject|7|||
143011782|NCT00267020|515581713|FG000|Overall Study|Physician Decision|3|||
143350386|NCT00708305|516829222|FG003|Period 3|Other Reason|0|||
143350387|NCT04789577|516829228|FG000|Overall Study|Withdrawal by Subject|1|||
143350388|NCT04789577|516829229|FG001|Overall Study|Withdrawal by Subject|1|||
143350389|NCT04789577|516829230|FG002|Overall Study|Withdrawal by Subject|1|||
143350390|NCT04789577|516829231|FG003|Overall Study|Withdrawal by Subject|3|||
143350391|NCT04789577|516829232|FG004|Overall Study|Withdrawal by Subject|1|||
143350392|NCT04789577|516829233|FG005|Overall Study|Withdrawal by Subject|7|||
143350393|NCT04789577|516829234|FG006|Overall Study|Withdrawal by Subject|1|||
143350394|NCT04789577|516829228|FG000|Overall Study|Lost to Follow-up|7|||
143350395|NCT04789577|516829229|FG001|Overall Study|Lost to Follow-up|12|||
143350396|NCT04789577|516829230|FG002|Overall Study|Lost to Follow-up|7|||
143350397|NCT04789577|516829231|FG003|Overall Study|Lost to Follow-up|10|||
143350398|NCT04789577|516829232|FG004|Overall Study|Lost to Follow-up|8|||
143350399|NCT04789577|516829233|FG005|Overall Study|Lost to Follow-up|6|||
143350400|NCT04789577|516829234|FG006|Overall Study|Lost to Follow-up|10|||
143350401|NCT04789577|516829228|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
143350402|NCT04789577|516829229|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
143350403|NCT04789577|516829230|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
143350404|NCT04789577|516829231|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
143350405|NCT04789577|516829232|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
143350406|NCT04789577|516829233|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
143350407|NCT04789577|516829234|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
143350408|NCT04789577|516829228|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
143350409|NCT04789577|516829229|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
143350410|NCT04789577|516829230|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
143350411|NCT04789577|516829231|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
143350412|NCT04789577|516829232|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
143350413|NCT04789577|516829233|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
143350414|NCT04789577|516829234|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
143350415|NCT01275196|516829235|FG000|Overall Study|Adverse Event|3|||
143350416|NCT01275196|516829236|FG001|Overall Study|Adverse Event|5|||
143350417|NCT01275196|516829235|FG000|Overall Study|Withdrawal by Subject|4|||
143350418|NCT01275196|516829236|FG001|Overall Study|Withdrawal by Subject|5|||
143350419|NCT01275196|516829235|FG000|Overall Study|Lost to Follow-up|1|||
143350420|NCT01275196|516829236|FG001|Overall Study|Lost to Follow-up|0|||
143350421|NCT01275196|516829235|FG000|Overall Study|Disease Progression|6|||
143350422|NCT01275196|516829236|FG001|Overall Study|Disease Progression|5|||
143350423|NCT01275196|516829235|FG000|Overall Study|Protocol Violation|1|||
143350424|NCT01275196|516829236|FG001|Overall Study|Protocol Violation|0|||
143350425|NCT01275196|516829235|FG000|Overall Study|Suboptimal response/treatment failure|5|||
143350426|NCT01275196|516829236|FG001|Overall Study|Suboptimal response/treatment failure|6|||
143350427|NCT01027364|516829237|FG000|Overall Study|Adverse Event|1|||
143350428|NCT01027364|516829238|FG001|Overall Study|Adverse Event|0|||
143350429|NCT01027364|516829239|FG002|Overall Study|Adverse Event|1|||
143350430|NCT01027364|516829240|FG003|Overall Study|Adverse Event|0|||
143350431|NCT01027364|516829237|FG000|Overall Study|Lost to Follow-up|1|||
143350432|NCT01027364|516829238|FG001|Overall Study|Lost to Follow-up|0|||
143350433|NCT01027364|516829239|FG002|Overall Study|Lost to Follow-up|0|||
143350434|NCT01027364|516829240|FG003|Overall Study|Lost to Follow-up|0|||
143350435|NCT01027364|516829237|FG000|Overall Study|Protocol Violation|1|||
143350436|NCT01027364|516829238|FG001|Overall Study|Protocol Violation|0|||
143350437|NCT01027364|516829239|FG002|Overall Study|Protocol Violation|0|||
143350438|NCT01027364|516829240|FG003|Overall Study|Protocol Violation|1|||
143350439|NCT01027364|516829237|FG000|Overall Study|Withdrawal by Subject|1|||
143350440|NCT01027364|516829238|FG001|Overall Study|Withdrawal by Subject|2|||
143350441|NCT01027364|516829239|FG002|Overall Study|Withdrawal by Subject|0|||
143350442|NCT01027364|516829240|FG003|Overall Study|Withdrawal by Subject|0|||
143350443|NCT03119610|516829241|FG000|Overall Study|Adverse Event|1|||
143350444|NCT03119610|516829242|FG001|Overall Study|Adverse Event|0|||
143350445|NCT03119610|516829241|FG000|Overall Study|Lost to Follow-up|0|||
143350446|NCT03119610|516829242|FG001|Overall Study|Lost to Follow-up|1|||
143350447|NCT00114634|516829267|FG000|Overall Study|failure to return forms|3|||
143350448|NCT03283696|516829268|FG000|Overall Study|Physician Decision|5|||
143350449|NCT03283696|516829269|FG001|Overall Study|Physician Decision|6|||
143350450|NCT03283696|516829268|FG000|Overall Study|Withdrawal by Subject|2|||
143350451|NCT03283696|516829269|FG001|Overall Study|Withdrawal by Subject|0|||
143350452|NCT00684762|516829272|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
143350453|NCT00684762|516829273|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
143350454|NCT00951509|516829284|FG000|Overall Study|Withdrawal by Subject|2|||
143350455|NCT03125941|516829286|FG000|Overall Study|did not receive intervention|1|||
143350456|NCT03125941|516829287|FG001|Overall Study|did not receive intervention|2|||
143350457|NCT00734214|516829288|FG000|Overall Study|Withdrawal by Subject|3|||
143350458|NCT00734214|516829289|FG001|Overall Study|Withdrawal by Subject|4|||
143350459|NCT00734214|516829288|FG000|Overall Study|MD withdrawal|1|||
143350460|NCT00734214|516829289|FG001|Overall Study|MD withdrawal|0|||
143350461|NCT00582491|516829290|FG000|Overall Study|Withdrawal by Subject|1|||
143350462|NCT00582491|516829291|FG001|Overall Study|Withdrawal by Subject|0|||
143350463|NCT04192630|516829292|FG000|Overall Study|Discontinued before surgery|2|||
143350464|NCT04192630|516829293|FG001|Overall Study|Discontinued before surgery|0|||
143350465|NCT04192630|516829292|FG000|Overall Study|Discontinued after surgery|5|||
143350466|NCT04192630|516829293|FG001|Overall Study|Discontinued after surgery|3|||
143350467|NCT01193582|516829294|FG000|Vaccination Series|Withdrawal by Subject|11|||
143350468|NCT01193582|516829295|FG001|Vaccination Series|Withdrawal by Subject|13|||
143350469|NCT01193582|516829296|FG002|Vaccination Series|Withdrawal by Subject|8|||
143350470|NCT01193582|516829297|FG003|Vaccination Series|Withdrawal by Subject|3|||
143350471|NCT01193582|516829294|FG000|12 Month Follow-up|Death|0|||
143011783|NCT00267020|515581714|FG001|Overall Study|Physician Decision|2|||
143011784|NCT00267020|515581713|FG000|Overall Study|Disease Progression|39|||
143011785|NCT00267020|515581714|FG001|Overall Study|Disease Progression|25|||
143011786|NCT00267020|515581713|FG000|Overall Study|Unrelated Complication|1|||
143011787|NCT00267020|515581714|FG001|Overall Study|Unrelated Complication|1|||
143011788|NCT00267020|515581713|FG000|Overall Study|Sponsor Request|1|||
143011789|NCT00267020|515581714|FG001|Overall Study|Sponsor Request|0|||
143011790|NCT00267020|515581713|FG000|Overall Study|Other|1|||
143011791|NCT00267020|515581714|FG001|Overall Study|Other|2|||
143011792|NCT00640614|515581716|FG000|Overall Study|Lost to Follow-up|1|||
143011793|NCT00640614|515581717|FG001|Overall Study|Lost to Follow-up|0|||
143011794|NCT00529802|515581718|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
143011795|NCT00529802|515581718|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
143011796|NCT00529802|515581718|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
143011797|NCT00529802|515581718|FG000|Evaluable for Primary Endpoint|Death|1|||
143011798|NCT00529802|515581718|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
143011799|NCT00529802|515581718|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
143011800|NCT00529802|515581718|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
143011801|NCT02209454|515581720|FG000|Second Period|Adverse Event|1|||
143011802|NCT02209454|515581721|FG001|Second Period|Adverse Event|0|||
143011803|NCT00740480|515581722|FG000|Overall Study|Adverse Event|1|||
143011804|NCT00740480|515581722|FG000|Overall Study|Physician Decision|1|||
143011805|NCT01856686|515581723|FG000|Overall Study|Lost to Follow-up|5|||
143011806|NCT01856686|515581724|FG001|Overall Study|Lost to Follow-up|11|||
143011807|NCT00602979|515581725|FG000|Overall Study|Lost to Follow-up|3|||
143011808|NCT00602979|515581726|FG001|Overall Study|Lost to Follow-up|2|||
143011809|NCT00602979|515581727|FG002|Overall Study|Lost to Follow-up|3|||
143011810|NCT00602979|515581728|FG003|Overall Study|Lost to Follow-up|2|||
143011811|NCT00602979|515581729|FG004|Overall Study|Lost to Follow-up|3|||
143011812|NCT00602979|515581725|FG000|Overall Study|Failed Intubation|0|||
143011813|NCT00602979|515581726|FG001|Overall Study|Failed Intubation|1|||
143011814|NCT00602979|515581727|FG002|Overall Study|Failed Intubation|0|||
143011815|NCT00602979|515581728|FG003|Overall Study|Failed Intubation|1|||
143011816|NCT00602979|515581729|FG004|Overall Study|Failed Intubation|0|||
143011817|NCT01461369|515581730|FG000|Overall Study|Lack of Efficacy|2|||
143011818|NCT01461369|515581731|FG001|Overall Study|Lack of Efficacy|0|||
143011819|NCT01461369|515581732|FG002|Overall Study|Lack of Efficacy|6|||
143011820|NCT01461369|515581730|FG000|Overall Study|Lost to Follow-up|0|||
143011821|NCT01461369|515581731|FG001|Overall Study|Lost to Follow-up|0|||
143011822|NCT01461369|515581732|FG002|Overall Study|Lost to Follow-up|3|||
143011823|NCT01461369|515581730|FG000|Overall Study|Adverse Event|9|||
143011824|NCT01461369|515581731|FG001|Overall Study|Adverse Event|12|||
143011825|NCT01461369|515581732|FG002|Overall Study|Adverse Event|4|||
143350472|NCT01193582|516829295|FG001|12 Month Follow-up|Death|0|||
143350473|NCT01193582|516829296|FG002|12 Month Follow-up|Death|1|||
143350474|NCT01193582|516829297|FG003|12 Month Follow-up|Death|0|||
143350475|NCT01193582|516829294|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
143350476|NCT01193582|516829295|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
143350477|NCT01193582|516829296|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
143350478|NCT01193582|516829297|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
143350479|NCT01425632|516829298|FG000|Overall Study|Adverse Event|0|||
143350480|NCT01425632|516829299|FG001|Overall Study|Adverse Event|1|||
143011826|NCT01461369|515581730|FG000|Overall Study|Protocol Violation|1|||
143011827|NCT01461369|515581731|FG001|Overall Study|Protocol Violation|2|||
143011828|NCT01461369|515581732|FG002|Overall Study|Protocol Violation|2|||
143011829|NCT01461369|515581730|FG000|Overall Study|Withdrawal by Subject|1|||
143011830|NCT01461369|515581731|FG001|Overall Study|Withdrawal by Subject|3|||
143011831|NCT01461369|515581732|FG002|Overall Study|Withdrawal by Subject|2|||
143011832|NCT00734617|515581735|FG000|Overall Study|Adverse Event|4|||
143011833|NCT00734617|515581736|FG001|Overall Study|Adverse Event|7|||
143011834|NCT00734617|515581735|FG000|Overall Study|Withdrawal by Subject|103|||
143011835|NCT00734617|515581736|FG001|Overall Study|Withdrawal by Subject|95|||
143011836|NCT02861534|515581739|FG000|Overall Study|Death|541|||
143350481|NCT01425632|516829300|FG002|Overall Study|Adverse Event|1|||
143350482|NCT01425632|516829298|FG000|Overall Study|Physician Decision|1|||
143350483|NCT01425632|516829299|FG001|Overall Study|Physician Decision|0|||
143350484|NCT01425632|516829300|FG002|Overall Study|Physician Decision|0|||
143011837|NCT02861534|515581740|FG001|Overall Study|Death|552|||
143011838|NCT02861534|515581739|FG000|Overall Study|Lost to Follow-up|14|||
143011839|NCT02861534|515581740|FG001|Overall Study|Lost to Follow-up|14|||
143011840|NCT02861534|515581739|FG000|Overall Study|Site Terminated by Sponsor|4|||
143350485|NCT01425632|516829298|FG000|Overall Study|Protocol Violation|0|||
143350486|NCT01425632|516829299|FG001|Overall Study|Protocol Violation|0|||
143350487|NCT01425632|516829300|FG002|Overall Study|Protocol Violation|2|||
143350488|NCT01425632|516829298|FG000|Overall Study|Withdrawal by Subject|0|||
143350489|NCT01425632|516829299|FG001|Overall Study|Withdrawal by Subject|0|||
143350490|NCT01425632|516829300|FG002|Overall Study|Withdrawal by Subject|1|||
143350491|NCT00406419|516829307|FG000|Overall Study|Death|3|||
143350492|NCT00406419|516829308|FG001|Overall Study|Death|1|||
143350493|NCT00406419|516829309|FG002|Overall Study|Death|4|||
143350494|NCT00406419|516829307|FG000|Overall Study|Protocol Violation|6|||
143350495|NCT00406419|516829308|FG001|Overall Study|Protocol Violation|2|||
143350496|NCT00406419|516829309|FG002|Overall Study|Protocol Violation|5|||
143350497|NCT00406419|516829307|FG000|Overall Study|Study Terminated by Sponsor|260|||
143350498|NCT00406419|516829308|FG001|Overall Study|Study Terminated by Sponsor|288|||
143350499|NCT00406419|516829309|FG002|Overall Study|Study Terminated by Sponsor|282|||
143350500|NCT00406419|516829307|FG000|Overall Study|Withdrawal by Subject|17|||
143350501|NCT00406419|516829308|FG001|Overall Study|Withdrawal by Subject|24|||
143350502|NCT00406419|516829309|FG002|Overall Study|Withdrawal by Subject|26|||
143350503|NCT00406419|516829307|FG000|Overall Study|Lack of Efficacy|12|||
143350504|NCT00406419|516829308|FG001|Overall Study|Lack of Efficacy|1|||
143350505|NCT00406419|516829309|FG002|Overall Study|Lack of Efficacy|6|||
143350506|NCT00406419|516829307|FG000|Overall Study|Non-Compliance with Study Drug|5|||
143350507|NCT00406419|516829308|FG001|Overall Study|Non-Compliance with Study Drug|6|||
143350508|NCT00406419|516829309|FG002|Overall Study|Non-Compliance with Study Drug|3|||
143350509|NCT00406419|516829307|FG000|Overall Study|Adverse Event|10|||
143350510|NCT00406419|516829308|FG001|Overall Study|Adverse Event|12|||
143350511|NCT00406419|516829309|FG002|Overall Study|Adverse Event|16|||
143350512|NCT00406419|516829307|FG000|Overall Study|Lost to Follow-up|11|||
143350513|NCT00406419|516829308|FG001|Overall Study|Lost to Follow-up|10|||
143350514|NCT00406419|516829309|FG002|Overall Study|Lost to Follow-up|5|||
143350515|NCT01775930|516829310|FG000|Overall Study|Futility stopping boundary met|1|||
143350516|NCT01208415|516829311|FG000|Overall Study|Death|1|||
143350517|NCT01208415|516829311|FG000|Overall Study|Lost to Follow-up|2|||
143350518|NCT01208415|516829311|FG000|Overall Study|Withdrawal by Subject|3|||
143350519|NCT01208415|516829311|FG000|Overall Study|Device not placed|1|||
143350520|NCT01208415|516829311|FG000|Overall Study|Still be eligible for follow-up|33|||
143350521|NCT02638623|516829312|FG000|Overall Study|Surgery timing|5|||
143350522|NCT02638623|516829313|FG001|Overall Study|Surgery timing|6|||
143350523|NCT02638623|516829312|FG000|Overall Study|Not given intervention|2|||
143350524|NCT02638623|516829313|FG001|Overall Study|Not given intervention|0|||
143350525|NCT02322814|516829314|FG000|Overall Study|Death|7|||
143350526|NCT02322814|516829315|FG001|Overall Study|Death|29|||
143350527|NCT02322814|516829316|FG002|Overall Study|Death|32|||
143350528|NCT02322814|516829317|FG003|Overall Study|Death|23|||
143350529|NCT02322814|516829318|FG004|Overall Study|Death|14|||
143350530|NCT02322814|516829314|FG000|Overall Study|Lost to Follow-up|1|||
143350531|NCT02322814|516829315|FG001|Overall Study|Lost to Follow-up|3|||
143350532|NCT02322814|516829316|FG002|Overall Study|Lost to Follow-up|3|||
143350533|NCT02322814|516829317|FG003|Overall Study|Lost to Follow-up|1|||
143350534|NCT02322814|516829318|FG004|Overall Study|Lost to Follow-up|0|||
143350535|NCT02322814|516829314|FG000|Overall Study|Various Reasons|2|||
143350536|NCT02322814|516829315|FG001|Overall Study|Various Reasons|0|||
143350537|NCT02322814|516829316|FG002|Overall Study|Various Reasons|1|||
143350538|NCT02322814|516829317|FG003|Overall Study|Various Reasons|1|||
143350539|NCT02322814|516829318|FG004|Overall Study|Various Reasons|0|||
143350540|NCT02322814|516829314|FG000|Overall Study|Progressive Disease|0|||
143350541|NCT02322814|516829315|FG001|Overall Study|Progressive Disease|0|||
143350542|NCT02322814|516829316|FG002|Overall Study|Progressive Disease|0|||
143350543|NCT02322814|516829317|FG003|Overall Study|Progressive Disease|1|||
143350544|NCT02322814|516829318|FG004|Overall Study|Progressive Disease|1|||
143350545|NCT02322814|516829314|FG000|Overall Study|Protocol Violation|1|||
143350546|NCT02322814|516829315|FG001|Overall Study|Protocol Violation|0|||
143350547|NCT02322814|516829316|FG002|Overall Study|Protocol Violation|0|||
143350548|NCT02322814|516829317|FG003|Overall Study|Protocol Violation|0|||
143350549|NCT02322814|516829318|FG004|Overall Study|Protocol Violation|0|||
143350550|NCT02322814|516829314|FG000|Overall Study|Study Terminated by Sponsor|0|||
143350551|NCT02322814|516829315|FG001|Overall Study|Study Terminated by Sponsor|7|||
143350552|NCT02322814|516829316|FG002|Overall Study|Study Terminated by Sponsor|9|||
143350553|NCT02322814|516829317|FG003|Overall Study|Study Terminated by Sponsor|5|||
143350554|NCT02322814|516829318|FG004|Overall Study|Study Terminated by Sponsor|13|||
143350555|NCT02322814|516829314|FG000|Overall Study|Withdrawal by Subject|5|||
143350556|NCT02322814|516829315|FG001|Overall Study|Withdrawal by Subject|4|||
143350557|NCT02322814|516829316|FG002|Overall Study|Withdrawal by Subject|2|||
143350558|NCT02322814|516829317|FG003|Overall Study|Withdrawal by Subject|1|||
143350559|NCT02322814|516829318|FG004|Overall Study|Withdrawal by Subject|3|||
143350560|NCT04152343|516829319|FG000|Overall Study|Transplanted|5|||
143350561|NCT04152343|516829319|FG000|Overall Study|Death|20|||
143350562|NCT04152343|516829319|FG000|Overall Study|Lost to Follow-up|3|||
143350563|NCT02459093|516829320|FG000|Overall Study|Protocol Violation|6|||
143350564|NCT02459093|516829321|FG001|Overall Study|Protocol Violation|11|||
143350565|NCT02459093|516829320|FG000|Overall Study|Lost to Follow-up|6|||
143350566|NCT02459093|516829321|FG001|Overall Study|Lost to Follow-up|7|||
143350567|NCT02090634|516829322|FG000|Overall Study|Lost to Follow-up|0|||
143350568|NCT02090634|516829323|FG001|Overall Study|Lost to Follow-up|1|||
143350569|NCT02090634|516829322|FG000|Overall Study|Death|0|||
143350570|NCT02090634|516829323|FG001|Overall Study|Death|1|||
143350571|NCT02090634|516829322|FG000|Overall Study|Protocol Violation|3|||
143350572|NCT02090634|516829323|FG001|Overall Study|Protocol Violation|1|||
143350573|NCT02090634|516829322|FG000|Overall Study|Adverse Event|2|||
143350574|NCT02090634|516829323|FG001|Overall Study|Adverse Event|0|||
143350575|NCT01164228|516829324|FG000|Overall Study|Progression|24|||
143350576|NCT01164228|516829325|FG001|Overall Study|Progression|25|||
143350577|NCT01164228|516829324|FG000|Overall Study|Adverse Event|13|||
143350578|NCT01164228|516829325|FG001|Overall Study|Adverse Event|7|||
143350579|NCT01164228|516829324|FG000|Overall Study|Death|1|||
143350580|NCT01164228|516829325|FG001|Overall Study|Death|1|||
143350581|NCT01164228|516829324|FG000|Overall Study|Withdrawal by Subject|2|||
143350582|NCT01164228|516829325|FG001|Overall Study|Withdrawal by Subject|0|||
143350583|NCT01164228|516829324|FG000|Overall Study|Physician Decision|1|||
143350584|NCT01164228|516829325|FG001|Overall Study|Physician Decision|2|||
143350585|NCT01164228|516829324|FG000|Overall Study|Symptomatic deterioration|1|||
143350586|NCT01164228|516829325|FG001|Overall Study|Symptomatic deterioration|0|||
143350587|NCT01164228|516829324|FG000|Overall Study|Never started treatment|1|||
143350588|NCT01164228|516829325|FG001|Overall Study|Never started treatment|3|||
143350589|NCT01164228|516829324|FG000|Overall Study|Ineligible|1|||
143350590|NCT01164228|516829325|FG001|Overall Study|Ineligible|0|||
143350591|NCT01965938|516829326|FG000|Overall Study|Withdrawal by Subject|1|||
143350592|NCT01965938|516829327|FG001|Overall Study|Withdrawal by Subject|0|||
143350593|NCT03757234|516829328|FG000|Overall Study|Adverse Event|0|||
143350594|NCT03757234|516829329|FG001|Overall Study|Adverse Event|0|||
143350595|NCT03757234|516829330|FG002|Overall Study|Adverse Event|0|||
143350596|NCT03757234|516829331|FG003|Overall Study|Adverse Event|0|||
143350597|NCT03757234|516829332|FG004|Overall Study|Adverse Event|1|||
143350598|NCT03757234|516829328|FG000|Overall Study|Lost to Follow-up|1|||
143350599|NCT03757234|516829329|FG001|Overall Study|Lost to Follow-up|0|||
143350600|NCT03757234|516829330|FG002|Overall Study|Lost to Follow-up|0|||
143350601|NCT03757234|516829331|FG003|Overall Study|Lost to Follow-up|0|||
143350602|NCT03757234|516829332|FG004|Overall Study|Lost to Follow-up|1|||
143350603|NCT03757234|516829328|FG000|Overall Study|Withdrawal by Subject|1|||
143350604|NCT03757234|516829329|FG001|Overall Study|Withdrawal by Subject|1|||
143350605|NCT03757234|516829330|FG002|Overall Study|Withdrawal by Subject|0|||
143350606|NCT03757234|516829331|FG003|Overall Study|Withdrawal by Subject|1|||
143350607|NCT03757234|516829332|FG004|Overall Study|Withdrawal by Subject|2|||
143350608|NCT03757234|516829328|FG000|Overall Study|Other|1|||
143350609|NCT03757234|516829329|FG001|Overall Study|Other|1|||
143350610|NCT03757234|516829330|FG002|Overall Study|Other|0|||
143350611|NCT03757234|516829331|FG003|Overall Study|Other|0|||
143350612|NCT03757234|516829332|FG004|Overall Study|Other|0|||
143350613|NCT03342053|516829335|FG000|Overall Study|Adverse Event|2|||
143350614|NCT03342053|516829336|FG001|Overall Study|Adverse Event|0|||
143350615|NCT03342053|516829335|FG000|Overall Study|Withdrawal by Subject|0|||
143350616|NCT03342053|516829336|FG001|Overall Study|Withdrawal by Subject|1|||
143350617|NCT00735644|516829337|FG000|Overall Study|Did not receive study vaccine|0|||
143350618|NCT00735644|516829338|FG001|Overall Study|Did not receive study vaccine|1|||
143350619|NCT00735644|516829339|FG002|Overall Study|Did not receive study vaccine|0|||
143350620|NCT00735644|516829340|FG003|Overall Study|Did not receive study vaccine|0|||
143350621|NCT00735644|516829341|FG004|Overall Study|Did not receive study vaccine|0|||
143350622|NCT00735644|516829337|FG000|Overall Study|Withdrawal by Subject|0|||
143350623|NCT00735644|516829338|FG001|Overall Study|Withdrawal by Subject|1|||
143350624|NCT00735644|516829339|FG002|Overall Study|Withdrawal by Subject|1|||
143350625|NCT00735644|516829340|FG003|Overall Study|Withdrawal by Subject|1|||
143350626|NCT00735644|516829341|FG004|Overall Study|Withdrawal by Subject|0|||
143350627|NCT03857841|516829344|FG000|Overall Study|Death|1|||
143350628|NCT03857841|516829345|FG001|Overall Study|Death|0|||
143350629|NCT03857841|516829346|FG002|Overall Study|Death|0|||
143350630|NCT03857841|516829347|FG003|Overall Study|Death|0|||
143350631|NCT03857841|516829344|FG000|Overall Study|Study Terminated by Sponsor|1|||
143350632|NCT03857841|516829345|FG001|Overall Study|Study Terminated by Sponsor|0|||
143350633|NCT03857841|516829346|FG002|Overall Study|Study Terminated by Sponsor|0|||
143350634|NCT03857841|516829347|FG003|Overall Study|Study Terminated by Sponsor|0|||
143350635|NCT04249336|516831064|FG000|Overall Study|Lost to Follow-up|3|||
143350636|NCT04249336|516831065|FG001|Overall Study|Lost to Follow-up|3|||
143350637|NCT04249336|516831066|FG002|Overall Study|Lost to Follow-up|3|||
143350638|NCT04249336|516831067|FG003|Overall Study|Lost to Follow-up|3|||
143350639|NCT01242176|516831068|FG000|Washout Period of 7 Days|Adverse Event|0|||
143350640|NCT01242176|516831069|FG001|Washout Period of 7 Days|Adverse Event|2|||
143350641|NCT01242176|516831068|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
143350642|NCT01242176|516831069|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
143350643|NCT00871351|516831070|FG000|Overall Study|Withdrawal by Subject|1|||
143350644|NCT00871351|516831071|FG001|Overall Study|Withdrawal by Subject|0|||
143350645|NCT00871351|516831072|FG002|Overall Study|Withdrawal by Subject|0|||
143350646|NCT00871351|516831070|FG000|Overall Study|Adverse Event|3|||
143350647|NCT00871351|516831071|FG001|Overall Study|Adverse Event|1|||
143350648|NCT00871351|516831072|FG002|Overall Study|Adverse Event|0|||
143350649|NCT01189890|516831073|FG000|Overall Study|Adverse Event|3|||
143350650|NCT01189890|516831074|FG001|Overall Study|Adverse Event|4|||
143350651|NCT01189890|516831073|FG000|Overall Study|Lack of Efficacy|7|||
143350652|NCT01189890|516831074|FG001|Overall Study|Lack of Efficacy|2|||
143350653|NCT01189890|516831073|FG000|Overall Study|Lost to Follow-up|1|||
143350654|NCT01189890|516831074|FG001|Overall Study|Lost to Follow-up|7|||
143350655|NCT01189890|516831073|FG000|Overall Study|Protocol Violation|1|||
143350656|NCT01189890|516831074|FG001|Overall Study|Protocol Violation|5|||
143350657|NCT01189890|516831073|FG000|Overall Study|Withdrawal by Subject|15|||
143350658|NCT01189890|516831074|FG001|Overall Study|Withdrawal by Subject|11|||
143350659|NCT01189890|516831073|FG000|Overall Study|Non Compliance|0|||
143350660|NCT01189890|516831074|FG001|Overall Study|Non Compliance|1|||
143350661|NCT01189890|516831073|FG000|Overall Study|Physician Decision|5|||
143350662|NCT01189890|516831074|FG001|Overall Study|Physician Decision|4|||
143350663|NCT01189890|516831073|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
143350664|NCT01189890|516831074|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
143350665|NCT02291289|516831076|FG000|Induction Treatment|Withdrawal by Subject|0|||
143350666|NCT02291289|516831077|FG001|Induction Treatment|Withdrawal by Subject|0|||
143350667|NCT02291289|516831078|FG002|Induction Treatment|Withdrawal by Subject|0|||
143350668|NCT02291289|516831079|FG003|Induction Treatment|Withdrawal by Subject|24|||
143350669|NCT02291289|516831080|FG004|Induction Treatment|Withdrawal by Subject|0|||
143350670|NCT02291289|516831081|FG005|Induction Treatment|Withdrawal by Subject|0|||
143350671|NCT02291289|516831082|FG006|Induction Treatment|Withdrawal by Subject|0|||
143350672|NCT02291289|516831083|FG007|Induction Treatment|Withdrawal by Subject|0|||
143350673|NCT02291289|516831084|FG008|Induction Treatment|Withdrawal by Subject|0|||
143350674|NCT02291289|516831085|FG009|Induction Treatment|Withdrawal by Subject|18|||
143350675|NCT02291289|516831086|FG010|Induction Treatment|Withdrawal by Subject|0|||
143350676|NCT02291289|516831087|FG011|Induction Treatment|Withdrawal by Subject|0|||
143350677|NCT02291289|516831088|FG012|Induction Treatment|Withdrawal by Subject|0|||
143350678|NCT02291289|516831076|FG000|Induction Treatment|Adverse Event|0|||
143350679|NCT02291289|516831077|FG001|Induction Treatment|Adverse Event|0|||
143350680|NCT02291289|516831078|FG002|Induction Treatment|Adverse Event|0|||
143350681|NCT02291289|516831079|FG003|Induction Treatment|Adverse Event|3|||
143350682|NCT02291289|516831080|FG004|Induction Treatment|Adverse Event|0|||
143350683|NCT02291289|516831081|FG005|Induction Treatment|Adverse Event|0|||
143350684|NCT02291289|516831082|FG006|Induction Treatment|Adverse Event|0|||
143350685|NCT02291289|516831083|FG007|Induction Treatment|Adverse Event|0|||
143350686|NCT02291289|516831084|FG008|Induction Treatment|Adverse Event|0|||
143350687|NCT02291289|516831085|FG009|Induction Treatment|Adverse Event|1|||
143350688|NCT02291289|516831086|FG010|Induction Treatment|Adverse Event|0|||
143350689|NCT02291289|516831087|FG011|Induction Treatment|Adverse Event|0|||
143350690|NCT02291289|516831088|FG012|Induction Treatment|Adverse Event|0|||
143350691|NCT02291289|516831076|FG000|Induction Treatment|Death|25|||
143350692|NCT02291289|516831077|FG001|Induction Treatment|Death|0|||
143350693|NCT02291289|516831078|FG002|Induction Treatment|Death|0|||
143350694|NCT02291289|516831079|FG003|Induction Treatment|Death|111|||
143350695|NCT02291289|516831080|FG004|Induction Treatment|Death|0|||
143350696|NCT02291289|516831081|FG005|Induction Treatment|Death|0|||
143350697|NCT02291289|516831082|FG006|Induction Treatment|Death|1|||
143350698|NCT02291289|516831083|FG007|Induction Treatment|Death|0|||
143350699|NCT02291289|516831084|FG008|Induction Treatment|Death|0|||
143350700|NCT02291289|516831085|FG009|Induction Treatment|Death|82|||
143350701|NCT02291289|516831086|FG010|Induction Treatment|Death|0|||
143350702|NCT02291289|516831087|FG011|Induction Treatment|Death|0|||
143350703|NCT02291289|516831088|FG012|Induction Treatment|Death|0|||
143350704|NCT02291289|516831076|FG000|Induction Treatment|Lost to Follow-up|1|||
143350705|NCT02291289|516831077|FG001|Induction Treatment|Lost to Follow-up|0|||
143350706|NCT02291289|516831078|FG002|Induction Treatment|Lost to Follow-up|0|||
143350707|NCT02291289|516831079|FG003|Induction Treatment|Lost to Follow-up|12|||
143350708|NCT02291289|516831080|FG004|Induction Treatment|Lost to Follow-up|0|||
143350709|NCT02291289|516831081|FG005|Induction Treatment|Lost to Follow-up|0|||
143350710|NCT02291289|516831082|FG006|Induction Treatment|Lost to Follow-up|0|||
143350711|NCT02291289|516831083|FG007|Induction Treatment|Lost to Follow-up|0|||
143350712|NCT02291289|516831084|FG008|Induction Treatment|Lost to Follow-up|0|||
143350713|NCT02291289|516831085|FG009|Induction Treatment|Lost to Follow-up|9|||
143350714|NCT02291289|516831086|FG010|Induction Treatment|Lost to Follow-up|0|||
143350715|NCT02291289|516831087|FG011|Induction Treatment|Lost to Follow-up|0|||
143350716|NCT02291289|516831088|FG012|Induction Treatment|Lost to Follow-up|0|||
143350717|NCT02291289|516831076|FG000|Induction Treatment|Non-Compliance|0|||
143350718|NCT02291289|516831077|FG001|Induction Treatment|Non-Compliance|0|||
143350719|NCT02291289|516831078|FG002|Induction Treatment|Non-Compliance|0|||
143350720|NCT02291289|516831079|FG003|Induction Treatment|Non-Compliance|1|||
143350721|NCT02291289|516831080|FG004|Induction Treatment|Non-Compliance|0|||
143350722|NCT02291289|516831081|FG005|Induction Treatment|Non-Compliance|0|||
143350723|NCT02291289|516831082|FG006|Induction Treatment|Non-Compliance|0|||
143124858|NCT00524680|516001322|FG003|Overall Study|Withdrawal by Subject|1|||
143124859|NCT00913770|516001325|FG000|Overall Study|Unable to contact|24|||
143124860|NCT00913770|516001326|FG001|Overall Study|Unable to contact|19|||
143124861|NCT00913770|516001327|FG002|Overall Study|Unable to contact|13|||
143124862|NCT00913770|516001325|FG000|Overall Study|Refused|11|||
143124863|NCT00913770|516001326|FG001|Overall Study|Refused|10|||
143124864|NCT00913770|516001327|FG002|Overall Study|Refused|8|||
143124865|NCT04399538|516001329|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
143124866|NCT04399538|516001330|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
143124867|NCT04399538|516001331|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
143124868|NCT04399538|516001332|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
143124869|NCT04399538|516001333|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
143011841|NCT02861534|515581740|FG001|Overall Study|Site Terminated by Sponsor|3|||
143011842|NCT02861534|515581739|FG000|Overall Study|Withdrawal by Subject|15|||
143011843|NCT02861534|515581740|FG001|Overall Study|Withdrawal by Subject|18|||
143011844|NCT02886494|515581741|FG000|Overall Study|Adverse Event|1|||
143124870|NCT04399538|516001329|FG000|Double-Blind Treatment|Adverse Event|0|||
143124871|NCT04399538|516001330|FG001|Double-Blind Treatment|Adverse Event|0|||
143124872|NCT04399538|516001331|FG002|Double-Blind Treatment|Adverse Event|0|||
143124873|NCT04399538|516001332|FG003|Double-Blind Treatment|Adverse Event|0|||
143124874|NCT04399538|516001333|FG004|Double-Blind Treatment|Adverse Event|1|||
143124875|NCT04399538|516001329|FG000|Follow-Up|Adverse Event|0|||
143124876|NCT04399538|516001330|FG001|Follow-Up|Adverse Event|0|||
143350724|NCT02291289|516831083|FG007|Induction Treatment|Non-Compliance|0|||
143350725|NCT02291289|516831084|FG008|Induction Treatment|Non-Compliance|0|||
143350726|NCT02291289|516831085|FG009|Induction Treatment|Non-Compliance|1|||
143350727|NCT02291289|516831086|FG010|Induction Treatment|Non-Compliance|0|||
143350728|NCT02291289|516831087|FG011|Induction Treatment|Non-Compliance|0|||
143011845|NCT02886494|515581742|FG001|Overall Study|Adverse Event|0|||
143011846|NCT02886494|515581741|FG000|Overall Study|Withdrawal by Subject|12|||
143011847|NCT02886494|515581742|FG001|Overall Study|Withdrawal by Subject|3|||
143011848|NCT02886494|515581741|FG000|Overall Study|Protocol Violation|4|||
143011849|NCT02886494|515581742|FG001|Overall Study|Protocol Violation|1|||
143011850|NCT02780115|515581745|FG000|Overall Study|Withdrawal by Subject|0|||
143011851|NCT02780115|515581746|FG001|Overall Study|Withdrawal by Subject|1|||
143011852|NCT02780115|515581747|FG002|Overall Study|Withdrawal by Subject|1|||
143011853|NCT02780115|515581748|FG003|Overall Study|Withdrawal by Subject|0|||
143011854|NCT02780115|515581749|FG004|Overall Study|Withdrawal by Subject|0|||
143011855|NCT02780115|515581745|FG000|Overall Study|Adverse Event|0|||
143011856|NCT02780115|515581746|FG001|Overall Study|Adverse Event|0|||
143011857|NCT02780115|515581747|FG002|Overall Study|Adverse Event|0|||
143011858|NCT02780115|515581748|FG003|Overall Study|Adverse Event|1|||
143011859|NCT02780115|515581749|FG004|Overall Study|Adverse Event|1|||
143011860|NCT00499252|515581759|FG000|Overall Study|Adverse Event|3|||
143011861|NCT00499252|515581759|FG000|Overall Study|Refused further treatment|2|||
143011862|NCT00499252|515581759|FG000|Overall Study|Ineligible|4|||
143011863|NCT00499252|515581759|FG000|Overall Study|<no further label>|3|||
143011864|NCT01988337|515581760|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
143011865|NCT02742818|515581761|FG000|Overall Study|Adverse Event|0|||
143011866|NCT02742818|515581762|FG001|Overall Study|Adverse Event|1|||
143011867|NCT02742818|515581761|FG000|Overall Study|Protocol Violation|0|||
143011868|NCT02742818|515581762|FG001|Overall Study|Protocol Violation|1|||
143011869|NCT00457418|515581763|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
143011870|NCT00457418|515581763|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
143011871|NCT00457418|515581763|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
143011872|NCT00457418|515581763|FG000|Post PK Maintenance|Adverse Event|10|||
143011873|NCT00457418|515581763|FG000|Post PK Maintenance|Progression of Disease|6|||
143011874|NCT00457418|515581763|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
143011875|NCT00457418|515581763|FG000|Post PK Maintenance|Lost to Follow-up|1|||
143011876|NCT01785472|515581764|FG000|Overall Study|Adverse Event|5|||
143011877|NCT01785472|515581765|FG001|Overall Study|Adverse Event|4|||
143011878|NCT01785472|515581766|FG002|Overall Study|Adverse Event|6|||
143011879|NCT01785472|515581764|FG000|Overall Study|Lack of Efficacy|2|||
143011880|NCT01785472|515581765|FG001|Overall Study|Lack of Efficacy|0|||
143011881|NCT01785472|515581766|FG002|Overall Study|Lack of Efficacy|1|||
143011882|NCT01785472|515581764|FG000|Overall Study|Lost to Follow-up|1|||
143011883|NCT01785472|515581765|FG001|Overall Study|Lost to Follow-up|2|||
143124877|NCT04399538|516001331|FG002|Follow-Up|Adverse Event|0|||
143124878|NCT04399538|516001332|FG003|Follow-Up|Adverse Event|0|||
143124879|NCT04399538|516001333|FG004|Follow-Up|Adverse Event|1|||
143124880|NCT04399538|516001329|FG000|Follow-Up|Withdrawal by Subject|0|||
143350729|NCT02291289|516831088|FG012|Induction Treatment|Non-Compliance|0|||
143011884|NCT01785472|515581766|FG002|Overall Study|Lost to Follow-up|0|||
143124881|NCT04399538|516001330|FG001|Follow-Up|Withdrawal by Subject|0|||
143124882|NCT04399538|516001331|FG002|Follow-Up|Withdrawal by Subject|0|||
143011885|NCT01785472|515581764|FG000|Overall Study|Physician Decision|1|||
143011886|NCT01785472|515581765|FG001|Overall Study|Physician Decision|1|||
143011887|NCT01785472|515581766|FG002|Overall Study|Physician Decision|1|||
143011888|NCT01785472|515581764|FG000|Overall Study|Protocol deviation|0|||
143011889|NCT01785472|515581765|FG001|Overall Study|Protocol deviation|2|||
143011890|NCT01785472|515581766|FG002|Overall Study|Protocol deviation|2|||
143011891|NCT01785472|515581764|FG000|Overall Study|Subject/guardian decision|15|||
143011892|NCT01785472|515581765|FG001|Overall Study|Subject/guardian decision|10|||
143011893|NCT01785472|515581766|FG002|Overall Study|Subject/guardian decision|11|||
143124883|NCT04399538|516001332|FG003|Follow-Up|Withdrawal by Subject|2|||
143124884|NCT04399538|516001333|FG004|Follow-Up|Withdrawal by Subject|0|||
143124885|NCT01416155|516001339|FG000|Overall Study|Adverse Event|8|||
143124886|NCT01416155|516001339|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
143124887|NCT01416155|516001339|FG000|Overall Study|Withdrawal by Subject|33|||
143124888|NCT01416155|516001339|FG000|Overall Study|Investigator decision|8|||
143124889|NCT01416155|516001339|FG000|Overall Study|Other|7|||
143124890|NCT01900899|516001343|FG000|Overall Study|Withdrawal by Subject|7|||
143124891|NCT01900899|516001344|FG001|Overall Study|Withdrawal by Subject|1|||
143124892|NCT01900899|516001343|FG000|Overall Study|Migrated from study area|2|||
143124893|NCT01900899|516001344|FG001|Overall Study|Migrated from study area|0|||
143124894|NCT02772809|516001347|FG000|Overall Study|not completed some tasks|6|||
143124895|NCT00534105|516001348|FG000|Overall Study|Lost to Follow-up|23|||
143124896|NCT00534105|516001349|FG001|Overall Study|Lost to Follow-up|39|||
143124897|NCT00520767|516001350|FG000|Overall Study|Death|2|||
143124898|NCT00398216|516003566|FG000|Overall Study|Adverse Event|4|||
143124899|NCT00398216|516003567|FG001|Overall Study|Adverse Event|2|||
143124900|NCT00398216|516003568|FG002|Overall Study|Adverse Event|5|||
143124901|NCT00398216|516003569|FG003|Overall Study|Adverse Event|7|||
143124902|NCT00398216|516003570|FG004|Overall Study|Adverse Event|2|||
143124903|NCT00398216|516003566|FG000|Overall Study|Protocol Violation|2|||
143124904|NCT00398216|516003567|FG001|Overall Study|Protocol Violation|4|||
143124905|NCT00398216|516003568|FG002|Overall Study|Protocol Violation|5|||
143124906|NCT00398216|516003569|FG003|Overall Study|Protocol Violation|7|||
143124907|NCT00398216|516003570|FG004|Overall Study|Protocol Violation|5|||
143124908|NCT00398216|516003566|FG000|Overall Study|Lost to Follow-up|1|||
143124909|NCT00398216|516003567|FG001|Overall Study|Lost to Follow-up|6|||
143124910|NCT00398216|516003568|FG002|Overall Study|Lost to Follow-up|4|||
143124911|NCT00398216|516003569|FG003|Overall Study|Lost to Follow-up|4|||
143124912|NCT00398216|516003570|FG004|Overall Study|Lost to Follow-up|1|||
143124913|NCT00398216|516003566|FG000|Overall Study|Death|0|||
143124914|NCT00398216|516003567|FG001|Overall Study|Death|3|||
143124915|NCT00398216|516003568|FG002|Overall Study|Death|0|||
143124916|NCT00398216|516003569|FG003|Overall Study|Death|0|||
143124917|NCT00398216|516003570|FG004|Overall Study|Death|0|||
143124918|NCT00398216|516003566|FG000|Overall Study|Withdrawal by Subject|1|||
143124919|NCT00398216|516003567|FG001|Overall Study|Withdrawal by Subject|0|||
143124920|NCT00398216|516003568|FG002|Overall Study|Withdrawal by Subject|3|||
143124921|NCT00398216|516003569|FG003|Overall Study|Withdrawal by Subject|1|||
143124922|NCT00398216|516003570|FG004|Overall Study|Withdrawal by Subject|2|||
143124923|NCT00398216|516003566|FG000|Overall Study|administrative reasons|3|||
143124924|NCT00398216|516003567|FG001|Overall Study|administrative reasons|4|||
143124925|NCT00398216|516003568|FG002|Overall Study|administrative reasons|4|||
143124926|NCT00398216|516003569|FG003|Overall Study|administrative reasons|3|||
143124927|NCT00398216|516003570|FG004|Overall Study|administrative reasons|3|||
143124928|NCT00398216|516003566|FG000|Overall Study|entrance criteria|0|||
143124929|NCT00398216|516003567|FG001|Overall Study|entrance criteria|0|||
143124930|NCT00398216|516003568|FG002|Overall Study|entrance criteria|0|||
143124931|NCT00398216|516003569|FG003|Overall Study|entrance criteria|0|||
143124932|NCT00398216|516003570|FG004|Overall Study|entrance criteria|2|||
143124933|NCT04378569|516003572|FG000|Overall Study|Adverse Event|0|||
143124934|NCT04378569|516003573|FG001|Overall Study|Adverse Event|0|||
143124935|NCT04378569|516003574|FG002|Overall Study|Adverse Event|2|||
143124936|NCT04378569|516003575|FG003|Overall Study|Adverse Event|0|||
143124937|NCT04378569|516003576|FG004|Overall Study|Adverse Event|3|||
143124938|NCT04378569|516003577|FG005|Overall Study|Adverse Event|3|||
143124939|NCT04378569|516003572|FG000|Overall Study|Lost to Follow-up|0|||
143124940|NCT04378569|516003573|FG001|Overall Study|Lost to Follow-up|3|||
143124941|NCT04378569|516003574|FG002|Overall Study|Lost to Follow-up|1|||
143124942|NCT04378569|516003575|FG003|Overall Study|Lost to Follow-up|0|||
143124943|NCT04378569|516003576|FG004|Overall Study|Lost to Follow-up|1|||
143124944|NCT04378569|516003577|FG005|Overall Study|Lost to Follow-up|1|||
143124945|NCT04378569|516003572|FG000|Overall Study|Protocol Violation|0|||
143124946|NCT04378569|516003573|FG001|Overall Study|Protocol Violation|0|||
143124947|NCT04378569|516003574|FG002|Overall Study|Protocol Violation|0|||
143124948|NCT04378569|516003575|FG003|Overall Study|Protocol Violation|0|||
143124949|NCT04378569|516003576|FG004|Overall Study|Protocol Violation|0|||
143124950|NCT04378569|516003577|FG005|Overall Study|Protocol Violation|1|||
143124951|NCT04378569|516003572|FG000|Overall Study|Withdrawal by Subject|0|||
143124952|NCT04378569|516003573|FG001|Overall Study|Withdrawal by Subject|6|||
143124953|NCT04378569|516003574|FG002|Overall Study|Withdrawal by Subject|7|||
143124954|NCT04378569|516003575|FG003|Overall Study|Withdrawal by Subject|4|||
143124955|NCT04378569|516003576|FG004|Overall Study|Withdrawal by Subject|5|||
143124956|NCT04378569|516003577|FG005|Overall Study|Withdrawal by Subject|4|||
143124957|NCT04378569|516003572|FG000|Overall Study|Lack of response|0|||
143124958|NCT04378569|516003573|FG001|Overall Study|Lack of response|0|||
143124959|NCT04378569|516003574|FG002|Overall Study|Lack of response|1|||
143124960|NCT04378569|516003575|FG003|Overall Study|Lack of response|0|||
143124961|NCT04378569|516003576|FG004|Overall Study|Lack of response|1|||
143124962|NCT04378569|516003577|FG005|Overall Study|Lack of response|1|||
143124963|NCT01048944|516003578|FG000|Overall Study|Protocol Violation|8|||
143124964|NCT01048944|516003579|FG001|Overall Study|Protocol Violation|10|||
143124965|NCT01048944|516003580|FG002|Overall Study|Protocol Violation|10|||
143124966|NCT01048944|516003581|FG003|Overall Study|Protocol Violation|2|||
143124967|NCT00376532|516003582|FG000|Overall Study|Lack sufficient blood sample|6|||
143124968|NCT00376532|516003583|FG001|Overall Study|Lack sufficient blood sample|6|||
143124969|NCT01844817|516003584|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
143124970|NCT01844817|516003585|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
143124971|NCT01844817|516003584|FG000|Treatment|Progressive Disease|27|||
143124972|NCT01844817|516003585|FG001|Treatment|Progressive Disease|36|||
143124973|NCT01844817|516003584|FG000|Treatment|Adverse Event|17|||
143124974|NCT01844817|516003585|FG001|Treatment|Adverse Event|9|||
143124975|NCT01844817|516003584|FG000|Treatment|Withdrawal by Subject|10|||
143124976|NCT01844817|516003585|FG001|Treatment|Withdrawal by Subject|6|||
143124977|NCT01844817|516003584|FG000|Treatment|Death|10|||
143124978|NCT01844817|516003585|FG001|Treatment|Death|8|||
143124979|NCT01844817|516003584|FG000|Treatment|Lost to Follow-up|0|||
143124980|NCT01844817|516003585|FG001|Treatment|Lost to Follow-up|1|||
143124981|NCT01844817|516003584|FG000|Treatment|Other|0|||
143124982|NCT01844817|516003585|FG001|Treatment|Other|3|||
143124983|NCT01133704|516003586|FG000|Overall Study|Death|44|||
143124984|NCT01133704|516003587|FG001|Overall Study|Death|26|||
143124985|NCT01133704|516003586|FG000|Overall Study|Patient refused to continue|4|||
143124986|NCT01133704|516003587|FG001|Overall Study|Patient refused to continue|0|||
143124987|NCT01133704|516003586|FG000|Overall Study|Study Closure|1|||
143124988|NCT01133704|516003587|FG001|Overall Study|Study Closure|0|||
143124989|NCT02207400|516003588|FG000|Overall Study|Adverse Event|1|||
143124990|NCT02207400|516003589|FG001|Overall Study|Adverse Event|1|||
143124991|NCT02207400|516003588|FG000|Overall Study|Lost to Follow-up|6|||
143124992|NCT02207400|516003589|FG001|Overall Study|Lost to Follow-up|7|||
143124993|NCT02207400|516003588|FG000|Overall Study|Protocol Violation|1|||
143124994|NCT02207400|516003589|FG001|Overall Study|Protocol Violation|1|||
143124995|NCT02207400|516003588|FG000|Overall Study|Withdrawal by Subject|8|||
143124996|NCT02207400|516003589|FG001|Overall Study|Withdrawal by Subject|4|||
143350730|NCT02291289|516831076|FG000|Induction Treatment|Reason Not Specified|0|||
143350731|NCT02291289|516831077|FG001|Induction Treatment|Reason Not Specified|0|||
143350732|NCT02291289|516831078|FG002|Induction Treatment|Reason Not Specified|0|||
143350733|NCT02291289|516831079|FG003|Induction Treatment|Reason Not Specified|4|||
143350734|NCT02291289|516831080|FG004|Induction Treatment|Reason Not Specified|0|||
143350735|NCT02291289|516831081|FG005|Induction Treatment|Reason Not Specified|0|||
143350736|NCT02291289|516831082|FG006|Induction Treatment|Reason Not Specified|0|||
143350737|NCT02291289|516831083|FG007|Induction Treatment|Reason Not Specified|0|||
143350738|NCT02291289|516831084|FG008|Induction Treatment|Reason Not Specified|0|||
143350739|NCT02291289|516831085|FG009|Induction Treatment|Reason Not Specified|7|||
143350740|NCT02291289|516831086|FG010|Induction Treatment|Reason Not Specified|0|||
143350741|NCT02291289|516831087|FG011|Induction Treatment|Reason Not Specified|0|||
143350742|NCT02291289|516831088|FG012|Induction Treatment|Reason Not Specified|0|||
143350743|NCT02291289|516831076|FG000|Induction Treatment|Physician Decision|0|||
143350744|NCT02291289|516831077|FG001|Induction Treatment|Physician Decision|0|||
143350745|NCT02291289|516831078|FG002|Induction Treatment|Physician Decision|0|||
143350746|NCT02291289|516831079|FG003|Induction Treatment|Physician Decision|3|||
143350747|NCT02291289|516831080|FG004|Induction Treatment|Physician Decision|0|||
143350748|NCT02291289|516831081|FG005|Induction Treatment|Physician Decision|0|||
143350749|NCT02291289|516831082|FG006|Induction Treatment|Physician Decision|0|||
143350750|NCT02291289|516831083|FG007|Induction Treatment|Physician Decision|0|||
143350751|NCT02291289|516831084|FG008|Induction Treatment|Physician Decision|0|||
143350752|NCT02291289|516831085|FG009|Induction Treatment|Physician Decision|1|||
143461407|NCT04494256|517235051|FG006|Part 1: Double Blinded Period|Adverse Event|0|||
143350753|NCT02291289|516831086|FG010|Induction Treatment|Physician Decision|0|||
143124997|NCT02207400|516003588|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
143124998|NCT02207400|516003589|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
143124999|NCT03396822|516003590|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
143125000|NCT03396822|516003590|FG000|Overall Study|Physician Decision|1|||
143125001|NCT03630705|516003593|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
143125002|NCT03630705|516003594|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
143125003|NCT03630705|516003595|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
143350754|NCT02291289|516831087|FG011|Induction Treatment|Physician Decision|0|||
143350755|NCT02291289|516831088|FG012|Induction Treatment|Physician Decision|0|||
143125004|NCT03630705|516003596|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
143125005|NCT03630705|516003593|FG000|Overall Study|Lost to Follow-up|1|||
143125006|NCT03630705|516003594|FG001|Overall Study|Lost to Follow-up|2|||
143125007|NCT03630705|516003595|FG002|Overall Study|Lost to Follow-up|0|||
143125008|NCT03630705|516003596|FG003|Overall Study|Lost to Follow-up|0|||
143125009|NCT02849704|516003597|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
143125010|NCT02849704|516003598|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
143125011|NCT02849704|516003597|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
143125012|NCT02849704|516003598|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
143125013|NCT02849704|516003597|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
143125014|NCT02849704|516003598|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
143125015|NCT03638466|516003601|FG000|Overall Study|Early Termination|0|||
143125016|NCT03638466|516003602|FG001|Overall Study|Early Termination|1|||
143125017|NCT03251482|516003603|FG000|Overall Study|Withdrawal by Subject|0|||
143125018|NCT03251482|516003604|FG001|Overall Study|Withdrawal by Subject|1|||
143125019|NCT03251482|516003605|FG002|Overall Study|Withdrawal by Subject|0|||
143125020|NCT03251482|516003606|FG003|Overall Study|Withdrawal by Subject|0|||
143125021|NCT03251482|516003607|FG004|Overall Study|Withdrawal by Subject|0|||
143125022|NCT02447328|516003610|FG000|Overall Study|Withdrawal by Subject|1|||
143125023|NCT01128400|516003611|FG000|Overall Study|Lost to Follow-up|1|||
143125024|NCT01128400|516003612|FG001|Overall Study|Lost to Follow-up|0|||
143125025|NCT01128400|516003613|FG002|Overall Study|Lost to Follow-up|1|||
143125026|NCT01128400|516003611|FG000|Overall Study|Screening failure|1|||
143125027|NCT01128400|516003612|FG001|Overall Study|Screening failure|0|||
143125028|NCT01128400|516003613|FG002|Overall Study|Screening failure|0|||
143125029|NCT01128400|516003611|FG000|Overall Study|were not invited to participate on taste|0|||
143125030|NCT01128400|516003612|FG001|Overall Study|were not invited to participate on taste|0|||
143125031|NCT01128400|516003613|FG002|Overall Study|were not invited to participate on taste|15|||
143125032|NCT01128400|516003611|FG000|Overall Study|Excluded due to sinus problems|0|||
143125033|NCT01128400|516003612|FG001|Overall Study|Excluded due to sinus problems|1|||
143125034|NCT01128400|516003613|FG002|Overall Study|Excluded due to sinus problems|0|||
143125035|NCT02362425|516003614|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
143125036|NCT02362425|516003615|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
143125037|NCT02362425|516003616|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
143125038|NCT02362425|516003617|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
143125039|NCT02362425|516003614|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
143125040|NCT02362425|516003615|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
143125041|NCT02362425|516003616|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
143350756|NCT02291289|516831076|FG000|Induction Treatment|Protocol Violation|0|||
143350757|NCT02291289|516831077|FG001|Induction Treatment|Protocol Violation|0|||
143350758|NCT02291289|516831078|FG002|Induction Treatment|Protocol Violation|0|||
143350759|NCT02291289|516831079|FG003|Induction Treatment|Protocol Violation|3|||
143350760|NCT02291289|516831080|FG004|Induction Treatment|Protocol Violation|0|||
143350761|NCT02291289|516831081|FG005|Induction Treatment|Protocol Violation|0|||
143350762|NCT02291289|516831082|FG006|Induction Treatment|Protocol Violation|0|||
143350763|NCT02291289|516831083|FG007|Induction Treatment|Protocol Violation|0|||
143350764|NCT02291289|516831084|FG008|Induction Treatment|Protocol Violation|0|||
143350765|NCT02291289|516831085|FG009|Induction Treatment|Protocol Violation|2|||
143350766|NCT02291289|516831086|FG010|Induction Treatment|Protocol Violation|0|||
143350767|NCT02291289|516831087|FG011|Induction Treatment|Protocol Violation|0|||
143350768|NCT02291289|516831088|FG012|Induction Treatment|Protocol Violation|0|||
143350769|NCT02291289|516831076|FG000|Induction Treatment|Missing|4|||
143350770|NCT02291289|516831077|FG001|Induction Treatment|Missing|0|||
143350771|NCT02291289|516831078|FG002|Induction Treatment|Missing|0|||
143350772|NCT02291289|516831079|FG003|Induction Treatment|Missing|14|||
143350773|NCT02291289|516831080|FG004|Induction Treatment|Missing|0|||
143350774|NCT02291289|516831081|FG005|Induction Treatment|Missing|0|||
143350775|NCT02291289|516831082|FG006|Induction Treatment|Missing|0|||
143350776|NCT02291289|516831083|FG007|Induction Treatment|Missing|0|||
143350777|NCT02291289|516831084|FG008|Induction Treatment|Missing|0|||
143350778|NCT02291289|516831085|FG009|Induction Treatment|Missing|54|||
143125042|NCT02362425|516003617|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
143125043|NCT02362425|516003614|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
143125044|NCT02362425|516003615|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
143350779|NCT02291289|516831086|FG010|Induction Treatment|Missing|0|||
143350780|NCT02291289|516831087|FG011|Induction Treatment|Missing|0|||
143125045|NCT02362425|516003616|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
143125046|NCT02362425|516003617|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
143125047|NCT02362425|516003614|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
143350781|NCT02291289|516831088|FG012|Induction Treatment|Missing|0|||
143350782|NCT02291289|516831076|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
143350783|NCT02291289|516831077|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
143350784|NCT02291289|516831078|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
143125048|NCT02362425|516003615|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
143125049|NCT02362425|516003616|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
143125050|NCT02362425|516003617|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
143125051|NCT02362425|516003614|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
143125052|NCT02362425|516003615|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
143125053|NCT02362425|516003616|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
143125054|NCT02362425|516003617|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
143125055|NCT02362425|516003614|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
143125056|NCT02362425|516003615|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
143125057|NCT02362425|516003616|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
143125058|NCT02362425|516003617|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
143125059|NCT02362425|516003614|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
143125060|NCT02362425|516003615|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
143125061|NCT02362425|516003616|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
143125062|NCT02362425|516003617|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
143125063|NCT02362425|516003614|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
143125064|NCT02362425|516003615|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
143125065|NCT02362425|516003616|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
143125066|NCT02362425|516003617|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
143125067|NCT00314808|516003623|FG000|Overall Study|Disease Progression without AE|4|||
143125068|NCT00314808|516003623|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
143125069|NCT04076319|516003625|FG000|Overall Study|Withdrawal by Subject|2|||
143125070|NCT04076319|516003626|FG001|Overall Study|Withdrawal by Subject|0|||
143125071|NCT04076319|516003625|FG000|Overall Study|Death|1|||
143125072|NCT04076319|516003626|FG001|Overall Study|Death|0|||
143125073|NCT03782571|516003627|FG000|Period 1|Withdrawal by Subject|1|||
143125074|NCT03782571|516003628|FG001|Period 1|Withdrawal by Subject|0|||
143125075|NCT03782571|516003629|FG002|Period 1|Withdrawal by Subject|0|||
143125076|NCT03782571|516003630|FG003|Period 1|Withdrawal by Subject|0|||
143125077|NCT03782571|516003627|FG000|Period 3|Subject Unable to Attend V5|1|||
143125078|NCT03782571|516003628|FG001|Period 3|Subject Unable to Attend V5|0|||
143125079|NCT03782571|516003629|FG002|Period 3|Subject Unable to Attend V5|0|||
143125080|NCT03782571|516003630|FG003|Period 3|Subject Unable to Attend V5|0|||
143125081|NCT03782571|516003627|FG000|Period 3|Adverse Event|1|||
143125082|NCT03782571|516003628|FG001|Period 3|Adverse Event|0|||
143125083|NCT03782571|516003629|FG002|Period 3|Adverse Event|0|||
143125084|NCT03782571|516003630|FG003|Period 3|Adverse Event|0|||
143125085|NCT01826981|516003643|FG000|Overall Study|Lack of Efficacy|0|||
143125086|NCT01826981|516003644|FG001|Overall Study|Lack of Efficacy|1|||
143125087|NCT01826981|516003645|FG002|Overall Study|Lack of Efficacy|0|||
143125088|NCT01826981|516003646|FG003|Overall Study|Lack of Efficacy|0|||
143125089|NCT01826981|516003647|FG004|Overall Study|Lack of Efficacy|5|||
143125090|NCT01826981|516003648|FG005|Overall Study|Lack of Efficacy|0|||
143125091|NCT01826981|516003649|FG006|Overall Study|Lack of Efficacy|0|||
143125092|NCT01826981|516003650|FG007|Overall Study|Lack of Efficacy|8|||
143125093|NCT01826981|516003651|FG008|Overall Study|Lack of Efficacy|7|||
143125094|NCT01826981|516003652|FG009|Overall Study|Lack of Efficacy|0|||
143125095|NCT01826981|516003653|FG010|Overall Study|Lack of Efficacy|1|||
143125096|NCT01826981|516003654|FG011|Overall Study|Lack of Efficacy|0|||
143125097|NCT01826981|516003655|FG012|Overall Study|Lack of Efficacy|0|||
143125098|NCT01826981|516003656|FG013|Overall Study|Lack of Efficacy|3|||
143125099|NCT01826981|516003657|FG014|Overall Study|Lack of Efficacy|0|||
143125100|NCT01826981|516003643|FG000|Overall Study|Lost to Follow-up|0|||
143125101|NCT01826981|516003644|FG001|Overall Study|Lost to Follow-up|0|||
143125102|NCT01826981|516003645|FG002|Overall Study|Lost to Follow-up|0|||
143125103|NCT01826981|516003646|FG003|Overall Study|Lost to Follow-up|0|||
143125104|NCT01826981|516003647|FG004|Overall Study|Lost to Follow-up|1|||
143125105|NCT01826981|516003648|FG005|Overall Study|Lost to Follow-up|1|||
143125106|NCT01826981|516003649|FG006|Overall Study|Lost to Follow-up|0|||
143125107|NCT01826981|516003650|FG007|Overall Study|Lost to Follow-up|1|||
143125108|NCT01826981|516003651|FG008|Overall Study|Lost to Follow-up|0|||
143125109|NCT01826981|516003652|FG009|Overall Study|Lost to Follow-up|1|||
143125110|NCT01826981|516003653|FG010|Overall Study|Lost to Follow-up|1|||
143125111|NCT01826981|516003654|FG011|Overall Study|Lost to Follow-up|1|||
143125112|NCT01826981|516003655|FG012|Overall Study|Lost to Follow-up|1|||
143125113|NCT01826981|516003656|FG013|Overall Study|Lost to Follow-up|0|||
143125114|NCT01826981|516003657|FG014|Overall Study|Lost to Follow-up|0|||
143125115|NCT01826981|516003643|FG000|Overall Study|Withdrew Consent|0|||
143125116|NCT01826981|516003644|FG001|Overall Study|Withdrew Consent|0|||
143125117|NCT01826981|516003645|FG002|Overall Study|Withdrew Consent|0|||
143125118|NCT01826981|516003646|FG003|Overall Study|Withdrew Consent|0|||
143125119|NCT01826981|516003647|FG004|Overall Study|Withdrew Consent|0|||
143125120|NCT01826981|516003648|FG005|Overall Study|Withdrew Consent|0|||
143125121|NCT01826981|516003649|FG006|Overall Study|Withdrew Consent|1|||
143125122|NCT01826981|516003650|FG007|Overall Study|Withdrew Consent|1|||
143125123|NCT01826981|516003651|FG008|Overall Study|Withdrew Consent|0|||
143125124|NCT01826981|516003652|FG009|Overall Study|Withdrew Consent|0|||
143125125|NCT01826981|516003653|FG010|Overall Study|Withdrew Consent|0|||
143125126|NCT01826981|516003654|FG011|Overall Study|Withdrew Consent|1|||
143125127|NCT01826981|516003655|FG012|Overall Study|Withdrew Consent|0|||
143125128|NCT01826981|516003656|FG013|Overall Study|Withdrew Consent|1|||
143125129|NCT01826981|516003657|FG014|Overall Study|Withdrew Consent|0|||
143125130|NCT01826981|516003643|FG000|Overall Study|Adverse Event|0|||
143125131|NCT01826981|516003644|FG001|Overall Study|Adverse Event|0|||
143125132|NCT01826981|516003645|FG002|Overall Study|Adverse Event|0|||
143125133|NCT01826981|516003646|FG003|Overall Study|Adverse Event|0|||
143125134|NCT01826981|516003647|FG004|Overall Study|Adverse Event|1|||
143125135|NCT01826981|516003648|FG005|Overall Study|Adverse Event|0|||
143125136|NCT01826981|516003649|FG006|Overall Study|Adverse Event|0|||
143125137|NCT01826981|516003650|FG007|Overall Study|Adverse Event|0|||
143125138|NCT01826981|516003651|FG008|Overall Study|Adverse Event|0|||
143125139|NCT01826981|516003652|FG009|Overall Study|Adverse Event|0|||
143125140|NCT01826981|516003653|FG010|Overall Study|Adverse Event|0|||
143125141|NCT01826981|516003654|FG011|Overall Study|Adverse Event|0|||
143125142|NCT01826981|516003655|FG012|Overall Study|Adverse Event|0|||
143125143|NCT01826981|516003656|FG013|Overall Study|Adverse Event|0|||
143125144|NCT01826981|516003657|FG014|Overall Study|Adverse Event|0|||
143125145|NCT01826981|516003643|FG000|Overall Study|Upper G-I Haemorrhage|0|||
143125146|NCT01826981|516003644|FG001|Overall Study|Upper G-I Haemorrhage|0|||
143125147|NCT01826981|516003645|FG002|Overall Study|Upper G-I Haemorrhage|0|||
143125148|NCT01826981|516003646|FG003|Overall Study|Upper G-I Haemorrhage|0|||
143125149|NCT01826981|516003647|FG004|Overall Study|Upper G-I Haemorrhage|0|||
143125150|NCT01826981|516003648|FG005|Overall Study|Upper G-I Haemorrhage|0|||
143125151|NCT01826981|516003649|FG006|Overall Study|Upper G-I Haemorrhage|0|||
143125152|NCT01826981|516003650|FG007|Overall Study|Upper G-I Haemorrhage|0|||
143125153|NCT01826981|516003651|FG008|Overall Study|Upper G-I Haemorrhage|0|||
143125154|NCT01826981|516003652|FG009|Overall Study|Upper G-I Haemorrhage|0|||
143125155|NCT01826981|516003653|FG010|Overall Study|Upper G-I Haemorrhage|0|||
143125156|NCT01826981|516003654|FG011|Overall Study|Upper G-I Haemorrhage|0|||
143125157|NCT01826981|516003655|FG012|Overall Study|Upper G-I Haemorrhage|0|||
143125158|NCT01826981|516003656|FG013|Overall Study|Upper G-I Haemorrhage|1|||
143125159|NCT01826981|516003657|FG014|Overall Study|Upper G-I Haemorrhage|0|||
143125160|NCT01826981|516003643|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
143125161|NCT01826981|516003644|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
143125162|NCT01826981|516003645|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
143125163|NCT01826981|516003646|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
143125164|NCT01826981|516003647|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
143125165|NCT01826981|516003648|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
143125166|NCT01826981|516003649|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
143125167|NCT01826981|516003650|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
143125168|NCT01826981|516003651|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
143125169|NCT01826981|516003652|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
143125170|NCT01826981|516003653|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
143125171|NCT01826981|516003654|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
143125172|NCT01826981|516003655|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
143125173|NCT01826981|516003656|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
143125174|NCT01826981|516003657|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
143125175|NCT00206427|516003658|FG000|Overall Study|Adverse Event|2|||
143125176|NCT05205005|516003662|FG000|Overall Study|Withdrawal by Subject|1|||
143125177|NCT05205005|516003663|FG001|Overall Study|Withdrawal by Subject|0|||
143125178|NCT05205005|516003662|FG000|Overall Study|Adverse Event|1|||
143125179|NCT05205005|516003663|FG001|Overall Study|Adverse Event|0|||
143125180|NCT01148459|516003664|FG000|Overall Study|Serious Adverse Event|5|||
143125181|NCT01148459|516003665|FG001|Overall Study|Serious Adverse Event|4|||
143125182|NCT01148459|516003664|FG000|Overall Study|Withdrawal by Subject|1|||
143125183|NCT01148459|516003665|FG001|Overall Study|Withdrawal by Subject|0|||
143350785|NCT02291289|516831079|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
143125184|NCT01148459|516003664|FG000|Overall Study|Migrated/moved from study area|3|||
143125185|NCT01148459|516003665|FG001|Overall Study|Migrated/moved from study area|6|||
143125186|NCT01148459|516003664|FG000|Overall Study|Lost to Follow-up|2|||
143125187|NCT01148459|516003665|FG001|Overall Study|Lost to Follow-up|0|||
143125188|NCT01148459|516003664|FG000|Overall Study|Refusal|1|||
143125189|NCT01148459|516003665|FG001|Overall Study|Refusal|0|||
143125190|NCT01148459|516003664|FG000|Overall Study|Failure to comply with study procedures|0|||
143350786|NCT02291289|516831080|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
143350787|NCT02291289|516831081|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
143125191|NCT01148459|516003665|FG001|Overall Study|Failure to comply with study procedures|1|||
143125192|NCT00741598|516003666|FG000|Overall Study|Lost to Follow-up|3|||
143125193|NCT00741598|516003667|FG001|Overall Study|Lost to Follow-up|4|||
143125194|NCT00741598|516003666|FG000|Overall Study|Lack of Efficacy|1|||
143125195|NCT00741598|516003667|FG001|Overall Study|Lack of Efficacy|2|||
143125196|NCT00741598|516003666|FG000|Overall Study|Physician Decision|1|||
143125197|NCT00741598|516003667|FG001|Overall Study|Physician Decision|1|||
143125198|NCT00741598|516003666|FG000|Overall Study|Pregnancy|1|||
143125199|NCT00741598|516003667|FG001|Overall Study|Pregnancy|0|||
143125200|NCT00741598|516003666|FG000|Overall Study|Withdrawal by Subject|3|||
143125201|NCT00741598|516003667|FG001|Overall Study|Withdrawal by Subject|2|||
143125202|NCT02768792|516003678|FG000|Overall Study|Adverse Event|1|||
143125203|NCT04676724|516003679|FG000|Overall Study|Adverse Event|2|||
143125204|NCT04676724|516003680|FG001|Overall Study|Adverse Event|0|||
143125205|NCT04676724|516003679|FG000|Overall Study|Lost to Follow-up|1|||
143125206|NCT04676724|516003680|FG001|Overall Study|Lost to Follow-up|0|||
143125207|NCT04676724|516003679|FG000|Overall Study|Physician Decision|0|||
143125208|NCT04676724|516003680|FG001|Overall Study|Physician Decision|1|||
143125209|NCT04676724|516003679|FG000|Overall Study|Withdrawal by Subject|3|||
143125210|NCT04676724|516003680|FG001|Overall Study|Withdrawal by Subject|2|||
143125211|NCT00237692|516003682|FG000|Overall Study|Lost to Follow-up|9|||
143125212|NCT00237692|516003683|FG001|Overall Study|Lost to Follow-up|3|||
143125213|NCT00237692|516003684|FG002|Overall Study|Lost to Follow-up|5|||
143125214|NCT00237692|516003685|FG003|Overall Study|Lost to Follow-up|3|||
143125215|NCT00237692|516003682|FG000|Overall Study|Death|1|||
143125216|NCT00237692|516003683|FG001|Overall Study|Death|2|||
143125217|NCT00237692|516003684|FG002|Overall Study|Death|2|||
143125218|NCT00237692|516003685|FG003|Overall Study|Death|3|||
143125219|NCT00237692|516003682|FG000|Overall Study|Excluded - did not meet criteria|4|||
143125220|NCT00237692|516003683|FG001|Overall Study|Excluded - did not meet criteria|3|||
143125221|NCT00237692|516003684|FG002|Overall Study|Excluded - did not meet criteria|5|||
143125222|NCT00237692|516003685|FG003|Overall Study|Excluded - did not meet criteria|9|||
143125223|NCT00237692|516003682|FG000|Overall Study|Withdrawal by Subject|4|||
143125224|NCT00237692|516003683|FG001|Overall Study|Withdrawal by Subject|6|||
143125225|NCT00237692|516003684|FG002|Overall Study|Withdrawal by Subject|10|||
143125226|NCT00237692|516003685|FG003|Overall Study|Withdrawal by Subject|4|||
143125227|NCT03882957|516003688|FG000|Overall Study|Did not complete all three arms|1|||
143125228|NCT03162328|516003691|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
143125229|NCT03162328|516003692|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
143125230|NCT03162328|516003693|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
143125231|NCT03162328|516003691|FG000|Screening Period|Withdrawal by Subject|1|||
143125232|NCT03162328|516003692|FG001|Screening Period|Withdrawal by Subject|0|||
143125233|NCT03162328|516003693|FG002|Screening Period|Withdrawal by Subject|0|||
143125234|NCT03162328|516003691|FG000|Study Period|Withdrawal by Subject|0|||
143125235|NCT03162328|516003692|FG001|Study Period|Withdrawal by Subject|0|||
143125236|NCT03162328|516003693|FG002|Study Period|Withdrawal by Subject|1|||
143125237|NCT03337048|516003697|FG000|Overall Study|Withdrawal by Subject|2|||
143125238|NCT03337048|516003698|FG001|Overall Study|Withdrawal by Subject|0|||
143125239|NCT03337048|516003699|FG002|Overall Study|Withdrawal by Subject|0|||
143125240|NCT03597139|516003701|FG000|Overall Study|Adverse Event|3|||
143125241|NCT03597139|516003702|FG001|Overall Study|Adverse Event|0|||
143125242|NCT03597139|516003701|FG000|Overall Study|Protocol Non-compliance|1|||
143125243|NCT03597139|516003702|FG001|Overall Study|Protocol Non-compliance|0|||
143125244|NCT04811664|516003705|FG000|Overall Study|Lost to Follow-up|78|||
143125245|NCT04811664|516003706|FG001|Overall Study|Lost to Follow-up|125|||
143125246|NCT04811664|516003707|FG002|Overall Study|Lost to Follow-up|46|||
143125247|NCT04811664|516003705|FG000|Overall Study|Withdrawal by Subject|39|||
143125248|NCT04811664|516003706|FG001|Overall Study|Withdrawal by Subject|76|||
143125249|NCT04811664|516003707|FG002|Overall Study|Withdrawal by Subject|12|||
143125250|NCT04811664|516003705|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
143125251|NCT04811664|516003706|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
143350788|NCT02291289|516831082|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
143350789|NCT02291289|516831083|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
143350790|NCT02291289|516831084|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
143350791|NCT02291289|516831085|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
143350792|NCT02291289|516831086|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
143350793|NCT02291289|516831087|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
143350794|NCT02291289|516831088|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
143350795|NCT02291289|516831076|FG000|Maintenance Treatment Phase|Death|0|||
143461408|NCT04494256|517235045|FG000|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
143461409|NCT04494256|517235046|FG001|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
143125252|NCT04811664|516003707|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
143125253|NCT04811664|516003705|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
143461410|NCT04494256|517235047|FG002|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
143125254|NCT04811664|516003706|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
143125255|NCT04811664|516003707|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
143125256|NCT04811664|516003705|FG000|Overall Study|Protocol Violation|0|||
143350796|NCT02291289|516831077|FG001|Maintenance Treatment Phase|Death|29|||
143350797|NCT02291289|516831078|FG002|Maintenance Treatment Phase|Death|16|||
143350798|NCT02291289|516831079|FG003|Maintenance Treatment Phase|Death|0|||
143350799|NCT02291289|516831080|FG004|Maintenance Treatment Phase|Death|188|||
143350800|NCT02291289|516831081|FG005|Maintenance Treatment Phase|Death|107|||
143350801|NCT02291289|516831082|FG006|Maintenance Treatment Phase|Death|0|||
143350802|NCT02291289|516831083|FG007|Maintenance Treatment Phase|Death|1|||
143350803|NCT02291289|516831084|FG008|Maintenance Treatment Phase|Death|1|||
143350804|NCT02291289|516831085|FG009|Maintenance Treatment Phase|Death|0|||
143350805|NCT02291289|516831086|FG010|Maintenance Treatment Phase|Death|46|||
143350806|NCT02291289|516831087|FG011|Maintenance Treatment Phase|Death|19|||
143350807|NCT02291289|516831088|FG012|Maintenance Treatment Phase|Death|0|||
143350808|NCT02291289|516831076|FG000|Maintenance Treatment Phase|Adverse Event|0|||
143350809|NCT02291289|516831077|FG001|Maintenance Treatment Phase|Adverse Event|0|||
143350810|NCT02291289|516831078|FG002|Maintenance Treatment Phase|Adverse Event|0|||
143350811|NCT02291289|516831079|FG003|Maintenance Treatment Phase|Adverse Event|0|||
143350812|NCT02291289|516831080|FG004|Maintenance Treatment Phase|Adverse Event|1|||
143350813|NCT02291289|516831081|FG005|Maintenance Treatment Phase|Adverse Event|1|||
143350814|NCT02291289|516831082|FG006|Maintenance Treatment Phase|Adverse Event|0|||
143350815|NCT02291289|516831083|FG007|Maintenance Treatment Phase|Adverse Event|0|||
143350816|NCT02291289|516831084|FG008|Maintenance Treatment Phase|Adverse Event|0|||
143350817|NCT02291289|516831085|FG009|Maintenance Treatment Phase|Adverse Event|0|||
143350818|NCT02291289|516831086|FG010|Maintenance Treatment Phase|Adverse Event|0|||
143350819|NCT02291289|516831087|FG011|Maintenance Treatment Phase|Adverse Event|0|||
143350820|NCT02291289|516831088|FG012|Maintenance Treatment Phase|Adverse Event|0|||
143350821|NCT02291289|516831076|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
143350822|NCT02291289|516831077|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
143350823|NCT02291289|516831078|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
143350824|NCT02291289|516831079|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
143350825|NCT02291289|516831080|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
143350826|NCT02291289|516831081|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
143350827|NCT02291289|516831082|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
143350828|NCT02291289|516831083|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
143350829|NCT02291289|516831084|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
143350830|NCT02291289|516831085|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
143350831|NCT02291289|516831086|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
143350832|NCT02291289|516831087|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
143350833|NCT02291289|516831088|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
143350834|NCT02291289|516831076|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
143350835|NCT02291289|516831077|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
143350836|NCT02291289|516831078|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
143350837|NCT02291289|516831079|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
143350838|NCT02291289|516831080|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
143350839|NCT02291289|516831081|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
143350840|NCT02291289|516831082|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
143350841|NCT02291289|516831083|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
143350842|NCT02291289|516831084|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
143350843|NCT02291289|516831085|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
143350844|NCT02291289|516831086|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
143350845|NCT02291289|516831087|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
143350846|NCT02291289|516831088|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
143350847|NCT02291289|516831076|FG000|Maintenance Treatment Phase|Physician Decision|0|||
143350848|NCT02291289|516831077|FG001|Maintenance Treatment Phase|Physician Decision|2|||
143350849|NCT02291289|516831078|FG002|Maintenance Treatment Phase|Physician Decision|0|||
143350850|NCT02291289|516831079|FG003|Maintenance Treatment Phase|Physician Decision|0|||
143350851|NCT02291289|516831080|FG004|Maintenance Treatment Phase|Physician Decision|3|||
143350852|NCT02291289|516831081|FG005|Maintenance Treatment Phase|Physician Decision|0|||
143350853|NCT02291289|516831082|FG006|Maintenance Treatment Phase|Physician Decision|0|||
143350854|NCT02291289|516831083|FG007|Maintenance Treatment Phase|Physician Decision|0|||
143461411|NCT04494256|517235048|FG003|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
143461412|NCT04494256|517235049|FG004|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|5|||
143461413|NCT04494256|517235050|FG005|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
143461414|NCT04494256|517235051|FG006|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
143350855|NCT02291289|516831084|FG008|Maintenance Treatment Phase|Physician Decision|0|||
143350856|NCT02291289|516831085|FG009|Maintenance Treatment Phase|Physician Decision|0|||
143350857|NCT02291289|516831086|FG010|Maintenance Treatment Phase|Physician Decision|1|||
143350858|NCT02291289|516831087|FG011|Maintenance Treatment Phase|Physician Decision|3|||
143350859|NCT02291289|516831088|FG012|Maintenance Treatment Phase|Physician Decision|0|||
143350860|NCT02291289|516831076|FG000|Maintenance Treatment Phase|Not Treated|0|||
143350861|NCT02291289|516831077|FG001|Maintenance Treatment Phase|Not Treated|0|||
143350862|NCT02291289|516831078|FG002|Maintenance Treatment Phase|Not Treated|2|||
143350863|NCT02291289|516831079|FG003|Maintenance Treatment Phase|Not Treated|0|||
143350864|NCT02291289|516831080|FG004|Maintenance Treatment Phase|Not Treated|0|||
143350865|NCT02291289|516831081|FG005|Maintenance Treatment Phase|Not Treated|0|||
143350866|NCT02291289|516831082|FG006|Maintenance Treatment Phase|Not Treated|0|||
143350867|NCT02291289|516831083|FG007|Maintenance Treatment Phase|Not Treated|0|||
143350868|NCT02291289|516831084|FG008|Maintenance Treatment Phase|Not Treated|0|||
143350869|NCT02291289|516831085|FG009|Maintenance Treatment Phase|Not Treated|0|||
143350870|NCT02291289|516831086|FG010|Maintenance Treatment Phase|Not Treated|0|||
143350871|NCT02291289|516831087|FG011|Maintenance Treatment Phase|Not Treated|0|||
143350872|NCT02291289|516831088|FG012|Maintenance Treatment Phase|Not Treated|0|||
143350873|NCT02291289|516831076|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
143350874|NCT02291289|516831077|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
143350875|NCT02291289|516831078|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
143350876|NCT02291289|516831079|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
143350877|NCT02291289|516831080|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
143350878|NCT02291289|516831081|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
143350879|NCT02291289|516831082|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
143350880|NCT02291289|516831083|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
143350881|NCT02291289|516831084|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
143350882|NCT02291289|516831085|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
143350883|NCT02291289|516831086|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
143350884|NCT02291289|516831087|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
143350885|NCT02291289|516831088|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
143350886|NCT02291289|516831076|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
143350887|NCT02291289|516831077|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
143350888|NCT02291289|516831078|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
143350889|NCT02291289|516831079|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
143350890|NCT02291289|516831080|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
143350891|NCT02291289|516831081|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
143350892|NCT02291289|516831082|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
143350893|NCT02291289|516831083|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
143350894|NCT02291289|516831084|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
143350895|NCT02291289|516831085|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
143350896|NCT02291289|516831086|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
143350897|NCT02291289|516831087|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
143350898|NCT02291289|516831088|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
143350899|NCT02291289|516831076|FG000|Early Disease Progression|Death|0|||
143350900|NCT02291289|516831077|FG001|Early Disease Progression|Death|0|||
143350901|NCT02291289|516831078|FG002|Early Disease Progression|Death|0|||
143350902|NCT02291289|516831079|FG003|Early Disease Progression|Death|0|||
143350903|NCT02291289|516831080|FG004|Early Disease Progression|Death|0|||
143350904|NCT02291289|516831081|FG005|Early Disease Progression|Death|0|||
143350905|NCT02291289|516831082|FG006|Early Disease Progression|Death|0|||
143350906|NCT02291289|516831083|FG007|Early Disease Progression|Death|0|||
143350907|NCT02291289|516831084|FG008|Early Disease Progression|Death|0|||
143350908|NCT02291289|516831085|FG009|Early Disease Progression|Death|0|||
143350909|NCT02291289|516831086|FG010|Early Disease Progression|Death|0|||
143350910|NCT02291289|516831087|FG011|Early Disease Progression|Death|0|||
143350911|NCT02291289|516831088|FG012|Early Disease Progression|Death|10|||
143350912|NCT02291289|516831076|FG000|Early Disease Progression|Lost to Follow-up|0|||
143350913|NCT02291289|516831077|FG001|Early Disease Progression|Lost to Follow-up|0|||
143350914|NCT02291289|516831078|FG002|Early Disease Progression|Lost to Follow-up|0|||
143350915|NCT02291289|516831079|FG003|Early Disease Progression|Lost to Follow-up|0|||
143350916|NCT02291289|516831080|FG004|Early Disease Progression|Lost to Follow-up|0|||
143350917|NCT02291289|516831081|FG005|Early Disease Progression|Lost to Follow-up|0|||
143350918|NCT02291289|516831082|FG006|Early Disease Progression|Lost to Follow-up|0|||
143350919|NCT02291289|516831083|FG007|Early Disease Progression|Lost to Follow-up|0|||
143350920|NCT02291289|516831084|FG008|Early Disease Progression|Lost to Follow-up|0|||
143350921|NCT02291289|516831085|FG009|Early Disease Progression|Lost to Follow-up|0|||
143350922|NCT02291289|516831086|FG010|Early Disease Progression|Lost to Follow-up|0|||
143350923|NCT02291289|516831087|FG011|Early Disease Progression|Lost to Follow-up|0|||
143350924|NCT02291289|516831088|FG012|Early Disease Progression|Lost to Follow-up|1|||
143350925|NCT00154063|516831089|FG000|Overall Study|Adverse Event|4|||
143350926|NCT00154063|516831090|FG001|Overall Study|Adverse Event|8|||
143350927|NCT00154063|516831089|FG000|Overall Study|Protocol Violation|1|||
143350928|NCT00154063|516831090|FG001|Overall Study|Protocol Violation|1|||
143350929|NCT00154063|516831089|FG000|Overall Study|Investigator or Sponsor Request|0|||
143350930|NCT00154063|516831090|FG001|Overall Study|Investigator or Sponsor Request|1|||
143350931|NCT00154063|516831089|FG000|Overall Study|Withdrawal by Subject|4|||
143350932|NCT00154063|516831090|FG001|Overall Study|Withdrawal by Subject|9|||
143350933|NCT00154063|516831089|FG000|Overall Study|Other|3|||
143350934|NCT00154063|516831090|FG001|Overall Study|Other|3|||
143350935|NCT00636792|516831098|FG000|Overall Study|Adverse Event|16|||
143461415|NCT04494256|517235045|FG000|Part 1: Double Blinded Period|Protocol Deviation|0|||
143461416|NCT04494256|517235046|FG001|Part 1: Double Blinded Period|Protocol Deviation|0|||
143461417|NCT04494256|517235047|FG002|Part 1: Double Blinded Period|Protocol Deviation|0|||
143461418|NCT04494256|517235048|FG003|Part 1: Double Blinded Period|Protocol Deviation|0|||
143461419|NCT04494256|517235049|FG004|Part 1: Double Blinded Period|Protocol Deviation|1|||
143461420|NCT04494256|517235050|FG005|Part 1: Double Blinded Period|Protocol Deviation|0|||
143461421|NCT04494256|517235051|FG006|Part 1: Double Blinded Period|Protocol Deviation|0|||
143350936|NCT00636792|516831098|FG000|Overall Study|Physician Decision|7|||
143350937|NCT00636792|516831098|FG000|Overall Study|Progressive Disease|4|||
143350938|NCT00636792|516831098|FG000|Overall Study|Withdrawal by Subject|3|||
143350939|NCT00636792|516831098|FG000|Overall Study|Other|3|||
143350940|NCT00251927|516831102|FG000|Overall Study|Adverse Event|3|||
143350941|NCT00251927|516831103|FG001|Overall Study|Adverse Event|15|||
143350942|NCT00251927|516831102|FG000|Overall Study|Lack of Efficacy|22|||
143350943|NCT00251927|516831103|FG001|Overall Study|Lack of Efficacy|16|||
143350944|NCT00251927|516831102|FG000|Overall Study|Lost to Follow-up|22|||
143350945|NCT00251927|516831103|FG001|Overall Study|Lost to Follow-up|8|||
143350946|NCT00251927|516831102|FG000|Overall Study|Protocol Violation|1|||
143350947|NCT00251927|516831103|FG001|Overall Study|Protocol Violation|2|||
143350948|NCT00251927|516831102|FG000|Overall Study|Pregnancy|2|||
143350949|NCT00251927|516831103|FG001|Overall Study|Pregnancy|0|||
143350950|NCT00251927|516831102|FG000|Overall Study|Withdrawal by Subject|40|||
143350951|NCT00251927|516831103|FG001|Overall Study|Withdrawal by Subject|25|||
143350952|NCT00251927|516831102|FG000|Overall Study|Study-specific discont. achieved|13|||
143350953|NCT00251927|516831103|FG001|Overall Study|Study-specific discont. achieved|2|||
143350954|NCT00251927|516831102|FG000|Overall Study|Study procedure non-compliance|5|||
143350955|NCT00251927|516831103|FG001|Overall Study|Study procedure non-compliance|6|||
143350956|NCT03237013|516831107|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
143350957|NCT03237013|516831108|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
143350958|NCT03237013|516831109|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
143350959|NCT00258440|516831114|FG000|Overall Study|Withdrawal by Subject|0|||
143350960|NCT00258440|516831115|FG001|Overall Study|Withdrawal by Subject|0|||
143350961|NCT00258440|516831116|FG002|Overall Study|Withdrawal by Subject|1|||
143350962|NCT00737061|516831117|FG000|Waiting Period|Lost to Follow-up|6|||
143350963|NCT00737061|516831117|FG000|Waiting Period|Withdrawal by Subject|1|||
143350964|NCT00737061|516831117|FG000|Waiting Period|Bilateral placement failure|34|||
143350965|NCT00737061|516831117|FG000|Waiting Period|Deemed patent following HSG|26|||
143350966|NCT00737061|516831117|FG000|Waiting Period|Alternative contraception failure|3|||
143350967|NCT00737061|516831117|FG000|Waiting Period|Elected surgical tubal ligation|5|||
143350968|NCT00737061|516831117|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
143350969|NCT00737061|516831117|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
143350970|NCT00737061|516831117|FG000|1 Year Wearing Period|Discontinued reilance|3|||
143350971|NCT00737061|516831117|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
143350972|NCT00439179|516831118|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
143350973|NCT00439179|516831119|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
143350974|NCT00439179|516831120|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
143350975|NCT00439179|516831121|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
143350976|NCT01844115|516831130|FG000|Overall Study|Adverse Event|4|||
143350977|NCT01844115|516831131|FG001|Overall Study|Adverse Event|22|||
143350978|NCT01844115|516831130|FG000|Overall Study|Lack of Efficacy|1|||
143350979|NCT01844115|516831131|FG001|Overall Study|Lack of Efficacy|4|||
143350980|NCT01844115|516831130|FG000|Overall Study|Protocol Violation|12|||
143350981|NCT01844115|516831131|FG001|Overall Study|Protocol Violation|10|||
143350982|NCT01844115|516831130|FG000|Overall Study|Withdrawal by Subject|11|||
143350983|NCT01844115|516831131|FG001|Overall Study|Withdrawal by Subject|11|||
143350984|NCT01844115|516831130|FG000|Overall Study|Lost to Follow-up|11|||
143350985|NCT01844115|516831131|FG001|Overall Study|Lost to Follow-up|10|||
143350986|NCT01844115|516831130|FG000|Overall Study|Pregnancy|0|||
143350987|NCT01844115|516831131|FG001|Overall Study|Pregnancy|1|||
143350988|NCT00758160|516831132|FG000|Overall Study|No Longer Requires Study Medication|4|||
143461422|NCT04494256|517235045|FG000|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
143461423|NCT04494256|517235046|FG001|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
143461424|NCT04494256|517235047|FG002|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
143350989|NCT00758160|516831132|FG000|Overall Study|Administration Problems|3|||
143350990|NCT00758160|516831132|FG000|Overall Study|Adverse Event|15|||
143350991|NCT00758160|516831132|FG000|Overall Study|Lack of Efficacy|10|||
143350992|NCT00758160|516831132|FG000|Overall Study|Lost to Follow-up|14|||
143350993|NCT00758160|516831132|FG000|Overall Study|Protocol Violation|12|||
143350994|NCT00758160|516831132|FG000|Overall Study|Withdrawal by Subject|8|||
143350995|NCT00545363|516831133|FG000|Overall Study|Adverse Event|6|||
143350996|NCT00545363|516831134|FG001|Overall Study|Adverse Event|7|||
143350997|NCT00545363|516831133|FG000|Overall Study|Withdrawal by Subject|6|||
143350998|NCT00545363|516831134|FG001|Overall Study|Withdrawal by Subject|5|||
143350999|NCT00545363|516831133|FG000|Overall Study|Non-compliance|3|||
143461425|NCT04494256|517235048|FG003|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|1|||
143461426|NCT04494256|517235049|FG004|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|3|||
143461427|NCT04494256|517235050|FG005|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
143125257|NCT04811664|516003706|FG001|Overall Study|Protocol Violation|5|||
143125258|NCT04811664|516003707|FG002|Overall Study|Protocol Violation|11|||
143351000|NCT00545363|516831134|FG001|Overall Study|Non-compliance|1|||
143351001|NCT00545363|516831133|FG000|Overall Study|Did not meet entry criteria|1|||
143351002|NCT00545363|516831134|FG001|Overall Study|Did not meet entry criteria|1|||
143351003|NCT00545363|516831133|FG000|Overall Study|Lost to Follow-up|2|||
143351004|NCT00545363|516831134|FG001|Overall Study|Lost to Follow-up|0|||
143351005|NCT00545363|516831133|FG000|Overall Study|Other|1|||
143351006|NCT00545363|516831134|FG001|Overall Study|Other|1|||
143351007|NCT00366301|516831135|FG000|Overall Study|Lost to Follow-up|4|||
143351008|NCT00366301|516831136|FG001|Overall Study|Lost to Follow-up|4|||
143351009|NCT00366301|516831137|FG002|Overall Study|Lost to Follow-up|3|||
143351010|NCT00366301|516831138|FG003|Overall Study|Lost to Follow-up|7|||
143351011|NCT00366301|516831135|FG000|Overall Study|Withdrawal by Subject|4|||
143351012|NCT00366301|516831136|FG001|Overall Study|Withdrawal by Subject|2|||
143351013|NCT00366301|516831137|FG002|Overall Study|Withdrawal by Subject|1|||
143351014|NCT00366301|516831138|FG003|Overall Study|Withdrawal by Subject|1|||
143351015|NCT01372605|516831141|FG000|Overall Study|Death|1|||
143351016|NCT01372605|516831142|FG001|Overall Study|Death|2|||
143351017|NCT01372605|516831141|FG000|Overall Study|Lost to Follow-up|2|||
143351018|NCT01372605|516831142|FG001|Overall Study|Lost to Follow-up|1|||
143351019|NCT01372605|516831141|FG000|Overall Study|Withdrawal by Subject|4|||
143351020|NCT01372605|516831142|FG001|Overall Study|Withdrawal by Subject|7|||
143351021|NCT01372605|516831141|FG000|Overall Study|Moved|3|||
143351022|NCT01372605|516831142|FG001|Overall Study|Moved|0|||
143351023|NCT01372605|516831141|FG000|Overall Study|Changed medical home|2|||
143351024|NCT01372605|516831142|FG001|Overall Study|Changed medical home|0|||
143351025|NCT01108510|516831143|FG000|Overall Study|Randomized but Not Treated|5|||
143351026|NCT01108510|516831144|FG001|Overall Study|Randomized but Not Treated|1|||
143351027|NCT01108510|516831143|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
143351028|NCT01108510|516831144|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
143351029|NCT01108510|516831143|FG000|Overall Study|Adverse Event|26|||
143351030|NCT01108510|516831144|FG001|Overall Study|Adverse Event|19|||
143351031|NCT01108510|516831143|FG000|Overall Study|Lost to Follow-up|20|||
143351032|NCT01108510|516831144|FG001|Overall Study|Lost to Follow-up|17|||
143351033|NCT01108510|516831143|FG000|Overall Study|Withdrew Consent|21|||
143125259|NCT04811664|516003705|FG000|Overall Study|Study Terminated by Sponsor|4|||
143125260|NCT04811664|516003706|FG001|Overall Study|Study Terminated by Sponsor|3|||
143125261|NCT04811664|516003707|FG002|Overall Study|Study Terminated by Sponsor|34|||
143351034|NCT01108510|516831144|FG001|Overall Study|Withdrew Consent|15|||
143351035|NCT01108510|516831143|FG000|Overall Study|Investigator's Discretion|12|||
143125262|NCT04811664|516003705|FG000|Overall Study|Early Study Closure|3|||
143125263|NCT04811664|516003706|FG001|Overall Study|Early Study Closure|7|||
143351036|NCT01108510|516831144|FG001|Overall Study|Investigator's Discretion|10|||
143351037|NCT01108510|516831143|FG000|Overall Study|Participant Noncompliance|5|||
143351038|NCT01108510|516831144|FG001|Overall Study|Participant Noncompliance|7|||
143351039|NCT01108510|516831143|FG000|Overall Study|Lack of Efficacy|3|||
143351040|NCT01108510|516831144|FG001|Overall Study|Lack of Efficacy|0|||
143351041|NCT01108510|516831143|FG000|Overall Study|Pregnancy|0|||
143351042|NCT01108510|516831144|FG001|Overall Study|Pregnancy|3|||
143351043|NCT01108510|516831143|FG000|Overall Study|Death|1|||
143351044|NCT01108510|516831144|FG001|Overall Study|Death|1|||
143351045|NCT01463293|516831145|FG000|Overall Study|Lost to Follow-up|1|||
143351046|NCT01463293|516831146|FG001|Overall Study|Lost to Follow-up|4|||
143351047|NCT01463293|516831147|FG002|Overall Study|Lost to Follow-up|5|||
143351048|NCT01463293|516831145|FG000|Overall Study|Adverse Event|1|||
143351049|NCT01463293|516831146|FG001|Overall Study|Adverse Event|2|||
143351050|NCT01463293|516831147|FG002|Overall Study|Adverse Event|0|||
143351051|NCT01463293|516831145|FG000|Overall Study|Withdrawal by Subject|4|||
143461428|NCT04494256|517235051|FG006|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
143461429|NCT04494256|517235045|FG000|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
143351052|NCT01463293|516831146|FG001|Overall Study|Withdrawal by Subject|10|||
143351053|NCT01463293|516831147|FG002|Overall Study|Withdrawal by Subject|5|||
143351054|NCT01463293|516831145|FG000|Overall Study|Other|0|||
143351055|NCT01463293|516831146|FG001|Overall Study|Other|0|||
143351056|NCT01463293|516831147|FG002|Overall Study|Other|2|||
143351057|NCT00210119|516831148|FG000|Overall Study|Protocol Violation|1|||
143351058|NCT00210119|516831148|FG000|Overall Study|Withdrawal by Subject|1|||
143351059|NCT01586338|516831157|FG000|Overall Study|Adverse Event|3|||
143351060|NCT01586338|516831157|FG000|Overall Study|Lost to Follow-up|1|||
143351061|NCT01586338|516831157|FG000|Overall Study|Withdrawal by participant|3|||
143351062|NCT01586338|516831157|FG000|Overall Study|Other|1|||
143351063|NCT03306043|516831158|FG000|Overall Study|Adverse Event|1|||
143351064|NCT03306043|516831158|FG000|Overall Study|Lost to Follow-up|1|||
143351065|NCT03306043|516831158|FG000|Overall Study|Withdrawal by Subject|2|||
143351066|NCT01544491|516831159|FG000|Overall Study|Withdrawal by Subject|3|||
143351067|NCT01544491|516831160|FG001|Overall Study|Withdrawal by Subject|2|||
143351068|NCT01544491|516831159|FG000|Overall Study|Lost to Follow-up|0|||
143351069|NCT01544491|516831160|FG001|Overall Study|Lost to Follow-up|1|||
143351070|NCT01544491|516831159|FG000|Overall Study|administrative problems|2|||
143351071|NCT01544491|516831160|FG001|Overall Study|administrative problems|0|||
143351072|NCT01799720|516831161|FG000|Overall Study|Withdrawal by Subject|3|||
143351073|NCT01799720|516831162|FG001|Overall Study|Withdrawal by Subject|0|||
143351074|NCT01799720|516831163|FG002|Overall Study|Withdrawal by Subject|0|||
143351075|NCT01799720|516831161|FG000|Overall Study|Protocol Violation|0|||
143351076|NCT01799720|516831162|FG001|Overall Study|Protocol Violation|1|||
143351077|NCT01799720|516831163|FG002|Overall Study|Protocol Violation|0|||
143351078|NCT01799720|516831161|FG000|Overall Study|Pregnancy|0|||
143351079|NCT01799720|516831162|FG001|Overall Study|Pregnancy|0|||
143351080|NCT01799720|516831163|FG002|Overall Study|Pregnancy|1|||
143351081|NCT00896454|516831165|FG000|Overall Study|Death|10|||
143351082|NCT00896454|516831165|FG000|Overall Study|Adverse Event|8|||
143351083|NCT00896454|516831165|FG000|Overall Study|Disease Progression|5|||
143351084|NCT00896454|516831165|FG000|Overall Study|Other|4|||
143351085|NCT00896454|516831165|FG000|Overall Study|Requirement for alternative therapy|3|||
143351086|NCT00896454|516831165|FG000|Overall Study|Ongoing in study|2|||
143351087|NCT00896454|516831165|FG000|Overall Study|Withdrawal by Subject|1|||
143351088|NCT01234649|516831166|FG000|Overall Study|Withdrawal by Subject|32|||
143351089|NCT01234649|516831167|FG001|Overall Study|Withdrawal by Subject|26|||
143351090|NCT01234649|516831166|FG000|Overall Study|Pregnancy|6|||
143351091|NCT01234649|516831167|FG001|Overall Study|Pregnancy|6|||
143351092|NCT01234649|516831166|FG000|Overall Study|intolerant to side effects|4|||
143351093|NCT01234649|516831167|FG001|Overall Study|intolerant to side effects|3|||
143461430|NCT04494256|517235046|FG001|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
143011894|NCT01785472|515581764|FG000|Overall Study|Technical problems|0|||
143011895|NCT01785472|515581765|FG001|Overall Study|Technical problems|0|||
143011896|NCT01785472|515581766|FG002|Overall Study|Technical problems|1|||
143011897|NCT02086968|515581768|FG000|Overall Study|Adverse Event|1|||
143011898|NCT02086968|515581769|FG001|Overall Study|Adverse Event|5|||
143011899|NCT02086968|515581768|FG000|Overall Study|Lost to Follow-up|2|||
143011900|NCT02086968|515581769|FG001|Overall Study|Lost to Follow-up|3|||
143011901|NCT02086968|515581768|FG000|Overall Study|Study drug received outside protocol|0|||
143011902|NCT02086968|515581769|FG001|Overall Study|Study drug received outside protocol|1|||
143011903|NCT02086968|515581768|FG000|Overall Study|Physician Decision|4|||
143011904|NCT02086968|515581769|FG001|Overall Study|Physician Decision|0|||
143011905|NCT02086968|515581768|FG000|Overall Study|Withdrawal by Subject|1|||
143011906|NCT02086968|515581769|FG001|Overall Study|Withdrawal by Subject|4|||
143011907|NCT00110084|515581773|FG000|Overall Study|Adverse Event|9|||
143351094|NCT01234649|516831166|FG000|Overall Study|Allergic reaction|1|||
143461431|NCT04494256|517235047|FG002|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
143461432|NCT04494256|517235048|FG003|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
143461433|NCT04494256|517235049|FG004|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
143461434|NCT04494256|517235050|FG005|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
143461435|NCT04494256|517235051|FG006|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
143461436|NCT04494256|517235045|FG000|Part 1: Double Blinded Period|Reason Not Specified|0|||
143461437|NCT04494256|517235046|FG001|Part 1: Double Blinded Period|Reason Not Specified|0|||
143461438|NCT04494256|517235047|FG002|Part 1: Double Blinded Period|Reason Not Specified|0|||
143461439|NCT04494256|517235048|FG003|Part 1: Double Blinded Period|Reason Not Specified|0|||
143461440|NCT04494256|517235049|FG004|Part 1: Double Blinded Period|Reason Not Specified|1|||
143461441|NCT04494256|517235050|FG005|Part 1: Double Blinded Period|Reason Not Specified|0|||
143461442|NCT04494256|517235051|FG006|Part 1: Double Blinded Period|Reason Not Specified|0|||
143461443|NCT04494256|517235045|FG000|Part 2: Open Label Period|Death|0|||
143461444|NCT04494256|517235046|FG001|Part 2: Open Label Period|Death|0|||
143461445|NCT04494256|517235047|FG002|Part 2: Open Label Period|Death|0|||
143461446|NCT04494256|517235048|FG003|Part 2: Open Label Period|Death|0|||
143461447|NCT04494256|517235049|FG004|Part 2: Open Label Period|Death|0|||
143461448|NCT04494256|517235050|FG005|Part 2: Open Label Period|Death|4|||
143461449|NCT04494256|517235051|FG006|Part 2: Open Label Period|Death|2|||
143461450|NCT04494256|517235045|FG000|Part 2: Open Label Period|Adverse Event|0|||
143011908|NCT00110084|515581773|FG000|Overall Study|Death|1|||
143011909|NCT00110084|515581773|FG000|Overall Study|Patient Refusal|10|||
143351095|NCT01234649|516831167|FG001|Overall Study|Allergic reaction|0|||
143351096|NCT01234649|516831166|FG000|Overall Study|Lack of Efficacy|0|||
143351097|NCT01234649|516831167|FG001|Overall Study|Lack of Efficacy|3|||
143351098|NCT01461993|516831172|FG000|Overall Study|Withdrawal by Subject|60|||
143351099|NCT01461993|516831173|FG001|Overall Study|Withdrawal by Subject|53|||
143351100|NCT01461993|516831174|FG002|Overall Study|Withdrawal by Subject|16|||
143351101|NCT01461993|516831172|FG000|Overall Study|Lost to Follow-up|44|||
143011910|NCT00110084|515581773|FG000|Overall Study|Alternate Therapy|5|||
143351102|NCT01461993|516831173|FG001|Overall Study|Lost to Follow-up|48|||
143351103|NCT01461993|516831174|FG002|Overall Study|Lost to Follow-up|22|||
143461451|NCT04494256|517235046|FG001|Part 2: Open Label Period|Adverse Event|0|||
143351104|NCT01461993|516831172|FG000|Overall Study|Protocol Violation|10|||
143351105|NCT01461993|516831173|FG001|Overall Study|Protocol Violation|9|||
143351106|NCT01461993|516831174|FG002|Overall Study|Protocol Violation|7|||
143351107|NCT01461993|516831172|FG000|Overall Study|Adverse Event|9|||
143351108|NCT01461993|516831173|FG001|Overall Study|Adverse Event|11|||
143351109|NCT01461993|516831174|FG002|Overall Study|Adverse Event|3|||
143351110|NCT01461993|516831172|FG000|Overall Study|No longer met eligibility criteria|13|||
143351111|NCT01461993|516831173|FG001|Overall Study|No longer met eligibility criteria|18|||
143351112|NCT01461993|516831174|FG002|Overall Study|No longer met eligibility criteria|10|||
143351113|NCT01461993|516831172|FG000|Overall Study|Did not meet entrance criteria|2|||
143351114|NCT01461993|516831173|FG001|Overall Study|Did not meet entrance criteria|3|||
143351115|NCT01461993|516831174|FG002|Overall Study|Did not meet entrance criteria|0|||
143351116|NCT01461993|516831172|FG000|Overall Study|Other|13|||
143351117|NCT01461993|516831173|FG001|Overall Study|Other|15|||
143351118|NCT01461993|516831174|FG002|Overall Study|Other|6|||
143351119|NCT00680056|516831176|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
143351120|NCT00680056|516831177|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
143351121|NCT00680056|516831176|FG000|Second Intervention|Protocol Violation|3|||
143351122|NCT00680056|516831177|FG001|Second Intervention|Protocol Violation|1|||
143351123|NCT02733042|516831178|FG000|Overall Study|Adverse Event|1|||
143351124|NCT02733042|516831179|FG001|Overall Study|Adverse Event|0|||
143351125|NCT02733042|516831180|FG002|Overall Study|Adverse Event|1|||
143351126|NCT02733042|516831181|FG003|Overall Study|Adverse Event|1|||
143351127|NCT02733042|516831182|FG004|Overall Study|Adverse Event|0|||
143351128|NCT02733042|516831183|FG005|Overall Study|Adverse Event|0|||
143351129|NCT02733042|516831184|FG006|Overall Study|Adverse Event|0|||
143351130|NCT02733042|516831185|FG007|Overall Study|Adverse Event|0|||
143351131|NCT02733042|516831186|FG008|Overall Study|Adverse Event|0|||
143351132|NCT02733042|516831187|FG009|Overall Study|Adverse Event|0|||
143351133|NCT02733042|516831188|FG010|Overall Study|Adverse Event|2|||
143351134|NCT02733042|516831189|FG011|Overall Study|Adverse Event|2|||
143351135|NCT02733042|516831190|FG012|Overall Study|Adverse Event|0|||
143351136|NCT02733042|516831191|FG013|Overall Study|Adverse Event|2|||
143351137|NCT02733042|516831192|FG014|Overall Study|Adverse Event|0|||
143351138|NCT02733042|516831193|FG015|Overall Study|Adverse Event|0|||
143351139|NCT02733042|516831194|FG016|Overall Study|Adverse Event|0|||
143351140|NCT02733042|516831195|FG017|Overall Study|Adverse Event|1|||
143351141|NCT02733042|516831196|FG018|Overall Study|Adverse Event|0|||
143351142|NCT02733042|516831178|FG000|Overall Study|Progressive Disease|2|||
143351143|NCT02733042|516831179|FG001|Overall Study|Progressive Disease|1|||
143351144|NCT02733042|516831180|FG002|Overall Study|Progressive Disease|3|||
143351145|NCT02733042|516831181|FG003|Overall Study|Progressive Disease|1|||
143351146|NCT02733042|516831182|FG004|Overall Study|Progressive Disease|2|||
143351147|NCT02733042|516831183|FG005|Overall Study|Progressive Disease|3|||
143351148|NCT02733042|516831184|FG006|Overall Study|Progressive Disease|0|||
143351149|NCT02733042|516831185|FG007|Overall Study|Progressive Disease|3|||
143351150|NCT02733042|516831186|FG008|Overall Study|Progressive Disease|3|||
143351151|NCT02733042|516831187|FG009|Overall Study|Progressive Disease|2|||
143351152|NCT02733042|516831188|FG010|Overall Study|Progressive Disease|2|||
143351153|NCT02733042|516831189|FG011|Overall Study|Progressive Disease|2|||
143351154|NCT02733042|516831190|FG012|Overall Study|Progressive Disease|8|||
143351155|NCT02733042|516831191|FG013|Overall Study|Progressive Disease|1|||
143351156|NCT02733042|516831192|FG014|Overall Study|Progressive Disease|4|||
143351157|NCT02733042|516831193|FG015|Overall Study|Progressive Disease|7|||
143351158|NCT02733042|516831194|FG016|Overall Study|Progressive Disease|2|||
143351159|NCT02733042|516831195|FG017|Overall Study|Progressive Disease|3|||
143351160|NCT02733042|516831196|FG018|Overall Study|Progressive Disease|4|||
143351161|NCT02733042|516831178|FG000|Overall Study|Withdrawal by Subject|0|||
143351162|NCT02733042|516831179|FG001|Overall Study|Withdrawal by Subject|1|||
143351163|NCT02733042|516831180|FG002|Overall Study|Withdrawal by Subject|2|||
143351164|NCT02733042|516831181|FG003|Overall Study|Withdrawal by Subject|1|||
143351165|NCT02733042|516831182|FG004|Overall Study|Withdrawal by Subject|1|||
143351166|NCT02733042|516831183|FG005|Overall Study|Withdrawal by Subject|0|||
143351167|NCT02733042|516831184|FG006|Overall Study|Withdrawal by Subject|0|||
143351168|NCT02733042|516831185|FG007|Overall Study|Withdrawal by Subject|0|||
143351169|NCT02733042|516831186|FG008|Overall Study|Withdrawal by Subject|1|||
143351170|NCT02733042|516831187|FG009|Overall Study|Withdrawal by Subject|1|||
143351171|NCT02733042|516831188|FG010|Overall Study|Withdrawal by Subject|0|||
143351172|NCT02733042|516831189|FG011|Overall Study|Withdrawal by Subject|2|||
143351173|NCT02733042|516831190|FG012|Overall Study|Withdrawal by Subject|1|||
143351174|NCT02733042|516831191|FG013|Overall Study|Withdrawal by Subject|1|||
143351175|NCT02733042|516831192|FG014|Overall Study|Withdrawal by Subject|0|||
143351176|NCT02733042|516831193|FG015|Overall Study|Withdrawal by Subject|0|||
143351177|NCT02733042|516831194|FG016|Overall Study|Withdrawal by Subject|0|||
143351178|NCT02733042|516831195|FG017|Overall Study|Withdrawal by Subject|0|||
143461452|NCT04494256|517235047|FG002|Part 2: Open Label Period|Adverse Event|0|||
143351179|NCT02733042|516831196|FG018|Overall Study|Withdrawal by Subject|0|||
143351180|NCT02733042|516831178|FG000|Overall Study|Other Reasons|0|||
143351181|NCT02733042|516831179|FG001|Overall Study|Other Reasons|0|||
143351182|NCT02733042|516831180|FG002|Overall Study|Other Reasons|1|||
143351183|NCT02733042|516831181|FG003|Overall Study|Other Reasons|0|||
143351184|NCT02733042|516831182|FG004|Overall Study|Other Reasons|0|||
143351185|NCT02733042|516831183|FG005|Overall Study|Other Reasons|0|||
143351186|NCT02733042|516831184|FG006|Overall Study|Other Reasons|0|||
143351187|NCT02733042|516831185|FG007|Overall Study|Other Reasons|0|||
143351188|NCT02733042|516831186|FG008|Overall Study|Other Reasons|0|||
143351189|NCT02733042|516831187|FG009|Overall Study|Other Reasons|1|||
143351190|NCT02733042|516831188|FG010|Overall Study|Other Reasons|1|||
143351191|NCT02733042|516831189|FG011|Overall Study|Other Reasons|0|||
143351192|NCT02733042|516831190|FG012|Overall Study|Other Reasons|0|||
143351193|NCT02733042|516831191|FG013|Overall Study|Other Reasons|0|||
143351194|NCT02733042|516831192|FG014|Overall Study|Other Reasons|0|||
143351195|NCT02733042|516831193|FG015|Overall Study|Other Reasons|1|||
143351196|NCT02733042|516831194|FG016|Overall Study|Other Reasons|0|||
143351197|NCT02733042|516831195|FG017|Overall Study|Other Reasons|1|||
143351198|NCT02733042|516831196|FG018|Overall Study|Other Reasons|0|||
143351199|NCT02733042|516831178|FG000|Overall Study|Death|0|||
143351200|NCT02733042|516831179|FG001|Overall Study|Death|0|||
143351201|NCT02733042|516831180|FG002|Overall Study|Death|0|||
143351202|NCT02733042|516831181|FG003|Overall Study|Death|0|||
143351203|NCT02733042|516831182|FG004|Overall Study|Death|0|||
143351204|NCT02733042|516831183|FG005|Overall Study|Death|0|||
143351205|NCT02733042|516831184|FG006|Overall Study|Death|1|||
143351206|NCT02733042|516831185|FG007|Overall Study|Death|0|||
143351207|NCT02733042|516831186|FG008|Overall Study|Death|1|||
143351208|NCT02733042|516831187|FG009|Overall Study|Death|0|||
143351209|NCT02733042|516831188|FG010|Overall Study|Death|1|||
143351210|NCT02733042|516831189|FG011|Overall Study|Death|0|||
143351211|NCT02733042|516831190|FG012|Overall Study|Death|0|||
143351212|NCT02733042|516831191|FG013|Overall Study|Death|0|||
143351213|NCT02733042|516831192|FG014|Overall Study|Death|1|||
143351214|NCT02733042|516831193|FG015|Overall Study|Death|2|||
143351215|NCT02733042|516831194|FG016|Overall Study|Death|0|||
143351216|NCT02733042|516831195|FG017|Overall Study|Death|0|||
143351217|NCT02733042|516831196|FG018|Overall Study|Death|0|||
143351218|NCT03688711|516831197|FG000|Overall Study|Withdrawal by Subject|0|||
143351219|NCT03688711|516831198|FG001|Overall Study|Withdrawal by Subject|1|||
143351220|NCT02838628|516831200|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
143351221|NCT02838628|516831201|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
143351222|NCT02838628|516831200|FG000|Recurrence Follow-up Period|Adverse Event|1|||
143351223|NCT02838628|516831201|FG001|Recurrence Follow-up Period|Adverse Event|0|||
143351224|NCT02838628|516831200|FG000|Recurrence Follow-up Period|Non-compliance|0|||
143351225|NCT02838628|516831201|FG001|Recurrence Follow-up Period|Non-compliance|1|||
143351226|NCT02838628|516831200|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
143351227|NCT02838628|516831201|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
143351228|NCT02838628|516831200|FG000|Recurrence Follow-up Period|Other un-specified|1|||
143351229|NCT02838628|516831201|FG001|Recurrence Follow-up Period|Other un-specified|1|||
143351230|NCT01821898|516831202|FG000|Overall Study|Withdrawal by Subject|2|||
143351231|NCT01821898|516831203|FG001|Overall Study|Withdrawal by Subject|1|||
143351232|NCT00337662|516831205|FG000|Study Period II|Lost to Follow-up|0|||
143351233|NCT00337662|516831206|FG001|Study Period II|Lost to Follow-up|0|||
143351234|NCT00337662|516831207|FG002|Study Period II|Lost to Follow-up|0|||
143351235|NCT00337662|516831208|FG003|Study Period II|Lost to Follow-up|35|||
143351236|NCT00337662|516831205|FG000|Study Period II|Withdrawal by Subject|0|||
143351237|NCT00337662|516831206|FG001|Study Period II|Withdrawal by Subject|0|||
143351238|NCT00337662|516831207|FG002|Study Period II|Withdrawal by Subject|0|||
143351239|NCT00337662|516831208|FG003|Study Period II|Withdrawal by Subject|20|||
143351240|NCT00337662|516831205|FG000|Study Period II|Adverse Event|0|||
143351241|NCT00337662|516831206|FG001|Study Period II|Adverse Event|0|||
143351242|NCT00337662|516831207|FG002|Study Period II|Adverse Event|0|||
143351243|NCT00337662|516831208|FG003|Study Period II|Adverse Event|16|||
143351244|NCT00337662|516831205|FG000|Study Period II|Physician Decision|0|||
143351245|NCT00337662|516831206|FG001|Study Period II|Physician Decision|0|||
143351246|NCT00337662|516831207|FG002|Study Period II|Physician Decision|0|||
143351247|NCT00337662|516831208|FG003|Study Period II|Physician Decision|13|||
143351248|NCT00337662|516831205|FG000|Study Period II|Entry Criteria Not Met|0|||
143351249|NCT00337662|516831206|FG001|Study Period II|Entry Criteria Not Met|0|||
143351250|NCT00337662|516831207|FG002|Study Period II|Entry Criteria Not Met|0|||
143351251|NCT00337662|516831208|FG003|Study Period II|Entry Criteria Not Met|6|||
143351252|NCT00337662|516831205|FG000|Study Period II|Protocol Violation|0|||
143351253|NCT00337662|516831206|FG001|Study Period II|Protocol Violation|0|||
143351254|NCT00337662|516831207|FG002|Study Period II|Protocol Violation|0|||
143351255|NCT00337662|516831208|FG003|Study Period II|Protocol Violation|6|||
143351256|NCT00337662|516831205|FG000|Study Period II|Lack of Efficacy|0|||
143351257|NCT00337662|516831206|FG001|Study Period II|Lack of Efficacy|0|||
143351258|NCT00337662|516831207|FG002|Study Period II|Lack of Efficacy|0|||
143351259|NCT00337662|516831208|FG003|Study Period II|Lack of Efficacy|7|||
143351260|NCT00337662|516831205|FG000|Study Period II|Sponsor Decision|0|||
143125264|NCT04811664|516003707|FG002|Overall Study|Early Study Closure|79|||
143351261|NCT00337662|516831206|FG001|Study Period II|Sponsor Decision|0|||
143351262|NCT00337662|516831207|FG002|Study Period II|Sponsor Decision|0|||
143351263|NCT00337662|516831208|FG003|Study Period II|Sponsor Decision|2|||
143351264|NCT00337662|516831205|FG000|Study Period II|Parent/Caregiver Decision|0|||
143351265|NCT00337662|516831206|FG001|Study Period II|Parent/Caregiver Decision|0|||
143351266|NCT00337662|516831207|FG002|Study Period II|Parent/Caregiver Decision|0|||
143351267|NCT00337662|516831208|FG003|Study Period II|Parent/Caregiver Decision|1|||
143351268|NCT00337662|516831205|FG000|Study Period III|Lost to Follow-up|14|||
143351269|NCT00337662|516831206|FG001|Study Period III|Lost to Follow-up|16|||
143351270|NCT00337662|516831207|FG002|Study Period III|Lost to Follow-up|14|||
143351271|NCT00337662|516831208|FG003|Study Period III|Lost to Follow-up|0|||
143351272|NCT00337662|516831205|FG000|Study Period III|Withdrawal by Subject|18|||
143351273|NCT00337662|516831206|FG001|Study Period III|Withdrawal by Subject|14|||
143351274|NCT00337662|516831207|FG002|Study Period III|Withdrawal by Subject|12|||
143351275|NCT00337662|516831208|FG003|Study Period III|Withdrawal by Subject|0|||
143351276|NCT00337662|516831205|FG000|Study Period III|Adverse Event|9|||
143351277|NCT00337662|516831206|FG001|Study Period III|Adverse Event|10|||
143351278|NCT00337662|516831207|FG002|Study Period III|Adverse Event|8|||
143351279|NCT00337662|516831208|FG003|Study Period III|Adverse Event|0|||
143351280|NCT00337662|516831205|FG000|Study Period III|Protocol Violation|3|||
143351281|NCT00337662|516831206|FG001|Study Period III|Protocol Violation|8|||
143351282|NCT00337662|516831207|FG002|Study Period III|Protocol Violation|2|||
143351283|NCT00337662|516831208|FG003|Study Period III|Protocol Violation|0|||
143351284|NCT00337662|516831205|FG000|Study Period III|Physician Decision|6|||
143351285|NCT00337662|516831206|FG001|Study Period III|Physician Decision|5|||
143351286|NCT00337662|516831207|FG002|Study Period III|Physician Decision|0|||
143351287|NCT00337662|516831208|FG003|Study Period III|Physician Decision|0|||
143351288|NCT00337662|516831205|FG000|Study Period III|Entry Criteria Not Met|4|||
143351289|NCT00337662|516831206|FG001|Study Period III|Entry Criteria Not Met|1|||
143351290|NCT00337662|516831207|FG002|Study Period III|Entry Criteria Not Met|3|||
143351291|NCT00337662|516831208|FG003|Study Period III|Entry Criteria Not Met|0|||
143351292|NCT00337662|516831205|FG000|Study Period III|Lack of Efficacy|4|||
143351293|NCT00337662|516831206|FG001|Study Period III|Lack of Efficacy|4|||
143351294|NCT00337662|516831207|FG002|Study Period III|Lack of Efficacy|2|||
143351295|NCT00337662|516831208|FG003|Study Period III|Lack of Efficacy|0|||
143351296|NCT00337662|516831205|FG000|Study Period III|Parent/Caregiver Decision|0|||
143351297|NCT00337662|516831206|FG001|Study Period III|Parent/Caregiver Decision|0|||
143351298|NCT00337662|516831207|FG002|Study Period III|Parent/Caregiver Decision|2|||
143351299|NCT00337662|516831208|FG003|Study Period III|Parent/Caregiver Decision|0|||
143351300|NCT00337662|516831205|FG000|Study Period III|Sponsor Decision|1|||
143351301|NCT00337662|516831206|FG001|Study Period III|Sponsor Decision|0|||
143351302|NCT00337662|516831207|FG002|Study Period III|Sponsor Decision|1|||
143351303|NCT00337662|516831208|FG003|Study Period III|Sponsor Decision|0|||
143351304|NCT00337662|516831205|FG000|Study Period III|Clinical Relapse|1|||
143351305|NCT00337662|516831206|FG001|Study Period III|Clinical Relapse|0|||
143351306|NCT00337662|516831207|FG002|Study Period III|Clinical Relapse|0|||
143351307|NCT00337662|516831208|FG003|Study Period III|Clinical Relapse|0|||
143351308|NCT01018563|516831218|FG000|Overall Study|Termination of the study by Sponsor|2|||
143351309|NCT01018563|516831219|FG001|Overall Study|Termination of the study by Sponsor|1|||
143351310|NCT02344537|516831220|FG000|Overall Study|Protocol Violation|1|||
143351311|NCT02344537|516831221|FG001|Overall Study|Protocol Violation|1|||
143351312|NCT02344537|516831220|FG000|Overall Study|Subject started another treatment after wk 6|1|||
143351313|NCT02344537|516831221|FG001|Overall Study|Subject started another treatment after wk 6|0|||
143351314|NCT02344537|516831220|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
143351315|NCT02344537|516831221|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
143351316|NCT00960752|516831223|FG000|Overall Study|Adverse Event|0|||
143351317|NCT00960752|516831224|FG001|Overall Study|Adverse Event|0|||
143351318|NCT00960752|516831225|FG002|Overall Study|Adverse Event|1|||
143125265|NCT04811664|516003705|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
143125266|NCT04811664|516003706|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
143125267|NCT04811664|516003707|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
143351319|NCT00960752|516831223|FG000|Overall Study|Progression|0|||
143125268|NCT05052697|516003708|FG000|Substudy A|Lost to Follow-up|0|||
143351320|NCT00960752|516831224|FG001|Overall Study|Progression|0|||
143351321|NCT00960752|516831225|FG002|Overall Study|Progression|1|||
143351322|NCT02306122|516831226|FG000|Initial Physician Randomization|Physician Decision|0|||
143125269|NCT05052697|516003709|FG001|Substudy A|Lost to Follow-up|0|||
143125270|NCT05052697|516003710|FG002|Substudy A|Lost to Follow-up|0|||
143125271|NCT05052697|516003711|FG003|Substudy A|Lost to Follow-up|0|||
143125272|NCT05052697|516003712|FG004|Substudy A|Lost to Follow-up|0|||
143351323|NCT02306122|516831227|FG001|Initial Physician Randomization|Physician Decision|0|||
143351324|NCT02306122|516831228|FG002|Initial Physician Randomization|Physician Decision|0|||
143351325|NCT02306122|516831229|FG003|Initial Physician Randomization|Physician Decision|0|||
143351326|NCT02306122|516831230|FG004|Initial Physician Randomization|Physician Decision|0|||
143351327|NCT02306122|516831231|FG005|Initial Physician Randomization|Physician Decision|0|||
143351328|NCT02306122|516831232|FG006|Initial Physician Randomization|Physician Decision|0|||
143351329|NCT02306122|516831233|FG007|Initial Physician Randomization|Physician Decision|0|||
143351330|NCT02306122|516831234|FG008|Initial Physician Randomization|Physician Decision|1|||
143351331|NCT02306122|516831235|FG009|Initial Physician Randomization|Physician Decision|0|||
143351332|NCT02306122|516831236|FG010|Initial Physician Randomization|Physician Decision|0|||
143351333|NCT03734991|516831238|FG000|Overall Study|Adverse Event|4|||
143351334|NCT03734991|516831239|FG001|Overall Study|Adverse Event|0|||
143351335|NCT03734991|516831238|FG000|Overall Study|Lost to Follow-up|4|||
143351336|NCT03734991|516831239|FG001|Overall Study|Lost to Follow-up|0|||
143351337|NCT03734991|516831238|FG000|Overall Study|Physician Decision|0|||
143351338|NCT03734991|516831239|FG001|Overall Study|Physician Decision|1|||
143351339|NCT03734991|516831238|FG000|Overall Study|Pregnancy|1|||
143461453|NCT04494256|517235048|FG003|Part 2: Open Label Period|Adverse Event|0|||
143461454|NCT04494256|517235049|FG004|Part 2: Open Label Period|Adverse Event|0|||
143461455|NCT04494256|517235050|FG005|Part 2: Open Label Period|Adverse Event|0|||
143461456|NCT04494256|517235051|FG006|Part 2: Open Label Period|Adverse Event|2|||
143461457|NCT04494256|517235045|FG000|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
143461458|NCT04494256|517235046|FG001|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
143461459|NCT04494256|517235047|FG002|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
143461460|NCT04494256|517235048|FG003|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
143461461|NCT04494256|517235049|FG004|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
143461462|NCT04494256|517235050|FG005|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|5|||
143461463|NCT04494256|517235051|FG006|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|6|||
143461464|NCT04494256|517235045|FG000|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
143461465|NCT04494256|517235046|FG001|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
143461466|NCT04494256|517235047|FG002|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
143461467|NCT04494256|517235048|FG003|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
143461468|NCT04494256|517235049|FG004|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
143461469|NCT04494256|517235050|FG005|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
143461470|NCT04494256|517235051|FG006|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|1|||
143461471|NCT04494256|517235045|FG000|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
143461472|NCT04494256|517235046|FG001|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
143461473|NCT04494256|517235047|FG002|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
143461474|NCT04494256|517235048|FG003|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
143461475|NCT04494256|517235049|FG004|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
143461476|NCT04494256|517235050|FG005|Part 2: Open Label Period|Study Terminated by Sponsor|4|||
143461477|NCT04494256|517235051|FG006|Part 2: Open Label Period|Study Terminated by Sponsor|35|||
143461478|NCT04494256|517235045|FG000|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
143461479|NCT04494256|517235046|FG001|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
143461480|NCT04494256|517235047|FG002|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
143461481|NCT04494256|517235048|FG003|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
143461482|NCT04494256|517235049|FG004|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
143461483|NCT04494256|517235050|FG005|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|5|||
143461484|NCT04494256|517235051|FG006|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|4|||
143461485|NCT04494256|517235045|FG000|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
143461486|NCT04494256|517235046|FG001|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
143461487|NCT04494256|517235047|FG002|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
143461488|NCT04494256|517235048|FG003|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
143461489|NCT04494256|517235049|FG004|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
143461490|NCT04494256|517235050|FG005|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
143461491|NCT04494256|517235051|FG006|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
143461492|NCT02128542|517235052|FG000|Overall Study|Lost to Follow-up|3|||
143461493|NCT02128542|517235053|FG001|Overall Study|Lost to Follow-up|0|||
143461494|NCT02128542|517235052|FG000|Overall Study|Withdrew Consent|1|||
143461495|NCT02128542|517235053|FG001|Overall Study|Withdrew Consent|0|||
143461496|NCT01778023|517235055|FG000|Overall Study|Withdrawal by Subject|0|||
143461497|NCT01778023|517235056|FG001|Overall Study|Withdrawal by Subject|3|||
143461498|NCT01411215|517235057|FG000|Overall Study|Adverse Event|1|||
143461499|NCT01411215|517235058|FG001|Overall Study|Adverse Event|2|||
143125273|NCT05052697|516003713|FG005|Substudy A|Lost to Follow-up|1|||
143461500|NCT01411215|517235057|FG000|Overall Study|Lack of Efficacy|2|||
143461501|NCT01411215|517235058|FG001|Overall Study|Lack of Efficacy|4|||
143461502|NCT01411215|517235057|FG000|Overall Study|Lost to Follow-up|12|||
143125274|NCT05052697|516003714|FG006|Substudy A|Lost to Follow-up|0|||
143125275|NCT05052697|516003715|FG007|Substudy A|Lost to Follow-up|0|||
143351340|NCT03734991|516831239|FG001|Overall Study|Pregnancy|0|||
143351341|NCT03734991|516831238|FG000|Overall Study|Withdrawal by Subject|6|||
143351342|NCT03734991|516831239|FG001|Overall Study|Withdrawal by Subject|3|||
143351343|NCT03734991|516831238|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
143351344|NCT03734991|516831239|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
143351345|NCT03734991|516831238|FG000|Overall Study|Other|2|||
143351346|NCT03734991|516831239|FG001|Overall Study|Other|2|||
143351347|NCT03012061|516831242|FG000|Overall Study|Withdrawal by Subject|1|||
143351348|NCT03012061|516831243|FG001|Overall Study|Withdrawal by Subject|5|||
143351349|NCT03012061|516831244|FG002|Overall Study|Withdrawal by Subject|4|||
143351350|NCT03012061|516831242|FG000|Overall Study|Investigator Site Closed|1|||
143351351|NCT03012061|516831243|FG001|Overall Study|Investigator Site Closed|2|||
143351352|NCT03012061|516831244|FG002|Overall Study|Investigator Site Closed|0|||
143351353|NCT03012061|516831242|FG000|Overall Study|Lost to Follow-up|2|||
143351354|NCT03012061|516831243|FG001|Overall Study|Lost to Follow-up|1|||
143351355|NCT03012061|516831244|FG002|Overall Study|Lost to Follow-up|0|||
143351356|NCT03012061|516831242|FG000|Overall Study|Study closed/ Terminated|0|||
143351357|NCT03012061|516831243|FG001|Overall Study|Study closed/ Terminated|0|||
143351358|NCT03012061|516831244|FG002|Overall Study|Study closed/ Terminated|1|||
143351359|NCT03012061|516831242|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
143351360|NCT03012061|516831243|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
143351361|NCT03012061|516831244|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
143351362|NCT03012061|516831242|FG000|Overall Study|Protocol Violation|0|||
143351363|NCT03012061|516831243|FG001|Overall Study|Protocol Violation|0|||
143351364|NCT03012061|516831244|FG002|Overall Study|Protocol Violation|2|||
143351365|NCT03012061|516831242|FG000|Overall Study|Lack of Efficacy|0|||
143351366|NCT03012061|516831243|FG001|Overall Study|Lack of Efficacy|1|||
143351367|NCT03012061|516831244|FG002|Overall Study|Lack of Efficacy|0|||
143351368|NCT03012061|516831242|FG000|Overall Study|Adverse Event|2|||
143351369|NCT03012061|516831243|FG001|Overall Study|Adverse Event|0|||
143351370|NCT03012061|516831244|FG002|Overall Study|Adverse Event|0|||
143351371|NCT02736968|516831246|FG000|Overall Study|Lost to Follow-up|0|||
143351372|NCT02736968|516831247|FG001|Overall Study|Lost to Follow-up|0|||
143351373|NCT02736968|516831248|FG002|Overall Study|Lost to Follow-up|0|||
143351374|NCT02736968|516831249|FG003|Overall Study|Lost to Follow-up|0|||
143351375|NCT02736968|516831250|FG004|Overall Study|Lost to Follow-up|0|||
143351376|NCT02736968|516831251|FG005|Overall Study|Lost to Follow-up|0|||
143351377|NCT02736968|516831252|FG006|Overall Study|Lost to Follow-up|5|||
143351378|NCT02736968|516831253|FG007|Overall Study|Lost to Follow-up|2|||
143351379|NCT02736968|516831246|FG000|Overall Study|COVID-19 Pandemic|0|||
143351380|NCT02736968|516831247|FG001|Overall Study|COVID-19 Pandemic|0|||
143351381|NCT02736968|516831248|FG002|Overall Study|COVID-19 Pandemic|0|||
143351382|NCT02736968|516831249|FG003|Overall Study|COVID-19 Pandemic|0|||
143351383|NCT02736968|516831250|FG004|Overall Study|COVID-19 Pandemic|0|||
143351384|NCT02736968|516831251|FG005|Overall Study|COVID-19 Pandemic|0|||
143351385|NCT02736968|516831252|FG006|Overall Study|COVID-19 Pandemic|2|||
143351386|NCT02736968|516831253|FG007|Overall Study|COVID-19 Pandemic|0|||
143351387|NCT02736968|516831246|FG000|Overall Study|Withdrawal by Subject|0|||
143351388|NCT02736968|516831247|FG001|Overall Study|Withdrawal by Subject|0|||
143351389|NCT02736968|516831248|FG002|Overall Study|Withdrawal by Subject|0|||
143351390|NCT02736968|516831249|FG003|Overall Study|Withdrawal by Subject|0|||
143351391|NCT02736968|516831250|FG004|Overall Study|Withdrawal by Subject|0|||
143351392|NCT02736968|516831251|FG005|Overall Study|Withdrawal by Subject|0|||
143351393|NCT02736968|516831252|FG006|Overall Study|Withdrawal by Subject|1|||
143351394|NCT02736968|516831253|FG007|Overall Study|Withdrawal by Subject|0|||
143351395|NCT02961374|516831254|FG000|Overall Study|Adverse Event|4|||
143351396|NCT00309608|516831255|FG000|Overall Study|Adverse Event|1|||
143351397|NCT00309608|516831256|FG001|Overall Study|Adverse Event|5|||
143351398|NCT00309608|516831257|FG002|Overall Study|Adverse Event|3|||
143351399|NCT00309608|516831258|FG003|Overall Study|Adverse Event|2|||
143351400|NCT00309608|516831259|FG004|Overall Study|Adverse Event|3|||
143351401|NCT00309608|516831255|FG000|Overall Study|Protocol Violation|2|||
143351402|NCT00309608|516831256|FG001|Overall Study|Protocol Violation|0|||
143351403|NCT00309608|516831257|FG002|Overall Study|Protocol Violation|0|||
143351404|NCT00309608|516831258|FG003|Overall Study|Protocol Violation|0|||
143351405|NCT00309608|516831259|FG004|Overall Study|Protocol Violation|0|||
143351406|NCT00309608|516831255|FG000|Overall Study|Lost to Follow-up|0|||
143351407|NCT00309608|516831256|FG001|Overall Study|Lost to Follow-up|0|||
143351408|NCT00309608|516831257|FG002|Overall Study|Lost to Follow-up|2|||
143351409|NCT00309608|516831258|FG003|Overall Study|Lost to Follow-up|0|||
143351410|NCT00309608|516831259|FG004|Overall Study|Lost to Follow-up|1|||
143351411|NCT00309608|516831255|FG000|Overall Study|Withdrawal by Subject|1|||
143351412|NCT00309608|516831256|FG001|Overall Study|Withdrawal by Subject|4|||
143351413|NCT00309608|516831257|FG002|Overall Study|Withdrawal by Subject|2|||
143351414|NCT00309608|516831258|FG003|Overall Study|Withdrawal by Subject|0|||
143351415|NCT00309608|516831259|FG004|Overall Study|Withdrawal by Subject|0|||
143351416|NCT00309608|516831255|FG000|Overall Study|Other incl. Lack of efficacy|10|||
143351417|NCT00309608|516831256|FG001|Overall Study|Other incl. Lack of efficacy|4|||
143351418|NCT00309608|516831257|FG002|Overall Study|Other incl. Lack of efficacy|3|||
143351419|NCT00309608|516831258|FG003|Overall Study|Other incl. Lack of efficacy|4|||
143351420|NCT00309608|516831259|FG004|Overall Study|Other incl. Lack of efficacy|0|||
143351421|NCT01051063|516831260|FG000|Overall Study|Death|2|||
143351422|NCT01051063|516831261|FG001|Overall Study|Death|2|||
143351423|NCT01051063|516831260|FG000|Overall Study|Withdrawal by Subject|1|||
143351424|NCT01051063|516831261|FG001|Overall Study|Withdrawal by Subject|1|||
143351425|NCT01051063|516831260|FG000|Overall Study|Termination of the study|5|||
143351426|NCT01051063|516831261|FG001|Overall Study|Termination of the study|0|||
143351427|NCT01051063|516831260|FG000|Overall Study|Moved from the study site area|1|||
143351428|NCT01051063|516831261|FG001|Overall Study|Moved from the study site area|0|||
143351429|NCT01051063|516831260|FG000|Overall Study|Other|1|||
143351430|NCT01051063|516831261|FG001|Overall Study|Other|0|||
143351431|NCT01051063|516831260|FG000|Overall Study|Lost to Follow-up|0|||
143351432|NCT01051063|516831261|FG001|Overall Study|Lost to Follow-up|1|||
143351433|NCT00874432|516831265|FG000|Overall Study|Withdrawal by Subject|1|||
143351434|NCT00874432|516831266|FG001|Overall Study|Withdrawal by Subject|0|||
143351435|NCT00874432|516831267|FG002|Overall Study|Withdrawal by Subject|0|||
143351436|NCT00874432|516831268|FG003|Overall Study|Withdrawal by Subject|0|||
143351437|NCT00874432|516831265|FG000|Overall Study|Physician Decision|1|||
143351438|NCT00874432|516831266|FG001|Overall Study|Physician Decision|0|||
143351439|NCT00874432|516831267|FG002|Overall Study|Physician Decision|0|||
143351440|NCT00874432|516831268|FG003|Overall Study|Physician Decision|0|||
143351441|NCT00874432|516831265|FG000|Overall Study|Other|1|||
143351442|NCT00874432|516831266|FG001|Overall Study|Other|2|||
143351443|NCT00874432|516831267|FG002|Overall Study|Other|8|||
143351444|NCT00874432|516831268|FG003|Overall Study|Other|3|||
143351445|NCT03713021|516831269|FG000|Overall Study|Did not have CT sim scan available|6|||
143351446|NCT03713021|516831269|FG000|Overall Study|Not eligible|4|||
143351447|NCT03713021|516831269|FG000|Overall Study|Issues with TraceIT markers|5|||
143351448|NCT06017999|516832628|FG000|Overall Study|Withdrawal by Subject|0|||
143351449|NCT06017999|516832629|FG001|Overall Study|Withdrawal by Subject|4|||
143351450|NCT06017999|516832630|FG002|Overall Study|Withdrawal by Subject|3|||
143351451|NCT06017999|516832628|FG000|Overall Study|Adverse Event|2|||
143351452|NCT06017999|516832629|FG001|Overall Study|Adverse Event|1|||
143351453|NCT06017999|516832630|FG002|Overall Study|Adverse Event|1|||
143351454|NCT06017999|516832628|FG000|Overall Study|Lost to Follow-up|0|||
143351455|NCT06017999|516832629|FG001|Overall Study|Lost to Follow-up|0|||
143351456|NCT06017999|516832630|FG002|Overall Study|Lost to Follow-up|1|||
143351457|NCT06017999|516832628|FG000|Overall Study|Physician Decision|1|||
143351458|NCT06017999|516832629|FG001|Overall Study|Physician Decision|1|||
143351459|NCT06017999|516832630|FG002|Overall Study|Physician Decision|0|||
143351460|NCT06017999|516832628|FG000|Overall Study|Non-Compliance|0|||
143351461|NCT06017999|516832629|FG001|Overall Study|Non-Compliance|0|||
143351462|NCT06017999|516832630|FG002|Overall Study|Non-Compliance|1|||
143351463|NCT06017999|516832628|FG000|Overall Study|Lack of Efficacy|1|||
143351464|NCT06017999|516832629|FG001|Overall Study|Lack of Efficacy|0|||
143351465|NCT06017999|516832630|FG002|Overall Study|Lack of Efficacy|7|||
143351466|NCT06017999|516832628|FG000|Overall Study|COVID Positive|0|||
143351467|NCT06017999|516832629|FG001|Overall Study|COVID Positive|1|||
143351468|NCT06017999|516832630|FG002|Overall Study|COVID Positive|0|||
143351469|NCT06017999|516832628|FG000|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
143351470|NCT06017999|516832629|FG001|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
143351471|NCT06017999|516832630|FG002|Overall Study|Did Not Disclose Amount of EtOH Consumed|1|||
143351472|NCT04338581|516832631|FG000|Overall Study|Lack of Efficacy|1|||
143351473|NCT04338581|516832632|FG001|Overall Study|Lack of Efficacy|0|||
143351474|NCT04338581|516832631|FG000|Overall Study|Withdrawal by Subject|4|||
143351475|NCT04338581|516832632|FG001|Overall Study|Withdrawal by Subject|4|||
143351476|NCT04338581|516832631|FG000|Overall Study|Prohibited Medication|1|||
143351477|NCT04338581|516832632|FG001|Overall Study|Prohibited Medication|0|||
143351478|NCT01757665|516832633|FG000|Overall Study|Still on Study - Visit Completed|240|||
143351479|NCT01757665|516832634|FG001|Overall Study|Still on Study - Visit Completed|30|||
143351480|NCT01757665|516832633|FG000|Overall Study|Still on Study - Visit Pending|398|||
143351481|NCT01757665|516832634|FG001|Overall Study|Still on Study - Visit Pending|40|||
143351482|NCT01757665|516832633|FG000|Overall Study|Still on Study - Missed Visit|14|||
143351483|NCT01757665|516832634|FG001|Overall Study|Still on Study - Missed Visit|1|||
143351484|NCT01757665|516832633|FG000|Overall Study|Death|25|||
143351485|NCT01757665|516832634|FG001|Overall Study|Death|8|||
143351486|NCT01757665|516832633|FG000|Overall Study|Explant|1|||
143351487|NCT01757665|516832634|FG001|Overall Study|Explant|2|||
143351488|NCT01757665|516832633|FG000|Overall Study|Withdrawal by Subject|10|||
143351489|NCT01757665|516832634|FG001|Overall Study|Withdrawal by Subject|0|||
143351490|NCT01757665|516832633|FG000|Overall Study|Lost to Follow-up|1|||
143351491|NCT01757665|516832634|FG001|Overall Study|Lost to Follow-up|1|||
143351492|NCT01757665|516832633|FG000|Overall Study|Not Implanted with Device|5|||
143351493|NCT01757665|516832634|FG001|Overall Study|Not Implanted with Device|1|||
143351494|NCT01857934|516832638|FG000|Overall Study|Relapse or progression|2|||
143351495|NCT01857934|516832638|FG000|Overall Study|Unacceptable toxicity|3|||
143125276|NCT05052697|516003716|FG008|Substudy A|Lost to Follow-up|0|||
143125277|NCT05052697|516003717|FG009|Substudy A|Lost to Follow-up|0|||
143125278|NCT05052697|516003718|FG010|Substudy A|Lost to Follow-up|0|||
143125279|NCT05052697|516003719|FG011|Substudy A|Lost to Follow-up|0|||
143125280|NCT05052697|516003720|FG012|Substudy A|Lost to Follow-up|0|||
143125281|NCT05052697|516003721|FG013|Substudy A|Lost to Follow-up|0|||
143125282|NCT05052697|516003722|FG014|Substudy A|Lost to Follow-up|0|||
143125283|NCT05052697|516003723|FG015|Substudy A|Lost to Follow-up|2|||
143125284|NCT05052697|516003724|FG016|Substudy A|Lost to Follow-up|0|||
143125285|NCT05052697|516003725|FG017|Substudy A|Lost to Follow-up|0|||
143351496|NCT01857934|516832638|FG000|Overall Study|Unwillingness or inability to comply|2|||
143351497|NCT01857934|516832638|FG000|Overall Study|Physician Decision|3|||
143351498|NCT06173570|516832639|FG000|Overall Study|Adverse Event|1|||
143351499|NCT06173570|516832640|FG001|Overall Study|Adverse Event|0|||
143351500|NCT06173570|516832641|FG002|Overall Study|Adverse Event|0|||
143351501|NCT06173570|516832642|FG003|Overall Study|Adverse Event|2|||
143351502|NCT06173570|516832643|FG004|Overall Study|Adverse Event|0|||
143351503|NCT06173570|516832639|FG000|Overall Study|Lost to Follow-up|1|||
143351504|NCT06173570|516832640|FG001|Overall Study|Lost to Follow-up|0|||
143351505|NCT06173570|516832641|FG002|Overall Study|Lost to Follow-up|0|||
143351506|NCT06173570|516832642|FG003|Overall Study|Lost to Follow-up|0|||
143351507|NCT06173570|516832643|FG004|Overall Study|Lost to Follow-up|2|||
143351508|NCT06173570|516832639|FG000|Overall Study|Protocol Violation|0|||
143351509|NCT06173570|516832640|FG001|Overall Study|Protocol Violation|2|||
143351510|NCT06173570|516832641|FG002|Overall Study|Protocol Violation|0|||
143351511|NCT06173570|516832642|FG003|Overall Study|Protocol Violation|0|||
143351512|NCT06173570|516832643|FG004|Overall Study|Protocol Violation|1|||
143351513|NCT06173570|516832639|FG000|Overall Study|Withdrawal by Subject|0|||
143351514|NCT06173570|516832640|FG001|Overall Study|Withdrawal by Subject|1|||
143351515|NCT06173570|516832641|FG002|Overall Study|Withdrawal by Subject|1|||
143351516|NCT06173570|516832642|FG003|Overall Study|Withdrawal by Subject|1|||
143351517|NCT06173570|516832643|FG004|Overall Study|Withdrawal by Subject|1|||
143351518|NCT06173570|516832639|FG000|Overall Study|Non-compliance with Study Drug|1|||
143351519|NCT06173570|516832640|FG001|Overall Study|Non-compliance with Study Drug|0|||
143351520|NCT06173570|516832641|FG002|Overall Study|Non-compliance with Study Drug|0|||
143351521|NCT06173570|516832642|FG003|Overall Study|Non-compliance with Study Drug|0|||
143351522|NCT06173570|516832643|FG004|Overall Study|Non-compliance with Study Drug|0|||
143351523|NCT06173570|516832639|FG000|Overall Study|Screen Failure|0|||
143351524|NCT06173570|516832640|FG001|Overall Study|Screen Failure|0|||
143351525|NCT06173570|516832641|FG002|Overall Study|Screen Failure|0|||
143351526|NCT06173570|516832642|FG003|Overall Study|Screen Failure|0|||
143351527|NCT06173570|516832643|FG004|Overall Study|Screen Failure|1|||
143351528|NCT06173570|516832639|FG000|Overall Study|Other|2|||
143351529|NCT06173570|516832640|FG001|Overall Study|Other|1|||
143351530|NCT06173570|516832641|FG002|Overall Study|Other|0|||
143351531|NCT06173570|516832642|FG003|Overall Study|Other|2|||
143351532|NCT06173570|516832643|FG004|Overall Study|Other|0|||
143351533|NCT01830881|516832644|FG000|Overall Study|Changed decision to have an abortion|0|||
143351534|NCT01830881|516832645|FG001|Overall Study|Changed decision to have an abortion|1|||
143351535|NCT00119262|516832646|FG000|Overall Study|Lack of Efficacy|0|||
143351536|NCT00119262|516832647|FG001|Overall Study|Lack of Efficacy|3|||
143351537|NCT00119262|516832646|FG000|Overall Study|Withdrawal by Subject|12|||
143351538|NCT00119262|516832647|FG001|Overall Study|Withdrawal by Subject|11|||
143351539|NCT00119262|516832646|FG000|Overall Study|Adverse Event|33|||
143351540|NCT00119262|516832647|FG001|Overall Study|Adverse Event|35|||
143351541|NCT00119262|516832646|FG000|Overall Study|other disease|0|||
143351542|NCT00119262|516832647|FG001|Overall Study|other disease|2|||
143351543|NCT00119262|516832646|FG000|Overall Study|ineligble|1|||
143351544|NCT00119262|516832647|FG001|Overall Study|ineligble|2|||
143351545|NCT00119262|516832646|FG000|Overall Study|others|0|||
143351546|NCT00119262|516832647|FG001|Overall Study|others|5|||
143351547|NCT01258660|516832648|FG000|Overall Study|Adverse Event|2|||
143351548|NCT01258660|516832649|FG001|Overall Study|Adverse Event|4|||
143125286|NCT05052697|516003726|FG018|Substudy A|Lost to Follow-up|0|||
143125287|NCT05052697|516003727|FG019|Substudy A|Lost to Follow-up|0|||
143351549|NCT01258660|516832648|FG000|Overall Study|Withdrawal by Subject|3|||
143351550|NCT01258660|516832649|FG001|Overall Study|Withdrawal by Subject|0|||
143351551|NCT01258660|516832648|FG000|Overall Study|due to relocation|2|||
143351552|NCT01258660|516832649|FG001|Overall Study|due to relocation|0|||
143351553|NCT01258660|516832648|FG000|Overall Study|Protocol Violation|0|||
143351554|NCT01258660|516832649|FG001|Overall Study|Protocol Violation|1|||
143351555|NCT01258660|516832648|FG000|Overall Study|Invalid for primary analysis data set|4|||
143351556|NCT01258660|516832649|FG001|Overall Study|Invalid for primary analysis data set|6|||
143351557|NCT03853317|516832650|FG000|Overall Study|Progressive Disease|5|||
143351558|NCT03853317|516832650|FG000|Overall Study|Adverse Event|1|||
143351559|NCT03853317|516832650|FG000|Overall Study|Death|1|||
143351560|NCT03853317|516832650|FG000|Overall Study|other event|2|||
143351561|NCT00779584|516832653|FG000|Overall Study|Protocol Violation|0|||
143351562|NCT00779584|516832654|FG001|Overall Study|Protocol Violation|0|||
143351563|NCT00779584|516832655|FG002|Overall Study|Protocol Violation|0|||
143351564|NCT00779584|516832656|FG003|Overall Study|Protocol Violation|0|||
143351565|NCT00779584|516832657|FG004|Overall Study|Protocol Violation|0|||
143351566|NCT00779584|516832658|FG005|Overall Study|Protocol Violation|1|||
143351567|NCT00779584|516832659|FG006|Overall Study|Protocol Violation|0|||
143351568|NCT00779584|516832660|FG007|Overall Study|Protocol Violation|0|||
143351569|NCT00779584|516832661|FG008|Overall Study|Protocol Violation|0|||
143351570|NCT00779584|516832653|FG000|Overall Study|Withdrawal by Subject|1|||
143351571|NCT00779584|516832654|FG001|Overall Study|Withdrawal by Subject|1|||
143351572|NCT00779584|516832655|FG002|Overall Study|Withdrawal by Subject|2|||
143351573|NCT00779584|516832656|FG003|Overall Study|Withdrawal by Subject|0|||
143351574|NCT00779584|516832657|FG004|Overall Study|Withdrawal by Subject|0|||
143351575|NCT00779584|516832658|FG005|Overall Study|Withdrawal by Subject|2|||
143351576|NCT00779584|516832659|FG006|Overall Study|Withdrawal by Subject|1|||
143351577|NCT00779584|516832660|FG007|Overall Study|Withdrawal by Subject|0|||
143351578|NCT00779584|516832661|FG008|Overall Study|Withdrawal by Subject|0|||
143351579|NCT00779584|516832653|FG000|Overall Study|Lost to Follow-up|0|||
143351580|NCT00779584|516832654|FG001|Overall Study|Lost to Follow-up|0|||
143351581|NCT00779584|516832655|FG002|Overall Study|Lost to Follow-up|0|||
143351582|NCT00779584|516832656|FG003|Overall Study|Lost to Follow-up|0|||
143351583|NCT00779584|516832657|FG004|Overall Study|Lost to Follow-up|1|||
143351584|NCT00779584|516832658|FG005|Overall Study|Lost to Follow-up|0|||
143351585|NCT00779584|516832659|FG006|Overall Study|Lost to Follow-up|0|||
143351586|NCT00779584|516832660|FG007|Overall Study|Lost to Follow-up|0|||
143351587|NCT00779584|516832661|FG008|Overall Study|Lost to Follow-up|0|||
143351588|NCT00779584|516832653|FG000|Overall Study|Progression of Disease|0|||
143461503|NCT01411215|517235058|FG001|Overall Study|Lost to Follow-up|18|||
143461504|NCT01411215|517235057|FG000|Overall Study|Did not meet entrance criteria|0|||
143461505|NCT01411215|517235058|FG001|Overall Study|Did not meet entrance criteria|1|||
143461506|NCT01411215|517235057|FG000|Overall Study|Study terminated by sponsor|2|||
143351589|NCT00779584|516832654|FG001|Overall Study|Progression of Disease|1|||
143351590|NCT00779584|516832655|FG002|Overall Study|Progression of Disease|2|||
143351591|NCT00779584|516832656|FG003|Overall Study|Progression of Disease|6|||
143461507|NCT01411215|517235058|FG001|Overall Study|Study terminated by sponsor|15|||
143461508|NCT01411215|517235057|FG000|Overall Study|Protocol Violation|3|||
143011911|NCT00110084|515581773|FG000|Overall Study|Intercurrent Illness|1|||
143011912|NCT00110084|515581773|FG000|Overall Study|Other|2|||
143011913|NCT04854707|515581775|FG000|Overall Study|Lack of Efficacy|78|||
143011914|NCT04854707|515581776|FG001|Overall Study|Lack of Efficacy|59|||
143011915|NCT04854707|515581777|FG002|Overall Study|Lack of Efficacy|30|||
143011916|NCT00537056|515581778|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
143011917|NCT01257737|515581780|FG000|Overall Study|Lost to Follow-up|1|||
143011918|NCT01257737|515581781|FG001|Overall Study|Lost to Follow-up|2|||
143011919|NCT01257737|515581780|FG000|Overall Study|Liver transplant|1|||
143011920|NCT01257737|515581781|FG001|Overall Study|Liver transplant|0|||
143011921|NCT01257737|515581780|FG000|Overall Study|Relocation out of the country|0|||
143011922|NCT01257737|515581781|FG001|Overall Study|Relocation out of the country|1|||
143011923|NCT01257737|515581780|FG000|Overall Study|Withdrew from study|0|||
143011924|NCT01257737|515581781|FG001|Overall Study|Withdrew from study|1|||
143011925|NCT04732728|515581792|FG000|Overall Study|Death|12|||
143011926|NCT04732728|515581792|FG000|Overall Study|Withdrawn|136|||
143011927|NCT02380248|515581804|FG000|Overall Study|Lost to Follow-up|11|||
143011928|NCT02380248|515581804|FG000|Overall Study|Withdrawal by Subject|3|||
143011929|NCT03083639|515581805|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
143011930|NCT03083639|515581806|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
143011931|NCT03083639|515581805|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
143011932|NCT03083639|515581806|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
143011933|NCT00960687|515581807|FG000|Washout Period of 7 Days|Adverse Event|3|||
143011934|NCT00960687|515581808|FG001|Washout Period of 7 Days|Adverse Event|2|||
143011935|NCT00960687|515581807|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
143011936|NCT00960687|515581808|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
143011937|NCT02704130|515581810|FG000|Overall Study|Physician Decision|5|||
143011938|NCT02704130|515581811|FG001|Overall Study|Physician Decision|3|||
143461509|NCT01411215|517235058|FG001|Overall Study|Protocol Violation|5|||
143011939|NCT01216319|515581812|FG000|Overall Study|Lost to Follow-up|2|||
143011940|NCT01216319|515581812|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
143011941|NCT00929864|515581816|FG000|Overall Study|Death|1|||
143011942|NCT00929864|515581817|FG001|Overall Study|Death|1|||
143011943|NCT00929864|515581816|FG000|Overall Study|Adverse Event|11|||
143351592|NCT00779584|516832657|FG004|Overall Study|Progression of Disease|5|||
143351593|NCT00779584|516832658|FG005|Overall Study|Progression of Disease|1|||
143351594|NCT00779584|516832659|FG006|Overall Study|Progression of Disease|4|||
143351595|NCT00779584|516832660|FG007|Overall Study|Progression of Disease|2|||
143351596|NCT00779584|516832661|FG008|Overall Study|Progression of Disease|1|||
143351597|NCT00779584|516832653|FG000|Overall Study|Adverse Event|1|||
143351598|NCT00779584|516832654|FG001|Overall Study|Adverse Event|0|||
143351599|NCT00779584|516832655|FG002|Overall Study|Adverse Event|2|||
143351600|NCT00779584|516832656|FG003|Overall Study|Adverse Event|0|||
143351601|NCT00779584|516832657|FG004|Overall Study|Adverse Event|0|||
143351602|NCT00779584|516832658|FG005|Overall Study|Adverse Event|0|||
143351603|NCT00779584|516832659|FG006|Overall Study|Adverse Event|2|||
143351604|NCT00779584|516832660|FG007|Overall Study|Adverse Event|1|||
143351605|NCT00779584|516832661|FG008|Overall Study|Adverse Event|1|||
143351606|NCT00779584|516832653|FG000|Overall Study|Symptomatic Deterioration|1|||
143351607|NCT00779584|516832654|FG001|Overall Study|Symptomatic Deterioration|1|||
143351608|NCT00779584|516832655|FG002|Overall Study|Symptomatic Deterioration|1|||
143351609|NCT00779584|516832656|FG003|Overall Study|Symptomatic Deterioration|0|||
143351610|NCT00779584|516832657|FG004|Overall Study|Symptomatic Deterioration|0|||
143351611|NCT00779584|516832658|FG005|Overall Study|Symptomatic Deterioration|1|||
143351612|NCT00779584|516832659|FG006|Overall Study|Symptomatic Deterioration|1|||
143351613|NCT00779584|516832660|FG007|Overall Study|Symptomatic Deterioration|0|||
143351614|NCT00779584|516832661|FG008|Overall Study|Symptomatic Deterioration|0|||
143351615|NCT00779584|516832653|FG000|Overall Study|Ongoing in Study|0|||
143351616|NCT00779584|516832654|FG001|Overall Study|Ongoing in Study|0|||
143351617|NCT00779584|516832655|FG002|Overall Study|Ongoing in Study|0|||
143351618|NCT00779584|516832656|FG003|Overall Study|Ongoing in Study|0|||
143351619|NCT00779584|516832657|FG004|Overall Study|Ongoing in Study|1|||
143351620|NCT00779584|516832658|FG005|Overall Study|Ongoing in Study|1|||
143351621|NCT00779584|516832659|FG006|Overall Study|Ongoing in Study|0|||
143351622|NCT00779584|516832660|FG007|Overall Study|Ongoing in Study|0|||
143351623|NCT00779584|516832661|FG008|Overall Study|Ongoing in Study|0|||
143351624|NCT03632434|516832664|FG000|Overall Study|Withdrawal by Subject|2|||
143351625|NCT01115491|516832665|FG000|Overall Study|Death|22|||
143351626|NCT01115491|516832665|FG000|Overall Study|Adverse Event|3|||
143351627|NCT01115491|516832665|FG000|Overall Study|Lost to Follow-up|3|||
143351628|NCT01115491|516832665|FG000|Overall Study|Withdrawal by Subject|1|||
143351629|NCT01115491|516832665|FG000|Overall Study|Physician Decision|1|||
143351630|NCT04297241|516832666|FG000|Overall Study|Withdrawal by Subject|1|||
143351631|NCT04297241|516832666|FG000|Overall Study|Adverse Event|1|||
143351632|NCT04297241|516832666|FG000|Overall Study|Physician Decision|3|||
143351633|NCT00786474|516832677|FG000|Overall Study|Death|5|||
143351634|NCT00786474|516832678|FG001|Overall Study|Death|4|||
143351635|NCT00786474|516832677|FG000|Overall Study|Withdrawal by Subject|23|||
143351636|NCT00786474|516832678|FG001|Overall Study|Withdrawal by Subject|31|||
143351637|NCT00786474|516832677|FG000|Overall Study|Lost to Follow-up|3|||
143351638|NCT00786474|516832678|FG001|Overall Study|Lost to Follow-up|3|||
143351639|NCT00786474|516832677|FG000|Overall Study|Physician Decision|2|||
143351640|NCT00786474|516832678|FG001|Overall Study|Physician Decision|1|||
143351641|NCT00786474|516832677|FG000|Overall Study|Other|4|||
143351642|NCT00786474|516832678|FG001|Overall Study|Other|4|||
143351643|NCT01868074|516832679|FG000|Overall Study|Lost to Follow-up|3|||
143351644|NCT01868074|516832680|FG001|Overall Study|Lost to Follow-up|2|||
143351645|NCT01868074|516832679|FG000|Overall Study|Withdrawal by Subject|4|||
143351646|NCT01868074|516832680|FG001|Overall Study|Withdrawal by Subject|2|||
143351647|NCT04654468|516832685|FG000|Overall Study|Death|1|||
143351648|NCT04654468|516832685|FG000|Overall Study|Ongoing in the Study|50|||
143351649|NCT06390826|516832686|FG000|Overall Study|Never Start Protocol Therapy|1|||
143351650|NCT06390826|516832686|FG000|Overall Study|Adverse Event|1|||
143351651|NCT06390826|516832686|FG000|Overall Study|Disease Progression|8|||
143351652|NCT03915951|516832696|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
143351653|NCT03915951|516832697|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
143351654|NCT03915951|516832696|FG000|Overall Study|Adverse Event|12|||
143351655|NCT03915951|516832697|FG001|Overall Study|Adverse Event|6|||
143351656|NCT03915951|516832696|FG000|Overall Study|Disease progression (radiological)|17|||
143351657|NCT03915951|516832697|FG001|Overall Study|Disease progression (radiological)|15|||
143351658|NCT03915951|516832696|FG000|Overall Study|Disease progression (clinical)|4|||
143351659|NCT03915951|516832697|FG001|Overall Study|Disease progression (clinical)|1|||
143351660|NCT03915951|516832696|FG000|Overall Study|Patient decision|0|||
143351661|NCT03915951|516832697|FG001|Overall Study|Patient decision|4|||
143351662|NCT03915951|516832696|FG000|Overall Study|Investigator decision|0|||
143351663|NCT03915951|516832697|FG001|Overall Study|Investigator decision|1|||
143351664|NCT03915951|516832696|FG000|Overall Study|Consent withdrawn|1|||
143351665|NCT03915951|516832697|FG001|Overall Study|Consent withdrawn|1|||
143351666|NCT03915951|516832696|FG000|Overall Study|Death|0|||
143351667|NCT03915951|516832697|FG001|Overall Study|Death|3|||
143351668|NCT05832437|516832698|FG000|Overall Study|time off work|1|||
143351669|NCT05832437|516832699|FG001|Overall Study|time off work|0|||
143351670|NCT05832437|516832700|FG002|Overall Study|time off work|0|||
143351671|NCT05832437|516832701|FG003|Overall Study|time off work|0|||
143125288|NCT05052697|516003728|FG020|Substudy A|Lost to Follow-up|0|||
143351672|NCT05376371|516832702|FG000|Overall Study|change in release date|10|||
143351673|NCT04159415|516832703|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
143351674|NCT04159415|516832704|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
143351675|NCT04159415|516832705|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
143351676|NCT04159415|516832706|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
143351677|NCT04159415|516832707|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
143351678|NCT04159415|516832708|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
143351679|NCT04159415|516832709|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
143351680|NCT04159415|516832710|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
143351681|NCT04159415|516832711|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
143351682|NCT04159415|516832712|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
143351683|NCT04159415|516832703|FG000|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
143351684|NCT04159415|516832704|FG001|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
143351685|NCT04159415|516832705|FG002|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
143351686|NCT04159415|516832706|FG003|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
143351687|NCT04159415|516832707|FG004|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
143351688|NCT04159415|516832708|FG005|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
143351689|NCT04159415|516832709|FG006|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
143351690|NCT04159415|516832710|FG007|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|1|||
143351691|NCT04159415|516832711|FG008|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
143351692|NCT04159415|516832712|FG009|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
143125289|NCT05052697|516003729|FG021|Substudy A|Lost to Follow-up|0|||
143351693|NCT04159415|516832703|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
143351694|NCT04159415|516832704|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
143351695|NCT04159415|516832705|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
143351696|NCT04159415|516832706|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
143351697|NCT04159415|516832707|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
143351698|NCT04159415|516832708|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
143351699|NCT04159415|516832709|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
143351700|NCT04159415|516832710|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|1|||
143351701|NCT04159415|516832711|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
143351702|NCT04159415|516832712|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
143351703|NCT04159415|516832703|FG000|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
143351704|NCT04159415|516832704|FG001|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
143351705|NCT04159415|516832705|FG002|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
143351706|NCT04159415|516832706|FG003|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
143351707|NCT04159415|516832707|FG004|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
143351708|NCT04159415|516832708|FG005|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
143351709|NCT04159415|516832709|FG006|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
143351710|NCT04159415|516832710|FG007|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
143351711|NCT04159415|516832711|FG008|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
143351712|NCT04159415|516832712|FG009|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|1|||
143351713|NCT05407311|516832713|FG000|Overall Study|Withdrawal by Subject|5|||
143351714|NCT05407311|516832713|FG000|Overall Study|Protocol Violation|3|||
143351715|NCT05407311|516832713|FG000|Overall Study|Physician Decision|1|||
143351716|NCT05407311|516832713|FG000|Overall Study|Non-compliance|1|||
143351717|NCT05490329|516832717|FG000|2-Arm Randomized Control Trial|Lost to Follow-up|8|||
143351718|NCT05490329|516832718|FG001|2-Arm Randomized Control Trial|Lost to Follow-up|25|||
143351719|NCT05490329|516832717|FG000|2-Arm Randomized Control Trial|Withdrawal by Subject|0|||
143351720|NCT05490329|516832718|FG001|2-Arm Randomized Control Trial|Withdrawal by Subject|1|||
143125290|NCT05052697|516003730|FG022|Substudy A|Lost to Follow-up|0|||
143125291|NCT05052697|516003731|FG023|Substudy A|Lost to Follow-up|0|||
143125292|NCT05052697|516003732|FG024|Substudy A|Lost to Follow-up|0|||
143125293|NCT05052697|516003733|FG025|Substudy A|Lost to Follow-up|0|||
143125294|NCT05052697|516003734|FG026|Substudy A|Lost to Follow-up|0|||
143125295|NCT05052697|516003735|FG027|Substudy A|Lost to Follow-up|0|||
143125296|NCT05052697|516003736|FG028|Substudy A|Lost to Follow-up|0|||
143125297|NCT05052697|516003737|FG029|Substudy A|Lost to Follow-up|0|||
143125298|NCT05052697|516003738|FG030|Substudy A|Lost to Follow-up|0|||
143125299|NCT05052697|516003739|FG031|Substudy A|Lost to Follow-up|0|||
143125300|NCT05052697|516003740|FG032|Substudy A|Lost to Follow-up|0|||
143125301|NCT05052697|516003741|FG033|Substudy A|Lost to Follow-up|0|||
143125302|NCT05052697|516003708|FG000|Substudy A|No longer met eligibility criteria|0|||
143351721|NCT05490329|516832717|FG000|Standard of Care - App Access Crossover|Lost to Follow-up|9|||
143351722|NCT05490329|516832718|FG001|Standard of Care - App Access Crossover|Lost to Follow-up|0|||
143351723|NCT00856661|516832719|FG000|Overall Study|Death|15|||
143351724|NCT00856661|516832720|FG001|Overall Study|Death|18|||
143351725|NCT00856661|516832719|FG000|Overall Study|Protocol Violation|2|||
143351726|NCT00856661|516832720|FG001|Overall Study|Protocol Violation|1|||
143351727|NCT00856661|516832719|FG000|Overall Study|Withdrawal by Subject|1|||
143351728|NCT00856661|516832720|FG001|Overall Study|Withdrawal by Subject|2|||
143351729|NCT00856661|516832719|FG000|Overall Study|Lost to Follow-up|1|||
143351730|NCT00856661|516832720|FG001|Overall Study|Lost to Follow-up|3|||
143351731|NCT00856661|516832719|FG000|Overall Study|Physician Judgement|8|||
143351732|NCT00856661|516832720|FG001|Overall Study|Physician Judgement|5|||
143351733|NCT00180713|516832724|FG000|Overall Study|Withdrawal by Subject|2|||
143351734|NCT00180713|516832725|FG001|Overall Study|Withdrawal by Subject|0|||
143351735|NCT00180713|516832724|FG000|Overall Study|Adverse Event|3|||
143351736|NCT00180713|516832725|FG001|Overall Study|Adverse Event|3|||
143351737|NCT01032044|516832728|FG000|Overall Study|Protocol Violation|14|||
143351738|NCT01032044|516832729|FG001|Overall Study|Protocol Violation|8|||
143351739|NCT01032044|516832728|FG000|Overall Study|Adverse Event|0|||
143351740|NCT01032044|516832729|FG001|Overall Study|Adverse Event|1|||
143351741|NCT01032044|516832728|FG000|Overall Study|Lost to Follow-up|11|||
143351742|NCT01032044|516832729|FG001|Overall Study|Lost to Follow-up|11|||
143351743|NCT01233609|516832730|FG000|Overall Study|Death|1|||
143351744|NCT01233609|516832731|FG001|Overall Study|Death|0|||
143351745|NCT01233609|516832730|FG000|Overall Study|Lost to Follow-up|3|||
143351746|NCT01233609|516832731|FG001|Overall Study|Lost to Follow-up|1|||
143351747|NCT01233609|516832730|FG000|Overall Study|Adverse Event|2|||
143125303|NCT05052697|516003709|FG001|Substudy A|No longer met eligibility criteria|0|||
143125304|NCT05052697|516003710|FG002|Substudy A|No longer met eligibility criteria|0|||
143125305|NCT05052697|516003711|FG003|Substudy A|No longer met eligibility criteria|0|||
143125306|NCT05052697|516003712|FG004|Substudy A|No longer met eligibility criteria|0|||
143125307|NCT05052697|516003713|FG005|Substudy A|No longer met eligibility criteria|0|||
143125308|NCT05052697|516003714|FG006|Substudy A|No longer met eligibility criteria|0|||
143125309|NCT05052697|516003715|FG007|Substudy A|No longer met eligibility criteria|0|||
143125310|NCT05052697|516003716|FG008|Substudy A|No longer met eligibility criteria|0|||
143125311|NCT05052697|516003717|FG009|Substudy A|No longer met eligibility criteria|0|||
143125312|NCT05052697|516003718|FG010|Substudy A|No longer met eligibility criteria|0|||
143351748|NCT01233609|516832731|FG001|Overall Study|Adverse Event|1|||
143351749|NCT01233609|516832730|FG000|Overall Study|Withdrawal by Subject|3|||
143351750|NCT01233609|516832731|FG001|Overall Study|Withdrawal by Subject|0|||
143351751|NCT03904693|516833635|FG000|DB Treatment Period (Week 1 to Week 16)|Death|0|||
143351752|NCT03904693|516833636|FG001|DB Treatment Period (Week 1 to Week 16)|Death|0|||
143351753|NCT03904693|516833637|FG002|DB Treatment Period (Week 1 to Week 16)|Death|3|||
143351754|NCT03904693|516833638|FG003|DB Treatment Period (Week 1 to Week 16)|Death|0|||
143351755|NCT03904693|516833639|FG004|DB Treatment Period (Week 1 to Week 16)|Death|0|||
143351756|NCT03904693|516833640|FG005|DB Treatment Period (Week 1 to Week 16)|Death|0|||
143351757|NCT03904693|516833635|FG000|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
143351758|NCT03904693|516833636|FG001|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
143351759|NCT03904693|516833637|FG002|DB Treatment Period (Week 1 to Week 16)|Physician Decision|2|||
143351760|NCT03904693|516833638|FG003|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
143351761|NCT03904693|516833639|FG004|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
143351762|NCT03904693|516833640|FG005|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
143351763|NCT03904693|516833635|FG000|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
143351764|NCT03904693|516833636|FG001|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|1|||
143351765|NCT03904693|516833637|FG002|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|4|||
143351766|NCT03904693|516833638|FG003|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
143351767|NCT03904693|516833639|FG004|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
143351768|NCT03904693|516833640|FG005|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
143351769|NCT03904693|516833635|FG000|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
143351770|NCT03904693|516833636|FG001|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
143351771|NCT03904693|516833637|FG002|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
143351772|NCT03904693|516833638|FG003|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|2|||
143351773|NCT03904693|516833639|FG004|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|4|||
143351774|NCT03904693|516833640|FG005|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|7|||
143125313|NCT05052697|516003719|FG011|Substudy A|No longer met eligibility criteria|0|||
143351775|NCT03904693|516833635|FG000|OL Treatment Period (Week 17 to Week189)|Death|0|||
143351776|NCT03904693|516833636|FG001|OL Treatment Period (Week 17 to Week189)|Death|0|||
143351777|NCT03904693|516833637|FG002|OL Treatment Period (Week 17 to Week189)|Death|0|||
143351778|NCT03904693|516833638|FG003|OL Treatment Period (Week 17 to Week189)|Death|0|||
143351779|NCT03904693|516833639|FG004|OL Treatment Period (Week 17 to Week189)|Death|0|||
143351780|NCT03904693|516833640|FG005|OL Treatment Period (Week 17 to Week189)|Death|5|||
143125314|NCT05052697|516003720|FG012|Substudy A|No longer met eligibility criteria|0|||
143125315|NCT05052697|516003721|FG013|Substudy A|No longer met eligibility criteria|1|||
143125316|NCT05052697|516003722|FG014|Substudy A|No longer met eligibility criteria|0|||
143125317|NCT05052697|516003723|FG015|Substudy A|No longer met eligibility criteria|0|||
143125318|NCT05052697|516003724|FG016|Substudy A|No longer met eligibility criteria|0|||
143125319|NCT05052697|516003725|FG017|Substudy A|No longer met eligibility criteria|0|||
143125320|NCT05052697|516003726|FG018|Substudy A|No longer met eligibility criteria|0|||
143125321|NCT05052697|516003727|FG019|Substudy A|No longer met eligibility criteria|0|||
143125322|NCT05052697|516003728|FG020|Substudy A|No longer met eligibility criteria|0|||
143125323|NCT05052697|516003729|FG021|Substudy A|No longer met eligibility criteria|0|||
143125324|NCT05052697|516003730|FG022|Substudy A|No longer met eligibility criteria|0|||
143125325|NCT05052697|516003731|FG023|Substudy A|No longer met eligibility criteria|0|||
143125326|NCT05052697|516003732|FG024|Substudy A|No longer met eligibility criteria|0|||
143125327|NCT05052697|516003733|FG025|Substudy A|No longer met eligibility criteria|0|||
143125328|NCT05052697|516003734|FG026|Substudy A|No longer met eligibility criteria|0|||
143125329|NCT05052697|516003735|FG027|Substudy A|No longer met eligibility criteria|0|||
143125330|NCT05052697|516003736|FG028|Substudy A|No longer met eligibility criteria|0|||
143125331|NCT05052697|516003737|FG029|Substudy A|No longer met eligibility criteria|0|||
143351781|NCT03904693|516833635|FG000|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
143351782|NCT03904693|516833636|FG001|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
143351783|NCT03904693|516833637|FG002|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
143351784|NCT03904693|516833638|FG003|OL Treatment Period (Week 17 to Week189)|Adverse Event|2|||
143351785|NCT03904693|516833639|FG004|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
143351786|NCT03904693|516833640|FG005|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
143351787|NCT03904693|516833635|FG000|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
143351788|NCT03904693|516833636|FG001|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
143351789|NCT03904693|516833637|FG002|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
143351790|NCT03904693|516833638|FG003|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|1|||
143351791|NCT03904693|516833639|FG004|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
143351792|NCT03904693|516833640|FG005|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
143351793|NCT03904693|516833635|FG000|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
143351794|NCT03904693|516833636|FG001|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
143351795|NCT03904693|516833637|FG002|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
143351796|NCT03904693|516833638|FG003|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
143351797|NCT03904693|516833639|FG004|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
143351798|NCT03904693|516833640|FG005|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|1|||
143351799|NCT03904693|516833635|FG000|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
143351800|NCT03904693|516833636|FG001|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
143351801|NCT03904693|516833637|FG002|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
143351802|NCT03904693|516833638|FG003|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
143351803|NCT03904693|516833639|FG004|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|1|||
143351804|NCT03904693|516833640|FG005|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
143351805|NCT03904693|516833635|FG000|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
143351806|NCT03904693|516833636|FG001|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
143351807|NCT03904693|516833637|FG002|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
143351808|NCT03904693|516833638|FG003|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
143351809|NCT03904693|516833639|FG004|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
143351810|NCT03904693|516833640|FG005|OL Treatment Period (Week 17 to Week189)|Technical problems|1|||
143351811|NCT03904693|516833635|FG000|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
143351812|NCT03904693|516833636|FG001|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
143351813|NCT03904693|516833637|FG002|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
143351814|NCT03904693|516833638|FG003|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
143351815|NCT03904693|516833639|FG004|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
143351816|NCT03904693|516833640|FG005|OL Treatment Period (Week 17 to Week189)|Family problems|1|||
143351817|NCT04175912|516833641|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
143351818|NCT04175912|516833642|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
143351819|NCT04175912|516833641|FG000|Overall Study|Adverse Event|0|||
143351820|NCT04175912|516833642|FG001|Overall Study|Adverse Event|3|||
143351821|NCT04175912|516833641|FG000|Overall Study|Never started treatment|3|||
143351822|NCT04175912|516833642|FG001|Overall Study|Never started treatment|3|||
143351823|NCT04175912|516833641|FG000|Overall Study|Death|0|||
143351824|NCT04175912|516833642|FG001|Overall Study|Death|1|||
143351825|NCT02303626|516833645|FG000|Overall Study|Lack of Efficacy|1|||
143351826|NCT02303626|516833646|FG001|Overall Study|Lack of Efficacy|0|||
143125332|NCT05052697|516003738|FG030|Substudy A|No longer met eligibility criteria|0|||
143011944|NCT00929864|515581817|FG001|Overall Study|Adverse Event|30|||
143011945|NCT00929864|515581816|FG000|Overall Study|Lack of Efficacy|19|||
143011946|NCT00929864|515581817|FG001|Overall Study|Lack of Efficacy|16|||
143011947|NCT00929864|515581816|FG000|Overall Study|Lost to Follow-up|7|||
143011948|NCT00929864|515581817|FG001|Overall Study|Lost to Follow-up|12|||
143011949|NCT00929864|515581816|FG000|Overall Study|Withdrawal by Subject|20|||
143011950|NCT00929864|515581817|FG001|Overall Study|Withdrawal by Subject|9|||
143011951|NCT00929864|515581816|FG000|Overall Study|No longer met criteria|2|||
143011952|NCT00929864|515581817|FG001|Overall Study|No longer met criteria|1|||
143011953|NCT00929864|515581816|FG000|Overall Study|Poor or non-compliance|3|||
143011954|NCT00929864|515581817|FG001|Overall Study|Poor or non-compliance|3|||
143011955|NCT00929864|515581816|FG000|Overall Study|Pregnancy|0|||
143011956|NCT00929864|515581817|FG001|Overall Study|Pregnancy|3|||
143011957|NCT00929864|515581816|FG000|Overall Study|Administrative reason by Sponsor|1|||
143011958|NCT00929864|515581817|FG001|Overall Study|Administrative reason by Sponsor|1|||
143011959|NCT00929864|515581816|FG000|Overall Study|Non-specified|2|||
143011960|NCT00929864|515581817|FG001|Overall Study|Non-specified|7|||
143011961|NCT03940742|515581818|FG000|Overall Study|Lost to Follow-up|0|||
143011962|NCT03940742|515581819|FG001|Overall Study|Lost to Follow-up|0|||
143011963|NCT03940742|515581820|FG002|Overall Study|Lost to Follow-up|0|||
143011964|NCT03940742|515581821|FG003|Overall Study|Lost to Follow-up|1|||
143011965|NCT03428217|515581822|FG000|Overall Study|Death|89|||
143011966|NCT03428217|515581823|FG001|Overall Study|Death|93|||
143011967|NCT03428217|515581822|FG000|Overall Study|Withdrawal by Subject|8|||
143011968|NCT03428217|515581823|FG001|Overall Study|Withdrawal by Subject|7|||
143011969|NCT03428217|515581822|FG000|Overall Study|Lost to Follow-up|1|||
143011970|NCT03428217|515581823|FG001|Overall Study|Lost to Follow-up|3|||
143011971|NCT03428217|515581822|FG000|Overall Study|Study terminated by sponsor|124|||
143011972|NCT03428217|515581823|FG001|Overall Study|Study terminated by sponsor|118|||
143011973|NCT03428217|515581822|FG000|Overall Study|Other, Not Specified|1|||
143011974|NCT03428217|515581823|FG001|Overall Study|Other, Not Specified|0|||
143011975|NCT00096031|515581824|FG000|Overall Study|Adverse Event|3|||
143011976|NCT00096031|515581824|FG000|Overall Study|Lack of Efficacy|42|||
143011977|NCT00096031|515581824|FG000|Overall Study|Death|4|||
143011978|NCT00096031|515581824|FG000|Overall Study|Withdrawal by Subject|1|||
143011979|NCT00096031|515581824|FG000|Overall Study|Ineligible|8|||
143011980|NCT00096031|515581824|FG000|Overall Study|Not protocol specified|5|||
143011981|NCT01283282|515581825|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
143011982|NCT01283282|515581826|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
143011983|NCT01283282|515581825|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
143011984|NCT01283282|515581826|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
143011985|NCT01283282|515581825|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
143011986|NCT01283282|515581826|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
143011987|NCT00777920|515581827|FG000|Overall Study|Adverse Event|39|||
143011988|NCT00777920|515581827|FG000|Overall Study|Withdrawal of Consent|4|||
143011989|NCT00777920|515581827|FG000|Overall Study|Lost to Follow-up|1|||
143011990|NCT00777920|515581827|FG000|Overall Study|Investigator's discretion|1|||
143011991|NCT00777920|515581827|FG000|Overall Study|Clinical status did not improve|1|||
143011992|NCT00777920|515581827|FG000|Overall Study|Other, not specified|4|||
143011993|NCT00483717|515581828|FG000|Overall Study|Protocol Violation|5|||
143011994|NCT00483717|515581829|FG001|Overall Study|Protocol Violation|7|||
143011995|NCT00483717|515581828|FG000|Overall Study|Time of dosing missing|1|||
143011996|NCT00483717|515581829|FG001|Overall Study|Time of dosing missing|1|||
143011997|NCT00483717|515581828|FG000|Overall Study|No treatment for migraine|16|||
143011998|NCT00483717|515581829|FG001|Overall Study|No treatment for migraine|13|||
143011999|NCT00483717|515581828|FG000|Overall Study|Lost to Follow-up|1|||
143012000|NCT00483717|515581829|FG001|Overall Study|Lost to Follow-up|0|||
143012001|NCT00483717|515581828|FG000|Overall Study|Withdrawal by Subject|1|||
143012002|NCT00483717|515581829|FG001|Overall Study|Withdrawal by Subject|0|||
143012003|NCT00083226|515581830|FG000|Overall Study|Lack of Efficacy|19|||
143012004|NCT00083226|515581830|FG000|Overall Study|Adverse Event|9|||
143012005|NCT00083226|515581830|FG000|Overall Study|Death|4|||
143012006|NCT00083226|515581830|FG000|Overall Study|Withdrawal by Subject|4|||
143012007|NCT00083226|515581830|FG000|Overall Study|Other|2|||
143012008|NCT00083226|515581830|FG000|Overall Study|ineligible or not receiving treatment|4|||
143012009|NCT00909857|515581831|FG000|Overall Study|Withdrawal by Subject|6|||
143012010|NCT00909857|515581832|FG001|Overall Study|Withdrawal by Subject|10|||
143012011|NCT00909857|515581831|FG000|Overall Study|Adverse Event|5|||
143012012|NCT00909857|515581832|FG001|Overall Study|Adverse Event|5|||
143012013|NCT00909857|515581831|FG000|Overall Study|Lost to Follow-up|2|||
143012014|NCT00909857|515581832|FG001|Overall Study|Lost to Follow-up|5|||
143012015|NCT00909857|515581831|FG000|Overall Study|Protocol Violation|2|||
143012016|NCT00909857|515581832|FG001|Overall Study|Protocol Violation|1|||
143012017|NCT00909857|515581831|FG000|Overall Study|Pregnancy|1|||
143012018|NCT00909857|515581832|FG001|Overall Study|Pregnancy|0|||
143012019|NCT00909857|515581831|FG000|Overall Study|Other|1|||
143012020|NCT00909857|515581832|FG001|Overall Study|Other|0|||
143012021|NCT00909857|515581831|FG000|Overall Study|Did not receive study medication|19|||
143351827|NCT02303626|516833647|FG002|Overall Study|Lack of Efficacy|1|||
143351828|NCT02303626|516833645|FG000|Overall Study|Adverse Event|0|||
143351829|NCT02303626|516833646|FG001|Overall Study|Adverse Event|2|||
143351830|NCT02303626|516833647|FG002|Overall Study|Adverse Event|0|||
143351831|NCT02303626|516833645|FG000|Overall Study|Protocol Violation|0|||
143351832|NCT02303626|516833646|FG001|Overall Study|Protocol Violation|1|||
143351833|NCT02303626|516833647|FG002|Overall Study|Protocol Violation|0|||
143351834|NCT02303626|516833645|FG000|Overall Study|Pregnancy|0|||
143351835|NCT02303626|516833646|FG001|Overall Study|Pregnancy|0|||
143351836|NCT02303626|516833647|FG002|Overall Study|Pregnancy|1|||
143351837|NCT02303626|516833645|FG000|Overall Study|Subject Non-Compliance|0|||
143351838|NCT02303626|516833646|FG001|Overall Study|Subject Non-Compliance|0|||
143351839|NCT02303626|516833647|FG002|Overall Study|Subject Non-Compliance|1|||
143351840|NCT03698019|516833648|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
143351841|NCT03698019|516833649|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
143351842|NCT03698019|516833648|FG000|Step 1: Registration|Withdrawal by Subject|7|||
143351843|NCT03698019|516833649|FG001|Step 1: Registration|Withdrawal by Subject|2|||
143351844|NCT03698019|516833648|FG000|Step 1: Registration|Toxicity|0|||
143351845|NCT03698019|516833649|FG001|Step 1: Registration|Toxicity|1|||
143351846|NCT03698019|516833648|FG000|Step 1: Registration|Disease Progression|0|||
143351847|NCT03698019|516833649|FG001|Step 1: Registration|Disease Progression|12|||
143351848|NCT03698019|516833648|FG000|Step 1: Registration|Co-morbidities|0|||
143351849|NCT03698019|516833649|FG001|Step 1: Registration|Co-morbidities|1|||
143351850|NCT03698019|516833648|FG000|Step 1: Registration|Scheduling Issues|1|||
143351851|NCT03698019|516833649|FG001|Step 1: Registration|Scheduling Issues|0|||
143351852|NCT03698019|516833648|FG000|Step 1: Registration|Participant Refusal|0|||
143351853|NCT03698019|516833649|FG001|Step 1: Registration|Participant Refusal|1|||
143351854|NCT03698019|516833648|FG000|Step 2: Surgery|Participant Refusal|2|||
143351855|NCT03698019|516833649|FG001|Step 2: Surgery|Participant Refusal|1|||
143351856|NCT03698019|516833648|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
143351857|NCT03698019|516833649|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
143351858|NCT03698019|516833648|FG000|Step 2: Surgery|Metastatic Disease|16|||
143351859|NCT03698019|516833649|FG001|Step 2: Surgery|Metastatic Disease|9|||
143351860|NCT03698019|516833648|FG000|Step 2: Surgery|Residual Disease|2|||
143351861|NCT03698019|516833649|FG001|Step 2: Surgery|Residual Disease|1|||
143351862|NCT03698019|516833648|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
143351863|NCT03698019|516833649|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
143351864|NCT03698019|516833648|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
143351865|NCT03698019|516833649|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
143351866|NCT03698019|516833648|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
143351867|NCT03698019|516833649|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
143351868|NCT03698019|516833648|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
143351869|NCT03698019|516833649|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
143351870|NCT03698019|516833648|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
143351871|NCT03698019|516833649|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
143012022|NCT00909857|515581832|FG001|Overall Study|Did not receive study medication|24|||
143012023|NCT03878108|515581833|FG000|Overall Study|Adverse Event|1|||
143012024|NCT03878108|515581834|FG001|Overall Study|Adverse Event|0|||
143012025|NCT00604175|515581841|FG000|Entry Through Week 28|Death|2|||
143012026|NCT00604175|515581842|FG001|Entry Through Week 28|Death|0|||
143012027|NCT00604175|515581843|FG002|Entry Through Week 28|Death|0|||
143012028|NCT00604175|515581841|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
143012029|NCT00604175|515581842|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
143012030|NCT00604175|515581843|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
143012031|NCT00604175|515581841|FG000|Entry Through Week 28|Lost to Follow-up|4|||
143012032|NCT00604175|515581842|FG001|Entry Through Week 28|Lost to Follow-up|3|||
143012033|NCT00604175|515581843|FG002|Entry Through Week 28|Lost to Follow-up|0|||
143012034|NCT00604175|515581841|FG000|Entry Through Week 28|Ineligible|1|||
143012035|NCT00604175|515581842|FG001|Entry Through Week 28|Ineligible|0|||
143012036|NCT00604175|515581843|FG002|Entry Through Week 28|Ineligible|0|||
143012037|NCT00604175|515581841|FG000|Entry Through Week 28|Did not start intervention|2|||
143012038|NCT00604175|515581842|FG001|Entry Through Week 28|Did not start intervention|0|||
143351872|NCT03698019|516833648|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
143351873|NCT03698019|516833649|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
143351874|NCT03698019|516833648|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
143351875|NCT03698019|516833649|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
143351876|NCT03698019|516833648|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
143351877|NCT03698019|516833649|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
143012039|NCT00604175|515581843|FG002|Entry Through Week 28|Did not start intervention|1|||
143351878|NCT05064735|516833650|FG000|Overall Study|Withdrawal by Subject|7|||
143351879|NCT05064735|516833651|FG001|Overall Study|Withdrawal by Subject|8|||
143461510|NCT01411215|517235057|FG000|Overall Study|Withdrawal by Subject|34|||
143351880|NCT05064735|516833650|FG000|Overall Study|Lost to Follow-up|7|||
143351881|NCT05064735|516833651|FG001|Overall Study|Lost to Follow-up|2|||
143351882|NCT05064735|516833650|FG000|Overall Study|Physician Decision|2|||
143125333|NCT05052697|516003739|FG031|Substudy A|No longer met eligibility criteria|0|||
143125334|NCT05052697|516003740|FG032|Substudy A|No longer met eligibility criteria|0|||
143125335|NCT05052697|516003741|FG033|Substudy A|No longer met eligibility criteria|0|||
143125336|NCT05052697|516003708|FG000|Substudy A|Not vaccinated|0|||
143351883|NCT05064735|516833651|FG001|Overall Study|Physician Decision|1|||
143351884|NCT05064735|516833650|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
143351885|NCT05064735|516833651|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
143351886|NCT05064735|516833650|FG000|Overall Study|Site Closure|7|||
143351887|NCT05064735|516833651|FG001|Overall Study|Site Closure|2|||
143351888|NCT04844970|516833657|FG000|Overall Study|Adverse Event|0|||
143351889|NCT04844970|516833658|FG001|Overall Study|Adverse Event|1|||
143351890|NCT04844970|516833657|FG000|Overall Study|Withdrawal by Subject|2|||
143351891|NCT04844970|516833658|FG001|Overall Study|Withdrawal by Subject|0|||
143351892|NCT05027074|516833659|FG000|Overall Study|Death|47|||
143351893|NCT05027074|516833660|FG001|Overall Study|Death|42|||
143351894|NCT05027074|516833661|FG002|Overall Study|Death|39|||
143351895|NCT05027074|516833659|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
143351896|NCT05027074|516833660|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
143351897|NCT05027074|516833661|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
143351898|NCT05027074|516833659|FG000|Overall Study|Site Terminated By Sponsor|3|||
143351899|NCT05027074|516833660|FG001|Overall Study|Site Terminated By Sponsor|0|||
143351900|NCT05027074|516833661|FG002|Overall Study|Site Terminated By Sponsor|2|||
143351901|NCT05027074|516833659|FG000|Overall Study|Withdrawal by Subject|13|||
143351902|NCT05027074|516833660|FG001|Overall Study|Withdrawal by Subject|8|||
143351903|NCT05027074|516833661|FG002|Overall Study|Withdrawal by Subject|10|||
143351904|NCT05027074|516833659|FG000|Overall Study|Lost to Follow-up|2|||
143351905|NCT05027074|516833660|FG001|Overall Study|Lost to Follow-up|4|||
143351906|NCT05027074|516833661|FG002|Overall Study|Lost to Follow-up|3|||
143351907|NCT05027074|516833659|FG000|Overall Study|Status Not Recorded|0|||
143351908|NCT05027074|516833660|FG001|Overall Study|Status Not Recorded|0|||
143351909|NCT05027074|516833661|FG002|Overall Study|Status Not Recorded|1|||
143351910|NCT03169881|516833662|FG000|Overall Study|Incomplete Follow-up|10|||
143351911|NCT03169881|516833663|FG001|Overall Study|Incomplete Follow-up|15|||
143351912|NCT03169881|516833662|FG000|Overall Study|Lost to Follow-up|18|||
143351913|NCT03169881|516833663|FG001|Overall Study|Lost to Follow-up|20|||
143351914|NCT03169881|516833662|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
143351915|NCT03169881|516833663|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
143351916|NCT03936777|516833664|FG000|Overall Study|Adverse Event|3|||
143351917|NCT03936777|516833664|FG000|Overall Study|Death|3|||
143351918|NCT03936777|516833664|FG000|Overall Study|Lack of Efficacy|24|||
143351919|NCT03936777|516833664|FG000|Overall Study|Lost to Follow-up|3|||
143351920|NCT03936777|516833664|FG000|Overall Study|Physician Decision|1|||
143351921|NCT03936777|516833664|FG000|Overall Study|Withdrawal by Subject|11|||
143351922|NCT03936777|516833664|FG000|Overall Study|Subjected Weaned of ZX008|1|||
143351923|NCT03936777|516833664|FG000|Overall Study|Missing|6|||
143351924|NCT05295732|516833665|FG000|Phase 3: Double-blind / MUsT: Treatment|Various reasons|14|||
143351925|NCT05295732|516833666|FG001|Phase 3: Double-blind / MUsT: Treatment|Various reasons|4|||
143351926|NCT05295732|516833667|FG002|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
143351927|NCT05295732|516833668|FG003|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
143351928|NCT05295732|516833669|FG004|Phase 3: Double-blind / MUsT: Treatment|Various reasons|2|||
143125337|NCT05052697|516003709|FG001|Substudy A|Not vaccinated|0|||
143125338|NCT05052697|516003710|FG002|Substudy A|Not vaccinated|0|||
143125339|NCT05052697|516003711|FG003|Substudy A|Not vaccinated|1|||
143125340|NCT05052697|516003712|FG004|Substudy A|Not vaccinated|0|||
143125341|NCT05052697|516003713|FG005|Substudy A|Not vaccinated|0|||
143125342|NCT05052697|516003714|FG006|Substudy A|Not vaccinated|0|||
143125343|NCT05052697|516003715|FG007|Substudy A|Not vaccinated|0|||
143125344|NCT05052697|516003716|FG008|Substudy A|Not vaccinated|1|||
143125345|NCT05052697|516003717|FG009|Substudy A|Not vaccinated|0|||
143125346|NCT05052697|516003718|FG010|Substudy A|Not vaccinated|0|||
143125347|NCT05052697|516003719|FG011|Substudy A|Not vaccinated|0|||
143125348|NCT05052697|516003720|FG012|Substudy A|Not vaccinated|0|||
143125349|NCT05052697|516003721|FG013|Substudy A|Not vaccinated|0|||
143125350|NCT05052697|516003722|FG014|Substudy A|Not vaccinated|0|||
143351929|NCT05295732|516833665|FG000|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
143351930|NCT05295732|516833666|FG001|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
143351931|NCT05295732|516833667|FG002|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
143351932|NCT05295732|516833668|FG003|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
143351933|NCT05295732|516833669|FG004|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
143351934|NCT04150029|516833670|FG000|Overall Study|Disease Relapse|0|||
143125351|NCT05052697|516003723|FG015|Substudy A|Not vaccinated|0|||
143125352|NCT05052697|516003724|FG016|Substudy A|Not vaccinated|0|||
143125353|NCT05052697|516003725|FG017|Substudy A|Not vaccinated|0|||
143351935|NCT04150029|516833671|FG001|Overall Study|Disease Relapse|18|||
143351936|NCT04150029|516833670|FG000|Overall Study|Progressive Disease|2|||
143351937|NCT04150029|516833671|FG001|Overall Study|Progressive Disease|16|||
143125354|NCT05052697|516003726|FG018|Substudy A|Not vaccinated|0|||
143125355|NCT05052697|516003727|FG019|Substudy A|Not vaccinated|0|||
143125356|NCT05052697|516003728|FG020|Substudy A|Not vaccinated|0|||
143125357|NCT05052697|516003729|FG021|Substudy A|Not vaccinated|0|||
143125358|NCT05052697|516003730|FG022|Substudy A|Not vaccinated|0|||
143125359|NCT05052697|516003731|FG023|Substudy A|Not vaccinated|0|||
143125360|NCT05052697|516003732|FG024|Substudy A|Not vaccinated|0|||
143125361|NCT05052697|516003733|FG025|Substudy A|Not vaccinated|0|||
143125362|NCT05052697|516003734|FG026|Substudy A|Not vaccinated|0|||
143125363|NCT05052697|516003735|FG027|Substudy A|Not vaccinated|0|||
143125364|NCT05052697|516003736|FG028|Substudy A|Not vaccinated|0|||
143125365|NCT05052697|516003737|FG029|Substudy A|Not vaccinated|0|||
143125366|NCT05052697|516003738|FG030|Substudy A|Not vaccinated|0|||
143125367|NCT05052697|516003739|FG031|Substudy A|Not vaccinated|0|||
143125368|NCT05052697|516003740|FG032|Substudy A|Not vaccinated|0|||
143125369|NCT05052697|516003741|FG033|Substudy A|Not vaccinated|0|||
143125370|NCT05052697|516003708|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
143125371|NCT05052697|516003709|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
143125372|NCT05052697|516003710|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
143125373|NCT05052697|516003711|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
143125374|NCT05052697|516003712|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
143125375|NCT05052697|516003713|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
143351938|NCT04150029|516833670|FG000|Overall Study|Adverse Event|1|||
143351939|NCT04150029|516833671|FG001|Overall Study|Adverse Event|11|||
143351940|NCT04150029|516833670|FG000|Overall Study|Physician Decision|0|||
143351941|NCT04150029|516833671|FG001|Overall Study|Physician Decision|10|||
143351942|NCT04150029|516833670|FG000|Overall Study|Study Terminated by Sponsor|1|||
143351943|NCT04150029|516833671|FG001|Overall Study|Study Terminated by Sponsor|10|||
143351944|NCT04150029|516833670|FG000|Overall Study|Death|0|||
143351945|NCT04150029|516833671|FG001|Overall Study|Death|8|||
143351946|NCT04150029|516833670|FG000|Overall Study|Participant Decision|0|||
143351947|NCT04150029|516833671|FG001|Overall Study|Participant Decision|7|||
143351948|NCT04150029|516833670|FG000|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|1|||
143351949|NCT04150029|516833671|FG001|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|5|||
143351950|NCT02364713|516833675|FG000|Overall Study|Ineligible|2|||
143351951|NCT02364713|516833676|FG001|Overall Study|Ineligible|2|||
143351952|NCT03797326|516833677|FG000|Overall Study|Lost to Follow-up|1|||
143351953|NCT03797326|516833678|FG001|Overall Study|Lost to Follow-up|0|||
143351954|NCT03797326|516833679|FG002|Overall Study|Lost to Follow-up|0|||
143351955|NCT03797326|516833680|FG003|Overall Study|Lost to Follow-up|1|||
143351956|NCT03797326|516833681|FG004|Overall Study|Lost to Follow-up|0|||
143351957|NCT03797326|516833682|FG005|Overall Study|Lost to Follow-up|0|||
143351958|NCT03797326|516833683|FG006|Overall Study|Lost to Follow-up|0|||
143351959|NCT03797326|516833684|FG007|Overall Study|Lost to Follow-up|0|||
143351960|NCT03797326|516833677|FG000|Overall Study|Withdrawal by Subject|0|||
143351961|NCT03797326|516833678|FG001|Overall Study|Withdrawal by Subject|0|||
143351962|NCT03797326|516833679|FG002|Overall Study|Withdrawal by Subject|1|||
143351963|NCT03797326|516833680|FG003|Overall Study|Withdrawal by Subject|3|||
143351964|NCT03797326|516833681|FG004|Overall Study|Withdrawal by Subject|0|||
143012040|NCT00604175|515581841|FG000|Week 29 Through Week 72|Death|0|||
143012041|NCT00604175|515581842|FG001|Week 29 Through Week 72|Death|0|||
143012042|NCT00604175|515581843|FG002|Week 29 Through Week 72|Death|1|||
143012043|NCT00604175|515581841|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
143012044|NCT00604175|515581842|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
143012045|NCT00604175|515581843|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
143012046|NCT00604175|515581841|FG000|Week 29 Through Week 72|Site closure|0|||
143012047|NCT00604175|515581842|FG001|Week 29 Through Week 72|Site closure|1|||
143012048|NCT00604175|515581843|FG002|Week 29 Through Week 72|Site closure|0|||
143012049|NCT00604175|515581841|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
143012050|NCT00604175|515581842|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
143012051|NCT00604175|515581843|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
143012052|NCT01682681|515581844|FG000|Overall Study|Lack of Efficacy|62|||
143012053|NCT01682681|515581844|FG000|Overall Study|Withdrawal by Subject|1|||
143012054|NCT01682681|515581844|FG000|Overall Study|Moved to other hospital|10|||
143012055|NCT01682681|515581844|FG000|Overall Study|Lost to Follow-up|174|||
143125376|NCT05052697|516003714|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
143351965|NCT03797326|516833682|FG005|Overall Study|Withdrawal by Subject|2|||
143351966|NCT03797326|516833683|FG006|Overall Study|Withdrawal by Subject|2|||
143351967|NCT03797326|516833684|FG007|Overall Study|Withdrawal by Subject|3|||
143125377|NCT05052697|516003715|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
143125378|NCT05052697|516003716|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
143125379|NCT05052697|516003717|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
143125380|NCT05052697|516003718|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
143125381|NCT05052697|516003719|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
143351968|NCT03797326|516833677|FG000|Overall Study|Sponsor Decision|3|||
143351969|NCT03797326|516833678|FG001|Overall Study|Sponsor Decision|3|||
143351970|NCT03797326|516833679|FG002|Overall Study|Sponsor Decision|3|||
143351971|NCT03797326|516833680|FG003|Overall Study|Sponsor Decision|6|||
143351972|NCT03797326|516833681|FG004|Overall Study|Sponsor Decision|0|||
143351973|NCT03797326|516833682|FG005|Overall Study|Sponsor Decision|3|||
143351974|NCT03797326|516833683|FG006|Overall Study|Sponsor Decision|3|||
143351975|NCT03797326|516833684|FG007|Overall Study|Sponsor Decision|2|||
143351976|NCT03797326|516833677|FG000|Overall Study|Death|27|||
143351977|NCT03797326|516833678|FG001|Overall Study|Death|28|||
143351978|NCT03797326|516833679|FG002|Overall Study|Death|95|||
143351979|NCT03797326|516833680|FG003|Overall Study|Death|95|||
143351980|NCT03797326|516833681|FG004|Overall Study|Death|30|||
143351981|NCT03797326|516833682|FG005|Overall Study|Death|96|||
143351982|NCT03797326|516833683|FG006|Overall Study|Death|97|||
143351983|NCT03797326|516833684|FG007|Overall Study|Death|98|||
143351984|NCT03797326|516833677|FG000|Overall Study|Enrolled in error|0|||
143351985|NCT03797326|516833678|FG001|Overall Study|Enrolled in error|0|||
143351986|NCT03797326|516833679|FG002|Overall Study|Enrolled in error|3|||
143351987|NCT03797326|516833680|FG003|Overall Study|Enrolled in error|2|||
143351988|NCT03797326|516833681|FG004|Overall Study|Enrolled in error|2|||
143351989|NCT03797326|516833682|FG005|Overall Study|Enrolled in error|1|||
143351990|NCT03797326|516833683|FG006|Overall Study|Enrolled in error|1|||
143351991|NCT03797326|516833684|FG007|Overall Study|Enrolled in error|0|||
143351992|NCT04908449|516833685|FG000|Overall Study|Patient with major surgical bleeding unerlated to block|0|||
143351993|NCT04908449|516833686|FG001|Overall Study|Patient with major surgical bleeding unerlated to block|1|||
143351994|NCT04908449|516833685|FG000|Overall Study|Patient required postop RVAD, unrelated to block|0|||
143351995|NCT04908449|516833686|FG001|Overall Study|Patient required postop RVAD, unrelated to block|1|||
143351996|NCT06385483|516833687|FG000|Overall Study|Withdrawal by Subject|2|||
143351997|NCT06385483|516833687|FG000|Overall Study|Never start protocol therapy|2|||
143351998|NCT06385483|516833687|FG000|Overall Study|Disease progression|15|||
143351999|NCT05256381|516833688|FG000|Overall Study|Withdrawal by Subject|4|||
143352000|NCT05256381|516833689|FG001|Overall Study|Withdrawal by Subject|0|||
143352001|NCT05256381|516833690|FG002|Overall Study|Withdrawal by Subject|2|||
143352002|NCT05256381|516833691|FG003|Overall Study|Withdrawal by Subject|2|||
143352003|NCT05256381|516833692|FG004|Overall Study|Withdrawal by Subject|8|||
143352004|NCT05256381|516833693|FG005|Overall Study|Withdrawal by Subject|6|||
143352005|NCT05256381|516833688|FG000|Overall Study|Physician Decision|0|||
143352006|NCT05256381|516833689|FG001|Overall Study|Physician Decision|0|||
143352007|NCT05256381|516833690|FG002|Overall Study|Physician Decision|1|||
143352008|NCT05256381|516833691|FG003|Overall Study|Physician Decision|0|||
143352009|NCT05256381|516833692|FG004|Overall Study|Physician Decision|2|||
143352010|NCT05256381|516833693|FG005|Overall Study|Physician Decision|0|||
143352011|NCT05256381|516833688|FG000|Overall Study|Death|17|||
143352012|NCT05256381|516833689|FG001|Overall Study|Death|3|||
143352013|NCT05256381|516833690|FG002|Overall Study|Death|4|||
143352014|NCT05256381|516833691|FG003|Overall Study|Death|5|||
143352015|NCT05256381|516833692|FG004|Overall Study|Death|24|||
143352016|NCT05256381|516833693|FG005|Overall Study|Death|21|||
143352017|NCT05256381|516833688|FG000|Overall Study|Other, not specified|0|||
143352018|NCT05256381|516833689|FG001|Overall Study|Other, not specified|0|||
143352019|NCT05256381|516833690|FG002|Overall Study|Other, not specified|0|||
143352020|NCT05256381|516833691|FG003|Overall Study|Other, not specified|0|||
143352021|NCT05256381|516833692|FG004|Overall Study|Other, not specified|2|||
143352022|NCT05256381|516833693|FG005|Overall Study|Other, not specified|1|||
143352023|NCT05256381|516833688|FG000|Overall Study|Study terminated by sponsor|18|||
143352024|NCT05256381|516833689|FG001|Overall Study|Study terminated by sponsor|5|||
143352025|NCT05256381|516833690|FG002|Overall Study|Study terminated by sponsor|5|||
143352026|NCT05256381|516833691|FG003|Overall Study|Study terminated by sponsor|5|||
143352027|NCT05256381|516833692|FG004|Overall Study|Study terminated by sponsor|18|||
143352028|NCT05256381|516833693|FG005|Overall Study|Study terminated by sponsor|11|||
143352029|NCT05256381|516833688|FG000|Overall Study|Lost to Follow-up|1|||
143352030|NCT05256381|516833689|FG001|Overall Study|Lost to Follow-up|0|||
143352031|NCT05256381|516833690|FG002|Overall Study|Lost to Follow-up|0|||
143352032|NCT05256381|516833691|FG003|Overall Study|Lost to Follow-up|0|||
143352033|NCT05256381|516833692|FG004|Overall Study|Lost to Follow-up|1|||
143352034|NCT05256381|516833693|FG005|Overall Study|Lost to Follow-up|0|||
143352035|NCT05569954|516833694|FG000|Overall Study|Lost to Follow-up|3|||
143352036|NCT05569954|516833695|FG001|Overall Study|Lost to Follow-up|4|||
143352037|NCT05569954|516833694|FG000|Overall Study|Protocol Violation|1|||
143352038|NCT05569954|516833695|FG001|Overall Study|Protocol Violation|2|||
143352039|NCT05569954|516833694|FG000|Overall Study|Withdrawal by Subject|4|||
143125382|NCT05052697|516003720|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
143352040|NCT05569954|516833695|FG001|Overall Study|Withdrawal by Subject|2|||
143352041|NCT02930122|516834621|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
143352042|NCT02930122|516834622|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
143352043|NCT00744237|516834623|FG000|Overall Study|Lack of Efficacy|1|||
143352044|NCT00744237|516834624|FG001|Overall Study|Lack of Efficacy|1|||
143352045|NCT00744237|516834625|FG002|Overall Study|Lack of Efficacy|0|||
143352046|NCT00744237|516834623|FG000|Overall Study|Withdrawal by Subject|9|||
143352047|NCT00744237|516834624|FG001|Overall Study|Withdrawal by Subject|5|||
143352048|NCT00744237|516834625|FG002|Overall Study|Withdrawal by Subject|3|||
143352049|NCT00744237|516834623|FG000|Overall Study|Lost to Follow-up|1|||
143352050|NCT00744237|516834624|FG001|Overall Study|Lost to Follow-up|1|||
143352051|NCT00744237|516834625|FG002|Overall Study|Lost to Follow-up|1|||
143352052|NCT00744237|516834623|FG000|Overall Study|Protocol Violation|3|||
143352053|NCT00744237|516834624|FG001|Overall Study|Protocol Violation|4|||
143352054|NCT00744237|516834625|FG002|Overall Study|Protocol Violation|3|||
143125383|NCT05052697|516003721|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
143125384|NCT05052697|516003722|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
143125385|NCT05052697|516003723|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
143125386|NCT05052697|516003724|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
143125387|NCT05052697|516003725|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
143125388|NCT05052697|516003726|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
143125389|NCT05052697|516003727|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
143125390|NCT05052697|516003728|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
143125391|NCT05052697|516003729|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
143125392|NCT05052697|516003730|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
143125393|NCT05052697|516003731|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
143125394|NCT05052697|516003732|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
143125395|NCT05052697|516003733|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
143125396|NCT05052697|516003734|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
143125397|NCT05052697|516003735|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
143125398|NCT05052697|516003736|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
143125399|NCT05052697|516003737|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
143125400|NCT05052697|516003738|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
143125401|NCT05052697|516003739|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
143125402|NCT05052697|516003740|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
143125403|NCT05052697|516003741|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
143125404|NCT05052697|516003708|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
143125405|NCT05052697|516003709|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
143125406|NCT05052697|516003710|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
143125407|NCT05052697|516003711|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
143125408|NCT05052697|516003712|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
143125409|NCT05052697|516003713|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
143125410|NCT05052697|516003714|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
143125411|NCT05052697|516003715|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
143125412|NCT05052697|516003716|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
143125413|NCT05052697|516003717|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
143125414|NCT05052697|516003718|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
143125415|NCT05052697|516003719|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
143125416|NCT05052697|516003720|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
143125417|NCT05052697|516003721|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
143125418|NCT05052697|516003722|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
143125419|NCT05052697|516003723|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
143125420|NCT05052697|516003724|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
143125421|NCT05052697|516003725|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
143125422|NCT05052697|516003726|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
143125423|NCT05052697|516003727|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
143125424|NCT05052697|516003728|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
143125425|NCT05052697|516003729|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
143125426|NCT05052697|516003730|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
143125427|NCT05052697|516003731|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
143125428|NCT05052697|516003732|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
143125429|NCT05052697|516003733|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
143125430|NCT05052697|516003734|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
143125431|NCT05052697|516003735|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
143125432|NCT05052697|516003736|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
143125433|NCT05052697|516003737|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
143125434|NCT05052697|516003738|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
143125435|NCT05052697|516003739|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
143352055|NCT00744237|516834623|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
143352056|NCT00744237|516834624|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
143125436|NCT05052697|516003740|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
143352057|NCT00744237|516834625|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
143352058|NCT00744237|516834623|FG000|Overall Study|Dosing Error|1|||
143125437|NCT05052697|516003741|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
143125438|NCT05052697|516003708|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
143352059|NCT00744237|516834624|FG001|Overall Study|Dosing Error|0|||
143352060|NCT00744237|516834625|FG002|Overall Study|Dosing Error|1|||
143352061|NCT00744237|516834623|FG000|Overall Study|Study Drug Error|1|||
143352062|NCT00744237|516834624|FG001|Overall Study|Study Drug Error|0|||
143352063|NCT00744237|516834625|FG002|Overall Study|Study Drug Error|0|||
143352064|NCT00744237|516834623|FG000|Overall Study|Prohibited Concomitant Medication|0|||
143352065|NCT00744237|516834624|FG001|Overall Study|Prohibited Concomitant Medication|0|||
143352066|NCT00744237|516834625|FG002|Overall Study|Prohibited Concomitant Medication|1|||
143352067|NCT00744237|516834623|FG000|Overall Study|Poor Compliance|0|||
143352068|NCT00744237|516834624|FG001|Overall Study|Poor Compliance|2|||
143352069|NCT00744237|516834625|FG002|Overall Study|Poor Compliance|0|||
143352070|NCT00744237|516834623|FG000|Overall Study|Administrative. Site Closed|1|||
143352071|NCT00744237|516834624|FG001|Overall Study|Administrative. Site Closed|1|||
143352072|NCT00744237|516834625|FG002|Overall Study|Administrative. Site Closed|1|||
143352073|NCT00744237|516834623|FG000|Overall Study|Adverse Event|9|||
143352074|NCT00744237|516834624|FG001|Overall Study|Adverse Event|13|||
143352075|NCT00744237|516834625|FG002|Overall Study|Adverse Event|5|||
143352076|NCT02091869|516834628|FG000|Overall Study|Withdrawal by Subject|0|||
143352077|NCT02091869|516834629|FG001|Overall Study|Withdrawal by Subject|3|||
143352078|NCT01375959|516834634|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
143352079|NCT01375959|516834635|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
143352080|NCT01375959|516834634|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
143352081|NCT01375959|516834635|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
143352082|NCT01375959|516834634|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
143352083|NCT01375959|516834635|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
143352084|NCT02771210|516834636|FG000|Period 1|Adverse Event|5|||
143352085|NCT02771210|516834637|FG001|Period 1|Adverse Event|3|||
143352086|NCT02771210|516834636|FG000|Period 1|Lack of Efficacy|3|||
143352087|NCT02771210|516834637|FG001|Period 1|Lack of Efficacy|6|||
143352088|NCT02771210|516834636|FG000|Period 1|Lost to Follow-up|2|||
143352089|NCT02771210|516834637|FG001|Period 1|Lost to Follow-up|0|||
143352090|NCT02771210|516834636|FG000|Period 1|Physician Decision|0|||
143352091|NCT02771210|516834637|FG001|Period 1|Physician Decision|1|||
143352092|NCT02771210|516834636|FG000|Period 1|Withdrawal by Subject|0|||
143352093|NCT02771210|516834637|FG001|Period 1|Withdrawal by Subject|3|||
143352094|NCT02771210|516834636|FG000|Period 1|Withdrawal of informed consent|1|||
143352095|NCT02771210|516834637|FG001|Period 1|Withdrawal of informed consent|5|||
143352096|NCT02771210|516834636|FG000|Period 2|Adverse Event|1|||
143352097|NCT02771210|516834637|FG001|Period 2|Adverse Event|0|||
143352098|NCT02771210|516834636|FG000|Period 2|Lack of Efficacy|0|||
143352099|NCT02771210|516834637|FG001|Period 2|Lack of Efficacy|1|||
143352100|NCT02771210|516834636|FG000|Period 2|Withdrawal by Subject|1|||
143352101|NCT02771210|516834637|FG001|Period 2|Withdrawal by Subject|0|||
143352102|NCT02771210|516834636|FG000|Period 2|Withdrawal of informed consent|0|||
143012056|NCT01682681|515581844|FG000|Overall Study|Adverse Event|46|||
143012057|NCT01682681|515581844|FG000|Overall Study|tapering of topiramate|5|||
143012058|NCT01682681|515581844|FG000|Overall Study|Other|21|||
143012059|NCT01682681|515581844|FG000|Overall Study|Low compliance|13|||
143012060|NCT02044094|515581845|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
143012061|NCT02044094|515581845|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
143012062|NCT02044094|515581845|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
143012063|NCT02044094|515581845|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
143012064|NCT02044094|515581845|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
143012065|NCT02044094|515581845|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
143012066|NCT02044094|515581845|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
143012067|NCT02044094|515581845|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
143012068|NCT00975000|515581848|FG000|Overall Study|Other|1|||
143012069|NCT00975000|515581849|FG001|Overall Study|Other|0|||
143012070|NCT00975000|515581848|FG000|Overall Study|Adverse Event|1|||
143012071|NCT00975000|515581849|FG001|Overall Study|Adverse Event|1|||
143012072|NCT00975000|515581848|FG000|Overall Study|Withdrawal by Subject|2|||
143012073|NCT00975000|515581849|FG001|Overall Study|Withdrawal by Subject|2|||
143012074|NCT00975000|515581848|FG000|Overall Study|Lost to Follow-up|0|||
143012075|NCT00975000|515581849|FG001|Overall Study|Lost to Follow-up|1|||
143012076|NCT00975000|515581848|FG000|Overall Study|Protocol-specified Criteria|1|||
143352103|NCT02771210|516834637|FG001|Period 2|Withdrawal of informed consent|2|||
143352104|NCT02572817|516834643|FG000|Overall Study|Death|6|||
143012077|NCT00975000|515581849|FG001|Overall Study|Protocol-specified Criteria|0|||
143012078|NCT00975000|515581848|FG000|Overall Study|Non-compliance|0|||
143012079|NCT00975000|515581849|FG001|Overall Study|Non-compliance|1|||
143012080|NCT05022121|515581850|FG000|Overall Study|Lack of Efficacy|1|||
143352105|NCT02572817|516834644|FG001|Overall Study|Death|3|||
143352106|NCT02572817|516834643|FG000|Overall Study|Lost to Follow-up|3|||
143352107|NCT02572817|516834644|FG001|Overall Study|Lost to Follow-up|3|||
143352108|NCT01394250|516834645|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
143352109|NCT01394250|516834646|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
143352110|NCT01394250|516834645|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
143352111|NCT01394250|516834646|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
143352112|NCT02310126|516834647|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
143352113|NCT02310126|516834648|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
143352114|NCT02310126|516834647|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
143352115|NCT02310126|516834648|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
143352116|NCT02222896|516834652|FG000|Abdomen|Did not qualify|34|||
143352117|NCT02222896|516834653|FG001|Abdomen|Did not qualify|10|||
143352118|NCT02222896|516834654|FG002|Abdomen|Did not qualify|32|||
143352119|NCT02222896|516834652|FG000|Groin|Did not qualify|43|||
143352120|NCT02222896|516834653|FG001|Groin|Did not qualify|9|||
143352121|NCT02222896|516834654|FG002|Groin|Did not qualify|40|||
143352122|NCT02441946|516834655|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
143352123|NCT02441946|516834656|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
143352124|NCT02441946|516834657|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
143352125|NCT02441946|516834655|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
143352126|NCT02441946|516834656|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
143352127|NCT02441946|516834657|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
143352128|NCT02441946|516834655|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
143352129|NCT02441946|516834656|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
143125439|NCT05052697|516003709|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
143125440|NCT05052697|516003710|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
143125441|NCT05052697|516003711|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
143125442|NCT05052697|516003712|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
143125443|NCT05052697|516003713|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
143125444|NCT05052697|516003714|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
143125445|NCT05052697|516003715|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
143125446|NCT05052697|516003716|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
143125447|NCT05052697|516003717|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
143125448|NCT05052697|516003718|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
143125449|NCT05052697|516003719|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
143125450|NCT05052697|516003720|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
143125451|NCT05052697|516003721|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
143125452|NCT05052697|516003722|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
143125453|NCT05052697|516003723|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
143125454|NCT05052697|516003724|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
143125455|NCT05052697|516003725|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
143125456|NCT05052697|516003726|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
143125457|NCT05052697|516003727|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
143125458|NCT05052697|516003728|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
143125459|NCT05052697|516003729|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
143125460|NCT05052697|516003730|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
143125461|NCT05052697|516003731|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
143125462|NCT05052697|516003732|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
143125463|NCT05052697|516003733|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
143125464|NCT05052697|516003734|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
143125465|NCT05052697|516003735|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
143125466|NCT05052697|516003736|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
143125467|NCT05052697|516003737|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
143125468|NCT05052697|516003738|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
143125469|NCT05052697|516003739|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
143125470|NCT05052697|516003740|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
143125471|NCT05052697|516003741|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
143125472|NCT05052697|516003708|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
143125473|NCT05052697|516003709|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
143125474|NCT05052697|516003710|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
143125475|NCT05052697|516003711|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
143125476|NCT05052697|516003712|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
143125477|NCT05052697|516003713|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
143125478|NCT05052697|516003714|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
143125479|NCT05052697|516003715|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
143125480|NCT05052697|516003716|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
143125481|NCT05052697|516003717|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
143125482|NCT05052697|516003718|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
143125483|NCT05052697|516003719|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
143125484|NCT05052697|516003720|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
143125485|NCT05052697|516003721|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
143352130|NCT02441946|516834657|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
143352131|NCT02441946|516834655|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
143352132|NCT02441946|516834656|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
143352133|NCT02441946|516834657|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
143461511|NCT01411215|517235058|FG001|Overall Study|Withdrawal by Subject|21|||
143352134|NCT02441946|516834655|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
143352135|NCT02441946|516834656|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
143352136|NCT02441946|516834657|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
143352137|NCT02441946|516834655|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
143352138|NCT02441946|516834656|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
143352139|NCT02441946|516834657|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
143352140|NCT02441946|516834655|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
143352141|NCT02441946|516834656|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
143352142|NCT02441946|516834657|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
143352143|NCT02441946|516834655|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
143352144|NCT02441946|516834656|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
143352145|NCT02441946|516834657|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
143352146|NCT02441946|516834655|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
143352147|NCT02441946|516834656|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
143352148|NCT02441946|516834657|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
143352149|NCT02441946|516834655|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
143352150|NCT02441946|516834656|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
143352151|NCT02441946|516834657|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
143352152|NCT02441946|516834655|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
143352153|NCT02441946|516834656|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
143352154|NCT02441946|516834657|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
143352155|NCT01865617|516834658|FG000|Overall Study|Death|27|||
143352156|NCT01865617|516834659|FG001|Overall Study|Death|3|||
143352157|NCT01865617|516834660|FG002|Overall Study|Death|1|||
143352158|NCT01865617|516834661|FG003|Overall Study|Death|1|||
143352159|NCT01865617|516834662|FG004|Overall Study|Death|5|||
143352160|NCT01865617|516834663|FG005|Overall Study|Death|1|||
143352161|NCT01865617|516834664|FG006|Overall Study|Death|11|||
143352162|NCT01865617|516834665|FG007|Overall Study|Death|1|||
143352163|NCT01865617|516834666|FG008|Overall Study|Death|11|||
143352164|NCT01865617|516834667|FG009|Overall Study|Death|3|||
143352165|NCT01865617|516834668|FG010|Overall Study|Death|32|||
143352166|NCT01865617|516834669|FG011|Overall Study|Death|6|||
143352167|NCT01865617|516834670|FG012|Overall Study|Death|13|||
143352168|NCT01865617|516834658|FG000|Overall Study|Lost to Follow-up|2|||
143352169|NCT01865617|516834659|FG001|Overall Study|Lost to Follow-up|0|||
143352170|NCT01865617|516834660|FG002|Overall Study|Lost to Follow-up|0|||
143352171|NCT01865617|516834661|FG003|Overall Study|Lost to Follow-up|0|||
143352172|NCT01865617|516834662|FG004|Overall Study|Lost to Follow-up|0|||
143352173|NCT01865617|516834663|FG005|Overall Study|Lost to Follow-up|0|||
143352174|NCT01865617|516834664|FG006|Overall Study|Lost to Follow-up|0|||
143352175|NCT01865617|516834665|FG007|Overall Study|Lost to Follow-up|0|||
143352176|NCT01865617|516834666|FG008|Overall Study|Lost to Follow-up|0|||
143352177|NCT01865617|516834667|FG009|Overall Study|Lost to Follow-up|0|||
143352178|NCT01865617|516834668|FG010|Overall Study|Lost to Follow-up|0|||
143352179|NCT01865617|516834669|FG011|Overall Study|Lost to Follow-up|0|||
143352180|NCT01865617|516834670|FG012|Overall Study|Lost to Follow-up|0|||
143352181|NCT01865617|516834658|FG000|Overall Study|Withdrawal by Subject|1|||
143352182|NCT01865617|516834659|FG001|Overall Study|Withdrawal by Subject|0|||
143352183|NCT01865617|516834660|FG002|Overall Study|Withdrawal by Subject|0|||
143352184|NCT01865617|516834661|FG003|Overall Study|Withdrawal by Subject|0|||
143352185|NCT01865617|516834662|FG004|Overall Study|Withdrawal by Subject|0|||
143352186|NCT01865617|516834663|FG005|Overall Study|Withdrawal by Subject|0|||
143352187|NCT01865617|516834664|FG006|Overall Study|Withdrawal by Subject|0|||
143352188|NCT01865617|516834665|FG007|Overall Study|Withdrawal by Subject|0|||
143352189|NCT01865617|516834666|FG008|Overall Study|Withdrawal by Subject|0|||
143461512|NCT01411215|517235057|FG000|Overall Study|Other|12|||
143125486|NCT05052697|516003722|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
143125487|NCT05052697|516003723|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
143461513|NCT01411215|517235058|FG001|Overall Study|Other|17|||
143461514|NCT01411215|517235057|FG000|Overall Study|Screen failure|0|||
143461515|NCT01411215|517235058|FG001|Overall Study|Screen failure|1|||
143461516|NCT00848926|517235059|FG000|Treatment Period|Progressive disease|45|||
143461517|NCT00848926|517235059|FG000|Treatment Period|Adverse Event|20|||
143461518|NCT00848926|517235059|FG000|Treatment Period|Physician Decision|12|||
143461519|NCT00848926|517235059|FG000|Treatment Period|Withdrawal by Subject|7|||
143461520|NCT00848926|517235059|FG000|Follow-up Period|Lost to Follow-up|7|||
143461521|NCT00848926|517235059|FG000|Follow-up Period|Withdrawal by Subject|3|||
143461522|NCT00848926|517235059|FG000|Follow-up Period|Other|2|||
143461523|NCT02203695|517235060|FG000|Overall Study|Patient withdrew consent|1|||
143461524|NCT02203695|517235061|FG001|Overall Study|Patient withdrew consent|1|||
143461525|NCT02203695|517235060|FG000|Overall Study|Started non-study treatment|1|||
143461526|NCT02203695|517235061|FG001|Overall Study|Started non-study treatment|0|||
143461527|NCT00903630|517235062|FG000|Phase 2|Adverse Event|0|||
143352190|NCT01865617|516834667|FG009|Overall Study|Withdrawal by Subject|0|||
143352191|NCT01865617|516834668|FG010|Overall Study|Withdrawal by Subject|0|||
143352192|NCT01865617|516834669|FG011|Overall Study|Withdrawal by Subject|0|||
143352193|NCT01865617|516834670|FG012|Overall Study|Withdrawal by Subject|0|||
143461528|NCT00903630|517235063|FG001|Phase 2|Adverse Event|0|||
143352194|NCT01865617|516834658|FG000|Overall Study|Patient proceeded to new therapy|0|||
143352195|NCT01865617|516834659|FG001|Overall Study|Patient proceeded to new therapy|0|||
143012081|NCT05022121|515581851|FG001|Overall Study|Lack of Efficacy|0|||
143012082|NCT05022121|515581850|FG000|Overall Study|Lost to Follow-up|0|||
143012083|NCT05022121|515581851|FG001|Overall Study|Lost to Follow-up|2|||
143012084|NCT05257109|515581852|FG000|Overall Study|Withdrawal by Subject|1|||
143012085|NCT05257109|515581853|FG001|Overall Study|Withdrawal by Subject|0|||
143012086|NCT05257109|515581854|FG002|Overall Study|Withdrawal by Subject|0|||
143012087|NCT05257109|515581855|FG003|Overall Study|Withdrawal by Subject|0|||
143012088|NCT00359073|515583528|FG000|Overall Study|Withdrawal by Subject|1|||
143012089|NCT00359073|515583529|FG001|Overall Study|Withdrawal by Subject|1|||
143012090|NCT00359073|515583528|FG000|Overall Study|Eligibility criteria no longer met|3|||
143012091|NCT00359073|515583529|FG001|Overall Study|Eligibility criteria no longer met|0|||
143012092|NCT00359073|515583528|FG000|Overall Study|developed RV16 antibody|0|||
143012093|NCT00359073|515583529|FG001|Overall Study|developed RV16 antibody|1|||
143012094|NCT01371006|515583530|FG000|Overall Study|Adverse Event|1|||
143012095|NCT01371006|515583531|FG001|Overall Study|Adverse Event|0|||
143012096|NCT00891527|515583532|FG000|Overall Study|Withdrawal by Subject|2|||
143012097|NCT01652573|515583540|FG000|Overall Study|Adverse Event|0|||
143012098|NCT01652573|515583541|FG001|Overall Study|Adverse Event|1|||
143012099|NCT00934622|515583542|FG000|Overall Study|Lost to Follow-up|7|||
143012100|NCT00934622|515583542|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
143012101|NCT03284424|515583543|FG000|Overall Study|Death|70|||
143012102|NCT03284424|515583544|FG001|Overall Study|Death|24|||
143012103|NCT03284424|515583543|FG000|Overall Study|Lost to Follow-up|3|||
143012104|NCT03284424|515583544|FG001|Overall Study|Lost to Follow-up|1|||
143012105|NCT03284424|515583543|FG000|Overall Study|Physician Decision|1|||
143012106|NCT03284424|515583544|FG001|Overall Study|Physician Decision|2|||
143012107|NCT03284424|515583543|FG000|Overall Study|Withdrawal by Subject|4|||
143012108|NCT03284424|515583544|FG001|Overall Study|Withdrawal by Subject|5|||
143012109|NCT03284424|515583543|FG000|Overall Study|Sponsor's decision|27|||
143012110|NCT03284424|515583544|FG001|Overall Study|Sponsor's decision|22|||
143012111|NCT01052038|515583547|FG000|Overall Study|Lost to Follow-up|2|||
143012112|NCT01052038|515583548|FG001|Overall Study|Lost to Follow-up|3|||
143012113|NCT01052038|515583549|FG002|Overall Study|Lost to Follow-up|1|||
143012114|NCT01052038|515583547|FG000|Overall Study|Protocol Violation|2|||
143012115|NCT01052038|515583548|FG001|Overall Study|Protocol Violation|3|||
143012116|NCT01052038|515583549|FG002|Overall Study|Protocol Violation|3|||
143012117|NCT03976076|515583550|FG000|Overall Study|Withdrawal by Subject|2|||
143012118|NCT03692078|515583551|FG000|Overall Study|Adverse Event|0|||
143012119|NCT03692078|515583552|FG001|Overall Study|Adverse Event|0|||
143012120|NCT03692078|515583553|FG002|Overall Study|Adverse Event|0|||
143012121|NCT03692078|515583554|FG003|Overall Study|Adverse Event|0|||
143012122|NCT03692078|515583555|FG004|Overall Study|Adverse Event|0|||
143012123|NCT03692078|515583556|FG005|Overall Study|Adverse Event|1|||
143012124|NCT03692078|515583557|FG006|Overall Study|Adverse Event|0|||
143012125|NCT03692078|515583551|FG000|Overall Study|Enrollment Closed|5|||
143012126|NCT03692078|515583552|FG001|Overall Study|Enrollment Closed|0|||
143012127|NCT03692078|515583553|FG002|Overall Study|Enrollment Closed|0|||
143012128|NCT03692078|515583554|FG003|Overall Study|Enrollment Closed|0|||
143012129|NCT03692078|515583555|FG004|Overall Study|Enrollment Closed|0|||
143012130|NCT03692078|515583556|FG005|Overall Study|Enrollment Closed|0|||
143012131|NCT03692078|515583557|FG006|Overall Study|Enrollment Closed|0|||
143012132|NCT03692078|515583551|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
143012133|NCT03692078|515583552|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
143012134|NCT03692078|515583553|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
143012135|NCT03692078|515583554|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
143012136|NCT03692078|515583555|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
143012137|NCT03692078|515583556|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
143012138|NCT03692078|515583557|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
143012139|NCT03692078|515583551|FG000|Overall Study|Withdrawal by Subject|0|||
143012140|NCT03692078|515583552|FG001|Overall Study|Withdrawal by Subject|2|||
143012141|NCT03692078|515583553|FG002|Overall Study|Withdrawal by Subject|0|||
143012142|NCT03692078|515583554|FG003|Overall Study|Withdrawal by Subject|1|||
143012143|NCT03692078|515583555|FG004|Overall Study|Withdrawal by Subject|5|||
143012144|NCT03692078|515583556|FG005|Overall Study|Withdrawal by Subject|3|||
143012145|NCT03692078|515583557|FG006|Overall Study|Withdrawal by Subject|3|||
143012146|NCT01563029|515583558|FG000|Overall Study|Adverse Event|1|||
143012147|NCT01563029|515583559|FG001|Overall Study|Adverse Event|0|||
143012148|NCT01563029|515583560|FG002|Overall Study|Adverse Event|1|||
143012149|NCT01563029|515583561|FG003|Overall Study|Adverse Event|2|||
143012150|NCT01563029|515583562|FG004|Overall Study|Adverse Event|1|||
143012151|NCT01563029|515583558|FG000|Overall Study|Lack of Efficacy|42|||
143012152|NCT01563029|515583559|FG001|Overall Study|Lack of Efficacy|16|||
143012153|NCT01563029|515583560|FG002|Overall Study|Lack of Efficacy|23|||
143012154|NCT01563029|515583561|FG003|Overall Study|Lack of Efficacy|21|||
143012155|NCT01563029|515583562|FG004|Overall Study|Lack of Efficacy|19|||
143125488|NCT05052697|516003724|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
143125489|NCT05052697|516003725|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
143125490|NCT05052697|516003726|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
143125491|NCT05052697|516003727|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
143125492|NCT05052697|516003728|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
143125493|NCT05052697|516003729|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
143125494|NCT05052697|516003730|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
143125495|NCT05052697|516003731|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
143125496|NCT05052697|516003732|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
143125497|NCT05052697|516003733|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
143125498|NCT05052697|516003734|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
143125499|NCT05052697|516003735|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
143125500|NCT05052697|516003736|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
143125501|NCT05052697|516003737|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
143125502|NCT05052697|516003738|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
143125503|NCT05052697|516003739|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
143125504|NCT05052697|516003740|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
143125505|NCT05052697|516003741|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
143125506|NCT05052697|516003708|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
143125507|NCT05052697|516003709|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
143125508|NCT05052697|516003710|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
143125509|NCT05052697|516003711|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
143125510|NCT05052697|516003712|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
143125511|NCT05052697|516003713|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
143125512|NCT05052697|516003714|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
143125513|NCT05052697|516003715|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
143125514|NCT05052697|516003716|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
143125515|NCT05052697|516003717|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
143125516|NCT05052697|516003718|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
143125517|NCT05052697|516003719|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
143125518|NCT05052697|516003720|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
143125519|NCT05052697|516003721|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
143125520|NCT05052697|516003722|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
143125521|NCT05052697|516003723|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
143125522|NCT05052697|516003724|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
143461529|NCT00903630|517235064|FG002|Phase 2|Adverse Event|1|||
143012156|NCT01563029|515583558|FG000|Overall Study|Protocol Violation|1|||
143012157|NCT01563029|515583559|FG001|Overall Study|Protocol Violation|2|||
143012158|NCT01563029|515583560|FG002|Overall Study|Protocol Violation|3|||
143012159|NCT01563029|515583561|FG003|Overall Study|Protocol Violation|1|||
143012160|NCT01563029|515583562|FG004|Overall Study|Protocol Violation|3|||
143012161|NCT01563029|515583558|FG000|Overall Study|Protocol defined stopping criteria|1|||
143012162|NCT01563029|515583559|FG001|Overall Study|Protocol defined stopping criteria|0|||
143012163|NCT01563029|515583560|FG002|Overall Study|Protocol defined stopping criteria|0|||
143012164|NCT01563029|515583561|FG003|Overall Study|Protocol defined stopping criteria|0|||
143012165|NCT01563029|515583562|FG004|Overall Study|Protocol defined stopping criteria|0|||
143012166|NCT01563029|515583558|FG000|Overall Study|Lost to Follow-up|1|||
143012167|NCT01563029|515583559|FG001|Overall Study|Lost to Follow-up|0|||
143012168|NCT01563029|515583560|FG002|Overall Study|Lost to Follow-up|1|||
143012169|NCT01563029|515583561|FG003|Overall Study|Lost to Follow-up|1|||
143012170|NCT01563029|515583562|FG004|Overall Study|Lost to Follow-up|1|||
143012171|NCT01563029|515583558|FG000|Overall Study|Physician Decision|3|||
143012172|NCT01563029|515583559|FG001|Overall Study|Physician Decision|5|||
143012173|NCT01563029|515583560|FG002|Overall Study|Physician Decision|2|||
143012174|NCT01563029|515583561|FG003|Overall Study|Physician Decision|4|||
143012175|NCT01563029|515583562|FG004|Overall Study|Physician Decision|2|||
143012176|NCT01563029|515583558|FG000|Overall Study|Withdrawal by Subject|4|||
143012177|NCT01563029|515583559|FG001|Overall Study|Withdrawal by Subject|1|||
143012178|NCT01563029|515583560|FG002|Overall Study|Withdrawal by Subject|3|||
143012179|NCT01563029|515583561|FG003|Overall Study|Withdrawal by Subject|4|||
143012180|NCT01563029|515583562|FG004|Overall Study|Withdrawal by Subject|3|||
143012181|NCT01569594|515583563|FG000|Overall Study|Physician Decision|4|||
143012182|NCT01569594|515583563|FG000|Overall Study|Death|13|||
143012183|NCT01569594|515583563|FG000|Overall Study|Lost to Follow-up|22|||
143012184|NCT01569594|515583563|FG000|Overall Study|Adverse Event|2|||
143012185|NCT01569594|515583563|FG000|Overall Study|Withdrawal by Subject|13|||
143012186|NCT01569594|515583563|FG000|Overall Study|Other|4|||
143012187|NCT01569594|515583563|FG000|Overall Study|No ECM used|9|||
143012188|NCT03901352|515583564|FG000|Double-blind Phase|Adverse Event|6|||
143012189|NCT03901352|515583565|FG001|Double-blind Phase|Adverse Event|4|||
143012190|NCT03901352|515583564|FG000|Double-blind Phase|Death|1|||
143012191|NCT03901352|515583565|FG001|Double-blind Phase|Death|0|||
143012192|NCT03901352|515583564|FG000|Double-blind Phase|Lack of Efficacy|0|||
143352196|NCT01865617|516834660|FG002|Overall Study|Patient proceeded to new therapy|0|||
143352197|NCT01865617|516834661|FG003|Overall Study|Patient proceeded to new therapy|0|||
143352198|NCT01865617|516834662|FG004|Overall Study|Patient proceeded to new therapy|2|||
143352199|NCT01865617|516834663|FG005|Overall Study|Patient proceeded to new therapy|0|||
143352200|NCT01865617|516834664|FG006|Overall Study|Patient proceeded to new therapy|0|||
143352201|NCT01865617|516834665|FG007|Overall Study|Patient proceeded to new therapy|0|||
143352202|NCT01865617|516834666|FG008|Overall Study|Patient proceeded to new therapy|0|||
143352203|NCT01865617|516834667|FG009|Overall Study|Patient proceeded to new therapy|0|||
143352204|NCT01865617|516834668|FG010|Overall Study|Patient proceeded to new therapy|0|||
143352205|NCT01865617|516834669|FG011|Overall Study|Patient proceeded to new therapy|0|||
143352206|NCT01865617|516834670|FG012|Overall Study|Patient proceeded to new therapy|0|||
143352207|NCT01865617|516834658|FG000|Overall Study|Other|0|||
143352208|NCT01865617|516834659|FG001|Overall Study|Other|0|||
143352209|NCT01865617|516834660|FG002|Overall Study|Other|0|||
143352210|NCT01865617|516834661|FG003|Overall Study|Other|0|||
143125523|NCT05052697|516003725|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
143125524|NCT05052697|516003726|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
143125525|NCT05052697|516003727|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
143352211|NCT01865617|516834662|FG004|Overall Study|Other|0|||
143352212|NCT01865617|516834663|FG005|Overall Study|Other|0|||
143352213|NCT01865617|516834664|FG006|Overall Study|Other|1|||
143352214|NCT01865617|516834665|FG007|Overall Study|Other|0|||
143352215|NCT01865617|516834666|FG008|Overall Study|Other|0|||
143352216|NCT01865617|516834667|FG009|Overall Study|Other|0|||
143352217|NCT01865617|516834668|FG010|Overall Study|Other|0|||
143352218|NCT01865617|516834669|FG011|Overall Study|Other|0|||
143352219|NCT01865617|516834670|FG012|Overall Study|Other|0|||
143352220|NCT00502996|516834671|FG000|Overall Study|Lost to Follow-up|9|||
143352221|NCT00502996|516834671|FG000|Overall Study|Protocol Violation|2|||
143352222|NCT00502996|516834671|FG000|Overall Study|Treatment failure|25|||
143352223|NCT00502996|516834671|FG000|Overall Study|Withdrawal Informed Consent|6|||
143352224|NCT00502996|516834671|FG000|Overall Study|Adverse Event|2|||
143352225|NCT02500979|516834672|FG000|Period 1|Hyperglycemia|1|||
143352226|NCT02500979|516834673|FG001|Period 1|Hyperglycemia|0|||
143352227|NCT02500979|516834672|FG000|Period 1|Severe non-compliance to protocol|0|||
143352228|NCT02500979|516834673|FG001|Period 1|Severe non-compliance to protocol|1|||
143352229|NCT02500979|516834672|FG000|Period 1|Adverse Event|1|||
143352230|NCT02500979|516834673|FG001|Period 1|Adverse Event|0|||
143352231|NCT02500979|516834672|FG000|Period 1|Subject decision|2|||
143352232|NCT02500979|516834673|FG001|Period 1|Subject decision|0|||
143352233|NCT02500979|516834672|FG000|Period 2|Change in risk|1|||
143352234|NCT02500979|516834673|FG001|Period 2|Change in risk|0|||
143352235|NCT01964521|516834674|FG000|Overall Study|Lost to Follow-up|4|||
143352236|NCT04267614|516834675|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
143352237|NCT04267614|516834675|FG000|Overall Study|Lost to Follow-up|115|||
143352238|NCT02796963|516834676|FG000|Overall Study|Lost to Follow-up|89|||
143352239|NCT02796963|516834677|FG001|Overall Study|Lost to Follow-up|76|||
143352240|NCT02796963|516834678|FG002|Overall Study|Lost to Follow-up|69|||
143125526|NCT05052697|516003728|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
143125527|NCT05052697|516003729|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
143125528|NCT05052697|516003730|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
143125529|NCT05052697|516003731|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
143125530|NCT05052697|516003732|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
143125531|NCT05052697|516003733|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
143125532|NCT05052697|516003734|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
143125533|NCT05052697|516003735|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
143125534|NCT05052697|516003736|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
143125535|NCT05052697|516003737|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
143125536|NCT05052697|516003738|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
143125537|NCT05052697|516003739|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
143352241|NCT02796963|516834679|FG003|Overall Study|Lost to Follow-up|72|||
143352242|NCT00988351|516834681|FG000|Overall Study|Withdrawal by Subject|8|||
143352243|NCT00988351|516834682|FG001|Overall Study|Withdrawal by Subject|0|||
143352244|NCT00988351|516834681|FG000|Overall Study|Lost to Follow-up|6|||
143352245|NCT00988351|516834682|FG001|Overall Study|Lost to Follow-up|9|||
143125538|NCT05052697|516003740|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
143125539|NCT05052697|516003741|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
143352246|NCT00988351|516834681|FG000|Overall Study|not using CPAP|5|||
143352247|NCT00988351|516834682|FG001|Overall Study|not using CPAP|3|||
143352248|NCT01794117|516834693|FG000|Overall Study|Adverse Event|1|||
143352249|NCT01794117|516834694|FG001|Overall Study|Adverse Event|0|||
143352250|NCT01794117|516834695|FG002|Overall Study|Adverse Event|0|||
143125540|NCT05052697|516003708|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
143352251|NCT01794117|516834696|FG003|Overall Study|Adverse Event|0|||
143352252|NCT01794117|516834693|FG000|Overall Study|Participant noncompliance|0|||
143352253|NCT01794117|516834694|FG001|Overall Study|Participant noncompliance|1|||
143352254|NCT01794117|516834695|FG002|Overall Study|Participant noncompliance|0|||
143352255|NCT01794117|516834696|FG003|Overall Study|Participant noncompliance|0|||
143352256|NCT01794117|516834693|FG000|Overall Study|Refused further treatment|0|||
143352257|NCT01794117|516834694|FG001|Overall Study|Refused further treatment|2|||
143352258|NCT01794117|516834695|FG002|Overall Study|Refused further treatment|0|||
143352259|NCT01794117|516834696|FG003|Overall Study|Refused further treatment|0|||
143352260|NCT02401308|516834698|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
143352261|NCT02401308|516834699|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
143352262|NCT00147225|516834700|FG000|Overall Study|Withdrawal by Subject|1|||
143352263|NCT00147225|516834701|FG001|Overall Study|Withdrawal by Subject|0|||
143352264|NCT00147225|516834702|FG002|Overall Study|Withdrawal by Subject|1|||
143352265|NCT00147225|516834703|FG003|Overall Study|Withdrawal by Subject|0|||
143352266|NCT00147225|516834704|FG004|Overall Study|Withdrawal by Subject|0|||
143352267|NCT00147225|516834705|FG005|Overall Study|Withdrawal by Subject|1|||
143352268|NCT00147225|516834700|FG000|Overall Study|Adverse Event|0|||
143352269|NCT00147225|516834701|FG001|Overall Study|Adverse Event|0|||
143352270|NCT00147225|516834702|FG002|Overall Study|Adverse Event|1|||
143352271|NCT00147225|516834703|FG003|Overall Study|Adverse Event|1|||
143352272|NCT00147225|516834704|FG004|Overall Study|Adverse Event|0|||
143352273|NCT00147225|516834705|FG005|Overall Study|Adverse Event|0|||
143352274|NCT00147225|516834700|FG000|Overall Study|Screen Failure|0|||
143352275|NCT00147225|516834701|FG001|Overall Study|Screen Failure|0|||
143352276|NCT00147225|516834702|FG002|Overall Study|Screen Failure|0|||
143352277|NCT00147225|516834703|FG003|Overall Study|Screen Failure|0|||
143352278|NCT00147225|516834704|FG004|Overall Study|Screen Failure|1|||
143352279|NCT00147225|516834705|FG005|Overall Study|Screen Failure|0|||
143352280|NCT00147225|516834700|FG000|Overall Study|Chemotherapy Changed|0|||
143352281|NCT00147225|516834701|FG001|Overall Study|Chemotherapy Changed|0|||
143352282|NCT00147225|516834702|FG002|Overall Study|Chemotherapy Changed|0|||
143352283|NCT00147225|516834703|FG003|Overall Study|Chemotherapy Changed|0|||
143352284|NCT00147225|516834704|FG004|Overall Study|Chemotherapy Changed|0|||
143352285|NCT00147225|516834705|FG005|Overall Study|Chemotherapy Changed|1|||
143352286|NCT02998021|516834706|FG000|Overall Study|Withdrawal by Subject|3|||
143352287|NCT02998021|516834707|FG001|Overall Study|Withdrawal by Subject|1|||
143352288|NCT02998021|516834706|FG000|Overall Study|unsafe home|0|||
143352289|NCT02998021|516834707|FG001|Overall Study|unsafe home|1|||
143352290|NCT00514046|516834708|FG000|Overall Study|transferred to another protocol|2|||
143352291|NCT00514046|516834709|FG001|Overall Study|transferred to another protocol|1|||
143352292|NCT00514046|516834710|FG002|Overall Study|transferred to another protocol|3|||
143352293|NCT00514046|516834711|FG003|Overall Study|transferred to another protocol|0|||
143352294|NCT00514046|516834712|FG004|Overall Study|transferred to another protocol|1|||
143352295|NCT00514046|516834713|FG005|Overall Study|transferred to another protocol|0|||
143352296|NCT00514046|516834714|FG006|Overall Study|transferred to another protocol|0|||
143352297|NCT00514046|516834715|FG007|Overall Study|transferred to another protocol|0|||
143352298|NCT00514046|516834716|FG008|Overall Study|transferred to another protocol|0|||
143352299|NCT00514046|516834708|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
143352300|NCT00514046|516834709|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
143352301|NCT00514046|516834710|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
143352302|NCT00514046|516834711|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
143352303|NCT00514046|516834712|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
143352304|NCT00514046|516834713|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
143352305|NCT00514046|516834714|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
143352306|NCT00514046|516834715|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
143352307|NCT00514046|516834716|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
143352308|NCT00514046|516834708|FG000|Overall Study|Disease progression on study|0|||
143352309|NCT00514046|516834709|FG001|Overall Study|Disease progression on study|0|||
143352310|NCT00514046|516834710|FG002|Overall Study|Disease progression on study|2|||
143352311|NCT00514046|516834711|FG003|Overall Study|Disease progression on study|0|||
143352312|NCT00514046|516834712|FG004|Overall Study|Disease progression on study|0|||
143352313|NCT00514046|516834713|FG005|Overall Study|Disease progression on study|1|||
143352314|NCT00514046|516834714|FG006|Overall Study|Disease progression on study|0|||
143352315|NCT00514046|516834715|FG007|Overall Study|Disease progression on study|0|||
143352316|NCT00514046|516834716|FG008|Overall Study|Disease progression on study|0|||
143352317|NCT00655551|516834717|FG000|All Periods Combined|Adverse Event|0|||
143352318|NCT00655551|516834718|FG001|All Periods Combined|Adverse Event|3|||
143352319|NCT00655551|516834719|FG002|All Periods Combined|Adverse Event|4|||
143352320|NCT00655551|516834717|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
143352321|NCT00655551|516834718|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
143352322|NCT00655551|516834719|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
143352323|NCT00655551|516834717|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
143352324|NCT00655551|516834718|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
143352325|NCT00655551|516834719|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
143352326|NCT00655551|516834717|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
143352327|NCT00655551|516834718|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
143352328|NCT00655551|516834719|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
143352329|NCT01734434|516834720|FG000|Overall Study|Death Infant|3|||
143352330|NCT01734434|516834721|FG001|Overall Study|Death Infant|1|||
143352331|NCT01734434|516834722|FG002|Overall Study|Death Infant|17|||
143352332|NCT01734434|516834723|FG003|Overall Study|Death Infant|5|||
143352333|NCT01734434|516834720|FG000|Overall Study|Lost to Follow-up|2|||
143352334|NCT01734434|516834721|FG001|Overall Study|Lost to Follow-up|9|||
143352335|NCT01734434|516834722|FG002|Overall Study|Lost to Follow-up|67|||
143352336|NCT01734434|516834723|FG003|Overall Study|Lost to Follow-up|11|||
143352337|NCT01734434|516834720|FG000|Overall Study|No Live Birth|1|||
143352338|NCT01734434|516834721|FG001|Overall Study|No Live Birth|2|||
143352339|NCT01734434|516834722|FG002|Overall Study|No Live Birth|32|||
143352340|NCT01734434|516834723|FG003|Overall Study|No Live Birth|6|||
143352341|NCT01734434|516834720|FG000|Overall Study|Withdrawal by Subject|4|||
143352342|NCT01734434|516834721|FG001|Overall Study|Withdrawal by Subject|0|||
143352343|NCT01734434|516834722|FG002|Overall Study|Withdrawal by Subject|8|||
143352344|NCT01734434|516834723|FG003|Overall Study|Withdrawal by Subject|1|||
143352345|NCT01734434|516834720|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
143352346|NCT01734434|516834721|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
143352347|NCT01734434|516834722|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
143352348|NCT01734434|516834723|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
143352349|NCT01734434|516834720|FG000|Overall Study|Subject Not Reachable|0|||
143352350|NCT01734434|516834721|FG001|Overall Study|Subject Not Reachable|0|||
143352351|NCT01734434|516834722|FG002|Overall Study|Subject Not Reachable|1|||
143352352|NCT01734434|516834723|FG003|Overall Study|Subject Not Reachable|0|||
143352353|NCT01734434|516834720|FG000|Overall Study|Treatment Defaulter|0|||
143352354|NCT01734434|516834721|FG001|Overall Study|Treatment Defaulter|0|||
143352355|NCT01734434|516834722|FG002|Overall Study|Treatment Defaulter|1|||
143352356|NCT01734434|516834723|FG003|Overall Study|Treatment Defaulter|0|||
143352357|NCT01734434|516834720|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
143352358|NCT01734434|516834721|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
143352359|NCT01734434|516834722|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
143352360|NCT01734434|516834723|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
143352361|NCT01734434|516834720|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
143352362|NCT01734434|516834721|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
143352363|NCT01734434|516834722|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
143352364|NCT01734434|516834723|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
143352365|NCT01567865|516834724|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
143352366|NCT01567865|516834725|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
143352367|NCT01567865|516834726|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
143352368|NCT01567865|516834727|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
143352369|NCT01567865|516834724|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
143352370|NCT01567865|516834725|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
143352371|NCT01567865|516834726|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
143352372|NCT01567865|516834727|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
143012193|NCT03901352|515583565|FG001|Double-blind Phase|Lack of Efficacy|1|||
143012194|NCT03901352|515583564|FG000|Double-blind Phase|Protocol Violation|0|||
143012195|NCT03901352|515583565|FG001|Double-blind Phase|Protocol Violation|1|||
143012196|NCT03901352|515583564|FG000|Double-blind Phase|Withdrawal by Subject|10|||
143012197|NCT03901352|515583565|FG001|Double-blind Phase|Withdrawal by Subject|8|||
143012198|NCT03901352|515583564|FG000|Open-label Extension Phase|Adverse Event|24|||
143012199|NCT03901352|515583565|FG001|Open-label Extension Phase|Adverse Event|0|||
143012200|NCT03901352|515583564|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
143012201|NCT03901352|515583565|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
143012202|NCT03901352|515583564|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
143012203|NCT03901352|515583565|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
143012204|NCT03901352|515583564|FG000|Open-label Extension Phase|Other|1|||
143012205|NCT03901352|515583565|FG001|Open-label Extension Phase|Other|0|||
143012206|NCT03069365|515583566|FG000|Overall Study|Adverse Event|1|||
143012207|NCT01826201|515583567|FG000|Overall Study|Non compliance with protocol|4|||
143125541|NCT05052697|516003709|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
143125542|NCT05052697|516003710|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
143125543|NCT05052697|516003711|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
143352373|NCT00127413|516834728|FG000|Overall Study|Lost to Follow-up|6|||
143352374|NCT00127413|516834729|FG001|Overall Study|Lost to Follow-up|4|||
143352375|NCT00127413|516834730|FG002|Overall Study|Lost to Follow-up|8|||
143352376|NCT00127413|516834731|FG003|Overall Study|Lost to Follow-up|2|||
143012208|NCT01615822|515583568|FG000|Period 1|Withdrawal by Subject|0|||
143012209|NCT01615822|515583569|FG001|Period 1|Withdrawal by Subject|1|||
143125544|NCT05052697|516003712|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
143012210|NCT01615822|515583570|FG002|Period 1|Withdrawal by Subject|0|||
143012211|NCT01615822|515583568|FG000|Period 1|Adverse Event|1|||
143352377|NCT02023879|516834732|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
143352378|NCT02023879|516834733|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
143352379|NCT02023879|516834734|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
143352380|NCT02023879|516834732|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
143352381|NCT02023879|516834733|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
143352382|NCT02023879|516834734|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
143352383|NCT02023879|516834732|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
143352384|NCT02023879|516834733|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
143352385|NCT02023879|516834734|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
143352386|NCT02023879|516834732|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
143352387|NCT02023879|516834733|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
143352388|NCT02023879|516834734|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
143352389|NCT02023879|516834732|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
143352390|NCT02023879|516834733|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
143352391|NCT02023879|516834734|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
143352392|NCT02023879|516834732|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
143352393|NCT02023879|516834733|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
143352394|NCT02023879|516834734|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
143352395|NCT02023879|516834732|FG000|Extension Open Label Treatment|Adverse Event|1|||
143352396|NCT02023879|516834733|FG001|Extension Open Label Treatment|Adverse Event|7|||
143352397|NCT02023879|516834734|FG002|Extension Open Label Treatment|Adverse Event|3|||
143352398|NCT02023879|516834732|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
143352399|NCT02023879|516834733|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
143352400|NCT02023879|516834734|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
143352401|NCT02023879|516834732|FG000|Extension Open Label Treatment|Participant moved|1|||
143352402|NCT02023879|516834733|FG001|Extension Open Label Treatment|Participant moved|2|||
143352403|NCT02023879|516834734|FG002|Extension Open Label Treatment|Participant moved|0|||
143352404|NCT02023879|516834732|FG000|Extension Open Label Treatment|Other than specified above|2|||
143352405|NCT02023879|516834733|FG001|Extension Open Label Treatment|Other than specified above|7|||
143352406|NCT02023879|516834734|FG002|Extension Open Label Treatment|Other than specified above|2|||
143352407|NCT01040780|516836506|FG000|Overall Study|Protocol Violation|1|||
143352408|NCT01040780|516836507|FG001|Overall Study|Protocol Violation|3|||
143352409|NCT03864926|516836510|FG000|Overall Study|Death|0|||
143352410|NCT03864926|516836511|FG001|Overall Study|Death|2|||
143352411|NCT00445601|516836512|FG000|Overall Study|Withdrawal by Subject|11|||
143352412|NCT00445601|516836513|FG001|Overall Study|Withdrawal by Subject|11|||
143352413|NCT00445601|516836512|FG000|Overall Study|TURBT Complication|12|||
143352414|NCT00445601|516836513|FG001|Overall Study|TURBT Complication|8|||
143352415|NCT00445601|516836512|FG000|Overall Study|Incorrect Disease Status|6|||
143352416|NCT00445601|516836513|FG001|Overall Study|Incorrect Disease Status|6|||
143352417|NCT00445601|516836512|FG000|Overall Study|Drug Delivery Issue|2|||
143352418|NCT00445601|516836513|FG001|Overall Study|Drug Delivery Issue|2|||
143352419|NCT00445601|516836512|FG000|Overall Study|Adverse Event|2|||
143352420|NCT00445601|516836513|FG001|Overall Study|Adverse Event|0|||
143352421|NCT00445601|516836512|FG000|Overall Study|Death prior to TURBT|0|||
143352422|NCT00445601|516836513|FG001|Overall Study|Death prior to TURBT|1|||
143352423|NCT01091428|516836514|FG000|Phase 1|Progressive Disease|24|||
143352424|NCT01091428|516836515|FG001|Phase 1|Progressive Disease|8|||
143352425|NCT01091428|516836516|FG002|Phase 1|Progressive Disease|0|||
143352426|NCT01091428|516836517|FG003|Phase 1|Progressive Disease|0|||
143352427|NCT01091428|516836514|FG000|Phase 1|Symptomatic Deterioration|3|||
143352428|NCT01091428|516836515|FG001|Phase 1|Symptomatic Deterioration|2|||
143352429|NCT01091428|516836516|FG002|Phase 1|Symptomatic Deterioration|0|||
143352430|NCT01091428|516836517|FG003|Phase 1|Symptomatic Deterioration|0|||
143012212|NCT01615822|515583569|FG001|Period 1|Adverse Event|1|||
143012213|NCT01615822|515583570|FG002|Period 1|Adverse Event|0|||
143012214|NCT01615822|515583568|FG000|Period 2|Lost to Follow-up|0|||
143012215|NCT01615822|515583569|FG001|Period 2|Lost to Follow-up|1|||
143012216|NCT01615822|515583570|FG002|Period 2|Lost to Follow-up|2|||
143012217|NCT03981614|515583571|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
143012218|NCT03981614|515583572|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
143012219|NCT03981614|515583573|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
143352431|NCT01091428|516836514|FG000|Phase 1|Adverse Event|2|||
143352432|NCT01091428|516836515|FG001|Phase 1|Adverse Event|0|||
143352433|NCT01091428|516836516|FG002|Phase 1|Adverse Event|0|||
143352434|NCT01091428|516836517|FG003|Phase 1|Adverse Event|0|||
143012220|NCT03901339|515583574|FG000|Overall Study|Death|220|||
143352435|NCT01091428|516836514|FG000|Phase 1|Withdrawal by Subject|7|||
143352436|NCT01091428|516836515|FG001|Phase 1|Withdrawal by Subject|0|||
143352437|NCT01091428|516836516|FG002|Phase 1|Withdrawal by Subject|0|||
143352438|NCT01091428|516836517|FG003|Phase 1|Withdrawal by Subject|0|||
143352439|NCT01091428|516836514|FG000|Phase 1|Reason not specified|0|||
143352440|NCT01091428|516836515|FG001|Phase 1|Reason not specified|1|||
143352441|NCT01091428|516836516|FG002|Phase 1|Reason not specified|0|||
143352442|NCT01091428|516836517|FG003|Phase 1|Reason not specified|0|||
143352443|NCT01091428|516836514|FG000|Phase 1|Single-Patient IND|2|||
143352444|NCT01091428|516836515|FG001|Phase 1|Single-Patient IND|0|||
143352445|NCT01091428|516836516|FG002|Phase 1|Single-Patient IND|0|||
143352446|NCT01091428|516836517|FG003|Phase 1|Single-Patient IND|0|||
143352447|NCT01091428|516836514|FG000|Phase 2|Progressive Disease|0|||
143352448|NCT01091428|516836515|FG001|Phase 2|Progressive Disease|0|||
143352449|NCT01091428|516836516|FG002|Phase 2|Progressive Disease|44|||
143352450|NCT01091428|516836517|FG003|Phase 2|Progressive Disease|46|||
143352451|NCT01091428|516836514|FG000|Phase 2|Symptomatic Deterioration|0|||
143352452|NCT01091428|516836515|FG001|Phase 2|Symptomatic Deterioration|0|||
143352453|NCT01091428|516836516|FG002|Phase 2|Symptomatic Deterioration|1|||
143352454|NCT01091428|516836517|FG003|Phase 2|Symptomatic Deterioration|6|||
143352455|NCT01091428|516836514|FG000|Phase 2|Adverse Event|0|||
143352456|NCT01091428|516836515|FG001|Phase 2|Adverse Event|0|||
143352457|NCT01091428|516836516|FG002|Phase 2|Adverse Event|12|||
143352458|NCT01091428|516836517|FG003|Phase 2|Adverse Event|5|||
143352459|NCT01091428|516836514|FG000|Phase 2|Withdrawal by Subject|0|||
143352460|NCT01091428|516836515|FG001|Phase 2|Withdrawal by Subject|0|||
143352461|NCT01091428|516836516|FG002|Phase 2|Withdrawal by Subject|9|||
143352462|NCT01091428|516836517|FG003|Phase 2|Withdrawal by Subject|8|||
143352463|NCT01091428|516836514|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
143352464|NCT01091428|516836515|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
143352465|NCT01091428|516836516|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
143352466|NCT01091428|516836517|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
143352467|NCT01091428|516836514|FG000|Phase 2|Reason not specified|0|||
143352468|NCT01091428|516836515|FG001|Phase 2|Reason not specified|0|||
143352469|NCT01091428|516836516|FG002|Phase 2|Reason not specified|4|||
143352470|NCT01091428|516836517|FG003|Phase 2|Reason not specified|3|||
143352471|NCT01091428|516836514|FG000|Phase 2|Physician Decision|0|||
143352472|NCT01091428|516836515|FG001|Phase 2|Physician Decision|0|||
143352473|NCT01091428|516836516|FG002|Phase 2|Physician Decision|2|||
143352474|NCT01091428|516836517|FG003|Phase 2|Physician Decision|0|||
143352475|NCT02391038|516836524|FG000|Overall Study|Progressive disease|3|||
143352476|NCT02391038|516836525|FG001|Overall Study|Progressive disease|3|||
143352477|NCT02391038|516836526|FG002|Overall Study|Progressive disease|6|||
143352478|NCT02959138|516836527|FG000|Overall Study|Enrolled but Never Treated|0|||
143352479|NCT02959138|516836528|FG001|Overall Study|Enrolled but Never Treated|1|||
143352480|NCT02959138|516836529|FG002|Overall Study|Enrolled but Never Treated|0|||
143352481|NCT04213989|516836535|FG000|Overall Study|Withdrawal by Subject|3|||
143352482|NCT04213989|516836536|FG001|Overall Study|Withdrawal by Subject|2|||
143352483|NCT04213989|516836535|FG000|Overall Study|Physician Decision|1|||
143352484|NCT04213989|516836536|FG001|Overall Study|Physician Decision|0|||
143352485|NCT04213989|516836535|FG000|Overall Study|Lost to Follow-up|0|||
143352486|NCT04213989|516836536|FG001|Overall Study|Lost to Follow-up|4|||
143352487|NCT01327547|516836537|FG000|Overall Study|Adverse Event|4|||
143352488|NCT01327547|516836538|FG001|Overall Study|Adverse Event|1|||
143352489|NCT01327547|516836537|FG000|Overall Study|Death|1|||
143352490|NCT01327547|516836538|FG001|Overall Study|Death|2|||
143352491|NCT01327547|516836537|FG000|Overall Study|Lost to Follow-up|6|||
143352492|NCT01327547|516836538|FG001|Overall Study|Lost to Follow-up|6|||
143352493|NCT01327547|516836537|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
143352494|NCT01327547|516836538|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
143352495|NCT01327547|516836537|FG000|Overall Study|Withdrawal by Subject|3|||
143352496|NCT01327547|516836538|FG001|Overall Study|Withdrawal by Subject|7|||
143352497|NCT01327547|516836537|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
143352498|NCT01327547|516836538|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
143352499|NCT01327547|516836537|FG000|Overall Study|Protocol Violation|1|||
143352500|NCT01327547|516836538|FG001|Overall Study|Protocol Violation|0|||
143352501|NCT01327547|516836537|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
143352502|NCT01327547|516836538|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
143352503|NCT01327547|516836537|FG000|Overall Study|Required prohibited medication|2|||
143352504|NCT01327547|516836538|FG001|Overall Study|Required prohibited medication|0|||
143352505|NCT01327547|516836537|FG000|Overall Study|Non-compliance with study procedures|1|||
143352506|NCT01327547|516836538|FG001|Overall Study|Non-compliance with study procedures|0|||
143352507|NCT01327547|516836537|FG000|Overall Study|By investigator in subject's interest|0|||
143352508|NCT01327547|516836538|FG001|Overall Study|By investigator in subject's interest|1|||
143352509|NCT00329719|516836539|FG000|Overall Study|Lost to Follow-up|0|||
143352510|NCT00329719|516836540|FG001|Overall Study|Lost to Follow-up|0|||
143352511|NCT00329719|516836541|FG002|Overall Study|Lost to Follow-up|0|||
143352512|NCT00329719|516836542|FG003|Overall Study|Lost to Follow-up|1|||
143352513|NCT03918239|516836546|FG000|Overall Study|Lost to Follow-up|3|||
143352514|NCT03918239|516836547|FG001|Overall Study|Lost to Follow-up|1|||
143352515|NCT03918239|516836546|FG000|Overall Study|Pregnancy|0|||
143352516|NCT03918239|516836547|FG001|Overall Study|Pregnancy|2|||
143352517|NCT03918239|516836546|FG000|Overall Study|Withdrawal by Subject|3|||
143352518|NCT03918239|516836547|FG001|Overall Study|Withdrawal by Subject|3|||
143352519|NCT03918239|516836546|FG000|Overall Study|positive urine drug screening results|4|||
143352520|NCT03918239|516836547|FG001|Overall Study|positive urine drug screening results|1|||
143352521|NCT03390036|516836550|FG000|Overall Study|Lost to Follow-up|1|||
143352522|NCT03390036|516836551|FG001|Overall Study|Lost to Follow-up|0|||
143352523|NCT03390036|516836552|FG002|Overall Study|Lost to Follow-up|0|||
143352524|NCT03390036|516836550|FG000|Overall Study|Lack of Efficacy|1|||
143352525|NCT03390036|516836551|FG001|Overall Study|Lack of Efficacy|0|||
143352526|NCT03390036|516836552|FG002|Overall Study|Lack of Efficacy|0|||
143352527|NCT01984424|516836555|FG000|Overall Study|Withdrawal by Subject|3|||
143352528|NCT01984424|516836556|FG001|Overall Study|Withdrawal by Subject|5|||
143352529|NCT01984424|516836555|FG000|Overall Study|Sponsor Decision|0|||
143352530|NCT01984424|516836556|FG001|Overall Study|Sponsor Decision|1|||
143352531|NCT01984424|516836555|FG000|Overall Study|Lost to Follow-up|0|||
143352532|NCT01984424|516836556|FG001|Overall Study|Lost to Follow-up|1|||
143352533|NCT01702428|516836559|FG000|Overall Study|Adverse Event|2|||
143352534|NCT01702428|516836560|FG001|Overall Study|Adverse Event|0|||
143352535|NCT01702428|516836561|FG002|Overall Study|Adverse Event|0|||
143352536|NCT01702428|516836562|FG003|Overall Study|Adverse Event|0|||
143352537|NCT01702428|516836559|FG000|Overall Study|Lost to Follow-up|33|||
143352538|NCT01702428|516836560|FG001|Overall Study|Lost to Follow-up|41|||
143352539|NCT01702428|516836561|FG002|Overall Study|Lost to Follow-up|37|||
143352540|NCT01702428|516836562|FG003|Overall Study|Lost to Follow-up|44|||
143352541|NCT01702428|516836559|FG000|Overall Study|Parents cannot assist to site|1|||
143352542|NCT01702428|516836560|FG001|Overall Study|Parents cannot assist to site|0|||
143352543|NCT01702428|516836561|FG002|Overall Study|Parents cannot assist to site|1|||
143352544|NCT01702428|516836562|FG003|Overall Study|Parents cannot assist to site|0|||
143352545|NCT01702428|516836559|FG000|Overall Study|Lost Coverage|0|||
143352546|NCT01702428|516836560|FG001|Overall Study|Lost Coverage|0|||
143352547|NCT01702428|516836561|FG002|Overall Study|Lost Coverage|0|||
143352548|NCT01702428|516836562|FG003|Overall Study|Lost Coverage|1|||
143352549|NCT01702428|516836559|FG000|Overall Study|Lost Health Plan|3|||
143352550|NCT01702428|516836560|FG001|Overall Study|Lost Health Plan|5|||
143352551|NCT01702428|516836561|FG002|Overall Study|Lost Health Plan|0|||
143352552|NCT01702428|516836562|FG003|Overall Study|Lost Health Plan|2|||
143352553|NCT01702428|516836559|FG000|Overall Study|Mother transferred care|0|||
143352554|NCT01702428|516836560|FG001|Overall Study|Mother transferred care|1|||
143352555|NCT01702428|516836561|FG002|Overall Study|Mother transferred care|0|||
143352556|NCT01702428|516836562|FG003|Overall Study|Mother transferred care|0|||
143352557|NCT01702428|516836559|FG000|Overall Study|Parents too busy|1|||
143352558|NCT01702428|516836560|FG001|Overall Study|Parents too busy|0|||
143352559|NCT01702428|516836561|FG002|Overall Study|Parents too busy|0|||
143352560|NCT01702428|516836562|FG003|Overall Study|Parents too busy|0|||
143352561|NCT01702428|516836559|FG000|Overall Study|Protocol Violation|3|||
143352562|NCT01702428|516836560|FG001|Overall Study|Protocol Violation|0|||
143352563|NCT01702428|516836561|FG002|Overall Study|Protocol Violation|1|||
143352564|NCT01702428|516836562|FG003|Overall Study|Protocol Violation|0|||
143352565|NCT01702428|516836559|FG000|Overall Study|Withdrawal by Subject|21|||
143352566|NCT01702428|516836560|FG001|Overall Study|Withdrawal by Subject|23|||
143352567|NCT01702428|516836561|FG002|Overall Study|Withdrawal by Subject|14|||
143352568|NCT01702428|516836562|FG003|Overall Study|Withdrawal by Subject|10|||
143352569|NCT01533714|516836563|FG000|Overall Study|Adverse Event|0|||
143352570|NCT01533714|516836564|FG001|Overall Study|Adverse Event|1|||
143352571|NCT01533714|516836565|FG002|Overall Study|Adverse Event|2|||
143352572|NCT01533714|516836566|FG003|Overall Study|Adverse Event|2|||
143352573|NCT01533714|516836567|FG004|Overall Study|Adverse Event|2|||
143352574|NCT01533714|516836568|FG005|Overall Study|Adverse Event|1|||
143461530|NCT04025580|517235065|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
143461531|NCT04025580|517235066|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
143461532|NCT04025580|517235067|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
143461533|NCT01249274|517235073|FG000|Overall Study|Lost to Follow-up|3|||
143461534|NCT01249274|517235074|FG001|Overall Study|Lost to Follow-up|4|||
143461535|NCT01249274|517235073|FG000|Overall Study|Received inpatient substance treatment|1|||
143461536|NCT01249274|517235074|FG001|Overall Study|Received inpatient substance treatment|2|||
143461537|NCT01000636|517235075|FG000|Overall Study|Withdrawal by Subject|1|||
143461538|NCT01000636|517235075|FG000|Overall Study|Adverse Event|1|||
143012221|NCT03901339|515583575|FG001|Overall Study|Death|192|||
143352575|NCT01533714|516836563|FG000|Overall Study|Lack of Efficacy|0|||
143461539|NCT00138671|517235076|FG000|Overall Study|Death|0|||
143461540|NCT00138671|517235077|FG001|Overall Study|Death|3|||
143461541|NCT00138671|517235076|FG000|Overall Study|Adverse Event|6|||
143012222|NCT03901339|515583574|FG000|Overall Study|Informed consent withdrawn|13|||
143352576|NCT01533714|516836564|FG001|Overall Study|Lack of Efficacy|0|||
143352577|NCT01533714|516836565|FG002|Overall Study|Lack of Efficacy|0|||
143352578|NCT01533714|516836566|FG003|Overall Study|Lack of Efficacy|0|||
143352579|NCT01533714|516836567|FG004|Overall Study|Lack of Efficacy|0|||
143352580|NCT01533714|516836568|FG005|Overall Study|Lack of Efficacy|1|||
143352581|NCT01533714|516836563|FG000|Overall Study|Withdrawal by Subject|0|||
143352582|NCT01533714|516836564|FG001|Overall Study|Withdrawal by Subject|1|||
143352583|NCT01533714|516836565|FG002|Overall Study|Withdrawal by Subject|0|||
143352584|NCT01533714|516836566|FG003|Overall Study|Withdrawal by Subject|1|||
143352585|NCT01533714|516836567|FG004|Overall Study|Withdrawal by Subject|1|||
143352586|NCT01533714|516836568|FG005|Overall Study|Withdrawal by Subject|0|||
143352587|NCT01533714|516836563|FG000|Overall Study|Exclusion criteria|0|||
143352588|NCT01533714|516836564|FG001|Overall Study|Exclusion criteria|1|||
143352589|NCT01533714|516836565|FG002|Overall Study|Exclusion criteria|0|||
143352590|NCT01533714|516836566|FG003|Overall Study|Exclusion criteria|0|||
143352591|NCT01533714|516836567|FG004|Overall Study|Exclusion criteria|0|||
143352592|NCT01533714|516836568|FG005|Overall Study|Exclusion criteria|0|||
143352593|NCT01533714|516836563|FG000|Overall Study|Positive for purified protein derivative|0|||
143352594|NCT01533714|516836564|FG001|Overall Study|Positive for purified protein derivative|0|||
143352595|NCT01533714|516836565|FG002|Overall Study|Positive for purified protein derivative|1|||
143352596|NCT01533714|516836566|FG003|Overall Study|Positive for purified protein derivative|0|||
143352597|NCT01533714|516836567|FG004|Overall Study|Positive for purified protein derivative|1|||
143352598|NCT01533714|516836568|FG005|Overall Study|Positive for purified protein derivative|0|||
143352599|NCT01533714|516836563|FG000|Overall Study|Withdrawal criteria|0|||
143352600|NCT01533714|516836564|FG001|Overall Study|Withdrawal criteria|0|||
143352601|NCT01533714|516836565|FG002|Overall Study|Withdrawal criteria|1|||
143352602|NCT01533714|516836566|FG003|Overall Study|Withdrawal criteria|0|||
143352603|NCT01533714|516836567|FG004|Overall Study|Withdrawal criteria|3|||
143352604|NCT01533714|516836568|FG005|Overall Study|Withdrawal criteria|1|||
143352605|NCT01533714|516836563|FG000|Overall Study|Ineligibility reason|0|||
143352606|NCT01533714|516836564|FG001|Overall Study|Ineligibility reason|0|||
143352607|NCT01533714|516836565|FG002|Overall Study|Ineligibility reason|0|||
143352608|NCT01533714|516836566|FG003|Overall Study|Ineligibility reason|1|||
143352609|NCT01533714|516836567|FG004|Overall Study|Ineligibility reason|0|||
143352610|NCT01533714|516836568|FG005|Overall Study|Ineligibility reason|0|||
143352611|NCT04012814|516836569|FG000|Overall Study|Lost to Follow-up|4|||
143352612|NCT04012814|516836569|FG000|Overall Study|Withdrawal by Subject|2|||
143352613|NCT04012814|516836569|FG000|Overall Study|Protocol Violation|1|||
143352614|NCT04012814|516836569|FG000|Overall Study|Adverse Event|1|||
143352615|NCT04397523|516836570|FG000|Overall Study|Lost to Follow-up|3|||
143352616|NCT04397523|516836570|FG000|Overall Study|Transfer from/to other hospital|8|||
143352617|NCT02111213|516836574|FG000|Overall Study|Withdrawal by Subject|3|||
143352618|NCT02111213|516836575|FG001|Overall Study|Withdrawal by Subject|2|||
143352619|NCT02111213|516836574|FG000|Overall Study|Lost to Follow-up|3|||
143352620|NCT02111213|516836575|FG001|Overall Study|Lost to Follow-up|4|||
143352621|NCT02226172|516836578|FG000|Overall Study|Participant refused further follow-up|4|||
143352622|NCT02226172|516836578|FG000|Overall Study|Other|5|||
143352623|NCT02226172|516836578|FG000|Overall Study|Death|1|||
143352624|NCT02226172|516836578|FG000|Overall Study|Study terminated by sponsor|1|||
143352625|NCT02226172|516836578|FG000|Overall Study|Adverse Event|6|||
143352626|NCT02153359|516836581|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
143352627|NCT02153359|516836582|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
143352628|NCT04422639|516836583|FG000|Overall Study|Death|1|||
143352629|NCT04422639|516836584|FG001|Overall Study|Death|0|||
143352630|NCT04422639|516836583|FG000|Overall Study|study closed prior to completion of FU visits|0|||
143352631|NCT04422639|516836584|FG001|Overall Study|study closed prior to completion of FU visits|2|||
143352632|NCT01551303|516836590|FG000|Overall Study|failed awareness check on vision test|4|||
143352633|NCT01551303|516836591|FG001|Overall Study|failed awareness check on vision test|7|||
143352634|NCT02878213|516836592|FG000|Overall Study|Withdrawal by Subject|2|||
143352635|NCT02878213|516836592|FG000|Overall Study|Adverse Event|1|||
143352636|NCT02471404|516836598|FG000|Overall Study|Adverse Event|7|||
143352637|NCT02471404|516836599|FG001|Overall Study|Adverse Event|1|||
143352638|NCT02471404|516836600|FG002|Overall Study|Adverse Event|2|||
143352639|NCT02471404|516836598|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
143352640|NCT02471404|516836599|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
143352641|NCT02471404|516836600|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
143352642|NCT02471404|516836598|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
143352643|NCT02471404|516836599|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
143352644|NCT02471404|516836600|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
143352645|NCT02471404|516836598|FG000|Overall Study|Lost to Follow-up|1|||
143352646|NCT02471404|516836599|FG001|Overall Study|Lost to Follow-up|1|||
143352647|NCT02471404|516836600|FG002|Overall Study|Lost to Follow-up|3|||
143352648|NCT02471404|516836598|FG000|Overall Study|Protocol Violation|1|||
143352649|NCT02471404|516836599|FG001|Overall Study|Protocol Violation|0|||
143352650|NCT02471404|516836600|FG002|Overall Study|Protocol Violation|0|||
143352651|NCT02471404|516836598|FG000|Overall Study|Withdrawal by Subject|8|||
143352652|NCT02471404|516836599|FG001|Overall Study|Withdrawal by Subject|4|||
143352653|NCT02471404|516836600|FG002|Overall Study|Withdrawal by Subject|5|||
143012223|NCT03901339|515583575|FG001|Overall Study|Informed consent withdrawn|40|||
143352654|NCT02471404|516836598|FG000|Overall Study|Other reasons not specified|10|||
143352655|NCT02471404|516836599|FG001|Overall Study|Other reasons not specified|7|||
143352656|NCT02471404|516836600|FG002|Overall Study|Other reasons not specified|12|||
143352657|NCT01927731|516836601|FG000|Overall Study|Graft Failure|1|||
143352658|NCT01927731|516836602|FG001|Overall Study|Graft Failure|2|||
143352659|NCT01927731|516836601|FG000|Overall Study|Physician Decision|2|||
143352660|NCT01927731|516836602|FG001|Overall Study|Physician Decision|3|||
143352661|NCT01927731|516836601|FG000|Overall Study|Withdrawal by Subject|0|||
143352662|NCT01927731|516836602|FG001|Overall Study|Withdrawal by Subject|2|||
143352663|NCT01927731|516836601|FG000|Overall Study|Death|0|||
143352664|NCT01927731|516836602|FG001|Overall Study|Death|3|||
143352665|NCT01464255|516836603|FG000|Overall Study|unresolve corneal staining|0|||
143352666|NCT01464255|516836604|FG001|Overall Study|unresolve corneal staining|1|||
143352667|NCT00785538|516836605|FG000|Treatment Period|Adverse Event|1|||
143352668|NCT00785538|516836606|FG001|Treatment Period|Adverse Event|2|||
143352669|NCT00785538|516836607|FG002|Treatment Period|Adverse Event|2|||
143352670|NCT00785538|516836608|FG003|Treatment Period|Adverse Event|0|||
143352671|NCT00785538|516836605|FG000|Treatment Period|Withdrawal by Subject|0|||
143352672|NCT00785538|516836606|FG001|Treatment Period|Withdrawal by Subject|0|||
143352673|NCT00785538|516836607|FG002|Treatment Period|Withdrawal by Subject|0|||
143352674|NCT00785538|516836608|FG003|Treatment Period|Withdrawal by Subject|1|||
143352675|NCT03382600|516836609|FG000|Overall Study|Adverse Event|3|||
143352676|NCT03382600|516836610|FG001|Overall Study|Adverse Event|3|||
143352677|NCT03382600|516836609|FG000|Overall Study|Clinical Disease Progression|2|||
143352678|NCT03382600|516836610|FG001|Overall Study|Clinical Disease Progression|4|||
143352679|NCT03382600|516836609|FG000|Overall Study|Radiological Progression|40|||
143352680|NCT03382600|516836610|FG001|Overall Study|Radiological Progression|31|||
143352681|NCT03382600|516836609|FG000|Overall Study|Withdrawal by Subject|0|||
143352682|NCT03382600|516836610|FG001|Overall Study|Withdrawal by Subject|1|||
143352683|NCT03382600|516836609|FG000|Overall Study|Other|9|||
143352684|NCT03382600|516836610|FG001|Overall Study|Other|7|||
143352685|NCT04276090|516836613|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
143352686|NCT04276090|516836614|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
143352687|NCT04642469|516836615|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
143012224|NCT03901339|515583574|FG000|Overall Study|Sponsor request|30|||
143012225|NCT03901339|515583575|FG001|Overall Study|Sponsor request|23|||
143012226|NCT03901339|515583574|FG000|Overall Study|Reason not specified|5|||
143012227|NCT03901339|515583575|FG001|Overall Study|Reason not specified|7|||
143012228|NCT03901339|515583574|FG000|Overall Study|Lost to Follow-up|4|||
143012229|NCT03901339|515583575|FG001|Overall Study|Lost to Follow-up|7|||
143012230|NCT03901339|515583574|FG000|Overall Study|Covid19|0|||
143012231|NCT03901339|515583575|FG001|Overall Study|Covid19|2|||
143012232|NCT03020966|515583578|FG000|Overall Study|Withdrawal by Subject|2|||
143012233|NCT03020966|515583579|FG001|Overall Study|Withdrawal by Subject|0|||
143012234|NCT02628418|515583585|FG000|Overall Study|Lost to Follow-up|1|||
143012235|NCT02628418|515583586|FG001|Overall Study|Lost to Follow-up|2|||
143012236|NCT01787188|515583587|FG000|Overall Study|Adverse Event|2|||
143012237|NCT01787188|515583588|FG001|Overall Study|Adverse Event|4|||
143012238|NCT01787188|515583589|FG002|Overall Study|Adverse Event|6|||
143012239|NCT01787188|515583587|FG000|Overall Study|Lack of Efficacy|7|||
143012240|NCT01787188|515583588|FG001|Overall Study|Lack of Efficacy|3|||
143012241|NCT01787188|515583589|FG002|Overall Study|Lack of Efficacy|5|||
143012242|NCT01787188|515583587|FG000|Overall Study|Non-compliance with Study Drug|0|||
143012243|NCT01787188|515583588|FG001|Overall Study|Non-compliance with Study Drug|1|||
143012244|NCT01787188|515583589|FG002|Overall Study|Non-compliance with Study Drug|0|||
143012245|NCT01787188|515583587|FG000|Overall Study|Withdrawal by Subject|4|||
143012246|NCT01787188|515583588|FG001|Overall Study|Withdrawal by Subject|3|||
143012247|NCT01787188|515583589|FG002|Overall Study|Withdrawal by Subject|2|||
143012248|NCT01787188|515583587|FG000|Overall Study|Protocol Violation|3|||
143012249|NCT01787188|515583588|FG001|Overall Study|Protocol Violation|2|||
143012250|NCT01787188|515583589|FG002|Overall Study|Protocol Violation|3|||
143012251|NCT01787188|515583587|FG000|Overall Study|Lost to Follow-up|1|||
143352688|NCT04642469|516836616|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
143012252|NCT01787188|515583588|FG001|Overall Study|Lost to Follow-up|2|||
143012253|NCT01787188|515583589|FG002|Overall Study|Lost to Follow-up|2|||
143352689|NCT04642469|516836615|FG000|Overall Study|Death|1|||
143352690|NCT04642469|516836616|FG001|Overall Study|Death|2|||
143352691|NCT04642469|516836615|FG000|Overall Study|Study/site closed following amendment 1|11|||
143352692|NCT04642469|516836616|FG001|Overall Study|Study/site closed following amendment 1|11|||
143012254|NCT01787188|515583587|FG000|Overall Study|Other, including patient moved|0|||
143012255|NCT01787188|515583588|FG001|Overall Study|Other, including patient moved|3|||
143012256|NCT01787188|515583589|FG002|Overall Study|Other, including patient moved|0|||
143012257|NCT05013749|515583592|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
143352693|NCT04642469|516836615|FG000|Overall Study|Other|1|||
143352694|NCT04642469|516836616|FG001|Overall Study|Other|1|||
143125545|NCT05052697|516003713|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
143352695|NCT04642469|516836615|FG000|Overall Study|Withdrawal by Subject|1|||
143461542|NCT00138671|517235077|FG001|Overall Study|Adverse Event|3|||
143352696|NCT04642469|516836616|FG001|Overall Study|Withdrawal by Subject|0|||
143352697|NCT01680458|516836618|FG000|Overall Study|Protocol Violation|3|||
143352698|NCT02302066|516836619|FG000|Overall Study|Adverse Event|1|||
143352699|NCT02302066|516836620|FG001|Overall Study|Adverse Event|1|||
143352700|NCT02302066|516836621|FG002|Overall Study|Adverse Event|3|||
143352701|NCT02302066|516836622|FG003|Overall Study|Adverse Event|0|||
143352702|NCT02302066|516836619|FG000|Overall Study|Lost to Follow-up|4|||
143352703|NCT02302066|516836620|FG001|Overall Study|Lost to Follow-up|5|||
143352704|NCT02302066|516836621|FG002|Overall Study|Lost to Follow-up|24|||
143352705|NCT02302066|516836622|FG003|Overall Study|Lost to Follow-up|7|||
143352706|NCT02302066|516836619|FG000|Overall Study|Withdrawal by Subject|25|||
143352707|NCT02302066|516836620|FG001|Overall Study|Withdrawal by Subject|58|||
143352708|NCT02302066|516836621|FG002|Overall Study|Withdrawal by Subject|124|||
143352709|NCT02302066|516836622|FG003|Overall Study|Withdrawal by Subject|33|||
143352710|NCT02302066|516836619|FG000|Overall Study|Pregnancy|2|||
143352711|NCT02302066|516836620|FG001|Overall Study|Pregnancy|10|||
143352712|NCT02302066|516836621|FG002|Overall Study|Pregnancy|12|||
143352713|NCT02302066|516836622|FG003|Overall Study|Pregnancy|0|||
143352714|NCT02302066|516836619|FG000|Overall Study|Reason Not Specified|1|||
143352715|NCT02302066|516836620|FG001|Overall Study|Reason Not Specified|1|||
143352716|NCT02302066|516836621|FG002|Overall Study|Reason Not Specified|9|||
143352717|NCT02302066|516836622|FG003|Overall Study|Reason Not Specified|1|||
143352718|NCT02180438|516836638|FG000|Overall Study|Lost to Follow-up|1|||
143352719|NCT02058290|516836639|FG000|Overall Study|Protocol Violation|2|||
143352720|NCT02058290|516836640|FG001|Overall Study|Protocol Violation|1|||
143352721|NCT02058290|516836639|FG000|Overall Study|Physician Decision|1|||
143352722|NCT02058290|516836640|FG001|Overall Study|Physician Decision|0|||
143352723|NCT02058290|516836639|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
143352724|NCT02058290|516836640|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
143352725|NCT02058290|516836639|FG000|Overall Study|Withdrawal by Subject|0|||
143352726|NCT02058290|516836640|FG001|Overall Study|Withdrawal by Subject|1|||
143352727|NCT00785707|516836642|FG000|Overall Study|Lost to Follow-up|7|||
143352728|NCT00105586|516836645|FG000|Overall Study|Adverse Event|4|||
143352729|NCT00105586|516836646|FG001|Overall Study|Adverse Event|3|||
143352730|NCT00105586|516836645|FG000|Overall Study|Physician Decision|13|||
143352731|NCT00105586|516836646|FG001|Overall Study|Physician Decision|13|||
143352732|NCT02262260|516836649|FG000|Overall Study|Adverse Event|4|||
143352733|NCT02262260|516836650|FG001|Overall Study|Adverse Event|1|||
143352734|NCT02262260|516836649|FG000|Overall Study|Withdrawal of consent|4|||
143352735|NCT02262260|516836650|FG001|Overall Study|Withdrawal of consent|2|||
143352736|NCT02262260|516836649|FG000|Overall Study|Lost to Follow-up|1|||
143352737|NCT02262260|516836650|FG001|Overall Study|Lost to Follow-up|2|||
143352738|NCT02262260|516836649|FG000|Overall Study|Protocol deviation|2|||
143352739|NCT02262260|516836650|FG001|Overall Study|Protocol deviation|5|||
143352740|NCT03391960|516836653|FG000|Overall Study|Protocol Violation|0|||
143352741|NCT03391960|516836654|FG001|Overall Study|Protocol Violation|0|||
143352742|NCT02924389|516836656|FG000|Overall Study|Lost to Follow-up|1|||
143352743|NCT02924389|516836657|FG001|Overall Study|Lost to Follow-up|0|||
143352744|NCT02924389|516836656|FG000|Overall Study|Physician Decision|2|||
143352745|NCT02924389|516836657|FG001|Overall Study|Physician Decision|0|||
143352746|NCT02924389|516836656|FG000|Overall Study|Withdrawal by Subject|3|||
143352747|NCT02924389|516836657|FG001|Overall Study|Withdrawal by Subject|0|||
143352748|NCT02924389|516836656|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
143352749|NCT02924389|516836657|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
143352750|NCT03681639|516838612|FG000|Overall Study|Death|4|||
143352751|NCT03681639|516838612|FG000|Overall Study|Lost to Follow-up|2|||
143352752|NCT03681639|516838612|FG000|Overall Study|Withdrawal by Subject|1|||
143352753|NCT03681639|516838612|FG000|Overall Study|Adverse Event|2|||
143352754|NCT00802737|516838613|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
143352755|NCT00802737|516838614|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
143352756|NCT00802737|516838615|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
143352757|NCT00802737|516838613|FG000|Overall Study|Death|6|||
143352758|NCT00802737|516838614|FG001|Overall Study|Death|5|||
143352759|NCT00802737|516838615|FG002|Overall Study|Death|1|||
143352760|NCT00802737|516838613|FG000|Overall Study|Adverse Event|1|||
143352761|NCT00802737|516838614|FG001|Overall Study|Adverse Event|0|||
143352762|NCT00802737|516838615|FG002|Overall Study|Adverse Event|0|||
143352763|NCT00802737|516838613|FG000|Overall Study|Received Prohibited Therapy|1|||
143352764|NCT00802737|516838614|FG001|Overall Study|Received Prohibited Therapy|0|||
143352765|NCT00802737|516838615|FG002|Overall Study|Received Prohibited Therapy|0|||
143352766|NCT00802737|516838613|FG000|Overall Study|Ongoing CLL-Treatment|0|||
143352767|NCT00802737|516838614|FG001|Overall Study|Ongoing CLL-Treatment|1|||
143352768|NCT00802737|516838615|FG002|Overall Study|Ongoing CLL-Treatment|0|||
143352769|NCT00802737|516838613|FG000|Overall Study|Participant too Unwell|0|||
143352770|NCT00802737|516838614|FG001|Overall Study|Participant too Unwell|2|||
143352771|NCT00802737|516838615|FG002|Overall Study|Participant too Unwell|0|||
143352772|NCT01625910|516838621|FG000|Overall Study|Lost to Follow-up|3|||
143352773|NCT01625910|516838622|FG001|Overall Study|Lost to Follow-up|4|||
143352774|NCT00358215|516838623|FG000|Overall Study|Ineligibility determined|4|||
143352775|NCT00358215|516838624|FG001|Overall Study|Ineligibility determined|3|||
143352776|NCT00358215|516838623|FG000|Overall Study|Adverse Event|83|||
143352777|NCT00358215|516838624|FG001|Overall Study|Adverse Event|65|||
143352778|NCT00358215|516838623|FG000|Overall Study|Withdrawal by Subject|111|||
143352779|NCT00358215|516838624|FG001|Overall Study|Withdrawal by Subject|102|||
143352780|NCT00358215|516838623|FG000|Overall Study|Participant request|65|||
143352781|NCT00358215|516838624|FG001|Overall Study|Participant request|64|||
143352782|NCT00358215|516838623|FG000|Overall Study|Physician Decision|47|||
143352783|NCT00358215|516838624|FG001|Overall Study|Physician Decision|39|||
143352784|NCT00358215|516838623|FG000|Overall Study|Lost to Follow-up|16|||
143352785|NCT00358215|516838624|FG001|Overall Study|Lost to Follow-up|22|||
143352786|NCT00358215|516838623|FG000|Overall Study|Death|265|||
143352787|NCT00358215|516838624|FG001|Overall Study|Death|281|||
143352788|NCT00358215|516838623|FG000|Overall Study|Protocol Violation|64|||
143352789|NCT00358215|516838624|FG001|Overall Study|Protocol Violation|59|||
143352790|NCT00358215|516838623|FG000|Overall Study|Pregnancy|1|||
143352791|NCT00358215|516838624|FG001|Overall Study|Pregnancy|0|||
143352792|NCT00358215|516838623|FG000|Overall Study|Other|21|||
143352793|NCT00358215|516838624|FG001|Overall Study|Other|14|||
143352794|NCT00358215|516838623|FG000|Overall Study|Did not receive investigational product|2|||
143352795|NCT00358215|516838624|FG001|Overall Study|Did not receive investigational product|3|||
143352796|NCT01681368|516838627|FG000|Overall Study|Refused further treatment|1|||
143352797|NCT01681368|516838627|FG000|Overall Study|Refused further follow up|1|||
143352798|NCT01807221|516838630|FG000|Overall Study|Progressive disease|1|||
143352799|NCT01807221|516838631|FG001|Overall Study|Progressive disease|0|||
143352800|NCT01807221|516838632|FG002|Overall Study|Progressive disease|1|||
143352801|NCT01807221|516838633|FG003|Overall Study|Progressive disease|0|||
143352802|NCT01807221|516838634|FG004|Overall Study|Progressive disease|0|||
143352803|NCT01807221|516838635|FG005|Overall Study|Progressive disease|0|||
143352804|NCT01807221|516838630|FG000|Overall Study|Death|7|||
143352805|NCT01807221|516838631|FG001|Overall Study|Death|9|||
143352806|NCT01807221|516838632|FG002|Overall Study|Death|4|||
143352807|NCT01807221|516838633|FG003|Overall Study|Death|2|||
143352808|NCT01807221|516838634|FG004|Overall Study|Death|1|||
143352809|NCT01807221|516838635|FG005|Overall Study|Death|6|||
143352810|NCT01807221|516838630|FG000|Overall Study|Physician Decision|2|||
143352811|NCT01807221|516838631|FG001|Overall Study|Physician Decision|1|||
143352812|NCT01807221|516838632|FG002|Overall Study|Physician Decision|0|||
143352813|NCT01807221|516838633|FG003|Overall Study|Physician Decision|0|||
143352814|NCT01807221|516838634|FG004|Overall Study|Physician Decision|0|||
143352815|NCT01807221|516838635|FG005|Overall Study|Physician Decision|0|||
143352816|NCT01807221|516838630|FG000|Overall Study|Adverse Event|33|||
143352817|NCT01807221|516838631|FG001|Overall Study|Adverse Event|22|||
143352818|NCT01807221|516838632|FG002|Overall Study|Adverse Event|26|||
143352819|NCT01807221|516838633|FG003|Overall Study|Adverse Event|25|||
143352820|NCT01807221|516838634|FG004|Overall Study|Adverse Event|18|||
143352821|NCT01807221|516838635|FG005|Overall Study|Adverse Event|21|||
143352822|NCT01807221|516838630|FG000|Overall Study|Protocol Violation|0|||
143352823|NCT01807221|516838631|FG001|Overall Study|Protocol Violation|2|||
143352824|NCT01807221|516838632|FG002|Overall Study|Protocol Violation|1|||
143352825|NCT01807221|516838633|FG003|Overall Study|Protocol Violation|2|||
143352826|NCT01807221|516838634|FG004|Overall Study|Protocol Violation|0|||
143352827|NCT01807221|516838635|FG005|Overall Study|Protocol Violation|1|||
143352828|NCT01807221|516838630|FG000|Overall Study|Non-compliance|1|||
143352829|NCT01807221|516838631|FG001|Overall Study|Non-compliance|2|||
143352830|NCT01807221|516838632|FG002|Overall Study|Non-compliance|0|||
143352831|NCT01807221|516838633|FG003|Overall Study|Non-compliance|1|||
143352832|NCT01807221|516838634|FG004|Overall Study|Non-compliance|0|||
143352833|NCT01807221|516838635|FG005|Overall Study|Non-compliance|0|||
143352834|NCT01807221|516838630|FG000|Overall Study|Logistical difficulties|0|||
143352835|NCT01807221|516838631|FG001|Overall Study|Logistical difficulties|1|||
143352836|NCT01807221|516838632|FG002|Overall Study|Logistical difficulties|0|||
143352837|NCT01807221|516838633|FG003|Overall Study|Logistical difficulties|0|||
143352838|NCT01807221|516838634|FG004|Overall Study|Logistical difficulties|1|||
143352839|NCT01807221|516838635|FG005|Overall Study|Logistical difficulties|0|||
143352840|NCT01807221|516838630|FG000|Overall Study|Withdrawal by Subject|33|||
143352841|NCT01807221|516838631|FG001|Overall Study|Withdrawal by Subject|15|||
143114859|NCT02345889|515962442|FG001|Overall Study|Polyposis identified during procedure|1|||
143352842|NCT01807221|516838632|FG002|Overall Study|Withdrawal by Subject|8|||
143352843|NCT01807221|516838633|FG003|Overall Study|Withdrawal by Subject|14|||
143352844|NCT01807221|516838634|FG004|Overall Study|Withdrawal by Subject|16|||
143352845|NCT01807221|516838635|FG005|Overall Study|Withdrawal by Subject|13|||
143352846|NCT01807221|516838630|FG000|Overall Study|Sponsor decision|2|||
143352847|NCT01807221|516838631|FG001|Overall Study|Sponsor decision|0|||
143352848|NCT01807221|516838632|FG002|Overall Study|Sponsor decision|1|||
143352849|NCT01807221|516838633|FG003|Overall Study|Sponsor decision|1|||
143352850|NCT01807221|516838634|FG004|Overall Study|Sponsor decision|0|||
143352851|NCT01807221|516838635|FG005|Overall Study|Sponsor decision|0|||
143352852|NCT01807221|516838630|FG000|Overall Study|Lost to Follow-up|1|||
143352853|NCT01807221|516838631|FG001|Overall Study|Lost to Follow-up|0|||
143352854|NCT01807221|516838632|FG002|Overall Study|Lost to Follow-up|2|||
143352855|NCT01807221|516838633|FG003|Overall Study|Lost to Follow-up|1|||
143352856|NCT01807221|516838634|FG004|Overall Study|Lost to Follow-up|0|||
143352857|NCT01807221|516838635|FG005|Overall Study|Lost to Follow-up|0|||
143352858|NCT01155388|516838638|FG000|Overall Study|Adverse Event|1|||
143352859|NCT01155388|516838639|FG001|Overall Study|Adverse Event|0|||
143461543|NCT00138671|517235076|FG000|Overall Study|Lost to Follow-up|1|||
143461544|NCT00138671|517235077|FG001|Overall Study|Lost to Follow-up|2|||
143461545|NCT00138671|517235076|FG000|Overall Study|Withdrawal by Subject|3|||
143461546|NCT00138671|517235077|FG001|Overall Study|Withdrawal by Subject|5|||
143461547|NCT00138671|517235076|FG000|Overall Study|Other|3|||
143461548|NCT00138671|517235077|FG001|Overall Study|Other|3|||
143461549|NCT03451162|517235078|FG000|Overall Study|Lost to Follow-up|1|||
143461550|NCT03451162|517235079|FG001|Overall Study|Lost to Follow-up|0|||
143461551|NCT03451162|517235080|FG002|Overall Study|Lost to Follow-up|0|||
143461552|NCT03451162|517235081|FG003|Overall Study|Lost to Follow-up|0|||
143461553|NCT03451162|517235082|FG004|Overall Study|Lost to Follow-up|0|||
143461554|NCT03451162|517235078|FG000|Overall Study|Physician Decision|0|||
143461555|NCT03451162|517235079|FG001|Overall Study|Physician Decision|1|||
143461556|NCT03451162|517235080|FG002|Overall Study|Physician Decision|0|||
143461557|NCT03451162|517235081|FG003|Overall Study|Physician Decision|0|||
143461558|NCT03451162|517235082|FG004|Overall Study|Physician Decision|0|||
143461559|NCT03451162|517235078|FG000|Overall Study|Withdrawal by Subject|1|||
143461560|NCT03451162|517235079|FG001|Overall Study|Withdrawal by Subject|1|||
143461561|NCT03451162|517235080|FG002|Overall Study|Withdrawal by Subject|0|||
143461562|NCT03451162|517235081|FG003|Overall Study|Withdrawal by Subject|0|||
143461563|NCT03451162|517235082|FG004|Overall Study|Withdrawal by Subject|0|||
143461564|NCT04634825|517235083|FG000|Overall Study|Death|10|||
143461565|NCT04634825|517235084|FG001|Overall Study|Death|3|||
143461566|NCT04634825|517235083|FG000|Overall Study|Lost to Follow-up|1|||
143461567|NCT04634825|517235084|FG001|Overall Study|Lost to Follow-up|0|||
143461568|NCT04634825|517235083|FG000|Overall Study|Study terminated by sponsor|35|||
143461569|NCT04634825|517235084|FG001|Overall Study|Study terminated by sponsor|11|||
143461570|NCT04634825|517235083|FG000|Overall Study|Withdrawal by Subject|2|||
143461571|NCT04634825|517235084|FG001|Overall Study|Withdrawal by Subject|0|||
143461572|NCT01100034|517235087|FG000|Overall Study|Lost to Follow-up|11|||
143461573|NCT01100034|517235087|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
143461574|NCT01100034|517235087|FG000|Overall Study|Withdrawal by Subject|4|||
143461575|NCT01100034|517235087|FG000|Overall Study|Sponsor decision|21|||
143461576|NCT01100034|517235087|FG000|Overall Study|Participated in another clinical trial|1|||
143461577|NCT01100034|517235087|FG000|Overall Study|Participants moved to another hospital|4|||
143461578|NCT01100034|517235087|FG000|Overall Study|Site closed due to non-responsiveness|1|||
143461579|NCT00402597|517235088|FG000|Overall Study|Death|15|||
143461580|NCT00402597|517235089|FG001|Overall Study|Death|7|||
143461581|NCT00402597|517235090|FG002|Overall Study|Death|6|||
143461582|NCT00402597|517235091|FG003|Overall Study|Death|4|||
143461583|NCT00402597|517235092|FG004|Overall Study|Death|6|||
143461584|NCT00402597|517235088|FG000|Overall Study|Adverse Event|81|||
143461585|NCT00402597|517235089|FG001|Overall Study|Adverse Event|18|||
143461586|NCT00402597|517235090|FG002|Overall Study|Adverse Event|106|||
143461587|NCT00402597|517235091|FG003|Overall Study|Adverse Event|39|||
143461588|NCT00402597|517235092|FG004|Overall Study|Adverse Event|71|||
143461589|NCT00402597|517235088|FG000|Overall Study|Lost to Follow-up|8|||
143461590|NCT00402597|517235089|FG001|Overall Study|Lost to Follow-up|1|||
143461591|NCT00402597|517235090|FG002|Overall Study|Lost to Follow-up|8|||
143461592|NCT00402597|517235091|FG003|Overall Study|Lost to Follow-up|2|||
143461593|NCT00402597|517235092|FG004|Overall Study|Lost to Follow-up|3|||
143461594|NCT00402597|517235088|FG000|Overall Study|Withdrawal by Subject|57|||
143461595|NCT00402597|517235089|FG001|Overall Study|Withdrawal by Subject|16|||
143461596|NCT00402597|517235090|FG002|Overall Study|Withdrawal by Subject|65|||
143461597|NCT00402597|517235091|FG003|Overall Study|Withdrawal by Subject|15|||
143461598|NCT00402597|517235092|FG004|Overall Study|Withdrawal by Subject|24|||
143461599|NCT00402597|517235088|FG000|Overall Study|reason not specified|30|||
143461600|NCT00402597|517235089|FG001|Overall Study|reason not specified|4|||
143461601|NCT00402597|517235090|FG002|Overall Study|reason not specified|27|||
143461602|NCT00402597|517235091|FG003|Overall Study|reason not specified|14|||
143461603|NCT00402597|517235092|FG004|Overall Study|reason not specified|20|||
143461604|NCT01136772|517235093|FG000|Overall Study|Adverse Event|15|||
143461605|NCT01136772|517235094|FG001|Overall Study|Adverse Event|14|||
143352860|NCT01004250|516838640|FG000|Induction Therapy Period|Adverse Event|10|||
143352861|NCT01004250|516838640|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
143461606|NCT01136772|517235093|FG000|Overall Study|Lack of Efficacy|42|||
143461607|NCT01136772|517235094|FG001|Overall Study|Lack of Efficacy|39|||
143461608|NCT01136772|517235093|FG000|Overall Study|Administrative|14|||
143461609|NCT01136772|517235094|FG001|Overall Study|Administrative|12|||
143461610|NCT01136772|517235093|FG000|Overall Study|Withdrawal by Subject|33|||
143461611|NCT01136772|517235094|FG001|Overall Study|Withdrawal by Subject|36|||
143461612|NCT01136772|517235093|FG000|Overall Study|Did not receive injection|10|||
143352862|NCT01004250|516838640|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
143352863|NCT01004250|516838640|FG000|Induction Therapy Period|Physician Decision|2|||
143352864|NCT01004250|516838640|FG000|Maintenance Therapy Period|Adverse Event|15|||
143352865|NCT01004250|516838640|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
143352866|NCT01004250|516838640|FG000|Maintenance Therapy Period|Protocol Violation|1|||
143352867|NCT01004250|516838640|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
143352868|NCT01004250|516838640|FG000|Maintenance Therapy Period|Physician Decision|4|||
143352869|NCT01004250|516838640|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
143352870|NCT03943589|516838641|FG000|Overall Study|Death|1|||
143352871|NCT03943589|516838641|FG000|Overall Study|Diagnosed with encephalomyelitis|1|||
143352872|NCT04329104|516838642|FG000|Efficacy Study|Withdrawal by Subject|0|||
143352873|NCT04329104|516838643|FG001|Efficacy Study|Withdrawal by Subject|0|||
143352874|NCT04329104|516838644|FG002|Efficacy Study|Withdrawal by Subject|0|||
143352875|NCT04329104|516838645|FG003|Efficacy Study|Withdrawal by Subject|5|||
143352876|NCT04329104|516838646|FG004|Efficacy Study|Withdrawal by Subject|6|||
143352877|NCT04329104|516838647|FG005|Efficacy Study|Withdrawal by Subject|8|||
143352878|NCT03884231|516838648|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
143352879|NCT03884231|516838648|FG000|Overall Study|Subject Withdrew Consent|1|||
143352880|NCT03884231|516838648|FG000|Overall Study|MRI Scan Not Performed|1|||
143352881|NCT00900627|516838649|FG000|Overall Study|Condition under investigation worsened|4|||
143352882|NCT00900627|516838650|FG001|Overall Study|Condition under investigation worsened|0|||
143352883|NCT00900627|516838651|FG002|Overall Study|Condition under investigation worsened|5|||
143352884|NCT00900627|516838652|FG003|Overall Study|Condition under investigation worsened|3|||
143352885|NCT00900627|516838653|FG004|Overall Study|Condition under investigation worsened|0|||
143012258|NCT05013749|515583593|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
143012259|NCT05013749|515583592|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
143012260|NCT05013749|515583593|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
143012261|NCT02426125|515583594|FG000|Overall Study|Lost to Follow-up|14|||
143012262|NCT02426125|515583595|FG001|Overall Study|Lost to Follow-up|12|||
143012263|NCT02426125|515583594|FG000|Overall Study|Withdrawal by Subject|13|||
143012264|NCT02426125|515583595|FG001|Overall Study|Withdrawal by Subject|14|||
143012265|NCT02426125|515583594|FG000|Overall Study|Death|185|||
143012266|NCT02426125|515583595|FG001|Overall Study|Death|200|||
143012267|NCT02426125|515583594|FG000|Overall Study|Randomized, But Never Treated|5|||
143012268|NCT02426125|515583595|FG001|Overall Study|Randomized, But Never Treated|2|||
143012269|NCT02858076|515583596|FG000|Overall Study|Death|6|||
143012270|NCT02858076|515583597|FG001|Overall Study|Death|3|||
143012271|NCT02858076|515583596|FG000|Overall Study|Withdrawal by Subject|1|||
143012272|NCT02858076|515583597|FG001|Overall Study|Withdrawal by Subject|5|||
143012273|NCT02858076|515583596|FG000|Overall Study|Lost to Follow-up|2|||
143012274|NCT02858076|515583597|FG001|Overall Study|Lost to Follow-up|7|||
143012275|NCT02858076|515583596|FG000|Overall Study|Completed Out of Window|1|||
143012276|NCT02858076|515583597|FG001|Overall Study|Completed Out of Window|3|||
143012277|NCT03506425|515583598|FG000|Overall Study|Adverse Event|1|||
143012278|NCT03506425|515583599|FG001|Overall Study|Adverse Event|3|||
143012279|NCT03506425|515583600|FG002|Overall Study|Adverse Event|0|||
143012280|NCT03506425|515583598|FG000|Overall Study|Death|1|||
143012281|NCT03506425|515583599|FG001|Overall Study|Death|0|||
143012282|NCT03506425|515583600|FG002|Overall Study|Death|0|||
143012283|NCT03506425|515583598|FG000|Overall Study|Withdrawal by Subject|0|||
143012284|NCT03506425|515583599|FG001|Overall Study|Withdrawal by Subject|0|||
143012285|NCT03506425|515583600|FG002|Overall Study|Withdrawal by Subject|1|||
143012286|NCT00938015|515583606|FG000|Overall Study|Death|2|||
143012287|NCT00938015|515583606|FG000|Overall Study|Lost to Follow-up|32|||
143012288|NCT00938015|515583606|FG000|Overall Study|Adverse Event|32|||
143012289|NCT00938015|515583606|FG000|Overall Study|Non-responder|52|||
143012290|NCT00938015|515583606|FG000|Overall Study|Reason not related to Etanercept|29|||
143012291|NCT00664066|515583608|FG000|Overall Study|Study terminated|3|||
143012292|NCT02180659|515583609|FG000|Overall Study|Adverse Event|1|||
143012293|NCT02180659|515583610|FG001|Overall Study|Adverse Event|0|||
143012294|NCT02180659|515583609|FG000|Overall Study|Lost to Follow-up|4|||
143352886|NCT00900627|516838654|FG005|Overall Study|Condition under investigation worsened|0|||
143352887|NCT00900627|516838649|FG000|Overall Study|Withdrawal by Subject|1|||
143352888|NCT00900627|516838650|FG001|Overall Study|Withdrawal by Subject|0|||
143012295|NCT02180659|515583610|FG001|Overall Study|Lost to Follow-up|2|||
143012296|NCT02180659|515583609|FG000|Overall Study|Subject incarcerated during conduct|1|||
143012297|NCT02180659|515583610|FG001|Overall Study|Subject incarcerated during conduct|0|||
143012298|NCT02180659|515583609|FG000|Overall Study|Withdrawal by Subject|0|||
143012299|NCT02180659|515583610|FG001|Overall Study|Withdrawal by Subject|2|||
143012300|NCT02180659|515583609|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
143012301|NCT02180659|515583610|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
143352889|NCT00900627|516838651|FG002|Overall Study|Withdrawal by Subject|1|||
143352890|NCT00900627|516838652|FG003|Overall Study|Withdrawal by Subject|0|||
143012302|NCT01495793|515583611|FG000|Overall Study|Lost to Follow-up|1|||
143352891|NCT00900627|516838653|FG004|Overall Study|Withdrawal by Subject|1|||
143352892|NCT00900627|516838654|FG005|Overall Study|Withdrawal by Subject|2|||
143352893|NCT00900627|516838649|FG000|Overall Study|Adverse Event|1|||
143352894|NCT00900627|516838650|FG001|Overall Study|Adverse Event|2|||
143352895|NCT00900627|516838651|FG002|Overall Study|Adverse Event|0|||
143352896|NCT00900627|516838652|FG003|Overall Study|Adverse Event|3|||
143352897|NCT00900627|516838653|FG004|Overall Study|Adverse Event|0|||
143352898|NCT00900627|516838654|FG005|Overall Study|Adverse Event|0|||
143352899|NCT00900627|516838649|FG000|Overall Study|Death|0|||
143352900|NCT00900627|516838650|FG001|Overall Study|Death|0|||
143352901|NCT00900627|516838651|FG002|Overall Study|Death|0|||
143352902|NCT00900627|516838652|FG003|Overall Study|Death|0|||
143352903|NCT00900627|516838653|FG004|Overall Study|Death|28|||
143352904|NCT00900627|516838654|FG005|Overall Study|Death|24|||
143352905|NCT00373295|516838655|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
143352906|NCT00373295|516838656|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
143352907|NCT00373295|516838657|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
143352908|NCT00373295|516838658|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
143352909|NCT00373295|516838659|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
143352910|NCT00373295|516838660|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
143352911|NCT00830947|516838661|FG000|Overall Study|Lost to Follow-up|4|||
143352912|NCT00830947|516838662|FG001|Overall Study|Lost to Follow-up|4|||
143352913|NCT01089556|516838670|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
143352914|NCT01089556|516838671|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
143352915|NCT01089556|516838672|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
143352916|NCT01089556|516838673|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
143352917|NCT01089556|516838674|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
143352918|NCT01089556|516838675|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
143352919|NCT01089556|516838670|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
143352920|NCT01089556|516838671|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
143352921|NCT01089556|516838672|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
143125546|NCT05052697|516003714|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
143125547|NCT05052697|516003715|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
143125548|NCT05052697|516003716|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
143125549|NCT05052697|516003717|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
143125550|NCT05052697|516003718|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
143125551|NCT05052697|516003719|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
143125552|NCT05052697|516003720|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
143125553|NCT05052697|516003721|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
143125554|NCT05052697|516003722|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
143125555|NCT05052697|516003723|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
143125556|NCT05052697|516003724|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
143125557|NCT05052697|516003725|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
143125558|NCT05052697|516003726|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
143125559|NCT05052697|516003727|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
143125560|NCT05052697|516003728|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
143125561|NCT05052697|516003729|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
143352922|NCT01089556|516838673|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
143352923|NCT01089556|516838674|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
143352924|NCT01089556|516838675|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
143352925|NCT01089556|516838670|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
143352926|NCT01089556|516838671|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
143352927|NCT01089556|516838672|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
143352928|NCT01089556|516838673|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
143352929|NCT01089556|516838674|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
143352930|NCT01089556|516838675|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
143352931|NCT01089556|516838670|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
143352932|NCT01089556|516838671|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
143352933|NCT01089556|516838672|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
143352934|NCT01089556|516838673|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
143352935|NCT01089556|516838674|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
143352936|NCT01089556|516838675|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
143352937|NCT01089556|516838670|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
143352938|NCT01089556|516838671|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
143352939|NCT01089556|516838672|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
143352940|NCT01089556|516838673|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
143352941|NCT01089556|516838674|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
143352942|NCT01089556|516838675|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
143352943|NCT01089556|516838670|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
143352944|NCT01089556|516838671|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
143352945|NCT01089556|516838672|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
143352946|NCT01089556|516838673|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
143352947|NCT01089556|516838674|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
143352948|NCT01089556|516838675|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
143352949|NCT01089556|516838670|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
143352950|NCT01089556|516838671|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
143352951|NCT01089556|516838672|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
143352952|NCT01089556|516838673|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
143352953|NCT01089556|516838674|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
143352954|NCT01089556|516838675|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
143352955|NCT01089556|516838670|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
143352956|NCT01089556|516838671|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
143352957|NCT01089556|516838672|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
143352958|NCT01089556|516838673|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
143352959|NCT01089556|516838674|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
143352960|NCT01089556|516838675|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
143352961|NCT01089556|516838670|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
143352962|NCT01089556|516838671|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
143352963|NCT01089556|516838672|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
143352964|NCT01089556|516838673|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
143352965|NCT01089556|516838674|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
143352966|NCT01089556|516838675|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
143352967|NCT01089556|516838670|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
143352968|NCT01089556|516838671|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
143352969|NCT01089556|516838672|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
143352970|NCT01089556|516838673|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
143352971|NCT01089556|516838674|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
143352972|NCT01089556|516838675|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
143352973|NCT01089556|516838670|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
143352974|NCT01089556|516838671|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
143352975|NCT01089556|516838672|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
143352976|NCT01089556|516838673|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
143352977|NCT01089556|516838674|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
143352978|NCT01089556|516838675|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
143352979|NCT01089556|516838670|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
143352980|NCT01089556|516838671|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
143352981|NCT01089556|516838672|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
143352982|NCT01089556|516838673|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
143352983|NCT01089556|516838674|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
143352984|NCT01089556|516838675|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
143352985|NCT01089556|516838670|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
143352986|NCT01089556|516838671|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
143352987|NCT01089556|516838672|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
143352988|NCT01089556|516838673|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
143352989|NCT01089556|516838674|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
143352990|NCT01089556|516838675|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
143352991|NCT01089556|516838670|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
143352992|NCT01089556|516838671|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
143352993|NCT01089556|516838672|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
143352994|NCT01089556|516838673|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
143352995|NCT01089556|516838674|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
143352996|NCT01089556|516838675|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
143352997|NCT01089556|516838670|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
143012303|NCT01495793|515583611|FG000|Overall Study|Violation of inclusion criteria|1|||
143012304|NCT00090259|515583614|FG000|Overall Study|Lost to Follow-up|30|||
143012305|NCT00090259|515583615|FG001|Overall Study|Lost to Follow-up|26|||
143012306|NCT00090259|515583614|FG000|Overall Study|Withdrawal by Subject|21|||
143012307|NCT00090259|515583615|FG001|Overall Study|Withdrawal by Subject|15|||
143352998|NCT01089556|516838671|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
143352999|NCT01089556|516838672|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
143353000|NCT01089556|516838673|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
143353001|NCT01089556|516838674|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
143353002|NCT01089556|516838675|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
143353003|NCT01238575|516838676|FG000|Overall Study|Lack of Efficacy|2|||
143353004|NCT01238575|516838677|FG001|Overall Study|Lack of Efficacy|4|||
143353005|NCT01238575|516838676|FG000|Overall Study|Adverse Event|2|||
143353006|NCT01238575|516838677|FG001|Overall Study|Adverse Event|0|||
143012308|NCT00090259|515583614|FG000|Overall Study|Investigator site closed|11|||
143012309|NCT00090259|515583615|FG001|Overall Study|Investigator site closed|7|||
143353007|NCT00962585|516838681|FG000|Overall Study|Adverse Event|0|||
143125562|NCT05052697|516003730|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
143353008|NCT00962585|516838682|FG001|Overall Study|Adverse Event|2|||
143353009|NCT00962585|516838683|FG002|Overall Study|Adverse Event|1|||
143353010|NCT00962585|516838684|FG003|Overall Study|Adverse Event|0|||
143353011|NCT00962585|516838681|FG000|Overall Study|Lost to Follow-up|3|||
143353012|NCT00962585|516838682|FG001|Overall Study|Lost to Follow-up|0|||
143353013|NCT00962585|516838683|FG002|Overall Study|Lost to Follow-up|1|||
143353014|NCT00962585|516838684|FG003|Overall Study|Lost to Follow-up|0|||
143353015|NCT00962585|516838681|FG000|Overall Study|Protocol Violation|0|||
143353016|NCT00962585|516838682|FG001|Overall Study|Protocol Violation|0|||
143353017|NCT00962585|516838683|FG002|Overall Study|Protocol Violation|1|||
143353018|NCT00962585|516838684|FG003|Overall Study|Protocol Violation|0|||
143353019|NCT00962585|516838681|FG000|Overall Study|Withdrawal by Subject|1|||
143353020|NCT00962585|516838682|FG001|Overall Study|Withdrawal by Subject|0|||
143353021|NCT00962585|516838683|FG002|Overall Study|Withdrawal by Subject|0|||
143353022|NCT00962585|516838684|FG003|Overall Study|Withdrawal by Subject|0|||
143353023|NCT00962585|516838681|FG000|Overall Study|Withdrew Consent|2|||
143353024|NCT00962585|516838682|FG001|Overall Study|Withdrew Consent|0|||
143353025|NCT00962585|516838683|FG002|Overall Study|Withdrew Consent|0|||
143353026|NCT00962585|516838684|FG003|Overall Study|Withdrew Consent|0|||
143353027|NCT02254421|516838685|FG000|Overall Study|Randomized but Not Treated|1|||
143353028|NCT02254421|516838686|FG001|Overall Study|Randomized but Not Treated|0|||
143353029|NCT02254421|516838685|FG000|Overall Study|Death|0|||
143353030|NCT02254421|516838686|FG001|Overall Study|Death|2|||
143353031|NCT02254421|516838685|FG000|Overall Study|Withdrew Consent|1|||
143353032|NCT02254421|516838686|FG001|Overall Study|Withdrew Consent|1|||
143353033|NCT00594906|516838689|FG000|Overall Study|Physician Decision|1|||
143353034|NCT00594906|516838690|FG001|Overall Study|Physician Decision|0|||
143353035|NCT00594906|516838689|FG000|Overall Study|Physician Decision|0|||
143353036|NCT00594906|516838690|FG001|Overall Study|Physician Decision|1|||
143353037|NCT00594906|516838689|FG000|Overall Study|Death|0|||
143353038|NCT00594906|516838690|FG001|Overall Study|Death|1|||
143353039|NCT00179010|516838692|FG000|Overall Study|Muscle probe defective|1|||
143353040|NCT00179010|516838693|FG001|Overall Study|Muscle probe defective|1|||
143353041|NCT00179010|516838692|FG000|Overall Study|Failure to place arterial line|0|||
143353042|NCT00179010|516838693|FG001|Overall Study|Failure to place arterial line|1|||
143353043|NCT02564055|516838694|FG000|Overall Study|Adverse Event|1|||
143353044|NCT02564055|516838695|FG001|Overall Study|Adverse Event|0|||
143353045|NCT02564055|516838696|FG002|Overall Study|Adverse Event|4|||
143353046|NCT02564055|516838697|FG003|Overall Study|Adverse Event|1|||
143353047|NCT02564055|516838698|FG004|Overall Study|Adverse Event|4|||
143353048|NCT02564055|516838699|FG005|Overall Study|Adverse Event|1|||
143353049|NCT02564055|516838694|FG000|Overall Study|Protocol Violation|1|||
143353050|NCT02564055|516838695|FG001|Overall Study|Protocol Violation|0|||
143353051|NCT02564055|516838696|FG002|Overall Study|Protocol Violation|0|||
143353052|NCT02564055|516838697|FG003|Overall Study|Protocol Violation|0|||
143353053|NCT02564055|516838698|FG004|Overall Study|Protocol Violation|0|||
143353054|NCT02564055|516838699|FG005|Overall Study|Protocol Violation|0|||
143353055|NCT02564055|516838694|FG000|Overall Study|Reached stopping criteria|0|||
143353056|NCT02564055|516838695|FG001|Overall Study|Reached stopping criteria|0|||
143353057|NCT02564055|516838696|FG002|Overall Study|Reached stopping criteria|0|||
143353058|NCT02564055|516838697|FG003|Overall Study|Reached stopping criteria|0|||
143353059|NCT02564055|516838698|FG004|Overall Study|Reached stopping criteria|0|||
143353060|NCT02564055|516838699|FG005|Overall Study|Reached stopping criteria|1|||
143353061|NCT02564055|516838694|FG000|Overall Study|Lost to Follow-up|0|||
143353062|NCT02564055|516838695|FG001|Overall Study|Lost to Follow-up|1|||
143353063|NCT02564055|516838696|FG002|Overall Study|Lost to Follow-up|4|||
143353064|NCT02564055|516838697|FG003|Overall Study|Lost to Follow-up|2|||
143353065|NCT02564055|516838698|FG004|Overall Study|Lost to Follow-up|1|||
143353066|NCT02564055|516838699|FG005|Overall Study|Lost to Follow-up|0|||
143353067|NCT02564055|516838694|FG000|Overall Study|Physician Decision|0|||
143353068|NCT02564055|516838695|FG001|Overall Study|Physician Decision|0|||
143353069|NCT02564055|516838696|FG002|Overall Study|Physician Decision|1|||
143353070|NCT02564055|516838697|FG003|Overall Study|Physician Decision|0|||
143353071|NCT02564055|516838698|FG004|Overall Study|Physician Decision|0|||
143353072|NCT02564055|516838699|FG005|Overall Study|Physician Decision|0|||
143353073|NCT02564055|516838694|FG000|Overall Study|Withdrawal by Subject|4|||
143461613|NCT01136772|517235094|FG001|Overall Study|Did not receive injection|7|||
143012310|NCT01275170|515583618|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
143012311|NCT01275170|515583619|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
143353074|NCT02564055|516838695|FG001|Overall Study|Withdrawal by Subject|4|||
143353075|NCT02564055|516838696|FG002|Overall Study|Withdrawal by Subject|3|||
143353076|NCT02564055|516838697|FG003|Overall Study|Withdrawal by Subject|3|||
143353077|NCT02564055|516838698|FG004|Overall Study|Withdrawal by Subject|10|||
143353078|NCT02564055|516838699|FG005|Overall Study|Withdrawal by Subject|10|||
143353079|NCT02823964|516838706|FG000|Overall Study|Adverse Event|2|||
143353080|NCT02823964|516838706|FG000|Overall Study|Physician Decision|1|||
143353081|NCT02823964|516838706|FG000|Overall Study|Lack of Efficacy|1|||
143353082|NCT02823964|516838706|FG000|Overall Study|Withdrawal by Subject|1|||
143353083|NCT01729728|516838716|FG000|Overall Study|Adverse Event|0|||
143125563|NCT05052697|516003731|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
143125564|NCT05052697|516003732|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
143125565|NCT05052697|516003733|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
143125566|NCT05052697|516003734|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
143353084|NCT01729728|516838717|FG001|Overall Study|Adverse Event|6|||
143353085|NCT01729728|516838718|FG002|Overall Study|Adverse Event|0|||
143353086|NCT01729728|516838716|FG000|Overall Study|Protocol Violation|1|||
143353087|NCT01729728|516838717|FG001|Overall Study|Protocol Violation|0|||
143125567|NCT05052697|516003735|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
143125568|NCT05052697|516003736|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
143125569|NCT05052697|516003737|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
143125570|NCT05052697|516003738|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
143125571|NCT05052697|516003739|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
143125572|NCT05052697|516003740|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
143125573|NCT05052697|516003741|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
143125574|NCT05052697|516003708|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
143125575|NCT05052697|516003709|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
143125576|NCT05052697|516003710|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
143125577|NCT05052697|516003711|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
143125578|NCT05052697|516003712|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
143125579|NCT05052697|516003713|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
143125580|NCT05052697|516003714|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
143125581|NCT05052697|516003715|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
143125582|NCT05052697|516003716|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
143125583|NCT05052697|516003717|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
143353088|NCT01729728|516838718|FG002|Overall Study|Protocol Violation|1|||
143353089|NCT01613027|516838723|FG000|Overall Study|Lost to Follow-up|5|||
143353090|NCT01613027|516838723|FG000|Overall Study|Switched Physician|1|||
143353091|NCT01613027|516838723|FG000|Overall Study|Lack of Efficacy|1|||
143353092|NCT01613027|516838723|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
143353093|NCT02001974|516838724|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
143353094|NCT02001974|516838725|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
143353095|NCT02001974|516838726|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
143353096|NCT02001974|516838724|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
143353097|NCT02001974|516838725|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
143353098|NCT02001974|516838726|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
143353099|NCT02001974|516838724|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
143353100|NCT02001974|516838725|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
143353101|NCT02001974|516838726|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
143353102|NCT02001974|516838724|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
143353103|NCT02001974|516838725|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
143353104|NCT02001974|516838726|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
143353105|NCT00993317|516838727|FG000|Overall Study|Adverse Event|2|||
143353106|NCT00993317|516838728|FG001|Overall Study|Adverse Event|4|||
143353107|NCT00993317|516838727|FG000|Overall Study|Lack of Efficacy|18|||
143353108|NCT00993317|516838728|FG001|Overall Study|Lack of Efficacy|18|||
143353109|NCT00993317|516838727|FG000|Overall Study|Withdrawal by Subject|0|||
143353110|NCT00993317|516838728|FG001|Overall Study|Withdrawal by Subject|2|||
143353111|NCT00993317|516838727|FG000|Overall Study|Investigator's opinion|0|||
143353112|NCT00993317|516838728|FG001|Overall Study|Investigator's opinion|1|||
143353113|NCT00993317|516838727|FG000|Overall Study|Early study termination at the site|1|||
143353114|NCT00993317|516838728|FG001|Overall Study|Early study termination at the site|0|||
143353115|NCT01380990|516838729|FG000|Overall Study|Treatment Failure|1|||
143353116|NCT01380990|516838730|FG001|Overall Study|Treatment Failure|0|||
143353117|NCT01380990|516838729|FG000|Overall Study|Death|0|||
143353118|NCT01380990|516838730|FG001|Overall Study|Death|1|||
143353119|NCT02038764|516838733|FG000|Overall Study|Adverse Event|0|||
143353120|NCT02038764|516838734|FG001|Overall Study|Adverse Event|0|||
143353121|NCT02038764|516838735|FG002|Overall Study|Adverse Event|1|||
143353122|NCT02038764|516838736|FG003|Overall Study|Adverse Event|0|||
143353123|NCT02038764|516838737|FG004|Overall Study|Adverse Event|0|||
143353124|NCT02038764|516838733|FG000|Overall Study|Lost to Follow-up|0|||
143353125|NCT02038764|516838734|FG001|Overall Study|Lost to Follow-up|1|||
143353126|NCT02038764|516838735|FG002|Overall Study|Lost to Follow-up|0|||
143353127|NCT02038764|516838736|FG003|Overall Study|Lost to Follow-up|0|||
143125584|NCT05052697|516003718|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
143125585|NCT05052697|516003719|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
143125586|NCT05052697|516003720|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
143353128|NCT02038764|516838737|FG004|Overall Study|Lost to Follow-up|0|||
143353129|NCT02038764|516838733|FG000|Overall Study|Withdrawal by Subject|0|||
143353130|NCT02038764|516838734|FG001|Overall Study|Withdrawal by Subject|0|||
143461614|NCT01136772|517235093|FG000|Overall Study|Did not follow up after first injection|2|||
143353131|NCT02038764|516838735|FG002|Overall Study|Withdrawal by Subject|0|||
143353132|NCT02038764|516838736|FG003|Overall Study|Withdrawal by Subject|0|||
143353133|NCT02038764|516838737|FG004|Overall Study|Withdrawal by Subject|1|||
143353134|NCT02038764|516838733|FG000|Overall Study|Other|1|||
143353135|NCT02038764|516838734|FG001|Overall Study|Other|0|||
143353136|NCT02038764|516838735|FG002|Overall Study|Other|1|||
143353137|NCT02038764|516838736|FG003|Overall Study|Other|0|||
143353138|NCT02038764|516838737|FG004|Overall Study|Other|0|||
143353139|NCT01558674|516838742|FG000|Part 1|Study Terminated by Sponsor|10|||
143353140|NCT01558674|516838743|FG001|Part 1|Study Terminated by Sponsor|0|||
143353141|NCT01558674|516838742|FG000|Part 1|Withdrawal by Subject|1|||
143353142|NCT01558674|516838743|FG001|Part 1|Withdrawal by Subject|0|||
143353143|NCT00924469|516838744|FG000|Overall Study|Adverse Event|2|||
143353144|NCT00924469|516838745|FG001|Overall Study|Adverse Event|0|||
143353145|NCT00924469|516838744|FG000|Overall Study|Withdrawal by Subject|0|||
143353146|NCT00924469|516838745|FG001|Overall Study|Withdrawal by Subject|1|||
143353147|NCT00924469|516838744|FG000|Overall Study|Lost to Follow-up|0|||
143353148|NCT00924469|516838745|FG001|Overall Study|Lost to Follow-up|1|||
143353149|NCT02066532|516838750|FG000|Phase II|Withdrawal by Subject|1|||
143353150|NCT02066532|516838751|FG001|Phase II|Withdrawal by Subject|0|||
143353151|NCT02066532|516838752|FG002|Phase II|Withdrawal by Subject|0|||
143353152|NCT02066532|516838753|FG003|Phase II|Withdrawal by Subject|0|||
143353153|NCT05033080|516838754|FG000|Overall Study|Adverse Event|4|||
143353154|NCT05033080|516838755|FG001|Overall Study|Adverse Event|4|||
143353155|NCT05033080|516838754|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
143353156|NCT05033080|516838755|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
143353157|NCT05033080|516838754|FG000|Overall Study|Lost to Follow-up|1|||
143353158|NCT05033080|516838755|FG001|Overall Study|Lost to Follow-up|0|||
143353159|NCT05033080|516838754|FG000|Overall Study|Other non-compliance|0|||
143353160|NCT05033080|516838755|FG001|Overall Study|Other non-compliance|1|||
143353161|NCT05033080|516838754|FG000|Overall Study|Physician Decision|0|||
143353162|NCT05033080|516838755|FG001|Overall Study|Physician Decision|1|||
143353163|NCT05033080|516838754|FG000|Overall Study|Other|1|||
143353164|NCT05033080|516838755|FG001|Overall Study|Other|1|||
143353165|NCT03560245|516838756|FG000|Overall Study|Withdrawal by Subject|3|||
143353166|NCT03560245|516838757|FG001|Overall Study|Withdrawal by Subject|2|||
143353167|NCT03560245|516838756|FG000|Overall Study|Adverse Event|1|||
143353168|NCT03560245|516838757|FG001|Overall Study|Adverse Event|1|||
143353169|NCT03560245|516838756|FG000|Overall Study|Protocol Violation|1|||
143353170|NCT03560245|516838757|FG001|Overall Study|Protocol Violation|0|||
143353171|NCT03560245|516838756|FG000|Overall Study|Death|0|||
143353172|NCT03560245|516838757|FG001|Overall Study|Death|1|||
143353173|NCT03560245|516838756|FG000|Overall Study|Lost to Follow-up|0|||
143353174|NCT03560245|516838757|FG001|Overall Study|Lost to Follow-up|1|||
143353175|NCT03560245|516838756|FG000|Overall Study|Physician Decision|0|||
143353176|NCT03560245|516838757|FG001|Overall Study|Physician Decision|1|||
143353177|NCT03560245|516838756|FG000|Overall Study|Other|0|||
143353178|NCT03560245|516838757|FG001|Overall Study|Other|1|||
143353179|NCT01265823|516838758|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
143353180|NCT01265823|516838758|FG000|Overall Study|Failure to Return|4|||
143353181|NCT01265823|516838758|FG000|Overall Study|Protocol Violation|1|||
143353182|NCT01265823|516838758|FG000|Overall Study|Participant Request|1|||
143353183|NCT01263106|516838759|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
143353184|NCT01263106|516838760|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
143353185|NCT02696902|516838766|FG000|Overall Study|Lost to Follow-up|0|||
143353186|NCT02696902|516838767|FG001|Overall Study|Lost to Follow-up|1|||
143353187|NCT02696902|516838768|FG002|Overall Study|Lost to Follow-up|1|||
143353188|NCT02696902|516838766|FG000|Overall Study|Withdrawal by Subject|0|||
143353189|NCT02696902|516838767|FG001|Overall Study|Withdrawal by Subject|0|||
143353190|NCT02696902|516838768|FG002|Overall Study|Withdrawal by Subject|1|||
143353191|NCT02696902|516838766|FG000|Overall Study|Death|19|||
143353192|NCT02696902|516838767|FG001|Overall Study|Death|3|||
143353193|NCT02696902|516838768|FG002|Overall Study|Death|24|||
143353194|NCT02696902|516838766|FG000|Overall Study|Participant not fit post-randomization|0|||
143353195|NCT02696902|516838767|FG001|Overall Study|Participant not fit post-randomization|0|||
143353196|NCT02696902|516838768|FG002|Overall Study|Participant not fit post-randomization|1|||
143353197|NCT02696902|516838766|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
143353198|NCT02696902|516838767|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
143353199|NCT02696902|516838768|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
143353200|NCT02696902|516838766|FG000|Overall Study|Principal investigator's decision|1|||
143353201|NCT02696902|516838767|FG001|Overall Study|Principal investigator's decision|0|||
143353202|NCT02696902|516838768|FG002|Overall Study|Principal investigator's decision|0|||
143353203|NCT02696902|516838766|FG000|Overall Study|Sponsor's decision|1|||
143353204|NCT02696902|516838767|FG001|Overall Study|Sponsor's decision|0|||
143353205|NCT02696902|516838768|FG002|Overall Study|Sponsor's decision|0|||
143353206|NCT02696902|516838766|FG000|Overall Study|Transferred to other hospital|1|||
143353207|NCT02696902|516838767|FG001|Overall Study|Transferred to other hospital|0|||
143353208|NCT02696902|516838768|FG002|Overall Study|Transferred to other hospital|0|||
143353209|NCT03406702|516838773|FG000|Overall Study|Missed Day 27 Dosing|1|||
143353210|NCT00383240|516838783|FG000|Overall Study|Adverse Event|4|||
143353211|NCT00383240|516838784|FG001|Overall Study|Adverse Event|6|||
143353212|NCT00383240|516838785|FG002|Overall Study|Adverse Event|9|||
143353213|NCT00383240|516838786|FG003|Overall Study|Adverse Event|7|||
143353214|NCT00383240|516838783|FG000|Overall Study|Treatment Failure|8|||
143353215|NCT00383240|516838784|FG001|Overall Study|Treatment Failure|13|||
143353216|NCT00383240|516838785|FG002|Overall Study|Treatment Failure|47|||
143353217|NCT00383240|516838786|FG003|Overall Study|Treatment Failure|46|||
143353218|NCT00383240|516838783|FG000|Overall Study|Lost to Follow-up|3|||
143353219|NCT00383240|516838784|FG001|Overall Study|Lost to Follow-up|0|||
143353220|NCT00383240|516838785|FG002|Overall Study|Lost to Follow-up|0|||
143353221|NCT00383240|516838786|FG003|Overall Study|Lost to Follow-up|2|||
143353222|NCT00383240|516838783|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
143353223|NCT00383240|516838784|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
143353224|NCT00383240|516838785|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
143353225|NCT00383240|516838786|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
143353226|NCT00383240|516838783|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
143353227|NCT00383240|516838784|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
143353228|NCT00383240|516838785|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
143353229|NCT00383240|516838786|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
143353230|NCT00383240|516838783|FG000|Overall Study|Protocol Violation|4|||
143353231|NCT00383240|516838784|FG001|Overall Study|Protocol Violation|5|||
143353232|NCT00383240|516838785|FG002|Overall Study|Protocol Violation|9|||
143353233|NCT00383240|516838786|FG003|Overall Study|Protocol Violation|6|||
143353234|NCT00383240|516838783|FG000|Overall Study|Did not meet protocol eligibility|9|||
143353235|NCT00383240|516838784|FG001|Overall Study|Did not meet protocol eligibility|4|||
143353236|NCT00383240|516838785|FG002|Overall Study|Did not meet protocol eligibility|9|||
143353237|NCT00383240|516838786|FG003|Overall Study|Did not meet protocol eligibility|3|||
143353238|NCT00383240|516838783|FG000|Overall Study|Administrative|1|||
143353239|NCT00383240|516838784|FG001|Overall Study|Administrative|1|||
143353240|NCT00383240|516838785|FG002|Overall Study|Administrative|0|||
143353241|NCT00383240|516838786|FG003|Overall Study|Administrative|0|||
143353242|NCT02049710|516838787|FG000|Overall Study|Lost to Follow-up|319|||
143353243|NCT02049710|516838788|FG001|Overall Study|Lost to Follow-up|324|||
143353244|NCT00581113|516840794|FG000|Overall Study|Withdrawal by Subject|0|||
143353245|NCT00581113|516840795|FG001|Overall Study|Withdrawal by Subject|1|||
143353246|NCT04834362|516840801|FG000|Overall Study|Death|1|||
143353247|NCT04834362|516840802|FG001|Overall Study|Death|2|||
143353248|NCT03095599|516840803|FG000|Overall Study|Withdrawal by Subject|1|||
143353249|NCT03095599|516840804|FG001|Overall Study|Withdrawal by Subject|0|||
143353250|NCT03095599|516840803|FG000|Overall Study|Lost to Follow-up|1|||
143353251|NCT03095599|516840804|FG001|Overall Study|Lost to Follow-up|0|||
143353252|NCT03095599|516840803|FG000|Overall Study|Withdrawal prior to vaccination|1|||
143353253|NCT03095599|516840804|FG001|Overall Study|Withdrawal prior to vaccination|0|||
143125587|NCT05052697|516003721|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
143125588|NCT05052697|516003722|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
143353254|NCT01853254|516840808|FG000|Overall Study|Abnormal Laboratory Test|1|||
143353255|NCT01853254|516840808|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
143353256|NCT01853254|516840808|FG000|Overall Study|Death|1|||
143012312|NCT01275170|515583620|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
143012313|NCT01275170|515583621|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
143012314|NCT01275170|515583622|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
143012315|NCT01275170|515583623|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
143012316|NCT01275170|515583624|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
143012317|NCT01275170|515583625|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
143012318|NCT00402779|515583628|FG000|Overall Study|Screen Failure|77|||
143012319|NCT00402779|515583629|FG001|Overall Study|Screen Failure|76|||
143012320|NCT05004181|515583633|FG000|Overall Study|Withdrawal of consent|0|||
143012321|NCT05004181|515583634|FG001|Overall Study|Withdrawal of consent|0|||
143012322|NCT05004181|515583635|FG002|Overall Study|Withdrawal of consent|1|||
143012323|NCT05004181|515583636|FG003|Overall Study|Withdrawal of consent|3|||
143353257|NCT01853254|516840808|FG000|Overall Study|Failure to Return|43|||
143353258|NCT01853254|516840808|FG000|Overall Study|Insufficient Therapeutic Response|22|||
143012324|NCT05004181|515583637|FG004|Overall Study|Withdrawal of consent|3|||
143012325|NCT05004181|515583638|FG005|Overall Study|Withdrawal of consent|0|||
143353259|NCT01853254|516840808|FG000|Overall Study|Refusal of Treatment|1|||
143012326|NCT05004181|515583639|FG006|Overall Study|Withdrawal of consent|30|||
143353260|NCT01853254|516840808|FG000|Overall Study|Other Protocol Violation|1|||
143353261|NCT01853254|516840808|FG000|Overall Study|Withdrawal of Consent|16|||
143353262|NCT01853254|516840808|FG000|Overall Study|Administrative/Other|16|||
143353263|NCT00867490|516840814|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
143353264|NCT00867490|516840814|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
143353265|NCT00867490|516840814|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
143353266|NCT00867490|516840814|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
143353267|NCT00867490|516840814|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
143353268|NCT00358150|516840815|FG000|Overall Study|Adverse Event|3|||
143353269|NCT00358150|516840815|FG000|Overall Study|Withdrawal by Subject|1|||
143353270|NCT00358150|516840815|FG000|Overall Study|Undefined|3|||
143353271|NCT03685708|516840816|FG000|Overall Study|Withdrawal by Subject|0|||
143353272|NCT03685708|516840817|FG001|Overall Study|Withdrawal by Subject|0|||
143353273|NCT03685708|516840818|FG002|Overall Study|Withdrawal by Subject|1|||
143353274|NCT03685708|516840816|FG000|Overall Study|Screen Fail|0|||
143353275|NCT03685708|516840817|FG001|Overall Study|Screen Fail|1|||
143353276|NCT03685708|516840818|FG002|Overall Study|Screen Fail|1|||
143012327|NCT05004181|515583640|FG007|Overall Study|Withdrawal of consent|9|||
143012328|NCT05004181|515583641|FG008|Overall Study|Withdrawal of consent|3|||
143012329|NCT05004181|515583642|FG009|Overall Study|Withdrawal of consent|2|||
143012330|NCT05004181|515583643|FG010|Overall Study|Withdrawal of consent|5|||
143012331|NCT05004181|515583644|FG011|Overall Study|Withdrawal of consent|1|||
143012332|NCT05004181|515583633|FG000|Overall Study|Lost to Follow-up|2|||
143012333|NCT05004181|515583634|FG001|Overall Study|Lost to Follow-up|4|||
143012334|NCT05004181|515583635|FG002|Overall Study|Lost to Follow-up|2|||
143012335|NCT05004181|515583636|FG003|Overall Study|Lost to Follow-up|3|||
143012336|NCT05004181|515583637|FG004|Overall Study|Lost to Follow-up|5|||
143012337|NCT05004181|515583638|FG005|Overall Study|Lost to Follow-up|2|||
143012338|NCT05004181|515583639|FG006|Overall Study|Lost to Follow-up|15|||
143012339|NCT05004181|515583640|FG007|Overall Study|Lost to Follow-up|12|||
143012340|NCT05004181|515583641|FG008|Overall Study|Lost to Follow-up|38|||
143012341|NCT05004181|515583642|FG009|Overall Study|Lost to Follow-up|6|||
143012342|NCT05004181|515583643|FG010|Overall Study|Lost to Follow-up|6|||
143012343|NCT05004181|515583644|FG011|Overall Study|Lost to Follow-up|0|||
143012344|NCT05004181|515583633|FG000|Overall Study|Death|0|||
143012345|NCT05004181|515583634|FG001|Overall Study|Death|0|||
143012346|NCT05004181|515583635|FG002|Overall Study|Death|0|||
143012347|NCT05004181|515583636|FG003|Overall Study|Death|0|||
143012348|NCT05004181|515583637|FG004|Overall Study|Death|0|||
143012349|NCT05004181|515583638|FG005|Overall Study|Death|0|||
143012350|NCT05004181|515583639|FG006|Overall Study|Death|1|||
143012351|NCT05004181|515583640|FG007|Overall Study|Death|0|||
143012352|NCT05004181|515583641|FG008|Overall Study|Death|2|||
143012353|NCT05004181|515583642|FG009|Overall Study|Death|0|||
143012354|NCT05004181|515583643|FG010|Overall Study|Death|0|||
143012355|NCT05004181|515583644|FG011|Overall Study|Death|0|||
143012356|NCT05004181|515583633|FG000|Overall Study|Physician Decision|0|||
143012357|NCT05004181|515583634|FG001|Overall Study|Physician Decision|0|||
143012358|NCT05004181|515583635|FG002|Overall Study|Physician Decision|0|||
143012359|NCT05004181|515583636|FG003|Overall Study|Physician Decision|0|||
143012360|NCT05004181|515583637|FG004|Overall Study|Physician Decision|0|||
143012361|NCT05004181|515583638|FG005|Overall Study|Physician Decision|0|||
143012362|NCT05004181|515583639|FG006|Overall Study|Physician Decision|2|||
143012363|NCT05004181|515583640|FG007|Overall Study|Physician Decision|0|||
143012364|NCT05004181|515583641|FG008|Overall Study|Physician Decision|7|||
143012365|NCT05004181|515583642|FG009|Overall Study|Physician Decision|0|||
143012366|NCT05004181|515583643|FG010|Overall Study|Physician Decision|0|||
143012367|NCT05004181|515583644|FG011|Overall Study|Physician Decision|0|||
143012368|NCT05004181|515583633|FG000|Overall Study|Withdrawal by Subject|2|||
143012369|NCT05004181|515583634|FG001|Overall Study|Withdrawal by Subject|3|||
143012370|NCT05004181|515583635|FG002|Overall Study|Withdrawal by Subject|2|||
143012371|NCT05004181|515583636|FG003|Overall Study|Withdrawal by Subject|2|||
143012372|NCT05004181|515583637|FG004|Overall Study|Withdrawal by Subject|4|||
143012373|NCT05004181|515583638|FG005|Overall Study|Withdrawal by Subject|2|||
143012374|NCT05004181|515583639|FG006|Overall Study|Withdrawal by Subject|4|||
143012375|NCT05004181|515583640|FG007|Overall Study|Withdrawal by Subject|22|||
143012376|NCT05004181|515583641|FG008|Overall Study|Withdrawal by Subject|8|||
143012377|NCT05004181|515583642|FG009|Overall Study|Withdrawal by Subject|1|||
143353277|NCT03685708|516840816|FG000|Overall Study|COVID 19 Pandemic|1|||
143353278|NCT03685708|516840817|FG001|Overall Study|COVID 19 Pandemic|1|||
143353279|NCT03685708|516840818|FG002|Overall Study|COVID 19 Pandemic|6|||
143012378|NCT05004181|515583643|FG010|Overall Study|Withdrawal by Subject|3|||
143012379|NCT05004181|515583644|FG011|Overall Study|Withdrawal by Subject|2|||
143012380|NCT05004181|515583633|FG000|Overall Study|Protocol Violation|2|||
143012381|NCT05004181|515583634|FG001|Overall Study|Protocol Violation|3|||
143012382|NCT05004181|515583635|FG002|Overall Study|Protocol Violation|0|||
143012383|NCT05004181|515583636|FG003|Overall Study|Protocol Violation|0|||
143012384|NCT05004181|515583637|FG004|Overall Study|Protocol Violation|1|||
143012385|NCT05004181|515583638|FG005|Overall Study|Protocol Violation|0|||
143012386|NCT05004181|515583639|FG006|Overall Study|Protocol Violation|16|||
143353280|NCT03685708|516840816|FG000|Overall Study|Disease Progression|0|||
143012387|NCT05004181|515583640|FG007|Overall Study|Protocol Violation|18|||
143353281|NCT03685708|516840817|FG001|Overall Study|Disease Progression|0|||
143353282|NCT03685708|516840818|FG002|Overall Study|Disease Progression|1|||
143012388|NCT05004181|515583641|FG008|Overall Study|Protocol Violation|2|||
143012389|NCT05004181|515583642|FG009|Overall Study|Protocol Violation|2|||
143353283|NCT00531011|516840830|FG000|Overall Study|Withdrawal by Subject|2|||
143353284|NCT00531011|516840831|FG001|Overall Study|Withdrawal by Subject|4|||
143353285|NCT00531011|516840830|FG000|Overall Study|Death|1|||
143353286|NCT00531011|516840831|FG001|Overall Study|Death|0|||
143353287|NCT00531011|516840830|FG000|Overall Study|Lost to Follow-up|1|||
143353288|NCT00531011|516840831|FG001|Overall Study|Lost to Follow-up|0|||
143353289|NCT00531011|516840830|FG000|Overall Study|Physician Decision|0|||
143353290|NCT00531011|516840831|FG001|Overall Study|Physician Decision|3|||
143353291|NCT00672958|516840840|FG000|Overall Study|Adverse Event|11|||
143353292|NCT00672958|516840841|FG001|Overall Study|Adverse Event|9|||
143353293|NCT00672958|516840840|FG000|Overall Study|Lack of Efficacy|6|||
143353294|NCT00672958|516840841|FG001|Overall Study|Lack of Efficacy|11|||
143353295|NCT00672958|516840840|FG000|Overall Study|Non-compliance with study drug|2|||
143353296|NCT00672958|516840841|FG001|Overall Study|Non-compliance with study drug|3|||
143353297|NCT00672958|516840840|FG000|Overall Study|Protocol deviations|11|||
143012390|NCT05004181|515583643|FG010|Overall Study|Protocol Violation|2|||
143012391|NCT05004181|515583644|FG011|Overall Study|Protocol Violation|1|||
143012392|NCT05004181|515583633|FG000|Overall Study|Not further specified|1|||
143012393|NCT05004181|515583634|FG001|Overall Study|Not further specified|0|||
143012394|NCT05004181|515583635|FG002|Overall Study|Not further specified|0|||
143012395|NCT05004181|515583636|FG003|Overall Study|Not further specified|0|||
143012396|NCT05004181|515583637|FG004|Overall Study|Not further specified|0|||
143012397|NCT05004181|515583638|FG005|Overall Study|Not further specified|0|||
143012398|NCT05004181|515583639|FG006|Overall Study|Not further specified|1|||
143012399|NCT05004181|515583640|FG007|Overall Study|Not further specified|0|||
143012400|NCT05004181|515583641|FG008|Overall Study|Not further specified|2|||
143012401|NCT05004181|515583642|FG009|Overall Study|Not further specified|1|||
143012402|NCT05004181|515583643|FG010|Overall Study|Not further specified|0|||
143012403|NCT05004181|515583644|FG011|Overall Study|Not further specified|1|||
143012404|NCT04278872|515583645|FG000|Overall Study|Adverse Event|1|||
143012405|NCT04278872|515583646|FG001|Overall Study|Adverse Event|0|||
143012406|NCT04278872|515583645|FG000|Overall Study|Protocol Violation|0|||
143012407|NCT04278872|515583646|FG001|Overall Study|Protocol Violation|1|||
143012408|NCT04278872|515583645|FG000|Overall Study|Study Termination|2|||
143012409|NCT04278872|515583646|FG001|Overall Study|Study Termination|0|||
143012410|NCT03353415|515583647|FG000|Masked CGM Wear|Lost to Follow-up|2|||
143012411|NCT03353415|515583647|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
143012412|NCT00005879|515583648|FG000|Overall Study|Withdrawal by Subject|8|||
143012413|NCT00005879|515583649|FG001|Overall Study|Withdrawal by Subject|10|||
143012414|NCT01238172|515583650|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
143012415|NCT01238172|515583651|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
143012416|NCT01238172|515583650|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
143012417|NCT01238172|515583651|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
143012418|NCT02038959|515585555|FG000|Overall Study|Withdrawal by Subject|6|||
143012419|NCT02038959|515585556|FG001|Overall Study|Withdrawal by Subject|8|||
143012420|NCT03515837|515585562|FG000|Overall Study|Death|219|||
143012421|NCT03515837|515585563|FG001|Overall Study|Death|227|||
143012422|NCT03515837|515585562|FG000|Overall Study|Lost to Follow-up|0|||
143012423|NCT03515837|515585563|FG001|Overall Study|Lost to Follow-up|1|||
143012424|NCT03515837|515585562|FG000|Overall Study|Withdrawal by Subject|0|||
143012425|NCT03515837|515585563|FG001|Overall Study|Withdrawal by Subject|4|||
143012426|NCT03515837|515585562|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
143012427|NCT03515837|515585563|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
143012428|NCT01964898|515585564|FG000|Overall Study|ineligible post-randomization|1|||
143012429|NCT01964898|515585565|FG001|Overall Study|ineligible post-randomization|1|||
143012430|NCT01964898|515585564|FG000|Overall Study|did not receive the allocated interventi|2|||
143012431|NCT01964898|515585565|FG001|Overall Study|did not receive the allocated interventi|1|||
143012432|NCT01964898|515585564|FG000|Overall Study|Lost to Follow-up|3|||
143012433|NCT01964898|515585565|FG001|Overall Study|Lost to Follow-up|5|||
143012434|NCT01964898|515585564|FG000|Overall Study|Withdrawal by Subject|1|||
143012435|NCT01964898|515585565|FG001|Overall Study|Withdrawal by Subject|0|||
143012436|NCT00819091|515585566|FG000|Overall Study|Adverse Event|3|||
143125589|NCT05052697|516003723|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
143353298|NCT00672958|516840841|FG001|Overall Study|Protocol deviations|5|||
143353299|NCT00672958|516840840|FG000|Overall Study|Voluntary withdrawal|12|||
143353300|NCT00672958|516840841|FG001|Overall Study|Voluntary withdrawal|8|||
143353301|NCT00672958|516840840|FG000|Overall Study|Lost to Follow-up|22|||
143012437|NCT00819091|515585567|FG001|Overall Study|Adverse Event|5|||
143012438|NCT00819091|515585566|FG000|Overall Study|Protocol Violation|0|||
143012439|NCT00819091|515585567|FG001|Overall Study|Protocol Violation|1|||
143012440|NCT00819091|515585566|FG000|Overall Study|Lost to Follow-up|2|||
143012441|NCT00819091|515585567|FG001|Overall Study|Lost to Follow-up|0|||
143012442|NCT00819091|515585566|FG000|Overall Study|Withdrawal by Subject|1|||
143012443|NCT00819091|515585567|FG001|Overall Study|Withdrawal by Subject|2|||
143012444|NCT00819091|515585566|FG000|Overall Study|Other|1|||
143353302|NCT00672958|516840841|FG001|Overall Study|Lost to Follow-up|17|||
143353303|NCT00672958|516840840|FG000|Overall Study|Reason not specified|0|||
143353304|NCT00672958|516840841|FG001|Overall Study|Reason not specified|3|||
143353305|NCT01009047|516840842|FG000|Overall Study|Adverse Event|5|||
143353306|NCT01009047|516840843|FG001|Overall Study|Adverse Event|0|||
143353307|NCT01009047|516840842|FG000|Overall Study|Lost to Follow-up|0|||
143353308|NCT01009047|516840843|FG001|Overall Study|Lost to Follow-up|2|||
143353309|NCT01009047|516840842|FG000|Overall Study|Lack of Efficacy|4|||
143353310|NCT01009047|516840843|FG001|Overall Study|Lack of Efficacy|11|||
143353311|NCT01009047|516840842|FG000|Overall Study|Withdrawal by consent|16|||
143353312|NCT01009047|516840843|FG001|Overall Study|Withdrawal by consent|11|||
143353313|NCT01009047|516840842|FG000|Overall Study|Other|3|||
143353314|NCT01009047|516840843|FG001|Overall Study|Other|2|||
143353315|NCT04716881|516840845|FG000|Overall Study|Adverse Event|1|||
143353316|NCT04716881|516840845|FG000|Overall Study|Lost to Follow-up|1|||
143353317|NCT01630590|516840847|FG000|Overall Study|Adverse Event|9|||
143353318|NCT01630590|516840847|FG000|Overall Study|Lack of Efficacy|37|||
143353319|NCT01630590|516840847|FG000|Overall Study|Withdrawal by Subject|4|||
143353320|NCT01630590|516840847|FG000|Overall Study|2nd primary tumor|2|||
143353321|NCT01630590|516840847|FG000|Overall Study|Automobile accident|1|||
143353322|NCT01630590|516840847|FG000|Overall Study|Maximum benefit|4|||
143353323|NCT02366936|516840851|FG000|Overall Study|Withdrawal by Subject|2|||
143353324|NCT02366936|516840851|FG000|Overall Study|Lost to Follow-up|4|||
143353325|NCT02366936|516840851|FG000|Overall Study|Physician Decision|2|||
143353326|NCT01751113|516840852|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
143353327|NCT01751113|516840853|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
143353328|NCT01751113|516840854|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
143353329|NCT01751113|516840855|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
143353330|NCT01751113|516840856|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
143353331|NCT01751113|516840857|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
143353332|NCT01751113|516840852|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
143353333|NCT01751113|516840853|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
143353334|NCT01751113|516840854|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
143353335|NCT01751113|516840855|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
143353336|NCT01751113|516840856|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
143353337|NCT01751113|516840857|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
143353338|NCT00630058|516840858|FG000|Overall Study|Adverse Event|1|||
143353339|NCT00630058|516840859|FG001|Overall Study|Adverse Event|1|||
143353340|NCT00630058|516840858|FG000|Overall Study|Withdrawal by Subject|0|||
143353341|NCT00630058|516840859|FG001|Overall Study|Withdrawal by Subject|1|||
143353342|NCT00630058|516840858|FG000|Overall Study|stopping criteria|3|||
143353343|NCT00630058|516840859|FG001|Overall Study|stopping criteria|2|||
143353344|NCT01651936|516840860|FG000|Base Study|Adverse Event|3|||
143353345|NCT01651936|516840861|FG001|Base Study|Adverse Event|0|||
143353346|NCT01651936|516840862|FG002|Base Study|Adverse Event|0|||
143353347|NCT01651936|516840860|FG000|Base Study|Withdrawal by Subject|1|||
143353348|NCT01651936|516840861|FG001|Base Study|Withdrawal by Subject|1|||
143353349|NCT01651936|516840862|FG002|Base Study|Withdrawal by Subject|0|||
143353350|NCT01651936|516840860|FG000|Base Study|Early Escape|2|||
143353351|NCT01651936|516840861|FG001|Base Study|Early Escape|8|||
143353352|NCT01651936|516840862|FG002|Base Study|Early Escape|0|||
143353353|NCT01651936|516840860|FG000|Base Study|Study terminated by sponsor|21|||
143353354|NCT01651936|516840861|FG001|Base Study|Study terminated by sponsor|16|||
143353355|NCT01651936|516840862|FG002|Base Study|Study terminated by sponsor|0|||
143461615|NCT01136772|517235094|FG001|Overall Study|Did not follow up after first injection|2|||
143461616|NCT01831856|517235095|FG000|Overall Study|Adverse Event|5|||
143461617|NCT01831856|517235096|FG001|Overall Study|Adverse Event|8|||
143461618|NCT01831856|517235095|FG000|Overall Study|Lack of Efficacy|13|||
143461619|NCT01831856|517235096|FG001|Overall Study|Lack of Efficacy|11|||
143461620|NCT01831856|517235095|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
143461621|NCT01831856|517235096|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
143461622|NCT01498653|517235098|FG000|Overall Study|Adverse Event|2|||
143461623|NCT01498653|517235099|FG001|Overall Study|Adverse Event|2|||
143461624|NCT01498653|517235098|FG000|Overall Study|Lack of Efficacy|12|||
143461625|NCT01498653|517235099|FG001|Overall Study|Lack of Efficacy|26|||
143461626|NCT01498653|517235098|FG000|Overall Study|Protocol Violation|0|||
143353356|NCT01651936|516840860|FG000|Extension Study|Lack of Efficacy|0|||
143353357|NCT01651936|516840861|FG001|Extension Study|Lack of Efficacy|0|||
143461627|NCT01498653|517235099|FG001|Overall Study|Protocol Violation|4|||
143461628|NCT01498653|517235098|FG000|Overall Study|Lost to Follow-up|1|||
143461629|NCT01498653|517235099|FG001|Overall Study|Lost to Follow-up|0|||
143461630|NCT01498653|517235098|FG000|Overall Study|Physician Decision|2|||
143353358|NCT01651936|516840862|FG002|Extension Study|Lack of Efficacy|1|||
143353359|NCT01651936|516840860|FG000|Extension Study|Study terminated by sponsor|0|||
143353360|NCT01651936|516840861|FG001|Extension Study|Study terminated by sponsor|0|||
143353361|NCT01651936|516840862|FG002|Extension Study|Study terminated by sponsor|13|||
143353362|NCT03044353|516840863|FG000|Overall Study|Adverse Event|0|||
143461631|NCT01498653|517235099|FG001|Overall Study|Physician Decision|0|||
143353363|NCT03044353|516840864|FG001|Overall Study|Adverse Event|1|||
143353364|NCT03044353|516840865|FG002|Overall Study|Adverse Event|0|||
143353365|NCT02141659|516840875|FG000|Overall Study|Major Protocol Deviation|0|||
143353366|NCT02141659|516840876|FG001|Overall Study|Major Protocol Deviation|1|||
143353367|NCT02141659|516840877|FG002|Overall Study|Major Protocol Deviation|0|||
143353368|NCT02141659|516840878|FG003|Overall Study|Major Protocol Deviation|0|||
143353369|NCT02141659|516840879|FG004|Overall Study|Major Protocol Deviation|0|||
143353370|NCT02141659|516840880|FG005|Overall Study|Major Protocol Deviation|0|||
143353371|NCT02141659|516840875|FG000|Overall Study|Lack of Efficacy|0|||
143353372|NCT02141659|516840876|FG001|Overall Study|Lack of Efficacy|0|||
143353373|NCT02141659|516840877|FG002|Overall Study|Lack of Efficacy|0|||
143353374|NCT02141659|516840878|FG003|Overall Study|Lack of Efficacy|0|||
143353375|NCT02141659|516840879|FG004|Overall Study|Lack of Efficacy|0|||
143353376|NCT02141659|516840880|FG005|Overall Study|Lack of Efficacy|1|||
143353377|NCT02141659|516840875|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
143353378|NCT02141659|516840876|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
143353379|NCT02141659|516840877|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
143353380|NCT02141659|516840878|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
143353381|NCT02141659|516840879|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
143353382|NCT02141659|516840880|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
143353383|NCT00305864|516840887|FG000|Overall Study|Ineligible / No protocol treatment|0|||
143353384|NCT00305864|516840888|FG001|Overall Study|Ineligible / No protocol treatment|1|||
143353385|NCT00305864|516840889|FG002|Overall Study|Ineligible / No protocol treatment|1|||
143353386|NCT00305864|516840890|FG003|Overall Study|Ineligible / No protocol treatment|13|||
143353387|NCT02836613|516840893|FG000|Overall Study|Accidental drowning|1|||
143353388|NCT02836613|516840894|FG001|Overall Study|Accidental drowning|0|||
143353389|NCT02836613|516840893|FG000|Overall Study|Lost to Follow-up|0|||
143353390|NCT02836613|516840894|FG001|Overall Study|Lost to Follow-up|1|||
143353391|NCT02836613|516840893|FG000|Overall Study|Withdrawal by Subject|0|||
143353392|NCT02836613|516840894|FG001|Overall Study|Withdrawal by Subject|2|||
143353393|NCT03881059|516840895|FG000|Treatment Period - Part A|Adverse Event|1|||
143353394|NCT03881059|516840896|FG001|Treatment Period - Part A|Adverse Event|3|||
143353395|NCT03881059|516840897|FG002|Treatment Period - Part A|Adverse Event|4|||
143353396|NCT03881059|516840895|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
143353397|NCT03881059|516840896|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
143353398|NCT03881059|516840897|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
143353399|NCT03881059|516840895|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
143353400|NCT03881059|516840896|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
143353401|NCT03881059|516840897|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
143353402|NCT03881059|516840895|FG000|Treatment Period - Part A|Other reasons|2|||
143353403|NCT03881059|516840896|FG001|Treatment Period - Part A|Other reasons|1|||
143353404|NCT03881059|516840897|FG002|Treatment Period - Part A|Other reasons|0|||
143353405|NCT03881059|516840895|FG000|Treatment Period - Part B|Adverse Event|0|||
143353406|NCT03881059|516840896|FG001|Treatment Period - Part B|Adverse Event|0|||
143012445|NCT00819091|515585567|FG001|Overall Study|Other|2|||
143353407|NCT03881059|516840897|FG002|Treatment Period - Part B|Adverse Event|3|||
143353408|NCT03881059|516840895|FG000|Treatment Period - Part B|Death|0|||
143353409|NCT03881059|516840896|FG001|Treatment Period - Part B|Death|1|||
143353410|NCT03881059|516840897|FG002|Treatment Period - Part B|Death|1|||
143353411|NCT03881059|516840895|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
143353412|NCT03881059|516840896|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
143353413|NCT03881059|516840897|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
143353414|NCT03881059|516840895|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
143353415|NCT03881059|516840896|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
143012446|NCT00424515|515585571|FG000|Overall Study|Progressive Disease|10|||
143012447|NCT00424515|515585572|FG001|Overall Study|Progressive Disease|11|||
143012448|NCT00424515|515585571|FG000|Overall Study|Adverse Event|0|||
143012449|NCT00424515|515585572|FG001|Overall Study|Adverse Event|1|||
143012450|NCT00424515|515585571|FG000|Overall Study|Intercurrent Illness|0|||
143012451|NCT00424515|515585572|FG001|Overall Study|Intercurrent Illness|1|||
143012452|NCT00424515|515585571|FG000|Overall Study|Withdrawal by Subject|1|||
143012453|NCT00424515|515585572|FG001|Overall Study|Withdrawal by Subject|0|||
143125590|NCT05052697|516003724|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
143353416|NCT03881059|516840897|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
143353417|NCT03881059|516840895|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
143353418|NCT03881059|516840896|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
143353419|NCT03881059|516840897|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
143353420|NCT03881059|516840895|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
143353421|NCT03881059|516840896|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
143353422|NCT03881059|516840897|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
143353423|NCT03881059|516840895|FG000|Treatment Period - Part B|Other reasons|4|||
143353424|NCT03881059|516840896|FG001|Treatment Period - Part B|Other reasons|3|||
143012454|NCT00858234|515585573|FG000|Overall Study|Adverse Event|6|||
143012455|NCT00858234|515585573|FG000|Overall Study|Progressive disease|2|||
143012456|NCT00858234|515585573|FG000|Overall Study|Status unknown|1|||
143125591|NCT05052697|516003725|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
143125592|NCT05052697|516003726|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
143125593|NCT05052697|516003727|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
143125594|NCT05052697|516003728|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
143125595|NCT05052697|516003729|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
143125596|NCT05052697|516003730|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
143125597|NCT05052697|516003731|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
143125598|NCT05052697|516003732|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
143125599|NCT05052697|516003733|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
143125600|NCT05052697|516003734|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
143125601|NCT05052697|516003735|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
143125602|NCT05052697|516003736|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
143125603|NCT05052697|516003737|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
143125604|NCT05052697|516003738|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
143125605|NCT05052697|516003739|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
143125606|NCT05052697|516003740|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
143353425|NCT03881059|516840897|FG002|Treatment Period - Part B|Other reasons|3|||
143353426|NCT05284019|516840898|FG000|Overall Study|Study terminated|2|||
143353427|NCT05284019|516840899|FG001|Overall Study|Study terminated|2|||
143353428|NCT05284019|516840900|FG002|Overall Study|Study terminated|2|||
143125607|NCT05052697|516003741|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
143125608|NCT05052697|516003708|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
143125609|NCT05052697|516003709|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
143125610|NCT05052697|516003710|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
143353429|NCT05284019|516840901|FG003|Overall Study|Study terminated|5|||
143353430|NCT05284019|516840902|FG004|Overall Study|Study terminated|15|||
143353431|NCT05284019|516840898|FG000|Overall Study|Withdrawal by Subject|0|||
143353432|NCT05284019|516840899|FG001|Overall Study|Withdrawal by Subject|0|||
143353433|NCT05284019|516840900|FG002|Overall Study|Withdrawal by Subject|0|||
143353434|NCT05284019|516840901|FG003|Overall Study|Withdrawal by Subject|1|||
143353435|NCT05284019|516840902|FG004|Overall Study|Withdrawal by Subject|1|||
143353436|NCT05284019|516840898|FG000|Overall Study|Lost to Follow-up|1|||
143353437|NCT05284019|516840899|FG001|Overall Study|Lost to Follow-up|0|||
143353438|NCT05284019|516840900|FG002|Overall Study|Lost to Follow-up|0|||
143353439|NCT05284019|516840901|FG003|Overall Study|Lost to Follow-up|2|||
143353440|NCT05284019|516840902|FG004|Overall Study|Lost to Follow-up|1|||
143353441|NCT02065570|516840903|FG000|Induction Study|Adverse Event|5|||
143353442|NCT02065570|516840904|FG001|Induction Study|Adverse Event|12|||
143353443|NCT02065570|516840905|FG002|Induction Study|Adverse Event|0|||
143353444|NCT02065570|516840906|FG003|Induction Study|Adverse Event|0|||
143353445|NCT02065570|516840903|FG000|Induction Study|Withdrawal by Subject|2|||
143353446|NCT02065570|516840904|FG001|Induction Study|Withdrawal by Subject|3|||
143353447|NCT02065570|516840905|FG002|Induction Study|Withdrawal by Subject|0|||
143353448|NCT02065570|516840906|FG003|Induction Study|Withdrawal by Subject|0|||
143353449|NCT02065570|516840903|FG000|Induction Study|Lost to Follow-up|1|||
143353450|NCT02065570|516840904|FG001|Induction Study|Lost to Follow-up|1|||
143353451|NCT02065570|516840905|FG002|Induction Study|Lost to Follow-up|0|||
143353452|NCT02065570|516840906|FG003|Induction Study|Lost to Follow-up|0|||
143353453|NCT02065570|516840903|FG000|Induction Study|Other, Not Specified|6|||
143353454|NCT02065570|516840904|FG001|Induction Study|Other, Not Specified|5|||
143353455|NCT02065570|516840905|FG002|Induction Study|Other, Not Specified|0|||
143353456|NCT02065570|516840906|FG003|Induction Study|Other, Not Specified|0|||
143353457|NCT02065570|516840903|FG000|Maintenance Study|Adverse Event|0|||
143353458|NCT02065570|516840904|FG001|Maintenance Study|Adverse Event|0|||
143353459|NCT02065570|516840905|FG002|Maintenance Study|Adverse Event|8|||
143353460|NCT02065570|516840906|FG003|Maintenance Study|Adverse Event|8|||
143353461|NCT02065570|516840903|FG000|Maintenance Study|Withdrawal by Subject|0|||
143353462|NCT02065570|516840904|FG001|Maintenance Study|Withdrawal by Subject|0|||
143353463|NCT02065570|516840905|FG002|Maintenance Study|Withdrawal by Subject|1|||
143353464|NCT02065570|516840906|FG003|Maintenance Study|Withdrawal by Subject|4|||
143353465|NCT02065570|516840903|FG000|Maintenance Study|Lost to Follow-up|0|||
143353466|NCT02065570|516840904|FG001|Maintenance Study|Lost to Follow-up|0|||
143353467|NCT02065570|516840905|FG002|Maintenance Study|Lost to Follow-up|2|||
143353468|NCT02065570|516840906|FG003|Maintenance Study|Lost to Follow-up|2|||
143353469|NCT02065570|516840903|FG000|Maintenance Study|Other, Not Specified|0|||
143353470|NCT02065570|516840904|FG001|Maintenance Study|Other, Not Specified|0|||
143353471|NCT02065570|516840905|FG002|Maintenance Study|Other, Not Specified|11|||
143353472|NCT02065570|516840906|FG003|Maintenance Study|Other, Not Specified|5|||
143353473|NCT02743793|516840907|FG000|Overall Study|Death|1|||
143353474|NCT02743793|516840908|FG001|Overall Study|Death|1|||
143353475|NCT02743793|516840907|FG000|Overall Study|Withdrawal by Subject|0|||
143353476|NCT02743793|516840908|FG001|Overall Study|Withdrawal by Subject|1|||
143353477|NCT02743793|516840907|FG000|Overall Study|Screen Failure|4|||
143353478|NCT02743793|516840908|FG001|Overall Study|Screen Failure|0|||
143012457|NCT04318535|515585574|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
143012458|NCT04318535|515585575|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
143012459|NCT04318535|515585576|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
143012460|NCT02156466|515585583|FG000|Overall Study|Adverse Event|0|||
143012461|NCT02156466|515585584|FG001|Overall Study|Adverse Event|0|||
143012462|NCT02156466|515585585|FG002|Overall Study|Adverse Event|1|||
143012463|NCT02156466|515585586|FG003|Overall Study|Adverse Event|1|||
143012464|NCT02156466|515585587|FG004|Overall Study|Adverse Event|0|||
143012465|NCT02156466|515585583|FG000|Overall Study|Quantiferon Positivity|0|||
143012466|NCT02156466|515585584|FG001|Overall Study|Quantiferon Positivity|0|||
143012467|NCT02156466|515585585|FG002|Overall Study|Quantiferon Positivity|0|||
143012468|NCT02156466|515585586|FG003|Overall Study|Quantiferon Positivity|1|||
143012469|NCT02156466|515585587|FG004|Overall Study|Quantiferon Positivity|0|||
143012470|NCT02237118|515585588|FG000|Overall Study|Protocol Violation|0|||
143012471|NCT02237118|515585589|FG001|Overall Study|Protocol Violation|1|||
143012472|NCT02237118|515585588|FG000|Overall Study|consent withdrawn|1|||
143012473|NCT02237118|515585589|FG001|Overall Study|consent withdrawn|0|||
143012474|NCT03044431|515585592|FG000|Overall Study|Lost to Follow-up|59|||
143012475|NCT04470622|515585593|FG000|Overall Study|Withdrawal by Subject|0|||
143012476|NCT04470622|515585594|FG001|Overall Study|Withdrawal by Subject|1|||
143012477|NCT04470622|515585593|FG000|Overall Study|Screen Failure|0|||
143012478|NCT04470622|515585594|FG001|Overall Study|Screen Failure|1|||
143012479|NCT04470622|515585593|FG000|Overall Study|Death|0|||
143012480|NCT04470622|515585594|FG001|Overall Study|Death|1|||
143012481|NCT02957682|515585595|FG000|Overall Study|Adverse Event|64|||
143012482|NCT02957682|515585596|FG001|Overall Study|Adverse Event|67|||
143012483|NCT02957682|515585595|FG000|Overall Study|Poor Compliance to Protocol|30|||
143012484|NCT02957682|515585596|FG001|Overall Study|Poor Compliance to Protocol|26|||
143012485|NCT02957682|515585595|FG000|Overall Study|Physician Decision|4|||
143012486|NCT02957682|515585596|FG001|Overall Study|Physician Decision|4|||
143012487|NCT02957682|515585595|FG000|Overall Study|Study Terminated by Sponsor|4|||
143012488|NCT02957682|515585596|FG001|Overall Study|Study Terminated by Sponsor|3|||
143012489|NCT02957682|515585595|FG000|Overall Study|Subject Moved|10|||
143012490|NCT02957682|515585596|FG001|Overall Study|Subject Moved|16|||
143012491|NCT02957682|515585595|FG000|Overall Study|Withdrawal by Subject|64|||
143012492|NCT02957682|515585596|FG001|Overall Study|Withdrawal by Subject|33|||
143012493|NCT02957682|515585595|FG000|Overall Study|Related to IMP Administration|3|||
143012494|NCT02957682|515585596|FG001|Overall Study|Related to IMP Administration|6|||
143012495|NCT02957682|515585595|FG000|Overall Study|Non-disclosed|16|||
143012496|NCT02957682|515585596|FG001|Overall Study|Non-disclosed|12|||
143012497|NCT02957682|515585595|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
143012498|NCT02957682|515585596|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
143012499|NCT00791154|515585602|FG000|Overall Study|Noncompliance|0|||
143012500|NCT00791154|515585603|FG001|Overall Study|Noncompliance|1|||
143012501|NCT00791154|515585604|FG002|Overall Study|Noncompliance|0|||
143012502|NCT00791154|515585605|FG003|Overall Study|Noncompliance|0|||
143012503|NCT00791154|515585606|FG004|Overall Study|Noncompliance|1|||
143012504|NCT00791154|515585607|FG005|Overall Study|Noncompliance|1|||
143012505|NCT00791154|515585608|FG006|Overall Study|Noncompliance|1|||
143012506|NCT00791154|515585602|FG000|Overall Study|Adverse Event|0|||
143012507|NCT00791154|515585603|FG001|Overall Study|Adverse Event|0|||
143012508|NCT00791154|515585604|FG002|Overall Study|Adverse Event|0|||
143012509|NCT00791154|515585605|FG003|Overall Study|Adverse Event|0|||
143012510|NCT00791154|515585606|FG004|Overall Study|Adverse Event|2|||
143012511|NCT00791154|515585607|FG005|Overall Study|Adverse Event|0|||
143012512|NCT00791154|515585608|FG006|Overall Study|Adverse Event|1|||
143012513|NCT00791154|515585602|FG000|Overall Study|Full Consent withdrawn|1|||
143012514|NCT00791154|515585603|FG001|Overall Study|Full Consent withdrawn|3|||
143012515|NCT00791154|515585604|FG002|Overall Study|Full Consent withdrawn|0|||
143012516|NCT00791154|515585605|FG003|Overall Study|Full Consent withdrawn|0|||
143012517|NCT00791154|515585606|FG004|Overall Study|Full Consent withdrawn|1|||
143012518|NCT00791154|515585607|FG005|Overall Study|Full Consent withdrawn|3|||
143353479|NCT02743793|516840907|FG000|Overall Study|No Primary Care Physician|0|||
143353480|NCT02743793|516840908|FG001|Overall Study|No Primary Care Physician|1|||
143353481|NCT02743793|516840907|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
143353482|NCT02743793|516840908|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
143353483|NCT02743793|516840907|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
143012519|NCT00791154|515585608|FG006|Overall Study|Full Consent withdrawn|1|||
143012520|NCT00791154|515585602|FG000|Overall Study|Lost to Follow-up|0|||
143012521|NCT00791154|515585603|FG001|Overall Study|Lost to Follow-up|0|||
143012522|NCT00791154|515585604|FG002|Overall Study|Lost to Follow-up|0|||
143012523|NCT00791154|515585605|FG003|Overall Study|Lost to Follow-up|1|||
143012524|NCT00791154|515585606|FG004|Overall Study|Lost to Follow-up|2|||
143012525|NCT00791154|515585607|FG005|Overall Study|Lost to Follow-up|0|||
143012526|NCT00791154|515585608|FG006|Overall Study|Lost to Follow-up|4|||
143012527|NCT00791154|515585602|FG000|Overall Study|Death|5|||
143125611|NCT05052697|516003711|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
143125612|NCT05052697|516003712|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
143125613|NCT05052697|516003713|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
143125614|NCT05052697|516003714|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
143125615|NCT05052697|516003715|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
143125616|NCT05052697|516003716|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
143125617|NCT05052697|516003717|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
143353484|NCT02743793|516840908|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
143353485|NCT01231503|516840909|FG000|Overall Study|Adverse Event|0|||
143353486|NCT01231503|516840910|FG001|Overall Study|Adverse Event|0|||
143353487|NCT01231503|516840911|FG002|Overall Study|Adverse Event|0|||
143353488|NCT01231503|516840912|FG003|Overall Study|Adverse Event|0|||
143353489|NCT01231503|516840913|FG004|Overall Study|Adverse Event|0|||
143353490|NCT01231503|516840914|FG005|Overall Study|Adverse Event|1|||
143353491|NCT01231503|516840915|FG006|Overall Study|Adverse Event|0|||
143353492|NCT01231503|516840916|FG007|Overall Study|Adverse Event|0|||
143353493|NCT01231503|516840909|FG000|Overall Study|Adverse event, serious fatal|0|||
143353494|NCT01231503|516840910|FG001|Overall Study|Adverse event, serious fatal|0|||
143353495|NCT01231503|516840911|FG002|Overall Study|Adverse event, serious fatal|1|||
143461632|NCT01498653|517235098|FG000|Overall Study|Withdrawal by Subject|2|||
143461633|NCT01498653|517235099|FG001|Overall Study|Withdrawal by Subject|3|||
143353496|NCT01231503|516840912|FG003|Overall Study|Adverse event, serious fatal|1|||
143353497|NCT01231503|516840913|FG004|Overall Study|Adverse event, serious fatal|0|||
143353498|NCT01231503|516840914|FG005|Overall Study|Adverse event, serious fatal|1|||
143353499|NCT01231503|516840915|FG006|Overall Study|Adverse event, serious fatal|0|||
143353500|NCT01231503|516840916|FG007|Overall Study|Adverse event, serious fatal|0|||
143353501|NCT01231503|516840909|FG000|Overall Study|Withdrawal by Subject|6|||
143353502|NCT01231503|516840910|FG001|Overall Study|Withdrawal by Subject|3|||
143353503|NCT01231503|516840911|FG002|Overall Study|Withdrawal by Subject|3|||
143353504|NCT01231503|516840912|FG003|Overall Study|Withdrawal by Subject|1|||
143353505|NCT01231503|516840913|FG004|Overall Study|Withdrawal by Subject|3|||
143353506|NCT01231503|516840914|FG005|Overall Study|Withdrawal by Subject|5|||
143353507|NCT01231503|516840915|FG006|Overall Study|Withdrawal by Subject|1|||
143353508|NCT01231503|516840916|FG007|Overall Study|Withdrawal by Subject|2|||
143353509|NCT01231503|516840909|FG000|Overall Study|Lost to Follow-up|8|||
143353510|NCT01231503|516840910|FG001|Overall Study|Lost to Follow-up|10|||
143353511|NCT01231503|516840911|FG002|Overall Study|Lost to Follow-up|8|||
143353512|NCT01231503|516840912|FG003|Overall Study|Lost to Follow-up|5|||
143353513|NCT01231503|516840913|FG004|Overall Study|Lost to Follow-up|7|||
143353514|NCT01231503|516840914|FG005|Overall Study|Lost to Follow-up|9|||
143353515|NCT01231503|516840915|FG006|Overall Study|Lost to Follow-up|6|||
143353516|NCT01231503|516840916|FG007|Overall Study|Lost to Follow-up|6|||
143353517|NCT01231503|516840909|FG000|Overall Study|Protocol Violation|0|||
143353518|NCT01231503|516840910|FG001|Overall Study|Protocol Violation|0|||
143353519|NCT01231503|516840911|FG002|Overall Study|Protocol Violation|0|||
143353520|NCT01231503|516840912|FG003|Overall Study|Protocol Violation|1|||
143353521|NCT01231503|516840913|FG004|Overall Study|Protocol Violation|0|||
143353522|NCT01231503|516840914|FG005|Overall Study|Protocol Violation|0|||
143353523|NCT01231503|516840915|FG006|Overall Study|Protocol Violation|0|||
143353524|NCT01231503|516840916|FG007|Overall Study|Protocol Violation|0|||
143353525|NCT01146574|516840921|FG000|Overall Study|Death|0|||
143353526|NCT01146574|516840922|FG001|Overall Study|Death|1|||
143353527|NCT01146574|516840923|FG002|Overall Study|Death|1|||
143353528|NCT01146574|516840924|FG003|Overall Study|Death|0|||
143353529|NCT01146574|516840925|FG004|Overall Study|Death|0|||
143353530|NCT01146574|516840926|FG005|Overall Study|Death|0|||
143353531|NCT01146574|516840927|FG006|Overall Study|Death|0|||
143353532|NCT01146574|516840921|FG000|Overall Study|Other reasons|0|||
143353533|NCT01146574|516840922|FG001|Overall Study|Other reasons|0|||
143353534|NCT01146574|516840923|FG002|Overall Study|Other reasons|3|||
143353535|NCT01146574|516840924|FG003|Overall Study|Other reasons|0|||
143353536|NCT01146574|516840925|FG004|Overall Study|Other reasons|0|||
143353537|NCT01146574|516840926|FG005|Overall Study|Other reasons|0|||
143353538|NCT01146574|516840927|FG006|Overall Study|Other reasons|0|||
143353539|NCT01146574|516840921|FG000|Overall Study|Kidney transplant|0|||
143353540|NCT01146574|516840922|FG001|Overall Study|Kidney transplant|0|||
143353541|NCT01146574|516840923|FG002|Overall Study|Kidney transplant|1|||
143353542|NCT01146574|516840924|FG003|Overall Study|Kidney transplant|1|||
143353543|NCT01146574|516840925|FG004|Overall Study|Kidney transplant|0|||
143353544|NCT01146574|516840926|FG005|Overall Study|Kidney transplant|0|||
143353545|NCT01146574|516840927|FG006|Overall Study|Kidney transplant|0|||
143353546|NCT01146574|516840921|FG000|Overall Study|Withdrew consent|0|||
143353547|NCT01146574|516840922|FG001|Overall Study|Withdrew consent|0|||
143353548|NCT01146574|516840923|FG002|Overall Study|Withdrew consent|1|||
143353549|NCT01146574|516840924|FG003|Overall Study|Withdrew consent|1|||
143353550|NCT01146574|516840925|FG004|Overall Study|Withdrew consent|2|||
143353551|NCT01146574|516840926|FG005|Overall Study|Withdrew consent|1|||
143353552|NCT01146574|516840927|FG006|Overall Study|Withdrew consent|1|||
143125618|NCT05052697|516003718|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
143125619|NCT05052697|516003719|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
143125620|NCT05052697|516003720|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
143125621|NCT05052697|516003721|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
143125622|NCT05052697|516003722|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
143125623|NCT05052697|516003723|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
143353553|NCT00849680|516840930|FG000|Overall Study|Adverse Event|0|||
143353554|NCT00849680|516840931|FG001|Overall Study|Adverse Event|0|||
143353555|NCT00849680|516840932|FG002|Overall Study|Adverse Event|0|||
143353556|NCT00849680|516840933|FG003|Overall Study|Adverse Event|0|||
143353557|NCT00849680|516840934|FG004|Overall Study|Adverse Event|0|||
143353558|NCT00849680|516840935|FG005|Overall Study|Adverse Event|0|||
143353559|NCT00849680|516840936|FG006|Overall Study|Adverse Event|2|||
143353560|NCT00849680|516840937|FG007|Overall Study|Adverse Event|0|||
143353561|NCT00849680|516840930|FG000|Overall Study|Lost to Follow-up|7|||
143353562|NCT00849680|516840931|FG001|Overall Study|Lost to Follow-up|3|||
143353563|NCT00849680|516840932|FG002|Overall Study|Lost to Follow-up|12|||
143353564|NCT00849680|516840933|FG003|Overall Study|Lost to Follow-up|11|||
143353565|NCT00849680|516840934|FG004|Overall Study|Lost to Follow-up|8|||
143353566|NCT00849680|516840935|FG005|Overall Study|Lost to Follow-up|11|||
143353567|NCT00849680|516840936|FG006|Overall Study|Lost to Follow-up|12|||
143353568|NCT00849680|516840937|FG007|Overall Study|Lost to Follow-up|5|||
143353569|NCT00849680|516840930|FG000|Overall Study|Subject moved|1|||
143353570|NCT00849680|516840931|FG001|Overall Study|Subject moved|0|||
143353571|NCT00849680|516840932|FG002|Overall Study|Subject moved|3|||
143353572|NCT00849680|516840933|FG003|Overall Study|Subject moved|1|||
143353573|NCT00849680|516840934|FG004|Overall Study|Subject moved|0|||
143353574|NCT00849680|516840935|FG005|Overall Study|Subject moved|2|||
143353575|NCT00849680|516840936|FG006|Overall Study|Subject moved|2|||
143353576|NCT00849680|516840937|FG007|Overall Study|Subject moved|2|||
143353577|NCT00849680|516840930|FG000|Overall Study|Withdrawal by Subject|2|||
143353578|NCT00849680|516840931|FG001|Overall Study|Withdrawal by Subject|0|||
143353579|NCT00849680|516840932|FG002|Overall Study|Withdrawal by Subject|0|||
143353580|NCT00849680|516840933|FG003|Overall Study|Withdrawal by Subject|2|||
143353581|NCT00849680|516840934|FG004|Overall Study|Withdrawal by Subject|2|||
143353582|NCT00849680|516840935|FG005|Overall Study|Withdrawal by Subject|2|||
143353583|NCT00849680|516840936|FG006|Overall Study|Withdrawal by Subject|1|||
143353584|NCT00849680|516840937|FG007|Overall Study|Withdrawal by Subject|1|||
143353585|NCT00849680|516840930|FG000|Overall Study|Subject unable to comply with protocol|1|||
143353586|NCT00849680|516840931|FG001|Overall Study|Subject unable to comply with protocol|0|||
143353587|NCT00849680|516840932|FG002|Overall Study|Subject unable to comply with protocol|0|||
143353588|NCT00849680|516840933|FG003|Overall Study|Subject unable to comply with protocol|0|||
143353589|NCT00849680|516840934|FG004|Overall Study|Subject unable to comply with protocol|0|||
143353590|NCT00849680|516840935|FG005|Overall Study|Subject unable to comply with protocol|0|||
143353591|NCT00849680|516840936|FG006|Overall Study|Subject unable to comply with protocol|0|||
143353592|NCT00849680|516840937|FG007|Overall Study|Subject unable to comply with protocol|0|||
143353593|NCT03053492|516840938|FG000|Overall Study|Adverse Event|1|||
143353594|NCT03053492|516840939|FG001|Overall Study|Adverse Event|1|||
143353595|NCT03053492|516840938|FG000|Overall Study|Withdrawal by Subject|7|||
143353596|NCT03053492|516840939|FG001|Overall Study|Withdrawal by Subject|5|||
143353597|NCT00967018|516840941|FG000|Overall Study|Adverse Event|2|||
143353598|NCT00967018|516840941|FG000|Overall Study|Physician Decision|7|||
143353599|NCT00967018|516840941|FG000|Overall Study|Lost to Follow-up|2|||
143353600|NCT00967018|516840941|FG000|Overall Study|Withdrawal by Subject|1|||
143353601|NCT00967018|516840941|FG000|Overall Study|Miscellaneous Reasons|9|||
143353602|NCT01000376|516840942|FG000|Cycle 1 Day 1|Adverse Event|1|||
143353603|NCT01000376|516840943|FG001|Cycle 1 Day 1|Adverse Event|0|||
143353604|NCT01000376|516840942|FG000|Cycle 1 Day 1|Progressive Disease|1|||
143353605|NCT01000376|516840943|FG001|Cycle 1 Day 1|Progressive Disease|0|||
143353606|NCT00318149|516840944|FG000|Overall Study|Adverse Event|0|||
143353607|NCT00318149|516840945|FG001|Overall Study|Adverse Event|0|||
143353608|NCT00318149|516840946|FG002|Overall Study|Adverse Event|0|||
143353609|NCT00318149|516840947|FG003|Overall Study|Adverse Event|0|||
143353610|NCT00318149|516840948|FG004|Overall Study|Adverse Event|0|||
143353611|NCT00318149|516840949|FG005|Overall Study|Adverse Event|2|||
143353612|NCT00219141|516840950|FG000|Overall Study|Adverse Event|4|||
143353613|NCT00219141|516840951|FG001|Overall Study|Adverse Event|10|||
143353614|NCT00219141|516840952|FG002|Overall Study|Adverse Event|5|||
143353615|NCT00219141|516840950|FG000|Overall Study|Lack of Efficacy|3|||
143353616|NCT00219141|516840951|FG001|Overall Study|Lack of Efficacy|2|||
143353617|NCT00219141|516840952|FG002|Overall Study|Lack of Efficacy|0|||
143353618|NCT00219141|516840950|FG000|Overall Study|Administrative problems|0|||
143353619|NCT00219141|516840951|FG001|Overall Study|Administrative problems|1|||
143353620|NCT00219141|516840952|FG002|Overall Study|Administrative problems|0|||
143353621|NCT00219141|516840950|FG000|Overall Study|Lost to Follow-up|2|||
143353622|NCT00219141|516840951|FG001|Overall Study|Lost to Follow-up|4|||
143353623|NCT00219141|516840952|FG002|Overall Study|Lost to Follow-up|1|||
143353624|NCT00219141|516840950|FG000|Overall Study|Protocol Violation|3|||
143353625|NCT00219141|516840951|FG001|Overall Study|Protocol Violation|1|||
143353626|NCT00219141|516840952|FG002|Overall Study|Protocol Violation|1|||
143353627|NCT00219141|516840950|FG000|Overall Study|Withdrawal by Subject|1|||
143353628|NCT00219141|516840951|FG001|Overall Study|Withdrawal by Subject|3|||
143353629|NCT00219141|516840952|FG002|Overall Study|Withdrawal by Subject|5|||
143353630|NCT00219141|516840950|FG000|Overall Study|Condition no longer requires study drug|1|||
143353631|NCT00219141|516840951|FG001|Overall Study|Condition no longer requires study drug|0|||
143353632|NCT00219141|516840952|FG002|Overall Study|Condition no longer requires study drug|0|||
143353633|NCT01088529|516840953|FG000|Overall Study|Did not receive study treatment|0|||
143353634|NCT01088529|516840954|FG001|Overall Study|Did not receive study treatment|1|||
143353635|NCT01267253|516840960|FG000|Overall Study|Ineligible - required test not done|1|||
143353636|NCT01267253|516840960|FG000|Overall Study|Inevaluable-never received study treatme|2|||
143353637|NCT04318093|516840961|FG000|Overall Study|Adverse Event|2|||
143353638|NCT04318093|516840962|FG001|Overall Study|Adverse Event|2|||
143353639|NCT04318093|516840961|FG000|Overall Study|Participant withdrew consent|1|||
143353640|NCT04318093|516840962|FG001|Overall Study|Participant withdrew consent|0|||
143353641|NCT04318093|516840961|FG000|Overall Study|Other reasons|0|||
143353642|NCT04318093|516840962|FG001|Overall Study|Other reasons|1|||
143353643|NCT02855164|516840966|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
143353644|NCT02855164|516840967|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
143353645|NCT02855164|516840968|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
143353646|NCT02855164|516840969|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
143353647|NCT02855164|516840970|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
143353648|NCT02855164|516840971|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
143353649|NCT02855164|516840972|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
143353650|NCT02855164|516840973|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
143353651|NCT02855164|516840966|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
143353652|NCT02855164|516840967|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
143353653|NCT02855164|516840968|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
143353654|NCT02855164|516840969|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
143353655|NCT02855164|516840970|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
143353656|NCT02855164|516840971|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
143353657|NCT02855164|516840972|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
143353658|NCT02855164|516840973|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
143461634|NCT05208866|517235100|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
143461635|NCT00836095|517235105|FG000|Overall Study|Physician Decision|0|||
143461636|NCT00836095|517235106|FG001|Overall Study|Physician Decision|3|||
143461637|NCT01602562|517235107|FG000|Overall Study|Adverse Event|3|||
143461638|NCT01602562|517235108|FG001|Overall Study|Adverse Event|1|||
143461639|NCT01602562|517235107|FG000|Overall Study|Physician Decision|1|||
143461640|NCT01602562|517235108|FG001|Overall Study|Physician Decision|1|||
143461641|NCT01602562|517235107|FG000|Overall Study|Withdrawal by Subject|1|||
143461642|NCT01602562|517235108|FG001|Overall Study|Withdrawal by Subject|1|||
143461643|NCT04964414|517235109|FG000|Overall Study|Lost to Follow-up|10|||
143461644|NCT04964414|517235110|FG001|Overall Study|Lost to Follow-up|8|||
143353659|NCT02855164|516840966|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
143353660|NCT02855164|516840967|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
143461645|NCT04964414|517235109|FG000|Overall Study|Withdrawal by Subject|1|||
143461646|NCT04964414|517235110|FG001|Overall Study|Withdrawal by Subject|1|||
143461647|NCT01078454|517235112|FG000|Overall Study|Adverse Event|1|||
143353661|NCT02855164|516840968|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
143353662|NCT02855164|516840969|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
143353663|NCT02855164|516840970|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
143353664|NCT02855164|516840971|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
143353665|NCT02855164|516840972|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
143353666|NCT02855164|516840973|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
143353667|NCT02855164|516840966|FG000|Part C (Randomized Set)|Adverse Event|0|||
143353668|NCT02855164|516840967|FG001|Part C (Randomized Set)|Adverse Event|0|||
143353669|NCT02855164|516840968|FG002|Part C (Randomized Set)|Adverse Event|0|||
143353670|NCT02855164|516840969|FG003|Part C (Randomized Set)|Adverse Event|0|||
143353671|NCT02855164|516840970|FG004|Part C (Randomized Set)|Adverse Event|0|||
143353672|NCT02855164|516840971|FG005|Part C (Randomized Set)|Adverse Event|5|||
143461648|NCT01078454|517235113|FG001|Overall Study|Adverse Event|1|||
143012528|NCT00791154|515585603|FG001|Overall Study|Death|4|||
143012529|NCT00791154|515585604|FG002|Overall Study|Death|4|||
143012530|NCT00791154|515585605|FG003|Overall Study|Death|7|||
143012531|NCT00791154|515585606|FG004|Overall Study|Death|54|||
143012532|NCT00791154|515585607|FG005|Overall Study|Death|54|||
143353673|NCT02855164|516840972|FG006|Part C (Randomized Set)|Adverse Event|9|||
143461649|NCT01078454|517235112|FG000|Overall Study|Death|0|||
143461650|NCT01078454|517235113|FG001|Overall Study|Death|1|||
143461651|NCT01919814|517237443|FG000|Overall Study|Adverse Event|1|||
143012533|NCT00791154|515585608|FG006|Overall Study|Death|52|||
143353674|NCT02855164|516840973|FG007|Part C (Randomized Set)|Adverse Event|2|||
143353675|NCT02855164|516840966|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
143353676|NCT02855164|516840967|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
143353677|NCT02855164|516840968|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
143353678|NCT02855164|516840969|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
143125624|NCT05052697|516003724|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
143125625|NCT05052697|516003725|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
143125626|NCT05052697|516003726|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
143125627|NCT05052697|516003727|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
143125628|NCT05052697|516003728|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
143125629|NCT05052697|516003729|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
143125630|NCT05052697|516003730|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
143125631|NCT05052697|516003731|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
143125632|NCT05052697|516003732|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
143125633|NCT05052697|516003733|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
143125634|NCT05052697|516003734|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
143125635|NCT05052697|516003735|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
143125636|NCT05052697|516003736|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
143125637|NCT05052697|516003737|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
143125638|NCT05052697|516003738|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
143125639|NCT05052697|516003739|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
143125640|NCT05052697|516003740|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
143125641|NCT05052697|516003741|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
143125642|NCT00978341|516003744|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
143125643|NCT00978341|516003745|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
143125644|NCT01402986|516003746|FG000|Overall Study|Withdrawal by Subject|7|||
143125645|NCT01402986|516003747|FG001|Overall Study|Withdrawal by Subject|10|||
143125646|NCT01402986|516003748|FG002|Overall Study|Withdrawal by Subject|7|||
143125647|NCT01402986|516003749|FG003|Overall Study|Withdrawal by Subject|13|||
143125648|NCT01402986|516003746|FG000|Overall Study|Death|0|||
143125649|NCT01402986|516003747|FG001|Overall Study|Death|0|||
143125650|NCT01402986|516003748|FG002|Overall Study|Death|0|||
143125651|NCT01402986|516003749|FG003|Overall Study|Death|2|||
143125652|NCT01402986|516003746|FG000|Overall Study|Lost to Follow-up|0|||
143125653|NCT01402986|516003747|FG001|Overall Study|Lost to Follow-up|0|||
143353679|NCT02855164|516840970|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
143353680|NCT02855164|516840971|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
143125654|NCT01402986|516003748|FG002|Overall Study|Lost to Follow-up|0|||
143125655|NCT01402986|516003749|FG003|Overall Study|Lost to Follow-up|1|||
143125656|NCT01402986|516003746|FG000|Overall Study|Other|2|||
143125657|NCT01402986|516003747|FG001|Overall Study|Other|5|||
143125658|NCT01402986|516003748|FG002|Overall Study|Other|1|||
143125659|NCT01402986|516003749|FG003|Overall Study|Other|6|||
143125660|NCT03749109|516003750|FG000|Overall Study|Adverse Event|2|||
143125661|NCT03749109|516003751|FG001|Overall Study|Adverse Event|0|||
143125662|NCT02634983|516003752|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
143125663|NCT02634983|516003753|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
143125664|NCT03178851|516003754|FG000|Overall Study|Death|48|||
143125665|NCT03178851|516003755|FG001|Overall Study|Death|2|||
143125666|NCT03178851|516003756|FG002|Overall Study|Death|25|||
143125667|NCT03178851|516003754|FG000|Overall Study|Withdrawal by Subject|8|||
143125668|NCT03178851|516003755|FG001|Overall Study|Withdrawal by Subject|0|||
143125669|NCT03178851|516003756|FG002|Overall Study|Withdrawal by Subject|0|||
143125670|NCT03178851|516003754|FG000|Overall Study|Lost to Follow-up|5|||
143353681|NCT02855164|516840972|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
143353682|NCT02855164|516840973|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
143353683|NCT02855164|516840966|FG000|Part C (Randomized Set)|Physician Decision|0|||
143353684|NCT02855164|516840967|FG001|Part C (Randomized Set)|Physician Decision|0|||
143353685|NCT02855164|516840968|FG002|Part C (Randomized Set)|Physician Decision|0|||
143125671|NCT03178851|516003755|FG001|Overall Study|Lost to Follow-up|2|||
143125672|NCT03178851|516003756|FG002|Overall Study|Lost to Follow-up|0|||
143125673|NCT03178851|516003754|FG000|Overall Study|Adverse Event|0|||
143125674|NCT03178851|516003755|FG001|Overall Study|Adverse Event|0|||
143125675|NCT03178851|516003756|FG002|Overall Study|Adverse Event|1|||
143353686|NCT02855164|516840969|FG003|Part C (Randomized Set)|Physician Decision|0|||
143125676|NCT03178851|516003754|FG000|Overall Study|Study Termination by Sponsor|31|||
143125677|NCT03178851|516003755|FG001|Overall Study|Study Termination by Sponsor|7|||
143125678|NCT03178851|516003756|FG002|Overall Study|Study Termination by Sponsor|26|||
143125679|NCT02226120|516003757|FG000|Overall Study|Adverse Event|60|||
143125680|NCT02226120|516003757|FG000|Overall Study|Death|172|||
143125681|NCT02226120|516003757|FG000|Overall Study|Study terminated by sponsor|1|||
143125682|NCT02226120|516003757|FG000|Overall Study|Technical problems|4|||
143353687|NCT02855164|516840970|FG004|Part C (Randomized Set)|Physician Decision|0|||
143125683|NCT02226120|516003757|FG000|Overall Study|Lost to Follow-up|13|||
143125684|NCT02226120|516003757|FG000|Overall Study|Physician Decision|21|||
143353688|NCT02855164|516840971|FG005|Part C (Randomized Set)|Physician Decision|1|||
143353689|NCT02855164|516840972|FG006|Part C (Randomized Set)|Physician Decision|0|||
143353690|NCT02855164|516840973|FG007|Part C (Randomized Set)|Physician Decision|1|||
143353691|NCT02855164|516840966|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
143353692|NCT02855164|516840967|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
143353693|NCT02855164|516840968|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
143353694|NCT02855164|516840969|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
143353695|NCT02855164|516840970|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
143353696|NCT02855164|516840971|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
143353697|NCT02855164|516840972|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
143353698|NCT02855164|516840973|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
143353699|NCT00547911|516840980|FG000|Overall Study|Adverse Event|0|||
143353700|NCT00547911|516840981|FG001|Overall Study|Adverse Event|0|||
143353701|NCT00547911|516840982|FG002|Overall Study|Adverse Event|0|||
143353702|NCT00547911|516840983|FG003|Overall Study|Adverse Event|1|||
143353703|NCT00547911|516840984|FG004|Overall Study|Adverse Event|0|||
143353704|NCT00547911|516840985|FG005|Overall Study|Adverse Event|0|||
143353705|NCT01644474|516840986|FG000|Overall Study|Poor compliance to protocol|1|||
143353706|NCT01644474|516840987|FG001|Overall Study|Poor compliance to protocol|0|||
143353707|NCT01644474|516840986|FG000|Overall Study|Consent withdrawn by participant|0|||
143353708|NCT01644474|516840987|FG001|Overall Study|Consent withdrawn by participant|1|||
143353709|NCT01644474|516840986|FG000|Overall Study|Participant moved|0|||
143353710|NCT01644474|516840987|FG001|Overall Study|Participant moved|1|||
143353711|NCT01644474|516840986|FG000|Overall Study|Adverse Event|4|||
143353712|NCT01644474|516840987|FG001|Overall Study|Adverse Event|5|||
143353713|NCT01644474|516840986|FG000|Overall Study|Site scheduling error|1|||
143353714|NCT01644474|516840987|FG001|Overall Study|Site scheduling error|1|||
143353715|NCT01644474|516840986|FG000|Overall Study|Protocol Violation|1|||
143353716|NCT01644474|516840987|FG001|Overall Study|Protocol Violation|0|||
143353717|NCT02044458|516840991|FG000|Overall Study|Protocol Violation|3|||
143353718|NCT02044458|516840992|FG001|Overall Study|Protocol Violation|8|||
143353719|NCT00654940|516842770|FG000|Period 1|Adverse Event|0|||
143012534|NCT00791154|515585602|FG000|Overall Study|Other event|0|||
143012535|NCT00791154|515585603|FG001|Overall Study|Other event|0|||
143012536|NCT00791154|515585604|FG002|Overall Study|Other event|2|||
143012537|NCT00791154|515585605|FG003|Overall Study|Other event|0|||
143012538|NCT00791154|515585606|FG004|Overall Study|Other event|2|||
143012539|NCT00791154|515585607|FG005|Overall Study|Other event|4|||
143012540|NCT00791154|515585608|FG006|Overall Study|Other event|2|||
143012541|NCT02953262|515585609|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
143012542|NCT02953262|515585610|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
143012543|NCT02953262|515585611|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
143012544|NCT02953262|515585612|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
143012545|NCT03349437|515585616|FG000|Screening|Screen Fail|4|||
143012546|NCT03349437|515585617|FG001|Screening|Screen Fail|0|||
143012547|NCT03349437|515585618|FG002|Screening|Screen Fail|0|||
143012548|NCT03349437|515585616|FG000|Screening|Withdrawn|1|||
143012549|NCT03349437|515585617|FG001|Screening|Withdrawn|0|||
143012550|NCT03349437|515585618|FG002|Screening|Withdrawn|0|||
143012551|NCT02406742|515585619|FG000|Overall Study|Progression of Disease|5|||
143012552|NCT02406742|515585620|FG001|Overall Study|Progression of Disease|1|||
143012553|NCT02406742|515585621|FG002|Overall Study|Progression of Disease|6|||
143012554|NCT02406742|515585619|FG000|Overall Study|Adverse Event|3|||
143012555|NCT02406742|515585620|FG001|Overall Study|Adverse Event|0|||
143012556|NCT02406742|515585621|FG002|Overall Study|Adverse Event|2|||
143012557|NCT02406742|515585619|FG000|Overall Study|Death|1|||
143012558|NCT02406742|515585620|FG001|Overall Study|Death|0|||
143012559|NCT02406742|515585621|FG002|Overall Study|Death|0|||
143012560|NCT02406742|515585619|FG000|Overall Study|Lack of Efficacy|0|||
143012561|NCT02406742|515585620|FG001|Overall Study|Lack of Efficacy|0|||
143012562|NCT02406742|515585621|FG002|Overall Study|Lack of Efficacy|1|||
143353720|NCT00654940|516842771|FG001|Period 1|Adverse Event|1|||
143353721|NCT00654940|516842770|FG000|Period 1|Intolerable Pain Level|1|||
143353722|NCT00654940|516842771|FG001|Period 1|Intolerable Pain Level|0|||
143461652|NCT01919814|517237444|FG001|Overall Study|Adverse Event|0|||
143012563|NCT02406742|515585619|FG000|Overall Study|Withdrawal by Participant|1|||
143012564|NCT02406742|515585620|FG001|Overall Study|Withdrawal by Participant|2|||
143012565|NCT02406742|515585621|FG002|Overall Study|Withdrawal by Participant|0|||
143012566|NCT02406742|515585619|FG000|Overall Study|Physician Decision|1|||
143012567|NCT02406742|515585620|FG001|Overall Study|Physician Decision|2|||
143353723|NCT00619476|516842772|FG000|Overall Study|Adverse Event|12|||
143353724|NCT00619476|516842773|FG001|Overall Study|Adverse Event|6|||
143353725|NCT00619476|516842774|FG002|Overall Study|Adverse Event|12|||
143353726|NCT00619476|516842775|FG003|Overall Study|Adverse Event|16|||
143353727|NCT00619476|516842772|FG000|Overall Study|Lack of Efficacy|6|||
143353728|NCT00619476|516842773|FG001|Overall Study|Lack of Efficacy|1|||
143353729|NCT00619476|516842774|FG002|Overall Study|Lack of Efficacy|1|||
143353730|NCT00619476|516842775|FG003|Overall Study|Lack of Efficacy|4|||
143353731|NCT00619476|516842772|FG000|Overall Study|Protocol Violation|5|||
143353732|NCT00619476|516842773|FG001|Overall Study|Protocol Violation|4|||
143353733|NCT00619476|516842774|FG002|Overall Study|Protocol Violation|4|||
143353734|NCT00619476|516842775|FG003|Overall Study|Protocol Violation|9|||
143353735|NCT00619476|516842772|FG000|Overall Study|Lost to Follow-up|1|||
143353736|NCT00619476|516842773|FG001|Overall Study|Lost to Follow-up|2|||
143353737|NCT00619476|516842774|FG002|Overall Study|Lost to Follow-up|0|||
143353738|NCT00619476|516842775|FG003|Overall Study|Lost to Follow-up|1|||
143353739|NCT00619476|516842772|FG000|Overall Study|Investigator Discretion|2|||
143353740|NCT00619476|516842773|FG001|Overall Study|Investigator Discretion|2|||
143353741|NCT00619476|516842774|FG002|Overall Study|Investigator Discretion|2|||
143353742|NCT00619476|516842775|FG003|Overall Study|Investigator Discretion|0|||
143353743|NCT00619476|516842772|FG000|Overall Study|Withdrawal by Subject|5|||
143353744|NCT00619476|516842773|FG001|Overall Study|Withdrawal by Subject|7|||
143353745|NCT00619476|516842774|FG002|Overall Study|Withdrawal by Subject|5|||
143353746|NCT00619476|516842775|FG003|Overall Study|Withdrawal by Subject|4|||
143353747|NCT02169830|516842776|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
143353748|NCT02169830|516842777|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
143353749|NCT02169830|516842778|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
143353750|NCT02169830|516842776|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
143353751|NCT02169830|516842777|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
143353752|NCT02169830|516842778|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
143353753|NCT02169830|516842776|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
143125685|NCT02226120|516003757|FG000|Overall Study|Withdrawal by parent/guardian|36|||
143125686|NCT02226120|516003757|FG000|Overall Study|Non-compliance with study drug|10|||
143125687|NCT02226120|516003757|FG000|Overall Study|Protocol deviation|1|||
143125688|NCT02226120|516003757|FG000|Overall Study|missing treatment disposition pages|2|||
143125689|NCT00401193|516006608|FG000|Overall Study|Adverse Event|1|||
143125690|NCT00401193|516006609|FG001|Overall Study|Adverse Event|3|||
143125691|NCT00401193|516006610|FG002|Overall Study|Adverse Event|1|||
143125692|NCT00401193|516006608|FG000|Overall Study|Protocol Violation|3|||
143125693|NCT00401193|516006609|FG001|Overall Study|Protocol Violation|1|||
143125694|NCT00401193|516006610|FG002|Overall Study|Protocol Violation|1|||
143125695|NCT00401193|516006608|FG000|Overall Study|Lost to Follow-up|6|||
143125696|NCT00401193|516006609|FG001|Overall Study|Lost to Follow-up|5|||
143125697|NCT00401193|516006610|FG002|Overall Study|Lost to Follow-up|1|||
143125698|NCT00401193|516006608|FG000|Overall Study|Withdrawal by Subject|2|||
143125699|NCT00401193|516006609|FG001|Overall Study|Withdrawal by Subject|0|||
143125700|NCT00401193|516006610|FG002|Overall Study|Withdrawal by Subject|1|||
143125701|NCT00401193|516006608|FG000|Overall Study|Other Event|3|||
143125702|NCT00401193|516006609|FG001|Overall Study|Other Event|2|||
143125703|NCT00401193|516006610|FG002|Overall Study|Other Event|2|||
143125704|NCT02526160|516006611|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
143125705|NCT02526160|516006612|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
143125706|NCT02526160|516006611|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
143125707|NCT02526160|516006612|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
143125708|NCT02526160|516006611|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
143125709|NCT02526160|516006612|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
143125710|NCT02526160|516006611|FG000|Open-Label Treatment Extension Period I|Death|0|||
143125711|NCT02526160|516006612|FG001|Open-Label Treatment Extension Period I|Death|1|||
143125712|NCT02526160|516006611|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
143125713|NCT02526160|516006612|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
143125714|NCT02526160|516006611|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
143125715|NCT02526160|516006612|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
143125716|NCT02526160|516006611|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
143125717|NCT02526160|516006612|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
143125718|NCT02526160|516006611|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
143125719|NCT02526160|516006612|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
143125720|NCT02576977|516006613|FG000|Overall Study|Adverse Event|13|||
143125721|NCT02576977|516006614|FG001|Overall Study|Adverse Event|2|||
143125722|NCT02576977|516006613|FG000|Overall Study|Death|73|||
143125723|NCT02576977|516006614|FG001|Overall Study|Death|60|||
143125724|NCT02576977|516006613|FG000|Overall Study|Screen failure|1|||
143353754|NCT02169830|516842777|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
143353755|NCT02169830|516842778|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
143353756|NCT02169830|516842776|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
143461653|NCT01919814|517237443|FG000|Overall Study|Protocol Violation|1|||
143461654|NCT01919814|517237444|FG001|Overall Study|Protocol Violation|0|||
143125725|NCT02576977|516006614|FG001|Overall Study|Screen failure|0|||
143125726|NCT02576977|516006613|FG000|Overall Study|Study Terminated at Selected Sites|27|||
143125727|NCT02576977|516006614|FG001|Overall Study|Study Terminated at Selected Sites|50|||
143353757|NCT02169830|516842777|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
143353758|NCT02169830|516842778|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
143461655|NCT01919814|517237443|FG000|Overall Study|Withdrawal by Subject|1|||
143353759|NCT02169830|516842776|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
143353760|NCT02169830|516842777|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
143353761|NCT02169830|516842778|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
143353762|NCT03204695|516842779|FG000|Overall Study|Death|1|||
143353763|NCT03204695|516842779|FG000|Overall Study|Participant was treated with another device|1|||
143353764|NCT03204695|516842779|FG000|Overall Study|Physician Decision|2|||
143353765|NCT02555371|516842780|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
143353766|NCT02555371|516842781|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
143353767|NCT02555371|516842782|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
143353768|NCT02555371|516842783|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
143353769|NCT02555371|516842784|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
143353770|NCT02555371|516842780|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
143353771|NCT02555371|516842781|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
143353772|NCT02555371|516842782|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
143353773|NCT02555371|516842783|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
143353774|NCT02555371|516842784|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
143353775|NCT02555371|516842780|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
143353776|NCT02555371|516842781|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
143353777|NCT02555371|516842782|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
143353778|NCT02555371|516842783|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
143353779|NCT02555371|516842784|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
143353780|NCT02555371|516842780|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
143353781|NCT02555371|516842781|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
143353782|NCT02555371|516842782|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
143353783|NCT02555371|516842783|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
143353784|NCT02555371|516842784|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
143353785|NCT02555371|516842780|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
143353786|NCT02555371|516842781|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
143353787|NCT02555371|516842782|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
143353788|NCT02555371|516842783|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
143353789|NCT02555371|516842784|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
143353790|NCT02555371|516842780|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
143353791|NCT02555371|516842781|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
143353792|NCT02555371|516842782|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
143353793|NCT02555371|516842783|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
143353794|NCT02555371|516842784|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
143353795|NCT02555371|516842780|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
143353796|NCT02555371|516842781|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
143353797|NCT02555371|516842782|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
143353798|NCT02555371|516842783|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
143353799|NCT02555371|516842784|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
143353800|NCT02555371|516842780|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
143353801|NCT02555371|516842781|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
143353802|NCT02555371|516842782|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
143353803|NCT02555371|516842783|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
143353804|NCT02555371|516842784|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
143353805|NCT02555371|516842780|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
143353806|NCT02555371|516842781|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
143353807|NCT02555371|516842782|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
143353808|NCT02555371|516842783|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
143353809|NCT02555371|516842784|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
143353810|NCT02555371|516842780|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
143353811|NCT02555371|516842781|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
143353812|NCT02555371|516842782|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
143353813|NCT02555371|516842783|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
143353814|NCT02555371|516842784|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
143353815|NCT02555371|516842780|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
143353816|NCT02555371|516842781|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
143353817|NCT02555371|516842782|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
143353818|NCT02555371|516842783|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
143353819|NCT02555371|516842784|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
143353820|NCT02555371|516842780|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
143353821|NCT02555371|516842781|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
143353822|NCT02555371|516842782|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
143353823|NCT02555371|516842783|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
143461656|NCT01919814|517237444|FG001|Overall Study|Withdrawal by Subject|0|||
143461657|NCT05220254|517237448|FG000|Overall Study|Withdrawal by Subject|4|||
143353824|NCT02555371|516842784|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
143353825|NCT02555371|516842780|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
143353826|NCT02555371|516842781|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
143353827|NCT02555371|516842782|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
143353828|NCT02555371|516842783|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
143353829|NCT02555371|516842784|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
143353830|NCT02555371|516842780|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
143353831|NCT02555371|516842781|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
143353832|NCT02555371|516842782|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
143353833|NCT02555371|516842783|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
143353834|NCT02555371|516842784|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
143353835|NCT00742885|516842787|FG000|Overall Study|Lost to Follow-up|1|||
143353836|NCT00742885|516842788|FG001|Overall Study|Lost to Follow-up|0|||
143353837|NCT04781647|516842789|FG000|Overall Study|Study terminated by Sponsor|11|||
143353838|NCT04781647|516842790|FG001|Overall Study|Study terminated by Sponsor|9|||
143353839|NCT04781647|516842791|FG002|Overall Study|Study terminated by Sponsor|9|||
143353840|NCT04781647|516842789|FG000|Overall Study|Withdrawal by Subject|1|||
143353841|NCT04781647|516842790|FG001|Overall Study|Withdrawal by Subject|2|||
143353842|NCT04781647|516842791|FG002|Overall Study|Withdrawal by Subject|0|||
143353843|NCT04781647|516842789|FG000|Overall Study|Adverse Event|0|||
143353844|NCT04781647|516842790|FG001|Overall Study|Adverse Event|1|||
143353845|NCT04781647|516842791|FG002|Overall Study|Adverse Event|1|||
143353846|NCT04781647|516842789|FG000|Overall Study|Protocol Violation|1|||
143353847|NCT04781647|516842790|FG001|Overall Study|Protocol Violation|0|||
143353848|NCT04781647|516842791|FG002|Overall Study|Protocol Violation|0|||
143353849|NCT04781647|516842789|FG000|Overall Study|Pregnancy|0|||
143353850|NCT04781647|516842790|FG001|Overall Study|Pregnancy|0|||
143353851|NCT04781647|516842791|FG002|Overall Study|Pregnancy|1|||
143353852|NCT04781647|516842789|FG000|Overall Study|Virology rebounded|1|||
143353853|NCT04781647|516842790|FG001|Overall Study|Virology rebounded|0|||
143353854|NCT04781647|516842791|FG002|Overall Study|Virology rebounded|0|||
143353855|NCT01755689|516842792|FG000|Overall Study|Withdrawal by Subject|1|||
143353856|NCT01755689|516842793|FG001|Overall Study|Withdrawal by Subject|3|||
143353857|NCT01755689|516842794|FG002|Overall Study|Withdrawal by Subject|2|||
143353858|NCT01755689|516842795|FG003|Overall Study|Withdrawal by Subject|1|||
143353859|NCT01755689|516842796|FG004|Overall Study|Withdrawal by Subject|1|||
143353860|NCT01755689|516842792|FG000|Overall Study|Migrated/moved from study area|0|||
143353861|NCT01755689|516842793|FG001|Overall Study|Migrated/moved from study area|1|||
143353862|NCT01755689|516842794|FG002|Overall Study|Migrated/moved from study area|1|||
143353863|NCT01755689|516842795|FG003|Overall Study|Migrated/moved from study area|1|||
143353864|NCT01755689|516842796|FG004|Overall Study|Migrated/moved from study area|1|||
143353865|NCT01755689|516842792|FG000|Overall Study|Lost to Follow-up|1|||
143353866|NCT01755689|516842793|FG001|Overall Study|Lost to Follow-up|0|||
143353867|NCT01755689|516842794|FG002|Overall Study|Lost to Follow-up|1|||
143353868|NCT01755689|516842795|FG003|Overall Study|Lost to Follow-up|0|||
143353869|NCT01755689|516842796|FG004|Overall Study|Lost to Follow-up|2|||
143353870|NCT01755689|516842792|FG000|Overall Study|Pregnancy|1|||
143353871|NCT01755689|516842793|FG001|Overall Study|Pregnancy|1|||
143353872|NCT01755689|516842794|FG002|Overall Study|Pregnancy|2|||
143353873|NCT01755689|516842795|FG003|Overall Study|Pregnancy|4|||
143353874|NCT01755689|516842796|FG004|Overall Study|Pregnancy|2|||
143353875|NCT02609659|516842799|FG000|Overall Study|Adverse Event|1|||
143353876|NCT02609659|516842799|FG000|Overall Study|Lost to Follow-up|6|||
143353877|NCT02609659|516842799|FG000|Overall Study|Other|1|||
143353878|NCT02462083|516842800|FG000|Overall Study|Sponsor request|39|||
143353879|NCT02462083|516842800|FG000|Overall Study|Withdrawal by Subject|87|||
143353880|NCT02462083|516842800|FG000|Overall Study|Lost to Follow-up|41|||
143353881|NCT02462083|516842800|FG000|Overall Study|Lack of Efficacy|151|||
143353882|NCT02462083|516842800|FG000|Overall Study|Pregnancy|1|||
143353883|NCT02462083|516842800|FG000|Overall Study|Protocol Violation|6|||
143353884|NCT02462083|516842800|FG000|Overall Study|Adverse Event|33|||
143353885|NCT02462083|516842800|FG000|Overall Study|Worsening condition|16|||
143353886|NCT02462083|516842800|FG000|Overall Study|Other than specified|45|||
143353887|NCT01668147|516842801|FG000|Overall Study|Withdrawal by Subject|6|||
143353888|NCT00506285|516842804|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
143353889|NCT00506285|516842805|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
143353890|NCT00506285|516842804|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
143353891|NCT00506285|516842805|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
143353892|NCT00506285|516842804|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
143353893|NCT00506285|516842805|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
143353894|NCT00506285|516842804|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
143353895|NCT00506285|516842805|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
143353896|NCT00506285|516842804|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
143353897|NCT00506285|516842805|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
143353898|NCT00593554|516842806|FG000|Overall Study|Death|1|||
143353899|NCT00593554|516842807|FG001|Overall Study|Death|2|||
143353900|NCT00593554|516842806|FG000|Overall Study|Physician Decision|0|||
143353901|NCT00593554|516842807|FG001|Overall Study|Physician Decision|1|||
143353902|NCT00593554|516842806|FG000|Overall Study|Withdrawal by Subject|1|||
143353903|NCT00593554|516842807|FG001|Overall Study|Withdrawal by Subject|0|||
143353904|NCT00593554|516842806|FG000|Overall Study|Disease Progression|1|||
143353905|NCT00593554|516842807|FG001|Overall Study|Disease Progression|2|||
143353906|NCT02726399|516842815|FG000|Overall Study|Participant Non-Compliance|1|||
143353907|NCT02726399|516842815|FG000|Overall Study|Adverse Event|2|||
143353908|NCT02726399|516842815|FG000|Overall Study|Progression of disease|4|||
143353909|NCT04254679|516842840|FG000|Overall Study|Protocol Violation|1|||
143353910|NCT04254679|516842841|FG001|Overall Study|Protocol Violation|1|||
143353911|NCT04254679|516842840|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
143353912|NCT04254679|516842841|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
143353913|NCT02206152|516842846|FG000|Pre-Randomization|Withdrawal by Subject|2|||
143353914|NCT00478608|516842847|FG000|Overall Study|Adverse Event|1|||
143353915|NCT00478608|516842847|FG000|Overall Study|Serious Adverse Event|14|||
143353916|NCT00478608|516842847|FG000|Overall Study|Withdrawal by Subject|2|||
143353917|NCT00478608|516842847|FG000|Overall Study|Protocol Violation|3|||
143353918|NCT00390455|516842849|FG000|Overall Study|Adverse Event|17|||
143353919|NCT00390455|516842850|FG001|Overall Study|Adverse Event|3|||
143353920|NCT00390455|516842849|FG000|Overall Study|Withdrawal by Subject|8|||
143353921|NCT00390455|516842850|FG001|Overall Study|Withdrawal by Subject|8|||
143353922|NCT00390455|516842849|FG000|Overall Study|Alternate Treatment|0|||
143353923|NCT00390455|516842850|FG001|Overall Study|Alternate Treatment|1|||
143353924|NCT00390455|516842849|FG000|Overall Study|Other Medical Reasons|7|||
143353925|NCT00390455|516842850|FG001|Overall Study|Other Medical Reasons|11|||
143353926|NCT00794820|516842856|FG000|Overall Study|Adverse Event|11|||
143353927|NCT00794820|516842856|FG000|Overall Study|Secondary Malignancies|2|||
143353928|NCT00794820|516842856|FG000|Overall Study|Resistant Disease|2|||
143353929|NCT00794820|516842856|FG000|Overall Study|Ineligible/Screen Failure|1|||
143353930|NCT04076020|516842857|FG000|Overall Study|Death|4|||
143353931|NCT04076020|516842858|FG001|Overall Study|Death|6|||
143125728|NCT02576977|516006613|FG000|Overall Study|Withdrawal by Subject|11|||
143125729|NCT02576977|516006614|FG001|Overall Study|Withdrawal by Subject|11|||
143125730|NCT02576977|516006613|FG000|Overall Study|Final Disposition Unknown|0|||
143125731|NCT02576977|516006614|FG001|Overall Study|Final Disposition Unknown|1|||
143125732|NCT02576977|516006613|FG000|Overall Study|Lost to Follow-up|1|||
143125733|NCT02576977|516006614|FG001|Overall Study|Lost to Follow-up|0|||
143125734|NCT02576977|516006613|FG000|Overall Study|Progressive Disease|0|||
143353932|NCT04076020|516842857|FG000|Overall Study|Withdrawal by Subject|12|||
143353933|NCT04076020|516842858|FG001|Overall Study|Withdrawal by Subject|8|||
143353934|NCT02406261|516842860|FG000|Period 1|Lost to Follow-up|2|||
143353935|NCT02406261|516842861|FG001|Period 1|Lost to Follow-up|0|||
143353936|NCT02406261|516842860|FG000|Period 1|Adverse Event|1|||
143353937|NCT02406261|516842861|FG001|Period 1|Adverse Event|0|||
143353938|NCT02406261|516842860|FG000|Period 2|Physician Decision|0|||
143353939|NCT02406261|516842861|FG001|Period 2|Physician Decision|1|||
143353940|NCT02406261|516842860|FG000|Period 2|Protocol Violation|0|||
143353941|NCT02406261|516842861|FG001|Period 2|Protocol Violation|1|||
143353942|NCT02406261|516842860|FG000|Period 2|Withdrawal by Subject|0|||
143353943|NCT02406261|516842861|FG001|Period 2|Withdrawal by Subject|1|||
143353944|NCT01591460|516842862|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
143353945|NCT01591460|516842862|FG000|Overall Study|Futility Rule (Week 12)|7|||
143353946|NCT01591460|516842862|FG000|Overall Study|Futility Rule (Week 24)|3|||
143353947|NCT01591460|516842862|FG000|Overall Study|Rebound or Breakthrough|3|||
143353948|NCT01591460|516842862|FG000|Overall Study|Treatment Discontinued by Error|1|||
143125735|NCT02576977|516006614|FG001|Overall Study|Progressive Disease|1|||
143125736|NCT00802672|516006615|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
143125737|NCT00802672|516006616|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
143125738|NCT00802672|516006617|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
143461658|NCT05220254|517237448|FG000|Overall Study|Removed due to ineligibility|1|||
143125739|NCT00802672|516006615|FG000|Overall Study|Adverse Event|1|||
143353949|NCT01591460|516842862|FG000|Overall Study|Lost to Follow-up|1|||
143353950|NCT01591460|516842862|FG000|Overall Study|Noncompliance|1|||
143353951|NCT01591460|516842862|FG000|Overall Study|Participant Refusal|3|||
143353952|NCT01591460|516842862|FG000|Overall Study|Withdrawal by Subject|1|||
143353953|NCT01591460|516842862|FG000|Overall Study|Protocol Violation|1|||
143353954|NCT03230864|516842863|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
143353955|NCT03230864|516842864|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
143353956|NCT03230864|516842865|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
143353957|NCT03230864|516842866|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
143353958|NCT03230864|516842863|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
143353959|NCT03230864|516842864|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
143353960|NCT03230864|516842865|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
143353961|NCT03230864|516842866|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
143461659|NCT05220254|517237448|FG000|Overall Study|Lost to Follow-up|7|||
143125740|NCT00802672|516006616|FG001|Overall Study|Adverse Event|1|||
143125741|NCT00802672|516006617|FG002|Overall Study|Adverse Event|1|||
143125742|NCT00802672|516006615|FG000|Overall Study|Protocol Violation|2|||
143125743|NCT00802672|516006616|FG001|Overall Study|Protocol Violation|1|||
143125744|NCT00802672|516006617|FG002|Overall Study|Protocol Violation|1|||
143125745|NCT00802672|516006615|FG000|Overall Study|Lost to Follow-up|5|||
143125746|NCT00802672|516006616|FG001|Overall Study|Lost to Follow-up|5|||
143125747|NCT00802672|516006617|FG002|Overall Study|Lost to Follow-up|3|||
143125748|NCT00802672|516006615|FG000|Overall Study|Withdrawal by Subject|1|||
143125749|NCT00802672|516006616|FG001|Overall Study|Withdrawal by Subject|1|||
143125750|NCT00802672|516006617|FG002|Overall Study|Withdrawal by Subject|2|||
143125751|NCT00802672|516006615|FG000|Overall Study|other|3|||
143125752|NCT00802672|516006616|FG001|Overall Study|other|1|||
143125753|NCT00802672|516006617|FG002|Overall Study|other|2|||
143125754|NCT02030119|516006621|FG000|Overall Study|Withdrawal by Subject|3|||
143125755|NCT02030119|516006622|FG001|Overall Study|Withdrawal by Subject|1|||
143125756|NCT02030119|516006623|FG002|Overall Study|Withdrawal by Subject|5|||
143125757|NCT02030119|516006624|FG003|Overall Study|Withdrawal by Subject|3|||
143125758|NCT02030119|516006621|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
143125759|NCT02030119|516006622|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
143125760|NCT02030119|516006623|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
143125761|NCT02030119|516006624|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
143125762|NCT00759655|516006625|FG000|Overall Study|Termination of the study by sponsor|1|||
143125763|NCT03746405|516006628|FG000|Overall Study|Withdrawal by Subject|3|||
143125764|NCT03746405|516006629|FG001|Overall Study|Withdrawal by Subject|0|||
143125765|NCT03746405|516006628|FG000|Overall Study|technical difficulties|0|||
143125766|NCT03746405|516006629|FG001|Overall Study|technical difficulties|2|||
143125767|NCT00412932|516006630|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
143125768|NCT00412932|516006630|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
143125769|NCT00412932|516006630|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
143125770|NCT00412932|516006630|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
143125771|NCT00412932|516006630|FG000|Olmesartan (Olm) 20 mg|Other|1|||
143125772|NCT00412932|516006630|FG000|Olmesartan 40 mg|Adverse Event|4|||
143125773|NCT00412932|516006630|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
143125774|NCT00412932|516006630|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
143125775|NCT00412932|516006630|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
143125776|NCT00412932|516006630|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
143125777|NCT00412932|516006630|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
143125778|NCT00412932|516006630|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
143125779|NCT01310127|516006631|FG000|Overall Study|Protocol Violation|1|||
143125780|NCT01310127|516006632|FG001|Overall Study|Protocol Violation|1|||
143125781|NCT01310127|516006631|FG000|Overall Study|advanced psc cataract outlier|1|||
143125782|NCT01310127|516006632|FG001|Overall Study|advanced psc cataract outlier|0|||
143125783|NCT02753816|516006636|FG000|Overall Study|Protocol Violation|0|||
143125784|NCT02753816|516006637|FG001|Overall Study|Protocol Violation|1|||
143125785|NCT02753816|516006638|FG002|Overall Study|Protocol Violation|0|||
143125786|NCT00534248|516006639|FG000|Overall Study|Adverse Event|19|||
143125787|NCT00534248|516006640|FG001|Overall Study|Adverse Event|29|||
143125788|NCT00534248|516006639|FG000|Overall Study|Lost to Follow-up|353|||
143125789|NCT00534248|516006640|FG001|Overall Study|Lost to Follow-up|375|||
143125790|NCT00534248|516006639|FG000|Overall Study|Other protocol specified criteria|13|||
143125791|NCT00534248|516006640|FG001|Overall Study|Other protocol specified criteria|3|||
143125792|NCT00534248|516006639|FG000|Overall Study|Physician Decision|10|||
143125793|NCT00534248|516006640|FG001|Overall Study|Physician Decision|7|||
143125794|NCT00534248|516006639|FG000|Overall Study|Protocol Violation|3|||
143125795|NCT00534248|516006640|FG001|Overall Study|Protocol Violation|4|||
143125796|NCT00534248|516006639|FG000|Overall Study|Withdrawal by Subject|263|||
143125797|NCT00534248|516006640|FG001|Overall Study|Withdrawal by Subject|255|||
143125798|NCT02259400|516006641|FG000|Overall Study|Death|0|||
143125799|NCT02259400|516006642|FG001|Overall Study|Death|2|||
143125800|NCT00697593|516006643|FG000|Overall Study|Adverse Event|3|||
143125801|NCT00697593|516006643|FG000|Overall Study|Protocol Violation|1|||
143125802|NCT00697593|516006643|FG000|Overall Study|Lack of Efficacy|3|||
143125803|NCT00697593|516006643|FG000|Overall Study|Suspension of the study by sponsor|12|||
143125804|NCT03498313|516006644|FG000|Experimental Period 1|Adverse Event|1|||
143125805|NCT03498313|516006645|FG001|Experimental Period 1|Adverse Event|0|||
143353962|NCT03230864|516842863|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
143353963|NCT03230864|516842864|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
143125806|NCT03498313|516006646|FG002|Experimental Period 1|Adverse Event|0|||
143125807|NCT03498313|516006647|FG003|Experimental Period 1|Adverse Event|1|||
143125808|NCT03498313|516006648|FG004|Experimental Period 1|Adverse Event|0|||
143353964|NCT03230864|516842865|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
143125809|NCT03498313|516006649|FG005|Experimental Period 1|Adverse Event|0|||
143125810|NCT03498313|516006644|FG000|Experimental Period 1|Withdrawal by Subject|0|||
143125811|NCT03498313|516006645|FG001|Experimental Period 1|Withdrawal by Subject|1|||
143125812|NCT03498313|516006646|FG002|Experimental Period 1|Withdrawal by Subject|0|||
143353965|NCT03230864|516842866|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
143353966|NCT03230864|516842863|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
143353967|NCT03230864|516842864|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
143353968|NCT03230864|516842865|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
143353969|NCT03230864|516842866|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
143353970|NCT03230864|516842863|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
143353971|NCT03230864|516842864|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
143353972|NCT03230864|516842865|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
143353973|NCT03230864|516842866|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
143353974|NCT03230864|516842863|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
143353975|NCT03230864|516842864|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
143353976|NCT03230864|516842865|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
143353977|NCT03230864|516842866|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
143353978|NCT03230864|516842863|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
143353979|NCT03230864|516842864|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
143353980|NCT03230864|516842865|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
143353981|NCT03230864|516842866|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
143353982|NCT03230864|516842863|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
143353983|NCT03230864|516842864|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
143353984|NCT03230864|516842865|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
143353985|NCT03230864|516842866|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
143353986|NCT03230864|516842863|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
143353987|NCT03230864|516842864|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
143353988|NCT03230864|516842865|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
143353989|NCT03230864|516842866|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
143353990|NCT03230864|516842863|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
143353991|NCT03230864|516842864|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
143353992|NCT03230864|516842865|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
143353993|NCT03230864|516842866|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
143353994|NCT01744496|516842877|FG000|Titration Period|Adverse Event|2|||
143353995|NCT01744496|516842878|FG001|Titration Period|Adverse Event|1|||
143353996|NCT01744496|516842877|FG000|Titration Period|Personal reasons|0|||
143353997|NCT01744496|516842878|FG001|Titration Period|Personal reasons|1|||
143353998|NCT01744496|516842877|FG000|Maintenance Period|Adverse Event|1|||
143353999|NCT01744496|516842878|FG001|Maintenance Period|Adverse Event|3|||
143354000|NCT01744496|516842877|FG000|Maintenance Period|Protocol Violation|1|||
143354001|NCT01744496|516842878|FG001|Maintenance Period|Protocol Violation|0|||
143354002|NCT01744496|516842877|FG000|Maintenance Period|Withdrawal by Subject|1|||
143354003|NCT01744496|516842878|FG001|Maintenance Period|Withdrawal by Subject|1|||
143354004|NCT01744496|516842877|FG000|Maintenance Period|Subject left town|1|||
143354005|NCT01744496|516842878|FG001|Maintenance Period|Subject left town|0|||
143354006|NCT03537261|516842879|FG000|Overall Study|Lost to Follow-up|4|||
143354007|NCT03537261|516842880|FG001|Overall Study|Lost to Follow-up|5|||
143354008|NCT03537261|516842879|FG000|Overall Study|Withdrawal by Subject|4|||
143354009|NCT03537261|516842880|FG001|Overall Study|Withdrawal by Subject|6|||
143354010|NCT03537261|516842879|FG000|Overall Study|Did not return study questionnaires|0|||
143354011|NCT03537261|516842880|FG001|Overall Study|Did not return study questionnaires|1|||
143354012|NCT01177813|516842887|FG000|Overall Study|Adverse Event|8|||
143354013|NCT01177813|516842888|FG001|Overall Study|Adverse Event|2|||
143354014|NCT01177813|516842889|FG002|Overall Study|Adverse Event|4|||
143354015|NCT01177813|516842890|FG003|Overall Study|Adverse Event|6|||
143354016|NCT01177813|516842891|FG004|Overall Study|Adverse Event|3|||
143354017|NCT01177813|516842887|FG000|Overall Study|Lack of Efficacy|1|||
143354018|NCT01177813|516842888|FG001|Overall Study|Lack of Efficacy|0|||
143354019|NCT01177813|516842889|FG002|Overall Study|Lack of Efficacy|0|||
143354020|NCT01177813|516842890|FG003|Overall Study|Lack of Efficacy|0|||
143354021|NCT01177813|516842891|FG004|Overall Study|Lack of Efficacy|0|||
143354022|NCT01177813|516842887|FG000|Overall Study|Protocol Violation|3|||
143354023|NCT01177813|516842888|FG001|Overall Study|Protocol Violation|2|||
143354024|NCT01177813|516842889|FG002|Overall Study|Protocol Violation|2|||
143354025|NCT01177813|516842890|FG003|Overall Study|Protocol Violation|0|||
143354026|NCT01177813|516842891|FG004|Overall Study|Protocol Violation|1|||
143012568|NCT02406742|515585621|FG002|Overall Study|Physician Decision|1|||
143354027|NCT01177813|516842887|FG000|Overall Study|Lost to Follow-up|12|||
143354028|NCT01177813|516842888|FG001|Overall Study|Lost to Follow-up|5|||
143354029|NCT01177813|516842889|FG002|Overall Study|Lost to Follow-up|6|||
143012569|NCT02406742|515585619|FG000|Overall Study|Transition to other treatment|2|||
143354030|NCT01177813|516842890|FG003|Overall Study|Lost to Follow-up|3|||
143354031|NCT01177813|516842891|FG004|Overall Study|Lost to Follow-up|0|||
143354032|NCT01177813|516842887|FG000|Overall Study|Withdrawal by Subject|12|||
143354033|NCT01177813|516842888|FG001|Overall Study|Withdrawal by Subject|7|||
143354034|NCT01177813|516842889|FG002|Overall Study|Withdrawal by Subject|6|||
143354035|NCT01177813|516842890|FG003|Overall Study|Withdrawal by Subject|5|||
143354036|NCT01177813|516842891|FG004|Overall Study|Withdrawal by Subject|3|||
143354037|NCT01177813|516842887|FG000|Overall Study|Other reason not defined above|5|||
143354038|NCT01177813|516842888|FG001|Overall Study|Other reason not defined above|2|||
143354039|NCT01177813|516842889|FG002|Overall Study|Other reason not defined above|2|||
143354040|NCT01177813|516842890|FG003|Overall Study|Other reason not defined above|3|||
143354041|NCT01177813|516842891|FG004|Overall Study|Other reason not defined above|2|||
143354042|NCT00610675|516842894|FG000|Overall Study|Untreated|4|||
143354043|NCT00610675|516842894|FG000|Overall Study|Adverse Event|67|||
143354044|NCT00610675|516842894|FG000|Overall Study|Insufficient Effect|31|||
143354045|NCT00610675|516842894|FG000|Overall Study|Withdrawal by Subject|28|||
143354046|NCT00610675|516842894|FG000|Overall Study|Reasons unrelated to trial|27|||
143354047|NCT00610675|516842894|FG000|Overall Study|Lack of Compliance|7|||
143354048|NCT00610675|516842894|FG000|Overall Study|Lost to Follow-up|31|||
143354049|NCT00610675|516842894|FG000|Overall Study|Other reason (not specified)|25|||
143354050|NCT03772314|516842897|FG000|Overall Study|Adverse Event|7|||
143354051|NCT03772314|516842898|FG001|Overall Study|Adverse Event|2|||
143354052|NCT04011384|516842899|FG000|Overall Study|Withdrawal by Subject|2|||
143354053|NCT04011384|516842900|FG001|Overall Study|Withdrawal by Subject|0|||
143354054|NCT03192215|516842901|FG000|Overall Study|Death|28|||
143354055|NCT03192215|516842902|FG001|Overall Study|Death|23|||
143354056|NCT03192215|516842901|FG000|Overall Study|Lost to Follow-up|10|||
143354057|NCT03192215|516842902|FG001|Overall Study|Lost to Follow-up|15|||
143354058|NCT03192215|516842901|FG000|Overall Study|Withdrawal by Subject|49|||
143354059|NCT03192215|516842902|FG001|Overall Study|Withdrawal by Subject|48|||
143354060|NCT03192215|516842901|FG000|Overall Study|Other as reported in analysis|4|||
143354061|NCT03192215|516842902|FG001|Overall Study|Other as reported in analysis|1|||
143354062|NCT01994720|516842904|FG000|Overall Study|Withdrawal by Subject|46|||
143354063|NCT01994720|516842905|FG001|Overall Study|Withdrawal by Subject|56|||
143354064|NCT00903786|516842909|FG000|Overall Study|Physician Decision|6|||
143354065|NCT00903786|516842909|FG000|Overall Study|Lack of Efficacy|5|||
143354066|NCT00903786|516842909|FG000|Overall Study|Reason other than lack of efficacy|4|||
143354067|NCT00845871|516842912|FG000|Assessment Period|Adverse Event|2|||
143354068|NCT00845871|516842912|FG000|Assessment Period|Abnormal laboratory values|1|||
143354069|NCT00845871|516842912|FG000|Assessment Period|Abnormal test procedure results|1|||
143354070|NCT00845871|516842912|FG000|Assessment Period|Patient withdrew consent|3|||
143354071|NCT01857622|516842913|FG000|Overall Study|Adverse Event|5|||
143354072|NCT01857622|516842914|FG001|Overall Study|Adverse Event|0|||
143354073|NCT01857622|516842915|FG002|Overall Study|Adverse Event|2|||
143354074|NCT01857622|516842913|FG000|Overall Study|Physician Decision|1|||
143354075|NCT01857622|516842914|FG001|Overall Study|Physician Decision|0|||
143354076|NCT01857622|516842915|FG002|Overall Study|Physician Decision|0|||
143354077|NCT01857622|516842913|FG000|Overall Study|Protocol Violation|4|||
143354078|NCT01857622|516842914|FG001|Overall Study|Protocol Violation|1|||
143354079|NCT01857622|516842915|FG002|Overall Study|Protocol Violation|0|||
143354080|NCT01857622|516842913|FG000|Overall Study|Withdrawal by Subject|1|||
143354081|NCT01857622|516842914|FG001|Overall Study|Withdrawal by Subject|0|||
143354082|NCT01857622|516842915|FG002|Overall Study|Withdrawal by Subject|0|||
143354083|NCT01291225|516842919|FG000|Overall Study|Lost to Follow-up|85|||
143354084|NCT01291225|516842920|FG001|Overall Study|Lost to Follow-up|39|||
143354085|NCT00876460|516842927|FG000|Combination Therapy Phase|Progressive disease|2|||
143354086|NCT00876460|516842928|FG001|Combination Therapy Phase|Progressive disease|3|||
143354087|NCT00876460|516842929|FG002|Combination Therapy Phase|Progressive disease|3|||
143354088|NCT00876460|516842930|FG003|Combination Therapy Phase|Progressive disease|3|||
143354089|NCT00876460|516842931|FG004|Combination Therapy Phase|Progressive disease|3|||
143354090|NCT00876460|516842932|FG005|Combination Therapy Phase|Progressive disease|1|||
143354091|NCT00876460|516842933|FG006|Combination Therapy Phase|Progressive disease|1|||
143354092|NCT00876460|516842934|FG007|Combination Therapy Phase|Progressive disease|1|||
143354093|NCT00876460|516842927|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
143354094|NCT00876460|516842928|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
143354095|NCT00876460|516842929|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
143354096|NCT00876460|516842930|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
143354097|NCT00876460|516842931|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
143354098|NCT00876460|516842932|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
143354099|NCT00876460|516842933|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
143354100|NCT00876460|516842934|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
143354101|NCT00876460|516842927|FG000|Combination Therapy Phase|Adverse Event|0|||
143354102|NCT00876460|516842928|FG001|Combination Therapy Phase|Adverse Event|2|||
143354103|NCT00876460|516842929|FG002|Combination Therapy Phase|Adverse Event|0|||
143354104|NCT00876460|516842930|FG003|Combination Therapy Phase|Adverse Event|2|||
143354105|NCT00876460|516842931|FG004|Combination Therapy Phase|Adverse Event|2|||
143354106|NCT00876460|516842932|FG005|Combination Therapy Phase|Adverse Event|0|||
143354107|NCT00876460|516842933|FG006|Combination Therapy Phase|Adverse Event|3|||
143354108|NCT00876460|516842934|FG007|Combination Therapy Phase|Adverse Event|2|||
143354109|NCT00876460|516842927|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
143354110|NCT00876460|516842928|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
143354111|NCT00876460|516842929|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
143354112|NCT00876460|516842930|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
143125813|NCT03498313|516006647|FG003|Experimental Period 1|Withdrawal by Subject|0|||
143354113|NCT00876460|516842931|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
143354114|NCT00876460|516842932|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
143354115|NCT00876460|516842933|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
143354116|NCT00876460|516842934|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
143354117|NCT00876460|516842927|FG000|Combination Therapy Phase|Other reason not defined above|0|||
143354118|NCT00876460|516842928|FG001|Combination Therapy Phase|Other reason not defined above|0|||
143354119|NCT00876460|516842929|FG002|Combination Therapy Phase|Other reason not defined above|0|||
143354120|NCT00876460|516842930|FG003|Combination Therapy Phase|Other reason not defined above|0|||
143354121|NCT00876460|516842931|FG004|Combination Therapy Phase|Other reason not defined above|0|||
143125814|NCT03498313|516006648|FG004|Experimental Period 1|Withdrawal by Subject|0|||
143125815|NCT03498313|516006649|FG005|Experimental Period 1|Withdrawal by Subject|0|||
143125816|NCT03498313|516006644|FG000|Washout Period 1|Anovulation|1|||
143125817|NCT03498313|516006645|FG001|Washout Period 1|Anovulation|0|||
143125818|NCT03498313|516006646|FG002|Washout Period 1|Anovulation|0|||
143125819|NCT03498313|516006647|FG003|Washout Period 1|Anovulation|0|||
143125820|NCT03498313|516006648|FG004|Washout Period 1|Anovulation|0|||
143125821|NCT03498313|516006649|FG005|Washout Period 1|Anovulation|0|||
143125822|NCT03498313|516006644|FG000|Washout Period 1|Withdrawal by Subject|0|||
143125823|NCT03498313|516006645|FG001|Washout Period 1|Withdrawal by Subject|3|||
143125824|NCT03498313|516006646|FG002|Washout Period 1|Withdrawal by Subject|0|||
143125825|NCT03498313|516006647|FG003|Washout Period 1|Withdrawal by Subject|1|||
143125826|NCT03498313|516006648|FG004|Washout Period 1|Withdrawal by Subject|0|||
143125827|NCT03498313|516006649|FG005|Washout Period 1|Withdrawal by Subject|1|||
143125828|NCT03498313|516006644|FG000|Experimental Period 2|Adverse Event|0|||
143125829|NCT03498313|516006645|FG001|Experimental Period 2|Adverse Event|0|||
143125830|NCT03498313|516006646|FG002|Experimental Period 2|Adverse Event|0|||
143125831|NCT03498313|516006647|FG003|Experimental Period 2|Adverse Event|0|||
143125832|NCT03498313|516006648|FG004|Experimental Period 2|Adverse Event|1|||
143125833|NCT03498313|516006649|FG005|Experimental Period 2|Adverse Event|2|||
143125834|NCT03498313|516006644|FG000|Washout Period 2|Physician Decision|1|||
143354122|NCT00876460|516842932|FG005|Combination Therapy Phase|Other reason not defined above|0|||
143354123|NCT00876460|516842933|FG006|Combination Therapy Phase|Other reason not defined above|1|||
143354124|NCT00876460|516842934|FG007|Combination Therapy Phase|Other reason not defined above|2|||
143354125|NCT00876460|516842927|FG000|Combination Therapy Phase|Not treated|0|||
143354126|NCT00876460|516842928|FG001|Combination Therapy Phase|Not treated|0|||
143354127|NCT00876460|516842929|FG002|Combination Therapy Phase|Not treated|0|||
143354128|NCT00876460|516842930|FG003|Combination Therapy Phase|Not treated|0|||
143354129|NCT00876460|516842931|FG004|Combination Therapy Phase|Not treated|0|||
143354130|NCT00876460|516842932|FG005|Combination Therapy Phase|Not treated|0|||
143354131|NCT00876460|516842933|FG006|Combination Therapy Phase|Not treated|1|||
143354132|NCT00876460|516842934|FG007|Combination Therapy Phase|Not treated|0|||
143354133|NCT00876460|516842927|FG000|Mono Therapy Phase|Progressive disease|0|||
143461660|NCT04363801|517237450|FG000|Overall Study|Death|18|||
143012570|NCT02406742|515585620|FG001|Overall Study|Transition to other treatment|0|||
143012571|NCT02406742|515585621|FG002|Overall Study|Transition to other treatment|1|||
143012572|NCT02406742|515585619|FG000|Overall Study|Other Reasons|1|||
143012573|NCT02406742|515585620|FG001|Overall Study|Other Reasons|11|||
143012574|NCT02406742|515585621|FG002|Overall Study|Other Reasons|5|||
143012575|NCT00765999|515585622|FG000|Overall Study|Adverse Event|203|||
143012576|NCT00765999|515585622|FG000|Overall Study|Insufficient Therapeutic Response|100|||
143012577|NCT00765999|515585622|FG000|Overall Study|Protocol Violation|95|||
143012578|NCT00765999|515585622|FG000|Overall Study|Consent Withdrawn|202|||
143012579|NCT00765999|515585622|FG000|Overall Study|Lost to Follow-up|131|||
143012580|NCT00765999|515585622|FG000|Overall Study|Study Terminated by Sponsor|2|||
143012581|NCT00765999|515585622|FG000|Overall Study|Other Miscellaneous Reasons|51|||
143012582|NCT02367729|515585623|FG000|Overall Study|Organic disorder diagnosed|2|||
143012583|NCT02367729|515585624|FG001|Overall Study|Organic disorder diagnosed|1|||
143012584|NCT02367729|515585623|FG000|Overall Study|Adverse Event|1|||
143012585|NCT02367729|515585624|FG001|Overall Study|Adverse Event|2|||
143012586|NCT02367729|515585623|FG000|Overall Study|Withdrawal by Subject|0|||
143012587|NCT02367729|515585624|FG001|Overall Study|Withdrawal by Subject|5|||
143012588|NCT00759174|515585629|FG000|Overall Study|Other|0|||
143012589|NCT00759174|515585630|FG001|Overall Study|Other|2|||
143012590|NCT01890109|515585631|FG000|Overall Study|Withdrawal by Subject|0|||
143012591|NCT01890109|515585632|FG001|Overall Study|Withdrawal by Subject|3|||
143012592|NCT01890109|515585631|FG000|Overall Study|Lost to Follow-up|1|||
143012593|NCT01890109|515585632|FG001|Overall Study|Lost to Follow-up|2|||
143125835|NCT03498313|516006645|FG001|Washout Period 2|Physician Decision|0|||
143125836|NCT03498313|516006646|FG002|Washout Period 2|Physician Decision|0|||
143125837|NCT03498313|516006647|FG003|Washout Period 2|Physician Decision|1|||
143461661|NCT04363801|517237451|FG001|Overall Study|Death|14|||
143354134|NCT00876460|516842928|FG001|Mono Therapy Phase|Progressive disease|0|||
143354135|NCT00876460|516842929|FG002|Mono Therapy Phase|Progressive disease|0|||
143354136|NCT00876460|516842930|FG003|Mono Therapy Phase|Progressive disease|0|||
143354137|NCT00876460|516842931|FG004|Mono Therapy Phase|Progressive disease|2|||
143354138|NCT00876460|516842932|FG005|Mono Therapy Phase|Progressive disease|0|||
143354139|NCT00876460|516842933|FG006|Mono Therapy Phase|Progressive disease|1|||
143354140|NCT00876460|516842934|FG007|Mono Therapy Phase|Progressive disease|3|||
143354141|NCT00876460|516842927|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
143354142|NCT00876460|516842928|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
143354143|NCT00876460|516842929|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
143354144|NCT00876460|516842930|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
143354145|NCT00876460|516842931|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
143354146|NCT00876460|516842932|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
143354147|NCT00876460|516842933|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
143354148|NCT00876460|516842934|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
143354149|NCT00876460|516842927|FG000|Mono Therapy Phase|Adverse Event|0|||
143354150|NCT00876460|516842928|FG001|Mono Therapy Phase|Adverse Event|0|||
143354151|NCT00876460|516842929|FG002|Mono Therapy Phase|Adverse Event|0|||
143354152|NCT00876460|516842930|FG003|Mono Therapy Phase|Adverse Event|1|||
143354153|NCT00876460|516842931|FG004|Mono Therapy Phase|Adverse Event|0|||
143354154|NCT00876460|516842932|FG005|Mono Therapy Phase|Adverse Event|0|||
143354155|NCT00876460|516842933|FG006|Mono Therapy Phase|Adverse Event|0|||
143354156|NCT00876460|516842934|FG007|Mono Therapy Phase|Adverse Event|0|||
143354157|NCT00064025|516842935|FG000|Overall Study|Ineligible|4|||
143354158|NCT00064025|516842935|FG000|Overall Study|Inevaluable|3|||
143354159|NCT02468934|516842936|FG000|Overall Study|Withdrawal by Subject|4|||
143354160|NCT02468934|516842936|FG000|Overall Study|Screen Failure|3|||
143354161|NCT01370603|516842939|FG000|Period 1|Adverse Event|5|||
143354162|NCT01370603|516842940|FG001|Period 1|Adverse Event|3|||
143354163|NCT01370603|516842939|FG000|Period 1|Lost to Follow-up|2|||
143354164|NCT01370603|516842940|FG001|Period 1|Lost to Follow-up|0|||
143354165|NCT01370603|516842939|FG000|Period 1|Protocol Violation|2|||
143354166|NCT01370603|516842940|FG001|Period 1|Protocol Violation|2|||
143354167|NCT01370603|516842939|FG000|Period 1|Withdrawal by Subject|5|||
143354168|NCT01370603|516842940|FG001|Period 1|Withdrawal by Subject|5|||
143354169|NCT01370603|516842939|FG000|Crossover Washout|Adverse Event|2|||
143354170|NCT01370603|516842940|FG001|Crossover Washout|Adverse Event|1|||
143354171|NCT01370603|516842939|FG000|Crossover Washout|Lost to Follow-up|2|||
143354172|NCT01370603|516842940|FG001|Crossover Washout|Lost to Follow-up|0|||
143354173|NCT01370603|516842939|FG000|Crossover Washout|Protocol Violation|1|||
143354174|NCT01370603|516842940|FG001|Crossover Washout|Protocol Violation|0|||
143354175|NCT01370603|516842939|FG000|Crossover Washout|Withdrawal by Subject|4|||
143354176|NCT01370603|516842940|FG001|Crossover Washout|Withdrawal by Subject|1|||
143354177|NCT01370603|516842939|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
143354178|NCT01370603|516842940|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
143354179|NCT01370603|516842939|FG000|Period 2|Adverse Event|1|||
143354180|NCT01370603|516842940|FG001|Period 2|Adverse Event|4|||
143354181|NCT01370603|516842939|FG000|Period 2|Lost to Follow-up|1|||
143354182|NCT01370603|516842940|FG001|Period 2|Lost to Follow-up|0|||
143354183|NCT01370603|516842939|FG000|Period 2|Withdrawal by Subject|1|||
143354184|NCT01370603|516842940|FG001|Period 2|Withdrawal by Subject|0|||
143354185|NCT00003458|516842945|FG000|Overall Study|Not evaluable|4|||
143354186|NCT02133924|516842946|FG000|Overall Study|Death|38|||
143354187|NCT02133924|516842946|FG000|Overall Study|Physician Decision|1|||
143354188|NCT02133924|516842946|FG000|Overall Study|Withdrawal by Subject|3|||
143354189|NCT01216293|516842953|FG000|Main Study|Adverse Event|1|||
143354190|NCT01216293|516842954|FG001|Main Study|Adverse Event|4|||
143354191|NCT01216293|516842955|FG002|Main Study|Adverse Event|2|||
143461662|NCT04363801|517237452|FG002|Overall Study|Death|16|||
143461663|NCT04363801|517237453|FG003|Overall Study|Death|48|||
143461664|NCT04363801|517237454|FG004|Overall Study|Death|38|||
143461665|NCT04363801|517237450|FG000|Overall Study|Withdrawal by Subject|1|||
143461666|NCT04363801|517237451|FG001|Overall Study|Withdrawal by Subject|6|||
143461667|NCT04363801|517237452|FG002|Overall Study|Withdrawal by Subject|1|||
143461668|NCT04363801|517237453|FG003|Overall Study|Withdrawal by Subject|4|||
143461669|NCT04363801|517237454|FG004|Overall Study|Withdrawal by Subject|14|||
143012594|NCT01643928|515585633|FG000|Overall Study|Lost to Follow-up|1|||
143354192|NCT01216293|516842953|FG000|Main Study|Major Protocol Deviation|1|||
143354193|NCT01216293|516842954|FG001|Main Study|Major Protocol Deviation|0|||
143354194|NCT01216293|516842955|FG002|Main Study|Major Protocol Deviation|1|||
143354195|NCT01216293|516842953|FG000|Main Study|Lost to Follow-up|3|||
143354196|NCT01216293|516842954|FG001|Main Study|Lost to Follow-up|1|||
143461670|NCT04363801|517237450|FG000|Overall Study|Sponsor Decision|6|||
143461671|NCT04363801|517237451|FG001|Overall Study|Sponsor Decision|4|||
143354197|NCT01216293|516842955|FG002|Main Study|Lost to Follow-up|0|||
143354198|NCT01216293|516842953|FG000|Main Study|Voluntary Withdrawal|2|||
143354199|NCT01216293|516842954|FG001|Main Study|Voluntary Withdrawal|2|||
143354200|NCT01216293|516842955|FG002|Main Study|Voluntary Withdrawal|2|||
143354201|NCT01216293|516842953|FG000|Main Study|Other Reason Not Specified|0|||
143125838|NCT03498313|516006648|FG004|Washout Period 2|Physician Decision|0|||
143125839|NCT03498313|516006649|FG005|Washout Period 2|Physician Decision|1|||
143125840|NCT03498313|516006644|FG000|Washout Period 2|Withdrawal by Subject|3|||
143125841|NCT03498313|516006645|FG001|Washout Period 2|Withdrawal by Subject|2|||
143125842|NCT03498313|516006646|FG002|Washout Period 2|Withdrawal by Subject|0|||
143125843|NCT03498313|516006647|FG003|Washout Period 2|Withdrawal by Subject|0|||
143125844|NCT03498313|516006648|FG004|Washout Period 2|Withdrawal by Subject|2|||
143125845|NCT03498313|516006649|FG005|Washout Period 2|Withdrawal by Subject|0|||
143125846|NCT03498313|516006644|FG000|Washout Period 2|Anovulation|0|||
143125847|NCT03498313|516006645|FG001|Washout Period 2|Anovulation|0|||
143125848|NCT03498313|516006646|FG002|Washout Period 2|Anovulation|0|||
143461672|NCT04363801|517237452|FG002|Overall Study|Sponsor Decision|10|||
143461673|NCT04363801|517237453|FG003|Overall Study|Sponsor Decision|33|||
143461674|NCT04363801|517237454|FG004|Overall Study|Sponsor Decision|32|||
143461675|NCT04363801|517237450|FG000|Overall Study|Lost to Follow-up|0|||
143461676|NCT04363801|517237451|FG001|Overall Study|Lost to Follow-up|0|||
143461677|NCT04363801|517237452|FG002|Overall Study|Lost to Follow-up|1|||
143461678|NCT04363801|517237453|FG003|Overall Study|Lost to Follow-up|0|||
143461679|NCT04363801|517237454|FG004|Overall Study|Lost to Follow-up|1|||
143354202|NCT01216293|516842954|FG001|Main Study|Other Reason Not Specified|1|||
143354203|NCT01216293|516842955|FG002|Main Study|Other Reason Not Specified|1|||
143354204|NCT01216293|516842953|FG000|Main Study|Randomized, Not Treated|1|||
143461680|NCT00448279|517237455|FG000|Overall Study|Lost to Follow-up|2|||
143461681|NCT00448279|517237456|FG001|Overall Study|Lost to Follow-up|2|||
143461682|NCT00448279|517237455|FG000|Overall Study|Adverse Event|1|||
143461683|NCT00448279|517237456|FG001|Overall Study|Adverse Event|1|||
143461684|NCT00448279|517237455|FG000|Overall Study|Disease progression|16|||
143461685|NCT00448279|517237456|FG001|Overall Study|Disease progression|18|||
143461686|NCT00448279|517237455|FG000|Overall Study|Withdrawal by Subject|4|||
143461687|NCT00448279|517237456|FG001|Overall Study|Withdrawal by Subject|3|||
143461688|NCT00448279|517237455|FG000|Overall Study|Other|6|||
143461689|NCT00448279|517237456|FG001|Overall Study|Other|4|||
143461690|NCT00448279|517237455|FG000|Overall Study|Protocol Violation|0|||
143461691|NCT00448279|517237456|FG001|Overall Study|Protocol Violation|1|||
143461692|NCT00440999|517237457|FG000|Overall Study|Adverse Event|0|||
143461693|NCT00440999|517237458|FG001|Overall Study|Adverse Event|2|||
143461694|NCT00440999|517237457|FG000|Overall Study|Lack of Efficacy|6|||
143354205|NCT01216293|516842954|FG001|Main Study|Randomized, Not Treated|0|||
143354206|NCT01216293|516842955|FG002|Main Study|Randomized, Not Treated|0|||
143354207|NCT01216293|516842953|FG000|Calcium Absorption Substudy|Adverse Event|0|||
143354208|NCT01216293|516842954|FG001|Calcium Absorption Substudy|Adverse Event|2|||
143354209|NCT01216293|516842955|FG002|Calcium Absorption Substudy|Adverse Event|0|||
143354210|NCT01216293|516842953|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
143354211|NCT01216293|516842954|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
143354212|NCT01216293|516842955|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
143354213|NCT01216293|516842953|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
143354214|NCT01216293|516842954|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
143354215|NCT01216293|516842955|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
143354216|NCT01818141|516844940|FG000|Overall Study|Withdrawal by Subject|2|||
143354217|NCT01818141|516844941|FG001|Overall Study|Withdrawal by Subject|0|||
143354218|NCT01818141|516844940|FG000|Overall Study|No baseline C.diff colonies|1|||
143354219|NCT01818141|516844941|FG001|Overall Study|No baseline C.diff colonies|1|||
143354220|NCT01818141|516844940|FG000|Overall Study|Lost to Follow-up|0|||
143354221|NCT01818141|516844941|FG001|Overall Study|Lost to Follow-up|2|||
143354222|NCT00513019|516844942|FG000|Overall Study|Adverse Event|1|||
143354223|NCT00513019|516844943|FG001|Overall Study|Adverse Event|0|||
143354224|NCT00513019|516844942|FG000|Overall Study|Withdrawal by Subject|4|||
143354225|NCT00513019|516844943|FG001|Overall Study|Withdrawal by Subject|5|||
143354226|NCT01642186|516844944|FG000|Overall Study|Death|0|||
143354227|NCT01642186|516844945|FG001|Overall Study|Death|2|||
143354228|NCT01642186|516844946|FG002|Overall Study|Death|2|||
143354229|NCT01642186|516844944|FG000|Overall Study|Lost to Follow-up|0|||
143461695|NCT00440999|517237458|FG001|Overall Study|Lack of Efficacy|7|||
143461696|NCT00440999|517237457|FG000|Overall Study|Lost to Follow-up|19|||
143461697|NCT00440999|517237458|FG001|Overall Study|Lost to Follow-up|12|||
143461698|NCT00440999|517237457|FG000|Overall Study|Protocol Violation|1|||
143461699|NCT00440999|517237458|FG001|Overall Study|Protocol Violation|0|||
143461700|NCT00440999|517237457|FG000|Overall Study|Withdrawal by Subject|2|||
143461701|NCT00440999|517237458|FG001|Overall Study|Withdrawal by Subject|5|||
143461702|NCT00440999|517237457|FG000|Overall Study|Subjets missed the visit|1|||
143354230|NCT01642186|516844945|FG001|Overall Study|Lost to Follow-up|0|||
143354231|NCT01642186|516844946|FG002|Overall Study|Lost to Follow-up|1|||
143354232|NCT01474512|516844947|FG000|Induction Period|Adverse Event|6|||
143461703|NCT00440999|517237458|FG001|Overall Study|Subjets missed the visit|0|||
143461704|NCT00440999|517237457|FG000|Overall Study|Mixed infection at entry|1|||
143461705|NCT00440999|517237458|FG001|Overall Study|Mixed infection at entry|0|||
143125849|NCT03498313|516006647|FG003|Washout Period 2|Anovulation|0|||
143461706|NCT00440999|517237457|FG000|Overall Study|P. falciparum malaria|5|||
143354233|NCT01474512|516844948|FG001|Induction Period|Adverse Event|10|||
143354234|NCT01474512|516844949|FG002|Induction Period|Adverse Event|10|||
143354235|NCT01474512|516844950|FG003|Induction Period|Adverse Event|0|||
143354236|NCT01474512|516844951|FG004|Induction Period|Adverse Event|0|||
143354237|NCT01474512|516844952|FG005|Induction Period|Adverse Event|0|||
143354238|NCT01474512|516844953|FG006|Induction Period|Adverse Event|0|||
143354239|NCT01474512|516844954|FG007|Induction Period|Adverse Event|0|||
143354240|NCT01474512|516844955|FG008|Induction Period|Adverse Event|0|||
143354241|NCT01474512|516844956|FG009|Induction Period|Adverse Event|0|||
143354242|NCT01474512|516844957|FG010|Induction Period|Adverse Event|0|||
143354243|NCT01474512|516844958|FG011|Induction Period|Adverse Event|0|||
143354244|NCT01474512|516844959|FG012|Induction Period|Adverse Event|0|||
143354245|NCT01474512|516844960|FG013|Induction Period|Adverse Event|0|||
143354246|NCT01474512|516844961|FG014|Induction Period|Adverse Event|0|||
143354247|NCT01474512|516844962|FG015|Induction Period|Adverse Event|0|||
143354248|NCT01474512|516844963|FG016|Induction Period|Adverse Event|0|||
143354249|NCT01474512|516844964|FG017|Induction Period|Adverse Event|0|||
143354250|NCT01474512|516844947|FG000|Induction Period|Lack of Efficacy|7|||
143354251|NCT01474512|516844948|FG001|Induction Period|Lack of Efficacy|1|||
143354252|NCT01474512|516844949|FG002|Induction Period|Lack of Efficacy|0|||
143354253|NCT01474512|516844950|FG003|Induction Period|Lack of Efficacy|0|||
143354254|NCT01474512|516844951|FG004|Induction Period|Lack of Efficacy|0|||
143354255|NCT01474512|516844952|FG005|Induction Period|Lack of Efficacy|0|||
143354256|NCT01474512|516844953|FG006|Induction Period|Lack of Efficacy|0|||
143354257|NCT01474512|516844954|FG007|Induction Period|Lack of Efficacy|0|||
143354258|NCT01474512|516844955|FG008|Induction Period|Lack of Efficacy|0|||
143354259|NCT01474512|516844956|FG009|Induction Period|Lack of Efficacy|0|||
143354260|NCT01474512|516844957|FG010|Induction Period|Lack of Efficacy|0|||
143354261|NCT01474512|516844958|FG011|Induction Period|Lack of Efficacy|0|||
143354262|NCT01474512|516844959|FG012|Induction Period|Lack of Efficacy|0|||
143354263|NCT01474512|516844960|FG013|Induction Period|Lack of Efficacy|0|||
143354264|NCT01474512|516844961|FG014|Induction Period|Lack of Efficacy|0|||
143354265|NCT01474512|516844962|FG015|Induction Period|Lack of Efficacy|0|||
143354266|NCT01474512|516844963|FG016|Induction Period|Lack of Efficacy|0|||
143354267|NCT01474512|516844964|FG017|Induction Period|Lack of Efficacy|0|||
143354268|NCT01474512|516844947|FG000|Induction Period|Withdrawal by Subject|6|||
143354269|NCT01474512|516844948|FG001|Induction Period|Withdrawal by Subject|6|||
143354270|NCT01474512|516844949|FG002|Induction Period|Withdrawal by Subject|5|||
143354271|NCT01474512|516844950|FG003|Induction Period|Withdrawal by Subject|0|||
143354272|NCT01474512|516844951|FG004|Induction Period|Withdrawal by Subject|0|||
143354273|NCT01474512|516844952|FG005|Induction Period|Withdrawal by Subject|0|||
143354274|NCT01474512|516844953|FG006|Induction Period|Withdrawal by Subject|0|||
143354275|NCT01474512|516844954|FG007|Induction Period|Withdrawal by Subject|0|||
143354276|NCT01474512|516844955|FG008|Induction Period|Withdrawal by Subject|0|||
143354277|NCT01474512|516844956|FG009|Induction Period|Withdrawal by Subject|0|||
143354278|NCT01474512|516844957|FG010|Induction Period|Withdrawal by Subject|0|||
143354279|NCT01474512|516844958|FG011|Induction Period|Withdrawal by Subject|0|||
143354280|NCT01474512|516844959|FG012|Induction Period|Withdrawal by Subject|0|||
143354281|NCT01474512|516844960|FG013|Induction Period|Withdrawal by Subject|0|||
143354282|NCT01474512|516844961|FG014|Induction Period|Withdrawal by Subject|0|||
143354283|NCT01474512|516844962|FG015|Induction Period|Withdrawal by Subject|0|||
143354284|NCT01474512|516844963|FG016|Induction Period|Withdrawal by Subject|0|||
143354285|NCT01474512|516844964|FG017|Induction Period|Withdrawal by Subject|0|||
143354286|NCT01474512|516844947|FG000|Induction Period|Protocol Violation|3|||
143354287|NCT01474512|516844948|FG001|Induction Period|Protocol Violation|6|||
143354288|NCT01474512|516844949|FG002|Induction Period|Protocol Violation|0|||
143354289|NCT01474512|516844950|FG003|Induction Period|Protocol Violation|0|||
143354290|NCT01474512|516844951|FG004|Induction Period|Protocol Violation|0|||
143354291|NCT01474512|516844952|FG005|Induction Period|Protocol Violation|0|||
143354292|NCT01474512|516844953|FG006|Induction Period|Protocol Violation|0|||
143354293|NCT01474512|516844954|FG007|Induction Period|Protocol Violation|0|||
143354294|NCT01474512|516844955|FG008|Induction Period|Protocol Violation|0|||
143354295|NCT01474512|516844956|FG009|Induction Period|Protocol Violation|0|||
143354296|NCT01474512|516844957|FG010|Induction Period|Protocol Violation|0|||
143354297|NCT01474512|516844958|FG011|Induction Period|Protocol Violation|0|||
143461707|NCT00440999|517237458|FG001|Overall Study|P. falciparum malaria|14|||
143354298|NCT01474512|516844959|FG012|Induction Period|Protocol Violation|0|||
143354299|NCT01474512|516844960|FG013|Induction Period|Protocol Violation|0|||
143354300|NCT01474512|516844961|FG014|Induction Period|Protocol Violation|0|||
143354301|NCT01474512|516844962|FG015|Induction Period|Protocol Violation|0|||
143354302|NCT01474512|516844963|FG016|Induction Period|Protocol Violation|0|||
143354303|NCT01474512|516844964|FG017|Induction Period|Protocol Violation|0|||
143354304|NCT01474512|516844947|FG000|Induction Period|Sponsor Decision|1|||
143354305|NCT01474512|516844948|FG001|Induction Period|Sponsor Decision|1|||
143354306|NCT01474512|516844949|FG002|Induction Period|Sponsor Decision|1|||
143354307|NCT01474512|516844950|FG003|Induction Period|Sponsor Decision|0|||
143354308|NCT01474512|516844951|FG004|Induction Period|Sponsor Decision|0|||
143354309|NCT01474512|516844952|FG005|Induction Period|Sponsor Decision|0|||
143354310|NCT01474512|516844953|FG006|Induction Period|Sponsor Decision|0|||
143354311|NCT01474512|516844954|FG007|Induction Period|Sponsor Decision|0|||
143354312|NCT01474512|516844955|FG008|Induction Period|Sponsor Decision|0|||
143354313|NCT01474512|516844956|FG009|Induction Period|Sponsor Decision|0|||
143354314|NCT01474512|516844957|FG010|Induction Period|Sponsor Decision|0|||
143354315|NCT01474512|516844958|FG011|Induction Period|Sponsor Decision|0|||
143354316|NCT01474512|516844959|FG012|Induction Period|Sponsor Decision|0|||
143354317|NCT01474512|516844960|FG013|Induction Period|Sponsor Decision|0|||
143354318|NCT01474512|516844961|FG014|Induction Period|Sponsor Decision|0|||
143354319|NCT01474512|516844962|FG015|Induction Period|Sponsor Decision|0|||
143354320|NCT01474512|516844963|FG016|Induction Period|Sponsor Decision|0|||
143354321|NCT01474512|516844964|FG017|Induction Period|Sponsor Decision|0|||
143354322|NCT01474512|516844947|FG000|Induction Period|Lost to Follow-up|1|||
143354323|NCT01474512|516844948|FG001|Induction Period|Lost to Follow-up|0|||
143354324|NCT01474512|516844949|FG002|Induction Period|Lost to Follow-up|2|||
143354325|NCT01474512|516844950|FG003|Induction Period|Lost to Follow-up|0|||
143354326|NCT01474512|516844951|FG004|Induction Period|Lost to Follow-up|0|||
143354327|NCT01474512|516844952|FG005|Induction Period|Lost to Follow-up|0|||
143354328|NCT01474512|516844953|FG006|Induction Period|Lost to Follow-up|0|||
143354329|NCT01474512|516844954|FG007|Induction Period|Lost to Follow-up|0|||
143354330|NCT01474512|516844955|FG008|Induction Period|Lost to Follow-up|0|||
143354331|NCT01474512|516844956|FG009|Induction Period|Lost to Follow-up|0|||
143354332|NCT01474512|516844957|FG010|Induction Period|Lost to Follow-up|0|||
143354333|NCT01474512|516844958|FG011|Induction Period|Lost to Follow-up|0|||
143354334|NCT01474512|516844959|FG012|Induction Period|Lost to Follow-up|0|||
143354335|NCT01474512|516844960|FG013|Induction Period|Lost to Follow-up|0|||
143354336|NCT01474512|516844961|FG014|Induction Period|Lost to Follow-up|0|||
143354337|NCT01474512|516844962|FG015|Induction Period|Lost to Follow-up|0|||
143354338|NCT01474512|516844963|FG016|Induction Period|Lost to Follow-up|0|||
143354339|NCT01474512|516844964|FG017|Induction Period|Lost to Follow-up|0|||
143354340|NCT01474512|516844947|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
143354341|NCT01474512|516844948|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
143354342|NCT01474512|516844949|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
143354343|NCT01474512|516844950|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
143354344|NCT01474512|516844951|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
143354345|NCT01474512|516844952|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
143354346|NCT01474512|516844953|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
143354347|NCT01474512|516844954|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
143354348|NCT01474512|516844955|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
143354349|NCT01474512|516844956|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
143354350|NCT01474512|516844957|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
143354351|NCT01474512|516844958|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
143354352|NCT01474512|516844959|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
143354353|NCT01474512|516844960|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
143354354|NCT01474512|516844961|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
143354355|NCT01474512|516844962|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
143354356|NCT01474512|516844963|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
143354357|NCT01474512|516844964|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
143354358|NCT01474512|516844947|FG000|Maintenance Period|Adverse Event|0|||
143354359|NCT01474512|516844948|FG001|Maintenance Period|Adverse Event|0|||
143354360|NCT01474512|516844949|FG002|Maintenance Period|Adverse Event|0|||
143354361|NCT01474512|516844950|FG003|Maintenance Period|Adverse Event|4|||
143354362|NCT01474512|516844951|FG004|Maintenance Period|Adverse Event|2|||
143354363|NCT01474512|516844952|FG005|Maintenance Period|Adverse Event|7|||
143354364|NCT01474512|516844953|FG006|Maintenance Period|Adverse Event|0|||
143354365|NCT01474512|516844954|FG007|Maintenance Period|Adverse Event|19|||
143354366|NCT01474512|516844955|FG008|Maintenance Period|Adverse Event|1|||
143354367|NCT01474512|516844956|FG009|Maintenance Period|Adverse Event|3|||
143354368|NCT01474512|516844957|FG010|Maintenance Period|Adverse Event|0|||
143354369|NCT01474512|516844958|FG011|Maintenance Period|Adverse Event|0|||
143354370|NCT01474512|516844959|FG012|Maintenance Period|Adverse Event|0|||
143354371|NCT01474512|516844960|FG013|Maintenance Period|Adverse Event|0|||
143354372|NCT01474512|516844961|FG014|Maintenance Period|Adverse Event|0|||
143354373|NCT01474512|516844962|FG015|Maintenance Period|Adverse Event|0|||
143354374|NCT01474512|516844963|FG016|Maintenance Period|Adverse Event|0|||
143354375|NCT01474512|516844964|FG017|Maintenance Period|Adverse Event|0|||
143354376|NCT01474512|516844947|FG000|Maintenance Period|Withdrawal by Subject|0|||
143354377|NCT01474512|516844948|FG001|Maintenance Period|Withdrawal by Subject|0|||
143354378|NCT01474512|516844949|FG002|Maintenance Period|Withdrawal by Subject|0|||
143354379|NCT01474512|516844950|FG003|Maintenance Period|Withdrawal by Subject|6|||
143354380|NCT01474512|516844951|FG004|Maintenance Period|Withdrawal by Subject|2|||
143354381|NCT01474512|516844952|FG005|Maintenance Period|Withdrawal by Subject|3|||
143354382|NCT01474512|516844953|FG006|Maintenance Period|Withdrawal by Subject|1|||
143354383|NCT01474512|516844954|FG007|Maintenance Period|Withdrawal by Subject|6|||
143354384|NCT01474512|516844955|FG008|Maintenance Period|Withdrawal by Subject|3|||
143354385|NCT01474512|516844956|FG009|Maintenance Period|Withdrawal by Subject|1|||
143354386|NCT01474512|516844957|FG010|Maintenance Period|Withdrawal by Subject|0|||
143354387|NCT01474512|516844958|FG011|Maintenance Period|Withdrawal by Subject|0|||
143354388|NCT01474512|516844959|FG012|Maintenance Period|Withdrawal by Subject|0|||
143354389|NCT01474512|516844960|FG013|Maintenance Period|Withdrawal by Subject|0|||
143354390|NCT01474512|516844961|FG014|Maintenance Period|Withdrawal by Subject|0|||
143354391|NCT01474512|516844962|FG015|Maintenance Period|Withdrawal by Subject|0|||
143354392|NCT01474512|516844963|FG016|Maintenance Period|Withdrawal by Subject|0|||
143354393|NCT01474512|516844964|FG017|Maintenance Period|Withdrawal by Subject|0|||
143354394|NCT01474512|516844947|FG000|Maintenance Period|Lost to Follow-up|0|||
143354395|NCT01474512|516844948|FG001|Maintenance Period|Lost to Follow-up|0|||
143354396|NCT01474512|516844949|FG002|Maintenance Period|Lost to Follow-up|0|||
143354397|NCT01474512|516844950|FG003|Maintenance Period|Lost to Follow-up|3|||
143354398|NCT01474512|516844951|FG004|Maintenance Period|Lost to Follow-up|3|||
143354399|NCT01474512|516844952|FG005|Maintenance Period|Lost to Follow-up|0|||
143354400|NCT01474512|516844953|FG006|Maintenance Period|Lost to Follow-up|0|||
143354401|NCT01474512|516844954|FG007|Maintenance Period|Lost to Follow-up|2|||
143354402|NCT01474512|516844955|FG008|Maintenance Period|Lost to Follow-up|1|||
143354403|NCT01474512|516844956|FG009|Maintenance Period|Lost to Follow-up|1|||
143354404|NCT01474512|516844957|FG010|Maintenance Period|Lost to Follow-up|0|||
143354405|NCT01474512|516844958|FG011|Maintenance Period|Lost to Follow-up|0|||
143354406|NCT01474512|516844959|FG012|Maintenance Period|Lost to Follow-up|0|||
143354407|NCT01474512|516844960|FG013|Maintenance Period|Lost to Follow-up|0|||
143354408|NCT01474512|516844961|FG014|Maintenance Period|Lost to Follow-up|0|||
143354409|NCT01474512|516844962|FG015|Maintenance Period|Lost to Follow-up|0|||
143354410|NCT01474512|516844963|FG016|Maintenance Period|Lost to Follow-up|0|||
143354411|NCT01474512|516844964|FG017|Maintenance Period|Lost to Follow-up|0|||
143354412|NCT01474512|516844947|FG000|Maintenance Period|Death|0|||
143354413|NCT01474512|516844948|FG001|Maintenance Period|Death|0|||
143354414|NCT01474512|516844949|FG002|Maintenance Period|Death|0|||
143354415|NCT01474512|516844950|FG003|Maintenance Period|Death|0|||
143354416|NCT01474512|516844951|FG004|Maintenance Period|Death|0|||
143354417|NCT01474512|516844952|FG005|Maintenance Period|Death|2|||
143354418|NCT01474512|516844953|FG006|Maintenance Period|Death|0|||
143354419|NCT01474512|516844954|FG007|Maintenance Period|Death|0|||
143354420|NCT01474512|516844955|FG008|Maintenance Period|Death|0|||
143354421|NCT01474512|516844956|FG009|Maintenance Period|Death|0|||
143354422|NCT01474512|516844957|FG010|Maintenance Period|Death|0|||
143354423|NCT01474512|516844958|FG011|Maintenance Period|Death|0|||
143354424|NCT01474512|516844959|FG012|Maintenance Period|Death|0|||
143354425|NCT01474512|516844960|FG013|Maintenance Period|Death|0|||
143354426|NCT01474512|516844961|FG014|Maintenance Period|Death|0|||
143354427|NCT01474512|516844962|FG015|Maintenance Period|Death|0|||
143354428|NCT01474512|516844963|FG016|Maintenance Period|Death|0|||
143354429|NCT01474512|516844964|FG017|Maintenance Period|Death|0|||
143354430|NCT01474512|516844947|FG000|Maintenance Period|Physician Decision|0|||
143354431|NCT01474512|516844948|FG001|Maintenance Period|Physician Decision|0|||
143354432|NCT01474512|516844949|FG002|Maintenance Period|Physician Decision|0|||
143354433|NCT01474512|516844950|FG003|Maintenance Period|Physician Decision|0|||
143354434|NCT01474512|516844951|FG004|Maintenance Period|Physician Decision|0|||
143354435|NCT01474512|516844952|FG005|Maintenance Period|Physician Decision|1|||
143354436|NCT01474512|516844953|FG006|Maintenance Period|Physician Decision|0|||
143354437|NCT01474512|516844954|FG007|Maintenance Period|Physician Decision|2|||
143354438|NCT01474512|516844955|FG008|Maintenance Period|Physician Decision|0|||
143354439|NCT01474512|516844956|FG009|Maintenance Period|Physician Decision|0|||
143354440|NCT01474512|516844957|FG010|Maintenance Period|Physician Decision|0|||
143354441|NCT01474512|516844958|FG011|Maintenance Period|Physician Decision|0|||
143354442|NCT01474512|516844959|FG012|Maintenance Period|Physician Decision|0|||
143354443|NCT01474512|516844960|FG013|Maintenance Period|Physician Decision|0|||
143354444|NCT01474512|516844961|FG014|Maintenance Period|Physician Decision|0|||
143354445|NCT01474512|516844962|FG015|Maintenance Period|Physician Decision|0|||
143354446|NCT01474512|516844963|FG016|Maintenance Period|Physician Decision|0|||
143354447|NCT01474512|516844964|FG017|Maintenance Period|Physician Decision|0|||
143354448|NCT01474512|516844947|FG000|Maintenance Period|Clinical Relapse|0|||
143354449|NCT01474512|516844948|FG001|Maintenance Period|Clinical Relapse|0|||
143354450|NCT01474512|516844949|FG002|Maintenance Period|Clinical Relapse|0|||
143354451|NCT01474512|516844950|FG003|Maintenance Period|Clinical Relapse|1|||
143354452|NCT01474512|516844951|FG004|Maintenance Period|Clinical Relapse|0|||
143354453|NCT01474512|516844952|FG005|Maintenance Period|Clinical Relapse|0|||
143354454|NCT01474512|516844953|FG006|Maintenance Period|Clinical Relapse|0|||
143354455|NCT01474512|516844954|FG007|Maintenance Period|Clinical Relapse|0|||
143354456|NCT01474512|516844955|FG008|Maintenance Period|Clinical Relapse|0|||
143012595|NCT01643928|515585634|FG001|Overall Study|Lost to Follow-up|0|||
143354457|NCT01474512|516844956|FG009|Maintenance Period|Clinical Relapse|0|||
143354458|NCT01474512|516844957|FG010|Maintenance Period|Clinical Relapse|0|||
143354459|NCT01474512|516844958|FG011|Maintenance Period|Clinical Relapse|0|||
143354460|NCT01474512|516844959|FG012|Maintenance Period|Clinical Relapse|0|||
143354461|NCT01474512|516844960|FG013|Maintenance Period|Clinical Relapse|0|||
143354462|NCT01474512|516844961|FG014|Maintenance Period|Clinical Relapse|0|||
143354463|NCT01474512|516844962|FG015|Maintenance Period|Clinical Relapse|0|||
143354464|NCT01474512|516844963|FG016|Maintenance Period|Clinical Relapse|0|||
143354465|NCT01474512|516844964|FG017|Maintenance Period|Clinical Relapse|0|||
143354466|NCT01474512|516844947|FG000|Maintenance Period|Lack of Efficacy|0|||
143354467|NCT01474512|516844948|FG001|Maintenance Period|Lack of Efficacy|0|||
143354468|NCT01474512|516844949|FG002|Maintenance Period|Lack of Efficacy|0|||
143354469|NCT01474512|516844950|FG003|Maintenance Period|Lack of Efficacy|1|||
143354470|NCT01474512|516844951|FG004|Maintenance Period|Lack of Efficacy|0|||
143354471|NCT01474512|516844952|FG005|Maintenance Period|Lack of Efficacy|0|||
143354472|NCT01474512|516844953|FG006|Maintenance Period|Lack of Efficacy|0|||
143354473|NCT01474512|516844954|FG007|Maintenance Period|Lack of Efficacy|11|||
143354474|NCT01474512|516844955|FG008|Maintenance Period|Lack of Efficacy|11|||
143354475|NCT01474512|516844956|FG009|Maintenance Period|Lack of Efficacy|12|||
143354476|NCT01474512|516844957|FG010|Maintenance Period|Lack of Efficacy|0|||
143354477|NCT01474512|516844958|FG011|Maintenance Period|Lack of Efficacy|0|||
143354478|NCT01474512|516844959|FG012|Maintenance Period|Lack of Efficacy|0|||
143354479|NCT01474512|516844960|FG013|Maintenance Period|Lack of Efficacy|0|||
143354480|NCT01474512|516844961|FG014|Maintenance Period|Lack of Efficacy|0|||
143354481|NCT01474512|516844962|FG015|Maintenance Period|Lack of Efficacy|0|||
143354482|NCT01474512|516844963|FG016|Maintenance Period|Lack of Efficacy|0|||
143354483|NCT01474512|516844964|FG017|Maintenance Period|Lack of Efficacy|0|||
143354484|NCT01474512|516844947|FG000|Maintenance Period|Protocol Violation|0|||
143354485|NCT01474512|516844948|FG001|Maintenance Period|Protocol Violation|0|||
143354486|NCT01474512|516844949|FG002|Maintenance Period|Protocol Violation|0|||
143354487|NCT01474512|516844950|FG003|Maintenance Period|Protocol Violation|1|||
143354488|NCT01474512|516844951|FG004|Maintenance Period|Protocol Violation|0|||
143354489|NCT01474512|516844952|FG005|Maintenance Period|Protocol Violation|0|||
143354490|NCT01474512|516844953|FG006|Maintenance Period|Protocol Violation|0|||
143354491|NCT01474512|516844954|FG007|Maintenance Period|Protocol Violation|1|||
143354492|NCT01474512|516844955|FG008|Maintenance Period|Protocol Violation|0|||
143354493|NCT01474512|516844956|FG009|Maintenance Period|Protocol Violation|1|||
143354494|NCT01474512|516844957|FG010|Maintenance Period|Protocol Violation|0|||
143354495|NCT01474512|516844958|FG011|Maintenance Period|Protocol Violation|0|||
143354496|NCT01474512|516844959|FG012|Maintenance Period|Protocol Violation|0|||
143354497|NCT01474512|516844960|FG013|Maintenance Period|Protocol Violation|0|||
143354498|NCT01474512|516844961|FG014|Maintenance Period|Protocol Violation|0|||
143354499|NCT01474512|516844962|FG015|Maintenance Period|Protocol Violation|0|||
143354500|NCT01474512|516844963|FG016|Maintenance Period|Protocol Violation|0|||
143354501|NCT01474512|516844964|FG017|Maintenance Period|Protocol Violation|0|||
143354502|NCT01474512|516844947|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
143354503|NCT01474512|516844948|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
143354504|NCT01474512|516844949|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
143354505|NCT01474512|516844950|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
143354506|NCT01474512|516844951|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
143354507|NCT01474512|516844952|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
143354508|NCT01474512|516844953|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
143354509|NCT01474512|516844954|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
143354510|NCT01474512|516844955|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
143354511|NCT01474512|516844956|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
143354512|NCT01474512|516844957|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
143354513|NCT01474512|516844958|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
143354514|NCT01474512|516844959|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
143354515|NCT01474512|516844960|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
143354516|NCT01474512|516844961|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
143354517|NCT01474512|516844962|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
143354518|NCT01474512|516844963|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
143354519|NCT01474512|516844964|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
143354520|NCT01474512|516844947|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
143354521|NCT01474512|516844948|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
143354522|NCT01474512|516844949|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
143354523|NCT01474512|516844950|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
143354524|NCT01474512|516844951|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
143354525|NCT01474512|516844952|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
143354526|NCT01474512|516844953|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
143354527|NCT01474512|516844954|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
143354528|NCT01474512|516844955|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
143354529|NCT01474512|516844956|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
143354530|NCT01474512|516844957|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
143354531|NCT01474512|516844958|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
143354532|NCT01474512|516844959|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
143354533|NCT01474512|516844960|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
143354534|NCT01474512|516844961|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
143354535|NCT01474512|516844962|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
143354536|NCT01474512|516844963|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
143354537|NCT01474512|516844964|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
143354538|NCT01474512|516844947|FG000|Long-Term Extension Period|Adverse Event|0|||
143354539|NCT01474512|516844948|FG001|Long-Term Extension Period|Adverse Event|0|||
143354540|NCT01474512|516844949|FG002|Long-Term Extension Period|Adverse Event|0|||
143354541|NCT01474512|516844950|FG003|Long-Term Extension Period|Adverse Event|0|||
143354542|NCT01474512|516844951|FG004|Long-Term Extension Period|Adverse Event|0|||
143354543|NCT01474512|516844952|FG005|Long-Term Extension Period|Adverse Event|0|||
143354544|NCT01474512|516844953|FG006|Long-Term Extension Period|Adverse Event|0|||
143354545|NCT01474512|516844954|FG007|Long-Term Extension Period|Adverse Event|0|||
143354546|NCT01474512|516844955|FG008|Long-Term Extension Period|Adverse Event|0|||
143354547|NCT01474512|516844956|FG009|Long-Term Extension Period|Adverse Event|0|||
143354548|NCT01474512|516844957|FG010|Long-Term Extension Period|Adverse Event|0|||
143354549|NCT01474512|516844958|FG011|Long-Term Extension Period|Adverse Event|1|||
143354550|NCT01474512|516844959|FG012|Long-Term Extension Period|Adverse Event|57|||
143354551|NCT01474512|516844960|FG013|Long-Term Extension Period|Adverse Event|58|||
143354552|NCT01474512|516844961|FG014|Long-Term Extension Period|Adverse Event|0|||
143354553|NCT01474512|516844962|FG015|Long-Term Extension Period|Adverse Event|0|||
143354554|NCT01474512|516844963|FG016|Long-Term Extension Period|Adverse Event|0|||
143354555|NCT01474512|516844964|FG017|Long-Term Extension Period|Adverse Event|0|||
143354556|NCT01474512|516844947|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
143354557|NCT01474512|516844948|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
143354558|NCT01474512|516844949|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
143354559|NCT01474512|516844950|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
143354560|NCT01474512|516844951|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
143354561|NCT01474512|516844952|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
143354562|NCT01474512|516844953|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
143354563|NCT01474512|516844954|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
143354564|NCT01474512|516844955|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
143354565|NCT01474512|516844956|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
143354566|NCT01474512|516844957|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
143354567|NCT01474512|516844958|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
143354568|NCT01474512|516844959|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
143354569|NCT01474512|516844960|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
143354570|NCT01474512|516844961|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
143354571|NCT01474512|516844962|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
143354572|NCT01474512|516844963|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
143354573|NCT01474512|516844964|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
143354574|NCT01474512|516844947|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
143354575|NCT01474512|516844948|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
143354576|NCT01474512|516844949|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
143354577|NCT01474512|516844950|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
143354578|NCT01474512|516844951|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
143354579|NCT01474512|516844952|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
143354580|NCT01474512|516844953|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
143354581|NCT01474512|516844954|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
143354582|NCT01474512|516844955|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
143354583|NCT01474512|516844956|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
143354584|NCT01474512|516844957|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
143354585|NCT01474512|516844958|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
143354586|NCT01474512|516844959|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
143354587|NCT01474512|516844960|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
143354588|NCT01474512|516844961|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
143354589|NCT01474512|516844962|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
143354590|NCT01474512|516844963|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
143354591|NCT01474512|516844964|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
143354592|NCT01474512|516844947|FG000|Long-Term Extension Period|Physician Decision|0|||
143354593|NCT01474512|516844948|FG001|Long-Term Extension Period|Physician Decision|0|||
143354594|NCT01474512|516844949|FG002|Long-Term Extension Period|Physician Decision|0|||
143354595|NCT01474512|516844950|FG003|Long-Term Extension Period|Physician Decision|0|||
143354596|NCT01474512|516844951|FG004|Long-Term Extension Period|Physician Decision|0|||
143354597|NCT01474512|516844952|FG005|Long-Term Extension Period|Physician Decision|0|||
143354598|NCT01474512|516844953|FG006|Long-Term Extension Period|Physician Decision|0|||
143354599|NCT01474512|516844954|FG007|Long-Term Extension Period|Physician Decision|0|||
143354600|NCT01474512|516844955|FG008|Long-Term Extension Period|Physician Decision|0|||
143354601|NCT01474512|516844956|FG009|Long-Term Extension Period|Physician Decision|0|||
143354602|NCT01474512|516844957|FG010|Long-Term Extension Period|Physician Decision|0|||
143354603|NCT01474512|516844958|FG011|Long-Term Extension Period|Physician Decision|0|||
143354604|NCT01474512|516844959|FG012|Long-Term Extension Period|Physician Decision|21|||
143354605|NCT01474512|516844960|FG013|Long-Term Extension Period|Physician Decision|21|||
143354606|NCT01474512|516844961|FG014|Long-Term Extension Period|Physician Decision|0|||
143354607|NCT01474512|516844962|FG015|Long-Term Extension Period|Physician Decision|0|||
143354608|NCT01474512|516844963|FG016|Long-Term Extension Period|Physician Decision|0|||
143354609|NCT01474512|516844964|FG017|Long-Term Extension Period|Physician Decision|0|||
143354610|NCT01474512|516844947|FG000|Long-Term Extension Period|Clinical Relapse|0|||
143354611|NCT01474512|516844948|FG001|Long-Term Extension Period|Clinical Relapse|0|||
143354612|NCT01474512|516844949|FG002|Long-Term Extension Period|Clinical Relapse|0|||
143354613|NCT01474512|516844950|FG003|Long-Term Extension Period|Clinical Relapse|0|||
143354614|NCT01474512|516844951|FG004|Long-Term Extension Period|Clinical Relapse|0|||
143354615|NCT01474512|516844952|FG005|Long-Term Extension Period|Clinical Relapse|0|||
143354616|NCT01474512|516844953|FG006|Long-Term Extension Period|Clinical Relapse|0|||
143354617|NCT01474512|516844954|FG007|Long-Term Extension Period|Clinical Relapse|0|||
143354618|NCT01474512|516844955|FG008|Long-Term Extension Period|Clinical Relapse|0|||
143354619|NCT01474512|516844956|FG009|Long-Term Extension Period|Clinical Relapse|0|||
143354620|NCT01474512|516844957|FG010|Long-Term Extension Period|Clinical Relapse|0|||
143354621|NCT01474512|516844958|FG011|Long-Term Extension Period|Clinical Relapse|0|||
143354622|NCT01474512|516844959|FG012|Long-Term Extension Period|Clinical Relapse|9|||
143354623|NCT01474512|516844960|FG013|Long-Term Extension Period|Clinical Relapse|9|||
143354624|NCT01474512|516844961|FG014|Long-Term Extension Period|Clinical Relapse|0|||
143354625|NCT01474512|516844962|FG015|Long-Term Extension Period|Clinical Relapse|0|||
143354626|NCT01474512|516844963|FG016|Long-Term Extension Period|Clinical Relapse|0|||
143354627|NCT01474512|516844964|FG017|Long-Term Extension Period|Clinical Relapse|0|||
143354628|NCT01474512|516844947|FG000|Long-Term Extension Period|Death|0|||
143354629|NCT01474512|516844948|FG001|Long-Term Extension Period|Death|0|||
143354630|NCT01474512|516844949|FG002|Long-Term Extension Period|Death|0|||
143354631|NCT01474512|516844950|FG003|Long-Term Extension Period|Death|0|||
143354632|NCT01474512|516844951|FG004|Long-Term Extension Period|Death|0|||
143354633|NCT01474512|516844952|FG005|Long-Term Extension Period|Death|0|||
143354634|NCT01474512|516844953|FG006|Long-Term Extension Period|Death|0|||
143354635|NCT01474512|516844954|FG007|Long-Term Extension Period|Death|0|||
143354636|NCT01474512|516844955|FG008|Long-Term Extension Period|Death|0|||
143354637|NCT01474512|516844956|FG009|Long-Term Extension Period|Death|0|||
143354638|NCT01474512|516844957|FG010|Long-Term Extension Period|Death|0|||
143354639|NCT01474512|516844958|FG011|Long-Term Extension Period|Death|0|||
143354640|NCT01474512|516844959|FG012|Long-Term Extension Period|Death|9|||
143354641|NCT01474512|516844960|FG013|Long-Term Extension Period|Death|9|||
143354642|NCT01474512|516844961|FG014|Long-Term Extension Period|Death|0|||
143354643|NCT01474512|516844962|FG015|Long-Term Extension Period|Death|0|||
143354644|NCT01474512|516844963|FG016|Long-Term Extension Period|Death|0|||
143354645|NCT01474512|516844964|FG017|Long-Term Extension Period|Death|0|||
143354646|NCT01474512|516844947|FG000|Long-Term Extension Period|Sponsor Decision|0|||
143354647|NCT01474512|516844948|FG001|Long-Term Extension Period|Sponsor Decision|0|||
143354648|NCT01474512|516844949|FG002|Long-Term Extension Period|Sponsor Decision|0|||
143354649|NCT01474512|516844950|FG003|Long-Term Extension Period|Sponsor Decision|0|||
143354650|NCT01474512|516844951|FG004|Long-Term Extension Period|Sponsor Decision|0|||
143354651|NCT01474512|516844952|FG005|Long-Term Extension Period|Sponsor Decision|0|||
143354652|NCT01474512|516844953|FG006|Long-Term Extension Period|Sponsor Decision|0|||
143354653|NCT01474512|516844954|FG007|Long-Term Extension Period|Sponsor Decision|0|||
143354654|NCT01474512|516844955|FG008|Long-Term Extension Period|Sponsor Decision|0|||
143354655|NCT01474512|516844956|FG009|Long-Term Extension Period|Sponsor Decision|0|||
143354656|NCT01474512|516844957|FG010|Long-Term Extension Period|Sponsor Decision|0|||
143354657|NCT01474512|516844958|FG011|Long-Term Extension Period|Sponsor Decision|0|||
143354658|NCT01474512|516844959|FG012|Long-Term Extension Period|Sponsor Decision|6|||
143354659|NCT01474512|516844960|FG013|Long-Term Extension Period|Sponsor Decision|6|||
143354660|NCT01474512|516844961|FG014|Long-Term Extension Period|Sponsor Decision|0|||
143354661|NCT01474512|516844962|FG015|Long-Term Extension Period|Sponsor Decision|0|||
143354662|NCT01474512|516844963|FG016|Long-Term Extension Period|Sponsor Decision|0|||
143354663|NCT01474512|516844964|FG017|Long-Term Extension Period|Sponsor Decision|0|||
143354664|NCT01474512|516844947|FG000|Long-Term Extension Period|Protocol Violation|0|||
143354665|NCT01474512|516844948|FG001|Long-Term Extension Period|Protocol Violation|0|||
143354666|NCT01474512|516844949|FG002|Long-Term Extension Period|Protocol Violation|0|||
143354667|NCT01474512|516844950|FG003|Long-Term Extension Period|Protocol Violation|0|||
143354668|NCT01474512|516844951|FG004|Long-Term Extension Period|Protocol Violation|0|||
143354669|NCT01474512|516844952|FG005|Long-Term Extension Period|Protocol Violation|0|||
143354670|NCT01474512|516844953|FG006|Long-Term Extension Period|Protocol Violation|0|||
143354671|NCT01474512|516844954|FG007|Long-Term Extension Period|Protocol Violation|0|||
143354672|NCT01474512|516844955|FG008|Long-Term Extension Period|Protocol Violation|0|||
143354673|NCT01474512|516844956|FG009|Long-Term Extension Period|Protocol Violation|0|||
143354674|NCT01474512|516844957|FG010|Long-Term Extension Period|Protocol Violation|0|||
143354675|NCT01474512|516844958|FG011|Long-Term Extension Period|Protocol Violation|0|||
143354676|NCT01474512|516844959|FG012|Long-Term Extension Period|Protocol Violation|5|||
143354677|NCT01474512|516844960|FG013|Long-Term Extension Period|Protocol Violation|5|||
143354678|NCT01474512|516844961|FG014|Long-Term Extension Period|Protocol Violation|0|||
143354679|NCT01474512|516844962|FG015|Long-Term Extension Period|Protocol Violation|0|||
143354680|NCT01474512|516844963|FG016|Long-Term Extension Period|Protocol Violation|0|||
143354681|NCT01474512|516844964|FG017|Long-Term Extension Period|Protocol Violation|0|||
143354682|NCT01474512|516844947|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
143354683|NCT01474512|516844948|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
143354684|NCT01474512|516844949|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
143354685|NCT01474512|516844950|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
143354686|NCT01474512|516844951|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
143354687|NCT01474512|516844952|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
143354688|NCT01474512|516844953|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
143354689|NCT01474512|516844954|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
143354690|NCT01474512|516844955|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
143354691|NCT01474512|516844956|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
143354692|NCT01474512|516844957|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
143354693|NCT01474512|516844958|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
143354694|NCT01474512|516844959|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
143354695|NCT01474512|516844960|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
143354696|NCT01474512|516844961|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
143354697|NCT01474512|516844962|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
143354698|NCT01474512|516844963|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
143354699|NCT01474512|516844964|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
143354700|NCT01474512|516844947|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
143354701|NCT01474512|516844948|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
143354702|NCT01474512|516844949|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
143354703|NCT01474512|516844950|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
143354704|NCT01474512|516844951|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
143354705|NCT01474512|516844952|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
143354706|NCT01474512|516844953|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
143354707|NCT01474512|516844954|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
143354708|NCT01474512|516844955|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
143354709|NCT01474512|516844956|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
143354710|NCT01474512|516844957|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
143354711|NCT01474512|516844958|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
143354712|NCT01474512|516844959|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
143354713|NCT01474512|516844960|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
143354714|NCT01474512|516844961|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
143354715|NCT01474512|516844962|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
143354716|NCT01474512|516844963|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
143354717|NCT01474512|516844964|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
143354718|NCT01474512|516844947|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
143354719|NCT01474512|516844948|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
143354720|NCT01474512|516844949|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
143354721|NCT01474512|516844950|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
143354722|NCT01474512|516844951|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
143354723|NCT01474512|516844952|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
143354724|NCT01474512|516844953|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
143354725|NCT01474512|516844954|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
143354726|NCT01474512|516844955|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
143354727|NCT01474512|516844956|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
143354728|NCT01474512|516844957|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
143354729|NCT01474512|516844958|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
143354730|NCT01474512|516844959|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
143354731|NCT01474512|516844960|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
143354732|NCT01474512|516844961|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
143012596|NCT01643928|515585635|FG002|Overall Study|Lost to Follow-up|2|||
143012597|NCT01643928|515585636|FG003|Overall Study|Lost to Follow-up|0|||
143012598|NCT01643928|515585637|FG004|Overall Study|Lost to Follow-up|0|||
143012599|NCT01643928|515585633|FG000|Overall Study|Withdrawal by Subject|2|||
143012600|NCT01643928|515585634|FG001|Overall Study|Withdrawal by Subject|0|||
143012601|NCT01643928|515585635|FG002|Overall Study|Withdrawal by Subject|0|||
143012602|NCT01643928|515585636|FG003|Overall Study|Withdrawal by Subject|1|||
143012603|NCT01643928|515585637|FG004|Overall Study|Withdrawal by Subject|0|||
143354733|NCT01474512|516844962|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
143354734|NCT01474512|516844963|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
143354735|NCT01474512|516844964|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
143354736|NCT01474512|516844947|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
143354737|NCT01474512|516844948|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
143012604|NCT01643928|515585633|FG000|Overall Study|Pregnancy|0|||
143012605|NCT01643928|515585634|FG001|Overall Study|Pregnancy|0|||
143012606|NCT01643928|515585635|FG002|Overall Study|Pregnancy|0|||
143012607|NCT01643928|515585636|FG003|Overall Study|Pregnancy|1|||
143012608|NCT01643928|515585637|FG004|Overall Study|Pregnancy|0|||
143012609|NCT01643928|515585633|FG000|Overall Study|Other|5|||
143012610|NCT01643928|515585634|FG001|Overall Study|Other|1|||
143012611|NCT01643928|515585635|FG002|Overall Study|Other|1|||
143012612|NCT01643928|515585636|FG003|Overall Study|Other|0|||
143012613|NCT01643928|515585637|FG004|Overall Study|Other|0|||
143012614|NCT01643928|515585633|FG000|Overall Study|Adverse Event|2|||
143012615|NCT01643928|515585634|FG001|Overall Study|Adverse Event|1|||
143012616|NCT01643928|515585635|FG002|Overall Study|Adverse Event|0|||
143012617|NCT01643928|515585636|FG003|Overall Study|Adverse Event|1|||
143012618|NCT01643928|515585637|FG004|Overall Study|Adverse Event|2|||
143012619|NCT04701658|515585641|FG000|Overall Study|Lost to Follow-up|6|||
143012620|NCT01346501|515585643|FG000|Overall Study|Initiated Other Biological Agents|3|||
143012621|NCT01346501|515585644|FG001|Overall Study|Initiated Other Biological Agents|1|||
143012622|NCT01346501|515585643|FG000|Overall Study|Other|8|||
143012623|NCT01346501|515585644|FG001|Overall Study|Other|12|||
143012624|NCT04101721|515585645|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
143012625|NCT04101721|515585646|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
143012626|NCT04101721|515585645|FG000|Overall Study|Death|0|||
143012627|NCT04101721|515585646|FG001|Overall Study|Death|1|||
143012628|NCT04101721|515585645|FG000|Overall Study|Lost to Follow-up|0|||
143012629|NCT04101721|515585646|FG001|Overall Study|Lost to Follow-up|3|||
143012630|NCT00756652|515585647|FG000|Original Phase|Withdrawal by Subject|864|||
143012631|NCT00756652|515585648|FG001|Original Phase|Withdrawal by Subject|23|||
143012632|NCT00756652|515585647|FG000|Original Phase|Lost to Follow-up|601|||
143012633|NCT00756652|515585648|FG001|Original Phase|Lost to Follow-up|0|||
143012634|NCT00756652|515585647|FG000|Original Phase|Other Discontinuation|797|||
143012635|NCT00756652|515585648|FG001|Original Phase|Other Discontinuation|5|||
143012636|NCT00756652|515585647|FG000|Original Phase|Participant Noncompliance|18622|||
143012637|NCT00756652|515585648|FG001|Original Phase|Participant Noncompliance|424|||
143012638|NCT00756652|515585647|FG000|Original Phase|Unknown Discontinuation Reason|2|||
143012639|NCT00756652|515585648|FG001|Original Phase|Unknown Discontinuation Reason|0|||
143012640|NCT00756652|515585647|FG000|Original Phase|Participants without data|3259|||
143012641|NCT00756652|515585648|FG001|Original Phase|Participants without data|466|||
143012642|NCT00756652|515585647|FG000|Original Phase|Death|168|||
143012643|NCT00756652|515585648|FG001|Original Phase|Death|1|||
143012644|NCT00756652|515585647|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
143012645|NCT00756652|515585648|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
143012646|NCT00756652|515585647|FG000|Re-Op Phase|Withdrawal by Subject|62|||
143012647|NCT00756652|515585648|FG001|Re-Op Phase|Withdrawal by Subject|0|||
143012648|NCT00756652|515585647|FG000|Re-Op Phase|Death|6|||
143012649|NCT00756652|515585648|FG001|Re-Op Phase|Death|0|||
143012650|NCT00756652|515585647|FG000|Re-Op Phase|Lost to Follow-up|340|||
143012651|NCT00756652|515585648|FG001|Re-Op Phase|Lost to Follow-up|0|||
143012652|NCT00756652|515585647|FG000|Re-Op Phase|Site Closed|2454|||
143012653|NCT00756652|515585648|FG001|Re-Op Phase|Site Closed|0|||
143012654|NCT00756652|515585647|FG000|Re-Op Phase|Withdrawn after explant|14|||
143012655|NCT00756652|515585648|FG001|Re-Op Phase|Withdrawn after explant|0|||
143012656|NCT02564952|515585649|FG000|Overall Study|Adverse Event|6|||
143012657|NCT02564952|515585649|FG000|Overall Study|Lost to Follow-up|1|||
143012658|NCT02564952|515585649|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
143012659|NCT02564952|515585649|FG000|Overall Study|Withdrawal by Subject|1|||
143012660|NCT02564952|515585649|FG000|Overall Study|Low Efficacy|1|||
143012661|NCT02564952|515585649|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
143012662|NCT01215955|515585650|FG000|Overall Study|Adverse Event|1|||
143012663|NCT01215955|515585651|FG001|Overall Study|Adverse Event|4|||
143012664|NCT01215955|515585652|FG002|Overall Study|Adverse Event|2|||
143012665|NCT01215955|515585653|FG003|Overall Study|Adverse Event|3|||
143012666|NCT01215955|515585650|FG000|Overall Study|Death|2|||
143012667|NCT01215955|515585651|FG001|Overall Study|Death|0|||
143012668|NCT01215955|515585652|FG002|Overall Study|Death|1|||
143461708|NCT00440999|517237457|FG000|Overall Study|Subj left hosp without inform staff|0|||
143461709|NCT00440999|517237458|FG001|Overall Study|Subj left hosp without inform staff|1|||
143461710|NCT04572841|517237459|FG000|Overall Study|Adverse Event|1|||
143461711|NCT04572841|517237460|FG001|Overall Study|Adverse Event|1|||
143461712|NCT04572841|517237459|FG000|Overall Study|Withdrawal by Subject|2|||
143461713|NCT04572841|517237460|FG001|Overall Study|Withdrawal by Subject|1|||
143461714|NCT00249002|517237461|FG000|Overall Study|Adverse Event|2|||
143461715|NCT00249002|517237461|FG000|Overall Study|Study cancellation|3|||
143461716|NCT00249002|517237461|FG000|Overall Study|Other|2|||
143461717|NCT03305731|517237463|FG000|Overall Study|Protocol Violation|1|||
143461718|NCT00455325|517237464|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
143461719|NCT00455325|517237465|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
143012669|NCT01215955|515585653|FG003|Overall Study|Death|3|||
143461720|NCT00455325|517237466|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
143012670|NCT01215955|515585650|FG000|Overall Study|Entry Criteria Not Met|1|||
143354738|NCT01474512|516844949|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
143354739|NCT01474512|516844950|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
143354740|NCT01474512|516844951|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
143354741|NCT01474512|516844952|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
143354742|NCT01474512|516844953|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
143354743|NCT01474512|516844954|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
143354744|NCT01474512|516844955|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
143354745|NCT01474512|516844956|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
143354746|NCT01474512|516844957|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
143354747|NCT01474512|516844958|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
143354748|NCT01474512|516844959|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
143354749|NCT01474512|516844960|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
143354750|NCT01474512|516844961|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
143354751|NCT01474512|516844962|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
143354752|NCT01474512|516844963|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
143354753|NCT01474512|516844964|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
143354754|NCT01474512|516844947|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
143354755|NCT01474512|516844948|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
143354756|NCT01474512|516844949|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
143354757|NCT01474512|516844950|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
143354758|NCT01474512|516844951|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
143354759|NCT01474512|516844952|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
143354760|NCT01474512|516844953|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
143354761|NCT01474512|516844954|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
143354762|NCT01474512|516844955|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
143354763|NCT01474512|516844956|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
143354764|NCT01474512|516844957|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
143354765|NCT01474512|516844958|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
143354766|NCT01474512|516844959|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
143354767|NCT01474512|516844960|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
143354768|NCT01474512|516844961|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
143354769|NCT01474512|516844962|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
143354770|NCT01474512|516844963|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
143354771|NCT01474512|516844964|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
143354772|NCT01474512|516844947|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
143354773|NCT01474512|516844948|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
143354774|NCT01474512|516844949|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
143354775|NCT01474512|516844950|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
143354776|NCT01474512|516844951|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
143354777|NCT01474512|516844952|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
143354778|NCT01474512|516844953|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
143354779|NCT01474512|516844954|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
143354780|NCT01474512|516844955|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
143354781|NCT01474512|516844956|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
143354782|NCT01474512|516844957|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
143354783|NCT01474512|516844958|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
143354784|NCT01474512|516844959|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
143354785|NCT01474512|516844960|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
143354786|NCT01474512|516844961|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
143354787|NCT01474512|516844962|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
143354788|NCT01474512|516844963|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
143354789|NCT01474512|516844964|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
143354790|NCT01474512|516844947|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
143354791|NCT01474512|516844948|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
143354792|NCT01474512|516844949|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
143354793|NCT01474512|516844950|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
143354794|NCT01474512|516844951|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
143354795|NCT01474512|516844952|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
143354796|NCT01474512|516844953|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
143354797|NCT01474512|516844954|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
143354798|NCT01474512|516844955|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
143354799|NCT01474512|516844956|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
143354800|NCT01474512|516844957|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
143354801|NCT01474512|516844958|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
143354802|NCT01474512|516844959|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
143354803|NCT01474512|516844960|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
143354804|NCT01474512|516844961|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
143354805|NCT01474512|516844962|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
143354806|NCT01474512|516844963|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
143354807|NCT01474512|516844964|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
143354808|NCT01474512|516844947|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
143354809|NCT01474512|516844948|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
143354810|NCT01474512|516844949|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
143354811|NCT01474512|516844950|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
143354812|NCT01474512|516844951|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
143354813|NCT01474512|516844952|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
143354814|NCT01474512|516844953|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
143354815|NCT01474512|516844954|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
143354816|NCT01474512|516844955|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
143354817|NCT01474512|516844956|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
143354818|NCT01474512|516844957|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
143354819|NCT01474512|516844958|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
143354820|NCT01474512|516844959|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
143354821|NCT01474512|516844960|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
143354822|NCT01474512|516844961|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
143354823|NCT01474512|516844962|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
143354824|NCT01474512|516844963|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
143354825|NCT01474512|516844964|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
143354826|NCT01474512|516844947|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
143354827|NCT01474512|516844948|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
143354828|NCT01474512|516844949|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
143354829|NCT01474512|516844950|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
143354830|NCT01474512|516844951|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
143354831|NCT01474512|516844952|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
143354832|NCT01474512|516844953|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
143354833|NCT01474512|516844954|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
143354834|NCT01474512|516844955|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
143354835|NCT01474512|516844956|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
143354836|NCT01474512|516844957|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
143354837|NCT01474512|516844958|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
143354838|NCT01474512|516844959|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
143354839|NCT01474512|516844960|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
143354840|NCT01474512|516844961|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
143354841|NCT01474512|516844962|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
143354842|NCT01474512|516844963|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
143354843|NCT01474512|516844964|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
143354844|NCT01474512|516844947|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
143354845|NCT01474512|516844948|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
143354846|NCT01474512|516844949|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
143354847|NCT01474512|516844950|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
143354848|NCT01474512|516844951|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
143354849|NCT01474512|516844952|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
143354850|NCT01474512|516844953|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
143354851|NCT01474512|516844954|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
143354852|NCT01474512|516844955|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
143354853|NCT01474512|516844956|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
143354854|NCT01474512|516844957|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
143354855|NCT01474512|516844958|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
143354856|NCT01474512|516844959|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
143354857|NCT01474512|516844960|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
143354858|NCT01474512|516844961|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
143354859|NCT01474512|516844962|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
143354860|NCT01474512|516844963|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
143354861|NCT01474512|516844964|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
143354862|NCT01474512|516844947|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
143354863|NCT01474512|516844948|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
143354864|NCT01474512|516844949|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
143354865|NCT01474512|516844950|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
143354866|NCT01474512|516844951|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
143354867|NCT01474512|516844952|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
143354868|NCT01474512|516844953|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
143354869|NCT01474512|516844954|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
143354870|NCT01474512|516844955|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
143354871|NCT01474512|516844956|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
143354872|NCT01474512|516844957|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
143354873|NCT01474512|516844958|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
143354874|NCT01474512|516844959|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
143354875|NCT01474512|516844960|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
143461721|NCT00455325|517237467|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
143354876|NCT01474512|516844961|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
143354877|NCT01474512|516844962|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
143354878|NCT01474512|516844963|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
143354879|NCT01474512|516844964|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
143354880|NCT01474512|516844947|FG000|Post-Treatment Follow-Up|Death|0|||
143354881|NCT01474512|516844948|FG001|Post-Treatment Follow-Up|Death|0|||
143354882|NCT01474512|516844949|FG002|Post-Treatment Follow-Up|Death|0|||
143354883|NCT01474512|516844950|FG003|Post-Treatment Follow-Up|Death|0|||
143354884|NCT01474512|516844951|FG004|Post-Treatment Follow-Up|Death|0|||
143354885|NCT01474512|516844952|FG005|Post-Treatment Follow-Up|Death|0|||
143354886|NCT01474512|516844953|FG006|Post-Treatment Follow-Up|Death|0|||
143354887|NCT01474512|516844954|FG007|Post-Treatment Follow-Up|Death|0|||
143354888|NCT01474512|516844955|FG008|Post-Treatment Follow-Up|Death|0|||
143354889|NCT01474512|516844956|FG009|Post-Treatment Follow-Up|Death|0|||
143354890|NCT01474512|516844957|FG010|Post-Treatment Follow-Up|Death|0|||
143354891|NCT01474512|516844958|FG011|Post-Treatment Follow-Up|Death|0|||
143354892|NCT01474512|516844959|FG012|Post-Treatment Follow-Up|Death|0|||
143354893|NCT01474512|516844960|FG013|Post-Treatment Follow-Up|Death|0|||
143354894|NCT01474512|516844961|FG014|Post-Treatment Follow-Up|Death|0|||
143354895|NCT01474512|516844962|FG015|Post-Treatment Follow-Up|Death|0|||
143354896|NCT01474512|516844963|FG016|Post-Treatment Follow-Up|Death|1|||
143354897|NCT01474512|516844964|FG017|Post-Treatment Follow-Up|Death|0|||
143354898|NCT01118962|516844967|FG000|Overall Study|Adverse Event|2|||
143354899|NCT01118962|516844967|FG000|Overall Study|Lack of Efficacy|1|||
143354900|NCT01118962|516844967|FG000|Overall Study|Protocol Violation|1|||
143354901|NCT01118962|516844967|FG000|Overall Study|Withdrawal by Subject|4|||
143354902|NCT01118962|516844967|FG000|Overall Study|Pregnancy|1|||
143354903|NCT01118962|516844967|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
143354904|NCT00551213|516844972|FG000|Overall Study|Adverse Event|6|||
143354905|NCT00551213|516844973|FG001|Overall Study|Adverse Event|3|||
143354906|NCT00551213|516844972|FG000|Overall Study|Progressive Disease|41|||
143354907|NCT00551213|516844973|FG001|Overall Study|Progressive Disease|12|||
143354908|NCT00551213|516844972|FG000|Overall Study|Withdrawal by Subject|2|||
143354909|NCT00551213|516844973|FG001|Overall Study|Withdrawal by Subject|0|||
143354910|NCT00551213|516844972|FG000|Overall Study|Not Treated|1|||
143354911|NCT00551213|516844973|FG001|Overall Study|Not Treated|2|||
143354912|NCT01254565|516844974|FG000|Overall Study|Non-compliance to Study Procedures|0|||
143354913|NCT01254565|516844975|FG001|Overall Study|Non-compliance to Study Procedures|0|||
143354914|NCT01254565|516844976|FG002|Overall Study|Non-compliance to Study Procedures|0|||
143354915|NCT01254565|516844977|FG003|Overall Study|Non-compliance to Study Procedures|0|||
143354916|NCT01254565|516844978|FG004|Overall Study|Non-compliance to Study Procedures|1|||
143354917|NCT01254565|516844979|FG005|Overall Study|Non-compliance to Study Procedures|0|||
143354918|NCT01254565|516844974|FG000|Overall Study|Did not Receive Treatment|1|||
143354919|NCT01254565|516844975|FG001|Overall Study|Did not Receive Treatment|1|||
143354920|NCT01254565|516844976|FG002|Overall Study|Did not Receive Treatment|0|||
143354921|NCT01254565|516844977|FG003|Overall Study|Did not Receive Treatment|0|||
143354922|NCT01254565|516844978|FG004|Overall Study|Did not Receive Treatment|3|||
143354923|NCT01254565|516844979|FG005|Overall Study|Did not Receive Treatment|4|||
143354924|NCT01254565|516844974|FG000|Overall Study|Other|0|||
143354925|NCT01254565|516844975|FG001|Overall Study|Other|0|||
143354926|NCT01254565|516844976|FG002|Overall Study|Other|0|||
143354927|NCT01254565|516844977|FG003|Overall Study|Other|1|||
143354928|NCT01254565|516844978|FG004|Overall Study|Other|0|||
143354929|NCT01254565|516844979|FG005|Overall Study|Other|0|||
143354930|NCT04747275|516844980|FG000|Overall Study|Study terminated|0|||
143354931|NCT04747275|516844981|FG001|Overall Study|Study terminated|1|||
143012671|NCT01215955|515585651|FG001|Overall Study|Entry Criteria Not Met|3|||
143012672|NCT01215955|515585652|FG002|Overall Study|Entry Criteria Not Met|4|||
143012673|NCT01215955|515585653|FG003|Overall Study|Entry Criteria Not Met|7|||
143012674|NCT01215955|515585650|FG000|Overall Study|Lack of Efficacy|1|||
143012675|NCT01215955|515585651|FG001|Overall Study|Lack of Efficacy|2|||
143012676|NCT01215955|515585652|FG002|Overall Study|Lack of Efficacy|1|||
143012677|NCT01215955|515585653|FG003|Overall Study|Lack of Efficacy|0|||
143012678|NCT01215955|515585650|FG000|Overall Study|Lost to Follow-up|4|||
143012679|NCT01215955|515585651|FG001|Overall Study|Lost to Follow-up|4|||
143012680|NCT01215955|515585652|FG002|Overall Study|Lost to Follow-up|8|||
143012681|NCT01215955|515585653|FG003|Overall Study|Lost to Follow-up|9|||
143012682|NCT01215955|515585650|FG000|Overall Study|Physician Decision|4|||
143012683|NCT01215955|515585651|FG001|Overall Study|Physician Decision|10|||
143012684|NCT01215955|515585652|FG002|Overall Study|Physician Decision|8|||
143354932|NCT03268590|516844984|FG000|Overall Study|Previously unknown exclusion criteria|1|||
143354933|NCT02086552|516844985|FG000|Overall Study|Withdrawal by Subject|1|||
143354934|NCT02080520|516844990|FG000|Overall Study|Self-reported symptoms|5|||
143354935|NCT02080520|516844991|FG001|Overall Study|Self-reported symptoms|6|||
143354936|NCT02080520|516844990|FG000|Overall Study|Unable to contact|2|||
143354937|NCT02080520|516844991|FG001|Overall Study|Unable to contact|1|||
143354938|NCT02080520|516844990|FG000|Overall Study|Initiated aspirin|2|||
143012685|NCT01215955|515585653|FG003|Overall Study|Physician Decision|11|||
143012686|NCT01215955|515585650|FG000|Overall Study|Protocol Violation|17|||
143354939|NCT02080520|516844991|FG001|Overall Study|Initiated aspirin|0|||
143354940|NCT02080520|516844990|FG000|Overall Study|Atrial fibrillation|1|||
143354941|NCT02080520|516844991|FG001|Overall Study|Atrial fibrillation|1|||
143354942|NCT02080520|516844990|FG000|Overall Study|Cancer|1|||
143354943|NCT02080520|516844991|FG001|Overall Study|Cancer|2|||
143354944|NCT02080520|516844990|FG000|Overall Study|Not interested in study|1|||
143354945|NCT02080520|516844991|FG001|Overall Study|Not interested in study|3|||
143354946|NCT02080520|516844990|FG000|Overall Study|Too busy|1|||
143354947|NCT02080520|516844991|FG001|Overall Study|Too busy|1|||
143354948|NCT02080520|516844990|FG000|Overall Study|Work-related injury|1|||
143354949|NCT02080520|516844991|FG001|Overall Study|Work-related injury|0|||
143354950|NCT02080520|516844990|FG000|Overall Study|Personal reasons|0|||
143354951|NCT02080520|516844991|FG001|Overall Study|Personal reasons|3|||
143354952|NCT00432679|516844994|FG000|Overall Study|Adverse Event|2|||
143354953|NCT00432679|516844995|FG001|Overall Study|Adverse Event|1|||
143354954|NCT00432679|516844994|FG000|Overall Study|Withdrawal by Subject|3|||
143354955|NCT00432679|516844995|FG001|Overall Study|Withdrawal by Subject|2|||
143354956|NCT01316692|516844996|FG000|Overall Study|Adverse Event|5|||
143354957|NCT01316692|516844996|FG000|Overall Study|Disease Progression|7|||
143354958|NCT01686932|516845001|FG000|Period 1|Adverse Event|1|||
143354959|NCT01686932|516845002|FG001|Period 1|Adverse Event|1|||
143354960|NCT02374593|516845003|FG000|Overall Study|non-compliant|2|||
143354961|NCT02374593|516845004|FG001|Overall Study|non-compliant|0|||
143354962|NCT01284140|516845006|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
143354963|NCT01284140|516845007|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
143354964|NCT01284140|516845006|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
143354965|NCT01284140|516845007|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
143354966|NCT00579982|516845008|FG000|Overall Study|Adverse Event|4|||
143354967|NCT00579982|516845008|FG000|Overall Study|Protocol Violation|4|||
143354968|NCT04844918|516845010|FG000|Overall Study|Adverse Event|7|||
143354969|NCT04844918|516845011|FG001|Overall Study|Adverse Event|8|||
143354970|NCT04844918|516845012|FG002|Overall Study|Adverse Event|5|||
143354971|NCT04844918|516845010|FG000|Overall Study|Physician Decision|0|||
143354972|NCT04844918|516845011|FG001|Overall Study|Physician Decision|1|||
143354973|NCT04844918|516845012|FG002|Overall Study|Physician Decision|0|||
143354974|NCT04844918|516845010|FG000|Overall Study|Withdrawal by Subject|6|||
143354975|NCT04844918|516845011|FG001|Overall Study|Withdrawal by Subject|3|||
143354976|NCT04844918|516845012|FG002|Overall Study|Withdrawal by Subject|3|||
143354977|NCT04844918|516845010|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
143354978|NCT04844918|516845011|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
143354979|NCT04844918|516845012|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
143354980|NCT00363896|516845013|FG000|Overall Study|Withdrawal by Subject|29|||
143354981|NCT00363896|516845014|FG001|Overall Study|Withdrawal by Subject|16|||
143354982|NCT00363896|516845013|FG000|Overall Study|Adverse Event|24|||
143354983|NCT00363896|516845014|FG001|Overall Study|Adverse Event|13|||
143354984|NCT00363896|516845013|FG000|Overall Study|COPD exacerbation|13|||
143354985|NCT00363896|516845014|FG001|Overall Study|COPD exacerbation|7|||
143354986|NCT00363896|516845013|FG000|Overall Study|Lack of Efficacy|12|||
143354987|NCT00363896|516845014|FG001|Overall Study|Lack of Efficacy|8|||
143354988|NCT00363896|516845013|FG000|Overall Study|Protocol Violation|6|||
143354989|NCT00363896|516845014|FG001|Overall Study|Protocol Violation|1|||
143354990|NCT00363896|516845013|FG000|Overall Study|Lost to Follow-up|3|||
143354991|NCT00363896|516845014|FG001|Overall Study|Lost to Follow-up|0|||
143354992|NCT00363896|516845013|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
143354993|NCT00363896|516845014|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
143354994|NCT00363896|516845013|FG000|Overall Study|Other|1|||
143354995|NCT00363896|516845014|FG001|Overall Study|Other|2|||
143354996|NCT04147260|516845016|FG000|Overall Study|Adverse Event|1|||
143354997|NCT04147260|516845017|FG001|Overall Study|Adverse Event|0|||
143354998|NCT04147260|516845018|FG002|Overall Study|Adverse Event|1|||
143354999|NCT04147260|516845019|FG003|Overall Study|Adverse Event|2|||
143355000|NCT04147260|516845020|FG004|Overall Study|Adverse Event|0|||
143355001|NCT04147260|516845016|FG000|Overall Study|Withdrawal by Subject|0|||
143355002|NCT04147260|516845017|FG001|Overall Study|Withdrawal by Subject|0|||
143355003|NCT04147260|516845018|FG002|Overall Study|Withdrawal by Subject|1|||
143461722|NCT00455325|517237464|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
143461723|NCT00455325|517237465|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
143355004|NCT04147260|516845019|FG003|Overall Study|Withdrawal by Subject|1|||
143355005|NCT04147260|516845020|FG004|Overall Study|Withdrawal by Subject|0|||
143355006|NCT01555021|516845023|FG000|Overall Study|Lost to Follow-up|1|||
143355007|NCT01555021|516845024|FG001|Overall Study|Lost to Follow-up|2|||
143355008|NCT03358329|516845028|FG000|Overall Study|Lost to Follow-up|2|||
143355009|NCT03358329|516845028|FG000|Overall Study|Withdrawal by Subject|2|||
143355010|NCT01313923|516845029|FG000|Overall Study|Physician Decision|3|||
143355011|NCT01388530|516845030|FG000|Overall Study|Lost to Follow-up|5|||
143355012|NCT02420327|516845031|FG000|Overall Study|Adverse Event|7|||
143355013|NCT02420327|516845031|FG000|Overall Study|Pregnancy|1|||
143355014|NCT02420327|516845031|FG000|Overall Study|Withdrawal by Subject|6|||
143355015|NCT02420327|516845031|FG000|Overall Study|Lost to Follow-up|1|||
143355016|NCT02420327|516845031|FG000|Overall Study|Protocol Violation|1|||
143461724|NCT00455325|517237466|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
143461725|NCT00455325|517237467|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
143461726|NCT00455325|517237464|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
143461727|NCT00455325|517237465|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
143461728|NCT00455325|517237466|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
143461729|NCT00455325|517237467|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
143355017|NCT01990300|516845032|FG000|Overall Study|Case Report Forms Uncollected|89|||
143355018|NCT01990300|516845032|FG000|Overall Study|Protocol Deviation|53|||
143461730|NCT00455325|517237464|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
143461731|NCT00455325|517237465|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
143461732|NCT00455325|517237466|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
143461733|NCT00455325|517237467|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
143461734|NCT00455325|517237464|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
143461735|NCT00455325|517237465|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
143461736|NCT00455325|517237466|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
143461737|NCT00455325|517237467|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
143461738|NCT00455325|517237464|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
143461739|NCT00455325|517237465|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
143461740|NCT00455325|517237466|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
143461741|NCT00455325|517237467|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
143461742|NCT00455325|517237464|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
143461743|NCT00455325|517237465|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
143461744|NCT00455325|517237466|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
143461745|NCT00455325|517237467|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
143461746|NCT04620811|517237468|FG000|Overall Study|Withdrawal by Subject|18|||
143461747|NCT04620811|517237469|FG001|Overall Study|Withdrawal by Subject|15|||
143461748|NCT04620811|517237468|FG000|Overall Study|Adverse Event|6|||
143461749|NCT04620811|517237469|FG001|Overall Study|Adverse Event|11|||
143461750|NCT04620811|517237468|FG000|Overall Study|Lost to Follow-up|4|||
143461751|NCT04620811|517237469|FG001|Overall Study|Lost to Follow-up|8|||
143461752|NCT04620811|517237468|FG000|Overall Study|Physician Decision|1|||
143461753|NCT04620811|517237469|FG001|Overall Study|Physician Decision|4|||
143461754|NCT04620811|517237468|FG000|Overall Study|Sponsor Decision|0|||
143461755|NCT04620811|517237469|FG001|Overall Study|Sponsor Decision|1|||
143461756|NCT04620811|517237468|FG000|Overall Study|Elevation of ALT or AST|1|||
143461757|NCT04620811|517237469|FG001|Overall Study|Elevation of ALT or AST|0|||
143461758|NCT04620811|517237468|FG000|Overall Study|Other|3|||
143461759|NCT04620811|517237469|FG001|Overall Study|Other|5|||
143461760|NCT00928746|517237475|FG000|Overall Study|Adverse Event|2|||
143461761|NCT00928746|517237475|FG000|Overall Study|Protocol Violation|1|||
143461762|NCT00928746|517237475|FG000|Overall Study|Withdrawal by Subject|1|||
143461763|NCT00928746|517237475|FG000|Overall Study|Other|2|||
143461764|NCT02004353|517237480|FG000|Overall Study|Voluntary participation|1334|||
143461765|NCT00819390|517237484|FG000|Overall Study|Lost to Follow-up|1|||
143461766|NCT00819390|517237485|FG001|Overall Study|Lost to Follow-up|1|||
143461767|NCT00819390|517237486|FG002|Overall Study|Lost to Follow-up|0|||
143461768|NCT00819390|517237487|FG003|Overall Study|Lost to Follow-up|0|||
143461769|NCT00819390|517237484|FG000|Overall Study|Withdrawal by Subject|2|||
143461770|NCT00819390|517237485|FG001|Overall Study|Withdrawal by Subject|0|||
143461771|NCT00819390|517237486|FG002|Overall Study|Withdrawal by Subject|0|||
143461772|NCT00819390|517237487|FG003|Overall Study|Withdrawal by Subject|0|||
143461773|NCT00819390|517237484|FG000|Overall Study|Adverse Event|0|||
143461774|NCT00819390|517237485|FG001|Overall Study|Adverse Event|0|||
143461775|NCT00819390|517237486|FG002|Overall Study|Adverse Event|1|||
143461776|NCT00819390|517237487|FG003|Overall Study|Adverse Event|0|||
143461777|NCT01759368|517237494|FG000|Overall Study|Lost to Follow-up|1|||
143461778|NCT01759368|517237495|FG001|Overall Study|Lost to Follow-up|0|||
143355019|NCT02204293|516845033|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
143355020|NCT02204293|516845034|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
143461779|NCT01191268|517237496|FG000|Overall Study|Withdrawal by Subject|19|||
143461780|NCT01191268|517237497|FG001|Overall Study|Withdrawal by Subject|25|||
143461781|NCT01191268|517237498|FG002|Overall Study|Withdrawal by Subject|21|||
143461782|NCT01191268|517237496|FG000|Overall Study|Adverse Event|21|||
143461783|NCT01191268|517237497|FG001|Overall Study|Adverse Event|13|||
143461784|NCT01191268|517237498|FG002|Overall Study|Adverse Event|8|||
143461785|NCT01191268|517237496|FG000|Overall Study|Physician Decision|6|||
143461786|NCT01191268|517237497|FG001|Overall Study|Physician Decision|8|||
143461787|NCT01191268|517237498|FG002|Overall Study|Physician Decision|9|||
143461788|NCT01191268|517237496|FG000|Overall Study|Lost to Follow-up|8|||
143461789|NCT01191268|517237497|FG001|Overall Study|Lost to Follow-up|5|||
143461790|NCT01191268|517237498|FG002|Overall Study|Lost to Follow-up|9|||
143461791|NCT01191268|517237496|FG000|Overall Study|Entry Criteria Not Met|3|||
143461792|NCT01191268|517237497|FG001|Overall Study|Entry Criteria Not Met|1|||
143461793|NCT01191268|517237498|FG002|Overall Study|Entry Criteria Not Met|1|||
143461794|NCT01191268|517237496|FG000|Overall Study|Death|0|||
143461795|NCT01191268|517237497|FG001|Overall Study|Death|1|||
143461796|NCT01191268|517237498|FG002|Overall Study|Death|3|||
143355021|NCT02204293|516845035|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
143355022|NCT02204293|516845036|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
143355023|NCT02204293|516845037|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
143355024|NCT02204293|516845038|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
143355025|NCT02204293|516845033|FG000|Core Study Part I|Adverse Event|1|||
143355026|NCT02204293|516845034|FG001|Core Study Part I|Adverse Event|0|||
143355027|NCT02204293|516845035|FG002|Core Study Part I|Adverse Event|0|||
143355028|NCT02204293|516845036|FG003|Core Study Part I|Adverse Event|0|||
143355029|NCT02204293|516845037|FG004|Core Study Part I|Adverse Event|0|||
143355030|NCT02204293|516845038|FG005|Core Study Part I|Adverse Event|0|||
143355031|NCT02204293|516845033|FG000|Core Study Part I|Physician Decision|0|||
143355032|NCT02204293|516845034|FG001|Core Study Part I|Physician Decision|3|||
143355033|NCT02204293|516845035|FG002|Core Study Part I|Physician Decision|0|||
143355034|NCT02204293|516845036|FG003|Core Study Part I|Physician Decision|0|||
143355035|NCT02204293|516845037|FG004|Core Study Part I|Physician Decision|0|||
143012687|NCT01215955|515585651|FG001|Overall Study|Protocol Violation|13|||
143012688|NCT01215955|515585652|FG002|Overall Study|Protocol Violation|8|||
143012689|NCT01215955|515585653|FG003|Overall Study|Protocol Violation|8|||
143012690|NCT01215955|515585650|FG000|Overall Study|Sponsor Decision|1|||
143012691|NCT01215955|515585651|FG001|Overall Study|Sponsor Decision|2|||
143012692|NCT01215955|515585652|FG002|Overall Study|Sponsor Decision|0|||
143012693|NCT01215955|515585653|FG003|Overall Study|Sponsor Decision|1|||
143012694|NCT01215955|515585650|FG000|Overall Study|Withdrawal by Subject|14|||
143012695|NCT01215955|515585651|FG001|Overall Study|Withdrawal by Subject|15|||
143012696|NCT01215955|515585652|FG002|Overall Study|Withdrawal by Subject|13|||
143012697|NCT01215955|515585653|FG003|Overall Study|Withdrawal by Subject|9|||
143012698|NCT01215955|515585650|FG000|Overall Study|Quality Issues|0|||
143012699|NCT01215955|515585651|FG001|Overall Study|Quality Issues|0|||
143012700|NCT01215955|515585652|FG002|Overall Study|Quality Issues|3|||
143012701|NCT01215955|515585653|FG003|Overall Study|Quality Issues|2|||
143012702|NCT00038467|515585654|FG000|Overall Study|Adverse Event|170|||
143012703|NCT00038467|515585655|FG001|Overall Study|Adverse Event|145|||
143012704|NCT00038467|515585654|FG000|Overall Study|Withdrawal by Subject|150|||
143012705|NCT00038467|515585655|FG001|Overall Study|Withdrawal by Subject|107|||
143012706|NCT00038467|515585654|FG000|Overall Study|Protocol Violation|19|||
143012707|NCT00038467|515585655|FG001|Overall Study|Protocol Violation|22|||
143012708|NCT00038467|515585654|FG000|Overall Study|Death|22|||
143012709|NCT00038467|515585655|FG001|Overall Study|Death|16|||
143012710|NCT00038467|515585654|FG000|Overall Study|Lost to Follow-up|15|||
143012711|NCT00038467|515585655|FG001|Overall Study|Lost to Follow-up|10|||
143012712|NCT00038467|515585654|FG000|Overall Study|Recurrence|109|||
143012713|NCT00038467|515585655|FG001|Overall Study|Recurrence|179|||
143012714|NCT00038467|515585654|FG000|Overall Study|Randomized, but not treated|31|||
143012715|NCT00038467|515585655|FG001|Overall Study|Randomized, but not treated|35|||
143012716|NCT00038467|515585654|FG000|Overall Study|Other|26|||
143012717|NCT00038467|515585655|FG001|Overall Study|Other|28|||
143012718|NCT02643394|515585656|FG000|Overall Study|Protocol Violation|4|||
143012719|NCT02643394|515585657|FG001|Overall Study|Protocol Violation|5|||
143012720|NCT00943384|515585658|FG000|Overall Study|Dispositioned prior to treatment|23|||
143012721|NCT00943384|515585658|FG000|Overall Study|Treated off protocol-protocol violation|5|||
143012722|NCT00943384|515585658|FG000|Overall Study|Lost to Follow-up|16|||
143012723|NCT00943384|515585658|FG000|Overall Study|Withdrawal by Subject|5|||
143012724|NCT04088734|515585659|FG000|Overall Study|Other, Not Specified|5|||
143012725|NCT00096200|515585660|FG000|Overall Study|Adverse Event|0|||
143012726|NCT00096200|515585661|FG001|Overall Study|Adverse Event|4|||
143012727|NCT00096200|515585662|FG002|Overall Study|Adverse Event|0|||
143012728|NCT00096200|515585660|FG000|Overall Study|Withdrawal by Subject|1|||
143012729|NCT00096200|515585661|FG001|Overall Study|Withdrawal by Subject|2|||
143012730|NCT00096200|515585662|FG002|Overall Study|Withdrawal by Subject|0|||
143012731|NCT00096200|515585660|FG000|Overall Study|Ineligible pathology|0|||
143012732|NCT00096200|515585661|FG001|Overall Study|Ineligible pathology|1|||
143012733|NCT00096200|515585662|FG002|Overall Study|Ineligible pathology|0|||
143012734|NCT00835068|515585665|FG000|Overall Study|Death|1|||
143012735|NCT00835068|515585666|FG001|Overall Study|Death|0|||
143012736|NCT00835068|515585665|FG000|Overall Study|Adverse Event|0|||
143355036|NCT02204293|516845038|FG005|Core Study Part I|Physician Decision|0|||
143355037|NCT02204293|516845033|FG000|LTE Phase|Study Suspended|0|||
143355038|NCT02204293|516845034|FG001|LTE Phase|Study Suspended|0|||
143012737|NCT00835068|515585666|FG001|Overall Study|Adverse Event|1|||
143012738|NCT00835068|515585665|FG000|Overall Study|Other|8|||
143012739|NCT00835068|515585666|FG001|Overall Study|Other|0|||
143012740|NCT00835068|515585665|FG000|Overall Study|Withdrawal by Subject|1|||
143012741|NCT00835068|515585666|FG001|Overall Study|Withdrawal by Subject|0|||
143012742|NCT02575807|515585667|FG000|Overall Study|Death|8|||
143012743|NCT02575807|515585668|FG001|Overall Study|Death|3|||
143012744|NCT02575807|515585669|FG002|Overall Study|Death|7|||
143012745|NCT02575807|515585670|FG003|Overall Study|Death|0|||
143012746|NCT02575807|515585671|FG004|Overall Study|Death|1|||
143012747|NCT02575807|515585667|FG000|Overall Study|Study terminated by Sponsor|0|||
143461797|NCT01191268|517237496|FG000|Overall Study|Protocol Violation|1|||
143461798|NCT01191268|517237497|FG001|Overall Study|Protocol Violation|0|||
143461799|NCT01191268|517237498|FG002|Overall Study|Protocol Violation|1|||
143461800|NCT01191268|517237496|FG000|Overall Study|Sponsor Decision|0|||
143461801|NCT01191268|517237497|FG001|Overall Study|Sponsor Decision|2|||
143461802|NCT01191268|517237498|FG002|Overall Study|Sponsor Decision|0|||
143461803|NCT00336895|517237499|FG000|Overall Study|diarrhea|1|||
143461804|NCT00336895|517237499|FG000|Overall Study|nausea and upset stomach|1|||
143461805|NCT00336895|517237499|FG000|Overall Study|Physician Decision|1|||
143461806|NCT00336895|517237499|FG000|Overall Study|screen failed|1|||
143461807|NCT03333837|517237504|FG000|Overall Study|Adverse Event|2|||
143461808|NCT03333837|517237505|FG001|Overall Study|Adverse Event|1|||
143461809|NCT03333837|517237506|FG002|Overall Study|Adverse Event|1|||
143461810|NCT03333837|517237507|FG003|Overall Study|Adverse Event|1|||
143461811|NCT03333837|517237508|FG004|Overall Study|Adverse Event|0|||
143461812|NCT03333837|517237504|FG000|Overall Study|Caregiver withdrew|0|||
143461813|NCT03333837|517237505|FG001|Overall Study|Caregiver withdrew|2|||
143461814|NCT03333837|517237506|FG002|Overall Study|Caregiver withdrew|1|||
143461815|NCT03333837|517237507|FG003|Overall Study|Caregiver withdrew|0|||
143461816|NCT03333837|517237508|FG004|Overall Study|Caregiver withdrew|0|||
143461817|NCT03333837|517237504|FG000|Overall Study|Withdrawal by Subject|0|||
143461818|NCT03333837|517237505|FG001|Overall Study|Withdrawal by Subject|0|||
143461819|NCT03333837|517237506|FG002|Overall Study|Withdrawal by Subject|1|||
143461820|NCT03333837|517237507|FG003|Overall Study|Withdrawal by Subject|1|||
143461821|NCT03333837|517237508|FG004|Overall Study|Withdrawal by Subject|3|||
143355039|NCT02204293|516845035|FG002|LTE Phase|Study Suspended|0|||
143355040|NCT02204293|516845036|FG003|LTE Phase|Study Suspended|0|||
143355041|NCT02204293|516845037|FG004|LTE Phase|Study Suspended|0|||
143355042|NCT02204293|516845038|FG005|LTE Phase|Study Suspended|7|||
143355043|NCT00287469|516845041|FG000|Overall Study|serious adverse event|1|||
143355044|NCT00287469|516845042|FG001|Overall Study|serious adverse event|6|||
143355045|NCT00287469|516845041|FG000|Overall Study|Adverse Event|1|||
143355046|NCT00287469|516845042|FG001|Overall Study|Adverse Event|1|||
143355047|NCT00287469|516845041|FG000|Overall Study|moved from area|144|||
143355048|NCT00287469|516845042|FG001|Overall Study|moved from area|138|||
143355049|NCT00287469|516845041|FG000|Overall Study|Lost to Follow-up|74|||
143355050|NCT00287469|516845042|FG001|Overall Study|Lost to Follow-up|69|||
143355051|NCT00065468|516845043|FG000|Overall Study|Death|172|||
143355052|NCT00065468|516845044|FG001|Overall Study|Death|169|||
143355053|NCT00065468|516845045|FG002|Overall Study|Death|171|||
143355054|NCT00065468|516845043|FG000|Overall Study|Withdrawal by Subject|3|||
143355055|NCT00065468|516845044|FG001|Overall Study|Withdrawal by Subject|4|||
143355056|NCT00065468|516845045|FG002|Overall Study|Withdrawal by Subject|5|||
143355057|NCT00065468|516845043|FG000|Overall Study|Lost to Follow-up|5|||
143355058|NCT00065468|516845044|FG001|Overall Study|Lost to Follow-up|3|||
143355059|NCT00065468|516845045|FG002|Overall Study|Lost to Follow-up|2|||
143355060|NCT00065468|516845043|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
143355061|NCT00065468|516845044|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
143355062|NCT00065468|516845045|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
143355063|NCT00065468|516845043|FG000|Overall Study|Disease progression|0|||
143355064|NCT00065468|516845044|FG001|Overall Study|Disease progression|0|||
143355065|NCT00065468|516845045|FG002|Overall Study|Disease progression|1|||
143355066|NCT00065468|516845043|FG000|Overall Study|Other|14|||
143355067|NCT00065468|516845044|FG001|Overall Study|Other|24|||
143355068|NCT00065468|516845045|FG002|Overall Study|Other|18|||
143355069|NCT01225835|516845046|FG000|Overall Study|Completed protocol|2|||
143355070|NCT01225835|516845047|FG001|Overall Study|Completed protocol|1|||
143355071|NCT01225835|516845046|FG000|Overall Study|Did not meet hCG criterion|2|||
143355072|NCT01225835|516845047|FG001|Overall Study|Did not meet hCG criterion|0|||
143355073|NCT01225835|516845046|FG000|Overall Study|Adverse Event|2|||
143355074|NCT01225835|516845047|FG001|Overall Study|Adverse Event|1|||
143355075|NCT01225835|516845046|FG000|Overall Study|Other|1|||
143355076|NCT01225835|516845047|FG001|Overall Study|Other|1|||
143355077|NCT02589392|516845048|FG000|Overall Study|Adverse Event|1|||
143355078|NCT02589392|516845049|FG001|Overall Study|Adverse Event|1|||
143355079|NCT02589392|516845048|FG000|Overall Study|Withdrawal by Subject|1|||
143355080|NCT02589392|516845049|FG001|Overall Study|Withdrawal by Subject|2|||
143355081|NCT02589392|516845048|FG000|Overall Study|Protocol Violation|1|||
143355082|NCT02589392|516845049|FG001|Overall Study|Protocol Violation|1|||
143355083|NCT02589392|516845048|FG000|Overall Study|Lost to Follow-up|2|||
143355084|NCT02589392|516845049|FG001|Overall Study|Lost to Follow-up|2|||
143461822|NCT03333837|517237504|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
143461823|NCT03333837|517237505|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
143461824|NCT03333837|517237506|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
143461825|NCT03333837|517237507|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
143355085|NCT02589392|516845048|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
143355086|NCT02589392|516845049|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
143355087|NCT03051659|516845050|FG000|Treatment Period|Withdrawal by Subject|0|||
143355088|NCT03051659|516845051|FG001|Treatment Period|Withdrawal by Subject|2|||
143355089|NCT03051659|516845050|FG000|Survival Follow-up|Lost to Follow-up|23|||
143355090|NCT03051659|516845051|FG001|Survival Follow-up|Lost to Follow-up|22|||
143355091|NCT01266993|516845052|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
143355092|NCT01266993|516845053|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
143355093|NCT01266993|516845052|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
143355094|NCT01266993|516845053|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
143355095|NCT02293837|516845054|FG000|Overall Study|Lost to Follow-up|0|||
143355096|NCT02293837|516845055|FG001|Overall Study|Lost to Follow-up|2|||
143355097|NCT02293837|516845056|FG002|Overall Study|Lost to Follow-up|1|||
143355098|NCT02293837|516845057|FG003|Overall Study|Lost to Follow-up|0|||
143355099|NCT02293837|516845054|FG000|Overall Study|Withdrawal by Subject|2|||
143355100|NCT02293837|516845055|FG001|Overall Study|Withdrawal by Subject|1|||
143355101|NCT02293837|516845056|FG002|Overall Study|Withdrawal by Subject|2|||
143355102|NCT02293837|516845057|FG003|Overall Study|Withdrawal by Subject|1|||
143355103|NCT02293837|516845054|FG000|Overall Study|COVID-19 Related|1|||
143355104|NCT02293837|516845055|FG001|Overall Study|COVID-19 Related|1|||
143355105|NCT02293837|516845056|FG002|Overall Study|COVID-19 Related|0|||
143355106|NCT02293837|516845057|FG003|Overall Study|COVID-19 Related|0|||
143355107|NCT02293837|516845054|FG000|Overall Study|Participant ill and could not be infused|0|||
143355108|NCT02293837|516845055|FG001|Overall Study|Participant ill and could not be infused|0|||
143355109|NCT02293837|516845056|FG002|Overall Study|Participant ill and could not be infused|1|||
143355110|NCT02293837|516845057|FG003|Overall Study|Participant ill and could not be infused|0|||
143355111|NCT04779242|516845058|FG000|Overall Study|Adverse Event|1|||
143355112|NCT04779242|516845059|FG001|Overall Study|Adverse Event|1|||
143355113|NCT04779242|516845058|FG000|Overall Study|Lost to Follow-up|2|||
143355114|NCT04779242|516845059|FG001|Overall Study|Lost to Follow-up|4|||
143355115|NCT04779242|516845058|FG000|Overall Study|Withdrawal by Subject|7|||
143355116|NCT04779242|516845059|FG001|Overall Study|Withdrawal by Subject|9|||
143355117|NCT04779242|516845058|FG000|Overall Study|Death|6|||
143355118|NCT04779242|516845059|FG001|Overall Study|Death|6|||
143355119|NCT04779242|516845058|FG000|Overall Study|COVID-19 related reasons|2|||
143355120|NCT04779242|516845059|FG001|Overall Study|COVID-19 related reasons|1|||
143355121|NCT04779242|516845058|FG000|Overall Study|Unavailability for post therapy evaluation Visit|8|||
143355122|NCT04779242|516845059|FG001|Overall Study|Unavailability for post therapy evaluation Visit|4|||
143355123|NCT04779242|516845058|FG000|Overall Study|Martial Law in Ukraine|2|||
143355124|NCT04779242|516845059|FG001|Overall Study|Martial Law in Ukraine|3|||
143355125|NCT03285113|516845060|FG000|Overall Study|Unable to implant leads|2|||
143355126|NCT01076088|516845064|FG000|Overall Study|Adverse Event|1|||
143355127|NCT01076088|516845065|FG001|Overall Study|Adverse Event|6|||
143355128|NCT01076088|516845066|FG002|Overall Study|Adverse Event|3|||
143355129|NCT01076088|516845067|FG003|Overall Study|Adverse Event|2|||
143355130|NCT01076088|516845068|FG004|Overall Study|Adverse Event|3|||
143355131|NCT01076088|516845069|FG005|Overall Study|Adverse Event|3|||
143355132|NCT01076088|516845064|FG000|Overall Study|Lost to Follow-up|1|||
143355133|NCT01076088|516845065|FG001|Overall Study|Lost to Follow-up|1|||
143355134|NCT01076088|516845066|FG002|Overall Study|Lost to Follow-up|0|||
143355135|NCT01076088|516845067|FG003|Overall Study|Lost to Follow-up|1|||
143355136|NCT01076088|516845068|FG004|Overall Study|Lost to Follow-up|1|||
143355137|NCT01076088|516845069|FG005|Overall Study|Lost to Follow-up|2|||
143355138|NCT01076088|516845064|FG000|Overall Study|Non-compliance with study drug|0|||
143355139|NCT01076088|516845065|FG001|Overall Study|Non-compliance with study drug|0|||
143355140|NCT01076088|516845066|FG002|Overall Study|Non-compliance with study drug|0|||
143355141|NCT01076088|516845067|FG003|Overall Study|Non-compliance with study drug|1|||
143355142|NCT01076088|516845068|FG004|Overall Study|Non-compliance with study drug|0|||
143355143|NCT01076088|516845069|FG005|Overall Study|Non-compliance with study drug|0|||
143355144|NCT01076088|516845064|FG000|Overall Study|Physician Decision|1|||
143355145|NCT01076088|516845065|FG001|Overall Study|Physician Decision|3|||
143355146|NCT01076088|516845066|FG002|Overall Study|Physician Decision|0|||
143355147|NCT01076088|516845067|FG003|Overall Study|Physician Decision|1|||
143355148|NCT01076088|516845068|FG004|Overall Study|Physician Decision|1|||
143355149|NCT01076088|516845069|FG005|Overall Study|Physician Decision|0|||
143355150|NCT01076088|516845064|FG000|Overall Study|Withdrawal by Subject|8|||
143355151|NCT01076088|516845065|FG001|Overall Study|Withdrawal by Subject|8|||
143355152|NCT01076088|516845066|FG002|Overall Study|Withdrawal by Subject|14|||
143355153|NCT01076088|516845067|FG003|Overall Study|Withdrawal by Subject|10|||
143355154|NCT01076088|516845068|FG004|Overall Study|Withdrawal by Subject|11|||
143355155|NCT01076088|516845069|FG005|Overall Study|Withdrawal by Subject|17|||
143355156|NCT01076088|516845064|FG000|Overall Study|Other protocol specified criteria|0|||
143125850|NCT03498313|516006648|FG004|Washout Period 2|Anovulation|0|||
143355157|NCT01076088|516845065|FG001|Overall Study|Other protocol specified criteria|0|||
143355158|NCT01076088|516845066|FG002|Overall Study|Other protocol specified criteria|0|||
143355159|NCT01076088|516845067|FG003|Overall Study|Other protocol specified criteria|0|||
143355160|NCT01076088|516845068|FG004|Overall Study|Other protocol specified criteria|0|||
143355161|NCT01076088|516845069|FG005|Overall Study|Other protocol specified criteria|1|||
143355162|NCT02207374|516845072|FG000|Overall Study|Withdrawal by Subject|5|||
143461826|NCT03333837|517237508|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
143461827|NCT00705523|517237509|FG000|Overall Study|Lost to Follow-up|2|||
143461828|NCT00705523|517237510|FG001|Overall Study|Lost to Follow-up|3|||
143461829|NCT01013285|517237512|FG000|Overall Study|Death|48|||
143461830|NCT01013285|517237513|FG001|Overall Study|Death|89|||
143461831|NCT02112708|517237527|FG000|Baseline|Physician Decision|16|||
143461832|NCT02112708|517237528|FG001|Baseline|Physician Decision|11|||
143461833|NCT02112708|517237527|FG000|Baseline|Lost to Follow-up|12|||
143461834|NCT02112708|517237528|FG001|Baseline|Lost to Follow-up|0|||
143461835|NCT02112708|517237527|FG000|4 Month|Death|0|||
143461836|NCT02112708|517237528|FG001|4 Month|Death|1|||
143461837|NCT02112708|517237527|FG000|4 Month|Withdrawal by Subject|12|||
143461838|NCT02112708|517237528|FG001|4 Month|Withdrawal by Subject|0|||
143461839|NCT03866473|517237531|FG000|Phase 1|Death|1|||
143461840|NCT03866473|517237532|FG001|Phase 1|Death|0|||
143461841|NCT03866473|517237531|FG000|Phase 2|Death|0|||
143461842|NCT03866473|517237532|FG001|Phase 2|Death|2|||
143461843|NCT03866473|517237531|FG000|Phase 2|Dropped|1|||
143461844|NCT03866473|517237532|FG001|Phase 2|Dropped|1|||
143461845|NCT03866473|517237531|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
143461846|NCT03866473|517237532|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
143461847|NCT03110185|517237533|FG000|Overall Study|Death|0|||
143461848|NCT03110185|517237534|FG001|Overall Study|Death|1|||
143461849|NCT03110185|517237533|FG000|Overall Study|Withdrawal by Subject|2|||
143355163|NCT02207374|516845073|FG001|Overall Study|Withdrawal by Subject|9|||
143355164|NCT02207374|516845074|FG002|Overall Study|Withdrawal by Subject|4|||
143355165|NCT02207374|516845072|FG000|Overall Study|Death|1|||
143355166|NCT02207374|516845073|FG001|Overall Study|Death|0|||
143355167|NCT02207374|516845074|FG002|Overall Study|Death|1|||
143355168|NCT02207374|516845072|FG000|Overall Study|Missing follow-up information|0|||
143355169|NCT02207374|516845073|FG001|Overall Study|Missing follow-up information|1|||
143355170|NCT02207374|516845074|FG002|Overall Study|Missing follow-up information|1|||
143355171|NCT02087150|516845075|FG000|Overall Study|Death|0|||
143355172|NCT02087150|516845076|FG001|Overall Study|Death|1|||
143355173|NCT02087150|516845077|FG002|Overall Study|Death|0|||
143355174|NCT02087150|516845075|FG000|Overall Study|Lost to Follow-up|6|||
143355175|NCT02087150|516845076|FG001|Overall Study|Lost to Follow-up|13|||
143355176|NCT02087150|516845077|FG002|Overall Study|Lost to Follow-up|7|||
143355177|NCT02087150|516845075|FG000|Overall Study|Withdrawal by Subject|2|||
143355178|NCT02087150|516845076|FG001|Overall Study|Withdrawal by Subject|5|||
143355179|NCT02087150|516845077|FG002|Overall Study|Withdrawal by Subject|3|||
143355180|NCT02087150|516845075|FG000|Overall Study|Physician Decision|0|||
143355181|NCT02087150|516845076|FG001|Overall Study|Physician Decision|1|||
143355182|NCT02087150|516845077|FG002|Overall Study|Physician Decision|0|||
143355183|NCT02087150|516845075|FG000|Overall Study|Procedure not done|1|||
143355184|NCT02087150|516845076|FG001|Overall Study|Procedure not done|13|||
143355185|NCT02087150|516845077|FG002|Overall Study|Procedure not done|0|||
143355186|NCT02087150|516845075|FG000|Overall Study|F/U not completed w/in study window|0|||
143355187|NCT02087150|516845076|FG001|Overall Study|F/U not completed w/in study window|0|||
143355188|NCT02087150|516845077|FG002|Overall Study|F/U not completed w/in study window|1|||
143355189|NCT02087150|516845075|FG000|Overall Study|Other|1|||
143355190|NCT02087150|516845076|FG001|Overall Study|Other|0|||
143355191|NCT02087150|516845077|FG002|Overall Study|Other|0|||
143355192|NCT02087150|516845075|FG000|Overall Study|Pt moved out of town|0|||
143355193|NCT02087150|516845076|FG001|Overall Study|Pt moved out of town|1|||
143355194|NCT02087150|516845077|FG002|Overall Study|Pt moved out of town|0|||
143355195|NCT00322374|516845079|FG000|Starting Dose|Physician Decision|2|||
143355196|NCT00322374|516845080|FG001|Starting Dose|Physician Decision|0|||
143355197|NCT00322374|516845081|FG002|Starting Dose|Physician Decision|0|||
143355198|NCT00322374|516845082|FG003|Starting Dose|Physician Decision|0|||
143355199|NCT00322374|516845079|FG000|Starting Dose|Study Drug Toxicity|4|||
143355200|NCT00322374|516845080|FG001|Starting Dose|Study Drug Toxicity|0|||
143355201|NCT00322374|516845081|FG002|Starting Dose|Study Drug Toxicity|0|||
143355202|NCT00322374|516845082|FG003|Starting Dose|Study Drug Toxicity|0|||
143355203|NCT00322374|516845079|FG000|First Escalation|Documented Disease Progression|0|||
143355204|NCT00322374|516845080|FG001|First Escalation|Documented Disease Progression|6|||
143461850|NCT03110185|517237534|FG001|Overall Study|Withdrawal by Subject|7|||
143461851|NCT03110185|517237533|FG000|Overall Study|Time Constraints|0|||
143355205|NCT00322374|516845081|FG002|First Escalation|Documented Disease Progression|0|||
143355206|NCT00322374|516845082|FG003|First Escalation|Documented Disease Progression|0|||
143355207|NCT00322374|516845079|FG000|First Escalation|Physician Decision|0|||
143355208|NCT00322374|516845080|FG001|First Escalation|Physician Decision|12|||
143355209|NCT00322374|516845081|FG002|First Escalation|Physician Decision|0|||
143355210|NCT00322374|516845082|FG003|First Escalation|Physician Decision|0|||
143461852|NCT03110185|517237534|FG001|Overall Study|Time Constraints|6|||
143461853|NCT03110185|517237533|FG000|Overall Study|Conflict with care|5|||
143461854|NCT03110185|517237534|FG001|Overall Study|Conflict with care|12|||
143461855|NCT03110185|517237533|FG000|Overall Study|Protocol Violation|1|||
143461856|NCT03110185|517237534|FG001|Overall Study|Protocol Violation|4|||
143461857|NCT03110185|517237533|FG000|Overall Study|MRI Incompatible|2|||
143461858|NCT03110185|517237534|FG001|Overall Study|MRI Incompatible|0|||
143461859|NCT03110185|517237533|FG000|Overall Study|Patient Refusal|0|||
143461860|NCT03110185|517237534|FG001|Overall Study|Patient Refusal|1|||
143461861|NCT02641496|517237535|FG000|Overall Study|Lost to Follow-up|13|||
143461862|NCT02641496|517237536|FG001|Overall Study|Lost to Follow-up|12|||
143461863|NCT02641496|517237535|FG000|Overall Study|Withdrawal by Subject|1|||
143461864|NCT02641496|517237536|FG001|Overall Study|Withdrawal by Subject|0|||
143461865|NCT03075410|517237539|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
143461866|NCT03075410|517237540|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
143461867|NCT03075410|517237541|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
143461868|NCT03075410|517237542|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
143461869|NCT03075410|517237543|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
143461870|NCT03075410|517237544|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
143461871|NCT03075410|517237545|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
143461872|NCT03075410|517237546|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
143461873|NCT03075410|517237547|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
143461874|NCT03075410|517237539|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
143461875|NCT03075410|517237540|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
143461876|NCT03075410|517237541|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
143461877|NCT03075410|517237542|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
143461878|NCT03075410|517237543|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
143461879|NCT03075410|517237544|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
143355211|NCT00322374|516845079|FG000|First Escalation|Study Drug Toxicity|0|||
143355212|NCT00322374|516845080|FG001|First Escalation|Study Drug Toxicity|11|||
143355213|NCT00322374|516845081|FG002|First Escalation|Study Drug Toxicity|0|||
143355214|NCT00322374|516845082|FG003|First Escalation|Study Drug Toxicity|0|||
143355215|NCT00322374|516845079|FG000|First Escalation|Participant Request|0|||
143355216|NCT00322374|516845080|FG001|First Escalation|Participant Request|1|||
143355217|NCT00322374|516845081|FG002|First Escalation|Participant Request|0|||
143355218|NCT00322374|516845082|FG003|First Escalation|Participant Request|0|||
143355219|NCT00322374|516845079|FG000|Second Escalation|Physician Decision|0|||
143355220|NCT00322374|516845080|FG001|Second Escalation|Physician Decision|0|||
143355221|NCT00322374|516845081|FG002|Second Escalation|Physician Decision|5|||
143355222|NCT00322374|516845082|FG003|Second Escalation|Physician Decision|0|||
143355223|NCT00322374|516845079|FG000|Second Escalation|Study Drug Toxicity|0|||
143355224|NCT00322374|516845080|FG001|Second Escalation|Study Drug Toxicity|0|||
143355225|NCT00322374|516845081|FG002|Second Escalation|Study Drug Toxicity|1|||
143355226|NCT00322374|516845082|FG003|Second Escalation|Study Drug Toxicity|0|||
143355227|NCT01448044|516845083|FG000|Treatment Period|Adverse Event|4|||
143355228|NCT01448044|516845084|FG001|Treatment Period|Adverse Event|3|||
143355229|NCT01448044|516845083|FG000|Treatment Period|Lack of Efficacy|5|||
143355230|NCT01448044|516845084|FG001|Treatment Period|Lack of Efficacy|12|||
143355231|NCT01448044|516845083|FG000|Treatment Period|Subject requested discontinue study drug|1|||
143355232|NCT01448044|516845084|FG001|Treatment Period|Subject requested discontinue study drug|0|||
143355233|NCT01448044|516845083|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
143355234|NCT01448044|516845084|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
143355235|NCT01448044|516845083|FG000|Treatment Period|Participant does not meet study criteria|1|||
143355236|NCT01448044|516845084|FG001|Treatment Period|Participant does not meet study criteria|0|||
143355237|NCT01448044|516845083|FG000|Treatment Period|Lost to Follow-up|2|||
143355238|NCT01448044|516845084|FG001|Treatment Period|Lost to Follow-up|1|||
143355239|NCT01448044|516845083|FG000|Treatment Period|Other reason|2|||
143355240|NCT01448044|516845084|FG001|Treatment Period|Other reason|0|||
143355241|NCT01448044|516845083|FG000|Follow Up Period|Withdrawal by Subject|1|||
143355242|NCT01448044|516845084|FG001|Follow Up Period|Withdrawal by Subject|1|||
143355243|NCT01448044|516845083|FG000|Follow Up Period|Lost to Follow-up|6|||
143461880|NCT03075410|517237545|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
143461881|NCT03075410|517237546|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
143355244|NCT01448044|516845084|FG001|Follow Up Period|Lost to Follow-up|2|||
143355245|NCT01448044|516845083|FG000|Follow Up Period|Other|5|||
143355246|NCT01448044|516845084|FG001|Follow Up Period|Other|11|||
143461882|NCT03075410|517237547|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
143355247|NCT00507026|516845087|FG000|Overall Study|Lack of Efficacy|6|||
143355248|NCT00507026|516845088|FG001|Overall Study|Lack of Efficacy|4|||
143461883|NCT01427751|517237548|FG000|Overall Study|Adverse Event|18|||
143461884|NCT01427751|517237549|FG001|Overall Study|Adverse Event|2|||
143461885|NCT01427751|517237548|FG000|Overall Study|No further treatment benefit expected|5|||
143461886|NCT01427751|517237549|FG001|Overall Study|No further treatment benefit expected|1|||
143461887|NCT01427751|517237548|FG000|Overall Study|Lost to Follow-up|3|||
143125851|NCT03498313|516006649|FG005|Washout Period 2|Anovulation|1|||
143355249|NCT00507026|516845089|FG002|Overall Study|Lack of Efficacy|21|||
143355250|NCT00507026|516845087|FG000|Overall Study|Withdrawal by Subject|2|||
143355251|NCT00507026|516845088|FG001|Overall Study|Withdrawal by Subject|0|||
143461888|NCT01427751|517237549|FG001|Overall Study|Lost to Follow-up|1|||
143461889|NCT01427751|517237548|FG000|Overall Study|Withdrawal of consent|2|||
143461890|NCT01427751|517237549|FG001|Overall Study|Withdrawal of consent|2|||
143461891|NCT01427751|517237548|FG000|Overall Study|Protocol Violation|6|||
143461892|NCT01427751|517237549|FG001|Overall Study|Protocol Violation|4|||
143461893|NCT01427751|517237548|FG000|Overall Study|Death|2|||
143461894|NCT01427751|517237549|FG001|Overall Study|Death|0|||
143461895|NCT01427751|517237548|FG000|Overall Study|Other miscellaneous reasons|6|||
143461896|NCT01427751|517237549|FG001|Overall Study|Other miscellaneous reasons|4|||
143461897|NCT01028027|517237550|FG000|Overall Study|Lost to Follow-up|4|||
143461898|NCT01028027|517237551|FG001|Overall Study|Lost to Follow-up|1|||
143461899|NCT01028027|517237550|FG000|Overall Study|Withdrawal by Subject|5|||
143461900|NCT01028027|517237551|FG001|Overall Study|Withdrawal by Subject|3|||
143461901|NCT01028027|517237550|FG000|Overall Study|Adverse Event|4|||
143461902|NCT01028027|517237551|FG001|Overall Study|Adverse Event|7|||
143461903|NCT01028027|517237550|FG000|Overall Study|Protocol Violation|3|||
143461904|NCT01028027|517237551|FG001|Overall Study|Protocol Violation|1|||
143461905|NCT01028027|517237550|FG000|Overall Study|Lack of Efficacy|0|||
143461906|NCT01028027|517237551|FG001|Overall Study|Lack of Efficacy|1|||
143461907|NCT00790751|517237563|FG000|Overall Study|Protocol non-compliance|16|||
143461908|NCT00790751|517237564|FG001|Overall Study|Protocol non-compliance|16|||
143461909|NCT00790751|517237565|FG002|Overall Study|Protocol non-compliance|10|||
143461910|NCT00790751|517237566|FG003|Overall Study|Protocol non-compliance|11|||
143461911|NCT00790751|517237563|FG000|Overall Study|Lost to Follow-up|4|||
143461912|NCT00790751|517237564|FG001|Overall Study|Lost to Follow-up|9|||
143461913|NCT00790751|517237565|FG002|Overall Study|Lost to Follow-up|4|||
143461914|NCT00790751|517237566|FG003|Overall Study|Lost to Follow-up|5|||
143461915|NCT00790751|517237563|FG000|Overall Study|Adverse Event|5|||
143461916|NCT00790751|517237564|FG001|Overall Study|Adverse Event|3|||
143461917|NCT00790751|517237565|FG002|Overall Study|Adverse Event|5|||
143461918|NCT00790751|517237566|FG003|Overall Study|Adverse Event|4|||
143461919|NCT00790751|517237563|FG000|Overall Study|Requirement for restricted medication|0|||
143461920|NCT00790751|517237564|FG001|Overall Study|Requirement for restricted medication|2|||
143461921|NCT00790751|517237565|FG002|Overall Study|Requirement for restricted medication|0|||
143461922|NCT00790751|517237566|FG003|Overall Study|Requirement for restricted medication|0|||
143461923|NCT00790751|517237563|FG000|Overall Study|Death|0|||
143461924|NCT00790751|517237564|FG001|Overall Study|Death|0|||
143461925|NCT00790751|517237565|FG002|Overall Study|Death|1|||
143461926|NCT00790751|517237566|FG003|Overall Study|Death|0|||
143461927|NCT00790751|517237563|FG000|Overall Study|Physician Decision|0|||
143461928|NCT00790751|517237564|FG001|Overall Study|Physician Decision|0|||
143461929|NCT00790751|517237565|FG002|Overall Study|Physician Decision|0|||
143461930|NCT00790751|517237566|FG003|Overall Study|Physician Decision|1|||
143461931|NCT05590884|517237567|FG000|Overall Study|Withdrawal by Subject|1|||
143461932|NCT05590884|517237568|FG001|Overall Study|Withdrawal by Subject|0|||
143461933|NCT05590884|517237569|FG002|Overall Study|Withdrawal by Subject|0|||
143461934|NCT04948333|517237570|FG000|Overall Study|Adverse Event|6|||
143461935|NCT04948333|517237571|FG001|Overall Study|Adverse Event|4|||
143461936|NCT04948333|517237572|FG002|Overall Study|Adverse Event|0|||
143461937|NCT04948333|517237573|FG003|Overall Study|Adverse Event|2|||
143461938|NCT04948333|517237570|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
143461939|NCT04948333|517237571|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
143461940|NCT04948333|517237572|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
143461941|NCT04948333|517237573|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
143461942|NCT04948333|517237570|FG000|Overall Study|Progressive Disease|1|||
143461943|NCT04948333|517237571|FG001|Overall Study|Progressive Disease|5|||
143461944|NCT04948333|517237572|FG002|Overall Study|Progressive Disease|0|||
143461945|NCT04948333|517237573|FG003|Overall Study|Progressive Disease|0|||
143461946|NCT04948333|517237570|FG000|Overall Study|Physician Decision|2|||
143461947|NCT04948333|517237571|FG001|Overall Study|Physician Decision|2|||
143355252|NCT00507026|516845089|FG002|Overall Study|Withdrawal by Subject|0|||
143355253|NCT00507026|516845087|FG000|Overall Study|Investigator Decision|1|||
143355254|NCT00507026|516845088|FG001|Overall Study|Investigator Decision|0|||
143355255|NCT00507026|516845089|FG002|Overall Study|Investigator Decision|0|||
143355256|NCT00507026|516845087|FG000|Overall Study|Adverse Event|2|||
143355257|NCT00507026|516845088|FG001|Overall Study|Adverse Event|0|||
143355258|NCT00507026|516845089|FG002|Overall Study|Adverse Event|0|||
143461948|NCT04948333|517237572|FG002|Overall Study|Physician Decision|0|||
143461949|NCT04948333|517237573|FG003|Overall Study|Physician Decision|0|||
143461950|NCT04948333|517237570|FG000|Overall Study|Failure To Meet Continuation Criteria|2|||
143461951|NCT04948333|517237571|FG001|Overall Study|Failure To Meet Continuation Criteria|1|||
143461952|NCT04948333|517237572|FG002|Overall Study|Failure To Meet Continuation Criteria|0|||
143461953|NCT04948333|517237573|FG003|Overall Study|Failure To Meet Continuation Criteria|0|||
143461954|NCT04948333|517237570|FG000|Overall Study|Withdrawal by Subject|2|||
143461955|NCT04948333|517237571|FG001|Overall Study|Withdrawal by Subject|0|||
143461956|NCT04948333|517237572|FG002|Overall Study|Withdrawal by Subject|0|||
143461957|NCT04948333|517237573|FG003|Overall Study|Withdrawal by Subject|1|||
143461958|NCT04948333|517237570|FG000|Overall Study|Protocol Violation|0|||
143461959|NCT04948333|517237571|FG001|Overall Study|Protocol Violation|1|||
143461960|NCT04948333|517237572|FG002|Overall Study|Protocol Violation|0|||
143461961|NCT04948333|517237573|FG003|Overall Study|Protocol Violation|0|||
143461962|NCT04948333|517237570|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
143461963|NCT04948333|517237571|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
143461964|NCT04948333|517237572|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|14|||
143461965|NCT04948333|517237573|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|13|||
143461966|NCT04976621|517237575|FG000|Overall Study|Lost to Follow-up|2|||
143461967|NCT04976621|517237576|FG001|Overall Study|Lost to Follow-up|2|||
143461968|NCT04976621|517237575|FG000|Overall Study|Withdrawal by Subject|1|||
143461969|NCT04976621|517237576|FG001|Overall Study|Withdrawal by Subject|1|||
143461970|NCT04443153|517237581|FG000|First intervention (8 weeks)|Withdrawal by Subject|2|||
143461971|NCT04443153|517237582|FG001|First intervention (8 weeks)|Withdrawal by Subject|0|||
143461972|NCT04443153|517237581|FG000|First intervention (8 weeks)|Lost to Follow-up|0|||
143461973|NCT04443153|517237582|FG001|First intervention (8 weeks)|Lost to Follow-up|2|||
143461974|NCT04443153|517237581|FG000|Second intervention (8 weeks)|Withdrawal by Subject|1|||
143461975|NCT04443153|517237582|FG001|Second intervention (8 weeks)|Withdrawal by Subject|1|||
143461976|NCT04443153|517237581|FG000|Second intervention (8 weeks)|Lost to Follow-up|2|||
143461977|NCT04443153|517237582|FG001|Second intervention (8 weeks)|Lost to Follow-up|0|||
143461978|NCT05330312|517237583|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
143461979|NCT05330312|517237584|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
143461980|NCT05330312|517237585|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
143461981|NCT05330312|517237583|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
143461982|NCT05330312|517237584|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
143461983|NCT05330312|517237585|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
143461984|NCT05330312|517237583|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
143461985|NCT05330312|517237584|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
143461986|NCT05330312|517237585|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
143461987|NCT05330312|517237583|FG000|Pivotal Investigation - Part 2|Death|1|||
143461988|NCT05330312|517237584|FG001|Pivotal Investigation - Part 2|Death|4|||
143461989|NCT05330312|517237585|FG002|Pivotal Investigation - Part 2|Death|0|||
143461990|NCT05182125|517237586|FG000|Overall Study|Withdrawal by Subject|0|||
143461991|NCT05182125|517237587|FG001|Overall Study|Withdrawal by Subject|0|||
143461992|NCT05182125|517237588|FG002|Overall Study|Withdrawal by Subject|0|||
143461993|NCT05182125|517237589|FG003|Overall Study|Withdrawal by Subject|0|||
143461994|NCT05182125|517237590|FG004|Overall Study|Withdrawal by Subject|2|||
143461995|NCT05182125|517237591|FG005|Overall Study|Withdrawal by Subject|0|||
143461996|NCT05182125|517237586|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
143461997|NCT05182125|517237587|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
143461998|NCT05182125|517237588|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
143461999|NCT05182125|517237589|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
143462000|NCT05182125|517237590|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
143462001|NCT05182125|517237591|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
143462002|NCT05182125|517237586|FG000|Overall Study|Death|0|||
143462003|NCT05182125|517237587|FG001|Overall Study|Death|0|||
143462004|NCT05182125|517237588|FG002|Overall Study|Death|0|||
143462005|NCT05182125|517237589|FG003|Overall Study|Death|0|||
143462006|NCT05182125|517237590|FG004|Overall Study|Death|1|||
143462007|NCT05182125|517237591|FG005|Overall Study|Death|0|||
143462008|NCT03519971|517237592|FG000|Overall Study|Death|142|||
143462009|NCT03519971|517237593|FG001|Overall Study|Death|69|||
143355259|NCT00507026|516845087|FG000|Overall Study|Protocol Violation|1|||
143355260|NCT00507026|516845088|FG001|Overall Study|Protocol Violation|0|||
143355261|NCT00507026|516845089|FG002|Overall Study|Protocol Violation|0|||
143355262|NCT00507026|516845087|FG000|Overall Study|Other|1|||
143355263|NCT00507026|516845088|FG001|Overall Study|Other|0|||
143355264|NCT00507026|516845089|FG002|Overall Study|Other|0|||
143355265|NCT02372058|516845090|FG000|Overall Study|Withdrawal by Subject|3|||
143355266|NCT00972179|516845093|FG000|Overall Study|Noncompliance|1|||
143355267|NCT00972179|516845094|FG001|Overall Study|Noncompliance|0|||
143462010|NCT03519971|517237592|FG000|Overall Study|Lost to Follow-up|0|||
143462011|NCT03519971|517237593|FG001|Overall Study|Lost to Follow-up|1|||
143355268|NCT00972179|516845095|FG002|Overall Study|Noncompliance|0|||
143355269|NCT00972179|516845096|FG003|Overall Study|Noncompliance|0|||
143462012|NCT03519971|517237592|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
143462013|NCT03519971|517237593|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
143125852|NCT02372383|516006655|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
143355270|NCT00972179|516845097|FG004|Overall Study|Noncompliance|1|||
143462014|NCT03519971|517237592|FG000|Overall Study|Withdrawal by Subject|3|||
143462015|NCT03519971|517237593|FG001|Overall Study|Withdrawal by Subject|2|||
143462016|NCT03519971|517237592|FG000|Overall Study|Other|1|||
143462017|NCT03519971|517237593|FG001|Overall Study|Other|0|||
143355271|NCT00972179|516845098|FG005|Overall Study|Noncompliance|0|||
143355272|NCT00972179|516845099|FG006|Overall Study|Noncompliance|1|||
143355273|NCT00972179|516845093|FG000|Overall Study|Withdrawal by Subject|0|||
143355274|NCT00972179|516845094|FG001|Overall Study|Withdrawal by Subject|3|||
143355275|NCT00972179|516845095|FG002|Overall Study|Withdrawal by Subject|0|||
143355276|NCT00972179|516845096|FG003|Overall Study|Withdrawal by Subject|1|||
143355277|NCT00972179|516845097|FG004|Overall Study|Withdrawal by Subject|0|||
143355278|NCT00972179|516845098|FG005|Overall Study|Withdrawal by Subject|0|||
143355279|NCT00972179|516845099|FG006|Overall Study|Withdrawal by Subject|2|||
143355280|NCT00972179|516845093|FG000|Overall Study|Administrative Decision|0|||
143355281|NCT00972179|516845094|FG001|Overall Study|Administrative Decision|0|||
143355282|NCT00972179|516845095|FG002|Overall Study|Administrative Decision|0|||
143355283|NCT00972179|516845096|FG003|Overall Study|Administrative Decision|0|||
143355284|NCT00972179|516845097|FG004|Overall Study|Administrative Decision|1|||
143355285|NCT00972179|516845098|FG005|Overall Study|Administrative Decision|0|||
143355286|NCT00972179|516845099|FG006|Overall Study|Administrative Decision|0|||
143355287|NCT00972179|516845093|FG000|Overall Study|Lost to Follow-up|0|||
143355288|NCT00972179|516845094|FG001|Overall Study|Lost to Follow-up|0|||
143355289|NCT00972179|516845095|FG002|Overall Study|Lost to Follow-up|1|||
143355290|NCT00972179|516845096|FG003|Overall Study|Lost to Follow-up|0|||
143355291|NCT00972179|516845097|FG004|Overall Study|Lost to Follow-up|0|||
143355292|NCT00972179|516845098|FG005|Overall Study|Lost to Follow-up|3|||
143355293|NCT00972179|516845099|FG006|Overall Study|Lost to Follow-up|1|||
143355294|NCT02061761|516845103|FG000|Overall Study|Disease progression|2|||
143355295|NCT02061761|516845104|FG001|Overall Study|Disease progression|8|||
143355296|NCT02061761|516845105|FG002|Overall Study|Disease progression|4|||
143355297|NCT02061761|516845106|FG003|Overall Study|Disease progression|5|||
143355298|NCT02061761|516845107|FG004|Overall Study|Disease progression|9|||
143355299|NCT02061761|516845108|FG005|Overall Study|Disease progression|3|||
143355300|NCT02061761|516845109|FG006|Overall Study|Disease progression|1|||
143355301|NCT02061761|516845110|FG007|Overall Study|Disease progression|2|||
143355302|NCT02061761|516845111|FG008|Overall Study|Disease progression|28|||
143355303|NCT02061761|516845103|FG000|Overall Study|Study Drug toxicity|0|||
143355304|NCT02061761|516845104|FG001|Overall Study|Study Drug toxicity|0|||
143355305|NCT02061761|516845105|FG002|Overall Study|Study Drug toxicity|0|||
143355306|NCT02061761|516845106|FG003|Overall Study|Study Drug toxicity|0|||
143355307|NCT02061761|516845107|FG004|Overall Study|Study Drug toxicity|0|||
143355308|NCT02061761|516845108|FG005|Overall Study|Study Drug toxicity|1|||
143355309|NCT02061761|516845109|FG006|Overall Study|Study Drug toxicity|0|||
143355310|NCT02061761|516845110|FG007|Overall Study|Study Drug toxicity|2|||
143355311|NCT02061761|516845111|FG008|Overall Study|Study Drug toxicity|6|||
143355312|NCT02061761|516845103|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
143355313|NCT02061761|516845104|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
143355314|NCT02061761|516845105|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
143355315|NCT02061761|516845106|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
143355316|NCT02061761|516845107|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
143355317|NCT02061761|516845108|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
143355318|NCT02061761|516845109|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
143355319|NCT02061761|516845110|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
143355320|NCT02061761|516845111|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
143355321|NCT02061761|516845103|FG000|Overall Study|Participant request to discontinue study treatment|0|||
143355322|NCT02061761|516845104|FG001|Overall Study|Participant request to discontinue study treatment|0|||
143355323|NCT02061761|516845105|FG002|Overall Study|Participant request to discontinue study treatment|2|||
143355324|NCT02061761|516845106|FG003|Overall Study|Participant request to discontinue study treatment|2|||
143355325|NCT02061761|516845107|FG004|Overall Study|Participant request to discontinue study treatment|0|||
143355326|NCT02061761|516845108|FG005|Overall Study|Participant request to discontinue study treatment|1|||
143355327|NCT02061761|516845109|FG006|Overall Study|Participant request to discontinue study treatment|0|||
143355328|NCT02061761|516845110|FG007|Overall Study|Participant request to discontinue study treatment|0|||
143355329|NCT02061761|516845111|FG008|Overall Study|Participant request to discontinue study treatment|2|||
143355330|NCT02061761|516845103|FG000|Overall Study|Withdrawal by Subject|0|||
143355331|NCT02061761|516845104|FG001|Overall Study|Withdrawal by Subject|0|||
143355332|NCT02061761|516845105|FG002|Overall Study|Withdrawal by Subject|0|||
143355333|NCT02061761|516845106|FG003|Overall Study|Withdrawal by Subject|0|||
143355334|NCT02061761|516845107|FG004|Overall Study|Withdrawal by Subject|0|||
143355335|NCT02061761|516845108|FG005|Overall Study|Withdrawal by Subject|0|||
143125853|NCT02372383|516006656|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
143355336|NCT02061761|516845109|FG006|Overall Study|Withdrawal by Subject|0|||
143355337|NCT02061761|516845110|FG007|Overall Study|Withdrawal by Subject|0|||
143355338|NCT02061761|516845111|FG008|Overall Study|Withdrawal by Subject|2|||
143355339|NCT02061761|516845103|FG000|Overall Study|Maximum clinical benefit|0|||
143355340|NCT02061761|516845104|FG001|Overall Study|Maximum clinical benefit|0|||
143355341|NCT02061761|516845105|FG002|Overall Study|Maximum clinical benefit|0|||
143355342|NCT02061761|516845106|FG003|Overall Study|Maximum clinical benefit|1|||
143355343|NCT02061761|516845107|FG004|Overall Study|Maximum clinical benefit|0|||
143355344|NCT02061761|516845108|FG005|Overall Study|Maximum clinical benefit|0|||
143355345|NCT02061761|516845109|FG006|Overall Study|Maximum clinical benefit|0|||
143355346|NCT02061761|516845110|FG007|Overall Study|Maximum clinical benefit|0|||
143355347|NCT02061761|516845111|FG008|Overall Study|Maximum clinical benefit|6|||
143355348|NCT02061761|516845103|FG000|Overall Study|Participant no longer meets study criteria|0|||
143355349|NCT02061761|516845104|FG001|Overall Study|Participant no longer meets study criteria|0|||
143355350|NCT02061761|516845105|FG002|Overall Study|Participant no longer meets study criteria|0|||
143355351|NCT02061761|516845106|FG003|Overall Study|Participant no longer meets study criteria|0|||
143355352|NCT02061761|516845107|FG004|Overall Study|Participant no longer meets study criteria|0|||
143355353|NCT02061761|516845108|FG005|Overall Study|Participant no longer meets study criteria|0|||
143012748|NCT02575807|515585668|FG001|Overall Study|Study terminated by Sponsor|1|||
143012749|NCT02575807|515585669|FG002|Overall Study|Study terminated by Sponsor|7|||
143012750|NCT02575807|515585670|FG003|Overall Study|Study terminated by Sponsor|0|||
143012751|NCT02575807|515585671|FG004|Overall Study|Study terminated by Sponsor|1|||
143012752|NCT02575807|515585667|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
143012753|NCT02575807|515585668|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
143012754|NCT02575807|515585669|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
143012755|NCT02575807|515585670|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
143012756|NCT02575807|515585671|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
143012757|NCT02575807|515585667|FG000|Overall Study|Terminated due to physician decision|0|||
143012758|NCT02575807|515585668|FG001|Overall Study|Terminated due to physician decision|0|||
143012759|NCT02575807|515585669|FG002|Overall Study|Terminated due to physician decision|1|||
143012760|NCT02575807|515585670|FG003|Overall Study|Terminated due to physician decision|0|||
143012761|NCT02575807|515585671|FG004|Overall Study|Terminated due to physician decision|0|||
143012762|NCT02575807|515585667|FG000|Overall Study|Subject ineligible - medical implant|0|||
143012763|NCT02575807|515585668|FG001|Overall Study|Subject ineligible - medical implant|0|||
143012764|NCT02575807|515585669|FG002|Overall Study|Subject ineligible - medical implant|0|||
143012765|NCT02575807|515585670|FG003|Overall Study|Subject ineligible - medical implant|1|||
143012766|NCT02575807|515585671|FG004|Overall Study|Subject ineligible - medical implant|0|||
143012767|NCT02575807|515585667|FG000|Overall Study|Withdrawal by Subject|0|||
143012768|NCT02575807|515585668|FG001|Overall Study|Withdrawal by Subject|0|||
143012769|NCT02575807|515585669|FG002|Overall Study|Withdrawal by Subject|1|||
143012770|NCT02575807|515585670|FG003|Overall Study|Withdrawal by Subject|1|||
143012771|NCT02575807|515585671|FG004|Overall Study|Withdrawal by Subject|2|||
143012772|NCT03014570|515585672|FG000|Overall Study|COVID-19 Restrictions|38|||
143012773|NCT03014570|515585673|FG001|Overall Study|COVID-19 Restrictions|24|||
143012774|NCT03014570|515585672|FG000|Overall Study|Death|70|||
143012775|NCT03014570|515585673|FG001|Overall Study|Death|79|||
143012776|NCT03014570|515585672|FG000|Overall Study|Transfer from facility|11|||
143012777|NCT03014570|515585673|FG001|Overall Study|Transfer from facility|14|||
143012778|NCT03014570|515585672|FG000|Overall Study|Hospitalized|5|||
143012779|NCT03014570|515585673|FG001|Overall Study|Hospitalized|3|||
143012780|NCT03014570|515585672|FG000|Overall Study|Transfer within facility|1|||
143012781|NCT03014570|515585673|FG001|Overall Study|Transfer within facility|0|||
143012782|NCT03014570|515585672|FG000|Overall Study|Site refusal|0|||
143012783|NCT03014570|515585673|FG001|Overall Study|Site refusal|11|||
143012784|NCT01154673|515585679|FG000|Overall Study|Lost to Follow-up|1|||
143012785|NCT01154673|515585680|FG001|Overall Study|Lost to Follow-up|0|||
143012786|NCT01154673|515585679|FG000|Overall Study|moved out of province|1|||
143012787|NCT01154673|515585680|FG001|Overall Study|moved out of province|0|||
143012788|NCT00478673|515585681|FG000|30-Days Post-Procedure|Death|2|||
143012789|NCT00478673|515585681|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
143012790|NCT00478673|515585681|FG000|30-Days Post-Procedure|Missed Visit|7|||
143012791|NCT00478673|515585681|FG000|12-Months Post-Procedure|Death|23|||
143012792|NCT00478673|515585681|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
143012793|NCT00478673|515585681|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
143012794|NCT00478673|515585681|FG000|12-Months Post-Procedure|Missed Visit|25|||
143012795|NCT00478673|515585681|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
143012796|NCT02032823|515585685|FG000|Overall Study|Death|75|||
143012797|NCT02032823|515585686|FG001|Overall Study|Death|109|||
143012798|NCT02032823|515585685|FG000|Overall Study|Lost to Follow-up|18|||
143012799|NCT02032823|515585686|FG001|Overall Study|Lost to Follow-up|17|||
143012800|NCT02032823|515585685|FG000|Overall Study|Withdrawal by Subject|70|||
143012801|NCT02032823|515585686|FG001|Overall Study|Withdrawal by Subject|53|||
143012802|NCT02032823|515585685|FG000|Overall Study|Ongoing study at data cut-off|755|||
143012803|NCT02032823|515585686|FG001|Overall Study|Ongoing study at data cut-off|731|||
143012804|NCT02032823|515585685|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
143012805|NCT02032823|515585686|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
143012806|NCT03889197|515585687|FG000|Overall Study|Withdrawal by Subject|1|||
143012807|NCT03889197|515585688|FG001|Overall Study|Withdrawal by Subject|0|||
143012808|NCT03889197|515585687|FG000|Overall Study|Physician Decision|0|||
143012809|NCT03889197|515585688|FG001|Overall Study|Physician Decision|1|||
143462018|NCT02572843|517237594|FG000|Accrual|Brain metastasis retrospectively detected|1|||
143462019|NCT02572843|517237594|FG000|Neoadjuvant chemotherapy|Physician Decision|2|||
143462020|NCT02572843|517237594|FG000|Neoadjuvant chemotherapy|Starting subsequent treatment due progressive disease clinically assessed|1|||
143462021|NCT02572843|517237594|FG000|Neoadjuvant chemotherapy|Withdrawal by Subject|1|||
143462022|NCT02572843|517237594|FG000|Neoadjuvant chemotherapy|Progressive disease|1|||
143462023|NCT02572843|517237594|FG000|Neoadjuvant immunotherapy|Progressive disease|2|||
143462024|NCT02572843|517237594|FG000|Neoadjuvant immunotherapy|Withdrawal by Subject|1|||
143462025|NCT02572843|517237594|FG000|Neoadjuvant immunotherapy|General status and respiratory capacity diminution|1|||
143462026|NCT02572843|517237594|FG000|Surgery|lost to follow up|7|||
143462027|NCT02572843|517237594|FG000|Surgery|Death|1|||
143462028|NCT05227703|517237597|FG000|Overall Study|Adverse Event|2|||
143462029|NCT05227703|517237598|FG001|Overall Study|Adverse Event|6|||
143462030|NCT05227703|517237599|FG002|Overall Study|Adverse Event|4|||
143462031|NCT05227703|517237597|FG000|Overall Study|Lack of Efficacy|4|||
143462032|NCT05227703|517237598|FG001|Overall Study|Lack of Efficacy|0|||
143462033|NCT05227703|517237599|FG002|Overall Study|Lack of Efficacy|1|||
143462034|NCT05227703|517237597|FG000|Overall Study|Physician Decision|2|||
143462035|NCT05227703|517237598|FG001|Overall Study|Physician Decision|2|||
143462036|NCT05227703|517237599|FG002|Overall Study|Physician Decision|1|||
143462037|NCT05227703|517237597|FG000|Overall Study|Protocol Violation|2|||
143462038|NCT05227703|517237598|FG001|Overall Study|Protocol Violation|1|||
143462039|NCT05227703|517237599|FG002|Overall Study|Protocol Violation|0|||
143462040|NCT05227703|517237597|FG000|Overall Study|Withdrawal by Subject|17|||
143462041|NCT05227703|517237598|FG001|Overall Study|Withdrawal by Subject|26|||
143462042|NCT05227703|517237599|FG002|Overall Study|Withdrawal by Subject|32|||
143462043|NCT05227703|517237597|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
143462044|NCT05227703|517237598|FG001|Overall Study|Non-Compliance with Study Schedule|1|||
143462045|NCT05227703|517237599|FG002|Overall Study|Non-Compliance with Study Schedule|0|||
143462046|NCT05227703|517237597|FG000|Overall Study|Other|1|||
143462047|NCT05227703|517237598|FG001|Overall Study|Other|1|||
143462048|NCT05227703|517237599|FG002|Overall Study|Other|0|||
143462049|NCT03464097|517237604|FG000|Overall Study|Withdrawal by Subject|15|||
143462050|NCT03464097|517237605|FG001|Overall Study|Withdrawal by Subject|13|||
143462051|NCT03464097|517237606|FG002|Overall Study|Withdrawal by Subject|11|||
143462052|NCT03464097|517237604|FG000|Overall Study|Study terminated by sponsor|47|||
143462053|NCT03464097|517237605|FG001|Overall Study|Study terminated by sponsor|44|||
143462054|NCT03464097|517237606|FG002|Overall Study|Study terminated by sponsor|40|||
143462055|NCT03464097|517237604|FG000|Overall Study|Pregnancy|0|||
143462056|NCT03464097|517237605|FG001|Overall Study|Pregnancy|1|||
143462057|NCT03464097|517237606|FG002|Overall Study|Pregnancy|0|||
143462058|NCT03464097|517237604|FG000|Overall Study|Other reasons|5|||
143462059|NCT03464097|517237605|FG001|Overall Study|Other reasons|12|||
143462060|NCT03464097|517237606|FG002|Overall Study|Other reasons|14|||
143462061|NCT03464097|517237604|FG000|Overall Study|Lost to Follow-up|0|||
143462062|NCT03464097|517237605|FG001|Overall Study|Lost to Follow-up|1|||
143462063|NCT03464097|517237606|FG002|Overall Study|Lost to Follow-up|1|||
143462064|NCT03464097|517237604|FG000|Overall Study|Lack of Efficacy|11|||
143462065|NCT03464097|517237605|FG001|Overall Study|Lack of Efficacy|18|||
143462066|NCT03464097|517237606|FG002|Overall Study|Lack of Efficacy|30|||
143462067|NCT03464097|517237604|FG000|Overall Study|Death|1|||
143462068|NCT03464097|517237605|FG001|Overall Study|Death|0|||
143462069|NCT03464097|517237606|FG002|Overall Study|Death|0|||
143462070|NCT03464097|517237604|FG000|Overall Study|Adverse Event|13|||
143462071|NCT03464097|517237605|FG001|Overall Study|Adverse Event|6|||
143462072|NCT03464097|517237606|FG002|Overall Study|Adverse Event|8|||
143462073|NCT03035201|517237607|FG000|Overall Study|Death|9|||
143355354|NCT02061761|516845109|FG006|Overall Study|Participant no longer meets study criteria|0|||
143355355|NCT02061761|516845110|FG007|Overall Study|Participant no longer meets study criteria|0|||
143355356|NCT02061761|516845111|FG008|Overall Study|Participant no longer meets study criteria|1|||
143355357|NCT02061761|516845103|FG000|Overall Study|Other reasons|0|||
143355358|NCT02061761|516845104|FG001|Overall Study|Other reasons|0|||
143355359|NCT02061761|516845105|FG002|Overall Study|Other reasons|0|||
143355360|NCT02061761|516845106|FG003|Overall Study|Other reasons|0|||
143355361|NCT02061761|516845107|FG004|Overall Study|Other reasons|2|||
143355362|NCT02061761|516845108|FG005|Overall Study|Other reasons|0|||
143355363|NCT02061761|516845109|FG006|Overall Study|Other reasons|0|||
143462074|NCT03035201|517237608|FG001|Overall Study|Death|12|||
143462075|NCT03035201|517237609|FG002|Overall Study|Death|9|||
143462076|NCT03035201|517237610|FG003|Overall Study|Death|10|||
143462077|NCT03035201|517237607|FG000|Overall Study|Withdrawal by Subject|51|||
143462078|NCT03035201|517237608|FG001|Overall Study|Withdrawal by Subject|49|||
143462079|NCT03035201|517237609|FG002|Overall Study|Withdrawal by Subject|37|||
143355364|NCT02061761|516845110|FG007|Overall Study|Other reasons|0|||
143462080|NCT03035201|517237610|FG003|Overall Study|Withdrawal by Subject|46|||
143462081|NCT03035201|517237607|FG000|Overall Study|Lost to Follow-up|67|||
143462082|NCT03035201|517237608|FG001|Overall Study|Lost to Follow-up|51|||
143462083|NCT03035201|517237609|FG002|Overall Study|Lost to Follow-up|64|||
143462084|NCT03035201|517237610|FG003|Overall Study|Lost to Follow-up|69|||
143355365|NCT02061761|516845111|FG008|Overall Study|Other reasons|6|||
143355366|NCT01556763|516845118|FG000|Overall Study|Withdrawal by Subject|0|||
143355367|NCT01556763|516845119|FG001|Overall Study|Withdrawal by Subject|1|||
143355368|NCT01556763|516845120|FG002|Overall Study|Withdrawal by Subject|0|||
143355369|NCT02258464|516845121|FG000|Overall Study|Progressive disease (PD)|9|||
143355370|NCT02258464|516845122|FG001|Overall Study|Progressive disease (PD)|17|||
143355371|NCT02258464|516845121|FG000|Overall Study|Study drug never administered|1|||
143355372|NCT02258464|516845122|FG001|Overall Study|Study drug never administered|1|||
143355373|NCT02258464|516845121|FG000|Overall Study|AE not related to clinical PD|1|||
143355374|NCT02258464|516845122|FG001|Overall Study|AE not related to clinical PD|3|||
143355375|NCT02258464|516845121|FG000|Overall Study|Withdrawal by Subject|5|||
143355376|NCT02258464|516845122|FG001|Overall Study|Withdrawal by Subject|4|||
143355377|NCT02258464|516845121|FG000|Overall Study|AE related to clinical PD|1|||
143355378|NCT02258464|516845122|FG001|Overall Study|AE related to clinical PD|0|||
143355379|NCT02138747|516845123|FG000|Treatment Period 1|Adverse Event|10|||
143355380|NCT02138747|516845124|FG001|Treatment Period 1|Adverse Event|14|||
143355381|NCT02138747|516845125|FG002|Treatment Period 1|Adverse Event|2|||
143355382|NCT02138747|516845126|FG003|Treatment Period 1|Adverse Event|1|||
143355383|NCT02138747|516845123|FG000|Treatment Period 1|Lost to Follow-up|0|||
143355384|NCT02138747|516845124|FG001|Treatment Period 1|Lost to Follow-up|1|||
143355385|NCT02138747|516845125|FG002|Treatment Period 1|Lost to Follow-up|1|||
143355386|NCT02138747|516845126|FG003|Treatment Period 1|Lost to Follow-up|0|||
143355387|NCT02138747|516845123|FG000|Treatment Period 1|Protocol Violation|0|||
143355388|NCT02138747|516845124|FG001|Treatment Period 1|Protocol Violation|2|||
143355389|NCT02138747|516845125|FG002|Treatment Period 1|Protocol Violation|0|||
143355390|NCT02138747|516845126|FG003|Treatment Period 1|Protocol Violation|0|||
143355391|NCT02138747|516845123|FG000|Treatment Period 1|Withdrawal by Subject|8|||
143355392|NCT02138747|516845124|FG001|Treatment Period 1|Withdrawal by Subject|4|||
143355393|NCT02138747|516845125|FG002|Treatment Period 1|Withdrawal by Subject|1|||
143355394|NCT02138747|516845126|FG003|Treatment Period 1|Withdrawal by Subject|3|||
143355395|NCT02138747|516845123|FG000|Treatment Period 1|Other - Miscellaneous|2|||
143355396|NCT02138747|516845124|FG001|Treatment Period 1|Other - Miscellaneous|4|||
143355397|NCT02138747|516845125|FG002|Treatment Period 1|Other - Miscellaneous|0|||
143355398|NCT02138747|516845126|FG003|Treatment Period 1|Other - Miscellaneous|0|||
143012810|NCT03889197|515585687|FG000|Overall Study|met exclusion criteria|0|||
143012811|NCT03889197|515585688|FG001|Overall Study|met exclusion criteria|1|||
143012812|NCT03889197|515585687|FG000|Overall Study|Protocol Violation|1|||
143012813|NCT03889197|515585688|FG001|Overall Study|Protocol Violation|0|||
143012814|NCT05899218|515585689|FG000|Overall Study|Lost to Follow-up|2|||
143012815|NCT05899218|515585690|FG001|Overall Study|Lost to Follow-up|2|||
143012816|NCT05899218|515585689|FG000|Overall Study|deemed ineligible out of country|1|||
143012817|NCT05899218|515585690|FG001|Overall Study|deemed ineligible out of country|0|||
143012818|NCT05246111|515585691|FG000|Period 01|NOT ELIGIBLE IC5|1|||
143012819|NCT05246111|515585692|FG001|Period 01|NOT ELIGIBLE IC5|0|||
143012820|NCT03151226|515585693|FG000|Overall Study|Withdrawal by Subject|2|||
143012821|NCT03151226|515585693|FG000|Overall Study|not wear device correctly|1|||
143012822|NCT00285012|515585694|FG000|Assigned to Study Treatment (Tx)|Other|2|||
143012823|NCT00285012|515585695|FG001|Assigned to Study Treatment (Tx)|Other|3|||
143012824|NCT00285012|515585694|FG000|Received Study Tx|Death|2|||
143012825|NCT00285012|515585695|FG001|Received Study Tx|Death|1|||
143012826|NCT00285012|515585694|FG000|Received Study Tx|Adverse Event|5|||
143012827|NCT00285012|515585695|FG001|Received Study Tx|Adverse Event|11|||
143012828|NCT00285012|515585694|FG000|Received Study Tx|Lack of Efficacy|0|||
143012829|NCT00285012|515585695|FG001|Received Study Tx|Lack of Efficacy|3|||
143012830|NCT00285012|515585694|FG000|Received Study Tx|Lost to Follow-up|29|||
143012831|NCT00285012|515585695|FG001|Received Study Tx|Lost to Follow-up|31|||
143012832|NCT00285012|515585694|FG000|Received Study Tx|Withdrawal by Subject|31|||
143012833|NCT00285012|515585695|FG001|Received Study Tx|Withdrawal by Subject|43|||
143012834|NCT00285012|515585694|FG000|Received Study Tx|Other|5|||
143012835|NCT00285012|515585695|FG001|Received Study Tx|Other|5|||
143012836|NCT03594175|515585700|FG000|Overall Study|Not treated|8|||
143012837|NCT03594175|515585701|FG001|Overall Study|Not treated|1|||
143012838|NCT03594175|515585702|FG002|Overall Study|Not treated|5|||
143012839|NCT03594175|515585700|FG000|Overall Study|Adverse Event|3|||
143012840|NCT03594175|515585701|FG001|Overall Study|Adverse Event|0|||
143355399|NCT02138747|516845123|FG000|Treatment Period 2|Adverse Event|6|||
143355400|NCT02138747|516845124|FG001|Treatment Period 2|Adverse Event|3|||
143355401|NCT02138747|516845125|FG002|Treatment Period 2|Adverse Event|1|||
143355402|NCT02138747|516845126|FG003|Treatment Period 2|Adverse Event|1|||
143355403|NCT02138747|516845123|FG000|Treatment Period 2|Lost to Follow-up|2|||
143012841|NCT03594175|515585702|FG002|Overall Study|Adverse Event|0|||
143355404|NCT02138747|516845124|FG001|Treatment Period 2|Lost to Follow-up|0|||
143012842|NCT03594175|515585700|FG000|Overall Study|Withdrawal by Subject|3|||
143012843|NCT03594175|515585701|FG001|Overall Study|Withdrawal by Subject|0|||
143012844|NCT03594175|515585702|FG002|Overall Study|Withdrawal by Subject|0|||
143012845|NCT03594175|515585700|FG000|Overall Study|Protocol Violation|2|||
143462085|NCT05572021|517237617|FG000|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|5|||
143462086|NCT05572021|517237618|FG001|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|0|||
143462087|NCT04576455|517237619|FG000|Overall Study|Ongoing in the Study|48|||
143462088|NCT04576455|517237620|FG001|Overall Study|Ongoing in the Study|58|||
143462089|NCT04576455|517237619|FG000|Overall Study|Death|83|||
143462090|NCT04576455|517237620|FG001|Overall Study|Death|77|||
143462091|NCT04576455|517237619|FG000|Overall Study|Lost to Follow-up|4|||
143462092|NCT04576455|517237620|FG001|Overall Study|Lost to Follow-up|5|||
143462093|NCT04576455|517237619|FG000|Overall Study|Withdrawal by Subject|16|||
143462094|NCT04576455|517237620|FG001|Overall Study|Withdrawal by Subject|12|||
143462095|NCT03432260|517237621|FG000|Overall Study|Lost to Follow-up|1|||
143462096|NCT03432260|517237622|FG001|Overall Study|Lost to Follow-up|1|||
143462097|NCT03432260|517237623|FG002|Overall Study|Lost to Follow-up|0|||
143462098|NCT03432260|517237624|FG003|Overall Study|Lost to Follow-up|0|||
143462099|NCT03432260|517237625|FG004|Overall Study|Lost to Follow-up|1|||
143462100|NCT02186847|517237626|FG000|Overall Study|Protocol Violation|3|||
143462101|NCT02186847|517237627|FG001|Overall Study|Protocol Violation|0|||
143462102|NCT04873232|517237631|FG000|Overall Study|Lost to Follow-up|1|||
143462103|NCT04873232|517237632|FG001|Overall Study|Lost to Follow-up|4|||
143462104|NCT04873232|517237631|FG000|Overall Study|Withdrawal by Subject|1|||
143462105|NCT04873232|517237632|FG001|Overall Study|Withdrawal by Subject|0|||
143462106|NCT03170349|517237633|FG000|At 30 Days Follow-up (±7 Days Window)|Death|1|||
143462107|NCT03170349|517237633|FG000|At 6 Months Follow-up (±30 Days Window)|Death|3|||
143462108|NCT03170349|517237633|FG000|At 6 Months Follow-up (±30 Days Window)|Withdrawal by Subject|1|||
143462109|NCT03170349|517237633|FG000|At 6 Months Follow-up (±30 Days Window)|Exited for Other Reasons|5|||
143462110|NCT03170349|517237633|FG000|At 1 Year Follow-up (±45 Days Window)|Death|6|||
143462111|NCT03170349|517237633|FG000|At 1 Year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
143462112|NCT03170349|517237633|FG000|At 2 Year Follow-up (±45 Days Window)|Death|13|||
143462113|NCT03170349|517237633|FG000|At 2 Year Follow-up (±45 Days Window)|Withdrawal by Subject|1|||
143462114|NCT03170349|517237633|FG000|At 2 Year Follow-up (±45 Days Window)|Missed Visit|4|||
143462115|NCT03170349|517237633|FG000|At 3 Year Follow-up (±45 Days Window)|Death|10|||
143462116|NCT03170349|517237633|FG000|At 3 Year Follow-up (±45 Days Window)|Lost to Follow-up|2|||
143462117|NCT03170349|517237633|FG000|At 3 Year Follow-up (±45 Days Window)|Withdrawal by Subject|2|||
143462118|NCT03170349|517237633|FG000|At 3 Year Follow-up (±45 Days Window)|Missed Visit|2|||
143462119|NCT03170349|517237633|FG000|At 4-year Follow-up (±45 Days Window)|Death|13|||
143462120|NCT03170349|517237633|FG000|At 4-year Follow-up (±45 Days Window)|Missed Visit|2|||
143462121|NCT03170349|517237633|FG000|At 4-year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
143462122|NCT01036763|517239259|FG000|Overall Study|Adverse Event|25|||
143462123|NCT01036763|517239259|FG000|Overall Study|Lost to Follow-up|28|||
143462124|NCT01036763|517239259|FG000|Overall Study|Other reason (not specified)|40|||
143462125|NCT04812548|517239260|FG000|Overall Study|Adverse Event|2|||
143462126|NCT04812548|517239261|FG001|Overall Study|Adverse Event|7|||
143462127|NCT04812548|517239260|FG000|Overall Study|HSCT Planned|2|||
143462128|NCT04812548|517239261|FG001|Overall Study|HSCT Planned|3|||
143462129|NCT04812548|517239260|FG000|Overall Study|Progressive Disease|0|||
143462130|NCT04812548|517239261|FG001|Overall Study|Progressive Disease|2|||
143462131|NCT04812548|517239260|FG000|Overall Study|Death|0|||
143462132|NCT04812548|517239261|FG001|Overall Study|Death|1|||
143462133|NCT04812548|517239260|FG000|Overall Study|Post Study Access to Treatment|0|||
143462134|NCT04812548|517239261|FG001|Overall Study|Post Study Access to Treatment|1|||
143462135|NCT04812548|517239260|FG000|Overall Study|Withdrawal by Subject|0|||
143462136|NCT04812548|517239261|FG001|Overall Study|Withdrawal by Subject|1|||
143462137|NCT04812548|517239260|FG000|Overall Study|Physician Decision|1|||
143462138|NCT04812548|517239261|FG001|Overall Study|Physician Decision|0|||
143462139|NCT03938545|517239263|FG000|Overall Study|Lost to Follow-up|0|||
143462140|NCT03938545|517239264|FG001|Overall Study|Lost to Follow-up|0|||
143462141|NCT03938545|517239265|FG002|Overall Study|Lost to Follow-up|0|||
143462142|NCT03938545|517239266|FG003|Overall Study|Lost to Follow-up|1|||
143462143|NCT03938545|517239263|FG000|Overall Study|Non-compliance with study drug|0|||
143462144|NCT03938545|517239264|FG001|Overall Study|Non-compliance with study drug|0|||
143462145|NCT03938545|517239265|FG002|Overall Study|Non-compliance with study drug|1|||
143462146|NCT03938545|517239266|FG003|Overall Study|Non-compliance with study drug|0|||
143462147|NCT03938545|517239263|FG000|Overall Study|Pregnancy|1|||
143355405|NCT02138747|516845125|FG002|Treatment Period 2|Lost to Follow-up|0|||
143355406|NCT02138747|516845126|FG003|Treatment Period 2|Lost to Follow-up|0|||
143355407|NCT02138747|516845123|FG000|Treatment Period 2|Protocol Violation|1|||
143355408|NCT02138747|516845124|FG001|Treatment Period 2|Protocol Violation|0|||
143355409|NCT02138747|516845125|FG002|Treatment Period 2|Protocol Violation|0|||
143355410|NCT02138747|516845126|FG003|Treatment Period 2|Protocol Violation|0|||
143462148|NCT03938545|517239264|FG001|Overall Study|Pregnancy|0|||
143462149|NCT03938545|517239265|FG002|Overall Study|Pregnancy|0|||
143462150|NCT03938545|517239266|FG003|Overall Study|Pregnancy|0|||
143462151|NCT03938545|517239263|FG000|Overall Study|Study terminated by sponsor|6|||
143462152|NCT03938545|517239264|FG001|Overall Study|Study terminated by sponsor|4|||
143462153|NCT03938545|517239265|FG002|Overall Study|Study terminated by sponsor|2|||
143462154|NCT03938545|517239266|FG003|Overall Study|Study terminated by sponsor|4|||
143462155|NCT03938545|517239263|FG000|Overall Study|Withdrawal by Subject|0|||
143462156|NCT03938545|517239264|FG001|Overall Study|Withdrawal by Subject|1|||
143462157|NCT03938545|517239265|FG002|Overall Study|Withdrawal by Subject|0|||
143462158|NCT03938545|517239266|FG003|Overall Study|Withdrawal by Subject|0|||
143462159|NCT03938545|517239263|FG000|Overall Study|Adverse Event|1|||
143462160|NCT03938545|517239264|FG001|Overall Study|Adverse Event|0|||
143462161|NCT03938545|517239265|FG002|Overall Study|Adverse Event|0|||
143462162|NCT03938545|517239266|FG003|Overall Study|Adverse Event|0|||
143462163|NCT00320541|517239267|FG000|Overall Study|Adverse Event|21|||
143462164|NCT00320541|517239268|FG001|Overall Study|Adverse Event|19|||
143462165|NCT00320541|517239267|FG000|Overall Study|Protocol Violation|0|||
143462166|NCT00320541|517239268|FG001|Overall Study|Protocol Violation|1|||
143462167|NCT00320541|517239267|FG000|Overall Study|Withdrawal by Subject|12|||
143462168|NCT00320541|517239268|FG001|Overall Study|Withdrawal by Subject|16|||
143462169|NCT00320541|517239267|FG000|Overall Study|Physician Decision|9|||
143462170|NCT00320541|517239268|FG001|Overall Study|Physician Decision|13|||
143462171|NCT00320541|517239267|FG000|Overall Study|Other|3|||
143462172|NCT00320541|517239268|FG001|Overall Study|Other|4|||
143462173|NCT00320541|517239267|FG000|Overall Study|Sponsor Decision|2|||
143462174|NCT00320541|517239268|FG001|Overall Study|Sponsor Decision|1|||
143462175|NCT00320541|517239267|FG000|Overall Study|Death due to Study Disease|1|||
143462176|NCT00320541|517239268|FG001|Overall Study|Death due to Study Disease|3|||
143462177|NCT00320541|517239267|FG000|Overall Study|Death due to Adverse Event(s)|1|||
143462178|NCT00320541|517239268|FG001|Overall Study|Death due to Adverse Event(s)|0|||
143462179|NCT00320541|517239267|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
143462180|NCT00320541|517239268|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
143462181|NCT02401867|517239269|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
143462182|NCT02401867|517239269|FG000|Analysis|Cervical assay could not be conducted|9|||
143462183|NCT01640054|517239270|FG000|Overall Study|Study-specific disc criteria|1|||
143462184|NCT01640054|517239270|FG000|Overall Study|Lack of Efficacy|3|||
143462185|NCT01640054|517239270|FG000|Overall Study|Adverse Event|2|||
143462186|NCT01206777|517239272|FG000|Overall Study|Death|1|||
143462187|NCT01206777|517239272|FG000|Overall Study|Adverse Event|1|||
143462188|NCT02080221|517239275|FG000|Overall Study|Withdrawal by Subject|1|||
143462189|NCT02080221|517239275|FG000|Overall Study|Clinical Progression of Disease|1|||
143462190|NCT03184870|517239279|FG000|Initial Treatment|Death|6|||
143462191|NCT03184870|517239280|FG001|Initial Treatment|Death|6|||
143462192|NCT03184870|517239281|FG002|Initial Treatment|Death|8|||
143462193|NCT03184870|517239282|FG003|Initial Treatment|Death|8|||
143462194|NCT03184870|517239283|FG004|Initial Treatment|Death|6|||
143462195|NCT03184870|517239284|FG005|Initial Treatment|Death|6|||
143462196|NCT03184870|517239285|FG006|Initial Treatment|Death|6|||
143462197|NCT03184870|517239286|FG007|Initial Treatment|Death|7|||
143462198|NCT03184870|517239287|FG008|Initial Treatment|Death|1|||
143462199|NCT03184870|517239288|FG009|Initial Treatment|Death|2|||
143462200|NCT03184870|517239289|FG010|Initial Treatment|Death|26|||
143462201|NCT03184870|517239290|FG011|Initial Treatment|Death|28|||
143462202|NCT03184870|517239291|FG012|Initial Treatment|Death|10|||
143462203|NCT03184870|517239292|FG013|Initial Treatment|Death|33|||
143462204|NCT03184870|517239293|FG014|Initial Treatment|Death|34|||
143462205|NCT03184870|517239294|FG015|Initial Treatment|Death|26|||
143462206|NCT03184870|517239295|FG016|Initial Treatment|Death|20|||
143462207|NCT03184870|517239296|FG017|Initial Treatment|Death|18|||
143462208|NCT03184870|517239279|FG000|Initial Treatment|Other Reasons|2|||
143355411|NCT02138747|516845123|FG000|Treatment Period 2|Withdrawal by Subject|5|||
143355412|NCT02138747|516845124|FG001|Treatment Period 2|Withdrawal by Subject|4|||
143355413|NCT02138747|516845125|FG002|Treatment Period 2|Withdrawal by Subject|1|||
143355414|NCT02138747|516845126|FG003|Treatment Period 2|Withdrawal by Subject|2|||
143355415|NCT02138747|516845123|FG000|Treatment Period 2|Other - Miscellaneous|3|||
143355416|NCT02138747|516845124|FG001|Treatment Period 2|Other - Miscellaneous|0|||
143355417|NCT02138747|516845125|FG002|Treatment Period 2|Other - Miscellaneous|0|||
143355418|NCT02138747|516845126|FG003|Treatment Period 2|Other - Miscellaneous|0|||
143355419|NCT00932646|516845127|FG000|Overall Study|Adverse Event|2|||
143355420|NCT00932646|516845128|FG001|Overall Study|Adverse Event|1|||
143462209|NCT03184870|517239280|FG001|Initial Treatment|Other Reasons|2|||
143462210|NCT03184870|517239281|FG002|Initial Treatment|Other Reasons|0|||
143462211|NCT03184870|517239282|FG003|Initial Treatment|Other Reasons|1|||
143462212|NCT03184870|517239283|FG004|Initial Treatment|Other Reasons|0|||
143462213|NCT03184870|517239284|FG005|Initial Treatment|Other Reasons|0|||
143462214|NCT03184870|517239285|FG006|Initial Treatment|Other Reasons|0|||
143462215|NCT03184870|517239286|FG007|Initial Treatment|Other Reasons|2|||
143462216|NCT03184870|517239287|FG008|Initial Treatment|Other Reasons|0|||
143462217|NCT03184870|517239288|FG009|Initial Treatment|Other Reasons|0|||
143462218|NCT03184870|517239289|FG010|Initial Treatment|Other Reasons|4|||
143462219|NCT03184870|517239290|FG011|Initial Treatment|Other Reasons|2|||
143462220|NCT03184870|517239291|FG012|Initial Treatment|Other Reasons|2|||
143462221|NCT03184870|517239292|FG013|Initial Treatment|Other Reasons|0|||
143462222|NCT03184870|517239293|FG014|Initial Treatment|Other Reasons|0|||
143462223|NCT03184870|517239294|FG015|Initial Treatment|Other Reasons|1|||
143462224|NCT03184870|517239295|FG016|Initial Treatment|Other Reasons|0|||
143462225|NCT03184870|517239296|FG017|Initial Treatment|Other Reasons|2|||
143462226|NCT03184870|517239279|FG000|Initial Treatment|Lost to Follow-up|2|||
143462227|NCT03184870|517239280|FG001|Initial Treatment|Lost to Follow-up|0|||
143462228|NCT03184870|517239281|FG002|Initial Treatment|Lost to Follow-up|0|||
143462229|NCT03184870|517239282|FG003|Initial Treatment|Lost to Follow-up|1|||
143462230|NCT03184870|517239283|FG004|Initial Treatment|Lost to Follow-up|1|||
143462231|NCT03184870|517239284|FG005|Initial Treatment|Lost to Follow-up|1|||
143462232|NCT03184870|517239285|FG006|Initial Treatment|Lost to Follow-up|0|||
143462233|NCT03184870|517239286|FG007|Initial Treatment|Lost to Follow-up|2|||
143462234|NCT03184870|517239287|FG008|Initial Treatment|Lost to Follow-up|0|||
143462235|NCT03184870|517239288|FG009|Initial Treatment|Lost to Follow-up|0|||
143462236|NCT03184870|517239289|FG010|Initial Treatment|Lost to Follow-up|2|||
143462237|NCT03184870|517239290|FG011|Initial Treatment|Lost to Follow-up|0|||
143462238|NCT03184870|517239291|FG012|Initial Treatment|Lost to Follow-up|2|||
143462239|NCT03184870|517239292|FG013|Initial Treatment|Lost to Follow-up|2|||
143355421|NCT00932646|516845129|FG002|Overall Study|Adverse Event|1|||
143355422|NCT00932646|516845130|FG003|Overall Study|Adverse Event|1|||
143355423|NCT00932646|516845127|FG000|Overall Study|Lost to Follow-up|2|||
143355424|NCT00932646|516845128|FG001|Overall Study|Lost to Follow-up|1|||
143355425|NCT00932646|516845129|FG002|Overall Study|Lost to Follow-up|0|||
143355426|NCT00932646|516845130|FG003|Overall Study|Lost to Follow-up|0|||
143355427|NCT00932646|516845127|FG000|Overall Study|Withdrawal by Subject|1|||
143355428|NCT00932646|516845128|FG001|Overall Study|Withdrawal by Subject|1|||
143355429|NCT00932646|516845129|FG002|Overall Study|Withdrawal by Subject|3|||
143355430|NCT00932646|516845130|FG003|Overall Study|Withdrawal by Subject|0|||
143355431|NCT04170296|516845131|FG000|Overall Study|Adverse Event|1|||
143355432|NCT04170296|516845132|FG001|Overall Study|Adverse Event|0|||
143355433|NCT04170296|516845131|FG000|Overall Study|Withdrawal by Subject|3|||
143355434|NCT04170296|516845132|FG001|Overall Study|Withdrawal by Subject|2|||
143355435|NCT04170296|516845131|FG000|Overall Study|Lost to Follow-up|4|||
143355436|NCT04170296|516845132|FG001|Overall Study|Lost to Follow-up|2|||
143355437|NCT02611830|516845133|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
143355438|NCT02611830|516845134|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
143355439|NCT02611830|516845135|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
143355440|NCT02611830|516845136|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
143355441|NCT02611830|516845133|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
143355442|NCT02611830|516845134|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
143355443|NCT02611830|516845135|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
143355444|NCT02611830|516845136|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
143355445|NCT02611830|516845133|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
143355446|NCT02611830|516845134|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
143355447|NCT02611830|516845135|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
143355448|NCT02611830|516845136|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
143355449|NCT02611830|516845133|FG000|OL Induction Phase|Lack of Efficacy|9|||
143355450|NCT02611830|516845134|FG001|OL Induction Phase|Lack of Efficacy|0|||
143355451|NCT02611830|516845135|FG002|OL Induction Phase|Lack of Efficacy|0|||
143355452|NCT02611830|516845136|FG003|OL Induction Phase|Lack of Efficacy|0|||
143355453|NCT02611830|516845133|FG000|OL Induction Phase|Reason not specified|3|||
143355454|NCT02611830|516845134|FG001|OL Induction Phase|Reason not specified|0|||
143355455|NCT02611830|516845135|FG002|OL Induction Phase|Reason not specified|0|||
143355456|NCT02611830|516845136|FG003|OL Induction Phase|Reason not specified|0|||
143355457|NCT02611830|516845133|FG000|Maintenance Phase|Lack of Efficacy|0|||
143355458|NCT02611830|516845134|FG001|Maintenance Phase|Lack of Efficacy|29|||
143355459|NCT02611830|516845135|FG002|Maintenance Phase|Lack of Efficacy|18|||
143355460|NCT02611830|516845136|FG003|Maintenance Phase|Lack of Efficacy|6|||
143355461|NCT02611830|516845133|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
143355462|NCT02611830|516845134|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
143355463|NCT02611830|516845135|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
143355464|NCT02611830|516845136|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
143355465|NCT02611830|516845133|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
143355466|NCT02611830|516845134|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
143355467|NCT02611830|516845135|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
143355468|NCT02611830|516845136|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
143355469|NCT02611830|516845133|FG000|Maintenance Phase|Lost to Follow-up|0|||
143355470|NCT02611830|516845134|FG001|Maintenance Phase|Lost to Follow-up|0|||
143462240|NCT03184870|517239293|FG014|Initial Treatment|Lost to Follow-up|0|||
143462241|NCT03184870|517239294|FG015|Initial Treatment|Lost to Follow-up|0|||
143462242|NCT03184870|517239295|FG016|Initial Treatment|Lost to Follow-up|2|||
143355471|NCT02611830|516845135|FG002|Maintenance Phase|Lost to Follow-up|0|||
143355472|NCT02611830|516845136|FG003|Maintenance Phase|Lost to Follow-up|1|||
143355473|NCT02611830|516845133|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
143355474|NCT02611830|516845134|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
143462243|NCT03184870|517239296|FG017|Initial Treatment|Lost to Follow-up|2|||
143462244|NCT03184870|517239279|FG000|Initial Treatment|Withdrawal by Subject|0|||
143462245|NCT03184870|517239280|FG001|Initial Treatment|Withdrawal by Subject|0|||
143462246|NCT03184870|517239281|FG002|Initial Treatment|Withdrawal by Subject|2|||
143462247|NCT03184870|517239282|FG003|Initial Treatment|Withdrawal by Subject|1|||
143462248|NCT03184870|517239283|FG004|Initial Treatment|Withdrawal by Subject|1|||
143462249|NCT03184870|517239284|FG005|Initial Treatment|Withdrawal by Subject|0|||
143462250|NCT03184870|517239285|FG006|Initial Treatment|Withdrawal by Subject|1|||
143462251|NCT03184870|517239286|FG007|Initial Treatment|Withdrawal by Subject|0|||
143462252|NCT03184870|517239287|FG008|Initial Treatment|Withdrawal by Subject|0|||
143462253|NCT03184870|517239288|FG009|Initial Treatment|Withdrawal by Subject|0|||
143462254|NCT03184870|517239289|FG010|Initial Treatment|Withdrawal by Subject|0|||
143462255|NCT03184870|517239290|FG011|Initial Treatment|Withdrawal by Subject|2|||
143462256|NCT03184870|517239291|FG012|Initial Treatment|Withdrawal by Subject|3|||
143462257|NCT03184870|517239292|FG013|Initial Treatment|Withdrawal by Subject|0|||
143462258|NCT03184870|517239293|FG014|Initial Treatment|Withdrawal by Subject|1|||
143462259|NCT03184870|517239294|FG015|Initial Treatment|Withdrawal by Subject|5|||
143462260|NCT03184870|517239295|FG016|Initial Treatment|Withdrawal by Subject|2|||
143462261|NCT03184870|517239296|FG017|Initial Treatment|Withdrawal by Subject|2|||
143462262|NCT03184870|517239279|FG000|Initial Treatment|Moved to crossover treatment|0|||
143462263|NCT03184870|517239280|FG001|Initial Treatment|Moved to crossover treatment|0|||
143462264|NCT03184870|517239281|FG002|Initial Treatment|Moved to crossover treatment|0|||
143462265|NCT03184870|517239282|FG003|Initial Treatment|Moved to crossover treatment|0|||
143462266|NCT03184870|517239283|FG004|Initial Treatment|Moved to crossover treatment|0|||
143462267|NCT03184870|517239284|FG005|Initial Treatment|Moved to crossover treatment|0|||
143462268|NCT03184870|517239285|FG006|Initial Treatment|Moved to crossover treatment|0|||
143462269|NCT03184870|517239286|FG007|Initial Treatment|Moved to crossover treatment|0|||
143462270|NCT03184870|517239287|FG008|Initial Treatment|Moved to crossover treatment|0|||
143462271|NCT03184870|517239288|FG009|Initial Treatment|Moved to crossover treatment|0|||
143462272|NCT03184870|517239289|FG010|Initial Treatment|Moved to crossover treatment|0|||
143462273|NCT03184870|517239290|FG011|Initial Treatment|Moved to crossover treatment|0|||
143462274|NCT03184870|517239291|FG012|Initial Treatment|Moved to crossover treatment|9|||
143462275|NCT03184870|517239292|FG013|Initial Treatment|Moved to crossover treatment|0|||
143462276|NCT03184870|517239293|FG014|Initial Treatment|Moved to crossover treatment|0|||
143462277|NCT03184870|517239294|FG015|Initial Treatment|Moved to crossover treatment|0|||
143462278|NCT03184870|517239295|FG016|Initial Treatment|Moved to crossover treatment|0|||
143462279|NCT03184870|517239296|FG017|Initial Treatment|Moved to crossover treatment|0|||
143462280|NCT03184870|517239279|FG000|Crossover Treatment|Other reasons|0|||
143462281|NCT03184870|517239280|FG001|Crossover Treatment|Other reasons|0|||
143462282|NCT03184870|517239281|FG002|Crossover Treatment|Other reasons|0|||
143462283|NCT03184870|517239282|FG003|Crossover Treatment|Other reasons|0|||
143462284|NCT03184870|517239283|FG004|Crossover Treatment|Other reasons|0|||
143462285|NCT03184870|517239284|FG005|Crossover Treatment|Other reasons|0|||
143462286|NCT03184870|517239285|FG006|Crossover Treatment|Other reasons|0|||
143462287|NCT03184870|517239286|FG007|Crossover Treatment|Other reasons|0|||
143462288|NCT03184870|517239287|FG008|Crossover Treatment|Other reasons|0|||
143462289|NCT03184870|517239288|FG009|Crossover Treatment|Other reasons|0|||
143462290|NCT03184870|517239289|FG010|Crossover Treatment|Other reasons|0|||
143462291|NCT03184870|517239290|FG011|Crossover Treatment|Other reasons|0|||
143462292|NCT03184870|517239291|FG012|Crossover Treatment|Other reasons|0|||
143462293|NCT03184870|517239292|FG013|Crossover Treatment|Other reasons|0|||
143462294|NCT03184870|517239293|FG014|Crossover Treatment|Other reasons|0|||
143462295|NCT03184870|517239294|FG015|Crossover Treatment|Other reasons|0|||
143462296|NCT03184870|517239295|FG016|Crossover Treatment|Other reasons|0|||
143462297|NCT03184870|517239296|FG017|Crossover Treatment|Other reasons|2|||
143462298|NCT03184870|517239279|FG000|Crossover Treatment|Death|0|||
143462299|NCT03184870|517239280|FG001|Crossover Treatment|Death|0|||
143462300|NCT03184870|517239281|FG002|Crossover Treatment|Death|0|||
143462301|NCT03184870|517239282|FG003|Crossover Treatment|Death|0|||
143462302|NCT03184870|517239283|FG004|Crossover Treatment|Death|0|||
143462303|NCT03184870|517239284|FG005|Crossover Treatment|Death|0|||
143462304|NCT03184870|517239285|FG006|Crossover Treatment|Death|0|||
143462305|NCT03184870|517239286|FG007|Crossover Treatment|Death|0|||
143462306|NCT03184870|517239287|FG008|Crossover Treatment|Death|0|||
143462307|NCT03184870|517239288|FG009|Crossover Treatment|Death|0|||
143462308|NCT03184870|517239289|FG010|Crossover Treatment|Death|0|||
143462309|NCT03184870|517239290|FG011|Crossover Treatment|Death|0|||
143462310|NCT03184870|517239291|FG012|Crossover Treatment|Death|0|||
143462311|NCT03184870|517239292|FG013|Crossover Treatment|Death|0|||
143462312|NCT03184870|517239293|FG014|Crossover Treatment|Death|0|||
143462313|NCT03184870|517239294|FG015|Crossover Treatment|Death|0|||
143462314|NCT03184870|517239295|FG016|Crossover Treatment|Death|0|||
143462315|NCT03184870|517239296|FG017|Crossover Treatment|Death|7|||
143462316|NCT03786783|517239297|FG000|Overall Study|Death|1|||
143462317|NCT03786783|517239297|FG000|Overall Study|Physician Decision|6|||
143462318|NCT03786783|517239297|FG000|Overall Study|Withdrawal by Subject|2|||
143462319|NCT03786783|517239297|FG000|Overall Study|Disease Progression|7|||
143462320|NCT03786783|517239297|FG000|Overall Study|Patient/Parent Refusal|4|||
143355475|NCT02611830|516845135|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
143012846|NCT03594175|515585701|FG001|Overall Study|Protocol Violation|2|||
143012847|NCT03594175|515585702|FG002|Overall Study|Protocol Violation|2|||
143012848|NCT01020773|515587959|FG000|Overall Study|Withdrawal by Subject|4|||
143012849|NCT01020773|515587960|FG001|Overall Study|Withdrawal by Subject|3|||
143012850|NCT01788163|515587961|FG000|Overall Study|Other|53|||
143012851|NCT01788163|515587962|FG001|Overall Study|Other|0|||
143012852|NCT01788163|515587963|FG002|Overall Study|Other|0|||
143012853|NCT01788163|515587964|FG003|Overall Study|Other|0|||
143012854|NCT01788163|515587965|FG004|Overall Study|Other|0|||
143012855|NCT01788163|515587966|FG005|Overall Study|Other|7|||
143012856|NCT01788163|515587967|FG006|Overall Study|Other|1|||
143012857|NCT01788163|515587968|FG007|Overall Study|Other|48|||
143012858|NCT01788163|515587969|FG008|Overall Study|Other|15|||
143012859|NCT01788163|515587961|FG000|Overall Study|Withdrawal by Subject|2|||
143012860|NCT01788163|515587962|FG001|Overall Study|Withdrawal by Subject|0|||
143012861|NCT01788163|515587963|FG002|Overall Study|Withdrawal by Subject|0|||
143012862|NCT01788163|515587964|FG003|Overall Study|Withdrawal by Subject|0|||
143012863|NCT01788163|515587965|FG004|Overall Study|Withdrawal by Subject|0|||
143012864|NCT01788163|515587966|FG005|Overall Study|Withdrawal by Subject|0|||
143012865|NCT01788163|515587967|FG006|Overall Study|Withdrawal by Subject|0|||
143012866|NCT01788163|515587968|FG007|Overall Study|Withdrawal by Subject|0|||
143012867|NCT01788163|515587969|FG008|Overall Study|Withdrawal by Subject|1|||
143012868|NCT00545441|515587970|FG000|Overall Study|Fistula draining at 6 months|2|||
143012869|NCT00545441|515587971|FG001|Overall Study|Fistula draining at 6 months|4|||
143012870|NCT00545441|515587970|FG000|Overall Study|Lost to Follow-up|9|||
143012871|NCT00545441|515587971|FG001|Overall Study|Lost to Follow-up|5|||
143012872|NCT00545441|515587970|FG000|Overall Study|Technical failure|0|||
143012873|NCT00545441|515587971|FG001|Overall Study|Technical failure|1|||
143012874|NCT00545441|515587970|FG000|Overall Study|Withdrawal by Subject|1|||
143012875|NCT00545441|515587971|FG001|Overall Study|Withdrawal by Subject|1|||
143012876|NCT00545441|515587970|FG000|Overall Study|Persistence or recurrence of fistula|5|||
143012877|NCT00545441|515587971|FG001|Overall Study|Persistence or recurrence of fistula|2|||
143012878|NCT00545441|515587970|FG000|Overall Study|Patients were not treated|1|||
143012879|NCT00545441|515587971|FG001|Overall Study|Patients were not treated|3|||
143012880|NCT03911960|515587972|FG000|Overall Study|Lost to Follow-up|5|||
143012881|NCT03911960|515587973|FG001|Overall Study|Lost to Follow-up|3|||
143012882|NCT00391092|515587974|FG000|Overall Study|Death|78|||
143012883|NCT00391092|515587975|FG001|Overall Study|Death|81|||
143012884|NCT00391092|515587974|FG000|Overall Study|Lost to Follow-up|13|||
143012885|NCT00391092|515587975|FG001|Overall Study|Lost to Follow-up|18|||
143012886|NCT00391092|515587974|FG000|Overall Study|Alive on treatment|29|||
143012887|NCT00391092|515587975|FG001|Overall Study|Alive on treatment|33|||
143012888|NCT00391092|515587974|FG000|Overall Study|Alive in follow-up|88|||
143012889|NCT00391092|515587975|FG001|Overall Study|Alive in follow-up|84|||
143012890|NCT02803138|515587976|FG000|Overall Study|Failure to return|38|||
143012891|NCT02803138|515587976|FG000|Overall Study|Insufficient virological response|2|||
143012892|NCT02803138|515587976|FG000|Overall Study|Withdrawn consent|1|||
143012893|NCT02803138|515587976|FG000|Overall Study|Death|1|||
143012894|NCT02803138|515587976|FG000|Overall Study|Other, not specified|28|||
143012895|NCT04071366|515587977|FG000|Part 1: Open-label (29 Days)|Death|4|||
143012896|NCT04071366|515587978|FG001|Part 1: Open-label (29 Days)|Death|2|||
143012897|NCT04071366|515587979|FG002|Part 1: Open-label (29 Days)|Death|8|||
143012898|NCT04071366|515587980|FG003|Part 1: Open-label (29 Days)|Death|0|||
143012899|NCT04071366|515587981|FG004|Part 1: Open-label (29 Days)|Death|0|||
143012900|NCT04071366|515587977|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
143012901|NCT04071366|515587978|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
143012902|NCT04071366|515587979|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
143012903|NCT04071366|515587980|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
143012904|NCT04071366|515587981|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
143012905|NCT04071366|515587977|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
143012906|NCT04071366|515587978|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
143012907|NCT04071366|515587979|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
143012908|NCT04071366|515587980|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
143012909|NCT04071366|515587981|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
143012910|NCT04071366|515587977|FG000|Part 2: Randomized (29 Days)|Death|0|||
143012911|NCT04071366|515587978|FG001|Part 2: Randomized (29 Days)|Death|0|||
143012912|NCT04071366|515587979|FG002|Part 2: Randomized (29 Days)|Death|0|||
143012913|NCT04071366|515587980|FG003|Part 2: Randomized (29 Days)|Death|2|||
143012914|NCT04071366|515587981|FG004|Part 2: Randomized (29 Days)|Death|2|||
143012915|NCT04071366|515587977|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
143012916|NCT04071366|515587978|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
143012917|NCT04071366|515587979|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
143012918|NCT04071366|515587980|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
143012919|NCT04071366|515587981|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
143355476|NCT02611830|516845136|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
143462321|NCT00250679|517239300|FG000|Overall Study|Adverse Event|12|||
143355477|NCT02611830|516845133|FG000|Maintenance Phase|Pregnancy|0|||
143355478|NCT02611830|516845134|FG001|Maintenance Phase|Pregnancy|0|||
143355479|NCT02611830|516845135|FG002|Maintenance Phase|Pregnancy|1|||
143355480|NCT02611830|516845136|FG003|Maintenance Phase|Pregnancy|0|||
143355481|NCT02611830|516845133|FG000|Maintenance Phase|Reason not specified|0|||
143355482|NCT02611830|516845134|FG001|Maintenance Phase|Reason not specified|1|||
143355483|NCT02611830|516845135|FG002|Maintenance Phase|Reason not specified|4|||
143355484|NCT02611830|516845136|FG003|Maintenance Phase|Reason not specified|0|||
143355485|NCT03567993|516845139|FG000|Overall Study|Lost to Follow-up|4|||
143355486|NCT03567993|516845140|FG001|Overall Study|Lost to Follow-up|2|||
143355487|NCT03567993|516845139|FG000|Overall Study|Death|1|||
143355488|NCT03567993|516845140|FG001|Overall Study|Death|1|||
143355489|NCT03567993|516845139|FG000|Overall Study|Withdrawal by Subject|1|||
143355490|NCT03567993|516845140|FG001|Overall Study|Withdrawal by Subject|0|||
143012920|NCT04071366|515587977|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
143012921|NCT04071366|515587978|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
143012922|NCT04071366|515587979|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
143012923|NCT04071366|515587980|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
143012924|NCT04071366|515587981|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
143012925|NCT04071366|515587977|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
143012926|NCT04071366|515587978|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
143012927|NCT04071366|515587979|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
143012928|NCT04071366|515587980|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
143012929|NCT04071366|515587981|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
143012930|NCT04071366|515587977|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
143012931|NCT04071366|515587978|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
143012932|NCT04071366|515587979|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
143012933|NCT04071366|515587980|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
143012934|NCT04071366|515587981|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
143012935|NCT04071366|515587977|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
143012936|NCT04071366|515587978|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
143012937|NCT04071366|515587979|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
143012938|NCT04071366|515587980|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
143012939|NCT04071366|515587981|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
143012940|NCT04071366|515587977|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
143012941|NCT04071366|515587978|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
143012942|NCT04071366|515587979|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
143012943|NCT04071366|515587980|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
143012944|NCT04071366|515587981|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
143012945|NCT02239692|515587982|FG000|Overall Study|Incomplete colonoscopy|1|||
143012946|NCT02239692|515587983|FG001|Overall Study|Incomplete colonoscopy|2|||
143012947|NCT02239692|515587982|FG000|Overall Study|Adverse Event|0|||
143012948|NCT02239692|515587983|FG001|Overall Study|Adverse Event|1|||
143012949|NCT02239692|515587982|FG000|Overall Study|Physician Decision|0|||
143012950|NCT02239692|515587983|FG001|Overall Study|Physician Decision|1|||
143012951|NCT02239692|515587982|FG000|Overall Study|Lost to Follow-up|1|||
143012952|NCT02239692|515587983|FG001|Overall Study|Lost to Follow-up|4|||
143012953|NCT02239692|515587982|FG000|Overall Study|Withdrawal by Subject|3|||
143012954|NCT02239692|515587983|FG001|Overall Study|Withdrawal by Subject|5|||
143012955|NCT02239692|515587982|FG000|Overall Study|Other reason|1|||
143012956|NCT02239692|515587983|FG001|Overall Study|Other reason|0|||
143012957|NCT01678924|515587984|FG000|Overall Study|Adverse Event|1|||
143012958|NCT01678924|515587985|FG001|Overall Study|Adverse Event|1|||
143012959|NCT01678924|515587986|FG002|Overall Study|Adverse Event|0|||
143012960|NCT01678924|515587987|FG003|Overall Study|Adverse Event|1|||
143012961|NCT01678924|515587984|FG000|Overall Study|Lack of Efficacy|7|||
143012962|NCT01678924|515587985|FG001|Overall Study|Lack of Efficacy|2|||
143012963|NCT01678924|515587986|FG002|Overall Study|Lack of Efficacy|0|||
143012964|NCT01678924|515587987|FG003|Overall Study|Lack of Efficacy|5|||
143012965|NCT01678924|515587984|FG000|Overall Study|Lost to Follow-up|0|||
143012966|NCT01678924|515587985|FG001|Overall Study|Lost to Follow-up|4|||
143012967|NCT01678924|515587986|FG002|Overall Study|Lost to Follow-up|0|||
143012968|NCT01678924|515587987|FG003|Overall Study|Lost to Follow-up|2|||
143012969|NCT01678924|515587984|FG000|Overall Study|Personal Reasons|2|||
143012970|NCT01678924|515587985|FG001|Overall Study|Personal Reasons|2|||
143012971|NCT01678924|515587986|FG002|Overall Study|Personal Reasons|2|||
143012972|NCT01678924|515587987|FG003|Overall Study|Personal Reasons|7|||
143012973|NCT01678924|515587984|FG000|Overall Study|Withdrawal by Subject|0|||
143355491|NCT04793464|516845141|FG000|Overall Study|Lost to Follow-up|458|||
143355492|NCT04793464|516845142|FG001|Overall Study|Lost to Follow-up|168|||
143355493|NCT04793464|516845143|FG002|Overall Study|Lost to Follow-up|5|||
143355494|NCT04793464|516845141|FG000|Overall Study|Withdrawal by Subject|43|||
143462322|NCT00250679|517239301|FG001|Overall Study|Adverse Event|15|||
143462323|NCT00250679|517239302|FG002|Overall Study|Adverse Event|16|||
143462324|NCT00250679|517239300|FG000|Overall Study|Protocol Violation|2|||
143462325|NCT00250679|517239301|FG001|Overall Study|Protocol Violation|4|||
143462326|NCT00250679|517239302|FG002|Overall Study|Protocol Violation|3|||
143462327|NCT00250679|517239300|FG000|Overall Study|Withdrawal by Subject|15|||
143462328|NCT00250679|517239301|FG001|Overall Study|Withdrawal by Subject|18|||
143462329|NCT00250679|517239302|FG002|Overall Study|Withdrawal by Subject|15|||
143462330|NCT00250679|517239300|FG000|Overall Study|Lost to Follow-up|3|||
143462331|NCT00250679|517239301|FG001|Overall Study|Lost to Follow-up|4|||
143462332|NCT00250679|517239302|FG002|Overall Study|Lost to Follow-up|2|||
143462333|NCT00250679|517239300|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
143462334|NCT00250679|517239301|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
143462335|NCT00250679|517239302|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
143462336|NCT00250679|517239300|FG000|Overall Study|Lack of Efficacy|0|||
143462337|NCT00250679|517239301|FG001|Overall Study|Lack of Efficacy|1|||
143462338|NCT00250679|517239302|FG002|Overall Study|Lack of Efficacy|3|||
143462339|NCT00250679|517239300|FG000|Overall Study|Technical Holter issues|1|||
143462340|NCT00250679|517239301|FG001|Overall Study|Technical Holter issues|0|||
143462341|NCT00250679|517239302|FG002|Overall Study|Technical Holter issues|2|||
143462342|NCT00250679|517239300|FG000|Overall Study|Moved|1|||
143462343|NCT00250679|517239301|FG001|Overall Study|Moved|1|||
143462344|NCT00250679|517239302|FG002|Overall Study|Moved|0|||
143462345|NCT00250679|517239300|FG000|Overall Study|Non-compliance|1|||
143462346|NCT00250679|517239301|FG001|Overall Study|Non-compliance|1|||
143462347|NCT00250679|517239302|FG002|Overall Study|Non-compliance|0|||
143462348|NCT00250679|517239300|FG000|Overall Study|various single events: hip surgery,diary|3|||
143462349|NCT00250679|517239301|FG001|Overall Study|various single events: hip surgery,diary|1|||
143462350|NCT00250679|517239302|FG002|Overall Study|various single events: hip surgery,diary|1|||
143462351|NCT03907410|517239303|FG000|Overall Study|Lost to Follow-up|4|||
143462352|NCT03907410|517239304|FG001|Overall Study|Lost to Follow-up|1|||
143462353|NCT03907410|517239305|FG002|Overall Study|Lost to Follow-up|1|||
143462354|NCT03907410|517239303|FG000|Overall Study|Lost to follow-up and research burden|0|||
143462355|NCT03907410|517239304|FG001|Overall Study|Lost to follow-up and research burden|0|||
143462356|NCT03907410|517239305|FG002|Overall Study|Lost to follow-up and research burden|1|||
143462357|NCT04776148|517239306|FG000|Overall Study|Death|249|||
143462358|NCT04776148|517239307|FG001|Overall Study|Death|260|||
143462359|NCT04776148|517239306|FG000|Overall Study|Lost to Follow-up|0|||
143462360|NCT04776148|517239307|FG001|Overall Study|Lost to Follow-up|1|||
143462361|NCT04776148|517239306|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
143462362|NCT04776148|517239307|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
143462363|NCT04776148|517239306|FG000|Overall Study|Withdrawal by Subject|3|||
143462364|NCT04776148|517239307|FG001|Overall Study|Withdrawal by Subject|4|||
143462365|NCT04776148|517239306|FG000|Overall Study|Sponsor Decision|30|||
143462366|NCT04776148|517239307|FG001|Overall Study|Sponsor Decision|15|||
143462367|NCT00666679|517239311|FG000|First Intervention|Lost to Follow-up|1|||
143462368|NCT00666679|517239312|FG001|First Intervention|Lost to Follow-up|0|||
143462369|NCT00666679|517239311|FG000|First Intervention|Protocol Violation|1|||
143462370|NCT00666679|517239312|FG001|First Intervention|Protocol Violation|0|||
143462371|NCT00666679|517239311|FG000|First Intervention|Withdrawal by Subject|1|||
143462372|NCT00666679|517239312|FG001|First Intervention|Withdrawal by Subject|0|||
143462373|NCT00666679|517239311|FG000|First Intervention|Randomized did not start treatment|1|||
143462374|NCT00666679|517239312|FG001|First Intervention|Randomized did not start treatment|1|||
143462375|NCT00666679|517239311|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
143462376|NCT00666679|517239312|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
143355495|NCT04793464|516845142|FG001|Overall Study|Withdrawal by Subject|15|||
143355496|NCT04793464|516845143|FG002|Overall Study|Withdrawal by Subject|0|||
143355497|NCT00195715|516845146|FG000|Overall Study|Adverse Event|122|||
143355498|NCT00195715|516845146|FG000|Overall Study|Withdrawal by Subject|58|||
143355499|NCT00195715|516845146|FG000|Overall Study|Lost to Follow-up|27|||
143355500|NCT00195715|516845146|FG000|Overall Study|Protocol Violation|13|||
143355501|NCT00195715|516845146|FG000|Overall Study|Lack of Efficacy|93|||
143012974|NCT01678924|515587985|FG001|Overall Study|Withdrawal by Subject|3|||
143012975|NCT01678924|515587986|FG002|Overall Study|Withdrawal by Subject|0|||
143355502|NCT00195715|516845146|FG000|Overall Study|Pregnancy|14|||
143012976|NCT01678924|515587987|FG003|Overall Study|Withdrawal by Subject|2|||
143012977|NCT01678924|515587984|FG000|Overall Study|Unable to attend scheduled visits|0|||
143012978|NCT01678924|515587985|FG001|Overall Study|Unable to attend scheduled visits|0|||
143012979|NCT01678924|515587986|FG002|Overall Study|Unable to attend scheduled visits|0|||
143012980|NCT01678924|515587987|FG003|Overall Study|Unable to attend scheduled visits|1|||
143012981|NCT02675426|515587988|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
143012982|NCT02675426|515587989|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
143012983|NCT02675426|515587990|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
143462377|NCT00666679|517239311|FG000|Washout Period of 1 Week|Protocol Violation|0|||
143462378|NCT00666679|517239312|FG001|Washout Period of 1 Week|Protocol Violation|1|||
143355503|NCT00195715|516845146|FG000|Overall Study|Investigative site closure|8|||
143462379|NCT00666679|517239311|FG000|Second Intervention|Adverse Event|1|||
143355504|NCT00195715|516845146|FG000|Overall Study|Subject moved/relocated|7|||
143012984|NCT02675426|515587991|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
143012985|NCT02675426|515587988|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
143012986|NCT02675426|515587989|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
143012987|NCT02675426|515587990|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
143012988|NCT02675426|515587991|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
143012989|NCT02675426|515587988|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
143012990|NCT02675426|515587989|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
143012991|NCT02675426|515587990|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
143012992|NCT02675426|515587991|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
143012993|NCT02675426|515587988|FG000|Period 1: Week 1 to Week 12|Other|2|||
143012994|NCT02675426|515587989|FG001|Period 1: Week 1 to Week 12|Other|1|||
143012995|NCT02675426|515587990|FG002|Period 1: Week 1 to Week 12|Other|0|||
143012996|NCT02675426|515587991|FG003|Period 1: Week 1 to Week 12|Other|2|||
143012997|NCT02675426|515587988|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
143012998|NCT02675426|515587989|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
143012999|NCT02675426|515587990|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
143013000|NCT02675426|515587991|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
143013001|NCT02675426|515587988|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
143013002|NCT02675426|515587989|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
143013003|NCT02675426|515587990|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
143013004|NCT02675426|515587991|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
143013005|NCT02675426|515587988|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
143013006|NCT02675426|515587989|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
143013007|NCT02675426|515587990|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
143013008|NCT02675426|515587991|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
143013009|NCT02675426|515587988|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
143013010|NCT02675426|515587989|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
143013011|NCT02675426|515587990|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
143013012|NCT02675426|515587991|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
143013013|NCT02675426|515587988|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
143013014|NCT02675426|515587989|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
143013015|NCT02675426|515587990|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
143013016|NCT02675426|515587991|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
143013017|NCT02675426|515587988|FG000|Period 2: Week 12 to Week 260|Other|8|||
143013018|NCT02675426|515587989|FG001|Period 2: Week 12 to Week 260|Other|12|||
143013019|NCT02675426|515587990|FG002|Period 2: Week 12 to Week 260|Other|23|||
143013020|NCT02675426|515587991|FG003|Period 2: Week 12 to Week 260|Other|15|||
143013021|NCT00080288|515587994|FG000|Overall Study|Adverse Event|7|||
143013022|NCT00080288|515587995|FG001|Overall Study|Adverse Event|4|||
143013023|NCT00080288|515587994|FG000|Overall Study|Lost to Follow-up|3|||
143355505|NCT00195715|516845146|FG000|Overall Study|Subject non-compliance|6|||
143355506|NCT00195715|516845146|FG000|Overall Study|Subject started commercial Humira|5|||
143355507|NCT00195715|516845146|FG000|Overall Study|Subject choice|3|||
143355508|NCT00195715|516845146|FG000|Overall Study|Loss of response/no improvement|3|||
143355509|NCT00195715|516845146|FG000|Overall Study|Sponsor stopped study|1|||
143355510|NCT00195715|516845146|FG000|Overall Study|Administrative reasons|2|||
143355511|NCT00195715|516845146|FG000|Overall Study|Investigator's decision|2|||
143355512|NCT00195715|516845146|FG000|Overall Study|Subject wants to get pregnant|4|||
143355513|NCT00195715|516845146|FG000|Overall Study|Use of prohibited medication|2|||
143355514|NCT00195715|516845146|FG000|Overall Study|Planned surgery|2|||
143355515|NCT00195715|516845146|FG000|Overall Study|Increased infection rate|1|||
143355516|NCT00195715|516845146|FG000|Overall Study|Ineligible|1|||
143355517|NCT00195715|516845146|FG000|Overall Study|Colonic stricture|1|||
143355518|NCT00195715|516845146|FG000|Overall Study|Sponsor discontinued trial|1|||
143355519|NCT00195715|516845146|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
143355520|NCT05822921|516845151|FG000|Overall Study|Lost to Follow-up|1|||
143355521|NCT05822921|516845152|FG001|Overall Study|Lost to Follow-up|1|||
143355522|NCT01163747|516845154|FG000|Overall Study|Adverse Event|0|||
143355523|NCT01163747|516845155|FG001|Overall Study|Adverse Event|5|||
143355524|NCT01163747|516845154|FG000|Overall Study|Insufficient Therapeutic Response|0|||
143355525|NCT01163747|516845155|FG001|Overall Study|Insufficient Therapeutic Response|1|||
143355526|NCT01163747|516845154|FG000|Overall Study|Protocol Violation|0|||
143355527|NCT01163747|516845155|FG001|Overall Study|Protocol Violation|1|||
143355528|NCT01163747|516845154|FG000|Overall Study|Refused Treatment|6|||
143013024|NCT00080288|515587995|FG001|Overall Study|Lost to Follow-up|5|||
143013025|NCT00080288|515587994|FG000|Overall Study|Physician Decision|6|||
143013026|NCT00080288|515587995|FG001|Overall Study|Physician Decision|2|||
143013027|NCT00080288|515587994|FG000|Overall Study|Withdrawal by Subject|3|||
143013028|NCT00080288|515587995|FG001|Overall Study|Withdrawal by Subject|16|||
143013029|NCT00080288|515587994|FG000|Overall Study|Miscellaneous|11|||
143355529|NCT01163747|516845155|FG001|Overall Study|Refused Treatment|4|||
143355530|NCT01671748|516845156|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
143462380|NCT00666679|517239312|FG001|Second Intervention|Adverse Event|0|||
143462381|NCT00666679|517239311|FG000|Second Intervention|Death|0|||
143462382|NCT00666679|517239312|FG001|Second Intervention|Death|1|||
143462383|NCT04882995|517239315|FG000|Overall Study|Withdrawal by Subject|1|||
143462384|NCT04882995|517239316|FG001|Overall Study|Withdrawal by Subject|2|||
143462385|NCT04882995|517239315|FG000|Overall Study|Protocol Violation|4|||
143462386|NCT04882995|517239316|FG001|Overall Study|Protocol Violation|4|||
143462387|NCT04882995|517239315|FG000|Overall Study|Surgery postponed due to COVID|1|||
143462388|NCT04882995|517239316|FG001|Overall Study|Surgery postponed due to COVID|1|||
143462389|NCT04371198|517239317|FG000|Overall Study|inadequate sample|4|||
143462390|NCT04754477|517239318|FG000|Overall Study|Withdrawal by Subject|1|||
143462391|NCT06469242|517239319|FG000|First Wear Period (Approx 14 Days)|Protocol Violation|4|||
143462392|NCT06469242|517239320|FG001|First Wear Period (Approx 14 Days)|Protocol Violation|3|||
143462393|NCT06469242|517239319|FG000|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
143462394|NCT06469242|517239320|FG001|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
143462395|NCT05041101|517239321|FG000|Overall Study|Adverse Event|1|||
143462396|NCT05041101|517239322|FG001|Overall Study|Adverse Event|0|||
143462397|NCT05041101|517239323|FG002|Overall Study|Adverse Event|0|||
143462398|NCT05041101|517239321|FG000|Overall Study|Diease Progression|5|||
143462399|NCT05041101|517239322|FG001|Overall Study|Diease Progression|0|||
143462400|NCT05041101|517239323|FG002|Overall Study|Diease Progression|0|||
143462401|NCT01205152|517239324|FG000|Overall Study|Death|1|||
143462402|NCT00069108|517239325|FG000|Overall Study|Withdrawal by Subject|5|||
143462403|NCT00069108|517239326|FG001|Overall Study|Withdrawal by Subject|9|||
143462404|NCT00069108|517239325|FG000|Overall Study|Adverse Event|64|||
143462405|NCT00069108|517239326|FG001|Overall Study|Adverse Event|42|||
143462406|NCT00069108|517239325|FG000|Overall Study|Death|6|||
143462407|NCT00069108|517239326|FG001|Overall Study|Death|6|||
143462408|NCT00069108|517239325|FG000|Overall Study|Administration|15|||
143462409|NCT00069108|517239326|FG001|Overall Study|Administration|4|||
143462410|NCT00069108|517239325|FG000|Overall Study|Insufficient therapy|117|||
143462411|NCT00069108|517239326|FG001|Overall Study|Insufficient therapy|144|||
143462412|NCT00069108|517239325|FG000|Overall Study|Violation criteria|1|||
143462413|NCT00069108|517239326|FG001|Overall Study|Violation criteria|4|||
143462414|NCT00069108|517239325|FG000|Overall Study|Refused treatment|5|||
143462415|NCT00069108|517239326|FG001|Overall Study|Refused treatment|10|||
143462416|NCT02783768|517239327|FG000|Overall Study|Lost to Follow-up|1|||
143462417|NCT02783768|517239328|FG001|Overall Study|Lost to Follow-up|0|||
143462418|NCT01323647|517239329|FG000|Overall Study|Migrated/moved from study area|2|||
143462419|NCT01323647|517239330|FG001|Overall Study|Migrated/moved from study area|0|||
143462420|NCT01323647|517239329|FG000|Overall Study|Withdrawal by Subject|5|||
143462421|NCT01323647|517239330|FG001|Overall Study|Withdrawal by Subject|0|||
143462422|NCT01323647|517239329|FG000|Overall Study|Lost to Follow-up|2|||
143462423|NCT01323647|517239330|FG001|Overall Study|Lost to Follow-up|0|||
143462424|NCT00262951|517239331|FG000|Overall Study|Progressive disease/relapse|3|||
143462425|NCT00262951|517239331|FG000|Overall Study|Adverse Event|7|||
143462426|NCT00262951|517239331|FG000|Overall Study|Death|1|||
143462427|NCT00262951|517239331|FG000|Overall Study|Withdrawal by Subject|1|||
143462428|NCT00262951|517239331|FG000|Overall Study|Alternative treatment|3|||
143462429|NCT00262951|517239331|FG000|Overall Study|Off treatment for other disease|1|||
143462430|NCT01853137|517239332|FG000|Overall Study|Lost to Follow-up|4|||
143462431|NCT01853137|517239333|FG001|Overall Study|Lost to Follow-up|1|||
143462432|NCT03401229|517239334|FG000|Overall Study|Lost to Follow-up|2|||
143462433|NCT03401229|517239335|FG001|Overall Study|Lost to Follow-up|1|||
143462434|NCT03401229|517239334|FG000|Overall Study|Other|1|||
143462435|NCT03401229|517239335|FG001|Overall Study|Other|3|||
143462436|NCT03401229|517239334|FG000|Overall Study|Adverse Event|8|||
143462437|NCT03401229|517239335|FG001|Overall Study|Adverse Event|6|||
143462438|NCT03401229|517239334|FG000|Overall Study|Withdrawal by Subject|29|||
143462439|NCT03401229|517239335|FG001|Overall Study|Withdrawal by Subject|26|||
143462440|NCT03401229|517239334|FG000|Overall Study|COVID-19|0|||
143462441|NCT03401229|517239335|FG001|Overall Study|COVID-19|1|||
143355531|NCT01671748|516845157|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
143462442|NCT00690820|517239336|FG000|Period 1|Withdrawal by Subject|0|||
143462443|NCT00690820|517239337|FG001|Period 1|Withdrawal by Subject|1|||
143462444|NCT05333224|517239338|FG000|Overall Study - Infants|Lost to Follow-up|1|||
143462445|NCT05333224|517239339|FG001|Overall Study - Infants|Lost to Follow-up|1|||
143355532|NCT01671748|516845156|FG000|4 Week run-in Phase|Adverse Event|1|||
143355533|NCT01671748|516845157|FG001|4 Week run-in Phase|Adverse Event|0|||
143462446|NCT01768117|517239341|FG000|Overall Study|Lost to Follow-up|1|||
143462447|NCT01768117|517239341|FG000|Overall Study|Withdrawal by Subject|2|||
143355534|NCT01671748|516845156|FG000|4 Week run-in Phase|Not eligible|9|||
143462448|NCT01768117|517239341|FG000|Overall Study|Protocol Violation|3|||
143462449|NCT00966277|517239343|FG000|Overall Study|Withdrawal by Subject|3|||
143462450|NCT00966277|517239344|FG001|Overall Study|Withdrawal by Subject|0|||
143462451|NCT00966277|517239343|FG000|Overall Study|Ineligible|1|||
143462452|NCT00966277|517239344|FG001|Overall Study|Ineligible|3|||
143462453|NCT00966277|517239343|FG000|Overall Study|Treatment Plan Changed|0|||
143462454|NCT00966277|517239344|FG001|Overall Study|Treatment Plan Changed|1|||
143462455|NCT03658668|517239345|FG000|Overall Study|Time Commitment|1|||
143462456|NCT03658668|517239346|FG001|Overall Study|Time Commitment|1|||
143462457|NCT01952054|517239347|FG000|Overall Study|Physician Decision|1|||
143462458|NCT01127139|517239348|FG000|Overall Study|Adverse Event|40|||
143462459|NCT01127139|517239348|FG000|Overall Study|Incompliance|12|||
143462460|NCT01127139|517239348|FG000|Overall Study|Lack of Efficacy|4|||
143462461|NCT01127139|517239348|FG000|Overall Study|Reason not specified|1|||
143462462|NCT03881553|517239356|FG000|Overall Study|Discharged prior to participation|1|||
143462463|NCT03881553|517239357|FG001|Overall Study|Discharged prior to participation|1|||
143462464|NCT03881553|517239358|FG002|Overall Study|Discharged prior to participation|0|||
143462465|NCT03881553|517239356|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
143462466|NCT03881553|517239357|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
143462467|NCT03881553|517239358|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
143462468|NCT01718353|517239359|FG000|Overall Study|Lost to Follow-up|0|||
143462469|NCT01718353|517239360|FG001|Overall Study|Lost to Follow-up|1|||
143462470|NCT01718353|517239359|FG000|Overall Study|Principal Investigator's Decision|10|||
143462471|NCT01718353|517239360|FG001|Overall Study|Principal Investigator's Decision|4|||
143462472|NCT01718353|517239359|FG000|Overall Study|Randomized but not treated|2|||
143462473|NCT01718353|517239360|FG001|Overall Study|Randomized but not treated|0|||
143462474|NCT01959516|517239361|FG000|Epoch 1|Adverse Event|4|||
143462475|NCT01959516|517239362|FG001|Epoch 1|Adverse Event|1|||
143462476|NCT01959516|517239361|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
143462477|NCT01959516|517239362|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
143462478|NCT01959516|517239361|FG000|Epoch 1|Subject withdrew consent|3|||
143462479|NCT01959516|517239362|FG001|Epoch 1|Subject withdrew consent|2|||
143462480|NCT01959516|517239361|FG000|Epoch 1|Administrative problems|1|||
143462481|NCT01959516|517239362|FG001|Epoch 1|Administrative problems|0|||
143462482|NCT01959516|517239361|FG000|Epoch 1|Use of prohibited treatment|1|||
143462483|NCT01959516|517239362|FG001|Epoch 1|Use of prohibited treatment|0|||
143462484|NCT01959516|517239361|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
143462485|NCT01959516|517239362|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
143462486|NCT01959516|517239361|FG000|Epoch 1|Protocol deviation|0|||
143462487|NCT01959516|517239362|FG001|Epoch 1|Protocol deviation|1|||
143462488|NCT01959516|517239361|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
143462489|NCT01959516|517239362|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
143462490|NCT01959516|517239361|FG000|Epoch 2|Subject withdrew consent|1|||
143462491|NCT01959516|517239362|FG001|Epoch 2|Subject withdrew consent|0|||
143462492|NCT01959516|517239361|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
143462493|NCT01959516|517239362|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
143462494|NCT01477333|517239363|FG000|Overall Study|Adverse Event|1|||
143462495|NCT01477333|517239363|FG000|Overall Study|Withdrawal by Subject|1|||
143355535|NCT01671748|516845157|FG001|4 Week run-in Phase|Not eligible|0|||
143355536|NCT04714216|516846827|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
143355537|NCT04714216|516846827|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
143355538|NCT01349829|516846830|FG000|Overall Study|Lost to Follow-up|4|||
143355539|NCT01349829|516846831|FG001|Overall Study|Lost to Follow-up|8|||
143355540|NCT01349829|516846830|FG000|Overall Study|Consent withdrawal|3|||
143355541|NCT01349829|516846831|FG001|Overall Study|Consent withdrawal|8|||
143355542|NCT01349829|516846830|FG000|Overall Study|Migrated/moved|2|||
143355543|NCT01349829|516846831|FG001|Overall Study|Migrated/moved|7|||
143355544|NCT01500226|516846834|FG000|Overall Study|Adverse Event|31|||
143355545|NCT01500226|516846835|FG001|Overall Study|Adverse Event|38|||
143462496|NCT01477333|517239363|FG000|Overall Study|Clinical Deterioration|1|||
143462497|NCT01078675|517239364|FG000|Overall Study|Withdrawal by Subject|7|||
143462498|NCT01078675|517239365|FG001|Overall Study|Withdrawal by Subject|3|||
143462499|NCT01078675|517239364|FG000|Overall Study|Protocol Violation|56|||
143462500|NCT01078675|517239365|FG001|Overall Study|Protocol Violation|0|||
143462501|NCT01078675|517239364|FG000|Overall Study|Provided in CRF for specific reasons|2|||
143462502|NCT01078675|517239365|FG001|Overall Study|Provided in CRF for specific reasons|3|||
143462503|NCT01078675|517239364|FG000|Overall Study|Adverse Event|3|||
143462504|NCT01078675|517239365|FG001|Overall Study|Adverse Event|0|||
143462505|NCT02513303|517239371|FG000|Overall Study|Withdrawal by Subject|9|||
143462506|NCT02513303|517239372|FG001|Overall Study|Withdrawal by Subject|7|||
143462507|NCT02513303|517239373|FG002|Overall Study|Withdrawal by Subject|2|||
143462508|NCT02513303|517239371|FG000|Overall Study|Lost to Follow-up|2|||
143462509|NCT02513303|517239372|FG001|Overall Study|Lost to Follow-up|4|||
143462510|NCT02513303|517239373|FG002|Overall Study|Lost to Follow-up|0|||
143462511|NCT02513303|517239371|FG000|Overall Study|Adverse Event|0|||
143462512|NCT02513303|517239372|FG001|Overall Study|Adverse Event|1|||
143462513|NCT02513303|517239373|FG002|Overall Study|Adverse Event|0|||
143462514|NCT02513303|517239371|FG000|Overall Study|Physician Decision|1|||
143462515|NCT02513303|517239372|FG001|Overall Study|Physician Decision|1|||
143462516|NCT02513303|517239373|FG002|Overall Study|Physician Decision|0|||
143462517|NCT02513303|517239371|FG000|Overall Study|Death|8|||
143462518|NCT02513303|517239372|FG001|Overall Study|Death|4|||
143462519|NCT02513303|517239373|FG002|Overall Study|Death|2|||
143462520|NCT01691768|517239374|FG000|Overall Study|Death|0|||
143462521|NCT01691768|517239375|FG001|Overall Study|Death|2|||
143462522|NCT01691768|517239374|FG000|Overall Study|Lost to Follow-up|4|||
143462523|NCT01691768|517239375|FG001|Overall Study|Lost to Follow-up|3|||
143462524|NCT01691768|517239374|FG000|Overall Study|Withdrawal by Subject|10|||
143462525|NCT01691768|517239375|FG001|Overall Study|Withdrawal by Subject|9|||
143462526|NCT01691768|517239374|FG000|Overall Study|Relocated|0|||
143462527|NCT01691768|517239375|FG001|Overall Study|Relocated|1|||
143462528|NCT01691768|517239374|FG000|Overall Study|Investigator decision|1|||
143462529|NCT01691768|517239375|FG001|Overall Study|Investigator decision|1|||
143462530|NCT02294227|517239380|FG000|Overall Study|Death|0|||
143462531|NCT02294227|517239381|FG001|Overall Study|Death|0|||
143462532|NCT02294227|517239382|FG002|Overall Study|Death|1|||
143462533|NCT02294227|517239380|FG000|Overall Study|Subject/Guardian Decision|6|||
143462534|NCT02294227|517239381|FG001|Overall Study|Subject/Guardian Decision|3|||
143462535|NCT02294227|517239382|FG002|Overall Study|Subject/Guardian Decision|7|||
143462536|NCT02294227|517239380|FG000|Overall Study|Physician Decision|1|||
143462537|NCT02294227|517239381|FG001|Overall Study|Physician Decision|2|||
143462538|NCT02294227|517239382|FG002|Overall Study|Physician Decision|1|||
143462539|NCT02294227|517239380|FG000|Overall Study|Lost to Follow-up|1|||
143462540|NCT02294227|517239381|FG001|Overall Study|Lost to Follow-up|0|||
143462541|NCT02294227|517239382|FG002|Overall Study|Lost to Follow-up|0|||
143462542|NCT02294227|517239380|FG000|Overall Study|Lack of Efficacy|11|||
143462543|NCT02294227|517239381|FG001|Overall Study|Lack of Efficacy|12|||
143462544|NCT02294227|517239382|FG002|Overall Study|Lack of Efficacy|8|||
143462545|NCT02294227|517239380|FG000|Overall Study|Adverse Event|6|||
143462546|NCT02294227|517239381|FG001|Overall Study|Adverse Event|8|||
143462547|NCT02294227|517239382|FG002|Overall Study|Adverse Event|2|||
143462548|NCT01768637|517239383|FG000|Overall Study|Lost to Follow-up|2|||
143462549|NCT01768637|517239384|FG001|Overall Study|Lost to Follow-up|7|||
143462550|NCT01768637|517239383|FG000|Overall Study|Difficult blood draw|1|||
143462551|NCT01768637|517239384|FG001|Overall Study|Difficult blood draw|0|||
143462552|NCT02481947|517239385|FG000|Overall Study|Withdrawal by Subject|24|||
143462553|NCT02481947|517239386|FG001|Overall Study|Withdrawal by Subject|10|||
143462554|NCT02481947|517239385|FG000|Overall Study|Lost to Follow-up|11|||
143462555|NCT02481947|517239386|FG001|Overall Study|Lost to Follow-up|5|||
143462556|NCT02481947|517239385|FG000|Overall Study|Adverse Event|6|||
143462557|NCT02481947|517239386|FG001|Overall Study|Adverse Event|11|||
143462558|NCT02481947|517239385|FG000|Overall Study|Physician Decision|4|||
143462559|NCT02481947|517239386|FG001|Overall Study|Physician Decision|5|||
143462560|NCT02481947|517239385|FG000|Overall Study|Protocol Violation|1|||
143462561|NCT02481947|517239386|FG001|Overall Study|Protocol Violation|5|||
143462562|NCT03426267|517239390|FG000|Overall Study|Physician Decision|1|||
143462563|NCT03426267|517239391|FG001|Overall Study|Physician Decision|4|||
143462564|NCT03426267|517239390|FG000|Overall Study|Lost to Follow-up|1|||
143462565|NCT03426267|517239391|FG001|Overall Study|Lost to Follow-up|0|||
143462566|NCT03426267|517239390|FG000|Overall Study|Withdrawal by Subject|4|||
143462567|NCT03426267|517239391|FG001|Overall Study|Withdrawal by Subject|10|||
143462568|NCT03426267|517239390|FG000|Overall Study|Protocol Violation|1|||
143462569|NCT03426267|517239391|FG001|Overall Study|Protocol Violation|3|||
143462570|NCT03426267|517239390|FG000|Overall Study|Adverse Event|9|||
143462571|NCT03426267|517239391|FG001|Overall Study|Adverse Event|27|||
143462572|NCT03426267|517239390|FG000|Overall Study|Prohibited Treatment Intake|2|||
143462573|NCT03426267|517239391|FG001|Overall Study|Prohibited Treatment Intake|3|||
143462574|NCT03426267|517239390|FG000|Overall Study|Lack of Efficacy|0|||
143462575|NCT03426267|517239391|FG001|Overall Study|Lack of Efficacy|25|||
143462576|NCT03426267|517239390|FG000|Overall Study|other|3|||
143462577|NCT03426267|517239391|FG001|Overall Study|other|0|||
143462578|NCT05195489|517240793|FG000|Overall Study|Lost to Follow-up|1|||
143462579|NCT05195489|517240794|FG001|Overall Study|Lost to Follow-up|0|||
143462580|NCT05195489|517240793|FG000|Overall Study|Protocol Violation|0|||
143462581|NCT05195489|517240794|FG001|Overall Study|Protocol Violation|2|||
143462582|NCT05195489|517240793|FG000|Overall Study|Withdrawal by Subject|1|||
143462583|NCT05195489|517240794|FG001|Overall Study|Withdrawal by Subject|1|||
143462584|NCT05195489|517240793|FG000|Overall Study|Removed|0|||
143462585|NCT05195489|517240794|FG001|Overall Study|Removed|1|||
143462586|NCT03440320|517240795|FG000|Overall Study|Withdrawal by Subject|0|||
143462587|NCT03440320|517240796|FG001|Overall Study|Withdrawal by Subject|1|||
143462588|NCT00409773|517240797|FG000|Overall Study|Adverse Event|3|||
143462589|NCT00409773|517240798|FG001|Overall Study|Adverse Event|4|||
143462590|NCT00409773|517240799|FG002|Overall Study|Adverse Event|4|||
143462591|NCT00409773|517240800|FG003|Overall Study|Adverse Event|2|||
143462592|NCT00409773|517240801|FG004|Overall Study|Adverse Event|6|||
143462593|NCT00409773|517240797|FG000|Overall Study|Lost to Follow-up|6|||
143462594|NCT00409773|517240798|FG001|Overall Study|Lost to Follow-up|1|||
143462595|NCT00409773|517240799|FG002|Overall Study|Lost to Follow-up|2|||
143462596|NCT00409773|517240800|FG003|Overall Study|Lost to Follow-up|3|||
143462597|NCT00409773|517240801|FG004|Overall Study|Lost to Follow-up|1|||
143462598|NCT00409773|517240797|FG000|Overall Study|Physician Decision|0|||
143462599|NCT00409773|517240798|FG001|Overall Study|Physician Decision|0|||
143462600|NCT00409773|517240799|FG002|Overall Study|Physician Decision|0|||
143462601|NCT00409773|517240800|FG003|Overall Study|Physician Decision|2|||
143462602|NCT00409773|517240801|FG004|Overall Study|Physician Decision|0|||
143462603|NCT00409773|517240797|FG000|Overall Study|Protocol Violation|0|||
143462604|NCT00409773|517240798|FG001|Overall Study|Protocol Violation|2|||
143462605|NCT00409773|517240799|FG002|Overall Study|Protocol Violation|3|||
143462606|NCT00409773|517240800|FG003|Overall Study|Protocol Violation|3|||
143462607|NCT00409773|517240801|FG004|Overall Study|Protocol Violation|1|||
143462608|NCT00409773|517240797|FG000|Overall Study|Withdrawal by Subject|0|||
143462609|NCT00409773|517240798|FG001|Overall Study|Withdrawal by Subject|0|||
143462610|NCT00409773|517240799|FG002|Overall Study|Withdrawal by Subject|0|||
143462611|NCT00409773|517240800|FG003|Overall Study|Withdrawal by Subject|2|||
143462612|NCT00409773|517240801|FG004|Overall Study|Withdrawal by Subject|1|||
143462613|NCT00409773|517240797|FG000|Overall Study|Lack of Eligibility|0|||
143462614|NCT00409773|517240798|FG001|Overall Study|Lack of Eligibility|0|||
143462615|NCT00409773|517240799|FG002|Overall Study|Lack of Eligibility|0|||
143462616|NCT00409773|517240800|FG003|Overall Study|Lack of Eligibility|0|||
143462617|NCT00409773|517240801|FG004|Overall Study|Lack of Eligibility|1|||
143462618|NCT01201343|517240802|FG000|Overall Study|Adverse Event|6|||
143462619|NCT01201343|517240802|FG000|Overall Study|Withdrawal by Subject|5|||
143462620|NCT01201343|517240802|FG000|Overall Study|Lost to Follow-up|2|||
143462621|NCT01201343|517240802|FG000|Overall Study|Lack of Efficacy|2|||
143462622|NCT01201343|517240802|FG000|Overall Study|Participant wrongly included in trial|1|||
143462623|NCT01201343|517240802|FG000|Overall Study|Randomized, not treated|3|||
143462624|NCT01440374|517240807|FG000|Part 1: Open-label Phase|Adverse Event|5|||
143462625|NCT01440374|517240808|FG001|Part 1: Open-label Phase|Adverse Event|0|||
143462626|NCT01440374|517240809|FG002|Part 1: Open-label Phase|Adverse Event|0|||
143462627|NCT01440374|517240810|FG003|Part 1: Open-label Phase|Adverse Event|0|||
143462628|NCT01440374|517240807|FG000|Part 1: Open-label Phase|Physician Decision|1|||
143462629|NCT01440374|517240808|FG001|Part 1: Open-label Phase|Physician Decision|0|||
143462630|NCT01440374|517240809|FG002|Part 1: Open-label Phase|Physician Decision|0|||
143462631|NCT01440374|517240810|FG003|Part 1: Open-label Phase|Physician Decision|0|||
143462632|NCT01440374|517240807|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
143462633|NCT01440374|517240808|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
143462634|NCT01440374|517240809|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
143462635|NCT01440374|517240810|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
143462636|NCT01440374|517240807|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
143462637|NCT01440374|517240808|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
143462638|NCT01440374|517240809|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
143462639|NCT01440374|517240810|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
143462640|NCT01440374|517240807|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
143462641|NCT01440374|517240808|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
143462642|NCT01440374|517240809|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
143462643|NCT01440374|517240810|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
143462644|NCT01440374|517240807|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
143462645|NCT01440374|517240808|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
143462646|NCT01440374|517240809|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
143462647|NCT01440374|517240810|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
143462648|NCT01440374|517240807|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
143462649|NCT01440374|517240808|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
143462650|NCT01440374|517240809|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
143462651|NCT01440374|517240810|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
143462652|NCT01440374|517240807|FG000|Part 2; Double-blind Phase|Not treated|0|||
143462653|NCT01440374|517240808|FG001|Part 2; Double-blind Phase|Not treated|0|||
143462654|NCT01440374|517240809|FG002|Part 2; Double-blind Phase|Not treated|1|||
143462655|NCT01440374|517240810|FG003|Part 2; Double-blind Phase|Not treated|0|||
143462656|NCT01440374|517240807|FG000|Part 3: Extension|Withdrawal by Subject|0|||
143462657|NCT01440374|517240808|FG001|Part 3: Extension|Withdrawal by Subject|0|||
143462658|NCT01440374|517240809|FG002|Part 3: Extension|Withdrawal by Subject|0|||
143462659|NCT01440374|517240810|FG003|Part 3: Extension|Withdrawal by Subject|5|||
143462660|NCT01440374|517240807|FG000|Part 3: Extension|Adverse Event|0|||
143462661|NCT01440374|517240808|FG001|Part 3: Extension|Adverse Event|0|||
143462662|NCT01440374|517240809|FG002|Part 3: Extension|Adverse Event|0|||
143462663|NCT01440374|517240810|FG003|Part 3: Extension|Adverse Event|13|||
143462664|NCT01440374|517240807|FG000|Part 3: Extension|Physician Decision|0|||
143462665|NCT01440374|517240808|FG001|Part 3: Extension|Physician Decision|0|||
143462666|NCT01440374|517240809|FG002|Part 3: Extension|Physician Decision|0|||
143462667|NCT01440374|517240810|FG003|Part 3: Extension|Physician Decision|14|||
143462668|NCT01650246|517240817|FG000|Overall Study|Adverse Event|23|||
143462669|NCT01650246|517240817|FG000|Overall Study|Protocol Violation|5|||
143462670|NCT01650246|517240817|FG000|Overall Study|Sponsor terminated study|53|||
143462671|NCT01650246|517240817|FG000|Overall Study|Lost to Follow-up|5|||
143462672|NCT01650246|517240817|FG000|Overall Study|Withdrawal by Subject|26|||
143462673|NCT01650246|517240817|FG000|Overall Study|Death|1|||
143462674|NCT01650246|517240817|FG000|Overall Study|Lack of Efficacy|30|||
143462675|NCT02795429|517240827|FG000|Overall Study|Adverse Event|1|||
143462676|NCT02795429|517240828|FG001|Overall Study|Adverse Event|2|||
143462677|NCT02795429|517240829|FG002|Overall Study|Adverse Event|1|||
143462678|NCT02795429|517240830|FG003|Overall Study|Adverse Event|2|||
143462679|NCT02795429|517240831|FG004|Overall Study|Adverse Event|1|||
143462680|NCT02795429|517240827|FG000|Overall Study|Death|1|||
143355546|NCT01500226|516846834|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
143355547|NCT01500226|516846835|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
143355548|NCT01500226|516846834|FG000|Overall Study|Withdrawal by Subject|93|||
143355549|NCT01500226|516846835|FG001|Overall Study|Withdrawal by Subject|96|||
143462681|NCT02795429|517240828|FG001|Overall Study|Death|0|||
143462682|NCT02795429|517240829|FG002|Overall Study|Death|1|||
143462683|NCT02795429|517240830|FG003|Overall Study|Death|2|||
143462684|NCT02795429|517240831|FG004|Overall Study|Death|1|||
143462685|NCT02795429|517240827|FG000|Overall Study|Physician Decision|0|||
143462686|NCT02795429|517240828|FG001|Overall Study|Physician Decision|0|||
143462687|NCT02795429|517240829|FG002|Overall Study|Physician Decision|2|||
143462688|NCT02795429|517240830|FG003|Overall Study|Physician Decision|1|||
143462689|NCT02795429|517240831|FG004|Overall Study|Physician Decision|5|||
143462690|NCT02795429|517240827|FG000|Overall Study|Progressive disease|3|||
143462691|NCT02795429|517240828|FG001|Overall Study|Progressive disease|7|||
143462692|NCT02795429|517240829|FG002|Overall Study|Progressive disease|6|||
143462693|NCT02795429|517240830|FG003|Overall Study|Progressive disease|26|||
143462694|NCT02795429|517240831|FG004|Overall Study|Progressive disease|20|||
143462695|NCT02795429|517240827|FG000|Overall Study|Subject/guardian decision|1|||
143462696|NCT02795429|517240828|FG001|Overall Study|Subject/guardian decision|1|||
143462697|NCT02795429|517240829|FG002|Overall Study|Subject/guardian decision|1|||
143462698|NCT02795429|517240830|FG003|Overall Study|Subject/guardian decision|1|||
143462699|NCT02795429|517240831|FG004|Overall Study|Subject/guardian decision|3|||
143462700|NCT03442985|517240832|FG000|Overall Study|Sponsor Request|55|||
143462701|NCT03442985|517240833|FG001|Overall Study|Sponsor Request|60|||
143462702|NCT03442985|517240834|FG002|Overall Study|Sponsor Request|54|||
143462703|NCT03442985|517240832|FG000|Overall Study|Lost to Follow-up|5|||
143462704|NCT03442985|517240833|FG001|Overall Study|Lost to Follow-up|2|||
143462705|NCT03442985|517240834|FG002|Overall Study|Lost to Follow-up|7|||
143462706|NCT03442985|517240832|FG000|Overall Study|Withdrawal by Subject|2|||
143462707|NCT03442985|517240833|FG001|Overall Study|Withdrawal by Subject|3|||
143462708|NCT03442985|517240834|FG002|Overall Study|Withdrawal by Subject|4|||
143462709|NCT03442985|517240832|FG000|Overall Study|Adverse Event|0|||
143462710|NCT03442985|517240833|FG001|Overall Study|Adverse Event|1|||
143462711|NCT03442985|517240834|FG002|Overall Study|Adverse Event|0|||
143462712|NCT01716117|517240838|FG000|Overall Study|Death|5|||
143462713|NCT01716117|517240839|FG001|Overall Study|Death|2|||
143462714|NCT01716117|517240838|FG000|Overall Study|Withdrawal by Subject|2|||
143462715|NCT01716117|517240839|FG001|Overall Study|Withdrawal by Subject|0|||
143462716|NCT01557283|517240840|FG000|Overall Study|Lost to Follow-up|7|||
143462717|NCT01557283|517240840|FG000|Overall Study|Non-responder|19|||
143462718|NCT01557283|517240840|FG000|Overall Study|Adverse Event|7|||
143462719|NCT01557283|517240840|FG000|Overall Study|Lack of Efficacy|1|||
143462720|NCT01557283|517240840|FG000|Overall Study|Non-compliance|1|||
143462721|NCT01557283|517240840|FG000|Overall Study|Withdrawal by Subject|1|||
143462722|NCT01557283|517240840|FG000|Overall Study|Participant's weight too high for dose|1|||
143462723|NCT01557283|517240840|FG000|Overall Study|Worsening of psoriasis|1|||
143355550|NCT01500226|516846834|FG000|Overall Study|Death|12|||
143355551|NCT01500226|516846835|FG001|Overall Study|Death|4|||
143355552|NCT01500226|516846834|FG000|Overall Study|Disease Progression|16|||
143355553|NCT01500226|516846835|FG001|Overall Study|Disease Progression|14|||
143355554|NCT01500226|516846834|FG000|Overall Study|Protocol Violation|53|||
143355555|NCT01500226|516846835|FG001|Overall Study|Protocol Violation|39|||
143355556|NCT01500226|516846834|FG000|Overall Study|Physician Decision|17|||
143355557|NCT01500226|516846835|FG001|Overall Study|Physician Decision|15|||
143355558|NCT01500226|516846834|FG000|Overall Study|Lack of Efficacy|14|||
143355559|NCT01500226|516846835|FG001|Overall Study|Lack of Efficacy|30|||
143355560|NCT01500226|516846834|FG000|Overall Study|Lost to Follow-up|9|||
143355561|NCT01500226|516846835|FG001|Overall Study|Lost to Follow-up|5|||
143355562|NCT01500226|516846834|FG000|Overall Study|Other Reasons|19|||
143355563|NCT01500226|516846835|FG001|Overall Study|Other Reasons|16|||
143355564|NCT04212169|516846836|FG000|Overall Study|Adverse Event|0|||
143355565|NCT04212169|516846837|FG001|Overall Study|Adverse Event|0|||
143355566|NCT04212169|516846838|FG002|Overall Study|Adverse Event|0|||
143355567|NCT04212169|516846839|FG003|Overall Study|Adverse Event|2|||
143355568|NCT04212169|516846836|FG000|Overall Study|Lost to Follow-up|1|||
143462724|NCT01557283|517240840|FG000|Overall Study|Other|6|||
143462725|NCT03645057|517240844|FG000|Randomization to Baseline|Lost to Follow-up|1|||
143462726|NCT03645057|517240845|FG001|Randomization to Baseline|Lost to Follow-up|0|||
143462727|NCT03645057|517240846|FG002|Randomization to Baseline|Lost to Follow-up|1|||
143462728|NCT03645057|517240847|FG003|Randomization to Baseline|Lost to Follow-up|0|||
143462729|NCT03645057|517240844|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
143462730|NCT03645057|517240845|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
143462731|NCT03645057|517240846|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
143462732|NCT03645057|517240847|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
143462733|NCT03645057|517240844|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
143462734|NCT03645057|517240845|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
143462735|NCT03645057|517240846|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
143462736|NCT03645057|517240847|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
143462737|NCT03645057|517240844|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
143462738|NCT03645057|517240845|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
143462739|NCT03645057|517240846|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
143462740|NCT03645057|517240847|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
143462741|NCT01873495|517240848|FG000|Overall Study|Withdrawal by Subject|1|||
143462742|NCT01873495|517240848|FG000|Overall Study|Physician Decision|3|||
143462743|NCT01873495|517240848|FG000|Overall Study|Adverse Event|1|||
143462744|NCT01873495|517240848|FG000|Overall Study|Removed for Transplantation|1|||
143462745|NCT01873495|517240848|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
143462746|NCT03214094|517240849|FG000|Overall Study|Case Report Forms Uncollected|14|||
143462747|NCT03214094|517240849|FG000|Overall Study|Protocol Deviation|46|||
143462748|NCT02435966|517240852|FG000|Overall Study|Withdrawal by Subject|0|||
143462749|NCT02435966|517240853|FG001|Overall Study|Withdrawal by Subject|1|||
143462750|NCT02435966|517240854|FG002|Overall Study|Withdrawal by Subject|0|||
143462751|NCT02745392|517240858|FG000|Overall Study|Lost to Follow-up|0|||
143462752|NCT02745392|517240859|FG001|Overall Study|Lost to Follow-up|1|||
143462753|NCT02745392|517240860|FG002|Overall Study|Lost to Follow-up|0|||
143462754|NCT02745392|517240861|FG003|Overall Study|Lost to Follow-up|0|||
143462755|NCT01959334|517240862|FG000|Second Dose|Adverse Event|1|||
143462756|NCT01959334|517240863|FG001|Second Dose|Adverse Event|0|||
143462757|NCT01959334|517240862|FG000|Third Dose|Adverse Event|0|||
143462758|NCT01959334|517240863|FG001|Third Dose|Adverse Event|1|||
143462759|NCT01007448|517240865|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
143462760|NCT01007448|517240866|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
143462761|NCT01007448|517240865|FG000|Overall Study|Staph Skin Infection Flare|1|||
143462762|NCT01007448|517240866|FG001|Overall Study|Staph Skin Infection Flare|0|||
143462763|NCT01007448|517240865|FG000|Overall Study|Participant Leaving the Country|1|||
143462764|NCT01007448|517240866|FG001|Overall Study|Participant Leaving the Country|0|||
143462765|NCT01007448|517240865|FG000|Overall Study|Participant Given Prohibited Medication|1|||
143462766|NCT01007448|517240866|FG001|Overall Study|Participant Given Prohibited Medication|0|||
143462767|NCT01007448|517240865|FG000|Overall Study|Progressive Disease|1|||
143462768|NCT01007448|517240866|FG001|Overall Study|Progressive Disease|2|||
143462769|NCT01007448|517240865|FG000|Overall Study|Lack of Efficacy|2|||
143462770|NCT01007448|517240866|FG001|Overall Study|Lack of Efficacy|0|||
143462771|NCT01007448|517240865|FG000|Overall Study|Withdrawal by Subject|2|||
143462772|NCT01007448|517240866|FG001|Overall Study|Withdrawal by Subject|3|||
143462773|NCT01007448|517240865|FG000|Overall Study|Adverse Event|1|||
143462774|NCT01007448|517240866|FG001|Overall Study|Adverse Event|4|||
143462775|NCT00887432|517240867|FG000|Overall Study|Start Excluded Therapy|3|||
143462776|NCT00887432|517240868|FG001|Overall Study|Start Excluded Therapy|0|||
143462777|NCT00887432|517240867|FG000|Overall Study|Did not complete treatment|6|||
143462778|NCT00887432|517240868|FG001|Overall Study|Did not complete treatment|8|||
143462779|NCT00887432|517240867|FG000|Overall Study|Protocol Violation|2|||
143462780|NCT00887432|517240868|FG001|Overall Study|Protocol Violation|3|||
143462781|NCT00887432|517240867|FG000|Overall Study|Withdrawal by Subject|3|||
143462782|NCT00887432|517240868|FG001|Overall Study|Withdrawal by Subject|2|||
143462783|NCT00887432|517240867|FG000|Overall Study|Lost to Follow-up|1|||
143462784|NCT00887432|517240868|FG001|Overall Study|Lost to Follow-up|0|||
143462785|NCT00887432|517240867|FG000|Overall Study|No reason provided|0|||
143462786|NCT00887432|517240868|FG001|Overall Study|No reason provided|1|||
143462787|NCT00899548|517240869|FG000|Overall Study|Physician Decision|3|||
143462788|NCT01337115|517240870|FG000|Overall Study|Protocol Violation|2|||
143462789|NCT01337115|517240871|FG001|Overall Study|Protocol Violation|0|||
143462790|NCT01636960|517240876|FG000|Induction Phase|Adverse Event|2|||
143462791|NCT01636960|517240876|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
143462792|NCT01636960|517240876|FG000|Maintenance Phase|Adverse Event|3|||
143462793|NCT01636960|517240876|FG000|Maintenance Phase|Progressive disease|1|||
143462794|NCT01209780|517240878|FG000|Overall Study|Adverse Event|0|||
143462795|NCT01209780|517240879|FG001|Overall Study|Adverse Event|1|||
143462796|NCT01209780|517240880|FG002|Overall Study|Adverse Event|0|||
143462797|NCT01209780|517240881|FG003|Overall Study|Adverse Event|0|||
143355569|NCT04212169|516846837|FG001|Overall Study|Lost to Follow-up|0|||
143355570|NCT04212169|516846838|FG002|Overall Study|Lost to Follow-up|0|||
143355571|NCT04212169|516846839|FG003|Overall Study|Lost to Follow-up|2|||
143462798|NCT01209780|517240882|FG004|Overall Study|Adverse Event|0|||
143462799|NCT01209780|517240878|FG000|Overall Study|Withdrawal by Subject|9|||
143462800|NCT01209780|517240879|FG001|Overall Study|Withdrawal by Subject|2|||
143462801|NCT01209780|517240880|FG002|Overall Study|Withdrawal by Subject|1|||
143462802|NCT01209780|517240881|FG003|Overall Study|Withdrawal by Subject|1|||
143462803|NCT01209780|517240882|FG004|Overall Study|Withdrawal by Subject|0|||
143462804|NCT01209780|517240878|FG000|Overall Study|Lost to Follow-up|17|||
143462805|NCT01209780|517240879|FG001|Overall Study|Lost to Follow-up|12|||
143355572|NCT04212169|516846836|FG000|Overall Study|Withdrawal by Subject|10|||
143355573|NCT04212169|516846837|FG001|Overall Study|Withdrawal by Subject|2|||
143355574|NCT04212169|516846838|FG002|Overall Study|Withdrawal by Subject|5|||
143355575|NCT04212169|516846839|FG003|Overall Study|Withdrawal by Subject|7|||
143355576|NCT04212169|516846836|FG000|Overall Study|Other reason, unspecified|3|||
143355577|NCT04212169|516846837|FG001|Overall Study|Other reason, unspecified|1|||
143355578|NCT04212169|516846838|FG002|Overall Study|Other reason, unspecified|0|||
143355579|NCT04212169|516846839|FG003|Overall Study|Other reason, unspecified|2|||
143355580|NCT02018861|516846849|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
143355581|NCT02018861|516846850|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
143355582|NCT02018861|516846851|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
143355583|NCT02018861|516846852|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
143355584|NCT02018861|516846853|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
143355585|NCT02018861|516846854|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
143355586|NCT02018861|516846855|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
143355587|NCT02018861|516846856|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
143355588|NCT02018861|516846857|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
143355589|NCT02018861|516846858|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
143355590|NCT02018861|516846849|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
143355591|NCT02018861|516846850|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
143355592|NCT02018861|516846851|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
143355593|NCT02018861|516846852|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
143355594|NCT02018861|516846853|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
143355595|NCT02018861|516846854|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
143355596|NCT02018861|516846855|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
143355597|NCT02018861|516846856|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
143355598|NCT02018861|516846857|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
143355599|NCT02018861|516846858|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
143355600|NCT02018861|516846849|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
143355601|NCT02018861|516846850|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
143355602|NCT02018861|516846851|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
143355603|NCT02018861|516846852|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
143355604|NCT02018861|516846853|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
143355605|NCT02018861|516846854|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
143355606|NCT02018861|516846855|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
143355607|NCT02018861|516846856|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
143355608|NCT02018861|516846857|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
143355609|NCT02018861|516846858|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
143355610|NCT02018861|516846849|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
143355611|NCT02018861|516846850|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
143355612|NCT02018861|516846851|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
143355613|NCT02018861|516846852|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
143355614|NCT02018861|516846853|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
143355615|NCT02018861|516846854|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
143355616|NCT02018861|516846855|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
143355617|NCT02018861|516846856|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
143355618|NCT02018861|516846857|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
143355619|NCT02018861|516846858|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
143355620|NCT02018861|516846849|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
143355621|NCT02018861|516846850|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
143355622|NCT02018861|516846851|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
143013030|NCT00080288|515587995|FG001|Overall Study|Miscellaneous|11|||
143013031|NCT03456726|515587996|FG000|Overall Study|Disease Progression|6|||
143013032|NCT03456726|515587997|FG001|Overall Study|Disease Progression|1|||
143013033|NCT03456726|515587996|FG000|Overall Study|Adverse Event|4|||
143013034|NCT03456726|515587997|FG001|Overall Study|Adverse Event|2|||
143013035|NCT03456726|515587996|FG000|Overall Study|Withdrawal by Subject|1|||
143355623|NCT02018861|516846852|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
143355624|NCT02018861|516846853|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
143355625|NCT02018861|516846854|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
143355626|NCT02018861|516846855|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
143355627|NCT02018861|516846856|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
143355628|NCT02018861|516846857|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
143013036|NCT03456726|515587997|FG001|Overall Study|Withdrawal by Subject|0|||
143013037|NCT03456726|515587996|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
143013038|NCT03456726|515587997|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
143013039|NCT00399490|515587998|FG000|Overall Study|Adverse Event|19|||
143462806|NCT01209780|517240880|FG002|Overall Study|Lost to Follow-up|3|||
143462807|NCT01209780|517240881|FG003|Overall Study|Lost to Follow-up|9|||
143462808|NCT01209780|517240882|FG004|Overall Study|Lost to Follow-up|4|||
143462809|NCT01209780|517240878|FG000|Overall Study|Protocol Violation|0|||
143462810|NCT01209780|517240879|FG001|Overall Study|Protocol Violation|1|||
143462811|NCT01209780|517240880|FG002|Overall Study|Protocol Violation|0|||
143462812|NCT01209780|517240881|FG003|Overall Study|Protocol Violation|0|||
143462813|NCT01209780|517240882|FG004|Overall Study|Protocol Violation|0|||
143462814|NCT01209780|517240878|FG000|Overall Study|Inappropriate enrollment|0|||
143462815|NCT01209780|517240879|FG001|Overall Study|Inappropriate enrollment|2|||
143462816|NCT01209780|517240880|FG002|Overall Study|Inappropriate enrollment|0|||
143462817|NCT01209780|517240881|FG003|Overall Study|Inappropriate enrollment|0|||
143462818|NCT01209780|517240882|FG004|Overall Study|Inappropriate enrollment|1|||
143462819|NCT01580969|517240883|FG000|Overall Study|Physician Decision|3|||
143462820|NCT01580969|517240884|FG001|Overall Study|Physician Decision|0|||
143462821|NCT01580969|517240885|FG002|Overall Study|Physician Decision|0|||
143462822|NCT01745848|517240886|FG000|Overall Study|Adverse Event|6|||
143462823|NCT00448123|517240887|FG000|Overall Study|Lost to Follow-up|9|||
143462824|NCT00448123|517240888|FG001|Overall Study|Lost to Follow-up|6|||
143462825|NCT00448123|517240887|FG000|Overall Study|Physician Decision|6|||
143462826|NCT00448123|517240888|FG001|Overall Study|Physician Decision|6|||
143462827|NCT02027623|517240890|FG000|Overall Study|Lost to Follow-up|3|||
143462828|NCT02027623|517240891|FG001|Overall Study|Lost to Follow-up|3|||
143462829|NCT02027623|517240890|FG000|Overall Study|Withdrawal by Subject|6|||
143462830|NCT02027623|517240891|FG001|Overall Study|Withdrawal by Subject|9|||
143462831|NCT01886378|517240894|FG000|Overall Study|Adverse Event|1|||
143462832|NCT01886378|517240894|FG000|Overall Study|Withdrawal by Subject|4|||
143462833|NCT02318797|517240895|FG000|Overall Study|Death|3|||
143462834|NCT02318797|517240896|FG001|Overall Study|Death|6|||
143462835|NCT02318797|517240895|FG000|Overall Study|Lost to Follow-up|85|||
143462836|NCT02318797|517240896|FG001|Overall Study|Lost to Follow-up|96|||
143462837|NCT00406653|517240900|FG000|Induction Period|Adverse Event|1|||
143462838|NCT00406653|517240901|FG001|Induction Period|Adverse Event|10|||
143462839|NCT00406653|517240902|FG002|Induction Period|Adverse Event|4|||
143462840|NCT00406653|517240903|FG003|Induction Period|Adverse Event|11|||
143462841|NCT00406653|517240904|FG004|Induction Period|Adverse Event|0|||
143462842|NCT00406653|517240905|FG005|Induction Period|Adverse Event|0|||
143462843|NCT00406653|517240906|FG006|Induction Period|Adverse Event|0|||
143462844|NCT00406653|517240900|FG000|Induction Period|Lack of Efficacy|11|||
143462845|NCT00406653|517240901|FG001|Induction Period|Lack of Efficacy|14|||
143462846|NCT00406653|517240902|FG002|Induction Period|Lack of Efficacy|8|||
143462847|NCT00406653|517240903|FG003|Induction Period|Lack of Efficacy|10|||
143462848|NCT00406653|517240904|FG004|Induction Period|Lack of Efficacy|0|||
143462849|NCT00406653|517240905|FG005|Induction Period|Lack of Efficacy|0|||
143462850|NCT00406653|517240906|FG006|Induction Period|Lack of Efficacy|0|||
143462851|NCT00406653|517240900|FG000|Induction Period|Lost to Follow-up|0|||
143462852|NCT00406653|517240901|FG001|Induction Period|Lost to Follow-up|2|||
143462853|NCT00406653|517240902|FG002|Induction Period|Lost to Follow-up|0|||
143462854|NCT00406653|517240903|FG003|Induction Period|Lost to Follow-up|0|||
143462855|NCT00406653|517240904|FG004|Induction Period|Lost to Follow-up|0|||
143462856|NCT00406653|517240905|FG005|Induction Period|Lost to Follow-up|0|||
143462857|NCT00406653|517240906|FG006|Induction Period|Lost to Follow-up|0|||
143462858|NCT00406653|517240900|FG000|Induction Period|Withdrawal of Consent|2|||
143462859|NCT00406653|517240901|FG001|Induction Period|Withdrawal of Consent|5|||
143462860|NCT00406653|517240902|FG002|Induction Period|Withdrawal of Consent|1|||
143462861|NCT00406653|517240903|FG003|Induction Period|Withdrawal of Consent|2|||
143462862|NCT00406653|517240904|FG004|Induction Period|Withdrawal of Consent|0|||
143462863|NCT00406653|517240905|FG005|Induction Period|Withdrawal of Consent|0|||
143462864|NCT00406653|517240906|FG006|Induction Period|Withdrawal of Consent|0|||
143462865|NCT00406653|517240900|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
143462866|NCT00406653|517240901|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
143462867|NCT00406653|517240902|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
143462868|NCT00406653|517240903|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
143462869|NCT00406653|517240904|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
143462870|NCT00406653|517240905|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
143462871|NCT00406653|517240906|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
143462872|NCT00406653|517240900|FG000|Induction Period|Pregnancy|1|||
143462873|NCT00406653|517240901|FG001|Induction Period|Pregnancy|0|||
143462874|NCT00406653|517240902|FG002|Induction Period|Pregnancy|0|||
143462875|NCT00406653|517240903|FG003|Induction Period|Pregnancy|0|||
143462876|NCT00406653|517240904|FG004|Induction Period|Pregnancy|0|||
143462877|NCT00406653|517240905|FG005|Induction Period|Pregnancy|0|||
143462878|NCT00406653|517240906|FG006|Induction Period|Pregnancy|0|||
143462879|NCT00406653|517240900|FG000|Induction Period|Declined participation but followup done|0|||
143462880|NCT00406653|517240901|FG001|Induction Period|Declined participation but followup done|2|||
143462881|NCT00406653|517240902|FG002|Induction Period|Declined participation but followup done|1|||
143462882|NCT00406653|517240903|FG003|Induction Period|Declined participation but followup done|1|||
143355629|NCT02018861|516846858|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
143355630|NCT02018861|516846849|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
143355631|NCT02018861|516846850|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
143355632|NCT02018861|516846851|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
143355633|NCT02018861|516846852|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
143355634|NCT02018861|516846853|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
143355635|NCT02018861|516846854|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
143355636|NCT02018861|516846855|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
143355637|NCT02018861|516846856|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
143355638|NCT02018861|516846857|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
143355639|NCT02018861|516846858|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
143355640|NCT02018861|516846849|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
143355641|NCT02018861|516846850|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
143355642|NCT02018861|516846851|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
143355643|NCT02018861|516846852|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
143355644|NCT02018861|516846853|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
143355645|NCT02018861|516846854|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
143355646|NCT02018861|516846855|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
143355647|NCT02018861|516846856|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
143355648|NCT02018861|516846857|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
143355649|NCT02018861|516846858|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
143355650|NCT02018861|516846849|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
143355651|NCT02018861|516846850|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
143355652|NCT02018861|516846851|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
143355653|NCT02018861|516846852|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
143355654|NCT02018861|516846853|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
143355655|NCT02018861|516846854|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
143355656|NCT02018861|516846855|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
143355657|NCT02018861|516846856|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
143355658|NCT02018861|516846857|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
143355659|NCT02018861|516846858|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
143355660|NCT02018861|516846849|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
143355661|NCT02018861|516846850|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
143355662|NCT02018861|516846851|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
143355663|NCT02018861|516846852|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
143355664|NCT02018861|516846853|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
143355665|NCT02018861|516846854|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
143355666|NCT02018861|516846855|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
143355667|NCT02018861|516846856|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
143355668|NCT02018861|516846857|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
143355669|NCT02018861|516846858|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
143355670|NCT02018861|516846849|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
143355671|NCT02018861|516846850|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
143355672|NCT02018861|516846851|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
143355673|NCT02018861|516846852|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
143355674|NCT02018861|516846853|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
143355675|NCT02018861|516846854|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
143355676|NCT02018861|516846855|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
143355677|NCT02018861|516846856|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
143355678|NCT02018861|516846857|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
143355679|NCT02018861|516846858|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
143355680|NCT02018861|516846849|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
143355681|NCT02018861|516846850|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
143355682|NCT02018861|516846851|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
143355683|NCT02018861|516846852|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
143355684|NCT02018861|516846853|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
143355685|NCT02018861|516846854|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
143355686|NCT02018861|516846855|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
143462883|NCT00406653|517240904|FG004|Induction Period|Declined participation but followup done|0|||
143462884|NCT00406653|517240905|FG005|Induction Period|Declined participation but followup done|0|||
143462885|NCT00406653|517240906|FG006|Induction Period|Declined participation but followup done|0|||
143462886|NCT00406653|517240900|FG000|Induction Period|Given prohibited drug|0|||
143462887|NCT00406653|517240901|FG001|Induction Period|Given prohibited drug|1|||
143462888|NCT00406653|517240902|FG002|Induction Period|Given prohibited drug|2|||
143462889|NCT00406653|517240903|FG003|Induction Period|Given prohibited drug|0|||
143462890|NCT00406653|517240904|FG004|Induction Period|Given prohibited drug|0|||
143462891|NCT00406653|517240905|FG005|Induction Period|Given prohibited drug|0|||
143462892|NCT00406653|517240906|FG006|Induction Period|Given prohibited drug|0|||
143462893|NCT00406653|517240900|FG000|Induction Period|Incarcerated|0|||
143462894|NCT00406653|517240901|FG001|Induction Period|Incarcerated|0|||
143462895|NCT00406653|517240902|FG002|Induction Period|Incarcerated|1|||
143462896|NCT00406653|517240903|FG003|Induction Period|Incarcerated|0|||
143462897|NCT00406653|517240904|FG004|Induction Period|Incarcerated|0|||
143462898|NCT00406653|517240905|FG005|Induction Period|Incarcerated|0|||
143462899|NCT00406653|517240906|FG006|Induction Period|Incarcerated|0|||
143462900|NCT00406653|517240900|FG000|Induction Period|Patient relocated|0|||
143462901|NCT00406653|517240901|FG001|Induction Period|Patient relocated|0|||
143462902|NCT00406653|517240902|FG002|Induction Period|Patient relocated|1|||
143462903|NCT00406653|517240903|FG003|Induction Period|Patient relocated|0|||
143462904|NCT00406653|517240904|FG004|Induction Period|Patient relocated|0|||
143462905|NCT00406653|517240905|FG005|Induction Period|Patient relocated|0|||
143462906|NCT00406653|517240906|FG006|Induction Period|Patient relocated|0|||
143462907|NCT00406653|517240900|FG000|Maintenance Period|Adverse Event|0|||
143462908|NCT00406653|517240901|FG001|Maintenance Period|Adverse Event|0|||
143462909|NCT00406653|517240902|FG002|Maintenance Period|Adverse Event|0|||
143462910|NCT00406653|517240903|FG003|Maintenance Period|Adverse Event|0|||
143462911|NCT00406653|517240904|FG004|Maintenance Period|Adverse Event|1|||
143462912|NCT00406653|517240905|FG005|Maintenance Period|Adverse Event|1|||
143462913|NCT00406653|517240906|FG006|Maintenance Period|Adverse Event|0|||
143462914|NCT00406653|517240900|FG000|Maintenance Period|Lack of Efficacy|0|||
143462915|NCT00406653|517240901|FG001|Maintenance Period|Lack of Efficacy|0|||
143355687|NCT02018861|516846856|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
143355688|NCT02018861|516846857|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
143355689|NCT02018861|516846858|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
143462916|NCT00406653|517240902|FG002|Maintenance Period|Lack of Efficacy|0|||
143462917|NCT00406653|517240903|FG003|Maintenance Period|Lack of Efficacy|0|||
143462918|NCT00406653|517240904|FG004|Maintenance Period|Lack of Efficacy|20|||
143462919|NCT00406653|517240905|FG005|Maintenance Period|Lack of Efficacy|26|||
143355690|NCT02018861|516846849|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
143355691|NCT02018861|516846850|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
143355692|NCT02018861|516846851|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
143355693|NCT02018861|516846852|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
143355694|NCT02018861|516846853|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
143355695|NCT02018861|516846854|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
143355696|NCT02018861|516846855|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
143355697|NCT02018861|516846856|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
143355698|NCT02018861|516846857|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
143355699|NCT02018861|516846858|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
143355700|NCT02018861|516846849|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
143355701|NCT02018861|516846850|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
143355702|NCT02018861|516846851|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
143355703|NCT02018861|516846852|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
143355704|NCT02018861|516846853|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
143355705|NCT02018861|516846854|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
143355706|NCT02018861|516846855|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
143355707|NCT02018861|516846856|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
143355708|NCT02018861|516846857|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
143355709|NCT02018861|516846858|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
143355710|NCT01809210|516846862|FG000|Overall Study|Withdrawal by Subject|0|||
143355711|NCT01809210|516846863|FG001|Overall Study|Withdrawal by Subject|0|||
143355712|NCT01809210|516846864|FG002|Overall Study|Withdrawal by Subject|1|||
143355713|NCT01809210|516846865|FG003|Overall Study|Withdrawal by Subject|1|||
143355714|NCT01809210|516846866|FG004|Overall Study|Withdrawal by Subject|1|||
143355715|NCT01809210|516846867|FG005|Overall Study|Withdrawal by Subject|0|||
143355716|NCT01809210|516846868|FG006|Overall Study|Withdrawal by Subject|4|||
143355717|NCT01809210|516846862|FG000|Overall Study|Death|1|||
143355718|NCT01809210|516846863|FG001|Overall Study|Death|1|||
143355719|NCT01809210|516846864|FG002|Overall Study|Death|2|||
143462920|NCT00406653|517240906|FG006|Maintenance Period|Lack of Efficacy|0|||
143462921|NCT00406653|517240900|FG000|Maintenance Period|Lost to Follow-up|0|||
143462922|NCT00406653|517240901|FG001|Maintenance Period|Lost to Follow-up|0|||
143462923|NCT00406653|517240902|FG002|Maintenance Period|Lost to Follow-up|0|||
143462924|NCT00406653|517240903|FG003|Maintenance Period|Lost to Follow-up|0|||
143462925|NCT00406653|517240904|FG004|Maintenance Period|Lost to Follow-up|2|||
143462926|NCT00406653|517240905|FG005|Maintenance Period|Lost to Follow-up|1|||
143462927|NCT00406653|517240906|FG006|Maintenance Period|Lost to Follow-up|0|||
143355720|NCT01809210|516846865|FG003|Overall Study|Death|0|||
143355721|NCT01809210|516846866|FG004|Overall Study|Death|1|||
143355722|NCT01809210|516846867|FG005|Overall Study|Death|3|||
143355723|NCT01809210|516846868|FG006|Overall Study|Death|1|||
143355724|NCT00590980|516846869|FG000|Overall Study|Did not meet all inclusion criteria|10|||
143355725|NCT00504348|516846870|FG000|Overall Study|Adverse Event|3|||
143355726|NCT00504348|516846870|FG000|Overall Study|Lack of Efficacy|4|||
143355727|NCT00504348|516846870|FG000|Overall Study|Physician Decision|1|||
143355728|NCT00224133|516846871|FG000|Overall Study|Adverse Event|93|||
143355729|NCT00224133|516846871|FG000|Overall Study|Protocol Violation|6|||
143355730|NCT00224133|516846871|FG000|Overall Study|Withdrawal by Subject|33|||
143355731|NCT00224133|516846871|FG000|Overall Study|Lack of Efficacy|58|||
143355732|NCT00224133|516846871|FG000|Overall Study|Lost to Follow-up|21|||
143355733|NCT00224133|516846871|FG000|Overall Study|Physician Decision|1|||
143355734|NCT00224133|516846871|FG000|Overall Study|Other|14|||
143355735|NCT03699124|516846875|FG000|Overall Study|Adverse Event|6|||
143355736|NCT03699124|516846876|FG001|Overall Study|Adverse Event|5|||
143355737|NCT03699124|516846877|FG002|Overall Study|Adverse Event|2|||
143355738|NCT03699124|516846875|FG000|Overall Study|Death|0|||
143355739|NCT03699124|516846876|FG001|Overall Study|Death|2|||
143355740|NCT03699124|516846877|FG002|Overall Study|Death|0|||
143355741|NCT03699124|516846875|FG000|Overall Study|Lost to Follow-up|20|||
143355742|NCT03699124|516846876|FG001|Overall Study|Lost to Follow-up|16|||
143355743|NCT03699124|516846877|FG002|Overall Study|Lost to Follow-up|15|||
143355744|NCT03699124|516846875|FG000|Overall Study|Protocol Violation|1|||
143355745|NCT03699124|516846876|FG001|Overall Study|Protocol Violation|0|||
143355746|NCT03699124|516846877|FG002|Overall Study|Protocol Violation|0|||
143355747|NCT03699124|516846875|FG000|Overall Study|Withdrawal by Subject|13|||
143355748|NCT03699124|516846876|FG001|Overall Study|Withdrawal by Subject|14|||
143355749|NCT03699124|516846877|FG002|Overall Study|Withdrawal by Subject|13|||
143355750|NCT03699124|516846875|FG000|Overall Study|Other reasons|5|||
143355751|NCT03699124|516846876|FG001|Overall Study|Other reasons|3|||
143355752|NCT03699124|516846877|FG002|Overall Study|Other reasons|10|||
143355753|NCT02718417|516846879|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
143355754|NCT02718417|516846880|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
143355755|NCT02718417|516846881|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
143355756|NCT02718417|516846879|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
143355757|NCT02718417|516846880|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
143355758|NCT02718417|516846881|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
143355759|NCT02718417|516846879|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
143355760|NCT02718417|516846880|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
143355761|NCT02718417|516846881|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
143355762|NCT02718417|516846879|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
143355763|NCT02718417|516846880|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
143355764|NCT02718417|516846881|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
143355765|NCT02718417|516846879|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
143355766|NCT02718417|516846880|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
143355767|NCT02718417|516846881|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
143355768|NCT02718417|516846879|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
143355769|NCT02718417|516846880|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
143355770|NCT02718417|516846881|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
143355771|NCT02718417|516846879|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
143355772|NCT02718417|516846880|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
143355773|NCT02718417|516846881|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
143355774|NCT02718417|516846879|FG000|Chemotherapy Phase (CP)|Other|2|||
143355775|NCT02718417|516846880|FG001|Chemotherapy Phase (CP)|Other|0|||
143355776|NCT02718417|516846881|FG002|Chemotherapy Phase (CP)|Other|1|||
143355777|NCT02718417|516846879|FG000|Maintenance Phase (MP)|Adverse Event|21|||
143355778|NCT02718417|516846880|FG001|Maintenance Phase (MP)|Adverse Event|26|||
143355779|NCT02718417|516846881|FG002|Maintenance Phase (MP)|Adverse Event|0|||
143355780|NCT02718417|516846879|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
143355781|NCT02718417|516846880|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
143355782|NCT02718417|516846881|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
143355783|NCT02718417|516846879|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
143355784|NCT02718417|516846880|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
143355785|NCT02718417|516846881|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
143355786|NCT02718417|516846879|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
143355787|NCT02718417|516846880|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
143355788|NCT02718417|516846881|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
143355789|NCT02718417|516846879|FG000|Maintenance Phase (MP)|Physician's decision|6|||
143355790|NCT02718417|516846880|FG001|Maintenance Phase (MP)|Physician's decision|7|||
143355791|NCT02718417|516846881|FG002|Maintenance Phase (MP)|Physician's decision|0|||
143462928|NCT00406653|517240900|FG000|Maintenance Period|Withdrawal of Consent|0|||
143462929|NCT00406653|517240901|FG001|Maintenance Period|Withdrawal of Consent|0|||
143462930|NCT00406653|517240902|FG002|Maintenance Period|Withdrawal of Consent|0|||
143462931|NCT00406653|517240903|FG003|Maintenance Period|Withdrawal of Consent|0|||
143462932|NCT00406653|517240904|FG004|Maintenance Period|Withdrawal of Consent|2|||
143462933|NCT00406653|517240905|FG005|Maintenance Period|Withdrawal of Consent|0|||
143462934|NCT00406653|517240906|FG006|Maintenance Period|Withdrawal of Consent|0|||
143462935|NCT00406653|517240900|FG000|Maintenance Period|Pregnancy|0|||
143462936|NCT00406653|517240901|FG001|Maintenance Period|Pregnancy|0|||
143462937|NCT00406653|517240902|FG002|Maintenance Period|Pregnancy|0|||
143462938|NCT00406653|517240903|FG003|Maintenance Period|Pregnancy|0|||
143462939|NCT00406653|517240904|FG004|Maintenance Period|Pregnancy|0|||
143462940|NCT00406653|517240905|FG005|Maintenance Period|Pregnancy|1|||
143462941|NCT00406653|517240906|FG006|Maintenance Period|Pregnancy|0|||
143462942|NCT00406653|517240900|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
143462943|NCT00406653|517240901|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
143462944|NCT00406653|517240902|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
143462945|NCT00406653|517240903|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
143462946|NCT00406653|517240904|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
143462947|NCT00406653|517240905|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
143462948|NCT00406653|517240906|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
143462949|NCT00406653|517240900|FG000|Maintenance Period|Error in disease score evaluation|0|||
143462950|NCT00406653|517240901|FG001|Maintenance Period|Error in disease score evaluation|0|||
143462951|NCT00406653|517240902|FG002|Maintenance Period|Error in disease score evaluation|0|||
143462952|NCT00406653|517240903|FG003|Maintenance Period|Error in disease score evaluation|0|||
143462953|NCT00406653|517240904|FG004|Maintenance Period|Error in disease score evaluation|1|||
143462954|NCT00406653|517240905|FG005|Maintenance Period|Error in disease score evaluation|0|||
143462955|NCT00406653|517240906|FG006|Maintenance Period|Error in disease score evaluation|0|||
143462956|NCT00406653|517240900|FG000|Open-Label Period|Death|0|||
143462957|NCT00406653|517240901|FG001|Open-Label Period|Death|0|||
143462958|NCT00406653|517240902|FG002|Open-Label Period|Death|0|||
143462959|NCT00406653|517240903|FG003|Open-Label Period|Death|0|||
143462960|NCT00406653|517240904|FG004|Open-Label Period|Death|0|||
143462961|NCT00406653|517240905|FG005|Open-Label Period|Death|0|||
143462962|NCT00406653|517240906|FG006|Open-Label Period|Death|1|||
143462963|NCT00406653|517240900|FG000|Open-Label Period|Adverse Event|0|||
143462964|NCT00406653|517240901|FG001|Open-Label Period|Adverse Event|0|||
143462965|NCT00406653|517240902|FG002|Open-Label Period|Adverse Event|0|||
143462966|NCT00406653|517240903|FG003|Open-Label Period|Adverse Event|0|||
143462967|NCT00406653|517240904|FG004|Open-Label Period|Adverse Event|0|||
143462968|NCT00406653|517240905|FG005|Open-Label Period|Adverse Event|0|||
143462969|NCT00406653|517240906|FG006|Open-Label Period|Adverse Event|18|||
143462970|NCT00406653|517240900|FG000|Open-Label Period|Lack of Efficacy|0|||
143462971|NCT00406653|517240901|FG001|Open-Label Period|Lack of Efficacy|0|||
143462972|NCT00406653|517240902|FG002|Open-Label Period|Lack of Efficacy|0|||
143462973|NCT00406653|517240903|FG003|Open-Label Period|Lack of Efficacy|0|||
143355792|NCT02718417|516846879|FG000|Maintenance Phase (MP)|Progressive disease|100|||
143355793|NCT02718417|516846880|FG001|Maintenance Phase (MP)|Progressive disease|88|||
143355794|NCT02718417|516846881|FG002|Maintenance Phase (MP)|Progressive disease|0|||
143355795|NCT02718417|516846879|FG000|Maintenance Phase (MP)|Other|2|||
143355796|NCT02718417|516846880|FG001|Maintenance Phase (MP)|Other|1|||
143355797|NCT02718417|516846881|FG002|Maintenance Phase (MP)|Other|0|||
143355798|NCT02718417|516846879|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
143355799|NCT02718417|516846880|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
143355800|NCT02718417|516846881|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
143355801|NCT02718417|516846879|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
143355802|NCT02718417|516846880|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
143355803|NCT02718417|516846881|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
143355804|NCT02718417|516846879|FG000|Observation Phase (OP)|Adverse Event|0|||
143355805|NCT02718417|516846880|FG001|Observation Phase (OP)|Adverse Event|0|||
143355806|NCT02718417|516846881|FG002|Observation Phase (OP)|Adverse Event|1|||
143355807|NCT02718417|516846879|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
143355808|NCT02718417|516846880|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
143355809|NCT02718417|516846881|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
143355810|NCT02718417|516846879|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
143355811|NCT02718417|516846880|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
143355812|NCT02718417|516846881|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
143355813|NCT02718417|516846879|FG000|Observation Phase (OP)|Physician Decision|0|||
143355814|NCT02718417|516846880|FG001|Observation Phase (OP)|Physician Decision|0|||
143355815|NCT02718417|516846881|FG002|Observation Phase (OP)|Physician Decision|9|||
143355816|NCT02718417|516846879|FG000|Observation Phase (OP)|Progressive disease|0|||
143355817|NCT02718417|516846880|FG001|Observation Phase (OP)|Progressive disease|0|||
143355818|NCT02718417|516846881|FG002|Observation Phase (OP)|Progressive disease|92|||
143355819|NCT02718417|516846879|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
143355820|NCT02718417|516846880|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
143355821|NCT02718417|516846881|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
143355822|NCT02718417|516846879|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
143355823|NCT02718417|516846880|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
143355824|NCT02718417|516846881|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
143355825|NCT02718417|516846879|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
143355826|NCT02718417|516846880|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
143355827|NCT02718417|516846881|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
143355828|NCT02718417|516846879|FG000|Observation Phase (OP)|Other|0|||
143355829|NCT02718417|516846880|FG001|Observation Phase (OP)|Other|0|||
143355830|NCT02718417|516846881|FG002|Observation Phase (OP)|Other|7|||
143355831|NCT02718417|516846879|FG000|Follow-up Phase|Adverse Event|3|||
143355832|NCT02718417|516846880|FG001|Follow-up Phase|Adverse Event|1|||
143355833|NCT02718417|516846881|FG002|Follow-up Phase|Adverse Event|1|||
143355834|NCT02718417|516846879|FG000|Follow-up Phase|Other|4|||
143355835|NCT02718417|516846880|FG001|Follow-up Phase|Other|6|||
143355836|NCT02718417|516846881|FG002|Follow-up Phase|Other|4|||
143355837|NCT02718417|516846879|FG000|Follow-up Phase|Withdrawal by Subject|19|||
143355838|NCT02718417|516846880|FG001|Follow-up Phase|Withdrawal by Subject|17|||
143355839|NCT02718417|516846881|FG002|Follow-up Phase|Withdrawal by Subject|5|||
143355840|NCT02718417|516846879|FG000|Follow-up Phase|Study terminated by sponsor|100|||
143355841|NCT02718417|516846880|FG001|Follow-up Phase|Study terminated by sponsor|138|||
143355842|NCT02718417|516846881|FG002|Follow-up Phase|Study terminated by sponsor|6|||
143355843|NCT02718417|516846879|FG000|Follow-up Phase|Lost to Follow-up|2|||
143355844|NCT02718417|516846880|FG001|Follow-up Phase|Lost to Follow-up|3|||
143355845|NCT02718417|516846881|FG002|Follow-up Phase|Lost to Follow-up|0|||
143355846|NCT02718417|516846879|FG000|Follow-up Phase|Death leading to discontinuation|7|||
143355847|NCT02718417|516846880|FG001|Follow-up Phase|Death leading to discontinuation|7|||
143355848|NCT02718417|516846881|FG002|Follow-up Phase|Death leading to discontinuation|3|||
143355849|NCT02718417|516846879|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
143355850|NCT02718417|516846880|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
143355851|NCT02718417|516846881|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
143355852|NCT02718417|516846879|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
143355853|NCT02718417|516846880|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
143355854|NCT02718417|516846881|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
143355855|NCT02718417|516846879|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
143355856|NCT02718417|516846880|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
143355857|NCT02718417|516846881|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
143355858|NCT02718417|516846879|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
143355859|NCT02718417|516846880|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
143355860|NCT02718417|516846881|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
143355861|NCT02718417|516846879|FG000|Long-term Follow-up Phase|Other|0|||
143355862|NCT02718417|516846880|FG001|Long-term Follow-up Phase|Other|2|||
143355863|NCT02718417|516846881|FG002|Long-term Follow-up Phase|Other|0|||
143355864|NCT01023308|516846882|FG000|Overall Study|Abnormal test proceedure results|3|||
143355865|NCT01023308|516846883|FG001|Overall Study|Abnormal test proceedure results|8|||
143355866|NCT01023308|516846882|FG000|Overall Study|Administrative problems|2|||
143355867|NCT01023308|516846883|FG001|Overall Study|Administrative problems|1|||
143355868|NCT01023308|516846882|FG000|Overall Study|Adverse Event|130|||
143355869|NCT01023308|516846883|FG001|Overall Study|Adverse Event|66|||
143355870|NCT01023308|516846882|FG000|Overall Study|Death|21|||
143355871|NCT01023308|516846883|FG001|Overall Study|Death|17|||
143355872|NCT01023308|516846882|FG000|Overall Study|Disease progression|82|||
143355873|NCT01023308|516846883|FG001|Overall Study|Disease progression|153|||
143355874|NCT01023308|516846882|FG000|Overall Study|New Cancer therapy|4|||
143355875|NCT01023308|516846883|FG001|Overall Study|New Cancer therapy|7|||
143355876|NCT01023308|516846882|FG000|Overall Study|Protocol Violation|3|||
143355877|NCT01023308|516846883|FG001|Overall Study|Protocol Violation|4|||
143355878|NCT01023308|516846882|FG000|Overall Study|Untreated|5|||
143355879|NCT01023308|516846883|FG001|Overall Study|Untreated|5|||
143355880|NCT01023308|516846882|FG000|Overall Study|Lost to Follow-up|1|||
143355881|NCT01023308|516846883|FG001|Overall Study|Lost to Follow-up|0|||
143355882|NCT01023308|516846882|FG000|Overall Study|Withdrawal by Subject|34|||
143355883|NCT01023308|516846883|FG001|Overall Study|Withdrawal by Subject|18|||
143355884|NCT01890967|516846884|FG000|Overall Study|Adverse Event|3|||
143355885|NCT01890967|516846885|FG001|Overall Study|Adverse Event|3|||
143355886|NCT01890967|516846886|FG002|Overall Study|Adverse Event|3|||
143355887|NCT01890967|516846887|FG003|Overall Study|Adverse Event|2|||
143355888|NCT01890967|516846888|FG004|Overall Study|Adverse Event|1|||
143355889|NCT01890967|516846889|FG005|Overall Study|Adverse Event|7|||
143355890|NCT01890967|516846884|FG000|Overall Study|Death|1|||
143355891|NCT01890967|516846885|FG001|Overall Study|Death|0|||
143355892|NCT01890967|516846886|FG002|Overall Study|Death|0|||
143355893|NCT01890967|516846887|FG003|Overall Study|Death|0|||
143355894|NCT01890967|516846888|FG004|Overall Study|Death|0|||
143355895|NCT01890967|516846889|FG005|Overall Study|Death|0|||
143355896|NCT01890967|516846884|FG000|Overall Study|Lost to Follow-up|1|||
143462974|NCT00406653|517240904|FG004|Open-Label Period|Lack of Efficacy|0|||
143462975|NCT00406653|517240905|FG005|Open-Label Period|Lack of Efficacy|0|||
143462976|NCT00406653|517240906|FG006|Open-Label Period|Lack of Efficacy|160|||
143462977|NCT00406653|517240900|FG000|Open-Label Period|Lost to Follow-up|0|||
143462978|NCT00406653|517240901|FG001|Open-Label Period|Lost to Follow-up|0|||
143462979|NCT00406653|517240902|FG002|Open-Label Period|Lost to Follow-up|0|||
143355897|NCT01890967|516846885|FG001|Overall Study|Lost to Follow-up|1|||
143355898|NCT01890967|516846886|FG002|Overall Study|Lost to Follow-up|1|||
143355899|NCT01890967|516846887|FG003|Overall Study|Lost to Follow-up|1|||
143355900|NCT01890967|516846888|FG004|Overall Study|Lost to Follow-up|0|||
143355901|NCT01890967|516846889|FG005|Overall Study|Lost to Follow-up|1|||
143355902|NCT01890967|516846884|FG000|Overall Study|Protocol Violation|0|||
143355903|NCT01890967|516846885|FG001|Overall Study|Protocol Violation|3|||
143355904|NCT01890967|516846886|FG002|Overall Study|Protocol Violation|3|||
143355905|NCT01890967|516846887|FG003|Overall Study|Protocol Violation|2|||
143355906|NCT01890967|516846888|FG004|Overall Study|Protocol Violation|4|||
143355907|NCT01890967|516846889|FG005|Overall Study|Protocol Violation|1|||
143462980|NCT00406653|517240903|FG003|Open-Label Period|Lost to Follow-up|0|||
143462981|NCT00406653|517240904|FG004|Open-Label Period|Lost to Follow-up|0|||
143462982|NCT00406653|517240905|FG005|Open-Label Period|Lost to Follow-up|0|||
143462983|NCT00406653|517240906|FG006|Open-Label Period|Lost to Follow-up|6|||
143462984|NCT00406653|517240900|FG000|Open-Label Period|Withdrawal of Consent|0|||
143462985|NCT00406653|517240901|FG001|Open-Label Period|Withdrawal of Consent|0|||
143462986|NCT00406653|517240902|FG002|Open-Label Period|Withdrawal of Consent|0|||
143462987|NCT00406653|517240903|FG003|Open-Label Period|Withdrawal of Consent|0|||
143462988|NCT00406653|517240904|FG004|Open-Label Period|Withdrawal of Consent|0|||
143462989|NCT00406653|517240905|FG005|Open-Label Period|Withdrawal of Consent|0|||
143462990|NCT00406653|517240906|FG006|Open-Label Period|Withdrawal of Consent|11|||
143462991|NCT00406653|517240900|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
143462992|NCT00406653|517240901|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
143462993|NCT00406653|517240902|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
143462994|NCT00406653|517240903|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
143462995|NCT00406653|517240904|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
143462996|NCT00406653|517240905|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
143462997|NCT00406653|517240906|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
143355908|NCT01890967|516846884|FG000|Overall Study|Sponsor Decision|2|||
143355909|NCT01890967|516846885|FG001|Overall Study|Sponsor Decision|0|||
143462998|NCT00406653|517240900|FG000|Open-Label Period|Pregnancy|0|||
143462999|NCT00406653|517240901|FG001|Open-Label Period|Pregnancy|0|||
143463000|NCT00406653|517240902|FG002|Open-Label Period|Pregnancy|0|||
143355910|NCT01890967|516846886|FG002|Overall Study|Sponsor Decision|1|||
143355911|NCT01890967|516846887|FG003|Overall Study|Sponsor Decision|3|||
143355912|NCT01890967|516846888|FG004|Overall Study|Sponsor Decision|2|||
143355913|NCT01890967|516846889|FG005|Overall Study|Sponsor Decision|3|||
143355914|NCT01890967|516846884|FG000|Overall Study|Withdrawal by Subject|3|||
143463001|NCT00406653|517240903|FG003|Open-Label Period|Pregnancy|0|||
143463002|NCT00406653|517240904|FG004|Open-Label Period|Pregnancy|0|||
143463003|NCT00406653|517240905|FG005|Open-Label Period|Pregnancy|0|||
143463004|NCT00406653|517240906|FG006|Open-Label Period|Pregnancy|2|||
143463005|NCT00406653|517240900|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
143463006|NCT00406653|517240901|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
143463007|NCT00406653|517240902|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
143463008|NCT00406653|517240903|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
143463009|NCT00406653|517240904|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
143463010|NCT00406653|517240905|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
143463011|NCT00406653|517240906|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
143463012|NCT00406653|517240900|FG000|Open-Label Period|Declined participation but followup done|0|||
143463013|NCT00406653|517240901|FG001|Open-Label Period|Declined participation but followup done|0|||
143463014|NCT00406653|517240902|FG002|Open-Label Period|Declined participation but followup done|0|||
143463015|NCT00406653|517240903|FG003|Open-Label Period|Declined participation but followup done|0|||
143463016|NCT00406653|517240904|FG004|Open-Label Period|Declined participation but followup done|0|||
143463017|NCT00406653|517240905|FG005|Open-Label Period|Declined participation but followup done|0|||
143463018|NCT00406653|517240906|FG006|Open-Label Period|Declined participation but followup done|8|||
143463019|NCT00406653|517240900|FG000|Open-Label Period|Discontinued by Sponsor|0|||
143463020|NCT00406653|517240901|FG001|Open-Label Period|Discontinued by Sponsor|0|||
143463021|NCT00406653|517240902|FG002|Open-Label Period|Discontinued by Sponsor|0|||
143463022|NCT00406653|517240903|FG003|Open-Label Period|Discontinued by Sponsor|0|||
143463023|NCT00406653|517240904|FG004|Open-Label Period|Discontinued by Sponsor|0|||
143463024|NCT00406653|517240905|FG005|Open-Label Period|Discontinued by Sponsor|0|||
143463025|NCT00406653|517240906|FG006|Open-Label Period|Discontinued by Sponsor|1|||
143463026|NCT00406653|517240900|FG000|Open-Label Period|Refused followup|0|||
143463027|NCT00406653|517240901|FG001|Open-Label Period|Refused followup|0|||
143463028|NCT00406653|517240902|FG002|Open-Label Period|Refused followup|0|||
143463029|NCT00406653|517240903|FG003|Open-Label Period|Refused followup|0|||
143463030|NCT00406653|517240904|FG004|Open-Label Period|Refused followup|0|||
143463031|NCT00406653|517240905|FG005|Open-Label Period|Refused followup|0|||
143463032|NCT00406653|517240906|FG006|Open-Label Period|Refused followup|1|||
143463033|NCT01275131|517240907|FG000|Period 1|Withdrawal by Subject|1|||
143463034|NCT01275131|517240908|FG001|Period 1|Withdrawal by Subject|0|||
143463035|NCT01275131|517240909|FG002|Period 1|Withdrawal by Subject|3|||
143463036|NCT01275131|517240910|FG003|Period 1|Withdrawal by Subject|2|||
143463037|NCT01275131|517240907|FG000|Period 1|Physician Decision|1|||
143463038|NCT01275131|517240908|FG001|Period 1|Physician Decision|0|||
143463039|NCT01275131|517240909|FG002|Period 1|Physician Decision|0|||
143463040|NCT01275131|517240910|FG003|Period 1|Physician Decision|0|||
143463041|NCT01275131|517240907|FG000|Period 2 (Crossover)|Adverse Event|0|||
143463042|NCT01275131|517240908|FG001|Period 2 (Crossover)|Adverse Event|1|||
143463043|NCT01275131|517240909|FG002|Period 2 (Crossover)|Adverse Event|0|||
143463044|NCT01275131|517240910|FG003|Period 2 (Crossover)|Adverse Event|0|||
143463045|NCT01275131|517240907|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
143463046|NCT01275131|517240908|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
143463047|NCT01275131|517240909|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
143013040|NCT00399490|515587998|FG000|Overall Study|Lack of Efficacy|31|||
143355915|NCT01890967|516846885|FG001|Overall Study|Withdrawal by Subject|4|||
143355916|NCT01890967|516846886|FG002|Overall Study|Withdrawal by Subject|2|||
143355917|NCT01890967|516846887|FG003|Overall Study|Withdrawal by Subject|3|||
143355918|NCT01890967|516846888|FG004|Overall Study|Withdrawal by Subject|3|||
143355919|NCT01890967|516846889|FG005|Overall Study|Withdrawal by Subject|1|||
143355920|NCT01383993|516846891|FG000|Overall Study|Adverse Event|1|||
143355921|NCT01383993|516846892|FG001|Overall Study|Adverse Event|1|||
143355922|NCT01383993|516846893|FG002|Overall Study|Adverse Event|0|||
143355923|NCT01383993|516846891|FG000|Overall Study|Withdrawal by Subject|0|||
143355924|NCT01383993|516846892|FG001|Overall Study|Withdrawal by Subject|0|||
143355925|NCT01383993|516846893|FG002|Overall Study|Withdrawal by Subject|1|||
143355926|NCT01383993|516846891|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
143355927|NCT01383993|516846892|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
143355928|NCT01383993|516846893|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
143355929|NCT00795132|516846897|FG000|Overall Study|Death|1|||
143355930|NCT00795132|516846897|FG000|Overall Study|Relapse|2|||
143355931|NCT02561455|516846898|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
143355932|NCT02561455|516846899|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
143355933|NCT02561455|516846900|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
143355934|NCT02561455|516846901|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
143355935|NCT02561455|516846898|FG000|Overall Study|Withdrawal by Subject|1|||
143013041|NCT00399490|515587998|FG000|Overall Study|Lost to Follow-up|5|||
143013042|NCT00399490|515587998|FG000|Overall Study|Withdrawal by Subject|18|||
143013043|NCT00399490|515587998|FG000|Overall Study|Other|25|||
143013044|NCT00953927|515588002|FG000|Overall Study|Lost to Follow-up|61|||
143355936|NCT02561455|516846899|FG001|Overall Study|Withdrawal by Subject|0|||
143355937|NCT02561455|516846900|FG002|Overall Study|Withdrawal by Subject|1|||
143355938|NCT02561455|516846901|FG003|Overall Study|Withdrawal by Subject|0|||
143355939|NCT02561455|516846898|FG000|Overall Study|Disease Progression|0|||
143355940|NCT02561455|516846899|FG001|Overall Study|Disease Progression|1|||
143355941|NCT02561455|516846900|FG002|Overall Study|Disease Progression|0|||
143355942|NCT02561455|516846901|FG003|Overall Study|Disease Progression|0|||
143355943|NCT02451930|516846905|FG000|Overall Study|Death|0|||
143355944|NCT02451930|516846906|FG001|Overall Study|Death|15|||
143355945|NCT02451930|516846905|FG000|Overall Study|Lost to Follow-up|0|||
143355946|NCT02451930|516846906|FG001|Overall Study|Lost to Follow-up|3|||
143355947|NCT02451930|516846905|FG000|Overall Study|Sponsor Decision|2|||
143355948|NCT02451930|516846906|FG001|Overall Study|Sponsor Decision|10|||
143355949|NCT02451930|516846905|FG000|Overall Study|Withdrawal by Subject|0|||
143355950|NCT02451930|516846906|FG001|Overall Study|Withdrawal by Subject|1|||
143355951|NCT02451930|516846905|FG000|Overall Study|Other|0|||
143355952|NCT02451930|516846906|FG001|Overall Study|Other|1|||
143355953|NCT00262743|516846907|FG000|Overall Study|Adverse Event|0|||
143355954|NCT00262743|516846908|FG001|Overall Study|Adverse Event|9|||
143355955|NCT00262743|516846907|FG000|Overall Study|Disease progression|0|||
143355956|NCT00262743|516846908|FG001|Overall Study|Disease progression|3|||
143355957|NCT01950273|516846918|FG000|Overall Study|Protocol Violation|1|||
143355958|NCT01950273|516846919|FG001|Overall Study|Protocol Violation|0|||
143355959|NCT01950273|516846918|FG000|Overall Study|Withdrawal by Subject|2|||
143355960|NCT01950273|516846919|FG001|Overall Study|Withdrawal by Subject|0|||
143355961|NCT01950273|516846918|FG000|Overall Study|Other not defined above|1|||
143355962|NCT01950273|516846919|FG001|Overall Study|Other not defined above|0|||
143355963|NCT00472186|516846920|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
143355964|NCT00472186|516846921|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
143355965|NCT03354637|516846926|FG000|Double-blind Period|Protocol Violation|2|||
143355966|NCT03354637|516846927|FG001|Double-blind Period|Protocol Violation|0|||
143355967|NCT03354637|516846928|FG002|Double-blind Period|Protocol Violation|0|||
143355968|NCT03354637|516846926|FG000|Double-blind Period|Adverse Event|1|||
143355969|NCT03354637|516846927|FG001|Double-blind Period|Adverse Event|2|||
143355970|NCT03354637|516846928|FG002|Double-blind Period|Adverse Event|0|||
143355971|NCT03354637|516846926|FG000|Double-blind Period|Lost to Follow-up|3|||
143355972|NCT03354637|516846927|FG001|Double-blind Period|Lost to Follow-up|4|||
143355973|NCT03354637|516846928|FG002|Double-blind Period|Lost to Follow-up|3|||
143355974|NCT03354637|516846926|FG000|Double-blind Period|Withdrawal by Subject|10|||
143355975|NCT03354637|516846927|FG001|Double-blind Period|Withdrawal by Subject|6|||
143355976|NCT03354637|516846928|FG002|Double-blind Period|Withdrawal by Subject|4|||
143355977|NCT03354637|516846926|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
143355978|NCT03354637|516846927|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
143355979|NCT03354637|516846928|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
143355980|NCT03354637|516846926|FG000|Open Label Extension|Adverse Event|0|||
143355981|NCT03354637|516846927|FG001|Open Label Extension|Adverse Event|0|||
143355982|NCT03354637|516846928|FG002|Open Label Extension|Adverse Event|1|||
143355983|NCT03354637|516846926|FG000|Open Label Extension|Lost to Follow-up|0|||
143355984|NCT03354637|516846927|FG001|Open Label Extension|Lost to Follow-up|0|||
143355985|NCT03354637|516846928|FG002|Open Label Extension|Lost to Follow-up|2|||
143355986|NCT03354637|516846926|FG000|Open Label Extension|Withdrawal by Subject|0|||
143355987|NCT03354637|516846927|FG001|Open Label Extension|Withdrawal by Subject|0|||
143355988|NCT03354637|516846928|FG002|Open Label Extension|Withdrawal by Subject|5|||
143355989|NCT03354637|516846926|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
143355990|NCT03354637|516846927|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
143355991|NCT03354637|516846928|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
143355992|NCT03354637|516846926|FG000|Open Label Extension|Subject Noncompliance|0|||
143355993|NCT03354637|516846927|FG001|Open Label Extension|Subject Noncompliance|0|||
143355994|NCT03354637|516846928|FG002|Open Label Extension|Subject Noncompliance|1|||
143355995|NCT03354637|516846926|FG000|Open Label Extension|Lack of Efficacy|0|||
143355996|NCT03354637|516846927|FG001|Open Label Extension|Lack of Efficacy|0|||
143355997|NCT03354637|516846928|FG002|Open Label Extension|Lack of Efficacy|1|||
143355998|NCT03354637|516846926|FG000|Open Label Extension|Physician Decision|0|||
143355999|NCT03354637|516846927|FG001|Open Label Extension|Physician Decision|0|||
143356000|NCT03354637|516846928|FG002|Open Label Extension|Physician Decision|1|||
143356001|NCT01154036|516846935|FG000|Phase I|Physician Decision|0|||
143356002|NCT01154036|516846936|FG001|Phase I|Physician Decision|1|||
143356003|NCT01154036|516846937|FG002|Phase I|Physician Decision|0|||
143356004|NCT01154036|516846938|FG003|Phase I|Physician Decision|0|||
143356005|NCT01154036|516846939|FG004|Phase I|Physician Decision|0|||
143356006|NCT01154036|516846940|FG005|Phase I|Physician Decision|0|||
143356007|NCT01154036|516846941|FG006|Phase I|Physician Decision|0|||
143356008|NCT01154036|516846942|FG007|Phase I|Physician Decision|0|||
143356009|NCT01154036|516846935|FG000|Phase I|Lost to Follow-up|0|||
143356010|NCT01154036|516846936|FG001|Phase I|Lost to Follow-up|3|||
143463048|NCT01275131|517240910|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
143463049|NCT00953745|517240911|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
143463050|NCT00953745|517240912|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
143463051|NCT00953745|517240911|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
143463052|NCT00953745|517240912|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
143463053|NCT00953745|517240911|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
143463054|NCT00953745|517240912|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
143463055|NCT00953745|517240911|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
143463056|NCT00953745|517240912|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
143463057|NCT00953745|517240911|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
143463058|NCT00953745|517240912|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
143463059|NCT00953745|517240911|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
143463060|NCT00953745|517240912|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
143463061|NCT02427464|517240915|FG000|Overall Study|Adverse Event|6|||
143463062|NCT02427464|517240916|FG001|Overall Study|Adverse Event|1|||
143463063|NCT02427464|517240915|FG000|Overall Study|Lost to Follow-up|16|||
143463064|NCT02427464|517240916|FG001|Overall Study|Lost to Follow-up|5|||
143463065|NCT02427464|517240915|FG000|Overall Study|Physician Decision|2|||
143463066|NCT02427464|517240916|FG001|Overall Study|Physician Decision|0|||
143463067|NCT02427464|517240915|FG000|Overall Study|Withdrawal by Subject|10|||
143463068|NCT02427464|517240916|FG001|Overall Study|Withdrawal by Subject|8|||
143463069|NCT02427464|517240915|FG000|Overall Study|Noncompliance|16|||
143463070|NCT02427464|517240916|FG001|Overall Study|Noncompliance|10|||
143463071|NCT04737187|517240918|FG000|Overall Study|Switched to marketed drug|32|||
143463072|NCT04737187|517240919|FG001|Overall Study|Switched to marketed drug|4|||
143463073|NCT04737187|517240918|FG000|Overall Study|Radiological Progressive Disease|145|||
143463074|NCT04737187|517240919|FG001|Overall Study|Radiological Progressive Disease|146|||
143463075|NCT04737187|517240918|FG000|Overall Study|Clinical Progressive Disease|20|||
143463076|NCT04737187|517240919|FG001|Overall Study|Clinical Progressive Disease|20|||
143463077|NCT04737187|517240918|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
143463078|NCT04737187|517240919|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
143463079|NCT04737187|517240918|FG000|Overall Study|Adverse Event|16|||
143463080|NCT04737187|517240919|FG001|Overall Study|Adverse Event|16|||
143463081|NCT04737187|517240918|FG000|Overall Study|Physician Decision|2|||
143463082|NCT04737187|517240919|FG001|Overall Study|Physician Decision|0|||
143463083|NCT04737187|517240918|FG000|Overall Study|Withdrawal by Subject|5|||
143463084|NCT04737187|517240919|FG001|Overall Study|Withdrawal by Subject|8|||
143463085|NCT03756129|517240920|FG000|Overall Study|Adverse Event|1|||
143463086|NCT03756129|517240921|FG001|Overall Study|Adverse Event|1|||
143463087|NCT03756129|517240922|FG002|Overall Study|Adverse Event|0|||
143463088|NCT03756129|517240923|FG003|Overall Study|Adverse Event|2|||
143463089|NCT03756129|517240924|FG004|Overall Study|Adverse Event|0|||
143463090|NCT03756129|517240925|FG005|Overall Study|Adverse Event|0|||
143463091|NCT03756129|517240920|FG000|Overall Study|Withdrawal by Subject|2|||
143463092|NCT03756129|517240921|FG001|Overall Study|Withdrawal by Subject|1|||
143463093|NCT03756129|517240922|FG002|Overall Study|Withdrawal by Subject|3|||
143463094|NCT03756129|517240923|FG003|Overall Study|Withdrawal by Subject|1|||
143463095|NCT03756129|517240924|FG004|Overall Study|Withdrawal by Subject|1|||
143463096|NCT03756129|517240925|FG005|Overall Study|Withdrawal by Subject|3|||
143463097|NCT03756129|517240920|FG000|Overall Study|Lost to Follow-up|0|||
143463098|NCT03756129|517240921|FG001|Overall Study|Lost to Follow-up|0|||
143463099|NCT03756129|517240922|FG002|Overall Study|Lost to Follow-up|0|||
143463100|NCT03756129|517240923|FG003|Overall Study|Lost to Follow-up|0|||
143463101|NCT03756129|517240924|FG004|Overall Study|Lost to Follow-up|0|||
143463102|NCT03756129|517240925|FG005|Overall Study|Lost to Follow-up|1|||
143463103|NCT03756129|517240920|FG000|Overall Study|Physician Decision|0|||
143463104|NCT03756129|517240921|FG001|Overall Study|Physician Decision|0|||
143463105|NCT03756129|517240922|FG002|Overall Study|Physician Decision|0|||
143463106|NCT03756129|517240923|FG003|Overall Study|Physician Decision|0|||
143463107|NCT03756129|517240924|FG004|Overall Study|Physician Decision|0|||
143463108|NCT03756129|517240925|FG005|Overall Study|Physician Decision|1|||
143463109|NCT01439360|517240926|FG000|Overall Study|Adverse Event|4|||
143463110|NCT01439360|517240927|FG001|Overall Study|Adverse Event|16|||
143463111|NCT01439360|517240926|FG000|Overall Study|Lost to Follow-up|43|||
143463112|NCT01439360|517240927|FG001|Overall Study|Lost to Follow-up|58|||
143463113|NCT01439360|517240926|FG000|Overall Study|Others|10|||
143463114|NCT01439360|517240927|FG001|Overall Study|Others|5|||
143463115|NCT01439360|517240926|FG000|Overall Study|Protocol Violation|1|||
143463116|NCT01439360|517240927|FG001|Overall Study|Protocol Violation|0|||
143463117|NCT01439360|517240926|FG000|Overall Study|Withdrawal by Subject|140|||
143463118|NCT01439360|517240927|FG001|Overall Study|Withdrawal by Subject|129|||
143463119|NCT00345293|517240928|FG000|Overall Study|Unable to access line for sample|1|||
143463120|NCT00345293|517240929|FG001|Overall Study|Unable to access line for sample|0|||
143463121|NCT00345293|517240928|FG000|Overall Study|Withdrawal by Subject|1|||
143463122|NCT00345293|517240929|FG001|Overall Study|Withdrawal by Subject|0|||
143463123|NCT03319849|517240930|FG000|Overall Study|Adverse Event|1|||
143356011|NCT01154036|516846937|FG002|Phase I|Lost to Follow-up|6|||
143356012|NCT01154036|516846938|FG003|Phase I|Lost to Follow-up|0|||
143356013|NCT01154036|516846939|FG004|Phase I|Lost to Follow-up|0|||
143356014|NCT01154036|516846940|FG005|Phase I|Lost to Follow-up|0|||
143356015|NCT01154036|516846941|FG006|Phase I|Lost to Follow-up|0|||
143356016|NCT01154036|516846942|FG007|Phase I|Lost to Follow-up|0|||
143356017|NCT01154036|516846935|FG000|Phase I|Protocol Violation|0|||
143356018|NCT01154036|516846936|FG001|Phase I|Protocol Violation|3|||
143356019|NCT01154036|516846937|FG002|Phase I|Protocol Violation|9|||
143356020|NCT01154036|516846938|FG003|Phase I|Protocol Violation|0|||
143356021|NCT01154036|516846939|FG004|Phase I|Protocol Violation|0|||
143356022|NCT01154036|516846940|FG005|Phase I|Protocol Violation|0|||
143356023|NCT01154036|516846941|FG006|Phase I|Protocol Violation|0|||
143356024|NCT01154036|516846942|FG007|Phase I|Protocol Violation|0|||
143356025|NCT01154036|516846935|FG000|Phase I|Withdrawal by Subject|2|||
143356026|NCT01154036|516846936|FG001|Phase I|Withdrawal by Subject|10|||
143356027|NCT01154036|516846937|FG002|Phase I|Withdrawal by Subject|29|||
143356028|NCT01154036|516846938|FG003|Phase I|Withdrawal by Subject|0|||
143356029|NCT01154036|516846939|FG004|Phase I|Withdrawal by Subject|0|||
143356030|NCT01154036|516846940|FG005|Phase I|Withdrawal by Subject|0|||
143356031|NCT01154036|516846941|FG006|Phase I|Withdrawal by Subject|0|||
143356032|NCT01154036|516846942|FG007|Phase I|Withdrawal by Subject|0|||
143356033|NCT01154036|516846935|FG000|Phase I|Adverse Event|1|||
143356034|NCT01154036|516846936|FG001|Phase I|Adverse Event|11|||
143356035|NCT01154036|516846937|FG002|Phase I|Adverse Event|12|||
143356036|NCT01154036|516846938|FG003|Phase I|Adverse Event|0|||
143356037|NCT01154036|516846939|FG004|Phase I|Adverse Event|0|||
143356038|NCT01154036|516846940|FG005|Phase I|Adverse Event|0|||
143356039|NCT01154036|516846941|FG006|Phase I|Adverse Event|0|||
143356040|NCT01154036|516846942|FG007|Phase I|Adverse Event|0|||
143356041|NCT01154036|516846935|FG000|Phase II|Adverse Event|0|||
143356042|NCT01154036|516846936|FG001|Phase II|Adverse Event|0|||
143356043|NCT01154036|516846937|FG002|Phase II|Adverse Event|0|||
143356044|NCT01154036|516846938|FG003|Phase II|Adverse Event|0|||
143356045|NCT01154036|516846939|FG004|Phase II|Adverse Event|1|||
143356046|NCT01154036|516846940|FG005|Phase II|Adverse Event|1|||
143356047|NCT01154036|516846941|FG006|Phase II|Adverse Event|1|||
143356048|NCT01154036|516846942|FG007|Phase II|Adverse Event|1|||
143356049|NCT01154036|516846935|FG000|Phase II|Physician Decision|0|||
143356050|NCT01154036|516846936|FG001|Phase II|Physician Decision|0|||
143356051|NCT01154036|516846937|FG002|Phase II|Physician Decision|0|||
143356052|NCT01154036|516846938|FG003|Phase II|Physician Decision|0|||
143356053|NCT01154036|516846939|FG004|Phase II|Physician Decision|0|||
143356054|NCT01154036|516846940|FG005|Phase II|Physician Decision|0|||
143356055|NCT01154036|516846941|FG006|Phase II|Physician Decision|1|||
143013045|NCT00953927|515588003|FG001|Overall Study|Lost to Follow-up|65|||
143013046|NCT00953927|515588002|FG000|Overall Study|Withdrawal by Subject|36|||
143013047|NCT00953927|515588003|FG001|Overall Study|Withdrawal by Subject|25|||
143013048|NCT00953927|515588002|FG000|Overall Study|Death|7|||
143013049|NCT00953927|515588003|FG001|Overall Study|Death|4|||
143013050|NCT00953927|515588002|FG000|Overall Study|Other study discontinuation|1|||
143013051|NCT00953927|515588003|FG001|Overall Study|Other study discontinuation|1|||
143013052|NCT01396161|515588004|FG000|Overall Study|Withdrawal by Subject|0|||
143013053|NCT01396161|515588005|FG001|Overall Study|Withdrawal by Subject|0|||
143013054|NCT01396161|515588006|FG002|Overall Study|Withdrawal by Subject|0|||
143013055|NCT01396161|515588007|FG003|Overall Study|Withdrawal by Subject|0|||
143013056|NCT01396161|515588008|FG004|Overall Study|Withdrawal by Subject|1|||
143013057|NCT01396161|515588009|FG005|Overall Study|Withdrawal by Subject|0|||
143013058|NCT01396161|515588010|FG006|Overall Study|Withdrawal by Subject|0|||
143013059|NCT01396161|515588004|FG000|Overall Study|Other|0|||
143013060|NCT01396161|515588005|FG001|Overall Study|Other|0|||
143013061|NCT01396161|515588006|FG002|Overall Study|Other|0|||
143013062|NCT01396161|515588007|FG003|Overall Study|Other|0|||
143013063|NCT01396161|515588008|FG004|Overall Study|Other|0|||
143013064|NCT01396161|515588009|FG005|Overall Study|Other|0|||
143013065|NCT01396161|515588010|FG006|Overall Study|Other|1|||
143013066|NCT02962739|515588015|FG000|Overall Study|Withdrawal by Subject|0|||
143013067|NCT02962739|515588016|FG001|Overall Study|Withdrawal by Subject|1|||
143013068|NCT02962739|515588017|FG002|Overall Study|Withdrawal by Subject|0|||
143013069|NCT02962739|515588018|FG003|Overall Study|Withdrawal by Subject|0|||
143013070|NCT02962739|515588019|FG004|Overall Study|Withdrawal by Subject|0|||
143013071|NCT02962739|515588020|FG005|Overall Study|Withdrawal by Subject|0|||
143013072|NCT02962739|515588015|FG000|Overall Study|Protocol Violation|0|||
143013073|NCT02962739|515588016|FG001|Overall Study|Protocol Violation|0|||
143013074|NCT02962739|515588017|FG002|Overall Study|Protocol Violation|1|||
143013075|NCT02962739|515588018|FG003|Overall Study|Protocol Violation|0|||
143013076|NCT02962739|515588019|FG004|Overall Study|Protocol Violation|1|||
143013077|NCT02962739|515588020|FG005|Overall Study|Protocol Violation|0|||
143356056|NCT01154036|516846942|FG007|Phase II|Physician Decision|0|||
143356057|NCT01154036|516846935|FG000|Phase II|Lost to Follow-up|0|||
143356058|NCT01154036|516846936|FG001|Phase II|Lost to Follow-up|0|||
143356059|NCT01154036|516846937|FG002|Phase II|Lost to Follow-up|0|||
143463124|NCT03319849|517240931|FG001|Overall Study|Adverse Event|0|||
143463125|NCT03319849|517240930|FG000|Overall Study|Physician Decision|0|||
143463126|NCT03319849|517240931|FG001|Overall Study|Physician Decision|1|||
143463127|NCT03319849|517240930|FG000|Overall Study|Withdrawal by Subject|0|||
143463128|NCT03319849|517240931|FG001|Overall Study|Withdrawal by Subject|1|||
143463129|NCT03319849|517240930|FG000|Overall Study|COVID-19|0|||
143463130|NCT03319849|517240931|FG001|Overall Study|COVID-19|1|||
143463131|NCT03319849|517240930|FG000|Overall Study|Other|1|||
143463132|NCT03319849|517240931|FG001|Overall Study|Other|2|||
143463133|NCT03319849|517240930|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
143463134|NCT03319849|517240931|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
143463135|NCT03319849|517240930|FG000|Overall Study|Lost to Follow-up|0|||
143463136|NCT03319849|517240931|FG001|Overall Study|Lost to Follow-up|2|||
143463137|NCT01912456|517242927|FG000|Period 1|Physician Decision|0|||
143463138|NCT01912456|517242928|FG001|Period 1|Physician Decision|0|||
143463139|NCT01912456|517242929|FG002|Period 1|Physician Decision|1|||
143463140|NCT01912456|517242930|FG003|Period 1|Physician Decision|0|||
143463141|NCT01912456|517242927|FG000|Period 1|non-compliance|1|||
143463142|NCT01912456|517242928|FG001|Period 1|non-compliance|0|||
143463143|NCT01912456|517242929|FG002|Period 1|non-compliance|0|||
143463144|NCT01912456|517242930|FG003|Period 1|non-compliance|1|||
143463145|NCT01912456|517242927|FG000|Period 1|Adverse Event|1|||
143463146|NCT01912456|517242928|FG001|Period 1|Adverse Event|0|||
143463147|NCT01912456|517242929|FG002|Period 1|Adverse Event|0|||
143463148|NCT01912456|517242930|FG003|Period 1|Adverse Event|1|||
143463149|NCT01912456|517242927|FG000|Period 1|Withdrawal by Subject|0|||
143463150|NCT01912456|517242928|FG001|Period 1|Withdrawal by Subject|1|||
143463151|NCT01912456|517242929|FG002|Period 1|Withdrawal by Subject|1|||
143463152|NCT01912456|517242930|FG003|Period 1|Withdrawal by Subject|1|||
143463153|NCT01912456|517242927|FG000|Period 2|Lack of Efficacy|0|||
143463154|NCT01912456|517242928|FG001|Period 2|Lack of Efficacy|2|||
143463155|NCT01912456|517242929|FG002|Period 2|Lack of Efficacy|0|||
143463156|NCT01912456|517242930|FG003|Period 2|Lack of Efficacy|0|||
143463157|NCT01912456|517242927|FG000|Period 2|Adverse Event|0|||
143463158|NCT01912456|517242928|FG001|Period 2|Adverse Event|0|||
143463159|NCT01912456|517242929|FG002|Period 2|Adverse Event|0|||
143463160|NCT01912456|517242930|FG003|Period 2|Adverse Event|1|||
143463161|NCT00171704|517242931|FG000|Overall Study|Adverse Event|24|||
143463162|NCT00171704|517242932|FG001|Overall Study|Adverse Event|33|||
143463163|NCT00171704|517242931|FG000|Overall Study|Disease Progression|14|||
143463164|NCT00171704|517242932|FG001|Overall Study|Disease Progression|9|||
143463165|NCT00171704|517242931|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
143463166|NCT00171704|517242932|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
143463167|NCT00171704|517242931|FG000|Overall Study|Administrative Problems|2|||
143463168|NCT00171704|517242932|FG001|Overall Study|Administrative Problems|1|||
143463169|NCT00171704|517242931|FG000|Overall Study|Death|2|||
143463170|NCT00171704|517242932|FG001|Overall Study|Death|2|||
143463171|NCT00171704|517242931|FG000|Overall Study|Withdrawal by Subject|1|||
143463172|NCT00171704|517242932|FG001|Overall Study|Withdrawal by Subject|3|||
143463173|NCT00171704|517242931|FG000|Overall Study|Protocol Violation|0|||
143463174|NCT00171704|517242932|FG001|Overall Study|Protocol Violation|1|||
143463175|NCT02141984|517242935|FG000|Overall Study|Lack of Efficacy|2|||
143463176|NCT01060540|517242936|FG000|Overall Study|Withdrawal by Subject|10|||
143463177|NCT01060540|517242937|FG001|Overall Study|Withdrawal by Subject|20|||
143463178|NCT01060540|517242936|FG000|Overall Study|Lost to Follow-up|52|||
143463179|NCT01060540|517242937|FG001|Overall Study|Lost to Follow-up|43|||
143463180|NCT01060540|517242936|FG000|Overall Study|Death|2|||
143463181|NCT01060540|517242937|FG001|Overall Study|Death|1|||
143463182|NCT01060540|517242936|FG000|Overall Study|Physician Decision|0|||
143463183|NCT01060540|517242937|FG001|Overall Study|Physician Decision|1|||
143463184|NCT00816400|517242938|FG000|Overall Study|Death|2|||
143463185|NCT00816400|517242939|FG001|Overall Study|Death|3|||
143463186|NCT00816400|517242940|FG002|Overall Study|Death|3|||
143463187|NCT00816400|517242941|FG003|Overall Study|Death|3|||
143463188|NCT00816400|517242942|FG004|Overall Study|Death|2|||
143463189|NCT00816400|517242943|FG005|Overall Study|Death|3|||
143463190|NCT00816400|517242944|FG006|Overall Study|Death|2|||
143463191|NCT00816400|517242945|FG007|Overall Study|Death|5|||
143463192|NCT00816400|517242946|FG008|Overall Study|Death|6|||
143463193|NCT00816400|517242938|FG000|Overall Study|In hospice care at the end of the study|0|||
143463194|NCT00816400|517242939|FG001|Overall Study|In hospice care at the end of the study|0|||
143463195|NCT00816400|517242940|FG002|Overall Study|In hospice care at the end of the study|2|||
143463196|NCT00816400|517242941|FG003|Overall Study|In hospice care at the end of the study|0|||
143463197|NCT00816400|517242942|FG004|Overall Study|In hospice care at the end of the study|0|||
143463198|NCT00816400|517242943|FG005|Overall Study|In hospice care at the end of the study|0|||
143463199|NCT00816400|517242944|FG006|Overall Study|In hospice care at the end of the study|0|||
143463200|NCT00816400|517242945|FG007|Overall Study|In hospice care at the end of the study|0|||
143463201|NCT00816400|517242946|FG008|Overall Study|In hospice care at the end of the study|0|||
143463202|NCT01222507|517242947|FG000|Overall Study|Physician Decision|1|||
143463203|NCT01222507|517242947|FG000|Overall Study|Withdrawal by Subject|1|||
143356060|NCT01154036|516846938|FG003|Phase II|Lost to Follow-up|1|||
143356061|NCT01154036|516846939|FG004|Phase II|Lost to Follow-up|2|||
143356062|NCT01154036|516846940|FG005|Phase II|Lost to Follow-up|0|||
143356063|NCT01154036|516846941|FG006|Phase II|Lost to Follow-up|2|||
143356064|NCT01154036|516846942|FG007|Phase II|Lost to Follow-up|1|||
143356065|NCT01154036|516846935|FG000|Phase II|Protocol Violation|0|||
143356066|NCT01154036|516846936|FG001|Phase II|Protocol Violation|0|||
143013078|NCT00817778|515588024|FG000|Overall Study|Adverse Event|1|||
143013079|NCT00817778|515588025|FG001|Overall Study|Adverse Event|0|||
143013080|NCT00817778|515588024|FG000|Overall Study|Withdrawal by Subject|1|||
143013081|NCT00817778|515588025|FG001|Overall Study|Withdrawal by Subject|1|||
143013082|NCT00817778|515588024|FG000|Overall Study|Protocol Violation|0|||
143013083|NCT00817778|515588025|FG001|Overall Study|Protocol Violation|1|||
143013084|NCT00817778|515588024|FG000|Overall Study|Study-specific discontinuation criteria|0|||
143013085|NCT00817778|515588025|FG001|Overall Study|Study-specific discontinuation criteria|1|||
143013086|NCT00817778|515588024|FG000|Overall Study|Poor venous access|1|||
143013087|NCT00817778|515588025|FG001|Overall Study|Poor venous access|0|||
143013088|NCT03343054|515588026|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
143013089|NCT03343054|515588027|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
143013090|NCT03343054|515588028|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
143013091|NCT03343054|515588026|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
143013092|NCT03343054|515588027|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
143013093|NCT03343054|515588028|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
143013094|NCT03343054|515588026|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
143013095|NCT03343054|515588027|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
143013096|NCT03343054|515588028|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
143013097|NCT03343054|515588026|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
143013098|NCT03343054|515588027|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
143013099|NCT03343054|515588028|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
143013100|NCT01988493|515588029|FG000|Overall Study|Randomized but not treated|0|||
143013101|NCT01988493|515588030|FG001|Overall Study|Randomized but not treated|0|||
143013102|NCT01988493|515588031|FG002|Overall Study|Randomized but not treated|0|||
143013103|NCT01988493|515588032|FG003|Overall Study|Randomized but not treated|0|||
143013104|NCT01988493|515588033|FG004|Overall Study|Randomized but not treated|1|||
143013105|NCT01447628|515588036|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
143013106|NCT01447628|515588037|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
143013107|NCT01447628|515588038|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
143013108|NCT01447628|515588039|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
143013109|NCT03087773|515588040|FG000|Overall Study|Withdrawal by Subject|8|||
143013110|NCT03087773|515588041|FG001|Overall Study|Withdrawal by Subject|4|||
143013111|NCT03087773|515588040|FG000|Overall Study|Lost to Follow-up|12|||
143013112|NCT03087773|515588041|FG001|Overall Study|Lost to Follow-up|8|||
143013113|NCT00627458|515588046|FG000|Overall Study|Migrated from study area|1|||
143013114|NCT00627458|515588047|FG001|Overall Study|Migrated from study area|0|||
143013115|NCT00627458|515588048|FG002|Overall Study|Migrated from study area|1|||
143013116|NCT00627458|515588046|FG000|Overall Study|Withdrawal by Subject|2|||
143013117|NCT00627458|515588047|FG001|Overall Study|Withdrawal by Subject|6|||
143013118|NCT00627458|515588048|FG002|Overall Study|Withdrawal by Subject|5|||
143013119|NCT00627458|515588046|FG000|Overall Study|Lost to Follow-up|1|||
143013120|NCT00627458|515588047|FG001|Overall Study|Lost to Follow-up|1|||
143013121|NCT00627458|515588048|FG002|Overall Study|Lost to Follow-up|0|||
143013122|NCT03891875|515588049|FG000|Overall Study|Withdrawal by Subject|20|||
143013123|NCT03891875|515588050|FG001|Overall Study|Withdrawal by Subject|3|||
143013124|NCT03891875|515588049|FG000|Overall Study|Adverse Event|10|||
143013125|NCT03891875|515588050|FG001|Overall Study|Adverse Event|4|||
143013126|NCT03891875|515588049|FG000|Overall Study|Physician Decision|1|||
143013127|NCT03891875|515588050|FG001|Overall Study|Physician Decision|1|||
143013128|NCT03891875|515588049|FG000|Overall Study|Protocol Violation|1|||
143013129|NCT03891875|515588050|FG001|Overall Study|Protocol Violation|0|||
143013130|NCT03891875|515588049|FG000|Overall Study|Lost to Follow-up|1|||
143013131|NCT03891875|515588050|FG001|Overall Study|Lost to Follow-up|0|||
143013132|NCT03891875|515588049|FG000|Overall Study|COVID-19 infection|1|||
143013133|NCT03891875|515588050|FG001|Overall Study|COVID-19 infection|0|||
143013134|NCT05349188|515588053|FG000|Overall Study|Withdrawal by Subject|1|||
143013135|NCT05349188|515588054|FG001|Overall Study|Withdrawal by Subject|0|||
143013136|NCT02756078|515588055|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
143013137|NCT02756078|515588056|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
143013138|NCT02756078|515588055|FG000|Period 1|Lost to Follow-up|0|||
143013139|NCT02756078|515588056|FG001|Period 1|Lost to Follow-up|2|||
143013140|NCT02756078|515588055|FG000|Period 1|Protocol Violation|0|||
143013141|NCT02756078|515588056|FG001|Period 1|Protocol Violation|1|||
143013142|NCT02756078|515588055|FG000|Period 1|Adverse Event|1|||
143013143|NCT02756078|515588056|FG001|Period 1|Adverse Event|10|||
143463204|NCT02647320|517242948|FG000|Overall Study|Adverse Event|0|||
143463205|NCT02647320|517242949|FG001|Overall Study|Adverse Event|1|||
143463206|NCT02647320|517242950|FG002|Overall Study|Adverse Event|3|||
143463207|NCT02647320|517242951|FG003|Overall Study|Adverse Event|2|||
143463208|NCT02647320|517242952|FG004|Overall Study|Adverse Event|1|||
143463209|NCT02647320|517242948|FG000|Overall Study|Protocol Violation|0|||
143463210|NCT02647320|517242949|FG001|Overall Study|Protocol Violation|0|||
143463211|NCT02647320|517242950|FG002|Overall Study|Protocol Violation|3|||
143463212|NCT02647320|517242951|FG003|Overall Study|Protocol Violation|0|||
143463213|NCT02647320|517242952|FG004|Overall Study|Protocol Violation|0|||
143463214|NCT02647320|517242948|FG000|Overall Study|Withdrawal by Subject|7|||
143463215|NCT02647320|517242949|FG001|Overall Study|Withdrawal by Subject|4|||
143463216|NCT02647320|517242950|FG002|Overall Study|Withdrawal by Subject|2|||
143463217|NCT02647320|517242951|FG003|Overall Study|Withdrawal by Subject|2|||
143463218|NCT02647320|517242952|FG004|Overall Study|Withdrawal by Subject|7|||
143463219|NCT02647320|517242948|FG000|Overall Study|Persistent hyperglycemia|0|||
143463220|NCT02647320|517242949|FG001|Overall Study|Persistent hyperglycemia|1|||
143463221|NCT02647320|517242950|FG002|Overall Study|Persistent hyperglycemia|1|||
143463222|NCT02647320|517242951|FG003|Overall Study|Persistent hyperglycemia|1|||
143463223|NCT02647320|517242952|FG004|Overall Study|Persistent hyperglycemia|1|||
143463224|NCT02647320|517242948|FG000|Overall Study|Study terminated by sponsor|1|||
143463225|NCT02647320|517242949|FG001|Overall Study|Study terminated by sponsor|1|||
143463226|NCT02647320|517242950|FG002|Overall Study|Study terminated by sponsor|1|||
143463227|NCT02647320|517242951|FG003|Overall Study|Study terminated by sponsor|1|||
143463228|NCT02647320|517242952|FG004|Overall Study|Study terminated by sponsor|2|||
143463229|NCT02647320|517242948|FG000|Overall Study|Reason not provided|0|||
143463230|NCT02647320|517242949|FG001|Overall Study|Reason not provided|0|||
143463231|NCT02647320|517242950|FG002|Overall Study|Reason not provided|1|||
143463232|NCT02647320|517242951|FG003|Overall Study|Reason not provided|0|||
143463233|NCT02647320|517242952|FG004|Overall Study|Reason not provided|2|||
143463234|NCT02647320|517242948|FG000|Overall Study|Lost to Follow-up|1|||
143463235|NCT02647320|517242949|FG001|Overall Study|Lost to Follow-up|1|||
143463236|NCT02647320|517242950|FG002|Overall Study|Lost to Follow-up|0|||
143463237|NCT02647320|517242951|FG003|Overall Study|Lost to Follow-up|0|||
143463238|NCT02647320|517242952|FG004|Overall Study|Lost to Follow-up|0|||
143463239|NCT02647320|517242948|FG000|Overall Study|Develop anemia|1|||
143463240|NCT02647320|517242949|FG001|Overall Study|Develop anemia|0|||
143463241|NCT02647320|517242950|FG002|Overall Study|Develop anemia|0|||
143463242|NCT02647320|517242951|FG003|Overall Study|Develop anemia|0|||
143463243|NCT02647320|517242952|FG004|Overall Study|Develop anemia|0|||
143463244|NCT02647320|517242948|FG000|Overall Study|Lack of Efficacy|0|||
143463245|NCT02647320|517242949|FG001|Overall Study|Lack of Efficacy|0|||
143463246|NCT02647320|517242950|FG002|Overall Study|Lack of Efficacy|0|||
143463247|NCT02647320|517242951|FG003|Overall Study|Lack of Efficacy|1|||
143463248|NCT02647320|517242952|FG004|Overall Study|Lack of Efficacy|0|||
143463249|NCT02647320|517242948|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
143463250|NCT02647320|517242949|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
143463251|NCT02647320|517242950|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
143463252|NCT02647320|517242951|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
143463253|NCT02647320|517242952|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
143463254|NCT00596427|517242954|FG000|Overall Study|Withdrawal by Subject|2|||
143463255|NCT00596427|517242955|FG001|Overall Study|Withdrawal by Subject|2|||
143463256|NCT00596427|517242954|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
143463257|NCT00596427|517242955|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
143463258|NCT00596427|517242954|FG000|Overall Study|Protocol Violation|1|||
143463259|NCT00596427|517242955|FG001|Overall Study|Protocol Violation|0|||
143463260|NCT00081770|517242960|FG000|Overall Study|Adverse Event|130|||
143463261|NCT00081770|517242961|FG001|Overall Study|Adverse Event|98|||
143463262|NCT00081770|517242962|FG002|Overall Study|Adverse Event|136|||
143356067|NCT01154036|516846937|FG002|Phase II|Protocol Violation|0|||
143463263|NCT00081770|517242960|FG000|Overall Study|Lack of Efficacy|262|||
143463264|NCT00081770|517242961|FG001|Overall Study|Lack of Efficacy|357|||
143463265|NCT00081770|517242962|FG002|Overall Study|Lack of Efficacy|211|||
143356068|NCT01154036|516846938|FG003|Phase II|Protocol Violation|0|||
143356069|NCT01154036|516846939|FG004|Phase II|Protocol Violation|1|||
143463266|NCT00081770|517242960|FG000|Overall Study|Lost to Follow-up|45|||
143463267|NCT00081770|517242961|FG001|Overall Study|Lost to Follow-up|34|||
143463268|NCT00081770|517242962|FG002|Overall Study|Lost to Follow-up|45|||
143463269|NCT00081770|517242960|FG000|Overall Study|Protocol Violation|15|||
143356070|NCT01154036|516846940|FG005|Phase II|Protocol Violation|2|||
143463270|NCT00081770|517242961|FG001|Overall Study|Protocol Violation|10|||
143463271|NCT00081770|517242962|FG002|Overall Study|Protocol Violation|10|||
143463272|NCT00081770|517242960|FG000|Overall Study|Withdrawal by Subject|45|||
143463273|NCT00081770|517242961|FG001|Overall Study|Withdrawal by Subject|40|||
143463274|NCT00081770|517242962|FG002|Overall Study|Withdrawal by Subject|42|||
143463275|NCT00081770|517242960|FG000|Overall Study|Did not meet protocol eligibility|2|||
143463276|NCT00081770|517242961|FG001|Overall Study|Did not meet protocol eligibility|0|||
143463277|NCT00081770|517242962|FG002|Overall Study|Did not meet protocol eligibility|3|||
143463278|NCT00081770|517242960|FG000|Overall Study|Administrative|1|||
143463279|NCT00081770|517242961|FG001|Overall Study|Administrative|0|||
143463280|NCT00081770|517242962|FG002|Overall Study|Administrative|1|||
143463281|NCT00081770|517242960|FG000|Overall Study|Other|2|||
143463282|NCT00081770|517242961|FG001|Overall Study|Other|7|||
143463283|NCT00081770|517242962|FG002|Overall Study|Other|8|||
143356071|NCT01154036|516846941|FG006|Phase II|Protocol Violation|0|||
143356072|NCT01154036|516846942|FG007|Phase II|Protocol Violation|0|||
143356073|NCT01154036|516846935|FG000|Phase II|Withdrawal by Subject|0|||
143356074|NCT01154036|516846936|FG001|Phase II|Withdrawal by Subject|0|||
143356075|NCT01154036|516846937|FG002|Phase II|Withdrawal by Subject|0|||
143356076|NCT01154036|516846938|FG003|Phase II|Withdrawal by Subject|0|||
143356077|NCT01154036|516846939|FG004|Phase II|Withdrawal by Subject|4|||
143356078|NCT01154036|516846940|FG005|Phase II|Withdrawal by Subject|2|||
143356079|NCT01154036|516846941|FG006|Phase II|Withdrawal by Subject|5|||
143356080|NCT01154036|516846942|FG007|Phase II|Withdrawal by Subject|4|||
143356081|NCT02264574|516846943|FG000|Overall Study|Death|21|||
143013144|NCT02756078|515588055|FG000|Period 1|Withdrawal by Subject|6|||
143013145|NCT02756078|515588056|FG001|Period 1|Withdrawal by Subject|6|||
143013146|NCT02756078|515588055|FG000|Period 1|Lens Discomfort|2|||
143013147|NCT02756078|515588056|FG001|Period 1|Lens Discomfort|2|||
143013148|NCT02756078|515588055|FG000|Period 2|Adverse Event|3|||
143013149|NCT02756078|515588056|FG001|Period 2|Adverse Event|5|||
143013150|NCT02756078|515588055|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
143013151|NCT02756078|515588056|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
143013152|NCT02756078|515588055|FG000|Period 2|Withdrawal by Subject|3|||
143013153|NCT02756078|515588056|FG001|Period 2|Withdrawal by Subject|1|||
143013154|NCT02268045|515588057|FG000|Overall Study|Death|4|||
143013155|NCT02268045|515588058|FG001|Overall Study|Death|4|||
143463284|NCT03435497|517242963|FG000|Overall Study|Lost to Follow-up|1|||
143463285|NCT03435497|517242964|FG001|Overall Study|Lost to Follow-up|0|||
143013156|NCT02268045|515588057|FG000|Overall Study|Disease Progression|2|||
143356082|NCT02264574|516846944|FG001|Overall Study|Death|21|||
143356083|NCT02264574|516846943|FG000|Overall Study|Withdrawal by Subject|8|||
143356084|NCT02264574|516846944|FG001|Overall Study|Withdrawal by Subject|6|||
143356085|NCT02264574|516846943|FG000|Overall Study|Other, Not Specified|0|||
143356086|NCT02264574|516846944|FG001|Overall Study|Other, Not Specified|3|||
143356087|NCT04102540|516846956|FG000|Overall Study|Withdrawn by PI|2|||
143356088|NCT04102540|516846956|FG000|Overall Study|Lost to Follow-up|6|||
143356089|NCT03405662|516846959|FG000|Overall Study|COVID-19 restriction|1|||
143356090|NCT03405662|516846960|FG001|Overall Study|COVID-19 restriction|0|||
143356091|NCT03405662|516846959|FG000|Overall Study|unblinding|0|||
143356092|NCT03405662|516846960|FG001|Overall Study|unblinding|1|||
143356093|NCT03405662|516846959|FG000|Overall Study|placement in memory care facility|0|||
143356094|NCT03405662|516846960|FG001|Overall Study|placement in memory care facility|2|||
143356095|NCT00280293|516846961|FG000|Overall Study|Protocol Violation|3|||
143356096|NCT00280293|516846962|FG001|Overall Study|Protocol Violation|0|||
143356097|NCT00280293|516846961|FG000|Overall Study|Physician Decision|5|||
143356098|NCT00280293|516846962|FG001|Overall Study|Physician Decision|4|||
143356099|NCT00280293|516846961|FG000|Overall Study|Lost to Follow-up|14|||
143356100|NCT00280293|516846962|FG001|Overall Study|Lost to Follow-up|12|||
143356101|NCT00280293|516846961|FG000|Overall Study|Withdrawal by Subject|3|||
143356102|NCT00280293|516846962|FG001|Overall Study|Withdrawal by Subject|5|||
143356103|NCT00280293|516846961|FG000|Overall Study|Incarceration/Legal Reasons|1|||
143356104|NCT00280293|516846962|FG001|Overall Study|Incarceration/Legal Reasons|1|||
143356105|NCT00280293|516846961|FG000|Overall Study|Adverse Event|0|||
143356106|NCT00280293|516846962|FG001|Overall Study|Adverse Event|1|||
143356107|NCT02982720|516846971|FG000|Overall Study|Adverse Event|3|||
143356108|NCT02982720|516846971|FG000|Overall Study|Death|1|||
143356109|NCT04230980|516846976|FG000|Overall Study|Lost to Follow-up|1|||
143356110|NCT04230980|516846977|FG001|Overall Study|Lost to Follow-up|2|||
143356111|NCT04230980|516846976|FG000|Overall Study|Adverse Event|0|||
143356112|NCT04230980|516846977|FG001|Overall Study|Adverse Event|1|||
143356113|NCT03523871|516846978|FG000|Overall Study|Death|1|||
143356114|NCT00653263|516846980|FG000|Overall Study|Withdrawal by Subject|1|||
143356115|NCT00653263|516846980|FG000|Overall Study|Physician Decision|1|||
143356116|NCT00776100|516846981|FG000|Overall Study|Disease Progression|1|||
143356117|NCT00776100|516846982|FG001|Overall Study|Disease Progression|0|||
143356118|NCT00777803|516848726|FG000|Overall Study|Lost to Follow-up|12|||
143356119|NCT00777803|516848727|FG001|Overall Study|Lost to Follow-up|5|||
143356120|NCT00777803|516848726|FG000|Overall Study|Adverse Event|1|||
143356121|NCT00777803|516848727|FG001|Overall Study|Adverse Event|0|||
143356122|NCT00777803|516848726|FG000|Overall Study|Non-compliance|2|||
143013157|NCT02268045|515588058|FG001|Overall Study|Disease Progression|1|||
143356123|NCT00777803|516848727|FG001|Overall Study|Non-compliance|2|||
143356124|NCT01995357|516848730|FG000|Period 5|Lack of Efficacy|1|||
143356125|NCT01995357|516848731|FG001|Period 5|Lack of Efficacy|0|||
143356126|NCT01995357|516848732|FG002|Period 5|Lack of Efficacy|0|||
143356127|NCT01995357|516848733|FG003|Period 5|Lack of Efficacy|0|||
143463286|NCT03435497|517242963|FG000|Overall Study|Death|1|||
143463287|NCT03435497|517242964|FG001|Overall Study|Death|0|||
143463288|NCT03435497|517242963|FG000|Overall Study|Withdrawal by Subject|0|||
143463289|NCT03435497|517242964|FG001|Overall Study|Withdrawal by Subject|4|||
143463290|NCT03435497|517242963|FG000|Overall Study|Wrong survey administered|0|||
143463291|NCT03435497|517242964|FG001|Overall Study|Wrong survey administered|2|||
143463292|NCT01786174|517242966|FG000|Overall Study|Discontinued Study Drug|2|||
143463293|NCT01786174|517242967|FG001|Overall Study|Discontinued Study Drug|0|||
143463294|NCT04281004|517242970|FG000|Overall Study|Physician Decision|1|||
143463295|NCT04281004|517242971|FG001|Overall Study|Physician Decision|0|||
143463296|NCT00701779|517242972|FG000|Overall Study|Adverse Event|6|||
143463297|NCT00701779|517242972|FG000|Overall Study|Lost to Follow-up|1|||
143463298|NCT00701779|517242972|FG000|Overall Study|Withdrawal by Subject|2|||
143463299|NCT01620255|517242975|FG000|Overall Study|Withdrawal by Subject|4|||
143463300|NCT01620255|517242976|FG001|Overall Study|Withdrawal by Subject|1|||
143463301|NCT01620255|517242977|FG002|Overall Study|Withdrawal by Subject|1|||
143463302|NCT01620255|517242978|FG003|Overall Study|Withdrawal by Subject|2|||
143463303|NCT01620255|517242979|FG004|Overall Study|Withdrawal by Subject|4|||
143463304|NCT01620255|517242975|FG000|Overall Study|Participant underwent fecal transplant|0|||
143463305|NCT01620255|517242976|FG001|Overall Study|Participant underwent fecal transplant|0|||
143463306|NCT01620255|517242977|FG002|Overall Study|Participant underwent fecal transplant|1|||
143463307|NCT01620255|517242978|FG003|Overall Study|Participant underwent fecal transplant|0|||
143463308|NCT01620255|517242979|FG004|Overall Study|Participant underwent fecal transplant|0|||
143463309|NCT01620255|517242975|FG000|Overall Study|Non-compliance|0|||
143463310|NCT01620255|517242976|FG001|Overall Study|Non-compliance|1|||
143463311|NCT01620255|517242977|FG002|Overall Study|Non-compliance|0|||
143463312|NCT01620255|517242978|FG003|Overall Study|Non-compliance|0|||
143463313|NCT01620255|517242979|FG004|Overall Study|Non-compliance|0|||
143463314|NCT01620255|517242975|FG000|Overall Study|Adverse Event|0|||
143463315|NCT01620255|517242976|FG001|Overall Study|Adverse Event|4|||
143463316|NCT01620255|517242977|FG002|Overall Study|Adverse Event|0|||
143463317|NCT01620255|517242978|FG003|Overall Study|Adverse Event|1|||
143463318|NCT01620255|517242979|FG004|Overall Study|Adverse Event|1|||
143463319|NCT01620255|517242975|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
143463320|NCT01620255|517242976|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
143463321|NCT01620255|517242977|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
143463322|NCT01620255|517242978|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
143463323|NCT01620255|517242979|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
143463324|NCT00876694|517242980|FG000|Overall Study|Adverse Event|10|||
143463325|NCT00876694|517242981|FG001|Overall Study|Adverse Event|7|||
143463326|NCT00876694|517242980|FG000|Overall Study|Subject withdrew consent|6|||
143463327|NCT00876694|517242981|FG001|Overall Study|Subject withdrew consent|4|||
143463328|NCT00876694|517242980|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
143463329|NCT00876694|517242981|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
143463330|NCT00876694|517242980|FG000|Overall Study|Abnormal test procedure result(s)|1|||
143463331|NCT00876694|517242981|FG001|Overall Study|Abnormal test procedure result(s)|0|||
143463332|NCT00876694|517242980|FG000|Overall Study|Administrative problems|1|||
143463333|NCT00876694|517242981|FG001|Overall Study|Administrative problems|1|||
143463334|NCT00876694|517242980|FG000|Overall Study|Death|1|||
143463335|NCT00876694|517242981|FG001|Overall Study|Death|0|||
143463336|NCT01386788|517242986|FG000|Overall Study|Lost to Follow-up|2|||
143463337|NCT00120406|517242989|FG000|Overall Study|Death|9|||
143463338|NCT00120406|517242990|FG001|Overall Study|Death|4|||
143463339|NCT00120406|517242989|FG000|Overall Study|Withdrawal by Subject|5|||
143463340|NCT00120406|517242990|FG001|Overall Study|Withdrawal by Subject|7|||
143463341|NCT00120406|517242989|FG000|Overall Study|Lost to Follow-up|5|||
143463342|NCT00120406|517242990|FG001|Overall Study|Lost to Follow-up|2|||
143463343|NCT00120406|517242989|FG000|Overall Study|received non-study stent|0|||
143463344|NCT00120406|517242990|FG001|Overall Study|received non-study stent|2|||
143125854|NCT02372383|516006657|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
143125855|NCT02239640|516006658|FG000|Overall Study|Withdrawal by Subject|3|||
143125856|NCT02239640|516006658|FG000|Overall Study|Lost to Follow-up|72|||
143125857|NCT02239640|516006658|FG000|Overall Study|Death|142|||
143125858|NCT00929994|516006659|FG000|Overall Study|Withdrawal by Subject|1|||
143125859|NCT00929994|516006659|FG000|Overall Study|medical issue unrelated to intervention|4|||
143125860|NCT00929994|516006659|FG000|Overall Study|employment|1|||
143125861|NCT02061813|516006662|FG000|Overall Study|Withdrawal by Subject|1|||
143125862|NCT02061813|516006662|FG000|Overall Study|Protocol Violation|2|||
143125863|NCT02075008|516006665|FG000|Overall Study|Technical problems|1|||
143125864|NCT02075008|516006665|FG000|Overall Study|Pregnancy|1|||
143125865|NCT02075008|516006665|FG000|Overall Study|Physician Decision|1|||
143125866|NCT02075008|516006665|FG000|Overall Study|Lost to Follow-up|1|||
143125867|NCT02075008|516006665|FG000|Overall Study|Lack of Efficacy|1|||
143125868|NCT02075008|516006665|FG000|Overall Study|Death|1|||
143125869|NCT02075008|516006665|FG000|Overall Study|Adverse Event|5|||
143463345|NCT00120406|517242989|FG000|Overall Study|patient moved but has not withdrawn|0|||
143463346|NCT00120406|517242990|FG001|Overall Study|patient moved but has not withdrawn|1|||
143463347|NCT01155375|517242991|FG000|Overall Study|Adverse Event|1|||
143356128|NCT01995357|516848734|FG004|Period 5|Lack of Efficacy|0|||
143013158|NCT02268045|515588057|FG000|Overall Study|Adverse Event|7|||
143013159|NCT02268045|515588058|FG001|Overall Study|Adverse Event|7|||
143356129|NCT01995357|516848735|FG005|Period 5|Lack of Efficacy|0|||
143356130|NCT01995357|516848730|FG000|Period 5|Adverse Event|1|||
143356131|NCT01995357|516848731|FG001|Period 5|Adverse Event|0|||
143356132|NCT01995357|516848732|FG002|Period 5|Adverse Event|1|||
143356133|NCT01995357|516848733|FG003|Period 5|Adverse Event|0|||
143356134|NCT01995357|516848734|FG004|Period 5|Adverse Event|0|||
143356135|NCT01995357|516848735|FG005|Period 5|Adverse Event|0|||
143356136|NCT04129580|516848736|FG000|Overall Study|Lost to Follow-up|14|||
143356137|NCT04129580|516848737|FG001|Overall Study|Lost to Follow-up|25|||
143356138|NCT02176928|516848740|FG000|Overall Study|Lost to Follow-up|2|||
143356139|NCT02176928|516848741|FG001|Overall Study|Lost to Follow-up|4|||
143356140|NCT04430335|516848747|FG000|Overall Study|Withdrawal by Subject|1|||
143356141|NCT03249376|516848749|FG000|Overall Study|Adverse Event|11|||
143356142|NCT03249376|516848750|FG001|Overall Study|Adverse Event|5|||
143356143|NCT03249376|516848749|FG000|Overall Study|Lack of Efficacy|2|||
143356144|NCT03249376|516848750|FG001|Overall Study|Lack of Efficacy|4|||
143356145|NCT03249376|516848749|FG000|Overall Study|Protocol Violation|3|||
143356146|NCT03249376|516848750|FG001|Overall Study|Protocol Violation|2|||
143356147|NCT03249376|516848749|FG000|Overall Study|Physician Decision|0|||
143356148|NCT03249376|516848750|FG001|Overall Study|Physician Decision|2|||
143356149|NCT03249376|516848749|FG000|Overall Study|Withdrawal by Subject|3|||
143356150|NCT03249376|516848750|FG001|Overall Study|Withdrawal by Subject|9|||
143356151|NCT03249376|516848749|FG000|Overall Study|LTFU|2|||
143356152|NCT03249376|516848750|FG001|Overall Study|LTFU|1|||
143356153|NCT01567163|516848751|FG000|Overall Study|Progressive Disease|2|||
143356154|NCT01567163|516848751|FG000|Overall Study|Lost to Follow-up|2|||
143356155|NCT02056119|516848752|FG000|Overall Study|Death|1|||
143356156|NCT02056119|516848753|FG001|Overall Study|Death|2|||
143356157|NCT02056119|516848752|FG000|Overall Study|Intubated for less than 24 hrs|2|||
143356158|NCT02056119|516848753|FG001|Overall Study|Intubated for less than 24 hrs|7|||
143356159|NCT02056119|516848752|FG000|Overall Study|No aerosol treatments were given.|3|||
143356160|NCT02056119|516848753|FG001|Overall Study|No aerosol treatments were given.|2|||
143356161|NCT02056119|516848752|FG000|Overall Study|Received Metaneb treatment|0|||
143356162|NCT02056119|516848753|FG001|Overall Study|Received Metaneb treatment|2|||
143356163|NCT02056119|516848752|FG000|Overall Study|Protocol Violation|4|||
143356164|NCT02056119|516848753|FG001|Overall Study|Protocol Violation|7|||
143356165|NCT04827134|516848759|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
143356166|NCT04827134|516848760|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
143356167|NCT04827134|516848761|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
143356168|NCT04827134|516848762|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
143356169|NCT02443103|516848763|FG000|Overall Study|Adverse Event|2|||
143356170|NCT02443103|516848763|FG000|Overall Study|Noncompliance|1|||
143356171|NCT03875911|516848766|FG000|Overall Study|Lost to Follow-up|3|||
143356172|NCT03875911|516848767|FG001|Overall Study|Lost to Follow-up|6|||
143356173|NCT03875911|516848768|FG002|Overall Study|Lost to Follow-up|2|||
143356174|NCT03875911|516848766|FG000|Overall Study|Surgery cancelled|1|||
143356175|NCT03875911|516848767|FG001|Overall Study|Surgery cancelled|0|||
143356176|NCT03875911|516848768|FG002|Overall Study|Surgery cancelled|1|||
143356177|NCT03875911|516848766|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
143463348|NCT01155375|517242992|FG001|Overall Study|Adverse Event|0|||
143463349|NCT00762970|517242993|FG000|Overall Study|Withdrawal by Subject|7|||
143356178|NCT03875911|516848767|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
143356179|NCT03875911|516848768|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
143356180|NCT03824938|516848769|FG000|Overall Study|Withdrawal by Subject|2|||
143356181|NCT03824938|516848770|FG001|Overall Study|Withdrawal by Subject|1|||
143356182|NCT03824938|516848771|FG002|Overall Study|Withdrawal by Subject|0|||
143356183|NCT03824938|516848772|FG003|Overall Study|Withdrawal by Subject|2|||
143356184|NCT03824938|516848773|FG004|Overall Study|Withdrawal by Subject|0|||
143356185|NCT03824938|516848774|FG005|Overall Study|Withdrawal by Subject|1|||
143356186|NCT03824938|516848769|FG000|Overall Study|Lost to Follow-up|0|||
143356187|NCT03824938|516848770|FG001|Overall Study|Lost to Follow-up|1|||
143356188|NCT03824938|516848771|FG002|Overall Study|Lost to Follow-up|0|||
143356189|NCT03824938|516848772|FG003|Overall Study|Lost to Follow-up|0|||
143356190|NCT03824938|516848773|FG004|Overall Study|Lost to Follow-up|1|||
143356191|NCT03824938|516848774|FG005|Overall Study|Lost to Follow-up|0|||
143356192|NCT02019602|516848783|FG000|Screening Period|Ineligibility|4|||
143356193|NCT02019602|516848784|FG001|Screening Period|Ineligibility|0|||
143356194|NCT02019602|516848783|FG000|Screening Period|Adverse Event|1|||
143356195|NCT02019602|516848784|FG001|Screening Period|Adverse Event|0|||
143356196|NCT00683449|516848785|FG000|Overall Study|Lost to Follow-up|0|||
143013160|NCT02268045|515588057|FG000|Overall Study|Withdrawal by Subject|2|||
143356197|NCT00683449|516848786|FG001|Overall Study|Lost to Follow-up|1|||
143463350|NCT00762970|517242994|FG001|Overall Study|Withdrawal by Subject|4|||
143356198|NCT00683449|516848787|FG002|Overall Study|Lost to Follow-up|0|||
143356199|NCT00683449|516848788|FG003|Overall Study|Lost to Follow-up|0|||
143356200|NCT00683449|516848789|FG004|Overall Study|Lost to Follow-up|0|||
143125870|NCT02075008|516006665|FG000|Overall Study|Withdrawal by Subject|6|||
143125871|NCT02075008|516006665|FG000|Overall Study|Study terminated by Sponsor|159|||
143125872|NCT03130959|516006666|FG000|Overall Study|Disease progression|19|||
143125873|NCT03130959|516006667|FG001|Overall Study|Disease progression|7|||
143125874|NCT03130959|516006668|FG002|Overall Study|Disease progression|12|||
143125875|NCT03130959|516006669|FG003|Overall Study|Disease progression|7|||
143125876|NCT03130959|516006670|FG004|Overall Study|Disease progression|12|||
143125877|NCT03130959|516006671|FG005|Overall Study|Disease progression|3|||
143125878|NCT03130959|516006672|FG006|Overall Study|Disease progression|6|||
143125879|NCT03130959|516006673|FG007|Overall Study|Disease progression|3|||
143125880|NCT03130959|516006674|FG008|Overall Study|Disease progression|15|||
143125881|NCT03130959|516006675|FG009|Overall Study|Disease progression|8|||
143125882|NCT03130959|516006666|FG000|Overall Study|Study drug toxicity|2|||
143125883|NCT03130959|516006667|FG001|Overall Study|Study drug toxicity|2|||
143125884|NCT03130959|516006668|FG002|Overall Study|Study drug toxicity|1|||
143125885|NCT03130959|516006669|FG003|Overall Study|Study drug toxicity|2|||
143125886|NCT03130959|516006670|FG004|Overall Study|Study drug toxicity|1|||
143125887|NCT03130959|516006671|FG005|Overall Study|Study drug toxicity|1|||
143125888|NCT03130959|516006672|FG006|Overall Study|Study drug toxicity|3|||
143125889|NCT03130959|516006673|FG007|Overall Study|Study drug toxicity|0|||
143125890|NCT03130959|516006674|FG008|Overall Study|Study drug toxicity|3|||
143125891|NCT03130959|516006675|FG009|Overall Study|Study drug toxicity|3|||
143125892|NCT03130959|516006666|FG000|Overall Study|Other reasons|0|||
143125893|NCT03130959|516006667|FG001|Overall Study|Other reasons|0|||
143125894|NCT03130959|516006668|FG002|Overall Study|Other reasons|0|||
143125895|NCT03130959|516006669|FG003|Overall Study|Other reasons|0|||
143125896|NCT03130959|516006670|FG004|Overall Study|Other reasons|0|||
143125897|NCT03130959|516006671|FG005|Overall Study|Other reasons|1|||
143125898|NCT03130959|516006672|FG006|Overall Study|Other reasons|1|||
143125899|NCT03130959|516006673|FG007|Overall Study|Other reasons|0|||
143125900|NCT03130959|516006674|FG008|Overall Study|Other reasons|0|||
143125901|NCT03130959|516006675|FG009|Overall Study|Other reasons|0|||
143125902|NCT03130959|516006666|FG000|Overall Study|Subject request to discontinue therapy|0|||
143125903|NCT03130959|516006667|FG001|Overall Study|Subject request to discontinue therapy|0|||
143125904|NCT03130959|516006668|FG002|Overall Study|Subject request to discontinue therapy|1|||
143125905|NCT03130959|516006669|FG003|Overall Study|Subject request to discontinue therapy|1|||
143125906|NCT03130959|516006670|FG004|Overall Study|Subject request to discontinue therapy|0|||
143125907|NCT03130959|516006671|FG005|Overall Study|Subject request to discontinue therapy|0|||
143125908|NCT03130959|516006672|FG006|Overall Study|Subject request to discontinue therapy|1|||
143125909|NCT03130959|516006673|FG007|Overall Study|Subject request to discontinue therapy|1|||
143125910|NCT03130959|516006674|FG008|Overall Study|Subject request to discontinue therapy|0|||
143125911|NCT03130959|516006675|FG009|Overall Study|Subject request to discontinue therapy|0|||
143125912|NCT03130959|516006666|FG000|Overall Study|Not reported|0|||
143125913|NCT03130959|516006667|FG001|Overall Study|Not reported|0|||
143125914|NCT03130959|516006668|FG002|Overall Study|Not reported|0|||
143125915|NCT03130959|516006669|FG003|Overall Study|Not reported|1|||
143125916|NCT03130959|516006670|FG004|Overall Study|Not reported|0|||
143125917|NCT03130959|516006671|FG005|Overall Study|Not reported|1|||
143125918|NCT03130959|516006672|FG006|Overall Study|Not reported|0|||
143125919|NCT03130959|516006673|FG007|Overall Study|Not reported|0|||
143125920|NCT03130959|516006674|FG008|Overall Study|Not reported|0|||
143125921|NCT03130959|516006675|FG009|Overall Study|Not reported|1|||
143125922|NCT03130959|516006666|FG000|Overall Study|Adverse Event unrelated to drug|0|||
143125923|NCT03130959|516006667|FG001|Overall Study|Adverse Event unrelated to drug|0|||
143125924|NCT03130959|516006668|FG002|Overall Study|Adverse Event unrelated to drug|1|||
143125925|NCT03130959|516006669|FG003|Overall Study|Adverse Event unrelated to drug|1|||
143125926|NCT03130959|516006670|FG004|Overall Study|Adverse Event unrelated to drug|1|||
143125927|NCT03130959|516006671|FG005|Overall Study|Adverse Event unrelated to drug|0|||
143356201|NCT01058863|516848790|FG000|Overall Study|Lost to Follow-up|1|||
143356202|NCT01058863|516848790|FG000|Overall Study|Withdrawal by Subject|1|||
143356203|NCT01058863|516848790|FG000|Overall Study|Sponsor requested withdrawal|1|||
143356204|NCT01058863|516848790|FG000|Overall Study|Randomized in error|1|||
143356205|NCT03653416|516848791|FG000|Overall Study|Protocol Violation|6|||
143125928|NCT03130959|516006672|FG006|Overall Study|Adverse Event unrelated to drug|1|||
143125929|NCT03130959|516006673|FG007|Overall Study|Adverse Event unrelated to drug|0|||
143125930|NCT03130959|516006674|FG008|Overall Study|Adverse Event unrelated to drug|1|||
143125931|NCT03130959|516006675|FG009|Overall Study|Adverse Event unrelated to drug|1|||
143125932|NCT03130959|516006666|FG000|Overall Study|Participant withdrew consent|0|||
143125933|NCT03130959|516006667|FG001|Overall Study|Participant withdrew consent|1|||
143125934|NCT03130959|516006668|FG002|Overall Study|Participant withdrew consent|0|||
143125935|NCT03130959|516006669|FG003|Overall Study|Participant withdrew consent|2|||
143125936|NCT03130959|516006670|FG004|Overall Study|Participant withdrew consent|1|||
143125937|NCT03130959|516006671|FG005|Overall Study|Participant withdrew consent|0|||
143125938|NCT03130959|516006672|FG006|Overall Study|Participant withdrew consent|0|||
143356206|NCT03653416|516848792|FG001|Overall Study|Protocol Violation|1|||
143356207|NCT00681187|516848793|FG000|Overall Study|Withdrawal by Subject|1|||
143125939|NCT03130959|516006673|FG007|Overall Study|Participant withdrew consent|0|||
143125940|NCT03130959|516006674|FG008|Overall Study|Participant withdrew consent|0|||
143125941|NCT03130959|516006675|FG009|Overall Study|Participant withdrew consent|2|||
143125942|NCT03130959|516006666|FG000|Overall Study|Administrative reason by sponsor|1|||
143125943|NCT03130959|516006667|FG001|Overall Study|Administrative reason by sponsor|0|||
143125944|NCT03130959|516006668|FG002|Overall Study|Administrative reason by sponsor|1|||
143125945|NCT03130959|516006669|FG003|Overall Study|Administrative reason by sponsor|0|||
143125946|NCT03130959|516006670|FG004|Overall Study|Administrative reason by sponsor|0|||
143125947|NCT03130959|516006671|FG005|Overall Study|Administrative reason by sponsor|0|||
143125948|NCT03130959|516006672|FG006|Overall Study|Administrative reason by sponsor|0|||
143125949|NCT03130959|516006673|FG007|Overall Study|Administrative reason by sponsor|0|||
143125950|NCT03130959|516006674|FG008|Overall Study|Administrative reason by sponsor|0|||
143125951|NCT03130959|516006675|FG009|Overall Study|Administrative reason by sponsor|0|||
143125952|NCT03130959|516006666|FG000|Overall Study|Lost to Follow-up|1|||
143125953|NCT03130959|516006667|FG001|Overall Study|Lost to Follow-up|0|||
143125954|NCT03130959|516006668|FG002|Overall Study|Lost to Follow-up|0|||
143125955|NCT03130959|516006669|FG003|Overall Study|Lost to Follow-up|0|||
143125956|NCT03130959|516006670|FG004|Overall Study|Lost to Follow-up|0|||
143125957|NCT03130959|516006671|FG005|Overall Study|Lost to Follow-up|0|||
143125958|NCT03130959|516006672|FG006|Overall Study|Lost to Follow-up|0|||
143125959|NCT03130959|516006673|FG007|Overall Study|Lost to Follow-up|0|||
143125960|NCT03130959|516006674|FG008|Overall Study|Lost to Follow-up|0|||
143125961|NCT03130959|516006675|FG009|Overall Study|Lost to Follow-up|0|||
143125962|NCT00694356|516006678|FG000|Overall Study|Adverse Event|1|||
143125963|NCT00694356|516006679|FG001|Overall Study|Adverse Event|0|||
143125964|NCT00694356|516006680|FG002|Overall Study|Adverse Event|0|||
143125965|NCT00694356|516006678|FG000|Overall Study|Progressive Disease|2|||
143125966|NCT00694356|516006679|FG001|Overall Study|Progressive Disease|6|||
143125967|NCT00694356|516006680|FG002|Overall Study|Progressive Disease|6|||
143125968|NCT03042910|516006681|FG000|Overall Study|Adverse Event|1|||
143125969|NCT03042910|516006681|FG000|Overall Study|Disease Progression|2|||
143125970|NCT03042910|516006681|FG000|Overall Study|Withdrawal by Subject|3|||
143125971|NCT03042910|516006681|FG000|Overall Study|Enrolled but not treated|1|||
143125972|NCT02187861|516006682|FG000|Overall Study|Adverse Event|2|||
143125973|NCT02187861|516006683|FG001|Overall Study|Adverse Event|1|||
143125974|NCT02187861|516006684|FG002|Overall Study|Adverse Event|2|||
143125975|NCT02187861|516006685|FG003|Overall Study|Adverse Event|1|||
143125976|NCT02187861|516006682|FG000|Overall Study|Death|0|||
143125977|NCT02187861|516006683|FG001|Overall Study|Death|3|||
143125978|NCT02187861|516006684|FG002|Overall Study|Death|1|||
143125979|NCT02187861|516006685|FG003|Overall Study|Death|2|||
143125980|NCT02187861|516006682|FG000|Overall Study|Physician Decision|0|||
143125981|NCT02187861|516006683|FG001|Overall Study|Physician Decision|1|||
143125982|NCT02187861|516006684|FG002|Overall Study|Physician Decision|0|||
143125983|NCT02187861|516006685|FG003|Overall Study|Physician Decision|3|||
143125984|NCT02187861|516006682|FG000|Overall Study|Progressive Disease|4|||
143125985|NCT02187861|516006683|FG001|Overall Study|Progressive Disease|42|||
143125986|NCT02187861|516006684|FG002|Overall Study|Progressive Disease|19|||
143125987|NCT02187861|516006685|FG003|Overall Study|Progressive Disease|22|||
143125988|NCT02187861|516006682|FG000|Overall Study|Withdrawal by Subject|0|||
143125989|NCT02187861|516006683|FG001|Overall Study|Withdrawal by Subject|0|||
143125990|NCT02187861|516006684|FG002|Overall Study|Withdrawal by Subject|3|||
143125991|NCT02187861|516006685|FG003|Overall Study|Withdrawal by Subject|3|||
143125992|NCT02187861|516006682|FG000|Overall Study|Other|0|||
143125993|NCT02187861|516006683|FG001|Overall Study|Other|1|||
143125994|NCT02187861|516006684|FG002|Overall Study|Other|7|||
143125995|NCT02187861|516006685|FG003|Overall Study|Other|1|||
143125996|NCT00313586|516006688|FG000|Overall Study|Disease progression|14|||
143356208|NCT00681187|516848794|FG001|Overall Study|Withdrawal by Subject|0|||
143356209|NCT00681187|516848793|FG000|Overall Study|Death|0|||
143356210|NCT00681187|516848794|FG001|Overall Study|Death|1|||
143356211|NCT00681187|516848793|FG000|Overall Study|Adverse Event|0|||
143356212|NCT00681187|516848794|FG001|Overall Study|Adverse Event|1|||
143356213|NCT02788006|516848798|FG000|Overall Study|Patient not treated|1|||
143125997|NCT00313586|516006689|FG001|Overall Study|Disease progression|19|||
143125998|NCT00313586|516006690|FG002|Overall Study|Disease progression|10|||
143125999|NCT00313586|516006691|FG003|Overall Study|Disease progression|3|||
143126000|NCT00313586|516006688|FG000|Overall Study|Adverse Event|12|||
143126001|NCT00313586|516006689|FG001|Overall Study|Adverse Event|18|||
143126002|NCT00313586|516006690|FG002|Overall Study|Adverse Event|3|||
143126003|NCT00313586|516006691|FG003|Overall Study|Adverse Event|10|||
143126004|NCT00313586|516006688|FG000|Overall Study|Death|11|||
143126005|NCT00313586|516006689|FG001|Overall Study|Death|8|||
143126006|NCT00313586|516006690|FG002|Overall Study|Death|1|||
143126007|NCT00313586|516006691|FG003|Overall Study|Death|7|||
143126008|NCT00313586|516006688|FG000|Overall Study|Withdrawal by Subject|13|||
143126009|NCT00313586|516006689|FG001|Overall Study|Withdrawal by Subject|6|||
143126010|NCT00313586|516006690|FG002|Overall Study|Withdrawal by Subject|6|||
143356214|NCT02269943|516848801|FG000|Treatment Period|Death|0|||
143356215|NCT02269943|516848802|FG001|Treatment Period|Death|1|||
143013161|NCT02268045|515588058|FG001|Overall Study|Withdrawal by Subject|6|||
143013162|NCT02268045|515588057|FG000|Overall Study|Physician Decision|0|||
143013163|NCT02268045|515588058|FG001|Overall Study|Physician Decision|1|||
143013164|NCT02268045|515588057|FG000|Overall Study|Protocol Violation|1|||
143013165|NCT02268045|515588058|FG001|Overall Study|Protocol Violation|1|||
143013166|NCT00481871|515588061|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
143013167|NCT00481871|515588062|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
143013168|NCT00481871|515588063|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
143013169|NCT00481871|515588064|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
143013170|NCT00481871|515588065|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
143013171|NCT03332212|515588066|FG000|Overall Study|Not treated|0|||
143013172|NCT03332212|515588067|FG001|Overall Study|Not treated|1|||
143013173|NCT03332212|515588068|FG002|Overall Study|Not treated|0|||
143013174|NCT03332212|515588069|FG003|Overall Study|Not treated|0|||
143013175|NCT03332212|515588066|FG000|Overall Study|Adverse Event|0|||
143013176|NCT03332212|515588067|FG001|Overall Study|Adverse Event|0|||
143013177|NCT03332212|515588068|FG002|Overall Study|Adverse Event|0|||
143013178|NCT03332212|515588069|FG003|Overall Study|Adverse Event|1|||
143013179|NCT03332212|515588066|FG000|Overall Study|worsening of disease under study|1|||
143013180|NCT03332212|515588067|FG001|Overall Study|worsening of disease under study|1|||
143013181|NCT03332212|515588068|FG002|Overall Study|worsening of disease under study|0|||
143013182|NCT03332212|515588069|FG003|Overall Study|worsening of disease under study|0|||
143013183|NCT01308762|515588073|FG000|Overall Study|Protocol Violation|0|||
143013184|NCT01308762|515588074|FG001|Overall Study|Protocol Violation|1|||
143013185|NCT01308762|515588075|FG002|Overall Study|Protocol Violation|0|||
143013186|NCT01556490|515588076|FG000|Randomized Patients Summary|Protocol Violation|22|||
143013187|NCT01556490|515588077|FG001|Randomized Patients Summary|Protocol Violation|23|||
143013188|NCT01556490|515588076|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
143013189|NCT01556490|515588077|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
143013190|NCT02362646|515588081|FG000|Overall Study|Death|15|||
143013191|NCT02362646|515588082|FG001|Overall Study|Death|8|||
143013192|NCT02362646|515588081|FG000|Overall Study|Withdrawal by Subject|2|||
143013193|NCT02362646|515588082|FG001|Overall Study|Withdrawal by Subject|2|||
143013194|NCT02362646|515588081|FG000|Overall Study|received transplant|21|||
143013195|NCT02362646|515588082|FG001|Overall Study|received transplant|14|||
143013196|NCT00865306|515588083|FG000|Controlled Trial|Lost to Follow-up|1|||
143013197|NCT00865306|515588084|FG001|Controlled Trial|Lost to Follow-up|1|||
143013198|NCT00865306|515588083|FG000|Controlled Trial|Difficulty commuting|2|||
143013199|NCT00865306|515588084|FG001|Controlled Trial|Difficulty commuting|0|||
143013200|NCT00865306|515588083|FG000|Controlled Trial|Improved btw baseline and first session|1|||
143013201|NCT00865306|515588084|FG001|Controlled Trial|Improved btw baseline and first session|0|||
143013202|NCT00865306|515588083|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
143013203|NCT00865306|515588084|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
143013204|NCT00865306|515588083|FG000|Controlled Trial|Withdrawal by Subject|0|||
143013205|NCT00865306|515588084|FG001|Controlled Trial|Withdrawal by Subject|1|||
143013206|NCT02058368|515588085|FG000|Overall Study|Adverse Event|15|||
143013207|NCT02058368|515588086|FG001|Overall Study|Adverse Event|20|||
143013208|NCT02058368|515588085|FG000|Overall Study|Lack of Efficacy|0|||
143013209|NCT02058368|515588086|FG001|Overall Study|Lack of Efficacy|1|||
143013210|NCT02058368|515588085|FG000|Overall Study|Protocol Violation|0|||
143013211|NCT02058368|515588086|FG001|Overall Study|Protocol Violation|4|||
143013212|NCT02058368|515588085|FG000|Overall Study|Lost to Follow-up|2|||
143013213|NCT02058368|515588086|FG001|Overall Study|Lost to Follow-up|0|||
143013214|NCT02058368|515588085|FG000|Overall Study|Physician Decision|2|||
143013215|NCT02058368|515588086|FG001|Overall Study|Physician Decision|3|||
143013216|NCT02058368|515588085|FG000|Overall Study|Withdrawal by Subject|22|||
143013217|NCT02058368|515588086|FG001|Overall Study|Withdrawal by Subject|26|||
143013218|NCT03611751|515588090|FG000|Pre-treatment|Randomized but not treated|1|||
143013219|NCT03611751|515588091|FG001|Pre-treatment|Randomized but not treated|1|||
143013220|NCT03611751|515588092|FG002|Pre-treatment|Randomized but not treated|0|||
143013221|NCT03611751|515588090|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
143013222|NCT03611751|515588091|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
143013223|NCT03611751|515588092|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
143013224|NCT03611751|515588090|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
143013225|NCT03611751|515588091|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
143013226|NCT03611751|515588092|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
143013227|NCT03611751|515588090|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
143013228|NCT03611751|515588091|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
143013229|NCT03611751|515588092|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
143013230|NCT03611751|515588090|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
143013231|NCT03611751|515588091|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
143013232|NCT03611751|515588092|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
143013233|NCT03611751|515588090|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
143013234|NCT03611751|515588091|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
143356216|NCT02269943|516848801|FG000|Treatment Period|Adverse Event|1|||
143013235|NCT03611751|515588092|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
143013236|NCT03611751|515588090|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
143013237|NCT03611751|515588091|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
143013238|NCT03611751|515588092|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
143013239|NCT03611751|515588090|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
143013240|NCT03611751|515588091|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
143013241|NCT03611751|515588092|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
143013242|NCT03611751|515588090|FG000|Treatment Week 0 - Week 16|Death|0|||
143013243|NCT03611751|515588091|FG001|Treatment Week 0 - Week 16|Death|0|||
143013244|NCT03611751|515588092|FG002|Treatment Week 0 - Week 16|Death|1|||
143013245|NCT03611751|515588090|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
143013246|NCT03611751|515588091|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
143013247|NCT03611751|515588092|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
143013248|NCT03611751|515588090|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
143013249|NCT03611751|515588091|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
143013250|NCT03611751|515588092|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
143013251|NCT03611751|515588090|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
143013252|NCT03611751|515588091|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
143013253|NCT03611751|515588092|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
143013254|NCT03611751|515588090|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
143013255|NCT03611751|515588091|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
143013256|NCT03611751|515588092|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
143013257|NCT03611751|515588090|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
143013258|NCT03611751|515588091|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
143013259|NCT03611751|515588092|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
143013260|NCT03611751|515588090|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
143013261|NCT03611751|515588091|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
143013262|NCT03611751|515588092|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
143013263|NCT03611751|515588090|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
143013264|NCT03611751|515588091|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
143013265|NCT03611751|515588092|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
143013266|NCT03611751|515588090|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
143013267|NCT03611751|515588091|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
143013268|NCT03611751|515588092|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
143013269|NCT03611751|515588090|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
143013270|NCT03611751|515588091|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
143013271|NCT03611751|515588092|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
143013272|NCT03611751|515588090|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
143126011|NCT00313586|516006691|FG003|Overall Study|Withdrawal by Subject|2|||
143126012|NCT00313586|516006688|FG000|Overall Study|Alternative therapy|3|||
143126013|NCT00313586|516006689|FG001|Overall Study|Alternative therapy|6|||
143126014|NCT00313586|516006690|FG002|Overall Study|Alternative therapy|2|||
143126015|NCT00313586|516006691|FG003|Overall Study|Alternative therapy|0|||
143356217|NCT02269943|516848802|FG001|Treatment Period|Adverse Event|10|||
143356218|NCT02269943|516848801|FG000|Treatment Period|Progressive Disease|5|||
143356219|NCT02269943|516848802|FG001|Treatment Period|Progressive Disease|17|||
143356220|NCT02269943|516848801|FG000|Treatment Period|Symptomatic Deterioration|0|||
143356221|NCT02269943|516848802|FG001|Treatment Period|Symptomatic Deterioration|2|||
143356222|NCT02269943|516848801|FG000|Follow-Up Survival Period|Death|3|||
143356223|NCT02269943|516848802|FG001|Follow-Up Survival Period|Death|16|||
143356224|NCT02269943|516848801|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
143356225|NCT02269943|516848802|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
143356226|NCT02269943|516848801|FG000|Follow-Up Survival Period|Alive|2|||
143356227|NCT02269943|516848802|FG001|Follow-Up Survival Period|Alive|8|||
143356228|NCT03541642|516848803|FG000|Overall Study|Withdrawal by Subject|1|||
143356229|NCT03541642|516848804|FG001|Overall Study|Withdrawal by Subject|2|||
143356230|NCT03541642|516848803|FG000|Overall Study|Lost to Follow-up|16|||
143356231|NCT03541642|516848804|FG001|Overall Study|Lost to Follow-up|12|||
143356232|NCT03541642|516848803|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
143356233|NCT03541642|516848804|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
143356234|NCT03050398|516848807|FG000|Overall Study|Study terminated by sponsor|8|||
143356235|NCT03055832|516848808|FG000|Week 2|Withdrawal by Subject|1|||
143356236|NCT03055832|516848809|FG001|Week 2|Withdrawal by Subject|0|||
143356237|NCT03619174|516848810|FG000|Overall Study|Lost to Follow-up|3|||
143356238|NCT03619174|516848811|FG001|Overall Study|Lost to Follow-up|0|||
143356239|NCT03619174|516848810|FG000|Overall Study|Withdrawal by Subject|4|||
143356240|NCT03619174|516848811|FG001|Overall Study|Withdrawal by Subject|3|||
143356241|NCT03619174|516848810|FG000|Overall Study|Pregnancy|1|||
143356242|NCT03619174|516848811|FG001|Overall Study|Pregnancy|1|||
143356243|NCT03619174|516848810|FG000|Overall Study|Discomfort during treatment|1|||
143356244|NCT03619174|516848811|FG001|Overall Study|Discomfort during treatment|0|||
143013273|NCT03611751|515588091|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
143013274|NCT03611751|515588092|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
143013275|NCT03611751|515588090|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
143126016|NCT00313586|516006688|FG000|Overall Study|Other complicating disease|2|||
143126017|NCT00313586|516006689|FG001|Overall Study|Other complicating disease|2|||
143126018|NCT00313586|516006690|FG002|Overall Study|Other complicating disease|0|||
143126019|NCT00313586|516006691|FG003|Overall Study|Other complicating disease|0|||
143126020|NCT00313586|516006688|FG000|Overall Study|Did not achieve HI-major/better response|10|||
143126021|NCT00313586|516006689|FG001|Overall Study|Did not achieve HI-major/better response|7|||
143126022|NCT00313586|516006690|FG002|Overall Study|Did not achieve HI-major/better response|2|||
143126023|NCT00313586|516006691|FG003|Overall Study|Did not achieve HI-major/better response|1|||
143126024|NCT00313586|516006688|FG000|Overall Study|Physician Decision|2|||
143126025|NCT00313586|516006689|FG001|Overall Study|Physician Decision|1|||
143126026|NCT00313586|516006690|FG002|Overall Study|Physician Decision|0|||
143126027|NCT00313586|516006691|FG003|Overall Study|Physician Decision|0|||
143126028|NCT00313586|516006688|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
143126029|NCT00313586|516006689|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
143126030|NCT00313586|516006690|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
143126031|NCT00313586|516006691|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
143126032|NCT00313586|516006688|FG000|Overall Study|Lost insurance|0|||
143126033|NCT00313586|516006689|FG001|Overall Study|Lost insurance|1|||
143126034|NCT00313586|516006690|FG002|Overall Study|Lost insurance|0|||
143126035|NCT00313586|516006691|FG003|Overall Study|Lost insurance|0|||
143126036|NCT00313586|516006688|FG000|Overall Study|Moved|0|||
143126037|NCT00313586|516006689|FG001|Overall Study|Moved|1|||
143126038|NCT00313586|516006690|FG002|Overall Study|Moved|0|||
143126039|NCT00313586|516006691|FG003|Overall Study|Moved|0|||
143126040|NCT00313586|516006688|FG000|Overall Study|Death before starting treatment|1|||
143126041|NCT00313586|516006689|FG001|Overall Study|Death before starting treatment|0|||
143126042|NCT00313586|516006690|FG002|Overall Study|Death before starting treatment|0|||
143126043|NCT00313586|516006691|FG003|Overall Study|Death before starting treatment|0|||
143126044|NCT01639703|516006692|FG000|Overall Study|Withdrawal by Subject|5|||
143126045|NCT01639703|516006692|FG000|Overall Study|Other reason|7|||
143126046|NCT01308463|516006693|FG000|Overall Study|Study Discontinued|23|||
143126047|NCT01308463|516006693|FG000|Overall Study|Death|4|||
143126048|NCT01308463|516006693|FG000|Overall Study|Revision|2|||
143126049|NCT03117361|516006695|FG000|Overall Study|Progressive disease|5|||
143126050|NCT03117361|516006695|FG000|Overall Study|Death|1|||
143126051|NCT03117361|516006695|FG000|Overall Study|Physician Decision|2|||
143126052|NCT03117361|516006695|FG000|Overall Study|On study treatment at the end of study|1|||
143126053|NCT03117361|516006695|FG000|Overall Study|Treatment-related adverse event|1|||
143126054|NCT01909973|516006699|FG000|Overall Study|Lost to Follow-up|1|||
143126055|NCT01909973|516006700|FG001|Overall Study|Lost to Follow-up|0|||
143126056|NCT00169104|516006701|FG000|Overall Study|Withdrawal by Subject|2|||
143126057|NCT00169104|516006702|FG001|Overall Study|Withdrawal by Subject|0|||
143126058|NCT00169104|516006701|FG000|Overall Study|Protocol Violation|0|||
143126059|NCT00169104|516006702|FG001|Overall Study|Protocol Violation|1|||
143126060|NCT00169104|516006701|FG000|Overall Study|Physician Decision|0|||
143126061|NCT00169104|516006702|FG001|Overall Study|Physician Decision|1|||
143126062|NCT00809094|516006703|FG000|Overall Study|Lost to Follow-up|0|||
143126063|NCT00809094|516006704|FG001|Overall Study|Lost to Follow-up|1|||
143126064|NCT01563913|516006705|FG000|Overall Study|Physician Decision|1|||
143126065|NCT01563913|516006706|FG001|Overall Study|Physician Decision|0|||
143126066|NCT01563913|516006705|FG000|Overall Study|Spouse Passed Away|1|||
143126067|NCT01563913|516006706|FG001|Overall Study|Spouse Passed Away|0|||
143126068|NCT00551525|516006709|FG000|Overall Study|Protocol Violation|5|||
143126069|NCT02081001|516006715|FG000|Overall Study|Adverse Event|0|||
143126070|NCT02081001|516006716|FG001|Overall Study|Adverse Event|0|||
143356245|NCT01991197|516848812|FG000|Overall Study|Lost to Follow-up|1|||
143356246|NCT01991197|516848813|FG001|Overall Study|Lost to Follow-up|1|||
143356247|NCT01991197|516848812|FG000|Overall Study|Physician Decision|0|||
143356248|NCT01991197|516848813|FG001|Overall Study|Physician Decision|2|||
143356249|NCT01991197|516848812|FG000|Overall Study|Withdrawal by Subject|2|||
143356250|NCT01991197|516848813|FG001|Overall Study|Withdrawal by Subject|0|||
143356251|NCT01010217|516848816|FG000|Overall Study|Lost to Follow-up|4|||
143356252|NCT01010217|516848817|FG001|Overall Study|Lost to Follow-up|5|||
143356253|NCT01010217|516848818|FG002|Overall Study|Lost to Follow-up|1|||
143356254|NCT01010217|516848819|FG003|Overall Study|Lost to Follow-up|0|||
143356255|NCT01010217|516848820|FG004|Overall Study|Lost to Follow-up|0|||
143356256|NCT01010217|516848816|FG000|Overall Study|Withdrawal by Subject|1|||
143356257|NCT01010217|516848817|FG001|Overall Study|Withdrawal by Subject|0|||
143356258|NCT01010217|516848818|FG002|Overall Study|Withdrawal by Subject|0|||
143356259|NCT01010217|516848819|FG003|Overall Study|Withdrawal by Subject|0|||
143356260|NCT01010217|516848820|FG004|Overall Study|Withdrawal by Subject|0|||
143356261|NCT01010217|516848816|FG000|Overall Study|Physician Decision|0|||
143126071|NCT02081001|516006717|FG002|Overall Study|Adverse Event|0|||
143126072|NCT02081001|516006718|FG003|Overall Study|Adverse Event|0|||
143126073|NCT02081001|516006719|FG004|Overall Study|Adverse Event|1|||
143126074|NCT02081001|516006720|FG005|Overall Study|Adverse Event|0|||
143126075|NCT02081001|516006721|FG006|Overall Study|Adverse Event|0|||
143126076|NCT02081001|516006722|FG007|Overall Study|Adverse Event|0|||
143126077|NCT02081001|516006723|FG008|Overall Study|Adverse Event|0|||
143126078|NCT02081001|516006724|FG009|Overall Study|Adverse Event|0|||
143126079|NCT02081001|516006725|FG010|Overall Study|Adverse Event|0|||
143126080|NCT02081001|516006726|FG011|Overall Study|Adverse Event|0|||
143126081|NCT01151345|516006732|FG000|First Intervention Period|Protocol Violation|0|||
143126082|NCT01151345|516006733|FG001|First Intervention Period|Protocol Violation|1|||
143126083|NCT04208412|516006734|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
143126084|NCT04208412|516006735|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
143126085|NCT04208412|516006734|FG000|Overall Study|Withdrawal by Subject|1|||
143126086|NCT04208412|516006735|FG001|Overall Study|Withdrawal by Subject|0|||
143126087|NCT04208412|516006734|FG000|Overall Study|Lost to Follow-up|0|||
143126088|NCT04208412|516006735|FG001|Overall Study|Lost to Follow-up|1|||
143126089|NCT02588092|516006738|FG000|Overall Study|Death|4|||
143126090|NCT02588092|516006739|FG001|Overall Study|Death|3|||
143126091|NCT02588092|516006740|FG002|Overall Study|Death|3|||
143126092|NCT02588092|516006741|FG003|Overall Study|Death|3|||
143126093|NCT02588092|516006742|FG004|Overall Study|Death|2|||
143126094|NCT02588092|516006743|FG005|Overall Study|Death|2|||
143126095|NCT02588092|516006744|FG006|Overall Study|Death|2|||
143126096|NCT02588092|516006745|FG007|Overall Study|Death|1|||
143126097|NCT02588092|516006746|FG008|Overall Study|Death|5|||
143126098|NCT02588092|516006747|FG009|Overall Study|Death|2|||
143126099|NCT02588092|516006738|FG000|Overall Study|Withdrawal by Subject|0|||
143126100|NCT02588092|516006739|FG001|Overall Study|Withdrawal by Subject|0|||
143126101|NCT02588092|516006740|FG002|Overall Study|Withdrawal by Subject|0|||
143126102|NCT02588092|516006741|FG003|Overall Study|Withdrawal by Subject|0|||
143126103|NCT02588092|516006742|FG004|Overall Study|Withdrawal by Subject|0|||
143126104|NCT02588092|516006743|FG005|Overall Study|Withdrawal by Subject|1|||
143126105|NCT02588092|516006744|FG006|Overall Study|Withdrawal by Subject|1|||
143126106|NCT02588092|516006745|FG007|Overall Study|Withdrawal by Subject|2|||
143126107|NCT02588092|516006746|FG008|Overall Study|Withdrawal by Subject|0|||
143126108|NCT02588092|516006747|FG009|Overall Study|Withdrawal by Subject|0|||
143126109|NCT02588092|516006738|FG000|Overall Study|Started Another Treatment|0|||
143126110|NCT02588092|516006739|FG001|Overall Study|Started Another Treatment|0|||
143126111|NCT02588092|516006740|FG002|Overall Study|Started Another Treatment|0|||
143126112|NCT02588092|516006741|FG003|Overall Study|Started Another Treatment|0|||
143126113|NCT02588092|516006742|FG004|Overall Study|Started Another Treatment|1|||
143126114|NCT02588092|516006743|FG005|Overall Study|Started Another Treatment|0|||
143126115|NCT02588092|516006744|FG006|Overall Study|Started Another Treatment|0|||
143126116|NCT02588092|516006745|FG007|Overall Study|Started Another Treatment|1|||
143126117|NCT02588092|516006746|FG008|Overall Study|Started Another Treatment|0|||
143126118|NCT02588092|516006747|FG009|Overall Study|Started Another Treatment|0|||
143126119|NCT02588092|516006738|FG000|Overall Study|Sponsor Decision|0|||
143126120|NCT02588092|516006739|FG001|Overall Study|Sponsor Decision|0|||
143126121|NCT02588092|516006740|FG002|Overall Study|Sponsor Decision|0|||
143126122|NCT02588092|516006741|FG003|Overall Study|Sponsor Decision|0|||
143126123|NCT02588092|516006742|FG004|Overall Study|Sponsor Decision|0|||
143126124|NCT02588092|516006743|FG005|Overall Study|Sponsor Decision|0|||
143126125|NCT02588092|516006744|FG006|Overall Study|Sponsor Decision|0|||
143126126|NCT02588092|516006745|FG007|Overall Study|Sponsor Decision|0|||
143126127|NCT02588092|516006746|FG008|Overall Study|Sponsor Decision|1|||
143126128|NCT02588092|516006747|FG009|Overall Study|Sponsor Decision|1|||
143126129|NCT01348100|516006748|FG000|Overall Study|Subject Withdrew Consent|0|||
143126130|NCT01348100|516006749|FG001|Overall Study|Subject Withdrew Consent|0|||
143463351|NCT00762970|517242995|FG002|Overall Study|Withdrawal by Subject|0|||
143356262|NCT01010217|516848817|FG001|Overall Study|Physician Decision|0|||
143356263|NCT01010217|516848818|FG002|Overall Study|Physician Decision|0|||
143356264|NCT01010217|516848819|FG003|Overall Study|Physician Decision|6|||
143356265|NCT01010217|516848820|FG004|Overall Study|Physician Decision|3|||
143126131|NCT01348100|516006750|FG002|Overall Study|Subject Withdrew Consent|2|||
143126132|NCT01348100|516006751|FG003|Overall Study|Subject Withdrew Consent|0|||
143126133|NCT01348100|516006752|FG004|Overall Study|Subject Withdrew Consent|1|||
143126134|NCT01348100|516006753|FG005|Overall Study|Subject Withdrew Consent|0|||
143126135|NCT01348100|516006754|FG006|Overall Study|Subject Withdrew Consent|1|||
143356266|NCT04285229|516848823|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
143356267|NCT04285229|516848824|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
143356268|NCT04285229|516848825|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
143356269|NCT04285229|516848826|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
143356270|NCT04285229|516848827|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
143126136|NCT01348100|516006748|FG000|Overall Study|Protocol Deviation|0|||
143126137|NCT01348100|516006749|FG001|Overall Study|Protocol Deviation|0|||
143126138|NCT01348100|516006750|FG002|Overall Study|Protocol Deviation|0|||
143126139|NCT01348100|516006751|FG003|Overall Study|Protocol Deviation|1|||
143126140|NCT01348100|516006752|FG004|Overall Study|Protocol Deviation|0|||
143356271|NCT04285229|516848828|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
143126141|NCT01348100|516006753|FG005|Overall Study|Protocol Deviation|0|||
143126142|NCT01348100|516006754|FG006|Overall Study|Protocol Deviation|0|||
143126143|NCT01348100|516006748|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
143126144|NCT01348100|516006749|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
143126145|NCT01348100|516006750|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
143126146|NCT01348100|516006751|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
143126147|NCT01348100|516006752|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
143126148|NCT01348100|516006753|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
143126149|NCT01348100|516006754|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
143126150|NCT01348100|516006748|FG000|Overall Study|Lost to Follow-up|0|||
143126151|NCT01348100|516006749|FG001|Overall Study|Lost to Follow-up|0|||
143126152|NCT01348100|516006750|FG002|Overall Study|Lost to Follow-up|0|||
143126153|NCT01348100|516006751|FG003|Overall Study|Lost to Follow-up|0|||
143126154|NCT01348100|516006752|FG004|Overall Study|Lost to Follow-up|0|||
143126155|NCT01348100|516006753|FG005|Overall Study|Lost to Follow-up|0|||
143126156|NCT01348100|516006754|FG006|Overall Study|Lost to Follow-up|1|||
143126157|NCT01348100|516006748|FG000|Overall Study|Administrative Problems|0|||
143126158|NCT01348100|516006749|FG001|Overall Study|Administrative Problems|0|||
143126159|NCT01348100|516006750|FG002|Overall Study|Administrative Problems|0|||
143126160|NCT01348100|516006751|FG003|Overall Study|Administrative Problems|0|||
143126161|NCT01348100|516006752|FG004|Overall Study|Administrative Problems|0|||
143126162|NCT01348100|516006753|FG005|Overall Study|Administrative Problems|1|||
143126163|NCT01348100|516006754|FG006|Overall Study|Administrative Problems|1|||
143126164|NCT03853291|516006755|FG000|Overall Study|Lost to Follow-up|1|||
143356272|NCT04285229|516848823|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
143356273|NCT04285229|516848824|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
143463352|NCT00762970|517242993|FG000|Overall Study|Protocol Violation|3|||
143463353|NCT00762970|517242994|FG001|Overall Study|Protocol Violation|1|||
143463354|NCT00762970|517242995|FG002|Overall Study|Protocol Violation|1|||
143126165|NCT03853291|516006756|FG001|Overall Study|Lost to Follow-up|2|||
143356274|NCT04285229|516848825|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
143356275|NCT04285229|516848826|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
143356276|NCT04285229|516848827|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
143356277|NCT04285229|516848828|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
143356278|NCT04285229|516848823|FG000|Extended Treatment Period|Adverse Event|0|||
143356279|NCT04285229|516848824|FG001|Extended Treatment Period|Adverse Event|0|||
143356280|NCT04285229|516848825|FG002|Extended Treatment Period|Adverse Event|0|||
143356281|NCT04285229|516848826|FG003|Extended Treatment Period|Adverse Event|1|||
143356282|NCT04285229|516848827|FG004|Extended Treatment Period|Adverse Event|0|||
143356283|NCT04285229|516848828|FG005|Extended Treatment Period|Adverse Event|0|||
143356284|NCT04285229|516848823|FG000|Extended Treatment Period|Physician Decision|0|||
143356285|NCT04285229|516848824|FG001|Extended Treatment Period|Physician Decision|0|||
143356286|NCT04285229|516848825|FG002|Extended Treatment Period|Physician Decision|1|||
143356287|NCT04285229|516848826|FG003|Extended Treatment Period|Physician Decision|0|||
143356288|NCT04285229|516848827|FG004|Extended Treatment Period|Physician Decision|0|||
143356289|NCT04285229|516848828|FG005|Extended Treatment Period|Physician Decision|0|||
143356290|NCT04285229|516848823|FG000|Follow-up Period|Adverse Event|0|||
143356291|NCT04285229|516848824|FG001|Follow-up Period|Adverse Event|0|||
143356292|NCT04285229|516848825|FG002|Follow-up Period|Adverse Event|0|||
143356293|NCT04285229|516848826|FG003|Follow-up Period|Adverse Event|0|||
143356294|NCT04285229|516848827|FG004|Follow-up Period|Adverse Event|1|||
143356295|NCT04285229|516848828|FG005|Follow-up Period|Adverse Event|4|||
143356296|NCT04285229|516848823|FG000|Follow-up Period|Withdrawal by Subject|0|||
143356297|NCT04285229|516848824|FG001|Follow-up Period|Withdrawal by Subject|0|||
143356298|NCT04285229|516848825|FG002|Follow-up Period|Withdrawal by Subject|0|||
143356299|NCT04285229|516848826|FG003|Follow-up Period|Withdrawal by Subject|0|||
143356300|NCT04285229|516848827|FG004|Follow-up Period|Withdrawal by Subject|0|||
143356301|NCT04285229|516848828|FG005|Follow-up Period|Withdrawal by Subject|5|||
143356302|NCT04285229|516848823|FG000|Follow-up Period|Covid-19|0|||
143356303|NCT04285229|516848824|FG001|Follow-up Period|Covid-19|0|||
143356304|NCT04285229|516848825|FG002|Follow-up Period|Covid-19|0|||
143356305|NCT04285229|516848826|FG003|Follow-up Period|Covid-19|0|||
143356306|NCT04285229|516848827|FG004|Follow-up Period|Covid-19|0|||
143126166|NCT03853291|516006757|FG002|Overall Study|Lost to Follow-up|0|||
143126167|NCT03853291|516006758|FG003|Overall Study|Lost to Follow-up|0|||
143126168|NCT03853291|516006759|FG004|Overall Study|Lost to Follow-up|0|||
143126169|NCT03853291|516006760|FG005|Overall Study|Lost to Follow-up|0|||
143356307|NCT04285229|516848828|FG005|Follow-up Period|Covid-19|2|||
143356308|NCT04285229|516848823|FG000|Follow-up Period|Physician Decision|0|||
143356309|NCT04285229|516848824|FG001|Follow-up Period|Physician Decision|0|||
143356310|NCT04285229|516848825|FG002|Follow-up Period|Physician Decision|0|||
143356311|NCT04285229|516848826|FG003|Follow-up Period|Physician Decision|0|||
143356312|NCT04285229|516848827|FG004|Follow-up Period|Physician Decision|0|||
143356313|NCT04285229|516848828|FG005|Follow-up Period|Physician Decision|1|||
143356314|NCT04242875|516848829|FG000|Overall Study|Adverse Event|2|||
143356315|NCT02397460|516848830|FG000|Treatment Period 2|Adverse Event|0|||
143463355|NCT00762970|517242993|FG000|Overall Study|Lost to Follow-up|1|||
143126170|NCT03853291|516006755|FG000|Overall Study|Determined to be ineligible|1|||
143126171|NCT03853291|516006756|FG001|Overall Study|Determined to be ineligible|1|||
143126172|NCT03853291|516006757|FG002|Overall Study|Determined to be ineligible|0|||
143126173|NCT03853291|516006758|FG003|Overall Study|Determined to be ineligible|0|||
143126174|NCT03853291|516006759|FG004|Overall Study|Determined to be ineligible|0|||
143126175|NCT03853291|516006760|FG005|Overall Study|Determined to be ineligible|0|||
143126176|NCT03883477|516006761|FG000|Overall Study|Death|1|||
143126177|NCT03883477|516006762|FG001|Overall Study|Death|0|||
143126178|NCT03883477|516006761|FG000|Overall Study|Protocol Violation|0|||
143126179|NCT03883477|516006762|FG001|Overall Study|Protocol Violation|1|||
143126180|NCT04186221|516006768|FG000|Overall Study|Death|1|||
143126181|NCT01904032|516006769|FG000|Overall Study|Adverse Event|3|||
143126182|NCT01904032|516006770|FG001|Overall Study|Adverse Event|1|||
143126183|NCT01904032|516006769|FG000|Overall Study|Lost to Follow-up|4|||
143126184|NCT01904032|516006770|FG001|Overall Study|Lost to Follow-up|2|||
143126185|NCT00531947|516006773|FG000|Overall Study|Adverse Event|5|||
143126186|NCT00531947|516006774|FG001|Overall Study|Adverse Event|10|||
143126187|NCT00531947|516006773|FG000|Overall Study|Lost to Follow-up|12|||
143126188|NCT00531947|516006774|FG001|Overall Study|Lost to Follow-up|9|||
143126189|NCT00531947|516006773|FG000|Overall Study|Withdrawal by Subject|14|||
143126190|NCT00531947|516006774|FG001|Overall Study|Withdrawal by Subject|19|||
143126191|NCT00531947|516006773|FG000|Overall Study|Protocol Violation|2|||
143126192|NCT00531947|516006774|FG001|Overall Study|Protocol Violation|1|||
143126193|NCT00531947|516006773|FG000|Overall Study|Non-Compliance|4|||
143126194|NCT00531947|516006774|FG001|Overall Study|Non-Compliance|7|||
143126195|NCT00531947|516006773|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
143126196|NCT00531947|516006774|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
143126197|NCT03148067|516006782|FG000|Overall Study|Lost to Follow-up|3|||
143126198|NCT03148067|516006782|FG000|Overall Study|Death|1|||
143126199|NCT02383355|516006786|FG000|Overall Study|Adverse Event|2|||
143126200|NCT02383355|516006787|FG001|Overall Study|Adverse Event|0|||
143126201|NCT04074330|516006793|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
143126202|NCT04074330|516006794|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
143126203|NCT04074330|516006795|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
143126204|NCT04074330|516006796|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
143126205|NCT04074330|516006797|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
143126206|NCT04074330|516006798|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
143126207|NCT04074330|516006799|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
143126208|NCT04074330|516006800|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
143126209|NCT04074330|516006801|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
143126210|NCT04074330|516006802|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
143126211|NCT04074330|516006793|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
143126212|NCT04074330|516006794|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
143356316|NCT02397460|516848831|FG001|Treatment Period 2|Adverse Event|0|||
143356317|NCT02397460|516848832|FG002|Treatment Period 2|Adverse Event|0|||
143356318|NCT02397460|516848833|FG003|Treatment Period 2|Adverse Event|0|||
143356319|NCT02397460|516848834|FG004|Treatment Period 2|Adverse Event|0|||
143356320|NCT02397460|516848835|FG005|Treatment Period 2|Adverse Event|0|||
143356321|NCT02397460|516848836|FG006|Treatment Period 2|Adverse Event|0|||
143356322|NCT02397460|516848837|FG007|Treatment Period 2|Adverse Event|1|||
143356323|NCT02397460|516848830|FG000|Treatment Period 4|Adverse Event|0|||
143356324|NCT02397460|516848831|FG001|Treatment Period 4|Adverse Event|1|||
143356325|NCT02397460|516848832|FG002|Treatment Period 4|Adverse Event|0|||
143356326|NCT02397460|516848833|FG003|Treatment Period 4|Adverse Event|0|||
143356327|NCT02397460|516848834|FG004|Treatment Period 4|Adverse Event|0|||
143356328|NCT02397460|516848835|FG005|Treatment Period 4|Adverse Event|0|||
143356329|NCT02397460|516848836|FG006|Treatment Period 4|Adverse Event|0|||
143356330|NCT02397460|516848837|FG007|Treatment Period 4|Adverse Event|0|||
143356331|NCT02397460|516848830|FG000|Treatment Period 4|Physician Decision|0|||
143356332|NCT02397460|516848831|FG001|Treatment Period 4|Physician Decision|0|||
143356333|NCT02397460|516848832|FG002|Treatment Period 4|Physician Decision|0|||
143356334|NCT02397460|516848833|FG003|Treatment Period 4|Physician Decision|0|||
143356335|NCT02397460|516848834|FG004|Treatment Period 4|Physician Decision|1|||
143126213|NCT04074330|516006795|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
143126214|NCT04074330|516006796|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
143126215|NCT04074330|516006797|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
143126216|NCT04074330|516006798|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
143126217|NCT04074330|516006799|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
143126218|NCT04074330|516006800|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
143126219|NCT04074330|516006801|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
143126220|NCT04074330|516006802|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
143356336|NCT02397460|516848835|FG005|Treatment Period 4|Physician Decision|0|||
143356337|NCT02397460|516848836|FG006|Treatment Period 4|Physician Decision|0|||
143356338|NCT02397460|516848837|FG007|Treatment Period 4|Physician Decision|0|||
143356339|NCT01012973|516848838|FG000|Overall Study|Adverse Event|5|||
143356340|NCT01012973|516848839|FG001|Overall Study|Adverse Event|5|||
143126221|NCT04074330|516006793|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
143126222|NCT04074330|516006794|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
143126223|NCT04074330|516006795|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
143126224|NCT04074330|516006796|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
143356341|NCT01012973|516848838|FG000|Overall Study|Lack of Efficacy|0|||
143356342|NCT01012973|516848839|FG001|Overall Study|Lack of Efficacy|5|||
143356343|NCT01012973|516848838|FG000|Overall Study|Lost to Follow-up|1|||
143356344|NCT01012973|516848839|FG001|Overall Study|Lost to Follow-up|0|||
143356345|NCT01012973|516848838|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
143356346|NCT01012973|516848839|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
143356347|NCT01012973|516848838|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
143356348|NCT01012973|516848839|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
143356349|NCT01012973|516848838|FG000|Overall Study|Protocol Violation|5|||
143356350|NCT01012973|516848839|FG001|Overall Study|Protocol Violation|2|||
143356351|NCT01012973|516848838|FG000|Overall Study|Withdrawal by Subject|4|||
143356352|NCT01012973|516848839|FG001|Overall Study|Withdrawal by Subject|6|||
143356353|NCT02213055|516848841|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
143356354|NCT02213055|516848842|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
143356355|NCT02213055|516848841|FG000|Overall Study|Protocol was not Followed during Study|1|||
143356356|NCT02213055|516848842|FG001|Overall Study|Protocol was not Followed during Study|0|||
143356357|NCT02213055|516848841|FG000|Overall Study|Documentation Issue at Enrollment|1|||
143356358|NCT02213055|516848842|FG001|Overall Study|Documentation Issue at Enrollment|0|||
143356359|NCT02213055|516848841|FG000|Overall Study|Documentation Issue during Study|10|||
143356360|NCT02213055|516848842|FG001|Overall Study|Documentation Issue during Study|0|||
143356361|NCT02213055|516848841|FG000|Overall Study|Did not have Live Lice|8|||
143356362|NCT02213055|516848842|FG001|Overall Study|Did not have Live Lice|0|||
143356363|NCT02213055|516848841|FG000|Overall Study|Had another Treatment during the Study|3|||
143356364|NCT02213055|516848842|FG001|Overall Study|Had another Treatment during the Study|0|||
143356365|NCT02213055|516848841|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
143356366|NCT02213055|516848842|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
143356367|NCT02213055|516848841|FG000|Overall Study|Did not Return to School|5|||
143356368|NCT02213055|516848842|FG001|Overall Study|Did not Return to School|0|||
143356369|NCT00231894|516848843|FG000|Overall Study|Withdrawal by Subject|1|||
143356370|NCT00231894|516848844|FG001|Overall Study|Withdrawal by Subject|1|||
143356371|NCT02025205|516848846|FG000|Overall Study|Withdrawal by Subject|1|||
143356372|NCT02025205|516848847|FG001|Overall Study|Withdrawal by Subject|1|||
143356373|NCT02025205|516848846|FG000|Overall Study|Protocol Violation|2|||
143356374|NCT02025205|516848847|FG001|Overall Study|Protocol Violation|1|||
143356375|NCT02025205|516848846|FG000|Overall Study|Death|0|||
143356376|NCT02025205|516848847|FG001|Overall Study|Death|1|||
143356377|NCT01767129|516848848|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
143356378|NCT01767129|516848849|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
143356379|NCT01024751|516848850|FG000|Enrolled Participants|Ineligible at baseline|3|||
143356380|NCT01024751|516848851|FG001|Enrolled Participants|Ineligible at baseline|4|||
143356381|NCT01024751|516848850|FG000|Eligible Participants|Withdrawal by Subject|0|||
143356382|NCT01024751|516848851|FG001|Eligible Participants|Withdrawal by Subject|1|||
143356383|NCT01024751|516848850|FG000|Eligible Participants|Lost to Follow-up|0|||
143356384|NCT01024751|516848851|FG001|Eligible Participants|Lost to Follow-up|1|||
143356385|NCT01024751|516848850|FG000|Eligible Participants|Ineligible|0|||
143356386|NCT01024751|516848851|FG001|Eligible Participants|Ineligible|1|||
143356387|NCT03246672|516848853|FG000|Overall Study|Lost to Follow-up|2|||
143356388|NCT02500316|516848854|FG000|Overall Study|Adverse Event|3|||
143356389|NCT02500316|516848854|FG000|Overall Study|Lost to Follow-up|2|||
143356390|NCT02500316|516848854|FG000|Overall Study|Protocol Violation|1|||
143356391|NCT02500316|516848854|FG000|Overall Study|Withdrawal by Subject|15|||
143356392|NCT02500316|516848854|FG000|Overall Study|Final height achieved|5|||
143356393|NCT02500316|516848854|FG000|Overall Study|Due to war activity|1|||
143356394|NCT01406717|516848855|FG000|Overall Study|Subject non-compliance|4|||
143356395|NCT01406717|516848856|FG001|Overall Study|Subject non-compliance|3|||
143356396|NCT01406717|516848855|FG000|Overall Study|Protocol Violation|5|||
143356397|NCT01406717|516848856|FG001|Overall Study|Protocol Violation|1|||
143356398|NCT01406717|516848855|FG000|Overall Study|Lost to Follow-up|14|||
143356399|NCT01406717|516848856|FG001|Overall Study|Lost to Follow-up|8|||
143463356|NCT00762970|517242994|FG001|Overall Study|Lost to Follow-up|2|||
143356400|NCT01406717|516848855|FG000|Overall Study|Withdrawal by Subject|19|||
143126225|NCT04074330|516006797|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
143126226|NCT04074330|516006798|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
143356401|NCT01406717|516848856|FG001|Overall Study|Withdrawal by Subject|15|||
143356402|NCT01406717|516848855|FG000|Overall Study|Adverse Event|1|||
143356403|NCT01406717|516848856|FG001|Overall Study|Adverse Event|2|||
143356404|NCT01406717|516848855|FG000|Overall Study|Lack of Efficacy|0|||
143356405|NCT01406717|516848856|FG001|Overall Study|Lack of Efficacy|1|||
143356406|NCT01406717|516848855|FG000|Overall Study|Non-completion of visit activity|0|||
143463357|NCT00762970|517242995|FG002|Overall Study|Lost to Follow-up|0|||
143463358|NCT00762970|517242993|FG000|Overall Study|Difficulty of handling lens|1|||
143463359|NCT00762970|517242994|FG001|Overall Study|Difficulty of handling lens|2|||
143463360|NCT00762970|517242995|FG002|Overall Study|Difficulty of handling lens|0|||
143463361|NCT00975507|517242996|FG000|Overall Study|Adverse Event|1|||
143463362|NCT00975507|517242997|FG001|Overall Study|Adverse Event|0|||
143463363|NCT00975507|517242996|FG000|Overall Study|Lost to Follow-up|7|||
143463364|NCT00975507|517242997|FG001|Overall Study|Lost to Follow-up|1|||
143013276|NCT03611751|515588091|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
143013277|NCT03611751|515588092|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
143013278|NCT03611751|515588090|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
143356407|NCT01406717|516848856|FG001|Overall Study|Non-completion of visit activity|1|||
143356408|NCT03257995|516848857|FG000|Overall Study|Adverse Event|0|||
143356409|NCT03257995|516848858|FG001|Overall Study|Adverse Event|1|||
143356410|NCT03257995|516848859|FG002|Overall Study|Adverse Event|0|||
143356411|NCT03257995|516848860|FG003|Overall Study|Adverse Event|0|||
143356412|NCT03257995|516848861|FG004|Overall Study|Adverse Event|0|||
143013279|NCT03611751|515588091|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
143013280|NCT03611751|515588092|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
143013281|NCT03611751|515588090|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
143013282|NCT03611751|515588091|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
143013283|NCT03611751|515588092|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
143013284|NCT03611751|515588090|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
143013285|NCT03611751|515588091|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
143013286|NCT03611751|515588092|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
143013287|NCT01892020|515588098|FG000|Period 1|Adverse Event|1|||
143013288|NCT01892020|515588099|FG001|Period 1|Adverse Event|1|||
143013289|NCT01892020|515588098|FG000|Period 1|Protocol Violation|2|||
143013290|NCT01892020|515588099|FG001|Period 1|Protocol Violation|4|||
143013291|NCT01892020|515588098|FG000|Period 1|Unclassified|0|||
143013292|NCT01892020|515588099|FG001|Period 1|Unclassified|1|||
143013293|NCT01892020|515588098|FG000|Period 2|Protocol Violation|1|||
143013294|NCT01892020|515588099|FG001|Period 2|Protocol Violation|0|||
143013295|NCT03078192|515588102|FG000|Overall Study|Withdrawal by Subject|2|||
143013296|NCT03078192|515588103|FG001|Overall Study|Withdrawal by Subject|1|||
143013297|NCT03078192|515588102|FG000|Overall Study|screen failure|0|||
143013298|NCT03078192|515588103|FG001|Overall Study|screen failure|3|||
143013299|NCT02873195|515588104|FG000|Overall Study|Ineligible|5|||
143013300|NCT02873195|515588105|FG001|Overall Study|Ineligible|0|||
143013301|NCT03107715|515588106|FG000|Overall Study|did not deliver at the home hospital|4|||
143013302|NCT03107715|515588107|FG001|Overall Study|did not deliver at the home hospital|6|||
143013303|NCT03107715|515588106|FG000|Overall Study|infant stillborn|0|||
143013304|NCT03107715|515588107|FG001|Overall Study|infant stillborn|1|||
143013305|NCT02508649|515588108|FG000|Overall Study|Withdrawal by Subject|4|||
143013306|NCT02508649|515588109|FG001|Overall Study|Withdrawal by Subject|6|||
143013307|NCT02508649|515588110|FG002|Overall Study|Withdrawal by Subject|5|||
143013308|NCT02508649|515588111|FG003|Overall Study|Withdrawal by Subject|6|||
143013309|NCT02508649|515588108|FG000|Overall Study|Investigator withdrew the subject|1|||
143013310|NCT02508649|515588109|FG001|Overall Study|Investigator withdrew the subject|2|||
143013311|NCT02508649|515588110|FG002|Overall Study|Investigator withdrew the subject|1|||
143013312|NCT02508649|515588111|FG003|Overall Study|Investigator withdrew the subject|0|||
143013313|NCT02508649|515588108|FG000|Overall Study|Post randomization screening failure|12|||
143013314|NCT02508649|515588109|FG001|Overall Study|Post randomization screening failure|4|||
143013315|NCT02508649|515588110|FG002|Overall Study|Post randomization screening failure|9|||
143013316|NCT02508649|515588111|FG003|Overall Study|Post randomization screening failure|3|||
143013317|NCT02508649|515588108|FG000|Overall Study|Lost to Follow-up|1|||
143013318|NCT02508649|515588109|FG001|Overall Study|Lost to Follow-up|1|||
143013319|NCT02508649|515588110|FG002|Overall Study|Lost to Follow-up|0|||
143013320|NCT02508649|515588111|FG003|Overall Study|Lost to Follow-up|1|||
143013321|NCT01915498|515588113|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
143013322|NCT01915498|515588114|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
143013323|NCT01915498|515588115|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
143356413|NCT03257995|516848862|FG005|Overall Study|Adverse Event|0|||
143013324|NCT01915498|515588116|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
143013325|NCT01915498|515588117|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
143181144|NCT04951622|516210470|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
143356414|NCT03257995|516848857|FG000|Overall Study|Protocol deviation|0|||
143356415|NCT03257995|516848858|FG001|Overall Study|Protocol deviation|0|||
143463365|NCT00975507|517242996|FG000|Overall Study|Protocol Violation|2|||
143463366|NCT00975507|517242997|FG001|Overall Study|Protocol Violation|0|||
143013326|NCT01915498|515588118|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
143013327|NCT01915498|515588119|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
143013328|NCT01915498|515588120|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
143356416|NCT03257995|516848859|FG002|Overall Study|Protocol deviation|0|||
143356417|NCT03257995|516848860|FG003|Overall Study|Protocol deviation|0|||
143356418|NCT03257995|516848861|FG004|Overall Study|Protocol deviation|0|||
143356419|NCT03257995|516848862|FG005|Overall Study|Protocol deviation|2|||
143356420|NCT02285595|516848871|FG000|Overall Study|Lost to Follow-up|14|||
143356421|NCT02285595|516848871|FG000|Overall Study|Withdrawal by Subject|1|||
143356422|NCT01960790|516848872|FG000|Overall Study|Survey forms could not be recovered|3|||
143356423|NCT01960790|516848872|FG000|Overall Study|Treat with Humira outside survey period|3|||
143356424|NCT01960790|516848872|FG000|Overall Study|Transferred to another hospital|4|||
143356425|NCT01960790|516848872|FG000|Overall Study|Unevaluable for safety|1|||
143356426|NCT00544544|516848876|FG000|Overall Study|Withdrawal by Subject|1|||
143356427|NCT00544544|516848876|FG000|Overall Study|Adverse Event|1|||
143356428|NCT00544544|516848876|FG000|Overall Study|Lost to Follow-up|1|||
143356429|NCT02036515|516848877|FG000|Overall Study|Adverse Event|1|||
143356430|NCT02036515|516848878|FG001|Overall Study|Adverse Event|1|||
143356431|NCT02036515|516848879|FG002|Overall Study|Adverse Event|2|||
143356432|NCT02036515|516848877|FG000|Overall Study|Lost to Follow-up|0|||
143356433|NCT02036515|516848878|FG001|Overall Study|Lost to Follow-up|2|||
143356434|NCT02036515|516848879|FG002|Overall Study|Lost to Follow-up|0|||
143356435|NCT02036515|516848877|FG000|Overall Study|Non-compliance with study drug|0|||
143126227|NCT04074330|516006799|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
143126228|NCT04074330|516006800|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
143126229|NCT04074330|516006801|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
143126230|NCT04074330|516006802|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
143126231|NCT04074330|516006793|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
143126232|NCT04074330|516006794|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
143126233|NCT04074330|516006795|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
143356436|NCT02036515|516848878|FG001|Overall Study|Non-compliance with study drug|0|||
143356437|NCT02036515|516848879|FG002|Overall Study|Non-compliance with study drug|2|||
143126234|NCT04074330|516006796|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
143356438|NCT02036515|516848877|FG000|Overall Study|Screen failure|0|||
143356439|NCT02036515|516848878|FG001|Overall Study|Screen failure|2|||
143356440|NCT02036515|516848879|FG002|Overall Study|Screen failure|0|||
143356441|NCT02036515|516848877|FG000|Overall Study|Withdrawal by Subject|4|||
143126235|NCT04074330|516006797|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
143356442|NCT02036515|516848878|FG001|Overall Study|Withdrawal by Subject|7|||
143356443|NCT02036515|516848879|FG002|Overall Study|Withdrawal by Subject|9|||
143356444|NCT02036515|516848877|FG000|Overall Study|Hyperglycemia|0|||
143356445|NCT02036515|516848878|FG001|Overall Study|Hyperglycemia|0|||
143356446|NCT02036515|516848879|FG002|Overall Study|Hyperglycemia|1|||
143356447|NCT03872388|516848882|FG000|Overall Study|Disease Progression|0|||
143356448|NCT03872388|516848883|FG001|Overall Study|Disease Progression|0|||
143356449|NCT03872388|516848884|FG002|Overall Study|Disease Progression|0|||
143126236|NCT04074330|516006798|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
143126237|NCT04074330|516006799|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
143126238|NCT04074330|516006800|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
143126239|NCT04074330|516006801|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
143126240|NCT04074330|516006802|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
143126241|NCT04074330|516006793|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
143126242|NCT04074330|516006794|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
143126243|NCT04074330|516006795|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
143126244|NCT04074330|516006796|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
143126245|NCT04074330|516006797|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
143126246|NCT04074330|516006798|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
143126247|NCT04074330|516006799|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
143126248|NCT04074330|516006800|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
143126249|NCT04074330|516006801|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
143126250|NCT04074330|516006802|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
143356450|NCT03872388|516848885|FG003|Overall Study|Disease Progression|0|||
143356451|NCT03872388|516848886|FG004|Overall Study|Disease Progression|0|||
143356452|NCT03872388|516848887|FG005|Overall Study|Disease Progression|0|||
143356453|NCT03872388|516848888|FG006|Overall Study|Disease Progression|1|||
143356454|NCT03872388|516848889|FG007|Overall Study|Disease Progression|1|||
143356455|NCT03615482|516850718|FG000|Overall Study|Death|1|||
143356456|NCT03615482|516850719|FG001|Overall Study|Death|0|||
143356457|NCT03615482|516850718|FG000|Overall Study|Lost to Follow-up|7|||
143356458|NCT03615482|516850719|FG001|Overall Study|Lost to Follow-up|7|||
143356459|NCT03615482|516850718|FG000|Overall Study|Physician Decision|2|||
143356460|NCT03615482|516850719|FG001|Overall Study|Physician Decision|3|||
143356461|NCT03615482|516850718|FG000|Overall Study|Withdrawal by Subject|7|||
143356462|NCT03615482|516850719|FG001|Overall Study|Withdrawal by Subject|7|||
143356463|NCT00322868|516850720|FG000|Overall Study|disease progression|1|||
143126251|NCT04074330|516006793|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
143126252|NCT04074330|516006794|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
143126253|NCT04074330|516006795|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
143126254|NCT04074330|516006796|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
143126255|NCT04074330|516006797|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
143126256|NCT04074330|516006798|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
143126257|NCT04074330|516006799|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
143126258|NCT04074330|516006800|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
143126259|NCT04074330|516006801|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
143126260|NCT04074330|516006802|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
143126261|NCT04074330|516006793|FG000|Dose Expansion (up to 42 Months)|Death|0|||
143126262|NCT04074330|516006794|FG001|Dose Expansion (up to 42 Months)|Death|0|||
143126263|NCT04074330|516006795|FG002|Dose Expansion (up to 42 Months)|Death|0|||
143126264|NCT04074330|516006796|FG003|Dose Expansion (up to 42 Months)|Death|0|||
143126265|NCT04074330|516006797|FG004|Dose Expansion (up to 42 Months)|Death|0|||
143126266|NCT04074330|516006798|FG005|Dose Expansion (up to 42 Months)|Death|0|||
143126267|NCT04074330|516006799|FG006|Dose Expansion (up to 42 Months)|Death|0|||
143126268|NCT04074330|516006800|FG007|Dose Expansion (up to 42 Months)|Death|0|||
143126269|NCT04074330|516006801|FG008|Dose Expansion (up to 42 Months)|Death|1|||
143126270|NCT04074330|516006802|FG009|Dose Expansion (up to 42 Months)|Death|0|||
143126271|NCT04074330|516006793|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
143126272|NCT04074330|516006794|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
143126273|NCT04074330|516006795|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
143126274|NCT04074330|516006796|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
143126275|NCT04074330|516006797|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
143126276|NCT04074330|516006798|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
143126277|NCT04074330|516006799|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
143126278|NCT04074330|516006800|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
143126279|NCT04074330|516006801|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
143126280|NCT04074330|516006802|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
143126281|NCT03124537|516006803|FG000|Overall Study|Lost to Follow-up|3|||
143126282|NCT03124537|516006804|FG001|Overall Study|Lost to Follow-up|5|||
143126283|NCT03124537|516006803|FG000|Overall Study|App Crash, Incomplete Data|7|||
143126284|NCT03124537|516006804|FG001|Overall Study|App Crash, Incomplete Data|8|||
143126285|NCT03681184|516006805|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
143126286|NCT03681184|516006806|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
143126287|NCT02787083|516006807|FG000|Overall Study|Adverse Event|1|||
143126288|NCT02787083|516006808|FG001|Overall Study|Adverse Event|0|||
143126289|NCT02787083|516006807|FG000|Overall Study|Withdrawal by Subject|2|||
143126290|NCT02787083|516006808|FG001|Overall Study|Withdrawal by Subject|2|||
143126291|NCT03301831|516006809|FG000|Overall Study|Lost to Follow-up|5|||
143126292|NCT03301831|516006810|FG001|Overall Study|Lost to Follow-up|3|||
143126293|NCT03301831|516006809|FG000|Overall Study|Protocol Violation|4|||
143126294|NCT03301831|516006810|FG001|Overall Study|Protocol Violation|0|||
143126295|NCT03301831|516006809|FG000|Overall Study|Withdrawal by Subject|11|||
143126296|NCT03301831|516006810|FG001|Overall Study|Withdrawal by Subject|0|||
143126297|NCT02348008|516006812|FG000|Overall Study|Adverse Event|2|||
143126298|NCT02348008|516006813|FG001|Overall Study|Adverse Event|3|||
143126299|NCT02348008|516006814|FG002|Overall Study|Adverse Event|3|||
143126300|NCT02348008|516006812|FG000|Overall Study|Disease Progression|1|||
143126301|NCT02348008|516006813|FG001|Overall Study|Disease Progression|5|||
143126302|NCT02348008|516006814|FG002|Overall Study|Disease Progression|16|||
143126303|NCT02348008|516006812|FG000|Overall Study|Withdrawal by Subject|0|||
143126304|NCT02348008|516006813|FG001|Overall Study|Withdrawal by Subject|1|||
143126305|NCT02348008|516006814|FG002|Overall Study|Withdrawal by Subject|0|||
143356464|NCT02955277|516850721|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
143356465|NCT02955277|516850722|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
143356466|NCT02955277|516850721|FG000|Post to Follow-up|Lost to Follow-up|8|||
143356467|NCT02955277|516850722|FG001|Post to Follow-up|Lost to Follow-up|11|||
143356468|NCT02819479|516850729|FG000|Overall Study|Adverse Event|2|||
143356469|NCT01646320|516850734|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
143356470|NCT01646320|516850735|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
143463367|NCT00975507|517242996|FG000|Overall Study|Withdrawal by Subject|10|||
143463368|NCT00975507|517242997|FG001|Overall Study|Withdrawal by Subject|3|||
143463369|NCT01295034|517242998|FG000|Overall Study|Lost to Follow-up|5|||
143126306|NCT02348008|516006812|FG000|Overall Study|Symptomatic Deterioration|0|||
143126307|NCT02348008|516006813|FG001|Overall Study|Symptomatic Deterioration|1|||
143126308|NCT02348008|516006814|FG002|Overall Study|Symptomatic Deterioration|0|||
143126309|NCT00893971|516006815|FG000|Overall Study|Physician Decision|3|||
143126310|NCT03268005|516006816|FG000|Overall Study|Death|2|||
143126311|NCT03268005|516006817|FG001|Overall Study|Death|1|||
143126312|NCT03268005|516006816|FG000|Overall Study|Lost to Follow-up|2|||
143356471|NCT01646320|516850734|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
143356472|NCT01646320|516850735|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
143356473|NCT01646320|516850734|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
143356474|NCT01646320|516850735|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
143356475|NCT01646320|516850734|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
143356476|NCT01646320|516850735|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
143356477|NCT01646320|516850734|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
143356478|NCT01646320|516850735|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
143356479|NCT01646320|516850734|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
143356480|NCT01646320|516850735|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
143356481|NCT01646320|516850734|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
143356482|NCT01646320|516850735|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
143356483|NCT01646320|516850734|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
143356484|NCT01646320|516850735|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
143356485|NCT01646320|516850734|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
143356486|NCT01646320|516850735|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
143356487|NCT01646320|516850734|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
143356488|NCT01646320|516850735|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
143356489|NCT01646320|516850734|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
143356490|NCT01646320|516850735|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
143356491|NCT02485353|516850736|FG000|Overall Study|Death|1|||
143356492|NCT02485353|516850736|FG000|Overall Study|Disease Progression|1|||
143356493|NCT00839917|516850737|FG000|Overall Study|Lost to Follow-up|1|||
143356494|NCT00839917|516850738|FG001|Overall Study|Lost to Follow-up|0|||
143013329|NCT01915498|515588121|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
143013330|NCT01915498|515588122|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
143013331|NCT01915498|515588123|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
143013332|NCT01915498|515588124|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
143013333|NCT01915498|515588125|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
143013334|NCT01915498|515588126|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
143013335|NCT01915498|515588127|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
143356495|NCT00839917|516850737|FG000|Overall Study|Did not receive vaccine|0|||
143356496|NCT00839917|516850738|FG001|Overall Study|Did not receive vaccine|1|||
143356497|NCT04006366|516850743|FG000|Overall Study|Withdrawal by Subject|1|||
143356498|NCT00627042|516850746|FG000|Overall Study|Withdrawal by Subject|2|||
143356499|NCT01440049|516850747|FG000|Overall Study|Adverse Event|5|||
143356500|NCT02268552|516850748|FG000|Part 1|Death|1|||
143356501|NCT02268552|516850749|FG001|Part 1|Death|1|||
143356502|NCT02268552|516850750|FG002|Part 1|Death|1|||
143356503|NCT02268552|516850751|FG003|Part 1|Death|2|||
143356504|NCT02268552|516850752|FG004|Part 1|Death|0|||
143356505|NCT02268552|516850753|FG005|Part 1|Death|0|||
143356506|NCT02268552|516850754|FG006|Part 1|Death|0|||
143356507|NCT02268552|516850748|FG000|Part 1|Subject/guardian decision|0|||
143356508|NCT02268552|516850749|FG001|Part 1|Subject/guardian decision|0|||
143463370|NCT01295034|517242999|FG001|Overall Study|Lost to Follow-up|5|||
143463371|NCT03818204|517243000|FG000|Overall Study|Could not close eye due to impaired facial nerve.|0|||
143356509|NCT02268552|516850750|FG002|Part 1|Subject/guardian decision|0|||
143356510|NCT02268552|516850751|FG003|Part 1|Subject/guardian decision|1|||
143463372|NCT03818204|517243001|FG001|Overall Study|Could not close eye due to impaired facial nerve.|0|||
143463373|NCT03818204|517243002|FG002|Overall Study|Could not close eye due to impaired facial nerve.|0|||
143463374|NCT03818204|517243003|FG003|Overall Study|Could not close eye due to impaired facial nerve.|0|||
143013336|NCT01915498|515588128|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
143356511|NCT02268552|516850752|FG004|Part 1|Subject/guardian decision|0|||
143356512|NCT02268552|516850753|FG005|Part 1|Subject/guardian decision|0|||
143356513|NCT02268552|516850754|FG006|Part 1|Subject/guardian decision|0|||
143356514|NCT02268552|516850748|FG000|Part 2|Death|0|||
143356515|NCT02268552|516850749|FG001|Part 2|Death|0|||
143356516|NCT02268552|516850750|FG002|Part 2|Death|0|||
143356517|NCT02268552|516850751|FG003|Part 2|Death|0|||
143356518|NCT02268552|516850752|FG004|Part 2|Death|0|||
143356519|NCT02268552|516850753|FG005|Part 2|Death|0|||
143356520|NCT02268552|516850754|FG006|Part 2|Death|2|||
143356521|NCT02268552|516850748|FG000|Part 2|Subject/guardian decision|0|||
143356522|NCT02268552|516850749|FG001|Part 2|Subject/guardian decision|0|||
143356523|NCT02268552|516850750|FG002|Part 2|Subject/guardian decision|0|||
143356524|NCT02268552|516850751|FG003|Part 2|Subject/guardian decision|0|||
143356525|NCT02268552|516850752|FG004|Part 2|Subject/guardian decision|0|||
143356526|NCT02268552|516850753|FG005|Part 2|Subject/guardian decision|0|||
143356527|NCT02268552|516850754|FG006|Part 2|Subject/guardian decision|1|||
143356528|NCT02268552|516850748|FG000|Part 3 Extension|Death|0|||
143013337|NCT01915498|515588129|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
143463375|NCT03818204|517243004|FG004|Overall Study|Could not close eye due to impaired facial nerve.|1|||
143356529|NCT02268552|516850749|FG001|Part 3 Extension|Death|1|||
143356530|NCT02268552|516850750|FG002|Part 3 Extension|Death|1|||
143356531|NCT02268552|516850751|FG003|Part 3 Extension|Death|1|||
143356532|NCT02268552|516850752|FG004|Part 3 Extension|Death|1|||
143356533|NCT02268552|516850753|FG005|Part 3 Extension|Death|1|||
143356534|NCT02268552|516850754|FG006|Part 3 Extension|Death|0|||
143356535|NCT02268552|516850748|FG000|Part 3 Extension|Early termination of trial|1|||
143356536|NCT02268552|516850749|FG001|Part 3 Extension|Early termination of trial|0|||
143463376|NCT03818204|517243005|FG005|Overall Study|Could not close eye due to impaired facial nerve.|0|||
143463377|NCT03818204|517243006|FG006|Overall Study|Could not close eye due to impaired facial nerve.|0|||
143463378|NCT03818204|517243007|FG007|Overall Study|Could not close eye due to impaired facial nerve.|0|||
143463379|NCT03818204|517243008|FG008|Overall Study|Could not close eye due to impaired facial nerve.|0|||
143463380|NCT03818204|517243009|FG009|Overall Study|Could not close eye due to impaired facial nerve.|0|||
143463381|NCT03818204|517243010|FG010|Overall Study|Could not close eye due to impaired facial nerve.|0|||
143463382|NCT03818204|517243011|FG011|Overall Study|Could not close eye due to impaired facial nerve.|0|||
143463383|NCT03818204|517243012|FG012|Overall Study|Could not close eye due to impaired facial nerve.|0|||
143463384|NCT03818204|517243013|FG013|Overall Study|Could not close eye due to impaired facial nerve.|1|||
143126313|NCT03268005|516006817|FG001|Overall Study|Lost to Follow-up|2|||
143356537|NCT02268552|516850750|FG002|Part 3 Extension|Early termination of trial|0|||
143356538|NCT02268552|516850751|FG003|Part 3 Extension|Early termination of trial|0|||
143356539|NCT02268552|516850752|FG004|Part 3 Extension|Early termination of trial|2|||
143356540|NCT02268552|516850753|FG005|Part 3 Extension|Early termination of trial|9|||
143356541|NCT02268552|516850754|FG006|Part 3 Extension|Early termination of trial|11|||
143356542|NCT02268552|516850748|FG000|Part 3 Extension|Subject/guardian decision|0|||
143356543|NCT02268552|516850749|FG001|Part 3 Extension|Subject/guardian decision|0|||
143356544|NCT02268552|516850750|FG002|Part 3 Extension|Subject/guardian decision|0|||
143356545|NCT02268552|516850751|FG003|Part 3 Extension|Subject/guardian decision|0|||
143356546|NCT02268552|516850752|FG004|Part 3 Extension|Subject/guardian decision|0|||
143356547|NCT02268552|516850753|FG005|Part 3 Extension|Subject/guardian decision|0|||
143356548|NCT02268552|516850754|FG006|Part 3 Extension|Subject/guardian decision|1|||
143356549|NCT02139982|516850756|FG000|Overall Study|Lack of Efficacy|0|||
143356550|NCT02139982|516850757|FG001|Overall Study|Lack of Efficacy|1|||
143356551|NCT02139982|516850758|FG002|Overall Study|Lack of Efficacy|0|||
143356552|NCT02139982|516850759|FG003|Overall Study|Lack of Efficacy|1|||
143356553|NCT02139982|516850760|FG004|Overall Study|Lack of Efficacy|0|||
143356554|NCT02139982|516850761|FG005|Overall Study|Lack of Efficacy|0|||
143356555|NCT02139982|516850762|FG006|Overall Study|Lack of Efficacy|0|||
143356556|NCT02139982|516850763|FG007|Overall Study|Lack of Efficacy|0|||
143356557|NCT02139982|516850764|FG008|Overall Study|Lack of Efficacy|0|||
143356558|NCT02139982|516850765|FG009|Overall Study|Lack of Efficacy|0|||
143356559|NCT02748512|516850768|FG000|Overall Study|Lost to Follow-up|1|||
143356560|NCT02748512|516850769|FG001|Overall Study|Lost to Follow-up|1|||
143356561|NCT00997243|516850771|FG000|Overall Study|Early termination of study by sponsor|7|||
143356562|NCT03415022|516850774|FG000|Overall Study|Withdrawal by Subject|1|||
143356563|NCT03415022|516850775|FG001|Overall Study|Withdrawal by Subject|2|||
143356564|NCT03415022|516850774|FG000|Overall Study|COVID-19 Suspension|2|||
143356565|NCT03415022|516850775|FG001|Overall Study|COVID-19 Suspension|3|||
143356566|NCT03415022|516850774|FG000|Overall Study|Lost to Follow-up|2|||
143356567|NCT03415022|516850775|FG001|Overall Study|Lost to Follow-up|0|||
143356568|NCT04466618|516850776|FG000|Overall Study|Withdrawal by Subject|0|||
143356569|NCT04466618|516850777|FG001|Overall Study|Withdrawal by Subject|1|||
143356570|NCT01349907|516850778|FG000|Overall Study|Adverse Event|37|||
143356571|NCT01349907|516850779|FG001|Overall Study|Adverse Event|11|||
143356572|NCT01349907|516850778|FG000|Overall Study|Treatment failure|13|||
143356573|NCT01349907|516850779|FG001|Overall Study|Treatment failure|4|||
143356574|NCT01349907|516850778|FG000|Overall Study|Lost to Follow-up|25|||
143356575|NCT01349907|516850779|FG001|Overall Study|Lost to Follow-up|6|||
143356576|NCT01349907|516850778|FG000|Overall Study|Withdrawal by Subject|30|||
143356577|NCT01349907|516850779|FG001|Overall Study|Withdrawal by Subject|8|||
143356578|NCT01349907|516850778|FG000|Overall Study|Protocol Violation|33|||
143356579|NCT01349907|516850779|FG001|Overall Study|Protocol Violation|13|||
143356580|NCT01349907|516850778|FG000|Overall Study|Administrative|1|||
143463385|NCT03818204|517243014|FG014|Overall Study|Could not close eye due to impaired facial nerve.|0|||
143463386|NCT03818204|517243015|FG015|Overall Study|Could not close eye due to impaired facial nerve.|0|||
143463387|NCT03818204|517243016|FG016|Overall Study|Could not close eye due to impaired facial nerve.|0|||
143463388|NCT03818204|517243017|FG017|Overall Study|Could not close eye due to impaired facial nerve.|0|||
143463389|NCT03818204|517243018|FG018|Overall Study|Could not close eye due to impaired facial nerve.|0|||
143463390|NCT03818204|517243000|FG000|Overall Study|Physician Decision|0|||
143463391|NCT03818204|517243001|FG001|Overall Study|Physician Decision|0|||
143463392|NCT03818204|517243002|FG002|Overall Study|Physician Decision|0|||
143463393|NCT03818204|517243003|FG003|Overall Study|Physician Decision|0|||
143463394|NCT03818204|517243004|FG004|Overall Study|Physician Decision|0|||
143463395|NCT03818204|517243005|FG005|Overall Study|Physician Decision|0|||
143463396|NCT03818204|517243006|FG006|Overall Study|Physician Decision|0|||
143463397|NCT03818204|517243007|FG007|Overall Study|Physician Decision|0|||
143463398|NCT03818204|517243008|FG008|Overall Study|Physician Decision|0|||
143463399|NCT03818204|517243009|FG009|Overall Study|Physician Decision|0|||
143463400|NCT03818204|517243010|FG010|Overall Study|Physician Decision|0|||
143463401|NCT03818204|517243011|FG011|Overall Study|Physician Decision|0|||
143463402|NCT03818204|517243012|FG012|Overall Study|Physician Decision|0|||
143463403|NCT03818204|517243013|FG013|Overall Study|Physician Decision|0|||
143013338|NCT01915498|515588130|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
143013339|NCT01915498|515588131|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
143356581|NCT01349907|516850779|FG001|Overall Study|Administrative|1|||
143356582|NCT03583541|516850785|FG000|Overall Study|Lost to Follow-up|31|||
143356583|NCT03583541|516850786|FG001|Overall Study|Lost to Follow-up|65|||
143356584|NCT00884286|516850789|FG000|Overall Study|Progressive disease|21|||
143356585|NCT00884286|516850790|FG001|Overall Study|Progressive disease|28|||
143356586|NCT00884286|516850789|FG000|Overall Study|Toxicity|4|||
143356587|NCT00884286|516850790|FG001|Overall Study|Toxicity|1|||
143356588|NCT00884286|516850789|FG000|Overall Study|Death|2|||
143356589|NCT00884286|516850790|FG001|Overall Study|Death|2|||
143356590|NCT00884286|516850789|FG000|Overall Study|Physician Decision|1|||
143356591|NCT00884286|516850790|FG001|Overall Study|Physician Decision|0|||
143356592|NCT00884286|516850789|FG000|Overall Study|Septic shock|1|||
143356593|NCT00884286|516850790|FG001|Overall Study|Septic shock|0|||
143356594|NCT00884286|516850789|FG000|Overall Study|Thrombus in right auricle|1|||
143356595|NCT00884286|516850790|FG001|Overall Study|Thrombus in right auricle|0|||
143356596|NCT00884286|516850789|FG000|Overall Study|Not treated|2|||
143356597|NCT00884286|516850790|FG001|Overall Study|Not treated|1|||
143356598|NCT00884286|516850789|FG000|Overall Study|Comprised lung carcinoma|0|||
143356599|NCT00884286|516850790|FG001|Overall Study|Comprised lung carcinoma|1|||
143356600|NCT00109928|516850791|FG000|Overall Study|Adverse Event|2|||
143356601|NCT00109928|516850791|FG000|Overall Study|Progression|6|||
143356602|NCT00109928|516850791|FG000|Overall Study|Death|2|||
143356603|NCT00109928|516850791|FG000|Overall Study|not protocol specified|2|||
143356604|NCT00109928|516850791|FG000|Overall Study|not eligible|1|||
143356605|NCT01196104|516850792|FG000|Overall Study|Lost to Follow-up|1|||
143356606|NCT01196104|516850793|FG001|Overall Study|Lost to Follow-up|0|||
143356607|NCT01196104|516850792|FG000|Overall Study|Physician Decision|0|||
143356608|NCT01196104|516850793|FG001|Overall Study|Physician Decision|1|||
143356609|NCT01196104|516850792|FG000|Overall Study|Withdrawal by Subject|3|||
143356610|NCT01196104|516850793|FG001|Overall Study|Withdrawal by Subject|3|||
143356611|NCT01196104|516850792|FG000|Overall Study|Various|0|||
143356612|NCT01196104|516850793|FG001|Overall Study|Various|1|||
143356613|NCT01458249|516850798|FG000|Overall Study|Not treated|1|||
143356614|NCT01458249|516850798|FG000|Overall Study|Adverse Event|4|||
143356615|NCT01458249|516850798|FG000|Overall Study|Other|2|||
143356616|NCT01458249|516850798|FG000|Overall Study|Ongoing|1|||
143356617|NCT01348854|516850799|FG000|Overall Study|Lost to Follow-up|2|||
143356618|NCT01348854|516850800|FG001|Overall Study|Lost to Follow-up|1|||
143356619|NCT01348854|516850799|FG000|Overall Study|Withdrawal by Subject|1|||
143356620|NCT01348854|516850800|FG001|Overall Study|Withdrawal by Subject|0|||
143356621|NCT03220737|516850801|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
143356622|NCT03220737|516850802|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
143356623|NCT03220737|516850803|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
143356624|NCT03220737|516850804|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
143356625|NCT03220737|516850805|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
143356626|NCT03220737|516850806|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
143463404|NCT03818204|517243014|FG014|Overall Study|Physician Decision|1|||
143463405|NCT03818204|517243015|FG015|Overall Study|Physician Decision|0|||
143463406|NCT03818204|517243016|FG016|Overall Study|Physician Decision|0|||
143463407|NCT03818204|517243017|FG017|Overall Study|Physician Decision|0|||
143356627|NCT03220737|516850807|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
143356628|NCT03220737|516850801|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
143356629|NCT03220737|516850802|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
143356630|NCT03220737|516850803|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
143356631|NCT03220737|516850804|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
143356632|NCT03220737|516850805|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
143356633|NCT03220737|516850806|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
143356634|NCT03220737|516850807|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
143356635|NCT03220737|516850801|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
143356636|NCT03220737|516850802|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
143356637|NCT03220737|516850803|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
143356638|NCT03220737|516850804|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
143356639|NCT03220737|516850805|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
143356640|NCT03220737|516850806|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
143356641|NCT03220737|516850807|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
143356642|NCT03220737|516850801|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
143356643|NCT03220737|516850802|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
143013340|NCT01915498|515588113|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
143013341|NCT01915498|515588114|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
143013342|NCT01915498|515588115|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
143013343|NCT01915498|515588116|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
143013344|NCT01915498|515588117|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
143013345|NCT01915498|515588118|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
143013346|NCT01915498|515588119|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
143013347|NCT01915498|515588120|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
143013348|NCT01915498|515588121|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
143013349|NCT01915498|515588122|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
143013350|NCT01915498|515588123|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
143013351|NCT01915498|515588124|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
143013352|NCT01915498|515588125|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
143013353|NCT01915498|515588126|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
143013354|NCT01915498|515588127|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
143013355|NCT01915498|515588128|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
143013356|NCT01915498|515588129|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
143013357|NCT01915498|515588130|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
143013358|NCT01915498|515588131|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
143013359|NCT01915498|515588113|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
143013360|NCT01915498|515588114|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
143013361|NCT01915498|515588115|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
143013362|NCT01915498|515588116|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
143013363|NCT01915498|515588117|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
143013364|NCT01915498|515588118|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
143013365|NCT01915498|515588119|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
143013366|NCT01915498|515588120|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
143013367|NCT01915498|515588121|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
143013368|NCT01915498|515588122|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
143013369|NCT01915498|515588123|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
143013370|NCT01915498|515588124|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
143013371|NCT01915498|515588125|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
143013372|NCT01915498|515588126|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
143013373|NCT01915498|515588127|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
143013374|NCT01915498|515588128|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
143013375|NCT01915498|515588129|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
143013376|NCT01915498|515588130|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
143013377|NCT01915498|515588131|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
143013378|NCT01915498|515588113|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
143013379|NCT01915498|515588114|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
143013380|NCT01915498|515588115|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
143013381|NCT01915498|515588116|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
143013382|NCT01915498|515588117|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
143013383|NCT01915498|515588118|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
143013384|NCT01915498|515588119|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
143013385|NCT01915498|515588120|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
143013386|NCT01915498|515588121|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
143013387|NCT01915498|515588122|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
143013388|NCT01915498|515588123|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
143013389|NCT01915498|515588124|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
143126314|NCT03268005|516006816|FG000|Overall Study|Withdrawal by Subject|11|||
143126315|NCT03268005|516006817|FG001|Overall Study|Withdrawal by Subject|11|||
143356644|NCT03220737|516850803|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
143463408|NCT03818204|517243018|FG018|Overall Study|Physician Decision|0|||
143463409|NCT00887250|517243019|FG000|Overall Study|Adverse Event|3|||
143463410|NCT00887250|517243020|FG001|Overall Study|Adverse Event|0|||
143463411|NCT00887250|517243021|FG002|Overall Study|Adverse Event|7|||
143463412|NCT00887250|517243019|FG000|Overall Study|Lack of Efficacy|9|||
143463413|NCT00887250|517243020|FG001|Overall Study|Lack of Efficacy|6|||
143463414|NCT00887250|517243021|FG002|Overall Study|Lack of Efficacy|1|||
143463415|NCT00887250|517243019|FG000|Overall Study|Lost to Follow-up|2|||
143463416|NCT00887250|517243020|FG001|Overall Study|Lost to Follow-up|3|||
143463417|NCT00887250|517243021|FG002|Overall Study|Lost to Follow-up|1|||
143463418|NCT00887250|517243019|FG000|Overall Study|Protocol Violation|2|||
143463419|NCT00887250|517243020|FG001|Overall Study|Protocol Violation|2|||
143463420|NCT00887250|517243021|FG002|Overall Study|Protocol Violation|1|||
143463421|NCT00887250|517243019|FG000|Overall Study|Withdrawal by Subject|2|||
143463422|NCT00887250|517243020|FG001|Overall Study|Withdrawal by Subject|1|||
143463423|NCT00887250|517243021|FG002|Overall Study|Withdrawal by Subject|2|||
143463424|NCT00887250|517243019|FG000|Overall Study|Patient uncooperative|0|||
143463425|NCT00887250|517243020|FG001|Overall Study|Patient uncooperative|0|||
143463426|NCT00887250|517243021|FG002|Overall Study|Patient uncooperative|1|||
143463427|NCT05754333|517243022|FG000|Overall Study|Miscellaneous|3|||
143463428|NCT05754333|517243023|FG001|Overall Study|Miscellaneous|0|||
143463429|NCT05754333|517243024|FG002|Overall Study|Miscellaneous|0|||
143463430|NCT05754333|517243025|FG003|Overall Study|Miscellaneous|0|||
143463431|NCT05754333|517243022|FG000|Overall Study|Lost to Follow-up|2|||
143463432|NCT05754333|517243023|FG001|Overall Study|Lost to Follow-up|1|||
143356645|NCT03220737|516850804|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
143356646|NCT03220737|516850805|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
143356647|NCT03220737|516850806|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
143356648|NCT03220737|516850807|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
143356649|NCT03220737|516850801|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
143356650|NCT03220737|516850802|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
143356651|NCT03220737|516850803|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
143356652|NCT03220737|516850804|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
143356653|NCT03220737|516850805|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
143356654|NCT03220737|516850806|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
143356655|NCT03220737|516850807|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
143356656|NCT03220737|516850801|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
143356657|NCT03220737|516850802|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
143356658|NCT03220737|516850803|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
143356659|NCT03220737|516850804|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
143356660|NCT03220737|516850805|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
143356661|NCT03220737|516850806|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
143356662|NCT03220737|516850807|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
143356663|NCT03220737|516850801|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
143356664|NCT03220737|516850802|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
143356665|NCT03220737|516850803|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
143356666|NCT03220737|516850804|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
143356667|NCT03220737|516850805|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
143356668|NCT03220737|516850806|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
143356669|NCT03220737|516850807|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
143356670|NCT03220737|516850801|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
143356671|NCT03220737|516850802|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
143356672|NCT03220737|516850803|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
143356673|NCT03220737|516850804|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
143356674|NCT03220737|516850805|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
143356675|NCT03220737|516850806|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
143356676|NCT03220737|516850807|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
143356677|NCT01720797|516850808|FG000|Overall Study|Withdrawal by Subject|3|||
143356678|NCT01720797|516850809|FG001|Overall Study|Withdrawal by Subject|0|||
143356679|NCT00983619|516850816|FG000|Overall Study|Lost to Follow-up|0|||
143356680|NCT00983619|516850817|FG001|Overall Study|Lost to Follow-up|1|||
143356681|NCT00983619|516850818|FG002|Overall Study|Lost to Follow-up|0|||
143356682|NCT00983619|516850819|FG003|Overall Study|Lost to Follow-up|0|||
143356683|NCT00983619|516850820|FG004|Overall Study|Lost to Follow-up|0|||
143356684|NCT00983619|516850821|FG005|Overall Study|Lost to Follow-up|2|||
143356685|NCT00983619|516850822|FG006|Overall Study|Lost to Follow-up|0|||
143356686|NCT00983619|516850823|FG007|Overall Study|Lost to Follow-up|0|||
143356687|NCT00983619|516850824|FG008|Overall Study|Lost to Follow-up|0|||
143463433|NCT05754333|517243024|FG002|Overall Study|Lost to Follow-up|0|||
143463434|NCT05754333|517243025|FG003|Overall Study|Lost to Follow-up|1|||
143463435|NCT03864146|517243026|FG000|Overall Study|Lost to Follow-up|14|||
143463436|NCT03864146|517243027|FG001|Overall Study|Lost to Follow-up|23|||
143126316|NCT00492232|516006818|FG000|Placebo Run-in|Adverse Event|0|||
143126317|NCT00492232|516006819|FG001|Placebo Run-in|Adverse Event|2|||
143126318|NCT00492232|516006818|FG000|Placebo Run-in|Protocol Violation|0|||
143126319|NCT00492232|516006819|FG001|Placebo Run-in|Protocol Violation|3|||
143126320|NCT00492232|516006818|FG000|Placebo Run-in|Lost to Follow-up|0|||
143126321|NCT00492232|516006819|FG001|Placebo Run-in|Lost to Follow-up|3|||
143126322|NCT00492232|516006818|FG000|Placebo Run-in|Withdrawal by Subject|0|||
143126323|NCT00492232|516006819|FG001|Placebo Run-in|Withdrawal by Subject|8|||
143126324|NCT00492232|516006818|FG000|Placebo Run-in|Pregnancy|0|||
143126325|NCT00492232|516006819|FG001|Placebo Run-in|Pregnancy|1|||
143126326|NCT00492232|516006818|FG000|Placebo Run-in|Entrance criteria not met|0|||
143126327|NCT00492232|516006819|FG001|Placebo Run-in|Entrance criteria not met|45|||
143126328|NCT00492232|516006818|FG000|Placebo Run-in|Other|0|||
143126329|NCT00492232|516006819|FG001|Placebo Run-in|Other|6|||
143126330|NCT00492232|516006818|FG000|Placebo Run-in|Missing|0|||
143126331|NCT00492232|516006819|FG001|Placebo Run-in|Missing|2|||
143126332|NCT00492232|516006818|FG000|Double-Blind Treatment|Adverse Event|1|||
143126333|NCT00492232|516006819|FG001|Double-Blind Treatment|Adverse Event|2|||
143126334|NCT00492232|516006818|FG000|Double-Blind Treatment|Protocol Violation|3|||
143126335|NCT00492232|516006819|FG001|Double-Blind Treatment|Protocol Violation|7|||
143126336|NCT00492232|516006818|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
143126337|NCT00492232|516006819|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
143126338|NCT00492232|516006818|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
143126339|NCT00492232|516006819|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
143126340|NCT00492232|516006818|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
143126341|NCT00492232|516006819|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
143126342|NCT00492232|516006818|FG000|Double-Blind Treatment|Other|6|||
143126343|NCT00492232|516006819|FG001|Double-Blind Treatment|Other|5|||
143126344|NCT00492232|516006818|FG000|Double-Blind Treatment|Randomized not treated|1|||
143126345|NCT00492232|516006819|FG001|Double-Blind Treatment|Randomized not treated|0|||
143126346|NCT00492232|516006818|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
143126347|NCT00492232|516006819|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
143126348|NCT02717442|516006820|FG000|Overall Study|Study Terminated by Sponsor|31|||
143126349|NCT02717442|516006821|FG001|Overall Study|Study Terminated by Sponsor|29|||
143126350|NCT02717442|516006820|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
143126351|NCT02717442|516006821|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
143126352|NCT02717442|516006820|FG000|Overall Study|Other - Not Specified|2|||
143126353|NCT02717442|516006821|FG001|Overall Study|Other - Not Specified|0|||
143126354|NCT00382109|516006822|FG000|Overall Study|Adverse Event|3|||
143126355|NCT00382109|516006823|FG001|Overall Study|Adverse Event|0|||
143126356|NCT00382109|516006822|FG000|Overall Study|Physician Decision|6|||
143126357|NCT00382109|516006823|FG001|Overall Study|Physician Decision|1|||
143126358|NCT00382109|516006822|FG000|Overall Study|Withdrawal by Subject|1|||
143126359|NCT00382109|516006823|FG001|Overall Study|Withdrawal by Subject|0|||
143126360|NCT00382109|516006822|FG000|Overall Study|ineligible|2|||
143126361|NCT00382109|516006823|FG001|Overall Study|ineligible|0|||
143126362|NCT00382109|516006822|FG000|Overall Study|Other|0|||
143126363|NCT00382109|516006823|FG001|Overall Study|Other|2|||
143126364|NCT00382109|516006822|FG000|Overall Study|consent withdrawal|0|||
143126365|NCT00382109|516006823|FG001|Overall Study|consent withdrawal|1|||
143126366|NCT03275389|516006824|FG000|Overall Study|Lost to Follow-up|10|||
143126367|NCT03275389|516006825|FG001|Overall Study|Lost to Follow-up|10|||
143126368|NCT03275389|516006826|FG002|Overall Study|Lost to Follow-up|19|||
143126369|NCT03275389|516006827|FG003|Overall Study|Lost to Follow-up|12|||
143126370|NCT03275389|516006828|FG004|Overall Study|Lost to Follow-up|11|||
143126371|NCT03275389|516006829|FG005|Overall Study|Lost to Follow-up|12|||
143126372|NCT03275389|516006830|FG006|Overall Study|Lost to Follow-up|21|||
143126373|NCT03275389|516006831|FG007|Overall Study|Lost to Follow-up|15|||
143126374|NCT03275389|516006832|FG008|Overall Study|Lost to Follow-up|12|||
143126375|NCT03275389|516006833|FG009|Overall Study|Lost to Follow-up|14|||
143126376|NCT03275389|516006824|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
143126377|NCT03275389|516006825|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
143126378|NCT03275389|516006826|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
143126379|NCT03275389|516006827|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
143356688|NCT00983619|516850825|FG009|Overall Study|Lost to Follow-up|0|||
143356689|NCT00983619|516850826|FG010|Overall Study|Lost to Follow-up|0|||
143356690|NCT00983619|516850827|FG011|Overall Study|Lost to Follow-up|2|||
143356691|NCT00983619|516850816|FG000|Overall Study|Withdrawal by Subject|2|||
143356692|NCT00983619|516850817|FG001|Overall Study|Withdrawal by Subject|1|||
143356693|NCT00983619|516850818|FG002|Overall Study|Withdrawal by Subject|1|||
143356694|NCT00983619|516850819|FG003|Overall Study|Withdrawal by Subject|3|||
143126380|NCT03275389|516006828|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
143126381|NCT03275389|516006829|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
143126382|NCT03275389|516006830|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
143126383|NCT03275389|516006831|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
143356695|NCT00983619|516850820|FG004|Overall Study|Withdrawal by Subject|1|||
143356696|NCT00983619|516850821|FG005|Overall Study|Withdrawal by Subject|23|||
143126384|NCT03275389|516006832|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
143126385|NCT03275389|516006833|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
143126386|NCT03275389|516006824|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
143126387|NCT03275389|516006825|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
143126388|NCT03275389|516006826|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
143126389|NCT03275389|516006827|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
143126390|NCT03275389|516006828|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
143126391|NCT03275389|516006829|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
143126392|NCT03275389|516006830|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
143126393|NCT03275389|516006831|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
143126394|NCT03275389|516006832|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
143126395|NCT03275389|516006833|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
143126396|NCT03275389|516006824|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143126397|NCT03275389|516006825|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
143126398|NCT03275389|516006826|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143126399|NCT03275389|516006827|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
143126400|NCT03275389|516006828|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143126401|NCT03275389|516006829|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143126402|NCT03275389|516006830|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
143126403|NCT03275389|516006831|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143126404|NCT03275389|516006832|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143126405|NCT03275389|516006833|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143126406|NCT03275389|516006824|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
143126407|NCT03275389|516006825|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
143126408|NCT03275389|516006826|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
143126409|NCT03275389|516006827|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
143126410|NCT03275389|516006828|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
143126411|NCT03275389|516006829|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
143126412|NCT03275389|516006830|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
143126413|NCT03275389|516006831|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
143126414|NCT03275389|516006832|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
143126415|NCT03275389|516006833|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
143126416|NCT03275389|516006824|FG000|Overall Study|Other|0|||
143126417|NCT03275389|516006825|FG001|Overall Study|Other|4|||
143126418|NCT03275389|516006826|FG002|Overall Study|Other|3|||
143126419|NCT03275389|516006827|FG003|Overall Study|Other|2|||
143126420|NCT03275389|516006828|FG004|Overall Study|Other|2|||
143126421|NCT03275389|516006829|FG005|Overall Study|Other|2|||
143126422|NCT03275389|516006830|FG006|Overall Study|Other|0|||
143126423|NCT03275389|516006831|FG007|Overall Study|Other|0|||
143126424|NCT03275389|516006832|FG008|Overall Study|Other|1|||
143126425|NCT03275389|516006833|FG009|Overall Study|Other|0|||
143126426|NCT03035916|516006834|FG000|Overall Study|Puncture failed|0|||
143126427|NCT03035916|516006835|FG001|Overall Study|Puncture failed|2|||
143126428|NCT03035916|516006836|FG002|Overall Study|Puncture failed|0|||
143126429|NCT01451554|516006837|FG000|Overall Study|Withdrawal by Subject|14|||
143126430|NCT01451554|516006838|FG001|Overall Study|Withdrawal by Subject|9|||
143126431|NCT04336475|516008923|FG000|Overall Study|pain|1|||
143126432|NCT04336475|516008924|FG001|Overall Study|pain|0|||
143126433|NCT04336475|516008923|FG000|Overall Study|upper respiratory infection|1|||
143126434|NCT04336475|516008924|FG001|Overall Study|upper respiratory infection|0|||
143126435|NCT04336475|516008923|FG000|Overall Study|Lost to Follow-up|0|||
143126436|NCT04336475|516008924|FG001|Overall Study|Lost to Follow-up|2|||
143126437|NCT01990573|516008927|FG000|Overall Study|Physician Decision|0|||
143126438|NCT01990573|516008928|FG001|Overall Study|Physician Decision|0|||
143126439|NCT01990573|516008929|FG002|Overall Study|Physician Decision|1|||
143126440|NCT01763827|516008934|FG000|Overall Study|Withdrawal by Subject|1|||
143126441|NCT01763827|516008935|FG001|Overall Study|Withdrawal by Subject|0|||
143126442|NCT01763827|516008936|FG002|Overall Study|Withdrawal by Subject|0|||
143126443|NCT01763827|516008937|FG003|Overall Study|Withdrawal by Subject|0|||
143126444|NCT01763827|516008938|FG004|Overall Study|Withdrawal by Subject|2|||
143126445|NCT01763827|516008939|FG005|Overall Study|Withdrawal by Subject|0|||
143463437|NCT03864146|517243026|FG000|Overall Study|Withdrawal by Subject|3|||
143463438|NCT03864146|517243027|FG001|Overall Study|Withdrawal by Subject|2|||
143463439|NCT00824161|517243028|FG000|Overall Study|Withdrawal by Subject|1|||
143126446|NCT01763827|516008934|FG000|Overall Study|Decision by sponsor|2|||
143126447|NCT01763827|516008935|FG001|Overall Study|Decision by sponsor|0|||
143126448|NCT01763827|516008936|FG002|Overall Study|Decision by sponsor|3|||
143463440|NCT00824161|517243028|FG000|Overall Study|Screen Failure|1|||
143126449|NCT01763827|516008937|FG003|Overall Study|Decision by sponsor|0|||
143126450|NCT01763827|516008938|FG004|Overall Study|Decision by sponsor|2|||
143126451|NCT01763827|516008939|FG005|Overall Study|Decision by sponsor|1|||
143126452|NCT01763827|516008934|FG000|Overall Study|Lost to Follow-up|0|||
143463441|NCT00879762|517243029|FG000|Overall Study|Lost to Follow-up|3|||
143463442|NCT00879762|517243030|FG001|Overall Study|Lost to Follow-up|1|||
143463443|NCT04981366|517243031|FG000|Overall Study|Withdrawal by Subject|5|||
143463444|NCT04981366|517243032|FG001|Overall Study|Withdrawal by Subject|4|||
143463445|NCT04981366|517243033|FG002|Overall Study|Withdrawal by Subject|8|||
143463446|NCT04981366|517243031|FG000|Overall Study|Health issues unrelated to the trial|1|||
143463447|NCT04981366|517243032|FG001|Overall Study|Health issues unrelated to the trial|2|||
143463448|NCT04981366|517243033|FG002|Overall Study|Health issues unrelated to the trial|0|||
143463449|NCT01112306|517243034|FG000|Overall Study|Death|175|||
143463450|NCT01112306|517243034|FG000|Overall Study|Lost to Follow-up|9|||
143463451|NCT01112306|517243034|FG000|Overall Study|Withdrawal by Subject|31|||
143463452|NCT01112306|517243034|FG000|Overall Study|Other|70|||
143463453|NCT00881608|517243035|FG000|Overall Study|Study prematurely terminated|11|||
143463454|NCT01313637|517243038|FG000|Overall Study|Adverse Event|17|||
143463455|NCT01313637|517243039|FG001|Overall Study|Adverse Event|24|||
143463456|NCT01313637|517243040|FG002|Overall Study|Adverse Event|25|||
143463457|NCT01313637|517243041|FG003|Overall Study|Adverse Event|18|||
143463458|NCT01313637|517243038|FG000|Overall Study|Lack of Efficacy|44|||
143463459|NCT01313637|517243039|FG001|Overall Study|Lack of Efficacy|38|||
143463460|NCT01313637|517243040|FG002|Overall Study|Lack of Efficacy|37|||
143463461|NCT01313637|517243041|FG003|Overall Study|Lack of Efficacy|24|||
143463462|NCT01313637|517243038|FG000|Overall Study|Protocol Violation|4|||
143463463|NCT01313637|517243039|FG001|Overall Study|Protocol Violation|3|||
143463464|NCT01313637|517243040|FG002|Overall Study|Protocol Violation|11|||
143463465|NCT01313637|517243041|FG003|Overall Study|Protocol Violation|5|||
143463466|NCT01313637|517243038|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
143463467|NCT01313637|517243039|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
143463468|NCT01313637|517243040|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
143463469|NCT01313637|517243041|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
143463470|NCT01313637|517243038|FG000|Overall Study|Lost to Follow-up|0|||
143463471|NCT01313637|517243039|FG001|Overall Study|Lost to Follow-up|2|||
143463472|NCT01313637|517243040|FG002|Overall Study|Lost to Follow-up|1|||
143463473|NCT01313637|517243041|FG003|Overall Study|Lost to Follow-up|3|||
143463474|NCT01313637|517243038|FG000|Overall Study|Withdrawal by Subject|11|||
143463475|NCT01313637|517243039|FG001|Overall Study|Withdrawal by Subject|13|||
143463476|NCT01313637|517243040|FG002|Overall Study|Withdrawal by Subject|18|||
143463477|NCT01313637|517243041|FG003|Overall Study|Withdrawal by Subject|15|||
143463478|NCT00795951|517243047|FG000|Overall Study|Lost to Follow-up|1|||
143463479|NCT00795951|517243047|FG000|Overall Study|Withdrawal by Subject|1|||
143463480|NCT00655486|517243054|FG000|Overall Study|Adverse Event|10|||
143463481|NCT00655486|517243054|FG000|Overall Study|Lack of Efficacy|8|||
143463482|NCT00655486|517243054|FG000|Overall Study|Withdrawal by Subject|4|||
143463483|NCT00655486|517243054|FG000|Overall Study|Protocol Violation|1|||
143463484|NCT00655486|517243054|FG000|Overall Study|Unsatisfactory compliance|2|||
143463485|NCT00655486|517243054|FG000|Overall Study|Other: Pregnancy|1|||
143463486|NCT00655486|517243054|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
143463487|NCT00655486|517243054|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
143013390|NCT01915498|515588125|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
143013391|NCT01915498|515588126|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
143013392|NCT01915498|515588127|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
143013393|NCT01915498|515588128|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
143013394|NCT01915498|515588129|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
143013395|NCT01915498|515588130|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
143013396|NCT01915498|515588131|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
143013397|NCT01915498|515588113|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
143013398|NCT01915498|515588114|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
143013399|NCT01915498|515588115|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
143013400|NCT01915498|515588116|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
143013401|NCT01915498|515588117|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
143013402|NCT01915498|515588118|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
143013403|NCT01915498|515588119|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
143013404|NCT01915498|515588120|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
143463488|NCT04218084|517243055|FG000|Overall Study|Adverse Event|7|||
143463489|NCT04218084|517243056|FG001|Overall Study|Adverse Event|2|||
143463490|NCT04218084|517243055|FG000|Overall Study|Withdrawal of Consent|4|||
143463491|NCT04218084|517243056|FG001|Overall Study|Withdrawal of Consent|5|||
143463492|NCT04218084|517243055|FG000|Overall Study|Physician Decision|1|||
143463493|NCT04218084|517243056|FG001|Overall Study|Physician Decision|1|||
143463494|NCT04218084|517243055|FG000|Overall Study|Lost to Follow-up|1|||
143463495|NCT04218084|517243056|FG001|Overall Study|Lost to Follow-up|1|||
143463496|NCT04218084|517243055|FG000|Overall Study|Non-compliance with study drug|1|||
143463497|NCT04218084|517243056|FG001|Overall Study|Non-compliance with study drug|1|||
143126453|NCT01763827|516008935|FG001|Overall Study|Lost to Follow-up|1|||
143463498|NCT04218084|517243055|FG000|Overall Study|Abnormal transcranial doppler (TCD)|19|||
143463499|NCT04218084|517243056|FG001|Overall Study|Abnormal transcranial doppler (TCD)|24|||
143463500|NCT04218084|517243055|FG000|Overall Study|Other|0|||
143013405|NCT01915498|515588121|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
143013406|NCT01915498|515588122|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
143013407|NCT01915498|515588123|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
143013408|NCT01915498|515588124|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
143013409|NCT01915498|515588125|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
143013410|NCT01915498|515588126|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
143013411|NCT01915498|515588127|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
143013412|NCT01915498|515588128|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
143013413|NCT01915498|515588129|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
143126454|NCT01763827|516008936|FG002|Overall Study|Lost to Follow-up|1|||
143126455|NCT01763827|516008937|FG003|Overall Study|Lost to Follow-up|1|||
143126456|NCT01763827|516008938|FG004|Overall Study|Lost to Follow-up|2|||
143126457|NCT01763827|516008939|FG005|Overall Study|Lost to Follow-up|1|||
143126458|NCT01490840|516008943|FG000|Phase 1|Lost to Follow-up|1|||
143126459|NCT01490840|516008944|FG001|Phase 1|Lost to Follow-up|0|||
143126460|NCT01490840|516008943|FG000|Phase 1|Adverse Event|2|||
143126461|NCT01490840|516008944|FG001|Phase 1|Adverse Event|1|||
143126462|NCT01490840|516008943|FG000|Phase 1|Withdrawal by Subject|6|||
143126463|NCT01490840|516008944|FG001|Phase 1|Withdrawal by Subject|5|||
143126464|NCT01490840|516008943|FG000|Phase 1|Visit 6a omitted|1|||
143126465|NCT01490840|516008944|FG001|Phase 1|Visit 6a omitted|0|||
143126466|NCT01490840|516008943|FG000|Phase 2|Withdrawal by Subject|4|||
143126467|NCT01490840|516008944|FG001|Phase 2|Withdrawal by Subject|3|||
143126468|NCT01490840|516008943|FG000|Phase 2|Permanent interruption of fingolimod|0|||
143126469|NCT01490840|516008944|FG001|Phase 2|Permanent interruption of fingolimod|1|||
143126470|NCT01490840|516008943|FG000|Phase 2|Lost to Follow-up|1|||
143126471|NCT01490840|516008944|FG001|Phase 2|Lost to Follow-up|1|||
143126472|NCT01490840|516008943|FG000|Phase 2|Adverse Event|1|||
143126473|NCT01490840|516008944|FG001|Phase 2|Adverse Event|1|||
143126474|NCT01025284|516008946|FG000|Overall Study|Investigator Decision|0|||
143126475|NCT01025284|516008947|FG001|Overall Study|Investigator Decision|1|||
143126476|NCT01025284|516008948|FG002|Overall Study|Investigator Decision|0|||
143013414|NCT01915498|515588130|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
143013415|NCT01915498|515588131|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
143013416|NCT01915498|515588113|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
143013417|NCT01915498|515588114|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
143013418|NCT01915498|515588115|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
143013419|NCT01915498|515588116|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
143013420|NCT01915498|515588117|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
143013421|NCT01915498|515588118|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
143013422|NCT01915498|515588119|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
143013423|NCT01915498|515588120|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
143013424|NCT01915498|515588121|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
143013425|NCT01915498|515588122|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
143013426|NCT01915498|515588123|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
143013427|NCT01915498|515588124|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
143013428|NCT01915498|515588125|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
143013429|NCT01915498|515588126|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
143013430|NCT01915498|515588127|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
143013431|NCT01915498|515588128|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
143013432|NCT01915498|515588129|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
143013433|NCT01915498|515588130|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
143013434|NCT01915498|515588131|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
143013435|NCT01915498|515588113|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
143126477|NCT01025284|516008946|FG000|Overall Study|Withdrawal by Subject|0|||
143356697|NCT00983619|516850822|FG006|Overall Study|Withdrawal by Subject|0|||
143356698|NCT00983619|516850823|FG007|Overall Study|Withdrawal by Subject|0|||
143356699|NCT00983619|516850824|FG008|Overall Study|Withdrawal by Subject|0|||
143356700|NCT00983619|516850825|FG009|Overall Study|Withdrawal by Subject|0|||
143356701|NCT00983619|516850826|FG010|Overall Study|Withdrawal by Subject|1|||
143356702|NCT00983619|516850827|FG011|Overall Study|Withdrawal by Subject|1|||
143356703|NCT00983619|516850816|FG000|Overall Study|Death|0|||
143356704|NCT00983619|516850817|FG001|Overall Study|Death|2|||
143356705|NCT00983619|516850818|FG002|Overall Study|Death|2|||
143356706|NCT00983619|516850819|FG003|Overall Study|Death|1|||
143356707|NCT00983619|516850820|FG004|Overall Study|Death|2|||
143356708|NCT00983619|516850821|FG005|Overall Study|Death|30|||
143356709|NCT00983619|516850822|FG006|Overall Study|Death|1|||
143126478|NCT01025284|516008947|FG001|Overall Study|Withdrawal by Subject|1|||
143126479|NCT01025284|516008948|FG002|Overall Study|Withdrawal by Subject|0|||
143126480|NCT01465230|516008949|FG000|Overall Study|Withdrawal by Subject|2|||
143126481|NCT00905567|516008950|FG000|Washout|Withdrawal by Subject|0|||
143126482|NCT00905567|516008951|FG001|Washout|Withdrawal by Subject|1|||
143126483|NCT00547248|516008957|FG000|Overall Study|Protocol Violation|0|||
143126484|NCT00547248|516008958|FG001|Overall Study|Protocol Violation|0|||
143126485|NCT00547248|516008959|FG002|Overall Study|Protocol Violation|1|||
143126486|NCT00547248|516008960|FG003|Overall Study|Protocol Violation|1|||
143126487|NCT00547248|516008957|FG000|Overall Study|Migrated/moved from study area|0|||
143126488|NCT00547248|516008958|FG001|Overall Study|Migrated/moved from study area|0|||
143126489|NCT00547248|516008959|FG002|Overall Study|Migrated/moved from study area|2|||
143126490|NCT00547248|516008960|FG003|Overall Study|Migrated/moved from study area|0|||
143126491|NCT00547248|516008957|FG000|Overall Study|Withdrawal by Subject|0|||
143126492|NCT00547248|516008958|FG001|Overall Study|Withdrawal by Subject|0|||
143126493|NCT00547248|516008959|FG002|Overall Study|Withdrawal by Subject|7|||
143126494|NCT00547248|516008960|FG003|Overall Study|Withdrawal by Subject|1|||
143126495|NCT02532257|516008963|FG000|Overall Study|Adverse Event|2|||
143126496|NCT02532257|516008963|FG000|Overall Study|Physician Decision|4|||
143126497|NCT02532257|516008963|FG000|Overall Study|Withdrawal by Subject|3|||
143126498|NCT02532257|516008963|FG000|Overall Study|Progressive Disease|10|||
143126499|NCT02090283|516008964|FG000|Overall Study|Withdrawal by Subject|6|||
143126500|NCT02090283|516008965|FG001|Overall Study|Withdrawal by Subject|6|||
143126501|NCT02090283|516008966|FG002|Overall Study|Withdrawal by Subject|6|||
143126502|NCT02090283|516008964|FG000|Overall Study|Sponsor Terminated Study|6|||
143126503|NCT02090283|516008965|FG001|Overall Study|Sponsor Terminated Study|6|||
143126504|NCT02090283|516008966|FG002|Overall Study|Sponsor Terminated Study|1|||
143126505|NCT02090283|516008964|FG000|Overall Study|Lost to Follow-up|2|||
143126506|NCT02090283|516008965|FG001|Overall Study|Lost to Follow-up|2|||
143126507|NCT02090283|516008966|FG002|Overall Study|Lost to Follow-up|3|||
143126508|NCT02090283|516008964|FG000|Overall Study|Adverse Event|1|||
143126509|NCT02090283|516008965|FG001|Overall Study|Adverse Event|1|||
143126510|NCT02090283|516008966|FG002|Overall Study|Adverse Event|0|||
143126511|NCT02090283|516008964|FG000|Overall Study|Protocol Violation|2|||
143126512|NCT02090283|516008965|FG001|Overall Study|Protocol Violation|0|||
143126513|NCT02090283|516008966|FG002|Overall Study|Protocol Violation|0|||
143126514|NCT02964338|516008973|FG000|Overall Study|Sponsor terminated study for futility|12|||
143126515|NCT02964338|516008974|FG001|Overall Study|Sponsor terminated study for futility|15|||
143126516|NCT02964338|516008975|FG002|Overall Study|Sponsor terminated study for futility|14|||
143126517|NCT02964338|516008973|FG000|Overall Study|Lack of Efficacy|0|||
143126518|NCT02964338|516008974|FG001|Overall Study|Lack of Efficacy|3|||
143126519|NCT02964338|516008975|FG002|Overall Study|Lack of Efficacy|0|||
143126520|NCT02964338|516008973|FG000|Overall Study|Lost to Follow-up|1|||
143126521|NCT02964338|516008974|FG001|Overall Study|Lost to Follow-up|0|||
143126522|NCT02964338|516008975|FG002|Overall Study|Lost to Follow-up|3|||
143126523|NCT02964338|516008973|FG000|Overall Study|Protocol Violation|0|||
143126524|NCT02964338|516008974|FG001|Overall Study|Protocol Violation|1|||
143126525|NCT02964338|516008975|FG002|Overall Study|Protocol Violation|0|||
143126526|NCT02964338|516008973|FG000|Overall Study|Withdrawal by Subject|1|||
143126527|NCT02964338|516008974|FG001|Overall Study|Withdrawal by Subject|3|||
143126528|NCT02964338|516008975|FG002|Overall Study|Withdrawal by Subject|1|||
143126529|NCT02964338|516008973|FG000|Overall Study|Adverse Event|2|||
143126530|NCT02964338|516008974|FG001|Overall Study|Adverse Event|1|||
143126531|NCT02964338|516008975|FG002|Overall Study|Adverse Event|1|||
143126532|NCT02964338|516008973|FG000|Overall Study|Non-compliant with e-diary|0|||
143126533|NCT02964338|516008974|FG001|Overall Study|Non-compliant with e-diary|1|||
143126534|NCT02964338|516008975|FG002|Overall Study|Non-compliant with e-diary|0|||
143126535|NCT02964338|516008973|FG000|Overall Study|Did not meet criteria|1|||
143126536|NCT02964338|516008974|FG001|Overall Study|Did not meet criteria|0|||
143126537|NCT02964338|516008975|FG002|Overall Study|Did not meet criteria|0|||
143126538|NCT02630563|516008976|FG000|Overall Study|Administrative|1|||
143463501|NCT04218084|517243056|FG001|Overall Study|Other|1|||
143126539|NCT00184002|516008979|FG000|Overall Study|Adverse Event|9|||
143463502|NCT04218084|517243055|FG000|Overall Study|Ongoing at data cut-off date|62|||
143463503|NCT04218084|517243056|FG001|Overall Study|Ongoing at data cut-off date|58|||
143463504|NCT00211185|517243059|FG000|Overall Study|Death|2|||
143463505|NCT00211185|517243059|FG000|Overall Study|Disease progression|7|||
143126540|NCT00184002|516008979|FG000|Overall Study|Death|3|||
143126541|NCT00184002|516008979|FG000|Overall Study|Physician Decision|1|||
143463506|NCT00211185|517243059|FG000|Overall Study|Withdrawal by Subject|6|||
143463507|NCT00211185|517243059|FG000|Overall Study|Physician Decision|5|||
143463508|NCT00986674|517243060|FG000|Overall Study|Lack of Efficacy|28|||
143126542|NCT00184002|516008979|FG000|Overall Study|Withdrawal by Subject|4|||
143126543|NCT02384538|516008987|FG000|Overall Study|Adverse Event|1|||
143126544|NCT02384538|516008988|FG001|Overall Study|Adverse Event|4|||
143126545|NCT02384538|516008987|FG000|Overall Study|Lack of Efficacy|4|||
143126546|NCT02384538|516008988|FG001|Overall Study|Lack of Efficacy|4|||
143126547|NCT02384538|516008987|FG000|Overall Study|Withdrew Consent|0|||
143126548|NCT02384538|516008988|FG001|Overall Study|Withdrew Consent|4|||
143126549|NCT02384538|516008987|FG000|Overall Study|Other|1|||
143126550|NCT02384538|516008988|FG001|Overall Study|Other|3|||
143126551|NCT02187029|516008992|FG000|Overall Study|Adverse Event|0|||
143126552|NCT02187029|516008993|FG001|Overall Study|Adverse Event|1|||
143126553|NCT02187029|516008994|FG002|Overall Study|Adverse Event|1|||
143126554|NCT02187029|516008995|FG003|Overall Study|Adverse Event|0|||
143126555|NCT02187029|516008992|FG000|Overall Study|Study Terminated by Sponsor|0|||
143126556|NCT02187029|516008993|FG001|Overall Study|Study Terminated by Sponsor|0|||
143126557|NCT02187029|516008994|FG002|Overall Study|Study Terminated by Sponsor|10|||
143126558|NCT02187029|516008995|FG003|Overall Study|Study Terminated by Sponsor|3|||
143126559|NCT02187029|516008992|FG000|Overall Study|Withdrawal by Subject|1|||
143126560|NCT02187029|516008993|FG001|Overall Study|Withdrawal by Subject|0|||
143126561|NCT02187029|516008994|FG002|Overall Study|Withdrawal by Subject|0|||
143126562|NCT02187029|516008995|FG003|Overall Study|Withdrawal by Subject|0|||
143126563|NCT01491841|516009006|FG000|Overall Study|Screen Failure|10|||
143126564|NCT01491841|516009006|FG000|Overall Study|Withdrawal by Subject|1|||
143126565|NCT02933528|516009007|FG000|Overall Study|Lost to Follow-up|2|||
143126566|NCT04105842|516009008|FG000|Overall Study|Withdrawal by Subject|2|||
143126567|NCT01301079|516009009|FG000|Overall Study|Lost to Follow-up|2|||
143126568|NCT01301079|516009010|FG001|Overall Study|Lost to Follow-up|2|||
143126569|NCT02087670|516009011|FG000|Overall Study|Withdrawal by Subject|3|||
143126570|NCT02087670|516009012|FG001|Overall Study|Withdrawal by Subject|2|||
143126571|NCT01042392|516009014|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
143126572|NCT01042392|516009015|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
143126573|NCT01042392|516009016|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
143126574|NCT01042392|516009017|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
143126575|NCT01042392|516009014|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
143126576|NCT01042392|516009015|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
143126577|NCT01042392|516009016|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
143126578|NCT01042392|516009017|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
143126579|NCT01042392|516009014|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
143126580|NCT01042392|516009015|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
143126581|NCT01042392|516009016|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
143126582|NCT01042392|516009017|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
143126583|NCT01042392|516009014|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
143126584|NCT01042392|516009015|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
143126585|NCT01042392|516009016|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
143126586|NCT01042392|516009017|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
143126587|NCT01042392|516009014|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
143126588|NCT01042392|516009015|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
143126589|NCT01042392|516009016|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
143126590|NCT01042392|516009017|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
143126591|NCT01042392|516009014|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
143126592|NCT01042392|516009015|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
143126593|NCT01042392|516009016|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
143126594|NCT01042392|516009017|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
143126595|NCT01042392|516009014|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
143126596|NCT01042392|516009015|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
143126597|NCT01042392|516009016|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
143126598|NCT01042392|516009017|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
143356710|NCT00983619|516850823|FG007|Overall Study|Death|0|||
143356711|NCT00983619|516850824|FG008|Overall Study|Death|1|||
143356712|NCT00983619|516850825|FG009|Overall Study|Death|2|||
143356713|NCT00983619|516850826|FG010|Overall Study|Death|9|||
143356714|NCT00983619|516850827|FG011|Overall Study|Death|8|||
143356715|NCT00983619|516850816|FG000|Overall Study|Other|1|||
143126599|NCT01042392|516009014|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
143126600|NCT01042392|516009015|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
143126601|NCT01042392|516009016|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
143126602|NCT01042392|516009017|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
143126603|NCT01042392|516009014|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
143126604|NCT01042392|516009015|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
143356716|NCT00983619|516850817|FG001|Overall Study|Other|0|||
143356717|NCT00983619|516850818|FG002|Overall Study|Other|0|||
143356718|NCT00983619|516850819|FG003|Overall Study|Other|1|||
143356719|NCT00983619|516850820|FG004|Overall Study|Other|0|||
143356720|NCT00983619|516850821|FG005|Overall Study|Other|12|||
143356721|NCT00983619|516850822|FG006|Overall Study|Other|2|||
143356722|NCT00983619|516850823|FG007|Overall Study|Other|2|||
143356723|NCT00983619|516850824|FG008|Overall Study|Other|0|||
143126605|NCT01042392|516009016|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
143126606|NCT01042392|516009017|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
143126607|NCT03519919|516009018|FG000|Overall Study|Withdrawal by Subject|1|||
143126608|NCT03519919|516009018|FG000|Overall Study|Lack of Efficacy|1|||
143126609|NCT03519919|516009018|FG000|Overall Study|Screen Failure|1|||
143126610|NCT00587795|516009019|FG000|Overall Study|Withdrawal by Subject|1|||
143126611|NCT00587795|516009020|FG001|Overall Study|Withdrawal by Subject|0|||
143126612|NCT02144077|516009021|FG000|Overall Study|Withdrawal by Subject|3|||
143126613|NCT02144077|516009022|FG001|Overall Study|Withdrawal by Subject|3|||
143126614|NCT02144077|516009021|FG000|Overall Study|Adverse Event|2|||
143126615|NCT02144077|516009022|FG001|Overall Study|Adverse Event|3|||
143126616|NCT02144077|516009021|FG000|Overall Study|Lost to Follow-up|2|||
143126617|NCT02144077|516009022|FG001|Overall Study|Lost to Follow-up|2|||
143126618|NCT02144077|516009021|FG000|Overall Study|Protocol Violation|1|||
143463509|NCT00986674|517243061|FG001|Overall Study|Lack of Efficacy|25|||
143463510|NCT00986674|517243062|FG002|Overall Study|Lack of Efficacy|23|||
143463511|NCT00986674|517243060|FG000|Overall Study|Adverse Event|4|||
143463512|NCT00986674|517243061|FG001|Overall Study|Adverse Event|8|||
143463513|NCT00986674|517243062|FG002|Overall Study|Adverse Event|9|||
143463514|NCT00986674|517243060|FG000|Overall Study|Death|5|||
143463515|NCT00986674|517243061|FG001|Overall Study|Death|0|||
143463516|NCT00986674|517243062|FG002|Overall Study|Death|4|||
143463517|NCT00986674|517243060|FG000|Overall Study|Withdrawal by Subject|6|||
143463518|NCT00986674|517243061|FG001|Overall Study|Withdrawal by Subject|2|||
143463519|NCT00986674|517243062|FG002|Overall Study|Withdrawal by Subject|1|||
143463520|NCT00986674|517243060|FG000|Overall Study|alternative therapy|0|||
143463521|NCT00986674|517243061|FG001|Overall Study|alternative therapy|0|||
143463522|NCT00986674|517243062|FG002|Overall Study|alternative therapy|1|||
143463523|NCT00986674|517243060|FG000|Overall Study|not start protocol therapy|4|||
143463524|NCT00986674|517243061|FG001|Overall Study|not start protocol therapy|3|||
143463525|NCT00986674|517243062|FG002|Overall Study|not start protocol therapy|1|||
143463526|NCT00986674|517243060|FG000|Overall Study|unknown/not specify|0|||
143463527|NCT00986674|517243061|FG001|Overall Study|unknown/not specify|7|||
143463528|NCT00986674|517243062|FG002|Overall Study|unknown/not specify|9|||
143463529|NCT00842985|517243065|FG000|Screening|Did not meet entrance requirements|27|||
143463530|NCT00842985|517243065|FG000|First Intervention|Withdrawal by Subject|3|||
143463531|NCT00842985|517243065|FG000|First Intervention|Protocol Violation|3|||
143463532|NCT00842985|517243065|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
143463533|NCT00842985|517243065|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
143463534|NCT01037244|517243066|FG000|Overall Study|Adverse Event|3|||
143463535|NCT01037244|517243067|FG001|Overall Study|Adverse Event|2|||
143463536|NCT01037244|517243068|FG002|Overall Study|Adverse Event|6|||
143463537|NCT01037244|517243069|FG003|Overall Study|Adverse Event|3|||
143463538|NCT01037244|517243066|FG000|Overall Study|Lack of Efficacy|1|||
143463539|NCT01037244|517243067|FG001|Overall Study|Lack of Efficacy|1|||
143463540|NCT01037244|517243068|FG002|Overall Study|Lack of Efficacy|0|||
143463541|NCT01037244|517243069|FG003|Overall Study|Lack of Efficacy|1|||
143463542|NCT01037244|517243066|FG000|Overall Study|Lost to Follow-up|3|||
143463543|NCT01037244|517243067|FG001|Overall Study|Lost to Follow-up|3|||
143463544|NCT01037244|517243068|FG002|Overall Study|Lost to Follow-up|4|||
143463545|NCT01037244|517243069|FG003|Overall Study|Lost to Follow-up|4|||
143463546|NCT01037244|517243066|FG000|Overall Study|Withdrawal by Subject|1|||
143463547|NCT01037244|517243067|FG001|Overall Study|Withdrawal by Subject|5|||
143463548|NCT01037244|517243068|FG002|Overall Study|Withdrawal by Subject|3|||
143463549|NCT01037244|517243069|FG003|Overall Study|Withdrawal by Subject|5|||
143463550|NCT01037244|517243066|FG000|Overall Study|Partner Withdrew Consent|2|||
143463551|NCT01037244|517243067|FG001|Overall Study|Partner Withdrew Consent|1|||
143463552|NCT01037244|517243068|FG002|Overall Study|Partner Withdrew Consent|0|||
143463553|NCT01037244|517243069|FG003|Overall Study|Partner Withdrew Consent|0|||
143463554|NCT01037244|517243066|FG000|Overall Study|Various|3|||
143463555|NCT01037244|517243067|FG001|Overall Study|Various|2|||
143463556|NCT01037244|517243068|FG002|Overall Study|Various|1|||
143463557|NCT01037244|517243069|FG003|Overall Study|Various|1|||
143463558|NCT04507126|517243070|FG000|Overall Study|Withdrawal by Subject|1|||
143463559|NCT04507126|517243070|FG000|Overall Study|Protocol Violation|2|||
143126619|NCT02144077|516009022|FG001|Overall Study|Protocol Violation|2|||
143126620|NCT02144077|516009021|FG000|Overall Study|Death|0|||
143463560|NCT04507126|517243070|FG000|Overall Study|Physician Decision|1|||
143463561|NCT02875977|517243071|FG000|Overall Study|Lost to Follow-up|42|||
143463562|NCT02875977|517243072|FG001|Overall Study|Lost to Follow-up|29|||
143463563|NCT03421431|517243075|FG000|Overall Study|Adverse Event|2|||
143463564|NCT03421431|517243076|FG001|Overall Study|Adverse Event|1|||
143463565|NCT03421431|517243077|FG002|Overall Study|Adverse Event|12|||
143126621|NCT02144077|516009022|FG001|Overall Study|Death|1|||
143463566|NCT03421431|517243075|FG000|Overall Study|Lost to Follow-up|1|||
143463567|NCT03421431|517243076|FG001|Overall Study|Lost to Follow-up|1|||
143463568|NCT03421431|517243077|FG002|Overall Study|Lost to Follow-up|1|||
143126622|NCT02144077|516009021|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
143126623|NCT02144077|516009022|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
143013436|NCT01915498|515588114|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
143013437|NCT01915498|515588115|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
143013438|NCT01915498|515588116|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
143013439|NCT01915498|515588117|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
143013440|NCT01915498|515588118|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
143013441|NCT01915498|515588119|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
143013442|NCT01915498|515588120|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
143013443|NCT01915498|515588121|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
143013444|NCT01915498|515588122|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
143013445|NCT01915498|515588123|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
143013446|NCT01915498|515588124|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
143013447|NCT01915498|515588125|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
143013448|NCT01915498|515588126|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
143013449|NCT01915498|515588127|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
143013450|NCT01915498|515588128|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
143013451|NCT01915498|515588129|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
143013452|NCT01915498|515588130|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
143013453|NCT01915498|515588131|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
143013454|NCT01915498|515588113|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
143013455|NCT01915498|515588114|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
143013456|NCT01915498|515588115|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
143013457|NCT01915498|515588116|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
143013458|NCT01915498|515588117|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
143013459|NCT01915498|515588118|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
143013460|NCT01915498|515588119|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
143013461|NCT01915498|515588120|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
143013462|NCT01915498|515588121|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
143013463|NCT01915498|515588122|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
143013464|NCT01915498|515588123|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
143013465|NCT01915498|515588124|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
143013466|NCT01915498|515588125|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
143013467|NCT01915498|515588126|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
143013468|NCT01915498|515588127|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
143013469|NCT01915498|515588128|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
143013470|NCT01915498|515588129|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
143013471|NCT01915498|515588130|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
143013472|NCT01915498|515588131|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
143013473|NCT01915498|515588113|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
143013474|NCT01915498|515588114|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
143013475|NCT01915498|515588115|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
143013476|NCT01915498|515588116|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
143013477|NCT01915498|515588117|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
143013478|NCT01915498|515588118|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
143013479|NCT01915498|515588119|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
143013480|NCT01915498|515588120|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
143013481|NCT01915498|515588121|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
143013482|NCT01915498|515588122|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
143013483|NCT01915498|515588123|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
143013484|NCT01915498|515588124|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
143013485|NCT01915498|515588125|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
143013486|NCT01915498|515588126|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
143013487|NCT01915498|515588127|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
143013488|NCT01915498|515588128|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
143013489|NCT01915498|515588129|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
143013490|NCT01915498|515588130|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
143013491|NCT01915498|515588131|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
143013492|NCT01915498|515588113|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
143013493|NCT01915498|515588114|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
143013494|NCT01915498|515588115|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
143013495|NCT01915498|515588116|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
143013496|NCT01915498|515588117|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
143013497|NCT01915498|515588118|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
143013498|NCT01915498|515588119|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
143013499|NCT01915498|515588120|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
143013500|NCT01915498|515588121|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
143013501|NCT01915498|515588122|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
143013502|NCT01915498|515588123|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
143126624|NCT02072941|516009023|FG000|Overall Study|Withdrawal by Subject|29|||
143126625|NCT02072941|516009024|FG001|Overall Study|Withdrawal by Subject|21|||
143126626|NCT02072941|516009023|FG000|Overall Study|Lost to Follow-up|4|||
143126627|NCT02072941|516009024|FG001|Overall Study|Lost to Follow-up|4|||
143126628|NCT02072941|516009023|FG000|Overall Study|Death|3|||
143126629|NCT02072941|516009024|FG001|Overall Study|Death|2|||
143126630|NCT02072941|516009023|FG000|Overall Study|Removed by Study Staff|2|||
143126631|NCT02072941|516009024|FG001|Overall Study|Removed by Study Staff|2|||
143126632|NCT01247350|516009025|FG000|Overall Study|Adverse Event|0|||
143126633|NCT01247350|516009026|FG001|Overall Study|Adverse Event|0|||
143126634|NCT01247350|516009027|FG002|Overall Study|Adverse Event|1|||
143126635|NCT01247350|516009028|FG003|Overall Study|Adverse Event|0|||
143126636|NCT01247350|516009029|FG004|Overall Study|Adverse Event|0|||
143126637|NCT01247350|516009025|FG000|Overall Study|Withdrawal by Subject|0|||
143126638|NCT01247350|516009026|FG001|Overall Study|Withdrawal by Subject|0|||
143126639|NCT01247350|516009027|FG002|Overall Study|Withdrawal by Subject|0|||
143126640|NCT01247350|516009028|FG003|Overall Study|Withdrawal by Subject|1|||
143126641|NCT01247350|516009029|FG004|Overall Study|Withdrawal by Subject|0|||
143126642|NCT01247350|516009025|FG000|Overall Study|Entry criteria not met|0|||
143126643|NCT01247350|516009026|FG001|Overall Study|Entry criteria not met|0|||
143126644|NCT01247350|516009027|FG002|Overall Study|Entry criteria not met|0|||
143126645|NCT01247350|516009028|FG003|Overall Study|Entry criteria not met|0|||
143126646|NCT01247350|516009029|FG004|Overall Study|Entry criteria not met|1|||
143126647|NCT00715299|516009030|FG000|Overall Study|Withdrawal by Subject|1|||
143126648|NCT00715299|516009030|FG000|Overall Study|Adverse Event|3|||
143126649|NCT00715299|516009030|FG000|Overall Study|failed the pre-screen exercise test|2|||
143126650|NCT02020889|516009031|FG000|Overall Study|Adverse Event|0|||
143126651|NCT02020889|516009032|FG001|Overall Study|Adverse Event|1|||
143126652|NCT02020889|516009031|FG000|Overall Study|Lack of Efficacy|1|||
143126653|NCT02020889|516009032|FG001|Overall Study|Lack of Efficacy|0|||
143126654|NCT02020889|516009031|FG000|Overall Study|Lost to Follow-up|1|||
143126655|NCT02020889|516009032|FG001|Overall Study|Lost to Follow-up|0|||
143126656|NCT02020889|516009031|FG000|Overall Study|Physician Decision|2|||
143126657|NCT02020889|516009032|FG001|Overall Study|Physician Decision|0|||
143126658|NCT02020889|516009031|FG000|Overall Study|Withdrawal by Subject|3|||
143126659|NCT02020889|516009032|FG001|Overall Study|Withdrawal by Subject|2|||
143126660|NCT01535443|516009034|FG000|Overall Study|Physician Decision|3|||
143126661|NCT02260817|516009035|FG000|Overall Study|Lost to Follow-up|0|||
143126662|NCT02260817|516009036|FG001|Overall Study|Lost to Follow-up|14|||
143126663|NCT02260817|516009035|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
143126664|NCT02260817|516009036|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
143126665|NCT02260817|516009035|FG000|Overall Study|Observation, no biopsy|0|||
143126666|NCT02260817|516009036|FG001|Overall Study|Observation, no biopsy|1|||
143126667|NCT02260817|516009035|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
143126668|NCT02260817|516009036|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
143126669|NCT02260817|516009035|FG000|Overall Study|Protocol Violation|0|||
143126670|NCT02260817|516009036|FG001|Overall Study|Protocol Violation|14|||
143126671|NCT03299101|516009037|FG000|Overall Study|Lost to Follow-up|1|||
143126672|NCT03299101|516009037|FG000|Overall Study|Withdrawal by Subject|5|||
143126673|NCT03299101|516009037|FG000|Overall Study|Surgery was changed|3|||
143126674|NCT03299101|516009037|FG000|Overall Study|Not enough time to complete prehab|1|||
143126675|NCT02982863|516009038|FG000|Overall Study|Not eligible patients|809|||
143126676|NCT02982863|516009039|FG001|Overall Study|Not eligible patients|4261|||
143126677|NCT02982863|516009040|FG002|Overall Study|Not eligible patients|1852|||
143126678|NCT02982863|516009041|FG003|Overall Study|Not eligible patients|1400|||
143126679|NCT02982863|516009042|FG004|Overall Study|Not eligible patients|492|||
143126680|NCT01882803|516009043|FG000|Overall Study|Disease Progression|1|||
143126681|NCT01882803|516009043|FG000|Overall Study|Withdrawal by Subject|9|||
143126682|NCT01882803|516009043|FG000|Overall Study|Death|68|||
143126683|NCT01882803|516009043|FG000|Overall Study|Physician Decision|3|||
143126684|NCT01882803|516009043|FG000|Overall Study|Lost to Follow-up|3|||
143126685|NCT01882803|516009043|FG000|Overall Study|Follow-up Completed|39|||
143126686|NCT01882803|516009043|FG000|Overall Study|Study Terminated by the Sponsor|6|||
143126687|NCT03066778|516009044|FG000|Overall Study|Death|195|||
143126688|NCT03066778|516009045|FG001|Overall Study|Death|205|||
143126689|NCT03066778|516009044|FG000|Overall Study|Withdrawal by Subject|5|||
143126690|NCT03066778|516009045|FG001|Overall Study|Withdrawal by Subject|7|||
143126691|NCT02091414|516009046|FG000|Overall Study|Withdrawal by Subject|2|||
143126692|NCT02091414|516009046|FG000|Overall Study|Death|2|||
143126693|NCT00435461|516009047|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
143126694|NCT00435461|516009048|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
143126695|NCT00435461|516009049|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
143356724|NCT00983619|516850825|FG009|Overall Study|Other|1|||
143356725|NCT00983619|516850826|FG010|Overall Study|Other|1|||
143356726|NCT00983619|516850827|FG011|Overall Study|Other|0|||
143126696|NCT00435461|516009047|FG000|Overall Study|Protocol Violation|6|||
143126697|NCT00435461|516009048|FG001|Overall Study|Protocol Violation|9|||
143356727|NCT00724061|516850828|FG000|Dose Escalation Phase|Adverse Event|2|||
143463569|NCT03421431|517243075|FG000|Overall Study|Withdrawal by Subject|3|||
143463570|NCT03421431|517243076|FG001|Overall Study|Withdrawal by Subject|2|||
143463571|NCT03421431|517243077|FG002|Overall Study|Withdrawal by Subject|1|||
143463572|NCT03421431|517243075|FG000|Overall Study|Protocol Violation|0|||
143463573|NCT03421431|517243076|FG001|Overall Study|Protocol Violation|1|||
143463574|NCT03421431|517243077|FG002|Overall Study|Protocol Violation|0|||
143463575|NCT03421431|517243075|FG000|Overall Study|Participant met Stopping Rules|0|||
143463576|NCT03421431|517243076|FG001|Overall Study|Participant met Stopping Rules|1|||
143463577|NCT03421431|517243077|FG002|Overall Study|Participant met Stopping Rules|0|||
143463578|NCT02216357|517243078|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
143463579|NCT02216357|517243079|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
143463580|NCT00141726|517243080|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
143463581|NCT00235326|517243085|FG000|Overall Study|Lost to Follow-up|746|||
143463582|NCT00235326|517243086|FG001|Overall Study|Lost to Follow-up|1400|||
143463583|NCT01178671|517243087|FG000|Overall Study|Adverse Event|4|||
143463584|NCT01178671|517243088|FG001|Overall Study|Adverse Event|6|||
143463585|NCT01178671|517243087|FG000|Overall Study|Protocol Violation|1|||
143463586|NCT01178671|517243088|FG001|Overall Study|Protocol Violation|1|||
143463587|NCT01178671|517243087|FG000|Overall Study|Lack of Efficacy|0|||
143463588|NCT01178671|517243088|FG001|Overall Study|Lack of Efficacy|1|||
143463589|NCT01178671|517243087|FG000|Overall Study|Lost to Follow-up|3|||
143463590|NCT01178671|517243088|FG001|Overall Study|Lost to Follow-up|1|||
143463591|NCT01178671|517243087|FG000|Overall Study|Physician Decision|4|||
143463592|NCT01178671|517243088|FG001|Overall Study|Physician Decision|6|||
143463593|NCT00551460|517243091|FG000|Overall Study|Adverse Event|1|||
143463594|NCT00551460|517243091|FG000|Overall Study|Withdrawal by Subject|1|||
143463595|NCT00551460|517243091|FG000|Overall Study|Physician Decision|1|||
143463596|NCT00551460|517243091|FG000|Overall Study|Death|7|||
143463597|NCT00551460|517243091|FG000|Overall Study|Ineligible|4|||
143463598|NCT00551460|517243091|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
143463599|NCT04781387|517243092|FG000|Overall Study|Withdrawal by Subject|1|||
143463600|NCT04781387|517243093|FG001|Overall Study|Withdrawal by Subject|0|||
143463601|NCT04781387|517243094|FG002|Overall Study|Withdrawal by Subject|1|||
143463602|NCT04781387|517243092|FG000|Overall Study|Lost to Follow-up|1|||
143463603|NCT04781387|517243093|FG001|Overall Study|Lost to Follow-up|0|||
143463604|NCT04781387|517243094|FG002|Overall Study|Lost to Follow-up|0|||
143463605|NCT00511472|517243100|FG000|Overall Study|Clinical Adverse Event|1|||
143463606|NCT00511472|517243101|FG001|Overall Study|Clinical Adverse Event|2|||
143463607|NCT00511472|517243100|FG000|Overall Study|Laboratory Adverse Event|0|||
143463608|NCT00511472|517243101|FG001|Overall Study|Laboratory Adverse Event|2|||
143463609|NCT00511472|517243100|FG000|Overall Study|Not reported|2|||
143463610|NCT00511472|517243101|FG001|Overall Study|Not reported|2|||
143463611|NCT00446992|517243102|FG000|Overall Study|Adverse Event|11|||
143463612|NCT00446992|517243102|FG000|Overall Study|Lost to Follow-up|5|||
143463613|NCT00818649|517243103|FG000|Overall Study|Declining performance status|2|||
143463614|NCT00818649|517243103|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
143463615|NCT00818649|517243103|FG000|Overall Study|Adverse Event|1|||
143463616|NCT03513588|517243104|FG000|Overall Study|Lost to Follow-up|0|||
143463617|NCT03513588|517243105|FG001|Overall Study|Lost to Follow-up|1|||
143463618|NCT03513588|517243106|FG002|Overall Study|Lost to Follow-up|1|||
143463619|NCT03513588|517243104|FG000|Overall Study|Study dosing paused by sponsor|1|||
143463620|NCT03513588|517243105|FG001|Overall Study|Study dosing paused by sponsor|1|||
143463621|NCT03513588|517243106|FG002|Overall Study|Study dosing paused by sponsor|0|||
143463622|NCT03513588|517243104|FG000|Overall Study|Death|0|||
143463623|NCT03513588|517243105|FG001|Overall Study|Death|0|||
143463624|NCT03513588|517243106|FG002|Overall Study|Death|1|||
143463625|NCT06338462|517243110|FG000|Overall Study|No intervention received due to inaccurate contact info, no WhatsApp, no internet, or no smartphone|52|||
143463626|NCT00069238|517243111|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
143356728|NCT00724061|516850828|FG000|Dose Escalation Phase|Disease Progression|3|||
143356729|NCT00594932|516850833|FG000|First 3 Months|Withdrawal by Subject|1|||
143356730|NCT00594932|516850834|FG001|First 3 Months|Withdrawal by Subject|3|||
143356731|NCT00594932|516850833|FG000|Final 3 Months|Withdrawal by Subject|4|||
143356732|NCT00594932|516850834|FG001|Final 3 Months|Withdrawal by Subject|3|||
143356733|NCT01094171|516850835|FG000|Overall Study|Lost to Follow-up|2|||
143356734|NCT01094171|516850835|FG000|Overall Study|Informed consent withdrawal|4|||
143356735|NCT01094171|516850835|FG000|Overall Study|Migration from the study area|3|||
143356736|NCT01094171|516850835|FG000|Overall Study|Other|1|||
143356737|NCT01536145|516850836|FG000|Overall Study|Progressive disease|3|||
143356738|NCT01536145|516850837|FG001|Overall Study|Progressive disease|4|||
143356739|NCT01536145|516850838|FG002|Overall Study|Progressive disease|1|||
143356740|NCT01536145|516850839|FG003|Overall Study|Progressive disease|2|||
143356741|NCT01536145|516850840|FG004|Overall Study|Progressive disease|1|||
143356742|NCT01536145|516850841|FG005|Overall Study|Progressive disease|2|||
143356743|NCT01536145|516850842|FG006|Overall Study|Progressive disease|1|||
143356744|NCT01536145|516850843|FG007|Overall Study|Progressive disease|2|||
143463627|NCT00069238|517243112|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
143126698|NCT00435461|516009049|FG002|Overall Study|Protocol Violation|10|||
143126699|NCT00435461|516009047|FG000|Overall Study|Participant randomized(inadequate score)|1|||
143126700|NCT00435461|516009048|FG001|Overall Study|Participant randomized(inadequate score)|0|||
143126701|NCT00435461|516009049|FG002|Overall Study|Participant randomized(inadequate score)|0|||
143356745|NCT01536145|516850844|FG008|Overall Study|Progressive disease|1|||
143356746|NCT01536145|516850845|FG009|Overall Study|Progressive disease|3|||
143356747|NCT01536145|516850846|FG010|Overall Study|Progressive disease|3|||
143126702|NCT00435461|516009047|FG000|Overall Study|Compliance less than 80 percent|1|||
143126703|NCT00435461|516009048|FG001|Overall Study|Compliance less than 80 percent|0|||
143126704|NCT00435461|516009049|FG002|Overall Study|Compliance less than 80 percent|0|||
143126705|NCT00435461|516009047|FG000|Overall Study|In error, two study medications switched|1|||
143126706|NCT00435461|516009048|FG001|Overall Study|In error, two study medications switched|0|||
143126707|NCT00435461|516009049|FG002|Overall Study|In error, two study medications switched|0|||
143126708|NCT00435461|516009047|FG000|Overall Study|Lack of Efficacy|2|||
143126709|NCT00435461|516009048|FG001|Overall Study|Lack of Efficacy|1|||
143126710|NCT00435461|516009049|FG002|Overall Study|Lack of Efficacy|0|||
143126711|NCT00435461|516009047|FG000|Overall Study|Withdrawal by Subject|1|||
143126712|NCT00435461|516009048|FG001|Overall Study|Withdrawal by Subject|0|||
143126713|NCT00435461|516009049|FG002|Overall Study|Withdrawal by Subject|2|||
143126714|NCT00435461|516009047|FG000|Overall Study|Randomized in error|1|||
143126715|NCT00435461|516009048|FG001|Overall Study|Randomized in error|0|||
143126716|NCT00435461|516009049|FG002|Overall Study|Randomized in error|0|||
143126717|NCT00435461|516009047|FG000|Overall Study|Participant could not tolerate symptoms|0|||
143126718|NCT00435461|516009048|FG001|Overall Study|Participant could not tolerate symptoms|0|||
143126719|NCT00435461|516009049|FG002|Overall Study|Participant could not tolerate symptoms|1|||
143126720|NCT00435461|516009047|FG000|Overall Study|Participant could not swallow capsule|0|||
143126721|NCT00435461|516009048|FG001|Overall Study|Participant could not swallow capsule|0|||
143126722|NCT00435461|516009049|FG002|Overall Study|Participant could not swallow capsule|1|||
143126723|NCT00435461|516009047|FG000|Overall Study|Pregnancy|2|||
143126724|NCT00435461|516009048|FG001|Overall Study|Pregnancy|0|||
143126725|NCT00435461|516009049|FG002|Overall Study|Pregnancy|0|||
143126726|NCT00435461|516009047|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
143126727|NCT00435461|516009048|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
143126728|NCT00435461|516009049|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
143126729|NCT00435461|516009047|FG000|Overall Study|Participant ended study one day early|1|||
143126730|NCT00435461|516009048|FG001|Overall Study|Participant ended study one day early|0|||
143126731|NCT00435461|516009049|FG002|Overall Study|Participant ended study one day early|0|||
143126732|NCT00435461|516009047|FG000|Overall Study|Noncompliance with study requirements|1|||
143126733|NCT00435461|516009048|FG001|Overall Study|Noncompliance with study requirements|1|||
143126734|NCT00435461|516009049|FG002|Overall Study|Noncompliance with study requirements|1|||
143126735|NCT00435461|516009047|FG000|Overall Study|Adverse Event|1|||
143126736|NCT00435461|516009048|FG001|Overall Study|Adverse Event|2|||
143126737|NCT00435461|516009049|FG002|Overall Study|Adverse Event|6|||
143126738|NCT00435461|516009047|FG000|Overall Study|Non-Compliance of diary|2|||
143126739|NCT00435461|516009048|FG001|Overall Study|Non-Compliance of diary|0|||
143126740|NCT00435461|516009049|FG002|Overall Study|Non-Compliance of diary|1|||
143356748|NCT01536145|516850836|FG000|Overall Study|Withdrawal by Subject|0|||
143356749|NCT01536145|516850837|FG001|Overall Study|Withdrawal by Subject|0|||
143356750|NCT01536145|516850838|FG002|Overall Study|Withdrawal by Subject|1|||
143356751|NCT01536145|516850839|FG003|Overall Study|Withdrawal by Subject|0|||
143356752|NCT01536145|516850840|FG004|Overall Study|Withdrawal by Subject|0|||
143356753|NCT01536145|516850841|FG005|Overall Study|Withdrawal by Subject|1|||
143356754|NCT01536145|516850842|FG006|Overall Study|Withdrawal by Subject|0|||
143356755|NCT01536145|516850843|FG007|Overall Study|Withdrawal by Subject|0|||
143356756|NCT01536145|516850844|FG008|Overall Study|Withdrawal by Subject|2|||
143356757|NCT01536145|516850845|FG009|Overall Study|Withdrawal by Subject|0|||
143356758|NCT01536145|516850846|FG010|Overall Study|Withdrawal by Subject|2|||
143356759|NCT01536145|516850836|FG000|Overall Study|Other|0|||
143356760|NCT01536145|516850837|FG001|Overall Study|Other|0|||
143356761|NCT01536145|516850838|FG002|Overall Study|Other|0|||
143356762|NCT01536145|516850839|FG003|Overall Study|Other|0|||
143356763|NCT01536145|516850840|FG004|Overall Study|Other|1|||
143356764|NCT01536145|516850841|FG005|Overall Study|Other|0|||
143356765|NCT01536145|516850842|FG006|Overall Study|Other|0|||
143356766|NCT01536145|516850843|FG007|Overall Study|Other|0|||
143356767|NCT01536145|516850844|FG008|Overall Study|Other|0|||
143356768|NCT01536145|516850845|FG009|Overall Study|Other|3|||
143356769|NCT01536145|516850846|FG010|Overall Study|Other|2|||
143126741|NCT00435461|516009047|FG000|Overall Study|Lost to Follow-up|1|||
143126742|NCT00435461|516009048|FG001|Overall Study|Lost to Follow-up|1|||
143356770|NCT01536145|516850836|FG000|Overall Study|Death|0|||
143356771|NCT01536145|516850837|FG001|Overall Study|Death|0|||
143356772|NCT01536145|516850838|FG002|Overall Study|Death|0|||
143356773|NCT01536145|516850839|FG003|Overall Study|Death|0|||
143356774|NCT01536145|516850840|FG004|Overall Study|Death|0|||
143356775|NCT01536145|516850841|FG005|Overall Study|Death|0|||
143463628|NCT00069238|517243113|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
143463629|NCT00069238|517243111|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
143463630|NCT00069238|517243112|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
143463631|NCT00069238|517243113|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
143463632|NCT00069238|517243111|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
143463633|NCT00069238|517243112|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
143463634|NCT00069238|517243113|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
143463635|NCT02070588|517244830|FG000|Overall Study|Withdrawal by Subject|29|||
143463636|NCT02070588|517244831|FG001|Overall Study|Withdrawal by Subject|1|||
143463637|NCT02070588|517244832|FG002|Overall Study|Withdrawal by Subject|0|||
143463638|NCT02070588|517244830|FG000|Overall Study|Writhdrawal due to early termination|9|||
143463639|NCT02070588|517244831|FG001|Overall Study|Writhdrawal due to early termination|0|||
143463640|NCT02070588|517244832|FG002|Overall Study|Writhdrawal due to early termination|0|||
143463641|NCT02070588|517244830|FG000|Overall Study|Adverse Event|1|||
143463642|NCT02070588|517244831|FG001|Overall Study|Adverse Event|0|||
143463643|NCT02070588|517244832|FG002|Overall Study|Adverse Event|0|||
143463644|NCT01790126|517244838|FG000|Overall Study|PSA Progression|12|||
143463645|NCT01790126|517244839|FG001|Overall Study|PSA Progression|16|||
143463646|NCT01790126|517244840|FG002|Overall Study|PSA Progression|16|||
143463647|NCT01790126|517244838|FG000|Overall Study|Other|5|||
143013503|NCT01915498|515588124|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
143013504|NCT01915498|515588125|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
143013505|NCT01915498|515588126|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
143013506|NCT01915498|515588127|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
143013507|NCT01915498|515588128|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
143013508|NCT01915498|515588129|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
143013509|NCT01915498|515588130|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
143013510|NCT01915498|515588131|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
143013511|NCT01915498|515588113|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
143013512|NCT01915498|515588114|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
143013513|NCT01915498|515588115|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
143463648|NCT01790126|517244839|FG001|Overall Study|Other|4|||
143463649|NCT01790126|517244840|FG002|Overall Study|Other|8|||
143463650|NCT01790126|517244838|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
143463651|NCT01790126|517244839|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
143463652|NCT01790126|517244840|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
143463653|NCT01790126|517244838|FG000|Overall Study|Withdrawal by Physician|1|||
143463654|NCT01790126|517244839|FG001|Overall Study|Withdrawal by Physician|1|||
143463655|NCT01790126|517244840|FG002|Overall Study|Withdrawal by Physician|2|||
143463656|NCT01790126|517244838|FG000|Overall Study|Withdrawal by Subject|3|||
143463657|NCT01790126|517244839|FG001|Overall Study|Withdrawal by Subject|1|||
143463658|NCT01790126|517244840|FG002|Overall Study|Withdrawal by Subject|2|||
143463659|NCT01790126|517244838|FG000|Overall Study|Lost to Follow-up|1|||
143463660|NCT01790126|517244839|FG001|Overall Study|Lost to Follow-up|0|||
143463661|NCT01790126|517244840|FG002|Overall Study|Lost to Follow-up|1|||
143463662|NCT01790126|517244838|FG000|Overall Study|Adverse Event|0|||
143463663|NCT01790126|517244839|FG001|Overall Study|Adverse Event|2|||
143463664|NCT01790126|517244840|FG002|Overall Study|Adverse Event|0|||
143463665|NCT01790126|517244838|FG000|Overall Study|Death|2|||
143463666|NCT01790126|517244839|FG001|Overall Study|Death|0|||
143463667|NCT01790126|517244840|FG002|Overall Study|Death|0|||
143463668|NCT01790126|517244838|FG000|Overall Study|Radiographic Progression|3|||
143463669|NCT01790126|517244839|FG001|Overall Study|Radiographic Progression|1|||
143463670|NCT01790126|517244840|FG002|Overall Study|Radiographic Progression|0|||
143463671|NCT01313689|517244841|FG000|24-Week Randomization 1|Adverse Event|10|||
143463672|NCT01313689|517244842|FG001|24-Week Randomization 1|Adverse Event|5|||
143463673|NCT01313689|517244843|FG002|24-Week Randomization 1|Adverse Event|0|||
143463674|NCT01313689|517244844|FG003|24-Week Randomization 1|Adverse Event|0|||
143463675|NCT01313689|517244845|FG004|24-Week Randomization 1|Adverse Event|0|||
143463676|NCT01313689|517244841|FG000|24-Week Randomization 1|Physician Decision|4|||
143463677|NCT01313689|517244842|FG001|24-Week Randomization 1|Physician Decision|5|||
143463678|NCT01313689|517244843|FG002|24-Week Randomization 1|Physician Decision|0|||
143463679|NCT01313689|517244844|FG003|24-Week Randomization 1|Physician Decision|0|||
143463680|NCT01313689|517244845|FG004|24-Week Randomization 1|Physician Decision|0|||
143463681|NCT01313689|517244841|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
143463682|NCT01313689|517244842|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
143463683|NCT01313689|517244843|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
143463684|NCT01313689|517244844|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
143463685|NCT01313689|517244845|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
143463686|NCT01313689|517244841|FG000|24-Week Randomization 2|Adverse Event|0|||
143013514|NCT01915498|515588116|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
143013515|NCT01915498|515588117|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
143126743|NCT00435461|516009049|FG002|Overall Study|Lost to Follow-up|2|||
143126744|NCT01768559|516009050|FG000|Overall Study|Randomized but not treated|0|||
143126745|NCT01768559|516009051|FG001|Overall Study|Randomized but not treated|0|||
143126746|NCT01768559|516009052|FG002|Overall Study|Randomized but not treated|1|||
143126747|NCT01768559|516009050|FG000|Overall Study|Adverse Event|15|||
143126748|NCT01768559|516009051|FG001|Overall Study|Adverse Event|2|||
143126749|NCT01768559|516009052|FG002|Overall Study|Adverse Event|5|||
143126750|NCT01768559|516009050|FG000|Overall Study|Lack of Efficacy|6|||
143126751|NCT01768559|516009051|FG001|Overall Study|Lack of Efficacy|4|||
143126752|NCT01768559|516009052|FG002|Overall Study|Lack of Efficacy|0|||
143126753|NCT01768559|516009050|FG000|Overall Study|Poor compliance to protocol|0|||
143126754|NCT01768559|516009051|FG001|Overall Study|Poor compliance to protocol|3|||
143126755|NCT01768559|516009052|FG002|Overall Study|Poor compliance to protocol|2|||
143126756|NCT01768559|516009050|FG000|Overall Study|Other than specified|9|||
143126757|NCT01768559|516009051|FG001|Overall Study|Other than specified|8|||
143126758|NCT01768559|516009052|FG002|Overall Study|Other than specified|5|||
143126759|NCT02504320|516009053|FG000|Treatment Period 1|Positive Drug Screen|0|||
143126760|NCT02504320|516009054|FG001|Treatment Period 1|Positive Drug Screen|0|||
143126761|NCT02504320|516009055|FG002|Treatment Period 1|Positive Drug Screen|1|||
143126762|NCT02504320|516009056|FG003|Treatment Period 1|Positive Drug Screen|0|||
143126763|NCT02504320|516009053|FG000|Treatment Period 2|Positive Drug Screen|0|||
143126764|NCT02504320|516009054|FG001|Treatment Period 2|Positive Drug Screen|1|||
143126765|NCT02504320|516009055|FG002|Treatment Period 2|Positive Drug Screen|0|||
143126766|NCT02504320|516009056|FG003|Treatment Period 2|Positive Drug Screen|0|||
143126767|NCT02504320|516009053|FG000|Treatment Period 3|Positive Drug Screen|0|||
143126768|NCT02504320|516009054|FG001|Treatment Period 3|Positive Drug Screen|0|||
143463687|NCT01313689|517244842|FG001|24-Week Randomization 2|Adverse Event|0|||
143463688|NCT01313689|517244843|FG002|24-Week Randomization 2|Adverse Event|2|||
143463689|NCT01313689|517244844|FG003|24-Week Randomization 2|Adverse Event|0|||
143463690|NCT01313689|517244845|FG004|24-Week Randomization 2|Adverse Event|8|||
143463691|NCT01313689|517244841|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
143463692|NCT01313689|517244842|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
143463693|NCT01313689|517244843|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
143463694|NCT01313689|517244844|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
143463695|NCT01313689|517244845|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
143463696|NCT01313689|517244841|FG000|24-Week Randomization 2|Physician Decision|0|||
143463697|NCT01313689|517244842|FG001|24-Week Randomization 2|Physician Decision|0|||
143463698|NCT01313689|517244843|FG002|24-Week Randomization 2|Physician Decision|0|||
143463699|NCT01313689|517244844|FG003|24-Week Randomization 2|Physician Decision|0|||
143463700|NCT01313689|517244845|FG004|24-Week Randomization 2|Physician Decision|4|||
143463701|NCT00679627|517244846|FG000|Overall Study|Death|41|||
143463702|NCT00679627|517244847|FG001|Overall Study|Death|29|||
143463703|NCT00679627|517244846|FG000|Overall Study|Adverse Event|43|||
143463704|NCT00679627|517244847|FG001|Overall Study|Adverse Event|53|||
143463705|NCT00679627|517244846|FG000|Overall Study|Withdrawal by Subject|168|||
143463706|NCT00679627|517244847|FG001|Overall Study|Withdrawal by Subject|172|||
143013516|NCT01915498|515588118|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
143013517|NCT01915498|515588119|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
143013518|NCT01915498|515588120|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
143013519|NCT01915498|515588121|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
143013520|NCT01915498|515588122|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
143013521|NCT01915498|515588123|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
143013522|NCT01915498|515588124|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
143013523|NCT01915498|515588125|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
143013524|NCT01915498|515588126|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
143013525|NCT01915498|515588127|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
143013526|NCT01915498|515588128|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
143013527|NCT01915498|515588129|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
143013528|NCT01915498|515588130|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
143013529|NCT01915498|515588131|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
143013530|NCT01915498|515588113|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
143013531|NCT01915498|515588114|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
143013532|NCT01915498|515588115|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
143013533|NCT01915498|515588116|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
143013534|NCT01915498|515588117|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
143013535|NCT01915498|515588118|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
143013536|NCT01915498|515588119|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
143013537|NCT01915498|515588120|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
143013538|NCT01915498|515588121|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
143126769|NCT02504320|516009055|FG002|Treatment Period 3|Positive Drug Screen|0|||
143126770|NCT02504320|516009056|FG003|Treatment Period 3|Positive Drug Screen|1|||
143463707|NCT00679627|517244846|FG000|Overall Study|Lost to Follow-up|22|||
143126771|NCT02504320|516009053|FG000|Treatment Period 3|Adverse Event|0|||
143126772|NCT02504320|516009054|FG001|Treatment Period 3|Adverse Event|0|||
143126773|NCT02504320|516009055|FG002|Treatment Period 3|Adverse Event|1|||
143126774|NCT02504320|516009056|FG003|Treatment Period 3|Adverse Event|0|||
143126775|NCT01765569|516009068|FG000|Period B|Withdrawal by Subject|1|||
143126776|NCT01765569|516009068|FG000|Period C|Death|1|||
143126777|NCT01030718|516009069|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
143126778|NCT01030718|516009070|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
143126779|NCT01030718|516009071|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
143126780|NCT01030718|516009069|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
143126781|NCT01030718|516009070|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
143126782|NCT01030718|516009071|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
143126783|NCT01030718|516009069|FG000|Studies CA180-031 and -036 Combined|Death|0|||
143126784|NCT01030718|516009070|FG001|Studies CA180-031 and -036 Combined|Death|1|||
143126785|NCT01030718|516009071|FG002|Studies CA180-031 and -036 Combined|Death|0|||
143126786|NCT01030718|516009069|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
143126787|NCT01030718|516009070|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
143126788|NCT01030718|516009071|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
143126789|NCT01030718|516009069|FG000|Study CA180-036 Only|insufficient effect|1|||
143126790|NCT01030718|516009070|FG001|Study CA180-036 Only|insufficient effect|1|||
143126791|NCT01030718|516009071|FG002|Study CA180-036 Only|insufficient effect|5|||
143126792|NCT01030718|516009069|FG000|Study CA180-036 Only|Adverse Event|2|||
143126793|NCT01030718|516009070|FG001|Study CA180-036 Only|Adverse Event|3|||
143126794|NCT01030718|516009071|FG002|Study CA180-036 Only|Adverse Event|0|||
143126795|NCT01030718|516009069|FG000|Study CA180-036 Only|Death|0|||
143126796|NCT01030718|516009070|FG001|Study CA180-036 Only|Death|1|||
143126797|NCT01030718|516009071|FG002|Study CA180-036 Only|Death|0|||
143126798|NCT01030718|516009069|FG000|Study CA180-036 Only|Other Reasons|0|||
143126799|NCT01030718|516009070|FG001|Study CA180-036 Only|Other Reasons|2|||
143126800|NCT01030718|516009071|FG002|Study CA180-036 Only|Other Reasons|0|||
143126801|NCT00423813|516009072|FG000|Overall Study|Adverse Event|11|||
143126802|NCT00423813|516009073|FG001|Overall Study|Adverse Event|30|||
143126803|NCT00423813|516009074|FG002|Overall Study|Adverse Event|40|||
143126804|NCT00423813|516009072|FG000|Overall Study|Withdrawal by Subject|6|||
143126805|NCT00423813|516009073|FG001|Overall Study|Withdrawal by Subject|8|||
143126806|NCT00423813|516009074|FG002|Overall Study|Withdrawal by Subject|5|||
143126807|NCT00423813|516009072|FG000|Overall Study|Lost to Follow-up|5|||
143126808|NCT00423813|516009073|FG001|Overall Study|Lost to Follow-up|4|||
143126809|NCT00423813|516009074|FG002|Overall Study|Lost to Follow-up|4|||
143126810|NCT00423813|516009072|FG000|Overall Study|Lack of Efficacy|23|||
143126811|NCT00423813|516009073|FG001|Overall Study|Lack of Efficacy|18|||
143126812|NCT00423813|516009074|FG002|Overall Study|Lack of Efficacy|19|||
143126813|NCT00423813|516009072|FG000|Overall Study|Physician Decision|2|||
143126814|NCT00423813|516009073|FG001|Overall Study|Physician Decision|0|||
143126815|NCT00423813|516009074|FG002|Overall Study|Physician Decision|0|||
143126816|NCT00423813|516009072|FG000|Overall Study|Sponsor Decision|0|||
143126817|NCT00423813|516009073|FG001|Overall Study|Sponsor Decision|1|||
143126818|NCT00423813|516009074|FG002|Overall Study|Sponsor Decision|0|||
143126819|NCT00423813|516009072|FG000|Overall Study|Protocol Violation|9|||
143126820|NCT00423813|516009073|FG001|Overall Study|Protocol Violation|4|||
143126821|NCT00423813|516009074|FG002|Overall Study|Protocol Violation|4|||
143126822|NCT00423813|516009072|FG000|Overall Study|Pregnancy|0|||
143126823|NCT00423813|516009073|FG001|Overall Study|Pregnancy|0|||
143126824|NCT00423813|516009074|FG002|Overall Study|Pregnancy|1|||
143126825|NCT00423813|516009072|FG000|Overall Study|Subject started night shift work|1|||
143126826|NCT00423813|516009073|FG001|Overall Study|Subject started night shift work|0|||
143126827|NCT00423813|516009074|FG002|Overall Study|Subject started night shift work|0|||
143126828|NCT00423813|516009072|FG000|Overall Study|Will start exclusionary medications|0|||
143126829|NCT00423813|516009073|FG001|Overall Study|Will start exclusionary medications|1|||
143126830|NCT00423813|516009074|FG002|Overall Study|Will start exclusionary medications|0|||
143126831|NCT00423813|516009072|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
143126832|NCT00423813|516009073|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
143356776|NCT01536145|516850842|FG006|Overall Study|Death|1|||
143356777|NCT01536145|516850843|FG007|Overall Study|Death|0|||
143356778|NCT01536145|516850844|FG008|Overall Study|Death|0|||
143356779|NCT01536145|516850845|FG009|Overall Study|Death|0|||
143356780|NCT01536145|516850846|FG010|Overall Study|Death|0|||
143356781|NCT01536145|516850836|FG000|Overall Study|Adverse Event|0|||
143356782|NCT01536145|516850837|FG001|Overall Study|Adverse Event|0|||
143356783|NCT01536145|516850838|FG002|Overall Study|Adverse Event|0|||
143013539|NCT01915498|515588122|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
143126833|NCT00423813|516009074|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
143126834|NCT01386944|516009075|FG000|Overall Study|Adverse Event|26|||
143126835|NCT01386944|516009075|FG000|Overall Study|Lack of Efficacy|14|||
143126836|NCT01386944|516009075|FG000|Overall Study|Lost to Follow-up|8|||
143126837|NCT01386944|516009075|FG000|Overall Study|Unspecified reason|8|||
143356784|NCT01536145|516850839|FG003|Overall Study|Adverse Event|0|||
143126838|NCT02559570|516009086|FG000|Overall Study|Adverse Event|0|||
143126839|NCT02559570|516009087|FG001|Overall Study|Adverse Event|2|||
143126840|NCT02559570|516009088|FG002|Overall Study|Adverse Event|0|||
143126841|NCT02559570|516009089|FG003|Overall Study|Adverse Event|1|||
143126842|NCT02559570|516009090|FG004|Overall Study|Adverse Event|0|||
143126843|NCT02559570|516009086|FG000|Overall Study|Withdrawal of Consent|0|||
143126844|NCT02559570|516009087|FG001|Overall Study|Withdrawal of Consent|0|||
143126845|NCT02559570|516009088|FG002|Overall Study|Withdrawal of Consent|1|||
143126846|NCT02559570|516009089|FG003|Overall Study|Withdrawal of Consent|2|||
143126847|NCT02559570|516009090|FG004|Overall Study|Withdrawal of Consent|1|||
143126848|NCT02559570|516009086|FG000|Overall Study|Lost to Follow-up|1|||
143126849|NCT02559570|516009087|FG001|Overall Study|Lost to Follow-up|0|||
143126850|NCT02559570|516009088|FG002|Overall Study|Lost to Follow-up|0|||
143126851|NCT02559570|516009089|FG003|Overall Study|Lost to Follow-up|0|||
143126852|NCT02559570|516009090|FG004|Overall Study|Lost to Follow-up|0|||
143126853|NCT02559570|516009086|FG000|Overall Study|Protocol Violation|1|||
143126854|NCT02559570|516009087|FG001|Overall Study|Protocol Violation|0|||
143126855|NCT02559570|516009088|FG002|Overall Study|Protocol Violation|0|||
143126856|NCT02559570|516009089|FG003|Overall Study|Protocol Violation|0|||
143126857|NCT02559570|516009090|FG004|Overall Study|Protocol Violation|1|||
143126858|NCT02559570|516009086|FG000|Overall Study|Other Miscellaneous Reasons|0|||
143126859|NCT02559570|516009087|FG001|Overall Study|Other Miscellaneous Reasons|0|||
143126860|NCT02559570|516009088|FG002|Overall Study|Other Miscellaneous Reasons|1|||
143126861|NCT02559570|516009089|FG003|Overall Study|Other Miscellaneous Reasons|0|||
143126862|NCT02559570|516009090|FG004|Overall Study|Other Miscellaneous Reasons|0|||
143126863|NCT00334295|516009096|FG000|Overall Study|Patients received fewer than 3 injection|5|||
143126864|NCT00792116|516009099|FG000|Overall Study|Lost to Follow-up|0|||
143126865|NCT00792116|516009100|FG001|Overall Study|Lost to Follow-up|1|||
143126866|NCT00792116|516009099|FG000|Overall Study|Discontnued intervention|1|||
143126867|NCT00792116|516009100|FG001|Overall Study|Discontnued intervention|0|||
143126868|NCT01962948|516011441|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
143126869|NCT01962948|516011442|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
143126870|NCT01962948|516011443|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
143126871|NCT01962948|516011444|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
143126872|NCT02579382|516011445|FG000|Main Study Phase|Lost to Follow-up|0|||
143126873|NCT02579382|516011446|FG001|Main Study Phase|Lost to Follow-up|0|||
143126874|NCT02579382|516011447|FG002|Main Study Phase|Lost to Follow-up|2|||
143126875|NCT02579382|516011448|FG003|Main Study Phase|Lost to Follow-up|0|||
143126876|NCT02579382|516011445|FG000|Main Study Phase|Withdrew Consent|0|||
143126877|NCT02579382|516011446|FG001|Main Study Phase|Withdrew Consent|0|||
143126878|NCT02579382|516011447|FG002|Main Study Phase|Withdrew Consent|0|||
143126879|NCT02579382|516011448|FG003|Main Study Phase|Withdrew Consent|2|||
143126880|NCT02579382|516011445|FG000|Main Study Phase|Lack of Efficacy|0|||
143126881|NCT02579382|516011446|FG001|Main Study Phase|Lack of Efficacy|0|||
143126882|NCT02579382|516011447|FG002|Main Study Phase|Lack of Efficacy|0|||
143126883|NCT02579382|516011448|FG003|Main Study Phase|Lack of Efficacy|1|||
143126884|NCT02579382|516011445|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
143126885|NCT02579382|516011446|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
143126886|NCT02579382|516011447|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
143126887|NCT02579382|516011448|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
143126888|NCT02579382|516011445|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
143126889|NCT02579382|516011446|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
143126890|NCT02579382|516011447|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
143126891|NCT02579382|516011448|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
143126892|NCT02579382|516011445|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
143463708|NCT00679627|517244847|FG001|Overall Study|Lost to Follow-up|26|||
143463709|NCT00679627|517244846|FG000|Overall Study|Early Study Closure|425|||
143463710|NCT00679627|517244847|FG001|Overall Study|Early Study Closure|405|||
143463711|NCT01079741|517244852|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
143463712|NCT01079741|517244853|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
143463713|NCT01079741|517244854|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
143013540|NCT01915498|515588123|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
143126893|NCT02579382|516011446|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
143126894|NCT02579382|516011447|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
143126895|NCT02579382|516011448|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
143126896|NCT02579382|516011445|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
143126897|NCT02579382|516011446|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
143126898|NCT02579382|516011447|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
143126899|NCT02579382|516011448|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
143126900|NCT02579382|516011445|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
143126901|NCT02579382|516011446|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
143126902|NCT02579382|516011447|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
143126903|NCT02579382|516011448|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
143126904|NCT02579382|516011445|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
143126905|NCT02579382|516011446|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
143126906|NCT02579382|516011447|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
143126907|NCT02579382|516011448|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
143126908|NCT00667992|516011449|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
143126909|NCT00667992|516011450|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
143126910|NCT00667992|516011449|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
143126911|NCT00667992|516011450|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
143126912|NCT00667992|516011449|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
143126913|NCT00667992|516011450|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
143126914|NCT00667992|516011449|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
143126915|NCT00667992|516011450|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
143126916|NCT00667992|516011449|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
143126917|NCT00667992|516011450|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
143126918|NCT00667992|516011449|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
143126919|NCT00667992|516011450|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
143126920|NCT00667992|516011449|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
143126921|NCT00667992|516011450|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
143126922|NCT00667992|516011449|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
143126923|NCT00667992|516011450|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
143126924|NCT00667992|516011449|FG000|Wash-out|Not within one doubling dilution|4|||
143126925|NCT00667992|516011450|FG001|Wash-out|Not within one doubling dilution|3|||
143126926|NCT00667992|516011449|FG000|Wash-out|Failure to wash-out|2|||
143126927|NCT00667992|516011450|FG001|Wash-out|Failure to wash-out|2|||
143126928|NCT00667992|516011449|FG000|Wash-out|Withdrawal by Subject|1|||
143126929|NCT00667992|516011450|FG001|Wash-out|Withdrawal by Subject|0|||
143126930|NCT00667992|516011449|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
143126931|NCT00667992|516011450|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
143126932|NCT00667992|516011449|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
143126933|NCT00667992|516011450|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
143126934|NCT02906579|516011458|FG000|Overall Study|Adverse Event|1|||
143126935|NCT02906579|516011458|FG000|Overall Study|Physician Decision|1|||
143126936|NCT02793947|516011459|FG000|Overall Study|Death|1|||
143126937|NCT02793947|516011460|FG001|Overall Study|Death|0|||
143126938|NCT02793947|516011459|FG000|Overall Study|Physician Decision|1|||
143126939|NCT02793947|516011460|FG001|Overall Study|Physician Decision|5|||
143126940|NCT02213380|516011463|FG000|Underwent Randomization|Withdrawal by Subject|2|||
143126941|NCT02213380|516011464|FG001|Underwent Randomization|Withdrawal by Subject|0|||
143126942|NCT02213380|516011463|FG000|Underwent Randomization|Not treated|3|||
143126943|NCT02213380|516011464|FG001|Underwent Randomization|Not treated|3|||
143126944|NCT02213380|516011463|FG000|Per-protocol Analysis|Protocol Violation|32|||
143126945|NCT02213380|516011464|FG001|Per-protocol Analysis|Protocol Violation|36|||
143126946|NCT02542397|516011468|FG000|Overall Study|Death|2|||
143126947|NCT02542397|516011468|FG000|Overall Study|Physician Decision|6|||
143126948|NCT02542397|516011468|FG000|Overall Study|Withdrawal by Subject|6|||
143126949|NCT02542397|516011468|FG000|Overall Study|Lost to Follow-up|2|||
143126950|NCT01738919|516011470|FG000|Overall Study|Lost to Follow-up|1|||
143126951|NCT01738919|516011471|FG001|Overall Study|Lost to Follow-up|0|||
143126952|NCT01738919|516011470|FG000|Overall Study|Immigrated|0|||
143126953|NCT01738919|516011471|FG001|Overall Study|Immigrated|1|||
143126954|NCT01738919|516011470|FG000|Overall Study|Withdrawal by Subject|0|||
143126955|NCT01738919|516011471|FG001|Overall Study|Withdrawal by Subject|1|||
143126956|NCT01738919|516011470|FG000|Overall Study|Not treated in accordance to guidelines|0|||
143126957|NCT01738919|516011471|FG001|Overall Study|Not treated in accordance to guidelines|1|||
143126958|NCT01473940|516011475|FG000|Induction Therapy|Death|0|||
143126959|NCT01473940|516011476|FG001|Induction Therapy|Death|0|||
143126960|NCT01473940|516011477|FG002|Induction Therapy|Death|1|||
143126961|NCT01473940|516011478|FG003|Induction Therapy|Death|1|||
143126962|NCT01473940|516011475|FG000|Induction Therapy|Progressive Disease|0|||
143126963|NCT01473940|516011476|FG001|Induction Therapy|Progressive Disease|1|||
143126964|NCT01473940|516011477|FG002|Induction Therapy|Progressive Disease|1|||
143126965|NCT01473940|516011478|FG003|Induction Therapy|Progressive Disease|0|||
143126966|NCT01473940|516011475|FG000|Maintenance Therapy|Progressive Disease|1|||
143126967|NCT01473940|516011476|FG001|Maintenance Therapy|Progressive Disease|2|||
143126968|NCT01473940|516011477|FG002|Maintenance Therapy|Progressive Disease|1|||
143126969|NCT01473940|516011478|FG003|Maintenance Therapy|Progressive Disease|4|||
143126970|NCT02849171|516011479|FG000|Overall Study|Withdrawal by Subject|1|||
143126971|NCT02849171|516011479|FG000|Overall Study|Not treated|1|||
143126972|NCT00621257|516011481|FG000|Overall Study|Lost to Follow-up|4|||
143126973|NCT00621257|516011482|FG001|Overall Study|Lost to Follow-up|0|||
143126974|NCT00621257|516011483|FG002|Overall Study|Lost to Follow-up|2|||
143126975|NCT00621257|516011484|FG003|Overall Study|Lost to Follow-up|4|||
143126976|NCT00621257|516011485|FG004|Overall Study|Lost to Follow-up|7|||
143126977|NCT00621257|516011481|FG000|Overall Study|Adverse Event|0|||
143126978|NCT00621257|516011482|FG001|Overall Study|Adverse Event|1|||
143126979|NCT00621257|516011483|FG002|Overall Study|Adverse Event|1|||
143126980|NCT00621257|516011484|FG003|Overall Study|Adverse Event|0|||
143126981|NCT00621257|516011485|FG004|Overall Study|Adverse Event|0|||
143126982|NCT00621257|516011481|FG000|Overall Study|Physician Decision|0|||
143126983|NCT00621257|516011482|FG001|Overall Study|Physician Decision|2|||
143126984|NCT00621257|516011483|FG002|Overall Study|Physician Decision|0|||
143126985|NCT00621257|516011484|FG003|Overall Study|Physician Decision|1|||
143126986|NCT00621257|516011485|FG004|Overall Study|Physician Decision|1|||
143126987|NCT00621257|516011481|FG000|Overall Study|Withdrawal by Subject|0|||
143126988|NCT00621257|516011482|FG001|Overall Study|Withdrawal by Subject|0|||
143126989|NCT00621257|516011483|FG002|Overall Study|Withdrawal by Subject|0|||
143126990|NCT00621257|516011484|FG003|Overall Study|Withdrawal by Subject|1|||
143126991|NCT00621257|516011485|FG004|Overall Study|Withdrawal by Subject|1|||
143126992|NCT01255904|516011489|FG000|Overall Study|Physician Decision|1|||
143126993|NCT01255904|516011490|FG001|Overall Study|Physician Decision|4|||
143126994|NCT02171429|516011492|FG000|Overall Study|Other|0|||
143126995|NCT02171429|516011493|FG001|Overall Study|Other|1|||
143126996|NCT02171429|516011494|FG002|Overall Study|Other|1|||
143126997|NCT02171429|516011492|FG000|Overall Study|Non-Compliance|0|||
143126998|NCT02171429|516011493|FG001|Overall Study|Non-Compliance|0|||
143126999|NCT02171429|516011494|FG002|Overall Study|Non-Compliance|1|||
143127000|NCT02171429|516011492|FG000|Overall Study|Physician Decision|0|||
143127001|NCT02171429|516011493|FG001|Overall Study|Physician Decision|0|||
143127002|NCT02171429|516011494|FG002|Overall Study|Physician Decision|1|||
143127003|NCT02171429|516011492|FG000|Overall Study|Withdrawal by Subject|1|||
143127004|NCT02171429|516011493|FG001|Overall Study|Withdrawal by Subject|1|||
143127005|NCT02171429|516011494|FG002|Overall Study|Withdrawal by Subject|1|||
143127006|NCT02171429|516011492|FG000|Overall Study|Lost to Follow-up|0|||
143127007|NCT02171429|516011493|FG001|Overall Study|Lost to Follow-up|1|||
143127008|NCT02171429|516011494|FG002|Overall Study|Lost to Follow-up|0|||
143127009|NCT02171429|516011492|FG000|Overall Study|Death|0|||
143127010|NCT02171429|516011493|FG001|Overall Study|Death|0|||
143127011|NCT02171429|516011494|FG002|Overall Study|Death|1|||
143127012|NCT01724177|516011497|FG000|Overall Study|Adverse Event|8|||
143127013|NCT01724177|516011497|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
143127014|NCT01724177|516011497|FG000|Overall Study|Nervous participant|1|||
143127015|NCT01724177|516011497|FG000|Overall Study|Serious Adverse Event Related|1|||
143127016|NCT01705080|516011501|FG000|Overall Study|Missed visit|10|||
143127017|NCT01705080|516011502|FG001|Overall Study|Missed visit|4|||
143127018|NCT01705080|516011503|FG002|Overall Study|Missed visit|1|||
143127019|NCT01705080|516011501|FG000|Overall Study|Death|4|||
143127020|NCT01705080|516011502|FG001|Overall Study|Death|4|||
143127021|NCT01705080|516011503|FG002|Overall Study|Death|6|||
143127022|NCT01705080|516011501|FG000|Overall Study|Withdrawal by Subject|61|||
143127023|NCT01705080|516011502|FG001|Overall Study|Withdrawal by Subject|44|||
143127024|NCT01705080|516011503|FG002|Overall Study|Withdrawal by Subject|9|||
143127025|NCT00281697|516011504|FG000|Overall Study|> 60 days since last dose of study drug|4|||
143127026|NCT00281697|516011505|FG001|Overall Study|> 60 days since last dose of study drug|4|||
143127027|NCT00281697|516011504|FG000|Overall Study|Adverse Event|54|||
143127028|NCT00281697|516011505|FG001|Overall Study|Adverse Event|15|||
143127029|NCT00281697|516011504|FG000|Overall Study|Death|8|||
143127030|NCT00281697|516011505|FG001|Overall Study|Death|3|||
143127031|NCT00281697|516011504|FG000|Overall Study|Disease progression|279|||
143127032|NCT00281697|516011505|FG001|Overall Study|Disease progression|149|||
143127033|NCT00281697|516011504|FG000|Overall Study|Other|5|||
143127034|NCT00281697|516011505|FG001|Overall Study|Other|6|||
143127035|NCT00281697|516011504|FG000|Overall Study|Physician's decision to withdraw|15|||
143127036|NCT00281697|516011505|FG001|Overall Study|Physician's decision to withdraw|12|||
143127037|NCT00281697|516011504|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
143127038|NCT00281697|516011505|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
143127039|NCT00281697|516011504|FG000|Overall Study|Did not receive study drug|3|||
143127040|NCT00281697|516011505|FG001|Overall Study|Did not receive study drug|2|||
143127041|NCT00632125|516011506|FG000|Overall Study|Death|82|||
143127042|NCT00632125|516011506|FG000|Overall Study|Withdrawal by Subject|44|||
143127043|NCT00632125|516011506|FG000|Overall Study|Adverse Event|36|||
143127044|NCT00632125|516011506|FG000|Overall Study|Renal transplantation|17|||
143127045|NCT00632125|516011506|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
143127046|NCT00632125|516011506|FG000|Overall Study|Non-compliance|8|||
143127047|NCT00632125|516011506|FG000|Overall Study|Development of uncontrolled hypertension|5|||
143127048|NCT00632125|516011506|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
143127049|NCT00572455|516011513|FG000|Stage I (14 Days)|Adverse Event|0|||
143127050|NCT00572455|516011514|FG001|Stage I (14 Days)|Adverse Event|0|||
143463714|NCT01079741|517244855|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
143127051|NCT00572455|516011515|FG002|Stage I (14 Days)|Adverse Event|0|||
143127052|NCT00572455|516011516|FG003|Stage I (14 Days)|Adverse Event|0|||
143127053|NCT00572455|516011517|FG004|Stage I (14 Days)|Adverse Event|0|||
143127054|NCT00572455|516011518|FG005|Stage I (14 Days)|Adverse Event|3|||
143127055|NCT00572455|516011519|FG006|Stage I (14 Days)|Adverse Event|0|||
143127056|NCT00572455|516011520|FG007|Stage I (14 Days)|Adverse Event|0|||
143127057|NCT00572455|516011521|FG008|Stage I (14 Days)|Adverse Event|0|||
143127058|NCT00572455|516011522|FG009|Stage I (14 Days)|Adverse Event|0|||
143127059|NCT00572455|516011523|FG010|Stage I (14 Days)|Adverse Event|0|||
143127060|NCT00572455|516011524|FG011|Stage I (14 Days)|Adverse Event|0|||
143127061|NCT00572455|516011525|FG012|Stage I (14 Days)|Adverse Event|0|||
143127062|NCT00572455|516011526|FG013|Stage I (14 Days)|Adverse Event|0|||
143127063|NCT00572455|516011513|FG000|Stage I (14 Days)|Other|0|||
143127064|NCT00572455|516011514|FG001|Stage I (14 Days)|Other|0|||
143127065|NCT00572455|516011515|FG002|Stage I (14 Days)|Other|0|||
143127066|NCT00572455|516011516|FG003|Stage I (14 Days)|Other|0|||
143127067|NCT00572455|516011517|FG004|Stage I (14 Days)|Other|1|||
143127068|NCT00572455|516011518|FG005|Stage I (14 Days)|Other|0|||
143127069|NCT00572455|516011519|FG006|Stage I (14 Days)|Other|0|||
143127070|NCT00572455|516011520|FG007|Stage I (14 Days)|Other|0|||
143127071|NCT00572455|516011521|FG008|Stage I (14 Days)|Other|0|||
143127072|NCT00572455|516011522|FG009|Stage I (14 Days)|Other|0|||
143127073|NCT00572455|516011523|FG010|Stage I (14 Days)|Other|0|||
143127074|NCT00572455|516011524|FG011|Stage I (14 Days)|Other|0|||
143127075|NCT00572455|516011525|FG012|Stage I (14 Days)|Other|0|||
143127076|NCT00572455|516011526|FG013|Stage I (14 Days)|Other|0|||
143127077|NCT00572455|516011513|FG000|Stage II (28 Days)|Adverse Event|0|||
143127078|NCT00572455|516011514|FG001|Stage II (28 Days)|Adverse Event|0|||
143127079|NCT00572455|516011515|FG002|Stage II (28 Days)|Adverse Event|0|||
143127080|NCT00572455|516011516|FG003|Stage II (28 Days)|Adverse Event|0|||
143127081|NCT00572455|516011517|FG004|Stage II (28 Days)|Adverse Event|0|||
143127082|NCT00572455|516011518|FG005|Stage II (28 Days)|Adverse Event|0|||
143127083|NCT00572455|516011519|FG006|Stage II (28 Days)|Adverse Event|0|||
143127084|NCT00572455|516011520|FG007|Stage II (28 Days)|Adverse Event|0|||
143127085|NCT00572455|516011521|FG008|Stage II (28 Days)|Adverse Event|1|||
143127086|NCT00572455|516011522|FG009|Stage II (28 Days)|Adverse Event|3|||
143127087|NCT00572455|516011523|FG010|Stage II (28 Days)|Adverse Event|3|||
143127088|NCT00572455|516011524|FG011|Stage II (28 Days)|Adverse Event|4|||
143127089|NCT00572455|516011525|FG012|Stage II (28 Days)|Adverse Event|5|||
143127090|NCT00572455|516011526|FG013|Stage II (28 Days)|Adverse Event|1|||
143127091|NCT00572455|516011513|FG000|Stage II (28 Days)|Death|0|||
143127092|NCT00572455|516011514|FG001|Stage II (28 Days)|Death|0|||
143127093|NCT00572455|516011515|FG002|Stage II (28 Days)|Death|0|||
143127094|NCT00572455|516011516|FG003|Stage II (28 Days)|Death|0|||
143127095|NCT00572455|516011517|FG004|Stage II (28 Days)|Death|0|||
143127096|NCT00572455|516011518|FG005|Stage II (28 Days)|Death|0|||
143127097|NCT00572455|516011519|FG006|Stage II (28 Days)|Death|0|||
143127098|NCT00572455|516011520|FG007|Stage II (28 Days)|Death|0|||
143127099|NCT00572455|516011521|FG008|Stage II (28 Days)|Death|1|||
143127100|NCT00572455|516011522|FG009|Stage II (28 Days)|Death|0|||
143127101|NCT00572455|516011523|FG010|Stage II (28 Days)|Death|0|||
143127102|NCT00572455|516011524|FG011|Stage II (28 Days)|Death|0|||
143127103|NCT00572455|516011525|FG012|Stage II (28 Days)|Death|0|||
143127104|NCT00572455|516011526|FG013|Stage II (28 Days)|Death|0|||
143127105|NCT00572455|516011513|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
143127106|NCT00572455|516011514|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
143127107|NCT00572455|516011515|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
143463715|NCT01079741|517244856|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
143463716|NCT01079741|517244852|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
143463717|NCT01079741|517244853|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
143463718|NCT01079741|517244854|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
143463719|NCT01079741|517244855|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
143127108|NCT00572455|516011516|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
143127109|NCT00572455|516011517|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
143127110|NCT00572455|516011518|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
143127111|NCT00572455|516011519|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
143127112|NCT00572455|516011520|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
143127113|NCT00572455|516011521|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
143127114|NCT00572455|516011522|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
143127115|NCT00572455|516011523|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
143127116|NCT00572455|516011524|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
143127117|NCT00572455|516011525|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
143127118|NCT00572455|516011526|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
143127119|NCT00572455|516011513|FG000|Stage II (28 Days)|Other|0|||
143127120|NCT00572455|516011514|FG001|Stage II (28 Days)|Other|0|||
143127121|NCT00572455|516011515|FG002|Stage II (28 Days)|Other|0|||
143127122|NCT00572455|516011516|FG003|Stage II (28 Days)|Other|0|||
143127123|NCT00572455|516011517|FG004|Stage II (28 Days)|Other|0|||
143127124|NCT00572455|516011518|FG005|Stage II (28 Days)|Other|0|||
143127125|NCT00572455|516011519|FG006|Stage II (28 Days)|Other|0|||
143127126|NCT00572455|516011520|FG007|Stage II (28 Days)|Other|0|||
143463720|NCT01079741|517244856|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
143463721|NCT02709096|517244857|FG000|Overall Study|non-compliance|1|||
143463722|NCT02709096|517244858|FG001|Overall Study|non-compliance|1|||
143463723|NCT00505284|517244859|FG000|Overall Study|Adverse Event|3|||
143463724|NCT00505284|517244860|FG001|Overall Study|Adverse Event|7|||
143463725|NCT00505284|517244861|FG002|Overall Study|Adverse Event|9|||
143463726|NCT00505284|517244862|FG003|Overall Study|Adverse Event|14|||
143463727|NCT00505284|517244863|FG004|Overall Study|Adverse Event|22|||
143463728|NCT00505284|517244859|FG000|Overall Study|Protocol Violation|0|||
143463729|NCT00505284|517244860|FG001|Overall Study|Protocol Violation|1|||
143463730|NCT00505284|517244861|FG002|Overall Study|Protocol Violation|1|||
143463731|NCT00505284|517244862|FG003|Overall Study|Protocol Violation|0|||
143463732|NCT00505284|517244863|FG004|Overall Study|Protocol Violation|0|||
143463733|NCT00505284|517244859|FG000|Overall Study|Withdrawal by Subject|2|||
143463734|NCT00505284|517244860|FG001|Overall Study|Withdrawal by Subject|6|||
143463735|NCT00505284|517244861|FG002|Overall Study|Withdrawal by Subject|1|||
143463736|NCT00505284|517244862|FG003|Overall Study|Withdrawal by Subject|0|||
143463737|NCT00505284|517244863|FG004|Overall Study|Withdrawal by Subject|6|||
143463738|NCT00505284|517244859|FG000|Overall Study|Lack of Efficacy|0|||
143463739|NCT00505284|517244860|FG001|Overall Study|Lack of Efficacy|1|||
143463740|NCT00505284|517244861|FG002|Overall Study|Lack of Efficacy|1|||
143463741|NCT00505284|517244862|FG003|Overall Study|Lack of Efficacy|1|||
143463742|NCT00505284|517244863|FG004|Overall Study|Lack of Efficacy|1|||
143463743|NCT00505284|517244859|FG000|Overall Study|Physician Decision|0|||
143463744|NCT00505284|517244860|FG001|Overall Study|Physician Decision|1|||
143463745|NCT00505284|517244861|FG002|Overall Study|Physician Decision|0|||
143463746|NCT00505284|517244862|FG003|Overall Study|Physician Decision|0|||
143463747|NCT00505284|517244863|FG004|Overall Study|Physician Decision|0|||
143463748|NCT00505284|517244859|FG000|Overall Study|Other|5|||
143463749|NCT00505284|517244860|FG001|Overall Study|Other|0|||
143463750|NCT00505284|517244861|FG002|Overall Study|Other|0|||
143463751|NCT00505284|517244862|FG003|Overall Study|Other|4|||
143463752|NCT00505284|517244863|FG004|Overall Study|Other|4|||
143463753|NCT00940108|517244864|FG000|Overall Study|Adverse Event|2|||
143463754|NCT00940108|517244865|FG001|Overall Study|Adverse Event|4|||
143463755|NCT00940108|517244866|FG002|Overall Study|Adverse Event|0|||
143463756|NCT00940108|517244867|FG003|Overall Study|Adverse Event|2|||
143463757|NCT00940108|517244864|FG000|Overall Study|Withdrew Consent|2|||
143463758|NCT00940108|517244865|FG001|Overall Study|Withdrew Consent|1|||
143463759|NCT00940108|517244866|FG002|Overall Study|Withdrew Consent|0|||
143463760|NCT00940108|517244867|FG003|Overall Study|Withdrew Consent|1|||
143463761|NCT00940108|517244864|FG000|Overall Study|Dose 2 contraindicated|1|||
143463762|NCT00940108|517244865|FG001|Overall Study|Dose 2 contraindicated|1|||
143463763|NCT00940108|517244866|FG002|Overall Study|Dose 2 contraindicated|0|||
143463764|NCT00940108|517244867|FG003|Overall Study|Dose 2 contraindicated|1|||
143463765|NCT00940108|517244864|FG000|Overall Study|Declined further vaccination|0|||
143463766|NCT00940108|517244865|FG001|Overall Study|Declined further vaccination|1|||
143463767|NCT00940108|517244866|FG002|Overall Study|Declined further vaccination|3|||
143463768|NCT00940108|517244867|FG003|Overall Study|Declined further vaccination|0|||
143463769|NCT00940108|517244864|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
143463770|NCT00940108|517244865|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
143463771|NCT00940108|517244866|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
143463772|NCT00940108|517244867|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
143463773|NCT00940108|517244864|FG000|Overall Study|Viral illness after Dose 1|0|||
143463774|NCT00940108|517244865|FG001|Overall Study|Viral illness after Dose 1|1|||
143463775|NCT00940108|517244866|FG002|Overall Study|Viral illness after Dose 1|0|||
143463776|NCT00940108|517244867|FG003|Overall Study|Viral illness after Dose 1|0|||
143463777|NCT00940108|517244864|FG000|Overall Study|Diagnosed with H1N1|0|||
143463778|NCT00940108|517244865|FG001|Overall Study|Diagnosed with H1N1|0|||
143463779|NCT00940108|517244866|FG002|Overall Study|Diagnosed with H1N1|0|||
143463780|NCT00940108|517244867|FG003|Overall Study|Diagnosed with H1N1|1|||
143463781|NCT01740323|517244868|FG000|Overall Study|Adverse Event|1|||
143463782|NCT01740323|517244869|FG001|Overall Study|Adverse Event|0|||
143463783|NCT01740323|517244868|FG000|Overall Study|Randomized but did not take study drug|1|||
143463784|NCT01740323|517244869|FG001|Overall Study|Randomized but did not take study drug|0|||
143463785|NCT02434939|517244874|FG000|Overall Study|Lack of Efficacy|34|||
143463786|NCT02434939|517244875|FG001|Overall Study|Lack of Efficacy|48|||
143463787|NCT02434939|517244874|FG000|Overall Study|Withdrawal by Subject|3|||
143463788|NCT02434939|517244875|FG001|Overall Study|Withdrawal by Subject|0|||
143463789|NCT02434939|517244874|FG000|Overall Study|Adverse Event|0|||
143463790|NCT02434939|517244875|FG001|Overall Study|Adverse Event|1|||
143463791|NCT00051363|517244885|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
143463792|NCT00051363|517244886|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
143463793|NCT00051363|517244885|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
143463794|NCT00051363|517244886|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
143463795|NCT00051363|517244885|FG000|Overall Study|Death|2|||
143463796|NCT00051363|517244886|FG001|Overall Study|Death|2|||
143463797|NCT00051363|517244885|FG000|Overall Study|Excluded Pre-Randomization|2|||
143127127|NCT00572455|516011521|FG008|Stage II (28 Days)|Other|1|||
143127128|NCT00572455|516011522|FG009|Stage II (28 Days)|Other|0|||
143127129|NCT00572455|516011523|FG010|Stage II (28 Days)|Other|0|||
143127130|NCT00572455|516011524|FG011|Stage II (28 Days)|Other|0|||
143127131|NCT00572455|516011525|FG012|Stage II (28 Days)|Other|0|||
143127132|NCT00572455|516011526|FG013|Stage II (28 Days)|Other|0|||
143127133|NCT00572455|516011513|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
143127134|NCT00572455|516011514|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
143127135|NCT00572455|516011515|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
143127136|NCT00572455|516011516|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
143127137|NCT00572455|516011517|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
143127138|NCT00572455|516011518|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
143127139|NCT00572455|516011519|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
143127140|NCT00572455|516011520|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
143127141|NCT00572455|516011521|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
143127142|NCT00572455|516011522|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
143127143|NCT00572455|516011523|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
143127144|NCT00572455|516011524|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
143127145|NCT00572455|516011525|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
143127146|NCT00572455|516011526|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
143127147|NCT04446429|516011527|FG000|Overall Study|Lost to Follow-up|6|||
143127148|NCT04446429|516011528|FG001|Overall Study|Lost to Follow-up|0|||
143127149|NCT01763203|516011529|FG000|Overall Study|Death|4|||
143127150|NCT01763203|516011530|FG001|Overall Study|Death|7|||
143127151|NCT01763203|516011529|FG000|Overall Study|Lost to Follow-up|12|||
143127152|NCT01763203|516011530|FG001|Overall Study|Lost to Follow-up|12|||
143127153|NCT01763203|516011529|FG000|Overall Study|Withdrawal by Subject|8|||
143127154|NCT01763203|516011530|FG001|Overall Study|Withdrawal by Subject|12|||
143127155|NCT01763203|516011529|FG000|Overall Study|Moved out of study region|7|||
143127156|NCT01763203|516011530|FG001|Overall Study|Moved out of study region|10|||
143127157|NCT01763203|516011529|FG000|Overall Study|Physician Decision|2|||
143127158|NCT01763203|516011530|FG001|Overall Study|Physician Decision|1|||
143127159|NCT02756819|516011531|FG000|Overall Study|Lost for observation|23|||
143127160|NCT02756819|516011531|FG000|Overall Study|Patient's unwillingness|16|||
143127161|NCT02756819|516011531|FG000|Overall Study|Insufficient efficacy|2|||
143127162|NCT02756819|516011531|FG000|Overall Study|Adverse Event|2|||
143127163|NCT02756819|516011531|FG000|Overall Study|Reason not Specified|9|||
143127164|NCT03076996|516011532|FG000|Overall Study|Withdrawal by Subject|2|||
143127165|NCT03076996|516011532|FG000|Overall Study|Lost to Follow-up|3|||
143127166|NCT03076996|516011532|FG000|Overall Study|Literacy precluded participation|1|||
143356785|NCT01536145|516850840|FG004|Overall Study|Adverse Event|0|||
143356786|NCT01536145|516850841|FG005|Overall Study|Adverse Event|0|||
143356787|NCT01536145|516850842|FG006|Overall Study|Adverse Event|0|||
143356788|NCT01536145|516850843|FG007|Overall Study|Adverse Event|2|||
143356789|NCT01536145|516850844|FG008|Overall Study|Adverse Event|0|||
143356790|NCT01536145|516850845|FG009|Overall Study|Adverse Event|0|||
143356791|NCT01536145|516850846|FG010|Overall Study|Adverse Event|3|||
143356792|NCT00088205|516850849|FG000|Overall Study|Adverse Event|4|||
143356793|NCT00088205|516850849|FG000|Overall Study|Progressive Disease|51|||
143356794|NCT00088205|516850849|FG000|Overall Study|Physician Decision|1|||
143356795|NCT00088205|516850849|FG000|Overall Study|Death Due to Study Disease|4|||
143356796|NCT05199233|516850850|FG000|Overall Study|Lack of Efficacy|1|||
143356797|NCT01364727|516850855|FG000|Overall Study|Not Eligible|2|||
143356798|NCT00688259|516850856|FG000|Overall Study|Lost to Follow-up|2|||
143356799|NCT00688259|516850857|FG001|Overall Study|Lost to Follow-up|4|||
143356800|NCT00688259|516850856|FG000|Overall Study|Physician Decision|1|||
143356801|NCT00688259|516850857|FG001|Overall Study|Physician Decision|0|||
143356802|NCT00688259|516850856|FG000|Overall Study|Withdrawal by Subject|2|||
143356803|NCT00688259|516850857|FG001|Overall Study|Withdrawal by Subject|0|||
143356804|NCT00688259|516850856|FG000|Overall Study|Declined Interview|2|||
143356805|NCT00688259|516850857|FG001|Overall Study|Declined Interview|3|||
143356806|NCT00688259|516850856|FG000|Overall Study|Hospitalized at Follow-up|0|||
143356807|NCT00688259|516850857|FG001|Overall Study|Hospitalized at Follow-up|1|||
143356808|NCT01676220|516850859|FG000|Overall Study|Randomized But Not Treated|4|||
143127167|NCT00943592|516011533|FG000|Overall Study|Death|3|||
143127168|NCT01540981|516011539|FG000|Overall Study|Withdrawal by Subject|1|||
143127169|NCT01540981|516011540|FG001|Overall Study|Withdrawal by Subject|0|||
143127170|NCT00232557|516011541|FG000|Overall Study|Lost to Follow-up|3|||
143127171|NCT00232557|516011542|FG001|Overall Study|Lost to Follow-up|5|||
143127172|NCT02438280|516011545|FG000|Overall Study|Physician Decision|1|||
143127173|NCT02438280|516011546|FG001|Overall Study|Physician Decision|0|||
143127174|NCT04435808|516011547|FG000|Overall Study|Study stopped by DSMB|0|||
143356809|NCT01676220|516850860|FG001|Overall Study|Randomized But Not Treated|1|||
143356810|NCT01676220|516850859|FG000|Overall Study|Adverse Event|10|||
143356811|NCT01676220|516850860|FG001|Overall Study|Adverse Event|8|||
143127175|NCT04435808|516011548|FG001|Overall Study|Study stopped by DSMB|1|||
143127176|NCT02457195|516011549|FG000|Overall Study|Adverse Event|3|||
143356812|NCT01676220|516850859|FG000|Overall Study|Lack of Efficacy|2|||
143463798|NCT00051363|517244886|FG001|Overall Study|Excluded Pre-Randomization|5|||
143463799|NCT02640157|517244888|FG000|Overall Study|Adverse Event|2|||
143463800|NCT02640157|517244889|FG001|Overall Study|Adverse Event|2|||
143463801|NCT02640157|517244890|FG002|Overall Study|Adverse Event|1|||
143463802|NCT02640157|517244888|FG000|Overall Study|Withdrew consent|2|||
143463803|NCT02640157|517244889|FG001|Overall Study|Withdrew consent|0|||
143463804|NCT02640157|517244890|FG002|Overall Study|Withdrew consent|2|||
143463805|NCT02640157|517244888|FG000|Overall Study|Lost to Follow-up|9|||
143463806|NCT02640157|517244889|FG001|Overall Study|Lost to Follow-up|2|||
143463807|NCT02640157|517244890|FG002|Overall Study|Lost to Follow-up|7|||
143463808|NCT02640157|517244888|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
143463809|NCT02640157|517244889|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
143463810|NCT02640157|517244890|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
143463811|NCT01679405|517244892|FG000|Overall Study|Death|2|||
143463812|NCT01679405|517244893|FG001|Overall Study|Death|5|||
143463813|NCT04677179|517244894|FG000|Induction Treatment Period|Adverse Event|1|||
143463814|NCT04677179|517244895|FG001|Induction Treatment Period|Adverse Event|0|||
143463815|NCT04677179|517244896|FG002|Induction Treatment Period|Adverse Event|0|||
143463816|NCT04677179|517244897|FG003|Induction Treatment Period|Adverse Event|0|||
143463817|NCT04677179|517244898|FG004|Induction Treatment Period|Adverse Event|0|||
143463818|NCT04677179|517244899|FG005|Induction Treatment Period|Adverse Event|0|||
143463819|NCT04677179|517244900|FG006|Induction Treatment Period|Adverse Event|0|||
143463820|NCT04677179|517244901|FG007|Induction Treatment Period|Adverse Event|0|||
143013541|NCT01915498|515588124|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
143127177|NCT02457195|516011549|FG000|Overall Study|Protocol Violation|2|||
143127178|NCT02457195|516011549|FG000|Overall Study|Withdrawal by Subject|4|||
143127179|NCT05359952|516011550|FG000|Overall Study|Lost to Follow-up|1|||
143127180|NCT05359952|516011551|FG001|Overall Study|Lost to Follow-up|0|||
143127181|NCT05980013|516011552|FG000|Overall Study|Withdrawal by Subject|0|||
143127182|NCT05980013|516011553|FG001|Overall Study|Withdrawal by Subject|1|||
143127183|NCT05980013|516011552|FG000|Overall Study|Device Error|0|||
143127184|NCT05980013|516011553|FG001|Overall Study|Device Error|1|||
143127185|NCT03146741|516011554|FG000|Overall Study|Txp with non-HCV+ heart|4|||
143127186|NCT03146741|516011554|FG000|Overall Study|Listeted for MOT|2|||
143127187|NCT03146741|516011554|FG000|Overall Study|Physician Decision|2|||
143127188|NCT03146741|516011554|FG000|Overall Study|Awaiting txp|2|||
143127189|NCT00685360|516011555|FG000|Overall Study|Lost to Follow-up|0|||
143127190|NCT00685360|516011556|FG001|Overall Study|Lost to Follow-up|1|||
143127191|NCT00685360|516011557|FG002|Overall Study|Lost to Follow-up|2|||
143127192|NCT00685360|516011555|FG000|Overall Study|Adverse Event|4|||
143127193|NCT00685360|516011556|FG001|Overall Study|Adverse Event|6|||
143127194|NCT00685360|516011557|FG002|Overall Study|Adverse Event|4|||
143127195|NCT00685360|516011555|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
143127196|NCT00685360|516011556|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
143127197|NCT00685360|516011557|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
143127198|NCT00685360|516011555|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
143127199|NCT00685360|516011556|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
143127200|NCT00685360|516011557|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
143127201|NCT00685360|516011555|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
143127202|NCT00685360|516011556|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
143127203|NCT00685360|516011557|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
143127204|NCT00685360|516011555|FG000|Overall Study|Protocol Deviation|0|||
143127205|NCT00685360|516011556|FG001|Overall Study|Protocol Deviation|1|||
143127206|NCT00685360|516011557|FG002|Overall Study|Protocol Deviation|1|||
143013542|NCT01915498|515588125|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
143013543|NCT01915498|515588126|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
143013544|NCT01915498|515588127|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
143013545|NCT01915498|515588128|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
143013546|NCT01915498|515588129|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
143013547|NCT01915498|515588130|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
143013548|NCT01915498|515588131|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
143013549|NCT01915498|515588113|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
143013550|NCT01915498|515588114|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
143127207|NCT03293394|516011558|FG000|Follow-up (6 Months)|Adverse Event|4|||
143127208|NCT03293394|516011559|FG001|Follow-up (6 Months)|Adverse Event|2|||
143127209|NCT00784719|516011562|FG000|Overall Study|Adverse Event|0|||
143463821|NCT04677179|517244902|FG008|Induction Treatment Period|Adverse Event|0|||
143463822|NCT04677179|517244903|FG009|Induction Treatment Period|Adverse Event|0|||
143463823|NCT04677179|517244894|FG000|Induction Treatment Period|Physician Decision|1|||
143463824|NCT04677179|517244895|FG001|Induction Treatment Period|Physician Decision|0|||
143463825|NCT04677179|517244896|FG002|Induction Treatment Period|Physician Decision|1|||
143463826|NCT04677179|517244897|FG003|Induction Treatment Period|Physician Decision|0|||
143127210|NCT00784719|516011563|FG001|Overall Study|Adverse Event|2|||
143127211|NCT00784719|516011564|FG002|Overall Study|Adverse Event|0|||
143127212|NCT00784719|516011565|FG003|Overall Study|Adverse Event|0|||
143127213|NCT00784719|516011566|FG004|Overall Study|Adverse Event|1|||
143127214|NCT00784719|516011567|FG005|Overall Study|Adverse Event|1|||
143127215|NCT00784719|516011568|FG006|Overall Study|Adverse Event|1|||
143127216|NCT00784719|516011562|FG000|Overall Study|Lost to Follow-up|0|||
143127217|NCT00784719|516011563|FG001|Overall Study|Lost to Follow-up|0|||
143127218|NCT00784719|516011564|FG002|Overall Study|Lost to Follow-up|0|||
143127219|NCT00784719|516011565|FG003|Overall Study|Lost to Follow-up|0|||
143127220|NCT00784719|516011566|FG004|Overall Study|Lost to Follow-up|1|||
143127221|NCT00784719|516011567|FG005|Overall Study|Lost to Follow-up|1|||
143127222|NCT00784719|516011568|FG006|Overall Study|Lost to Follow-up|0|||
143127223|NCT00784719|516011562|FG000|Overall Study|Other|2|||
143127224|NCT00784719|516011563|FG001|Overall Study|Other|1|||
143127225|NCT00784719|516011564|FG002|Overall Study|Other|1|||
143127226|NCT00784719|516011565|FG003|Overall Study|Other|0|||
143127227|NCT00784719|516011566|FG004|Overall Study|Other|2|||
143127228|NCT00784719|516011567|FG005|Overall Study|Other|1|||
143127229|NCT00784719|516011568|FG006|Overall Study|Other|3|||
143127230|NCT00784719|516011562|FG000|Overall Study|Withdrawal by Subject|1|||
143127231|NCT00784719|516011563|FG001|Overall Study|Withdrawal by Subject|0|||
143127232|NCT00784719|516011564|FG002|Overall Study|Withdrawal by Subject|0|||
143127233|NCT00784719|516011565|FG003|Overall Study|Withdrawal by Subject|0|||
143127234|NCT00784719|516011566|FG004|Overall Study|Withdrawal by Subject|2|||
143127235|NCT00784719|516011567|FG005|Overall Study|Withdrawal by Subject|0|||
143127236|NCT00784719|516011568|FG006|Overall Study|Withdrawal by Subject|1|||
143127237|NCT01408901|516011571|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
143127238|NCT01408901|516011572|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
143127239|NCT01408901|516011573|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
143127240|NCT01408901|516011574|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
143127241|NCT01408901|516011571|FG000|6-Week Follow-Up|Death|1|||
143127242|NCT01408901|516011572|FG001|6-Week Follow-Up|Death|0|||
143127243|NCT01408901|516011573|FG002|6-Week Follow-Up|Death|0|||
143127244|NCT01408901|516011574|FG003|6-Week Follow-Up|Death|0|||
143127245|NCT01408901|516011571|FG000|6-Week Follow-Up|Cancelled visit|0|||
143127246|NCT01408901|516011572|FG001|6-Week Follow-Up|Cancelled visit|1|||
143127247|NCT01408901|516011573|FG002|6-Week Follow-Up|Cancelled visit|0|||
143127248|NCT01408901|516011574|FG003|6-Week Follow-Up|Cancelled visit|2|||
143127249|NCT01408901|516011571|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
143127250|NCT01408901|516011572|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
143127251|NCT01408901|516011573|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
143127252|NCT01408901|516011574|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
143127253|NCT01408901|516011571|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
143127254|NCT01408901|516011572|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
143127255|NCT01408901|516011573|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
143127256|NCT01408901|516011574|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
143127257|NCT01408901|516011571|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
143127258|NCT01408901|516011572|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
143127259|NCT01408901|516011573|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
143127260|NCT01408901|516011574|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
143127261|NCT01408901|516011571|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
143127262|NCT01408901|516011572|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
143127263|NCT01408901|516011573|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
143127264|NCT01408901|516011574|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
143127265|NCT01408901|516011571|FG000|26-Week Follow-Up|Death|0|||
143127266|NCT01408901|516011572|FG001|26-Week Follow-Up|Death|1|||
143127267|NCT01408901|516011573|FG002|26-Week Follow-Up|Death|0|||
143127268|NCT01408901|516011574|FG003|26-Week Follow-Up|Death|0|||
143127269|NCT02497404|516011575|FG000|Overall Study|Adverse Event|1|||
143127270|NCT02098395|516011578|FG000|Overall Study|Protocol Violation|2|||
143127271|NCT02098395|516011579|FG001|Overall Study|Protocol Violation|2|||
143127272|NCT02098395|516011580|FG002|Overall Study|Protocol Violation|0|||
143127273|NCT02098395|516011581|FG003|Overall Study|Protocol Violation|7|||
143127274|NCT02098395|516011578|FG000|Overall Study|Withdrawal by Subject|10|||
143127275|NCT02098395|516011579|FG001|Overall Study|Withdrawal by Subject|10|||
143127276|NCT02098395|516011580|FG002|Overall Study|Withdrawal by Subject|5|||
143127277|NCT02098395|516011581|FG003|Overall Study|Withdrawal by Subject|13|||
143127278|NCT02098395|516011578|FG000|Overall Study|Adverse Event|12|||
143127279|NCT02098395|516011579|FG001|Overall Study|Adverse Event|19|||
143127280|NCT02098395|516011580|FG002|Overall Study|Adverse Event|34|||
143127281|NCT02098395|516011581|FG003|Overall Study|Adverse Event|2|||
143356813|NCT01676220|516850860|FG001|Overall Study|Lack of Efficacy|5|||
143356814|NCT01676220|516850859|FG000|Overall Study|Protocol Violation|11|||
143356815|NCT01676220|516850860|FG001|Overall Study|Protocol Violation|12|||
143127282|NCT02098395|516011578|FG000|Overall Study|Lost to Follow-up|2|||
143356816|NCT01676220|516850859|FG000|Overall Study|Received Rescue Therapy|14|||
143127283|NCT02098395|516011579|FG001|Overall Study|Lost to Follow-up|1|||
143463827|NCT04677179|517244898|FG004|Induction Treatment Period|Physician Decision|0|||
143463828|NCT04677179|517244899|FG005|Induction Treatment Period|Physician Decision|0|||
143463829|NCT04677179|517244900|FG006|Induction Treatment Period|Physician Decision|0|||
143463830|NCT04677179|517244901|FG007|Induction Treatment Period|Physician Decision|0|||
143463831|NCT04677179|517244902|FG008|Induction Treatment Period|Physician Decision|0|||
143463832|NCT04677179|517244903|FG009|Induction Treatment Period|Physician Decision|0|||
143463833|NCT04677179|517244894|FG000|Induction Treatment Period|Protocol Violation|0|||
143463834|NCT04677179|517244895|FG001|Induction Treatment Period|Protocol Violation|1|||
143463835|NCT04677179|517244896|FG002|Induction Treatment Period|Protocol Violation|0|||
143463836|NCT04677179|517244897|FG003|Induction Treatment Period|Protocol Violation|0|||
143463837|NCT04677179|517244898|FG004|Induction Treatment Period|Protocol Violation|0|||
143463838|NCT04677179|517244899|FG005|Induction Treatment Period|Protocol Violation|0|||
143463839|NCT04677179|517244900|FG006|Induction Treatment Period|Protocol Violation|0|||
143463840|NCT04677179|517244901|FG007|Induction Treatment Period|Protocol Violation|0|||
143463841|NCT04677179|517244902|FG008|Induction Treatment Period|Protocol Violation|0|||
143463842|NCT04677179|517244903|FG009|Induction Treatment Period|Protocol Violation|0|||
143463843|NCT04677179|517244894|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
143463844|NCT04677179|517244895|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
143463845|NCT04677179|517244896|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
143463846|NCT04677179|517244897|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
143463847|NCT04677179|517244898|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
143463848|NCT04677179|517244899|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
143463849|NCT04677179|517244900|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
143463850|NCT04677179|517244901|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
143463851|NCT04677179|517244902|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
143463852|NCT04677179|517244903|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
143463853|NCT04677179|517244894|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
143463854|NCT04677179|517244895|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
143463855|NCT04677179|517244896|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
143463856|NCT04677179|517244897|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
143463857|NCT04677179|517244898|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
143013551|NCT01915498|515588115|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
143013552|NCT01915498|515588116|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
143013553|NCT01915498|515588117|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
143013554|NCT01915498|515588118|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
143463858|NCT04677179|517244899|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
143463859|NCT04677179|517244900|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
143463860|NCT04677179|517244901|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
143463861|NCT04677179|517244902|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
143463862|NCT04677179|517244903|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
143463863|NCT04677179|517244894|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
143463864|NCT04677179|517244895|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
143463865|NCT04677179|517244896|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
143463866|NCT04677179|517244897|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
143463867|NCT04677179|517244898|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
143463868|NCT04677179|517244899|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
143463869|NCT04677179|517244900|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
143463870|NCT04677179|517244901|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
143463871|NCT04677179|517244902|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
143463872|NCT04677179|517244903|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
143463873|NCT04677179|517244894|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
143463874|NCT04677179|517244895|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
143463875|NCT04677179|517244896|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
143463876|NCT04677179|517244897|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
143463877|NCT04677179|517244898|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
143463878|NCT04677179|517244899|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
143463879|NCT04677179|517244900|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
143463880|NCT04677179|517244901|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
143463881|NCT04677179|517244902|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
143463882|NCT04677179|517244903|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
143463883|NCT04677179|517244894|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
143463884|NCT04677179|517244895|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
143463885|NCT04677179|517244896|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
143463886|NCT04677179|517244897|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
143463887|NCT04677179|517244898|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
143463888|NCT04677179|517244899|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
143013555|NCT01915498|515588119|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
143463889|NCT04677179|517244900|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
143127284|NCT02098395|516011580|FG002|Overall Study|Lost to Follow-up|0|||
143127285|NCT02098395|516011581|FG003|Overall Study|Lost to Follow-up|3|||
143127286|NCT02098395|516011578|FG000|Overall Study|Unclassified|0|||
143127287|NCT02098395|516011579|FG001|Overall Study|Unclassified|0|||
143127288|NCT02098395|516011580|FG002|Overall Study|Unclassified|3|||
143127289|NCT02098395|516011581|FG003|Overall Study|Unclassified|2|||
143127290|NCT04633226|516011582|FG000|Overall Study|Withdrawal by parent/guardian|4|||
143127291|NCT04633226|516011582|FG000|Overall Study|Randomized by mistake without study treatment|1|||
143127292|NCT00972283|516011587|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
143127293|NCT00972283|516011588|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
143127294|NCT00972283|516011587|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
143127295|NCT00972283|516011588|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
143127296|NCT00972283|516011587|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
143127297|NCT00972283|516011588|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
143127298|NCT00972283|516011587|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
143127299|NCT00972283|516011588|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
143127300|NCT00972283|516011587|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
143127301|NCT00972283|516011588|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
143127302|NCT00972283|516011587|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
143127303|NCT00972283|516011588|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
143127304|NCT00972283|516011587|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
143127305|NCT00972283|516011588|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
143127306|NCT00972283|516011587|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
143127307|NCT00972283|516011588|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
143356817|NCT01676220|516850860|FG001|Overall Study|Received Rescue Therapy|22|||
143356818|NCT01676220|516850859|FG000|Overall Study|Personal Reason|34|||
143356819|NCT01676220|516850860|FG001|Overall Study|Personal Reason|45|||
143356820|NCT01676220|516850859|FG000|Overall Study|Lost to Follow-up|11|||
143356821|NCT01676220|516850860|FG001|Overall Study|Lost to Follow-up|18|||
143356822|NCT01676220|516850859|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
143356823|NCT01676220|516850860|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
143356824|NCT01676220|516850859|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
143356825|NCT01676220|516850860|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
143356826|NCT01676220|516850859|FG000|Overall Study|Perceived Lack of Efficacy|3|||
143356827|NCT01676220|516850860|FG001|Overall Study|Perceived Lack of Efficacy|1|||
143356828|NCT01676220|516850859|FG000|Overall Study|Non Serious Hypoglycemia|2|||
143356829|NCT01676220|516850860|FG001|Overall Study|Non Serious Hypoglycemia|0|||
143356830|NCT01676220|516850859|FG000|Overall Study|No More Need of Insulin|1|||
143356831|NCT01676220|516850860|FG001|Overall Study|No More Need of Insulin|0|||
143356832|NCT00750893|516850865|FG000|Overall Study|Adverse Event|5|||
143356833|NCT00750893|516850865|FG000|Overall Study|Withdrawal by Subject|10|||
143356834|NCT00750893|516850865|FG000|Overall Study|Lost to Follow-up|510|||
143356835|NCT00750893|516850865|FG000|Overall Study|Other|17|||
143356836|NCT03018106|516850866|FG000|Overall Study|Lost to Follow-up|0|||
143356837|NCT03018106|516850867|FG001|Overall Study|Lost to Follow-up|1|||
143356838|NCT00136916|516850868|FG000|Overall Study|Never received study treatment|3|||
143356839|NCT00136916|516850869|FG001|Overall Study|Never received study treatment|5|||
143356840|NCT00136916|516850868|FG000|Overall Study|Death|1|||
143356841|NCT00136916|516850869|FG001|Overall Study|Death|3|||
143356842|NCT00136916|516850868|FG000|Overall Study|Adverse Event|27|||
143356843|NCT00136916|516850869|FG001|Overall Study|Adverse Event|8|||
143356844|NCT00136916|516850868|FG000|Overall Study|Laboratory abnormality|0|||
143356845|NCT00136916|516850869|FG001|Overall Study|Laboratory abnormality|1|||
143356846|NCT00136916|516850868|FG000|Overall Study|Lack of Efficacy|13|||
143356847|NCT00136916|516850869|FG001|Overall Study|Lack of Efficacy|3|||
143356848|NCT00136916|516850868|FG000|Overall Study|Lost to Follow-up|12|||
143356849|NCT00136916|516850869|FG001|Overall Study|Lost to Follow-up|14|||
143356850|NCT00136916|516850868|FG000|Overall Study|Withdrawal by Subject|44|||
143356851|NCT00136916|516850869|FG001|Overall Study|Withdrawal by Subject|46|||
143127308|NCT00972283|516011587|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
143127309|NCT00972283|516011588|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
143127310|NCT00972283|516011587|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
143127311|NCT00972283|516011588|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
143127312|NCT02453256|516011590|FG000|Double Blind Period|Death|1|||
143127313|NCT02453256|516011591|FG001|Double Blind Period|Death|1|||
143127314|NCT02453256|516011590|FG000|Double Blind Period|Adverse Event|3|||
143356852|NCT00136916|516850868|FG000|Overall Study|Other|22|||
143356853|NCT00136916|516850869|FG001|Overall Study|Other|24|||
143356854|NCT00136916|516850868|FG000|Overall Study|Discontinued in follow up period|3|||
143356855|NCT00136916|516850869|FG001|Overall Study|Discontinued in follow up period|0|||
143356856|NCT01513967|516850889|FG000|Overall Study|Pregnancy|0|||
143356857|NCT01513967|516850890|FG001|Overall Study|Pregnancy|0|||
143356858|NCT01513967|516850891|FG002|Overall Study|Pregnancy|0|||
143356859|NCT01513967|516850892|FG003|Overall Study|Pregnancy|0|||
143356860|NCT01513967|516850893|FG004|Overall Study|Pregnancy|0|||
143463890|NCT04677179|517244901|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
143127315|NCT02453256|516011591|FG001|Double Blind Period|Adverse Event|2|||
143127316|NCT02453256|516011590|FG000|Double Blind Period|Withdrawal by Subject|9|||
143127317|NCT02453256|516011591|FG001|Double Blind Period|Withdrawal by Subject|5|||
143127318|NCT02453256|516011590|FG000|Double Blind Period|Other|0|||
143127319|NCT02453256|516011591|FG001|Double Blind Period|Other|1|||
143127320|NCT02453256|516011590|FG000|Open Label Period|Adverse Event|1|||
143127321|NCT02453256|516011591|FG001|Open Label Period|Adverse Event|3|||
143127322|NCT02453256|516011590|FG000|Open Label Period|Death|0|||
143127323|NCT02453256|516011591|FG001|Open Label Period|Death|1|||
143127324|NCT02453256|516011590|FG000|Open Label Period|Lost to Follow-up|1|||
143127325|NCT02453256|516011591|FG001|Open Label Period|Lost to Follow-up|0|||
143127326|NCT02453256|516011590|FG000|Open Label Period|Other|0|||
143127327|NCT02453256|516011591|FG001|Open Label Period|Other|2|||
143127328|NCT02453256|516011590|FG000|Open Label Period|Withdrawal by Subject|5|||
143127329|NCT02453256|516011591|FG001|Open Label Period|Withdrawal by Subject|1|||
143127330|NCT00980655|516011592|FG000|Overall Study|Adverse Event|13|||
143127331|NCT00980655|516011593|FG001|Overall Study|Adverse Event|31|||
143127332|NCT00980655|516011592|FG000|Overall Study|Death|0|||
143127333|NCT00980655|516011593|FG001|Overall Study|Death|7|||
143127334|NCT00980655|516011592|FG000|Overall Study|Protocol Violation|2|||
143127335|NCT00980655|516011593|FG001|Overall Study|Protocol Violation|7|||
143127336|NCT00980655|516011592|FG000|Overall Study|Withdrawal by Subject|0|||
143127337|NCT00980655|516011593|FG001|Overall Study|Withdrawal by Subject|4|||
143127338|NCT00980655|516011592|FG000|Overall Study|Lost to Follow-up|0|||
143127339|NCT00980655|516011593|FG001|Overall Study|Lost to Follow-up|1|||
143127340|NCT00980655|516011592|FG000|Overall Study|Parent/legal guardian request|1|||
143127341|NCT00980655|516011593|FG001|Overall Study|Parent/legal guardian request|0|||
143127342|NCT00980655|516011592|FG000|Overall Study|Other|0|||
143127343|NCT00980655|516011593|FG001|Overall Study|Other|1|||
143127344|NCT00845676|516011599|FG000|Overall Study|Virologic breakthrough at week 20|1|||
143127345|NCT00845676|516011599|FG000|Overall Study|Adverse Event|1|||
143127346|NCT03373461|516011600|FG000|Part 2|Adverse Event|0|||
143127347|NCT03373461|516011601|FG001|Part 2|Adverse Event|1|||
143127348|NCT03373461|516011602|FG002|Part 2|Adverse Event|0|||
143127349|NCT03373461|516011603|FG003|Part 2|Adverse Event|0|||
143127350|NCT03373461|516011604|FG004|Part 2|Adverse Event|1|||
143127351|NCT00481767|516011605|FG000|Overall Study|Withdrawal by Subject|16|||
143127352|NCT00481767|516011606|FG001|Overall Study|Withdrawal by Subject|11|||
143127353|NCT00481767|516011605|FG000|Overall Study|Lost to Follow-up|16|||
143127354|NCT00481767|516011606|FG001|Overall Study|Lost to Follow-up|10|||
143127355|NCT00524173|516011607|FG000|Overall Study|Lost to Follow-up|0|||
143127356|NCT00524173|516011608|FG001|Overall Study|Lost to Follow-up|1|||
143127357|NCT00524173|516011607|FG000|Overall Study|Death|1|||
143127358|NCT00524173|516011608|FG001|Overall Study|Death|0|||
143127359|NCT00524173|516011607|FG000|Overall Study|Had not reached endpoint at study close|4|||
143127360|NCT00524173|516011608|FG001|Overall Study|Had not reached endpoint at study close|1|||
143127361|NCT01790516|516011609|FG000|Overall Study|Physician Decision|1|||
143127362|NCT01790516|516011610|FG001|Overall Study|Physician Decision|0|||
143463891|NCT04677179|517244902|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
143463892|NCT04677179|517244903|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
143463893|NCT04677179|517244894|FG000|Extension Treatment Period|Lack of Efficacy|0|||
143463894|NCT04677179|517244895|FG001|Extension Treatment Period|Lack of Efficacy|0|||
143463895|NCT04677179|517244896|FG002|Extension Treatment Period|Lack of Efficacy|0|||
143463896|NCT04677179|517244897|FG003|Extension Treatment Period|Lack of Efficacy|0|||
143463897|NCT04677179|517244898|FG004|Extension Treatment Period|Lack of Efficacy|0|||
143463898|NCT04677179|517244899|FG005|Extension Treatment Period|Lack of Efficacy|0|||
143463899|NCT04677179|517244900|FG006|Extension Treatment Period|Lack of Efficacy|6|||
143463900|NCT04677179|517244901|FG007|Extension Treatment Period|Lack of Efficacy|0|||
143463901|NCT04677179|517244902|FG008|Extension Treatment Period|Lack of Efficacy|0|||
143463902|NCT04677179|517244903|FG009|Extension Treatment Period|Lack of Efficacy|0|||
143463903|NCT04677179|517244894|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
143463904|NCT04677179|517244895|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
143127363|NCT03034135|516011611|FG000|Overall Study|Withdrawal by Subject|2|||
143127364|NCT01972464|516011614|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
143127365|NCT01972464|516011615|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
143463905|NCT04677179|517244896|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
143463906|NCT04677179|517244897|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
143127366|NCT01972464|516011614|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
143127367|NCT01972464|516011615|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
143127368|NCT01972464|516011614|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
143127369|NCT01972464|516011615|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
143127370|NCT01972464|516011614|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
143127371|NCT01972464|516011615|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
143127372|NCT02823470|516012777|FG000|Overall Study|Adverse Event|1|||
143127373|NCT02823470|516012778|FG001|Overall Study|Adverse Event|0|||
143127374|NCT02823470|516012777|FG000|Overall Study|Study terminated by sponsor|8|||
143127375|NCT02823470|516012778|FG001|Overall Study|Study terminated by sponsor|15|||
143127376|NCT02821416|516012781|FG000|Overall Study|Adverse Event|0|||
143127377|NCT02821416|516012782|FG001|Overall Study|Adverse Event|1|||
143127378|NCT02821416|516012781|FG000|Overall Study|Withdrawal by Subject|2|||
143127379|NCT02821416|516012782|FG001|Overall Study|Withdrawal by Subject|0|||
143127380|NCT02821416|516012781|FG000|Overall Study|Lost to Follow-up|1|||
143127381|NCT02821416|516012782|FG001|Overall Study|Lost to Follow-up|0|||
143127382|NCT02256917|516012783|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
143127383|NCT02256917|516012783|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
143127384|NCT02256917|516012783|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
143127385|NCT02256917|516012783|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
143127386|NCT02256917|516012783|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
143127387|NCT04152083|516012784|FG000|Overall Study|Lost to Follow-up|2|||
143127388|NCT04152083|516012785|FG001|Overall Study|Lost to Follow-up|1|||
143127389|NCT04152083|516012784|FG000|Overall Study|Adverse Event|1|||
143127390|NCT04152083|516012785|FG001|Overall Study|Adverse Event|0|||
143127391|NCT04152083|516012784|FG000|Overall Study|Randomized but not treated|3|||
143127392|NCT04152083|516012785|FG001|Overall Study|Randomized but not treated|2|||
143127393|NCT01135524|516012788|FG000|Overall Study|Withdrawal by Subject|14|||
143127394|NCT01135524|516012788|FG000|Overall Study|Adverse Event|20|||
143127395|NCT01135524|516012788|FG000|Overall Study|Lost to Follow-up|3|||
143127396|NCT01135524|516012788|FG000|Overall Study|Administrative|151|||
143127397|NCT01135524|516012788|FG000|Overall Study|Lack of Efficacy|8|||
143127398|NCT04819438|516012792|FG000|Overall Study|Withdrawal by Subject|1|||
143127399|NCT04819438|516012793|FG001|Overall Study|Withdrawal by Subject|0|||
143127400|NCT04819438|516012792|FG000|Overall Study|Adverse Event|0|||
143127401|NCT04819438|516012793|FG001|Overall Study|Adverse Event|1|||
143127402|NCT04819438|516012792|FG000|Overall Study|Protocol Violation|0|||
143127403|NCT04819438|516012793|FG001|Overall Study|Protocol Violation|1|||
143127404|NCT02869893|516012794|FG000|Overall Study|participant aversion to IV|5|||
143127405|NCT02869893|516012794|FG000|Overall Study|participant fear of MRI scanner|2|||
143127406|NCT02328937|516012795|FG000|Period 1|Lost to Follow-up|0|||
143463907|NCT04677179|517244898|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
143463908|NCT04677179|517244899|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
143463909|NCT04677179|517244900|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
143463910|NCT04677179|517244901|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
143463911|NCT04677179|517244902|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
143463912|NCT04677179|517244903|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
143463913|NCT04677179|517244894|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
143463914|NCT04677179|517244895|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
143463915|NCT04677179|517244896|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
143463916|NCT04677179|517244897|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
143463917|NCT04677179|517244898|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
143463918|NCT04677179|517244899|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
143463919|NCT04677179|517244900|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
143463920|NCT04677179|517244901|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
143463921|NCT04677179|517244902|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
143013556|NCT01915498|515588120|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
143013557|NCT01915498|515588121|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
143013558|NCT01915498|515588122|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
143013559|NCT01915498|515588123|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
143013560|NCT01915498|515588124|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
143013561|NCT01915498|515588125|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
143013562|NCT01915498|515588126|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
143013563|NCT01915498|515588127|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
143013564|NCT01915498|515588128|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
143013565|NCT01915498|515588129|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
143013566|NCT01915498|515588130|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
143013567|NCT01915498|515588131|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
143013568|NCT01915498|515588113|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
143013569|NCT01915498|515588114|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
143013570|NCT01915498|515588115|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
143013571|NCT01915498|515588116|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
143127407|NCT02328937|516012796|FG001|Period 1|Lost to Follow-up|0|||
143127408|NCT02328937|516012797|FG002|Period 1|Lost to Follow-up|0|||
143127409|NCT02328937|516012798|FG003|Period 1|Lost to Follow-up|1|||
143127410|NCT02328937|516012799|FG004|Period 1|Lost to Follow-up|0|||
143463922|NCT04677179|517244903|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
143127411|NCT02328937|516012800|FG005|Period 1|Lost to Follow-up|0|||
143127412|NCT02328937|516012795|FG000|Period 2|Adverse Event|0|||
143127413|NCT02328937|516012796|FG001|Period 2|Adverse Event|0|||
143127414|NCT02328937|516012797|FG002|Period 2|Adverse Event|1|||
143127415|NCT02328937|516012798|FG003|Period 2|Adverse Event|0|||
143127416|NCT02328937|516012799|FG004|Period 2|Adverse Event|0|||
143127417|NCT02328937|516012800|FG005|Period 2|Adverse Event|0|||
143127418|NCT03665077|516012803|FG000|Overall Study|Lost to Follow-up|2|||
143127419|NCT03665077|516012803|FG000|Overall Study|Physician Decision|2|||
143127420|NCT00837967|516012806|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
143127421|NCT00837967|516012807|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
143127422|NCT02609984|516012815|FG000|Overall Study|Death|29|||
143127423|NCT02609984|516012816|FG001|Overall Study|Death|26|||
143127424|NCT02609984|516012815|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
143127425|NCT02609984|516012816|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
143127426|NCT02609984|516012815|FG000|Overall Study|Lost to Follow-up|1|||
143127427|NCT02609984|516012816|FG001|Overall Study|Lost to Follow-up|2|||
143356861|NCT01513967|516850894|FG005|Overall Study|Pregnancy|0|||
143356862|NCT01513967|516850895|FG006|Overall Study|Pregnancy|1|||
143356863|NCT01513967|516850896|FG007|Overall Study|Pregnancy|0|||
143356864|NCT01513967|516850889|FG000|Overall Study|missed a study visit|0|||
143356865|NCT01513967|516850890|FG001|Overall Study|missed a study visit|0|||
143356866|NCT01513967|516850891|FG002|Overall Study|missed a study visit|0|||
143356867|NCT01513967|516850892|FG003|Overall Study|missed a study visit|0|||
143356868|NCT01513967|516850893|FG004|Overall Study|missed a study visit|0|||
143356869|NCT01513967|516850894|FG005|Overall Study|missed a study visit|0|||
143356870|NCT01513967|516850895|FG006|Overall Study|missed a study visit|1|||
143356871|NCT01513967|516850896|FG007|Overall Study|missed a study visit|0|||
143356872|NCT01513967|516850889|FG000|Overall Study|excluded due to positive drug screen|0|||
143356873|NCT01513967|516850890|FG001|Overall Study|excluded due to positive drug screen|0|||
143356874|NCT01513967|516850891|FG002|Overall Study|excluded due to positive drug screen|0|||
143356875|NCT01513967|516850892|FG003|Overall Study|excluded due to positive drug screen|0|||
143356876|NCT01513967|516850893|FG004|Overall Study|excluded due to positive drug screen|0|||
143356877|NCT01513967|516850894|FG005|Overall Study|excluded due to positive drug screen|0|||
143356878|NCT01513967|516850895|FG006|Overall Study|excluded due to positive drug screen|0|||
143356879|NCT01513967|516850896|FG007|Overall Study|excluded due to positive drug screen|2|||
143356880|NCT01513967|516850889|FG000|Overall Study|Physician Decision|0|||
143356881|NCT01513967|516850890|FG001|Overall Study|Physician Decision|0|||
143356882|NCT01513967|516850891|FG002|Overall Study|Physician Decision|0|||
143356883|NCT01513967|516850892|FG003|Overall Study|Physician Decision|0|||
143356884|NCT01513967|516850893|FG004|Overall Study|Physician Decision|0|||
143356885|NCT01513967|516850894|FG005|Overall Study|Physician Decision|1|||
143356886|NCT01513967|516850895|FG006|Overall Study|Physician Decision|0|||
143356887|NCT01513967|516850896|FG007|Overall Study|Physician Decision|0|||
143356888|NCT02906202|516850897|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
143356889|NCT01987830|516850898|FG000|Overall Study|Never received baseline scan|1|||
143356890|NCT00057811|516850904|FG000|Overall Study|Lack of Efficacy|1|||
143356891|NCT00057811|516850905|FG001|Overall Study|Lack of Efficacy|4|||
143356892|NCT00057811|516850904|FG000|Overall Study|Physician Decision|1|||
143356893|NCT00057811|516850905|FG001|Overall Study|Physician Decision|0|||
143356894|NCT00057811|516850904|FG000|Overall Study|Withdrawal by Subject|3|||
143463923|NCT04677179|517244894|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
143463924|NCT04677179|517244895|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
143463925|NCT04677179|517244896|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
143463926|NCT04677179|517244897|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
143463927|NCT04677179|517244898|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
143463928|NCT04677179|517244899|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
143463929|NCT04677179|517244900|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
143463930|NCT04677179|517244901|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
143463931|NCT04677179|517244902|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
143463932|NCT04677179|517244903|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
143463933|NCT04677179|517244894|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
143463934|NCT04677179|517244895|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
143463935|NCT04677179|517244896|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
143463936|NCT04677179|517244897|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
143127428|NCT02609984|516012815|FG000|Overall Study|Withdrawal by Subject|0|||
143127429|NCT02609984|516012816|FG001|Overall Study|Withdrawal by Subject|1|||
143463937|NCT04677179|517244898|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
143127430|NCT02609984|516012815|FG000|Overall Study|Disease Progression|2|||
143127431|NCT02609984|516012816|FG001|Overall Study|Disease Progression|0|||
143127432|NCT02306850|516012817|FG000|Overall Study|Lack of Efficacy|2|||
143356895|NCT00057811|516850905|FG001|Overall Study|Withdrawal by Subject|4|||
143356896|NCT00057811|516850904|FG000|Overall Study|Ineligible|4|||
143356897|NCT00057811|516850905|FG001|Overall Study|Ineligible|2|||
143356898|NCT00057811|516850904|FG000|Overall Study|Inevaluable|1|||
143356899|NCT00057811|516850905|FG001|Overall Study|Inevaluable|2|||
143356900|NCT00556374|516850906|FG000|Overall Study|Withdrawal by Subject|235|||
143013572|NCT01915498|515588117|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
143013573|NCT01915498|515588118|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
143013574|NCT01915498|515588119|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
143013575|NCT01915498|515588120|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
143013576|NCT01915498|515588121|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
143013577|NCT01915498|515588122|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
143013578|NCT01915498|515588123|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
143013579|NCT01915498|515588124|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
143013580|NCT01915498|515588125|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
143013581|NCT01915498|515588126|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
143013582|NCT01915498|515588127|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
143013583|NCT01915498|515588128|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
143013584|NCT01915498|515588129|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
143013585|NCT01915498|515588130|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
143013586|NCT01915498|515588131|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
143013587|NCT00265239|515589965|FG000|Overall Study|Adverse Event|2|||
143013588|NCT00265239|515589966|FG001|Overall Study|Adverse Event|1|||
143013589|NCT02428231|515589967|FG000|Overall Study|Other|10|||
143013590|NCT02428231|515589968|FG001|Overall Study|Other|16|||
143013591|NCT02428231|515589967|FG000|Overall Study|Required Symptomatic Therapy|0|||
143013592|NCT02428231|515589968|FG001|Overall Study|Required Symptomatic Therapy|1|||
143013593|NCT02428231|515589967|FG000|Overall Study|Adverse Event|3|||
143013594|NCT02428231|515589968|FG001|Overall Study|Adverse Event|0|||
143013595|NCT01784419|515589969|FG000|Overall Study|Adverse Event|3|||
143013596|NCT02253654|515589970|FG000|Overall Study|Withdrawal by Subject|12|||
143013597|NCT02253654|515589971|FG001|Overall Study|Withdrawal by Subject|4|||
143013598|NCT02253654|515589970|FG000|Overall Study|Decision by Sponsor|1|||
143013599|NCT02253654|515589971|FG001|Overall Study|Decision by Sponsor|1|||
143013600|NCT02253654|515589970|FG000|Overall Study|Lost to Follow-up|2|||
143013601|NCT02253654|515589971|FG001|Overall Study|Lost to Follow-up|5|||
143013602|NCT02253654|515589970|FG000|Overall Study|Death|4|||
143013603|NCT02253654|515589971|FG001|Overall Study|Death|7|||
143013604|NCT02253654|515589970|FG000|Overall Study|Did Not Receive Study Treatment|4|||
143013605|NCT02253654|515589971|FG001|Overall Study|Did Not Receive Study Treatment|1|||
143013606|NCT02576054|515589972|FG000|Overall Study|Withdrawal by Subject|1|||
143013607|NCT01586624|515589974|FG000|Overall Study|Adverse Event|3|||
143013608|NCT01586624|515589975|FG001|Overall Study|Adverse Event|0|||
143013609|NCT01586624|515589976|FG002|Overall Study|Adverse Event|2|||
143013610|NCT01586624|515589977|FG003|Overall Study|Adverse Event|1|||
143013611|NCT01586624|515589978|FG004|Overall Study|Adverse Event|3|||
143013612|NCT01586624|515589979|FG005|Overall Study|Adverse Event|3|||
143013613|NCT01586624|515589980|FG006|Overall Study|Adverse Event|2|||
143013614|NCT01586624|515589981|FG007|Overall Study|Adverse Event|3|||
143013615|NCT01586624|515589974|FG000|Overall Study|Physician Decision|0|||
143013616|NCT01586624|515589975|FG001|Overall Study|Physician Decision|1|||
143013617|NCT01586624|515589976|FG002|Overall Study|Physician Decision|1|||
143013618|NCT01586624|515589977|FG003|Overall Study|Physician Decision|0|||
143013619|NCT01586624|515589978|FG004|Overall Study|Physician Decision|2|||
143013620|NCT01586624|515589979|FG005|Overall Study|Physician Decision|0|||
143013621|NCT01586624|515589980|FG006|Overall Study|Physician Decision|1|||
143013622|NCT01586624|515589981|FG007|Overall Study|Physician Decision|1|||
143013623|NCT01586624|515589974|FG000|Overall Study|Withdrawal by Subject|0|||
143013624|NCT01586624|515589975|FG001|Overall Study|Withdrawal by Subject|0|||
143013625|NCT01586624|515589976|FG002|Overall Study|Withdrawal by Subject|0|||
143013626|NCT01586624|515589977|FG003|Overall Study|Withdrawal by Subject|1|||
143013627|NCT01586624|515589978|FG004|Overall Study|Withdrawal by Subject|0|||
143013628|NCT01586624|515589979|FG005|Overall Study|Withdrawal by Subject|0|||
143013629|NCT01586624|515589980|FG006|Overall Study|Withdrawal by Subject|0|||
143013630|NCT01586624|515589981|FG007|Overall Study|Withdrawal by Subject|0|||
143013631|NCT01586624|515589974|FG000|Overall Study|Evidence of disease progression|1|||
143013632|NCT01586624|515589975|FG001|Overall Study|Evidence of disease progression|3|||
143013633|NCT01586624|515589976|FG002|Overall Study|Evidence of disease progression|2|||
143013634|NCT01586624|515589977|FG003|Overall Study|Evidence of disease progression|5|||
143013635|NCT01586624|515589978|FG004|Overall Study|Evidence of disease progression|3|||
143013636|NCT01586624|515589979|FG005|Overall Study|Evidence of disease progression|5|||
143013637|NCT01586624|515589980|FG006|Overall Study|Evidence of disease progression|4|||
143013638|NCT01586624|515589981|FG007|Overall Study|Evidence of disease progression|6|||
143013639|NCT01586624|515589974|FG000|Overall Study|Screen failure (no treatment received)|0|||
143013640|NCT01586624|515589975|FG001|Overall Study|Screen failure (no treatment received)|0|||
143013641|NCT01586624|515589976|FG002|Overall Study|Screen failure (no treatment received)|0|||
143013642|NCT01586624|515589977|FG003|Overall Study|Screen failure (no treatment received)|0|||
143013643|NCT01586624|515589978|FG004|Overall Study|Screen failure (no treatment received)|0|||
143127433|NCT01210222|516012818|FG000|Overall Study|Ineligible|2|||
143013644|NCT01586624|515589979|FG005|Overall Study|Screen failure (no treatment received)|0|||
143013645|NCT01586624|515589980|FG006|Overall Study|Screen failure (no treatment received)|1|||
143013646|NCT01586624|515589981|FG007|Overall Study|Screen failure (no treatment received)|0|||
143013647|NCT03578276|515589982|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
143013648|NCT03578276|515589983|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
143013649|NCT03869684|515589988|FG000|Overall Study|Adverse Event|0|||
143013650|NCT03869684|515589989|FG001|Overall Study|Adverse Event|3|||
143013651|NCT03869684|515589990|FG002|Overall Study|Adverse Event|1|||
143013652|NCT03869684|515589988|FG000|Overall Study|Withdrawal by Subject|1|||
143013653|NCT03869684|515589989|FG001|Overall Study|Withdrawal by Subject|0|||
143013654|NCT03869684|515589990|FG002|Overall Study|Withdrawal by Subject|0|||
143356901|NCT00556374|516850907|FG001|Overall Study|Withdrawal by Subject|205|||
143356902|NCT00556374|516850906|FG000|Overall Study|Death|158|||
143356903|NCT00556374|516850907|FG001|Overall Study|Death|127|||
143356904|NCT00556374|516850906|FG000|Overall Study|Lost to Follow-up|24|||
143356905|NCT00556374|516850907|FG001|Overall Study|Lost to Follow-up|17|||
143356906|NCT00556374|516850906|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
143356907|NCT00556374|516850907|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
143356908|NCT04423393|516852883|FG000|Overall Study|Withdrawal by Subject|0|||
143356909|NCT04423393|516852884|FG001|Overall Study|Withdrawal by Subject|0|||
143356910|NCT04423393|516852885|FG002|Overall Study|Withdrawal by Subject|0|||
143356911|NCT04423393|516852886|FG003|Overall Study|Withdrawal by Subject|0|||
143356912|NCT04423393|516852887|FG004|Overall Study|Withdrawal by Subject|0|||
143356913|NCT04423393|516852888|FG005|Overall Study|Withdrawal by Subject|1|||
143356914|NCT04423393|516852889|FG006|Overall Study|Withdrawal by Subject|0|||
143356915|NCT04423393|516852890|FG007|Overall Study|Withdrawal by Subject|0|||
143356916|NCT04423393|516852891|FG008|Overall Study|Withdrawal by Subject|0|||
143356917|NCT04423393|516852892|FG009|Overall Study|Withdrawal by Subject|0|||
143356918|NCT04423393|516852893|FG010|Overall Study|Withdrawal by Subject|0|||
143356919|NCT04423393|516852894|FG011|Overall Study|Withdrawal by Subject|0|||
143356920|NCT04423393|516852895|FG012|Overall Study|Withdrawal by Subject|0|||
143356921|NCT04423393|516852896|FG013|Overall Study|Withdrawal by Subject|1|||
143356922|NCT04423393|516852897|FG014|Overall Study|Withdrawal by Subject|0|||
143356923|NCT04423393|516852898|FG015|Overall Study|Withdrawal by Subject|0|||
143356924|NCT04423393|516852899|FG016|Overall Study|Withdrawal by Subject|0|||
143356925|NCT04423393|516852900|FG017|Overall Study|Withdrawal by Subject|0|||
143356926|NCT04423393|516852883|FG000|Overall Study|Sponsor Decision|0|||
143356927|NCT04423393|516852884|FG001|Overall Study|Sponsor Decision|0|||
143356928|NCT04423393|516852885|FG002|Overall Study|Sponsor Decision|0|||
143356929|NCT04423393|516852886|FG003|Overall Study|Sponsor Decision|0|||
143356930|NCT04423393|516852887|FG004|Overall Study|Sponsor Decision|0|||
143356931|NCT04423393|516852888|FG005|Overall Study|Sponsor Decision|0|||
143356932|NCT04423393|516852889|FG006|Overall Study|Sponsor Decision|0|||
143356933|NCT04423393|516852890|FG007|Overall Study|Sponsor Decision|0|||
143356934|NCT04423393|516852891|FG008|Overall Study|Sponsor Decision|0|||
143356935|NCT04423393|516852892|FG009|Overall Study|Sponsor Decision|0|||
143356936|NCT04423393|516852893|FG010|Overall Study|Sponsor Decision|0|||
143356937|NCT04423393|516852894|FG011|Overall Study|Sponsor Decision|0|||
143356938|NCT04423393|516852895|FG012|Overall Study|Sponsor Decision|0|||
143356939|NCT04423393|516852896|FG013|Overall Study|Sponsor Decision|1|||
143356940|NCT04423393|516852897|FG014|Overall Study|Sponsor Decision|0|||
143356941|NCT04423393|516852898|FG015|Overall Study|Sponsor Decision|0|||
143356942|NCT04423393|516852899|FG016|Overall Study|Sponsor Decision|0|||
143356943|NCT04423393|516852900|FG017|Overall Study|Sponsor Decision|0|||
143356944|NCT02692235|516852901|FG000|Overall Study|Withdrawal by Subject|2|||
143356945|NCT02692235|516852902|FG001|Overall Study|Withdrawal by Subject|1|||
143356946|NCT02692235|516852901|FG000|Overall Study|Adverse Event|1|||
143356947|NCT02692235|516852902|FG001|Overall Study|Adverse Event|2|||
143356948|NCT02711995|516852904|FG000|Washout (90 Days)|Conflicting medication|1|||
143356949|NCT01929993|516852908|FG000|Overall Study|Protocol Violation|4|||
143356950|NCT01929993|516852909|FG001|Overall Study|Protocol Violation|6|||
143356951|NCT01929993|516852908|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
143356952|NCT01929993|516852909|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
143356953|NCT01852162|516852910|FG000|Overall Study|Adverse Event|1|||
143356954|NCT01852162|516852911|FG001|Overall Study|Adverse Event|0|||
143356955|NCT01852162|516852910|FG000|Overall Study|Withdrawal by Subject|3|||
143356956|NCT01852162|516852911|FG001|Overall Study|Withdrawal by Subject|1|||
143356957|NCT00107380|516852912|FG000|Overall Study|Adverse Event|7|||
143356958|NCT00107380|516852912|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
143356959|NCT00107380|516852912|FG000|Overall Study|Progression/relapse|4|||
143356960|NCT00107380|516852912|FG000|Overall Study|Death|3|||
143356961|NCT00107380|516852912|FG000|Overall Study|Other - not protocol specified|7|||
143356962|NCT00107380|516852912|FG000|Overall Study|Ineligible|2|||
143356963|NCT03673098|516852913|FG000|Overall Study|Lost to Follow-up|2|||
143356964|NCT03673098|516852914|FG001|Overall Study|Lost to Follow-up|3|||
143356965|NCT03673098|516852913|FG000|Overall Study|Withdrawal by Subject|6|||
143127434|NCT01210222|516012818|FG000|Overall Study|Never treated|1|||
143127435|NCT01737879|516012819|FG000|Overall Study|Death|1|||
143127436|NCT01737879|516012819|FG000|Overall Study|Sponsor decision|40|||
143127437|NCT00941304|516012820|FG000|Overall Study|Lost to Follow-up|1|||
143127438|NCT00941304|516012821|FG001|Overall Study|Lost to Follow-up|0|||
143127439|NCT00941304|516012822|FG002|Overall Study|Lost to Follow-up|0|||
143127440|NCT00941304|516012823|FG003|Overall Study|Lost to Follow-up|0|||
143127441|NCT00941304|516012824|FG004|Overall Study|Lost to Follow-up|0|||
143127442|NCT04978337|516012825|FG000|Overall Study|Withdrawal by Subject|0|||
143127443|NCT04978337|516012826|FG001|Overall Study|Withdrawal by Subject|1|||
143127444|NCT04865419|516012827|FG000|Overall Study|Other|1|||
143127445|NCT04865419|516012828|FG001|Overall Study|Other|2|||
143127446|NCT04865419|516012829|FG002|Overall Study|Other|2|||
143127447|NCT04865419|516012830|FG003|Overall Study|Other|1|||
143127448|NCT04865419|516012831|FG004|Overall Study|Other|3|||
143127449|NCT04865419|516012832|FG005|Overall Study|Other|0|||
143127450|NCT04865419|516012833|FG006|Overall Study|Other|0|||
143356966|NCT03673098|516852914|FG001|Overall Study|Withdrawal by Subject|1|||
143356967|NCT03673098|516852913|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
143356968|NCT03673098|516852914|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
143356969|NCT00163215|516852917|FG000|Overall Study|Lack of Efficacy|3|||
143356970|NCT00163215|516852917|FG000|Overall Study|Withdrawal by Subject|5|||
143356971|NCT00163215|516852917|FG000|Overall Study|Other|7|||
143356972|NCT01115998|516852918|FG000|Overall Study|Lost to Follow-up|6|||
143356973|NCT01115998|516852919|FG001|Overall Study|Lost to Follow-up|6|||
143356974|NCT01268059|516852920|FG000|Overall Study|Lost to Follow-up|0|||
143356975|NCT01268059|516852921|FG001|Overall Study|Lost to Follow-up|1|||
143356976|NCT01268059|516852922|FG002|Overall Study|Lost to Follow-up|0|||
143356977|NCT01268059|516852923|FG003|Overall Study|Lost to Follow-up|0|||
143356978|NCT01268059|516852920|FG000|Overall Study|Withdrawal by Subject|7|||
143356979|NCT01268059|516852921|FG001|Overall Study|Withdrawal by Subject|4|||
143356980|NCT01268059|516852922|FG002|Overall Study|Withdrawal by Subject|0|||
143356981|NCT01268059|516852923|FG003|Overall Study|Withdrawal by Subject|0|||
143356982|NCT01268059|516852920|FG000|Overall Study|Death|20|||
143356983|NCT01268059|516852921|FG001|Overall Study|Death|30|||
143356984|NCT01268059|516852922|FG002|Overall Study|Death|3|||
143356985|NCT01268059|516852923|FG003|Overall Study|Death|5|||
143356986|NCT01268059|516852920|FG000|Overall Study|Progression of disease|1|||
143356987|NCT01268059|516852921|FG001|Overall Study|Progression of disease|0|||
143356988|NCT01268059|516852922|FG002|Overall Study|Progression of disease|0|||
143356989|NCT01268059|516852923|FG003|Overall Study|Progression of disease|0|||
143356990|NCT03660943|516852924|FG000|Overall Study|Adverse Event|5|||
143356991|NCT03660943|516852925|FG001|Overall Study|Adverse Event|3|||
143356992|NCT03660943|516852924|FG000|Overall Study|Death|0|||
143356993|NCT03660943|516852925|FG001|Overall Study|Death|2|||
143356994|NCT03660943|516852924|FG000|Overall Study|Lost to Follow-up|7|||
143356995|NCT03660943|516852925|FG001|Overall Study|Lost to Follow-up|3|||
143356996|NCT03660943|516852924|FG000|Overall Study|Protocol Violation|3|||
143356997|NCT03660943|516852925|FG001|Overall Study|Protocol Violation|5|||
143356998|NCT03660943|516852924|FG000|Overall Study|Withdrawal by Subject|8|||
143356999|NCT03660943|516852925|FG001|Overall Study|Withdrawal by Subject|15|||
143357000|NCT03660943|516852924|FG000|Overall Study|Lack of Efficacy|9|||
143357001|NCT03660943|516852925|FG001|Overall Study|Lack of Efficacy|12|||
143357002|NCT03660943|516852924|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
143463938|NCT04677179|517244899|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
143127451|NCT04865419|516012834|FG007|Overall Study|Other|1|||
143127452|NCT04865419|516012835|FG008|Overall Study|Other|0|||
143127453|NCT04865419|516012836|FG009|Overall Study|Other|0|||
143127454|NCT04865419|516012837|FG010|Overall Study|Other|0|||
143127455|NCT04865419|516012827|FG000|Overall Study|Withdrawal by Subject|0|||
143127456|NCT04865419|516012828|FG001|Overall Study|Withdrawal by Subject|1|||
143357003|NCT03660943|516852925|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
143357004|NCT03850444|516852926|FG000|Overall Study|Adverse Event|16|||
143357005|NCT03850444|516852927|FG001|Overall Study|Adverse Event|10|||
143357006|NCT03850444|516852926|FG000|Overall Study|Death|87|||
143357007|NCT03850444|516852927|FG001|Overall Study|Death|107|||
143357008|NCT03850444|516852926|FG000|Overall Study|Lost to Follow-up|1|||
143357009|NCT03850444|516852927|FG001|Overall Study|Lost to Follow-up|1|||
143357010|NCT03850444|516852926|FG000|Overall Study|Withdrawal by Subject|1|||
143357011|NCT03850444|516852927|FG001|Overall Study|Withdrawal by Subject|5|||
143357012|NCT03850444|516852926|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
143357013|NCT03850444|516852927|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
143357014|NCT03531905|516852928|FG000|Overall Study|Withdrawal by Subject|3|||
143357015|NCT03531905|516852929|FG001|Overall Study|Withdrawal by Subject|3|||
143357016|NCT03531905|516852930|FG002|Overall Study|Withdrawal by Subject|2|||
143357017|NCT03531905|516852928|FG000|Overall Study|Lost to Follow-up|2|||
143357018|NCT03531905|516852929|FG001|Overall Study|Lost to Follow-up|2|||
143357019|NCT03531905|516852930|FG002|Overall Study|Lost to Follow-up|1|||
143463939|NCT04677179|517244900|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
143463940|NCT04677179|517244901|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
143463941|NCT04677179|517244902|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
143463942|NCT04677179|517244903|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
143463943|NCT04677179|517244894|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
143463944|NCT04677179|517244895|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
143463945|NCT04677179|517244896|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
143463946|NCT04677179|517244897|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
143463947|NCT04677179|517244898|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
143463948|NCT04677179|517244899|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
143463949|NCT04677179|517244900|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
143463950|NCT04677179|517244901|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
143463951|NCT04677179|517244902|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
143463952|NCT04677179|517244903|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
143463953|NCT04677179|517244894|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
143463954|NCT04677179|517244895|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
143463955|NCT04677179|517244896|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
143463956|NCT04677179|517244897|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
143463957|NCT04677179|517244898|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
143463958|NCT04677179|517244899|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
143463959|NCT04677179|517244900|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
143463960|NCT04677179|517244901|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
143463961|NCT04677179|517244902|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
143463962|NCT04677179|517244903|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
143463963|NCT04677179|517244894|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
143463964|NCT04677179|517244895|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
143463965|NCT04677179|517244896|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
143463966|NCT04677179|517244897|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
143463967|NCT04677179|517244898|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
143463968|NCT04677179|517244899|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
143463969|NCT04677179|517244900|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
143463970|NCT04677179|517244901|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
143463971|NCT04677179|517244902|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
143463972|NCT04677179|517244903|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
143463973|NCT00511901|517244908|FG000|Overall Study|Withdrawal by Subject|1|||
143463974|NCT00511901|517244909|FG001|Overall Study|Withdrawal by Subject|3|||
143463975|NCT04640077|517244913|FG000|Period 1|Withdrawal by Subject|4|||
143463976|NCT04640077|517244914|FG001|Period 1|Withdrawal by Subject|5|||
143463977|NCT04640077|517244915|FG002|Period 1|Withdrawal by Subject|0|||
143463978|NCT04640077|517244913|FG000|Period 1|Adverse Event|1|||
143463979|NCT04640077|517244914|FG001|Period 1|Adverse Event|1|||
143463980|NCT04640077|517244915|FG002|Period 1|Adverse Event|0|||
143463981|NCT04640077|517244913|FG000|Period 1|Screen Failure|2|||
143463982|NCT04640077|517244914|FG001|Period 1|Screen Failure|0|||
143463983|NCT04640077|517244915|FG002|Period 1|Screen Failure|0|||
143463984|NCT04640077|517244913|FG000|Period 2|Withdrawal by Subject|0|||
143463985|NCT04640077|517244914|FG001|Period 2|Withdrawal by Subject|0|||
143463986|NCT04640077|517244915|FG002|Period 2|Withdrawal by Subject|18|||
143463987|NCT04640077|517244913|FG000|Period 2|Adverse Event|0|||
143463988|NCT04640077|517244914|FG001|Period 2|Adverse Event|0|||
143463989|NCT04640077|517244915|FG002|Period 2|Adverse Event|6|||
143463990|NCT04640077|517244913|FG000|Period 2|Lost to Follow-up|0|||
143463991|NCT04640077|517244914|FG001|Period 2|Lost to Follow-up|0|||
143463992|NCT04640077|517244915|FG002|Period 2|Lost to Follow-up|2|||
143463993|NCT04640077|517244913|FG000|Period 2|Death|0|||
143463994|NCT04640077|517244914|FG001|Period 2|Death|0|||
143463995|NCT04640077|517244915|FG002|Period 2|Death|2|||
143463996|NCT04640077|517244913|FG000|Period 2|Progressive Disease|0|||
143463997|NCT04640077|517244914|FG001|Period 2|Progressive Disease|0|||
143463998|NCT04640077|517244915|FG002|Period 2|Progressive Disease|1|||
143463999|NCT04640077|517244913|FG000|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
143464000|NCT04640077|517244914|FG001|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
143464001|NCT04640077|517244915|FG002|Period 2|Withdrawal Due To Caregiver Circumstances|1|||
143464002|NCT01257425|517244916|FG000|Overall Study|Lack of Efficacy|3|||
143464003|NCT01257425|517244917|FG001|Overall Study|Lack of Efficacy|3|||
143464004|NCT01257425|517244916|FG000|Overall Study|Adverse Event|1|||
143464005|NCT01257425|517244917|FG001|Overall Study|Adverse Event|1|||
143464006|NCT01257425|517244916|FG000|Overall Study|Protocol Violation|1|||
143464007|NCT01257425|517244917|FG001|Overall Study|Protocol Violation|1|||
143464008|NCT01257425|517244916|FG000|Overall Study|Withdrawal by Subject|0|||
143464009|NCT01257425|517244917|FG001|Overall Study|Withdrawal by Subject|1|||
143464010|NCT01257425|517244916|FG000|Overall Study|Death|1|||
143464011|NCT01257425|517244917|FG001|Overall Study|Death|0|||
143464012|NCT00368992|517244922|FG000|Overall Study|Ineligible|5|||
143127457|NCT04865419|516012829|FG002|Overall Study|Withdrawal by Subject|1|||
143127458|NCT04865419|516012830|FG003|Overall Study|Withdrawal by Subject|0|||
143127459|NCT04865419|516012831|FG004|Overall Study|Withdrawal by Subject|0|||
143127460|NCT04865419|516012832|FG005|Overall Study|Withdrawal by Subject|0|||
143127461|NCT04865419|516012833|FG006|Overall Study|Withdrawal by Subject|0|||
143127462|NCT04865419|516012834|FG007|Overall Study|Withdrawal by Subject|1|||
143127463|NCT04865419|516012835|FG008|Overall Study|Withdrawal by Subject|2|||
143127464|NCT04865419|516012836|FG009|Overall Study|Withdrawal by Subject|1|||
143127465|NCT04865419|516012837|FG010|Overall Study|Withdrawal by Subject|0|||
143127466|NCT04865419|516012827|FG000|Overall Study|Study terminated by Sponsor|0|||
143127467|NCT04865419|516012828|FG001|Overall Study|Study terminated by Sponsor|0|||
143127468|NCT04865419|516012829|FG002|Overall Study|Study terminated by Sponsor|0|||
143127469|NCT04865419|516012830|FG003|Overall Study|Study terminated by Sponsor|2|||
143127470|NCT04865419|516012831|FG004|Overall Study|Study terminated by Sponsor|2|||
143127471|NCT04865419|516012832|FG005|Overall Study|Study terminated by Sponsor|0|||
143127472|NCT04865419|516012833|FG006|Overall Study|Study terminated by Sponsor|0|||
143127473|NCT04865419|516012834|FG007|Overall Study|Study terminated by Sponsor|0|||
143127474|NCT04865419|516012835|FG008|Overall Study|Study terminated by Sponsor|0|||
143127475|NCT04865419|516012836|FG009|Overall Study|Study terminated by Sponsor|0|||
143127476|NCT04865419|516012837|FG010|Overall Study|Study terminated by Sponsor|1|||
143127477|NCT04865419|516012827|FG000|Overall Study|Death|3|||
143127478|NCT04865419|516012828|FG001|Overall Study|Death|1|||
143127479|NCT04865419|516012829|FG002|Overall Study|Death|4|||
143127480|NCT04865419|516012830|FG003|Overall Study|Death|2|||
143127481|NCT04865419|516012831|FG004|Overall Study|Death|5|||
143127482|NCT04865419|516012832|FG005|Overall Study|Death|2|||
143127483|NCT04865419|516012833|FG006|Overall Study|Death|1|||
143127484|NCT04865419|516012834|FG007|Overall Study|Death|1|||
143127485|NCT04865419|516012835|FG008|Overall Study|Death|2|||
143127486|NCT04865419|516012836|FG009|Overall Study|Death|2|||
143357020|NCT03531905|516852928|FG000|Overall Study|Participant was out of town|1|||
143127487|NCT04865419|516012837|FG010|Overall Study|Death|1|||
143127488|NCT04865419|516012827|FG000|Overall Study|Lost to Follow-up|0|||
143127489|NCT04865419|516012828|FG001|Overall Study|Lost to Follow-up|0|||
143357021|NCT03531905|516852929|FG001|Overall Study|Participant was out of town|0|||
143357022|NCT03531905|516852930|FG002|Overall Study|Participant was out of town|0|||
143357023|NCT03531905|516852928|FG000|Overall Study|Could not speak with the participant|1|||
143357024|NCT03531905|516852929|FG001|Overall Study|Could not speak with the participant|0|||
143357025|NCT03531905|516852930|FG002|Overall Study|Could not speak with the participant|0|||
143357026|NCT01489020|516852931|FG000|Overall Study|Withdrawal by Subject|1|||
143357027|NCT01489020|516852932|FG001|Overall Study|Withdrawal by Subject|0|||
143357028|NCT01489020|516852933|FG002|Overall Study|Withdrawal by Subject|0|||
143357029|NCT01489020|516852934|FG003|Overall Study|Withdrawal by Subject|0|||
143357030|NCT01489020|516852935|FG004|Overall Study|Withdrawal by Subject|0|||
143357031|NCT01489020|516852936|FG005|Overall Study|Withdrawal by Subject|0|||
143357032|NCT01489020|516852931|FG000|Overall Study|Adverse Event|0|||
143357033|NCT01489020|516852932|FG001|Overall Study|Adverse Event|0|||
143357034|NCT01489020|516852933|FG002|Overall Study|Adverse Event|3|||
143357035|NCT01489020|516852934|FG003|Overall Study|Adverse Event|0|||
143357036|NCT01489020|516852935|FG004|Overall Study|Adverse Event|3|||
143357037|NCT01489020|516852936|FG005|Overall Study|Adverse Event|0|||
143357038|NCT01489020|516852931|FG000|Overall Study|Concomitant disease|0|||
143357039|NCT01489020|516852932|FG001|Overall Study|Concomitant disease|0|||
143357040|NCT01489020|516852933|FG002|Overall Study|Concomitant disease|0|||
143357041|NCT01489020|516852934|FG003|Overall Study|Concomitant disease|0|||
143357042|NCT01489020|516852935|FG004|Overall Study|Concomitant disease|3|||
143357043|NCT01489020|516852936|FG005|Overall Study|Concomitant disease|0|||
143357044|NCT01174550|516852937|FG000|Overall Study|Death|75|||
143357045|NCT01174550|516852938|FG001|Overall Study|Death|74|||
143357046|NCT01174550|516852937|FG000|Overall Study|Lost to Follow-up|652|||
143357047|NCT01174550|516852938|FG001|Overall Study|Lost to Follow-up|510|||
143357048|NCT01174550|516852937|FG000|Overall Study|Withdrawal by Subject|543|||
143127490|NCT04865419|516012829|FG002|Overall Study|Lost to Follow-up|0|||
143127491|NCT04865419|516012830|FG003|Overall Study|Lost to Follow-up|0|||
143127492|NCT04865419|516012831|FG004|Overall Study|Lost to Follow-up|0|||
143127493|NCT04865419|516012832|FG005|Overall Study|Lost to Follow-up|0|||
143127494|NCT04865419|516012833|FG006|Overall Study|Lost to Follow-up|0|||
143127495|NCT04865419|516012834|FG007|Overall Study|Lost to Follow-up|0|||
143127496|NCT04865419|516012835|FG008|Overall Study|Lost to Follow-up|0|||
143127497|NCT04865419|516012836|FG009|Overall Study|Lost to Follow-up|1|||
143127498|NCT04865419|516012837|FG010|Overall Study|Lost to Follow-up|0|||
143127499|NCT05446142|516012838|FG000|Period 2|Adverse Event|1|||
143357049|NCT01174550|516852938|FG001|Overall Study|Withdrawal by Subject|289|||
143357050|NCT02411591|516852939|FG000|Overall Study|Adverse Event|0|||
143357051|NCT02411591|516852940|FG001|Overall Study|Adverse Event|4|||
143357052|NCT02411591|516852941|FG002|Overall Study|Adverse Event|2|||
143357053|NCT02411591|516852939|FG000|Overall Study|Withdrawal by Subject|0|||
143357054|NCT02411591|516852940|FG001|Overall Study|Withdrawal by Subject|3|||
143357055|NCT02411591|516852941|FG002|Overall Study|Withdrawal by Subject|0|||
143357056|NCT02411591|516852939|FG000|Overall Study|Physician Decision|0|||
143357057|NCT02411591|516852940|FG001|Overall Study|Physician Decision|3|||
143357058|NCT02411591|516852941|FG002|Overall Study|Physician Decision|1|||
143357059|NCT02491892|516852942|FG000|Overall Study|Adverse Event|1|||
143357060|NCT02491892|516852943|FG001|Overall Study|Adverse Event|1|||
143357061|NCT02491892|516852942|FG000|Overall Study|Death|1|||
143357062|NCT02491892|516852943|FG001|Overall Study|Death|1|||
143357063|NCT02491892|516852942|FG000|Overall Study|Lack of Efficacy|37|||
143357064|NCT02491892|516852943|FG001|Overall Study|Lack of Efficacy|36|||
143357065|NCT02491892|516852942|FG000|Overall Study|Refused Treatment|1|||
143357066|NCT02491892|516852943|FG001|Overall Study|Refused Treatment|0|||
143357067|NCT02491892|516852942|FG000|Overall Study|Lost to Follow-up|1|||
143357068|NCT02491892|516852943|FG001|Overall Study|Lost to Follow-up|0|||
143357069|NCT04227340|516852944|FG000|Overall Study|Withdrawal by Subject|3|||
143357070|NCT01734850|516852945|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
143357071|NCT01734850|516852946|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
143357072|NCT01734850|516852947|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
143357073|NCT01734850|516852945|FG000|Overall Study|Not infused due to manufacturing failure|0|||
143357074|NCT01734850|516852946|FG001|Overall Study|Not infused due to manufacturing failure|0|||
143357075|NCT01734850|516852947|FG002|Overall Study|Not infused due to manufacturing failure|1|||
143357076|NCT00661258|516852949|FG000|Overall Study|Death|1|||
143357077|NCT00661258|516852950|FG001|Overall Study|Death|0|||
143357078|NCT00661258|516852949|FG000|Overall Study|caught by police and in detox center|2|||
143357079|NCT00661258|516852950|FG001|Overall Study|caught by police and in detox center|1|||
143357080|NCT00393094|516852951|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
143357081|NCT00393094|516852951|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
143357082|NCT04496167|516852952|FG000|Overall Study|Adverse Event|6|||
143357083|NCT04496167|516852953|FG001|Overall Study|Adverse Event|2|||
143357084|NCT04496167|516852952|FG000|Overall Study|Withdrawal by Subject|7|||
143357085|NCT04496167|516852953|FG001|Overall Study|Withdrawal by Subject|6|||
143357086|NCT04496167|516852952|FG000|Overall Study|Lost to Follow-up|3|||
143357087|NCT04496167|516852953|FG001|Overall Study|Lost to Follow-up|5|||
143357088|NCT04496167|516852952|FG000|Overall Study|Not Treated|1|||
143357089|NCT04496167|516852953|FG001|Overall Study|Not Treated|2|||
143357090|NCT04496167|516852952|FG000|Overall Study|Other Than Specified|1|||
143357091|NCT04496167|516852953|FG001|Overall Study|Other Than Specified|1|||
143357092|NCT00598481|516852956|FG000|Treatment|Physician Decision|1|||
143357093|NCT01628510|516852964|FG000|Overall Study|Withdrawal by Subject|0|||
143357094|NCT01628510|516852965|FG001|Overall Study|Withdrawal by Subject|4|||
143357095|NCT01628510|516852964|FG000|Overall Study|Death|3|||
143357096|NCT01628510|516852965|FG001|Overall Study|Death|1|||
143357097|NCT03100838|516852966|FG000|Overall Study|Adverse Event|1|||
143357098|NCT03100838|516852967|FG001|Overall Study|Adverse Event|0|||
143357099|NCT03100838|516852968|FG002|Overall Study|Adverse Event|0|||
143357100|NCT03100838|516852969|FG003|Overall Study|Adverse Event|0|||
143357101|NCT03100838|516852966|FG000|Overall Study|Physician Decision|1|||
143357102|NCT03100838|516852967|FG001|Overall Study|Physician Decision|1|||
143357103|NCT03100838|516852968|FG002|Overall Study|Physician Decision|1|||
143357104|NCT03100838|516852969|FG003|Overall Study|Physician Decision|1|||
143357105|NCT03100838|516852966|FG000|Overall Study|Pregnancy|0|||
143357106|NCT03100838|516852967|FG001|Overall Study|Pregnancy|1|||
143357107|NCT03100838|516852968|FG002|Overall Study|Pregnancy|0|||
143357108|NCT03100838|516852969|FG003|Overall Study|Pregnancy|0|||
143357109|NCT03100838|516852966|FG000|Overall Study|Lost to Follow-up|0|||
143357110|NCT03100838|516852967|FG001|Overall Study|Lost to Follow-up|0|||
143357111|NCT03100838|516852968|FG002|Overall Study|Lost to Follow-up|1|||
143357112|NCT03100838|516852969|FG003|Overall Study|Lost to Follow-up|0|||
143357113|NCT04707391|516852970|FG000|Overall Study|Adverse Event|5|||
143357114|NCT04707391|516852971|FG001|Overall Study|Adverse Event|8|||
143357115|NCT04707391|516852970|FG000|Overall Study|Lost to Follow-up|44|||
143357116|NCT04707391|516852971|FG001|Overall Study|Lost to Follow-up|31|||
143357117|NCT04707391|516852970|FG000|Overall Study|Protocol Violation|1|||
143357118|NCT04707391|516852971|FG001|Overall Study|Protocol Violation|5|||
143357119|NCT04707391|516852970|FG000|Overall Study|Withdrawal by Subject|27|||
143357120|NCT04707391|516852971|FG001|Overall Study|Withdrawal by Subject|25|||
143357121|NCT04707391|516852970|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
143357122|NCT04707391|516852971|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
143357123|NCT04707391|516852970|FG000|Overall Study|Other|0|||
143357124|NCT04707391|516852971|FG001|Overall Study|Other|2|||
143357125|NCT02040090|516852972|FG000|Overall Study|Adverse Event|2|||
143357126|NCT02040090|516852973|FG001|Overall Study|Adverse Event|0|||
143357127|NCT02040090|516852972|FG000|Overall Study|Physician Decision|1|||
143357128|NCT02040090|516852973|FG001|Overall Study|Physician Decision|0|||
143357129|NCT02040090|516852972|FG000|Overall Study|Withdrawal by Subject|0|||
143357130|NCT02040090|516852973|FG001|Overall Study|Withdrawal by Subject|1|||
143357131|NCT02040090|516852972|FG000|Overall Study|Lost to Follow-up|0|||
143357132|NCT02040090|516852973|FG001|Overall Study|Lost to Follow-up|1|||
143357133|NCT03259373|516852974|FG000|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|636|||
143464013|NCT00368992|517244922|FG000|Overall Study|Refused treatment|3|||
143464014|NCT00368992|517244922|FG000|Overall Study|Lack of Efficacy|63|||
143464015|NCT00368992|517244922|FG000|Overall Study|Adverse Event|26|||
143464016|NCT00368992|517244922|FG000|Overall Study|Death|4|||
143464017|NCT00368992|517244922|FG000|Overall Study|Other|9|||
143464018|NCT01013597|517244929|FG000|Overall Study|Withdrawal by Subject|1|||
143464019|NCT00427895|517244930|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
143464020|NCT00427895|517244931|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
143127500|NCT05446142|516012839|FG001|Period 2|Adverse Event|0|||
143127501|NCT05446142|516012840|FG002|Period 2|Adverse Event|0|||
143127502|NCT05446142|516012841|FG003|Period 2|Adverse Event|0|||
143127503|NCT05446142|516012842|FG004|Period 2|Adverse Event|0|||
143127504|NCT05446142|516012843|FG005|Period 2|Adverse Event|0|||
143464021|NCT00427895|517244932|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
143464022|NCT00427895|517244933|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
143464023|NCT00427895|517244934|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
143464024|NCT00427895|517244935|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
143464025|NCT00427895|517244936|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
143464026|NCT00427895|517244937|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
143464027|NCT00427895|517244930|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
143464028|NCT00427895|517244931|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
143464029|NCT00427895|517244932|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
143464030|NCT00427895|517244933|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
143464031|NCT00427895|517244934|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
143464032|NCT00427895|517244935|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
143464033|NCT00427895|517244936|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
143464034|NCT00427895|517244937|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
143464035|NCT00427895|517244930|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
143464036|NCT00427895|517244931|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
143464037|NCT00427895|517244932|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
143464038|NCT00427895|517244933|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
143464039|NCT00427895|517244934|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
143464040|NCT00427895|517244935|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
143464041|NCT00427895|517244936|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
143464042|NCT00427895|517244937|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
143464043|NCT00427895|517244930|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
143464044|NCT00427895|517244931|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
143464045|NCT00427895|517244932|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
143464046|NCT00427895|517244933|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
143464047|NCT00427895|517244934|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
143464048|NCT00427895|517244935|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
143464049|NCT00427895|517244936|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
143127505|NCT00547157|516012850|FG000|Overall Study|Other|1|||
143464050|NCT00427895|517244937|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
143464051|NCT00427895|517244930|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
143464052|NCT00427895|517244931|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
143464053|NCT00427895|517244932|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
143127506|NCT00547157|516012851|FG001|Overall Study|Other|0|||
143127507|NCT00547157|516012850|FG000|Overall Study|Death|38|||
143127508|NCT00547157|516012851|FG001|Overall Study|Death|18|||
143127509|NCT00547157|516012850|FG000|Overall Study|Withdrawal by Subject|3|||
143127510|NCT00547157|516012851|FG001|Overall Study|Withdrawal by Subject|1|||
143127511|NCT00547157|516012850|FG000|Overall Study|Administrative decision|3|||
143127512|NCT00547157|516012851|FG001|Overall Study|Administrative decision|2|||
143127513|NCT00547157|516012850|FG000|Overall Study|Lost to Follow-up|4|||
143127514|NCT00547157|516012851|FG001|Overall Study|Lost to Follow-up|2|||
143127515|NCT05415462|516012858|FG000|Overall Study|Death|18|||
143127516|NCT05415462|516012859|FG001|Overall Study|Death|10|||
143127517|NCT05415462|516012858|FG000|Overall Study|Lost to Follow-up|72|||
143127518|NCT05415462|516012859|FG001|Overall Study|Lost to Follow-up|64|||
143127519|NCT05415462|516012858|FG000|Overall Study|Physician Decision|5|||
143127520|NCT05415462|516012859|FG001|Overall Study|Physician Decision|5|||
143127521|NCT05415462|516012858|FG000|Overall Study|Protocol Deviation|1|||
143127522|NCT05415462|516012859|FG001|Overall Study|Protocol Deviation|0|||
143127523|NCT05415462|516012858|FG000|Overall Study|Withdrawal by Subject|129|||
143127524|NCT05415462|516012859|FG001|Overall Study|Withdrawal by Subject|101|||
143127525|NCT05415462|516012858|FG000|Overall Study|Other Than Specified|8|||
143127526|NCT05415462|516012859|FG001|Overall Study|Other Than Specified|8|||
143127527|NCT01087203|516012861|FG000|Overall Study|Lost to Follow-up|2|||
143464054|NCT00427895|517244933|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
143464055|NCT00427895|517244934|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
143464056|NCT00427895|517244935|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
143127528|NCT01087203|516012862|FG001|Overall Study|Lost to Follow-up|0|||
143127529|NCT01087203|516012861|FG000|Overall Study|Withdrawal by Subject|2|||
143464057|NCT00427895|517244936|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
143464058|NCT00427895|517244937|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
143464059|NCT00427895|517244930|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
143464060|NCT00427895|517244931|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
143464061|NCT00427895|517244932|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
143464062|NCT00427895|517244933|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
143464063|NCT00427895|517244934|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
143464064|NCT00427895|517244935|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
143464065|NCT00427895|517244936|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
143464066|NCT00427895|517244937|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
143464067|NCT00427895|517244930|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
143464068|NCT00427895|517244931|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
143464069|NCT00427895|517244932|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
143464070|NCT00427895|517244933|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
143464071|NCT00427895|517244934|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
143464072|NCT00427895|517244935|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
143464073|NCT00427895|517244936|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
143464074|NCT00427895|517244937|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
143464075|NCT00427895|517244930|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
143464076|NCT00427895|517244931|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
143464077|NCT00427895|517244932|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
143464078|NCT00427895|517244933|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
143464079|NCT00427895|517244934|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
143464080|NCT00427895|517244935|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
143464081|NCT00427895|517244936|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
143464082|NCT00427895|517244937|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
143464083|NCT00427895|517244930|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
143464084|NCT00427895|517244931|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
143464085|NCT00427895|517244932|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
143464086|NCT00427895|517244933|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
143464087|NCT00427895|517244934|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
143464088|NCT00427895|517244935|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
143464089|NCT00427895|517244936|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
143464090|NCT00427895|517244937|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
143464091|NCT00427895|517244930|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
143464092|NCT00427895|517244931|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
143464093|NCT00427895|517244932|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
143464094|NCT00427895|517244933|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
143464095|NCT00427895|517244934|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
143464096|NCT00427895|517244935|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
143464097|NCT00427895|517244936|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
143464098|NCT00427895|517244937|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
143464099|NCT00427895|517244930|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
143464100|NCT00427895|517244931|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
143464101|NCT00427895|517244932|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
143464102|NCT00427895|517244933|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
143464103|NCT00427895|517244934|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
143464104|NCT00427895|517244935|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
143464105|NCT00427895|517244936|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
143464106|NCT00427895|517244937|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
143464107|NCT00427895|517244930|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
143464108|NCT00427895|517244931|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
143464109|NCT00427895|517244932|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
143464110|NCT00427895|517244933|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
143464111|NCT00427895|517244934|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
143464112|NCT00427895|517244935|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
143464113|NCT00427895|517244936|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
143464114|NCT00427895|517244937|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
143464115|NCT00427895|517244930|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
143464116|NCT00427895|517244931|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
143464117|NCT00427895|517244932|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
143464118|NCT00427895|517244933|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
143464119|NCT00427895|517244934|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
143464120|NCT00427895|517244935|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
143464121|NCT00427895|517244936|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
143464122|NCT00427895|517244937|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
143464123|NCT00427895|517244930|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
143464124|NCT00427895|517244931|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
143013655|NCT03869684|515589988|FG000|Overall Study|Lost to Follow-up|1|||
143464125|NCT00427895|517244932|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
143464126|NCT00427895|517244933|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
143464127|NCT00427895|517244934|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
143464128|NCT00427895|517244935|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
143464129|NCT00427895|517244936|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
143464130|NCT00427895|517244937|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
143464131|NCT00427895|517244930|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
143464132|NCT00427895|517244931|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
143464133|NCT00427895|517244932|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
143464134|NCT00427895|517244933|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
143464135|NCT00427895|517244934|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
143464136|NCT00427895|517244935|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
143464137|NCT00427895|517244936|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
143464138|NCT00427895|517244937|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
143464139|NCT00427895|517244930|FG000|Vax 1/Year 1 Follow-up|Death|1|||
143464140|NCT00427895|517244931|FG001|Vax 1/Year 1 Follow-up|Death|0|||
143464141|NCT00427895|517244932|FG002|Vax 1/Year 1 Follow-up|Death|0|||
143464142|NCT00427895|517244933|FG003|Vax 1/Year 1 Follow-up|Death|0|||
143464143|NCT00427895|517244934|FG004|Vax 1/Year 1 Follow-up|Death|0|||
143464144|NCT00427895|517244935|FG005|Vax 1/Year 1 Follow-up|Death|0|||
143464145|NCT00427895|517244936|FG006|Vax 1/Year 1 Follow-up|Death|0|||
143464146|NCT00427895|517244937|FG007|Vax 1/Year 1 Follow-up|Death|0|||
143464147|NCT00427895|517244930|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
143464148|NCT00427895|517244931|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
143464149|NCT00427895|517244932|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
143464150|NCT00427895|517244933|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
143464151|NCT00427895|517244934|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
143464152|NCT00427895|517244935|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
143464153|NCT00427895|517244936|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
143464154|NCT00427895|517244937|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
143464155|NCT00427895|517244930|FG000|Vax 1/Year 1 Follow-up|Other|0|||
143464156|NCT00427895|517244931|FG001|Vax 1/Year 1 Follow-up|Other|0|||
143464157|NCT00427895|517244932|FG002|Vax 1/Year 1 Follow-up|Other|0|||
143464158|NCT00427895|517244933|FG003|Vax 1/Year 1 Follow-up|Other|2|||
143464159|NCT00427895|517244934|FG004|Vax 1/Year 1 Follow-up|Other|0|||
143464160|NCT00427895|517244935|FG005|Vax 1/Year 1 Follow-up|Other|0|||
143464161|NCT00427895|517244936|FG006|Vax 1/Year 1 Follow-up|Other|0|||
143464162|NCT00427895|517244937|FG007|Vax 1/Year 1 Follow-up|Other|0|||
143464163|NCT00427895|517244930|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
143464164|NCT00427895|517244931|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
143464165|NCT00427895|517244932|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
143464166|NCT00427895|517244933|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
143464167|NCT00427895|517244934|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
143464168|NCT00427895|517244935|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
143464169|NCT00427895|517244936|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
143464170|NCT00427895|517244937|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
143464171|NCT00585195|517244939|FG000|Overall Study|Adverse Event|0|||
143464172|NCT00585195|517244940|FG001|Overall Study|Adverse Event|0|||
143464173|NCT00585195|517244941|FG002|Overall Study|Adverse Event|0|||
143464174|NCT00585195|517244942|FG003|Overall Study|Adverse Event|0|||
143464175|NCT00585195|517244943|FG004|Overall Study|Adverse Event|2|||
143464176|NCT00585195|517244944|FG005|Overall Study|Adverse Event|1|||
143464177|NCT00585195|517244945|FG006|Overall Study|Adverse Event|0|||
143464178|NCT00585195|517244946|FG007|Overall Study|Adverse Event|1|||
143464179|NCT00585195|517244947|FG008|Overall Study|Adverse Event|0|||
143464180|NCT00585195|517244948|FG009|Overall Study|Adverse Event|0|||
143464181|NCT00585195|517244949|FG010|Overall Study|Adverse Event|3|||
143464182|NCT00585195|517244950|FG011|Overall Study|Adverse Event|0|||
143464183|NCT00585195|517244951|FG012|Overall Study|Adverse Event|8|||
143464184|NCT00585195|517244952|FG013|Overall Study|Adverse Event|6|||
143464185|NCT00585195|517244953|FG014|Overall Study|Adverse Event|4|||
143464186|NCT00585195|517244954|FG015|Overall Study|Adverse Event|1|||
143464187|NCT00585195|517244955|FG016|Overall Study|Adverse Event|14|||
143464188|NCT00585195|517244956|FG017|Overall Study|Adverse Event|9|||
143464189|NCT00585195|517244957|FG018|Overall Study|Adverse Event|2|||
143464190|NCT00585195|517244958|FG019|Overall Study|Adverse Event|3|||
143464191|NCT00585195|517244959|FG020|Overall Study|Adverse Event|1|||
143464192|NCT00585195|517244939|FG000|Overall Study|Progressive Disease|2|||
143464193|NCT00585195|517244940|FG001|Overall Study|Progressive Disease|2|||
143464194|NCT00585195|517244941|FG002|Overall Study|Progressive Disease|5|||
143464195|NCT00585195|517244942|FG003|Overall Study|Progressive Disease|4|||
143127530|NCT01087203|516012862|FG001|Overall Study|Withdrawal by Subject|6|||
143464196|NCT00585195|517244943|FG004|Overall Study|Progressive Disease|6|||
143464197|NCT00585195|517244944|FG005|Overall Study|Progressive Disease|4|||
143464198|NCT00585195|517244945|FG006|Overall Study|Progressive Disease|6|||
143464199|NCT00585195|517244946|FG007|Overall Study|Progressive Disease|3|||
143464200|NCT00585195|517244947|FG008|Overall Study|Progressive Disease|0|||
143464201|NCT00585195|517244948|FG009|Overall Study|Progressive Disease|5|||
143464202|NCT00585195|517244949|FG010|Overall Study|Progressive Disease|2|||
143464203|NCT00585195|517244950|FG011|Overall Study|Progressive Disease|25|||
143464204|NCT00585195|517244951|FG012|Overall Study|Progressive Disease|29|||
143464205|NCT00585195|517244952|FG013|Overall Study|Progressive Disease|26|||
143464206|NCT00585195|517244953|FG014|Overall Study|Progressive Disease|21|||
143464207|NCT00585195|517244954|FG015|Overall Study|Progressive Disease|12|||
143464208|NCT00585195|517244955|FG016|Overall Study|Progressive Disease|94|||
143464209|NCT00585195|517244956|FG017|Overall Study|Progressive Disease|42|||
143464210|NCT00585195|517244957|FG018|Overall Study|Progressive Disease|4|||
143464211|NCT00585195|517244958|FG019|Overall Study|Progressive Disease|9|||
143464212|NCT00585195|517244959|FG020|Overall Study|Progressive Disease|8|||
143464213|NCT00585195|517244939|FG000|Overall Study|Withdrawal by Subject|1|||
143464214|NCT00585195|517244940|FG001|Overall Study|Withdrawal by Subject|1|||
143464215|NCT00585195|517244941|FG002|Overall Study|Withdrawal by Subject|2|||
143464216|NCT00585195|517244942|FG003|Overall Study|Withdrawal by Subject|2|||
143464217|NCT00585195|517244943|FG004|Overall Study|Withdrawal by Subject|0|||
143464218|NCT00585195|517244944|FG005|Overall Study|Withdrawal by Subject|0|||
143464219|NCT00585195|517244945|FG006|Overall Study|Withdrawal by Subject|0|||
143464220|NCT00585195|517244946|FG007|Overall Study|Withdrawal by Subject|1|||
143464221|NCT00585195|517244947|FG008|Overall Study|Withdrawal by Subject|0|||
143464222|NCT00585195|517244948|FG009|Overall Study|Withdrawal by Subject|0|||
143464223|NCT00585195|517244949|FG010|Overall Study|Withdrawal by Subject|3|||
143464224|NCT00585195|517244950|FG011|Overall Study|Withdrawal by Subject|8|||
143464225|NCT00585195|517244951|FG012|Overall Study|Withdrawal by Subject|15|||
143013656|NCT03869684|515589989|FG001|Overall Study|Lost to Follow-up|0|||
143013657|NCT03869684|515589990|FG002|Overall Study|Lost to Follow-up|0|||
143013658|NCT03869684|515589988|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
143013659|NCT03869684|515589989|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
143013660|NCT03869684|515589990|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
143013661|NCT04056299|515589991|FG000|Overall Study|Sponsor discontinued study|3|||
143013662|NCT04056299|515589992|FG001|Overall Study|Sponsor discontinued study|3|||
143013663|NCT01227954|515589997|FG000|Overall Study|Protocol Violation|6|||
143013664|NCT01227954|515589997|FG000|Overall Study|No protocol treatment|7|||
143013665|NCT00078312|515590000|FG000|Overall Study|Adverse Event|43|||
143013666|NCT00078312|515590000|FG000|Overall Study|Lack of Efficacy|15|||
143013667|NCT00078312|515590000|FG000|Overall Study|Lost to Follow-up|41|||
143013668|NCT00078312|515590000|FG000|Overall Study|Physician Decision|9|||
143013669|NCT00078312|515590000|FG000|Overall Study|Protocol Violation|3|||
143013670|NCT00078312|515590000|FG000|Overall Study|Withdrawal by Subject|33|||
143013671|NCT00078312|515590000|FG000|Overall Study|Miscellaneous|33|||
143013672|NCT01296152|515590001|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
143013673|NCT04840901|515590002|FG000|Overall Study|Lost to Follow-up|3|||
143013674|NCT04840901|515590003|FG001|Overall Study|Lost to Follow-up|1|||
143013675|NCT04840901|515590002|FG000|Overall Study|Moved|1|||
143013676|NCT04840901|515590003|FG001|Overall Study|Moved|0|||
143013677|NCT04840901|515590002|FG000|Overall Study|Unable to comply with study schedule|0|||
143013678|NCT04840901|515590003|FG001|Overall Study|Unable to comply with study schedule|1|||
143013679|NCT04840901|515590002|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
143013680|NCT04840901|515590003|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
143013681|NCT01268683|515590004|FG000|Overall Study|Lost to Follow-up|1|||
143013682|NCT01268683|515590004|FG000|Overall Study|Death|1|||
143013683|NCT02216214|515590005|FG000|Overall Study|Randomized Never Received Study Drug|1|||
143013684|NCT02216214|515590006|FG001|Overall Study|Randomized Never Received Study Drug|0|||
143013685|NCT02216214|515590005|FG000|Overall Study|Adverse Event|10|||
143013686|NCT02216214|515590006|FG001|Overall Study|Adverse Event|8|||
143013687|NCT02216214|515590005|FG000|Overall Study|Lack of Efficacy|2|||
143013688|NCT02216214|515590006|FG001|Overall Study|Lack of Efficacy|2|||
143013689|NCT02216214|515590005|FG000|Overall Study|Lost to Follow-up|3|||
143013690|NCT02216214|515590006|FG001|Overall Study|Lost to Follow-up|2|||
143013691|NCT02216214|515590005|FG000|Overall Study|Protocol Violation|4|||
143013692|NCT02216214|515590006|FG001|Overall Study|Protocol Violation|2|||
143013693|NCT02216214|515590005|FG000|Overall Study|Withdrawal by Subject|22|||
143013694|NCT02216214|515590006|FG001|Overall Study|Withdrawal by Subject|20|||
143013695|NCT02216214|515590005|FG000|Overall Study|Study Terminated By Sponsor|0|||
143013696|NCT02216214|515590006|FG001|Overall Study|Study Terminated By Sponsor|1|||
143013697|NCT02216214|515590005|FG000|Overall Study|Miscellaneous|1|||
143013698|NCT02216214|515590006|FG001|Overall Study|Miscellaneous|1|||
143013699|NCT00103259|515590009|FG000|Overall Study|Death|3|||
143013700|NCT00103259|515590010|FG001|Overall Study|Death|2|||
143013701|NCT00103259|515590009|FG000|Overall Study|Withdrawal by Subject|2|||
143464226|NCT00585195|517244952|FG013|Overall Study|Withdrawal by Subject|0|||
143013702|NCT00103259|515590010|FG001|Overall Study|Withdrawal by Subject|3|||
143013703|NCT00103259|515590009|FG000|Overall Study|alternative therapy|1|||
143464227|NCT00585195|517244953|FG014|Overall Study|Withdrawal by Subject|3|||
143464228|NCT00585195|517244954|FG015|Overall Study|Withdrawal by Subject|0|||
143127531|NCT01087203|516012861|FG000|Overall Study|Lack of Efficacy|1|||
143127532|NCT01087203|516012862|FG001|Overall Study|Lack of Efficacy|2|||
143127533|NCT01087203|516012861|FG000|Overall Study|Study terminated by sponsor|27|||
143127534|NCT01087203|516012862|FG001|Overall Study|Study terminated by sponsor|27|||
143127535|NCT05095311|516012868|FG000|Overall Study|Lost to Follow-up|7|||
143127536|NCT05095311|516012869|FG001|Overall Study|Lost to Follow-up|0|||
143127537|NCT05095311|516012870|FG002|Overall Study|Lost to Follow-up|0|||
143127538|NCT02588664|516012873|FG000|Overall Study|Death|56|||
143127539|NCT02588664|516012874|FG001|Overall Study|Death|55|||
143127540|NCT02588664|516012873|FG000|Overall Study|Lost to Follow-up|1305|||
143127541|NCT02588664|516012874|FG001|Overall Study|Lost to Follow-up|990|||
143127542|NCT00396383|516012877|FG000|Overall Study|Death|2|||
143127543|NCT00396383|516012877|FG000|Overall Study|Lost to Follow-up|1|||
143127544|NCT01216332|516012878|FG000|Overall Study|Withdrawal by Subject|4|||
143127545|NCT01216332|516012879|FG001|Overall Study|Withdrawal by Subject|0|||
143127546|NCT01124292|516012880|FG000|Overall Study|Lost to Follow-up|2|||
143127547|NCT01124292|516012881|FG001|Overall Study|Lost to Follow-up|4|||
143127548|NCT01124292|516012882|FG002|Overall Study|Lost to Follow-up|3|||
143127549|NCT01124292|516012880|FG000|Overall Study|Physician Decision|0|||
143127550|NCT01124292|516012881|FG001|Overall Study|Physician Decision|3|||
143127551|NCT01124292|516012882|FG002|Overall Study|Physician Decision|2|||
143127552|NCT01124292|516012880|FG000|Overall Study|Withdrawal by Subject|0|||
143127553|NCT01124292|516012881|FG001|Overall Study|Withdrawal by Subject|6|||
143127554|NCT01124292|516012882|FG002|Overall Study|Withdrawal by Subject|2|||
143127555|NCT01124292|516012880|FG000|Overall Study|medical issue unrelated to the study|0|||
143127556|NCT01124292|516012881|FG001|Overall Study|medical issue unrelated to the study|0|||
143127557|NCT01124292|516012882|FG002|Overall Study|medical issue unrelated to the study|2|||
143127558|NCT01124292|516012880|FG000|Overall Study|piercing track closed|0|||
143127559|NCT01124292|516012881|FG001|Overall Study|piercing track closed|2|||
143127560|NCT01124292|516012882|FG002|Overall Study|piercing track closed|1|||
143127561|NCT01554163|516012885|FG000|Overall Study|Adverse Event|3|||
143127562|NCT01554163|516012886|FG001|Overall Study|Adverse Event|0|||
143127563|NCT01554163|516012885|FG000|Overall Study|Lack of Efficacy|1|||
143127564|NCT01554163|516012886|FG001|Overall Study|Lack of Efficacy|0|||
143127565|NCT01554163|516012885|FG000|Overall Study|Lost to Follow-up|1|||
143127566|NCT01554163|516012886|FG001|Overall Study|Lost to Follow-up|0|||
143127567|NCT01554163|516012885|FG000|Overall Study|Non-Compliance With Study Drug|1|||
143127568|NCT01554163|516012886|FG001|Overall Study|Non-Compliance With Study Drug|1|||
143127569|NCT01554163|516012885|FG000|Overall Study|Protocol Violation|0|||
143127570|NCT01554163|516012886|FG001|Overall Study|Protocol Violation|4|||
143127571|NCT01554163|516012885|FG000|Overall Study|Withdrawal by Subject|1|||
143127572|NCT01554163|516012886|FG001|Overall Study|Withdrawal by Subject|5|||
143127573|NCT01554163|516012885|FG000|Overall Study|Not Treated|1|||
143127574|NCT01554163|516012886|FG001|Overall Study|Not Treated|0|||
143127575|NCT02557516|516012888|FG000|Overall Study|Adverse Event|1|||
143127576|NCT02557516|516012889|FG001|Overall Study|Adverse Event|0|||
143357134|NCT03259373|516852975|FG001|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|118|||
143357135|NCT03259373|516852974|FG000|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|320|||
143357136|NCT03259373|516852975|FG001|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|344|||
143357137|NCT03259373|516852974|FG000|Overall Study|Unable to be identified in dataset used for analysis|43|||
143357138|NCT03259373|516852975|FG001|Overall Study|Unable to be identified in dataset used for analysis|49|||
143369022|NCT02001623|516894559|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
143369023|NCT02001623|516894560|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
143127577|NCT02557516|516012890|FG002|Overall Study|Adverse Event|2|||
143127578|NCT02557516|516012891|FG003|Overall Study|Adverse Event|1|||
143127579|NCT02557516|516012888|FG000|Overall Study|Disease progression|0|||
143127580|NCT02557516|516012889|FG001|Overall Study|Disease progression|2|||
143127581|NCT02557516|516012890|FG002|Overall Study|Disease progression|0|||
143127582|NCT02557516|516012891|FG003|Overall Study|Disease progression|0|||
143127583|NCT02557516|516012888|FG000|Overall Study|Physician Decision|0|||
143127584|NCT02557516|516012889|FG001|Overall Study|Physician Decision|2|||
143369024|NCT02001623|516894561|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
143369025|NCT02001623|516894562|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
143369026|NCT02001623|516894563|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
143369027|NCT02001623|516894564|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
143369028|NCT02001623|516894565|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
143369029|NCT02001623|516894566|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
143369030|NCT02001623|516894567|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
143369031|NCT02001623|516894568|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
143369032|NCT02001623|516894569|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
143369033|NCT02001623|516894570|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
143369034|NCT02001623|516894571|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
143369035|NCT02001623|516894572|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
143369036|NCT02001623|516894558|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
143357139|NCT03259373|516852974|FG000|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3446|||
143357140|NCT03259373|516852975|FG001|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3599|||
143357141|NCT03259373|516852974|FG000|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|32|||
143357142|NCT03259373|516852975|FG001|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|63|||
143357143|NCT03259373|516852974|FG000|Overall Study|On OAC treatment at follow up start (due to data lags)|4272|||
143357144|NCT03259373|516852975|FG001|Overall Study|On OAC treatment at follow up start (due to data lags)|4411|||
143357145|NCT02584855|516852978|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
143357146|NCT02584855|516852979|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
143357147|NCT02584855|516852980|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
143357148|NCT02584855|516852981|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
143357149|NCT02584855|516852982|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
143357150|NCT02584855|516852983|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
143357151|NCT02584855|516852978|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
143357152|NCT02584855|516852979|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
143357153|NCT02584855|516852980|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
143357154|NCT02584855|516852981|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
143357155|NCT02584855|516852982|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
143357156|NCT02584855|516852983|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
143357157|NCT02584855|516852978|FG000|Open-Label Treatment Period|Adverse Event|14|||
143357158|NCT02584855|516852979|FG001|Open-Label Treatment Period|Adverse Event|0|||
143357159|NCT02584855|516852980|FG002|Open-Label Treatment Period|Adverse Event|0|||
143357160|NCT02584855|516852981|FG003|Open-Label Treatment Period|Adverse Event|0|||
143357161|NCT02584855|516852982|FG004|Open-Label Treatment Period|Adverse Event|0|||
143357162|NCT02584855|516852983|FG005|Open-Label Treatment Period|Adverse Event|0|||
143357163|NCT02584855|516852978|FG000|Open-Label Treatment Period|Death|2|||
143357164|NCT02584855|516852979|FG001|Open-Label Treatment Period|Death|0|||
143357165|NCT02584855|516852980|FG002|Open-Label Treatment Period|Death|0|||
143357166|NCT02584855|516852981|FG003|Open-Label Treatment Period|Death|0|||
143357167|NCT02584855|516852982|FG004|Open-Label Treatment Period|Death|0|||
143357168|NCT02584855|516852983|FG005|Open-Label Treatment Period|Death|0|||
143357169|NCT02584855|516852978|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
143357170|NCT02584855|516852979|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
143357171|NCT02584855|516852980|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
143357172|NCT02584855|516852981|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
143357173|NCT02584855|516852982|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
143357174|NCT02584855|516852983|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
143357175|NCT02584855|516852978|FG000|Open-Label Treatment Period|Protocol Violation|1|||
143357176|NCT02584855|516852979|FG001|Open-Label Treatment Period|Protocol Violation|0|||
143357177|NCT02584855|516852980|FG002|Open-Label Treatment Period|Protocol Violation|0|||
143357178|NCT02584855|516852981|FG003|Open-Label Treatment Period|Protocol Violation|0|||
143357179|NCT02584855|516852982|FG004|Open-Label Treatment Period|Protocol Violation|0|||
143357180|NCT02584855|516852983|FG005|Open-Label Treatment Period|Protocol Violation|0|||
143357181|NCT02584855|516852978|FG000|Open-Label Treatment Period|No PI Available|2|||
143357182|NCT02584855|516852979|FG001|Open-Label Treatment Period|No PI Available|0|||
143357183|NCT02584855|516852980|FG002|Open-Label Treatment Period|No PI Available|0|||
143357184|NCT02584855|516852981|FG003|Open-Label Treatment Period|No PI Available|0|||
143357185|NCT02584855|516852982|FG004|Open-Label Treatment Period|No PI Available|0|||
143357186|NCT02584855|516852983|FG005|Open-Label Treatment Period|No PI Available|0|||
143357187|NCT02584855|516852978|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
143357188|NCT02584855|516852979|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
143357189|NCT02584855|516852980|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
143357190|NCT02584855|516852981|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
143357191|NCT02584855|516852982|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
143357192|NCT02584855|516852983|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
143357193|NCT02584855|516852978|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
143357194|NCT02584855|516852979|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
143357195|NCT02584855|516852980|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
143357196|NCT02584855|516852981|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
143357197|NCT02584855|516852982|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
143357198|NCT02584855|516852983|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
143357199|NCT02584855|516852978|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
143357200|NCT02584855|516852979|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
143357201|NCT02584855|516852980|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
143127585|NCT02557516|516012890|FG002|Overall Study|Physician Decision|0|||
143357202|NCT02584855|516852981|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
143357203|NCT02584855|516852982|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
143357204|NCT02584855|516852983|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
143357205|NCT02584855|516852978|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
143013704|NCT00103259|515590010|FG001|Overall Study|alternative therapy|0|||
143013705|NCT00103259|515590009|FG000|Overall Study|other (reasons were not specified)|2|||
143013706|NCT00103259|515590010|FG001|Overall Study|other (reasons were not specified)|1|||
143013707|NCT00103259|515590009|FG000|Overall Study|ineligible/no protocol therapy|4|||
143013708|NCT00103259|515590010|FG001|Overall Study|ineligible/no protocol therapy|6|||
143013709|NCT02610842|515590013|FG000|Overall Study|Lost to Follow-up|5|||
143127586|NCT02557516|516012891|FG003|Overall Study|Physician Decision|0|||
143357206|NCT02584855|516852979|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
143357207|NCT02584855|516852980|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
143357208|NCT02584855|516852981|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
143357209|NCT02584855|516852982|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
143357210|NCT02584855|516852983|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
143357211|NCT02584855|516852978|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
143357212|NCT02584855|516852979|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
143357213|NCT02584855|516852980|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
143357214|NCT02584855|516852981|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
143357215|NCT02584855|516852982|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
143357216|NCT02584855|516852983|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
143357217|NCT02584855|516852978|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
143357218|NCT02584855|516852979|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
143357219|NCT02584855|516852980|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
143357220|NCT02584855|516852981|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
143357221|NCT02584855|516852982|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
143357222|NCT02584855|516852983|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
143357223|NCT02584855|516852978|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
143357224|NCT02584855|516852979|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
143357225|NCT02584855|516852980|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
143357226|NCT02584855|516852981|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
143357227|NCT02584855|516852982|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
143357228|NCT02584855|516852983|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
143357229|NCT02337478|516852984|FG000|Overall Study|Lack of Efficacy|5|||
143357230|NCT00895843|516852985|FG000|Overall Study|Protocol Violation|12|||
143357231|NCT00895843|516852986|FG001|Overall Study|Protocol Violation|12|||
143357232|NCT04963062|516852990|FG000|Overall Study|withdrew by the study team|4|||
143357233|NCT04963062|516852991|FG001|Overall Study|withdrew by the study team|2|||
143357234|NCT00996580|516852992|FG000|Overall Study|Adverse Event|466|||
143357235|NCT00996580|516852992|FG000|Overall Study|Lost to Follow-up|480|||
143357236|NCT00996580|516852992|FG000|Overall Study|Noncompliance with the protocol|137|||
143357237|NCT00996580|516852992|FG000|Overall Study|Physician Decision|5|||
143357238|NCT00996580|516852992|FG000|Overall Study|Pregnancy|68|||
143357239|NCT00996580|516852992|FG000|Overall Study|Protocol Violation|16|||
143357240|NCT00996580|516852992|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
143357241|NCT00996580|516852992|FG000|Overall Study|Withdrawal by Subject|217|||
143357242|NCT00996580|516852992|FG000|Overall Study|Other|29|||
143357243|NCT00641186|516852993|FG000|Overall Study|Adverse Event|3|||
143357244|NCT03428815|516852996|FG000|Overall Study|Lost to Follow-up|2|||
143357245|NCT03428815|516852997|FG001|Overall Study|Lost to Follow-up|2|||
143357246|NCT03428815|516852996|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
143357247|NCT03428815|516852997|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
143357248|NCT03428815|516852996|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
143357249|NCT03428815|516852997|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
143357250|NCT05221749|516852998|FG000|Overall Study|Lost to Follow-up|2|||
143357251|NCT05221749|516852999|FG001|Overall Study|Lost to Follow-up|3|||
143357252|NCT02218489|516853000|FG000|Overall Study|Withdrawal by Subject|4|||
143357253|NCT02218489|516853001|FG001|Overall Study|Withdrawal by Subject|3|||
143357254|NCT02218489|516853000|FG000|Overall Study|Lost to Follow-up|1|||
143357255|NCT02218489|516853001|FG001|Overall Study|Lost to Follow-up|0|||
143357256|NCT02404493|516853002|FG000|Overall Study|Adverse Event|1|||
143357257|NCT02404493|516853003|FG001|Overall Study|Adverse Event|1|||
143357258|NCT01700348|516853004|FG000|Overall Study|Withdrawal by Subject|22|||
143357259|NCT01700348|516853004|FG000|Overall Study|Lost to Follow-up|1|||
143357260|NCT02388074|516853005|FG000|Overall Study|Lost in Transit|2|||
143357261|NCT02388074|516853005|FG000|Overall Study|Sample Not Returned|1|||
143357262|NCT03958630|516853012|FG000|Overall Study|Withdrawal by Subject|0|||
143357263|NCT03958630|516853013|FG001|Overall Study|Withdrawal by Subject|0|||
143357264|NCT03958630|516853014|FG002|Overall Study|Withdrawal by Subject|1|||
143357265|NCT03958630|516853012|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
143357266|NCT03958630|516853013|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
143357267|NCT03958630|516853014|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
143357268|NCT01254890|516853015|FG000|Overall Study|Ineligible|0|||
143357269|NCT01254890|516853016|FG001|Overall Study|Ineligible|3|||
143464229|NCT00585195|517244955|FG016|Overall Study|Withdrawal by Subject|7|||
143464230|NCT00585195|517244956|FG017|Overall Study|Withdrawal by Subject|1|||
143464231|NCT00585195|517244957|FG018|Overall Study|Withdrawal by Subject|2|||
143464232|NCT00585195|517244958|FG019|Overall Study|Withdrawal by Subject|2|||
143464233|NCT00585195|517244959|FG020|Overall Study|Withdrawal by Subject|0|||
143464234|NCT00585195|517244939|FG000|Overall Study|Other|0|||
143464235|NCT00585195|517244940|FG001|Overall Study|Other|1|||
143464236|NCT00585195|517244941|FG002|Overall Study|Other|1|||
143464237|NCT00585195|517244942|FG003|Overall Study|Other|1|||
143464238|NCT00585195|517244943|FG004|Overall Study|Other|0|||
143464239|NCT00585195|517244944|FG005|Overall Study|Other|1|||
143464240|NCT00585195|517244945|FG006|Overall Study|Other|0|||
143464241|NCT00585195|517244946|FG007|Overall Study|Other|0|||
143464242|NCT00585195|517244947|FG008|Overall Study|Other|2|||
143464243|NCT00585195|517244948|FG009|Overall Study|Other|1|||
143464244|NCT00585195|517244949|FG010|Overall Study|Other|0|||
143464245|NCT00585195|517244950|FG011|Overall Study|Other|19|||
143464246|NCT00585195|517244951|FG012|Overall Study|Other|24|||
143464247|NCT00585195|517244952|FG013|Overall Study|Other|7|||
143464248|NCT00585195|517244953|FG014|Overall Study|Other|11|||
143464249|NCT00585195|517244954|FG015|Overall Study|Other|3|||
143464250|NCT00585195|517244955|FG016|Overall Study|Other|28|||
143464251|NCT00585195|517244956|FG017|Overall Study|Other|12|||
143464252|NCT00585195|517244957|FG018|Overall Study|Other|10|||
143464253|NCT00585195|517244958|FG019|Overall Study|Other|4|||
143464254|NCT00585195|517244959|FG020|Overall Study|Other|2|||
143464255|NCT00585195|517244939|FG000|Overall Study|Randomized not treated|0|||
143464256|NCT00585195|517244940|FG001|Overall Study|Randomized not treated|0|||
143464257|NCT00585195|517244941|FG002|Overall Study|Randomized not treated|1|||
143464258|NCT00585195|517244942|FG003|Overall Study|Randomized not treated|0|||
143464259|NCT00585195|517244943|FG004|Overall Study|Randomized not treated|1|||
143464260|NCT00585195|517244944|FG005|Overall Study|Randomized not treated|0|||
143464261|NCT00585195|517244945|FG006|Overall Study|Randomized not treated|1|||
143464262|NCT00585195|517244946|FG007|Overall Study|Randomized not treated|0|||
143464263|NCT00585195|517244947|FG008|Overall Study|Randomized not treated|0|||
143464264|NCT00585195|517244948|FG009|Overall Study|Randomized not treated|0|||
143464265|NCT00585195|517244949|FG010|Overall Study|Randomized not treated|2|||
143464266|NCT00585195|517244950|FG011|Overall Study|Randomized not treated|0|||
143464267|NCT00585195|517244951|FG012|Overall Study|Randomized not treated|0|||
143464268|NCT00585195|517244952|FG013|Overall Study|Randomized not treated|0|||
143464269|NCT00585195|517244953|FG014|Overall Study|Randomized not treated|0|||
143464270|NCT00585195|517244954|FG015|Overall Study|Randomized not treated|1|||
143464271|NCT00585195|517244955|FG016|Overall Study|Randomized not treated|0|||
143464272|NCT00585195|517244956|FG017|Overall Study|Randomized not treated|1|||
143464273|NCT00585195|517244957|FG018|Overall Study|Randomized not treated|3|||
143464274|NCT00585195|517244958|FG019|Overall Study|Randomized not treated|0|||
143464275|NCT00585195|517244959|FG020|Overall Study|Randomized not treated|2|||
143464276|NCT00585195|517244939|FG000|Overall Study|Death|0|||
143464277|NCT00585195|517244940|FG001|Overall Study|Death|0|||
143464278|NCT00585195|517244941|FG002|Overall Study|Death|0|||
143464279|NCT00585195|517244942|FG003|Overall Study|Death|0|||
143464280|NCT00585195|517244943|FG004|Overall Study|Death|0|||
143464281|NCT00585195|517244944|FG005|Overall Study|Death|0|||
143464282|NCT00585195|517244945|FG006|Overall Study|Death|0|||
143464283|NCT00585195|517244946|FG007|Overall Study|Death|0|||
143464284|NCT00585195|517244947|FG008|Overall Study|Death|1|||
143464285|NCT00585195|517244948|FG009|Overall Study|Death|0|||
143464286|NCT00585195|517244949|FG010|Overall Study|Death|1|||
143464287|NCT00585195|517244950|FG011|Overall Study|Death|1|||
143464288|NCT00585195|517244951|FG012|Overall Study|Death|7|||
143464289|NCT00585195|517244952|FG013|Overall Study|Death|2|||
143464290|NCT00585195|517244953|FG014|Overall Study|Death|8|||
143464291|NCT00585195|517244954|FG015|Overall Study|Death|2|||
143464292|NCT00585195|517244955|FG016|Overall Study|Death|11|||
143464293|NCT00585195|517244956|FG017|Overall Study|Death|0|||
143464294|NCT00585195|517244957|FG018|Overall Study|Death|0|||
143464295|NCT00585195|517244958|FG019|Overall Study|Death|0|||
143464296|NCT00585195|517244959|FG020|Overall Study|Death|1|||
143464297|NCT00585195|517244939|FG000|Overall Study|Lost to Follow-up|0|||
143464298|NCT00585195|517244940|FG001|Overall Study|Lost to Follow-up|0|||
143464299|NCT00585195|517244941|FG002|Overall Study|Lost to Follow-up|0|||
143464300|NCT00585195|517244942|FG003|Overall Study|Lost to Follow-up|0|||
143464301|NCT00585195|517244943|FG004|Overall Study|Lost to Follow-up|0|||
143464302|NCT00585195|517244944|FG005|Overall Study|Lost to Follow-up|0|||
143464303|NCT00585195|517244945|FG006|Overall Study|Lost to Follow-up|0|||
143464304|NCT00585195|517244946|FG007|Overall Study|Lost to Follow-up|0|||
143464305|NCT00585195|517244947|FG008|Overall Study|Lost to Follow-up|0|||
143464306|NCT00585195|517244948|FG009|Overall Study|Lost to Follow-up|0|||
143127587|NCT02557516|516012888|FG000|Overall Study|Sponsor decision|0|||
143464307|NCT00585195|517244949|FG010|Overall Study|Lost to Follow-up|0|||
143464308|NCT00585195|517244950|FG011|Overall Study|Lost to Follow-up|0|||
143464309|NCT00585195|517244951|FG012|Overall Study|Lost to Follow-up|1|||
143464310|NCT00585195|517244952|FG013|Overall Study|Lost to Follow-up|0|||
143464311|NCT00585195|517244953|FG014|Overall Study|Lost to Follow-up|0|||
143464312|NCT00585195|517244954|FG015|Overall Study|Lost to Follow-up|0|||
143464313|NCT00585195|517244955|FG016|Overall Study|Lost to Follow-up|0|||
143464314|NCT00585195|517244956|FG017|Overall Study|Lost to Follow-up|2|||
143464315|NCT00585195|517244957|FG018|Overall Study|Lost to Follow-up|0|||
143464316|NCT00585195|517244958|FG019|Overall Study|Lost to Follow-up|0|||
143464317|NCT00585195|517244959|FG020|Overall Study|Lost to Follow-up|0|||
143464318|NCT00585195|517244939|FG000|Overall Study|Site Terminated by Sponsor|0|||
143464319|NCT00585195|517244940|FG001|Overall Study|Site Terminated by Sponsor|0|||
143464320|NCT00585195|517244941|FG002|Overall Study|Site Terminated by Sponsor|0|||
143464321|NCT00585195|517244942|FG003|Overall Study|Site Terminated by Sponsor|0|||
143464322|NCT00585195|517244943|FG004|Overall Study|Site Terminated by Sponsor|0|||
143464323|NCT00585195|517244944|FG005|Overall Study|Site Terminated by Sponsor|0|||
143464324|NCT00585195|517244945|FG006|Overall Study|Site Terminated by Sponsor|0|||
143464325|NCT00585195|517244946|FG007|Overall Study|Site Terminated by Sponsor|0|||
143464326|NCT00585195|517244947|FG008|Overall Study|Site Terminated by Sponsor|0|||
143464327|NCT00585195|517244948|FG009|Overall Study|Site Terminated by Sponsor|0|||
143464328|NCT00585195|517244949|FG010|Overall Study|Site Terminated by Sponsor|0|||
143127588|NCT02557516|516012889|FG001|Overall Study|Sponsor decision|1|||
143127589|NCT02557516|516012890|FG002|Overall Study|Sponsor decision|2|||
143127590|NCT02557516|516012891|FG003|Overall Study|Sponsor decision|8|||
143127591|NCT04530838|516014498|FG000|Overall Study|Other|2|||
143127592|NCT04530838|516014499|FG001|Overall Study|Other|1|||
143127593|NCT04530838|516014500|FG002|Overall Study|Other|0|||
143127594|NCT04530838|516014498|FG000|Overall Study|Physician Decision|0|||
143127595|NCT04530838|516014499|FG001|Overall Study|Physician Decision|0|||
143127596|NCT04530838|516014500|FG002|Overall Study|Physician Decision|1|||
143127597|NCT04530838|516014498|FG000|Overall Study|Death|0|||
143127598|NCT04530838|516014499|FG001|Overall Study|Death|0|||
143127599|NCT04530838|516014500|FG002|Overall Study|Death|1|||
143127600|NCT04530838|516014498|FG000|Overall Study|Adverse Event|0|||
143127601|NCT04530838|516014499|FG001|Overall Study|Adverse Event|1|||
143127602|NCT04530838|516014500|FG002|Overall Study|Adverse Event|0|||
143127603|NCT04530838|516014498|FG000|Overall Study|No longer meets eligibility criteria|1|||
143127604|NCT04530838|516014499|FG001|Overall Study|No longer meets eligibility criteria|0|||
143127605|NCT04530838|516014500|FG002|Overall Study|No longer meets eligibility criteria|2|||
143127606|NCT04530838|516014498|FG000|Overall Study|Withdrawal by parent/guardian|5|||
143127607|NCT04530838|516014499|FG001|Overall Study|Withdrawal by parent/guardian|2|||
143464329|NCT00585195|517244950|FG011|Overall Study|Site Terminated by Sponsor|0|||
143464330|NCT00585195|517244951|FG012|Overall Study|Site Terminated by Sponsor|1|||
143464331|NCT00585195|517244952|FG013|Overall Study|Site Terminated by Sponsor|0|||
143464332|NCT00585195|517244953|FG014|Overall Study|Site Terminated by Sponsor|0|||
143464333|NCT00585195|517244954|FG015|Overall Study|Site Terminated by Sponsor|0|||
143464334|NCT00585195|517244955|FG016|Overall Study|Site Terminated by Sponsor|0|||
143464335|NCT00585195|517244956|FG017|Overall Study|Site Terminated by Sponsor|0|||
143464336|NCT00585195|517244957|FG018|Overall Study|Site Terminated by Sponsor|0|||
143464337|NCT00585195|517244958|FG019|Overall Study|Site Terminated by Sponsor|0|||
143464338|NCT00585195|517244959|FG020|Overall Study|Site Terminated by Sponsor|0|||
143464339|NCT00585195|517244939|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
143464340|NCT00585195|517244940|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
143464341|NCT00585195|517244941|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
143464342|NCT00585195|517244942|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
143464343|NCT00585195|517244943|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
143464344|NCT00585195|517244944|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
143464345|NCT00585195|517244945|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
143464346|NCT00585195|517244946|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
143464347|NCT00585195|517244947|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
143464348|NCT00585195|517244948|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
143464349|NCT00585195|517244949|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
143464350|NCT00585195|517244950|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
143127608|NCT04530838|516014500|FG002|Overall Study|Withdrawal by parent/guardian|2|||
143464351|NCT00585195|517244951|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
143464352|NCT00585195|517244952|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
143127609|NCT00803712|516014501|FG000|Overall Study|Noncompliance|3|||
143127610|NCT00803712|516014502|FG001|Overall Study|Noncompliance|0|||
143127611|NCT00803712|516014501|FG000|Overall Study|Adverse Event|5|||
143464353|NCT00585195|517244953|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
143464354|NCT00585195|517244954|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
143464355|NCT00585195|517244955|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
143464356|NCT00585195|517244956|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
143464357|NCT00585195|517244957|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
143464358|NCT00585195|517244958|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
143464359|NCT00585195|517244959|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
143127612|NCT00803712|516014502|FG001|Overall Study|Adverse Event|0|||
143127613|NCT00803712|516014501|FG000|Overall Study|Death|8|||
143127614|NCT00803712|516014502|FG001|Overall Study|Death|7|||
143127615|NCT00803712|516014501|FG000|Overall Study|Lost to Follow-up|3|||
143127616|NCT00803712|516014502|FG001|Overall Study|Lost to Follow-up|1|||
143127617|NCT00803712|516014501|FG000|Overall Study|Withdrawal by Subject|2|||
143127618|NCT00803712|516014502|FG001|Overall Study|Withdrawal by Subject|4|||
143127619|NCT00803712|516014501|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
143127620|NCT00803712|516014502|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
143127621|NCT00803712|516014501|FG000|Overall Study|Protocol criteria (other)|0|||
143127622|NCT00803712|516014502|FG001|Overall Study|Protocol criteria (other)|2|||
143127623|NCT00803712|516014501|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
143127624|NCT00803712|516014502|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
143127625|NCT00803712|516014501|FG000|Overall Study|Administrative decision|2|||
143127626|NCT00803712|516014502|FG001|Overall Study|Administrative decision|3|||
143127627|NCT00803712|516014501|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
143127628|NCT00803712|516014502|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
143127629|NCT01073163|516014505|FG000|Overall Study|Adverse Event|1|||
143127630|NCT01073163|516014505|FG000|Overall Study|Disease Progression|1|||
143127631|NCT01073163|516014505|FG000|Overall Study|Early termination|1|||
143127632|NCT00703677|516014506|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
143127633|NCT04441788|516014507|FG000|Overall Study|Voluntary Withdrawl|0|||
143127634|NCT04441788|516014508|FG001|Overall Study|Voluntary Withdrawl|1|||
143127635|NCT04441788|516014509|FG002|Overall Study|Voluntary Withdrawl|0|||
143127636|NCT04441788|516014507|FG000|Overall Study|Ineligibility|1|||
143127637|NCT04441788|516014508|FG001|Overall Study|Ineligibility|0|||
143127638|NCT04441788|516014509|FG002|Overall Study|Ineligibility|0|||
143127639|NCT04441788|516014507|FG000|Overall Study|Adverse Event|0|||
143127640|NCT04441788|516014508|FG001|Overall Study|Adverse Event|0|||
143127641|NCT04441788|516014509|FG002|Overall Study|Adverse Event|4|||
143127642|NCT04441788|516014507|FG000|Overall Study|Study Terminated by Sponsor|16|||
143127643|NCT04441788|516014508|FG001|Overall Study|Study Terminated by Sponsor|16|||
143127644|NCT04441788|516014509|FG002|Overall Study|Study Terminated by Sponsor|12|||
143127645|NCT03859648|516014516|FG000|Overall Study|Lost to Follow-up|1|||
143127646|NCT03859648|516014516|FG000|Overall Study|Adverse Event|1|||
143127647|NCT02315664|516014517|FG000|Overall Study|Lost to Follow-up|1|||
143127648|NCT02315664|516014518|FG001|Overall Study|Lost to Follow-up|1|||
143127649|NCT02315664|516014517|FG000|Overall Study|Withdrawal by Subject|0|||
143127650|NCT02315664|516014518|FG001|Overall Study|Withdrawal by Subject|3|||
143127651|NCT01677182|516014519|FG000|Overall Study|Adverse Event|2|||
143127652|NCT01677182|516014520|FG001|Overall Study|Adverse Event|1|||
143127653|NCT01677182|516014521|FG002|Overall Study|Adverse Event|8|||
143127654|NCT01677182|516014519|FG000|Overall Study|Protocol Violation|5|||
143127655|NCT01677182|516014520|FG001|Overall Study|Protocol Violation|1|||
143127656|NCT01677182|516014521|FG002|Overall Study|Protocol Violation|4|||
143127657|NCT01677182|516014519|FG000|Overall Study|Lost to Follow-up|4|||
143127658|NCT01677182|516014520|FG001|Overall Study|Lost to Follow-up|0|||
143127659|NCT01677182|516014521|FG002|Overall Study|Lost to Follow-up|3|||
143127660|NCT01677182|516014519|FG000|Overall Study|Withdrawal by Subject|7|||
143127661|NCT01677182|516014520|FG001|Overall Study|Withdrawal by Subject|12|||
143127662|NCT01677182|516014521|FG002|Overall Study|Withdrawal by Subject|10|||
143127663|NCT01677182|516014519|FG000|Overall Study|Study termination|12|||
143127664|NCT01677182|516014520|FG001|Overall Study|Study termination|9|||
143127665|NCT01677182|516014521|FG002|Overall Study|Study termination|11|||
143127666|NCT01677182|516014519|FG000|Overall Study|Lack of Efficacy|3|||
143127667|NCT01677182|516014520|FG001|Overall Study|Lack of Efficacy|0|||
143127668|NCT01677182|516014521|FG002|Overall Study|Lack of Efficacy|1|||
143127669|NCT01677182|516014519|FG000|Overall Study|Other reasons|1|||
143127670|NCT01677182|516014520|FG001|Overall Study|Other reasons|5|||
143357270|NCT01254890|516853015|FG000|Overall Study|Withdrawal by Subject|1|||
143357271|NCT01254890|516853016|FG001|Overall Study|Withdrawal by Subject|2|||
143357272|NCT01254890|516853015|FG000|Overall Study|Disease Progression|0|||
143357273|NCT01254890|516853016|FG001|Overall Study|Disease Progression|5|||
143357274|NCT01815736|516853019|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
143357275|NCT01815736|516853020|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
143357276|NCT01815736|516853019|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
143357277|NCT01815736|516853020|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
143357278|NCT01815736|516853019|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
143357279|NCT01815736|516853020|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
143357280|NCT01815736|516853019|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
143357281|NCT01815736|516853020|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
143357282|NCT01815736|516853019|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
143127671|NCT01677182|516014521|FG002|Overall Study|Other reasons|2|||
143127672|NCT02501161|516014522|FG000|Overall Study|Adverse Event|2|||
143127673|NCT02501161|516014523|FG001|Overall Study|Adverse Event|6|||
143127674|NCT02501161|516014522|FG000|Overall Study|Lost to Follow-up|7|||
143127675|NCT02501161|516014523|FG001|Overall Study|Lost to Follow-up|4|||
143127676|NCT02501161|516014522|FG000|Overall Study|Withdrawal by Subject|10|||
143464360|NCT02796560|517244965|FG000|Overall Study|Adverse Event|2|||
143464361|NCT02796560|517244966|FG001|Overall Study|Adverse Event|0|||
143464362|NCT02796560|517244965|FG000|Overall Study|Withdrawal by Subject|2|||
143464363|NCT02796560|517244966|FG001|Overall Study|Withdrawal by Subject|2|||
143464364|NCT02533570|517244967|FG000|Overall Study|Adverse Event|0|||
143464365|NCT02533570|517244968|FG001|Overall Study|Adverse Event|1|||
143464366|NCT02533570|517244969|FG002|Overall Study|Adverse Event|1|||
143464367|NCT00529958|517244970|FG000|2-Year Follow-up|Lost to Follow-up|1|||
143464368|NCT00529958|517244971|FG001|2-Year Follow-up|Lost to Follow-up|2|||
143464369|NCT00529958|517244972|FG002|2-Year Follow-up|Lost to Follow-up|2|||
143464370|NCT00529958|517244970|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
143464371|NCT00529958|517244971|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
143464372|NCT00529958|517244972|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
143464373|NCT00529958|517244970|FG000|5-Year Follow-up|Lost to Follow-up|2|||
143464374|NCT00529958|517244971|FG001|5-Year Follow-up|Lost to Follow-up|3|||
143464375|NCT00529958|517244972|FG002|5-Year Follow-up|Lost to Follow-up|1|||
143464376|NCT00529958|517244970|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
143013710|NCT03747939|515590014|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
143013711|NCT03747939|515590015|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
143013712|NCT03747939|515590016|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
143464377|NCT00529958|517244971|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
143464378|NCT00529958|517244972|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
143464379|NCT03816332|517244973|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
143464380|NCT03816332|517244973|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
143464381|NCT03534284|517244976|FG000|Overall Study|Death|2|||
143464382|NCT03534284|517244977|FG001|Overall Study|Death|3|||
143464383|NCT03534284|517244978|FG002|Overall Study|Death|3|||
143464384|NCT03534284|517244976|FG000|Overall Study|Withdrawal by Subject|5|||
143464385|NCT03534284|517244977|FG001|Overall Study|Withdrawal by Subject|0|||
143464386|NCT03534284|517244978|FG002|Overall Study|Withdrawal by Subject|0|||
143464387|NCT03164564|517244979|FG000|Overall Study|Death|3|||
143464388|NCT03164564|517244980|FG001|Overall Study|Death|0|||
143464389|NCT03164564|517244979|FG000|Overall Study|Withdrawal by Subject|20|||
143464390|NCT03164564|517244980|FG001|Overall Study|Withdrawal by Subject|15|||
143464391|NCT03164564|517244979|FG000|Overall Study|Lost to Follow-up|2|||
143464392|NCT03164564|517244980|FG001|Overall Study|Lost to Follow-up|0|||
143464393|NCT03164564|517244979|FG000|Overall Study|Physician Decision|0|||
143464394|NCT03164564|517244980|FG001|Overall Study|Physician Decision|1|||
143464395|NCT03164564|517244979|FG000|Overall Study|Adverse Event|0|||
143464396|NCT03164564|517244980|FG001|Overall Study|Adverse Event|1|||
143464397|NCT03164564|517244979|FG000|Overall Study|Ongoing|1586|||
143464398|NCT03164564|517244980|FG001|Overall Study|Ongoing|1586|||
143464399|NCT02656823|517244981|FG000|Overall Study|Adverse Event|3|||
143464400|NCT02656823|517244981|FG000|Overall Study|Lost to Follow-up|2|||
143464401|NCT01315353|517244982|FG000|Overall Study|Death|2|||
143464402|NCT01315353|517244983|FG001|Overall Study|Death|1|||
143464403|NCT01315353|517244984|FG002|Overall Study|Death|0|||
143464404|NCT01315353|517244982|FG000|Overall Study|Withdrawal by Subject|2|||
143464405|NCT01315353|517244983|FG001|Overall Study|Withdrawal by Subject|6|||
143464406|NCT01315353|517244984|FG002|Overall Study|Withdrawal by Subject|1|||
143464407|NCT01315353|517244982|FG000|Overall Study|Lost to Follow-up|13|||
143464408|NCT01315353|517244983|FG001|Overall Study|Lost to Follow-up|6|||
143464409|NCT01315353|517244984|FG002|Overall Study|Lost to Follow-up|6|||
143464410|NCT01315353|517244982|FG000|Overall Study|Unwilling to adhere to requirements|5|||
143464411|NCT01315353|517244983|FG001|Overall Study|Unwilling to adhere to requirements|5|||
143464412|NCT01315353|517244984|FG002|Overall Study|Unwilling to adhere to requirements|4|||
143464413|NCT01315353|517244982|FG000|Overall Study|Site closing|7|||
143464414|NCT01315353|517244983|FG001|Overall Study|Site closing|4|||
143464415|NCT01315353|517244984|FG002|Overall Study|Site closing|0|||
143464416|NCT01315353|517244982|FG000|Overall Study|Taken off study by site in error|0|||
143464417|NCT01315353|517244983|FG001|Overall Study|Taken off study by site in error|1|||
143464418|NCT01315353|517244984|FG002|Overall Study|Taken off study by site in error|0|||
143464419|NCT01315353|517244982|FG000|Overall Study|Inadvertent randomization/assignment|0|||
143464420|NCT01315353|517244983|FG001|Overall Study|Inadvertent randomization/assignment|0|||
143464421|NCT01315353|517244984|FG002|Overall Study|Inadvertent randomization/assignment|2|||
143464422|NCT03567434|517244985|FG000|Overall Study|Lost to Follow-up|1|||
143464423|NCT03567434|517244986|FG001|Overall Study|Lost to Follow-up|3|||
143464424|NCT01009580|517244987|FG000|Overall Study|Adverse Event|4|||
143464425|NCT01009580|517244988|FG001|Overall Study|Adverse Event|4|||
143464426|NCT01009580|517244987|FG000|Overall Study|Lack of Efficacy|0|||
143464427|NCT01009580|517244988|FG001|Overall Study|Lack of Efficacy|1|||
143464428|NCT01009580|517244987|FG000|Overall Study|Protocol Violation|2|||
143464429|NCT01009580|517244988|FG001|Overall Study|Protocol Violation|3|||
143464430|NCT01009580|517244987|FG000|Overall Study|Withdrawal Criteria|4|||
143013713|NCT03747939|515590017|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
143464431|NCT01009580|517244988|FG001|Overall Study|Withdrawal Criteria|6|||
143013714|NCT03747939|515590014|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
143464432|NCT01009580|517244987|FG000|Overall Study|Unclassified|17|||
143464433|NCT01009580|517244988|FG001|Overall Study|Unclassified|21|||
143464434|NCT04469270|517244989|FG000|Overall Study|Adverse Event|2|||
143464435|NCT04469270|517244990|FG001|Overall Study|Adverse Event|0|||
143464436|NCT04469270|517244989|FG000|Overall Study|Lost to Follow-up|4|||
143464437|NCT04469270|517244990|FG001|Overall Study|Lost to Follow-up|3|||
143464438|NCT04469270|517244989|FG000|Overall Study|Withdrawal by Subject|7|||
143464439|NCT04469270|517244990|FG001|Overall Study|Withdrawal by Subject|3|||
143464440|NCT04469270|517244989|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
143464441|NCT04469270|517244990|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
143464442|NCT04469270|517244989|FG000|Overall Study|missing|1|||
143464443|NCT04469270|517244990|FG001|Overall Study|missing|0|||
143464444|NCT02254278|517244993|FG000|Overall Study|Protocol Violation|1|||
143464445|NCT02254278|517244994|FG001|Overall Study|Protocol Violation|1|||
143464446|NCT05437510|517244999|FG000|Overall Study|Adverse Event|2|||
143464447|NCT05437510|517245000|FG001|Overall Study|Adverse Event|1|||
143464448|NCT05437510|517244999|FG000|Overall Study|Protocol Deviation|1|||
143464449|NCT05437510|517245000|FG001|Overall Study|Protocol Deviation|6|||
143464450|NCT05437510|517244999|FG000|Overall Study|Withdrawal by Parent/Guardian|23|||
143464451|NCT05437510|517245000|FG001|Overall Study|Withdrawal by Parent/Guardian|23|||
143127677|NCT02501161|516014523|FG001|Overall Study|Withdrawal by Subject|15|||
143127678|NCT02501161|516014522|FG000|Overall Study|Other|3|||
143127679|NCT02501161|516014523|FG001|Overall Study|Other|0|||
143127680|NCT00762762|516014528|FG000|Overall Study|Did not return for appointments|6|||
143127681|NCT00762762|516014529|FG001|Overall Study|Did not return for appointments|8|||
143127682|NCT02489448|516014530|FG000|Overall Study|Death|3|||
143127683|NCT02489448|516014530|FG000|Overall Study|Withdrawal by Subject|2|||
143127684|NCT02609386|516014538|FG000|Overall Study|Withdrawal by Subject|6|||
143127685|NCT02609386|516014539|FG001|Overall Study|Withdrawal by Subject|1|||
143127686|NCT02609386|516014538|FG000|Overall Study|Lost to Follow-up|3|||
143127687|NCT02609386|516014539|FG001|Overall Study|Lost to Follow-up|5|||
143127688|NCT02609386|516014538|FG000|Overall Study|Death|19|||
143127689|NCT02609386|516014539|FG001|Overall Study|Death|9|||
143127690|NCT02609386|516014538|FG000|Overall Study|Physician Decision|0|||
143127691|NCT02609386|516014539|FG001|Overall Study|Physician Decision|2|||
143127692|NCT00540644|516014540|FG000|Overall Study|Adverse Event|3|||
143127693|NCT00540644|516014541|FG001|Overall Study|Adverse Event|1|||
143127694|NCT00540644|516014540|FG000|Overall Study|Disease Progression|3|||
143127695|NCT00540644|516014541|FG001|Overall Study|Disease Progression|1|||
143127696|NCT00540644|516014540|FG000|Overall Study|Physician Decision|0|||
143127697|NCT00540644|516014541|FG001|Overall Study|Physician Decision|5|||
143127698|NCT00540644|516014540|FG000|Overall Study|Withdrawal by Subject|2|||
143127699|NCT00540644|516014541|FG001|Overall Study|Withdrawal by Subject|2|||
143127700|NCT00540644|516014540|FG000|Overall Study|Noncomplilance|1|||
143127701|NCT00540644|516014541|FG001|Overall Study|Noncomplilance|0|||
143127702|NCT03280056|516014542|FG000|Overall Study|Withdrawal by Subject|12|||
143127703|NCT03280056|516014543|FG001|Overall Study|Withdrawal by Subject|14|||
143127704|NCT03280056|516014542|FG000|Overall Study|Death|9|||
143127705|NCT03280056|516014543|FG001|Overall Study|Death|2|||
143127706|NCT03280056|516014542|FG000|Overall Study|Adverse Event|1|||
143127707|NCT03280056|516014543|FG001|Overall Study|Adverse Event|3|||
143127708|NCT03280056|516014542|FG000|Overall Study|Lost to Follow-up|1|||
143127709|NCT03280056|516014543|FG001|Overall Study|Lost to Follow-up|1|||
143127710|NCT03280056|516014542|FG000|Overall Study|Physician Decision|0|||
143127711|NCT03280056|516014543|FG001|Overall Study|Physician Decision|1|||
143127712|NCT03280056|516014542|FG000|Overall Study|Early Discontinuation|1|||
143127713|NCT03280056|516014543|FG001|Overall Study|Early Discontinuation|0|||
143127714|NCT01869777|516014544|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
143127715|NCT03318003|516014549|FG000|Overall Study|Withdrawal by Subject|1|||
143127716|NCT03318003|516014550|FG001|Overall Study|Withdrawal by Subject|1|||
143127717|NCT03318003|516014549|FG000|Overall Study|fetal loss|0|||
143464452|NCT05437510|517244999|FG000|Overall Study|Lost to Follow-up|265|||
143464453|NCT05437510|517245000|FG001|Overall Study|Lost to Follow-up|358|||
143127718|NCT03318003|516014550|FG001|Overall Study|fetal loss|1|||
143127719|NCT00397189|516014551|FG000|3 Weeks Period|Lost to Follow-up|5|||
143127720|NCT00397189|516014552|FG001|3 Weeks Period|Lost to Follow-up|4|||
143127721|NCT00397189|516014551|FG000|3 Weeks Period|Adverse Event|3|||
143127722|NCT00397189|516014552|FG001|3 Weeks Period|Adverse Event|2|||
143127723|NCT00397189|516014551|FG000|3 Weeks Period|Withdrawal by Subject|13|||
143127724|NCT00397189|516014552|FG001|3 Weeks Period|Withdrawal by Subject|9|||
143127725|NCT00397189|516014551|FG000|3 Weeks Period|Physician Decision|0|||
143127726|NCT00397189|516014552|FG001|3 Weeks Period|Physician Decision|2|||
143127727|NCT00397189|516014551|FG000|3 Weeks Period|Protocol Violation|0|||
143127728|NCT00397189|516014552|FG001|3 Weeks Period|Protocol Violation|3|||
143464454|NCT03573401|517245001|FG000|Overall Study|Withdrawal by Subject|2|||
143464455|NCT03573401|517245002|FG001|Overall Study|Withdrawal by Subject|0|||
143464456|NCT03573401|517245001|FG000|Overall Study|Subject non-compliance with study schedule|1|||
143464457|NCT03573401|517245002|FG001|Overall Study|Subject non-compliance with study schedule|0|||
143464458|NCT03573401|517245001|FG000|Overall Study|Discontinuation of study treatment due to subject decision|1|||
143464459|NCT03573401|517245002|FG001|Overall Study|Discontinuation of study treatment due to subject decision|0|||
143464460|NCT03573401|517245001|FG000|Overall Study|Subject required prohibited medication for concomitant medical condition|0|||
143464461|NCT03573401|517245002|FG001|Overall Study|Subject required prohibited medication for concomitant medical condition|1|||
143464462|NCT00001962|517246286|FG000|Overall Study|Lack of Efficacy|18|||
143464463|NCT00001962|517246286|FG000|Overall Study|Lack of Accrual|6|||
143464464|NCT00001962|517246286|FG000|Overall Study|Death|1|||
143464465|NCT00001962|517246286|FG000|Overall Study|Lost to Follow-up|2|||
143464466|NCT00001962|517246286|FG000|Overall Study|Adverse Event|1|||
143464467|NCT01614197|517246288|FG000|Overall Study|Withdrawal by Subject|0|||
143464468|NCT01614197|517246289|FG001|Overall Study|Withdrawal by Subject|1|||
143464469|NCT01614197|517246290|FG002|Overall Study|Withdrawal by Subject|0|||
143464470|NCT01614197|517246291|FG003|Overall Study|Withdrawal by Subject|0|||
143464471|NCT02986334|517246296|FG000|Overall Study|Withdrawal by Subject|0|||
143464472|NCT02986334|517246297|FG001|Overall Study|Withdrawal by Subject|1|||
143464473|NCT02986334|517246298|FG002|Overall Study|Withdrawal by Subject|2|||
143464474|NCT02986334|517246296|FG000|Overall Study|Lost to Follow-up|1|||
143464475|NCT02986334|517246297|FG001|Overall Study|Lost to Follow-up|2|||
143464476|NCT02986334|517246298|FG002|Overall Study|Lost to Follow-up|1|||
143464477|NCT02986334|517246296|FG000|Overall Study|Adverse Event|0|||
143464478|NCT02986334|517246297|FG001|Overall Study|Adverse Event|2|||
143127729|NCT00397189|516014551|FG000|3 Weeks Period|Other|0|||
143127730|NCT00397189|516014552|FG001|3 Weeks Period|Other|2|||
143127731|NCT03410992|516014555|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
143127732|NCT03410992|516014556|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
143127733|NCT03410992|516014557|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
143127734|NCT03410992|516014558|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
143127735|NCT03410992|516014559|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
143127736|NCT03410992|516014560|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
143127737|NCT03410992|516014561|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
143127738|NCT03410992|516014562|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
143127739|NCT03410992|516014563|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
143127740|NCT03410992|516014564|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
143127741|NCT03410992|516014565|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
143127742|NCT03410992|516014555|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
143127743|NCT03410992|516014556|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
143127744|NCT03410992|516014557|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
143127745|NCT03410992|516014558|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
143127746|NCT03410992|516014559|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
143127747|NCT03410992|516014560|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
143127748|NCT03410992|516014561|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
143127749|NCT03410992|516014562|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
143127750|NCT03410992|516014563|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
143127751|NCT03410992|516014564|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
143127752|NCT03410992|516014565|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
143127753|NCT03410992|516014555|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
143127754|NCT03410992|516014556|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
143127755|NCT03410992|516014557|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
143127756|NCT03410992|516014558|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
143127757|NCT03410992|516014559|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
143127758|NCT03410992|516014560|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
143127759|NCT03410992|516014561|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
143127760|NCT03410992|516014562|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
143127761|NCT03410992|516014563|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
143127762|NCT03410992|516014564|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
143127763|NCT03410992|516014565|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
143127764|NCT03410992|516014555|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
143127765|NCT03410992|516014556|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
143127766|NCT03410992|516014557|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
143127767|NCT03410992|516014558|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
143127768|NCT03410992|516014559|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
143127769|NCT03410992|516014560|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
143127770|NCT03410992|516014561|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
143127771|NCT03410992|516014562|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
143127772|NCT03410992|516014563|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
143127773|NCT03410992|516014564|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
143464479|NCT02986334|517246298|FG002|Overall Study|Adverse Event|1|||
143464480|NCT02986334|517246296|FG000|Overall Study|non compliance in phone ratings|2|||
143127774|NCT03410992|516014565|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
143127775|NCT03410992|516014555|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
143127776|NCT03410992|516014556|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
143127777|NCT03410992|516014557|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
143127778|NCT03410992|516014558|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
143127779|NCT03410992|516014559|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
143127780|NCT03410992|516014560|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
143127781|NCT03410992|516014561|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
143127782|NCT03410992|516014562|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
143127783|NCT03410992|516014563|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
143127784|NCT03410992|516014564|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
143127785|NCT03410992|516014565|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
143127786|NCT03410992|516014555|FG000|Week 16 Assessment|Incorrect escapers|0|||
143127787|NCT03410992|516014556|FG001|Week 16 Assessment|Incorrect escapers|6|||
143127788|NCT03410992|516014557|FG002|Week 16 Assessment|Incorrect escapers|0|||
143127789|NCT03410992|516014558|FG003|Week 16 Assessment|Incorrect escapers|0|||
143127790|NCT03410992|516014559|FG004|Week 16 Assessment|Incorrect escapers|0|||
143127791|NCT03410992|516014560|FG005|Week 16 Assessment|Incorrect escapers|0|||
143127792|NCT03410992|516014561|FG006|Week 16 Assessment|Incorrect escapers|0|||
143127793|NCT03410992|516014562|FG007|Week 16 Assessment|Incorrect escapers|0|||
143127794|NCT03410992|516014563|FG008|Week 16 Assessment|Incorrect escapers|0|||
143127795|NCT03410992|516014564|FG009|Week 16 Assessment|Incorrect escapers|0|||
143127796|NCT03410992|516014565|FG010|Week 16 Assessment|Incorrect escapers|0|||
143127797|NCT03410992|516014555|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
143127798|NCT03410992|516014556|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
143127799|NCT03410992|516014557|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
143127800|NCT03410992|516014558|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
143127801|NCT03410992|516014559|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
143127802|NCT03410992|516014560|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
143127803|NCT03410992|516014561|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
143127804|NCT03410992|516014562|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
143127805|NCT03410992|516014563|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
143127806|NCT03410992|516014564|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
143127807|NCT03410992|516014565|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
143127808|NCT03410992|516014555|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
143127809|NCT03410992|516014556|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
143127810|NCT03410992|516014557|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
143127811|NCT03410992|516014558|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
143127812|NCT03410992|516014559|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
143127813|NCT03410992|516014560|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
143127814|NCT03410992|516014561|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
143127815|NCT03410992|516014562|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
143127816|NCT03410992|516014563|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
143127817|NCT03410992|516014564|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
143127818|NCT03410992|516014565|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
143127819|NCT03410992|516014555|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
143127820|NCT03410992|516014556|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
143127821|NCT03410992|516014557|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
143127822|NCT03410992|516014558|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
143127823|NCT03410992|516014559|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
143127824|NCT03410992|516014560|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
143127825|NCT03410992|516014561|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
143127826|NCT03410992|516014562|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
143127827|NCT03410992|516014563|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
143127828|NCT03410992|516014564|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
143464481|NCT02986334|517246297|FG001|Overall Study|non compliance in phone ratings|1|||
143464482|NCT02986334|517246298|FG002|Overall Study|non compliance in phone ratings|2|||
143464483|NCT02986334|517246296|FG000|Overall Study|undisclosed comorbidities|0|||
143464484|NCT02986334|517246297|FG001|Overall Study|undisclosed comorbidities|1|||
143464485|NCT02986334|517246298|FG002|Overall Study|undisclosed comorbidities|1|||
143464486|NCT05580588|517246299|FG000|Overall Study|Lack of Efficacy|12|||
143464487|NCT00712673|517246302|FG000|Overall Study|Adverse Event|3|||
143464488|NCT00712673|517246303|FG001|Overall Study|Adverse Event|3|||
143464489|NCT00712673|517246304|FG002|Overall Study|Adverse Event|21|||
143464490|NCT00712673|517246305|FG003|Overall Study|Adverse Event|26|||
143464491|NCT00712673|517246302|FG000|Overall Study|Lack of Efficacy|2|||
143464492|NCT00712673|517246303|FG001|Overall Study|Lack of Efficacy|8|||
143464493|NCT00712673|517246304|FG002|Overall Study|Lack of Efficacy|8|||
143464494|NCT00712673|517246305|FG003|Overall Study|Lack of Efficacy|6|||
143464495|NCT00712673|517246302|FG000|Overall Study|Poor Compliance to Protocol|3|||
143464496|NCT00712673|517246303|FG001|Overall Study|Poor Compliance to Protocol|3|||
143464497|NCT00712673|517246304|FG002|Overall Study|Poor Compliance to Protocol|4|||
143464498|NCT00712673|517246305|FG003|Overall Study|Poor Compliance to Protocol|16|||
143464499|NCT00712673|517246302|FG000|Overall Study|Lost to Follow-up|1|||
143464500|NCT00712673|517246303|FG001|Overall Study|Lost to Follow-up|0|||
143464501|NCT00712673|517246304|FG002|Overall Study|Lost to Follow-up|2|||
143464502|NCT00712673|517246305|FG003|Overall Study|Lost to Follow-up|0|||
143464503|NCT00712673|517246302|FG000|Overall Study|Withdrawal by Subject|6|||
143464504|NCT00712673|517246303|FG001|Overall Study|Withdrawal by Subject|7|||
143464505|NCT00712673|517246304|FG002|Overall Study|Withdrawal by Subject|15|||
143464506|NCT00712673|517246305|FG003|Overall Study|Withdrawal by Subject|20|||
143464507|NCT00712673|517246302|FG000|Overall Study|Familial and Personal Reasons|5|||
143464508|NCT00712673|517246303|FG001|Overall Study|Familial and Personal Reasons|0|||
143464509|NCT00712673|517246304|FG002|Overall Study|Familial and Personal Reasons|5|||
143464510|NCT00712673|517246305|FG003|Overall Study|Familial and Personal Reasons|2|||
143464511|NCT00712673|517246302|FG000|Overall Study|Investigator's Decision|1|||
143464512|NCT00712673|517246303|FG001|Overall Study|Investigator's Decision|0|||
143464513|NCT00712673|517246304|FG002|Overall Study|Investigator's Decision|0|||
143464514|NCT00712673|517246305|FG003|Overall Study|Investigator's Decision|0|||
143464515|NCT00712673|517246302|FG000|Overall Study|Protocol Violation|0|||
143464516|NCT00712673|517246303|FG001|Overall Study|Protocol Violation|0|||
143464517|NCT00712673|517246304|FG002|Overall Study|Protocol Violation|2|||
143464518|NCT00712673|517246305|FG003|Overall Study|Protocol Violation|0|||
143464519|NCT03603028|517246306|FG000|Overall Study|Withdrawal by Subject|1|||
143464520|NCT02963610|517246309|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
143464521|NCT00063154|517246310|FG000|Overall Study|Disease progression|27|||
143464522|NCT00063154|517246310|FG000|Overall Study|Adverse Event|2|||
143464523|NCT00063154|517246310|FG000|Overall Study|Physician Decision|10|||
143464524|NCT00063154|517246310|FG000|Overall Study|Death|3|||
143464525|NCT00063154|517246310|FG000|Overall Study|Reason unspecified|1|||
143464526|NCT00063154|517246310|FG000|Overall Study|Did not receive treatment|8|||
143464527|NCT01122862|517246311|FG000|Period 1|Protocol Violation|0|||
143464528|NCT01122862|517246312|FG001|Period 1|Protocol Violation|1|||
143464529|NCT01122862|517246313|FG002|Period 1|Protocol Violation|0|||
143464530|NCT01122862|517246311|FG000|Period 2|Adverse Event|0|||
143464531|NCT01122862|517246312|FG001|Period 2|Adverse Event|0|||
143464532|NCT01122862|517246313|FG002|Period 2|Adverse Event|1|||
143464533|NCT00846391|517246315|FG000|Overall Study|Physician Decision|0|||
143464534|NCT00846391|517246316|FG001|Overall Study|Physician Decision|0|||
143464535|NCT00846391|517246317|FG002|Overall Study|Physician Decision|1|||
143464536|NCT00846391|517246315|FG000|Overall Study|Study Terminated by Sponsor|1|||
143464537|NCT00846391|517246316|FG001|Overall Study|Study Terminated by Sponsor|2|||
143464538|NCT00846391|517246317|FG002|Overall Study|Study Terminated by Sponsor|2|||
143464539|NCT02924064|517246318|FG000|Overall Study|Adverse Event|2|||
143464540|NCT02924064|517246319|FG001|Overall Study|Adverse Event|2|||
143464541|NCT02924064|517246318|FG000|Overall Study|Lost to Follow-up|0|||
143464542|NCT02924064|517246319|FG001|Overall Study|Lost to Follow-up|2|||
143464543|NCT02924064|517246318|FG000|Overall Study|Physician Decision|0|||
143464544|NCT02924064|517246319|FG001|Overall Study|Physician Decision|2|||
143464545|NCT02924064|517246318|FG000|Overall Study|Protocol Violation|1|||
143464546|NCT02924064|517246319|FG001|Overall Study|Protocol Violation|3|||
143464547|NCT02924064|517246318|FG000|Overall Study|Withdrawal by Subject|4|||
143464548|NCT02924064|517246319|FG001|Overall Study|Withdrawal by Subject|5|||
143464549|NCT02924064|517246318|FG000|Overall Study|Other|17|||
143464550|NCT02924064|517246319|FG001|Overall Study|Other|29|||
143464551|NCT02699983|517246321|FG000|Overall Study|Withdrawal by Subject|1|||
143464552|NCT02699983|517246322|FG001|Overall Study|Withdrawal by Subject|0|||
143464553|NCT03575143|517246323|FG000|Overall Study|Lost to Follow-up|0|||
143464554|NCT03575143|517246324|FG001|Overall Study|Lost to Follow-up|0|||
143464555|NCT03575143|517246325|FG002|Overall Study|Lost to Follow-up|4|||
143464556|NCT03575143|517246323|FG000|Overall Study|Withdrawal by Subject|0|||
143464557|NCT03575143|517246324|FG001|Overall Study|Withdrawal by Subject|0|||
143464558|NCT03575143|517246325|FG002|Overall Study|Withdrawal by Subject|5|||
143464559|NCT03575143|517246323|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
143464560|NCT03575143|517246324|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
143464561|NCT03575143|517246325|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
143464562|NCT01287065|517246328|FG000|Treatment Period 1|Adverse Event|0|||
143464563|NCT01287065|517246329|FG001|Treatment Period 1|Adverse Event|0|||
143464564|NCT01287065|517246330|FG002|Treatment Period 1|Adverse Event|0|||
143464565|NCT01287065|517246331|FG003|Treatment Period 1|Adverse Event|0|||
143464566|NCT01287065|517246332|FG004|Treatment Period 1|Adverse Event|1|||
143464567|NCT01287065|517246333|FG005|Treatment Period 1|Adverse Event|0|||
143464568|NCT01287065|517246328|FG000|Treatment Period 1|Withdrawal by Subject|0|||
143464569|NCT01287065|517246329|FG001|Treatment Period 1|Withdrawal by Subject|0|||
143464570|NCT01287065|517246330|FG002|Treatment Period 1|Withdrawal by Subject|0|||
143464571|NCT01287065|517246331|FG003|Treatment Period 1|Withdrawal by Subject|0|||
143464572|NCT01287065|517246332|FG004|Treatment Period 1|Withdrawal by Subject|0|||
143464573|NCT01287065|517246333|FG005|Treatment Period 1|Withdrawal by Subject|1|||
143464574|NCT01259726|517246334|FG000|Overall Study|Death|1|||
143464575|NCT01259726|517246335|FG001|Overall Study|Death|0|||
143464576|NCT01259726|517246336|FG002|Overall Study|Death|0|||
143464577|NCT01259726|517246337|FG003|Overall Study|Death|0|||
143464578|NCT01259726|517246334|FG000|Overall Study|Physician Decision|2|||
143464579|NCT01259726|517246335|FG001|Overall Study|Physician Decision|0|||
143464580|NCT01259726|517246336|FG002|Overall Study|Physician Decision|1|||
143464581|NCT01259726|517246337|FG003|Overall Study|Physician Decision|1|||
143464582|NCT01259726|517246334|FG000|Overall Study|Withdrawal by Subject|1|||
143464583|NCT01259726|517246335|FG001|Overall Study|Withdrawal by Subject|3|||
143464584|NCT01259726|517246336|FG002|Overall Study|Withdrawal by Subject|2|||
143464585|NCT01259726|517246337|FG003|Overall Study|Withdrawal by Subject|1|||
143464586|NCT01259726|517246334|FG000|Overall Study|Lost to Follow-up|1|||
143464587|NCT01259726|517246335|FG001|Overall Study|Lost to Follow-up|1|||
143464588|NCT01259726|517246336|FG002|Overall Study|Lost to Follow-up|1|||
143464589|NCT01259726|517246337|FG003|Overall Study|Lost to Follow-up|3|||
143464590|NCT01009203|517246338|FG000|Overall Study|Withdrawal by Subject|1|||
143464591|NCT01009203|517246338|FG000|Overall Study|Adverse Event|5|||
143464592|NCT01009203|517246338|FG000|Overall Study|Treatment-unrelated death|1|||
143464593|NCT02076178|517246340|FG000|Oral Phase|Adverse Event|0|||
143464594|NCT02076178|517246341|FG001|Oral Phase|Adverse Event|7|||
143464595|NCT02076178|517246340|FG000|Oral Phase|Withdrawal by Subject|0|||
143464596|NCT02076178|517246341|FG001|Oral Phase|Withdrawal by Subject|4|||
143464597|NCT02076178|517246340|FG000|Oral Phase|Physician Decision|0|||
143464598|NCT02076178|517246341|FG001|Oral Phase|Physician Decision|1|||
143464599|NCT02076178|517246340|FG000|Injection Phase|Protocol defined stopping criteria|1|||
143464600|NCT02076178|517246341|FG001|Injection Phase|Protocol defined stopping criteria|0|||
143464601|NCT02076178|517246340|FG000|Injection Phase|Withdrawal by Subject|0|||
143464602|NCT02076178|517246341|FG001|Injection Phase|Withdrawal by Subject|3|||
143464603|NCT02076178|517246340|FG000|Injection Phase|Physician Decision|0|||
143464604|NCT02076178|517246341|FG001|Injection Phase|Physician Decision|3|||
143464605|NCT02076178|517246340|FG000|Injection Phase|Lost to Follow-up|0|||
143464606|NCT02076178|517246341|FG001|Injection Phase|Lost to Follow-up|1|||
143464607|NCT03021954|517246344|FG000|Overall Study|Lost to Follow-up|10|||
143464608|NCT03021954|517246345|FG001|Overall Study|Lost to Follow-up|43|||
143464609|NCT03021954|517246344|FG000|Overall Study|Subjects had avulsion trauma|4|||
143464610|NCT03021954|517246345|FG001|Overall Study|Subjects had avulsion trauma|1|||
143464611|NCT01001832|517246346|FG000|Short-term Period|Adverse Event|2|||
143464612|NCT01001832|517246347|FG001|Short-term Period|Adverse Event|3|||
143464613|NCT01001832|517246346|FG000|Long-term Period|Adverse Event|2|||
143464614|NCT01001832|517246347|FG001|Long-term Period|Adverse Event|1|||
143464615|NCT01001832|517246346|FG000|Long-term Period|Withdrawal by Subject|1|||
143464616|NCT01001832|517246347|FG001|Long-term Period|Withdrawal by Subject|0|||
143464617|NCT01001832|517246346|FG000|Long-term Period|Lack of Efficacy|0|||
143464618|NCT01001832|517246347|FG001|Long-term Period|Lack of Efficacy|2|||
143464619|NCT01001832|517246346|FG000|Long-term Period|Other|1|||
143464620|NCT01001832|517246347|FG001|Long-term Period|Other|2|||
143464621|NCT01001832|517246346|FG000|Follow-up Period|Withdrawal by Subject|1|||
143464622|NCT01001832|517246347|FG001|Follow-up Period|Withdrawal by Subject|0|||
143464623|NCT01001832|517246346|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
143464624|NCT01001832|517246347|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
143464625|NCT01001832|517246346|FG000|Follow-up Period|Other|2|||
143464626|NCT01001832|517246347|FG001|Follow-up Period|Other|1|||
143464627|NCT01012713|517246352|FG000|Overall Study|Lack of Efficacy|3|||
143464628|NCT01242800|517246353|FG000|Overall Study|Patient refusal|0|||
143464629|NCT01242800|517246354|FG001|Overall Study|Patient refusal|10|||
143464630|NCT01242800|517246353|FG000|Overall Study|Physician Decision|0|||
143464631|NCT01242800|517246354|FG001|Overall Study|Physician Decision|1|||
143464632|NCT01242800|517246353|FG000|Overall Study|Disease progression|0|||
143464633|NCT01242800|517246354|FG001|Overall Study|Disease progression|3|||
143464634|NCT01242800|517246353|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
143464635|NCT01242800|517246354|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
143464636|NCT01242800|517246353|FG000|Overall Study|Reasons not reported|0|||
143464637|NCT01242800|517246354|FG001|Overall Study|Reasons not reported|4|||
143464638|NCT01596621|517246356|FG000|Overall Study|Death|4|||
143464639|NCT01596621|517246356|FG000|Overall Study|Withdrawal by Subject|9|||
143464640|NCT01596621|517246356|FG000|Overall Study|Disease Progression|49|||
143464641|NCT01596621|517246356|FG000|Overall Study|Lost to Follow-up|3|||
143464642|NCT01596621|517246356|FG000|Overall Study|Other than specified|13|||
143464643|NCT00710021|517246357|FG000|Overall Study|Lost to Follow-up|1|||
143464644|NCT00710021|517246358|FG001|Overall Study|Lost to Follow-up|0|||
143464645|NCT00710021|517246359|FG002|Overall Study|Lost to Follow-up|0|||
143464646|NCT00710021|517246357|FG000|Overall Study|Subject's Decision|0|||
143464647|NCT00710021|517246358|FG001|Overall Study|Subject's Decision|1|||
143464648|NCT00710021|517246359|FG002|Overall Study|Subject's Decision|0|||
143464649|NCT00710021|517246357|FG000|Overall Study|Subject misrandomized|0|||
143464650|NCT00710021|517246358|FG001|Overall Study|Subject misrandomized|1|||
143464651|NCT00710021|517246359|FG002|Overall Study|Subject misrandomized|1|||
143464652|NCT00710021|517246357|FG000|Overall Study|Physician Decision|0|||
143464653|NCT00710021|517246358|FG001|Overall Study|Physician Decision|1|||
143464654|NCT00710021|517246359|FG002|Overall Study|Physician Decision|0|||
143464655|NCT01536015|517246360|FG000|Overall Study|Adverse Event|1|||
143464656|NCT01536015|517246361|FG001|Overall Study|Adverse Event|4|||
143464657|NCT01536015|517246360|FG000|Overall Study|Lost to Follow-up|0|||
143464658|NCT01536015|517246361|FG001|Overall Study|Lost to Follow-up|1|||
143464659|NCT01536015|517246360|FG000|Overall Study|Inclusion Criterion not met|2|||
143464660|NCT01536015|517246361|FG001|Overall Study|Inclusion Criterion not met|0|||
143464661|NCT01536015|517246360|FG000|Overall Study|Study closure|5|||
143464662|NCT01536015|517246361|FG001|Overall Study|Study closure|5|||
143464663|NCT04508023|517246362|FG000|Overall Study|Withdrawal by Subject|1|||
143464664|NCT04508023|517246363|FG001|Overall Study|Withdrawal by Subject|2|||
143464665|NCT03581825|517246371|FG000|Period 1|Lens Discomfort|1|||
143464666|NCT03581825|517246372|FG001|Period 1|Lens Discomfort|0|||
143464667|NCT03581825|517246371|FG000|Period 2|Unsatisfactory Vision to Test|0|||
143464668|NCT03581825|517246372|FG001|Period 2|Unsatisfactory Vision to Test|1|||
143464669|NCT01668667|517246373|FG000|Overall Study|Adverse Event|3|||
143464670|NCT01668667|517246374|FG001|Overall Study|Adverse Event|6|||
143464671|NCT01668667|517246375|FG002|Overall Study|Adverse Event|4|||
143464672|NCT01668667|517246376|FG003|Overall Study|Adverse Event|4|||
143464673|NCT01668667|517246373|FG000|Overall Study|Lack of Efficacy|3|||
143464674|NCT01668667|517246374|FG001|Overall Study|Lack of Efficacy|2|||
143464675|NCT01668667|517246375|FG002|Overall Study|Lack of Efficacy|2|||
143464676|NCT01668667|517246376|FG003|Overall Study|Lack of Efficacy|3|||
143464677|NCT01668667|517246373|FG000|Overall Study|Protocol Violation|6|||
143464678|NCT01668667|517246374|FG001|Overall Study|Protocol Violation|10|||
143464679|NCT01668667|517246375|FG002|Overall Study|Protocol Violation|12|||
143464680|NCT01668667|517246376|FG003|Overall Study|Protocol Violation|5|||
143464681|NCT01668667|517246373|FG000|Overall Study|Lost to Follow-up|9|||
143464682|NCT01668667|517246374|FG001|Overall Study|Lost to Follow-up|4|||
143464683|NCT01668667|517246375|FG002|Overall Study|Lost to Follow-up|7|||
143464684|NCT01668667|517246376|FG003|Overall Study|Lost to Follow-up|6|||
143464685|NCT01668667|517246373|FG000|Overall Study|Physician Decision|3|||
143464686|NCT01668667|517246374|FG001|Overall Study|Physician Decision|0|||
143464687|NCT01668667|517246375|FG002|Overall Study|Physician Decision|1|||
143464688|NCT01668667|517246376|FG003|Overall Study|Physician Decision|0|||
143464689|NCT01668667|517246373|FG000|Overall Study|Withdrawal by Subject|7|||
143464690|NCT01668667|517246374|FG001|Overall Study|Withdrawal by Subject|4|||
143464691|NCT01668667|517246375|FG002|Overall Study|Withdrawal by Subject|5|||
143464692|NCT01668667|517246376|FG003|Overall Study|Withdrawal by Subject|5|||
143464693|NCT01204398|517246377|FG000|Overall Study|Adverse Event|1|||
143464694|NCT03261700|517246378|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
143464695|NCT03261700|517246379|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
143464696|NCT01723254|517246381|FG000|Overall Study|Conflict with work schedule|0|||
143464697|NCT01723254|517246382|FG001|Overall Study|Conflict with work schedule|0|||
143464698|NCT01723254|517246383|FG002|Overall Study|Conflict with work schedule|0|||
143464699|NCT01723254|517246384|FG003|Overall Study|Conflict with work schedule|0|||
143464700|NCT01723254|517246385|FG004|Overall Study|Conflict with work schedule|0|||
143464701|NCT01723254|517246386|FG005|Overall Study|Conflict with work schedule|0|||
143464702|NCT01723254|517246387|FG006|Overall Study|Conflict with work schedule|0|||
143464703|NCT01723254|517246388|FG007|Overall Study|Conflict with work schedule|1|||
143464704|NCT01723254|517246381|FG000|Overall Study|Personal issues|0|||
143464705|NCT01723254|517246382|FG001|Overall Study|Personal issues|0|||
143464706|NCT01723254|517246383|FG002|Overall Study|Personal issues|0|||
143464707|NCT01723254|517246384|FG003|Overall Study|Personal issues|0|||
143464708|NCT01723254|517246385|FG004|Overall Study|Personal issues|0|||
143464709|NCT01723254|517246386|FG005|Overall Study|Personal issues|1|||
143464710|NCT01723254|517246387|FG006|Overall Study|Personal issues|0|||
143464711|NCT01723254|517246388|FG007|Overall Study|Personal issues|0|||
143464712|NCT01723254|517246381|FG000|Overall Study|No longer have time to participate|0|||
143464713|NCT01723254|517246382|FG001|Overall Study|No longer have time to participate|0|||
143464714|NCT01723254|517246383|FG002|Overall Study|No longer have time to participate|0|||
143464715|NCT01723254|517246384|FG003|Overall Study|No longer have time to participate|1|||
143464716|NCT01723254|517246385|FG004|Overall Study|No longer have time to participate|0|||
143464717|NCT01723254|517246386|FG005|Overall Study|No longer have time to participate|0|||
143464718|NCT01723254|517246387|FG006|Overall Study|No longer have time to participate|0|||
143464719|NCT01723254|517246388|FG007|Overall Study|No longer have time to participate|0|||
143464720|NCT01723254|517246381|FG000|Overall Study|Move/Left to another country/city|0|||
143464721|NCT01723254|517246382|FG001|Overall Study|Move/Left to another country/city|0|||
143464722|NCT01723254|517246383|FG002|Overall Study|Move/Left to another country/city|2|||
143464723|NCT01723254|517246384|FG003|Overall Study|Move/Left to another country/city|1|||
143464724|NCT01723254|517246385|FG004|Overall Study|Move/Left to another country/city|1|||
143464725|NCT01723254|517246386|FG005|Overall Study|Move/Left to another country/city|0|||
143464726|NCT01723254|517246387|FG006|Overall Study|Move/Left to another country/city|0|||
143464727|NCT01723254|517246388|FG007|Overall Study|Move/Left to another country/city|0|||
143464728|NCT01723254|517246381|FG000|Overall Study|Protocol Violation|0|||
143464729|NCT01723254|517246382|FG001|Overall Study|Protocol Violation|1|||
143464730|NCT01723254|517246383|FG002|Overall Study|Protocol Violation|0|||
143464731|NCT01723254|517246384|FG003|Overall Study|Protocol Violation|0|||
143464732|NCT01723254|517246385|FG004|Overall Study|Protocol Violation|0|||
143464733|NCT01723254|517246386|FG005|Overall Study|Protocol Violation|0|||
143464734|NCT01723254|517246387|FG006|Overall Study|Protocol Violation|0|||
143464735|NCT01723254|517246388|FG007|Overall Study|Protocol Violation|0|||
143464736|NCT01723254|517246381|FG000|Overall Study|Withdrawal by Subject|1|||
143464737|NCT01723254|517246382|FG001|Overall Study|Withdrawal by Subject|2|||
143464738|NCT01723254|517246383|FG002|Overall Study|Withdrawal by Subject|1|||
143464739|NCT01723254|517246384|FG003|Overall Study|Withdrawal by Subject|0|||
143464740|NCT01723254|517246385|FG004|Overall Study|Withdrawal by Subject|1|||
143464741|NCT01723254|517246386|FG005|Overall Study|Withdrawal by Subject|1|||
143464742|NCT01723254|517246387|FG006|Overall Study|Withdrawal by Subject|1|||
143464743|NCT01723254|517246388|FG007|Overall Study|Withdrawal by Subject|2|||
143464744|NCT02668185|517246389|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
143464745|NCT02668185|517246390|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
143464746|NCT02668185|517246389|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
143464747|NCT02668185|517246390|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
143464748|NCT02668185|517246389|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
143464749|NCT02668185|517246390|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
143464750|NCT02668185|517246389|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
143464751|NCT02668185|517246390|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
143464752|NCT00770341|517246391|FG000|Overall Study|Did not meet eligibility criteria|1|||
143464753|NCT00770341|517246392|FG001|Overall Study|Did not meet eligibility criteria|0|||
143464754|NCT00770341|517246393|FG002|Overall Study|Did not meet eligibility criteria|0|||
143464755|NCT00770341|517246391|FG000|Overall Study|Withdrawal by Subject|0|||
143464756|NCT00770341|517246392|FG001|Overall Study|Withdrawal by Subject|1|||
143464757|NCT00770341|517246393|FG002|Overall Study|Withdrawal by Subject|0|||
143464758|NCT00770341|517246391|FG000|Overall Study|Clinical Adverse Event|3|||
143464759|NCT00770341|517246392|FG001|Overall Study|Clinical Adverse Event|1|||
143464760|NCT00770341|517246393|FG002|Overall Study|Clinical Adverse Event|2|||
143464761|NCT00770341|517246391|FG000|Overall Study|Laboratory adverse event|3|||
143464762|NCT00770341|517246392|FG001|Overall Study|Laboratory adverse event|3|||
143464763|NCT00770341|517246393|FG002|Overall Study|Laboratory adverse event|0|||
143464764|NCT00770341|517246391|FG000|Overall Study|Lack of Efficacy|3|||
143464765|NCT00770341|517246392|FG001|Overall Study|Lack of Efficacy|0|||
143464766|NCT00770341|517246393|FG002|Overall Study|Lack of Efficacy|1|||
143464767|NCT00770341|517246391|FG000|Overall Study|Other|1|||
143464768|NCT00770341|517246392|FG001|Overall Study|Other|0|||
143464769|NCT00770341|517246393|FG002|Overall Study|Other|0|||
143464770|NCT00770341|517246391|FG000|Overall Study|Not treated|1|||
143464771|NCT00770341|517246392|FG001|Overall Study|Not treated|0|||
143464772|NCT00770341|517246393|FG002|Overall Study|Not treated|0|||
143464773|NCT03316300|517246395|FG000|Overall Study|Withdrawal by Subject|3|||
143464774|NCT03316300|517246396|FG001|Overall Study|Withdrawal by Subject|2|||
143464775|NCT03316300|517246395|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
143464776|NCT03316300|517246396|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
143464777|NCT03316300|517246395|FG000|Overall Study|Adverse Event|1|||
143464778|NCT03316300|517246396|FG001|Overall Study|Adverse Event|0|||
143464779|NCT03316300|517246395|FG000|Overall Study|COVID-19|0|||
143464780|NCT03316300|517246396|FG001|Overall Study|COVID-19|1|||
143464781|NCT02390245|517246400|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
143464782|NCT02390245|517246401|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
143464783|NCT02390245|517246402|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
143464784|NCT02390245|517246400|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
143464785|NCT02390245|517246401|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
143464786|NCT02390245|517246402|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
143464787|NCT01340196|517247965|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
143464788|NCT00604279|517247969|FG000|Overall Study|Lack of Efficacy|22|||
143464789|NCT00604279|517247970|FG001|Overall Study|Lack of Efficacy|9|||
143464790|NCT00604279|517247969|FG000|Overall Study|Lost to Follow-up|9|||
143464791|NCT00604279|517247970|FG001|Overall Study|Lost to Follow-up|14|||
143464792|NCT00604279|517247969|FG000|Overall Study|Pregnancy|2|||
143464793|NCT00604279|517247970|FG001|Overall Study|Pregnancy|0|||
143464794|NCT00604279|517247969|FG000|Overall Study|Protocol Violation|3|||
143464795|NCT00604279|517247970|FG001|Overall Study|Protocol Violation|1|||
143464796|NCT00604279|517247969|FG000|Overall Study|Withdrawal by Subject|16|||
143464797|NCT00604279|517247970|FG001|Overall Study|Withdrawal by Subject|5|||
143464798|NCT00604279|517247969|FG000|Overall Study|Adverse Event|4|||
143464799|NCT00604279|517247970|FG001|Overall Study|Adverse Event|5|||
143464800|NCT00604279|517247969|FG000|Overall Study|Other|8|||
143464801|NCT00604279|517247970|FG001|Overall Study|Other|4|||
143464802|NCT00601419|517247971|FG000|Overall Study|Lost to Follow-up|3|||
143464803|NCT00601419|517247971|FG000|Overall Study|Missed Visits|1|||
143464804|NCT03628898|517247973|FG000|Overall Study|Device deficiency|1|||
143464805|NCT00971932|517247974|FG000|Overall Study|Withdrawal by Subject|1|||
143127829|NCT03410992|516014565|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
143127830|NCT03410992|516014555|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
143127831|NCT03410992|516014556|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
143127832|NCT03410992|516014557|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
143127833|NCT03410992|516014558|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
143127834|NCT03410992|516014559|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
143127835|NCT03410992|516014560|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
143127836|NCT03410992|516014561|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
143127837|NCT03410992|516014562|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
143127838|NCT03410992|516014563|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
143127839|NCT03410992|516014564|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
143127840|NCT03410992|516014565|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
143127841|NCT03410992|516014555|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
143127842|NCT03410992|516014556|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
143127843|NCT03410992|516014557|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
143127844|NCT03410992|516014558|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
143127845|NCT03410992|516014559|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
143127846|NCT03410992|516014560|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
143127847|NCT03410992|516014561|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
143127848|NCT03410992|516014562|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
143127849|NCT03410992|516014563|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
143127850|NCT03410992|516014564|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
143127851|NCT03410992|516014565|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
143127852|NCT03410992|516014555|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
143127853|NCT03410992|516014556|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
143127854|NCT03410992|516014557|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
143127855|NCT03410992|516014558|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
143127856|NCT03410992|516014559|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
143127857|NCT03410992|516014560|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
143127858|NCT03410992|516014561|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
143127859|NCT03410992|516014562|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
143127860|NCT03410992|516014563|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
143127861|NCT03410992|516014564|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
143127862|NCT03410992|516014565|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
143127863|NCT02620787|516014566|FG000|Overall Study|Adverse Event|1|||
143127864|NCT02620787|516014567|FG001|Overall Study|Adverse Event|0|||
143127865|NCT02620787|516014566|FG000|Overall Study|Eligibility Criteria Not Met|1|||
143127866|NCT02620787|516014567|FG001|Overall Study|Eligibility Criteria Not Met|0|||
143127867|NCT01896193|516014569|FG000|Overall Study|Lack of Efficacy|20|||
143127868|NCT01896193|516014570|FG001|Overall Study|Lack of Efficacy|11|||
143127869|NCT01896193|516014569|FG000|Overall Study|Protocol Violation|0|||
143127870|NCT01896193|516014570|FG001|Overall Study|Protocol Violation|1|||
143127871|NCT01896193|516014569|FG000|Overall Study|Withdrew Consent|1|||
143127872|NCT01896193|516014570|FG001|Overall Study|Withdrew Consent|0|||
143127873|NCT02420262|516014579|FG000|Overall Study|Adverse Event|1|||
143127874|NCT02420262|516014580|FG001|Overall Study|Adverse Event|0|||
143127875|NCT02420262|516014579|FG000|Overall Study|Withdrawal by Subject|1|||
143127876|NCT02420262|516014580|FG001|Overall Study|Withdrawal by Subject|4|||
143127877|NCT02420262|516014579|FG000|Overall Study|Unclassified|0|||
143127878|NCT02420262|516014580|FG001|Overall Study|Unclassified|1|||
143127879|NCT01436227|516014587|FG000|Overall Study|Adverse Event|7|||
143127880|NCT01436227|516014587|FG000|Overall Study|Death|1|||
143127881|NCT01436227|516014587|FG000|Overall Study|Lack of Efficacy|1|||
143127882|NCT01436227|516014587|FG000|Overall Study|Lost to Follow-up|3|||
143127883|NCT01436227|516014587|FG000|Overall Study|Physician Decision|1|||
143127884|NCT01436227|516014587|FG000|Overall Study|Withdrawal by Subject|7|||
143464806|NCT00971932|517247974|FG000|Overall Study|Investigator's decision|2|||
143127885|NCT01436227|516014587|FG000|Overall Study|Disease progression, relapse|6|||
143127886|NCT00110357|516014590|FG000|Overall Study|Deterioration without progression|2|||
143127887|NCT00110357|516014591|FG001|Overall Study|Deterioration without progression|0|||
143127888|NCT00110357|516014590|FG000|Overall Study|Disease progression/relapse|20|||
143127889|NCT00110357|516014591|FG001|Overall Study|Disease progression/relapse|15|||
143127890|NCT00110357|516014590|FG000|Overall Study|Study Closure|1|||
143127891|NCT00110357|516014591|FG001|Overall Study|Study Closure|0|||
143230343|NCT00446849|516393205|FG000|Maintenance Phase|Lost to Follow-up|3|||
143464807|NCT00971932|517247974|FG000|Overall Study|Ongoing|4|||
143464808|NCT01217957|517247975|FG000|Phase 1|Withdrawal by Patient|1|||
143464809|NCT01217957|517247976|FG001|Phase 1|Withdrawal by Patient|0|||
143464810|NCT01217957|517247977|FG002|Phase 1|Withdrawal by Patient|1|||
143464811|NCT01217957|517247978|FG003|Phase 1|Withdrawal by Patient|1|||
143464812|NCT01217957|517247979|FG004|Phase 1|Withdrawal by Patient|0|||
143464813|NCT01217957|517247975|FG000|Phase 2|Withdrawal by Patient|0|||
143464814|NCT01217957|517247976|FG001|Phase 2|Withdrawal by Patient|0|||
143464815|NCT01217957|517247977|FG002|Phase 2|Withdrawal by Patient|0|||
143464816|NCT01217957|517247978|FG003|Phase 2|Withdrawal by Patient|0|||
143464817|NCT01217957|517247979|FG004|Phase 2|Withdrawal by Patient|1|||
143464818|NCT01765192|517247983|FG000|Treatment Period 1|Adverse Event|0|||
143464819|NCT01765192|517247984|FG001|Treatment Period 1|Adverse Event|1|||
143464820|NCT01765192|517247983|FG000|Washout Period|Voluntary Withdrawal|1|||
143464821|NCT01765192|517247984|FG001|Washout Period|Voluntary Withdrawal|1|||
143464822|NCT01765192|517247983|FG000|Washout Period|Reason not specified|1|||
143464823|NCT01765192|517247984|FG001|Washout Period|Reason not specified|0|||
143464824|NCT01765192|517247983|FG000|Treatment Period 2|Reason not specified|0|||
143464825|NCT01765192|517247984|FG001|Treatment Period 2|Reason not specified|2|||
143464826|NCT01765192|517247983|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
143464827|NCT01765192|517247984|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
143464828|NCT00288509|517247991|FG000|Treatment Cycle 1|Adverse Event|1|||
143464829|NCT00288509|517247991|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
143464830|NCT00288509|517247991|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
143464831|NCT00288509|517247991|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
143464832|NCT00288509|517247991|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
143464833|NCT00288509|517247991|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
143464834|NCT00288509|517247991|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
143464835|NCT00288509|517247991|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
143464836|NCT00288509|517247991|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
143464837|NCT00288509|517247991|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
143464838|NCT00288509|517247991|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
143464839|NCT00288509|517247991|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
143464840|NCT00288509|517247991|FG000|Treatment Cycle 4|Physician Decision|4|||
143464841|NCT00288509|517247991|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
143464842|NCT01215422|517247992|FG000|Overall Study|Relocation|1|||
143464843|NCT01215422|517247993|FG001|Overall Study|Relocation|0|||
143464844|NCT01215422|517247994|FG002|Overall Study|Relocation|0|||
143464845|NCT01215422|517247995|FG003|Overall Study|Relocation|0|||
143464846|NCT01215422|517247992|FG000|Overall Study|Failed intubations|0|||
143464847|NCT01215422|517247993|FG001|Overall Study|Failed intubations|0|||
143464848|NCT01215422|517247994|FG002|Overall Study|Failed intubations|3|||
143464849|NCT01215422|517247995|FG003|Overall Study|Failed intubations|8|||
143464850|NCT01215422|517247992|FG000|Overall Study|Did not complete all intubations|7|||
143464851|NCT01215422|517247993|FG001|Overall Study|Did not complete all intubations|0|||
143464852|NCT01215422|517247994|FG002|Overall Study|Did not complete all intubations|0|||
143464853|NCT01215422|517247995|FG003|Overall Study|Did not complete all intubations|0|||
143464854|NCT06336603|517248000|FG000|Overall Study|Withdrawal by Subject|1|||
143464855|NCT06336603|517248000|FG000|Overall Study|Lost to Follow-up|2|||
143464856|NCT01146054|517248003|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
143464857|NCT01146054|517248003|FG000|Overall Study|Rapid tumor progression|2|||
143464858|NCT01146054|517248003|FG000|Overall Study|Other illness precluded treatment|2|||
143464859|NCT01146054|517248003|FG000|Overall Study|Lost to Follow-up|1|||
143464860|NCT04335812|517248004|FG000|Overall Study|Withdrawal by Subject|1|||
143464861|NCT04335812|517248005|FG001|Overall Study|Withdrawal by Subject|3|||
143464862|NCT04335812|517248004|FG000|Overall Study|Lost to Follow-up|12|||
143464863|NCT04335812|517248005|FG001|Overall Study|Lost to Follow-up|12|||
143464864|NCT04335812|517248004|FG000|Overall Study|Did not engage in the intervention|22|||
143464865|NCT04335812|517248005|FG001|Overall Study|Did not engage in the intervention|18|||
143464866|NCT02901041|517248011|FG000|Overall Study|Withdrawal by PI|4|||
143464867|NCT02901041|517248012|FG001|Overall Study|Withdrawal by PI|8|||
143464868|NCT02901041|517248011|FG000|Overall Study|Withdrawal by Subject|7|||
143464869|NCT02901041|517248012|FG001|Overall Study|Withdrawal by Subject|3|||
143464870|NCT01480674|517248013|FG000|Overall Study|Death|23|||
143464871|NCT01480674|517248013|FG000|Overall Study|Lost to Follow-up|2|||
143464872|NCT01480674|517248013|FG000|Overall Study|visit not done|10|||
143464873|NCT03249714|517248017|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
143464874|NCT03249714|517248018|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
143464875|NCT03249714|517248017|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
143464876|NCT03249714|517248018|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
143464877|NCT03249714|517248017|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
143464878|NCT03249714|517248018|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
143464879|NCT03249714|517248017|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
143464880|NCT03249714|517248018|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
143127892|NCT00110357|516014590|FG000|Overall Study|Study Drug Toxicity|1|||
143464881|NCT00655863|517248026|FG000|Overall Study|Lost to Follow-up|0|||
143464882|NCT00655863|517248027|FG001|Overall Study|Lost to Follow-up|0|||
143127893|NCT00110357|516014591|FG001|Overall Study|Study Drug Toxicity|3|||
143127894|NCT00110357|516014590|FG000|Overall Study|Withdrawal by Subject|3|||
143127895|NCT00110357|516014591|FG001|Overall Study|Withdrawal by Subject|1|||
143127896|NCT03382418|516014592|FG000|Overall Study|Withdrawal by Subject|1|||
143127897|NCT03382418|516014593|FG001|Overall Study|Withdrawal by Subject|0|||
143127898|NCT03382418|516014594|FG002|Overall Study|Withdrawal by Subject|0|||
143127899|NCT03382418|516014592|FG000|Overall Study|Lost to Follow-up|2|||
143127900|NCT03382418|516014593|FG001|Overall Study|Lost to Follow-up|3|||
143127901|NCT03382418|516014594|FG002|Overall Study|Lost to Follow-up|0|||
143127902|NCT02137226|516014599|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
143127903|NCT02137226|516014600|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
143127904|NCT02137226|516014601|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
143127905|NCT02137226|516014602|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
143127906|NCT02137226|516014603|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
143127907|NCT02137226|516014599|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
143464883|NCT00655863|517248028|FG002|Overall Study|Lost to Follow-up|1|||
143464884|NCT01138007|517248029|FG000|Overall Study|Adverse Event|4|||
143464885|NCT01138007|517248030|FG001|Overall Study|Adverse Event|12|||
143464886|NCT01138007|517248031|FG002|Overall Study|Adverse Event|9|||
143464887|NCT01138007|517248029|FG000|Overall Study|Lack of Efficacy|2|||
143464888|NCT01138007|517248030|FG001|Overall Study|Lack of Efficacy|0|||
143464889|NCT01138007|517248031|FG002|Overall Study|Lack of Efficacy|6|||
143464890|NCT01138007|517248029|FG000|Overall Study|Protocol Violation|2|||
143464891|NCT01138007|517248030|FG001|Overall Study|Protocol Violation|3|||
143464892|NCT01138007|517248031|FG002|Overall Study|Protocol Violation|2|||
143464893|NCT01138007|517248029|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
143464894|NCT01138007|517248030|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
143464895|NCT01138007|517248031|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
143464896|NCT01138007|517248029|FG000|Overall Study|Lost to Follow-up|3|||
143464897|NCT01138007|517248030|FG001|Overall Study|Lost to Follow-up|3|||
143464898|NCT01138007|517248031|FG002|Overall Study|Lost to Follow-up|5|||
143464899|NCT01138007|517248029|FG000|Overall Study|Physician Decision|0|||
143464900|NCT01138007|517248030|FG001|Overall Study|Physician Decision|5|||
143464901|NCT01138007|517248031|FG002|Overall Study|Physician Decision|3|||
143464902|NCT01138007|517248029|FG000|Overall Study|Withdrawal by Subject|5|||
143464903|NCT01138007|517248030|FG001|Overall Study|Withdrawal by Subject|6|||
143464904|NCT01138007|517248031|FG002|Overall Study|Withdrawal by Subject|15|||
143464905|NCT03548987|517248032|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
143464906|NCT03548987|517248033|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
143464907|NCT03548987|517248032|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
143464908|NCT03548987|517248033|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
143464909|NCT03548987|517248032|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
143464910|NCT03548987|517248033|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
143464911|NCT03548987|517248032|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
143464912|NCT03548987|517248033|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
143464913|NCT03548987|517248032|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
143464914|NCT03548987|517248033|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
143464915|NCT03548987|517248032|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
143464916|NCT03548987|517248033|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
143464917|NCT03548987|517248032|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
143464918|NCT03548987|517248033|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
143464919|NCT03548987|517248032|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
143464920|NCT03548987|517248033|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
143464921|NCT03548987|517248032|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
143464922|NCT03548987|517248033|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
143464923|NCT03548987|517248032|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
143464924|NCT03548987|517248033|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
143464925|NCT03548987|517248032|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
143464926|NCT03548987|517248033|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
143464927|NCT03548987|517248032|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
143464928|NCT03548987|517248033|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
143464929|NCT03548987|517248032|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
143464930|NCT03548987|517248033|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
143464931|NCT03548987|517248032|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
143464932|NCT03548987|517248033|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
143464933|NCT04661878|517248034|FG000|Overall Study|Lost to Follow-up|6|||
143464934|NCT04661878|517248035|FG001|Overall Study|Lost to Follow-up|5|||
143464935|NCT00640016|517248038|FG000|Overall Study|Withdrawal by Subject|0|||
143464936|NCT00640016|517248039|FG001|Overall Study|Withdrawal by Subject|1|||
143464937|NCT00640016|517248040|FG002|Overall Study|Withdrawal by Subject|0|||
143127908|NCT02137226|516014600|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
143127909|NCT02137226|516014601|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
143127910|NCT02137226|516014602|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
143464938|NCT00640016|517248041|FG003|Overall Study|Withdrawal by Subject|0|||
143464939|NCT00640016|517248038|FG000|Overall Study|Study termination|2|||
143464940|NCT00640016|517248039|FG001|Overall Study|Study termination|1|||
143464941|NCT00640016|517248040|FG002|Overall Study|Study termination|3|||
143464942|NCT00640016|517248041|FG003|Overall Study|Study termination|2|||
143464943|NCT00640016|517248038|FG000|Overall Study|Adverse Event|0|||
143464944|NCT00640016|517248039|FG001|Overall Study|Adverse Event|0|||
143127911|NCT02137226|516014603|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
143127912|NCT02137226|516014599|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
143127913|NCT02137226|516014600|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
143127914|NCT02137226|516014601|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
143127915|NCT02137226|516014602|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
143127916|NCT02137226|516014603|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
143127917|NCT02137226|516014599|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
143127918|NCT02137226|516014600|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
143127919|NCT02137226|516014601|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
143127920|NCT02137226|516014602|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
143127921|NCT02137226|516014603|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
143127922|NCT02137226|516014599|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
143127923|NCT02137226|516014600|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
143127924|NCT02137226|516014601|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
143127925|NCT02137226|516014602|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
143127926|NCT02137226|516014603|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
143127927|NCT02137226|516014599|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
143127928|NCT02137226|516014600|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
143127929|NCT02137226|516014601|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
143127930|NCT02137226|516014602|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
143127931|NCT02137226|516014603|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
143127932|NCT02137226|516014599|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
143127933|NCT02137226|516014600|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
143127934|NCT02137226|516014601|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
143127935|NCT02137226|516014602|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
143127936|NCT02137226|516014603|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
143127937|NCT02137226|516014599|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
143127938|NCT02137226|516014600|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
143127939|NCT02137226|516014601|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
143127940|NCT02137226|516014602|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
143127941|NCT02137226|516014603|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
143127942|NCT02137226|516014599|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
143127943|NCT02137226|516014600|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
143127944|NCT02137226|516014601|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
143127945|NCT02137226|516014602|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
143127946|NCT02137226|516014603|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
143127947|NCT02137226|516014599|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
143127948|NCT02137226|516014600|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
143127949|NCT02137226|516014601|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
143127950|NCT02137226|516014602|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
143127951|NCT02137226|516014603|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
143127952|NCT02137226|516014599|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
143127953|NCT02137226|516014600|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
143127954|NCT02137226|516014601|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
143127955|NCT02137226|516014602|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
143127956|NCT02137226|516014603|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
143127957|NCT02137226|516014599|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
143127958|NCT02137226|516014600|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
143127959|NCT02137226|516014601|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
143127960|NCT02137226|516014602|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
143127961|NCT02137226|516014603|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
143127962|NCT00571662|516014615|FG000|Overall Study|Withdrawal by Subject|2|||
143127963|NCT00571662|516014615|FG000|Overall Study|psychiatric instability|1|||
143127964|NCT00571662|516014615|FG000|Overall Study|Adverse Event|5|||
143464945|NCT00640016|517248040|FG002|Overall Study|Adverse Event|0|||
143464946|NCT00640016|517248041|FG003|Overall Study|Adverse Event|1|||
143464947|NCT00615836|517248042|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
143464948|NCT00615836|517248043|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
143464949|NCT00615836|517248044|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
143464950|NCT00615836|517248045|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
143464951|NCT00615836|517248046|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
143464952|NCT00615836|517248042|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
143464953|NCT00615836|517248043|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
143464954|NCT00615836|517248044|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
143464955|NCT00615836|517248045|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
143464956|NCT00615836|517248046|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
143464957|NCT00615836|517248042|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
143464958|NCT00615836|517248043|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
143464959|NCT00615836|517248044|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
143464960|NCT00615836|517248045|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
143464961|NCT00615836|517248046|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
143464962|NCT00615836|517248042|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
143464963|NCT00615836|517248043|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
143464964|NCT00615836|517248044|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
143464965|NCT00615836|517248045|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
143464966|NCT00615836|517248046|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
143464967|NCT00615836|517248042|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
143464968|NCT00615836|517248043|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
143464969|NCT00615836|517248044|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
143464970|NCT00615836|517248045|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
143464971|NCT00615836|517248046|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
143464972|NCT00615836|517248042|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
143464973|NCT00615836|517248043|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
143464974|NCT00615836|517248044|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
143464975|NCT00615836|517248045|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
143464976|NCT00615836|517248046|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
143464977|NCT00615836|517248042|FG000|Extension Study (FE992026 CS31)|Other|10|||
143464978|NCT00615836|517248043|FG001|Extension Study (FE992026 CS31)|Other|7|||
143464979|NCT00615836|517248044|FG002|Extension Study (FE992026 CS31)|Other|8|||
143464980|NCT00615836|517248045|FG003|Extension Study (FE992026 CS31)|Other|8|||
143464981|NCT00615836|517248046|FG004|Extension Study (FE992026 CS31)|Other|0|||
143464982|NCT00615836|517248042|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
143464983|NCT00615836|517248043|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
143464984|NCT00615836|517248044|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
143464985|NCT00615836|517248045|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
143464986|NCT00615836|517248046|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
143464987|NCT00615836|517248042|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
143464988|NCT00615836|517248043|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
143464989|NCT00615836|517248044|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
143464990|NCT00615836|517248045|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
143464991|NCT00615836|517248046|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
143464992|NCT01630434|517248047|FG000|Overall Study|Donor lungs turned down|1|||
143464993|NCT01630434|517248048|FG001|Overall Study|Donor lungs turned down|0|||
143464994|NCT01630434|517248047|FG000|Overall Study|Protocol Violation|9|||
143464995|NCT01630434|517248048|FG001|Overall Study|Protocol Violation|4|||
143464996|NCT01630434|517248047|FG000|Overall Study|Death|20|||
143464997|NCT01630434|517248048|FG001|Overall Study|Death|26|||
143464998|NCT00687973|517248049|FG000|Overall Study|Adverse Event|18|||
143464999|NCT00687973|517248050|FG001|Overall Study|Adverse Event|28|||
143465000|NCT00687973|517248049|FG000|Overall Study|Lack of Efficacy|2|||
143465001|NCT00687973|517248050|FG001|Overall Study|Lack of Efficacy|3|||
143465002|NCT00687973|517248049|FG000|Overall Study|Protocol Violation|1|||
143465003|NCT00687973|517248050|FG001|Overall Study|Protocol Violation|2|||
143465004|NCT00687973|517248049|FG000|Overall Study|Administrative Reasons|0|||
143465005|NCT00687973|517248050|FG001|Overall Study|Administrative Reasons|2|||
143465006|NCT00687973|517248049|FG000|Overall Study|Withdrawal by Subject|3|||
143465007|NCT00687973|517248050|FG001|Overall Study|Withdrawal by Subject|3|||
143465008|NCT02578862|517248052|FG000|Overall Study|Withdrawal by Subject|0|||
143465009|NCT02578862|517248053|FG001|Overall Study|Withdrawal by Subject|1|||
143465010|NCT02578862|517248052|FG000|Overall Study|Unplanned unilateral procedure|0|||
143465011|NCT02578862|517248053|FG001|Overall Study|Unplanned unilateral procedure|1|||
143465012|NCT00343252|517248057|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
143465013|NCT00343252|517248058|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
143465014|NCT00343252|517248057|FG000|6 Months (All Treated Participants)|Death|0|||
143465015|NCT00343252|517248058|FG001|6 Months (All Treated Participants)|Death|2|||
143465016|NCT00343252|517248057|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
143465017|NCT00343252|517248058|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
143465018|NCT00343252|517248057|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
143465019|NCT00343252|517248058|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
143465020|NCT00343252|517248057|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
143465021|NCT00343252|517248058|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
143465022|NCT00343252|517248057|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
143013715|NCT03747939|515590015|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
143013716|NCT03747939|515590016|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
143013717|NCT03747939|515590017|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
143013718|NCT03747939|515590014|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
143013719|NCT03747939|515590015|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
143013720|NCT03747939|515590016|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
143013721|NCT03747939|515590017|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
143013722|NCT03747939|515590014|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
143013723|NCT03747939|515590015|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
143013724|NCT03747939|515590016|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
143013725|NCT03747939|515590017|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
143013726|NCT03747939|515590014|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
143013727|NCT03747939|515590015|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
143013728|NCT03747939|515590016|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
143013729|NCT03747939|515590017|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
143013730|NCT03747939|515590014|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
143013731|NCT03747939|515590015|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
143013732|NCT03747939|515590016|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
143013733|NCT03747939|515590017|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
143013734|NCT03747939|515590014|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
143013735|NCT03747939|515590015|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
143013736|NCT03747939|515590016|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
143013737|NCT03747939|515590017|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
143013738|NCT03747939|515590014|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
143013739|NCT03747939|515590015|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
143013740|NCT03747939|515590016|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
143013741|NCT03747939|515590017|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
143013742|NCT03747939|515590014|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
143013743|NCT03747939|515590015|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
143013744|NCT03747939|515590016|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
143013745|NCT03747939|515590017|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
143013746|NCT03747939|515590014|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
143013747|NCT03747939|515590015|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
143013748|NCT03747939|515590016|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
143013749|NCT03747939|515590017|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
143013750|NCT03747939|515590014|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
143013751|NCT03747939|515590015|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
143013752|NCT03747939|515590016|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
143013753|NCT03747939|515590017|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
143013754|NCT03747939|515590014|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
143013755|NCT03747939|515590015|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
143013756|NCT03747939|515590016|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
143013757|NCT03747939|515590017|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
143013758|NCT03747939|515590014|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
143013759|NCT03747939|515590015|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
143013760|NCT03747939|515590016|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
143013761|NCT03747939|515590017|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
143013762|NCT03747939|515590014|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
143013763|NCT03747939|515590015|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
143013764|NCT03747939|515590016|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
143013765|NCT03747939|515590017|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
143013766|NCT00185731|515590018|FG000|Overall Study|Withdrawal by Subject|1|||
143013767|NCT00185731|515590018|FG000|Overall Study|Not Eligible|1|||
143013768|NCT02494583|515590019|FG000|Overall Study|Death|224|||
143013769|NCT02494583|515590020|FG001|Overall Study|Death|214|||
143013770|NCT02494583|515590021|FG002|Overall Study|Death|225|||
143013771|NCT02494583|515590019|FG000|Overall Study|Lost to Follow-up|1|||
143013772|NCT02494583|515590020|FG001|Overall Study|Lost to Follow-up|0|||
143013773|NCT02494583|515590021|FG002|Overall Study|Lost to Follow-up|0|||
143013774|NCT02494583|515590019|FG000|Overall Study|Protocol Violation|1|||
143013775|NCT02494583|515590020|FG001|Overall Study|Protocol Violation|2|||
143013776|NCT02494583|515590021|FG002|Overall Study|Protocol Violation|0|||
143013777|NCT02494583|515590019|FG000|Overall Study|Screen Failure|0|||
143013778|NCT02494583|515590020|FG001|Overall Study|Screen Failure|1|||
143013779|NCT02494583|515590021|FG002|Overall Study|Screen Failure|0|||
143013780|NCT02494583|515590019|FG000|Overall Study|Transferred to Extension Study|15|||
143013781|NCT02494583|515590020|FG001|Overall Study|Transferred to Extension Study|15|||
143465023|NCT00343252|517248058|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
143465024|NCT00343252|517248057|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
143465025|NCT00343252|517248058|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
143465026|NCT00343252|517248057|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
143127965|NCT01868165|516014616|FG000|Overall Study|Withdrawal by Subject|36|||
143127966|NCT01868165|516014616|FG000|Overall Study|Physician Decision|2|||
143127967|NCT01868165|516014616|FG000|Overall Study|Lost to Follow-up|3|||
143127968|NCT01868165|516014616|FG000|Overall Study|Death|4|||
143127969|NCT01429298|516014617|FG000|Overall Study|Protocol Violation|4|||
143127970|NCT01429298|516014618|FG001|Overall Study|Protocol Violation|6|||
143127971|NCT02903420|516014621|FG000|Overall Study|Death|3|||
143127972|NCT02710084|516014624|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
143127973|NCT02710084|516014625|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
143127974|NCT05305989|516014626|FG000|Overall Study|Other|3|||
143127975|NCT05305989|516014627|FG001|Overall Study|Other|2|||
143127976|NCT05305989|516014628|FG002|Overall Study|Other|0|||
143127977|NCT05305989|516014626|FG000|Overall Study|Sponsor decision|2|||
143127978|NCT05305989|516014627|FG001|Overall Study|Sponsor decision|1|||
143127979|NCT05305989|516014628|FG002|Overall Study|Sponsor decision|0|||
143127980|NCT05305989|516014626|FG000|Overall Study|Protocol Violation|0|||
143127981|NCT05305989|516014627|FG001|Overall Study|Protocol Violation|1|||
143127982|NCT05305989|516014628|FG002|Overall Study|Protocol Violation|0|||
143127983|NCT05305989|516014626|FG000|Overall Study|Investigator decision|1|||
143127984|NCT05305989|516014627|FG001|Overall Study|Investigator decision|2|||
143127985|NCT05305989|516014628|FG002|Overall Study|Investigator decision|0|||
143127986|NCT05305989|516014626|FG000|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|3|||
143127987|NCT05305989|516014627|FG001|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
143127988|NCT05305989|516014628|FG002|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
143127989|NCT05305989|516014626|FG000|Overall Study|Adverse Event|1|||
143127990|NCT05305989|516014627|FG001|Overall Study|Adverse Event|1|||
143127991|NCT05305989|516014628|FG002|Overall Study|Adverse Event|0|||
143127992|NCT05305989|516014626|FG000|Overall Study|Enrolled but never dosed|3|||
143127993|NCT05305989|516014627|FG001|Overall Study|Enrolled but never dosed|2|||
143127994|NCT05305989|516014628|FG002|Overall Study|Enrolled but never dosed|1|||
143127995|NCT00282152|516014629|FG000|Overall Study|Withdrawal by Subject|1|||
143127996|NCT00282152|516014630|FG001|Overall Study|Withdrawal by Subject|0|||
143127997|NCT00585325|516014631|FG000|Overall Study|Withdrawal by Subject|1|||
143127998|NCT00585325|516014632|FG001|Overall Study|Withdrawal by Subject|1|||
143127999|NCT03092791|516014633|FG000|Overall Study|Lost to Follow-up|0|||
143128000|NCT03092791|516014634|FG001|Overall Study|Lost to Follow-up|0|||
143128001|NCT03092791|516014635|FG002|Overall Study|Lost to Follow-up|0|||
143128002|NCT03092791|516014636|FG003|Overall Study|Lost to Follow-up|0|||
143128003|NCT03092791|516014637|FG004|Overall Study|Lost to Follow-up|0|||
143128004|NCT03092791|516014638|FG005|Overall Study|Lost to Follow-up|0|||
143128005|NCT03092791|516014639|FG006|Overall Study|Lost to Follow-up|1|||
143128006|NCT03092791|516014640|FG007|Overall Study|Lost to Follow-up|0|||
143128007|NCT03092791|516014633|FG000|Overall Study|Withdrawal of Consent|0|||
143128008|NCT03092791|516014634|FG001|Overall Study|Withdrawal of Consent|0|||
143128009|NCT03092791|516014635|FG002|Overall Study|Withdrawal of Consent|0|||
143128010|NCT03092791|516014636|FG003|Overall Study|Withdrawal of Consent|0|||
143128011|NCT03092791|516014637|FG004|Overall Study|Withdrawal of Consent|4|||
143128012|NCT03092791|516014638|FG005|Overall Study|Withdrawal of Consent|12|||
143128013|NCT03092791|516014639|FG006|Overall Study|Withdrawal of Consent|6|||
143128014|NCT03092791|516014640|FG007|Overall Study|Withdrawal of Consent|4|||
143128015|NCT03092791|516014633|FG000|Overall Study|Study Termination|0|||
143128016|NCT03092791|516014634|FG001|Overall Study|Study Termination|0|||
143128017|NCT03092791|516014635|FG002|Overall Study|Study Termination|0|||
143128018|NCT03092791|516014636|FG003|Overall Study|Study Termination|0|||
143128019|NCT03092791|516014637|FG004|Overall Study|Study Termination|55|||
143128020|NCT03092791|516014638|FG005|Overall Study|Study Termination|46|||
143128021|NCT03092791|516014639|FG006|Overall Study|Study Termination|53|||
143128022|NCT03092791|516014640|FG007|Overall Study|Study Termination|55|||
143128023|NCT03092791|516014633|FG000|Overall Study|Death|0|||
143465027|NCT00343252|517248058|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
143128024|NCT03092791|516014634|FG001|Overall Study|Death|0|||
143128025|NCT03092791|516014635|FG002|Overall Study|Death|0|||
143128026|NCT03092791|516014636|FG003|Overall Study|Death|0|||
143230344|NCT00446849|516393205|FG000|Maintenance Phase|Pregnancy|1|||
143128027|NCT03092791|516014637|FG004|Overall Study|Death|0|||
143128028|NCT03092791|516014638|FG005|Overall Study|Death|1|||
143128029|NCT03092791|516014639|FG006|Overall Study|Death|0|||
143128030|NCT03092791|516014640|FG007|Overall Study|Death|1|||
143128031|NCT03092791|516014633|FG000|Overall Study|Reason Not Specified|0|||
143128032|NCT03092791|516014634|FG001|Overall Study|Reason Not Specified|0|||
143128033|NCT03092791|516014635|FG002|Overall Study|Reason Not Specified|0|||
143128034|NCT03092791|516014636|FG003|Overall Study|Reason Not Specified|0|||
143128035|NCT03092791|516014637|FG004|Overall Study|Reason Not Specified|1|||
143128036|NCT03092791|516014638|FG005|Overall Study|Reason Not Specified|1|||
143128037|NCT03092791|516014639|FG006|Overall Study|Reason Not Specified|0|||
143128038|NCT03092791|516014640|FG007|Overall Study|Reason Not Specified|0|||
143128039|NCT02182830|516014641|FG000|Overall Study|Not Treated|1|||
143128040|NCT02182830|516014642|FG001|Overall Study|Not Treated|1|||
143128041|NCT02182830|516014641|FG000|Overall Study|Trial stopped, reason missing|3|||
143128042|NCT02182830|516014642|FG001|Overall Study|Trial stopped, reason missing|3|||
143128043|NCT02182830|516014641|FG000|Overall Study|Consent withdrawn|8|||
143128044|NCT02182830|516014642|FG001|Overall Study|Consent withdrawn|8|||
143128045|NCT02182830|516014641|FG000|Overall Study|Lost to Follow-up|3|||
143128046|NCT02182830|516014642|FG001|Overall Study|Lost to Follow-up|3|||
143128047|NCT00154375|516014643|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
143128048|NCT00154375|516014644|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
143128049|NCT00154375|516014643|FG000|Overall Study|Adverse Event|18|||
143128050|NCT00154375|516014644|FG001|Overall Study|Adverse Event|20|||
143128051|NCT00154375|516014643|FG000|Overall Study|Withdrawal by Subject|14|||
143128052|NCT00154375|516014644|FG001|Overall Study|Withdrawal by Subject|10|||
143128053|NCT00154375|516014643|FG000|Overall Study|Death|5|||
143465028|NCT00343252|517248057|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
143465029|NCT00343252|517248058|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
143465030|NCT00343252|517248057|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
143465031|NCT00343252|517248058|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
143465032|NCT00343252|517248057|FG000|12 Months (All Treated Participants)|Death|3|||
143465033|NCT00343252|517248058|FG001|12 Months (All Treated Participants)|Death|3|||
143465034|NCT00343252|517248057|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
143465035|NCT00343252|517248058|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
143128054|NCT00154375|516014644|FG001|Overall Study|Death|13|||
143128055|NCT00154375|516014643|FG000|Overall Study|Study drug no longer required|5|||
143128056|NCT00154375|516014644|FG001|Overall Study|Study drug no longer required|3|||
143128057|NCT00154375|516014643|FG000|Overall Study|Lost to Follow-up|2|||
143465036|NCT00343252|517248057|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
143465037|NCT00343252|517248058|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
143465038|NCT00343252|517248057|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
143465039|NCT00343252|517248058|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
143465040|NCT00343252|517248057|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
143465041|NCT00343252|517248058|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
143465042|NCT00343252|517248057|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
143465043|NCT00343252|517248058|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
143465044|NCT00343252|517248057|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
143465045|NCT00343252|517248058|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
143465046|NCT00343252|517248057|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
143465047|NCT00343252|517248058|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
143465048|NCT00343252|517248057|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
143465049|NCT00343252|517248058|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
143465050|NCT00343252|517248057|FG000|18 Months (All Treated Participants)|Death|4|||
143465051|NCT00343252|517248058|FG001|18 Months (All Treated Participants)|Death|5|||
143465052|NCT00343252|517248057|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
143465053|NCT00343252|517248058|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
143465054|NCT00343252|517248057|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
143465055|NCT00343252|517248058|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
143465056|NCT00343252|517248057|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
143465057|NCT00343252|517248058|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
143465058|NCT00343252|517248057|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
143465059|NCT00343252|517248058|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
143465060|NCT00343252|517248057|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
143465061|NCT00343252|517248058|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
143465062|NCT00343252|517248057|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
143465063|NCT00343252|517248058|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
143465064|NCT00343252|517248057|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
143465065|NCT00343252|517248058|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
143128058|NCT00154375|516014644|FG001|Overall Study|Lost to Follow-up|1|||
143128059|NCT00154375|516014643|FG000|Overall Study|Abnormal laboratory value(s)|0|||
143128060|NCT00154375|516014644|FG001|Overall Study|Abnormal laboratory value(s)|2|||
143128061|NCT00154375|516014643|FG000|Overall Study|Protocol Violation|0|||
143128062|NCT00154375|516014644|FG001|Overall Study|Protocol Violation|1|||
143465066|NCT00731120|517248059|FG000|Overall Study|Adverse Event|7|||
143128063|NCT00154375|516014643|FG000|Overall Study|Suspected progression of disease|44|||
143128064|NCT00154375|516014644|FG001|Overall Study|Suspected progression of disease|30|||
143128065|NCT03538691|516014645|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
143128066|NCT03538691|516014646|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
143128067|NCT03538691|516014647|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
143128068|NCT03538691|516014648|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
143128069|NCT03538691|516014645|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
143128070|NCT03538691|516014646|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
143128071|NCT03538691|516014647|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
143128072|NCT03538691|516014648|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
143128073|NCT03538691|516014645|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
143128074|NCT03538691|516014646|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
143128075|NCT03538691|516014647|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
143128076|NCT03538691|516014648|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
143128077|NCT03538691|516014645|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
143128078|NCT03538691|516014646|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
143128079|NCT03538691|516014647|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
143128080|NCT03538691|516014648|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
143128081|NCT03538691|516014645|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
143128082|NCT03538691|516014646|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
143128083|NCT03538691|516014647|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
143128084|NCT03538691|516014648|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
143128085|NCT03538691|516014645|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
143128086|NCT03538691|516014646|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
143128087|NCT03538691|516014647|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
143128088|NCT03538691|516014648|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
143128089|NCT03538691|516014645|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
143128090|NCT03538691|516014646|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
143128091|NCT03538691|516014647|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
143128092|NCT03538691|516014648|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
143128093|NCT03538691|516014645|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
143128094|NCT03538691|516014646|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
143128095|NCT03538691|516014647|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
143128096|NCT03538691|516014648|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
143128097|NCT03538691|516014645|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
143128098|NCT03538691|516014646|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
143128099|NCT03538691|516014647|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
143128100|NCT03538691|516014648|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
143128101|NCT03538691|516014645|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
143128102|NCT03538691|516014646|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
143128103|NCT03538691|516014647|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
143128104|NCT03538691|516014648|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
143128105|NCT03538691|516014645|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
143128106|NCT03538691|516014646|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
143128107|NCT03538691|516014647|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
143128108|NCT03538691|516014648|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
143128109|NCT03538691|516014645|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
143128110|NCT03538691|516014646|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
143128111|NCT03538691|516014647|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
143128112|NCT03538691|516014648|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
143128113|NCT03538691|516014645|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
143128114|NCT03538691|516014646|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
143128115|NCT03538691|516014647|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
143128116|NCT03538691|516014648|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
143128117|NCT03538691|516014645|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
143128118|NCT03538691|516014646|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
143128119|NCT03538691|516014647|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
143128120|NCT03538691|516014648|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
143128121|NCT03538691|516014645|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
143230345|NCT00446849|516393205|FG000|Maintenance Phase|noncompliance|2|||
143230346|NCT00446849|516393205|FG000|Maintenance Phase|prohibited medication use|2|||
143230347|NCT00446849|516393205|FG000|Maintenance Phase|antibiotic use|1|||
143230348|NCT00446849|516393205|FG000|Maintenance Phase|study closure|1|||
143230349|NCT00446849|516393205|FG000|Maintenance Phase|hydrocodone use|1|||
143230350|NCT00446849|516393205|FG000|Maintenance Phase|concomitant medication use|1|||
143230351|NCT01194830|516393206|FG000|Overall Study|Adverse Event|3|||
143230352|NCT01194830|516393207|FG001|Overall Study|Adverse Event|2|||
143128122|NCT03538691|516014646|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
143128123|NCT03538691|516014647|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
143128124|NCT03538691|516014648|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
143128125|NCT03538691|516014645|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
143128126|NCT03538691|516014646|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
143128127|NCT03538691|516014647|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
143128128|NCT03538691|516014648|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
143128129|NCT03538691|516014645|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
143128130|NCT03538691|516014646|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
143128131|NCT03538691|516014647|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
143128132|NCT03538691|516014648|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
143128133|NCT03538691|516014645|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
143128134|NCT03538691|516014646|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
143230353|NCT01194830|516393206|FG000|Overall Study|Protocol Violation|5|||
143357283|NCT01815736|516853020|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
143357284|NCT01815736|516853019|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
143357285|NCT01815736|516853020|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
143357286|NCT01815736|516853019|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
143357287|NCT01815736|516853020|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
143357288|NCT01815736|516853019|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
143357289|NCT01815736|516853020|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
143357290|NCT01815736|516853019|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
143357291|NCT01815736|516853020|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
143357292|NCT01815736|516853019|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
143357293|NCT01815736|516853020|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
143357294|NCT01815736|516853019|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
143357295|NCT01815736|516853020|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
143357296|NCT01815736|516853019|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
143357297|NCT01815736|516853020|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
143357298|NCT01815736|516853019|FG000|Extension Treatment Phase- After Week 96|Death|1|||
143357299|NCT01815736|516853020|FG001|Extension Treatment Phase- After Week 96|Death|0|||
143357300|NCT04039503|516853021|FG000|Overall Study|Adverse Event|3|||
143357301|NCT04039503|516853022|FG001|Overall Study|Adverse Event|0|||
143357302|NCT04039503|516853023|FG002|Overall Study|Adverse Event|2|||
143357303|NCT04039503|516853024|FG003|Overall Study|Adverse Event|0|||
143357304|NCT04039503|516853021|FG000|Overall Study|Lost to Follow-up|0|||
143357305|NCT04039503|516853022|FG001|Overall Study|Lost to Follow-up|0|||
143357306|NCT04039503|516853023|FG002|Overall Study|Lost to Follow-up|1|||
143357307|NCT04039503|516853024|FG003|Overall Study|Lost to Follow-up|0|||
143357308|NCT04039503|516853021|FG000|Overall Study|Protocol Violation|0|||
143357309|NCT04039503|516853022|FG001|Overall Study|Protocol Violation|1|||
143357310|NCT04039503|516853023|FG002|Overall Study|Protocol Violation|2|||
143357311|NCT04039503|516853024|FG003|Overall Study|Protocol Violation|1|||
143357312|NCT04039503|516853021|FG000|Overall Study|Withdrawal by Subject|4|||
143357313|NCT04039503|516853022|FG001|Overall Study|Withdrawal by Subject|3|||
143357314|NCT04039503|516853023|FG002|Overall Study|Withdrawal by Subject|5|||
143357315|NCT04039503|516853024|FG003|Overall Study|Withdrawal by Subject|2|||
143357316|NCT04157686|516853028|FG000|Overall Study|Adverse Event|1|||
143357317|NCT04157686|516853029|FG001|Overall Study|Adverse Event|0|||
143357318|NCT04157686|516853030|FG002|Overall Study|Adverse Event|1|||
143357319|NCT04157686|516853031|FG003|Overall Study|Adverse Event|0|||
143357320|NCT04157686|516853032|FG004|Overall Study|Adverse Event|1|||
143357321|NCT04157686|516853033|FG005|Overall Study|Adverse Event|0|||
143357322|NCT04157686|516853034|FG006|Overall Study|Adverse Event|0|||
143357323|NCT04157686|516853035|FG007|Overall Study|Adverse Event|0|||
143357324|NCT04157686|516853028|FG000|Overall Study|Pregnancy|0|||
143357325|NCT04157686|516853029|FG001|Overall Study|Pregnancy|1|||
143357326|NCT04157686|516853030|FG002|Overall Study|Pregnancy|3|||
143357327|NCT04157686|516853031|FG003|Overall Study|Pregnancy|0|||
143357328|NCT04157686|516853032|FG004|Overall Study|Pregnancy|0|||
143357329|NCT04157686|516853033|FG005|Overall Study|Pregnancy|0|||
143357330|NCT04157686|516853034|FG006|Overall Study|Pregnancy|3|||
143357331|NCT04157686|516853035|FG007|Overall Study|Pregnancy|0|||
143357332|NCT04157686|516853028|FG000|Overall Study|Lost to Follow-up|1|||
143357333|NCT04157686|516853029|FG001|Overall Study|Lost to Follow-up|2|||
143357334|NCT04157686|516853030|FG002|Overall Study|Lost to Follow-up|8|||
143357335|NCT04157686|516853031|FG003|Overall Study|Lost to Follow-up|6|||
143357336|NCT04157686|516853032|FG004|Overall Study|Lost to Follow-up|6|||
143357337|NCT04157686|516853033|FG005|Overall Study|Lost to Follow-up|3|||
143357338|NCT04157686|516853034|FG006|Overall Study|Lost to Follow-up|7|||
143357339|NCT04157686|516853035|FG007|Overall Study|Lost to Follow-up|9|||
143357340|NCT04157686|516853028|FG000|Overall Study|Lack of Efficacy|0|||
143357341|NCT04157686|516853029|FG001|Overall Study|Lack of Efficacy|0|||
143357342|NCT04157686|516853030|FG002|Overall Study|Lack of Efficacy|0|||
143465067|NCT00731120|517248060|FG001|Overall Study|Adverse Event|6|||
143465068|NCT00731120|517248061|FG002|Overall Study|Adverse Event|8|||
143465069|NCT00731120|517248059|FG000|Overall Study|Lack of Efficacy|4|||
143465070|NCT00731120|517248060|FG001|Overall Study|Lack of Efficacy|5|||
143465071|NCT00731120|517248061|FG002|Overall Study|Lack of Efficacy|4|||
143465072|NCT00731120|517248059|FG000|Overall Study|Noncompliance with Study Drug|3|||
143465073|NCT00731120|517248060|FG001|Overall Study|Noncompliance with Study Drug|3|||
143465074|NCT00731120|517248061|FG002|Overall Study|Noncompliance with Study Drug|1|||
143465075|NCT00731120|517248059|FG000|Overall Study|Protocol Deviations|1|||
143465076|NCT00731120|517248060|FG001|Overall Study|Protocol Deviations|6|||
143465077|NCT00731120|517248061|FG002|Overall Study|Protocol Deviations|1|||
143465078|NCT00731120|517248059|FG000|Overall Study|Withdrawal of Consent|13|||
143465079|NCT00731120|517248060|FG001|Overall Study|Withdrawal of Consent|8|||
143465080|NCT00731120|517248061|FG002|Overall Study|Withdrawal of Consent|4|||
143465081|NCT00731120|517248059|FG000|Overall Study|Lost to Follow-up|10|||
143465082|NCT00731120|517248060|FG001|Overall Study|Lost to Follow-up|15|||
143465083|NCT00731120|517248061|FG002|Overall Study|Lost to Follow-up|17|||
143465084|NCT00731120|517248059|FG000|Overall Study|Other|4|||
143465085|NCT00731120|517248060|FG001|Overall Study|Other|0|||
143465086|NCT00731120|517248061|FG002|Overall Study|Other|1|||
143465087|NCT01142596|517248062|FG000|Overall Study|Withdrawal by Subject|9|||
143465088|NCT01142596|517248063|FG001|Overall Study|Withdrawal by Subject|35|||
143465089|NCT01142596|517248062|FG000|Overall Study|Adverse Event|8|||
143465090|NCT01142596|517248063|FG001|Overall Study|Adverse Event|35|||
143465091|NCT01142596|517248062|FG000|Overall Study|Lack of Efficacy|5|||
143465092|NCT01142596|517248063|FG001|Overall Study|Lack of Efficacy|9|||
143465093|NCT01142596|517248062|FG000|Overall Study|Lost to Follow-up|2|||
143465094|NCT01142596|517248063|FG001|Overall Study|Lost to Follow-up|3|||
143465095|NCT01142596|517248062|FG000|Overall Study|Other reason (not specified)|5|||
143465096|NCT01142596|517248063|FG001|Overall Study|Other reason (not specified)|4|||
143465097|NCT03181451|517248066|FG000|Overall Study|Adverse Event|0|||
143465098|NCT03181451|517248067|FG001|Overall Study|Adverse Event|1|||
143465099|NCT03181451|517248068|FG002|Overall Study|Adverse Event|0|||
143465100|NCT03181451|517248066|FG000|Overall Study|Withdrawal by Subject|0|||
143465101|NCT03181451|517248067|FG001|Overall Study|Withdrawal by Subject|1|||
143465102|NCT03181451|517248068|FG002|Overall Study|Withdrawal by Subject|0|||
143465103|NCT00723021|517248075|FG000|Intervention Period 4|Adverse Event|0|||
143465104|NCT00723021|517248076|FG001|Intervention Period 4|Adverse Event|0|||
143465105|NCT00723021|517248077|FG002|Intervention Period 4|Adverse Event|0|||
143465106|NCT00723021|517248078|FG003|Intervention Period 4|Adverse Event|0|||
143465107|NCT00723021|517248079|FG004|Intervention Period 4|Adverse Event|1|||
143465108|NCT04002401|517248080|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
143465109|NCT04002401|517248080|FG000|Overall Study|Death|10|||
143465110|NCT04002401|517248080|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
143465111|NCT04002401|517248080|FG000|Overall Study|Enrolled but Never Treated|1|||
143465112|NCT04002401|517248080|FG000|Overall Study|Lost to Follow-up|1|||
143465113|NCT01910181|517248083|FG000|Overall Study|Death|37|||
143465114|NCT01910181|517248083|FG000|Overall Study|Lost to Follow-up|3|||
143465115|NCT01910181|517248083|FG000|Overall Study|Study Terminated by Sponsor|6|||
143465116|NCT01340651|517248084|FG000|Overall Study|Adverse Event|3|||
143465117|NCT01340651|517248084|FG000|Overall Study|Consent Withdrawn|2|||
143465118|NCT01340651|517248084|FG000|Overall Study|Commercial Supply per Sponsor|12|||
143465119|NCT05269355|517248086|FG000|Overall Study|Progressive Disease|104|||
143465120|NCT05269355|517248087|FG001|Overall Study|Progressive Disease|68|||
143465121|NCT05269355|517248086|FG000|Overall Study|Study Terminated by Sponsor|87|||
143465122|NCT05269355|517248087|FG001|Overall Study|Study Terminated by Sponsor|29|||
143465123|NCT05269355|517248086|FG000|Overall Study|Adverse Event|15|||
143465124|NCT05269355|517248087|FG001|Overall Study|Adverse Event|8|||
143465125|NCT05269355|517248086|FG000|Overall Study|Withdrawal by Subject|18|||
143465126|NCT05269355|517248087|FG001|Overall Study|Withdrawal by Subject|5|||
143465127|NCT05269355|517248086|FG000|Overall Study|Physician Decision|6|||
143465128|NCT05269355|517248087|FG001|Overall Study|Physician Decision|4|||
143465129|NCT05269355|517248086|FG000|Overall Study|Death|3|||
143128135|NCT03538691|516014647|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
143128136|NCT03538691|516014648|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
143465130|NCT05269355|517248087|FG001|Overall Study|Death|5|||
143465131|NCT05269355|517248086|FG000|Overall Study|Other Than Specified|5|||
143465132|NCT05269355|517248087|FG001|Overall Study|Other Than Specified|1|||
143465133|NCT05269355|517248086|FG000|Overall Study|Randomized But Not Treated|1|||
143465134|NCT05269355|517248087|FG001|Overall Study|Randomized But Not Treated|0|||
143465135|NCT01050790|517248088|FG000|Overall Study|Adverse Event|1|||
143230354|NCT01194830|516393207|FG001|Overall Study|Protocol Violation|4|||
143465136|NCT03705832|517248089|FG000|Overall Study|Physician Decision|0|||
143465137|NCT03705832|517248090|FG001|Overall Study|Physician Decision|1|||
143465138|NCT03705832|517248089|FG000|Overall Study|Withdrawal by Subject|1|||
143465139|NCT03705832|517248090|FG001|Overall Study|Withdrawal by Subject|0|||
143465140|NCT01880528|517248091|FG000|Overall Study|Other|1|||
143465141|NCT01880528|517248092|FG001|Overall Study|Other|1|||
143465142|NCT00081497|517248093|FG000|Overall Study|Adverse Event|2|||
143465143|NCT00081497|517248094|FG001|Overall Study|Adverse Event|0|||
143465144|NCT00081497|517248093|FG000|Overall Study|Death|0|||
143465145|NCT00081497|517248094|FG001|Overall Study|Death|1|||
143465146|NCT00081497|517248093|FG000|Overall Study|Withdrawal by Subject|1|||
143465147|NCT00081497|517248094|FG001|Overall Study|Withdrawal by Subject|0|||
143465148|NCT00081497|517248093|FG000|Overall Study|Non-compliance|0|||
143465149|NCT00081497|517248094|FG001|Overall Study|Non-compliance|1|||
143465150|NCT00959647|517248095|FG000|Overall Study|Adverse Event|2|||
143465151|NCT00959647|517248095|FG000|Overall Study|Progressive disease|6|||
143465152|NCT00959647|517248095|FG000|Overall Study|Study terminated by sponsor|4|||
143465153|NCT00959647|517248095|FG000|Overall Study|Withdrawal by Subject|7|||
143465154|NCT00355056|517249449|FG000|Randomization Period|Early Termination|4|||
143465155|NCT00355056|517249450|FG001|Randomization Period|Early Termination|6|||
143465156|NCT01072877|517249454|FG000|Overall Study|Lost to Follow-up|1|||
143465157|NCT01072877|517249455|FG001|Overall Study|Lost to Follow-up|1|||
143465158|NCT01072877|517249456|FG002|Overall Study|Lost to Follow-up|0|||
143465159|NCT01072877|517249457|FG003|Overall Study|Lost to Follow-up|2|||
143465160|NCT01072877|517249458|FG004|Overall Study|Lost to Follow-up|0|||
143128137|NCT03538691|516014645|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
143128138|NCT03538691|516014646|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
143128139|NCT03538691|516014647|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
143128140|NCT03538691|516014648|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
143128141|NCT03538691|516014645|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
143128142|NCT03538691|516014646|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
143128143|NCT03538691|516014647|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
143128144|NCT03538691|516014648|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
143128145|NCT03538691|516014645|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
143128146|NCT03538691|516014646|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
143128147|NCT03538691|516014647|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
143128148|NCT03538691|516014648|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
143128149|NCT03538691|516014645|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
143128150|NCT03538691|516014646|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
143128151|NCT03538691|516014647|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
143128152|NCT03538691|516014648|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
143128153|NCT03538691|516014645|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
143128154|NCT03538691|516014646|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
143128155|NCT03538691|516014647|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
143128156|NCT03538691|516014648|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
143128157|NCT03538691|516014645|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
143128158|NCT03538691|516014646|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
143128159|NCT03538691|516014647|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
143128160|NCT03538691|516014648|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
143128161|NCT03538691|516014645|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
143128162|NCT03538691|516014646|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
143128163|NCT03538691|516014647|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
143128164|NCT03538691|516014648|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
143128165|NCT03538691|516014645|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
143128166|NCT03538691|516014646|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
143128167|NCT03538691|516014647|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
143128168|NCT03538691|516014648|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
143128169|NCT03538691|516014645|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
143465161|NCT00995020|517249459|FG000|Overall Study|margin analysis not performed|2|||
143465162|NCT00995020|517249460|FG001|Overall Study|margin analysis not performed|5|||
143465163|NCT00995020|517249459|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
143465164|NCT00995020|517249460|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
143465165|NCT02245672|517249461|FG000|Overall Study|Adverse Event|4|||
143465166|NCT02245672|517249462|FG001|Overall Study|Adverse Event|4|||
143465167|NCT02245672|517249463|FG002|Overall Study|Adverse Event|4|||
143465168|NCT02245672|517249461|FG000|Overall Study|Lost to Follow-up|3|||
143465169|NCT02245672|517249462|FG001|Overall Study|Lost to Follow-up|5|||
143465170|NCT02245672|517249463|FG002|Overall Study|Lost to Follow-up|1|||
143465171|NCT02245672|517249461|FG000|Overall Study|Withdrawal by Subject|6|||
143465172|NCT02245672|517249462|FG001|Overall Study|Withdrawal by Subject|3|||
143465173|NCT02245672|517249463|FG002|Overall Study|Withdrawal by Subject|0|||
143465174|NCT02245672|517249461|FG000|Overall Study|Randomized in error (not treated)|0|||
143465175|NCT02245672|517249462|FG001|Overall Study|Randomized in error (not treated)|1|||
143465176|NCT02245672|517249463|FG002|Overall Study|Randomized in error (not treated)|0|||
143465177|NCT02382016|517249464|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
143465178|NCT02382016|517249465|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
143465179|NCT02382016|517249464|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
143465180|NCT02382016|517249465|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
143465181|NCT02382016|517249464|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
143465182|NCT02382016|517249465|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
143128170|NCT03538691|516014646|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
143128171|NCT03538691|516014647|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
143128172|NCT03538691|516014648|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
143128173|NCT03538691|516014645|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
143128174|NCT03538691|516014646|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
143128175|NCT03538691|516014647|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
143128176|NCT03538691|516014648|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
143128177|NCT01588405|516014653|FG000|Overall Study|Adverse Event|1|||
143128178|NCT01588405|516014653|FG000|Overall Study|Clinical Worsening|1|||
143128179|NCT01366638|516014655|FG000|Overall Study|Withdrawal by Subject|0|||
143128180|NCT01366638|516014656|FG001|Overall Study|Withdrawal by Subject|0|||
143128181|NCT01366638|516014657|FG002|Overall Study|Withdrawal by Subject|6|||
143128182|NCT01366638|516014655|FG000|Overall Study|Other|1|||
143128183|NCT01366638|516014656|FG001|Overall Study|Other|0|||
143128184|NCT01366638|516014657|FG002|Overall Study|Other|0|||
143128185|NCT00636636|516014658|FG000|Overall Study|Other reason|4|||
143128186|NCT00636636|516014659|FG001|Overall Study|Other reason|6|||
143128187|NCT00636636|516014658|FG000|Overall Study|Adverse Event|19|||
143128188|NCT00636636|516014659|FG001|Overall Study|Adverse Event|8|||
143128189|NCT00636636|516014658|FG000|Overall Study|Lack of Efficacy|7|||
143128190|NCT00636636|516014659|FG001|Overall Study|Lack of Efficacy|12|||
143128191|NCT00636636|516014658|FG000|Overall Study|Protocol Violation|2|||
143128192|NCT00636636|516014659|FG001|Overall Study|Protocol Violation|2|||
143128193|NCT00636636|516014658|FG000|Overall Study|Lost to Follow-up|0|||
143128194|NCT00636636|516014659|FG001|Overall Study|Lost to Follow-up|1|||
143128195|NCT00636636|516014658|FG000|Overall Study|Death|0|||
143128196|NCT00636636|516014659|FG001|Overall Study|Death|1|||
143128197|NCT00636636|516014658|FG000|Overall Study|Withdrawal by Subject|4|||
143128198|NCT00636636|516014659|FG001|Overall Study|Withdrawal by Subject|9|||
143128199|NCT01237327|516014660|FG000|Overall Study|Protocol Violation: Core Study|1|||
143128200|NCT01237327|516014661|FG001|Overall Study|Protocol Violation: Core Study|0|||
143128201|NCT01237327|516014660|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
143128202|NCT01237327|516014661|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
143128203|NCT01237327|516014660|FG000|Overall Study|Progression of Disease: Core Study|18|||
143128204|NCT01237327|516014661|FG001|Overall Study|Progression of Disease: Core Study|22|||
143128205|NCT01237327|516014660|FG000|Overall Study|Progression of Disease: Extension Study|15|||
143128206|NCT01237327|516014661|FG001|Overall Study|Progression of Disease: Extension Study|13|||
143128207|NCT01237327|516014660|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
143128208|NCT01237327|516014661|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
143128209|NCT01237327|516014660|FG000|Overall Study|Withdrawal by Subject|1|||
143128210|NCT01237327|516014661|FG001|Overall Study|Withdrawal by Subject|3|||
143128211|NCT01237327|516014660|FG000|Overall Study|Lost to Follow-up|3|||
143128212|NCT01237327|516014661|FG001|Overall Study|Lost to Follow-up|0|||
143128213|NCT02748057|516016392|FG000|Overall Study|Adverse Event|1|||
143128214|NCT02748057|516016393|FG001|Overall Study|Adverse Event|0|||
143128215|NCT02748057|516016392|FG000|Overall Study|Physician Decision|0|||
143128216|NCT02748057|516016393|FG001|Overall Study|Physician Decision|1|||
143128217|NCT02748057|516016392|FG000|Overall Study|Protocol Violation|2|||
143128218|NCT02748057|516016393|FG001|Overall Study|Protocol Violation|1|||
143128219|NCT02748057|516016392|FG000|Overall Study|Participant Moved|1|||
143128220|NCT02748057|516016393|FG001|Overall Study|Participant Moved|0|||
143128221|NCT02748057|516016392|FG000|Overall Study|Withdrawal by Subject|1|||
143128222|NCT02748057|516016393|FG001|Overall Study|Withdrawal by Subject|0|||
143128223|NCT03335813|516016396|FG000|Overall Study|Withdrawal by Subject|1|||
143128224|NCT02861664|516016397|FG000|Overall Study|Withdrawal of Consent|0|||
143128225|NCT02861664|516016398|FG001|Overall Study|Withdrawal of Consent|1|||
143128226|NCT00905632|516016399|FG000|Overall Study|Adverse Event|0|||
143128227|NCT00905632|516016400|FG001|Overall Study|Adverse Event|0|||
143128228|NCT00905632|516016401|FG002|Overall Study|Adverse Event|0|||
143128229|NCT00905632|516016402|FG003|Overall Study|Adverse Event|0|||
143128230|NCT00905632|516016403|FG004|Overall Study|Adverse Event|0|||
143128231|NCT00905632|516016404|FG005|Overall Study|Adverse Event|1|||
143128232|NCT00905632|516016405|FG006|Overall Study|Adverse Event|4|||
143128233|NCT00524771|516016408|FG000|Overall Study|Protocol Violation|220|||
143128234|NCT00524771|516016409|FG001|Overall Study|Protocol Violation|585|||
143128235|NCT01223404|516016410|FG000|First Intervention (1 Day)|Adverse Event|0|||
143128236|NCT01223404|516016411|FG001|First Intervention (1 Day)|Adverse Event|0|||
143465183|NCT02382016|517249464|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
143465184|NCT02382016|517249465|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
143128237|NCT01223404|516016412|FG002|First Intervention (1 Day)|Adverse Event|0|||
143128238|NCT01223404|516016413|FG003|First Intervention (1 Day)|Adverse Event|1|||
143128239|NCT01223404|516016414|FG004|First Intervention (1 Day)|Adverse Event|0|||
143128240|NCT01223404|516016415|FG005|First Intervention (1 Day)|Adverse Event|0|||
143128241|NCT01223404|516016410|FG000|Second Intervention (1 Day)|Adverse Event|1|||
143128242|NCT01223404|516016411|FG001|Second Intervention (1 Day)|Adverse Event|0|||
143128243|NCT01223404|516016412|FG002|Second Intervention (1 Day)|Adverse Event|0|||
143128244|NCT01223404|516016413|FG003|Second Intervention (1 Day)|Adverse Event|0|||
143128245|NCT01223404|516016414|FG004|Second Intervention (1 Day)|Adverse Event|0|||
143128246|NCT01223404|516016415|FG005|Second Intervention (1 Day)|Adverse Event|0|||
143128247|NCT01223404|516016410|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
143128248|NCT01223404|516016411|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
143128249|NCT01223404|516016412|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
143128250|NCT01223404|516016413|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
143128251|NCT01223404|516016414|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
143128252|NCT01223404|516016415|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
143128253|NCT00707057|516016416|FG000|Overall Study|Withdrawal by Subject|8|||
143128254|NCT00707057|516016417|FG001|Overall Study|Withdrawal by Subject|3|||
143128255|NCT00707057|516016416|FG000|Overall Study|Dosed incorrectly|0|||
143128256|NCT00707057|516016417|FG001|Overall Study|Dosed incorrectly|1|||
143128257|NCT02492165|516016418|FG000|Overall Study|Withdrawal by Subject|0|||
143128258|NCT02492165|516016419|FG001|Overall Study|Withdrawal by Subject|1|||
143128259|NCT02492165|516016420|FG002|Overall Study|Withdrawal by Subject|0|||
143128260|NCT02492165|516016421|FG003|Overall Study|Withdrawal by Subject|0|||
143128261|NCT00305227|516016424|FG000|Overall Study|Lost to Follow-up|7|||
143128262|NCT00305227|516016425|FG001|Overall Study|Lost to Follow-up|6|||
143128263|NCT00577772|516016429|FG000|Overall Study|Lost to Follow-up|0|||
143128264|NCT00577772|516016430|FG001|Overall Study|Lost to Follow-up|1|||
143128265|NCT00856999|516016431|FG000|Overall Study|Withdrawal by Subject|5|||
143128266|NCT00610168|516016433|FG000|Overall Study|Withdrawal by Subject|2|||
143128267|NCT00610168|516016434|FG001|Overall Study|Withdrawal by Subject|0|||
143128268|NCT00878800|516016441|FG000|Overall Study|Adverse Event|0|||
143128269|NCT00878800|516016442|FG001|Overall Study|Adverse Event|0|||
143128270|NCT00878800|516016443|FG002|Overall Study|Adverse Event|2|||
143128271|NCT00878800|516016444|FG003|Overall Study|Adverse Event|0|||
143465185|NCT02382016|517249464|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
143465186|NCT02382016|517249465|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
143465187|NCT02382016|517249464|FG000|Open-label (OL) Treatment Period|Death|4|||
143465188|NCT02382016|517249465|FG001|Open-label (OL) Treatment Period|Death|0|||
143465189|NCT02382016|517249464|FG000|OL Extension Period|Physician Decision|3|||
143465190|NCT02382016|517249465|FG001|OL Extension Period|Physician Decision|0|||
143465191|NCT02382016|517249464|FG000|OL Extension Period|Death|2|||
143465192|NCT02382016|517249465|FG001|OL Extension Period|Death|0|||
143465193|NCT02382016|517249464|FG000|OL Extension Period|Withdrawal by Subject|1|||
143465194|NCT02382016|517249465|FG001|OL Extension Period|Withdrawal by Subject|0|||
143465195|NCT00084266|517249466|FG000|Overall Study|Death|42|||
143465196|NCT00084266|517249467|FG001|Overall Study|Death|39|||
143465197|NCT00084266|517249466|FG000|Overall Study|Adverse Event|8|||
143465198|NCT00084266|517249467|FG001|Overall Study|Adverse Event|5|||
143465199|NCT00084266|517249466|FG000|Overall Study|Lack of Efficacy|2|||
143465200|NCT00084266|517249467|FG001|Overall Study|Lack of Efficacy|4|||
143465201|NCT00084266|517249466|FG000|Overall Study|Lost to Follow-up|5|||
143465202|NCT00084266|517249467|FG001|Overall Study|Lost to Follow-up|3|||
143465203|NCT00084266|517249466|FG000|Overall Study|Participant not willing to participate|3|||
143465204|NCT00084266|517249467|FG001|Overall Study|Participant not willing to participate|8|||
143465205|NCT00084266|517249466|FG000|Overall Study|Other|360|||
143465206|NCT00084266|517249467|FG001|Overall Study|Other|344|||
143465207|NCT00084266|517249466|FG000|Overall Study|Randomized not treated|21|||
143465208|NCT00084266|517249467|FG001|Overall Study|Randomized not treated|20|||
143465209|NCT00730171|517249468|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
143465210|NCT00730171|517249468|FG000|Overall Study|Adverse Event|193|||
143128272|NCT00878800|516016445|FG004|Overall Study|Adverse Event|1|||
143128273|NCT00878800|516016441|FG000|Overall Study|Progressive disease|1|||
143128274|NCT00878800|516016442|FG001|Overall Study|Progressive disease|5|||
143128275|NCT00878800|516016443|FG002|Overall Study|Progressive disease|6|||
143128276|NCT00878800|516016444|FG003|Overall Study|Progressive disease|5|||
143128277|NCT00878800|516016445|FG004|Overall Study|Progressive disease|13|||
143128278|NCT00878800|516016441|FG000|Overall Study|Withdrew consent|1|||
143465211|NCT00730171|517249468|FG000|Overall Study|Protocol Violation|48|||
143465212|NCT00730171|517249468|FG000|Overall Study|Withdrawal by Subject|202|||
143128279|NCT00878800|516016442|FG001|Overall Study|Withdrew consent|1|||
143128280|NCT00878800|516016443|FG002|Overall Study|Withdrew consent|0|||
143465213|NCT00730171|517249468|FG000|Overall Study|Lost to Follow-up|121|||
143465214|NCT00730171|517249468|FG000|Overall Study|Insufficient Therapeutic Response|141|||
143465215|NCT00730171|517249468|FG000|Overall Study|Other|61|||
143465216|NCT01729156|517249469|FG000|Overall Study|Withdrawal by Subject|1|||
143465217|NCT01729156|517249470|FG001|Overall Study|Withdrawal by Subject|0|||
143465218|NCT01729156|517249471|FG002|Overall Study|Withdrawal by Subject|0|||
143465219|NCT01256658|517249472|FG000|Period 1|Lost to Follow-up|837|||
143465220|NCT01256658|517249473|FG001|Period 1|Lost to Follow-up|661|||
143465221|NCT01256658|517249472|FG000|Period 1|Withdrawal by Subject|35|||
143465222|NCT01256658|517249473|FG001|Period 1|Withdrawal by Subject|43|||
143465223|NCT01256658|517249472|FG000|Period 1|Death|48|||
143465224|NCT01256658|517249473|FG001|Period 1|Death|44|||
143465225|NCT00719563|517249474|FG000|Overall Study|Adverse Event|16|||
143465226|NCT00719563|517249475|FG001|Overall Study|Adverse Event|13|||
143465227|NCT00719563|517249474|FG000|Overall Study|Medical condition changed|3|||
143465228|NCT00719563|517249475|FG001|Overall Study|Medical condition changed|5|||
143465229|NCT00719563|517249474|FG000|Overall Study|Lack of Efficacy|3|||
143465230|NCT00719563|517249475|FG001|Overall Study|Lack of Efficacy|7|||
143465231|NCT00719563|517249474|FG000|Overall Study|Personal reasons|6|||
143465232|NCT00719563|517249475|FG001|Overall Study|Personal reasons|7|||
143465233|NCT00719563|517249474|FG000|Overall Study|Unknown reasons|4|||
143465234|NCT00719563|517249475|FG001|Overall Study|Unknown reasons|6|||
143465235|NCT00719563|517249474|FG000|Overall Study|Noncompliant|1|||
143465236|NCT00719563|517249475|FG001|Overall Study|Noncompliant|1|||
143465237|NCT00719563|517249474|FG000|Overall Study|Lost to Follow-up|5|||
143465238|NCT00719563|517249475|FG001|Overall Study|Lost to Follow-up|3|||
143465239|NCT00294554|517249476|FG000|Overall Study|Lack of Efficacy|0|||
143465240|NCT00294554|517249477|FG001|Overall Study|Lack of Efficacy|1|||
143465241|NCT00294554|517249476|FG000|Overall Study|Physician Decision|0|||
143465242|NCT00294554|517249477|FG001|Overall Study|Physician Decision|1|||
143465243|NCT00462865|517249478|FG000|Overall Study|Adverse Event|1|||
143465244|NCT04142450|517249479|FG000|Overall Study|Screen Failure|1|||
143465245|NCT04142450|517249479|FG000|Overall Study|Lost to Follow-up|1|||
143465246|NCT02768870|517249480|FG000|Overall Study|Death|1|||
143465247|NCT02768870|517249480|FG000|Overall Study|Reoperation|6|||
143465248|NCT02768870|517249480|FG000|Overall Study|Lost to Follow-up|1|||
143465249|NCT02768870|517249480|FG000|Overall Study|Exit|4|||
143465250|NCT01774110|517249481|FG000|Overall Study|Lost to Follow-up|7|||
143465251|NCT00887679|517249483|FG000|Overall Study|Withdrawal by Subject|1|||
143465252|NCT00887679|517249483|FG000|Overall Study|Lost to Follow-up|4|||
143465253|NCT00887679|517249483|FG000|Overall Study|Physician Decision|5|||
143465254|NCT01776424|517249484|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
143465255|NCT01776424|517249485|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
143465256|NCT01776424|517249486|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
143465257|NCT01776424|517249484|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
143465258|NCT01776424|517249485|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
143465259|NCT01776424|517249486|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
143128281|NCT00878800|516016444|FG003|Overall Study|Withdrew consent|1|||
143128282|NCT00878800|516016445|FG004|Overall Study|Withdrew consent|1|||
143128283|NCT00878800|516016441|FG000|Overall Study|Death|0|||
143128284|NCT00878800|516016442|FG001|Overall Study|Death|0|||
143128285|NCT00878800|516016443|FG002|Overall Study|Death|1|||
143128286|NCT00878800|516016444|FG003|Overall Study|Death|0|||
143128287|NCT00878800|516016445|FG004|Overall Study|Death|0|||
143128288|NCT00878800|516016441|FG000|Overall Study|Other|1|||
143128289|NCT00878800|516016442|FG001|Overall Study|Other|1|||
143128290|NCT00878800|516016443|FG002|Overall Study|Other|0|||
143128291|NCT00878800|516016444|FG003|Overall Study|Other|0|||
143128292|NCT00878800|516016445|FG004|Overall Study|Other|1|||
143128293|NCT00613821|516016446|FG000|Overall Study|Withdrawal by Subject|1|||
143128294|NCT00613821|516016447|FG001|Overall Study|Withdrawal by Subject|0|||
143128295|NCT00613821|516016446|FG000|Overall Study|Physician Decision|1|||
143128296|NCT00613821|516016447|FG001|Overall Study|Physician Decision|1|||
143128297|NCT01266824|516016448|FG000|Overall Study|Study terminated prior to completion|2|||
143128298|NCT01266824|516016449|FG001|Overall Study|Study terminated prior to completion|3|||
143128299|NCT02302846|516016450|FG000|Overall Study|Withdrawal by Subject|1|||
143128300|NCT01059773|516016451|FG000|Overall Study|Adverse Event|2|||
143128301|NCT01059773|516016452|FG001|Overall Study|Adverse Event|2|||
143465260|NCT01776424|517249484|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
143465261|NCT01776424|517249485|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
143465262|NCT01776424|517249486|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
143465263|NCT01776424|517249484|FG000|LTOLE Part (Open Label)|Refused|5|||
143465264|NCT01776424|517249485|FG001|LTOLE Part (Open Label)|Refused|2|||
143465265|NCT01776424|517249486|FG002|LTOLE Part (Open Label)|Refused|11|||
143465266|NCT01776424|517249484|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
143465267|NCT01776424|517249485|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
143465268|NCT01776424|517249486|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
143465269|NCT02075541|517249491|FG000|Overall Study|Serious Adverse Event|1|||
143128302|NCT01059773|516016451|FG000|Overall Study|Withdrawal by Subject|1|||
143128303|NCT01059773|516016452|FG001|Overall Study|Withdrawal by Subject|5|||
143465270|NCT02075541|517249492|FG001|Overall Study|Serious Adverse Event|4|||
143128304|NCT01059773|516016451|FG000|Overall Study|Lost to Follow-up|1|||
143128305|NCT01059773|516016452|FG001|Overall Study|Lost to Follow-up|1|||
143128306|NCT01059773|516016451|FG000|Overall Study|Pregnancy|1|||
143128307|NCT01059773|516016452|FG001|Overall Study|Pregnancy|1|||
143128308|NCT01059773|516016451|FG000|Overall Study|Protocol Violation|6|||
143128309|NCT01059773|516016452|FG001|Overall Study|Protocol Violation|2|||
143128310|NCT01059773|516016451|FG000|Overall Study|Physician Decision|5|||
143128311|NCT01059773|516016452|FG001|Overall Study|Physician Decision|4|||
143128312|NCT01059773|516016451|FG000|Overall Study|Lack of Efficacy|3|||
143128313|NCT01059773|516016452|FG001|Overall Study|Lack of Efficacy|3|||
143128314|NCT01059773|516016451|FG000|Overall Study|Death|0|||
143128315|NCT01059773|516016452|FG001|Overall Study|Death|1|||
143128316|NCT01059773|516016451|FG000|Overall Study|Malignancy including squamous cell skin|0|||
143128317|NCT01059773|516016452|FG001|Overall Study|Malignancy including squamous cell skin|1|||
143128318|NCT01059773|516016451|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
143128319|NCT01059773|516016452|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
143128320|NCT01059773|516016451|FG000|Overall Study|Other|1|||
143128321|NCT01059773|516016452|FG001|Overall Study|Other|3|||
143128322|NCT00872521|516016453|FG000|Completed PAD Induction|Patient choice|0|||
143128323|NCT00872521|516016454|FG001|Completed PAD Induction|Patient choice|1|||
143128324|NCT00872521|516016455|FG002|Completed PAD Induction|Patient choice|0|||
143128325|NCT00872521|516016453|FG000|Completed PAD Induction|Disease progression|0|||
143128326|NCT00872521|516016454|FG001|Completed PAD Induction|Disease progression|2|||
143128327|NCT00872521|516016455|FG002|Completed PAD Induction|Disease progression|0|||
143128328|NCT00872521|516016453|FG000|Completed PAD Induction|Adverse Event|4|||
143128329|NCT00872521|516016454|FG001|Completed PAD Induction|Adverse Event|0|||
143128330|NCT00872521|516016455|FG002|Completed PAD Induction|Adverse Event|0|||
143128331|NCT00872521|516016453|FG000|Completed PAD Induction|Death|1|||
143128332|NCT00872521|516016454|FG001|Completed PAD Induction|Death|1|||
143128333|NCT00872521|516016455|FG002|Completed PAD Induction|Death|0|||
143128334|NCT00872521|516016453|FG000|Primary Endpoint Analysis|Other|1|||
143128335|NCT00872521|516016454|FG001|Primary Endpoint Analysis|Other|2|||
143128336|NCT00872521|516016455|FG002|Primary Endpoint Analysis|Other|0|||
143128337|NCT00872521|516016453|FG000|Primary Endpoint Analysis|Patient choice|0|||
143128338|NCT00872521|516016454|FG001|Primary Endpoint Analysis|Patient choice|1|||
143128339|NCT00872521|516016455|FG002|Primary Endpoint Analysis|Patient choice|0|||
143128340|NCT00872521|516016453|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
143128341|NCT00872521|516016454|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
143128342|NCT00872521|516016455|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
143357343|NCT04157686|516853031|FG003|Overall Study|Lack of Efficacy|0|||
143357344|NCT04157686|516853032|FG004|Overall Study|Lack of Efficacy|0|||
143357345|NCT04157686|516853033|FG005|Overall Study|Lack of Efficacy|2|||
143357346|NCT04157686|516853034|FG006|Overall Study|Lack of Efficacy|0|||
143357347|NCT04157686|516853035|FG007|Overall Study|Lack of Efficacy|1|||
143357348|NCT04157686|516853028|FG000|Overall Study|Withdrawal by Subject|10|||
143357349|NCT04157686|516853029|FG001|Overall Study|Withdrawal by Subject|10|||
143357350|NCT04157686|516853030|FG002|Overall Study|Withdrawal by Subject|12|||
143357351|NCT04157686|516853031|FG003|Overall Study|Withdrawal by Subject|20|||
143357352|NCT04157686|516853032|FG004|Overall Study|Withdrawal by Subject|12|||
143357353|NCT04157686|516853033|FG005|Overall Study|Withdrawal by Subject|11|||
143357354|NCT04157686|516853034|FG006|Overall Study|Withdrawal by Subject|18|||
143357355|NCT04157686|516853035|FG007|Overall Study|Withdrawal by Subject|24|||
143357356|NCT04157686|516853028|FG000|Overall Study|Physician Decision|0|||
143357357|NCT04157686|516853029|FG001|Overall Study|Physician Decision|0|||
143357358|NCT04157686|516853030|FG002|Overall Study|Physician Decision|1|||
143357359|NCT04157686|516853031|FG003|Overall Study|Physician Decision|0|||
143357360|NCT04157686|516853032|FG004|Overall Study|Physician Decision|1|||
143357361|NCT04157686|516853033|FG005|Overall Study|Physician Decision|0|||
143357362|NCT04157686|516853034|FG006|Overall Study|Physician Decision|3|||
143357363|NCT04157686|516853035|FG007|Overall Study|Physician Decision|0|||
143357364|NCT04157686|516853028|FG000|Overall Study|Death|0|||
143357365|NCT04157686|516853029|FG001|Overall Study|Death|0|||
143357366|NCT04157686|516853030|FG002|Overall Study|Death|0|||
143357367|NCT04157686|516853031|FG003|Overall Study|Death|2|||
143357368|NCT04157686|516853032|FG004|Overall Study|Death|0|||
143357369|NCT04157686|516853033|FG005|Overall Study|Death|0|||
143128343|NCT00872521|516016453|FG000|Primary Endpoint Analysis|Patient response missing|0|||
143357370|NCT04157686|516853034|FG006|Overall Study|Death|0|||
143357371|NCT04157686|516853035|FG007|Overall Study|Death|0|||
143357372|NCT04157686|516853028|FG000|Overall Study|Protocol Violation|0|||
143357373|NCT04157686|516853029|FG001|Overall Study|Protocol Violation|0|||
143357374|NCT04157686|516853030|FG002|Overall Study|Protocol Violation|0|||
143357375|NCT04157686|516853031|FG003|Overall Study|Protocol Violation|0|||
143357376|NCT04157686|516853032|FG004|Overall Study|Protocol Violation|1|||
143357377|NCT04157686|516853033|FG005|Overall Study|Protocol Violation|0|||
143357378|NCT04157686|516853034|FG006|Overall Study|Protocol Violation|0|||
143357379|NCT04157686|516853035|FG007|Overall Study|Protocol Violation|0|||
143357380|NCT04157686|516853028|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
143128344|NCT00872521|516016454|FG001|Primary Endpoint Analysis|Patient response missing|0|||
143128345|NCT00872521|516016455|FG002|Primary Endpoint Analysis|Patient response missing|1|||
143128346|NCT00872521|516016453|FG000|Completed 3-month Follow up|Other|0|||
143128347|NCT00872521|516016454|FG001|Completed 3-month Follow up|Other|2|||
143128348|NCT00872521|516016455|FG002|Completed 3-month Follow up|Other|0|||
143128349|NCT00872521|516016453|FG000|Completed 3-month Follow up|Physician Decision|0|||
143128350|NCT00872521|516016454|FG001|Completed 3-month Follow up|Physician Decision|1|||
143128351|NCT00872521|516016455|FG002|Completed 3-month Follow up|Physician Decision|0|||
143128352|NCT00872521|516016453|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
143128353|NCT00872521|516016454|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
143128354|NCT00872521|516016455|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
143128355|NCT00141518|516016457|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
143128356|NCT00141518|516016458|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
143128357|NCT00141518|516016459|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
143128358|NCT00141518|516016457|FG000|Overall Study|Adverse Event|7|||
143128359|NCT00141518|516016458|FG001|Overall Study|Adverse Event|5|||
143128360|NCT00141518|516016459|FG002|Overall Study|Adverse Event|2|||
143128361|NCT00141518|516016457|FG000|Overall Study|Withdrawal by Subject|2|||
143128362|NCT00141518|516016458|FG001|Overall Study|Withdrawal by Subject|0|||
143128363|NCT00141518|516016459|FG002|Overall Study|Withdrawal by Subject|2|||
143128364|NCT00141518|516016457|FG000|Overall Study|Protocol Violation|1|||
143128365|NCT00141518|516016458|FG001|Overall Study|Protocol Violation|1|||
143357381|NCT04157686|516853029|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
143357382|NCT04157686|516853030|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
143357383|NCT04157686|516853031|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
143357384|NCT04157686|516853032|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
143357385|NCT04157686|516853033|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
143357386|NCT04157686|516853034|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
143357387|NCT04157686|516853035|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
143357388|NCT03363659|516853043|FG000|Overall Study|Adverse Event|1|||
143357389|NCT03363659|516853043|FG000|Overall Study|Screen fail|1|||
143357390|NCT03363659|516853043|FG000|Overall Study|Withdrawal by Subject|1|||
143357391|NCT00904150|516853044|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
143357392|NCT00904150|516853045|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
143357393|NCT00904150|516853044|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
143357394|NCT00904150|516853045|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
143357395|NCT02601937|516853046|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
143357396|NCT02601937|516853047|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
143357397|NCT02601937|516853048|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
143357398|NCT02601937|516853049|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
143357399|NCT02601937|516853050|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
143357400|NCT02601937|516853051|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
143357401|NCT02601937|516853052|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
143357402|NCT02601937|516853053|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
143357403|NCT02601937|516853054|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
143357404|NCT02601937|516853055|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
143357405|NCT02601937|516853056|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
143357406|NCT02601937|516853046|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
143357407|NCT02601937|516853047|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
143357408|NCT02601937|516853048|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
143357409|NCT02601937|516853049|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
143357410|NCT02601937|516853050|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
143357411|NCT02601937|516853051|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
143357412|NCT02601937|516853052|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
143357413|NCT02601937|516853053|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
143357414|NCT02601937|516853054|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
143357415|NCT02601937|516853055|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
143357416|NCT02601937|516853056|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
143357417|NCT02601937|516853046|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
143357418|NCT02601937|516853047|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
143357419|NCT02601937|516853048|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
143357420|NCT02601937|516853049|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
143128366|NCT00141518|516016459|FG002|Overall Study|Protocol Violation|2|||
143128367|NCT00141518|516016457|FG000|Overall Study|Lack of Efficacy|5|||
143128368|NCT00141518|516016458|FG001|Overall Study|Lack of Efficacy|0|||
143128369|NCT00141518|516016459|FG002|Overall Study|Lack of Efficacy|0|||
143128370|NCT01806168|516016461|FG000|Overall Study|Adverse Event|1|||
143128371|NCT01806168|516016462|FG001|Overall Study|Adverse Event|0|||
143465271|NCT02075541|517249491|FG000|Overall Study|Protocol Violation|1|||
143465272|NCT02075541|517249492|FG001|Overall Study|Protocol Violation|0|||
143465273|NCT02075541|517249491|FG000|Overall Study|Withdrawal by Subject|1|||
143465274|NCT02075541|517249492|FG001|Overall Study|Withdrawal by Subject|3|||
143465275|NCT02075541|517249491|FG000|Overall Study|Sponsor study termination|0|||
143465276|NCT02075541|517249492|FG001|Overall Study|Sponsor study termination|1|||
143465277|NCT02075541|517249491|FG000|Overall Study|Other- unable to perform study procedure|1|||
143465278|NCT02075541|517249492|FG001|Overall Study|Other- unable to perform study procedure|0|||
143465279|NCT02019927|517249496|FG000|Overall Study|Lost to Follow-up|2|||
143465280|NCT02019927|517249497|FG001|Overall Study|Lost to Follow-up|4|||
143465281|NCT02019927|517249498|FG002|Overall Study|Lost to Follow-up|1|||
143465282|NCT02019927|517249499|FG003|Overall Study|Lost to Follow-up|2|||
143465283|NCT02019927|517249500|FG004|Overall Study|Lost to Follow-up|3|||
143465284|NCT02019927|517249501|FG005|Overall Study|Lost to Follow-up|1|||
143465285|NCT01054846|517249504|FG000|Overall Study|Lost to Follow-up|76|||
143465286|NCT01054846|517249505|FG001|Overall Study|Lost to Follow-up|17|||
143465287|NCT00394953|517249506|FG000|First Treatment Period|Adverse Event|1|||
143465288|NCT00394953|517249507|FG001|First Treatment Period|Adverse Event|2|||
143465289|NCT00394953|517249506|FG000|First Treatment Period|Death|6|||
143465290|NCT00394953|517249507|FG001|First Treatment Period|Death|7|||
143465291|NCT00394953|517249506|FG000|First Treatment Period|Lack of Efficacy|1|||
143465292|NCT00394953|517249507|FG001|First Treatment Period|Lack of Efficacy|1|||
143465293|NCT00394953|517249506|FG000|First Treatment Period|Withdrawal by Subject|6|||
143465294|NCT00394953|517249507|FG001|First Treatment Period|Withdrawal by Subject|3|||
143465295|NCT00394953|517249506|FG000|First Treatment Period|Lost to Follow-up|0|||
143465296|NCT00394953|517249507|FG001|First Treatment Period|Lost to Follow-up|1|||
143465297|NCT00394953|517249506|FG000|First Treatment Period|Renal transplant|11|||
143465298|NCT00394953|517249507|FG001|First Treatment Period|Renal transplant|7|||
143465299|NCT00394953|517249506|FG000|First Treatment Period|Not defined|4|||
143465300|NCT00394953|517249507|FG001|First Treatment Period|Not defined|1|||
143465301|NCT00394953|517249506|FG000|Second Treatment Period|Adverse Event|2|||
143465302|NCT00394953|517249507|FG001|Second Treatment Period|Adverse Event|5|||
143465303|NCT00394953|517249506|FG000|Second Treatment Period|Death|8|||
143465304|NCT00394953|517249507|FG001|Second Treatment Period|Death|4|||
143465305|NCT00394953|517249506|FG000|Second Treatment Period|Lack of Efficacy|9|||
143465306|NCT00394953|517249507|FG001|Second Treatment Period|Lack of Efficacy|47|||
143465307|NCT00394953|517249506|FG000|Second Treatment Period|Withdrawal by Subject|3|||
143465308|NCT00394953|517249507|FG001|Second Treatment Period|Withdrawal by Subject|3|||
143465309|NCT00394953|517249506|FG000|Second Treatment Period|Lost to Follow-up|0|||
143465310|NCT00394953|517249507|FG001|Second Treatment Period|Lost to Follow-up|1|||
143465311|NCT00394953|517249506|FG000|Second Treatment Period|Renal transplant|4|||
143465312|NCT00394953|517249507|FG001|Second Treatment Period|Renal transplant|6|||
143465313|NCT00394953|517249506|FG000|Second Treatment Period|Not defined|3|||
143465314|NCT00394953|517249507|FG001|Second Treatment Period|Not defined|8|||
143465315|NCT00928447|517249516|FG000|Overall Study|Withdrawal by Subject|1|||
143465316|NCT00928447|517249516|FG000|Overall Study|Investigator's decision|1|||
143465317|NCT01259284|517249517|FG000|Overall Study|Study Termination|2|||
143465318|NCT01259284|517249518|FG001|Overall Study|Study Termination|0|||
143465319|NCT01259284|517249519|FG002|Overall Study|Study Termination|0|||
143465320|NCT01592864|517249528|FG000|Overall Study|Withdrawal by Subject|0|||
143465321|NCT01592864|517249529|FG001|Overall Study|Withdrawal by Subject|1|||
143465322|NCT00985153|517249531|FG000|Overall Study|Lost to Follow-up|16|||
143465323|NCT00985153|517249532|FG001|Overall Study|Lost to Follow-up|19|||
143465324|NCT00985153|517249533|FG002|Overall Study|Lost to Follow-up|17|||
143465325|NCT00985153|517249534|FG003|Overall Study|Lost to Follow-up|20|||
143465326|NCT00985153|517249531|FG000|Overall Study|Protocol Violation|3|||
143465327|NCT00985153|517249532|FG001|Overall Study|Protocol Violation|2|||
143465328|NCT00985153|517249533|FG002|Overall Study|Protocol Violation|4|||
143465329|NCT00985153|517249534|FG003|Overall Study|Protocol Violation|3|||
143465330|NCT00985153|517249531|FG000|Overall Study|Withdrawal by Subject|6|||
143465331|NCT00985153|517249532|FG001|Overall Study|Withdrawal by Subject|11|||
143465332|NCT00985153|517249533|FG002|Overall Study|Withdrawal by Subject|11|||
143465333|NCT00985153|517249534|FG003|Overall Study|Withdrawal by Subject|10|||
143465334|NCT00985153|517249531|FG000|Overall Study|Missed One or More Bleeds|7|||
143465335|NCT00985153|517249532|FG001|Overall Study|Missed One or More Bleeds|7|||
143465336|NCT00985153|517249533|FG002|Overall Study|Missed One or More Bleeds|8|||
143465337|NCT00985153|517249534|FG003|Overall Study|Missed One or More Bleeds|10|||
143465338|NCT00985153|517249531|FG000|Overall Study|Incomplete Safety Follow-up|3|||
143465339|NCT00985153|517249532|FG001|Overall Study|Incomplete Safety Follow-up|5|||
143465340|NCT00985153|517249533|FG002|Overall Study|Incomplete Safety Follow-up|4|||
143465341|NCT00985153|517249534|FG003|Overall Study|Incomplete Safety Follow-up|4|||
143465342|NCT02571049|517249535|FG000|Screening|Did not meet entry criteria|2|||
143465343|NCT02571049|517249536|FG001|Screening|Did not meet entry criteria|2|||
143465344|NCT02571049|517249535|FG000|Randomization|No migraine attack|0|||
143465345|NCT02571049|517249536|FG001|Randomization|No migraine attack|1|||
143465346|NCT02571049|517249535|FG000|Randomization|Adverse Event|0|||
143465347|NCT02571049|517249536|FG001|Randomization|Adverse Event|1|||
143465348|NCT03370471|517249537|FG000|Overall Study|Withdrawal by Subject|6|||
143465349|NCT03370471|517249538|FG001|Overall Study|Withdrawal by Subject|1|||
143465350|NCT03370471|517249537|FG000|Overall Study|Unable to access veins for blood draw|0|||
143465351|NCT03370471|517249538|FG001|Overall Study|Unable to access veins for blood draw|1|||
143128372|NCT01806168|516016463|FG002|Overall Study|Adverse Event|0|||
143128373|NCT01806168|516016461|FG000|Overall Study|Withdrawal by Subject|0|||
143128374|NCT01806168|516016462|FG001|Overall Study|Withdrawal by Subject|1|||
143128375|NCT01806168|516016463|FG002|Overall Study|Withdrawal by Subject|2|||
143128376|NCT01806168|516016461|FG000|Overall Study|Protocol Violation|0|||
143128377|NCT01806168|516016462|FG001|Overall Study|Protocol Violation|0|||
143128378|NCT01806168|516016463|FG002|Overall Study|Protocol Violation|1|||
143128379|NCT01029262|516016466|FG000|Overall Study|Adverse Event|9|||
143128380|NCT01029262|516016467|FG001|Overall Study|Adverse Event|52|||
143128381|NCT01029262|516016466|FG000|Overall Study|Lack of therapeutic effect|57|||
143128382|NCT01029262|516016467|FG001|Overall Study|Lack of therapeutic effect|76|||
143465352|NCT03370471|517249537|FG000|Overall Study|Screen fail|1|||
143465353|NCT03370471|517249538|FG001|Overall Study|Screen fail|0|||
143465354|NCT00561951|517249539|FG000|Overall Study|Adverse Event|11|||
143465355|NCT00561951|517249540|FG001|Overall Study|Adverse Event|14|||
143465356|NCT00561951|517249541|FG002|Overall Study|Adverse Event|14|||
143465357|NCT00561951|517249539|FG000|Overall Study|Lack of Efficacy|5|||
143465358|NCT00561951|517249540|FG001|Overall Study|Lack of Efficacy|3|||
143465359|NCT00561951|517249541|FG002|Overall Study|Lack of Efficacy|2|||
143465360|NCT00561951|517249539|FG000|Overall Study|Lost to Follow-up|1|||
143465361|NCT00561951|517249540|FG001|Overall Study|Lost to Follow-up|1|||
143465362|NCT00561951|517249541|FG002|Overall Study|Lost to Follow-up|0|||
143465363|NCT00561951|517249539|FG000|Overall Study|Withdrawal by Subject|10|||
143465364|NCT00561951|517249540|FG001|Overall Study|Withdrawal by Subject|9|||
143465365|NCT00561951|517249541|FG002|Overall Study|Withdrawal by Subject|10|||
143465366|NCT00561951|517249539|FG000|Overall Study|Protocol Violation|4|||
143465367|NCT00561951|517249540|FG001|Overall Study|Protocol Violation|3|||
143465368|NCT00561951|517249541|FG002|Overall Study|Protocol Violation|4|||
143465369|NCT00561951|517249539|FG000|Overall Study|Physician Decision|1|||
143465370|NCT00561951|517249540|FG001|Overall Study|Physician Decision|0|||
143128383|NCT01029262|516016466|FG000|Overall Study|Withdrawal by Subject|10|||
143128384|NCT01029262|516016467|FG001|Overall Study|Withdrawal by Subject|17|||
143128385|NCT01029262|516016466|FG000|Overall Study|Protocol Violation|2|||
143128386|NCT01029262|516016467|FG001|Overall Study|Protocol Violation|3|||
143128387|NCT01029262|516016466|FG000|Overall Study|Miscellaneous|1|||
143128388|NCT01029262|516016467|FG001|Overall Study|Miscellaneous|9|||
143128389|NCT01029262|516016466|FG000|Overall Study|Death|0|||
143128390|NCT01029262|516016467|FG001|Overall Study|Death|3|||
143128391|NCT00807612|516016468|FG000|Overall Study|Death|8|||
143128392|NCT00807612|516016468|FG000|Overall Study|Study early termination|5|||
143128393|NCT00807612|516016468|FG000|Overall Study|Withdrawal by Subject|1|||
143128394|NCT04607135|516016470|FG000|Overall Study|Physician Decision|1|||
143128395|NCT04607135|516016470|FG000|Overall Study|Withdrawal by Subject|1|||
143128396|NCT04607135|516016470|FG000|Overall Study|Equipment not working|3|||
143128397|NCT03465709|516016471|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
143128398|NCT03465709|516016471|FG000|Overall Study|Withdrawal by Subject|3|||
143128399|NCT04892446|516016472|FG000|Overall Study|Death|4|||
143128400|NCT04892446|516016473|FG001|Overall Study|Death|4|||
143128401|NCT04892446|516016474|FG002|Overall Study|Death|0|||
143128402|NCT04892446|516016472|FG000|Overall Study|Withdrew consent|3|||
143128403|NCT04892446|516016473|FG001|Overall Study|Withdrew consent|0|||
143128404|NCT04892446|516016474|FG002|Overall Study|Withdrew consent|1|||
143128405|NCT04892446|516016472|FG000|Overall Study|Investigator's discretion|1|||
143128406|NCT04892446|516016473|FG001|Overall Study|Investigator's discretion|1|||
143128407|NCT04892446|516016474|FG002|Overall Study|Investigator's discretion|0|||
143128408|NCT04892446|516016472|FG000|Overall Study|Study terminated by sponsor|0|||
143465371|NCT00561951|517249541|FG002|Overall Study|Physician Decision|0|||
143465372|NCT00561951|517249539|FG000|Overall Study|Pregnancy|0|||
143465373|NCT00561951|517249540|FG001|Overall Study|Pregnancy|1|||
143465374|NCT00561951|517249541|FG002|Overall Study|Pregnancy|0|||
143465375|NCT00561951|517249539|FG000|Overall Study|Meet Withdrawal Criterion|0|||
143465376|NCT00561951|517249540|FG001|Overall Study|Meet Withdrawal Criterion|1|||
143465377|NCT00561951|517249541|FG002|Overall Study|Meet Withdrawal Criterion|1|||
143128409|NCT04892446|516016473|FG001|Overall Study|Study terminated by sponsor|0|||
143128410|NCT04892446|516016474|FG002|Overall Study|Study terminated by sponsor|2|||
143128411|NCT03193047|516016476|FG000|Overall Study|Physician Decision|1|||
143128412|NCT03193047|516016477|FG001|Overall Study|Physician Decision|0|||
143128413|NCT03193047|516016476|FG000|Overall Study|Participant Left State|1|||
143128414|NCT03193047|516016477|FG001|Overall Study|Participant Left State|0|||
143128415|NCT00705341|516016478|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
143128416|NCT00705341|516016479|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
143465378|NCT00561951|517249539|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
143465379|NCT00561951|517249540|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
143128417|NCT00705341|516016480|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
143465380|NCT00561951|517249541|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
143465381|NCT00392327|517249553|FG000|Overall Study|Death|1|||
143128418|NCT00705341|516016481|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
143128419|NCT00705341|516016478|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
143128420|NCT00705341|516016479|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
143128421|NCT00705341|516016480|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
143128422|NCT00705341|516016481|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
143128423|NCT02585713|516016483|FG000|Overall Study|Withdrew prior to treatment|2|||
143128424|NCT02585713|516016484|FG001|Overall Study|Withdrew prior to treatment|7|||
143128425|NCT02585713|516016483|FG000|Overall Study|Other|3|||
143128426|NCT02585713|516016484|FG001|Overall Study|Other|1|||
143128427|NCT03173456|516016485|FG000|Baseline|Medication dispensing system malfunction'|0|||
143128428|NCT03173456|516016486|FG001|Baseline|Medication dispensing system malfunction'|1|||
143128429|NCT03173456|516016487|FG002|Baseline|Medication dispensing system malfunction'|0|||
143128430|NCT03173456|516016488|FG003|Baseline|Medication dispensing system malfunction'|0|||
143128431|NCT03173456|516016489|FG004|Baseline|Medication dispensing system malfunction'|2|||
143128432|NCT03173456|516016485|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
143128433|NCT03173456|516016486|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
143128434|NCT03173456|516016487|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
143128435|NCT03173456|516016488|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
143128436|NCT03173456|516016489|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
143128437|NCT01733121|516016490|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
143128438|NCT01733121|516016491|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
143128439|NCT01733121|516016490|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
143357421|NCT02601937|516853050|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
143357422|NCT02601937|516853051|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
143357423|NCT02601937|516853052|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
143357424|NCT02601937|516853053|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
143357425|NCT02601937|516853054|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
143357426|NCT02601937|516853055|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
143357427|NCT02601937|516853056|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
143357428|NCT02601937|516853046|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
143357429|NCT02601937|516853047|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
143357430|NCT02601937|516853048|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
143357431|NCT02601937|516853049|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
143357432|NCT02601937|516853050|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
143357433|NCT02601937|516853051|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
143357434|NCT02601937|516853052|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
143357435|NCT02601937|516853053|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
143357436|NCT02601937|516853054|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
143357437|NCT02601937|516853055|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
143357438|NCT02601937|516853056|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
143357439|NCT02601937|516853046|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
143357440|NCT02601937|516853047|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
143357441|NCT02601937|516853048|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
143357442|NCT02601937|516853049|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
143357443|NCT02601937|516853050|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
143357444|NCT02601937|516853051|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
143357445|NCT02601937|516853052|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
143357446|NCT02601937|516853053|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
143357447|NCT02601937|516853054|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
143357448|NCT02601937|516853055|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
143357449|NCT02601937|516853056|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
143357450|NCT02601937|516853046|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
143357451|NCT02601937|516853047|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
143357452|NCT02601937|516853048|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
143357453|NCT02601937|516853049|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
143357454|NCT02601937|516853050|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
143357455|NCT02601937|516853051|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
143357456|NCT02601937|516853052|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
143357457|NCT02601937|516853053|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
143357458|NCT02601937|516853054|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
143357459|NCT02601937|516853055|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
143357460|NCT02601937|516853056|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
143013782|NCT02494583|515590021|FG002|Overall Study|Transferred to Extension Study|6|||
143230355|NCT01194830|516393206|FG000|Overall Study|Lost to Follow-up|9|||
143128440|NCT01733121|516016491|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
143128441|NCT01733121|516016490|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
143128442|NCT01733121|516016491|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
143128443|NCT01733121|516016490|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
143128444|NCT01733121|516016491|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
143128445|NCT03061188|516016492|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
143128446|NCT03061188|516016493|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
143128447|NCT03061188|516016494|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
143128448|NCT03061188|516016495|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
143128449|NCT03061188|516016492|FG000|On Follow-up for 3 Years|Death|0|||
143128450|NCT03061188|516016493|FG001|On Follow-up for 3 Years|Death|3|||
143357461|NCT02601937|516853046|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
143357462|NCT02601937|516853047|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
143357463|NCT02601937|516853048|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
143357464|NCT02601937|516853049|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
143357465|NCT02601937|516853050|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
143357466|NCT02601937|516853051|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
143357467|NCT02601937|516853052|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
143357468|NCT02601937|516853053|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
143357469|NCT02601937|516853054|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
143357470|NCT02601937|516853055|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
143357471|NCT02601937|516853056|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
143357472|NCT02601937|516853046|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
143357473|NCT02601937|516853047|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
143357474|NCT02601937|516853048|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
143357475|NCT02601937|516853049|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
143357476|NCT02601937|516853050|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
143357477|NCT02601937|516853051|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
143357478|NCT02601937|516853052|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
143357479|NCT02601937|516853053|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
143357480|NCT02601937|516853054|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
143357481|NCT02601937|516853055|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
143357482|NCT02601937|516853056|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
143357483|NCT02601937|516853046|FG000|Period 2: Dose Expansion Cohort|Other|0|||
143357484|NCT02601937|516853047|FG001|Period 2: Dose Expansion Cohort|Other|0|||
143357485|NCT02601937|516853048|FG002|Period 2: Dose Expansion Cohort|Other|0|||
143357486|NCT02601937|516853049|FG003|Period 2: Dose Expansion Cohort|Other|0|||
143357487|NCT02601937|516853050|FG004|Period 2: Dose Expansion Cohort|Other|0|||
143357488|NCT02601937|516853051|FG005|Period 2: Dose Expansion Cohort|Other|0|||
143357489|NCT02601937|516853052|FG006|Period 2: Dose Expansion Cohort|Other|0|||
143357490|NCT02601937|516853053|FG007|Period 2: Dose Expansion Cohort|Other|0|||
143357491|NCT02601937|516853054|FG008|Period 2: Dose Expansion Cohort|Other|2|||
143357492|NCT02601937|516853055|FG009|Period 2: Dose Expansion Cohort|Other|2|||
143357493|NCT02601937|516853056|FG010|Period 2: Dose Expansion Cohort|Other|0|||
143357494|NCT02601937|516853046|FG000|Period 2: Dose Expansion Cohort|Death|0|||
143357495|NCT02601937|516853047|FG001|Period 2: Dose Expansion Cohort|Death|0|||
143357496|NCT02601937|516853048|FG002|Period 2: Dose Expansion Cohort|Death|0|||
143357497|NCT02601937|516853049|FG003|Period 2: Dose Expansion Cohort|Death|0|||
143357498|NCT02601937|516853050|FG004|Period 2: Dose Expansion Cohort|Death|0|||
143357499|NCT02601937|516853051|FG005|Period 2: Dose Expansion Cohort|Death|0|||
143357500|NCT02601937|516853052|FG006|Period 2: Dose Expansion Cohort|Death|0|||
143357501|NCT02601937|516853053|FG007|Period 2: Dose Expansion Cohort|Death|0|||
143357502|NCT02601937|516853054|FG008|Period 2: Dose Expansion Cohort|Death|1|||
143357503|NCT02601937|516853055|FG009|Period 2: Dose Expansion Cohort|Death|0|||
143357504|NCT02601937|516853056|FG010|Period 2: Dose Expansion Cohort|Death|0|||
143357505|NCT01036087|516854376|FG000|Overall Study|Adverse Event|2|||
143357506|NCT01036087|516854376|FG000|Overall Study|Lack of Efficacy|1|||
143357507|NCT01021878|516854379|FG000|Overall Study|Lost to Follow-up|4|||
143357508|NCT01021878|516854380|FG001|Overall Study|Lost to Follow-up|3|||
143357509|NCT01021878|516854379|FG000|Overall Study|Death|0|||
143357510|NCT01021878|516854380|FG001|Overall Study|Death|1|||
143357511|NCT01021878|516854379|FG000|Overall Study|Adverse Event|6|||
143357512|NCT01021878|516854380|FG001|Overall Study|Adverse Event|5|||
143357513|NCT01021878|516854379|FG000|Overall Study|Transplantation|6|||
143357514|NCT01021878|516854380|FG001|Overall Study|Transplantation|1|||
143357515|NCT01155726|516854383|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
143357516|NCT01155726|516854384|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
143357517|NCT01155726|516854385|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
143357518|NCT01155726|516854386|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
143357519|NCT02892409|516854387|FG000|Overall Study|Adverse Event|1|||
143357520|NCT02892409|516854388|FG001|Overall Study|Adverse Event|0|||
143357521|NCT02892409|516854387|FG000|Overall Study|Withdrawal by Subject|2|||
143128451|NCT03061188|516016494|FG002|On Follow-up for 3 Years|Death|5|||
143128452|NCT03061188|516016495|FG003|On Follow-up for 3 Years|Death|4|||
143128453|NCT03061188|516016492|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
143128454|NCT03061188|516016493|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
143128455|NCT03061188|516016494|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
143128456|NCT03061188|516016495|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
143128457|NCT00436826|516016499|FG000|Double Blind Period (DBP)|Adverse Event|2|||
143128458|NCT00436826|516016500|FG001|Double Blind Period (DBP)|Adverse Event|0|||
143128459|NCT00436826|516016501|FG002|Double Blind Period (DBP)|Adverse Event|0|||
143128460|NCT00436826|516016502|FG003|Double Blind Period (DBP)|Adverse Event|0|||
143128461|NCT00436826|516016503|FG004|Double Blind Period (DBP)|Adverse Event|0|||
143128462|NCT00436826|516016504|FG005|Double Blind Period (DBP)|Adverse Event|0|||
143128463|NCT00436826|516016499|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
143128464|NCT00436826|516016500|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
143128465|NCT00436826|516016501|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
143128466|NCT00436826|516016502|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
143128467|NCT00436826|516016503|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
143128468|NCT00436826|516016504|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
143128469|NCT00436826|516016499|FG000|Double Blind Period (DBP)|Other|10|||
143128470|NCT00436826|516016500|FG001|Double Blind Period (DBP)|Other|11|||
143128471|NCT00436826|516016501|FG002|Double Blind Period (DBP)|Other|0|||
143128472|NCT00436826|516016502|FG003|Double Blind Period (DBP)|Other|0|||
143128473|NCT00436826|516016503|FG004|Double Blind Period (DBP)|Other|0|||
143128474|NCT00436826|516016504|FG005|Double Blind Period (DBP)|Other|0|||
143128475|NCT00436826|516016499|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
143128476|NCT00436826|516016500|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
143128477|NCT00436826|516016501|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
143128478|NCT00436826|516016502|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
143465382|NCT00392327|517249554|FG001|Overall Study|Death|0|||
143465383|NCT00392327|517249555|FG002|Overall Study|Death|1|||
143465384|NCT00392327|517249556|FG003|Overall Study|Death|0|||
143465385|NCT00392327|517249557|FG004|Overall Study|Death|0|||
143465386|NCT00392327|517249558|FG005|Overall Study|Death|0|||
143465387|NCT00392327|517249559|FG006|Overall Study|Death|0|||
143465388|NCT00392327|517249560|FG007|Overall Study|Death|0|||
143465389|NCT00392327|517249553|FG000|Overall Study|Lack of Efficacy|8|||
143465390|NCT00392327|517249554|FG001|Overall Study|Lack of Efficacy|8|||
143465391|NCT00392327|517249555|FG002|Overall Study|Lack of Efficacy|9|||
143465392|NCT00392327|517249556|FG003|Overall Study|Lack of Efficacy|6|||
143465393|NCT00392327|517249557|FG004|Overall Study|Lack of Efficacy|3|||
143465394|NCT00392327|517249558|FG005|Overall Study|Lack of Efficacy|3|||
143465395|NCT00392327|517249559|FG006|Overall Study|Lack of Efficacy|3|||
143465396|NCT00392327|517249560|FG007|Overall Study|Lack of Efficacy|3|||
143465397|NCT00392327|517249553|FG000|Overall Study|Physician Decision|3|||
143465398|NCT00392327|517249554|FG001|Overall Study|Physician Decision|5|||
143465399|NCT00392327|517249555|FG002|Overall Study|Physician Decision|2|||
143465400|NCT00392327|517249556|FG003|Overall Study|Physician Decision|2|||
143465401|NCT00392327|517249557|FG004|Overall Study|Physician Decision|0|||
143465402|NCT00392327|517249558|FG005|Overall Study|Physician Decision|1|||
143465403|NCT00392327|517249559|FG006|Overall Study|Physician Decision|5|||
143465404|NCT00392327|517249560|FG007|Overall Study|Physician Decision|3|||
143465405|NCT00392327|517249553|FG000|Overall Study|Protocol Violation|0|||
143465406|NCT00392327|517249554|FG001|Overall Study|Protocol Violation|0|||
143465407|NCT00392327|517249555|FG002|Overall Study|Protocol Violation|1|||
143465408|NCT00392327|517249556|FG003|Overall Study|Protocol Violation|0|||
143465409|NCT00392327|517249557|FG004|Overall Study|Protocol Violation|0|||
143465410|NCT00392327|517249558|FG005|Overall Study|Protocol Violation|0|||
143465411|NCT00392327|517249559|FG006|Overall Study|Protocol Violation|0|||
143465412|NCT00392327|517249560|FG007|Overall Study|Protocol Violation|0|||
143465413|NCT00392327|517249553|FG000|Overall Study|Withdrawal by Subject|3|||
143465414|NCT00392327|517249554|FG001|Overall Study|Withdrawal by Subject|2|||
143465415|NCT00392327|517249555|FG002|Overall Study|Withdrawal by Subject|4|||
143465416|NCT00392327|517249556|FG003|Overall Study|Withdrawal by Subject|6|||
143465417|NCT00392327|517249557|FG004|Overall Study|Withdrawal by Subject|0|||
143128479|NCT00436826|516016503|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
143128480|NCT00436826|516016504|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
143128481|NCT00436826|516016499|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
143128482|NCT00436826|516016500|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
143128483|NCT00436826|516016501|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
143465418|NCT00392327|517249558|FG005|Overall Study|Withdrawal by Subject|1|||
143465419|NCT00392327|517249559|FG006|Overall Study|Withdrawal by Subject|1|||
143465420|NCT00392327|517249560|FG007|Overall Study|Withdrawal by Subject|5|||
143465421|NCT00392327|517249553|FG000|Overall Study|Ineligible|0|||
143465422|NCT00392327|517249554|FG001|Overall Study|Ineligible|4|||
143465423|NCT00392327|517249555|FG002|Overall Study|Ineligible|3|||
143465424|NCT00392327|517249556|FG003|Overall Study|Ineligible|2|||
143465425|NCT00392327|517249557|FG004|Overall Study|Ineligible|0|||
143128484|NCT00436826|516016502|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
143128485|NCT00436826|516016503|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
143128486|NCT00436826|516016504|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
143128487|NCT00436826|516016499|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
143128488|NCT00436826|516016500|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
143128489|NCT00436826|516016501|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
143128490|NCT00436826|516016502|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
143128491|NCT00436826|516016503|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
143128492|NCT00436826|516016504|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
143128493|NCT04004260|516016505|FG000|Overall Study|Withdrawal by Subject|7|||
143128494|NCT04004260|516016506|FG001|Overall Study|Withdrawal by Subject|3|||
143128495|NCT04004260|516016505|FG000|Overall Study|Lost to Follow-up|22|||
143128496|NCT04004260|516016506|FG001|Overall Study|Lost to Follow-up|12|||
143128497|NCT04004260|516016505|FG000|Overall Study|Did not engage in intervention|13|||
143128498|NCT04004260|516016506|FG001|Overall Study|Did not engage in intervention|17|||
143128499|NCT02360280|516016507|FG000|Overall Study|Withdrawal by Subject|2|||
143128500|NCT02360280|516016508|FG001|Overall Study|Withdrawal by Subject|0|||
143128501|NCT02360280|516016507|FG000|Overall Study|Adverse Event|0|||
143128502|NCT02360280|516016508|FG001|Overall Study|Adverse Event|1|||
143128503|NCT02360280|516016507|FG000|Overall Study|Lost to Follow-up|1|||
143128504|NCT02360280|516016508|FG001|Overall Study|Lost to Follow-up|0|||
143128505|NCT00320788|516016509|FG000|Overall Study|Adverse Event|0|||
143128506|NCT00320788|516016510|FG001|Overall Study|Adverse Event|0|||
143128507|NCT00320788|516016511|FG002|Overall Study|Adverse Event|0|||
143128508|NCT00320788|516016512|FG003|Overall Study|Adverse Event|1|||
143128509|NCT00320788|516016513|FG004|Overall Study|Adverse Event|0|||
143128510|NCT00320788|516016509|FG000|Overall Study|Death|0|||
143128511|NCT00320788|516016510|FG001|Overall Study|Death|0|||
143128512|NCT00320788|516016511|FG002|Overall Study|Death|1|||
143128513|NCT00320788|516016512|FG003|Overall Study|Death|0|||
143128514|NCT00320788|516016513|FG004|Overall Study|Death|1|||
143128515|NCT00320788|516016509|FG000|Overall Study|Lost to Follow-up|0|||
143128516|NCT00320788|516016510|FG001|Overall Study|Lost to Follow-up|2|||
143128517|NCT00320788|516016511|FG002|Overall Study|Lost to Follow-up|1|||
143128518|NCT00320788|516016512|FG003|Overall Study|Lost to Follow-up|0|||
143128519|NCT00320788|516016513|FG004|Overall Study|Lost to Follow-up|0|||
143128520|NCT00320788|516016509|FG000|Overall Study|Decision by the Sponsor|1|||
143128521|NCT00320788|516016510|FG001|Overall Study|Decision by the Sponsor|1|||
143128522|NCT00320788|516016511|FG002|Overall Study|Decision by the Sponsor|0|||
143128523|NCT00320788|516016512|FG003|Overall Study|Decision by the Sponsor|0|||
143128524|NCT00320788|516016513|FG004|Overall Study|Decision by the Sponsor|1|||
143128525|NCT00320788|516016509|FG000|Overall Study|Other|1|||
143128526|NCT00320788|516016510|FG001|Overall Study|Other|2|||
143128527|NCT00320788|516016511|FG002|Overall Study|Other|1|||
143128528|NCT00320788|516016512|FG003|Overall Study|Other|1|||
143128529|NCT00320788|516016513|FG004|Overall Study|Other|1|||
143128530|NCT00320788|516016509|FG000|Overall Study|Physician Decision|1|||
143128531|NCT00320788|516016510|FG001|Overall Study|Physician Decision|1|||
143128532|NCT00320788|516016511|FG002|Overall Study|Physician Decision|0|||
143128533|NCT00320788|516016512|FG003|Overall Study|Physician Decision|0|||
143128534|NCT00320788|516016513|FG004|Overall Study|Physician Decision|0|||
143128535|NCT00320788|516016509|FG000|Overall Study|Protocol Violation|0|||
143128536|NCT00320788|516016510|FG001|Overall Study|Protocol Violation|0|||
143128537|NCT00320788|516016511|FG002|Overall Study|Protocol Violation|0|||
143128538|NCT00320788|516016512|FG003|Overall Study|Protocol Violation|0|||
143128539|NCT00320788|516016513|FG004|Overall Study|Protocol Violation|1|||
143128540|NCT00320788|516016509|FG000|Overall Study|Withdrawal by Subject|3|||
143128541|NCT00320788|516016510|FG001|Overall Study|Withdrawal by Subject|0|||
143128542|NCT00320788|516016511|FG002|Overall Study|Withdrawal by Subject|0|||
143128543|NCT00320788|516016512|FG003|Overall Study|Withdrawal by Subject|3|||
143128544|NCT00320788|516016513|FG004|Overall Study|Withdrawal by Subject|1|||
143128545|NCT04533438|516016514|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
143128546|NCT04533438|516016515|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
143128547|NCT02998996|516016516|FG000|Overall Study|Lost to Follow-up|0|||
143128548|NCT02998996|516016517|FG001|Overall Study|Lost to Follow-up|0|||
143128549|NCT02998996|516016518|FG002|Overall Study|Lost to Follow-up|1|||
143128550|NCT02998996|516016519|FG003|Overall Study|Lost to Follow-up|0|||
143128551|NCT02998996|516016520|FG004|Overall Study|Lost to Follow-up|0|||
143128552|NCT02998996|516016521|FG005|Overall Study|Lost to Follow-up|0|||
143128553|NCT02998996|516016516|FG000|Overall Study|Pregnancy|0|||
143128554|NCT02998996|516016517|FG001|Overall Study|Pregnancy|1|||
143128555|NCT02998996|516016518|FG002|Overall Study|Pregnancy|0|||
143128556|NCT02998996|516016519|FG003|Overall Study|Pregnancy|0|||
143128557|NCT02998996|516016520|FG004|Overall Study|Pregnancy|0|||
143128558|NCT02998996|516016521|FG005|Overall Study|Pregnancy|0|||
143128559|NCT02998996|516016516|FG000|Overall Study|Family reasons|0|||
143128560|NCT02998996|516016517|FG001|Overall Study|Family reasons|0|||
143128561|NCT02998996|516016518|FG002|Overall Study|Family reasons|0|||
143128562|NCT02998996|516016519|FG003|Overall Study|Family reasons|0|||
143128563|NCT02998996|516016520|FG004|Overall Study|Family reasons|1|||
143128564|NCT02998996|516016521|FG005|Overall Study|Family reasons|0|||
143128565|NCT00003896|516016524|FG000|Overall Study|Adverse Event|16|||
143128566|NCT00003896|516016524|FG000|Overall Study|Withdrawal by Subject|1|||
143128567|NCT00003896|516016524|FG000|Overall Study|Lack of Efficacy|1|||
143128568|NCT00003896|516016524|FG000|Overall Study|Death|3|||
143128569|NCT00003896|516016524|FG000|Overall Study|not protocol specified|3|||
143128570|NCT00003896|516016524|FG000|Overall Study|ineligible|5|||
143128571|NCT01398358|516016525|FG000|Overall Study|Lost to Follow-up|11|||
143357522|NCT02892409|516854388|FG001|Overall Study|Withdrawal by Subject|1|||
143357523|NCT05305040|516854389|FG000|Overall Study|Not Dosed|37|||
143357524|NCT05305040|516854390|FG001|Overall Study|Not Dosed|37|||
143357525|NCT05305040|516854389|FG000|Overall Study|Study Closure|34|||
143357526|NCT05305040|516854390|FG001|Overall Study|Study Closure|46|||
143357527|NCT05305040|516854389|FG000|Overall Study|Death|14|||
143357528|NCT05305040|516854390|FG001|Overall Study|Death|13|||
143357529|NCT05305040|516854389|FG000|Overall Study|Withdrawal by Subject|15|||
143357530|NCT05305040|516854390|FG001|Overall Study|Withdrawal by Subject|10|||
143357531|NCT05305040|516854389|FG000|Overall Study|Other|13|||
143357532|NCT05305040|516854390|FG001|Overall Study|Other|10|||
143357533|NCT05305040|516854389|FG000|Overall Study|Primary Malignancy Relapse|3|||
143357534|NCT05305040|516854390|FG001|Overall Study|Primary Malignancy Relapse|4|||
143357535|NCT05305040|516854389|FG000|Overall Study|Adverse Event|3|||
143357536|NCT05305040|516854390|FG001|Overall Study|Adverse Event|3|||
143357537|NCT05305040|516854389|FG000|Overall Study|Lost to Follow-up|2|||
143357538|NCT05305040|516854390|FG001|Overall Study|Lost to Follow-up|1|||
143357539|NCT05305040|516854389|FG000|Overall Study|Graft versus host disease|2|||
143357540|NCT05305040|516854390|FG001|Overall Study|Graft versus host disease|0|||
143357541|NCT05305040|516854389|FG000|Overall Study|Investigator's Decision|1|||
143357542|NCT05305040|516854390|FG001|Overall Study|Investigator's Decision|1|||
143357543|NCT05305040|516854389|FG000|Overall Study|COVID-19 Reasons|1|||
143357544|NCT05305040|516854390|FG001|Overall Study|COVID-19 Reasons|0|||
143357545|NCT01195675|516854394|FG000|Overall Study|Adverse Event|1|||
143357546|NCT01195675|516854394|FG000|Overall Study|Withdrawal by Subject|2|||
143357547|NCT02424344|516854395|FG000|Overall Study|Lack of Efficacy|0|||
143357548|NCT02424344|516854396|FG001|Overall Study|Lack of Efficacy|1|||
143357549|NCT02424344|516854395|FG000|Overall Study|Withdrawal by Subject|2|||
143357550|NCT02424344|516854396|FG001|Overall Study|Withdrawal by Subject|1|||
143357551|NCT02424344|516854395|FG000|Overall Study|Lost to Follow-up|1|||
143357552|NCT02424344|516854396|FG001|Overall Study|Lost to Follow-up|0|||
143357553|NCT02424344|516854395|FG000|Overall Study|Adverse Event|4|||
143357554|NCT02424344|516854396|FG001|Overall Study|Adverse Event|8|||
143357555|NCT01536262|516854397|FG000|Overall Study|Adverse Event|6|||
143357556|NCT01536262|516854398|FG001|Overall Study|Adverse Event|1|||
143357557|NCT01536262|516854399|FG002|Overall Study|Adverse Event|2|||
143357558|NCT01536262|516854397|FG000|Overall Study|Withdrawal by Subject|1|||
143357559|NCT01536262|516854398|FG001|Overall Study|Withdrawal by Subject|1|||
143357560|NCT01536262|516854399|FG002|Overall Study|Withdrawal by Subject|0|||
143357561|NCT01536262|516854397|FG000|Overall Study|Other than stated above|1|||
143357562|NCT01536262|516854398|FG001|Overall Study|Other than stated above|0|||
143357563|NCT01536262|516854399|FG002|Overall Study|Other than stated above|0|||
143357564|NCT05257837|516854403|FG000|Overall Study|Excluded (did not find the guns)|4|||
143357565|NCT05257837|516854404|FG001|Overall Study|Excluded (did not find the guns)|2|||
143357566|NCT05257837|516854405|FG002|Overall Study|Excluded (did not find the guns)|4|||
143357567|NCT05257837|516854406|FG003|Overall Study|Excluded (did not find the guns)|0|||
143357568|NCT01781611|516854407|FG000|Overall Study|Adverse Event|4|||
143357569|NCT01781611|516854408|FG001|Overall Study|Adverse Event|0|||
143357570|NCT01625338|516854409|FG000|Overall Study|Enrolled but not Treated|0|||
143357571|NCT01625338|516854410|FG001|Overall Study|Enrolled but not Treated|0|||
143357572|NCT01625338|516854411|FG002|Overall Study|Enrolled but not Treated|1|||
143357573|NCT01625338|516854409|FG000|Overall Study|Efficacy Failure|27|||
143357574|NCT01625338|516854410|FG001|Overall Study|Efficacy Failure|39|||
143357575|NCT01625338|516854411|FG002|Overall Study|Efficacy Failure|31|||
143357576|NCT01625338|516854409|FG000|Overall Study|Lost to Follow-up|3|||
143357577|NCT01625338|516854410|FG001|Overall Study|Lost to Follow-up|3|||
143357578|NCT01625338|516854411|FG002|Overall Study|Lost to Follow-up|2|||
143357579|NCT01625338|516854409|FG000|Overall Study|Investigator Decision|0|||
143357580|NCT01625338|516854410|FG001|Overall Study|Investigator Decision|2|||
143357581|NCT01625338|516854411|FG002|Overall Study|Investigator Decision|1|||
143357582|NCT01625338|516854409|FG000|Overall Study|Subject Withdrew Consent|1|||
143357583|NCT01625338|516854410|FG001|Overall Study|Subject Withdrew Consent|0|||
143357584|NCT01625338|516854411|FG002|Overall Study|Subject Withdrew Consent|2|||
143128572|NCT01398358|516016526|FG001|Overall Study|Lost to Follow-up|21|||
143357585|NCT01625338|516854409|FG000|Overall Study|Adverse Event|1|||
143357586|NCT01625338|516854410|FG001|Overall Study|Adverse Event|0|||
143357587|NCT01625338|516854411|FG002|Overall Study|Adverse Event|1|||
143357588|NCT01625338|516854409|FG000|Overall Study|Study Discontinued by Sponsor|0|||
143465426|NCT00392327|517249558|FG005|Overall Study|Ineligible|0|||
143465427|NCT00392327|517249559|FG006|Overall Study|Ineligible|0|||
143128573|NCT01398358|516016527|FG002|Overall Study|Lost to Follow-up|18|||
143128574|NCT01398358|516016525|FG000|Overall Study|Withdrawal by Subject|3|||
143128575|NCT01398358|516016526|FG001|Overall Study|Withdrawal by Subject|2|||
143465428|NCT00392327|517249560|FG007|Overall Study|Ineligible|0|||
143465429|NCT02988622|517249561|FG000|Overall Study|Lost to Follow-up|17|||
143128576|NCT01398358|516016527|FG002|Overall Study|Withdrawal by Subject|2|||
143128577|NCT01398358|516016525|FG000|Overall Study|no longer eligible|1|||
143128578|NCT01398358|516016526|FG001|Overall Study|no longer eligible|0|||
143128579|NCT01398358|516016527|FG002|Overall Study|no longer eligible|1|||
143128580|NCT00985686|516016530|FG000|Overall Study|Lost to Follow-up|1|||
143128581|NCT00985686|516016531|FG001|Overall Study|Lost to Follow-up|1|||
143128582|NCT00985686|516016532|FG002|Overall Study|Lost to Follow-up|0|||
143128583|NCT00985686|516016533|FG003|Overall Study|Lost to Follow-up|2|||
143128584|NCT01670045|516016534|FG000|Overall Study|Withdrawal by Subject|3|||
143128585|NCT01670045|516016534|FG000|Overall Study|Adverse Event|1|||
143128586|NCT01670045|516016534|FG000|Overall Study|Death|1|||
143128587|NCT01670045|516016534|FG000|Overall Study|Lost to Follow-up|11|||
143128588|NCT03134911|516016535|FG000|Overall Study|Screen failure|31|||
143128589|NCT03134911|516016535|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
143128590|NCT00420628|516016538|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
143128591|NCT00420628|516016539|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
143128592|NCT00420628|516016538|FG000|Overall Study|Lost to Follow-up|3|||
143128593|NCT00420628|516016539|FG001|Overall Study|Lost to Follow-up|2|||
143128594|NCT00420628|516016538|FG000|Overall Study|Adverse Event|1|||
143128595|NCT00420628|516016539|FG001|Overall Study|Adverse Event|0|||
143128596|NCT00184093|516016544|FG000|Overall Study|Adverse Event|3|||
143128597|NCT00184093|516016544|FG000|Overall Study|Lost to Follow-up|3|||
143128598|NCT00184093|516016544|FG000|Overall Study|Physician Decision|1|||
143128599|NCT00184093|516016544|FG000|Overall Study|Withdrawal by Subject|2|||
143128600|NCT00805129|516016546|FG000|Overall Study|Not treated|1|||
143128601|NCT01839916|516016547|FG000|Overall Study|Death|9|||
143128602|NCT01839916|516016547|FG000|Overall Study|Physician Decision|17|||
143128603|NCT01839916|516016547|FG000|Overall Study|Relapse|12|||
143128604|NCT01839916|516016547|FG000|Overall Study|GVHD|2|||
143128605|NCT01839916|516016547|FG000|Overall Study|Graft Failure|1|||
143128606|NCT00534638|516016550|FG000|Overall Study|Withdrawal by Subject|3|||
143128607|NCT00534638|516016551|FG001|Overall Study|Withdrawal by Subject|4|||
143128608|NCT00534638|516016550|FG000|Overall Study|Migrated/moved from study area|13|||
143128609|NCT00534638|516016551|FG001|Overall Study|Migrated/moved from study area|11|||
143128610|NCT00534638|516016550|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
143128611|NCT00534638|516016551|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
143128612|NCT00534638|516016550|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
143128613|NCT00534638|516016551|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
143128614|NCT00534638|516016550|FG000|Overall Study|Other|1685|||
143128615|NCT00534638|516016551|FG001|Overall Study|Other|902|||
143128616|NCT02500719|516016552|FG000|Overall Study|Lost to Follow-up|2|||
143128617|NCT02500719|516016553|FG001|Overall Study|Lost to Follow-up|3|||
143128618|NCT02500719|516016552|FG000|Overall Study|Trauma history|1|||
143128619|NCT02500719|516016553|FG001|Overall Study|Trauma history|0|||
143128620|NCT02500719|516016552|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
143128621|NCT02500719|516016553|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
143128622|NCT02500719|516016552|FG000|Overall Study|Did not meet criteria for PTSD|0|||
143128623|NCT02500719|516016553|FG001|Overall Study|Did not meet criteria for PTSD|1|||
143128624|NCT02500719|516016552|FG000|Overall Study|Claustrophobia|0|||
143128625|NCT02500719|516016553|FG001|Overall Study|Claustrophobia|1|||
143128626|NCT02500719|516016552|FG000|Overall Study|History of head trauma|0|||
143128627|NCT02500719|516016553|FG001|Overall Study|History of head trauma|1|||
143128628|NCT00181883|516016556|FG000|Overall Study|Lack of Efficacy|2|||
143128629|NCT00181883|516016556|FG000|Overall Study|Treatment Limiting AEs|3|||
143465430|NCT02447172|517249562|FG000|Overall Study|Adverse Event|11|||
143128630|NCT00181883|516016556|FG000|Overall Study|Withdrawal by Subject|4|||
143128631|NCT00181883|516016556|FG000|Overall Study|Lost to Follow-up|1|||
143128632|NCT01990768|516016557|FG000|Intervention Started|Found to be ineligible|14|||
143128633|NCT01990768|516016558|FG001|Intervention Started|Found to be ineligible|13|||
143128634|NCT01990768|516016559|FG002|Intervention Started|Found to be ineligible|11|||
143128635|NCT01990768|516016557|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
143128636|NCT01990768|516016558|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
143128637|NCT01990768|516016559|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
143128638|NCT01990768|516016557|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
143465431|NCT02447172|517249563|FG001|Overall Study|Adverse Event|8|||
143465432|NCT02447172|517249564|FG002|Overall Study|Adverse Event|7|||
143128639|NCT01990768|516016558|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
143128640|NCT01990768|516016559|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
143465433|NCT02447172|517249562|FG000|Overall Study|Death|3|||
143128641|NCT01990768|516016557|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
143465434|NCT02447172|517249563|FG001|Overall Study|Death|1|||
143465435|NCT02447172|517249564|FG002|Overall Study|Death|0|||
143465436|NCT02447172|517249562|FG000|Overall Study|Protocol Violation|2|||
143465437|NCT02447172|517249563|FG001|Overall Study|Protocol Violation|1|||
143465438|NCT02447172|517249564|FG002|Overall Study|Protocol Violation|2|||
143465439|NCT02447172|517249562|FG000|Overall Study|Lost to Follow-up|7|||
143465440|NCT02447172|517249563|FG001|Overall Study|Lost to Follow-up|4|||
143465441|NCT02447172|517249564|FG002|Overall Study|Lost to Follow-up|4|||
143465442|NCT02447172|517249562|FG000|Overall Study|Withdrawal by Subject|5|||
143128642|NCT01990768|516016558|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
143128643|NCT01990768|516016559|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
143128644|NCT01990768|516016557|FG000|Intervention Started|Patient care priority|1|||
143128645|NCT01990768|516016558|FG001|Intervention Started|Patient care priority|2|||
143128646|NCT01990768|516016559|FG002|Intervention Started|Patient care priority|3|||
143128647|NCT01990768|516016557|FG000|Intervention Started|IV lost|2|||
143128648|NCT01990768|516016558|FG001|Intervention Started|IV lost|2|||
143128649|NCT01990768|516016559|FG002|Intervention Started|IV lost|2|||
143128650|NCT01990768|516016557|FG000|Intervention Started|Required CPR|1|||
143128651|NCT01990768|516016558|FG001|Intervention Started|Required CPR|1|||
143128652|NCT01990768|516016559|FG002|Intervention Started|Required CPR|0|||
143128653|NCT01990768|516016557|FG000|Intervention Started|Seizure or hx of seizure|0|||
143128654|NCT01990768|516016558|FG001|Intervention Started|Seizure or hx of seizure|0|||
143128655|NCT01990768|516016559|FG002|Intervention Started|Seizure or hx of seizure|2|||
143128656|NCT01990768|516016557|FG000|Intervention Started|Discovered to be pregnant|0|||
143128657|NCT01990768|516016558|FG001|Intervention Started|Discovered to be pregnant|1|||
143128658|NCT01990768|516016559|FG002|Intervention Started|Discovered to be pregnant|0|||
143128659|NCT01990768|516016557|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
143128660|NCT01990768|516016558|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
143128661|NCT01990768|516016559|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
143128662|NCT01990768|516016557|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
143128663|NCT01990768|516016558|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
143128664|NCT01990768|516016559|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
143128665|NCT01990768|516016557|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
143128666|NCT01990768|516016558|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
143128667|NCT01990768|516016559|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
143128668|NCT01990768|516016557|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
143128669|NCT01990768|516016558|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
143128670|NCT01990768|516016559|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
143128671|NCT01990768|516016557|FG000|Prehospital Study Drug Infusion|Death|3|||
143128672|NCT01990768|516016558|FG001|Prehospital Study Drug Infusion|Death|1|||
143128673|NCT01990768|516016559|FG002|Prehospital Study Drug Infusion|Death|1|||
143128674|NCT01990768|516016557|FG000|Prehospital Study Drug Infusion|Discharged|2|||
143128675|NCT01990768|516016558|FG001|Prehospital Study Drug Infusion|Discharged|1|||
143128676|NCT01990768|516016559|FG002|Prehospital Study Drug Infusion|Discharged|0|||
143128677|NCT01990768|516016557|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
143128678|NCT01990768|516016558|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
143128679|NCT01990768|516016559|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
143128680|NCT01990768|516016557|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
143128681|NCT01990768|516016558|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
143128682|NCT01990768|516016559|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
143128683|NCT01990768|516016557|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
143128684|NCT01990768|516016558|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
143128685|NCT01990768|516016559|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
143128686|NCT01990768|516016557|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
143128687|NCT01990768|516016558|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
143128688|NCT01990768|516016559|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
143128689|NCT01990768|516016557|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
143128690|NCT01990768|516016558|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
143128691|NCT01990768|516016559|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
143128692|NCT01990768|516016557|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
143465443|NCT02447172|517249563|FG001|Overall Study|Withdrawal by Subject|1|||
143465444|NCT02447172|517249564|FG002|Overall Study|Withdrawal by Subject|3|||
143128693|NCT01990768|516016558|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
143128694|NCT01990768|516016559|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
143128695|NCT01990768|516016557|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
143465445|NCT02447172|517249562|FG000|Overall Study|protocol specific treatment unrelated|3|||
143128696|NCT01990768|516016558|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
143128697|NCT01990768|516016559|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
143465446|NCT02447172|517249563|FG001|Overall Study|protocol specific treatment unrelated|0|||
143128698|NCT01990768|516016557|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
143128699|NCT01990768|516016558|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
143128700|NCT01990768|516016559|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
143128701|NCT01990768|516016557|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
143128702|NCT01990768|516016558|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
143128703|NCT01990768|516016559|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
143128704|NCT01990768|516016557|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
143128705|NCT01990768|516016558|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
143128706|NCT01990768|516016559|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
143128707|NCT01990768|516016557|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
143128708|NCT01990768|516016558|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
143128709|NCT01990768|516016559|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
143128710|NCT01990768|516016557|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
143128711|NCT01990768|516016558|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
143128712|NCT01990768|516016559|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
143128713|NCT01990768|516016557|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
143128714|NCT01990768|516016558|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
143128715|NCT01990768|516016559|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
143128716|NCT01990768|516016557|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
143128717|NCT01990768|516016558|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
143128718|NCT01990768|516016559|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
143128719|NCT01990768|516016557|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
143128720|NCT01990768|516016558|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
143128721|NCT01990768|516016559|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
143128722|NCT01990768|516016557|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
143128723|NCT01990768|516016558|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
143128724|NCT01990768|516016559|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
143128725|NCT01990768|516016557|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
143128726|NCT01990768|516016558|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
143128727|NCT01990768|516016559|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
143128728|NCT01990768|516016557|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
143128729|NCT01990768|516016558|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
143128730|NCT01990768|516016559|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
143128731|NCT01990768|516016557|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
143128732|NCT01990768|516016558|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
143128733|NCT01990768|516016559|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
143128734|NCT01990768|516016557|FG000|6-Month Follow-up|No contact information|5|||
143128735|NCT01990768|516016558|FG001|6-Month Follow-up|No contact information|6|||
143128736|NCT01990768|516016559|FG002|6-Month Follow-up|No contact information|5|||
143357589|NCT01625338|516854410|FG001|Overall Study|Study Discontinued by Sponsor|0|||
143357590|NCT01625338|516854411|FG002|Overall Study|Study Discontinued by Sponsor|1|||
143357591|NCT03639675|516854412|FG000|Overall Study|Withdrawal by Subject|1|||
143357592|NCT02459587|516854413|FG000|3-Month Follow-up Assessment|Death|0|||
143357593|NCT02459587|516854414|FG001|3-Month Follow-up Assessment|Death|2|||
143357594|NCT02459587|516854413|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
143357595|NCT02459587|516854414|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
143357596|NCT02459587|516854413|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
143357597|NCT02459587|516854414|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
143357598|NCT02459587|516854413|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
143357599|NCT02459587|516854414|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
143357600|NCT02459587|516854413|FG000|6-month Follow-up Assessment|Death|2|||
143357601|NCT02459587|516854414|FG001|6-month Follow-up Assessment|Death|1|||
143357602|NCT02459587|516854413|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
143357603|NCT02459587|516854414|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
143357604|NCT02459587|516854413|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
143357605|NCT02459587|516854414|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
143357606|NCT02459587|516854413|FG000|12-month Follow-up Assessment|Death|2|||
143357607|NCT02459587|516854414|FG001|12-month Follow-up Assessment|Death|0|||
143357608|NCT02459587|516854413|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
143357609|NCT02459587|516854414|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
143357610|NCT02459587|516854413|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
143357611|NCT02459587|516854414|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
143357612|NCT02459587|516854413|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
143357613|NCT02459587|516854414|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
143128737|NCT01990768|516016557|FG000|6-Month Follow-up|Homeless|4|||
143128738|NCT01990768|516016558|FG001|6-Month Follow-up|Homeless|3|||
143128739|NCT01990768|516016559|FG002|6-Month Follow-up|Homeless|6|||
143128740|NCT01990768|516016557|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
143128741|NCT01990768|516016558|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
143128742|NCT01990768|516016559|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
143128743|NCT01990768|516016557|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
143128744|NCT01990768|516016558|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
143128745|NCT01990768|516016559|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
143128746|NCT01990768|516016557|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
143128747|NCT01990768|516016558|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
143128748|NCT01990768|516016559|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
143128749|NCT04162795|516016560|FG000|Overall Study|Other|16|||
143128750|NCT04162795|516016560|FG000|Overall Study|Screen failures|10|||
143128751|NCT01941537|516016561|FG000|Overall Study|Lack of Efficacy|1|||
143128752|NCT01941537|516016562|FG001|Overall Study|Lack of Efficacy|2|||
143128753|NCT01941537|516016561|FG000|Overall Study|Lost to Follow-up|1|||
143128754|NCT01941537|516016562|FG001|Overall Study|Lost to Follow-up|0|||
143128755|NCT01941537|516016561|FG000|Overall Study|Pregnancy|1|||
143128756|NCT01941537|516016562|FG001|Overall Study|Pregnancy|0|||
143128757|NCT01941537|516016561|FG000|Overall Study|Adverse Event|1|||
143128758|NCT01941537|516016562|FG001|Overall Study|Adverse Event|0|||
143128759|NCT01941537|516016561|FG000|Overall Study|Withdrawal by Subject|0|||
143128760|NCT01941537|516016562|FG001|Overall Study|Withdrawal by Subject|1|||
143128761|NCT01243177|516016563|FG000|Overall Study|Lack of Efficacy|47|||
143128762|NCT01243177|516016564|FG001|Overall Study|Lack of Efficacy|31|||
143128763|NCT01243177|516016563|FG000|Overall Study|Protocol Violation|11|||
143128764|NCT01243177|516016564|FG001|Overall Study|Protocol Violation|10|||
143128765|NCT01243177|516016563|FG000|Overall Study|Lost to Follow-up|15|||
143128766|NCT01243177|516016564|FG001|Overall Study|Lost to Follow-up|18|||
143128767|NCT01243177|516016563|FG000|Overall Study|Withdrawal by Subject|46|||
143128768|NCT01243177|516016564|FG001|Overall Study|Withdrawal by Subject|38|||
143128769|NCT01243177|516016563|FG000|Overall Study|AE, serious fatal|0|||
143128770|NCT01243177|516016564|FG001|Overall Study|AE, serious fatal|1|||
143128771|NCT01243177|516016563|FG000|Overall Study|SAE, non-fatal|7|||
143128772|NCT01243177|516016564|FG001|Overall Study|SAE, non-fatal|9|||
143128773|NCT01243177|516016563|FG000|Overall Study|AE, non-serious non-fatal|40|||
143128774|NCT01243177|516016564|FG001|Overall Study|AE, non-serious non-fatal|58|||
143128775|NCT01243177|516016563|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
143128776|NCT01243177|516016564|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
143128777|NCT01243177|516016563|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
143128778|NCT01243177|516016564|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
143128779|NCT01243177|516016563|FG000|Overall Study|Other Reason|11|||
143128780|NCT01243177|516016564|FG001|Overall Study|Other Reason|12|||
143128781|NCT05251233|516017798|FG000|Overall Study|Disease progression - did not start treatment|0|||
143128782|NCT05251233|516017799|FG001|Overall Study|Disease progression - did not start treatment|0|||
143128783|NCT05251233|516017800|FG002|Overall Study|Disease progression - did not start treatment|5|||
143357614|NCT05343455|516854419|FG000|Overall Study|Withdrawal by Subject|4|||
143357615|NCT05343455|516854420|FG001|Overall Study|Withdrawal by Subject|9|||
143357616|NCT05343455|516854421|FG002|Overall Study|Withdrawal by Subject|7|||
143357617|NCT05343455|516854419|FG000|Overall Study|Adverse Event|2|||
143357618|NCT05343455|516854420|FG001|Overall Study|Adverse Event|1|||
143357619|NCT05343455|516854421|FG002|Overall Study|Adverse Event|2|||
143357620|NCT05343455|516854419|FG000|Overall Study|Lost to Follow-up|1|||
143357621|NCT05343455|516854420|FG001|Overall Study|Lost to Follow-up|1|||
143357622|NCT05343455|516854421|FG002|Overall Study|Lost to Follow-up|3|||
143357623|NCT05343455|516854419|FG000|Overall Study|Pregnancy|1|||
143357624|NCT05343455|516854420|FG001|Overall Study|Pregnancy|0|||
143357625|NCT05343455|516854421|FG002|Overall Study|Pregnancy|0|||
143357626|NCT05343455|516854419|FG000|Overall Study|Physician Decision|0|||
143357627|NCT05343455|516854420|FG001|Overall Study|Physician Decision|0|||
143357628|NCT05343455|516854421|FG002|Overall Study|Physician Decision|1|||
143357629|NCT05343455|516854419|FG000|Overall Study|Protocol Violation|0|||
143357630|NCT05343455|516854420|FG001|Overall Study|Protocol Violation|1|||
143357631|NCT05343455|516854421|FG002|Overall Study|Protocol Violation|1|||
143357632|NCT01083160|516854426|FG000|Overall Study|Adverse Event|1|||
143357633|NCT00918749|516854427|FG000|Overall Study|Adverse Event|1|||
143128784|NCT05251233|516017798|FG000|Overall Study|Determined to be ineligible - did not start treatment|0|||
143128785|NCT05251233|516017799|FG001|Overall Study|Determined to be ineligible - did not start treatment|0|||
143128786|NCT05251233|516017800|FG002|Overall Study|Determined to be ineligible - did not start treatment|7|||
143128787|NCT05251233|516017798|FG000|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
143128788|NCT05251233|516017799|FG001|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
143128789|NCT05251233|516017800|FG002|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|1|||
143357634|NCT00918749|516854428|FG001|Overall Study|Adverse Event|0|||
143357635|NCT00918749|516854429|FG002|Overall Study|Adverse Event|1|||
143357636|NCT00918749|516854427|FG000|Overall Study|Lost to Follow-up|0|||
143357637|NCT00918749|516854428|FG001|Overall Study|Lost to Follow-up|0|||
143357638|NCT00918749|516854429|FG002|Overall Study|Lost to Follow-up|1|||
143465447|NCT02447172|517249564|FG002|Overall Study|protocol specific treatment unrelated|2|||
143128790|NCT05251233|516017798|FG000|Overall Study|Had a total gastrectomy - did not start treatment|0|||
143128791|NCT05251233|516017799|FG001|Overall Study|Had a total gastrectomy - did not start treatment|0|||
143128792|NCT05251233|516017800|FG002|Overall Study|Had a total gastrectomy - did not start treatment|1|||
143128793|NCT05251233|516017798|FG000|Overall Study|Death - did not start treatment|3|||
143128794|NCT05251233|516017799|FG001|Overall Study|Death - did not start treatment|0|||
143128795|NCT05251233|516017800|FG002|Overall Study|Death - did not start treatment|0|||
143128796|NCT05251233|516017798|FG000|Overall Study|Withdrawal by Subject|2|||
143128797|NCT05251233|516017799|FG001|Overall Study|Withdrawal by Subject|2|||
143128798|NCT05251233|516017800|FG002|Overall Study|Withdrawal by Subject|0|||
143128799|NCT05251233|516017798|FG000|Overall Study|Other complicating disease|2|||
143128800|NCT05251233|516017799|FG001|Overall Study|Other complicating disease|1|||
143128801|NCT05251233|516017800|FG002|Overall Study|Other complicating disease|0|||
143128802|NCT05251233|516017798|FG000|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
143128803|NCT05251233|516017799|FG001|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
143128804|NCT05251233|516017800|FG002|Overall Study|Attending physician did not order medication for patient - did not start treatment|1|||
143128805|NCT05251233|516017798|FG000|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
143128806|NCT05251233|516017799|FG001|Overall Study|Patient was ordered NPO and had NGT placed.|1|||
143128807|NCT05251233|516017800|FG002|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
143128808|NCT02100839|516017810|FG000|Multiple Ascending Dose|Adverse Event|2|||
143128809|NCT02100839|516017811|FG001|Multiple Ascending Dose|Adverse Event|0|||
143128810|NCT02100839|516017810|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
143128811|NCT02100839|516017811|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
143128812|NCT00669318|516017816|FG000|Overall Study|Withdrawal by Subject|2|||
143128813|NCT00940888|516017817|FG000|Overall Study|Unsuccessful Implant|4|||
143128814|NCT00940888|516017817|FG000|Overall Study|Death|461|||
143128815|NCT00940888|516017817|FG000|Overall Study|Withdrawn - Non-Death|364|||
143128816|NCT00940888|516017817|FG000|Overall Study|Lost to Follow-up|6|||
143128817|NCT01239394|516017820|FG000|Overall Study|Adverse Event|1|||
143128818|NCT01639144|516017825|FG000|Overall Study|Withdrawal by Subject|4|||
143128819|NCT01639144|516017826|FG001|Overall Study|Withdrawal by Subject|2|||
143128820|NCT01639144|516017825|FG000|Overall Study|Physician Decision|2|||
143128821|NCT01639144|516017826|FG001|Overall Study|Physician Decision|0|||
143128822|NCT01639144|516017825|FG000|Overall Study|Met postoperative exclusion criteria|4|||
143128823|NCT01639144|516017826|FG001|Overall Study|Met postoperative exclusion criteria|3|||
143128824|NCT03492437|516017829|FG000|Treatment Period 2|Withdrawal by Subject|0|||
143128825|NCT03492437|516017830|FG001|Treatment Period 2|Withdrawal by Subject|1|||
143128826|NCT04534517|516017832|FG000|Overall Study|Adverse Event|1|||
143128827|NCT04534517|516017832|FG000|Overall Study|Withdrawal by Subject|1|||
143128828|NCT04534517|516017832|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
143465448|NCT03562247|517249568|FG000|Overall Study|Lost to Follow-up|3|||
143465449|NCT03562247|517249569|FG001|Overall Study|Lost to Follow-up|1|||
143465450|NCT03562247|517249570|FG002|Overall Study|Lost to Follow-up|1|||
143465451|NCT00983931|517249571|FG000|14 Day Washout Period|Physician Decision|1|||
143128829|NCT04534517|516017832|FG000|Overall Study|COVID-19 Related|1|||
143128830|NCT03872843|516017833|FG000|Overall Study|Lost to Follow-up|5|||
143128831|NCT03872843|516017834|FG001|Overall Study|Lost to Follow-up|7|||
143128832|NCT00823264|516017835|FG000|Overall Study|Protocol Violation|2|||
143128833|NCT00823264|516017836|FG001|Overall Study|Protocol Violation|0|||
143128834|NCT05133323|516017837|FG000|Overall Study|Lack of Efficacy|0|||
143128835|NCT05133323|516017838|FG001|Overall Study|Lack of Efficacy|0|||
143128836|NCT05133323|516017839|FG002|Overall Study|Lack of Efficacy|1|||
143465452|NCT01281969|517249574|FG000|Overall Study|not randomized didn't meet criteria|0|||
143465453|NCT01281969|517249575|FG001|Overall Study|not randomized didn't meet criteria|0|||
143465454|NCT01281969|517249576|FG002|Overall Study|not randomized didn't meet criteria|7|||
143465455|NCT01281969|517249574|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
143465456|NCT01281969|517249575|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
143465457|NCT01281969|517249576|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
143465458|NCT01281969|517249574|FG000|Overall Study|not randomized, child consent not given|0|||
143465459|NCT01281969|517249575|FG001|Overall Study|not randomized, child consent not given|0|||
143465460|NCT01281969|517249576|FG002|Overall Study|not randomized, child consent not given|2|||
143465461|NCT01201265|517249577|FG000|Overall Study|Death|14|||
143128837|NCT05133323|516017837|FG000|Overall Study|Withdrawal by Subject|2|||
143128838|NCT05133323|516017838|FG001|Overall Study|Withdrawal by Subject|1|||
143128839|NCT05133323|516017839|FG002|Overall Study|Withdrawal by Subject|0|||
143128840|NCT01714544|516017840|FG000|Overall Study|Lost to Follow-up|1|||
143128841|NCT01714544|516017840|FG000|Overall Study|Physician Decision|1|||
143128842|NCT01714544|516017840|FG000|Overall Study|Withdrawal by Subject|1|||
143128843|NCT01462630|516017855|FG000|Overall Study|Did not initiate therapy|3|||
143128844|NCT01462630|516017855|FG000|Overall Study|Death|1|||
143128845|NCT01462630|516017855|FG000|Overall Study|Protocol Violation|2|||
143128846|NCT01462630|516017855|FG000|Overall Study|Adverse Event|1|||
143128847|NCT01096160|516017860|FG000|Overall Study|Adverse Event|0|||
143128848|NCT01096160|516017861|FG001|Overall Study|Adverse Event|0|||
143128849|NCT01096160|516017862|FG002|Overall Study|Adverse Event|1|||
143128850|NCT01096160|516017863|FG003|Overall Study|Adverse Event|0|||
143128851|NCT01096160|516017864|FG004|Overall Study|Adverse Event|0|||
143128852|NCT01096160|516017865|FG005|Overall Study|Adverse Event|0|||
143128853|NCT01096160|516017866|FG006|Overall Study|Adverse Event|0|||
143128854|NCT01096160|516017867|FG007|Overall Study|Adverse Event|0|||
143128855|NCT01096160|516017868|FG008|Overall Study|Adverse Event|0|||
143128856|NCT01096160|516017869|FG009|Overall Study|Adverse Event|1|||
143128857|NCT01096160|516017860|FG000|Overall Study|Met stopping criteria per protocol|0|||
143128858|NCT01096160|516017861|FG001|Overall Study|Met stopping criteria per protocol|0|||
143128859|NCT01096160|516017862|FG002|Overall Study|Met stopping criteria per protocol|0|||
143128860|NCT01096160|516017863|FG003|Overall Study|Met stopping criteria per protocol|0|||
143128861|NCT01096160|516017864|FG004|Overall Study|Met stopping criteria per protocol|1|||
143128862|NCT01096160|516017865|FG005|Overall Study|Met stopping criteria per protocol|0|||
143128863|NCT01096160|516017866|FG006|Overall Study|Met stopping criteria per protocol|2|||
143128864|NCT01096160|516017867|FG007|Overall Study|Met stopping criteria per protocol|0|||
143128865|NCT01096160|516017868|FG008|Overall Study|Met stopping criteria per protocol|2|||
143128866|NCT01096160|516017869|FG009|Overall Study|Met stopping criteria per protocol|0|||
143128867|NCT01048541|516017871|FG000|Overall Study|Withdrawal by Subject|1|||
143357639|NCT00918749|516854427|FG000|Overall Study|Withdrawal by Subject|5|||
143357640|NCT00918749|516854428|FG001|Overall Study|Withdrawal by Subject|3|||
143465462|NCT01201265|517249577|FG000|Overall Study|Insufficient Therapeutic Response|3|||
143465463|NCT01201265|517249577|FG000|Overall Study|Lost to Follow-up|10|||
143465464|NCT01201265|517249577|FG000|Overall Study|Withdrawal by Subject|7|||
143465465|NCT01201265|517249577|FG000|Overall Study|Disease Progression|4|||
143465466|NCT01323634|517249578|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
143465467|NCT01323634|517249579|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
143465468|NCT01323634|517249580|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
143465469|NCT01323634|517249578|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
143465470|NCT01323634|517249579|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
143465471|NCT01323634|517249580|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
143465472|NCT01323634|517249578|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
143465473|NCT01323634|517249579|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
143465474|NCT01323634|517249580|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
143465475|NCT01323634|517249578|FG000|2-week Run-in Period|Physician Decision|5|||
143465476|NCT01323634|517249579|FG001|2-week Run-in Period|Physician Decision|0|||
143465477|NCT01323634|517249580|FG002|2-week Run-in Period|Physician Decision|0|||
143465478|NCT01323634|517249578|FG000|2-week Run-in Period|Protocol Violation|1|||
143465479|NCT01323634|517249579|FG001|2-week Run-in Period|Protocol Violation|0|||
143465480|NCT01323634|517249580|FG002|2-week Run-in Period|Protocol Violation|0|||
143465481|NCT01323634|517249578|FG000|2-week Run-in Period|Adverse Event|1|||
143357641|NCT00918749|516854429|FG002|Overall Study|Withdrawal by Subject|5|||
143357642|NCT00918749|516854427|FG000|Overall Study|No Study Medication Taken|1|||
143357643|NCT00918749|516854428|FG001|Overall Study|No Study Medication Taken|0|||
143357644|NCT00918749|516854429|FG002|Overall Study|No Study Medication Taken|0|||
143357645|NCT01951092|516854430|FG000|Overall Study|Lost to Follow-up|10|||
143357646|NCT01951092|516854430|FG000|Overall Study|Incarceration|1|||
143357647|NCT01951092|516854430|FG000|Overall Study|Transfer of Care|1|||
143357648|NCT01712789|516854431|FG000|Overall Study|Lack of Efficacy|2|||
143357649|NCT01712789|516854431|FG000|Overall Study|Lost to Follow-up|1|||
143357650|NCT01712789|516854431|FG000|Overall Study|Progressive Disease|504|||
143357651|NCT01712789|516854431|FG000|Overall Study|Death|57|||
143357652|NCT01712789|516854431|FG000|Overall Study|Adverse Event|52|||
143357653|NCT01712789|516854431|FG000|Overall Study|Miscellaneous|31|||
143357654|NCT01712789|516854431|FG000|Overall Study|Withdrawal by Subject|21|||
143357655|NCT01712789|516854431|FG000|Overall Study|Transition to Commercial Treatment|8|||
143357656|NCT01712789|516854431|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
143357657|NCT01708187|516854432|FG000|Overall Study|Lost to Follow-up|0|||
143465482|NCT01323634|517249579|FG001|2-week Run-in Period|Adverse Event|0|||
143465483|NCT01323634|517249580|FG002|2-week Run-in Period|Adverse Event|0|||
143465484|NCT01323634|517249578|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
143128868|NCT01048541|516017872|FG001|Overall Study|Withdrawal by Subject|0|||
143128869|NCT00627497|516017873|FG000|Overall Study|Lost to Follow-up|1|||
143128870|NCT00627497|516017874|FG001|Overall Study|Lost to Follow-up|1|||
143128871|NCT00627497|516017875|FG002|Overall Study|Lost to Follow-up|0|||
143128872|NCT00627497|516017876|FG003|Overall Study|Lost to Follow-up|0|||
143128873|NCT00791700|516017882|FG000|Overall Study|Insufficient clinical response|1|||
143128874|NCT00791700|516017883|FG001|Overall Study|Insufficient clinical response|4|||
143128875|NCT00791700|516017884|FG002|Overall Study|Insufficient clinical response|1|||
143357658|NCT01708187|516854433|FG001|Overall Study|Lost to Follow-up|1|||
143357659|NCT01439711|516854434|FG000|Overall Study|Ineligible|13|||
143357660|NCT01439711|516854434|FG000|Overall Study|Cancel|3|||
143357661|NCT01439711|516854434|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
143465485|NCT01323634|517249579|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
143465486|NCT01323634|517249580|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
143465487|NCT01323634|517249578|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
143465488|NCT01323634|517249579|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
143465489|NCT01323634|517249580|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
143465490|NCT01323634|517249578|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
143465491|NCT01323634|517249579|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
143465492|NCT01323634|517249580|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
143465493|NCT01323634|517249578|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
143465494|NCT01323634|517249579|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
143465495|NCT01323634|517249580|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
143465496|NCT01323634|517249578|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
143465497|NCT01323634|517249579|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
143465498|NCT01323634|517249580|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
143128876|NCT00791700|516017885|FG003|Overall Study|Insufficient clinical response|8|||
143128877|NCT00791700|516017882|FG000|Overall Study|No longer willing to participate|1|||
143128878|NCT00791700|516017883|FG001|Overall Study|No longer willing to participate|1|||
143128879|NCT00791700|516017884|FG002|Overall Study|No longer willing to participate|0|||
143128880|NCT00791700|516017885|FG003|Overall Study|No longer willing to participate|8|||
143465499|NCT01323634|517249578|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
143465500|NCT01323634|517249579|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
143465501|NCT01323634|517249580|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
143465502|NCT01323634|517249578|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
143465503|NCT01323634|517249579|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
143128881|NCT00791700|516017882|FG000|Overall Study|Non-compliance with study treatment|0|||
143128882|NCT00791700|516017883|FG001|Overall Study|Non-compliance with study treatment|2|||
143128883|NCT00791700|516017884|FG002|Overall Study|Non-compliance with study treatment|0|||
143128884|NCT00791700|516017885|FG003|Overall Study|Non-compliance with study treatment|4|||
143128885|NCT00791700|516017882|FG000|Overall Study|Withdrawn due to pregnancy|0|||
143128886|NCT00791700|516017883|FG001|Overall Study|Withdrawn due to pregnancy|0|||
143128887|NCT00791700|516017884|FG002|Overall Study|Withdrawn due to pregnancy|0|||
143128888|NCT00791700|516017885|FG003|Overall Study|Withdrawn due to pregnancy|1|||
143128889|NCT00791700|516017882|FG000|Overall Study|Other|0|||
143128890|NCT00791700|516017883|FG001|Overall Study|Other|1|||
143128891|NCT00791700|516017884|FG002|Overall Study|Other|0|||
143128892|NCT00791700|516017885|FG003|Overall Study|Other|1|||
143128893|NCT00791700|516017882|FG000|Overall Study|Death|0|||
143128894|NCT00791700|516017883|FG001|Overall Study|Death|0|||
143128895|NCT00791700|516017884|FG002|Overall Study|Death|0|||
143128896|NCT00791700|516017885|FG003|Overall Study|Death|1|||
143128897|NCT00791700|516017882|FG000|Overall Study|Lost to Follow-up|4|||
143128898|NCT00791700|516017883|FG001|Overall Study|Lost to Follow-up|3|||
143128899|NCT00791700|516017884|FG002|Overall Study|Lost to Follow-up|4|||
143128900|NCT00791700|516017885|FG003|Overall Study|Lost to Follow-up|6|||
143128901|NCT00791700|516017882|FG000|Overall Study|Adverse Event|0|||
143128902|NCT00791700|516017883|FG001|Overall Study|Adverse Event|0|||
143128903|NCT00791700|516017884|FG002|Overall Study|Adverse Event|1|||
143128904|NCT00791700|516017885|FG003|Overall Study|Adverse Event|1|||
143128905|NCT01720524|516017888|FG000|Part A|Insufficient Clinical Response|2|||
143128906|NCT01720524|516017889|FG001|Part A|Insufficient Clinical Response|4|||
143128907|NCT01720524|516017888|FG000|Part A|Adverse Event|2|||
143128908|NCT01720524|516017889|FG001|Part A|Adverse Event|2|||
143128909|NCT01720524|516017888|FG000|Part A|Death|2|||
143128910|NCT01720524|516017889|FG001|Part A|Death|1|||
143128911|NCT01720524|516017888|FG000|Part A|Lost to Follow-up|0|||
143128912|NCT01720524|516017889|FG001|Part A|Lost to Follow-up|1|||
143128913|NCT01720524|516017888|FG000|Part A|Missed 28 day follow-up visit|1|||
143128914|NCT01720524|516017889|FG001|Part A|Missed 28 day follow-up visit|1|||
143128915|NCT01720524|516017888|FG000|Part A|Withdrawal by Subject|0|||
143128916|NCT01720524|516017889|FG001|Part A|Withdrawal by Subject|1|||
143128917|NCT01720524|516017888|FG000|Part A|Other|0|||
143128918|NCT01720524|516017889|FG001|Part A|Other|1|||
143128919|NCT01720524|516017888|FG000|Part A|Lost to Follow-up|0|||
143465504|NCT01323634|517249580|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
143465505|NCT01575028|517249581|FG000|Overall Study|Physician Decision|0|||
143128920|NCT01720524|516017889|FG001|Part A|Lost to Follow-up|1|||
143128921|NCT01720524|516017888|FG000|Part B|No longer willing to participate in study|1|||
143128922|NCT01720524|516017889|FG001|Part B|No longer willing to participate in study|4|||
143128923|NCT01720524|516017888|FG000|Part B|Other|2|||
143128924|NCT01720524|516017889|FG001|Part B|Other|0|||
143128925|NCT01720524|516017888|FG000|Part B|Lost to Follow-up|2|||
143128926|NCT01720524|516017889|FG001|Part B|Lost to Follow-up|3|||
143128927|NCT01720524|516017888|FG000|Part B|Death|0|||
143128928|NCT01720524|516017889|FG001|Part B|Death|2|||
143128929|NCT00996034|516017890|FG000|Overall Study|Lost to Follow-up|2|||
143128930|NCT00996034|516017890|FG000|Overall Study|withdrawn by PI|1|||
143128931|NCT00158262|516017894|FG000|Overall Study|Lost to Follow-up|1|||
143128932|NCT00158262|516017895|FG001|Overall Study|Lost to Follow-up|1|||
143128933|NCT02105285|516017896|FG000|Overall Study|Adverse Event|1|||
143128934|NCT02105285|516017897|FG001|Overall Study|Adverse Event|1|||
143128935|NCT02105285|516017898|FG002|Overall Study|Adverse Event|0|||
143128936|NCT02105285|516017896|FG000|Overall Study|Protocol Violation|0|||
143128937|NCT02105285|516017897|FG001|Overall Study|Protocol Violation|1|||
143128938|NCT02105285|516017898|FG002|Overall Study|Protocol Violation|0|||
143128939|NCT02105285|516017896|FG000|Overall Study|Withdrawal by Subject|1|||
143128940|NCT02105285|516017897|FG001|Overall Study|Withdrawal by Subject|0|||
143128941|NCT02105285|516017898|FG002|Overall Study|Withdrawal by Subject|0|||
143128942|NCT02959918|516017900|FG000|Overall Study|Adverse Event|1|||
143128943|NCT02959918|516017901|FG001|Overall Study|Adverse Event|1|||
143128944|NCT02959918|516017902|FG002|Overall Study|Adverse Event|2|||
143128945|NCT02959918|516017903|FG003|Overall Study|Adverse Event|0|||
143128946|NCT02959918|516017904|FG004|Overall Study|Adverse Event|0|||
143128947|NCT02959918|516017905|FG005|Overall Study|Adverse Event|2|||
143128948|NCT02959918|516017906|FG006|Overall Study|Adverse Event|2|||
143128949|NCT02959918|516017907|FG007|Overall Study|Adverse Event|1|||
143128950|NCT02959918|516017908|FG008|Overall Study|Adverse Event|2|||
143128951|NCT02959918|516017909|FG009|Overall Study|Adverse Event|1|||
143128952|NCT02959918|516017910|FG010|Overall Study|Adverse Event|1|||
143128953|NCT02959918|516017911|FG011|Overall Study|Adverse Event|3|||
143128954|NCT02959918|516017912|FG012|Overall Study|Adverse Event|2|||
143128955|NCT02959918|516017913|FG013|Overall Study|Adverse Event|4|||
143128956|NCT02959918|516017900|FG000|Overall Study|Lost to Follow-up|0|||
143128957|NCT02959918|516017901|FG001|Overall Study|Lost to Follow-up|0|||
143128958|NCT02959918|516017902|FG002|Overall Study|Lost to Follow-up|0|||
143128959|NCT02959918|516017903|FG003|Overall Study|Lost to Follow-up|0|||
143128960|NCT02959918|516017904|FG004|Overall Study|Lost to Follow-up|0|||
143128961|NCT02959918|516017905|FG005|Overall Study|Lost to Follow-up|0|||
143128962|NCT02959918|516017906|FG006|Overall Study|Lost to Follow-up|0|||
143128963|NCT02959918|516017907|FG007|Overall Study|Lost to Follow-up|0|||
143128964|NCT02959918|516017908|FG008|Overall Study|Lost to Follow-up|0|||
143128965|NCT02959918|516017909|FG009|Overall Study|Lost to Follow-up|1|||
143128966|NCT02959918|516017910|FG010|Overall Study|Lost to Follow-up|0|||
143128967|NCT02959918|516017911|FG011|Overall Study|Lost to Follow-up|0|||
143128968|NCT02959918|516017912|FG012|Overall Study|Lost to Follow-up|1|||
143128969|NCT02959918|516017913|FG013|Overall Study|Lost to Follow-up|0|||
143128970|NCT02959918|516017900|FG000|Overall Study|Withdrawal by Subject|0|||
143128971|NCT02959918|516017901|FG001|Overall Study|Withdrawal by Subject|0|||
143128972|NCT02959918|516017902|FG002|Overall Study|Withdrawal by Subject|1|||
143128973|NCT02959918|516017903|FG003|Overall Study|Withdrawal by Subject|2|||
143128974|NCT02959918|516017904|FG004|Overall Study|Withdrawal by Subject|0|||
143128975|NCT02959918|516017905|FG005|Overall Study|Withdrawal by Subject|0|||
143128976|NCT02959918|516017906|FG006|Overall Study|Withdrawal by Subject|1|||
143128977|NCT02959918|516017907|FG007|Overall Study|Withdrawal by Subject|0|||
143128978|NCT02959918|516017908|FG008|Overall Study|Withdrawal by Subject|1|||
143128979|NCT02959918|516017909|FG009|Overall Study|Withdrawal by Subject|1|||
143357662|NCT01439711|516854434|FG000|Overall Study|Adverse Event|5|||
143357663|NCT01439711|516854434|FG000|Overall Study|Withdrawal by Subject|3|||
143357664|NCT01439711|516854434|FG000|Overall Study|Progression During Active Tx|3|||
143357665|NCT01439711|516854434|FG000|Overall Study|Noncompliance|3|||
143357666|NCT01439711|516854434|FG000|Overall Study|No MRI|9|||
143357667|NCT01473420|516854437|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
143357668|NCT01473420|516854438|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
143357669|NCT01473420|516854437|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
143357670|NCT01473420|516854438|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
143357671|NCT01473420|516854437|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
143357672|NCT01473420|516854438|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
143357673|NCT01473420|516854437|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
143357674|NCT01473420|516854438|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
143357675|NCT01473420|516854437|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
143357676|NCT01473420|516854438|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
143357677|NCT01473420|516854437|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
143128980|NCT02959918|516017910|FG010|Overall Study|Withdrawal by Subject|2|||
143128981|NCT02959918|516017911|FG011|Overall Study|Withdrawal by Subject|3|||
143128982|NCT02959918|516017912|FG012|Overall Study|Withdrawal by Subject|1|||
143128983|NCT02959918|516017913|FG013|Overall Study|Withdrawal by Subject|1|||
143128984|NCT02959918|516017900|FG000|Overall Study|Protocol Violation|0|||
143128985|NCT02959918|516017901|FG001|Overall Study|Protocol Violation|0|||
143128986|NCT02959918|516017902|FG002|Overall Study|Protocol Violation|1|||
143128987|NCT02959918|516017903|FG003|Overall Study|Protocol Violation|0|||
143128988|NCT02959918|516017904|FG004|Overall Study|Protocol Violation|0|||
143357678|NCT01473420|516854438|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
143357679|NCT01473420|516854437|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
143357680|NCT01473420|516854438|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
143128989|NCT02959918|516017905|FG005|Overall Study|Protocol Violation|1|||
143128990|NCT02959918|516017906|FG006|Overall Study|Protocol Violation|0|||
143128991|NCT02959918|516017907|FG007|Overall Study|Protocol Violation|0|||
143128992|NCT02959918|516017908|FG008|Overall Study|Protocol Violation|2|||
143128993|NCT02959918|516017909|FG009|Overall Study|Protocol Violation|1|||
143128994|NCT02959918|516017910|FG010|Overall Study|Protocol Violation|0|||
143128995|NCT02959918|516017911|FG011|Overall Study|Protocol Violation|1|||
143128996|NCT02959918|516017912|FG012|Overall Study|Protocol Violation|1|||
143128997|NCT02959918|516017913|FG013|Overall Study|Protocol Violation|0|||
143128998|NCT02959918|516017900|FG000|Overall Study|Stopping Rule Met|1|||
143128999|NCT02959918|516017901|FG001|Overall Study|Stopping Rule Met|0|||
143129000|NCT02959918|516017902|FG002|Overall Study|Stopping Rule Met|3|||
143129001|NCT02959918|516017903|FG003|Overall Study|Stopping Rule Met|4|||
143129002|NCT02959918|516017904|FG004|Overall Study|Stopping Rule Met|5|||
143129003|NCT02959918|516017905|FG005|Overall Study|Stopping Rule Met|3|||
143129004|NCT02959918|516017906|FG006|Overall Study|Stopping Rule Met|2|||
143129005|NCT02959918|516017907|FG007|Overall Study|Stopping Rule Met|4|||
143129006|NCT02959918|516017908|FG008|Overall Study|Stopping Rule Met|1|||
143129007|NCT02959918|516017909|FG009|Overall Study|Stopping Rule Met|1|||
143129008|NCT02959918|516017910|FG010|Overall Study|Stopping Rule Met|3|||
143129009|NCT02959918|516017911|FG011|Overall Study|Stopping Rule Met|5|||
143129010|NCT02959918|516017912|FG012|Overall Study|Stopping Rule Met|2|||
143129011|NCT02959918|516017913|FG013|Overall Study|Stopping Rule Met|1|||
143129012|NCT02959918|516017900|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
143129013|NCT02959918|516017901|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
143129014|NCT02959918|516017902|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
143129015|NCT02959918|516017903|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
143129016|NCT02959918|516017904|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
143129017|NCT02959918|516017905|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
143129018|NCT02959918|516017906|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
143129019|NCT02959918|516017907|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
143129020|NCT02959918|516017908|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
143129021|NCT02959918|516017909|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
143129022|NCT02959918|516017910|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
143129023|NCT02959918|516017911|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
143129024|NCT02959918|516017912|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
143129025|NCT02959918|516017913|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
143129026|NCT02959918|516017900|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
143129027|NCT02959918|516017901|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
143129028|NCT02959918|516017902|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
143129029|NCT02959918|516017903|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
143129030|NCT02959918|516017904|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
143129031|NCT02959918|516017905|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
143129032|NCT02959918|516017906|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
143129033|NCT02959918|516017907|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
143129034|NCT02959918|516017908|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
143129035|NCT02959918|516017909|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
143129036|NCT02959918|516017910|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
143129037|NCT02959918|516017911|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
143129038|NCT02959918|516017912|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
143129039|NCT02959918|516017913|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
143129040|NCT02959918|516017900|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
143129041|NCT02959918|516017901|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
143129042|NCT02959918|516017902|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
143129043|NCT02959918|516017903|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
143129044|NCT02959918|516017904|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
143129045|NCT02959918|516017905|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
143129046|NCT02959918|516017906|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
143129047|NCT02959918|516017907|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
143129048|NCT02959918|516017908|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
143129049|NCT02959918|516017909|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
143357681|NCT01473420|516854437|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
143357682|NCT01473420|516854438|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
143357683|NCT01473420|516854437|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
143129050|NCT02959918|516017910|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
143129051|NCT02959918|516017911|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
143129052|NCT02959918|516017912|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
143129053|NCT02959918|516017913|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
143465506|NCT01575028|517249582|FG001|Overall Study|Physician Decision|1|||
143465507|NCT01182194|517249583|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
143465508|NCT01182194|517249584|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
143465509|NCT03343301|517249585|FG000|Overall Study|Withdrawal by Subject|1|||
143465510|NCT03343301|517249586|FG001|Overall Study|Withdrawal by Subject|1|||
143465511|NCT03343301|517249585|FG000|Overall Study|Death|0|||
143465512|NCT03343301|517249586|FG001|Overall Study|Death|2|||
143465513|NCT03343301|517249585|FG000|Overall Study|Other|0|||
143129054|NCT02959918|516017900|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
143129055|NCT02959918|516017901|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
143129056|NCT02959918|516017902|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
143129057|NCT02959918|516017903|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
143129058|NCT02959918|516017904|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
143129059|NCT02959918|516017905|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
143129060|NCT02959918|516017906|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
143129061|NCT02959918|516017907|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
143129062|NCT02959918|516017908|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
143465514|NCT03343301|517249586|FG001|Overall Study|Other|6|||
143465515|NCT03343301|517249585|FG000|Overall Study|Missing|2|||
143465516|NCT03343301|517249586|FG001|Overall Study|Missing|0|||
143465517|NCT05959629|517249602|FG000|Overall Study|partially necrotic/technical issues|2|||
143465518|NCT05959629|517249603|FG001|Overall Study|partially necrotic/technical issues|2|||
143465519|NCT01717989|517251050|FG000|Overall Study|Ineligibility determined|6|||
143465520|NCT01717989|517251050|FG000|Overall Study|Protocol deviation|6|||
143465521|NCT01717989|517251050|FG000|Overall Study|Withdrawal by Subject|11|||
143465522|NCT01717989|517251050|FG000|Overall Study|Physician Decision|2|||
143465523|NCT01717989|517251050|FG000|Overall Study|Lost to Follow-up|11|||
143465524|NCT01717989|517251050|FG000|Overall Study|Death|439|||
143129063|NCT02959918|516017909|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
143129064|NCT02959918|516017910|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
143129065|NCT02959918|516017911|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
143129066|NCT02959918|516017912|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
143129067|NCT02959918|516017913|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
143129068|NCT02364388|516017914|FG000|Overall Study|Protocol Violation|1|||
143129069|NCT02364388|516017914|FG000|Overall Study|Technical Failure|3|||
143129070|NCT02364388|516017914|FG000|Overall Study|No OA/US data|2|||
143129071|NCT02364388|516017914|FG000|Overall Study|No Biopsy|2|||
143129072|NCT05464420|516017918|FG000|Overall Study|Death|0|||
143129073|NCT05464420|516017919|FG001|Overall Study|Death|0|||
143129074|NCT05464420|516017920|FG002|Overall Study|Death|0|||
143129075|NCT05464420|516017921|FG003|Overall Study|Death|1|||
143129076|NCT05464420|516017918|FG000|Overall Study|Lost to Follow-up|16|||
143129077|NCT05464420|516017919|FG001|Overall Study|Lost to Follow-up|11|||
143129078|NCT05464420|516017920|FG002|Overall Study|Lost to Follow-up|11|||
143129079|NCT05464420|516017921|FG003|Overall Study|Lost to Follow-up|11|||
143129080|NCT05464420|516017918|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
143129081|NCT05464420|516017919|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
143129082|NCT05464420|516017920|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
143129083|NCT05464420|516017921|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
143129084|NCT05464420|516017918|FG000|Overall Study|Withdrawal by Subject|4|||
143129085|NCT05464420|516017919|FG001|Overall Study|Withdrawal by Subject|8|||
143129086|NCT05464420|516017920|FG002|Overall Study|Withdrawal by Subject|3|||
143129087|NCT05464420|516017921|FG003|Overall Study|Withdrawal by Subject|1|||
143129088|NCT05464420|516017918|FG000|Overall Study|Protocol Violation|0|||
143129089|NCT05464420|516017919|FG001|Overall Study|Protocol Violation|0|||
143129090|NCT05464420|516017920|FG002|Overall Study|Protocol Violation|1|||
143129091|NCT05464420|516017921|FG003|Overall Study|Protocol Violation|1|||
143129092|NCT05464420|516017918|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
143129093|NCT05464420|516017919|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
143129094|NCT05464420|516017920|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
143129095|NCT05464420|516017921|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
143129096|NCT01383018|516017922|FG000|Overall Study|Adverse Event|14|||
143465525|NCT01717989|517251050|FG000|Overall Study|Protocol-specified criteria|551|||
143129097|NCT01383018|516017922|FG000|Overall Study|Death|10|||
143129098|NCT01383018|516017922|FG000|Overall Study|Lost to Follow-up|5|||
143129099|NCT01383018|516017922|FG000|Overall Study|Physician Decision|5|||
143465526|NCT01717989|517251050|FG000|Overall Study|Other|40|||
143465527|NCT03224325|517251051|FG000|Overall Study|Adverse Event|1|||
143129100|NCT01383018|516017922|FG000|Overall Study|Withdrawal by Subject|9|||
143129101|NCT01383018|516017922|FG000|Overall Study|Subject not implanted|76|||
143465528|NCT03224325|517251052|FG001|Overall Study|Adverse Event|0|||
143465529|NCT03224325|517251053|FG002|Overall Study|Adverse Event|0|||
143465530|NCT03224325|517251054|FG003|Overall Study|Adverse Event|0|||
143465531|NCT03224325|517251055|FG004|Overall Study|Adverse Event|0|||
143129102|NCT01383018|516017922|FG000|Overall Study|Missed Visit|247|||
143129103|NCT01383018|516017922|FG000|Overall Study|Site closed early-not compliance related|7|||
143129104|NCT01383018|516017922|FG000|Overall Study|Patient moved away from site|1|||
143129105|NCT01383018|516017922|FG000|Overall Study|Subject Incarcerated|1|||
143129106|NCT03414229|516017923|FG000|Overall Study|Adverse Event|1|||
143129107|NCT03414229|516017924|FG001|Overall Study|Adverse Event|0|||
143129108|NCT03414229|516017925|FG002|Overall Study|Adverse Event|2|||
143129109|NCT03414229|516017926|FG003|Overall Study|Adverse Event|1|||
143129110|NCT03414229|516017923|FG000|Overall Study|Lack of Efficacy|7|||
143129111|NCT03414229|516017924|FG001|Overall Study|Lack of Efficacy|4|||
143129112|NCT03414229|516017925|FG002|Overall Study|Lack of Efficacy|1|||
143129113|NCT03414229|516017926|FG003|Overall Study|Lack of Efficacy|9|||
143129114|NCT03414229|516017923|FG000|Overall Study|Change in therapy|1|||
143129115|NCT03414229|516017924|FG001|Overall Study|Change in therapy|0|||
143129116|NCT03414229|516017925|FG002|Overall Study|Change in therapy|0|||
143129117|NCT03414229|516017926|FG003|Overall Study|Change in therapy|0|||
143129118|NCT03414229|516017923|FG000|Overall Study|Pregnancy|0|||
143129119|NCT03414229|516017924|FG001|Overall Study|Pregnancy|0|||
143129120|NCT03414229|516017925|FG002|Overall Study|Pregnancy|1|||
143129121|NCT03414229|516017926|FG003|Overall Study|Pregnancy|0|||
143129122|NCT03414229|516017923|FG000|Overall Study|Withdrawal by Subject|0|||
143129123|NCT03414229|516017924|FG001|Overall Study|Withdrawal by Subject|1|||
143129124|NCT03414229|516017925|FG002|Overall Study|Withdrawal by Subject|1|||
143129125|NCT03414229|516017926|FG003|Overall Study|Withdrawal by Subject|0|||
143129126|NCT05568797|516017933|FG000|Overall Study|Adverse Event|0|||
143129127|NCT05568797|516017934|FG001|Overall Study|Adverse Event|8|||
143129128|NCT05568797|516017933|FG000|Overall Study|Lost to Follow-up|2|||
143129129|NCT05568797|516017934|FG001|Overall Study|Lost to Follow-up|3|||
143129130|NCT05568797|516017933|FG000|Overall Study|Withdrawal by Subject|1|||
143129131|NCT05568797|516017934|FG001|Overall Study|Withdrawal by Subject|10|||
143129132|NCT05568797|516017933|FG000|Overall Study|Other|2|||
143129133|NCT05568797|516017934|FG001|Overall Study|Other|2|||
143129134|NCT00099632|516017935|FG000|Overall Study|Lost to Follow-up|1|||
143129135|NCT00099632|516017936|FG001|Overall Study|Lost to Follow-up|0|||
143129136|NCT00099632|516017937|FG002|Overall Study|Lost to Follow-up|3|||
143129137|NCT00099632|516017938|FG003|Overall Study|Lost to Follow-up|1|||
143129138|NCT00099632|516017939|FG004|Overall Study|Lost to Follow-up|1|||
143129139|NCT00099632|516017940|FG005|Overall Study|Lost to Follow-up|0|||
143129140|NCT00099632|516017935|FG000|Overall Study|Withdrawal by Subject|0|||
143129141|NCT00099632|516017936|FG001|Overall Study|Withdrawal by Subject|1|||
143129142|NCT00099632|516017937|FG002|Overall Study|Withdrawal by Subject|0|||
143129143|NCT00099632|516017938|FG003|Overall Study|Withdrawal by Subject|0|||
143129144|NCT00099632|516017939|FG004|Overall Study|Withdrawal by Subject|0|||
143129145|NCT00099632|516017940|FG005|Overall Study|Withdrawal by Subject|1|||
143129146|NCT00099632|516017935|FG000|Overall Study|Protocol Violation|0|||
143129147|NCT00099632|516017936|FG001|Overall Study|Protocol Violation|0|||
143129148|NCT00099632|516017937|FG002|Overall Study|Protocol Violation|0|||
143465532|NCT03224325|517251056|FG005|Overall Study|Adverse Event|0|||
143465533|NCT03224325|517251057|FG006|Overall Study|Adverse Event|1|||
143465534|NCT03224325|517251051|FG000|Overall Study|Withdrawal by Subject|0|||
143465535|NCT03224325|517251052|FG001|Overall Study|Withdrawal by Subject|0|||
143465536|NCT03224325|517251053|FG002|Overall Study|Withdrawal by Subject|0|||
143465537|NCT03224325|517251054|FG003|Overall Study|Withdrawal by Subject|1|||
143465538|NCT03224325|517251055|FG004|Overall Study|Withdrawal by Subject|0|||
143465539|NCT03224325|517251056|FG005|Overall Study|Withdrawal by Subject|0|||
143465540|NCT03224325|517251057|FG006|Overall Study|Withdrawal by Subject|0|||
143465541|NCT02864381|517251058|FG000|Overall Study|Death|58|||
143465542|NCT02864381|517251059|FG001|Overall Study|Death|61|||
143465543|NCT02864381|517251058|FG000|Overall Study|Withdrew Consent|5|||
143465544|NCT02864381|517251059|FG001|Overall Study|Withdrew Consent|6|||
143465545|NCT02864381|517251058|FG000|Overall Study|Reason Unknown|7|||
143465546|NCT02864381|517251059|FG001|Overall Study|Reason Unknown|3|||
143465547|NCT02864381|517251058|FG000|Overall Study|Lost to Follow-up|1|||
143465548|NCT02864381|517251059|FG001|Overall Study|Lost to Follow-up|1|||
143465549|NCT02864381|517251058|FG000|Overall Study|Investigator's Discretion|1|||
143129149|NCT00099632|516017938|FG003|Overall Study|Protocol Violation|0|||
143129150|NCT00099632|516017939|FG004|Overall Study|Protocol Violation|0|||
143129151|NCT00099632|516017940|FG005|Overall Study|Protocol Violation|1|||
143129152|NCT01066871|516017964|FG000|Overall Study|Lost to Follow-up|0|||
143129153|NCT01066871|516017965|FG001|Overall Study|Lost to Follow-up|2|||
143129154|NCT01066871|516017966|FG002|Overall Study|Lost to Follow-up|2|||
143129155|NCT01066871|516017967|FG003|Overall Study|Lost to Follow-up|0|||
143465550|NCT02864381|517251059|FG001|Overall Study|Investigator's Discretion|0|||
143465551|NCT02864381|517251058|FG000|Overall Study|Protocol Violation|0|||
143129156|NCT01066871|516017964|FG000|Overall Study|Protocol Violation|1|||
143129157|NCT01066871|516017965|FG001|Overall Study|Protocol Violation|0|||
143129158|NCT01066871|516017966|FG002|Overall Study|Protocol Violation|3|||
143129159|NCT01066871|516017967|FG003|Overall Study|Protocol Violation|2|||
143129160|NCT01066871|516017964|FG000|Overall Study|Lack of Efficacy|0|||
143465552|NCT02864381|517251059|FG001|Overall Study|Protocol Violation|1|||
143129161|NCT01066871|516017965|FG001|Overall Study|Lack of Efficacy|0|||
143129162|NCT01066871|516017966|FG002|Overall Study|Lack of Efficacy|0|||
143129163|NCT01066871|516017967|FG003|Overall Study|Lack of Efficacy|1|||
143129164|NCT01066871|516017964|FG000|Overall Study|Withdrawal by Subject|3|||
143129165|NCT01066871|516017965|FG001|Overall Study|Withdrawal by Subject|1|||
143129166|NCT01066871|516017966|FG002|Overall Study|Withdrawal by Subject|0|||
143129167|NCT01066871|516017967|FG003|Overall Study|Withdrawal by Subject|0|||
143129168|NCT01066871|516017964|FG000|Overall Study|Other|0|||
143129169|NCT01066871|516017965|FG001|Overall Study|Other|2|||
143129170|NCT01066871|516017966|FG002|Overall Study|Other|1|||
143129171|NCT01066871|516017967|FG003|Overall Study|Other|2|||
143129172|NCT02029274|516017972|FG000|Overall Study|Adverse Event|1|||
143129173|NCT02029274|516017973|FG001|Overall Study|Adverse Event|0|||
143129174|NCT02029274|516017974|FG002|Overall Study|Adverse Event|2|||
143129175|NCT02029274|516017975|FG003|Overall Study|Adverse Event|2|||
143129176|NCT03300180|516017976|FG000|Baseline|Withdrawal by Subject|4|||
143129177|NCT03300180|516017977|FG001|Baseline|Withdrawal by Subject|6|||
143129178|NCT03300180|516017978|FG002|Baseline|Withdrawal by Subject|4|||
143129179|NCT03300180|516017976|FG000|6 Month Outcome|Withdrawal by Subject|12|||
143129180|NCT03300180|516017977|FG001|6 Month Outcome|Withdrawal by Subject|12|||
143129181|NCT03300180|516017978|FG002|6 Month Outcome|Withdrawal by Subject|19|||
143129182|NCT03300180|516017976|FG000|6 Month Outcome|Death|2|||
143129183|NCT03300180|516017977|FG001|6 Month Outcome|Death|4|||
143129184|NCT03300180|516017978|FG002|6 Month Outcome|Death|3|||
143129185|NCT03300180|516017976|FG000|6 Month Outcome|Missed Assessment|43|||
143129186|NCT03300180|516017977|FG001|6 Month Outcome|Missed Assessment|52|||
143129187|NCT03300180|516017978|FG002|6 Month Outcome|Missed Assessment|46|||
143129188|NCT03300180|516017976|FG000|12 Month Outcome|Withdrawal by Subject|3|||
143129189|NCT03300180|516017977|FG001|12 Month Outcome|Withdrawal by Subject|6|||
143129190|NCT03300180|516017978|FG002|12 Month Outcome|Withdrawal by Subject|6|||
143129191|NCT03300180|516017976|FG000|12 Month Outcome|Death|9|||
143129192|NCT03300180|516017977|FG001|12 Month Outcome|Death|6|||
143129193|NCT03300180|516017978|FG002|12 Month Outcome|Death|6|||
143129194|NCT03300180|516017976|FG000|12 Month Outcome|Missed Assessment|62|||
143129195|NCT03300180|516017977|FG001|12 Month Outcome|Missed Assessment|59|||
143465553|NCT02120625|517251061|FG000|Overall Study|Physician Decision|2|||
143465554|NCT02525861|517251062|FG000|Overall Study|Adverse Event|1|||
143129196|NCT03300180|516017978|FG002|12 Month Outcome|Missed Assessment|58|||
143465555|NCT02525861|517251063|FG001|Overall Study|Adverse Event|0|||
143465556|NCT02525861|517251062|FG000|Overall Study|Withdrawal by Subject|0|||
143465557|NCT02525861|517251063|FG001|Overall Study|Withdrawal by Subject|1|||
143465558|NCT02525861|517251062|FG000|Overall Study|Physician Decision|0|||
143465559|NCT02525861|517251063|FG001|Overall Study|Physician Decision|1|||
143465560|NCT03278106|517251064|FG000|Overall Study|No protocol treatment|1|||
143465561|NCT03952806|517251066|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
143465562|NCT03952806|517251067|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
143465563|NCT03952806|517251066|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
143465564|NCT03952806|517251067|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
143465565|NCT03952806|517251066|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
143465566|NCT03952806|517251067|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
143465567|NCT03952806|517251066|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
143465568|NCT03952806|517251067|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
143465569|NCT03952806|517251066|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
143465570|NCT03952806|517251067|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
143465571|NCT03952806|517251066|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
143465572|NCT03952806|517251067|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
143465573|NCT03952806|517251066|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
143465574|NCT03952806|517251067|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
143465575|NCT03952806|517251066|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
143465576|NCT03952806|517251067|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
143465577|NCT03952806|517251066|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
143465578|NCT03952806|517251067|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
143465579|NCT03952806|517251066|FG000|OLE Phase (48 Weeks)|Other|16|||
143465580|NCT03952806|517251067|FG001|OLE Phase (48 Weeks)|Other|13|||
143465581|NCT02168842|517251073|FG000|Overall Study|Withdrawal by Subject|5|||
143465582|NCT02168842|517251074|FG001|Overall Study|Withdrawal by Subject|3|||
143129197|NCT03300180|516017976|FG000|18 Month Outcome Assessment|Withdrawal by Subject|14|||
143129198|NCT03300180|516017977|FG001|18 Month Outcome Assessment|Withdrawal by Subject|4|||
143129199|NCT03300180|516017978|FG002|18 Month Outcome Assessment|Withdrawal by Subject|13|||
143465583|NCT02168842|517251073|FG000|Overall Study|Lost to Follow-up|0|||
143465584|NCT02168842|517251074|FG001|Overall Study|Lost to Follow-up|2|||
143465585|NCT02168842|517251073|FG000|Overall Study|Death|2|||
143129200|NCT03300180|516017976|FG000|18 Month Outcome Assessment|Death|8|||
143129201|NCT03300180|516017977|FG001|18 Month Outcome Assessment|Death|5|||
143129202|NCT03300180|516017978|FG002|18 Month Outcome Assessment|Death|5|||
143129203|NCT03300180|516017976|FG000|18 Month Outcome Assessment|Missed Assessment|49|||
143465586|NCT02168842|517251074|FG001|Overall Study|Death|1|||
143465587|NCT02168842|517251073|FG000|Overall Study|Physician Decision|1|||
143465588|NCT02168842|517251074|FG001|Overall Study|Physician Decision|2|||
143465589|NCT00892723|517251075|FG000|Overall Study|Lost to Follow-up|1|||
143465590|NCT00892723|517251076|FG001|Overall Study|Lost to Follow-up|3|||
143465591|NCT00892723|517251077|FG002|Overall Study|Lost to Follow-up|1|||
143465592|NCT00892723|517251075|FG000|Overall Study|Withdrawal by Subject|1|||
143129204|NCT03300180|516017977|FG001|18 Month Outcome Assessment|Missed Assessment|61|||
143129205|NCT03300180|516017978|FG002|18 Month Outcome Assessment|Missed Assessment|44|||
143129206|NCT03300180|516017976|FG000|24 Month Outcome Assessment|Withdrawal by Subject|6|||
143129207|NCT03300180|516017977|FG001|24 Month Outcome Assessment|Withdrawal by Subject|10|||
143129208|NCT03300180|516017978|FG002|24 Month Outcome Assessment|Withdrawal by Subject|4|||
143129209|NCT03300180|516017976|FG000|24 Month Outcome Assessment|Death|13|||
143129210|NCT03300180|516017977|FG001|24 Month Outcome Assessment|Death|13|||
143357684|NCT01473420|516854438|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
143357685|NCT01473420|516854437|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
143357686|NCT01473420|516854438|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
143357687|NCT01473420|516854437|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
143357688|NCT01473420|516854438|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
143357689|NCT01473420|516854437|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
143357690|NCT01473420|516854438|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
143357691|NCT01473420|516854437|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
143357692|NCT01473420|516854438|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
143357693|NCT04172987|516854442|FG000|Lead In Period|Adverse Event|1|||
143357694|NCT04172987|516854442|FG000|Lead In Period|Protocol Violation|1|||
143357695|NCT04172987|516854442|FG000|Period 1|Physician Decision|1|||
143357696|NCT04172987|516854442|FG000|Period 2|Adverse Event|5|||
143357697|NCT04172987|516854442|FG000|Period 2|Dosing Termination by Sponsor|4|||
143357698|NCT01603121|516854446|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
143357699|NCT01603121|516854447|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
143357700|NCT00577720|516854448|FG000|Overall Study|Adverse Event|2|||
143357701|NCT00577720|516854449|FG001|Overall Study|Adverse Event|1|||
143357702|NCT00577720|516854450|FG002|Overall Study|Adverse Event|0|||
143357703|NCT00577720|516854451|FG003|Overall Study|Adverse Event|4|||
143357704|NCT00577720|516854448|FG000|Overall Study|Lost to Follow-up|0|||
143357705|NCT00577720|516854449|FG001|Overall Study|Lost to Follow-up|0|||
143357706|NCT00577720|516854450|FG002|Overall Study|Lost to Follow-up|1|||
143357707|NCT00577720|516854451|FG003|Overall Study|Lost to Follow-up|0|||
143357708|NCT00577720|516854448|FG000|Overall Study|Protocol Violation|0|||
143357709|NCT00577720|516854449|FG001|Overall Study|Protocol Violation|0|||
143357710|NCT00577720|516854450|FG002|Overall Study|Protocol Violation|0|||
143357711|NCT00577720|516854451|FG003|Overall Study|Protocol Violation|1|||
143357712|NCT00577720|516854448|FG000|Overall Study|Withdrawal by Subject|2|||
143357713|NCT00577720|516854449|FG001|Overall Study|Withdrawal by Subject|0|||
143357714|NCT00577720|516854450|FG002|Overall Study|Withdrawal by Subject|0|||
143357715|NCT00577720|516854451|FG003|Overall Study|Withdrawal by Subject|2|||
143357716|NCT00738530|516854457|FG000|Overall Study|Death|220|||
143357717|NCT00738530|516854458|FG001|Overall Study|Death|224|||
143357718|NCT00738530|516854457|FG000|Overall Study|Lost to Follow-up|8|||
143357719|NCT00738530|516854458|FG001|Overall Study|Lost to Follow-up|6|||
143357720|NCT00738530|516854457|FG000|Overall Study|Withdrawal by Subject|6|||
143357721|NCT00738530|516854458|FG001|Overall Study|Withdrawal by Subject|8|||
143357722|NCT01656759|516854459|FG000|Overall Study|Protocol Violation|2|||
143357723|NCT01656759|516854460|FG001|Overall Study|Protocol Violation|3|||
143357724|NCT01932996|516854461|FG000|Overall Study|Protocol Violation|2|||
143357725|NCT01932996|516854462|FG001|Overall Study|Protocol Violation|0|||
143357726|NCT04894903|516854465|FG000|Overall Study|Death|1|||
143357727|NCT04894903|516854466|FG001|Overall Study|Death|0|||
143357728|NCT04894903|516854465|FG000|Overall Study|Pregnancy|1|||
143357729|NCT04894903|516854466|FG001|Overall Study|Pregnancy|0|||
143357730|NCT04894903|516854465|FG000|Overall Study|Withdrawal by Subject|1|||
143357731|NCT04894903|516854466|FG001|Overall Study|Withdrawal by Subject|1|||
143357732|NCT04894903|516854465|FG000|Overall Study|moved or exited health system|1|||
143357733|NCT04894903|516854466|FG001|Overall Study|moved or exited health system|3|||
143465593|NCT00892723|517251076|FG001|Overall Study|Withdrawal by Subject|1|||
143357734|NCT01923428|516854468|FG000|Overall Study|Adverse Event|8|||
143357735|NCT01923428|516854469|FG001|Overall Study|Adverse Event|6|||
143357736|NCT01923428|516854470|FG002|Overall Study|Adverse Event|3|||
143357737|NCT01923428|516854471|FG003|Overall Study|Adverse Event|3|||
143357738|NCT01923428|516854468|FG000|Overall Study|Withdrawal by Subject|5|||
143357739|NCT01923428|516854469|FG001|Overall Study|Withdrawal by Subject|3|||
143357740|NCT01923428|516854470|FG002|Overall Study|Withdrawal by Subject|0|||
143357741|NCT01923428|516854471|FG003|Overall Study|Withdrawal by Subject|4|||
143357742|NCT01923428|516854468|FG000|Overall Study|Lost to Follow-up|2|||
143357743|NCT01923428|516854469|FG001|Overall Study|Lost to Follow-up|1|||
143357744|NCT01923428|516854470|FG002|Overall Study|Lost to Follow-up|5|||
143357745|NCT01923428|516854471|FG003|Overall Study|Lost to Follow-up|0|||
143129211|NCT03300180|516017978|FG002|24 Month Outcome Assessment|Death|3|||
143129212|NCT03300180|516017976|FG000|24 Month Outcome Assessment|Missed Assessment|17|||
143129213|NCT03300180|516017977|FG001|24 Month Outcome Assessment|Missed Assessment|21|||
143129214|NCT03300180|516017978|FG002|24 Month Outcome Assessment|Missed Assessment|38|||
143129215|NCT05259163|516019560|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
143129216|NCT05259163|516019561|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
143129217|NCT00103285|516019562|FG000|Induction|Adverse Event|14|||
143129218|NCT00103285|516019563|FG001|Induction|Adverse Event|0|||
143129219|NCT00103285|516019564|FG002|Induction|Adverse Event|0|||
143129220|NCT00103285|516019565|FG003|Induction|Adverse Event|0|||
143129221|NCT00103285|516019566|FG004|Induction|Adverse Event|0|||
143129222|NCT00103285|516019567|FG005|Induction|Adverse Event|0|||
143129223|NCT00103285|516019568|FG006|Induction|Adverse Event|0|||
143129224|NCT00103285|516019569|FG007|Induction|Adverse Event|0|||
143129225|NCT00103285|516019562|FG000|Induction|Death|24|||
143129226|NCT00103285|516019563|FG001|Induction|Death|0|||
143129227|NCT00103285|516019564|FG002|Induction|Death|0|||
143129228|NCT00103285|516019565|FG003|Induction|Death|0|||
143129229|NCT00103285|516019566|FG004|Induction|Death|0|||
143129230|NCT00103285|516019567|FG005|Induction|Death|0|||
143129231|NCT00103285|516019568|FG006|Induction|Death|0|||
143129232|NCT00103285|516019569|FG007|Induction|Death|0|||
143129233|NCT00103285|516019562|FG000|Induction|Physician Decision|103|||
143129234|NCT00103285|516019563|FG001|Induction|Physician Decision|0|||
143129235|NCT00103285|516019564|FG002|Induction|Physician Decision|0|||
143129236|NCT00103285|516019565|FG003|Induction|Physician Decision|0|||
143129237|NCT00103285|516019566|FG004|Induction|Physician Decision|0|||
143129238|NCT00103285|516019567|FG005|Induction|Physician Decision|0|||
143129239|NCT00103285|516019568|FG006|Induction|Physician Decision|0|||
143129240|NCT00103285|516019569|FG007|Induction|Physician Decision|0|||
143129241|NCT00103285|516019562|FG000|Induction|Withdrawal by Subject|1|||
143129242|NCT00103285|516019563|FG001|Induction|Withdrawal by Subject|0|||
143129243|NCT00103285|516019564|FG002|Induction|Withdrawal by Subject|0|||
143129244|NCT00103285|516019565|FG003|Induction|Withdrawal by Subject|0|||
143129245|NCT00103285|516019566|FG004|Induction|Withdrawal by Subject|0|||
143129246|NCT00103285|516019567|FG005|Induction|Withdrawal by Subject|0|||
143129247|NCT00103285|516019568|FG006|Induction|Withdrawal by Subject|0|||
143129248|NCT00103285|516019569|FG007|Induction|Withdrawal by Subject|0|||
143129249|NCT00103285|516019562|FG000|Induction|Ineligible|43|||
143129250|NCT00103285|516019563|FG001|Induction|Ineligible|0|||
143129251|NCT00103285|516019564|FG002|Induction|Ineligible|0|||
143129252|NCT00103285|516019565|FG003|Induction|Ineligible|0|||
143357746|NCT01923428|516854468|FG000|Overall Study|Protocol Violation|3|||
143357747|NCT01923428|516854469|FG001|Overall Study|Protocol Violation|0|||
143357748|NCT01923428|516854470|FG002|Overall Study|Protocol Violation|2|||
143357749|NCT01923428|516854471|FG003|Overall Study|Protocol Violation|1|||
143357750|NCT01923428|516854468|FG000|Overall Study|Non Compliance to treatment|1|||
143357751|NCT01923428|516854469|FG001|Overall Study|Non Compliance to treatment|2|||
143357752|NCT01923428|516854470|FG002|Overall Study|Non Compliance to treatment|0|||
143357753|NCT01923428|516854471|FG003|Overall Study|Non Compliance to treatment|1|||
143357754|NCT01923428|516854468|FG000|Overall Study|Lack of Efficacy|0|||
143357755|NCT01923428|516854469|FG001|Overall Study|Lack of Efficacy|0|||
143357756|NCT01923428|516854470|FG002|Overall Study|Lack of Efficacy|1|||
143357757|NCT01923428|516854471|FG003|Overall Study|Lack of Efficacy|1|||
143357758|NCT01822353|516854472|FG000|Overall Study|Adverse Event|1|||
143357759|NCT01822353|516854473|FG001|Overall Study|Adverse Event|3|||
143357760|NCT01822353|516854474|FG002|Overall Study|Adverse Event|1|||
143357761|NCT01822353|516854472|FG000|Overall Study|Pregnancy|0|||
143357762|NCT01822353|516854473|FG001|Overall Study|Pregnancy|1|||
143357763|NCT01822353|516854474|FG002|Overall Study|Pregnancy|0|||
143357764|NCT01822353|516854472|FG000|Overall Study|Withdrawal by Subject|3|||
143357765|NCT01822353|516854473|FG001|Overall Study|Withdrawal by Subject|1|||
143357766|NCT01822353|516854474|FG002|Overall Study|Withdrawal by Subject|0|||
143357767|NCT02550873|516854475|FG000|Randomized Double Blind|Adverse Event|3|||
143357768|NCT02550873|516854476|FG001|Randomized Double Blind|Adverse Event|1|||
143357769|NCT02550873|516854477|FG002|Randomized Double Blind|Adverse Event|0|||
143357770|NCT02550873|516854475|FG000|Randomized Double Blind|Disease progression|1|||
143129253|NCT00103285|516019566|FG004|Induction|Ineligible|0|||
143129254|NCT00103285|516019567|FG005|Induction|Ineligible|0|||
143129255|NCT00103285|516019568|FG006|Induction|Ineligible|0|||
143357771|NCT02550873|516854476|FG001|Randomized Double Blind|Disease progression|1|||
143357772|NCT02550873|516854477|FG002|Randomized Double Blind|Disease progression|0|||
143357773|NCT02550873|516854475|FG000|Open Label Extension|Study ongoing|0|||
143129256|NCT00103285|516019569|FG007|Induction|Ineligible|0|||
143129257|NCT00103285|516019562|FG000|Induction|Refusal|906|||
143129258|NCT00103285|516019563|FG001|Induction|Refusal|0|||
143129259|NCT00103285|516019564|FG002|Induction|Refusal|0|||
143357774|NCT02550873|516854476|FG001|Open Label Extension|Study ongoing|0|||
143357775|NCT02550873|516854477|FG002|Open Label Extension|Study ongoing|111|||
143357776|NCT00885495|516854478|FG000|Overall Study|Adverse Event|1|||
143129260|NCT00103285|516019565|FG003|Induction|Refusal|0|||
143129261|NCT00103285|516019566|FG004|Induction|Refusal|0|||
143129262|NCT00103285|516019567|FG005|Induction|Refusal|0|||
143129263|NCT00103285|516019568|FG006|Induction|Refusal|0|||
143129264|NCT00103285|516019569|FG007|Induction|Refusal|0|||
143129265|NCT00103285|516019562|FG000|Induction|Other|258|||
143129266|NCT00103285|516019563|FG001|Induction|Other|0|||
143129267|NCT00103285|516019564|FG002|Induction|Other|0|||
143129268|NCT00103285|516019565|FG003|Induction|Other|0|||
143129269|NCT00103285|516019566|FG004|Induction|Other|0|||
143129270|NCT00103285|516019567|FG005|Induction|Other|0|||
143129271|NCT00103285|516019568|FG006|Induction|Other|0|||
143129272|NCT00103285|516019569|FG007|Induction|Other|0|||
143129273|NCT00103285|516019562|FG000|Response Assignment|Adverse Event|0|||
143129274|NCT00103285|516019563|FG001|Response Assignment|Adverse Event|8|||
143129275|NCT00103285|516019564|FG002|Response Assignment|Adverse Event|3|||
143129276|NCT00103285|516019565|FG003|Response Assignment|Adverse Event|2|||
143129277|NCT00103285|516019566|FG004|Response Assignment|Adverse Event|3|||
143129278|NCT00103285|516019567|FG005|Response Assignment|Adverse Event|1|||
143129279|NCT00103285|516019568|FG006|Response Assignment|Adverse Event|1|||
143129280|NCT00103285|516019569|FG007|Response Assignment|Adverse Event|2|||
143129281|NCT00103285|516019562|FG000|Response Assignment|Death|0|||
143129282|NCT00103285|516019563|FG001|Response Assignment|Death|5|||
143129283|NCT00103285|516019564|FG002|Response Assignment|Death|2|||
143129284|NCT00103285|516019565|FG003|Response Assignment|Death|2|||
143129285|NCT00103285|516019566|FG004|Response Assignment|Death|3|||
143129286|NCT00103285|516019567|FG005|Response Assignment|Death|1|||
143129287|NCT00103285|516019568|FG006|Response Assignment|Death|0|||
143129288|NCT00103285|516019569|FG007|Response Assignment|Death|8|||
143129289|NCT00103285|516019562|FG000|Response Assignment|Lost to Follow-up|0|||
143129290|NCT00103285|516019563|FG001|Response Assignment|Lost to Follow-up|9|||
143129291|NCT00103285|516019564|FG002|Response Assignment|Lost to Follow-up|5|||
143129292|NCT00103285|516019565|FG003|Response Assignment|Lost to Follow-up|5|||
143129293|NCT00103285|516019566|FG004|Response Assignment|Lost to Follow-up|1|||
143129294|NCT00103285|516019567|FG005|Response Assignment|Lost to Follow-up|2|||
143129295|NCT00103285|516019568|FG006|Response Assignment|Lost to Follow-up|2|||
143129296|NCT00103285|516019569|FG007|Response Assignment|Lost to Follow-up|5|||
143129297|NCT00103285|516019562|FG000|Response Assignment|Physician Decision|0|||
143129298|NCT00103285|516019563|FG001|Response Assignment|Physician Decision|13|||
143129299|NCT00103285|516019564|FG002|Response Assignment|Physician Decision|14|||
143129300|NCT00103285|516019565|FG003|Response Assignment|Physician Decision|9|||
143129301|NCT00103285|516019566|FG004|Response Assignment|Physician Decision|13|||
143129302|NCT00103285|516019567|FG005|Response Assignment|Physician Decision|7|||
143129303|NCT00103285|516019568|FG006|Response Assignment|Physician Decision|4|||
143129304|NCT00103285|516019569|FG007|Response Assignment|Physician Decision|35|||
143129305|NCT00103285|516019562|FG000|Response Assignment|Protocol Violation|0|||
143129306|NCT00103285|516019563|FG001|Response Assignment|Protocol Violation|2|||
143129307|NCT00103285|516019564|FG002|Response Assignment|Protocol Violation|0|||
143465594|NCT00892723|517251077|FG002|Overall Study|Withdrawal by Subject|1|||
143465595|NCT02121834|517251080|FG000|Overall Study|Protocol Violation|0|||
143465596|NCT02121834|517251081|FG001|Overall Study|Protocol Violation|1|||
143465597|NCT02121834|517251082|FG002|Overall Study|Protocol Violation|0|||
143465598|NCT02121834|517251083|FG003|Overall Study|Protocol Violation|0|||
143465599|NCT02121834|517251084|FG004|Overall Study|Protocol Violation|0|||
143465600|NCT02121834|517251085|FG005|Overall Study|Protocol Violation|0|||
143465601|NCT02121834|517251086|FG006|Overall Study|Protocol Violation|0|||
143465602|NCT02121834|517251080|FG000|Overall Study|Withdrawal by Subject|0|||
143465603|NCT02121834|517251081|FG001|Overall Study|Withdrawal by Subject|1|||
143465604|NCT02121834|517251082|FG002|Overall Study|Withdrawal by Subject|1|||
143465605|NCT02121834|517251083|FG003|Overall Study|Withdrawal by Subject|0|||
143465606|NCT02121834|517251084|FG004|Overall Study|Withdrawal by Subject|0|||
143129308|NCT00103285|516019565|FG003|Response Assignment|Protocol Violation|0|||
143129309|NCT00103285|516019566|FG004|Response Assignment|Protocol Violation|0|||
143129310|NCT00103285|516019567|FG005|Response Assignment|Protocol Violation|0|||
143129311|NCT00103285|516019568|FG006|Response Assignment|Protocol Violation|0|||
143129312|NCT00103285|516019569|FG007|Response Assignment|Protocol Violation|0|||
143129313|NCT00103285|516019562|FG000|Response Assignment|Withdrawal by Subject|0|||
143129314|NCT00103285|516019563|FG001|Response Assignment|Withdrawal by Subject|4|||
143129315|NCT00103285|516019564|FG002|Response Assignment|Withdrawal by Subject|1|||
143129316|NCT00103285|516019565|FG003|Response Assignment|Withdrawal by Subject|1|||
143129317|NCT00103285|516019566|FG004|Response Assignment|Withdrawal by Subject|2|||
143129318|NCT00103285|516019567|FG005|Response Assignment|Withdrawal by Subject|2|||
143129319|NCT00103285|516019568|FG006|Response Assignment|Withdrawal by Subject|0|||
143465607|NCT02121834|517251085|FG005|Overall Study|Withdrawal by Subject|0|||
143465608|NCT02121834|517251086|FG006|Overall Study|Withdrawal by Subject|0|||
143465609|NCT02121834|517251080|FG000|Overall Study|Lost to Follow-up|0|||
143129320|NCT00103285|516019569|FG007|Response Assignment|Withdrawal by Subject|2|||
143129321|NCT00103285|516019562|FG000|Response Assignment|Ineligible|0|||
143129322|NCT00103285|516019563|FG001|Response Assignment|Ineligible|8|||
143129323|NCT00103285|516019564|FG002|Response Assignment|Ineligible|6|||
143129324|NCT00103285|516019565|FG003|Response Assignment|Ineligible|2|||
143129325|NCT00103285|516019566|FG004|Response Assignment|Ineligible|0|||
143129326|NCT00103285|516019567|FG005|Response Assignment|Ineligible|3|||
143129327|NCT00103285|516019568|FG006|Response Assignment|Ineligible|1|||
143129328|NCT00103285|516019569|FG007|Response Assignment|Ineligible|5|||
143129329|NCT00103285|516019562|FG000|Response Assignment|Refusal|0|||
143129330|NCT00103285|516019563|FG001|Response Assignment|Refusal|53|||
143129331|NCT00103285|516019564|FG002|Response Assignment|Refusal|5|||
143129332|NCT00103285|516019565|FG003|Response Assignment|Refusal|3|||
143129333|NCT00103285|516019566|FG004|Response Assignment|Refusal|25|||
143129334|NCT00103285|516019567|FG005|Response Assignment|Refusal|15|||
143129335|NCT00103285|516019568|FG006|Response Assignment|Refusal|30|||
143129336|NCT00103285|516019569|FG007|Response Assignment|Refusal|10|||
143129337|NCT00103285|516019562|FG000|Response Assignment|Other|0|||
143129338|NCT00103285|516019563|FG001|Response Assignment|Other|30|||
143129339|NCT00103285|516019564|FG002|Response Assignment|Other|48|||
143129340|NCT00103285|516019565|FG003|Response Assignment|Other|38|||
143129341|NCT00103285|516019566|FG004|Response Assignment|Other|37|||
143129342|NCT00103285|516019567|FG005|Response Assignment|Other|17|||
143129343|NCT00103285|516019568|FG006|Response Assignment|Other|11|||
143129344|NCT00103285|516019569|FG007|Response Assignment|Other|53|||
143129345|NCT01381926|516019572|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
143129346|NCT01381926|516019573|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
143129347|NCT01381926|516019572|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
143129348|NCT01381926|516019573|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
143129349|NCT02624947|516019577|FG000|Maternal Participants|Adverse Event|5|||
143129350|NCT02624947|516019578|FG001|Maternal Participants|Adverse Event|0|||
143129351|NCT02624947|516019577|FG000|Maternal Participants|Investigator Decision|5|||
143129352|NCT02624947|516019578|FG001|Maternal Participants|Investigator Decision|3|||
143129353|NCT02624947|516019577|FG000|Maternal Participants|Lost to Follow-up|54|||
143129354|NCT02624947|516019578|FG001|Maternal Participants|Lost to Follow-up|24|||
143129355|NCT02624947|516019577|FG000|Maternal Participants|Non Compliance|8|||
143129356|NCT02624947|516019578|FG001|Maternal Participants|Non Compliance|5|||
143129357|NCT02624947|516019577|FG000|Maternal Participants|Sponsor Request|1|||
143129358|NCT02624947|516019578|FG001|Maternal Participants|Sponsor Request|1|||
143129359|NCT02624947|516019577|FG000|Maternal Participants|Voluntary withdrawal unrelated to AE|48|||
143129360|NCT02624947|516019578|FG001|Maternal Participants|Voluntary withdrawal unrelated to AE|27|||
143129361|NCT02624947|516019577|FG000|Maternal Participants|Miscellaneous|23|||
143129362|NCT02624947|516019578|FG001|Maternal Participants|Miscellaneous|15|||
143129363|NCT02624947|516019577|FG000|Infant Participants|Adverse Event|18|||
143465610|NCT02121834|517251081|FG001|Overall Study|Lost to Follow-up|0|||
143465611|NCT02121834|517251082|FG002|Overall Study|Lost to Follow-up|1|||
143465612|NCT02121834|517251083|FG003|Overall Study|Lost to Follow-up|0|||
143465613|NCT02121834|517251084|FG004|Overall Study|Lost to Follow-up|0|||
143465614|NCT02121834|517251085|FG005|Overall Study|Lost to Follow-up|0|||
143465615|NCT02121834|517251086|FG006|Overall Study|Lost to Follow-up|0|||
143129364|NCT02624947|516019578|FG001|Infant Participants|Adverse Event|11|||
143129365|NCT02624947|516019577|FG000|Infant Participants|Investigator Decision|5|||
143129366|NCT02624947|516019578|FG001|Infant Participants|Investigator Decision|4|||
143129367|NCT02624947|516019577|FG000|Infant Participants|Lost to Follow-up|93|||
143129368|NCT02624947|516019578|FG001|Infant Participants|Lost to Follow-up|58|||
143129369|NCT02624947|516019577|FG000|Infant Participants|Non Compliance|17|||
143129370|NCT02624947|516019578|FG001|Infant Participants|Non Compliance|7|||
143129371|NCT02624947|516019577|FG000|Infant Participants|Sponsor Request|0|||
143129372|NCT02624947|516019578|FG001|Infant Participants|Sponsor Request|1|||
143129373|NCT02624947|516019577|FG000|Infant Participants|Voluntary Withdrawal unrelated to AE|48|||
143129374|NCT02624947|516019578|FG001|Infant Participants|Voluntary Withdrawal unrelated to AE|25|||
143129375|NCT02624947|516019577|FG000|Infant Participants|Miscellaneous|50|||
143129376|NCT02624947|516019578|FG001|Infant Participants|Miscellaneous|26|||
143129377|NCT03654729|516019583|FG000|Overall Study|Death|9|||
143129378|NCT03654729|516019584|FG001|Overall Study|Death|9|||
143129379|NCT03654729|516019585|FG002|Overall Study|Death|16|||
143129380|NCT03654729|516019583|FG000|Overall Study|Withdrawal by Subject|8|||
143129381|NCT03654729|516019584|FG001|Overall Study|Withdrawal by Subject|6|||
143129382|NCT03654729|516019585|FG002|Overall Study|Withdrawal by Subject|4|||
143465616|NCT01026454|517251087|FG000|Second Intervention|Pregnancy|1|||
143465617|NCT01026454|517251088|FG001|Second Intervention|Pregnancy|1|||
143465618|NCT02196714|517251089|FG000|Overall Study|Protocol Violation|0|||
143465619|NCT02196714|517251090|FG001|Overall Study|Protocol Violation|0|||
143129383|NCT03654729|516019583|FG000|Overall Study|Study terminated by Sponsor|3|||
143129384|NCT03654729|516019584|FG001|Overall Study|Study terminated by Sponsor|5|||
143129385|NCT03654729|516019585|FG002|Overall Study|Study terminated by Sponsor|4|||
143129386|NCT03654729|516019583|FG000|Overall Study|Not reported|2|||
143129387|NCT03654729|516019584|FG001|Overall Study|Not reported|4|||
143129388|NCT03654729|516019585|FG002|Overall Study|Not reported|5|||
143129389|NCT03654729|516019583|FG000|Overall Study|Progressive disease|3|||
143129390|NCT03654729|516019584|FG001|Overall Study|Progressive disease|0|||
143465620|NCT02196714|517251091|FG002|Overall Study|Protocol Violation|1|||
143465621|NCT02196714|517251092|FG003|Overall Study|Protocol Violation|0|||
143129391|NCT03654729|516019585|FG002|Overall Study|Progressive disease|0|||
143129392|NCT03654729|516019583|FG000|Overall Study|Lost to Follow-up|2|||
143129393|NCT03654729|516019584|FG001|Overall Study|Lost to Follow-up|0|||
143465622|NCT01326533|517251095|FG000|Overall Study|Lost to Follow-up|2|||
143465623|NCT01326533|517251096|FG001|Overall Study|Lost to Follow-up|0|||
143465624|NCT01326533|517251095|FG000|Overall Study|Withdrawal by Subject|1|||
143465625|NCT01326533|517251096|FG001|Overall Study|Withdrawal by Subject|0|||
143465626|NCT01326533|517251095|FG000|Overall Study|Adverse Event|1|||
143465627|NCT01326533|517251096|FG001|Overall Study|Adverse Event|0|||
143465628|NCT01971203|517251097|FG000|Overall Study|Protocol Violation|3|||
143465629|NCT01971203|517251098|FG001|Overall Study|Protocol Violation|2|||
143465630|NCT01971203|517251097|FG000|Overall Study|Withdrawal by Subject|5|||
143465631|NCT01971203|517251098|FG001|Overall Study|Withdrawal by Subject|6|||
143465632|NCT01971203|517251097|FG000|Overall Study|Adverse Event|1|||
143465633|NCT01971203|517251098|FG001|Overall Study|Adverse Event|0|||
143465634|NCT04079803|517251099|FG000|Overall Study|Withdrawal by Subject|0|||
143465635|NCT04079803|517251100|FG001|Overall Study|Withdrawal by Subject|0|||
143465636|NCT04079803|517251101|FG002|Overall Study|Withdrawal by Subject|1|||
143465637|NCT03353350|517251102|FG000|30-week Core Treatment Period|Protocol Violation|1|||
143465638|NCT03353350|517251103|FG001|30-week Core Treatment Period|Protocol Violation|1|||
143465639|NCT03353350|517251104|FG002|30-week Core Treatment Period|Protocol Violation|1|||
143465640|NCT03353350|517251105|FG003|30-week Core Treatment Period|Protocol Violation|0|||
143465641|NCT03353350|517251102|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
143465642|NCT03353350|517251103|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
143465643|NCT03353350|517251104|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
143465644|NCT03353350|517251105|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
143465645|NCT03353350|517251102|FG000|30-week Core Treatment Period|Adverse Event|0|||
143465646|NCT03353350|517251103|FG001|30-week Core Treatment Period|Adverse Event|4|||
143465647|NCT03353350|517251104|FG002|30-week Core Treatment Period|Adverse Event|2|||
143465648|NCT03353350|517251105|FG003|30-week Core Treatment Period|Adverse Event|3|||
143465649|NCT03353350|517251102|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
143465650|NCT03353350|517251103|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
143230356|NCT01194830|516393207|FG001|Overall Study|Lost to Follow-up|7|||
143230357|NCT01194830|516393206|FG000|Overall Study|Withdrawal by Subject|2|||
143230358|NCT01194830|516393207|FG001|Overall Study|Withdrawal by Subject|1|||
143230359|NCT01194830|516393206|FG000|Overall Study|Lack of Efficacy|1|||
143230360|NCT01194830|516393207|FG001|Overall Study|Lack of Efficacy|1|||
143230361|NCT01194830|516393206|FG000|Overall Study|Non-compliance issues|4|||
143230362|NCT01194830|516393207|FG001|Overall Study|Non-compliance issues|4|||
143230363|NCT01194830|516393206|FG000|Overall Study|Other Reason|12|||
143230364|NCT01194830|516393207|FG001|Overall Study|Other Reason|8|||
143230365|NCT03115359|516393208|FG000|Overall Study|Withdrawal by Subject|29|||
143230366|NCT03115359|516393209|FG001|Overall Study|Withdrawal by Subject|39|||
143230367|NCT03115359|516393208|FG000|Overall Study|Scheduling conflict|25|||
143230368|NCT03115359|516393209|FG001|Overall Study|Scheduling conflict|23|||
143230369|NCT03115359|516393208|FG000|Overall Study|Personal reasons including health|12|||
143230370|NCT03115359|516393209|FG001|Overall Study|Personal reasons including health|9|||
143230371|NCT03115359|516393208|FG000|Overall Study|Transportation barriers|3|||
143230372|NCT03115359|516393209|FG001|Overall Study|Transportation barriers|0|||
143230373|NCT03115359|516393208|FG000|Overall Study|No longer interested|5|||
143230374|NCT03115359|516393209|FG001|Overall Study|No longer interested|4|||
143230375|NCT03115359|516393208|FG000|Overall Study|No reason provided|45|||
143230376|NCT03115359|516393209|FG001|Overall Study|No reason provided|47|||
143230377|NCT01317472|516393212|FG000|Overall Study|Withdrawal by Subject|1|||
143230378|NCT01317472|516393213|FG001|Overall Study|Withdrawal by Subject|0|||
143230379|NCT01317472|516393212|FG000|Overall Study|Unrelated hospitalization|1|||
143129394|NCT03654729|516019585|FG002|Overall Study|Lost to Follow-up|0|||
143129395|NCT03654729|516019583|FG000|Overall Study|Physician Decision|2|||
143129396|NCT03654729|516019584|FG001|Overall Study|Physician Decision|0|||
143129397|NCT03654729|516019585|FG002|Overall Study|Physician Decision|0|||
143129398|NCT03654729|516019583|FG000|Overall Study|Protocol Violation|1|||
143129399|NCT03654729|516019584|FG001|Overall Study|Protocol Violation|1|||
143230380|NCT01317472|516393213|FG001|Overall Study|Unrelated hospitalization|0|||
143230381|NCT01815918|516393214|FG000|Overall Study|Patient samples not analyzable|3|||
143230382|NCT01815918|516393215|FG001|Overall Study|Patient samples not analyzable|4|||
143230383|NCT01815918|516393214|FG000|Overall Study|Lack of Efficacy|15|||
143465651|NCT03353350|517251104|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
143465652|NCT03353350|517251105|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
143465653|NCT03353350|517251102|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
143129400|NCT03654729|516019585|FG002|Overall Study|Protocol Violation|0|||
143465654|NCT03353350|517251103|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
143129401|NCT03654729|516019583|FG000|Overall Study|Non-compliance with study drug|0|||
143465655|NCT03353350|517251104|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
143129402|NCT03654729|516019584|FG001|Overall Study|Non-compliance with study drug|1|||
143129403|NCT03654729|516019585|FG002|Overall Study|Non-compliance with study drug|0|||
143129404|NCT03654729|516019583|FG000|Overall Study|Site terminated by Sponsor|1|||
143129405|NCT03654729|516019584|FG001|Overall Study|Site terminated by Sponsor|0|||
143129406|NCT03654729|516019585|FG002|Overall Study|Site terminated by Sponsor|0|||
143129407|NCT01919164|516019591|FG000|Overall Study|Adverse Event|6|||
143129408|NCT01919164|516019592|FG001|Overall Study|Adverse Event|4|||
143129409|NCT01919164|516019593|FG002|Overall Study|Adverse Event|9|||
143129410|NCT01919164|516019594|FG003|Overall Study|Adverse Event|3|||
143129411|NCT01919164|516019595|FG004|Overall Study|Adverse Event|2|||
143129412|NCT01919164|516019591|FG000|Overall Study|Lost to Follow-up|2|||
143129413|NCT01919164|516019592|FG001|Overall Study|Lost to Follow-up|2|||
143129414|NCT01919164|516019593|FG002|Overall Study|Lost to Follow-up|2|||
143129415|NCT01919164|516019594|FG003|Overall Study|Lost to Follow-up|0|||
143129416|NCT01919164|516019595|FG004|Overall Study|Lost to Follow-up|4|||
143129417|NCT01919164|516019591|FG000|Overall Study|Death|1|||
143129418|NCT01919164|516019592|FG001|Overall Study|Death|0|||
143129419|NCT01919164|516019593|FG002|Overall Study|Death|0|||
143129420|NCT01919164|516019594|FG003|Overall Study|Death|0|||
143129421|NCT01919164|516019595|FG004|Overall Study|Death|0|||
143129422|NCT01919164|516019591|FG000|Overall Study|Protocol Violation|6|||
143129423|NCT01919164|516019592|FG001|Overall Study|Protocol Violation|0|||
143129424|NCT01919164|516019593|FG002|Overall Study|Protocol Violation|3|||
143129425|NCT01919164|516019594|FG003|Overall Study|Protocol Violation|2|||
143129426|NCT01919164|516019595|FG004|Overall Study|Protocol Violation|2|||
143129427|NCT01919164|516019591|FG000|Overall Study|Disease progression|2|||
143129428|NCT01919164|516019592|FG001|Overall Study|Disease progression|2|||
143129429|NCT01919164|516019593|FG002|Overall Study|Disease progression|1|||
143129430|NCT01919164|516019594|FG003|Overall Study|Disease progression|2|||
143129431|NCT01919164|516019595|FG004|Overall Study|Disease progression|1|||
143129432|NCT01919164|516019591|FG000|Overall Study|Withdrew consent|13|||
143129433|NCT01919164|516019592|FG001|Overall Study|Withdrew consent|13|||
143129434|NCT01919164|516019593|FG002|Overall Study|Withdrew consent|14|||
143129435|NCT01919164|516019594|FG003|Overall Study|Withdrew consent|14|||
143129436|NCT01919164|516019595|FG004|Overall Study|Withdrew consent|9|||
143129437|NCT01919164|516019591|FG000|Overall Study|Other Un-specified|13|||
143129438|NCT01919164|516019592|FG001|Overall Study|Other Un-specified|9|||
143129439|NCT01919164|516019593|FG002|Overall Study|Other Un-specified|8|||
143129440|NCT01919164|516019594|FG003|Overall Study|Other Un-specified|7|||
143129441|NCT01919164|516019595|FG004|Overall Study|Other Un-specified|15|||
143129442|NCT00588146|516019596|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
143129443|NCT00588146|516019597|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
143129444|NCT00463801|516019598|FG000|Overall Study|Protocol Violation|1|||
143129445|NCT00463801|516019598|FG000|Overall Study|Lack of Efficacy|2|||
143129446|NCT00463801|516019598|FG000|Overall Study|Adverse Event|4|||
143129447|NCT00463801|516019598|FG000|Overall Study|Lost to Follow-up|5|||
143129448|NCT00463801|516019598|FG000|Overall Study|No longer require therapy|1|||
143129449|NCT03272347|516019599|FG000|Overall Study|Death|0|||
143129450|NCT03272347|516019600|FG001|Overall Study|Death|0|||
143129451|NCT03272347|516019601|FG002|Overall Study|Death|0|||
143129452|NCT03272347|516019602|FG003|Overall Study|Death|1|||
143129453|NCT03272347|516019599|FG000|Overall Study|Lost to Follow-up|1|||
143129454|NCT03272347|516019600|FG001|Overall Study|Lost to Follow-up|3|||
143129455|NCT03272347|516019601|FG002|Overall Study|Lost to Follow-up|5|||
143129456|NCT03272347|516019602|FG003|Overall Study|Lost to Follow-up|1|||
143129457|NCT03272347|516019599|FG000|Overall Study|Physician Decision|4|||
143129458|NCT03272347|516019600|FG001|Overall Study|Physician Decision|2|||
143129459|NCT03272347|516019601|FG002|Overall Study|Physician Decision|5|||
143129460|NCT03272347|516019602|FG003|Overall Study|Physician Decision|4|||
143129461|NCT03272347|516019599|FG000|Overall Study|Screen Failure|1|||
143129462|NCT03272347|516019600|FG001|Overall Study|Screen Failure|0|||
143129463|NCT03272347|516019601|FG002|Overall Study|Screen Failure|0|||
143129464|NCT03272347|516019602|FG003|Overall Study|Screen Failure|0|||
143129465|NCT03272347|516019599|FG000|Overall Study|Withdrawal by Subject|5|||
143357777|NCT00885495|516854479|FG001|Overall Study|Adverse Event|2|||
143357778|NCT00885495|516854478|FG000|Overall Study|Protocol Violation|0|||
143357779|NCT00885495|516854479|FG001|Overall Study|Protocol Violation|1|||
143357780|NCT00885495|516854478|FG000|Overall Study|Withdrawal by Subject|1|||
143357781|NCT00885495|516854479|FG001|Overall Study|Withdrawal by Subject|0|||
143357782|NCT01368211|516854483|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
143357783|NCT01368211|516854484|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
143357784|NCT01349660|516854488|FG000|Overall Study|Still Receiving Study Treatment|0|||
143129466|NCT03272347|516019600|FG001|Overall Study|Withdrawal by Subject|1|||
143129467|NCT03272347|516019601|FG002|Overall Study|Withdrawal by Subject|2|||
143129468|NCT03272347|516019602|FG003|Overall Study|Withdrawal by Subject|1|||
143129469|NCT01409915|516019609|FG000|Overall Study|Adverse Event|0|||
143129470|NCT01409915|516019610|FG001|Overall Study|Adverse Event|2|||
143129471|NCT01409915|516019609|FG000|Overall Study|Withdrawal by Subject|0|||
143129472|NCT01409915|516019610|FG001|Overall Study|Withdrawal by Subject|1|||
143129473|NCT01409915|516019609|FG000|Overall Study|Protocol Violation|1|||
143129474|NCT01409915|516019610|FG001|Overall Study|Protocol Violation|0|||
143129475|NCT02781818|516019611|FG000|Overall Study|Lost to Follow-up|4|||
143129476|NCT02781818|516019612|FG001|Overall Study|Lost to Follow-up|2|||
143129477|NCT02781818|516019613|FG002|Overall Study|Lost to Follow-up|1|||
143129478|NCT01957579|516019615|FG000|Overall Study|Withdrawal of concent|0|||
143129479|NCT01957579|516019616|FG001|Overall Study|Withdrawal of concent|1|||
143129480|NCT01957579|516019617|FG002|Overall Study|Withdrawal of concent|0|||
143129481|NCT01957579|516019618|FG003|Overall Study|Withdrawal of concent|0|||
143129482|NCT01957579|516019615|FG000|Overall Study|Death|0|||
143129483|NCT01957579|516019616|FG001|Overall Study|Death|0|||
143129484|NCT01957579|516019617|FG002|Overall Study|Death|2|||
143129485|NCT01957579|516019618|FG003|Overall Study|Death|0|||
143129486|NCT02750332|516019619|FG000|Treatment Period 1|Withdrawal by Subject|0|||
143129487|NCT02750332|516019620|FG001|Treatment Period 1|Withdrawal by Subject|1|||
143129488|NCT02937740|516019621|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
143129489|NCT02937740|516019622|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
143129490|NCT02937740|516019621|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
143129491|NCT02937740|516019622|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
143129492|NCT02937740|516019621|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
143129493|NCT02937740|516019622|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
143129494|NCT02937740|516019621|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
143129495|NCT02937740|516019622|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
143129496|NCT02937740|516019621|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
143129497|NCT02937740|516019622|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
143129498|NCT02937740|516019621|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
143129499|NCT02937740|516019622|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
143129500|NCT02485483|516019625|FG000|Overall Study|Depression at baseline|15|||
143129501|NCT02485483|516019626|FG001|Overall Study|Depression at baseline|0|||
143129502|NCT02485483|516019625|FG000|Overall Study|Discontinued after baseline|39|||
143129503|NCT02485483|516019626|FG001|Overall Study|Discontinued after baseline|0|||
143129504|NCT02915159|516019631|FG000|Overall Study|Participant no longer meets criteria|2|||
143129505|NCT02915159|516019632|FG001|Overall Study|Participant no longer meets criteria|0|||
143129506|NCT02915159|516019631|FG000|Overall Study|poor/non-compliance|1|||
143129507|NCT02915159|516019632|FG001|Overall Study|poor/non-compliance|0|||
143129508|NCT02915159|516019631|FG000|Overall Study|Participant withdrew consent|5|||
143129509|NCT02915159|516019632|FG001|Overall Study|Participant withdrew consent|1|||
143129510|NCT02915159|516019631|FG000|Overall Study|Request to discontinue treatment|1|||
143129511|NCT02915159|516019632|FG001|Overall Study|Request to discontinue treatment|2|||
143129512|NCT02915159|516019631|FG000|Overall Study|Adverse Event|2|||
143129513|NCT02915159|516019632|FG001|Overall Study|Adverse Event|2|||
143129514|NCT02915159|516019631|FG000|Overall Study|Lack of Efficacy|0|||
143129515|NCT02915159|516019632|FG001|Overall Study|Lack of Efficacy|3|||
143129516|NCT00003483|516019633|FG000|Overall Study|Not evaluable|1|||
143129517|NCT01093586|516019640|FG000|Overall Study|Failed to engraft|3|||
143129518|NCT01968811|516019641|FG000|Overall Study|Protocol Violation|4|||
143129519|NCT01968811|516019641|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
143129520|NCT00411450|516019642|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
143129521|NCT01716663|516019643|FG000|Overall Study|Withdrawn prior to procedure|4|||
143129522|NCT01716663|516019643|FG000|Overall Study|Treated with non-study catheter|2|||
143129523|NCT03006562|516019645|FG000|Overall Study|Lost to Follow-up|0|||
143129524|NCT03006562|516019646|FG001|Overall Study|Lost to Follow-up|1|||
143357785|NCT01349660|516854489|FG001|Overall Study|Still Receiving Study Treatment|0|||
143357786|NCT01349660|516854490|FG002|Overall Study|Still Receiving Study Treatment|1|||
143357787|NCT01349660|516854488|FG000|Overall Study|Disease Progression|2|||
143357788|NCT01349660|516854489|FG001|Overall Study|Disease Progression|4|||
143357789|NCT01349660|516854490|FG002|Overall Study|Disease Progression|50|||
143357790|NCT01349660|516854488|FG000|Overall Study|Adverse Event|1|||
143357791|NCT01349660|516854489|FG001|Overall Study|Adverse Event|1|||
143357792|NCT01349660|516854490|FG002|Overall Study|Adverse Event|12|||
143357793|NCT01349660|516854488|FG000|Overall Study|Withdrawal by Subject|2|||
143357794|NCT01349660|516854489|FG001|Overall Study|Withdrawal by Subject|0|||
143357795|NCT01349660|516854490|FG002|Overall Study|Withdrawal by Subject|9|||
143357796|NCT01349660|516854488|FG000|Overall Study|Death|1|||
143357797|NCT01349660|516854489|FG001|Overall Study|Death|1|||
143357798|NCT01349660|516854490|FG002|Overall Study|Death|0|||
143357799|NCT01349660|516854488|FG000|Overall Study|Non-Permitted Interventions|0|||
143357800|NCT01349660|516854489|FG001|Overall Study|Non-Permitted Interventions|0|||
143357801|NCT01349660|516854490|FG002|Overall Study|Non-Permitted Interventions|2|||
143013783|NCT02494583|515590019|FG000|Overall Study|Did Not Continue on Extension Study|8|||
143129525|NCT03904420|516019647|FG000|Overall Study|Study terminated|2|||
143129526|NCT03904420|516019648|FG001|Overall Study|Study terminated|2|||
143129527|NCT01001910|516019649|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
143129528|NCT00614874|516019650|FG000|Overall Study|Protocol Violation|1|||
143129529|NCT00614874|516019650|FG000|Overall Study|Withdrawal by Subject|1|||
143129530|NCT01089127|516019655|FG000|Overall Study|Adverse Event|5|||
143129531|NCT01089127|516019656|FG001|Overall Study|Adverse Event|1|||
143129532|NCT01089127|516019657|FG002|Overall Study|Adverse Event|1|||
143129533|NCT01089127|516019658|FG003|Overall Study|Adverse Event|0|||
143129534|NCT01089127|516019659|FG004|Overall Study|Adverse Event|0|||
143129535|NCT01089127|516019660|FG005|Overall Study|Adverse Event|1|||
143129536|NCT01089127|516019655|FG000|Overall Study|Subject withdrew consent|0|||
143129537|NCT01089127|516019656|FG001|Overall Study|Subject withdrew consent|1|||
143129538|NCT01089127|516019657|FG002|Overall Study|Subject withdrew consent|1|||
143129539|NCT01089127|516019658|FG003|Overall Study|Subject withdrew consent|1|||
143129540|NCT01089127|516019659|FG004|Overall Study|Subject withdrew consent|0|||
143129541|NCT01089127|516019660|FG005|Overall Study|Subject withdrew consent|2|||
143129542|NCT01089127|516019655|FG000|Overall Study|Abnormal test procedure result(s)|2|||
143129543|NCT01089127|516019656|FG001|Overall Study|Abnormal test procedure result(s)|1|||
143129544|NCT01089127|516019657|FG002|Overall Study|Abnormal test procedure result(s)|0|||
143129545|NCT01089127|516019658|FG003|Overall Study|Abnormal test procedure result(s)|0|||
143129546|NCT01089127|516019659|FG004|Overall Study|Abnormal test procedure result(s)|0|||
143129547|NCT01089127|516019660|FG005|Overall Study|Abnormal test procedure result(s)|0|||
143129548|NCT01089127|516019655|FG000|Overall Study|Lost to Follow-up|1|||
143129549|NCT01089127|516019656|FG001|Overall Study|Lost to Follow-up|1|||
143129550|NCT01089127|516019657|FG002|Overall Study|Lost to Follow-up|0|||
143129551|NCT01089127|516019658|FG003|Overall Study|Lost to Follow-up|0|||
143129552|NCT01089127|516019659|FG004|Overall Study|Lost to Follow-up|1|||
143129553|NCT01089127|516019660|FG005|Overall Study|Lost to Follow-up|0|||
143129554|NCT01089127|516019655|FG000|Overall Study|Protocol deviation|0|||
143129555|NCT01089127|516019656|FG001|Overall Study|Protocol deviation|1|||
143129556|NCT01089127|516019657|FG002|Overall Study|Protocol deviation|0|||
143129557|NCT01089127|516019658|FG003|Overall Study|Protocol deviation|0|||
143129558|NCT01089127|516019659|FG004|Overall Study|Protocol deviation|1|||
143129559|NCT01089127|516019660|FG005|Overall Study|Protocol deviation|0|||
143129560|NCT01468454|516019661|FG000|Overall Study|Did not have surgery after PET|9|||
143129561|NCT00511810|516019664|FG000|Overall Study|Lost to Follow-up|1|||
143129562|NCT00511810|516019665|FG001|Overall Study|Lost to Follow-up|2|||
143129563|NCT00511810|516019664|FG000|Overall Study|Lack of Efficacy|0|||
143129564|NCT00511810|516019665|FG001|Overall Study|Lack of Efficacy|2|||
143129565|NCT00511810|516019664|FG000|Overall Study|Refused second scn|0|||
143129566|NCT00511810|516019665|FG001|Overall Study|Refused second scn|1|||
143129567|NCT01300247|516019666|FG000|Overall Study|Death|1|||
143129568|NCT01300247|516019667|FG001|Overall Study|Death|1|||
143129569|NCT01300247|516019666|FG000|Overall Study|Lost to Follow-up|2|||
143129570|NCT01300247|516019667|FG001|Overall Study|Lost to Follow-up|0|||
143129571|NCT01300247|516019666|FG000|Overall Study|Withdrawal by Subject|1|||
143129572|NCT01300247|516019667|FG001|Overall Study|Withdrawal by Subject|0|||
143129573|NCT01300247|516019666|FG000|Overall Study|Non-Compliance|0|||
143129574|NCT01300247|516019667|FG001|Overall Study|Non-Compliance|1|||
143129575|NCT06060496|516019668|FG000|Overall Study|Withdrawal by Subject|2|||
143129576|NCT06060496|516019668|FG000|Overall Study|Lost to Follow-up|2|||
143129577|NCT02258659|516019669|FG000|Overall Study|Withdrawal by Subject|1|||
143129578|NCT03990051|516019670|FG000|Masked Period|Lost to Follow-up|1|||
143129579|NCT03990051|516019671|FG001|Masked Period|Lost to Follow-up|0|||
143129580|NCT03990051|516019670|FG000|Long Term Period|Death|1|||
143129581|NCT03990051|516019671|FG001|Long Term Period|Death|1|||
143129582|NCT03990051|516019670|FG000|Long Term Period|Lost to Follow-up|7|||
143129583|NCT03990051|516019671|FG001|Long Term Period|Lost to Follow-up|2|||
143129584|NCT00272844|516019672|FG000|Overall Study|Withdrawal by Subject|5|||
143129585|NCT03060291|516019673|FG000|3-month Follow-up|Declined to respond|8|||
143129586|NCT03060291|516019674|FG001|3-month Follow-up|Declined to respond|10|||
143129587|NCT03060291|516019675|FG002|3-month Follow-up|Declined to respond|2|||
143129588|NCT03060291|516019673|FG000|6-month Follow-up|Declined to respond|7|||
143129589|NCT03060291|516019674|FG001|6-month Follow-up|Declined to respond|13|||
143129590|NCT03060291|516019675|FG002|6-month Follow-up|Declined to respond|4|||
143129591|NCT03060291|516019673|FG000|12-month Follow-up|Declined to respond|7|||
143129592|NCT03060291|516019674|FG001|12-month Follow-up|Declined to respond|16|||
143129593|NCT03060291|516019675|FG002|12-month Follow-up|Declined to respond|6|||
143129594|NCT00618826|516019676|FG000|Overall Study|Adverse Event|1|||
143129595|NCT01509664|516019677|FG000|Overall Study|Lost to Follow-up|15|||
143129596|NCT01509664|516019678|FG001|Overall Study|Lost to Follow-up|21|||
143129597|NCT01556932|516019679|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
143129598|NCT01556932|516019680|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
143129599|NCT01421641|516019685|FG000|Overall Study|Protocol Violation|2|||
143129600|NCT01421641|516019686|FG001|Overall Study|Protocol Violation|2|||
143129601|NCT02420119|516019687|FG000|Overall Study|insufficient laboratory data|5|||
143129602|NCT03231306|516019688|FG000|Overall Study|<15% reduction in target tumor volume from baseline after Course 8 of therapy|3|||
143129603|NCT03231306|516019688|FG000|Overall Study|<20% reduction in target tumor volume from baseline after Course 12 of therapy|4|||
143129604|NCT03231306|516019688|FG000|Overall Study|Treatment delay > 21 days|2|||
143129605|NCT03231306|516019688|FG000|Overall Study|Refusal of further protocol therapy by subject/parent/guardian|6|||
143129606|NCT03231306|516019688|FG000|Overall Study|Non-compliance that in the opinion of the investigator does not allow for ongoing participation|5|||
143129607|NCT03231306|516019688|FG000|Overall Study|Binimetinib-related toxicity requiring removal from protocol therapy|3|||
143129608|NCT03231306|516019688|FG000|Overall Study|Subject Relocation Due to Covid Restrictions|1|||
143129609|NCT03231306|516019688|FG000|Overall Study|More than 1 Reason|2|||
143129610|NCT01808261|516019689|FG000|Overall Study|Physician Decision|0|||
143129611|NCT01808261|516019690|FG001|Overall Study|Physician Decision|2|||
143129612|NCT01808261|516019689|FG000|Overall Study|Study Closed/Terminated|25|||
143129613|NCT01808261|516019690|FG001|Overall Study|Study Closed/Terminated|23|||
143129614|NCT01808261|516019689|FG000|Overall Study|Adverse event, non-fatal|2|||
143129615|NCT01808261|516019690|FG001|Overall Study|Adverse event, non-fatal|0|||
143129616|NCT01808261|516019689|FG000|Overall Study|Consent withdrawn by subject|6|||
143129617|NCT01808261|516019690|FG001|Overall Study|Consent withdrawn by subject|7|||
143129618|NCT01808261|516019689|FG000|Overall Study|Lost to Follow-up|3|||
143129619|NCT01808261|516019690|FG001|Overall Study|Lost to Follow-up|1|||
143129620|NCT04501952|516019695|FG000|Overall Study|Adverse Event|0|||
143129621|NCT04501952|516019696|FG001|Overall Study|Adverse Event|3|||
143129622|NCT04501952|516019695|FG000|Overall Study|Investigator's Discretion|0|||
143129623|NCT04501952|516019696|FG001|Overall Study|Investigator's Discretion|1|||
143129624|NCT04501952|516019695|FG000|Overall Study|Protocol Violation|1|||
143129625|NCT04501952|516019696|FG001|Overall Study|Protocol Violation|1|||
143129626|NCT04501952|516019695|FG000|Overall Study|Withdrew Consent|5|||
143129627|NCT04501952|516019696|FG001|Overall Study|Withdrew Consent|4|||
143129628|NCT04501952|516019695|FG000|Overall Study|Lost to Follow-up|7|||
143129629|NCT04501952|516019696|FG001|Overall Study|Lost to Follow-up|2|||
143129630|NCT04501952|516019695|FG000|Overall Study|Randomized and Never Treated|13|||
143129631|NCT04501952|516019696|FG001|Overall Study|Randomized and Never Treated|9|||
143129632|NCT00991289|516019697|FG000|Overall Study|Adverse Event|1|||
143129633|NCT00991289|516019697|FG000|Overall Study|Physician Decision|2|||
143129634|NCT00991289|516019697|FG000|Overall Study|Withdrawal by Subject|3|||
143129635|NCT00991289|516019697|FG000|Overall Study|Lost to Follow-up|4|||
143129636|NCT00991289|516019697|FG000|Overall Study|Protocol Violation|2|||
143129637|NCT02472886|516019698|FG000|Overall Study|Lack of Efficacy|0|||
143129638|NCT02472886|516019699|FG001|Overall Study|Lack of Efficacy|2|||
143357802|NCT01349660|516854488|FG000|Overall Study|Study Compliance|0|||
143357803|NCT01349660|516854489|FG001|Overall Study|Study Compliance|0|||
143357804|NCT01349660|516854490|FG002|Overall Study|Study Compliance|1|||
143357805|NCT01349660|516854488|FG000|Overall Study|Declining Performance Status|0|||
143357806|NCT01349660|516854489|FG001|Overall Study|Declining Performance Status|0|||
143357807|NCT01349660|516854490|FG002|Overall Study|Declining Performance Status|1|||
143357808|NCT01563978|516854491|FG000|Overall Study|Physician Decision|1|||
143357809|NCT01563978|516854492|FG001|Overall Study|Physician Decision|0|||
143357810|NCT01563978|516854491|FG000|Overall Study|Lost to Follow-up|1|||
143357811|NCT01563978|516854492|FG001|Overall Study|Lost to Follow-up|0|||
143357812|NCT01563978|516854491|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
143357813|NCT01563978|516854492|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
143357814|NCT01563978|516854491|FG000|Overall Study|Adverse Event|1|||
143357815|NCT01563978|516854492|FG001|Overall Study|Adverse Event|2|||
143357816|NCT05764239|516854493|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
143357817|NCT05764239|516854493|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
143357818|NCT05764239|516854493|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
143357819|NCT05764239|516854493|FG000|DEP (Part 1)|Adverse Event|1|||
143357820|NCT05764239|516854493|FG000|DEP (Part 1)|Lost to Follow-up|1|||
143357821|NCT05764239|516854493|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
143357822|NCT05764239|516854493|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
143357823|NCT05764239|516854493|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
143357824|NCT05764239|516854493|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
143357825|NCT04131907|516854496|FG000|Overall Study|Adverse Event|2|||
143357826|NCT04131907|516854497|FG001|Overall Study|Adverse Event|0|||
143357827|NCT04131907|516854498|FG002|Overall Study|Adverse Event|0|||
143357828|NCT04131907|516854496|FG000|Overall Study|Physician Decision|4|||
143357829|NCT04131907|516854497|FG001|Overall Study|Physician Decision|22|||
143357830|NCT04131907|516854498|FG002|Overall Study|Physician Decision|0|||
143357831|NCT04131907|516854496|FG000|Overall Study|Withdrawal by Subject|2|||
143357832|NCT04131907|516854497|FG001|Overall Study|Withdrawal by Subject|0|||
143357833|NCT04131907|516854498|FG002|Overall Study|Withdrawal by Subject|1|||
143357834|NCT04131907|516854496|FG000|Overall Study|Treatment failure|2|||
143357835|NCT04131907|516854497|FG001|Overall Study|Treatment failure|0|||
143357836|NCT04131907|516854498|FG002|Overall Study|Treatment failure|1|||
143357837|NCT00847301|516854499|FG000|Overall Study|Adverse Event|35|||
143129639|NCT02472886|516019700|FG002|Overall Study|Lack of Efficacy|1|||
143129640|NCT02797678|516019702|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
143129641|NCT02797678|516019703|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
143357838|NCT00847301|516854499|FG000|Overall Study|Switch to other anticoagulants|16|||
143129642|NCT02797678|516019704|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
143129643|NCT02797678|516019705|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
143357839|NCT00847301|516854499|FG000|Overall Study|Lost to Follow-up|1|||
143357840|NCT00847301|516854499|FG000|Overall Study|No prescription after hospital discharge|1|||
143465656|NCT03353350|517251105|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
143465657|NCT03353350|517251102|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
143129644|NCT02797678|516019702|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
143129645|NCT02797678|516019703|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
143465658|NCT03353350|517251103|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
143465659|NCT03353350|517251104|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
143465660|NCT03353350|517251105|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
143129646|NCT02797678|516019704|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
143129647|NCT02797678|516019705|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
143129648|NCT02797678|516019702|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
143129649|NCT02797678|516019703|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
143465661|NCT03353350|517251102|FG000|26-week Treatment Extension Period|Adverse Event|1|||
143465662|NCT03353350|517251103|FG001|26-week Treatment Extension Period|Adverse Event|0|||
143465663|NCT03353350|517251104|FG002|26-week Treatment Extension Period|Adverse Event|0|||
143465664|NCT03353350|517251105|FG003|26-week Treatment Extension Period|Adverse Event|1|||
143465665|NCT03353350|517251102|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
143465666|NCT03353350|517251103|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
143465667|NCT03353350|517251104|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
143129650|NCT02797678|516019704|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
143129651|NCT02797678|516019705|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
143129652|NCT03131687|516019706|FG000|Overall Study|Adverse Event|0|||
143129653|NCT03131687|516019707|FG001|Overall Study|Adverse Event|1|||
143129654|NCT03131687|516019708|FG002|Overall Study|Adverse Event|0|||
143129655|NCT03131687|516019709|FG003|Overall Study|Adverse Event|1|||
143129656|NCT03131687|516019710|FG004|Overall Study|Adverse Event|2|||
143129657|NCT03131687|516019711|FG005|Overall Study|Adverse Event|2|||
143465668|NCT03353350|517251105|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
143465669|NCT03037619|517251106|FG000|Overall Study|Lost to Follow-up|0|||
143465670|NCT03037619|517251107|FG001|Overall Study|Lost to Follow-up|1|||
143230384|NCT01815918|516393215|FG001|Overall Study|Lack of Efficacy|15|||
143465671|NCT01294683|517251111|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
143465672|NCT01294683|517251112|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
143129658|NCT03131687|516019706|FG000|Overall Study|Death|1|||
143129659|NCT03131687|516019707|FG001|Overall Study|Death|0|||
143129660|NCT03131687|516019708|FG002|Overall Study|Death|0|||
143129661|NCT03131687|516019709|FG003|Overall Study|Death|0|||
143129662|NCT03131687|516019710|FG004|Overall Study|Death|0|||
143129663|NCT03131687|516019711|FG005|Overall Study|Death|0|||
143129664|NCT03131687|516019706|FG000|Overall Study|Withdrawal by Subject|3|||
143129665|NCT03131687|516019707|FG001|Overall Study|Withdrawal by Subject|3|||
143129666|NCT03131687|516019708|FG002|Overall Study|Withdrawal by Subject|3|||
143129667|NCT03131687|516019709|FG003|Overall Study|Withdrawal by Subject|1|||
143129668|NCT03131687|516019710|FG004|Overall Study|Withdrawal by Subject|2|||
143129669|NCT03131687|516019711|FG005|Overall Study|Withdrawal by Subject|1|||
143129670|NCT03131687|516019706|FG000|Overall Study|Lost to Follow-up|1|||
143129671|NCT03131687|516019707|FG001|Overall Study|Lost to Follow-up|4|||
143129672|NCT03131687|516019708|FG002|Overall Study|Lost to Follow-up|0|||
143129673|NCT03131687|516019709|FG003|Overall Study|Lost to Follow-up|1|||
143129674|NCT03131687|516019710|FG004|Overall Study|Lost to Follow-up|4|||
143129675|NCT03131687|516019711|FG005|Overall Study|Lost to Follow-up|2|||
143129676|NCT03131687|516019706|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
143129677|NCT03131687|516019707|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
143129678|NCT03131687|516019708|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
143129679|NCT03131687|516019709|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
143129680|NCT03131687|516019710|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
143129681|NCT03131687|516019711|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
143129682|NCT03131687|516019706|FG000|Overall Study|Principle Investigator Decision|0|||
143129683|NCT03131687|516019707|FG001|Overall Study|Principle Investigator Decision|1|||
143465673|NCT01294683|517251111|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
143129684|NCT03131687|516019708|FG002|Overall Study|Principle Investigator Decision|0|||
143129685|NCT03131687|516019709|FG003|Overall Study|Principle Investigator Decision|0|||
143129686|NCT03131687|516019710|FG004|Overall Study|Principle Investigator Decision|0|||
143129687|NCT03131687|516019711|FG005|Overall Study|Principle Investigator Decision|0|||
143129688|NCT03131687|516019706|FG000|Overall Study|Inadvertent Enrollment|0|||
143129689|NCT03131687|516019707|FG001|Overall Study|Inadvertent Enrollment|0|||
143230385|NCT03284710|516393218|FG000|Overall Study|Withdrawal by Subject|1|||
143230386|NCT03284710|516393219|FG001|Overall Study|Withdrawal by Subject|0|||
143129690|NCT03131687|516019708|FG002|Overall Study|Inadvertent Enrollment|0|||
143230387|NCT03284710|516393220|FG002|Overall Study|Withdrawal by Subject|1|||
143230388|NCT03284710|516393221|FG003|Overall Study|Withdrawal by Subject|6|||
143230389|NCT03284710|516393218|FG000|Overall Study|Lost to Follow-up|3|||
143230390|NCT03284710|516393219|FG001|Overall Study|Lost to Follow-up|3|||
143129691|NCT03131687|516019709|FG003|Overall Study|Inadvertent Enrollment|1|||
143129692|NCT03131687|516019710|FG004|Overall Study|Inadvertent Enrollment|0|||
143129693|NCT03131687|516019711|FG005|Overall Study|Inadvertent Enrollment|0|||
143129694|NCT03046953|516019712|FG000|Overall Study|Relapse/progressive disease|21|||
143129695|NCT03046953|516019712|FG000|Overall Study|Death|2|||
143129696|NCT03046953|516019712|FG000|Overall Study|Withdrawal by Subject|3|||
143129697|NCT02716584|516019713|FG000|Overall Study|Lost to Follow-up|8|||
143129698|NCT02716584|516019714|FG001|Overall Study|Lost to Follow-up|5|||
143129699|NCT02282163|516019715|FG000|Overall Study|Protocol Violation|1|||
143129700|NCT01971567|516021924|FG000|Overall Study|Withdrawal by Subject|3|||
143129701|NCT01971567|516021925|FG001|Overall Study|Withdrawal by Subject|2|||
143129702|NCT01971567|516021924|FG000|Overall Study|Lost to Follow-up|1|||
143129703|NCT01971567|516021925|FG001|Overall Study|Lost to Follow-up|0|||
143129704|NCT00391872|516021926|FG000|Overall Study|Protocol Violation|7|||
143129705|NCT00391872|516021927|FG001|Overall Study|Protocol Violation|2|||
143129706|NCT00391872|516021926|FG000|Overall Study|Withdrawal by Subject|296|||
143129707|NCT00391872|516021927|FG001|Overall Study|Withdrawal by Subject|249|||
143129708|NCT00391872|516021926|FG000|Overall Study|Reason unknown|2|||
143129709|NCT00391872|516021927|FG001|Overall Study|Reason unknown|4|||
143129710|NCT00391872|516021926|FG000|Overall Study|Lost to Follow-up|2|||
143129711|NCT00391872|516021927|FG001|Overall Study|Lost to Follow-up|0|||
143129712|NCT02250300|516021928|FG000|Expansion Phase|Death|6|||
143129713|NCT02250300|516021929|FG001|Expansion Phase|Death|7|||
143129714|NCT02250300|516021930|FG002|Expansion Phase|Death|0|||
143129715|NCT02250300|516021931|FG003|Expansion Phase|Death|0|||
143129716|NCT00215644|516021932|FG000|Overall Study|Disease Progression|28|||
143129717|NCT00215644|516021933|FG001|Overall Study|Disease Progression|10|||
143129718|NCT00215644|516021932|FG000|Overall Study|Adverse Event|2|||
143129719|NCT00215644|516021933|FG001|Overall Study|Adverse Event|9|||
143129720|NCT00215644|516021932|FG000|Overall Study|Death|1|||
143129721|NCT00215644|516021933|FG001|Overall Study|Death|2|||
143129722|NCT00215644|516021932|FG000|Overall Study|Withdrawal by Subject|1|||
143129723|NCT00215644|516021933|FG001|Overall Study|Withdrawal by Subject|0|||
143129724|NCT00215644|516021932|FG000|Overall Study|Other|3|||
143129725|NCT00215644|516021933|FG001|Overall Study|Other|15|||
143129726|NCT00215644|516021932|FG000|Overall Study|Randomized but Not Treated|1|||
143129727|NCT00215644|516021933|FG001|Overall Study|Randomized but Not Treated|0|||
143129728|NCT03569098|516021934|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
143129729|NCT03569098|516021935|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
143129730|NCT03569098|516021936|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
143129731|NCT03569098|516021934|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
143129732|NCT03569098|516021935|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
143129733|NCT03569098|516021936|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
143129734|NCT03569098|516021934|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
143129735|NCT03569098|516021935|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
143129736|NCT03569098|516021936|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
143129737|NCT03569098|516021934|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
143129738|NCT03569098|516021935|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
143129739|NCT03569098|516021936|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
143129740|NCT03569098|516021934|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
143129741|NCT03569098|516021935|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
143129742|NCT03569098|516021936|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
143129743|NCT03569098|516021934|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
143129744|NCT03569098|516021935|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
143129745|NCT03569098|516021936|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
143129746|NCT03569098|516021934|FG000|Double-Blind Treatment Cycle 1|Other|1|||
143129747|NCT03569098|516021935|FG001|Double-Blind Treatment Cycle 1|Other|0|||
143129748|NCT03569098|516021936|FG002|Double-Blind Treatment Cycle 1|Other|1|||
143129749|NCT03569098|516021934|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
143129750|NCT03569098|516021935|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
143129751|NCT03569098|516021936|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
143129752|NCT03569098|516021934|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
143129753|NCT03569098|516021935|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
143129754|NCT03569098|516021936|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
143129755|NCT03569098|516021934|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
143129756|NCT03569098|516021935|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
143129757|NCT03569098|516021936|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
143129758|NCT03569098|516021934|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
143129759|NCT03569098|516021935|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
143230391|NCT03284710|516393220|FG002|Overall Study|Lost to Follow-up|1|||
143129760|NCT03569098|516021936|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
143230392|NCT03284710|516393221|FG003|Overall Study|Lost to Follow-up|0|||
143129761|NCT03569098|516021934|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
143129762|NCT03569098|516021935|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
143129763|NCT03569098|516021936|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
143129764|NCT03569098|516021934|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
143129765|NCT03569098|516021935|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
143129766|NCT03569098|516021936|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
143129767|NCT01516736|516021941|FG000|Overall Study|Withdrawal by Subject|10|||
143129768|NCT01516736|516021942|FG001|Overall Study|Withdrawal by Subject|4|||
143129769|NCT01516736|516021941|FG000|Overall Study|Adverse Event|4|||
143129770|NCT01516736|516021942|FG001|Overall Study|Adverse Event|5|||
143129771|NCT01516736|516021941|FG000|Overall Study|Death|3|||
143129772|NCT01516736|516021942|FG001|Overall Study|Death|1|||
143129773|NCT01516736|516021941|FG000|Overall Study|Physician Decision|2|||
143129774|NCT01516736|516021942|FG001|Overall Study|Physician Decision|1|||
143129775|NCT01516736|516021941|FG000|Overall Study|Lack of Efficacy|1|||
143129776|NCT01516736|516021942|FG001|Overall Study|Lack of Efficacy|0|||
143129777|NCT01516736|516021941|FG000|Overall Study|Protocol Violation|0|||
143129778|NCT01516736|516021942|FG001|Overall Study|Protocol Violation|1|||
143129779|NCT01516736|516021941|FG000|Overall Study|Other (not specified)|0|||
143129780|NCT01516736|516021942|FG001|Overall Study|Other (not specified)|1|||
143129781|NCT01877668|516021943|FG000|Overall Study|Death|0|||
143129782|NCT01877668|516021944|FG001|Overall Study|Death|0|||
143129783|NCT01877668|516021945|FG002|Overall Study|Death|0|||
143129784|NCT01877668|516021946|FG003|Overall Study|Death|1|||
143129785|NCT01877668|516021947|FG004|Overall Study|Death|0|||
143129786|NCT01877668|516021943|FG000|Overall Study|No longer met study criteria|1|||
143129787|NCT01877668|516021944|FG001|Overall Study|No longer met study criteria|0|||
143129788|NCT01877668|516021945|FG002|Overall Study|No longer met study criteria|1|||
143129789|NCT01877668|516021946|FG003|Overall Study|No longer met study criteria|0|||
143129790|NCT01877668|516021947|FG004|Overall Study|No longer met study criteria|0|||
143129791|NCT01877668|516021943|FG000|Overall Study|Insufficient clinical response|0|||
143129792|NCT01877668|516021944|FG001|Overall Study|Insufficient clinical response|1|||
143129793|NCT01877668|516021945|FG002|Overall Study|Insufficient clinical response|2|||
143129794|NCT01877668|516021946|FG003|Overall Study|Insufficient clinical response|2|||
143129795|NCT01877668|516021947|FG004|Overall Study|Insufficient clinical response|0|||
143129796|NCT01877668|516021943|FG000|Overall Study|Lost to Follow-up|0|||
143129797|NCT01877668|516021944|FG001|Overall Study|Lost to Follow-up|2|||
143129798|NCT01877668|516021945|FG002|Overall Study|Lost to Follow-up|1|||
143129799|NCT01877668|516021946|FG003|Overall Study|Lost to Follow-up|0|||
143129800|NCT01877668|516021947|FG004|Overall Study|Lost to Follow-up|0|||
143129801|NCT01877668|516021943|FG000|Overall Study|Withdrawal by Subject|2|||
143129802|NCT01877668|516021944|FG001|Overall Study|Withdrawal by Subject|0|||
143129803|NCT01877668|516021945|FG002|Overall Study|Withdrawal by Subject|3|||
143129804|NCT01877668|516021946|FG003|Overall Study|Withdrawal by Subject|2|||
143129805|NCT01877668|516021947|FG004|Overall Study|Withdrawal by Subject|2|||
143129806|NCT01877668|516021943|FG000|Overall Study|Other|1|||
143129807|NCT01877668|516021944|FG001|Overall Study|Other|1|||
143129808|NCT01877668|516021945|FG002|Overall Study|Other|1|||
143129809|NCT01877668|516021946|FG003|Overall Study|Other|1|||
143230393|NCT03284710|516393218|FG000|Overall Study|Physician Decision|1|||
143230394|NCT03284710|516393219|FG001|Overall Study|Physician Decision|0|||
143230395|NCT03284710|516393220|FG002|Overall Study|Physician Decision|0|||
143230396|NCT03284710|516393221|FG003|Overall Study|Physician Decision|0|||
143230397|NCT03284710|516393218|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
143230398|NCT03284710|516393219|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
143230399|NCT03284710|516393220|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
143230400|NCT03284710|516393221|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
143230401|NCT03284710|516393218|FG000|Overall Study|HIV Infection|0|||
143230402|NCT03284710|516393219|FG001|Overall Study|HIV Infection|2|||
143230403|NCT03284710|516393220|FG002|Overall Study|HIV Infection|2|||
143230404|NCT03284710|516393221|FG003|Overall Study|HIV Infection|1|||
143230405|NCT02412306|516393223|FG000|Overall Study|Lost to Follow-up|0|||
143129810|NCT01877668|516021947|FG004|Overall Study|Other|3|||
143129811|NCT01877668|516021943|FG000|Overall Study|Protocol Violation|1|||
143129812|NCT01877668|516021944|FG001|Overall Study|Protocol Violation|1|||
143129813|NCT01877668|516021945|FG002|Overall Study|Protocol Violation|0|||
143129814|NCT01877668|516021946|FG003|Overall Study|Protocol Violation|0|||
143129815|NCT01877668|516021947|FG004|Overall Study|Protocol Violation|3|||
143129816|NCT01877668|516021943|FG000|Overall Study|Adverse event related to study drug|2|||
143230406|NCT02412306|516393224|FG001|Overall Study|Lost to Follow-up|1|||
143129817|NCT01877668|516021944|FG001|Overall Study|Adverse event related to study drug|2|||
143129818|NCT01877668|516021945|FG002|Overall Study|Adverse event related to study drug|2|||
143129819|NCT01877668|516021946|FG003|Overall Study|Adverse event related to study drug|2|||
143129820|NCT01877668|516021947|FG004|Overall Study|Adverse event related to study drug|1|||
143129821|NCT01877668|516021943|FG000|Overall Study|Adverse event unrelated to study drug|4|||
143230407|NCT02412306|516393225|FG002|Overall Study|Lost to Follow-up|0|||
143129822|NCT01877668|516021944|FG001|Overall Study|Adverse event unrelated to study drug|1|||
143129823|NCT01877668|516021945|FG002|Overall Study|Adverse event unrelated to study drug|2|||
143230408|NCT02412306|516393226|FG003|Overall Study|Lost to Follow-up|0|||
143230409|NCT02412306|516393227|FG004|Overall Study|Lost to Follow-up|0|||
143230410|NCT02412306|516393223|FG000|Overall Study|Withdrawal by Subject|0|||
143230411|NCT02412306|516393224|FG001|Overall Study|Withdrawal by Subject|0|||
143230412|NCT02412306|516393225|FG002|Overall Study|Withdrawal by Subject|1|||
143230413|NCT02412306|516393226|FG003|Overall Study|Withdrawal by Subject|0|||
143230414|NCT02412306|516393227|FG004|Overall Study|Withdrawal by Subject|0|||
143230415|NCT02412306|516393223|FG000|Overall Study|Death|5|||
143230416|NCT02412306|516393224|FG001|Overall Study|Death|7|||
143230417|NCT02412306|516393225|FG002|Overall Study|Death|15|||
143230418|NCT02412306|516393226|FG003|Overall Study|Death|0|||
143230419|NCT02412306|516393227|FG004|Overall Study|Death|2|||
143230420|NCT03760029|516393235|FG000|Overall Study|Death|1|||
143230421|NCT03760029|516393236|FG001|Overall Study|Death|0|||
143230422|NCT03760029|516393237|FG002|Overall Study|Death|0|||
143230423|NCT03760029|516393235|FG000|Overall Study|Lost to Follow-up|0|||
143230424|NCT03760029|516393236|FG001|Overall Study|Lost to Follow-up|2|||
143230425|NCT03760029|516393237|FG002|Overall Study|Lost to Follow-up|1|||
143230426|NCT03760029|516393235|FG000|Overall Study|Withdrawal by Subject|1|||
143230427|NCT03760029|516393236|FG001|Overall Study|Withdrawal by Subject|4|||
143230428|NCT03760029|516393237|FG002|Overall Study|Withdrawal by Subject|1|||
143230429|NCT03760029|516393235|FG000|Overall Study|Withdrawal by parent/guardian|4|||
143230430|NCT03760029|516393236|FG001|Overall Study|Withdrawal by parent/guardian|4|||
143230431|NCT03760029|516393237|FG002|Overall Study|Withdrawal by parent/guardian|1|||
143465674|NCT01294683|517251112|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
143465675|NCT01294683|517251111|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
143465676|NCT01294683|517251112|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
143465677|NCT01294683|517251111|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
143465678|NCT01294683|517251112|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
143465679|NCT01294683|517251111|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
143465680|NCT01294683|517251112|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
143465681|NCT01294683|517251111|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
143465682|NCT01294683|517251112|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
143465683|NCT01294683|517251111|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
143465684|NCT01294683|517251112|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
143465685|NCT01294683|517251111|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
143465686|NCT01294683|517251112|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
143465687|NCT01294683|517251111|FG000|Post Crossover (Period III)|Adverse Event|6|||
143465688|NCT01294683|517251112|FG001|Post Crossover (Period III)|Adverse Event|6|||
143465689|NCT01294683|517251111|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
143230432|NCT03760029|516393235|FG000|Overall Study|Other|2|||
143230433|NCT03760029|516393236|FG001|Overall Study|Other|1|||
143230434|NCT03760029|516393237|FG002|Overall Study|Other|0|||
143230435|NCT05316597|516393241|FG000|First Session|Withdrawal by Subject|0|||
143230436|NCT05316597|516393242|FG001|First Session|Withdrawal by Subject|1|||
143230437|NCT05316597|516393241|FG000|Washout Period|Lost to Follow-up|1|||
143230438|NCT05316597|516393242|FG001|Washout Period|Lost to Follow-up|2|||
143230439|NCT05316597|516393241|FG000|Washout Period|Physician Decision|1|||
143465690|NCT01294683|517251112|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
143465691|NCT01294683|517251111|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
143230440|NCT05316597|516393242|FG001|Washout Period|Physician Decision|1|||
143230441|NCT05316597|516393241|FG000|Washout Period|Excluded before second session|1|||
143230442|NCT05316597|516393242|FG001|Washout Period|Excluded before second session|1|||
143230443|NCT05316597|516393241|FG000|Washout Period|Withdrawal by Subject|0|||
143230444|NCT05316597|516393242|FG001|Washout Period|Withdrawal by Subject|4|||
143129824|NCT01877668|516021946|FG003|Overall Study|Adverse event unrelated to study drug|0|||
143129825|NCT01877668|516021947|FG004|Overall Study|Adverse event unrelated to study drug|1|||
143129826|NCT01302418|516021948|FG000|Overall Study|Protocol Violation|9|||
143230445|NCT03547518|516393245|FG000|Overall Study|Lost to Follow-up|2|||
143230446|NCT03547518|516393246|FG001|Overall Study|Lost to Follow-up|0|||
143129827|NCT01302418|516021948|FG000|Overall Study|Non-evaluable|9|||
143230447|NCT02953652|516393253|FG000|Overall Study|Adverse Event|18|||
143230448|NCT02953652|516393253|FG000|Overall Study|Withdrawal by Subject|6|||
143230449|NCT02953652|516393253|FG000|Overall Study|Protocol Violation|1|||
143230450|NCT02953652|516393253|FG000|Overall Study|Disease Progression|27|||
143230451|NCT03192176|516393255|FG000|Overall Study|Adverse Event|1|||
143230452|NCT03192176|516393256|FG001|Overall Study|Adverse Event|0|||
143230453|NCT03192176|516393257|FG002|Overall Study|Adverse Event|4|||
143230454|NCT03192176|516393258|FG003|Overall Study|Adverse Event|5|||
143230455|NCT03192176|516393259|FG004|Overall Study|Adverse Event|3|||
143230456|NCT03192176|516393260|FG005|Overall Study|Adverse Event|2|||
143230457|NCT03192176|516393261|FG006|Overall Study|Adverse Event|3|||
143230458|NCT03192176|516393262|FG007|Overall Study|Adverse Event|3|||
143230459|NCT03192176|516393255|FG000|Overall Study|Lost to Follow-up|0|||
143230460|NCT03192176|516393256|FG001|Overall Study|Lost to Follow-up|0|||
143230461|NCT03192176|516393257|FG002|Overall Study|Lost to Follow-up|1|||
143230462|NCT03192176|516393258|FG003|Overall Study|Lost to Follow-up|2|||
143129828|NCT01697800|516021949|FG000|Overall Study|Death|0|||
143129829|NCT01697800|516021950|FG001|Overall Study|Death|1|||
143129830|NCT01000974|516021955|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
143129831|NCT01000974|516021956|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
143129832|NCT01000974|516021957|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
143129833|NCT01000974|516021955|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
143129834|NCT01000974|516021956|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
143129835|NCT01000974|516021957|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
143129836|NCT01000974|516021955|FG000|Primary Vaccination Phase|Protocol Violation|40|||
143129837|NCT01000974|516021956|FG001|Primary Vaccination Phase|Protocol Violation|3|||
143129838|NCT01000974|516021957|FG002|Primary Vaccination Phase|Protocol Violation|2|||
143129839|NCT01000974|516021955|FG000|Primary Vaccination Phase|Adverse Event|14|||
143129840|NCT01000974|516021956|FG001|Primary Vaccination Phase|Adverse Event|2|||
143129841|NCT01000974|516021957|FG002|Primary Vaccination Phase|Adverse Event|2|||
143129842|NCT01000974|516021955|FG000|Primary Vaccination Phase|Other|4|||
143129843|NCT01000974|516021956|FG001|Primary Vaccination Phase|Other|9|||
143129844|NCT01000974|516021957|FG002|Primary Vaccination Phase|Other|12|||
143129845|NCT01000974|516021955|FG000|Booster Vaccination Phase|Protocol Violation|0|||
143129846|NCT01000974|516021956|FG001|Booster Vaccination Phase|Protocol Violation|0|||
143129847|NCT01000974|516021957|FG002|Booster Vaccination Phase|Protocol Violation|2|||
143129848|NCT01000974|516021955|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
143129849|NCT01000974|516021956|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
143129850|NCT01000974|516021957|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
143129851|NCT01000974|516021955|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
143129852|NCT01000974|516021956|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
143129853|NCT01000974|516021957|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
143129854|NCT01000974|516021955|FG000|Booster Vaccination Phase|Other|24|||
143129855|NCT01000974|516021956|FG001|Booster Vaccination Phase|Other|6|||
143129856|NCT01000974|516021957|FG002|Booster Vaccination Phase|Other|4|||
143129857|NCT01307891|516021959|FG000|Overall Study|Progressive Disease|3|||
143129858|NCT01307891|516021960|FG001|Overall Study|Progressive Disease|1|||
143129859|NCT03365934|516021961|FG000|Overall Study|Adverse Event|1|||
143129860|NCT03365934|516021961|FG000|Overall Study|Withdrawal by Subject|1|||
143129861|NCT02291029|516021967|FG000|Overall Study|Withdrawal by Subject|0|||
143129862|NCT02291029|516021968|FG001|Overall Study|Withdrawal by Subject|0|||
143129863|NCT02291029|516021969|FG002|Overall Study|Withdrawal by Subject|1|||
143129864|NCT02291029|516021970|FG003|Overall Study|Withdrawal by Subject|0|||
143129865|NCT02291029|516021971|FG004|Overall Study|Withdrawal by Subject|0|||
143129866|NCT02291029|516021972|FG005|Overall Study|Withdrawal by Subject|0|||
143129867|NCT02291029|516021967|FG000|Overall Study|Adverse Event|0|||
143129868|NCT02291029|516021968|FG001|Overall Study|Adverse Event|1|||
143129869|NCT02291029|516021969|FG002|Overall Study|Adverse Event|0|||
143129870|NCT02291029|516021970|FG003|Overall Study|Adverse Event|0|||
143357841|NCT00847301|516854499|FG000|Overall Study|Other reason not defined above|1|||
143357842|NCT05593211|516854500|FG000|Overall Study|Withdrawal by Subject|1|||
143357843|NCT04248465|516854504|FG000|Randomized-Controlled Period|Death|12|||
143357844|NCT04248465|516854505|FG001|Randomized-Controlled Period|Death|5|||
143357845|NCT04248465|516854504|FG000|Randomized-Controlled Period|Adverse Event|2|||
143357846|NCT04248465|516854505|FG001|Randomized-Controlled Period|Adverse Event|0|||
143357847|NCT04248465|516854504|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
143357848|NCT04248465|516854505|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
143357849|NCT04248465|516854504|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
143357850|NCT04248465|516854505|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
143357851|NCT04248465|516854504|FG000|Randomized-Controlled Period|Physician Decision|1|||
143357852|NCT04248465|516854505|FG001|Randomized-Controlled Period|Physician Decision|1|||
143357853|NCT04248465|516854504|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
143357854|NCT04248465|516854505|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
143357855|NCT04248465|516854504|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
143357856|NCT04248465|516854505|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
143357857|NCT04248465|516854504|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
143357858|NCT04248465|516854505|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
143357859|NCT05708846|516854506|FG000|Overall Study|Death|5|||
143357860|NCT05708846|516854506|FG000|Overall Study|Withdrawal by Subject|20|||
143357861|NCT00442286|516854507|FG000|Overall Study|Death|2|||
143230463|NCT03192176|516393259|FG004|Overall Study|Lost to Follow-up|3|||
143129871|NCT02291029|516021971|FG004|Overall Study|Adverse Event|0|||
143129872|NCT02291029|516021972|FG005|Overall Study|Adverse Event|0|||
143129873|NCT04085601|516021973|FG000|Overall Study|Lost to Follow-up|1|||
143357862|NCT00442286|516854508|FG001|Overall Study|Death|2|||
143230464|NCT03192176|516393260|FG005|Overall Study|Lost to Follow-up|1|||
143230465|NCT03192176|516393261|FG006|Overall Study|Lost to Follow-up|1|||
143013784|NCT02494583|515590020|FG001|Overall Study|Did Not Continue on Extension Study|10|||
143129874|NCT04085601|516021974|FG001|Overall Study|Lost to Follow-up|0|||
143129875|NCT04085601|516021973|FG000|Overall Study|Death|1|||
143230466|NCT03192176|516393262|FG007|Overall Study|Lost to Follow-up|1|||
143230467|NCT03192176|516393255|FG000|Overall Study|Physician Decision|1|||
143230468|NCT03192176|516393256|FG001|Overall Study|Physician Decision|0|||
143230469|NCT03192176|516393257|FG002|Overall Study|Physician Decision|0|||
143230470|NCT03192176|516393258|FG003|Overall Study|Physician Decision|0|||
143230471|NCT03192176|516393259|FG004|Overall Study|Physician Decision|0|||
143230472|NCT03192176|516393260|FG005|Overall Study|Physician Decision|2|||
143230473|NCT03192176|516393261|FG006|Overall Study|Physician Decision|1|||
143230474|NCT03192176|516393262|FG007|Overall Study|Physician Decision|0|||
143230475|NCT03192176|516393255|FG000|Overall Study|Protocol Deviation|1|||
143230476|NCT03192176|516393256|FG001|Overall Study|Protocol Deviation|1|||
143230477|NCT03192176|516393257|FG002|Overall Study|Protocol Deviation|0|||
143230478|NCT03192176|516393258|FG003|Overall Study|Protocol Deviation|0|||
143230479|NCT03192176|516393259|FG004|Overall Study|Protocol Deviation|2|||
143230480|NCT03192176|516393260|FG005|Overall Study|Protocol Deviation|0|||
143230481|NCT03192176|516393261|FG006|Overall Study|Protocol Deviation|0|||
143230482|NCT03192176|516393262|FG007|Overall Study|Protocol Deviation|0|||
143129876|NCT04085601|516021974|FG001|Overall Study|Death|1|||
143129877|NCT00113295|516021975|FG000|Overall Study|Adverse Event|4|||
143129878|NCT00113295|516021976|FG001|Overall Study|Adverse Event|1|||
143129879|NCT00113295|516021975|FG000|Overall Study|Unrelated Medical Illness|1|||
143129880|NCT00113295|516021976|FG001|Overall Study|Unrelated Medical Illness|0|||
143230483|NCT03192176|516393255|FG000|Overall Study|Withdrawal by Subject|3|||
143230484|NCT03192176|516393256|FG001|Overall Study|Withdrawal by Subject|4|||
143230485|NCT03192176|516393257|FG002|Overall Study|Withdrawal by Subject|0|||
143230486|NCT03192176|516393258|FG003|Overall Study|Withdrawal by Subject|4|||
143230487|NCT03192176|516393259|FG004|Overall Study|Withdrawal by Subject|3|||
143230488|NCT03192176|516393260|FG005|Overall Study|Withdrawal by Subject|4|||
143230489|NCT03192176|516393261|FG006|Overall Study|Withdrawal by Subject|4|||
143230490|NCT03192176|516393262|FG007|Overall Study|Withdrawal by Subject|2|||
143230491|NCT03192176|516393255|FG000|Overall Study|Miscellaneous|1|||
143230492|NCT03192176|516393256|FG001|Overall Study|Miscellaneous|0|||
143230493|NCT03192176|516393257|FG002|Overall Study|Miscellaneous|1|||
143230494|NCT03192176|516393258|FG003|Overall Study|Miscellaneous|1|||
143230495|NCT03192176|516393259|FG004|Overall Study|Miscellaneous|1|||
143230496|NCT03192176|516393260|FG005|Overall Study|Miscellaneous|2|||
143230497|NCT03192176|516393261|FG006|Overall Study|Miscellaneous|0|||
143230498|NCT03192176|516393262|FG007|Overall Study|Miscellaneous|1|||
143230499|NCT02384551|516393265|FG000|Overall Study|Lost to Follow-up|13|||
143230500|NCT02384551|516393266|FG001|Overall Study|Lost to Follow-up|14|||
143230501|NCT02384551|516393267|FG002|Overall Study|Lost to Follow-up|14|||
143230502|NCT02384551|516393268|FG003|Overall Study|Lost to Follow-up|14|||
143230503|NCT04349891|516393269|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
143230504|NCT04349891|516393270|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
143230505|NCT04349891|516393269|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
143230506|NCT04349891|516393270|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
143230507|NCT04349891|516393269|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
143230508|NCT04349891|516393270|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
143230509|NCT04349891|516393269|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
143230510|NCT04349891|516393270|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
143230511|NCT02927301|516393275|FG000|Overall Study|Death|39|||
143230512|NCT02927301|516393275|FG000|Overall Study|Lost to Follow-up|8|||
143230513|NCT02927301|516393275|FG000|Overall Study|Physician Decision|2|||
143230514|NCT02927301|516393275|FG000|Overall Study|Withdrawal by Subject|12|||
143230515|NCT02927301|516393275|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
143230516|NCT04247347|516393278|FG000|Overall Study|Withdrawal by Subject|2|||
143230517|NCT04247347|516393279|FG001|Overall Study|Withdrawal by Subject|3|||
143230518|NCT04247347|516393280|FG002|Overall Study|Withdrawal by Subject|3|||
143230519|NCT04247347|516393278|FG000|Overall Study|Lost to Follow-up|1|||
143230520|NCT04247347|516393279|FG001|Overall Study|Lost to Follow-up|1|||
143230521|NCT04247347|516393280|FG002|Overall Study|Lost to Follow-up|1|||
143230522|NCT01089504|516393283|FG000|Overall Study|Lost to Follow-up|1|||
143129881|NCT00994110|516021977|FG000|Overall Study|Withdrawal by Subject|9|||
143230523|NCT01089504|516393284|FG001|Overall Study|Lost to Follow-up|1|||
143230524|NCT01089504|516393283|FG000|Overall Study|Withdrawal by Subject|2|||
143230525|NCT01089504|516393284|FG001|Overall Study|Withdrawal by Subject|0|||
143129882|NCT00994110|516021978|FG001|Overall Study|Withdrawal by Subject|9|||
143129883|NCT00994110|516021977|FG000|Overall Study|Not Treated|4|||
143230526|NCT00001832|516393285|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
143230527|NCT00001832|516393286|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
143230528|NCT00001832|516393287|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
143230529|NCT00001832|516393288|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
143230530|NCT00001832|516393289|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
143230531|NCT00001832|516393290|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
143230532|NCT00001832|516393291|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
143230533|NCT00001832|516393292|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
143230534|NCT00001832|516393293|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
143357863|NCT00442286|516854507|FG000|Overall Study|Lost to Follow-up|1|||
143357864|NCT00442286|516854508|FG001|Overall Study|Lost to Follow-up|0|||
143357865|NCT00442286|516854507|FG000|Overall Study|Withdrawal by Subject|2|||
143357866|NCT00442286|516854508|FG001|Overall Study|Withdrawal by Subject|0|||
143357867|NCT00442286|516854507|FG000|Overall Study|System explanted|1|||
143357868|NCT00442286|516854508|FG001|Overall Study|System explanted|0|||
143357869|NCT00442286|516854507|FG000|Overall Study|Patient Injury|1|||
143357870|NCT00442286|516854508|FG001|Overall Study|Patient Injury|0|||
143357871|NCT00519636|516854511|FG000|Treatment Period 1|Adverse Event|1|||
143357872|NCT00519636|516854512|FG001|Treatment Period 1|Adverse Event|0|||
143357873|NCT00519636|516854513|FG002|Treatment Period 1|Adverse Event|1|||
143357874|NCT00519636|516854514|FG003|Treatment Period 1|Adverse Event|0|||
143357875|NCT00519636|516854511|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
143357876|NCT00519636|516854512|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
143357877|NCT00519636|516854513|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
143357878|NCT00519636|516854514|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
143357879|NCT00519636|516854511|FG000|Washout Period|Adverse Event|2|||
143357880|NCT00519636|516854512|FG001|Washout Period|Adverse Event|1|||
143357881|NCT00519636|516854513|FG002|Washout Period|Adverse Event|1|||
143357882|NCT00519636|516854514|FG003|Washout Period|Adverse Event|0|||
143357883|NCT00519636|516854511|FG000|Washout Period|Lost to Follow-up|1|||
143357884|NCT00519636|516854512|FG001|Washout Period|Lost to Follow-up|0|||
143357885|NCT00519636|516854513|FG002|Washout Period|Lost to Follow-up|0|||
143357886|NCT00519636|516854514|FG003|Washout Period|Lost to Follow-up|0|||
143357887|NCT00519636|516854511|FG000|Washout Period|Protocol Violation|0|||
143357888|NCT00519636|516854512|FG001|Washout Period|Protocol Violation|0|||
143357889|NCT00519636|516854513|FG002|Washout Period|Protocol Violation|1|||
143357890|NCT00519636|516854514|FG003|Washout Period|Protocol Violation|2|||
143357891|NCT00519636|516854511|FG000|Washout Period|Withdrawal by Subject|1|||
143357892|NCT00519636|516854512|FG001|Washout Period|Withdrawal by Subject|0|||
143357893|NCT00519636|516854513|FG002|Washout Period|Withdrawal by Subject|1|||
143357894|NCT00519636|516854514|FG003|Washout Period|Withdrawal by Subject|0|||
143357895|NCT00519636|516854511|FG000|Washout Period|Failed to meet continuation criteria|14|||
143357896|NCT00519636|516854512|FG001|Washout Period|Failed to meet continuation criteria|11|||
143357897|NCT00519636|516854513|FG002|Washout Period|Failed to meet continuation criteria|9|||
143357898|NCT00519636|516854514|FG003|Washout Period|Failed to meet continuation criteria|3|||
143357899|NCT00519636|516854511|FG000|Washout Period|Out of pollen area > 48 hours|1|||
143357900|NCT00519636|516854512|FG001|Washout Period|Out of pollen area > 48 hours|0|||
143357901|NCT00519636|516854513|FG002|Washout Period|Out of pollen area > 48 hours|0|||
143357902|NCT00519636|516854514|FG003|Washout Period|Out of pollen area > 48 hours|0|||
143357903|NCT00519636|516854511|FG000|Washout Period|Participating in study at another site|1|||
143357904|NCT00519636|516854512|FG001|Washout Period|Participating in study at another site|0|||
143357905|NCT00519636|516854513|FG002|Washout Period|Participating in study at another site|0|||
143357906|NCT00519636|516854514|FG003|Washout Period|Participating in study at another site|0|||
143357907|NCT00519636|516854511|FG000|Washout Period|Non-compliant|0|||
143357908|NCT00519636|516854512|FG001|Washout Period|Non-compliant|1|||
143357909|NCT00519636|516854513|FG002|Washout Period|Non-compliant|0|||
143357910|NCT00519636|516854514|FG003|Washout Period|Non-compliant|0|||
143357911|NCT00519636|516854511|FG000|Washout Period|Per doctors request|0|||
143357912|NCT00519636|516854512|FG001|Washout Period|Per doctors request|1|||
143357913|NCT00519636|516854513|FG002|Washout Period|Per doctors request|0|||
143357914|NCT00519636|516854514|FG003|Washout Period|Per doctors request|0|||
143357915|NCT00519636|516854511|FG000|Washout Period|Subject randomized in error|0|||
143357916|NCT00519636|516854512|FG001|Washout Period|Subject randomized in error|0|||
143357917|NCT00519636|516854513|FG002|Washout Period|Subject randomized in error|1|||
143357918|NCT00519636|516854514|FG003|Washout Period|Subject randomized in error|0|||
143357919|NCT00519636|516854511|FG000|Washout Period|Prohibited medications|0|||
143357920|NCT00519636|516854512|FG001|Washout Period|Prohibited medications|0|||
143357921|NCT00519636|516854513|FG002|Washout Period|Prohibited medications|1|||
143357922|NCT00519636|516854514|FG003|Washout Period|Prohibited medications|0|||
143357923|NCT00519636|516854511|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
143357924|NCT00519636|516854512|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
143357925|NCT00519636|516854513|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
143357926|NCT00519636|516854514|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
143357927|NCT00519636|516854511|FG000|Treatment Period 2|Subject randomized in error|0|||
143357928|NCT00519636|516854512|FG001|Treatment Period 2|Subject randomized in error|1|||
143357929|NCT00519636|516854513|FG002|Treatment Period 2|Subject randomized in error|0|||
143357930|NCT00519636|516854514|FG003|Treatment Period 2|Subject randomized in error|0|||
143357931|NCT00519636|516854511|FG000|Treatment Period 2|Per doctors request|0|||
143357932|NCT00519636|516854512|FG001|Treatment Period 2|Per doctors request|0|||
143357933|NCT00519636|516854513|FG002|Treatment Period 2|Per doctors request|1|||
143357934|NCT00519636|516854514|FG003|Treatment Period 2|Per doctors request|0|||
143357935|NCT00519636|516854511|FG000|Treatment Period 2|Subject misrandomized|0|||
143230535|NCT00001832|516393294|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
143230536|NCT00001832|516393295|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
143230537|NCT00001832|516393296|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
143230538|NCT00001832|516393297|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
143230539|NCT00001832|516393298|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
143230540|NCT00001832|516393299|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
143230541|NCT00001832|516393285|FG000|Treatment Period|Death during treatment|0|||
143230542|NCT00001832|516393286|FG001|Treatment Period|Death during treatment|0|||
143230543|NCT00001832|516393287|FG002|Treatment Period|Death during treatment|0|||
143230544|NCT00001832|516393288|FG003|Treatment Period|Death during treatment|0|||
143230545|NCT00001832|516393289|FG004|Treatment Period|Death during treatment|0|||
143230546|NCT00001832|516393290|FG005|Treatment Period|Death during treatment|1|||
143230547|NCT00001832|516393291|FG006|Treatment Period|Death during treatment|0|||
143230548|NCT00001832|516393292|FG007|Treatment Period|Death during treatment|0|||
143230549|NCT00001832|516393293|FG008|Treatment Period|Death during treatment|0|||
143230550|NCT00001832|516393294|FG009|Treatment Period|Death during treatment|0|||
143230551|NCT00001832|516393295|FG010|Treatment Period|Death during treatment|0|||
143230552|NCT00001832|516393296|FG011|Treatment Period|Death during treatment|0|||
143230553|NCT00001832|516393297|FG012|Treatment Period|Death during treatment|0|||
143230554|NCT00001832|516393298|FG013|Treatment Period|Death during treatment|0|||
143230555|NCT00001832|516393299|FG014|Treatment Period|Death during treatment|0|||
143230556|NCT00001832|516393285|FG000|Treatment Period|Not treated|0|||
143230557|NCT00001832|516393286|FG001|Treatment Period|Not treated|0|||
143230558|NCT00001832|516393287|FG002|Treatment Period|Not treated|0|||
143230559|NCT00001832|516393288|FG003|Treatment Period|Not treated|0|||
143230560|NCT00001832|516393289|FG004|Treatment Period|Not treated|0|||
143230561|NCT00001832|516393290|FG005|Treatment Period|Not treated|0|||
143230562|NCT00001832|516393291|FG006|Treatment Period|Not treated|0|||
143230563|NCT00001832|516393292|FG007|Treatment Period|Not treated|1|||
143230564|NCT00001832|516393293|FG008|Treatment Period|Not treated|0|||
143230565|NCT00001832|516393294|FG009|Treatment Period|Not treated|0|||
143230566|NCT00001832|516393295|FG010|Treatment Period|Not treated|0|||
143230567|NCT00001832|516393296|FG011|Treatment Period|Not treated|0|||
143230568|NCT00001832|516393297|FG012|Treatment Period|Not treated|0|||
143230569|NCT00001832|516393298|FG013|Treatment Period|Not treated|0|||
143230570|NCT00001832|516393299|FG014|Treatment Period|Not treated|0|||
143230571|NCT04196686|516393300|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
143230572|NCT04196686|516393301|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
143230573|NCT05106959|516393302|FG000|Overall Study|Lost to Follow-up|1|||
143230574|NCT00265564|516393303|FG000|Overall Study|Lost to Follow-up|5|||
143230575|NCT00265564|516393304|FG001|Overall Study|Lost to Follow-up|7|||
143230576|NCT00265564|516393303|FG000|Overall Study|met exclusion criteria|5|||
143230577|NCT00265564|516393304|FG001|Overall Study|met exclusion criteria|2|||
143230578|NCT03582215|516393309|FG000|Overall Study|Adverse Event|1|||
143230579|NCT03582215|516393310|FG001|Overall Study|Adverse Event|0|||
143230580|NCT03582215|516393311|FG002|Overall Study|Adverse Event|0|||
143230581|NCT03582215|516393312|FG003|Overall Study|Adverse Event|0|||
143230582|NCT03582215|516393313|FG004|Overall Study|Adverse Event|0|||
143230583|NCT03582215|516393314|FG005|Overall Study|Adverse Event|0|||
143230584|NCT03582215|516393315|FG006|Overall Study|Adverse Event|2|||
143230585|NCT03582215|516393316|FG007|Overall Study|Adverse Event|2|||
143230586|NCT00659061|516393317|FG000|Overall Study|Migration due to political unrest|21|||
143230587|NCT00659061|516393318|FG001|Overall Study|Migration due to political unrest|15|||
143230588|NCT03186209|516393321|FG000|Overall Study|Withdrawal by Subject|11|||
143230589|NCT03186209|516393322|FG001|Overall Study|Withdrawal by Subject|22|||
143230590|NCT03186209|516393321|FG000|Overall Study|Pregnancy|1|||
143230591|NCT03186209|516393322|FG001|Overall Study|Pregnancy|0|||
143230592|NCT03186209|516393321|FG000|Overall Study|Adverse Event|4|||
143230593|NCT03186209|516393322|FG001|Overall Study|Adverse Event|0|||
143230594|NCT03186209|516393321|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
143230595|NCT03186209|516393322|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
143230596|NCT03186209|516393321|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
143129884|NCT00994110|516021978|FG001|Overall Study|Not Treated|8|||
143230597|NCT03186209|516393322|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
143230598|NCT03186209|516393321|FG000|Overall Study|Fail to meet randomization criteria|0|||
143230599|NCT03186209|516393322|FG001|Overall Study|Fail to meet randomization criteria|1|||
143230600|NCT03186209|516393321|FG000|Overall Study|Lost to Follow-up|0|||
143230601|NCT03186209|516393322|FG001|Overall Study|Lost to Follow-up|1|||
143230602|NCT01277744|516393323|FG000|Overall Study|Physician Decision|2|||
143230603|NCT05083351|516393331|FG000|Overall Study|Adverse Event|3|||
143230604|NCT05083351|516393331|FG000|Overall Study|Did not meet data inclusion criteria|8|||
143230605|NCT05083351|516393331|FG000|Overall Study|Did not meet eligibility criteria|19|||
143230606|NCT05083351|516393331|FG000|Overall Study|Study Staff Decision|19|||
143230607|NCT01323582|516393335|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
143230608|NCT01323582|516393336|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
143230609|NCT01323582|516393335|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
143230610|NCT01323582|516393336|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
143230611|NCT01323582|516393335|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
143230612|NCT01323582|516393336|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
143230613|NCT03416868|516393337|FG000|Overall Study|Withdrawal by Subject|2|||
143230614|NCT03416868|516393337|FG000|Overall Study|Lost to Follow-up|1|||
143230615|NCT01759420|516393338|FG000|Overall Study|Screen failure|5|||
143230616|NCT01759420|516393338|FG000|Overall Study|Inaccurate EKG machine readings|1|||
143230617|NCT00525512|516393344|FG000|Double-Blind Phase|Adverse Event|48|||
143230618|NCT00525512|516393345|FG001|Double-Blind Phase|Adverse Event|28|||
143230619|NCT00525512|516393346|FG002|Double-Blind Phase|Adverse Event|0|||
143230620|NCT00525512|516393347|FG003|Double-Blind Phase|Adverse Event|0|||
143230621|NCT00525512|516393344|FG000|Double-Blind Phase|Protocol Violation|3|||
143230622|NCT00525512|516393345|FG001|Double-Blind Phase|Protocol Violation|1|||
143230623|NCT00525512|516393346|FG002|Double-Blind Phase|Protocol Violation|0|||
143230624|NCT00525512|516393347|FG003|Double-Blind Phase|Protocol Violation|0|||
143230625|NCT00525512|516393344|FG000|Double-Blind Phase|Lost to Follow-up|3|||
143230626|NCT00525512|516393345|FG001|Double-Blind Phase|Lost to Follow-up|7|||
143230627|NCT00525512|516393346|FG002|Double-Blind Phase|Lost to Follow-up|0|||
143230628|NCT00525512|516393347|FG003|Double-Blind Phase|Lost to Follow-up|0|||
143230629|NCT00525512|516393344|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
143230630|NCT00525512|516393345|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
143230631|NCT00525512|516393346|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
143230632|NCT00525512|516393347|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
143230633|NCT00525512|516393344|FG000|Double-Blind Phase|Lack of Efficacy|13|||
143129885|NCT00994110|516021977|FG000|Overall Study|Adverse Event|1|||
143129886|NCT00994110|516021978|FG001|Overall Study|Adverse Event|0|||
143129887|NCT00994110|516021977|FG000|Overall Study|Patient not resected|41|||
143129888|NCT00994110|516021978|FG001|Overall Study|Patient not resected|52|||
143129889|NCT00994110|516021977|FG000|Overall Study|Pt not eligible|10|||
143129890|NCT00994110|516021978|FG001|Overall Study|Pt not eligible|5|||
143129891|NCT01914393|516021979|FG000|Overall Study|Protocol Violation|11|||
143129892|NCT01914393|516021980|FG001|Overall Study|Protocol Violation|3|||
143129893|NCT01914393|516021981|FG002|Overall Study|Protocol Violation|19|||
143230634|NCT00525512|516393345|FG001|Double-Blind Phase|Lack of Efficacy|5|||
143230635|NCT00525512|516393346|FG002|Double-Blind Phase|Lack of Efficacy|0|||
143230636|NCT00525512|516393347|FG003|Double-Blind Phase|Lack of Efficacy|0|||
143230637|NCT00525512|516393344|FG000|Double-Blind Phase|Other reason (not specified)|12|||
143230638|NCT00525512|516393345|FG001|Double-Blind Phase|Other reason (not specified)|13|||
143230639|NCT00525512|516393346|FG002|Double-Blind Phase|Other reason (not specified)|0|||
143129894|NCT01914393|516021979|FG000|Overall Study|Lack of Efficacy|11|||
143129895|NCT01914393|516021980|FG001|Overall Study|Lack of Efficacy|16|||
143230640|NCT00525512|516393347|FG003|Double-Blind Phase|Other reason (not specified)|0|||
143230641|NCT00525512|516393344|FG000|Open-Label Phase|Adverse Event|0|||
143230642|NCT00525512|516393345|FG001|Open-Label Phase|Adverse Event|0|||
143230643|NCT00525512|516393346|FG002|Open-Label Phase|Adverse Event|1|||
143230644|NCT00525512|516393347|FG003|Open-Label Phase|Adverse Event|0|||
143230645|NCT00525512|516393344|FG000|Open-Label Phase|Lost to Follow-up|0|||
143230646|NCT00525512|516393345|FG001|Open-Label Phase|Lost to Follow-up|0|||
143230647|NCT00525512|516393346|FG002|Open-Label Phase|Lost to Follow-up|1|||
143230648|NCT00525512|516393347|FG003|Open-Label Phase|Lost to Follow-up|0|||
143230649|NCT00525512|516393344|FG000|Open-Label Phase|Other reason (not specified)|0|||
143230650|NCT00525512|516393345|FG001|Open-Label Phase|Other reason (not specified)|0|||
143230651|NCT00525512|516393346|FG002|Open-Label Phase|Other reason (not specified)|4|||
143230652|NCT00525512|516393347|FG003|Open-Label Phase|Other reason (not specified)|5|||
143259552|NCT02720094|516505771|FG000|Overall Study|Withdrawal by Subject|55|||
143259553|NCT02720094|516505772|FG001|Overall Study|Withdrawal by Subject|56|||
143259554|NCT02720094|516505771|FG000|Overall Study|Lost to Follow-up|2|||
143259555|NCT02720094|516505772|FG001|Overall Study|Lost to Follow-up|7|||
143259556|NCT02720094|516505771|FG000|Overall Study|Physician Decision|1|||
143259557|NCT02720094|516505772|FG001|Overall Study|Physician Decision|3|||
143259558|NCT02720094|516505771|FG000|Overall Study|Inappropriate enrollment|1|||
143259559|NCT02720094|516505772|FG001|Overall Study|Inappropriate enrollment|3|||
143259560|NCT02720094|516505771|FG000|Overall Study|Relocation|1|||
143259561|NCT02720094|516505772|FG001|Overall Study|Relocation|1|||
143259562|NCT00732940|516505779|FG000|Overall Study|Withdrawal by Subject|1|||
143259563|NCT00732940|516505780|FG001|Overall Study|Withdrawal by Subject|2|||
143259564|NCT00732940|516505779|FG000|Overall Study|Adverse Event|0|||
143259565|NCT00732940|516505780|FG001|Overall Study|Adverse Event|1|||
143259566|NCT00732940|516505779|FG000|Overall Study|Lost to Follow-up|1|||
143259567|NCT00732940|516505780|FG001|Overall Study|Lost to Follow-up|0|||
143259568|NCT02241889|516505781|FG000|Overall Study|device issues|0|||
143259569|NCT02241889|516505782|FG001|Overall Study|device issues|0|||
143259570|NCT02241889|516505783|FG002|Overall Study|device issues|1|||
143259571|NCT02241889|516505784|FG003|Overall Study|device issues|0|||
143259572|NCT02241889|516505785|FG004|Overall Study|device issues|0|||
143259573|NCT02241889|516505786|FG005|Overall Study|device issues|0|||
143129896|NCT01914393|516021981|FG002|Overall Study|Lack of Efficacy|5|||
143129897|NCT01914393|516021979|FG000|Overall Study|no reason given|14|||
143357936|NCT00519636|516854512|FG001|Treatment Period 2|Subject misrandomized|0|||
143357937|NCT00519636|516854513|FG002|Treatment Period 2|Subject misrandomized|0|||
143357938|NCT00519636|516854514|FG003|Treatment Period 2|Subject misrandomized|1|||
143357939|NCT00519636|516854511|FG000|Post Study Period|Subject randomized in error|0|||
143357940|NCT00519636|516854512|FG001|Post Study Period|Subject randomized in error|0|||
143357941|NCT00519636|516854513|FG002|Post Study Period|Subject randomized in error|0|||
143357942|NCT00519636|516854514|FG003|Post Study Period|Subject randomized in error|1|||
143357943|NCT01778062|516854515|FG000|Overall Study|Adverse Event|1|||
143357944|NCT01778062|516854516|FG001|Overall Study|Adverse Event|3|||
143357945|NCT01778062|516854515|FG000|Overall Study|Consent Withdrawal|1|||
143357946|NCT01778062|516854516|FG001|Overall Study|Consent Withdrawal|5|||
143357947|NCT01778062|516854515|FG000|Overall Study|major protocol deviation|4|||
143357948|NCT01778062|516854516|FG001|Overall Study|major protocol deviation|3|||
143357949|NCT03387514|516854517|FG000|Overall Study|Withdrawal by Subject|2|||
143357950|NCT03387514|516854517|FG000|Overall Study|Physician Decision|1|||
143357951|NCT03387514|516854517|FG000|Overall Study|Lost to Follow-up|2|||
143357952|NCT03040687|516854528|FG000|Overall Study|Withdrawal by Subject|1|||
143357953|NCT03040687|516854529|FG001|Overall Study|Withdrawal by Subject|0|||
143357954|NCT03040687|516854530|FG002|Overall Study|Withdrawal by Subject|0|||
143357955|NCT03317379|516854531|FG000|Overall Study|Lost to Follow-up|0|||
143357956|NCT03317379|516854532|FG001|Overall Study|Lost to Follow-up|3|||
143357957|NCT03317379|516854533|FG002|Overall Study|Lost to Follow-up|2|||
143357958|NCT02846558|516854534|FG000|Overall Study|Adverse Event|1|||
143357959|NCT02846558|516854535|FG001|Overall Study|Adverse Event|0|||
143357960|NCT02846558|516854536|FG002|Overall Study|Adverse Event|0|||
143357961|NCT02846558|516854537|FG003|Overall Study|Adverse Event|0|||
143357962|NCT02846558|516854534|FG000|Overall Study|Withdrawal by Subject|5|||
143357963|NCT02846558|516854535|FG001|Overall Study|Withdrawal by Subject|4|||
143357964|NCT02846558|516854536|FG002|Overall Study|Withdrawal by Subject|2|||
143357965|NCT02846558|516854537|FG003|Overall Study|Withdrawal by Subject|2|||
143357966|NCT02846558|516854534|FG000|Overall Study|Lost to Follow-up|2|||
143357967|NCT02846558|516854535|FG001|Overall Study|Lost to Follow-up|0|||
143357968|NCT02846558|516854536|FG002|Overall Study|Lost to Follow-up|0|||
143357969|NCT02846558|516854537|FG003|Overall Study|Lost to Follow-up|0|||
143357970|NCT04445155|516854538|FG000|Overall Study|Lost to Follow-up|11|||
143357971|NCT04445155|516854539|FG001|Overall Study|Lost to Follow-up|2|||
143357972|NCT04445155|516854540|FG002|Overall Study|Lost to Follow-up|3|||
143357973|NCT04445155|516854541|FG003|Overall Study|Lost to Follow-up|0|||
143357974|NCT04445155|516854538|FG000|Overall Study|Withdrawal by Subject|8|||
143357975|NCT04445155|516854539|FG001|Overall Study|Withdrawal by Subject|0|||
143357976|NCT04445155|516854540|FG002|Overall Study|Withdrawal by Subject|0|||
143357977|NCT04445155|516854541|FG003|Overall Study|Withdrawal by Subject|0|||
143357978|NCT04445155|516854538|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
143357979|NCT04445155|516854539|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
143357980|NCT04445155|516854540|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
143357981|NCT04445155|516854541|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
143357982|NCT04445155|516854538|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
143357983|NCT04445155|516854539|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
143357984|NCT04445155|516854540|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
143357985|NCT04445155|516854541|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
143357986|NCT01274338|516856073|FG000|Overall Study|Lack of Efficacy|72|||
143357987|NCT01274338|516856074|FG001|Overall Study|Lack of Efficacy|108|||
143357988|NCT01274338|516856075|FG002|Overall Study|Lack of Efficacy|116|||
143357989|NCT01274338|516856076|FG003|Overall Study|Lack of Efficacy|0|||
143357990|NCT01274338|516856077|FG004|Overall Study|Lack of Efficacy|0|||
143357991|NCT01274338|516856078|FG005|Overall Study|Lack of Efficacy|0|||
143357992|NCT01274338|516856073|FG000|Overall Study|Adverse Event|272|||
143357993|NCT01274338|516856074|FG001|Overall Study|Adverse Event|105|||
143357994|NCT01274338|516856075|FG002|Overall Study|Adverse Event|180|||
143357995|NCT01274338|516856076|FG003|Overall Study|Adverse Event|1|||
143357996|NCT01274338|516856077|FG004|Overall Study|Adverse Event|0|||
143357997|NCT01274338|516856078|FG005|Overall Study|Adverse Event|0|||
143357998|NCT01274338|516856073|FG000|Overall Study|Death|8|||
143357999|NCT01274338|516856074|FG001|Overall Study|Death|1|||
143358000|NCT01274338|516856075|FG002|Overall Study|Death|0|||
143358001|NCT01274338|516856076|FG003|Overall Study|Death|0|||
143358002|NCT01274338|516856077|FG004|Overall Study|Death|0|||
143358003|NCT01274338|516856078|FG005|Overall Study|Death|0|||
143358004|NCT01274338|516856073|FG000|Overall Study|Withdrawal by Subject|27|||
143358005|NCT01274338|516856074|FG001|Overall Study|Withdrawal by Subject|99|||
143358006|NCT01274338|516856075|FG002|Overall Study|Withdrawal by Subject|17|||
143358007|NCT01274338|516856076|FG003|Overall Study|Withdrawal by Subject|0|||
143358008|NCT01274338|516856077|FG004|Overall Study|Withdrawal by Subject|0|||
143230653|NCT00633477|516395438|FG000|Overall Study|Death|1|||
143230654|NCT00633477|516395439|FG001|Overall Study|Death|0|||
143230655|NCT00633477|516395438|FG000|Overall Study|Randomized but not treated|1|||
143230656|NCT00633477|516395439|FG001|Overall Study|Randomized but not treated|0|||
143230657|NCT00770653|516395443|FG000|Overall Study|Adverse Event|13|||
143230658|NCT00770653|516395444|FG001|Overall Study|Adverse Event|5|||
143230659|NCT00770653|516395443|FG000|Overall Study|Protocol Violation|8|||
143230660|NCT00770653|516395444|FG001|Overall Study|Protocol Violation|6|||
143230661|NCT00770653|516395443|FG000|Overall Study|Withdrawal by Subject|4|||
143230662|NCT00770653|516395444|FG001|Overall Study|Withdrawal by Subject|7|||
143230663|NCT00770653|516395443|FG000|Overall Study|Lack of Compliance|1|||
143230664|NCT00770653|516395444|FG001|Overall Study|Lack of Compliance|4|||
143230665|NCT00770653|516395443|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
143230666|NCT00770653|516395444|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
143230667|NCT00770653|516395443|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
143230668|NCT00770653|516395444|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
143230669|NCT00770653|516395443|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
143230670|NCT00770653|516395444|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
143230671|NCT00770653|516395443|FG000|Overall Study|Lost to Follow-up|1|||
143230672|NCT00770653|516395444|FG001|Overall Study|Lost to Follow-up|2|||
143230673|NCT00770653|516395443|FG000|Overall Study|Physician Decision|1|||
143230674|NCT00770653|516395444|FG001|Overall Study|Physician Decision|0|||
143230675|NCT00179621|516395446|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
143230676|NCT00179621|516395447|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
143230677|NCT00179621|516395448|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
143230678|NCT00179621|516395449|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
143230679|NCT00179621|516395446|FG000|Double-Blind Period|Adverse Event|2|||
143230680|NCT00179621|516395447|FG001|Double-Blind Period|Adverse Event|7|||
143230681|NCT00179621|516395448|FG002|Double-Blind Period|Adverse Event|4|||
143230682|NCT00179621|516395449|FG003|Double-Blind Period|Adverse Event|0|||
143230683|NCT00179621|516395446|FG000|Double-Blind Period|Withdrawal by Subject|2|||
143230684|NCT00179621|516395447|FG001|Double-Blind Period|Withdrawal by Subject|1|||
143230685|NCT00179621|516395448|FG002|Double-Blind Period|Withdrawal by Subject|3|||
143230686|NCT00179621|516395449|FG003|Double-Blind Period|Withdrawal by Subject|0|||
143230687|NCT00179621|516395446|FG000|Double-Blind Period|Death|0|||
143230688|NCT00179621|516395447|FG001|Double-Blind Period|Death|1|||
143230689|NCT00179621|516395448|FG002|Double-Blind Period|Death|2|||
143230690|NCT00179621|516395449|FG003|Double-Blind Period|Death|0|||
143230691|NCT00179621|516395446|FG000|Double-Blind Period|Protocol Violation|1|||
143230692|NCT00179621|516395447|FG001|Double-Blind Period|Protocol Violation|0|||
143230693|NCT00179621|516395448|FG002|Double-Blind Period|Protocol Violation|0|||
143230694|NCT00179621|516395449|FG003|Double-Blind Period|Protocol Violation|0|||
143230695|NCT00179621|516395446|FG000|Double-Blind Period|Other|0|||
143230696|NCT00179621|516395447|FG001|Double-Blind Period|Other|2|||
143230697|NCT00179621|516395448|FG002|Double-Blind Period|Other|2|||
143230698|NCT00179621|516395449|FG003|Double-Blind Period|Other|0|||
143129898|NCT01914393|516021980|FG001|Overall Study|no reason given|8|||
143230699|NCT00179621|516395446|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
143230700|NCT00179621|516395447|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
143230701|NCT00179621|516395448|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
143230702|NCT00179621|516395449|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
143230703|NCT00179621|516395446|FG000|Open-Label Period|Adverse Event|0|||
143230704|NCT00179621|516395447|FG001|Open-Label Period|Adverse Event|6|||
143230705|NCT00179621|516395448|FG002|Open-Label Period|Adverse Event|5|||
143230706|NCT00179621|516395449|FG003|Open-Label Period|Adverse Event|6|||
143230707|NCT00179621|516395446|FG000|Open-Label Period|Withdrawal by Subject|0|||
143129899|NCT01914393|516021981|FG002|Overall Study|no reason given|16|||
143129900|NCT01914393|516021979|FG000|Overall Study|Adverse Event|29|||
143129901|NCT01914393|516021980|FG001|Overall Study|Adverse Event|18|||
143129902|NCT01914393|516021981|FG002|Overall Study|Adverse Event|31|||
143129903|NCT01914393|516021979|FG000|Overall Study|Withdrawal by Subject|38|||
143129904|NCT01914393|516021980|FG001|Overall Study|Withdrawal by Subject|20|||
143129905|NCT01914393|516021981|FG002|Overall Study|Withdrawal by Subject|47|||
143230708|NCT00179621|516395447|FG001|Open-Label Period|Withdrawal by Subject|2|||
143230709|NCT00179621|516395448|FG002|Open-Label Period|Withdrawal by Subject|2|||
143129906|NCT01914393|516021979|FG000|Overall Study|Lost to Follow-up|12|||
143129907|NCT01914393|516021980|FG001|Overall Study|Lost to Follow-up|6|||
143129908|NCT01914393|516021981|FG002|Overall Study|Lost to Follow-up|19|||
143129909|NCT01914393|516021979|FG000|Overall Study|subject never dosed|0|||
143129910|NCT01914393|516021980|FG001|Overall Study|subject never dosed|0|||
143230710|NCT00179621|516395449|FG003|Open-Label Period|Withdrawal by Subject|2|||
143230711|NCT00179621|516395446|FG000|Open-Label Period|Death|0|||
143230712|NCT00179621|516395447|FG001|Open-Label Period|Death|0|||
143230713|NCT00179621|516395448|FG002|Open-Label Period|Death|1|||
143230714|NCT00179621|516395449|FG003|Open-Label Period|Death|2|||
143230715|NCT00179621|516395446|FG000|Open-Label Period|Other|0|||
143230716|NCT00179621|516395447|FG001|Open-Label Period|Other|1|||
143230717|NCT00179621|516395448|FG002|Open-Label Period|Other|1|||
143230718|NCT00179621|516395449|FG003|Open-Label Period|Other|2|||
143129911|NCT01914393|516021981|FG002|Overall Study|subject never dosed|1|||
143129912|NCT01111565|516021982|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
143129913|NCT01111565|516021983|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
143129914|NCT01111565|516021984|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
143129915|NCT01111565|516021985|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
143129916|NCT01111565|516021986|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
143129917|NCT01111565|516021982|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
143129918|NCT01111565|516021983|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
143129919|NCT01111565|516021984|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
143129920|NCT01111565|516021985|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
143129921|NCT01111565|516021986|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
143129922|NCT01111565|516021982|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
143358009|NCT01274338|516856078|FG005|Overall Study|Withdrawal by Subject|0|||
143358010|NCT01274338|516856073|FG000|Overall Study|Did not start treatment|8|||
143358011|NCT01274338|516856074|FG001|Overall Study|Did not start treatment|116|||
143358012|NCT01274338|516856075|FG002|Overall Study|Did not start treatment|7|||
143358013|NCT01274338|516856076|FG003|Overall Study|Did not start treatment|0|||
143358014|NCT01274338|516856077|FG004|Overall Study|Did not start treatment|0|||
143358015|NCT01274338|516856078|FG005|Overall Study|Did not start treatment|0|||
143358016|NCT01274338|516856073|FG000|Overall Study|Alternative therapy|0|||
143358017|NCT01274338|516856074|FG001|Overall Study|Alternative therapy|1|||
143358018|NCT01274338|516856075|FG002|Overall Study|Alternative therapy|0|||
143358019|NCT01274338|516856076|FG003|Overall Study|Alternative therapy|0|||
143358020|NCT01274338|516856077|FG004|Overall Study|Alternative therapy|0|||
143358021|NCT01274338|516856078|FG005|Overall Study|Alternative therapy|0|||
143358022|NCT01274338|516856073|FG000|Overall Study|Other complicating diseases|0|||
143358023|NCT01274338|516856074|FG001|Overall Study|Other complicating diseases|3|||
143358024|NCT01274338|516856075|FG002|Overall Study|Other complicating diseases|1|||
143358025|NCT01274338|516856076|FG003|Overall Study|Other complicating diseases|0|||
143358026|NCT01274338|516856077|FG004|Overall Study|Other complicating diseases|0|||
143358027|NCT01274338|516856078|FG005|Overall Study|Other complicating diseases|0|||
143358028|NCT01274338|516856073|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
143358029|NCT01274338|516856074|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
143358030|NCT01274338|516856075|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
143358031|NCT01274338|516856076|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
143358032|NCT01274338|516856077|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
143358033|NCT01274338|516856078|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
143358034|NCT01274338|516856073|FG000|Overall Study|Pregnancy|0|||
143358035|NCT01274338|516856074|FG001|Overall Study|Pregnancy|0|||
143358036|NCT01274338|516856075|FG002|Overall Study|Pregnancy|1|||
143358037|NCT01274338|516856076|FG003|Overall Study|Pregnancy|0|||
143358038|NCT01274338|516856077|FG004|Overall Study|Pregnancy|0|||
143358039|NCT01274338|516856078|FG005|Overall Study|Pregnancy|0|||
143358040|NCT01274338|516856073|FG000|Overall Study|Reason not reported|12|||
143358041|NCT01274338|516856074|FG001|Overall Study|Reason not reported|21|||
143358042|NCT01274338|516856075|FG002|Overall Study|Reason not reported|3|||
143358043|NCT01274338|516856076|FG003|Overall Study|Reason not reported|0|||
143358044|NCT01274338|516856077|FG004|Overall Study|Reason not reported|1|||
143358045|NCT01274338|516856078|FG005|Overall Study|Reason not reported|0|||
143358046|NCT03280563|516856080|FG000|Stage 1|Death|2|||
143358047|NCT03280563|516856081|FG001|Stage 1|Death|1|||
143358048|NCT03280563|516856082|FG002|Stage 1|Death|0|||
143358049|NCT03280563|516856083|FG003|Stage 1|Death|0|||
143358050|NCT03280563|516856084|FG004|Stage 1|Death|0|||
143358051|NCT03280563|516856085|FG005|Stage 1|Death|3|||
143358052|NCT03280563|516856086|FG006|Stage 1|Death|0|||
143358053|NCT03280563|516856087|FG007|Stage 1|Death|0|||
143358054|NCT03280563|516856088|FG008|Stage 1|Death|0|||
143358055|NCT03280563|516856080|FG000|Stage 1|Study Ended by Sponsor|0|||
143358056|NCT03280563|516856081|FG001|Stage 1|Study Ended by Sponsor|0|||
143358057|NCT03280563|516856082|FG002|Stage 1|Study Ended by Sponsor|1|||
143358058|NCT03280563|516856083|FG003|Stage 1|Study Ended by Sponsor|0|||
143358059|NCT03280563|516856084|FG004|Stage 1|Study Ended by Sponsor|0|||
143129923|NCT01111565|516021983|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
143129924|NCT01111565|516021984|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
143129925|NCT01111565|516021985|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
143358060|NCT03280563|516856085|FG005|Stage 1|Study Ended by Sponsor|1|||
143358061|NCT03280563|516856086|FG006|Stage 1|Study Ended by Sponsor|0|||
143358062|NCT03280563|516856087|FG007|Stage 1|Study Ended by Sponsor|0|||
143358063|NCT03280563|516856088|FG008|Stage 1|Study Ended by Sponsor|0|||
143358064|NCT03280563|516856080|FG000|Stage 1|Withdrawal by Subject|5|||
143358065|NCT03280563|516856081|FG001|Stage 1|Withdrawal by Subject|1|||
143358066|NCT03280563|516856082|FG002|Stage 1|Withdrawal by Subject|2|||
143358067|NCT03280563|516856083|FG003|Stage 1|Withdrawal by Subject|0|||
143358068|NCT03280563|516856084|FG004|Stage 1|Withdrawal by Subject|0|||
143358069|NCT03280563|516856085|FG005|Stage 1|Withdrawal by Subject|2|||
143358070|NCT03280563|516856086|FG006|Stage 1|Withdrawal by Subject|0|||
143358071|NCT03280563|516856087|FG007|Stage 1|Withdrawal by Subject|0|||
143358072|NCT03280563|516856088|FG008|Stage 1|Withdrawal by Subject|0|||
143129926|NCT01111565|516021986|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
143129927|NCT01111565|516021982|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
143129928|NCT01111565|516021983|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
143129929|NCT01111565|516021984|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
143129930|NCT01111565|516021985|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
143230719|NCT00262860|516395454|FG000|Overall Study|Adverse Event|2|||
143230720|NCT03598036|516395458|FG000|Overall Study|Withdrawal by Subject|1|||
143230721|NCT03598036|516395459|FG001|Overall Study|Withdrawal by Subject|0|||
143230722|NCT04607668|516395465|FG000|Overall Study|Death|49|||
143230723|NCT04607668|516395466|FG001|Overall Study|Death|26|||
143230724|NCT04607668|516395465|FG000|Overall Study|Lost to Follow-up|3|||
143230725|NCT04607668|516395466|FG001|Overall Study|Lost to Follow-up|4|||
143230726|NCT04607668|516395465|FG000|Overall Study|Study terminated by Sponsor|92|||
143230727|NCT04607668|516395466|FG001|Overall Study|Study terminated by Sponsor|114|||
143230728|NCT04607668|516395465|FG000|Overall Study|Withdrawal by Subject|12|||
143230729|NCT04607668|516395466|FG001|Overall Study|Withdrawal by Subject|11|||
143230730|NCT04607668|516395465|FG000|Overall Study|Other, unspecified|8|||
143230731|NCT04607668|516395466|FG001|Overall Study|Other, unspecified|7|||
143230732|NCT04199351|516395467|FG000|Overall Study|Decision by sponsor|0|||
143230733|NCT04199351|516395468|FG001|Overall Study|Decision by sponsor|0|||
143230734|NCT04199351|516395469|FG002|Overall Study|Decision by sponsor|0|||
143230735|NCT04199351|516395470|FG003|Overall Study|Decision by sponsor|2|||
143230736|NCT04199351|516395471|FG004|Overall Study|Decision by sponsor|0|||
143230737|NCT04199351|516395472|FG005|Overall Study|Decision by sponsor|0|||
143230738|NCT04199351|516395473|FG006|Overall Study|Decision by sponsor|0|||
143230739|NCT04199351|516395474|FG007|Overall Study|Decision by sponsor|0|||
143230740|NCT04199351|516395475|FG008|Overall Study|Decision by sponsor|0|||
143230741|NCT04199351|516395476|FG009|Overall Study|Decision by sponsor|6|||
143230742|NCT04199351|516395467|FG000|Overall Study|Lost to Follow-up|0|||
143230743|NCT04199351|516395468|FG001|Overall Study|Lost to Follow-up|0|||
143230744|NCT04199351|516395469|FG002|Overall Study|Lost to Follow-up|1|||
143230745|NCT04199351|516395470|FG003|Overall Study|Lost to Follow-up|0|||
143230746|NCT04199351|516395471|FG004|Overall Study|Lost to Follow-up|0|||
143230747|NCT04199351|516395472|FG005|Overall Study|Lost to Follow-up|1|||
143230748|NCT04199351|516395473|FG006|Overall Study|Lost to Follow-up|0|||
143230749|NCT04199351|516395474|FG007|Overall Study|Lost to Follow-up|0|||
143230750|NCT04199351|516395475|FG008|Overall Study|Lost to Follow-up|0|||
143230751|NCT04199351|516395476|FG009|Overall Study|Lost to Follow-up|0|||
143230752|NCT04199351|516395467|FG000|Overall Study|Withdrawal by Subject|0|||
143230753|NCT04199351|516395468|FG001|Overall Study|Withdrawal by Subject|1|||
143230754|NCT04199351|516395469|FG002|Overall Study|Withdrawal by Subject|0|||
143230755|NCT04199351|516395470|FG003|Overall Study|Withdrawal by Subject|0|||
143230756|NCT04199351|516395471|FG004|Overall Study|Withdrawal by Subject|1|||
143230757|NCT04199351|516395472|FG005|Overall Study|Withdrawal by Subject|4|||
143230758|NCT04199351|516395473|FG006|Overall Study|Withdrawal by Subject|2|||
143230759|NCT04199351|516395474|FG007|Overall Study|Withdrawal by Subject|0|||
143230760|NCT04199351|516395475|FG008|Overall Study|Withdrawal by Subject|3|||
143230761|NCT04199351|516395476|FG009|Overall Study|Withdrawal by Subject|0|||
143230762|NCT01838694|516395477|FG000|Overall Study|Adverse Event|0|||
143230763|NCT01838694|516395478|FG001|Overall Study|Adverse Event|1|||
143129931|NCT01111565|516021986|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
143129932|NCT01111565|516021982|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
143129933|NCT01111565|516021983|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
143129934|NCT01111565|516021984|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
143129935|NCT01111565|516021985|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
143129936|NCT01111565|516021986|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
143129937|NCT01111565|516021982|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
143129938|NCT01111565|516021983|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
143129939|NCT01111565|516021984|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
143129940|NCT01111565|516021985|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
143129941|NCT01111565|516021986|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
143129942|NCT01111565|516021982|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
143129943|NCT01111565|516021983|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
143129944|NCT01111565|516021984|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
143129945|NCT01111565|516021985|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
143129946|NCT01111565|516021986|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
143129947|NCT01111565|516021982|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
143230764|NCT00672555|516395479|FG000|Overall Study|Lost to Follow-up|4|||
143230765|NCT00672555|516395479|FG000|Overall Study|Did not want to answer questionnaire|2|||
143230766|NCT05546476|516395484|FG000|Period 1: Part A|Adverse Event|2|||
143230767|NCT05546476|516395485|FG001|Period 1: Part A|Adverse Event|0|||
143230768|NCT05546476|516395486|FG002|Period 1: Part A|Adverse Event|0|||
143230769|NCT05546476|516395487|FG003|Period 1: Part A|Adverse Event|1|||
143230770|NCT05546476|516395484|FG000|Period 1: Part A|Death|4|||
143230771|NCT05546476|516395485|FG001|Period 1: Part A|Death|4|||
143230772|NCT05546476|516395486|FG002|Period 1: Part A|Death|5|||
143230773|NCT05546476|516395487|FG003|Period 1: Part A|Death|6|||
143230774|NCT05546476|516395484|FG000|Period 1: Part A|Lack of Efficacy|0|||
143230775|NCT05546476|516395485|FG001|Period 1: Part A|Lack of Efficacy|0|||
143230776|NCT05546476|516395486|FG002|Period 1: Part A|Lack of Efficacy|0|||
143230777|NCT05546476|516395487|FG003|Period 1: Part A|Lack of Efficacy|1|||
143230778|NCT05546476|516395484|FG000|Period 1: Part A|Lost to Follow-up|0|||
143230779|NCT05546476|516395485|FG001|Period 1: Part A|Lost to Follow-up|0|||
143230780|NCT05546476|516395486|FG002|Period 1: Part A|Lost to Follow-up|0|||
143230781|NCT05546476|516395487|FG003|Period 1: Part A|Lost to Follow-up|1|||
143230782|NCT05546476|516395484|FG000|Period 1: Part A|Physician Decision|1|||
143230783|NCT05546476|516395485|FG001|Period 1: Part A|Physician Decision|0|||
143230784|NCT05546476|516395486|FG002|Period 1: Part A|Physician Decision|0|||
143230785|NCT05546476|516395487|FG003|Period 1: Part A|Physician Decision|0|||
143230786|NCT05546476|516395484|FG000|Period 1: Part A|Progressive disease|3|||
143230787|NCT05546476|516395485|FG001|Period 1: Part A|Progressive disease|5|||
143230788|NCT05546476|516395486|FG002|Period 1: Part A|Progressive disease|0|||
143230789|NCT05546476|516395487|FG003|Period 1: Part A|Progressive disease|1|||
143230790|NCT05546476|516395484|FG000|Period 1: Part A|Withdrawal by Subject|1|||
143230791|NCT05546476|516395485|FG001|Period 1: Part A|Withdrawal by Subject|1|||
143230792|NCT05546476|516395486|FG002|Period 1: Part A|Withdrawal by Subject|1|||
143230793|NCT05546476|516395487|FG003|Period 1: Part A|Withdrawal by Subject|2|||
143230794|NCT05546476|516395484|FG000|Period 1: Part A|Global deterioration of health status|2|||
143230795|NCT05546476|516395485|FG001|Period 1: Part A|Global deterioration of health status|2|||
143230796|NCT05546476|516395486|FG002|Period 1: Part A|Global deterioration of health status|1|||
143230797|NCT05546476|516395487|FG003|Period 1: Part A|Global deterioration of health status|4|||
143230798|NCT05546476|516395484|FG000|Period 1: Part A|Other: Unspecified|0|||
143230799|NCT05546476|516395485|FG001|Period 1: Part A|Other: Unspecified|2|||
143230800|NCT05546476|516395486|FG002|Period 1: Part A|Other: Unspecified|0|||
143230801|NCT05546476|516395487|FG003|Period 1: Part A|Other: Unspecified|0|||
143230802|NCT05546476|516395484|FG000|Period 2: Part B|Ongoing|26|||
143230803|NCT05546476|516395485|FG001|Period 2: Part B|Ongoing|27|||
143230804|NCT05546476|516395486|FG002|Period 2: Part B|Ongoing|35|||
143230805|NCT05546476|516395487|FG003|Period 2: Part B|Ongoing|29|||
143230806|NCT02814916|516395491|FG000|Overall Study|Withdrawal of consent|0|||
143230807|NCT02814916|516395492|FG001|Overall Study|Withdrawal of consent|2|||
143230808|NCT02814916|516395493|FG002|Overall Study|Withdrawal of consent|0|||
143230809|NCT02814916|516395491|FG000|Overall Study|Lost to Follow-up|0|||
143230810|NCT02814916|516395492|FG001|Overall Study|Lost to Follow-up|1|||
143230811|NCT02814916|516395493|FG002|Overall Study|Lost to Follow-up|0|||
143230812|NCT02814916|516395491|FG000|Overall Study|Other, not specified|0|||
143230813|NCT02814916|516395492|FG001|Overall Study|Other, not specified|1|||
143230814|NCT02814916|516395493|FG002|Overall Study|Other, not specified|0|||
143230815|NCT04890652|516395500|FG000|Overall Study|Withdrawal by Subject|2|||
143230816|NCT05543265|516395501|FG000|Overall Study|Lost to Follow-up|3|||
143230817|NCT05543265|516395502|FG001|Overall Study|Lost to Follow-up|3|||
143230818|NCT05543265|516395501|FG000|Overall Study|Withdrawal by Subject|0|||
143230819|NCT05543265|516395502|FG001|Overall Study|Withdrawal by Subject|1|||
143230820|NCT04750824|516395506|FG000|Overall Study|Toxicity/intolerability|3|||
143230821|NCT04750824|516395507|FG001|Overall Study|Toxicity/intolerability|1|||
143230822|NCT04750824|516395506|FG000|Overall Study|Death|1|||
143230823|NCT04750824|516395507|FG001|Overall Study|Death|3|||
143230824|NCT04750824|516395506|FG000|Overall Study|Scheduled duration of therapy complete|1|||
143230825|NCT04750824|516395507|FG001|Overall Study|Scheduled duration of therapy complete|9|||
143129948|NCT01111565|516021983|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
143230826|NCT04750824|516395506|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
143230827|NCT04750824|516395507|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
143230828|NCT01706458|516395510|FG000|Overall Study|Physician Decision|3|||
143129949|NCT01111565|516021984|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
143129950|NCT01111565|516021985|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
143129951|NCT01111565|516021986|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
143129952|NCT01111565|516021982|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
143230829|NCT01706458|516395511|FG001|Overall Study|Physician Decision|4|||
143230830|NCT03035032|516395512|FG000|Overall Study|Adverse Event|2|||
143230831|NCT03035032|516395512|FG000|Overall Study|Death|9|||
143230832|NCT03035032|516395512|FG000|Overall Study|Lost to Follow-up|1|||
143230833|NCT03035032|516395512|FG000|Overall Study|Progressive Disease|22|||
143230834|NCT03035032|516395512|FG000|Overall Study|Protocol Violation|2|||
143230835|NCT03035032|516395512|FG000|Overall Study|Withdrawal by Subject|2|||
143230836|NCT03035032|516395512|FG000|Overall Study|Physician Decision|5|||
143230837|NCT00836589|516395513|FG000|Overall Study|Lost to Follow-up|246|||
143230838|NCT00836589|516395513|FG000|Overall Study|Death|429|||
143230839|NCT00836589|516395513|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
143230840|NCT01018030|516395516|FG000|Overall Study|Adverse Event|10|||
143230841|NCT01018030|516395517|FG001|Overall Study|Adverse Event|5|||
143230842|NCT01018030|516395518|FG002|Overall Study|Adverse Event|5|||
143230843|NCT01018030|516395516|FG000|Overall Study|Withdrawal by Subject|2|||
143230844|NCT01018030|516395517|FG001|Overall Study|Withdrawal by Subject|2|||
143230845|NCT01018030|516395518|FG002|Overall Study|Withdrawal by Subject|4|||
143230846|NCT01018030|516395516|FG000|Overall Study|Lost to Follow-up|2|||
143230847|NCT01018030|516395517|FG001|Overall Study|Lost to Follow-up|0|||
143230848|NCT01018030|516395518|FG002|Overall Study|Lost to Follow-up|3|||
143230849|NCT01018030|516395516|FG000|Overall Study|Protocol Violation|2|||
143230850|NCT01018030|516395517|FG001|Overall Study|Protocol Violation|1|||
143129953|NCT01111565|516021983|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
143129954|NCT01111565|516021984|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
143129955|NCT01111565|516021985|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
143129956|NCT01111565|516021986|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
143129957|NCT01111565|516021982|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
143129958|NCT01111565|516021983|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
143129959|NCT01111565|516021984|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
143129960|NCT01111565|516021985|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
143129961|NCT01111565|516021986|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
143129962|NCT01111565|516021982|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
143129963|NCT01111565|516021983|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
143129964|NCT01111565|516021984|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
143129965|NCT01111565|516021985|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
143129966|NCT01111565|516021986|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
143129967|NCT01111565|516021982|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
143129968|NCT01111565|516021983|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
143129969|NCT01111565|516021984|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
143129970|NCT01111565|516021985|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
143129971|NCT01111565|516021986|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
143230851|NCT01018030|516395518|FG002|Overall Study|Protocol Violation|0|||
143230852|NCT01018030|516395516|FG000|Overall Study|Physician Decision|1|||
143230853|NCT01018030|516395517|FG001|Overall Study|Physician Decision|0|||
143230854|NCT01018030|516395518|FG002|Overall Study|Physician Decision|1|||
143230855|NCT01018030|516395516|FG000|Overall Study|Lack of Efficacy|1|||
143230856|NCT01018030|516395517|FG001|Overall Study|Lack of Efficacy|0|||
143129972|NCT02824224|516021987|FG000|Overall Study|Discontinued, IUS expulsion|0|||
143129973|NCT02824224|516021988|FG001|Overall Study|Discontinued, IUS expulsion|1|||
143129974|NCT02824224|516021987|FG000|Overall Study|Did not show up for allocation visit|2|||
143230857|NCT01018030|516395518|FG002|Overall Study|Lack of Efficacy|0|||
143230858|NCT01018030|516395516|FG000|Overall Study|Did Not Receive Study Drug|1|||
143358073|NCT03280563|516856080|FG000|Stage 1|Reason Not Specified|0|||
143358074|NCT03280563|516856081|FG001|Stage 1|Reason Not Specified|0|||
143358075|NCT03280563|516856082|FG002|Stage 1|Reason Not Specified|0|||
143358076|NCT03280563|516856083|FG003|Stage 1|Reason Not Specified|0|||
143358077|NCT03280563|516856084|FG004|Stage 1|Reason Not Specified|0|||
143358078|NCT03280563|516856085|FG005|Stage 1|Reason Not Specified|1|||
143358079|NCT03280563|516856086|FG006|Stage 1|Reason Not Specified|0|||
143358080|NCT03280563|516856087|FG007|Stage 1|Reason Not Specified|0|||
143358081|NCT03280563|516856088|FG008|Stage 1|Reason Not Specified|0|||
143358082|NCT03280563|516856080|FG000|Stage 1|Physician Decision|0|||
143358083|NCT03280563|516856081|FG001|Stage 1|Physician Decision|1|||
143358084|NCT03280563|516856082|FG002|Stage 1|Physician Decision|0|||
143358085|NCT03280563|516856083|FG003|Stage 1|Physician Decision|0|||
143358086|NCT03280563|516856084|FG004|Stage 1|Physician Decision|0|||
143358087|NCT03280563|516856085|FG005|Stage 1|Physician Decision|0|||
143358088|NCT03280563|516856086|FG006|Stage 1|Physician Decision|0|||
143358089|NCT03280563|516856087|FG007|Stage 1|Physician Decision|0|||
143358090|NCT03280563|516856088|FG008|Stage 1|Physician Decision|0|||
143358091|NCT03280563|516856080|FG000|Stage 2|Death|0|||
143358092|NCT03280563|516856081|FG001|Stage 2|Death|0|||
143358093|NCT03280563|516856082|FG002|Stage 2|Death|0|||
143358094|NCT03280563|516856083|FG003|Stage 2|Death|0|||
143358095|NCT03280563|516856084|FG004|Stage 2|Death|0|||
143358096|NCT03280563|516856085|FG005|Stage 2|Death|0|||
143358097|NCT03280563|516856086|FG006|Stage 2|Death|0|||
143358098|NCT03280563|516856087|FG007|Stage 2|Death|1|||
143358099|NCT03280563|516856088|FG008|Stage 2|Death|0|||
143358100|NCT03280563|516856080|FG000|Stage 2|Progressive Disease|0|||
143358101|NCT03280563|516856081|FG001|Stage 2|Progressive Disease|0|||
143358102|NCT03280563|516856082|FG002|Stage 2|Progressive Disease|0|||
143358103|NCT03280563|516856083|FG003|Stage 2|Progressive Disease|0|||
143358104|NCT03280563|516856084|FG004|Stage 2|Progressive Disease|0|||
143358105|NCT03280563|516856085|FG005|Stage 2|Progressive Disease|0|||
143358106|NCT03280563|516856086|FG006|Stage 2|Progressive Disease|2|||
143358107|NCT03280563|516856087|FG007|Stage 2|Progressive Disease|0|||
143358108|NCT03280563|516856088|FG008|Stage 2|Progressive Disease|0|||
143129975|NCT02824224|516021988|FG001|Overall Study|Did not show up for allocation visit|0|||
143129976|NCT00103662|516021989|FG000|Overall Study|Entered Rescue Procedure|0|||
143129977|NCT00103662|516021990|FG001|Overall Study|Entered Rescue Procedure|7|||
143129978|NCT00103662|516021989|FG000|Overall Study|Death|7|||
143129979|NCT00103662|516021990|FG001|Overall Study|Death|7|||
143129980|NCT00103662|516021989|FG000|Overall Study|Elective Withdrawal|5|||
143129981|NCT00103662|516021990|FG001|Overall Study|Elective Withdrawal|5|||
143129982|NCT00103662|516021989|FG000|Overall Study|Lost to Follow-up|0|||
143129983|NCT00103662|516021990|FG001|Overall Study|Lost to Follow-up|1|||
143129984|NCT00103662|516021989|FG000|Overall Study|Other|6|||
143129985|NCT00103662|516021990|FG001|Overall Study|Other|9|||
143129986|NCT00103662|516021989|FG000|Overall Study|Failed mobilization|0|||
143129987|NCT00103662|516021990|FG001|Overall Study|Failed mobilization|4|||
143129988|NCT00103662|516021989|FG000|Overall Study|Intercurrent illness|1|||
143129989|NCT00103662|516021990|FG001|Overall Study|Intercurrent illness|0|||
143129990|NCT03334188|516021993|FG000|Overall Study|Withdrawal by Subject|0|||
143129991|NCT03334188|516021994|FG001|Overall Study|Withdrawal by Subject|1|||
143129992|NCT03334188|516021993|FG000|Overall Study|Death|1|||
143129993|NCT03334188|516021994|FG001|Overall Study|Death|0|||
143129994|NCT03334188|516021993|FG000|Overall Study|Never had qualifying clinic visit|7|||
143129995|NCT03334188|516021994|FG001|Overall Study|Never had qualifying clinic visit|7|||
143129996|NCT03373760|516021995|FG000|Overall Study|Adverse Event|8|||
143129997|NCT03373760|516021995|FG000|Overall Study|Disease Progression|46|||
143129998|NCT03373760|516021995|FG000|Overall Study|Death|4|||
143129999|NCT03442088|516021998|FG000|Overall Study|Adverse Event|1|||
143130000|NCT03442088|516021998|FG000|Overall Study|Lack of Efficacy|2|||
143130001|NCT03442088|516021998|FG000|Overall Study|Lost to Follow-up|2|||
143130002|NCT00105989|516021999|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
143130003|NCT00105989|516022000|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
143130004|NCT00105989|516021999|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
143130005|NCT00105989|516022000|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
143130006|NCT00105989|516021999|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
143130007|NCT00105989|516022000|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
143130008|NCT00105989|516021999|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
143130009|NCT00105989|516022000|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
143130010|NCT00105989|516021999|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
143130011|NCT00105989|516022000|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
143130012|NCT00105989|516021999|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
143130013|NCT00105989|516022000|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
143130014|NCT00105989|516021999|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
143130015|NCT00105989|516022000|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
143130016|NCT00105989|516021999|FG000|Acute - Open Label: Week 0-10|Death|1|||
143130017|NCT00105989|516022000|FG001|Acute - Open Label: Week 0-10|Death|0|||
143130018|NCT00105989|516021999|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
143130019|NCT00105989|516022000|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
143130020|NCT00105989|516021999|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
143130021|NCT00105989|516022000|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
143130022|NCT00105989|516021999|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
143130023|NCT00105989|516022000|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
143130024|NCT00105989|516021999|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
143130025|NCT00105989|516022000|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
143130026|NCT00105989|516021999|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
143130027|NCT00105989|516022000|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
143130028|NCT00105989|516021999|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
143130029|NCT00105989|516022000|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
143130030|NCT00105989|516021999|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
143130031|NCT00105989|516022000|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
143130032|NCT00105989|516021999|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
143130033|NCT00105989|516022000|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
143130034|NCT00105989|516021999|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
143130035|NCT00105989|516022000|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
143130036|NCT00105989|516021999|FG000|Continuation - Open Label:Week 10-34|Death|0|||
143130037|NCT00105989|516022000|FG001|Continuation - Open Label:Week 10-34|Death|0|||
143130038|NCT00105989|516021999|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
143130039|NCT00105989|516022000|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
143130040|NCT00105989|516021999|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
143130041|NCT00105989|516022000|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
143130042|NCT00105989|516021999|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
143130043|NCT00105989|516022000|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
143130044|NCT00105989|516021999|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
143130045|NCT00105989|516022000|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
143130046|NCT00105989|516021999|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
143130047|NCT00105989|516022000|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
143130048|NCT00105989|516021999|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
143130049|NCT00105989|516022000|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
143130050|NCT00105989|516021999|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
143130051|NCT00105989|516022000|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
143130052|NCT00105989|516021999|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
143130053|NCT00105989|516022000|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
143130054|NCT00105989|516021999|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
143130055|NCT00105989|516022000|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
143130056|NCT00105989|516021999|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
143130057|NCT00105989|516022000|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
143130058|NCT00105989|516021999|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
143130059|NCT00105989|516022000|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
143130060|NCT00105989|516021999|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
143130061|NCT00105989|516022000|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
143130062|NCT01001520|516022001|FG000|Medication Period 1|Withdrawal by Subject|2|||
143130063|NCT01001520|516022002|FG001|Medication Period 1|Withdrawal by Subject|2|||
143130064|NCT01001520|516022001|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
143130065|NCT01001520|516022002|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
143130066|NCT01001520|516022001|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
143130067|NCT01001520|516022002|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
143130068|NCT01001520|516022001|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
143130069|NCT01001520|516022002|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
143130070|NCT01001520|516022001|FG000|Washout Period|Withdrawal by Subject|2|||
143130071|NCT01001520|516022002|FG001|Washout Period|Withdrawal by Subject|1|||
143130072|NCT01001520|516022001|FG000|Medication Period 2|Withdrawal by Subject|0|||
143130073|NCT01001520|516022002|FG001|Medication Period 2|Withdrawal by Subject|3|||
143130074|NCT00357877|516022005|FG000|Overall Study|Death|2|||
143130075|NCT00357877|516022006|FG001|Overall Study|Death|1|||
143130076|NCT00357877|516022005|FG000|Overall Study|Lost to Follow-up|20|||
143130077|NCT00357877|516022006|FG001|Overall Study|Lost to Follow-up|23|||
143130078|NCT00357877|516022005|FG000|Overall Study|Withdrawal by Subject|3|||
143130079|NCT00357877|516022006|FG001|Overall Study|Withdrawal by Subject|3|||
143130080|NCT00357877|516022005|FG000|Overall Study|Administrative withdrawal|1|||
143130081|NCT00357877|516022006|FG001|Overall Study|Administrative withdrawal|1|||
143130082|NCT00357877|516022005|FG000|Overall Study|Other|0|||
143130083|NCT00357877|516022006|FG001|Overall Study|Other|2|||
143130084|NCT04668209|516022007|FG000|Overall Study|Withdrawal by Subject|2|||
143130085|NCT04668209|516022008|FG001|Overall Study|Withdrawal by Subject|2|||
143130086|NCT04668209|516022007|FG000|Overall Study|Lost to Follow-up|3|||
143130087|NCT04668209|516022008|FG001|Overall Study|Lost to Follow-up|4|||
143130088|NCT04668209|516022007|FG000|Overall Study|Subject Expired|2|||
143130089|NCT04668209|516022008|FG001|Overall Study|Subject Expired|0|||
143130090|NCT04668209|516022007|FG000|Overall Study|Withdrawn from study|0|||
143130091|NCT04668209|516022008|FG001|Overall Study|Withdrawn from study|1|||
143130092|NCT04668209|516022007|FG000|Overall Study|Adverse Event|0|||
143130093|NCT04668209|516022008|FG001|Overall Study|Adverse Event|1|||
143130094|NCT00613366|516022018|FG000|Overall Study|Withdrawal by Subject|3|||
143130095|NCT00613366|516022019|FG001|Overall Study|Withdrawal by Subject|2|||
143130096|NCT02907463|516022020|FG000|Overall Study|Lost to Follow-up|17|||
143130097|NCT02907463|516022020|FG000|Overall Study|Death|10|||
143130098|NCT02907463|516022020|FG000|Overall Study|Withdrawal by Subject|4|||
143130099|NCT02907463|516022020|FG000|Overall Study|MIS Approach was not used|2|||
143130100|NCT02907463|516022020|FG000|Overall Study|Not Implanted with Study Device|2|||
143130101|NCT02907463|516022020|FG000|Overall Study|Device Explanted|1|||
143130102|NCT02907463|516022020|FG000|Overall Study|Missing Exit Form|1|||
143130103|NCT04878055|516022021|FG000|Overall Study|Patient transferred in another department|0|||
143130104|NCT04878055|516022022|FG001|Overall Study|Patient transferred in another department|2|||
143130105|NCT04878055|516022021|FG000|Overall Study|Physician Decision|1|||
143130106|NCT04878055|516022022|FG001|Overall Study|Physician Decision|1|||
143130107|NCT04878055|516022021|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
143130108|NCT04878055|516022022|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
143130109|NCT04878055|516022021|FG000|Overall Study|Adverse Event|12|||
143130110|NCT04878055|516022022|FG001|Overall Study|Adverse Event|7|||
143130111|NCT04878055|516022021|FG000|Overall Study|Other|5|||
143130112|NCT04878055|516022022|FG001|Overall Study|Other|0|||
143130113|NCT04878055|516022021|FG000|Overall Study|Withdrawal by Subject|7|||
143130114|NCT04878055|516022022|FG001|Overall Study|Withdrawal by Subject|3|||
143130115|NCT04878055|516022021|FG000|Overall Study|Lost to Follow-up|10|||
143130116|NCT04878055|516022022|FG001|Overall Study|Lost to Follow-up|1|||
143130117|NCT05225558|516022028|FG000|Overall Study|Withdrawal by Subject|4|||
143130118|NCT05225558|516022029|FG001|Overall Study|Withdrawal by Subject|3|||
143130119|NCT05225558|516022028|FG000|Overall Study|Adverse Event|1|||
143130120|NCT05225558|516022029|FG001|Overall Study|Adverse Event|0|||
143130121|NCT05225558|516022028|FG000|Overall Study|If the following treatment failure criteria are met during treatment period|1|||
143130122|NCT05225558|516022029|FG001|Overall Study|If the following treatment failure criteria are met during treatment period|2|||
143130123|NCT05225558|516022028|FG000|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|4|||
143130124|NCT05225558|516022029|FG001|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|2|||
143130125|NCT02427841|516022030|FG000|Overall Study|Lack of Efficacy|5|||
143130126|NCT02427841|516022030|FG000|Overall Study|Physician Decision|2|||
143130127|NCT02427841|516022030|FG000|Overall Study|Withdrawal by Subject|1|||
143130128|NCT02592447|516022031|FG000|Overall Study|Lost to Follow-up|1|||
143130129|NCT02592447|516022032|FG001|Overall Study|Lost to Follow-up|0|||
143130130|NCT02592447|516022031|FG000|Overall Study|Ineligible after randomization|1|||
143130131|NCT02592447|516022032|FG001|Overall Study|Ineligible after randomization|0|||
143130132|NCT02592447|516022031|FG000|Overall Study|Withdrawal by Subject|0|||
143130133|NCT02592447|516022032|FG001|Overall Study|Withdrawal by Subject|1|||
143130134|NCT00922116|516022038|FG000|Overall Study|Adverse Event|4|||
143130135|NCT00922116|516022038|FG000|Overall Study|Death|1|||
143130136|NCT00922116|516022038|FG000|Overall Study|Lost to Follow-up|1|||
143130137|NCT00922116|516022038|FG000|Overall Study|Withdrawal by Subject|4|||
143130138|NCT00922116|516022038|FG000|Overall Study|Other|5|||
143130139|NCT02028507|516022039|FG000|Overall Study|Progressive Disease|122|||
143130140|NCT02028507|516022040|FG001|Overall Study|Progressive Disease|90|||
143130141|NCT02028507|516022041|FG002|Overall Study|Progressive Disease|102|||
143130142|NCT02028507|516022042|FG003|Overall Study|Progressive Disease|89|||
143130143|NCT02028507|516022039|FG000|Overall Study|Adverse Event|8|||
143130144|NCT02028507|516022040|FG001|Overall Study|Adverse Event|25|||
143130145|NCT02028507|516022041|FG002|Overall Study|Adverse Event|3|||
143130146|NCT02028507|516022042|FG003|Overall Study|Adverse Event|16|||
143230859|NCT01018030|516395517|FG001|Overall Study|Did Not Receive Study Drug|3|||
143130147|NCT02028507|516022039|FG000|Overall Study|Withdrawal by Subject|6|||
143130148|NCT02028507|516022040|FG001|Overall Study|Withdrawal by Subject|8|||
143130149|NCT02028507|516022041|FG002|Overall Study|Withdrawal by Subject|5|||
143130150|NCT02028507|516022042|FG003|Overall Study|Withdrawal by Subject|9|||
143130151|NCT02028507|516022039|FG000|Overall Study|Protocol Violation|2|||
143130152|NCT02028507|516022040|FG001|Overall Study|Protocol Violation|4|||
143130153|NCT02028507|516022041|FG002|Overall Study|Protocol Violation|1|||
143130154|NCT02028507|516022042|FG003|Overall Study|Protocol Violation|3|||
143130155|NCT02028507|516022039|FG000|Overall Study|Physician Decision|0|||
143130156|NCT02028507|516022040|FG001|Overall Study|Physician Decision|4|||
143130157|NCT02028507|516022041|FG002|Overall Study|Physician Decision|0|||
143130158|NCT02028507|516022042|FG003|Overall Study|Physician Decision|0|||
143130159|NCT02028507|516022039|FG000|Overall Study|Death|1|||
143130160|NCT02028507|516022040|FG001|Overall Study|Death|0|||
143130161|NCT02028507|516022041|FG002|Overall Study|Death|1|||
143130162|NCT02028507|516022042|FG003|Overall Study|Death|3|||
143130163|NCT02028507|516022039|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
143130164|NCT02028507|516022040|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
143130165|NCT02028507|516022041|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
143130166|NCT02028507|516022042|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
143130167|NCT02028507|516022039|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
143130168|NCT02028507|516022040|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
143130169|NCT02028507|516022041|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
143130170|NCT02028507|516022042|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
143130171|NCT02028507|516022039|FG000|Overall Study|Randomized But Not Treated|3|||
143130172|NCT02028507|516022040|FG001|Overall Study|Randomized But Not Treated|6|||
143130173|NCT02028507|516022041|FG002|Overall Study|Randomized But Not Treated|0|||
143130174|NCT02028507|516022042|FG003|Overall Study|Randomized But Not Treated|4|||
143130175|NCT02028507|516022039|FG000|Overall Study|Enzyme defect|0|||
143130176|NCT02028507|516022040|FG001|Overall Study|Enzyme defect|0|||
143130177|NCT02028507|516022041|FG002|Overall Study|Enzyme defect|0|||
143130178|NCT02028507|516022042|FG003|Overall Study|Enzyme defect|1|||
143130179|NCT02028507|516022039|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
143130180|NCT02028507|516022040|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
143130181|NCT02028507|516022041|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
143130182|NCT02028507|516022042|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
143130183|NCT02028507|516022039|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
143130184|NCT02028507|516022040|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
143130185|NCT02028507|516022041|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
143130186|NCT02028507|516022042|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
143230860|NCT01018030|516395518|FG002|Overall Study|Did Not Receive Study Drug|0|||
143130187|NCT03743025|516022043|FG000|Overall Study|Surgery was cancelled|2|||
143130188|NCT03743025|516022044|FG001|Overall Study|Surgery was cancelled|1|||
143130189|NCT00627926|516022045|FG000|Overall Study|Adverse Event|26|||
143130190|NCT00627926|516022046|FG001|Overall Study|Adverse Event|37|||
143130191|NCT00627926|516022047|FG002|Overall Study|Adverse Event|36|||
143130192|NCT00627926|516022045|FG000|Overall Study|Death|1|||
143130193|NCT00627926|516022046|FG001|Overall Study|Death|0|||
143130194|NCT00627926|516022047|FG002|Overall Study|Death|0|||
143130195|NCT00627926|516022045|FG000|Overall Study|Lost to Follow-up|4|||
143130196|NCT00627926|516022046|FG001|Overall Study|Lost to Follow-up|3|||
143130197|NCT00627926|516022047|FG002|Overall Study|Lost to Follow-up|4|||
143130198|NCT00627926|516022045|FG000|Overall Study|Withdrawal by Subject|2|||
143130199|NCT00627926|516022046|FG001|Overall Study|Withdrawal by Subject|1|||
143130200|NCT00627926|516022047|FG002|Overall Study|Withdrawal by Subject|0|||
143130201|NCT00627926|516022045|FG000|Overall Study|Lack of Efficacy|118|||
143130202|NCT00627926|516022046|FG001|Overall Study|Lack of Efficacy|40|||
143130203|NCT00627926|516022047|FG002|Overall Study|Lack of Efficacy|38|||
143130204|NCT00627926|516022045|FG000|Overall Study|Noncompliance/unspecified|8|||
143130205|NCT00627926|516022046|FG001|Overall Study|Noncompliance/unspecified|23|||
143130206|NCT00627926|516022047|FG002|Overall Study|Noncompliance/unspecified|17|||
143130207|NCT02401035|516022048|FG000|Overall Study|Withdrawal by Subject|1|||
143130208|NCT02401035|516022049|FG001|Overall Study|Withdrawal by Subject|0|||
143130209|NCT00869128|516022050|FG000|Overall Study|lack of Compliance|6|||
143130210|NCT00869128|516022051|FG001|Overall Study|lack of Compliance|6|||
143130211|NCT01118663|516022058|FG000|Overall Study|Adverse Event|2|||
143130212|NCT01118663|516022059|FG001|Overall Study|Adverse Event|1|||
143130213|NCT01118663|516022058|FG000|Overall Study|Withdrawal by Subject|0|||
143130214|NCT01118663|516022059|FG001|Overall Study|Withdrawal by Subject|1|||
143130215|NCT04039204|516022060|FG000|Overall Study|Withdrawal by Subject|0|||
143130216|NCT04039204|516022061|FG001|Overall Study|Withdrawal by Subject|2|||
143130217|NCT01189461|516022062|FG000|Overall Study|Lack of Efficacy|13|||
143130218|NCT01189461|516022062|FG000|Overall Study|Lost to Follow-up|1|||
143130219|NCT01189461|516022062|FG000|Overall Study|Withdrawal by Subject|6|||
143130220|NCT01189461|516022062|FG000|Overall Study|Protocol Violation|1|||
143130221|NCT01189461|516022062|FG000|Overall Study|Adverse Event|2|||
143130222|NCT01189461|516022062|FG000|Overall Study|Did not meet entrance criteria|3|||
143130223|NCT01189461|516022062|FG000|Overall Study|Other|8|||
143130224|NCT00656175|516022063|FG000|Overall Study|Adverse Event|1|||
143130225|NCT00656175|516022064|FG001|Overall Study|Adverse Event|0|||
143130226|NCT00656175|516022063|FG000|Overall Study|Transportation issues|0|||
143130227|NCT00656175|516022064|FG001|Overall Study|Transportation issues|1|||
143130228|NCT05279131|516022065|FG000|Overall Study|Lost to Follow-up|1|||
143130229|NCT05279131|516022065|FG000|Overall Study|Death|1|||
143130230|NCT05279131|516022065|FG000|Overall Study|Physician Decision|1|||
143130231|NCT01903993|516022069|FG000|Overall Study|Death|118|||
143130232|NCT01903993|516022070|FG001|Overall Study|Death|121|||
143130233|NCT01903993|516022069|FG000|Overall Study|Withdrawal by Subject|15|||
143130234|NCT01903993|516022070|FG001|Overall Study|Withdrawal by Subject|4|||
143130235|NCT01903993|516022069|FG000|Overall Study|Lost to Follow-up|2|||
143130236|NCT01903993|516022070|FG001|Overall Study|Lost to Follow-up|3|||
143130237|NCT01903993|516022069|FG000|Overall Study|Study Terminated by Sponsor|8|||
143130238|NCT01903993|516022070|FG001|Overall Study|Study Terminated by Sponsor|14|||
143130239|NCT01903993|516022069|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
143130240|NCT01903993|516022070|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
143130241|NCT03472521|516022077|FG000|Overall Study|Lost to Follow-up|3|||
143130242|NCT03472521|516022078|FG001|Overall Study|Lost to Follow-up|2|||
143130243|NCT03472521|516022077|FG000|Overall Study|Discontinued intervention|3|||
143130244|NCT03472521|516022078|FG001|Overall Study|Discontinued intervention|1|||
143130245|NCT02385110|516022079|FG000|Overall Study|Early Death|1|||
143130246|NCT02385110|516022080|FG001|Overall Study|Early Death|0|||
143130247|NCT00452439|516024113|FG000|Overall Study|Lost to Follow-up|1|||
143130248|NCT00452439|516024114|FG001|Overall Study|Lost to Follow-up|1|||
143130249|NCT00452439|516024113|FG000|Overall Study|Refused Treatment|4|||
143130250|NCT00452439|516024114|FG001|Overall Study|Refused Treatment|3|||
143130251|NCT00452439|516024113|FG000|Overall Study|Death|3|||
143130252|NCT00452439|516024114|FG001|Overall Study|Death|1|||
143130253|NCT00452439|516024113|FG000|Overall Study|Bone Marrow Transplant|0|||
143130254|NCT00452439|516024114|FG001|Overall Study|Bone Marrow Transplant|1|||
143130255|NCT00452439|516024113|FG000|Overall Study|Too Ill to Continue|0|||
143130256|NCT00452439|516024114|FG001|Overall Study|Too Ill to Continue|1|||
143130257|NCT00452439|516024113|FG000|Overall Study|Failed to achieve complete response|2|||
143130258|NCT00452439|516024114|FG001|Overall Study|Failed to achieve complete response|0|||
143130259|NCT00452439|516024113|FG000|Overall Study|Relapse|3|||
143130260|NCT00452439|516024114|FG001|Overall Study|Relapse|0|||
143130261|NCT00452439|516024113|FG000|Overall Study|Fracture|1|||
143130262|NCT00452439|516024114|FG001|Overall Study|Fracture|0|||
143130263|NCT04826484|516024123|FG000|Overall Study|Lost to Follow-up|2|||
143130264|NCT04826484|516024124|FG001|Overall Study|Lost to Follow-up|0|||
143130265|NCT03512353|516024127|FG000|Overall Study|Sponsor Decision|3|||
143130266|NCT03512353|516024127|FG000|Overall Study|Death|1|||
143130267|NCT00758498|516024128|FG000|Overall Study|Adverse Event|2|||
143130268|NCT00758498|516024129|FG001|Overall Study|Adverse Event|2|||
143130269|NCT00758498|516024130|FG002|Overall Study|Adverse Event|3|||
143130270|NCT00758498|516024128|FG000|Overall Study|Subject legally detained out of state|1|||
143130271|NCT00758498|516024129|FG001|Overall Study|Subject legally detained out of state|0|||
143130272|NCT00758498|516024130|FG002|Overall Study|Subject legally detained out of state|0|||
143130273|NCT00758498|516024128|FG000|Overall Study|Withdrawal by Subject|0|||
143130274|NCT00758498|516024129|FG001|Overall Study|Withdrawal by Subject|0|||
143130275|NCT00758498|516024130|FG002|Overall Study|Withdrawal by Subject|1|||
143130276|NCT00758498|516024128|FG000|Overall Study|Noncompliance to study procedures|0|||
143130277|NCT00758498|516024129|FG001|Overall Study|Noncompliance to study procedures|0|||
143130278|NCT00758498|516024130|FG002|Overall Study|Noncompliance to study procedures|1|||
143130279|NCT02581488|516024134|FG000|Overall Study|Adverse Event|6|||
143130280|NCT02581488|516024135|FG001|Overall Study|Adverse Event|7|||
143130281|NCT02581488|516024134|FG000|Overall Study|Lost to Follow-up|1|||
143130282|NCT02581488|516024135|FG001|Overall Study|Lost to Follow-up|0|||
143130283|NCT02581488|516024134|FG000|Overall Study|Withdrawal by Subject|1|||
143130284|NCT02581488|516024135|FG001|Overall Study|Withdrawal by Subject|0|||
143130285|NCT02581488|516024134|FG000|Overall Study|Non-Compliance|1|||
143130286|NCT02581488|516024135|FG001|Overall Study|Non-Compliance|0|||
143130287|NCT02581488|516024134|FG000|Overall Study|Protocol Violation|0|||
143130288|NCT02581488|516024135|FG001|Overall Study|Protocol Violation|4|||
143130289|NCT00954122|516024136|FG000|Overall Study|Withdrawal by Subject|5|||
143130290|NCT00954122|516024136|FG000|Overall Study|Adverse Event|1|||
143130291|NCT00954122|516024136|FG000|Overall Study|Safety Reason|1|||
143130292|NCT00522548|516024137|FG000|Overall Study|Adverse Event|2|||
143130293|NCT00522548|516024138|FG001|Overall Study|Adverse Event|2|||
143130294|NCT00522548|516024137|FG000|Overall Study|Withdrawal by Subject|0|||
143130295|NCT00522548|516024138|FG001|Overall Study|Withdrawal by Subject|2|||
143130296|NCT00493012|516024139|FG000|Overall Study|Lost to Follow-up|18|||
143130297|NCT00493012|516024140|FG001|Overall Study|Lost to Follow-up|17|||
143130298|NCT00666211|516024141|FG000|Overall Study|Withdrawal by Subject|10|||
143130299|NCT00666211|516024142|FG001|Overall Study|Withdrawal by Subject|13|||
143130300|NCT00666211|516024141|FG000|Overall Study|went off medication, no more pain|1|||
143130301|NCT00666211|516024142|FG001|Overall Study|went off medication, no more pain|0|||
143130302|NCT00666211|516024141|FG000|Overall Study|patient non-compliant|6|||
143130303|NCT00666211|516024142|FG001|Overall Study|patient non-compliant|6|||
143130304|NCT00666211|516024141|FG000|Overall Study|disease progression|1|||
143130305|NCT00666211|516024142|FG001|Overall Study|disease progression|8|||
143130306|NCT00666211|516024141|FG000|Overall Study|Lost to Follow-up|2|||
143130307|NCT00666211|516024142|FG001|Overall Study|Lost to Follow-up|0|||
143130308|NCT00666211|516024141|FG000|Overall Study|toxicity|0|||
143130309|NCT00666211|516024142|FG001|Overall Study|toxicity|2|||
143130310|NCT00666211|516024141|FG000|Overall Study|hospital admission|0|||
143130311|NCT00666211|516024142|FG001|Overall Study|hospital admission|5|||
143130312|NCT00666211|516024141|FG000|Overall Study|Death|0|||
143130313|NCT00666211|516024142|FG001|Overall Study|Death|2|||
143130314|NCT00666211|516024141|FG000|Overall Study|off tx for other complicating disease|0|||
143130315|NCT00666211|516024142|FG001|Overall Study|off tx for other complicating disease|1|||
143130316|NCT00666211|516024141|FG000|Overall Study|Physician Decision|0|||
143130317|NCT00666211|516024142|FG001|Overall Study|Physician Decision|1|||
143130318|NCT02999789|516024143|FG000|Overall Study|Withdrawal by Subject|0|||
143130319|NCT02999789|516024144|FG001|Overall Study|Withdrawal by Subject|1|||
143130320|NCT02999789|516024143|FG000|Overall Study|Became ineligible|1|||
143130321|NCT02999789|516024144|FG001|Overall Study|Became ineligible|2|||
143130322|NCT02683239|516024145|FG000|Overall Study|Protocol Violation|35|||
143130323|NCT02683239|516024146|FG001|Overall Study|Protocol Violation|23|||
143130324|NCT02683239|516024147|FG002|Overall Study|Protocol Violation|26|||
143130325|NCT02683239|516024148|FG003|Overall Study|Protocol Violation|4|||
143130326|NCT02683239|516024149|FG004|Overall Study|Protocol Violation|35|||
143130327|NCT02683239|516024150|FG005|Overall Study|Protocol Violation|4|||
143130328|NCT02683239|516024151|FG006|Overall Study|Protocol Violation|5|||
143130329|NCT02683239|516024145|FG000|Overall Study|Adverse Event|64|||
143130330|NCT02683239|516024146|FG001|Overall Study|Adverse Event|39|||
143130331|NCT02683239|516024147|FG002|Overall Study|Adverse Event|42|||
143230861|NCT00189540|516395519|FG000|Overall Study|Withdrawal by Subject|3|||
143230862|NCT00189540|516395520|FG001|Overall Study|Withdrawal by Subject|0|||
143230863|NCT00189540|516395519|FG000|Overall Study|Death|4|||
143230864|NCT00189540|516395520|FG001|Overall Study|Death|1|||
143230865|NCT01903356|516395521|FG000|Overall Study|Lost to Follow-up|7|||
143130332|NCT02683239|516024148|FG003|Overall Study|Adverse Event|16|||
143130333|NCT02683239|516024149|FG004|Overall Study|Adverse Event|189|||
143130334|NCT02683239|516024150|FG005|Overall Study|Adverse Event|9|||
143130335|NCT02683239|516024151|FG006|Overall Study|Adverse Event|9|||
143130336|NCT02683239|516024145|FG000|Overall Study|Physician Decision|38|||
143130337|NCT02683239|516024146|FG001|Overall Study|Physician Decision|19|||
143130338|NCT02683239|516024147|FG002|Overall Study|Physician Decision|14|||
143130339|NCT02683239|516024148|FG003|Overall Study|Physician Decision|73|||
143130340|NCT02683239|516024149|FG004|Overall Study|Physician Decision|143|||
143130341|NCT02683239|516024150|FG005|Overall Study|Physician Decision|14|||
143130342|NCT02683239|516024151|FG006|Overall Study|Physician Decision|15|||
143130343|NCT02683239|516024145|FG000|Overall Study|Withdrawal by Subject|187|||
143130344|NCT02683239|516024146|FG001|Overall Study|Withdrawal by Subject|99|||
143130345|NCT02683239|516024147|FG002|Overall Study|Withdrawal by Subject|91|||
143130346|NCT02683239|516024148|FG003|Overall Study|Withdrawal by Subject|18|||
143130347|NCT02683239|516024149|FG004|Overall Study|Withdrawal by Subject|248|||
143130348|NCT02683239|516024150|FG005|Overall Study|Withdrawal by Subject|22|||
143130349|NCT02683239|516024151|FG006|Overall Study|Withdrawal by Subject|28|||
143130350|NCT02683239|516024145|FG000|Overall Study|Lost to Follow-up|77|||
143130351|NCT02683239|516024146|FG001|Overall Study|Lost to Follow-up|24|||
143130352|NCT02683239|516024147|FG002|Overall Study|Lost to Follow-up|25|||
143130353|NCT02683239|516024148|FG003|Overall Study|Lost to Follow-up|7|||
143130354|NCT02683239|516024149|FG004|Overall Study|Lost to Follow-up|88|||
143130355|NCT02683239|516024150|FG005|Overall Study|Lost to Follow-up|8|||
143130356|NCT02683239|516024151|FG006|Overall Study|Lost to Follow-up|11|||
143130357|NCT02683239|516024145|FG000|Overall Study|Death|9|||
143130358|NCT02683239|516024146|FG001|Overall Study|Death|5|||
143130359|NCT02683239|516024147|FG002|Overall Study|Death|8|||
143130360|NCT02683239|516024148|FG003|Overall Study|Death|0|||
143130361|NCT02683239|516024149|FG004|Overall Study|Death|12|||
143130362|NCT02683239|516024150|FG005|Overall Study|Death|1|||
143130363|NCT02683239|516024151|FG006|Overall Study|Death|0|||
143130364|NCT02683239|516024145|FG000|Overall Study|Lack of Efficacy|50|||
143130365|NCT02683239|516024146|FG001|Overall Study|Lack of Efficacy|23|||
143130366|NCT02683239|516024147|FG002|Overall Study|Lack of Efficacy|12|||
143130367|NCT02683239|516024148|FG003|Overall Study|Lack of Efficacy|2|||
143130368|NCT02683239|516024149|FG004|Overall Study|Lack of Efficacy|29|||
143130369|NCT02683239|516024150|FG005|Overall Study|Lack of Efficacy|2|||
143130370|NCT02683239|516024151|FG006|Overall Study|Lack of Efficacy|3|||
143130371|NCT02683239|516024145|FG000|Overall Study|Missing data|0|||
143130372|NCT02683239|516024146|FG001|Overall Study|Missing data|1|||
143130373|NCT02683239|516024147|FG002|Overall Study|Missing data|1|||
143130374|NCT02683239|516024148|FG003|Overall Study|Missing data|0|||
143130375|NCT02683239|516024149|FG004|Overall Study|Missing data|1|||
143130376|NCT02683239|516024150|FG005|Overall Study|Missing data|0|||
143130377|NCT02683239|516024151|FG006|Overall Study|Missing data|0|||
143130378|NCT00368108|516024154|FG000|Overall Study|Adverse Event|38|||
143130379|NCT00368108|516024155|FG001|Overall Study|Adverse Event|26|||
143130380|NCT00368108|516024156|FG002|Overall Study|Adverse Event|44|||
143130381|NCT00368108|516024154|FG000|Overall Study|Abnormal Laboratory Value|0|||
143130382|NCT00368108|516024155|FG001|Overall Study|Abnormal Laboratory Value|0|||
143130383|NCT00368108|516024156|FG002|Overall Study|Abnormal Laboratory Value|3|||
143130384|NCT00368108|516024154|FG000|Overall Study|Protocol Violation|5|||
143130385|NCT00368108|516024155|FG001|Overall Study|Protocol Violation|9|||
143130386|NCT00368108|516024156|FG002|Overall Study|Protocol Violation|9|||
143130387|NCT00368108|516024154|FG000|Overall Study|Withdrawal by Subject|9|||
143130388|NCT00368108|516024155|FG001|Overall Study|Withdrawal by Subject|3|||
143130389|NCT00368108|516024156|FG002|Overall Study|Withdrawal by Subject|5|||
143130390|NCT00368108|516024154|FG000|Overall Study|Lack of Efficacy|7|||
143130391|NCT00368108|516024155|FG001|Overall Study|Lack of Efficacy|8|||
143130392|NCT00368108|516024156|FG002|Overall Study|Lack of Efficacy|5|||
143130393|NCT00368108|516024154|FG000|Overall Study|Physician Decision|2|||
143130394|NCT00368108|516024155|FG001|Overall Study|Physician Decision|0|||
143130395|NCT00368108|516024156|FG002|Overall Study|Physician Decision|1|||
143130396|NCT00368108|516024154|FG000|Overall Study|Other|3|||
143130397|NCT00368108|516024155|FG001|Overall Study|Other|7|||
143130398|NCT00368108|516024156|FG002|Overall Study|Other|1|||
143130399|NCT02465437|516024161|FG000|Overall Study|Physician Decision|0|||
143130400|NCT02465437|516024162|FG001|Overall Study|Physician Decision|0|||
143130401|NCT02465437|516024163|FG002|Overall Study|Physician Decision|1|||
143130402|NCT02465437|516024164|FG003|Overall Study|Physician Decision|0|||
143130403|NCT02465437|516024161|FG000|Overall Study|Withdrawal by Subject|1|||
143130404|NCT02465437|516024162|FG001|Overall Study|Withdrawal by Subject|0|||
143130405|NCT02465437|516024163|FG002|Overall Study|Withdrawal by Subject|0|||
143358109|NCT03280563|516856080|FG000|Long-term Survival Follow-up|Death|10|||
143358110|NCT03280563|516856081|FG001|Long-term Survival Follow-up|Death|14|||
143358111|NCT03280563|516856082|FG002|Long-term Survival Follow-up|Death|15|||
143358112|NCT03280563|516856083|FG003|Long-term Survival Follow-up|Death|3|||
143358113|NCT03280563|516856084|FG004|Long-term Survival Follow-up|Death|6|||
143358114|NCT03280563|516856085|FG005|Long-term Survival Follow-up|Death|18|||
143358115|NCT03280563|516856086|FG006|Long-term Survival Follow-up|Death|11|||
143130406|NCT02465437|516024164|FG003|Overall Study|Withdrawal by Subject|1|||
143130407|NCT02465437|516024161|FG000|Overall Study|Adverse Event|0|||
143130408|NCT02465437|516024162|FG001|Overall Study|Adverse Event|1|||
143130409|NCT02465437|516024163|FG002|Overall Study|Adverse Event|0|||
143130410|NCT02465437|516024164|FG003|Overall Study|Adverse Event|0|||
143130411|NCT04131712|516024165|FG000|Overall Study|COVID related|0|||
143130412|NCT04131712|516024166|FG001|Overall Study|COVID related|0|||
143130413|NCT04131712|516024167|FG002|Overall Study|COVID related|2|||
143130414|NCT04131712|516024168|FG003|Overall Study|COVID related|0|||
143130415|NCT04131712|516024165|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
143130416|NCT04131712|516024166|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
143130417|NCT04131712|516024167|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
143130418|NCT04131712|516024168|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
143130419|NCT02299388|516024173|FG000|Overall Study|Withdrawal by Subject|0|||
143130420|NCT02299388|516024174|FG001|Overall Study|Withdrawal by Subject|1|||
143130421|NCT00716456|516024175|FG000|Overall Study|Adverse Event|0|||
143130422|NCT00716456|516024176|FG001|Overall Study|Adverse Event|2|||
143130423|NCT00716456|516024177|FG002|Overall Study|Adverse Event|0|||
143130424|NCT00447772|516024178|FG000|Overall Study|Lack of Efficacy|3|||
143130425|NCT00447772|516024178|FG000|Overall Study|Insufficient compliance|6|||
143130426|NCT00447772|516024178|FG000|Overall Study|Discontinuation of drug therapy|1|||
143130427|NCT00447772|516024178|FG000|Overall Study|Lost to Follow-up|9|||
143130428|NCT00447772|516024178|FG000|Overall Study|Withdrawal by Subject|1|||
143130429|NCT00447772|516024178|FG000|Overall Study|Unable to attend all study visits|2|||
143130430|NCT00447772|516024178|FG000|Overall Study|Adverse Event|1|||
143130431|NCT00447772|516024178|FG000|Overall Study|Patient relocated|1|||
143130432|NCT00447772|516024178|FG000|Overall Study|Incomplete documentation at visit 1|1|||
143130433|NCT00447772|516024178|FG000|Overall Study|Chemotherapy for lung cancer|1|||
143130434|NCT00447772|516024178|FG000|Overall Study|Premature re-injection required|1|||
143130435|NCT00875563|516024183|FG000|Overall Study|Death|4|||
143130436|NCT00875563|516024183|FG000|Overall Study|Withdrawal by Subject|7|||
143130437|NCT00875563|516024183|FG000|Overall Study|No long-term (3-5 year) consent|6|||
143130438|NCT00875563|516024183|FG000|Overall Study|Still be eligible for follow-up|7|||
143130439|NCT02896569|516024184|FG000|Overall Study|Lost to Follow-up|2|||
143130440|NCT02896569|516024185|FG001|Overall Study|Lost to Follow-up|1|||
143130441|NCT02896569|516024184|FG000|Overall Study|Physician Decision|1|||
143130442|NCT02896569|516024185|FG001|Overall Study|Physician Decision|3|||
143130443|NCT02896569|516024184|FG000|Overall Study|Adverse Event|0|||
143130444|NCT02896569|516024185|FG001|Overall Study|Adverse Event|1|||
143130445|NCT02896569|516024184|FG000|Overall Study|Withdrawal by Subject|1|||
143130446|NCT02896569|516024185|FG001|Overall Study|Withdrawal by Subject|0|||
143130447|NCT03257436|516024186|FG000|Overall Study|Withdrawal by Subject|76|||
143130448|NCT03257436|516024186|FG000|Overall Study|Death|19|||
143130449|NCT00970489|516024187|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
143130450|NCT00970489|516024188|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
143130451|NCT02659943|516024189|FG000|Overall Study|Switched to alternative treatment|1|||
143130452|NCT02659943|516024190|FG001|Overall Study|Switched to alternative treatment|1|||
143130453|NCT02659943|516024191|FG002|Overall Study|Switched to alternative treatment|0|||
143130454|NCT02659943|516024192|FG003|Overall Study|Switched to alternative treatment|2|||
143130455|NCT02659943|516024193|FG004|Overall Study|Switched to alternative treatment|1|||
143130456|NCT02659943|516024194|FG005|Overall Study|Switched to alternative treatment|0|||
143130457|NCT02659943|516024195|FG006|Overall Study|Switched to alternative treatment|1|||
143130458|NCT02659943|516024189|FG000|Overall Study|Disease progression on study|0|||
143130459|NCT02659943|516024190|FG001|Overall Study|Disease progression on study|1|||
143130460|NCT02659943|516024191|FG002|Overall Study|Disease progression on study|1|||
143130461|NCT02659943|516024192|FG003|Overall Study|Disease progression on study|1|||
143130462|NCT02659943|516024193|FG004|Overall Study|Disease progression on study|1|||
143130463|NCT02659943|516024194|FG005|Overall Study|Disease progression on study|4|||
143130464|NCT02659943|516024195|FG006|Overall Study|Disease progression on study|0|||
143130465|NCT02659943|516024189|FG000|Overall Study|Patient's condition per principal investigator|0|||
143130466|NCT02659943|516024190|FG001|Overall Study|Patient's condition per principal investigator|0|||
143130467|NCT02659943|516024191|FG002|Overall Study|Patient's condition per principal investigator|0|||
143130468|NCT02659943|516024192|FG003|Overall Study|Patient's condition per principal investigator|0|||
143130469|NCT02659943|516024193|FG004|Overall Study|Patient's condition per principal investigator|0|||
143130470|NCT02659943|516024194|FG005|Overall Study|Patient's condition per principal investigator|1|||
143130471|NCT02659943|516024195|FG006|Overall Study|Patient's condition per principal investigator|0|||
143130472|NCT02659943|516024189|FG000|Overall Study|Ineligible|0|||
143130473|NCT02659943|516024190|FG001|Overall Study|Ineligible|0|||
143130474|NCT02659943|516024191|FG002|Overall Study|Ineligible|0|||
143130475|NCT02659943|516024192|FG003|Overall Study|Ineligible|0|||
143130476|NCT02659943|516024193|FG004|Overall Study|Ineligible|0|||
143130477|NCT02659943|516024194|FG005|Overall Study|Ineligible|0|||
143130478|NCT02659943|516024195|FG006|Overall Study|Ineligible|1|||
143130479|NCT02659943|516024189|FG000|Overall Study|No longer meets eligibility|0|||
143130480|NCT02659943|516024190|FG001|Overall Study|No longer meets eligibility|0|||
143130481|NCT02659943|516024191|FG002|Overall Study|No longer meets eligibility|0|||
143130482|NCT02659943|516024192|FG003|Overall Study|No longer meets eligibility|0|||
143130483|NCT02659943|516024193|FG004|Overall Study|No longer meets eligibility|0|||
143130484|NCT02659943|516024194|FG005|Overall Study|No longer meets eligibility|0|||
143130485|NCT02659943|516024195|FG006|Overall Study|No longer meets eligibility|1|||
143130486|NCT02659943|516024189|FG000|Overall Study|No treatment, per protocol|0|||
143130487|NCT02659943|516024190|FG001|Overall Study|No treatment, per protocol|0|||
143130488|NCT02659943|516024191|FG002|Overall Study|No treatment, per protocol|0|||
143130489|NCT02659943|516024192|FG003|Overall Study|No treatment, per protocol|0|||
143130490|NCT02659943|516024193|FG004|Overall Study|No treatment, per protocol|0|||
143130491|NCT02659943|516024194|FG005|Overall Study|No treatment, per protocol|0|||
143130492|NCT02659943|516024195|FG006|Overall Study|No treatment, per protocol|3|||
143130493|NCT01723072|516024200|FG000|Overall Study|Withdrawal by Subject|7|||
143130494|NCT01723072|516024201|FG001|Overall Study|Withdrawal by Subject|13|||
143130495|NCT01723072|516024200|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
143130496|NCT01723072|516024201|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
143130497|NCT01723072|516024200|FG000|Overall Study|Other|4|||
143130498|NCT01723072|516024201|FG001|Overall Study|Other|3|||
143130499|NCT03428100|516024202|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
143130500|NCT03428100|516024203|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
143130501|NCT03428100|516024204|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
143130502|NCT03428100|516024205|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
143130503|NCT03428100|516024206|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
143130504|NCT03428100|516024207|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
143130505|NCT03428100|516024208|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
143230866|NCT01903356|516395521|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
143230867|NCT01903356|516395521|FG000|Overall Study|Violated the dosage and administration|3|||
143130506|NCT03428100|516024209|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
143130507|NCT03428100|516024210|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
143130508|NCT03428100|516024211|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
143130509|NCT03428100|516024212|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
143130510|NCT03428100|516024213|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
143130511|NCT03428100|516024214|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
143130512|NCT03428100|516024215|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
143130513|NCT03428100|516024216|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
143130514|NCT03428100|516024217|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
143230868|NCT04529083|516395522|FG000|Overall Study|Withdrawal by Subject|3|||
143230869|NCT02240485|516395527|FG000|3 Months Post-admission|Lost to Follow-up|1|||
143230870|NCT02240485|516395528|FG001|3 Months Post-admission|Lost to Follow-up|5|||
143230871|NCT02240485|516395527|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
143230872|NCT02240485|516395528|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
143230873|NCT02240485|516395527|FG000|9 Months Post-admission|Lost to Follow-up|3|||
143230874|NCT02240485|516395528|FG001|9 Months Post-admission|Lost to Follow-up|1|||
143230875|NCT02240485|516395527|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
143230876|NCT02240485|516395528|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
143230877|NCT02240485|516395527|FG000|18 Months Post-admission|Lost to Follow-up|1|||
143230878|NCT02240485|516395528|FG001|18 Months Post-admission|Lost to Follow-up|1|||
143230879|NCT02240485|516395527|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
143230880|NCT02240485|516395528|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
143230881|NCT04038359|516395529|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
143230882|NCT04038359|516395530|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
143230883|NCT04038359|516395529|FG000|Overall Study|Death|8|||
143230884|NCT04038359|516395530|FG001|Overall Study|Death|7|||
143230885|NCT04038359|516395529|FG000|Overall Study|Lost to Follow-up|3|||
143230886|NCT04038359|516395530|FG001|Overall Study|Lost to Follow-up|0|||
143230887|NCT04038359|516395529|FG000|Overall Study|Participant Moved|1|||
143230888|NCT04038359|516395530|FG001|Overall Study|Participant Moved|0|||
143230889|NCT04038359|516395529|FG000|Overall Study|Withdrawal by Subject|4|||
143230890|NCT04038359|516395530|FG001|Overall Study|Withdrawal by Subject|3|||
143230891|NCT04038359|516395529|FG000|Overall Study|Physician Decision|3|||
143230892|NCT04038359|516395530|FG001|Overall Study|Physician Decision|2|||
143230893|NCT04038359|516395529|FG000|Overall Study|Adverse Event|0|||
143230894|NCT04038359|516395530|FG001|Overall Study|Adverse Event|2|||
143230895|NCT04038359|516395529|FG000|Overall Study|Progressive Disease|0|||
143230896|NCT04038359|516395530|FG001|Overall Study|Progressive Disease|1|||
143230897|NCT00475670|516395531|FG000|Overall Study|Death|0|||
143230898|NCT00475670|516395532|FG001|Overall Study|Death|1|||
143230899|NCT00475670|516395531|FG000|Overall Study|Lack of Efficacy|3|||
143230900|NCT00475670|516395532|FG001|Overall Study|Lack of Efficacy|34|||
143130515|NCT03428100|516024218|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
143130516|NCT03428100|516024219|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
143230901|NCT00475670|516395531|FG000|Overall Study|Refused treatment|0|||
143230902|NCT00475670|516395532|FG001|Overall Study|Refused treatment|2|||
143230903|NCT00475670|516395531|FG000|Overall Study|Failure to Return|0|||
143230904|NCT00475670|516395532|FG001|Overall Study|Failure to Return|1|||
143230905|NCT00475670|516395531|FG000|Overall Study|Other|0|||
143230906|NCT00475670|516395532|FG001|Overall Study|Other|3|||
143230907|NCT03259230|516395533|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
143230908|NCT03259230|516395534|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
143130517|NCT03428100|516024220|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
143130518|NCT03428100|516024202|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
143230909|NCT02913482|516395535|FG000|Overall Study|Death|0|||
143230910|NCT02913482|516395536|FG001|Overall Study|Death|2|||
143230911|NCT02913482|516395537|FG002|Overall Study|Death|2|||
143230912|NCT02913482|516395535|FG000|Overall Study|Progressive Disease|1|||
143230913|NCT02913482|516395536|FG001|Overall Study|Progressive Disease|1|||
143230914|NCT02913482|516395537|FG002|Overall Study|Progressive Disease|1|||
143130519|NCT03428100|516024203|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
143130520|NCT03428100|516024204|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
143130521|NCT03428100|516024205|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
143130522|NCT03428100|516024206|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
143130523|NCT03428100|516024207|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
143130524|NCT03428100|516024208|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
143130525|NCT03428100|516024209|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
143130526|NCT03428100|516024210|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
143130527|NCT03428100|516024211|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
143130528|NCT03428100|516024212|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
143130529|NCT03428100|516024213|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
143130530|NCT03428100|516024214|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
143130531|NCT03428100|516024215|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
143130532|NCT03428100|516024216|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
143130533|NCT03428100|516024217|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
143130534|NCT03428100|516024218|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
143130535|NCT03428100|516024219|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
143130536|NCT03428100|516024220|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
143130537|NCT03428100|516024202|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
143130538|NCT03428100|516024203|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
143130539|NCT03428100|516024204|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
143130540|NCT03428100|516024205|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
143130541|NCT03428100|516024206|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
143130542|NCT03428100|516024207|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
143130543|NCT03428100|516024208|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
143130544|NCT03428100|516024209|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
143130545|NCT03428100|516024210|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
143130546|NCT03428100|516024211|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
143130547|NCT03428100|516024212|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
143130548|NCT03428100|516024213|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
143130549|NCT03428100|516024214|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
143130550|NCT03428100|516024215|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
143130551|NCT03428100|516024216|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
143130552|NCT03428100|516024217|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
143130553|NCT03428100|516024218|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
143130554|NCT03428100|516024219|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
143130555|NCT03428100|516024220|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
143130556|NCT03428100|516024202|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
143130557|NCT03428100|516024203|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
143130558|NCT03428100|516024204|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
143130559|NCT03428100|516024205|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
143130560|NCT03428100|516024206|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
143130561|NCT03428100|516024207|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
143130562|NCT03428100|516024208|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
143130563|NCT03428100|516024209|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
143130564|NCT03428100|516024210|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
143130565|NCT03428100|516024211|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
143130566|NCT03428100|516024212|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
143130567|NCT03428100|516024213|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
143130568|NCT03428100|516024214|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
143130569|NCT03428100|516024215|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
143230915|NCT02913482|516395535|FG000|Overall Study|Reason not specified|0|||
143230916|NCT02913482|516395536|FG001|Overall Study|Reason not specified|0|||
143230917|NCT02913482|516395537|FG002|Overall Study|Reason not specified|1|||
143230918|NCT02913482|516395535|FG000|Overall Study|Withdrawal by Subject|0|||
143230919|NCT02913482|516395536|FG001|Overall Study|Withdrawal by Subject|1|||
143230920|NCT02913482|516395537|FG002|Overall Study|Withdrawal by Subject|1|||
143230921|NCT02978417|516395538|FG000|Overall Study|Lost to Follow-up|2|||
143130570|NCT03428100|516024216|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
143130571|NCT03428100|516024217|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
143130572|NCT03428100|516024218|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
143130573|NCT03428100|516024219|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
143130574|NCT03428100|516024220|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
143130575|NCT03428100|516024202|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
143130576|NCT03428100|516024203|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
143130577|NCT03428100|516024204|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
143130578|NCT03428100|516024205|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
143130579|NCT03428100|516024206|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
143130580|NCT03428100|516024207|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
143130581|NCT03428100|516024208|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
143130582|NCT03428100|516024209|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
143130583|NCT03428100|516024210|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
143130584|NCT03428100|516024211|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
143130585|NCT03428100|516024212|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
143130586|NCT03428100|516024213|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
143130587|NCT03428100|516024214|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
143130588|NCT03428100|516024215|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
143130589|NCT03428100|516024216|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
143130590|NCT03428100|516024217|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
143130591|NCT03428100|516024218|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
143130592|NCT03428100|516024219|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
143130593|NCT03428100|516024220|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
143130594|NCT03428100|516024202|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
143130595|NCT03428100|516024203|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
143130596|NCT03428100|516024204|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
143130597|NCT03428100|516024205|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
143130598|NCT03428100|516024206|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
143130599|NCT03428100|516024207|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
143130600|NCT03428100|516024208|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
143130601|NCT03428100|516024209|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
143130602|NCT03428100|516024210|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
143130603|NCT03428100|516024211|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
143130604|NCT03428100|516024212|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
143130605|NCT03428100|516024213|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
143130606|NCT03428100|516024214|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
143130607|NCT03428100|516024215|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
143130608|NCT03428100|516024216|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
143130609|NCT03428100|516024217|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
143130610|NCT03428100|516024218|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
143130611|NCT03428100|516024219|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
143130612|NCT03428100|516024220|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
143130613|NCT03428100|516024202|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
143130614|NCT03428100|516024203|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
143130615|NCT03428100|516024204|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
143130616|NCT03428100|516024205|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
143130617|NCT03428100|516024206|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
143130618|NCT03428100|516024207|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
143130619|NCT03428100|516024208|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
143130620|NCT03428100|516024209|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
143130621|NCT03428100|516024210|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
143130622|NCT03428100|516024211|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
143130623|NCT03428100|516024212|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
143130624|NCT03428100|516024213|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
143130625|NCT03428100|516024214|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
143130626|NCT03428100|516024215|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
143130627|NCT03428100|516024216|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
143130628|NCT03428100|516024217|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
143130629|NCT03428100|516024218|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
143130630|NCT03428100|516024219|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
143130631|NCT03428100|516024220|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
143130632|NCT03428100|516024202|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
143130633|NCT03428100|516024203|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
143013785|NCT02494583|515590021|FG002|Overall Study|Did Not Continue on Extension Study|4|||
143130634|NCT03428100|516024204|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
143130635|NCT03428100|516024205|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
143130636|NCT03428100|516024206|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
143130637|NCT03428100|516024207|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
143130638|NCT03428100|516024208|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
143130639|NCT03428100|516024209|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
143130640|NCT03428100|516024210|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
143130641|NCT03428100|516024211|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
143130642|NCT03428100|516024212|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
143130643|NCT03428100|516024213|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
143130644|NCT03428100|516024214|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
143130645|NCT03428100|516024215|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
143130646|NCT03428100|516024216|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
143130647|NCT03428100|516024217|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
143130648|NCT03428100|516024218|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
143130649|NCT03428100|516024219|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
143130650|NCT03428100|516024220|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
143130651|NCT03428100|516024202|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
143130652|NCT03428100|516024203|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
143130653|NCT03428100|516024204|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
143130654|NCT03428100|516024205|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
143130655|NCT03428100|516024206|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
143230922|NCT02978417|516395539|FG001|Overall Study|Lost to Follow-up|2|||
143230923|NCT00960375|516395550|FG000|Overall Study|Lost to Follow-up|20|||
143230924|NCT00960375|516395551|FG001|Overall Study|Lost to Follow-up|22|||
143230925|NCT03624881|516395552|FG000|Overall Study|Screen Failure|14|||
143230926|NCT03624881|516395553|FG001|Overall Study|Screen Failure|0|||
143230927|NCT03624881|516395552|FG000|Overall Study|No Catheter Inserted|6|||
143230928|NCT03624881|516395553|FG001|Overall Study|No Catheter Inserted|1|||
143230929|NCT03624881|516395552|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
143230930|NCT03624881|516395553|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
143230931|NCT03624881|516395552|FG000|Overall Study|Death|2|||
143230932|NCT03624881|516395553|FG001|Overall Study|Death|0|||
143230933|NCT03624881|516395552|FG000|Overall Study|Lost to Follow-up|10|||
143230934|NCT03624881|516395553|FG001|Overall Study|Lost to Follow-up|4|||
143230935|NCT03624881|516395552|FG000|Overall Study|Withdrawal by Subject|12|||
143465692|NCT01294683|517251112|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
143465693|NCT01294683|517251111|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
143465694|NCT01294683|517251112|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
143465695|NCT01794923|517251117|FG000|Overall Study|Adverse Event|0|||
143465696|NCT01794923|517251118|FG001|Overall Study|Adverse Event|0|||
143465697|NCT01794923|517251119|FG002|Overall Study|Adverse Event|1|||
143465698|NCT01881750|517251120|FG000|Overall Study|Changes in concomitant therapies|2|||
143465699|NCT01881750|517251121|FG001|Overall Study|Changes in concomitant therapies|3|||
143465700|NCT01881750|517251120|FG000|Overall Study|Lost to Follow-up|0|||
143465701|NCT01881750|517251121|FG001|Overall Study|Lost to Follow-up|1|||
143465702|NCT00307125|517251124|FG000|Screening Phase|Adverse Event|1|||
143465703|NCT00307125|517251125|FG001|Screening Phase|Adverse Event|0|||
143465704|NCT00307125|517251126|FG002|Screening Phase|Adverse Event|0|||
143465705|NCT00307125|517251124|FG000|Screening Phase|Protocol Violation|27|||
143465706|NCT00307125|517251125|FG001|Screening Phase|Protocol Violation|0|||
143465707|NCT00307125|517251126|FG002|Screening Phase|Protocol Violation|0|||
143465708|NCT00307125|517251124|FG000|Screening Phase|Lost to Follow-up|87|||
143465709|NCT00307125|517251125|FG001|Screening Phase|Lost to Follow-up|0|||
143465710|NCT00307125|517251126|FG002|Screening Phase|Lost to Follow-up|0|||
143465711|NCT00307125|517251124|FG000|Screening Phase|Death|10|||
143465712|NCT00307125|517251125|FG001|Screening Phase|Death|0|||
143465713|NCT00307125|517251126|FG002|Screening Phase|Death|0|||
143465714|NCT00307125|517251124|FG000|Screening Phase|Withdrawal by Subject|77|||
143130656|NCT03428100|516024207|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
143130657|NCT03428100|516024208|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
143130658|NCT03428100|516024209|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
143130659|NCT03428100|516024210|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
143130660|NCT03428100|516024211|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
143230936|NCT03624881|516395553|FG001|Overall Study|Withdrawal by Subject|1|||
143465715|NCT00307125|517251125|FG001|Screening Phase|Withdrawal by Subject|0|||
143465716|NCT00307125|517251126|FG002|Screening Phase|Withdrawal by Subject|0|||
143465717|NCT00307125|517251124|FG000|Screening Phase|Physician Decision|26|||
143465718|NCT00307125|517251125|FG001|Screening Phase|Physician Decision|0|||
143465719|NCT00307125|517251126|FG002|Screening Phase|Physician Decision|0|||
143465720|NCT00307125|517251124|FG000|Screening Phase|Sponsor Decision|4|||
143465721|NCT00307125|517251125|FG001|Screening Phase|Sponsor Decision|0|||
143130661|NCT03428100|516024212|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
143130662|NCT03428100|516024213|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
143130663|NCT03428100|516024214|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
143130664|NCT03428100|516024215|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
143130665|NCT03428100|516024216|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
143130666|NCT03428100|516024217|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
143130667|NCT03428100|516024218|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
143130668|NCT03428100|516024219|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
143130669|NCT03428100|516024220|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
143130670|NCT03428100|516024202|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
143130671|NCT03428100|516024203|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
143130672|NCT03428100|516024204|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
143130673|NCT03428100|516024205|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
143130674|NCT03428100|516024206|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
143130675|NCT03428100|516024207|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
143130676|NCT03428100|516024208|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
143130677|NCT03428100|516024209|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
143130678|NCT03428100|516024210|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
143130679|NCT03428100|516024211|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
143465722|NCT00307125|517251126|FG002|Screening Phase|Sponsor Decision|0|||
143465723|NCT00307125|517251124|FG000|Screening Phase|Study Terminated|17|||
143465724|NCT00307125|517251125|FG001|Screening Phase|Study Terminated|0|||
143465725|NCT00307125|517251126|FG002|Screening Phase|Study Terminated|0|||
143465726|NCT00307125|517251124|FG000|Screening Phase|Graft Loss|3|||
143465727|NCT00307125|517251125|FG001|Screening Phase|Graft Loss|0|||
143465728|NCT00307125|517251126|FG002|Screening Phase|Graft Loss|0|||
143465729|NCT00307125|517251124|FG000|Screening Phase|Graft Failure|8|||
143465730|NCT00307125|517251125|FG001|Screening Phase|Graft Failure|0|||
143465731|NCT00307125|517251126|FG002|Screening Phase|Graft Failure|0|||
143465732|NCT00307125|517251124|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
143465733|NCT00307125|517251125|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
143465734|NCT00307125|517251126|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
143465735|NCT00307125|517251124|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
143465736|NCT00307125|517251125|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
143465737|NCT00307125|517251126|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
143465738|NCT00307125|517251124|FG000|Screening Phase|Moved or transferred facilities|34|||
143465739|NCT00307125|517251125|FG001|Screening Phase|Moved or transferred facilities|0|||
143465740|NCT00307125|517251126|FG002|Screening Phase|Moved or transferred facilities|0|||
143465741|NCT00307125|517251124|FG000|Screening Phase|Received Pancreas Transplant|8|||
143465742|NCT00307125|517251125|FG001|Screening Phase|Received Pancreas Transplant|0|||
143465743|NCT00307125|517251126|FG002|Screening Phase|Received Pancreas Transplant|0|||
143465744|NCT00307125|517251124|FG000|Screening Phase|Ineligible for pilot|4|||
143465745|NCT00307125|517251125|FG001|Screening Phase|Ineligible for pilot|0|||
143465746|NCT00307125|517251126|FG002|Screening Phase|Ineligible for pilot|0|||
143465747|NCT00307125|517251124|FG000|Screening Phase|Try to get pregnant|1|||
143465748|NCT00307125|517251125|FG001|Screening Phase|Try to get pregnant|0|||
143465749|NCT00307125|517251126|FG002|Screening Phase|Try to get pregnant|0|||
143465750|NCT00307125|517251124|FG000|Screening Phase|Developed acute leukemia|1|||
143465751|NCT00307125|517251125|FG001|Screening Phase|Developed acute leukemia|0|||
143465752|NCT00307125|517251126|FG002|Screening Phase|Developed acute leukemia|0|||
143465753|NCT00307125|517251124|FG000|Screening Phase|Metastatic colon cancer|1|||
143465754|NCT00307125|517251125|FG001|Screening Phase|Metastatic colon cancer|0|||
143465755|NCT00307125|517251126|FG002|Screening Phase|Metastatic colon cancer|0|||
143465756|NCT00307125|517251124|FG000|Screening Phase|Malignancy|1|||
143465757|NCT00307125|517251125|FG001|Screening Phase|Malignancy|0|||
143465758|NCT00307125|517251126|FG002|Screening Phase|Malignancy|0|||
143465759|NCT00307125|517251124|FG000|Screening Phase|PAK|1|||
143465760|NCT00307125|517251125|FG001|Screening Phase|PAK|0|||
143465761|NCT00307125|517251126|FG002|Screening Phase|PAK|0|||
143465762|NCT00307125|517251124|FG000|Screening Phase|Ineligible|1|||
143230937|NCT04258423|516395560|FG000|Overall Study|Study Closure|2|||
143230938|NCT04258423|516395561|FG001|Overall Study|Study Closure|2|||
143013786|NCT02494583|515590019|FG000|Overall Study|Withdrawal by Subject|7|||
143230939|NCT01601535|516395564|FG000|Phase 1|Adverse Event|1|||
143013787|NCT02494583|515590020|FG001|Overall Study|Withdrawal by Subject|15|||
143465763|NCT00307125|517251125|FG001|Screening Phase|Ineligible|0|||
143465764|NCT00307125|517251126|FG002|Screening Phase|Ineligible|0|||
143465765|NCT00307125|517251124|FG000|Screening Phase|Screen Error|1|||
143465766|NCT00307125|517251125|FG001|Screening Phase|Screen Error|0|||
143465767|NCT00307125|517251126|FG002|Screening Phase|Screen Error|0|||
143465768|NCT00307125|517251124|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
143465769|NCT00307125|517251125|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
143465770|NCT00307125|517251126|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
143465771|NCT00307125|517251124|FG000|Screening Phase|AMR and treated with rituximab|1|||
143130680|NCT03428100|516024212|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
143130681|NCT03428100|516024213|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
143130682|NCT03428100|516024214|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
143130683|NCT03428100|516024215|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
143130684|NCT03428100|516024216|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
143130685|NCT03428100|516024217|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
143130686|NCT03428100|516024218|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
143130687|NCT03428100|516024219|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
143130688|NCT03428100|516024220|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
143130689|NCT03428100|516024202|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
143130690|NCT03428100|516024203|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
143130691|NCT03428100|516024204|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
143130692|NCT03428100|516024205|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
143130693|NCT03428100|516024206|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
143130694|NCT03428100|516024207|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
143130695|NCT03428100|516024208|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
143130696|NCT03428100|516024209|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
143130697|NCT03428100|516024210|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
143130698|NCT03428100|516024211|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
143130699|NCT03428100|516024212|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
143130700|NCT03428100|516024213|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
143130701|NCT03428100|516024214|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
143130702|NCT03428100|516024215|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
143130703|NCT03428100|516024216|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
143130704|NCT03428100|516024217|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
143130705|NCT03428100|516024218|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
143130706|NCT03428100|516024219|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
143130707|NCT03428100|516024220|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
143130708|NCT03428100|516024202|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
143130709|NCT03428100|516024203|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
143130710|NCT03428100|516024204|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
143130711|NCT03428100|516024205|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
143130712|NCT03428100|516024206|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
143130713|NCT03428100|516024207|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
143130714|NCT03428100|516024208|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
143130715|NCT03428100|516024209|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
143130716|NCT03428100|516024210|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
143130717|NCT03428100|516024211|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
143130718|NCT03428100|516024212|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
143130719|NCT03428100|516024213|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
143130720|NCT03428100|516024214|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
143130721|NCT03428100|516024215|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
143130722|NCT03428100|516024216|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
143130723|NCT03428100|516024217|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
143130724|NCT03428100|516024218|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
143130725|NCT03428100|516024219|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
143130726|NCT03428100|516024220|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
143130727|NCT03428100|516024202|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
143130728|NCT03428100|516024203|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
143130729|NCT03428100|516024204|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
143130730|NCT03428100|516024205|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
143130731|NCT03428100|516024206|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
143130732|NCT03428100|516024207|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
143130733|NCT03428100|516024208|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
143130734|NCT03428100|516024209|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
143130735|NCT03428100|516024210|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
143130736|NCT03428100|516024211|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
143130737|NCT03428100|516024212|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
143130738|NCT03428100|516024213|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
143130739|NCT03428100|516024214|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
143130740|NCT03428100|516024215|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
143230940|NCT01601535|516395565|FG001|Phase 1|Adverse Event|0|||
143130741|NCT03428100|516024216|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
143130742|NCT03428100|516024217|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
143130743|NCT03428100|516024218|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
143130744|NCT03428100|516024219|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
143130745|NCT03428100|516024220|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
143130746|NCT00527826|516024229|FG000|Overall Study|Adverse Event|10|||
143130747|NCT00527826|516024230|FG001|Overall Study|Adverse Event|10|||
143130748|NCT00527826|516024229|FG000|Overall Study|Lost to Follow-up|3|||
143130749|NCT00527826|516024230|FG001|Overall Study|Lost to Follow-up|2|||
143130750|NCT00527826|516024229|FG000|Overall Study|Withdrawal by Subject|5|||
143130751|NCT00527826|516024230|FG001|Overall Study|Withdrawal by Subject|8|||
143130752|NCT00527826|516024229|FG000|Overall Study|Inclusion Criteria Not Met|3|||
143130753|NCT00527826|516024230|FG001|Overall Study|Inclusion Criteria Not Met|3|||
143130754|NCT00527826|516024229|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
143130755|NCT00527826|516024230|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
143130756|NCT00527826|516024229|FG000|Overall Study|Additional Intake of Viani forte|0|||
143130757|NCT00527826|516024230|FG001|Overall Study|Additional Intake of Viani forte|1|||
143130758|NCT00527826|516024229|FG000|Overall Study|Participant moved away|0|||
143130759|NCT00527826|516024230|FG001|Overall Study|Participant moved away|1|||
143130760|NCT00327717|516024231|FG000|Overall Study|Adverse Event|6|||
143130761|NCT00327717|516024232|FG001|Overall Study|Adverse Event|6|||
143130762|NCT00327717|516024231|FG000|Overall Study|Lack of Efficacy|0|||
143130763|NCT00327717|516024232|FG001|Overall Study|Lack of Efficacy|1|||
143130764|NCT00327717|516024231|FG000|Overall Study|Withdrawal by Subject|3|||
143130765|NCT00327717|516024232|FG001|Overall Study|Withdrawal by Subject|7|||
143130766|NCT01502033|516024233|FG000|Overall Study|1 participant had scalp discomfort|1|||
143130767|NCT01502033|516024233|FG000|Overall Study|1 participant had worsening depression|1|||
143130768|NCT01502033|516024233|FG000|Overall Study|1 participant went back to school|1|||
143130769|NCT02080364|516024234|FG000|Baseline Period|Protocol Violation|2|||
143130770|NCT02080364|516024235|FG001|Baseline Period|Protocol Violation|1|||
143130771|NCT02080364|516024236|FG002|Baseline Period|Protocol Violation|0|||
143130772|NCT02080364|516024237|FG003|Baseline Period|Protocol Violation|0|||
143130773|NCT02080364|516024234|FG000|Baseline Period|Other|0|||
143130774|NCT02080364|516024235|FG001|Baseline Period|Other|1|||
143130775|NCT02080364|516024236|FG002|Baseline Period|Other|1|||
143130776|NCT02080364|516024237|FG003|Baseline Period|Other|0|||
143130777|NCT02080364|516024234|FG000|Treatment Period|Adverse Event|10|||
143130778|NCT02080364|516024235|FG001|Treatment Period|Adverse Event|15|||
143130779|NCT02080364|516024236|FG002|Treatment Period|Adverse Event|11|||
143130780|NCT02080364|516024237|FG003|Treatment Period|Adverse Event|14|||
143130781|NCT02080364|516024234|FG000|Treatment Period|Lost to Follow-up|2|||
143130782|NCT02080364|516024235|FG001|Treatment Period|Lost to Follow-up|3|||
143130783|NCT02080364|516024236|FG002|Treatment Period|Lost to Follow-up|5|||
143130784|NCT02080364|516024237|FG003|Treatment Period|Lost to Follow-up|0|||
143130785|NCT02080364|516024234|FG000|Treatment Period|Protocol Violation|5|||
143130786|NCT02080364|516024235|FG001|Treatment Period|Protocol Violation|3|||
143130787|NCT02080364|516024236|FG002|Treatment Period|Protocol Violation|5|||
143130788|NCT02080364|516024237|FG003|Treatment Period|Protocol Violation|1|||
143130789|NCT02080364|516024234|FG000|Treatment Period|Withdrawal by Subject|16|||
143130790|NCT02080364|516024235|FG001|Treatment Period|Withdrawal by Subject|16|||
143130791|NCT02080364|516024236|FG002|Treatment Period|Withdrawal by Subject|15|||
143130792|NCT02080364|516024237|FG003|Treatment Period|Withdrawal by Subject|10|||
143130793|NCT02080364|516024234|FG000|Treatment Period|Study Terminated by Sponsor|0|||
143130794|NCT02080364|516024235|FG001|Treatment Period|Study Terminated by Sponsor|0|||
143130795|NCT02080364|516024236|FG002|Treatment Period|Study Terminated by Sponsor|180|||
143130796|NCT02080364|516024237|FG003|Treatment Period|Study Terminated by Sponsor|183|||
143130797|NCT02080364|516024234|FG000|Treatment Period|Other|14|||
143130798|NCT02080364|516024235|FG001|Treatment Period|Other|12|||
143130799|NCT02080364|516024236|FG002|Treatment Period|Other|21|||
143130800|NCT02080364|516024237|FG003|Treatment Period|Other|16|||
143130801|NCT03804268|516024238|FG000|Overall Study|Adverse Event|2|||
143230941|NCT01601535|516395566|FG002|Phase 1|Adverse Event|2|||
143230942|NCT01601535|516395567|FG003|Phase 1|Adverse Event|1|||
143130802|NCT03804268|516024239|FG001|Overall Study|Adverse Event|2|||
143130803|NCT03804268|516024238|FG000|Overall Study|Withdrawal by Subject|2|||
143130804|NCT03804268|516024239|FG001|Overall Study|Withdrawal by Subject|0|||
143130805|NCT03804268|516024238|FG000|Overall Study|Lost to Follow-up|1|||
143130806|NCT03804268|516024239|FG001|Overall Study|Lost to Follow-up|0|||
143130807|NCT03804268|516024238|FG000|Overall Study|Physician Decision|2|||
143130808|NCT03804268|516024239|FG001|Overall Study|Physician Decision|0|||
143130809|NCT02256839|516024240|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
143130810|NCT02256839|516024241|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
143130811|NCT01843803|516024242|FG000|Overall Study|not a Veteran, did not see provider|1|||
143130812|NCT01843803|516024243|FG001|Overall Study|not a Veteran, did not see provider|3|||
143130813|NCT03311841|516024244|FG000|14-day Wash-out|Adverse Event|0|||
143230943|NCT01601535|516395568|FG004|Phase 1|Adverse Event|0|||
143130814|NCT03311841|516024245|FG001|14-day Wash-out|Adverse Event|1|||
143130815|NCT03311841|516024246|FG002|14-day Wash-out|Adverse Event|0|||
143130816|NCT03311841|516024247|FG003|14-day Wash-out|Adverse Event|0|||
143130817|NCT03311841|516024248|FG004|14-day Wash-out|Adverse Event|0|||
143130818|NCT03311841|516024244|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
143130819|NCT03311841|516024245|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
143130820|NCT03311841|516024246|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
143130821|NCT03311841|516024247|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
143130822|NCT03311841|516024248|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
143130823|NCT05285787|516024253|FG000|Overall Study|Withdrawal by Subject|1|||
143130824|NCT01051817|516024261|FG000|Overall Study|Adverse Event|0|||
143130825|NCT01051817|516024262|FG001|Overall Study|Adverse Event|2|||
143130826|NCT01051817|516024261|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
143130827|NCT01051817|516024262|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
143130828|NCT01051817|516024261|FG000|Overall Study|Withdrawal by Subject|3|||
143130829|NCT01051817|516024262|FG001|Overall Study|Withdrawal by Subject|5|||
143130830|NCT01051817|516024261|FG000|Overall Study|Protocol Violation|0|||
143130831|NCT01051817|516024262|FG001|Overall Study|Protocol Violation|1|||
143130832|NCT04346199|516024263|FG000|Overall Study|Death|8|||
143130833|NCT04346199|516024264|FG001|Overall Study|Death|9|||
143130834|NCT04346199|516024263|FG000|Overall Study|Lost to Follow-up|0|||
143130835|NCT04346199|516024264|FG001|Overall Study|Lost to Follow-up|1|||
143130836|NCT04346199|516024263|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
143130837|NCT04346199|516024264|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
143130838|NCT04346199|516024263|FG000|Overall Study|Withdrawal by Subject|5|||
143130839|NCT04346199|516024264|FG001|Overall Study|Withdrawal by Subject|1|||
143130840|NCT01026948|516024265|FG000|Overall Study|Physician Decision|8|||
143130841|NCT02039778|516024268|FG000|Overall Study|Death|2|||
143130842|NCT02039778|516024268|FG000|Overall Study|Withdrawal by Subject|1|||
143130843|NCT02039778|516024268|FG000|Overall Study|Never started the protocol treatment|1|||
143130844|NCT01462110|516024275|FG000|Overall Study|Adverse Event|1|||
143130845|NCT01462110|516024276|FG001|Overall Study|Adverse Event|0|||
143130846|NCT03283930|516024277|FG000|Overall Study|Scheduling conflict|8|||
143130847|NCT03283930|516024278|FG001|Overall Study|Scheduling conflict|10|||
143130848|NCT03283930|516024277|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
143130849|NCT03283930|516024278|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
143130850|NCT03283930|516024277|FG000|Overall Study|Technical software issue|2|||
143130851|NCT03283930|516024278|FG001|Overall Study|Technical software issue|2|||
143130852|NCT00964028|516024284|FG000|Overall Study|Withdrawal by Subject|0|||
143130853|NCT00964028|516024285|FG001|Overall Study|Withdrawal by Subject|1|||
143130854|NCT01603407|516024286|FG000|Overall Study|Adverse Event|1|||
143130855|NCT01603407|516024287|FG001|Overall Study|Adverse Event|1|||
143130856|NCT01603407|516024288|FG002|Overall Study|Adverse Event|1|||
143130857|NCT01603407|516024286|FG000|Overall Study|Protocol Violation|2|||
143130858|NCT01603407|516024287|FG001|Overall Study|Protocol Violation|2|||
143130859|NCT01603407|516024288|FG002|Overall Study|Protocol Violation|0|||
143130860|NCT01603407|516024286|FG000|Overall Study|Withdrawal by Subject|8|||
143130861|NCT01603407|516024287|FG001|Overall Study|Withdrawal by Subject|5|||
143130862|NCT01603407|516024288|FG002|Overall Study|Withdrawal by Subject|7|||
143130863|NCT01603407|516024286|FG000|Overall Study|Lost to Follow-up|0|||
143130864|NCT01603407|516024287|FG001|Overall Study|Lost to Follow-up|3|||
143130865|NCT01603407|516024288|FG002|Overall Study|Lost to Follow-up|2|||
143130866|NCT00069823|516024293|FG000|Overall Study|Did not have follow-up diary cards|6|||
143130867|NCT00069823|516024294|FG001|Overall Study|Did not have follow-up diary cards|3|||
143130868|NCT03560869|516024295|FG000|Overall Study|Withdrawal by Subject|3|||
143130869|NCT03560869|516024296|FG001|Overall Study|Withdrawal by Subject|4|||
143130870|NCT03560869|516024295|FG000|Overall Study|Screening failure|4|||
143130871|NCT03560869|516024296|FG001|Overall Study|Screening failure|4|||
143130872|NCT03560869|516024295|FG000|Overall Study|Withdrawal by PI|0|||
143130873|NCT03560869|516024296|FG001|Overall Study|Withdrawal by PI|1|||
143130874|NCT01801111|516024297|FG000|Overall Study|Adverse Event|12|||
143130875|NCT01801111|516024297|FG000|Overall Study|Death|8|||
143130876|NCT01801111|516024297|FG000|Overall Study|Physician Decision|5|||
143358116|NCT03280563|516856087|FG007|Long-term Survival Follow-up|Death|1|||
143130877|NCT01801111|516024297|FG000|Overall Study|Other|1|||
143130878|NCT01801111|516024297|FG000|Overall Study|Withdrawal by Subject|4|||
143130879|NCT01801111|516024297|FG000|Overall Study|Study Terminated by Sponsor|27|||
143130880|NCT01801111|516024297|FG000|Overall Study|Progressive Disease|81|||
143130881|NCT01210482|516024298|FG000|Overall Study|Protocol Violation|1|||
143130882|NCT01210482|516024298|FG000|Overall Study|Case Report Forms were not collected|18|||
143130883|NCT01210482|516024298|FG000|Overall Study|Duplicated|2|||
143130884|NCT01210482|516024298|FG000|Overall Study|No Drug Administration|28|||
143130885|NCT01223937|516024299|FG000|Overall Study|Withdrawal by Subject|3|||
143130886|NCT01223937|516024300|FG001|Overall Study|Withdrawal by Subject|2|||
143130887|NCT01223937|516024299|FG000|Overall Study|Lost to Follow-up|1|||
143130888|NCT01223937|516024300|FG001|Overall Study|Lost to Follow-up|4|||
143130889|NCT01223937|516024299|FG000|Overall Study|Adverse Event|1|||
143130890|NCT01223937|516024300|FG001|Overall Study|Adverse Event|4|||
143130891|NCT01223937|516024299|FG000|Overall Study|Protocol Violation|8|||
143130892|NCT01223937|516024300|FG001|Overall Study|Protocol Violation|7|||
143130893|NCT01223937|516024299|FG000|Overall Study|Other|4|||
143130894|NCT01223937|516024300|FG001|Overall Study|Other|1|||
143130895|NCT00765817|516024301|FG000|Overall Study|Adverse Event|13|||
143130896|NCT00765817|516024302|FG001|Overall Study|Adverse Event|1|||
143130897|NCT00765817|516024301|FG000|Overall Study|Death|0|||
143130898|NCT00765817|516024302|FG001|Overall Study|Death|1|||
143130899|NCT00765817|516024301|FG000|Overall Study|Entry criteria not met|2|||
143130900|NCT00765817|516024302|FG001|Overall Study|Entry criteria not met|2|||
143130901|NCT00765817|516024301|FG000|Overall Study|Loss of glucose control|0|||
143130902|NCT00765817|516024302|FG001|Overall Study|Loss of glucose control|2|||
143130903|NCT00765817|516024301|FG000|Overall Study|Lost to Follow-up|1|||
143130904|NCT00765817|516024302|FG001|Overall Study|Lost to Follow-up|3|||
143130905|NCT00765817|516024301|FG000|Overall Study|Physician Decision|2|||
143130906|NCT00765817|516024302|FG001|Overall Study|Physician Decision|1|||
143130907|NCT00765817|516024301|FG000|Overall Study|Protocol Violation|1|||
143130908|NCT00765817|516024302|FG001|Overall Study|Protocol Violation|1|||
143130909|NCT00765817|516024301|FG000|Overall Study|Subject decision|7|||
143130910|NCT00765817|516024302|FG001|Overall Study|Subject decision|11|||
143130911|NCT06597084|516024303|FG000|Overall Study|Withdrawal by Subject|4|||
143130912|NCT06597084|516024304|FG001|Overall Study|Withdrawal by Subject|9|||
143130913|NCT06597084|516024303|FG000|Overall Study|Consent was not given by the patient until V2|0|||
143130914|NCT06597084|516024304|FG001|Overall Study|Consent was not given by the patient until V2|3|||
143130915|NCT06597084|516024303|FG000|Overall Study|Physician Decision|1|||
143130916|NCT06597084|516024304|FG001|Overall Study|Physician Decision|0|||
143130917|NCT06597084|516024303|FG000|Overall Study|Adverse Event|3|||
143130918|NCT06597084|516024304|FG001|Overall Study|Adverse Event|2|||
143130919|NCT06597084|516024303|FG000|Overall Study|Death|4|||
143130920|NCT06597084|516024304|FG001|Overall Study|Death|0|||
143130921|NCT06597084|516024303|FG000|Overall Study|Stroke more than 7 days after primary stroke|2|||
143130922|NCT06597084|516024304|FG001|Overall Study|Stroke more than 7 days after primary stroke|6|||
143130923|NCT06597084|516024303|FG000|Overall Study|Lost to Follow-up|4|||
143130924|NCT06597084|516024304|FG001|Overall Study|Lost to Follow-up|2|||
143130925|NCT06597084|516024303|FG000|Overall Study|Other. Not specified|1|||
143130926|NCT06597084|516024304|FG001|Overall Study|Other. Not specified|0|||
143130927|NCT00255164|516024309|FG000|Overall Study|Adverse Event|10|||
143130928|NCT00255164|516024310|FG001|Overall Study|Adverse Event|6|||
143130929|NCT00255164|516024311|FG002|Overall Study|Adverse Event|9|||
143130930|NCT00255164|516024309|FG000|Overall Study|Lost to Follow-up|4|||
143130931|NCT00255164|516024310|FG001|Overall Study|Lost to Follow-up|3|||
143130932|NCT00255164|516024311|FG002|Overall Study|Lost to Follow-up|4|||
143130933|NCT00255164|516024309|FG000|Overall Study|Withdrawal by Subject|18|||
143130934|NCT00255164|516024310|FG001|Overall Study|Withdrawal by Subject|17|||
143130935|NCT00255164|516024311|FG002|Overall Study|Withdrawal by Subject|8|||
143130936|NCT00255164|516024309|FG000|Overall Study|Noncompliance|0|||
143130937|NCT00255164|516024310|FG001|Overall Study|Noncompliance|1|||
143130938|NCT00255164|516024311|FG002|Overall Study|Noncompliance|2|||
143130939|NCT00255164|516024309|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
143130940|NCT00255164|516024310|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
143130941|NCT00255164|516024311|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
143130942|NCT00255164|516024309|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
143130943|NCT00255164|516024310|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
143130944|NCT00255164|516024311|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
143130945|NCT00255164|516024309|FG000|Overall Study|Possible Barrett's Esophagus|1|||
143130946|NCT00255164|516024310|FG001|Overall Study|Possible Barrett's Esophagus|3|||
143130947|NCT00255164|516024311|FG002|Overall Study|Possible Barrett's Esophagus|8|||
143230944|NCT01601535|516395569|FG005|Phase 1|Adverse Event|0|||
143230945|NCT01601535|516395564|FG000|Phase 1|Withdrawal by Subject|2|||
143230946|NCT01601535|516395565|FG001|Phase 1|Withdrawal by Subject|1|||
143130948|NCT00255164|516024309|FG000|Overall Study|Esophageal Stricture|0|||
143130949|NCT00255164|516024310|FG001|Overall Study|Esophageal Stricture|0|||
143130950|NCT00255164|516024311|FG002|Overall Study|Esophageal Stricture|1|||
143130951|NCT00255164|516024309|FG000|Overall Study|Therapeutic Failure|11|||
143130952|NCT00255164|516024310|FG001|Overall Study|Therapeutic Failure|2|||
143130953|NCT00255164|516024311|FG002|Overall Study|Therapeutic Failure|3|||
143130954|NCT03677869|516024312|FG000|Overall Study|Withdrawal by Subject|1|||
143130955|NCT01845597|516025682|FG000|Overall Study|Death|8|||
143130956|NCT01845597|516025682|FG000|Overall Study|Lost to Follow-up|22|||
143130957|NCT04194489|516025684|FG000|Overall Study|Withdrawal by Subject|5|||
143130958|NCT04194489|516025684|FG000|Overall Study|Lost to Follow-up|48|||
143130959|NCT00377637|516025688|FG000|Induction Phase|Adverse Event|12|||
143230947|NCT01601535|516395566|FG002|Phase 1|Withdrawal by Subject|1|||
143130960|NCT00377637|516025689|FG001|Induction Phase|Adverse Event|21|||
143130961|NCT00377637|516025690|FG002|Induction Phase|Adverse Event|0|||
143230948|NCT01601535|516395567|FG003|Phase 1|Withdrawal by Subject|2|||
143130962|NCT00377637|516025691|FG003|Induction Phase|Adverse Event|0|||
143130963|NCT00377637|516025688|FG000|Induction Phase|Deterioration/serum creatinine|2|||
143130964|NCT00377637|516025689|FG001|Induction Phase|Deterioration/serum creatinine|0|||
143130965|NCT00377637|516025690|FG002|Induction Phase|Deterioration/serum creatinine|0|||
143130966|NCT00377637|516025691|FG003|Induction Phase|Deterioration/serum creatinine|0|||
143130967|NCT00377637|516025688|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
143130968|NCT00377637|516025689|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
143130969|NCT00377637|516025690|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
143130970|NCT00377637|516025691|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
143130971|NCT00377637|516025688|FG000|Induction Phase|Lost to Follow-up|2|||
143130972|NCT00377637|516025689|FG001|Induction Phase|Lost to Follow-up|1|||
143130973|NCT00377637|516025690|FG002|Induction Phase|Lost to Follow-up|0|||
143130974|NCT00377637|516025691|FG003|Induction Phase|Lost to Follow-up|0|||
143130975|NCT00377637|516025688|FG000|Induction Phase|Death|1|||
143130976|NCT00377637|516025689|FG001|Induction Phase|Death|3|||
143130977|NCT00377637|516025690|FG002|Induction Phase|Death|0|||
143130978|NCT00377637|516025691|FG003|Induction Phase|Death|0|||
143130979|NCT00377637|516025688|FG000|Induction Phase|Withdrawal by Subject|5|||
143130980|NCT00377637|516025689|FG001|Induction Phase|Withdrawal by Subject|6|||
143130981|NCT00377637|516025690|FG002|Induction Phase|Withdrawal by Subject|0|||
143130982|NCT00377637|516025691|FG003|Induction Phase|Withdrawal by Subject|0|||
143130983|NCT00377637|516025688|FG000|Induction Phase|Physician Decision|3|||
143130984|NCT00377637|516025689|FG001|Induction Phase|Physician Decision|1|||
143130985|NCT00377637|516025690|FG002|Induction Phase|Physician Decision|0|||
143130986|NCT00377637|516025691|FG003|Induction Phase|Physician Decision|0|||
143130987|NCT00377637|516025688|FG000|Induction Phase|Sponsor decision|1|||
143130988|NCT00377637|516025689|FG001|Induction Phase|Sponsor decision|2|||
143130989|NCT00377637|516025690|FG002|Induction Phase|Sponsor decision|0|||
143130990|NCT00377637|516025691|FG003|Induction Phase|Sponsor decision|0|||
143130991|NCT00377637|516025688|FG000|Induction Phase|Non-Compliance|1|||
143130992|NCT00377637|516025689|FG001|Induction Phase|Non-Compliance|0|||
143130993|NCT00377637|516025690|FG002|Induction Phase|Non-Compliance|0|||
143130994|NCT00377637|516025691|FG003|Induction Phase|Non-Compliance|0|||
143130995|NCT00377637|516025688|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
143130996|NCT00377637|516025689|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
143130997|NCT00377637|516025690|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
143130998|NCT00377637|516025691|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
143130999|NCT00377637|516025688|FG000|Maintenance Phase|Adverse Event|0|||
143131000|NCT00377637|516025689|FG001|Maintenance Phase|Adverse Event|0|||
143131001|NCT00377637|516025690|FG002|Maintenance Phase|Adverse Event|29|||
143131002|NCT00377637|516025691|FG003|Maintenance Phase|Adverse Event|43|||
143131003|NCT00377637|516025688|FG000|Maintenance Phase|Physician Decision|0|||
143131004|NCT00377637|516025689|FG001|Maintenance Phase|Physician Decision|0|||
143131005|NCT00377637|516025690|FG002|Maintenance Phase|Physician Decision|5|||
143131006|NCT00377637|516025691|FG003|Maintenance Phase|Physician Decision|4|||
143131007|NCT00377637|516025688|FG000|Maintenance Phase|Lost to Follow-up|0|||
143131008|NCT00377637|516025689|FG001|Maintenance Phase|Lost to Follow-up|0|||
143131009|NCT00377637|516025690|FG002|Maintenance Phase|Lost to Follow-up|3|||
143131010|NCT00377637|516025691|FG003|Maintenance Phase|Lost to Follow-up|1|||
143131011|NCT00377637|516025688|FG000|Maintenance Phase|Withdrawal by Subject|0|||
143131012|NCT00377637|516025689|FG001|Maintenance Phase|Withdrawal by Subject|0|||
143131013|NCT00377637|516025690|FG002|Maintenance Phase|Withdrawal by Subject|3|||
143131014|NCT00377637|516025691|FG003|Maintenance Phase|Withdrawal by Subject|3|||
143131015|NCT00377637|516025688|FG000|Maintenance Phase|Sponsor decision|0|||
143131016|NCT00377637|516025689|FG001|Maintenance Phase|Sponsor decision|0|||
143131017|NCT00377637|516025690|FG002|Maintenance Phase|Sponsor decision|2|||
143131018|NCT00377637|516025691|FG003|Maintenance Phase|Sponsor decision|3|||
143131019|NCT00377637|516025688|FG000|Maintenance Phase|Non-compliance|0|||
143131020|NCT00377637|516025689|FG001|Maintenance Phase|Non-compliance|0|||
143131021|NCT00377637|516025690|FG002|Maintenance Phase|Non-compliance|1|||
143131022|NCT00377637|516025691|FG003|Maintenance Phase|Non-compliance|1|||
143131023|NCT00377637|516025688|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
143131024|NCT00377637|516025689|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
143131025|NCT00377637|516025690|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
143131026|NCT00377637|516025691|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
143131027|NCT00377637|516025688|FG000|Maintenance Phase|Death|0|||
143131028|NCT00377637|516025689|FG001|Maintenance Phase|Death|0|||
143131029|NCT00377637|516025690|FG002|Maintenance Phase|Death|0|||
143131030|NCT00377637|516025691|FG003|Maintenance Phase|Death|1|||
143131031|NCT04147247|516025692|FG000|Overall Study|Progressive disease|3|||
143131032|NCT04147247|516025693|FG001|Overall Study|Progressive disease|3|||
143131033|NCT04147247|516025694|FG002|Overall Study|Progressive disease|4|||
143131034|NCT04147247|516025695|FG003|Overall Study|Progressive disease|4|||
143131035|NCT04147247|516025696|FG004|Overall Study|Progressive disease|3|||
143131036|NCT04147247|516025692|FG000|Overall Study|Physician Decision|0|||
143131037|NCT04147247|516025693|FG001|Overall Study|Physician Decision|1|||
143131038|NCT04147247|516025694|FG002|Overall Study|Physician Decision|0|||
143131039|NCT04147247|516025695|FG003|Overall Study|Physician Decision|0|||
143131040|NCT04147247|516025696|FG004|Overall Study|Physician Decision|0|||
143131041|NCT04147247|516025692|FG000|Overall Study|Clinical Disease Progression|0|||
143131042|NCT04147247|516025693|FG001|Overall Study|Clinical Disease Progression|0|||
143131043|NCT04147247|516025694|FG002|Overall Study|Clinical Disease Progression|0|||
143131044|NCT04147247|516025695|FG003|Overall Study|Clinical Disease Progression|0|||
143131045|NCT04147247|516025696|FG004|Overall Study|Clinical Disease Progression|1|||
143131046|NCT04147247|516025692|FG000|Overall Study|Adverse Event|0|||
143131047|NCT04147247|516025693|FG001|Overall Study|Adverse Event|0|||
143131048|NCT04147247|516025694|FG002|Overall Study|Adverse Event|1|||
143131049|NCT04147247|516025695|FG003|Overall Study|Adverse Event|0|||
143131050|NCT04147247|516025696|FG004|Overall Study|Adverse Event|1|||
143131051|NCT02121795|516025697|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
143131052|NCT02121795|516025698|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
143131053|NCT02121795|516025697|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
143131054|NCT02121795|516025698|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
143131055|NCT02121795|516025697|FG000|Double-Blind Phase|Lost to Follow-up|7|||
143131056|NCT02121795|516025698|FG001|Double-Blind Phase|Lost to Follow-up|4|||
143131057|NCT02121795|516025697|FG000|Double-Blind Phase|Physician Decision|2|||
143131058|NCT02121795|516025698|FG001|Double-Blind Phase|Physician Decision|5|||
143131059|NCT02121795|516025697|FG000|Double-Blind Phase|Adverse Event|5|||
143131060|NCT02121795|516025698|FG001|Double-Blind Phase|Adverse Event|0|||
143131061|NCT02121795|516025697|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
143131062|NCT02121795|516025698|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
143131063|NCT02121795|516025697|FG000|Double-Blind Phase|Protocol Violation|0|||
143131064|NCT02121795|516025698|FG001|Double-Blind Phase|Protocol Violation|3|||
143131065|NCT02121795|516025697|FG000|Double-Blind Phase|Death|1|||
143131066|NCT02121795|516025698|FG001|Double-Blind Phase|Death|1|||
143131067|NCT02121795|516025697|FG000|Open-Label Phase|Physician Decision|8|||
143131068|NCT02121795|516025698|FG001|Open-Label Phase|Physician Decision|8|||
143131069|NCT02121795|516025697|FG000|Open-Label Phase|Withdrawal by Subject|3|||
143131070|NCT02121795|516025698|FG001|Open-Label Phase|Withdrawal by Subject|2|||
143131071|NCT02121795|516025697|FG000|Open-Label Phase|Lost to Follow-up|1|||
143131072|NCT02121795|516025698|FG001|Open-Label Phase|Lost to Follow-up|0|||
143131073|NCT04155463|516025699|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
143131074|NCT04155463|516025700|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
143131075|NCT01348139|516025703|FG000|Period 1|Adverse Event|1|||
143131076|NCT01348139|516025704|FG001|Period 1|Adverse Event|0|||
143131077|NCT01348139|516025705|FG002|Period 1|Adverse Event|0|||
143131078|NCT01348139|516025706|FG003|Period 1|Adverse Event|0|||
143131079|NCT01348139|516025707|FG004|Period 1|Adverse Event|0|||
143131080|NCT01348139|516025708|FG005|Period 1|Adverse Event|0|||
143131081|NCT02762084|516025709|FG000|Overall Study|Withdrawal by Subject|1|||
143131082|NCT02762084|516025710|FG001|Overall Study|Withdrawal by Subject|0|||
143131083|NCT02762084|516025711|FG002|Overall Study|Withdrawal by Subject|0|||
143131084|NCT02762084|516025709|FG000|Overall Study|Adverse Event|0|||
143131085|NCT02762084|516025710|FG001|Overall Study|Adverse Event|0|||
143131086|NCT02762084|516025711|FG002|Overall Study|Adverse Event|1|||
143131087|NCT02254772|516025714|FG000|Overall Study|Ineligible|1|||
143131088|NCT02254772|516025714|FG000|Overall Study|Withdrawal by Subject|1|||
143131089|NCT01781962|516025715|FG000|Overall Study|Other Miscellaneous Reasons|5|||
143131090|NCT03200548|516025716|FG000|Overall Study|Withdrawal by Subject|5|||
143131091|NCT03200548|516025717|FG001|Overall Study|Withdrawal by Subject|11|||
143131092|NCT03200548|516025718|FG002|Overall Study|Withdrawal by Subject|7|||
143131093|NCT03200548|516025719|FG003|Overall Study|Withdrawal by Subject|6|||
143131094|NCT00313846|516025720|FG000|Overall Study|Withdrawal by Subject|2|||
143131095|NCT00313846|516025721|FG001|Overall Study|Withdrawal by Subject|0|||
143131096|NCT00313846|516025720|FG000|Overall Study|Adverse Event|1|||
143131097|NCT00313846|516025721|FG001|Overall Study|Adverse Event|8|||
143131098|NCT00313846|516025720|FG000|Overall Study|Administrative|2|||
143131099|NCT00313846|516025721|FG001|Overall Study|Administrative|3|||
143131100|NCT01765296|516025722|FG000|Overall Study|Protocol Violation|0|||
143131101|NCT01765296|516025723|FG001|Overall Study|Protocol Violation|5|||
143131102|NCT01765296|516025724|FG002|Overall Study|Protocol Violation|4|||
143131103|NCT01765296|516025722|FG000|Overall Study|Withdrawal by Subject|4|||
143131104|NCT01765296|516025723|FG001|Overall Study|Withdrawal by Subject|2|||
143131105|NCT01765296|516025724|FG002|Overall Study|Withdrawal by Subject|2|||
143131106|NCT01765296|516025722|FG000|Overall Study|Adverse Event|1|||
143131107|NCT01765296|516025723|FG001|Overall Study|Adverse Event|13|||
143131108|NCT01765296|516025724|FG002|Overall Study|Adverse Event|5|||
143131109|NCT01765296|516025722|FG000|Overall Study|Lack of Efficacy|0|||
143131110|NCT01765296|516025723|FG001|Overall Study|Lack of Efficacy|0|||
143131111|NCT01765296|516025724|FG002|Overall Study|Lack of Efficacy|2|||
143131112|NCT01619852|516025725|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
143131113|NCT01619852|516025726|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
143131114|NCT01619852|516025725|FG000|3 Month Follow up|Lost to Follow-up|31|||
143131115|NCT01619852|516025726|FG001|3 Month Follow up|Lost to Follow-up|34|||
143131116|NCT01841970|516025727|FG000|Overall Study|Withdrawal by Subject|1|||
143131117|NCT01841970|516025727|FG000|Overall Study|Physician Decision|2|||
143131118|NCT01841970|516025727|FG000|Overall Study|Lost to Follow-up|8|||
143131119|NCT03478371|516025728|FG000|Overall Study|non-compliance|1|||
143131120|NCT03478371|516025728|FG000|Overall Study|Lost to Follow-up|4|||
143131121|NCT04556760|516025729|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
143131122|NCT04556760|516025730|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
143131123|NCT04556760|516025731|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
143131124|NCT04556760|516025732|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
143131125|NCT04556760|516025733|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
143131126|NCT04556760|516025734|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
143131127|NCT04556760|516025729|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
143131128|NCT04556760|516025730|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
143131129|NCT04556760|516025731|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
143131130|NCT04556760|516025732|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
143131131|NCT04556760|516025733|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
143131132|NCT04556760|516025734|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
143131133|NCT02849743|516025735|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
143131134|NCT02849743|516025736|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
143131135|NCT02849743|516025735|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
143131136|NCT02849743|516025736|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
143131137|NCT02168491|516025740|FG000|Overall Study|Withdrawal by Subject|1|||
143131138|NCT03874013|516025741|FG000|Overall Study|Adverse Event|0|||
143131139|NCT03874013|516025742|FG001|Overall Study|Adverse Event|1|||
143131140|NCT01705977|516025758|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
143131141|NCT01705977|516025759|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
143131142|NCT01705977|516025758|FG000|Treatment Period (Year 1)|Adverse Event|57|||
143131143|NCT01705977|516025759|FG001|Treatment Period (Year 1)|Adverse Event|49|||
143131144|NCT01705977|516025758|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
143131145|NCT01705977|516025759|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
143131146|NCT01705977|516025758|FG000|Treatment Period (Year 1)|Site closure|3|||
143131147|NCT01705977|516025759|FG001|Treatment Period (Year 1)|Site closure|2|||
143131148|NCT01705977|516025758|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
143131149|NCT01705977|516025759|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
143131150|NCT01705977|516025758|FG000|Treatment Period (Year 1)|Physician Decision|48|||
143131151|NCT01705977|516025759|FG001|Treatment Period (Year 1)|Physician Decision|38|||
143131152|NCT01705977|516025758|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
143230949|NCT01601535|516395568|FG004|Phase 1|Withdrawal by Subject|0|||
143230950|NCT01601535|516395569|FG005|Phase 1|Withdrawal by Subject|0|||
143230951|NCT01601535|516395564|FG000|Phase 1|Progressive Disease|2|||
143230952|NCT01601535|516395565|FG001|Phase 1|Progressive Disease|3|||
143230953|NCT01601535|516395566|FG002|Phase 1|Progressive Disease|2|||
143230954|NCT01601535|516395567|FG003|Phase 1|Progressive Disease|1|||
143230955|NCT01601535|516395568|FG004|Phase 1|Progressive Disease|0|||
143230956|NCT01601535|516395569|FG005|Phase 1|Progressive Disease|0|||
143230957|NCT01601535|516395564|FG000|Phase 1|Started Another Treatment|1|||
143230958|NCT01601535|516395565|FG001|Phase 1|Started Another Treatment|2|||
143230959|NCT01601535|516395566|FG002|Phase 1|Started Another Treatment|0|||
143230960|NCT01601535|516395567|FG003|Phase 1|Started Another Treatment|0|||
143230961|NCT01601535|516395568|FG004|Phase 1|Started Another Treatment|0|||
143230962|NCT01601535|516395569|FG005|Phase 1|Started Another Treatment|0|||
143230963|NCT01601535|516395564|FG000|Phase 2|Adverse Event|0|||
143230964|NCT01601535|516395565|FG001|Phase 2|Adverse Event|0|||
143230965|NCT01601535|516395566|FG002|Phase 2|Adverse Event|0|||
143230966|NCT01601535|516395567|FG003|Phase 2|Adverse Event|0|||
143230967|NCT01601535|516395568|FG004|Phase 2|Adverse Event|5|||
143230968|NCT01601535|516395569|FG005|Phase 2|Adverse Event|1|||
143230969|NCT01601535|516395564|FG000|Phase 2|Withdrawal by Subject|0|||
143230970|NCT01601535|516395565|FG001|Phase 2|Withdrawal by Subject|0|||
143230971|NCT01601535|516395566|FG002|Phase 2|Withdrawal by Subject|0|||
143230972|NCT01601535|516395567|FG003|Phase 2|Withdrawal by Subject|0|||
143230973|NCT01601535|516395568|FG004|Phase 2|Withdrawal by Subject|8|||
143230974|NCT01601535|516395569|FG005|Phase 2|Withdrawal by Subject|2|||
143230975|NCT01601535|516395564|FG000|Phase 2|Progressive Disease|0|||
143131153|NCT01705977|516025759|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
143230976|NCT01601535|516395565|FG001|Phase 2|Progressive Disease|0|||
143230977|NCT01601535|516395566|FG002|Phase 2|Progressive Disease|0|||
143230978|NCT01601535|516395567|FG003|Phase 2|Progressive Disease|0|||
143230979|NCT01601535|516395568|FG004|Phase 2|Progressive Disease|5|||
143230980|NCT01601535|516395569|FG005|Phase 2|Progressive Disease|7|||
143230981|NCT01601535|516395564|FG000|Phase 2|Started Another Treatment|0|||
143230982|NCT01601535|516395565|FG001|Phase 2|Started Another Treatment|0|||
143230983|NCT01601535|516395566|FG002|Phase 2|Started Another Treatment|0|||
143131154|NCT01705977|516025758|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
143131155|NCT01705977|516025759|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
143131156|NCT01705977|516025758|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
143131157|NCT01705977|516025759|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
143131158|NCT01705977|516025758|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
143131159|NCT01705977|516025759|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
143131160|NCT01705977|516025758|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
143131161|NCT01705977|516025759|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
143131162|NCT01705977|516025758|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
143131163|NCT01705977|516025759|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
143131164|NCT02989402|516025762|FG000|Overall Study|Adverse event, or serious adverse event|4|||
143131165|NCT02989402|516025762|FG000|Overall Study|Death|2|||
143131166|NCT02989402|516025762|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
143131167|NCT02989402|516025762|FG000|Overall Study|Lost to Follow-up|8|||
143131168|NCT02989402|516025762|FG000|Overall Study|Patient no longer on monotherapy|1|||
143131169|NCT02989402|516025762|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
143131170|NCT02989402|516025762|FG000|Overall Study|Withdrawal by Subject|7|||
143131171|NCT02989402|516025762|FG000|Overall Study|Other|2|||
143131172|NCT00753675|516025768|FG000|Overall Study|other reason|11|||
143131173|NCT00753675|516025769|FG001|Overall Study|other reason|12|||
143131174|NCT00753675|516025770|FG002|Overall Study|other reason|13|||
143131175|NCT00753675|516025768|FG000|Overall Study|Death|1|||
143131176|NCT00753675|516025769|FG001|Overall Study|Death|2|||
143131177|NCT00753675|516025770|FG002|Overall Study|Death|4|||
143131178|NCT00753675|516025768|FG000|Overall Study|Adverse Event|11|||
143131179|NCT00753675|516025769|FG001|Overall Study|Adverse Event|9|||
143131180|NCT00753675|516025770|FG002|Overall Study|Adverse Event|4|||
143131181|NCT00753675|516025768|FG000|Overall Study|Objective progression of disease|35|||
143131182|NCT00753675|516025769|FG001|Overall Study|Objective progression of disease|35|||
143131183|NCT00753675|516025770|FG002|Overall Study|Objective progression of disease|35|||
143131184|NCT00753675|516025768|FG000|Overall Study|Withdrawal by Subject|0|||
143131185|NCT00753675|516025769|FG001|Overall Study|Withdrawal by Subject|1|||
143131186|NCT00753675|516025770|FG002|Overall Study|Withdrawal by Subject|0|||
143131187|NCT00753675|516025768|FG000|Overall Study|Lost to Follow-up|1|||
143131188|NCT00753675|516025769|FG001|Overall Study|Lost to Follow-up|0|||
143131189|NCT00753675|516025770|FG002|Overall Study|Lost to Follow-up|0|||
143131190|NCT02149264|516025777|FG000|Overall Study|Withdrawal by Subject|9|||
143131191|NCT02149264|516025777|FG000|Overall Study|Adverse Event|7|||
143131192|NCT02149264|516025777|FG000|Overall Study|Physician Decision|3|||
143131193|NCT02149264|516025777|FG000|Overall Study|Protocol Violation|1|||
143131194|NCT02824627|516025781|FG000|Overall Study|Adverse Event|1|||
143131195|NCT02824627|516025782|FG001|Overall Study|Adverse Event|2|||
143131196|NCT02824627|516025781|FG000|Overall Study|Lost to Follow-up|2|||
143131197|NCT02824627|516025782|FG001|Overall Study|Lost to Follow-up|1|||
143131198|NCT00672633|516025783|FG000|Overall Study|Withdrawal by Subject|0|||
143131199|NCT00672633|516025784|FG001|Overall Study|Withdrawal by Subject|1|||
143131200|NCT01938846|516025785|FG000|Overall Study|Progressive disease|26|||
143131201|NCT01938846|516025786|FG001|Overall Study|Progressive disease|18|||
143131202|NCT01938846|516025787|FG002|Overall Study|Progressive disease|16|||
143131203|NCT01938846|516025785|FG000|Overall Study|Adverse Event|8|||
143131204|NCT01938846|516025786|FG001|Overall Study|Adverse Event|4|||
143131205|NCT01938846|516025787|FG002|Overall Study|Adverse Event|3|||
143131206|NCT01938846|516025785|FG000|Overall Study|Withdrawal by Subject|2|||
143131207|NCT01938846|516025786|FG001|Overall Study|Withdrawal by Subject|2|||
143131208|NCT01938846|516025787|FG002|Overall Study|Withdrawal by Subject|1|||
143131209|NCT01938846|516025785|FG000|Overall Study|Other than listed|5|||
143131210|NCT01938846|516025786|FG001|Overall Study|Other than listed|1|||
143131211|NCT01938846|516025787|FG002|Overall Study|Other than listed|4|||
143131212|NCT02499120|516025788|FG000|Overall Study|Death|52|||
143131213|NCT02499120|516025789|FG001|Overall Study|Death|43|||
143131214|NCT02499120|516025788|FG000|Overall Study|Lost to Follow-up|1|||
143131215|NCT02499120|516025789|FG001|Overall Study|Lost to Follow-up|2|||
143230984|NCT01601535|516395567|FG003|Phase 2|Started Another Treatment|0|||
143131216|NCT02499120|516025788|FG000|Overall Study|Participant refused further follow-up|1|||
143131217|NCT02499120|516025789|FG001|Overall Study|Participant refused further follow-up|0|||
143131218|NCT02499120|516025788|FG000|Overall Study|Withdrawal by Subject|2|||
143131219|NCT02499120|516025789|FG001|Overall Study|Withdrawal by Subject|5|||
143131220|NCT02499120|516025788|FG000|Overall Study|Other|9|||
143131221|NCT02499120|516025789|FG001|Overall Study|Other|10|||
143131222|NCT02106351|516025798|FG000|Treatment Cycle 1|Adverse Event|2|||
143131223|NCT02106351|516025799|FG001|Treatment Cycle 1|Adverse Event|0|||
143131224|NCT02106351|516025800|FG002|Treatment Cycle 1|Adverse Event|0|||
143131225|NCT02106351|516025798|FG000|Treatment Cycle 1|Consent withdrawn|1|||
143131226|NCT02106351|516025799|FG001|Treatment Cycle 1|Consent withdrawn|0|||
143131227|NCT02106351|516025800|FG002|Treatment Cycle 1|Consent withdrawn|2|||
143131228|NCT02106351|516025798|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
143131229|NCT02106351|516025799|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
143131230|NCT02106351|516025800|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
143131231|NCT02106351|516025798|FG000|Treatment Cycle 1|Other|0|||
143131232|NCT02106351|516025799|FG001|Treatment Cycle 1|Other|3|||
143131233|NCT02106351|516025800|FG002|Treatment Cycle 1|Other|1|||
143131234|NCT02106351|516025798|FG000|Treatment Cycle 1|Randomised but not treated|1|||
143131235|NCT02106351|516025799|FG001|Treatment Cycle 1|Randomised but not treated|0|||
143131236|NCT02106351|516025800|FG002|Treatment Cycle 1|Randomised but not treated|1|||
143131237|NCT02106351|516025798|FG000|Treatment Cycle 2|Adverse Event|0|||
143131238|NCT02106351|516025799|FG001|Treatment Cycle 2|Adverse Event|2|||
143131239|NCT02106351|516025800|FG002|Treatment Cycle 2|Adverse Event|0|||
143131240|NCT02106351|516025798|FG000|Treatment Cycle 2|Consent withdrawn|0|||
143131241|NCT02106351|516025799|FG001|Treatment Cycle 2|Consent withdrawn|1|||
143131242|NCT02106351|516025800|FG002|Treatment Cycle 2|Consent withdrawn|1|||
143131243|NCT02106351|516025798|FG000|Treatment Cycle 2|Other|0|||
143131244|NCT02106351|516025799|FG001|Treatment Cycle 2|Other|2|||
143131245|NCT02106351|516025800|FG002|Treatment Cycle 2|Other|2|||
143131246|NCT02106351|516025798|FG000|Treatment Cycle 3|Adverse Event|0|||
143131247|NCT02106351|516025799|FG001|Treatment Cycle 3|Adverse Event|1|||
143131248|NCT02106351|516025800|FG002|Treatment Cycle 3|Adverse Event|0|||
143131249|NCT02106351|516025798|FG000|Treatment Cycle 3|Consent withdrawn|0|||
143131250|NCT02106351|516025799|FG001|Treatment Cycle 3|Consent withdrawn|0|||
143131251|NCT02106351|516025800|FG002|Treatment Cycle 3|Consent withdrawn|2|||
143131252|NCT02106351|516025798|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
143131253|NCT02106351|516025799|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
143131254|NCT02106351|516025800|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
143131255|NCT02106351|516025798|FG000|Treatment Cycle 3|Other|0|||
143131256|NCT02106351|516025799|FG001|Treatment Cycle 3|Other|2|||
143131257|NCT02106351|516025800|FG002|Treatment Cycle 3|Other|3|||
143131258|NCT02106351|516025798|FG000|Treatment Cycle 4|Consent withdrawn|0|||
143131259|NCT02106351|516025799|FG001|Treatment Cycle 4|Consent withdrawn|0|||
143131260|NCT02106351|516025800|FG002|Treatment Cycle 4|Consent withdrawn|2|||
143131261|NCT02106351|516025798|FG000|Treatment Cycle 4|Other|0|||
143131262|NCT02106351|516025799|FG001|Treatment Cycle 4|Other|1|||
143131263|NCT02106351|516025800|FG002|Treatment Cycle 4|Other|0|||
143131264|NCT00520039|516025803|FG000|Overall Study|Exclusion criteria met at first visit|7|||
143131265|NCT00520039|516025804|FG001|Overall Study|Exclusion criteria met at first visit|5|||
143131266|NCT05176717|516025806|FG000|Overall Study|Sponsor Decision|1|||
143131267|NCT05176717|516025807|FG001|Overall Study|Sponsor Decision|2|||
143131268|NCT05176717|516025808|FG002|Overall Study|Sponsor Decision|2|||
143131269|NCT05219968|516025812|FG000|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|6|||
143131270|NCT05219968|516025813|FG001|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
143131271|NCT05219968|516025814|FG002|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
143131272|NCT05219968|516025815|FG003|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
143131273|NCT05219968|516025816|FG004|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
143131274|NCT05219968|516025812|FG000|Week 24 Treatment Period|Bilateral dislodgement|13|||
143131275|NCT05219968|516025813|FG001|Week 24 Treatment Period|Bilateral dislodgement|0|||
143131276|NCT05219968|516025814|FG002|Week 24 Treatment Period|Bilateral dislodgement|0|||
143131277|NCT05219968|516025815|FG003|Week 24 Treatment Period|Bilateral dislodgement|0|||
143131278|NCT05219968|516025816|FG004|Week 24 Treatment Period|Bilateral dislodgement|0|||
143131279|NCT05219968|516025812|FG000|Week 24 Treatment Period|Withdrawal by Subject|2|||
143131280|NCT05219968|516025813|FG001|Week 24 Treatment Period|Withdrawal by Subject|2|||
143131281|NCT05219968|516025814|FG002|Week 24 Treatment Period|Withdrawal by Subject|0|||
143131282|NCT05219968|516025815|FG003|Week 24 Treatment Period|Withdrawal by Subject|0|||
143131283|NCT05219968|516025816|FG004|Week 24 Treatment Period|Withdrawal by Subject|0|||
143131284|NCT05219968|516025812|FG000|Week 24 Treatment Period|Adverse Event|3|||
143131285|NCT05219968|516025813|FG001|Week 24 Treatment Period|Adverse Event|0|||
143131286|NCT05219968|516025814|FG002|Week 24 Treatment Period|Adverse Event|0|||
143131287|NCT05219968|516025815|FG003|Week 24 Treatment Period|Adverse Event|0|||
143131288|NCT05219968|516025816|FG004|Week 24 Treatment Period|Adverse Event|0|||
143131289|NCT05219968|516025812|FG000|Week 24 Treatment Period|Physician Decision|0|||
143131290|NCT05219968|516025813|FG001|Week 24 Treatment Period|Physician Decision|1|||
143131291|NCT05219968|516025814|FG002|Week 24 Treatment Period|Physician Decision|0|||
143131292|NCT05219968|516025815|FG003|Week 24 Treatment Period|Physician Decision|0|||
143131293|NCT05219968|516025816|FG004|Week 24 Treatment Period|Physician Decision|0|||
143131294|NCT05219968|516025812|FG000|Week 24 Treatment Period|Other, not specified|3|||
143131295|NCT05219968|516025813|FG001|Week 24 Treatment Period|Other, not specified|0|||
143131296|NCT05219968|516025814|FG002|Week 24 Treatment Period|Other, not specified|0|||
143131297|NCT05219968|516025815|FG003|Week 24 Treatment Period|Other, not specified|0|||
143131298|NCT05219968|516025816|FG004|Week 24 Treatment Period|Other, not specified|0|||
143131299|NCT05219968|516025812|FG000|Safety Extension Period|Treatment administration failure|0|||
143131300|NCT05219968|516025813|FG001|Safety Extension Period|Treatment administration failure|0|||
143131301|NCT05219968|516025814|FG002|Safety Extension Period|Treatment administration failure|0|||
143131302|NCT05219968|516025815|FG003|Safety Extension Period|Treatment administration failure|1|||
143131303|NCT05219968|516025816|FG004|Safety Extension Period|Treatment administration failure|4|||
143131304|NCT05219968|516025812|FG000|Safety Extension Period|Bilateral dislodgement|0|||
143131305|NCT05219968|516025813|FG001|Safety Extension Period|Bilateral dislodgement|0|||
143131306|NCT05219968|516025814|FG002|Safety Extension Period|Bilateral dislodgement|4|||
143131307|NCT05219968|516025815|FG003|Safety Extension Period|Bilateral dislodgement|0|||
143131308|NCT05219968|516025816|FG004|Safety Extension Period|Bilateral dislodgement|1|||
143131309|NCT05219968|516025812|FG000|Safety Extension Period|Withdrawal by Subject|0|||
143131310|NCT05219968|516025813|FG001|Safety Extension Period|Withdrawal by Subject|0|||
143131311|NCT05219968|516025814|FG002|Safety Extension Period|Withdrawal by Subject|2|||
143131312|NCT05219968|516025815|FG003|Safety Extension Period|Withdrawal by Subject|0|||
143131313|NCT05219968|516025816|FG004|Safety Extension Period|Withdrawal by Subject|4|||
143131314|NCT05219968|516025812|FG000|Safety Extension Period|Adverse Event|0|||
143131315|NCT05219968|516025813|FG001|Safety Extension Period|Adverse Event|0|||
143131316|NCT05219968|516025814|FG002|Safety Extension Period|Adverse Event|2|||
143131317|NCT05219968|516025815|FG003|Safety Extension Period|Adverse Event|1|||
143131318|NCT05219968|516025816|FG004|Safety Extension Period|Adverse Event|1|||
143131319|NCT05219968|516025812|FG000|Safety Extension Period|Lost to Follow-up|0|||
143131320|NCT05219968|516025813|FG001|Safety Extension Period|Lost to Follow-up|0|||
143131321|NCT05219968|516025814|FG002|Safety Extension Period|Lost to Follow-up|0|||
143131322|NCT05219968|516025815|FG003|Safety Extension Period|Lost to Follow-up|1|||
143131323|NCT05219968|516025816|FG004|Safety Extension Period|Lost to Follow-up|0|||
143131324|NCT00327340|516027305|FG000|Overall Study|Withdrawal by Subject|1|||
143131325|NCT00327340|516027306|FG001|Overall Study|Withdrawal by Subject|5|||
143131326|NCT00327340|516027305|FG000|Overall Study|Physician Decision|1|||
143131327|NCT00327340|516027306|FG001|Overall Study|Physician Decision|1|||
143131328|NCT00327340|516027305|FG000|Overall Study|Disease Progression|10|||
143131329|NCT00327340|516027306|FG001|Overall Study|Disease Progression|19|||
143131330|NCT00327340|516027305|FG000|Overall Study|Symptomatic Disease|0|||
143131331|NCT00327340|516027306|FG001|Overall Study|Symptomatic Disease|2|||
143131332|NCT00327340|516027305|FG000|Overall Study|Adverse Event|3|||
143131333|NCT00327340|516027306|FG001|Overall Study|Adverse Event|3|||
143131334|NCT00956839|516027307|FG000|Overall Study|Lost to Follow-up|3|||
143131335|NCT00956839|516027308|FG001|Overall Study|Lost to Follow-up|0|||
143131336|NCT00956839|516027309|FG002|Overall Study|Lost to Follow-up|3|||
143131337|NCT00130689|516027311|FG000|Overall Study|Progressive Disease|29|||
143131338|NCT00130689|516027311|FG000|Overall Study|Death|1|||
143131339|NCT00130689|516027311|FG000|Overall Study|Clinical Deterioration|4|||
143131340|NCT00130689|516027311|FG000|Overall Study|Withdrawal by Subject|3|||
143131341|NCT00130689|516027311|FG000|Overall Study|Ineligible|6|||
143131342|NCT00766597|516027312|FG000|Overall Study|Unexpected closure of study|4|||
143131343|NCT00766597|516027312|FG000|Overall Study|Without CCR5-tropic virus|5|||
143131344|NCT00943397|516027313|FG000|Overall Study|Adverse Event|0|||
143131345|NCT00943397|516027314|FG001|Overall Study|Adverse Event|6|||
143131346|NCT00943397|516027313|FG000|Overall Study|Lost to Follow-up|0|||
143131347|NCT00943397|516027314|FG001|Overall Study|Lost to Follow-up|4|||
143131348|NCT00943397|516027313|FG000|Overall Study|Protocol Violation|2|||
143131349|NCT00943397|516027314|FG001|Overall Study|Protocol Violation|5|||
143131350|NCT00943397|516027313|FG000|Overall Study|Withdrawal by Subject|1|||
143131351|NCT00943397|516027314|FG001|Overall Study|Withdrawal by Subject|1|||
143131352|NCT00943397|516027313|FG000|Overall Study|Site terminated and other|12|||
143131353|NCT00943397|516027314|FG001|Overall Study|Site terminated and other|56|||
143131354|NCT01254656|516027315|FG000|Overall Study|Discontinued due to termination of study|40|||
143131355|NCT01254656|516027316|FG001|Overall Study|Discontinued due to termination of study|39|||
143131356|NCT01254656|516027317|FG002|Overall Study|Discontinued due to termination of study|13|||
143131357|NCT01254656|516027315|FG000|Overall Study|Lack of Efficacy|3|||
143131358|NCT01254656|516027316|FG001|Overall Study|Lack of Efficacy|0|||
143131359|NCT01254656|516027317|FG002|Overall Study|Lack of Efficacy|0|||
143131360|NCT01254656|516027315|FG000|Overall Study|Lost to Follow-up|1|||
143131361|NCT01254656|516027316|FG001|Overall Study|Lost to Follow-up|0|||
143131362|NCT01254656|516027317|FG002|Overall Study|Lost to Follow-up|2|||
143131363|NCT01254656|516027315|FG000|Overall Study|Withdrawal by Subject|2|||
143131364|NCT01254656|516027316|FG001|Overall Study|Withdrawal by Subject|2|||
143131365|NCT01254656|516027317|FG002|Overall Study|Withdrawal by Subject|1|||
143131366|NCT01254656|516027315|FG000|Overall Study|Pregnancy|0|||
143131367|NCT01254656|516027316|FG001|Overall Study|Pregnancy|0|||
143131368|NCT01254656|516027317|FG002|Overall Study|Pregnancy|2|||
143131369|NCT01254656|516027315|FG000|Overall Study|Adverse Event|1|||
143131370|NCT01254656|516027316|FG001|Overall Study|Adverse Event|1|||
143131371|NCT01254656|516027317|FG002|Overall Study|Adverse Event|0|||
143131372|NCT01254656|516027315|FG000|Overall Study|Death|0|||
143131373|NCT01254656|516027316|FG001|Overall Study|Death|1|||
143131374|NCT01254656|516027317|FG002|Overall Study|Death|0|||
143131375|NCT02948829|516027318|FG000|Overall Study|Lost to Follow-up|2|||
143131376|NCT02948829|516027318|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
143131377|NCT02948829|516027318|FG000|Overall Study|Pregnancy|1|||
143131378|NCT02948829|516027318|FG000|Overall Study|Other: Reason not Specified|8|||
143131379|NCT01004978|516027319|FG000|Overall Study|Disease progression|31|||
143131380|NCT01004978|516027320|FG001|Overall Study|Disease progression|48|||
143131381|NCT01004978|516027319|FG000|Overall Study|Adverse Event|42|||
143131382|NCT01004978|516027320|FG001|Overall Study|Adverse Event|22|||
143131383|NCT01004978|516027319|FG000|Overall Study|Death|3|||
143131384|NCT01004978|516027320|FG001|Overall Study|Death|2|||
143131385|NCT01004978|516027319|FG000|Overall Study|Withdrawal by Subject|16|||
143131386|NCT01004978|516027320|FG001|Overall Study|Withdrawal by Subject|16|||
143131387|NCT01004978|516027319|FG000|Overall Study|Alternative therapy|4|||
143131388|NCT01004978|516027320|FG001|Overall Study|Alternative therapy|8|||
143131389|NCT01004978|516027319|FG000|Overall Study|Physician Decision|6|||
143131390|NCT01004978|516027320|FG001|Overall Study|Physician Decision|3|||
143131391|NCT01004978|516027319|FG000|Overall Study|Other complicating disease|2|||
143131392|NCT01004978|516027320|FG001|Overall Study|Other complicating disease|2|||
143131393|NCT01004978|516027319|FG000|Overall Study|Protocol Violation|2|||
143131394|NCT01004978|516027320|FG001|Overall Study|Protocol Violation|3|||
143131395|NCT01004978|516027319|FG000|Overall Study|Non-compliance|3|||
143131396|NCT01004978|516027320|FG001|Overall Study|Non-compliance|2|||
143131397|NCT01004978|516027319|FG000|Overall Study|Ineligible|1|||
143131398|NCT01004978|516027320|FG001|Overall Study|Ineligible|0|||
143131399|NCT01004978|516027319|FG000|Overall Study|Unblinded|0|||
143131400|NCT01004978|516027320|FG001|Overall Study|Unblinded|1|||
143131401|NCT01004978|516027319|FG000|Overall Study|Performance status worsening|0|||
143131402|NCT01004978|516027320|FG001|Overall Study|Performance status worsening|1|||
143131403|NCT01004978|516027319|FG000|Overall Study|Never started treatment|8|||
143131404|NCT01004978|516027320|FG001|Overall Study|Never started treatment|9|||
143131405|NCT00369915|516027321|FG000|Overall Study|expected side effects|2|||
143131406|NCT00369915|516027322|FG001|Overall Study|expected side effects|1|||
143131407|NCT00369915|516027321|FG000|Overall Study|Withdrawal by Subject|4|||
143131408|NCT00369915|516027322|FG001|Overall Study|Withdrawal by Subject|1|||
143131409|NCT00369915|516027321|FG000|Overall Study|W/drawl by investigators|0|||
143131410|NCT00369915|516027322|FG001|Overall Study|W/drawl by investigators|1|||
143131411|NCT02326272|516027325|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
143131412|NCT02326272|516027326|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
143131413|NCT02326272|516027327|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
143131414|NCT02326272|516027328|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
143131415|NCT02326272|516027329|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
143131416|NCT02326272|516027330|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
143131417|NCT02326272|516027331|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
143131418|NCT02326272|516027332|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
143131419|NCT02326272|516027333|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
143131420|NCT02326272|516027334|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
143131421|NCT02326272|516027335|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
143131422|NCT02326272|516027336|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
143131423|NCT02326272|516027337|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
143131424|NCT02326272|516027338|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
143131425|NCT02326272|516027339|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
143131426|NCT02326272|516027325|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
143131427|NCT02326272|516027326|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
143131428|NCT02326272|516027327|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
143131429|NCT02326272|516027328|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
143131430|NCT02326272|516027329|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
143131431|NCT02326272|516027330|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
143131432|NCT02326272|516027331|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
143131433|NCT02326272|516027332|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
143131434|NCT02326272|516027333|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
143131435|NCT02326272|516027334|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
143131436|NCT02326272|516027335|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
143131437|NCT02326272|516027336|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
143131438|NCT02326272|516027337|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
143131439|NCT02326272|516027338|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
143131440|NCT02326272|516027339|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
143131441|NCT02326272|516027325|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
143131442|NCT02326272|516027326|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
143131443|NCT02326272|516027327|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
143131444|NCT02326272|516027328|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
143131445|NCT02326272|516027329|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
143131446|NCT02326272|516027330|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
143131447|NCT02326272|516027331|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
143131448|NCT02326272|516027332|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
143131449|NCT02326272|516027333|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
143131450|NCT02326272|516027334|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
143358117|NCT03280563|516856088|FG008|Long-term Survival Follow-up|Death|3|||
143131451|NCT02326272|516027335|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
143131452|NCT02326272|516027336|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
143131453|NCT02326272|516027337|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
143131454|NCT02326272|516027338|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
143131455|NCT02326272|516027339|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
143131456|NCT02326272|516027325|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
143131457|NCT02326272|516027326|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
143131458|NCT02326272|516027327|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
143131459|NCT02326272|516027328|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
143131460|NCT02326272|516027329|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
143131461|NCT02326272|516027330|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
143131462|NCT02326272|516027331|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
143131463|NCT02326272|516027332|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
143131464|NCT02326272|516027333|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
143131465|NCT02326272|516027334|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
143131466|NCT02326272|516027335|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
143131467|NCT02326272|516027336|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
143131468|NCT02326272|516027337|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
143131469|NCT02326272|516027338|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
143131470|NCT02326272|516027339|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
143131471|NCT02326272|516027325|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
143131472|NCT02326272|516027326|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
143131473|NCT02326272|516027327|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
143131474|NCT02326272|516027328|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
143131475|NCT02326272|516027329|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
143131476|NCT02326272|516027330|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
143131477|NCT02326272|516027331|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
143131478|NCT02326272|516027332|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
143131479|NCT02326272|516027333|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
143131480|NCT02326272|516027334|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
143131481|NCT02326272|516027335|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
143131482|NCT02326272|516027336|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
143131483|NCT02326272|516027337|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
143131484|NCT02326272|516027338|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
143131485|NCT02326272|516027339|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
143131486|NCT02326272|516027325|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
143131487|NCT02326272|516027326|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
143131488|NCT02326272|516027327|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
143131489|NCT02326272|516027328|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
143131490|NCT02326272|516027329|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
143131491|NCT02326272|516027330|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
143131492|NCT02326272|516027331|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
143131493|NCT02326272|516027332|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
143131494|NCT02326272|516027333|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
143131495|NCT02326272|516027334|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
143131496|NCT02326272|516027335|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
143131497|NCT02326272|516027336|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
143131498|NCT02326272|516027337|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
143131499|NCT02326272|516027338|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
143131500|NCT02326272|516027339|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
143131501|NCT02326272|516027325|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
143131502|NCT02326272|516027326|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
143131503|NCT02326272|516027327|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
143131504|NCT02326272|516027328|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
143131505|NCT02326272|516027329|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
143131506|NCT02326272|516027330|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
143131507|NCT02326272|516027331|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
143230985|NCT01601535|516395568|FG004|Phase 2|Started Another Treatment|1|||
143131508|NCT02326272|516027332|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
143230986|NCT01601535|516395569|FG005|Phase 2|Started Another Treatment|2|||
143230987|NCT03353675|516395571|FG000|Overall Study|Adverse Event|4|||
143230988|NCT03309020|516395572|FG000|Overall Study|Death|1|||
143230989|NCT03309020|516395573|FG001|Overall Study|Death|0|||
143230990|NCT03309020|516395572|FG000|Overall Study|Did not undergo surgery|2|||
143465772|NCT00307125|517251125|FG001|Screening Phase|AMR and treated with rituximab|0|||
143465773|NCT00307125|517251126|FG002|Screening Phase|AMR and treated with rituximab|0|||
143465774|NCT00307125|517251124|FG000|Screening Phase|Coronary artery bypass|1|||
143465775|NCT00307125|517251125|FG001|Screening Phase|Coronary artery bypass|0|||
143465776|NCT00307125|517251126|FG002|Screening Phase|Coronary artery bypass|0|||
143465777|NCT00307125|517251124|FG000|Pilot Phase|Lost to Follow-up|0|||
143465778|NCT00307125|517251125|FG001|Pilot Phase|Lost to Follow-up|1|||
143465779|NCT00307125|517251126|FG002|Pilot Phase|Lost to Follow-up|0|||
143230991|NCT03309020|516395573|FG001|Overall Study|Did not undergo surgery|1|||
143230992|NCT00402168|516395574|FG000|Randomized|Lost to Follow-up|1|||
143230993|NCT00402168|516395575|FG001|Randomized|Lost to Follow-up|0|||
143230994|NCT00402168|516395574|FG000|Randomized|Withdrawal by Subject|0|||
143230995|NCT00402168|516395575|FG001|Randomized|Withdrawal by Subject|1|||
143230996|NCT00402168|516395574|FG000|Treatment (up to 12 Months)|Death|0|||
143230997|NCT00402168|516395575|FG001|Treatment (up to 12 Months)|Death|1|||
143230998|NCT00402168|516395574|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
143230999|NCT00402168|516395575|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
143231000|NCT00402168|516395574|FG000|Treatment (up to 12 Months)|non-specified|0|||
143231001|NCT00402168|516395575|FG001|Treatment (up to 12 Months)|non-specified|1|||
143231002|NCT00402168|516395574|FG000|Long Term (LT)|Adverse Event|1|||
143231003|NCT00402168|516395575|FG001|Long Term (LT)|Adverse Event|5|||
143231004|NCT00402168|516395574|FG000|Long Term (LT)|Withdrawal by Subject|4|||
143231005|NCT00402168|516395575|FG001|Long Term (LT)|Withdrawal by Subject|7|||
143231006|NCT00402168|516395574|FG000|Long Term (LT)|Pregnancy|0|||
143231007|NCT00402168|516395575|FG001|Long Term (LT)|Pregnancy|1|||
143231008|NCT00402168|516395574|FG000|Long Term (LT)|Lost to Follow-up|1|||
143231009|NCT00402168|516395575|FG001|Long Term (LT)|Lost to Follow-up|0|||
143231010|NCT00402168|516395574|FG000|Long Term (LT)|Death|4|||
143231011|NCT00402168|516395575|FG001|Long Term (LT)|Death|0|||
143231012|NCT00402168|516395574|FG000|Long Term (LT)|Lack of Efficacy|0|||
143231013|NCT00402168|516395575|FG001|Long Term (LT)|Lack of Efficacy|2|||
143231014|NCT00402168|516395574|FG000|Long Term (LT)|non-specified|1|||
143231015|NCT00402168|516395575|FG001|Long Term (LT)|non-specified|2|||
143231016|NCT00402168|516395574|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
143231017|NCT00402168|516395575|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
143231018|NCT00402168|516395574|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
143231019|NCT00402168|516395575|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
143231020|NCT00601835|516395579|FG000|Overall Study|Withdrawal by Subject|9|||
143231021|NCT00601835|516395580|FG001|Overall Study|Withdrawal by Subject|6|||
143231022|NCT00601835|516395579|FG000|Overall Study|Physician Decision|1|||
143231023|NCT00601835|516395580|FG001|Overall Study|Physician Decision|0|||
143231024|NCT00601835|516395579|FG000|Overall Study|Lost to Follow-up|37|||
143231025|NCT00601835|516395580|FG001|Overall Study|Lost to Follow-up|5|||
143231026|NCT00601835|516395579|FG000|Overall Study|Adverse Event|1|||
143231027|NCT00601835|516395580|FG001|Overall Study|Adverse Event|1|||
143013788|NCT02494583|515590021|FG002|Overall Study|Withdrawal by Subject|15|||
143013789|NCT01766310|515590024|FG000|Overall Study|Lost to Follow-up|1|||
143013790|NCT01766310|515590025|FG001|Overall Study|Lost to Follow-up|3|||
143013791|NCT03151707|515590026|FG000|Overall Study|Lost to Follow-up|6|||
143013792|NCT02125734|515590028|FG000|Period 2|Adverse Event|0|||
143013793|NCT02125734|515590029|FG001|Period 2|Adverse Event|1|||
143013794|NCT01591499|515590030|FG000|Baseline Visit|Withdrawal by Subject|0|||
143013795|NCT01591499|515590031|FG001|Baseline Visit|Withdrawal by Subject|2|||
143013796|NCT01591499|515590032|FG002|Baseline Visit|Withdrawal by Subject|0|||
143013797|NCT01591499|515590033|FG003|Baseline Visit|Withdrawal by Subject|2|||
143013798|NCT01591499|515590030|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
143013799|NCT01591499|515590031|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
143013800|NCT01591499|515590032|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
143013801|NCT01591499|515590033|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
143013802|NCT01591499|515590030|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
143231028|NCT00601835|516395579|FG000|Overall Study|Relocate|12|||
143231029|NCT00601835|516395580|FG001|Overall Study|Relocate|2|||
143013803|NCT01591499|515590031|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
143013804|NCT01591499|515590032|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
143013805|NCT01591499|515590033|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
143231030|NCT04764162|516395583|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
143231031|NCT04764162|516395584|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
143231032|NCT05556265|516395585|FG000|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
143231033|NCT05556265|516395586|FG001|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|1|||
143231034|NCT05556265|516395587|FG002|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
143231035|NCT05556265|516395588|FG003|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
143131509|NCT02326272|516027333|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
143131510|NCT02326272|516027334|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
143131511|NCT02326272|516027335|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
143131512|NCT02326272|516027336|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
143131513|NCT02326272|516027337|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
143131514|NCT02326272|516027338|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
143131515|NCT02326272|516027339|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
143131516|NCT02326272|516027325|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143131517|NCT02326272|516027326|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143131518|NCT02326272|516027327|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143131519|NCT02326272|516027328|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143131520|NCT02326272|516027329|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
143131521|NCT02326272|516027330|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
143131522|NCT02326272|516027331|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
143131523|NCT02326272|516027332|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
143131524|NCT02326272|516027333|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
143131525|NCT02326272|516027334|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143131526|NCT02326272|516027335|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143131527|NCT02326272|516027336|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143131528|NCT02326272|516027337|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143131529|NCT02326272|516027338|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143131530|NCT02326272|516027339|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143131531|NCT02326272|516027325|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
143131532|NCT02326272|516027326|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
143131533|NCT02326272|516027327|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
143131534|NCT02326272|516027328|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
143131535|NCT02326272|516027329|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
143131536|NCT02326272|516027330|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
143131537|NCT02326272|516027331|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
143131538|NCT02326272|516027332|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
143131539|NCT02326272|516027333|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
143131540|NCT02326272|516027334|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
143131541|NCT02326272|516027335|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
143131542|NCT02326272|516027336|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
143131543|NCT02326272|516027337|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
143131544|NCT02326272|516027338|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
143131545|NCT02326272|516027339|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
143131546|NCT02326272|516027325|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143131547|NCT02326272|516027326|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143131548|NCT02326272|516027327|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143131549|NCT02326272|516027328|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143131550|NCT02326272|516027329|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143131551|NCT02326272|516027330|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
143131552|NCT02326272|516027331|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143131553|NCT02326272|516027332|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
143131554|NCT02326272|516027333|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143131555|NCT02326272|516027334|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143131556|NCT02326272|516027335|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143131557|NCT02326272|516027336|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143131558|NCT02326272|516027337|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143131559|NCT02326272|516027338|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143131560|NCT02326272|516027339|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143131561|NCT02326272|516027325|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
143131562|NCT02326272|516027326|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
143131563|NCT02326272|516027327|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
143131564|NCT02326272|516027328|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
143131565|NCT02326272|516027329|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
143131566|NCT02326272|516027330|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
143131567|NCT02326272|516027331|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
143131568|NCT02326272|516027332|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
143131569|NCT02326272|516027333|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
143131570|NCT02326272|516027334|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
143131571|NCT02326272|516027335|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
143465780|NCT00307125|517251124|FG000|Pilot Phase|Withdrawal by Subject|0|||
143131572|NCT02326272|516027336|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
143131573|NCT02326272|516027337|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
143131574|NCT02326272|516027338|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
143131575|NCT02326272|516027339|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
143131576|NCT02326272|516027325|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
143131577|NCT02326272|516027326|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
143131578|NCT02326272|516027327|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
143131579|NCT02326272|516027328|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
143131580|NCT02326272|516027329|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
143131581|NCT02326272|516027330|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
143131582|NCT02326272|516027331|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
143131583|NCT02326272|516027332|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
143131584|NCT02326272|516027333|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
143131585|NCT02326272|516027334|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
143131586|NCT02326272|516027335|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
143131587|NCT02326272|516027336|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
143131588|NCT02326272|516027337|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
143131589|NCT02326272|516027338|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
143131590|NCT02326272|516027339|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
143131591|NCT02326272|516027325|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
143131592|NCT02326272|516027326|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
143131593|NCT02326272|516027327|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
143131594|NCT02326272|516027328|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
143131595|NCT02326272|516027329|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
143131596|NCT02326272|516027330|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
143131597|NCT02326272|516027331|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
143131598|NCT02326272|516027332|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
143131599|NCT02326272|516027333|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
143131600|NCT02326272|516027334|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
143131601|NCT02326272|516027335|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
143131602|NCT02326272|516027336|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
143131603|NCT02326272|516027337|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
143131604|NCT02326272|516027338|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
143131605|NCT02326272|516027339|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
143131606|NCT02326272|516027325|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
143131607|NCT02326272|516027326|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
143131608|NCT02326272|516027327|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
143131609|NCT02326272|516027328|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
143131610|NCT02326272|516027329|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
143131611|NCT02326272|516027330|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
143131612|NCT02326272|516027331|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
143131613|NCT02326272|516027332|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
143131614|NCT02326272|516027333|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
143131615|NCT02326272|516027334|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
143131616|NCT02326272|516027335|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
143131617|NCT02326272|516027336|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
143131618|NCT02326272|516027337|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
143131619|NCT02326272|516027338|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
143131620|NCT02326272|516027339|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
143131621|NCT02326272|516027325|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
143131622|NCT02326272|516027326|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
143131623|NCT02326272|516027327|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
143131624|NCT02326272|516027328|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
143131625|NCT02326272|516027329|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
143131626|NCT02326272|516027330|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
143131627|NCT02326272|516027331|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
143131628|NCT02326272|516027332|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
143131629|NCT02326272|516027333|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
143131630|NCT02326272|516027334|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
143131631|NCT02326272|516027335|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
143131632|NCT02326272|516027336|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
143131633|NCT02326272|516027337|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
143131634|NCT02326272|516027338|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
143131635|NCT02326272|516027339|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
143131636|NCT02326272|516027325|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
143131637|NCT02326272|516027326|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
143131638|NCT02326272|516027327|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
143131639|NCT02326272|516027328|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
143131640|NCT02326272|516027329|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
143131641|NCT02326272|516027330|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
143131642|NCT02326272|516027331|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
143131643|NCT02326272|516027332|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
143131644|NCT02326272|516027333|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
143131645|NCT02326272|516027334|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
143131646|NCT02326272|516027335|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
143131647|NCT02326272|516027336|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
143131648|NCT02326272|516027337|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
143131649|NCT02326272|516027338|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
143131650|NCT02326272|516027339|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
143131651|NCT02326272|516027325|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
143131652|NCT02326272|516027326|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
143131653|NCT02326272|516027327|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
143131654|NCT02326272|516027328|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
143131655|NCT02326272|516027329|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
143131656|NCT02326272|516027330|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
143131657|NCT02326272|516027331|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
143131658|NCT02326272|516027332|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
143131659|NCT02326272|516027333|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
143131660|NCT02326272|516027334|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
143131661|NCT02326272|516027335|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
143131662|NCT02326272|516027336|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
143131663|NCT02326272|516027337|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
143131664|NCT02326272|516027338|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
143131665|NCT02326272|516027339|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
143131666|NCT02326272|516027325|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
143131667|NCT02326272|516027326|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
143131668|NCT02326272|516027327|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
143131669|NCT02326272|516027328|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
143131670|NCT02326272|516027329|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
143131671|NCT02326272|516027330|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
143131672|NCT02326272|516027331|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
143131673|NCT02326272|516027332|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
143131674|NCT02326272|516027333|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
143131675|NCT02326272|516027334|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
143131676|NCT02326272|516027335|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
143131677|NCT02326272|516027336|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
143131678|NCT02326272|516027337|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
143131679|NCT02326272|516027338|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
143131680|NCT02326272|516027339|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
143131681|NCT02326272|516027325|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
143131682|NCT02326272|516027326|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
143131683|NCT02326272|516027327|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
143131684|NCT02326272|516027328|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
143131685|NCT02326272|516027329|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
143131686|NCT02326272|516027330|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
143131687|NCT02326272|516027331|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
143131688|NCT02326272|516027332|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
143131689|NCT02326272|516027333|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
143131690|NCT02326272|516027334|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
143131691|NCT02326272|516027335|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
143231036|NCT05556265|516395589|FG004|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
143259574|NCT02241889|516505781|FG000|Overall Study|Withdrawal by Subject|0|||
143013806|NCT00646282|515590034|FG000|Overall Study|Protocol terminated|4|||
143013807|NCT00646282|515590035|FG001|Overall Study|Protocol terminated|4|||
143013808|NCT02617446|515590036|FG000|Overall Study|Withdrawal by Subject|0|||
143131692|NCT02326272|516027336|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
143131693|NCT02326272|516027337|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
143131694|NCT02326272|516027338|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
143131695|NCT02326272|516027339|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
143131696|NCT02326272|516027325|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143131697|NCT02326272|516027326|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143131698|NCT02326272|516027327|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143131699|NCT02326272|516027328|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143131700|NCT02326272|516027329|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143131701|NCT02326272|516027330|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143131702|NCT02326272|516027331|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143131703|NCT02326272|516027332|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143131704|NCT02326272|516027333|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143131705|NCT02326272|516027334|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143131706|NCT02326272|516027335|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
143131707|NCT02326272|516027336|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143131708|NCT02326272|516027337|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
143131709|NCT02326272|516027338|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143131710|NCT02326272|516027339|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143131711|NCT02326272|516027325|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
143131712|NCT02326272|516027326|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
143131713|NCT02326272|516027327|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
143131714|NCT02326272|516027328|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
143131715|NCT02326272|516027329|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
143131716|NCT02326272|516027330|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
143131717|NCT02326272|516027331|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
143131718|NCT02326272|516027332|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
143131719|NCT02326272|516027333|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
143131720|NCT02326272|516027334|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
143131721|NCT02326272|516027335|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
143131722|NCT02326272|516027336|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
143131723|NCT02326272|516027337|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
143131724|NCT02326272|516027338|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
143131725|NCT02326272|516027339|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
143131726|NCT02326272|516027325|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143131727|NCT02326272|516027326|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143131728|NCT02326272|516027327|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143131729|NCT02326272|516027328|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143131730|NCT02326272|516027329|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143131731|NCT02326272|516027330|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143131732|NCT02326272|516027331|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143131733|NCT02326272|516027332|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143131734|NCT02326272|516027333|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143131735|NCT02326272|516027334|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143131736|NCT02326272|516027335|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
143131737|NCT02326272|516027336|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143131738|NCT02326272|516027337|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
143131739|NCT02326272|516027338|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143131740|NCT02326272|516027339|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
143131741|NCT02326272|516027325|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143131742|NCT02326272|516027326|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143131743|NCT02326272|516027327|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143131744|NCT02326272|516027328|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143131745|NCT02326272|516027329|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143131746|NCT02326272|516027330|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143131747|NCT02326272|516027331|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143131748|NCT02326272|516027332|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143131749|NCT02326272|516027333|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143131750|NCT02326272|516027334|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143131751|NCT02326272|516027335|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143131752|NCT02326272|516027336|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
143131753|NCT02326272|516027337|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143131754|NCT02326272|516027338|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143465781|NCT00307125|517251125|FG001|Pilot Phase|Withdrawal by Subject|1|||
143131755|NCT02326272|516027339|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
143131756|NCT02326272|516027325|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
143131757|NCT02326272|516027326|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
143131758|NCT02326272|516027327|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
143131759|NCT02326272|516027328|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
143131760|NCT02326272|516027329|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
143131761|NCT02326272|516027330|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
143131762|NCT02326272|516027331|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
143131763|NCT02326272|516027332|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
143131764|NCT02326272|516027333|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
143131765|NCT02326272|516027334|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
143131766|NCT02326272|516027335|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
143131767|NCT02326272|516027336|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
143131768|NCT02326272|516027337|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
143131769|NCT02326272|516027338|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
143131770|NCT02326272|516027339|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
143131771|NCT02326272|516027325|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
143131772|NCT02326272|516027326|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
143131773|NCT02326272|516027327|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
143131774|NCT02326272|516027328|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
143131775|NCT02326272|516027329|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
143131776|NCT02326272|516027330|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
143131777|NCT02326272|516027331|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
143131778|NCT02326272|516027332|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
143131779|NCT02326272|516027333|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
143131780|NCT02326272|516027334|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
143131781|NCT02326272|516027335|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
143131782|NCT02326272|516027336|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
143131783|NCT02326272|516027337|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
143131784|NCT02326272|516027338|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
143131785|NCT02326272|516027339|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
143131786|NCT02326272|516027325|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
143131787|NCT02326272|516027326|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
143131788|NCT02326272|516027327|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
143131789|NCT02326272|516027328|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
143131790|NCT02326272|516027329|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
143131791|NCT02326272|516027330|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
143131792|NCT02326272|516027331|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
143131793|NCT02326272|516027332|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
143131794|NCT02326272|516027333|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
143131795|NCT02326272|516027334|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
143131796|NCT02326272|516027335|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
143131797|NCT02326272|516027336|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
143131798|NCT02326272|516027337|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
143131799|NCT02326272|516027338|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
143131800|NCT02326272|516027339|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
143131801|NCT01447407|516027365|FG000|Overall Study|Withdrawal by Subject|2|||
143131802|NCT01447407|516027366|FG001|Overall Study|Withdrawal by Subject|0|||
143131803|NCT01447407|516027367|FG002|Overall Study|Withdrawal by Subject|0|||
143131804|NCT01447407|516027368|FG003|Overall Study|Withdrawal by Subject|1|||
143131805|NCT01447407|516027365|FG000|Overall Study|Physician Decision|0|||
143131806|NCT01447407|516027366|FG001|Overall Study|Physician Decision|0|||
143131807|NCT01447407|516027367|FG002|Overall Study|Physician Decision|1|||
143131808|NCT01447407|516027368|FG003|Overall Study|Physician Decision|1|||
143131809|NCT01265394|516027371|FG000|Overall Study|Subjects withdrawn|37|||
143131810|NCT00268983|516027372|FG000|Overall Study|Death|3|||
143131811|NCT00268983|516027373|FG001|Overall Study|Death|0|||
143131812|NCT01719380|516027374|FG000|Overall Study|Adverse Event|0|||
143131813|NCT01719380|516027375|FG001|Overall Study|Adverse Event|0|||
143131814|NCT01719380|516027376|FG002|Overall Study|Adverse Event|1|||
143131815|NCT01719380|516027377|FG003|Overall Study|Adverse Event|2|||
143131816|NCT01719380|516027378|FG004|Overall Study|Adverse Event|0|||
143131817|NCT01719380|516027379|FG005|Overall Study|Adverse Event|1|||
143131818|NCT01719380|516027380|FG006|Overall Study|Adverse Event|0|||
143131819|NCT01719380|516027381|FG007|Overall Study|Adverse Event|1|||
143131820|NCT01719380|516027382|FG008|Overall Study|Adverse Event|4|||
143131821|NCT01719380|516027383|FG009|Overall Study|Adverse Event|3|||
143131822|NCT01719380|516027374|FG000|Overall Study|Death|0|||
143131823|NCT01719380|516027375|FG001|Overall Study|Death|1|||
143131824|NCT01719380|516027376|FG002|Overall Study|Death|0|||
143131825|NCT01719380|516027377|FG003|Overall Study|Death|0|||
143131826|NCT01719380|516027378|FG004|Overall Study|Death|0|||
143131827|NCT01719380|516027379|FG005|Overall Study|Death|0|||
143131828|NCT01719380|516027380|FG006|Overall Study|Death|0|||
143131829|NCT01719380|516027381|FG007|Overall Study|Death|0|||
143131830|NCT01719380|516027382|FG008|Overall Study|Death|3|||
143131831|NCT01719380|516027383|FG009|Overall Study|Death|3|||
143131832|NCT01719380|516027374|FG000|Overall Study|Participant/Guardian Decision|0|||
143131833|NCT01719380|516027375|FG001|Overall Study|Participant/Guardian Decision|0|||
143131834|NCT01719380|516027376|FG002|Overall Study|Participant/Guardian Decision|1|||
143131835|NCT01719380|516027377|FG003|Overall Study|Participant/Guardian Decision|0|||
143131836|NCT01719380|516027378|FG004|Overall Study|Participant/Guardian Decision|0|||
143131837|NCT01719380|516027379|FG005|Overall Study|Participant/Guardian Decision|0|||
143131838|NCT01719380|516027380|FG006|Overall Study|Participant/Guardian Decision|0|||
143131839|NCT01719380|516027381|FG007|Overall Study|Participant/Guardian Decision|0|||
143131840|NCT01719380|516027382|FG008|Overall Study|Participant/Guardian Decision|2|||
143131841|NCT01719380|516027383|FG009|Overall Study|Participant/Guardian Decision|2|||
143131842|NCT01719380|516027374|FG000|Overall Study|Physician Decision|0|||
143131843|NCT01719380|516027375|FG001|Overall Study|Physician Decision|0|||
143131844|NCT01719380|516027376|FG002|Overall Study|Physician Decision|2|||
143131845|NCT01719380|516027377|FG003|Overall Study|Physician Decision|0|||
143131846|NCT01719380|516027378|FG004|Overall Study|Physician Decision|0|||
143131847|NCT01719380|516027379|FG005|Overall Study|Physician Decision|0|||
143131848|NCT01719380|516027380|FG006|Overall Study|Physician Decision|0|||
143131849|NCT01719380|516027381|FG007|Overall Study|Physician Decision|0|||
143131850|NCT01719380|516027382|FG008|Overall Study|Physician Decision|1|||
143131851|NCT01719380|516027383|FG009|Overall Study|Physician Decision|1|||
143131852|NCT01719380|516027374|FG000|Overall Study|Lack of Efficacy|2|||
143131853|NCT01719380|516027375|FG001|Overall Study|Lack of Efficacy|6|||
143131854|NCT01719380|516027376|FG002|Overall Study|Lack of Efficacy|5|||
143131855|NCT01719380|516027377|FG003|Overall Study|Lack of Efficacy|6|||
143131856|NCT01719380|516027378|FG004|Overall Study|Lack of Efficacy|3|||
143131857|NCT01719380|516027379|FG005|Overall Study|Lack of Efficacy|7|||
143131858|NCT01719380|516027380|FG006|Overall Study|Lack of Efficacy|10|||
143131859|NCT01719380|516027381|FG007|Overall Study|Lack of Efficacy|6|||
143131860|NCT01719380|516027382|FG008|Overall Study|Lack of Efficacy|39|||
143131861|NCT01719380|516027383|FG009|Overall Study|Lack of Efficacy|42|||
143131862|NCT01719380|516027374|FG000|Overall Study|Progressive Disease|0|||
143131863|NCT01719380|516027375|FG001|Overall Study|Progressive Disease|0|||
143131864|NCT01719380|516027376|FG002|Overall Study|Progressive Disease|0|||
143131865|NCT01719380|516027377|FG003|Overall Study|Progressive Disease|0|||
143131866|NCT01719380|516027378|FG004|Overall Study|Progressive Disease|0|||
143131867|NCT01719380|516027379|FG005|Overall Study|Progressive Disease|0|||
143131868|NCT01719380|516027380|FG006|Overall Study|Progressive Disease|0|||
143131869|NCT01719380|516027381|FG007|Overall Study|Progressive Disease|0|||
143131870|NCT01719380|516027382|FG008|Overall Study|Progressive Disease|1|||
143131871|NCT01719380|516027383|FG009|Overall Study|Progressive Disease|0|||
143131872|NCT03131167|516027393|FG000|Overall Study|Other (Unspecified)|0|||
143131873|NCT03131167|516027394|FG001|Overall Study|Other (Unspecified)|0|||
143131874|NCT03131167|516027395|FG002|Overall Study|Other (Unspecified)|0|||
143131875|NCT03131167|516027396|FG003|Overall Study|Other (Unspecified)|0|||
143131876|NCT03131167|516027397|FG004|Overall Study|Other (Unspecified)|0|||
143131877|NCT03131167|516027398|FG005|Overall Study|Other (Unspecified)|1|||
143131878|NCT03131167|516027399|FG006|Overall Study|Other (Unspecified)|0|||
143131879|NCT03131167|516027400|FG007|Overall Study|Other (Unspecified)|0|||
143131880|NCT03131167|516027401|FG008|Overall Study|Other (Unspecified)|0|||
143131881|NCT03131167|516027402|FG009|Overall Study|Other (Unspecified)|0|||
143131882|NCT03131167|516027403|FG010|Overall Study|Other (Unspecified)|0|||
143131883|NCT03131167|516027404|FG011|Overall Study|Other (Unspecified)|0|||
143131884|NCT03131167|516027405|FG012|Overall Study|Other (Unspecified)|0|||
143131885|NCT02532374|516027406|FG000|Overall Study|Withdrawal by Subject|1|||
143131886|NCT02532374|516027406|FG000|Overall Study|Physician Decision|1|||
143131887|NCT00809445|516027409|FG000|1 Month Follow-up|Lost contact|1|||
143131888|NCT00809445|516027410|FG001|1 Month Follow-up|Lost contact|2|||
143131889|NCT00809445|516027411|FG002|1 Month Follow-up|Lost contact|1|||
143131890|NCT00809445|516027409|FG000|1 Month Follow-up|Withdrew consent|1|||
143131891|NCT00809445|516027410|FG001|1 Month Follow-up|Withdrew consent|1|||
143131892|NCT00809445|516027411|FG002|1 Month Follow-up|Withdrew consent|1|||
143131893|NCT00809445|516027409|FG000|1 Month Follow-up|Death|0|||
143131894|NCT00809445|516027410|FG001|1 Month Follow-up|Death|1|||
143131895|NCT00809445|516027411|FG002|1 Month Follow-up|Death|1|||
143131896|NCT00809445|516027409|FG000|1 Month Follow-up|Incarcerated|0|||
143131897|NCT00809445|516027410|FG001|1 Month Follow-up|Incarcerated|0|||
143131898|NCT00809445|516027411|FG002|1 Month Follow-up|Incarcerated|1|||
143131899|NCT00809445|516027409|FG000|6 Month Follow-up|Lost contact|16|||
143131900|NCT00809445|516027410|FG001|6 Month Follow-up|Lost contact|14|||
143131901|NCT00809445|516027411|FG002|6 Month Follow-up|Lost contact|14|||
143131902|NCT00809445|516027409|FG000|6 Month Follow-up|Death|2|||
143131903|NCT00809445|516027410|FG001|6 Month Follow-up|Death|1|||
143131904|NCT00809445|516027411|FG002|6 Month Follow-up|Death|1|||
143131905|NCT00809445|516027409|FG000|6 Month Follow-up|Incarcerated|6|||
143131906|NCT00809445|516027410|FG001|6 Month Follow-up|Incarcerated|8|||
143131907|NCT00809445|516027411|FG002|6 Month Follow-up|Incarcerated|8|||
143131908|NCT00809445|516027409|FG000|6 Month Follow-up|Withdrew consent|0|||
143131909|NCT00809445|516027410|FG001|6 Month Follow-up|Withdrew consent|0|||
143131910|NCT00809445|516027411|FG002|6 Month Follow-up|Withdrew consent|1|||
143131911|NCT01610037|516027413|FG000|All Patients|Adverse Event|27|||
143131912|NCT01610037|516027414|FG001|All Patients|Adverse Event|22|||
143131913|NCT01610037|516027415|FG002|All Patients|Adverse Event|26|||
143131914|NCT01610037|516027413|FG000|All Patients|Withdrawal by Subject|12|||
143131915|NCT01610037|516027414|FG001|All Patients|Withdrawal by Subject|10|||
143131916|NCT01610037|516027415|FG002|All Patients|Withdrawal by Subject|20|||
143131917|NCT01610037|516027413|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
143131918|NCT01610037|516027414|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
143131919|NCT01610037|516027415|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
143131920|NCT01610037|516027413|FG000|All Patients|Death|4|||
143131921|NCT01610037|516027414|FG001|All Patients|Death|2|||
143131922|NCT01610037|516027415|FG002|All Patients|Death|1|||
143131923|NCT01610037|516027413|FG000|All Patients|Protocol deviation|4|||
143131924|NCT01610037|516027414|FG001|All Patients|Protocol deviation|3|||
143131925|NCT01610037|516027415|FG002|All Patients|Protocol deviation|3|||
143131926|NCT01610037|516027413|FG000|All Patients|Abnormal laboratory value|1|||
143131927|NCT01610037|516027414|FG001|All Patients|Abnormal laboratory value|1|||
143131928|NCT01610037|516027415|FG002|All Patients|Abnormal laboratory value|0|||
143131929|NCT01610037|516027413|FG000|All Patients|Administrative problems|1|||
143131930|NCT01610037|516027414|FG001|All Patients|Administrative problems|4|||
143131931|NCT01610037|516027415|FG002|All Patients|Administrative problems|4|||
143131932|NCT01610037|516027413|FG000|All Patients|Lost to Follow-up|1|||
143131933|NCT01610037|516027414|FG001|All Patients|Lost to Follow-up|0|||
143131934|NCT01610037|516027415|FG002|All Patients|Lost to Follow-up|0|||
143131935|NCT01610037|516027413|FG000|All Patients|Abnormal test procedure result(s)|0|||
143131936|NCT01610037|516027414|FG001|All Patients|Abnormal test procedure result(s)|1|||
143131937|NCT01610037|516027415|FG002|All Patients|Abnormal test procedure result(s)|3|||
143131938|NCT01610037|516027413|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
143131939|NCT01610037|516027414|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
143131940|NCT01610037|516027415|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
143131941|NCT01610037|516027413|FG000|Treatment and Follow up Period|Death|10|||
143131942|NCT01610037|516027414|FG001|Treatment and Follow up Period|Death|5|||
143131943|NCT01610037|516027415|FG002|Treatment and Follow up Period|Death|4|||
143131944|NCT01610037|516027413|FG000|Treatment and Follow up Period|Administrative problems|1|||
143131945|NCT01610037|516027414|FG001|Treatment and Follow up Period|Administrative problems|3|||
143131946|NCT01610037|516027415|FG002|Treatment and Follow up Period|Administrative problems|2|||
143131947|NCT01610037|516027413|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
143131948|NCT01610037|516027414|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
143131949|NCT01610037|516027415|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
143131950|NCT00705757|516027417|FG000|Overall Study|Lack of Efficacy|5|||
143131951|NCT00705757|516027418|FG001|Overall Study|Lack of Efficacy|1|||
143131952|NCT00705757|516027419|FG002|Overall Study|Lack of Efficacy|3|||
143131953|NCT00705757|516027417|FG000|Overall Study|Lost to Follow-up|7|||
143131954|NCT00705757|516027418|FG001|Overall Study|Lost to Follow-up|6|||
143131955|NCT00705757|516027419|FG002|Overall Study|Lost to Follow-up|6|||
143131956|NCT00705757|516027417|FG000|Overall Study|Withdrawal by Subject|1|||
143131957|NCT00705757|516027418|FG001|Overall Study|Withdrawal by Subject|1|||
143131958|NCT00705757|516027419|FG002|Overall Study|Withdrawal by Subject|2|||
143131959|NCT00807885|516027422|FG000|Overall Study|Lost to Follow-up|0|||
143131960|NCT00807885|516027423|FG001|Overall Study|Lost to Follow-up|0|||
143131961|NCT00807885|516027424|FG002|Overall Study|Lost to Follow-up|0|||
143131962|NCT00807885|516027425|FG003|Overall Study|Lost to Follow-up|0|||
143131963|NCT00807885|516027426|FG004|Overall Study|Lost to Follow-up|0|||
143131964|NCT00807885|516027427|FG005|Overall Study|Lost to Follow-up|1|||
143131965|NCT00807885|516027428|FG006|Overall Study|Lost to Follow-up|0|||
143131966|NCT00807885|516027429|FG007|Overall Study|Lost to Follow-up|0|||
143131967|NCT00807885|516027430|FG008|Overall Study|Lost to Follow-up|0|||
143131968|NCT03489343|516027434|FG000|Overall Study|Documented progressive disease|1|||
143131969|NCT03489343|516027435|FG001|Overall Study|Documented progressive disease|0|||
143131970|NCT03489343|516027436|FG002|Overall Study|Documented progressive disease|3|||
143131971|NCT03489343|516027437|FG003|Overall Study|Documented progressive disease|1|||
143131972|NCT03489343|516027438|FG004|Overall Study|Documented progressive disease|3|||
143131973|NCT03489343|516027439|FG005|Overall Study|Documented progressive disease|5|||
143131974|NCT03489343|516027440|FG006|Overall Study|Documented progressive disease|4|||
143131975|NCT03489343|516027434|FG000|Overall Study|Adverse Event|0|||
143131976|NCT03489343|516027435|FG001|Overall Study|Adverse Event|1|||
143131977|NCT03489343|516027436|FG002|Overall Study|Adverse Event|0|||
143131978|NCT03489343|516027437|FG003|Overall Study|Adverse Event|0|||
143131979|NCT03489343|516027438|FG004|Overall Study|Adverse Event|0|||
143131980|NCT03489343|516027439|FG005|Overall Study|Adverse Event|1|||
143131981|NCT03489343|516027440|FG006|Overall Study|Adverse Event|0|||
143131982|NCT03489343|516027434|FG000|Overall Study|Withdrawal by Subject|0|||
143131983|NCT03489343|516027435|FG001|Overall Study|Withdrawal by Subject|0|||
143131984|NCT03489343|516027436|FG002|Overall Study|Withdrawal by Subject|0|||
143131985|NCT03489343|516027437|FG003|Overall Study|Withdrawal by Subject|1|||
143131986|NCT03489343|516027438|FG004|Overall Study|Withdrawal by Subject|0|||
143131987|NCT03489343|516027439|FG005|Overall Study|Withdrawal by Subject|1|||
143131988|NCT03489343|516027440|FG006|Overall Study|Withdrawal by Subject|1|||
143131989|NCT03489343|516027434|FG000|Overall Study|Clinical progression|0|||
143131990|NCT03489343|516027435|FG001|Overall Study|Clinical progression|0|||
143131991|NCT03489343|516027436|FG002|Overall Study|Clinical progression|0|||
143131992|NCT03489343|516027437|FG003|Overall Study|Clinical progression|1|||
143131993|NCT03489343|516027438|FG004|Overall Study|Clinical progression|0|||
143131994|NCT03489343|516027439|FG005|Overall Study|Clinical progression|0|||
143131995|NCT03489343|516027440|FG006|Overall Study|Clinical progression|1|||
143131996|NCT00186485|516027442|FG000|Overall Study|Lost to Follow-up|3|||
143131997|NCT00905424|516027443|FG000|Overall Study|Lost to Follow-up|3|||
143131998|NCT00905424|516027444|FG001|Overall Study|Lost to Follow-up|3|||
143131999|NCT00905424|516027443|FG000|Overall Study|Withdrawal by Subject|1|||
143132000|NCT00905424|516027444|FG001|Overall Study|Withdrawal by Subject|2|||
143132001|NCT00905424|516027443|FG000|Overall Study|Adverse Event|4|||
143132002|NCT00905424|516027444|FG001|Overall Study|Adverse Event|2|||
143132003|NCT00905424|516027443|FG000|Overall Study|Non-compliance with study medication|2|||
143132004|NCT00905424|516027444|FG001|Overall Study|Non-compliance with study medication|0|||
143132005|NCT00905424|516027443|FG000|Overall Study|Sponsor decision|1|||
143132006|NCT00905424|516027444|FG001|Overall Study|Sponsor decision|0|||
143132007|NCT00905424|516027443|FG000|Overall Study|Positive urine drug screen|0|||
143132008|NCT00905424|516027444|FG001|Overall Study|Positive urine drug screen|1|||
143132009|NCT00905424|516027443|FG000|Overall Study|Non-adherence to visit schedule|0|||
143132010|NCT00905424|516027444|FG001|Overall Study|Non-adherence to visit schedule|1|||
143132011|NCT01585246|516027447|FG000|Overall Study|Lost to Follow-up|0|||
143132012|NCT01585246|516027448|FG001|Overall Study|Lost to Follow-up|0|||
143132013|NCT01585246|516027449|FG002|Overall Study|Lost to Follow-up|2|||
143132014|NCT01585246|516027450|FG003|Overall Study|Lost to Follow-up|1|||
143132015|NCT01585246|516027451|FG004|Overall Study|Lost to Follow-up|0|||
143132016|NCT01585246|516027447|FG000|Overall Study|Protocol Violation|0|||
143132017|NCT01585246|516027448|FG001|Overall Study|Protocol Violation|0|||
143132018|NCT01585246|516027449|FG002|Overall Study|Protocol Violation|0|||
143132019|NCT01585246|516027450|FG003|Overall Study|Protocol Violation|0|||
143132020|NCT01585246|516027451|FG004|Overall Study|Protocol Violation|1|||
143132021|NCT01585246|516027447|FG000|Overall Study|Withdrawal by Subject|0|||
143132022|NCT01585246|516027448|FG001|Overall Study|Withdrawal by Subject|0|||
143132023|NCT01585246|516027449|FG002|Overall Study|Withdrawal by Subject|1|||
143132024|NCT01585246|516027450|FG003|Overall Study|Withdrawal by Subject|2|||
143132025|NCT01585246|516027451|FG004|Overall Study|Withdrawal by Subject|1|||
143132026|NCT01585246|516027447|FG000|Overall Study|Other|0|||
143132027|NCT01585246|516027448|FG001|Overall Study|Other|1|||
143132028|NCT01585246|516027449|FG002|Overall Study|Other|1|||
143132029|NCT01585246|516027450|FG003|Overall Study|Other|1|||
143132030|NCT01585246|516027451|FG004|Overall Study|Other|0|||
143132031|NCT01657162|516027456|FG000|Overall Study|Adverse Event|26|||
143132032|NCT01657162|516027457|FG001|Overall Study|Adverse Event|36|||
143132033|NCT01657162|516027456|FG000|Overall Study|Withdrawal by Subject|13|||
143132034|NCT01657162|516027457|FG001|Overall Study|Withdrawal by Subject|13|||
143132035|NCT01657162|516027456|FG000|Overall Study|Continuing Significant Deterioration|9|||
143132036|NCT01657162|516027457|FG001|Overall Study|Continuing Significant Deterioration|3|||
143132037|NCT01657162|516027456|FG000|Overall Study|Refusal of Treatment|4|||
143132038|NCT01657162|516027457|FG001|Overall Study|Refusal of Treatment|6|||
143132039|NCT01657162|516027456|FG000|Overall Study|Lost to Follow-up|3|||
143132040|NCT01657162|516027457|FG001|Overall Study|Lost to Follow-up|4|||
143132041|NCT01657162|516027456|FG000|Overall Study|Death|2|||
143132042|NCT01657162|516027457|FG001|Overall Study|Death|3|||
143132043|NCT01657162|516027456|FG000|Overall Study|Inability to Complete Study Procedures|1|||
143132044|NCT01657162|516027457|FG001|Overall Study|Inability to Complete Study Procedures|7|||
143132045|NCT01657162|516027456|FG000|Overall Study|Protocol Violation|1|||
143132046|NCT01657162|516027457|FG001|Overall Study|Protocol Violation|0|||
143132047|NCT01657162|516027456|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
143132048|NCT01657162|516027457|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
143132049|NCT01657162|516027456|FG000|Overall Study|Other than Specified|0|||
143132050|NCT01657162|516027457|FG001|Overall Study|Other than Specified|2|||
143132051|NCT00838097|516027458|FG000|Overall Study|Ineligibility determined|6|||
143132052|NCT00838097|516027458|FG000|Overall Study|Adverse Event|2|||
143132053|NCT00838097|516027458|FG000|Overall Study|Withdrawal by Subject|3|||
143132054|NCT00838097|516027458|FG000|Overall Study|Requirement for alternative therapy|2|||
143132055|NCT00838097|516027458|FG000|Overall Study|Physician Decision|4|||
143132056|NCT00838097|516027458|FG000|Overall Study|Lost to Follow-up|11|||
143132057|NCT00838097|516027458|FG000|Overall Study|Death|6|||
143132058|NCT00838097|516027458|FG000|Overall Study|Protocol-specified criteria|142|||
143132059|NCT01951417|516027473|FG000|Overall Study|Withdrawal by Subject|1|||
143132060|NCT01951417|516027473|FG000|Overall Study|Protocol Violation|2|||
143132061|NCT01951417|516027473|FG000|Overall Study|Lost to Follow-up|6|||
143132062|NCT00977613|516027474|FG000|Overall Study|Lost to Follow-up|16|||
143132063|NCT02329327|516027478|FG000|Overall Study|Death|78|||
143132064|NCT02329327|516027479|FG001|Overall Study|Death|0|||
143132065|NCT02329327|516027478|FG000|Overall Study|Withdrawal by Subject|3|||
143132066|NCT02329327|516027479|FG001|Overall Study|Withdrawal by Subject|0|||
143132067|NCT02329327|516027478|FG000|Overall Study|Lost to Follow-up|4|||
143132068|NCT02329327|516027479|FG001|Overall Study|Lost to Follow-up|0|||
143132069|NCT03284853|516027480|FG000|Overall Study|Adverse Event|40|||
143132070|NCT03284853|516027481|FG001|Overall Study|Adverse Event|4|||
143132071|NCT03284853|516027480|FG000|Overall Study|Withdrawal by Subject|5|||
143132072|NCT03284853|516027481|FG001|Overall Study|Withdrawal by Subject|1|||
143132073|NCT03284853|516027480|FG000|Overall Study|Lost to Follow-up|1|||
143132074|NCT03284853|516027481|FG001|Overall Study|Lost to Follow-up|0|||
143132075|NCT03284853|516027480|FG000|Overall Study|Lack of Efficacy|1|||
143132076|NCT03284853|516027481|FG001|Overall Study|Lack of Efficacy|0|||
143132077|NCT03284853|516027480|FG000|Overall Study|Disallowed Concurrent Medication|1|||
143132078|NCT03284853|516027481|FG001|Overall Study|Disallowed Concurrent Medication|1|||
143132079|NCT03284853|516027480|FG000|Overall Study|Protocol Violation|3|||
143132080|NCT03284853|516027481|FG001|Overall Study|Protocol Violation|3|||
143132081|NCT03284853|516027480|FG000|Overall Study|Death|0|||
143132082|NCT03284853|516027481|FG001|Overall Study|Death|1|||
143132083|NCT03284853|516027480|FG000|Overall Study|Other - Reason not reported in CSR|4|||
143132084|NCT03284853|516027481|FG001|Overall Study|Other - Reason not reported in CSR|3|||
143231037|NCT05556265|516395585|FG000|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
143231038|NCT05556265|516395586|FG001|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|2|||
143132085|NCT02143024|516027482|FG000|Overall Study|Lost to Follow-up|1|||
143132086|NCT02143024|516027483|FG001|Overall Study|Lost to Follow-up|1|||
143132087|NCT02143024|516027482|FG000|Overall Study|Withdrawal by Subject|1|||
143132088|NCT02143024|516027483|FG001|Overall Study|Withdrawal by Subject|0|||
143132089|NCT02308228|516027484|FG000|Overall Study|Adverse Event|3|||
143132090|NCT02308228|516027485|FG001|Overall Study|Adverse Event|4|||
143132091|NCT02308228|516027484|FG000|Overall Study|Withdrawal by Subject|5|||
143132092|NCT02308228|516027485|FG001|Overall Study|Withdrawal by Subject|3|||
143132093|NCT03999749|516027486|FG000|Overall Study|Toxicity|16|||
143132094|NCT03999749|516027486|FG000|Overall Study|Withdrawal by Subject|3|||
143132095|NCT03999749|516027486|FG000|Overall Study|Disease progression|26|||
143132096|NCT03999749|516027486|FG000|Overall Study|Physician Decision|4|||
143132097|NCT03999749|516027486|FG000|Overall Study|Death|5|||
143132098|NCT03999749|516027486|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
143132099|NCT04888494|516027487|FG000|Overall Study|Lost to Follow-up|2|||
143132100|NCT04888494|516027488|FG001|Overall Study|Lost to Follow-up|3|||
143132101|NCT04888494|516027487|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
143132102|NCT04888494|516027488|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
143132103|NCT03430856|516027489|FG000|Overall Study|Adverse Event|0|||
143132104|NCT03430856|516027490|FG001|Overall Study|Adverse Event|1|||
143132105|NCT03430856|516027491|FG002|Overall Study|Adverse Event|0|||
143132106|NCT03430856|516027489|FG000|Overall Study|Rescue criteria|1|||
143132107|NCT03430856|516027490|FG001|Overall Study|Rescue criteria|1|||
143132108|NCT03430856|516027491|FG002|Overall Study|Rescue criteria|0|||
143132109|NCT03430856|516027489|FG000|Overall Study|Voluntary withdrawal of consent|1|||
143132110|NCT03430856|516027490|FG001|Overall Study|Voluntary withdrawal of consent|1|||
143132111|NCT03430856|516027491|FG002|Overall Study|Voluntary withdrawal of consent|1|||
143132112|NCT04587336|516027493|FG000|Overall Study|Lost to Follow-up|1|||
143132113|NCT04587336|516027494|FG001|Overall Study|Lost to Follow-up|0|||
143132114|NCT02358031|516029186|FG000|Overall Study|Death|253|||
143132115|NCT02358031|516029187|FG001|Overall Study|Death|237|||
143132116|NCT02358031|516029188|FG002|Overall Study|Death|266|||
143132117|NCT02358031|516029186|FG000|Overall Study|Lost to Follow-up|1|||
143132118|NCT02358031|516029187|FG001|Overall Study|Lost to Follow-up|1|||
143231039|NCT05556265|516395587|FG002|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
143259575|NCT02241889|516505782|FG001|Overall Study|Withdrawal by Subject|0|||
143132119|NCT02358031|516029188|FG002|Overall Study|Lost to Follow-up|0|||
143132120|NCT02358031|516029186|FG000|Overall Study|Withdrawal by Subject|19|||
143132121|NCT02358031|516029187|FG001|Overall Study|Withdrawal by Subject|14|||
143132122|NCT02358031|516029188|FG002|Overall Study|Withdrawal by Subject|18|||
143132123|NCT02358031|516029186|FG000|Overall Study|Sponsor Decision|26|||
143132124|NCT02358031|516029187|FG001|Overall Study|Sponsor Decision|28|||
143132125|NCT02358031|516029188|FG002|Overall Study|Sponsor Decision|16|||
143132126|NCT01212094|516029189|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
143132127|NCT01212094|516029190|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
143132128|NCT01212094|516029191|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
143132129|NCT01212094|516029189|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
143132130|NCT01212094|516029190|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
143132131|NCT01212094|516029191|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
143132132|NCT01212094|516029189|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
143132133|NCT01212094|516029190|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
143132134|NCT01212094|516029191|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
143132135|NCT01212094|516029189|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
143132136|NCT01212094|516029190|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
143132137|NCT01212094|516029191|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
143132138|NCT01212094|516029189|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
143132139|NCT01212094|516029190|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
143132140|NCT01212094|516029191|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
143132141|NCT01212094|516029189|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
143132142|NCT01212094|516029190|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
143132143|NCT01212094|516029191|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
143132144|NCT05664581|516029193|FG000|Overall Study|Withdrawal by Subject|2|||
143132145|NCT03101150|516029194|FG000|Overall Study|Lost to Follow-up|2|||
143132146|NCT03101150|516029195|FG001|Overall Study|Lost to Follow-up|4|||
143132147|NCT03101150|516029194|FG000|Overall Study|Miscarriage|3|||
143132148|NCT03101150|516029195|FG001|Overall Study|Miscarriage|6|||
143132149|NCT02787304|516029197|FG000|Overall Study|Adverse Event|9|||
143132150|NCT02787304|516029198|FG001|Overall Study|Adverse Event|3|||
143132151|NCT02787304|516029199|FG002|Overall Study|Adverse Event|8|||
143132152|NCT02787304|516029200|FG003|Overall Study|Adverse Event|1|||
143132153|NCT02787304|516029197|FG000|Overall Study|Withdrawal by Subject|1|||
143132154|NCT02787304|516029198|FG001|Overall Study|Withdrawal by Subject|4|||
143132155|NCT02787304|516029199|FG002|Overall Study|Withdrawal by Subject|0|||
143132156|NCT02787304|516029200|FG003|Overall Study|Withdrawal by Subject|0|||
143132157|NCT02787304|516029197|FG000|Overall Study|Lost to Follow-up|1|||
143132158|NCT02787304|516029198|FG001|Overall Study|Lost to Follow-up|0|||
143132159|NCT02787304|516029199|FG002|Overall Study|Lost to Follow-up|0|||
143132160|NCT02787304|516029200|FG003|Overall Study|Lost to Follow-up|1|||
143132161|NCT02787304|516029197|FG000|Overall Study|Noncompliance with study drug|0|||
143132162|NCT02787304|516029198|FG001|Overall Study|Noncompliance with study drug|0|||
143132163|NCT02787304|516029199|FG002|Overall Study|Noncompliance with study drug|1|||
143132164|NCT02787304|516029200|FG003|Overall Study|Noncompliance with study drug|0|||
143132165|NCT02787304|516029197|FG000|Overall Study|Physician Decision|0|||
143132166|NCT02787304|516029198|FG001|Overall Study|Physician Decision|0|||
143132167|NCT02787304|516029199|FG002|Overall Study|Physician Decision|1|||
143132168|NCT02787304|516029200|FG003|Overall Study|Physician Decision|0|||
143132169|NCT02787304|516029197|FG000|Overall Study|Study terminated by sponsor|25|||
143132170|NCT02787304|516029198|FG001|Overall Study|Study terminated by sponsor|31|||
143132171|NCT02787304|516029199|FG002|Overall Study|Study terminated by sponsor|31|||
143132172|NCT02787304|516029200|FG003|Overall Study|Study terminated by sponsor|32|||
143132173|NCT00823134|516029202|FG000|Overall Study|Invalid measurement|1|||
143132174|NCT01519817|516029204|FG000|Overall Study|Withdrawal by Subject|1|||
143132175|NCT01519817|516029205|FG001|Overall Study|Withdrawal by Subject|0|||
143132176|NCT01519817|516029206|FG002|Overall Study|Withdrawal by Subject|0|||
143132177|NCT01519817|516029207|FG003|Overall Study|Withdrawal by Subject|0|||
143132178|NCT01519817|516029204|FG000|Overall Study|Off study due to infection|0|||
143132179|NCT01519817|516029205|FG001|Overall Study|Off study due to infection|0|||
143132180|NCT01519817|516029206|FG002|Overall Study|Off study due to infection|0|||
143132181|NCT01519817|516029207|FG003|Overall Study|Off study due to infection|1|||
143132182|NCT01325350|516029210|FG000|Overall Study|Adverse Event|3|||
143132183|NCT01325350|516029211|FG001|Overall Study|Adverse Event|3|||
143132184|NCT01325350|516029212|FG002|Overall Study|Adverse Event|3|||
143132185|NCT01325350|516029213|FG003|Overall Study|Adverse Event|1|||
143132186|NCT01325350|516029214|FG004|Overall Study|Adverse Event|2|||
143358118|NCT03280563|516856080|FG000|Long-term Survival Follow-up|Study Ended by Sponsor|4|||
143358119|NCT03280563|516856081|FG001|Long-term Survival Follow-up|Study Ended by Sponsor|9|||
143358120|NCT03280563|516856082|FG002|Long-term Survival Follow-up|Study Ended by Sponsor|3|||
143358121|NCT03280563|516856083|FG003|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
143358122|NCT03280563|516856084|FG004|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
143132187|NCT01325350|516029210|FG000|Overall Study|Pregnancy|0|||
143013809|NCT02617446|515590037|FG001|Overall Study|Withdrawal by Subject|2|||
143132188|NCT01325350|516029211|FG001|Overall Study|Pregnancy|0|||
143132189|NCT01325350|516029212|FG002|Overall Study|Pregnancy|1|||
143132190|NCT01325350|516029213|FG003|Overall Study|Pregnancy|0|||
143132191|NCT01325350|516029214|FG004|Overall Study|Pregnancy|1|||
143132192|NCT01325350|516029210|FG000|Overall Study|Lost to Follow-up|1|||
143132193|NCT01325350|516029211|FG001|Overall Study|Lost to Follow-up|0|||
143132194|NCT01325350|516029212|FG002|Overall Study|Lost to Follow-up|5|||
143132195|NCT01325350|516029213|FG003|Overall Study|Lost to Follow-up|1|||
143132196|NCT01325350|516029214|FG004|Overall Study|Lost to Follow-up|5|||
143132197|NCT01325350|516029210|FG000|Overall Study|Personal Reasons|2|||
143132198|NCT01325350|516029211|FG001|Overall Study|Personal Reasons|1|||
143132199|NCT01325350|516029212|FG002|Overall Study|Personal Reasons|6|||
143132200|NCT01325350|516029213|FG003|Overall Study|Personal Reasons|5|||
143132201|NCT01325350|516029214|FG004|Overall Study|Personal Reasons|3|||
143132202|NCT01325350|516029210|FG000|Overall Study|Protocol Violation|0|||
143132203|NCT01325350|516029211|FG001|Overall Study|Protocol Violation|0|||
143132204|NCT01325350|516029212|FG002|Overall Study|Protocol Violation|0|||
143132205|NCT01325350|516029213|FG003|Overall Study|Protocol Violation|1|||
143132206|NCT01325350|516029214|FG004|Overall Study|Protocol Violation|0|||
143132207|NCT01325350|516029210|FG000|Overall Study|Withdrawal by Subject|0|||
143132208|NCT01325350|516029211|FG001|Overall Study|Withdrawal by Subject|0|||
143132209|NCT01325350|516029212|FG002|Overall Study|Withdrawal by Subject|1|||
143132210|NCT01325350|516029213|FG003|Overall Study|Withdrawal by Subject|1|||
143132211|NCT01325350|516029214|FG004|Overall Study|Withdrawal by Subject|0|||
143132212|NCT01325350|516029210|FG000|Overall Study|Did Not Receive Treatment|0|||
143132213|NCT01325350|516029211|FG001|Overall Study|Did Not Receive Treatment|1|||
143132214|NCT01325350|516029212|FG002|Overall Study|Did Not Receive Treatment|1|||
143132215|NCT01325350|516029213|FG003|Overall Study|Did Not Receive Treatment|0|||
143132216|NCT01325350|516029214|FG004|Overall Study|Did Not Receive Treatment|1|||
143132217|NCT02692586|516029217|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
143132218|NCT02692586|516029217|FG000|Overall Study|Received adjunctive thrombolytics|2|||
143132219|NCT01128296|516029218|FG000|Overall Study|Physician Decision|0|||
143132220|NCT01128296|516029219|FG001|Overall Study|Physician Decision|0|||
143132221|NCT01128296|516029220|FG002|Overall Study|Physician Decision|0|||
143132222|NCT01128296|516029221|FG003|Overall Study|Physician Decision|0|||
143132223|NCT01128296|516029222|FG004|Overall Study|Physician Decision|0|||
143132224|NCT01128296|516029223|FG005|Overall Study|Physician Decision|3|||
143132225|NCT01128296|516029218|FG000|Overall Study|Withdrawal by Subject|0|||
143132226|NCT01128296|516029219|FG001|Overall Study|Withdrawal by Subject|0|||
143132227|NCT01128296|516029220|FG002|Overall Study|Withdrawal by Subject|0|||
143132228|NCT01128296|516029221|FG003|Overall Study|Withdrawal by Subject|0|||
143132229|NCT01128296|516029222|FG004|Overall Study|Withdrawal by Subject|0|||
143132230|NCT01128296|516029223|FG005|Overall Study|Withdrawal by Subject|2|||
143132231|NCT03316586|516029228|FG000|Overall Study|Adverse Event|2|||
143132232|NCT03316586|516029228|FG000|Overall Study|Physician Decision|3|||
143132233|NCT03316586|516029228|FG000|Overall Study|Lack of Efficacy|10|||
143132234|NCT03316586|516029228|FG000|Overall Study|still on treatment|1|||
143132235|NCT03316586|516029228|FG000|Overall Study|Patient needed radiation therapy|1|||
143132236|NCT03316586|516029228|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
143132237|NCT00873730|516029230|FG000|Overall Study|Protocol Deviation|5|||
143132238|NCT00873730|516029231|FG001|Overall Study|Protocol Deviation|2|||
143132239|NCT00873730|516029230|FG000|Overall Study|Adverse Event|0|||
143132240|NCT00873730|516029231|FG001|Overall Study|Adverse Event|2|||
143132241|NCT00873730|516029230|FG000|Overall Study|Withdrawal by Subject|0|||
143132242|NCT00873730|516029231|FG001|Overall Study|Withdrawal by Subject|1|||
143132243|NCT00873730|516029230|FG000|Overall Study|Sponsor decision|1|||
143132244|NCT00873730|516029231|FG001|Overall Study|Sponsor decision|0|||
143132245|NCT04613739|516029232|FG000|Overall Study|Lost to Follow-up|6|||
143132246|NCT04613739|516029233|FG001|Overall Study|Lost to Follow-up|9|||
143132247|NCT04613739|516029232|FG000|Overall Study|potentially duplicative/fraudulent|1|||
143132248|NCT04613739|516029233|FG001|Overall Study|potentially duplicative/fraudulent|3|||
143132249|NCT00003537|516029234|FG000|Overall Study|Not evalauable|1|||
143132250|NCT01051557|516029235|FG000|Overall Study|Physician Decision|1|||
143132251|NCT01051557|516029236|FG001|Overall Study|Physician Decision|0|||
143132252|NCT01051557|516029237|FG002|Overall Study|Physician Decision|0|||
143132253|NCT01051557|516029238|FG003|Overall Study|Physician Decision|0|||
143132254|NCT01051557|516029239|FG004|Overall Study|Physician Decision|0|||
143132255|NCT01051557|516029240|FG005|Overall Study|Physician Decision|0|||
143132256|NCT01051557|516029241|FG006|Overall Study|Physician Decision|0|||
143132257|NCT01051557|516029235|FG000|Overall Study|disease progression|3|||
143132258|NCT01051557|516029236|FG001|Overall Study|disease progression|3|||
143132259|NCT01051557|516029237|FG002|Overall Study|disease progression|5|||
143132260|NCT01051557|516029238|FG003|Overall Study|disease progression|2|||
143132261|NCT01051557|516029239|FG004|Overall Study|disease progression|4|||
143132262|NCT01051557|516029240|FG005|Overall Study|disease progression|3|||
143132263|NCT01051557|516029241|FG006|Overall Study|disease progression|1|||
143132264|NCT01051557|516029235|FG000|Overall Study|Withdrawal by Subject|0|||
143132265|NCT01051557|516029236|FG001|Overall Study|Withdrawal by Subject|0|||
143132266|NCT01051557|516029237|FG002|Overall Study|Withdrawal by Subject|1|||
143132267|NCT01051557|516029238|FG003|Overall Study|Withdrawal by Subject|0|||
143132268|NCT01051557|516029239|FG004|Overall Study|Withdrawal by Subject|2|||
143132269|NCT01051557|516029240|FG005|Overall Study|Withdrawal by Subject|0|||
143132270|NCT01051557|516029241|FG006|Overall Study|Withdrawal by Subject|1|||
143132271|NCT01051557|516029235|FG000|Overall Study|Adverse Event|0|||
143132272|NCT01051557|516029236|FG001|Overall Study|Adverse Event|0|||
143132273|NCT01051557|516029237|FG002|Overall Study|Adverse Event|0|||
143132274|NCT01051557|516029238|FG003|Overall Study|Adverse Event|1|||
143132275|NCT01051557|516029239|FG004|Overall Study|Adverse Event|1|||
143132276|NCT01051557|516029240|FG005|Overall Study|Adverse Event|3|||
143132277|NCT01051557|516029241|FG006|Overall Study|Adverse Event|4|||
143132278|NCT01178125|516029242|FG000|Overall Study|Lost to Follow-up|397|||
143132279|NCT01178125|516029242|FG000|Overall Study|Adverse Event|244|||
143132280|NCT01178125|516029242|FG000|Overall Study|Withdrawal by Subject|209|||
143132281|NCT01178125|516029242|FG000|Overall Study|Noncompliance|184|||
143132282|NCT01178125|516029242|FG000|Overall Study|Pregnancy|55|||
143132283|NCT01178125|516029242|FG000|Overall Study|Other Reason|39|||
143132284|NCT01178125|516029242|FG000|Overall Study|Sponsor Decision|28|||
143132285|NCT01178125|516029242|FG000|Overall Study|Protocol Violation|17|||
143132286|NCT01178125|516029242|FG000|Overall Study|Investigator Decision|5|||
143132287|NCT00735943|516029243|FG000|Overall Study|Lost to Follow-up|1|||
143132288|NCT00735943|516029243|FG000|Overall Study|Adverse Event|1|||
143132289|NCT01064414|516029244|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
143132290|NCT01064414|516029245|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
143132291|NCT01064414|516029246|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
143132292|NCT01064414|516029244|FG000|Core Period: Baseline to Week 26|Death|0|||
143132293|NCT01064414|516029245|FG001|Core Period: Baseline to Week 26|Death|1|||
143132294|NCT01064414|516029246|FG002|Core Period: Baseline to Week 26|Death|0|||
143132295|NCT01064414|516029244|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
143132296|NCT01064414|516029245|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
143132297|NCT01064414|516029246|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
143132298|NCT01064414|516029244|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
143132299|NCT01064414|516029245|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
143132300|NCT01064414|516029246|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
143132301|NCT01064414|516029244|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
143132302|NCT01064414|516029245|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
143132303|NCT01064414|516029246|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
143132304|NCT01064414|516029244|FG000|Core Period: Baseline to Week 26|Other|4|||
143132305|NCT01064414|516029245|FG001|Core Period: Baseline to Week 26|Other|7|||
143132306|NCT01064414|516029246|FG002|Core Period: Baseline to Week 26|Other|2|||
143132307|NCT01064414|516029244|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
143132308|NCT01064414|516029245|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
143132309|NCT01064414|516029246|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
143132310|NCT01064414|516029244|FG000|Extension Period: Week 26 to Week 52|Death|0|||
143132311|NCT01064414|516029245|FG001|Extension Period: Week 26 to Week 52|Death|1|||
143132312|NCT01064414|516029246|FG002|Extension Period: Week 26 to Week 52|Death|0|||
143132313|NCT01064414|516029244|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
143132314|NCT01064414|516029245|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
143132315|NCT01064414|516029246|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
143132316|NCT01064414|516029244|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
143132317|NCT01064414|516029245|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
143132318|NCT01064414|516029246|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
143132319|NCT01064414|516029244|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
143132320|NCT01064414|516029245|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
143132321|NCT01064414|516029246|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
143132322|NCT01064414|516029244|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
143132323|NCT01064414|516029245|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
143132324|NCT01064414|516029246|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
143132325|NCT01064414|516029244|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
143132326|NCT01064414|516029245|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
143132327|NCT01064414|516029246|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
143132328|NCT01064414|516029244|FG000|Extension Period: Week 26 to Week 52|Other|5|||
143132329|NCT01064414|516029245|FG001|Extension Period: Week 26 to Week 52|Other|2|||
143132330|NCT01064414|516029246|FG002|Extension Period: Week 26 to Week 52|Other|1|||
143132331|NCT02185417|516029247|FG000|Overall Study|Death|448|||
143132332|NCT02185417|516029248|FG001|Overall Study|Death|446|||
143132333|NCT02185417|516029249|FG002|Overall Study|Death|0|||
143132334|NCT02185417|516029247|FG000|Overall Study|Withdrawal by Subject|7|||
143132335|NCT02185417|516029248|FG001|Overall Study|Withdrawal by Subject|12|||
143132336|NCT02185417|516029249|FG002|Overall Study|Withdrawal by Subject|0|||
143132337|NCT03933449|516029250|FG000|Overall Study|Adverse Event|6|||
143132338|NCT03933449|516029251|FG001|Overall Study|Adverse Event|4|||
143132339|NCT03933449|516029250|FG000|Overall Study|Death|55|||
143132340|NCT03933449|516029251|FG001|Overall Study|Death|57|||
143132341|NCT03933449|516029250|FG000|Overall Study|Sponsor Decision|1|||
143132342|NCT03933449|516029251|FG001|Overall Study|Sponsor Decision|0|||
143132343|NCT03075267|516029254|FG000|Overall Study|Protocol Violation|1|||
143132344|NCT03075267|516029255|FG001|Overall Study|Protocol Violation|0|||
143132345|NCT03075267|516029256|FG002|Overall Study|Protocol Violation|0|||
143132346|NCT01411852|516029260|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
143132347|NCT01411852|516029261|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
143465782|NCT00307125|517251126|FG002|Pilot Phase|Withdrawal by Subject|1|||
143132348|NCT01411852|516029260|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
143132349|NCT01411852|516029261|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
143132350|NCT01411852|516029260|FG000|Prehospital Intervention Phase|Found to be under age|0|||
143132351|NCT01411852|516029261|FG001|Prehospital Intervention Phase|Found to be under age|1|||
143132352|NCT01411852|516029260|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
143132353|NCT01411852|516029261|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
143132354|NCT01411852|516029260|FG000|Hospital Intervention Phase|Severe head injury|5|||
143132355|NCT01411852|516029261|FG001|Hospital Intervention Phase|Severe head injury|4|||
143132356|NCT01411852|516029260|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
143132357|NCT01411852|516029261|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
143132358|NCT01411852|516029260|FG000|Hospital Intervention Phase|Miscommunication error|1|||
143132359|NCT01411852|516029261|FG001|Hospital Intervention Phase|Miscommunication error|2|||
143132360|NCT01411852|516029260|FG000|Hospital Intervention Phase|CPR administered|3|||
143132361|NCT01411852|516029261|FG001|Hospital Intervention Phase|CPR administered|1|||
143132362|NCT01411852|516029260|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
143132363|NCT01411852|516029261|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
143132364|NCT01411852|516029260|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
143132365|NCT01411852|516029261|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
143132366|NCT01411852|516029260|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
143132367|NCT01411852|516029261|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
143132368|NCT01411852|516029260|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
143132369|NCT01411852|516029261|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
143132370|NCT01411852|516029260|FG000|Hospital Intervention Phase|Other ineligible|2|||
143132371|NCT01411852|516029261|FG001|Hospital Intervention Phase|Other ineligible|2|||
143132372|NCT01411852|516029260|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
143132373|NCT01411852|516029261|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
143132374|NCT01411852|516029260|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
143132375|NCT01411852|516029261|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
143132376|NCT01411852|516029260|FG000|Hospital Intervention Phase|Vascular access failed|1|||
143132377|NCT01411852|516029261|FG001|Hospital Intervention Phase|Vascular access failed|0|||
143132378|NCT00321906|516029262|FG000|Overall Study|Adverse Event|36|||
143132379|NCT00321906|516029263|FG001|Overall Study|Adverse Event|44|||
143132380|NCT00321906|516029262|FG000|Overall Study|Death|9|||
143132381|NCT00321906|516029263|FG001|Overall Study|Death|6|||
143132382|NCT00321906|516029262|FG000|Overall Study|Lost to Follow-up|1|||
143132383|NCT00321906|516029263|FG001|Overall Study|Lost to Follow-up|2|||
143132384|NCT00321906|516029262|FG000|Overall Study|Withdrawal by Subject|0|||
143132385|NCT00321906|516029263|FG001|Overall Study|Withdrawal by Subject|4|||
143132386|NCT01272908|516029267|FG000|Initial Treatment Period|Adverse Event|1|||
143132387|NCT01272908|516029267|FG000|Initial Treatment Period|Lack of Efficacy|5|||
143132388|NCT01272908|516029267|FG000|Initial Treatment Period|Protocol Violation|1|||
143132389|NCT01272908|516029267|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
143132390|NCT01272908|516029267|FG000|Re-Treatment Period|Adverse Event|2|||
143132391|NCT01272908|516029267|FG000|Re-Treatment Period|Lack of Efficacy|3|||
143132392|NCT01272908|516029267|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
143132393|NCT02221648|516029268|FG000|Overall Study|Withdrawal by Subject|3|||
143132394|NCT02221648|516029269|FG001|Overall Study|Withdrawal by Subject|3|||
143132395|NCT00149396|516029270|FG000|Overall Study|Death|15|||
143132396|NCT00149396|516029270|FG000|Overall Study|Withdrawal by Subject|1|||
143132397|NCT00149396|516029270|FG000|Overall Study|Subject noncompliance|2|||
143132398|NCT00149396|516029270|FG000|Overall Study|other treatment|5|||
143132399|NCT00810069|516029271|FG000|Lead-in Period I|Adverse Event|43|||
143132400|NCT00810069|516029272|FG001|Lead-in Period I|Adverse Event|0|||
143132401|NCT00810069|516029273|FG002|Lead-in Period I|Adverse Event|0|||
143132402|NCT00810069|516029271|FG000|Lead-in Period I|Lack of Efficacy|1|||
143132403|NCT00810069|516029272|FG001|Lead-in Period I|Lack of Efficacy|0|||
143132404|NCT00810069|516029273|FG002|Lead-in Period I|Lack of Efficacy|0|||
143132405|NCT00810069|516029271|FG000|Lead-in Period I|Lost to Follow-up|19|||
143132406|NCT00810069|516029272|FG001|Lead-in Period I|Lost to Follow-up|0|||
143132407|NCT00810069|516029273|FG002|Lead-in Period I|Lost to Follow-up|0|||
143132408|NCT00810069|516029271|FG000|Lead-in Period I|Physician Decision|1|||
143132409|NCT00810069|516029272|FG001|Lead-in Period I|Physician Decision|0|||
143132410|NCT00810069|516029273|FG002|Lead-in Period I|Physician Decision|0|||
143132411|NCT00810069|516029271|FG000|Lead-in Period I|Protocol Violation|1|||
143132412|NCT00810069|516029272|FG001|Lead-in Period I|Protocol Violation|0|||
143013810|NCT02617446|515590038|FG002|Overall Study|Withdrawal by Subject|0|||
143132413|NCT00810069|516029273|FG002|Lead-in Period I|Protocol Violation|0|||
143132414|NCT00810069|516029271|FG000|Lead-in Period I|Withdrawal by Subject|46|||
143013811|NCT02617446|515590036|FG000|Overall Study|Adverse Event|1|||
143013812|NCT02617446|515590037|FG001|Overall Study|Adverse Event|0|||
143013813|NCT02617446|515590038|FG002|Overall Study|Adverse Event|5|||
143013814|NCT02617446|515590036|FG000|Overall Study|Lost to Follow-up|3|||
143132415|NCT00810069|516029272|FG001|Lead-in Period I|Withdrawal by Subject|0|||
143132416|NCT00810069|516029273|FG002|Lead-in Period I|Withdrawal by Subject|0|||
143132417|NCT00810069|516029271|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
143132418|NCT00810069|516029272|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
143132419|NCT00810069|516029273|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
143132420|NCT00810069|516029271|FG000|Lead-in Period I|Randomization criteria not met|158|||
143132421|NCT00810069|516029272|FG001|Lead-in Period I|Randomization criteria not met|0|||
143132422|NCT00810069|516029273|FG002|Lead-in Period I|Randomization criteria not met|0|||
143132423|NCT00810069|516029271|FG000|Double-Blind Period II|Adverse Event|0|||
143132424|NCT00810069|516029272|FG001|Double-Blind Period II|Adverse Event|9|||
143132425|NCT00810069|516029273|FG002|Double-Blind Period II|Adverse Event|8|||
143132426|NCT00810069|516029271|FG000|Double-Blind Period II|Lack of Efficacy|0|||
143132427|NCT00810069|516029272|FG001|Double-Blind Period II|Lack of Efficacy|7|||
143132428|NCT00810069|516029273|FG002|Double-Blind Period II|Lack of Efficacy|12|||
143132429|NCT00810069|516029271|FG000|Double-Blind Period II|Lost to Follow-up|0|||
143132430|NCT00810069|516029272|FG001|Double-Blind Period II|Lost to Follow-up|9|||
143132431|NCT00810069|516029273|FG002|Double-Blind Period II|Lost to Follow-up|9|||
143132432|NCT00810069|516029271|FG000|Double-Blind Period II|Physician Decision|0|||
143132433|NCT00810069|516029272|FG001|Double-Blind Period II|Physician Decision|0|||
143132434|NCT00810069|516029273|FG002|Double-Blind Period II|Physician Decision|1|||
143132435|NCT00810069|516029271|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
143132436|NCT00810069|516029272|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
143132437|NCT00810069|516029273|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
143132438|NCT00810069|516029271|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
143132439|NCT00810069|516029272|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
143132440|NCT00810069|516029273|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
143132441|NCT00810069|516029271|FG000|Double-Blind Period II|Clinical relapse|0|||
143132442|NCT00810069|516029272|FG001|Double-Blind Period II|Clinical relapse|3|||
143132443|NCT00810069|516029273|FG002|Double-Blind Period II|Clinical relapse|0|||
143132444|NCT00810069|516029271|FG000|Double-Blind Period II|Protocol Violation|0|||
143132445|NCT00810069|516029272|FG001|Double-Blind Period II|Protocol Violation|7|||
143132446|NCT00810069|516029273|FG002|Double-Blind Period II|Protocol Violation|6|||
143132447|NCT01158261|516029274|FG000|Overall Study|Lost to Follow-up|9|||
143132448|NCT01158261|516029274|FG000|Overall Study|Death|7|||
143132449|NCT01158261|516029274|FG000|Overall Study|Withdrawal by Subject|1|||
143132450|NCT01630135|516029278|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
143132451|NCT01630135|516029279|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
143132452|NCT02899065|516029281|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
143132453|NCT02899065|516029282|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
143132454|NCT02899065|516029281|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
143132455|NCT02899065|516029282|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
143132456|NCT02899065|516029281|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
143132457|NCT02899065|516029282|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
143132458|NCT00971867|516029283|FG000|Overall Study|Adverse Event|4|||
143132459|NCT00971867|516029283|FG000|Overall Study|Participant Withdrew Consent|1|||
143132460|NCT00971867|516029283|FG000|Overall Study|Disease Progression|6|||
143132461|NCT04767373|516029284|FG000|Overall Study|Death|6|||
143132462|NCT04767373|516029285|FG001|Overall Study|Death|3|||
143132463|NCT04767373|516029284|FG000|Overall Study|Lost to Follow-up|67|||
143132464|NCT04767373|516029285|FG001|Overall Study|Lost to Follow-up|35|||
143132465|NCT04767373|516029284|FG000|Overall Study|Physician Decision|15|||
143132466|NCT04767373|516029285|FG001|Overall Study|Physician Decision|4|||
143132467|NCT04767373|516029284|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
143132468|NCT04767373|516029285|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
143132469|NCT04767373|516029284|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
143132470|NCT04767373|516029285|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
143132471|NCT04767373|516029284|FG000|Overall Study|Other|1|||
143132472|NCT04767373|516029285|FG001|Overall Study|Other|2|||
143132473|NCT02658669|516029286|FG000|Overall Study|Lost to Follow-up|7|||
143132474|NCT02658669|516029287|FG001|Overall Study|Lost to Follow-up|5|||
143132475|NCT03126786|516029288|FG000|Overall Study|Adverse Event|3|||
143132476|NCT03126786|516029289|FG001|Overall Study|Adverse Event|0|||
143132477|NCT03126786|516029288|FG000|Overall Study|Lost to Follow-up|0|||
143132478|NCT03126786|516029289|FG001|Overall Study|Lost to Follow-up|1|||
143132479|NCT03126786|516029288|FG000|Overall Study|Withdrawal by Subject|3|||
143132480|NCT03126786|516029289|FG001|Overall Study|Withdrawal by Subject|1|||
143132481|NCT00379899|516029290|FG000|Overall Study|Adverse Event|7|||
143132482|NCT00379899|516029291|FG001|Overall Study|Adverse Event|3|||
143132483|NCT00379899|516029290|FG000|Overall Study|Death|10|||
143132484|NCT00379899|516029291|FG001|Overall Study|Death|10|||
143132485|NCT00379899|516029290|FG000|Overall Study|Lost to Follow-up|2|||
143132486|NCT00379899|516029291|FG001|Overall Study|Lost to Follow-up|4|||
143132487|NCT00379899|516029290|FG000|Overall Study|Physician Decision|3|||
143132488|NCT00379899|516029291|FG001|Overall Study|Physician Decision|4|||
143465783|NCT00807235|517251129|FG000|Overall Study|Adverse Event|1|||
143132489|NCT00379899|516029290|FG000|Overall Study|Withdrawal by Subject|5|||
143132490|NCT00379899|516029291|FG001|Overall Study|Withdrawal by Subject|5|||
143132491|NCT00379899|516029290|FG000|Overall Study|Ineligibility determined|0|||
143132492|NCT00379899|516029291|FG001|Overall Study|Ineligibility determined|1|||
143132493|NCT00379899|516029290|FG000|Overall Study|Noncompliance|1|||
143132494|NCT00379899|516029291|FG001|Overall Study|Noncompliance|1|||
143132495|NCT00379899|516029290|FG000|Overall Study|Parathyroidectomy|0|||
143132496|NCT00379899|516029291|FG001|Overall Study|Parathyroidectomy|2|||
143132497|NCT00379899|516029290|FG000|Overall Study|Renal transplantation|5|||
143132498|NCT00379899|516029291|FG001|Overall Study|Renal transplantation|4|||
143132499|NCT00379899|516029290|FG000|Overall Study|Coronary artery bypass graft|1|||
143132500|NCT00379899|516029291|FG001|Overall Study|Coronary artery bypass graft|1|||
143132501|NCT00379899|516029290|FG000|Overall Study|Other protocol-specified criteria|3|||
143132502|NCT00379899|516029291|FG001|Overall Study|Other protocol-specified criteria|4|||
143132503|NCT00379899|516029290|FG000|Overall Study|Other|3|||
143132504|NCT00379899|516029291|FG001|Overall Study|Other|1|||
143132505|NCT01922258|516029292|FG000|Overall Study|Lost to Follow-up|1|||
143132506|NCT01922258|516029293|FG001|Overall Study|Lost to Follow-up|1|||
143132507|NCT01922258|516029292|FG000|Overall Study|Adverse Event|9|||
143132508|NCT01922258|516029293|FG001|Overall Study|Adverse Event|2|||
143132509|NCT01922258|516029292|FG000|Overall Study|Met Withdrawal Criteria|0|||
143132510|NCT01922258|516029293|FG001|Overall Study|Met Withdrawal Criteria|4|||
143132511|NCT01922258|516029292|FG000|Overall Study|Withdrawn by the Investigator|1|||
143132512|NCT01922258|516029293|FG001|Overall Study|Withdrawn by the Investigator|4|||
143132513|NCT01922258|516029292|FG000|Overall Study|Withdrawal by participant|5|||
143132514|NCT01922258|516029293|FG001|Overall Study|Withdrawal by participant|5|||
143132515|NCT05225389|516029294|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
143132516|NCT04552132|516029295|FG000|Overall Study|Lost to Follow-up|4|||
143132517|NCT04552132|516029296|FG001|Overall Study|Lost to Follow-up|3|||
143132518|NCT04552132|516029295|FG000|Overall Study|Protocol Violation|1|||
143132519|NCT04552132|516029296|FG001|Overall Study|Protocol Violation|0|||
143132520|NCT01598610|516029299|FG000|Overall Study|Adverse Event|1|||
143132521|NCT03360019|516029300|FG000|Overall Study|Withdrawal by Subject|2|||
143132522|NCT03360019|516029301|FG001|Overall Study|Withdrawal by Subject|0|||
143132523|NCT03360019|516029302|FG002|Overall Study|Withdrawal by Subject|0|||
143132524|NCT03360019|516029300|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
143132525|NCT03360019|516029301|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
143132526|NCT03360019|516029302|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
143132527|NCT04235504|516029305|FG000|Study Phase|Withdrawal by Subject|5|||
143132528|NCT04235504|516029306|FG001|Study Phase|Withdrawal by Subject|2|||
143132529|NCT04235504|516029307|FG002|Study Phase|Withdrawal by Subject|0|||
143132530|NCT04235504|516029308|FG003|Study Phase|Withdrawal by Subject|0|||
143132531|NCT04235504|516029305|FG000|Continuation Phase|Withdrawal by Subject|0|||
143132532|NCT04235504|516029306|FG001|Continuation Phase|Withdrawal by Subject|4|||
143132533|NCT04235504|516029307|FG002|Continuation Phase|Withdrawal by Subject|0|||
143132534|NCT04235504|516029308|FG003|Continuation Phase|Withdrawal by Subject|0|||
143132535|NCT04235504|516029305|FG000|Continuation Phase|Adverse Event|0|||
143132536|NCT04235504|516029306|FG001|Continuation Phase|Adverse Event|1|||
143132537|NCT04235504|516029307|FG002|Continuation Phase|Adverse Event|0|||
143132538|NCT04235504|516029308|FG003|Continuation Phase|Adverse Event|0|||
143132539|NCT04235504|516029305|FG000|Continuation Phase|Physician Decision|1|||
143132540|NCT04235504|516029306|FG001|Continuation Phase|Physician Decision|2|||
143132541|NCT04235504|516029307|FG002|Continuation Phase|Physician Decision|1|||
143132542|NCT04235504|516029308|FG003|Continuation Phase|Physician Decision|0|||
143132543|NCT01931397|516029315|FG000|Overall Study|Physician Decision|2|||
143132544|NCT01931397|516029315|FG000|Overall Study|Withdrawal by Subject|8|||
143132545|NCT01931397|516029315|FG000|Overall Study|moved out of state|1|||
143132546|NCT05404711|516029316|FG000|Completed Study Visit|Withdrawal by Subject|1|||
143132547|NCT05404711|516029316|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
143132548|NCT05404711|516029316|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
143132549|NCT05404711|516029316|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
143132550|NCT05404711|516029316|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
143132551|NCT05404711|516029316|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
143132552|NCT00325819|516029317|FG000|Overall Study|Study product lost in mail|2|||
143132553|NCT00325819|516029318|FG001|Overall Study|Study product lost in mail|1|||
143132554|NCT00325819|516029317|FG000|Overall Study|Did not take a dose of study product|4|||
143132555|NCT00325819|516029318|FG001|Overall Study|Did not take a dose of study product|9|||
143132556|NCT00325819|516029317|FG000|Overall Study|Lost to Follow-up|3|||
143132557|NCT00325819|516029318|FG001|Overall Study|Lost to Follow-up|3|||
143132558|NCT02058589|516029320|FG000|Overall Study|Serious Adverse Event|1|||
143132559|NCT02058589|516029321|FG001|Overall Study|Serious Adverse Event|1|||
143132560|NCT02058589|516029320|FG000|Overall Study|Non-Serious Adverse Event|1|||
143132561|NCT02058589|516029321|FG001|Overall Study|Non-Serious Adverse Event|0|||
143132562|NCT02058589|516029320|FG000|Overall Study|Withdrawal by Subject|0|||
143013815|NCT02617446|515590037|FG001|Overall Study|Lost to Follow-up|0|||
143013816|NCT02617446|515590038|FG002|Overall Study|Lost to Follow-up|0|||
143013817|NCT02617446|515590036|FG000|Overall Study|Death|0|||
143013818|NCT02617446|515590037|FG001|Overall Study|Death|0|||
143013819|NCT02617446|515590038|FG002|Overall Study|Death|2|||
143013820|NCT00530088|515590047|FG000|Overall Study|Disease Progression|4|||
143013821|NCT00530088|515590047|FG000|Overall Study|Physician Decision|4|||
143013822|NCT00530088|515590047|FG000|Overall Study|Other Not Specified|2|||
143013823|NCT00902278|515590048|FG000|Overall Study|Physician Decision|1|||
143013824|NCT00902278|515590049|FG001|Overall Study|Physician Decision|0|||
143013825|NCT00902278|515590050|FG002|Overall Study|Physician Decision|2|||
143013826|NCT00902278|515590051|FG003|Overall Study|Physician Decision|0|||
143013827|NCT00902278|515590052|FG004|Overall Study|Physician Decision|1|||
143013828|NCT00902278|515590048|FG000|Overall Study|Lost to Follow-up|3|||
143013829|NCT00902278|515590049|FG001|Overall Study|Lost to Follow-up|2|||
143013830|NCT00902278|515590050|FG002|Overall Study|Lost to Follow-up|3|||
143013831|NCT00902278|515590051|FG003|Overall Study|Lost to Follow-up|0|||
143013832|NCT00902278|515590052|FG004|Overall Study|Lost to Follow-up|1|||
143013833|NCT02181842|515590059|FG000|Overall Study|Case Report Forms Uncollected|2|||
143013834|NCT01652872|515590060|FG000|Overall Study|Death|36|||
143013835|NCT01652872|515590061|FG001|Overall Study|Death|39|||
143013836|NCT01652872|515590060|FG000|Overall Study|Lost to Follow-up|28|||
143013837|NCT01652872|515590061|FG001|Overall Study|Lost to Follow-up|23|||
143013838|NCT01652872|515590060|FG000|Overall Study|Decision by sponsor|5|||
143013839|NCT01652872|515590061|FG001|Overall Study|Decision by sponsor|7|||
143013840|NCT01652872|515590060|FG000|Overall Study|Withdrawal by Subject|76|||
143013841|NCT01652872|515590061|FG001|Overall Study|Withdrawal by Subject|84|||
143013842|NCT03454672|515590071|FG000|Overall Study|Adverse Event|1|||
143013843|NCT03454672|515590072|FG001|Overall Study|Adverse Event|1|||
143013844|NCT03454672|515590071|FG000|Overall Study|Lost to Follow-up|1|||
143013845|NCT03454672|515590072|FG001|Overall Study|Lost to Follow-up|3|||
143013846|NCT03454672|515590071|FG000|Overall Study|painful|1|||
143013847|NCT03454672|515590072|FG001|Overall Study|painful|2|||
143013848|NCT03454672|515590071|FG000|Overall Study|Non-compliance|2|||
143013849|NCT03454672|515590072|FG001|Overall Study|Non-compliance|4|||
143013850|NCT03454672|515590071|FG000|Overall Study|personal reasons|3|||
143013851|NCT03454672|515590072|FG001|Overall Study|personal reasons|2|||
143013852|NCT03454672|515590071|FG000|Overall Study|Withdrawal by Subject|1|||
143013853|NCT03454672|515590072|FG001|Overall Study|Withdrawal by Subject|0|||
143013854|NCT03985293|515590075|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
143013855|NCT03985293|515590076|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
143013856|NCT03985293|515590077|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
143013857|NCT03985293|515590078|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
143013858|NCT03985293|515590079|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
143013859|NCT03985293|515590080|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
143013860|NCT03985293|515590075|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
143013861|NCT03985293|515590076|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
143013862|NCT03985293|515590077|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
143013863|NCT03985293|515590078|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
143013864|NCT03985293|515590079|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
143013865|NCT03985293|515590080|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
143013866|NCT03985293|515590075|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
143013867|NCT03985293|515590076|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
143013868|NCT03985293|515590077|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
143013869|NCT03985293|515590078|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
143013870|NCT03985293|515590079|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
143013871|NCT03985293|515590080|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
143013872|NCT03985293|515590075|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
143013873|NCT03985293|515590076|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
143013874|NCT03985293|515590077|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
143013875|NCT03985293|515590078|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
143013876|NCT03985293|515590079|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
143013877|NCT03985293|515590080|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
143013878|NCT03985293|515590075|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
143013879|NCT03985293|515590076|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
143013880|NCT03985293|515590077|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
143013881|NCT03985293|515590078|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
143013882|NCT03985293|515590079|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
143013883|NCT03985293|515590080|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
143013884|NCT03985293|515590075|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
143013885|NCT03985293|515590076|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
143013886|NCT03985293|515590077|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
143013887|NCT03985293|515590078|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
143013888|NCT03985293|515590079|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
143013889|NCT03985293|515590080|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
143013890|NCT03985293|515590075|FG000|FOLLOW-UP|Lost to Follow-up|0|||
143013891|NCT03985293|515590076|FG001|FOLLOW-UP|Lost to Follow-up|0|||
143132563|NCT02058589|516029321|FG001|Overall Study|Withdrawal by Subject|1|||
143132564|NCT00490971|516029325|FG000|Acute/Continuation|Adverse Event|62|||
143132565|NCT00490971|516029326|FG001|Acute/Continuation|Adverse Event|13|||
143132566|NCT00490971|516029327|FG002|Acute/Continuation|Adverse Event|0|||
143132567|NCT00490971|516029328|FG003|Acute/Continuation|Adverse Event|0|||
143132568|NCT00490971|516029329|FG004|Acute/Continuation|Adverse Event|0|||
143132569|NCT00490971|516029325|FG000|Acute/Continuation|Death|2|||
143132570|NCT00490971|516029326|FG001|Acute/Continuation|Death|0|||
143132571|NCT00490971|516029327|FG002|Acute/Continuation|Death|0|||
143132572|NCT00490971|516029328|FG003|Acute/Continuation|Death|0|||
143132573|NCT00490971|516029329|FG004|Acute/Continuation|Death|0|||
143132574|NCT00490971|516029325|FG000|Acute/Continuation|Lack of Efficacy|106|||
143132575|NCT00490971|516029326|FG001|Acute/Continuation|Lack of Efficacy|12|||
143132576|NCT00490971|516029327|FG002|Acute/Continuation|Lack of Efficacy|0|||
143132577|NCT00490971|516029328|FG003|Acute/Continuation|Lack of Efficacy|0|||
143132578|NCT00490971|516029329|FG004|Acute/Continuation|Lack of Efficacy|0|||
143132579|NCT00490971|516029325|FG000|Acute/Continuation|Lost to Follow-up|23|||
143132580|NCT00490971|516029326|FG001|Acute/Continuation|Lost to Follow-up|7|||
143132581|NCT00490971|516029327|FG002|Acute/Continuation|Lost to Follow-up|0|||
143132582|NCT00490971|516029328|FG003|Acute/Continuation|Lost to Follow-up|0|||
143132583|NCT00490971|516029329|FG004|Acute/Continuation|Lost to Follow-up|0|||
143132584|NCT00490971|516029325|FG000|Acute/Continuation|Protocol Violation|10|||
143132585|NCT00490971|516029326|FG001|Acute/Continuation|Protocol Violation|2|||
143132586|NCT00490971|516029327|FG002|Acute/Continuation|Protocol Violation|0|||
143132587|NCT00490971|516029328|FG003|Acute/Continuation|Protocol Violation|0|||
143132588|NCT00490971|516029329|FG004|Acute/Continuation|Protocol Violation|0|||
143132589|NCT00490971|516029325|FG000|Acute/Continuation|Withdrawal by Subject|92|||
143132590|NCT00490971|516029326|FG001|Acute/Continuation|Withdrawal by Subject|24|||
143132591|NCT00490971|516029327|FG002|Acute/Continuation|Withdrawal by Subject|0|||
143132592|NCT00490971|516029328|FG003|Acute/Continuation|Withdrawal by Subject|0|||
143132593|NCT00490971|516029329|FG004|Acute/Continuation|Withdrawal by Subject|0|||
143132594|NCT00490971|516029325|FG000|Acute/Continuation|Other|11|||
143132595|NCT00490971|516029326|FG001|Acute/Continuation|Other|4|||
143132596|NCT00490971|516029327|FG002|Acute/Continuation|Other|0|||
143132597|NCT00490971|516029328|FG003|Acute/Continuation|Other|0|||
143132598|NCT00490971|516029329|FG004|Acute/Continuation|Other|0|||
143132599|NCT00490971|516029325|FG000|Maintenance|Adverse Event|0|||
143132600|NCT00490971|516029326|FG001|Maintenance|Adverse Event|0|||
143132601|NCT00490971|516029327|FG002|Maintenance|Adverse Event|4|||
143132602|NCT00490971|516029328|FG003|Maintenance|Adverse Event|5|||
143132603|NCT00490971|516029329|FG004|Maintenance|Adverse Event|7|||
143132604|NCT00490971|516029325|FG000|Maintenance|Death|0|||
143132605|NCT00490971|516029326|FG001|Maintenance|Death|0|||
143132606|NCT00490971|516029327|FG002|Maintenance|Death|0|||
143132607|NCT00490971|516029328|FG003|Maintenance|Death|2|||
143132608|NCT00490971|516029329|FG004|Maintenance|Death|0|||
143132609|NCT00490971|516029325|FG000|Maintenance|Lost to Follow-up|0|||
143132610|NCT00490971|516029326|FG001|Maintenance|Lost to Follow-up|0|||
143132611|NCT00490971|516029327|FG002|Maintenance|Lost to Follow-up|5|||
143132612|NCT00490971|516029328|FG003|Maintenance|Lost to Follow-up|8|||
143132613|NCT00490971|516029329|FG004|Maintenance|Lost to Follow-up|10|||
143132614|NCT00490971|516029325|FG000|Maintenance|Pregnancy|0|||
143132615|NCT00490971|516029326|FG001|Maintenance|Pregnancy|0|||
143132616|NCT00490971|516029327|FG002|Maintenance|Pregnancy|1|||
143132617|NCT00490971|516029328|FG003|Maintenance|Pregnancy|0|||
143132618|NCT00490971|516029329|FG004|Maintenance|Pregnancy|0|||
143132619|NCT00490971|516029325|FG000|Maintenance|Protocol Violation|0|||
143132620|NCT00490971|516029326|FG001|Maintenance|Protocol Violation|0|||
143132621|NCT00490971|516029327|FG002|Maintenance|Protocol Violation|4|||
143132622|NCT00490971|516029328|FG003|Maintenance|Protocol Violation|1|||
143132623|NCT00490971|516029329|FG004|Maintenance|Protocol Violation|1|||
143132624|NCT00490971|516029325|FG000|Maintenance|Withdrawal by Subject|0|||
143132625|NCT00490971|516029326|FG001|Maintenance|Withdrawal by Subject|0|||
143132626|NCT00490971|516029327|FG002|Maintenance|Withdrawal by Subject|26|||
143132627|NCT00490971|516029328|FG003|Maintenance|Withdrawal by Subject|28|||
143358123|NCT03280563|516856085|FG005|Long-term Survival Follow-up|Study Ended by Sponsor|13|||
143358124|NCT03280563|516856086|FG006|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
143132628|NCT00490971|516029329|FG004|Maintenance|Withdrawal by Subject|18|||
143132629|NCT00490971|516029325|FG000|Maintenance|Other|0|||
143132630|NCT00490971|516029326|FG001|Maintenance|Other|0|||
143132631|NCT00490971|516029327|FG002|Maintenance|Other|11|||
143132632|NCT00490971|516029328|FG003|Maintenance|Other|9|||
143132633|NCT00490971|516029329|FG004|Maintenance|Other|3|||
143132634|NCT00565604|516029340|FG000|Overall Study|Failure to treat|2|||
143132635|NCT00565604|516029340|FG000|Overall Study|Lost to Follow-up|2|||
143132636|NCT04754542|516029341|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
143132637|NCT04754542|516029342|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
143132638|NCT01317641|516031488|FG000|Overall Study|Not treated|0|||
143132639|NCT01317641|516031489|FG001|Overall Study|Not treated|0|||
143132640|NCT01317641|516031490|FG002|Overall Study|Not treated|0|||
143132641|NCT01317641|516031491|FG003|Overall Study|Not treated|0|||
143132642|NCT01317641|516031492|FG004|Overall Study|Not treated|0|||
143132643|NCT01317641|516031493|FG005|Overall Study|Not treated|0|||
143132644|NCT01317641|516031494|FG006|Overall Study|Not treated|0|||
143132645|NCT01317641|516031495|FG007|Overall Study|Not treated|1|||
143132646|NCT01317641|516031496|FG008|Overall Study|Not treated|1|||
143132647|NCT01317641|516031488|FG000|Overall Study|Adverse Event|0|||
143132648|NCT01317641|516031489|FG001|Overall Study|Adverse Event|1|||
143132649|NCT01317641|516031490|FG002|Overall Study|Adverse Event|0|||
143132650|NCT01317641|516031491|FG003|Overall Study|Adverse Event|1|||
143132651|NCT01317641|516031492|FG004|Overall Study|Adverse Event|0|||
143132652|NCT01317641|516031493|FG005|Overall Study|Adverse Event|0|||
143132653|NCT01317641|516031494|FG006|Overall Study|Adverse Event|2|||
143132654|NCT01317641|516031495|FG007|Overall Study|Adverse Event|1|||
143132655|NCT01317641|516031496|FG008|Overall Study|Adverse Event|0|||
143132656|NCT01317641|516031488|FG000|Overall Study|Protocol Violation|1|||
143132657|NCT01317641|516031489|FG001|Overall Study|Protocol Violation|0|||
143231040|NCT05556265|516395588|FG003|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
143231041|NCT05556265|516395589|FG004|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
143231042|NCT05556265|516395585|FG000|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
143231043|NCT05556265|516395586|FG001|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|2|||
143231044|NCT05556265|516395587|FG002|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
143465784|NCT00807235|517251130|FG001|Overall Study|Adverse Event|0|||
143465785|NCT02804178|517251131|FG000|Overall Study|Adverse Event|1|||
143465786|NCT01055262|517251134|FG000|Overall Study|Adverse Event|5|||
143465787|NCT01055262|517251134|FG000|Overall Study|Protocol Violation|3|||
143132658|NCT01317641|516031490|FG002|Overall Study|Protocol Violation|0|||
143132659|NCT01317641|516031491|FG003|Overall Study|Protocol Violation|0|||
143132660|NCT01317641|516031492|FG004|Overall Study|Protocol Violation|0|||
143132661|NCT01317641|516031493|FG005|Overall Study|Protocol Violation|0|||
143132662|NCT01317641|516031494|FG006|Overall Study|Protocol Violation|0|||
143132663|NCT01317641|516031495|FG007|Overall Study|Protocol Violation|0|||
143132664|NCT01317641|516031496|FG008|Overall Study|Protocol Violation|0|||
143132665|NCT01317641|516031488|FG000|Overall Study|Disease progression|0|||
143132666|NCT01317641|516031489|FG001|Overall Study|Disease progression|0|||
143132667|NCT01317641|516031490|FG002|Overall Study|Disease progression|0|||
143132668|NCT01317641|516031491|FG003|Overall Study|Disease progression|0|||
143132669|NCT01317641|516031492|FG004|Overall Study|Disease progression|0|||
143132670|NCT01317641|516031493|FG005|Overall Study|Disease progression|0|||
143132671|NCT01317641|516031494|FG006|Overall Study|Disease progression|0|||
143132672|NCT01317641|516031495|FG007|Overall Study|Disease progression|3|||
143132673|NCT01317641|516031496|FG008|Overall Study|Disease progression|4|||
143132674|NCT01317641|516031488|FG000|Overall Study|Withdrawal by Subject|0|||
143132675|NCT01317641|516031489|FG001|Overall Study|Withdrawal by Subject|0|||
143132676|NCT01317641|516031490|FG002|Overall Study|Withdrawal by Subject|0|||
143132677|NCT01317641|516031491|FG003|Overall Study|Withdrawal by Subject|0|||
143132678|NCT01317641|516031492|FG004|Overall Study|Withdrawal by Subject|0|||
143132679|NCT01317641|516031493|FG005|Overall Study|Withdrawal by Subject|0|||
143132680|NCT01317641|516031494|FG006|Overall Study|Withdrawal by Subject|1|||
143132681|NCT01317641|516031495|FG007|Overall Study|Withdrawal by Subject|0|||
143132682|NCT01317641|516031496|FG008|Overall Study|Withdrawal by Subject|0|||
143132683|NCT00715559|516031497|FG000|Overall Study|medication not tolerated - nausea|1|||
143132684|NCT02019550|516031498|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
143132685|NCT02019550|516031499|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
143132686|NCT04771013|516031502|FG000|Overall Study|Withdrawal by Subject|2|||
143132687|NCT04771013|516031503|FG001|Overall Study|Withdrawal by Subject|0|||
143132688|NCT04771013|516031502|FG000|Overall Study|Death|0|||
143132689|NCT04771013|516031503|FG001|Overall Study|Death|5|||
143132690|NCT04771013|516031502|FG000|Overall Study|Referred to another hospital before day 20|0|||
143132691|NCT04771013|516031503|FG001|Overall Study|Referred to another hospital before day 20|1|||
143132692|NCT00419757|516031507|FG000|Overall Study|Adverse Event|1|||
143132693|NCT00419757|516031508|FG001|Overall Study|Adverse Event|4|||
143132694|NCT00419757|516031507|FG000|Overall Study|Lost to Follow-up|1|||
143132695|NCT00419757|516031508|FG001|Overall Study|Lost to Follow-up|4|||
143132696|NCT00419757|516031507|FG000|Overall Study|Withdrawal by Subject|7|||
143132697|NCT00419757|516031508|FG001|Overall Study|Withdrawal by Subject|1|||
143132698|NCT00419757|516031507|FG000|Overall Study|Protocol Violation|2|||
143013892|NCT03985293|515590077|FG002|FOLLOW-UP|Lost to Follow-up|1|||
143132699|NCT00419757|516031508|FG001|Overall Study|Protocol Violation|3|||
143132700|NCT00419757|516031507|FG000|Overall Study|Study specific discontinuation criteria|4|||
143132701|NCT00419757|516031508|FG001|Overall Study|Study specific discontinuation criteria|8|||
143132702|NCT00419757|516031507|FG000|Overall Study|Multiple reasons|3|||
143132703|NCT00419757|516031508|FG001|Overall Study|Multiple reasons|1|||
143132704|NCT02922153|516031512|FG000|Overall Study|Death|8|||
143132705|NCT02922153|516031513|FG001|Overall Study|Death|1|||
143132706|NCT02922153|516031512|FG000|Overall Study|Lost to Follow-up|1|||
143132707|NCT02922153|516031513|FG001|Overall Study|Lost to Follow-up|0|||
143132708|NCT02922153|516031512|FG000|Overall Study|Physician Decision|1|||
143132709|NCT02922153|516031513|FG001|Overall Study|Physician Decision|1|||
143132710|NCT00735709|516031515|FG000|Overall Study|Adverse Event|2|||
143132711|NCT00735709|516031516|FG001|Overall Study|Adverse Event|3|||
143132712|NCT00735709|516031517|FG002|Overall Study|Adverse Event|1|||
143132713|NCT00735709|516031518|FG003|Overall Study|Adverse Event|5|||
143132714|NCT00735709|516031515|FG000|Overall Study|Lack of Efficacy|8|||
143132715|NCT00735709|516031516|FG001|Overall Study|Lack of Efficacy|4|||
143132716|NCT00735709|516031517|FG002|Overall Study|Lack of Efficacy|2|||
143132717|NCT00735709|516031518|FG003|Overall Study|Lack of Efficacy|3|||
143132718|NCT00735709|516031515|FG000|Overall Study|Noncompliance|0|||
143132719|NCT00735709|516031516|FG001|Overall Study|Noncompliance|0|||
143132720|NCT00735709|516031517|FG002|Overall Study|Noncompliance|1|||
143132721|NCT00735709|516031518|FG003|Overall Study|Noncompliance|0|||
143132722|NCT00735709|516031515|FG000|Overall Study|Protocol deviations|1|||
143132723|NCT00735709|516031516|FG001|Overall Study|Protocol deviations|2|||
143132724|NCT00735709|516031517|FG002|Overall Study|Protocol deviations|1|||
143132725|NCT00735709|516031518|FG003|Overall Study|Protocol deviations|1|||
143132726|NCT00735709|516031515|FG000|Overall Study|Voluntary Withdrawal|1|||
143132727|NCT00735709|516031516|FG001|Overall Study|Voluntary Withdrawal|3|||
143132728|NCT00735709|516031517|FG002|Overall Study|Voluntary Withdrawal|5|||
143132729|NCT00735709|516031518|FG003|Overall Study|Voluntary Withdrawal|7|||
143132730|NCT00735709|516031515|FG000|Overall Study|Lost to Follow-up|0|||
143132731|NCT00735709|516031516|FG001|Overall Study|Lost to Follow-up|1|||
143132732|NCT00735709|516031517|FG002|Overall Study|Lost to Follow-up|1|||
143132733|NCT00735709|516031518|FG003|Overall Study|Lost to Follow-up|1|||
143132734|NCT00735709|516031515|FG000|Overall Study|Excluded medication|1|||
143132735|NCT00735709|516031516|FG001|Overall Study|Excluded medication|0|||
143132736|NCT00735709|516031517|FG002|Overall Study|Excluded medication|0|||
143132737|NCT00735709|516031518|FG003|Overall Study|Excluded medication|1|||
143132738|NCT04547140|516031521|FG000|Overall Study|Adverse Event|0|||
143132739|NCT04547140|516031522|FG001|Overall Study|Adverse Event|1|||
143132740|NCT04547140|516031521|FG000|Overall Study|Withdrawal by Subject|0|||
143132741|NCT04547140|516031522|FG001|Overall Study|Withdrawal by Subject|1|||
143132742|NCT04547140|516031521|FG000|Overall Study|Lost to Follow-up|3|||
143132743|NCT04547140|516031522|FG001|Overall Study|Lost to Follow-up|1|||
143132744|NCT04547140|516031521|FG000|Overall Study|Death|2|||
143132745|NCT04547140|516031522|FG001|Overall Study|Death|1|||
143132746|NCT04547140|516031521|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
143132747|NCT04547140|516031522|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
143132748|NCT04547140|516031521|FG000|Overall Study|Pregnancy|1|||
143132749|NCT04547140|516031522|FG001|Overall Study|Pregnancy|0|||
143132750|NCT04547140|516031521|FG000|Overall Study|Reason Not Specified|4|||
143132751|NCT04547140|516031522|FG001|Overall Study|Reason Not Specified|1|||
143132752|NCT04110314|516031523|FG000|Overall Study|Did not meet inclusion criteria|35255|||
143132753|NCT04110314|516031524|FG001|Overall Study|Did not meet inclusion criteria|35104|||
143132754|NCT04110314|516031525|FG002|Overall Study|Did not meet inclusion criteria|35636|||
143132755|NCT04110314|516031526|FG003|Overall Study|Did not meet inclusion criteria|35135|||
143132756|NCT04110314|516031527|FG004|Overall Study|Did not meet inclusion criteria|35247|||
143132757|NCT04110314|516031528|FG005|Overall Study|Did not meet inclusion criteria|35727|||
143132758|NCT00249873|516031531|FG000|Overall Study|Not treated|7|||
143132759|NCT00249873|516031532|FG001|Overall Study|Not treated|8|||
143132760|NCT00249873|516031531|FG000|Overall Study|Significant thrombocytopenia|9|||
143132761|NCT00249873|516031532|FG001|Overall Study|Significant thrombocytopenia|8|||
143132762|NCT00249873|516031531|FG000|Overall Study|Severe allergic reaction|8|||
143132763|NCT00249873|516031532|FG001|Overall Study|Severe allergic reaction|1|||
143132764|NCT00249873|516031531|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
143132765|NCT00249873|516031532|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
143132766|NCT00249873|516031531|FG000|Overall Study|Other Serious Adverse Event|86|||
143132767|NCT00249873|516031532|FG001|Overall Study|Other Serious Adverse Event|97|||
143132768|NCT00249873|516031531|FG000|Overall Study|Qualifying condition not present|20|||
143132769|NCT00249873|516031532|FG001|Overall Study|Qualifying condition not present|23|||
143132770|NCT00249873|516031531|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
143132771|NCT00249873|516031532|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
143132772|NCT00249873|516031531|FG000|Overall Study|Withdrawal by Subject|504|||
143132773|NCT00249873|516031532|FG001|Overall Study|Withdrawal by Subject|466|||
143132774|NCT00249873|516031531|FG000|Overall Study|Lost to Follow-up|4|||
143132775|NCT00249873|516031532|FG001|Overall Study|Lost to Follow-up|7|||
143132776|NCT00249873|516031531|FG000|Overall Study|Minor bleeding|99|||
143132777|NCT00249873|516031532|FG001|Overall Study|Minor bleeding|37|||
143132778|NCT00249873|516031531|FG000|Overall Study|Non-compliance|41|||
143132779|NCT00249873|516031532|FG001|Overall Study|Non-compliance|46|||
143132780|NCT00249873|516031531|FG000|Overall Study|Other non serious Adverse Event|112|||
143132781|NCT00249873|516031532|FG001|Overall Study|Other non serious Adverse Event|108|||
143132782|NCT00249873|516031531|FG000|Overall Study|Other contraindicated medication|1|||
143132783|NCT00249873|516031532|FG001|Overall Study|Other contraindicated medication|0|||
143132784|NCT00249873|516031531|FG000|Overall Study|Patient not wish to continue after May08|3|||
143132785|NCT00249873|516031532|FG001|Overall Study|Patient not wish to continue after May08|4|||
143465788|NCT01055262|517251134|FG000|Overall Study|Uncooperativeness|1|||
143231045|NCT05556265|516395588|FG003|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
143231046|NCT05556265|516395589|FG004|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
143231047|NCT05556265|516395585|FG000|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
143231048|NCT05556265|516395586|FG001|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
143231049|NCT05556265|516395587|FG002|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|0|||
143132786|NCT00249873|516031531|FG000|Overall Study|Physician withdrew consent|59|||
143132787|NCT00249873|516031532|FG001|Overall Study|Physician withdrew consent|60|||
143132788|NCT00249873|516031531|FG000|Overall Study|Open label clopidogrel required|31|||
143132789|NCT00249873|516031532|FG001|Overall Study|Open label clopidogrel required|42|||
143132790|NCT00249873|516031531|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
143132791|NCT00249873|516031532|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
143132792|NCT00249873|516031531|FG000|Overall Study|Oral anticoagulant required|159|||
143132793|NCT00249873|516031532|FG001|Overall Study|Oral anticoagulant required|157|||
143132794|NCT00249873|516031531|FG000|Overall Study|Study drug intolerance|5|||
143231050|NCT05556265|516395588|FG003|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|3|||
143231051|NCT05556265|516395589|FG004|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|1|||
143231052|NCT05556265|516395585|FG000|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
143231053|NCT05556265|516395586|FG001|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|3|||
143132795|NCT00249873|516031532|FG001|Overall Study|Study drug intolerance|0|||
143132796|NCT00249873|516031531|FG000|Overall Study|Surgery/ procedure|9|||
143132797|NCT00249873|516031532|FG001|Overall Study|Surgery/ procedure|9|||
143132798|NCT00249873|516031531|FG000|Overall Study|Event related to cardiac condition|12|||
143132799|NCT00249873|516031532|FG001|Overall Study|Event related to cardiac condition|21|||
143132800|NCT00249873|516031531|FG000|Overall Study|Thromboembolic/outcome event|82|||
143132801|NCT00249873|516031532|FG001|Overall Study|Thromboembolic/outcome event|122|||
143132802|NCT00974311|516031535|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
143132803|NCT00974311|516031536|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
143132804|NCT00974311|516031535|FG000|DB Phase (up to 24 Months)|Death|561|||
143132805|NCT00974311|516031536|FG001|DB Phase (up to 24 Months)|Death|298|||
143132806|NCT00974311|516031535|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
143132807|NCT00974311|516031536|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
143132808|NCT00974311|516031535|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
143132809|NCT00974311|516031536|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
143132810|NCT00974311|516031535|FG000|DB Phase (up to 24 Months)|Other|1|||
143132811|NCT00974311|516031536|FG001|DB Phase (up to 24 Months)|Other|0|||
143132812|NCT00974311|516031535|FG000|OLE Phase (up to 77 Months)|Death|14|||
143132813|NCT00974311|516031536|FG001|OLE Phase (up to 77 Months)|Death|21|||
143132814|NCT00974311|516031535|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
143132815|NCT00974311|516031536|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
143132816|NCT00974311|516031535|FG000|OLE Phase (up to 77 Months)|Other|15|||
143132817|NCT00974311|516031536|FG001|OLE Phase (up to 77 Months)|Other|2|||
143132818|NCT00974311|516031535|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
143231054|NCT05556265|516395587|FG002|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
143231055|NCT05556265|516395588|FG003|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
143231056|NCT05556265|516395589|FG004|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
143132819|NCT00974311|516031536|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
143132820|NCT00643201|516031539|FG000|Randomized, Completed 6 Months of Study|Death|20|||
143132821|NCT00643201|516031540|FG001|Randomized, Completed 6 Months of Study|Death|26|||
143132822|NCT00643201|516031539|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
143132823|NCT00643201|516031540|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
143132824|NCT00643201|516031539|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
143132825|NCT00643201|516031540|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
143132826|NCT00643201|516031539|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
143132827|NCT00643201|516031540|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
143231057|NCT05556265|516395585|FG000|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|19|||
143231058|NCT05556265|516395586|FG001|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|12|||
143231059|NCT05556265|516395587|FG002|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|0|||
143231060|NCT05556265|516395588|FG003|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|6|||
143231061|NCT05556265|516395589|FG004|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|9|||
143231062|NCT05556265|516395585|FG000|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
143231063|NCT05556265|516395586|FG001|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|2|||
143231064|NCT05556265|516395587|FG002|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
143132828|NCT00643201|516031539|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
143132829|NCT00643201|516031540|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
143132830|NCT00643201|516031539|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
143013893|NCT03985293|515590078|FG003|FOLLOW-UP|Lost to Follow-up|0|||
143013894|NCT03985293|515590079|FG004|FOLLOW-UP|Lost to Follow-up|0|||
143132831|NCT00643201|516031540|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
143132832|NCT00643201|516031539|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
143132833|NCT00643201|516031540|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
143132834|NCT00643201|516031539|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
143132835|NCT00643201|516031540|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
143132836|NCT00643201|516031539|FG000|Randomized, Completed 6 Months of Study|Other|107|||
143132837|NCT00643201|516031540|FG001|Randomized, Completed 6 Months of Study|Other|107|||
143132838|NCT00643201|516031539|FG000|Completed Study Follow Up|Death|28|||
143132839|NCT00643201|516031540|FG001|Completed Study Follow Up|Death|34|||
143132840|NCT00643201|516031539|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
143132841|NCT00643201|516031540|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
143132842|NCT00643201|516031539|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
143132843|NCT00643201|516031540|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
143132844|NCT00643201|516031539|FG000|Completed Study Follow Up|non-specified|1|||
143132845|NCT00643201|516031540|FG001|Completed Study Follow Up|non-specified|0|||
143132846|NCT00165503|516031541|FG000|Overall Study|Death|1|||
143132847|NCT00165503|516031541|FG000|Overall Study|Lost to Follow-up|12|||
143132848|NCT00165503|516031541|FG000|Overall Study|Unresectable|3|||
143132849|NCT02976519|516031542|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
143132850|NCT02976519|516031543|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
143132851|NCT02976519|516031544|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
143132852|NCT02976519|516031545|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
143132853|NCT02976519|516031546|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
143132854|NCT02976519|516031547|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
143132855|NCT02976519|516031548|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
143132856|NCT02976519|516031542|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
143132857|NCT02976519|516031543|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
143132858|NCT02976519|516031544|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
143132859|NCT02976519|516031545|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
143132860|NCT02976519|516031546|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
143132861|NCT02976519|516031547|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
143132862|NCT02976519|516031548|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
143132863|NCT02976519|516031542|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
143132864|NCT02976519|516031543|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
143132865|NCT02976519|516031544|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
143132866|NCT02976519|516031545|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
143132867|NCT02976519|516031546|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
143132868|NCT02976519|516031547|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
143132869|NCT02976519|516031548|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
143132870|NCT02976519|516031542|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
143132871|NCT02976519|516031543|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
143132872|NCT02976519|516031544|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
143132873|NCT02976519|516031545|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
143132874|NCT02976519|516031546|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
143132875|NCT02976519|516031547|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
143132876|NCT02976519|516031548|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
143132877|NCT02976519|516031542|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
143132878|NCT02976519|516031543|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
143132879|NCT02976519|516031544|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
143132880|NCT02976519|516031545|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
143132881|NCT02976519|516031546|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
143132882|NCT02976519|516031547|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
143132883|NCT02976519|516031548|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
143132884|NCT02346708|516031549|FG000|Overall Study|Adverse Event|2|||
143132885|NCT02346708|516031550|FG001|Overall Study|Adverse Event|0|||
143132886|NCT02346708|516031549|FG000|Overall Study|Protocol Violation|0|||
143132887|NCT02346708|516031550|FG001|Overall Study|Protocol Violation|1|||
143132888|NCT00928434|516031553|FG000|Overall Study|Adverse Event|14|||
143132889|NCT00928434|516031554|FG001|Overall Study|Adverse Event|5|||
143132890|NCT00928434|516031555|FG002|Overall Study|Adverse Event|18|||
143132891|NCT00928434|516031553|FG000|Overall Study|Protocol Violation|5|||
143132892|NCT00928434|516031554|FG001|Overall Study|Protocol Violation|0|||
143132893|NCT00928434|516031555|FG002|Overall Study|Protocol Violation|8|||
143132894|NCT00928434|516031553|FG000|Overall Study|Physician Decision|2|||
143132895|NCT00928434|516031554|FG001|Overall Study|Physician Decision|0|||
143132896|NCT00928434|516031555|FG002|Overall Study|Physician Decision|3|||
143132897|NCT00928434|516031553|FG000|Overall Study|Lost to Follow-up|1|||
143132898|NCT00928434|516031554|FG001|Overall Study|Lost to Follow-up|0|||
143132899|NCT00928434|516031555|FG002|Overall Study|Lost to Follow-up|3|||
143132900|NCT00928434|516031553|FG000|Overall Study|Withdrawal by Subject|5|||
143132901|NCT00928434|516031554|FG001|Overall Study|Withdrawal by Subject|3|||
143132902|NCT00928434|516031555|FG002|Overall Study|Withdrawal by Subject|2|||
143132903|NCT00928434|516031553|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
143132904|NCT00928434|516031554|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
143132905|NCT00928434|516031555|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
143132906|NCT00928434|516031553|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
143132907|NCT00928434|516031554|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
143132908|NCT00928434|516031555|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
143132909|NCT00928434|516031553|FG000|Overall Study|Other (not meeting above criteria)|5|||
143132910|NCT00928434|516031554|FG001|Overall Study|Other (not meeting above criteria)|1|||
143132911|NCT00928434|516031555|FG002|Overall Study|Other (not meeting above criteria)|2|||
143132912|NCT01278342|516031557|FG000|Overall Study|Physician Decision|0|||
143132913|NCT01278342|516031558|FG001|Overall Study|Physician Decision|1|||
143132914|NCT01278342|516031559|FG002|Overall Study|Physician Decision|0|||
143132915|NCT01278342|516031557|FG000|Overall Study|Lost to Follow-up|1|||
143132916|NCT01278342|516031558|FG001|Overall Study|Lost to Follow-up|0|||
143132917|NCT01278342|516031559|FG002|Overall Study|Lost to Follow-up|0|||
143132918|NCT01278342|516031557|FG000|Overall Study|Administrative problems|2|||
143132919|NCT01278342|516031558|FG001|Overall Study|Administrative problems|0|||
143132920|NCT01278342|516031559|FG002|Overall Study|Administrative problems|0|||
143132921|NCT01278342|516031557|FG000|Overall Study|Other|1|||
143132922|NCT01278342|516031558|FG001|Overall Study|Other|0|||
143132923|NCT01278342|516031559|FG002|Overall Study|Other|0|||
143132924|NCT05417412|516031569|FG000|Overall Study|Lost to Follow-up|2|||
143132925|NCT01576575|516031570|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
143132926|NCT01576575|516031570|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
143132927|NCT01576575|516031570|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
143132928|NCT01656395|516031572|FG000|Overall Study|Adverse Event|1|||
143132929|NCT01656395|516031573|FG001|Overall Study|Adverse Event|14|||
143132930|NCT01656395|516031574|FG002|Overall Study|Adverse Event|5|||
143132931|NCT01656395|516031575|FG003|Overall Study|Adverse Event|4|||
143132932|NCT01656395|516031576|FG004|Overall Study|Adverse Event|5|||
143132933|NCT01656395|516031577|FG005|Overall Study|Adverse Event|7|||
143132934|NCT01656395|516031578|FG006|Overall Study|Adverse Event|0|||
143132935|NCT01656395|516031579|FG007|Overall Study|Adverse Event|0|||
143132936|NCT01656395|516031572|FG000|Overall Study|Lack of Efficacy|1|||
143132937|NCT01656395|516031573|FG001|Overall Study|Lack of Efficacy|8|||
143132938|NCT01656395|516031574|FG002|Overall Study|Lack of Efficacy|6|||
143132939|NCT01656395|516031575|FG003|Overall Study|Lack of Efficacy|1|||
143132940|NCT01656395|516031576|FG004|Overall Study|Lack of Efficacy|1|||
143132941|NCT01656395|516031577|FG005|Overall Study|Lack of Efficacy|6|||
143132942|NCT01656395|516031578|FG006|Overall Study|Lack of Efficacy|0|||
143132943|NCT01656395|516031579|FG007|Overall Study|Lack of Efficacy|0|||
143132944|NCT01656395|516031572|FG000|Overall Study|Lost to Follow-up|1|||
143132945|NCT01656395|516031573|FG001|Overall Study|Lost to Follow-up|0|||
143132946|NCT01656395|516031574|FG002|Overall Study|Lost to Follow-up|0|||
143132947|NCT01656395|516031575|FG003|Overall Study|Lost to Follow-up|0|||
143132948|NCT01656395|516031576|FG004|Overall Study|Lost to Follow-up|0|||
143132949|NCT01656395|516031577|FG005|Overall Study|Lost to Follow-up|0|||
143132950|NCT01656395|516031578|FG006|Overall Study|Lost to Follow-up|0|||
143132951|NCT01656395|516031579|FG007|Overall Study|Lost to Follow-up|0|||
143132952|NCT01656395|516031572|FG000|Overall Study|Non-Compliance with Study Drug|1|||
143132953|NCT01656395|516031573|FG001|Overall Study|Non-Compliance with Study Drug|1|||
143132954|NCT01656395|516031574|FG002|Overall Study|Non-Compliance with Study Drug|0|||
143132955|NCT01656395|516031575|FG003|Overall Study|Non-Compliance with Study Drug|0|||
143132956|NCT01656395|516031576|FG004|Overall Study|Non-Compliance with Study Drug|1|||
143132957|NCT01656395|516031577|FG005|Overall Study|Non-Compliance with Study Drug|1|||
143132958|NCT01656395|516031578|FG006|Overall Study|Non-Compliance with Study Drug|0|||
143132959|NCT01656395|516031579|FG007|Overall Study|Non-Compliance with Study Drug|0|||
143132960|NCT01656395|516031572|FG000|Overall Study|Other|0|||
143132961|NCT01656395|516031573|FG001|Overall Study|Other|0|||
143231065|NCT05556265|516395588|FG003|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
143132962|NCT01656395|516031574|FG002|Overall Study|Other|1|||
143132963|NCT01656395|516031575|FG003|Overall Study|Other|0|||
143132964|NCT01656395|516031576|FG004|Overall Study|Other|0|||
143132965|NCT01656395|516031577|FG005|Overall Study|Other|1|||
143132966|NCT01656395|516031578|FG006|Overall Study|Other|0|||
143132967|NCT01656395|516031579|FG007|Overall Study|Other|0|||
143132968|NCT01656395|516031572|FG000|Overall Study|Physician Decision|2|||
143132969|NCT01656395|516031573|FG001|Overall Study|Physician Decision|3|||
143132970|NCT01656395|516031574|FG002|Overall Study|Physician Decision|3|||
143132971|NCT01656395|516031575|FG003|Overall Study|Physician Decision|2|||
143132972|NCT01656395|516031576|FG004|Overall Study|Physician Decision|3|||
143132973|NCT01656395|516031577|FG005|Overall Study|Physician Decision|3|||
143231066|NCT05556265|516395589|FG004|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|1|||
143013895|NCT03985293|515590080|FG005|FOLLOW-UP|Lost to Follow-up|0|||
143132974|NCT01656395|516031578|FG006|Overall Study|Physician Decision|0|||
143132975|NCT01656395|516031579|FG007|Overall Study|Physician Decision|0|||
143132976|NCT01656395|516031572|FG000|Overall Study|Pregnancy|0|||
143132977|NCT01656395|516031573|FG001|Overall Study|Pregnancy|0|||
143132978|NCT01656395|516031574|FG002|Overall Study|Pregnancy|1|||
143132979|NCT01656395|516031575|FG003|Overall Study|Pregnancy|0|||
143132980|NCT01656395|516031576|FG004|Overall Study|Pregnancy|0|||
143132981|NCT01656395|516031577|FG005|Overall Study|Pregnancy|0|||
143132982|NCT01656395|516031578|FG006|Overall Study|Pregnancy|0|||
143132983|NCT01656395|516031579|FG007|Overall Study|Pregnancy|0|||
143132984|NCT01656395|516031572|FG000|Overall Study|Progressive Disease|0|||
143132985|NCT01656395|516031573|FG001|Overall Study|Progressive Disease|0|||
143132986|NCT01656395|516031574|FG002|Overall Study|Progressive Disease|0|||
143132987|NCT01656395|516031575|FG003|Overall Study|Progressive Disease|0|||
143132988|NCT01656395|516031576|FG004|Overall Study|Progressive Disease|0|||
143132989|NCT01656395|516031577|FG005|Overall Study|Progressive Disease|1|||
143132990|NCT01656395|516031578|FG006|Overall Study|Progressive Disease|0|||
143132991|NCT01656395|516031579|FG007|Overall Study|Progressive Disease|0|||
143132992|NCT01656395|516031572|FG000|Overall Study|Protocol Violation|6|||
143132993|NCT01656395|516031573|FG001|Overall Study|Protocol Violation|6|||
143132994|NCT01656395|516031574|FG002|Overall Study|Protocol Violation|9|||
143231067|NCT05556265|516395585|FG000|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
143231068|NCT05556265|516395586|FG001|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
143231069|NCT05556265|516395587|FG002|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
143231070|NCT05556265|516395588|FG003|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
143231071|NCT05556265|516395589|FG004|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
143231072|NCT05556265|516395585|FG000|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
143132995|NCT01656395|516031575|FG003|Overall Study|Protocol Violation|2|||
143132996|NCT01656395|516031576|FG004|Overall Study|Protocol Violation|4|||
143132997|NCT01656395|516031577|FG005|Overall Study|Protocol Violation|10|||
143132998|NCT01656395|516031578|FG006|Overall Study|Protocol Violation|0|||
143231073|NCT05556265|516395586|FG001|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
143231074|NCT05556265|516395587|FG002|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
143231075|NCT05556265|516395588|FG003|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
143132999|NCT01656395|516031579|FG007|Overall Study|Protocol Violation|0|||
143133000|NCT01656395|516031572|FG000|Overall Study|Screen Failure|2|||
143133001|NCT01656395|516031573|FG001|Overall Study|Screen Failure|1|||
143231076|NCT05556265|516395589|FG004|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
143231077|NCT03077542|516395590|FG000|Overall Study|Death|4|||
143231078|NCT03077542|516395591|FG001|Overall Study|Death|0|||
143231079|NCT03077542|516395590|FG000|Overall Study|Physician Decision|6|||
143231080|NCT03077542|516395591|FG001|Overall Study|Physician Decision|1|||
143231081|NCT03077542|516395590|FG000|Overall Study|Withdrawal by Subject|0|||
143231082|NCT03077542|516395591|FG001|Overall Study|Withdrawal by Subject|1|||
143133002|NCT01656395|516031574|FG002|Overall Study|Screen Failure|7|||
143133003|NCT01656395|516031575|FG003|Overall Study|Screen Failure|1|||
143133004|NCT01656395|516031576|FG004|Overall Study|Screen Failure|0|||
143133005|NCT01656395|516031577|FG005|Overall Study|Screen Failure|8|||
143133006|NCT01656395|516031578|FG006|Overall Study|Screen Failure|0|||
143133007|NCT01656395|516031579|FG007|Overall Study|Screen Failure|0|||
143133008|NCT01656395|516031572|FG000|Overall Study|Withdrawal by Subject|3|||
143133009|NCT01656395|516031573|FG001|Overall Study|Withdrawal by Subject|1|||
143133010|NCT01656395|516031574|FG002|Overall Study|Withdrawal by Subject|4|||
143133011|NCT01656395|516031575|FG003|Overall Study|Withdrawal by Subject|2|||
143133012|NCT01656395|516031576|FG004|Overall Study|Withdrawal by Subject|0|||
143133013|NCT01656395|516031577|FG005|Overall Study|Withdrawal by Subject|3|||
143133014|NCT01656395|516031578|FG006|Overall Study|Withdrawal by Subject|0|||
143133015|NCT01656395|516031579|FG007|Overall Study|Withdrawal by Subject|0|||
143133016|NCT01566604|516031580|FG000|Overall Study|Patient's inability to use the device|1|||
143133017|NCT01566604|516031581|FG001|Overall Study|Patient's inability to use the device|0|||
143133018|NCT01566604|516031580|FG000|Overall Study|Administrative problems|1|||
143133019|NCT01566604|516031581|FG001|Overall Study|Administrative problems|0|||
143133020|NCT01566604|516031580|FG000|Overall Study|Lack of Efficacy|1|||
143133021|NCT01566604|516031581|FG001|Overall Study|Lack of Efficacy|2|||
143133022|NCT01566604|516031580|FG000|Overall Study|Protocol deviation|2|||
143133023|NCT01566604|516031581|FG001|Overall Study|Protocol deviation|0|||
143133024|NCT01566604|516031580|FG000|Overall Study|Abnormal laboratory value|2|||
143133025|NCT01566604|516031581|FG001|Overall Study|Abnormal laboratory value|0|||
143133026|NCT01566604|516031580|FG000|Overall Study|Death|4|||
143133027|NCT01566604|516031581|FG001|Overall Study|Death|1|||
143133028|NCT01566604|516031580|FG000|Overall Study|Adverse Event|4|||
143133029|NCT01566604|516031581|FG001|Overall Study|Adverse Event|2|||
143133030|NCT01566604|516031580|FG000|Overall Study|Withdrawal by Subject|9|||
143231083|NCT03980730|516395592|FG000|Overall Study|Study Terminated by Sponsor|0|||
143133031|NCT01566604|516031581|FG001|Overall Study|Withdrawal by Subject|6|||
143133032|NCT00661089|516031582|FG000|Overall Study|1 subject withdrawal|0|||
143133033|NCT00661089|516031583|FG001|Overall Study|1 subject withdrawal|1|||
143133034|NCT00661089|516031582|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
143133035|NCT00661089|516031583|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
143133036|NCT01443858|516031590|FG000|Overall Study|Withdrawal by Subject|9|||
143133037|NCT01443858|516031591|FG001|Overall Study|Withdrawal by Subject|8|||
143133038|NCT01443858|516031592|FG002|Overall Study|Withdrawal by Subject|5|||
143133039|NCT01443858|516031590|FG000|Overall Study|Lack of Efficacy|1|||
143133040|NCT01443858|516031591|FG001|Overall Study|Lack of Efficacy|0|||
143133041|NCT01443858|516031592|FG002|Overall Study|Lack of Efficacy|0|||
143133042|NCT01443858|516031590|FG000|Overall Study|Lost to Follow-up|5|||
143133043|NCT01443858|516031591|FG001|Overall Study|Lost to Follow-up|5|||
143133044|NCT01443858|516031592|FG002|Overall Study|Lost to Follow-up|2|||
143133045|NCT03361306|516031593|FG000|Overall Study|Death|6|||
143133046|NCT02983045|516031594|FG000|Overall Study|Withdrawal by Subject|0|||
143133047|NCT02983045|516031595|FG001|Overall Study|Withdrawal by Subject|1|||
143133048|NCT02983045|516031596|FG002|Overall Study|Withdrawal by Subject|0|||
143133049|NCT02983045|516031597|FG003|Overall Study|Withdrawal by Subject|5|||
143133050|NCT02983045|516031598|FG004|Overall Study|Withdrawal by Subject|0|||
143133051|NCT02983045|516031599|FG005|Overall Study|Withdrawal by Subject|72|||
143133052|NCT02983045|516031600|FG006|Overall Study|Withdrawal by Subject|0|||
143133053|NCT02983045|516031601|FG007|Overall Study|Withdrawal by Subject|0|||
143133054|NCT02983045|516031602|FG008|Overall Study|Withdrawal by Subject|0|||
143133055|NCT02983045|516031603|FG009|Overall Study|Withdrawal by Subject|2|||
143133056|NCT02983045|516031594|FG000|Overall Study|Lost to Follow-up|0|||
143133057|NCT02983045|516031595|FG001|Overall Study|Lost to Follow-up|0|||
143133058|NCT02983045|516031596|FG002|Overall Study|Lost to Follow-up|0|||
143133059|NCT02983045|516031597|FG003|Overall Study|Lost to Follow-up|0|||
143133060|NCT02983045|516031598|FG004|Overall Study|Lost to Follow-up|0|||
143133061|NCT02983045|516031599|FG005|Overall Study|Lost to Follow-up|10|||
143133062|NCT02983045|516031600|FG006|Overall Study|Lost to Follow-up|0|||
143133063|NCT02983045|516031601|FG007|Overall Study|Lost to Follow-up|0|||
143133064|NCT02983045|516031602|FG008|Overall Study|Lost to Follow-up|0|||
143133065|NCT02983045|516031603|FG009|Overall Study|Lost to Follow-up|0|||
143133066|NCT04805671|516031604|FG000|Overall Study|Death|2|||
143133067|NCT04805671|516031605|FG001|Overall Study|Death|7|||
143133068|NCT04805671|516031604|FG000|Overall Study|Lost to Follow-up|1|||
143133069|NCT04805671|516031605|FG001|Overall Study|Lost to Follow-up|0|||
143133070|NCT04805671|516031604|FG000|Overall Study|Withdrawal by Subject|9|||
143133071|NCT04805671|516031605|FG001|Overall Study|Withdrawal by Subject|7|||
143133072|NCT04805671|516031604|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
143133073|NCT04805671|516031605|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
143133074|NCT01261390|516031606|FG000|Overall Study|Significant Concurrent Illness|1|||
143133075|NCT01261390|516031607|FG001|Overall Study|Significant Concurrent Illness|0|||
143133076|NCT01261390|516031608|FG002|Overall Study|Significant Concurrent Illness|1|||
143133077|NCT01261390|516031609|FG003|Overall Study|Significant Concurrent Illness|0|||
143133078|NCT01261390|516031606|FG000|Overall Study|Dissatisfaction with Treatment|2|||
143133079|NCT01261390|516031607|FG001|Overall Study|Dissatisfaction with Treatment|1|||
143133080|NCT01261390|516031608|FG002|Overall Study|Dissatisfaction with Treatment|1|||
143133081|NCT01261390|516031609|FG003|Overall Study|Dissatisfaction with Treatment|2|||
143133082|NCT01261390|516031606|FG000|Overall Study|Relocation|0|||
143133083|NCT01261390|516031607|FG001|Overall Study|Relocation|1|||
143133084|NCT01261390|516031608|FG002|Overall Study|Relocation|0|||
143133085|NCT01261390|516031609|FG003|Overall Study|Relocation|0|||
143133086|NCT01261390|516031606|FG000|Overall Study|Loss of Interest in the Study|3|||
143133087|NCT01261390|516031607|FG001|Overall Study|Loss of Interest in the Study|1|||
143133088|NCT01261390|516031608|FG002|Overall Study|Loss of Interest in the Study|0|||
143133089|NCT01261390|516031609|FG003|Overall Study|Loss of Interest in the Study|0|||
143133090|NCT01261390|516031606|FG000|Overall Study|Lost to Follow-up|1|||
143358125|NCT03280563|516856087|FG007|Long-term Survival Follow-up|Study Ended by Sponsor|2|||
143358126|NCT03280563|516856088|FG008|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
143358127|NCT03280563|516856080|FG000|Long-term Survival Follow-up|Withdrawal by Subject|1|||
143358128|NCT03280563|516856081|FG001|Long-term Survival Follow-up|Withdrawal by Subject|1|||
143358129|NCT03280563|516856082|FG002|Long-term Survival Follow-up|Withdrawal by Subject|1|||
143358130|NCT03280563|516856083|FG003|Long-term Survival Follow-up|Withdrawal by Subject|0|||
143358131|NCT03280563|516856084|FG004|Long-term Survival Follow-up|Withdrawal by Subject|1|||
143358132|NCT03280563|516856085|FG005|Long-term Survival Follow-up|Withdrawal by Subject|0|||
143358133|NCT03280563|516856086|FG006|Long-term Survival Follow-up|Withdrawal by Subject|0|||
143013896|NCT01488071|515590081|FG000|Overall Study|Adverse Event|15|||
143133091|NCT01261390|516031607|FG001|Overall Study|Lost to Follow-up|6|||
143133092|NCT01261390|516031608|FG002|Overall Study|Lost to Follow-up|5|||
143133093|NCT01261390|516031609|FG003|Overall Study|Lost to Follow-up|6|||
143133094|NCT01497067|516031610|FG000|Overall Study|Lost to Follow-up|56|||
143133095|NCT01497067|516031610|FG000|Overall Study|Adverse Event|3|||
143133096|NCT01497067|516031610|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
143133097|NCT01497067|516031610|FG000|Overall Study|Other|13|||
143133098|NCT03066830|516031613|FG000|Overall Study|At the Participant's own Request|16|||
143133099|NCT03066830|516031614|FG001|Overall Study|At the Participant's own Request|17|||
143133100|NCT03066830|516031613|FG000|Overall Study|Other|3|||
143133101|NCT03066830|516031614|FG001|Overall Study|Other|0|||
143133102|NCT03066830|516031613|FG000|Overall Study|Poor Compliance to Protocol|1|||
143133103|NCT03066830|516031614|FG001|Overall Study|Poor Compliance to Protocol|0|||
143133104|NCT03066830|516031613|FG000|Overall Study|Adverse Event|2|||
143133105|NCT03066830|516031614|FG001|Overall Study|Adverse Event|2|||
143133106|NCT03066830|516031613|FG000|Overall Study|Lost to Follow-up|11|||
143133107|NCT03066830|516031614|FG001|Overall Study|Lost to Follow-up|3|||
143133108|NCT00096538|516031618|FG000|Overall Study|Withdrawal by Subject|1|||
143133109|NCT02686164|516031620|FG000|Overall Study|Adverse Event|1|||
143133110|NCT02686164|516031620|FG000|Overall Study|Withdrawal of consent|1|||
143133111|NCT02686164|516031620|FG000|Overall Study|Clinical progression|1|||
143133112|NCT01691378|516031621|FG000|Overall Study|Withdrawal by Subject|2|||
143231084|NCT03980730|516395593|FG001|Overall Study|Study Terminated by Sponsor|3|||
143133113|NCT01691378|516031622|FG001|Overall Study|Withdrawal by Subject|0|||
143133114|NCT01691378|516031621|FG000|Overall Study|Lost to Follow-up|5|||
143231085|NCT03980730|516395592|FG000|Overall Study|Adverse Event|2|||
143133115|NCT01691378|516031622|FG001|Overall Study|Lost to Follow-up|2|||
143133116|NCT01827592|516031623|FG000|Overall Study|Adverse Event|11|||
143133117|NCT01827592|516031624|FG001|Overall Study|Adverse Event|9|||
143133118|NCT01827592|516031625|FG002|Overall Study|Adverse Event|2|||
143133119|NCT01827592|516031623|FG000|Overall Study|Physician Decision|0|||
143133120|NCT01827592|516031624|FG001|Overall Study|Physician Decision|2|||
143133121|NCT01827592|516031625|FG002|Overall Study|Physician Decision|1|||
143133122|NCT01827592|516031623|FG000|Overall Study|Protocol Violation|2|||
143133123|NCT01827592|516031624|FG001|Overall Study|Protocol Violation|1|||
143133124|NCT01827592|516031625|FG002|Overall Study|Protocol Violation|0|||
143133125|NCT01827592|516031623|FG000|Overall Study|Lost to Follow-up|1|||
143133126|NCT01827592|516031624|FG001|Overall Study|Lost to Follow-up|2|||
143133127|NCT01827592|516031625|FG002|Overall Study|Lost to Follow-up|2|||
143133128|NCT01827592|516031623|FG000|Overall Study|Withdrawal by Subject|12|||
143133129|NCT01827592|516031624|FG001|Overall Study|Withdrawal by Subject|11|||
143133130|NCT01827592|516031625|FG002|Overall Study|Withdrawal by Subject|11|||
143133131|NCT01827592|516031623|FG000|Overall Study|Patient's substantial non-compliance|1|||
143133132|NCT01827592|516031624|FG001|Overall Study|Patient's substantial non-compliance|1|||
143133133|NCT01827592|516031625|FG002|Overall Study|Patient's substantial non-compliance|6|||
143133134|NCT01827592|516031623|FG000|Overall Study|Trial terminated by Sponsor|47|||
143133135|NCT01827592|516031624|FG001|Overall Study|Trial terminated by Sponsor|53|||
143133136|NCT01827592|516031625|FG002|Overall Study|Trial terminated by Sponsor|51|||
143133137|NCT01827592|516031623|FG000|Overall Study|Others|0|||
143133138|NCT01827592|516031624|FG001|Overall Study|Others|1|||
143133139|NCT01827592|516031625|FG002|Overall Study|Others|3|||
143133140|NCT02324361|516031626|FG000|Overall Study|Lost to Follow-up|5|||
143133141|NCT02324361|516031627|FG001|Overall Study|Lost to Follow-up|2|||
143133142|NCT00101868|516031640|FG000|Overall Study|Death|10|||
143133143|NCT00101868|516031641|FG001|Overall Study|Death|10|||
143133144|NCT00101868|516031640|FG000|Overall Study|Withdrawal by Subject|8|||
143133145|NCT00101868|516031641|FG001|Overall Study|Withdrawal by Subject|9|||
143133146|NCT00101868|516031640|FG000|Overall Study|Protocol Violation|3|||
143133147|NCT00101868|516031641|FG001|Overall Study|Protocol Violation|0|||
143133148|NCT00101868|516031640|FG000|Overall Study|Lost to Follow-up|8|||
143133149|NCT00101868|516031641|FG001|Overall Study|Lost to Follow-up|13|||
143133150|NCT04001803|516031642|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
143133151|NCT04001803|516031642|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
143133152|NCT04001803|516031642|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
143133153|NCT04001803|516031642|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
143133154|NCT04001803|516031642|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
143133155|NCT04001803|516031642|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
143133156|NCT04001803|516031642|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
143133157|NCT04001803|516031642|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
143133158|NCT04001803|516031642|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
143133159|NCT04001803|516031642|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
143133160|NCT02493517|516031646|FG000|Overall Study|Protocol Violation|1|||
143133161|NCT02493517|516031647|FG001|Overall Study|Protocol Violation|2|||
143133162|NCT02493517|516031646|FG000|Overall Study|Withdrawal by Subject|1|||
143133163|NCT02493517|516031647|FG001|Overall Study|Withdrawal by Subject|2|||
143133164|NCT02493517|516031646|FG000|Overall Study|Adverse Event|0|||
143133165|NCT02493517|516031647|FG001|Overall Study|Adverse Event|2|||
143133166|NCT02493517|516031646|FG000|Overall Study|Missed study visit|0|||
143133167|NCT02493517|516031647|FG001|Overall Study|Missed study visit|1|||
143133168|NCT01367249|516031648|FG000|Overall Study|Withdrawal by Subject|6|||
143133169|NCT01367249|516031649|FG001|Overall Study|Withdrawal by Subject|6|||
143133170|NCT01367249|516031648|FG000|Overall Study|Other|3|||
143133171|NCT01367249|516031649|FG001|Overall Study|Other|10|||
143133172|NCT01945944|516031650|FG000|Overall Study|Adverse Event|0|||
143133173|NCT01945944|516031651|FG001|Overall Study|Adverse Event|2|||
143133174|NCT01945944|516031650|FG000|Overall Study|Physician Decision|1|||
143133175|NCT01945944|516031651|FG001|Overall Study|Physician Decision|0|||
143133176|NCT01945944|516031650|FG000|Overall Study|Withdrawal by Subject|0|||
143133177|NCT01945944|516031651|FG001|Overall Study|Withdrawal by Subject|1|||
143013897|NCT01488071|515590082|FG001|Overall Study|Adverse Event|23|||
143133178|NCT02346877|516031652|FG000|Overall Study|Adverse Event|1|||
143133179|NCT02346877|516031653|FG001|Overall Study|Adverse Event|0|||
143133180|NCT02346877|516031652|FG000|Overall Study|Administrative Decision|1|||
143133181|NCT02346877|516031653|FG001|Overall Study|Administrative Decision|0|||
143133182|NCT02346877|516031652|FG000|Overall Study|Sponsor Decision|12|||
143133183|NCT02346877|516031653|FG001|Overall Study|Sponsor Decision|0|||
143133184|NCT02346877|516031652|FG000|Overall Study|Missing|5|||
143133185|NCT02346877|516031653|FG001|Overall Study|Missing|0|||
143133186|NCT02317991|516033276|FG000|Overall Study|Adverse Event|12|||
143133187|NCT02317991|516033276|FG000|Overall Study|Death|4|||
143133188|NCT02317991|516033276|FG000|Overall Study|Withdrawal by Subject|8|||
143133189|NCT02317991|516033276|FG000|Overall Study|Progressive Disease|41|||
143133190|NCT01051921|516033277|FG000|Overall Study|Physician Decision|9|||
143133191|NCT01051921|516033277|FG000|Overall Study|Adverse Event|8|||
143133192|NCT01051921|516033277|FG000|Overall Study|Withdrawal by Subject|7|||
143133193|NCT01051921|516033277|FG000|Overall Study|Lost to Follow-up|4|||
143133194|NCT01051921|516033277|FG000|Overall Study|virological failure|1|||
143133195|NCT01051921|516033277|FG000|Overall Study|patient moved|1|||
143133196|NCT00379834|516033278|FG000|Overall Study|Time constraints|2|||
143133197|NCT01716806|516033283|FG000|Overall Study|Patient withdrawal of consent|4|||
143133198|NCT01716806|516033284|FG001|Overall Study|Patient withdrawal of consent|2|||
143133199|NCT01716806|516033285|FG002|Overall Study|Patient withdrawal of consent|4|||
143133200|NCT01716806|516033286|FG003|Overall Study|Patient withdrawal of consent|3|||
143133201|NCT01716806|516033287|FG004|Overall Study|Patient withdrawal of consent|2|||
143133202|NCT01716806|516033288|FG005|Overall Study|Patient withdrawal of consent|0|||
143133203|NCT01716806|516033283|FG000|Overall Study|Lost to Follow-up|3|||
143133204|NCT01716806|516033284|FG001|Overall Study|Lost to Follow-up|3|||
143133205|NCT01716806|516033285|FG002|Overall Study|Lost to Follow-up|0|||
143133206|NCT01716806|516033286|FG003|Overall Study|Lost to Follow-up|2|||
143133207|NCT01716806|516033287|FG004|Overall Study|Lost to Follow-up|1|||
143133208|NCT01716806|516033288|FG005|Overall Study|Lost to Follow-up|0|||
143133209|NCT01716806|516033283|FG000|Overall Study|Death|13|||
143133210|NCT01716806|516033284|FG001|Overall Study|Death|9|||
143133211|NCT01716806|516033285|FG002|Overall Study|Death|12|||
143133212|NCT01716806|516033286|FG003|Overall Study|Death|4|||
143133213|NCT01716806|516033287|FG004|Overall Study|Death|10|||
143133214|NCT01716806|516033288|FG005|Overall Study|Death|5|||
143133215|NCT01716806|516033283|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
143181145|NCT04951622|516210471|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
143181146|NCT04951622|516210472|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|77|||
143181147|NCT04951622|516210473|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|74|||
143181148|NCT04951622|516210474|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|15|||
143181149|NCT04951622|516210470|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
143181150|NCT04951622|516210471|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
143181151|NCT04951622|516210472|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
143181152|NCT04951622|516210473|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
143181153|NCT04951622|516210474|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|1|||
143181154|NCT01544348|516210479|FG000|Overall Study|Lost to Follow-up|1|||
143181155|NCT01544348|516210480|FG001|Overall Study|Lost to Follow-up|0|||
143181156|NCT01544348|516210481|FG002|Overall Study|Lost to Follow-up|0|||
143181157|NCT01544348|516210482|FG003|Overall Study|Lost to Follow-up|0|||
143181158|NCT01544348|516210483|FG004|Overall Study|Lost to Follow-up|0|||
143181159|NCT01544348|516210484|FG005|Overall Study|Lost to Follow-up|0|||
143181160|NCT01544348|516210485|FG006|Overall Study|Lost to Follow-up|1|||
143181161|NCT01544348|516210486|FG007|Overall Study|Lost to Follow-up|0|||
143181162|NCT01544348|516210479|FG000|Overall Study|Withdrawal by Subject|1|||
143181163|NCT01544348|516210480|FG001|Overall Study|Withdrawal by Subject|0|||
143181164|NCT01544348|516210481|FG002|Overall Study|Withdrawal by Subject|0|||
143181165|NCT01544348|516210482|FG003|Overall Study|Withdrawal by Subject|0|||
143181166|NCT01544348|516210483|FG004|Overall Study|Withdrawal by Subject|1|||
143181167|NCT01544348|516210484|FG005|Overall Study|Withdrawal by Subject|2|||
143181168|NCT01544348|516210485|FG006|Overall Study|Withdrawal by Subject|1|||
143181169|NCT01544348|516210486|FG007|Overall Study|Withdrawal by Subject|0|||
143181170|NCT01544348|516210479|FG000|Overall Study|Physician Decision|0|||
143181171|NCT01544348|516210480|FG001|Overall Study|Physician Decision|0|||
143181172|NCT01544348|516210481|FG002|Overall Study|Physician Decision|0|||
143181173|NCT01544348|516210482|FG003|Overall Study|Physician Decision|0|||
143181174|NCT01544348|516210483|FG004|Overall Study|Physician Decision|0|||
143133216|NCT01716806|516033284|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
143133217|NCT01716806|516033285|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
143133218|NCT01716806|516033286|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
143133219|NCT01716806|516033287|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
143133220|NCT01716806|516033288|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
143133221|NCT01716806|516033283|FG000|Overall Study|PI decision|0|||
143133222|NCT01716806|516033284|FG001|Overall Study|PI decision|0|||
143133223|NCT01716806|516033285|FG002|Overall Study|PI decision|0|||
143133224|NCT01716806|516033286|FG003|Overall Study|PI decision|0|||
143133225|NCT01716806|516033287|FG004|Overall Study|PI decision|1|||
143133226|NCT01716806|516033288|FG005|Overall Study|PI decision|0|||
143133227|NCT01716806|516033283|FG000|Overall Study|Change in performance status|1|||
143133228|NCT01716806|516033284|FG001|Overall Study|Change in performance status|0|||
143133229|NCT01716806|516033285|FG002|Overall Study|Change in performance status|0|||
143133230|NCT01716806|516033286|FG003|Overall Study|Change in performance status|0|||
143133231|NCT01716806|516033287|FG004|Overall Study|Change in performance status|0|||
143133232|NCT01716806|516033288|FG005|Overall Study|Change in performance status|0|||
143133233|NCT01716806|516033283|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
143013898|NCT01488071|515590081|FG000|Overall Study|Lack of Efficacy|11|||
143133234|NCT01716806|516033284|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
143133235|NCT01716806|516033285|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
143133236|NCT01716806|516033286|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
143133237|NCT01716806|516033287|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
143133238|NCT01716806|516033288|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
143133239|NCT01716806|516033283|FG000|Overall Study|Sponsor direction|7|||
143133240|NCT01716806|516033284|FG001|Overall Study|Sponsor direction|8|||
143133241|NCT01716806|516033285|FG002|Overall Study|Sponsor direction|5|||
143133242|NCT01716806|516033286|FG003|Overall Study|Sponsor direction|12|||
143133243|NCT01716806|516033287|FG004|Overall Study|Sponsor direction|16|||
143133244|NCT01716806|516033288|FG005|Overall Study|Sponsor direction|1|||
143133245|NCT03506438|516033291|FG000|Overall Study|Lost to Follow-up|8|||
143133246|NCT03506438|516033292|FG001|Overall Study|Lost to Follow-up|7|||
143133247|NCT03506438|516033293|FG002|Overall Study|Lost to Follow-up|8|||
143358134|NCT03280563|516856087|FG007|Long-term Survival Follow-up|Withdrawal by Subject|0|||
143358135|NCT03280563|516856088|FG008|Long-term Survival Follow-up|Withdrawal by Subject|0|||
143358136|NCT03280563|516856080|FG000|Long-term Survival Follow-up|Lost to Follow-up|0|||
143358137|NCT03280563|516856081|FG001|Long-term Survival Follow-up|Lost to Follow-up|1|||
143358138|NCT03280563|516856082|FG002|Long-term Survival Follow-up|Lost to Follow-up|1|||
143358139|NCT03280563|516856083|FG003|Long-term Survival Follow-up|Lost to Follow-up|0|||
143358140|NCT03280563|516856084|FG004|Long-term Survival Follow-up|Lost to Follow-up|2|||
143358141|NCT03280563|516856085|FG005|Long-term Survival Follow-up|Lost to Follow-up|1|||
143358142|NCT03280563|516856086|FG006|Long-term Survival Follow-up|Lost to Follow-up|0|||
143358143|NCT03280563|516856087|FG007|Long-term Survival Follow-up|Lost to Follow-up|0|||
143358144|NCT03280563|516856088|FG008|Long-term Survival Follow-up|Lost to Follow-up|0|||
143358145|NCT04213846|516856089|FG000|Overall Study|Withdrawal by Subject|7|||
143358146|NCT04213846|516856090|FG001|Overall Study|Withdrawal by Subject|6|||
143358147|NCT04213846|516856089|FG000|Overall Study|Lost to Follow-up|15|||
143358148|NCT04213846|516856090|FG001|Overall Study|Lost to Follow-up|21|||
143358149|NCT03038672|516856091|FG000|Initial Treatment|Unacceptable chemistry|0|||
143358150|NCT03038672|516856092|FG001|Initial Treatment|Unacceptable chemistry|1|||
143358151|NCT03038672|516856091|FG000|Initial Treatment|Progression prior to treatment|1|||
143358152|NCT03038672|516856092|FG001|Initial Treatment|Progression prior to treatment|0|||
143358153|NCT03038672|516856091|FG000|Initial Treatment|No treatment per protocol|1|||
143358154|NCT03038672|516856092|FG001|Initial Treatment|No treatment per protocol|0|||
143358155|NCT05220501|516856093|FG000|Overall Study|Withdrawal by Subject|11|||
143358156|NCT05220501|516856094|FG001|Overall Study|Withdrawal by Subject|21|||
143358157|NCT05220501|516856095|FG002|Overall Study|Withdrawal by Subject|32|||
143358158|NCT05220501|516856093|FG000|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|5|||
143358159|NCT05220501|516856094|FG001|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|16|||
143358160|NCT05220501|516856095|FG002|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|39|||
143358161|NCT03468426|516856098|FG000|Overall Study|Progressive disease|3|||
143358162|NCT03468426|516856099|FG001|Overall Study|Progressive disease|0|||
143358163|NCT03468426|516856100|FG002|Overall Study|Progressive disease|4|||
143358164|NCT03468426|516856101|FG003|Overall Study|Progressive disease|20|||
143358165|NCT03468426|516856102|FG004|Overall Study|Progressive disease|23|||
143358166|NCT03468426|516856103|FG005|Overall Study|Progressive disease|15|||
143358167|NCT03468426|516856104|FG006|Overall Study|Progressive disease|24|||
143358168|NCT03468426|516856105|FG007|Overall Study|Progressive disease|27|||
143358169|NCT03468426|516856106|FG008|Overall Study|Progressive disease|13|||
143358170|NCT03468426|516856107|FG009|Overall Study|Progressive disease|13|||
143133248|NCT03506438|516033294|FG003|Overall Study|Lost to Follow-up|7|||
143133249|NCT03506438|516033295|FG004|Overall Study|Lost to Follow-up|0|||
143133250|NCT03506438|516033296|FG005|Overall Study|Lost to Follow-up|0|||
143133251|NCT03934216|516033299|FG000|Overall Study|Other Reasons|5|||
143133252|NCT03934216|516033300|FG001|Overall Study|Other Reasons|5|||
143133253|NCT03934216|516033299|FG000|Overall Study|Adverse Event|22|||
143133254|NCT03934216|516033300|FG001|Overall Study|Adverse Event|11|||
143133255|NCT03934216|516033299|FG000|Overall Study|Lack of Efficacy|8|||
143133256|NCT03934216|516033300|FG001|Overall Study|Lack of Efficacy|7|||
143133257|NCT03934216|516033299|FG000|Overall Study|Lost to Follow-up|2|||
143133258|NCT03934216|516033300|FG001|Overall Study|Lost to Follow-up|0|||
143133259|NCT03934216|516033299|FG000|Overall Study|Non-Compliance with Study Drug|1|||
143133260|NCT03934216|516033300|FG001|Overall Study|Non-Compliance with Study Drug|1|||
143133261|NCT03934216|516033299|FG000|Overall Study|Pregnancy|1|||
143133262|NCT03934216|516033300|FG001|Overall Study|Pregnancy|0|||
143133263|NCT03934216|516033299|FG000|Overall Study|Withdrawal by Subject|18|||
143231086|NCT03980730|516395593|FG001|Overall Study|Adverse Event|0|||
143231087|NCT03980730|516395592|FG000|Overall Study|Sponsor Request|0|||
143231088|NCT03980730|516395593|FG001|Overall Study|Sponsor Request|1|||
143231089|NCT01300728|516395594|FG000|Overall Study|Withdrawal by Subject|1|||
143231090|NCT01300728|516395595|FG001|Overall Study|Withdrawal by Subject|1|||
143231091|NCT01300728|516395594|FG000|Overall Study|Physician Decision|1|||
143231092|NCT01300728|516395595|FG001|Overall Study|Physician Decision|0|||
143231093|NCT02081677|516397317|FG000|Overall Study|Adverse Event|0|||
143231094|NCT02081677|516397318|FG001|Overall Study|Adverse Event|0|||
143231095|NCT02081677|516397319|FG002|Overall Study|Adverse Event|1|||
143231096|NCT02081677|516397320|FG003|Overall Study|Adverse Event|0|||
143133264|NCT03934216|516033300|FG001|Overall Study|Withdrawal by Subject|6|||
143133265|NCT03934216|516033299|FG000|Overall Study|Randomized but not treated|1|||
143133266|NCT03934216|516033300|FG001|Overall Study|Randomized but not treated|1|||
143133267|NCT01053741|516033303|FG000|2nd Study Intervention|Physician Decision|0|||
143133268|NCT01053741|516033304|FG001|2nd Study Intervention|Physician Decision|1|||
143133269|NCT01396083|516033305|FG000|Overall Study|Adverse Event|2|||
143133270|NCT01396083|516033306|FG001|Overall Study|Adverse Event|28|||
143133271|NCT01396083|516033305|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
143133272|NCT01396083|516033306|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
143133273|NCT01396083|516033305|FG000|Overall Study|Consent withdrawn|4|||
143133274|NCT01396083|516033306|FG001|Overall Study|Consent withdrawn|5|||
143133275|NCT01396083|516033305|FG000|Overall Study|Protocol deviation(s)|0|||
143133276|NCT01396083|516033306|FG001|Overall Study|Protocol deviation(s)|1|||
143133277|NCT01396083|516033305|FG000|Overall Study|Abnormal laboratory value(s)|1|||
143133278|NCT01396083|516033306|FG001|Overall Study|Abnormal laboratory value(s)|0|||
143133279|NCT01396083|516033305|FG000|Overall Study|Administrative problems|1|||
143133280|NCT01396083|516033306|FG001|Overall Study|Administrative problems|0|||
143133281|NCT01396083|516033305|FG000|Overall Study|Lost to Follow-up|1|||
143133282|NCT01396083|516033306|FG001|Overall Study|Lost to Follow-up|0|||
143133283|NCT00619827|516033307|FG000|Overall Study|Adverse Event|1|||
143133284|NCT00619827|516033308|FG001|Overall Study|Adverse Event|2|||
143133285|NCT00619827|516033307|FG000|Overall Study|Withdrawal by Subject|2|||
143133286|NCT00619827|516033308|FG001|Overall Study|Withdrawal by Subject|2|||
143133287|NCT02806713|516033309|FG000|Overall Study|Urethral injury during procedure|1|||
143133288|NCT02806713|516033310|FG001|Overall Study|Urethral injury during procedure|0|||
143133289|NCT02806713|516033309|FG000|Overall Study|cancelled surgery|1|||
143133290|NCT02806713|516033310|FG001|Overall Study|cancelled surgery|2|||
143133291|NCT00521365|516033330|FG000|Overall Study|Adverse Event|3|||
143133292|NCT00521365|516033330|FG000|Overall Study|Lost to Follow-up|6|||
143133293|NCT00521365|516033330|FG000|Overall Study|Protocol deviation|2|||
143133294|NCT00521365|516033330|FG000|Overall Study|Drug compliance|3|||
143133295|NCT00521365|516033330|FG000|Overall Study|Usage of not allowed drugs|6|||
143133296|NCT03150082|516033331|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
143133297|NCT03150082|516033332|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
143133298|NCT01718483|516033333|FG000|Overall Study|Withdrawal by Subject|14|||
143133299|NCT01718483|516033334|FG001|Overall Study|Withdrawal by Subject|12|||
143133300|NCT01718483|516033333|FG000|Overall Study|Adverse Event|5|||
143133301|NCT01718483|516033334|FG001|Overall Study|Adverse Event|12|||
143133302|NCT01718483|516033333|FG000|Overall Study|Lost to Follow-up|8|||
143133303|NCT01718483|516033334|FG001|Overall Study|Lost to Follow-up|3|||
143231097|NCT02081677|516397317|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
143231098|NCT02081677|516397318|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
143231099|NCT02081677|516397319|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
143231100|NCT02081677|516397320|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
143133304|NCT01718483|516033333|FG000|Overall Study|Protocol Violation|4|||
143133305|NCT01718483|516033334|FG001|Overall Study|Protocol Violation|2|||
143133306|NCT01718483|516033333|FG000|Overall Study|Other|1|||
143133307|NCT01718483|516033334|FG001|Overall Study|Other|4|||
143133308|NCT01718483|516033333|FG000|Overall Study|Pregnancy|1|||
143133309|NCT01718483|516033334|FG001|Overall Study|Pregnancy|1|||
143133310|NCT01718483|516033333|FG000|Overall Study|Lack of Efficacy|1|||
143231101|NCT02081677|516397317|FG000|Overall Study|Not comfortable with lens care system|1|||
143231102|NCT02081677|516397318|FG001|Overall Study|Not comfortable with lens care system|0|||
143231103|NCT02081677|516397319|FG002|Overall Study|Not comfortable with lens care system|0|||
143231104|NCT02081677|516397320|FG003|Overall Study|Not comfortable with lens care system|0|||
143231105|NCT02081677|516397317|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
143231106|NCT02081677|516397318|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
143231107|NCT02081677|516397319|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
143231108|NCT02081677|516397320|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
143231109|NCT01097668|516397321|FG000|Overall Study|Withdrawal by Subject|1|||
143231110|NCT01097668|516397322|FG001|Overall Study|Withdrawal by Subject|2|||
143231111|NCT01097668|516397321|FG000|Overall Study|Lost to Follow-up|1|||
143231112|NCT01097668|516397322|FG001|Overall Study|Lost to Follow-up|0|||
143231113|NCT01910298|516397323|FG000|Overall Study|Adverse Event|1|||
143231114|NCT01910298|516397324|FG001|Overall Study|Adverse Event|0|||
143231115|NCT01910298|516397323|FG000|Overall Study|Withdrawal by Subject|2|||
143231116|NCT01910298|516397324|FG001|Overall Study|Withdrawal by Subject|7|||
143231117|NCT01910298|516397323|FG000|Overall Study|Protocol Deviation|0|||
143231118|NCT01910298|516397324|FG001|Overall Study|Protocol Deviation|5|||
143231119|NCT01910298|516397323|FG000|Overall Study|Lost to Follow-up|1|||
143231120|NCT01910298|516397324|FG001|Overall Study|Lost to Follow-up|1|||
143231121|NCT01910298|516397323|FG000|Overall Study|Study Terminated by Sponsor|1|||
143231122|NCT01910298|516397324|FG001|Overall Study|Study Terminated by Sponsor|17|||
143231123|NCT01910298|516397323|FG000|Overall Study|Other Miscellaneous Reasons|0|||
143231124|NCT01910298|516397324|FG001|Overall Study|Other Miscellaneous Reasons|2|||
143231125|NCT03037385|516397327|FG000|Overall Study|Adverse Event|0|||
143231126|NCT03037385|516397328|FG001|Overall Study|Adverse Event|0|||
143231127|NCT03037385|516397329|FG002|Overall Study|Adverse Event|1|||
143231128|NCT03037385|516397330|FG003|Overall Study|Adverse Event|0|||
143231129|NCT03037385|516397331|FG004|Overall Study|Adverse Event|0|||
143231130|NCT03037385|516397332|FG005|Overall Study|Adverse Event|0|||
143231131|NCT03037385|516397333|FG006|Overall Study|Adverse Event|0|||
143231132|NCT03037385|516397334|FG007|Overall Study|Adverse Event|0|||
143231133|NCT03037385|516397335|FG008|Overall Study|Adverse Event|0|||
143231134|NCT03037385|516397336|FG009|Overall Study|Adverse Event|6|||
143231135|NCT03037385|516397327|FG000|Overall Study|Death|1|||
143231136|NCT03037385|516397328|FG001|Overall Study|Death|4|||
143231137|NCT03037385|516397329|FG002|Overall Study|Death|2|||
143231138|NCT03037385|516397330|FG003|Overall Study|Death|2|||
143231139|NCT03037385|516397331|FG004|Overall Study|Death|5|||
143231140|NCT03037385|516397332|FG005|Overall Study|Death|2|||
143231141|NCT03037385|516397333|FG006|Overall Study|Death|1|||
143231142|NCT03037385|516397334|FG007|Overall Study|Death|4|||
143231143|NCT03037385|516397335|FG008|Overall Study|Death|3|||
143231144|NCT03037385|516397336|FG009|Overall Study|Death|240|||
143231145|NCT03037385|516397327|FG000|Overall Study|Initiation of Another Therapy|1|||
143231146|NCT03037385|516397328|FG001|Overall Study|Initiation of Another Therapy|0|||
143231147|NCT03037385|516397329|FG002|Overall Study|Initiation of Another Therapy|0|||
143231148|NCT03037385|516397330|FG003|Overall Study|Initiation of Another Therapy|0|||
143231149|NCT03037385|516397331|FG004|Overall Study|Initiation of Another Therapy|0|||
143231150|NCT03037385|516397332|FG005|Overall Study|Initiation of Another Therapy|0|||
143231151|NCT03037385|516397333|FG006|Overall Study|Initiation of Another Therapy|0|||
143465789|NCT01765179|517251136|FG000|Overall Study|Adverse Event|3|||
143465790|NCT01765179|517251136|FG000|Overall Study|Lost to Follow-up|5|||
143465791|NCT01765179|517251136|FG000|Overall Study|Non-compliance with study drug|2|||
143465792|NCT01765179|517251136|FG000|Overall Study|Protocol Violation|1|||
143465793|NCT01765179|517251136|FG000|Overall Study|Withdrawal by Subject|8|||
143465794|NCT01765179|517251136|FG000|Overall Study|Hematocrit >54%|3|||
143465795|NCT01765179|517251136|FG000|Overall Study|prohibited med|1|||
143465796|NCT01765179|517251136|FG000|Overall Study|Out of country unable to finish study|1|||
143465797|NCT01765179|517251136|FG000|Overall Study|lack of venous access|1|||
143465798|NCT01765179|517251136|FG000|Overall Study|work conflict|1|||
143465799|NCT01765179|517251136|FG000|Overall Study|Ca elevated 10.6|1|||
143465800|NCT00178126|517251139|FG000|Overall Study|Lost to Follow-up|21|||
143465801|NCT00178126|517251140|FG001|Overall Study|Lost to Follow-up|21|||
143465802|NCT00178126|517251139|FG000|Overall Study|did not receive intervention|4|||
143465803|NCT00178126|517251140|FG001|Overall Study|did not receive intervention|6|||
143465804|NCT00421707|517251141|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
143465805|NCT00421707|517251142|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
143465806|NCT00421707|517251141|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
143465807|NCT00421707|517251142|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
143465808|NCT00421707|517251141|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
143465809|NCT00421707|517251142|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
143465810|NCT00421707|517251141|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
143465811|NCT00421707|517251142|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
143465812|NCT00421707|517251141|FG000|Period 2: Washout|Adverse Event|1|||
143231152|NCT03037385|516397334|FG007|Overall Study|Initiation of Another Therapy|1|||
143133311|NCT01718483|516033334|FG001|Overall Study|Lack of Efficacy|0|||
143133312|NCT02119299|516033335|FG000|Overall Study|Withdrawal by Subject|7|||
143133313|NCT02119299|516033335|FG000|Overall Study|Lack of Efficacy|1|||
143133314|NCT02119299|516033335|FG000|Overall Study|Pregnancy|1|||
143133315|NCT00048035|516033336|FG000|Core Period|Early Withdrawals|4|||
143133316|NCT00048035|516033337|FG001|Core Period|Early Withdrawals|2|||
143133317|NCT00048035|516033338|FG002|Core Period|Early Withdrawals|1|||
143133318|NCT00048035|516033339|FG003|Core Period|Early Withdrawals|1|||
143133319|NCT00048035|516033340|FG004|Core Period|Early Withdrawals|1|||
143133320|NCT00048035|516033341|FG005|Core Period|Early Withdrawals|1|||
143133321|NCT00048035|516033342|FG006|Core Period|Early Withdrawals|0|||
143133322|NCT00048035|516033343|FG007|Core Period|Early Withdrawals|0|||
143133323|NCT00048035|516033336|FG000|Extension Year 1|Early Withdrawals|0|||
143133324|NCT00048035|516033337|FG001|Extension Year 1|Early Withdrawals|0|||
143133325|NCT00048035|516033338|FG002|Extension Year 1|Early Withdrawals|0|||
143133326|NCT00048035|516033339|FG003|Extension Year 1|Early Withdrawals|0|||
143133327|NCT00048035|516033340|FG004|Extension Year 1|Early Withdrawals|0|||
143133328|NCT00048035|516033341|FG005|Extension Year 1|Early Withdrawals|0|||
143133329|NCT00048035|516033342|FG006|Extension Year 1|Early Withdrawals|11|||
143133330|NCT00048035|516033343|FG007|Extension Year 1|Early Withdrawals|11|||
143133331|NCT00048035|516033336|FG000|Extension Year 2|Early Withdrawals|0|||
143133332|NCT00048035|516033337|FG001|Extension Year 2|Early Withdrawals|0|||
143133333|NCT00048035|516033338|FG002|Extension Year 2|Early Withdrawals|0|||
143133334|NCT00048035|516033339|FG003|Extension Year 2|Early Withdrawals|0|||
143133335|NCT00048035|516033340|FG004|Extension Year 2|Early Withdrawals|0|||
143133336|NCT00048035|516033341|FG005|Extension Year 2|Early Withdrawals|0|||
143133337|NCT00048035|516033342|FG006|Extension Year 2|Early Withdrawals|3|||
143133338|NCT00048035|516033343|FG007|Extension Year 2|Early Withdrawals|3|||
143133339|NCT05137717|516033348|FG000|Overall Study|Death|2|||
143133340|NCT05137717|516033348|FG000|Overall Study|Withdrawal by Subject|6|||
143133341|NCT02735980|516033350|FG000|Overall Study|Adverse Event|0|||
143133342|NCT02735980|516033351|FG001|Overall Study|Adverse Event|4|||
143133343|NCT02735980|516033352|FG002|Overall Study|Adverse Event|1|||
143465813|NCT00421707|517251142|FG001|Period 2: Washout|Adverse Event|1|||
143465814|NCT00421707|517251141|FG000|Period 2: Washout|Withdrawal by Subject|0|||
143133344|NCT02735980|516033350|FG000|Overall Study|Death|5|||
143133345|NCT02735980|516033351|FG001|Overall Study|Death|4|||
143133346|NCT02735980|516033352|FG002|Overall Study|Death|0|||
143133347|NCT02735980|516033350|FG000|Overall Study|Physician Decision|3|||
143133348|NCT02735980|516033351|FG001|Overall Study|Physician Decision|1|||
143133349|NCT02735980|516033352|FG002|Overall Study|Physician Decision|0|||
143133350|NCT02735980|516033350|FG000|Overall Study|Screen failure|1|||
143133351|NCT02735980|516033351|FG001|Overall Study|Screen failure|0|||
143133352|NCT02735980|516033352|FG002|Overall Study|Screen failure|0|||
143133353|NCT02735980|516033350|FG000|Overall Study|Withdrawal by Subject|1|||
143133354|NCT02735980|516033351|FG001|Overall Study|Withdrawal by Subject|2|||
143133355|NCT02735980|516033352|FG002|Overall Study|Withdrawal by Subject|0|||
143133356|NCT00509899|516033353|FG000|Overall Study|Progressive disease|1|||
143133357|NCT00509899|516033354|FG001|Overall Study|Progressive disease|3|||
143133358|NCT00509899|516033355|FG002|Overall Study|Progressive disease|5|||
143133359|NCT00509899|516033356|FG003|Overall Study|Progressive disease|1|||
143133360|NCT00509899|516033357|FG004|Overall Study|Progressive disease|0|||
143133361|NCT00509899|516033358|FG005|Overall Study|Progressive disease|1|||
143133362|NCT00509899|516033359|FG006|Overall Study|Progressive disease|0|||
143133363|NCT00509899|516033360|FG007|Overall Study|Progressive disease|0|||
143133364|NCT00509899|516033353|FG000|Overall Study|Unacceptable Toxicity|1|||
143465815|NCT00421707|517251142|FG001|Period 2: Washout|Withdrawal by Subject|1|||
143465816|NCT00421707|517251141|FG000|Period 2: Washout|Lost to Follow-up|0|||
143465817|NCT00421707|517251142|FG001|Period 2: Washout|Lost to Follow-up|1|||
143465818|NCT00421707|517251141|FG000|Period 2: Washout|Other: Pregnancy|0|||
143465819|NCT00421707|517251142|FG001|Period 2: Washout|Other: Pregnancy|1|||
143133365|NCT00509899|516033354|FG001|Overall Study|Unacceptable Toxicity|0|||
143133366|NCT00509899|516033355|FG002|Overall Study|Unacceptable Toxicity|0|||
143133367|NCT00509899|516033356|FG003|Overall Study|Unacceptable Toxicity|2|||
143133368|NCT00509899|516033357|FG004|Overall Study|Unacceptable Toxicity|0|||
143133369|NCT00509899|516033358|FG005|Overall Study|Unacceptable Toxicity|0|||
143133370|NCT00509899|516033359|FG006|Overall Study|Unacceptable Toxicity|0|||
143133371|NCT00509899|516033360|FG007|Overall Study|Unacceptable Toxicity|0|||
143465820|NCT00421707|517251141|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
143465821|NCT00421707|517251142|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
143013899|NCT01488071|515590082|FG001|Overall Study|Lack of Efficacy|17|||
143133372|NCT00509899|516033353|FG000|Overall Study|Withdrawal by Subject|6|||
143133373|NCT00509899|516033354|FG001|Overall Study|Withdrawal by Subject|2|||
143465822|NCT00421707|517251141|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
143133374|NCT00509899|516033355|FG002|Overall Study|Withdrawal by Subject|3|||
143133375|NCT00509899|516033356|FG003|Overall Study|Withdrawal by Subject|0|||
143133376|NCT00509899|516033357|FG004|Overall Study|Withdrawal by Subject|3|||
143133377|NCT00509899|516033358|FG005|Overall Study|Withdrawal by Subject|2|||
143465823|NCT00421707|517251142|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
143465824|NCT00421707|517251141|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
143465825|NCT00421707|517251142|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
143465826|NCT02739360|517251145|FG000|Overall Study|Adverse Event|1|||
143465827|NCT02739360|517251145|FG000|Overall Study|Study terminated by Sponsor|2|||
143465828|NCT01163916|517251146|FG000|Overall Study|Withdrawal by Subject|2|||
143465829|NCT01163916|517251147|FG001|Overall Study|Withdrawal by Subject|0|||
143465830|NCT01163916|517251148|FG002|Overall Study|Withdrawal by Subject|2|||
143465831|NCT01163916|517251146|FG000|Overall Study|Adverse Event|2|||
143013900|NCT01488071|515590081|FG000|Overall Study|Non-compliance with study drug|2|||
143231153|NCT03037385|516397335|FG008|Overall Study|Initiation of Another Therapy|0|||
143465832|NCT01163916|517251147|FG001|Overall Study|Adverse Event|0|||
143465833|NCT01163916|517251148|FG002|Overall Study|Adverse Event|1|||
143465834|NCT01163916|517251146|FG000|Overall Study|Lack of Efficacy|2|||
143465835|NCT01163916|517251147|FG001|Overall Study|Lack of Efficacy|0|||
143465836|NCT01163916|517251148|FG002|Overall Study|Lack of Efficacy|1|||
143465837|NCT01163916|517251146|FG000|Overall Study|Other|24|||
143465838|NCT01163916|517251147|FG001|Overall Study|Other|4|||
143465839|NCT01163916|517251148|FG002|Overall Study|Other|16|||
143231154|NCT03037385|516397336|FG009|Overall Study|Initiation of Another Therapy|2|||
143231155|NCT03037385|516397327|FG000|Overall Study|Lost to Follow-up|0|||
143231156|NCT03037385|516397328|FG001|Overall Study|Lost to Follow-up|0|||
143231157|NCT03037385|516397329|FG002|Overall Study|Lost to Follow-up|0|||
143231158|NCT03037385|516397330|FG003|Overall Study|Lost to Follow-up|0|||
143231159|NCT03037385|516397331|FG004|Overall Study|Lost to Follow-up|0|||
143231160|NCT03037385|516397332|FG005|Overall Study|Lost to Follow-up|1|||
143231161|NCT03037385|516397333|FG006|Overall Study|Lost to Follow-up|0|||
143231162|NCT03037385|516397334|FG007|Overall Study|Lost to Follow-up|0|||
143231163|NCT03037385|516397335|FG008|Overall Study|Lost to Follow-up|0|||
143231164|NCT03037385|516397336|FG009|Overall Study|Lost to Follow-up|16|||
143231165|NCT03037385|516397327|FG000|Overall Study|Physician Decision|0|||
143231166|NCT03037385|516397328|FG001|Overall Study|Physician Decision|0|||
143231167|NCT03037385|516397329|FG002|Overall Study|Physician Decision|0|||
143231168|NCT03037385|516397330|FG003|Overall Study|Physician Decision|0|||
143231169|NCT03037385|516397331|FG004|Overall Study|Physician Decision|0|||
143231170|NCT03037385|516397332|FG005|Overall Study|Physician Decision|0|||
143231171|NCT03037385|516397333|FG006|Overall Study|Physician Decision|0|||
143231172|NCT03037385|516397334|FG007|Overall Study|Physician Decision|0|||
143231173|NCT03037385|516397335|FG008|Overall Study|Physician Decision|0|||
143231174|NCT03037385|516397336|FG009|Overall Study|Physician Decision|1|||
143231175|NCT03037385|516397327|FG000|Overall Study|Progressive Disease|0|||
143465840|NCT00423930|517251149|FG000|Overall Study|Withdrawal by Subject|2|||
143465841|NCT02337751|517251150|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
143465842|NCT02337751|517251151|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
143465843|NCT02337751|517251150|FG000|Overall Study|Voluntary Withdrawal|6|||
143465844|NCT02337751|517251151|FG001|Overall Study|Voluntary Withdrawal|8|||
143465845|NCT02337751|517251150|FG000|Overall Study|Lack of Efficacy|2|||
143465846|NCT02337751|517251151|FG001|Overall Study|Lack of Efficacy|5|||
143465847|NCT02337751|517251150|FG000|Overall Study|Investigator's Judgement|1|||
143465848|NCT02337751|517251151|FG001|Overall Study|Investigator's Judgement|0|||
143465849|NCT02881957|517251153|FG000|Overall Study|Comfort care|0|||
143465850|NCT02881957|517251154|FG001|Overall Study|Comfort care|1|||
143465851|NCT02881957|517251153|FG000|Overall Study|Concurrent trial enrollment|0|||
143465852|NCT02881957|517251154|FG001|Overall Study|Concurrent trial enrollment|1|||
143465853|NCT02881957|517251153|FG000|Overall Study|Discharged within 48 hours|0|||
143465854|NCT02881957|517251154|FG001|Overall Study|Discharged within 48 hours|1|||
143465855|NCT02881957|517251153|FG000|Overall Study|Withdrawal by Subject|2|||
143231176|NCT03037385|516397328|FG001|Overall Study|Progressive Disease|1|||
143231177|NCT03037385|516397329|FG002|Overall Study|Progressive Disease|1|||
143231178|NCT03037385|516397330|FG003|Overall Study|Progressive Disease|5|||
143231179|NCT03037385|516397331|FG004|Overall Study|Progressive Disease|2|||
143231180|NCT03037385|516397332|FG005|Overall Study|Progressive Disease|0|||
143231181|NCT03037385|516397333|FG006|Overall Study|Progressive Disease|1|||
143231182|NCT03037385|516397334|FG007|Overall Study|Progressive Disease|0|||
143231183|NCT03037385|516397335|FG008|Overall Study|Progressive Disease|0|||
143231184|NCT03037385|516397336|FG009|Overall Study|Progressive Disease|30|||
143231185|NCT03037385|516397327|FG000|Overall Study|Withdrawal by Subject|0|||
143231186|NCT03037385|516397328|FG001|Overall Study|Withdrawal by Subject|0|||
143231187|NCT03037385|516397329|FG002|Overall Study|Withdrawal by Subject|1|||
143465856|NCT02881957|517251154|FG001|Overall Study|Withdrawal by Subject|1|||
143465857|NCT02881957|517251153|FG000|Overall Study|Protocol Violation|1|||
143465858|NCT02881957|517251154|FG001|Overall Study|Protocol Violation|0|||
143465859|NCT04223856|517251156|FG000|Overall Study|Progressive disease|153|||
143231188|NCT03037385|516397330|FG003|Overall Study|Withdrawal by Subject|2|||
143231189|NCT03037385|516397331|FG004|Overall Study|Withdrawal by Subject|1|||
143465860|NCT04223856|517251157|FG001|Overall Study|Progressive disease|73|||
143465861|NCT04223856|517251156|FG000|Overall Study|Adverse Event|97|||
143465862|NCT04223856|517251157|FG001|Overall Study|Adverse Event|62|||
143465863|NCT04223856|517251156|FG000|Overall Study|Physician Decision|9|||
143231190|NCT03037385|516397332|FG005|Overall Study|Withdrawal by Subject|3|||
143231191|NCT03037385|516397333|FG006|Overall Study|Withdrawal by Subject|0|||
143231192|NCT03037385|516397334|FG007|Overall Study|Withdrawal by Subject|0|||
143231193|NCT03037385|516397335|FG008|Overall Study|Withdrawal by Subject|0|||
143231194|NCT03037385|516397336|FG009|Overall Study|Withdrawal by Subject|52|||
143231195|NCT03037385|516397327|FG000|Overall Study|Reason Not Specified|0|||
143231196|NCT03037385|516397328|FG001|Overall Study|Reason Not Specified|1|||
143231197|NCT03037385|516397329|FG002|Overall Study|Reason Not Specified|0|||
143231198|NCT03037385|516397330|FG003|Overall Study|Reason Not Specified|4|||
143231199|NCT03037385|516397331|FG004|Overall Study|Reason Not Specified|3|||
143133378|NCT00509899|516033359|FG006|Overall Study|Withdrawal by Subject|0|||
143133379|NCT00509899|516033360|FG007|Overall Study|Withdrawal by Subject|0|||
143133380|NCT00509899|516033353|FG000|Overall Study|Physician Decision|4|||
143133381|NCT00509899|516033354|FG001|Overall Study|Physician Decision|2|||
143133382|NCT00509899|516033355|FG002|Overall Study|Physician Decision|7|||
143133383|NCT00509899|516033356|FG003|Overall Study|Physician Decision|0|||
143133384|NCT00509899|516033357|FG004|Overall Study|Physician Decision|1|||
143358171|NCT03468426|516856108|FG010|Overall Study|Progressive disease|0|||
143358172|NCT03468426|516856098|FG000|Overall Study|Other adverse event or clinical progression|0|||
143358173|NCT03468426|516856099|FG001|Overall Study|Other adverse event or clinical progression|1|||
143358174|NCT03468426|516856100|FG002|Overall Study|Other adverse event or clinical progression|3|||
143358175|NCT03468426|516856101|FG003|Overall Study|Other adverse event or clinical progression|14|||
143358176|NCT03468426|516856102|FG004|Overall Study|Other adverse event or clinical progression|10|||
143358177|NCT03468426|516856103|FG005|Overall Study|Other adverse event or clinical progression|8|||
143358178|NCT03468426|516856104|FG006|Overall Study|Other adverse event or clinical progression|5|||
143358179|NCT03468426|516856105|FG007|Overall Study|Other adverse event or clinical progression|4|||
143358180|NCT03468426|516856106|FG008|Overall Study|Other adverse event or clinical progression|6|||
143358181|NCT03468426|516856107|FG009|Overall Study|Other adverse event or clinical progression|11|||
143358182|NCT03468426|516856108|FG010|Overall Study|Other adverse event or clinical progression|0|||
143358183|NCT03468426|516856098|FG000|Overall Study|Refused to continue taking trial medication|0|||
143358184|NCT03468426|516856099|FG001|Overall Study|Refused to continue taking trial medication|0|||
143358185|NCT03468426|516856100|FG002|Overall Study|Refused to continue taking trial medication|0|||
143358186|NCT03468426|516856101|FG003|Overall Study|Refused to continue taking trial medication|2|||
143358187|NCT03468426|516856102|FG004|Overall Study|Refused to continue taking trial medication|0|||
143358188|NCT03468426|516856103|FG005|Overall Study|Refused to continue taking trial medication|3|||
143358189|NCT03468426|516856104|FG006|Overall Study|Refused to continue taking trial medication|0|||
143358190|NCT03468426|516856105|FG007|Overall Study|Refused to continue taking trial medication|0|||
143358191|NCT03468426|516856106|FG008|Overall Study|Refused to continue taking trial medication|1|||
143358192|NCT03468426|516856107|FG009|Overall Study|Refused to continue taking trial medication|0|||
143358193|NCT03468426|516856108|FG010|Overall Study|Refused to continue taking trial medication|0|||
143358194|NCT03468426|516856098|FG000|Overall Study|Other than listed|0|||
143358195|NCT03468426|516856099|FG001|Overall Study|Other than listed|1|||
143358196|NCT03468426|516856100|FG002|Overall Study|Other than listed|0|||
143358197|NCT03468426|516856101|FG003|Overall Study|Other than listed|0|||
143358198|NCT03468426|516856102|FG004|Overall Study|Other than listed|2|||
143358199|NCT03468426|516856103|FG005|Overall Study|Other than listed|2|||
143358200|NCT03468426|516856104|FG006|Overall Study|Other than listed|0|||
143358201|NCT03468426|516856105|FG007|Overall Study|Other than listed|0|||
143358202|NCT03468426|516856106|FG008|Overall Study|Other than listed|4|||
143358203|NCT03468426|516856107|FG009|Overall Study|Other than listed|4|||
143358204|NCT03468426|516856108|FG010|Overall Study|Other than listed|1|||
143358205|NCT03468426|516856098|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
143358206|NCT03468426|516856099|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
143358207|NCT03468426|516856100|FG002|Overall Study|Dose Limiting Toxicity (DLT)|1|||
143358208|NCT03468426|516856101|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
143358209|NCT03468426|516856102|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
143358210|NCT03468426|516856103|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
143358211|NCT03468426|516856104|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
143358212|NCT03468426|516856105|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
143358213|NCT03468426|516856106|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
143358214|NCT03468426|516856107|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
143358215|NCT03468426|516856108|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
143358216|NCT03468426|516856098|FG000|Overall Study|missing reason|0|||
143358217|NCT03468426|516856099|FG001|Overall Study|missing reason|0|||
143358218|NCT03468426|516856100|FG002|Overall Study|missing reason|0|||
143358219|NCT03468426|516856101|FG003|Overall Study|missing reason|0|||
143358220|NCT03468426|516856102|FG004|Overall Study|missing reason|0|||
143358221|NCT03468426|516856103|FG005|Overall Study|missing reason|0|||
143358222|NCT03468426|516856104|FG006|Overall Study|missing reason|0|||
143358223|NCT03468426|516856105|FG007|Overall Study|missing reason|0|||
143358224|NCT03468426|516856106|FG008|Overall Study|missing reason|0|||
143358225|NCT03468426|516856107|FG009|Overall Study|missing reason|1|||
143231200|NCT03037385|516397332|FG005|Overall Study|Reason Not Specified|6|||
143231201|NCT03037385|516397333|FG006|Overall Study|Reason Not Specified|2|||
143231202|NCT03037385|516397334|FG007|Overall Study|Reason Not Specified|0|||
143231203|NCT03037385|516397335|FG008|Overall Study|Reason Not Specified|1|||
143231204|NCT03037385|516397336|FG009|Overall Study|Reason Not Specified|181|||
143231205|NCT04515771|516397337|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
143231206|NCT04515771|516397338|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
143231207|NCT04515771|516397337|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
143231208|NCT04515771|516397338|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
143231209|NCT04515771|516397337|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
143231210|NCT04515771|516397338|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
143231211|NCT01021020|516397339|FG000|Period I|Protocol Violation|1|||
143231212|NCT01021020|516397339|FG000|Period I|Withdrawal by Subject|1|||
143231213|NCT01021020|516397339|FG000|14 Day Washout Period A|Physician Decision|1|||
143231214|NCT00948246|516397342|FG000|Overall Study|Lost to Follow-up|11|||
143231215|NCT00948246|516397342|FG000|Overall Study|Adverse Event|11|||
143231216|NCT00948246|516397342|FG000|Overall Study|Death|1|||
143231217|NCT00948246|516397342|FG000|Overall Study|Withdrawal by Subject|1|||
143231218|NCT00148317|516397343|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
143231219|NCT00148317|516397343|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
143231220|NCT00148317|516397343|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
143231221|NCT03623243|516397345|FG000|Overall Study|Adverse Event|15|||
143231222|NCT03623243|516397345|FG000|Overall Study|Guardian Decision|1|||
143231223|NCT03623243|516397345|FG000|Overall Study|New Therapy for Study Indication|1|||
143231224|NCT03623243|516397345|FG000|Overall Study|Protocol Deviation|3|||
143231225|NCT03623243|516397345|FG000|Overall Study|Physician Decision|4|||
143231226|NCT03623243|516397345|FG000|Overall Study|Patient Decision|15|||
143231227|NCT03007966|516397346|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
143231228|NCT03007966|516397347|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
143231229|NCT00474487|516397351|FG000|Overall Study|Withdrawal by Subject|6|||
143231230|NCT00474487|516397352|FG001|Overall Study|Withdrawal by Subject|0|||
143231231|NCT00474487|516397353|FG002|Overall Study|Withdrawal by Subject|0|||
143231232|NCT00474487|516397354|FG003|Overall Study|Withdrawal by Subject|0|||
143231233|NCT00474487|516397351|FG000|Overall Study|Lost to Follow-up|20|||
143231234|NCT00474487|516397352|FG001|Overall Study|Lost to Follow-up|1|||
143231235|NCT00474487|516397353|FG002|Overall Study|Lost to Follow-up|7|||
143231236|NCT00474487|516397354|FG003|Overall Study|Lost to Follow-up|0|||
143231237|NCT00474487|516397351|FG000|Overall Study|Inappropriate enrollment|4|||
143231238|NCT00474487|516397352|FG001|Overall Study|Inappropriate enrollment|0|||
143231239|NCT00474487|516397353|FG002|Overall Study|Inappropriate enrollment|7|||
143231240|NCT00474487|516397354|FG003|Overall Study|Inappropriate enrollment|0|||
143231241|NCT00474487|516397351|FG000|Overall Study|Death|0|||
143231242|NCT00474487|516397352|FG001|Overall Study|Death|1|||
143231243|NCT00474487|516397353|FG002|Overall Study|Death|0|||
143231244|NCT00474487|516397354|FG003|Overall Study|Death|0|||
143231245|NCT01428258|516397355|FG000|Intervention 1|Withdrawal by Subject|2|||
143231246|NCT01428258|516397356|FG001|Intervention 1|Withdrawal by Subject|0|||
143231247|NCT00419393|516397357|FG000|Overall Study|Adverse Event|5|||
143231248|NCT00419393|516397357|FG000|Overall Study|Protocol Violation|5|||
143231249|NCT00419393|516397357|FG000|Overall Study|Withdrawal by Subject|7|||
143231250|NCT00419393|516397357|FG000|Overall Study|Other: Sponsor request|3|||
143231251|NCT00419393|516397357|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
143231252|NCT00419393|516397357|FG000|Overall Study|Other: Site closure|1|||
143231253|NCT00419393|516397357|FG000|Overall Study|Other: Other health problems|1|||
143231254|NCT00419393|516397357|FG000|Overall Study|Other: Investigator decision|1|||
143231255|NCT00979901|516397358|FG000|Overall Study|Adverse Event|1|||
143231256|NCT00979901|516397359|FG001|Overall Study|Adverse Event|3|||
143231257|NCT00979901|516397360|FG002|Overall Study|Adverse Event|9|||
143231258|NCT00979901|516397361|FG003|Overall Study|Adverse Event|2|||
143231259|NCT00979901|516397358|FG000|Overall Study|Lack of Efficacy|8|||
143231260|NCT00979901|516397359|FG001|Overall Study|Lack of Efficacy|4|||
143231261|NCT00979901|516397360|FG002|Overall Study|Lack of Efficacy|9|||
143231262|NCT00979901|516397361|FG003|Overall Study|Lack of Efficacy|0|||
143231263|NCT00979901|516397358|FG000|Overall Study|Lost to Follow-up|1|||
143231264|NCT00979901|516397359|FG001|Overall Study|Lost to Follow-up|1|||
143231265|NCT00979901|516397360|FG002|Overall Study|Lost to Follow-up|2|||
143231266|NCT00979901|516397361|FG003|Overall Study|Lost to Follow-up|0|||
143231267|NCT00979901|516397358|FG000|Overall Study|Protocol Violation|2|||
143231268|NCT00979901|516397359|FG001|Overall Study|Protocol Violation|2|||
143231269|NCT00979901|516397360|FG002|Overall Study|Protocol Violation|7|||
143231270|NCT00979901|516397361|FG003|Overall Study|Protocol Violation|1|||
143231271|NCT00979901|516397358|FG000|Overall Study|Withdrawal by Subject|2|||
143231272|NCT00979901|516397359|FG001|Overall Study|Withdrawal by Subject|1|||
143231273|NCT00979901|516397360|FG002|Overall Study|Withdrawal by Subject|1|||
143013901|NCT01488071|515590082|FG001|Overall Study|Non-compliance with study drug|0|||
143013902|NCT01488071|515590081|FG000|Overall Study|Protocol Violation|5|||
143231274|NCT00979901|516397361|FG003|Overall Study|Withdrawal by Subject|1|||
143231275|NCT00979901|516397358|FG000|Overall Study|Noncompliance|1|||
143231276|NCT00979901|516397359|FG001|Overall Study|Noncompliance|0|||
143231277|NCT00979901|516397360|FG002|Overall Study|Noncompliance|0|||
143231278|NCT00979901|516397361|FG003|Overall Study|Noncompliance|0|||
143231279|NCT00979901|516397358|FG000|Overall Study|out-of-state|1|||
143231280|NCT00979901|516397359|FG001|Overall Study|out-of-state|0|||
143231281|NCT00979901|516397360|FG002|Overall Study|out-of-state|0|||
143231282|NCT00979901|516397361|FG003|Overall Study|out-of-state|0|||
143231283|NCT00979901|516397358|FG000|Overall Study|vacation|1|||
143231284|NCT00979901|516397359|FG001|Overall Study|vacation|0|||
143231285|NCT00979901|516397360|FG002|Overall Study|vacation|0|||
143231286|NCT00979901|516397361|FG003|Overall Study|vacation|0|||
143231287|NCT00979901|516397358|FG000|Overall Study|elevated lab values pre-randomization|1|||
143231288|NCT00979901|516397359|FG001|Overall Study|elevated lab values pre-randomization|0|||
143231289|NCT00979901|516397360|FG002|Overall Study|elevated lab values pre-randomization|0|||
143231290|NCT00979901|516397361|FG003|Overall Study|elevated lab values pre-randomization|0|||
143231291|NCT00979901|516397358|FG000|Overall Study|Discontinued in Error|0|||
143231292|NCT00979901|516397359|FG001|Overall Study|Discontinued in Error|1|||
143231293|NCT00979901|516397360|FG002|Overall Study|Discontinued in Error|0|||
143231294|NCT00979901|516397361|FG003|Overall Study|Discontinued in Error|0|||
143231295|NCT00979901|516397358|FG000|Overall Study|Left Country|0|||
143231296|NCT00979901|516397359|FG001|Overall Study|Left Country|0|||
143231297|NCT00979901|516397360|FG002|Overall Study|Left Country|1|||
143231298|NCT00979901|516397361|FG003|Overall Study|Left Country|0|||
143231299|NCT00979901|516397358|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
143231300|NCT00979901|516397359|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
143231301|NCT00979901|516397360|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
143231302|NCT00979901|516397361|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
143231303|NCT03924622|516397363|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
143231304|NCT03924622|516397364|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
143231305|NCT03924622|516397365|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
143231306|NCT03924622|516397366|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
143231307|NCT03924622|516397367|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
143231308|NCT03924622|516397368|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
143231309|NCT00807911|516397369|FG000|Overall Study|Withdrawal by Subject|12|||
143231310|NCT00807911|516397370|FG001|Overall Study|Withdrawal by Subject|10|||
143231311|NCT00807911|516397369|FG000|Overall Study|Ineligible|0|||
143231312|NCT00807911|516397370|FG001|Overall Study|Ineligible|4|||
143231313|NCT00286468|516397371|FG000|Overall Study|Hyperglycemic Rescue|28|||
143231314|NCT00286468|516397372|FG001|Overall Study|Hyperglycemic Rescue|30|||
143231315|NCT00286468|516397373|FG002|Overall Study|Hyperglycemic Rescue|31|||
143231316|NCT00286468|516397371|FG000|Overall Study|Adverse Event|2|||
143231317|NCT00286468|516397372|FG001|Overall Study|Adverse Event|6|||
143231318|NCT00286468|516397373|FG002|Overall Study|Adverse Event|4|||
143231319|NCT00286468|516397371|FG000|Overall Study|Protocol Violation|0|||
143231320|NCT00286468|516397372|FG001|Overall Study|Protocol Violation|3|||
143231321|NCT00286468|516397373|FG002|Overall Study|Protocol Violation|1|||
143231322|NCT00286468|516397371|FG000|Overall Study|Lost to Follow-up|1|||
143231323|NCT00286468|516397372|FG001|Overall Study|Lost to Follow-up|1|||
143231324|NCT00286468|516397373|FG002|Overall Study|Lost to Follow-up|2|||
143231325|NCT00286468|516397371|FG000|Overall Study|Withdrawal by Subject|3|||
143231326|NCT00286468|516397372|FG001|Overall Study|Withdrawal by Subject|8|||
143231327|NCT00286468|516397373|FG002|Overall Study|Withdrawal by Subject|11|||
143231328|NCT00286468|516397371|FG000|Overall Study|Physician Decision|3|||
143231329|NCT00286468|516397372|FG001|Overall Study|Physician Decision|2|||
143231330|NCT00286468|516397373|FG002|Overall Study|Physician Decision|1|||
143231331|NCT04742556|516397374|FG000|Overall Study|Withdrawal by Subject|0|||
143231332|NCT04742556|516397375|FG001|Overall Study|Withdrawal by Subject|1|||
143231333|NCT04742556|516397376|FG002|Overall Study|Withdrawal by Subject|0|||
143231334|NCT04742556|516397374|FG000|Overall Study|Adverse Event|0|||
143231335|NCT04742556|516397375|FG001|Overall Study|Adverse Event|0|||
143231336|NCT04742556|516397376|FG002|Overall Study|Adverse Event|2|||
143231337|NCT04742556|516397374|FG000|Overall Study|Clinical disease progression|0|||
143231338|NCT04742556|516397375|FG001|Overall Study|Clinical disease progression|1|||
143231339|NCT04742556|516397376|FG002|Overall Study|Clinical disease progression|2|||
143231340|NCT04742556|516397374|FG000|Overall Study|Objective disease progression|3|||
143231341|NCT04742556|516397375|FG001|Overall Study|Objective disease progression|2|||
143231342|NCT04742556|516397376|FG002|Overall Study|Objective disease progression|4|||
143231343|NCT02923726|516397377|FG000|Overall Study|Death|196|||
143231344|NCT02923726|516397378|FG001|Overall Study|Death|175|||
143231345|NCT02923726|516397377|FG000|Overall Study|Withdrawal by Subject|337|||
143231346|NCT02923726|516397378|FG001|Overall Study|Withdrawal by Subject|307|||
143358226|NCT03468426|516856108|FG010|Overall Study|missing reason|0|||
143013903|NCT01488071|515590082|FG001|Overall Study|Protocol Violation|7|||
143231347|NCT02914639|516397379|FG000|Overall Study|Withdrawal by Subject|0|||
143231348|NCT02914639|516397380|FG001|Overall Study|Withdrawal by Subject|2|||
143231349|NCT01553084|516397400|FG000|Overall Study|Withdrawal by Subject|15|||
143231350|NCT01553084|516397401|FG001|Overall Study|Withdrawal by Subject|13|||
143231351|NCT01553084|516397402|FG002|Overall Study|Withdrawal by Subject|35|||
143231352|NCT03988400|516397403|FG000|Overall Study|Adverse Event|1|||
143231353|NCT03988400|516397404|FG001|Overall Study|Adverse Event|0|||
143231354|NCT03988400|516397403|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
143231355|NCT03988400|516397404|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
143231356|NCT03988400|516397403|FG000|Overall Study|Lost to Follow-up|0|||
143231357|NCT03988400|516397404|FG001|Overall Study|Lost to Follow-up|1|||
143231358|NCT02542865|516397406|FG000|Overall Study|Identified as screen failure|1|||
143231359|NCT02542865|516397407|FG001|Overall Study|Identified as screen failure|0|||
143231360|NCT02542865|516397406|FG000|Overall Study|Withdrawal by Subject|16|||
143231361|NCT02542865|516397407|FG001|Overall Study|Withdrawal by Subject|0|||
143231362|NCT04913610|516397408|FG000|Randomized Participants|Did Not Receive Treatment|0|||
143231363|NCT04913610|516397409|FG001|Randomized Participants|Did Not Receive Treatment|0|||
143231364|NCT04913610|516397410|FG002|Randomized Participants|Did Not Receive Treatment|1|||
143231365|NCT04913610|516397411|FG003|Randomized Participants|Did Not Receive Treatment|1|||
143231366|NCT04913610|516397412|FG004|Randomized Participants|Did Not Receive Treatment|0|||
143231367|NCT04913610|516397408|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
143231368|NCT04913610|516397409|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
143231369|NCT04913610|516397410|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
143231370|NCT04913610|516397411|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
143231371|NCT04913610|516397412|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
143231372|NCT00953667|516397413|FG000|Overall Study|Lost to Follow-up|11|||
143231373|NCT00953667|516397413|FG000|Overall Study|Physician Decision|35|||
143231374|NCT00953667|516397413|FG000|Overall Study|Withdrawal by Subject|63|||
143231375|NCT00953667|516397413|FG000|Overall Study|Adverse Event|10|||
143231376|NCT00953667|516397413|FG000|Overall Study|poor venous access,unable to draw blood|4|||
143231377|NCT05468814|516397414|FG000|Overall Study|Lost to Follow-up|5|||
143231378|NCT05468814|516397415|FG001|Overall Study|Lost to Follow-up|6|||
143231379|NCT01069484|516397420|FG000|Overall Study|Death-in-near-family|1|||
143231380|NCT01069484|516397421|FG001|Overall Study|Death-in-near-family|0|||
143231381|NCT01069484|516397420|FG000|Overall Study|No specific reason|8|||
143231382|NCT01069484|516397421|FG001|Overall Study|No specific reason|2|||
143231383|NCT01069484|516397420|FG000|Overall Study|Illness mother or child|3|||
143231384|NCT01069484|516397421|FG001|Overall Study|Illness mother or child|1|||
143231385|NCT05435339|516397422|FG000|Overall Study|Death|1|||
143231386|NCT05435339|516397423|FG001|Overall Study|Death|0|||
143231387|NCT05435339|516397424|FG002|Overall Study|Death|3|||
143231388|NCT05435339|516397425|FG003|Overall Study|Death|1|||
143231389|NCT05435339|516397426|FG004|Overall Study|Death|3|||
143231390|NCT05435339|516397427|FG005|Overall Study|Death|2|||
143231391|NCT05435339|516397428|FG006|Overall Study|Death|4|||
143231392|NCT05435339|516397429|FG007|Overall Study|Death|6|||
143231393|NCT05435339|516397422|FG000|Overall Study|Sponsor Decision|0|||
143231394|NCT05435339|516397423|FG001|Overall Study|Sponsor Decision|1|||
143231395|NCT05435339|516397424|FG002|Overall Study|Sponsor Decision|0|||
143231396|NCT05435339|516397425|FG003|Overall Study|Sponsor Decision|0|||
143231397|NCT05435339|516397426|FG004|Overall Study|Sponsor Decision|2|||
143231398|NCT05435339|516397427|FG005|Overall Study|Sponsor Decision|1|||
143231399|NCT05435339|516397428|FG006|Overall Study|Sponsor Decision|2|||
143231400|NCT05435339|516397429|FG007|Overall Study|Sponsor Decision|2|||
143231401|NCT05435339|516397422|FG000|Overall Study|Withdrawal by Subject|0|||
143465864|NCT04223856|517251157|FG001|Overall Study|Physician Decision|28|||
143465865|NCT04223856|517251156|FG000|Overall Study|Withdrawal by Subject|22|||
143465866|NCT04223856|517251157|FG001|Overall Study|Withdrawal by Subject|24|||
143465867|NCT04223856|517251156|FG000|Overall Study|Other|7|||
143231402|NCT05435339|516397423|FG001|Overall Study|Withdrawal by Subject|0|||
143231403|NCT05435339|516397424|FG002|Overall Study|Withdrawal by Subject|0|||
143231404|NCT05435339|516397425|FG003|Overall Study|Withdrawal by Subject|0|||
143231405|NCT05435339|516397426|FG004|Overall Study|Withdrawal by Subject|1|||
143231406|NCT05435339|516397427|FG005|Overall Study|Withdrawal by Subject|0|||
143231407|NCT05435339|516397428|FG006|Overall Study|Withdrawal by Subject|1|||
143231408|NCT05435339|516397429|FG007|Overall Study|Withdrawal by Subject|1|||
143231409|NCT00849940|516397433|FG000|Overall Study|Physician Decision|4|||
143231410|NCT00321789|516397434|FG000|Overall Study|Lost to Follow-up|4|||
143231411|NCT00321789|516397435|FG001|Overall Study|Lost to Follow-up|7|||
143231412|NCT00321789|516397434|FG000|Overall Study|Withdrawal by Subject|6|||
143231413|NCT00321789|516397435|FG001|Overall Study|Withdrawal by Subject|6|||
143231414|NCT00321789|516397434|FG000|Overall Study|Protocol Violation|5|||
143231415|NCT00321789|516397435|FG001|Overall Study|Protocol Violation|3|||
143231416|NCT00301808|516397437|FG000|Overall Study|Adverse Event|5|||
143231417|NCT00301808|516397437|FG000|Overall Study|Death|3|||
143231418|NCT00301808|516397437|FG000|Overall Study|Lack of Efficacy|4|||
143231419|NCT01607957|516397438|FG000|Overall Study|Not treated|1|||
143231420|NCT01607957|516397439|FG001|Overall Study|Not treated|1|||
143231421|NCT01607957|516397438|FG000|Overall Study|Death|367|||
143231422|NCT01607957|516397439|FG001|Overall Study|Death|211|||
143231423|NCT01607957|516397438|FG000|Overall Study|Lost to Follow-up|3|||
143231424|NCT01607957|516397439|FG001|Overall Study|Lost to Follow-up|3|||
143231425|NCT01607957|516397438|FG000|Overall Study|Participant refusal|1|||
143231426|NCT01607957|516397439|FG001|Overall Study|Participant refusal|0|||
143231427|NCT04972786|516397442|FG000|First Intervention (1 Day)|Adverse Event|1|||
143231428|NCT04972786|516397443|FG001|First Intervention (1 Day)|Adverse Event|0|||
143231429|NCT02016781|516397444|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
143231430|NCT02016781|516397445|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
143231431|NCT02016781|516397444|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
143231432|NCT02016781|516397445|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
143231433|NCT02016781|516397444|FG000|Final Database Lock|Withdrawal by Subject|2|||
143231434|NCT02016781|516397445|FG001|Final Database Lock|Withdrawal by Subject|1|||
143231435|NCT02016781|516397444|FG000|Final Database Lock|Lost to Follow-up|11|||
143231436|NCT02016781|516397445|FG001|Final Database Lock|Lost to Follow-up|4|||
143231437|NCT02016781|516397444|FG000|Final Database Lock|Missing data|0|||
143231438|NCT02016781|516397445|FG001|Final Database Lock|Missing data|3|||
143231439|NCT03724942|516397449|FG000|Overall Study|Adverse Event|20|||
143231440|NCT03724942|516397450|FG001|Overall Study|Adverse Event|14|||
143231441|NCT03724942|516397449|FG000|Overall Study|Lack of Efficacy|0|||
143231442|NCT03724942|516397450|FG001|Overall Study|Lack of Efficacy|1|||
143231443|NCT03724942|516397449|FG000|Overall Study|Physician Decision|5|||
143231444|NCT03724942|516397450|FG001|Overall Study|Physician Decision|2|||
143231445|NCT03724942|516397449|FG000|Overall Study|Protocol Violation|1|||
143465868|NCT04223856|517251157|FG001|Overall Study|Other|2|||
143465869|NCT04223856|517251156|FG000|Overall Study|Randomized but not treated|2|||
143465870|NCT04223856|517251157|FG001|Overall Study|Randomized but not treated|11|||
143465871|NCT04223856|517251156|FG000|Overall Study|On-treatment|144|||
143465872|NCT04223856|517251157|FG001|Overall Study|On-treatment|0|||
143465873|NCT03442114|517251158|FG000|Overall Study|Lost to Follow-up|13|||
143465874|NCT03442114|517251159|FG001|Overall Study|Lost to Follow-up|13|||
143465875|NCT03442114|517251158|FG000|Overall Study|Physician Decision|2|||
143465876|NCT03442114|517251159|FG001|Overall Study|Physician Decision|2|||
143465877|NCT03442114|517251158|FG000|Overall Study|Protocol Violation|0|||
143231446|NCT03724942|516397450|FG001|Overall Study|Protocol Violation|0|||
143231447|NCT03724942|516397449|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
143231448|NCT03724942|516397450|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
143231449|NCT03724942|516397449|FG000|Overall Study|Withdrawal by Legal Representative|3|||
143231450|NCT03724942|516397450|FG001|Overall Study|Withdrawal by Legal Representative|0|||
143231451|NCT02429830|516397451|FG000|Overall Study|Lost to Follow-up|1|||
143231452|NCT02429830|516397451|FG000|Overall Study|Device Explant|2|||
143231453|NCT02399215|516399672|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
143231454|NCT02399215|516399672|FG000|Overall Study|Withdrawal by Subject|1|||
143231455|NCT00772538|516399673|FG000|Overall Study|Adverse Event|6|||
143231456|NCT00772538|516399674|FG001|Overall Study|Adverse Event|6|||
143231457|NCT00772538|516399673|FG000|Overall Study|Protocol Violation|3|||
143231458|NCT00772538|516399674|FG001|Overall Study|Protocol Violation|3|||
143231459|NCT00772538|516399673|FG000|Overall Study|Lost to Follow-up|1|||
143231460|NCT00772538|516399674|FG001|Overall Study|Lost to Follow-up|1|||
143231461|NCT00772538|516399673|FG000|Overall Study|Withdrawal by Subject|3|||
143231462|NCT00772538|516399674|FG001|Overall Study|Withdrawal by Subject|8|||
143231463|NCT00772538|516399673|FG000|Overall Study|Lack of Efficacy|0|||
143231464|NCT00772538|516399674|FG001|Overall Study|Lack of Efficacy|1|||
143231465|NCT00772538|516399673|FG000|Overall Study|Other|7|||
143231466|NCT00772538|516399674|FG001|Overall Study|Other|7|||
143231467|NCT03617172|516399677|FG000|Overall Study|Lost to Follow-up|1|||
143231468|NCT03617172|516399678|FG001|Overall Study|Lost to Follow-up|0|||
143231469|NCT00713609|516399679|FG000|Overall Study|Adverse Event|2|||
143231470|NCT00713609|516399680|FG001|Overall Study|Adverse Event|0|||
143231471|NCT00713609|516399681|FG002|Overall Study|Adverse Event|2|||
143231472|NCT00713609|516399682|FG003|Overall Study|Adverse Event|2|||
143231473|NCT00713609|516399683|FG004|Overall Study|Adverse Event|3|||
143231474|NCT00713609|516399684|FG005|Overall Study|Adverse Event|1|||
143231475|NCT00713609|516399679|FG000|Overall Study|Lost to Follow-up|5|||
143231476|NCT00713609|516399680|FG001|Overall Study|Lost to Follow-up|7|||
143231477|NCT00713609|516399681|FG002|Overall Study|Lost to Follow-up|5|||
143231478|NCT00713609|516399682|FG003|Overall Study|Lost to Follow-up|5|||
143231479|NCT00713609|516399683|FG004|Overall Study|Lost to Follow-up|7|||
143013904|NCT01488071|515590081|FG000|Overall Study|Withdrawal of Consent|14|||
143231480|NCT00713609|516399684|FG005|Overall Study|Lost to Follow-up|0|||
143231481|NCT00713609|516399679|FG000|Overall Study|Lack of Efficacy|1|||
143231482|NCT00713609|516399680|FG001|Overall Study|Lack of Efficacy|3|||
143231483|NCT00713609|516399681|FG002|Overall Study|Lack of Efficacy|0|||
143231484|NCT00713609|516399682|FG003|Overall Study|Lack of Efficacy|0|||
143231485|NCT00713609|516399683|FG004|Overall Study|Lack of Efficacy|1|||
143465878|NCT03442114|517251159|FG001|Overall Study|Protocol Violation|2|||
143231486|NCT00713609|516399684|FG005|Overall Study|Lack of Efficacy|0|||
143231487|NCT00713609|516399679|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
143231488|NCT00713609|516399680|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
143231489|NCT00713609|516399681|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
143231490|NCT00713609|516399682|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
143231491|NCT00713609|516399683|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
143231492|NCT00713609|516399684|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
143231493|NCT00713609|516399679|FG000|Overall Study|Withdrawal by Subject|6|||
143231494|NCT00713609|516399680|FG001|Overall Study|Withdrawal by Subject|1|||
143231495|NCT00713609|516399681|FG002|Overall Study|Withdrawal by Subject|5|||
143231496|NCT00713609|516399682|FG003|Overall Study|Withdrawal by Subject|1|||
143231497|NCT00713609|516399683|FG004|Overall Study|Withdrawal by Subject|5|||
143231498|NCT00713609|516399684|FG005|Overall Study|Withdrawal by Subject|7|||
143231499|NCT00713609|516399679|FG000|Overall Study|Protocol Violation|6|||
143231500|NCT00713609|516399680|FG001|Overall Study|Protocol Violation|3|||
143231501|NCT00713609|516399681|FG002|Overall Study|Protocol Violation|1|||
143231502|NCT00713609|516399682|FG003|Overall Study|Protocol Violation|1|||
143231503|NCT00713609|516399683|FG004|Overall Study|Protocol Violation|2|||
143231504|NCT00713609|516399684|FG005|Overall Study|Protocol Violation|0|||
143231505|NCT03305666|516399685|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
143231506|NCT03305666|516399686|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
143231507|NCT02546609|516399690|FG000|Overall Study|Withdrawal by Subject|0|||
143231508|NCT02546609|516399691|FG001|Overall Study|Withdrawal by Subject|1|||
143231509|NCT02546609|516399692|FG002|Overall Study|Withdrawal by Subject|2|||
143231510|NCT02546609|516399690|FG000|Overall Study|Adverse Event|0|||
143231511|NCT02546609|516399691|FG001|Overall Study|Adverse Event|6|||
143231512|NCT02546609|516399692|FG002|Overall Study|Adverse Event|1|||
143231513|NCT02546609|516399690|FG000|Overall Study|Protocol Violation|0|||
143231514|NCT02546609|516399691|FG001|Overall Study|Protocol Violation|1|||
143231515|NCT02546609|516399692|FG002|Overall Study|Protocol Violation|1|||
143231516|NCT02546609|516399690|FG000|Overall Study|Lost to Follow-up|2|||
143231517|NCT02546609|516399691|FG001|Overall Study|Lost to Follow-up|3|||
143465879|NCT03442114|517251158|FG000|Overall Study|Withdrawal by Subject|1|||
143465880|NCT03442114|517251159|FG001|Overall Study|Withdrawal by Subject|3|||
143465881|NCT03442114|517251158|FG000|Overall Study|Guardianship Change|0|||
143465882|NCT03442114|517251159|FG001|Overall Study|Guardianship Change|1|||
143231518|NCT02546609|516399692|FG002|Overall Study|Lost to Follow-up|1|||
143231519|NCT02546609|516399690|FG000|Overall Study|travel or work schedule restriction|0|||
143231520|NCT02546609|516399691|FG001|Overall Study|travel or work schedule restriction|0|||
143231521|NCT02546609|516399692|FG002|Overall Study|travel or work schedule restriction|2|||
143231522|NCT03780452|516399697|FG000|Overall Study|Screening failure|2|||
143231523|NCT00914849|516399700|FG000|Overall Study|Withdrawal by Subject|1|||
143465883|NCT02903368|517251160|FG000|Part 1|Adverse Event|3|||
143465884|NCT02903368|517251161|FG001|Part 1|Adverse Event|0|||
143465885|NCT02903368|517251162|FG002|Part 1|Adverse Event|0|||
143465886|NCT02903368|517251163|FG003|Part 1|Adverse Event|0|||
143465887|NCT02903368|517251160|FG000|Part 1|Withdrawal by Subject|1|||
143465888|NCT02903368|517251161|FG001|Part 1|Withdrawal by Subject|0|||
143465889|NCT02903368|517251162|FG002|Part 1|Withdrawal by Subject|0|||
143465890|NCT02903368|517251163|FG003|Part 1|Withdrawal by Subject|0|||
143465891|NCT02903368|517251160|FG000|Part 2|Adverse Event|0|||
143465892|NCT02903368|517251161|FG001|Part 2|Adverse Event|0|||
143465893|NCT02903368|517251162|FG002|Part 2|Adverse Event|5|||
143465894|NCT02903368|517251163|FG003|Part 2|Adverse Event|0|||
143465895|NCT02903368|517251160|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
143465896|NCT02903368|517251161|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
143465897|NCT02903368|517251162|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
143465898|NCT02903368|517251163|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
143465899|NCT02903368|517251160|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
143465900|NCT02903368|517251161|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
143231524|NCT00914849|516399701|FG001|Overall Study|Withdrawal by Subject|0|||
143231525|NCT00914849|516399700|FG000|Overall Study|Not eligible|0|||
143231526|NCT00914849|516399701|FG001|Overall Study|Not eligible|1|||
143231527|NCT01001221|516399702|FG000|Overall Study|Adverse Event|1|||
143231528|NCT01001221|516399703|FG001|Overall Study|Adverse Event|2|||
143231529|NCT01001221|516399704|FG002|Overall Study|Adverse Event|0|||
143231530|NCT01001221|516399705|FG003|Overall Study|Adverse Event|2|||
143231531|NCT01001221|516399706|FG004|Overall Study|Adverse Event|0|||
143465901|NCT02903368|517251162|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
143465902|NCT02903368|517251163|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
143465903|NCT02903368|517251160|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
143231532|NCT01001221|516399702|FG000|Overall Study|Disease progression|3|||
143231533|NCT01001221|516399703|FG001|Overall Study|Disease progression|2|||
143231534|NCT01001221|516399704|FG002|Overall Study|Disease progression|2|||
143231535|NCT01001221|516399705|FG003|Overall Study|Disease progression|4|||
143231536|NCT01001221|516399706|FG004|Overall Study|Disease progression|0|||
143231537|NCT01001221|516399702|FG000|Overall Study|Other|1|||
143231538|NCT01001221|516399703|FG001|Overall Study|Other|1|||
143231539|NCT01001221|516399704|FG002|Overall Study|Other|0|||
143231540|NCT01001221|516399705|FG003|Overall Study|Other|0|||
143231541|NCT01001221|516399706|FG004|Overall Study|Other|0|||
143231542|NCT01001221|516399702|FG000|Overall Study|Not treated; protocol exclusion|0|||
143231543|NCT01001221|516399703|FG001|Overall Study|Not treated; protocol exclusion|0|||
143231544|NCT01001221|516399704|FG002|Overall Study|Not treated; protocol exclusion|1|||
143231545|NCT01001221|516399705|FG003|Overall Study|Not treated; protocol exclusion|0|||
143231546|NCT01001221|516399706|FG004|Overall Study|Not treated; protocol exclusion|0|||
143231547|NCT02388269|516399707|FG000|Overall Study|Adverse Event|2|||
143231548|NCT02388269|516399708|FG001|Overall Study|Adverse Event|0|||
143231549|NCT02388269|516399709|FG002|Overall Study|Adverse Event|0|||
143231550|NCT02388269|516399707|FG000|Overall Study|Withdrawal by Subject|1|||
143231551|NCT02388269|516399708|FG001|Overall Study|Withdrawal by Subject|2|||
143231552|NCT02388269|516399709|FG002|Overall Study|Withdrawal by Subject|0|||
143231553|NCT02388269|516399707|FG000|Overall Study|less than 50% stimulations|1|||
143231554|NCT02388269|516399708|FG001|Overall Study|less than 50% stimulations|0|||
143231555|NCT02388269|516399709|FG002|Overall Study|less than 50% stimulations|0|||
143231556|NCT02388269|516399707|FG000|Overall Study|no diary data|3|||
143231557|NCT02388269|516399708|FG001|Overall Study|no diary data|0|||
143231558|NCT02388269|516399709|FG002|Overall Study|no diary data|0|||
143231559|NCT02388269|516399707|FG000|Overall Study|Protocol Violation|2|||
143231560|NCT02388269|516399708|FG001|Overall Study|Protocol Violation|0|||
143231561|NCT02388269|516399709|FG002|Overall Study|Protocol Violation|0|||
143231562|NCT02388269|516399707|FG000|Overall Study|Screen Failure|0|||
143231563|NCT02388269|516399708|FG001|Overall Study|Screen Failure|0|||
143231564|NCT02388269|516399709|FG002|Overall Study|Screen Failure|10|||
143231565|NCT03448406|516399710|FG000|Overall Study|Noncompliance of scheduled visits|1|||
143231566|NCT03448406|516399711|FG001|Overall Study|Noncompliance of scheduled visits|2|||
143231567|NCT03448406|516399710|FG000|Overall Study|Withdrawal by Subject|1|||
143231568|NCT03448406|516399711|FG001|Overall Study|Withdrawal by Subject|2|||
143231569|NCT03448406|516399710|FG000|Overall Study|Protocol Violation|1|||
143231570|NCT03448406|516399711|FG001|Overall Study|Protocol Violation|0|||
143231571|NCT03448406|516399710|FG000|Overall Study|Adverse Event|8|||
143231572|NCT03448406|516399711|FG001|Overall Study|Adverse Event|9|||
143231573|NCT01292486|516399712|FG000|Overall Study|Protocol Violation|2|||
143231574|NCT01292486|516399712|FG000|Overall Study|Did not meet screening criteria|2|||
143231575|NCT01292486|516399712|FG000|Overall Study|Adverse Event|1|||
143231576|NCT01292486|516399712|FG000|Overall Study|Physician Decision|1|||
143231577|NCT04602390|516399713|FG000|Overall Study|Withdrawal by Subject|0|||
143465904|NCT02903368|517251161|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
143465905|NCT02903368|517251162|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
143465906|NCT02903368|517251163|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
143465907|NCT06515483|517251164|FG000|Overall Study|Subject withdraw due to family issues|1|||
143465908|NCT06515483|517251165|FG001|Overall Study|Subject withdraw due to family issues|0|||
143465909|NCT00147823|517251166|FG000|Overall Study|Lost to Follow-up|6|||
143231578|NCT04602390|516399714|FG001|Overall Study|Withdrawal by Subject|0|||
143231579|NCT04602390|516399715|FG002|Overall Study|Withdrawal by Subject|0|||
143231580|NCT04602390|516399716|FG003|Overall Study|Withdrawal by Subject|0|||
143231581|NCT04602390|516399717|FG004|Overall Study|Withdrawal by Subject|1|||
143231582|NCT04602390|516399718|FG005|Overall Study|Withdrawal by Subject|0|||
143231583|NCT04602390|516399713|FG000|Overall Study|Adverse Event|0|||
143231584|NCT04602390|516399714|FG001|Overall Study|Adverse Event|0|||
143231585|NCT04602390|516399715|FG002|Overall Study|Adverse Event|0|||
143231586|NCT04602390|516399716|FG003|Overall Study|Adverse Event|0|||
143231587|NCT04602390|516399717|FG004|Overall Study|Adverse Event|0|||
143231588|NCT04602390|516399718|FG005|Overall Study|Adverse Event|1|||
143013905|NCT01488071|515590082|FG001|Overall Study|Withdrawal of Consent|12|||
143231589|NCT03882021|516399719|FG000|Enrollment|Procedure aborted/cancelled|2|||
143231590|NCT03882021|516399719|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
143231591|NCT03882021|516399719|FG000|Enrollment to 3-Month|Death|1|||
143231592|NCT03882021|516399719|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
143231593|NCT03882021|516399719|FG000|Enrollment to 3-Month|Missed Visit|4|||
143231594|NCT03882021|516399719|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
143013906|NCT01488071|515590081|FG000|Overall Study|Lost to Follow-up|1|||
143231595|NCT03882021|516399719|FG000|6-Month to 12-Month Visit|Death|1|||
143231596|NCT03882021|516399719|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
143231597|NCT01546857|516399720|FG000|Overall Study|Withdrawal by Subject|2|||
143231598|NCT01546857|516399721|FG001|Overall Study|Withdrawal by Subject|3|||
143231599|NCT01176032|516399722|FG000|Overall Study|Adverse Event|1|||
143231600|NCT01176032|516399723|FG001|Overall Study|Adverse Event|0|||
143231601|NCT01176032|516399722|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
143231602|NCT01176032|516399723|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
143231603|NCT01176032|516399722|FG000|Overall Study|Protocol Violation|1|||
143231604|NCT01176032|516399723|FG001|Overall Study|Protocol Violation|0|||
143231605|NCT01176032|516399722|FG000|Overall Study|Informed consent withdrawn|3|||
143231606|NCT01176032|516399723|FG001|Overall Study|Informed consent withdrawn|0|||
143465910|NCT00147823|517251167|FG001|Overall Study|Lost to Follow-up|12|||
143465911|NCT00147823|517251166|FG000|Overall Study|Physician Decision|1|||
143465912|NCT00147823|517251167|FG001|Overall Study|Physician Decision|0|||
143465913|NCT00147823|517251166|FG000|Overall Study|Withdrawal by Subject|0|||
143465914|NCT00147823|517251167|FG001|Overall Study|Withdrawal by Subject|1|||
143465915|NCT00147823|517251166|FG000|Overall Study|Did not receive vitoss due to infection|6|||
143465916|NCT00147823|517251167|FG001|Overall Study|Did not receive vitoss due to infection|2|||
143465917|NCT02544217|517253667|FG000|Overall Study|Withdrawal by Subject|1|||
143465918|NCT02544217|517253668|FG001|Overall Study|Withdrawal by Subject|1|||
143465919|NCT02544217|517253669|FG002|Overall Study|Withdrawal by Subject|0|||
143231607|NCT01176032|516399722|FG000|Overall Study|Other|1|||
143231608|NCT01176032|516399723|FG001|Overall Study|Other|0|||
143231609|NCT01469221|516399724|FG000|Double Blind Phase|Protocol Violation|1|||
143231610|NCT01469221|516399725|FG001|Double Blind Phase|Protocol Violation|0|||
143231611|NCT01469221|516399726|FG002|Double Blind Phase|Protocol Violation|0|||
143231612|NCT01469221|516399724|FG000|Double Blind Phase|Physician Decision|1|||
143231613|NCT01469221|516399725|FG001|Double Blind Phase|Physician Decision|1|||
143231614|NCT01469221|516399726|FG002|Double Blind Phase|Physician Decision|0|||
143231615|NCT01469221|516399724|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
143231616|NCT01469221|516399725|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
143231617|NCT01469221|516399726|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
143231618|NCT01791244|516399737|FG000|Overall Study|Adverse Event|5|||
143231619|NCT01791244|516399738|FG001|Overall Study|Adverse Event|7|||
143231620|NCT01791244|516399737|FG000|Overall Study|Insufficient clinical response|10|||
143231621|NCT01791244|516399738|FG001|Overall Study|Insufficient clinical response|10|||
143231622|NCT01791244|516399737|FG000|Overall Study|Laboratory Abnormality|0|||
143231623|NCT01791244|516399738|FG001|Overall Study|Laboratory Abnormality|1|||
143231624|NCT04914364|516399743|FG000|Overall Study|No longer eligible for study|1|||
143231625|NCT04914364|516399743|FG000|Overall Study|Lost to Follow-up|2|||
143231626|NCT02358473|516399744|FG000|Overall Study|Disease Progession|6|||
143231627|NCT02358473|516399744|FG000|Overall Study|Adverse Event|3|||
143231628|NCT02358473|516399744|FG000|Overall Study|Withdrawal by Subject|2|||
143465920|NCT02544217|517253670|FG003|Overall Study|Withdrawal by Subject|0|||
143465921|NCT02544217|517253671|FG004|Overall Study|Withdrawal by Subject|0|||
143465922|NCT02544217|517253672|FG005|Overall Study|Withdrawal by Subject|0|||
143465923|NCT00937833|517253673|FG000|Overall Study|Protocol Violation|1|||
143465924|NCT00937833|517253674|FG001|Overall Study|Protocol Violation|2|||
143465925|NCT00937833|517253673|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
143465926|NCT00937833|517253674|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
143465927|NCT00937833|517253673|FG000|Overall Study|Lost to Follow-up|10|||
143465928|NCT00937833|517253674|FG001|Overall Study|Lost to Follow-up|8|||
143465929|NCT00937833|517253673|FG000|Overall Study|Withdrawal by Subject|4|||
143465930|NCT00937833|517253674|FG001|Overall Study|Withdrawal by Subject|6|||
143465931|NCT01607554|517253678|FG000|Overall Study|Disease progression|2|||
143465932|NCT00818389|517253679|FG000|Overall Study|Death|1|||
143465933|NCT00818389|517253680|FG001|Overall Study|Death|3|||
143465934|NCT00818389|517253679|FG000|Overall Study|ALS Disease Progression|1|||
143465935|NCT00818389|517253680|FG001|Overall Study|ALS Disease Progression|0|||
143231629|NCT02358473|516399744|FG000|Overall Study|Physician Decision|2|||
143231630|NCT01263769|516399747|FG000|Overall Study|Non-Compliant with treatment|1|||
143231631|NCT01346358|516399760|FG000|Overall Study|Withdrawal by Subject|1|||
143231632|NCT01346358|516399761|FG001|Overall Study|Withdrawal by Subject|0|||
143231633|NCT01346358|516399762|FG002|Overall Study|Withdrawal by Subject|1|||
143231634|NCT01346358|516399763|FG003|Overall Study|Withdrawal by Subject|1|||
143231635|NCT01346358|516399764|FG004|Overall Study|Withdrawal by Subject|0|||
143231636|NCT01346358|516399765|FG005|Overall Study|Withdrawal by Subject|2|||
143231637|NCT01346358|516399766|FG006|Overall Study|Withdrawal by Subject|1|||
143231638|NCT01346358|516399767|FG007|Overall Study|Withdrawal by Subject|1|||
143013907|NCT01488071|515590082|FG001|Overall Study|Lost to Follow-up|0|||
143013908|NCT01488071|515590081|FG000|Overall Study|Administrative or Other Reason(s)|5|||
143231639|NCT01346358|516399768|FG008|Overall Study|Withdrawal by Subject|1|||
143231640|NCT01346358|516399760|FG000|Overall Study|Adverse Event|1|||
143231641|NCT01346358|516399761|FG001|Overall Study|Adverse Event|0|||
143231642|NCT01346358|516399762|FG002|Overall Study|Adverse Event|0|||
143231643|NCT01346358|516399763|FG003|Overall Study|Adverse Event|0|||
143231644|NCT01346358|516399764|FG004|Overall Study|Adverse Event|1|||
143231645|NCT01346358|516399765|FG005|Overall Study|Adverse Event|0|||
143013909|NCT01488071|515590082|FG001|Overall Study|Administrative or Other Reason(s)|4|||
143013910|NCT02139306|515590083|FG000|Overall Study|Withdrawal by Subject|4|||
143231646|NCT01346358|516399766|FG006|Overall Study|Adverse Event|0|||
143465936|NCT00818389|517253679|FG000|Overall Study|Withdrawal by Subject|2|||
143465937|NCT00818389|517253680|FG001|Overall Study|Withdrawal by Subject|2|||
143465938|NCT00818389|517253679|FG000|Overall Study|Adverse Event|0|||
143231647|NCT01346358|516399767|FG007|Overall Study|Adverse Event|0|||
143231648|NCT01346358|516399768|FG008|Overall Study|Adverse Event|1|||
143231649|NCT01346358|516399760|FG000|Overall Study|Non-Compliance|0|||
143231650|NCT01346358|516399761|FG001|Overall Study|Non-Compliance|0|||
143231651|NCT01346358|516399762|FG002|Overall Study|Non-Compliance|0|||
143465939|NCT00818389|517253680|FG001|Overall Study|Adverse Event|1|||
143465940|NCT01137955|517253681|FG000|Overall Study|Withdrawal by Subject|5|||
143465941|NCT01137955|517253682|FG001|Overall Study|Withdrawal by Subject|4|||
143465942|NCT04442737|517253685|FG000|Overall Study|Lost to Follow-up|1|||
143465943|NCT04442737|517253686|FG001|Overall Study|Lost to Follow-up|3|||
143465944|NCT04442737|517253685|FG000|Overall Study|Withdrawal by Subject|3|||
143465945|NCT04442737|517253686|FG001|Overall Study|Withdrawal by Subject|2|||
143465946|NCT04442737|517253685|FG000|Overall Study|Adverse Event|3|||
143465947|NCT04442737|517253686|FG001|Overall Study|Adverse Event|2|||
143465948|NCT04442737|517253685|FG000|Overall Study|Death|0|||
143465949|NCT04442737|517253686|FG001|Overall Study|Death|1|||
143465950|NCT04442737|517253685|FG000|Overall Study|Protocol Violation|0|||
143465951|NCT04442737|517253686|FG001|Overall Study|Protocol Violation|2|||
143465952|NCT04442737|517253685|FG000|Overall Study|Other|1|||
143465953|NCT04442737|517253686|FG001|Overall Study|Other|1|||
143465954|NCT03588728|517253688|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
143465955|NCT03588728|517253689|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
143465956|NCT03588728|517253690|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
143465957|NCT03588728|517253691|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
143465958|NCT03588728|517253688|FG000|Overall Study|Lab shut down due to COVID-19|0|||
143465959|NCT03588728|517253689|FG001|Overall Study|Lab shut down due to COVID-19|0|||
143465960|NCT03588728|517253690|FG002|Overall Study|Lab shut down due to COVID-19|0|||
143465961|NCT03588728|517253691|FG003|Overall Study|Lab shut down due to COVID-19|1|||
143465962|NCT03588728|517253688|FG000|Overall Study|multiple technical issues|1|||
143465963|NCT03588728|517253689|FG001|Overall Study|multiple technical issues|0|||
143465964|NCT03588728|517253690|FG002|Overall Study|multiple technical issues|0|||
143465965|NCT03588728|517253691|FG003|Overall Study|multiple technical issues|0|||
143465966|NCT03588728|517253688|FG000|Overall Study|Hospitalized for COVID|1|||
143465967|NCT03588728|517253689|FG001|Overall Study|Hospitalized for COVID|0|||
143465968|NCT03588728|517253690|FG002|Overall Study|Hospitalized for COVID|0|||
143465969|NCT03588728|517253691|FG003|Overall Study|Hospitalized for COVID|0|||
143465970|NCT03588728|517253688|FG000|Overall Study|Schedule change unable to attend sessions|1|||
143465971|NCT03588728|517253689|FG001|Overall Study|Schedule change unable to attend sessions|0|||
143465972|NCT03588728|517253690|FG002|Overall Study|Schedule change unable to attend sessions|0|||
143465973|NCT03588728|517253691|FG003|Overall Study|Schedule change unable to attend sessions|0|||
143465974|NCT02027701|517253692|FG000|Overall Study|Adverse Event|3|||
143465975|NCT02027701|517253692|FG000|Overall Study|Lack of Efficacy|8|||
143231652|NCT01346358|516399763|FG003|Overall Study|Non-Compliance|0|||
143231653|NCT01346358|516399764|FG004|Overall Study|Non-Compliance|0|||
143231654|NCT01346358|516399765|FG005|Overall Study|Non-Compliance|0|||
143231655|NCT01346358|516399766|FG006|Overall Study|Non-Compliance|0|||
143231656|NCT01346358|516399767|FG007|Overall Study|Non-Compliance|2|||
143231657|NCT01346358|516399768|FG008|Overall Study|Non-Compliance|0|||
143231658|NCT01346358|516399760|FG000|Overall Study|Physician Decision|0|||
143231659|NCT01346358|516399761|FG001|Overall Study|Physician Decision|1|||
143231660|NCT01346358|516399762|FG002|Overall Study|Physician Decision|0|||
143231661|NCT01346358|516399763|FG003|Overall Study|Physician Decision|0|||
143133385|NCT00509899|516033358|FG005|Overall Study|Physician Decision|4|||
143133386|NCT00509899|516033359|FG006|Overall Study|Physician Decision|0|||
143133387|NCT00509899|516033360|FG007|Overall Study|Physician Decision|0|||
143231662|NCT01346358|516399764|FG004|Overall Study|Physician Decision|0|||
143231663|NCT01346358|516399765|FG005|Overall Study|Physician Decision|0|||
143231664|NCT01346358|516399766|FG006|Overall Study|Physician Decision|0|||
143231665|NCT01346358|516399767|FG007|Overall Study|Physician Decision|1|||
143231666|NCT01346358|516399768|FG008|Overall Study|Physician Decision|1|||
143231667|NCT05058365|516399771|FG000|Overall Study|Migration|1|||
143231668|NCT05058365|516399772|FG001|Overall Study|Migration|1|||
143231669|NCT05121766|516399775|FG000|Overall Study|Covid reinfection|3|||
143231670|NCT05121766|516399776|FG001|Overall Study|Covid reinfection|0|||
143231671|NCT05121766|516399775|FG000|Overall Study|Withdrawal by Subject|3|||
143231672|NCT05121766|516399776|FG001|Overall Study|Withdrawal by Subject|1|||
143231673|NCT05121766|516399775|FG000|Overall Study|Adverse Event|2|||
143231674|NCT05121766|516399776|FG001|Overall Study|Adverse Event|4|||
143231675|NCT05121766|516399775|FG000|Overall Study|Lost to Follow-up|0|||
143231676|NCT05121766|516399776|FG001|Overall Study|Lost to Follow-up|1|||
143231677|NCT01033240|516399778|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
143231678|NCT01033240|516399779|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
143231679|NCT01033240|516399780|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
143231680|NCT01033240|516399778|FG000|Overall Study|Death|2|||
143133388|NCT00509899|516033353|FG000|Overall Study|Intercurrent Illness|1|||
143231681|NCT01033240|516399779|FG001|Overall Study|Death|0|||
143231682|NCT01033240|516399780|FG002|Overall Study|Death|0|||
143231683|NCT01033240|516399778|FG000|Overall Study|Withdrew Consent|2|||
143231684|NCT01033240|516399779|FG001|Overall Study|Withdrew Consent|9|||
143231685|NCT01033240|516399780|FG002|Overall Study|Withdrew Consent|2|||
143231686|NCT01033240|516399778|FG000|Overall Study|Disease Progression|35|||
143231687|NCT01033240|516399779|FG001|Overall Study|Disease Progression|32|||
143231688|NCT01033240|516399780|FG002|Overall Study|Disease Progression|41|||
143231689|NCT01033240|516399778|FG000|Overall Study|Investigator Discretion|0|||
143231690|NCT01033240|516399779|FG001|Overall Study|Investigator Discretion|0|||
143231691|NCT01033240|516399780|FG002|Overall Study|Investigator Discretion|2|||
143231692|NCT01033240|516399778|FG000|Overall Study|Other|0|||
143231693|NCT01033240|516399779|FG001|Overall Study|Other|1|||
143231694|NCT01033240|516399780|FG002|Overall Study|Other|2|||
143231695|NCT04716426|516399783|FG000|Overall Study|Vaccination|1|||
143231696|NCT04716426|516399784|FG001|Overall Study|Vaccination|1|||
143231697|NCT04716426|516399783|FG000|Overall Study|Contamination|1|||
143231698|NCT04716426|516399784|FG001|Overall Study|Contamination|0|||
143231699|NCT01046565|516399785|FG000|Overall Study|Adverse Event|2|||
143231700|NCT01046565|516399785|FG000|Overall Study|Withdrawal by Subject|7|||
143231701|NCT01650558|516399786|FG000|Overall Study|Migration out of study area|61|||
143231702|NCT01650558|516399787|FG001|Overall Study|Migration out of study area|71|||
143231703|NCT01650558|516399788|FG002|Overall Study|Migration out of study area|56|||
143231704|NCT01650558|516399786|FG000|Overall Study|Lost to Follow-up|10|||
143231705|NCT01650558|516399787|FG001|Overall Study|Lost to Follow-up|13|||
143231706|NCT01650558|516399788|FG002|Overall Study|Lost to Follow-up|6|||
143231707|NCT01650558|516399786|FG000|Overall Study|Death|10|||
143231708|NCT01650558|516399787|FG001|Overall Study|Death|6|||
143231709|NCT01650558|516399788|FG002|Overall Study|Death|8|||
143231710|NCT01650558|516399786|FG000|Overall Study|Withdrawal by Subject|1|||
143231711|NCT01650558|516399787|FG001|Overall Study|Withdrawal by Subject|1|||
143231712|NCT01650558|516399788|FG002|Overall Study|Withdrawal by Subject|3|||
143231713|NCT01650558|516399786|FG000|Overall Study|Non-compliant participant|1|||
143231714|NCT01650558|516399787|FG001|Overall Study|Non-compliant participant|0|||
143231715|NCT01650558|516399788|FG002|Overall Study|Non-compliant participant|2|||
143231716|NCT01650558|516399786|FG000|Overall Study|Physician Decision|0|||
143231717|NCT01650558|516399787|FG001|Overall Study|Physician Decision|1|||
143231718|NCT01650558|516399788|FG002|Overall Study|Physician Decision|0|||
143231719|NCT02960217|516399789|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
143231720|NCT02960217|516399790|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
143231721|NCT02960217|516399789|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
143231722|NCT02960217|516399790|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
143231723|NCT02960217|516399789|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
143231724|NCT02960217|516399790|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
143231725|NCT02960217|516399789|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
143231726|NCT02960217|516399790|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
143231727|NCT02960217|516399789|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
143231728|NCT02960217|516399790|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
143231729|NCT02960217|516399789|FG000|Open-Label Extension Phase|Adverse Event|1|||
143231730|NCT02960217|516399790|FG001|Open-Label Extension Phase|Adverse Event|0|||
143231731|NCT02960217|516399789|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
143231732|NCT02960217|516399790|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
143133389|NCT00509899|516033354|FG001|Overall Study|Intercurrent Illness|0|||
143133390|NCT00509899|516033355|FG002|Overall Study|Intercurrent Illness|0|||
143133391|NCT00509899|516033356|FG003|Overall Study|Intercurrent Illness|1|||
143133392|NCT00509899|516033357|FG004|Overall Study|Intercurrent Illness|0|||
143133393|NCT00509899|516033358|FG005|Overall Study|Intercurrent Illness|1|||
143133394|NCT00509899|516033359|FG006|Overall Study|Intercurrent Illness|0|||
143133395|NCT00509899|516033360|FG007|Overall Study|Intercurrent Illness|0|||
143133396|NCT00509899|516033353|FG000|Overall Study|Death|2|||
143133397|NCT00509899|516033354|FG001|Overall Study|Death|2|||
143133398|NCT00509899|516033355|FG002|Overall Study|Death|3|||
143133399|NCT00509899|516033356|FG003|Overall Study|Death|0|||
143133400|NCT00509899|516033357|FG004|Overall Study|Death|1|||
143133401|NCT00509899|516033358|FG005|Overall Study|Death|1|||
143231733|NCT02960217|516399789|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
143231734|NCT02960217|516399790|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
143231735|NCT02960217|516399789|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
143231736|NCT02960217|516399790|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
143231737|NCT00918385|516399791|FG000|Monotherapy|Adverse Event|1|||
143231738|NCT00918385|516399792|FG001|Monotherapy|Adverse Event|6|||
143231739|NCT00918385|516399791|FG000|Monotherapy|Complicating illness|1|||
143231740|NCT00918385|516399792|FG001|Monotherapy|Complicating illness|0|||
143231741|NCT00918385|516399791|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
143231742|NCT00918385|516399792|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
143133402|NCT00509899|516033359|FG006|Overall Study|Death|1|||
143133403|NCT00509899|516033360|FG007|Overall Study|Death|1|||
143133404|NCT00509899|516033353|FG000|Overall Study|Lack of Efficacy|1|||
143133405|NCT00509899|516033354|FG001|Overall Study|Lack of Efficacy|0|||
143133406|NCT00509899|516033355|FG002|Overall Study|Lack of Efficacy|2|||
143133407|NCT00509899|516033356|FG003|Overall Study|Lack of Efficacy|0|||
143133408|NCT00509899|516033357|FG004|Overall Study|Lack of Efficacy|0|||
143133409|NCT00509899|516033358|FG005|Overall Study|Lack of Efficacy|1|||
143133410|NCT00509899|516033359|FG006|Overall Study|Lack of Efficacy|0|||
143133411|NCT00509899|516033360|FG007|Overall Study|Lack of Efficacy|0|||
143358227|NCT01152554|516856113|FG000|Overall Study|Withdrawal by Subject|73|||
143358228|NCT01152554|516856114|FG001|Overall Study|Withdrawal by Subject|28|||
143358229|NCT01152554|516856113|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
143358230|NCT01152554|516856114|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
143358231|NCT01152554|516856113|FG000|Overall Study|Adverse Event|67|||
143358232|NCT01152554|516856114|FG001|Overall Study|Adverse Event|14|||
143358233|NCT01152554|516856113|FG000|Overall Study|Severe non-compliance to protocol|36|||
143358234|NCT01152554|516856114|FG001|Overall Study|Severe non-compliance to protocol|14|||
143358235|NCT01152554|516856113|FG000|Overall Study|Condition under investigation worsened|5|||
143358236|NCT01152554|516856114|FG001|Overall Study|Condition under investigation worsened|2|||
143358237|NCT01152554|516856113|FG000|Overall Study|Lack of Efficacy|20|||
143358238|NCT01152554|516856114|FG001|Overall Study|Lack of Efficacy|3|||
143358239|NCT01152554|516856113|FG000|Overall Study|Study-specific withdrawal criteria|17|||
143358240|NCT01152554|516856114|FG001|Overall Study|Study-specific withdrawal criteria|8|||
143358241|NCT01152554|516856113|FG000|Overall Study|Lost to Follow-up|87|||
143358242|NCT01152554|516856114|FG001|Overall Study|Lost to Follow-up|32|||
143358243|NCT01152554|516856113|FG000|Overall Study|Other|28|||
143358244|NCT01152554|516856114|FG001|Overall Study|Other|8|||
143358245|NCT01152554|516856113|FG000|Overall Study|Death|1|||
143358246|NCT01152554|516856114|FG001|Overall Study|Death|1|||
143358247|NCT02117544|516856115|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
143358248|NCT02117544|516856116|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
143358249|NCT03486899|516856117|FG000|Overall Study|Lost to Follow-up|4|||
143358250|NCT03486899|516856118|FG001|Overall Study|Lost to Follow-up|1|||
143358251|NCT03486899|516856119|FG002|Overall Study|Lost to Follow-up|4|||
143358252|NCT03486899|516856120|FG003|Overall Study|Lost to Follow-up|3|||
143358253|NCT03486899|516856117|FG000|Overall Study|Death|1|||
143358254|NCT03486899|516856118|FG001|Overall Study|Death|0|||
143358255|NCT03486899|516856119|FG002|Overall Study|Death|0|||
143358256|NCT03486899|516856120|FG003|Overall Study|Death|1|||
143358257|NCT03486899|516856117|FG000|Overall Study|Adverse Event|0|||
143358258|NCT03486899|516856118|FG001|Overall Study|Adverse Event|2|||
143358259|NCT03486899|516856119|FG002|Overall Study|Adverse Event|0|||
143358260|NCT03486899|516856120|FG003|Overall Study|Adverse Event|2|||
143358261|NCT03486899|516856117|FG000|Overall Study|Withdrawal by Subject|3|||
143358262|NCT03486899|516856118|FG001|Overall Study|Withdrawal by Subject|7|||
143358263|NCT03486899|516856119|FG002|Overall Study|Withdrawal by Subject|4|||
143358264|NCT03486899|516856120|FG003|Overall Study|Withdrawal by Subject|3|||
143358265|NCT03486899|516856117|FG000|Overall Study|Other Reasons|0|||
143358266|NCT03486899|516856118|FG001|Overall Study|Other Reasons|1|||
143358267|NCT03486899|516856119|FG002|Overall Study|Other Reasons|0|||
143358268|NCT03486899|516856120|FG003|Overall Study|Other Reasons|1|||
143358269|NCT02408549|516856121|FG000|Overall Study|Adverse Event|15|||
143358270|NCT02408549|516856121|FG000|Overall Study|Death|4|||
143358271|NCT02408549|516856121|FG000|Overall Study|Lack of Efficacy|17|||
143358272|NCT02408549|516856121|FG000|Overall Study|Protocol Violation|4|||
143358273|NCT02408549|516856121|FG000|Overall Study|Lost to Follow-up|6|||
143358274|NCT02408549|516856121|FG000|Overall Study|Consent withdrawn|30|||
143358275|NCT02408549|516856121|FG000|Overall Study|Neurology research program closing at site|1|||
143358276|NCT02408549|516856121|FG000|Overall Study|Site closure|1|||
143358277|NCT02408549|516856121|FG000|Overall Study|Pregnancy|1|||
143358278|NCT02408549|516856121|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
143358279|NCT02408549|516856121|FG000|Overall Study|Subject moved to another place, far from site|1|||
143358280|NCT02408549|516856121|FG000|Overall Study|Study terminated at site|1|||
143358281|NCT01232556|516856122|FG000|Overall Study|Withdrawal by Subject|21|||
143358282|NCT01232556|516856123|FG001|Overall Study|Withdrawal by Subject|17|||
143358283|NCT01232556|516856122|FG000|Overall Study|Death|97|||
143358284|NCT01232556|516856123|FG001|Overall Study|Death|97|||
143358285|NCT01232556|516856122|FG000|Overall Study|Lost to Follow-up|0|||
143358286|NCT01232556|516856123|FG001|Overall Study|Lost to Follow-up|2|||
143358287|NCT01232556|516856122|FG000|Overall Study|Terminated by Sponsor|35|||
143358288|NCT01232556|516856123|FG001|Overall Study|Terminated by Sponsor|51|||
143133412|NCT01711983|516033365|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
143133413|NCT01711983|516033365|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
143133414|NCT01711983|516033365|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
143133415|NCT01711983|516033365|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
143133416|NCT00737100|516033366|FG000|Overall Study|Adverse Event|6|||
143358289|NCT01232556|516856122|FG000|Overall Study|Other|6|||
143358290|NCT01232556|516856123|FG001|Overall Study|Other|4|||
143358291|NCT01272037|516856137|FG000|Overall Study|Death|25|||
143231743|NCT00918385|516399791|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
143231744|NCT00918385|516399792|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
143231745|NCT00918385|516399791|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
143231746|NCT00918385|516399792|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
143231747|NCT00918385|516399791|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
143231748|NCT00918385|516399792|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
143231749|NCT00083889|516399797|FG000|Overall Study|Adverse Event|76|||
143231750|NCT00083889|516399798|FG001|Overall Study|Adverse Event|86|||
143231751|NCT00083889|516399797|FG000|Overall Study|Protocol Violation|2|||
143231752|NCT00083889|516399798|FG001|Overall Study|Protocol Violation|2|||
143231753|NCT00083889|516399797|FG000|Overall Study|Withdrawal by Subject|22|||
143231754|NCT00083889|516399798|FG001|Overall Study|Withdrawal by Subject|24|||
143231755|NCT00083889|516399797|FG000|Overall Study|Lack of Efficacy|240|||
143231756|NCT00083889|516399798|FG001|Overall Study|Lack of Efficacy|219|||
143231757|NCT00083889|516399797|FG000|Overall Study|Decision of sponsor|32|||
143231758|NCT00083889|516399798|FG001|Overall Study|Decision of sponsor|4|||
143231759|NCT00083889|516399797|FG000|Overall Study|Randomized: did not take study drug|0|||
143231760|NCT00083889|516399798|FG001|Overall Study|Randomized: did not take study drug|15|||
143231761|NCT00083889|516399797|FG000|Overall Study|Completed on marketed sunitinub|3|||
143231762|NCT00083889|516399798|FG001|Overall Study|Completed on marketed sunitinub|0|||
143231763|NCT00083889|516399797|FG000|Overall Study|Crossover to SU011248|0|||
143231764|NCT00083889|516399798|FG001|Overall Study|Crossover to SU011248|25|||
143231765|NCT00168844|516399799|FG000|Overall Study|Adverse Event|31|||
143231766|NCT00168844|516399800|FG001|Overall Study|Adverse Event|32|||
143231767|NCT00168844|516399801|FG002|Overall Study|Adverse Event|48|||
143231768|NCT00168844|516399799|FG000|Overall Study|Lost to Follow-up|4|||
143231769|NCT00168844|516399800|FG001|Overall Study|Lost to Follow-up|5|||
143231770|NCT00168844|516399801|FG002|Overall Study|Lost to Follow-up|11|||
143231771|NCT00168844|516399799|FG000|Overall Study|Withdrawal by Subject|12|||
143231772|NCT00168844|516399800|FG001|Overall Study|Withdrawal by Subject|9|||
143231773|NCT00168844|516399801|FG002|Overall Study|Withdrawal by Subject|19|||
143231774|NCT00168844|516399799|FG000|Overall Study|Protocol Violation|2|||
143231775|NCT00168844|516399800|FG001|Overall Study|Protocol Violation|2|||
143231776|NCT00168844|516399801|FG002|Overall Study|Protocol Violation|4|||
143231777|NCT00168844|516399799|FG000|Overall Study|Other|6|||
143231778|NCT00168844|516399800|FG001|Overall Study|Other|7|||
143231779|NCT00168844|516399801|FG002|Overall Study|Other|9|||
143231780|NCT03557970|516399806|FG000|Overall Study|Study closure|1|||
143231781|NCT03557970|516399807|FG001|Overall Study|Study closure|0|||
143231782|NCT03557970|516399806|FG000|Overall Study|Physician Decision|0|||
143231783|NCT03557970|516399807|FG001|Overall Study|Physician Decision|1|||
143231784|NCT03557970|516399806|FG000|Overall Study|Death|0|||
143231785|NCT03557970|516399807|FG001|Overall Study|Death|1|||
143231786|NCT00112736|516399808|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
143231787|NCT00112736|516399809|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
143231788|NCT02138890|516399810|FG000|Overall Study|Adverse Event|1|||
143231789|NCT02138890|516399811|FG001|Overall Study|Adverse Event|0|||
143231790|NCT03019406|516399812|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
143231791|NCT03019406|516399813|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
143231792|NCT03019406|516399814|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
143231793|NCT03019406|516399815|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
143231794|NCT02362724|516399817|FG000|Overall Study|Withdrawal by Subject|3|||
143231795|NCT02362724|516399818|FG001|Overall Study|Withdrawal by Subject|1|||
143231796|NCT02362724|516399817|FG000|Overall Study|Adverse Event|3|||
143231797|NCT02362724|516399818|FG001|Overall Study|Adverse Event|0|||
143231798|NCT02025179|516399819|FG000|Overall Study|Lost to Follow-up|0|||
143231799|NCT02025179|516399820|FG001|Overall Study|Lost to Follow-up|0|||
143231800|NCT02025179|516399821|FG002|Overall Study|Lost to Follow-up|1|||
143231801|NCT01927497|516399824|FG000|Overall Study|Death|0|||
143231802|NCT01927497|516399825|FG001|Overall Study|Death|1|||
143231803|NCT01927497|516399824|FG000|Overall Study|Protocol Violation|2|||
143013911|NCT02139306|515590084|FG001|Overall Study|Withdrawal by Subject|6|||
143013912|NCT02139306|515590083|FG000|Overall Study|Adverse Event|3|||
143231804|NCT01927497|516399825|FG001|Overall Study|Protocol Violation|0|||
143231805|NCT00395746|516399826|FG000|Overall Study|Adverse Event|5|||
143231806|NCT00395746|516399827|FG001|Overall Study|Adverse Event|2|||
143231807|NCT00395746|516399828|FG002|Overall Study|Adverse Event|2|||
143231808|NCT00395746|516399826|FG000|Overall Study|Protocol Violation|0|||
143231809|NCT00395746|516399827|FG001|Overall Study|Protocol Violation|1|||
143231810|NCT00395746|516399828|FG002|Overall Study|Protocol Violation|0|||
143231811|NCT00395746|516399826|FG000|Overall Study|Lack of Efficacy|2|||
143231812|NCT00395746|516399827|FG001|Overall Study|Lack of Efficacy|0|||
143231813|NCT00395746|516399828|FG002|Overall Study|Lack of Efficacy|17|||
143231814|NCT00395746|516399826|FG000|Overall Study|Hypoglycaemia|2|||
143231815|NCT00395746|516399827|FG001|Overall Study|Hypoglycaemia|1|||
143231816|NCT00395746|516399828|FG002|Overall Study|Hypoglycaemia|0|||
143231817|NCT00395746|516399826|FG000|Overall Study|Subject decision|0|||
143013913|NCT02139306|515590084|FG001|Overall Study|Adverse Event|4|||
143231818|NCT00395746|516399827|FG001|Overall Study|Subject decision|0|||
143465976|NCT02027701|517253692|FG000|Overall Study|Physician Decision|2|||
143465977|NCT02027701|517253692|FG000|Overall Study|Withdrawal by Subject|3|||
143465978|NCT02982187|517253693|FG000|Overall Study|Withdrawal by Subject|0|||
143465979|NCT02982187|517253694|FG001|Overall Study|Withdrawal by Subject|0|||
143231819|NCT00395746|516399828|FG002|Overall Study|Subject decision|1|||
143231820|NCT00395746|516399826|FG000|Overall Study|Withdrawal of consent|0|||
143231821|NCT00395746|516399827|FG001|Overall Study|Withdrawal of consent|0|||
143231822|NCT00395746|516399828|FG002|Overall Study|Withdrawal of consent|1|||
143231823|NCT00395746|516399826|FG000|Overall Study|Difficultulty in use of device|0|||
143231824|NCT00395746|516399827|FG001|Overall Study|Difficultulty in use of device|0|||
143231825|NCT00395746|516399828|FG002|Overall Study|Difficultulty in use of device|1|||
143231826|NCT00395746|516399826|FG000|Overall Study|Unable to visit site on schedule|1|||
143231827|NCT00395746|516399827|FG001|Overall Study|Unable to visit site on schedule|0|||
143231828|NCT00395746|516399828|FG002|Overall Study|Unable to visit site on schedule|0|||
143231829|NCT04528641|516399829|FG000|Overall Study|Withdrawal by Subject|0|||
143231830|NCT04528641|516399830|FG001|Overall Study|Withdrawal by Subject|0|||
143231831|NCT04528641|516399831|FG002|Overall Study|Withdrawal by Subject|0|||
143231832|NCT04528641|516399832|FG003|Overall Study|Withdrawal by Subject|1|||
143231833|NCT04528641|516399833|FG004|Overall Study|Withdrawal by Subject|0|||
143231834|NCT04528641|516399834|FG005|Overall Study|Withdrawal by Subject|1|||
143231835|NCT03413891|516399835|FG000|Overall Study|Lost to Follow-up|2|||
143231836|NCT03413891|516399836|FG001|Overall Study|Lost to Follow-up|1|||
143231837|NCT03413891|516399835|FG000|Overall Study|Protocol Violation|0|||
143231838|NCT03413891|516399836|FG001|Overall Study|Protocol Violation|1|||
143231839|NCT03137992|516399839|FG000|Washout Period 1|Adverse Event|1|||
143231840|NCT03137992|516399840|FG001|Washout Period 1|Adverse Event|1|||
143231841|NCT03137992|516399841|FG002|Washout Period 1|Adverse Event|0|||
143231842|NCT03137992|516399842|FG003|Washout Period 1|Adverse Event|0|||
143231843|NCT03137992|516399843|FG004|Washout Period 1|Adverse Event|0|||
143231844|NCT03137992|516399844|FG005|Washout Period 1|Adverse Event|1|||
143231845|NCT03137992|516399839|FG000|Washout Period 1|Withdrawal by Subject|0|||
143231846|NCT03137992|516399840|FG001|Washout Period 1|Withdrawal by Subject|1|||
143231847|NCT03137992|516399841|FG002|Washout Period 1|Withdrawal by Subject|1|||
143231848|NCT03137992|516399842|FG003|Washout Period 1|Withdrawal by Subject|0|||
143465980|NCT02982187|517253695|FG002|Overall Study|Withdrawal by Subject|0|||
143465981|NCT02982187|517253696|FG003|Overall Study|Withdrawal by Subject|0|||
143465982|NCT02982187|517253697|FG004|Overall Study|Withdrawal by Subject|0|||
143231849|NCT03137992|516399843|FG004|Washout Period 1|Withdrawal by Subject|0|||
143231850|NCT03137992|516399844|FG005|Washout Period 1|Withdrawal by Subject|0|||
143231851|NCT03137992|516399839|FG000|Washout Period 1|Principal Investigator Discretion|0|||
143231852|NCT03137992|516399840|FG001|Washout Period 1|Principal Investigator Discretion|1|||
143231853|NCT03137992|516399841|FG002|Washout Period 1|Principal Investigator Discretion|0|||
143231854|NCT03137992|516399842|FG003|Washout Period 1|Principal Investigator Discretion|0|||
143231855|NCT03137992|516399843|FG004|Washout Period 1|Principal Investigator Discretion|0|||
143231856|NCT03137992|516399844|FG005|Washout Period 1|Principal Investigator Discretion|0|||
143231857|NCT03137992|516399839|FG000|Washout Period 1|COPD Exacerbation|1|||
143231858|NCT03137992|516399840|FG001|Washout Period 1|COPD Exacerbation|1|||
143231859|NCT03137992|516399841|FG002|Washout Period 1|COPD Exacerbation|1|||
143231860|NCT03137992|516399842|FG003|Washout Period 1|COPD Exacerbation|0|||
143231861|NCT03137992|516399843|FG004|Washout Period 1|COPD Exacerbation|1|||
143465983|NCT02982187|517253698|FG005|Overall Study|Withdrawal by Subject|0|||
143465984|NCT02982187|517253699|FG006|Overall Study|Withdrawal by Subject|1|||
143465985|NCT02982187|517253700|FG007|Overall Study|Withdrawal by Subject|0|||
143465986|NCT01128738|517253701|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
143465987|NCT01128738|517253702|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
143465988|NCT01128738|517253701|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
143465989|NCT01128738|517253702|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
143465990|NCT01128738|517253701|FG000|Second TP|Lost to Follow-up|0|||
143465991|NCT01128738|517253702|FG001|Second TP|Lost to Follow-up|1|||
143465992|NCT01128738|517253701|FG000|Second TP|Withdrawal by Subject|0|||
143465993|NCT01128738|517253702|FG001|Second TP|Withdrawal by Subject|2|||
143465994|NCT01211197|517253703|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
143465995|NCT01211197|517253704|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
143465996|NCT01211197|517253705|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
143465997|NCT01211197|517253706|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
143465998|NCT01211197|517253707|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
143465999|NCT01211197|517253708|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
143466000|NCT01211197|517253703|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
143466001|NCT01211197|517253704|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
143133417|NCT00737100|516033367|FG001|Overall Study|Adverse Event|5|||
143466002|NCT01211197|517253705|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
143466003|NCT01211197|517253706|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
143466004|NCT01211197|517253707|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
143358292|NCT01272037|516856138|FG001|Overall Study|Death|28|||
143358293|NCT01272037|516856137|FG000|Overall Study|Adverse Event|12|||
143358294|NCT01272037|516856138|FG001|Overall Study|Adverse Event|7|||
143358295|NCT01272037|516856137|FG000|Overall Study|Withdrawal by Subject|175|||
143358296|NCT01272037|516856138|FG001|Overall Study|Withdrawal by Subject|93|||
143358297|NCT01272037|516856137|FG000|Overall Study|Disease progression|70|||
143358298|NCT01272037|516856138|FG001|Overall Study|Disease progression|111|||
143466005|NCT01211197|517253708|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
143466006|NCT05116046|517253711|FG000|Overall Study|Withdrawal by parent/guardian|2|||
143466007|NCT05116046|517253712|FG001|Overall Study|Withdrawal by parent/guardian|1|||
143466008|NCT05116046|517253713|FG002|Overall Study|Withdrawal by parent/guardian|1|||
143466009|NCT05116046|517253711|FG000|Overall Study|Study terminated by sponsor|14|||
143133418|NCT00737100|516033368|FG002|Overall Study|Adverse Event|3|||
143133419|NCT00737100|516033366|FG000|Overall Study|Lost to Follow-up|0|||
143133420|NCT00737100|516033367|FG001|Overall Study|Lost to Follow-up|1|||
143133421|NCT00737100|516033368|FG002|Overall Study|Lost to Follow-up|0|||
143133422|NCT00737100|516033366|FG000|Overall Study|Withdrawal by Subject|0|||
143133423|NCT00737100|516033367|FG001|Overall Study|Withdrawal by Subject|0|||
143133424|NCT00737100|516033368|FG002|Overall Study|Withdrawal by Subject|3|||
143133425|NCT00737100|516033366|FG000|Overall Study|Reason discontinued not explained above|1|||
143133426|NCT00737100|516033367|FG001|Overall Study|Reason discontinued not explained above|1|||
143133427|NCT00737100|516033368|FG002|Overall Study|Reason discontinued not explained above|1|||
143133428|NCT00115778|516033370|FG000|Overall Study|Withdrawal by Subject|0|||
143133429|NCT00115778|516033371|FG001|Overall Study|Withdrawal by Subject|1|||
143133430|NCT03713684|516033374|FG000|Overall Study|Adverse Event|1|||
143133431|NCT03713684|516033375|FG001|Overall Study|Adverse Event|3|||
143133432|NCT03713684|516033376|FG002|Overall Study|Adverse Event|1|||
143133433|NCT03713684|516033377|FG003|Overall Study|Adverse Event|0|||
143133434|NCT03713684|516033374|FG000|Overall Study|Poor compliance to protocol|2|||
143133435|NCT03713684|516033375|FG001|Overall Study|Poor compliance to protocol|1|||
143133436|NCT03713684|516033376|FG002|Overall Study|Poor compliance to protocol|0|||
143133437|NCT03713684|516033377|FG003|Overall Study|Poor compliance to protocol|1|||
143133438|NCT03713684|516033374|FG000|Overall Study|Withdrawal by Subject|14|||
143466010|NCT05116046|517253712|FG001|Overall Study|Study terminated by sponsor|16|||
143466011|NCT05116046|517253713|FG002|Overall Study|Study terminated by sponsor|1|||
143466012|NCT00261846|517253714|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
143466013|NCT00261846|517253715|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
143466014|NCT00261846|517253716|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
143466015|NCT00261846|517253717|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
143466016|NCT00261846|517253718|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
143466017|NCT00261846|517253719|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
143231862|NCT03137992|516399844|FG005|Washout Period 1|COPD Exacerbation|1|||
143231863|NCT03137992|516399839|FG000|Washout Period 1|Subject Noncompliance|1|||
143231864|NCT03137992|516399840|FG001|Washout Period 1|Subject Noncompliance|0|||
143231865|NCT03137992|516399841|FG002|Washout Period 1|Subject Noncompliance|0|||
143231866|NCT03137992|516399842|FG003|Washout Period 1|Subject Noncompliance|0|||
143231867|NCT03137992|516399843|FG004|Washout Period 1|Subject Noncompliance|1|||
143231868|NCT03137992|516399844|FG005|Washout Period 1|Subject Noncompliance|0|||
143231869|NCT03137992|516399839|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
143231870|NCT03137992|516399840|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
143231871|NCT03137992|516399841|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
143466018|NCT00261846|517253720|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
143466019|NCT00261846|517253721|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
143466020|NCT00261846|517253722|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
143231872|NCT03137992|516399842|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
143231873|NCT03137992|516399843|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
143231874|NCT03137992|516399844|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
143231875|NCT03137992|516399839|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
143231876|NCT03137992|516399840|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
143133439|NCT03713684|516033375|FG001|Overall Study|Withdrawal by Subject|6|||
143133440|NCT03713684|516033376|FG002|Overall Study|Withdrawal by Subject|14|||
143231877|NCT03137992|516399841|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
143231878|NCT03137992|516399842|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
143231879|NCT03137992|516399843|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
143231880|NCT03137992|516399844|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
143133441|NCT03713684|516033377|FG003|Overall Study|Withdrawal by Subject|16|||
143133442|NCT03713684|516033374|FG000|Overall Study|Other than specified|69|||
143133443|NCT03713684|516033375|FG001|Overall Study|Other than specified|77|||
143133444|NCT03713684|516033376|FG002|Overall Study|Other than specified|73|||
143231881|NCT03137992|516399839|FG000|Period 2 (Visit 3)|Adverse Event|0|||
143231882|NCT03137992|516399840|FG001|Period 2 (Visit 3)|Adverse Event|1|||
143358299|NCT01272037|516856137|FG000|Overall Study|Other reason|42|||
143358300|NCT01272037|516856138|FG001|Overall Study|Other reason|41|||
143358301|NCT01272037|516856137|FG000|Overall Study|Delinquent data|24|||
143358302|NCT01272037|516856138|FG001|Overall Study|Delinquent data|19|||
143358303|NCT01272037|516856137|FG000|Overall Study|Reason under review|33|||
143358304|NCT01272037|516856138|FG001|Overall Study|Reason under review|29|||
143358305|NCT01272037|516856137|FG000|Overall Study|On treatment|626|||
143358306|NCT01272037|516856138|FG001|Overall Study|On treatment|632|||
143358307|NCT01670500|516856139|FG000|Overall Study|Withdrawal by Subject|1|||
143358308|NCT01670500|516856140|FG001|Overall Study|Withdrawal by Subject|0|||
143358309|NCT01857323|516856142|FG000|Overall Study|Adverse Event|1|||
143358310|NCT01857323|516856142|FG000|Overall Study|Withdrawal by Subject|3|||
143358311|NCT01857323|516856142|FG000|Overall Study|Non-compliance|1|||
143358312|NCT01857323|516856142|FG000|Overall Study|Protocol Violation|6|||
143358313|NCT01857323|516856142|FG000|Overall Study|Lost to Follow-up|1|||
143358314|NCT01857323|516856142|FG000|Overall Study|Other|4|||
143358315|NCT01857323|516856142|FG000|Overall Study|Did not complete 180 doses|48|||
143358316|NCT03873246|516856143|FG000|Overall Study|Adverse Event|1|||
143358317|NCT03873246|516856144|FG001|Overall Study|Adverse Event|3|||
143358318|NCT03873246|516856145|FG002|Overall Study|Adverse Event|3|||
143358319|NCT03873246|516856143|FG000|Overall Study|Lost to Follow-up|4|||
143358320|NCT03873246|516856144|FG001|Overall Study|Lost to Follow-up|4|||
143358321|NCT03873246|516856145|FG002|Overall Study|Lost to Follow-up|5|||
143358322|NCT03873246|516856143|FG000|Overall Study|Protocol Violation|0|||
143358323|NCT03873246|516856144|FG001|Overall Study|Protocol Violation|1|||
143358324|NCT03873246|516856145|FG002|Overall Study|Protocol Violation|0|||
143358325|NCT03873246|516856143|FG000|Overall Study|Withdrawal by Subject|0|||
143358326|NCT03873246|516856144|FG001|Overall Study|Withdrawal by Subject|4|||
143358327|NCT03873246|516856145|FG002|Overall Study|Withdrawal by Subject|1|||
143358328|NCT02107443|516856146|FG000|Overall Study|Death|42|||
143358329|NCT02107443|516856147|FG001|Overall Study|Death|30|||
143358330|NCT02107443|516856146|FG000|Overall Study|Study Protocol Violation|3|||
143358331|NCT02107443|516856147|FG001|Overall Study|Study Protocol Violation|1|||
143358332|NCT02107443|516856146|FG000|Overall Study|Registered but Not Eligible|0|||
143358333|NCT02107443|516856147|FG001|Overall Study|Registered but Not Eligible|1|||
143358334|NCT02107443|516856146|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
143358335|NCT02107443|516856147|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
143358336|NCT02107443|516856146|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
143358337|NCT02107443|516856147|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
143358338|NCT02107443|516856146|FG000|Overall Study|Withdrawal: Changed Mind|2|||
143358339|NCT02107443|516856147|FG001|Overall Study|Withdrawal: Changed Mind|0|||
143358340|NCT02107443|516856146|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
143358341|NCT02107443|516856147|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
143358342|NCT02107443|516856146|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
143358343|NCT02107443|516856147|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
143358344|NCT02107443|516856146|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
143358345|NCT02107443|516856147|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
143358346|NCT02107443|516856146|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
143358347|NCT02107443|516856147|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
143358348|NCT02107443|516856146|FG000|Overall Study|Withdrawal: Other Medical|9|||
143358349|NCT02107443|516856147|FG001|Overall Study|Withdrawal: Other Medical|5|||
143358350|NCT02107443|516856146|FG000|Overall Study|Withdrawal: Disease Progression|4|||
143358351|NCT02107443|516856147|FG001|Overall Study|Withdrawal: Disease Progression|2|||
143358352|NCT02107443|516856146|FG000|Overall Study|Withdrawal: Personal Issues|0|||
143358353|NCT02107443|516856147|FG001|Overall Study|Withdrawal: Personal Issues|3|||
143358354|NCT03658811|516856148|FG000|Overall Study|Lost to Follow-up|3|||
143358355|NCT00946647|516856149|FG000|Phase 1 Part|Adverse Event|2|||
143358356|NCT00946647|516856150|FG001|Phase 1 Part|Adverse Event|5|||
143358357|NCT00946647|516856151|FG002|Phase 1 Part|Adverse Event|3|||
143358358|NCT00946647|516856152|FG003|Phase 1 Part|Adverse Event|0|||
143358359|NCT00946647|516856153|FG004|Phase 1 Part|Adverse Event|0|||
143358360|NCT00946647|516856149|FG000|Phase 1 Part|Disease progression|3|||
143358361|NCT00946647|516856150|FG001|Phase 1 Part|Disease progression|6|||
143358362|NCT00946647|516856151|FG002|Phase 1 Part|Disease progression|1|||
143358363|NCT00946647|516856152|FG003|Phase 1 Part|Disease progression|0|||
143358364|NCT00946647|516856153|FG004|Phase 1 Part|Disease progression|0|||
143358365|NCT00946647|516856149|FG000|Phase 1 Part|Withdrawal by Subject|1|||
143358366|NCT00946647|516856150|FG001|Phase 1 Part|Withdrawal by Subject|4|||
143358367|NCT00946647|516856151|FG002|Phase 1 Part|Withdrawal by Subject|3|||
143358368|NCT00946647|516856152|FG003|Phase 1 Part|Withdrawal by Subject|0|||
143358369|NCT00946647|516856153|FG004|Phase 1 Part|Withdrawal by Subject|0|||
143358370|NCT00946647|516856149|FG000|Phase 1 Part|Abnormal values|0|||
143358371|NCT00946647|516856150|FG001|Phase 1 Part|Abnormal values|2|||
143358372|NCT00946647|516856151|FG002|Phase 1 Part|Abnormal values|0|||
143358373|NCT00946647|516856152|FG003|Phase 1 Part|Abnormal values|0|||
143358374|NCT00946647|516856153|FG004|Phase 1 Part|Abnormal values|0|||
143358375|NCT00946647|516856149|FG000|Phase 1 Part|Reason missing|0|||
143358376|NCT00946647|516856150|FG001|Phase 1 Part|Reason missing|1|||
143358377|NCT00946647|516856151|FG002|Phase 1 Part|Reason missing|0|||
143231883|NCT03137992|516399841|FG002|Period 2 (Visit 3)|Adverse Event|0|||
143231884|NCT03137992|516399842|FG003|Period 2 (Visit 3)|Adverse Event|0|||
143231885|NCT03137992|516399843|FG004|Period 2 (Visit 3)|Adverse Event|0|||
143231886|NCT03137992|516399844|FG005|Period 2 (Visit 3)|Adverse Event|0|||
143231887|NCT03137992|516399839|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
143231888|NCT03137992|516399840|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
143231889|NCT03137992|516399841|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
143231890|NCT03137992|516399842|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
143231891|NCT03137992|516399843|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
143231892|NCT03137992|516399844|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
143231893|NCT03137992|516399839|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
143231894|NCT03137992|516399840|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
143231895|NCT03137992|516399841|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
143231896|NCT03137992|516399842|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
143231897|NCT03137992|516399843|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
143231898|NCT03137992|516399844|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
143231899|NCT03137992|516399839|FG000|Washout Period 2|COPD Exacerbation|1|||
143231900|NCT03137992|516399840|FG001|Washout Period 2|COPD Exacerbation|1|||
143231901|NCT03137992|516399841|FG002|Washout Period 2|COPD Exacerbation|0|||
143231902|NCT03137992|516399842|FG003|Washout Period 2|COPD Exacerbation|0|||
143231903|NCT03137992|516399843|FG004|Washout Period 2|COPD Exacerbation|1|||
143231904|NCT03137992|516399844|FG005|Washout Period 2|COPD Exacerbation|0|||
143231905|NCT03137992|516399839|FG000|Washout Period 2|Subject Non-compliance|0|||
143231906|NCT03137992|516399840|FG001|Washout Period 2|Subject Non-compliance|1|||
143231907|NCT03137992|516399841|FG002|Washout Period 2|Subject Non-compliance|0|||
143231908|NCT03137992|516399842|FG003|Washout Period 2|Subject Non-compliance|0|||
143231909|NCT03137992|516399843|FG004|Washout Period 2|Subject Non-compliance|0|||
143231910|NCT03137992|516399844|FG005|Washout Period 2|Subject Non-compliance|0|||
143231911|NCT03137992|516399839|FG000|Washout Period 2|Adverse Event|0|||
143231912|NCT03137992|516399840|FG001|Washout Period 2|Adverse Event|0|||
143231913|NCT03137992|516399841|FG002|Washout Period 2|Adverse Event|0|||
143231914|NCT03137992|516399842|FG003|Washout Period 2|Adverse Event|1|||
143231915|NCT03137992|516399843|FG004|Washout Period 2|Adverse Event|1|||
143231916|NCT03137992|516399844|FG005|Washout Period 2|Adverse Event|0|||
143231917|NCT03137992|516399839|FG000|Washout Period 2|Withdrawal by Subject|1|||
143231918|NCT03137992|516399840|FG001|Washout Period 2|Withdrawal by Subject|0|||
143231919|NCT03137992|516399841|FG002|Washout Period 2|Withdrawal by Subject|0|||
143231920|NCT03137992|516399842|FG003|Washout Period 2|Withdrawal by Subject|0|||
143231921|NCT03137992|516399843|FG004|Washout Period 2|Withdrawal by Subject|1|||
143231922|NCT03137992|516399844|FG005|Washout Period 2|Withdrawal by Subject|0|||
143231923|NCT03137992|516399839|FG000|Washout Period 2|Sponsor Decision|0|||
143231924|NCT03137992|516399840|FG001|Washout Period 2|Sponsor Decision|0|||
143231925|NCT03137992|516399841|FG002|Washout Period 2|Sponsor Decision|0|||
143231926|NCT03137992|516399842|FG003|Washout Period 2|Sponsor Decision|0|||
143231927|NCT03137992|516399843|FG004|Washout Period 2|Sponsor Decision|0|||
143231928|NCT03137992|516399844|FG005|Washout Period 2|Sponsor Decision|1|||
143231929|NCT03137992|516399839|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
143231930|NCT03137992|516399840|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
143231931|NCT03137992|516399841|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
143231932|NCT03137992|516399842|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
143231933|NCT03137992|516399843|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
143231934|NCT03137992|516399844|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
143231935|NCT03137992|516399839|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
143231936|NCT03137992|516399840|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
143231937|NCT03137992|516399841|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
143231938|NCT03137992|516399842|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
143231939|NCT03137992|516399843|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
143231940|NCT03137992|516399844|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
143231941|NCT03137992|516399839|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
143231942|NCT03137992|516399840|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
143231943|NCT03137992|516399841|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
143231944|NCT03137992|516399842|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
143231945|NCT03137992|516399843|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
143013914|NCT02139306|515590083|FG000|Overall Study|Physician Decision|0|||
143013915|NCT02139306|515590084|FG001|Overall Study|Physician Decision|1|||
143133445|NCT03713684|516033377|FG003|Overall Study|Other than specified|70|||
143133446|NCT00528424|516033378|FG000|Overall Study|Lost to Follow-up|13|||
143231946|NCT03137992|516399844|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
143231947|NCT03137992|516399839|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
143231948|NCT03137992|516399840|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
143231949|NCT03137992|516399841|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
143231950|NCT03137992|516399842|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
143231951|NCT03137992|516399843|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
143133447|NCT00528424|516033378|FG000|Overall Study|Withdrew consent|2|||
143231952|NCT03137992|516399844|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
143231953|NCT03137992|516399839|FG000|Part 2 (Open-label Extension)|Per study team|1|||
143231954|NCT03137992|516399840|FG001|Part 2 (Open-label Extension)|Per study team|0|||
143231955|NCT03137992|516399841|FG002|Part 2 (Open-label Extension)|Per study team|0|||
143231956|NCT03137992|516399842|FG003|Part 2 (Open-label Extension)|Per study team|0|||
143231957|NCT03137992|516399843|FG004|Part 2 (Open-label Extension)|Per study team|0|||
143231958|NCT03137992|516399844|FG005|Part 2 (Open-label Extension)|Per study team|0|||
143231959|NCT03137992|516399839|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
143231960|NCT03137992|516399840|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
143231961|NCT03137992|516399841|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
143231962|NCT03137992|516399842|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
143231963|NCT03137992|516399843|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
143231964|NCT03137992|516399844|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
143231965|NCT00795704|516399849|FG000|Overall Study|Withdrawal by Subject|3|||
143231966|NCT00795704|516399850|FG001|Overall Study|Withdrawal by Subject|2|||
143231967|NCT00795704|516399849|FG000|Overall Study|Adverse Event|1|||
143231968|NCT00795704|516399850|FG001|Overall Study|Adverse Event|1|||
143231969|NCT01247324|516399851|FG000|Overall Study|Death|6|||
143231970|NCT01247324|516399852|FG001|Overall Study|Death|10|||
143231971|NCT01247324|516399851|FG000|Overall Study|Physician Decision|2|||
143231972|NCT01247324|516399852|FG001|Overall Study|Physician Decision|3|||
143231973|NCT01247324|516399851|FG000|Overall Study|Non-compliance with study drug|3|||
143231974|NCT01247324|516399852|FG001|Overall Study|Non-compliance with study drug|0|||
143231975|NCT01247324|516399851|FG000|Overall Study|Lack of Efficacy|24|||
143231976|NCT01247324|516399852|FG001|Overall Study|Lack of Efficacy|14|||
143231977|NCT01247324|516399851|FG000|Overall Study|Non-compliance|3|||
143231978|NCT01247324|516399852|FG001|Overall Study|Non-compliance|2|||
143231979|NCT01247324|516399851|FG000|Overall Study|Pregnancy|5|||
143231980|NCT01247324|516399852|FG001|Overall Study|Pregnancy|10|||
143231981|NCT01247324|516399851|FG000|Overall Study|Protocol Violation|1|||
143231982|NCT01247324|516399852|FG001|Overall Study|Protocol Violation|1|||
143231983|NCT01247324|516399851|FG000|Overall Study|Reason not specified|42|||
143231984|NCT01247324|516399852|FG001|Overall Study|Reason not specified|32|||
143231985|NCT01247324|516399851|FG000|Overall Study|Consent withdrawn by participant|41|||
143231986|NCT01247324|516399852|FG001|Overall Study|Consent withdrawn by participant|56|||
143231987|NCT01247324|516399851|FG000|Overall Study|Adverse Event|49|||
143231988|NCT01247324|516399852|FG001|Overall Study|Adverse Event|35|||
143231989|NCT01247324|516399851|FG000|Overall Study|Lost to Follow-up|3|||
143231990|NCT01247324|516399852|FG001|Overall Study|Lost to Follow-up|6|||
143231991|NCT01247324|516399851|FG000|Overall Study|Study Terminated by Sponsor|4|||
143231992|NCT01247324|516399852|FG001|Overall Study|Study Terminated by Sponsor|1|||
143231993|NCT01247324|516399851|FG000|Overall Study|Missing|2|||
143231994|NCT01247324|516399852|FG001|Overall Study|Missing|1|||
143231995|NCT01691794|516399855|FG000|Overall Study|Poor/Non-Compliance|1|||
143231996|NCT01691794|516399856|FG001|Overall Study|Poor/Non-Compliance|4|||
143231997|NCT01691794|516399857|FG002|Overall Study|Poor/Non-Compliance|1|||
143231998|NCT01691794|516399855|FG000|Overall Study|Death|0|||
143231999|NCT01691794|516399856|FG001|Overall Study|Death|0|||
143232000|NCT01691794|516399857|FG002|Overall Study|Death|1|||
143232001|NCT01691794|516399855|FG000|Overall Study|Lack of Efficacy|0|||
143232002|NCT01691794|516399856|FG001|Overall Study|Lack of Efficacy|7|||
143232003|NCT01691794|516399857|FG002|Overall Study|Lack of Efficacy|1|||
143232004|NCT01691794|516399855|FG000|Overall Study|Participant request to discontinue|0|||
143232005|NCT01691794|516399856|FG001|Overall Study|Participant request to discontinue|1|||
143232006|NCT01691794|516399857|FG002|Overall Study|Participant request to discontinue|0|||
143232007|NCT01691794|516399855|FG000|Overall Study|Adverse Event|0|||
143232008|NCT01691794|516399856|FG001|Overall Study|Adverse Event|1|||
143232009|NCT01691794|516399857|FG002|Overall Study|Adverse Event|1|||
143232010|NCT01691794|516399855|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
143232011|NCT01691794|516399856|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
143232012|NCT01691794|516399857|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
143232013|NCT01691794|516399855|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
143232014|NCT01691794|516399856|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
143232015|NCT01691794|516399857|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
143232016|NCT00844844|516399858|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
143232017|NCT00844844|516399858|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
143232018|NCT00844844|516399858|FG000|Extension Treatment Period|Adverse Event|2|||
143232019|NCT00844844|516399858|FG000|Post Treatment Period|Withdrawal by Subject|1|||
143232020|NCT03905096|516399859|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
143232021|NCT03905096|516399860|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
143232022|NCT00945009|516399864|FG000|Overall Study|Lack of Efficacy|10|||
143232023|NCT00945009|516399865|FG001|Overall Study|Lack of Efficacy|0|||
143232024|NCT00945009|516399866|FG002|Overall Study|Lack of Efficacy|0|||
143232025|NCT00945009|516399864|FG000|Overall Study|Physician Decision|21|||
143232026|NCT00945009|516399865|FG001|Overall Study|Physician Decision|4|||
143232027|NCT00945009|516399866|FG002|Overall Study|Physician Decision|3|||
143232028|NCT00945009|516399864|FG000|Overall Study|Protocol Violation|6|||
143232029|NCT00945009|516399865|FG001|Overall Study|Protocol Violation|1|||
143232030|NCT00945009|516399866|FG002|Overall Study|Protocol Violation|0|||
143232031|NCT00945009|516399864|FG000|Overall Study|Withdrawal by Subject|1|||
143232032|NCT00945009|516399865|FG001|Overall Study|Withdrawal by Subject|0|||
143232033|NCT00945009|516399866|FG002|Overall Study|Withdrawal by Subject|0|||
143232034|NCT00945009|516399864|FG000|Overall Study|Ineligible|6|||
143232035|NCT00945009|516399865|FG001|Overall Study|Ineligible|1|||
143232036|NCT00945009|516399866|FG002|Overall Study|Ineligible|0|||
143232037|NCT00945009|516399864|FG000|Overall Study|Inevaluable|0|||
143232038|NCT00945009|516399865|FG001|Overall Study|Inevaluable|1|||
143232039|NCT00945009|516399866|FG002|Overall Study|Inevaluable|0|||
143232040|NCT00945009|516399864|FG000|Overall Study|Refusal of further protocol|1|||
143232041|NCT00945009|516399865|FG001|Overall Study|Refusal of further protocol|0|||
143232042|NCT00945009|516399866|FG002|Overall Study|Refusal of further protocol|0|||
143232043|NCT01352117|516401950|FG000|Overall Study|Death|15|||
143232044|NCT01352117|516401951|FG001|Overall Study|Death|16|||
143232045|NCT01352117|516401950|FG000|Overall Study|Withdrawal by Subject|1|||
143232046|NCT01352117|516401951|FG001|Overall Study|Withdrawal by Subject|0|||
143232047|NCT01352117|516401950|FG000|Overall Study|Lost to Follow-up|2|||
143232048|NCT01352117|516401951|FG001|Overall Study|Lost to Follow-up|7|||
143232049|NCT01352117|516401950|FG000|Overall Study|Non-adherent to study requirements|1|||
143232050|NCT01352117|516401951|FG001|Overall Study|Non-adherent to study requirements|1|||
143232051|NCT01352117|516401950|FG000|Overall Study|Did not initiate study treatment|1|||
143232052|NCT01352117|516401951|FG001|Overall Study|Did not initiate study treatment|0|||
143232053|NCT01352117|516401950|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
143232054|NCT01352117|516401951|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
143232055|NCT01766050|516401952|FG000|Overall Study|Adverse Event|1|||
143232056|NCT01766050|516401952|FG000|Overall Study|Lost to Follow-up|1|||
143232057|NCT01766050|516401952|FG000|Overall Study|Withdrawal by Subject|2|||
143232058|NCT02994108|516401954|FG000|Intervention Messages|Withdrawal by Subject|2|||
143232059|NCT02994108|516401955|FG001|Intervention Messages|Withdrawal by Subject|0|||
143232060|NCT02994108|516401954|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
143232061|NCT02994108|516401955|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
143232062|NCT02994108|516401954|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
143232063|NCT02994108|516401955|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
143232064|NCT02994108|516401954|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
143232065|NCT02994108|516401955|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
143232066|NCT00089297|516401956|FG000|Overall Study|Adverse Event|9|||
143232067|NCT00089297|516401956|FG000|Overall Study|Death|1|||
143232068|NCT00089297|516401956|FG000|Overall Study|Withdrawal by Subject|12|||
143232069|NCT00089297|516401956|FG000|Overall Study|Disease progression|2|||
143232070|NCT00089297|516401956|FG000|Overall Study|Ineligible|11|||
143232071|NCT00089297|516401956|FG000|Overall Study|Secondary malignancy|1|||
143232072|NCT00089297|516401956|FG000|Overall Study|IRB approval not ready|1|||
143232073|NCT00089297|516401956|FG000|Overall Study|Non-compliance|1|||
143232074|NCT00385671|516401959|FG000|Overall Study|Adverse Event|14|||
143232075|NCT00385671|516401960|FG001|Overall Study|Adverse Event|27|||
143232076|NCT00385671|516401961|FG002|Overall Study|Adverse Event|18|||
143232077|NCT00385671|516401959|FG000|Overall Study|Lack of Efficacy|5|||
143232078|NCT00385671|516401960|FG001|Overall Study|Lack of Efficacy|9|||
143232079|NCT00385671|516401961|FG002|Overall Study|Lack of Efficacy|5|||
143232080|NCT00385671|516401959|FG000|Overall Study|Lost to Follow-up|6|||
143232081|NCT00385671|516401960|FG001|Overall Study|Lost to Follow-up|6|||
143232082|NCT00385671|516401961|FG002|Overall Study|Lost to Follow-up|5|||
143232083|NCT00385671|516401959|FG000|Overall Study|Physician Decision|2|||
143232084|NCT00385671|516401960|FG001|Overall Study|Physician Decision|1|||
143232085|NCT00385671|516401961|FG002|Overall Study|Physician Decision|2|||
143232086|NCT00385671|516401959|FG000|Overall Study|Protocol Violation|5|||
143232087|NCT00385671|516401960|FG001|Overall Study|Protocol Violation|2|||
143232088|NCT00385671|516401961|FG002|Overall Study|Protocol Violation|1|||
143232089|NCT00385671|516401959|FG000|Overall Study|Sponsor Decision|2|||
143232090|NCT00385671|516401960|FG001|Overall Study|Sponsor Decision|2|||
143232091|NCT00385671|516401961|FG002|Overall Study|Sponsor Decision|1|||
143232092|NCT00385671|516401959|FG000|Overall Study|Withdrawal by Subject|4|||
143232093|NCT00385671|516401960|FG001|Overall Study|Withdrawal by Subject|4|||
143232094|NCT00385671|516401961|FG002|Overall Study|Withdrawal by Subject|4|||
143232095|NCT00755183|516401967|FG000|Overall Study|Adverse Event|5|||
143232096|NCT00755183|516401968|FG001|Overall Study|Adverse Event|2|||
143232097|NCT00755183|516401967|FG000|Overall Study|Protocol Violation|0|||
143232098|NCT00755183|516401968|FG001|Overall Study|Protocol Violation|1|||
143232099|NCT00755183|516401967|FG000|Overall Study|Withdrawal by Subject|0|||
143232100|NCT00755183|516401968|FG001|Overall Study|Withdrawal by Subject|2|||
143232101|NCT00755183|516401967|FG000|Overall Study|Administrative|2|||
143232102|NCT00755183|516401968|FG001|Overall Study|Administrative|1|||
143232103|NCT02766023|516401971|FG000|Overall Study|Lost to Follow-up|23|||
143232104|NCT02766023|516401972|FG001|Overall Study|Lost to Follow-up|11|||
143232105|NCT02766023|516401971|FG000|Overall Study|Pregnancy|1|||
143232106|NCT02766023|516401972|FG001|Overall Study|Pregnancy|0|||
143232107|NCT02766023|516401971|FG000|Overall Study|Adverse Event|1|||
143232108|NCT02766023|516401972|FG001|Overall Study|Adverse Event|0|||
143232109|NCT02766023|516401971|FG000|Overall Study|Withdrawal by Subject|4|||
143232110|NCT02766023|516401972|FG001|Overall Study|Withdrawal by Subject|5|||
143232111|NCT02766023|516401971|FG000|Overall Study|Physician Decision|1|||
143232112|NCT02766023|516401972|FG001|Overall Study|Physician Decision|0|||
143232113|NCT02766023|516401971|FG000|Overall Study|Not Eligible at Enrollment|0|||
143232114|NCT02766023|516401972|FG001|Overall Study|Not Eligible at Enrollment|1|||
143232115|NCT00087152|516401983|FG000|Overall Study|Ineligible|6|||
143232116|NCT02476617|516401984|FG000|Overall Study|Adverse Event|1|||
143232117|NCT02476617|516401984|FG000|Overall Study|Lost to Follow-up|1|||
143232118|NCT01149096|516401986|FG000|Overall Study|Lost to Follow-up|0|||
143232119|NCT01149096|516401987|FG001|Overall Study|Lost to Follow-up|1|||
143232120|NCT00702702|516401991|FG000|Overall Study|Study prematurely terminated|56|||
143232121|NCT04819945|516401992|FG000|Overall Study|Lost to Follow-up|1|||
143232122|NCT00703014|516401993|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
143232123|NCT00703014|516401994|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
143232124|NCT00703014|516401995|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
143232125|NCT00703014|516401996|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
143232126|NCT00703014|516401993|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
143232127|NCT00703014|516401994|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
143232128|NCT00703014|516401995|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
143232129|NCT00703014|516401996|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
143232130|NCT02004236|516401997|FG000|Overall Study|Lack of Efficacy|0|||
143232131|NCT02004236|516401998|FG001|Overall Study|Lack of Efficacy|0|||
143232132|NCT02004236|516401999|FG002|Overall Study|Lack of Efficacy|16|||
143232133|NCT00625131|516402004|FG000|Overall Study|Lost to Follow-up|3|||
143232134|NCT00625131|516402005|FG001|Overall Study|Lost to Follow-up|2|||
143232135|NCT00625131|516402006|FG002|Overall Study|Lost to Follow-up|0|||
143232136|NCT00625131|516402004|FG000|Overall Study|Withdrawal by Subject|1|||
143232137|NCT00625131|516402005|FG001|Overall Study|Withdrawal by Subject|0|||
143232138|NCT00625131|516402006|FG002|Overall Study|Withdrawal by Subject|5|||
143232139|NCT00918281|516402009|FG000|Overall Study|Physician Decision|29|||
143232140|NCT01667900|516402010|FG000|Part B|Death|0|||
143232141|NCT01667900|516402011|FG001|Part B|Death|0|||
143232142|NCT01667900|516402012|FG002|Part B|Death|0|||
143232143|NCT01667900|516402013|FG003|Part B|Death|0|||
143232144|NCT01667900|516402014|FG004|Part B|Death|0|||
143232145|NCT01667900|516402015|FG005|Part B|Death|0|||
143232146|NCT01667900|516402016|FG006|Part B|Death|0|||
143232147|NCT01667900|516402017|FG007|Part B|Death|0|||
143232148|NCT01667900|516402018|FG008|Part B|Death|0|||
143232149|NCT01667900|516402019|FG009|Part B|Death|0|||
143232150|NCT01667900|516402020|FG010|Part B|Death|0|||
143232151|NCT01667900|516402021|FG011|Part B|Death|0|||
143232152|NCT01667900|516402022|FG012|Part B|Death|0|||
143232153|NCT01667900|516402023|FG013|Part B|Death|0|||
143232154|NCT01667900|516402024|FG014|Part B|Death|0|||
143232155|NCT01667900|516402025|FG015|Part B|Death|0|||
143232156|NCT01667900|516402026|FG016|Part B|Death|1|||
143232157|NCT01667900|516402027|FG017|Part B|Death|0|||
143232158|NCT01667900|516402028|FG018|Part B|Death|0|||
143232159|NCT01667900|516402029|FG019|Part B|Death|0|||
143232160|NCT01446159|516402032|FG000|Overall Study|Withdrawal by Subject|1|||
143232161|NCT01446159|516402033|FG001|Overall Study|Withdrawal by Subject|0|||
143232162|NCT01446159|516402034|FG002|Overall Study|Withdrawal by Subject|14|||
143232163|NCT01446159|516402035|FG003|Overall Study|Withdrawal by Subject|11|||
143232164|NCT01446159|516402032|FG000|Overall Study|Lost to Follow-up|0|||
143232165|NCT01446159|516402033|FG001|Overall Study|Lost to Follow-up|0|||
143232166|NCT01446159|516402034|FG002|Overall Study|Lost to Follow-up|1|||
143232167|NCT01446159|516402035|FG003|Overall Study|Lost to Follow-up|2|||
143232168|NCT01446159|516402032|FG000|Overall Study|Death|2|||
143232169|NCT01446159|516402033|FG001|Overall Study|Death|3|||
143232170|NCT01446159|516402034|FG002|Overall Study|Death|43|||
143232171|NCT01446159|516402035|FG003|Overall Study|Death|36|||
143466021|NCT00261846|517253723|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
143466022|NCT00261846|517253724|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
143466023|NCT00261846|517253725|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
143466024|NCT00261846|517253714|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
143466025|NCT00261846|517253715|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
143466026|NCT00261846|517253716|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
143466027|NCT00261846|517253717|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
143466028|NCT00261846|517253718|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
143466029|NCT00261846|517253719|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
143466030|NCT00261846|517253720|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
143013916|NCT02139306|515590083|FG000|Overall Study|Other Unspecified|2|||
143013917|NCT02139306|515590084|FG001|Overall Study|Other Unspecified|3|||
143466031|NCT00261846|517253721|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
143466032|NCT00261846|517253722|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
143466033|NCT00261846|517253723|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
143466034|NCT00261846|517253724|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
143466035|NCT00261846|517253725|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
143466036|NCT00261846|517253714|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
143466037|NCT00261846|517253715|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
143466038|NCT00261846|517253716|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
143466039|NCT00261846|517253717|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
143466040|NCT00261846|517253718|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
143466041|NCT00261846|517253719|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
143466042|NCT00261846|517253720|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
143466043|NCT00261846|517253721|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
143466044|NCT00261846|517253722|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
143466045|NCT00261846|517253723|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
143466046|NCT00261846|517253724|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
143466047|NCT00261846|517253725|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
143466048|NCT00261846|517253714|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
143466049|NCT00261846|517253715|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
143466050|NCT00261846|517253716|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
143466051|NCT00261846|517253717|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
143466052|NCT00261846|517253718|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
143466053|NCT00261846|517253719|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
143466054|NCT00261846|517253720|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
143466055|NCT00261846|517253721|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
143466056|NCT00261846|517253722|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
143466057|NCT00261846|517253723|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
143466058|NCT00261846|517253724|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
143466059|NCT00261846|517253725|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
143466060|NCT00261846|517253714|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
143466061|NCT00261846|517253715|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
143466062|NCT00261846|517253716|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
143466063|NCT00261846|517253717|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
143466064|NCT00261846|517253718|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
143466065|NCT00261846|517253719|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
143466066|NCT00261846|517253720|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
143466067|NCT00261846|517253721|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
143466068|NCT00261846|517253722|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
143466069|NCT00261846|517253723|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
143466070|NCT00261846|517253724|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
143466071|NCT00261846|517253725|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
143466072|NCT00261846|517253714|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
143466073|NCT00261846|517253715|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
143466074|NCT00261846|517253716|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
143466075|NCT00261846|517253717|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
143466076|NCT00261846|517253718|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
143466077|NCT00261846|517253719|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
143466078|NCT00261846|517253720|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
143466079|NCT00261846|517253721|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
143466080|NCT00261846|517253722|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
143466081|NCT00261846|517253723|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
143466082|NCT00261846|517253724|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
143466083|NCT00261846|517253725|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
143466084|NCT00261846|517253714|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
143466085|NCT00261846|517253715|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
143466086|NCT00261846|517253716|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
143466087|NCT00261846|517253717|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
143466088|NCT00261846|517253718|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
143466089|NCT00261846|517253719|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
143466090|NCT00261846|517253720|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
143466091|NCT00261846|517253721|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
143466092|NCT00261846|517253722|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
143466093|NCT00261846|517253723|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
143466094|NCT00261846|517253724|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
143466095|NCT00261846|517253725|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
143466096|NCT00325039|517253726|FG000|Overall Study|Lost to Follow-up|18|||
143466097|NCT00325039|517253727|FG001|Overall Study|Lost to Follow-up|14|||
143466098|NCT02147353|517253728|FG000|Overall Study|Lost to Follow-up|2|||
143466099|NCT02147353|517253729|FG001|Overall Study|Lost to Follow-up|0|||
143466100|NCT02147353|517253728|FG000|Overall Study|unable to make visits|4|||
143466101|NCT02147353|517253729|FG001|Overall Study|unable to make visits|0|||
143466102|NCT02147353|517253728|FG000|Overall Study|medication noncompliance|3|||
143466103|NCT02147353|517253729|FG001|Overall Study|medication noncompliance|0|||
143466104|NCT02974088|517253734|FG000|Overall Study|Lost to Follow-up|0|||
143466105|NCT02974088|517253735|FG001|Overall Study|Lost to Follow-up|2|||
143466106|NCT02974088|517253734|FG000|Overall Study|Adverse Event|0|||
143466107|NCT02974088|517253735|FG001|Overall Study|Adverse Event|1|||
143466108|NCT00150969|517253736|FG000|24 Month Main Study|Adverse Event|3|||
143466109|NCT00150969|517253737|FG001|24 Month Main Study|Adverse Event|4|||
143466110|NCT00150969|517253736|FG000|24 Month Main Study|Death|1|||
143466111|NCT00150969|517253737|FG001|24 Month Main Study|Death|1|||
143466112|NCT00150969|517253736|FG000|24 Month Main Study|Lack of Efficacy|1|||
143466113|NCT00150969|517253737|FG001|24 Month Main Study|Lack of Efficacy|8|||
143466114|NCT00150969|517253736|FG000|24 Month Main Study|Lost to Follow-up|3|||
143466115|NCT00150969|517253737|FG001|24 Month Main Study|Lost to Follow-up|2|||
143466116|NCT00150969|517253736|FG000|24 Month Main Study|Protocol Violation|4|||
143466117|NCT00150969|517253737|FG001|24 Month Main Study|Protocol Violation|2|||
143466118|NCT00150969|517253736|FG000|24 Month Main Study|Withdrawal by Subject|7|||
143466119|NCT00150969|517253737|FG001|24 Month Main Study|Withdrawal by Subject|4|||
143466120|NCT00150969|517253736|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
143466121|NCT00150969|517253737|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
143466122|NCT00150969|517253736|FG000|24-48 Month Extension|Lack of Efficacy|0|||
143466123|NCT00150969|517253737|FG001|24-48 Month Extension|Lack of Efficacy|1|||
143466124|NCT00150969|517253736|FG000|24-48 Month Extension|Adverse Event|1|||
143466125|NCT00150969|517253737|FG001|24-48 Month Extension|Adverse Event|3|||
143466126|NCT00150969|517253736|FG000|24-48 Month Extension|Other Reason|81|||
143466127|NCT00150969|517253737|FG001|24-48 Month Extension|Other Reason|91|||
143466128|NCT00146757|517253738|FG000|Overall Study|Death|1|||
143466129|NCT00146757|517253739|FG001|Overall Study|Death|0|||
143466130|NCT00146757|517253738|FG000|Overall Study|Adverse Event|1|||
143466131|NCT00146757|517253739|FG001|Overall Study|Adverse Event|0|||
143466132|NCT01176773|517253751|FG000|Overall Study|Screen Failure|2|||
143466133|NCT01176773|517253751|FG000|Overall Study|Withdrew consent|1|||
143466134|NCT02446886|517253755|FG000|Overall Study|Adverse Event|1|||
143466135|NCT02446886|517253756|FG001|Overall Study|Adverse Event|3|||
143466136|NCT02446886|517253755|FG000|Overall Study|Withdrawal by Subject|1|||
143466137|NCT02446886|517253756|FG001|Overall Study|Withdrawal by Subject|1|||
143466138|NCT01423253|517253759|FG000|Overall Study|Adverse Event|2|||
143466139|NCT01423253|517253759|FG000|Overall Study|Lack of Efficacy|2|||
143466140|NCT01423253|517253759|FG000|Overall Study|Lost to Follow-up|1|||
143466141|NCT01423253|517253759|FG000|Overall Study|Protocol Violation|2|||
143466142|NCT01423253|517253759|FG000|Overall Study|Withdrawal by Subject|2|||
143466143|NCT00926211|517253760|FG000|Overall Study|Lost to Follow-up|1|||
143466144|NCT01032382|517253763|FG000|Overall Study|Disease dissemination|1|||
143466145|NCT01032382|517253764|FG001|Overall Study|Disease dissemination|1|||
143466146|NCT01032382|517253763|FG000|Overall Study|Treatment failure|3|||
143466147|NCT01032382|517253764|FG001|Overall Study|Treatment failure|1|||
143466148|NCT01032382|517253763|FG000|Overall Study|Index lesion relapse|1|||
143466149|NCT01032382|517253764|FG001|Overall Study|Index lesion relapse|3|||
143466150|NCT00894686|517253765|FG000|Overall Study|Withdrawal by Subject|50|||
143466151|NCT00894686|517253765|FG000|Overall Study|Physician Decision|1|||
143466152|NCT00894686|517253765|FG000|Overall Study|Other|5|||
143466153|NCT00564018|517253766|FG000|Overall Study|Withdrawal by Subject|2|||
143466154|NCT00564018|517253767|FG001|Overall Study|Withdrawal by Subject|3|||
143466155|NCT00564018|517253768|FG002|Overall Study|Withdrawal by Subject|1|||
143466156|NCT00986440|517253769|FG000|Overall Study|Progressive disease|27|||
143466157|NCT00986440|517253770|FG001|Overall Study|Progressive disease|37|||
143466158|NCT00986440|517253769|FG000|Overall Study|Serious adverse event or adverse event|9|||
143466159|NCT00986440|517253770|FG001|Overall Study|Serious adverse event or adverse event|2|||
143466160|NCT00986440|517253769|FG000|Overall Study|Withdrawal by Subject|1|||
143466161|NCT00986440|517253770|FG001|Overall Study|Withdrawal by Subject|2|||
143466162|NCT00986440|517253769|FG000|Overall Study|Screen failure (not dosed)|4|||
143466163|NCT00986440|517253770|FG001|Overall Study|Screen failure (not dosed)|2|||
143466164|NCT05056987|517253773|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
143466165|NCT05056987|517253774|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
143466166|NCT05056987|517253773|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
143466167|NCT05056987|517253774|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
143466168|NCT02409368|517253775|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
143466169|NCT02409368|517253776|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
143466170|NCT02409368|517253777|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
143466171|NCT02409368|517253778|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
143466172|NCT02409368|517253775|FG000|ECOG Reclassification|Death|1|||
143466173|NCT02409368|517253776|FG001|ECOG Reclassification|Death|5|||
143466174|NCT02409368|517253777|FG002|ECOG Reclassification|Death|0|||
143466175|NCT02409368|517253778|FG003|ECOG Reclassification|Death|0|||
143466176|NCT02409368|517253775|FG000|ECOG Reclassification|Disease Progression|113|||
143466177|NCT02409368|517253776|FG001|ECOG Reclassification|Disease Progression|382|||
143466178|NCT02409368|517253777|FG002|ECOG Reclassification|Disease Progression|70|||
143466179|NCT02409368|517253778|FG003|ECOG Reclassification|Disease Progression|1|||
143466180|NCT02409368|517253775|FG000|ECOG Reclassification|Lost to Follow-up|1|||
143358378|NCT00946647|516856152|FG003|Phase 1 Part|Reason missing|0|||
143358379|NCT00946647|516856153|FG004|Phase 1 Part|Reason missing|0|||
143358380|NCT00946647|516856149|FG000|Phase ll Part|Untreated|0|||
143358381|NCT00946647|516856150|FG001|Phase ll Part|Untreated|0|||
143358382|NCT00946647|516856151|FG002|Phase ll Part|Untreated|0|||
143358383|NCT00946647|516856152|FG003|Phase ll Part|Untreated|0|||
143358384|NCT00946647|516856153|FG004|Phase ll Part|Untreated|2|||
143358385|NCT00946647|516856149|FG000|Phase ll Part|Adverse Event|0|||
143358386|NCT00946647|516856150|FG001|Phase ll Part|Adverse Event|0|||
143358387|NCT00946647|516856151|FG002|Phase ll Part|Adverse Event|0|||
143358388|NCT00946647|516856152|FG003|Phase ll Part|Adverse Event|10|||
143358389|NCT00946647|516856153|FG004|Phase ll Part|Adverse Event|6|||
143358390|NCT00946647|516856149|FG000|Phase ll Part|Withdrawal by Subject|0|||
143358391|NCT00946647|516856150|FG001|Phase ll Part|Withdrawal by Subject|0|||
143358392|NCT00946647|516856151|FG002|Phase ll Part|Withdrawal by Subject|0|||
143358393|NCT00946647|516856152|FG003|Phase ll Part|Withdrawal by Subject|8|||
143358394|NCT00946647|516856153|FG004|Phase ll Part|Withdrawal by Subject|6|||
143358395|NCT00946647|516856149|FG000|Phase ll Part|Administrative problems|0|||
143358396|NCT00946647|516856150|FG001|Phase ll Part|Administrative problems|0|||
143358397|NCT00946647|516856151|FG002|Phase ll Part|Administrative problems|0|||
143358398|NCT00946647|516856152|FG003|Phase ll Part|Administrative problems|3|||
143358399|NCT00946647|516856153|FG004|Phase ll Part|Administrative problems|8|||
143358400|NCT00946647|516856149|FG000|Phase ll Part|Death|0|||
143358401|NCT00946647|516856150|FG001|Phase ll Part|Death|0|||
143358402|NCT00946647|516856151|FG002|Phase ll Part|Death|0|||
143358403|NCT00946647|516856152|FG003|Phase ll Part|Death|7|||
143358404|NCT00946647|516856153|FG004|Phase ll Part|Death|4|||
143358405|NCT00946647|516856149|FG000|Phase ll Part|Disease progression|0|||
143358406|NCT00946647|516856150|FG001|Phase ll Part|Disease progression|0|||
143358407|NCT00946647|516856151|FG002|Phase ll Part|Disease progression|0|||
143358408|NCT00946647|516856152|FG003|Phase ll Part|Disease progression|6|||
143358409|NCT00946647|516856153|FG004|Phase ll Part|Disease progression|14|||
143358410|NCT00946647|516856149|FG000|Phase ll Part|Protocol Violation|0|||
143358411|NCT00946647|516856150|FG001|Phase ll Part|Protocol Violation|0|||
143358412|NCT00946647|516856151|FG002|Phase ll Part|Protocol Violation|0|||
143358413|NCT00946647|516856152|FG003|Phase ll Part|Protocol Violation|4|||
143358414|NCT00946647|516856153|FG004|Phase ll Part|Protocol Violation|2|||
143358415|NCT00946647|516856149|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
143358416|NCT00946647|516856150|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
143358417|NCT00946647|516856151|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
143358418|NCT00946647|516856152|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
143358419|NCT00946647|516856153|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
143358420|NCT04504916|516856154|FG000|Overall Study|Study terminated|7|||
143358421|NCT04504916|516856155|FG001|Overall Study|Study terminated|8|||
143358422|NCT04504916|516856154|FG000|Overall Study|Death|54|||
143358423|NCT04504916|516856155|FG001|Overall Study|Death|18|||
143358424|NCT04504916|516856154|FG000|Overall Study|Lost to Follow-up|1|||
143358425|NCT04504916|516856155|FG001|Overall Study|Lost to Follow-up|1|||
143358426|NCT04504916|516856154|FG000|Overall Study|Withdrawal by Subject|8|||
143358427|NCT04504916|516856155|FG001|Overall Study|Withdrawal by Subject|4|||
143358428|NCT04504916|516856154|FG000|Overall Study|Did not agree to follow-up|0|||
143358429|NCT04504916|516856155|FG001|Overall Study|Did not agree to follow-up|1|||
143358430|NCT04209790|516856156|FG000|Overall Study|Physician Decision|1|||
143358431|NCT03706690|516856158|FG000|Overall Study|Withdrawal by Subject|8|||
143358432|NCT03706690|516856159|FG001|Overall Study|Withdrawal by Subject|8|||
143358433|NCT03706690|516856158|FG000|Overall Study|Death|143|||
143358434|NCT03706690|516856159|FG001|Overall Study|Death|75|||
143358435|NCT03706690|516856158|FG000|Overall Study|Ongoing at DCO|121|||
143358436|NCT03706690|516856159|FG001|Overall Study|Ongoing at DCO|52|||
143358437|NCT02711826|516856160|FG000|Overall Study|Physician Decision|0|||
143358438|NCT02711826|516856161|FG001|Overall Study|Physician Decision|0|||
143358439|NCT02711826|516856162|FG002|Overall Study|Physician Decision|0|||
143358440|NCT02711826|516856163|FG003|Overall Study|Physician Decision|1|||
143358441|NCT02711826|516856164|FG004|Overall Study|Physician Decision|0|||
143358442|NCT02711826|516856160|FG000|Overall Study|Withdrawal by Subject|0|||
143358443|NCT02711826|516856161|FG001|Overall Study|Withdrawal by Subject|1|||
143358444|NCT02711826|516856162|FG002|Overall Study|Withdrawal by Subject|0|||
143358445|NCT02711826|516856163|FG003|Overall Study|Withdrawal by Subject|4|||
143358446|NCT02711826|516856164|FG004|Overall Study|Withdrawal by Subject|0|||
143358447|NCT02711826|516856160|FG000|Overall Study|Failure to manufacture cellular product|0|||
143358448|NCT02711826|516856161|FG001|Overall Study|Failure to manufacture cellular product|0|||
143358449|NCT02711826|516856162|FG002|Overall Study|Failure to manufacture cellular product|5|||
143358450|NCT02711826|516856163|FG003|Overall Study|Failure to manufacture cellular product|0|||
143358451|NCT02711826|516856164|FG004|Overall Study|Failure to manufacture cellular product|0|||
143358452|NCT02711826|516856160|FG000|Overall Study|Infusion canceled for active infection|0|||
143358453|NCT02711826|516856161|FG001|Overall Study|Infusion canceled for active infection|1|||
143358454|NCT02711826|516856162|FG002|Overall Study|Infusion canceled for active infection|0|||
143466181|NCT02409368|517253776|FG001|ECOG Reclassification|Lost to Follow-up|5|||
143466182|NCT02409368|517253777|FG002|ECOG Reclassification|Lost to Follow-up|0|||
143466183|NCT02409368|517253778|FG003|ECOG Reclassification|Lost to Follow-up|0|||
143466184|NCT02409368|517253775|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
143466185|NCT02409368|517253776|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
143466186|NCT02409368|517253777|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
143466187|NCT02409368|517253778|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
143466188|NCT02409368|517253775|FG000|ECOG Reclassification|Poor/non-compliance|0|||
143466189|NCT02409368|517253776|FG001|ECOG Reclassification|Poor/non-compliance|3|||
143466190|NCT02409368|517253777|FG002|ECOG Reclassification|Poor/non-compliance|2|||
143466191|NCT02409368|517253778|FG003|ECOG Reclassification|Poor/non-compliance|0|||
143466192|NCT02409368|517253775|FG000|ECOG Reclassification|Study drug toxicity|17|||
143466193|NCT02409368|517253776|FG001|ECOG Reclassification|Study drug toxicity|42|||
143466194|NCT02409368|517253777|FG002|ECOG Reclassification|Study drug toxicity|7|||
143466195|NCT02409368|517253778|FG003|ECOG Reclassification|Study drug toxicity|0|||
143466196|NCT02409368|517253775|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
143466197|NCT02409368|517253776|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
143466198|NCT02409368|517253777|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
143466199|NCT02409368|517253778|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
143466200|NCT02409368|517253775|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
143466201|NCT02409368|517253776|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
143466202|NCT02409368|517253777|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
143466203|NCT02409368|517253778|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
143466204|NCT02409368|517253775|FG000|ECOG Reclassification|Participant withdrew consent|2|||
143466205|NCT02409368|517253776|FG001|ECOG Reclassification|Participant withdrew consent|3|||
143466206|NCT02409368|517253777|FG002|ECOG Reclassification|Participant withdrew consent|4|||
143466207|NCT02409368|517253778|FG003|ECOG Reclassification|Participant withdrew consent|0|||
143466208|NCT02409368|517253775|FG000|ECOG Reclassification|Other Reasons|5|||
143466209|NCT02409368|517253776|FG001|ECOG Reclassification|Other Reasons|26|||
143466210|NCT02409368|517253777|FG002|ECOG Reclassification|Other Reasons|2|||
143466211|NCT02409368|517253778|FG003|ECOG Reclassification|Other Reasons|0|||
143466212|NCT02409368|517253775|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
143466213|NCT02409368|517253776|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
143466214|NCT02409368|517253777|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
143466215|NCT02409368|517253778|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
143466216|NCT01296347|517253779|FG000|Allocation|Withdrawal by Subject|1|||
143466217|NCT01296347|517253780|FG001|Allocation|Withdrawal by Subject|2|||
143466218|NCT01296347|517253779|FG000|Allocation|Lack of Efficacy|1|||
143466219|NCT01296347|517253780|FG001|Allocation|Lack of Efficacy|2|||
143466220|NCT01296347|517253779|FG000|Allocation|not received infusion|1|||
143466221|NCT01296347|517253780|FG001|Allocation|not received infusion|0|||
143466222|NCT01296347|517253779|FG000|6 Week Follow up|Death|0|||
143466223|NCT01296347|517253780|FG001|6 Week Follow up|Death|1|||
143466224|NCT01296347|517253779|FG000|3 Month Follow up|Death|1|||
143466225|NCT01296347|517253780|FG001|3 Month Follow up|Death|0|||
143466226|NCT01296347|517253779|FG000|3 Month Follow up|Lost to Follow-up|0|||
143466227|NCT01296347|517253780|FG001|3 Month Follow up|Lost to Follow-up|1|||
143466228|NCT01296347|517253779|FG000|6 Month Follow up|Death|2|||
143466229|NCT01296347|517253780|FG001|6 Month Follow up|Death|1|||
143466230|NCT01296347|517253779|FG000|6 Month Follow up|Lost to Follow-up|0|||
143466231|NCT01296347|517253780|FG001|6 Month Follow up|Lost to Follow-up|1|||
143466232|NCT01296347|517253779|FG000|12 Month Follow up|Lost to Follow-up|3|||
143466233|NCT01296347|517253780|FG001|12 Month Follow up|Lost to Follow-up|1|||
143466234|NCT01296347|517253779|FG000|12 Month Follow up|Death|1|||
143466235|NCT01296347|517253780|FG001|12 Month Follow up|Death|1|||
143466236|NCT01296347|517253779|FG000|12 Month Follow up|Withdrawal by Subject|0|||
143466237|NCT01296347|517253780|FG001|12 Month Follow up|Withdrawal by Subject|1|||
143466238|NCT02240693|517253781|FG000|Overall Study|Adverse Event|0|||
143466239|NCT02240693|517253782|FG001|Overall Study|Adverse Event|0|||
143466240|NCT02240693|517253783|FG002|Overall Study|Adverse Event|0|||
143466241|NCT02240693|517253784|FG003|Overall Study|Adverse Event|0|||
143466242|NCT02240693|517253785|FG004|Overall Study|Adverse Event|1|||
143466243|NCT02240693|517253781|FG000|Overall Study|Withdrawal by Subject|0|||
143466244|NCT02240693|517253782|FG001|Overall Study|Withdrawal by Subject|0|||
143466245|NCT02240693|517253783|FG002|Overall Study|Withdrawal by Subject|2|||
143466246|NCT02240693|517253784|FG003|Overall Study|Withdrawal by Subject|1|||
143466247|NCT02240693|517253785|FG004|Overall Study|Withdrawal by Subject|0|||
143466248|NCT02240693|517253781|FG000|Overall Study|Other than specified|0|||
143466249|NCT02240693|517253782|FG001|Overall Study|Other than specified|0|||
143013918|NCT02139306|515590083|FG000|Overall Study|Protocol Violation|4|||
143466250|NCT02240693|517253783|FG002|Overall Study|Other than specified|2|||
143466251|NCT02240693|517253784|FG003|Overall Study|Other than specified|0|||
143013919|NCT02139306|515590084|FG001|Overall Study|Protocol Violation|0|||
143013920|NCT04449354|515590085|FG000|Overall Study|Withdrawal by Subject|1|||
143466252|NCT02240693|517253785|FG004|Overall Study|Other than specified|0|||
143466253|NCT01948908|517253786|FG000|Overall Study|Protocol Violation|1|||
143466254|NCT01948908|517253787|FG001|Overall Study|Protocol Violation|0|||
143466255|NCT01948908|517253788|FG002|Overall Study|Protocol Violation|2|||
143466256|NCT01585987|517253789|FG000|Randomized|Withdrawal by Subject|0|||
143466257|NCT01585987|517253790|FG001|Randomized|Withdrawal by Subject|4|||
143466258|NCT01585987|517253789|FG000|Randomized|No longer met criteria|0|||
143466259|NCT01585987|517253790|FG001|Randomized|No longer met criteria|2|||
143466260|NCT01585987|517253789|FG000|Treated|Disease Progression|39|||
143466261|NCT01585987|517253790|FG001|Treated|Disease Progression|36|||
143466262|NCT01585987|517253789|FG000|Treated|Study Drug Toxicity|9|||
143466263|NCT01585987|517253790|FG001|Treated|Study Drug Toxicity|5|||
143466264|NCT01585987|517253789|FG000|Treated|Adverse Event|3|||
143466265|NCT01585987|517253790|FG001|Treated|Adverse Event|0|||
143466266|NCT01585987|517253789|FG000|Treated|Withdrawal by Subject|1|||
143466267|NCT01585987|517253790|FG001|Treated|Withdrawal by Subject|2|||
143466268|NCT01585987|517253789|FG000|Treated|Death|1|||
143466269|NCT01585987|517253790|FG001|Treated|Death|0|||
143466270|NCT01585987|517253789|FG000|Treated|Lost to Follow-up|0|||
143466271|NCT01585987|517253790|FG001|Treated|Lost to Follow-up|1|||
143466272|NCT01585987|517253789|FG000|Treated|Maximum Clinical Benefit|0|||
143466273|NCT01585987|517253790|FG001|Treated|Maximum Clinical Benefit|1|||
143466274|NCT01585987|517253789|FG000|Treated|Non-Specified|1|||
143466275|NCT01585987|517253790|FG001|Treated|Non-Specified|2|||
143466276|NCT01585987|517253789|FG000|Treated|Subject Request|0|||
143466277|NCT01585987|517253790|FG001|Treated|Subject Request|1|||
143466278|NCT01585987|517253789|FG000|Treated|Poor/Non-Compliance|0|||
143466279|NCT01585987|517253790|FG001|Treated|Poor/Non-Compliance|1|||
143466280|NCT02041520|517253792|FG000|Overall Study|Adverse Event|2|||
143466281|NCT02041520|517253793|FG001|Overall Study|Adverse Event|1|||
143466282|NCT02041520|517253792|FG000|Overall Study|Withdrawal by Subject|3|||
143466283|NCT02041520|517253793|FG001|Overall Study|Withdrawal by Subject|4|||
143466284|NCT02041520|517253792|FG000|Overall Study|Protocol Violation|1|||
143466285|NCT02041520|517253793|FG001|Overall Study|Protocol Violation|0|||
143466286|NCT02041520|517253792|FG000|Overall Study|Lost to Follow-up|0|||
143466287|NCT02041520|517253793|FG001|Overall Study|Lost to Follow-up|1|||
143466288|NCT02041520|517253792|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
143466289|NCT02041520|517253793|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
143466290|NCT00413972|517253796|FG000|Overall Study|Adverse Event|2|||
143466291|NCT00413972|517253797|FG001|Overall Study|Adverse Event|1|||
143466292|NCT00413972|517253798|FG002|Overall Study|Adverse Event|0|||
143466293|NCT00413972|517253799|FG003|Overall Study|Adverse Event|0|||
143466294|NCT00413972|517253796|FG000|Overall Study|Lost to Follow-up|1|||
143466295|NCT00413972|517253797|FG001|Overall Study|Lost to Follow-up|2|||
143466296|NCT00413972|517253798|FG002|Overall Study|Lost to Follow-up|1|||
143466297|NCT00413972|517253799|FG003|Overall Study|Lost to Follow-up|0|||
143466298|NCT00413972|517253796|FG000|Overall Study|Withdrawal by Subject|4|||
143466299|NCT00413972|517253797|FG001|Overall Study|Withdrawal by Subject|5|||
143466300|NCT00413972|517253798|FG002|Overall Study|Withdrawal by Subject|7|||
143466301|NCT00413972|517253799|FG003|Overall Study|Withdrawal by Subject|2|||
143466302|NCT00413972|517253796|FG000|Overall Study|Protocol Violation|0|||
143466303|NCT00413972|517253797|FG001|Overall Study|Protocol Violation|0|||
143466304|NCT00413972|517253798|FG002|Overall Study|Protocol Violation|2|||
143466305|NCT00413972|517253799|FG003|Overall Study|Protocol Violation|0|||
143466306|NCT00413972|517253796|FG000|Overall Study|Other|0|||
143466307|NCT00413972|517253797|FG001|Overall Study|Other|0|||
143466308|NCT00413972|517253798|FG002|Overall Study|Other|0|||
143466309|NCT00413972|517253799|FG003|Overall Study|Other|1|||
143466310|NCT01759407|517253800|FG000|Overall Study|Protocol Violation|0|||
143466311|NCT01759407|517253801|FG001|Overall Study|Protocol Violation|2|||
143466312|NCT02520284|517253802|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
143013921|NCT02587325|515590086|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
143466313|NCT02520284|517253803|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
143466314|NCT02520284|517253804|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
143466315|NCT02520284|517253802|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
143466316|NCT02520284|517253803|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
143466317|NCT02520284|517253804|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
143466318|NCT02520284|517253802|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
143466319|NCT02520284|517253803|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
143466320|NCT02520284|517253804|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
143013922|NCT02587325|515590087|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
143466321|NCT02520284|517253802|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
143466322|NCT02520284|517253803|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
143466323|NCT02520284|517253804|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
143466324|NCT02520284|517253802|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
143466325|NCT02520284|517253803|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
143466326|NCT02520284|517253804|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
143466327|NCT02520284|517253802|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
143466328|NCT02520284|517253803|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
143466329|NCT02520284|517253804|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
143466330|NCT02520284|517253802|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
143466331|NCT02520284|517253803|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
143466332|NCT02520284|517253804|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
143466333|NCT02520284|517253802|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
143466334|NCT02520284|517253803|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
143466335|NCT02520284|517253804|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
143466336|NCT02520284|517253802|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
143466337|NCT02520284|517253803|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
143466338|NCT02520284|517253804|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
143466339|NCT02520284|517253802|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
143466340|NCT02520284|517253803|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
143466341|NCT02520284|517253804|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
143466342|NCT02520284|517253802|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
143466343|NCT02520284|517253803|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
143466344|NCT02520284|517253804|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
143466345|NCT01898923|517253805|FG000|Overall Study|Lack of Efficacy|5|||
143466346|NCT01898923|517253806|FG001|Overall Study|Lack of Efficacy|6|||
143466347|NCT01898923|517253805|FG000|Overall Study|Adverse Event|3|||
143466348|NCT01898923|517253806|FG001|Overall Study|Adverse Event|1|||
143466349|NCT01898923|517253805|FG000|Overall Study|Lost to Follow-up|0|||
143466350|NCT01898923|517253806|FG001|Overall Study|Lost to Follow-up|1|||
143466351|NCT01898923|517253805|FG000|Overall Study|Withdrawal by Subject|4|||
143466352|NCT01898923|517253806|FG001|Overall Study|Withdrawal by Subject|7|||
143466353|NCT01898923|517253805|FG000|Overall Study|Physician Decision|3|||
143466354|NCT01898923|517253806|FG001|Overall Study|Physician Decision|4|||
143466355|NCT01898923|517253805|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
143466356|NCT01898923|517253806|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
143466357|NCT02678247|517253807|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
143466358|NCT02678247|517253808|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
143466359|NCT02678247|517253807|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
143466360|NCT02678247|517253808|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
143466361|NCT02678247|517253807|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
143466362|NCT02678247|517253808|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
143466363|NCT02678247|517253807|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
143466364|NCT02678247|517253808|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
143466365|NCT02678247|517253807|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
143466366|NCT02678247|517253808|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
143466367|NCT02678247|517253807|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
143466368|NCT02678247|517253808|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
143466369|NCT00026208|517253811|FG000|Overall Study|Complications of auto accident|1|||
143466370|NCT00026208|517253812|FG001|Overall Study|Complications of auto accident|0|||
143466371|NCT02225353|517253813|FG000|Overall Study|Lost to Follow-up|0|||
143466372|NCT02225353|517253814|FG001|Overall Study|Lost to Follow-up|1|||
143466373|NCT02225353|517253815|FG002|Overall Study|Lost to Follow-up|3|||
143466374|NCT02225353|517253813|FG000|Overall Study|Protocol Violation|4|||
143466375|NCT02225353|517253814|FG001|Overall Study|Protocol Violation|5|||
143466376|NCT02225353|517253815|FG002|Overall Study|Protocol Violation|12|||
143466377|NCT02910739|517253817|FG000|Overall Study|Adverse Event|1|||
143466378|NCT02910739|517253818|FG001|Overall Study|Adverse Event|0|||
143466379|NCT02910739|517253819|FG002|Overall Study|Adverse Event|0|||
143466380|NCT02910739|517253820|FG003|Overall Study|Adverse Event|0|||
143466381|NCT03226275|517253828|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
143466382|NCT03226275|517253829|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
143466383|NCT03226275|517253830|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
143466384|NCT03226275|517253831|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
143466385|NCT03226275|517253828|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
143466386|NCT03226275|517253829|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
143466387|NCT03226275|517253830|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
143466388|NCT03226275|517253831|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
143466389|NCT05677893|517255678|FG000|Overall Study|Withdrawal by Subject|0|||
143466390|NCT05677893|517255679|FG001|Overall Study|Withdrawal by Subject|0|||
143466391|NCT05677893|517255680|FG002|Overall Study|Withdrawal by Subject|0|||
143466392|NCT05677893|517255681|FG003|Overall Study|Withdrawal by Subject|0|||
143466393|NCT05677893|517255682|FG004|Overall Study|Withdrawal by Subject|1|||
143466394|NCT05677893|517255683|FG005|Overall Study|Withdrawal by Subject|1|||
143466395|NCT05677893|517255684|FG006|Overall Study|Withdrawal by Subject|0|||
143466396|NCT05677893|517255678|FG000|Overall Study|Others|1|||
143466397|NCT05677893|517255679|FG001|Overall Study|Others|0|||
143466398|NCT05677893|517255680|FG002|Overall Study|Others|0|||
143466399|NCT05677893|517255681|FG003|Overall Study|Others|0|||
143466400|NCT05677893|517255682|FG004|Overall Study|Others|0|||
143466401|NCT05677893|517255683|FG005|Overall Study|Others|0|||
143466402|NCT05677893|517255684|FG006|Overall Study|Others|0|||
143466403|NCT03217266|517255685|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
143466404|NCT03217266|517255686|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
143466405|NCT03217266|517255687|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
143466406|NCT03217266|517255688|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
143466407|NCT03217266|517255685|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
143466408|NCT03217266|517255686|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
143466409|NCT03217266|517255687|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
143466410|NCT03217266|517255688|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
143466411|NCT03217266|517255685|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
143466412|NCT03217266|517255686|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
143466413|NCT03217266|517255687|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
143466414|NCT03217266|517255688|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
143466415|NCT00720941|517255693|FG000|Overall Study|Protocol Violation|1|||
143466416|NCT00720941|517255694|FG001|Overall Study|Protocol Violation|2|||
143466417|NCT00720941|517255693|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|8|||
143466418|NCT00720941|517255694|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|7|||
143466419|NCT00720941|517255693|FG000|Overall Study|Lost to Follow-up|20|||
143466420|NCT00720941|517255694|FG001|Overall Study|Lost to Follow-up|15|||
143466421|NCT00720941|517255693|FG000|Overall Study|Physician Decision|14|||
143466422|NCT00720941|517255694|FG001|Overall Study|Physician Decision|12|||
143466423|NCT00720941|517255693|FG000|Overall Study|Withdrawal by Subject|29|||
143466424|NCT00720941|517255694|FG001|Overall Study|Withdrawal by Subject|36|||
143466425|NCT00792805|517255696|FG000|Overall Study|Adverse Event|12|||
143466426|NCT00792805|517255697|FG001|Overall Study|Adverse Event|10|||
143466427|NCT00792805|517255698|FG002|Overall Study|Adverse Event|10|||
143466428|NCT00792805|517255696|FG000|Overall Study|Subject withdrew consent|5|||
143466429|NCT00792805|517255697|FG001|Overall Study|Subject withdrew consent|6|||
143133448|NCT00528424|516033378|FG000|Overall Study|Administrative reason|2|||
143133449|NCT00528424|516033378|FG000|Overall Study|Other|12|||
143133450|NCT02515630|516033379|FG000|Overall Study|Withdrawal by Subject|5|||
143358455|NCT02711826|516856163|FG003|Overall Study|Infusion canceled for active infection|0|||
143358456|NCT02711826|516856164|FG004|Overall Study|Infusion canceled for active infection|0|||
143358457|NCT02711826|516856160|FG000|Overall Study|Screen failures|0|||
143358458|NCT02711826|516856161|FG001|Overall Study|Screen failures|0|||
143358459|NCT02711826|516856162|FG002|Overall Study|Screen failures|0|||
143358460|NCT02711826|516856163|FG003|Overall Study|Screen failures|4|||
143358461|NCT02711826|516856164|FG004|Overall Study|Screen failures|0|||
143358462|NCT02169219|516856167|FG000|Overall Study|Lack of Efficacy|6|||
143358463|NCT02886936|516856168|FG000|Overall Study|Lost to Follow-up|4|||
143358464|NCT02886936|516856169|FG001|Overall Study|Lost to Follow-up|3|||
143358465|NCT02886936|516856170|FG002|Overall Study|Lost to Follow-up|0|||
143358466|NCT04562779|516856171|FG000|Overall Study|Lost to Follow-up|7|||
143358467|NCT04562779|516856172|FG001|Overall Study|Lost to Follow-up|5|||
143358468|NCT04562779|516856173|FG002|Overall Study|Lost to Follow-up|10|||
143358469|NCT04562779|516856171|FG000|Overall Study|Protocol Violation|2|||
143358470|NCT04562779|516856172|FG001|Overall Study|Protocol Violation|2|||
143358471|NCT04562779|516856173|FG002|Overall Study|Protocol Violation|0|||
143358472|NCT02320721|516856174|FG000|Overall Study|Adverse Event|6|||
143358473|NCT02320721|516856175|FG001|Overall Study|Adverse Event|6|||
143358474|NCT02320721|516856174|FG000|Overall Study|Lack of Efficacy|2|||
143358475|NCT02320721|516856175|FG001|Overall Study|Lack of Efficacy|0|||
143358476|NCT02320721|516856174|FG000|Overall Study|Poor compliance to protocol|3|||
143358477|NCT02320721|516856175|FG001|Overall Study|Poor compliance to protocol|7|||
143358478|NCT02320721|516856174|FG000|Overall Study|Randomized but not treated|0|||
143358479|NCT02320721|516856175|FG001|Overall Study|Randomized but not treated|1|||
143358480|NCT02320721|516856174|FG000|Overall Study|Hypoglycemia|1|||
143466430|NCT00792805|517255698|FG002|Overall Study|Subject withdrew consent|5|||
143133451|NCT02515630|516033379|FG000|Overall Study|Adverse Event|4|||
143358481|NCT02320721|516856175|FG001|Overall Study|Hypoglycemia|0|||
143358482|NCT02320721|516856174|FG000|Overall Study|Other than specified above|15|||
143358483|NCT02320721|516856175|FG001|Overall Study|Other than specified above|20|||
143358484|NCT04630756|516856176|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
143466431|NCT00792805|517255696|FG000|Overall Study|Administrative problems|2|||
143466432|NCT00792805|517255697|FG001|Overall Study|Administrative problems|0|||
143466433|NCT00792805|517255698|FG002|Overall Study|Administrative problems|4|||
143466434|NCT00792805|517255696|FG000|Overall Study|Abnormal test procedure result(s)|1|||
143133452|NCT02515630|516033379|FG000|Overall Study|Physician Decision|4|||
143358485|NCT04630756|516856177|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
143358486|NCT04630756|516856178|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
143358487|NCT03077620|516856179|FG000|Overall Study|Unable to place lumbar catheter|1|||
143358488|NCT03077620|516856180|FG001|Overall Study|Unable to place lumbar catheter|0|||
143358489|NCT03077620|516856181|FG002|Overall Study|Unable to place lumbar catheter|1|||
143358490|NCT03077620|516856182|FG003|Overall Study|Unable to place lumbar catheter|0|||
143358491|NCT03077620|516856179|FG000|Overall Study|Withdrawal by Subject|0|||
143358492|NCT03077620|516856180|FG001|Overall Study|Withdrawal by Subject|1|||
143358493|NCT03077620|516856181|FG002|Overall Study|Withdrawal by Subject|0|||
143358494|NCT03077620|516856182|FG003|Overall Study|Withdrawal by Subject|0|||
143358495|NCT03077620|516856179|FG000|Overall Study|Physician Decision|0|||
143358496|NCT03077620|516856180|FG001|Overall Study|Physician Decision|0|||
143358497|NCT03077620|516856181|FG002|Overall Study|Physician Decision|1|||
143358498|NCT03077620|516856182|FG003|Overall Study|Physician Decision|0|||
143358499|NCT03225846|516856183|FG000|Overall Study|Adverse Event|0|||
143358500|NCT03225846|516856184|FG001|Overall Study|Adverse Event|0|||
143358501|NCT03225846|516856185|FG002|Overall Study|Adverse Event|0|||
143358502|NCT03225846|516856186|FG003|Overall Study|Adverse Event|0|||
143358503|NCT03225846|516856187|FG004|Overall Study|Adverse Event|0|||
143358504|NCT03225846|516856188|FG005|Overall Study|Adverse Event|0|||
143358505|NCT03225846|516856189|FG006|Overall Study|Adverse Event|6|||
143358506|NCT03225846|516856183|FG000|Overall Study|Withdrawal by Subject|0|||
143358507|NCT03225846|516856184|FG001|Overall Study|Withdrawal by Subject|1|||
143358508|NCT03225846|516856185|FG002|Overall Study|Withdrawal by Subject|0|||
143358509|NCT03225846|516856186|FG003|Overall Study|Withdrawal by Subject|0|||
143358510|NCT03225846|516856187|FG004|Overall Study|Withdrawal by Subject|0|||
143358511|NCT03225846|516856188|FG005|Overall Study|Withdrawal by Subject|0|||
143358512|NCT03225846|516856189|FG006|Overall Study|Withdrawal by Subject|0|||
143358513|NCT03225846|516856183|FG000|Overall Study|Death|0|||
143358514|NCT03225846|516856184|FG001|Overall Study|Death|1|||
143358515|NCT03225846|516856185|FG002|Overall Study|Death|0|||
143358516|NCT03225846|516856186|FG003|Overall Study|Death|0|||
143358517|NCT03225846|516856187|FG004|Overall Study|Death|0|||
143358518|NCT03225846|516856188|FG005|Overall Study|Death|0|||
143358519|NCT03225846|516856189|FG006|Overall Study|Death|0|||
143358520|NCT03225846|516856183|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
143358521|NCT03225846|516856184|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
143358522|NCT03225846|516856185|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
143358523|NCT03225846|516856186|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
143358524|NCT03225846|516856187|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
143358525|NCT03225846|516856188|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
143358526|NCT03225846|516856189|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
143358527|NCT03225846|516856183|FG000|Overall Study|Patient decision|0|||
143358528|NCT03225846|516856184|FG001|Overall Study|Patient decision|0|||
143358529|NCT03225846|516856185|FG002|Overall Study|Patient decision|0|||
143358530|NCT03225846|516856186|FG003|Overall Study|Patient decision|0|||
143358531|NCT03225846|516856187|FG004|Overall Study|Patient decision|0|||
143358532|NCT03225846|516856188|FG005|Overall Study|Patient decision|0|||
143358533|NCT03225846|516856189|FG006|Overall Study|Patient decision|1|||
143358534|NCT00238420|516856190|FG000|Overall Study|Protocol Violation|1|||
143358535|NCT00238420|516856191|FG001|Overall Study|Protocol Violation|1|||
143358536|NCT04140890|516856192|FG000|Overall Study|Withdrawal by Subject|0|||
143358537|NCT04140890|516856193|FG001|Overall Study|Withdrawal by Subject|1|||
143358538|NCT02102464|516856194|FG000|Randomized Study|Withdrawal by Subject|0|||
143358539|NCT02102464|516856195|FG001|Randomized Study|Withdrawal by Subject|1|||
143358540|NCT02102464|516856196|FG002|Randomized Study|Withdrawal by Subject|0|||
143358541|NCT01824472|516856197|FG000|Overall Study|Lost to Follow-up|0|||
143358542|NCT01824472|516856198|FG001|Overall Study|Lost to Follow-up|0|||
143358543|NCT01824472|516856199|FG002|Overall Study|Lost to Follow-up|1|||
143358544|NCT01824472|516856197|FG000|Overall Study|Withdrawal by Subject|1|||
143358545|NCT01824472|516856198|FG001|Overall Study|Withdrawal by Subject|5|||
143358546|NCT01824472|516856199|FG002|Overall Study|Withdrawal by Subject|3|||
143358547|NCT01824472|516856197|FG000|Overall Study|Ineligible post randomization&screening|0|||
143358548|NCT01824472|516856198|FG001|Overall Study|Ineligible post randomization&screening|2|||
143358549|NCT01824472|516856199|FG002|Overall Study|Ineligible post randomization&screening|0|||
143358550|NCT00245011|516856200|FG000|Overall Study|Lack of Efficacy|1|||
143358551|NCT00550173|516856203|FG000|Overall Study|Death|45|||
143358552|NCT00550173|516856204|FG001|Overall Study|Death|38|||
143358553|NCT00550173|516856205|FG002|Overall Study|Death|50|||
143358554|NCT00550173|516856203|FG000|Overall Study|Physician Decision|1|||
143358555|NCT00550173|516856204|FG001|Overall Study|Physician Decision|2|||
143358556|NCT00550173|516856205|FG002|Overall Study|Physician Decision|2|||
143358557|NCT00550173|516856203|FG000|Overall Study|Withdrawal by Subject|9|||
143358558|NCT00550173|516856204|FG001|Overall Study|Withdrawal by Subject|12|||
143358559|NCT00550173|516856205|FG002|Overall Study|Withdrawal by Subject|17|||
143358560|NCT00550173|516856203|FG000|Overall Study|Sponsor Decision|13|||
143358561|NCT00550173|516856204|FG001|Overall Study|Sponsor Decision|7|||
143358562|NCT00550173|516856205|FG002|Overall Study|Sponsor Decision|1|||
143358563|NCT00550173|516856203|FG000|Overall Study|Lost to Follow-up|4|||
143358564|NCT00550173|516856204|FG001|Overall Study|Lost to Follow-up|4|||
143358565|NCT00550173|516856205|FG002|Overall Study|Lost to Follow-up|3|||
143358566|NCT00810641|516856214|FG000|Overall Study|Withdrawal by Subject|0|||
143358567|NCT00810641|516856215|FG001|Overall Study|Withdrawal by Subject|1|||
143358568|NCT00810641|516856216|FG002|Overall Study|Withdrawal by Subject|2|||
143358569|NCT01556243|516856217|FG000|Overall Study|Ineligible|34|||
143358570|NCT01556243|516856217|FG000|Overall Study|Converted to mastectomy|14|||
143358571|NCT01556243|516856217|FG000|Overall Study|Unable to achieve negative margins|2|||
143358572|NCT01556243|516856217|FG000|Overall Study|Withdrawal by Subject|16|||
143358573|NCT01388543|516856218|FG000|Day 14|Adverse Event|1|||
143358574|NCT01388543|516856219|FG001|Day 14|Adverse Event|4|||
143358575|NCT02325713|516856222|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
143358576|NCT02325713|516856223|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
143358577|NCT02325713|516856224|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
143358578|NCT02325713|516856225|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
143358579|NCT02325713|516856226|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
143358580|NCT02325713|516856227|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
143358581|NCT02325713|516856228|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
143358582|NCT02325713|516856229|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
143358583|NCT02325713|516856230|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
143358584|NCT02325713|516856231|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
143358585|NCT02325713|516856232|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
143358586|NCT02325713|516856233|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
143358587|NCT02325713|516856234|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
143358588|NCT02325713|516856235|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
143358589|NCT02325713|516856236|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
143358590|NCT02325713|516856237|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
143358591|NCT02325713|516856222|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
143358592|NCT02325713|516856223|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
143358593|NCT02325713|516856224|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
143358594|NCT02325713|516856225|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
143358595|NCT02325713|516856226|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
143358596|NCT02325713|516856227|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
143358597|NCT02325713|516856228|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
143358598|NCT02325713|516856229|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
143358599|NCT02325713|516856230|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
143358600|NCT02325713|516856231|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
143358601|NCT02325713|516856232|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
143358602|NCT02325713|516856233|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
143358603|NCT02325713|516856234|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
143358604|NCT02325713|516856235|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
143358605|NCT02325713|516856236|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
143358606|NCT02325713|516856237|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
143358607|NCT02325713|516856222|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
143358608|NCT02325713|516856223|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
143358609|NCT02325713|516856224|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
143358610|NCT02325713|516856225|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
143358611|NCT02325713|516856226|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
143358612|NCT02325713|516856227|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
143358613|NCT02325713|516856228|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
143358614|NCT02325713|516856229|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
143358615|NCT02325713|516856230|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
143358616|NCT02325713|516856231|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
143358617|NCT02325713|516856232|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
143358618|NCT02325713|516856233|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
143358619|NCT02325713|516856234|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
143358620|NCT02325713|516856235|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
143358621|NCT02325713|516856236|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
143358622|NCT02325713|516856237|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
143358623|NCT01213173|516856238|FG000|Overall Study|Protocol Violation|2|||
143358624|NCT01213173|516856239|FG001|Overall Study|Protocol Violation|0|||
143358625|NCT01213173|516856238|FG000|Overall Study|Adverse Event|4|||
143358626|NCT01213173|516856239|FG001|Overall Study|Adverse Event|8|||
143358627|NCT01213173|516856238|FG000|Overall Study|Withdrawal by Subject|5|||
143358628|NCT01213173|516856239|FG001|Overall Study|Withdrawal by Subject|5|||
143358629|NCT01213173|516856238|FG000|Overall Study|Incorrect Enrollment|1|||
143466435|NCT00792805|517255697|FG001|Overall Study|Abnormal test procedure result(s)|2|||
143466436|NCT00792805|517255698|FG002|Overall Study|Abnormal test procedure result(s)|0|||
143133453|NCT02515630|516033379|FG000|Overall Study|Death|2|||
143358630|NCT01213173|516856239|FG001|Overall Study|Incorrect Enrollment|3|||
143358631|NCT02253316|516856240|FG000|Consolidation|Progression|4|||
143358632|NCT02253316|516856241|FG001|Consolidation|Progression|0|||
143358633|NCT02253316|516856242|FG002|Consolidation|Progression|0|||
143358634|NCT02253316|516856240|FG000|Consolidation|Non-Compliance|1|||
143358635|NCT02253316|516856241|FG001|Consolidation|Non-Compliance|0|||
143358636|NCT02253316|516856242|FG002|Consolidation|Non-Compliance|0|||
143358637|NCT02253316|516856240|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
143358638|NCT02253316|516856241|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
143358639|NCT02253316|516856242|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
143358640|NCT02253316|516856240|FG000|Consolidation|Secondary Malignancy|2|||
143358641|NCT02253316|516856241|FG001|Consolidation|Secondary Malignancy|0|||
143358642|NCT02253316|516856242|FG002|Consolidation|Secondary Malignancy|0|||
143358643|NCT02253316|516856240|FG000|Consolidation|Adverse Event|7|||
143358644|NCT02253316|516856241|FG001|Consolidation|Adverse Event|0|||
143358645|NCT02253316|516856242|FG002|Consolidation|Adverse Event|0|||
143358646|NCT02253316|516856240|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
143358647|NCT02253316|516856241|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
143358648|NCT02253316|516856242|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
143358649|NCT02253316|516856240|FG000|Maintenance|Physician Decision|0|||
143358650|NCT02253316|516856241|FG001|Maintenance|Physician Decision|7|||
143358651|NCT02253316|516856242|FG002|Maintenance|Physician Decision|16|||
143358652|NCT02253316|516856240|FG000|Maintenance|Non-Compliance|0|||
143358653|NCT02253316|516856241|FG001|Maintenance|Non-Compliance|1|||
143358654|NCT02253316|516856242|FG002|Maintenance|Non-Compliance|1|||
143358655|NCT02253316|516856240|FG000|Maintenance|Secondary Malignancy|0|||
143358656|NCT02253316|516856241|FG001|Maintenance|Secondary Malignancy|2|||
143358657|NCT02253316|516856242|FG002|Maintenance|Secondary Malignancy|6|||
143358658|NCT02253316|516856240|FG000|Maintenance|Adverse Event|0|||
143358659|NCT02253316|516856241|FG001|Maintenance|Adverse Event|8|||
143358660|NCT02253316|516856242|FG002|Maintenance|Adverse Event|12|||
143358661|NCT02253316|516856240|FG000|Maintenance|Still receiving active treatment|0|||
143358662|NCT02253316|516856241|FG001|Maintenance|Still receiving active treatment|4|||
143358663|NCT02253316|516856242|FG002|Maintenance|Still receiving active treatment|0|||
143358664|NCT00802841|516857827|FG000|Overall Study|Administrative problems|1|||
143358665|NCT00802841|516857828|FG001|Overall Study|Administrative problems|0|||
143358666|NCT00802841|516857827|FG000|Overall Study|Lost to Follow-up|2|||
143358667|NCT00802841|516857828|FG001|Overall Study|Lost to Follow-up|1|||
143358668|NCT00802841|516857827|FG000|Overall Study|Death|1|||
143358669|NCT00802841|516857828|FG001|Overall Study|Death|2|||
143358670|NCT00802841|516857827|FG000|Overall Study|Adverse Event|8|||
143358671|NCT00802841|516857828|FG001|Overall Study|Adverse Event|2|||
143358672|NCT00802841|516857827|FG000|Overall Study|Disease progression|7|||
143358673|NCT00802841|516857828|FG001|Overall Study|Disease progression|3|||
143358674|NCT00802841|516857827|FG000|Overall Study|Withdrawal by Subject|9|||
143358675|NCT00802841|516857828|FG001|Overall Study|Withdrawal by Subject|5|||
143358676|NCT00802841|516857827|FG000|Overall Study|Protocol deviation|2|||
143358677|NCT00802841|516857828|FG001|Overall Study|Protocol deviation|6|||
143358678|NCT00802841|516857827|FG000|Overall Study|Treatment duration completed|66|||
143358679|NCT00802841|516857828|FG001|Overall Study|Treatment duration completed|76|||
143358680|NCT04096365|516857829|FG000|Overall Study|Adverse Event|1|||
143358681|NCT03527277|516857833|FG000|Overall Study|Withdrawal by Subject|5|||
143358682|NCT03527277|516857834|FG001|Overall Study|Withdrawal by Subject|0|||
143358683|NCT03527277|516857833|FG000|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|0|||
143358684|NCT03527277|516857834|FG001|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|1|||
143358685|NCT03527277|516857833|FG000|Overall Study|Withdrawn by PI due to dietary miscompliance|1|||
143358686|NCT03527277|516857834|FG001|Overall Study|Withdrawn by PI due to dietary miscompliance|0|||
143358687|NCT03930186|516857835|FG000|Weeks 0 to 16|Adverse Event|6|||
143358688|NCT03930186|516857835|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
143358689|NCT03930186|516857835|FG000|Weeks 16 to 32|Adverse Event|1|||
143358690|NCT03930186|516857835|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
143358691|NCT04004208|516857839|FG000|Overall Study|Withdrawal by parent/guardian|1|||
143358692|NCT04004208|516857840|FG001|Overall Study|Withdrawal by parent/guardian|1|||
143358693|NCT04004208|516857839|FG000|Overall Study|Death|3|||
143358694|NCT04004208|516857840|FG001|Overall Study|Death|0|||
143358695|NCT04004208|516857839|FG000|Overall Study|COVID-19 pandemic|1|||
143358696|NCT04004208|516857840|FG001|Overall Study|COVID-19 pandemic|0|||
143358697|NCT04004208|516857839|FG000|Overall Study|Physician Decision|1|||
143358698|NCT04004208|516857840|FG001|Overall Study|Physician Decision|0|||
143358699|NCT04004208|516857839|FG000|Overall Study|Adverse Event|1|||
143358700|NCT04004208|516857840|FG001|Overall Study|Adverse Event|1|||
143358701|NCT02118714|516857846|FG000|Overall Study|Lost to Follow-up|2|||
143358702|NCT02118714|516857846|FG000|Overall Study|Protocol Violation|1|||
143466437|NCT00792805|517255696|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
143358703|NCT01310868|516857847|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
143358704|NCT01628874|516857854|FG000|Overall Study|Physician Decision|1|||
143358705|NCT01628874|516857855|FG001|Overall Study|Physician Decision|1|||
143358706|NCT01628874|516857854|FG000|Overall Study|Age >4 months|4|||
143358707|NCT01628874|516857855|FG001|Overall Study|Age >4 months|2|||
143358708|NCT01169337|516857856|FG000|Overall Study|Lack of Efficacy|5|||
143358709|NCT01169337|516857857|FG001|Overall Study|Lack of Efficacy|7|||
143358710|NCT01169337|516857858|FG002|Overall Study|Lack of Efficacy|0|||
143358711|NCT01169337|516857856|FG000|Overall Study|Adverse Event|12|||
143358712|NCT01169337|516857857|FG001|Overall Study|Adverse Event|18|||
143358713|NCT01169337|516857858|FG002|Overall Study|Adverse Event|0|||
143358714|NCT01169337|516857856|FG000|Overall Study|Death|2|||
143358715|NCT01169337|516857857|FG001|Overall Study|Death|0|||
143358716|NCT01169337|516857858|FG002|Overall Study|Death|0|||
143358717|NCT01169337|516857856|FG000|Overall Study|Withdrawal by Subject|11|||
143358718|NCT01169337|516857857|FG001|Overall Study|Withdrawal by Subject|11|||
143358719|NCT01169337|516857858|FG002|Overall Study|Withdrawal by Subject|6|||
143358720|NCT01169337|516857856|FG000|Overall Study|Noncompliance|2|||
143358721|NCT01169337|516857857|FG001|Overall Study|Noncompliance|0|||
143358722|NCT01169337|516857858|FG002|Overall Study|Noncompliance|0|||
143358723|NCT01169337|516857856|FG000|Overall Study|Other complicating disease|1|||
143358724|NCT01169337|516857857|FG001|Overall Study|Other complicating disease|1|||
143358725|NCT01169337|516857858|FG002|Overall Study|Other complicating disease|0|||
143358726|NCT01169337|516857856|FG000|Overall Study|Physician Decision|1|||
143358727|NCT01169337|516857857|FG001|Overall Study|Physician Decision|5|||
143358728|NCT01169337|516857858|FG002|Overall Study|Physician Decision|0|||
143358729|NCT01169337|516857856|FG000|Overall Study|Alternative therapy|0|||
143358730|NCT01169337|516857857|FG001|Overall Study|Alternative therapy|2|||
143358731|NCT01169337|516857858|FG002|Overall Study|Alternative therapy|0|||
143358732|NCT01169337|516857856|FG000|Overall Study|Changed hospital|0|||
143358733|NCT01169337|516857857|FG001|Overall Study|Changed hospital|1|||
143358734|NCT01169337|516857858|FG002|Overall Study|Changed hospital|0|||
143358735|NCT01169337|516857856|FG000|Overall Study|Never started treatment|0|||
143358736|NCT01169337|516857857|FG001|Overall Study|Never started treatment|2|||
143358737|NCT01169337|516857858|FG002|Overall Study|Never started treatment|0|||
143358738|NCT01169337|516857856|FG000|Overall Study|Reason not reported|1|||
143358739|NCT01169337|516857857|FG001|Overall Study|Reason not reported|0|||
143358740|NCT01169337|516857858|FG002|Overall Study|Reason not reported|0|||
143358741|NCT01169337|516857856|FG000|Overall Study|Continuing lenalidomide|9|||
143358742|NCT01169337|516857857|FG001|Overall Study|Continuing lenalidomide|43|||
143358743|NCT01169337|516857858|FG002|Overall Study|Continuing lenalidomide|0|||
143358744|NCT00873093|516857859|FG000|Overall Study|Adverse Event|0|||
143358745|NCT00873093|516857860|FG001|Overall Study|Adverse Event|2|||
143358746|NCT00873093|516857861|FG002|Overall Study|Adverse Event|0|||
143358747|NCT00873093|516857862|FG003|Overall Study|Adverse Event|0|||
143358748|NCT00873093|516857863|FG004|Overall Study|Adverse Event|0|||
143358749|NCT00873093|516857859|FG000|Overall Study|Death|0|||
143358750|NCT00873093|516857860|FG001|Overall Study|Death|3|||
143358751|NCT00873093|516857861|FG002|Overall Study|Death|2|||
143358752|NCT00873093|516857862|FG003|Overall Study|Death|0|||
143358753|NCT00873093|516857863|FG004|Overall Study|Death|0|||
143358754|NCT00873093|516857859|FG000|Overall Study|Physician Decision|0|||
143358755|NCT00873093|516857860|FG001|Overall Study|Physician Decision|17|||
143358756|NCT00873093|516857861|FG002|Overall Study|Physician Decision|10|||
143358757|NCT00873093|516857862|FG003|Overall Study|Physician Decision|10|||
143358758|NCT00873093|516857863|FG004|Overall Study|Physician Decision|2|||
143358759|NCT00873093|516857859|FG000|Overall Study|Withdrawal by Subject|1|||
143358760|NCT00873093|516857860|FG001|Overall Study|Withdrawal by Subject|4|||
143358761|NCT00873093|516857861|FG002|Overall Study|Withdrawal by Subject|4|||
143358762|NCT00873093|516857862|FG003|Overall Study|Withdrawal by Subject|0|||
143358763|NCT00873093|516857863|FG004|Overall Study|Withdrawal by Subject|0|||
143466438|NCT00792805|517255697|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
143466439|NCT00792805|517255698|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
143133454|NCT02515630|516033379|FG000|Overall Study|Disease Progression|1|||
143358764|NCT00873093|516857859|FG000|Overall Study|Ineligible|0|||
143358765|NCT00873093|516857860|FG001|Overall Study|Ineligible|1|||
143358766|NCT00873093|516857861|FG002|Overall Study|Ineligible|0|||
143358767|NCT00873093|516857862|FG003|Overall Study|Ineligible|1|||
143358768|NCT00873093|516857863|FG004|Overall Study|Ineligible|0|||
143358769|NCT01782326|516857864|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
143358770|NCT01782326|516857865|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
143358771|NCT01782326|516857864|FG000|Planned Treatment Epoch|Death|29|||
143358772|NCT01782326|516857865|FG001|Planned Treatment Epoch|Death|30|||
143358773|NCT01782326|516857864|FG000|Planned Treatment Epoch|Physician Decision|18|||
143358774|NCT01782326|516857865|FG001|Planned Treatment Epoch|Physician Decision|16|||
143358775|NCT01782326|516857864|FG000|Planned Treatment Epoch|Protocol deviation|2|||
143358776|NCT01782326|516857865|FG001|Planned Treatment Epoch|Protocol deviation|3|||
143358777|NCT01782326|516857864|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
143358778|NCT01782326|516857865|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
143466440|NCT00792805|517255696|FG000|Overall Study|Lost to Follow-up|1|||
143466441|NCT00792805|517255697|FG001|Overall Study|Lost to Follow-up|1|||
143466442|NCT00792805|517255698|FG002|Overall Study|Lost to Follow-up|6|||
143466443|NCT00792805|517255696|FG000|Overall Study|Abnormal laboratory value(s)|0|||
143466444|NCT00792805|517255697|FG001|Overall Study|Abnormal laboratory value(s)|0|||
143466445|NCT00792805|517255698|FG002|Overall Study|Abnormal laboratory value(s)|1|||
143466446|NCT00792805|517255696|FG000|Overall Study|Protocol deviation|0|||
143466447|NCT00792805|517255697|FG001|Overall Study|Protocol deviation|1|||
143466448|NCT00792805|517255698|FG002|Overall Study|Protocol deviation|1|||
143466449|NCT04356183|517255699|FG000|Overall Study|Lost to Follow-up|1|||
143466450|NCT04356183|517255700|FG001|Overall Study|Lost to Follow-up|0|||
143466451|NCT04356183|517255699|FG000|Overall Study|Withdrawal by Subject|1|||
143466452|NCT04356183|517255700|FG001|Overall Study|Withdrawal by Subject|1|||
143466453|NCT00667355|517255701|FG000|Overall Study|Adverse Event|5|||
143466454|NCT00667355|517255701|FG000|Overall Study|Lost to Follow-up|1|||
143466455|NCT00667355|517255701|FG000|Overall Study|Other reason was not specified|5|||
143466456|NCT02175004|517255702|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
143466457|NCT02175004|517255703|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
143466458|NCT02175004|517255702|FG000|Overall Study|Investigator Judgment|1|||
143466459|NCT02175004|517255703|FG001|Overall Study|Investigator Judgment|4|||
143466460|NCT02175004|517255702|FG000|Overall Study|Voluntary Withdrawal|6|||
143466461|NCT02175004|517255703|FG001|Overall Study|Voluntary Withdrawal|19|||
143466462|NCT02175004|517255702|FG000|Overall Study|Liver Transplant|1|||
143466463|NCT02175004|517255703|FG001|Overall Study|Liver Transplant|0|||
143466464|NCT02175004|517255702|FG000|Overall Study|Disease Progression|1|||
143466465|NCT02175004|517255703|FG001|Overall Study|Disease Progression|0|||
143466466|NCT02175004|517255702|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
143466467|NCT02175004|517255703|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
143466468|NCT00162032|517255704|FG000|Overall Study|Lost to Follow-up|4|||
143466469|NCT00162032|517255705|FG001|Overall Study|Lost to Follow-up|2|||
143466470|NCT00162032|517255704|FG000|Overall Study|Reason not specified|1|||
143466471|NCT00162032|517255705|FG001|Overall Study|Reason not specified|0|||
143466472|NCT05193500|517255706|FG000|Overall Study|Withdrawal by Subject|7|||
143466473|NCT05193500|517255707|FG001|Overall Study|Withdrawal by Subject|4|||
143466474|NCT05193500|517255708|FG002|Overall Study|Withdrawal by Subject|3|||
143466475|NCT05193500|517255709|FG003|Overall Study|Withdrawal by Subject|5|||
143466476|NCT03840486|517255710|FG000|Overall Study|Withdrawal by Subject|0|||
143466477|NCT03840486|517255711|FG001|Overall Study|Withdrawal by Subject|1|||
143466478|NCT03840486|517255712|FG002|Overall Study|Withdrawal by Subject|0|||
143466479|NCT03840486|517255713|FG003|Overall Study|Withdrawal by Subject|0|||
143466480|NCT03840486|517255714|FG004|Overall Study|Withdrawal by Subject|0|||
143466481|NCT03840486|517255715|FG005|Overall Study|Withdrawal by Subject|0|||
143466482|NCT03840486|517255716|FG006|Overall Study|Withdrawal by Subject|0|||
143466483|NCT03840486|517255717|FG007|Overall Study|Withdrawal by Subject|0|||
143466484|NCT03840486|517255718|FG008|Overall Study|Withdrawal by Subject|0|||
143466485|NCT03840486|517255719|FG009|Overall Study|Withdrawal by Subject|0|||
143466486|NCT03840486|517255720|FG010|Overall Study|Withdrawal by Subject|0|||
143466487|NCT03840486|517255721|FG011|Overall Study|Withdrawal by Subject|0|||
143466488|NCT00744523|517255722|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
143466489|NCT00744523|517255723|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
143466490|NCT01139021|517255726|FG000|Overall Study|Adverse Event|0|||
143466491|NCT01139021|517255727|FG001|Overall Study|Adverse Event|0|||
143466492|NCT01139021|517255728|FG002|Overall Study|Adverse Event|0|||
143466493|NCT01139021|517255729|FG003|Overall Study|Adverse Event|0|||
143466494|NCT01139021|517255730|FG004|Overall Study|Adverse Event|1|||
143466495|NCT01139021|517255731|FG005|Overall Study|Adverse Event|0|||
143466496|NCT01139021|517255726|FG000|Overall Study|Lost to Follow-up|0|||
143133455|NCT02595502|516033380|FG000|Period 1|Adverse Event|0|||
143133456|NCT02595502|516033381|FG001|Period 1|Adverse Event|1|||
143133457|NCT02595502|516033380|FG000|Period 1|Withdrawal by Subject|1|||
143133458|NCT02595502|516033381|FG001|Period 1|Withdrawal by Subject|0|||
143133459|NCT02595502|516033380|FG000|Period 1|Lost to Follow-up|0|||
143133460|NCT02595502|516033381|FG001|Period 1|Lost to Follow-up|1|||
143133461|NCT02595502|516033380|FG000|Period 2|Adverse Event|1|||
143133462|NCT02595502|516033381|FG001|Period 2|Adverse Event|1|||
143466497|NCT01139021|517255727|FG001|Overall Study|Lost to Follow-up|0|||
143466498|NCT01139021|517255728|FG002|Overall Study|Lost to Follow-up|0|||
143133463|NCT02595502|516033380|FG000|Period 2|Received incorrect lens at Period 1|0|||
143466499|NCT01139021|517255729|FG003|Overall Study|Lost to Follow-up|0|||
143466500|NCT01139021|517255730|FG004|Overall Study|Lost to Follow-up|2|||
143466501|NCT01139021|517255731|FG005|Overall Study|Lost to Follow-up|0|||
143466502|NCT01139021|517255726|FG000|Overall Study|Protocol Violation|1|||
143133464|NCT02595502|516033381|FG001|Period 2|Received incorrect lens at Period 1|1|||
143133465|NCT02595502|516033380|FG000|Period 3|Protocol Violation|0|||
143466503|NCT01139021|517255727|FG001|Overall Study|Protocol Violation|0|||
143466504|NCT01139021|517255728|FG002|Overall Study|Protocol Violation|0|||
143358779|NCT01782326|516857864|FG000|Planned Treatment Epoch|Technical problems|0|||
143358780|NCT01782326|516857865|FG001|Planned Treatment Epoch|Technical problems|4|||
143358781|NCT01782326|516857864|FG000|Double-blind Treatment|Adverse Event|129|||
143358782|NCT01782326|516857865|FG001|Double-blind Treatment|Adverse Event|145|||
143358783|NCT01782326|516857864|FG000|Double-blind Treatment|Subject/guardian decision|111|||
143358784|NCT01782326|516857865|FG001|Double-blind Treatment|Subject/guardian decision|125|||
143358785|NCT01782326|516857864|FG000|Double-blind Treatment|Lack of Efficacy|17|||
143358786|NCT01782326|516857865|FG001|Double-blind Treatment|Lack of Efficacy|22|||
143358787|NCT01782326|516857864|FG000|Double-blind Treatment|Physician Decision|13|||
143358788|NCT01782326|516857865|FG001|Double-blind Treatment|Physician Decision|16|||
143358789|NCT01782326|516857864|FG000|Double-blind Treatment|Protocol deviation|8|||
143358790|NCT01782326|516857865|FG001|Double-blind Treatment|Protocol deviation|7|||
143358791|NCT01782326|516857864|FG000|Double-blind Treatment|Technical problems|0|||
143358792|NCT01782326|516857865|FG001|Double-blind Treatment|Technical problems|5|||
143358793|NCT02559817|516857866|FG000|Treatment Period|Adverse Event|1|||
143358794|NCT02559817|516857867|FG001|Treatment Period|Adverse Event|0|||
143358795|NCT02559817|516857868|FG002|Treatment Period|Adverse Event|1|||
143358796|NCT02559817|516857869|FG003|Treatment Period|Adverse Event|0|||
143358797|NCT02559817|516857870|FG004|Treatment Period|Adverse Event|0|||
143358798|NCT02559817|516857866|FG000|Treatment Period|Lack of Efficacy|0|||
143358799|NCT02559817|516857867|FG001|Treatment Period|Lack of Efficacy|1|||
143358800|NCT02559817|516857868|FG002|Treatment Period|Lack of Efficacy|0|||
143358801|NCT02559817|516857869|FG003|Treatment Period|Lack of Efficacy|0|||
143358802|NCT02559817|516857870|FG004|Treatment Period|Lack of Efficacy|0|||
143358803|NCT02559817|516857866|FG000|Treatment Period|Lost to Follow-up|0|||
143358804|NCT02559817|516857867|FG001|Treatment Period|Lost to Follow-up|1|||
143358805|NCT02559817|516857868|FG002|Treatment Period|Lost to Follow-up|0|||
143358806|NCT02559817|516857869|FG003|Treatment Period|Lost to Follow-up|1|||
143358807|NCT02559817|516857870|FG004|Treatment Period|Lost to Follow-up|0|||
143358808|NCT02559817|516857866|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
143358809|NCT02559817|516857867|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
143358810|NCT02559817|516857868|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
143358811|NCT02559817|516857869|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
143358812|NCT02559817|516857870|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
143358813|NCT02559817|516857866|FG000|Treatment Period|Protocol Violation|0|||
143358814|NCT02559817|516857867|FG001|Treatment Period|Protocol Violation|0|||
143358815|NCT02559817|516857868|FG002|Treatment Period|Protocol Violation|0|||
143358816|NCT02559817|516857869|FG003|Treatment Period|Protocol Violation|1|||
143358817|NCT02559817|516857870|FG004|Treatment Period|Protocol Violation|0|||
143358818|NCT03389893|516857871|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
143358819|NCT03389893|516857872|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
143358820|NCT03389893|516857873|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
143358821|NCT03389893|516857874|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
143358822|NCT03389893|516857871|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
143358823|NCT03389893|516857872|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
143358824|NCT03389893|516857873|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
143358825|NCT03389893|516857874|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
143358826|NCT03389893|516857871|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
143358827|NCT03389893|516857872|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
143358828|NCT03389893|516857873|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
143358829|NCT03389893|516857874|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
143358830|NCT03389893|516857871|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
143358831|NCT03389893|516857872|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
143358832|NCT03389893|516857873|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
143358833|NCT03389893|516857874|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
143358834|NCT02448719|516857875|FG000|Overall Study|Withdrawal by Subject|0|||
143358835|NCT02448719|516857876|FG001|Overall Study|Withdrawal by Subject|0|||
143358836|NCT02448719|516857877|FG002|Overall Study|Withdrawal by Subject|0|||
143358837|NCT02448719|516857878|FG003|Overall Study|Withdrawal by Subject|0|||
143358838|NCT02448719|516857879|FG004|Overall Study|Withdrawal by Subject|1|||
143358839|NCT02448719|516857880|FG005|Overall Study|Withdrawal by Subject|0|||
143358840|NCT02448719|516857881|FG006|Overall Study|Withdrawal by Subject|0|||
143358841|NCT02448719|516857882|FG007|Overall Study|Withdrawal by Subject|0|||
143358842|NCT02448719|516857883|FG008|Overall Study|Withdrawal by Subject|0|||
143358843|NCT02448719|516857884|FG009|Overall Study|Withdrawal by Subject|0|||
143358844|NCT02448719|516857885|FG010|Overall Study|Withdrawal by Subject|0|||
143358845|NCT04179461|516857886|FG000|Overall Study|Lost to Follow-up|4|||
143358846|NCT00184028|516857887|FG000|Overall Study|Death|1|||
143358847|NCT00184028|516857887|FG000|Overall Study|Lack of Efficacy|4|||
143358848|NCT00184028|516857887|FG000|Overall Study|Adverse Event|2|||
143358849|NCT00184028|516857887|FG000|Overall Study|Withdrawal by Subject|1|||
143358850|NCT00184028|516857887|FG000|Overall Study|Non-compliance|2|||
143358851|NCT01141660|516857888|FG000|Overall Study|Physician Decision|0|||
143133466|NCT02595502|516033381|FG001|Period 3|Protocol Violation|1|||
143133467|NCT02595502|516033380|FG000|Period 3|Lost to Follow-up|1|||
143133468|NCT02595502|516033381|FG001|Period 3|Lost to Follow-up|0|||
143133469|NCT02595502|516033380|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
143133470|NCT02595502|516033381|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
143133471|NCT03286218|516033382|FG000|Qualification Phase Period 1|Adverse Event|1|||
143133472|NCT03286218|516033383|FG001|Qualification Phase Period 1|Adverse Event|0|||
143133473|NCT03286218|516033384|FG002|Qualification Phase Period 1|Adverse Event|0|||
143133474|NCT03286218|516033385|FG003|Qualification Phase Period 1|Adverse Event|0|||
143133475|NCT03286218|516033386|FG004|Qualification Phase Period 1|Adverse Event|0|||
143133476|NCT03286218|516033387|FG005|Qualification Phase Period 1|Adverse Event|0|||
143133477|NCT03286218|516033388|FG006|Qualification Phase Period 1|Adverse Event|0|||
143358852|NCT01141660|516857889|FG001|Overall Study|Physician Decision|12|||
143358853|NCT00209027|516857890|FG000|Overall Study|study terminated|10|||
143358854|NCT00209027|516857891|FG001|Overall Study|study terminated|0|||
143358855|NCT03785340|516857892|FG000|Overall Study|Lost to Follow-up|2|||
143358856|NCT03785340|516857893|FG001|Overall Study|Lost to Follow-up|0|||
143358857|NCT03785340|516857892|FG000|Overall Study|Adverse Event|1|||
143358858|NCT03785340|516857893|FG001|Overall Study|Adverse Event|0|||
143358859|NCT03160079|516857894|FG000|Overall Study|Adverse Event|2|||
143358860|NCT03160079|516857895|FG001|Overall Study|Adverse Event|0|||
143358861|NCT03160079|516857894|FG000|Overall Study|Disease Progression|1|||
143358862|NCT03160079|516857895|FG001|Overall Study|Disease Progression|0|||
143358863|NCT03160079|516857894|FG000|Overall Study|Physician Decision|1|||
143358864|NCT03160079|516857895|FG001|Overall Study|Physician Decision|0|||
143358865|NCT02003222|516857896|FG000|Induction|Never started treatment|0|||
143358866|NCT02003222|516857897|FG001|Induction|Never started treatment|0|||
143358867|NCT02003222|516857898|FG002|Induction|Never started treatment|0|||
143358868|NCT02003222|516857899|FG003|Induction|Never started treatment|0|||
143358869|NCT02003222|516857900|FG004|Induction|Never started treatment|8|||
143358870|NCT02003222|516857896|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
143358871|NCT02003222|516857897|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
143358872|NCT02003222|516857898|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
143358873|NCT02003222|516857899|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
143358874|NCT02003222|516857900|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
143358875|NCT02003222|516857896|FG000|Induction|Adverse Event|0|||
143358876|NCT02003222|516857897|FG001|Induction|Adverse Event|0|||
143358877|NCT02003222|516857898|FG002|Induction|Adverse Event|0|||
143358878|NCT02003222|516857899|FG003|Induction|Adverse Event|0|||
143358879|NCT02003222|516857900|FG004|Induction|Adverse Event|13|||
143358880|NCT02003222|516857896|FG000|Induction|Alternative therapy|0|||
143358881|NCT02003222|516857897|FG001|Induction|Alternative therapy|0|||
143358882|NCT02003222|516857898|FG002|Induction|Alternative therapy|0|||
143358883|NCT02003222|516857899|FG003|Induction|Alternative therapy|0|||
143358884|NCT02003222|516857900|FG004|Induction|Alternative therapy|12|||
143358885|NCT02003222|516857896|FG000|Induction|Disease progression|0|||
143358886|NCT02003222|516857897|FG001|Induction|Disease progression|0|||
143358887|NCT02003222|516857898|FG002|Induction|Disease progression|0|||
143358888|NCT02003222|516857899|FG003|Induction|Disease progression|0|||
143358889|NCT02003222|516857900|FG004|Induction|Disease progression|22|||
143358890|NCT02003222|516857896|FG000|Induction|Death|0|||
143358891|NCT02003222|516857897|FG001|Induction|Death|0|||
143358892|NCT02003222|516857898|FG002|Induction|Death|0|||
143358893|NCT02003222|516857899|FG003|Induction|Death|0|||
143358894|NCT02003222|516857900|FG004|Induction|Death|3|||
143358895|NCT02003222|516857896|FG000|Induction|Withdrawal by Subject|0|||
143358896|NCT02003222|516857897|FG001|Induction|Withdrawal by Subject|0|||
143358897|NCT02003222|516857898|FG002|Induction|Withdrawal by Subject|0|||
143358898|NCT02003222|516857899|FG003|Induction|Withdrawal by Subject|0|||
143133478|NCT03286218|516033389|FG007|Qualification Phase Period 1|Adverse Event|0|||
143133479|NCT03286218|516033390|FG008|Qualification Phase Period 1|Adverse Event|0|||
143358899|NCT02003222|516857900|FG004|Induction|Withdrawal by Subject|8|||
143358900|NCT02003222|516857896|FG000|Induction|Other reasons|0|||
143133480|NCT03286218|516033391|FG009|Qualification Phase Period 1|Adverse Event|0|||
143133481|NCT03286218|516033392|FG010|Qualification Phase Period 1|Adverse Event|0|||
143358901|NCT02003222|516857897|FG001|Induction|Other reasons|0|||
143358902|NCT02003222|516857898|FG002|Induction|Other reasons|0|||
143358903|NCT02003222|516857899|FG003|Induction|Other reasons|0|||
143358904|NCT02003222|516857900|FG004|Induction|Other reasons|22|||
143358905|NCT02003222|516857896|FG000|Intensification|Never started treatment|0|||
143358906|NCT02003222|516857897|FG001|Intensification|Never started treatment|0|||
143358907|NCT02003222|516857898|FG002|Intensification|Never started treatment|0|||
143358908|NCT02003222|516857899|FG003|Intensification|Never started treatment|0|||
143358909|NCT02003222|516857900|FG004|Intensification|Never started treatment|2|||
143358910|NCT02003222|516857896|FG000|Intensification|Adverse Event|0|||
143358911|NCT02003222|516857897|FG001|Intensification|Adverse Event|0|||
143358912|NCT02003222|516857898|FG002|Intensification|Adverse Event|0|||
143358913|NCT02003222|516857899|FG003|Intensification|Adverse Event|0|||
143466505|NCT01139021|517255729|FG003|Overall Study|Protocol Violation|0|||
143466506|NCT01139021|517255730|FG004|Overall Study|Protocol Violation|2|||
143466507|NCT01139021|517255731|FG005|Overall Study|Protocol Violation|0|||
143466508|NCT01139021|517255726|FG000|Overall Study|Withdrawal by Subject|0|||
143466509|NCT01139021|517255727|FG001|Overall Study|Withdrawal by Subject|0|||
143466510|NCT01139021|517255728|FG002|Overall Study|Withdrawal by Subject|0|||
143466511|NCT01139021|517255729|FG003|Overall Study|Withdrawal by Subject|1|||
143466512|NCT01139021|517255730|FG004|Overall Study|Withdrawal by Subject|4|||
143466513|NCT01139021|517255731|FG005|Overall Study|Withdrawal by Subject|0|||
143466514|NCT00756470|517255735|FG000|Overall Study|Withdrawal by Subject|1|||
143466515|NCT00756470|517255735|FG000|Overall Study|Adverse Event|4|||
143466516|NCT00820027|517255736|FG000|Overall Study|Adverse Event|15|||
143466517|NCT00820027|517255737|FG001|Overall Study|Adverse Event|8|||
143466518|NCT00820027|517255738|FG002|Overall Study|Adverse Event|10|||
143466519|NCT00820027|517255739|FG003|Overall Study|Adverse Event|5|||
143466520|NCT00820027|517255736|FG000|Overall Study|Lack of Efficacy|2|||
143466521|NCT00820027|517255737|FG001|Overall Study|Lack of Efficacy|1|||
143466522|NCT00820027|517255738|FG002|Overall Study|Lack of Efficacy|2|||
143466523|NCT00820027|517255739|FG003|Overall Study|Lack of Efficacy|2|||
143466524|NCT00820027|517255736|FG000|Overall Study|Physician Decision|0|||
143466525|NCT00820027|517255737|FG001|Overall Study|Physician Decision|1|||
143466526|NCT00820027|517255738|FG002|Overall Study|Physician Decision|1|||
143466527|NCT00820027|517255739|FG003|Overall Study|Physician Decision|0|||
143466528|NCT00820027|517255736|FG000|Overall Study|Protocol Violation|3|||
143466529|NCT00820027|517255737|FG001|Overall Study|Protocol Violation|0|||
143466530|NCT00820027|517255738|FG002|Overall Study|Protocol Violation|4|||
143466531|NCT00820027|517255739|FG003|Overall Study|Protocol Violation|0|||
143466532|NCT00820027|517255736|FG000|Overall Study|Withdrawal by Subject|6|||
143466533|NCT00820027|517255737|FG001|Overall Study|Withdrawal by Subject|4|||
143466534|NCT00820027|517255738|FG002|Overall Study|Withdrawal by Subject|4|||
143466535|NCT00820027|517255739|FG003|Overall Study|Withdrawal by Subject|6|||
143466536|NCT01978262|517255740|FG000|Overall Study|Withdrawal by Subject|9|||
143466537|NCT01978262|517255740|FG000|Overall Study|Lost to Follow-up|2|||
143466538|NCT02604433|517255741|FG000|Overall Study|Withdrawal by Subject|37|||
143466539|NCT02604433|517255742|FG001|Overall Study|Withdrawal by Subject|16|||
143466540|NCT02604433|517255741|FG000|Overall Study|Adverse Event|4|||
143466541|NCT02604433|517255742|FG001|Overall Study|Adverse Event|0|||
143466542|NCT02604433|517255741|FG000|Overall Study|Other reasons|3|||
143466543|NCT02604433|517255742|FG001|Overall Study|Other reasons|5|||
143466544|NCT02604433|517255741|FG000|Overall Study|Death|4|||
143466545|NCT02604433|517255742|FG001|Overall Study|Death|1|||
143466546|NCT02604433|517255741|FG000|Overall Study|Transition to Rollover Protocol|169|||
143466547|NCT02604433|517255742|FG001|Overall Study|Transition to Rollover Protocol|82|||
143466548|NCT02604433|517255741|FG000|Overall Study|Physician Decision|1|||
143466549|NCT02604433|517255742|FG001|Overall Study|Physician Decision|1|||
143466550|NCT02604433|517255741|FG000|Overall Study|Lack of Efficacy|0|||
143466551|NCT02604433|517255742|FG001|Overall Study|Lack of Efficacy|1|||
143466552|NCT03285178|517255743|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
143466553|NCT03285178|517255744|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
143466554|NCT03285178|517255745|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
143466555|NCT03285178|517255746|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
143466556|NCT03285178|517255747|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
143466557|NCT03285178|517255748|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
143466558|NCT03285178|517255749|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
143466559|NCT03285178|517255743|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
143466560|NCT03285178|517255744|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
143466561|NCT03285178|517255745|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
143466562|NCT03285178|517255746|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
143466563|NCT03285178|517255747|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
143466564|NCT03285178|517255748|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
143466565|NCT03285178|517255749|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
143466566|NCT03285178|517255743|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
143466567|NCT03285178|517255744|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
143466568|NCT03285178|517255745|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
143466569|NCT03285178|517255746|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
143466570|NCT03285178|517255747|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
143181175|NCT01544348|516210484|FG005|Overall Study|Physician Decision|1|||
143466571|NCT03285178|517255748|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
143466572|NCT03285178|517255749|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
143466573|NCT03285178|517255743|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
143466574|NCT03285178|517255744|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
143466575|NCT03285178|517255745|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
143466576|NCT03285178|517255746|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
143466577|NCT03285178|517255747|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
143466578|NCT03285178|517255748|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
143466579|NCT03285178|517255749|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
143466580|NCT03285178|517255743|FG000|Single-Blind Run-In Period|Physician Decision|2|||
143466581|NCT03285178|517255744|FG001|Single-Blind Run-In Period|Physician Decision|0|||
143466582|NCT03285178|517255745|FG002|Single-Blind Run-In Period|Physician Decision|0|||
143466583|NCT03285178|517255746|FG003|Single-Blind Run-In Period|Physician Decision|0|||
143466584|NCT03285178|517255747|FG004|Single-Blind Run-In Period|Physician Decision|0|||
143466585|NCT03285178|517255748|FG005|Single-Blind Run-In Period|Physician Decision|0|||
143466586|NCT03285178|517255749|FG006|Single-Blind Run-In Period|Physician Decision|0|||
143466587|NCT03285178|517255743|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
143466588|NCT03285178|517255744|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
143466589|NCT03285178|517255745|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
143466590|NCT03285178|517255746|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
143466591|NCT03285178|517255747|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
143466592|NCT03285178|517255748|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
143466593|NCT03285178|517255749|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
143466594|NCT03285178|517255743|FG000|Double-Blind Treatment Period|Adverse Event|0|||
143466595|NCT03285178|517255744|FG001|Double-Blind Treatment Period|Adverse Event|0|||
143466596|NCT03285178|517255745|FG002|Double-Blind Treatment Period|Adverse Event|0|||
143466597|NCT03285178|517255746|FG003|Double-Blind Treatment Period|Adverse Event|0|||
143466598|NCT03285178|517255747|FG004|Double-Blind Treatment Period|Adverse Event|0|||
143466599|NCT03285178|517255748|FG005|Double-Blind Treatment Period|Adverse Event|0|||
143466600|NCT03285178|517255749|FG006|Double-Blind Treatment Period|Adverse Event|2|||
143466601|NCT03285178|517255743|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
143466602|NCT03285178|517255744|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
143466603|NCT03285178|517255745|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
143466604|NCT03285178|517255746|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
143466605|NCT03285178|517255747|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
143466606|NCT03285178|517255748|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
143466607|NCT03285178|517255749|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
143466608|NCT03285178|517255743|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
143466609|NCT03285178|517255744|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
143466610|NCT03285178|517255745|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
143466611|NCT03285178|517255746|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
143466612|NCT03285178|517255747|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
143466613|NCT03285178|517255748|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
143466614|NCT03285178|517255749|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
143466615|NCT03285178|517255743|FG000|Double-Blind Treatment Period|COVID-19|0|||
143466616|NCT03285178|517255744|FG001|Double-Blind Treatment Period|COVID-19|0|||
143466617|NCT03285178|517255745|FG002|Double-Blind Treatment Period|COVID-19|1|||
143466618|NCT03285178|517255746|FG003|Double-Blind Treatment Period|COVID-19|0|||
143466619|NCT03285178|517255747|FG004|Double-Blind Treatment Period|COVID-19|0|||
143466620|NCT03285178|517255748|FG005|Double-Blind Treatment Period|COVID-19|0|||
143466621|NCT03285178|517255749|FG006|Double-Blind Treatment Period|COVID-19|0|||
143466622|NCT01388790|517255750|FG000|Overall Study|Ongoing at data cut-off date|8|||
143466623|NCT01128894|517255751|FG000|Overall Study|Adverse Event|31|||
143466624|NCT01128894|517255752|FG001|Overall Study|Adverse Event|41|||
143466625|NCT01128894|517255751|FG000|Overall Study|Protocol Violation|2|||
143466626|NCT01128894|517255752|FG001|Overall Study|Protocol Violation|1|||
143466627|NCT01128894|517255751|FG000|Overall Study|Noncompliance|4|||
143466628|NCT01128894|517255752|FG001|Overall Study|Noncompliance|5|||
143466629|NCT01128894|517255751|FG000|Overall Study|Lost to Follow-up|8|||
143466630|NCT01128894|517255752|FG001|Overall Study|Lost to Follow-up|8|||
143466631|NCT01128894|517255751|FG000|Overall Study|Withdrawal by Subject|10|||
143466632|NCT01128894|517255752|FG001|Overall Study|Withdrawal by Subject|12|||
143466633|NCT01128894|517255751|FG000|Overall Study|Physician Decision|2|||
143466634|NCT01128894|517255752|FG001|Overall Study|Physician Decision|1|||
143466635|NCT01128894|517255751|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
143466636|NCT01128894|517255752|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
143466637|NCT03437278|517255753|FG000|Overall Study|Adverse Event|0|||
143466638|NCT03437278|517255754|FG001|Overall Study|Adverse Event|0|||
143466639|NCT03437278|517255755|FG002|Overall Study|Adverse Event|1|||
143466640|NCT03437278|517255753|FG000|Overall Study|Progressive disease|1|||
143466641|NCT03437278|517255754|FG001|Overall Study|Progressive disease|0|||
143466642|NCT03437278|517255755|FG002|Overall Study|Progressive disease|0|||
143133482|NCT03286218|516033393|FG011|Qualification Phase Period 1|Adverse Event|0|||
143133483|NCT03286218|516033382|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
143358914|NCT02003222|516857900|FG004|Intensification|Adverse Event|6|||
143358915|NCT02003222|516857896|FG000|Intensification|Alternative therapy|0|||
143358916|NCT02003222|516857897|FG001|Intensification|Alternative therapy|0|||
143358917|NCT02003222|516857898|FG002|Intensification|Alternative therapy|0|||
143358918|NCT02003222|516857899|FG003|Intensification|Alternative therapy|0|||
143358919|NCT02003222|516857900|FG004|Intensification|Alternative therapy|8|||
143358920|NCT02003222|516857896|FG000|Intensification|Disease progression|0|||
143358921|NCT02003222|516857897|FG001|Intensification|Disease progression|0|||
143358922|NCT02003222|516857898|FG002|Intensification|Disease progression|0|||
143358923|NCT02003222|516857899|FG003|Intensification|Disease progression|0|||
143358924|NCT02003222|516857900|FG004|Intensification|Disease progression|18|||
143358925|NCT02003222|516857896|FG000|Intensification|Withdrawal by Subject|0|||
143358926|NCT02003222|516857897|FG001|Intensification|Withdrawal by Subject|0|||
143358927|NCT02003222|516857898|FG002|Intensification|Withdrawal by Subject|0|||
143358928|NCT02003222|516857899|FG003|Intensification|Withdrawal by Subject|0|||
143358929|NCT02003222|516857900|FG004|Intensification|Withdrawal by Subject|5|||
143358930|NCT02003222|516857896|FG000|Intensification|Other reasons|0|||
143358931|NCT02003222|516857897|FG001|Intensification|Other reasons|0|||
143358932|NCT02003222|516857898|FG002|Intensification|Other reasons|0|||
143358933|NCT02003222|516857899|FG003|Intensification|Other reasons|0|||
143358934|NCT02003222|516857900|FG004|Intensification|Other reasons|8|||
143358935|NCT01848834|516857901|FG000|Overall Study|Adverse Event|3|||
143358936|NCT01848834|516857902|FG001|Overall Study|Adverse Event|11|||
143358937|NCT01848834|516857903|FG002|Overall Study|Adverse Event|3|||
143358938|NCT01848834|516857904|FG003|Overall Study|Adverse Event|5|||
143358939|NCT01848834|516857905|FG004|Overall Study|Adverse Event|9|||
143358940|NCT01848834|516857901|FG000|Overall Study|Death|2|||
143466643|NCT03437278|517255753|FG000|Overall Study|Physician Decision|1|||
143466644|NCT03437278|517255754|FG001|Overall Study|Physician Decision|0|||
143466645|NCT03437278|517255755|FG002|Overall Study|Physician Decision|1|||
143466646|NCT00195507|517255756|FG000|Overall Study|Adverse Event|24|||
143466647|NCT00195507|517255757|FG001|Overall Study|Adverse Event|13|||
143466648|NCT00195507|517255756|FG000|Overall Study|Death|0|||
143466649|NCT00195507|517255757|FG001|Overall Study|Death|1|||
143466650|NCT00195507|517255756|FG000|Overall Study|Failed to Return|4|||
143466651|NCT00195507|517255757|FG001|Overall Study|Failed to Return|3|||
143466652|NCT00195507|517255756|FG000|Overall Study|Physician Decision|1|||
143466653|NCT00195507|517255757|FG001|Overall Study|Physician Decision|2|||
143466654|NCT00195507|517255756|FG000|Overall Study|Lost to Follow-up|3|||
143466655|NCT00195507|517255757|FG001|Overall Study|Lost to Follow-up|2|||
143466656|NCT00195507|517255756|FG000|Overall Study|Protocol Violation|5|||
143466657|NCT00195507|517255757|FG001|Overall Study|Protocol Violation|4|||
143466658|NCT00195507|517255756|FG000|Overall Study|Lack of Efficacy|40|||
143466659|NCT00195507|517255757|FG001|Overall Study|Lack of Efficacy|67|||
143466660|NCT00195507|517255756|FG000|Overall Study|Withdrawal by Subject|16|||
143466661|NCT00195507|517255757|FG001|Overall Study|Withdrawal by Subject|23|||
143466662|NCT00195507|517255756|FG000|Overall Study|Protocol Deviation|6|||
143466663|NCT00195507|517255757|FG001|Overall Study|Protocol Deviation|3|||
143466664|NCT00973362|517255758|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
143358941|NCT01848834|516857902|FG001|Overall Study|Death|11|||
143358942|NCT01848834|516857903|FG002|Overall Study|Death|1|||
143358943|NCT01848834|516857904|FG003|Overall Study|Death|8|||
143358944|NCT01848834|516857905|FG004|Overall Study|Death|27|||
143358945|NCT01848834|516857901|FG000|Overall Study|Excluded Medication|5|||
143358946|NCT01848834|516857902|FG001|Overall Study|Excluded Medication|4|||
143358947|NCT01848834|516857903|FG002|Overall Study|Excluded Medication|3|||
143358948|NCT01848834|516857904|FG003|Overall Study|Excluded Medication|6|||
143358949|NCT01848834|516857905|FG004|Overall Study|Excluded Medication|6|||
143358950|NCT01848834|516857901|FG000|Overall Study|Lost to Follow-up|5|||
143358951|NCT01848834|516857902|FG001|Overall Study|Lost to Follow-up|5|||
143358952|NCT01848834|516857903|FG002|Overall Study|Lost to Follow-up|3|||
143358953|NCT01848834|516857904|FG003|Overall Study|Lost to Follow-up|0|||
143358954|NCT01848834|516857905|FG004|Overall Study|Lost to Follow-up|3|||
143358955|NCT01848834|516857901|FG000|Overall Study|Physician Decision|1|||
143181176|NCT01544348|516210485|FG006|Overall Study|Physician Decision|0|||
143358956|NCT01848834|516857902|FG001|Overall Study|Physician Decision|3|||
143358957|NCT01848834|516857903|FG002|Overall Study|Physician Decision|4|||
143358958|NCT01848834|516857904|FG003|Overall Study|Physician Decision|0|||
143358959|NCT01848834|516857905|FG004|Overall Study|Physician Decision|11|||
143358960|NCT01848834|516857901|FG000|Overall Study|Protocol Violation|0|||
143358961|NCT01848834|516857902|FG001|Overall Study|Protocol Violation|0|||
143358962|NCT01848834|516857903|FG002|Overall Study|Protocol Violation|0|||
143358963|NCT01848834|516857904|FG003|Overall Study|Protocol Violation|0|||
143358964|NCT01848834|516857905|FG004|Overall Study|Protocol Violation|1|||
143358965|NCT01848834|516857901|FG000|Overall Study|Sponsor Decision|1|||
143358966|NCT01848834|516857902|FG001|Overall Study|Sponsor Decision|1|||
143466665|NCT00973362|517255759|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
143358967|NCT01848834|516857903|FG002|Overall Study|Sponsor Decision|0|||
143358968|NCT01848834|516857904|FG003|Overall Study|Sponsor Decision|1|||
143358969|NCT01848834|516857905|FG004|Overall Study|Sponsor Decision|1|||
143358970|NCT01848834|516857901|FG000|Overall Study|Withdrawal by Subject|2|||
143358971|NCT01848834|516857902|FG001|Overall Study|Withdrawal by Subject|13|||
143358972|NCT01848834|516857903|FG002|Overall Study|Withdrawal by Subject|10|||
143358973|NCT01848834|516857904|FG003|Overall Study|Withdrawal by Subject|6|||
143358974|NCT01848834|516857905|FG004|Overall Study|Withdrawal by Subject|36|||
143358975|NCT01886872|516857906|FG000|Overall Study|Ineligible|7|||
143358976|NCT01886872|516857907|FG001|Overall Study|Ineligible|4|||
143358977|NCT01886872|516857908|FG002|Overall Study|Ineligible|12|||
143358978|NCT00588770|516857911|FG000|Overall Study|Disease progression|85|||
143358979|NCT00588770|516857912|FG001|Overall Study|Disease progression|68|||
143358980|NCT00588770|516857911|FG000|Overall Study|Adverse Event|29|||
143358981|NCT00588770|516857912|FG001|Overall Study|Adverse Event|58|||
143358982|NCT00588770|516857911|FG000|Overall Study|Death|13|||
143358983|NCT00588770|516857912|FG001|Overall Study|Death|22|||
143358984|NCT00588770|516857911|FG000|Overall Study|Withdrawal by Subject|15|||
143358985|NCT00588770|516857912|FG001|Overall Study|Withdrawal by Subject|25|||
143358986|NCT00588770|516857911|FG000|Overall Study|Alternative therapy|2|||
143358987|NCT00588770|516857912|FG001|Overall Study|Alternative therapy|4|||
143358988|NCT00588770|516857911|FG000|Overall Study|Other complicating disease|3|||
143358989|NCT00588770|516857912|FG001|Overall Study|Other complicating disease|2|||
143358990|NCT00588770|516857911|FG000|Overall Study|Not start protocol therapy|0|||
143358991|NCT00588770|516857912|FG001|Overall Study|Not start protocol therapy|9|||
143358992|NCT00588770|516857911|FG000|Overall Study|Lack of Efficacy|8|||
143358993|NCT00588770|516857912|FG001|Overall Study|Lack of Efficacy|10|||
143358994|NCT00588770|516857911|FG000|Overall Study|Physician discretion|2|||
143358995|NCT00588770|516857912|FG001|Overall Study|Physician discretion|0|||
143358996|NCT00588770|516857911|FG000|Overall Study|Patient non-compliance|2|||
143358997|NCT00588770|516857912|FG001|Overall Study|Patient non-compliance|2|||
143358998|NCT01400893|516857914|FG000|Overall Study|Death|27|||
143358999|NCT01400893|516857915|FG001|Overall Study|Death|21|||
143359000|NCT01400893|516857914|FG000|Overall Study|Lost to Follow-up|0|||
143359001|NCT01400893|516857915|FG001|Overall Study|Lost to Follow-up|6|||
143359002|NCT03057834|516857916|FG000|Overall Study|Withdrawal by Subject|25|||
143359003|NCT03057834|516857917|FG001|Overall Study|Withdrawal by Subject|29|||
143359004|NCT03803774|516857920|FG000|Dose Escalation|Withdrawal by Subject|0|||
143359005|NCT03803774|516857921|FG001|Dose Escalation|Withdrawal by Subject|0|||
143359006|NCT03803774|516857922|FG002|Dose Escalation|Withdrawal by Subject|0|||
143359007|NCT03803774|516857923|FG003|Dose Escalation|Withdrawal by Subject|1|||
143359008|NCT03803774|516857924|FG004|Dose Escalation|Withdrawal by Subject|0|||
143359009|NCT05617040|516857925|FG000|Overall Study|Adverse Event|0|||
143359010|NCT05617040|516857926|FG001|Overall Study|Adverse Event|1|||
143359011|NCT05617040|516857927|FG002|Overall Study|Adverse Event|0|||
143359012|NCT05617040|516857925|FG000|Overall Study|Death|0|||
143359013|NCT05617040|516857926|FG001|Overall Study|Death|0|||
143359014|NCT05617040|516857927|FG002|Overall Study|Death|1|||
143359015|NCT03990363|516857928|FG000|Overall Study|Withdrawal by Subject|10|||
143359016|NCT03990363|516857929|FG001|Overall Study|Withdrawal by Subject|9|||
143359017|NCT03990363|516857930|FG002|Overall Study|Withdrawal by Subject|18|||
143359018|NCT03990363|516857931|FG003|Overall Study|Withdrawal by Subject|11|||
143359019|NCT03990363|516857932|FG004|Overall Study|Withdrawal by Subject|9|||
143359020|NCT03990363|516857928|FG000|Overall Study|Physician Decision|1|||
143013923|NCT02587325|515590088|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
143013924|NCT02587325|515590089|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
143013925|NCT02587325|515590090|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
143013926|NCT02587325|515590086|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
143013927|NCT02587325|515590087|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
143013928|NCT02587325|515590088|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
143013929|NCT02587325|515590089|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
143181177|NCT01544348|516210486|FG007|Overall Study|Physician Decision|0|||
143359021|NCT03990363|516857929|FG001|Overall Study|Physician Decision|0|||
143359022|NCT03990363|516857930|FG002|Overall Study|Physician Decision|0|||
143359023|NCT03990363|516857931|FG003|Overall Study|Physician Decision|0|||
143359024|NCT03990363|516857932|FG004|Overall Study|Physician Decision|0|||
143359025|NCT03990363|516857928|FG000|Overall Study|Adverse Event|1|||
143359026|NCT03990363|516857929|FG001|Overall Study|Adverse Event|3|||
143359027|NCT03990363|516857930|FG002|Overall Study|Adverse Event|2|||
143359028|NCT03990363|516857931|FG003|Overall Study|Adverse Event|2|||
143359029|NCT03990363|516857932|FG004|Overall Study|Adverse Event|0|||
143359030|NCT03990363|516857928|FG000|Overall Study|Death|14|||
143359031|NCT03990363|516857929|FG001|Overall Study|Death|8|||
143359032|NCT03990363|516857930|FG002|Overall Study|Death|14|||
143359033|NCT03990363|516857931|FG003|Overall Study|Death|10|||
143359034|NCT03990363|516857932|FG004|Overall Study|Death|11|||
143359035|NCT03990363|516857928|FG000|Overall Study|Failure to meet randomization criteria|0|||
143359036|NCT03990363|516857929|FG001|Overall Study|Failure to meet randomization criteria|1|||
143133484|NCT03286218|516033383|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
143133485|NCT03286218|516033384|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
143133486|NCT03286218|516033385|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
143133487|NCT03286218|516033386|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
143133488|NCT03286218|516033387|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
143133489|NCT03286218|516033388|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
143133490|NCT03286218|516033389|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
143133491|NCT03286218|516033390|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
143133492|NCT03286218|516033391|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
143133493|NCT03286218|516033392|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
143133494|NCT03286218|516033393|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
143133495|NCT03286218|516033382|FG000|Qualification Phase Period 2|Adverse Event|0|||
143133496|NCT03286218|516033383|FG001|Qualification Phase Period 2|Adverse Event|1|||
143133497|NCT03286218|516033384|FG002|Qualification Phase Period 2|Adverse Event|0|||
143133498|NCT03286218|516033385|FG003|Qualification Phase Period 2|Adverse Event|0|||
143133499|NCT03286218|516033386|FG004|Qualification Phase Period 2|Adverse Event|0|||
143133500|NCT03286218|516033387|FG005|Qualification Phase Period 2|Adverse Event|0|||
143133501|NCT03286218|516033388|FG006|Qualification Phase Period 2|Adverse Event|0|||
143133502|NCT03286218|516033389|FG007|Qualification Phase Period 2|Adverse Event|0|||
143133503|NCT03286218|516033390|FG008|Qualification Phase Period 2|Adverse Event|0|||
143133504|NCT03286218|516033391|FG009|Qualification Phase Period 2|Adverse Event|0|||
143133505|NCT03286218|516033392|FG010|Qualification Phase Period 2|Adverse Event|0|||
143133506|NCT03286218|516033393|FG011|Qualification Phase Period 2|Adverse Event|0|||
143133507|NCT03286218|516033382|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
143133508|NCT03286218|516033383|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
143133509|NCT03286218|516033384|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
143133510|NCT03286218|516033385|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
143133511|NCT03286218|516033386|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
143133512|NCT03286218|516033387|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
143133513|NCT03286218|516033388|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
143133514|NCT03286218|516033389|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
143133515|NCT03286218|516033390|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
143133516|NCT03286218|516033391|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
143133517|NCT03286218|516033392|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
143133518|NCT03286218|516033393|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
143133519|NCT03286218|516033382|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
143133520|NCT03286218|516033383|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
143133521|NCT03286218|516033384|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
143133522|NCT03286218|516033385|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
143133523|NCT03286218|516033386|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
143133524|NCT03286218|516033387|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
143133525|NCT03286218|516033388|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
143133526|NCT03286218|516033389|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
143133527|NCT03286218|516033390|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
143133528|NCT03286218|516033391|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
143133529|NCT03286218|516033392|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
143133530|NCT03286218|516033393|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
143133531|NCT03286218|516033382|FG000|Qualification Phase Period 2|Protocol Violation|2|||
143133532|NCT03286218|516033383|FG001|Qualification Phase Period 2|Protocol Violation|0|||
143133533|NCT03286218|516033384|FG002|Qualification Phase Period 2|Protocol Violation|0|||
143133534|NCT03286218|516033385|FG003|Qualification Phase Period 2|Protocol Violation|0|||
143133535|NCT03286218|516033386|FG004|Qualification Phase Period 2|Protocol Violation|0|||
143133536|NCT03286218|516033387|FG005|Qualification Phase Period 2|Protocol Violation|0|||
143133537|NCT03286218|516033388|FG006|Qualification Phase Period 2|Protocol Violation|0|||
143133538|NCT03286218|516033389|FG007|Qualification Phase Period 2|Protocol Violation|0|||
143133539|NCT03286218|516033390|FG008|Qualification Phase Period 2|Protocol Violation|0|||
143133540|NCT03286218|516033391|FG009|Qualification Phase Period 2|Protocol Violation|0|||
143133541|NCT03286218|516033392|FG010|Qualification Phase Period 2|Protocol Violation|0|||
143133542|NCT03286218|516033393|FG011|Qualification Phase Period 2|Protocol Violation|0|||
143133543|NCT03286218|516033382|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
143133544|NCT03286218|516033383|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
143133545|NCT03286218|516033384|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
143133546|NCT03286218|516033385|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
143133547|NCT03286218|516033386|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
143359037|NCT03990363|516857930|FG002|Overall Study|Failure to meet randomization criteria|1|||
143359038|NCT03990363|516857931|FG003|Overall Study|Failure to meet randomization criteria|0|||
143466666|NCT00973362|517255758|FG000|Baseline Evaluation|No colposcopy visit|62|||
143466667|NCT00973362|517255759|FG001|Baseline Evaluation|No colposcopy visit|0|||
143466668|NCT00973362|517255758|FG000|Baseline Evaluation|Inevaluable|686|||
143466669|NCT00973362|517255759|FG001|Baseline Evaluation|Inevaluable|223|||
143466670|NCT00973362|517255758|FG000|3-Year Follow-up|Lost to Follow-up|17|||
143466671|NCT00973362|517255759|FG001|3-Year Follow-up|Lost to Follow-up|0|||
143466672|NCT02202551|517255760|FG000|Overall Study|Adverse Event|8|||
143466673|NCT02202551|517255761|FG001|Overall Study|Adverse Event|19|||
143466674|NCT02202551|517255762|FG002|Overall Study|Adverse Event|5|||
143466675|NCT02202551|517255763|FG003|Overall Study|Adverse Event|9|||
143466676|NCT02202551|517255760|FG000|Overall Study|Death|3|||
143466677|NCT02202551|517255761|FG001|Overall Study|Death|2|||
143466678|NCT02202551|517255762|FG002|Overall Study|Death|1|||
143466679|NCT02202551|517255763|FG003|Overall Study|Death|1|||
143466680|NCT02202551|517255760|FG000|Overall Study|Lost to Follow-up|0|||
143466681|NCT02202551|517255761|FG001|Overall Study|Lost to Follow-up|1|||
143466682|NCT02202551|517255762|FG002|Overall Study|Lost to Follow-up|0|||
143466683|NCT02202551|517255763|FG003|Overall Study|Lost to Follow-up|1|||
143359039|NCT03990363|516857932|FG004|Overall Study|Failure to meet randomization criteria|0|||
143359040|NCT03990363|516857928|FG000|Overall Study|Lost to Follow-up|0|||
143359041|NCT03990363|516857929|FG001|Overall Study|Lost to Follow-up|0|||
143359042|NCT03990363|516857930|FG002|Overall Study|Lost to Follow-up|0|||
143359043|NCT03990363|516857931|FG003|Overall Study|Lost to Follow-up|1|||
143359044|NCT03990363|516857932|FG004|Overall Study|Lost to Follow-up|2|||
143359045|NCT03990363|516857928|FG000|Overall Study|Non-compliance with study drug|2|||
143359046|NCT03990363|516857929|FG001|Overall Study|Non-compliance with study drug|1|||
143359047|NCT03990363|516857930|FG002|Overall Study|Non-compliance with study drug|2|||
143359048|NCT03990363|516857931|FG003|Overall Study|Non-compliance with study drug|0|||
143359049|NCT03990363|516857932|FG004|Overall Study|Non-compliance with study drug|0|||
143359050|NCT03990363|516857928|FG000|Overall Study|Study terminated by sponsor|0|||
143359051|NCT03990363|516857929|FG001|Overall Study|Study terminated by sponsor|1|||
143359052|NCT03990363|516857930|FG002|Overall Study|Study terminated by sponsor|0|||
143359053|NCT03990363|516857931|FG003|Overall Study|Study terminated by sponsor|0|||
143359054|NCT03990363|516857932|FG004|Overall Study|Study terminated by sponsor|0|||
143359055|NCT03990363|516857928|FG000|Overall Study|Site terminated by sponsor|2|||
143359056|NCT03990363|516857929|FG001|Overall Study|Site terminated by sponsor|1|||
143359057|NCT03990363|516857930|FG002|Overall Study|Site terminated by sponsor|2|||
143359058|NCT03990363|516857931|FG003|Overall Study|Site terminated by sponsor|0|||
143359059|NCT03990363|516857932|FG004|Overall Study|Site terminated by sponsor|2|||
143359060|NCT03990363|516857928|FG000|Overall Study|Not categorized|5|||
143359061|NCT03990363|516857929|FG001|Overall Study|Not categorized|5|||
143359062|NCT03990363|516857930|FG002|Overall Study|Not categorized|3|||
143359063|NCT03990363|516857931|FG003|Overall Study|Not categorized|2|||
143359064|NCT03990363|516857932|FG004|Overall Study|Not categorized|2|||
143359065|NCT03173248|516857933|FG000|Overall Study|Death|28|||
143359066|NCT03173248|516857934|FG001|Overall Study|Death|46|||
143359067|NCT03173248|516857933|FG000|Overall Study|Lost to Follow-up|0|||
143359068|NCT03173248|516857934|FG001|Overall Study|Lost to Follow-up|1|||
143359069|NCT03173248|516857933|FG000|Overall Study|Withdrawal by Subject|6|||
143359070|NCT03173248|516857934|FG001|Overall Study|Withdrawal by Subject|4|||
143359071|NCT03173248|516857933|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
143359072|NCT03173248|516857934|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
143359073|NCT03621982|516857936|FG000|Overall Study|Withdrawal by Subject|1|||
143359074|NCT03621982|516857937|FG001|Overall Study|Withdrawal by Subject|0|||
143359075|NCT03621982|516857938|FG002|Overall Study|Withdrawal by Subject|0|||
143359076|NCT03621982|516857939|FG003|Overall Study|Withdrawal by Subject|1|||
143359077|NCT03621982|516857940|FG004|Overall Study|Withdrawal by Subject|0|||
143359078|NCT03621982|516857941|FG005|Overall Study|Withdrawal by Subject|1|||
143359079|NCT03621982|516857942|FG006|Overall Study|Withdrawal by Subject|1|||
143359080|NCT03621982|516857943|FG007|Overall Study|Withdrawal by Subject|0|||
143359081|NCT03621982|516857944|FG008|Overall Study|Withdrawal by Subject|1|||
143359082|NCT03621982|516857945|FG009|Overall Study|Withdrawal by Subject|0|||
143359083|NCT03621982|516857946|FG010|Overall Study|Withdrawal by Subject|2|||
143466684|NCT02202551|517255760|FG000|Overall Study|Needed to take excluded medication|0|||
143466685|NCT02202551|517255761|FG001|Overall Study|Needed to take excluded medication|2|||
143466686|NCT02202551|517255762|FG002|Overall Study|Needed to take excluded medication|0|||
143466687|NCT02202551|517255763|FG003|Overall Study|Needed to take excluded medication|1|||
143466688|NCT02202551|517255760|FG000|Overall Study|Subject moved away|0|||
143466689|NCT02202551|517255761|FG001|Overall Study|Subject moved away|1|||
143359084|NCT03621982|516857947|FG011|Overall Study|Withdrawal by Subject|1|||
143359085|NCT03621982|516857948|FG012|Overall Study|Withdrawal by Subject|2|||
143359086|NCT03621982|516857949|FG013|Overall Study|Withdrawal by Subject|2|||
143359087|NCT03621982|516857936|FG000|Overall Study|Investigator/Sponsor decision|0|||
143359088|NCT03621982|516857937|FG001|Overall Study|Investigator/Sponsor decision|0|||
143359089|NCT03621982|516857938|FG002|Overall Study|Investigator/Sponsor decision|0|||
143359090|NCT03621982|516857939|FG003|Overall Study|Investigator/Sponsor decision|0|||
143133548|NCT03286218|516033387|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
143133549|NCT03286218|516033388|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
143133550|NCT03286218|516033389|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
143133551|NCT03286218|516033390|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
143133552|NCT03286218|516033391|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
143133553|NCT03286218|516033392|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
143133554|NCT03286218|516033393|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
143133555|NCT03286218|516033382|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
143133556|NCT03286218|516033383|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
143133557|NCT03286218|516033384|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
143133558|NCT03286218|516033385|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
143133559|NCT03286218|516033386|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
143133560|NCT03286218|516033387|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
143133561|NCT03286218|516033388|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
143133562|NCT03286218|516033389|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
143359091|NCT03621982|516857940|FG004|Overall Study|Investigator/Sponsor decision|0|||
143359092|NCT03621982|516857941|FG005|Overall Study|Investigator/Sponsor decision|0|||
143359093|NCT03621982|516857942|FG006|Overall Study|Investigator/Sponsor decision|0|||
143359094|NCT03621982|516857943|FG007|Overall Study|Investigator/Sponsor decision|0|||
143359095|NCT03621982|516857944|FG008|Overall Study|Investigator/Sponsor decision|0|||
143359096|NCT03621982|516857945|FG009|Overall Study|Investigator/Sponsor decision|0|||
143359097|NCT03621982|516857946|FG010|Overall Study|Investigator/Sponsor decision|0|||
143359098|NCT03621982|516857947|FG011|Overall Study|Investigator/Sponsor decision|4|||
143359099|NCT03621982|516857948|FG012|Overall Study|Investigator/Sponsor decision|0|||
143359100|NCT03621982|516857949|FG013|Overall Study|Investigator/Sponsor decision|2|||
143359101|NCT03621982|516857936|FG000|Overall Study|Death|2|||
143359102|NCT03621982|516857937|FG001|Overall Study|Death|4|||
143359103|NCT03621982|516857938|FG002|Overall Study|Death|4|||
143359104|NCT03621982|516857939|FG003|Overall Study|Death|3|||
143359105|NCT03621982|516857940|FG004|Overall Study|Death|8|||
143359106|NCT03621982|516857941|FG005|Overall Study|Death|4|||
143359107|NCT03621982|516857942|FG006|Overall Study|Death|6|||
143359108|NCT03621982|516857943|FG007|Overall Study|Death|3|||
143359109|NCT03621982|516857944|FG008|Overall Study|Death|0|||
143359110|NCT03621982|516857945|FG009|Overall Study|Death|3|||
143359111|NCT03621982|516857946|FG010|Overall Study|Death|8|||
143359112|NCT03621982|516857947|FG011|Overall Study|Death|4|||
143359113|NCT03621982|516857948|FG012|Overall Study|Death|2|||
143359114|NCT03621982|516857949|FG013|Overall Study|Death|2|||
143359115|NCT03621982|516857936|FG000|Overall Study|Lost to Follow-up|0|||
143359116|NCT03621982|516857937|FG001|Overall Study|Lost to Follow-up|0|||
143359117|NCT03621982|516857938|FG002|Overall Study|Lost to Follow-up|1|||
143359118|NCT03621982|516857939|FG003|Overall Study|Lost to Follow-up|0|||
143359119|NCT03621982|516857940|FG004|Overall Study|Lost to Follow-up|0|||
143359120|NCT03621982|516857941|FG005|Overall Study|Lost to Follow-up|0|||
143359121|NCT03621982|516857942|FG006|Overall Study|Lost to Follow-up|1|||
143359122|NCT03621982|516857943|FG007|Overall Study|Lost to Follow-up|0|||
143359123|NCT03621982|516857944|FG008|Overall Study|Lost to Follow-up|0|||
143359124|NCT03621982|516857945|FG009|Overall Study|Lost to Follow-up|1|||
143359125|NCT03621982|516857946|FG010|Overall Study|Lost to Follow-up|0|||
143359126|NCT03621982|516857947|FG011|Overall Study|Lost to Follow-up|0|||
143359127|NCT03621982|516857948|FG012|Overall Study|Lost to Follow-up|0|||
143359128|NCT03621982|516857949|FG013|Overall Study|Lost to Follow-up|0|||
143359129|NCT02353832|516857952|FG000|Overall Study|Ineligible after enrollment|1|||
143359130|NCT02353832|516857952|FG000|Overall Study|Lost to Follow-up|1|||
143359131|NCT02684903|516857953|FG000|Overall Study|COVID-19 shutdown of lab|4|||
143359132|NCT02684903|516857954|FG001|Overall Study|COVID-19 shutdown of lab|6|||
143359133|NCT02684903|516857953|FG000|Overall Study|Lost to Follow-up|31|||
143359134|NCT02684903|516857954|FG001|Overall Study|Lost to Follow-up|41|||
143359135|NCT05397470|516857955|FG000|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
143359136|NCT05397470|516857956|FG001|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|1|||
143359137|NCT05397470|516857957|FG002|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
143359138|NCT05397470|516857955|FG000|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
143359139|NCT05397470|516857956|FG001|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
143359140|NCT05397470|516857957|FG002|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|0|||
143359141|NCT05397470|516857955|FG000|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|2|||
143013930|NCT02587325|515590090|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
143359142|NCT05397470|516857956|FG001|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|1|||
143359143|NCT05397470|516857957|FG002|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|0|||
143359144|NCT05397470|516857955|FG000|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
143359145|NCT05397470|516857956|FG001|Part A: PCT Period (Up to 48 Weeks)|Other|1|||
143013931|NCT02587325|515590086|FG000|32-Week Optional Extension Part|Adverse Event|0|||
143359146|NCT05397470|516857957|FG002|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
143359147|NCT05397470|516857955|FG000|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
143359148|NCT05397470|516857956|FG001|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
143466690|NCT02202551|517255762|FG002|Overall Study|Subject moved away|0|||
143466691|NCT02202551|517255763|FG003|Overall Study|Subject moved away|0|||
143133563|NCT03286218|516033390|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
143133564|NCT03286218|516033391|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
143133565|NCT03286218|516033392|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
143133566|NCT03286218|516033393|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
143133567|NCT03286218|516033382|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
143133568|NCT03286218|516033383|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
143133569|NCT03286218|516033384|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
143133570|NCT03286218|516033385|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
143133571|NCT03286218|516033386|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
143133572|NCT03286218|516033387|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
143133573|NCT03286218|516033388|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
143466692|NCT02202551|517255760|FG000|Overall Study|DBS surgery|3|||
143466693|NCT02202551|517255761|FG001|Overall Study|DBS surgery|0|||
143466694|NCT02202551|517255762|FG002|Overall Study|DBS surgery|0|||
143466695|NCT02202551|517255763|FG003|Overall Study|DBS surgery|0|||
143466696|NCT02202551|517255760|FG000|Overall Study|Dyskinesia upon taper|1|||
143466697|NCT02202551|517255761|FG001|Overall Study|Dyskinesia upon taper|0|||
143466698|NCT02202551|517255762|FG002|Overall Study|Dyskinesia upon taper|0|||
143466699|NCT02202551|517255763|FG003|Overall Study|Dyskinesia upon taper|0|||
143466700|NCT02202551|517255760|FG000|Overall Study|Lack of Efficacy|0|||
143466701|NCT02202551|517255761|FG001|Overall Study|Lack of Efficacy|1|||
143466702|NCT02202551|517255762|FG002|Overall Study|Lack of Efficacy|0|||
143466703|NCT02202551|517255763|FG003|Overall Study|Lack of Efficacy|0|||
143466704|NCT02202551|517255760|FG000|Overall Study|Physician Decision|1|||
143466705|NCT02202551|517255761|FG001|Overall Study|Physician Decision|0|||
143466706|NCT02202551|517255762|FG002|Overall Study|Physician Decision|0|||
143466707|NCT02202551|517255763|FG003|Overall Study|Physician Decision|0|||
143466708|NCT02202551|517255760|FG000|Overall Study|Site closure|3|||
143466709|NCT02202551|517255761|FG001|Overall Study|Site closure|0|||
143466710|NCT02202551|517255762|FG002|Overall Study|Site closure|0|||
143466711|NCT02202551|517255763|FG003|Overall Study|Site closure|1|||
143466712|NCT02202551|517255760|FG000|Overall Study|Unable to complete visits per protocol|1|||
143466713|NCT02202551|517255761|FG001|Overall Study|Unable to complete visits per protocol|0|||
143466714|NCT02202551|517255762|FG002|Overall Study|Unable to complete visits per protocol|0|||
143466715|NCT02202551|517255763|FG003|Overall Study|Unable to complete visits per protocol|0|||
143466716|NCT02202551|517255760|FG000|Overall Study|Worsening Dyskinesia|0|||
143466717|NCT02202551|517255761|FG001|Overall Study|Worsening Dyskinesia|0|||
143466718|NCT02202551|517255762|FG002|Overall Study|Worsening Dyskinesia|0|||
143466719|NCT02202551|517255763|FG003|Overall Study|Worsening Dyskinesia|1|||
143466720|NCT02202551|517255760|FG000|Overall Study|Protocol Violation|0|||
143466721|NCT02202551|517255761|FG001|Overall Study|Protocol Violation|1|||
143466722|NCT02202551|517255762|FG002|Overall Study|Protocol Violation|0|||
143466723|NCT02202551|517255763|FG003|Overall Study|Protocol Violation|0|||
143466724|NCT02202551|517255760|FG000|Overall Study|Sponsor's decision|2|||
143466725|NCT02202551|517255761|FG001|Overall Study|Sponsor's decision|0|||
143466726|NCT02202551|517255762|FG002|Overall Study|Sponsor's decision|0|||
143466727|NCT02202551|517255763|FG003|Overall Study|Sponsor's decision|0|||
143466728|NCT02202551|517255760|FG000|Overall Study|Subject unwilling to proceed|1|||
143466729|NCT02202551|517255761|FG001|Overall Study|Subject unwilling to proceed|5|||
143466730|NCT02202551|517255762|FG002|Overall Study|Subject unwilling to proceed|3|||
143466731|NCT02202551|517255763|FG003|Overall Study|Subject unwilling to proceed|5|||
143466732|NCT02202551|517255760|FG000|Overall Study|Subject consent withdrawn|0|||
143466733|NCT02202551|517255761|FG001|Overall Study|Subject consent withdrawn|3|||
143466734|NCT02202551|517255762|FG002|Overall Study|Subject consent withdrawn|1|||
143466735|NCT02202551|517255763|FG003|Overall Study|Subject consent withdrawn|2|||
143466736|NCT02202551|517255760|FG000|Overall Study|eGFR<50mL/min/m2|2|||
143466737|NCT02202551|517255761|FG001|Overall Study|eGFR<50mL/min/m2|2|||
143466738|NCT02202551|517255762|FG002|Overall Study|eGFR<50mL/min/m2|0|||
143466739|NCT02202551|517255763|FG003|Overall Study|eGFR<50mL/min/m2|1|||
143466740|NCT02349451|517255764|FG000|Overall Study|Withdrawal by Subject|0|||
143133574|NCT03286218|516033389|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
143466741|NCT02349451|517255765|FG001|Overall Study|Withdrawal by Subject|1|||
143466742|NCT02349451|517255766|FG002|Overall Study|Withdrawal by Subject|2|||
143466743|NCT02349451|517255767|FG003|Overall Study|Withdrawal by Subject|1|||
143466744|NCT02683941|517255768|FG000|Double-blind Phase|Adverse Event|0|||
143466745|NCT02683941|517255769|FG001|Double-blind Phase|Adverse Event|1|||
143466746|NCT02683941|517255768|FG000|Double-blind Phase|Withdrawal by Subject|4|||
143466747|NCT02683941|517255769|FG001|Double-blind Phase|Withdrawal by Subject|2|||
143466748|NCT02683941|517255768|FG000|Double-blind Phase|Lost to Follow-up|1|||
143466749|NCT02683941|517255769|FG001|Double-blind Phase|Lost to Follow-up|0|||
143466750|NCT02683941|517255768|FG000|Double-blind Phase|Disease Progression|5|||
143466751|NCT02683941|517255769|FG001|Double-blind Phase|Disease Progression|2|||
143466752|NCT02683941|517255768|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
143466753|NCT02683941|517255769|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
143466754|NCT02683941|517255768|FG000|Open-label Treatment Phase|Disease Progression|1|||
143466755|NCT02683941|517255769|FG001|Open-label Treatment Phase|Disease Progression|2|||
143466756|NCT02683941|517255768|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
143466757|NCT02683941|517255769|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
143466758|NCT02683941|517255768|FG000|Open-label Treatment Phase|Other|1|||
143466759|NCT02683941|517255769|FG001|Open-label Treatment Phase|Other|0|||
143133575|NCT03286218|516033390|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
143133576|NCT03286218|516033391|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
143133577|NCT03286218|516033392|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
143133578|NCT03286218|516033393|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
143133579|NCT00458003|516033394|FG000|Overall Study|Non protocol spinal anesthesia|1|||
143133580|NCT00458003|516033395|FG001|Overall Study|Non protocol spinal anesthesia|1|||
143133581|NCT02157519|516033399|FG000|Overall Study|Death|3|||
143133582|NCT02157519|516033400|FG001|Overall Study|Death|1|||
143133583|NCT02157519|516033399|FG000|Overall Study|Withdrawal by Subject|7|||
143359149|NCT05397470|516857957|FG002|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|4|||
143359150|NCT05397470|516857955|FG000|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
143359151|NCT05397470|516857956|FG001|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
143359152|NCT05397470|516857957|FG002|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|1|||
143359153|NCT05397470|516857955|FG000|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
143359154|NCT05397470|516857956|FG001|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
143359155|NCT05397470|516857957|FG002|Part B: OLE Period (Up to Week 127)|Study closed/terminated|244|||
143359156|NCT06403605|516857959|FG000|Follow-up|Withdrawn per protocol with PAR <50% at week 6|17|||
143359157|NCT06403605|516857960|FG001|Follow-up|Withdrawn per protocol with PAR <50% at week 6|19|||
143359158|NCT06403605|516857959|FG000|Follow-up|Adverse Event|4|||
143359159|NCT06403605|516857960|FG001|Follow-up|Adverse Event|2|||
143359160|NCT06403605|516857959|FG000|Follow-up|Withdrawal by Subject|2|||
143359161|NCT06403605|516857960|FG001|Follow-up|Withdrawal by Subject|3|||
143359162|NCT06403605|516857959|FG000|Follow-up|Lost to Follow-up|1|||
143359163|NCT06403605|516857960|FG001|Follow-up|Lost to Follow-up|0|||
143359164|NCT06403605|516857959|FG000|Follow-up|Death|1|||
143359165|NCT06403605|516857960|FG001|Follow-up|Death|0|||
143359166|NCT06403605|516857959|FG000|Follow-up|Other reasons|0|||
143359167|NCT06403605|516857960|FG001|Follow-up|Other reasons|4|||
143359168|NCT05194735|516859749|FG000|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
143359169|NCT05194735|516859750|FG001|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|1|||
143359170|NCT05194735|516859751|FG002|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
143359171|NCT05194735|516859749|FG000|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
143359172|NCT05194735|516859750|FG001|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|1|||
143359173|NCT05194735|516859751|FG002|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
143359174|NCT05194735|516859749|FG000|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
143359175|NCT05194735|516859750|FG001|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|3|||
143359176|NCT05194735|516859751|FG002|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
143359177|NCT05194735|516859749|FG000|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
143359178|NCT05194735|516859750|FG001|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|1|||
143359179|NCT05194735|516859751|FG002|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
143359180|NCT00731042|516859752|FG000|Second Intervention|Did not meet inclusion criteria|0|||
143359181|NCT00731042|516859753|FG001|Second Intervention|Did not meet inclusion criteria|2|||
143359182|NCT00432159|516859756|FG000|Overall Study|Death|0|||
143359183|NCT00432159|516859757|FG001|Overall Study|Death|1|||
143359184|NCT00432159|516859758|FG002|Overall Study|Death|0|||
143359185|NCT00432159|516859759|FG003|Overall Study|Death|0|||
143359186|NCT00432159|516859760|FG004|Overall Study|Death|0|||
143359187|NCT00432159|516859756|FG000|Overall Study|Failure|9|||
143359188|NCT00432159|516859757|FG001|Overall Study|Failure|5|||
143359189|NCT00432159|516859758|FG002|Overall Study|Failure|3|||
143359190|NCT00432159|516859759|FG003|Overall Study|Failure|2|||
143359191|NCT00432159|516859760|FG004|Overall Study|Failure|3|||
143359192|NCT00432159|516859756|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
143359193|NCT00432159|516859757|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
143359194|NCT00432159|516859758|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
143359195|NCT00432159|516859759|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
143359196|NCT00432159|516859760|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
143359197|NCT05310084|516859762|FG000|Overall Study|Withdrawal by Subject|2|||
143359198|NCT05310084|516859763|FG001|Overall Study|Withdrawal by Subject|3|||
143359199|NCT05310084|516859762|FG000|Overall Study|Participant availability|0|||
143359200|NCT05310084|516859763|FG001|Overall Study|Participant availability|4|||
143359201|NCT05310084|516859762|FG000|Overall Study|Lost to Follow-up|1|||
143359202|NCT05310084|516859763|FG001|Overall Study|Lost to Follow-up|1|||
143466760|NCT02683941|517255768|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
143466761|NCT02683941|517255769|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
143466762|NCT02683941|517255768|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
143466763|NCT02683941|517255769|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
143466764|NCT02683941|517255768|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
143466765|NCT02683941|517255769|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
143466766|NCT02683941|517255768|FG000|Open-label Follow-up Phase|Other|8|||
143466767|NCT02683941|517255769|FG001|Open-label Follow-up Phase|Other|1|||
143466768|NCT02893930|517255772|FG000|Overall Study|Adverse Event|3|||
143466769|NCT02893930|517255772|FG000|Overall Study|Death|1|||
143466770|NCT02893930|517255772|FG000|Overall Study|Disease progression|5|||
143466771|NCT02893930|517255772|FG000|Overall Study|Withdrawal by Subject|2|||
143466772|NCT02893930|517255772|FG000|Overall Study|Physician Decision|1|||
143466773|NCT02893930|517255772|FG000|Overall Study|Ineligible|1|||
143466774|NCT02349360|517255773|FG000|Overall Study|Withdrawal by Subject|0|||
143466775|NCT02349360|517255774|FG001|Overall Study|Withdrawal by Subject|1|||
143466776|NCT01498289|517255787|FG000|Overall Study|Adverse Event|16|||
143466777|NCT01498289|517255788|FG001|Overall Study|Adverse Event|18|||
143466778|NCT01498289|517255787|FG000|Overall Study|Death|6|||
143466779|NCT01498289|517255788|FG001|Overall Study|Death|8|||
143466780|NCT01498289|517255787|FG000|Overall Study|Withdrawal unrelated to AE|16|||
143466781|NCT01498289|517255788|FG001|Overall Study|Withdrawal unrelated to AE|16|||
143466782|NCT01498289|517255787|FG000|Overall Study|Progression/relapse|53|||
143466783|NCT01498289|517255788|FG001|Overall Study|Progression/relapse|59|||
143466784|NCT01498289|517255787|FG000|Overall Study|Not protocol specified|7|||
143466785|NCT01498289|517255788|FG001|Overall Study|Not protocol specified|2|||
143466786|NCT01498289|517255787|FG000|Overall Study|Reason under review|0|||
143466787|NCT01498289|517255788|FG001|Overall Study|Reason under review|1|||
143466788|NCT00412971|517255794|FG000|Overall Study|Lost to Follow-up|17|||
143466789|NCT00412971|517255795|FG001|Overall Study|Lost to Follow-up|9|||
143466790|NCT00412971|517255794|FG000|Overall Study|Protocol Violation|13|||
143466791|NCT00412971|517255795|FG001|Overall Study|Protocol Violation|1|||
143466792|NCT01290601|517255796|FG000|Overall Study|Adverse Event|0|||
143466793|NCT01290601|517255797|FG001|Overall Study|Adverse Event|2|||
143466794|NCT01290601|517255798|FG002|Overall Study|Adverse Event|0|||
143466795|NCT01290601|517255799|FG003|Overall Study|Adverse Event|0|||
143466796|NCT01290601|517255796|FG000|Overall Study|Lack of Efficacy|2|||
143466797|NCT01290601|517255797|FG001|Overall Study|Lack of Efficacy|1|||
143466798|NCT01290601|517255798|FG002|Overall Study|Lack of Efficacy|0|||
143466799|NCT01290601|517255799|FG003|Overall Study|Lack of Efficacy|0|||
143466800|NCT01290601|517255796|FG000|Overall Study|Lost to Follow-up|7|||
143466801|NCT01290601|517255797|FG001|Overall Study|Lost to Follow-up|2|||
143466802|NCT01290601|517255798|FG002|Overall Study|Lost to Follow-up|0|||
143466803|NCT01290601|517255799|FG003|Overall Study|Lost to Follow-up|0|||
143466804|NCT01290601|517255796|FG000|Overall Study|Other|1|||
143466805|NCT01290601|517255797|FG001|Overall Study|Other|0|||
143466806|NCT01290601|517255798|FG002|Overall Study|Other|0|||
143466807|NCT01290601|517255799|FG003|Overall Study|Other|0|||
143466808|NCT01290601|517255796|FG000|Overall Study|Protocol Violation|1|||
143133584|NCT02157519|516033400|FG001|Overall Study|Withdrawal by Subject|0|||
143466809|NCT01290601|517255797|FG001|Overall Study|Protocol Violation|0|||
143466810|NCT01290601|517255798|FG002|Overall Study|Protocol Violation|0|||
143466811|NCT01290601|517255799|FG003|Overall Study|Protocol Violation|0|||
143466812|NCT00775450|517255800|FG000|Overall Study|Serious Adverse Event|2|||
143466813|NCT00775450|517255801|FG001|Overall Study|Serious Adverse Event|0|||
143466814|NCT00775450|517255802|FG002|Overall Study|Serious Adverse Event|0|||
143466815|NCT00775450|517255803|FG003|Overall Study|Serious Adverse Event|0|||
143466816|NCT00775450|517255804|FG004|Overall Study|Serious Adverse Event|0|||
143466817|NCT00775450|517255800|FG000|Overall Study|Protocol Violation|0|||
143466818|NCT00775450|517255801|FG001|Overall Study|Protocol Violation|0|||
143466819|NCT00775450|517255802|FG002|Overall Study|Protocol Violation|0|||
143466820|NCT00775450|517255803|FG003|Overall Study|Protocol Violation|0|||
143466821|NCT00775450|517255804|FG004|Overall Study|Protocol Violation|1|||
143133585|NCT02157519|516033399|FG000|Overall Study|Lost to Follow-up|1|||
143133586|NCT02157519|516033400|FG001|Overall Study|Lost to Follow-up|0|||
143133587|NCT02048722|516033407|FG000|2 Cycles of Treatment|Adverse Event|2|||
143133588|NCT02048722|516033407|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
143466822|NCT00775450|517255800|FG000|Overall Study|Withdrawal by Subject|1|||
143466823|NCT00775450|517255801|FG001|Overall Study|Withdrawal by Subject|0|||
143133589|NCT02048722|516033407|FG000|2 Cycles of Treatment|Progressive Disease|2|||
143133590|NCT02048722|516033407|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
143466824|NCT00775450|517255802|FG002|Overall Study|Withdrawal by Subject|0|||
143466825|NCT00775450|517255803|FG003|Overall Study|Withdrawal by Subject|0|||
143466826|NCT00775450|517255804|FG004|Overall Study|Withdrawal by Subject|1|||
143466827|NCT01749540|517255812|FG000|Overall Study|Protocol Violation|0|||
143466828|NCT01749540|517255813|FG001|Overall Study|Protocol Violation|0|||
143466829|NCT01749540|517255814|FG002|Overall Study|Protocol Violation|0|||
143466830|NCT01749540|517255815|FG003|Overall Study|Protocol Violation|0|||
143133591|NCT02048722|516033407|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
143133592|NCT02048722|516033407|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
143466831|NCT01749540|517255816|FG004|Overall Study|Protocol Violation|0|||
143466832|NCT01749540|517255817|FG005|Overall Study|Protocol Violation|1|||
143466833|NCT01749540|517255818|FG006|Overall Study|Protocol Violation|1|||
143466834|NCT01749540|517255812|FG000|Overall Study|Withdrawal by Subject|0|||
143466835|NCT01749540|517255813|FG001|Overall Study|Withdrawal by Subject|0|||
143466836|NCT01749540|517255814|FG002|Overall Study|Withdrawal by Subject|0|||
143466837|NCT01749540|517255815|FG003|Overall Study|Withdrawal by Subject|1|||
143466838|NCT01749540|517255816|FG004|Overall Study|Withdrawal by Subject|0|||
143466839|NCT01749540|517255817|FG005|Overall Study|Withdrawal by Subject|0|||
143466840|NCT01749540|517255818|FG006|Overall Study|Withdrawal by Subject|0|||
143466841|NCT01749540|517255812|FG000|Overall Study|Initiated into extension study A536-06|0|||
143466842|NCT01749540|517255813|FG001|Overall Study|Initiated into extension study A536-06|0|||
143466843|NCT01749540|517255814|FG002|Overall Study|Initiated into extension study A536-06|0|||
143466844|NCT01749540|517255815|FG003|Overall Study|Initiated into extension study A536-06|0|||
143466845|NCT01749540|517255816|FG004|Overall Study|Initiated into extension study A536-06|0|||
143466846|NCT01749540|517255817|FG005|Overall Study|Initiated into extension study A536-06|2|||
143466847|NCT01749540|517255818|FG006|Overall Study|Initiated into extension study A536-06|24|||
143466848|NCT00752622|517255819|FG000|Induction Phase|Adverse Event|3|||
143466849|NCT00752622|517255819|FG000|Induction Phase|Other|3|||
143466850|NCT00752622|517255819|FG000|Induction Phase|Non-responder|14|||
143466851|NCT00752622|517255819|FG000|Induction Phase|Withdrawal by Subject|1|||
143466852|NCT00752622|517255819|FG000|Induction Phase|Premature study termination|14|||
143466853|NCT00752622|517255819|FG000|Observational Phase|Premature Study Termination|36|||
143466854|NCT00752622|517255819|FG000|Observational Phase|Non-responder|2|||
143466855|NCT00752622|517255819|FG000|Observational Phase|Withdrawal by Subject|2|||
143466856|NCT00752622|517255819|FG000|Observational Phase|Adverse Event|1|||
143466857|NCT00752622|517255819|FG000|Observational Phase|Other|2|||
143466858|NCT00752622|517255819|FG000|Interventional Phase|Non-responder|2|||
143466859|NCT00752622|517255819|FG000|Interventional Phase|Physician Decision|1|||
143466860|NCT00752622|517255819|FG000|Interventional Phase|Premature Study Termination|5|||
143466861|NCT00576836|517255820|FG000|Overall Study|Death|0|||
143466862|NCT00576836|517255821|FG001|Overall Study|Death|1|||
143466863|NCT00576836|517255820|FG000|Overall Study|Physician Decision|0|||
143466864|NCT00576836|517255821|FG001|Overall Study|Physician Decision|1|||
143466865|NCT03267940|517255824|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
143466866|NCT03267940|517255825|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
143133593|NCT04742673|516033413|FG000|Overall Study|Did not receive any study drug and not included in assessments or results|4|||
143133594|NCT04742673|516033414|FG001|Overall Study|Did not receive any study drug and not included in assessments or results|3|||
143133595|NCT00227539|516033424|FG000|Overall Study|Protocol Violation|1|||
143133596|NCT01166750|516033425|FG000|Overall Study|Lost to Follow-up|1|||
143133597|NCT01166750|516033426|FG001|Overall Study|Lost to Follow-up|0|||
143133598|NCT03113968|516033427|FG000|Overall Study|Withdrawal by Subject|31|||
143133599|NCT03113968|516033428|FG001|Overall Study|Withdrawal by Subject|4|||
143133600|NCT02111174|516033429|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
143133601|NCT02111174|516033430|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
143133602|NCT02111174|516033429|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
143133603|NCT02111174|516033430|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
143133604|NCT02111174|516033429|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
143133605|NCT02111174|516033430|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
143133606|NCT02111174|516033429|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
143133607|NCT02111174|516033430|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
143133608|NCT00901342|516033431|FG000|Overall Study|Adverse Event|1|||
143133609|NCT00901342|516033431|FG000|Overall Study|Death|4|||
143133610|NCT00901342|516033431|FG000|Overall Study|Disease progression|1|||
143133611|NCT00901342|516033431|FG000|Overall Study|Withdrawal by Subject|9|||
143133612|NCT02716779|516033432|FG000|Monotherapy|Adverse Event|0|||
143133613|NCT02716779|516033433|FG001|Monotherapy|Adverse Event|1|||
143133614|NCT02716779|516033434|FG002|Monotherapy|Adverse Event|1|||
143133615|NCT02716779|516033432|FG000|Combination Therapy|Adverse Event|0|||
143133616|NCT02716779|516033433|FG001|Combination Therapy|Adverse Event|2|||
143133617|NCT02716779|516033434|FG002|Combination Therapy|Adverse Event|1|||
143466867|NCT03267940|517255826|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
143466868|NCT03267940|517255827|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
143466869|NCT03267940|517255828|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
143466870|NCT03267940|517255829|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
143133618|NCT03718429|516033442|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
143133619|NCT03718429|516033443|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
143133620|NCT03718429|516033444|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
143181178|NCT00707993|516210487|FG000|Overall Study|Adverse Event|16|||
143133621|NCT03718429|516033445|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
143133622|NCT03877224|516033456|FG000|Overall Study|Death|3|||
143133623|NCT03877224|516033457|FG001|Overall Study|Death|2|||
143133624|NCT03877224|516033456|FG000|Overall Study|Withdrawal by Subject|1|||
143133625|NCT03877224|516033457|FG001|Overall Study|Withdrawal by Subject|6|||
143133626|NCT03877224|516033456|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
143133627|NCT03877224|516033457|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
143133628|NCT04980014|516034950|FG000|Overall Study|Participants who are Duplicated|1|||
143133629|NCT04980014|516034950|FG000|Overall Study|Follow-up Failure|13|||
143133630|NCT04980014|516034950|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
143133631|NCT04980014|516034950|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
143133632|NCT04980014|516034950|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
143133633|NCT01001429|516034952|FG000|Overall Study|surgery cancelled|0|||
143133634|NCT01001429|516034953|FG001|Overall Study|surgery cancelled|1|||
143133635|NCT01063855|516034957|FG000|Overall Study|Adverse Event|4|||
143133636|NCT01063855|516034958|FG001|Overall Study|Adverse Event|4|||
143133637|NCT01063855|516034957|FG000|Overall Study|Death|0|||
143133638|NCT01063855|516034958|FG001|Overall Study|Death|1|||
143133639|NCT01063855|516034957|FG000|Overall Study|Lost to Follow-up|8|||
143133640|NCT01063855|516034958|FG001|Overall Study|Lost to Follow-up|4|||
143133641|NCT01063855|516034957|FG000|Overall Study|Pregnancy|1|||
143133642|NCT01063855|516034958|FG001|Overall Study|Pregnancy|0|||
143133643|NCT01063855|516034957|FG000|Overall Study|Lack of Efficacy|0|||
143133644|NCT01063855|516034958|FG001|Overall Study|Lack of Efficacy|1|||
143133645|NCT01063855|516034957|FG000|Overall Study|Withdrawal by Subject|11|||
143133646|NCT01063855|516034958|FG001|Overall Study|Withdrawal by Subject|8|||
143133647|NCT01063855|516034957|FG000|Overall Study|Reason not specified|13|||
143133648|NCT01063855|516034958|FG001|Overall Study|Reason not specified|11|||
143133649|NCT01165307|516034960|FG000|Overall Study|Lost to Follow-up|11|||
143133650|NCT01165307|516034961|FG001|Overall Study|Lost to Follow-up|3|||
143133651|NCT01165307|516034960|FG000|Overall Study|Withdrawal by Subject|2|||
143133652|NCT01165307|516034961|FG001|Overall Study|Withdrawal by Subject|0|||
143133653|NCT01165307|516034960|FG000|Overall Study|Subject not available for contact|1|||
143133654|NCT01165307|516034961|FG001|Overall Study|Subject not available for contact|0|||
143133655|NCT03234036|516034962|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
143133656|NCT03234036|516034963|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
143133657|NCT03234036|516034964|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
143133658|NCT03234036|516034965|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
143133659|NCT02163395|516034970|FG000|Overall Study|Withdrawal by Subject|1|||
143133660|NCT02163395|516034970|FG000|Overall Study|Lost to Follow-up|3|||
143133661|NCT02163395|516034970|FG000|Overall Study|Adverse Event|1|||
143133662|NCT03627832|516034971|FG000|Overall Study|Withdrawal by Subject|10|||
143133663|NCT03627832|516034972|FG001|Overall Study|Withdrawal by Subject|1|||
143133664|NCT01145482|516034976|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
143133665|NCT01145482|516034977|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
143133666|NCT02619617|516034980|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
143133667|NCT02619617|516034981|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
143133668|NCT02619617|516034980|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
143133669|NCT02619617|516034981|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
143359203|NCT05310084|516859762|FG000|Overall Study|Adverse Event|1|||
143359204|NCT05310084|516859763|FG001|Overall Study|Adverse Event|1|||
143359205|NCT05310084|516859762|FG000|Overall Study|Randomized but not vaccinated|4|||
143359206|NCT05310084|516859763|FG001|Overall Study|Randomized but not vaccinated|2|||
143359207|NCT02107274|516859764|FG000|Treatment vs. Placebo|Adverse Event|3|||
143359208|NCT02107274|516859765|FG001|Treatment vs. Placebo|Adverse Event|0|||
143359209|NCT02107274|516859764|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
143359210|NCT02107274|516859765|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
143133670|NCT01854697|516034982|FG000|Overall Study|Adverse Event|1|||
143133671|NCT01854697|516034983|FG001|Overall Study|Adverse Event|0|||
143133672|NCT01854697|516034984|FG002|Overall Study|Adverse Event|0|||
143133673|NCT01854697|516034985|FG003|Overall Study|Adverse Event|0|||
143133674|NCT01854697|516034986|FG004|Overall Study|Adverse Event|1|||
143133675|NCT01854697|516034982|FG000|Overall Study|Lost to Follow-up|4|||
143133676|NCT01854697|516034983|FG001|Overall Study|Lost to Follow-up|1|||
143133677|NCT01854697|516034984|FG002|Overall Study|Lost to Follow-up|1|||
143133678|NCT01854697|516034985|FG003|Overall Study|Lost to Follow-up|2|||
143133679|NCT01854697|516034986|FG004|Overall Study|Lost to Follow-up|0|||
143133680|NCT01854697|516034982|FG000|Overall Study|To enter another AbbVie study|1|||
143133681|NCT01854697|516034983|FG001|Overall Study|To enter another AbbVie study|0|||
143133682|NCT01854697|516034984|FG002|Overall Study|To enter another AbbVie study|0|||
143133683|NCT01854697|516034985|FG003|Overall Study|To enter another AbbVie study|0|||
143359211|NCT02107274|516859764|FG000|Control Phase|Lost to Follow-up|1|||
143359212|NCT02107274|516859765|FG001|Control Phase|Lost to Follow-up|1|||
143359213|NCT02107274|516859764|FG000|Control Phase|Death|2|||
143466871|NCT03267940|517255824|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
143466872|NCT03267940|517255825|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
143466873|NCT03267940|517255826|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
143466874|NCT03267940|517255827|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
143466875|NCT03267940|517255828|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
143466876|NCT03267940|517255829|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
143466877|NCT03267940|517255824|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
143466878|NCT03267940|517255825|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
143466879|NCT03267940|517255826|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
143466880|NCT03267940|517255827|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
143466881|NCT03267940|517255828|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
143466882|NCT03267940|517255829|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
143466883|NCT03267940|517255824|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
143466884|NCT03267940|517255825|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
143466885|NCT03267940|517255826|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
143466886|NCT03267940|517255827|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
143466887|NCT03267940|517255828|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
143466888|NCT03267940|517255829|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
143466889|NCT03267940|517255824|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
143466890|NCT03267940|517255825|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
143466891|NCT03267940|517255826|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
143466892|NCT03267940|517255827|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
143466893|NCT03267940|517255828|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
143466894|NCT03267940|517255829|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
143466895|NCT03267940|517255824|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
143466896|NCT03267940|517255825|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
143466897|NCT03267940|517255826|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
143466898|NCT03267940|517255827|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
143466899|NCT03267940|517255828|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
143466900|NCT03267940|517255829|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
143466901|NCT03267940|517255824|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
143466902|NCT03267940|517255825|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
143466903|NCT03267940|517255826|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
143466904|NCT03267940|517255827|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
143466905|NCT03267940|517255828|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
143466906|NCT03267940|517255829|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
143013932|NCT02587325|515590087|FG001|32-Week Optional Extension Part|Adverse Event|0|||
143013933|NCT02587325|515590088|FG002|32-Week Optional Extension Part|Adverse Event|1|||
143013934|NCT02587325|515590089|FG003|32-Week Optional Extension Part|Adverse Event|0|||
143013935|NCT02587325|515590090|FG004|32-Week Optional Extension Part|Adverse Event|0|||
143013936|NCT02587325|515590086|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
143013937|NCT02587325|515590087|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
143013938|NCT02587325|515590088|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
143013939|NCT02587325|515590089|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
143013940|NCT02587325|515590090|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
143013941|NCT00390572|515590091|FG000|Overall Study|Lost to Follow-up|8|||
143013942|NCT00390572|515590092|FG001|Overall Study|Lost to Follow-up|4|||
143013943|NCT00390572|515590091|FG000|Overall Study|health condition|0|||
143013944|NCT00390572|515590092|FG001|Overall Study|health condition|1|||
143013945|NCT02913261|515590099|FG000|Overall Study|Technical problems|0|||
143013946|NCT02913261|515590100|FG001|Overall Study|Technical problems|1|||
143013947|NCT02913261|515590099|FG000|Overall Study|Lack of Efficacy|32|||
143013948|NCT02913261|515590100|FG001|Overall Study|Lack of Efficacy|69|||
143013949|NCT02913261|515590099|FG000|Overall Study|Adverse Event|27|||
143013950|NCT02913261|515590100|FG001|Overall Study|Adverse Event|5|||
143013951|NCT02913261|515590099|FG000|Overall Study|Death|25|||
143013952|NCT02913261|515590100|FG001|Overall Study|Death|22|||
143013953|NCT02913261|515590099|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
143013954|NCT02913261|515590100|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
143013955|NCT02913261|515590099|FG000|Overall Study|Disease relapse|8|||
143133684|NCT01854697|516034986|FG004|Overall Study|To enter another AbbVie study|1|||
143013956|NCT02913261|515590100|FG001|Overall Study|Disease relapse|13|||
143013957|NCT02913261|515590099|FG000|Overall Study|Physician Decision|8|||
143013958|NCT02913261|515590100|FG001|Overall Study|Physician Decision|9|||
143013959|NCT02913261|515590099|FG000|Overall Study|Subject/guardian decision|4|||
143133685|NCT01854697|516034982|FG000|Overall Study|Withdrew Consent|0|||
143133686|NCT01854697|516034983|FG001|Overall Study|Withdrew Consent|1|||
143013960|NCT02913261|515590100|FG001|Overall Study|Subject/guardian decision|6|||
143013961|NCT02913261|515590099|FG000|Overall Study|Graft loss|2|||
143013962|NCT02913261|515590100|FG001|Overall Study|Graft loss|0|||
143359214|NCT02107274|516859765|FG001|Control Phase|Death|0|||
143359215|NCT02107274|516859764|FG000|Control Phase|Adverse Event|0|||
143359216|NCT02107274|516859765|FG001|Control Phase|Adverse Event|1|||
143359217|NCT02652130|516859768|FG000|Overall Study|Death|1|||
143359218|NCT00354029|516859769|FG000|Overall Study|Protocol Violation|4|||
143359219|NCT00354029|516859770|FG001|Overall Study|Protocol Violation|2|||
143359220|NCT01021332|516859771|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
143359221|NCT01021332|516859771|FG000|Overall Study|Adverse Event|43|||
143359222|NCT01021332|516859771|FG000|Overall Study|Lack of Efficacy|19|||
143359223|NCT01021332|516859771|FG000|Overall Study|Withdrawal of Consent|23|||
143359224|NCT01021332|516859771|FG000|Overall Study|Lost to Follow-up|4|||
143359225|NCT01021332|516859771|FG000|Overall Study|Protocol Violation|9|||
143359226|NCT01021332|516859771|FG000|Overall Study|Miscellaneous|3|||
143359227|NCT00031447|516859775|FG000|Overall Study|Lost to Follow-up|0|||
143359228|NCT00031447|516859776|FG001|Overall Study|Lost to Follow-up|1|||
143359229|NCT00031447|516859775|FG000|Overall Study|Non-compliant|1|||
143359230|NCT00031447|516859776|FG001|Overall Study|Non-compliant|1|||
143359231|NCT00031447|516859775|FG000|Overall Study|Re-activation of Disease|2|||
143359232|NCT00031447|516859776|FG001|Overall Study|Re-activation of Disease|1|||
143359233|NCT00031447|516859775|FG000|Overall Study|Disruption of blinded study drug supply|7|||
143359234|NCT00031447|516859776|FG001|Overall Study|Disruption of blinded study drug supply|4|||
143359235|NCT01477749|516859780|FG000|Overall Study|Physician Decision|4|||
143359236|NCT02800928|516859781|FG000|Overall Study|Withdrawal by Subject|1|||
143359237|NCT02800928|516859782|FG001|Overall Study|Withdrawal by Subject|1|||
143359238|NCT02800928|516859781|FG000|Overall Study|Protocol Violation|1|||
143359239|NCT02800928|516859782|FG001|Overall Study|Protocol Violation|1|||
143359240|NCT02886728|516859792|FG000|Overall Study|Withdrew Consent|31|||
143359241|NCT02886728|516859793|FG001|Overall Study|Withdrew Consent|13|||
143359242|NCT02886728|516859794|FG002|Overall Study|Withdrew Consent|11|||
143359243|NCT02886728|516859795|FG003|Overall Study|Withdrew Consent|47|||
143359244|NCT02886728|516859792|FG000|Overall Study|Lost to Follow-up|12|||
143359245|NCT02886728|516859793|FG001|Overall Study|Lost to Follow-up|6|||
143359246|NCT02886728|516859794|FG002|Overall Study|Lost to Follow-up|13|||
143359247|NCT02886728|516859795|FG003|Overall Study|Lost to Follow-up|12|||
143359248|NCT02886728|516859792|FG000|Overall Study|Adverse Event|13|||
143359249|NCT02886728|516859793|FG001|Overall Study|Adverse Event|5|||
143359250|NCT02886728|516859794|FG002|Overall Study|Adverse Event|5|||
143359251|NCT02886728|516859795|FG003|Overall Study|Adverse Event|11|||
143359252|NCT02886728|516859792|FG000|Overall Study|Investigator's Discretion|11|||
143359253|NCT02886728|516859793|FG001|Overall Study|Investigator's Discretion|7|||
143359254|NCT02886728|516859794|FG002|Overall Study|Investigator's Discretion|5|||
143359255|NCT02886728|516859795|FG003|Overall Study|Investigator's Discretion|11|||
143359256|NCT02886728|516859792|FG000|Overall Study|Death|3|||
143359257|NCT02886728|516859793|FG001|Overall Study|Death|1|||
143359258|NCT02886728|516859794|FG002|Overall Study|Death|0|||
143359259|NCT02886728|516859795|FG003|Overall Study|Death|0|||
143359260|NCT02886728|516859792|FG000|Overall Study|Protocol Violation|0|||
143359261|NCT02886728|516859793|FG001|Overall Study|Protocol Violation|0|||
143359262|NCT02886728|516859794|FG002|Overall Study|Protocol Violation|0|||
143359263|NCT02886728|516859795|FG003|Overall Study|Protocol Violation|4|||
143359264|NCT02886728|516859792|FG000|Overall Study|Non-Compliance with Study Drug|1|||
143359265|NCT02886728|516859793|FG001|Overall Study|Non-Compliance with Study Drug|0|||
143359266|NCT02886728|516859794|FG002|Overall Study|Non-Compliance with Study Drug|1|||
143359267|NCT02886728|516859795|FG003|Overall Study|Non-Compliance with Study Drug|0|||
143359268|NCT02886728|516859792|FG000|Overall Study|Pregnancy|0|||
143359269|NCT02886728|516859793|FG001|Overall Study|Pregnancy|0|||
143359270|NCT02886728|516859794|FG002|Overall Study|Pregnancy|1|||
143359271|NCT02886728|516859795|FG003|Overall Study|Pregnancy|0|||
143359272|NCT02886728|516859792|FG000|Overall Study|Randomized but Not Dosed|1|||
143359273|NCT02886728|516859793|FG001|Overall Study|Randomized but Not Dosed|0|||
143359274|NCT02886728|516859794|FG002|Overall Study|Randomized but Not Dosed|0|||
143359275|NCT02886728|516859795|FG003|Overall Study|Randomized but Not Dosed|2|||
143359276|NCT01066156|516859796|FG000|Overall Study|ineligible|2|||
143359277|NCT01066156|516859796|FG000|Overall Study|Lost to Follow-up|7|||
143359278|NCT01066156|516859796|FG000|Overall Study|Withdrawal by Subject|1|||
143359279|NCT00479674|516859797|FG000|Overall Study|Adverse Event|18|||
143359280|NCT00479674|516859797|FG000|Overall Study|Withdrawal by Subject|6|||
143359281|NCT00479674|516859797|FG000|Overall Study|Physician Decision|14|||
143359282|NCT00479674|516859797|FG000|Overall Study|none provided|3|||
143359283|NCT00146640|516859798|FG000|Overall Study|Adverse Event|12|||
143013963|NCT02304302|515590123|FG000|Overall Study|Adverse Event|2|||
143359284|NCT00146640|516859799|FG001|Overall Study|Adverse Event|10|||
143359285|NCT00146640|516859798|FG000|Overall Study|Medical Reasons|3|||
143359286|NCT00146640|516859799|FG001|Overall Study|Medical Reasons|0|||
143359287|NCT00146640|516859798|FG000|Overall Study|Non-Medical Reasons|8|||
143359288|NCT00146640|516859799|FG001|Overall Study|Non-Medical Reasons|4|||
143359289|NCT02013687|516859803|FG000|Overall Study|Lost to Follow-up|0|||
143466907|NCT03267940|517255824|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
143466908|NCT03267940|517255825|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
143466909|NCT03267940|517255826|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
143466910|NCT03267940|517255827|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
143466911|NCT03267940|517255828|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
143466912|NCT03267940|517255829|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
143466913|NCT03267940|517255824|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
143466914|NCT03267940|517255825|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
143466915|NCT03267940|517255826|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
143466916|NCT03267940|517255827|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
143466917|NCT03267940|517255828|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
143466918|NCT03267940|517255829|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
143466919|NCT00388154|517255836|FG000|Overall Study|Withdrawal by Subject|1|||
143466920|NCT03291587|517255837|FG000|Overall Study|Lost to Follow-up|62|||
143466921|NCT03291587|517255838|FG001|Overall Study|Lost to Follow-up|43|||
143466922|NCT03291587|517255837|FG000|Overall Study|Refused to Answer|5|||
143466923|NCT03291587|517255838|FG001|Overall Study|Refused to Answer|2|||
143133687|NCT01854697|516034984|FG002|Overall Study|Withdrew Consent|0|||
143133688|NCT01854697|516034985|FG003|Overall Study|Withdrew Consent|1|||
143133689|NCT01854697|516034986|FG004|Overall Study|Withdrew Consent|0|||
143133690|NCT01854697|516034982|FG000|Overall Study|Other|0|||
143133691|NCT01854697|516034983|FG001|Overall Study|Other|1|||
143466924|NCT03291587|517255837|FG000|Overall Study|Death|2|||
143466925|NCT03291587|517255838|FG001|Overall Study|Death|4|||
143466926|NCT03291587|517255837|FG000|Overall Study|Not interested in participating|8|||
143466927|NCT03291587|517255838|FG001|Overall Study|Not interested in participating|6|||
143466928|NCT03291587|517255837|FG000|Overall Study|Too busy to participate|4|||
143466929|NCT03291587|517255838|FG001|Overall Study|Too busy to participate|2|||
143466930|NCT00796120|517255839|FG000|Overall Study|Death|3|||
143466931|NCT00796120|517255840|FG001|Overall Study|Death|0|||
143466932|NCT00796120|517255839|FG000|Overall Study|Adverse Event|11|||
143466933|NCT00796120|517255840|FG001|Overall Study|Adverse Event|6|||
143466934|NCT00796120|517255839|FG000|Overall Study|Progressive disease|22|||
143466935|NCT00796120|517255840|FG001|Overall Study|Progressive disease|13|||
143466936|NCT00796120|517255839|FG000|Overall Study|Participant refusal|3|||
143466937|NCT00796120|517255840|FG001|Overall Study|Participant refusal|4|||
143466938|NCT00796120|517255839|FG000|Overall Study|Other|6|||
143466939|NCT00796120|517255840|FG001|Overall Study|Other|17|||
143466940|NCT00796120|517255839|FG000|Overall Study|Physician Decision|16|||
143466941|NCT00796120|517255840|FG001|Overall Study|Physician Decision|17|||
143466942|NCT00796120|517255839|FG000|Overall Study|Randomized but not treated|0|||
143466943|NCT00796120|517255840|FG001|Overall Study|Randomized but not treated|3|||
143466944|NCT03737474|517255844|FG000|Overall Study|Adverse Event|18|||
143466945|NCT03737474|517255845|FG001|Overall Study|Adverse Event|48|||
143466946|NCT03737474|517255844|FG000|Overall Study|Lack of Efficacy|1|||
143466947|NCT03737474|517255845|FG001|Overall Study|Lack of Efficacy|3|||
143466948|NCT03737474|517255844|FG000|Overall Study|Protocol Violation|0|||
143466949|NCT03737474|517255845|FG001|Overall Study|Protocol Violation|8|||
143466950|NCT03737474|517255844|FG000|Overall Study|Withdrawal by Subject|5|||
143466951|NCT03737474|517255845|FG001|Overall Study|Withdrawal by Subject|20|||
143466952|NCT03737474|517255844|FG000|Overall Study|Non-compliance With Study Drug|0|||
143466953|NCT03737474|517255845|FG001|Overall Study|Non-compliance With Study Drug|1|||
143466954|NCT03737474|517255844|FG000|Overall Study|Physician Decision|1|||
143466955|NCT03737474|517255845|FG001|Overall Study|Physician Decision|4|||
143466956|NCT02513745|517255848|FG000|Overall Study|Criteria at time of surgery not met.|3|||
143466957|NCT02513745|517255849|FG001|Overall Study|Criteria at time of surgery not met.|3|||
143466958|NCT01209143|517255850|FG000|Overall Study|Adverse Event|2|||
143466959|NCT01209143|517255851|FG001|Overall Study|Adverse Event|1|||
143466960|NCT01209143|517255850|FG000|Overall Study|Death|0|||
143466961|NCT01209143|517255851|FG001|Overall Study|Death|1|||
143466962|NCT01209143|517255850|FG000|Overall Study|Physician Decision|3|||
143466963|NCT01209143|517255851|FG001|Overall Study|Physician Decision|1|||
143466964|NCT01209143|517255850|FG000|Overall Study|Lost to Follow-up|1|||
143466965|NCT01209143|517255851|FG001|Overall Study|Lost to Follow-up|0|||
143466966|NCT01209143|517255850|FG000|Overall Study|Withdrawal by Subject|2|||
143466967|NCT01209143|517255851|FG001|Overall Study|Withdrawal by Subject|1|||
143466968|NCT01209143|517255850|FG000|Overall Study|Disease progression|11|||
143466969|NCT01209143|517255851|FG001|Overall Study|Disease progression|16|||
143466970|NCT01145755|517255855|FG000|Overall Study|Adverse Event|2|||
143466971|NCT01145755|517255856|FG001|Overall Study|Adverse Event|4|||
143466972|NCT01145755|517255857|FG002|Overall Study|Adverse Event|2|||
143466973|NCT01145755|517255855|FG000|Overall Study|Withdrawal by Subject|2|||
143466974|NCT01145755|517255856|FG001|Overall Study|Withdrawal by Subject|2|||
143466975|NCT01145755|517255857|FG002|Overall Study|Withdrawal by Subject|2|||
143466976|NCT01145755|517255855|FG000|Overall Study|Lost to Follow-up|2|||
143466977|NCT01145755|517255856|FG001|Overall Study|Lost to Follow-up|3|||
143133692|NCT01854697|516034984|FG002|Overall Study|Other|1|||
143466978|NCT01145755|517255857|FG002|Overall Study|Lost to Follow-up|1|||
143466979|NCT01145755|517255855|FG000|Overall Study|Protocol Violation|0|||
143466980|NCT01145755|517255856|FG001|Overall Study|Protocol Violation|3|||
143466981|NCT01145755|517255857|FG002|Overall Study|Protocol Violation|1|||
143466982|NCT01145755|517255855|FG000|Overall Study|Study Closure|14|||
143466983|NCT01145755|517255856|FG001|Overall Study|Study Closure|14|||
143466984|NCT01145755|517255857|FG002|Overall Study|Study Closure|17|||
143466985|NCT01145755|517255855|FG000|Overall Study|Lack of Efficacy|0|||
143466986|NCT01145755|517255856|FG001|Overall Study|Lack of Efficacy|1|||
143466987|NCT01145755|517255857|FG002|Overall Study|Lack of Efficacy|0|||
143466988|NCT01145755|517255855|FG000|Overall Study|Patient could not swollow medication|0|||
143466989|NCT01145755|517255856|FG001|Overall Study|Patient could not swollow medication|0|||
143466990|NCT01145755|517255857|FG002|Overall Study|Patient could not swollow medication|1|||
143466991|NCT01145755|517255855|FG000|Overall Study|Withdrawal by Subject|0|||
143466992|NCT01145755|517255856|FG001|Overall Study|Withdrawal by Subject|0|||
143466993|NCT01145755|517255857|FG002|Overall Study|Withdrawal by Subject|1|||
143466994|NCT01145755|517255855|FG000|Overall Study|Positive urine ethanol|0|||
143133693|NCT01854697|516034985|FG003|Overall Study|Other|0|||
143133694|NCT01854697|516034986|FG004|Overall Study|Other|0|||
143133695|NCT02087774|516034995|FG000|Overall Study|Were absent day of data collection|8|||
143133696|NCT02087774|516034996|FG001|Overall Study|Were absent day of data collection|20|||
143133697|NCT04919317|516035003|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
143133698|NCT04919317|516035004|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
143133699|NCT04919317|516035003|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
143133700|NCT04919317|516035004|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
143133701|NCT03225170|516035005|FG000|Overall Study|Lost to Follow-up|4|||
143133702|NCT03225170|516035006|FG001|Overall Study|Lost to Follow-up|4|||
143133703|NCT03225170|516035007|FG002|Overall Study|Lost to Follow-up|0|||
143133704|NCT03225170|516035005|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
143133705|NCT03225170|516035006|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
143133706|NCT03225170|516035007|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
143133707|NCT00274742|516035008|FG000|Overall Study|Adverse Event|0|||
143133708|NCT00274742|516035009|FG001|Overall Study|Adverse Event|4|||
143133709|NCT00274742|516035010|FG002|Overall Study|Adverse Event|1|||
143133710|NCT00274742|516035011|FG003|Overall Study|Adverse Event|4|||
143133711|NCT00274742|516035012|FG004|Overall Study|Adverse Event|12|||
143133712|NCT00274742|516035013|FG005|Overall Study|Adverse Event|3|||
143133713|NCT00274742|516035008|FG000|Overall Study|Lost to Follow-up|0|||
143133714|NCT00274742|516035009|FG001|Overall Study|Lost to Follow-up|0|||
143133715|NCT00274742|516035010|FG002|Overall Study|Lost to Follow-up|0|||
143133716|NCT00274742|516035011|FG003|Overall Study|Lost to Follow-up|0|||
143133717|NCT00274742|516035012|FG004|Overall Study|Lost to Follow-up|1|||
143133718|NCT00274742|516035013|FG005|Overall Study|Lost to Follow-up|0|||
143133719|NCT00274742|516035008|FG000|Overall Study|End of Study|0|||
143133720|NCT00274742|516035009|FG001|Overall Study|End of Study|0|||
143133721|NCT00274742|516035010|FG002|Overall Study|End of Study|0|||
143133722|NCT00274742|516035011|FG003|Overall Study|End of Study|1|||
143133723|NCT00274742|516035012|FG004|Overall Study|End of Study|0|||
143133724|NCT00274742|516035013|FG005|Overall Study|End of Study|0|||
143133725|NCT00274742|516035008|FG000|Overall Study|Disease Progression|0|||
143133726|NCT00274742|516035009|FG001|Overall Study|Disease Progression|1|||
143133727|NCT00274742|516035010|FG002|Overall Study|Disease Progression|1|||
143133728|NCT00274742|516035011|FG003|Overall Study|Disease Progression|0|||
143133729|NCT00274742|516035012|FG004|Overall Study|Disease Progression|1|||
143133730|NCT00274742|516035013|FG005|Overall Study|Disease Progression|0|||
143133731|NCT00274742|516035008|FG000|Overall Study|Other|0|||
143133732|NCT00274742|516035009|FG001|Overall Study|Other|3|||
143133733|NCT00274742|516035010|FG002|Overall Study|Other|0|||
143133734|NCT00274742|516035011|FG003|Overall Study|Other|0|||
143133735|NCT00274742|516035012|FG004|Overall Study|Other|2|||
143133736|NCT00274742|516035013|FG005|Overall Study|Other|0|||
143133737|NCT01529606|516035014|FG000|Overall Study|Lost to Follow-up|21|||
143133738|NCT01529606|516035015|FG001|Overall Study|Lost to Follow-up|18|||
143466995|NCT01145755|517255856|FG001|Overall Study|Positive urine ethanol|1|||
143466996|NCT01145755|517255857|FG002|Overall Study|Positive urine ethanol|0|||
143466997|NCT01211522|517255858|FG000|Overall Study|Withdrawal by Subject|3|||
143133739|NCT05209880|516035022|FG000|1-Month Follow-up|Spoke with Doctor|5|||
143466998|NCT01211522|517255859|FG001|Overall Study|Withdrawal by Subject|7|||
143466999|NCT01211522|517255860|FG002|Overall Study|Withdrawal by Subject|5|||
143467000|NCT01116882|517255866|FG000|30-day|Lost to Follow-up|50|||
143467001|NCT01116882|517255867|FG001|30-day|Lost to Follow-up|21|||
143467002|NCT01116882|517255866|FG000|30-day|Withdrawal by Subject|2|||
143133740|NCT05209880|516035023|FG001|1-Month Follow-up|Spoke with Doctor|5|||
143133741|NCT05209880|516035022|FG000|1-Month Follow-up|Lost to Follow-up|7|||
143133742|NCT05209880|516035023|FG001|1-Month Follow-up|Lost to Follow-up|9|||
143133743|NCT05209880|516035022|FG000|1-Month Follow-up|Discontinued|0|||
143133744|NCT05209880|516035023|FG001|1-Month Follow-up|Discontinued|1|||
143467003|NCT01116882|517255867|FG001|30-day|Withdrawal by Subject|4|||
143133745|NCT05209880|516035022|FG000|3-Month Follow-up|Spoke with Doctor|17|||
143359290|NCT02013687|516859804|FG001|Overall Study|Lost to Follow-up|0|||
143359291|NCT02013687|516859805|FG002|Overall Study|Lost to Follow-up|1|||
143359292|NCT02013687|516859806|FG003|Overall Study|Lost to Follow-up|0|||
143359293|NCT02013687|516859803|FG000|Overall Study|Protocol Violation|0|||
143359294|NCT02013687|516859804|FG001|Overall Study|Protocol Violation|0|||
143359295|NCT02013687|516859805|FG002|Overall Study|Protocol Violation|0|||
143359296|NCT02013687|516859806|FG003|Overall Study|Protocol Violation|1|||
143359297|NCT02013687|516859803|FG000|Overall Study|Withdrawal by Subject|0|||
143359298|NCT02013687|516859804|FG001|Overall Study|Withdrawal by Subject|0|||
143359299|NCT02013687|516859805|FG002|Overall Study|Withdrawal by Subject|0|||
143359300|NCT02013687|516859806|FG003|Overall Study|Withdrawal by Subject|1|||
143359301|NCT02013687|516859803|FG000|Overall Study|Missed visits due to patient travel|0|||
143359302|NCT02013687|516859804|FG001|Overall Study|Missed visits due to patient travel|0|||
143359303|NCT02013687|516859805|FG002|Overall Study|Missed visits due to patient travel|1|||
143359304|NCT02013687|516859806|FG003|Overall Study|Missed visits due to patient travel|0|||
143359305|NCT01627340|516859807|FG000|Overall Study|Adverse Event|1|||
143359306|NCT01627340|516859808|FG001|Overall Study|Adverse Event|0|||
143359307|NCT01627340|516859807|FG000|Overall Study|Lost to Follow-up|8|||
143359308|NCT01627340|516859808|FG001|Overall Study|Lost to Follow-up|4|||
143359309|NCT01627340|516859807|FG000|Overall Study|Pregnancy|1|||
143359310|NCT01627340|516859808|FG001|Overall Study|Pregnancy|0|||
143359311|NCT01627340|516859807|FG000|Overall Study|Withdrawal by Subject|2|||
143359312|NCT01627340|516859808|FG001|Overall Study|Withdrawal by Subject|0|||
143359313|NCT03633903|516859811|FG000|Overall Study|Withdrawal by Subject|1|||
143359314|NCT03633903|516859812|FG001|Overall Study|Withdrawal by Subject|2|||
143359315|NCT03633903|516859811|FG000|Overall Study|Lost to Follow-up|5|||
143359316|NCT03633903|516859812|FG001|Overall Study|Lost to Follow-up|5|||
143359317|NCT01653847|516859822|FG000|Overall Study|Withdrawal by Subject|1|||
143359318|NCT01653847|516859823|FG001|Overall Study|Withdrawal by Subject|0|||
143359319|NCT00131911|516859824|FG000|Overall Study|Withdrawal by Subject|1|||
143359320|NCT00131911|516859825|FG001|Overall Study|Withdrawal by Subject|0|||
143359321|NCT02554513|516859826|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
143359322|NCT02554513|516859827|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
143359323|NCT01347645|516859828|FG000|Overall Study|Death|1|||
143359324|NCT01347645|516859829|FG001|Overall Study|Death|5|||
143359325|NCT01347645|516859830|FG002|Overall Study|Death|2|||
143359326|NCT01347645|516859831|FG003|Overall Study|Death|7|||
143359327|NCT01347645|516859832|FG004|Overall Study|Death|7|||
143359328|NCT01347645|516859828|FG000|Overall Study|Lost to Follow-up|1|||
143359329|NCT01347645|516859829|FG001|Overall Study|Lost to Follow-up|1|||
143359330|NCT01347645|516859830|FG002|Overall Study|Lost to Follow-up|0|||
143359331|NCT01347645|516859831|FG003|Overall Study|Lost to Follow-up|1|||
143359332|NCT01347645|516859832|FG004|Overall Study|Lost to Follow-up|1|||
143359333|NCT01347645|516859828|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
143359334|NCT01347645|516859829|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
143359335|NCT01347645|516859830|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
143359336|NCT01347645|516859831|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
143359337|NCT01347645|516859832|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
143359338|NCT01347645|516859828|FG000|Overall Study|Other|1|||
143359339|NCT01347645|516859829|FG001|Overall Study|Other|0|||
143359340|NCT01347645|516859830|FG002|Overall Study|Other|0|||
143359341|NCT01347645|516859831|FG003|Overall Study|Other|0|||
143359342|NCT01347645|516859832|FG004|Overall Study|Other|1|||
143359343|NCT01347645|516859828|FG000|Overall Study|Withdrawal by Subject|0|||
143359344|NCT01347645|516859829|FG001|Overall Study|Withdrawal by Subject|0|||
143359345|NCT01347645|516859830|FG002|Overall Study|Withdrawal by Subject|0|||
143359346|NCT01347645|516859831|FG003|Overall Study|Withdrawal by Subject|3|||
143359347|NCT01347645|516859832|FG004|Overall Study|Withdrawal by Subject|3|||
143359348|NCT01347645|516859828|FG000|Overall Study|Physician Decision|0|||
143359349|NCT01347645|516859829|FG001|Overall Study|Physician Decision|0|||
143359350|NCT01347645|516859830|FG002|Overall Study|Physician Decision|0|||
143359351|NCT01347645|516859831|FG003|Overall Study|Physician Decision|0|||
143467004|NCT01116882|517255866|FG000|30-day|Other Reasons|16|||
143467005|NCT01116882|517255867|FG001|30-day|Other Reasons|6|||
143013964|NCT02304302|515590124|FG001|Overall Study|Adverse Event|3|||
143133746|NCT05209880|516035023|FG001|3-Month Follow-up|Spoke with Doctor|7|||
143359352|NCT01347645|516859832|FG004|Overall Study|Physician Decision|1|||
143359353|NCT01347645|516859828|FG000|Overall Study|Adverse Event|0|||
143359354|NCT01347645|516859829|FG001|Overall Study|Adverse Event|0|||
143359355|NCT01347645|516859830|FG002|Overall Study|Adverse Event|0|||
143359356|NCT01347645|516859831|FG003|Overall Study|Adverse Event|1|||
143359357|NCT01347645|516859832|FG004|Overall Study|Adverse Event|1|||
143359358|NCT00388362|516859835|FG000|Enrolled|Ineligible|1|||
143359359|NCT00388362|516859835|FG000|Enrolled|Adverse Event|9|||
143359360|NCT00388362|516859835|FG000|Enrolled|Death|1|||
143467006|NCT01116882|517255866|FG000|12-month|Lost to Follow-up|111|||
143467007|NCT01116882|517255867|FG001|12-month|Lost to Follow-up|42|||
143467008|NCT01116882|517255866|FG000|12-month|Other Reasons|151|||
143467009|NCT01116882|517255867|FG001|12-month|Other Reasons|49|||
143467010|NCT01116882|517255866|FG000|12-month|Withdrawal by Subject|5|||
143467011|NCT01116882|517255867|FG001|12-month|Withdrawal by Subject|8|||
143467012|NCT00547365|517255868|FG000|Overall Study|Physician Decision|1|||
143467013|NCT00547365|517255868|FG000|Overall Study|Lost to Follow-up|1|||
143467014|NCT00547365|517255868|FG000|Overall Study|Protocol Violation|2|||
143467015|NCT00547365|517255868|FG000|Overall Study|death (not related to study)|4|||
143467016|NCT02101034|517257620|FG000|Overall Study|Enrolled but did not start treatment|0|||
143467017|NCT02101034|517257621|FG001|Overall Study|Enrolled but did not start treatment|0|||
143467018|NCT02101034|517257622|FG002|Overall Study|Enrolled but did not start treatment|1|||
143467019|NCT02101034|517257623|FG003|Overall Study|Enrolled but did not start treatment|0|||
143467020|NCT02101034|517257624|FG004|Overall Study|Enrolled but did not start treatment|0|||
143467021|NCT02276872|517257633|FG000|Overall Study|Adverse Event|1|||
143467022|NCT02276872|517257634|FG001|Overall Study|Adverse Event|0|||
143467023|NCT02276872|517257635|FG002|Overall Study|Adverse Event|0|||
143467024|NCT04263909|517257638|FG000|Overall Study|Physician Decision|1|||
143467025|NCT04263909|517257639|FG001|Overall Study|Physician Decision|0|||
143467026|NCT04263909|517257640|FG002|Overall Study|Physician Decision|0|||
143467027|NCT04263909|517257638|FG000|Overall Study|Adverse Event|3|||
143467028|NCT04263909|517257639|FG001|Overall Study|Adverse Event|0|||
143467029|NCT04263909|517257640|FG002|Overall Study|Adverse Event|0|||
143467030|NCT04263909|517257638|FG000|Overall Study|Protocol Violation|5|||
143467031|NCT04263909|517257639|FG001|Overall Study|Protocol Violation|0|||
143467032|NCT04263909|517257640|FG002|Overall Study|Protocol Violation|0|||
143467033|NCT01106404|517257641|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
143467034|NCT01106404|517257642|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
143467035|NCT01106404|517257641|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
143467036|NCT01106404|517257642|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
143467037|NCT01106404|517257641|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
143467038|NCT01106404|517257642|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
143467039|NCT01106404|517257641|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
143467040|NCT01106404|517257642|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
143467041|NCT01074216|517257643|FG000|Overall Study|Physician Decision|1|||
143467042|NCT01074216|517257643|FG000|Overall Study|Not Treated|12|||
143467043|NCT00381303|517257644|FG000|Overall Study|Lost to Follow-up|25|||
143467044|NCT00381303|517257645|FG001|Overall Study|Lost to Follow-up|9|||
143467045|NCT00381303|517257644|FG000|Overall Study|AE/HIV-related event|22|||
143467046|NCT00381303|517257645|FG001|Overall Study|AE/HIV-related event|6|||
143467047|NCT00381303|517257644|FG000|Overall Study|Non-Adherence|13|||
143467048|NCT00381303|517257645|FG001|Overall Study|Non-Adherence|6|||
143467049|NCT00381303|517257644|FG000|Overall Study|Withdrawal by Subject|13|||
143467050|NCT00381303|517257645|FG001|Overall Study|Withdrawal by Subject|6|||
143467051|NCT00381303|517257644|FG000|Overall Study|Virologic failure|6|||
143467052|NCT00381303|517257645|FG001|Overall Study|Virologic failure|4|||
143467053|NCT00381303|517257644|FG000|Overall Study|Ineligible to continue the trial|2|||
143467054|NCT00381303|517257645|FG001|Overall Study|Ineligible to continue the trial|1|||
143467055|NCT00381303|517257644|FG000|Overall Study|Pregnancy|2|||
143467056|NCT00381303|517257645|FG001|Overall Study|Pregnancy|0|||
143467057|NCT00381303|517257644|FG000|Overall Study|Physician Decision|1|||
143467058|NCT00381303|517257645|FG001|Overall Study|Physician Decision|0|||
143467059|NCT00381303|517257644|FG000|Overall Study|Physician's decision to close the site|3|||
143467060|NCT00381303|517257645|FG001|Overall Study|Physician's decision to close the site|1|||
143467061|NCT00381303|517257644|FG000|Overall Study|Subject moved out of state|2|||
143467062|NCT00381303|517257645|FG001|Overall Study|Subject moved out of state|0|||
143467063|NCT00381303|517257644|FG000|Overall Study|Subject taking too many different meds|1|||
143467064|NCT00381303|517257645|FG001|Overall Study|Subject taking too many different meds|0|||
143467065|NCT00381303|517257644|FG000|Overall Study|No virologic response by week 12|1|||
143467066|NCT00381303|517257645|FG001|Overall Study|No virologic response by week 12|0|||
143467067|NCT00381303|517257644|FG000|Overall Study|Subject was too busy for appointments|1|||
143467068|NCT00381303|517257645|FG001|Overall Study|Subject was too busy for appointments|0|||
143467069|NCT00381303|517257644|FG000|Overall Study|Subject did not continue visits|1|||
143467070|NCT00381303|517257645|FG001|Overall Study|Subject did not continue visits|0|||
143467071|NCT00381303|517257644|FG000|Overall Study|Subject primary physician's decision|1|||
143467072|NCT00381303|517257645|FG001|Overall Study|Subject primary physician's decision|0|||
143467073|NCT01777269|517257646|FG000|Overall Study|Adverse Event|24|||
143013965|NCT02304302|515590123|FG000|Overall Study|Lost to Follow-up|1|||
143467074|NCT01777269|517257647|FG001|Overall Study|Adverse Event|33|||
143467075|NCT01777269|517257646|FG000|Overall Study|Lack of Efficacy|8|||
143467076|NCT01777269|517257647|FG001|Overall Study|Lack of Efficacy|10|||
143467077|NCT01777269|517257646|FG000|Overall Study|Protocol Violation|4|||
143467078|NCT01777269|517257647|FG001|Overall Study|Protocol Violation|4|||
143467079|NCT01777269|517257646|FG000|Overall Study|Participants reached stopping criteria|1|||
143467080|NCT01777269|517257647|FG001|Overall Study|Participants reached stopping criteria|1|||
143467081|NCT01777269|517257646|FG000|Overall Study|Lost to Follow-up|4|||
143467082|NCT01777269|517257647|FG001|Overall Study|Lost to Follow-up|0|||
143467083|NCT01777269|517257646|FG000|Overall Study|Physician Decision|5|||
143467084|NCT01777269|517257647|FG001|Overall Study|Physician Decision|2|||
143467085|NCT01777269|517257646|FG000|Overall Study|Withdrawal by Subject|9|||
143467086|NCT01777269|517257647|FG001|Overall Study|Withdrawal by Subject|9|||
143467087|NCT00504881|517257648|FG000|Overall Study|Lack of Efficacy|1|||
143467088|NCT00504881|517257649|FG001|Overall Study|Lack of Efficacy|5|||
143467089|NCT00504881|517257648|FG000|Overall Study|Lost to Follow-up|0|||
143467090|NCT00504881|517257649|FG001|Overall Study|Lost to Follow-up|2|||
143467091|NCT00504881|517257648|FG000|Overall Study|Withdrawal by Subject|1|||
143467092|NCT00504881|517257649|FG001|Overall Study|Withdrawal by Subject|4|||
143467093|NCT00504881|517257648|FG000|Overall Study|Non-Compliance|1|||
143467094|NCT00504881|517257649|FG001|Overall Study|Non-Compliance|0|||
143467095|NCT00504881|517257648|FG000|Overall Study|No Birth Control|0|||
143467096|NCT00504881|517257649|FG001|Overall Study|No Birth Control|1|||
143133747|NCT05209880|516035022|FG000|3-Month Follow-up|Lost to Follow-up|8|||
143133748|NCT05209880|516035023|FG001|3-Month Follow-up|Lost to Follow-up|10|||
143133749|NCT05209880|516035022|FG000|3-Month Follow-up|Discontinued|1|||
143133750|NCT05209880|516035023|FG001|3-Month Follow-up|Discontinued|3|||
143133751|NCT05209880|516035022|FG000|6-Month Follow-up|Spoke with Doctor|25|||
143133752|NCT05209880|516035023|FG001|6-Month Follow-up|Spoke with Doctor|14|||
143133753|NCT05209880|516035022|FG000|6-Month Follow-up|Lost to Follow-up|9|||
143133754|NCT05209880|516035023|FG001|6-Month Follow-up|Lost to Follow-up|14|||
143133755|NCT05209880|516035022|FG000|6-Month Follow-up|Discontinued|1|||
143133756|NCT05209880|516035023|FG001|6-Month Follow-up|Discontinued|3|||
143133757|NCT04073303|516035024|FG000|Overall Study|Adverse Event|0|||
143133758|NCT04073303|516035025|FG001|Overall Study|Adverse Event|2|||
143133759|NCT04073303|516035024|FG000|Overall Study|Withdrawal by Subject|16|||
143133760|NCT04073303|516035025|FG001|Overall Study|Withdrawal by Subject|36|||
143133761|NCT04073303|516035024|FG000|Overall Study|Lost to Follow-up|6|||
143133762|NCT04073303|516035025|FG001|Overall Study|Lost to Follow-up|1|||
143133763|NCT04073303|516035024|FG000|Overall Study|Protocol Deviation|0|||
143133764|NCT04073303|516035025|FG001|Overall Study|Protocol Deviation|4|||
143133765|NCT04073303|516035024|FG000|Overall Study|Other|1|||
143133766|NCT04073303|516035025|FG001|Overall Study|Other|1|||
143133767|NCT04144322|516035028|FG000|Overall Study|Lack of Efficacy|2|||
143133768|NCT04144322|516035029|FG001|Overall Study|Lack of Efficacy|2|||
143359361|NCT00388362|516859835|FG000|Enrolled|Loss insurance|1|||
143359362|NCT00388362|516859835|FG000|Enrolled|Withdrawal by Subject|1|||
143359363|NCT00388362|516859835|FG000|Remained on Study Median of 514 Days|Death|2|||
143359364|NCT01354938|516859836|FG000|Overall Study|Lost to Follow-up|1|||
143359365|NCT01708954|516859843|FG000|Step 1|Disease progression|26|||
143359366|NCT01708954|516859844|FG001|Step 1|Disease progression|17|||
143359367|NCT01708954|516859845|FG002|Step 1|Disease progression|14|||
143359368|NCT01708954|516859843|FG000|Step 1|Adverse Event|3|||
143359369|NCT01708954|516859844|FG001|Step 1|Adverse Event|11|||
143359370|NCT01708954|516859845|FG002|Step 1|Adverse Event|13|||
143359371|NCT01708954|516859843|FG000|Step 1|Death|3|||
143359372|NCT01708954|516859844|FG001|Step 1|Death|2|||
143359373|NCT01708954|516859845|FG002|Step 1|Death|3|||
143359374|NCT01708954|516859843|FG000|Step 1|Withdrawal by Subject|2|||
143359375|NCT01708954|516859844|FG001|Step 1|Withdrawal by Subject|5|||
143359376|NCT01708954|516859845|FG002|Step 1|Withdrawal by Subject|3|||
143359377|NCT01708954|516859843|FG000|Step 1|Other complicating disease|0|||
143359378|NCT01708954|516859844|FG001|Step 1|Other complicating disease|2|||
143359379|NCT01708954|516859845|FG002|Step 1|Other complicating disease|0|||
143359380|NCT01708954|516859843|FG000|Step 1|Crossed over to Step 2|2|||
143359381|NCT01708954|516859844|FG001|Step 1|Crossed over to Step 2|0|||
143359382|NCT01708954|516859845|FG002|Step 1|Crossed over to Step 2|0|||
143467097|NCT00504881|517257648|FG000|Overall Study|Safety Visit not performed|0|||
143467098|NCT00504881|517257649|FG001|Overall Study|Safety Visit not performed|1|||
143467099|NCT00504881|517257648|FG000|Overall Study|AE, serious fatal|0|||
143467100|NCT00504881|517257649|FG001|Overall Study|AE, serious fatal|1|||
143467101|NCT00504881|517257648|FG000|Overall Study|SAE, non-fatal|2|||
143467102|NCT00504881|517257649|FG001|Overall Study|SAE, non-fatal|6|||
143013966|NCT02304302|515590124|FG001|Overall Study|Lost to Follow-up|4|||
143133769|NCT04817332|516035030|FG000|Overall Study|Lost to Follow-up|3|||
143133770|NCT04817332|516035031|FG001|Overall Study|Lost to Follow-up|3|||
143133771|NCT04817332|516035030|FG000|Overall Study|Protocol Violation|2|||
143133772|NCT04817332|516035031|FG001|Overall Study|Protocol Violation|0|||
143359383|NCT01708954|516859843|FG000|Step 1|Symptomatic deterioration|1|||
143359384|NCT01708954|516859844|FG001|Step 1|Symptomatic deterioration|0|||
143359385|NCT01708954|516859845|FG002|Step 1|Symptomatic deterioration|1|||
143359386|NCT01708954|516859843|FG000|Step 1|Off-treatment reason not submitted|1|||
143359387|NCT01708954|516859844|FG001|Step 1|Off-treatment reason not submitted|1|||
143181179|NCT00707993|516210488|FG001|Overall Study|Adverse Event|20|||
143359388|NCT01708954|516859845|FG002|Step 1|Off-treatment reason not submitted|1|||
143359389|NCT01708954|516859843|FG000|Step 1|Ineligible or never received treatment|4|||
143467103|NCT00504881|517257648|FG000|Overall Study|AE, non-serious non-fatal|4|||
143467104|NCT00504881|517257649|FG001|Overall Study|AE, non-serious non-fatal|14|||
143467105|NCT00504881|517257648|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
143467106|NCT00504881|517257649|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
143467107|NCT00504881|517257648|FG000|Overall Study|AE of unknown type|1|||
143467108|NCT00504881|517257649|FG001|Overall Study|AE of unknown type|0|||
143467109|NCT00753272|517257657|FG000|Overall Study|Adverse Event|878|||
143467110|NCT00753272|517257658|FG001|Overall Study|Adverse Event|869|||
143467111|NCT00753272|517257657|FG000|Overall Study|Protocol Violation|28|||
143467112|NCT00753272|517257658|FG001|Overall Study|Protocol Violation|46|||
143467113|NCT00753272|517257657|FG000|Overall Study|Withdrawal by Subject|2481|||
143467114|NCT00753272|517257658|FG001|Overall Study|Withdrawal by Subject|2407|||
143467115|NCT00753272|517257657|FG000|Overall Study|Lost to Follow-up|491|||
143467116|NCT00753272|517257658|FG001|Overall Study|Lost to Follow-up|497|||
143467117|NCT00753272|517257657|FG000|Overall Study|Other|1104|||
143467118|NCT00753272|517257658|FG001|Overall Study|Other|1088|||
143467119|NCT00803270|517257659|FG000|Overall Study|Lost to Follow-up|1|||
143467120|NCT00803270|517257660|FG001|Overall Study|Lost to Follow-up|2|||
143467121|NCT00971243|517257661|FG000|Double Blind Period|Adverse Event|2|||
143467122|NCT00971243|517257662|FG001|Double Blind Period|Adverse Event|3|||
143467123|NCT00971243|517257663|FG002|Double Blind Period|Adverse Event|2|||
143467124|NCT00971243|517257664|FG003|Double Blind Period|Adverse Event|2|||
143467125|NCT00971243|517257665|FG004|Double Blind Period|Adverse Event|3|||
143467126|NCT00971243|517257661|FG000|Double Blind Period|Lost to Follow-up|0|||
143467127|NCT00971243|517257662|FG001|Double Blind Period|Lost to Follow-up|1|||
143467128|NCT00971243|517257663|FG002|Double Blind Period|Lost to Follow-up|1|||
143467129|NCT00971243|517257664|FG003|Double Blind Period|Lost to Follow-up|0|||
143467130|NCT00971243|517257665|FG004|Double Blind Period|Lost to Follow-up|1|||
143467131|NCT00971243|517257661|FG000|Double Blind Period|Physician Decision|10|||
143467132|NCT00971243|517257662|FG001|Double Blind Period|Physician Decision|6|||
143467133|NCT00971243|517257663|FG002|Double Blind Period|Physician Decision|7|||
143467134|NCT00971243|517257664|FG003|Double Blind Period|Physician Decision|6|||
143467135|NCT00971243|517257665|FG004|Double Blind Period|Physician Decision|7|||
143467136|NCT00971243|517257661|FG000|Double Blind Period|Protocol Violation|2|||
143467137|NCT00971243|517257662|FG001|Double Blind Period|Protocol Violation|0|||
143467138|NCT00971243|517257663|FG002|Double Blind Period|Protocol Violation|3|||
143467139|NCT00971243|517257664|FG003|Double Blind Period|Protocol Violation|2|||
143467140|NCT00971243|517257665|FG004|Double Blind Period|Protocol Violation|2|||
143467141|NCT00971243|517257661|FG000|Double Blind Period|Withdrawal by Subject|4|||
143467142|NCT00971243|517257662|FG001|Double Blind Period|Withdrawal by Subject|1|||
143467143|NCT00971243|517257663|FG002|Double Blind Period|Withdrawal by Subject|4|||
143467144|NCT00971243|517257664|FG003|Double Blind Period|Withdrawal by Subject|4|||
143467145|NCT00971243|517257665|FG004|Double Blind Period|Withdrawal by Subject|4|||
143467146|NCT00971243|517257661|FG000|Double Blind Period|Other reasons|1|||
143467147|NCT00971243|517257662|FG001|Double Blind Period|Other reasons|0|||
143467148|NCT00971243|517257663|FG002|Double Blind Period|Other reasons|2|||
143467149|NCT00971243|517257664|FG003|Double Blind Period|Other reasons|0|||
143467150|NCT00971243|517257665|FG004|Double Blind Period|Other reasons|1|||
143467151|NCT00971243|517257661|FG000|Open-label Period|Adverse Event|1|||
143467152|NCT00971243|517257662|FG001|Open-label Period|Adverse Event|0|||
143467153|NCT00971243|517257663|FG002|Open-label Period|Adverse Event|1|||
143467154|NCT00971243|517257664|FG003|Open-label Period|Adverse Event|1|||
143467155|NCT00971243|517257665|FG004|Open-label Period|Adverse Event|0|||
143467156|NCT00971243|517257661|FG000|Open-label Period|Physician Decision|5|||
143467157|NCT00971243|517257662|FG001|Open-label Period|Physician Decision|9|||
143467158|NCT00971243|517257663|FG002|Open-label Period|Physician Decision|3|||
143467159|NCT00971243|517257664|FG003|Open-label Period|Physician Decision|7|||
143467160|NCT00971243|517257665|FG004|Open-label Period|Physician Decision|2|||
143467161|NCT00971243|517257661|FG000|Open-label Period|Protocol Violation|1|||
143467162|NCT00971243|517257662|FG001|Open-label Period|Protocol Violation|1|||
143013967|NCT02304302|515590123|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
143013968|NCT02304302|515590124|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
143133773|NCT05635045|516035032|FG000|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
143467163|NCT00971243|517257663|FG002|Open-label Period|Protocol Violation|1|||
143467164|NCT00971243|517257664|FG003|Open-label Period|Protocol Violation|0|||
143467165|NCT00971243|517257665|FG004|Open-label Period|Protocol Violation|1|||
143467166|NCT00971243|517257661|FG000|Open-label Period|Withdrawal by Subject|1|||
143467167|NCT00971243|517257662|FG001|Open-label Period|Withdrawal by Subject|0|||
143467168|NCT00971243|517257663|FG002|Open-label Period|Withdrawal by Subject|0|||
143467169|NCT00971243|517257664|FG003|Open-label Period|Withdrawal by Subject|2|||
143467170|NCT00971243|517257665|FG004|Open-label Period|Withdrawal by Subject|1|||
143467171|NCT00971243|517257661|FG000|Open-label Period|Other reason|0|||
143467172|NCT00971243|517257662|FG001|Open-label Period|Other reason|0|||
143467173|NCT00971243|517257663|FG002|Open-label Period|Other reason|0|||
143013969|NCT00391118|515590125|FG000|Overall Study|Adverse Event|3|||
143181180|NCT00707993|516210487|FG000|Overall Study|Protocol Violation|4|||
143467174|NCT00971243|517257664|FG003|Open-label Period|Other reason|0|||
143467175|NCT00971243|517257665|FG004|Open-label Period|Other reason|2|||
143467176|NCT01966471|517257668|FG000|Overall Study|Death|44|||
143467177|NCT01966471|517257669|FG001|Overall Study|Death|56|||
143467178|NCT01966471|517257668|FG000|Overall Study|Lost to Follow-up|46|||
143467179|NCT01966471|517257669|FG001|Overall Study|Lost to Follow-up|39|||
143467180|NCT01966471|517257668|FG000|Overall Study|Various reasons|4|||
143467181|NCT01966471|517257669|FG001|Overall Study|Various reasons|4|||
143467182|NCT01966471|517257668|FG000|Overall Study|Physician Decision|7|||
143467183|NCT01966471|517257669|FG001|Overall Study|Physician Decision|5|||
143467184|NCT01966471|517257668|FG000|Overall Study|Study Terminated By Sponsor|758|||
143467185|NCT01966471|517257669|FG001|Overall Study|Study Terminated By Sponsor|773|||
143467186|NCT01966471|517257668|FG000|Overall Study|Withdrawal by Subject|59|||
143467187|NCT01966471|517257669|FG001|Overall Study|Withdrawal by Subject|51|||
143467188|NCT00960531|517257670|FG000|Overall Study|Lack of Efficacy|1|||
143467189|NCT00960531|517257671|FG001|Overall Study|Lack of Efficacy|0|||
143467190|NCT00960531|517257672|FG002|Overall Study|Lack of Efficacy|0|||
143467191|NCT00960531|517257673|FG003|Overall Study|Lack of Efficacy|0|||
143467192|NCT00960531|517257674|FG004|Overall Study|Lack of Efficacy|0|||
143467193|NCT00960531|517257675|FG005|Overall Study|Lack of Efficacy|0|||
143467194|NCT00960531|517257676|FG006|Overall Study|Lack of Efficacy|0|||
143467195|NCT00960531|517257677|FG007|Overall Study|Lack of Efficacy|0|||
143467196|NCT00960531|517257678|FG008|Overall Study|Lack of Efficacy|0|||
143467197|NCT00960531|517257679|FG009|Overall Study|Lack of Efficacy|0|||
143467198|NCT00960531|517257670|FG000|Overall Study|Withdrawal by Subject|1|||
143467199|NCT00960531|517257671|FG001|Overall Study|Withdrawal by Subject|0|||
143467200|NCT00960531|517257672|FG002|Overall Study|Withdrawal by Subject|5|||
143467201|NCT00960531|517257673|FG003|Overall Study|Withdrawal by Subject|2|||
143467202|NCT00960531|517257674|FG004|Overall Study|Withdrawal by Subject|0|||
143467203|NCT00960531|517257675|FG005|Overall Study|Withdrawal by Subject|0|||
143467204|NCT00960531|517257676|FG006|Overall Study|Withdrawal by Subject|2|||
143467205|NCT00960531|517257677|FG007|Overall Study|Withdrawal by Subject|0|||
143467206|NCT00960531|517257678|FG008|Overall Study|Withdrawal by Subject|1|||
143467207|NCT00960531|517257679|FG009|Overall Study|Withdrawal by Subject|0|||
143467208|NCT00960531|517257670|FG000|Overall Study|Caregiver Request|2|||
143467209|NCT00960531|517257671|FG001|Overall Study|Caregiver Request|0|||
143467210|NCT00960531|517257672|FG002|Overall Study|Caregiver Request|6|||
143467211|NCT00960531|517257673|FG003|Overall Study|Caregiver Request|5|||
143467212|NCT00960531|517257674|FG004|Overall Study|Caregiver Request|0|||
143467213|NCT00960531|517257675|FG005|Overall Study|Caregiver Request|2|||
143467214|NCT00960531|517257676|FG006|Overall Study|Caregiver Request|3|||
143467215|NCT00960531|517257677|FG007|Overall Study|Caregiver Request|1|||
143467216|NCT00960531|517257678|FG008|Overall Study|Caregiver Request|3|||
143467217|NCT00960531|517257679|FG009|Overall Study|Caregiver Request|0|||
143467218|NCT00960531|517257670|FG000|Overall Study|Investigator Request|0|||
143467219|NCT00960531|517257671|FG001|Overall Study|Investigator Request|0|||
143467220|NCT00960531|517257672|FG002|Overall Study|Investigator Request|1|||
143467221|NCT00960531|517257673|FG003|Overall Study|Investigator Request|0|||
143467222|NCT00960531|517257674|FG004|Overall Study|Investigator Request|0|||
143467223|NCT00960531|517257675|FG005|Overall Study|Investigator Request|0|||
143467224|NCT00960531|517257676|FG006|Overall Study|Investigator Request|0|||
143467225|NCT00960531|517257677|FG007|Overall Study|Investigator Request|0|||
143467226|NCT00960531|517257678|FG008|Overall Study|Investigator Request|0|||
143467227|NCT00960531|517257679|FG009|Overall Study|Investigator Request|0|||
143467228|NCT00960531|517257670|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
143467229|NCT00960531|517257671|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
143467230|NCT00960531|517257672|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
143467231|NCT00960531|517257673|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
143467232|NCT00960531|517257674|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
143467233|NCT00960531|517257675|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
143467234|NCT00960531|517257676|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
143467235|NCT00960531|517257677|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
143467236|NCT00960531|517257678|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
143467237|NCT00960531|517257679|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
143467238|NCT00960531|517257670|FG000|Overall Study|Lost to Follow-up|0|||
143133774|NCT05635045|516035033|FG001|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
143467239|NCT00960531|517257671|FG001|Overall Study|Lost to Follow-up|0|||
143467240|NCT00960531|517257672|FG002|Overall Study|Lost to Follow-up|1|||
143181181|NCT00707993|516210488|FG001|Overall Study|Protocol Violation|7|||
143467241|NCT00960531|517257673|FG003|Overall Study|Lost to Follow-up|0|||
143467242|NCT00960531|517257674|FG004|Overall Study|Lost to Follow-up|0|||
143467243|NCT00960531|517257675|FG005|Overall Study|Lost to Follow-up|0|||
143467244|NCT00960531|517257676|FG006|Overall Study|Lost to Follow-up|1|||
143467245|NCT00960531|517257677|FG007|Overall Study|Lost to Follow-up|0|||
143467246|NCT00960531|517257678|FG008|Overall Study|Lost to Follow-up|0|||
143467247|NCT00960531|517257679|FG009|Overall Study|Lost to Follow-up|0|||
143467248|NCT00960531|517257670|FG000|Overall Study|Failed to Return|2|||
143133775|NCT05635045|516035034|FG002|Overall Study|measurements were not usable due material error in imaging agent supplied|1|||
143133776|NCT05635045|516035035|FG003|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
143133777|NCT02689804|516035036|FG000|Overall Study|Withdrawal by Subject|2|||
143133778|NCT02689804|516035037|FG001|Overall Study|Withdrawal by Subject|0|||
143133779|NCT00426764|516035038|FG000|Overall Study|Protocol Violation|1|||
143133780|NCT00426764|516035038|FG000|Overall Study|Withdrawal by Subject|4|||
143133781|NCT00426764|516035038|FG000|Overall Study|Physician Decision|6|||
143133782|NCT00426764|516035038|FG000|Overall Study|Compassionate Use|1|||
143133783|NCT00426764|516035038|FG000|Overall Study|Progressive Disease|83|||
143467249|NCT00960531|517257671|FG001|Overall Study|Failed to Return|0|||
143467250|NCT00960531|517257672|FG002|Overall Study|Failed to Return|0|||
143467251|NCT00960531|517257673|FG003|Overall Study|Failed to Return|0|||
143467252|NCT00960531|517257674|FG004|Overall Study|Failed to Return|0|||
143467253|NCT00960531|517257675|FG005|Overall Study|Failed to Return|0|||
143467254|NCT00960531|517257676|FG006|Overall Study|Failed to Return|0|||
143467255|NCT00960531|517257677|FG007|Overall Study|Failed to Return|2|||
143467256|NCT00960531|517257678|FG008|Overall Study|Failed to Return|0|||
143467257|NCT00960531|517257679|FG009|Overall Study|Failed to Return|0|||
143467258|NCT00960531|517257670|FG000|Overall Study|Adverse Event (AE)|2|||
143467259|NCT00960531|517257671|FG001|Overall Study|Adverse Event (AE)|0|||
143467260|NCT00960531|517257672|FG002|Overall Study|Adverse Event (AE)|0|||
143467261|NCT00960531|517257673|FG003|Overall Study|Adverse Event (AE)|0|||
143467262|NCT00960531|517257674|FG004|Overall Study|Adverse Event (AE)|0|||
143467263|NCT00960531|517257675|FG005|Overall Study|Adverse Event (AE)|1|||
143467264|NCT00960531|517257676|FG006|Overall Study|Adverse Event (AE)|2|||
143467265|NCT00960531|517257677|FG007|Overall Study|Adverse Event (AE)|0|||
143467266|NCT00960531|517257678|FG008|Overall Study|Adverse Event (AE)|2|||
143467267|NCT00960531|517257679|FG009|Overall Study|Adverse Event (AE)|0|||
143467268|NCT00960531|517257670|FG000|Overall Study|Reason not Specified|2|||
143467269|NCT00960531|517257671|FG001|Overall Study|Reason not Specified|1|||
143467270|NCT00960531|517257672|FG002|Overall Study|Reason not Specified|13|||
143467271|NCT00960531|517257673|FG003|Overall Study|Reason not Specified|1|||
143467272|NCT00960531|517257674|FG004|Overall Study|Reason not Specified|2|||
143467273|NCT00960531|517257675|FG005|Overall Study|Reason not Specified|0|||
143467274|NCT00960531|517257676|FG006|Overall Study|Reason not Specified|16|||
143467275|NCT00960531|517257677|FG007|Overall Study|Reason not Specified|0|||
143467276|NCT00960531|517257678|FG008|Overall Study|Reason not Specified|8|||
143467277|NCT00960531|517257679|FG009|Overall Study|Reason not Specified|1|||
143467278|NCT01193920|517257680|FG000|Overall Study|Withdrawal by Subject|1|||
143467279|NCT01193920|517257681|FG001|Overall Study|Withdrawal by Subject|0|||
143467280|NCT01193920|517257682|FG002|Overall Study|Withdrawal by Subject|5|||
143467281|NCT01193920|517257683|FG003|Overall Study|Withdrawal by Subject|1|||
143467282|NCT01193920|517257684|FG004|Overall Study|Withdrawal by Subject|3|||
143467283|NCT01193920|517257685|FG005|Overall Study|Withdrawal by Subject|1|||
143467284|NCT01193920|517257686|FG006|Overall Study|Withdrawal by Subject|3|||
143467285|NCT01193920|517257687|FG007|Overall Study|Withdrawal by Subject|0|||
143467286|NCT01193920|517257688|FG008|Overall Study|Withdrawal by Subject|1|||
143467287|NCT01193920|517257689|FG009|Overall Study|Withdrawal by Subject|0|||
143467288|NCT01193920|517257680|FG000|Overall Study|Lost to Follow-up|1|||
143467289|NCT01193920|517257681|FG001|Overall Study|Lost to Follow-up|0|||
143467290|NCT01193920|517257682|FG002|Overall Study|Lost to Follow-up|1|||
143467291|NCT01193920|517257683|FG003|Overall Study|Lost to Follow-up|1|||
143467292|NCT01193920|517257684|FG004|Overall Study|Lost to Follow-up|3|||
143467293|NCT01193920|517257685|FG005|Overall Study|Lost to Follow-up|3|||
143467294|NCT01193920|517257686|FG006|Overall Study|Lost to Follow-up|1|||
143467295|NCT01193920|517257687|FG007|Overall Study|Lost to Follow-up|0|||
143467296|NCT01193920|517257688|FG008|Overall Study|Lost to Follow-up|2|||
143467297|NCT01193920|517257689|FG009|Overall Study|Lost to Follow-up|3|||
143467298|NCT01193920|517257680|FG000|Overall Study|Protocol Violation|1|||
143467299|NCT01193920|517257681|FG001|Overall Study|Protocol Violation|0|||
143467300|NCT01193920|517257682|FG002|Overall Study|Protocol Violation|0|||
143467301|NCT01193920|517257683|FG003|Overall Study|Protocol Violation|0|||
143467302|NCT01193920|517257684|FG004|Overall Study|Protocol Violation|0|||
143467303|NCT01193920|517257685|FG005|Overall Study|Protocol Violation|0|||
143467304|NCT01193920|517257686|FG006|Overall Study|Protocol Violation|0|||
143467305|NCT01193920|517257687|FG007|Overall Study|Protocol Violation|0|||
143467306|NCT01193920|517257688|FG008|Overall Study|Protocol Violation|0|||
143467307|NCT01193920|517257689|FG009|Overall Study|Protocol Violation|0|||
143467308|NCT01193920|517257680|FG000|Overall Study|Death|0|||
143467309|NCT01193920|517257681|FG001|Overall Study|Death|0|||
143467310|NCT01193920|517257682|FG002|Overall Study|Death|0|||
143467311|NCT01193920|517257683|FG003|Overall Study|Death|1|||
143467312|NCT01193920|517257684|FG004|Overall Study|Death|0|||
143467313|NCT01193920|517257685|FG005|Overall Study|Death|0|||
143467314|NCT01193920|517257686|FG006|Overall Study|Death|2|||
143013970|NCT00391118|515590126|FG001|Overall Study|Adverse Event|10|||
143467315|NCT01193920|517257687|FG007|Overall Study|Death|3|||
143467316|NCT01193920|517257688|FG008|Overall Study|Death|2|||
143467317|NCT01193920|517257689|FG009|Overall Study|Death|4|||
143467318|NCT01193920|517257680|FG000|Overall Study|Unable to classify|0|||
143467319|NCT01193920|517257681|FG001|Overall Study|Unable to classify|0|||
143467320|NCT01193920|517257682|FG002|Overall Study|Unable to classify|0|||
143467321|NCT01193920|517257683|FG003|Overall Study|Unable to classify|1|||
143467322|NCT01193920|517257684|FG004|Overall Study|Unable to classify|0|||
143467323|NCT01193920|517257685|FG005|Overall Study|Unable to classify|0|||
143467324|NCT01193920|517257686|FG006|Overall Study|Unable to classify|0|||
143467325|NCT01193920|517257687|FG007|Overall Study|Unable to classify|1|||
143467326|NCT01193920|517257688|FG008|Overall Study|Unable to classify|0|||
143467327|NCT01193920|517257689|FG009|Overall Study|Unable to classify|0|||
143467328|NCT00332189|517257690|FG000|Overall Study|Adverse Event|3|||
143467329|NCT00332189|517257690|FG000|Overall Study|Uncooperative/Noncompliant|3|||
143467330|NCT00332189|517257690|FG000|Overall Study|Withdrawal by Subject|9|||
143467331|NCT00332189|517257690|FG000|Overall Study|Lack of Efficacy|4|||
143467332|NCT00332189|517257690|FG000|Overall Study|Moved out of country|2|||
143467333|NCT02370043|517257691|FG000|Overall Study|Withdrawal by Subject|0|||
143467334|NCT02370043|517257692|FG001|Overall Study|Withdrawal by Subject|0|||
143467335|NCT02370043|517257693|FG002|Overall Study|Withdrawal by Subject|0|||
143467336|NCT02370043|517257694|FG003|Overall Study|Withdrawal by Subject|0|||
143467337|NCT02370043|517257695|FG004|Overall Study|Withdrawal by Subject|1|||
143467338|NCT02370043|517257696|FG005|Overall Study|Withdrawal by Subject|1|||
143467339|NCT01231516|517257697|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
143467340|NCT01231516|517257698|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
143467341|NCT01231516|517257697|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
143467342|NCT01231516|517257698|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
143467343|NCT01231516|517257697|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
143467344|NCT01231516|517257698|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
143467345|NCT01231516|517257697|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
143467346|NCT01231516|517257698|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
143467347|NCT01231516|517257697|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
143467348|NCT01231516|517257698|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
143467349|NCT01231516|517257697|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
143467350|NCT01231516|517257698|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
143467351|NCT01231516|517257697|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
143467352|NCT01231516|517257698|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
143467353|NCT01231516|517257697|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
143467354|NCT01231516|517257698|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
143467355|NCT01231516|517257697|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
143467356|NCT01231516|517257698|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
143467357|NCT01231516|517257697|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
143467358|NCT01231516|517257698|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
143467359|NCT01231516|517257697|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
143467360|NCT01231516|517257698|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
143467361|NCT01231516|517257697|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
143467362|NCT01231516|517257698|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
143467363|NCT01231516|517257697|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
143467364|NCT01231516|517257698|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
143467365|NCT01231516|517257697|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
143467366|NCT01231516|517257698|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
143467367|NCT01231516|517257697|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
143467368|NCT01231516|517257698|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
143467369|NCT01231516|517257697|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
143467370|NCT01231516|517257698|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
143467371|NCT05266586|517257699|FG000|Overall Study|Adverse Event|2|||
143467372|NCT05266586|517257700|FG001|Overall Study|Adverse Event|2|||
143467373|NCT05266586|517257701|FG002|Overall Study|Adverse Event|1|||
143013971|NCT00391118|515590127|FG002|Overall Study|Adverse Event|7|||
143013972|NCT00391118|515590125|FG000|Overall Study|Lost to Follow-up|0|||
143013973|NCT00391118|515590126|FG001|Overall Study|Lost to Follow-up|2|||
143013974|NCT00391118|515590127|FG002|Overall Study|Lost to Follow-up|3|||
143013975|NCT00391118|515590125|FG000|Overall Study|Withdrawal by Subject|0|||
143013976|NCT00391118|515590126|FG001|Overall Study|Withdrawal by Subject|9|||
143013977|NCT00391118|515590127|FG002|Overall Study|Withdrawal by Subject|1|||
143013978|NCT00391118|515590125|FG000|Overall Study|Death|0|||
143467374|NCT05266586|517257699|FG000|Overall Study|Withdrawal by Subject|1|||
143467375|NCT05266586|517257700|FG001|Overall Study|Withdrawal by Subject|0|||
143467376|NCT05266586|517257701|FG002|Overall Study|Withdrawal by Subject|1|||
143467377|NCT05266586|517257699|FG000|Overall Study|Non-compliance with study drug|0|||
143467378|NCT05266586|517257700|FG001|Overall Study|Non-compliance with study drug|1|||
143467379|NCT05266586|517257701|FG002|Overall Study|Non-compliance with study drug|0|||
143467380|NCT05266586|517257699|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
143467381|NCT05266586|517257700|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
143467382|NCT05266586|517257701|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
143467383|NCT03707925|517257702|FG000|Overall Study|Inevaluable|1|||
143467384|NCT05245097|517257705|FG000|Overall Study|Adverse Event|13|||
143467385|NCT05245097|517257706|FG001|Overall Study|Adverse Event|2|||
143467386|NCT05245097|517257705|FG000|Overall Study|Protocol Violation|8|||
143467387|NCT05245097|517257706|FG001|Overall Study|Protocol Violation|6|||
143467388|NCT05245097|517257705|FG000|Overall Study|Withdrawal by Subject|18|||
143467389|NCT05245097|517257706|FG001|Overall Study|Withdrawal by Subject|0|||
143467390|NCT05245097|517257705|FG000|Overall Study|Death|6|||
143467391|NCT05245097|517257706|FG001|Overall Study|Death|7|||
143467392|NCT05245097|517257705|FG000|Overall Study|Physician Decision|6|||
143467393|NCT05245097|517257706|FG001|Overall Study|Physician Decision|0|||
143467394|NCT05245097|517257705|FG000|Overall Study|Relocation|4|||
143467395|NCT05245097|517257706|FG001|Overall Study|Relocation|3|||
143467396|NCT04683731|517257711|FG000|Overall Study|Withdrawal by Subject|1|||
143467397|NCT04683731|517257712|FG001|Overall Study|Withdrawal by Subject|0|||
143467398|NCT04683731|517257713|FG002|Overall Study|Withdrawal by Subject|3|||
143467399|NCT04683731|517257714|FG003|Overall Study|Withdrawal by Subject|2|||
143467400|NCT04683731|517257711|FG000|Overall Study|Determined patient was not eligible|3|||
143467401|NCT04683731|517257712|FG001|Overall Study|Determined patient was not eligible|3|||
143467402|NCT04683731|517257713|FG002|Overall Study|Determined patient was not eligible|12|||
143467403|NCT04683731|517257714|FG003|Overall Study|Determined patient was not eligible|3|||
143467404|NCT00883051|517257716|FG000|Overall Study|Lost to Follow-up|0|||
143467405|NCT00883051|517257717|FG001|Overall Study|Lost to Follow-up|0|||
143467406|NCT00883051|517257718|FG002|Overall Study|Lost to Follow-up|0|||
143467407|NCT00883051|517257719|FG003|Overall Study|Lost to Follow-up|0|||
143467408|NCT00883051|517257720|FG004|Overall Study|Lost to Follow-up|1|||
143467409|NCT00883051|517257716|FG000|Overall Study|Did not use study medication|24|||
143467410|NCT00883051|517257717|FG001|Overall Study|Did not use study medication|22|||
143467411|NCT00883051|517257718|FG002|Overall Study|Did not use study medication|29|||
143467412|NCT00883051|517257719|FG003|Overall Study|Did not use study medication|29|||
143467413|NCT00883051|517257720|FG004|Overall Study|Did not use study medication|17|||
143467414|NCT01411839|517257723|FG000|Overall Study|Lost to Follow-up|4|||
143467415|NCT01411839|517257724|FG001|Overall Study|Lost to Follow-up|3|||
143467416|NCT03604523|517257725|FG000|Overall Study|Physician Decision|1|||
143467417|NCT03604523|517257726|FG001|Overall Study|Physician Decision|0|||
143467418|NCT00810394|517257733|FG000|Overall Study|Withdrawal by Subject|3|||
143467419|NCT03282240|517257734|FG000|Overall Study|Adverse Event|2|||
143467420|NCT03282240|517257735|FG001|Overall Study|Adverse Event|2|||
143467421|NCT03282240|517257736|FG002|Overall Study|Adverse Event|0|||
143467422|NCT03282240|517257734|FG000|Overall Study|Lost to Follow-up|3|||
143467423|NCT03282240|517257735|FG001|Overall Study|Lost to Follow-up|0|||
143467424|NCT03282240|517257736|FG002|Overall Study|Lost to Follow-up|0|||
143467425|NCT03282240|517257734|FG000|Overall Study|Protocol Deviation|4|||
143467426|NCT03282240|517257735|FG001|Overall Study|Protocol Deviation|1|||
143467427|NCT03282240|517257736|FG002|Overall Study|Protocol Deviation|2|||
143467428|NCT03282240|517257734|FG000|Overall Study|Withdrawal by Subject|1|||
143359390|NCT01708954|516859844|FG001|Step 1|Ineligible or never received treatment|2|||
143359391|NCT01708954|516859845|FG002|Step 1|Ineligible or never received treatment|8|||
143359392|NCT01708954|516859843|FG000|Step 2|Disease progression|9|||
143359393|NCT01708954|516859844|FG001|Step 2|Disease progression|4|||
143359394|NCT01708954|516859845|FG002|Step 2|Disease progression|0|||
143359395|NCT01708954|516859843|FG000|Step 2|Adverse Event|3|||
143359396|NCT01708954|516859844|FG001|Step 2|Adverse Event|2|||
143359397|NCT01708954|516859845|FG002|Step 2|Adverse Event|0|||
143359398|NCT01708954|516859843|FG000|Step 2|Withdrawal by Subject|1|||
143359399|NCT01708954|516859844|FG001|Step 2|Withdrawal by Subject|1|||
143359400|NCT01708954|516859845|FG002|Step 2|Withdrawal by Subject|0|||
143359401|NCT01856192|516859855|FG000|Overall Study|Adverse Event|12|||
143359402|NCT01856192|516859856|FG001|Overall Study|Adverse Event|4|||
143467429|NCT03282240|517257735|FG001|Overall Study|Withdrawal by Subject|0|||
143467430|NCT03282240|517257736|FG002|Overall Study|Withdrawal by Subject|1|||
143467431|NCT01675479|517257737|FG000|Overall Study|Lost to Follow-up|11|||
143467432|NCT03254485|517257738|FG000|Overall Study|Adverse Event|3|||
143467433|NCT03254485|517257739|FG001|Overall Study|Adverse Event|0|||
143467434|NCT03254485|517257740|FG002|Overall Study|Adverse Event|0|||
143467435|NCT03254485|517257741|FG003|Overall Study|Adverse Event|6|||
143467436|NCT03254485|517257738|FG000|Overall Study|Protocol Violation|6|||
143467437|NCT03254485|517257739|FG001|Overall Study|Protocol Violation|0|||
143467438|NCT03254485|517257740|FG002|Overall Study|Protocol Violation|0|||
143467439|NCT03254485|517257741|FG003|Overall Study|Protocol Violation|2|||
143359403|NCT01856192|516859855|FG000|Overall Study|Alternative therapy|0|||
143359404|NCT01856192|516859856|FG001|Overall Study|Alternative therapy|3|||
143359405|NCT01856192|516859855|FG000|Overall Study|Death|3|||
143359406|NCT01856192|516859856|FG001|Overall Study|Death|5|||
143467440|NCT03254485|517257738|FG000|Overall Study|Withdrawal by Subject|1|||
143467441|NCT03254485|517257739|FG001|Overall Study|Withdrawal by Subject|0|||
143467442|NCT03254485|517257740|FG002|Overall Study|Withdrawal by Subject|0|||
143467443|NCT03254485|517257741|FG003|Overall Study|Withdrawal by Subject|4|||
143467444|NCT03254485|517257738|FG000|Overall Study|Death|0|||
143467445|NCT03254485|517257739|FG001|Overall Study|Death|0|||
143467446|NCT03254485|517257740|FG002|Overall Study|Death|0|||
143467447|NCT03254485|517257741|FG003|Overall Study|Death|1|||
143467448|NCT03254485|517257738|FG000|Overall Study|Lost to Follow-up|1|||
143467449|NCT03254485|517257739|FG001|Overall Study|Lost to Follow-up|0|||
143467450|NCT03254485|517257740|FG002|Overall Study|Lost to Follow-up|0|||
143467451|NCT03254485|517257741|FG003|Overall Study|Lost to Follow-up|0|||
143467452|NCT03254485|517257738|FG000|Overall Study|Other|1|||
143467453|NCT03254485|517257739|FG001|Overall Study|Other|0|||
143467454|NCT03254485|517257740|FG002|Overall Study|Other|0|||
143467455|NCT03254485|517257741|FG003|Overall Study|Other|2|||
143467456|NCT00467285|517257742|FG000|Overall Study|Lost to Follow-up|4|||
143467457|NCT00467285|517257743|FG001|Overall Study|Lost to Follow-up|4|||
143467458|NCT03891524|517257744|FG000|Overall Study|Death|0|||
143467459|NCT03891524|517257745|FG001|Overall Study|Death|0|||
143467460|NCT03891524|517257746|FG002|Overall Study|Death|0|||
143467461|NCT03891524|517257747|FG003|Overall Study|Death|0|||
143467462|NCT03891524|517257748|FG004|Overall Study|Death|0|||
143467463|NCT03891524|517257749|FG005|Overall Study|Death|0|||
143467464|NCT03891524|517257750|FG006|Overall Study|Death|0|||
143467465|NCT03891524|517257751|FG007|Overall Study|Death|1|||
143467466|NCT03891524|517257744|FG000|Overall Study|Withdrawal by Subject|0|||
143467467|NCT03891524|517257745|FG001|Overall Study|Withdrawal by Subject|1|||
143467468|NCT03891524|517257746|FG002|Overall Study|Withdrawal by Subject|2|||
143467469|NCT03891524|517257747|FG003|Overall Study|Withdrawal by Subject|1|||
143467470|NCT03891524|517257748|FG004|Overall Study|Withdrawal by Subject|2|||
143467471|NCT03891524|517257749|FG005|Overall Study|Withdrawal by Subject|2|||
143467472|NCT03891524|517257750|FG006|Overall Study|Withdrawal by Subject|2|||
143467473|NCT03891524|517257751|FG007|Overall Study|Withdrawal by Subject|1|||
143467474|NCT01572922|517257753|FG000|Overall Study|Adverse Event|1|||
143467475|NCT01572922|517257753|FG000|Overall Study|Protocol Violation|1|||
143467476|NCT01572922|517257753|FG000|Overall Study|Death|1|||
143467477|NCT02818920|517257754|FG000|Overall Study|Unresectable|4|||
143467478|NCT02818920|517257754|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
143467479|NCT02818920|517257754|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
143467480|NCT02818920|517257754|FG000|Overall Study|Adverse Event|3|||
143467481|NCT02818920|517257754|FG000|Overall Study|Developed Other Disease|1|||
143467482|NCT02818920|517257754|FG000|Overall Study|Refused Further Treatment|1|||
143467483|NCT01335009|517257755|FG000|Overall Study|Too ill to travel to study sites|1|||
143467484|NCT01335009|517257756|FG001|Overall Study|Too ill to travel to study sites|0|||
143467485|NCT01335009|517257755|FG000|Overall Study|Death|28|||
143467486|NCT01335009|517257756|FG001|Overall Study|Death|32|||
143467487|NCT01335009|517257755|FG000|Overall Study|Withdrawal by Subject|1|||
143467488|NCT01335009|517257756|FG001|Overall Study|Withdrawal by Subject|1|||
143467489|NCT01335009|517257755|FG000|Overall Study|Lost to Follow-up|1|||
143467490|NCT01335009|517257756|FG001|Overall Study|Lost to Follow-up|0|||
143467491|NCT00445068|517257757|FG000|Overall Study|Disease progression|26|||
143467492|NCT00445068|517257757|FG000|Overall Study|Adverse Event|5|||
143467493|NCT00445068|517257757|FG000|Overall Study|Abnormal laboratory value|2|||
143467494|NCT00445068|517257757|FG000|Overall Study|Withdrawal by Subject|2|||
143467495|NCT00445068|517257757|FG000|Overall Study|Death|1|||
143467496|NCT04824521|517257758|FG000|Overall Study|Lost to Follow-up|1|||
143467497|NCT04821869|517257759|FG000|Overall Study|Adverse Event|4|||
143467498|NCT04821869|517257759|FG000|Overall Study|Withdrawal by Subject|2|||
143467499|NCT04821869|517257759|FG000|Overall Study|Did not meet FEV1 criteria|1|||
143467500|NCT03444324|517257760|FG000|Overall Study|Withdrawal by Subject|0|||
143467501|NCT03444324|517257761|FG001|Overall Study|Withdrawal by Subject|1|||
143467502|NCT03444324|517257760|FG000|Overall Study|Lost to Follow-up|4|||
143467503|NCT03444324|517257761|FG001|Overall Study|Lost to Follow-up|2|||
143467504|NCT03444324|517257760|FG000|Overall Study|Protocol Violation|0|||
143467505|NCT03444324|517257761|FG001|Overall Study|Protocol Violation|1|||
143467506|NCT03444324|517257760|FG000|Overall Study|Lack of Trial Compliance|1|||
143467507|NCT03444324|517257761|FG001|Overall Study|Lack of Trial Compliance|1|||
143467508|NCT03444324|517257760|FG000|Overall Study|Physical disability to come to the site for the closing visit|0|||
143467509|NCT03444324|517257761|FG001|Overall Study|Physical disability to come to the site for the closing visit|1|||
143467510|NCT01598311|517257762|FG000|Overall Study|Physician Decision|4|||
143467511|NCT01598311|517257763|FG001|Overall Study|Physician Decision|5|||
143467512|NCT01598311|517257762|FG000|Overall Study|Adverse Event|9|||
143467513|NCT01598311|517257763|FG001|Overall Study|Adverse Event|13|||
143467514|NCT01598311|517257762|FG000|Overall Study|Lost to Follow-up|7|||
143467515|NCT01598311|517257763|FG001|Overall Study|Lost to Follow-up|12|||
143467516|NCT01598311|517257762|FG000|Overall Study|Withdrawal by Subject|9|||
143467517|NCT01598311|517257763|FG001|Overall Study|Withdrawal by Subject|13|||
143467518|NCT01598311|517257762|FG000|Overall Study|No reason provided.|0|||
143133784|NCT00426764|516035038|FG000|Overall Study|Adverse Event|24|||
143359407|NCT01856192|516859855|FG000|Overall Study|Lack of Efficacy|0|||
143359408|NCT01856192|516859856|FG001|Overall Study|Lack of Efficacy|5|||
143359409|NCT01856192|516859855|FG000|Overall Study|Withdrawal by Subject|1|||
143359410|NCT01856192|516859856|FG001|Overall Study|Withdrawal by Subject|1|||
143359411|NCT01856192|516859855|FG000|Overall Study|Other diseases|1|||
143359412|NCT01856192|516859856|FG001|Overall Study|Other diseases|0|||
143359413|NCT01856192|516859855|FG000|Overall Study|Never started treatment|7|||
143359414|NCT01856192|516859856|FG001|Overall Study|Never started treatment|5|||
143359415|NCT01856192|516859855|FG000|Overall Study|Path ineligible|20|||
143359416|NCT01856192|516859856|FG001|Overall Study|Path ineligible|34|||
143359417|NCT01856192|516859855|FG000|Overall Study|Non-path ineligible|2|||
143359418|NCT01856192|516859856|FG001|Overall Study|Non-path ineligible|2|||
143359419|NCT01856192|516859855|FG000|Overall Study|Physician Decision|1|||
143359420|NCT01856192|516859856|FG001|Overall Study|Physician Decision|1|||
143359421|NCT01856192|516859855|FG000|Overall Study|Suspicion of progressive disease|1|||
143359422|NCT01856192|516859856|FG001|Overall Study|Suspicion of progressive disease|0|||
143359423|NCT01856192|516859855|FG000|Overall Study|Non-compliance|1|||
143359424|NCT01856192|516859856|FG001|Overall Study|Non-compliance|0|||
143359425|NCT04770220|516859857|FG000|Overall Study|Adverse Event|2|||
143359426|NCT04770220|516859858|FG001|Overall Study|Adverse Event|11|||
143359427|NCT04770220|516859857|FG000|Overall Study|Withdrawal by Subject|5|||
143359428|NCT04770220|516859858|FG001|Overall Study|Withdrawal by Subject|11|||
143359429|NCT04770220|516859857|FG000|Overall Study|Lost to Follow-up|4|||
143359430|NCT04770220|516859858|FG001|Overall Study|Lost to Follow-up|3|||
143359431|NCT04770220|516859857|FG000|Overall Study|not otherwise specified|2|||
143359432|NCT04770220|516859858|FG001|Overall Study|not otherwise specified|3|||
143359433|NCT04770220|516859857|FG000|Overall Study|Physician Decision|1|||
143359434|NCT04770220|516859858|FG001|Overall Study|Physician Decision|3|||
143359435|NCT04955626|516859859|FG000|Blinded Period|Lost to Follow-up|28|||
143359436|NCT04955626|516859860|FG001|Blinded Period|Lost to Follow-up|28|||
143359437|NCT04955626|516859861|FG002|Blinded Period|Lost to Follow-up|7|||
143359438|NCT04955626|516859862|FG003|Blinded Period|Lost to Follow-up|14|||
143359439|NCT04955626|516859863|FG004|Blinded Period|Lost to Follow-up|3|||
143359440|NCT04955626|516859864|FG005|Blinded Period|Lost to Follow-up|2|||
143359441|NCT04955626|516859865|FG006|Blinded Period|Lost to Follow-up|6|||
143359442|NCT04955626|516859866|FG007|Blinded Period|Lost to Follow-up|4|||
143359443|NCT04955626|516859867|FG008|Blinded Period|Lost to Follow-up|5|||
143359444|NCT04955626|516859868|FG009|Blinded Period|Lost to Follow-up|8|||
143359445|NCT04955626|516859869|FG010|Blinded Period|Lost to Follow-up|10|||
143359446|NCT04955626|516859870|FG011|Blinded Period|Lost to Follow-up|32|||
143359447|NCT04955626|516859871|FG012|Blinded Period|Lost to Follow-up|0|||
143359448|NCT04955626|516859872|FG013|Blinded Period|Lost to Follow-up|0|||
143359449|NCT04955626|516859873|FG014|Blinded Period|Lost to Follow-up|0|||
143359450|NCT04955626|516859874|FG015|Blinded Period|Lost to Follow-up|12|||
143359451|NCT04955626|516859875|FG016|Blinded Period|Lost to Follow-up|2|||
143359452|NCT04955626|516859876|FG017|Blinded Period|Lost to Follow-up|5|||
143359453|NCT04955626|516859877|FG018|Blinded Period|Lost to Follow-up|0|||
143359454|NCT04955626|516859878|FG019|Blinded Period|Lost to Follow-up|0|||
143359455|NCT04955626|516859879|FG020|Blinded Period|Lost to Follow-up|0|||
143359456|NCT04955626|516859880|FG021|Blinded Period|Lost to Follow-up|0|||
143359457|NCT04955626|516859881|FG022|Blinded Period|Lost to Follow-up|0|||
143359458|NCT04955626|516859882|FG023|Blinded Period|Lost to Follow-up|0|||
143359459|NCT04955626|516859883|FG024|Blinded Period|Lost to Follow-up|3|||
143359460|NCT04955626|516859884|FG025|Blinded Period|Lost to Follow-up|1|||
143359461|NCT04955626|516859885|FG026|Blinded Period|Lost to Follow-up|2|||
143359462|NCT04955626|516859886|FG027|Blinded Period|Lost to Follow-up|2|||
143359463|NCT04955626|516859887|FG028|Blinded Period|Lost to Follow-up|2|||
143133785|NCT00426764|516035038|FG000|Overall Study|Other|1|||
143133786|NCT00426764|516035038|FG000|Overall Study|Death|1|||
143359464|NCT04955626|516859888|FG029|Blinded Period|Lost to Follow-up|0|||
143359465|NCT04955626|516859889|FG030|Blinded Period|Lost to Follow-up|0|||
143359466|NCT04955626|516859890|FG031|Blinded Period|Lost to Follow-up|0|||
143359467|NCT04955626|516859891|FG032|Blinded Period|Lost to Follow-up|0|||
143359468|NCT04955626|516859892|FG033|Blinded Period|Lost to Follow-up|0|||
143359469|NCT04955626|516859893|FG034|Blinded Period|Lost to Follow-up|0|||
143359470|NCT04955626|516859894|FG035|Blinded Period|Lost to Follow-up|0|||
143359471|NCT04955626|516859859|FG000|Blinded Period|Protocol Violation|5|||
143359472|NCT04955626|516859860|FG001|Blinded Period|Protocol Violation|14|||
143359473|NCT04955626|516859861|FG002|Blinded Period|Protocol Violation|0|||
143359474|NCT04955626|516859862|FG003|Blinded Period|Protocol Violation|1|||
143359475|NCT04955626|516859863|FG004|Blinded Period|Protocol Violation|2|||
143359476|NCT04955626|516859864|FG005|Blinded Period|Protocol Violation|2|||
143359477|NCT04955626|516859865|FG006|Blinded Period|Protocol Violation|0|||
143359478|NCT04955626|516859866|FG007|Blinded Period|Protocol Violation|0|||
143359479|NCT04955626|516859867|FG008|Blinded Period|Protocol Violation|0|||
143359480|NCT04955626|516859868|FG009|Blinded Period|Protocol Violation|4|||
143359481|NCT04955626|516859869|FG010|Blinded Period|Protocol Violation|6|||
143359482|NCT04955626|516859870|FG011|Blinded Period|Protocol Violation|1|||
143359483|NCT04955626|516859871|FG012|Blinded Period|Protocol Violation|0|||
143467519|NCT01598311|517257763|FG001|Overall Study|No reason provided.|5|||
143467520|NCT01598311|517257762|FG000|Overall Study|Randomized but never treated|8|||
143467521|NCT01598311|517257763|FG001|Overall Study|Randomized but never treated|5|||
143467522|NCT01598311|517257762|FG000|Overall Study|Treated but no confirmed CDAD|9|||
143467523|NCT01598311|517257763|FG001|Overall Study|Treated but no confirmed CDAD|8|||
143467524|NCT01598311|517257762|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
143467525|NCT01598311|517257763|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
143467526|NCT00658684|517257764|FG000|Overall Study|Adverse Event|10|||
143467527|NCT00658684|517257765|FG001|Overall Study|Adverse Event|8|||
143467528|NCT00658684|517257766|FG002|Overall Study|Adverse Event|2|||
143467529|NCT00658684|517257767|FG003|Overall Study|Adverse Event|0|||
143467530|NCT00658684|517257764|FG000|Overall Study|Withdrawal by Subject|6|||
143467531|NCT00658684|517257765|FG001|Overall Study|Withdrawal by Subject|4|||
143467532|NCT00658684|517257766|FG002|Overall Study|Withdrawal by Subject|1|||
143467533|NCT00658684|517257767|FG003|Overall Study|Withdrawal by Subject|1|||
143467534|NCT00658684|517257764|FG000|Overall Study|Lack of Efficacy|1|||
143467535|NCT00658684|517257765|FG001|Overall Study|Lack of Efficacy|1|||
143467536|NCT00658684|517257766|FG002|Overall Study|Lack of Efficacy|0|||
143467537|NCT00658684|517257767|FG003|Overall Study|Lack of Efficacy|0|||
143467538|NCT00658684|517257764|FG000|Overall Study|Protocol Violation|1|||
143467539|NCT00658684|517257765|FG001|Overall Study|Protocol Violation|1|||
143467540|NCT00658684|517257766|FG002|Overall Study|Protocol Violation|0|||
143467541|NCT00658684|517257767|FG003|Overall Study|Protocol Violation|0|||
143467542|NCT00658684|517257764|FG000|Overall Study|Pregnancy|1|||
143467543|NCT00658684|517257765|FG001|Overall Study|Pregnancy|1|||
143467544|NCT00658684|517257766|FG002|Overall Study|Pregnancy|0|||
143467545|NCT00658684|517257767|FG003|Overall Study|Pregnancy|0|||
143467546|NCT00688103|517257768|FG000|Overall Study|Adverse Event|4|||
143467547|NCT00688103|517257769|FG001|Overall Study|Adverse Event|1|||
143467548|NCT00688103|517257768|FG000|Overall Study|Lack of Efficacy|11|||
143467549|NCT00688103|517257769|FG001|Overall Study|Lack of Efficacy|1|||
143467550|NCT00688103|517257768|FG000|Overall Study|Withdrawal by Subject|4|||
143467551|NCT00688103|517257769|FG001|Overall Study|Withdrawal by Subject|2|||
143467552|NCT00688103|517257768|FG000|Overall Study|complex reasons|11|||
143467553|NCT00688103|517257769|FG001|Overall Study|complex reasons|9|||
143467554|NCT04751656|517259332|FG000|Overall Study|Lost to Follow-up|1|||
143467555|NCT01485354|517259335|FG000|Overall Study|Withdrawal by Subject|5|||
143467556|NCT03566810|517259336|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
143467557|NCT03566810|517259337|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
143467558|NCT03566810|517259338|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
143467559|NCT03566810|517259339|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
143467560|NCT01390181|517259340|FG000|Overall Study|Lost to Follow-up|1|||
143467561|NCT01390181|517259340|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
143467562|NCT01103245|517259341|FG000|Overall Study|Withdrawal by Subject|1|||
143467563|NCT01103245|517259342|FG001|Overall Study|Withdrawal by Subject|0|||
143467564|NCT01103245|517259343|FG002|Overall Study|Withdrawal by Subject|3|||
143359484|NCT04955626|516859872|FG013|Blinded Period|Protocol Violation|0|||
143359485|NCT04955626|516859873|FG014|Blinded Period|Protocol Violation|2|||
143359486|NCT04955626|516859874|FG015|Blinded Period|Protocol Violation|6|||
143359487|NCT04955626|516859875|FG016|Blinded Period|Protocol Violation|4|||
143359488|NCT04955626|516859876|FG017|Blinded Period|Protocol Violation|6|||
143359489|NCT04955626|516859877|FG018|Blinded Period|Protocol Violation|0|||
143359490|NCT04955626|516859878|FG019|Blinded Period|Protocol Violation|1|||
143359491|NCT04955626|516859879|FG020|Blinded Period|Protocol Violation|0|||
143359492|NCT04955626|516859880|FG021|Blinded Period|Protocol Violation|1|||
143359493|NCT04955626|516859881|FG022|Blinded Period|Protocol Violation|0|||
143359494|NCT04955626|516859882|FG023|Blinded Period|Protocol Violation|0|||
143359495|NCT04955626|516859883|FG024|Blinded Period|Protocol Violation|4|||
143359496|NCT04955626|516859884|FG025|Blinded Period|Protocol Violation|6|||
143359497|NCT04955626|516859885|FG026|Blinded Period|Protocol Violation|5|||
143359498|NCT04955626|516859886|FG027|Blinded Period|Protocol Violation|3|||
143359499|NCT04955626|516859887|FG028|Blinded Period|Protocol Violation|4|||
143359500|NCT04955626|516859888|FG029|Blinded Period|Protocol Violation|3|||
143359501|NCT04955626|516859889|FG030|Blinded Period|Protocol Violation|0|||
143359502|NCT04955626|516859890|FG031|Blinded Period|Protocol Violation|0|||
143359503|NCT04955626|516859891|FG032|Blinded Period|Protocol Violation|0|||
143359504|NCT04955626|516859892|FG033|Blinded Period|Protocol Violation|0|||
143359505|NCT04955626|516859893|FG034|Blinded Period|Protocol Violation|0|||
143359506|NCT04955626|516859894|FG035|Blinded Period|Protocol Violation|0|||
143359507|NCT04955626|516859859|FG000|Blinded Period|Death|0|||
143359508|NCT04955626|516859860|FG001|Blinded Period|Death|2|||
143359509|NCT04955626|516859861|FG002|Blinded Period|Death|0|||
143359510|NCT04955626|516859862|FG003|Blinded Period|Death|0|||
143359511|NCT04955626|516859863|FG004|Blinded Period|Death|0|||
143359512|NCT04955626|516859864|FG005|Blinded Period|Death|0|||
143359513|NCT04955626|516859865|FG006|Blinded Period|Death|0|||
143359514|NCT04955626|516859866|FG007|Blinded Period|Death|2|||
143359515|NCT04955626|516859867|FG008|Blinded Period|Death|1|||
143359516|NCT04955626|516859868|FG009|Blinded Period|Death|1|||
143359517|NCT04955626|516859869|FG010|Blinded Period|Death|0|||
143359518|NCT04955626|516859870|FG011|Blinded Period|Death|2|||
143359519|NCT04955626|516859871|FG012|Blinded Period|Death|0|||
143359520|NCT04955626|516859872|FG013|Blinded Period|Death|0|||
143359521|NCT04955626|516859873|FG014|Blinded Period|Death|0|||
143359522|NCT04955626|516859874|FG015|Blinded Period|Death|0|||
143359523|NCT04955626|516859875|FG016|Blinded Period|Death|0|||
143359524|NCT04955626|516859876|FG017|Blinded Period|Death|0|||
143359525|NCT04955626|516859877|FG018|Blinded Period|Death|0|||
143359526|NCT04955626|516859878|FG019|Blinded Period|Death|0|||
143359527|NCT04955626|516859879|FG020|Blinded Period|Death|0|||
143359528|NCT04955626|516859880|FG021|Blinded Period|Death|0|||
143359529|NCT04955626|516859881|FG022|Blinded Period|Death|0|||
143359530|NCT04955626|516859882|FG023|Blinded Period|Death|1|||
143359531|NCT04955626|516859883|FG024|Blinded Period|Death|0|||
143359532|NCT04955626|516859884|FG025|Blinded Period|Death|0|||
143359533|NCT04955626|516859885|FG026|Blinded Period|Death|1|||
143359534|NCT04955626|516859886|FG027|Blinded Period|Death|1|||
143359535|NCT04955626|516859887|FG028|Blinded Period|Death|0|||
143359536|NCT04955626|516859888|FG029|Blinded Period|Death|1|||
143359537|NCT04955626|516859889|FG030|Blinded Period|Death|0|||
143359538|NCT04955626|516859890|FG031|Blinded Period|Death|0|||
143359539|NCT04955626|516859891|FG032|Blinded Period|Death|0|||
143359540|NCT04955626|516859892|FG033|Blinded Period|Death|0|||
143359541|NCT04955626|516859893|FG034|Blinded Period|Death|0|||
143359542|NCT04955626|516859894|FG035|Blinded Period|Death|0|||
143359543|NCT04955626|516859859|FG000|Blinded Period|Adverse Event|0|||
143359544|NCT04955626|516859860|FG001|Blinded Period|Adverse Event|1|||
143359545|NCT04955626|516859861|FG002|Blinded Period|Adverse Event|1|||
143359546|NCT04955626|516859862|FG003|Blinded Period|Adverse Event|1|||
143359547|NCT04955626|516859863|FG004|Blinded Period|Adverse Event|0|||
143359548|NCT04955626|516859864|FG005|Blinded Period|Adverse Event|0|||
143359549|NCT04955626|516859865|FG006|Blinded Period|Adverse Event|0|||
143359550|NCT04955626|516859866|FG007|Blinded Period|Adverse Event|0|||
143359551|NCT04955626|516859867|FG008|Blinded Period|Adverse Event|0|||
143359552|NCT04955626|516859868|FG009|Blinded Period|Adverse Event|1|||
143359553|NCT04955626|516859869|FG010|Blinded Period|Adverse Event|1|||
143359554|NCT04955626|516859870|FG011|Blinded Period|Adverse Event|0|||
143359555|NCT04955626|516859871|FG012|Blinded Period|Adverse Event|0|||
143359556|NCT04955626|516859872|FG013|Blinded Period|Adverse Event|0|||
143359557|NCT04955626|516859873|FG014|Blinded Period|Adverse Event|0|||
143359558|NCT04955626|516859874|FG015|Blinded Period|Adverse Event|0|||
143359559|NCT04955626|516859875|FG016|Blinded Period|Adverse Event|0|||
143359560|NCT04955626|516859876|FG017|Blinded Period|Adverse Event|0|||
143359561|NCT04955626|516859877|FG018|Blinded Period|Adverse Event|1|||
143359562|NCT04955626|516859878|FG019|Blinded Period|Adverse Event|0|||
143359563|NCT04955626|516859879|FG020|Blinded Period|Adverse Event|0|||
143359564|NCT04955626|516859880|FG021|Blinded Period|Adverse Event|0|||
143359565|NCT04955626|516859881|FG022|Blinded Period|Adverse Event|0|||
143359566|NCT04955626|516859882|FG023|Blinded Period|Adverse Event|0|||
143359567|NCT04955626|516859883|FG024|Blinded Period|Adverse Event|0|||
143359568|NCT04955626|516859884|FG025|Blinded Period|Adverse Event|0|||
143359569|NCT04955626|516859885|FG026|Blinded Period|Adverse Event|1|||
143359570|NCT04955626|516859886|FG027|Blinded Period|Adverse Event|0|||
143359571|NCT04955626|516859887|FG028|Blinded Period|Adverse Event|0|||
143359572|NCT04955626|516859888|FG029|Blinded Period|Adverse Event|0|||
143359573|NCT04955626|516859889|FG030|Blinded Period|Adverse Event|0|||
143359574|NCT04955626|516859890|FG031|Blinded Period|Adverse Event|0|||
143359575|NCT04955626|516859891|FG032|Blinded Period|Adverse Event|0|||
143359576|NCT04955626|516859892|FG033|Blinded Period|Adverse Event|0|||
143359577|NCT04955626|516859893|FG034|Blinded Period|Adverse Event|0|||
143359578|NCT04955626|516859894|FG035|Blinded Period|Adverse Event|0|||
143359579|NCT04955626|516859859|FG000|Blinded Period|No longer meets eligibility criteria|1|||
143359580|NCT04955626|516859860|FG001|Blinded Period|No longer meets eligibility criteria|2|||
143359581|NCT04955626|516859861|FG002|Blinded Period|No longer meets eligibility criteria|0|||
143359582|NCT04955626|516859862|FG003|Blinded Period|No longer meets eligibility criteria|1|||
143359583|NCT04955626|516859863|FG004|Blinded Period|No longer meets eligibility criteria|0|||
143359584|NCT04955626|516859864|FG005|Blinded Period|No longer meets eligibility criteria|0|||
143359585|NCT04955626|516859865|FG006|Blinded Period|No longer meets eligibility criteria|0|||
143359586|NCT04955626|516859866|FG007|Blinded Period|No longer meets eligibility criteria|0|||
143359587|NCT04955626|516859867|FG008|Blinded Period|No longer meets eligibility criteria|1|||
143359588|NCT04955626|516859868|FG009|Blinded Period|No longer meets eligibility criteria|0|||
143359589|NCT04955626|516859869|FG010|Blinded Period|No longer meets eligibility criteria|1|||
143359590|NCT04955626|516859870|FG011|Blinded Period|No longer meets eligibility criteria|1|||
143359591|NCT04955626|516859871|FG012|Blinded Period|No longer meets eligibility criteria|0|||
143359592|NCT04955626|516859872|FG013|Blinded Period|No longer meets eligibility criteria|0|||
143359593|NCT04955626|516859873|FG014|Blinded Period|No longer meets eligibility criteria|0|||
143359594|NCT04955626|516859874|FG015|Blinded Period|No longer meets eligibility criteria|3|||
143359595|NCT04955626|516859875|FG016|Blinded Period|No longer meets eligibility criteria|0|||
143467565|NCT01103245|517259344|FG003|Overall Study|Withdrawal by Subject|0|||
143467566|NCT01103245|517259341|FG000|Overall Study|Inadequate IV access|1|||
143467567|NCT01103245|517259342|FG001|Overall Study|Inadequate IV access|0|||
143467568|NCT01103245|517259343|FG002|Overall Study|Inadequate IV access|0|||
143467569|NCT01103245|517259344|FG003|Overall Study|Inadequate IV access|0|||
143467570|NCT01103245|517259341|FG000|Overall Study|Adverse Event|0|||
143467571|NCT01103245|517259342|FG001|Overall Study|Adverse Event|2|||
143467572|NCT01103245|517259343|FG002|Overall Study|Adverse Event|1|||
143467573|NCT01103245|517259344|FG003|Overall Study|Adverse Event|0|||
143467574|NCT01103245|517259341|FG000|Overall Study|Physician Decision|1|||
143467575|NCT01103245|517259342|FG001|Overall Study|Physician Decision|0|||
143467576|NCT01103245|517259343|FG002|Overall Study|Physician Decision|0|||
143467577|NCT01103245|517259344|FG003|Overall Study|Physician Decision|0|||
143467578|NCT01101477|517259345|FG000|Overall Study|Protocol Violation|5|||
143467579|NCT01101477|517259346|FG001|Overall Study|Protocol Violation|3|||
143467580|NCT01101477|517259347|FG002|Overall Study|Protocol Violation|1|||
143467581|NCT00826111|517259348|FG000|Overall Study|Lost to Follow-up|0|||
143467582|NCT00826111|517259349|FG001|Overall Study|Lost to Follow-up|1|||
143467583|NCT00826111|517259348|FG000|Overall Study|Protocol Violation|1|||
143467584|NCT00826111|517259349|FG001|Overall Study|Protocol Violation|0|||
143467585|NCT00826111|517259348|FG000|Overall Study|Withdrawal by Subject|5|||
143467586|NCT00826111|517259349|FG001|Overall Study|Withdrawal by Subject|0|||
143467587|NCT00826111|517259348|FG000|Overall Study|Physician Decision|1|||
143467588|NCT00826111|517259349|FG001|Overall Study|Physician Decision|1|||
143467589|NCT02805725|517259350|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
143467590|NCT02805725|517259351|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
143467591|NCT02805725|517259352|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
143467592|NCT02805725|517259353|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
143467593|NCT02805725|517259354|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
143467594|NCT02805725|517259350|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
143467595|NCT02805725|517259351|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
143467596|NCT02805725|517259352|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
143467597|NCT02805725|517259353|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
143467598|NCT02805725|517259354|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
143467599|NCT02805725|517259350|FG000|Phase II|Protocol Violation|0|||
143467600|NCT02805725|517259351|FG001|Phase II|Protocol Violation|0|||
143467601|NCT02805725|517259352|FG002|Phase II|Protocol Violation|0|||
143467602|NCT02805725|517259353|FG003|Phase II|Protocol Violation|0|||
143467603|NCT02805725|517259354|FG004|Phase II|Protocol Violation|6|||
143467604|NCT01195545|517259357|FG000|Overall Study|Protocol Violation|4|||
143467605|NCT02425644|517259360|FG000|Overall Study|Lost to Follow-up|2|||
143467606|NCT02425644|517259361|FG001|Overall Study|Lost to Follow-up|3|||
143467607|NCT02425644|517259360|FG000|Overall Study|Withdrawal by Subject|41|||
143467608|NCT02425644|517259361|FG001|Overall Study|Withdrawal by Subject|36|||
143467609|NCT02425644|517259360|FG000|Overall Study|Lack of Efficacy|3|||
143467610|NCT02425644|517259361|FG001|Overall Study|Lack of Efficacy|10|||
143467611|NCT02425644|517259360|FG000|Overall Study|Adverse Event|13|||
143467612|NCT02425644|517259361|FG001|Overall Study|Adverse Event|3|||
143467613|NCT02425644|517259360|FG000|Overall Study|Death|0|||
143467614|NCT02425644|517259361|FG001|Overall Study|Death|2|||
143467615|NCT02425644|517259360|FG000|Overall Study|Other|18|||
143467616|NCT02425644|517259361|FG001|Overall Study|Other|17|||
143467617|NCT02720536|517259364|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
143467618|NCT02720536|517259364|FG000|Overall Study|PR - pregnancy|2|||
143467619|NCT02720536|517259364|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
143467620|NCT02720536|517259364|FG000|Overall Study|PR - death|1|||
143467621|NCT02720536|517259364|FG000|Overall Study|PR - adverse event|1|||
143467622|NCT02720536|517259364|FG000|Overall Study|PR - abnormal lab value(s)|1|||
143467623|NCT02720536|517259364|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
143467624|NCT01028222|517259365|FG000|Overall Study|Protocol deviation|1|||
143467625|NCT01028222|517259366|FG001|Overall Study|Protocol deviation|0|||
143467626|NCT01028222|517259365|FG000|Overall Study|Disease progression|33|||
143467627|NCT01028222|517259366|FG001|Overall Study|Disease progression|9|||
143467628|NCT01028222|517259365|FG000|Overall Study|Administrative problems|1|||
143467629|NCT01028222|517259366|FG001|Overall Study|Administrative problems|1|||
143467630|NCT01028222|517259365|FG000|Overall Study|Lost to Follow-up|0|||
143467631|NCT01028222|517259366|FG001|Overall Study|Lost to Follow-up|1|||
143467632|NCT01028222|517259365|FG000|Overall Study|Withdrawal by Subject|1|||
143467633|NCT01028222|517259366|FG001|Overall Study|Withdrawal by Subject|0|||
143467634|NCT01028222|517259365|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
143467635|NCT01028222|517259366|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
143013979|NCT00391118|515590126|FG001|Overall Study|Death|1|||
143467636|NCT01028222|517259365|FG000|Overall Study|Adverse Event|2|||
143467637|NCT01028222|517259366|FG001|Overall Study|Adverse Event|0|||
143467638|NCT00146328|517259367|FG000|Overall Study|Adverse Event|39|||
143467639|NCT00146328|517259368|FG001|Overall Study|Adverse Event|48|||
143467640|NCT00146328|517259369|FG002|Overall Study|Adverse Event|79|||
143467641|NCT00146328|517259367|FG000|Overall Study|Protocol Violation|11|||
143467642|NCT00146328|517259368|FG001|Overall Study|Protocol Violation|6|||
143467643|NCT00146328|517259369|FG002|Overall Study|Protocol Violation|12|||
143467644|NCT00146328|517259367|FG000|Overall Study|Lost to Follow-up|7|||
143467645|NCT00146328|517259368|FG001|Overall Study|Lost to Follow-up|4|||
143467646|NCT00146328|517259369|FG002|Overall Study|Lost to Follow-up|7|||
143467647|NCT00146328|517259367|FG000|Overall Study|Withdrawal by Subject|16|||
143467648|NCT00146328|517259368|FG001|Overall Study|Withdrawal by Subject|16|||
143467649|NCT00146328|517259369|FG002|Overall Study|Withdrawal by Subject|22|||
143467650|NCT00146328|517259367|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
143467651|NCT00146328|517259368|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
143467652|NCT00146328|517259369|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
143467653|NCT00146328|517259367|FG000|Overall Study|Trial ended/site closed|8|||
143467654|NCT00146328|517259368|FG001|Overall Study|Trial ended/site closed|2|||
143467655|NCT00146328|517259369|FG002|Overall Study|Trial ended/site closed|19|||
143467656|NCT00146328|517259367|FG000|Overall Study|Patient decision to end|0|||
143467657|NCT00146328|517259368|FG001|Overall Study|Patient decision to end|1|||
143467658|NCT00146328|517259369|FG002|Overall Study|Patient decision to end|6|||
143467659|NCT00146328|517259367|FG000|Overall Study|Enroll into other trial|2|||
143467660|NCT00146328|517259368|FG001|Overall Study|Enroll into other trial|4|||
143467661|NCT00146328|517259369|FG002|Overall Study|Enroll into other trial|2|||
143467662|NCT00146328|517259367|FG000|Overall Study|Death|0|||
143467663|NCT00146328|517259368|FG001|Overall Study|Death|1|||
143467664|NCT00146328|517259369|FG002|Overall Study|Death|1|||
143467665|NCT00146328|517259367|FG000|Overall Study|Moved|2|||
143467666|NCT00146328|517259368|FG001|Overall Study|Moved|0|||
143467667|NCT00146328|517259369|FG002|Overall Study|Moved|0|||
143467668|NCT00146328|517259367|FG000|Overall Study|Interaction with other medication|2|||
143467669|NCT00146328|517259368|FG001|Overall Study|Interaction with other medication|0|||
143467670|NCT00146328|517259369|FG002|Overall Study|Interaction with other medication|1|||
143467671|NCT00300781|517259370|FG000|Overall Study|Disease Progression|55|||
143467672|NCT00300781|517259371|FG001|Overall Study|Disease Progression|52|||
143467673|NCT00300781|517259370|FG000|Overall Study|Adverse Event|5|||
143467674|NCT00300781|517259371|FG001|Overall Study|Adverse Event|6|||
143467675|NCT00300781|517259370|FG000|Overall Study|Withdrawal by Subject|1|||
143467676|NCT00300781|517259371|FG001|Overall Study|Withdrawal by Subject|2|||
143467677|NCT00300781|517259370|FG000|Overall Study|Physician Decision|1|||
143467678|NCT00300781|517259371|FG001|Overall Study|Physician Decision|0|||
143467679|NCT00300781|517259370|FG000|Overall Study|Not Recorded|0|||
143133787|NCT00426764|516035038|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
143133788|NCT00673257|516035039|FG000|Overall Study|Withdrawal by Subject|4|||
143133789|NCT00673257|516035039|FG000|Overall Study|Unable to obtain specimen|1|||
143133790|NCT04396626|516035046|FG000|Overall Study|Premature termination of study|975|||
143133791|NCT02417753|516035049|FG000|Overall Study|Death|1|||
143133792|NCT02849587|516035052|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
143133793|NCT02849587|516035053|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
143133794|NCT02849587|516035054|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
143133795|NCT02849587|516035052|FG000|Overall Study|Withdrawal by Subject|0|||
143133796|NCT02849587|516035053|FG001|Overall Study|Withdrawal by Subject|1|||
143133797|NCT02849587|516035054|FG002|Overall Study|Withdrawal by Subject|0|||
143133798|NCT00871234|516035055|FG000|Overall Study|Adverse Event|2|||
143133799|NCT00871234|516035055|FG000|Overall Study|Lost to Follow-up|3|||
143133800|NCT00792909|516035058|FG000|Overall Study|Withdrawal by Subject|0|||
143133801|NCT00792909|516035059|FG001|Overall Study|Withdrawal by Subject|1|||
143133802|NCT00792909|516035060|FG002|Overall Study|Withdrawal by Subject|0|||
143133803|NCT00128661|516035063|FG000|Overall Study|Adverse Event|14|||
143133804|NCT00128661|516035064|FG001|Overall Study|Adverse Event|11|||
143133805|NCT00128661|516035063|FG000|Overall Study|Lost to Follow-up|10|||
143133806|NCT00128661|516035064|FG001|Overall Study|Lost to Follow-up|7|||
143133807|NCT00128661|516035063|FG000|Overall Study|Withdrawal by Subject|243|||
143133808|NCT00128661|516035064|FG001|Overall Study|Withdrawal by Subject|232|||
143133809|NCT00128661|516035063|FG000|Overall Study|Other|7|||
143133810|NCT00128661|516035064|FG001|Overall Study|Other|8|||
143467680|NCT00300781|517259371|FG001|Overall Study|Not Recorded|1|||
143467681|NCT00300781|517259370|FG000|Overall Study|Symptomatic Deterioration|1|||
143467682|NCT00300781|517259371|FG001|Overall Study|Symptomatic Deterioration|0|||
143467683|NCT00300781|517259370|FG000|Overall Study|Lost to Follow-up|0|||
143467684|NCT00300781|517259371|FG001|Overall Study|Lost to Follow-up|1|||
143133811|NCT03421379|516035066|FG000|Period 1|Withdrawal by Subject|0|||
143133812|NCT03421379|516035067|FG001|Period 1|Withdrawal by Subject|1|||
143133813|NCT03421379|516035066|FG000|Period 1|Physician Decision|1|||
143467685|NCT00567268|517259372|FG000|Overall Study|Protocol Violation|7|||
143467686|NCT00567268|517259372|FG000|Overall Study|Lost to Follow-up|36|||
143467687|NCT00567268|517259372|FG000|Overall Study|No Visit After First Day of Treatment|2|||
143467688|NCT00567268|517259372|FG000|Overall Study|No Drug Administration|4|||
143467689|NCT00567268|517259372|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
143467690|NCT02952001|517259378|FG000|Overall Study|Adverse Event|3|||
143467691|NCT02952001|517259379|FG001|Overall Study|Adverse Event|0|||
143467692|NCT02952001|517259378|FG000|Overall Study|Prohibited therapy|10|||
143467693|NCT02952001|517259379|FG001|Overall Study|Prohibited therapy|3|||
143467694|NCT02952001|517259378|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
143467695|NCT02952001|517259379|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
143467696|NCT01794520|517259384|FG000|Overall Study|Adverse events- related to progression|0|||
143467697|NCT01794520|517259385|FG001|Overall Study|Adverse events- related to progression|0|||
143467698|NCT01794520|517259386|FG002|Overall Study|Adverse events- related to progression|1|||
143467699|NCT01794520|517259387|FG003|Overall Study|Adverse events- related to progression|2|||
143467700|NCT01794520|517259388|FG004|Overall Study|Adverse events- related to progression|0|||
143467701|NCT01794520|517259389|FG005|Overall Study|Adverse events- related to progression|1|||
143467702|NCT01794520|517259390|FG006|Overall Study|Adverse events- related to progression|0|||
143467703|NCT01794520|517259384|FG000|Overall Study|Adverse event- not related to progression|1|||
143467704|NCT01794520|517259385|FG001|Overall Study|Adverse event- not related to progression|1|||
143467705|NCT01794520|517259386|FG002|Overall Study|Adverse event- not related to progression|0|||
143467706|NCT01794520|517259387|FG003|Overall Study|Adverse event- not related to progression|0|||
143467707|NCT01794520|517259388|FG004|Overall Study|Adverse event- not related to progression|2|||
143467708|NCT01794520|517259389|FG005|Overall Study|Adverse event- not related to progression|0|||
143467709|NCT01794520|517259390|FG006|Overall Study|Adverse event- not related to progression|0|||
143467710|NCT01794520|517259384|FG000|Overall Study|Progressive disease|5|||
143467711|NCT01794520|517259385|FG001|Overall Study|Progressive disease|6|||
143467712|NCT01794520|517259386|FG002|Overall Study|Progressive disease|2|||
143467713|NCT01794520|517259387|FG003|Overall Study|Progressive disease|5|||
143467714|NCT01794520|517259388|FG004|Overall Study|Progressive disease|27|||
143467715|NCT01794520|517259389|FG005|Overall Study|Progressive disease|18|||
143467716|NCT01794520|517259390|FG006|Overall Study|Progressive disease|0|||
143467717|NCT01794520|517259384|FG000|Overall Study|Withdrew consent|0|||
143467718|NCT01794520|517259385|FG001|Overall Study|Withdrew consent|0|||
143467719|NCT01794520|517259386|FG002|Overall Study|Withdrew consent|1|||
143467720|NCT01794520|517259387|FG003|Overall Study|Withdrew consent|1|||
143467721|NCT01794520|517259388|FG004|Overall Study|Withdrew consent|0|||
143467722|NCT01794520|517259389|FG005|Overall Study|Withdrew consent|0|||
143467723|NCT01794520|517259390|FG006|Overall Study|Withdrew consent|0|||
143467724|NCT01794520|517259384|FG000|Overall Study|Lost to Follow-up|0|||
143467725|NCT01794520|517259385|FG001|Overall Study|Lost to Follow-up|0|||
143467726|NCT01794520|517259386|FG002|Overall Study|Lost to Follow-up|0|||
143467727|NCT01794520|517259387|FG003|Overall Study|Lost to Follow-up|0|||
143467728|NCT01794520|517259388|FG004|Overall Study|Lost to Follow-up|1|||
143467729|NCT01794520|517259389|FG005|Overall Study|Lost to Follow-up|0|||
143467730|NCT01794520|517259390|FG006|Overall Study|Lost to Follow-up|0|||
143467731|NCT01794520|517259384|FG000|Overall Study|Toxicity|0|||
143467732|NCT01794520|517259385|FG001|Overall Study|Toxicity|2|||
143467733|NCT01794520|517259386|FG002|Overall Study|Toxicity|0|||
143467734|NCT01794520|517259387|FG003|Overall Study|Toxicity|0|||
143467735|NCT01794520|517259388|FG004|Overall Study|Toxicity|0|||
143467736|NCT01794520|517259389|FG005|Overall Study|Toxicity|0|||
143467737|NCT01794520|517259390|FG006|Overall Study|Toxicity|0|||
143467738|NCT01794520|517259384|FG000|Overall Study|Study terminated by sponsor|0|||
143467739|NCT01794520|517259385|FG001|Overall Study|Study terminated by sponsor|0|||
143467740|NCT01794520|517259386|FG002|Overall Study|Study terminated by sponsor|1|||
143467741|NCT01794520|517259387|FG003|Overall Study|Study terminated by sponsor|0|||
143467742|NCT01794520|517259388|FG004|Overall Study|Study terminated by sponsor|1|||
143467743|NCT01794520|517259389|FG005|Overall Study|Study terminated by sponsor|0|||
143467744|NCT01794520|517259390|FG006|Overall Study|Study terminated by sponsor|7|||
143467745|NCT01794520|517259384|FG000|Overall Study|Death|0|||
143467746|NCT01794520|517259385|FG001|Overall Study|Death|0|||
143467747|NCT01794520|517259386|FG002|Overall Study|Death|0|||
143467748|NCT01794520|517259387|FG003|Overall Study|Death|0|||
143467749|NCT01794520|517259388|FG004|Overall Study|Death|1|||
143467750|NCT01794520|517259389|FG005|Overall Study|Death|0|||
143467751|NCT01794520|517259390|FG006|Overall Study|Death|22|||
143467752|NCT01794520|517259384|FG000|Overall Study|Other, not specified|0|||
143467753|NCT01794520|517259385|FG001|Overall Study|Other, not specified|0|||
143467754|NCT01794520|517259386|FG002|Overall Study|Other, not specified|1|||
143467755|NCT01794520|517259387|FG003|Overall Study|Other, not specified|1|||
143467756|NCT01794520|517259388|FG004|Overall Study|Other, not specified|4|||
143467757|NCT01794520|517259389|FG005|Overall Study|Other, not specified|1|||
143467758|NCT01794520|517259390|FG006|Overall Study|Other, not specified|2|||
143467759|NCT04175808|517259391|FG000|Part A|Miscellaneous|2|||
143467760|NCT04175808|517259392|FG001|Part A|Miscellaneous|0|||
143467761|NCT04175808|517259393|FG002|Part A|Miscellaneous|0|||
143467762|NCT04175808|517259394|FG003|Part A|Miscellaneous|0|||
143467763|NCT04175808|517259395|FG004|Part A|Miscellaneous|0|||
143467764|NCT04175808|517259396|FG005|Part A|Miscellaneous|0|||
143467765|NCT04175808|517259397|FG006|Part A|Miscellaneous|0|||
143467766|NCT04796896|517259399|FG000|Overall Study|Adverse Event|1|||
143467767|NCT04796896|517259400|FG001|Overall Study|Adverse Event|0|||
143467768|NCT04796896|517259401|FG002|Overall Study|Adverse Event|0|||
143467769|NCT04796896|517259402|FG003|Overall Study|Adverse Event|0|||
143467770|NCT04796896|517259403|FG004|Overall Study|Adverse Event|0|||
143467771|NCT04796896|517259404|FG005|Overall Study|Adverse Event|1|||
143467772|NCT04796896|517259405|FG006|Overall Study|Adverse Event|1|||
143467773|NCT04796896|517259406|FG007|Overall Study|Adverse Event|0|||
143467774|NCT04796896|517259407|FG008|Overall Study|Adverse Event|1|||
143467775|NCT04796896|517259408|FG009|Overall Study|Adverse Event|1|||
143467776|NCT04796896|517259409|FG010|Overall Study|Adverse Event|1|||
143467777|NCT04796896|517259410|FG011|Overall Study|Adverse Event|0|||
143467778|NCT04796896|517259399|FG000|Overall Study|Lost to Follow-up|24|||
143467779|NCT04796896|517259400|FG001|Overall Study|Lost to Follow-up|15|||
143467780|NCT04796896|517259401|FG002|Overall Study|Lost to Follow-up|6|||
143467781|NCT04796896|517259402|FG003|Overall Study|Lost to Follow-up|4|||
143467782|NCT04796896|517259403|FG004|Overall Study|Lost to Follow-up|21|||
143467783|NCT04796896|517259404|FG005|Overall Study|Lost to Follow-up|55|||
143467784|NCT04796896|517259405|FG006|Overall Study|Lost to Follow-up|237|||
143467785|NCT04796896|517259406|FG007|Overall Study|Lost to Follow-up|52|||
143467786|NCT04796896|517259407|FG008|Overall Study|Lost to Follow-up|221|||
143467787|NCT04796896|517259408|FG009|Overall Study|Lost to Follow-up|43|||
143467788|NCT04796896|517259409|FG010|Overall Study|Lost to Follow-up|142|||
143467789|NCT04796896|517259410|FG011|Overall Study|Lost to Follow-up|18|||
143467790|NCT04796896|517259399|FG000|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|5|||
143467791|NCT04796896|517259400|FG001|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|4|||
143467792|NCT04796896|517259401|FG002|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|0|||
143467793|NCT04796896|517259402|FG003|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|3|||
143467794|NCT04796896|517259403|FG004|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
143467795|NCT04796896|517259404|FG005|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|194|||
143467796|NCT04796896|517259405|FG006|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|37|||
143467797|NCT04796896|517259406|FG007|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|222|||
143467798|NCT04796896|517259407|FG008|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|29|||
143467799|NCT04796896|517259408|FG009|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|115|||
143467800|NCT04796896|517259409|FG010|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|9|||
143467801|NCT04796896|517259410|FG011|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
143467802|NCT04796896|517259399|FG000|Overall Study|Physician Decision|1|||
143467803|NCT04796896|517259400|FG001|Overall Study|Physician Decision|0|||
143467804|NCT04796896|517259401|FG002|Overall Study|Physician Decision|0|||
143467805|NCT04796896|517259402|FG003|Overall Study|Physician Decision|0|||
143467806|NCT04796896|517259403|FG004|Overall Study|Physician Decision|0|||
143467807|NCT04796896|517259404|FG005|Overall Study|Physician Decision|3|||
143467808|NCT04796896|517259405|FG006|Overall Study|Physician Decision|18|||
143467809|NCT04796896|517259406|FG007|Overall Study|Physician Decision|1|||
143467810|NCT04796896|517259407|FG008|Overall Study|Physician Decision|7|||
143467811|NCT04796896|517259408|FG009|Overall Study|Physician Decision|0|||
143467812|NCT04796896|517259409|FG010|Overall Study|Physician Decision|5|||
143467813|NCT04796896|517259410|FG011|Overall Study|Physician Decision|0|||
143467814|NCT04796896|517259399|FG000|Overall Study|Withdrawal by Subject|36|||
143467815|NCT04796896|517259400|FG001|Overall Study|Withdrawal by Subject|31|||
143467816|NCT04796896|517259401|FG002|Overall Study|Withdrawal by Subject|11|||
143467817|NCT04796896|517259402|FG003|Overall Study|Withdrawal by Subject|8|||
143467818|NCT04796896|517259403|FG004|Overall Study|Withdrawal by Subject|16|||
143467819|NCT04796896|517259404|FG005|Overall Study|Withdrawal by Subject|162|||
143467820|NCT04796896|517259405|FG006|Overall Study|Withdrawal by Subject|299|||
143467821|NCT04796896|517259406|FG007|Overall Study|Withdrawal by Subject|149|||
143467822|NCT04796896|517259407|FG008|Overall Study|Withdrawal by Subject|303|||
143467823|NCT04796896|517259408|FG009|Overall Study|Withdrawal by Subject|94|||
143467824|NCT04796896|517259409|FG010|Overall Study|Withdrawal by Subject|192|||
143467825|NCT04796896|517259410|FG011|Overall Study|Withdrawal by Subject|16|||
143467826|NCT04796896|517259399|FG000|Overall Study|Other Than Specified|6|||
143467827|NCT04796896|517259400|FG001|Overall Study|Other Than Specified|5|||
143467828|NCT04796896|517259401|FG002|Overall Study|Other Than Specified|3|||
143467829|NCT04796896|517259402|FG003|Overall Study|Other Than Specified|2|||
143467830|NCT04796896|517259403|FG004|Overall Study|Other Than Specified|6|||
143467831|NCT04796896|517259404|FG005|Overall Study|Other Than Specified|31|||
143467832|NCT04796896|517259405|FG006|Overall Study|Other Than Specified|86|||
143467833|NCT04796896|517259406|FG007|Overall Study|Other Than Specified|66|||
143467834|NCT04796896|517259407|FG008|Overall Study|Other Than Specified|388|||
143467835|NCT04796896|517259408|FG009|Overall Study|Other Than Specified|48|||
143467836|NCT04796896|517259409|FG010|Overall Study|Other Than Specified|258|||
143467837|NCT04796896|517259410|FG011|Overall Study|Other Than Specified|4|||
143467838|NCT04796896|517259399|FG000|Overall Study|Protocol Deviation|0|||
143467839|NCT04796896|517259400|FG001|Overall Study|Protocol Deviation|0|||
143467840|NCT04796896|517259401|FG002|Overall Study|Protocol Deviation|0|||
143467841|NCT04796896|517259402|FG003|Overall Study|Protocol Deviation|1|||
143467842|NCT04796896|517259403|FG004|Overall Study|Protocol Deviation|1|||
143467843|NCT04796896|517259404|FG005|Overall Study|Protocol Deviation|2|||
143467844|NCT04796896|517259405|FG006|Overall Study|Protocol Deviation|2|||
143467845|NCT04796896|517259406|FG007|Overall Study|Protocol Deviation|2|||
143467846|NCT04796896|517259407|FG008|Overall Study|Protocol Deviation|2|||
143467847|NCT04796896|517259408|FG009|Overall Study|Protocol Deviation|1|||
143467848|NCT04796896|517259409|FG010|Overall Study|Protocol Deviation|0|||
143467849|NCT04796896|517259410|FG011|Overall Study|Protocol Deviation|0|||
143467850|NCT04796896|517259399|FG000|Overall Study|Missing|0|||
143467851|NCT04796896|517259400|FG001|Overall Study|Missing|0|||
143467852|NCT04796896|517259401|FG002|Overall Study|Missing|0|||
143467853|NCT04796896|517259402|FG003|Overall Study|Missing|0|||
143467854|NCT04796896|517259403|FG004|Overall Study|Missing|0|||
143467855|NCT04796896|517259404|FG005|Overall Study|Missing|0|||
143467856|NCT04796896|517259405|FG006|Overall Study|Missing|2|||
143467857|NCT04796896|517259406|FG007|Overall Study|Missing|1|||
143467858|NCT04796896|517259407|FG008|Overall Study|Missing|2|||
143467859|NCT04796896|517259408|FG009|Overall Study|Missing|1|||
143467860|NCT04796896|517259409|FG010|Overall Study|Missing|1|||
143467861|NCT04796896|517259410|FG011|Overall Study|Missing|0|||
143467862|NCT04796896|517259399|FG000|Overall Study|Death|0|||
143467863|NCT04796896|517259400|FG001|Overall Study|Death|0|||
143467864|NCT04796896|517259401|FG002|Overall Study|Death|0|||
143467865|NCT04796896|517259402|FG003|Overall Study|Death|0|||
143467866|NCT04796896|517259403|FG004|Overall Study|Death|0|||
143467867|NCT04796896|517259404|FG005|Overall Study|Death|0|||
143467868|NCT04796896|517259405|FG006|Overall Study|Death|0|||
143467869|NCT04796896|517259406|FG007|Overall Study|Death|0|||
143467870|NCT04796896|517259407|FG008|Overall Study|Death|1|||
143467871|NCT04796896|517259408|FG009|Overall Study|Death|0|||
143467872|NCT04796896|517259409|FG010|Overall Study|Death|0|||
143467873|NCT04796896|517259410|FG011|Overall Study|Death|0|||
143467874|NCT02021292|517259411|FG000|Overall Study|Physician Decision|0|||
143467875|NCT02021292|517259412|FG001|Overall Study|Physician Decision|1|||
143467876|NCT02021292|517259411|FG000|Overall Study|Lost to Follow-up|0|||
143467877|NCT02021292|517259412|FG001|Overall Study|Lost to Follow-up|1|||
143467878|NCT02021292|517259411|FG000|Overall Study|Death|0|||
143467879|NCT02021292|517259412|FG001|Overall Study|Death|1|||
143467880|NCT05972733|517259415|FG000|Overall Study|Lost to Follow-up|2|||
143467881|NCT05972733|517259415|FG000|Overall Study|Withdrawal by Subject|1|||
143467882|NCT01177787|517259418|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
143467883|NCT01177787|517259418|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
143467884|NCT01177787|517259418|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
143467885|NCT00402363|517259421|FG000|Overall Study|Adverse Event|9|||
143467886|NCT00402363|517259422|FG001|Overall Study|Adverse Event|14|||
143467887|NCT00402363|517259423|FG002|Overall Study|Adverse Event|2|||
143467888|NCT00402363|517259424|FG003|Overall Study|Adverse Event|2|||
143467889|NCT00402363|517259421|FG000|Overall Study|Withdrew Consent|10|||
143467890|NCT00402363|517259422|FG001|Overall Study|Withdrew Consent|5|||
143467891|NCT00402363|517259423|FG002|Overall Study|Withdrew Consent|2|||
143467892|NCT00402363|517259424|FG003|Overall Study|Withdrew Consent|1|||
143467893|NCT00402363|517259421|FG000|Overall Study|Protocol Violation|3|||
143467894|NCT00402363|517259422|FG001|Overall Study|Protocol Violation|5|||
143467895|NCT00402363|517259423|FG002|Overall Study|Protocol Violation|0|||
143467896|NCT00402363|517259424|FG003|Overall Study|Protocol Violation|3|||
143467897|NCT00402363|517259421|FG000|Overall Study|Lost to Follow-up|5|||
143467898|NCT00402363|517259422|FG001|Overall Study|Lost to Follow-up|4|||
143467899|NCT00402363|517259423|FG002|Overall Study|Lost to Follow-up|0|||
143467900|NCT00402363|517259424|FG003|Overall Study|Lost to Follow-up|2|||
143467901|NCT00402363|517259421|FG000|Overall Study|"Captured as Other"|6|||
143467902|NCT00402363|517259422|FG001|Overall Study|"Captured as Other"|2|||
143467903|NCT00402363|517259423|FG002|Overall Study|"Captured as Other"|2|||
143467904|NCT00402363|517259424|FG003|Overall Study|"Captured as Other"|2|||
143467905|NCT00823901|517259435|FG000|Overall Study|Adverse Event|1|||
143467906|NCT00823901|517259436|FG001|Overall Study|Adverse Event|1|||
143467907|NCT00823901|517259435|FG000|Overall Study|Lack of Efficacy|1|||
143467908|NCT00823901|517259436|FG001|Overall Study|Lack of Efficacy|0|||
143467909|NCT00823901|517259435|FG000|Overall Study|Lost to Follow-up|2|||
143467910|NCT00823901|517259436|FG001|Overall Study|Lost to Follow-up|1|||
143467911|NCT01369511|517259437|FG000|Overall Study|Adverse Event|1|||
143467912|NCT01369511|517259438|FG001|Overall Study|Adverse Event|1|||
143467913|NCT01369511|517259439|FG002|Overall Study|Adverse Event|5|||
143467914|NCT01369511|517259440|FG003|Overall Study|Adverse Event|0|||
143013980|NCT00391118|515590127|FG002|Overall Study|Death|0|||
143013981|NCT00391118|515590125|FG000|Overall Study|Physician Decision|0|||
143467915|NCT01369511|517259437|FG000|Overall Study|Entry criteria not met|2|||
143467916|NCT01369511|517259438|FG001|Overall Study|Entry criteria not met|0|||
143467917|NCT01369511|517259439|FG002|Overall Study|Entry criteria not met|0|||
143467918|NCT01369511|517259440|FG003|Overall Study|Entry criteria not met|1|||
143467919|NCT01369511|517259437|FG000|Overall Study|Lost to Follow-up|0|||
143467920|NCT01369511|517259438|FG001|Overall Study|Lost to Follow-up|1|||
143467921|NCT01369511|517259439|FG002|Overall Study|Lost to Follow-up|1|||
143467922|NCT01369511|517259440|FG003|Overall Study|Lost to Follow-up|2|||
143467923|NCT01369511|517259437|FG000|Overall Study|Protocol Violation|0|||
143467924|NCT01369511|517259438|FG001|Overall Study|Protocol Violation|1|||
143133814|NCT03421379|516035067|FG001|Period 1|Physician Decision|1|||
143133815|NCT03421379|516035066|FG000|Period 1|Did not receive treatment|1|||
143133816|NCT03421379|516035067|FG001|Period 1|Did not receive treatment|2|||
143133817|NCT00196105|516035069|FG000|Overall Study|Lost to Follow-up|4|||
143359596|NCT04955626|516859876|FG017|Blinded Period|No longer meets eligibility criteria|2|||
143359597|NCT04955626|516859877|FG018|Blinded Period|No longer meets eligibility criteria|0|||
143359598|NCT04955626|516859878|FG019|Blinded Period|No longer meets eligibility criteria|0|||
143359599|NCT04955626|516859879|FG020|Blinded Period|No longer meets eligibility criteria|0|||
143359600|NCT04955626|516859880|FG021|Blinded Period|No longer meets eligibility criteria|0|||
143359601|NCT04955626|516859881|FG022|Blinded Period|No longer meets eligibility criteria|0|||
143359602|NCT04955626|516859882|FG023|Blinded Period|No longer meets eligibility criteria|0|||
143359603|NCT04955626|516859883|FG024|Blinded Period|No longer meets eligibility criteria|1|||
143359604|NCT04955626|516859884|FG025|Blinded Period|No longer meets eligibility criteria|0|||
143359605|NCT04955626|516859885|FG026|Blinded Period|No longer meets eligibility criteria|0|||
143359606|NCT04955626|516859886|FG027|Blinded Period|No longer meets eligibility criteria|1|||
143359607|NCT04955626|516859887|FG028|Blinded Period|No longer meets eligibility criteria|0|||
143359608|NCT04955626|516859888|FG029|Blinded Period|No longer meets eligibility criteria|0|||
143359609|NCT04955626|516859889|FG030|Blinded Period|No longer meets eligibility criteria|0|||
143359610|NCT04955626|516859890|FG031|Blinded Period|No longer meets eligibility criteria|0|||
143359611|NCT04955626|516859891|FG032|Blinded Period|No longer meets eligibility criteria|0|||
143359612|NCT04955626|516859892|FG033|Blinded Period|No longer meets eligibility criteria|0|||
143359613|NCT04955626|516859893|FG034|Blinded Period|No longer meets eligibility criteria|0|||
143359614|NCT04955626|516859894|FG035|Blinded Period|No longer meets eligibility criteria|0|||
143359615|NCT04955626|516859859|FG000|Blinded Period|Other|54|||
143359616|NCT04955626|516859860|FG001|Blinded Period|Other|3|||
143359617|NCT04955626|516859861|FG002|Blinded Period|Other|4|||
143359618|NCT04955626|516859862|FG003|Blinded Period|Other|2|||
143359619|NCT04955626|516859863|FG004|Blinded Period|Other|0|||
143359620|NCT04955626|516859864|FG005|Blinded Period|Other|0|||
143359621|NCT04955626|516859865|FG006|Blinded Period|Other|2|||
143359622|NCT04955626|516859866|FG007|Blinded Period|Other|2|||
143359623|NCT04955626|516859867|FG008|Blinded Period|Other|1|||
143359624|NCT04955626|516859868|FG009|Blinded Period|Other|0|||
143359625|NCT04955626|516859869|FG010|Blinded Period|Other|1|||
143359626|NCT04955626|516859870|FG011|Blinded Period|Other|1|||
143359627|NCT04955626|516859871|FG012|Blinded Period|Other|0|||
143359628|NCT04955626|516859872|FG013|Blinded Period|Other|0|||
143359629|NCT04955626|516859873|FG014|Blinded Period|Other|0|||
143359630|NCT04955626|516859874|FG015|Blinded Period|Other|0|||
143359631|NCT04955626|516859875|FG016|Blinded Period|Other|0|||
143359632|NCT04955626|516859876|FG017|Blinded Period|Other|1|||
143359633|NCT04955626|516859877|FG018|Blinded Period|Other|0|||
143359634|NCT04955626|516859878|FG019|Blinded Period|Other|0|||
143359635|NCT04955626|516859879|FG020|Blinded Period|Other|0|||
143359636|NCT04955626|516859880|FG021|Blinded Period|Other|0|||
143359637|NCT04955626|516859881|FG022|Blinded Period|Other|0|||
143359638|NCT04955626|516859882|FG023|Blinded Period|Other|0|||
143359639|NCT04955626|516859883|FG024|Blinded Period|Other|0|||
143359640|NCT04955626|516859884|FG025|Blinded Period|Other|0|||
143359641|NCT04955626|516859885|FG026|Blinded Period|Other|2|||
143359642|NCT04955626|516859886|FG027|Blinded Period|Other|0|||
143359643|NCT04955626|516859887|FG028|Blinded Period|Other|0|||
143359644|NCT04955626|516859888|FG029|Blinded Period|Other|0|||
143359645|NCT04955626|516859889|FG030|Blinded Period|Other|0|||
143359646|NCT04955626|516859890|FG031|Blinded Period|Other|0|||
143359647|NCT04955626|516859891|FG032|Blinded Period|Other|0|||
143359648|NCT04955626|516859892|FG033|Blinded Period|Other|0|||
143359649|NCT04955626|516859893|FG034|Blinded Period|Other|0|||
143359650|NCT04955626|516859894|FG035|Blinded Period|Other|0|||
143359651|NCT04955626|516859859|FG000|Blinded Period|Physician Decision|1|||
143359652|NCT04955626|516859860|FG001|Blinded Period|Physician Decision|1|||
143359653|NCT04955626|516859861|FG002|Blinded Period|Physician Decision|0|||
143359654|NCT04955626|516859862|FG003|Blinded Period|Physician Decision|3|||
143359655|NCT04955626|516859863|FG004|Blinded Period|Physician Decision|0|||
143359656|NCT04955626|516859864|FG005|Blinded Period|Physician Decision|0|||
143359657|NCT04955626|516859865|FG006|Blinded Period|Physician Decision|1|||
143359658|NCT04955626|516859866|FG007|Blinded Period|Physician Decision|1|||
143359659|NCT04955626|516859867|FG008|Blinded Period|Physician Decision|0|||
143359660|NCT04955626|516859868|FG009|Blinded Period|Physician Decision|0|||
143359661|NCT04955626|516859869|FG010|Blinded Period|Physician Decision|0|||
143359662|NCT04955626|516859870|FG011|Blinded Period|Physician Decision|5|||
143359663|NCT04955626|516859871|FG012|Blinded Period|Physician Decision|0|||
143359664|NCT04955626|516859872|FG013|Blinded Period|Physician Decision|0|||
143359665|NCT04955626|516859873|FG014|Blinded Period|Physician Decision|0|||
143359666|NCT04955626|516859874|FG015|Blinded Period|Physician Decision|0|||
143359667|NCT04955626|516859875|FG016|Blinded Period|Physician Decision|0|||
143359668|NCT04955626|516859876|FG017|Blinded Period|Physician Decision|0|||
143359669|NCT04955626|516859877|FG018|Blinded Period|Physician Decision|0|||
143359670|NCT04955626|516859878|FG019|Blinded Period|Physician Decision|0|||
143467925|NCT01369511|517259439|FG002|Overall Study|Protocol Violation|0|||
143467926|NCT01369511|517259440|FG003|Overall Study|Protocol Violation|2|||
143467927|NCT01369511|517259437|FG000|Overall Study|Physician Decision|3|||
143467928|NCT01369511|517259438|FG001|Overall Study|Physician Decision|4|||
143467929|NCT01369511|517259439|FG002|Overall Study|Physician Decision|0|||
143467930|NCT01369511|517259440|FG003|Overall Study|Physician Decision|0|||
143467931|NCT01369511|517259437|FG000|Overall Study|Sponsor decision|2|||
143467932|NCT01369511|517259438|FG001|Overall Study|Sponsor decision|0|||
143467933|NCT01369511|517259439|FG002|Overall Study|Sponsor decision|1|||
143467934|NCT01369511|517259440|FG003|Overall Study|Sponsor decision|0|||
143467935|NCT01369511|517259437|FG000|Overall Study|Withdrawal by Subject|5|||
143467936|NCT01369511|517259438|FG001|Overall Study|Withdrawal by Subject|6|||
143467937|NCT01369511|517259439|FG002|Overall Study|Withdrawal by Subject|4|||
143467938|NCT01369511|517259440|FG003|Overall Study|Withdrawal by Subject|6|||
143467939|NCT01376349|517259441|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
143467940|NCT01376349|517259442|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
143467941|NCT01376349|517259443|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
143467942|NCT01376349|517259441|FG000|Raondomized Treatment|Adverse Event|13|||
143467943|NCT01376349|517259442|FG001|Raondomized Treatment|Adverse Event|17|||
143467944|NCT01376349|517259443|FG002|Raondomized Treatment|Adverse Event|14|||
143467945|NCT01376349|517259441|FG000|Raondomized Treatment|Unkown|1|||
143467946|NCT01376349|517259442|FG001|Raondomized Treatment|Unkown|2|||
143467947|NCT01376349|517259443|FG002|Raondomized Treatment|Unkown|1|||
143467948|NCT01376349|517259441|FG000|Raondomized Treatment|Alternative Treatment|0|||
143467949|NCT01376349|517259442|FG001|Raondomized Treatment|Alternative Treatment|0|||
143467950|NCT01376349|517259443|FG002|Raondomized Treatment|Alternative Treatment|1|||
143467951|NCT01180998|517259444|FG000|Overall Study|Poor Vision|0|||
143467952|NCT01180998|517259445|FG001|Overall Study|Poor Vision|2|||
143467953|NCT01180998|517259446|FG002|Overall Study|Poor Vision|2|||
143467954|NCT01180998|517259444|FG000|Overall Study|Lost to Follow-up|0|||
143467955|NCT01180998|517259445|FG001|Overall Study|Lost to Follow-up|0|||
143467956|NCT01180998|517259446|FG002|Overall Study|Lost to Follow-up|1|||
143467957|NCT01180998|517259444|FG000|Overall Study|Protocol Violation|1|||
143467958|NCT01180998|517259445|FG001|Overall Study|Protocol Violation|2|||
143467959|NCT01180998|517259446|FG002|Overall Study|Protocol Violation|0|||
143467960|NCT01180998|517259444|FG000|Overall Study|Withdrawal by Subject|0|||
143467961|NCT01180998|517259445|FG001|Overall Study|Withdrawal by Subject|0|||
143467962|NCT01180998|517259446|FG002|Overall Study|Withdrawal by Subject|1|||
143467963|NCT01180998|517259444|FG000|Overall Study|Poor comfort|3|||
143467964|NCT01180998|517259445|FG001|Overall Study|Poor comfort|0|||
143467965|NCT01180998|517259446|FG002|Overall Study|Poor comfort|4|||
143467966|NCT01180998|517259444|FG000|Overall Study|Poor lens handling|0|||
143467967|NCT01180998|517259445|FG001|Overall Study|Poor lens handling|0|||
143467968|NCT01180998|517259446|FG002|Overall Study|Poor lens handling|2|||
143467969|NCT00068588|517259449|FG000|Overall Study|Adverse Event|0|||
143467970|NCT00068588|517259450|FG001|Overall Study|Adverse Event|0|||
143467971|NCT00068588|517259451|FG002|Overall Study|Adverse Event|2|||
143467972|NCT00068588|517259449|FG000|Overall Study|Withdrawal by Subject|0|||
143467973|NCT00068588|517259450|FG001|Overall Study|Withdrawal by Subject|0|||
143467974|NCT00068588|517259451|FG002|Overall Study|Withdrawal by Subject|1|||
143467975|NCT00068588|517259449|FG000|Overall Study|Poor KPS|0|||
143467976|NCT00068588|517259450|FG001|Overall Study|Poor KPS|0|||
143467977|NCT00068588|517259451|FG002|Overall Study|Poor KPS|1|||
143467978|NCT04098068|517259452|FG000|Overall Study|Disease Progression|7|||
143467979|NCT04098068|517259452|FG000|Overall Study|Withdrawal by Subject|2|||
143467980|NCT04098068|517259452|FG000|Overall Study|New Cancer Diagnosis|1|||
143467981|NCT03871829|517259453|FG000|Overall Study|Lost to Follow-up|0|||
143467982|NCT03871829|517259454|FG001|Overall Study|Lost to Follow-up|1|||
143467983|NCT03871829|517259453|FG000|Overall Study|Withdrawal by Subject|1|||
143467984|NCT03871829|517259454|FG001|Overall Study|Withdrawal by Subject|1|||
143467985|NCT03871829|517259453|FG000|Overall Study|Death|12|||
143467986|NCT03871829|517259454|FG001|Overall Study|Death|8|||
143467987|NCT03871829|517259453|FG000|Overall Study|Study terminated by sponsor|31|||
143467988|NCT03871829|517259454|FG001|Overall Study|Study terminated by sponsor|34|||
143467989|NCT05458479|517259459|FG000|Overall Study|Lost to Follow-up|1|||
143467990|NCT02465463|517259466|FG000|Overall Study|Lost to Follow-up|2|||
143467991|NCT02465463|517259467|FG001|Overall Study|Lost to Follow-up|1|||
143467992|NCT02465463|517259466|FG000|Overall Study|Death|1|||
143467993|NCT02465463|517259467|FG001|Overall Study|Death|0|||
143467994|NCT02465463|517259466|FG000|Overall Study|Protocol Violation|1|||
143467995|NCT02465463|517259467|FG001|Overall Study|Protocol Violation|0|||
143467996|NCT01139658|517259473|FG000|Overall Study|Adverse Event|10|||
143467997|NCT01139658|517259474|FG001|Overall Study|Adverse Event|27|||
143467998|NCT01139658|517259473|FG000|Overall Study|Lack of Efficacy|15|||
143467999|NCT01139658|517259474|FG001|Overall Study|Lack of Efficacy|7|||
143468000|NCT01139658|517259473|FG000|Overall Study|Withdrawal by Subject|2|||
143468001|NCT01139658|517259474|FG001|Overall Study|Withdrawal by Subject|4|||
143468002|NCT01139658|517259473|FG000|Overall Study|No documentation of treatment|1|||
143468003|NCT01139658|517259474|FG001|Overall Study|No documentation of treatment|0|||
143468004|NCT01139658|517259473|FG000|Overall Study|Other|28|||
143133818|NCT00196105|516035070|FG001|Overall Study|Lost to Follow-up|5|||
143133819|NCT00196105|516035071|FG002|Overall Study|Lost to Follow-up|7|||
143133820|NCT04863872|516035072|FG000|Overall Study|Withdrawal by Subject|4|||
143133821|NCT04863872|516035073|FG001|Overall Study|Withdrawal by Subject|15|||
143133822|NCT04863872|516035072|FG000|Overall Study|Death|5|||
143133823|NCT04863872|516035073|FG001|Overall Study|Death|2|||
143468005|NCT01139658|517259474|FG001|Overall Study|Other|75|||
143468006|NCT02092220|517259475|FG000|Period 1|Unrelated Illness|0|||
143468007|NCT02092220|517259476|FG001|Period 1|Unrelated Illness|2|||
143468008|NCT02092220|517259475|FG000|Period 2|Severe Hypoglycaemia|1|||
143468009|NCT02092220|517259476|FG001|Period 2|Severe Hypoglycaemia|0|||
143468010|NCT02092220|517259475|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
143468011|NCT02092220|517259476|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
143468012|NCT00593957|517259478|FG000|Overall Study|Physician Decision|0|||
143468013|NCT00593957|517259479|FG001|Overall Study|Physician Decision|1|||
143468014|NCT00593957|517259480|FG002|Overall Study|Physician Decision|2|||
143468015|NCT02411578|517259483|FG000|Crossover Trial Phase|Pregnancy|0|||
143468016|NCT02411578|517259484|FG001|Crossover Trial Phase|Pregnancy|1|||
143468017|NCT00494481|517259485|FG000|Overall Study|Condition under investigation worsened|11|||
143468018|NCT00494481|517259486|FG001|Overall Study|Condition under investigation worsened|13|||
143468019|NCT00494481|517259485|FG000|Overall Study|Adverse Event|15|||
143468020|NCT00494481|517259486|FG001|Overall Study|Adverse Event|11|||
143468021|NCT00494481|517259485|FG000|Overall Study|Other|1|||
143468022|NCT00494481|517259486|FG001|Overall Study|Other|0|||
143468023|NCT00494481|517259485|FG000|Overall Study|Never received IP|2|||
143468024|NCT00494481|517259486|FG001|Overall Study|Never received IP|0|||
143468025|NCT01030198|517259487|FG000|Overall Study|Could not measure efficacy accurately|0|||
143468026|NCT01030198|517259488|FG001|Overall Study|Could not measure efficacy accurately|7|||
143468027|NCT02876835|517259489|FG000|Treatment Period (51.1 Month)|Other|1|||
143468028|NCT02876835|517259490|FG001|Treatment Period (51.1 Month)|Other|0|||
143468029|NCT02876835|517259489|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
143468030|NCT02876835|517259490|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
143468031|NCT02876835|517259489|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
143468032|NCT02876835|517259490|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
143468033|NCT02876835|517259489|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
143468034|NCT02876835|517259490|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
143468035|NCT03511053|517261545|FG000|Overall Study|Withdrawal by Subject|1|||
143468036|NCT03236246|517261546|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
143468037|NCT03236246|517261547|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
143468038|NCT03236246|517261546|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
143468039|NCT03236246|517261547|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
143468040|NCT03236246|517261546|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
143468041|NCT03236246|517261547|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
143468042|NCT03236246|517261546|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
143468043|NCT03236246|517261547|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
143468044|NCT03236246|517261546|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
143468045|NCT03236246|517261547|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
143468046|NCT03236246|517261546|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
143468047|NCT03236246|517261547|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
143468048|NCT03236246|517261546|FG000|24-Week Dose Titration Period|Death|3|||
143468049|NCT03236246|517261547|FG001|24-Week Dose Titration Period|Death|1|||
143468050|NCT03236246|517261546|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
143468051|NCT03236246|517261547|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
143468052|NCT03236246|517261546|FG000|24-Week Dose Titration Period|Adverse Event|7|||
143468053|NCT03236246|517261547|FG001|24-Week Dose Titration Period|Adverse Event|8|||
143468054|NCT03236246|517261546|FG000|24-Week Dose Titration Period|Captured as Other|1|||
143468055|NCT03236246|517261547|FG001|24-Week Dose Titration Period|Captured as Other|2|||
143468056|NCT03236246|517261546|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
143468057|NCT03236246|517261547|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
143468058|NCT03236246|517261546|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
143468059|NCT03236246|517261547|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
143468060|NCT03236246|517261546|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
143468061|NCT03236246|517261547|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
143468062|NCT03236246|517261546|FG000|24-Week Dose Maintenance Period|Death|0|||
143468063|NCT03236246|517261547|FG001|24-Week Dose Maintenance Period|Death|1|||
143468064|NCT03236246|517261546|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
143468065|NCT03236246|517261547|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
143468066|NCT02598557|517261548|FG000|Overall Study|Withdrawal by Subject|1|||
143468067|NCT02598557|517261549|FG001|Overall Study|Withdrawal by Subject|0|||
143468068|NCT02598557|517261550|FG002|Overall Study|Withdrawal by Subject|1|||
143133824|NCT04863872|516035072|FG000|Overall Study|Lost to Follow-up|2|||
143468069|NCT02598557|517261548|FG000|Overall Study|Participant did not start treatment|2|||
143468070|NCT02598557|517261549|FG001|Overall Study|Participant did not start treatment|1|||
143468071|NCT02598557|517261550|FG002|Overall Study|Participant did not start treatment|1|||
143468072|NCT02598557|517261548|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
143468073|NCT02598557|517261549|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
143468074|NCT02598557|517261550|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
143468075|NCT02598557|517261548|FG000|Overall Study|Adverse Event|1|||
143468076|NCT02598557|517261549|FG001|Overall Study|Adverse Event|1|||
143468077|NCT02598557|517261550|FG002|Overall Study|Adverse Event|0|||
143468078|NCT02072434|517261551|FG000|Overall Study|Protocol Violation|10|||
143468079|NCT02072434|517261552|FG001|Overall Study|Protocol Violation|9|||
143468080|NCT02072434|517261551|FG000|Overall Study|Physician Decision|5|||
143468081|NCT02072434|517261552|FG001|Overall Study|Physician Decision|10|||
143468082|NCT02072434|517261551|FG000|Overall Study|Adverse event, serious fatal|1|||
143468083|NCT02072434|517261552|FG001|Overall Study|Adverse event, serious fatal|6|||
143468084|NCT02072434|517261551|FG000|Overall Study|Adverse Event|7|||
143468085|NCT02072434|517261552|FG001|Overall Study|Adverse Event|6|||
143468086|NCT02072434|517261551|FG000|Overall Study|Withdrawal by Subject|17|||
143468087|NCT02072434|517261552|FG001|Overall Study|Withdrawal by Subject|29|||
143468088|NCT02072434|517261551|FG000|Overall Study|Other|14|||
143468089|NCT02072434|517261552|FG001|Overall Study|Other|29|||
143468090|NCT02072434|517261551|FG000|Overall Study|Lost to Follow-up|0|||
143468091|NCT02072434|517261552|FG001|Overall Study|Lost to Follow-up|1|||
143468092|NCT00888433|517261553|FG000|Overall Study|Withdrawal by Subject|1|||
143468093|NCT00888433|517261554|FG001|Overall Study|Withdrawal by Subject|2|||
143468094|NCT00888433|517261553|FG000|Overall Study|Missed Visit|2|||
143468095|NCT00888433|517261554|FG001|Overall Study|Missed Visit|1|||
143468096|NCT02824263|517261557|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
143468097|NCT02824263|517261558|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
143468098|NCT02824263|517261557|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
143468099|NCT02824263|517261558|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
143468100|NCT00568321|517261559|FG000|Overall Study|Adverse Event|1|||
143468101|NCT00568321|517261560|FG001|Overall Study|Adverse Event|0|||
143468102|NCT00568321|517261561|FG002|Overall Study|Adverse Event|0|||
143468103|NCT00568321|517261559|FG000|Overall Study|Lack of Efficacy|8|||
143468104|NCT00568321|517261560|FG001|Overall Study|Lack of Efficacy|5|||
143468105|NCT00568321|517261561|FG002|Overall Study|Lack of Efficacy|6|||
143468106|NCT00568321|517261559|FG000|Overall Study|Lost to Follow-up|0|||
143468107|NCT00568321|517261560|FG001|Overall Study|Lost to Follow-up|0|||
143468108|NCT00568321|517261561|FG002|Overall Study|Lost to Follow-up|1|||
143468109|NCT00568321|517261559|FG000|Overall Study|Withdrawal by Subject|2|||
143468110|NCT00568321|517261560|FG001|Overall Study|Withdrawal by Subject|0|||
143468111|NCT00568321|517261561|FG002|Overall Study|Withdrawal by Subject|0|||
143468112|NCT00568321|517261559|FG000|Overall Study|Protocol Violation|0|||
143468113|NCT00568321|517261560|FG001|Overall Study|Protocol Violation|0|||
143468114|NCT00568321|517261561|FG002|Overall Study|Protocol Violation|1|||
143468115|NCT00568321|517261559|FG000|Overall Study|Randomized, not treated|2|||
143468116|NCT00568321|517261560|FG001|Overall Study|Randomized, not treated|0|||
143468117|NCT00568321|517261561|FG002|Overall Study|Randomized, not treated|1|||
143468118|NCT01676909|517261563|FG000|Overall Study|Withdrawal by Subject|3|||
143468119|NCT01676909|517261564|FG001|Overall Study|Withdrawal by Subject|5|||
143468120|NCT01676909|517261563|FG000|Overall Study|Lost to Follow-up|15|||
143468121|NCT01676909|517261564|FG001|Overall Study|Lost to Follow-up|9|||
143133825|NCT04863872|516035073|FG001|Overall Study|Lost to Follow-up|1|||
143133826|NCT03771963|516035074|FG000|Overall Study|Lost to Follow-up|22|||
143133827|NCT03771963|516035074|FG000|Overall Study|Withdrawal of Consent|10|||
143133828|NCT05607576|516035076|FG000|Overall Study|immediate sensor error|2|||
143133829|NCT05607576|516035076|FG000|Overall Study|Physician Decision|2|||
143133830|NCT00751140|516035077|FG000|Overall Study|benign angioma excluded from analysis|1|||
143133831|NCT00003471|516035080|FG000|Overall Study|Not evaluable|4|||
143133832|NCT00808067|516035081|FG000|Overall Study|Major/minor bleed|30|||
143133833|NCT00808067|516035082|FG001|Overall Study|Major/minor bleed|44|||
143133834|NCT00808067|516035081|FG000|Overall Study|Outcome event - other|33|||
143133835|NCT00808067|516035082|FG001|Overall Study|Outcome event - other|25|||
143013982|NCT00391118|515590126|FG001|Overall Study|Physician Decision|3|||
143133836|NCT00808067|516035081|FG000|Overall Study|Adverse Event|111|||
143133837|NCT00808067|516035082|FG001|Overall Study|Adverse Event|121|||
143133838|NCT00808067|516035081|FG000|Overall Study|Hospitalization (not including surgery)|18|||
143468122|NCT02076113|517261565|FG000|Overall Study|Lost to Follow-up|4|||
143468123|NCT02076113|517261566|FG001|Overall Study|Lost to Follow-up|1|||
143468124|NCT02076113|517261565|FG000|Overall Study|Withdrawal by Subject|2|||
143468125|NCT02076113|517261566|FG001|Overall Study|Withdrawal by Subject|3|||
143468126|NCT02076113|517261565|FG000|Overall Study|Death|1|||
143468127|NCT02076113|517261566|FG001|Overall Study|Death|3|||
143468128|NCT01176968|517261571|FG000|Overall Study|Adverse Event|10|||
143013983|NCT00391118|515590127|FG002|Overall Study|Physician Decision|0|||
143181182|NCT00707993|516210487|FG000|Overall Study|Lost to Follow-up|0|||
143468129|NCT01176968|517261572|FG001|Overall Study|Adverse Event|11|||
143468130|NCT01176968|517261571|FG000|Overall Study|Death|2|||
143468131|NCT01176968|517261572|FG001|Overall Study|Death|3|||
143468132|NCT01176968|517261571|FG000|Overall Study|Lack of Efficacy|0|||
143468133|NCT01176968|517261572|FG001|Overall Study|Lack of Efficacy|1|||
143468134|NCT01176968|517261571|FG000|Overall Study|Lost to Follow-up|16|||
143468135|NCT01176968|517261572|FG001|Overall Study|Lost to Follow-up|14|||
143468136|NCT01176968|517261571|FG000|Overall Study|Withdrawal by Subject|48|||
143468137|NCT01176968|517261572|FG001|Overall Study|Withdrawal by Subject|48|||
143468138|NCT01176968|517261571|FG000|Overall Study|Protocol Violation|2|||
143468139|NCT01176968|517261572|FG001|Overall Study|Protocol Violation|1|||
143468140|NCT01176968|517261571|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
143468141|NCT01176968|517261572|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
143468142|NCT01176968|517261571|FG000|Overall Study|Study terminated by sponsor|0|||
143468143|NCT01176968|517261572|FG001|Overall Study|Study terminated by sponsor|1|||
143468144|NCT01176968|517261571|FG000|Overall Study|Reason not defined|5|||
143468145|NCT01176968|517261572|FG001|Overall Study|Reason not defined|3|||
143468146|NCT00718640|517261573|FG000|Overall Study|Adverse Event|4|||
143468147|NCT00718640|517261573|FG000|Overall Study|Death|1|||
143468148|NCT00718640|517261573|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
143468149|NCT04485104|517261574|FG000|Overall Study|Physician Decision|2|||
143468150|NCT04485104|517261575|FG001|Overall Study|Physician Decision|0|||
143468151|NCT04485104|517261574|FG000|Overall Study|Decision by sponsor|0|||
143468152|NCT04485104|517261575|FG001|Overall Study|Decision by sponsor|1|||
143468153|NCT01386658|517261576|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
143468154|NCT01386658|517261577|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
143468155|NCT01386658|517261576|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
143468156|NCT01386658|517261577|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
143468157|NCT01067326|517261582|FG000|Overall Study|Adverse Event|0|||
143468158|NCT01067326|517261583|FG001|Overall Study|Adverse Event|2|||
143468159|NCT01067326|517261582|FG000|Overall Study|Withdrawal by Subject|1|||
143468160|NCT01067326|517261583|FG001|Overall Study|Withdrawal by Subject|0|||
143468161|NCT01067326|517261582|FG000|Overall Study|Early Study Termination|1|||
143468162|NCT01067326|517261583|FG001|Overall Study|Early Study Termination|1|||
143468163|NCT00769860|517261584|FG000|Overall Study|Withdrawal by Subject|2|||
143468164|NCT00769860|517261585|FG001|Overall Study|Withdrawal by Subject|0|||
143468165|NCT03170154|517261590|FG000|Overall Study|Lost to Follow-up|4|||
143468166|NCT03170154|517261590|FG000|Overall Study|Death|2|||
143468167|NCT03170154|517261590|FG000|Overall Study|Withdrawal by Subject|2|||
143468168|NCT02279862|517261591|FG000|Overall Study|Study drug toxicity|3|||
143468169|NCT02279862|517261592|FG001|Overall Study|Study drug toxicity|6|||
143468170|NCT02279862|517261591|FG000|Overall Study|No longer meets criteria|0|||
143468171|NCT02279862|517261592|FG001|Overall Study|No longer meets criteria|1|||
143468172|NCT02279862|517261591|FG000|Overall Study|Administrative reason by sponsor|0|||
143468173|NCT02279862|517261592|FG001|Overall Study|Administrative reason by sponsor|1|||
143468174|NCT02279862|517261591|FG000|Overall Study|Disease progression|5|||
143468175|NCT02279862|517261592|FG001|Overall Study|Disease progression|2|||
143468176|NCT02279862|517261591|FG000|Overall Study|Study closed by sponsor|16|||
143468177|NCT02279862|517261592|FG001|Overall Study|Study closed by sponsor|13|||
143468178|NCT02279862|517261591|FG000|Overall Study|Other|1|||
143468179|NCT02279862|517261592|FG001|Overall Study|Other|2|||
143468180|NCT02279862|517261591|FG000|Overall Study|Withdrawal by Subject|1|||
143468181|NCT02279862|517261592|FG001|Overall Study|Withdrawal by Subject|0|||
143359671|NCT04955626|516859879|FG020|Blinded Period|Physician Decision|0|||
143359672|NCT04955626|516859880|FG021|Blinded Period|Physician Decision|0|||
143359673|NCT04955626|516859881|FG022|Blinded Period|Physician Decision|0|||
143359674|NCT04955626|516859882|FG023|Blinded Period|Physician Decision|0|||
143359675|NCT04955626|516859883|FG024|Blinded Period|Physician Decision|0|||
143359676|NCT04955626|516859884|FG025|Blinded Period|Physician Decision|0|||
143359677|NCT04955626|516859885|FG026|Blinded Period|Physician Decision|0|||
143359678|NCT04955626|516859886|FG027|Blinded Period|Physician Decision|0|||
143468182|NCT03431857|517261595|FG000|Overall Study|Death|6|||
143468183|NCT03431857|517261595|FG000|Overall Study|Lost to Follow-up|41|||
143468184|NCT03431857|517261595|FG000|Overall Study|Adverse Event|6|||
143468185|NCT03431857|517261595|FG000|Overall Study|Withdrawal by Subject|1|||
143133839|NCT00808067|516035082|FG001|Overall Study|Hospitalization (not including surgery)|17|||
143181183|NCT00707993|516210488|FG001|Overall Study|Lost to Follow-up|4|||
143359679|NCT04955626|516859887|FG028|Blinded Period|Physician Decision|0|||
143468186|NCT01323621|517261596|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
143468187|NCT01323621|517261597|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
143468188|NCT01323621|517261598|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
143468189|NCT01323621|517261596|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
143468190|NCT01323621|517261597|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
143468191|NCT01323621|517261598|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
143359680|NCT04955626|516859888|FG029|Blinded Period|Physician Decision|0|||
143359681|NCT04955626|516859889|FG030|Blinded Period|Physician Decision|0|||
143468192|NCT01323621|517261596|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
143468193|NCT01323621|517261597|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
143468194|NCT01323621|517261598|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
143468195|NCT01323621|517261596|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
143468196|NCT01323621|517261597|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
143468197|NCT01323621|517261598|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
143468198|NCT01323621|517261596|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
143468199|NCT01323621|517261597|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
143468200|NCT01323621|517261598|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
143468201|NCT01323621|517261596|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
143468202|NCT01323621|517261597|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
143468203|NCT01323621|517261598|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
143468204|NCT01323621|517261596|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
143468205|NCT01323621|517261597|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
143468206|NCT01323621|517261598|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
143468207|NCT01323621|517261596|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
143468208|NCT01323621|517261597|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
143468209|NCT01323621|517261598|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
143468210|NCT01323621|517261596|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
143468211|NCT01323621|517261597|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
143468212|NCT01323621|517261598|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
143468213|NCT01323621|517261596|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
143468214|NCT01323621|517261597|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
143468215|NCT01323621|517261598|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
143133840|NCT00808067|516035081|FG000|Overall Study|Hospitalization due to surgery|37|||
143133841|NCT00808067|516035082|FG001|Overall Study|Hospitalization due to surgery|40|||
143133842|NCT00808067|516035081|FG000|Overall Study|Reduced creatinine clearance|53|||
143133843|NCT00808067|516035082|FG001|Overall Study|Reduced creatinine clearance|55|||
143133844|NCT00808067|516035081|FG000|Overall Study|Elevated LFT results|7|||
143133845|NCT00808067|516035082|FG001|Overall Study|Elevated LFT results|3|||
143133846|NCT00808067|516035081|FG000|Overall Study|Patient refused to take study medication|65|||
143133847|NCT00808067|516035082|FG001|Overall Study|Patient refused to take study medication|76|||
143133848|NCT00808067|516035081|FG000|Overall Study|Missing|1|||
143133849|NCT00808067|516035082|FG001|Overall Study|Missing|0|||
143133850|NCT00808067|516035081|FG000|Overall Study|Death|1|||
143133851|NCT00808067|516035082|FG001|Overall Study|Death|1|||
143468216|NCT01323621|517261596|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
143468217|NCT01323621|517261597|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
143468218|NCT01323621|517261598|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
143468219|NCT01323621|517261596|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
143468220|NCT01323621|517261597|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
143468221|NCT01323621|517261598|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
143133852|NCT00808067|516035081|FG000|Overall Study|Procedure|6|||
143133853|NCT00808067|516035082|FG001|Overall Study|Procedure|7|||
143133854|NCT00808067|516035081|FG000|Overall Study|Withdrawal by Subject|21|||
143359682|NCT04955626|516859890|FG031|Blinded Period|Physician Decision|0|||
143359683|NCT04955626|516859891|FG032|Blinded Period|Physician Decision|0|||
143359684|NCT04955626|516859892|FG033|Blinded Period|Physician Decision|0|||
143359685|NCT04955626|516859893|FG034|Blinded Period|Physician Decision|0|||
143359686|NCT04955626|516859894|FG035|Blinded Period|Physician Decision|0|||
143359687|NCT04955626|516859859|FG000|Blinded Period|Withdrawal by Subject|26|||
143359688|NCT04955626|516859860|FG001|Blinded Period|Withdrawal by Subject|62|||
143359689|NCT04955626|516859861|FG002|Blinded Period|Withdrawal by Subject|14|||
143359690|NCT04955626|516859862|FG003|Blinded Period|Withdrawal by Subject|16|||
143359691|NCT04955626|516859863|FG004|Blinded Period|Withdrawal by Subject|1|||
143359692|NCT04955626|516859864|FG005|Blinded Period|Withdrawal by Subject|2|||
143359693|NCT04955626|516859865|FG006|Blinded Period|Withdrawal by Subject|9|||
143359694|NCT04955626|516859866|FG007|Blinded Period|Withdrawal by Subject|5|||
143359695|NCT04955626|516859867|FG008|Blinded Period|Withdrawal by Subject|3|||
143359696|NCT04955626|516859868|FG009|Blinded Period|Withdrawal by Subject|15|||
143359697|NCT04955626|516859869|FG010|Blinded Period|Withdrawal by Subject|11|||
143359698|NCT04955626|516859870|FG011|Blinded Period|Withdrawal by Subject|7|||
143359699|NCT04955626|516859871|FG012|Blinded Period|Withdrawal by Subject|2|||
143133855|NCT00808067|516035082|FG001|Overall Study|Withdrawal by Subject|25|||
143133856|NCT00808067|516035081|FG000|Overall Study|Site closed|4|||
143359700|NCT04955626|516859872|FG013|Blinded Period|Withdrawal by Subject|0|||
143359701|NCT04955626|516859873|FG014|Blinded Period|Withdrawal by Subject|1|||
143133857|NCT00808067|516035082|FG001|Overall Study|Site closed|3|||
143359702|NCT04955626|516859874|FG015|Blinded Period|Withdrawal by Subject|11|||
143133858|NCT00808067|516035081|FG000|Overall Study|Physician Decision|47|||
143359703|NCT04955626|516859875|FG016|Blinded Period|Withdrawal by Subject|2|||
143468222|NCT00651157|517261599|FG000|Overall Study|Death|1|||
143468223|NCT00651157|517261599|FG000|Overall Study|Protocol Violation|1|||
143468224|NCT01117857|517261603|FG000|Overall Study|Lost to Follow-up|4|||
143468225|NCT01117857|517261603|FG000|Overall Study|Withdrawal by Subject|4|||
143468226|NCT01117857|517261603|FG000|Overall Study|Physician Decision|1|||
143468227|NCT01163721|517261605|FG000|Overall Study|Adverse Event|5|||
143468228|NCT01163721|517261606|FG001|Overall Study|Adverse Event|6|||
143133859|NCT00808067|516035082|FG001|Overall Study|Physician Decision|38|||
143468229|NCT01163721|517261605|FG000|Overall Study|Withdrawal by Subject|3|||
143468230|NCT01163721|517261606|FG001|Overall Study|Withdrawal by Subject|4|||
143468231|NCT01163721|517261605|FG000|Overall Study|Lost to Follow-up|0|||
143468232|NCT01163721|517261606|FG001|Overall Study|Lost to Follow-up|1|||
143468233|NCT01163721|517261605|FG000|Overall Study|Physician Decision|0|||
143468234|NCT01163721|517261606|FG001|Overall Study|Physician Decision|1|||
143468235|NCT00688181|517261607|FG000|Overall Study|Lost to Follow-up|17|||
143468236|NCT00688181|517261607|FG000|Overall Study|Unknown Reason|4|||
143468237|NCT00688181|517261607|FG000|Overall Study|Non-clinical Reason|2|||
143468238|NCT01050205|517261608|FG000|Overall Study|Lost to Follow-up|7|||
143468239|NCT01050205|517261609|FG001|Overall Study|Lost to Follow-up|1|||
143468240|NCT01050205|517261608|FG000|Overall Study|Withdrawal by Subject|1|||
143468241|NCT01050205|517261609|FG001|Overall Study|Withdrawal by Subject|1|||
143468242|NCT01050205|517261608|FG000|Overall Study|Relocated from area|1|||
143468243|NCT01050205|517261609|FG001|Overall Study|Relocated from area|2|||
143468244|NCT01050205|517261608|FG000|Overall Study|Discontinued Intervention|2|||
143468245|NCT01050205|517261609|FG001|Overall Study|Discontinued Intervention|0|||
143468246|NCT01295281|517261612|FG000|First Intervention (7 Days)|Death|0|||
143468247|NCT01295281|517261613|FG001|First Intervention (7 Days)|Death|1|||
143468248|NCT00292461|517261614|FG000|Overall Study|Adverse Event|4|||
143468249|NCT00292461|517261615|FG001|Overall Study|Adverse Event|2|||
143468250|NCT00292461|517261614|FG000|Overall Study|Lack of Efficacy|1|||
143468251|NCT00292461|517261615|FG001|Overall Study|Lack of Efficacy|0|||
143468252|NCT00292461|517261614|FG000|Overall Study|Withdrawal by Subject|0|||
143468253|NCT00292461|517261615|FG001|Overall Study|Withdrawal by Subject|1|||
143468254|NCT00292461|517261614|FG000|Overall Study|Protocol Violation|4|||
143468255|NCT00292461|517261615|FG001|Overall Study|Protocol Violation|3|||
143468256|NCT00292461|517261614|FG000|Overall Study|Lost to Follow-up|1|||
143468257|NCT00292461|517261615|FG001|Overall Study|Lost to Follow-up|0|||
143468258|NCT01119001|517261616|FG000|Overall Study|Withdrawal by Subject|2|||
143468259|NCT00954421|517261617|FG000|Screening|screen failures|3|||
143468260|NCT00954421|517261617|FG000|6 Months of DBS|Withdrawal by Subject|1|||
143468261|NCT00954421|517261617|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
143468262|NCT01891721|517261618|FG000|Overall Study|Lost to Follow-up|10|||
143468263|NCT01891721|517261619|FG001|Overall Study|Lost to Follow-up|5|||
143468264|NCT01891721|517261620|FG002|Overall Study|Lost to Follow-up|1|||
143468265|NCT00633061|517261621|FG000|Overall Study|Study closed|86|||
143468266|NCT00633061|517261622|FG001|Overall Study|Study closed|0|||
143468267|NCT04343248|517261627|FG000|Overall Study|Withdrawal by Subject|5|||
143468268|NCT04343248|517261628|FG001|Overall Study|Withdrawal by Subject|6|||
143468269|NCT04343248|517261627|FG000|Overall Study|Death|1|||
143468270|NCT04343248|517261628|FG001|Overall Study|Death|2|||
143133860|NCT00808067|516035081|FG000|Overall Study|Protocol Violation|3|||
143133861|NCT00808067|516035082|FG001|Overall Study|Protocol Violation|11|||
143133862|NCT00808067|516035081|FG000|Overall Study|Patient elected|7|||
143133863|NCT00808067|516035082|FG001|Overall Study|Patient elected|9|||
143133864|NCT00808067|516035081|FG000|Overall Study|Site closed for cause|19|||
143133865|NCT00808067|516035082|FG001|Overall Study|Site closed for cause|19|||
143133866|NCT00808067|516035081|FG000|Overall Study|Other reason not defined above|5|||
143133867|NCT00808067|516035082|FG001|Overall Study|Other reason not defined above|5|||
143133868|NCT00808067|516035081|FG000|Overall Study|Excluded from analysis|13|||
143133869|NCT00808067|516035082|FG001|Overall Study|Excluded from analysis|19|||
143133870|NCT02532283|516035083|FG000|Overall Study|Adverse Event|0|||
143133871|NCT02532283|516035084|FG001|Overall Study|Adverse Event|1|||
143133872|NCT02532283|516035083|FG000|Overall Study|Death|1|||
143468271|NCT04343248|517261627|FG000|Overall Study|Lost to Follow-up|9|||
143468272|NCT04343248|517261628|FG001|Overall Study|Lost to Follow-up|6|||
143468273|NCT04343248|517261627|FG000|Overall Study|Physician Decision|0|||
143133873|NCT02532283|516035084|FG001|Overall Study|Death|0|||
143468274|NCT04343248|517261628|FG001|Overall Study|Physician Decision|1|||
143468275|NCT04343248|517261627|FG000|Overall Study|Adverse Event|1|||
143468276|NCT04343248|517261628|FG001|Overall Study|Adverse Event|0|||
143468277|NCT02708095|517261629|FG000|Overall Study|Adverse Event|4|||
143468278|NCT02708095|517261630|FG001|Overall Study|Adverse Event|10|||
143468279|NCT02708095|517261631|FG002|Overall Study|Adverse Event|11|||
143468280|NCT02708095|517261629|FG000|Overall Study|Lack of Efficacy|9|||
143468281|NCT02708095|517261630|FG001|Overall Study|Lack of Efficacy|3|||
143468282|NCT02708095|517261631|FG002|Overall Study|Lack of Efficacy|0|||
143468283|NCT02708095|517261629|FG000|Overall Study|Lost to Follow-up|2|||
143133874|NCT02532283|516035083|FG000|Overall Study|Lost to Follow-up|0|||
143468284|NCT02708095|517261630|FG001|Overall Study|Lost to Follow-up|0|||
143468285|NCT02708095|517261631|FG002|Overall Study|Lost to Follow-up|0|||
143468286|NCT02708095|517261629|FG000|Overall Study|Physician Decision|2|||
143468287|NCT02708095|517261630|FG001|Overall Study|Physician Decision|3|||
143468288|NCT02708095|517261631|FG002|Overall Study|Physician Decision|2|||
143468289|NCT02708095|517261629|FG000|Overall Study|Protocol Violation|0|||
143468290|NCT02708095|517261630|FG001|Overall Study|Protocol Violation|0|||
143468291|NCT02708095|517261631|FG002|Overall Study|Protocol Violation|1|||
143468292|NCT02708095|517261629|FG000|Overall Study|Withdrawal by Subject|5|||
143468293|NCT02708095|517261630|FG001|Overall Study|Withdrawal by Subject|3|||
143468294|NCT02708095|517261631|FG002|Overall Study|Withdrawal by Subject|4|||
143468295|NCT05125679|517261632|FG000|Overall Study|Study Terminated by Sponsor|2|||
143468296|NCT05125679|517261633|FG001|Overall Study|Study Terminated by Sponsor|5|||
143468297|NCT04908189|517261650|FG000|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|1|||
143468298|NCT04908189|517261651|FG001|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|3|||
143468299|NCT04908189|517261652|FG002|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|0|||
143468300|NCT04908189|517261650|FG000|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|6|||
143468301|NCT04908189|517261651|FG001|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|4|||
143468302|NCT04908189|517261652|FG002|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|10|||
143468303|NCT04908189|517261650|FG000|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
143468304|NCT04908189|517261651|FG001|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|4|||
143468305|NCT04908189|517261652|FG002|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
143468306|NCT04908189|517261650|FG000|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|6|||
143468307|NCT04908189|517261651|FG001|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|8|||
143468308|NCT04908189|517261652|FG002|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|3|||
143468309|NCT04908189|517261650|FG000|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|3|||
143468310|NCT04908189|517261651|FG001|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
143468311|NCT04908189|517261652|FG002|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
143468312|NCT04908189|517261650|FG000|Placebo-Controlled (Week 0 - Week 16)|Other reasons|2|||
143468313|NCT04908189|517261651|FG001|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
143468314|NCT04908189|517261652|FG002|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
143468315|NCT04908189|517261650|FG000|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
143468316|NCT04908189|517261651|FG001|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
143468317|NCT04908189|517261652|FG002|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|1|||
143468318|NCT04908189|517261650|FG000|Active Treatment (Week 16 - Week 52)|Adverse Event|9|||
143468319|NCT04908189|517261651|FG001|Active Treatment (Week 16 - Week 52)|Adverse Event|7|||
143468320|NCT04908189|517261652|FG002|Active Treatment (Week 16 - Week 52)|Adverse Event|3|||
143468321|NCT04908189|517261650|FG000|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
143468322|NCT04908189|517261651|FG001|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
143468323|NCT04908189|517261652|FG002|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|4|||
143468324|NCT04908189|517261650|FG000|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
143468325|NCT04908189|517261651|FG001|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
143468326|NCT04908189|517261652|FG002|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|2|||
143468327|NCT04908189|517261650|FG000|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|2|||
143468328|NCT04908189|517261651|FG001|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|1|||
143468329|NCT04908189|517261652|FG002|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|0|||
143468330|NCT04908189|517261650|FG000|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
143468331|NCT04908189|517261651|FG001|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
143468332|NCT04908189|517261652|FG002|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
143468333|NCT00607022|517261654|FG000|Overall Study|Withdrawal by Subject|1|||
143468334|NCT00607022|517261655|FG001|Overall Study|Withdrawal by Subject|0|||
143468335|NCT00607022|517261656|FG002|Overall Study|Withdrawal by Subject|0|||
143468336|NCT01210118|517261658|FG000|Overall Study|Lost to Follow-up|1|||
143468337|NCT01210118|517261659|FG001|Overall Study|Lost to Follow-up|1|||
143468338|NCT01210118|517261658|FG000|Overall Study|Protocol Violation|1|||
143468339|NCT01210118|517261659|FG001|Overall Study|Protocol Violation|1|||
143468340|NCT01210118|517261658|FG000|Overall Study|Spontaneous abortion|1|||
143468341|NCT01210118|517261659|FG001|Overall Study|Spontaneous abortion|3|||
143468342|NCT00777946|517261660|FG000|Overall Study|Adverse Event|11|||
143468343|NCT00777946|517261661|FG001|Overall Study|Adverse Event|1|||
143468344|NCT00777946|517261662|FG002|Overall Study|Adverse Event|3|||
143468345|NCT00777946|517261660|FG000|Overall Study|Lack of Efficacy|0|||
143468346|NCT00777946|517261661|FG001|Overall Study|Lack of Efficacy|0|||
143468347|NCT00777946|517261662|FG002|Overall Study|Lack of Efficacy|9|||
143468348|NCT00777946|517261660|FG000|Overall Study|Condition no longer required study drug|1|||
143468349|NCT00777946|517261661|FG001|Overall Study|Condition no longer required study drug|0|||
143468350|NCT00777946|517261662|FG002|Overall Study|Condition no longer required study drug|0|||
143468351|NCT00777946|517261660|FG000|Overall Study|Patient withdrew consent|3|||
143468352|NCT00777946|517261661|FG001|Overall Study|Patient withdrew consent|2|||
143468353|NCT00777946|517261662|FG002|Overall Study|Patient withdrew consent|3|||
143468354|NCT00777946|517261660|FG000|Overall Study|Lost to Follow-up|3|||
143468355|NCT00777946|517261661|FG001|Overall Study|Lost to Follow-up|1|||
143468356|NCT00777946|517261662|FG002|Overall Study|Lost to Follow-up|0|||
143468357|NCT00777946|517261660|FG000|Overall Study|Protocol deviation|2|||
143468358|NCT00777946|517261661|FG001|Overall Study|Protocol deviation|1|||
143468359|NCT00777946|517261662|FG002|Overall Study|Protocol deviation|1|||
143468360|NCT00777946|517261660|FG000|Overall Study|Randomized in error|1|||
143468361|NCT00777946|517261661|FG001|Overall Study|Randomized in error|1|||
143468362|NCT00777946|517261662|FG002|Overall Study|Randomized in error|0|||
143468363|NCT05066724|517261666|FG000|Overall Study|Adverse Event|1|||
143468364|NCT05066724|517261666|FG000|Overall Study|Non-Compliance With Study Drug|5|||
143468365|NCT05066724|517261666|FG000|Overall Study|Withdrawal by Subject|6|||
143468366|NCT05066724|517261666|FG000|Overall Study|Physician Decision|2|||
143468367|NCT00475033|517261681|FG000|Infant Series|Failed to return|3|||
143468368|NCT00475033|517261682|FG001|Infant Series|Failed to return|4|||
143468369|NCT00475033|517261681|FG000|Infant Series|Parent or legal guardian request|1|||
143468370|NCT00475033|517261682|FG001|Infant Series|Parent or legal guardian request|5|||
143468371|NCT00475033|517261681|FG000|Infant Series|Protocol Violation|1|||
143468372|NCT00475033|517261682|FG001|Infant Series|Protocol Violation|2|||
143468373|NCT00475033|517261681|FG000|Infant Series|Lost to Follow-up|2|||
143468374|NCT00475033|517261682|FG001|Infant Series|Lost to Follow-up|0|||
143468375|NCT00475033|517261681|FG000|Infant Series|Adverse Event|0|||
143468376|NCT00475033|517261682|FG001|Infant Series|Adverse Event|2|||
143468377|NCT00475033|517261681|FG000|After the Infant Series|Adverse Event|0|||
143468378|NCT00475033|517261682|FG001|After the Infant Series|Adverse Event|4|||
143468379|NCT00475033|517261681|FG000|After the Infant Series|Parent or legal guardian request|2|||
143468380|NCT00475033|517261682|FG001|After the Infant Series|Parent or legal guardian request|2|||
143468381|NCT00475033|517261681|FG000|After the Infant Series|Failed to return|2|||
143468382|NCT00475033|517261682|FG001|After the Infant Series|Failed to return|1|||
143468383|NCT00475033|517261681|FG000|After the Infant Series|Protocol Violation|1|||
143468384|NCT00475033|517261682|FG001|After the Infant Series|Protocol Violation|0|||
143468385|NCT00475033|517261681|FG000|After the Infant Series|Lost to Follow-up|1|||
143468386|NCT00475033|517261682|FG001|After the Infant Series|Lost to Follow-up|0|||
143468387|NCT00475033|517261681|FG000|After the Infant Series|Other|0|||
143468388|NCT00475033|517261682|FG001|After the Infant Series|Other|1|||
143468389|NCT00475033|517261681|FG000|Toddler Dose|Parent or legal guardian request|2|||
143468390|NCT00475033|517261682|FG001|Toddler Dose|Parent or legal guardian request|0|||
143468391|NCT00475033|517261681|FG000|Toddler Dose|Failed to return|1|||
143468392|NCT00475033|517261682|FG001|Toddler Dose|Failed to return|0|||
143468393|NCT00475033|517261681|FG000|Toddler Dose|Lost to Follow-up|1|||
143468394|NCT00475033|517261682|FG001|Toddler Dose|Lost to Follow-up|0|||
143468395|NCT01696942|517261684|FG000|Overall Study|Withdrawal by Subject|1|||
143468396|NCT01696942|517261685|FG001|Overall Study|Withdrawal by Subject|0|||
143468397|NCT01696942|517261684|FG000|Overall Study|Protocol Violation|1|||
143468398|NCT01696942|517261685|FG001|Overall Study|Protocol Violation|2|||
143468399|NCT01696942|517261684|FG000|Overall Study|screen failure|0|||
143468400|NCT01696942|517261685|FG001|Overall Study|screen failure|1|||
143468401|NCT03231943|517261687|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
143468402|NCT03231943|517261688|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
143468403|NCT03231943|517261689|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
143468404|NCT03231943|517261690|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
143468405|NCT03231943|517261691|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
143468406|NCT03231943|517261692|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
143468407|NCT03231943|517261693|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
143468408|NCT03231943|517261694|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
143468409|NCT03231943|517261695|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
143468410|NCT03231943|517261696|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
143468411|NCT03231943|517261697|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
143468412|NCT03231943|517261698|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
143468413|NCT03231943|517261699|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
143468414|NCT03231943|517261687|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
143468415|NCT03231943|517261688|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
143468416|NCT03231943|517261689|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
143468417|NCT03231943|517261690|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
143468418|NCT03231943|517261691|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
143468419|NCT03231943|517261692|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
143468420|NCT03231943|517261693|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
143468421|NCT03231943|517261694|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
143468422|NCT03231943|517261695|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
143468423|NCT03231943|517261696|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
143468424|NCT03231943|517261697|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
143468425|NCT03231943|517261698|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
143468426|NCT03231943|517261699|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
143468427|NCT03231943|517261687|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
143468428|NCT03231943|517261688|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
143468429|NCT03231943|517261689|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
143468430|NCT03231943|517261690|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
143468431|NCT03231943|517261691|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
143468432|NCT03231943|517261692|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
143468433|NCT03231943|517261693|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
143468434|NCT03231943|517261694|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
143468435|NCT03231943|517261695|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
143468436|NCT03231943|517261696|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
143468437|NCT03231943|517261697|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
143468438|NCT03231943|517261698|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
143468439|NCT03231943|517261699|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
143468440|NCT03231943|517261687|FG000|Part 2|Adverse Event|0|||
143468441|NCT03231943|517261688|FG001|Part 2|Adverse Event|0|||
143468442|NCT03231943|517261689|FG002|Part 2|Adverse Event|0|||
143468443|NCT03231943|517261690|FG003|Part 2|Adverse Event|0|||
143468444|NCT03231943|517261691|FG004|Part 2|Adverse Event|0|||
143468445|NCT03231943|517261692|FG005|Part 2|Adverse Event|0|||
143468446|NCT03231943|517261693|FG006|Part 2|Adverse Event|0|||
143468447|NCT03231943|517261694|FG007|Part 2|Adverse Event|0|||
143468448|NCT03231943|517261695|FG008|Part 2|Adverse Event|0|||
143468449|NCT03231943|517261696|FG009|Part 2|Adverse Event|0|||
143468450|NCT03231943|517261697|FG010|Part 2|Adverse Event|1|||
143468451|NCT03231943|517261698|FG011|Part 2|Adverse Event|0|||
143468452|NCT03231943|517261699|FG012|Part 2|Adverse Event|0|||
143468453|NCT03231943|517261687|FG000|Part 2|Withdrawal by Subject|0|||
143468454|NCT03231943|517261688|FG001|Part 2|Withdrawal by Subject|0|||
143468455|NCT03231943|517261689|FG002|Part 2|Withdrawal by Subject|0|||
143468456|NCT03231943|517261690|FG003|Part 2|Withdrawal by Subject|0|||
143468457|NCT03231943|517261691|FG004|Part 2|Withdrawal by Subject|0|||
143468458|NCT03231943|517261692|FG005|Part 2|Withdrawal by Subject|0|||
143468459|NCT03231943|517261693|FG006|Part 2|Withdrawal by Subject|0|||
143468460|NCT03231943|517261694|FG007|Part 2|Withdrawal by Subject|0|||
143468461|NCT03231943|517261695|FG008|Part 2|Withdrawal by Subject|0|||
143468462|NCT03231943|517261696|FG009|Part 2|Withdrawal by Subject|0|||
143468463|NCT03231943|517261697|FG010|Part 2|Withdrawal by Subject|0|||
143468464|NCT03231943|517261698|FG011|Part 2|Withdrawal by Subject|1|||
143468465|NCT03231943|517261699|FG012|Part 2|Withdrawal by Subject|0|||
143468466|NCT02673619|517261700|FG000|Overall Study|Lost to Follow-up|1|||
143468467|NCT02673619|517261701|FG001|Overall Study|Lost to Follow-up|0|||
143468468|NCT02673619|517261702|FG002|Overall Study|Lost to Follow-up|0|||
143468469|NCT02673619|517261703|FG003|Overall Study|Lost to Follow-up|0|||
143468470|NCT02673619|517261700|FG000|Overall Study|Withdrawal by Subject|1|||
143468471|NCT02673619|517261701|FG001|Overall Study|Withdrawal by Subject|1|||
143468472|NCT02673619|517261702|FG002|Overall Study|Withdrawal by Subject|1|||
143468473|NCT02673619|517261703|FG003|Overall Study|Withdrawal by Subject|0|||
143468474|NCT02673619|517261700|FG000|Overall Study|Adverse Event|0|||
143468475|NCT02673619|517261701|FG001|Overall Study|Adverse Event|0|||
143468476|NCT02673619|517261702|FG002|Overall Study|Adverse Event|1|||
143468477|NCT02673619|517261703|FG003|Overall Study|Adverse Event|0|||
143468478|NCT02673619|517261700|FG000|Overall Study|Lack of Efficacy|0|||
143468479|NCT02673619|517261701|FG001|Overall Study|Lack of Efficacy|0|||
143468480|NCT02673619|517261702|FG002|Overall Study|Lack of Efficacy|1|||
143468481|NCT02673619|517261703|FG003|Overall Study|Lack of Efficacy|0|||
143468482|NCT03769181|517263034|FG000|Overall Study|Adverse Event|1|||
143468483|NCT03769181|517263035|FG001|Overall Study|Adverse Event|0|||
143468484|NCT03769181|517263036|FG002|Overall Study|Adverse Event|2|||
143468485|NCT03769181|517263037|FG003|Overall Study|Adverse Event|4|||
143468486|NCT03769181|517263034|FG000|Overall Study|Withdrawal by Subject|1|||
143468487|NCT03769181|517263035|FG001|Overall Study|Withdrawal by Subject|0|||
143468488|NCT03769181|517263036|FG002|Overall Study|Withdrawal by Subject|2|||
143468489|NCT03769181|517263037|FG003|Overall Study|Withdrawal by Subject|1|||
143468490|NCT03769181|517263034|FG000|Overall Study|Progressive disease|9|||
143133875|NCT02532283|516035084|FG001|Overall Study|Lost to Follow-up|1|||
143468491|NCT03769181|517263035|FG001|Overall Study|Progressive disease|7|||
143468492|NCT03769181|517263036|FG002|Overall Study|Progressive disease|13|||
143468493|NCT03769181|517263037|FG003|Overall Study|Progressive disease|6|||
143468494|NCT03769181|517263034|FG000|Overall Study|Other - Unspecified|2|||
143468495|NCT03769181|517263035|FG001|Overall Study|Other - Unspecified|1|||
143468496|NCT03769181|517263036|FG002|Overall Study|Other - Unspecified|0|||
143468497|NCT03769181|517263037|FG003|Overall Study|Other - Unspecified|0|||
143468498|NCT03971422|517263038|FG000|Overall Study|Lost to Follow-up|0|||
143468499|NCT03971422|517263039|FG001|Overall Study|Lost to Follow-up|1|||
143133876|NCT02532283|516035083|FG000|Overall Study|Withdrawal by Subject|8|||
143468500|NCT03971422|517263040|FG002|Overall Study|Lost to Follow-up|0|||
143468501|NCT03971422|517263038|FG000|Overall Study|Lack of Efficacy|5|||
143468502|NCT03971422|517263039|FG001|Overall Study|Lack of Efficacy|1|||
143468503|NCT03971422|517263040|FG002|Overall Study|Lack of Efficacy|1|||
143468504|NCT03971422|517263038|FG000|Overall Study|Adverse event, not fatal|2|||
143468505|NCT03971422|517263039|FG001|Overall Study|Adverse event, not fatal|2|||
143468506|NCT03971422|517263040|FG002|Overall Study|Adverse event, not fatal|5|||
143468507|NCT03971422|517263038|FG000|Overall Study|Worsening of MG Symptoms|1|||
143468508|NCT03971422|517263039|FG001|Overall Study|Worsening of MG Symptoms|4|||
143468509|NCT03971422|517263040|FG002|Overall Study|Worsening of MG Symptoms|2|||
143468510|NCT03971422|517263038|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
143468511|NCT03971422|517263039|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
143468512|NCT03971422|517263040|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
143468513|NCT03971422|517263038|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
143468514|NCT03971422|517263039|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
143468515|NCT03971422|517263040|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
143468516|NCT03971422|517263038|FG000|Overall Study|Due to COVID-19 pandemic|0|||
143468517|NCT03971422|517263039|FG001|Overall Study|Due to COVID-19 pandemic|1|||
143468518|NCT03971422|517263040|FG002|Overall Study|Due to COVID-19 pandemic|1|||
143468519|NCT01955122|517263044|FG000|Overall Study|Physician Decision|5|||
143468520|NCT01955122|517263045|FG001|Overall Study|Physician Decision|5|||
143468521|NCT01672788|517263046|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
143468522|NCT01672788|517263047|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
143468523|NCT01672788|517263048|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
143468524|NCT01672788|517263049|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
143468525|NCT03338192|517263050|FG000|Year One to Year Two|High Blood Pressure|7|||
143468526|NCT03338192|517263051|FG001|Year One to Year Two|High Blood Pressure|1|||
143468527|NCT03338192|517263050|FG000|Year One to Year Two|HIV +|1|||
143468528|NCT03338192|517263051|FG001|Year One to Year Two|HIV +|0|||
143468529|NCT03338192|517263050|FG000|Year Two to Year Four|High Blood Pressure|1|||
143468530|NCT03338192|517263051|FG001|Year Two to Year Four|High Blood Pressure|0|||
143468531|NCT03338192|517263050|FG000|Year Two to Year Four|HIV +|2|||
143468532|NCT03338192|517263051|FG001|Year Two to Year Four|HIV +|0|||
143468533|NCT03338192|517263050|FG000|Year Four to Year Six|High Blood Pressure|2|||
143468534|NCT03338192|517263051|FG001|Year Four to Year Six|High Blood Pressure|1|||
143468535|NCT03329196|517263052|FG000|Overall Study|Adverse Event|10|||
143468536|NCT03329196|517263053|FG001|Overall Study|Adverse Event|5|||
143468537|NCT03329196|517263052|FG000|Overall Study|Physician Decision|2|||
143468538|NCT03329196|517263053|FG001|Overall Study|Physician Decision|2|||
143468539|NCT03329196|517263052|FG000|Overall Study|Withdrawal by Subject|11|||
143468540|NCT03329196|517263053|FG001|Overall Study|Withdrawal by Subject|3|||
143468541|NCT03329196|517263052|FG000|Overall Study|Hepatic function abnormalities|0|||
143468542|NCT03329196|517263053|FG001|Overall Study|Hepatic function abnormalities|1|||
143468543|NCT03329196|517263052|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
143468544|NCT03329196|517263053|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
143468545|NCT03329196|517263052|FG000|Overall Study|Difficult to control Hb|2|||
143468546|NCT03329196|517263053|FG001|Overall Study|Difficult to control Hb|3|||
143468547|NCT03329196|517263052|FG000|Overall Study|Dialysis or renal transplant|13|||
143468548|NCT03329196|517263053|FG001|Overall Study|Dialysis or renal transplant|15|||
143468549|NCT01128361|517263056|FG000|Overall Study|Lost to Follow-up|0|||
143468550|NCT01128361|517263057|FG001|Overall Study|Lost to Follow-up|1|||
143468551|NCT01128361|517263056|FG000|Overall Study|Withdrawal by Subject|5|||
143468552|NCT01128361|517263057|FG001|Overall Study|Withdrawal by Subject|2|||
143468553|NCT01929980|517263058|FG000|Overall Study|Physician Decision|1|||
143468554|NCT04082429|517263059|FG000|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
143468555|NCT04082429|517263060|FG001|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
143468556|NCT04082429|517263061|FG002|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
143468557|NCT04082429|517263062|FG003|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
143468558|NCT04082429|517263063|FG004|Main Part (Before the Treatment Pause)|Withdrawal by Subject|3|||
143468559|NCT04082429|517263064|FG005|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
143468560|NCT04082429|517263065|FG006|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
143468561|NCT04082429|517263066|FG007|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
143468562|NCT04082429|517263067|FG008|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
143468563|NCT04082429|517263059|FG000|Main Part (Before the Treatment Pause)|Physician Decision|0|||
143468564|NCT04082429|517263060|FG001|Main Part (Before the Treatment Pause)|Physician Decision|0|||
143468565|NCT04082429|517263061|FG002|Main Part (Before the Treatment Pause)|Physician Decision|0|||
143468566|NCT04082429|517263062|FG003|Main Part (Before the Treatment Pause)|Physician Decision|0|||
143468567|NCT04082429|517263063|FG004|Main Part (Before the Treatment Pause)|Physician Decision|2|||
143468568|NCT04082429|517263064|FG005|Main Part (Before the Treatment Pause)|Physician Decision|0|||
143468569|NCT04082429|517263065|FG006|Main Part (Before the Treatment Pause)|Physician Decision|0|||
143468570|NCT04082429|517263066|FG007|Main Part (Before the Treatment Pause)|Physician Decision|0|||
143468571|NCT04082429|517263067|FG008|Main Part (Before the Treatment Pause)|Physician Decision|0|||
143468572|NCT04082429|517263059|FG000|Main Part (After the Treatment Pause)|Death|0|||
143468573|NCT04082429|517263060|FG001|Main Part (After the Treatment Pause)|Death|0|||
143468574|NCT04082429|517263061|FG002|Main Part (After the Treatment Pause)|Death|0|||
143468575|NCT04082429|517263062|FG003|Main Part (After the Treatment Pause)|Death|0|||
143468576|NCT04082429|517263063|FG004|Main Part (After the Treatment Pause)|Death|1|||
143468577|NCT04082429|517263064|FG005|Main Part (After the Treatment Pause)|Death|0|||
143468578|NCT04082429|517263065|FG006|Main Part (After the Treatment Pause)|Death|0|||
143468579|NCT04082429|517263066|FG007|Main Part (After the Treatment Pause)|Death|0|||
143468580|NCT04082429|517263067|FG008|Main Part (After the Treatment Pause)|Death|0|||
143468581|NCT04082429|517263059|FG000|Main Part (After the Treatment Pause)|Physician Decision|0|||
143468582|NCT04082429|517263060|FG001|Main Part (After the Treatment Pause)|Physician Decision|0|||
143468583|NCT04082429|517263061|FG002|Main Part (After the Treatment Pause)|Physician Decision|0|||
143468584|NCT04082429|517263062|FG003|Main Part (After the Treatment Pause)|Physician Decision|2|||
143133877|NCT02532283|516035084|FG001|Overall Study|Withdrawal by Subject|3|||
143133878|NCT01817075|516035087|FG000|Overall Study|Adverse Event|7|||
143133879|NCT01817075|516035088|FG001|Overall Study|Adverse Event|5|||
143133880|NCT01817075|516035087|FG000|Overall Study|Physician Decision|9|||
143133881|NCT01817075|516035088|FG001|Overall Study|Physician Decision|12|||
143133882|NCT01817075|516035087|FG000|Overall Study|Withdrawal by Subject|31|||
143133883|NCT01817075|516035088|FG001|Overall Study|Withdrawal by Subject|15|||
143133884|NCT01817075|516035087|FG000|Overall Study|Received Sorafenib after enrollment|0|||
143133885|NCT01817075|516035088|FG001|Overall Study|Received Sorafenib after enrollment|1|||
143133886|NCT01817075|516035087|FG000|Overall Study|Ineligible|0|||
143133887|NCT01817075|516035088|FG001|Overall Study|Ineligible|2|||
143133888|NCT05027815|516035089|FG000|Overall Study|Death|2|||
143133889|NCT05027815|516035090|FG001|Overall Study|Death|1|||
143133890|NCT01395810|516035091|FG000|Overall Study|Adverse Event|0|||
143133891|NCT01395810|516035092|FG001|Overall Study|Adverse Event|1|||
143133892|NCT01395810|516035093|FG002|Overall Study|Adverse Event|0|||
143133893|NCT01395810|516035094|FG003|Overall Study|Adverse Event|0|||
143133894|NCT01395810|516035091|FG000|Overall Study|Lack of Efficacy|0|||
143133895|NCT01395810|516035092|FG001|Overall Study|Lack of Efficacy|1|||
143133896|NCT01395810|516035093|FG002|Overall Study|Lack of Efficacy|0|||
143133897|NCT01395810|516035094|FG003|Overall Study|Lack of Efficacy|0|||
143133898|NCT01395810|516035091|FG000|Overall Study|Withdrawal criteria|0|||
143133899|NCT01395810|516035092|FG001|Overall Study|Withdrawal criteria|2|||
143133900|NCT01395810|516035093|FG002|Overall Study|Withdrawal criteria|0|||
143133901|NCT01395810|516035094|FG003|Overall Study|Withdrawal criteria|0|||
143133902|NCT01395810|516035091|FG000|Overall Study|Unclassified|2|||
143133903|NCT01395810|516035092|FG001|Overall Study|Unclassified|0|||
143133904|NCT01395810|516035093|FG002|Overall Study|Unclassified|0|||
143133905|NCT01395810|516035094|FG003|Overall Study|Unclassified|0|||
143133906|NCT01405560|516037174|FG000|Overall Study|Physician Decision|1|||
143133907|NCT01484951|516037179|FG000|Overall Study|Adverse Event|3|||
143133908|NCT01484951|516037179|FG000|Overall Study|Personal Reasons|1|||
143133909|NCT01484951|516037179|FG000|Overall Study|Non-Compliance|1|||
143133910|NCT01831427|516037180|FG000|Overall Study|Adverse Event|0|||
143133911|NCT01831427|516037181|FG001|Overall Study|Adverse Event|1|||
143133912|NCT01831427|516037182|FG002|Overall Study|Adverse Event|0|||
143133913|NCT01831427|516037183|FG003|Overall Study|Adverse Event|0|||
143133914|NCT01831427|516037184|FG004|Overall Study|Adverse Event|0|||
143133915|NCT01831427|516037185|FG005|Overall Study|Adverse Event|1|||
143133916|NCT01831427|516037186|FG006|Overall Study|Adverse Event|0|||
143133917|NCT01831427|516037187|FG007|Overall Study|Adverse Event|1|||
143133918|NCT01831427|516037188|FG008|Overall Study|Adverse Event|0|||
143133919|NCT01831427|516037189|FG009|Overall Study|Adverse Event|0|||
143133920|NCT01831427|516037190|FG010|Overall Study|Adverse Event|2|||
143133921|NCT01831427|516037180|FG000|Overall Study|Investigator's Discretion|0|||
143133922|NCT01831427|516037181|FG001|Overall Study|Investigator's Discretion|0|||
143133923|NCT01831427|516037182|FG002|Overall Study|Investigator's Discretion|0|||
143133924|NCT01831427|516037183|FG003|Overall Study|Investigator's Discretion|1|||
143133925|NCT01831427|516037184|FG004|Overall Study|Investigator's Discretion|0|||
143133926|NCT01831427|516037185|FG005|Overall Study|Investigator's Discretion|0|||
143133927|NCT01831427|516037186|FG006|Overall Study|Investigator's Discretion|0|||
143133928|NCT01831427|516037187|FG007|Overall Study|Investigator's Discretion|0|||
143133929|NCT01831427|516037188|FG008|Overall Study|Investigator's Discretion|0|||
143133930|NCT01831427|516037189|FG009|Overall Study|Investigator's Discretion|0|||
143133931|NCT01831427|516037190|FG010|Overall Study|Investigator's Discretion|0|||
143133932|NCT01831427|516037180|FG000|Overall Study|Withdrew Consent|0|||
143133933|NCT01831427|516037181|FG001|Overall Study|Withdrew Consent|0|||
143133934|NCT01831427|516037182|FG002|Overall Study|Withdrew Consent|0|||
143133935|NCT01831427|516037183|FG003|Overall Study|Withdrew Consent|0|||
143133936|NCT01831427|516037184|FG004|Overall Study|Withdrew Consent|0|||
143133937|NCT01831427|516037185|FG005|Overall Study|Withdrew Consent|0|||
143133938|NCT01831427|516037186|FG006|Overall Study|Withdrew Consent|2|||
143133939|NCT01831427|516037187|FG007|Overall Study|Withdrew Consent|0|||
143133940|NCT01831427|516037188|FG008|Overall Study|Withdrew Consent|0|||
143133941|NCT01831427|516037189|FG009|Overall Study|Withdrew Consent|1|||
143133942|NCT01831427|516037190|FG010|Overall Study|Withdrew Consent|1|||
143133943|NCT02169505|516037191|FG000|Overall Study|Withdrawal by Subject|1|||
143468585|NCT04082429|517263063|FG004|Main Part (After the Treatment Pause)|Physician Decision|0|||
143133944|NCT02035553|516037192|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
143133945|NCT02035553|516037193|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
143133946|NCT02035553|516037192|FG000|Overall Study|Adverse Event|10|||
143133947|NCT02035553|516037193|FG001|Overall Study|Adverse Event|6|||
143133948|NCT02035553|516037192|FG000|Overall Study|Physician Decision|3|||
143133949|NCT02035553|516037193|FG001|Overall Study|Physician Decision|2|||
143133950|NCT02035553|516037192|FG000|Overall Study|Lack of Efficacy|1|||
143133951|NCT02035553|516037193|FG001|Overall Study|Lack of Efficacy|1|||
143133952|NCT02035553|516037192|FG000|Overall Study|Withdrawal by Subject|4|||
143133953|NCT02035553|516037193|FG001|Overall Study|Withdrawal by Subject|7|||
143359704|NCT04955626|516859876|FG017|Blinded Period|Withdrawal by Subject|5|||
143359705|NCT04955626|516859877|FG018|Blinded Period|Withdrawal by Subject|0|||
143359706|NCT04955626|516859878|FG019|Blinded Period|Withdrawal by Subject|0|||
143359707|NCT04955626|516859879|FG020|Blinded Period|Withdrawal by Subject|1|||
143359708|NCT04955626|516859880|FG021|Blinded Period|Withdrawal by Subject|0|||
143359709|NCT04955626|516859881|FG022|Blinded Period|Withdrawal by Subject|0|||
143359710|NCT04955626|516859882|FG023|Blinded Period|Withdrawal by Subject|0|||
143359711|NCT04955626|516859883|FG024|Blinded Period|Withdrawal by Subject|5|||
143359712|NCT04955626|516859884|FG025|Blinded Period|Withdrawal by Subject|1|||
143359713|NCT04955626|516859885|FG026|Blinded Period|Withdrawal by Subject|5|||
143359714|NCT04955626|516859886|FG027|Blinded Period|Withdrawal by Subject|1|||
143359715|NCT04955626|516859887|FG028|Blinded Period|Withdrawal by Subject|4|||
143359716|NCT04955626|516859888|FG029|Blinded Period|Withdrawal by Subject|2|||
143359717|NCT04955626|516859889|FG030|Blinded Period|Withdrawal by Subject|0|||
143359718|NCT04955626|516859890|FG031|Blinded Period|Withdrawal by Subject|0|||
143359719|NCT04955626|516859891|FG032|Blinded Period|Withdrawal by Subject|0|||
143359720|NCT04955626|516859892|FG033|Blinded Period|Withdrawal by Subject|0|||
143359721|NCT04955626|516859893|FG034|Blinded Period|Withdrawal by Subject|0|||
143359722|NCT04955626|516859894|FG035|Blinded Period|Withdrawal by Subject|0|||
143359723|NCT04955626|516859859|FG000|Blinded Period|Refused further study procedures|0|||
143359724|NCT04955626|516859860|FG001|Blinded Period|Refused further study procedures|0|||
143359725|NCT04955626|516859861|FG002|Blinded Period|Refused further study procedures|0|||
143359726|NCT04955626|516859862|FG003|Blinded Period|Refused further study procedures|0|||
143359727|NCT04955626|516859863|FG004|Blinded Period|Refused further study procedures|0|||
143359728|NCT04955626|516859864|FG005|Blinded Period|Refused further study procedures|0|||
143359729|NCT04955626|516859865|FG006|Blinded Period|Refused further study procedures|1|||
143359730|NCT04955626|516859866|FG007|Blinded Period|Refused further study procedures|0|||
143359731|NCT04955626|516859867|FG008|Blinded Period|Refused further study procedures|0|||
143359732|NCT04955626|516859868|FG009|Blinded Period|Refused further study procedures|0|||
143359733|NCT04955626|516859869|FG010|Blinded Period|Refused further study procedures|0|||
143359734|NCT04955626|516859870|FG011|Blinded Period|Refused further study procedures|2|||
143359735|NCT04955626|516859871|FG012|Blinded Period|Refused further study procedures|0|||
143359736|NCT04955626|516859872|FG013|Blinded Period|Refused further study procedures|0|||
143359737|NCT04955626|516859873|FG014|Blinded Period|Refused further study procedures|0|||
143359738|NCT04955626|516859874|FG015|Blinded Period|Refused further study procedures|0|||
143359739|NCT04955626|516859875|FG016|Blinded Period|Refused further study procedures|0|||
143359740|NCT04955626|516859876|FG017|Blinded Period|Refused further study procedures|0|||
143359741|NCT04955626|516859877|FG018|Blinded Period|Refused further study procedures|0|||
143359742|NCT04955626|516859878|FG019|Blinded Period|Refused further study procedures|0|||
143359743|NCT04955626|516859879|FG020|Blinded Period|Refused further study procedures|0|||
143359744|NCT04955626|516859880|FG021|Blinded Period|Refused further study procedures|0|||
143359745|NCT04955626|516859881|FG022|Blinded Period|Refused further study procedures|0|||
143359746|NCT04955626|516859882|FG023|Blinded Period|Refused further study procedures|0|||
143359747|NCT04955626|516859883|FG024|Blinded Period|Refused further study procedures|0|||
143359748|NCT04955626|516859884|FG025|Blinded Period|Refused further study procedures|0|||
143359749|NCT04955626|516859885|FG026|Blinded Period|Refused further study procedures|0|||
143359750|NCT04955626|516859886|FG027|Blinded Period|Refused further study procedures|0|||
143359751|NCT04955626|516859887|FG028|Blinded Period|Refused further study procedures|0|||
143359752|NCT04955626|516859888|FG029|Blinded Period|Refused further study procedures|0|||
143359753|NCT04955626|516859889|FG030|Blinded Period|Refused further study procedures|0|||
143359754|NCT04955626|516859890|FG031|Blinded Period|Refused further study procedures|0|||
143359755|NCT04955626|516859891|FG032|Blinded Period|Refused further study procedures|0|||
143359756|NCT04955626|516859892|FG033|Blinded Period|Refused further study procedures|0|||
143359757|NCT04955626|516859893|FG034|Blinded Period|Refused further study procedures|0|||
143359758|NCT04955626|516859894|FG035|Blinded Period|Refused further study procedures|0|||
143133954|NCT02035553|516037192|FG000|Overall Study|Non-compliance with Study Drug|0|||
143133955|NCT02035553|516037193|FG001|Overall Study|Non-compliance with Study Drug|1|||
143359759|NCT04955626|516859859|FG000|Blinded Period|Participants entered open label period|4544|||
143359760|NCT04955626|516859860|FG001|Blinded Period|Participants entered open label period|4906|||
143359761|NCT04955626|516859861|FG002|Blinded Period|Participants entered open label period|0|||
143359762|NCT04955626|516859862|FG003|Blinded Period|Participants entered open label period|0|||
143359763|NCT04955626|516859863|FG004|Blinded Period|Participants entered open label period|0|||
143359764|NCT04955626|516859864|FG005|Blinded Period|Participants entered open label period|0|||
143133956|NCT02035553|516037192|FG000|Overall Study|Lost to Follow-up|0|||
143133957|NCT02035553|516037193|FG001|Overall Study|Lost to Follow-up|1|||
143133958|NCT02035553|516037192|FG000|Overall Study|Other Reason|0|||
143359765|NCT04955626|516859865|FG006|Blinded Period|Participants entered open label period|0|||
143359766|NCT04955626|516859866|FG007|Blinded Period|Participants entered open label period|0|||
143359767|NCT04955626|516859867|FG008|Blinded Period|Participants entered open label period|0|||
143359768|NCT04955626|516859868|FG009|Blinded Period|Participants entered open label period|0|||
143359769|NCT04955626|516859869|FG010|Blinded Period|Participants entered open label period|0|||
143359770|NCT04955626|516859870|FG011|Blinded Period|Participants entered open label period|0|||
143359771|NCT04955626|516859871|FG012|Blinded Period|Participants entered open label period|0|||
143359772|NCT04955626|516859872|FG013|Blinded Period|Participants entered open label period|0|||
143359773|NCT04955626|516859873|FG014|Blinded Period|Participants entered open label period|0|||
143359774|NCT04955626|516859874|FG015|Blinded Period|Participants entered open label period|0|||
143359775|NCT04955626|516859875|FG016|Blinded Period|Participants entered open label period|0|||
143359776|NCT04955626|516859876|FG017|Blinded Period|Participants entered open label period|0|||
143359777|NCT04955626|516859877|FG018|Blinded Period|Participants entered open label period|0|||
143359778|NCT04955626|516859878|FG019|Blinded Period|Participants entered open label period|0|||
143359779|NCT04955626|516859879|FG020|Blinded Period|Participants entered open label period|0|||
143359780|NCT04955626|516859880|FG021|Blinded Period|Participants entered open label period|0|||
143359781|NCT04955626|516859881|FG022|Blinded Period|Participants entered open label period|0|||
143359782|NCT04955626|516859882|FG023|Blinded Period|Participants entered open label period|0|||
143359783|NCT04955626|516859883|FG024|Blinded Period|Participants entered open label period|0|||
143359784|NCT04955626|516859884|FG025|Blinded Period|Participants entered open label period|0|||
143359785|NCT04955626|516859885|FG026|Blinded Period|Participants entered open label period|0|||
143359786|NCT04955626|516859886|FG027|Blinded Period|Participants entered open label period|0|||
143359787|NCT04955626|516859887|FG028|Blinded Period|Participants entered open label period|0|||
143359788|NCT04955626|516859888|FG029|Blinded Period|Participants entered open label period|0|||
143359789|NCT04955626|516859889|FG030|Blinded Period|Participants entered open label period|0|||
143359790|NCT04955626|516859890|FG031|Blinded Period|Participants entered open label period|0|||
143359791|NCT04955626|516859891|FG032|Blinded Period|Participants entered open label period|0|||
143359792|NCT04955626|516859892|FG033|Blinded Period|Participants entered open label period|0|||
143359793|NCT04955626|516859893|FG034|Blinded Period|Participants entered open label period|0|||
143359794|NCT04955626|516859894|FG035|Blinded Period|Participants entered open label period|0|||
143359795|NCT04955626|516859859|FG000|Blinded Period|Withdrawal by parent/guardian|0|||
143359796|NCT04955626|516859860|FG001|Blinded Period|Withdrawal by parent/guardian|0|||
143359797|NCT04955626|516859861|FG002|Blinded Period|Withdrawal by parent/guardian|1|||
143359798|NCT04955626|516859862|FG003|Blinded Period|Withdrawal by parent/guardian|1|||
143359799|NCT04955626|516859863|FG004|Blinded Period|Withdrawal by parent/guardian|0|||
143359800|NCT04955626|516859864|FG005|Blinded Period|Withdrawal by parent/guardian|1|||
143359801|NCT04955626|516859865|FG006|Blinded Period|Withdrawal by parent/guardian|0|||
143359802|NCT04955626|516859866|FG007|Blinded Period|Withdrawal by parent/guardian|0|||
143359803|NCT04955626|516859867|FG008|Blinded Period|Withdrawal by parent/guardian|0|||
143359804|NCT04955626|516859868|FG009|Blinded Period|Withdrawal by parent/guardian|0|||
143359805|NCT04955626|516859869|FG010|Blinded Period|Withdrawal by parent/guardian|0|||
143359806|NCT04955626|516859870|FG011|Blinded Period|Withdrawal by parent/guardian|0|||
143359807|NCT04955626|516859871|FG012|Blinded Period|Withdrawal by parent/guardian|0|||
143359808|NCT04955626|516859872|FG013|Blinded Period|Withdrawal by parent/guardian|0|||
143359809|NCT04955626|516859873|FG014|Blinded Period|Withdrawal by parent/guardian|0|||
143359810|NCT04955626|516859874|FG015|Blinded Period|Withdrawal by parent/guardian|0|||
143359811|NCT04955626|516859875|FG016|Blinded Period|Withdrawal by parent/guardian|0|||
143359812|NCT04955626|516859876|FG017|Blinded Period|Withdrawal by parent/guardian|0|||
143359813|NCT04955626|516859877|FG018|Blinded Period|Withdrawal by parent/guardian|0|||
143359814|NCT04955626|516859878|FG019|Blinded Period|Withdrawal by parent/guardian|0|||
143359815|NCT04955626|516859879|FG020|Blinded Period|Withdrawal by parent/guardian|0|||
143359816|NCT04955626|516859880|FG021|Blinded Period|Withdrawal by parent/guardian|0|||
143359817|NCT04955626|516859881|FG022|Blinded Period|Withdrawal by parent/guardian|0|||
143359818|NCT04955626|516859882|FG023|Blinded Period|Withdrawal by parent/guardian|0|||
143359819|NCT04955626|516859883|FG024|Blinded Period|Withdrawal by parent/guardian|0|||
143359820|NCT04955626|516859884|FG025|Blinded Period|Withdrawal by parent/guardian|0|||
143359821|NCT04955626|516859885|FG026|Blinded Period|Withdrawal by parent/guardian|0|||
143359822|NCT04955626|516859886|FG027|Blinded Period|Withdrawal by parent/guardian|0|||
143359823|NCT04955626|516859887|FG028|Blinded Period|Withdrawal by parent/guardian|0|||
143359824|NCT04955626|516859888|FG029|Blinded Period|Withdrawal by parent/guardian|0|||
143359825|NCT04955626|516859889|FG030|Blinded Period|Withdrawal by parent/guardian|0|||
143359826|NCT04955626|516859890|FG031|Blinded Period|Withdrawal by parent/guardian|0|||
143133959|NCT02035553|516037193|FG001|Overall Study|Other Reason|4|||
143359827|NCT04955626|516859891|FG032|Blinded Period|Withdrawal by parent/guardian|0|||
143359828|NCT04955626|516859892|FG033|Blinded Period|Withdrawal by parent/guardian|0|||
143468586|NCT04082429|517263064|FG005|Main Part (After the Treatment Pause)|Physician Decision|1|||
143468587|NCT04082429|517263065|FG006|Main Part (After the Treatment Pause)|Physician Decision|0|||
143468588|NCT04082429|517263066|FG007|Main Part (After the Treatment Pause)|Physician Decision|0|||
143468589|NCT04082429|517263067|FG008|Main Part (After the Treatment Pause)|Physician Decision|0|||
143468590|NCT04082429|517263059|FG000|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
143468591|NCT04082429|517263060|FG001|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
143468592|NCT04082429|517263061|FG002|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
143468593|NCT04082429|517263062|FG003|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
143468594|NCT04082429|517263063|FG004|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
143468595|NCT04082429|517263064|FG005|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
143468596|NCT04082429|517263065|FG006|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
143468597|NCT04082429|517263066|FG007|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
143468598|NCT04082429|517263067|FG008|Main Part (After the Treatment Pause)|Withdrawal by Subject|5|||
143468599|NCT04082429|517263059|FG000|Main Part (After the Treatment Pause)|Unspecified reason|2|||
143468600|NCT04082429|517263060|FG001|Main Part (After the Treatment Pause)|Unspecified reason|0|||
143468601|NCT04082429|517263061|FG002|Main Part (After the Treatment Pause)|Unspecified reason|0|||
143468602|NCT04082429|517263062|FG003|Main Part (After the Treatment Pause)|Unspecified reason|0|||
143468603|NCT04082429|517263063|FG004|Main Part (After the Treatment Pause)|Unspecified reason|0|||
143468604|NCT04082429|517263064|FG005|Main Part (After the Treatment Pause)|Unspecified reason|1|||
143468605|NCT04082429|517263065|FG006|Main Part (After the Treatment Pause)|Unspecified reason|0|||
143468606|NCT04082429|517263066|FG007|Main Part (After the Treatment Pause)|Unspecified reason|0|||
143468607|NCT04082429|517263067|FG008|Main Part (After the Treatment Pause)|Unspecified reason|0|||
143468608|NCT04082429|517263059|FG000|Extension Part|Ongoing|0|||
143468609|NCT04082429|517263060|FG001|Extension Part|Ongoing|7|||
143468610|NCT04082429|517263061|FG002|Extension Part|Ongoing|17|||
143468611|NCT04082429|517263062|FG003|Extension Part|Ongoing|6|||
143468612|NCT04082429|517263063|FG004|Extension Part|Ongoing|45|||
143468613|NCT04082429|517263064|FG005|Extension Part|Ongoing|0|||
143468614|NCT04082429|517263065|FG006|Extension Part|Ongoing|10|||
143468615|NCT04082429|517263066|FG007|Extension Part|Ongoing|23|||
143468616|NCT04082429|517263067|FG008|Extension Part|Ongoing|25|||
143468617|NCT00993915|517263068|FG000|Overall Study|Insufficient clinical response|3|||
143468618|NCT00993915|517263068|FG000|Overall Study|Withdrawal by Subject|2|||
143468619|NCT00993915|517263068|FG000|Overall Study|Other|1|||
143468620|NCT00993915|517263068|FG000|Overall Study|Ongoing|3|||
143468621|NCT02030405|517263069|FG000|Overall Study|Withdrawal by Subject|1|||
143468622|NCT02030405|517263069|FG000|Overall Study|Lost to Follow-up|1|||
143468623|NCT00132496|517263070|FG000|Overall Study|Withdrawal by Subject|1|||
143468624|NCT00132496|517263071|FG001|Overall Study|Withdrawal by Subject|2|||
143468625|NCT00132496|517263070|FG000|Overall Study|Physician Decision|1|||
143468626|NCT00132496|517263071|FG001|Overall Study|Physician Decision|0|||
143468627|NCT02973048|517263072|FG000|Overall Study|Epidural catheter insertion failure|1|||
143468628|NCT02973048|517263073|FG001|Overall Study|Epidural catheter insertion failure|0|||
143468629|NCT02973048|517263072|FG000|Overall Study|Withdrawal by Subject|0|||
143468630|NCT02973048|517263073|FG001|Overall Study|Withdrawal by Subject|3|||
143468631|NCT01906346|517263077|FG000|Overall Study|AEs|1|||
143468632|NCT00364156|517263080|FG000|Overall Study|Withdrawal by Subject|73|||
143468633|NCT00364156|517263081|FG001|Overall Study|Withdrawal by Subject|80|||
143468634|NCT00364156|517263080|FG000|Overall Study|Protocol Violation|6|||
143468635|NCT00364156|517263081|FG001|Overall Study|Protocol Violation|1|||
143468636|NCT02511678|517263082|FG000|Overall Study|Withdrawal by Subject|2|||
143468637|NCT02511678|517263082|FG000|Overall Study|Lost to Follow-up|4|||
143468638|NCT02511678|517263082|FG000|Overall Study|Death|19|||
143468639|NCT02511678|517263082|FG000|Overall Study|Adverse Event|1|||
143468640|NCT02511678|517263082|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
143468641|NCT02511678|517263082|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
143468642|NCT02511678|517263082|FG000|Overall Study|Required Radiofrequency Ablation|1|||
143468643|NCT02511678|517263082|FG000|Overall Study|Biopsy was Negative|1|||
143468644|NCT02511678|517263082|FG000|Overall Study|Protocol Violation|1|||
143468645|NCT02511678|517263082|FG000|Overall Study|Received Radiation Treatment|1|||
143468646|NCT00458341|517263086|FG000|Cycle 1|Adverse Event|1|||
143468647|NCT00458341|517263087|FG001|Cycle 1|Adverse Event|0|||
143468648|NCT04540133|517263088|FG000|Overall Study|Lost to Follow-up|1|||
143468649|NCT04540133|517263089|FG001|Overall Study|Lost to Follow-up|0|||
143468650|NCT05461794|517263090|FG000|Overall Study|Withdrawal by Subject|1|||
143468651|NCT05461794|517263091|FG001|Overall Study|Withdrawal by Subject|1|||
143468652|NCT05461794|517263092|FG002|Overall Study|Withdrawal by Subject|3|||
143468653|NCT05461794|517263090|FG000|Overall Study|Study Terminated By Sponsor|18|||
143468654|NCT05461794|517263091|FG001|Overall Study|Study Terminated By Sponsor|13|||
143468655|NCT05461794|517263092|FG002|Overall Study|Study Terminated By Sponsor|16|||
143468656|NCT05461794|517263090|FG000|Overall Study|Death|20|||
143468657|NCT05461794|517263091|FG001|Overall Study|Death|5|||
143468658|NCT05461794|517263092|FG002|Overall Study|Death|19|||
143133960|NCT01607593|516037194|FG000|Overall Study|Adverse Event|15|||
143133961|NCT01607593|516037194|FG000|Overall Study|Lack of Efficacy|16|||
143468659|NCT02730598|517263095|FG000|Overall Study|Withdrawal by Subject|3|||
143468660|NCT02730598|517263096|FG001|Overall Study|Withdrawal by Subject|3|||
143468661|NCT02730598|517263095|FG000|Overall Study|Protocol Violation|0|||
143468662|NCT02730598|517263096|FG001|Overall Study|Protocol Violation|1|||
143468663|NCT02730598|517263095|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
143468664|NCT02730598|517263096|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
143468665|NCT02146326|517263097|FG000|Overall Study|Lost to Follow-up|3|||
143468666|NCT02146326|517263098|FG001|Overall Study|Lost to Follow-up|3|||
143468667|NCT02146326|517263099|FG002|Overall Study|Lost to Follow-up|11|||
143468668|NCT02146326|517263100|FG003|Overall Study|Lost to Follow-up|19|||
143468669|NCT02146326|517263097|FG000|Overall Study|Withdrawal by Subject|2|||
143468670|NCT02146326|517263098|FG001|Overall Study|Withdrawal by Subject|1|||
143468671|NCT02146326|517263099|FG002|Overall Study|Withdrawal by Subject|15|||
143468672|NCT02146326|517263100|FG003|Overall Study|Withdrawal by Subject|11|||
143133962|NCT01607593|516037194|FG000|Overall Study|Lost to Follow-up|25|||
143468673|NCT02146326|517263097|FG000|Overall Study|Separated from mental health center|23|||
143468674|NCT02146326|517263098|FG001|Overall Study|Separated from mental health center|33|||
143468675|NCT02146326|517263099|FG002|Overall Study|Separated from mental health center|0|||
143468676|NCT02146326|517263100|FG003|Overall Study|Separated from mental health center|0|||
143133963|NCT01607593|516037194|FG000|Overall Study|Continuation|33|||
143133964|NCT01607593|516037194|FG000|Overall Study|Other|4|||
143133965|NCT00483652|516037195|FG000|Double-blind Treatment Period|Protocol Violation|2|||
143133966|NCT00483652|516037196|FG001|Double-blind Treatment Period|Protocol Violation|1|||
143133967|NCT00483652|516037195|FG000|Double-blind Treatment Period|Adverse Event|3|||
143133968|NCT00483652|516037196|FG001|Double-blind Treatment Period|Adverse Event|4|||
143133969|NCT00483652|516037195|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
143133970|NCT00483652|516037196|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
143133971|NCT00483652|516037195|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
143133972|NCT00483652|516037196|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
143133973|NCT00468585|516037197|FG000|Overall Study|Patient not treated|1|||
143133974|NCT00468585|516037198|FG001|Overall Study|Patient not treated|0|||
143133975|NCT00468585|516037199|FG002|Overall Study|Patient not treated|1|||
143133976|NCT00468585|516037200|FG003|Overall Study|Patient not treated|0|||
143133977|NCT00468585|516037197|FG000|Overall Study|Patient found to be ineligible|0|||
143133978|NCT00468585|516037198|FG001|Overall Study|Patient found to be ineligible|0|||
143133979|NCT00468585|516037199|FG002|Overall Study|Patient found to be ineligible|1|||
143133980|NCT00468585|516037200|FG003|Overall Study|Patient found to be ineligible|0|||
143133981|NCT00468585|516037197|FG000|Overall Study|Adverse Event|0|||
143133982|NCT00468585|516037198|FG001|Overall Study|Adverse Event|0|||
143133983|NCT00468585|516037199|FG002|Overall Study|Adverse Event|1|||
143133984|NCT00468585|516037200|FG003|Overall Study|Adverse Event|0|||
143133985|NCT00468585|516037197|FG000|Overall Study|Withdrawal by Subject|0|||
143133986|NCT00468585|516037198|FG001|Overall Study|Withdrawal by Subject|0|||
143133987|NCT00468585|516037199|FG002|Overall Study|Withdrawal by Subject|2|||
143133988|NCT00468585|516037200|FG003|Overall Study|Withdrawal by Subject|1|||
143133989|NCT02154139|516037207|FG000|Overall Study|Injection not administered|2|||
143133990|NCT02154139|516037207|FG000|Overall Study|Other|2|||
143133991|NCT02154139|516037207|FG000|Overall Study|Investigator transferred|3|||
143133992|NCT01290718|516037208|FG000|Overall Study|Early termination of the study|4|||
143133993|NCT00473655|516037209|FG000|Overall Study|Lost to Follow-up|9|||
143133994|NCT00473655|516037210|FG001|Overall Study|Lost to Follow-up|5|||
143133995|NCT00473655|516037211|FG002|Overall Study|Lost to Follow-up|8|||
143133996|NCT00243919|516037220|FG000|Overall Study|Death|3|||
143133997|NCT00243919|516037221|FG001|Overall Study|Death|4|||
143133998|NCT00243919|516037222|FG002|Overall Study|Death|6|||
143133999|NCT00243919|516037220|FG000|Overall Study|Withdrawal by Subject|6|||
143134000|NCT00243919|516037221|FG001|Overall Study|Withdrawal by Subject|6|||
143134001|NCT00243919|516037222|FG002|Overall Study|Withdrawal by Subject|2|||
143134002|NCT00243919|516037220|FG000|Overall Study|Lost to Follow-up|6|||
143134003|NCT00243919|516037221|FG001|Overall Study|Lost to Follow-up|7|||
143134004|NCT00243919|516037222|FG002|Overall Study|Lost to Follow-up|3|||
143134005|NCT00243919|516037220|FG000|Overall Study|Administrative Error|1|||
143134006|NCT00243919|516037221|FG001|Overall Study|Administrative Error|0|||
143468677|NCT02146326|517263097|FG000|Overall Study|Incarcerated|0|||
143468678|NCT02146326|517263098|FG001|Overall Study|Incarcerated|0|||
143468679|NCT02146326|517263099|FG002|Overall Study|Incarcerated|3|||
143134007|NCT00243919|516037222|FG002|Overall Study|Administrative Error|0|||
143134008|NCT00243919|516037220|FG000|Overall Study|Physician Decision|1|||
143134009|NCT00243919|516037221|FG001|Overall Study|Physician Decision|1|||
143134010|NCT00243919|516037222|FG002|Overall Study|Physician Decision|0|||
143134011|NCT02059239|516037223|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
143134012|NCT02059239|516037224|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
143134013|NCT02059239|516037223|FG000|Overall Study|Physician Decision|1|||
143134014|NCT02059239|516037224|FG001|Overall Study|Physician Decision|0|||
143134015|NCT01268267|516037225|FG000|Overall Study|Protocol Violation|1|||
143134016|NCT04176939|516037230|FG000|Overall Study|Withdrawal by Subject|5|||
143134017|NCT04176939|516037230|FG000|Overall Study|Migrated / Moved From The Study Area|1|||
143134018|NCT04176939|516037230|FG000|Overall Study|Lost to Follow-up|2|||
143134019|NCT04176939|516037230|FG000|Overall Study|Unspecified reason|4|||
143134020|NCT04176939|516037230|FG000|Overall Study|Adverse Event Requiring Expedited Reporting|7|||
143134021|NCT00230048|516037231|FG000|Overall Study|Lost to Follow-up|13|||
143134022|NCT00230048|516037232|FG001|Overall Study|Lost to Follow-up|18|||
143134023|NCT02869789|516037233|FG000|Overall Study|Disease progression|184|||
143134024|NCT02869789|516037234|FG001|Overall Study|Disease progression|109|||
143134025|NCT02869789|516037235|FG002|Overall Study|Disease progression|260|||
143134026|NCT02869789|516037236|FG003|Overall Study|Disease progression|19|||
143134027|NCT02869789|516037233|FG000|Overall Study|Study drug toxicity|90|||
143134028|NCT02869789|516037234|FG001|Overall Study|Study drug toxicity|32|||
143468680|NCT02146326|517263100|FG003|Overall Study|Incarcerated|8|||
143468681|NCT02146326|517263097|FG000|Overall Study|Death|0|||
143468682|NCT02146326|517263098|FG001|Overall Study|Death|0|||
143468683|NCT02146326|517263099|FG002|Overall Study|Death|4|||
143468684|NCT02146326|517263100|FG003|Overall Study|Death|4|||
143468685|NCT02146326|517263097|FG000|Overall Study|Unable to complete interview|0|||
143468686|NCT02146326|517263098|FG001|Overall Study|Unable to complete interview|0|||
143468687|NCT02146326|517263099|FG002|Overall Study|Unable to complete interview|10|||
143468688|NCT02146326|517263100|FG003|Overall Study|Unable to complete interview|6|||
143468689|NCT02958267|517263103|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
143468690|NCT02958267|517263104|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
143468691|NCT02958267|517263103|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
143468692|NCT02958267|517263104|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
143468693|NCT02958267|517263103|FG000|Follow-up Visits|Additional treatment pursued|2|||
143468694|NCT02958267|517263104|FG001|Follow-up Visits|Additional treatment pursued|1|||
143468695|NCT01079130|517263105|FG000|Overall Study|Adverse Event|1|||
143468696|NCT01079130|517263106|FG001|Overall Study|Adverse Event|1|||
143468697|NCT01079130|517263107|FG002|Overall Study|Adverse Event|0|||
143468698|NCT01079130|517263108|FG003|Overall Study|Adverse Event|1|||
143468699|NCT01079130|517263109|FG004|Overall Study|Adverse Event|5|||
143468700|NCT01079130|517263110|FG005|Overall Study|Adverse Event|1|||
143468701|NCT01079130|517263105|FG000|Overall Study|Administrative problems|1|||
143468702|NCT01079130|517263106|FG001|Overall Study|Administrative problems|3|||
143468703|NCT01079130|517263107|FG002|Overall Study|Administrative problems|0|||
143468704|NCT01079130|517263108|FG003|Overall Study|Administrative problems|0|||
143468705|NCT01079130|517263109|FG004|Overall Study|Administrative problems|0|||
143468706|NCT01079130|517263110|FG005|Overall Study|Administrative problems|1|||
143468707|NCT01079130|517263105|FG000|Overall Study|Withdrawal by Subject|0|||
143468708|NCT01079130|517263106|FG001|Overall Study|Withdrawal by Subject|1|||
143468709|NCT01079130|517263107|FG002|Overall Study|Withdrawal by Subject|0|||
143468710|NCT01079130|517263108|FG003|Overall Study|Withdrawal by Subject|0|||
143468711|NCT01079130|517263109|FG004|Overall Study|Withdrawal by Subject|1|||
143468712|NCT01079130|517263110|FG005|Overall Study|Withdrawal by Subject|3|||
143468713|NCT01079130|517263105|FG000|Overall Study|Protocol deviation|0|||
143468714|NCT01079130|517263106|FG001|Overall Study|Protocol deviation|2|||
143468715|NCT01079130|517263107|FG002|Overall Study|Protocol deviation|1|||
143468716|NCT01079130|517263108|FG003|Overall Study|Protocol deviation|2|||
143468717|NCT01079130|517263109|FG004|Overall Study|Protocol deviation|0|||
143468718|NCT01079130|517263110|FG005|Overall Study|Protocol deviation|0|||
143468719|NCT01079130|517263105|FG000|Overall Study|Abnormal test procedure result(s)|0|||
143468720|NCT01079130|517263106|FG001|Overall Study|Abnormal test procedure result(s)|0|||
143468721|NCT01079130|517263107|FG002|Overall Study|Abnormal test procedure result(s)|0|||
143468722|NCT01079130|517263108|FG003|Overall Study|Abnormal test procedure result(s)|0|||
143468723|NCT01079130|517263109|FG004|Overall Study|Abnormal test procedure result(s)|1|||
143468724|NCT01079130|517263110|FG005|Overall Study|Abnormal test procedure result(s)|0|||
143468725|NCT01079130|517263105|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
143468726|NCT01079130|517263106|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
143134029|NCT02869789|516037235|FG002|Overall Study|Study drug toxicity|55|||
143134030|NCT02869789|516037236|FG003|Overall Study|Study drug toxicity|14|||
143134031|NCT02869789|516037233|FG000|Overall Study|Death|7|||
143134032|NCT02869789|516037234|FG001|Overall Study|Death|3|||
143134033|NCT02869789|516037235|FG002|Overall Study|Death|5|||
143134034|NCT02869789|516037236|FG003|Overall Study|Death|1|||
143134035|NCT02869789|516037233|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
143468727|NCT01079130|517263107|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
143468728|NCT01079130|517263108|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
143468729|NCT01079130|517263109|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
143468730|NCT01079130|517263110|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
143468731|NCT01079130|517263105|FG000|Overall Study|Lost to Follow-up|0|||
143134036|NCT02869789|516037234|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
143134037|NCT02869789|516037235|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
143134038|NCT02869789|516037236|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
143468732|NCT01079130|517263106|FG001|Overall Study|Lost to Follow-up|0|||
143468733|NCT01079130|517263107|FG002|Overall Study|Lost to Follow-up|0|||
143468734|NCT01079130|517263108|FG003|Overall Study|Lost to Follow-up|0|||
143468735|NCT01079130|517263109|FG004|Overall Study|Lost to Follow-up|1|||
143468736|NCT01079130|517263110|FG005|Overall Study|Lost to Follow-up|0|||
143468737|NCT01853982|517263111|FG000|Overall Study|Withdrawal by Subject|1|||
143468738|NCT01853982|517263112|FG001|Overall Study|Withdrawal by Subject|0|||
143468739|NCT01853982|517263111|FG000|Overall Study|Death|1|||
143468740|NCT01853982|517263112|FG001|Overall Study|Death|0|||
143468741|NCT01853982|517263111|FG000|Overall Study|Lost to Follow-up|0|||
143468742|NCT01853982|517263112|FG001|Overall Study|Lost to Follow-up|1|||
143468743|NCT00390910|517263113|FG000|Overall Study|Adverse Event|1|||
143468744|NCT00390910|517263114|FG001|Overall Study|Adverse Event|0|||
143468745|NCT00390910|517263115|FG002|Overall Study|Adverse Event|0|||
143468746|NCT00390910|517263113|FG000|Overall Study|Lost to Follow-up|0|||
143468747|NCT00390910|517263114|FG001|Overall Study|Lost to Follow-up|1|||
143468748|NCT00390910|517263115|FG002|Overall Study|Lost to Follow-up|5|||
143468749|NCT00390910|517263113|FG000|Overall Study|Withdrawal by Subject|1|||
143468750|NCT00390910|517263114|FG001|Overall Study|Withdrawal by Subject|3|||
143468751|NCT00390910|517263115|FG002|Overall Study|Withdrawal by Subject|2|||
143468752|NCT00390910|517263113|FG000|Overall Study|Migrated/moved from study area|0|||
143468753|NCT00390910|517263114|FG001|Overall Study|Migrated/moved from study area|0|||
143468754|NCT00390910|517263115|FG002|Overall Study|Migrated/moved from study area|3|||
143468755|NCT01422850|517263124|FG000|Overall Study|Physician Decision|3|||
143468756|NCT04484831|517263125|FG000|Overall Study|Withdrawal by Subject|1|||
143468757|NCT04484831|517263126|FG001|Overall Study|Withdrawal by Subject|0|||
143468758|NCT02244996|517263127|FG000|Overall Study|Lack of Efficacy|2|||
143468759|NCT02244996|517263128|FG001|Overall Study|Lack of Efficacy|6|||
143468760|NCT00174265|517263129|FG000|Overall Study|Adverse Event|7|||
143468761|NCT00174265|517263130|FG001|Overall Study|Adverse Event|4|||
143468762|NCT00174265|517263129|FG000|Overall Study|Lack of Efficacy|2|||
143468763|NCT00174265|517263130|FG001|Overall Study|Lack of Efficacy|2|||
143468764|NCT00174265|517263129|FG000|Overall Study|Withdrawal by Subject|3|||
143468765|NCT00174265|517263130|FG001|Overall Study|Withdrawal by Subject|5|||
143468766|NCT00174265|517263129|FG000|Overall Study|Lost to Follow-up|1|||
143468767|NCT00174265|517263130|FG001|Overall Study|Lost to Follow-up|0|||
143468768|NCT00174265|517263129|FG000|Overall Study|Other (Not specified)|16|||
143468769|NCT00174265|517263130|FG001|Overall Study|Other (Not specified)|10|||
143468770|NCT03471871|517263132|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
143468771|NCT03471871|517263133|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
143468772|NCT03471871|517263134|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
143468773|NCT03471871|517263135|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
143468774|NCT03471871|517263136|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
143468775|NCT03471871|517263132|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
143468776|NCT03471871|517263133|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
143468777|NCT03471871|517263134|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
143468778|NCT03471871|517263135|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
143468779|NCT03471871|517263136|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
143468780|NCT03471871|517263132|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
143468781|NCT03471871|517263133|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
143468782|NCT03471871|517263134|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
143468783|NCT03471871|517263135|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
143468784|NCT03471871|517263136|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
143468785|NCT03471871|517263132|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
143468786|NCT03471871|517263133|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
143468787|NCT03471871|517263134|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
143468788|NCT03471871|517263135|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
143468789|NCT03471871|517263136|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
143468790|NCT03471871|517263132|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
143468791|NCT03471871|517263133|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
143468792|NCT03471871|517263134|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
143468793|NCT03471871|517263135|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
143468794|NCT03471871|517263136|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
143468795|NCT03040622|517263138|FG000|Overall Study|unable to implant device|3|||
143468796|NCT03144804|517263140|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
143468797|NCT01313117|517263143|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
143468798|NCT01313117|517263143|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
143468799|NCT03602261|517263148|FG000|Overall Study|Adverse Event|5|||
143468800|NCT03602261|517263149|FG001|Overall Study|Adverse Event|1|||
143468801|NCT03602261|517263148|FG000|Overall Study|Physician Decision|1|||
143232172|NCT01446159|516402032|FG000|Overall Study|Other|0|||
143134039|NCT02869789|516037233|FG000|Overall Study|Participant request to discontinue study treatment|10|||
143134040|NCT02869789|516037234|FG001|Overall Study|Participant request to discontinue study treatment|5|||
143134041|NCT02869789|516037235|FG002|Overall Study|Participant request to discontinue study treatment|5|||
143134042|NCT02869789|516037236|FG003|Overall Study|Participant request to discontinue study treatment|3|||
143134043|NCT02869789|516037233|FG000|Overall Study|Withdrawal by Subject|5|||
143134044|NCT02869789|516037234|FG001|Overall Study|Withdrawal by Subject|2|||
143134045|NCT02869789|516037235|FG002|Overall Study|Withdrawal by Subject|7|||
143134046|NCT02869789|516037236|FG003|Overall Study|Withdrawal by Subject|2|||
143359829|NCT04955626|516859893|FG034|Blinded Period|Withdrawal by parent/guardian|0|||
143359830|NCT04955626|516859894|FG035|Blinded Period|Withdrawal by parent/guardian|0|||
143359831|NCT04955626|516859859|FG000|Blinded Period|Medication error|0|||
143359832|NCT04955626|516859860|FG001|Blinded Period|Medication error|0|||
143359833|NCT04955626|516859861|FG002|Blinded Period|Medication error|0|||
143359834|NCT04955626|516859862|FG003|Blinded Period|Medication error|0|||
143359835|NCT04955626|516859863|FG004|Blinded Period|Medication error|0|||
143359836|NCT04955626|516859864|FG005|Blinded Period|Medication error|0|||
143359837|NCT04955626|516859865|FG006|Blinded Period|Medication error|0|||
143359838|NCT04955626|516859866|FG007|Blinded Period|Medication error|0|||
143359839|NCT04955626|516859867|FG008|Blinded Period|Medication error|0|||
143359840|NCT04955626|516859868|FG009|Blinded Period|Medication error|0|||
143359841|NCT04955626|516859869|FG010|Blinded Period|Medication error|2|||
143359842|NCT04955626|516859870|FG011|Blinded Period|Medication error|0|||
143359843|NCT04955626|516859871|FG012|Blinded Period|Medication error|0|||
143359844|NCT04955626|516859872|FG013|Blinded Period|Medication error|0|||
143359845|NCT04955626|516859873|FG014|Blinded Period|Medication error|0|||
143359846|NCT04955626|516859874|FG015|Blinded Period|Medication error|0|||
143359847|NCT04955626|516859875|FG016|Blinded Period|Medication error|0|||
143359848|NCT04955626|516859876|FG017|Blinded Period|Medication error|0|||
143359849|NCT04955626|516859877|FG018|Blinded Period|Medication error|0|||
143359850|NCT04955626|516859878|FG019|Blinded Period|Medication error|0|||
143359851|NCT04955626|516859879|FG020|Blinded Period|Medication error|0|||
143359852|NCT04955626|516859880|FG021|Blinded Period|Medication error|0|||
143359853|NCT04955626|516859881|FG022|Blinded Period|Medication error|0|||
143359854|NCT04955626|516859882|FG023|Blinded Period|Medication error|0|||
143359855|NCT04955626|516859883|FG024|Blinded Period|Medication error|0|||
143359856|NCT04955626|516859884|FG025|Blinded Period|Medication error|0|||
143359857|NCT04955626|516859885|FG026|Blinded Period|Medication error|0|||
143359858|NCT04955626|516859886|FG027|Blinded Period|Medication error|0|||
143359859|NCT04955626|516859887|FG028|Blinded Period|Medication error|4|||
143359860|NCT04955626|516859888|FG029|Blinded Period|Medication error|0|||
143359861|NCT04955626|516859889|FG030|Blinded Period|Medication error|0|||
143359862|NCT04955626|516859890|FG031|Blinded Period|Medication error|0|||
143359863|NCT04955626|516859891|FG032|Blinded Period|Medication error|0|||
143359864|NCT04955626|516859892|FG033|Blinded Period|Medication error|0|||
143359865|NCT04955626|516859893|FG034|Blinded Period|Medication error|0|||
143359866|NCT04955626|516859894|FG035|Blinded Period|Medication error|0|||
143359867|NCT04955626|516859859|FG000|Open-Label Period|Lost to Follow-up|109|||
143359868|NCT04955626|516859860|FG001|Open-Label Period|Lost to Follow-up|41|||
143359869|NCT04955626|516859861|FG002|Open-Label Period|Lost to Follow-up|0|||
143359870|NCT04955626|516859862|FG003|Open-Label Period|Lost to Follow-up|0|||
143359871|NCT04955626|516859863|FG004|Open-Label Period|Lost to Follow-up|0|||
143359872|NCT04955626|516859864|FG005|Open-Label Period|Lost to Follow-up|0|||
143359873|NCT04955626|516859865|FG006|Open-Label Period|Lost to Follow-up|0|||
143359874|NCT04955626|516859866|FG007|Open-Label Period|Lost to Follow-up|0|||
143359875|NCT04955626|516859867|FG008|Open-Label Period|Lost to Follow-up|0|||
143359876|NCT04955626|516859868|FG009|Open-Label Period|Lost to Follow-up|0|||
143359877|NCT04955626|516859869|FG010|Open-Label Period|Lost to Follow-up|0|||
143359878|NCT04955626|516859870|FG011|Open-Label Period|Lost to Follow-up|0|||
143359879|NCT04955626|516859871|FG012|Open-Label Period|Lost to Follow-up|0|||
143359880|NCT04955626|516859872|FG013|Open-Label Period|Lost to Follow-up|0|||
143359881|NCT04955626|516859873|FG014|Open-Label Period|Lost to Follow-up|0|||
143359882|NCT04955626|516859874|FG015|Open-Label Period|Lost to Follow-up|0|||
143359883|NCT04955626|516859875|FG016|Open-Label Period|Lost to Follow-up|0|||
143359884|NCT04955626|516859876|FG017|Open-Label Period|Lost to Follow-up|0|||
143359885|NCT04955626|516859877|FG018|Open-Label Period|Lost to Follow-up|0|||
143359886|NCT04955626|516859878|FG019|Open-Label Period|Lost to Follow-up|0|||
143359887|NCT04955626|516859879|FG020|Open-Label Period|Lost to Follow-up|0|||
143359888|NCT04955626|516859880|FG021|Open-Label Period|Lost to Follow-up|0|||
143359889|NCT04955626|516859881|FG022|Open-Label Period|Lost to Follow-up|0|||
143359890|NCT04955626|516859882|FG023|Open-Label Period|Lost to Follow-up|0|||
143359891|NCT04955626|516859883|FG024|Open-Label Period|Lost to Follow-up|0|||
143359892|NCT04955626|516859884|FG025|Open-Label Period|Lost to Follow-up|0|||
143359893|NCT04955626|516859885|FG026|Open-Label Period|Lost to Follow-up|0|||
143359894|NCT04955626|516859886|FG027|Open-Label Period|Lost to Follow-up|0|||
143359895|NCT04955626|516859887|FG028|Open-Label Period|Lost to Follow-up|0|||
143359896|NCT04955626|516859888|FG029|Open-Label Period|Lost to Follow-up|0|||
143359897|NCT04955626|516859889|FG030|Open-Label Period|Lost to Follow-up|0|||
143134047|NCT02869789|516037233|FG000|Overall Study|Lost to Follow-up|0|||
143134048|NCT02869789|516037234|FG001|Overall Study|Lost to Follow-up|0|||
143134049|NCT02869789|516037235|FG002|Overall Study|Lost to Follow-up|2|||
143134050|NCT02869789|516037236|FG003|Overall Study|Lost to Follow-up|0|||
143134051|NCT02869789|516037233|FG000|Overall Study|Maximum clinical benefit|5|||
143134052|NCT02869789|516037234|FG001|Overall Study|Maximum clinical benefit|2|||
143134053|NCT02869789|516037235|FG002|Overall Study|Maximum clinical benefit|1|||
143359898|NCT04955626|516859890|FG031|Open-Label Period|Lost to Follow-up|0|||
143359899|NCT04955626|516859891|FG032|Open-Label Period|Lost to Follow-up|0|||
143359900|NCT04955626|516859892|FG033|Open-Label Period|Lost to Follow-up|0|||
143359901|NCT04955626|516859893|FG034|Open-Label Period|Lost to Follow-up|0|||
143359902|NCT04955626|516859894|FG035|Open-Label Period|Lost to Follow-up|0|||
143359903|NCT04955626|516859859|FG000|Open-Label Period|Protocol Violation|377|||
143359904|NCT04955626|516859860|FG001|Open-Label Period|Protocol Violation|48|||
143359905|NCT04955626|516859861|FG002|Open-Label Period|Protocol Violation|0|||
143359906|NCT04955626|516859862|FG003|Open-Label Period|Protocol Violation|0|||
143359907|NCT04955626|516859863|FG004|Open-Label Period|Protocol Violation|0|||
143359908|NCT04955626|516859864|FG005|Open-Label Period|Protocol Violation|0|||
143359909|NCT04955626|516859865|FG006|Open-Label Period|Protocol Violation|0|||
143359910|NCT04955626|516859866|FG007|Open-Label Period|Protocol Violation|0|||
143359911|NCT04955626|516859867|FG008|Open-Label Period|Protocol Violation|0|||
143359912|NCT04955626|516859868|FG009|Open-Label Period|Protocol Violation|0|||
143359913|NCT04955626|516859869|FG010|Open-Label Period|Protocol Violation|0|||
143359914|NCT04955626|516859870|FG011|Open-Label Period|Protocol Violation|0|||
143359915|NCT04955626|516859871|FG012|Open-Label Period|Protocol Violation|0|||
143359916|NCT04955626|516859872|FG013|Open-Label Period|Protocol Violation|0|||
143359917|NCT04955626|516859873|FG014|Open-Label Period|Protocol Violation|0|||
143359918|NCT04955626|516859874|FG015|Open-Label Period|Protocol Violation|0|||
143359919|NCT04955626|516859875|FG016|Open-Label Period|Protocol Violation|0|||
143359920|NCT04955626|516859876|FG017|Open-Label Period|Protocol Violation|0|||
143359921|NCT04955626|516859877|FG018|Open-Label Period|Protocol Violation|0|||
143359922|NCT04955626|516859878|FG019|Open-Label Period|Protocol Violation|0|||
143359923|NCT04955626|516859879|FG020|Open-Label Period|Protocol Violation|0|||
143359924|NCT04955626|516859880|FG021|Open-Label Period|Protocol Violation|0|||
143359925|NCT04955626|516859881|FG022|Open-Label Period|Protocol Violation|0|||
143359926|NCT04955626|516859882|FG023|Open-Label Period|Protocol Violation|0|||
143359927|NCT04955626|516859883|FG024|Open-Label Period|Protocol Violation|0|||
143359928|NCT04955626|516859884|FG025|Open-Label Period|Protocol Violation|0|||
143359929|NCT04955626|516859885|FG026|Open-Label Period|Protocol Violation|0|||
143359930|NCT04955626|516859886|FG027|Open-Label Period|Protocol Violation|0|||
143359931|NCT04955626|516859887|FG028|Open-Label Period|Protocol Violation|0|||
143359932|NCT04955626|516859888|FG029|Open-Label Period|Protocol Violation|0|||
143359933|NCT04955626|516859889|FG030|Open-Label Period|Protocol Violation|0|||
143359934|NCT04955626|516859890|FG031|Open-Label Period|Protocol Violation|0|||
143359935|NCT04955626|516859891|FG032|Open-Label Period|Protocol Violation|0|||
143359936|NCT04955626|516859892|FG033|Open-Label Period|Protocol Violation|0|||
143359937|NCT04955626|516859893|FG034|Open-Label Period|Protocol Violation|0|||
143359938|NCT04955626|516859894|FG035|Open-Label Period|Protocol Violation|0|||
143359939|NCT04955626|516859859|FG000|Open-Label Period|Death|5|||
143359940|NCT04955626|516859860|FG001|Open-Label Period|Death|5|||
143359941|NCT04955626|516859861|FG002|Open-Label Period|Death|0|||
143359942|NCT04955626|516859862|FG003|Open-Label Period|Death|0|||
143359943|NCT04955626|516859863|FG004|Open-Label Period|Death|0|||
143359944|NCT04955626|516859864|FG005|Open-Label Period|Death|0|||
143359945|NCT04955626|516859865|FG006|Open-Label Period|Death|0|||
143359946|NCT04955626|516859866|FG007|Open-Label Period|Death|0|||
143134054|NCT02869789|516037236|FG003|Overall Study|Maximum clinical benefit|0|||
143134055|NCT02869789|516037233|FG000|Overall Study|Poor/Non-compliance|0|||
143134056|NCT02869789|516037234|FG001|Overall Study|Poor/Non-compliance|2|||
143134057|NCT02869789|516037235|FG002|Overall Study|Poor/Non-compliance|1|||
143134058|NCT02869789|516037236|FG003|Overall Study|Poor/Non-compliance|0|||
143134059|NCT02869789|516037233|FG000|Overall Study|Participant no longer meets study criteria|0|||
143134060|NCT02869789|516037234|FG001|Overall Study|Participant no longer meets study criteria|1|||
143134061|NCT02869789|516037235|FG002|Overall Study|Participant no longer meets study criteria|1|||
143134062|NCT02869789|516037236|FG003|Overall Study|Participant no longer meets study criteria|0|||
143134063|NCT02869789|516037233|FG000|Overall Study|Administrative reason by sponsor|0|||
143134064|NCT02869789|516037234|FG001|Overall Study|Administrative reason by sponsor|0|||
143468802|NCT03602261|517263149|FG001|Overall Study|Physician Decision|0|||
143134065|NCT02869789|516037235|FG002|Overall Study|Administrative reason by sponsor|1|||
143468803|NCT03602261|517263148|FG000|Overall Study|Withdrawal by Subject|1|||
143134066|NCT02869789|516037236|FG003|Overall Study|Administrative reason by sponsor|0|||
143134067|NCT02869789|516037233|FG000|Overall Study|Other reasons|4|||
143359947|NCT04955626|516859867|FG008|Open-Label Period|Death|0|||
143134068|NCT02869789|516037234|FG001|Overall Study|Other reasons|8|||
143134069|NCT02869789|516037235|FG002|Overall Study|Other reasons|6|||
143134070|NCT02869789|516037236|FG003|Overall Study|Other reasons|0|||
143468804|NCT03602261|517263149|FG001|Overall Study|Withdrawal by Subject|1|||
143134071|NCT00676403|516037239|FG000|Overall Study|Adverse Event|1|||
143359948|NCT04955626|516859868|FG009|Open-Label Period|Death|0|||
143359949|NCT04955626|516859869|FG010|Open-Label Period|Death|0|||
143359950|NCT04955626|516859870|FG011|Open-Label Period|Death|0|||
143359951|NCT04955626|516859871|FG012|Open-Label Period|Death|0|||
143359952|NCT04955626|516859872|FG013|Open-Label Period|Death|0|||
143359953|NCT04955626|516859873|FG014|Open-Label Period|Death|0|||
143359954|NCT04955626|516859874|FG015|Open-Label Period|Death|0|||
143359955|NCT04955626|516859875|FG016|Open-Label Period|Death|0|||
143359956|NCT04955626|516859876|FG017|Open-Label Period|Death|0|||
143359957|NCT04955626|516859877|FG018|Open-Label Period|Death|0|||
143359958|NCT04955626|516859878|FG019|Open-Label Period|Death|0|||
143359959|NCT04955626|516859879|FG020|Open-Label Period|Death|0|||
143359960|NCT04955626|516859880|FG021|Open-Label Period|Death|0|||
143359961|NCT04955626|516859881|FG022|Open-Label Period|Death|0|||
143359962|NCT04955626|516859882|FG023|Open-Label Period|Death|0|||
143359963|NCT04955626|516859883|FG024|Open-Label Period|Death|0|||
143359964|NCT04955626|516859884|FG025|Open-Label Period|Death|0|||
143359965|NCT04955626|516859885|FG026|Open-Label Period|Death|0|||
143359966|NCT04955626|516859886|FG027|Open-Label Period|Death|0|||
143359967|NCT04955626|516859887|FG028|Open-Label Period|Death|0|||
143359968|NCT04955626|516859888|FG029|Open-Label Period|Death|0|||
143359969|NCT04955626|516859889|FG030|Open-Label Period|Death|0|||
143359970|NCT04955626|516859890|FG031|Open-Label Period|Death|0|||
143359971|NCT04955626|516859891|FG032|Open-Label Period|Death|0|||
143359972|NCT04955626|516859892|FG033|Open-Label Period|Death|0|||
143359973|NCT04955626|516859893|FG034|Open-Label Period|Death|0|||
143359974|NCT04955626|516859894|FG035|Open-Label Period|Death|0|||
143359975|NCT04955626|516859859|FG000|Open-Label Period|No longer meets eligibility criteria|20|||
143359976|NCT04955626|516859860|FG001|Open-Label Period|No longer meets eligibility criteria|4|||
143359977|NCT04955626|516859861|FG002|Open-Label Period|No longer meets eligibility criteria|0|||
143359978|NCT04955626|516859862|FG003|Open-Label Period|No longer meets eligibility criteria|0|||
143359979|NCT04955626|516859863|FG004|Open-Label Period|No longer meets eligibility criteria|0|||
143359980|NCT04955626|516859864|FG005|Open-Label Period|No longer meets eligibility criteria|0|||
143359981|NCT04955626|516859865|FG006|Open-Label Period|No longer meets eligibility criteria|0|||
143359982|NCT04955626|516859866|FG007|Open-Label Period|No longer meets eligibility criteria|0|||
143359983|NCT04955626|516859867|FG008|Open-Label Period|No longer meets eligibility criteria|0|||
143359984|NCT04955626|516859868|FG009|Open-Label Period|No longer meets eligibility criteria|0|||
143359985|NCT04955626|516859869|FG010|Open-Label Period|No longer meets eligibility criteria|0|||
143359986|NCT04955626|516859870|FG011|Open-Label Period|No longer meets eligibility criteria|0|||
143359987|NCT04955626|516859871|FG012|Open-Label Period|No longer meets eligibility criteria|0|||
143359988|NCT04955626|516859872|FG013|Open-Label Period|No longer meets eligibility criteria|0|||
143359989|NCT04955626|516859873|FG014|Open-Label Period|No longer meets eligibility criteria|0|||
143359990|NCT04955626|516859874|FG015|Open-Label Period|No longer meets eligibility criteria|0|||
143359991|NCT04955626|516859875|FG016|Open-Label Period|No longer meets eligibility criteria|0|||
143359992|NCT04955626|516859876|FG017|Open-Label Period|No longer meets eligibility criteria|0|||
143359993|NCT04955626|516859877|FG018|Open-Label Period|No longer meets eligibility criteria|0|||
143359994|NCT04955626|516859878|FG019|Open-Label Period|No longer meets eligibility criteria|0|||
143359995|NCT04955626|516859879|FG020|Open-Label Period|No longer meets eligibility criteria|0|||
143359996|NCT04955626|516859880|FG021|Open-Label Period|No longer meets eligibility criteria|0|||
143359997|NCT04955626|516859881|FG022|Open-Label Period|No longer meets eligibility criteria|0|||
143359998|NCT04955626|516859882|FG023|Open-Label Period|No longer meets eligibility criteria|0|||
143359999|NCT04955626|516859883|FG024|Open-Label Period|No longer meets eligibility criteria|0|||
143360000|NCT04955626|516859884|FG025|Open-Label Period|No longer meets eligibility criteria|0|||
143360001|NCT04955626|516859885|FG026|Open-Label Period|No longer meets eligibility criteria|0|||
143360002|NCT04955626|516859886|FG027|Open-Label Period|No longer meets eligibility criteria|0|||
143360003|NCT04955626|516859887|FG028|Open-Label Period|No longer meets eligibility criteria|0|||
143360004|NCT04955626|516859888|FG029|Open-Label Period|No longer meets eligibility criteria|0|||
143360005|NCT04955626|516859889|FG030|Open-Label Period|No longer meets eligibility criteria|0|||
143360006|NCT04955626|516859890|FG031|Open-Label Period|No longer meets eligibility criteria|0|||
143360007|NCT04955626|516859891|FG032|Open-Label Period|No longer meets eligibility criteria|0|||
143360008|NCT04955626|516859892|FG033|Open-Label Period|No longer meets eligibility criteria|0|||
143360009|NCT04955626|516859893|FG034|Open-Label Period|No longer meets eligibility criteria|0|||
143360010|NCT04955626|516859894|FG035|Open-Label Period|No longer meets eligibility criteria|0|||
143360011|NCT04955626|516859859|FG000|Open-Label Period|Other|621|||
143360012|NCT04955626|516859860|FG001|Open-Label Period|Other|429|||
143360013|NCT04955626|516859861|FG002|Open-Label Period|Other|0|||
143360014|NCT04955626|516859862|FG003|Open-Label Period|Other|0|||
143360015|NCT04955626|516859863|FG004|Open-Label Period|Other|0|||
143360016|NCT04955626|516859864|FG005|Open-Label Period|Other|0|||
143360017|NCT04955626|516859865|FG006|Open-Label Period|Other|0|||
143360018|NCT04955626|516859866|FG007|Open-Label Period|Other|0|||
143360019|NCT04955626|516859867|FG008|Open-Label Period|Other|0|||
143360020|NCT04955626|516859868|FG009|Open-Label Period|Other|0|||
143360021|NCT04955626|516859869|FG010|Open-Label Period|Other|0|||
143360022|NCT04955626|516859870|FG011|Open-Label Period|Other|0|||
143134072|NCT00676403|516037240|FG001|Overall Study|Adverse Event|2|||
143134073|NCT00676403|516037241|FG002|Overall Study|Adverse Event|0|||
143134074|NCT00676403|516037242|FG003|Overall Study|Adverse Event|5|||
143134075|NCT00676403|516037243|FG004|Overall Study|Adverse Event|1|||
143134076|NCT00676403|516037244|FG005|Overall Study|Adverse Event|2|||
143134077|NCT00676403|516037239|FG000|Overall Study|Lost to Follow-up|0|||
143134078|NCT00676403|516037240|FG001|Overall Study|Lost to Follow-up|0|||
143134079|NCT00676403|516037241|FG002|Overall Study|Lost to Follow-up|0|||
143134080|NCT00676403|516037242|FG003|Overall Study|Lost to Follow-up|0|||
143134081|NCT00676403|516037243|FG004|Overall Study|Lost to Follow-up|0|||
143134082|NCT00676403|516037244|FG005|Overall Study|Lost to Follow-up|1|||
143468805|NCT03602261|517263148|FG000|Overall Study|Lack of Efficacy|0|||
143468806|NCT03602261|517263149|FG001|Overall Study|Lack of Efficacy|1|||
143468807|NCT03602261|517263148|FG000|Overall Study|Subject moving out of state|1|||
143468808|NCT03602261|517263149|FG001|Overall Study|Subject moving out of state|0|||
143468809|NCT00909792|517264298|FG000|Period 1|Did not meet inclusion criteria|0|||
143468810|NCT00909792|517264299|FG001|Period 1|Did not meet inclusion criteria|1|||
143468811|NCT00909792|517264298|FG000|Period 2|Biomicroscopy|1|||
143468812|NCT00909792|517264299|FG001|Period 2|Biomicroscopy|0|||
143468813|NCT00909792|517264298|FG000|Period 2|Lost to Follow-up|0|||
143468814|NCT00909792|517264299|FG001|Period 2|Lost to Follow-up|1|||
143468815|NCT02464228|517264300|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
143468816|NCT02464228|517264301|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
143468817|NCT02464228|517264302|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
143468818|NCT02464228|517264303|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
143468819|NCT02464228|517264300|FG000|Overall Study|Physician Decision|2|||
143468820|NCT02464228|517264301|FG001|Overall Study|Physician Decision|0|||
143468821|NCT02464228|517264302|FG002|Overall Study|Physician Decision|1|||
143468822|NCT02464228|517264303|FG003|Overall Study|Physician Decision|0|||
143468823|NCT02464228|517264300|FG000|Overall Study|Miscellaneous|1|||
143468824|NCT02464228|517264301|FG001|Overall Study|Miscellaneous|0|||
143134083|NCT00676403|516037239|FG000|Overall Study|Reason Unspecified|1|||
143134084|NCT00676403|516037240|FG001|Overall Study|Reason Unspecified|0|||
143134085|NCT00676403|516037241|FG002|Overall Study|Reason Unspecified|1|||
143134086|NCT00676403|516037242|FG003|Overall Study|Reason Unspecified|0|||
143134087|NCT00676403|516037243|FG004|Overall Study|Reason Unspecified|0|||
143134088|NCT00676403|516037244|FG005|Overall Study|Reason Unspecified|1|||
143134089|NCT00676403|516037239|FG000|Overall Study|Withdrawal by Subject|0|||
143134090|NCT00676403|516037240|FG001|Overall Study|Withdrawal by Subject|0|||
143134091|NCT00676403|516037241|FG002|Overall Study|Withdrawal by Subject|0|||
143134092|NCT00676403|516037242|FG003|Overall Study|Withdrawal by Subject|0|||
143134093|NCT00676403|516037243|FG004|Overall Study|Withdrawal by Subject|0|||
143134094|NCT00676403|516037244|FG005|Overall Study|Withdrawal by Subject|1|||
143134095|NCT01746862|516037246|FG000|Overall Study|Withdrawal by Subject|1|||
143134096|NCT01746862|516037247|FG001|Overall Study|Withdrawal by Subject|1|||
143134097|NCT01746862|516037246|FG000|Overall Study|Protocol Violation|1|||
143134098|NCT01746862|516037247|FG001|Overall Study|Protocol Violation|0|||
143134099|NCT01746862|516037246|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
143134100|NCT01746862|516037247|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
143134101|NCT01746862|516037246|FG000|Overall Study|Entered puberty during the study|1|||
143134102|NCT01746862|516037247|FG001|Overall Study|Entered puberty during the study|0|||
143134103|NCT01825200|516037251|FG000|Overall Study|Lost to Follow-up|5|||
143134104|NCT01825200|516037252|FG001|Overall Study|Lost to Follow-up|6|||
143134105|NCT01825200|516037251|FG000|Overall Study|Withdrawal by Subject|0|||
143134106|NCT01825200|516037252|FG001|Overall Study|Withdrawal by Subject|1|||
143134107|NCT00731822|516037256|FG000|Overall Study|Adverse Event|2|||
143134108|NCT00731822|516037257|FG001|Overall Study|Adverse Event|1|||
143134109|NCT00731822|516037256|FG000|Overall Study|Protocol Violation|1|||
143134110|NCT00731822|516037257|FG001|Overall Study|Protocol Violation|0|||
143468825|NCT02464228|517264302|FG002|Overall Study|Miscellaneous|1|||
143468826|NCT02464228|517264303|FG003|Overall Study|Miscellaneous|0|||
143468827|NCT02464228|517264300|FG000|Overall Study|Adverse Event|9|||
143468828|NCT02464228|517264301|FG001|Overall Study|Adverse Event|0|||
143468829|NCT02464228|517264302|FG002|Overall Study|Adverse Event|3|||
143468830|NCT02464228|517264303|FG003|Overall Study|Adverse Event|0|||
143468831|NCT02464228|517264300|FG000|Overall Study|Withdrawal by Subject|1|||
143468832|NCT02464228|517264301|FG001|Overall Study|Withdrawal by Subject|1|||
143468833|NCT02464228|517264302|FG002|Overall Study|Withdrawal by Subject|1|||
143134111|NCT00731822|516037256|FG000|Overall Study|Lost to Follow-up|1|||
143134112|NCT00731822|516037257|FG001|Overall Study|Lost to Follow-up|0|||
143134113|NCT02131064|516037264|FG000|Overall Study|Death|5|||
143134114|NCT02131064|516037265|FG001|Overall Study|Death|6|||
143134115|NCT02131064|516037264|FG000|Overall Study|Lost to Follow-up|4|||
143134116|NCT02131064|516037265|FG001|Overall Study|Lost to Follow-up|8|||
143134117|NCT02131064|516037264|FG000|Overall Study|Withdrawal by Subject|14|||
143134118|NCT02131064|516037265|FG001|Overall Study|Withdrawal by Subject|18|||
143468834|NCT02464228|517264303|FG003|Overall Study|Withdrawal by Subject|0|||
143468835|NCT02464228|517264300|FG000|Overall Study|Disease Progression|22|||
143134119|NCT02131064|516037264|FG000|Overall Study|Other|2|||
143134120|NCT02131064|516037265|FG001|Overall Study|Other|2|||
143360023|NCT04955626|516859871|FG012|Open-Label Period|Other|0|||
143360024|NCT04955626|516859872|FG013|Open-Label Period|Other|0|||
143360025|NCT04955626|516859873|FG014|Open-Label Period|Other|0|||
143360026|NCT04955626|516859874|FG015|Open-Label Period|Other|0|||
143360027|NCT04955626|516859875|FG016|Open-Label Period|Other|0|||
143360028|NCT04955626|516859876|FG017|Open-Label Period|Other|0|||
143360029|NCT04955626|516859877|FG018|Open-Label Period|Other|0|||
143360030|NCT04955626|516859878|FG019|Open-Label Period|Other|0|||
143360031|NCT04955626|516859879|FG020|Open-Label Period|Other|0|||
143360032|NCT04955626|516859880|FG021|Open-Label Period|Other|0|||
143360033|NCT04955626|516859881|FG022|Open-Label Period|Other|0|||
143360034|NCT04955626|516859882|FG023|Open-Label Period|Other|0|||
143360035|NCT04955626|516859883|FG024|Open-Label Period|Other|0|||
143360036|NCT04955626|516859884|FG025|Open-Label Period|Other|0|||
143360037|NCT04955626|516859885|FG026|Open-Label Period|Other|0|||
143360038|NCT04955626|516859886|FG027|Open-Label Period|Other|0|||
143360039|NCT04955626|516859887|FG028|Open-Label Period|Other|0|||
143360040|NCT04955626|516859888|FG029|Open-Label Period|Other|0|||
143360041|NCT04955626|516859889|FG030|Open-Label Period|Other|0|||
143360042|NCT04955626|516859890|FG031|Open-Label Period|Other|0|||
143360043|NCT04955626|516859891|FG032|Open-Label Period|Other|0|||
143360044|NCT04955626|516859892|FG033|Open-Label Period|Other|0|||
143360045|NCT04955626|516859893|FG034|Open-Label Period|Other|0|||
143360046|NCT04955626|516859894|FG035|Open-Label Period|Other|0|||
143360047|NCT04955626|516859859|FG000|Open-Label Period|Physician Decision|2|||
143360048|NCT04955626|516859860|FG001|Open-Label Period|Physician Decision|0|||
143360049|NCT04955626|516859861|FG002|Open-Label Period|Physician Decision|0|||
143360050|NCT04955626|516859862|FG003|Open-Label Period|Physician Decision|0|||
143360051|NCT04955626|516859863|FG004|Open-Label Period|Physician Decision|0|||
143360052|NCT04955626|516859864|FG005|Open-Label Period|Physician Decision|0|||
143360053|NCT04955626|516859865|FG006|Open-Label Period|Physician Decision|0|||
143360054|NCT04955626|516859866|FG007|Open-Label Period|Physician Decision|0|||
143360055|NCT04955626|516859867|FG008|Open-Label Period|Physician Decision|0|||
143360056|NCT04955626|516859868|FG009|Open-Label Period|Physician Decision|0|||
143360057|NCT04955626|516859869|FG010|Open-Label Period|Physician Decision|0|||
143360058|NCT04955626|516859870|FG011|Open-Label Period|Physician Decision|0|||
143360059|NCT04955626|516859871|FG012|Open-Label Period|Physician Decision|0|||
143360060|NCT04955626|516859872|FG013|Open-Label Period|Physician Decision|0|||
143360061|NCT04955626|516859873|FG014|Open-Label Period|Physician Decision|0|||
143360062|NCT04955626|516859874|FG015|Open-Label Period|Physician Decision|0|||
143360063|NCT04955626|516859875|FG016|Open-Label Period|Physician Decision|0|||
143360064|NCT04955626|516859876|FG017|Open-Label Period|Physician Decision|0|||
143360065|NCT04955626|516859877|FG018|Open-Label Period|Physician Decision|0|||
143360066|NCT04955626|516859878|FG019|Open-Label Period|Physician Decision|0|||
143360067|NCT04955626|516859879|FG020|Open-Label Period|Physician Decision|0|||
143360068|NCT04955626|516859880|FG021|Open-Label Period|Physician Decision|0|||
143360069|NCT04955626|516859881|FG022|Open-Label Period|Physician Decision|0|||
143360070|NCT04955626|516859882|FG023|Open-Label Period|Physician Decision|0|||
143360071|NCT04955626|516859883|FG024|Open-Label Period|Physician Decision|0|||
143360072|NCT04955626|516859884|FG025|Open-Label Period|Physician Decision|0|||
143360073|NCT04955626|516859885|FG026|Open-Label Period|Physician Decision|0|||
143360074|NCT04955626|516859886|FG027|Open-Label Period|Physician Decision|0|||
143360075|NCT04955626|516859887|FG028|Open-Label Period|Physician Decision|0|||
143360076|NCT04955626|516859888|FG029|Open-Label Period|Physician Decision|0|||
143360077|NCT04955626|516859889|FG030|Open-Label Period|Physician Decision|0|||
143360078|NCT04955626|516859890|FG031|Open-Label Period|Physician Decision|0|||
143360079|NCT04955626|516859891|FG032|Open-Label Period|Physician Decision|0|||
143360080|NCT04955626|516859892|FG033|Open-Label Period|Physician Decision|0|||
143360081|NCT04955626|516859893|FG034|Open-Label Period|Physician Decision|0|||
143360082|NCT04955626|516859894|FG035|Open-Label Period|Physician Decision|0|||
143360083|NCT04955626|516859859|FG000|Open-Label Period|Withdrawal by Subject|135|||
143360084|NCT04955626|516859860|FG001|Open-Label Period|Withdrawal by Subject|25|||
143360085|NCT04955626|516859861|FG002|Open-Label Period|Withdrawal by Subject|0|||
143360086|NCT04955626|516859862|FG003|Open-Label Period|Withdrawal by Subject|0|||
143360087|NCT04955626|516859863|FG004|Open-Label Period|Withdrawal by Subject|0|||
143360088|NCT04955626|516859864|FG005|Open-Label Period|Withdrawal by Subject|0|||
143360089|NCT04955626|516859865|FG006|Open-Label Period|Withdrawal by Subject|0|||
143360090|NCT04955626|516859866|FG007|Open-Label Period|Withdrawal by Subject|0|||
143360091|NCT04955626|516859867|FG008|Open-Label Period|Withdrawal by Subject|0|||
143360092|NCT04955626|516859868|FG009|Open-Label Period|Withdrawal by Subject|0|||
143360093|NCT04955626|516859869|FG010|Open-Label Period|Withdrawal by Subject|0|||
143360094|NCT04955626|516859870|FG011|Open-Label Period|Withdrawal by Subject|0|||
143134121|NCT03589807|516037268|FG000|Overall Study|Lost to Follow-up|0|||
143134122|NCT03589807|516037269|FG001|Overall Study|Lost to Follow-up|2|||
143360095|NCT04955626|516859871|FG012|Open-Label Period|Withdrawal by Subject|0|||
143360096|NCT04955626|516859872|FG013|Open-Label Period|Withdrawal by Subject|0|||
143360097|NCT04955626|516859873|FG014|Open-Label Period|Withdrawal by Subject|0|||
143468836|NCT02464228|517264301|FG001|Overall Study|Disease Progression|12|||
143468837|NCT02464228|517264302|FG002|Overall Study|Disease Progression|5|||
143468838|NCT02464228|517264303|FG003|Overall Study|Disease Progression|2|||
143468839|NCT01117454|517264306|FG000|Overall Study|Pregnancy|0|||
143468840|NCT01117454|517264307|FG001|Overall Study|Pregnancy|1|||
143468841|NCT02502266|517264311|FG000|Overall Study|Adverse Event|0|||
143468842|NCT02502266|517264312|FG001|Overall Study|Adverse Event|0|||
143468843|NCT02502266|517264313|FG002|Overall Study|Adverse Event|0|||
143468844|NCT02502266|517264314|FG003|Overall Study|Adverse Event|0|||
143468845|NCT02502266|517264315|FG004|Overall Study|Adverse Event|1|||
143468846|NCT02502266|517264316|FG005|Overall Study|Adverse Event|1|||
143468847|NCT02502266|517264317|FG006|Overall Study|Adverse Event|1|||
143468848|NCT02502266|517264311|FG000|Overall Study|Withdrawal by Subject|30|||
143468849|NCT02502266|517264312|FG001|Overall Study|Withdrawal by Subject|15|||
143468850|NCT02502266|517264313|FG002|Overall Study|Withdrawal by Subject|16|||
143468851|NCT02502266|517264314|FG003|Overall Study|Withdrawal by Subject|0|||
143468852|NCT02502266|517264315|FG004|Overall Study|Withdrawal by Subject|0|||
143468853|NCT02502266|517264316|FG005|Overall Study|Withdrawal by Subject|0|||
143468854|NCT02502266|517264317|FG006|Overall Study|Withdrawal by Subject|0|||
143468855|NCT02502266|517264311|FG000|Overall Study|Still on Treatment|0|||
143468856|NCT02502266|517264312|FG001|Overall Study|Still on Treatment|0|||
143468857|NCT02502266|517264313|FG002|Overall Study|Still on Treatment|1|||
143468858|NCT02502266|517264314|FG003|Overall Study|Still on Treatment|0|||
143468859|NCT02502266|517264315|FG004|Overall Study|Still on Treatment|0|||
143468860|NCT02502266|517264316|FG005|Overall Study|Still on Treatment|0|||
143468861|NCT02502266|517264317|FG006|Overall Study|Still on Treatment|0|||
143468862|NCT02502266|517264311|FG000|Overall Study|Other Reasons|19|||
143468863|NCT02502266|517264312|FG001|Overall Study|Other Reasons|6|||
143468864|NCT02502266|517264313|FG002|Overall Study|Other Reasons|14|||
143468865|NCT02502266|517264314|FG003|Overall Study|Other Reasons|0|||
143468866|NCT02502266|517264315|FG004|Overall Study|Other Reasons|1|||
143468867|NCT02502266|517264316|FG005|Overall Study|Other Reasons|1|||
143468868|NCT02502266|517264317|FG006|Overall Study|Other Reasons|0|||
143468869|NCT02502266|517264311|FG000|Overall Study|Arm 4 Discontinued|0|||
143468870|NCT02502266|517264312|FG001|Overall Study|Arm 4 Discontinued|0|||
143468871|NCT02502266|517264313|FG002|Overall Study|Arm 4 Discontinued|0|||
143468872|NCT02502266|517264314|FG003|Overall Study|Arm 4 Discontinued|52|||
143468873|NCT02502266|517264315|FG004|Overall Study|Arm 4 Discontinued|0|||
143468874|NCT02502266|517264316|FG005|Overall Study|Arm 4 Discontinued|0|||
143468875|NCT02502266|517264317|FG006|Overall Study|Arm 4 Discontinued|0|||
143468876|NCT02502266|517264311|FG000|Overall Study|Never treated|0|||
143468877|NCT02502266|517264312|FG001|Overall Study|Never treated|0|||
143468878|NCT02502266|517264313|FG002|Overall Study|Never treated|0|||
143468879|NCT02502266|517264314|FG003|Overall Study|Never treated|0|||
143468880|NCT02502266|517264315|FG004|Overall Study|Never treated|0|||
143468881|NCT02502266|517264316|FG005|Overall Study|Never treated|1|||
143468882|NCT02502266|517264317|FG006|Overall Study|Never treated|0|||
143468883|NCT01637623|517264318|FG000|Overall Study|Lost to Follow-up|0|||
143468884|NCT01637623|517264319|FG001|Overall Study|Lost to Follow-up|0|||
143468885|NCT01637623|517264320|FG002|Overall Study|Lost to Follow-up|2|||
143468886|NCT01637623|517264318|FG000|Overall Study|Physician Decision|1|||
143468887|NCT01637623|517264319|FG001|Overall Study|Physician Decision|0|||
143468888|NCT01637623|517264320|FG002|Overall Study|Physician Decision|1|||
143468889|NCT02634346|517264323|FG000|Overall Study|Withdrawal by Subject|8|||
143468890|NCT02634346|517264324|FG001|Overall Study|Withdrawal by Subject|9|||
143468891|NCT02634346|517264325|FG002|Overall Study|Withdrawal by Subject|8|||
143468892|NCT02634346|517264323|FG000|Overall Study|Adverse Event|2|||
143468893|NCT02634346|517264324|FG001|Overall Study|Adverse Event|2|||
143468894|NCT02634346|517264325|FG002|Overall Study|Adverse Event|7|||
143468895|NCT02634346|517264323|FG000|Overall Study|Lack of Efficacy|1|||
143468896|NCT02634346|517264324|FG001|Overall Study|Lack of Efficacy|2|||
143468897|NCT02634346|517264325|FG002|Overall Study|Lack of Efficacy|8|||
143468898|NCT02634346|517264323|FG000|Overall Study|Lost to Follow-up|1|||
143468899|NCT02634346|517264324|FG001|Overall Study|Lost to Follow-up|0|||
143468900|NCT02634346|517264325|FG002|Overall Study|Lost to Follow-up|0|||
143468901|NCT02634346|517264323|FG000|Overall Study|Protocol Violation|0|||
143468902|NCT02634346|517264324|FG001|Overall Study|Protocol Violation|1|||
143468903|NCT02634346|517264325|FG002|Overall Study|Protocol Violation|0|||
143468904|NCT04615247|517264326|FG000|Overall Study|Adverse Event|0|||
143468905|NCT04615247|517264327|FG001|Overall Study|Adverse Event|2|||
143468906|NCT04615247|517264326|FG000|Overall Study|Withdrawal by Subject|1|||
143468907|NCT04615247|517264327|FG001|Overall Study|Withdrawal by Subject|1|||
143468908|NCT00221195|517264332|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
143468909|NCT00221195|517264333|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
143468910|NCT00221195|517264332|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
143468911|NCT00221195|517264333|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
143468912|NCT00221195|517264332|FG000|Washout Period (Months 7-9)|Death|0|||
143468913|NCT00221195|517264333|FG001|Washout Period (Months 7-9)|Death|1|||
143468914|NCT00221195|517264332|FG000|Therapy 2 (Months 10-15)|Death|1|||
143468915|NCT00221195|517264333|FG001|Therapy 2 (Months 10-15)|Death|0|||
143134123|NCT03589807|516037270|FG002|Overall Study|Lost to Follow-up|2|||
143134124|NCT03589807|516037271|FG003|Overall Study|Lost to Follow-up|3|||
143468916|NCT00221195|517264332|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
143468917|NCT00221195|517264333|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
143468918|NCT00216203|517264335|FG000|Overall Study|Withdrawal by Subject|2|||
143468919|NCT02596620|517264336|FG000|Overall Study|Lost to Follow-up|1|||
143468920|NCT02596620|517264337|FG001|Overall Study|Lost to Follow-up|1|||
143468921|NCT04658186|517264338|FG000|Overall Study|Adverse Event|4|||
143468922|NCT04658186|517264339|FG001|Overall Study|Adverse Event|18|||
143468923|NCT04658186|517264340|FG002|Overall Study|Adverse Event|15|||
143468924|NCT04658186|517264338|FG000|Overall Study|Lack of Efficacy|1|||
143468925|NCT04658186|517264339|FG001|Overall Study|Lack of Efficacy|1|||
143468926|NCT04658186|517264340|FG002|Overall Study|Lack of Efficacy|0|||
143468927|NCT04658186|517264338|FG000|Overall Study|Protocol Violation|0|||
143468928|NCT04658186|517264339|FG001|Overall Study|Protocol Violation|0|||
143468929|NCT04658186|517264340|FG002|Overall Study|Protocol Violation|1|||
143468930|NCT04658186|517264338|FG000|Overall Study|Lost to Follow-up|0|||
143468931|NCT04658186|517264339|FG001|Overall Study|Lost to Follow-up|0|||
143468932|NCT04658186|517264340|FG002|Overall Study|Lost to Follow-up|2|||
143468933|NCT04658186|517264338|FG000|Overall Study|Participant Not Eligible. Randomized In Error|1|||
143468934|NCT04658186|517264339|FG001|Overall Study|Participant Not Eligible. Randomized In Error|0|||
143468935|NCT04658186|517264340|FG002|Overall Study|Participant Not Eligible. Randomized In Error|1|||
143468936|NCT04658186|517264338|FG000|Overall Study|Participant is Moving in Another Province|0|||
143468937|NCT04658186|517264339|FG001|Overall Study|Participant is Moving in Another Province|1|||
143468938|NCT04658186|517264340|FG002|Overall Study|Participant is Moving in Another Province|0|||
143468939|NCT04658186|517264338|FG000|Overall Study|Non-Compliance|0|||
143468940|NCT04658186|517264339|FG001|Overall Study|Non-Compliance|1|||
143468941|NCT04658186|517264340|FG002|Overall Study|Non-Compliance|1|||
143468942|NCT04658186|517264338|FG000|Overall Study|Site Closure; Participant declined transfer|0|||
143468943|NCT04658186|517264339|FG001|Overall Study|Site Closure; Participant declined transfer|1|||
143468944|NCT04658186|517264340|FG002|Overall Study|Site Closure; Participant declined transfer|0|||
143468945|NCT04658186|517264338|FG000|Overall Study|Dropout on the Promotor's Decision|0|||
143468946|NCT04658186|517264339|FG001|Overall Study|Dropout on the Promotor's Decision|0|||
143468947|NCT04658186|517264340|FG002|Overall Study|Dropout on the Promotor's Decision|1|||
143468948|NCT04658186|517264338|FG000|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
143468949|NCT04658186|517264339|FG001|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
143468950|NCT04658186|517264340|FG002|Overall Study|Worsening Symptoms; Participant Withdrew|1|||
143468951|NCT04658186|517264338|FG000|Overall Study|PI Decision due to Participant Safety|0|||
143468952|NCT04658186|517264339|FG001|Overall Study|PI Decision due to Participant Safety|0|||
143468953|NCT04658186|517264340|FG002|Overall Study|PI Decision due to Participant Safety|1|||
143468954|NCT04658186|517264338|FG000|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|5|||
143468955|NCT04658186|517264339|FG001|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|6|||
143468956|NCT04658186|517264340|FG002|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|3|||
143468957|NCT03801902|517264341|FG000|Overall Study|Did not receive protocol treatment.|1|||
143468958|NCT03801902|517264342|FG001|Overall Study|Did not receive protocol treatment.|0|||
143468959|NCT03801902|517264343|FG002|Overall Study|Did not receive protocol treatment.|0|||
143468960|NCT03801902|517264344|FG003|Overall Study|Did not receive protocol treatment.|0|||
143468961|NCT02993523|517264350|FG000|Overall Study|Withdrew Consent|0|||
143134125|NCT03589807|516037272|FG004|Overall Study|Lost to Follow-up|1|||
143134126|NCT03589807|516037273|FG005|Overall Study|Lost to Follow-up|1|||
143134127|NCT03589807|516037268|FG000|Overall Study|Withdrawal by Subject|0|||
143134128|NCT03589807|516037269|FG001|Overall Study|Withdrawal by Subject|5|||
143134129|NCT03589807|516037270|FG002|Overall Study|Withdrawal by Subject|0|||
143134130|NCT03589807|516037271|FG003|Overall Study|Withdrawal by Subject|0|||
143134131|NCT03589807|516037272|FG004|Overall Study|Withdrawal by Subject|0|||
143134132|NCT03589807|516037273|FG005|Overall Study|Withdrawal by Subject|0|||
143134133|NCT03589807|516037268|FG000|Overall Study|Protocol Violation|0|||
143134134|NCT03589807|516037269|FG001|Overall Study|Protocol Violation|0|||
143134135|NCT03589807|516037270|FG002|Overall Study|Protocol Violation|0|||
143134136|NCT03589807|516037271|FG003|Overall Study|Protocol Violation|1|||
143134137|NCT03589807|516037272|FG004|Overall Study|Protocol Violation|0|||
143134138|NCT03589807|516037273|FG005|Overall Study|Protocol Violation|0|||
143134139|NCT03589807|516037268|FG000|Overall Study|Enrolled but treatment not administered|0|||
143134140|NCT03589807|516037269|FG001|Overall Study|Enrolled but treatment not administered|0|||
143134141|NCT03589807|516037270|FG002|Overall Study|Enrolled but treatment not administered|0|||
143468962|NCT02993523|517264351|FG001|Overall Study|Withdrew Consent|0|||
143468963|NCT02993523|517264352|FG002|Overall Study|Withdrew Consent|2|||
143468964|NCT02993523|517264353|FG003|Overall Study|Withdrew Consent|9|||
143468965|NCT02993523|517264354|FG004|Overall Study|Withdrew Consent|0|||
143134142|NCT03589807|516037271|FG003|Overall Study|Enrolled but treatment not administered|0|||
143134143|NCT03589807|516037272|FG004|Overall Study|Enrolled but treatment not administered|1|||
143134144|NCT03589807|516037273|FG005|Overall Study|Enrolled but treatment not administered|0|||
143134145|NCT03143101|516037274|FG000|Overall Study|Withdrawal by Subject|0|||
143134146|NCT03143101|516037275|FG001|Overall Study|Withdrawal by Subject|1|||
143134147|NCT03143101|516037276|FG002|Overall Study|Withdrawal by Subject|0|||
143134148|NCT03143101|516037274|FG000|Overall Study|Lost to Follow-up|2|||
143134149|NCT03143101|516037275|FG001|Overall Study|Lost to Follow-up|2|||
143134150|NCT03143101|516037276|FG002|Overall Study|Lost to Follow-up|0|||
143134151|NCT05227118|516037279|FG000|Overall Study|Adverse Event|0|||
143134152|NCT05227118|516037280|FG001|Overall Study|Adverse Event|0|||
143134153|NCT05227118|516037281|FG002|Overall Study|Adverse Event|1|||
143134154|NCT05227118|516037282|FG003|Overall Study|Adverse Event|0|||
143134155|NCT05227118|516037279|FG000|Overall Study|Withdrawal by Subject|0|||
143134156|NCT05227118|516037280|FG001|Overall Study|Withdrawal by Subject|0|||
143134157|NCT05227118|516037281|FG002|Overall Study|Withdrawal by Subject|2|||
143134158|NCT05227118|516037282|FG003|Overall Study|Withdrawal by Subject|0|||
143134159|NCT01435759|516037283|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
143134160|NCT01435759|516037284|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
143134161|NCT01435759|516037285|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
143134162|NCT01435759|516037286|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
143134163|NCT01435759|516037287|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
143134164|NCT01435759|516037288|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
143134165|NCT01435759|516037283|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
143134166|NCT01435759|516037284|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
143134167|NCT01435759|516037285|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
143134168|NCT01435759|516037286|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
143134169|NCT01435759|516037287|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
143134170|NCT01435759|516037288|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
143134171|NCT01435759|516037283|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
143134172|NCT01435759|516037284|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
143134173|NCT01435759|516037285|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
143134174|NCT01435759|516037286|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
143134175|NCT01435759|516037287|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
143134176|NCT01435759|516037288|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
143134177|NCT01435759|516037283|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
143134178|NCT01435759|516037284|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
143134179|NCT01435759|516037285|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
143134180|NCT01435759|516037286|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
143134181|NCT01435759|516037287|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
143134182|NCT01435759|516037288|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
143134183|NCT01435759|516037283|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
143134184|NCT01435759|516037284|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
143134185|NCT01435759|516037285|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
143134186|NCT01435759|516037286|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
143134187|NCT01435759|516037287|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
143134188|NCT01435759|516037288|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
143134189|NCT01435759|516037283|FG000|Antidepressant Lead-in Phase|Other|119|||
143134190|NCT01435759|516037284|FG001|Antidepressant Lead-in Phase|Other|0|||
143134191|NCT01435759|516037285|FG002|Antidepressant Lead-in Phase|Other|0|||
143134192|NCT01435759|516037286|FG003|Antidepressant Lead-in Phase|Other|0|||
143134193|NCT01435759|516037287|FG004|Antidepressant Lead-in Phase|Other|0|||
143360098|NCT04955626|516859874|FG015|Open-Label Period|Withdrawal by Subject|0|||
143360099|NCT04955626|516859875|FG016|Open-Label Period|Withdrawal by Subject|0|||
143360100|NCT04955626|516859876|FG017|Open-Label Period|Withdrawal by Subject|0|||
143360101|NCT04955626|516859877|FG018|Open-Label Period|Withdrawal by Subject|0|||
143360102|NCT04955626|516859878|FG019|Open-Label Period|Withdrawal by Subject|0|||
143360103|NCT04955626|516859879|FG020|Open-Label Period|Withdrawal by Subject|0|||
143360104|NCT04955626|516859880|FG021|Open-Label Period|Withdrawal by Subject|0|||
143360105|NCT04955626|516859881|FG022|Open-Label Period|Withdrawal by Subject|0|||
143360106|NCT04955626|516859882|FG023|Open-Label Period|Withdrawal by Subject|0|||
143360107|NCT04955626|516859883|FG024|Open-Label Period|Withdrawal by Subject|0|||
143360108|NCT04955626|516859884|FG025|Open-Label Period|Withdrawal by Subject|0|||
143360109|NCT04955626|516859885|FG026|Open-Label Period|Withdrawal by Subject|0|||
143360110|NCT04955626|516859886|FG027|Open-Label Period|Withdrawal by Subject|0|||
143360111|NCT04955626|516859887|FG028|Open-Label Period|Withdrawal by Subject|0|||
143360112|NCT04955626|516859888|FG029|Open-Label Period|Withdrawal by Subject|0|||
143360113|NCT04955626|516859889|FG030|Open-Label Period|Withdrawal by Subject|0|||
143360114|NCT04955626|516859890|FG031|Open-Label Period|Withdrawal by Subject|0|||
143360115|NCT04955626|516859891|FG032|Open-Label Period|Withdrawal by Subject|0|||
143360116|NCT04955626|516859892|FG033|Open-Label Period|Withdrawal by Subject|0|||
143134194|NCT01435759|516037288|FG005|Antidepressant Lead-in Phase|Other|0|||
143134195|NCT01435759|516037283|FG000|Double-blind Phase|Adverse Event|7|||
143134196|NCT01435759|516037284|FG001|Double-blind Phase|Adverse Event|0|||
143360117|NCT04955626|516859893|FG034|Open-Label Period|Withdrawal by Subject|0|||
143360118|NCT04955626|516859894|FG035|Open-Label Period|Withdrawal by Subject|0|||
143468966|NCT02993523|517264350|FG000|Overall Study|Lost to Follow-up|0|||
143468967|NCT02993523|517264351|FG001|Overall Study|Lost to Follow-up|0|||
143468968|NCT02993523|517264352|FG002|Overall Study|Lost to Follow-up|3|||
143468969|NCT02993523|517264353|FG003|Overall Study|Lost to Follow-up|6|||
143468970|NCT02993523|517264354|FG004|Overall Study|Lost to Follow-up|0|||
143468971|NCT02993523|517264350|FG000|Overall Study|Death|1|||
143468972|NCT02993523|517264351|FG001|Overall Study|Death|1|||
143468973|NCT02993523|517264352|FG002|Overall Study|Death|138|||
143468974|NCT02993523|517264353|FG003|Overall Study|Death|222|||
143468975|NCT02993523|517264354|FG004|Overall Study|Death|6|||
143468976|NCT02993523|517264350|FG000|Overall Study|Reason not Specified|0|||
143468977|NCT02993523|517264351|FG001|Overall Study|Reason not Specified|0|||
143468978|NCT02993523|517264352|FG002|Overall Study|Reason not Specified|1|||
143468979|NCT02993523|517264353|FG003|Overall Study|Reason not Specified|1|||
143468980|NCT02993523|517264354|FG004|Overall Study|Reason not Specified|0|||
143468981|NCT03694418|517264355|FG000|Overall Study|Lost to Follow-up|115|||
143468982|NCT03694418|517264356|FG001|Overall Study|Lost to Follow-up|23|||
143468983|NCT03694418|517264357|FG002|Overall Study|Lost to Follow-up|12|||
143468984|NCT03694418|517264358|FG003|Overall Study|Lost to Follow-up|12|||
143468985|NCT03694418|517264359|FG004|Overall Study|Lost to Follow-up|13|||
143468986|NCT04288778|517264374|FG000|Overall Study|Withdrawal by Subject|2|||
143468987|NCT04288778|517264374|FG000|Overall Study|Adverse Event|5|||
143468988|NCT04288778|517264374|FG000|Overall Study|Non-Compliance With Study Drug|1|||
143468989|NCT04288778|517264374|FG000|Overall Study|Other|1|||
143468990|NCT04288778|517264374|FG000|Overall Study|Started but not treated|2|||
143468991|NCT05057247|517264375|FG000|Overall Study|Death|4|||
143468992|NCT05057247|517264375|FG000|Overall Study|Physician Decision|3|||
143468993|NCT05057247|517264375|FG000|Overall Study|Progressive Disease|7|||
143468994|NCT05057247|517264375|FG000|Overall Study|Withdrawal by Subject|3|||
143468995|NCT05057247|517264375|FG000|Overall Study|Adverse Event|6|||
143468996|NCT05057247|517264375|FG000|Overall Study|Subject Non-Compliance|1|||
143468997|NCT05057247|517264375|FG000|Overall Study|On treatment|2|||
143468998|NCT00784693|517264376|FG000|Overall Study|Lost to Follow-up|0|||
143468999|NCT00784693|517264377|FG001|Overall Study|Lost to Follow-up|1|||
143469000|NCT00784693|517264376|FG000|Overall Study|Lack of Efficacy|1|||
143469001|NCT00784693|517264377|FG001|Overall Study|Lack of Efficacy|1|||
143469002|NCT00784693|517264376|FG000|Overall Study|Withdrawal by Subject|0|||
143469003|NCT00784693|517264377|FG001|Overall Study|Withdrawal by Subject|4|||
143134197|NCT01435759|516037285|FG002|Double-blind Phase|Adverse Event|1|||
143134198|NCT01435759|516037286|FG003|Double-blind Phase|Adverse Event|1|||
143134199|NCT01435759|516037287|FG004|Double-blind Phase|Adverse Event|1|||
143134200|NCT01435759|516037288|FG005|Double-blind Phase|Adverse Event|3|||
143469004|NCT00784693|517264376|FG000|Overall Study|Randomized but not Treated|1|||
143469005|NCT00784693|517264377|FG001|Overall Study|Randomized but not Treated|0|||
143469006|NCT00784693|517264376|FG000|Overall Study|Other|1|||
143469007|NCT00784693|517264377|FG001|Overall Study|Other|0|||
143469008|NCT00528866|517264378|FG000|Overall Study|Protocol Violation|6|||
143469009|NCT02260882|517264379|FG000|Overall Study|Protocol Violation|0|||
143469010|NCT02260882|517264380|FG001|Overall Study|Protocol Violation|1|||
143469011|NCT02119325|517264381|FG000|Washout Period 1|Adverse Event|0|||
143469012|NCT02119325|517264382|FG001|Washout Period 1|Adverse Event|1|||
143469013|NCT01601847|517264383|FG000|Overall Study|Death|1|||
143469014|NCT01601847|517264384|FG001|Overall Study|Death|0|||
143469015|NCT01601847|517264383|FG000|Overall Study|Withdrawal by Subject|11|||
143469016|NCT01601847|517264384|FG001|Overall Study|Withdrawal by Subject|7|||
143469017|NCT01601847|517264383|FG000|Overall Study|Lost to Follow-up|1|||
143469018|NCT01601847|517264384|FG001|Overall Study|Lost to Follow-up|3|||
143469019|NCT00954174|517264390|FG000|Overall Study|Adverse Event|28|||
143469020|NCT00954174|517264391|FG001|Overall Study|Adverse Event|23|||
143469021|NCT00954174|517264392|FG002|Overall Study|Adverse Event|4|||
143013984|NCT00391118|515590125|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
143013985|NCT00391118|515590126|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
143469022|NCT00954174|517264393|FG003|Overall Study|Adverse Event|9|||
143469023|NCT00954174|517264390|FG000|Overall Study|Death|4|||
143469024|NCT00954174|517264391|FG001|Overall Study|Death|2|||
143469025|NCT00954174|517264392|FG002|Overall Study|Death|0|||
143469026|NCT00954174|517264393|FG003|Overall Study|Death|0|||
143469027|NCT00954174|517264390|FG000|Overall Study|Lack of Efficacy|32|||
143469028|NCT00954174|517264391|FG001|Overall Study|Lack of Efficacy|22|||
143134201|NCT01435759|516037283|FG000|Double-blind Phase|Protocol Violation|2|||
143469029|NCT00954174|517264392|FG002|Overall Study|Lack of Efficacy|8|||
143469030|NCT00954174|517264393|FG003|Overall Study|Lack of Efficacy|6|||
143469031|NCT00954174|517264390|FG000|Overall Study|Withdrawal by Subject|14|||
143469032|NCT00954174|517264391|FG001|Overall Study|Withdrawal by Subject|10|||
143469033|NCT00954174|517264392|FG002|Overall Study|Withdrawal by Subject|4|||
143469034|NCT00954174|517264393|FG003|Overall Study|Withdrawal by Subject|3|||
143469035|NCT00954174|517264390|FG000|Overall Study|Medical Reason|4|||
143469036|NCT00954174|517264391|FG001|Overall Study|Medical Reason|2|||
143469037|NCT00954174|517264392|FG002|Overall Study|Medical Reason|1|||
143469038|NCT00954174|517264393|FG003|Overall Study|Medical Reason|0|||
143469039|NCT00954174|517264390|FG000|Overall Study|Ineligible|40|||
143469040|NCT00954174|517264391|FG001|Overall Study|Ineligible|47|||
143469041|NCT00954174|517264392|FG002|Overall Study|Ineligible|7|||
143469042|NCT00954174|517264393|FG003|Overall Study|Ineligible|4|||
143469043|NCT00954174|517264390|FG000|Overall Study|Never Treated|4|||
143469044|NCT00954174|517264391|FG001|Overall Study|Never Treated|17|||
143469045|NCT00954174|517264392|FG002|Overall Study|Never Treated|0|||
143469046|NCT00954174|517264393|FG003|Overall Study|Never Treated|3|||
143134202|NCT01435759|516037284|FG001|Double-blind Phase|Protocol Violation|0|||
143134203|NCT01435759|516037285|FG002|Double-blind Phase|Protocol Violation|1|||
143469047|NCT02234323|517264394|FG000|All Enrolled|Not Treated: Completed study in database|2|||
143469048|NCT02234323|517264394|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
143469049|NCT02234323|517264394|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
143469050|NCT02234323|517264394|FG000|All Treated|Death|1|||
143469051|NCT02234323|517264394|FG000|All Treated|Physician Decision|5|||
143469052|NCT02234323|517264394|FG000|All Treated|Lack of Efficacy|3|||
143469053|NCT02234323|517264394|FG000|All Treated|Exceeded lab value limit|2|||
143469054|NCT02234323|517264394|FG000|All Treated|Other|7|||
143469055|NCT04209621|517264395|FG000|Overall Study|Death|1|||
143469056|NCT04209621|517264395|FG000|Overall Study|Study Terminated Early|2|||
143469057|NCT02249767|517264396|FG000|Overall Study|Did not use medication|8|||
143469058|NCT02249767|517264397|FG001|Overall Study|Did not use medication|9|||
143469059|NCT02249767|517264398|FG002|Overall Study|Did not use medication|8|||
143469060|NCT01372410|517264399|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
143469061|NCT01372410|517264400|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
143469062|NCT01372410|517264401|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
143469063|NCT01372410|517264402|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
143469064|NCT01372410|517264403|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
143469065|NCT01372410|517264404|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
143469066|NCT01372410|517264405|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
143469067|NCT01372410|517264406|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
143469068|NCT01372410|517264399|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
143469069|NCT01372410|517264400|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
143469070|NCT01372410|517264401|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
143469071|NCT01372410|517264402|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
143469072|NCT01372410|517264403|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
143469073|NCT01372410|517264404|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
143469074|NCT01372410|517264405|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
143469075|NCT01372410|517264406|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
143469076|NCT01372410|517264399|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
143469077|NCT01372410|517264400|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
143469078|NCT01372410|517264401|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
143469079|NCT01372410|517264402|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
143469080|NCT01372410|517264403|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
143469081|NCT01372410|517264404|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
143134204|NCT01435759|516037286|FG003|Double-blind Phase|Protocol Violation|2|||
143134205|NCT01435759|516037287|FG004|Double-blind Phase|Protocol Violation|0|||
143134206|NCT01435759|516037288|FG005|Double-blind Phase|Protocol Violation|1|||
143134207|NCT01435759|516037283|FG000|Double-blind Phase|Withdrawal by Subject|17|||
143134208|NCT01435759|516037284|FG001|Double-blind Phase|Withdrawal by Subject|4|||
143134209|NCT01435759|516037285|FG002|Double-blind Phase|Withdrawal by Subject|3|||
143134210|NCT01435759|516037286|FG003|Double-blind Phase|Withdrawal by Subject|4|||
143134211|NCT01435759|516037287|FG004|Double-blind Phase|Withdrawal by Subject|2|||
143134212|NCT01435759|516037288|FG005|Double-blind Phase|Withdrawal by Subject|2|||
143134213|NCT01435759|516037283|FG000|Double-blind Phase|Lost to Follow-up|31|||
143134214|NCT01435759|516037284|FG001|Double-blind Phase|Lost to Follow-up|1|||
143134215|NCT01435759|516037285|FG002|Double-blind Phase|Lost to Follow-up|2|||
143134216|NCT01435759|516037286|FG003|Double-blind Phase|Lost to Follow-up|0|||
143134217|NCT01435759|516037287|FG004|Double-blind Phase|Lost to Follow-up|3|||
143134218|NCT01435759|516037288|FG005|Double-blind Phase|Lost to Follow-up|3|||
143134219|NCT01435759|516037283|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
143360119|NCT04955626|516859859|FG000|Open-Label Period|Refused further study procedures|1|||
143360120|NCT04955626|516859860|FG001|Open-Label Period|Refused further study procedures|0|||
143360121|NCT04955626|516859861|FG002|Open-Label Period|Refused further study procedures|0|||
143360122|NCT04955626|516859862|FG003|Open-Label Period|Refused further study procedures|0|||
143360123|NCT04955626|516859863|FG004|Open-Label Period|Refused further study procedures|0|||
143360124|NCT04955626|516859864|FG005|Open-Label Period|Refused further study procedures|0|||
143360125|NCT04955626|516859865|FG006|Open-Label Period|Refused further study procedures|0|||
143469082|NCT01372410|517264405|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
143469083|NCT01372410|517264406|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
143469084|NCT01372410|517264399|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
143134220|NCT01435759|516037284|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
143469085|NCT01372410|517264400|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
143469086|NCT01372410|517264401|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
143469087|NCT01372410|517264402|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
143469088|NCT01372410|517264403|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
143469089|NCT01372410|517264404|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
143469090|NCT01372410|517264405|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
143469091|NCT01372410|517264406|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
143469092|NCT01372410|517264399|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
143469093|NCT01372410|517264400|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
143469094|NCT01372410|517264401|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
143469095|NCT01372410|517264402|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
143469096|NCT01372410|517264403|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
143469097|NCT01372410|517264404|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
143469098|NCT01372410|517264405|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
143469099|NCT01372410|517264406|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
143469100|NCT01372410|517264399|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
143469101|NCT01372410|517264400|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
143469102|NCT01372410|517264401|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
143469103|NCT01372410|517264402|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
143469104|NCT01372410|517264403|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
143469105|NCT01372410|517264404|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
143469106|NCT01372410|517264405|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
143469107|NCT01372410|517264406|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
143469108|NCT01372410|517264399|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
143469109|NCT01372410|517264400|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
143469110|NCT01372410|517264401|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
143469111|NCT01372410|517264402|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
143469112|NCT01372410|517264403|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
143469113|NCT01372410|517264404|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
143469114|NCT01372410|517264405|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
143469115|NCT01372410|517264406|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
143469116|NCT01372410|517264399|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
143469117|NCT01372410|517264400|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
143469118|NCT01372410|517264401|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
143469119|NCT01372410|517264402|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
143134221|NCT01435759|516037285|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
143134222|NCT01435759|516037286|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
143134223|NCT01435759|516037287|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
143134224|NCT01435759|516037288|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
143134225|NCT01435759|516037283|FG000|Double-blind Phase|Other|8|||
143134226|NCT01435759|516037284|FG001|Double-blind Phase|Other|2|||
143134227|NCT01435759|516037285|FG002|Double-blind Phase|Other|0|||
143134228|NCT01435759|516037286|FG003|Double-blind Phase|Other|2|||
143134229|NCT01435759|516037287|FG004|Double-blind Phase|Other|0|||
143134230|NCT01435759|516037288|FG005|Double-blind Phase|Other|0|||
143134231|NCT03727841|516037294|FG000|Overall Study|Physician Decision|3|||
143134232|NCT03727841|516037295|FG001|Overall Study|Physician Decision|1|||
143134233|NCT01601496|516037296|FG000|Overall Study|Physician Decision|1|||
143134234|NCT01601496|516037296|FG000|Overall Study|Withdrawal by Subject|1|||
143134235|NCT01601496|516037296|FG000|Overall Study|Lost to Follow-up|6|||
143134236|NCT01601496|516037296|FG000|Overall Study|Death|4|||
143134237|NCT01601496|516037296|FG000|Overall Study|Other: patient refusal to continue|3|||
143134238|NCT03243305|516037297|FG000|Overall Study|Lost to Follow-up|250|||
143134239|NCT03243305|516037297|FG000|Overall Study|Withdrawal by Subject|170|||
143134240|NCT03243305|516037297|FG000|Overall Study|Pregnancy|104|||
143134241|NCT03243305|516037297|FG000|Overall Study|Non-Compliance with Study Drug|38|||
143134242|NCT03243305|516037297|FG000|Overall Study|Adverse Event|23|||
143134243|NCT03243305|516037297|FG000|Overall Study|No sexually active|26|||
143134244|NCT03243305|516037297|FG000|Overall Study|Physician Decision|22|||
143134245|NCT03243305|516037297|FG000|Overall Study|Protocol Violation|22|||
143134246|NCT03243305|516037297|FG000|Overall Study|Study method no longer primary method|12|||
143134247|NCT03243305|516037297|FG000|Overall Study|Study Terminated by Sponsor|1|||
143134248|NCT03243305|516037297|FG000|Overall Study|Early terminations|267|||
143134249|NCT02782741|516037300|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
143469120|NCT01372410|517264403|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
143134250|NCT02782741|516037301|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
143134251|NCT02782741|516037302|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
143134252|NCT02782741|516037300|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
143134253|NCT02782741|516037301|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
143134254|NCT02782741|516037302|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
143134255|NCT02782741|516037300|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
143134256|NCT02782741|516037301|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
143134257|NCT02782741|516037302|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
143134258|NCT02782741|516037300|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
143134259|NCT02782741|516037301|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
143469121|NCT01372410|517264404|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
143469122|NCT01372410|517264405|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
143469123|NCT01372410|517264406|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
143469124|NCT01372410|517264399|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
143469125|NCT01372410|517264400|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
143469126|NCT01372410|517264401|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
143469127|NCT01372410|517264402|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
143469128|NCT01372410|517264403|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
143469129|NCT01372410|517264404|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
143469130|NCT01372410|517264405|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
143469131|NCT01372410|517264406|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
143469132|NCT01372410|517264399|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
143469133|NCT01372410|517264400|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
143469134|NCT01372410|517264401|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
143469135|NCT01372410|517264402|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
143469136|NCT01372410|517264403|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
143469137|NCT01372410|517264404|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
143469138|NCT01372410|517264405|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
143469139|NCT01372410|517264406|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
143469140|NCT04585646|517264407|FG000|First Intervention|Physician Decision|1|||
143469141|NCT04585646|517264408|FG001|First Intervention|Physician Decision|0|||
143469142|NCT04585646|517264407|FG000|First Intervention|Lost to Follow-up|0|||
143469143|NCT04585646|517264408|FG001|First Intervention|Lost to Follow-up|3|||
143469144|NCT04585646|517264407|FG000|First Intervention|Withdrawal by Subject|0|||
143469145|NCT04585646|517264408|FG001|First Intervention|Withdrawal by Subject|1|||
143469146|NCT00867113|517264409|FG000|Treatment Period|Adverse Event|15|||
143469147|NCT00867113|517264409|FG000|Treatment Period|Death|2|||
143469148|NCT00867113|517264409|FG000|Treatment Period|Withdrawal by Subject|19|||
143469149|NCT00867113|517264409|FG000|Treatment Period|Lost to Follow-up|3|||
143469150|NCT00867113|517264409|FG000|Treatment Period|Administrative problems|1|||
143469151|NCT00867113|517264409|FG000|Treatment Period|Disease progression/relapse|1|||
143469152|NCT00867113|517264409|FG000|Treatment Period|Protocol Violation|4|||
143469153|NCT00867113|517264409|FG000|Post Treatment After Survival Follow-up|Death|1|||
143469154|NCT00867113|517264409|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
143469155|NCT00867113|517264409|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
143469156|NCT00867113|517264409|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
143469157|NCT01886313|517264410|FG000|Overall Study|Adverse Event|1|||
143469158|NCT01886313|517264411|FG001|Overall Study|Adverse Event|1|||
143469159|NCT04614662|517264412|FG000|Overall Study|Withdrawal by Subject|0|||
143469160|NCT04614662|517264413|FG001|Overall Study|Withdrawal by Subject|1|||
143469161|NCT01230788|517264416|FG000|Overall Study|Prescribed exclusion drug|1|||
143469162|NCT01717768|517264418|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
143469163|NCT01717768|517264419|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
143469164|NCT01717768|517264420|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
143469165|NCT01717768|517264421|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
143469166|NCT01717768|517264422|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
143469167|NCT01717768|517264423|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
143469168|NCT01717768|517264424|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
143469169|NCT01717768|517264425|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
143469170|NCT01717768|517264426|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
143469171|NCT01717768|517264427|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
143469172|NCT01717768|517264428|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
143134260|NCT02782741|516037302|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
143134261|NCT02782741|516037300|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
143134262|NCT02782741|516037301|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
143134263|NCT02782741|516037302|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
143134264|NCT01275144|516037303|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
143134265|NCT01275144|516037304|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
143134266|NCT02998151|516037310|FG000|Overall Study|Withdrawal by Subject|3|||
143134267|NCT02998151|516037310|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
143469173|NCT01717768|517264429|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
143469174|NCT01717768|517264418|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
143469175|NCT01717768|517264419|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
143013986|NCT00391118|515590127|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
143134268|NCT02998151|516037310|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
143134269|NCT02573259|516037311|FG000|Overall Study|Death|1|||
143469176|NCT01717768|517264420|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
143469177|NCT01717768|517264421|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
143469178|NCT01717768|517264422|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
143469179|NCT01717768|517264423|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
143469180|NCT01717768|517264424|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
143469181|NCT01717768|517264425|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
143469182|NCT01717768|517264426|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
143469183|NCT01717768|517264427|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
143469184|NCT01717768|517264428|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
143469185|NCT01717768|517264429|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
143469186|NCT01717768|517264418|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
143469187|NCT01717768|517264419|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
143469188|NCT01717768|517264420|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
143469189|NCT01717768|517264421|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
143469190|NCT01717768|517264422|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
143469191|NCT01717768|517264423|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
143469192|NCT01717768|517264424|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
143469193|NCT01717768|517264425|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
143469194|NCT01717768|517264426|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
143469195|NCT01717768|517264427|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
143469196|NCT01717768|517264428|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
143469197|NCT01717768|517264429|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
143469198|NCT01717768|517264418|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
143469199|NCT01717768|517264419|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
143469200|NCT01717768|517264420|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
143469201|NCT01717768|517264421|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
143469202|NCT01717768|517264422|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
143469203|NCT01717768|517264423|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
143469204|NCT01717768|517264424|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
143469205|NCT01717768|517264425|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
143469206|NCT01717768|517264426|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
143469207|NCT01717768|517264427|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
143469208|NCT01717768|517264428|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
143469209|NCT01717768|517264429|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
143469210|NCT01774084|517264430|FG000|Overall Study|Personal reasons|1|||
143469211|NCT01774084|517264431|FG001|Overall Study|Personal reasons|0|||
143469212|NCT02430051|517264435|FG000|Overall Study|Withdrawal by Subject|6|||
143469213|NCT02430051|517264436|FG001|Overall Study|Withdrawal by Subject|3|||
143469214|NCT02430051|517264435|FG000|Overall Study|Dropped due to not meeting scheduling requirements|6|||
143469215|NCT02430051|517264436|FG001|Overall Study|Dropped due to not meeting scheduling requirements|9|||
143469216|NCT02430051|517264435|FG000|Overall Study|Protocol Violation|1|||
143469217|NCT02430051|517264436|FG001|Overall Study|Protocol Violation|0|||
143469218|NCT04526197|517264441|FG000|Period 1|Adverse Event|0|||
143134270|NCT02573259|516037312|FG001|Overall Study|Death|6|||
143134271|NCT02573259|516037313|FG002|Overall Study|Death|5|||
143134272|NCT02573259|516037314|FG003|Overall Study|Death|6|||
143134273|NCT02573259|516037315|FG004|Overall Study|Death|9|||
143134274|NCT02573259|516037316|FG005|Overall Study|Death|32|||
143134275|NCT02573259|516037317|FG006|Overall Study|Death|21|||
143134276|NCT02573259|516037311|FG000|Overall Study|Lost to Follow-up|0|||
143134277|NCT02573259|516037312|FG001|Overall Study|Lost to Follow-up|0|||
143134278|NCT02573259|516037313|FG002|Overall Study|Lost to Follow-up|0|||
143134279|NCT02573259|516037314|FG003|Overall Study|Lost to Follow-up|0|||
143134280|NCT02573259|516037315|FG004|Overall Study|Lost to Follow-up|0|||
143134281|NCT02573259|516037316|FG005|Overall Study|Lost to Follow-up|2|||
143134282|NCT02573259|516037317|FG006|Overall Study|Lost to Follow-up|1|||
143134283|NCT02573259|516037311|FG000|Overall Study|Participant refused further follow-up|0|||
143134284|NCT02573259|516037312|FG001|Overall Study|Participant refused further follow-up|2|||
143134285|NCT02573259|516037313|FG002|Overall Study|Participant refused further follow-up|1|||
143134286|NCT02573259|516037314|FG003|Overall Study|Participant refused further follow-up|0|||
143134287|NCT02573259|516037315|FG004|Overall Study|Participant refused further follow-up|3|||
143134288|NCT02573259|516037316|FG005|Overall Study|Participant refused further follow-up|20|||
143134289|NCT02573259|516037317|FG006|Overall Study|Participant refused further follow-up|7|||
143134290|NCT02573259|516037311|FG000|Overall Study|Other|0|||
143134291|NCT02573259|516037312|FG001|Overall Study|Other|0|||
143134292|NCT02573259|516037313|FG002|Overall Study|Other|0|||
143134293|NCT02573259|516037314|FG003|Overall Study|Other|0|||
143134294|NCT02573259|516037315|FG004|Overall Study|Other|1|||
143134295|NCT02573259|516037316|FG005|Overall Study|Other|4|||
143469219|NCT04526197|517264442|FG001|Period 1|Adverse Event|1|||
143469220|NCT04526197|517264441|FG000|Period 1|Withdrawal by Subject|1|||
143469221|NCT04526197|517264442|FG001|Period 1|Withdrawal by Subject|0|||
143469222|NCT04526197|517264441|FG000|Period 2|Adverse Event|0|||
143469223|NCT04526197|517264442|FG001|Period 2|Adverse Event|1|||
143469224|NCT04526197|517264441|FG000|Period 2|Withdrawal by Subject|0|||
143469225|NCT04526197|517264442|FG001|Period 2|Withdrawal by Subject|1|||
143469226|NCT01136811|517264443|FG000|Overall Study|Physician Decision|11|||
143469227|NCT00372385|517264444|FG000|Overall Study|Adverse Event|6|||
143469228|NCT00372385|517264445|FG001|Overall Study|Adverse Event|11|||
143469229|NCT00372385|517264446|FG002|Overall Study|Adverse Event|9|||
143469230|NCT00372385|517264447|FG003|Overall Study|Adverse Event|7|||
143469231|NCT00372385|517264444|FG000|Overall Study|Noncompliance|0|||
143469232|NCT00372385|517264445|FG001|Overall Study|Noncompliance|1|||
143469233|NCT00372385|517264446|FG002|Overall Study|Noncompliance|1|||
143469234|NCT00372385|517264447|FG003|Overall Study|Noncompliance|1|||
143469235|NCT00372385|517264444|FG000|Overall Study|Physician Decision|1|||
143134296|NCT02573259|516037317|FG006|Overall Study|Other|5|||
143134297|NCT00689338|516037321|FG000|Overall Study|Death|65|||
143134298|NCT00689338|516037321|FG000|Overall Study|Adverse Event|13|||
143134299|NCT00689338|516037321|FG000|Overall Study|Insufficient Clinical Response|1|||
143134300|NCT00689338|516037321|FG000|Overall Study|Lack of Efficacy|6|||
143134301|NCT00689338|516037321|FG000|Overall Study|Other|8|||
143134302|NCT00689338|516037321|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
143134303|NCT00689338|516037321|FG000|Overall Study|Lost to Follow-up|5|||
143134304|NCT00689338|516037321|FG000|Overall Study|Withdrawal by Subject|3|||
143134305|NCT00689338|516037321|FG000|Overall Study|Protocol Violation|15|||
143134306|NCT00715403|516037322|FG000|Overall Study|Progressive disease|0|||
143469236|NCT00372385|517264445|FG001|Overall Study|Physician Decision|0|||
143469237|NCT00372385|517264446|FG002|Overall Study|Physician Decision|0|||
143469238|NCT00372385|517264447|FG003|Overall Study|Physician Decision|0|||
143469239|NCT00372385|517264444|FG000|Overall Study|Lost to Follow-up|2|||
143469240|NCT00372385|517264445|FG001|Overall Study|Lost to Follow-up|0|||
143134307|NCT00715403|516037323|FG001|Overall Study|Progressive disease|1|||
143134308|NCT00715403|516037324|FG002|Overall Study|Progressive disease|3|||
143134309|NCT00715403|516037325|FG003|Overall Study|Progressive disease|9|||
143134310|NCT00715403|516037326|FG004|Overall Study|Progressive disease|5|||
143134311|NCT00715403|516037327|FG005|Overall Study|Progressive disease|14|||
143134312|NCT00715403|516037328|FG006|Overall Study|Progressive disease|1|||
143134313|NCT00715403|516037322|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
143134314|NCT00715403|516037323|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
143134315|NCT00715403|516037324|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
143360126|NCT04955626|516859866|FG007|Open-Label Period|Refused further study procedures|0|||
143360127|NCT04955626|516859867|FG008|Open-Label Period|Refused further study procedures|0|||
143360128|NCT04955626|516859868|FG009|Open-Label Period|Refused further study procedures|0|||
143360129|NCT04955626|516859869|FG010|Open-Label Period|Refused further study procedures|0|||
143360130|NCT04955626|516859870|FG011|Open-Label Period|Refused further study procedures|0|||
143360131|NCT04955626|516859871|FG012|Open-Label Period|Refused further study procedures|0|||
143360132|NCT04955626|516859872|FG013|Open-Label Period|Refused further study procedures|0|||
143360133|NCT04955626|516859873|FG014|Open-Label Period|Refused further study procedures|0|||
143360134|NCT04955626|516859874|FG015|Open-Label Period|Refused further study procedures|0|||
143360135|NCT04955626|516859875|FG016|Open-Label Period|Refused further study procedures|0|||
143360136|NCT04955626|516859876|FG017|Open-Label Period|Refused further study procedures|0|||
143360137|NCT04955626|516859877|FG018|Open-Label Period|Refused further study procedures|0|||
143360138|NCT04955626|516859878|FG019|Open-Label Period|Refused further study procedures|0|||
143360139|NCT04955626|516859879|FG020|Open-Label Period|Refused further study procedures|0|||
143360140|NCT04955626|516859880|FG021|Open-Label Period|Refused further study procedures|0|||
143360141|NCT04955626|516859881|FG022|Open-Label Period|Refused further study procedures|0|||
143360142|NCT04955626|516859882|FG023|Open-Label Period|Refused further study procedures|0|||
143360143|NCT04955626|516859883|FG024|Open-Label Period|Refused further study procedures|0|||
143360144|NCT04955626|516859884|FG025|Open-Label Period|Refused further study procedures|0|||
143360145|NCT04955626|516859885|FG026|Open-Label Period|Refused further study procedures|0|||
143360146|NCT04955626|516859886|FG027|Open-Label Period|Refused further study procedures|0|||
143360147|NCT04955626|516859887|FG028|Open-Label Period|Refused further study procedures|0|||
143360148|NCT04955626|516859888|FG029|Open-Label Period|Refused further study procedures|0|||
143360149|NCT04955626|516859889|FG030|Open-Label Period|Refused further study procedures|0|||
143360150|NCT04955626|516859890|FG031|Open-Label Period|Refused further study procedures|0|||
143360151|NCT04955626|516859891|FG032|Open-Label Period|Refused further study procedures|0|||
143360152|NCT04955626|516859892|FG033|Open-Label Period|Refused further study procedures|0|||
143360153|NCT04955626|516859893|FG034|Open-Label Period|Refused further study procedures|0|||
143469241|NCT00372385|517264446|FG002|Overall Study|Lost to Follow-up|0|||
143469242|NCT00372385|517264447|FG003|Overall Study|Lost to Follow-up|0|||
143469243|NCT00372385|517264444|FG000|Overall Study|Withdrawal by Subject|2|||
143469244|NCT00372385|517264445|FG001|Overall Study|Withdrawal by Subject|1|||
143469245|NCT00372385|517264446|FG002|Overall Study|Withdrawal by Subject|0|||
143469246|NCT00372385|517264447|FG003|Overall Study|Withdrawal by Subject|0|||
143469247|NCT00372385|517264444|FG000|Overall Study|Refusal of Treatment|3|||
143469248|NCT00372385|517264445|FG001|Overall Study|Refusal of Treatment|6|||
143469249|NCT00372385|517264446|FG002|Overall Study|Refusal of Treatment|0|||
143469250|NCT00372385|517264447|FG003|Overall Study|Refusal of Treatment|0|||
143469251|NCT00372385|517264444|FG000|Overall Study|No Response|1|||
143469252|NCT00372385|517264445|FG001|Overall Study|No Response|1|||
143469253|NCT00372385|517264446|FG002|Overall Study|No Response|0|||
143469254|NCT00372385|517264447|FG003|Overall Study|No Response|0|||
143469255|NCT00372385|517264444|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
143469256|NCT00372385|517264445|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
143469257|NCT00372385|517264446|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
143469258|NCT00372385|517264447|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
143469259|NCT00372385|517264444|FG000|Overall Study|Virologic Stopping Rule|17|||
143469260|NCT00372385|517264445|FG001|Overall Study|Virologic Stopping Rule|0|||
143469261|NCT00372385|517264446|FG002|Overall Study|Virologic Stopping Rule|0|||
143469262|NCT00372385|517264447|FG003|Overall Study|Virologic Stopping Rule|0|||
143469263|NCT01839487|517264449|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
143469264|NCT01839487|517264450|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
143469265|NCT01839487|517264451|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
143469266|NCT01839487|517264452|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
143469267|NCT01839487|517264453|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
143469268|NCT01839487|517264454|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
143469269|NCT01839487|517264449|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
143469270|NCT01839487|517264450|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
143469271|NCT01839487|517264451|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
143469272|NCT01839487|517264452|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
143469273|NCT01839487|517264453|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
143469274|NCT01839487|517264454|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
143469275|NCT01839487|517264449|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
143469276|NCT01839487|517264450|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
143469277|NCT01839487|517264451|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
143469278|NCT01839487|517264452|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
143469279|NCT01839487|517264453|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
143469280|NCT01839487|517264454|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
143469281|NCT01839487|517264449|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
143469282|NCT01839487|517264450|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
143469283|NCT01839487|517264451|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
143469284|NCT01839487|517264452|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
143469285|NCT01839487|517264453|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
143469286|NCT01839487|517264454|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
143469287|NCT01839487|517264449|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
143469288|NCT01839487|517264450|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
143469289|NCT01839487|517264451|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
143469290|NCT01839487|517264452|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
143469291|NCT01839487|517264453|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
143469292|NCT01839487|517264454|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
143469293|NCT01839487|517264449|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
143469294|NCT01839487|517264450|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
143469295|NCT01839487|517264451|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
143469296|NCT01839487|517264452|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
143469297|NCT01839487|517264453|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
143469298|NCT01839487|517264454|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
143469299|NCT01839487|517264449|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
143469300|NCT01839487|517264450|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
143469301|NCT01839487|517264451|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
143469302|NCT01839487|517264452|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
143469303|NCT01839487|517264453|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
143469304|NCT01839487|517264454|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
143469305|NCT01839487|517264449|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
143469306|NCT01839487|517264450|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
143469307|NCT01839487|517264451|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
143469308|NCT01839487|517264452|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
143469309|NCT01839487|517264453|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
143469310|NCT01839487|517264454|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
143469311|NCT01839487|517264449|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
143469312|NCT01839487|517264450|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
143469313|NCT01839487|517264451|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
143469314|NCT01839487|517264452|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
143469315|NCT01839487|517264453|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
143469316|NCT01839487|517264454|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
143469317|NCT06071754|517264455|FG000|Overall Study|Device rhythm classifications not obtained from subjects due to protocol not being completed|9|||
143469318|NCT05028517|517264456|FG000|Overall Study|Lost to Follow-up|13|||
143469319|NCT05028517|517264457|FG001|Overall Study|Lost to Follow-up|20|||
143469320|NCT05028517|517264458|FG002|Overall Study|Lost to Follow-up|12|||
143469321|NCT05028517|517264456|FG000|Overall Study|Withdrawal by Subject|0|||
143469322|NCT05028517|517264457|FG001|Overall Study|Withdrawal by Subject|0|||
143469323|NCT05028517|517264458|FG002|Overall Study|Withdrawal by Subject|1|||
143469324|NCT03078907|517265979|FG000|Overall Study|Adverse Event|2|||
143469325|NCT03078907|517265980|FG001|Overall Study|Adverse Event|0|||
143469326|NCT03078907|517265979|FG000|Overall Study|Other|1|||
143469327|NCT03078907|517265980|FG001|Overall Study|Other|0|||
143469328|NCT03078907|517265979|FG000|Overall Study|Protocol Violation|0|||
143469329|NCT03078907|517265980|FG001|Overall Study|Protocol Violation|1|||
143469330|NCT01444651|517265981|FG000|Overall Study|Adverse Event|3|||
143469331|NCT01444651|517265982|FG001|Overall Study|Adverse Event|2|||
143469332|NCT01444651|517265981|FG000|Overall Study|Lost to Follow-up|5|||
143469333|NCT01444651|517265982|FG001|Overall Study|Lost to Follow-up|5|||
143469334|NCT01444651|517265981|FG000|Overall Study|Non-fasting|2|||
143469335|NCT01444651|517265982|FG001|Overall Study|Non-fasting|1|||
143469336|NCT01444651|517265981|FG000|Overall Study|Missing data|1|||
143469337|NCT01444651|517265982|FG001|Overall Study|Missing data|1|||
143469338|NCT00985166|517265983|FG000|Overall Study|Lost to Follow-up|3|||
143469339|NCT00985166|517265984|FG001|Overall Study|Lost to Follow-up|2|||
143469340|NCT00985166|517265985|FG002|Overall Study|Lost to Follow-up|2|||
143469341|NCT00985166|517265983|FG000|Overall Study|Withdrawal by Subject|3|||
143469342|NCT00985166|517265984|FG001|Overall Study|Withdrawal by Subject|2|||
143469343|NCT00985166|517265985|FG002|Overall Study|Withdrawal by Subject|0|||
143469344|NCT00985166|517265983|FG000|Overall Study|Test not done|2|||
143469345|NCT00985166|517265984|FG001|Overall Study|Test not done|0|||
143469346|NCT00985166|517265985|FG002|Overall Study|Test not done|4|||
143469347|NCT00985166|517265983|FG000|Overall Study|Other|1|||
143469348|NCT00985166|517265984|FG001|Overall Study|Other|0|||
143469349|NCT00985166|517265985|FG002|Overall Study|Other|1|||
143469350|NCT03434353|517265989|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
143469351|NCT03434353|517265990|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
143469352|NCT03434353|517265991|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
143469353|NCT03434353|517265992|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
143469354|NCT03434353|517265993|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
143469355|NCT03434353|517265989|FG000|Overall Study|Withdrew consent|1|||
143469356|NCT03434353|517265990|FG001|Overall Study|Withdrew consent|0|||
143469357|NCT03434353|517265991|FG002|Overall Study|Withdrew consent|3|||
143469358|NCT03434353|517265992|FG003|Overall Study|Withdrew consent|0|||
143469359|NCT03434353|517265993|FG004|Overall Study|Withdrew consent|0|||
143469360|NCT03434353|517265989|FG000|Overall Study|Adverse Event|1|||
143469361|NCT03434353|517265990|FG001|Overall Study|Adverse Event|0|||
143469362|NCT03434353|517265991|FG002|Overall Study|Adverse Event|0|||
143469363|NCT03434353|517265992|FG003|Overall Study|Adverse Event|0|||
143469364|NCT03434353|517265993|FG004|Overall Study|Adverse Event|1|||
143469365|NCT03434353|517265989|FG000|Overall Study|Lost to Follow-up|2|||
143469366|NCT03434353|517265990|FG001|Overall Study|Lost to Follow-up|0|||
143469367|NCT03434353|517265991|FG002|Overall Study|Lost to Follow-up|0|||
143469368|NCT03434353|517265992|FG003|Overall Study|Lost to Follow-up|0|||
143469369|NCT03434353|517265993|FG004|Overall Study|Lost to Follow-up|0|||
143469370|NCT01990534|517265994|FG000|Overall Study|Death|22|||
143469371|NCT01990534|517265994|FG000|Overall Study|Progressive disease|3|||
143469372|NCT01990534|517265994|FG000|Overall Study|Protocol Violation|1|||
143469373|NCT01990534|517265994|FG000|Overall Study|Withdrawal of Informed Consent|2|||
143469374|NCT01990534|517265994|FG000|Overall Study|Symptomatic Deterioration|1|||
143469375|NCT01990534|517265994|FG000|Overall Study|Withdrawal by Subject|3|||
143013987|NCT00391118|515590125|FG000|Overall Study|Progressive Disease|7|||
143469376|NCT01990534|517265994|FG000|Overall Study|Reason not Specified|2|||
143469377|NCT01990534|517265994|FG000|Overall Study|Lost to Follow-up|1|||
143469378|NCT00234494|517265995|FG000|Overall Study|Protocol Violation|2|||
143469379|NCT01831544|517265998|FG000|Overall Study|Death|1|||
143469380|NCT01831544|517265998|FG000|Overall Study|Still on original MVAD device|2|||
143469381|NCT01681628|517266001|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
143469382|NCT01681628|517266002|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
143469383|NCT01681628|517266001|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
143469384|NCT01681628|517266002|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
143469385|NCT01681628|517266001|FG000|19 Months Follow-up|Death|1|||
143469386|NCT01681628|517266002|FG001|19 Months Follow-up|Death|0|||
143134316|NCT00715403|516037325|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
143134317|NCT00715403|516037326|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
143134318|NCT00715403|516037327|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
143134319|NCT00715403|516037328|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
143134320|NCT00715403|516037322|FG000|Overall Study|Other Adverse Event than DLT|1|||
143134321|NCT00715403|516037323|FG001|Overall Study|Other Adverse Event than DLT|0|||
143134322|NCT00715403|516037324|FG002|Overall Study|Other Adverse Event than DLT|0|||
143134323|NCT00715403|516037325|FG003|Overall Study|Other Adverse Event than DLT|0|||
143134324|NCT00715403|516037326|FG004|Overall Study|Other Adverse Event than DLT|0|||
143134325|NCT00715403|516037327|FG005|Overall Study|Other Adverse Event than DLT|2|||
143134326|NCT00715403|516037328|FG006|Overall Study|Other Adverse Event than DLT|0|||
143134327|NCT00715403|516037322|FG000|Overall Study|Protocol Violation|0|||
143134328|NCT00715403|516037323|FG001|Overall Study|Protocol Violation|0|||
143134329|NCT00715403|516037324|FG002|Overall Study|Protocol Violation|0|||
143134330|NCT00715403|516037325|FG003|Overall Study|Protocol Violation|0|||
143134331|NCT00715403|516037326|FG004|Overall Study|Protocol Violation|0|||
143134332|NCT00715403|516037327|FG005|Overall Study|Protocol Violation|1|||
143134333|NCT00715403|516037328|FG006|Overall Study|Protocol Violation|0|||
143134334|NCT00715403|516037322|FG000|Overall Study|Other reason not defined above|0|||
143134335|NCT00715403|516037323|FG001|Overall Study|Other reason not defined above|0|||
143134336|NCT00715403|516037324|FG002|Overall Study|Other reason not defined above|1|||
143134337|NCT00715403|516037325|FG003|Overall Study|Other reason not defined above|0|||
143134338|NCT00715403|516037326|FG004|Overall Study|Other reason not defined above|1|||
143134339|NCT00715403|516037327|FG005|Overall Study|Other reason not defined above|1|||
143134340|NCT00715403|516037328|FG006|Overall Study|Other reason not defined above|0|||
143134341|NCT02104895|516037329|FG000|Overall Study|Withdrawal by Subject|0|||
143134342|NCT02104895|516037330|FG001|Overall Study|Withdrawal by Subject|14|||
143134343|NCT03839394|516037331|FG000|Overall Study|Lost to Follow-up|6|||
143134344|NCT03839394|516037332|FG001|Overall Study|Lost to Follow-up|8|||
143134345|NCT03839394|516037331|FG000|Overall Study|Withdrawal by Subject|0|||
143134346|NCT03839394|516037332|FG001|Overall Study|Withdrawal by Subject|2|||
143134347|NCT04376515|516037337|FG000|Overall Study|Found to have been vaccinated before study start|6|||
143134348|NCT04376515|516037338|FG001|Overall Study|Found to have been vaccinated before study start|6|||
143134349|NCT03811821|516037339|FG000|Overall Study|Adverse Event|1|||
143134350|NCT03811821|516037340|FG001|Overall Study|Adverse Event|1|||
143134351|NCT03811821|516037339|FG000|Overall Study|Withdrawal by Subject|5|||
143134352|NCT03811821|516037340|FG001|Overall Study|Withdrawal by Subject|4|||
143134353|NCT03811821|516037339|FG000|Overall Study|Lost to Follow-up|2|||
143134354|NCT03811821|516037340|FG001|Overall Study|Lost to Follow-up|2|||
143360154|NCT04955626|516859894|FG035|Open-Label Period|Refused further study procedures|0|||
143360155|NCT04955626|516859859|FG000|Open-Label Period|Adverse Event|1|||
143360156|NCT04955626|516859860|FG001|Open-Label Period|Adverse Event|0|||
143360157|NCT04955626|516859861|FG002|Open-Label Period|Adverse Event|0|||
143360158|NCT04955626|516859862|FG003|Open-Label Period|Adverse Event|0|||
143360159|NCT04955626|516859863|FG004|Open-Label Period|Adverse Event|0|||
143360160|NCT04955626|516859864|FG005|Open-Label Period|Adverse Event|0|||
143360161|NCT04955626|516859865|FG006|Open-Label Period|Adverse Event|0|||
143360162|NCT04955626|516859866|FG007|Open-Label Period|Adverse Event|0|||
143360163|NCT04955626|516859867|FG008|Open-Label Period|Adverse Event|0|||
143360164|NCT04955626|516859868|FG009|Open-Label Period|Adverse Event|0|||
143360165|NCT04955626|516859869|FG010|Open-Label Period|Adverse Event|0|||
143360166|NCT04955626|516859870|FG011|Open-Label Period|Adverse Event|0|||
143360167|NCT04955626|516859871|FG012|Open-Label Period|Adverse Event|0|||
143360168|NCT04955626|516859872|FG013|Open-Label Period|Adverse Event|0|||
143360169|NCT04955626|516859873|FG014|Open-Label Period|Adverse Event|0|||
143360170|NCT04955626|516859874|FG015|Open-Label Period|Adverse Event|0|||
143360171|NCT04955626|516859875|FG016|Open-Label Period|Adverse Event|0|||
143360172|NCT04955626|516859876|FG017|Open-Label Period|Adverse Event|0|||
143360173|NCT04955626|516859877|FG018|Open-Label Period|Adverse Event|0|||
143360174|NCT04955626|516859878|FG019|Open-Label Period|Adverse Event|0|||
143360175|NCT04955626|516859879|FG020|Open-Label Period|Adverse Event|0|||
143360176|NCT04955626|516859880|FG021|Open-Label Period|Adverse Event|0|||
143360177|NCT04955626|516859881|FG022|Open-Label Period|Adverse Event|0|||
143360178|NCT04955626|516859882|FG023|Open-Label Period|Adverse Event|0|||
143360179|NCT04955626|516859883|FG024|Open-Label Period|Adverse Event|0|||
143360180|NCT04955626|516859884|FG025|Open-Label Period|Adverse Event|0|||
143134355|NCT03811821|516037339|FG000|Overall Study|Contraindication for treatment|0|||
143134356|NCT03811821|516037340|FG001|Overall Study|Contraindication for treatment|1|||
143134357|NCT03811821|516037339|FG000|Overall Study|Tolerability|0|||
143134358|NCT03811821|516037340|FG001|Overall Study|Tolerability|3|||
143134359|NCT03811821|516037339|FG000|Overall Study|Comorbidities|0|||
143360181|NCT04955626|516859885|FG026|Open-Label Period|Adverse Event|0|||
143360182|NCT04955626|516859886|FG027|Open-Label Period|Adverse Event|0|||
143360183|NCT04955626|516859887|FG028|Open-Label Period|Adverse Event|0|||
143360184|NCT04955626|516859888|FG029|Open-Label Period|Adverse Event|0|||
143360185|NCT04955626|516859889|FG030|Open-Label Period|Adverse Event|0|||
143360186|NCT04955626|516859890|FG031|Open-Label Period|Adverse Event|0|||
143469387|NCT01681628|517266001|FG000|19 Months Follow-up|Lost to Follow-up|61|||
143469388|NCT01681628|517266002|FG001|19 Months Follow-up|Lost to Follow-up|43|||
143469389|NCT01521897|517266003|FG000|Overall Study|Protocol Violation|18|||
143469390|NCT01521897|517266003|FG000|Overall Study|Lost to Follow-up|5|||
143469391|NCT02194062|517266010|FG000|Overall Study|Lost to Follow-up|2|||
143469392|NCT02194062|517266011|FG001|Overall Study|Lost to Follow-up|2|||
143469393|NCT02194062|517266012|FG002|Overall Study|Lost to Follow-up|5|||
143469394|NCT03055013|517266013|FG000|Overall Study|Adverse Event|78|||
143469395|NCT03055013|517266014|FG001|Overall Study|Adverse Event|0|||
143469396|NCT03055013|517266013|FG000|Overall Study|Death|6|||
143469397|NCT03055013|517266014|FG001|Overall Study|Death|0|||
143469398|NCT03055013|517266013|FG000|Overall Study|Disease relapse|33|||
143469399|NCT03055013|517266014|FG001|Overall Study|Disease relapse|0|||
143469400|NCT03055013|517266013|FG000|Overall Study|Withdrawal by Subject|28|||
143469401|NCT03055013|517266014|FG001|Overall Study|Withdrawal by Subject|0|||
143469402|NCT03055013|517266013|FG000|Overall Study|Other complicating disease|5|||
143469403|NCT03055013|517266014|FG001|Overall Study|Other complicating disease|0|||
143469404|NCT03055013|517266013|FG000|Overall Study|Physician Decision|1|||
143469405|NCT03055013|517266014|FG001|Overall Study|Physician Decision|0|||
143469406|NCT03055013|517266013|FG000|Overall Study|Benign mass/non-RCC|4|||
143469407|NCT03055013|517266014|FG001|Overall Study|Benign mass/non-RCC|0|||
143469408|NCT03055013|517266013|FG000|Overall Study|Enrolled in another trial|1|||
143469409|NCT03055013|517266014|FG001|Overall Study|Enrolled in another trial|0|||
143469410|NCT03055013|517266013|FG000|Overall Study|Non-protocol therapy|1|||
143469411|NCT03055013|517266014|FG001|Overall Study|Non-protocol therapy|0|||
143469412|NCT03055013|517266013|FG000|Overall Study|Incompliance|1|||
143469413|NCT03055013|517266014|FG001|Overall Study|Incompliance|0|||
143469414|NCT03055013|517266013|FG000|Overall Study|Insurance issues|1|||
143469415|NCT03055013|517266014|FG001|Overall Study|Insurance issues|0|||
143469416|NCT03055013|517266013|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
143469417|NCT03055013|517266014|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
143469418|NCT03055013|517266013|FG000|Overall Study|Did not receive nivolumab|10|||
143469419|NCT03055013|517266014|FG001|Overall Study|Did not receive nivolumab|0|||
143469420|NCT03055013|517266013|FG000|Overall Study|Did not receive surgery|0|||
143469421|NCT03055013|517266014|FG001|Overall Study|Did not receive surgery|28|||
143469422|NCT03422172|517266018|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
143469423|NCT03422172|517266018|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
143469424|NCT03422172|517266018|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
143469425|NCT05736211|517266020|FG000|Overall Study|Lost to Follow-up|6|||
143469426|NCT05736211|517266021|FG001|Overall Study|Lost to Follow-up|0|||
143469427|NCT00293722|517266022|FG000|Overall Study|Other|427|||
143469428|NCT01008696|517266023|FG000|Overall Study|Participant's evasion of hospital visit|5|||
143469429|NCT01008696|517266024|FG001|Overall Study|Participant's evasion of hospital visit|4|||
143469430|NCT01008696|517266023|FG000|Overall Study|Withdrawal by Subject|2|||
143469431|NCT01008696|517266024|FG001|Overall Study|Withdrawal by Subject|4|||
143469432|NCT01008696|517266023|FG000|Overall Study|Physician Decision|5|||
143469433|NCT01008696|517266024|FG001|Overall Study|Physician Decision|1|||
143469434|NCT01008696|517266023|FG000|Overall Study|Adverse Event|1|||
143469435|NCT01008696|517266024|FG001|Overall Study|Adverse Event|0|||
143469436|NCT01008696|517266023|FG000|Overall Study|Participants' non-cooperation|2|||
143469437|NCT01008696|517266024|FG001|Overall Study|Participants' non-cooperation|3|||
143469438|NCT01008696|517266023|FG000|Overall Study|Other|2|||
143469439|NCT01008696|517266024|FG001|Overall Study|Other|3|||
143469440|NCT01008696|517266023|FG000|Overall Study|Other|0|||
143469441|NCT01008696|517266024|FG001|Overall Study|Other|2|||
143469442|NCT00992511|517266025|FG000|Overall Study|Migrated/moved from study area|1|||
143469443|NCT00992511|517266026|FG001|Overall Study|Migrated/moved from study area|0|||
143469444|NCT00992511|517266027|FG002|Overall Study|Migrated/moved from study area|1|||
143469445|NCT00992511|517266028|FG003|Overall Study|Migrated/moved from study area|2|||
143469446|NCT00992511|517266025|FG000|Overall Study|Lost to Follow-up|1|||
143469447|NCT00992511|517266026|FG001|Overall Study|Lost to Follow-up|0|||
143469448|NCT00992511|517266027|FG002|Overall Study|Lost to Follow-up|0|||
143469449|NCT00992511|517266028|FG003|Overall Study|Lost to Follow-up|2|||
143469450|NCT00992511|517266025|FG000|Overall Study|Withdrawal by Subject|0|||
143469451|NCT00992511|517266026|FG001|Overall Study|Withdrawal by Subject|0|||
143469452|NCT00992511|517266027|FG002|Overall Study|Withdrawal by Subject|1|||
143469453|NCT00992511|517266028|FG003|Overall Study|Withdrawal by Subject|1|||
143469454|NCT04498169|517266029|FG000|Study Completion|Adverse Event|1|||
143469455|NCT04498169|517266030|FG001|Study Completion|Adverse Event|1|||
143469456|NCT02960854|517266031|FG000|Overall Study|Not Disclosed|2|||
143469457|NCT02960854|517266032|FG001|Overall Study|Not Disclosed|2|||
143469458|NCT02960854|517266031|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
143469459|NCT02960854|517266032|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
143469460|NCT02960854|517266031|FG000|Overall Study|Subject Withdrew Consent|0|||
143469461|NCT02960854|517266032|FG001|Overall Study|Subject Withdrew Consent|1|||
143469462|NCT02960854|517266031|FG000|Overall Study|Death|4|||
143469463|NCT02960854|517266032|FG001|Overall Study|Death|6|||
143469464|NCT00833911|517266033|FG000|Titration|Adverse Event|18|||
143469465|NCT00833911|517266033|FG000|Titration|Withdrawal by Subject|3|||
143469466|NCT00833911|517266033|FG000|Maintenance Phase I|Adverse Event|73|||
143469467|NCT00833911|517266033|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
143469468|NCT00833911|517266033|FG000|Maintenance Phase I|Physician Decision|10|||
143469469|NCT00833911|517266033|FG000|Maintenance Phase I|Lack of Efficacy|4|||
143469470|NCT00833911|517266033|FG000|Maintenance Phase II|Adverse Event|6|||
143469471|NCT00833911|517266033|FG000|Maintenance Phase II|Physician Decision|2|||
143469472|NCT00833911|517266033|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
143469473|NCT00833911|517266033|FG000|Maintenance Phase II|Lack of Efficacy|1|||
143469474|NCT01207596|517266036|FG000|Overall Study|Physician Decision|4|||
143469475|NCT01207596|517266036|FG000|Overall Study|Lack of Efficacy|1|||
143469476|NCT01207596|517266036|FG000|Overall Study|Adverse Event|3|||
143469477|NCT01207596|517266036|FG000|Overall Study|Withdrawal by Subject|1|||
143469478|NCT00908232|517266041|FG000|Cycle 1 to 4|Death|5|||
143469479|NCT00908232|517266042|FG001|Cycle 1 to 4|Death|0|||
143469480|NCT00908232|517266043|FG002|Cycle 1 to 4|Death|0|||
143469481|NCT00908232|517266044|FG003|Cycle 1 to 4|Death|0|||
143469482|NCT00908232|517266041|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
143469483|NCT00908232|517266042|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
143469484|NCT00908232|517266043|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
143469485|NCT00908232|517266044|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
143469486|NCT00908232|517266041|FG000|Cycle 1 to 4|Progressive Disease|6|||
143469487|NCT00908232|517266042|FG001|Cycle 1 to 4|Progressive Disease|0|||
143469488|NCT00908232|517266043|FG002|Cycle 1 to 4|Progressive Disease|0|||
143469489|NCT00908232|517266044|FG003|Cycle 1 to 4|Progressive Disease|0|||
143469490|NCT00908232|517266041|FG000|Cycle 1 to 4|Adverse Event|12|||
143469491|NCT00908232|517266042|FG001|Cycle 1 to 4|Adverse Event|0|||
143469492|NCT00908232|517266043|FG002|Cycle 1 to 4|Adverse Event|0|||
143469493|NCT00908232|517266044|FG003|Cycle 1 to 4|Adverse Event|0|||
143469494|NCT00908232|517266041|FG000|Cycle 1 to 4|Other|1|||
143469495|NCT00908232|517266042|FG001|Cycle 1 to 4|Other|0|||
143469496|NCT00908232|517266043|FG002|Cycle 1 to 4|Other|0|||
143469497|NCT00908232|517266044|FG003|Cycle 1 to 4|Other|0|||
143469498|NCT00908232|517266041|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
143469499|NCT00908232|517266042|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
143134360|NCT03811821|516037340|FG001|Overall Study|Comorbidities|2|||
143134361|NCT01683604|516037341|FG000|Overall Study|Adverse Event|2|||
143134362|NCT01683604|516037341|FG000|Overall Study|Lack of Efficacy|1|||
143134363|NCT01683604|516037341|FG000|Overall Study|Other|2|||
143134364|NCT00447902|516037344|FG000|Overall Study|Adverse Event|0|||
143134365|NCT00447902|516037345|FG001|Overall Study|Adverse Event|3|||
143134366|NCT00447902|516037344|FG000|Overall Study|Protocol Violation|1|||
143134367|NCT00447902|516037345|FG001|Overall Study|Protocol Violation|0|||
143134368|NCT00447902|516037344|FG000|Overall Study|Withdrawal by Subject|0|||
143134369|NCT00447902|516037345|FG001|Overall Study|Withdrawal by Subject|1|||
143134370|NCT00447902|516037344|FG000|Overall Study|included patients who discontinued|1|||
143134371|NCT00447902|516037345|FG001|Overall Study|included patients who discontinued|1|||
143134372|NCT00447902|516037344|FG000|Overall Study|Lack of Efficacy|2|||
143134373|NCT00447902|516037345|FG001|Overall Study|Lack of Efficacy|1|||
143134374|NCT01386606|516039288|FG000|Overall Study|Adverse Event|0|||
143134375|NCT01386606|516039289|FG001|Overall Study|Adverse Event|1|||
143134376|NCT01386606|516039290|FG002|Overall Study|Adverse Event|0|||
143134377|NCT01386606|516039291|FG003|Overall Study|Adverse Event|0|||
143134378|NCT01386606|516039288|FG000|Overall Study|Withdrawal by Subject|0|||
143134379|NCT01386606|516039289|FG001|Overall Study|Withdrawal by Subject|1|||
143134380|NCT01386606|516039290|FG002|Overall Study|Withdrawal by Subject|1|||
143134381|NCT01386606|516039291|FG003|Overall Study|Withdrawal by Subject|0|||
143134382|NCT01386606|516039288|FG000|Overall Study|Protocol Violation|1|||
143134383|NCT01386606|516039289|FG001|Overall Study|Protocol Violation|0|||
143134384|NCT01386606|516039290|FG002|Overall Study|Protocol Violation|1|||
143134385|NCT01386606|516039291|FG003|Overall Study|Protocol Violation|1|||
143134386|NCT01386606|516039288|FG000|Overall Study|Lost to Follow-up|2|||
143134387|NCT01386606|516039289|FG001|Overall Study|Lost to Follow-up|0|||
143134388|NCT01386606|516039290|FG002|Overall Study|Lost to Follow-up|0|||
143134389|NCT01386606|516039291|FG003|Overall Study|Lost to Follow-up|0|||
143134390|NCT01386606|516039288|FG000|Overall Study|Subject incarcerated|0|||
143134391|NCT01386606|516039289|FG001|Overall Study|Subject incarcerated|1|||
143134392|NCT01386606|516039290|FG002|Overall Study|Subject incarcerated|0|||
143469500|NCT00908232|517266043|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
143469501|NCT00908232|517266044|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
143469502|NCT00908232|517266041|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
143469503|NCT00908232|517266042|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
143469504|NCT00908232|517266043|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
143469505|NCT00908232|517266044|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
143134393|NCT01386606|516039291|FG003|Overall Study|Subject incarcerated|0|||
143134394|NCT01386606|516039288|FG000|Overall Study|Unable to draw PK|1|||
143134395|NCT01386606|516039289|FG001|Overall Study|Unable to draw PK|0|||
143134396|NCT01386606|516039290|FG002|Overall Study|Unable to draw PK|0|||
143134397|NCT01386606|516039291|FG003|Overall Study|Unable to draw PK|0|||
143134398|NCT01386606|516039288|FG000|Overall Study|T levels too high|0|||
143134399|NCT01386606|516039289|FG001|Overall Study|T levels too high|1|||
143134400|NCT01386606|516039290|FG002|Overall Study|T levels too high|1|||
143134401|NCT01386606|516039291|FG003|Overall Study|T levels too high|0|||
143134402|NCT01095835|516039294|FG000|Overall Study|Adverse Event|8|||
143134403|NCT01095835|516039295|FG001|Overall Study|Adverse Event|6|||
143134404|NCT01095835|516039296|FG002|Overall Study|Adverse Event|6|||
143134405|NCT01095835|516039294|FG000|Overall Study|Lack of Efficacy|0|||
143134406|NCT01095835|516039295|FG001|Overall Study|Lack of Efficacy|1|||
143134407|NCT01095835|516039296|FG002|Overall Study|Lack of Efficacy|0|||
143134408|NCT01095835|516039294|FG000|Overall Study|Physician Decision|0|||
143134409|NCT01095835|516039295|FG001|Overall Study|Physician Decision|0|||
143134410|NCT01095835|516039296|FG002|Overall Study|Physician Decision|1|||
143134411|NCT01095835|516039294|FG000|Overall Study|Withdrawal by Subject|1|||
143134412|NCT01095835|516039295|FG001|Overall Study|Withdrawal by Subject|3|||
143134413|NCT01095835|516039296|FG002|Overall Study|Withdrawal by Subject|0|||
143134414|NCT01095835|516039294|FG000|Overall Study|Non study compliance|0|||
143134415|NCT01095835|516039295|FG001|Overall Study|Non study compliance|0|||
143134416|NCT01095835|516039296|FG002|Overall Study|Non study compliance|1|||
143134417|NCT01095835|516039294|FG000|Overall Study|Protocol Violation|1|||
143134418|NCT01095835|516039295|FG001|Overall Study|Protocol Violation|2|||
143134419|NCT01095835|516039296|FG002|Overall Study|Protocol Violation|0|||
143134420|NCT03110354|516039300|FG000|Overall Study|Death|1|||
143134421|NCT03110354|516039301|FG001|Overall Study|Death|0|||
143134422|NCT03110354|516039302|FG002|Overall Study|Death|0|||
143134423|NCT03110354|516039303|FG003|Overall Study|Death|1|||
143134424|NCT03110354|516039304|FG004|Overall Study|Death|0|||
143134425|NCT03110354|516039300|FG000|Overall Study|Start of new therapy|0|||
143134426|NCT03110354|516039301|FG001|Overall Study|Start of new therapy|0|||
143134427|NCT03110354|516039302|FG002|Overall Study|Start of new therapy|0|||
143134428|NCT03110354|516039303|FG003|Overall Study|Start of new therapy|0|||
143134429|NCT03110354|516039304|FG004|Overall Study|Start of new therapy|1|||
143134430|NCT03110354|516039300|FG000|Overall Study|Failure to achieve response|2|||
143134431|NCT03110354|516039301|FG001|Overall Study|Failure to achieve response|3|||
143134432|NCT03110354|516039302|FG002|Overall Study|Failure to achieve response|0|||
143134433|NCT03110354|516039303|FG003|Overall Study|Failure to achieve response|2|||
143134434|NCT03110354|516039304|FG004|Overall Study|Failure to achieve response|1|||
143134435|NCT03110354|516039300|FG000|Overall Study|Progressive disease|1|||
143134436|NCT03110354|516039301|FG001|Overall Study|Progressive disease|1|||
143134437|NCT03110354|516039302|FG002|Overall Study|Progressive disease|3|||
143134438|NCT03110354|516039303|FG003|Overall Study|Progressive disease|4|||
143134439|NCT03110354|516039304|FG004|Overall Study|Progressive disease|2|||
143134440|NCT03110354|516039300|FG000|Overall Study|Adverse Event|0|||
143134441|NCT03110354|516039301|FG001|Overall Study|Adverse Event|0|||
143134442|NCT03110354|516039302|FG002|Overall Study|Adverse Event|0|||
143134443|NCT03110354|516039303|FG003|Overall Study|Adverse Event|2|||
143134444|NCT03110354|516039304|FG004|Overall Study|Adverse Event|2|||
143134445|NCT03110354|516039300|FG000|Overall Study|Other|0|||
143134446|NCT03110354|516039301|FG001|Overall Study|Other|0|||
143134447|NCT03110354|516039302|FG002|Overall Study|Other|0|||
143134448|NCT03110354|516039303|FG003|Overall Study|Other|1|||
143134449|NCT03110354|516039304|FG004|Overall Study|Other|1|||
143134450|NCT00116688|516039309|FG000|Overall Study|Protocol deviation|1|||
143134451|NCT00116688|516039310|FG001|Overall Study|Protocol deviation|0|||
143134452|NCT00116688|516039309|FG000|Overall Study|Noncompliance|3|||
143134453|NCT00116688|516039310|FG001|Overall Study|Noncompliance|1|||
143134454|NCT00116688|516039309|FG000|Overall Study|Adverse Event|11|||
143134455|NCT00116688|516039310|FG001|Overall Study|Adverse Event|0|||
143134456|NCT00116688|516039309|FG000|Overall Study|Withdrawal by Subject|26|||
143134457|NCT00116688|516039310|FG001|Overall Study|Withdrawal by Subject|2|||
143134458|NCT00116688|516039309|FG000|Overall Study|Requirement for alternative therapy|11|||
143134459|NCT00116688|516039310|FG001|Overall Study|Requirement for alternative therapy|1|||
143134460|NCT00116688|516039309|FG000|Overall Study|Physician Decision|7|||
143134461|NCT00116688|516039310|FG001|Overall Study|Physician Decision|0|||
143134462|NCT00116688|516039309|FG000|Overall Study|Lost to Follow-up|3|||
143134463|NCT00116688|516039310|FG001|Overall Study|Lost to Follow-up|0|||
143134464|NCT00116688|516039309|FG000|Overall Study|Death|15|||
143134465|NCT00116688|516039310|FG001|Overall Study|Death|0|||
143134466|NCT00116688|516039309|FG000|Overall Study|Protocol-specified criteria|3|||
143134467|NCT00116688|516039310|FG001|Overall Study|Protocol-specified criteria|0|||
143469506|NCT00908232|517266041|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
143134468|NCT00116688|516039309|FG000|Overall Study|Pregnancy|1|||
143134469|NCT00116688|516039310|FG001|Overall Study|Pregnancy|0|||
143134470|NCT00116688|516039309|FG000|Overall Study|Other|11|||
143134471|NCT00116688|516039310|FG001|Overall Study|Other|0|||
143134472|NCT01775670|516039314|FG000|Overall Study|Lost to Follow-up|1|||
143134473|NCT01775670|516039315|FG001|Overall Study|Lost to Follow-up|1|||
143469507|NCT00908232|517266042|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
143469508|NCT00908232|517266043|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
143469509|NCT00908232|517266044|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
143469510|NCT00908232|517266041|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
143469511|NCT00908232|517266042|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
143469512|NCT00908232|517266043|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
143469513|NCT00908232|517266044|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
143469514|NCT00908232|517266041|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
143469515|NCT00908232|517266042|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
143469516|NCT00908232|517266043|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
143469517|NCT00908232|517266044|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
143469518|NCT00908232|517266041|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
143469519|NCT00908232|517266042|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
143469520|NCT00908232|517266043|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
143469521|NCT00908232|517266044|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
143469522|NCT00908232|517266041|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
143469523|NCT00908232|517266042|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
143469524|NCT00908232|517266043|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
143469525|NCT00908232|517266044|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
143469526|NCT00908232|517266041|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
143469527|NCT00908232|517266042|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
143469528|NCT00908232|517266043|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
143469529|NCT00908232|517266044|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
143469530|NCT04226833|517266046|FG000|Overall Study|Death|0|||
143469531|NCT04226833|517266047|FG001|Overall Study|Death|0|||
143469532|NCT04226833|517266048|FG002|Overall Study|Death|1|||
143469533|NCT04226833|517266049|FG003|Overall Study|Death|0|||
143469534|NCT02540538|517266050|FG000|Overall Study|Pregnancy|0|||
143469535|NCT02540538|517266051|FG001|Overall Study|Pregnancy|1|||
143469536|NCT02540538|517266052|FG002|Overall Study|Pregnancy|0|||
143134474|NCT01298700|516039316|FG000|Overall Study|Adverse Event|50|||
143134475|NCT01298700|516039317|FG001|Overall Study|Adverse Event|51|||
143134476|NCT01298700|516039316|FG000|Overall Study|Lack of Efficacy|9|||
143134477|NCT01298700|516039317|FG001|Overall Study|Lack of Efficacy|14|||
143134478|NCT01298700|516039316|FG000|Overall Study|Lost to Follow-up|5|||
143134479|NCT01298700|516039317|FG001|Overall Study|Lost to Follow-up|2|||
143134480|NCT01298700|516039316|FG000|Overall Study|Withdrawal by Subject|12|||
143134481|NCT01298700|516039317|FG001|Overall Study|Withdrawal by Subject|9|||
143134482|NCT01298700|516039316|FG000|Overall Study|Protocol Violation|6|||
143134483|NCT01298700|516039317|FG001|Overall Study|Protocol Violation|4|||
143134484|NCT01298700|516039316|FG000|Overall Study|Other Miscellaneous Reasons|16|||
143134485|NCT01298700|516039317|FG001|Overall Study|Other Miscellaneous Reasons|15|||
143134486|NCT01298700|516039316|FG000|Overall Study|Did not Receive Study Drug|3|||
143134487|NCT01298700|516039317|FG001|Overall Study|Did not Receive Study Drug|5|||
143134488|NCT04006145|516039318|FG000|Overall Study|Lost to Follow-up|0|||
143134489|NCT04006145|516039319|FG001|Overall Study|Lost to Follow-up|1|||
143134490|NCT04006145|516039318|FG000|Overall Study|Other|1|||
143134491|NCT04006145|516039319|FG001|Overall Study|Other|2|||
143134492|NCT00010257|516039322|FG000|Overall Study|Withdrawal by Subject|1|||
143134493|NCT00010257|516039323|FG001|Overall Study|Withdrawal by Subject|0|||
143134494|NCT02063672|516039324|FG000|Overall Study|Ongoing Follow-up|27|||
143134495|NCT02063672|516039325|FG001|Overall Study|Ongoing Follow-up|14|||
143134496|NCT02063672|516039324|FG000|Overall Study|Death|5|||
143134497|NCT02063672|516039325|FG001|Overall Study|Death|3|||
143134498|NCT02063672|516039324|FG000|Overall Study|Lost to Follow-up|1|||
143134499|NCT02063672|516039325|FG001|Overall Study|Lost to Follow-up|3|||
143134500|NCT02063672|516039324|FG000|Overall Study|Withdrawal by Subject|2|||
143134501|NCT02063672|516039325|FG001|Overall Study|Withdrawal by Subject|2|||
143134502|NCT01307787|516039326|FG000|Overall Study|Withdrawal by Subject|2|||
143134503|NCT01307787|516039327|FG001|Overall Study|Withdrawal by Subject|0|||
143134504|NCT01965327|516039329|FG000|Overall Study|Physician Decision|2|||
143134505|NCT00104052|516039330|FG000|Overall Study|Adverse Event|1|||
143134506|NCT00104052|516039330|FG000|Overall Study|Lack of Efficacy|26|||
143134507|NCT00104052|516039330|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
143134508|NCT02498678|516039331|FG000|Overall Study|interference from the surgical team|0|||
143134509|NCT02498678|516039332|FG001|Overall Study|interference from the surgical team|2|||
143134510|NCT01294423|516039337|FG000|Overall Study|Adverse Event|1|||
143134511|NCT01294423|516039338|FG001|Overall Study|Adverse Event|2|||
143134512|NCT01294423|516039339|FG002|Overall Study|Adverse Event|3|||
143134513|NCT01294423|516039337|FG000|Overall Study|Withdrawal by Subject|1|||
143469537|NCT01472380|517266056|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
143469538|NCT01472380|517266056|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
143469539|NCT01557348|517266057|FG000|Overall Study|Adverse Event|6|||
143469540|NCT01557348|517266058|FG001|Overall Study|Adverse Event|16|||
143134514|NCT01294423|516039338|FG001|Overall Study|Withdrawal by Subject|2|||
143134515|NCT01294423|516039339|FG002|Overall Study|Withdrawal by Subject|2|||
143469541|NCT01557348|517266057|FG000|Overall Study|Infusion reaction event|5|||
143469542|NCT01557348|517266058|FG001|Overall Study|Infusion reaction event|5|||
143469543|NCT01557348|517266057|FG000|Overall Study|Death|7|||
143469544|NCT01557348|517266058|FG001|Overall Study|Death|4|||
143469545|NCT01557348|517266057|FG000|Overall Study|Insufficient Therapeutic Response|13|||
143469546|NCT01557348|517266058|FG001|Overall Study|Insufficient Therapeutic Response|28|||
143469547|NCT01557348|517266057|FG000|Overall Study|Withdrawal by Subject|5|||
143469548|NCT01557348|517266058|FG001|Overall Study|Withdrawal by Subject|4|||
143469549|NCT01557348|517266057|FG000|Overall Study|Lost to Follow-up|26|||
143469550|NCT01557348|517266058|FG001|Overall Study|Lost to Follow-up|22|||
143469551|NCT01557348|517266057|FG000|Overall Study|Administrative|18|||
143469552|NCT01557348|517266058|FG001|Overall Study|Administrative|11|||
143469553|NCT00403754|517266059|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
143469554|NCT00403754|517266060|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
143469555|NCT00403754|517266061|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
143469556|NCT00403754|517266062|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
143469557|NCT00403754|517266059|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
143469558|NCT00403754|517266060|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
143469559|NCT00403754|517266061|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
143469560|NCT00403754|517266062|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
143469561|NCT02000427|517266067|FG000|Overall Study|Death|22|||
143469562|NCT03829319|517266068|FG000|Overall Study|Sponsor's Decision|4|||
143469563|NCT03829319|517266069|FG001|Overall Study|Sponsor's Decision|90|||
143469564|NCT03829319|517266070|FG002|Overall Study|Sponsor's Decision|102|||
143469565|NCT03829319|517266068|FG000|Overall Study|Withdrawal by Subject|1|||
143469566|NCT03829319|517266069|FG001|Overall Study|Withdrawal by Subject|5|||
143469567|NCT03829319|517266070|FG002|Overall Study|Withdrawal by Subject|4|||
143469568|NCT03829319|517266068|FG000|Overall Study|Physician Decision|0|||
143469569|NCT03829319|517266069|FG001|Overall Study|Physician Decision|3|||
143469570|NCT03829319|517266070|FG002|Overall Study|Physician Decision|0|||
143469571|NCT03829319|517266068|FG000|Overall Study|Lost to Follow-up|0|||
143469572|NCT03829319|517266069|FG001|Overall Study|Lost to Follow-up|0|||
143469573|NCT03829319|517266070|FG002|Overall Study|Lost to Follow-up|1|||
143469574|NCT03829319|517266068|FG000|Overall Study|Death|8|||
143469575|NCT03829319|517266069|FG001|Overall Study|Death|277|||
143469576|NCT03829319|517266070|FG002|Overall Study|Death|266|||
143469577|NCT04484259|517266071|FG000|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
143469578|NCT04484259|517266072|FG001|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
143469579|NCT04484259|517266073|FG002|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
143469580|NCT04484259|517266074|FG003|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|9|||
143469581|NCT04484259|517266075|FG004|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
143469582|NCT04484259|517266071|FG000|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
143469583|NCT04484259|517266072|FG001|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
143469584|NCT04484259|517266073|FG002|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
143469585|NCT04484259|517266074|FG003|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|4|||
143469586|NCT04484259|517266075|FG004|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
143469587|NCT04484259|517266071|FG000|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
143469588|NCT04484259|517266072|FG001|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
143469589|NCT04484259|517266073|FG002|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
143469590|NCT04484259|517266074|FG003|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|2|||
143469591|NCT04484259|517266075|FG004|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
143469592|NCT04484259|517266071|FG000|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
143469593|NCT04484259|517266072|FG001|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
143469594|NCT04484259|517266073|FG002|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
143469595|NCT04484259|517266074|FG003|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|4|||
143469596|NCT04484259|517266075|FG004|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
143469597|NCT04484259|517266071|FG000|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
143469598|NCT04484259|517266072|FG001|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
143469599|NCT04484259|517266073|FG002|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
143469600|NCT04484259|517266074|FG003|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
143469601|NCT04484259|517266075|FG004|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|1|||
143469602|NCT04484259|517266071|FG000|Randomized Treatment|Withdrawal by Subject|1|||
143469603|NCT04484259|517266072|FG001|Randomized Treatment|Withdrawal by Subject|0|||
143469604|NCT04484259|517266073|FG002|Randomized Treatment|Withdrawal by Subject|0|||
143469605|NCT04484259|517266074|FG003|Randomized Treatment|Withdrawal by Subject|0|||
143469606|NCT04484259|517266075|FG004|Randomized Treatment|Withdrawal by Subject|0|||
143469607|NCT03951220|517266076|FG000|Overall Study|Withdrawal by Subject|9|||
143469608|NCT03951220|517266077|FG001|Overall Study|Withdrawal by Subject|2|||
143469609|NCT03951220|517266078|FG002|Overall Study|Withdrawal by Subject|0|||
143469610|NCT04498832|517266079|FG000|Overall Study|Adverse Event|1|||
143469611|NCT04498832|517266080|FG001|Overall Study|Adverse Event|3|||
143469612|NCT04498832|517266079|FG000|Overall Study|Withdrawal by Subject|0|||
143469613|NCT04498832|517266080|FG001|Overall Study|Withdrawal by Subject|1|||
143469614|NCT05359003|517266081|FG000|Overall Study|Withdrawal by Subject|1|||
143469615|NCT05359003|517266082|FG001|Overall Study|Withdrawal by Subject|3|||
143469616|NCT01313650|517266085|FG000|Overall Study|Adverse Event|9|||
143469617|NCT01313650|517266086|FG001|Overall Study|Adverse Event|34|||
143469618|NCT01313650|517266087|FG002|Overall Study|Adverse Event|24|||
143469619|NCT01313650|517266088|FG003|Overall Study|Adverse Event|23|||
143469620|NCT01313650|517266085|FG000|Overall Study|Lack of Efficacy|37|||
143469621|NCT01313650|517266086|FG001|Overall Study|Lack of Efficacy|20|||
143469622|NCT01313650|517266087|FG002|Overall Study|Lack of Efficacy|32|||
143469623|NCT01313650|517266088|FG003|Overall Study|Lack of Efficacy|20|||
143469624|NCT01313650|517266085|FG000|Overall Study|Lost to Follow-up|1|||
143469625|NCT01313650|517266086|FG001|Overall Study|Lost to Follow-up|0|||
143469626|NCT01313650|517266087|FG002|Overall Study|Lost to Follow-up|3|||
143469627|NCT01313650|517266088|FG003|Overall Study|Lost to Follow-up|2|||
143469628|NCT01313650|517266085|FG000|Overall Study|Withdrawal by Subject|16|||
143469629|NCT01313650|517266086|FG001|Overall Study|Withdrawal by Subject|20|||
143469630|NCT01313650|517266087|FG002|Overall Study|Withdrawal by Subject|15|||
143469631|NCT01313650|517266088|FG003|Overall Study|Withdrawal by Subject|15|||
143469632|NCT01313650|517266085|FG000|Overall Study|Protocol Violation|4|||
143469633|NCT01313650|517266086|FG001|Overall Study|Protocol Violation|7|||
143469634|NCT01313650|517266087|FG002|Overall Study|Protocol Violation|5|||
143469635|NCT01313650|517266088|FG003|Overall Study|Protocol Violation|6|||
143469636|NCT01313650|517266085|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
143469637|NCT01313650|517266086|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
143469638|NCT01313650|517266087|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
143469639|NCT01313650|517266088|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
143469640|NCT05393037|517266091|FG000|Part A|Death|1|||
143469641|NCT05393037|517266092|FG001|Part A|Death|0|||
143469642|NCT05393037|517266091|FG000|Part A|Lost to Follow-up|1|||
143469643|NCT05393037|517266092|FG001|Part A|Lost to Follow-up|1|||
143469644|NCT05393037|517266091|FG000|Part A|Withdrawal by Subject|2|||
143469645|NCT05393037|517266092|FG001|Part A|Withdrawal by Subject|4|||
143469646|NCT05393037|517266091|FG000|Part B|Lost to Follow-up|1|||
143469647|NCT05393037|517266092|FG001|Part B|Lost to Follow-up|0|||
143469648|NCT01012739|517266093|FG000|Treatment Period 1|Adverse Event|0|||
143469649|NCT01012739|517266094|FG001|Treatment Period 1|Adverse Event|0|||
143469650|NCT01012739|517266095|FG002|Treatment Period 1|Adverse Event|0|||
143469651|NCT01012739|517266096|FG003|Treatment Period 1|Adverse Event|1|||
143469652|NCT01012739|517266093|FG000|Treatment Period 2|Abnormal test procedure results|0|||
143469653|NCT01012739|517266094|FG001|Treatment Period 2|Abnormal test procedure results|0|||
143469654|NCT01012739|517266095|FG002|Treatment Period 2|Abnormal test procedure results|0|||
143469655|NCT01012739|517266096|FG003|Treatment Period 2|Abnormal test procedure results|1|||
143469656|NCT03049735|517266107|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
143469657|NCT03049735|517266108|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
143469658|NCT03049735|517266109|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
143469659|NCT03049735|517266107|FG000|Overall Study|Other|5|||
143469660|NCT03049735|517266108|FG001|Overall Study|Other|3|||
143469661|NCT03049735|517266109|FG002|Overall Study|Other|1|||
143469662|NCT03049735|517266107|FG000|Overall Study|Lack of Efficacy|4|||
143469663|NCT03049735|517266108|FG001|Overall Study|Lack of Efficacy|0|||
143469664|NCT03049735|517266109|FG002|Overall Study|Lack of Efficacy|3|||
143469665|NCT03049735|517266107|FG000|Overall Study|Protocol deviation|1|||
143469666|NCT03049735|517266108|FG001|Overall Study|Protocol deviation|0|||
143469667|NCT03049735|517266109|FG002|Overall Study|Protocol deviation|0|||
143469668|NCT03049735|517266107|FG000|Overall Study|Pregnancy|0|||
143469669|NCT03049735|517266108|FG001|Overall Study|Pregnancy|0|||
143469670|NCT03049735|517266109|FG002|Overall Study|Pregnancy|1|||
143469671|NCT03049735|517266107|FG000|Overall Study|Adverse Event|7|||
143469672|NCT03049735|517266108|FG001|Overall Study|Adverse Event|18|||
143469673|NCT03049735|517266109|FG002|Overall Study|Adverse Event|5|||
143469674|NCT03049735|517266107|FG000|Overall Study|Withdrawal by Subject|10|||
143469675|NCT03049735|517266108|FG001|Overall Study|Withdrawal by Subject|3|||
143469676|NCT03049735|517266109|FG002|Overall Study|Withdrawal by Subject|7|||
143469677|NCT03049735|517266107|FG000|Overall Study|Lost to Follow-up|1|||
143469678|NCT03049735|517266108|FG001|Overall Study|Lost to Follow-up|5|||
143469679|NCT03049735|517266109|FG002|Overall Study|Lost to Follow-up|5|||
143469680|NCT03153111|517266110|FG000|Overall Study|Death|2|||
143469681|NCT03153111|517266111|FG001|Overall Study|Death|5|||
143469682|NCT03153111|517266110|FG000|Overall Study|Lost to Follow-up|1|||
143469683|NCT03153111|517266111|FG001|Overall Study|Lost to Follow-up|0|||
143469684|NCT03153111|517266110|FG000|Overall Study|Physician Decision|5|||
143469685|NCT03153111|517266111|FG001|Overall Study|Physician Decision|1|||
143469686|NCT03153111|517266110|FG000|Overall Study|Withdrawal by Subject|3|||
143469687|NCT03153111|517266111|FG001|Overall Study|Withdrawal by Subject|3|||
143469688|NCT02684357|517266112|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
143469689|NCT02684357|517266113|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
143469690|NCT02684357|517266114|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
143469691|NCT02684357|517266115|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
143469692|NCT02684357|517266116|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
143469693|NCT02684357|517266117|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
143469694|NCT02684357|517266112|FG000|Part A|Lost to Follow-up|0|||
143469695|NCT02684357|517266113|FG001|Part A|Lost to Follow-up|2|||
143469696|NCT02684357|517266114|FG002|Part A|Lost to Follow-up|2|||
143469697|NCT02684357|517266115|FG003|Part A|Lost to Follow-up|0|||
143469698|NCT02684357|517266116|FG004|Part A|Lost to Follow-up|0|||
143469699|NCT02684357|517266117|FG005|Part A|Lost to Follow-up|0|||
143469700|NCT02684357|517266112|FG000|Part A|Withdrawal by Subject|3|||
143469701|NCT02684357|517266113|FG001|Part A|Withdrawal by Subject|0|||
143469702|NCT02684357|517266114|FG002|Part A|Withdrawal by Subject|0|||
143469703|NCT02684357|517266115|FG003|Part A|Withdrawal by Subject|0|||
143469704|NCT02684357|517266116|FG004|Part A|Withdrawal by Subject|0|||
143469705|NCT02684357|517266117|FG005|Part A|Withdrawal by Subject|0|||
143469706|NCT02684357|517266112|FG000|Part A|Other|0|||
143469707|NCT02684357|517266113|FG001|Part A|Other|1|||
143469708|NCT02684357|517266114|FG002|Part A|Other|0|||
143469709|NCT02684357|517266115|FG003|Part A|Other|0|||
143469710|NCT02684357|517266116|FG004|Part A|Other|0|||
143469711|NCT02684357|517266117|FG005|Part A|Other|0|||
143469712|NCT02684357|517266112|FG000|Part B|Adverse Event (Other)|0|||
143469713|NCT02684357|517266113|FG001|Part B|Adverse Event (Other)|0|||
143469714|NCT02684357|517266114|FG002|Part B|Adverse Event (Other)|0|||
143469715|NCT02684357|517266115|FG003|Part B|Adverse Event (Other)|1|||
143469716|NCT02684357|517266116|FG004|Part B|Adverse Event (Other)|1|||
143469717|NCT02684357|517266117|FG005|Part B|Adverse Event (Other)|1|||
143469718|NCT02684357|517266112|FG000|Part B|Lost to Follow-up|0|||
143469719|NCT02684357|517266113|FG001|Part B|Lost to Follow-up|0|||
143469720|NCT02684357|517266114|FG002|Part B|Lost to Follow-up|0|||
143469721|NCT02684357|517266115|FG003|Part B|Lost to Follow-up|1|||
143469722|NCT02684357|517266116|FG004|Part B|Lost to Follow-up|1|||
143469723|NCT02684357|517266117|FG005|Part B|Lost to Follow-up|7|||
143469724|NCT02684357|517266112|FG000|Part B|Withdrawal by Subject|0|||
143469725|NCT02684357|517266113|FG001|Part B|Withdrawal by Subject|0|||
143469726|NCT02684357|517266114|FG002|Part B|Withdrawal by Subject|0|||
143469727|NCT02684357|517266115|FG003|Part B|Withdrawal by Subject|0|||
143469728|NCT02684357|517266116|FG004|Part B|Withdrawal by Subject|2|||
143469729|NCT02684357|517266117|FG005|Part B|Withdrawal by Subject|4|||
143469730|NCT02684357|517266112|FG000|Part B|Other|0|||
143469731|NCT02684357|517266113|FG001|Part B|Other|0|||
143469732|NCT02684357|517266114|FG002|Part B|Other|0|||
143469733|NCT02684357|517266115|FG003|Part B|Other|1|||
143469734|NCT02684357|517266116|FG004|Part B|Other|0|||
143134516|NCT01294423|516039337|FG000|Overall Study|subject no longer meets study criteria|2|||
143134517|NCT01294423|516039338|FG001|Overall Study|subject no longer meets study criteria|5|||
143134518|NCT01294423|516039339|FG002|Overall Study|subject no longer meets study criteria|2|||
143134519|NCT01294423|516039337|FG000|Overall Study|poor/non-compliance|1|||
143134520|NCT01294423|516039338|FG001|Overall Study|poor/non-compliance|0|||
143134521|NCT01294423|516039339|FG002|Overall Study|poor/non-compliance|1|||
143134522|NCT01241279|516039340|FG000|Overall Study|Lost to Follow-up|0|||
143134523|NCT01241279|516039341|FG001|Overall Study|Lost to Follow-up|1|||
143134524|NCT00239720|516039345|FG000|Overall Study|Adverse Event|1|||
143134525|NCT00239720|516039346|FG001|Overall Study|Adverse Event|0|||
143134526|NCT00239720|516039345|FG000|Overall Study|Lost to Follow-up|0|||
143134527|NCT00239720|516039346|FG001|Overall Study|Lost to Follow-up|1|||
143134528|NCT01811732|516039347|FG000|Overall Study|Lost to Follow-up|24|||
143134529|NCT01811732|516039348|FG001|Overall Study|Lost to Follow-up|30|||
143134530|NCT01811732|516039347|FG000|Overall Study|Withdrawal by Subject|16|||
143469735|NCT02684357|517266117|FG005|Part B|Other|1|||
143469736|NCT01658826|517266118|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
143469737|NCT01658826|517266119|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
143134531|NCT01811732|516039348|FG001|Overall Study|Withdrawal by Subject|10|||
143134532|NCT01811732|516039347|FG000|Overall Study|Adverse Event|3|||
143134533|NCT01811732|516039348|FG001|Overall Study|Adverse Event|9|||
143469738|NCT01658826|517266118|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
143469739|NCT01658826|517266119|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
143469740|NCT01658826|517266118|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
143469741|NCT01658826|517266119|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
143469742|NCT01658826|517266118|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
143469743|NCT01658826|517266119|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
143469744|NCT01658826|517266118|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
143469745|NCT01658826|517266119|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
143469746|NCT01658826|517266118|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
143469747|NCT01658826|517266119|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
143469748|NCT01658826|517266118|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
143469749|NCT01658826|517266119|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
143469750|NCT01658826|517266118|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
143469751|NCT01658826|517266119|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
143469752|NCT01658826|517266118|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
143469753|NCT01658826|517266119|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
143469754|NCT00047320|517266120|FG000|Overall Study|Lack of Efficacy|8|||
143469755|NCT00047320|517266120|FG000|Overall Study|Lost to Follow-up|1|||
143469756|NCT00047320|517266120|FG000|Overall Study|Physician Decision|8|||
143469757|NCT00047320|517266120|FG000|Overall Study|Withdrawal by Subject|9|||
143469758|NCT00047320|517266120|FG000|Overall Study|Ineligible|2|||
143469759|NCT04567615|517266121|FG000|Randomization|Participant withdrew consent|1|||
143469760|NCT04567615|517266122|FG001|Randomization|Participant withdrew consent|0|||
143469761|NCT04567615|517266123|FG002|Randomization|Participant withdrew consent|0|||
143469762|NCT04567615|517266121|FG000|Randomization|Adverse event unrelated to study drug|0|||
143469763|NCT04567615|517266122|FG001|Randomization|Adverse event unrelated to study drug|1|||
143469764|NCT04567615|517266123|FG002|Randomization|Adverse event unrelated to study drug|0|||
143469765|NCT04567615|517266121|FG000|Treatment Period|Participant Withdrew Consent|2|||
143469766|NCT04567615|517266122|FG001|Treatment Period|Participant Withdrew Consent|5|||
143469767|NCT04567615|517266123|FG002|Treatment Period|Participant Withdrew Consent|1|||
143469768|NCT04567615|517266121|FG000|Treatment Period|Death|1|||
143469769|NCT04567615|517266122|FG001|Treatment Period|Death|2|||
143469770|NCT04567615|517266123|FG002|Treatment Period|Death|0|||
143469771|NCT04567615|517266121|FG000|Treatment Period|Lost to Follow-up|0|||
143469772|NCT04567615|517266122|FG001|Treatment Period|Lost to Follow-up|1|||
143469773|NCT04567615|517266123|FG002|Treatment Period|Lost to Follow-up|0|||
143469774|NCT04567615|517266121|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
143469775|NCT04567615|517266122|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
143469776|NCT04567615|517266123|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
143469777|NCT04567615|517266121|FG000|Treatment Period|Disease Progression|85|||
143469778|NCT04567615|517266122|FG001|Treatment Period|Disease Progression|63|||
143469779|NCT04567615|517266123|FG002|Treatment Period|Disease Progression|16|||
143469780|NCT04567615|517266121|FG000|Treatment Period|Study Drug Toxicity|3|||
143469781|NCT04567615|517266122|FG001|Treatment Period|Study Drug Toxicity|10|||
143013988|NCT00391118|515590126|FG001|Overall Study|Progressive Disease|26|||
143134534|NCT01811732|516039347|FG000|Overall Study|Lack of Efficacy|3|||
143134535|NCT01811732|516039348|FG001|Overall Study|Lack of Efficacy|1|||
143134536|NCT01811732|516039347|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
143134537|NCT01811732|516039348|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
143134538|NCT01811732|516039347|FG000|Overall Study|Physician Decision|2|||
143134539|NCT01811732|516039348|FG001|Overall Study|Physician Decision|0|||
143134540|NCT01811732|516039347|FG000|Overall Study|Death|1|||
143134541|NCT01811732|516039348|FG001|Overall Study|Death|1|||
143134542|NCT01811732|516039347|FG000|Overall Study|Insufficient venous access|0|||
143134543|NCT01811732|516039348|FG001|Overall Study|Insufficient venous access|1|||
143134544|NCT01811732|516039347|FG000|Overall Study|Protocol Violation|0|||
143134545|NCT01811732|516039348|FG001|Overall Study|Protocol Violation|1|||
143134546|NCT01811732|516039347|FG000|Overall Study|Subject incarcerated|1|||
143134547|NCT01811732|516039348|FG001|Overall Study|Subject incarcerated|2|||
143134548|NCT01811732|516039347|FG000|Overall Study|Admitted to another facility|1|||
143134549|NCT01811732|516039348|FG001|Overall Study|Admitted to another facility|0|||
143134550|NCT01811732|516039347|FG000|Overall Study|Correct study drug not available on site|1|||
143134551|NCT01811732|516039348|FG001|Overall Study|Correct study drug not available on site|0|||
143134552|NCT00536510|516039350|FG000|Overall Study|Adverse Event|27|||
143134553|NCT00536510|516039351|FG001|Overall Study|Adverse Event|4|||
143134554|NCT00536510|516039350|FG000|Overall Study|Lost to Follow-up|11|||
143134555|NCT00536510|516039351|FG001|Overall Study|Lost to Follow-up|8|||
143134556|NCT00536510|516039350|FG000|Overall Study|Protocol Violation|4|||
143134557|NCT00536510|516039351|FG001|Overall Study|Protocol Violation|5|||
143134558|NCT00536510|516039350|FG000|Overall Study|Withdrawal by Subject|16|||
143134559|NCT00536510|516039351|FG001|Overall Study|Withdrawal by Subject|9|||
143134560|NCT00536510|516039350|FG000|Overall Study|Flushing with Product|20|||
143134561|NCT00536510|516039351|FG001|Overall Study|Flushing with Product|0|||
143134562|NCT00536510|516039350|FG000|Overall Study|Laboratory Adverse Event|2|||
143134563|NCT00536510|516039351|FG001|Overall Study|Laboratory Adverse Event|1|||
143134564|NCT00536510|516039350|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
143134565|NCT00536510|516039351|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
143134566|NCT02771275|516039352|FG000|Overall Study|Reoperation|3|||
143134567|NCT02771275|516039352|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
143134568|NCT05556148|516039353|FG000|Overall Study|Early Termination|29|||
143134569|NCT05556148|516039353|FG000|Overall Study|Baseline Tasks Expired|4|||
143232173|NCT01446159|516402033|FG001|Overall Study|Other|0|||
143469782|NCT04567615|517266123|FG002|Treatment Period|Study Drug Toxicity|4|||
143469783|NCT04567615|517266121|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
143469784|NCT04567615|517266122|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
143469785|NCT04567615|517266123|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
143134570|NCT05556148|516039353|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
143134571|NCT05556148|516039353|FG000|Overall Study|No Longer Wished to Participate|1|||
143134572|NCT05556148|516039353|FG000|Overall Study|Bacterial Conjunctivitis|1|||
143134573|NCT01900444|516039358|FG000|Overall Study|Protocol Violation|2|||
143134574|NCT01900444|516039358|FG000|Overall Study|Lost to Follow-up|1|||
143134575|NCT00490035|516039359|FG000|Overall Study|AE, non-serious non-fatal|3|||
143134576|NCT00490035|516039360|FG001|Overall Study|AE, non-serious non-fatal|4|||
143134577|NCT00490035|516039361|FG002|Overall Study|AE, non-serious non-fatal|4|||
143134578|NCT00490035|516039362|FG003|Overall Study|AE, non-serious non-fatal|5|||
143134579|NCT00490035|516039359|FG000|Overall Study|Lost to Follow-up|2|||
143134580|NCT00490035|516039360|FG001|Overall Study|Lost to Follow-up|0|||
143134581|NCT00490035|516039361|FG002|Overall Study|Lost to Follow-up|1|||
143134582|NCT00490035|516039362|FG003|Overall Study|Lost to Follow-up|0|||
143134583|NCT00490035|516039359|FG000|Overall Study|Withdrawal by Subject|2|||
143134584|NCT00490035|516039360|FG001|Overall Study|Withdrawal by Subject|1|||
143134585|NCT00490035|516039361|FG002|Overall Study|Withdrawal by Subject|1|||
143134586|NCT00490035|516039362|FG003|Overall Study|Withdrawal by Subject|0|||
143134587|NCT00490035|516039359|FG000|Overall Study|Other reason|0|||
143134588|NCT00490035|516039360|FG001|Overall Study|Other reason|1|||
143134589|NCT00490035|516039361|FG002|Overall Study|Other reason|3|||
143134590|NCT00490035|516039362|FG003|Overall Study|Other reason|1|||
143134591|NCT00490035|516039359|FG000|Overall Study|AE, serious fatal|1|||
143134592|NCT00490035|516039360|FG001|Overall Study|AE, serious fatal|0|||
143134593|NCT00490035|516039361|FG002|Overall Study|AE, serious fatal|0|||
143134594|NCT00490035|516039362|FG003|Overall Study|AE, serious fatal|0|||
143134595|NCT00490035|516039359|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
143134596|NCT00490035|516039360|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
143134597|NCT00490035|516039361|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
143134598|NCT00490035|516039362|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
143134599|NCT00490035|516039359|FG000|Overall Study|AE of unknown type|0|||
143134600|NCT00490035|516039360|FG001|Overall Study|AE of unknown type|0|||
143134601|NCT00490035|516039361|FG002|Overall Study|AE of unknown type|2|||
143134602|NCT00490035|516039362|FG003|Overall Study|AE of unknown type|0|||
143134603|NCT06058390|516039367|FG000|Overall Study|Lost to Follow-up|0|||
143134604|NCT06058390|516039368|FG001|Overall Study|Lost to Follow-up|0|||
143134605|NCT06058390|516039369|FG002|Overall Study|Lost to Follow-up|2|||
143134606|NCT06058390|516039370|FG003|Overall Study|Lost to Follow-up|1|||
143134607|NCT06058390|516039367|FG000|Overall Study|Physician Decision|0|||
143134608|NCT06058390|516039368|FG001|Overall Study|Physician Decision|0|||
143134609|NCT06058390|516039369|FG002|Overall Study|Physician Decision|0|||
143134610|NCT06058390|516039370|FG003|Overall Study|Physician Decision|1|||
143134611|NCT06058390|516039367|FG000|Overall Study|Participants did not receive any study intervention|0|||
143134612|NCT06058390|516039368|FG001|Overall Study|Participants did not receive any study intervention|0|||
143134613|NCT06058390|516039369|FG002|Overall Study|Participants did not receive any study intervention|0|||
143134614|NCT06058390|516039370|FG003|Overall Study|Participants did not receive any study intervention|1|||
143360187|NCT04955626|516859891|FG032|Open-Label Period|Adverse Event|0|||
143360188|NCT04955626|516859892|FG033|Open-Label Period|Adverse Event|0|||
143360189|NCT04955626|516859893|FG034|Open-Label Period|Adverse Event|0|||
143360190|NCT04955626|516859894|FG035|Open-Label Period|Adverse Event|0|||
143360191|NCT04955626|516859859|FG000|Open-Label Period|Withdrawal by parent/guardian|1|||
143360192|NCT04955626|516859860|FG001|Open-Label Period|Withdrawal by parent/guardian|0|||
143360193|NCT04955626|516859861|FG002|Open-Label Period|Withdrawal by parent/guardian|0|||
143360194|NCT04955626|516859862|FG003|Open-Label Period|Withdrawal by parent/guardian|0|||
143360195|NCT04955626|516859863|FG004|Open-Label Period|Withdrawal by parent/guardian|0|||
143360196|NCT04955626|516859864|FG005|Open-Label Period|Withdrawal by parent/guardian|0|||
143360197|NCT04955626|516859865|FG006|Open-Label Period|Withdrawal by parent/guardian|0|||
143360198|NCT04955626|516859866|FG007|Open-Label Period|Withdrawal by parent/guardian|0|||
143360199|NCT04955626|516859867|FG008|Open-Label Period|Withdrawal by parent/guardian|0|||
143360200|NCT04955626|516859868|FG009|Open-Label Period|Withdrawal by parent/guardian|0|||
143360201|NCT04955626|516859869|FG010|Open-Label Period|Withdrawal by parent/guardian|0|||
143360202|NCT04955626|516859870|FG011|Open-Label Period|Withdrawal by parent/guardian|0|||
143360203|NCT04955626|516859871|FG012|Open-Label Period|Withdrawal by parent/guardian|0|||
143360204|NCT04955626|516859872|FG013|Open-Label Period|Withdrawal by parent/guardian|0|||
143360205|NCT04955626|516859873|FG014|Open-Label Period|Withdrawal by parent/guardian|0|||
143360206|NCT04955626|516859874|FG015|Open-Label Period|Withdrawal by parent/guardian|0|||
143360207|NCT04955626|516859875|FG016|Open-Label Period|Withdrawal by parent/guardian|0|||
143360208|NCT04955626|516859876|FG017|Open-Label Period|Withdrawal by parent/guardian|0|||
143360209|NCT04955626|516859877|FG018|Open-Label Period|Withdrawal by parent/guardian|0|||
143134615|NCT02127658|516039371|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
143134616|NCT02127658|516039372|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
143134617|NCT02127658|516039371|FG000|Overall Study|Withdrawal by Subject|0|||
143134618|NCT02127658|516039372|FG001|Overall Study|Withdrawal by Subject|2|||
143360210|NCT04955626|516859878|FG019|Open-Label Period|Withdrawal by parent/guardian|0|||
143134619|NCT02127658|516039371|FG000|Overall Study|Physician Decision|0|||
143134620|NCT02127658|516039372|FG001|Overall Study|Physician Decision|1|||
143134621|NCT00593918|516039375|FG000|Overall Study|Withdrawal by Subject|5|||
143469786|NCT04567615|517266121|FG000|Treatment Period|Other Reasons|1|||
143469787|NCT04567615|517266122|FG001|Treatment Period|Other Reasons|2|||
143469788|NCT04567615|517266123|FG002|Treatment Period|Other Reasons|0|||
143469789|NCT04567615|517266121|FG000|Treatment Period|Still On-going Treatment|21|||
143469790|NCT04567615|517266122|FG001|Treatment Period|Still On-going Treatment|22|||
143469791|NCT04567615|517266123|FG002|Treatment Period|Still On-going Treatment|2|||
143469792|NCT04982588|517268091|FG000|Overall Study|Withdrawal by Subject|2|||
143469793|NCT02170389|517268092|FG000|Overall Study|Study terminated prior to start of treat|1|||
143469794|NCT02366728|517268093|FG000|Overall Study|Death|0|||
143469795|NCT02366728|517268094|FG001|Overall Study|Death|0|||
143469796|NCT02366728|517268095|FG002|Overall Study|Death|1|||
143469797|NCT02366728|517268093|FG000|Overall Study|Adverse Event|1|||
143134622|NCT00593918|516039376|FG001|Overall Study|Withdrawal by Subject|24|||
143134623|NCT03380377|516039387|FG000|Overall Study|Physician Decision|1|||
143134624|NCT03380377|516039387|FG000|Overall Study|Withdrawal by Subject|1|||
143134625|NCT02600923|516039388|FG000|Overall Study|Death|10|||
143134626|NCT02600923|516039388|FG000|Overall Study|Adverse Event|3|||
143134627|NCT02600923|516039388|FG000|Overall Study|Global deterioration of health status|2|||
143134628|NCT02600923|516039388|FG000|Overall Study|Insufficient clinical response|6|||
143134629|NCT02600923|516039388|FG000|Overall Study|Lost to Follow-up|1|||
143134630|NCT02600923|516039388|FG000|Overall Study|Withdrawal by Subject|5|||
143134631|NCT02600923|516039388|FG000|Overall Study|Objective progression or relapse|50|||
143134632|NCT02600923|516039388|FG000|Overall Study|Study terminated by Sponsor|53|||
143134633|NCT02600923|516039388|FG000|Overall Study|Not treated|1|||
143134634|NCT00385918|516039392|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
143134635|NCT00385918|516039393|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
143134636|NCT00385918|516039394|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
143134637|NCT00385918|516039392|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
143134638|NCT00385918|516039393|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
143134639|NCT00385918|516039394|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
143134640|NCT00385918|516039392|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
143134641|NCT00385918|516039393|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
143134642|NCT00385918|516039394|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
143134643|NCT00385918|516039392|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
143134644|NCT00385918|516039393|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
143134645|NCT00385918|516039394|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
143134646|NCT00385918|516039392|FG000|Intervention Phase After Randomization|Physician Decision|1|||
143134647|NCT00385918|516039393|FG001|Intervention Phase After Randomization|Physician Decision|0|||
143134648|NCT00385918|516039394|FG002|Intervention Phase After Randomization|Physician Decision|0|||
143134649|NCT00385918|516039392|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
143134650|NCT00385918|516039393|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
143134651|NCT00385918|516039394|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
143134652|NCT04157088|516039395|FG000|Overall Study|Study terminated by sponsor|23|||
143134653|NCT04157088|516039395|FG000|Overall Study|Withdrawal by Subject|4|||
143134654|NCT04157088|516039395|FG000|Overall Study|Lost to Follow-up|2|||
143134655|NCT04157088|516039395|FG000|Overall Study|Death|1|||
143134656|NCT02421419|516039396|FG000|Overall Study|Physician Decision|0|||
143134657|NCT02421419|516039397|FG001|Overall Study|Physician Decision|0|||
143134658|NCT02421419|516039398|FG002|Overall Study|Physician Decision|1|||
143134659|NCT01676701|516039400|FG000|Overall Study|Protocol Violation|1|||
143134660|NCT01676701|516039401|FG001|Overall Study|Protocol Violation|0|||
143134661|NCT01676701|516039400|FG000|Overall Study|Sponsor Decision|3|||
143134662|NCT01676701|516039401|FG001|Overall Study|Sponsor Decision|4|||
143134663|NCT02115607|516039402|FG000|Overall Study|Withdrawal by Subject|1|||
143134664|NCT00549549|516039406|FG000|Overall Study|Adverse Event|5|||
143134665|NCT00549549|516039407|FG001|Overall Study|Adverse Event|3|||
143469798|NCT02366728|517268094|FG001|Overall Study|Adverse Event|0|||
143469799|NCT02366728|517268095|FG002|Overall Study|Adverse Event|0|||
143469800|NCT02366728|517268093|FG000|Overall Study|Screen Failure|2|||
143469801|NCT02366728|517268094|FG001|Overall Study|Screen Failure|1|||
143134666|NCT00549549|516039408|FG002|Overall Study|Adverse Event|1|||
143134667|NCT00549549|516039409|FG003|Overall Study|Adverse Event|9|||
143134668|NCT00549549|516039406|FG000|Overall Study|Lack of Efficacy|9|||
143134669|NCT00549549|516039407|FG001|Overall Study|Lack of Efficacy|6|||
143134670|NCT00549549|516039408|FG002|Overall Study|Lack of Efficacy|4|||
143134671|NCT00549549|516039409|FG003|Overall Study|Lack of Efficacy|2|||
143134672|NCT00549549|516039406|FG000|Overall Study|Lost to Follow-up|1|||
143134673|NCT00549549|516039407|FG001|Overall Study|Lost to Follow-up|0|||
143134674|NCT00549549|516039408|FG002|Overall Study|Lost to Follow-up|1|||
143134675|NCT00549549|516039409|FG003|Overall Study|Lost to Follow-up|2|||
143469802|NCT02366728|517268095|FG002|Overall Study|Screen Failure|0|||
143360211|NCT04955626|516859879|FG020|Open-Label Period|Withdrawal by parent/guardian|0|||
143360212|NCT04955626|516859880|FG021|Open-Label Period|Withdrawal by parent/guardian|0|||
143360213|NCT04955626|516859881|FG022|Open-Label Period|Withdrawal by parent/guardian|0|||
143360214|NCT04955626|516859882|FG023|Open-Label Period|Withdrawal by parent/guardian|0|||
143360215|NCT04955626|516859883|FG024|Open-Label Period|Withdrawal by parent/guardian|0|||
143360216|NCT04955626|516859884|FG025|Open-Label Period|Withdrawal by parent/guardian|0|||
143360217|NCT04955626|516859885|FG026|Open-Label Period|Withdrawal by parent/guardian|0|||
143360218|NCT04955626|516859886|FG027|Open-Label Period|Withdrawal by parent/guardian|0|||
143360219|NCT04955626|516859887|FG028|Open-Label Period|Withdrawal by parent/guardian|0|||
143360220|NCT04955626|516859888|FG029|Open-Label Period|Withdrawal by parent/guardian|0|||
143360221|NCT04955626|516859889|FG030|Open-Label Period|Withdrawal by parent/guardian|0|||
143360222|NCT04955626|516859890|FG031|Open-Label Period|Withdrawal by parent/guardian|0|||
143360223|NCT04955626|516859891|FG032|Open-Label Period|Withdrawal by parent/guardian|0|||
143360224|NCT04955626|516859892|FG033|Open-Label Period|Withdrawal by parent/guardian|0|||
143360225|NCT04955626|516859893|FG034|Open-Label Period|Withdrawal by parent/guardian|0|||
143360226|NCT04955626|516859894|FG035|Open-Label Period|Withdrawal by parent/guardian|0|||
143360227|NCT04955626|516859859|FG000|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
143360228|NCT04955626|516859860|FG001|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|476|||
143360229|NCT04955626|516859861|FG002|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
143360230|NCT04955626|516859862|FG003|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
143360231|NCT04955626|516859863|FG004|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
143360232|NCT04955626|516859864|FG005|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
143360233|NCT04955626|516859865|FG006|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
143360234|NCT04955626|516859866|FG007|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
143360235|NCT04955626|516859867|FG008|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
143360236|NCT04955626|516859868|FG009|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
143360237|NCT04955626|516859869|FG010|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
143360238|NCT04955626|516859870|FG011|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
143360239|NCT04955626|516859871|FG012|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
143360240|NCT04955626|516859872|FG013|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
143360241|NCT04955626|516859873|FG014|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
143360242|NCT04955626|516859874|FG015|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
143360243|NCT04955626|516859875|FG016|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
143360244|NCT04955626|516859876|FG017|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
143360245|NCT04955626|516859877|FG018|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
143360246|NCT04955626|516859878|FG019|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
143360247|NCT04955626|516859879|FG020|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
143360248|NCT04955626|516859880|FG021|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
143360249|NCT04955626|516859881|FG022|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
143360250|NCT04955626|516859882|FG023|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
143360251|NCT04955626|516859883|FG024|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
143360252|NCT04955626|516859884|FG025|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
143360253|NCT04955626|516859885|FG026|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
143360254|NCT04955626|516859886|FG027|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
143360255|NCT04955626|516859887|FG028|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
143360256|NCT04955626|516859888|FG029|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
143360257|NCT04955626|516859889|FG030|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
143360258|NCT04955626|516859890|FG031|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
143360259|NCT04955626|516859891|FG032|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
143360260|NCT04955626|516859892|FG033|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
143360261|NCT04955626|516859893|FG034|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
143360262|NCT04955626|516859894|FG035|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
143360263|NCT04320615|516859895|FG000|Overall Study|Withdrawal by Subject|4|||
143360264|NCT04320615|516859896|FG001|Overall Study|Withdrawal by Subject|10|||
143360265|NCT04320615|516859895|FG000|Overall Study|Physician Decision|2|||
143360266|NCT04320615|516859896|FG001|Overall Study|Physician Decision|0|||
143360267|NCT04320615|516859895|FG000|Overall Study|Other|2|||
143360268|NCT04320615|516859896|FG001|Overall Study|Other|0|||
143360269|NCT04320615|516859895|FG000|Overall Study|Lost to Follow-up|5|||
143360270|NCT04320615|516859896|FG001|Overall Study|Lost to Follow-up|23|||
143360271|NCT04320615|516859895|FG000|Overall Study|Death|35|||
143360272|NCT04320615|516859896|FG001|Overall Study|Death|71|||
143360273|NCT02419755|516859897|FG000|Overall Study|Death|1|||
143360274|NCT02419755|516859898|FG001|Overall Study|Death|3|||
143360275|NCT02419755|516859897|FG000|Overall Study|Relapse|0|||
143360276|NCT02419755|516859898|FG001|Overall Study|Relapse|1|||
143360277|NCT02419755|516859897|FG000|Overall Study|Ineligible|1|||
143360278|NCT02419755|516859898|FG001|Overall Study|Ineligible|0|||
143469803|NCT02366728|517268093|FG000|Overall Study|Only yielded 2 vaccines|1|||
143469804|NCT02366728|517268094|FG001|Overall Study|Only yielded 2 vaccines|0|||
143469805|NCT02366728|517268095|FG002|Overall Study|Only yielded 2 vaccines|0|||
143469806|NCT01383161|517268097|FG000|Overall Study|Adverse Event|5|||
143469807|NCT01383161|517268098|FG001|Overall Study|Adverse Event|1|||
143469808|NCT01383161|517268097|FG000|Overall Study|Withdrawal by Subject|0|||
143469809|NCT01383161|517268098|FG001|Overall Study|Withdrawal by Subject|2|||
143469810|NCT01383161|517268097|FG000|Overall Study|Lack of Efficacy|0|||
143469811|NCT01383161|517268098|FG001|Overall Study|Lack of Efficacy|1|||
143469812|NCT03942406|517268105|FG000|Overall Study|Lost to Follow-up|4|||
143469813|NCT03942406|517268106|FG001|Overall Study|Lost to Follow-up|5|||
143469814|NCT03942406|517268107|FG002|Overall Study|Lost to Follow-up|3|||
143469815|NCT03942406|517268108|FG003|Overall Study|Lost to Follow-up|7|||
143469816|NCT03942406|517268109|FG004|Overall Study|Lost to Follow-up|1|||
143469817|NCT03942406|517268110|FG005|Overall Study|Lost to Follow-up|0|||
143469818|NCT03942406|517268111|FG006|Overall Study|Lost to Follow-up|0|||
143469819|NCT03942406|517268105|FG000|Overall Study|Withdrawal by Subject|3|||
143469820|NCT03942406|517268106|FG001|Overall Study|Withdrawal by Subject|1|||
143469821|NCT03942406|517268107|FG002|Overall Study|Withdrawal by Subject|1|||
143469822|NCT03942406|517268108|FG003|Overall Study|Withdrawal by Subject|3|||
143469823|NCT03942406|517268109|FG004|Overall Study|Withdrawal by Subject|0|||
143469824|NCT03942406|517268110|FG005|Overall Study|Withdrawal by Subject|0|||
143469825|NCT03942406|517268111|FG006|Overall Study|Withdrawal by Subject|0|||
143469826|NCT03942406|517268105|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
143469827|NCT03942406|517268106|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
143469828|NCT03942406|517268107|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
143469829|NCT03942406|517268108|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
143469830|NCT03942406|517268109|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
143469831|NCT03942406|517268110|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
143469832|NCT03942406|517268111|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
143469833|NCT01054144|517268112|FG000|Overall Study|Death|2|||
143469834|NCT02748018|517268113|FG000|Study Period|Adverse Event|1|||
143469835|NCT02748018|517268114|FG001|Study Period|Adverse Event|3|||
143469836|NCT02748018|517268115|FG002|Study Period|Adverse Event|4|||
143469837|NCT02748018|517268116|FG003|Study Period|Adverse Event|0|||
143469838|NCT02748018|517268117|FG004|Study Period|Adverse Event|3|||
143469839|NCT02748018|517268118|FG005|Study Period|Adverse Event|3|||
143469840|NCT02748018|517268113|FG000|Study Period|Withdrawal by Subject|7|||
143469841|NCT02748018|517268114|FG001|Study Period|Withdrawal by Subject|4|||
143469842|NCT02748018|517268115|FG002|Study Period|Withdrawal by Subject|4|||
143469843|NCT02748018|517268116|FG003|Study Period|Withdrawal by Subject|11|||
143469844|NCT02748018|517268117|FG004|Study Period|Withdrawal by Subject|12|||
143469845|NCT02748018|517268118|FG005|Study Period|Withdrawal by Subject|10|||
143469846|NCT02748018|517268113|FG000|Study Period|Pregnancy|0|||
143469847|NCT02748018|517268114|FG001|Study Period|Pregnancy|1|||
143469848|NCT02748018|517268115|FG002|Study Period|Pregnancy|0|||
143469849|NCT02748018|517268116|FG003|Study Period|Pregnancy|0|||
143469850|NCT02748018|517268117|FG004|Study Period|Pregnancy|1|||
143469851|NCT02748018|517268118|FG005|Study Period|Pregnancy|0|||
143469852|NCT02748018|517268113|FG000|Study Period|Physician Decision|2|||
143469853|NCT02748018|517268114|FG001|Study Period|Physician Decision|2|||
143469854|NCT02748018|517268115|FG002|Study Period|Physician Decision|1|||
143469855|NCT02748018|517268116|FG003|Study Period|Physician Decision|0|||
143469856|NCT02748018|517268117|FG004|Study Period|Physician Decision|2|||
143469857|NCT02748018|517268118|FG005|Study Period|Physician Decision|0|||
143469858|NCT02748018|517268113|FG000|Study Period|Lost to Follow-up|0|||
143469859|NCT02748018|517268114|FG001|Study Period|Lost to Follow-up|0|||
143469860|NCT02748018|517268115|FG002|Study Period|Lost to Follow-up|0|||
143469861|NCT02748018|517268116|FG003|Study Period|Lost to Follow-up|2|||
143469862|NCT02748018|517268117|FG004|Study Period|Lost to Follow-up|0|||
143469863|NCT02748018|517268118|FG005|Study Period|Lost to Follow-up|1|||
143469864|NCT02748018|517268113|FG000|Continuation Period|Adverse Event|2|||
143469865|NCT02748018|517268114|FG001|Continuation Period|Adverse Event|0|||
143469866|NCT02748018|517268115|FG002|Continuation Period|Adverse Event|1|||
143469867|NCT02748018|517268116|FG003|Continuation Period|Adverse Event|1|||
143134676|NCT00549549|516039406|FG000|Overall Study|Withdrawal by Subject|0|||
143134677|NCT00549549|516039407|FG001|Overall Study|Withdrawal by Subject|4|||
143469868|NCT02748018|517268117|FG004|Continuation Period|Adverse Event|1|||
143469869|NCT02748018|517268118|FG005|Continuation Period|Adverse Event|4|||
143469870|NCT02748018|517268113|FG000|Continuation Period|Withdrawal by Subject|3|||
143469871|NCT02748018|517268114|FG001|Continuation Period|Withdrawal by Subject|5|||
143469872|NCT02748018|517268115|FG002|Continuation Period|Withdrawal by Subject|3|||
143469873|NCT02748018|517268116|FG003|Continuation Period|Withdrawal by Subject|9|||
143469874|NCT02748018|517268117|FG004|Continuation Period|Withdrawal by Subject|11|||
143469875|NCT02748018|517268118|FG005|Continuation Period|Withdrawal by Subject|1|||
143469876|NCT02748018|517268113|FG000|Continuation Period|Lost to Follow-up|0|||
143469877|NCT02748018|517268114|FG001|Continuation Period|Lost to Follow-up|2|||
143134678|NCT00549549|516039408|FG002|Overall Study|Withdrawal by Subject|1|||
143134679|NCT00549549|516039409|FG003|Overall Study|Withdrawal by Subject|0|||
143134680|NCT00549549|516039406|FG000|Overall Study|Other|9|||
143134681|NCT00549549|516039407|FG001|Overall Study|Other|9|||
143134682|NCT00549549|516039408|FG002|Overall Study|Other|9|||
143134683|NCT00549549|516039409|FG003|Overall Study|Other|11|||
143134684|NCT00549549|516039406|FG000|Overall Study|Randomized but not treated|0|||
143134685|NCT00549549|516039407|FG001|Overall Study|Randomized but not treated|0|||
143134686|NCT00549549|516039408|FG002|Overall Study|Randomized but not treated|1|||
143134687|NCT00549549|516039409|FG003|Overall Study|Randomized but not treated|1|||
143360279|NCT02419755|516859897|FG000|Overall Study|Withdrawal by Subject|1|||
143360280|NCT02419755|516859898|FG001|Overall Study|Withdrawal by Subject|0|||
143360281|NCT01950390|516859902|FG000|Overall Study|Never started treatment|3|||
143360282|NCT01950390|516859903|FG001|Overall Study|Never started treatment|2|||
143360283|NCT01950390|516859902|FG000|Overall Study|Disease progression|45|||
143360284|NCT01950390|516859903|FG001|Overall Study|Disease progression|52|||
143360285|NCT01950390|516859902|FG000|Overall Study|Adverse Event|22|||
143360286|NCT01950390|516859903|FG001|Overall Study|Adverse Event|16|||
143360287|NCT01950390|516859902|FG000|Overall Study|Death|5|||
143360288|NCT01950390|516859903|FG001|Overall Study|Death|3|||
143360289|NCT01950390|516859902|FG000|Overall Study|Withdrawal by Subject|5|||
143360290|NCT01950390|516859903|FG001|Overall Study|Withdrawal by Subject|1|||
143360291|NCT01950390|516859902|FG000|Overall Study|Alternative therapy|0|||
143360292|NCT01950390|516859903|FG001|Overall Study|Alternative therapy|3|||
143360293|NCT01950390|516859902|FG000|Overall Study|Complicating disease|1|||
143360294|NCT01950390|516859903|FG001|Overall Study|Complicating disease|0|||
143360295|NCT01950390|516859902|FG000|Overall Study|On treatment|1|||
143360296|NCT01950390|516859903|FG001|Overall Study|On treatment|0|||
143360297|NCT01950390|516859902|FG000|Overall Study|Symptomatic deterioration|2|||
143360298|NCT01950390|516859903|FG001|Overall Study|Symptomatic deterioration|1|||
143360299|NCT01950390|516859902|FG000|Overall Study|Physician Decision|0|||
143360300|NCT01950390|516859903|FG001|Overall Study|Physician Decision|4|||
143360301|NCT01950390|516859902|FG000|Overall Study|Lack of clinical benefit|0|||
143360302|NCT01950390|516859903|FG001|Overall Study|Lack of clinical benefit|1|||
143360303|NCT01950390|516859902|FG000|Overall Study|Maintained PR and moved to observation only|0|||
143360304|NCT01950390|516859903|FG001|Overall Study|Maintained PR and moved to observation only|1|||
143360305|NCT05567952|516861393|FG000|Overall Study|Lost to Follow-up|3|||
143360306|NCT05567952|516861394|FG001|Overall Study|Lost to Follow-up|2|||
143360307|NCT05567952|516861393|FG000|Overall Study|Withdrawal by Subject|6|||
143360308|NCT05567952|516861394|FG001|Overall Study|Withdrawal by Subject|3|||
143360309|NCT05567952|516861393|FG000|Overall Study|Other|3|||
143360310|NCT05567952|516861394|FG001|Overall Study|Other|1|||
143360311|NCT03158948|516861404|FG000|Overall Study|Death|1|||
143360312|NCT03158948|516861405|FG001|Overall Study|Death|1|||
143360313|NCT03158948|516861406|FG002|Overall Study|Death|3|||
143360314|NCT03158948|516861407|FG003|Overall Study|Death|2|||
143360315|NCT03158948|516861404|FG000|Overall Study|Physician Decision|0|||
143360316|NCT03158948|516861405|FG001|Overall Study|Physician Decision|0|||
143360317|NCT03158948|516861406|FG002|Overall Study|Physician Decision|0|||
143360318|NCT03158948|516861407|FG003|Overall Study|Physician Decision|1|||
143360319|NCT01286272|516861408|FG000|Overall Study|Ineligible after beginning treatment|1|||
143360320|NCT01286272|516861409|FG001|Overall Study|Ineligible after beginning treatment|3|||
143360321|NCT04730947|516861410|FG000|Overall Study|Withdrawal by Subject|0|||
143360322|NCT04730947|516861411|FG001|Overall Study|Withdrawal by Subject|1|||
143360323|NCT02123966|516861414|FG000|Overall Study|Intercurrent Illness|1|||
143360324|NCT01460381|516861415|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
143360325|NCT01460381|516861416|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
143360326|NCT01033643|516861420|FG000|Overall Study|Withdrew Consent|0|||
143360327|NCT01033643|516861421|FG001|Overall Study|Withdrew Consent|3|||
143360328|NCT01033643|516861422|FG002|Overall Study|Withdrew Consent|0|||
143360329|NCT01033643|516861423|FG003|Overall Study|Withdrew Consent|0|||
143360330|NCT01033643|516861424|FG004|Overall Study|Withdrew Consent|0|||
143360331|NCT01033643|516861425|FG005|Overall Study|Withdrew Consent|1|||
143360332|NCT02028884|516861432|FG000|Double-blind Period|Adverse Event|5|||
143360333|NCT02028884|516861433|FG001|Double-blind Period|Adverse Event|3|||
143360334|NCT02028884|516861434|FG002|Double-blind Period|Adverse Event|0|||
143360335|NCT02028884|516861432|FG000|Double-blind Period|Eligibility Violation|1|||
143013989|NCT00391118|515590127|FG002|Overall Study|Progressive Disease|43|||
143134688|NCT02155699|516039413|FG000|Overall Study|Withdrawal by Subject|0|||
143134689|NCT02155699|516039414|FG001|Overall Study|Withdrawal by Subject|3|||
143134690|NCT02155699|516039415|FG002|Overall Study|Withdrawal by Subject|6|||
143360336|NCT02028884|516861433|FG001|Double-blind Period|Eligibility Violation|0|||
143360337|NCT02028884|516861434|FG002|Double-blind Period|Eligibility Violation|0|||
143360338|NCT02028884|516861432|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
143360339|NCT02028884|516861433|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
143360340|NCT02028884|516861434|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
143360341|NCT02028884|516861432|FG000|Double-blind Period|Withdrawal by Subject|2|||
143360342|NCT02028884|516861433|FG001|Double-blind Period|Withdrawal by Subject|0|||
143469878|NCT02748018|517268115|FG002|Continuation Period|Lost to Follow-up|1|||
143469879|NCT02748018|517268116|FG003|Continuation Period|Lost to Follow-up|0|||
143469880|NCT02748018|517268117|FG004|Continuation Period|Lost to Follow-up|1|||
143469881|NCT02748018|517268118|FG005|Continuation Period|Lost to Follow-up|0|||
143134691|NCT02155699|516039416|FG003|Overall Study|Withdrawal by Subject|1|||
143134692|NCT02155699|516039413|FG000|Overall Study|Lost to Follow-up|0|||
143134693|NCT02155699|516039414|FG001|Overall Study|Lost to Follow-up|0|||
143134694|NCT02155699|516039415|FG002|Overall Study|Lost to Follow-up|0|||
143134695|NCT02155699|516039416|FG003|Overall Study|Lost to Follow-up|3|||
143469882|NCT02748018|517268113|FG000|Continuation Period|Pregnancy|1|||
143469883|NCT02748018|517268114|FG001|Continuation Period|Pregnancy|2|||
143469884|NCT02748018|517268115|FG002|Continuation Period|Pregnancy|0|||
143469885|NCT02748018|517268116|FG003|Continuation Period|Pregnancy|0|||
143469886|NCT02748018|517268117|FG004|Continuation Period|Pregnancy|0|||
143469887|NCT02748018|517268118|FG005|Continuation Period|Pregnancy|0|||
143469888|NCT02748018|517268113|FG000|Continuation Period|Physician Decision|0|||
143469889|NCT02748018|517268114|FG001|Continuation Period|Physician Decision|1|||
143469890|NCT02748018|517268115|FG002|Continuation Period|Physician Decision|2|||
143469891|NCT02748018|517268116|FG003|Continuation Period|Physician Decision|0|||
143469892|NCT02748018|517268117|FG004|Continuation Period|Physician Decision|2|||
143469893|NCT02748018|517268118|FG005|Continuation Period|Physician Decision|1|||
143469894|NCT02748018|517268113|FG000|Continuation Period|Protocol Violation|0|||
143469895|NCT02748018|517268114|FG001|Continuation Period|Protocol Violation|1|||
143469896|NCT02748018|517268115|FG002|Continuation Period|Protocol Violation|0|||
143469897|NCT02748018|517268116|FG003|Continuation Period|Protocol Violation|0|||
143469898|NCT02748018|517268117|FG004|Continuation Period|Protocol Violation|0|||
143469899|NCT02748018|517268118|FG005|Continuation Period|Protocol Violation|0|||
143469900|NCT05628285|517268119|FG000|Overall Study|Lost to Follow-up|1|||
143469901|NCT06069778|517268120|FG000|Overall Study|Withdrawal by Subject|1|||
143469902|NCT02856893|517268121|FG000|Overall Study|Lack of Efficacy|27|||
143469903|NCT02856893|517268122|FG001|Overall Study|Lack of Efficacy|15|||
143469904|NCT02856893|517268123|FG002|Overall Study|Lack of Efficacy|19|||
143469905|NCT02856893|517268121|FG000|Overall Study|Death|1|||
143469906|NCT02856893|517268122|FG001|Overall Study|Death|0|||
143469907|NCT02856893|517268123|FG002|Overall Study|Death|0|||
143469908|NCT02856893|517268121|FG000|Overall Study|Adverse Event|2|||
143469909|NCT02856893|517268122|FG001|Overall Study|Adverse Event|0|||
143469910|NCT02856893|517268123|FG002|Overall Study|Adverse Event|0|||
143469911|NCT02856893|517268121|FG000|Overall Study|Physician Decision|0|||
143469912|NCT02856893|517268122|FG001|Overall Study|Physician Decision|2|||
143469913|NCT02856893|517268123|FG002|Overall Study|Physician Decision|3|||
143469914|NCT02856893|517268121|FG000|Overall Study|Withdrawal by Subject|1|||
143469915|NCT02856893|517268122|FG001|Overall Study|Withdrawal by Subject|1|||
143469916|NCT02856893|517268123|FG002|Overall Study|Withdrawal by Subject|0|||
143469917|NCT02856893|517268121|FG000|Overall Study|Other reasons|2|||
143469918|NCT02856893|517268122|FG001|Overall Study|Other reasons|1|||
143469919|NCT02856893|517268123|FG002|Overall Study|Other reasons|2|||
143469920|NCT02310672|517268124|FG000|Overall Study|Death|1|||
143469921|NCT02310672|517268124|FG000|Overall Study|Lost to Follow-up|1|||
143469922|NCT02310672|517268124|FG000|Overall Study|Withdrawal by Subject|1|||
143469923|NCT02310672|517268124|FG000|Overall Study|Sponsor's decision|12|||
143469924|NCT04704336|517268128|FG000|Overall Study|Death|2|||
143469925|NCT04704336|517268129|FG001|Overall Study|Death|2|||
143469926|NCT04704336|517268128|FG000|Overall Study|Lost to Follow-up|33|||
143469927|NCT04704336|517268129|FG001|Overall Study|Lost to Follow-up|40|||
143469928|NCT03118674|517268130|FG000|Overall Study|Lost to Follow-up|2|||
143469929|NCT03118674|517268130|FG000|Overall Study|Screen Faliure|8|||
143469930|NCT03118674|517268130|FG000|Overall Study|Withdrawal by Subject|5|||
143469931|NCT01324323|517268131|FG000|Overall Study|Withdrawal by Subject|1|||
143469932|NCT00537485|517268132|FG000|Overall Study|Adverse Event|10|||
143469933|NCT00537485|517268133|FG001|Overall Study|Adverse Event|5|||
143469934|NCT00537485|517268132|FG000|Overall Study|Withdrawal by Subject|3|||
143469935|NCT00537485|517268133|FG001|Overall Study|Withdrawal by Subject|2|||
143469936|NCT00537485|517268132|FG000|Overall Study|Withdrawal by Subject|1|||
143469937|NCT00537485|517268133|FG001|Overall Study|Withdrawal by Subject|3|||
143469938|NCT00537485|517268132|FG000|Overall Study|Physician Decision|1|||
143469939|NCT00537485|517268133|FG001|Overall Study|Physician Decision|0|||
143469940|NCT03153137|517268134|FG000|Overall Study|Lost to Follow-up|1|||
143469941|NCT03153137|517268135|FG001|Overall Study|Lost to Follow-up|0|||
143469942|NCT03153137|517268134|FG000|Overall Study|Withdrawal by Subject|2|||
143469943|NCT03153137|517268135|FG001|Overall Study|Withdrawal by Subject|1|||
143134696|NCT02155699|516039413|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
143469944|NCT03153137|517268134|FG000|Overall Study|Physician Decision|0|||
143469945|NCT03153137|517268135|FG001|Overall Study|Physician Decision|3|||
143469946|NCT01284062|517268145|FG000|Overall Study|Adverse Event|4|||
143469947|NCT01284062|517268146|FG001|Overall Study|Adverse Event|5|||
143469948|NCT01284062|517268147|FG002|Overall Study|Adverse Event|0|||
143469949|NCT01284062|517268148|FG003|Overall Study|Adverse Event|5|||
143469950|NCT01284062|517268145|FG000|Overall Study|Lack of Efficacy|3|||
143134697|NCT02155699|516039414|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
143134698|NCT02155699|516039415|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
143134699|NCT02155699|516039416|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
143134700|NCT04058028|516039417|FG000|Overall Study|Withdrawal of Consent from Study|12|||
143134701|NCT04058028|516039418|FG001|Overall Study|Withdrawal of Consent from Study|8|||
143134702|NCT04058028|516039419|FG002|Overall Study|Withdrawal of Consent from Study|6|||
143360343|NCT02028884|516861434|FG002|Double-blind Period|Withdrawal by Subject|0|||
143360344|NCT02028884|516861432|FG000|Open-label Extension Period|Adverse Event|3|||
143360345|NCT02028884|516861433|FG001|Open-label Extension Period|Adverse Event|1|||
143360346|NCT02028884|516861434|FG002|Open-label Extension Period|Adverse Event|0|||
143360347|NCT02028884|516861432|FG000|Open-label Extension Period|Lack of Efficacy|3|||
143360348|NCT02028884|516861433|FG001|Open-label Extension Period|Lack of Efficacy|0|||
143360349|NCT02028884|516861434|FG002|Open-label Extension Period|Lack of Efficacy|0|||
143360350|NCT02028884|516861432|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
143360351|NCT02028884|516861433|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
143360352|NCT02028884|516861434|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
143360353|NCT02028884|516861432|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
143360354|NCT02028884|516861433|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
143360355|NCT02028884|516861434|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
143360356|NCT02028884|516861432|FG000|Open-label Extension Period|Switched to another treatment option|3|||
143360357|NCT02028884|516861433|FG001|Open-label Extension Period|Switched to another treatment option|0|||
143360358|NCT02028884|516861434|FG002|Open-label Extension Period|Switched to another treatment option|0|||
143360359|NCT02403674|516861435|FG000|Base Study|Death|1|||
143360360|NCT02403674|516861436|FG001|Base Study|Death|4|||
143360361|NCT02403674|516861435|FG000|Base Study|Adverse Event|11|||
143360362|NCT02403674|516861436|FG001|Base Study|Adverse Event|26|||
143360363|NCT02403674|516861435|FG000|Base Study|Lack of Efficacy|31|||
143360364|NCT02403674|516861436|FG001|Base Study|Lack of Efficacy|23|||
143360365|NCT02403674|516861435|FG000|Base Study|Lost to Follow-up|6|||
143360366|NCT02403674|516861436|FG001|Base Study|Lost to Follow-up|8|||
143360367|NCT02403674|516861435|FG000|Base Study|Withdrawal by Subject|10|||
143360368|NCT02403674|516861436|FG001|Base Study|Withdrawal by Subject|17|||
143360369|NCT02403674|516861435|FG000|Base Study|Physician Decision|2|||
143360370|NCT02403674|516861436|FG001|Base Study|Physician Decision|2|||
143360371|NCT02403674|516861435|FG000|Base Study|Pregnancy|2|||
143360372|NCT02403674|516861436|FG001|Base Study|Pregnancy|2|||
143360373|NCT02403674|516861435|FG000|Base Study|Protocol Violation|8|||
143360374|NCT02403674|516861436|FG001|Base Study|Protocol Violation|4|||
143360375|NCT02403674|516861435|FG000|Base Study|Non-Compliance with study drug|1|||
143360376|NCT02403674|516861436|FG001|Base Study|Non-Compliance with study drug|4|||
143360377|NCT02403674|516861435|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
143360378|NCT02403674|516861436|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
143360379|NCT02403674|516861435|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
143360380|NCT02403674|516861436|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
143360381|NCT02403674|516861435|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
143360382|NCT02403674|516861436|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
143360383|NCT02403674|516861435|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
143360384|NCT02403674|516861436|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
143360385|NCT02403674|516861435|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
143360386|NCT02403674|516861436|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
143360387|NCT02403674|516861435|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
143360388|NCT02403674|516861436|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
143360389|NCT02403674|516861435|FG000|Study Extension 1 (Open-Label)|Death|1|||
143360390|NCT02403674|516861436|FG001|Study Extension 1 (Open-Label)|Death|0|||
143360391|NCT02403674|516861435|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
143360392|NCT02403674|516861436|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
143360393|NCT02403674|516861435|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
143360394|NCT02403674|516861436|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
143360395|NCT02403674|516861435|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
143360396|NCT02403674|516861436|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
143360397|NCT02403674|516861435|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
143360398|NCT02403674|516861436|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
143360399|NCT02403674|516861435|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
143360400|NCT02403674|516861436|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
143360401|NCT02403674|516861435|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
143360402|NCT02403674|516861436|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
143360403|NCT02403674|516861435|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
143360404|NCT02403674|516861436|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
143360405|NCT02403674|516861435|FG000|Study Extension 2 (Open-Label)|Death|2|||
143360406|NCT02403674|516861436|FG001|Study Extension 2 (Open-Label)|Death|2|||
143360407|NCT02403674|516861435|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
143469951|NCT01284062|517268146|FG001|Overall Study|Lack of Efficacy|2|||
143469952|NCT01284062|517268147|FG002|Overall Study|Lack of Efficacy|2|||
143469953|NCT01284062|517268148|FG003|Overall Study|Lack of Efficacy|1|||
143469954|NCT01284062|517268145|FG000|Overall Study|Medication error without adverse event|0|||
143469955|NCT01284062|517268146|FG001|Overall Study|Medication error without adverse event|0|||
143469956|NCT01284062|517268147|FG002|Overall Study|Medication error without adverse event|1|||
143469957|NCT01284062|517268148|FG003|Overall Study|Medication error without adverse event|0|||
143469958|NCT01284062|517268145|FG000|Overall Study|Protocol Violation|1|||
143469959|NCT01284062|517268146|FG001|Overall Study|Protocol Violation|0|||
143469960|NCT01284062|517268147|FG002|Overall Study|Protocol Violation|0|||
143469961|NCT01284062|517268148|FG003|Overall Study|Protocol Violation|2|||
143469962|NCT01284062|517268145|FG000|Overall Study|Withdrawal by Subject|3|||
143469963|NCT01284062|517268146|FG001|Overall Study|Withdrawal by Subject|1|||
143469964|NCT01284062|517268147|FG002|Overall Study|Withdrawal by Subject|2|||
143469965|NCT01284062|517268148|FG003|Overall Study|Withdrawal by Subject|5|||
143469966|NCT01284062|517268145|FG000|Overall Study|Other|0|||
143469967|NCT01284062|517268146|FG001|Overall Study|Other|0|||
143469968|NCT01284062|517268147|FG002|Overall Study|Other|0|||
143469969|NCT01284062|517268148|FG003|Overall Study|Other|1|||
143469970|NCT01284062|517268145|FG000|Overall Study|Site Closed|0|||
143469971|NCT01284062|517268146|FG001|Overall Study|Site Closed|0|||
143469972|NCT01284062|517268147|FG002|Overall Study|Site Closed|1|||
143469973|NCT01284062|517268148|FG003|Overall Study|Site Closed|0|||
143469974|NCT00559585|517268149|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
143469975|NCT00559585|517268150|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
143469976|NCT00559585|517268149|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
143469977|NCT00559585|517268150|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
143469978|NCT00559585|517268149|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
143469979|NCT00559585|517268150|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
143469980|NCT00559585|517268149|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
143469981|NCT00559585|517268150|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
143469982|NCT00559585|517268149|FG000|Double Blind ST Period Main Study|Death|1|||
143469983|NCT00559585|517268150|FG001|Double Blind ST Period Main Study|Death|1|||
143469984|NCT00559585|517268149|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
143469985|NCT00559585|517268150|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
143469986|NCT00559585|517268149|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
143469987|NCT00559585|517268150|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
143469988|NCT00559585|517268149|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
143469989|NCT00559585|517268150|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
143469990|NCT00559585|517268149|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
143469991|NCT00559585|517268150|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
143469992|NCT00559585|517268149|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
143469993|NCT00559585|517268150|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
143469994|NCT00559585|517268149|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
143469995|NCT00559585|517268150|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
143469996|NCT00559585|517268149|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
143469997|NCT00559585|517268150|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
143469998|NCT00559585|517268149|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
143469999|NCT00559585|517268150|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
143470000|NCT00559585|517268149|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
143470001|NCT00559585|517268150|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
143470002|NCT00559585|517268149|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
143470003|NCT00559585|517268150|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
143470004|NCT00559585|517268149|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
143470005|NCT00559585|517268150|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
143470006|NCT00559585|517268149|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
143470007|NCT00559585|517268150|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
143470008|NCT00559585|517268149|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
143470009|NCT00559585|517268150|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
143470010|NCT00559585|517268149|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
143470011|NCT00559585|517268150|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
143470012|NCT00559585|517268149|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
143470013|NCT00559585|517268150|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
143470014|NCT00559585|517268149|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
143470015|NCT00559585|517268150|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
143470016|NCT00559585|517268149|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
143470017|NCT00559585|517268150|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
143470018|NCT00559585|517268149|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
143470019|NCT00559585|517268150|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
143134703|NCT04058028|516039420|FG003|Overall Study|Withdrawal of Consent from Study|7|||
143134704|NCT04058028|516039417|FG000|Overall Study|Decision by Sponsor|13|||
143134705|NCT04058028|516039418|FG001|Overall Study|Decision by Sponsor|4|||
143134706|NCT04058028|516039419|FG002|Overall Study|Decision by Sponsor|1|||
143470020|NCT00559585|517268149|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
143470021|NCT00559585|517268150|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
143470022|NCT00559585|517268149|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
143470023|NCT00559585|517268150|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
143470024|NCT00559585|517268149|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
143470025|NCT00559585|517268150|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
143470026|NCT00559585|517268149|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
143470027|NCT00559585|517268150|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
143470028|NCT00559585|517268149|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
143470029|NCT00559585|517268150|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
143470030|NCT02644941|517268151|FG000|18 Months|Subjects lost graft during the study up to the data cut-off|49|||
143470031|NCT02644941|517268152|FG001|18 Months|Subjects lost graft during the study up to the data cut-off|52|||
143470032|NCT01145495|517268153|FG000|Overall Study|Adverse Event|6|||
143470033|NCT01145495|517268153|FG000|Overall Study|Withdrawal by Subject|6|||
143470034|NCT01145495|517268153|FG000|Overall Study|Disease progression after respone|2|||
143470035|NCT00323297|517268164|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
143470036|NCT00323297|517268165|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
143470037|NCT00323297|517268164|FG000|Part A (Double Blind Randomized)|Death|0|||
143470038|NCT00323297|517268165|FG001|Part A (Double Blind Randomized)|Death|1|||
143470039|NCT00323297|517268164|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
143470040|NCT00323297|517268165|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
143470041|NCT00323297|517268164|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
143470042|NCT00323297|517268165|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
143470043|NCT00323297|517268164|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
143470044|NCT00323297|517268165|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
143470045|NCT00323297|517268164|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
143470046|NCT00323297|517268165|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
143470047|NCT00323297|517268164|FG000|Part B (Open-label)|Death|0|||
143470048|NCT00323297|517268165|FG001|Part B (Open-label)|Death|1|||
143470049|NCT00323297|517268164|FG000|Part B (Open-label)|Reason unspecified|0|||
143470050|NCT00323297|517268165|FG001|Part B (Open-label)|Reason unspecified|1|||
143470051|NCT00323297|517268164|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
143470052|NCT00323297|517268165|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
143470053|NCT00323297|517268164|FG000|Part B (Open-label)|Lack of Efficacy|3|||
143470054|NCT00323297|517268165|FG001|Part B (Open-label)|Lack of Efficacy|1|||
143470055|NCT00323297|517268164|FG000|Part B (Open-label)|Adverse Event|5|||
143470056|NCT00323297|517268165|FG001|Part B (Open-label)|Adverse Event|5|||
143470057|NCT00323297|517268164|FG000|Part B (Open-label)|Protocol Violation|0|||
143470058|NCT00323297|517268165|FG001|Part B (Open-label)|Protocol Violation|1|||
143470059|NCT01603082|517268167|FG000|Overall Study|Adverse Event|0|||
143470060|NCT01603082|517268168|FG001|Overall Study|Adverse Event|1|||
143470061|NCT01603082|517268167|FG000|Overall Study|Withdrawal by Subject|1|||
143470062|NCT01603082|517268168|FG001|Overall Study|Withdrawal by Subject|0|||
143470063|NCT01603082|517268167|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
143470064|NCT01603082|517268168|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
143470065|NCT00634010|517268173|FG000|Overall Study|Adverse Event|2|||
143470066|NCT00634010|517268174|FG001|Overall Study|Adverse Event|5|||
143470067|NCT00634010|517268173|FG000|Overall Study|Withdrawal by Subject|5|||
143470068|NCT00634010|517268174|FG001|Overall Study|Withdrawal by Subject|6|||
143470069|NCT00634010|517268173|FG000|Overall Study|Physician Decision|1|||
143470070|NCT00634010|517268174|FG001|Overall Study|Physician Decision|1|||
143470071|NCT00634010|517268173|FG000|Overall Study|Disease Progression|1|||
143470072|NCT00634010|517268174|FG001|Overall Study|Disease Progression|1|||
143470073|NCT00634010|517268173|FG000|Overall Study|Non-Compliant|1|||
143470074|NCT00634010|517268174|FG001|Overall Study|Non-Compliant|1|||
143134707|NCT04058028|516039420|FG003|Overall Study|Decision by Sponsor|35|||
143470075|NCT01026142|517268175|FG000|Overall Study|Death|136|||
143134708|NCT04058028|516039417|FG000|Overall Study|Lost to Follow-up|1|||
143470076|NCT01026142|517268176|FG001|Overall Study|Death|134|||
143470077|NCT01026142|517268175|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
143470078|NCT01026142|517268176|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
143470079|NCT01862640|517268181|FG000|Overall Study|Adverse Event|4|||
143470080|NCT01862640|517268182|FG001|Overall Study|Adverse Event|10|||
143134709|NCT04058028|516039418|FG001|Overall Study|Lost to Follow-up|1|||
143470081|NCT01862640|517268183|FG002|Overall Study|Adverse Event|6|||
143470082|NCT01862640|517268184|FG003|Overall Study|Adverse Event|8|||
143470083|NCT01862640|517268181|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
143134710|NCT04058028|516039419|FG002|Overall Study|Lost to Follow-up|1|||
143470084|NCT01862640|517268182|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
143470085|NCT01862640|517268183|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
143470086|NCT01862640|517268184|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
143470087|NCT01862640|517268181|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
143470088|NCT01862640|517268182|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
143470089|NCT01862640|517268183|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
143470090|NCT01862640|517268184|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
143470091|NCT01862640|517268181|FG000|Overall Study|Withdrawal by Subject|2|||
143470092|NCT01862640|517268182|FG001|Overall Study|Withdrawal by Subject|4|||
143470093|NCT01862640|517268183|FG002|Overall Study|Withdrawal by Subject|8|||
143470094|NCT01862640|517268184|FG003|Overall Study|Withdrawal by Subject|5|||
143470095|NCT01862640|517268181|FG000|Overall Study|Protocol Deviation|0|||
143470096|NCT01862640|517268182|FG001|Overall Study|Protocol Deviation|0|||
143470097|NCT01862640|517268183|FG002|Overall Study|Protocol Deviation|1|||
143470098|NCT01862640|517268184|FG003|Overall Study|Protocol Deviation|0|||
143470099|NCT01019317|517268187|FG000|Overall Study|Not Eligible|4|||
143470100|NCT02178553|517268188|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
143470101|NCT02178553|517268189|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
143470102|NCT02178553|517268188|FG000|Overall Study|Physician Decision|0|||
143470103|NCT02178553|517268189|FG001|Overall Study|Physician Decision|4|||
143470104|NCT02178553|517268188|FG000|Overall Study|Technical problem with injection|1|||
143470105|NCT02178553|517268189|FG001|Overall Study|Technical problem with injection|3|||
143470106|NCT05085665|517268190|FG000|Overall Study|Physician Decision|2|||
143470107|NCT01641809|517268191|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
143470108|NCT01641809|517268192|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
143470109|NCT01641809|517268193|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
143470110|NCT01641809|517268194|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
143470111|NCT01641809|517268191|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
143470112|NCT01641809|517268192|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
143470113|NCT01641809|517268193|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
143470114|NCT01641809|517268194|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
143470115|NCT01641809|517268191|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
143470116|NCT01641809|517268192|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
143470117|NCT01641809|517268193|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
143470118|NCT01641809|517268194|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
143470119|NCT01641809|517268191|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
143470120|NCT01641809|517268192|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
143470121|NCT01641809|517268193|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
143470122|NCT01641809|517268194|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
143470123|NCT01641809|517268191|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
143470124|NCT01641809|517268192|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
143470125|NCT01641809|517268193|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
143470126|NCT01641809|517268194|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
143470127|NCT01641809|517268191|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
143470128|NCT01641809|517268192|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
143470129|NCT01641809|517268193|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
143470130|NCT01641809|517268194|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
143470131|NCT01641809|517268191|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
143470132|NCT01641809|517268192|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
143470133|NCT01641809|517268193|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
143470134|NCT01641809|517268194|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
143470135|NCT01641809|517268191|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
143470136|NCT01641809|517268192|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
143470137|NCT01641809|517268193|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
143470138|NCT01641809|517268194|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
143470139|NCT01641809|517268191|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
143470140|NCT01641809|517268192|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
143470141|NCT01641809|517268193|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
143470142|NCT01641809|517268194|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
143470143|NCT01641809|517268191|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
143470144|NCT01641809|517268192|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
143470145|NCT01641809|517268193|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
143470146|NCT01641809|517268194|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
143470147|NCT01641809|517268191|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
143470148|NCT01641809|517268192|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
143470149|NCT01641809|517268193|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
143470150|NCT01641809|517268194|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
143470151|NCT01641809|517268191|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
143134711|NCT04058028|516039420|FG003|Overall Study|Lost to Follow-up|0|||
143134712|NCT04058028|516039417|FG000|Overall Study|Death|0|||
143134713|NCT04058028|516039418|FG001|Overall Study|Death|1|||
143134714|NCT04058028|516039419|FG002|Overall Study|Death|0|||
143360408|NCT02403674|516861436|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
143360409|NCT02403674|516861435|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
143360410|NCT02403674|516861436|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
143360411|NCT02403674|516861435|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
143360412|NCT02403674|516861436|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
143360413|NCT02403674|516861435|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
143360414|NCT02403674|516861436|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
143360415|NCT02403674|516861435|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
143360416|NCT02403674|516861436|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
143360417|NCT02403674|516861435|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
143360418|NCT02403674|516861436|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
143360419|NCT02403674|516861435|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
143360420|NCT02403674|516861436|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
143360421|NCT00826280|516861437|FG000|Overall Study|Randomized but drug not received|1|||
143360422|NCT00826280|516861438|FG001|Overall Study|Randomized but drug not received|0|||
143360423|NCT00826280|516861439|FG002|Overall Study|Randomized but drug not received|1|||
143360424|NCT00826280|516861437|FG000|Overall Study|Adverse Event|1|||
143360425|NCT00826280|516861438|FG001|Overall Study|Adverse Event|3|||
143360426|NCT00826280|516861439|FG002|Overall Study|Adverse Event|0|||
143360427|NCT00826280|516861437|FG000|Overall Study|Lost to Follow-up|0|||
143360428|NCT00826280|516861438|FG001|Overall Study|Lost to Follow-up|1|||
143360429|NCT00826280|516861439|FG002|Overall Study|Lost to Follow-up|0|||
143360430|NCT00826280|516861437|FG000|Overall Study|Sponsor discontinued subject or study|1|||
143360431|NCT00826280|516861438|FG001|Overall Study|Sponsor discontinued subject or study|0|||
143360432|NCT00826280|516861439|FG002|Overall Study|Sponsor discontinued subject or study|0|||
143360433|NCT00826280|516861437|FG000|Overall Study|Reversible ischemic defect not present|43|||
143360434|NCT00826280|516861438|FG001|Overall Study|Reversible ischemic defect not present|40|||
143360435|NCT00826280|516861439|FG002|Overall Study|Reversible ischemic defect not present|44|||
143360436|NCT00826280|516861437|FG000|Overall Study|Interpretation Failure|1|||
143360437|NCT00826280|516861438|FG001|Overall Study|Interpretation Failure|0|||
143360438|NCT00826280|516861439|FG002|Overall Study|Interpretation Failure|0|||
143360439|NCT00826280|516861437|FG000|Overall Study|Machine Failure|1|||
143360440|NCT00826280|516861438|FG001|Overall Study|Machine Failure|1|||
143360441|NCT00826280|516861439|FG002|Overall Study|Machine Failure|0|||
143360442|NCT00826280|516861437|FG000|Overall Study|One or more non-interpretable scan|0|||
143360443|NCT00826280|516861438|FG001|Overall Study|One or more non-interpretable scan|1|||
143360444|NCT00826280|516861439|FG002|Overall Study|One or more non-interpretable scan|1|||
143360445|NCT03487666|516861440|FG000|Overall Study|Disease progression|4|||
143360446|NCT03487666|516861441|FG001|Overall Study|Disease progression|2|||
143360447|NCT03487666|516861442|FG002|Overall Study|Disease progression|0|||
143360448|NCT03487666|516861440|FG000|Overall Study|Adverse Event|0|||
143360449|NCT03487666|516861441|FG001|Overall Study|Adverse Event|0|||
143360450|NCT03487666|516861442|FG002|Overall Study|Adverse Event|1|||
143360451|NCT03201757|516861443|FG000|Overall Study|Withdrawal by Subject|133|||
143360452|NCT03201757|516861443|FG000|Overall Study|Adverse Event|44|||
143360453|NCT03201757|516861443|FG000|Overall Study|Lost to Follow-up|37|||
143360454|NCT03201757|516861443|FG000|Overall Study|Pregnancy|2|||
143360455|NCT03201757|516861443|FG000|Overall Study|Lack of Efficacy|1|||
143360456|NCT03201757|516861443|FG000|Overall Study|Protocol Violation|20|||
143360457|NCT03201757|516861443|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
143360458|NCT03201757|516861443|FG000|Overall Study|Not Yet Determined|5|||
143360459|NCT03201757|516861443|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
143360460|NCT03201757|516861443|FG000|Overall Study|Other|20|||
143360461|NCT00765362|516861444|FG000|Overall Study|Death|9|||
143360462|NCT00765362|516861444|FG000|Overall Study|Adverse Event|2|||
143360463|NCT00765362|516861444|FG000|Overall Study|Protocol Violation|18|||
143360464|NCT00765362|516861444|FG000|Overall Study|Withdrawal by Subject|13|||
143360465|NCT00765362|516861444|FG000|Overall Study|Lost to Follow-up|95|||
143360466|NCT01636362|516861446|FG000|Overall Study|Physician Decision|6|||
143360467|NCT01636362|516861446|FG000|Overall Study|Subject healed, not returning|1|||
143360468|NCT01636362|516861446|FG000|Overall Study|Withdrawal by Subject|1|||
143360469|NCT00519779|516861449|FG000|Overall Study|Withdrawal by Subject|0|||
143360470|NCT00519779|516861450|FG001|Overall Study|Withdrawal by Subject|1|||
143360471|NCT01323660|516861456|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
143360472|NCT01323660|516861457|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
143360473|NCT01323660|516861458|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
143360474|NCT01323660|516861459|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
143360475|NCT01323660|516861460|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
143360476|NCT01323660|516861461|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
143134715|NCT04058028|516039420|FG003|Overall Study|Death|0|||
143470152|NCT01641809|517268192|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
143470153|NCT01641809|517268193|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
143470154|NCT01641809|517268194|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
143470155|NCT01641809|517268191|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
143470156|NCT01641809|517268192|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
143470157|NCT01641809|517268193|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
143470158|NCT01641809|517268194|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
143470159|NCT01641809|517268191|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
143470160|NCT01641809|517268192|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
143470161|NCT01641809|517268193|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
143470162|NCT01641809|517268194|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
143470163|NCT01641809|517268191|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
143470164|NCT01641809|517268192|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
143470165|NCT01641809|517268193|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
143470166|NCT01641809|517268194|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
143470167|NCT01641809|517268191|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
143470168|NCT01641809|517268192|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
143470169|NCT01641809|517268193|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
143470170|NCT01641809|517268194|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
143470171|NCT01641809|517268191|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
143470172|NCT01641809|517268192|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
143470173|NCT01641809|517268193|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
143470174|NCT01641809|517268194|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
143470175|NCT01641809|517268191|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
143470176|NCT01641809|517268192|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
143470177|NCT01641809|517268193|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
143470178|NCT01641809|517268194|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
143470179|NCT03294109|517268197|FG000|Overall Study|Withdrawal by Subject|6|||
143470180|NCT03294109|517268198|FG001|Overall Study|Withdrawal by Subject|5|||
143470181|NCT03690141|517268199|FG000|Overall Study|Adverse Event|5|||
143470182|NCT03690141|517268199|FG000|Overall Study|Withdrawal by Subject|3|||
143470183|NCT03690141|517268199|FG000|Overall Study|Physician Decision|4|||
143470184|NCT03690141|517268199|FG000|Overall Study|Disease progression|4|||
143470185|NCT04744285|517268200|FG000|Overall Study|Withdrawal by Subject|1|||
143470186|NCT04744285|517268201|FG001|Overall Study|Withdrawal by Subject|1|||
143470187|NCT04744285|517268202|FG002|Overall Study|Withdrawal by Subject|2|||
143470188|NCT04744285|517268203|FG003|Overall Study|Withdrawal by Subject|1|||
143470189|NCT00448435|517268204|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
143470190|NCT00448435|517268205|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
143470191|NCT04195581|517268208|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
143470192|NCT04195581|517268208|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
143470193|NCT04195581|517268208|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
143470194|NCT04195581|517268208|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
143470195|NCT04195581|517268208|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
143470196|NCT04195581|517268208|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
143470197|NCT01182766|517268211|FG000|Overall Study|Lost to Follow-up|32|||
143470198|NCT01182766|517268212|FG001|Overall Study|Lost to Follow-up|36|||
143470199|NCT01182766|517268213|FG002|Overall Study|Lost to Follow-up|29|||
143470200|NCT01182766|517268211|FG000|Overall Study|Withdrawal by Subject|14|||
143470201|NCT01182766|517268212|FG001|Overall Study|Withdrawal by Subject|3|||
143470202|NCT01182766|517268213|FG002|Overall Study|Withdrawal by Subject|6|||
143470203|NCT01182766|517268211|FG000|Overall Study|Physician Decision|1|||
143470204|NCT01182766|517268212|FG001|Overall Study|Physician Decision|0|||
143470205|NCT01182766|517268213|FG002|Overall Study|Physician Decision|0|||
143470206|NCT01182766|517268211|FG000|Overall Study|Non-compliance|1|||
143470207|NCT01182766|517268212|FG001|Overall Study|Non-compliance|1|||
143470208|NCT01182766|517268213|FG002|Overall Study|Non-compliance|1|||
143470209|NCT02510560|517268214|FG000|Overall Study|Discontinued from Treatment|27|||
143470210|NCT02510560|517268215|FG001|Overall Study|Discontinued from Treatment|18|||
143470211|NCT02510560|517268216|FG002|Overall Study|Discontinued from Treatment|19|||
143470212|NCT02510560|517268214|FG000|Overall Study|Other|4|||
143470213|NCT02510560|517268215|FG001|Overall Study|Other|4|||
143470214|NCT02510560|517268216|FG002|Overall Study|Other|3|||
143470215|NCT01699789|517268217|FG000|Overall Study|Withdrawal by Subject|18|||
143470216|NCT01699789|517268218|FG001|Overall Study|Withdrawal by Subject|23|||
143470217|NCT01699789|517268217|FG000|Overall Study|Death|1|||
143470218|NCT01699789|517268218|FG001|Overall Study|Death|2|||
143470219|NCT01699789|517268217|FG000|Overall Study|Lost to Follow-up|83|||
143470220|NCT01699789|517268218|FG001|Overall Study|Lost to Follow-up|101|||
143470221|NCT02554903|517268219|FG000|Overall Study|Death|1|||
143470222|NCT02554903|517268220|FG001|Overall Study|Death|1|||
143470223|NCT02554903|517268219|FG000|Overall Study|Physician Decision|2|||
143470224|NCT02554903|517268220|FG001|Overall Study|Physician Decision|2|||
143134716|NCT02227784|516039421|FG000|Double-Blind Phase|Adverse Event|3|||
143134717|NCT02227784|516039422|FG001|Double-Blind Phase|Adverse Event|2|||
143134718|NCT02227784|516039423|FG002|Double-Blind Phase|Adverse Event|1|||
143134719|NCT02227784|516039424|FG003|Double-Blind Phase|Adverse Event|3|||
143134720|NCT02227784|516039425|FG004|Double-Blind Phase|Adverse Event|0|||
143134721|NCT02227784|516039421|FG000|Double-Blind Phase|Physician Decision|1|||
143134722|NCT02227784|516039422|FG001|Double-Blind Phase|Physician Decision|0|||
143134723|NCT02227784|516039423|FG002|Double-Blind Phase|Physician Decision|0|||
143134724|NCT02227784|516039424|FG003|Double-Blind Phase|Physician Decision|1|||
143134725|NCT02227784|516039425|FG004|Double-Blind Phase|Physician Decision|0|||
143134726|NCT02227784|516039421|FG000|Double-Blind Phase|Protocol Violation|0|||
143134727|NCT02227784|516039422|FG001|Double-Blind Phase|Protocol Violation|0|||
143134728|NCT02227784|516039423|FG002|Double-Blind Phase|Protocol Violation|1|||
143134729|NCT02227784|516039424|FG003|Double-Blind Phase|Protocol Violation|1|||
143134730|NCT02227784|516039425|FG004|Double-Blind Phase|Protocol Violation|0|||
143134731|NCT02227784|516039421|FG000|Double-Blind Phase|Sponsor Decision|34|||
143134732|NCT02227784|516039422|FG001|Double-Blind Phase|Sponsor Decision|15|||
143134733|NCT02227784|516039423|FG002|Double-Blind Phase|Sponsor Decision|14|||
143134734|NCT02227784|516039424|FG003|Double-Blind Phase|Sponsor Decision|32|||
143134735|NCT02227784|516039425|FG004|Double-Blind Phase|Sponsor Decision|0|||
143134736|NCT02227784|516039421|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
143134737|NCT02227784|516039422|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
143134738|NCT02227784|516039423|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
143134739|NCT02227784|516039424|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
143134740|NCT02227784|516039425|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
143134741|NCT02227784|516039421|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
143134742|NCT02227784|516039422|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
143134743|NCT02227784|516039423|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
143134744|NCT02227784|516039424|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
143134745|NCT02227784|516039425|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
143134746|NCT02227784|516039421|FG000|Open-Label Extension Phase (OLE)|Death|0|||
143134747|NCT02227784|516039422|FG001|Open-Label Extension Phase (OLE)|Death|0|||
143134748|NCT02227784|516039423|FG002|Open-Label Extension Phase (OLE)|Death|0|||
143134749|NCT02227784|516039424|FG003|Open-Label Extension Phase (OLE)|Death|0|||
143134750|NCT02227784|516039425|FG004|Open-Label Extension Phase (OLE)|Death|1|||
143134751|NCT02227784|516039421|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
143134752|NCT02227784|516039422|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
143134753|NCT02227784|516039423|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
143134754|NCT02227784|516039424|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
143134755|NCT02227784|516039425|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
143134756|NCT02227784|516039421|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
143134757|NCT02227784|516039422|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
143134758|NCT02227784|516039423|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
143134759|NCT02227784|516039424|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
143134760|NCT02227784|516039425|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
143134761|NCT00485069|516039426|FG000|Overall Study|Adverse Event|10|||
143134762|NCT00485069|516039427|FG001|Overall Study|Adverse Event|4|||
143134763|NCT00485069|516039426|FG000|Overall Study|Lack of Efficacy|2|||
143134764|NCT00485069|516039427|FG001|Overall Study|Lack of Efficacy|1|||
143134765|NCT00485069|516039426|FG000|Overall Study|Protocol Violation|0|||
143134766|NCT00485069|516039427|FG001|Overall Study|Protocol Violation|1|||
143134767|NCT00485069|516039426|FG000|Overall Study|Withdrawal by Subject|6|||
143134768|NCT00485069|516039427|FG001|Overall Study|Withdrawal by Subject|6|||
143134769|NCT00828113|516039430|FG000|Overall Study|Withdrawal by Subject|27|||
143134770|NCT00828113|516039431|FG001|Overall Study|Withdrawal by Subject|26|||
143134771|NCT00828113|516039430|FG000|Overall Study|Lost to Follow-up|3|||
143134772|NCT00828113|516039431|FG001|Overall Study|Lost to Follow-up|5|||
143134773|NCT01365130|516039432|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
143134774|NCT05616013|516039433|FG000|Overall Study|Adverse Event|6|||
143134775|NCT05616013|516039434|FG001|Overall Study|Adverse Event|12|||
143134776|NCT05616013|516039435|FG002|Overall Study|Adverse Event|8|||
143134777|NCT05616013|516039436|FG003|Overall Study|Adverse Event|4|||
143134778|NCT05616013|516039437|FG004|Overall Study|Adverse Event|6|||
143134779|NCT05616013|516039438|FG005|Overall Study|Adverse Event|8|||
143134780|NCT05616013|516039439|FG006|Overall Study|Adverse Event|3|||
143134781|NCT05616013|516039440|FG007|Overall Study|Adverse Event|6|||
143134782|NCT05616013|516039441|FG008|Overall Study|Adverse Event|1|||
143134783|NCT05616013|516039433|FG000|Overall Study|Lost to Follow-up|5|||
143134784|NCT05616013|516039434|FG001|Overall Study|Lost to Follow-up|4|||
143134785|NCT05616013|516039435|FG002|Overall Study|Lost to Follow-up|3|||
143134786|NCT05616013|516039436|FG003|Overall Study|Lost to Follow-up|2|||
143134787|NCT05616013|516039437|FG004|Overall Study|Lost to Follow-up|0|||
143134788|NCT05616013|516039438|FG005|Overall Study|Lost to Follow-up|5|||
143134789|NCT05616013|516039439|FG006|Overall Study|Lost to Follow-up|2|||
143134790|NCT05616013|516039440|FG007|Overall Study|Lost to Follow-up|1|||
143134791|NCT05616013|516039441|FG008|Overall Study|Lost to Follow-up|2|||
143013990|NCT00391118|515590125|FG000|Overall Study|Sponsor Decision|0|||
143134792|NCT05616013|516039433|FG000|Overall Study|Non-compliance with study requirements|2|||
143134793|NCT05616013|516039434|FG001|Overall Study|Non-compliance with study requirements|2|||
143134794|NCT05616013|516039435|FG002|Overall Study|Non-compliance with study requirements|2|||
143134795|NCT05616013|516039436|FG003|Overall Study|Non-compliance with study requirements|3|||
143134796|NCT05616013|516039437|FG004|Overall Study|Non-compliance with study requirements|0|||
143134797|NCT05616013|516039438|FG005|Overall Study|Non-compliance with study requirements|2|||
143134798|NCT05616013|516039439|FG006|Overall Study|Non-compliance with study requirements|1|||
143134799|NCT05616013|516039440|FG007|Overall Study|Non-compliance with study requirements|1|||
143134800|NCT05616013|516039441|FG008|Overall Study|Non-compliance with study requirements|4|||
143134801|NCT05616013|516039433|FG000|Overall Study|Withdrawal by Subject|11|||
143134802|NCT05616013|516039434|FG001|Overall Study|Withdrawal by Subject|9|||
143134803|NCT05616013|516039435|FG002|Overall Study|Withdrawal by Subject|8|||
143134804|NCT05616013|516039436|FG003|Overall Study|Withdrawal by Subject|6|||
143134805|NCT05616013|516039437|FG004|Overall Study|Withdrawal by Subject|3|||
143134806|NCT05616013|516039438|FG005|Overall Study|Withdrawal by Subject|4|||
143134807|NCT05616013|516039439|FG006|Overall Study|Withdrawal by Subject|6|||
143134808|NCT05616013|516039440|FG007|Overall Study|Withdrawal by Subject|5|||
143134809|NCT05616013|516039441|FG008|Overall Study|Withdrawal by Subject|4|||
143134810|NCT05616013|516039433|FG000|Overall Study|Physician Decision|0|||
143134811|NCT05616013|516039434|FG001|Overall Study|Physician Decision|0|||
143134812|NCT05616013|516039435|FG002|Overall Study|Physician Decision|1|||
143134813|NCT05616013|516039436|FG003|Overall Study|Physician Decision|0|||
143134814|NCT05616013|516039437|FG004|Overall Study|Physician Decision|0|||
143134815|NCT05616013|516039438|FG005|Overall Study|Physician Decision|1|||
143134816|NCT05616013|516039439|FG006|Overall Study|Physician Decision|3|||
143134817|NCT05616013|516039440|FG007|Overall Study|Physician Decision|0|||
143134818|NCT05616013|516039441|FG008|Overall Study|Physician Decision|0|||
143134819|NCT05616013|516039433|FG000|Overall Study|Protocol Violation|0|||
143134820|NCT05616013|516039434|FG001|Overall Study|Protocol Violation|0|||
143134821|NCT05616013|516039435|FG002|Overall Study|Protocol Violation|0|||
143134822|NCT05616013|516039436|FG003|Overall Study|Protocol Violation|0|||
143134823|NCT05616013|516039437|FG004|Overall Study|Protocol Violation|0|||
143134824|NCT05616013|516039438|FG005|Overall Study|Protocol Violation|0|||
143134825|NCT05616013|516039439|FG006|Overall Study|Protocol Violation|1|||
143134826|NCT05616013|516039440|FG007|Overall Study|Protocol Violation|0|||
143134827|NCT05616013|516039441|FG008|Overall Study|Protocol Violation|2|||
143134828|NCT05616013|516039433|FG000|Overall Study|Did not Fulfill Enrollment criteria|1|||
143134829|NCT05616013|516039434|FG001|Overall Study|Did not Fulfill Enrollment criteria|0|||
143134830|NCT05616013|516039435|FG002|Overall Study|Did not Fulfill Enrollment criteria|0|||
143134831|NCT05616013|516039436|FG003|Overall Study|Did not Fulfill Enrollment criteria|0|||
143134832|NCT05616013|516039437|FG004|Overall Study|Did not Fulfill Enrollment criteria|0|||
143134833|NCT05616013|516039438|FG005|Overall Study|Did not Fulfill Enrollment criteria|0|||
143134834|NCT05616013|516039439|FG006|Overall Study|Did not Fulfill Enrollment criteria|0|||
143360477|NCT01323660|516861456|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
143360478|NCT01323660|516861457|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
143360479|NCT01323660|516861458|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
143360480|NCT01323660|516861459|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
143360481|NCT01323660|516861460|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
143360482|NCT01323660|516861461|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
143360483|NCT01323660|516861456|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
143360484|NCT01323660|516861457|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
143360485|NCT01323660|516861458|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
143360486|NCT01323660|516861459|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
143360487|NCT01323660|516861460|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
143360488|NCT01323660|516861461|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
143360489|NCT01323660|516861456|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
143360490|NCT01323660|516861457|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
143360491|NCT01323660|516861458|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
143360492|NCT01323660|516861459|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
143360493|NCT01323660|516861460|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
143360494|NCT01323660|516861461|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
143360495|NCT01323660|516861456|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
143360496|NCT01323660|516861457|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
143360497|NCT01323660|516861458|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
143360498|NCT01323660|516861459|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
143360499|NCT01323660|516861460|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
143360500|NCT01323660|516861461|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
143360501|NCT01323660|516861456|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
143360502|NCT01323660|516861457|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
143360503|NCT01323660|516861458|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
143470225|NCT02554903|517268219|FG000|Overall Study|Heart Transplant|1|||
143470226|NCT02554903|517268220|FG001|Overall Study|Heart Transplant|2|||
143470227|NCT00639223|517268225|FG000|Overall Study|Lost to Follow-up|0|||
143470228|NCT00639223|517268226|FG001|Overall Study|Lost to Follow-up|2|||
143470229|NCT04936841|517268227|FG000|Overall Study|Death|1|||
143470230|NCT02846532|517268230|FG000|Overall Study|Lost to Follow-up|0|||
143470231|NCT02846532|517268231|FG001|Overall Study|Lost to Follow-up|1|||
143470232|NCT02846532|517268232|FG002|Overall Study|Lost to Follow-up|1|||
143470233|NCT02846532|517268230|FG000|Overall Study|Withdrawal by Subject|1|||
143470234|NCT02846532|517268231|FG001|Overall Study|Withdrawal by Subject|2|||
143470235|NCT02846532|517268232|FG002|Overall Study|Withdrawal by Subject|0|||
143470236|NCT01019980|517268238|FG000|Overall Study|Drug not available.|2|||
143470237|NCT01019980|517268239|FG001|Overall Study|Drug not available.|0|||
143470238|NCT01306890|517270047|FG000|Overall Study|Adverse Event|2|||
143470239|NCT01306890|517270047|FG000|Overall Study|Death|1223|||
143470240|NCT01306890|517270047|FG000|Overall Study|Lost to Follow-up|58|||
143470241|NCT01306890|517270047|FG000|Overall Study|Withdrawal by Subject|88|||
143470242|NCT01306890|517270047|FG000|Overall Study|Unspecified reasons|104|||
143470243|NCT01306890|517270047|FG000|Overall Study|Study Termination|3|||
143470244|NCT01306890|517270047|FG000|Overall Study|No discontinuation documentation|41|||
143470245|NCT03808688|517270048|FG000|Overall Study|Adverse Event|13|||
143470246|NCT03808688|517270049|FG001|Overall Study|Adverse Event|17|||
143470247|NCT03808688|517270048|FG000|Overall Study|Lack of Efficacy|2|||
143470248|NCT03808688|517270049|FG001|Overall Study|Lack of Efficacy|0|||
143470249|NCT03808688|517270048|FG000|Overall Study|Lost to Follow-up|0|||
143470250|NCT03808688|517270049|FG001|Overall Study|Lost to Follow-up|2|||
143470251|NCT03808688|517270048|FG000|Overall Study|Withdrawal by Subject|1|||
143470252|NCT03808688|517270049|FG001|Overall Study|Withdrawal by Subject|0|||
143470253|NCT03808688|517270048|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
143470254|NCT03808688|517270049|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
143470255|NCT03808688|517270048|FG000|Overall Study|IOP Too High|1|||
143470256|NCT03808688|517270049|FG001|Overall Study|IOP Too High|1|||
143470257|NCT03808688|517270048|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
143470258|NCT03808688|517270049|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
143470259|NCT03808688|517270048|FG000|Overall Study|Visit Out of Window|0|||
143470260|NCT03808688|517270049|FG001|Overall Study|Visit Out of Window|1|||
143470261|NCT03808688|517270048|FG000|Overall Study|Medication Non-Compliance|0|||
143470262|NCT03808688|517270049|FG001|Overall Study|Medication Non-Compliance|1|||
143470263|NCT02217436|517270050|FG000|Overall Study|Protocol Violation|1|||
143470264|NCT02217436|517270051|FG001|Overall Study|Protocol Violation|1|||
143470265|NCT02217436|517270050|FG000|Overall Study|Incomplete data|0|||
143470266|NCT02217436|517270051|FG001|Overall Study|Incomplete data|1|||
143470267|NCT01940354|517270052|FG000|Overall Study|Withdrawal by Subject|4|||
143470268|NCT01940354|517270053|FG001|Overall Study|Withdrawal by Subject|2|||
143470269|NCT01890148|517270054|FG000|Overall Study|Adverse Event|1|||
143470270|NCT01215175|517270055|FG000|Overall Study|Lost to Follow-up|0|||
143470271|NCT01215175|517270056|FG001|Overall Study|Lost to Follow-up|1|||
143470272|NCT01215175|517270057|FG002|Overall Study|Lost to Follow-up|0|||
143470273|NCT01215175|517270058|FG003|Overall Study|Lost to Follow-up|1|||
143470274|NCT01215175|517270059|FG004|Overall Study|Lost to Follow-up|0|||
143470275|NCT03739762|517270060|FG000|Overall Study|Lost to Follow-up|1|||
143470276|NCT03739762|517270061|FG001|Overall Study|Lost to Follow-up|1|||
143470277|NCT03739762|517270060|FG000|Overall Study|Withdrawal by Subject|2|||
143470278|NCT03739762|517270061|FG001|Overall Study|Withdrawal by Subject|6|||
143470279|NCT00607880|517270062|FG000|Overall Study|Unable to place port due to occlusion|1|||
143470280|NCT00607880|517270063|FG001|Overall Study|Unable to place port due to occlusion|0|||
143470281|NCT04964960|517270065|FG000|Overall Study|Withdrawal by Subject|1|||
143470282|NCT04964960|517270065|FG000|Overall Study|Did not complete cycles|1|||
143470283|NCT00821431|517270073|FG000|Overall Study|Adverse Event|6|||
143470284|NCT00821431|517270074|FG001|Overall Study|Adverse Event|3|||
143470285|NCT00821431|517270073|FG000|Overall Study|Withdrawal by Subject|5|||
143470286|NCT00821431|517270074|FG001|Overall Study|Withdrawal by Subject|0|||
143470287|NCT00821431|517270073|FG000|Overall Study|Lost to Follow-up|1|||
143470288|NCT00821431|517270074|FG001|Overall Study|Lost to Follow-up|0|||
143470289|NCT00821431|517270073|FG000|Overall Study|Protocol Violation|3|||
143470290|NCT00821431|517270074|FG001|Overall Study|Protocol Violation|1|||
143470291|NCT00821431|517270073|FG000|Overall Study|Physician Decision|0|||
143470292|NCT00821431|517270074|FG001|Overall Study|Physician Decision|1|||
143470293|NCT01387230|517270075|FG000|Overall Study|Adverse Event|0|||
143470294|NCT01387230|517270076|FG001|Overall Study|Adverse Event|1|||
143470295|NCT01387230|517270077|FG002|Overall Study|Adverse Event|3|||
143470296|NCT01387230|517270075|FG000|Overall Study|Lack of Efficacy|8|||
143470297|NCT01387230|517270076|FG001|Overall Study|Lack of Efficacy|5|||
143470298|NCT01387230|517270077|FG002|Overall Study|Lack of Efficacy|4|||
143470299|NCT01387230|517270075|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
143470300|NCT01387230|517270076|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
143470301|NCT01387230|517270077|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
143470302|NCT01387230|517270075|FG000|Overall Study|Lost to Follow-up|0|||
143470303|NCT01387230|517270076|FG001|Overall Study|Lost to Follow-up|0|||
143470304|NCT01387230|517270077|FG002|Overall Study|Lost to Follow-up|1|||
143470305|NCT01387230|517270075|FG000|Overall Study|Withdrawal by Subject|4|||
143470306|NCT01387230|517270076|FG001|Overall Study|Withdrawal by Subject|1|||
143470307|NCT01387230|517270077|FG002|Overall Study|Withdrawal by Subject|0|||
143470308|NCT03026127|517270078|FG000|CRISP R61|Adverse Event|5|||
143470309|NCT03026127|517270079|FG001|CRISP R61|Adverse Event|0|||
143470310|NCT03026127|517270080|FG002|CRISP R61|Adverse Event|0|||
143470311|NCT03026127|517270078|FG000|CRISP R61|Lost to Follow-up|2|||
143470312|NCT03026127|517270079|FG001|CRISP R61|Lost to Follow-up|0|||
143470313|NCT03026127|517270080|FG002|CRISP R61|Lost to Follow-up|0|||
143470314|NCT03026127|517270078|FG000|CRISP R61|Dropped before therapy|5|||
143470315|NCT03026127|517270079|FG001|CRISP R61|Dropped before therapy|0|||
143470316|NCT03026127|517270080|FG002|CRISP R61|Dropped before therapy|0|||
143470317|NCT03026127|517270078|FG000|CRISP R33|Lost to Follow-up|0|||
143470318|NCT03026127|517270079|FG001|CRISP R33|Lost to Follow-up|5|||
143470319|NCT03026127|517270080|FG002|CRISP R33|Lost to Follow-up|4|||
143470320|NCT03026127|517270078|FG000|CRISP R33|Adverse Event|0|||
143470321|NCT03026127|517270079|FG001|CRISP R33|Adverse Event|9|||
143470322|NCT03026127|517270080|FG002|CRISP R33|Adverse Event|5|||
143470323|NCT03026127|517270078|FG000|CRISP R33|Withdrawal by Subject|0|||
143470324|NCT03026127|517270079|FG001|CRISP R33|Withdrawal by Subject|9|||
143470325|NCT03026127|517270080|FG002|CRISP R33|Withdrawal by Subject|1|||
143470326|NCT03026127|517270078|FG000|CRISP R33|Lack of Efficacy|0|||
143470327|NCT03026127|517270079|FG001|CRISP R33|Lack of Efficacy|3|||
143470328|NCT03026127|517270080|FG002|CRISP R33|Lack of Efficacy|2|||
143470329|NCT03026127|517270078|FG000|CRISP R33|Physician Decision|0|||
143470330|NCT03026127|517270079|FG001|CRISP R33|Physician Decision|3|||
143470331|NCT03026127|517270080|FG002|CRISP R33|Physician Decision|1|||
143470332|NCT03026127|517270078|FG000|CRISP R33|Transportation|0|||
143470333|NCT03026127|517270079|FG001|CRISP R33|Transportation|2|||
143470334|NCT03026127|517270080|FG002|CRISP R33|Transportation|1|||
143470335|NCT03027557|517270086|FG000|Overall Study|Adverse Event|1|||
143470336|NCT03027557|517270087|FG001|Overall Study|Adverse Event|0|||
143470337|NCT03027557|517270088|FG002|Overall Study|Adverse Event|0|||
143134835|NCT05616013|516039440|FG007|Overall Study|Did not Fulfill Enrollment criteria|0|||
143134836|NCT05616013|516039441|FG008|Overall Study|Did not Fulfill Enrollment criteria|0|||
143134837|NCT05616013|516039433|FG000|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|1|||
143134838|NCT05616013|516039434|FG001|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
143134839|NCT05616013|516039435|FG002|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
143134840|NCT05616013|516039436|FG003|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
143134841|NCT05616013|516039437|FG004|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
143134842|NCT05616013|516039438|FG005|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
143134843|NCT05616013|516039439|FG006|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
143134844|NCT05616013|516039440|FG007|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
143134845|NCT05616013|516039441|FG008|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
143134846|NCT05616013|516039433|FG000|Overall Study|Participant Withdrawal due to use of Restricted Medication|1|||
143134847|NCT05616013|516039434|FG001|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
143134848|NCT05616013|516039435|FG002|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
143134849|NCT05616013|516039436|FG003|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
143134850|NCT05616013|516039437|FG004|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
143134851|NCT05616013|516039438|FG005|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
143134852|NCT05616013|516039439|FG006|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
143134853|NCT05616013|516039440|FG007|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
143134854|NCT05616013|516039441|FG008|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
143134855|NCT05616013|516039433|FG000|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
143134856|NCT05616013|516039434|FG001|Overall Study|Participant Cannot Continue study due to Work Commitments|1|||
143134857|NCT05616013|516039435|FG002|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
143134858|NCT05616013|516039436|FG003|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
143134859|NCT05616013|516039437|FG004|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
143134860|NCT05616013|516039438|FG005|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
143181184|NCT00707993|516210487|FG000|Overall Study|Withdrawal by Subject|12|||
143470338|NCT01237340|517270093|FG000|Overall Study|Adverse Event|3|||
143470339|NCT01237340|517270093|FG000|Overall Study|Withdrawal by Subject|1|||
143470340|NCT01237340|517270093|FG000|Overall Study|Early termination of the trial|36|||
143470341|NCT01610687|517270094|FG000|Overall Study|Lack of Efficacy|26|||
143470342|NCT01610687|517270094|FG000|Overall Study|Adverse Event|18|||
143470343|NCT01610687|517270094|FG000|Overall Study|Moved out of area|6|||
143470344|NCT01610687|517270094|FG000|Overall Study|Withdrawal by Subject|7|||
143470345|NCT01610687|517270094|FG000|Overall Study|Lost to Follow-up|4|||
143134861|NCT05616013|516039439|FG006|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
143134862|NCT05616013|516039440|FG007|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
143134863|NCT05616013|516039441|FG008|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
143134864|NCT05616013|516039433|FG000|Overall Study|Participant Decision, Time Constraints|0|||
143134865|NCT05616013|516039434|FG001|Overall Study|Participant Decision, Time Constraints|1|||
143134866|NCT05616013|516039435|FG002|Overall Study|Participant Decision, Time Constraints|0|||
143134867|NCT05616013|516039436|FG003|Overall Study|Participant Decision, Time Constraints|0|||
143134868|NCT05616013|516039437|FG004|Overall Study|Participant Decision, Time Constraints|0|||
143134869|NCT05616013|516039438|FG005|Overall Study|Participant Decision, Time Constraints|0|||
143134870|NCT05616013|516039439|FG006|Overall Study|Participant Decision, Time Constraints|0|||
143134871|NCT05616013|516039440|FG007|Overall Study|Participant Decision, Time Constraints|0|||
143360504|NCT01323660|516861459|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
143360505|NCT01323660|516861460|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
143360506|NCT01323660|516861461|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
143360507|NCT01323660|516861456|FG000|Washout Period (14 Days)|Adverse Event|0|||
143360508|NCT01323660|516861457|FG001|Washout Period (14 Days)|Adverse Event|0|||
143360509|NCT01323660|516861458|FG002|Washout Period (14 Days)|Adverse Event|0|||
143360510|NCT01323660|516861459|FG003|Washout Period (14 Days)|Adverse Event|0|||
143360511|NCT01323660|516861460|FG004|Washout Period (14 Days)|Adverse Event|1|||
143360512|NCT01323660|516861461|FG005|Washout Period (14 Days)|Adverse Event|0|||
143360513|NCT01323660|516861456|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
143360514|NCT01323660|516861457|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
143360515|NCT01323660|516861458|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
143360516|NCT01323660|516861459|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
143360517|NCT01323660|516861460|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
143360518|NCT01323660|516861461|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
143360519|NCT01323660|516861456|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
143360520|NCT01323660|516861457|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
143360521|NCT01323660|516861458|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
143360522|NCT01323660|516861459|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
143360523|NCT01323660|516861460|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
143360524|NCT01323660|516861461|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
143360525|NCT01323660|516861456|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
143360526|NCT01323660|516861457|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
143360527|NCT01323660|516861458|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
143360528|NCT01323660|516861459|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
143360529|NCT01323660|516861460|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
143360530|NCT01323660|516861461|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
143360531|NCT01323660|516861456|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
143360532|NCT01323660|516861457|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
143360533|NCT01323660|516861458|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
143360534|NCT01323660|516861459|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
143360535|NCT01323660|516861460|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
143360536|NCT01323660|516861461|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
143360537|NCT01323660|516861456|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
143360538|NCT01323660|516861457|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
143360539|NCT01323660|516861458|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
143360540|NCT01323660|516861459|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
143360541|NCT01323660|516861460|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
143360542|NCT01323660|516861461|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
143360543|NCT01323660|516861456|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
143360544|NCT01323660|516861457|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
143360545|NCT01323660|516861458|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
143360546|NCT01323660|516861459|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
143360547|NCT01323660|516861460|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
143360548|NCT01323660|516861461|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
143360549|NCT04990440|516861468|FG000|Overall Study|Sponsor's Decision|0|||
143360550|NCT04990440|516861469|FG001|Overall Study|Sponsor's Decision|0|||
143360551|NCT04990440|516861470|FG002|Overall Study|Sponsor's Decision|1|||
143360552|NCT03712098|516861471|FG000|Overall Study|Lost to Follow-up|3|||
143360553|NCT03712098|516861472|FG001|Overall Study|Lost to Follow-up|7|||
143360554|NCT03712098|516861471|FG000|Overall Study|Withdrawal by Subject|9|||
143360555|NCT03712098|516861472|FG001|Overall Study|Withdrawal by Subject|4|||
143360556|NCT03712098|516861471|FG000|Overall Study|Protocol Violation|2|||
143360557|NCT03712098|516861472|FG001|Overall Study|Protocol Violation|1|||
143360558|NCT00425503|516861481|FG000|Overall Study|Adverse Event|2|||
143360559|NCT00425503|516861481|FG000|Overall Study|Protocol Violation|1|||
143360560|NCT00570661|516861482|FG000|Overall Study|Disease worsening|5|||
143360561|NCT00570661|516861482|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
143470346|NCT01610687|517270094|FG000|Overall Study|Symptom control without study medication|2|||
143470347|NCT01610687|517270094|FG000|Overall Study|Unable to make journey|1|||
143470348|NCT01610687|517270094|FG000|Overall Study|Death|1|||
143470349|NCT01610687|517270094|FG000|Overall Study|Cannabis affecting job|1|||
143470350|NCT01610687|517270094|FG000|Overall Study|Felt more alter without study medication|1|||
143470351|NCT03836807|517270095|FG000|Overall Study|Physician Decision|1|||
143470352|NCT03836807|517270096|FG001|Overall Study|Physician Decision|0|||
143470353|NCT01272947|517270097|FG000|Overall Study|Abnormal Laboratory Value|2|||
143470354|NCT01272947|517270098|FG001|Overall Study|Abnormal Laboratory Value|2|||
143470355|NCT02019420|517270101|FG000|Overall Study|Did not receive study drug|2|||
143470356|NCT02019420|517270102|FG001|Overall Study|Did not receive study drug|2|||
143470357|NCT02019420|517270101|FG000|Overall Study|Withdrawal by Subject|1|||
143470358|NCT02019420|517270102|FG001|Overall Study|Withdrawal by Subject|3|||
143470359|NCT02019420|517270101|FG000|Overall Study|At request of sponsor or investigator|0|||
143470360|NCT02019420|517270102|FG001|Overall Study|At request of sponsor or investigator|1|||
143470361|NCT02019420|517270101|FG000|Overall Study|Death|104|||
143470362|NCT02019420|517270102|FG001|Overall Study|Death|99|||
143470363|NCT02019420|517270101|FG000|Overall Study|Transferred to other care facility|1|||
143470364|NCT02019420|517270102|FG001|Overall Study|Transferred to other care facility|1|||
143470365|NCT01093625|517270107|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
143470366|NCT01093625|517270108|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
143470367|NCT01093625|517270107|FG000|2-Week Visit|Withdrawal by Subject|1|||
143470368|NCT01093625|517270108|FG001|2-Week Visit|Withdrawal by Subject|0|||
143470369|NCT01093625|517270107|FG000|1-Month Visit|Lost to Follow-up|2|||
143470370|NCT01093625|517270108|FG001|1-Month Visit|Lost to Follow-up|0|||
143470371|NCT01093625|517270107|FG000|3-Month Visit|Lost to Follow-up|2|||
143470372|NCT01093625|517270108|FG001|3-Month Visit|Lost to Follow-up|0|||
143470373|NCT01093625|517270107|FG000|6-Month Visit|Withdrawal by Subject|6|||
143470374|NCT01093625|517270108|FG001|6-Month Visit|Withdrawal by Subject|7|||
143470375|NCT01093625|517270107|FG000|6-Month Visit|Lost to Follow-up|2|||
143134872|NCT05616013|516039441|FG008|Overall Study|Participant Decision, Time Constraints|0|||
143134873|NCT05616013|516039433|FG000|Overall Study|Prohibited Concomitant Medication|0|||
143134874|NCT05616013|516039434|FG001|Overall Study|Prohibited Concomitant Medication|0|||
143134875|NCT05616013|516039435|FG002|Overall Study|Prohibited Concomitant Medication|1|||
143134876|NCT05616013|516039436|FG003|Overall Study|Prohibited Concomitant Medication|0|||
143470376|NCT01093625|517270108|FG001|6-Month Visit|Lost to Follow-up|2|||
143470377|NCT01093625|517270107|FG000|1-Year Visit|Lost to Follow-up|5|||
143134877|NCT05616013|516039437|FG004|Overall Study|Prohibited Concomitant Medication|0|||
143134878|NCT05616013|516039438|FG005|Overall Study|Prohibited Concomitant Medication|0|||
143134879|NCT05616013|516039439|FG006|Overall Study|Prohibited Concomitant Medication|0|||
143134880|NCT05616013|516039440|FG007|Overall Study|Prohibited Concomitant Medication|0|||
143134881|NCT05616013|516039441|FG008|Overall Study|Prohibited Concomitant Medication|0|||
143134882|NCT05616013|516039433|FG000|Overall Study|Medical history condition Requiring Further Treatment|0|||
143134883|NCT05616013|516039434|FG001|Overall Study|Medical history condition Requiring Further Treatment|0|||
143134884|NCT05616013|516039435|FG002|Overall Study|Medical history condition Requiring Further Treatment|1|||
143134885|NCT05616013|516039436|FG003|Overall Study|Medical history condition Requiring Further Treatment|0|||
143134886|NCT05616013|516039437|FG004|Overall Study|Medical history condition Requiring Further Treatment|0|||
143134887|NCT05616013|516039438|FG005|Overall Study|Medical history condition Requiring Further Treatment|0|||
143134888|NCT05616013|516039439|FG006|Overall Study|Medical history condition Requiring Further Treatment|0|||
143134889|NCT05616013|516039440|FG007|Overall Study|Medical history condition Requiring Further Treatment|0|||
143134890|NCT05616013|516039441|FG008|Overall Study|Medical history condition Requiring Further Treatment|0|||
143134891|NCT05616013|516039433|FG000|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
143134892|NCT05616013|516039434|FG001|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
143134893|NCT05616013|516039435|FG002|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
143134894|NCT05616013|516039436|FG003|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|1|||
143134895|NCT05616013|516039437|FG004|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
143134896|NCT05616013|516039438|FG005|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
143134897|NCT05616013|516039439|FG006|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
143134898|NCT05616013|516039440|FG007|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
143134899|NCT05616013|516039441|FG008|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
143134900|NCT05616013|516039433|FG000|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
143134901|NCT05616013|516039434|FG001|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
143134902|NCT05616013|516039435|FG002|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
143470378|NCT01093625|517270108|FG001|1-Year Visit|Lost to Follow-up|3|||
143470379|NCT04233164|517270113|FG000|Overall Study|Unable to obtain specimen|0|||
143470380|NCT04233164|517270114|FG001|Overall Study|Unable to obtain specimen|1|||
143470381|NCT01843218|517270115|FG000|Overall Study|Withdrawal by Subject|5|||
143470382|NCT01431534|517270116|FG000|Treatment Phase|Adverse Event|0|||
143470383|NCT01431534|517270117|FG001|Treatment Phase|Adverse Event|0|||
143470384|NCT01431534|517270118|FG002|Treatment Phase|Adverse Event|1|||
143470385|NCT01431534|517270116|FG000|Treatment Phase|Progressive Disease|4|||
143470386|NCT01431534|517270117|FG001|Treatment Phase|Progressive Disease|3|||
143470387|NCT01431534|517270118|FG002|Treatment Phase|Progressive Disease|10|||
143470388|NCT01009554|517270119|FG000|Overall Study|Adverse Event|1|||
143470389|NCT01009554|517270120|FG001|Overall Study|Adverse Event|1|||
143470390|NCT01009554|517270119|FG000|Overall Study|Withdrawal by Subject|1|||
143470391|NCT01009554|517270120|FG001|Overall Study|Withdrawal by Subject|3|||
143470392|NCT01009554|517270119|FG000|Overall Study|Noncompliant with Study Product|0|||
143470393|NCT01009554|517270120|FG001|Overall Study|Noncompliant with Study Product|3|||
143470394|NCT01605253|517270121|FG000|Overall Study|Physician Decision|3|||
143470395|NCT01605253|517270122|FG001|Overall Study|Physician Decision|2|||
143470396|NCT01605253|517270121|FG000|Overall Study|Lost to Follow-up|3|||
143470397|NCT01605253|517270122|FG001|Overall Study|Lost to Follow-up|1|||
143470398|NCT04427501|517270125|FG000|Overall Study|Death|0|||
143470399|NCT04427501|517270126|FG001|Overall Study|Death|0|||
143470400|NCT04427501|517270127|FG002|Overall Study|Death|0|||
143470401|NCT04427501|517270128|FG003|Overall Study|Death|0|||
143470402|NCT04427501|517270129|FG004|Overall Study|Death|0|||
143470403|NCT04427501|517270130|FG005|Overall Study|Death|15|||
143470404|NCT04427501|517270131|FG006|Overall Study|Death|0|||
143470405|NCT04427501|517270132|FG007|Overall Study|Death|0|||
143470406|NCT04427501|517270133|FG008|Overall Study|Death|0|||
143470407|NCT04427501|517270134|FG009|Overall Study|Death|0|||
143470408|NCT04427501|517270135|FG010|Overall Study|Death|0|||
143470409|NCT04427501|517270136|FG011|Overall Study|Death|0|||
143470410|NCT04427501|517270125|FG000|Overall Study|Lost to Follow-up|5|||
143470411|NCT04427501|517270126|FG001|Overall Study|Lost to Follow-up|1|||
143470412|NCT04427501|517270127|FG002|Overall Study|Lost to Follow-up|2|||
143470413|NCT04427501|517270128|FG003|Overall Study|Lost to Follow-up|0|||
143470414|NCT04427501|517270129|FG004|Overall Study|Lost to Follow-up|2|||
143470415|NCT04427501|517270130|FG005|Overall Study|Lost to Follow-up|11|||
143470416|NCT04427501|517270131|FG006|Overall Study|Lost to Follow-up|10|||
143470417|NCT04427501|517270132|FG007|Overall Study|Lost to Follow-up|10|||
143470418|NCT04427501|517270133|FG008|Overall Study|Lost to Follow-up|2|||
143470419|NCT04427501|517270134|FG009|Overall Study|Lost to Follow-up|5|||
143470420|NCT04427501|517270135|FG010|Overall Study|Lost to Follow-up|2|||
143470421|NCT04427501|517270136|FG011|Overall Study|Lost to Follow-up|0|||
143470422|NCT04427501|517270125|FG000|Overall Study|Physician Decision|0|||
143470423|NCT04427501|517270126|FG001|Overall Study|Physician Decision|3|||
143470424|NCT04427501|517270127|FG002|Overall Study|Physician Decision|0|||
143470425|NCT04427501|517270128|FG003|Overall Study|Physician Decision|0|||
143470426|NCT04427501|517270129|FG004|Overall Study|Physician Decision|0|||
143470427|NCT04427501|517270130|FG005|Overall Study|Physician Decision|0|||
143470428|NCT04427501|517270131|FG006|Overall Study|Physician Decision|2|||
143470429|NCT04427501|517270132|FG007|Overall Study|Physician Decision|0|||
143470430|NCT04427501|517270133|FG008|Overall Study|Physician Decision|0|||
143470431|NCT04427501|517270134|FG009|Overall Study|Physician Decision|0|||
143470432|NCT04427501|517270135|FG010|Overall Study|Physician Decision|0|||
143470433|NCT04427501|517270136|FG011|Overall Study|Physician Decision|0|||
143470434|NCT04427501|517270125|FG000|Overall Study|Withdrawal by Subject|9|||
143470435|NCT04427501|517270126|FG001|Overall Study|Withdrawal by Subject|2|||
143470436|NCT04427501|517270127|FG002|Overall Study|Withdrawal by Subject|2|||
143470437|NCT04427501|517270128|FG003|Overall Study|Withdrawal by Subject|3|||
143470438|NCT04427501|517270129|FG004|Overall Study|Withdrawal by Subject|7|||
143470439|NCT04427501|517270130|FG005|Overall Study|Withdrawal by Subject|25|||
143470440|NCT04427501|517270131|FG006|Overall Study|Withdrawal by Subject|15|||
143470441|NCT04427501|517270132|FG007|Overall Study|Withdrawal by Subject|7|||
143470442|NCT04427501|517270133|FG008|Overall Study|Withdrawal by Subject|4|||
143470443|NCT04427501|517270134|FG009|Overall Study|Withdrawal by Subject|1|||
143470444|NCT04427501|517270135|FG010|Overall Study|Withdrawal by Subject|4|||
143470445|NCT04427501|517270136|FG011|Overall Study|Withdrawal by Subject|0|||
143470446|NCT04427501|517270125|FG000|Overall Study|Other - as reported by the investigator|1|||
143470447|NCT04427501|517270126|FG001|Overall Study|Other - as reported by the investigator|0|||
143470448|NCT04427501|517270127|FG002|Overall Study|Other - as reported by the investigator|0|||
143470449|NCT04427501|517270128|FG003|Overall Study|Other - as reported by the investigator|0|||
143470450|NCT04427501|517270129|FG004|Overall Study|Other - as reported by the investigator|0|||
143470451|NCT04427501|517270130|FG005|Overall Study|Other - as reported by the investigator|6|||
143470452|NCT04427501|517270131|FG006|Overall Study|Other - as reported by the investigator|6|||
143470453|NCT04427501|517270132|FG007|Overall Study|Other - as reported by the investigator|0|||
143470454|NCT04427501|517270133|FG008|Overall Study|Other - as reported by the investigator|0|||
143470455|NCT04427501|517270134|FG009|Overall Study|Other - as reported by the investigator|0|||
143470456|NCT04427501|517270135|FG010|Overall Study|Other - as reported by the investigator|0|||
143470457|NCT04427501|517270136|FG011|Overall Study|Other - as reported by the investigator|0|||
143470458|NCT04427501|517270125|FG000|Overall Study|Other|0|||
143470459|NCT04427501|517270126|FG001|Overall Study|Other|0|||
143470460|NCT04427501|517270127|FG002|Overall Study|Other|0|||
143470461|NCT04427501|517270128|FG003|Overall Study|Other|0|||
143470462|NCT04427501|517270129|FG004|Overall Study|Other|0|||
143470463|NCT04427501|517270130|FG005|Overall Study|Other|0|||
143470464|NCT04427501|517270131|FG006|Overall Study|Other|0|||
143470465|NCT04427501|517270132|FG007|Overall Study|Other|0|||
143470466|NCT04427501|517270133|FG008|Overall Study|Other|0|||
143470467|NCT04427501|517270134|FG009|Overall Study|Other|0|||
143470468|NCT04427501|517270135|FG010|Overall Study|Other|0|||
143470469|NCT04427501|517270136|FG011|Overall Study|Other|1|||
143470470|NCT04598477|517270139|FG000|Overall Study|Adverse Event|2|||
143470471|NCT04598477|517270140|FG001|Overall Study|Adverse Event|0|||
143470472|NCT04598477|517270139|FG000|Overall Study|Death|0|||
143470473|NCT04598477|517270140|FG001|Overall Study|Death|1|||
143470474|NCT04598477|517270139|FG000|Overall Study|Lost to Follow-up|1|||
143470475|NCT04598477|517270140|FG001|Overall Study|Lost to Follow-up|0|||
143470476|NCT04598477|517270139|FG000|Overall Study|Physician Decision|7|||
143470477|NCT04598477|517270140|FG001|Overall Study|Physician Decision|2|||
143470478|NCT04598477|517270139|FG000|Overall Study|Pregnancy|0|||
143470479|NCT04598477|517270140|FG001|Overall Study|Pregnancy|1|||
143470480|NCT04598477|517270139|FG000|Overall Study|Requires Prohibited Medication|0|||
143470481|NCT04598477|517270140|FG001|Overall Study|Requires Prohibited Medication|1|||
143470482|NCT04598477|517270139|FG000|Overall Study|Study Terminated by Sponsor|18|||
143470483|NCT04598477|517270140|FG001|Overall Study|Study Terminated by Sponsor|12|||
143470484|NCT04598477|517270139|FG000|Overall Study|Withdrawal by Subject|16|||
143470485|NCT04598477|517270140|FG001|Overall Study|Withdrawal by Subject|12|||
143470486|NCT04598477|517270139|FG000|Overall Study|Other|15|||
143470487|NCT04598477|517270140|FG001|Overall Study|Other|8|||
143470488|NCT05579990|517270141|FG000|Overall Study|Lost to Follow-up|3|||
143470489|NCT05118204|517270142|FG000|Overall Study|Lost to Follow-up|3|||
143470490|NCT05118204|517270143|FG001|Overall Study|Lost to Follow-up|2|||
143470491|NCT05118204|517270142|FG000|Overall Study|Withdrawal by Subject|0|||
143134903|NCT05616013|516039436|FG003|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
143134904|NCT05616013|516039437|FG004|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
143134905|NCT05616013|516039438|FG005|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
143134906|NCT05616013|516039439|FG006|Overall Study|Withdrawn due to Elevated Blood Pressure|1|||
143134907|NCT05616013|516039440|FG007|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
143134908|NCT05616013|516039441|FG008|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
143134909|NCT05616013|516039433|FG000|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
143134910|NCT05616013|516039434|FG001|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
143134911|NCT05616013|516039435|FG002|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
143134912|NCT05616013|516039436|FG003|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
143134913|NCT05616013|516039437|FG004|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
143134914|NCT05616013|516039438|FG005|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
143134915|NCT05616013|516039439|FG006|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
143134916|NCT05616013|516039440|FG007|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
143134917|NCT05616013|516039441|FG008|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|1|||
143134918|NCT05616013|516039433|FG000|Overall Study|Unable to Visit site as Participant Moved town|0|||
143134919|NCT05616013|516039434|FG001|Overall Study|Unable to Visit site as Participant Moved town|0|||
143134920|NCT05616013|516039435|FG002|Overall Study|Unable to Visit site as Participant Moved town|0|||
143470492|NCT05118204|517270143|FG001|Overall Study|Withdrawal by Subject|2|||
143470493|NCT02466971|517270145|FG000|Overall Study|eligible and never treated|14|||
143470494|NCT02466971|517270146|FG001|Overall Study|eligible and never treated|20|||
143470495|NCT02466971|517270145|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
143470496|NCT02466971|517270146|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
143470497|NCT02466971|517270145|FG000|Overall Study|ineligible and treated|1|||
143470498|NCT02466971|517270146|FG001|Overall Study|ineligible and treated|0|||
143470499|NCT02466971|517270145|FG000|Overall Study|ineligible and never treated|0|||
143470500|NCT02466971|517270146|FG001|Overall Study|ineligible and never treated|1|||
143470501|NCT04029480|517270147|FG000|Overall Study|Physician Decision|0|||
143470502|NCT04029480|517270148|FG001|Overall Study|Physician Decision|0|||
143470503|NCT04029480|517270149|FG002|Overall Study|Physician Decision|2|||
143470504|NCT04029480|517270150|FG003|Overall Study|Physician Decision|1|||
143470505|NCT04029480|517270147|FG000|Overall Study|Withdrawal by Subject|2|||
143470506|NCT04029480|517270148|FG001|Overall Study|Withdrawal by Subject|0|||
143470507|NCT04029480|517270149|FG002|Overall Study|Withdrawal by Subject|1|||
143470508|NCT04029480|517270150|FG003|Overall Study|Withdrawal by Subject|1|||
143470509|NCT04786119|517270151|FG000|Overall Study|Withdrawal by Subject|4|||
143470510|NCT04786119|517270152|FG001|Overall Study|Withdrawal by Subject|5|||
143470511|NCT04786119|517270151|FG000|Overall Study|Lost to Follow-up|5|||
143470512|NCT04786119|517270152|FG001|Overall Study|Lost to Follow-up|5|||
143470513|NCT04786119|517270151|FG000|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|1|||
143134921|NCT05616013|516039436|FG003|Overall Study|Unable to Visit site as Participant Moved town|0|||
143134922|NCT05616013|516039437|FG004|Overall Study|Unable to Visit site as Participant Moved town|0|||
143134923|NCT05616013|516039438|FG005|Overall Study|Unable to Visit site as Participant Moved town|0|||
143134924|NCT05616013|516039439|FG006|Overall Study|Unable to Visit site as Participant Moved town|0|||
143134925|NCT05616013|516039440|FG007|Overall Study|Unable to Visit site as Participant Moved town|0|||
143134926|NCT05616013|516039441|FG008|Overall Study|Unable to Visit site as Participant Moved town|1|||
143360562|NCT00570661|516861482|FG000|Overall Study|Adverse Event|1|||
143360563|NCT01723826|516861486|FG000|Overall Study|Adverse Event|4|||
143360564|NCT01723826|516861487|FG001|Overall Study|Adverse Event|1|||
143360565|NCT01723826|516861488|FG002|Overall Study|Adverse Event|4|||
143360566|NCT01723826|516861489|FG003|Overall Study|Adverse Event|5|||
143360567|NCT01723826|516861486|FG000|Overall Study|Death according to AE eCRF|2|||
143360568|NCT01723826|516861487|FG001|Overall Study|Death according to AE eCRF|3|||
143360569|NCT01723826|516861488|FG002|Overall Study|Death according to AE eCRF|3|||
143360570|NCT01723826|516861489|FG003|Overall Study|Death according to AE eCRF|7|||
143360571|NCT01723826|516861486|FG000|Overall Study|Lost to Follow-up|1|||
143360572|NCT01723826|516861487|FG001|Overall Study|Lost to Follow-up|3|||
143360573|NCT01723826|516861488|FG002|Overall Study|Lost to Follow-up|1|||
143360574|NCT01723826|516861489|FG003|Overall Study|Lost to Follow-up|1|||
143360575|NCT01723826|516861486|FG000|Overall Study|Non-compliance|0|||
143360576|NCT01723826|516861487|FG001|Overall Study|Non-compliance|1|||
143360577|NCT01723826|516861488|FG002|Overall Study|Non-compliance|3|||
143360578|NCT01723826|516861489|FG003|Overall Study|Non-compliance|3|||
143360579|NCT01723826|516861486|FG000|Overall Study|Non-compliance With Study Drug|0|||
143360580|NCT01723826|516861487|FG001|Overall Study|Non-compliance With Study Drug|1|||
143360581|NCT01723826|516861488|FG002|Overall Study|Non-compliance With Study Drug|0|||
143360582|NCT01723826|516861489|FG003|Overall Study|Non-compliance With Study Drug|0|||
143360583|NCT01723826|516861486|FG000|Overall Study|Other Reason|8|||
143360584|NCT01723826|516861487|FG001|Overall Study|Other Reason|6|||
143360585|NCT01723826|516861488|FG002|Overall Study|Other Reason|12|||
143360586|NCT01723826|516861489|FG003|Overall Study|Other Reason|14|||
143360587|NCT01723826|516861486|FG000|Overall Study|Physician Decision|1|||
143360588|NCT01723826|516861487|FG001|Overall Study|Physician Decision|3|||
143360589|NCT01723826|516861488|FG002|Overall Study|Physician Decision|4|||
143360590|NCT01723826|516861489|FG003|Overall Study|Physician Decision|11|||
143360591|NCT01723826|516861486|FG000|Overall Study|Protocol Violation|1|||
143360592|NCT01723826|516861487|FG001|Overall Study|Protocol Violation|1|||
143360593|NCT01723826|516861488|FG002|Overall Study|Protocol Violation|3|||
143360594|NCT01723826|516861489|FG003|Overall Study|Protocol Violation|1|||
143360595|NCT01723826|516861486|FG000|Overall Study|Withdrawal by Subject|10|||
143360596|NCT01723826|516861487|FG001|Overall Study|Withdrawal by Subject|17|||
143360597|NCT01723826|516861488|FG002|Overall Study|Withdrawal by Subject|27|||
143360598|NCT01723826|516861489|FG003|Overall Study|Withdrawal by Subject|48|||
143360599|NCT01272011|516861492|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
143360600|NCT01272011|516861493|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
143360601|NCT01272011|516861494|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
143360602|NCT01657032|516861495|FG000|Overall Study|Lost to Follow-up|0|||
143360603|NCT01657032|516861496|FG001|Overall Study|Lost to Follow-up|7|||
143360604|NCT05968482|516861497|FG000|First Crossover Period|Withdrawal by Subject|0|||
143360605|NCT05968482|516861498|FG001|First Crossover Period|Withdrawal by Subject|0|||
143360606|NCT05968482|516861499|FG002|First Crossover Period|Withdrawal by Subject|1|||
143360607|NCT05968482|516861500|FG003|First Crossover Period|Withdrawal by Subject|0|||
143360608|NCT05968482|516861501|FG004|First Crossover Period|Withdrawal by Subject|0|||
143360609|NCT05968482|516861502|FG005|First Crossover Period|Withdrawal by Subject|0|||
143360610|NCT05968482|516861497|FG000|First Crossover Period|Adverse Event|0|||
143360611|NCT05968482|516861498|FG001|First Crossover Period|Adverse Event|0|||
143360612|NCT05968482|516861499|FG002|First Crossover Period|Adverse Event|0|||
143360613|NCT05968482|516861500|FG003|First Crossover Period|Adverse Event|0|||
143360614|NCT05968482|516861501|FG004|First Crossover Period|Adverse Event|0|||
143360615|NCT05968482|516861502|FG005|First Crossover Period|Adverse Event|1|||
143360616|NCT05968482|516861497|FG000|Second Crossover Period|Withdrawal by Subject|0|||
143360617|NCT05968482|516861498|FG001|Second Crossover Period|Withdrawal by Subject|0|||
143360618|NCT05968482|516861499|FG002|Second Crossover Period|Withdrawal by Subject|0|||
143134927|NCT05067972|516039442|FG000|Part 1: Treatment|Global Deterioration of Health Status|0|||
143134928|NCT05067972|516039443|FG001|Part 1: Treatment|Global Deterioration of Health Status|1|||
143360619|NCT05968482|516861500|FG003|Second Crossover Period|Withdrawal by Subject|0|||
143360620|NCT05968482|516861501|FG004|Second Crossover Period|Withdrawal by Subject|1|||
143360621|NCT05968482|516861502|FG005|Second Crossover Period|Withdrawal by Subject|0|||
143360622|NCT05968482|516861497|FG000|Third Crossover Period|Adverse Event|0|||
143360623|NCT05968482|516861498|FG001|Third Crossover Period|Adverse Event|0|||
143360624|NCT05968482|516861499|FG002|Third Crossover Period|Adverse Event|0|||
143360625|NCT05968482|516861500|FG003|Third Crossover Period|Adverse Event|0|||
143360626|NCT05968482|516861501|FG004|Third Crossover Period|Adverse Event|1|||
143360627|NCT05968482|516861502|FG005|Third Crossover Period|Adverse Event|0|||
143360628|NCT05968482|516861497|FG000|Third Crossover Period|failure to meet continuation criteria|0|||
143360629|NCT05968482|516861498|FG001|Third Crossover Period|failure to meet continuation criteria|1|||
143360630|NCT05968482|516861499|FG002|Third Crossover Period|failure to meet continuation criteria|0|||
143360631|NCT05968482|516861500|FG003|Third Crossover Period|failure to meet continuation criteria|0|||
143360632|NCT05968482|516861501|FG004|Third Crossover Period|failure to meet continuation criteria|0|||
143360633|NCT05968482|516861502|FG005|Third Crossover Period|failure to meet continuation criteria|0|||
143360634|NCT02300311|516861506|FG000|Overall Study|Other than the reason specified|1|||
143360635|NCT02300311|516861507|FG001|Overall Study|Other than the reason specified|0|||
143360636|NCT02300311|516861506|FG000|Overall Study|Refused to continue taking medication|18|||
143360637|NCT02300311|516861507|FG001|Overall Study|Refused to continue taking medication|0|||
143360638|NCT00419003|516861508|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
143360639|NCT00419003|516861509|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
143360640|NCT00419003|516861508|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
143360641|NCT00419003|516861509|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
143360642|NCT02687919|516861510|FG000|Overall Study|Withdrawal by Subject|6|||
143360643|NCT02687919|516861511|FG001|Overall Study|Withdrawal by Subject|6|||
143360644|NCT02687919|516861510|FG000|Overall Study|Protocol Violation|2|||
143360645|NCT02687919|516861511|FG001|Overall Study|Protocol Violation|0|||
143360646|NCT00772928|516861512|FG000|Overall Study|Lost to Follow-up|9|||
143360647|NCT00772928|516861513|FG001|Overall Study|Lost to Follow-up|6|||
143360648|NCT00772928|516861512|FG000|Overall Study|Protocol Violation|10|||
143360649|NCT00772928|516861513|FG001|Overall Study|Protocol Violation|12|||
143360650|NCT00772928|516861512|FG000|Overall Study|Withdrawal by Subject|25|||
143360651|NCT00772928|516861513|FG001|Overall Study|Withdrawal by Subject|22|||
143360652|NCT00772928|516861512|FG000|Overall Study|Did not receive vaccine|0|||
143360653|NCT00772928|516861513|FG001|Overall Study|Did not receive vaccine|1|||
143360654|NCT02015195|516861519|FG000|Overall Study|Adverse Event|0|||
143360655|NCT02015195|516861520|FG001|Overall Study|Adverse Event|0|||
143360656|NCT02015195|516861521|FG002|Overall Study|Adverse Event|0|||
143360657|NCT02015195|516861522|FG003|Overall Study|Adverse Event|1|||
143360658|NCT02015195|516861523|FG004|Overall Study|Adverse Event|0|||
143360659|NCT02015195|516861524|FG005|Overall Study|Adverse Event|0|||
143360660|NCT02015195|516861525|FG006|Overall Study|Adverse Event|0|||
143360661|NCT01606189|516861526|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
143360662|NCT01606189|516861527|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
143360663|NCT01606189|516861528|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
143360664|NCT01606189|516861529|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
143360665|NCT01606189|516861530|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
143360666|NCT01606189|516861531|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
143360667|NCT01606189|516861526|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
143360668|NCT01606189|516861527|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
143360669|NCT01606189|516861528|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
143360670|NCT01606189|516861529|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
143360671|NCT01606189|516861530|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
143360672|NCT01606189|516861531|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
143360673|NCT00162942|516861532|FG000|Overall Study|Adverse Event|10|||
143360674|NCT00162942|516861533|FG001|Overall Study|Adverse Event|6|||
143360675|NCT00162942|516861532|FG000|Overall Study|Death|1|||
143360676|NCT00162942|516861533|FG001|Overall Study|Death|0|||
143360677|NCT00162942|516861532|FG000|Overall Study|Withdrawal by Subject|3|||
143360678|NCT00162942|516861533|FG001|Overall Study|Withdrawal by Subject|6|||
143360679|NCT00162942|516861532|FG000|Overall Study|Physician Decision|1|||
143360680|NCT00162942|516861533|FG001|Overall Study|Physician Decision|0|||
143360681|NCT00162942|516861532|FG000|Overall Study|Enter Open-Label Study|76|||
143360682|NCT00162942|516861533|FG001|Overall Study|Enter Open-Label Study|35|||
143360683|NCT00162942|516861532|FG000|Overall Study|Alternate Therapy|6|||
143360684|NCT00162942|516861533|FG001|Overall Study|Alternate Therapy|2|||
143360685|NCT00162942|516861532|FG000|Overall Study|Lack of Efficacy|1|||
143360686|NCT00162942|516861533|FG001|Overall Study|Lack of Efficacy|0|||
143360687|NCT00162942|516861532|FG000|Overall Study|Flare During Active Treatment|7|||
143360688|NCT00162942|516861533|FG001|Overall Study|Flare During Active Treatment|3|||
143360689|NCT00162942|516861532|FG000|Overall Study|2 or more consecutive treatments missed|1|||
143360690|NCT00162942|516861533|FG001|Overall Study|2 or more consecutive treatments missed|0|||
143360691|NCT01167023|516861534|FG000|Overall Study|Lost to Follow-up|0|||
143360692|NCT01167023|516861535|FG001|Overall Study|Lost to Follow-up|1|||
143360693|NCT01167023|516861536|FG002|Overall Study|Lost to Follow-up|1|||
143360694|NCT01167023|516861534|FG000|Overall Study|Screen Failure|0|||
143360695|NCT01167023|516861535|FG001|Overall Study|Screen Failure|1|||
143360696|NCT01167023|516861536|FG002|Overall Study|Screen Failure|0|||
143360697|NCT01167023|516861534|FG000|Overall Study|Sponsor Decision|0|||
143360698|NCT01167023|516861535|FG001|Overall Study|Sponsor Decision|1|||
143360699|NCT01167023|516861536|FG002|Overall Study|Sponsor Decision|0|||
143360700|NCT01167023|516861534|FG000|Overall Study|Withdrawal by Subject|0|||
143360701|NCT01167023|516861535|FG001|Overall Study|Withdrawal by Subject|0|||
143470514|NCT04786119|517270152|FG001|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|0|||
143470515|NCT06268288|517270153|FG000|Overall Study|Withdrawal by Subject|1|||
143470516|NCT06268288|517270154|FG001|Overall Study|Withdrawal by Subject|2|||
143470517|NCT02593786|517270155|FG000|Overall Study|Disease progression|12|||
143470518|NCT02593786|517270156|FG001|Overall Study|Disease progression|16|||
143470519|NCT02593786|517270157|FG002|Overall Study|Disease progression|10|||
143470520|NCT02593786|517270158|FG003|Overall Study|Disease progression|7|||
143470521|NCT02593786|517270155|FG000|Overall Study|Study drug toxicity|1|||
143470522|NCT02593786|517270156|FG001|Overall Study|Study drug toxicity|0|||
143470523|NCT02593786|517270157|FG002|Overall Study|Study drug toxicity|0|||
143470524|NCT02593786|517270158|FG003|Overall Study|Study drug toxicity|0|||
143470525|NCT02593786|517270155|FG000|Overall Study|Adverse event unrelated to study drug|1|||
143470526|NCT02593786|517270156|FG001|Overall Study|Adverse event unrelated to study drug|1|||
143470527|NCT02593786|517270157|FG002|Overall Study|Adverse event unrelated to study drug|1|||
143470528|NCT02593786|517270158|FG003|Overall Study|Adverse event unrelated to study drug|0|||
143470529|NCT02593786|517270155|FG000|Overall Study|Participant request to discontinue study therapy|0|||
143470530|NCT02593786|517270156|FG001|Overall Study|Participant request to discontinue study therapy|2|||
143470531|NCT02593786|517270157|FG002|Overall Study|Participant request to discontinue study therapy|0|||
143470532|NCT02593786|517270158|FG003|Overall Study|Participant request to discontinue study therapy|0|||
143470533|NCT02593786|517270155|FG000|Overall Study|Other reasons|1|||
143470534|NCT02593786|517270156|FG001|Overall Study|Other reasons|1|||
143470535|NCT02593786|517270157|FG002|Overall Study|Other reasons|0|||
143470536|NCT02593786|517270158|FG003|Overall Study|Other reasons|5|||
143470537|NCT02038920|517270163|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
143470538|NCT02038920|517270164|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
143470539|NCT02038920|517270165|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
143470540|NCT02038920|517270166|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
143470541|NCT02038920|517270167|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
143470542|NCT02038920|517270168|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
143470543|NCT02038920|517270163|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
143470544|NCT02038920|517270164|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
143470545|NCT02038920|517270165|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
143470546|NCT02038920|517270166|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
143470547|NCT02038920|517270167|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
143470548|NCT02038920|517270168|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
143470549|NCT02038920|517270163|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
143470550|NCT02038920|517270164|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
143470551|NCT02038920|517270165|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
143470552|NCT02038920|517270166|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
143470553|NCT02038920|517270167|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
143470554|NCT02038920|517270168|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
143470555|NCT02038920|517270163|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
143470556|NCT02038920|517270164|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
143470557|NCT02038920|517270165|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
143470558|NCT02038920|517270166|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
143470559|NCT02038920|517270167|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
143470560|NCT02038920|517270168|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
143470561|NCT02038920|517270163|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
143470562|NCT02038920|517270164|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
143470563|NCT02038920|517270165|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
143470564|NCT02038920|517270166|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
143470565|NCT02038920|517270167|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
143470566|NCT02038920|517270168|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
143470567|NCT02038920|517270163|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
143470568|NCT02038920|517270164|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
143470569|NCT02038920|517270165|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
143470570|NCT02038920|517270166|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
143470571|NCT02038920|517270167|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
143470572|NCT02038920|517270168|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
143470573|NCT02038920|517270163|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
143470574|NCT02038920|517270164|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
143470575|NCT02038920|517270165|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
143470576|NCT02038920|517270166|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
143470577|NCT02038920|517270167|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
143470578|NCT02038920|517270168|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
143470579|NCT02038920|517270163|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
143470580|NCT02038920|517270164|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
143470581|NCT02038920|517270165|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
143470582|NCT02038920|517270166|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
143470583|NCT02038920|517270167|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
143470584|NCT02038920|517270168|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
143470585|NCT02038920|517270163|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
143470586|NCT02038920|517270164|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
143470587|NCT02038920|517270165|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
143470588|NCT02038920|517270166|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
143470589|NCT02038920|517270167|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
143470590|NCT02038920|517270168|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
143470591|NCT02038920|517270163|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
143470592|NCT02038920|517270164|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
143470593|NCT02038920|517270165|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
143470594|NCT02038920|517270166|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
143470595|NCT02038920|517270167|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
143470596|NCT02038920|517270168|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
143470597|NCT02038920|517270163|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
143470598|NCT02038920|517270164|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
143470599|NCT02038920|517270165|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
143470600|NCT02038920|517270166|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
143470601|NCT02038920|517270167|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
143470602|NCT02038920|517270168|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
143470603|NCT02038920|517270163|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
143470604|NCT02038920|517270164|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
143470605|NCT02038920|517270165|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
143470606|NCT02038920|517270166|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
143470607|NCT02038920|517270167|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
143470608|NCT02038920|517270168|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
143470609|NCT02383589|517270169|FG000|Treatment Period|Adverse Event|1|||
143470610|NCT02383589|517270170|FG001|Treatment Period|Adverse Event|3|||
143470611|NCT02383589|517270169|FG000|Treatment Period|Lost to Follow-up|0|||
143470612|NCT02383589|517270170|FG001|Treatment Period|Lost to Follow-up|1|||
143470613|NCT02383589|517270169|FG000|Treatment Period|Withdrawal by Subject|0|||
143470614|NCT02383589|517270170|FG001|Treatment Period|Withdrawal by Subject|5|||
143470615|NCT02383589|517270169|FG000|Treatment Period|Non-compliance with study drug|0|||
143470616|NCT02383589|517270170|FG001|Treatment Period|Non-compliance with study drug|1|||
143470617|NCT02383589|517270169|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
143470618|NCT02383589|517270170|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
143470619|NCT02383589|517270169|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
143470620|NCT02383589|517270170|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
143470621|NCT02383589|517270169|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
143470622|NCT02383589|517270170|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
143470623|NCT00866697|517270171|FG000|Overall Study|Study closed/terminated|156|||
143470624|NCT00866697|517270172|FG001|Overall Study|Study closed/terminated|138|||
143470625|NCT00866697|517270171|FG000|Overall Study|Lost to Follow-up|22|||
143470626|NCT00866697|517270172|FG001|Overall Study|Lost to Follow-up|28|||
143470627|NCT00866697|517270171|FG000|Overall Study|Physician Decision|3|||
143470628|NCT00866697|517270172|FG001|Overall Study|Physician Decision|5|||
143470629|NCT00866697|517270171|FG000|Overall Study|Withdrawal by Subject|33|||
143470630|NCT00866697|517270172|FG001|Overall Study|Withdrawal by Subject|57|||
143470631|NCT02906787|517270175|FG000|Overall Study|Withdrawal by Subject|12|||
143470632|NCT02906787|517270176|FG001|Overall Study|Withdrawal by Subject|10|||
143470633|NCT02906787|517270175|FG000|Overall Study|Missed|24|||
143470634|NCT02906787|517270176|FG001|Overall Study|Missed|22|||
143470635|NCT04275297|517270177|FG000|Overall Study|Lost to Follow-up|1|||
143470636|NCT04275297|517270178|FG001|Overall Study|Lost to Follow-up|1|||
143470637|NCT00447382|517270179|FG000|Overall Study|Adverse Event|1|||
143470638|NCT00447382|517270180|FG001|Overall Study|Adverse Event|1|||
143470639|NCT00447382|517270179|FG000|Overall Study|Lack of Efficacy|1|||
143470640|NCT00447382|517270180|FG001|Overall Study|Lack of Efficacy|0|||
143470641|NCT00447382|517270179|FG000|Overall Study|Protocol Violation|2|||
143470642|NCT00447382|517270180|FG001|Overall Study|Protocol Violation|0|||
143470643|NCT00447382|517270179|FG000|Overall Study|Unclassified|2|||
143470644|NCT00447382|517270180|FG001|Overall Study|Unclassified|5|||
143470645|NCT03901053|517270183|FG000|Overall Study|Lost to Follow-up|6|||
143470646|NCT03901053|517270184|FG001|Overall Study|Lost to Follow-up|2|||
143470647|NCT03901053|517270183|FG000|Overall Study|Withdrawal by Subject|4|||
143470648|NCT03901053|517270184|FG001|Overall Study|Withdrawal by Subject|3|||
143470649|NCT03901053|517270183|FG000|Overall Study|Unsatisfactory Device|1|||
143470650|NCT03901053|517270184|FG001|Overall Study|Unsatisfactory Device|2|||
143470651|NCT03901053|517270183|FG000|Overall Study|No longer meets study criteria|1|||
143470652|NCT03901053|517270184|FG001|Overall Study|No longer meets study criteria|3|||
143470653|NCT03901053|517270183|FG000|Overall Study|Subject's Medical Status|0|||
143470654|NCT03901053|517270184|FG001|Overall Study|Subject's Medical Status|1|||
143470655|NCT03901053|517270183|FG000|Overall Study|Screening Failure|1|||
143470656|NCT03901053|517270184|FG001|Overall Study|Screening Failure|0|||
143470657|NCT04739800|517270185|FG000|Overall Study|Adverse Event|2|||
143470658|NCT04739800|517270186|FG001|Overall Study|Adverse Event|1|||
143470659|NCT04739800|517270187|FG002|Overall Study|Adverse Event|4|||
143470660|NCT04739800|517270188|FG003|Overall Study|Adverse Event|5|||
143470661|NCT04739800|517270185|FG000|Overall Study|Never Treated|2|||
143470662|NCT04739800|517270186|FG001|Overall Study|Never Treated|0|||
143470663|NCT04739800|517270187|FG002|Overall Study|Never Treated|1|||
143470664|NCT04739800|517270188|FG003|Overall Study|Never Treated|1|||
143470665|NCT04739800|517270185|FG000|Overall Study|On Treatment|5|||
143470666|NCT04739800|517270186|FG001|Overall Study|On Treatment|9|||
143470667|NCT04739800|517270187|FG002|Overall Study|On Treatment|9|||
143470668|NCT04739800|517270188|FG003|Overall Study|On Treatment|9|||
143470669|NCT04739800|517270185|FG000|Overall Study|Symptomatic Deterioration|1|||
143470670|NCT04739800|517270186|FG001|Overall Study|Symptomatic Deterioration|1|||
143470671|NCT04739800|517270187|FG002|Overall Study|Symptomatic Deterioration|3|||
143470672|NCT04739800|517270188|FG003|Overall Study|Symptomatic Deterioration|0|||
143470673|NCT04739800|517270185|FG000|Overall Study|Withdrawal by Subject|1|||
143470674|NCT04739800|517270186|FG001|Overall Study|Withdrawal by Subject|2|||
143470675|NCT04739800|517270187|FG002|Overall Study|Withdrawal by Subject|1|||
143470676|NCT04739800|517270188|FG003|Overall Study|Withdrawal by Subject|3|||
143470677|NCT04739800|517270185|FG000|Overall Study|Other Reason|1|||
143470678|NCT04739800|517270186|FG001|Overall Study|Other Reason|3|||
143470679|NCT04739800|517270187|FG002|Overall Study|Other Reason|5|||
143470680|NCT04739800|517270188|FG003|Overall Study|Other Reason|4|||
143470681|NCT04091451|517270189|FG000|Overall Study|Adverse Event|15|||
143470682|NCT04091451|517270190|FG001|Overall Study|Adverse Event|10|||
143470683|NCT04091451|517270189|FG000|Overall Study|Lost to Follow-up|8|||
143470684|NCT04091451|517270190|FG001|Overall Study|Lost to Follow-up|8|||
143470685|NCT04091451|517270189|FG000|Overall Study|Protocol Violation|5|||
143470686|NCT04091451|517270190|FG001|Overall Study|Protocol Violation|4|||
143470687|NCT04091451|517270189|FG000|Overall Study|Withdrawal by Subject|21|||
143360702|NCT01167023|516861536|FG002|Overall Study|Withdrawal by Subject|1|||
143360703|NCT02335268|516861537|FG000|Overall Study|Physician Decision|5|||
143360704|NCT02335268|516861538|FG001|Overall Study|Physician Decision|1|||
143360705|NCT02335268|516861537|FG000|Overall Study|Lack of Efficacy|2|||
143360706|NCT02335268|516861538|FG001|Overall Study|Lack of Efficacy|1|||
143360707|NCT02335268|516861537|FG000|Overall Study|Adverse Event|5|||
143360708|NCT02335268|516861538|FG001|Overall Study|Adverse Event|2|||
143360709|NCT02335268|516861537|FG000|Overall Study|increase blasts|2|||
143360710|NCT02335268|516861538|FG001|Overall Study|increase blasts|0|||
143360711|NCT02335268|516861537|FG000|Overall Study|Withdrawal by Subject|3|||
143360712|NCT02335268|516861538|FG001|Overall Study|Withdrawal by Subject|2|||
143360713|NCT01192295|516861539|FG000|Overall Study|Adverse Event|3|||
143360714|NCT01192295|516861540|FG001|Overall Study|Adverse Event|7|||
143360715|NCT01192295|516861539|FG000|Overall Study|Withdrawal by Subject|3|||
143360716|NCT01192295|516861540|FG001|Overall Study|Withdrawal by Subject|4|||
143360717|NCT01192295|516861539|FG000|Overall Study|Lost to Follow-up|0|||
143360718|NCT01192295|516861540|FG001|Overall Study|Lost to Follow-up|1|||
143360719|NCT01192295|516861539|FG000|Overall Study|Lack of Efficacy|0|||
143360720|NCT01192295|516861540|FG001|Overall Study|Lack of Efficacy|5|||
143360721|NCT01192295|516861539|FG000|Overall Study|Administrative|4|||
143360722|NCT01192295|516861540|FG001|Overall Study|Administrative|6|||
143360723|NCT05893797|516861544|FG000|Study Period 1 (Weeks 1 to 6)|Adverse Event|1|||
143360724|NCT05893797|516861544|FG000|Study Period 1 (Weeks 1 to 6)|Lost to Follow-up|1|||
143360725|NCT05893797|516861544|FG000|Study Period 1 (Weeks 1 to 6)|Withdrawal by Subject|2|||
143360726|NCT05893797|516861544|FG000|Study Period 2 (Weeks 7 to 18)|Physician Decision|2|||
143360727|NCT00003509|516861545|FG000|Overall Study|Not evaluable|5|||
143360728|NCT00114959|516861547|FG000|Overall Study|Lack of Efficacy|6|||
143360729|NCT00114959|516861547|FG000|Overall Study|Physician Decision|1|||
143360730|NCT00114959|516861547|FG000|Overall Study|Death|1|||
143360731|NCT04060680|516861548|FG000|Overall Study|Unsuccessful implant|17|||
143360732|NCT04060680|516861549|FG001|Overall Study|Unsuccessful implant|2|||
143360733|NCT04060680|516861548|FG000|Overall Study|Adverse Event|3|||
143360734|NCT04060680|516861549|FG001|Overall Study|Adverse Event|0|||
143470688|NCT04091451|517270190|FG001|Overall Study|Withdrawal by Subject|27|||
143232174|NCT01446159|516402034|FG002|Overall Study|Other|13|||
143470689|NCT04091451|517270189|FG000|Overall Study|Non-emergency unblinding/Non-compliance|15|||
143470690|NCT04091451|517270190|FG001|Overall Study|Non-emergency unblinding/Non-compliance|18|||
143470691|NCT04091451|517270189|FG000|Overall Study|Migrated/moved from the study area|3|||
143470692|NCT04091451|517270190|FG001|Overall Study|Migrated/moved from the study area|5|||
143470693|NCT04091451|517270189|FG000|Overall Study|Suspected HZ episode|1|||
143360735|NCT04060680|516861548|FG000|Overall Study|Death|2|||
143470694|NCT04091451|517270190|FG001|Overall Study|Suspected HZ episode|0|||
143470695|NCT00217737|517270191|FG000|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
143470696|NCT00217737|517270192|FG001|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
143470697|NCT00217737|517270193|FG002|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
143470698|NCT00217737|517270194|FG003|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|252|||
143470699|NCT00217737|517270191|FG000|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
143470700|NCT00217737|517270192|FG001|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
143470701|NCT00217737|517270193|FG002|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
143470702|NCT00217737|517270194|FG003|Step 1 Registration (Risk Assessment)|No tumor block assessments|83|||
143470703|NCT00217737|517270191|FG000|Step 1 Registration (Risk Assessment)|Ineligible|0|||
143470704|NCT00217737|517270192|FG001|Step 1 Registration (Risk Assessment)|Ineligible|0|||
143470705|NCT00217737|517270193|FG002|Step 1 Registration (Risk Assessment)|Ineligible|0|||
143470706|NCT00217737|517270194|FG003|Step 1 Registration (Risk Assessment)|Ineligible|68|||
143470707|NCT00217737|517270191|FG000|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
143470708|NCT00217737|517270192|FG001|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
143470709|NCT00217737|517270193|FG002|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
143470710|NCT00217737|517270194|FG003|Step 1 Registration (Risk Assessment)|Uninformative tumor block|18|||
143470711|NCT00217737|517270191|FG000|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
143470712|NCT00217737|517270192|FG001|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
143470713|NCT00217737|517270193|FG002|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
143470714|NCT00217737|517270194|FG003|Step 1 Registration (Risk Assessment)|Physician Decision|16|||
143470715|NCT00217737|517270191|FG000|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
143470716|NCT00217737|517270192|FG001|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
143470717|NCT00217737|517270193|FG002|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
143470718|NCT00217737|517270194|FG003|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|16|||
143470719|NCT00217737|517270191|FG000|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
143470720|NCT00217737|517270192|FG001|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
143470721|NCT00217737|517270193|FG002|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
143470722|NCT00217737|517270194|FG003|Step 1 Registration (Risk Assessment)|Staff/site error|9|||
143470723|NCT00217737|517270191|FG000|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
143470724|NCT00217737|517270192|FG001|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
143470725|NCT00217737|517270193|FG002|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
143134929|NCT05067972|516039444|FG002|Part 1: Treatment|Global Deterioration of Health Status|0|||
143134930|NCT05067972|516039445|FG003|Part 1: Treatment|Global Deterioration of Health Status|1|||
143134931|NCT05067972|516039446|FG004|Part 1: Treatment|Global Deterioration of Health Status|0|||
143134932|NCT05067972|516039447|FG005|Part 1: Treatment|Global Deterioration of Health Status|0|||
143134933|NCT05067972|516039448|FG006|Part 1: Treatment|Global Deterioration of Health Status|1|||
143134934|NCT05067972|516039442|FG000|Part 1: Treatment|Withdrawal by Subject|0|||
143134935|NCT05067972|516039443|FG001|Part 1: Treatment|Withdrawal by Subject|0|||
143134936|NCT05067972|516039444|FG002|Part 1: Treatment|Withdrawal by Subject|0|||
143360736|NCT04060680|516861549|FG001|Overall Study|Death|0|||
143360737|NCT04060680|516861548|FG000|Overall Study|Study product no longer in use|1|||
143360738|NCT04060680|516861549|FG001|Overall Study|Study product no longer in use|0|||
143360739|NCT04060680|516861548|FG000|Overall Study|Withdrawal by Subject|1|||
143360740|NCT04060680|516861549|FG001|Overall Study|Withdrawal by Subject|0|||
143360741|NCT02507219|516861553|FG000|Overall Study|Physician Decision|1|||
143360742|NCT02507219|516861554|FG001|Overall Study|Physician Decision|0|||
143360743|NCT02507219|516861555|FG002|Overall Study|Physician Decision|0|||
143360744|NCT02507219|516861556|FG003|Overall Study|Physician Decision|0|||
143360745|NCT02507219|516861557|FG004|Overall Study|Physician Decision|0|||
143360746|NCT02507219|516861558|FG005|Overall Study|Physician Decision|0|||
143360747|NCT02507219|516861553|FG000|Overall Study|Withdrawal by Subject|0|||
143360748|NCT02507219|516861554|FG001|Overall Study|Withdrawal by Subject|0|||
143360749|NCT02507219|516861555|FG002|Overall Study|Withdrawal by Subject|0|||
143360750|NCT02507219|516861556|FG003|Overall Study|Withdrawal by Subject|0|||
143360751|NCT02507219|516861557|FG004|Overall Study|Withdrawal by Subject|1|||
143360752|NCT02507219|516861558|FG005|Overall Study|Withdrawal by Subject|0|||
143360753|NCT01544582|516861559|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
143360754|NCT01544582|516861560|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
143360755|NCT01544582|516861561|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
143360756|NCT01544582|516861562|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
143360757|NCT01544582|516861559|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
143360758|NCT01544582|516861560|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
143360759|NCT01544582|516861561|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
143360760|NCT01544582|516861562|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
143360761|NCT01544582|516861559|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
143360762|NCT01544582|516861560|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
143470726|NCT00217737|517270194|FG003|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|9|||
143470727|NCT00217737|517270191|FG000|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
143470728|NCT00217737|517270192|FG001|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
143470729|NCT00217737|517270193|FG002|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
143470730|NCT00217737|517270194|FG003|Step 1 Registration (Risk Assessment)|Adverse Event|6|||
143470731|NCT00217737|517270191|FG000|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
143470732|NCT00217737|517270192|FG001|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
143470733|NCT00217737|517270193|FG002|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
143470734|NCT00217737|517270194|FG003|Step 1 Registration (Risk Assessment)|Insurance issues|4|||
143470735|NCT00217737|517270191|FG000|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
143470736|NCT00217737|517270192|FG001|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
143470737|NCT00217737|517270193|FG002|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
143470738|NCT00217737|517270194|FG003|Step 1 Registration (Risk Assessment)|Non-compliance|2|||
143470739|NCT00217737|517270191|FG000|Step 1 Registration (Risk Assessment)|Death|0|||
143470740|NCT00217737|517270192|FG001|Step 1 Registration (Risk Assessment)|Death|0|||
143470741|NCT00217737|517270193|FG002|Step 1 Registration (Risk Assessment)|Death|0|||
143470742|NCT00217737|517270194|FG003|Step 1 Registration (Risk Assessment)|Death|1|||
143470743|NCT00217737|517270191|FG000|Step 1 Registration (Risk Assessment)|Disease progression|0|||
143470744|NCT00217737|517270192|FG001|Step 1 Registration (Risk Assessment)|Disease progression|0|||
143470745|NCT00217737|517270193|FG002|Step 1 Registration (Risk Assessment)|Disease progression|0|||
143470746|NCT00217737|517270194|FG003|Step 1 Registration (Risk Assessment)|Disease progression|1|||
143470747|NCT00217737|517270191|FG000|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
143470748|NCT00217737|517270192|FG001|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
143470749|NCT00217737|517270193|FG002|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
143470750|NCT00217737|517270194|FG003|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|1|||
143470751|NCT00217737|517270191|FG000|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
143470752|NCT00217737|517270192|FG001|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
143470753|NCT00217737|517270193|FG002|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
143470754|NCT00217737|517270194|FG003|Step 1 Registration (Risk Assessment)|Lost to Follow-up|1|||
143470755|NCT00217737|517270191|FG000|Step 1 Registration (Risk Assessment)|Other|0|||
143470756|NCT00217737|517270192|FG001|Step 1 Registration (Risk Assessment)|Other|0|||
143470757|NCT00217737|517270193|FG002|Step 1 Registration (Risk Assessment)|Other|0|||
143470758|NCT00217737|517270194|FG003|Step 1 Registration (Risk Assessment)|Other|12|||
143470759|NCT00217737|517270191|FG000|Step 1 Registration (Risk Assessment)|Registration error|0|||
143470760|NCT00217737|517270192|FG001|Step 1 Registration (Risk Assessment)|Registration error|0|||
143470761|NCT00217737|517270193|FG002|Step 1 Registration (Risk Assessment)|Registration error|0|||
143470762|NCT00217737|517270194|FG003|Step 1 Registration (Risk Assessment)|Registration error|1|||
143470763|NCT00217737|517270191|FG000|Step 2 Randomization/Registration|Adverse Event|59|||
143470764|NCT00217737|517270192|FG001|Step 2 Randomization/Registration|Adverse Event|98|||
143470765|NCT00217737|517270193|FG002|Step 2 Randomization/Registration|Adverse Event|0|||
143470766|NCT00217737|517270194|FG003|Step 2 Randomization/Registration|Adverse Event|0|||
143470767|NCT00217737|517270191|FG000|Step 2 Randomization/Registration|Withdrawal by Subject|53|||
143470768|NCT00217737|517270192|FG001|Step 2 Randomization/Registration|Withdrawal by Subject|105|||
143470769|NCT00217737|517270193|FG002|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
143470770|NCT00217737|517270194|FG003|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
143470771|NCT00217737|517270191|FG000|Step 2 Randomization/Registration|Study suspension|0|||
143470772|NCT00217737|517270192|FG001|Step 2 Randomization/Registration|Study suspension|45|||
143470773|NCT00217737|517270193|FG002|Step 2 Randomization/Registration|Study suspension|0|||
143470774|NCT00217737|517270194|FG003|Step 2 Randomization/Registration|Study suspension|0|||
143470775|NCT00217737|517270191|FG000|Step 2 Randomization/Registration|Complicating disease|5|||
143470776|NCT00217737|517270192|FG001|Step 2 Randomization/Registration|Complicating disease|5|||
143470777|NCT00217737|517270193|FG002|Step 2 Randomization/Registration|Complicating disease|0|||
143470778|NCT00217737|517270194|FG003|Step 2 Randomization/Registration|Complicating disease|0|||
143470779|NCT00217737|517270191|FG000|Step 2 Randomization/Registration|Death|2|||
143470780|NCT00217737|517270192|FG001|Step 2 Randomization/Registration|Death|3|||
143470781|NCT00217737|517270193|FG002|Step 2 Randomization/Registration|Death|0|||
143470782|NCT00217737|517270194|FG003|Step 2 Randomization/Registration|Death|0|||
143470783|NCT00217737|517270191|FG000|Step 2 Randomization/Registration|Non-compliant|2|||
143470784|NCT00217737|517270192|FG001|Step 2 Randomization/Registration|Non-compliant|4|||
143470785|NCT00217737|517270193|FG002|Step 2 Randomization/Registration|Non-compliant|0|||
143470786|NCT00217737|517270194|FG003|Step 2 Randomization/Registration|Non-compliant|0|||
143470787|NCT00217737|517270191|FG000|Step 2 Randomization/Registration|Physician Decision|2|||
143470788|NCT00217737|517270192|FG001|Step 2 Randomization/Registration|Physician Decision|2|||
143470789|NCT00217737|517270193|FG002|Step 2 Randomization/Registration|Physician Decision|0|||
143470790|NCT00217737|517270194|FG003|Step 2 Randomization/Registration|Physician Decision|0|||
143470791|NCT00217737|517270191|FG000|Step 2 Randomization/Registration|Alternative therapy|0|||
143470792|NCT00217737|517270192|FG001|Step 2 Randomization/Registration|Alternative therapy|1|||
143470793|NCT00217737|517270193|FG002|Step 2 Randomization/Registration|Alternative therapy|0|||
143470794|NCT00217737|517270194|FG003|Step 2 Randomization/Registration|Alternative therapy|0|||
143470795|NCT00217737|517270191|FG000|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
143470796|NCT00217737|517270192|FG001|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|1|||
143470797|NCT00217737|517270193|FG002|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
143470798|NCT00217737|517270194|FG003|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
143470799|NCT00217737|517270191|FG000|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
143470800|NCT00217737|517270192|FG001|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|1|||
143470801|NCT00217737|517270193|FG002|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
143470802|NCT00217737|517270194|FG003|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
143470803|NCT00217737|517270191|FG000|Step 2 Randomization/Registration|Incorrect Cancer Stage|1|||
143470804|NCT00217737|517270192|FG001|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
143470805|NCT00217737|517270193|FG002|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
143470806|NCT00217737|517270194|FG003|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
143470807|NCT00217737|517270191|FG000|Step 2 Randomization/Registration|Never started protocol therapy|31|||
143470808|NCT00217737|517270192|FG001|Step 2 Randomization/Registration|Never started protocol therapy|48|||
143470809|NCT00217737|517270193|FG002|Step 2 Randomization/Registration|Never started protocol therapy|0|||
143470810|NCT00217737|517270194|FG003|Step 2 Randomization/Registration|Never started protocol therapy|0|||
143470811|NCT00217737|517270191|FG000|Step 2 Randomization/Registration|Other|1|||
143470812|NCT00217737|517270192|FG001|Step 2 Randomization/Registration|Other|2|||
143470813|NCT00217737|517270193|FG002|Step 2 Randomization/Registration|Other|0|||
143470814|NCT00217737|517270194|FG003|Step 2 Randomization/Registration|Other|0|||
143470815|NCT01678209|517271616|FG000|Overall Study|could not scan twice|1|||
143470816|NCT01678209|517271617|FG001|Overall Study|could not scan twice|1|||
143470817|NCT01678209|517271618|FG002|Overall Study|could not scan twice|1|||
143470818|NCT01678209|517271616|FG000|Overall Study|scheduling conflicts|0|||
143470819|NCT01678209|517271617|FG001|Overall Study|scheduling conflicts|0|||
143470820|NCT01678209|517271618|FG002|Overall Study|scheduling conflicts|1|||
143470821|NCT01678209|517271616|FG000|Overall Study|screen fail|16|||
143470822|NCT01678209|517271617|FG001|Overall Study|screen fail|17|||
143470823|NCT01678209|517271618|FG002|Overall Study|screen fail|16|||
143470824|NCT03756350|517271619|FG000|Overall Study|Lost to Follow-up|1|||
143470825|NCT03308942|517271620|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
143470826|NCT03308942|517271621|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
143470827|NCT03308942|517271622|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
143470828|NCT03308942|517271623|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
143470829|NCT03308942|517271624|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
143470830|NCT03308942|517271620|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
143470831|NCT03308942|517271621|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
143470832|NCT03308942|517271622|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
143470833|NCT03308942|517271623|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
143470834|NCT03308942|517271624|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
143470835|NCT03308942|517271620|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
143470836|NCT03308942|517271621|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
143470837|NCT03308942|517271622|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
143470838|NCT03308942|517271623|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
143470839|NCT03308942|517271624|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
143470840|NCT03308942|517271620|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
143470841|NCT03308942|517271621|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
143470842|NCT03308942|517271622|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
143470843|NCT03308942|517271623|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
143470844|NCT03308942|517271624|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
143470845|NCT03308942|517271620|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
143470846|NCT03308942|517271621|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
143470847|NCT03308942|517271622|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
143470848|NCT03308942|517271623|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
143470849|NCT03308942|517271624|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
143470850|NCT03308942|517271620|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
143134937|NCT05067972|516039445|FG003|Part 1: Treatment|Withdrawal by Subject|0|||
143134938|NCT05067972|516039446|FG004|Part 1: Treatment|Withdrawal by Subject|1|||
143470851|NCT03308942|517271621|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
143470852|NCT03308942|517271622|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
143470853|NCT03308942|517271623|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
143470854|NCT03308942|517271624|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
143134939|NCT05067972|516039447|FG005|Part 1: Treatment|Withdrawal by Subject|2|||
143134940|NCT05067972|516039448|FG006|Part 1: Treatment|Withdrawal by Subject|1|||
143470855|NCT03308942|517271620|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
143134941|NCT05067972|516039442|FG000|Part 1: Treatment|Progressive Disease|3|||
143134942|NCT05067972|516039443|FG001|Part 1: Treatment|Progressive Disease|3|||
143134943|NCT05067972|516039444|FG002|Part 1: Treatment|Progressive Disease|4|||
143134944|NCT05067972|516039445|FG003|Part 1: Treatment|Progressive Disease|2|||
143134945|NCT05067972|516039446|FG004|Part 1: Treatment|Progressive Disease|3|||
143134946|NCT05067972|516039447|FG005|Part 1: Treatment|Progressive Disease|0|||
143134947|NCT05067972|516039448|FG006|Part 1: Treatment|Progressive Disease|2|||
143134948|NCT05067972|516039442|FG000|Part 1: Treatment|Physician Decision|0|||
143134949|NCT05067972|516039443|FG001|Part 1: Treatment|Physician Decision|0|||
143134950|NCT05067972|516039444|FG002|Part 1: Treatment|Physician Decision|0|||
143134951|NCT05067972|516039445|FG003|Part 1: Treatment|Physician Decision|1|||
143134952|NCT05067972|516039446|FG004|Part 1: Treatment|Physician Decision|0|||
143134953|NCT05067972|516039447|FG005|Part 1: Treatment|Physician Decision|0|||
143134954|NCT05067972|516039448|FG006|Part 1: Treatment|Physician Decision|0|||
143134955|NCT05067972|516039442|FG000|Part 1: Treatment|Death|0|||
143134956|NCT05067972|516039443|FG001|Part 1: Treatment|Death|0|||
143470856|NCT03308942|517271621|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
143470857|NCT03308942|517271622|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
143470858|NCT03308942|517271623|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
143470859|NCT03308942|517271624|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
143470860|NCT01131351|517271625|FG000|Overall Study|Adverse Event|0|||
143470861|NCT01131351|517271626|FG001|Overall Study|Adverse Event|2|||
143470862|NCT01131351|517271625|FG000|Overall Study|Protocol Deviation|0|||
143470863|NCT01131351|517271626|FG001|Overall Study|Protocol Deviation|1|||
143470864|NCT04147234|517271627|FG000|Overall Study|Clinical deterioration|0|||
143470865|NCT04147234|517271628|FG001|Overall Study|Clinical deterioration|0|||
143470866|NCT04147234|517271629|FG002|Overall Study|Clinical deterioration|1|||
143470867|NCT04147234|517271630|FG003|Overall Study|Clinical deterioration|0|||
143470868|NCT04147234|517271631|FG004|Overall Study|Clinical deterioration|0|||
143470869|NCT04147234|517271632|FG005|Overall Study|Clinical deterioration|0|||
143470870|NCT04147234|517271633|FG006|Overall Study|Clinical deterioration|0|||
143470871|NCT04147234|517271627|FG000|Overall Study|Withdrawal by Subject|0|||
143470872|NCT04147234|517271628|FG001|Overall Study|Withdrawal by Subject|1|||
143470873|NCT04147234|517271629|FG002|Overall Study|Withdrawal by Subject|1|||
143470874|NCT04147234|517271630|FG003|Overall Study|Withdrawal by Subject|0|||
143470875|NCT04147234|517271631|FG004|Overall Study|Withdrawal by Subject|0|||
143470876|NCT04147234|517271632|FG005|Overall Study|Withdrawal by Subject|0|||
143470877|NCT04147234|517271633|FG006|Overall Study|Withdrawal by Subject|0|||
143470878|NCT04147234|517271627|FG000|Overall Study|Clinical disease progression|1|||
143470879|NCT04147234|517271628|FG001|Overall Study|Clinical disease progression|3|||
143470880|NCT04147234|517271629|FG002|Overall Study|Clinical disease progression|1|||
143470881|NCT04147234|517271630|FG003|Overall Study|Clinical disease progression|1|||
143470882|NCT04147234|517271631|FG004|Overall Study|Clinical disease progression|0|||
143470883|NCT04147234|517271632|FG005|Overall Study|Clinical disease progression|1|||
143470884|NCT04147234|517271633|FG006|Overall Study|Clinical disease progression|0|||
143470885|NCT04147234|517271627|FG000|Overall Study|Objective disease progression|6|||
143470886|NCT04147234|517271628|FG001|Overall Study|Objective disease progression|4|||
143470887|NCT04147234|517271629|FG002|Overall Study|Objective disease progression|3|||
143470888|NCT04147234|517271630|FG003|Overall Study|Objective disease progression|3|||
143470889|NCT04147234|517271631|FG004|Overall Study|Objective disease progression|5|||
143470890|NCT04147234|517271632|FG005|Overall Study|Objective disease progression|2|||
143470891|NCT04147234|517271633|FG006|Overall Study|Objective disease progression|3|||
143470892|NCT04147234|517271627|FG000|Overall Study|Adverse Event|0|||
143470893|NCT04147234|517271628|FG001|Overall Study|Adverse Event|0|||
143470894|NCT04147234|517271629|FG002|Overall Study|Adverse Event|0|||
143470895|NCT04147234|517271630|FG003|Overall Study|Adverse Event|0|||
143470896|NCT04147234|517271631|FG004|Overall Study|Adverse Event|1|||
143470897|NCT04147234|517271632|FG005|Overall Study|Adverse Event|0|||
143470898|NCT04147234|517271633|FG006|Overall Study|Adverse Event|0|||
143470899|NCT01524133|517271638|FG000|Treatment Phase|Withdrawal by Subject|13|||
143470900|NCT01524133|517271639|FG001|Treatment Phase|Withdrawal by Subject|28|||
143470901|NCT01524133|517271640|FG002|Treatment Phase|Withdrawal by Subject|31|||
143470902|NCT01524133|517271638|FG000|Treatment Phase|Physician Decision|6|||
143470903|NCT01524133|517271639|FG001|Treatment Phase|Physician Decision|3|||
143134957|NCT05067972|516039444|FG002|Part 1: Treatment|Death|0|||
143470904|NCT01524133|517271640|FG002|Treatment Phase|Physician Decision|3|||
143470905|NCT01524133|517271638|FG000|Treatment Phase|Lost to Follow-up|0|||
143134958|NCT05067972|516039445|FG003|Part 1: Treatment|Death|2|||
143134959|NCT05067972|516039446|FG004|Part 1: Treatment|Death|0|||
143134960|NCT05067972|516039447|FG005|Part 1: Treatment|Death|0|||
143134961|NCT05067972|516039448|FG006|Part 1: Treatment|Death|0|||
143470906|NCT01524133|517271639|FG001|Treatment Phase|Lost to Follow-up|1|||
143470907|NCT01524133|517271640|FG002|Treatment Phase|Lost to Follow-up|2|||
143470908|NCT01524133|517271638|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
143360763|NCT01544582|516861561|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
143360764|NCT01544582|516861562|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
143360765|NCT01544582|516861559|FG000|Analysis Population|Physician Decision|0|||
143360766|NCT01544582|516861560|FG001|Analysis Population|Physician Decision|13|||
143360767|NCT01544582|516861561|FG002|Analysis Population|Physician Decision|10|||
143360768|NCT01544582|516861562|FG003|Analysis Population|Physician Decision|9|||
143360769|NCT01544582|516861559|FG000|Analysis Population|Safety Reason|0|||
143360770|NCT01544582|516861560|FG001|Analysis Population|Safety Reason|33|||
143360771|NCT01544582|516861561|FG002|Analysis Population|Safety Reason|31|||
143360772|NCT01544582|516861562|FG003|Analysis Population|Safety Reason|8|||
143360773|NCT01544582|516861559|FG000|Analysis Population|Effectiveness Reason|0|||
143360774|NCT01544582|516861560|FG001|Analysis Population|Effectiveness Reason|48|||
143360775|NCT01544582|516861561|FG002|Analysis Population|Effectiveness Reason|29|||
143360776|NCT01544582|516861562|FG003|Analysis Population|Effectiveness Reason|12|||
143360777|NCT01544582|516861559|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
143360778|NCT01544582|516861560|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
143360779|NCT01544582|516861561|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
143360780|NCT01544582|516861562|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
143360781|NCT01544582|516861559|FG000|Analysis Population|Lost to Follow-up|0|||
143360782|NCT01544582|516861560|FG001|Analysis Population|Lost to Follow-up|6|||
143360783|NCT01544582|516861561|FG002|Analysis Population|Lost to Follow-up|6|||
143360784|NCT01544582|516861562|FG003|Analysis Population|Lost to Follow-up|5|||
143360785|NCT01544582|516861559|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
143360786|NCT01544582|516861560|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
143360787|NCT01544582|516861561|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
143360788|NCT01544582|516861562|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
143360789|NCT01544582|516861559|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
143360790|NCT01544582|516861560|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
143360791|NCT01544582|516861561|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
143360792|NCT01544582|516861562|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
143360793|NCT01544582|516861559|FG000|Analysis Population|Intolerance|0|||
143360794|NCT01544582|516861560|FG001|Analysis Population|Intolerance|1|||
143360795|NCT01544582|516861561|FG002|Analysis Population|Intolerance|0|||
143360796|NCT01544582|516861562|FG003|Analysis Population|Intolerance|0|||
143360797|NCT01544582|516861559|FG000|Analysis Population|Liver Transplantation|0|||
143360798|NCT01544582|516861560|FG001|Analysis Population|Liver Transplantation|0|||
143360799|NCT01544582|516861561|FG002|Analysis Population|Liver Transplantation|1|||
143360800|NCT01544582|516861562|FG003|Analysis Population|Liver Transplantation|0|||
143360801|NCT01544582|516861559|FG000|Analysis Population|No Social Insurance|0|||
143360802|NCT01544582|516861560|FG001|Analysis Population|No Social Insurance|0|||
143360803|NCT01544582|516861561|FG002|Analysis Population|No Social Insurance|1|||
143360804|NCT01544582|516861562|FG003|Analysis Population|No Social Insurance|0|||
143360805|NCT01544582|516861559|FG000|Analysis Population|Poor Adherence|0|||
143360806|NCT01544582|516861560|FG001|Analysis Population|Poor Adherence|0|||
143360807|NCT01544582|516861561|FG002|Analysis Population|Poor Adherence|1|||
143360808|NCT01544582|516861562|FG003|Analysis Population|Poor Adherence|0|||
143360809|NCT01544582|516861559|FG000|Analysis Population|Poor Participant Compliance|0|||
143360810|NCT01544582|516861560|FG001|Analysis Population|Poor Participant Compliance|1|||
143360811|NCT01544582|516861561|FG002|Analysis Population|Poor Participant Compliance|0|||
143360812|NCT01544582|516861562|FG003|Analysis Population|Poor Participant Compliance|0|||
143360813|NCT01544582|516861559|FG000|Analysis Population|Programmed Surgery|0|||
143360814|NCT01544582|516861560|FG001|Analysis Population|Programmed Surgery|1|||
143360815|NCT01544582|516861561|FG002|Analysis Population|Programmed Surgery|0|||
143360816|NCT01544582|516861562|FG003|Analysis Population|Programmed Surgery|0|||
143360817|NCT01544582|516861559|FG000|Analysis Population|Participant in Jail|0|||
143360818|NCT01544582|516861560|FG001|Analysis Population|Participant in Jail|0|||
143360819|NCT01544582|516861561|FG002|Analysis Population|Participant in Jail|1|||
143360820|NCT01544582|516861562|FG003|Analysis Population|Participant in Jail|0|||
143360821|NCT04880161|516861565|FG000|Overall Study|Withdrawal by Subject|1|||
143360822|NCT04880161|516861566|FG001|Overall Study|Withdrawal by Subject|0|||
143360823|NCT04880161|516861565|FG000|Overall Study|Lack of Compliance|1|||
143360824|NCT04880161|516861566|FG001|Overall Study|Lack of Compliance|1|||
143360825|NCT04880161|516861565|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
143360826|NCT04880161|516861566|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
143360827|NCT04880161|516861565|FG000|Overall Study|Screen Failure|0|||
143360828|NCT04880161|516861566|FG001|Overall Study|Screen Failure|1|||
143360829|NCT00394095|516863576|FG000|Screening|Withdrawal by Subject|1|||
143360830|NCT00394095|516863577|FG001|Screening|Withdrawal by Subject|0|||
143360831|NCT00394095|516863576|FG000|Randomized|Withdrawal by Subject|5|||
143360832|NCT00394095|516863577|FG001|Randomized|Withdrawal by Subject|1|||
143360833|NCT00394095|516863576|FG000|Randomized|Adverse Event|1|||
143360834|NCT00394095|516863577|FG001|Randomized|Adverse Event|1|||
143360835|NCT00394095|516863576|FG000|Randomized|Overdose|1|||
143360836|NCT00394095|516863577|FG001|Randomized|Overdose|0|||
143360837|NCT00394095|516863576|FG000|Randomized|Lost to Follow-up|1|||
143134962|NCT05067972|516039442|FG000|Part 1: Treatment|Adverse Event|0|||
143134963|NCT05067972|516039443|FG001|Part 1: Treatment|Adverse Event|0|||
143134964|NCT05067972|516039444|FG002|Part 1: Treatment|Adverse Event|0|||
143134965|NCT05067972|516039445|FG003|Part 1: Treatment|Adverse Event|0|||
143134966|NCT05067972|516039446|FG004|Part 1: Treatment|Adverse Event|0|||
143134967|NCT05067972|516039447|FG005|Part 1: Treatment|Adverse Event|2|||
143134968|NCT05067972|516039448|FG006|Part 1: Treatment|Adverse Event|1|||
143134969|NCT05067972|516039442|FG000|Part 1: Follow-up|Adverse Event|0|||
143134970|NCT05067972|516039443|FG001|Part 1: Follow-up|Adverse Event|0|||
143134971|NCT05067972|516039444|FG002|Part 1: Follow-up|Adverse Event|0|||
143134972|NCT05067972|516039445|FG003|Part 1: Follow-up|Adverse Event|0|||
143134973|NCT05067972|516039446|FG004|Part 1: Follow-up|Adverse Event|0|||
143134974|NCT05067972|516039447|FG005|Part 1: Follow-up|Adverse Event|1|||
143134975|NCT05067972|516039448|FG006|Part 1: Follow-up|Adverse Event|0|||
143134976|NCT05067972|516039442|FG000|Part 1: Follow-up|Withdrawal by Subject|0|||
143134977|NCT05067972|516039443|FG001|Part 1: Follow-up|Withdrawal by Subject|0|||
143134978|NCT05067972|516039444|FG002|Part 1: Follow-up|Withdrawal by Subject|0|||
143134979|NCT05067972|516039445|FG003|Part 1: Follow-up|Withdrawal by Subject|0|||
143134980|NCT05067972|516039446|FG004|Part 1: Follow-up|Withdrawal by Subject|0|||
143134981|NCT05067972|516039447|FG005|Part 1: Follow-up|Withdrawal by Subject|0|||
143134982|NCT05067972|516039448|FG006|Part 1: Follow-up|Withdrawal by Subject|1|||
143134983|NCT05067972|516039442|FG000|Part 1: Follow-up|Study Terminated by Sponsor|0|||
143134984|NCT05067972|516039443|FG001|Part 1: Follow-up|Study Terminated by Sponsor|0|||
143134985|NCT05067972|516039444|FG002|Part 1: Follow-up|Study Terminated by Sponsor|0|||
143134986|NCT05067972|516039445|FG003|Part 1: Follow-up|Study Terminated by Sponsor|0|||
143134987|NCT05067972|516039446|FG004|Part 1: Follow-up|Study Terminated by Sponsor|0|||
143134988|NCT05067972|516039447|FG005|Part 1: Follow-up|Study Terminated by Sponsor|1|||
143134989|NCT05067972|516039448|FG006|Part 1: Follow-up|Study Terminated by Sponsor|0|||
143134990|NCT05067972|516039442|FG000|Part 1: Follow-up|Physician Decision|0|||
143134991|NCT05067972|516039443|FG001|Part 1: Follow-up|Physician Decision|0|||
143134992|NCT05067972|516039444|FG002|Part 1: Follow-up|Physician Decision|0|||
143134993|NCT05067972|516039445|FG003|Part 1: Follow-up|Physician Decision|1|||
143134994|NCT05067972|516039446|FG004|Part 1: Follow-up|Physician Decision|0|||
143134995|NCT05067972|516039447|FG005|Part 1: Follow-up|Physician Decision|0|||
143134996|NCT05067972|516039448|FG006|Part 1: Follow-up|Physician Decision|0|||
143134997|NCT05067972|516039442|FG000|Part 1: Follow-up|Death|1|||
143134998|NCT05067972|516039443|FG001|Part 1: Follow-up|Death|2|||
143134999|NCT05067972|516039444|FG002|Part 1: Follow-up|Death|1|||
143135000|NCT05067972|516039445|FG003|Part 1: Follow-up|Death|0|||
143135001|NCT05067972|516039446|FG004|Part 1: Follow-up|Death|1|||
143360838|NCT00394095|516863577|FG001|Randomized|Lost to Follow-up|2|||
143360839|NCT01256476|516863579|FG000|Overall Study|Adverse Event|2|||
143360840|NCT01256476|516863580|FG001|Overall Study|Adverse Event|1|||
143360841|NCT01256476|516863579|FG000|Overall Study|Withdrawal by Subject|2|||
143360842|NCT01256476|516863580|FG001|Overall Study|Withdrawal by Subject|1|||
143360843|NCT01256476|516863579|FG000|Overall Study|Lost to Follow-up|1|||
143360844|NCT01256476|516863580|FG001|Overall Study|Lost to Follow-up|2|||
143360845|NCT01256476|516863579|FG000|Overall Study|Persistent ALT or AST elevation|1|||
143360846|NCT01256476|516863580|FG001|Overall Study|Persistent ALT or AST elevation|0|||
143360847|NCT01256476|516863579|FG000|Overall Study|Physician Decision|0|||
143360848|NCT01256476|516863580|FG001|Overall Study|Physician Decision|1|||
143360849|NCT01256476|516863579|FG000|Overall Study|Subject non-compliance|0|||
143360850|NCT01256476|516863580|FG001|Overall Study|Subject non-compliance|1|||
143360851|NCT01256476|516863579|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
143360852|NCT01256476|516863580|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
143360853|NCT02401529|516863581|FG000|Overall Study|Lost to Follow-up|2|||
143360854|NCT02401529|516863582|FG001|Overall Study|Lost to Follow-up|1|||
143360855|NCT02401529|516863581|FG000|Overall Study|Physician Decision|2|||
143360856|NCT02401529|516863582|FG001|Overall Study|Physician Decision|6|||
143360857|NCT02401529|516863581|FG000|Overall Study|Protocol Violation|5|||
143360858|NCT02401529|516863582|FG001|Overall Study|Protocol Violation|0|||
143360859|NCT01939158|516863583|FG000|Overall Study|Adverse Event|1|||
143360860|NCT01939158|516863584|FG001|Overall Study|Adverse Event|0|||
143470909|NCT01524133|517271639|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
143135002|NCT05067972|516039447|FG005|Part 1: Follow-up|Death|0|||
143135003|NCT05067972|516039448|FG006|Part 1: Follow-up|Death|1|||
143135004|NCT02287038|516039458|FG000|Overall Study|Stopped attending appointments|3|||
143360861|NCT01939158|516863585|FG002|Overall Study|Adverse Event|0|||
143360862|NCT01939158|516863586|FG003|Overall Study|Adverse Event|0|||
143360863|NCT01939158|516863583|FG000|Overall Study|Withdrawal by Subject|22|||
143360864|NCT01939158|516863584|FG001|Overall Study|Withdrawal by Subject|25|||
143135005|NCT02287038|516039459|FG001|Overall Study|Stopped attending appointments|2|||
143135006|NCT02287038|516039458|FG000|Overall Study|Anxiety after starting medication|0|||
143135007|NCT02287038|516039459|FG001|Overall Study|Anxiety after starting medication|1|||
143135008|NCT02287038|516039458|FG000|Overall Study|Nausea after starting medication|1|||
143135009|NCT02287038|516039459|FG001|Overall Study|Nausea after starting medication|0|||
143135010|NCT02287038|516039458|FG000|Overall Study|Abnormal ECG after starting medication|1|||
143135011|NCT02287038|516039459|FG001|Overall Study|Abnormal ECG after starting medication|0|||
143135012|NCT05502302|516039467|FG000|Overall Study|Lost to Follow-up|6|||
143135013|NCT05502302|516039467|FG000|Overall Study|Death|2|||
143135014|NCT02155985|516039476|FG000|Overall Study|Withdrawal by Subject|0|||
143135015|NCT02155985|516039477|FG001|Overall Study|Withdrawal by Subject|0|||
143135016|NCT02155985|516039478|FG002|Overall Study|Withdrawal by Subject|1|||
143135017|NCT02155985|516039476|FG000|Overall Study|Lost to Follow-up|1|||
143135018|NCT02155985|516039477|FG001|Overall Study|Lost to Follow-up|0|||
143135019|NCT02155985|516039478|FG002|Overall Study|Lost to Follow-up|0|||
143135020|NCT02481050|516041350|FG000|Overall Study|Adverse Event|1|||
143135021|NCT02481050|516041350|FG000|Overall Study|Disease Progression|47|||
143135022|NCT02481050|516041350|FG000|Overall Study|Withdrawal by Subject|7|||
143135023|NCT02481050|516041350|FG000|Overall Study|Other|3|||
143135024|NCT03246347|516041351|FG000|Overall Study|On Study|23|||
143135025|NCT02188160|516041352|FG000|Overall Study|Adverse Event|1|||
143135026|NCT02188160|516041353|FG001|Overall Study|Adverse Event|0|||
143135027|NCT02188160|516041352|FG000|Overall Study|Use of an excluded medication|0|||
143360865|NCT01939158|516863585|FG002|Overall Study|Withdrawal by Subject|15|||
143360866|NCT01939158|516863586|FG003|Overall Study|Withdrawal by Subject|17|||
143360867|NCT01939158|516863583|FG000|Overall Study|Migrated/moved from study area|5|||
143360868|NCT01939158|516863584|FG001|Overall Study|Migrated/moved from study area|7|||
143360869|NCT01939158|516863585|FG002|Overall Study|Migrated/moved from study area|3|||
143360870|NCT01939158|516863586|FG003|Overall Study|Migrated/moved from study area|6|||
143360871|NCT01939158|516863583|FG000|Overall Study|Lost to Follow-up|18|||
143360872|NCT01939158|516863584|FG001|Overall Study|Lost to Follow-up|17|||
143360873|NCT01939158|516863585|FG002|Overall Study|Lost to Follow-up|17|||
143360874|NCT01939158|516863586|FG003|Overall Study|Lost to Follow-up|17|||
143360875|NCT01939158|516863583|FG000|Overall Study|Death|0|||
143360876|NCT01939158|516863584|FG001|Overall Study|Death|0|||
143360877|NCT01939158|516863585|FG002|Overall Study|Death|1|||
143360878|NCT01939158|516863586|FG003|Overall Study|Death|1|||
143360879|NCT01939158|516863583|FG000|Overall Study|No longer meets eligibility criteria|0|||
143360880|NCT01939158|516863584|FG001|Overall Study|No longer meets eligibility criteria|0|||
143360881|NCT01939158|516863585|FG002|Overall Study|No longer meets eligibility criteria|1|||
143360882|NCT01939158|516863586|FG003|Overall Study|No longer meets eligibility criteria|0|||
143360883|NCT01939158|516863583|FG000|Overall Study|Other|1|||
143360884|NCT01939158|516863584|FG001|Overall Study|Other|3|||
143360885|NCT01939158|516863585|FG002|Overall Study|Other|4|||
143360886|NCT01939158|516863586|FG003|Overall Study|Other|3|||
143360887|NCT02065245|516863587|FG000|Infusion 1|Lost to Follow-up|0|||
143360888|NCT02065245|516863588|FG001|Infusion 1|Lost to Follow-up|0|||
143360889|NCT02065245|516863589|FG002|Infusion 1|Lost to Follow-up|0|||
143360890|NCT02065245|516863590|FG003|Infusion 1|Lost to Follow-up|0|||
143360891|NCT02065245|516863591|FG004|Infusion 1|Lost to Follow-up|0|||
143360892|NCT02065245|516863592|FG005|Infusion 1|Lost to Follow-up|0|||
143360893|NCT02065245|516863593|FG006|Infusion 1|Lost to Follow-up|1|||
143360894|NCT02065245|516863587|FG000|Infusion 1|Death|0|||
143360895|NCT02065245|516863588|FG001|Infusion 1|Death|0|||
143360896|NCT02065245|516863589|FG002|Infusion 1|Death|1|||
143360897|NCT02065245|516863590|FG003|Infusion 1|Death|0|||
143360898|NCT02065245|516863591|FG004|Infusion 1|Death|1|||
143360899|NCT02065245|516863592|FG005|Infusion 1|Death|0|||
143360900|NCT02065245|516863593|FG006|Infusion 1|Death|0|||
143360901|NCT02065245|516863587|FG000|Infusion 2|Death|0|||
143360902|NCT02065245|516863588|FG001|Infusion 2|Death|0|||
143360903|NCT02065245|516863589|FG002|Infusion 2|Death|0|||
143360904|NCT02065245|516863590|FG003|Infusion 2|Death|0|||
143360905|NCT02065245|516863591|FG004|Infusion 2|Death|0|||
143360906|NCT02065245|516863592|FG005|Infusion 2|Death|0|||
143360907|NCT02065245|516863593|FG006|Infusion 2|Death|1|||
143360908|NCT02065245|516863587|FG000|Infusion 3|Lost to Follow-up|1|||
143360909|NCT02065245|516863588|FG001|Infusion 3|Lost to Follow-up|1|||
143360910|NCT02065245|516863589|FG002|Infusion 3|Lost to Follow-up|0|||
143360911|NCT02065245|516863590|FG003|Infusion 3|Lost to Follow-up|0|||
143360912|NCT02065245|516863591|FG004|Infusion 3|Lost to Follow-up|0|||
143360913|NCT02065245|516863592|FG005|Infusion 3|Lost to Follow-up|0|||
143360914|NCT02065245|516863593|FG006|Infusion 3|Lost to Follow-up|0|||
143360915|NCT01518257|516863594|FG000|Overall Study|Lost to Follow-up|1|||
143360916|NCT01518257|516863595|FG001|Overall Study|Lost to Follow-up|0|||
143135028|NCT02188160|516041353|FG001|Overall Study|Use of an excluded medication|1|||
143135029|NCT00916578|516041354|FG000|Overall Study|Physician Decision|2|||
143135030|NCT00916578|516041354|FG000|Overall Study|Withdrawal by Subject|3|||
143360917|NCT01518257|516863594|FG000|Overall Study|Other Miscellaneous Reason|1|||
143360918|NCT01518257|516863595|FG001|Overall Study|Other Miscellaneous Reason|0|||
143360919|NCT00924664|516863596|FG000|Overall Study|Adverse Event|23|||
143360920|NCT00924664|516863597|FG001|Overall Study|Adverse Event|39|||
143360921|NCT00924664|516863596|FG000|Overall Study|Lack of Efficacy|10|||
143360922|NCT00924664|516863597|FG001|Overall Study|Lack of Efficacy|15|||
143360923|NCT00924664|516863596|FG000|Overall Study|Lost to Follow-up|10|||
143360924|NCT00924664|516863597|FG001|Overall Study|Lost to Follow-up|12|||
143360925|NCT00924664|516863596|FG000|Overall Study|Withdrawal by Subject|47|||
143470910|NCT01524133|517271640|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
143470911|NCT01524133|517271638|FG000|Overall Study 52 Weeks|Physician Decision|1|||
143470912|NCT01524133|517271639|FG001|Overall Study 52 Weeks|Physician Decision|0|||
143470913|NCT01524133|517271640|FG002|Overall Study 52 Weeks|Physician Decision|2|||
143470914|NCT01524133|517271638|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
143470915|NCT01524133|517271639|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
143470916|NCT01524133|517271640|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
143470917|NCT05104476|517271641|FG000|Overall Study|Randomized But Not Treated|1|||
143470918|NCT05104476|517271642|FG001|Overall Study|Randomized But Not Treated|2|||
143470919|NCT05104476|517271641|FG000|Overall Study|Adverse Event|2|||
143470920|NCT05104476|517271642|FG001|Overall Study|Adverse Event|2|||
143470921|NCT05104476|517271641|FG000|Overall Study|Withdrawal by Subject|3|||
143470922|NCT05104476|517271642|FG001|Overall Study|Withdrawal by Subject|3|||
143470923|NCT05104476|517271641|FG000|Overall Study|Other Than Specified|0|||
143470924|NCT05104476|517271642|FG001|Overall Study|Other Than Specified|3|||
143470925|NCT04606771|517271643|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
143470926|NCT04606771|517271644|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
143470927|NCT04606771|517271643|FG000|Overall Study|Death|5|||
143470928|NCT04606771|517271644|FG001|Overall Study|Death|6|||
143470929|NCT04606771|517271643|FG000|Overall Study|Wrong randomisation|0|||
143470930|NCT04606771|517271644|FG001|Overall Study|Wrong randomisation|1|||
143470931|NCT01423812|517271648|FG000|Overall Study|Lost to Follow-up|2|||
143470932|NCT01423812|517271649|FG001|Overall Study|Lost to Follow-up|2|||
143470933|NCT01423812|517271648|FG000|Overall Study|Withdrawal by Subject|1|||
143470934|NCT01423812|517271649|FG001|Overall Study|Withdrawal by Subject|2|||
143470935|NCT03155373|517271650|FG000|Overall Study|No longer required surgery|1|||
143470936|NCT03155373|517271650|FG000|Overall Study|Protocol Violation|1|||
143470937|NCT03155373|517271650|FG000|Overall Study|Death|2|||
143470938|NCT03155373|517271650|FG000|Overall Study|Withdrawal by Subject|3|||
143470939|NCT02616614|517271651|FG000|Overall Study|Withdrawal by Subject|10|||
143470940|NCT02616614|517271652|FG001|Overall Study|Withdrawal by Subject|5|||
143470941|NCT02616614|517271653|FG002|Overall Study|Withdrawal by Subject|6|||
143470942|NCT02616614|517271651|FG000|Overall Study|Physician Decision|2|||
143470943|NCT02616614|517271652|FG001|Overall Study|Physician Decision|1|||
143470944|NCT02616614|517271653|FG002|Overall Study|Physician Decision|0|||
143470945|NCT02616614|517271651|FG000|Overall Study|Adverse Event|1|||
143470946|NCT02616614|517271652|FG001|Overall Study|Adverse Event|4|||
143470947|NCT02616614|517271653|FG002|Overall Study|Adverse Event|1|||
143470948|NCT02616614|517271651|FG000|Overall Study|Protocol Violation|0|||
143470949|NCT02616614|517271652|FG001|Overall Study|Protocol Violation|3|||
143470950|NCT02616614|517271653|FG002|Overall Study|Protocol Violation|1|||
143470951|NCT02616614|517271651|FG000|Overall Study|Prohibited Medication|12|||
143470952|NCT02616614|517271652|FG001|Overall Study|Prohibited Medication|9|||
143470953|NCT02616614|517271653|FG002|Overall Study|Prohibited Medication|5|||
143470954|NCT02616614|517271651|FG000|Overall Study|More than 3 applications missed|6|||
143470955|NCT02616614|517271652|FG001|Overall Study|More than 3 applications missed|8|||
143470956|NCT02616614|517271653|FG002|Overall Study|More than 3 applications missed|1|||
143470957|NCT02616614|517271651|FG000|Overall Study|Lost to Follow-up|31|||
143470958|NCT02616614|517271652|FG001|Overall Study|Lost to Follow-up|28|||
143470959|NCT02616614|517271653|FG002|Overall Study|Lost to Follow-up|13|||
143470960|NCT02616614|517271651|FG000|Overall Study|Pregnancy|2|||
143470961|NCT02616614|517271652|FG001|Overall Study|Pregnancy|0|||
143470962|NCT02616614|517271653|FG002|Overall Study|Pregnancy|1|||
143470963|NCT02616614|517271651|FG000|Overall Study|Other|1|||
143470964|NCT02616614|517271652|FG001|Overall Study|Other|2|||
143470965|NCT02616614|517271653|FG002|Overall Study|Other|1|||
143470966|NCT01214187|517271656|FG000|Overall Study|Adverse Event|6|||
143470967|NCT01214187|517271657|FG001|Overall Study|Adverse Event|2|||
143470968|NCT01214187|517271656|FG000|Overall Study|Death|1|||
143470969|NCT01214187|517271657|FG001|Overall Study|Death|1|||
143470970|NCT01214187|517271656|FG000|Overall Study|Withdrawal by Subject|0|||
143470971|NCT01214187|517271657|FG001|Overall Study|Withdrawal by Subject|3|||
143470972|NCT01233869|517271658|FG000|Initial Treatment Period (24 Months)|Death|1|||
143470973|NCT01233869|517271659|FG001|Initial Treatment Period (24 Months)|Death|0|||
143470974|NCT01233869|517271660|FG002|Initial Treatment Period (24 Months)|Death|0|||
143135031|NCT00916578|516041354|FG000|Overall Study|Insurance Denial|2|||
143135032|NCT01022203|516041357|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
143470975|NCT01233869|517271661|FG003|Initial Treatment Period (24 Months)|Death|0|||
143470976|NCT01233869|517271658|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
143470977|NCT01233869|517271659|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
143470978|NCT01233869|517271660|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
143470979|NCT01233869|517271661|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
143470980|NCT01233869|517271658|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
143470981|NCT01233869|517271659|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
143470982|NCT01233869|517271660|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
143135033|NCT01022203|516041358|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
143470983|NCT01233869|517271661|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
143470984|NCT01233869|517271658|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
143470985|NCT01233869|517271659|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
143470986|NCT01233869|517271660|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
143470987|NCT01233869|517271661|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
143470988|NCT01233869|517271658|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
143470989|NCT01233869|517271659|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
143470990|NCT01233869|517271660|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
143470991|NCT01233869|517271661|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
143470992|NCT01233869|517271658|FG000|Extended Treatment Period (46 Months)|Other|3|||
143470993|NCT01233869|517271659|FG001|Extended Treatment Period (46 Months)|Other|0|||
143470994|NCT01233869|517271660|FG002|Extended Treatment Period (46 Months)|Other|0|||
143470995|NCT01233869|517271661|FG003|Extended Treatment Period (46 Months)|Other|3|||
143470996|NCT01233869|517271658|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
143470997|NCT01233869|517271659|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
143470998|NCT01233869|517271660|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
143470999|NCT01233869|517271661|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
143471000|NCT04464265|517271663|FG000|Overall Study|Physician Decision|2|||
143471001|NCT00312221|517271666|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
143471002|NCT00312221|517271667|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
143471003|NCT00312221|517271668|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
143471004|NCT00312221|517271669|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
143471005|NCT00312221|517271666|FG000|Open-label Run-in Period|Adverse Event|74|||
143471006|NCT00312221|517271667|FG001|Open-label Run-in Period|Adverse Event|0|||
143471007|NCT00312221|517271668|FG002|Open-label Run-in Period|Adverse Event|0|||
143471008|NCT00312221|517271669|FG003|Open-label Run-in Period|Adverse Event|0|||
143471009|NCT00312221|517271666|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
143471010|NCT00312221|517271667|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
143471011|NCT00312221|517271668|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
143471012|NCT00312221|517271669|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
143471013|NCT00312221|517271666|FG000|Open-label Run-in Period|Administrative|42|||
143471014|NCT00312221|517271667|FG001|Open-label Run-in Period|Administrative|0|||
143471015|NCT00312221|517271668|FG002|Open-label Run-in Period|Administrative|0|||
143471016|NCT00312221|517271669|FG003|Open-label Run-in Period|Administrative|0|||
143471017|NCT00312221|517271666|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
143471018|NCT00312221|517271667|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
143471019|NCT00312221|517271668|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
143471020|NCT00312221|517271669|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
143471021|NCT00312221|517271666|FG000|Open-label Run-in Period|Did not qualify|5|||
143471022|NCT00312221|517271667|FG001|Open-label Run-in Period|Did not qualify|0|||
143471023|NCT00312221|517271668|FG002|Open-label Run-in Period|Did not qualify|0|||
143471024|NCT00312221|517271669|FG003|Open-label Run-in Period|Did not qualify|0|||
143471025|NCT00312221|517271666|FG000|Double-blind Phase|Withdrawal by Subject|0|||
143471026|NCT00312221|517271667|FG001|Double-blind Phase|Withdrawal by Subject|6|||
143471027|NCT00312221|517271668|FG002|Double-blind Phase|Withdrawal by Subject|8|||
143471028|NCT00312221|517271669|FG003|Double-blind Phase|Withdrawal by Subject|7|||
143471029|NCT00312221|517271666|FG000|Double-blind Phase|Adverse Event|0|||
143471030|NCT00312221|517271667|FG001|Double-blind Phase|Adverse Event|10|||
143471031|NCT00312221|517271668|FG002|Double-blind Phase|Adverse Event|19|||
143471032|NCT00312221|517271669|FG003|Double-blind Phase|Adverse Event|18|||
143471033|NCT00312221|517271666|FG000|Double-blind Phase|Lost to Follow-up|0|||
143471034|NCT00312221|517271667|FG001|Double-blind Phase|Lost to Follow-up|0|||
143471035|NCT00312221|517271668|FG002|Double-blind Phase|Lost to Follow-up|2|||
143471036|NCT00312221|517271669|FG003|Double-blind Phase|Lost to Follow-up|2|||
143471037|NCT00312221|517271666|FG000|Double-blind Phase|Administrative|0|||
143471038|NCT00312221|517271667|FG001|Double-blind Phase|Administrative|26|||
143471039|NCT00312221|517271668|FG002|Double-blind Phase|Administrative|37|||
143471040|NCT00312221|517271669|FG003|Double-blind Phase|Administrative|33|||
143471041|NCT00312221|517271666|FG000|Double-blind Phase|Lack of Efficacy|0|||
143471042|NCT00312221|517271667|FG001|Double-blind Phase|Lack of Efficacy|17|||
143471043|NCT00312221|517271668|FG002|Double-blind Phase|Lack of Efficacy|6|||
143135034|NCT01022203|516041357|FG000|Post Treatment Assessment|Physician Decision|2|||
143471044|NCT00312221|517271669|FG003|Double-blind Phase|Lack of Efficacy|10|||
143471045|NCT00866723|517271670|FG000|Overall Study|Withdrawal by Subject|1|||
143013991|NCT00391118|515590126|FG001|Overall Study|Sponsor Decision|1|||
143232175|NCT01446159|516402035|FG003|Overall Study|Other|13|||
143471046|NCT00866723|517271670|FG000|Overall Study|Disease Progression|4|||
143471047|NCT04178967|517271671|FG000|Induction Period|Adverse Event|4|||
143471048|NCT04178967|517271672|FG001|Induction Period|Adverse Event|6|||
143471049|NCT04178967|517271673|FG002|Induction Period|Adverse Event|0|||
143471050|NCT04178967|517271674|FG003|Induction Period|Adverse Event|0|||
143471051|NCT04178967|517271675|FG004|Induction Period|Adverse Event|0|||
143471052|NCT04178967|517271676|FG005|Induction Period|Adverse Event|0|||
143135035|NCT01022203|516041358|FG001|Post Treatment Assessment|Physician Decision|0|||
143135036|NCT01022203|516041357|FG000|Post Treatment Assessment|Adverse Event|0|||
143135037|NCT01022203|516041358|FG001|Post Treatment Assessment|Adverse Event|2|||
143135038|NCT01022203|516041357|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
143135039|NCT01022203|516041358|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
143135040|NCT01228591|516041359|FG000|Baseline|Lack of Efficacy|1|||
143135041|NCT01228591|516041360|FG001|Baseline|Lack of Efficacy|2|||
143135042|NCT03205150|516041363|FG000|Overall Study|Protocol deviation|1|||
143135043|NCT03205150|516041364|FG001|Overall Study|Protocol deviation|3|||
143135044|NCT03205150|516041365|FG002|Overall Study|Protocol deviation|0|||
143135045|NCT03205150|516041363|FG000|Overall Study|Patient/guardian decision|0|||
143135046|NCT03205150|516041364|FG001|Overall Study|Patient/guardian decision|3|||
143135047|NCT03205150|516041365|FG002|Overall Study|Patient/guardian decision|0|||
143135048|NCT03205150|516041363|FG000|Overall Study|Adverse Event|1|||
143135049|NCT03205150|516041364|FG001|Overall Study|Adverse Event|1|||
143135050|NCT03205150|516041365|FG002|Overall Study|Adverse Event|1|||
143135051|NCT03205150|516041363|FG000|Overall Study|Lost to Follow-up|0|||
143135052|NCT03205150|516041364|FG001|Overall Study|Lost to Follow-up|0|||
143135053|NCT03205150|516041365|FG002|Overall Study|Lost to Follow-up|1|||
143135054|NCT02723188|516041366|FG000|Overall Study|Withdrawal by Subject|1|||
143135055|NCT02723188|516041367|FG001|Overall Study|Withdrawal by Subject|0|||
143135056|NCT02723188|516041368|FG002|Overall Study|Withdrawal by Subject|0|||
143135057|NCT03652818|516041369|FG000|Overall Study|Adverse Event|1|||
143135058|NCT03652818|516041370|FG001|Overall Study|Adverse Event|0|||
143135059|NCT03652818|516041371|FG002|Overall Study|Adverse Event|0|||
143135060|NCT03652818|516041372|FG003|Overall Study|Adverse Event|0|||
143360926|NCT00924664|516863597|FG001|Overall Study|Withdrawal by Subject|71|||
143360927|NCT00924664|516863596|FG000|Overall Study|Protocol Violation|2|||
143360928|NCT00924664|516863597|FG001|Overall Study|Protocol Violation|5|||
143360929|NCT00924664|516863596|FG000|Overall Study|Pregnancy|1|||
143360930|NCT00924664|516863597|FG001|Overall Study|Pregnancy|1|||
143360931|NCT00924664|516863596|FG000|Overall Study|Death|0|||
143360932|NCT00924664|516863597|FG001|Overall Study|Death|2|||
143360933|NCT00924664|516863596|FG000|Overall Study|Study terminated by sponsor|199|||
143360934|NCT00924664|516863597|FG001|Overall Study|Study terminated by sponsor|330|||
143360935|NCT00924664|516863596|FG000|Overall Study|Other|29|||
143360936|NCT00924664|516863597|FG001|Overall Study|Other|52|||
143360937|NCT00924664|516863596|FG000|Overall Study|Randomized but not Treated|1|||
143360938|NCT00924664|516863597|FG001|Overall Study|Randomized but not Treated|0|||
143360939|NCT01616563|516863600|FG000|Overall Study|Lost to Follow-up|40|||
143360940|NCT01106287|516863601|FG000|Overall Study|Adverse Event|1|||
143360941|NCT01106287|516863602|FG001|Overall Study|Adverse Event|0|||
143360942|NCT01106287|516863603|FG002|Overall Study|Adverse Event|0|||
143360943|NCT01106287|516863604|FG003|Overall Study|Adverse Event|0|||
143360944|NCT00072475|516863605|FG000|Overall Study|Adverse Event|44|||
143360945|NCT00072475|516863605|FG000|Overall Study|Death|3|||
143360946|NCT00072475|516863605|FG000|Overall Study|Withdrawal by Subject|46|||
143360947|NCT00072475|516863605|FG000|Overall Study|Patient/Investigator Decision|4|||
143360948|NCT01097655|516863606|FG000|Overall Study|Withdrawal by Subject|1|||
143360949|NCT01097655|516863606|FG000|Overall Study|Subject Documented Twice|1|||
143360950|NCT01097655|516863606|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
143360951|NCT00557505|516863607|FG000|Overall Study|Death|0|||
143360952|NCT00557505|516863608|FG001|Overall Study|Death|0|||
143360953|NCT00557505|516863609|FG002|Overall Study|Death|0|||
143360954|NCT00557505|516863610|FG003|Overall Study|Death|0|||
143360955|NCT00557505|516863611|FG004|Overall Study|Death|0|||
143360956|NCT00557505|516863612|FG005|Overall Study|Death|0|||
143360957|NCT00557505|516863613|FG006|Overall Study|Death|0|||
143360958|NCT00557505|516863614|FG007|Overall Study|Death|0|||
143360959|NCT00557505|516863615|FG008|Overall Study|Death|1|||
143360960|NCT00557505|516863607|FG000|Overall Study|Adverse Event|0|||
143360961|NCT00557505|516863608|FG001|Overall Study|Adverse Event|0|||
143360962|NCT00557505|516863609|FG002|Overall Study|Adverse Event|1|||
143360963|NCT00557505|516863610|FG003|Overall Study|Adverse Event|0|||
143360964|NCT00557505|516863611|FG004|Overall Study|Adverse Event|0|||
143360965|NCT00557505|516863612|FG005|Overall Study|Adverse Event|0|||
143360966|NCT00557505|516863613|FG006|Overall Study|Adverse Event|1|||
143360967|NCT00557505|516863614|FG007|Overall Study|Adverse Event|0|||
143360968|NCT00557505|516863615|FG008|Overall Study|Adverse Event|0|||
143360969|NCT00557505|516863607|FG000|Overall Study|Global deterioration of health|1|||
143360970|NCT00557505|516863608|FG001|Overall Study|Global deterioration of health|0|||
143135061|NCT03652818|516041373|FG004|Overall Study|Adverse Event|0|||
143135062|NCT03652818|516041369|FG000|Overall Study|Physician Decision|1|||
143135063|NCT03652818|516041370|FG001|Overall Study|Physician Decision|0|||
143360971|NCT00557505|516863609|FG002|Overall Study|Global deterioration of health|0|||
143360972|NCT00557505|516863610|FG003|Overall Study|Global deterioration of health|0|||
143360973|NCT00557505|516863611|FG004|Overall Study|Global deterioration of health|0|||
143360974|NCT00557505|516863612|FG005|Overall Study|Global deterioration of health|0|||
143360975|NCT00557505|516863613|FG006|Overall Study|Global deterioration of health|0|||
143471053|NCT04178967|517271677|FG006|Induction Period|Adverse Event|0|||
143360976|NCT00557505|516863614|FG007|Overall Study|Global deterioration of health|0|||
143360977|NCT00557505|516863615|FG008|Overall Study|Global deterioration of health|0|||
143360978|NCT00557505|516863607|FG000|Overall Study|Objective progression or relapse|2|||
143360979|NCT00557505|516863608|FG001|Overall Study|Objective progression or relapse|3|||
143360980|NCT00557505|516863609|FG002|Overall Study|Objective progression or relapse|3|||
143360981|NCT00557505|516863610|FG003|Overall Study|Objective progression or relapse|2|||
143360982|NCT00557505|516863611|FG004|Overall Study|Objective progression or relapse|2|||
143360983|NCT00557505|516863612|FG005|Overall Study|Objective progression or relapse|3|||
143360984|NCT00557505|516863613|FG006|Overall Study|Objective progression or relapse|2|||
143360985|NCT00557505|516863614|FG007|Overall Study|Objective progression or relapse|5|||
143360986|NCT00557505|516863615|FG008|Overall Study|Objective progression or relapse|15|||
143360987|NCT00557505|516863607|FG000|Overall Study|Withdrawal by Subject|0|||
143360988|NCT00557505|516863608|FG001|Overall Study|Withdrawal by Subject|0|||
143360989|NCT00557505|516863609|FG002|Overall Study|Withdrawal by Subject|0|||
143360990|NCT00557505|516863610|FG003|Overall Study|Withdrawal by Subject|1|||
143360991|NCT00557505|516863611|FG004|Overall Study|Withdrawal by Subject|0|||
143360992|NCT00557505|516863612|FG005|Overall Study|Withdrawal by Subject|0|||
143360993|NCT00557505|516863613|FG006|Overall Study|Withdrawal by Subject|0|||
143360994|NCT00557505|516863614|FG007|Overall Study|Withdrawal by Subject|0|||
143360995|NCT00557505|516863615|FG008|Overall Study|Withdrawal by Subject|1|||
143360996|NCT02179918|516863616|FG000|Overall Study|Death|0|||
143360997|NCT02179918|516863617|FG001|Overall Study|Death|0|||
143360998|NCT02179918|516863618|FG002|Overall Study|Death|0|||
143360999|NCT02179918|516863619|FG003|Overall Study|Death|1|||
143361000|NCT02179918|516863620|FG004|Overall Study|Death|0|||
143361001|NCT02179918|516863616|FG000|Overall Study|Lost to Follow-up|0|||
143361002|NCT02179918|516863617|FG001|Overall Study|Lost to Follow-up|0|||
143361003|NCT02179918|516863618|FG002|Overall Study|Lost to Follow-up|1|||
143361004|NCT02179918|516863619|FG003|Overall Study|Lost to Follow-up|0|||
143361005|NCT02179918|516863620|FG004|Overall Study|Lost to Follow-up|0|||
143361006|NCT02179918|516863616|FG000|Overall Study|Progressive Disease|4|||
143361007|NCT02179918|516863617|FG001|Overall Study|Progressive Disease|1|||
143361008|NCT02179918|516863618|FG002|Overall Study|Progressive Disease|1|||
143361009|NCT02179918|516863619|FG003|Overall Study|Progressive Disease|2|||
143361010|NCT02179918|516863620|FG004|Overall Study|Progressive Disease|6|||
143361011|NCT02179918|516863616|FG000|Overall Study|Other|0|||
143361012|NCT02179918|516863617|FG001|Overall Study|Other|1|||
143361013|NCT02179918|516863618|FG002|Overall Study|Other|0|||
143361014|NCT02179918|516863619|FG003|Overall Study|Other|0|||
143361015|NCT02179918|516863620|FG004|Overall Study|Other|1|||
143361016|NCT02179918|516863616|FG000|Overall Study|Subject refused further follow-up|0|||
143361017|NCT02179918|516863617|FG001|Overall Study|Subject refused further follow-up|1|||
143361018|NCT02179918|516863618|FG002|Overall Study|Subject refused further follow-up|0|||
143361019|NCT02179918|516863619|FG003|Overall Study|Subject refused further follow-up|0|||
143361020|NCT02179918|516863620|FG004|Overall Study|Subject refused further follow-up|1|||
143361021|NCT02954575|516863624|FG000|Overall Study|Withdrawal by Subject|2|||
143361022|NCT02954575|516863624|FG000|Overall Study|Adverse Event|1|||
143361023|NCT01734382|516863629|FG000|Part 1|Adverse Event|2|||
143361024|NCT01734382|516863630|FG001|Part 1|Adverse Event|0|||
143361025|NCT01734382|516863631|FG002|Part 1|Adverse Event|0|||
143361026|NCT01734382|516863629|FG000|Part 2|Adverse Event|0|||
143361027|NCT01734382|516863630|FG001|Part 2|Adverse Event|0|||
143361028|NCT01734382|516863631|FG002|Part 2|Adverse Event|1|||
143361029|NCT01734382|516863629|FG000|Part 2|Lack of Efficacy|0|||
143361030|NCT01734382|516863630|FG001|Part 2|Lack of Efficacy|1|||
143361031|NCT01734382|516863631|FG002|Part 2|Lack of Efficacy|1|||
143361032|NCT01734382|516863629|FG000|Part 2|Other|0|||
143361033|NCT01734382|516863630|FG001|Part 2|Other|0|||
143361034|NCT01734382|516863631|FG002|Part 2|Other|1|||
143361035|NCT01734382|516863629|FG000|Part 2|Physician Decision|0|||
143361036|NCT01734382|516863630|FG001|Part 2|Physician Decision|0|||
143361037|NCT01734382|516863631|FG002|Part 2|Physician Decision|3|||
143361038|NCT01734382|516863629|FG000|Part 2|Protocol Violation|0|||
143361039|NCT01734382|516863630|FG001|Part 2|Protocol Violation|1|||
143361040|NCT01734382|516863631|FG002|Part 2|Protocol Violation|0|||
143361041|NCT01734382|516863629|FG000|Part 2|Withdrawal by Subject|0|||
143361042|NCT01734382|516863630|FG001|Part 2|Withdrawal by Subject|0|||
143361043|NCT01734382|516863631|FG002|Part 2|Withdrawal by Subject|1|||
143361044|NCT03890120|516863633|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
143361045|NCT03890120|516863634|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
143361046|NCT03890120|516863635|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
143013992|NCT00391118|515590127|FG002|Overall Study|Sponsor Decision|3|||
143135064|NCT03652818|516041371|FG002|Overall Study|Physician Decision|0|||
143135065|NCT03652818|516041372|FG003|Overall Study|Physician Decision|0|||
143361047|NCT03890120|516863636|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
143361048|NCT03890120|516863633|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
143361049|NCT03890120|516863634|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
143361050|NCT03890120|516863635|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
143471054|NCT04178967|517271678|FG007|Induction Period|Adverse Event|0|||
143471055|NCT04178967|517271679|FG008|Induction Period|Adverse Event|0|||
143471056|NCT04178967|517271680|FG009|Induction Period|Adverse Event|0|||
143471057|NCT04178967|517271681|FG010|Induction Period|Adverse Event|0|||
143471058|NCT04178967|517271671|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
143471059|NCT04178967|517271672|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
143471060|NCT04178967|517271673|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
143471061|NCT04178967|517271674|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
143471062|NCT04178967|517271675|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
143471063|NCT04178967|517271676|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
143471064|NCT04178967|517271677|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
143471065|NCT04178967|517271678|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
143471066|NCT04178967|517271679|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
143471067|NCT04178967|517271680|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
143471068|NCT04178967|517271681|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
143471069|NCT04178967|517271671|FG000|Induction Period|Lack of Efficacy|4|||
143471070|NCT04178967|517271672|FG001|Induction Period|Lack of Efficacy|1|||
143471071|NCT04178967|517271673|FG002|Induction Period|Lack of Efficacy|0|||
143471072|NCT04178967|517271674|FG003|Induction Period|Lack of Efficacy|0|||
143471073|NCT04178967|517271675|FG004|Induction Period|Lack of Efficacy|0|||
143471074|NCT04178967|517271676|FG005|Induction Period|Lack of Efficacy|0|||
143471075|NCT04178967|517271677|FG006|Induction Period|Lack of Efficacy|0|||
143471076|NCT04178967|517271678|FG007|Induction Period|Lack of Efficacy|0|||
143471077|NCT04178967|517271679|FG008|Induction Period|Lack of Efficacy|0|||
143471078|NCT04178967|517271680|FG009|Induction Period|Lack of Efficacy|0|||
143471079|NCT04178967|517271681|FG010|Induction Period|Lack of Efficacy|0|||
143471080|NCT04178967|517271671|FG000|Induction Period|Protocol Violation|0|||
143471081|NCT04178967|517271672|FG001|Induction Period|Protocol Violation|6|||
143471082|NCT04178967|517271673|FG002|Induction Period|Protocol Violation|0|||
143471083|NCT04178967|517271674|FG003|Induction Period|Protocol Violation|0|||
143471084|NCT04178967|517271675|FG004|Induction Period|Protocol Violation|0|||
143471085|NCT04178967|517271676|FG005|Induction Period|Protocol Violation|0|||
143471086|NCT04178967|517271677|FG006|Induction Period|Protocol Violation|0|||
143471087|NCT04178967|517271678|FG007|Induction Period|Protocol Violation|0|||
143471088|NCT04178967|517271679|FG008|Induction Period|Protocol Violation|0|||
143471089|NCT04178967|517271680|FG009|Induction Period|Protocol Violation|0|||
143471090|NCT04178967|517271681|FG010|Induction Period|Protocol Violation|0|||
143471091|NCT04178967|517271671|FG000|Induction Period|Withdrawal by Subject|6|||
143471092|NCT04178967|517271672|FG001|Induction Period|Withdrawal by Subject|4|||
143471093|NCT04178967|517271673|FG002|Induction Period|Withdrawal by Subject|0|||
143471094|NCT04178967|517271674|FG003|Induction Period|Withdrawal by Subject|0|||
143471095|NCT04178967|517271675|FG004|Induction Period|Withdrawal by Subject|0|||
143471096|NCT04178967|517271676|FG005|Induction Period|Withdrawal by Subject|0|||
143471097|NCT04178967|517271677|FG006|Induction Period|Withdrawal by Subject|0|||
143471098|NCT04178967|517271678|FG007|Induction Period|Withdrawal by Subject|0|||
143471099|NCT04178967|517271679|FG008|Induction Period|Withdrawal by Subject|0|||
143471100|NCT04178967|517271680|FG009|Induction Period|Withdrawal by Subject|0|||
143471101|NCT04178967|517271681|FG010|Induction Period|Withdrawal by Subject|0|||
143471102|NCT04178967|517271671|FG000|Induction Period|Lost to Follow-up|2|||
143471103|NCT04178967|517271672|FG001|Induction Period|Lost to Follow-up|0|||
143471104|NCT04178967|517271673|FG002|Induction Period|Lost to Follow-up|0|||
143471105|NCT04178967|517271674|FG003|Induction Period|Lost to Follow-up|0|||
143471106|NCT04178967|517271675|FG004|Induction Period|Lost to Follow-up|0|||
143471107|NCT04178967|517271676|FG005|Induction Period|Lost to Follow-up|0|||
143471108|NCT04178967|517271677|FG006|Induction Period|Lost to Follow-up|0|||
143471109|NCT04178967|517271678|FG007|Induction Period|Lost to Follow-up|0|||
143471110|NCT04178967|517271679|FG008|Induction Period|Lost to Follow-up|0|||
143471111|NCT04178967|517271680|FG009|Induction Period|Lost to Follow-up|0|||
143471112|NCT04178967|517271681|FG010|Induction Period|Lost to Follow-up|0|||
143471113|NCT04178967|517271671|FG000|Induction Period|Participant Missed Study Visits|0|||
143471114|NCT04178967|517271672|FG001|Induction Period|Participant Missed Study Visits|1|||
143471115|NCT04178967|517271673|FG002|Induction Period|Participant Missed Study Visits|0|||
143471116|NCT04178967|517271674|FG003|Induction Period|Participant Missed Study Visits|0|||
143471117|NCT04178967|517271675|FG004|Induction Period|Participant Missed Study Visits|0|||
143471118|NCT04178967|517271676|FG005|Induction Period|Participant Missed Study Visits|0|||
143471119|NCT04178967|517271677|FG006|Induction Period|Participant Missed Study Visits|0|||
143471120|NCT04178967|517271678|FG007|Induction Period|Participant Missed Study Visits|0|||
143013993|NCT00391118|515590125|FG000|Overall Study|Protocol Violation|1|||
143471121|NCT04178967|517271679|FG008|Induction Period|Participant Missed Study Visits|0|||
143471122|NCT04178967|517271680|FG009|Induction Period|Participant Missed Study Visits|0|||
143471123|NCT04178967|517271681|FG010|Induction Period|Participant Missed Study Visits|0|||
143471124|NCT04178967|517271671|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
143471125|NCT04178967|517271672|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
143471126|NCT04178967|517271673|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
143471127|NCT04178967|517271674|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
143135066|NCT03652818|516041373|FG004|Overall Study|Physician Decision|0|||
143135067|NCT03652818|516041369|FG000|Overall Study|Lost to Follow-up|0|||
143135068|NCT03652818|516041370|FG001|Overall Study|Lost to Follow-up|1|||
143135069|NCT03652818|516041371|FG002|Overall Study|Lost to Follow-up|2|||
143135070|NCT03652818|516041372|FG003|Overall Study|Lost to Follow-up|1|||
143135071|NCT03652818|516041373|FG004|Overall Study|Lost to Follow-up|1|||
143135072|NCT03964207|516041374|FG000|First Treatment|Withdrawal by Subject|1|||
143135073|NCT03964207|516041375|FG001|First Treatment|Withdrawal by Subject|2|||
143135074|NCT03964207|516041374|FG000|First Treatment|Protocol Violation|1|||
143135075|NCT03964207|516041375|FG001|First Treatment|Protocol Violation|0|||
143135076|NCT03964207|516041374|FG000|First Treatment|Lost to Follow-up|1|||
143135077|NCT03964207|516041375|FG001|First Treatment|Lost to Follow-up|0|||
143135078|NCT03964207|516041374|FG000|Second Treatment|Lost to Follow-up|0|||
143135079|NCT03964207|516041375|FG001|Second Treatment|Lost to Follow-up|1|||
143135080|NCT03964207|516041374|FG000|Second Treatment|Adverse Event|1|||
143135081|NCT03964207|516041375|FG001|Second Treatment|Adverse Event|2|||
143135082|NCT00830219|516041376|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
143135083|NCT00830219|516041377|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
143135084|NCT01699750|516041378|FG000|Overall Study|Withdrew Consent|0|||
143135085|NCT01699750|516041379|FG001|Overall Study|Withdrew Consent|1|||
143135086|NCT01699750|516041378|FG000|Overall Study|Other|0|||
143135087|NCT01699750|516041379|FG001|Overall Study|Other|2|||
143135088|NCT02452047|516041380|FG000|Overall Study|Adverse Event|0|||
143135089|NCT02452047|516041381|FG001|Overall Study|Adverse Event|1|||
143135090|NCT02452047|516041382|FG002|Overall Study|Adverse Event|1|||
143135091|NCT02452047|516041380|FG000|Overall Study|Death|1|||
143135092|NCT02452047|516041381|FG001|Overall Study|Death|3|||
143135093|NCT02452047|516041382|FG002|Overall Study|Death|1|||
143135094|NCT02452047|516041380|FG000|Overall Study|Physician Decision|1|||
143135095|NCT02452047|516041381|FG001|Overall Study|Physician Decision|0|||
143135096|NCT02452047|516041382|FG002|Overall Study|Physician Decision|0|||
143135097|NCT02452047|516041380|FG000|Overall Study|Lost to Follow-up|1|||
143135098|NCT02452047|516041381|FG001|Overall Study|Lost to Follow-up|1|||
143135099|NCT02452047|516041382|FG002|Overall Study|Lost to Follow-up|0|||
143135100|NCT02452047|516041380|FG000|Overall Study|Withdrawal by Subject|1|||
143135101|NCT02452047|516041381|FG001|Overall Study|Withdrawal by Subject|0|||
143135102|NCT02452047|516041382|FG002|Overall Study|Withdrawal by Subject|0|||
143135103|NCT01868646|516041384|FG000|Overall Study|Do not meet inclusion criteria|3|||
143135104|NCT01868646|516041385|FG001|Overall Study|Do not meet inclusion criteria|5|||
143135105|NCT01783743|516041386|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
143135106|NCT01783743|516041387|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
143135107|NCT01783743|516041386|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
143135108|NCT01783743|516041387|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
143135109|NCT01783743|516041386|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
143135110|NCT01783743|516041387|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
143135111|NCT03191799|516041388|FG000|Overall Study|Withdrawal by Subject|4|||
143135112|NCT03191799|516041388|FG000|Overall Study|Physician Decision|2|||
143135113|NCT03191799|516041388|FG000|Overall Study|Lost to Follow-up|1|||
143135114|NCT03191799|516041388|FG000|Overall Study|Death|2|||
143135115|NCT00728494|516041401|FG000|Overall Study|Adverse Event|7|||
143361051|NCT03890120|516863636|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
143361052|NCT03890120|516863633|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
143361053|NCT03890120|516863634|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
143361054|NCT03890120|516863635|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
143361055|NCT03890120|516863636|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
143361056|NCT03890120|516863633|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
143361057|NCT03890120|516863634|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
143361058|NCT03890120|516863635|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
143361059|NCT03890120|516863636|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
143361060|NCT03890120|516863633|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
143361061|NCT03890120|516863634|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
143361062|NCT03890120|516863635|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
143361063|NCT03890120|516863636|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
143361064|NCT03890120|516863633|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
143361065|NCT03890120|516863634|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
143471128|NCT04178967|517271675|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
143471129|NCT04178967|517271676|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
143135116|NCT00728494|516041402|FG001|Overall Study|Adverse Event|0|||
143135117|NCT00728494|516041401|FG000|Overall Study|Withdrawal by Subject|0|||
143135118|NCT00728494|516041402|FG001|Overall Study|Withdrawal by Subject|2|||
143361066|NCT03890120|516863635|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
143135119|NCT00728494|516041401|FG000|Overall Study|Lack of Efficacy|2|||
143135120|NCT00728494|516041402|FG001|Overall Study|Lack of Efficacy|4|||
143471130|NCT04178967|517271677|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
143471131|NCT04178967|517271678|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
143471132|NCT04178967|517271679|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
143471133|NCT04178967|517271680|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
143471134|NCT04178967|517271681|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
143471135|NCT04178967|517271671|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
143471136|NCT04178967|517271672|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
143135121|NCT00728494|516041401|FG000|Overall Study|No data available|0|||
143471137|NCT04178967|517271673|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
143471138|NCT04178967|517271674|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
143471139|NCT04178967|517271675|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
143471140|NCT04178967|517271676|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
143471141|NCT04178967|517271677|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
143471142|NCT04178967|517271678|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
143471143|NCT04178967|517271679|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
143471144|NCT04178967|517271680|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
143471145|NCT04178967|517271681|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
143471146|NCT04178967|517271671|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
143471147|NCT04178967|517271672|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
143471148|NCT04178967|517271673|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
143471149|NCT04178967|517271674|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
143471150|NCT04178967|517271675|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
143471151|NCT04178967|517271676|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
143471152|NCT04178967|517271677|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
143471153|NCT04178967|517271678|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
143471154|NCT04178967|517271679|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
143471155|NCT04178967|517271680|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
143471156|NCT04178967|517271681|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
143471157|NCT04178967|517271671|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
143471158|NCT04178967|517271672|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
143471159|NCT04178967|517271673|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
143471160|NCT04178967|517271674|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
143471161|NCT04178967|517271675|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
143135122|NCT00728494|516041402|FG001|Overall Study|No data available|1|||
143135123|NCT00126594|516041403|FG000|Overall Study|Ineligible|2|||
143135124|NCT00126594|516041404|FG001|Overall Study|Ineligible|0|||
143135125|NCT00126594|516041403|FG000|Overall Study|Withdrawal by Subject|0|||
143135126|NCT00126594|516041404|FG001|Overall Study|Withdrawal by Subject|4|||
143135127|NCT00126594|516041403|FG000|Overall Study|Physician Decision|1|||
143135128|NCT00126594|516041404|FG001|Overall Study|Physician Decision|3|||
143135129|NCT00126594|516041403|FG000|Overall Study|Adverse Event|7|||
143135130|NCT00126594|516041404|FG001|Overall Study|Adverse Event|5|||
143135131|NCT00126594|516041403|FG000|Overall Study|Non-compliance|0|||
143135132|NCT00126594|516041404|FG001|Overall Study|Non-compliance|1|||
143135133|NCT00126594|516041403|FG000|Overall Study|Disease Progression|29|||
143135134|NCT00126594|516041404|FG001|Overall Study|Disease Progression|24|||
143135135|NCT00853762|516041405|FG000|Overall Study|Premature Termination|16|||
143135136|NCT00853762|516041406|FG001|Overall Study|Premature Termination|15|||
143135137|NCT00853762|516041407|FG002|Overall Study|Premature Termination|14|||
143135138|NCT00853762|516041408|FG003|Overall Study|Premature Termination|21|||
143135139|NCT00853762|516041405|FG000|Overall Study|Protocol Violation|0|||
143135140|NCT00853762|516041406|FG001|Overall Study|Protocol Violation|0|||
143135141|NCT00853762|516041407|FG002|Overall Study|Protocol Violation|0|||
143135142|NCT00853762|516041408|FG003|Overall Study|Protocol Violation|1|||
143135143|NCT00853762|516041405|FG000|Overall Study|Withdrawal by Subject|0|||
143135144|NCT00853762|516041406|FG001|Overall Study|Withdrawal by Subject|0|||
143135145|NCT00853762|516041407|FG002|Overall Study|Withdrawal by Subject|1|||
143135146|NCT00853762|516041408|FG003|Overall Study|Withdrawal by Subject|0|||
143135147|NCT00853762|516041405|FG000|Overall Study|Other|0|||
143135148|NCT00853762|516041406|FG001|Overall Study|Other|2|||
143135149|NCT00853762|516041407|FG002|Overall Study|Other|0|||
143471162|NCT04178967|517271676|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
143471163|NCT04178967|517271677|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
143471164|NCT04178967|517271678|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
143135150|NCT00853762|516041408|FG003|Overall Study|Other|0|||
143135151|NCT00853762|516041405|FG000|Overall Study|Randomised but not Treated|0|||
143135152|NCT00853762|516041406|FG001|Overall Study|Randomised but not Treated|2|||
143135153|NCT00853762|516041407|FG002|Overall Study|Randomised but not Treated|2|||
143135154|NCT00853762|516041408|FG003|Overall Study|Randomised but not Treated|0|||
143135155|NCT00891813|516041413|FG000|Overall Study|Adverse Event|3|||
143135156|NCT00891813|516041413|FG000|Overall Study|Withdrawal by Subject|1|||
143135157|NCT00891813|516041413|FG000|Overall Study|Patient Noncompliance|6|||
143471165|NCT04178967|517271679|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
143471166|NCT04178967|517271680|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
143471167|NCT04178967|517271681|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
143471168|NCT04178967|517271671|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
143471169|NCT04178967|517271672|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
143471170|NCT04178967|517271673|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
143471171|NCT04178967|517271674|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
143471172|NCT04178967|517271675|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
143471173|NCT04178967|517271676|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
143471174|NCT04178967|517271677|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
143471175|NCT04178967|517271678|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
143471176|NCT04178967|517271679|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
143471177|NCT04178967|517271680|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
143471178|NCT04178967|517271681|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
143471179|NCT04178967|517271671|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
143471180|NCT04178967|517271672|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
143471181|NCT04178967|517271673|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
143471182|NCT04178967|517271674|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
143471183|NCT04178967|517271675|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
143471184|NCT04178967|517271676|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
143471185|NCT04178967|517271677|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
143471186|NCT04178967|517271678|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
143471187|NCT04178967|517271679|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
143471188|NCT04178967|517271680|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
143471189|NCT04178967|517271681|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
143471190|NCT04178967|517271671|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
143471191|NCT04178967|517271672|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
143471192|NCT04178967|517271673|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
143471193|NCT04178967|517271674|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
143471194|NCT04178967|517271675|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
143471195|NCT04178967|517271676|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
143471196|NCT04178967|517271677|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
143471197|NCT04178967|517271678|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
143471198|NCT04178967|517271679|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
143471199|NCT04178967|517271680|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
143471200|NCT04178967|517271681|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
143471201|NCT04178967|517271671|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
143471202|NCT04178967|517271672|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
143471203|NCT04178967|517271673|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
143471204|NCT04178967|517271674|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
143471205|NCT04178967|517271675|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
143471206|NCT04178967|517271676|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
143471207|NCT04178967|517271677|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
143471208|NCT04178967|517271678|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
143471209|NCT04178967|517271679|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
143471210|NCT04178967|517271680|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
143471211|NCT04178967|517271681|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
143471212|NCT04178967|517271671|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
143471213|NCT04178967|517271672|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
143471214|NCT04178967|517271673|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
143471215|NCT04178967|517271674|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
143471216|NCT04178967|517271675|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
143471217|NCT04178967|517271676|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
143471218|NCT04178967|517271677|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
143471219|NCT04178967|517271678|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
143471220|NCT04178967|517271679|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
143471221|NCT04178967|517271680|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
143471222|NCT04178967|517271681|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
143471223|NCT04178967|517271671|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
143471224|NCT04178967|517271672|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
143471225|NCT04178967|517271673|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
143471226|NCT04178967|517271674|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
143471227|NCT04178967|517271675|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
143471228|NCT04178967|517271676|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
143471229|NCT04178967|517271677|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
143135158|NCT00891813|516041413|FG000|Overall Study|Protocol Violation|2|||
143135159|NCT02456727|516041414|FG000|Overall Study|Lost to Follow-up|63|||
143135160|NCT02456727|516041415|FG001|Overall Study|Lost to Follow-up|65|||
143135161|NCT02456727|516041414|FG000|Overall Study|Death|2|||
143135162|NCT02456727|516041415|FG001|Overall Study|Death|1|||
143135163|NCT02456727|516041414|FG000|Overall Study|Withdrawal by Subject|1|||
143135164|NCT02456727|516041415|FG001|Overall Study|Withdrawal by Subject|10|||
143361067|NCT03890120|516863636|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
143361068|NCT03890120|516863633|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
143361069|NCT03890120|516863634|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
143361070|NCT03890120|516863635|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
143361071|NCT03890120|516863636|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
143361072|NCT03890120|516863633|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
143361073|NCT03890120|516863634|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
143361074|NCT03890120|516863635|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
143361075|NCT03890120|516863636|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
143361076|NCT03890120|516863633|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
143361077|NCT03890120|516863634|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
143361078|NCT03890120|516863635|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
143361079|NCT03890120|516863636|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
143361080|NCT03890120|516863633|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
143361081|NCT03890120|516863634|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
143361082|NCT03890120|516863635|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
143361083|NCT03890120|516863636|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
143361084|NCT03890120|516863633|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
143361085|NCT03890120|516863634|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
143361086|NCT03890120|516863635|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
143361087|NCT03890120|516863636|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
143361088|NCT03890120|516863633|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
143361089|NCT03890120|516863634|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
143361090|NCT03890120|516863635|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
143361091|NCT03890120|516863636|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
143361092|NCT03890120|516863633|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
143361093|NCT03890120|516863634|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
143361094|NCT03890120|516863635|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
143361095|NCT03890120|516863636|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
143361096|NCT04003974|516863637|FG000|Overall Study|Missing|1|||
143361097|NCT04003974|516863638|FG001|Overall Study|Missing|0|||
143361098|NCT04003974|516863637|FG000|Overall Study|Withdrawal by Subject|0|||
143361099|NCT04003974|516863638|FG001|Overall Study|Withdrawal by Subject|2|||
143361100|NCT02400307|516863639|FG000|Overall Study|Enrolled and Never Dosed|1|||
143361101|NCT02400307|516863640|FG001|Overall Study|Enrolled and Never Dosed|0|||
143361102|NCT01052662|516863643|FG000|Overall Study|Lost to Follow-up|15|||
143361103|NCT01052662|516863644|FG001|Overall Study|Lost to Follow-up|13|||
143361104|NCT01052662|516863645|FG002|Overall Study|Lost to Follow-up|18|||
143361105|NCT01052662|516863643|FG000|Overall Study|Withdrawal by Subject|3|||
143361106|NCT01052662|516863644|FG001|Overall Study|Withdrawal by Subject|2|||
143361107|NCT01052662|516863645|FG002|Overall Study|Withdrawal by Subject|1|||
143361108|NCT01052662|516863643|FG000|Overall Study|Pharmacy issue|1|||
143361109|NCT01052662|516863644|FG001|Overall Study|Pharmacy issue|3|||
143361110|NCT01052662|516863645|FG002|Overall Study|Pharmacy issue|3|||
143361111|NCT01052662|516863643|FG000|Overall Study|Adverse Event|1|||
143361112|NCT01052662|516863644|FG001|Overall Study|Adverse Event|1|||
143361113|NCT01052662|516863645|FG002|Overall Study|Adverse Event|0|||
143361114|NCT01052662|516863643|FG000|Overall Study|Legal Problem|2|||
143361115|NCT01052662|516863644|FG001|Overall Study|Legal Problem|0|||
143361116|NCT01052662|516863645|FG002|Overall Study|Legal Problem|0|||
143361117|NCT01052662|516863643|FG000|Overall Study|Administrative|0|||
143361118|NCT01052662|516863644|FG001|Overall Study|Administrative|3|||
143361119|NCT01052662|516863645|FG002|Overall Study|Administrative|0|||
143361120|NCT02015663|516863646|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
143361121|NCT02015663|516863647|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
143361122|NCT02015663|516863646|FG000|Overall Study|Withdrawal by Subject|1|||
143361123|NCT02015663|516863647|FG001|Overall Study|Withdrawal by Subject|0|||
143361124|NCT02015663|516863646|FG000|Overall Study|Protocol Violation|0|||
143361125|NCT02015663|516863647|FG001|Overall Study|Protocol Violation|1|||
143135165|NCT02456727|516041414|FG000|Overall Study|Never Initiated Treatment|43|||
143135166|NCT02456727|516041415|FG001|Overall Study|Never Initiated Treatment|30|||
143135167|NCT02513550|516041416|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
143135168|NCT02513550|516041417|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
143361126|NCT02015663|516863646|FG000|Overall Study|Adverse Event|3|||
143361127|NCT02015663|516863647|FG001|Overall Study|Adverse Event|0|||
143135169|NCT02513550|516041418|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
143135170|NCT02513550|516041419|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
143013994|NCT00391118|515590126|FG001|Overall Study|Protocol Violation|0|||
143135171|NCT02513550|516041420|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
143135172|NCT02513550|516041421|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
143135173|NCT02513550|516041416|FG000|Double Blind Treatment Period|Adverse Event|5|||
143135174|NCT02513550|516041417|FG001|Double Blind Treatment Period|Adverse Event|13|||
143135175|NCT02513550|516041418|FG002|Double Blind Treatment Period|Adverse Event|17|||
143135176|NCT02513550|516041419|FG003|Double Blind Treatment Period|Adverse Event|0|||
143135177|NCT02513550|516041420|FG004|Double Blind Treatment Period|Adverse Event|1|||
143135178|NCT02513550|516041421|FG005|Double Blind Treatment Period|Adverse Event|0|||
143135179|NCT02513550|516041416|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
143135180|NCT02513550|516041417|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
143135181|NCT02513550|516041418|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
143135182|NCT02513550|516041419|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
143135183|NCT02513550|516041420|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
143135184|NCT02513550|516041421|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
143135185|NCT02513550|516041416|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
143135186|NCT02513550|516041417|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
143135187|NCT02513550|516041418|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
143135188|NCT02513550|516041419|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
143135189|NCT02513550|516041420|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
143135190|NCT02513550|516041421|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
143135191|NCT02513550|516041416|FG000|Double Blind Treatment Period|Protocol Violation|1|||
143135192|NCT02513550|516041417|FG001|Double Blind Treatment Period|Protocol Violation|1|||
143135193|NCT02513550|516041418|FG002|Double Blind Treatment Period|Protocol Violation|4|||
143135194|NCT02513550|516041419|FG003|Double Blind Treatment Period|Protocol Violation|0|||
143135195|NCT02513550|516041420|FG004|Double Blind Treatment Period|Protocol Violation|0|||
143135196|NCT02513550|516041421|FG005|Double Blind Treatment Period|Protocol Violation|0|||
143135197|NCT02513550|516041416|FG000|Double Blind Treatment Period|Physician Decision|2|||
143135198|NCT02513550|516041417|FG001|Double Blind Treatment Period|Physician Decision|0|||
143135199|NCT02513550|516041418|FG002|Double Blind Treatment Period|Physician Decision|4|||
143135200|NCT02513550|516041419|FG003|Double Blind Treatment Period|Physician Decision|0|||
143135201|NCT02513550|516041420|FG004|Double Blind Treatment Period|Physician Decision|0|||
143135202|NCT02513550|516041421|FG005|Double Blind Treatment Period|Physician Decision|0|||
143135203|NCT02513550|516041416|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
143135204|NCT02513550|516041417|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
143135205|NCT02513550|516041418|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
143135206|NCT02513550|516041419|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
143361128|NCT02015663|516863646|FG000|Overall Study|Administrative problems|10|||
143361129|NCT02015663|516863647|FG001|Overall Study|Administrative problems|11|||
143361130|NCT02059161|516863653|FG000|Overall Study|Pregnancy|0|||
143361131|NCT02059161|516863654|FG001|Overall Study|Pregnancy|2|||
143361132|NCT02059161|516863653|FG000|Overall Study|Adverse Event|2|||
143361133|NCT02059161|516863654|FG001|Overall Study|Adverse Event|6|||
143361134|NCT02059161|516863653|FG000|Overall Study|Lost to Follow-up|20|||
143361135|NCT02059161|516863654|FG001|Overall Study|Lost to Follow-up|12|||
143361136|NCT02059161|516863653|FG000|Overall Study|Physician Decision|4|||
143361137|NCT02059161|516863654|FG001|Overall Study|Physician Decision|4|||
143361138|NCT02059161|516863653|FG000|Overall Study|Protocol Violation|1|||
143361139|NCT02059161|516863654|FG001|Overall Study|Protocol Violation|1|||
143361140|NCT02059161|516863653|FG000|Overall Study|Withdrawal by Subject|16|||
143361141|NCT02059161|516863654|FG001|Overall Study|Withdrawal by Subject|13|||
143361142|NCT02059161|516863653|FG000|Overall Study|Randomized in error, no study drug|0|||
143361143|NCT02059161|516863654|FG001|Overall Study|Randomized in error, no study drug|1|||
143361144|NCT02059161|516863653|FG000|Overall Study|Non-compliance with study drug|6|||
143361145|NCT02059161|516863654|FG001|Overall Study|Non-compliance with study drug|2|||
143361146|NCT03293485|516863655|FG000|Overall Study|Death|1|||
143361147|NCT03293485|516863655|FG000|Overall Study|Screen Failure|2|||
143361148|NCT03293485|516863655|FG000|Overall Study|Withdrawal by Subject|2|||
143361149|NCT00087490|516863656|FG000|Overall Study|Death|6|||
143361150|NCT00087490|516863657|FG001|Overall Study|Death|4|||
143361151|NCT00087490|516863656|FG000|Overall Study|Adverse Event|3|||
143361152|NCT00087490|516863657|FG001|Overall Study|Adverse Event|8|||
143361153|NCT00087490|516863656|FG000|Overall Study|Lack of Efficacy|0|||
143361154|NCT00087490|516863657|FG001|Overall Study|Lack of Efficacy|2|||
143361155|NCT00087490|516863656|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
143361156|NCT00087490|516863657|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
143361157|NCT00087490|516863656|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
143361158|NCT00087490|516863657|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
143013995|NCT00391118|515590127|FG002|Overall Study|Protocol Violation|0|||
143013996|NCT03252756|515590130|FG000|Overall Study|Protocol Violation|2|||
143361159|NCT00087490|516863656|FG000|Overall Study|Randomized but not treated|7|||
143135207|NCT02513550|516041420|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
143135208|NCT02513550|516041421|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
143135209|NCT02513550|516041416|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
143135210|NCT02513550|516041417|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
143471230|NCT04178967|517271678|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
143471231|NCT04178967|517271679|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
143471232|NCT04178967|517271680|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
143471233|NCT04178967|517271681|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
143471234|NCT04178967|517271671|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
143471235|NCT04178967|517271672|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
143471236|NCT04178967|517271673|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
143471237|NCT04178967|517271674|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
143471238|NCT04178967|517271675|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
143471239|NCT04178967|517271676|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
143471240|NCT04178967|517271677|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
143471241|NCT04178967|517271678|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
143471242|NCT04178967|517271679|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
143471243|NCT04178967|517271680|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
143471244|NCT04178967|517271681|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
143471245|NCT04178967|517271671|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
143471246|NCT04178967|517271672|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
143471247|NCT04178967|517271673|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
143471248|NCT04178967|517271674|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
143471249|NCT04178967|517271675|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
143471250|NCT04178967|517271676|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
143471251|NCT04178967|517271677|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
143471252|NCT04178967|517271678|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
143471253|NCT04178967|517271679|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
143471254|NCT04178967|517271680|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
143471255|NCT04178967|517271681|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
143471256|NCT04178967|517271671|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
143471257|NCT04178967|517271672|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
143471258|NCT04178967|517271673|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
143471259|NCT04178967|517271674|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
143471260|NCT04178967|517271675|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
143471261|NCT04178967|517271676|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
143471262|NCT04178967|517271677|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
143471263|NCT04178967|517271678|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
143471264|NCT04178967|517271679|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
143471265|NCT04178967|517271680|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
143471266|NCT04178967|517271681|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
143471267|NCT00628251|517271682|FG000|Randomised Part|Withdrawal by Subject|0|||
143471268|NCT00628251|517271683|FG001|Randomised Part|Withdrawal by Subject|0|||
143471269|NCT00628251|517271684|FG002|Randomised Part|Withdrawal by Subject|1|||
143471270|NCT00628251|517271682|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
143471271|NCT00628251|517271683|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
143471272|NCT00628251|517271684|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
143471273|NCT00628251|517271682|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
143471274|NCT00628251|517271683|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
143471275|NCT00628251|517271684|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
143471276|NCT00628251|517271682|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
143471277|NCT00628251|517271683|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
143471278|NCT00628251|517271684|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
143471279|NCT00628251|517271682|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
143471280|NCT00628251|517271683|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
143471281|NCT00628251|517271684|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
143471282|NCT00628251|517271682|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
143471283|NCT00628251|517271683|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
143471284|NCT00628251|517271684|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
143471285|NCT03933397|517271687|FG000|Overall Study|No emergency department visit|65|||
143471286|NCT03933397|517271688|FG001|Overall Study|No emergency department visit|71|||
143471287|NCT03933397|517271687|FG000|Overall Study|Missed emergency department visit|25|||
143471288|NCT03933397|517271688|FG001|Overall Study|Missed emergency department visit|30|||
143135211|NCT02513550|516041418|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
143135212|NCT02513550|516041419|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
143135213|NCT02513550|516041420|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
143135214|NCT02513550|516041421|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
143135215|NCT02513550|516041416|FG000|Double Blind Treatment Period|Due to personal business|2|||
143135216|NCT02513550|516041417|FG001|Double Blind Treatment Period|Due to personal business|0|||
143135217|NCT02513550|516041418|FG002|Double Blind Treatment Period|Due to personal business|1|||
143135218|NCT02513550|516041419|FG003|Double Blind Treatment Period|Due to personal business|0|||
143135219|NCT02513550|516041420|FG004|Double Blind Treatment Period|Due to personal business|0|||
143135220|NCT02513550|516041421|FG005|Double Blind Treatment Period|Due to personal business|0|||
143135221|NCT02513550|516041416|FG000|Double Blind Treatment Period|Death|1|||
143135222|NCT02513550|516041417|FG001|Double Blind Treatment Period|Death|0|||
143135223|NCT02513550|516041418|FG002|Double Blind Treatment Period|Death|2|||
143135224|NCT02513550|516041419|FG003|Double Blind Treatment Period|Death|0|||
143135225|NCT02513550|516041420|FG004|Double Blind Treatment Period|Death|0|||
143135226|NCT02513550|516041421|FG005|Double Blind Treatment Period|Death|0|||
143135227|NCT02513550|516041416|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
143135228|NCT02513550|516041417|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
143135229|NCT02513550|516041418|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
143135230|NCT02513550|516041419|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
143135231|NCT02513550|516041420|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
143135232|NCT02513550|516041421|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
143135233|NCT02513550|516041416|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
143135234|NCT02513550|516041417|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
143135235|NCT02513550|516041418|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
143135236|NCT02513550|516041419|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
143135237|NCT02513550|516041420|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
143135238|NCT02513550|516041421|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
143135239|NCT02513550|516041416|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
143135240|NCT02513550|516041417|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
143135241|NCT02513550|516041418|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
143135242|NCT02513550|516041419|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
143135243|NCT02513550|516041420|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
143135244|NCT02513550|516041421|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
143135245|NCT02513550|516041416|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
143135246|NCT02513550|516041417|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
143135247|NCT02513550|516041418|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
143135248|NCT02513550|516041419|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
143135249|NCT02513550|516041420|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
143135250|NCT02513550|516041421|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
143135251|NCT02513550|516041416|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
143135252|NCT02513550|516041417|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
143135253|NCT02513550|516041418|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
143135254|NCT02513550|516041419|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
143135255|NCT02513550|516041420|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
143135256|NCT02513550|516041421|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
143135257|NCT02513550|516041416|FG000|Post-Treatment Follow-up Period|Death|0|||
143135258|NCT02513550|516041417|FG001|Post-Treatment Follow-up Period|Death|0|||
143135259|NCT02513550|516041418|FG002|Post-Treatment Follow-up Period|Death|1|||
143135260|NCT02513550|516041419|FG003|Post-Treatment Follow-up Period|Death|0|||
143135261|NCT02513550|516041420|FG004|Post-Treatment Follow-up Period|Death|0|||
143135262|NCT02513550|516041421|FG005|Post-Treatment Follow-up Period|Death|0|||
143135263|NCT02513550|516041416|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
143135264|NCT02513550|516041417|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
143135265|NCT02513550|516041418|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
143135266|NCT02513550|516041419|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
143135267|NCT02513550|516041420|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
143135268|NCT02513550|516041421|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
143361160|NCT00087490|516863657|FG001|Overall Study|Randomized but not treated|18|||
143361161|NCT01925170|516863658|FG000|Overall Study|Unverified cancer status|53|||
143361162|NCT00761774|516863659|FG000|Overall Study|Adverse Event|17|||
143361163|NCT00761774|516863659|FG000|Overall Study|Lack of Efficacy|37|||
143361164|NCT00761774|516863659|FG000|Overall Study|Lost to Follow-up|2|||
143361165|NCT00761774|516863659|FG000|Overall Study|Withdrawal by Subject|9|||
143135269|NCT02513550|516041416|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
143135270|NCT02513550|516041417|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
143361166|NCT00761774|516863659|FG000|Overall Study|Non-compliance|4|||
143361167|NCT00761774|516863659|FG000|Overall Study|End of study|2|||
143361168|NCT00761774|516863659|FG000|Overall Study|Reclassification of seizures|1|||
143471289|NCT03933397|517271687|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
143471290|NCT03933397|517271688|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
143471291|NCT03933397|517271687|FG000|Overall Study|Withdrawal by Subject|1|||
143471292|NCT03933397|517271688|FG001|Overall Study|Withdrawal by Subject|0|||
143471293|NCT03933397|517271687|FG000|Overall Study|Physician Decision|1|||
143471294|NCT03933397|517271688|FG001|Overall Study|Physician Decision|1|||
143471295|NCT03933397|517271687|FG000|Overall Study|missing pain score|1|||
143471296|NCT03933397|517271688|FG001|Overall Study|missing pain score|1|||
143135271|NCT02513550|516041418|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
143135272|NCT02513550|516041419|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
143135273|NCT02513550|516041420|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
143471297|NCT03933397|517271687|FG000|Overall Study|Confirmed COVID-19|1|||
143471298|NCT03933397|517271688|FG001|Overall Study|Confirmed COVID-19|2|||
143471299|NCT02066051|517271690|FG000|Overall Study|Subject developed active GVHD|1|||
143471300|NCT00835120|517271695|FG000|Overall Study|Lack of Efficacy|1|||
143471301|NCT00835120|517271695|FG000|Overall Study|Lost to Follow-up|3|||
143471302|NCT00835120|517271695|FG000|Overall Study|Adverse Event|2|||
143471303|NCT00835120|517271695|FG000|Overall Study|Withdrawal by Subject|2|||
143471304|NCT02499770|517271696|FG000|Overall Study|Death|17|||
143471305|NCT02499770|517271697|FG001|Overall Study|Death|56|||
143471306|NCT02499770|517271696|FG000|Overall Study|Study completion|1|||
143471307|NCT02499770|517271697|FG001|Overall Study|Study completion|10|||
143471308|NCT02499770|517271696|FG000|Overall Study|Withdrawal by Subject|0|||
143471309|NCT02499770|517271697|FG001|Overall Study|Withdrawal by Subject|7|||
143471310|NCT02499770|517271696|FG000|Overall Study|Lost to Follow-up|0|||
143471311|NCT02499770|517271697|FG001|Overall Study|Lost to Follow-up|2|||
143471312|NCT02499770|517271696|FG000|Overall Study|Subject declined further treatment|1|||
143135274|NCT02513550|516041421|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
143135275|NCT02513550|516041416|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
143135276|NCT02513550|516041417|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
143135277|NCT02513550|516041418|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
143135278|NCT02513550|516041419|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
143135279|NCT02513550|516041420|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
143135280|NCT02513550|516041421|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
143135281|NCT01222104|516041423|FG000|Overall Study|Lost to Follow-up|37|||
143135282|NCT01222104|516041423|FG000|Overall Study|Death|10|||
143135283|NCT03575702|516041424|FG000|Overall Study|Withdrawal by Subject|1|||
143135284|NCT03575702|516041425|FG001|Overall Study|Withdrawal by Subject|1|||
143135285|NCT03575702|516041424|FG000|Overall Study|Lost to Follow-up|1|||
143135286|NCT03575702|516041425|FG001|Overall Study|Lost to Follow-up|2|||
143135287|NCT03575702|516041424|FG000|Overall Study|Protocol Violation|0|||
143135288|NCT03575702|516041425|FG001|Overall Study|Protocol Violation|1|||
143135289|NCT03575702|516041424|FG000|Overall Study|Patient non compliance|4|||
143135290|NCT03575702|516041425|FG001|Overall Study|Patient non compliance|0|||
143135291|NCT01545388|516041426|FG000|Overall Study|Adverse Event|2|||
143135292|NCT01545388|516041427|FG001|Overall Study|Adverse Event|4|||
143135293|NCT01545388|516041428|FG002|Overall Study|Adverse Event|1|||
143135294|NCT01545388|516041426|FG000|Overall Study|Lack of Efficacy|3|||
143135295|NCT01545388|516041427|FG001|Overall Study|Lack of Efficacy|2|||
143135296|NCT01545388|516041428|FG002|Overall Study|Lack of Efficacy|5|||
143135297|NCT01545388|516041426|FG000|Overall Study|Participant moved or relocated|1|||
143135298|NCT01545388|516041427|FG001|Overall Study|Participant moved or relocated|0|||
143135299|NCT01545388|516041428|FG002|Overall Study|Participant moved or relocated|0|||
143135300|NCT01545388|516041426|FG000|Overall Study|Withdrawal by Subject|1|||
143135301|NCT01545388|516041427|FG001|Overall Study|Withdrawal by Subject|4|||
143135302|NCT01545388|516041428|FG002|Overall Study|Withdrawal by Subject|2|||
143135303|NCT01545388|516041426|FG000|Overall Study|Other|1|||
143135304|NCT01545388|516041427|FG001|Overall Study|Other|1|||
143135305|NCT01545388|516041428|FG002|Overall Study|Other|0|||
143135306|NCT00072384|516041429|FG000|Overall Study|Physician Decision|1|||
143135307|NCT00072384|516041429|FG000|Overall Study|Ineligible|8|||
143135308|NCT01255163|516041430|FG000|Overall Study|Withdrawal by Subject|1|||
143135309|NCT01255163|516041431|FG001|Overall Study|Withdrawal by Subject|0|||
143135310|NCT01255163|516041430|FG000|Overall Study|Lost to Follow-up|2|||
143135311|NCT01255163|516041431|FG001|Overall Study|Lost to Follow-up|0|||
143135312|NCT01255163|516041430|FG000|Overall Study|Adverse Event|0|||
143135313|NCT01255163|516041431|FG001|Overall Study|Adverse Event|2|||
143135314|NCT01255163|516041430|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
143135315|NCT01255163|516041431|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
143471313|NCT02499770|517271697|FG001|Overall Study|Subject declined further treatment|0|||
143471314|NCT02499770|517271696|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
143471315|NCT02499770|517271697|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
143471316|NCT02499770|517271696|FG000|Overall Study|Randomized but not enrolled|0|||
143471317|NCT02499770|517271697|FG001|Overall Study|Randomized but not enrolled|1|||
143135316|NCT03834493|516041432|FG000|Overall Study|Participants Ongoing|311|||
143135317|NCT03834493|516041433|FG001|Overall Study|Participants Ongoing|324|||
143135318|NCT03834493|516041432|FG000|Overall Study|Withdrawal by Subject|20|||
143135319|NCT03834493|516041433|FG001|Overall Study|Withdrawal by Subject|17|||
143135320|NCT03834493|516041432|FG000|Overall Study|Physician Decision|1|||
143135321|NCT03834493|516041433|FG001|Overall Study|Physician Decision|0|||
143135322|NCT03834493|516041432|FG000|Overall Study|Death|289|||
143135323|NCT03834493|516041433|FG001|Overall Study|Death|282|||
143135324|NCT02277028|516041436|FG000|Overall Study|Lost to Follow-up|1|||
143135325|NCT02277028|516041437|FG001|Overall Study|Lost to Follow-up|0|||
143135326|NCT02277028|516041436|FG000|Overall Study|Withdrawal by Subject|0|||
143135327|NCT02277028|516041437|FG001|Overall Study|Withdrawal by Subject|1|||
143135328|NCT02718911|516041438|FG000|Overall Study|Adverse Event|0|||
143135329|NCT02718911|516041439|FG001|Overall Study|Adverse Event|0|||
143135330|NCT02718911|516041440|FG002|Overall Study|Adverse Event|0|||
143135331|NCT02718911|516041441|FG003|Overall Study|Adverse Event|0|||
143135332|NCT02718911|516041442|FG004|Overall Study|Adverse Event|0|||
143135333|NCT02718911|516041443|FG005|Overall Study|Adverse Event|0|||
143135334|NCT02718911|516041444|FG006|Overall Study|Adverse Event|0|||
143135335|NCT02718911|516041445|FG007|Overall Study|Adverse Event|0|||
143135336|NCT02718911|516041446|FG008|Overall Study|Adverse Event|0|||
143135337|NCT02718911|516041447|FG009|Overall Study|Adverse Event|2|||
143135338|NCT02718911|516041438|FG000|Overall Study|Death|2|||
143135339|NCT02718911|516041439|FG001|Overall Study|Death|3|||
143135340|NCT02718911|516041440|FG002|Overall Study|Death|1|||
143135341|NCT02718911|516041441|FG003|Overall Study|Death|0|||
143135342|NCT02718911|516041442|FG004|Overall Study|Death|1|||
143135343|NCT02718911|516041443|FG005|Overall Study|Death|3|||
143135344|NCT02718911|516041444|FG006|Overall Study|Death|1|||
143135345|NCT02718911|516041445|FG007|Overall Study|Death|1|||
143135346|NCT02718911|516041446|FG008|Overall Study|Death|4|||
143135347|NCT02718911|516041447|FG009|Overall Study|Death|3|||
143135348|NCT02718911|516041438|FG000|Overall Study|Lost to Follow-up|0|||
143135349|NCT02718911|516041439|FG001|Overall Study|Lost to Follow-up|0|||
143135350|NCT02718911|516041440|FG002|Overall Study|Lost to Follow-up|0|||
143135351|NCT02718911|516041441|FG003|Overall Study|Lost to Follow-up|0|||
143135352|NCT02718911|516041442|FG004|Overall Study|Lost to Follow-up|0|||
143135353|NCT02718911|516041443|FG005|Overall Study|Lost to Follow-up|0|||
143135354|NCT02718911|516041444|FG006|Overall Study|Lost to Follow-up|0|||
143135355|NCT02718911|516041445|FG007|Overall Study|Lost to Follow-up|0|||
143135356|NCT02718911|516041446|FG008|Overall Study|Lost to Follow-up|1|||
143135357|NCT02718911|516041447|FG009|Overall Study|Lost to Follow-up|0|||
143135358|NCT02718911|516041438|FG000|Overall Study|Physician Decision|2|||
143135359|NCT02718911|516041439|FG001|Overall Study|Physician Decision|0|||
143135360|NCT02718911|516041440|FG002|Overall Study|Physician Decision|1|||
143135361|NCT02718911|516041441|FG003|Overall Study|Physician Decision|1|||
143135362|NCT02718911|516041442|FG004|Overall Study|Physician Decision|0|||
143135363|NCT02718911|516041443|FG005|Overall Study|Physician Decision|0|||
143135364|NCT02718911|516041444|FG006|Overall Study|Physician Decision|0|||
143135365|NCT02718911|516041445|FG007|Overall Study|Physician Decision|1|||
143135366|NCT02718911|516041446|FG008|Overall Study|Physician Decision|2|||
143135367|NCT02718911|516041447|FG009|Overall Study|Physician Decision|1|||
143135368|NCT02718911|516041438|FG000|Overall Study|Withdrawal by Subject|0|||
143135369|NCT02718911|516041439|FG001|Overall Study|Withdrawal by Subject|0|||
143135370|NCT02718911|516041440|FG002|Overall Study|Withdrawal by Subject|0|||
143135371|NCT02718911|516041441|FG003|Overall Study|Withdrawal by Subject|0|||
143135372|NCT02718911|516041442|FG004|Overall Study|Withdrawal by Subject|1|||
143471318|NCT00671554|517271708|FG000|Overall Study|Disease progression|3|||
143471319|NCT00708175|517271716|FG000|Overall Study|Adverse Event|4|||
143471320|NCT00708175|517271717|FG001|Overall Study|Adverse Event|5|||
143471321|NCT00708175|517271716|FG000|Overall Study|Protocol Violation|2|||
143471322|NCT00708175|517271717|FG001|Overall Study|Protocol Violation|3|||
143471323|NCT00708175|517271716|FG000|Overall Study|Lost to Follow-up|5|||
143135373|NCT02718911|516041443|FG005|Overall Study|Withdrawal by Subject|0|||
143135374|NCT02718911|516041444|FG006|Overall Study|Withdrawal by Subject|0|||
143135375|NCT02718911|516041445|FG007|Overall Study|Withdrawal by Subject|0|||
143471324|NCT00708175|517271717|FG001|Overall Study|Lost to Follow-up|3|||
143135376|NCT02718911|516041446|FG008|Overall Study|Withdrawal by Subject|1|||
143135377|NCT02718911|516041447|FG009|Overall Study|Withdrawal by Subject|4|||
143135378|NCT02718911|516041438|FG000|Overall Study|Reason Not Collected|0|||
143135379|NCT02718911|516041439|FG001|Overall Study|Reason Not Collected|0|||
143135380|NCT02718911|516041440|FG002|Overall Study|Reason Not Collected|1|||
143135381|NCT02718911|516041441|FG003|Overall Study|Reason Not Collected|0|||
143135382|NCT02718911|516041442|FG004|Overall Study|Reason Not Collected|0|||
143135383|NCT02718911|516041443|FG005|Overall Study|Reason Not Collected|0|||
143135384|NCT02718911|516041444|FG006|Overall Study|Reason Not Collected|2|||
143135385|NCT02718911|516041445|FG007|Overall Study|Reason Not Collected|1|||
143471325|NCT00708175|517271716|FG000|Overall Study|Withdrawal by Subject|5|||
143471326|NCT00708175|517271717|FG001|Overall Study|Withdrawal by Subject|7|||
143471327|NCT00708175|517271716|FG000|Overall Study|BMD loss >7%|2|||
143471328|NCT00708175|517271717|FG001|Overall Study|BMD loss >7%|3|||
143471329|NCT04376060|517271720|FG000|Overall Study|Physician Decision|1|||
143471330|NCT04600336|517271723|FG000|Initial Treatment|Withdrawal by Subject|1|||
143471331|NCT04600336|517271724|FG001|Initial Treatment|Withdrawal by Subject|2|||
143471332|NCT04600336|517271725|FG002|Initial Treatment|Withdrawal by Subject|0|||
143471333|NCT04600336|517271726|FG003|Initial Treatment|Withdrawal by Subject|0|||
143471334|NCT04600336|517271723|FG000|Initial Treatment|Adverse Event|0|||
143471335|NCT04600336|517271724|FG001|Initial Treatment|Adverse Event|2|||
143471336|NCT04600336|517271725|FG002|Initial Treatment|Adverse Event|0|||
143471337|NCT04600336|517271726|FG003|Initial Treatment|Adverse Event|0|||
143471338|NCT04600336|517271723|FG000|Initial Treatment|Other complicating disease|0|||
143471339|NCT04600336|517271724|FG001|Initial Treatment|Other complicating disease|0|||
143471340|NCT04600336|517271725|FG002|Initial Treatment|Other complicating disease|1|||
143471341|NCT04600336|517271726|FG003|Initial Treatment|Other complicating disease|0|||
143471342|NCT04600336|517271723|FG000|Crossover Treatment|Withdrawal by Subject|0|||
143471343|NCT04600336|517271724|FG001|Crossover Treatment|Withdrawal by Subject|0|||
143471344|NCT04600336|517271725|FG002|Crossover Treatment|Withdrawal by Subject|2|||
143471345|NCT04600336|517271726|FG003|Crossover Treatment|Withdrawal by Subject|1|||
143471346|NCT04600336|517271723|FG000|Crossover Treatment|Adverse Event|0|||
143471347|NCT04600336|517271724|FG001|Crossover Treatment|Adverse Event|0|||
143471348|NCT04600336|517271725|FG002|Crossover Treatment|Adverse Event|1|||
143471349|NCT04600336|517271726|FG003|Crossover Treatment|Adverse Event|1|||
143471350|NCT04225806|517271727|FG000|Overall Study|Trial termination|15|||
143471351|NCT02408861|517271730|FG000|Overall Study|Death|0|||
143471352|NCT02408861|517271731|FG001|Overall Study|Death|3|||
143471353|NCT02408861|517271732|FG002|Overall Study|Death|1|||
143471354|NCT02408861|517271733|FG003|Overall Study|Death|2|||
143471355|NCT02408861|517271734|FG004|Overall Study|Death|4|||
143471356|NCT02408861|517271735|FG005|Overall Study|Death|1|||
143471357|NCT02408861|517271736|FG006|Overall Study|Death|0|||
143471358|NCT02408861|517271730|FG000|Overall Study|Lost to Follow-up|0|||
143471359|NCT02408861|517271731|FG001|Overall Study|Lost to Follow-up|0|||
143471360|NCT02408861|517271732|FG002|Overall Study|Lost to Follow-up|1|||
143471361|NCT02408861|517271733|FG003|Overall Study|Lost to Follow-up|1|||
143471362|NCT02408861|517271734|FG004|Overall Study|Lost to Follow-up|4|||
143471363|NCT02408861|517271735|FG005|Overall Study|Lost to Follow-up|2|||
143471364|NCT02408861|517271736|FG006|Overall Study|Lost to Follow-up|1|||
143471365|NCT02408861|517271730|FG000|Overall Study|Disease Progression|0|||
143471366|NCT02408861|517271731|FG001|Overall Study|Disease Progression|0|||
143471367|NCT02408861|517271732|FG002|Overall Study|Disease Progression|1|||
143471368|NCT02408861|517271733|FG003|Overall Study|Disease Progression|0|||
143471369|NCT02408861|517271734|FG004|Overall Study|Disease Progression|3|||
143471370|NCT02408861|517271735|FG005|Overall Study|Disease Progression|1|||
143471371|NCT02408861|517271736|FG006|Overall Study|Disease Progression|1|||
143471372|NCT02408861|517271730|FG000|Overall Study|Adverse Event|1|||
143471373|NCT02408861|517271731|FG001|Overall Study|Adverse Event|0|||
143471374|NCT02408861|517271732|FG002|Overall Study|Adverse Event|1|||
143471375|NCT02408861|517271733|FG003|Overall Study|Adverse Event|0|||
143471376|NCT02408861|517271734|FG004|Overall Study|Adverse Event|2|||
143471377|NCT02408861|517271735|FG005|Overall Study|Adverse Event|0|||
143471378|NCT02408861|517271736|FG006|Overall Study|Adverse Event|0|||
143471379|NCT02408861|517271730|FG000|Overall Study|Physician Decision|1|||
143471380|NCT02408861|517271731|FG001|Overall Study|Physician Decision|1|||
143471381|NCT02408861|517271732|FG002|Overall Study|Physician Decision|1|||
143471382|NCT02408861|517271733|FG003|Overall Study|Physician Decision|0|||
143471383|NCT02408861|517271734|FG004|Overall Study|Physician Decision|0|||
143471384|NCT02408861|517271735|FG005|Overall Study|Physician Decision|1|||
143471385|NCT02408861|517271736|FG006|Overall Study|Physician Decision|0|||
143471386|NCT02408861|517271730|FG000|Overall Study|Protocol Violation|1|||
143471387|NCT02408861|517271731|FG001|Overall Study|Protocol Violation|0|||
143471388|NCT02408861|517271732|FG002|Overall Study|Protocol Violation|0|||
143471389|NCT02408861|517271733|FG003|Overall Study|Protocol Violation|0|||
143471390|NCT02408861|517271734|FG004|Overall Study|Protocol Violation|0|||
143471391|NCT02408861|517271735|FG005|Overall Study|Protocol Violation|0|||
143471392|NCT02408861|517271736|FG006|Overall Study|Protocol Violation|0|||
143471393|NCT02408861|517271730|FG000|Overall Study|Withdrawal by Subject|0|||
143471394|NCT02408861|517271731|FG001|Overall Study|Withdrawal by Subject|0|||
143471395|NCT02408861|517271732|FG002|Overall Study|Withdrawal by Subject|0|||
143471396|NCT02408861|517271733|FG003|Overall Study|Withdrawal by Subject|0|||
143471397|NCT02408861|517271734|FG004|Overall Study|Withdrawal by Subject|1|||
143471398|NCT02408861|517271735|FG005|Overall Study|Withdrawal by Subject|1|||
143471399|NCT02408861|517271736|FG006|Overall Study|Withdrawal by Subject|0|||
143471400|NCT02408861|517271730|FG000|Overall Study|Other Treatment|0|||
143471401|NCT02408861|517271731|FG001|Overall Study|Other Treatment|0|||
143471402|NCT02408861|517271732|FG002|Overall Study|Other Treatment|0|||
143471403|NCT02408861|517271733|FG003|Overall Study|Other Treatment|0|||
143471404|NCT02408861|517271734|FG004|Overall Study|Other Treatment|0|||
143471405|NCT02408861|517271735|FG005|Overall Study|Other Treatment|1|||
143471406|NCT02408861|517271736|FG006|Overall Study|Other Treatment|1|||
143471407|NCT04667247|517271741|FG000|Overall Study|Withdrawal by Subject|0|||
143471408|NCT04667247|517271742|FG001|Overall Study|Withdrawal by Subject|1|||
143135386|NCT02718911|516041446|FG008|Overall Study|Reason Not Collected|4|||
143135387|NCT02718911|516041447|FG009|Overall Study|Reason Not Collected|9|||
143135388|NCT01867008|516041448|FG000|Overall Study|Withdrawal by Subject|1|||
143135389|NCT00983372|516041449|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
143471409|NCT05460273|517271743|FG000|Overall Study|Death|43|||
143471410|NCT05460273|517271744|FG001|Overall Study|Death|9|||
143471411|NCT05460273|517271743|FG000|Overall Study|Lost to Follow-up|7|||
143471412|NCT05460273|517271744|FG001|Overall Study|Lost to Follow-up|0|||
143471413|NCT05460273|517271743|FG000|Overall Study|Ongoing participants at NSCLC primary analysis DCO|0|||
143471414|NCT05460273|517271744|FG001|Overall Study|Ongoing participants at NSCLC primary analysis DCO|31|||
143471415|NCT04124614|517271745|FG000|Placebo Run-in Period|Not Randomized|34|||
143471416|NCT04124614|517271746|FG001|Placebo Run-in Period|Not Randomized|0|||
143471417|NCT04124614|517271747|FG002|Placebo Run-in Period|Not Randomized|0|||
143471418|NCT04124614|517271745|FG000|Double Blind Treatment Period|Adverse Event|0|||
143471419|NCT04124614|517271746|FG001|Double Blind Treatment Period|Adverse Event|7|||
143471420|NCT04124614|517271747|FG002|Double Blind Treatment Period|Adverse Event|22|||
143471421|NCT04124614|517271745|FG000|Double Blind Treatment Period|Death|0|||
143471422|NCT04124614|517271746|FG001|Double Blind Treatment Period|Death|0|||
143471423|NCT04124614|517271747|FG002|Double Blind Treatment Period|Death|1|||
143471424|NCT04124614|517271745|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
143471425|NCT04124614|517271746|FG001|Double Blind Treatment Period|Lost to Follow-up|18|||
143471426|NCT04124614|517271747|FG002|Double Blind Treatment Period|Lost to Follow-up|25|||
143471427|NCT04124614|517271745|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
143471428|NCT04124614|517271746|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
143471429|NCT04124614|517271747|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
143471430|NCT04124614|517271745|FG000|Double Blind Treatment Period|Physician Decision|0|||
143471431|NCT04124614|517271746|FG001|Double Blind Treatment Period|Physician Decision|0|||
143471432|NCT04124614|517271747|FG002|Double Blind Treatment Period|Physician Decision|3|||
143471433|NCT04124614|517271745|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
143471434|NCT04124614|517271746|FG001|Double Blind Treatment Period|Protocol Deviation|10|||
143471435|NCT04124614|517271747|FG002|Double Blind Treatment Period|Protocol Deviation|4|||
143471436|NCT04124614|517271745|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
143471437|NCT04124614|517271746|FG001|Double Blind Treatment Period|Withdrawal by Subject|26|||
143471438|NCT04124614|517271747|FG002|Double Blind Treatment Period|Withdrawal by Subject|22|||
143471439|NCT04124614|517271745|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
143471440|NCT04124614|517271746|FG001|Double Blind Treatment Period|Reason Not Specified|11|||
143471441|NCT04124614|517271747|FG002|Double Blind Treatment Period|Reason Not Specified|7|||
143471442|NCT05749952|517271748|FG000|Symphonie Aqua System - Non-Digital|Lost to Follow-up|2|||
143471443|NCT06950879|517271749|FG000|Overall Study|Unable to complete task due to motor impairment|1|||
143471444|NCT02113579|517273472|FG000|Overall Study|Adverse Event|1|||
143471445|NCT02113579|517273473|FG001|Overall Study|Adverse Event|0|||
143471446|NCT02113579|517273472|FG000|Overall Study|Withdrawal by Subject|3|||
143471447|NCT02113579|517273473|FG001|Overall Study|Withdrawal by Subject|2|||
143471448|NCT02113579|517273472|FG000|Overall Study|Lost to Follow-up|6|||
143471449|NCT02113579|517273473|FG001|Overall Study|Lost to Follow-up|2|||
143471450|NCT00726622|517273474|FG000|Overall Study|Withdrawal by Subject|16|||
143471451|NCT00726622|517273475|FG001|Overall Study|Withdrawal by Subject|2|||
143471452|NCT00726622|517273474|FG000|Overall Study|Physician Decision|0|||
143471453|NCT00726622|517273475|FG001|Overall Study|Physician Decision|1|||
143471454|NCT00726622|517273474|FG000|Overall Study|Metastasis|2|||
143471455|NCT00726622|517273475|FG001|Overall Study|Metastasis|0|||
143471456|NCT01016964|517273479|FG000|Overall Study|Lost to Follow-up|3|||
143471457|NCT01016964|517273480|FG001|Overall Study|Lost to Follow-up|3|||
143471458|NCT03872453|517273481|FG000|Overall Study|Adverse Event|1|||
143471459|NCT03872453|517273482|FG001|Overall Study|Adverse Event|1|||
143471460|NCT03872453|517273483|FG002|Overall Study|Adverse Event|0|||
143471461|NCT03872453|517273484|FG003|Overall Study|Adverse Event|0|||
143471462|NCT03872453|517273481|FG000|Overall Study|Lost to Follow-up|8|||
143471463|NCT03872453|517273482|FG001|Overall Study|Lost to Follow-up|7|||
143471464|NCT03872453|517273483|FG002|Overall Study|Lost to Follow-up|4|||
143471465|NCT03872453|517273484|FG003|Overall Study|Lost to Follow-up|4|||
143471466|NCT03872453|517273481|FG000|Overall Study|Never Treated Migraine|19|||
143135390|NCT00983372|516041449|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
143471467|NCT03872453|517273482|FG001|Overall Study|Never Treated Migraine|17|||
143471468|NCT03872453|517273483|FG002|Overall Study|Never Treated Migraine|13|||
143471469|NCT03872453|517273484|FG003|Overall Study|Never Treated Migraine|12|||
143471470|NCT03872453|517273481|FG000|Overall Study|Pregnancy|1|||
143471471|NCT03872453|517273482|FG001|Overall Study|Pregnancy|0|||
143471472|NCT03872453|517273483|FG002|Overall Study|Pregnancy|0|||
143471473|NCT03872453|517273484|FG003|Overall Study|Pregnancy|0|||
143471474|NCT03872453|517273481|FG000|Overall Study|Protocol Deviation|2|||
143471475|NCT03872453|517273482|FG001|Overall Study|Protocol Deviation|0|||
143471476|NCT03872453|517273483|FG002|Overall Study|Protocol Deviation|0|||
143471477|NCT03872453|517273484|FG003|Overall Study|Protocol Deviation|2|||
143471478|NCT03872453|517273481|FG000|Overall Study|Withdrawal by Subject|0|||
143471479|NCT03872453|517273482|FG001|Overall Study|Withdrawal by Subject|1|||
143471480|NCT03872453|517273483|FG002|Overall Study|Withdrawal by Subject|2|||
143471481|NCT03872453|517273484|FG003|Overall Study|Withdrawal by Subject|0|||
143471482|NCT03872453|517273481|FG000|Overall Study|Other Than Specified|1|||
143471483|NCT03872453|517273482|FG001|Overall Study|Other Than Specified|0|||
143471484|NCT03872453|517273483|FG002|Overall Study|Other Than Specified|0|||
143471485|NCT03872453|517273484|FG003|Overall Study|Other Than Specified|0|||
143471486|NCT00352885|517273485|FG000|Overall Study|Withdrawal by Subject|0|||
143471487|NCT00352885|517273486|FG001|Overall Study|Withdrawal by Subject|3|||
143471488|NCT00352885|517273485|FG000|Overall Study|Development of major depression|0|||
143471489|NCT00352885|517273486|FG001|Overall Study|Development of major depression|1|||
143471490|NCT00352885|517273485|FG000|Overall Study|Progression of metastatic melanoma|5|||
143471491|NCT00352885|517273486|FG001|Overall Study|Progression of metastatic melanoma|3|||
143471492|NCT00352885|517273485|FG000|Overall Study|Side effects of IL-2 administration|1|||
143471493|NCT00352885|517273486|FG001|Overall Study|Side effects of IL-2 administration|0|||
143471494|NCT03873493|517273487|FG000|Overall Study|Withdrawal by Subject|1|||
143471495|NCT03873493|517273487|FG000|Overall Study|Death|9|||
143471496|NCT03873493|517273487|FG000|Overall Study|Lost to Follow-up|1|||
143471497|NCT03873493|517273487|FG000|Overall Study|Study Terminated by Sponsor|1|||
143471498|NCT03873493|517273487|FG000|Overall Study|Other|2|||
143471499|NCT00440700|517273491|FG000|Overall Study|Withdrawal by Subject|8|||
143471500|NCT00440700|517273492|FG001|Overall Study|Withdrawal by Subject|8|||
143471501|NCT00440700|517273493|FG002|Overall Study|Withdrawal by Subject|4|||
143471502|NCT01096342|517273494|FG000|Overall Study|Protocol Violation|1|||
143471503|NCT04906616|517273495|FG000|Overall Study|Divorce|3|||
143471504|NCT04906616|517273496|FG001|Overall Study|Divorce|2|||
143471505|NCT00929656|517273497|FG000|Overall Study|Lost to Follow-up|0|||
143471506|NCT00929656|517273498|FG001|Overall Study|Lost to Follow-up|1|||
143471507|NCT00698451|517273509|FG000|Overall Study|Adverse Event|22|||
143471508|NCT00698451|517273509|FG000|Overall Study|Physician Decision|2|||
143471509|NCT00698451|517273509|FG000|Overall Study|Protocol Violation|6|||
143471510|NCT00698451|517273509|FG000|Overall Study|Withdrawal by Subject|6|||
143471511|NCT00698451|517273509|FG000|Overall Study|Disease progression|3|||
143471512|NCT00733304|517273512|FG000|Overall Study|Adverse Event|3|||
143471513|NCT00733304|517273513|FG001|Overall Study|Adverse Event|0|||
143471514|NCT00733304|517273514|FG002|Overall Study|Adverse Event|0|||
143471515|NCT00733304|517273512|FG000|Overall Study|Lack of Efficacy|0|||
143471516|NCT00733304|517273513|FG001|Overall Study|Lack of Efficacy|0|||
143471517|NCT00733304|517273514|FG002|Overall Study|Lack of Efficacy|2|||
143471518|NCT00733304|517273512|FG000|Overall Study|Lost to Follow-up|0|||
143471519|NCT00733304|517273513|FG001|Overall Study|Lost to Follow-up|1|||
143471520|NCT00733304|517273514|FG002|Overall Study|Lost to Follow-up|0|||
143471521|NCT00733304|517273512|FG000|Overall Study|Physician Decision|3|||
143471522|NCT00733304|517273513|FG001|Overall Study|Physician Decision|1|||
143471523|NCT00733304|517273514|FG002|Overall Study|Physician Decision|3|||
143471524|NCT00733304|517273512|FG000|Overall Study|Withdrawal by Subject|1|||
143471525|NCT00733304|517273513|FG001|Overall Study|Withdrawal by Subject|1|||
143471526|NCT00733304|517273514|FG002|Overall Study|Withdrawal by Subject|0|||
143471527|NCT01187550|517273515|FG000|Overall Study|Protocol Violation|3|||
143471528|NCT01187550|517273516|FG001|Overall Study|Protocol Violation|1|||
143471529|NCT01187550|517273515|FG000|Overall Study|Other|3|||
143471530|NCT01187550|517273516|FG001|Overall Study|Other|0|||
143471531|NCT01187550|517273515|FG000|Overall Study|Randomized but not treated|8|||
143471532|NCT01187550|517273516|FG001|Overall Study|Randomized but not treated|0|||
143471533|NCT02445755|517273526|FG000|Overall Study|Withdrawal by Subject|2|||
143471534|NCT02445755|517273526|FG000|Overall Study|Protocol Violation|6|||
143471535|NCT02445755|517273526|FG000|Overall Study|Screen Failure|5|||
143471536|NCT01438151|517273527|FG000|Overall Study|study terminated|8|||
143471537|NCT02459769|517273528|FG000|Overall Study|Withdrawal by Subject|7|||
143135391|NCT00983372|516041449|FG000|Diltiazem ER Alone|Adverse Event|1|||
143135392|NCT01534273|516041452|FG000|Period 1|Physician Decision|0|||
143135393|NCT01534273|516041453|FG001|Period 1|Physician Decision|0|||
143135394|NCT01534273|516041454|FG002|Period 1|Physician Decision|0|||
143135395|NCT01534273|516041455|FG003|Period 1|Physician Decision|1|||
143471538|NCT02459769|517273529|FG001|Overall Study|Withdrawal by Subject|4|||
143471539|NCT02459769|517273530|FG002|Overall Study|Withdrawal by Subject|8|||
143471540|NCT02459769|517273531|FG003|Overall Study|Withdrawal by Subject|5|||
143471541|NCT02459769|517273528|FG000|Overall Study|Lost to Follow-up|1|||
143471542|NCT02459769|517273529|FG001|Overall Study|Lost to Follow-up|0|||
143471543|NCT02459769|517273530|FG002|Overall Study|Lost to Follow-up|1|||
143471544|NCT02459769|517273531|FG003|Overall Study|Lost to Follow-up|0|||
143471545|NCT02060721|517273532|FG000|Overall Study|Lost to Follow-up|1|||
143471546|NCT02060721|517273532|FG000|Overall Study|Physician Decision|2|||
143471547|NCT02060721|517273532|FG000|Overall Study|Death|14|||
143471548|NCT02060721|517273532|FG000|Overall Study|Withdrawal by Subject|2|||
143471549|NCT02060721|517273532|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
143471550|NCT00041067|517273536|FG000|Overall Study|Adverse Event|20|||
143471551|NCT00041067|517273536|FG000|Overall Study|Progression|19|||
143135396|NCT01534273|516041456|FG004|Period 1|Physician Decision|0|||
143135397|NCT01534273|516041457|FG005|Period 1|Physician Decision|0|||
143135398|NCT01534273|516041458|FG006|Period 1|Physician Decision|0|||
143135399|NCT01619865|516041459|FG000|Overall Study|Adverse Event|1|||
143135400|NCT01619865|516041459|FG000|Overall Study|Death|2|||
143135401|NCT01619865|516041459|FG000|Overall Study|subject not able to comply|1|||
143135402|NCT03586050|516041460|FG000|Overall Study|Death|3|||
143135403|NCT03586050|516041460|FG000|Overall Study|Withdrawal by Subject|2|||
143135404|NCT01494818|516041461|FG000|Overall Study|Relocation|1|||
143135405|NCT01494818|516041462|FG001|Overall Study|Relocation|2|||
143135406|NCT01494818|516041461|FG000|Overall Study|Lost to Follow-up|1|||
143135407|NCT01494818|516041462|FG001|Overall Study|Lost to Follow-up|0|||
143135408|NCT00791999|516041463|FG000|Overall Study|Protocol planed withdrawal|14|||
143135409|NCT00791999|516041464|FG001|Overall Study|Protocol planed withdrawal|11|||
143135410|NCT00791999|516041465|FG002|Overall Study|Protocol planed withdrawal|11|||
143135411|NCT00791999|516041466|FG003|Overall Study|Protocol planed withdrawal|45|||
143135412|NCT00791999|516041463|FG000|Overall Study|Withdrawal by Subject|0|||
143135413|NCT00791999|516041464|FG001|Overall Study|Withdrawal by Subject|1|||
143135414|NCT00791999|516041465|FG002|Overall Study|Withdrawal by Subject|0|||
143135415|NCT00791999|516041466|FG003|Overall Study|Withdrawal by Subject|2|||
143135416|NCT00791999|516041463|FG000|Overall Study|Protocol Violation|3|||
143135417|NCT00791999|516041464|FG001|Overall Study|Protocol Violation|0|||
143135418|NCT00791999|516041465|FG002|Overall Study|Protocol Violation|1|||
143135419|NCT00791999|516041466|FG003|Overall Study|Protocol Violation|0|||
143135420|NCT00791999|516041463|FG000|Overall Study|Adverse Event|3|||
143135421|NCT00791999|516041464|FG001|Overall Study|Adverse Event|3|||
143135422|NCT00791999|516041465|FG002|Overall Study|Adverse Event|7|||
143135423|NCT00791999|516041466|FG003|Overall Study|Adverse Event|3|||
143135424|NCT00791999|516041463|FG000|Overall Study|Lack of Efficacy|0|||
143135425|NCT00791999|516041464|FG001|Overall Study|Lack of Efficacy|1|||
143135426|NCT00791999|516041465|FG002|Overall Study|Lack of Efficacy|0|||
143135427|NCT00791999|516041466|FG003|Overall Study|Lack of Efficacy|2|||
143135428|NCT00791999|516041463|FG000|Overall Study|Reason other than those above|1|||
143135429|NCT00791999|516041464|FG001|Overall Study|Reason other than those above|0|||
143135430|NCT00791999|516041465|FG002|Overall Study|Reason other than those above|1|||
143135431|NCT00791999|516041466|FG003|Overall Study|Reason other than those above|0|||
143135432|NCT00570401|516041467|FG000|Overall Study|Adverse Event|2|||
143135433|NCT01710020|516041468|FG000|Period 1|Protocol Violation|1|||
143135434|NCT01764841|516041469|FG000|Overall Study|Logistical Difficulties|0|||
143135435|NCT01764841|516041470|FG001|Overall Study|Logistical Difficulties|1|||
143135436|NCT01764841|516041471|FG002|Overall Study|Logistical Difficulties|0|||
143135437|NCT01764841|516041472|FG003|Overall Study|Logistical Difficulties|0|||
143135438|NCT01764841|516041469|FG000|Overall Study|Death|3|||
143135439|NCT01764841|516041470|FG001|Overall Study|Death|0|||
143135440|NCT01764841|516041471|FG002|Overall Study|Death|1|||
143135441|NCT01764841|516041472|FG003|Overall Study|Death|4|||
143471552|NCT00041067|517273536|FG000|Overall Study|Patient refusal|12|||
143471553|NCT00041067|517273536|FG000|Overall Study|Other reasons|23|||
143471554|NCT00041067|517273536|FG000|Overall Study|Ineligible|2|||
143471555|NCT01251120|517273537|FG000|Overall Study|Lack of Efficacy|0|||
143471556|NCT01251120|517273538|FG001|Overall Study|Lack of Efficacy|1|||
143471557|NCT01822522|517273539|FG000|Overall Study|Adverse Event|1|||
143471558|NCT01822522|517273540|FG001|Overall Study|Adverse Event|1|||
143471559|NCT01822522|517273541|FG002|Overall Study|Adverse Event|1|||
143471560|NCT01822522|517273542|FG003|Overall Study|Adverse Event|0|||
143471561|NCT01822522|517273543|FG004|Overall Study|Adverse Event|0|||
143471562|NCT01822522|517273544|FG005|Overall Study|Adverse Event|1|||
143471563|NCT01822522|517273539|FG000|Overall Study|Death|3|||
143471564|NCT01822522|517273540|FG001|Overall Study|Death|0|||
143471565|NCT01822522|517273541|FG002|Overall Study|Death|2|||
143471566|NCT01822522|517273542|FG003|Overall Study|Death|0|||
143471567|NCT01822522|517273543|FG004|Overall Study|Death|0|||
143135442|NCT01764841|516041469|FG000|Overall Study|No Follow Up|1|||
143135443|NCT01764841|516041470|FG001|Overall Study|No Follow Up|0|||
143471568|NCT01822522|517273544|FG005|Overall Study|Death|0|||
143135444|NCT01764841|516041471|FG002|Overall Study|No Follow Up|1|||
143135445|NCT01764841|516041472|FG003|Overall Study|No Follow Up|0|||
143135446|NCT01764841|516041469|FG000|Overall Study|Protocol Violation|0|||
143135447|NCT01764841|516041470|FG001|Overall Study|Protocol Violation|1|||
143471569|NCT01822522|517273539|FG000|Overall Study|Lost to Follow-up|0|||
143135448|NCT01764841|516041471|FG002|Overall Study|Protocol Violation|0|||
143135449|NCT01764841|516041472|FG003|Overall Study|Protocol Violation|0|||
143135450|NCT01764841|516041469|FG000|Overall Study|Withdrawal by Subject|16|||
143135451|NCT01764841|516041470|FG001|Overall Study|Withdrawal by Subject|24|||
143135452|NCT01764841|516041471|FG002|Overall Study|Withdrawal by Subject|11|||
143135453|NCT01764841|516041472|FG003|Overall Study|Withdrawal by Subject|15|||
143471570|NCT01822522|517273540|FG001|Overall Study|Lost to Follow-up|0|||
143471571|NCT01822522|517273541|FG002|Overall Study|Lost to Follow-up|1|||
143471572|NCT01822522|517273542|FG003|Overall Study|Lost to Follow-up|1|||
143471573|NCT01822522|517273543|FG004|Overall Study|Lost to Follow-up|0|||
143471574|NCT01822522|517273544|FG005|Overall Study|Lost to Follow-up|1|||
143471575|NCT01822522|517273539|FG000|Overall Study|Withdrawal by Subject|0|||
143471576|NCT01822522|517273540|FG001|Overall Study|Withdrawal by Subject|0|||
143471577|NCT01822522|517273541|FG002|Overall Study|Withdrawal by Subject|0|||
143471578|NCT01822522|517273542|FG003|Overall Study|Withdrawal by Subject|1|||
143471579|NCT01822522|517273543|FG004|Overall Study|Withdrawal by Subject|0|||
143471580|NCT01822522|517273544|FG005|Overall Study|Withdrawal by Subject|0|||
143471581|NCT01822522|517273539|FG000|Overall Study|Lack of Efficacy|0|||
143471582|NCT01822522|517273540|FG001|Overall Study|Lack of Efficacy|0|||
143471583|NCT01822522|517273541|FG002|Overall Study|Lack of Efficacy|0|||
143471584|NCT01822522|517273542|FG003|Overall Study|Lack of Efficacy|0|||
143471585|NCT01822522|517273543|FG004|Overall Study|Lack of Efficacy|0|||
143471586|NCT01822522|517273544|FG005|Overall Study|Lack of Efficacy|2|||
143471587|NCT01807923|517273545|FG000|Overall Study|Adverse Event|2|||
143471588|NCT01807923|517273546|FG001|Overall Study|Adverse Event|1|||
143471589|NCT01807923|517273547|FG002|Overall Study|Adverse Event|2|||
143471590|NCT01807923|517273545|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
143471591|NCT01807923|517273546|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
143471592|NCT01807923|517273547|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
143471593|NCT01807923|517273545|FG000|Overall Study|Physician Decision|0|||
143471594|NCT01807923|517273546|FG001|Overall Study|Physician Decision|0|||
143471595|NCT01807923|517273547|FG002|Overall Study|Physician Decision|1|||
143471596|NCT01807923|517273545|FG000|Overall Study|Not Eligible (Genotype)|0|||
143471597|NCT01807923|517273546|FG001|Overall Study|Not Eligible (Genotype)|0|||
143471598|NCT01807923|517273547|FG002|Overall Study|Not Eligible (Genotype)|1|||
143471599|NCT01807923|517273545|FG000|Overall Study|Randomized But Not Treated|3|||
143471600|NCT01807923|517273546|FG001|Overall Study|Randomized But Not Treated|2|||
143471601|NCT01807923|517273547|FG002|Overall Study|Randomized But Not Treated|5|||
143471602|NCT02558231|517273548|FG000|Overall Study|Death|4|||
143471603|NCT02558231|517273549|FG001|Overall Study|Death|12|||
143471604|NCT02558231|517273548|FG000|Overall Study|Lost to Follow-up|7|||
143471605|NCT02558231|517273549|FG001|Overall Study|Lost to Follow-up|4|||
143471606|NCT02558231|517273548|FG000|Overall Study|Withdrawal by Subject|7|||
143471607|NCT02558231|517273549|FG001|Overall Study|Withdrawal by Subject|4|||
143471608|NCT02558231|517273548|FG000|Overall Study|Physician Decision|7|||
143135454|NCT01764841|516041469|FG000|Overall Study|Lost to Follow-up|3|||
143135455|NCT01764841|516041470|FG001|Overall Study|Lost to Follow-up|0|||
143135456|NCT01764841|516041471|FG002|Overall Study|Lost to Follow-up|1|||
143135457|NCT01764841|516041472|FG003|Overall Study|Lost to Follow-up|0|||
143135458|NCT04010461|516041473|FG000|Overall Study|COVID based withdrawal|5|||
143135459|NCT04010461|516041473|FG000|Overall Study|Withdrawal by Subject|5|||
143135460|NCT04010461|516041473|FG000|Overall Study|Adverse Event|1|||
143135461|NCT04010461|516041473|FG000|Overall Study|No Motor Threshold obtainable|1|||
143135462|NCT04010461|516041473|FG000|Overall Study|Physician Decision|1|||
143135463|NCT00102596|516041474|FG000|Part A|Screen failures|6|||
143135464|NCT00102596|516041475|FG001|Part A|Screen failures|0|||
143135465|NCT00102596|516041474|FG000|Part A|Adverse Event|1|||
143135466|NCT00102596|516041475|FG001|Part A|Adverse Event|0|||
143135467|NCT00248651|516041476|FG000|Overall Study|Withdrawal by Subject|28|||
143135468|NCT00248651|516041477|FG001|Overall Study|Withdrawal by Subject|40|||
143135469|NCT00248651|516041478|FG002|Overall Study|Withdrawal by Subject|32|||
143135470|NCT02688933|516041479|FG000|Overall Study|Adverse Event|3|||
143135471|NCT02688933|516041480|FG001|Overall Study|Adverse Event|1|||
143135472|NCT02688933|516041479|FG000|Overall Study|Lack of Efficacy|2|||
143135473|NCT02688933|516041480|FG001|Overall Study|Lack of Efficacy|2|||
143135474|NCT02688933|516041479|FG000|Overall Study|Poor compliance to protocol|7|||
143135475|NCT02688933|516041480|FG001|Overall Study|Poor compliance to protocol|4|||
143135476|NCT02688933|516041479|FG000|Overall Study|Hypoglycemia|2|||
143135477|NCT02688933|516041480|FG001|Overall Study|Hypoglycemia|0|||
143135478|NCT02688933|516041479|FG000|Overall Study|Other than Specified|14|||
143135479|NCT02688933|516041480|FG001|Overall Study|Other than Specified|25|||
143135480|NCT02688933|516041479|FG000|Overall Study|Lost to Follow-up|1|||
143135481|NCT02688933|516041480|FG001|Overall Study|Lost to Follow-up|5|||
143135482|NCT05547386|516041481|FG000|Overall Study|Withdrawal by Subject|7|||
143135483|NCT04622969|516041482|FG000|Overall Study|Withdrawal by Subject|2|||
143135484|NCT04622969|516041483|FG001|Overall Study|Withdrawal by Subject|3|||
143135485|NCT05116202|516041484|FG000|Overall Study|Study Terminated by Sponsor|21|||
143135486|NCT05116202|516041485|FG001|Overall Study|Study Terminated by Sponsor|38|||
143135487|NCT05116202|516041486|FG002|Overall Study|Study Terminated by Sponsor|17|||
143471609|NCT02558231|517273549|FG001|Overall Study|Physician Decision|5|||
143471610|NCT02558231|517273548|FG000|Overall Study|Sponsor Decision|0|||
143471611|NCT02558231|517273549|FG001|Overall Study|Sponsor Decision|1|||
143471612|NCT00995007|517273550|FG000|Overall Study|Withdrew consent|1|||
143471613|NCT00995007|517273551|FG001|Overall Study|Withdrew consent|0|||
143471614|NCT00995007|517273550|FG000|Overall Study|Refused further treatment|8|||
143135488|NCT05116202|516041487|FG003|Overall Study|Study Terminated by Sponsor|18|||
143471615|NCT00995007|517273551|FG001|Overall Study|Refused further treatment|2|||
143471616|NCT00995007|517273550|FG000|Overall Study|Toxicity|8|||
143135489|NCT05116202|516041488|FG004|Overall Study|Study Terminated by Sponsor|0|||
143471617|NCT00995007|517273551|FG001|Overall Study|Toxicity|0|||
143471618|NCT04029116|517273552|FG000|Overall Study|Adverse Event|0|||
143471619|NCT04029116|517273553|FG001|Overall Study|Adverse Event|2|||
143471620|NCT04029116|517273552|FG000|Overall Study|Lost to Follow-up|3|||
143135490|NCT05116202|516041484|FG000|Overall Study|Withdrawal by Subject|0|||
143135491|NCT05116202|516041485|FG001|Overall Study|Withdrawal by Subject|1|||
143135492|NCT05116202|516041486|FG002|Overall Study|Withdrawal by Subject|1|||
143135493|NCT05116202|516041487|FG003|Overall Study|Withdrawal by Subject|1|||
143135494|NCT05116202|516041488|FG004|Overall Study|Withdrawal by Subject|1|||
143135495|NCT05116202|516041484|FG000|Overall Study|Lost to Follow-up|0|||
143135496|NCT05116202|516041485|FG001|Overall Study|Lost to Follow-up|0|||
143135497|NCT05116202|516041486|FG002|Overall Study|Lost to Follow-up|0|||
143135498|NCT05116202|516041487|FG003|Overall Study|Lost to Follow-up|0|||
143135499|NCT05116202|516041488|FG004|Overall Study|Lost to Follow-up|2|||
143135500|NCT05116202|516041484|FG000|Overall Study|Death|1|||
143135501|NCT05116202|516041485|FG001|Overall Study|Death|1|||
143135502|NCT05116202|516041486|FG002|Overall Study|Death|2|||
143135503|NCT05116202|516041487|FG003|Overall Study|Death|1|||
143135504|NCT05116202|516041488|FG004|Overall Study|Death|5|||
143135505|NCT04391842|516041489|FG000|Overall Study|Withdrawal by Subject|2|||
143135506|NCT00810199|516041490|FG000|Overall Study|Adverse Event|24|||
143135507|NCT00810199|516041491|FG001|Overall Study|Adverse Event|26|||
143135508|NCT00810199|516041490|FG000|Overall Study|Death|4|||
143135509|NCT00810199|516041491|FG001|Overall Study|Death|6|||
143135510|NCT00810199|516041490|FG000|Overall Study|Withdrew consent|9|||
143135511|NCT00810199|516041491|FG001|Overall Study|Withdrew consent|12|||
143135512|NCT00810199|516041490|FG000|Overall Study|Insufficient therapeutic response|5|||
143135513|NCT00810199|516041491|FG001|Overall Study|Insufficient therapeutic response|14|||
143135514|NCT00810199|516041490|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
143135515|NCT00810199|516041491|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
143471621|NCT04029116|517273553|FG001|Overall Study|Lost to Follow-up|5|||
143471622|NCT04029116|517273552|FG000|Overall Study|Physician Decision|2|||
143471623|NCT04029116|517273553|FG001|Overall Study|Physician Decision|0|||
143471624|NCT04029116|517273552|FG000|Overall Study|Pregnancy|1|||
143471625|NCT04029116|517273553|FG001|Overall Study|Pregnancy|2|||
143471626|NCT04029116|517273552|FG000|Overall Study|Withdrawal by Subject|4|||
143471627|NCT04029116|517273553|FG001|Overall Study|Withdrawal by Subject|6|||
143471628|NCT04029116|517273552|FG000|Overall Study|Other|2|||
143471629|NCT04029116|517273553|FG001|Overall Study|Other|1|||
143471630|NCT02469896|517273554|FG000|Overall Study|Withdrawal by Subject|2|||
143471631|NCT02469896|517273555|FG001|Overall Study|Withdrawal by Subject|0|||
143471632|NCT01294150|517273556|FG000|Overall Study|Physician Decision|2|||
143471633|NCT01294150|517273557|FG001|Overall Study|Physician Decision|2|||
143471634|NCT03675776|517273558|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
143471635|NCT03675776|517273559|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
143471636|NCT03675776|517273560|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
143471637|NCT03675776|517273558|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
143471638|NCT03675776|517273559|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
143471639|NCT03675776|517273560|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
143471640|NCT02401412|517273561|FG000|Overall Study|Lost to Follow-up|1|||
143471641|NCT02401412|517273562|FG001|Overall Study|Lost to Follow-up|0|||
143471642|NCT02401412|517273561|FG000|Overall Study|Discontinued Intervention|15|||
143471643|NCT02401412|517273562|FG001|Overall Study|Discontinued Intervention|21|||
143471644|NCT02401412|517273561|FG000|Overall Study|Withdrawal by Subject|4|||
143471645|NCT02401412|517273562|FG001|Overall Study|Withdrawal by Subject|4|||
143471646|NCT02401412|517273561|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
143471647|NCT02401412|517273562|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
143471648|NCT02401412|517273561|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
143135516|NCT00810199|516041490|FG000|Overall Study|Administrative/Other|5|||
143135517|NCT00810199|516041491|FG001|Overall Study|Administrative/Other|6|||
143135518|NCT00810199|516041490|FG000|Overall Study|Protocol Violation|2|||
143135519|NCT00810199|516041491|FG001|Overall Study|Protocol Violation|6|||
143135520|NCT00810199|516041490|FG000|Overall Study|Failure to return|1|||
143135521|NCT00810199|516041491|FG001|Overall Study|Failure to return|4|||
143135522|NCT00810199|516041490|FG000|Overall Study|Did not receive study drug|2|||
143135523|NCT00810199|516041491|FG001|Overall Study|Did not receive study drug|1|||
143471649|NCT02401412|517273562|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
143471650|NCT00882310|517273563|FG000|Overall Study|Screen Failure|10|||
143471651|NCT00882310|517273563|FG000|Overall Study|Never received treatment|1|||
143135524|NCT00992017|516041493|FG000|Overall Study|Lost to Follow-up|2|||
143135525|NCT00992017|516041493|FG000|Overall Study|Withdrawal by Subject|2|||
143135526|NCT00992017|516041493|FG000|Overall Study|Unable to get to clinic|5|||
143135527|NCT00992017|516041493|FG000|Overall Study|Not adhere to study requirements|1|||
143135528|NCT02864407|516041494|FG000|Overall Study|Protocol Violation|3|||
143471652|NCT00882310|517273563|FG000|Overall Study|Death|6|||
143471653|NCT00882310|517273563|FG000|Overall Study|Progression of disease|4|||
143471654|NCT00882310|517273563|FG000|Overall Study|Adverse Event|1|||
143471655|NCT04513665|517273566|FG000|Overall Study|Adverse Event|2|||
143471656|NCT04513665|517273567|FG001|Overall Study|Adverse Event|0|||
143471657|NCT04513665|517273566|FG000|Overall Study|Lack of Efficacy|14|||
143471658|NCT04513665|517273567|FG001|Overall Study|Lack of Efficacy|0|||
143471659|NCT02014740|517273568|FG000|Overall Study|Lost to Follow-up|4|||
143471660|NCT02014740|517273569|FG001|Overall Study|Lost to Follow-up|4|||
143471661|NCT02014740|517273568|FG000|Overall Study|Withdrawal by Subject|2|||
143471662|NCT02014740|517273569|FG001|Overall Study|Withdrawal by Subject|1|||
143471663|NCT02608879|517273570|FG000|Overall Study|Lost to Follow-up|1|||
143471664|NCT02608879|517273571|FG001|Overall Study|Lost to Follow-up|0|||
143135529|NCT02864407|516041494|FG000|Overall Study|Lost to Follow-up|115|||
143135530|NCT02864407|516041494|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
143135531|NCT02864407|516041494|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
143135532|NCT02864407|516041494|FG000|Overall Study|Consent prior to the contract date|1|||
143135533|NCT04577794|516041495|FG000|Overall Study|Adverse Event|1|||
143135534|NCT04577794|516041496|FG001|Overall Study|Adverse Event|1|||
143135535|NCT02849080|516041499|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
143135536|NCT02849080|516041500|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
143135537|NCT02849080|516041501|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
143135538|NCT02849080|516041502|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
143135539|NCT02849080|516041499|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
143135540|NCT02849080|516041500|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
143135541|NCT02849080|516041501|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
143135542|NCT02849080|516041502|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
143135543|NCT02849080|516041499|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
143135544|NCT02849080|516041500|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
143135545|NCT02849080|516041501|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
143135546|NCT02849080|516041502|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
143135547|NCT02849080|516041499|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
143471665|NCT02608879|517273572|FG002|Overall Study|Lost to Follow-up|0|||
143471666|NCT02608879|517273570|FG000|Overall Study|Did not meet continuation criteria|0|||
143471667|NCT02608879|517273571|FG001|Overall Study|Did not meet continuation criteria|0|||
143471668|NCT02608879|517273572|FG002|Overall Study|Did not meet continuation criteria|3|||
143471669|NCT02742766|517273579|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
143471670|NCT02742766|517273580|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
143471671|NCT02742766|517273581|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
143471672|NCT02742766|517273582|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
143471673|NCT02742766|517273583|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
143471674|NCT02742766|517273584|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
143471675|NCT02742766|517273585|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
143471676|NCT02742766|517273586|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
143471677|NCT02742766|517273587|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
143471678|NCT02742766|517273588|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
143471679|NCT02742766|517273589|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
143471680|NCT02742766|517273590|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
143471681|NCT02742766|517273591|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
143471682|NCT02742766|517273592|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
143471683|NCT02742766|517273593|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
143471684|NCT02742766|517273594|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
143471685|NCT02742766|517273595|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
143471686|NCT02742766|517273596|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
143471687|NCT02742766|517273597|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
143471688|NCT02742766|517273579|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
143471689|NCT02742766|517273580|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
143471690|NCT02742766|517273581|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
143471691|NCT02742766|517273582|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
143471692|NCT02742766|517273583|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
143471693|NCT02742766|517273584|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
143135548|NCT02849080|516041500|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
143135549|NCT02849080|516041501|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
143471694|NCT02742766|517273585|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
143135550|NCT02849080|516041502|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
143135551|NCT02849080|516041499|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
143135552|NCT02849080|516041500|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
143135553|NCT02849080|516041501|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
143135554|NCT02849080|516041502|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
143471695|NCT02742766|517273586|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
143471696|NCT02742766|517273587|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
143471697|NCT02742766|517273588|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
143471698|NCT02742766|517273589|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
143471699|NCT02742766|517273590|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
143471700|NCT02742766|517273591|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
143135555|NCT02849080|516041499|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
143135556|NCT02849080|516041500|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
143135557|NCT02849080|516041501|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
143135558|NCT02849080|516041502|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
143135559|NCT01819727|516041503|FG000|Overall Study|Adverse Event|8|||
143135560|NCT01819727|516041504|FG001|Overall Study|Adverse Event|9|||
143471701|NCT02742766|517273592|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
143471702|NCT02742766|517273593|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
143135561|NCT01819727|516041503|FG000|Overall Study|Death|1|||
143135562|NCT01819727|516041504|FG001|Overall Study|Death|0|||
143135563|NCT01819727|516041503|FG000|Overall Study|Lost to Follow-up|1|||
143135564|NCT01819727|516041504|FG001|Overall Study|Lost to Follow-up|1|||
143135565|NCT01819727|516041503|FG000|Overall Study|Physician Decision|3|||
143471703|NCT02742766|517273594|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
143471704|NCT02742766|517273595|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
143471705|NCT02742766|517273596|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
143471706|NCT02742766|517273597|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
143471707|NCT03739437|517273600|FG000|Overall Study|Lost to Follow-up|2|||
143471708|NCT03739437|517273601|FG001|Overall Study|Lost to Follow-up|5|||
143471709|NCT01351623|517273605|FG000|Overall Study|Protocol Violation|2|||
143471710|NCT01351623|517273605|FG000|Overall Study|Adverse Event|4|||
143471711|NCT01351623|517273605|FG000|Overall Study|Withdrawal by Subject|1|||
143471712|NCT01351623|517273605|FG000|Overall Study|Death|2|||
143471713|NCT04201821|517273606|FG000|Overall Study|Withdrawal by Subject|2|||
143471714|NCT01130974|517273607|FG000|Overall Study|Protocol Violation|10|||
143471715|NCT01130974|517273608|FG001|Overall Study|Protocol Violation|10|||
143471716|NCT01130974|517273607|FG000|Overall Study|Withdrawal by Subject|0|||
143471717|NCT01130974|517273608|FG001|Overall Study|Withdrawal by Subject|1|||
143471718|NCT01130974|517273607|FG000|Overall Study|Ineligibility criteria|5|||
143471719|NCT01130974|517273608|FG001|Overall Study|Ineligibility criteria|2|||
143471720|NCT01395316|517273609|FG000|Overall Study|Lost to Follow-up|2|||
143471721|NCT01395316|517273609|FG000|Overall Study|poor MRI quality|1|||
143471722|NCT03359590|517273611|FG000|First Intervention|Withdrawal by Subject|1|||
143471723|NCT03359590|517273612|FG001|First Intervention|Withdrawal by Subject|1|||
143471724|NCT03359590|517273611|FG000|First Intervention|Protocol Violation|0|||
143471725|NCT03359590|517273612|FG001|First Intervention|Protocol Violation|1|||
143471726|NCT06132425|517273614|FG000|Overall Study|Withdrawal by Subject|3|||
143471727|NCT06132425|517273615|FG001|Overall Study|Withdrawal by Subject|0|||
143471728|NCT06132425|517273614|FG000|Overall Study|Did not follow study instructions|0|||
143471729|NCT06132425|517273615|FG001|Overall Study|Did not follow study instructions|2|||
143471730|NCT06132425|517273614|FG000|Overall Study|Lost to Follow-up|3|||
143471731|NCT06132425|517273615|FG001|Overall Study|Lost to Follow-up|5|||
143471732|NCT02446600|517273618|FG000|Overall Study|Never treated|20|||
143471733|NCT02446600|517273619|FG001|Overall Study|Never treated|2|||
143471734|NCT02446600|517273620|FG002|Overall Study|Never treated|6|||
143471735|NCT02446600|517273621|FG003|Overall Study|Never treated|0|||
143471736|NCT02446600|517273618|FG000|Overall Study|Withdrawal by Subject|19|||
143471737|NCT02446600|517273619|FG001|Overall Study|Withdrawal by Subject|5|||
143471738|NCT02446600|517273620|FG002|Overall Study|Withdrawal by Subject|17|||
143135566|NCT01819727|516041504|FG001|Overall Study|Physician Decision|2|||
143135567|NCT01819727|516041503|FG000|Overall Study|Pregnancy|1|||
143135568|NCT01819727|516041504|FG001|Overall Study|Pregnancy|0|||
143135569|NCT01819727|516041503|FG000|Overall Study|Protocol Violation|0|||
143135570|NCT01819727|516041504|FG001|Overall Study|Protocol Violation|2|||
143135571|NCT01819727|516041503|FG000|Overall Study|Study Terminated by Sponsor|0|||
143135572|NCT01819727|516041504|FG001|Overall Study|Study Terminated by Sponsor|1|||
143135573|NCT01819727|516041503|FG000|Overall Study|Withdrawal by Subject|6|||
143135574|NCT01819727|516041504|FG001|Overall Study|Withdrawal by Subject|11|||
143135575|NCT01819727|516041503|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
143135576|NCT01819727|516041504|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
143135577|NCT01819727|516041503|FG000|Overall Study|Quit due to lack of health benifits|0|||
143135578|NCT01819727|516041504|FG001|Overall Study|Quit due to lack of health benifits|1|||
143471739|NCT02446600|517273621|FG003|Overall Study|Withdrawal by Subject|0|||
143471740|NCT02446600|517273618|FG000|Overall Study|Ineligible|1|||
143471741|NCT02446600|517273619|FG001|Overall Study|Ineligible|4|||
143135579|NCT01628848|516041505|FG000|Overall Study|Adverse Event|9|||
143135580|NCT01628848|516041506|FG001|Overall Study|Adverse Event|7|||
143471742|NCT02446600|517273620|FG002|Overall Study|Ineligible|4|||
143471743|NCT02446600|517273621|FG003|Overall Study|Ineligible|1|||
143471744|NCT02446600|517273618|FG000|Overall Study|Duplicate Enrollment|0|||
143471745|NCT02446600|517273619|FG001|Overall Study|Duplicate Enrollment|1|||
143471746|NCT02446600|517273620|FG002|Overall Study|Duplicate Enrollment|0|||
143135581|NCT01628848|516041505|FG000|Overall Study|Lack of Efficacy|0|||
143135582|NCT01628848|516041506|FG001|Overall Study|Lack of Efficacy|4|||
143135583|NCT01628848|516041505|FG000|Overall Study|Withdrawal by Subject|0|||
143471747|NCT02446600|517273621|FG003|Overall Study|Duplicate Enrollment|0|||
143471748|NCT04409353|517273622|FG000|Overall Study|Discontinued intervention prior to end of follow-up|4|||
143361169|NCT00761774|516863659|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
143361170|NCT00761774|516863659|FG000|Overall Study|Sponsor decision|1|||
143361171|NCT00761774|516863659|FG000|Overall Study|Investigator clinical judgement|1|||
143361172|NCT00761774|516863659|FG000|Overall Study|Patient moved out of study area|1|||
143361173|NCT00761774|516863659|FG000|Overall Study|Coordinator leaving site|1|||
143361174|NCT00761774|516863659|FG000|Overall Study|Subject IP non-compliance|1|||
143361175|NCT00761774|516863659|FG000|Overall Study|IP stopped by hospital physician|1|||
143361176|NCT01077024|516863660|FG000|Overall Study|Lost to Follow-up|20|||
143361177|NCT01077024|516863661|FG001|Overall Study|Lost to Follow-up|14|||
143361178|NCT01077024|516863660|FG000|Overall Study|Withdrawal by Subject|0|||
143361179|NCT01077024|516863661|FG001|Overall Study|Withdrawal by Subject|2|||
143361180|NCT01077024|516863660|FG000|Overall Study|Incarcerated|7|||
143361181|NCT01077024|516863661|FG001|Overall Study|Incarcerated|8|||
143361182|NCT01077024|516863660|FG000|Overall Study|Other|4|||
143361183|NCT01077024|516863661|FG001|Overall Study|Other|4|||
143361184|NCT02034435|516863662|FG000|Overall Study|Withdrawal by Subject|1|||
143361185|NCT02034435|516863663|FG001|Overall Study|Withdrawal by Subject|0|||
143361186|NCT02034435|516863664|FG002|Overall Study|Withdrawal by Subject|0|||
143361187|NCT02034435|516863665|FG003|Overall Study|Withdrawal by Subject|0|||
143361188|NCT02034435|516863662|FG000|Overall Study|Illness|0|||
143361189|NCT02034435|516863663|FG001|Overall Study|Illness|2|||
143361190|NCT02034435|516863664|FG002|Overall Study|Illness|0|||
143361191|NCT02034435|516863665|FG003|Overall Study|Illness|0|||
143361192|NCT02034435|516863662|FG000|Overall Study|Inadequate IV access|1|||
143361193|NCT02034435|516863663|FG001|Overall Study|Inadequate IV access|0|||
143361194|NCT02034435|516863664|FG002|Overall Study|Inadequate IV access|0|||
143361195|NCT02034435|516863665|FG003|Overall Study|Inadequate IV access|1|||
143361196|NCT00801242|516863666|FG000|Overall Study|Adverse Event|10|||
143361197|NCT00801242|516863666|FG000|Overall Study|Withdrawal by Subject|13|||
143361198|NCT00801242|516863666|FG000|Overall Study|Protocol Violation|5|||
143361199|NCT00801242|516863666|FG000|Overall Study|Physician Decision|3|||
143361200|NCT00801242|516863666|FG000|Overall Study|Lost to Follow-up|1|||
143361201|NCT00801242|516863666|FG000|Overall Study|Miscellaneous reasons|20|||
143361202|NCT01318811|516863667|FG000|Overall Study|Physician Decision|1|||
143361203|NCT01318811|516863668|FG001|Overall Study|Physician Decision|1|||
143361204|NCT01318811|516863667|FG000|Overall Study|CRRT stopped for head CT|0|||
143361205|NCT01318811|516863668|FG001|Overall Study|CRRT stopped for head CT|1|||
143361206|NCT01318811|516863667|FG000|Overall Study|Death|0|||
143361207|NCT01318811|516863668|FG001|Overall Study|Death|1|||
143361208|NCT01318811|516863667|FG000|Overall Study|CRRT stopped for head MRI|0|||
143361209|NCT01318811|516863668|FG001|Overall Study|CRRT stopped for head MRI|1|||
143361210|NCT00811187|516863669|FG000|Overall Study|Unable to place device / procedure abort|3|||
143361211|NCT00811187|516863670|FG001|Overall Study|Unable to place device / procedure abort|3|||
143361212|NCT00329303|516863671|FG000|Overall Study|Lack of Efficacy|1|||
143361213|NCT00329303|516863672|FG001|Overall Study|Lack of Efficacy|0|||
143361214|NCT00329303|516863671|FG000|Overall Study|Decision of the sponsor|0|||
143361215|NCT00329303|516863672|FG001|Overall Study|Decision of the sponsor|1|||
143361216|NCT00329303|516863671|FG000|Overall Study|Patient no longer available|1|||
143361217|NCT00329303|516863672|FG001|Overall Study|Patient no longer available|0|||
143361218|NCT00329303|516863671|FG000|Overall Study|Patient relocated|0|||
143361219|NCT00329303|516863672|FG001|Overall Study|Patient relocated|1|||
143361220|NCT00994279|516863679|FG000|Overall Study|Withdrawal by Subject|2|||
143361221|NCT00994279|516863680|FG001|Overall Study|Withdrawal by Subject|2|||
143361222|NCT00994279|516863679|FG000|Overall Study|Toxicity|1|||
143361223|NCT00994279|516863680|FG001|Overall Study|Toxicity|0|||
143361224|NCT00994279|516863679|FG000|Overall Study|Multiple reasons|1|||
143361225|NCT00994279|516863680|FG001|Overall Study|Multiple reasons|3|||
143361226|NCT00859014|516863681|FG000|Overall Study|Death|4|||
143361227|NCT00859014|516863681|FG000|Overall Study|Lost to Follow-up|1|||
143361228|NCT01163149|516863685|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
143361229|NCT01163149|516863686|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
143361230|NCT01163149|516863687|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
143361231|NCT01163149|516863685|FG000|Extension Treatment Period|Adverse Event|0|||
143361232|NCT01163149|516863686|FG001|Extension Treatment Period|Adverse Event|1|||
143361233|NCT01163149|516863687|FG002|Extension Treatment Period|Adverse Event|0|||
143361234|NCT01163149|516863685|FG000|Extension Treatment Period|Noncompliance|0|||
143361235|NCT01163149|516863686|FG001|Extension Treatment Period|Noncompliance|0|||
143361236|NCT01163149|516863687|FG002|Extension Treatment Period|Noncompliance|1|||
143361237|NCT01700530|516863688|FG000|Overall Study|Withdrawal by Subject|0|||
143361238|NCT01700530|516863689|FG001|Overall Study|Withdrawal by Subject|3|||
143361239|NCT01700530|516863690|FG002|Overall Study|Withdrawal by Subject|1|||
143361240|NCT02806336|516863696|FG000|Overall Study|Physician Decision|1|||
143361241|NCT02806336|516863697|FG001|Overall Study|Physician Decision|0|||
143361242|NCT02806336|516863696|FG000|Overall Study|Withdrawal by Subject|2|||
143361243|NCT02806336|516863697|FG001|Overall Study|Withdrawal by Subject|4|||
143361244|NCT02806336|516863696|FG000|Overall Study|COVID-19 research shut down|3|||
143361245|NCT02806336|516863697|FG001|Overall Study|COVID-19 research shut down|4|||
143135584|NCT01628848|516041506|FG001|Overall Study|Withdrawal by Subject|2|||
143135585|NCT01628848|516041505|FG000|Overall Study|Physician Decision|3|||
143135586|NCT01628848|516041506|FG001|Overall Study|Physician Decision|1|||
143361246|NCT02806336|516863696|FG000|Overall Study|Lack of Efficacy|0|||
143361247|NCT02806336|516863697|FG001|Overall Study|Lack of Efficacy|1|||
143361248|NCT04529538|516863698|FG000|Overall Study|Lost to Follow-up|3|||
143361249|NCT04529538|516863699|FG001|Overall Study|Lost to Follow-up|2|||
143361250|NCT04529538|516863700|FG002|Overall Study|Lost to Follow-up|1|||
143361251|NCT04529538|516863701|FG003|Overall Study|Lost to Follow-up|0|||
143361252|NCT04529538|516863702|FG004|Overall Study|Lost to Follow-up|1|||
143361253|NCT04529538|516863703|FG005|Overall Study|Lost to Follow-up|1|||
143361254|NCT04529538|516863704|FG006|Overall Study|Lost to Follow-up|2|||
143361255|NCT04529538|516863705|FG007|Overall Study|Lost to Follow-up|0|||
143361256|NCT04529538|516863698|FG000|Overall Study|Not eligible at enrollment|0|||
143361257|NCT04529538|516863699|FG001|Overall Study|Not eligible at enrollment|1|||
143361258|NCT04529538|516863700|FG002|Overall Study|Not eligible at enrollment|2|||
143361259|NCT04529538|516863701|FG003|Overall Study|Not eligible at enrollment|1|||
143361260|NCT04529538|516863702|FG004|Overall Study|Not eligible at enrollment|0|||
143361261|NCT04529538|516863703|FG005|Overall Study|Not eligible at enrollment|0|||
143361262|NCT04529538|516863704|FG006|Overall Study|Not eligible at enrollment|0|||
143361263|NCT04529538|516863705|FG007|Overall Study|Not eligible at enrollment|1|||
143361264|NCT04529538|516863698|FG000|Overall Study|Withdrawal by Subject|0|||
143361265|NCT04529538|516863699|FG001|Overall Study|Withdrawal by Subject|1|||
143361266|NCT04529538|516863700|FG002|Overall Study|Withdrawal by Subject|1|||
143361267|NCT04529538|516863701|FG003|Overall Study|Withdrawal by Subject|2|||
143361268|NCT04529538|516863702|FG004|Overall Study|Withdrawal by Subject|0|||
143361269|NCT04529538|516863703|FG005|Overall Study|Withdrawal by Subject|2|||
143361270|NCT04529538|516863704|FG006|Overall Study|Withdrawal by Subject|3|||
143361271|NCT04529538|516863705|FG007|Overall Study|Withdrawal by Subject|0|||
143361272|NCT04529538|516863698|FG000|Overall Study|Other|0|||
143361273|NCT04529538|516863699|FG001|Overall Study|Other|1|||
143361274|NCT04529538|516863700|FG002|Overall Study|Other|0|||
143361275|NCT04529538|516863701|FG003|Overall Study|Other|0|||
143361276|NCT04529538|516863702|FG004|Overall Study|Other|0|||
143361277|NCT04529538|516863703|FG005|Overall Study|Other|0|||
143361278|NCT04529538|516863704|FG006|Overall Study|Other|0|||
143361279|NCT04529538|516863705|FG007|Overall Study|Other|0|||
143361280|NCT04529538|516863698|FG000|Overall Study|Adverse Event|0|||
143361281|NCT04529538|516863699|FG001|Overall Study|Adverse Event|0|||
143361282|NCT04529538|516863700|FG002|Overall Study|Adverse Event|0|||
143361283|NCT04529538|516863701|FG003|Overall Study|Adverse Event|1|||
143361284|NCT04529538|516863702|FG004|Overall Study|Adverse Event|0|||
143361285|NCT04529538|516863703|FG005|Overall Study|Adverse Event|0|||
143361286|NCT04529538|516863704|FG006|Overall Study|Adverse Event|0|||
143361287|NCT04529538|516863705|FG007|Overall Study|Adverse Event|0|||
143361288|NCT04529538|516863698|FG000|Overall Study|Protocol Deviation|0|||
143361289|NCT04529538|516863699|FG001|Overall Study|Protocol Deviation|0|||
143361290|NCT04529538|516863700|FG002|Overall Study|Protocol Deviation|0|||
143361291|NCT04529538|516863701|FG003|Overall Study|Protocol Deviation|1|||
143361292|NCT04529538|516863702|FG004|Overall Study|Protocol Deviation|0|||
143361293|NCT04529538|516863703|FG005|Overall Study|Protocol Deviation|0|||
143361294|NCT04529538|516863704|FG006|Overall Study|Protocol Deviation|0|||
143361295|NCT04529538|516863705|FG007|Overall Study|Protocol Deviation|0|||
143361296|NCT04529538|516863698|FG000|Overall Study|Physician Decision|0|||
143361297|NCT04529538|516863699|FG001|Overall Study|Physician Decision|0|||
143361298|NCT04529538|516863700|FG002|Overall Study|Physician Decision|0|||
143361299|NCT04529538|516863701|FG003|Overall Study|Physician Decision|0|||
143361300|NCT04529538|516863702|FG004|Overall Study|Physician Decision|0|||
143361301|NCT04529538|516863703|FG005|Overall Study|Physician Decision|1|||
143361302|NCT04529538|516863704|FG006|Overall Study|Physician Decision|0|||
143361303|NCT04529538|516863705|FG007|Overall Study|Physician Decision|1|||
143361304|NCT02223182|516863706|FG000|Double-Blind Period|Adverse Event|0|||
143361305|NCT02223182|516863707|FG001|Double-Blind Period|Adverse Event|2|||
143361306|NCT02223182|516863708|FG002|Double-Blind Period|Adverse Event|1|||
143361307|NCT02223182|516863709|FG003|Double-Blind Period|Adverse Event|0|||
143361308|NCT02223182|516863706|FG000|Double-Blind Period|Withdrawal by Subject|1|||
143135587|NCT02667301|516041509|FG000|Overall Study|Adverse Event|1|||
143361309|NCT02223182|516863707|FG001|Double-Blind Period|Withdrawal by Subject|1|||
143361310|NCT02223182|516863708|FG002|Double-Blind Period|Withdrawal by Subject|1|||
143361311|NCT02223182|516863709|FG003|Double-Blind Period|Withdrawal by Subject|0|||
143135588|NCT02667301|516041509|FG000|Overall Study|Lack of Efficacy|1|||
143361312|NCT02223182|516863706|FG000|Double-Blind Period|Lost to Follow-up|0|||
143361313|NCT02223182|516863707|FG001|Double-Blind Period|Lost to Follow-up|1|||
143361314|NCT02223182|516863708|FG002|Double-Blind Period|Lost to Follow-up|0|||
143135589|NCT00735007|516041510|FG000|Overall Study|Adverse Event|4|||
143361315|NCT02223182|516863709|FG003|Double-Blind Period|Lost to Follow-up|0|||
143361316|NCT02223182|516863706|FG000|Double-Blind Period|Non Compliance|0|||
143361317|NCT02223182|516863707|FG001|Double-Blind Period|Non Compliance|0|||
143361318|NCT02223182|516863708|FG002|Double-Blind Period|Non Compliance|0|||
143361319|NCT02223182|516863709|FG003|Double-Blind Period|Non Compliance|1|||
143471749|NCT04409353|517273623|FG001|Overall Study|Discontinued intervention prior to end of follow-up|11|||
143471750|NCT04409353|517273624|FG002|Overall Study|Discontinued intervention prior to end of follow-up|6|||
143471751|NCT04409353|517273622|FG000|Overall Study|Lost to Follow-up|6|||
143471752|NCT04409353|517273623|FG001|Overall Study|Lost to Follow-up|8|||
143471753|NCT04409353|517273624|FG002|Overall Study|Lost to Follow-up|7|||
143471754|NCT04409353|517273622|FG000|Overall Study|Major surgery during participation window|4|||
143471755|NCT04409353|517273623|FG001|Overall Study|Major surgery during participation window|3|||
143471756|NCT04409353|517273624|FG002|Overall Study|Major surgery during participation window|3|||
143471757|NCT04409353|517273622|FG000|Overall Study|Life event occurred during participation window|3|||
143471758|NCT04409353|517273623|FG001|Overall Study|Life event occurred during participation window|2|||
143471759|NCT04409353|517273624|FG002|Overall Study|Life event occurred during participation window|4|||
143471760|NCT04409353|517273622|FG000|Overall Study|Lack of Efficacy|4|||
143471761|NCT04409353|517273623|FG001|Overall Study|Lack of Efficacy|1|||
143471762|NCT04409353|517273624|FG002|Overall Study|Lack of Efficacy|3|||
143471763|NCT04409353|517273622|FG000|Overall Study|Adverse Event|2|||
143471764|NCT04409353|517273623|FG001|Overall Study|Adverse Event|1|||
143471765|NCT04409353|517273624|FG002|Overall Study|Adverse Event|1|||
143471766|NCT04409353|517273622|FG000|Overall Study|Disease burden - unable to participate|0|||
143471767|NCT04409353|517273623|FG001|Overall Study|Disease burden - unable to participate|1|||
143471768|NCT04409353|517273624|FG002|Overall Study|Disease burden - unable to participate|1|||
143471769|NCT04409353|517273622|FG000|Overall Study|Intervention too complicated|1|||
143471770|NCT04409353|517273623|FG001|Overall Study|Intervention too complicated|0|||
143471771|NCT04409353|517273624|FG002|Overall Study|Intervention too complicated|1|||
143471772|NCT05390580|517273625|FG000|Overall Study|Physician Decision|3|||
143471773|NCT05390580|517273626|FG001|Overall Study|Physician Decision|2|||
143471774|NCT04014361|517273627|FG000|Period 2|Physician Decision|0|||
143471775|NCT04014361|517273628|FG001|Period 2|Physician Decision|0|||
143471776|NCT04014361|517273629|FG002|Period 2|Physician Decision|0|||
143471777|NCT04014361|517273630|FG003|Period 2|Physician Decision|1|||
143471778|NCT04014361|517273631|FG004|Period 2|Physician Decision|0|||
143471779|NCT04014361|517273632|FG005|Period 2|Physician Decision|0|||
143471780|NCT04014361|517273633|FG006|Period 2|Physician Decision|0|||
143471781|NCT04014361|517273634|FG007|Period 2|Physician Decision|0|||
143471782|NCT06308666|517273635|FG000|Overall Study|Withdrawal by Subject|1|||
143471783|NCT06308666|517273635|FG000|Overall Study|Protocol Violation|2|||
143471784|NCT01130051|517273637|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
143471785|NCT01130051|517273638|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
143471786|NCT01130051|517273637|FG000|Washout Period of 14 Days|Protocol Violation|1|||
143471787|NCT01130051|517273638|FG001|Washout Period of 14 Days|Protocol Violation|1|||
143471788|NCT01298518|517273641|FG000|Overall Study|Withdrawal by Subject|0|||
143471789|NCT01298518|517273642|FG001|Overall Study|Withdrawal by Subject|0|||
143471790|NCT01298518|517273643|FG002|Overall Study|Withdrawal by Subject|1|||
143471791|NCT03610165|517273644|FG000|Overall Study|Device didn't work|0|||
143471792|NCT03610165|517273645|FG001|Overall Study|Device didn't work|1|||
143471793|NCT02129205|517273646|FG000|Overall Study|Withdrawal by Subject|0|||
143471794|NCT02129205|517273647|FG001|Overall Study|Withdrawal by Subject|0|||
143471795|NCT02129205|517273648|FG002|Overall Study|Withdrawal by Subject|0|||
143471796|NCT02129205|517273649|FG003|Overall Study|Withdrawal by Subject|0|||
143471797|NCT02129205|517273650|FG004|Overall Study|Withdrawal by Subject|1|||
143471798|NCT02129205|517273651|FG005|Overall Study|Withdrawal by Subject|1|||
143471799|NCT02129205|517273652|FG006|Overall Study|Withdrawal by Subject|1|||
143471800|NCT02129205|517273653|FG007|Overall Study|Withdrawal by Subject|0|||
143471801|NCT02129205|517273654|FG008|Overall Study|Withdrawal by Subject|1|||
143471802|NCT02129205|517273655|FG009|Overall Study|Withdrawal by Subject|0|||
143471803|NCT02129205|517273646|FG000|Overall Study|Other|1|||
143471804|NCT02129205|517273647|FG001|Overall Study|Other|0|||
143471805|NCT02129205|517273648|FG002|Overall Study|Other|0|||
143471806|NCT02129205|517273649|FG003|Overall Study|Other|0|||
143471807|NCT02129205|517273650|FG004|Overall Study|Other|2|||
143471808|NCT02129205|517273651|FG005|Overall Study|Other|3|||
143471809|NCT02129205|517273652|FG006|Overall Study|Other|3|||
143471810|NCT02129205|517273653|FG007|Overall Study|Other|2|||
143471811|NCT02129205|517273654|FG008|Overall Study|Other|1|||
143471812|NCT02129205|517273655|FG009|Overall Study|Other|0|||
143471813|NCT00977574|517273659|FG000|Overall Study|Never Treated|4|||
143471814|NCT00977574|517273660|FG001|Overall Study|Never Treated|2|||
143471815|NCT00977574|517273661|FG002|Overall Study|Never Treated|4|||
143471816|NCT07052682|517273662|FG000|Overall Study|Withdrawal by Subject|4|||
143471817|NCT04890054|517275022|FG000|Overall Study|Lost to Follow-up|202|||
143471818|NCT04890054|517275023|FG001|Overall Study|Lost to Follow-up|219|||
143471819|NCT00928564|517275030|FG000|Overall Study|Lost to Follow-up|6|||
143471820|NCT00928564|517275031|FG001|Overall Study|Lost to Follow-up|0|||
143471821|NCT00385203|517275034|FG000|Overall Study|Adverse Event|5|||
143471822|NCT00385203|517275035|FG001|Overall Study|Adverse Event|4|||
143471823|NCT00385203|517275034|FG000|Overall Study|Death|1|||
143471824|NCT00385203|517275035|FG001|Overall Study|Death|0|||
143471825|NCT00385203|517275034|FG000|Overall Study|Condition under investigation worsened|18|||
143135590|NCT00735007|516041510|FG000|Overall Study|Protocol Violation|1|||
143135591|NCT03644017|516041511|FG000|Overall Study|Access Abandonment|5|||
143135592|NCT03644017|516041511|FG000|Overall Study|Kidney Transplant|2|||
143135593|NCT02340000|516041514|FG000|Time Period 1|Withdrawal by Subject|6|||
143135594|NCT02340000|516041515|FG001|Time Period 1|Withdrawal by Subject|8|||
143135595|NCT02340000|516041514|FG000|Time Period 1|Lost to Follow-up|6|||
143135596|NCT02340000|516041515|FG001|Time Period 1|Lost to Follow-up|7|||
143471826|NCT00385203|517275035|FG001|Overall Study|Condition under investigation worsened|3|||
143471827|NCT00385203|517275034|FG000|Overall Study|Incorrect enrollment|2|||
143471828|NCT00385203|517275035|FG001|Overall Study|Incorrect enrollment|0|||
143471829|NCT02294682|517275036|FG000|Overall Study|Could not swallow pills|1|||
143471830|NCT02294682|517275037|FG001|Overall Study|Could not swallow pills|0|||
143471831|NCT00059839|517275041|FG000|Overall Study|Death|1|||
143471832|NCT00059839|517275042|FG001|Overall Study|Death|1|||
143471833|NCT00059839|517275041|FG000|Overall Study|Lack of Efficacy|6|||
143471834|NCT00059839|517275042|FG001|Overall Study|Lack of Efficacy|5|||
143471835|NCT00059839|517275041|FG000|Overall Study|Lost to Follow-up|2|||
143471836|NCT00059839|517275042|FG001|Overall Study|Lost to Follow-up|0|||
143471837|NCT00059839|517275041|FG000|Overall Study|Physician Decision|1|||
143471838|NCT00059839|517275042|FG001|Overall Study|Physician Decision|2|||
143471839|NCT00059839|517275041|FG000|Overall Study|Withdrawal by Subject|1|||
143471840|NCT00059839|517275042|FG001|Overall Study|Withdrawal by Subject|6|||
143471841|NCT00059839|517275041|FG000|Overall Study|Ineligible|1|||
143471842|NCT00059839|517275042|FG001|Overall Study|Ineligible|3|||
143471843|NCT03829241|517275043|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
143471844|NCT03829241|517275044|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
143471845|NCT03829241|517275043|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
143471846|NCT03829241|517275044|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
143471847|NCT03829241|517275043|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
143471848|NCT03829241|517275044|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
143471849|NCT03829241|517275043|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
143471850|NCT03829241|517275044|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
143471851|NCT03829241|517275043|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
143471852|NCT03829241|517275044|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
143471853|NCT03829241|517275043|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
143471854|NCT03829241|517275044|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
143471855|NCT03829241|517275043|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
143471856|NCT03829241|517275044|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
143471857|NCT03829241|517275043|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
143471858|NCT03829241|517275044|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
143471859|NCT03829241|517275043|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
143471860|NCT03829241|517275044|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
143471861|NCT03829241|517275043|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
143471862|NCT03829241|517275044|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
143471863|NCT03829241|517275043|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
143471864|NCT03829241|517275044|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
143471865|NCT03829241|517275043|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
143471866|NCT03829241|517275044|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
143471867|NCT03829241|517275043|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
143471868|NCT03829241|517275044|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
143471869|NCT03829241|517275043|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
143471870|NCT03829241|517275044|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
143471871|NCT02224599|517275045|FG000|Overall Study|Physician Decision|1|||
143471872|NCT02224599|517275045|FG000|Overall Study|Progression of Disease|1|||
143471873|NCT00129623|517275046|FG000|Overall Study|Adverse Event|3|||
143471874|NCT00129623|517275047|FG001|Overall Study|Adverse Event|7|||
143471875|NCT00129623|517275046|FG000|Overall Study|Refused Treatment|5|||
143471876|NCT00129623|517275047|FG001|Overall Study|Refused Treatment|3|||
143471877|NCT00129623|517275046|FG000|Overall Study|Failure to Return|1|||
143471878|NCT00129623|517275047|FG001|Overall Study|Failure to Return|1|||
143471879|NCT00129623|517275046|FG000|Overall Study|Relocated job out of state|1|||
143471880|NCT00129623|517275047|FG001|Overall Study|Relocated job out of state|0|||
143471881|NCT00129623|517275046|FG000|Overall Study|Uncertainty to return|0|||
143471882|NCT00129623|517275047|FG001|Overall Study|Uncertainty to return|1|||
143471883|NCT00596934|517275048|FG000|Overall Study|Protocol Violation|1|||
143471884|NCT00596934|517275048|FG000|Overall Study|Withdrawal by Subject|1|||
143471885|NCT02315898|517275051|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
143471886|NCT02315898|517275052|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
143471887|NCT02315898|517275053|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
143471888|NCT02315898|517275054|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
143135597|NCT02340000|516041514|FG000|Time Period 2|Withdrawal by Subject|9|||
143135598|NCT02340000|516041515|FG001|Time Period 2|Withdrawal by Subject|7|||
143135599|NCT02340000|516041514|FG000|Time Period 2|Lost to Follow-up|10|||
143135600|NCT02340000|516041515|FG001|Time Period 2|Lost to Follow-up|8|||
143135601|NCT01883895|516041516|FG000|Overall Study|Lost to Follow-up|2|||
143135602|NCT02895295|516041517|FG000|Overall Study|Survey Non-response|71|||
143135603|NCT02895295|516041518|FG001|Overall Study|Survey Non-response|94|||
143135604|NCT02895295|516041519|FG002|Overall Study|Survey Non-response|92|||
143135605|NCT04414787|516041524|FG000|Overall Study|Patient Death|18|||
143135606|NCT04414787|516041525|FG001|Overall Study|Patient Death|18|||
143135607|NCT04414787|516041526|FG002|Overall Study|Patient Death|15|||
143135608|NCT04414787|516041527|FG003|Overall Study|Patient Death|15|||
143135609|NCT04414787|516041524|FG000|Overall Study|Patient Hospitalization|1|||
143135610|NCT04414787|516041525|FG001|Overall Study|Patient Hospitalization|1|||
143135611|NCT04414787|516041526|FG002|Overall Study|Patient Hospitalization|2|||
143135612|NCT04414787|516041527|FG003|Overall Study|Patient Hospitalization|2|||
143135613|NCT04414787|516041524|FG000|Overall Study|Lost to Follow-up|7|||
143135614|NCT04414787|516041525|FG001|Overall Study|Lost to Follow-up|7|||
143135615|NCT04414787|516041526|FG002|Overall Study|Lost to Follow-up|5|||
143135616|NCT04414787|516041527|FG003|Overall Study|Lost to Follow-up|5|||
143135617|NCT04414787|516041524|FG000|Overall Study|Residence in post-acute care facility|3|||
143135618|NCT04414787|516041525|FG001|Overall Study|Residence in post-acute care facility|3|||
143135619|NCT04414787|516041526|FG002|Overall Study|Residence in post-acute care facility|5|||
143135620|NCT04414787|516041527|FG003|Overall Study|Residence in post-acute care facility|5|||
143135621|NCT01949142|516041528|FG000|Overall Study|Withdrawal of consent|1|||
143135622|NCT01949142|516041529|FG001|Overall Study|Withdrawal of consent|0|||
143135623|NCT01949142|516041528|FG000|Overall Study|Lost to Follow-up|1|||
143135624|NCT01949142|516041529|FG001|Overall Study|Lost to Follow-up|1|||
143135625|NCT01949142|516041528|FG000|Overall Study|Parent changed their mind|1|||
143135626|NCT01949142|516041529|FG001|Overall Study|Parent changed their mind|0|||
143135627|NCT00490919|516041530|FG000|Open-label Run-in Period|Adverse Event|239|||
143135628|NCT00490919|516041531|FG001|Open-label Run-in Period|Adverse Event|0|||
143135629|NCT00490919|516041532|FG002|Open-label Run-in Period|Adverse Event|0|||
143135630|NCT00490919|516041530|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
143135631|NCT00490919|516041531|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
143135632|NCT00490919|516041532|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
143135633|NCT00490919|516041530|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
143135634|NCT00490919|516041531|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
143135635|NCT00490919|516041532|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
143135636|NCT00490919|516041530|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
143135637|NCT00490919|516041531|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
143135638|NCT00490919|516041532|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
143135639|NCT00490919|516041530|FG000|Open-label Run-in Period|Administrative|40|||
143135640|NCT00490919|516041531|FG001|Open-label Run-in Period|Administrative|0|||
143135641|NCT00490919|516041532|FG002|Open-label Run-in Period|Administrative|0|||
143135642|NCT00490919|516041530|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
143471889|NCT03239483|517275055|FG000|Overall Study|Lost to Follow-up|1|||
143471890|NCT03239483|517275056|FG001|Overall Study|Lost to Follow-up|0|||
143135643|NCT00490919|516041531|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
143135644|NCT00490919|516041532|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
143471891|NCT03239483|517275055|FG000|Overall Study|Withdrawal by Subject|1|||
143471892|NCT03239483|517275056|FG001|Overall Study|Withdrawal by Subject|0|||
143471893|NCT05352048|517275059|FG000|Overall Study|Lost to Follow-up|1|||
143471894|NCT05352048|517275059|FG000|Overall Study|did not get EMG-MMG readings intraoperatively|3|||
143471895|NCT02308007|517275069|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
143471896|NCT02308007|517275070|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
143471897|NCT02308007|517275071|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
143471898|NCT02308007|517275069|FG000|Overall Study|Positive for STD at Baseline|7|||
143471899|NCT02308007|517275070|FG001|Overall Study|Positive for STD at Baseline|11|||
143471900|NCT02308007|517275071|FG002|Overall Study|Positive for STD at Baseline|7|||
143471901|NCT02308007|517275069|FG000|Overall Study|Lost to Follow-up|3|||
143135645|NCT00490919|516041530|FG000|Double-blind Phase|Adverse Event|0|||
143135646|NCT00490919|516041531|FG001|Double-blind Phase|Adverse Event|40|||
143135647|NCT00490919|516041532|FG002|Double-blind Phase|Adverse Event|20|||
143135648|NCT00490919|516041530|FG000|Double-blind Phase|Withdrawal by Subject|0|||
143135649|NCT00490919|516041531|FG001|Double-blind Phase|Withdrawal by Subject|10|||
143135650|NCT00490919|516041532|FG002|Double-blind Phase|Withdrawal by Subject|11|||
143135651|NCT00490919|516041530|FG000|Double-blind Phase|Lost to Follow-up|0|||
143135652|NCT00490919|516041531|FG001|Double-blind Phase|Lost to Follow-up|8|||
143135653|NCT00490919|516041532|FG002|Double-blind Phase|Lost to Follow-up|11|||
143135654|NCT00490919|516041530|FG000|Double-blind Phase|Lack of Efficacy|0|||
143135655|NCT00490919|516041531|FG001|Double-blind Phase|Lack of Efficacy|22|||
143471902|NCT02308007|517275070|FG001|Overall Study|Lost to Follow-up|0|||
143471903|NCT02308007|517275071|FG002|Overall Study|Lost to Follow-up|1|||
143471904|NCT00528567|517275077|FG000|Overall Study|Death|4|||
143471905|NCT00528567|517275078|FG001|Overall Study|Death|5|||
143471906|NCT00528567|517275077|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
143471907|NCT00528567|517275078|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
143471908|NCT00528567|517275077|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
143471909|NCT00528567|517275078|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
143471910|NCT00528567|517275077|FG000|Overall Study|Violation Criteria at Entry|3|||
143471911|NCT00528567|517275078|FG001|Overall Study|Violation Criteria at Entry|17|||
143471912|NCT00528567|517275077|FG000|Overall Study|Withdrew Consent|59|||
143471913|NCT00528567|517275078|FG001|Overall Study|Withdrew Consent|55|||
143471914|NCT00528567|517275077|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
143471915|NCT00528567|517275078|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
143471916|NCT00528567|517275077|FG000|Overall Study|Failure to Return|1|||
143471917|NCT00528567|517275078|FG001|Overall Study|Failure to Return|4|||
143471918|NCT00528567|517275077|FG000|Overall Study|Other Protocol Violation|5|||
143471919|NCT00528567|517275078|FG001|Overall Study|Other Protocol Violation|21|||
143471920|NCT00528567|517275077|FG000|Overall Study|Administrative/Other|22|||
143471921|NCT00528567|517275078|FG001|Overall Study|Administrative/Other|75|||
143471922|NCT00631189|517275079|FG000|Initial Phase|Protocol Violation|347|||
143471923|NCT00631189|517275080|FG001|Initial Phase|Protocol Violation|0|||
143471924|NCT00631189|517275081|FG002|Initial Phase|Protocol Violation|0|||
143471925|NCT00631189|517275082|FG003|Initial Phase|Protocol Violation|0|||
143471926|NCT00631189|517275079|FG000|Initial Phase|Withdrawal by Subject|4|||
143471927|NCT00631189|517275080|FG001|Initial Phase|Withdrawal by Subject|0|||
143471928|NCT00631189|517275081|FG002|Initial Phase|Withdrawal by Subject|0|||
143471929|NCT00631189|517275082|FG003|Initial Phase|Withdrawal by Subject|0|||
143471930|NCT00631189|517275079|FG000|Treatment Phase|Withdrawal by Subject|0|||
143471931|NCT00631189|517275080|FG001|Treatment Phase|Withdrawal by Subject|2|||
143471932|NCT00631189|517275081|FG002|Treatment Phase|Withdrawal by Subject|1|||
143471933|NCT00631189|517275082|FG003|Treatment Phase|Withdrawal by Subject|1|||
143471934|NCT00631189|517275079|FG000|Treatment Phase|Protocol Violation|0|||
143471935|NCT00631189|517275080|FG001|Treatment Phase|Protocol Violation|1|||
143471936|NCT00631189|517275081|FG002|Treatment Phase|Protocol Violation|6|||
143471937|NCT00631189|517275082|FG003|Treatment Phase|Protocol Violation|2|||
143471938|NCT00631189|517275079|FG000|Treatment Phase|Adverse Event|0|||
143471939|NCT00631189|517275080|FG001|Treatment Phase|Adverse Event|3|||
143471940|NCT00631189|517275081|FG002|Treatment Phase|Adverse Event|2|||
143471941|NCT00631189|517275082|FG003|Treatment Phase|Adverse Event|4|||
143471942|NCT00631189|517275079|FG000|Treatment Phase|Lost to Follow-up|0|||
143471943|NCT00631189|517275080|FG001|Treatment Phase|Lost to Follow-up|1|||
143471944|NCT00631189|517275081|FG002|Treatment Phase|Lost to Follow-up|0|||
143471945|NCT00631189|517275082|FG003|Treatment Phase|Lost to Follow-up|0|||
143471946|NCT00631189|517275079|FG000|Treatment Phase|Pregnancy|0|||
143471947|NCT00631189|517275080|FG001|Treatment Phase|Pregnancy|0|||
143471948|NCT00631189|517275081|FG002|Treatment Phase|Pregnancy|1|||
143471949|NCT00631189|517275082|FG003|Treatment Phase|Pregnancy|0|||
143471950|NCT00631189|517275079|FG000|Treatment Phase|patient did not take pravastatin|0|||
143471951|NCT00631189|517275080|FG001|Treatment Phase|patient did not take pravastatin|0|||
143471952|NCT00631189|517275081|FG002|Treatment Phase|patient did not take pravastatin|1|||
143471953|NCT00631189|517275082|FG003|Treatment Phase|patient did not take pravastatin|0|||
143471954|NCT00974090|517275083|FG000|Period 1: Double Blind Period|Adverse Event|2|||
143471955|NCT00974090|517275084|FG001|Period 1: Double Blind Period|Adverse Event|1|||
143471956|NCT00974090|517275083|FG000|Period 1: Double Blind Period|Physician Decision|1|||
143471957|NCT00974090|517275084|FG001|Period 1: Double Blind Period|Physician Decision|0|||
143471958|NCT00974090|517275083|FG000|Period 2: Open-label Period|Adverse Event|4|||
143471959|NCT00974090|517275084|FG001|Period 2: Open-label Period|Adverse Event|6|||
143471960|NCT00974090|517275083|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
143471961|NCT00974090|517275084|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
143471962|NCT00974090|517275083|FG000|Period 2: Open-label Period|Physician Decision|0|||
143471963|NCT00974090|517275084|FG001|Period 2: Open-label Period|Physician Decision|3|||
143471964|NCT00974090|517275083|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
143471965|NCT00974090|517275084|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
143471966|NCT03189862|517275085|FG000|Overall Study|Withdrawal by Subject|1|||
143471967|NCT03189862|517275086|FG001|Overall Study|Withdrawal by Subject|0|||
143471968|NCT03189862|517275085|FG000|Overall Study|Lost to Follow-up|54|||
143471969|NCT03189862|517275086|FG001|Overall Study|Lost to Follow-up|62|||
143232176|NCT00537394|516402036|FG000|First Year of Follow-up|Death|7|||
143471970|NCT01122576|517275087|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
143471971|NCT01122576|517275088|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
143471972|NCT01122576|517275089|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
143471973|NCT01122576|517275087|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
143471974|NCT01122576|517275088|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
143471975|NCT01122576|517275089|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
143471976|NCT01122576|517275087|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
143471977|NCT01122576|517275088|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
143471978|NCT01122576|517275089|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
143135656|NCT00490919|516041532|FG002|Double-blind Phase|Lack of Efficacy|36|||
143135657|NCT00490919|516041530|FG000|Double-blind Phase|Administrative|0|||
143135658|NCT00490919|516041531|FG001|Double-blind Phase|Administrative|6|||
143135659|NCT00490919|516041532|FG002|Double-blind Phase|Administrative|6|||
143135660|NCT02357459|516043779|FG000|Overall Study|Adverse Event|0|||
143135661|NCT02357459|516043780|FG001|Overall Study|Adverse Event|1|||
143135662|NCT02357459|516043781|FG002|Overall Study|Adverse Event|1|||
143135663|NCT02357459|516043779|FG000|Overall Study|Withdrawal by Subject|5|||
143135664|NCT02357459|516043780|FG001|Overall Study|Withdrawal by Subject|3|||
143135665|NCT02357459|516043781|FG002|Overall Study|Withdrawal by Subject|3|||
143135666|NCT02357459|516043779|FG000|Overall Study|Physician Decision|0|||
143135667|NCT02357459|516043780|FG001|Overall Study|Physician Decision|2|||
143135668|NCT02357459|516043781|FG002|Overall Study|Physician Decision|0|||
143135669|NCT02357459|516043779|FG000|Overall Study|Protocol Violation|1|||
143135670|NCT02357459|516043780|FG001|Overall Study|Protocol Violation|1|||
143135671|NCT02357459|516043781|FG002|Overall Study|Protocol Violation|0|||
143135672|NCT02357459|516043779|FG000|Overall Study|Lost to Follow-up|1|||
143135673|NCT02357459|516043780|FG001|Overall Study|Lost to Follow-up|3|||
143135674|NCT02357459|516043781|FG002|Overall Study|Lost to Follow-up|0|||
143135675|NCT02357459|516043779|FG000|Overall Study|Lack of Efficacy|7|||
143135676|NCT02357459|516043780|FG001|Overall Study|Lack of Efficacy|4|||
143135677|NCT02357459|516043781|FG002|Overall Study|Lack of Efficacy|4|||
143135678|NCT02357459|516043779|FG000|Overall Study|Patient Relocated|2|||
143135679|NCT02357459|516043780|FG001|Overall Study|Patient Relocated|0|||
143135680|NCT02357459|516043781|FG002|Overall Study|Patient Relocated|0|||
143135681|NCT02357459|516043779|FG000|Overall Study|Instruction from PCP|1|||
143135682|NCT02357459|516043780|FG001|Overall Study|Instruction from PCP|0|||
143135683|NCT02357459|516043781|FG002|Overall Study|Instruction from PCP|0|||
143135684|NCT02357459|516043779|FG000|Overall Study|Incarceration|0|||
143135685|NCT02357459|516043780|FG001|Overall Study|Incarceration|0|||
143135686|NCT02357459|516043781|FG002|Overall Study|Incarceration|1|||
143135687|NCT02357459|516043779|FG000|Overall Study|Pre-planned Knee surgery|0|||
143135688|NCT02357459|516043780|FG001|Overall Study|Pre-planned Knee surgery|0|||
143135689|NCT02357459|516043781|FG002|Overall Study|Pre-planned Knee surgery|2|||
143135690|NCT02357459|516043779|FG000|Overall Study|Job Commitments|0|||
143135691|NCT02357459|516043780|FG001|Overall Study|Job Commitments|0|||
143135692|NCT02357459|516043781|FG002|Overall Study|Job Commitments|1|||
143135693|NCT04113694|516043782|FG000|Overall Study|Adverse Event|2|||
143135694|NCT04113694|516043782|FG000|Overall Study|Lost to Follow-up|2|||
143135695|NCT04113694|516043782|FG000|Overall Study|Withdrawal by Subject|6|||
143135696|NCT04113694|516043782|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
143135697|NCT03163446|516043787|FG000|Overall Study|Unable to return for Day 180 visit|2|||
143135698|NCT03163446|516043788|FG001|Overall Study|Unable to return for Day 180 visit|0|||
143135699|NCT03163446|516043787|FG000|Overall Study|Withdrawal by Subject|2|||
143135700|NCT03163446|516043788|FG001|Overall Study|Withdrawal by Subject|6|||
143135701|NCT03163446|516043787|FG000|Overall Study|Death|16|||
143135702|NCT03163446|516043788|FG001|Overall Study|Death|5|||
143135703|NCT03163446|516043787|FG000|Overall Study|Lost to Follow-up|6|||
143135704|NCT03163446|516043788|FG001|Overall Study|Lost to Follow-up|5|||
143135705|NCT03163446|516043787|FG000|Overall Study|Physician Decision|1|||
143135706|NCT03163446|516043788|FG001|Overall Study|Physician Decision|1|||
143135707|NCT03163446|516043787|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
143135708|NCT03163446|516043788|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
143135709|NCT03638128|516043789|FG000|Overall Study|Withdrawal by Subject|1|||
143135710|NCT03638128|516043790|FG001|Overall Study|Withdrawal by Subject|7|||
143135711|NCT03638128|516043791|FG002|Overall Study|Withdrawal by Subject|6|||
143135712|NCT03638128|516043789|FG000|Overall Study|Sponsor Decision|15|||
143135713|NCT03638128|516043790|FG001|Overall Study|Sponsor Decision|12|||
143135714|NCT03638128|516043791|FG002|Overall Study|Sponsor Decision|19|||
143135715|NCT03638128|516043789|FG000|Overall Study|Lost to Follow-up|0|||
143135716|NCT03638128|516043790|FG001|Overall Study|Lost to Follow-up|0|||
143135717|NCT03638128|516043791|FG002|Overall Study|Lost to Follow-up|1|||
143135718|NCT00611806|516043793|FG000|Overall Study|Withdrawal by Subject|8|||
143135719|NCT00611806|516043794|FG001|Overall Study|Withdrawal by Subject|2|||
143135720|NCT00611806|516043793|FG000|Overall Study|Adverse Event|2|||
143135721|NCT00611806|516043794|FG001|Overall Study|Adverse Event|1|||
143135722|NCT00611806|516043793|FG000|Overall Study|Lost to Follow-up|6|||
143135723|NCT00611806|516043794|FG001|Overall Study|Lost to Follow-up|0|||
143135724|NCT00903201|516043795|FG000|Overall Study|Adverse Event|1|||
143135725|NCT00903201|516043796|FG001|Overall Study|Adverse Event|4|||
143135726|NCT00903201|516043797|FG002|Overall Study|Adverse Event|0|||
143135727|NCT00903201|516043795|FG000|Overall Study|Protocol Violation|2|||
143135728|NCT00903201|516043796|FG001|Overall Study|Protocol Violation|1|||
143135729|NCT00903201|516043797|FG002|Overall Study|Protocol Violation|0|||
143135730|NCT00903201|516043795|FG000|Overall Study|Lost to Follow-up|0|||
143135731|NCT00903201|516043796|FG001|Overall Study|Lost to Follow-up|1|||
143135732|NCT00903201|516043797|FG002|Overall Study|Lost to Follow-up|0|||
143135733|NCT00903201|516043795|FG000|Overall Study|Physician Decision|1|||
143135734|NCT00903201|516043796|FG001|Overall Study|Physician Decision|0|||
143135735|NCT00903201|516043797|FG002|Overall Study|Physician Decision|1|||
143135736|NCT00903201|516043795|FG000|Overall Study|Withdrawal by Subject|1|||
143135737|NCT00903201|516043796|FG001|Overall Study|Withdrawal by Subject|0|||
143135738|NCT00903201|516043797|FG002|Overall Study|Withdrawal by Subject|1|||
143135739|NCT00329108|516043798|FG000|Overall Study|Adverse Event|2|||
143135740|NCT00329108|516043799|FG001|Overall Study|Adverse Event|2|||
143135741|NCT00329108|516043798|FG000|Overall Study|Lack of Efficacy|3|||
143135742|NCT00329108|516043799|FG001|Overall Study|Lack of Efficacy|3|||
143135743|NCT00329108|516043798|FG000|Overall Study|Withdrawal by Subject|0|||
143135744|NCT00329108|516043799|FG001|Overall Study|Withdrawal by Subject|2|||
143135745|NCT00329108|516043798|FG000|Overall Study|symptomatic deterioration|1|||
143135746|NCT00329108|516043799|FG001|Overall Study|symptomatic deterioration|1|||
143135747|NCT00329108|516043798|FG000|Overall Study|Subject no longer willing to participate|2|||
143135748|NCT00329108|516043799|FG001|Overall Study|Subject no longer willing to participate|2|||
143135749|NCT00329108|516043798|FG000|Overall Study|study terminated by sponsor|1|||
143135750|NCT00329108|516043799|FG001|Overall Study|study terminated by sponsor|0|||
143135751|NCT00329108|516043798|FG000|Overall Study|withdrew patient after SAE resolved|1|||
143135752|NCT00329108|516043799|FG001|Overall Study|withdrew patient after SAE resolved|0|||
143135753|NCT00329108|516043798|FG000|Overall Study|Protocol Violation|0|||
143135754|NCT00329108|516043799|FG001|Overall Study|Protocol Violation|2|||
143135755|NCT01094288|516043802|FG000|Overall Study|Adverse Event|0|||
143135756|NCT01094288|516043803|FG001|Overall Study|Adverse Event|3|||
143135757|NCT01094288|516043804|FG002|Overall Study|Adverse Event|1|||
143135758|NCT01094288|516043805|FG003|Overall Study|Adverse Event|1|||
143135759|NCT01094288|516043806|FG004|Overall Study|Adverse Event|0|||
143135760|NCT01094288|516043807|FG005|Overall Study|Adverse Event|0|||
143135761|NCT01094288|516043808|FG006|Overall Study|Adverse Event|0|||
143135762|NCT01094288|516043809|FG007|Overall Study|Adverse Event|0|||
143135763|NCT01094288|516043802|FG000|Overall Study|Withdrawal by Subject|0|||
143135764|NCT01094288|516043803|FG001|Overall Study|Withdrawal by Subject|1|||
143135765|NCT01094288|516043804|FG002|Overall Study|Withdrawal by Subject|2|||
143135766|NCT01094288|516043805|FG003|Overall Study|Withdrawal by Subject|0|||
143135767|NCT01094288|516043806|FG004|Overall Study|Withdrawal by Subject|0|||
143135768|NCT01094288|516043807|FG005|Overall Study|Withdrawal by Subject|0|||
143135769|NCT01094288|516043808|FG006|Overall Study|Withdrawal by Subject|0|||
143135770|NCT01094288|516043809|FG007|Overall Study|Withdrawal by Subject|2|||
143135771|NCT01094288|516043802|FG000|Overall Study|Initiation of Alternative Therapy|0|||
143135772|NCT01094288|516043803|FG001|Overall Study|Initiation of Alternative Therapy|0|||
143135773|NCT01094288|516043804|FG002|Overall Study|Initiation of Alternative Therapy|1|||
143135774|NCT01094288|516043805|FG003|Overall Study|Initiation of Alternative Therapy|0|||
143135775|NCT01094288|516043806|FG004|Overall Study|Initiation of Alternative Therapy|0|||
143135776|NCT01094288|516043807|FG005|Overall Study|Initiation of Alternative Therapy|0|||
143135777|NCT01094288|516043808|FG006|Overall Study|Initiation of Alternative Therapy|0|||
143135778|NCT01094288|516043809|FG007|Overall Study|Initiation of Alternative Therapy|0|||
143135779|NCT01094288|516043802|FG000|Overall Study|Reason not Specified|2|||
143135780|NCT01094288|516043803|FG001|Overall Study|Reason not Specified|3|||
143135781|NCT01094288|516043804|FG002|Overall Study|Reason not Specified|0|||
143135782|NCT01094288|516043805|FG003|Overall Study|Reason not Specified|1|||
143135783|NCT01094288|516043806|FG004|Overall Study|Reason not Specified|0|||
143135784|NCT01094288|516043807|FG005|Overall Study|Reason not Specified|0|||
143135785|NCT01094288|516043808|FG006|Overall Study|Reason not Specified|0|||
143135786|NCT01094288|516043809|FG007|Overall Study|Reason not Specified|0|||
143135787|NCT01094288|516043802|FG000|Overall Study|Ongoing Participants|0|||
143135788|NCT01094288|516043803|FG001|Overall Study|Ongoing Participants|3|||
143135789|NCT01094288|516043804|FG002|Overall Study|Ongoing Participants|0|||
143135790|NCT01094288|516043805|FG003|Overall Study|Ongoing Participants|0|||
143135791|NCT01094288|516043806|FG004|Overall Study|Ongoing Participants|0|||
143135792|NCT01094288|516043807|FG005|Overall Study|Ongoing Participants|0|||
143135793|NCT01094288|516043808|FG006|Overall Study|Ongoing Participants|0|||
143135794|NCT01094288|516043809|FG007|Overall Study|Ongoing Participants|0|||
143232177|NCT00537394|516402037|FG001|First Year of Follow-up|Death|0|||
143361320|NCT02223182|516863706|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
143361321|NCT02223182|516863707|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
143361322|NCT02223182|516863708|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
143361323|NCT02223182|516863709|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
143361324|NCT02223182|516863706|FG000|Open-Label 500 Period|Adverse Event|1|||
143361325|NCT02223182|516863707|FG001|Open-Label 500 Period|Adverse Event|0|||
143361326|NCT02223182|516863708|FG002|Open-Label 500 Period|Adverse Event|2|||
143361327|NCT02223182|516863709|FG003|Open-Label 500 Period|Adverse Event|1|||
143361328|NCT02223182|516863706|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
143361329|NCT02223182|516863707|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
143361330|NCT02223182|516863708|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
143361331|NCT02223182|516863709|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
143135795|NCT02611882|516043810|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
143135796|NCT02611882|516043811|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
143135797|NCT02611882|516043812|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
143135798|NCT01389232|516043813|FG000|Overall Study|Had scaffold removed|15|||
143135799|NCT01389232|516043813|FG000|Overall Study|Personal reasons|2|||
143135800|NCT01389232|516043813|FG000|Overall Study|Adverse Event|1|||
143135801|NCT01389232|516043813|FG000|Overall Study|Death|1|||
143135802|NCT01317940|516043814|FG000|Overall Study|Death|1|||
143135803|NCT01317940|516043815|FG001|Overall Study|Death|0|||
143135804|NCT01317940|516043816|FG002|Overall Study|Death|1|||
143135805|NCT01317940|516043817|FG003|Overall Study|Death|0|||
143135806|NCT01317940|516043818|FG004|Overall Study|Death|0|||
143135807|NCT01317940|516043819|FG005|Overall Study|Death|0|||
143135808|NCT01317940|516043814|FG000|Overall Study|Lost to Follow-up|0|||
143135809|NCT01317940|516043815|FG001|Overall Study|Lost to Follow-up|0|||
143135810|NCT01317940|516043816|FG002|Overall Study|Lost to Follow-up|1|||
143135811|NCT01317940|516043817|FG003|Overall Study|Lost to Follow-up|1|||
143135812|NCT01317940|516043818|FG004|Overall Study|Lost to Follow-up|1|||
143135813|NCT01317940|516043819|FG005|Overall Study|Lost to Follow-up|0|||
143135814|NCT01317940|516043814|FG000|Overall Study|Change in therapy plan|0|||
143135815|NCT01317940|516043815|FG001|Overall Study|Change in therapy plan|0|||
143135816|NCT01317940|516043816|FG002|Overall Study|Change in therapy plan|3|||
143135817|NCT01317940|516043817|FG003|Overall Study|Change in therapy plan|0|||
143135818|NCT01317940|516043818|FG004|Overall Study|Change in therapy plan|0|||
143135819|NCT01317940|516043819|FG005|Overall Study|Change in therapy plan|0|||
143135820|NCT00945243|516043821|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
143135821|NCT03256578|516043822|FG000|Overall Study|Excluded Post Randomization|66|||
143135822|NCT03256578|516043823|FG001|Overall Study|Excluded Post Randomization|56|||
143135823|NCT02371616|516043824|FG000|Overall Study|Protocol Violation|2|||
143135824|NCT02371616|516043825|FG001|Overall Study|Protocol Violation|1|||
143135825|NCT02371616|516043824|FG000|Overall Study|Adverse Event|0|||
143135826|NCT02371616|516043825|FG001|Overall Study|Adverse Event|1|||
143135827|NCT02371616|516043824|FG000|Overall Study|Withdrawal of Consent|1|||
143135828|NCT02371616|516043825|FG001|Overall Study|Withdrawal of Consent|0|||
143135829|NCT02371616|516043824|FG000|Overall Study|Other (Not specified)|1|||
143135830|NCT02371616|516043825|FG001|Overall Study|Other (Not specified)|5|||
143135831|NCT00754741|516043828|FG000|Overall Study|Died or disenrolled|57|||
143135832|NCT00754741|516043829|FG001|Overall Study|Died or disenrolled|69|||
143135833|NCT00754741|516043830|FG002|Overall Study|Died or disenrolled|54|||
143135834|NCT04152200|516043832|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
143135835|NCT04152200|516043833|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
143135836|NCT04969289|516043834|FG000|Overall Study|Lost to Follow-up|13|||
143135837|NCT04969289|516043835|FG001|Overall Study|Lost to Follow-up|9|||
143135838|NCT00593814|516043836|FG000|Overall Study|Death|7|||
143135839|NCT00593814|516043837|FG001|Overall Study|Death|0|||
143135840|NCT00593814|516043836|FG000|Overall Study|Withdrawal by Subject|7|||
143135841|NCT00593814|516043837|FG001|Overall Study|Withdrawal by Subject|0|||
143135842|NCT00593814|516043836|FG000|Overall Study|Lost to Follow-up|7|||
143135843|NCT00593814|516043837|FG001|Overall Study|Lost to Follow-up|0|||
143135844|NCT00593814|516043836|FG000|Overall Study|Physician Decision|3|||
143135845|NCT00593814|516043837|FG001|Overall Study|Physician Decision|0|||
143135846|NCT02699996|516043838|FG000|Overall Study|Withdrawal by Subject|5|||
143135847|NCT02699996|516043839|FG001|Overall Study|Withdrawal by Subject|2|||
143135848|NCT01921517|516043840|FG000|Overall Study|Lost to Follow-up|5|||
143135849|NCT01921517|516043841|FG001|Overall Study|Lost to Follow-up|0|||
143135850|NCT01921517|516043840|FG000|Overall Study|Newly diagnosed health concern|2|||
143135851|NCT01921517|516043841|FG001|Overall Study|Newly diagnosed health concern|0|||
143135852|NCT01921517|516043840|FG000|Overall Study|Physician Decision|0|||
143135853|NCT01921517|516043841|FG001|Overall Study|Physician Decision|2|||
143135854|NCT01921517|516043840|FG000|Overall Study|Withdrawal by Subject|7|||
143135855|NCT01921517|516043841|FG001|Overall Study|Withdrawal by Subject|3|||
143135856|NCT01921517|516043840|FG000|Overall Study|Subject missed final imaging|1|||
143135857|NCT01921517|516043841|FG001|Overall Study|Subject missed final imaging|4|||
143135858|NCT04069715|516043842|FG000|Overall Study|Lost to Follow-up|1|||
143135859|NCT04069715|516043843|FG001|Overall Study|Lost to Follow-up|1|||
143135860|NCT04069715|516043842|FG000|Overall Study|Physician Decision|1|||
143135861|NCT04069715|516043843|FG001|Overall Study|Physician Decision|1|||
143135862|NCT04069715|516043842|FG000|Overall Study|Withdrawal by Subject|3|||
143135863|NCT04069715|516043843|FG001|Overall Study|Withdrawal by Subject|3|||
143135864|NCT01198002|516043846|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
143135865|NCT01198002|516043847|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
143135866|NCT01198002|516043848|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
143135867|NCT01198002|516043846|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
143135868|NCT01198002|516043847|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
143135869|NCT01198002|516043848|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
143135870|NCT01198002|516043846|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
143135871|NCT01198002|516043847|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
143135872|NCT01198002|516043848|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
143135873|NCT01198002|516043846|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
143135874|NCT01198002|516043847|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
143135875|NCT01198002|516043848|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
143135876|NCT01198002|516043846|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
143135877|NCT01198002|516043847|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
143135878|NCT01198002|516043848|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
143135879|NCT01198002|516043846|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
143135880|NCT01198002|516043847|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
143135881|NCT01198002|516043848|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
143135882|NCT01198002|516043846|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
143135883|NCT01198002|516043847|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
143135884|NCT01198002|516043848|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
143135885|NCT01198002|516043846|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
143135886|NCT01198002|516043847|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
143135887|NCT01198002|516043848|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
143135888|NCT01198002|516043846|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
143135889|NCT01198002|516043847|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
143135890|NCT01198002|516043848|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
143135891|NCT01198002|516043846|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
143135892|NCT01198002|516043847|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
143135893|NCT01198002|516043848|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
143135894|NCT01198002|516043846|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
143135895|NCT01198002|516043847|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
143135896|NCT01198002|516043848|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
143135897|NCT01198002|516043846|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
143135898|NCT01198002|516043847|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
143135899|NCT01198002|516043848|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
143135900|NCT01198002|516043846|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
143135901|NCT01198002|516043847|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
143135902|NCT01198002|516043848|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
143135903|NCT01198002|516043846|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
143135904|NCT01198002|516043847|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
143135905|NCT01198002|516043848|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
143135906|NCT01198002|516043846|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
143135907|NCT01198002|516043847|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
143135908|NCT01198002|516043848|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
143135909|NCT03353792|516043856|FG000|Overall Study|Lost to Follow-up|1|||
143135910|NCT03353792|516043857|FG001|Overall Study|Lost to Follow-up|0|||
143135911|NCT03353792|516043856|FG000|Overall Study|Participant Unable to Manage Device|1|||
143135912|NCT03353792|516043857|FG001|Overall Study|Participant Unable to Manage Device|0|||
143135913|NCT00789321|516043858|FG000|Overall Study|Adverse Event|0|||
143135914|NCT00789321|516043859|FG001|Overall Study|Adverse Event|1|||
143135915|NCT04456686|516043862|FG000|Overall Study|Adverse Event|2|||
143135916|NCT04456686|516043863|FG001|Overall Study|Adverse Event|1|||
143135917|NCT04456686|516043862|FG000|Overall Study|Lack of Efficacy|3|||
143135918|NCT04456686|516043863|FG001|Overall Study|Lack of Efficacy|1|||
143135919|NCT04456686|516043862|FG000|Overall Study|Withdrew consent|3|||
143135920|NCT04456686|516043863|FG001|Overall Study|Withdrew consent|1|||
143135921|NCT04456686|516043862|FG000|Overall Study|Physician Decision|2|||
143135922|NCT04456686|516043863|FG001|Overall Study|Physician Decision|2|||
143135923|NCT04456686|516043862|FG000|Overall Study|Withdrawal by Subject|5|||
143135924|NCT04456686|516043863|FG001|Overall Study|Withdrawal by Subject|1|||
143135925|NCT04456686|516043862|FG000|Overall Study|Protocol Violation|0|||
143135926|NCT04456686|516043863|FG001|Overall Study|Protocol Violation|1|||
143135927|NCT01408706|516043864|FG000|Overall Study|Physician Decision|1|||
143135928|NCT01408706|516043865|FG001|Overall Study|Physician Decision|0|||
143135929|NCT00888654|516043866|FG000|Overall Study|Problems swallowing oral meds.|1|||
143135930|NCT00888654|516043866|FG000|Overall Study|Not enough oral meds before surgery|3|||
143135931|NCT00888654|516043866|FG000|Overall Study|Surgery aborted|2|||
143135932|NCT00888654|516043866|FG000|Overall Study|Withdrawal by Subject|1|||
143135933|NCT00888654|516043866|FG000|Overall Study|Inelig. due to contraindication of med|1|||
143135934|NCT00888654|516043866|FG000|Overall Study|Change in surg date|1|||
143135935|NCT00888654|516043866|FG000|Overall Study|Stopped meds due to headaches|1|||
143135936|NCT01418339|516043867|FG000|Overall Study|Adverse Event|5|||
143135937|NCT01418339|516043868|FG001|Overall Study|Adverse Event|2|||
143135938|NCT01418339|516043867|FG000|Overall Study|Subject Withdrew Consent|1|||
143135939|NCT01418339|516043868|FG001|Overall Study|Subject Withdrew Consent|2|||
143135940|NCT01418339|516043867|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
143135941|NCT01418339|516043868|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
143135942|NCT02204917|516043871|FG000|Overall Study|Protocol Violation|1|||
143135943|NCT00909844|516043872|FG000|Overall Study|Adverse Event|1|||
143135944|NCT00909844|516043872|FG000|Overall Study|Withdrawal by Subject|1|||
143135945|NCT00909844|516043872|FG000|Overall Study|Lost to Follow-up|2|||
143135946|NCT02219685|516043873|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
143135947|NCT02219685|516043874|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
143135948|NCT02219685|516043873|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
143135949|NCT02219685|516043874|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
143135950|NCT00698815|516043875|FG000|Overall Study|Death|1|||
143135951|NCT00698815|516043876|FG001|Overall Study|Death|2|||
143135952|NCT00698815|516043877|FG002|Overall Study|Death|4|||
143135953|NCT00698815|516043875|FG000|Overall Study|Withdrawal by Subject|6|||
143135954|NCT00698815|516043876|FG001|Overall Study|Withdrawal by Subject|3|||
143135955|NCT00698815|516043877|FG002|Overall Study|Withdrawal by Subject|2|||
143135956|NCT00698815|516043875|FG000|Overall Study|MD discretion|2|||
143135957|NCT00698815|516043876|FG001|Overall Study|MD discretion|7|||
143135958|NCT00698815|516043877|FG002|Overall Study|MD discretion|2|||
143135959|NCT00698815|516043875|FG000|Overall Study|Did not receive protocol treatment|1|||
143135960|NCT00698815|516043876|FG001|Overall Study|Did not receive protocol treatment|2|||
143135961|NCT00698815|516043877|FG002|Overall Study|Did not receive protocol treatment|2|||
143135962|NCT00706004|516043878|FG000|Overall Study|Did not meet eligibility criteria|2|||
143135963|NCT00297648|516043879|FG000|Overall Study|Adverse Event|13|||
143135964|NCT00297648|516043879|FG000|Overall Study|Lack of Efficacy|18|||
143135965|NCT00297648|516043879|FG000|Overall Study|Lost to Follow-up|1|||
143135966|NCT00297648|516043879|FG000|Overall Study|Withdrawal by Subject|3|||
143135967|NCT00297648|516043879|FG000|Overall Study|Other: Incompliance|1|||
143135968|NCT01211145|516043882|FG000|Overall Study|Reason not specified|3|||
143135969|NCT01211145|516043883|FG001|Overall Study|Reason not specified|2|||
143135970|NCT01211145|516043884|FG002|Overall Study|Reason not specified|2|||
143135971|NCT01211145|516043885|FG003|Overall Study|Reason not specified|1|||
143135972|NCT01211145|516043882|FG000|Overall Study|Lost to Follow-up|3|||
143135973|NCT01211145|516043883|FG001|Overall Study|Lost to Follow-up|2|||
143135974|NCT01211145|516043884|FG002|Overall Study|Lost to Follow-up|1|||
143135975|NCT01211145|516043885|FG003|Overall Study|Lost to Follow-up|2|||
143135976|NCT01211145|516043882|FG000|Overall Study|Study-specific withdrawal criteria|1|||
143135977|NCT01211145|516043883|FG001|Overall Study|Study-specific withdrawal criteria|0|||
143135978|NCT01211145|516043884|FG002|Overall Study|Study-specific withdrawal criteria|0|||
143135979|NCT01211145|516043885|FG003|Overall Study|Study-specific withdrawal criteria|0|||
143135980|NCT01211145|516043882|FG000|Overall Study|Severe noncompliance to protocol|1|||
143135981|NCT01211145|516043883|FG001|Overall Study|Severe noncompliance to protocol|0|||
143135982|NCT01211145|516043884|FG002|Overall Study|Severe noncompliance to protocol|0|||
143135983|NCT01211145|516043885|FG003|Overall Study|Severe noncompliance to protocol|0|||
143135984|NCT01211145|516043882|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
143135985|NCT01211145|516043883|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
143135986|NCT01211145|516043884|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
143135987|NCT01211145|516043885|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
143135988|NCT01211145|516043882|FG000|Overall Study|Patient decision|2|||
143135989|NCT01211145|516043883|FG001|Overall Study|Patient decision|1|||
143135990|NCT01211145|516043884|FG002|Overall Study|Patient decision|0|||
143135991|NCT01211145|516043885|FG003|Overall Study|Patient decision|2|||
143135992|NCT00427908|516043886|FG000|Primary Phase|Lost to Follow-up|4|||
143135993|NCT00427908|516043887|FG001|Primary Phase|Lost to Follow-up|0|||
143135994|NCT00427908|516043888|FG002|Primary Phase|Lost to Follow-up|2|||
143135995|NCT00427908|516043889|FG003|Primary Phase|Lost to Follow-up|0|||
143135996|NCT00427908|516043886|FG000|Primary Phase|Withdrawal by Subject|1|||
143135997|NCT00427908|516043887|FG001|Primary Phase|Withdrawal by Subject|2|||
143135998|NCT00427908|516043888|FG002|Primary Phase|Withdrawal by Subject|1|||
143135999|NCT00427908|516043889|FG003|Primary Phase|Withdrawal by Subject|0|||
143136000|NCT00427908|516043886|FG000|Primary Phase|Adverse Event|0|||
143136001|NCT00427908|516043887|FG001|Primary Phase|Adverse Event|1|||
143136002|NCT00427908|516043888|FG002|Primary Phase|Adverse Event|0|||
143136003|NCT00427908|516043889|FG003|Primary Phase|Adverse Event|0|||
143136004|NCT04202497|516043893|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
143136005|NCT04202497|516043894|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
143136006|NCT04202497|516043895|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
143136007|NCT04202497|516043896|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
143136008|NCT04344301|516043897|FG000|Overall Study|Withdrawal by Subject|1|||
143136009|NCT04344301|516043898|FG001|Overall Study|Withdrawal by Subject|0|||
143136010|NCT04344301|516043897|FG000|Overall Study|Death|0|||
143136011|NCT04344301|516043898|FG001|Overall Study|Death|1|||
143136012|NCT05214118|516043912|FG000|Overall Study|Lost to Follow-up|0|||
143136013|NCT05214118|516043913|FG001|Overall Study|Lost to Follow-up|2|||
143136014|NCT05214118|516043912|FG000|Overall Study|delivered late preterm 34 wks gestation|1|||
143136015|NCT05214118|516043913|FG001|Overall Study|delivered late preterm 34 wks gestation|1|||
143136016|NCT05214118|516043912|FG000|Overall Study|moved|1|||
143136017|NCT05214118|516043913|FG001|Overall Study|moved|0|||
143471979|NCT05696236|517275090|FG000|Overall Study|Lost to Follow-up|1|||
143471980|NCT05696236|517275091|FG001|Overall Study|Lost to Follow-up|0|||
143471981|NCT05696236|517275090|FG000|Overall Study|Later determined to not be eligible for participation|0|||
143136018|NCT03014206|516043916|FG000|Overall Study|Registration Violation|12|||
143136019|NCT01091246|516043917|FG000|Overall Study|Lost to Follow-up|23|||
143136020|NCT01091246|516043918|FG001|Overall Study|Lost to Follow-up|11|||
143136021|NCT01091246|516043919|FG002|Overall Study|Lost to Follow-up|7|||
143136022|NCT01091246|516043917|FG000|Overall Study|Adverse Event|1|||
143136023|NCT01091246|516043918|FG001|Overall Study|Adverse Event|0|||
143136024|NCT01091246|516043919|FG002|Overall Study|Adverse Event|1|||
143136025|NCT01091246|516043917|FG000|Overall Study|Withdrawal by Subject|9|||
143136026|NCT01091246|516043918|FG001|Overall Study|Withdrawal by Subject|5|||
143136027|NCT01091246|516043919|FG002|Overall Study|Withdrawal by Subject|4|||
143136028|NCT01091246|516043917|FG000|Overall Study|Subject not dosed|2|||
143136029|NCT01091246|516043918|FG001|Overall Study|Subject not dosed|0|||
143136030|NCT01091246|516043919|FG002|Overall Study|Subject not dosed|1|||
143136031|NCT04460326|516043925|FG000|Completed at Least 4 Meals|Early discharge|5|||
143136032|NCT04460326|516043926|FG001|Completed at Least 4 Meals|Early discharge|5|||
143136033|NCT04460326|516043925|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
143136034|NCT04460326|516043926|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
143136035|NCT04460326|516043925|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
143136036|NCT04460326|516043926|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
143136037|NCT04460326|516043925|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
143136038|NCT04460326|516043926|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
143136039|NCT04460326|516043925|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
143136040|NCT04460326|516043926|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
143136041|NCT04460326|516043925|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
143136042|NCT04460326|516043926|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
143136043|NCT03160716|516043927|FG000|Overall Study|Lost to Follow-up|1|||
143136044|NCT02283658|516043928|FG000|Overall Study|Withdrawal by Subject|1|||
143136045|NCT02700048|516043929|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
143136046|NCT02700048|516043930|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
143136047|NCT03311945|516043936|FG000|Overall Study|Adverse Event|2|||
143136048|NCT03311945|516043936|FG000|Overall Study|Lack of Efficacy|1|||
143136049|NCT01107925|516043937|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
143136050|NCT01107925|516043938|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
143136051|NCT01107925|516043939|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
143136052|NCT01107925|516043940|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
143136053|NCT01107925|516043941|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
143136054|NCT01107925|516043942|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
143136055|NCT01107925|516043937|FG000|Period 2|Withdrawal by Subject|0|||
143136056|NCT01107925|516043938|FG001|Period 2|Withdrawal by Subject|1|||
143136057|NCT01107925|516043939|FG002|Period 2|Withdrawal by Subject|0|||
143136058|NCT01107925|516043940|FG003|Period 2|Withdrawal by Subject|0|||
143136059|NCT01107925|516043941|FG004|Period 2|Withdrawal by Subject|0|||
143136060|NCT01107925|516043942|FG005|Period 2|Withdrawal by Subject|1|||
143136061|NCT04877990|516043943|FG000|Treatment|Other reasons|3|||
143136062|NCT04877990|516043944|FG001|Treatment|Other reasons|1|||
143136063|NCT04877990|516043943|FG000|Treatment|Administrative reasons by sponsor|17|||
143136064|NCT04877990|516043944|FG001|Treatment|Administrative reasons by sponsor|33|||
143136065|NCT04877990|516043943|FG000|Treatment|Withdrawal by Subject|2|||
143136066|NCT04877990|516043944|FG001|Treatment|Withdrawal by Subject|6|||
143136067|NCT04877990|516043943|FG000|Treatment|Adverse Event|2|||
143136068|NCT04877990|516043944|FG001|Treatment|Adverse Event|1|||
143136069|NCT01619878|516043945|FG000|6 Week Follow-up Phase|Adverse Event|1|||
143136070|NCT01619878|516043945|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
143136071|NCT01619878|516043945|FG000|Follow-up at 12 Months of Age|Death|2|||
143136072|NCT01305564|516043946|FG000|Overall Study|Death|21|||
143471982|NCT05696236|517275091|FG001|Overall Study|Later determined to not be eligible for participation|1|||
143471983|NCT05696236|517275090|FG000|Overall Study|Withdrawal by Subject|2|||
143471984|NCT05696236|517275091|FG001|Overall Study|Withdrawal by Subject|2|||
143471985|NCT01829360|517275092|FG000|Overall Study|Protocol Violation|0|||
143471986|NCT01829360|517275093|FG001|Overall Study|Protocol Violation|0|||
143136073|NCT01305564|516043946|FG000|Overall Study|Lost to Follow-up|12|||
143136074|NCT01305564|516043946|FG000|Overall Study|Withdrawal by Subject|1|||
143136075|NCT01305564|516043946|FG000|Overall Study|Physician Decision|3|||
143136076|NCT00960804|516043959|FG000|Overall Study|Adverse Event|1|||
143136077|NCT00960804|516043960|FG001|Overall Study|Adverse Event|0|||
143136078|NCT00960804|516043961|FG002|Overall Study|Adverse Event|0|||
143136079|NCT00960804|516043959|FG000|Overall Study|Withdrawal by Subject|1|||
143136080|NCT00960804|516043960|FG001|Overall Study|Withdrawal by Subject|0|||
143136081|NCT00960804|516043961|FG002|Overall Study|Withdrawal by Subject|0|||
143232178|NCT00537394|516402038|FG002|First Year of Follow-up|Death|0|||
143136082|NCT00960804|516043959|FG000|Overall Study|Study terminated by the sponsor|5|||
143136083|NCT00960804|516043960|FG001|Overall Study|Study terminated by the sponsor|4|||
143136084|NCT00960804|516043961|FG002|Overall Study|Study terminated by the sponsor|10|||
143136085|NCT03028142|516045972|FG000|Overall Study|Adverse Event|1|||
143136086|NCT03028142|516045973|FG001|Overall Study|Adverse Event|1|||
143136087|NCT03028142|516045974|FG002|Overall Study|Adverse Event|0|||
143136088|NCT03028142|516045975|FG003|Overall Study|Adverse Event|0|||
143136089|NCT03028142|516045976|FG004|Overall Study|Adverse Event|0|||
143136090|NCT03028142|516045977|FG005|Overall Study|Adverse Event|1|||
143136091|NCT03028142|516045972|FG000|Overall Study|Withdrawal by Subject|0|||
143136092|NCT03028142|516045973|FG001|Overall Study|Withdrawal by Subject|0|||
143136093|NCT03028142|516045974|FG002|Overall Study|Withdrawal by Subject|0|||
143136094|NCT03028142|516045975|FG003|Overall Study|Withdrawal by Subject|0|||
143136095|NCT03028142|516045976|FG004|Overall Study|Withdrawal by Subject|1|||
143136096|NCT03028142|516045977|FG005|Overall Study|Withdrawal by Subject|0|||
143136097|NCT00643760|516045980|FG000|Overall Study|Adverse Event|11|||
143136098|NCT00643760|516045981|FG001|Overall Study|Adverse Event|5|||
143136099|NCT00643760|516045982|FG002|Overall Study|Adverse Event|12|||
143136100|NCT00643760|516045983|FG003|Overall Study|Adverse Event|21|||
143136101|NCT00643760|516045984|FG004|Overall Study|Adverse Event|6|||
143136102|NCT00643760|516045980|FG000|Overall Study|Lack of Efficacy|3|||
143136103|NCT00643760|516045981|FG001|Overall Study|Lack of Efficacy|1|||
143136104|NCT00643760|516045982|FG002|Overall Study|Lack of Efficacy|0|||
143136105|NCT00643760|516045983|FG003|Overall Study|Lack of Efficacy|4|||
143136106|NCT00643760|516045984|FG004|Overall Study|Lack of Efficacy|3|||
143136107|NCT00643760|516045980|FG000|Overall Study|Protocol Violation|7|||
143136108|NCT00643760|516045981|FG001|Overall Study|Protocol Violation|6|||
143136109|NCT00643760|516045982|FG002|Overall Study|Protocol Violation|4|||
143136110|NCT00643760|516045983|FG003|Overall Study|Protocol Violation|4|||
143471987|NCT01829360|517275094|FG002|Overall Study|Protocol Violation|1|||
143136111|NCT00643760|516045984|FG004|Overall Study|Protocol Violation|6|||
143471988|NCT01829360|517275095|FG003|Overall Study|Protocol Violation|0|||
143471989|NCT02378220|517275100|FG000|Overall Study|Death|6|||
143471990|NCT02378220|517275101|FG001|Overall Study|Death|1|||
143471991|NCT00578786|517275102|FG000|Overall Study|Adverse Event|27|||
143471992|NCT00578786|517275103|FG001|Overall Study|Adverse Event|37|||
143471993|NCT00578786|517275104|FG002|Overall Study|Adverse Event|17|||
143471994|NCT00578786|517275102|FG000|Overall Study|Lack of Efficacy|2|||
143471995|NCT00578786|517275103|FG001|Overall Study|Lack of Efficacy|5|||
143136112|NCT00643760|516045980|FG000|Overall Study|Lost to Follow-up|6|||
143136113|NCT00643760|516045981|FG001|Overall Study|Lost to Follow-up|2|||
143136114|NCT00643760|516045982|FG002|Overall Study|Lost to Follow-up|1|||
143136115|NCT00643760|516045983|FG003|Overall Study|Lost to Follow-up|3|||
143136116|NCT00643760|516045984|FG004|Overall Study|Lost to Follow-up|3|||
143136117|NCT00643760|516045980|FG000|Overall Study|Investigator Discretion|0|||
143136118|NCT00643760|516045981|FG001|Overall Study|Investigator Discretion|0|||
143136119|NCT00643760|516045982|FG002|Overall Study|Investigator Discretion|0|||
143136120|NCT00643760|516045983|FG003|Overall Study|Investigator Discretion|2|||
143136121|NCT00643760|516045984|FG004|Overall Study|Investigator Discretion|0|||
143136122|NCT00643760|516045980|FG000|Overall Study|Withdrawal by Subject|3|||
143136123|NCT00643760|516045981|FG001|Overall Study|Withdrawal by Subject|1|||
143136124|NCT00643760|516045982|FG002|Overall Study|Withdrawal by Subject|2|||
143136125|NCT00643760|516045983|FG003|Overall Study|Withdrawal by Subject|4|||
143136126|NCT00643760|516045984|FG004|Overall Study|Withdrawal by Subject|1|||
143136127|NCT01249417|516045996|FG000|Randomised Population|Study treatment not received|0|||
143136128|NCT01249417|516045997|FG001|Randomised Population|Study treatment not received|0|||
143136129|NCT01249417|516045998|FG002|Randomised Population|Study treatment not received|2|||
143136130|NCT01249417|516045996|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
143136131|NCT01249417|516045997|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
143136132|NCT01249417|516045998|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
143136133|NCT01249417|516045996|FG000|Treatment Phase - ITT Population|Other|0|||
143136134|NCT01249417|516045997|FG001|Treatment Phase - ITT Population|Other|0|||
143136135|NCT01249417|516045998|FG002|Treatment Phase - ITT Population|Other|1|||
143136136|NCT01249417|516045996|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
143136137|NCT01249417|516045997|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
143136138|NCT01249417|516045998|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
143136139|NCT01249417|516045996|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
143136140|NCT01249417|516045997|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
143471996|NCT00578786|517275104|FG002|Overall Study|Lack of Efficacy|2|||
143471997|NCT00578786|517275102|FG000|Overall Study|Early Escape from Prior Study|2|||
143471998|NCT00578786|517275103|FG001|Overall Study|Early Escape from Prior Study|1|||
143471999|NCT00578786|517275104|FG002|Overall Study|Early Escape from Prior Study|2|||
143136141|NCT01249417|516045998|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
143136142|NCT01249417|516045996|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
143472000|NCT00578786|517275102|FG000|Overall Study|Withdrawal by Subject|7|||
143472001|NCT00578786|517275103|FG001|Overall Study|Withdrawal by Subject|8|||
143136143|NCT01249417|516045997|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
143136144|NCT01249417|516045998|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
143136145|NCT00917124|516045999|FG000|Overall Study|Protocol Violation|4|||
143136146|NCT00917124|516046000|FG001|Overall Study|Protocol Violation|6|||
143136147|NCT03769649|516046005|FG000|Overall Study|Lost to Follow-up|4|||
143136148|NCT02858401|516046009|FG000|Overall Study|Withdrew Consent|0|||
143136149|NCT02858401|516046010|FG001|Overall Study|Withdrew Consent|0|||
143136150|NCT02858401|516046011|FG002|Overall Study|Withdrew Consent|0|||
143136151|NCT02858401|516046012|FG003|Overall Study|Withdrew Consent|0|||
143136152|NCT02858401|516046013|FG004|Overall Study|Withdrew Consent|0|||
143136153|NCT02858401|516046014|FG005|Overall Study|Withdrew Consent|1|||
143136154|NCT02858401|516046015|FG006|Overall Study|Withdrew Consent|0|||
143136155|NCT02858401|516046009|FG000|Overall Study|Lost to Follow-up|0|||
143136156|NCT02858401|516046010|FG001|Overall Study|Lost to Follow-up|1|||
143136157|NCT02858401|516046011|FG002|Overall Study|Lost to Follow-up|0|||
143136158|NCT02858401|516046012|FG003|Overall Study|Lost to Follow-up|0|||
143136159|NCT02858401|516046013|FG004|Overall Study|Lost to Follow-up|0|||
143136160|NCT02858401|516046014|FG005|Overall Study|Lost to Follow-up|0|||
143136161|NCT02858401|516046015|FG006|Overall Study|Lost to Follow-up|0|||
143136162|NCT00748241|516046016|FG000|Overall Study|Implant failure|1|||
143136163|NCT00748241|516046016|FG000|Overall Study|Lost to Follow-up|5|||
143136164|NCT00748241|516046016|FG000|Overall Study|Death|2|||
143136165|NCT02974868|516046022|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
143136166|NCT02974868|516046023|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
143136167|NCT02974868|516046024|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
143136168|NCT02974868|516046025|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
143136169|NCT02974868|516046022|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
143136170|NCT02974868|516046023|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
143136171|NCT02974868|516046024|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
143136172|NCT02974868|516046025|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
143136173|NCT02974868|516046022|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
143136174|NCT02974868|516046023|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
143136175|NCT02974868|516046024|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
143136176|NCT02974868|516046025|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
143136177|NCT02974868|516046022|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
143136178|NCT02974868|516046023|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
143136179|NCT02974868|516046024|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
143136180|NCT02974868|516046025|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
143136181|NCT02674516|516046026|FG000|Overall Study|Lost to Follow-up|3|||
143136182|NCT02674516|516046027|FG001|Overall Study|Lost to Follow-up|0|||
143136183|NCT02674516|516046026|FG000|Overall Study|Protocol Violation|0|||
143136184|NCT02674516|516046027|FG001|Overall Study|Protocol Violation|4|||
143136185|NCT02674516|516046026|FG000|Overall Study|Knowledge of study hypothesis|1|||
143136186|NCT02674516|516046027|FG001|Overall Study|Knowledge of study hypothesis|0|||
143136187|NCT01064479|516046028|FG000|Overall Study|Death|10|||
143136188|NCT01064479|516046029|FG001|Overall Study|Death|11|||
143472002|NCT00578786|517275104|FG002|Overall Study|Withdrawal by Subject|5|||
143472003|NCT00578786|517275102|FG000|Overall Study|Protocol Violation|0|||
143472004|NCT00578786|517275103|FG001|Overall Study|Protocol Violation|3|||
143472005|NCT00578786|517275104|FG002|Overall Study|Protocol Violation|1|||
143472006|NCT00578786|517275102|FG000|Overall Study|Physician Decision|1|||
143472007|NCT00578786|517275103|FG001|Overall Study|Physician Decision|0|||
143472008|NCT00578786|517275104|FG002|Overall Study|Physician Decision|1|||
143472009|NCT00578786|517275102|FG000|Overall Study|Sponsor Decision|0|||
143472010|NCT00578786|517275103|FG001|Overall Study|Sponsor Decision|0|||
143472011|NCT00578786|517275104|FG002|Overall Study|Sponsor Decision|1|||
143472012|NCT00578786|517275102|FG000|Overall Study|Lost to Follow-up|0|||
143472013|NCT00578786|517275103|FG001|Overall Study|Lost to Follow-up|4|||
143472014|NCT00578786|517275104|FG002|Overall Study|Lost to Follow-up|0|||
143472015|NCT00578786|517275102|FG000|Overall Study|Pregnancy|0|||
143472016|NCT00578786|517275103|FG001|Overall Study|Pregnancy|1|||
143472017|NCT00578786|517275104|FG002|Overall Study|Pregnancy|0|||
143136189|NCT01064479|516046028|FG000|Overall Study|Withdrawal by Subject|2|||
143136190|NCT01064479|516046029|FG001|Overall Study|Withdrawal by Subject|2|||
143136191|NCT01064479|516046028|FG000|Overall Study|Disease progression|1|||
143136192|NCT01064479|516046029|FG001|Overall Study|Disease progression|1|||
143136193|NCT01064479|516046028|FG000|Overall Study|Toxicity|1|||
143472018|NCT00578786|517275102|FG000|Overall Study|Not Otherwise Specified|0|||
143472019|NCT00578786|517275103|FG001|Overall Study|Not Otherwise Specified|4|||
143472020|NCT00578786|517275104|FG002|Overall Study|Not Otherwise Specified|1|||
143136194|NCT01064479|516046029|FG001|Overall Study|Toxicity|1|||
143136195|NCT01064479|516046028|FG000|Overall Study|Other|1|||
143136196|NCT01064479|516046029|FG001|Overall Study|Other|2|||
143472021|NCT00578786|517275102|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
143472022|NCT00578786|517275103|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
143472023|NCT00578786|517275104|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
143472024|NCT05105789|517275105|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
143472025|NCT01975428|517275109|FG000|Overall Study|Lost to Follow-up|17|||
143472026|NCT01975428|517275110|FG001|Overall Study|Lost to Follow-up|4|||
143472027|NCT01975428|517275109|FG000|Overall Study|Withdrawal by Subject|3|||
143472028|NCT01975428|517275110|FG001|Overall Study|Withdrawal by Subject|10|||
143472029|NCT02545322|517275111|FG000|Overall Study|Withdrawal by Subject|3|||
143472030|NCT00778622|517275112|FG000|Overall Study|Adverse Event|5|||
143472031|NCT00778622|517275113|FG001|Overall Study|Adverse Event|4|||
143472032|NCT00778622|517275114|FG002|Overall Study|Adverse Event|7|||
143472033|NCT00778622|517275112|FG000|Overall Study|Withdrawal by Subject|4|||
143472034|NCT00778622|517275113|FG001|Overall Study|Withdrawal by Subject|5|||
143472035|NCT00778622|517275114|FG002|Overall Study|Withdrawal by Subject|5|||
143472036|NCT00778622|517275112|FG000|Overall Study|Lost to Follow-up|3|||
143472037|NCT00778622|517275113|FG001|Overall Study|Lost to Follow-up|3|||
143136197|NCT03903172|516046034|FG000|Overall Study|screen fail|4|||
143136198|NCT03903172|516046035|FG001|Overall Study|screen fail|1|||
143136199|NCT02495389|516046036|FG000|Overall Study|Withdrawal by Subject|40|||
143136200|NCT01802385|516046040|FG000|Overall Study|Death|106|||
143136201|NCT01802385|516046041|FG001|Overall Study|Death|120|||
143136202|NCT05559905|516046042|FG000|Overall Study|Withdrawal by Subject|1|||
143136203|NCT05559905|516046043|FG001|Overall Study|Withdrawal by Subject|0|||
143136204|NCT05559905|516046044|FG002|Overall Study|Withdrawal by Subject|0|||
143136205|NCT05559905|516046042|FG000|Overall Study|Not Reported|1|||
143136206|NCT05559905|516046043|FG001|Overall Study|Not Reported|0|||
143136207|NCT05559905|516046044|FG002|Overall Study|Not Reported|0|||
143136208|NCT04003103|516046045|FG000|Overall Study|Death|1|||
143136209|NCT04003103|516046046|FG001|Overall Study|Death|0|||
143136210|NCT04003103|516046047|FG002|Overall Study|Death|0|||
143136211|NCT04003103|516046045|FG000|Overall Study|Lost to Follow-up|4|||
143136212|NCT04003103|516046046|FG001|Overall Study|Lost to Follow-up|3|||
143136213|NCT04003103|516046047|FG002|Overall Study|Lost to Follow-up|2|||
143136214|NCT04003103|516046045|FG000|Overall Study|Withdrawal by Subject|10|||
143136215|NCT04003103|516046046|FG001|Overall Study|Withdrawal by Subject|1|||
143136216|NCT04003103|516046047|FG002|Overall Study|Withdrawal by Subject|1|||
143136217|NCT04003103|516046045|FG000|Overall Study|Status not recorded|0|||
143136218|NCT04003103|516046046|FG001|Overall Study|Status not recorded|2|||
143136219|NCT04003103|516046047|FG002|Overall Study|Status not recorded|0|||
143136220|NCT05518539|516046048|FG000|Overall Study|Lost to Follow-up|6|||
143136221|NCT01077323|516046049|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
143136222|NCT01077323|516046050|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
143136223|NCT01077323|516046051|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
143136224|NCT01077323|516046049|FG000|Overall Study|Dispensing of drug in baseline period|0|||
143136225|NCT01077323|516046050|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
143136226|NCT01077323|516046051|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
143136227|NCT01077323|516046049|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
143136228|NCT01077323|516046050|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
143136229|NCT01077323|516046051|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
143136230|NCT00617357|516046052|FG000|Overall Study|Lost to Follow-up|7|||
143136231|NCT00617357|516046052|FG000|Overall Study|Death|5|||
143136232|NCT00617357|516046052|FG000|Overall Study|insurance concerns|2|||
143136233|NCT00617357|516046052|FG000|Overall Study|Withdrawal by Subject|1|||
143136234|NCT00617357|516046052|FG000|Overall Study|Physician Decision|1|||
143136235|NCT01747499|516046053|FG000|Overall Study|Steroid refractory aGvHD|1|||
143136236|NCT01747499|516046054|FG001|Overall Study|Steroid refractory aGvHD|0|||
143136237|NCT01747499|516046055|FG002|Overall Study|Steroid refractory aGvHD|0|||
143136238|NCT01747499|516046056|FG003|Overall Study|Steroid refractory aGvHD|1|||
143136239|NCT01747499|516046057|FG004|Overall Study|Steroid refractory aGvHD|4|||
143136240|NCT01747499|516046053|FG000|Overall Study|Physician Decision|0|||
143136241|NCT01747499|516046054|FG001|Overall Study|Physician Decision|1|||
143136242|NCT01747499|516046055|FG002|Overall Study|Physician Decision|0|||
143136243|NCT01747499|516046056|FG003|Overall Study|Physician Decision|0|||
143136244|NCT01747499|516046057|FG004|Overall Study|Physician Decision|2|||
143136245|NCT01747499|516046053|FG000|Overall Study|Death|0|||
143136246|NCT01747499|516046054|FG001|Overall Study|Death|0|||
143136247|NCT01747499|516046055|FG002|Overall Study|Death|0|||
143136248|NCT01747499|516046056|FG003|Overall Study|Death|1|||
143472038|NCT00778622|517275114|FG002|Overall Study|Lost to Follow-up|2|||
143136249|NCT01747499|516046057|FG004|Overall Study|Death|1|||
143136250|NCT01747499|516046053|FG000|Overall Study|Withdrawal by Subject|0|||
143136251|NCT01747499|516046054|FG001|Overall Study|Withdrawal by Subject|0|||
143136252|NCT01747499|516046055|FG002|Overall Study|Withdrawal by Subject|0|||
143013997|NCT03252756|515590131|FG001|Overall Study|Protocol Violation|4|||
143136253|NCT01747499|516046056|FG003|Overall Study|Withdrawal by Subject|0|||
143136254|NCT01747499|516046057|FG004|Overall Study|Withdrawal by Subject|6|||
143136255|NCT01747499|516046053|FG000|Overall Study|Developed AML and death|0|||
143136256|NCT01747499|516046054|FG001|Overall Study|Developed AML and death|0|||
143472039|NCT00778622|517275112|FG000|Overall Study|Protocol Violation|0|||
143472040|NCT00778622|517275113|FG001|Overall Study|Protocol Violation|3|||
143136257|NCT01747499|516046055|FG002|Overall Study|Developed AML and death|0|||
143136258|NCT01747499|516046056|FG003|Overall Study|Developed AML and death|0|||
143136259|NCT01747499|516046057|FG004|Overall Study|Developed AML and death|1|||
143136260|NCT01747499|516046053|FG000|Overall Study|Determined not to be eligible|0|||
143136261|NCT01747499|516046054|FG001|Overall Study|Determined not to be eligible|0|||
143136262|NCT01747499|516046055|FG002|Overall Study|Determined not to be eligible|0|||
143136263|NCT01747499|516046056|FG003|Overall Study|Determined not to be eligible|0|||
143136264|NCT01747499|516046057|FG004|Overall Study|Determined not to be eligible|1|||
143136265|NCT01791985|516046058|FG000|Overall Study|Adverse Event|7|||
143136266|NCT01791985|516046058|FG000|Overall Study|Withdrawal by Subject|1|||
143136267|NCT00372424|516046059|FG000|Overall Study|Adverse Event|2|||
143136268|NCT00372424|516046059|FG000|Overall Study|Withdrawal by Subject|1|||
143136269|NCT00372424|516046059|FG000|Overall Study|Death|1|||
143136270|NCT00372424|516046059|FG000|Overall Study|Objective Progression or Relapse|14|||
143136271|NCT00372424|516046059|FG000|Overall Study|Other|7|||
143136272|NCT00372424|516046059|FG000|Overall Study|Enrolled, Not Treated|1|||
143136273|NCT00072410|516046060|FG000|Overall Study|Progressive disease|0|||
143136274|NCT00072410|516046061|FG001|Overall Study|Progressive disease|3|||
143136275|NCT03797898|516046067|FG000|Overall Study|Lost to Follow-up|60|||
143136276|NCT03797898|516046068|FG001|Overall Study|Lost to Follow-up|69|||
143136277|NCT03797898|516046067|FG000|Overall Study|Withdrawal by Subject|9|||
143136278|NCT03797898|516046068|FG001|Overall Study|Withdrawal by Subject|7|||
143136279|NCT03797898|516046067|FG000|Overall Study|Became ineligible|5|||
143136280|NCT03797898|516046068|FG001|Overall Study|Became ineligible|2|||
143136281|NCT01614470|516046069|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
143136282|NCT01614470|516046070|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
143136283|NCT01614470|516046071|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
143136284|NCT01614470|516046069|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
143136285|NCT01614470|516046070|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
143136286|NCT01614470|516046071|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
143136287|NCT03217591|516046072|FG000|Overall Study|Adverse Event|1|||
143136288|NCT03217591|516046073|FG001|Overall Study|Adverse Event|2|||
143136289|NCT03217591|516046074|FG002|Overall Study|Adverse Event|6|||
143136290|NCT03217591|516046072|FG000|Overall Study|Withdrawal by Subject|0|||
143136291|NCT03217591|516046073|FG001|Overall Study|Withdrawal by Subject|1|||
143136292|NCT03217591|516046074|FG002|Overall Study|Withdrawal by Subject|3|||
143136293|NCT03217591|516046072|FG000|Overall Study|Lost to Follow-up|1|||
143136294|NCT03217591|516046073|FG001|Overall Study|Lost to Follow-up|0|||
143136295|NCT03217591|516046074|FG002|Overall Study|Lost to Follow-up|0|||
143136296|NCT03217591|516046072|FG000|Overall Study|Protocol Violation|1|||
143136297|NCT03217591|516046073|FG001|Overall Study|Protocol Violation|0|||
143136298|NCT03217591|516046074|FG002|Overall Study|Protocol Violation|1|||
143136299|NCT00086190|516046075|FG000|Overall Study|Adverse Event|6|||
143136300|NCT00086190|516046076|FG001|Overall Study|Adverse Event|2|||
143136301|NCT00086190|516046077|FG002|Overall Study|Adverse Event|2|||
143136302|NCT00086190|516046075|FG000|Overall Study|Withdrawal by Subject|0|||
143136303|NCT00086190|516046076|FG001|Overall Study|Withdrawal by Subject|2|||
143136304|NCT00086190|516046077|FG002|Overall Study|Withdrawal by Subject|2|||
143136305|NCT00086190|516046075|FG000|Overall Study|Protocol Violation|1|||
143136306|NCT00086190|516046076|FG001|Overall Study|Protocol Violation|0|||
143136307|NCT00086190|516046077|FG002|Overall Study|Protocol Violation|0|||
143136308|NCT00086190|516046075|FG000|Overall Study|Moved|1|||
143136309|NCT00086190|516046076|FG001|Overall Study|Moved|0|||
143136310|NCT00086190|516046077|FG002|Overall Study|Moved|0|||
143136311|NCT00086190|516046075|FG000|Overall Study|Worsening depression|0|||
143136312|NCT00086190|516046076|FG001|Overall Study|Worsening depression|0|||
143136313|NCT00086190|516046077|FG002|Overall Study|Worsening depression|2|||
143136314|NCT04467515|516046078|FG000|Overall Study|Lost to Follow-up|1|||
143136315|NCT04467515|516046079|FG001|Overall Study|Lost to Follow-up|0|||
143136316|NCT04467515|516046080|FG002|Overall Study|Lost to Follow-up|0|||
143136317|NCT04467515|516046078|FG000|Overall Study|Withdrawal by Subject|1|||
143472041|NCT00778622|517275114|FG002|Overall Study|Protocol Violation|0|||
143472042|NCT00778622|517275112|FG000|Overall Study|Lack of Efficacy|2|||
143472043|NCT00778622|517275113|FG001|Overall Study|Lack of Efficacy|0|||
143136318|NCT04467515|516046079|FG001|Overall Study|Withdrawal by Subject|0|||
143136319|NCT04467515|516046080|FG002|Overall Study|Withdrawal by Subject|1|||
143136320|NCT04467515|516046078|FG000|Overall Study|Progressive Disease|0|||
143472044|NCT00778622|517275114|FG002|Overall Study|Lack of Efficacy|0|||
143472045|NCT00778622|517275112|FG000|Overall Study|immigration|1|||
143472046|NCT00778622|517275113|FG001|Overall Study|immigration|0|||
143136321|NCT04467515|516046079|FG001|Overall Study|Progressive Disease|1|||
143136322|NCT04467515|516046080|FG002|Overall Study|Progressive Disease|3|||
143136323|NCT04467515|516046078|FG000|Overall Study|Death|0|||
143136324|NCT04467515|516046079|FG001|Overall Study|Death|1|||
143136325|NCT04467515|516046080|FG002|Overall Study|Death|0|||
143136326|NCT03834506|516046081|FG000|Overall Study|Death|336|||
143136327|NCT03834506|516046082|FG001|Overall Study|Death|326|||
143472047|NCT00778622|517275114|FG002|Overall Study|immigration|0|||
143136328|NCT03834506|516046081|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
143136329|NCT03834506|516046082|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
143136330|NCT03834506|516046081|FG000|Overall Study|Withdrawal by Subject|10|||
143136331|NCT03834506|516046082|FG001|Overall Study|Withdrawal by Subject|8|||
143136332|NCT03834506|516046081|FG000|Overall Study|Sponsor decision|165|||
143136333|NCT03834506|516046082|FG001|Overall Study|Sponsor decision|178|||
143136334|NCT03834506|516046081|FG000|Overall Study|Physician Decision|3|||
143136335|NCT03834506|516046082|FG001|Overall Study|Physician Decision|1|||
143361332|NCT02223182|516863706|FG000|Open-Label 500 Period|Physician Decision|0|||
143361333|NCT02223182|516863707|FG001|Open-Label 500 Period|Physician Decision|0|||
143361334|NCT02223182|516863708|FG002|Open-Label 500 Period|Physician Decision|0|||
143361335|NCT02223182|516863709|FG003|Open-Label 500 Period|Physician Decision|1|||
143361336|NCT02223182|516863706|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
143361337|NCT02223182|516863707|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
143361338|NCT02223182|516863708|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
143361339|NCT02223182|516863709|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
143361340|NCT02223182|516863706|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
143361341|NCT02223182|516863707|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
143361342|NCT02223182|516863708|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
143361343|NCT02223182|516863709|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
143361344|NCT02223182|516863706|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
143361345|NCT02223182|516863707|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
143361346|NCT02223182|516863708|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
143361347|NCT02223182|516863709|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
143361348|NCT02223182|516863706|FG000|Open-Label 300 Period|Non Compliance|0|||
143361349|NCT02223182|516863707|FG001|Open-Label 300 Period|Non Compliance|2|||
143361350|NCT02223182|516863708|FG002|Open-Label 300 Period|Non Compliance|1|||
143361351|NCT02223182|516863709|FG003|Open-Label 300 Period|Non Compliance|0|||
143361352|NCT02099539|516863712|FG000|Overall Study|Progressive Disease|3|||
143361353|NCT02099539|516863713|FG001|Overall Study|Progressive Disease|2|||
143361354|NCT02099539|516863714|FG002|Overall Study|Progressive Disease|2|||
143361355|NCT02099539|516863715|FG003|Overall Study|Progressive Disease|1|||
143361356|NCT02099539|516863716|FG004|Overall Study|Progressive Disease|4|||
143361357|NCT02099539|516863717|FG005|Overall Study|Progressive Disease|2|||
143361358|NCT02099539|516863718|FG006|Overall Study|Progressive Disease|0|||
143361359|NCT02099539|516863712|FG000|Overall Study|Adverse Event|0|||
143361360|NCT02099539|516863713|FG001|Overall Study|Adverse Event|0|||
143361361|NCT02099539|516863714|FG002|Overall Study|Adverse Event|1|||
143361362|NCT02099539|516863715|FG003|Overall Study|Adverse Event|1|||
143361363|NCT02099539|516863716|FG004|Overall Study|Adverse Event|0|||
143361364|NCT02099539|516863717|FG005|Overall Study|Adverse Event|0|||
143361365|NCT02099539|516863718|FG006|Overall Study|Adverse Event|0|||
143361366|NCT02099539|516863712|FG000|Overall Study|Physician Decision|0|||
143361367|NCT02099539|516863713|FG001|Overall Study|Physician Decision|0|||
143361368|NCT02099539|516863714|FG002|Overall Study|Physician Decision|0|||
143361369|NCT02099539|516863715|FG003|Overall Study|Physician Decision|0|||
143361370|NCT02099539|516863716|FG004|Overall Study|Physician Decision|0|||
143361371|NCT02099539|516863717|FG005|Overall Study|Physician Decision|1|||
143361372|NCT02099539|516863718|FG006|Overall Study|Physician Decision|0|||
143361373|NCT03473756|516863720|FG000|Overall Study|Withdrawal by Subject|1|||
143361374|NCT03473756|516863721|FG001|Overall Study|Withdrawal by Subject|4|||
143361375|NCT03473756|516863720|FG000|Overall Study|Adverse Event|6|||
143361376|NCT03473756|516863721|FG001|Overall Study|Adverse Event|7|||
143361377|NCT03473756|516863720|FG000|Overall Study|Lack of Efficacy|3|||
143361378|NCT03473756|516863721|FG001|Overall Study|Lack of Efficacy|10|||
143361379|NCT03473756|516863720|FG000|Overall Study|Physician Decision|0|||
143361380|NCT03473756|516863721|FG001|Overall Study|Physician Decision|2|||
143361381|NCT03473756|516863720|FG000|Overall Study|End of study treatment|0|||
143361382|NCT03473756|516863721|FG001|Overall Study|End of study treatment|2|||
143361383|NCT03473756|516863720|FG000|Overall Study|Lost to Follow-up|0|||
143361384|NCT03473756|516863721|FG001|Overall Study|Lost to Follow-up|1|||
143361385|NCT03714022|516863722|FG000|Overall Study|Adverse Event|1|||
143361386|NCT03714022|516863723|FG001|Overall Study|Adverse Event|0|||
143361387|NCT03714022|516863722|FG000|Overall Study|Consent withdrawal|0|||
143361388|NCT03714022|516863723|FG001|Overall Study|Consent withdrawal|1|||
143361389|NCT03714022|516863722|FG000|Overall Study|Lost to Follow-up|3|||
143472048|NCT00778622|517275112|FG000|Overall Study|Other|1|||
143361390|NCT03714022|516863723|FG001|Overall Study|Lost to Follow-up|2|||
143361391|NCT01449721|516863724|FG000|Overall Study|Physician Decision|0|||
143361392|NCT01449721|516863725|FG001|Overall Study|Physician Decision|1|||
143361393|NCT01449721|516863724|FG000|Overall Study|Physician Decision|0|||
143361394|NCT01449721|516863725|FG001|Overall Study|Physician Decision|1|||
143136336|NCT03834506|516046081|FG000|Overall Study|Lost to Follow-up|0|||
143361395|NCT04951479|516863729|FG000|Overall Study|Pre-existing Acute Knee Injury|1|||
143361396|NCT00729690|516863730|FG000|Overall Study|IT Catheter Malfunction|0|||
143472049|NCT00778622|517275113|FG001|Overall Study|Other|0|||
143136337|NCT03834506|516046082|FG001|Overall Study|Lost to Follow-up|1|||
143136338|NCT01676012|516046084|FG000|Overall Study|Adverse Event|2|||
143136339|NCT01676012|516046084|FG000|Overall Study|incomplete set of videos|1|||
143136340|NCT04794751|516046088|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
143136341|NCT04794751|516046089|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
143136342|NCT04794751|516046088|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
143136343|NCT04794751|516046089|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
143136344|NCT04794751|516046088|FG000|Period 1|Protocol Violation|0|||
143136345|NCT04794751|516046089|FG001|Period 1|Protocol Violation|2|||
143136346|NCT04794751|516046088|FG000|Period 1|Withdrawal by Subject|0|||
143136347|NCT04794751|516046089|FG001|Period 1|Withdrawal by Subject|1|||
143136348|NCT04794751|516046088|FG000|Period 2|Withdrawal by Subject|0|||
143136349|NCT04794751|516046089|FG001|Period 2|Withdrawal by Subject|1|||
143136350|NCT04794751|516046088|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
143136351|NCT04794751|516046089|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
143136352|NCT04794751|516046088|FG000|Period 2|Protocol Violation|1|||
143136353|NCT04794751|516046089|FG001|Period 2|Protocol Violation|0|||
143136354|NCT03528551|516046091|FG000|Overall Study|Lost to Follow-up|0|||
143136355|NCT03528551|516046092|FG001|Overall Study|Lost to Follow-up|1|||
143136356|NCT03528551|516046093|FG002|Overall Study|Lost to Follow-up|0|||
143136357|NCT03528551|516046091|FG000|Overall Study|Transferred to other arm/group|2|||
143136358|NCT03528551|516046092|FG001|Overall Study|Transferred to other arm/group|3|||
143136359|NCT03528551|516046093|FG002|Overall Study|Transferred to other arm/group|0|||
143136360|NCT03528551|516046091|FG000|Overall Study|Withdrawal by parent/guardian|0|||
143136361|NCT03528551|516046092|FG001|Overall Study|Withdrawal by parent/guardian|5|||
143136362|NCT03528551|516046093|FG002|Overall Study|Withdrawal by parent/guardian|0|||
143136363|NCT03528551|516046091|FG000|Overall Study|Protocol Violation|0|||
143136364|NCT03528551|516046092|FG001|Overall Study|Protocol Violation|3|||
143136365|NCT03528551|516046093|FG002|Overall Study|Protocol Violation|0|||
143136366|NCT03528551|516046091|FG000|Overall Study|Withdrawal by Subject|0|||
143136367|NCT03528551|516046092|FG001|Overall Study|Withdrawal by Subject|7|||
143136368|NCT03528551|516046093|FG002|Overall Study|Withdrawal by Subject|0|||
143136369|NCT01939314|516046096|FG000|Overall Study|Withdrawal by Subject|3|||
143136370|NCT01939314|516046097|FG001|Overall Study|Withdrawal by Subject|1|||
143136371|NCT01939314|516046096|FG000|Overall Study|Protocol Violation|1|||
143136372|NCT01939314|516046097|FG001|Overall Study|Protocol Violation|0|||
143136373|NCT01939314|516046096|FG000|Overall Study|Pregnancy|0|||
143136374|NCT01939314|516046097|FG001|Overall Study|Pregnancy|1|||
143136375|NCT01939314|516046096|FG000|Overall Study|Lost to Follow-up|5|||
143136376|NCT01939314|516046097|FG001|Overall Study|Lost to Follow-up|6|||
143136377|NCT01789047|516046098|FG000|Overall Study|Adverse Event|3|||
143136378|NCT01789047|516046099|FG001|Overall Study|Adverse Event|2|||
143136379|NCT01789047|516046098|FG000|Overall Study|Withdrawal by Subject|1|||
143136380|NCT01789047|516046099|FG001|Overall Study|Withdrawal by Subject|2|||
143136381|NCT02175225|516046100|FG000|Overall Study|Withdrawal by Subject|1|||
143136382|NCT02175225|516046101|FG001|Overall Study|Withdrawal by Subject|2|||
143136383|NCT02175225|516046100|FG000|Overall Study|Lost to Follow-up|6|||
143136384|NCT02175225|516046101|FG001|Overall Study|Lost to Follow-up|7|||
143136385|NCT02175225|516046100|FG000|Overall Study|Study drug not administered|1|||
143136386|NCT02175225|516046101|FG001|Overall Study|Study drug not administered|2|||
143136387|NCT00969228|516046102|FG000|Overall Study|Adverse Event|1|||
143136388|NCT00969228|516046103|FG001|Overall Study|Adverse Event|0|||
143136389|NCT00969228|516046102|FG000|Overall Study|Withdrawal by Subject|4|||
143136390|NCT00969228|516046103|FG001|Overall Study|Withdrawal by Subject|0|||
143136391|NCT00969228|516046102|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
143136392|NCT00969228|516046103|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
143136393|NCT02668640|516046104|FG000|Overall Study|Lost to Follow-up|13|||
143136394|NCT02668640|516046104|FG000|Overall Study|Other, not specified|1|||
143136395|NCT02322749|516046107|FG000|Period 2|Adverse Event|0|||
143136396|NCT02322749|516046108|FG001|Period 2|Adverse Event|0|||
143136397|NCT02322749|516046109|FG002|Period 2|Adverse Event|0|||
143136398|NCT02322749|516046110|FG003|Period 2|Adverse Event|1|||
143136399|NCT02322749|516046111|FG004|Period 2|Adverse Event|0|||
143136400|NCT02322749|516046112|FG005|Period 2|Adverse Event|0|||
143136401|NCT02322749|516046107|FG000|Period 2|Withdrawal by Subject|0|||
143136402|NCT02322749|516046108|FG001|Period 2|Withdrawal by Subject|0|||
143136403|NCT02322749|516046109|FG002|Period 2|Withdrawal by Subject|0|||
143136404|NCT02322749|516046110|FG003|Period 2|Withdrawal by Subject|1|||
143136405|NCT02322749|516046111|FG004|Period 2|Withdrawal by Subject|0|||
143136406|NCT02322749|516046112|FG005|Period 2|Withdrawal by Subject|0|||
143136407|NCT02322749|516046107|FG000|Period 3|Withdrawal by Subject|0|||
143136408|NCT02322749|516046108|FG001|Period 3|Withdrawal by Subject|0|||
143136409|NCT02322749|516046109|FG002|Period 3|Withdrawal by Subject|1|||
143136410|NCT02322749|516046110|FG003|Period 3|Withdrawal by Subject|0|||
143136411|NCT02322749|516046111|FG004|Period 3|Withdrawal by Subject|0|||
143136412|NCT02322749|516046112|FG005|Period 3|Withdrawal by Subject|0|||
143136413|NCT00073918|516046113|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
143136414|NCT00073918|516046113|FG000|Overall Study|Rapid disease progression|2|||
143136415|NCT00073918|516046113|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
143136416|NCT01190813|516046114|FG000|Overall Study|Lost to Follow-up|1|||
143136417|NCT01190813|516046115|FG001|Overall Study|Lost to Follow-up|2|||
143136418|NCT01190813|516046114|FG000|Overall Study|Withdrawal by Subject|2|||
143136419|NCT01190813|516046115|FG001|Overall Study|Withdrawal by Subject|1|||
143136420|NCT01190813|516046114|FG000|Overall Study|Refused study treatment after randomized|1|||
143136421|NCT01190813|516046115|FG001|Overall Study|Refused study treatment after randomized|0|||
143136422|NCT01190813|516046114|FG000|Overall Study|Adverse Event|0|||
143136423|NCT01190813|516046115|FG001|Overall Study|Adverse Event|1|||
143136424|NCT04821830|516046118|FG000|Overall Study|Withdrawal by Subject|1|||
143136425|NCT04821830|516046119|FG001|Overall Study|Withdrawal by Subject|0|||
143136426|NCT00919633|516046120|FG000|Overall Study|Adverse Event|1|||
143136427|NCT00919633|516046121|FG001|Overall Study|Adverse Event|9|||
143136428|NCT00919633|516046122|FG002|Overall Study|Adverse Event|12|||
143136429|NCT00919633|516046123|FG003|Overall Study|Adverse Event|10|||
143136430|NCT00919633|516046120|FG000|Overall Study|Death|0|||
143136431|NCT00919633|516046121|FG001|Overall Study|Death|0|||
143136432|NCT00919633|516046122|FG002|Overall Study|Death|2|||
143136433|NCT00919633|516046123|FG003|Overall Study|Death|0|||
143136434|NCT00919633|516046120|FG000|Overall Study|Lack of Efficacy|17|||
143136435|NCT00919633|516046121|FG001|Overall Study|Lack of Efficacy|3|||
143136436|NCT00919633|516046122|FG002|Overall Study|Lack of Efficacy|2|||
143136437|NCT00919633|516046123|FG003|Overall Study|Lack of Efficacy|3|||
143136438|NCT00919633|516046120|FG000|Overall Study|Withdrawal by Subject|1|||
143136439|NCT00919633|516046121|FG001|Overall Study|Withdrawal by Subject|2|||
143136440|NCT00919633|516046122|FG002|Overall Study|Withdrawal by Subject|4|||
143136441|NCT00919633|516046123|FG003|Overall Study|Withdrawal by Subject|3|||
143136442|NCT00919633|516046120|FG000|Overall Study|Lost to Follow-up|3|||
143136443|NCT00919633|516046121|FG001|Overall Study|Lost to Follow-up|1|||
143136444|NCT00919633|516046122|FG002|Overall Study|Lost to Follow-up|0|||
143136445|NCT00919633|516046123|FG003|Overall Study|Lost to Follow-up|2|||
143136446|NCT00919633|516046120|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
143136447|NCT00919633|516046121|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
143136448|NCT00919633|516046122|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
143136449|NCT00919633|516046123|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
143136450|NCT00919633|516046120|FG000|Overall Study|Protocol Violation|0|||
143136451|NCT00919633|516046121|FG001|Overall Study|Protocol Violation|0|||
143136452|NCT00919633|516046122|FG002|Overall Study|Protocol Violation|0|||
143136453|NCT00919633|516046123|FG003|Overall Study|Protocol Violation|1|||
143136454|NCT00919633|516046120|FG000|Overall Study|Physician Decision|0|||
143136455|NCT00919633|516046121|FG001|Overall Study|Physician Decision|0|||
143136456|NCT00919633|516046122|FG002|Overall Study|Physician Decision|0|||
143136457|NCT00919633|516046123|FG003|Overall Study|Physician Decision|1|||
143136458|NCT00919633|516046120|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
143136459|NCT00919633|516046121|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
143136460|NCT00919633|516046122|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
143472050|NCT00778622|517275114|FG002|Overall Study|Other|1|||
143472051|NCT01968070|517275115|FG000|Period 1|Withdrawal by Subject|0|||
143472052|NCT01968070|517275116|FG001|Period 1|Withdrawal by Subject|1|||
143472053|NCT01968070|517275117|FG002|Period 1|Withdrawal by Subject|0|||
143472054|NCT01968070|517275118|FG003|Period 1|Withdrawal by Subject|0|||
143472055|NCT01968070|517275119|FG004|Period 1|Withdrawal by Subject|0|||
143472056|NCT01968070|517275120|FG005|Period 1|Withdrawal by Subject|0|||
143472057|NCT01968070|517275121|FG006|Period 1|Withdrawal by Subject|1|||
143472058|NCT01968070|517275122|FG007|Period 1|Withdrawal by Subject|0|||
143472059|NCT01968070|517275123|FG008|Period 1|Withdrawal by Subject|0|||
143472060|NCT01968070|517275124|FG009|Period 1|Withdrawal by Subject|0|||
143472061|NCT01968070|517275125|FG010|Period 1|Withdrawal by Subject|0|||
143472062|NCT01968070|517275126|FG011|Period 1|Withdrawal by Subject|0|||
143472063|NCT01968070|517275127|FG012|Period 1|Withdrawal by Subject|0|||
143136461|NCT00919633|516046123|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
143136462|NCT00919633|516046120|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
143136463|NCT00919633|516046121|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
143472064|NCT01968070|517275128|FG013|Period 1|Withdrawal by Subject|0|||
143472065|NCT01968070|517275129|FG014|Period 1|Withdrawal by Subject|0|||
143472066|NCT01968070|517275130|FG015|Period 1|Withdrawal by Subject|1|||
143472067|NCT01968070|517275131|FG016|Period 1|Withdrawal by Subject|0|||
143136464|NCT00919633|516046122|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
143136465|NCT00919633|516046123|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
143136466|NCT01526785|516046124|FG000|Overall Study|Study Terminated by Sponsor|8|||
143136467|NCT01526785|516046124|FG000|Overall Study|Death|2|||
143136468|NCT01526785|516046124|FG000|Overall Study|Physician Decision|1|||
143472068|NCT01968070|517275132|FG017|Period 1|Withdrawal by Subject|0|||
143136469|NCT01526785|516046124|FG000|Overall Study|Withdrawal by Subject|2|||
143136470|NCT02007720|516046127|FG000|Overall Study|Withdrawal by Subject|9|||
143136471|NCT02007720|516046128|FG001|Overall Study|Withdrawal by Subject|11|||
143472069|NCT01968070|517275115|FG000|Period 1|Protocol Violation|0|||
143136472|NCT02007720|516046127|FG000|Overall Study|study terminated by sponsor|58|||
143136473|NCT02007720|516046128|FG001|Overall Study|study terminated by sponsor|54|||
143136474|NCT02007720|516046127|FG000|Overall Study|technical problem|4|||
143136475|NCT02007720|516046128|FG001|Overall Study|technical problem|2|||
143136476|NCT02007720|516046127|FG000|Overall Study|patient followd less than 165 days|11|||
143136477|NCT02007720|516046128|FG001|Overall Study|patient followd less than 165 days|5|||
143136478|NCT04265261|516046129|FG000|Overall Study|Adverse Event|2|||
143136479|NCT04265261|516046130|FG001|Overall Study|Adverse Event|0|||
143136480|NCT04265261|516046131|FG002|Overall Study|Adverse Event|0|||
143136481|NCT04265261|516046129|FG000|Overall Study|Death|1|||
143136482|NCT04265261|516046130|FG001|Overall Study|Death|0|||
143136483|NCT04265261|516046131|FG002|Overall Study|Death|0|||
143136484|NCT04265261|516046129|FG000|Overall Study|Lost to Follow-up|4|||
143136485|NCT04265261|516046130|FG001|Overall Study|Lost to Follow-up|1|||
143136486|NCT04265261|516046131|FG002|Overall Study|Lost to Follow-up|3|||
143136487|NCT04265261|516046129|FG000|Overall Study|Non-Compliance with Study Drug|1|||
143136488|NCT04265261|516046130|FG001|Overall Study|Non-Compliance with Study Drug|1|||
143136489|NCT04265261|516046131|FG002|Overall Study|Non-Compliance with Study Drug|0|||
143136490|NCT04265261|516046129|FG000|Overall Study|Physician Decision|0|||
143136491|NCT04265261|516046130|FG001|Overall Study|Physician Decision|0|||
143136492|NCT04265261|516046131|FG002|Overall Study|Physician Decision|1|||
143136493|NCT04265261|516046129|FG000|Overall Study|Protocol Deviation|0|||
143136494|NCT04265261|516046130|FG001|Overall Study|Protocol Deviation|2|||
143136495|NCT04265261|516046131|FG002|Overall Study|Protocol Deviation|0|||
143136496|NCT04265261|516046129|FG000|Overall Study|Withdrawal by Subject|2|||
143136497|NCT04265261|516046130|FG001|Overall Study|Withdrawal by Subject|1|||
143136498|NCT04265261|516046131|FG002|Overall Study|Withdrawal by Subject|4|||
143136499|NCT01548599|516047531|FG000|Overall Study|Lost to Follow-up|0|||
143136500|NCT01548599|516047532|FG001|Overall Study|Lost to Follow-up|1|||
143136501|NCT01548599|516047531|FG000|Overall Study|Withdrawal by Subject|4|||
143136502|NCT01548599|516047532|FG001|Overall Study|Withdrawal by Subject|0|||
143136503|NCT01548599|516047531|FG000|Overall Study|Death|2|||
143136504|NCT01548599|516047532|FG001|Overall Study|Death|1|||
143136505|NCT00496769|516047537|FG000|Double Blind|>=1 reason assigned per patient|558|||
143136506|NCT00496769|516047538|FG001|Double Blind|>=1 reason assigned per patient|649|||
143136507|NCT00496769|516047539|FG002|Double Blind|>=1 reason assigned per patient|0|||
143472070|NCT01968070|517275116|FG001|Period 1|Protocol Violation|0|||
143472071|NCT01968070|517275117|FG002|Period 1|Protocol Violation|0|||
143472072|NCT01968070|517275118|FG003|Period 1|Protocol Violation|1|||
143472073|NCT01968070|517275119|FG004|Period 1|Protocol Violation|1|||
143472074|NCT01968070|517275120|FG005|Period 1|Protocol Violation|0|||
143472075|NCT01968070|517275121|FG006|Period 1|Protocol Violation|0|||
143472076|NCT01968070|517275122|FG007|Period 1|Protocol Violation|0|||
143472077|NCT01968070|517275123|FG008|Period 1|Protocol Violation|0|||
143472078|NCT01968070|517275124|FG009|Period 1|Protocol Violation|0|||
143472079|NCT01968070|517275125|FG010|Period 1|Protocol Violation|0|||
143472080|NCT01968070|517275126|FG011|Period 1|Protocol Violation|0|||
143472081|NCT01968070|517275127|FG012|Period 1|Protocol Violation|0|||
143472082|NCT01968070|517275128|FG013|Period 1|Protocol Violation|0|||
143472083|NCT01968070|517275129|FG014|Period 1|Protocol Violation|0|||
143472084|NCT01968070|517275130|FG015|Period 1|Protocol Violation|0|||
143472085|NCT01968070|517275131|FG016|Period 1|Protocol Violation|0|||
143472086|NCT01968070|517275132|FG017|Period 1|Protocol Violation|0|||
143472087|NCT01968070|517275115|FG000|Period 1|Lost to Follow-up|0|||
143472088|NCT01968070|517275116|FG001|Period 1|Lost to Follow-up|0|||
143472089|NCT01968070|517275117|FG002|Period 1|Lost to Follow-up|0|||
143472090|NCT01968070|517275118|FG003|Period 1|Lost to Follow-up|1|||
143472091|NCT01968070|517275119|FG004|Period 1|Lost to Follow-up|0|||
143472092|NCT01968070|517275120|FG005|Period 1|Lost to Follow-up|0|||
143472093|NCT01968070|517275121|FG006|Period 1|Lost to Follow-up|0|||
143472094|NCT01968070|517275122|FG007|Period 1|Lost to Follow-up|0|||
143136508|NCT00496769|516047537|FG000|Open Label|>=1 reason assigned per patient|0|||
143136509|NCT00496769|516047538|FG001|Open Label|>=1 reason assigned per patient|0|||
143136510|NCT00496769|516047539|FG002|Open Label|>=1 reason assigned per patient|1011|||
143136511|NCT02486692|516047540|FG000|Overall Study|did not login for randomization|4|||
143136512|NCT02486692|516047541|FG001|Overall Study|did not login for randomization|7|||
143136513|NCT02810418|516047542|FG000|Arm A Dose Escalation|Adverse Event|2|||
143472095|NCT01968070|517275123|FG008|Period 1|Lost to Follow-up|0|||
143136514|NCT02810418|516047543|FG001|Arm A Dose Escalation|Adverse Event|1|||
143136515|NCT02810418|516047544|FG002|Arm A Dose Escalation|Adverse Event|0|||
143472096|NCT01968070|517275124|FG009|Period 1|Lost to Follow-up|0|||
143472097|NCT01968070|517275125|FG010|Period 1|Lost to Follow-up|0|||
143013998|NCT03252756|515590130|FG000|Overall Study|COVID-19 Pandemic|1|||
143136516|NCT02810418|516047545|FG003|Arm A Dose Escalation|Adverse Event|0|||
143136517|NCT02810418|516047546|FG004|Arm A Dose Escalation|Adverse Event|0|||
143136518|NCT02810418|516047547|FG005|Arm A Dose Escalation|Adverse Event|0|||
143472098|NCT01968070|517275126|FG011|Period 1|Lost to Follow-up|0|||
143472099|NCT01968070|517275127|FG012|Period 1|Lost to Follow-up|0|||
143136519|NCT02810418|516047548|FG006|Arm A Dose Escalation|Adverse Event|0|||
143136520|NCT02810418|516047542|FG000|Dose Expansion|Adverse Event|0|||
143136521|NCT02810418|516047543|FG001|Dose Expansion|Adverse Event|1|||
143136522|NCT02810418|516047544|FG002|Dose Expansion|Adverse Event|1|||
143136523|NCT02810418|516047545|FG003|Dose Expansion|Adverse Event|0|||
143136524|NCT02810418|516047546|FG004|Dose Expansion|Adverse Event|0|||
143136525|NCT02810418|516047547|FG005|Dose Expansion|Adverse Event|0|||
143136526|NCT02810418|516047548|FG006|Dose Expansion|Adverse Event|0|||
143136527|NCT02810418|516047542|FG000|Dose Expansion|Physician Decision|0|||
143136528|NCT02810418|516047543|FG001|Dose Expansion|Physician Decision|0|||
143136529|NCT02810418|516047544|FG002|Dose Expansion|Physician Decision|2|||
143136530|NCT02810418|516047545|FG003|Dose Expansion|Physician Decision|0|||
143136531|NCT02810418|516047546|FG004|Dose Expansion|Physician Decision|0|||
143136532|NCT02810418|516047547|FG005|Dose Expansion|Physician Decision|0|||
143136533|NCT02810418|516047548|FG006|Dose Expansion|Physician Decision|0|||
143136534|NCT02810418|516047542|FG000|Arm B Dose Escalation|Adverse Event|0|||
143136535|NCT02810418|516047543|FG001|Arm B Dose Escalation|Adverse Event|0|||
143136536|NCT02810418|516047544|FG002|Arm B Dose Escalation|Adverse Event|0|||
143136537|NCT02810418|516047545|FG003|Arm B Dose Escalation|Adverse Event|0|||
143136538|NCT02810418|516047546|FG004|Arm B Dose Escalation|Adverse Event|1|||
143136539|NCT02810418|516047547|FG005|Arm B Dose Escalation|Adverse Event|2|||
143136540|NCT02810418|516047548|FG006|Arm B Dose Escalation|Adverse Event|0|||
143136541|NCT02224625|516047549|FG000|Irritation|Adverse Event|6|||
143136542|NCT02224625|516047549|FG000|Sensitization|Adverse Event|55|||
143136543|NCT01573000|516047550|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
143136544|NCT01573000|516047551|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
143136545|NCT01573000|516047550|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
143136546|NCT01573000|516047551|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
143136547|NCT01573000|516047550|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
143136548|NCT01573000|516047551|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
143136549|NCT01573000|516047550|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
143136550|NCT01573000|516047551|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
143136551|NCT01573000|516047550|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
143136552|NCT01573000|516047551|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
143361397|NCT00729690|516863731|FG001|Overall Study|IT Catheter Malfunction|2|||
143361398|NCT00729690|516863732|FG002|Overall Study|IT Catheter Malfunction|2|||
143361399|NCT03212365|516863733|FG000|Overall Study|Discharged prior to Xa level|12|||
143361400|NCT03212365|516863734|FG001|Overall Study|Discharged prior to Xa level|8|||
143361401|NCT03212365|516863733|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
143361402|NCT03212365|516863734|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
143361403|NCT03212365|516863733|FG000|Overall Study|Refused study medication|3|||
143361404|NCT03212365|516863734|FG001|Overall Study|Refused study medication|0|||
143361405|NCT03212365|516863733|FG000|Overall Study|Initiated heparin infusion on floor|1|||
143361406|NCT03212365|516863734|FG001|Overall Study|Initiated heparin infusion on floor|1|||
143361407|NCT03212365|516863733|FG000|Overall Study|Unexpected return to OR|1|||
143361408|NCT03212365|516863734|FG001|Overall Study|Unexpected return to OR|1|||
143361409|NCT03212365|516863733|FG000|Overall Study|Medication distribution error|1|||
143361410|NCT03212365|516863734|FG001|Overall Study|Medication distribution error|0|||
143361411|NCT03212365|516863733|FG000|Overall Study|Required epidural placement|1|||
143361412|NCT03212365|516863734|FG001|Overall Study|Required epidural placement|0|||
143361413|NCT03212365|516863733|FG000|Overall Study|Withdrawal by Subject|0|||
143361414|NCT03212365|516863734|FG001|Overall Study|Withdrawal by Subject|1|||
143361415|NCT03212365|516863733|FG000|Overall Study|developed acute renal failure|0|||
143361416|NCT03212365|516863734|FG001|Overall Study|developed acute renal failure|1|||
143361417|NCT00333138|516863735|FG000|Core Study (6 Months)|Adverse Event|4|||
143361418|NCT00333138|516863736|FG001|Core Study (6 Months)|Adverse Event|5|||
143361419|NCT00333138|516863737|FG002|Core Study (6 Months)|Adverse Event|8|||
143361420|NCT00333138|516863735|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
143361421|NCT00333138|516863736|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
143361422|NCT00333138|516863737|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
143361423|NCT00333138|516863735|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
143361424|NCT00333138|516863736|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
143361425|NCT00333138|516863737|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
143361426|NCT00333138|516863735|FG000|Core Study (6 Months)|Protocol Violation|1|||
143361427|NCT00333138|516863736|FG001|Core Study (6 Months)|Protocol Violation|0|||
143361428|NCT00333138|516863737|FG002|Core Study (6 Months)|Protocol Violation|1|||
143361429|NCT00333138|516863735|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
143361430|NCT00333138|516863736|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
143472100|NCT01968070|517275128|FG013|Period 1|Lost to Follow-up|0|||
143361431|NCT00333138|516863737|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
143361432|NCT00333138|516863735|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
143472101|NCT01968070|517275129|FG014|Period 1|Lost to Follow-up|0|||
143472102|NCT01968070|517275130|FG015|Period 1|Lost to Follow-up|0|||
143472103|NCT01968070|517275131|FG016|Period 1|Lost to Follow-up|0|||
143472104|NCT01968070|517275132|FG017|Period 1|Lost to Follow-up|0|||
143136553|NCT01573000|516047550|FG000|Crossover Phase|Lack of Efficacy|0|||
143136554|NCT01573000|516047551|FG001|Crossover Phase|Lack of Efficacy|13|||
143136555|NCT01573000|516047550|FG000|Crossover Phase|Lost to Follow-up|0|||
143136556|NCT01573000|516047551|FG001|Crossover Phase|Lost to Follow-up|2|||
143136557|NCT01573000|516047550|FG000|Crossover Phase|Death|0|||
143136558|NCT01573000|516047551|FG001|Crossover Phase|Death|3|||
143136559|NCT01573000|516047550|FG000|Long-Term Follow-Up|Death|3|||
143136560|NCT01573000|516047551|FG001|Long-Term Follow-Up|Death|0|||
143136561|NCT01573000|516047550|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
143136562|NCT01573000|516047551|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
143136563|NCT01100853|516047556|FG000|Overall Study|Lost to Follow-up|11|||
143136564|NCT01100853|516047557|FG001|Overall Study|Lost to Follow-up|6|||
143136565|NCT01100853|516047556|FG000|Overall Study|Received <4 study injections|10|||
143136566|NCT01100853|516047557|FG001|Overall Study|Received <4 study injections|13|||
143136567|NCT01100853|516047556|FG000|Overall Study|Withdrawal by Subject|6|||
143136568|NCT01100853|516047557|FG001|Overall Study|Withdrawal by Subject|4|||
143136569|NCT01384877|516047558|FG000|Treatment 2|Lost to Follow-up|2|||
143136570|NCT01384877|516047559|FG001|Treatment 2|Lost to Follow-up|2|||
143136571|NCT04161391|516047560|FG000|Overall Study|Adverse Event|0|||
143136572|NCT04161391|516047561|FG001|Overall Study|Adverse Event|1|||
143136573|NCT04161391|516047562|FG002|Overall Study|Adverse Event|0|||
143136574|NCT04161391|516047563|FG003|Overall Study|Adverse Event|1|||
143136575|NCT04161391|516047564|FG004|Overall Study|Adverse Event|0|||
143136576|NCT04161391|516047565|FG005|Overall Study|Adverse Event|0|||
143136577|NCT04161391|516047566|FG006|Overall Study|Adverse Event|0|||
143136578|NCT04161391|516047567|FG007|Overall Study|Adverse Event|3|||
143136579|NCT04161391|516047568|FG008|Overall Study|Adverse Event|0|||
143136580|NCT04161391|516047560|FG000|Overall Study|Death|0|||
143136581|NCT04161391|516047561|FG001|Overall Study|Death|0|||
143136582|NCT04161391|516047562|FG002|Overall Study|Death|0|||
143136583|NCT04161391|516047563|FG003|Overall Study|Death|0|||
143136584|NCT04161391|516047564|FG004|Overall Study|Death|0|||
143136585|NCT04161391|516047565|FG005|Overall Study|Death|0|||
143136586|NCT04161391|516047566|FG006|Overall Study|Death|0|||
143136587|NCT04161391|516047567|FG007|Overall Study|Death|1|||
143136588|NCT04161391|516047568|FG008|Overall Study|Death|0|||
143136589|NCT04161391|516047560|FG000|Overall Study|Physician Decision|0|||
143136590|NCT04161391|516047561|FG001|Overall Study|Physician Decision|0|||
143136591|NCT04161391|516047562|FG002|Overall Study|Physician Decision|1|||
143136592|NCT04161391|516047563|FG003|Overall Study|Physician Decision|2|||
143136593|NCT04161391|516047564|FG004|Overall Study|Physician Decision|0|||
143136594|NCT04161391|516047565|FG005|Overall Study|Physician Decision|0|||
143136595|NCT04161391|516047566|FG006|Overall Study|Physician Decision|2|||
143136596|NCT04161391|516047567|FG007|Overall Study|Physician Decision|0|||
143136597|NCT04161391|516047568|FG008|Overall Study|Physician Decision|0|||
143136598|NCT04161391|516047560|FG000|Overall Study|Progressive Disease|4|||
143472105|NCT01968070|517275115|FG000|Period 1|Adverse Event|0|||
143472106|NCT01968070|517275116|FG001|Period 1|Adverse Event|0|||
143472107|NCT01968070|517275117|FG002|Period 1|Adverse Event|0|||
143472108|NCT01968070|517275118|FG003|Period 1|Adverse Event|0|||
143472109|NCT01968070|517275119|FG004|Period 1|Adverse Event|0|||
143472110|NCT01968070|517275120|FG005|Period 1|Adverse Event|0|||
143472111|NCT01968070|517275121|FG006|Period 1|Adverse Event|1|||
143472112|NCT01968070|517275122|FG007|Period 1|Adverse Event|0|||
143472113|NCT01968070|517275123|FG008|Period 1|Adverse Event|0|||
143472114|NCT01968070|517275124|FG009|Period 1|Adverse Event|0|||
143472115|NCT01968070|517275125|FG010|Period 1|Adverse Event|0|||
143472116|NCT01968070|517275126|FG011|Period 1|Adverse Event|0|||
143136599|NCT04161391|516047561|FG001|Overall Study|Progressive Disease|3|||
143136600|NCT04161391|516047562|FG002|Overall Study|Progressive Disease|3|||
143136601|NCT04161391|516047563|FG003|Overall Study|Progressive Disease|5|||
143136602|NCT04161391|516047564|FG004|Overall Study|Progressive Disease|3|||
143136603|NCT04161391|516047565|FG005|Overall Study|Progressive Disease|3|||
143136604|NCT04161391|516047566|FG006|Overall Study|Progressive Disease|5|||
143136605|NCT04161391|516047567|FG007|Overall Study|Progressive Disease|2|||
143136606|NCT04161391|516047568|FG008|Overall Study|Progressive Disease|2|||
143136607|NCT01162343|516047571|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
143136608|NCT01162343|516047571|FG000|Overall Study|Refused psychiatrist assessment|12|||
143136609|NCT01930539|516047583|FG000|Overall Study|Withdrawal by Subject|2|||
143472117|NCT01968070|517275127|FG012|Period 1|Adverse Event|0|||
143472118|NCT01968070|517275128|FG013|Period 1|Adverse Event|0|||
143136610|NCT01930539|516047584|FG001|Overall Study|Withdrawal by Subject|2|||
143136611|NCT01548404|516047585|FG000|Overall Study|Adverse Event|3|||
143136612|NCT01548404|516047586|FG001|Overall Study|Adverse Event|1|||
143136613|NCT01548404|516047585|FG000|Overall Study|Physician Decision|2|||
143136614|NCT01548404|516047586|FG001|Overall Study|Physician Decision|1|||
143136615|NCT01548404|516047585|FG000|Overall Study|Inadequate response to study treatment|23|||
143136616|NCT01548404|516047586|FG001|Overall Study|Inadequate response to study treatment|7|||
143472119|NCT01968070|517275129|FG014|Period 1|Adverse Event|0|||
143472120|NCT01968070|517275130|FG015|Period 1|Adverse Event|0|||
143472121|NCT01968070|517275131|FG016|Period 1|Adverse Event|0|||
143136617|NCT01548404|516047585|FG000|Overall Study|Lost to Follow-up|2|||
143136618|NCT01548404|516047586|FG001|Overall Study|Lost to Follow-up|0|||
143136619|NCT01548404|516047585|FG000|Overall Study|Withdrawal by Subject|0|||
143136620|NCT01548404|516047586|FG001|Overall Study|Withdrawal by Subject|3|||
143136621|NCT01548404|516047585|FG000|Overall Study|Other than specified above|0|||
143136622|NCT01548404|516047586|FG001|Overall Study|Other than specified above|2|||
143136623|NCT00737048|516047587|FG000|Overall Study|Physician Decision|0|||
143136624|NCT00737048|516047588|FG001|Overall Study|Physician Decision|0|||
143136625|NCT00737048|516047589|FG002|Overall Study|Physician Decision|1|||
143136626|NCT00737048|516047587|FG000|Overall Study|Adverse Event|0|||
143136627|NCT00737048|516047588|FG001|Overall Study|Adverse Event|1|||
143136628|NCT00737048|516047589|FG002|Overall Study|Adverse Event|0|||
143136629|NCT00737048|516047587|FG000|Overall Study|Worsening of the symptoms|3|||
143136630|NCT00737048|516047588|FG001|Overall Study|Worsening of the symptoms|5|||
143136631|NCT00737048|516047589|FG002|Overall Study|Worsening of the symptoms|3|||
143136632|NCT00641056|516047590|FG000|Overall Study|Adverse Event|12|||
143136633|NCT00641056|516047591|FG001|Overall Study|Adverse Event|2|||
143136634|NCT00641056|516047590|FG000|Overall Study|Lost to Follow-up|2|||
143136635|NCT00641056|516047591|FG001|Overall Study|Lost to Follow-up|1|||
143136636|NCT00641056|516047590|FG000|Overall Study|Physician Decision|3|||
143136637|NCT00641056|516047591|FG001|Overall Study|Physician Decision|1|||
143136638|NCT00641056|516047590|FG000|Overall Study|Protocol Violation|2|||
143136639|NCT00641056|516047591|FG001|Overall Study|Protocol Violation|0|||
143136640|NCT00641056|516047590|FG000|Overall Study|Entry Criteria Not Met|3|||
143136641|NCT00641056|516047591|FG001|Overall Study|Entry Criteria Not Met|0|||
143136642|NCT00641056|516047590|FG000|Overall Study|Subject Decision|6|||
143136643|NCT00641056|516047591|FG001|Overall Study|Subject Decision|19|||
143136644|NCT00641056|516047590|FG000|Overall Study|Sponsor Decision|1|||
143136645|NCT00641056|516047591|FG001|Overall Study|Sponsor Decision|2|||
143136646|NCT00896493|516047594|FG000|Overall Study|Early disease relapse|3|||
143136647|NCT02026141|516047597|FG000|Overall Study|Protocol Violation|0|||
143136648|NCT02026141|516047598|FG001|Overall Study|Protocol Violation|1|||
143136649|NCT03102762|516047601|FG000|Overall Study|Lost to Follow-up|1|||
143136650|NCT03102762|516047602|FG001|Overall Study|Lost to Follow-up|0|||
143136651|NCT01232790|516047603|FG000|Randomization|Withdrawal by Subject|2|||
143136652|NCT01232790|516047604|FG001|Randomization|Withdrawal by Subject|0|||
143136653|NCT01232790|516047603|FG000|Randomization|Protocol Violation|0|||
143136654|NCT01232790|516047604|FG001|Randomization|Protocol Violation|1|||
143136655|NCT01232790|516047603|FG000|Randomization|Physician Decision|0|||
143136656|NCT01232790|516047604|FG001|Randomization|Physician Decision|1|||
143136657|NCT01232790|516047603|FG000|Initial Assessment|Withdrawal by Subject|0|||
143136658|NCT01232790|516047604|FG001|Initial Assessment|Withdrawal by Subject|1|||
143136659|NCT01232790|516047603|FG000|First Crossover|Withdrawal by Subject|1|||
143136660|NCT01232790|516047604|FG001|First Crossover|Withdrawal by Subject|0|||
143136661|NCT01232790|516047603|FG000|Second Crossover|Withdrawal by Subject|1|||
143136662|NCT01232790|516047604|FG001|Second Crossover|Withdrawal by Subject|2|||
143136663|NCT02000921|516047605|FG000|Overall Study|Withdrawal by Subject|3|||
143136664|NCT02000921|516047606|FG001|Overall Study|Withdrawal by Subject|10|||
143136665|NCT02000921|516047607|FG002|Overall Study|Withdrawal by Subject|5|||
143136666|NCT02000921|516047605|FG000|Overall Study|Lost to Follow-up|2|||
143136667|NCT02000921|516047606|FG001|Overall Study|Lost to Follow-up|4|||
143136668|NCT02000921|516047607|FG002|Overall Study|Lost to Follow-up|5|||
143136669|NCT02000921|516047605|FG000|Overall Study|Physician Decision|0|||
143136670|NCT02000921|516047606|FG001|Overall Study|Physician Decision|2|||
143136671|NCT02000921|516047607|FG002|Overall Study|Physician Decision|0|||
143136672|NCT02631941|516047612|FG000|Overall Study|Physician Decision|0|||
143136673|NCT02631941|516047613|FG001|Overall Study|Physician Decision|1|||
143136674|NCT02631941|516047614|FG002|Overall Study|Physician Decision|0|||
143136675|NCT02631941|516047615|FG003|Overall Study|Physician Decision|0|||
143136676|NCT02631941|516047616|FG004|Overall Study|Physician Decision|0|||
143136677|NCT02631941|516047617|FG005|Overall Study|Physician Decision|0|||
143136678|NCT02631941|516047618|FG006|Overall Study|Physician Decision|0|||
143013999|NCT03252756|515590131|FG001|Overall Study|COVID-19 Pandemic|1|||
143136679|NCT02631941|516047619|FG007|Overall Study|Physician Decision|0|||
143136680|NCT02631941|516047620|FG008|Overall Study|Physician Decision|0|||
143136681|NCT02631941|516047621|FG009|Overall Study|Physician Decision|0|||
143136682|NCT02631941|516047612|FG000|Overall Study|Adverse Event|0|||
143136683|NCT02631941|516047613|FG001|Overall Study|Adverse Event|1|||
143136684|NCT02631941|516047614|FG002|Overall Study|Adverse Event|0|||
143136685|NCT02631941|516047615|FG003|Overall Study|Adverse Event|0|||
143136686|NCT02631941|516047616|FG004|Overall Study|Adverse Event|0|||
143136687|NCT02631941|516047617|FG005|Overall Study|Adverse Event|0|||
143136688|NCT02631941|516047618|FG006|Overall Study|Adverse Event|0|||
143136689|NCT02631941|516047619|FG007|Overall Study|Adverse Event|0|||
143136690|NCT02631941|516047620|FG008|Overall Study|Adverse Event|0|||
143136691|NCT02631941|516047621|FG009|Overall Study|Adverse Event|0|||
143136692|NCT02631941|516047612|FG000|Overall Study|Withdrawal by Subject|0|||
143136693|NCT02631941|516047613|FG001|Overall Study|Withdrawal by Subject|0|||
143136694|NCT02631941|516047614|FG002|Overall Study|Withdrawal by Subject|0|||
143136695|NCT02631941|516047615|FG003|Overall Study|Withdrawal by Subject|0|||
143472122|NCT01968070|517275132|FG017|Period 1|Adverse Event|0|||
143136696|NCT02631941|516047616|FG004|Overall Study|Withdrawal by Subject|1|||
143136697|NCT02631941|516047617|FG005|Overall Study|Withdrawal by Subject|0|||
143136698|NCT02631941|516047618|FG006|Overall Study|Withdrawal by Subject|0|||
143136699|NCT02631941|516047619|FG007|Overall Study|Withdrawal by Subject|1|||
143136700|NCT02631941|516047620|FG008|Overall Study|Withdrawal by Subject|0|||
143136701|NCT02631941|516047621|FG009|Overall Study|Withdrawal by Subject|0|||
143136702|NCT02631941|516047612|FG000|Overall Study|Lost to Follow-up|0|||
143136703|NCT02631941|516047613|FG001|Overall Study|Lost to Follow-up|0|||
143136704|NCT02631941|516047614|FG002|Overall Study|Lost to Follow-up|0|||
143136705|NCT02631941|516047615|FG003|Overall Study|Lost to Follow-up|0|||
143136706|NCT02631941|516047616|FG004|Overall Study|Lost to Follow-up|0|||
143136707|NCT02631941|516047617|FG005|Overall Study|Lost to Follow-up|0|||
143136708|NCT02631941|516047618|FG006|Overall Study|Lost to Follow-up|0|||
143136709|NCT02631941|516047619|FG007|Overall Study|Lost to Follow-up|0|||
143136710|NCT02631941|516047620|FG008|Overall Study|Lost to Follow-up|1|||
143136711|NCT02631941|516047621|FG009|Overall Study|Lost to Follow-up|0|||
143136712|NCT03722576|516047627|FG000|Overall Study|Withdrawal by Subject|3|||
143136713|NCT03722576|516047627|FG000|Overall Study|Adverse Event|2|||
143472123|NCT01968070|517275115|FG000|Period 1|Physician Decision|0|||
143472124|NCT01968070|517275116|FG001|Period 1|Physician Decision|0|||
143472125|NCT01968070|517275117|FG002|Period 1|Physician Decision|0|||
143136714|NCT03722576|516047627|FG000|Overall Study|Physician Decision|1|||
143136715|NCT03722576|516047627|FG000|Overall Study|Lost to Follow-up|1|||
143136716|NCT01240382|516047628|FG000|Overall Study|Adverse Event|2|||
143136717|NCT01240382|516047629|FG001|Overall Study|Adverse Event|1|||
143136718|NCT01240382|516047628|FG000|Overall Study|Lack of Efficacy|0|||
143136719|NCT01240382|516047629|FG001|Overall Study|Lack of Efficacy|2|||
143136720|NCT01240382|516047628|FG000|Overall Study|Fear of adverse events|0|||
143136721|NCT01240382|516047629|FG001|Overall Study|Fear of adverse events|1|||
143136722|NCT01663402|516047633|FG000|Overall Study|Randomized but not treated|19|||
143136723|NCT01663402|516047634|FG001|Overall Study|Randomized but not treated|11|||
143136724|NCT01663402|516047633|FG000|Overall Study|Adverse Event|347|||
143136725|NCT01663402|516047634|FG001|Overall Study|Adverse Event|362|||
143136726|NCT01663402|516047633|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
143136727|NCT01663402|516047634|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
143136728|NCT01663402|516047633|FG000|Overall Study|Poor compliance to protocol|529|||
143136729|NCT01663402|516047634|FG001|Overall Study|Poor compliance to protocol|454|||
143136730|NCT01663402|516047633|FG000|Overall Study|Physician Decision|77|||
143136731|NCT01663402|516047634|FG001|Overall Study|Physician Decision|62|||
143136732|NCT01663402|516047633|FG000|Overall Study|Site terminated by sponsor|1|||
143136733|NCT01663402|516047634|FG001|Overall Study|Site terminated by sponsor|3|||
143136734|NCT01663402|516047633|FG000|Overall Study|Participant moved|139|||
143136735|NCT01663402|516047634|FG001|Overall Study|Participant moved|104|||
143136736|NCT01663402|516047633|FG000|Overall Study|Withdrawal by Subject|118|||
143136737|NCT01663402|516047634|FG001|Overall Study|Withdrawal by Subject|91|||
143136738|NCT01663402|516047633|FG000|Overall Study|Related to study drug administration|96|||
143136739|NCT01663402|516047634|FG001|Overall Study|Related to study drug administration|105|||
143136740|NCT01663402|516047633|FG000|Overall Study|Lost to Follow-up|17|||
143136741|NCT01663402|516047634|FG001|Overall Study|Lost to Follow-up|15|||
143136742|NCT01663402|516047633|FG000|Overall Study|Other than specified above|172|||
143136743|NCT01663402|516047634|FG001|Overall Study|Other than specified above|147|||
143136744|NCT03585270|516047639|FG000|Overall Study|Withdrawal by Subject|2|||
143136745|NCT03585270|516047640|FG001|Overall Study|Withdrawal by Subject|6|||
143136746|NCT03585270|516047639|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
143136747|NCT03585270|516047640|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
143136748|NCT03585270|516047639|FG000|Overall Study|Adverse Event|5|||
143136749|NCT03585270|516047640|FG001|Overall Study|Adverse Event|2|||
143136750|NCT03585270|516047639|FG000|Overall Study|Lost to Follow-up|1|||
143136751|NCT03585270|516047640|FG001|Overall Study|Lost to Follow-up|4|||
143136752|NCT03585270|516047639|FG000|Overall Study|Death|5|||
143136753|NCT03585270|516047640|FG001|Overall Study|Death|3|||
143136754|NCT03585270|516047639|FG000|Overall Study|Other reasons|2|||
143136755|NCT03585270|516047640|FG001|Overall Study|Other reasons|2|||
143136756|NCT05002972|516047643|FG000|Overall Study|Withdrawal by Subject|2|||
143136757|NCT01664091|516047644|FG000|Overall Study|Death|1|||
143136758|NCT01664091|516047644|FG000|Overall Study|Disease Progression|2|||
143136759|NCT01664091|516047644|FG000|Overall Study|Lost to Follow-up|2|||
143136760|NCT01664091|516047644|FG000|Overall Study|Withdrawal by Subject|1|||
143136761|NCT01172873|516047647|FG000|Overall Study|Withdrawal by Subject|3|||
143136762|NCT01172873|516047648|FG001|Overall Study|Withdrawal by Subject|2|||
143136763|NCT02053493|516047651|FG000|Overall Study|Withdrawal by Subject|1|||
143136764|NCT02053493|516047652|FG001|Overall Study|Withdrawal by Subject|1|||
143136765|NCT04613518|516047655|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
143136766|NCT04613518|516047656|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
143472126|NCT01968070|517275118|FG003|Period 1|Physician Decision|0|||
143472127|NCT01968070|517275119|FG004|Period 1|Physician Decision|0|||
143472128|NCT01968070|517275120|FG005|Period 1|Physician Decision|0|||
143472129|NCT01968070|517275121|FG006|Period 1|Physician Decision|0|||
143472130|NCT01968070|517275122|FG007|Period 1|Physician Decision|0|||
143472131|NCT01968070|517275123|FG008|Period 1|Physician Decision|0|||
143472132|NCT01968070|517275124|FG009|Period 1|Physician Decision|0|||
143472133|NCT01968070|517275125|FG010|Period 1|Physician Decision|0|||
143472134|NCT01968070|517275126|FG011|Period 1|Physician Decision|1|||
143472135|NCT01968070|517275127|FG012|Period 1|Physician Decision|0|||
143472136|NCT01968070|517275128|FG013|Period 1|Physician Decision|0|||
143472137|NCT01968070|517275129|FG014|Period 1|Physician Decision|0|||
143472138|NCT01968070|517275130|FG015|Period 1|Physician Decision|0|||
143472139|NCT01968070|517275131|FG016|Period 1|Physician Decision|0|||
143472140|NCT01968070|517275132|FG017|Period 1|Physician Decision|0|||
143472141|NCT01968070|517275115|FG000|Period 2|Withdrawal by Subject|0|||
143472142|NCT01968070|517275116|FG001|Period 2|Withdrawal by Subject|0|||
143472143|NCT01968070|517275117|FG002|Period 2|Withdrawal by Subject|0|||
143136767|NCT04613518|516047657|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
143136768|NCT04613518|516047655|FG000|Double-Blind Treatment Period|Adverse Event|2|||
143472144|NCT01968070|517275118|FG003|Period 2|Withdrawal by Subject|0|||
143472145|NCT01968070|517275119|FG004|Period 2|Withdrawal by Subject|1|||
143472146|NCT01968070|517275120|FG005|Period 2|Withdrawal by Subject|0|||
143472147|NCT01968070|517275121|FG006|Period 2|Withdrawal by Subject|0|||
143472148|NCT01968070|517275122|FG007|Period 2|Withdrawal by Subject|0|||
143472149|NCT01968070|517275123|FG008|Period 2|Withdrawal by Subject|0|||
143472150|NCT01968070|517275124|FG009|Period 2|Withdrawal by Subject|0|||
143472151|NCT01968070|517275125|FG010|Period 2|Withdrawal by Subject|0|||
143472152|NCT01968070|517275126|FG011|Period 2|Withdrawal by Subject|0|||
143472153|NCT01968070|517275127|FG012|Period 2|Withdrawal by Subject|0|||
143472154|NCT01968070|517275128|FG013|Period 2|Withdrawal by Subject|0|||
143136769|NCT04613518|516047656|FG001|Double-Blind Treatment Period|Adverse Event|0|||
143136770|NCT04613518|516047657|FG002|Double-Blind Treatment Period|Adverse Event|1|||
143136771|NCT04613518|516047655|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
143136772|NCT04613518|516047656|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
143136773|NCT04613518|516047657|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
143136774|NCT04613518|516047655|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
143136775|NCT04613518|516047656|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
143136776|NCT04613518|516047657|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
143136777|NCT04613518|516047655|FG000|Double-Blind Treatment Period|Other Reasons|2|||
143136778|NCT04613518|516047656|FG001|Double-Blind Treatment Period|Other Reasons|0|||
143136779|NCT04613518|516047657|FG002|Double-Blind Treatment Period|Other Reasons|0|||
143136780|NCT04613518|516047655|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
143136781|NCT04613518|516047656|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
143136782|NCT04613518|516047657|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
143136783|NCT04613518|516047655|FG000|Open-Label Treatment Period|Adverse Event|1|||
143136784|NCT04613518|516047656|FG001|Open-Label Treatment Period|Adverse Event|0|||
143136785|NCT04613518|516047657|FG002|Open-Label Treatment Period|Adverse Event|3|||
143136786|NCT04613518|516047655|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
143136787|NCT04613518|516047656|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
143136788|NCT04613518|516047657|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
143136789|NCT04613518|516047655|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
143136790|NCT04613518|516047656|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
143136791|NCT04613518|516047657|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
143136792|NCT04613518|516047655|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
143136793|NCT04613518|516047656|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
143136794|NCT04613518|516047657|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
143136795|NCT04613518|516047655|FG000|Open-Label Treatment Period|Other reasons|1|||
143136796|NCT04613518|516047656|FG001|Open-Label Treatment Period|Other reasons|0|||
143136797|NCT04613518|516047657|FG002|Open-Label Treatment Period|Other reasons|0|||
143136798|NCT01076543|516047659|FG000|Overall Study|Withdrawal by Subject|2|||
143136799|NCT01076543|516047660|FG001|Overall Study|Withdrawal by Subject|0|||
143136800|NCT01076543|516047661|FG002|Overall Study|Withdrawal by Subject|0|||
143136801|NCT01076543|516047662|FG003|Overall Study|Withdrawal by Subject|0|||
143472155|NCT01968070|517275129|FG014|Period 2|Withdrawal by Subject|0|||
143472156|NCT01968070|517275130|FG015|Period 2|Withdrawal by Subject|0|||
143472157|NCT01968070|517275131|FG016|Period 2|Withdrawal by Subject|0|||
143472158|NCT01968070|517275132|FG017|Period 2|Withdrawal by Subject|0|||
143472159|NCT00890929|517275135|FG000|Overall Study|Death before treatment|2|||
143472160|NCT00890929|517275135|FG000|Overall Study|Withdrawal by Subject|3|||
143472161|NCT00890929|517275135|FG000|Overall Study|Physician Decision|1|||
143472162|NCT00108069|517275136|FG000|Overall Study|Never rec'd study drug|0|||
143472163|NCT00108069|517275137|FG001|Overall Study|Never rec'd study drug|1|||
143472164|NCT00108069|517275136|FG000|Overall Study|Adverse Event|1|||
143472165|NCT00108069|517275137|FG001|Overall Study|Adverse Event|1|||
143136802|NCT01076543|516047663|FG004|Overall Study|Withdrawal by Subject|0|||
143136803|NCT01076543|516047664|FG005|Overall Study|Withdrawal by Subject|0|||
143136804|NCT00338741|516047665|FG000|Overall Study|Lost to Follow-up|2|||
143136805|NCT00338741|516047666|FG001|Overall Study|Lost to Follow-up|0|||
143136806|NCT02984982|516047667|FG000|Overall Study|Adverse Event|2|||
143136807|NCT02984982|516047668|FG001|Overall Study|Adverse Event|5|||
143136808|NCT02984982|516047667|FG000|Overall Study|Poor Compliance to Protocol|4|||
143361433|NCT00333138|516863736|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
143361434|NCT00333138|516863737|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
143361435|NCT00333138|516863735|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
143361436|NCT00333138|516863736|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
143361437|NCT00333138|516863737|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
143361438|NCT00333138|516863735|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
143361439|NCT00333138|516863736|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
143361440|NCT00333138|516863737|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
143361441|NCT00333138|516863735|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
143361442|NCT00333138|516863736|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
143361443|NCT00333138|516863737|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
143361444|NCT00333138|516863735|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
143361445|NCT00333138|516863736|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
143361446|NCT00333138|516863737|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
143361447|NCT00333138|516863735|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
143361448|NCT00333138|516863736|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
143361449|NCT00333138|516863737|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
143361450|NCT00333138|516863735|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
143361451|NCT00333138|516863736|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
143361452|NCT00333138|516863737|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
143361453|NCT00333138|516863735|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
143361454|NCT00333138|516863736|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
143361455|NCT00333138|516863737|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
143361456|NCT00333138|516863735|FG000|Extension Study (Month6 to End of Study)|Death|0|||
143361457|NCT00333138|516863736|FG001|Extension Study (Month6 to End of Study)|Death|1|||
143361458|NCT00333138|516863737|FG002|Extension Study (Month6 to End of Study)|Death|0|||
143361459|NCT01342887|516863739|FG000|Overall Study|Death|2|||
143361460|NCT04822298|516865610|FG000|Overall Study|Death|3|||
143361461|NCT01789203|516865614|FG000|Overall Study|Adverse Event|2|||
143361462|NCT01789203|516865615|FG001|Overall Study|Adverse Event|2|||
143361463|NCT01789203|516865614|FG000|Overall Study|Withdrawal by Subject|1|||
143361464|NCT01789203|516865615|FG001|Overall Study|Withdrawal by Subject|0|||
143361465|NCT01789203|516865614|FG000|Overall Study|Death|1|||
143361466|NCT01789203|516865615|FG001|Overall Study|Death|0|||
143361467|NCT01789203|516865614|FG000|Overall Study|Protocol Violation|2|||
143361468|NCT01789203|516865615|FG001|Overall Study|Protocol Violation|1|||
143361469|NCT01789203|516865614|FG000|Overall Study|Other|1|||
143361470|NCT01789203|516865615|FG001|Overall Study|Other|1|||
143361471|NCT01789203|516865614|FG000|Overall Study|patient non-adherent|2|||
143361472|NCT01789203|516865615|FG001|Overall Study|patient non-adherent|0|||
143361473|NCT01254305|516865616|FG000|Overall Study|Adverse Event|6|||
143361474|NCT01254305|516865617|FG001|Overall Study|Adverse Event|3|||
143361475|NCT01254305|516865618|FG002|Overall Study|Adverse Event|2|||
143361476|NCT01254305|516865616|FG000|Overall Study|Lack of Efficacy|1|||
143361477|NCT01254305|516865617|FG001|Overall Study|Lack of Efficacy|0|||
143361478|NCT01254305|516865618|FG002|Overall Study|Lack of Efficacy|1|||
143361479|NCT01254305|516865616|FG000|Overall Study|Protocol Violation|1|||
143361480|NCT01254305|516865617|FG001|Overall Study|Protocol Violation|7|||
143361481|NCT01254305|516865618|FG002|Overall Study|Protocol Violation|3|||
143361482|NCT01254305|516865616|FG000|Overall Study|Withdrawal by Subject|4|||
143361483|NCT01254305|516865617|FG001|Overall Study|Withdrawal by Subject|2|||
143361484|NCT01254305|516865618|FG002|Overall Study|Withdrawal by Subject|4|||
143361485|NCT01254305|516865616|FG000|Overall Study|Lost to Follow-up|10|||
143361486|NCT01254305|516865617|FG001|Overall Study|Lost to Follow-up|6|||
143361487|NCT01254305|516865618|FG002|Overall Study|Lost to Follow-up|5|||
143361488|NCT01254305|516865616|FG000|Overall Study|Other Reasons|0|||
143361489|NCT01254305|516865617|FG001|Overall Study|Other Reasons|0|||
143361490|NCT01254305|516865618|FG002|Overall Study|Other Reasons|2|||
143361491|NCT01511536|516865619|FG000|Phase 1|Other|0|||
143361492|NCT01511536|516865620|FG001|Phase 1|Other|1|||
143361493|NCT01511536|516865621|FG002|Phase 1|Other|0|||
143361494|NCT01511536|516865619|FG000|Phase 2|Other|0|||
143361495|NCT01511536|516865620|FG001|Phase 2|Other|0|||
143361496|NCT01511536|516865621|FG002|Phase 2|Other|9|||
143361497|NCT02297503|516865625|FG000|Overall Study|Withdrawal by Subject|1|||
143361498|NCT02297503|516865626|FG001|Overall Study|Withdrawal by Subject|1|||
143136809|NCT02984982|516047668|FG001|Overall Study|Poor Compliance to Protocol|4|||
143136810|NCT02984982|516047667|FG000|Overall Study|Withdrawal by Subject|2|||
143136811|NCT02984982|516047668|FG001|Overall Study|Withdrawal by Subject|0|||
143136812|NCT02984982|516047667|FG000|Overall Study|Randomized but not treated|0|||
143136813|NCT02984982|516047668|FG001|Overall Study|Randomized but not treated|1|||
143136814|NCT02153918|516047669|FG000|Overall Study|Refused further treatment|1|||
143136815|NCT02616783|516047670|FG000|Overall Study|Randomized but Not Treated|1|||
143136816|NCT02616783|516047671|FG001|Overall Study|Randomized but Not Treated|0|||
143136817|NCT02616783|516047670|FG000|Overall Study|Adverse Event|1|||
143136818|NCT02616783|516047671|FG001|Overall Study|Adverse Event|0|||
143136819|NCT02616783|516047670|FG000|Overall Study|Death|1|||
143136820|NCT02616783|516047671|FG001|Overall Study|Death|0|||
143136821|NCT02616783|516047670|FG000|Overall Study|Non-Compliance with Study Drug|1|||
143136822|NCT02616783|516047671|FG001|Overall Study|Non-Compliance with Study Drug|0|||
143136823|NCT02616783|516047670|FG000|Overall Study|Protocol Violation|1|||
143136824|NCT02616783|516047671|FG001|Overall Study|Protocol Violation|1|||
143136825|NCT02616783|516047670|FG000|Overall Study|Withdrew Consent|1|||
143136826|NCT02616783|516047671|FG001|Overall Study|Withdrew Consent|1|||
143136827|NCT03902613|516047672|FG000|Overall Study|Physician Decision|1|||
143136828|NCT01061606|516047679|FG000|Overall Study|Adverse Event|1|||
143136829|NCT01061606|516047679|FG000|Overall Study|Death|1|||
143136830|NCT01061606|516047679|FG000|Overall Study|Disease Progression|4|||
143136831|NCT01061606|516047679|FG000|Overall Study|alternative therapy|2|||
143136832|NCT01204671|516047680|FG000|Overall Study|Adverse Event|4|||
143136833|NCT01204671|516047681|FG001|Overall Study|Adverse Event|3|||
143136834|NCT01204671|516047682|FG002|Overall Study|Adverse Event|3|||
143136835|NCT01204671|516047683|FG003|Overall Study|Adverse Event|3|||
143136836|NCT01204671|516047684|FG004|Overall Study|Adverse Event|1|||
143136837|NCT01204671|516047680|FG000|Overall Study|Withdrawal by Subject|2|||
143136838|NCT01204671|516047681|FG001|Overall Study|Withdrawal by Subject|3|||
143136839|NCT01204671|516047682|FG002|Overall Study|Withdrawal by Subject|4|||
143136840|NCT01204671|516047683|FG003|Overall Study|Withdrawal by Subject|5|||
143136841|NCT01204671|516047684|FG004|Overall Study|Withdrawal by Subject|3|||
143136842|NCT01204671|516047680|FG000|Overall Study|Lost to Follow-up|7|||
143136843|NCT01204671|516047681|FG001|Overall Study|Lost to Follow-up|8|||
143136844|NCT01204671|516047682|FG002|Overall Study|Lost to Follow-up|6|||
143136845|NCT01204671|516047683|FG003|Overall Study|Lost to Follow-up|4|||
143136846|NCT01204671|516047684|FG004|Overall Study|Lost to Follow-up|0|||
143136847|NCT01204671|516047680|FG000|Overall Study|Unknown Completion Status|1|||
143136848|NCT01204671|516047681|FG001|Overall Study|Unknown Completion Status|1|||
143136849|NCT01204671|516047682|FG002|Overall Study|Unknown Completion Status|0|||
143136850|NCT01204671|516047683|FG003|Overall Study|Unknown Completion Status|0|||
143136851|NCT01204671|516047684|FG004|Overall Study|Unknown Completion Status|0|||
143136852|NCT01204671|516047680|FG000|Overall Study|Physician Decision|0|||
143136853|NCT01204671|516047681|FG001|Overall Study|Physician Decision|0|||
143136854|NCT01204671|516047682|FG002|Overall Study|Physician Decision|0|||
143136855|NCT01204671|516047683|FG003|Overall Study|Physician Decision|1|||
143136856|NCT01204671|516047684|FG004|Overall Study|Physician Decision|0|||
143136857|NCT03810456|516047685|FG000|Treatment|Urgent Family Matters|3|||
143136858|NCT03810456|516047686|FG001|Treatment|Urgent Family Matters|0|||
143136859|NCT03810456|516047687|FG002|Treatment|Urgent Family Matters|0|||
143136860|NCT03810456|516047685|FG000|Treatment|Scheduling Conflicts|0|||
143136861|NCT03810456|516047686|FG001|Treatment|Scheduling Conflicts|11|||
143136862|NCT03810456|516047687|FG002|Treatment|Scheduling Conflicts|0|||
143136863|NCT03810456|516047685|FG000|Treatment|No Longer Interested|0|||
143136864|NCT03810456|516047686|FG001|Treatment|No Longer Interested|12|||
143136865|NCT03810456|516047687|FG002|Treatment|No Longer Interested|0|||
143136866|NCT03810456|516047685|FG000|Treatment|Transportation Issues|0|||
143136867|NCT03810456|516047686|FG001|Treatment|Transportation Issues|1|||
143136868|NCT03810456|516047687|FG002|Treatment|Transportation Issues|0|||
143136869|NCT03810456|516047685|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
143136870|NCT03810456|516047686|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
143136871|NCT03810456|516047687|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
143136872|NCT03810456|516047685|FG000|1 Month Follow-Up|Relocated to Different State|1|||
143136873|NCT03810456|516047686|FG001|1 Month Follow-Up|Relocated to Different State|0|||
143136874|NCT03810456|516047687|FG002|1 Month Follow-Up|Relocated to Different State|1|||
143361499|NCT02297503|516865625|FG000|Overall Study|Protocol Violation|1|||
143361500|NCT02297503|516865626|FG001|Overall Study|Protocol Violation|0|||
143361501|NCT02297503|516865625|FG000|Overall Study|Pregnancy|0|||
143361502|NCT02297503|516865626|FG001|Overall Study|Pregnancy|1|||
143361503|NCT02297503|516865625|FG000|Overall Study|Lost to Follow-up|0|||
143136875|NCT03810456|516047685|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
143136876|NCT03810456|516047686|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
143136877|NCT03810456|516047687|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
143136878|NCT03810456|516047685|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
143136879|NCT03810456|516047686|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
143136880|NCT03810456|516047687|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
143136881|NCT03810456|516047685|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
143136882|NCT03810456|516047686|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
143361504|NCT02297503|516865626|FG001|Overall Study|Lost to Follow-up|1|||
143014000|NCT03252756|515590130|FG000|Overall Study|Study Drug Expiration|0|||
143014001|NCT03252756|515590131|FG001|Overall Study|Study Drug Expiration|1|||
143014002|NCT01907516|515590132|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
143014003|NCT01907516|515590133|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
143014004|NCT01907516|515590132|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
143014005|NCT01907516|515590133|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
143014006|NCT01907516|515590132|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
143014007|NCT01907516|515590133|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
143014008|NCT01907516|515590132|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
143014009|NCT01907516|515590133|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
143014010|NCT00131937|515590135|FG000|Overall Study|Adverse Event|3|||
143014011|NCT00131937|515590135|FG000|Overall Study|Withdrawal by Subject|2|||
143014012|NCT00131937|515590135|FG000|Overall Study|Physician Decision|1|||
143014013|NCT00131937|515590135|FG000|Overall Study|Disease Progression|7|||
143014014|NCT00131937|515590135|FG000|Overall Study|Alternative therapy|1|||
143014015|NCT00414011|515591573|FG000|Overall Study|Physician Decision|3|||
143014016|NCT00414011|515591573|FG000|Overall Study|Withdrawal by Subject|2|||
143014017|NCT00306852|515591576|FG000|Overall Study|Death|14|||
143014018|NCT00306852|515591577|FG001|Overall Study|Death|14|||
143014019|NCT00306852|515591576|FG000|Overall Study|Lost to Follow-up|15|||
143014020|NCT00306852|515591577|FG001|Overall Study|Lost to Follow-up|24|||
143014021|NCT02360397|515591578|FG000|Overall Study|Incomplete screening|3|||
143014022|NCT02360397|515591578|FG000|Overall Study|Adverse Event|1|||
143136883|NCT03810456|516047687|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
143136884|NCT03810456|516047685|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
143136885|NCT03810456|516047686|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
143136886|NCT03810456|516047687|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
143136887|NCT03810456|516047685|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
143136888|NCT03810456|516047686|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
143136889|NCT03810456|516047687|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
143136890|NCT04350827|516047691|FG000|Overall Study|Lost to Follow-up|1|||
143136891|NCT04350827|516047692|FG001|Overall Study|Lost to Follow-up|2|||
143136892|NCT02990000|516048995|FG000|Overall Study|Failed to provide data beyond baseline|36|||
143136893|NCT02990000|516048996|FG001|Overall Study|Failed to provide data beyond baseline|34|||
143136894|NCT00870727|516048997|FG000|Overall Study|Lost to Follow-up|0|||
143136895|NCT00870727|516048998|FG001|Overall Study|Lost to Follow-up|1|||
143136896|NCT00870727|516048997|FG000|Overall Study|Lack of Efficacy|1|||
143136897|NCT00870727|516048998|FG001|Overall Study|Lack of Efficacy|3|||
143136898|NCT00870727|516048997|FG000|Overall Study|Adverse Event|0|||
143136899|NCT00870727|516048998|FG001|Overall Study|Adverse Event|1|||
143136900|NCT00557466|516048999|FG000|Overall Study|Adverse Event|3|||
143136901|NCT00557466|516049000|FG001|Overall Study|Adverse Event|1|||
143136902|NCT00557466|516049001|FG002|Overall Study|Adverse Event|4|||
143136903|NCT00557466|516049002|FG003|Overall Study|Adverse Event|1|||
143136904|NCT00557466|516049003|FG004|Overall Study|Adverse Event|2|||
143136905|NCT00557466|516049004|FG005|Overall Study|Adverse Event|4|||
143136906|NCT00557466|516048999|FG000|Overall Study|Abnormal laboratory value(s)|1|||
143136907|NCT00557466|516049000|FG001|Overall Study|Abnormal laboratory value(s)|2|||
143136908|NCT00557466|516049001|FG002|Overall Study|Abnormal laboratory value(s)|0|||
143136909|NCT00557466|516049002|FG003|Overall Study|Abnormal laboratory value(s)|0|||
143361505|NCT02297503|516865625|FG000|Overall Study|Medical reason|0|||
143361506|NCT02297503|516865626|FG001|Overall Study|Medical reason|1|||
143361507|NCT03019458|516865629|FG000|Overall Study|Death|0|||
143361508|NCT03019458|516865630|FG001|Overall Study|Death|1|||
143361509|NCT03169361|516865631|FG000|Overall Study|Protocol Violation|32|||
143361510|NCT02788656|516865632|FG000|Overall Study|Withdrawal by Subject|1|||
143361511|NCT02788656|516865633|FG001|Overall Study|Withdrawal by Subject|0|||
143361512|NCT02263885|516865634|FG000|Overall Study|Withdrawal by Subject|7|||
143361513|NCT02263885|516865634|FG000|Overall Study|Alternative Treatment|3|||
143361514|NCT01561079|516865639|FG000|Overall Study|Physician Decision|17|||
143361515|NCT01561079|516865639|FG000|Overall Study|Withdrawal by Subject|59|||
143361516|NCT01561079|516865639|FG000|Overall Study|Protocol Violation|2|||
143361517|NCT03330119|516865640|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
143361518|NCT03330119|516865641|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
143361519|NCT00664521|516865648|FG000|Overall Study|Adverse Event|4|||
143361520|NCT00664521|516865649|FG001|Overall Study|Adverse Event|1|||
143361521|NCT00664521|516865648|FG000|Overall Study|Lost to Follow-up|1|||
143361522|NCT00664521|516865649|FG001|Overall Study|Lost to Follow-up|0|||
143361523|NCT00664521|516865648|FG000|Overall Study|Other|1|||
143361524|NCT00664521|516865649|FG001|Overall Study|Other|0|||
143361525|NCT00550732|516865652|FG000|Overall Study|Death|4|||
143361526|NCT00550732|516865652|FG000|Overall Study|Withdrawal by Subject|2|||
143361527|NCT00550732|516865652|FG000|Overall Study|Physician Decision|2|||
143361528|NCT00550732|516865652|FG000|Overall Study|Lost to Follow-up|1|||
143361529|NCT00550732|516865652|FG000|Overall Study|Palliative care|1|||
143361530|NCT00550732|516865652|FG000|Overall Study|Adverse Event|1|||
143136910|NCT00557466|516049003|FG004|Overall Study|Abnormal laboratory value(s)|0|||
143136911|NCT00557466|516049004|FG005|Overall Study|Abnormal laboratory value(s)|0|||
143136912|NCT00557466|516048999|FG000|Overall Study|Protocol deviation|0|||
143136913|NCT00557466|516049000|FG001|Overall Study|Protocol deviation|1|||
143136914|NCT00557466|516049001|FG002|Overall Study|Protocol deviation|0|||
143136915|NCT00557466|516049002|FG003|Overall Study|Protocol deviation|2|||
143472166|NCT00108069|517275136|FG000|Overall Study|Withdrawal by Subject|1|||
143472167|NCT00108069|517275137|FG001|Overall Study|Withdrawal by Subject|0|||
143472168|NCT00108069|517275136|FG000|Overall Study|Death|1|||
143472169|NCT00108069|517275137|FG001|Overall Study|Death|0|||
143472170|NCT00108069|517275136|FG000|Overall Study|Progessive disease|27|||
143472171|NCT00108069|517275137|FG001|Overall Study|Progessive disease|11|||
143472172|NCT00685685|517275139|FG000|Washout Period of 7 Days|Adverse Event|2|||
143472173|NCT00685685|517275140|FG001|Washout Period of 7 Days|Adverse Event|0|||
143472174|NCT00685685|517275139|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
143472175|NCT00685685|517275140|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
143472176|NCT03684642|517275143|FG000|Overall Study|Adverse Event|6|||
143472177|NCT03684642|517275144|FG001|Overall Study|Adverse Event|15|||
143472178|NCT03684642|517275145|FG002|Overall Study|Adverse Event|11|||
143472179|NCT03684642|517275143|FG000|Overall Study|Withdrawal by Subject|35|||
143472180|NCT03684642|517275144|FG001|Overall Study|Withdrawal by Subject|53|||
143472181|NCT03684642|517275145|FG002|Overall Study|Withdrawal by Subject|23|||
143472182|NCT03684642|517275143|FG000|Overall Study|Lack of Efficacy|0|||
143472183|NCT03684642|517275144|FG001|Overall Study|Lack of Efficacy|0|||
143472184|NCT03684642|517275145|FG002|Overall Study|Lack of Efficacy|1|||
143472185|NCT03684642|517275143|FG000|Overall Study|Poor compliance to protocol|0|||
143136916|NCT00557466|516049003|FG004|Overall Study|Protocol deviation|0|||
143136917|NCT00557466|516049004|FG005|Overall Study|Protocol deviation|0|||
143136918|NCT00557466|516048999|FG000|Overall Study|Subject withdrew consent|0|||
143136919|NCT00557466|516049000|FG001|Overall Study|Subject withdrew consent|0|||
143136920|NCT00557466|516049001|FG002|Overall Study|Subject withdrew consent|0|||
143136921|NCT00557466|516049002|FG003|Overall Study|Subject withdrew consent|0|||
143136922|NCT00557466|516049003|FG004|Overall Study|Subject withdrew consent|1|||
143136923|NCT00557466|516049004|FG005|Overall Study|Subject withdrew consent|2|||
143136924|NCT00557466|516048999|FG000|Overall Study|Administrative problems|0|||
143136925|NCT00557466|516049000|FG001|Overall Study|Administrative problems|1|||
143136926|NCT00557466|516049001|FG002|Overall Study|Administrative problems|1|||
143136927|NCT00557466|516049002|FG003|Overall Study|Administrative problems|0|||
143136928|NCT00557466|516049003|FG004|Overall Study|Administrative problems|0|||
143136929|NCT00557466|516049004|FG005|Overall Study|Administrative problems|0|||
143136930|NCT00557466|516048999|FG000|Overall Study|Abnormal test procedure results|0|||
143136931|NCT00557466|516049000|FG001|Overall Study|Abnormal test procedure results|0|||
143136932|NCT00557466|516049001|FG002|Overall Study|Abnormal test procedure results|1|||
143136933|NCT00557466|516049002|FG003|Overall Study|Abnormal test procedure results|0|||
143136934|NCT00557466|516049003|FG004|Overall Study|Abnormal test procedure results|0|||
143136935|NCT00557466|516049004|FG005|Overall Study|Abnormal test procedure results|0|||
143136936|NCT00557466|516048999|FG000|Overall Study|Lost to Follow-up|0|||
143136937|NCT00557466|516049000|FG001|Overall Study|Lost to Follow-up|0|||
143136938|NCT00557466|516049001|FG002|Overall Study|Lost to Follow-up|0|||
143136939|NCT00557466|516049002|FG003|Overall Study|Lost to Follow-up|1|||
143136940|NCT00557466|516049003|FG004|Overall Study|Lost to Follow-up|0|||
143136941|NCT00557466|516049004|FG005|Overall Study|Lost to Follow-up|0|||
143136942|NCT01712516|516049005|FG000|Overall Study|Technical problems|0|||
143136943|NCT01712516|516049006|FG001|Overall Study|Technical problems|0|||
143136944|NCT01712516|516049007|FG002|Overall Study|Technical problems|0|||
143136945|NCT01712516|516049008|FG003|Overall Study|Technical problems|2|||
143136946|NCT01712516|516049005|FG000|Overall Study|Lost to Follow-up|0|||
143136947|NCT01712516|516049006|FG001|Overall Study|Lost to Follow-up|0|||
143136948|NCT01712516|516049007|FG002|Overall Study|Lost to Follow-up|2|||
143136949|NCT01712516|516049008|FG003|Overall Study|Lost to Follow-up|1|||
143136950|NCT01712516|516049005|FG000|Overall Study|Death|0|||
143472186|NCT03684642|517275144|FG001|Overall Study|Poor compliance to protocol|4|||
143472187|NCT03684642|517275145|FG002|Overall Study|Poor compliance to protocol|1|||
143136951|NCT01712516|516049006|FG001|Overall Study|Death|1|||
143136952|NCT01712516|516049007|FG002|Overall Study|Death|0|||
143136953|NCT01712516|516049008|FG003|Overall Study|Death|0|||
143136954|NCT01712516|516049005|FG000|Overall Study|Protocol deviation|1|||
143136955|NCT01712516|516049006|FG001|Overall Study|Protocol deviation|0|||
143136956|NCT01712516|516049007|FG002|Overall Study|Protocol deviation|1|||
143136957|NCT01712516|516049008|FG003|Overall Study|Protocol deviation|0|||
143136958|NCT01712516|516049005|FG000|Overall Study|Physician Decision|2|||
143136959|NCT01712516|516049006|FG001|Overall Study|Physician Decision|0|||
143136960|NCT01712516|516049007|FG002|Overall Study|Physician Decision|0|||
143136961|NCT01712516|516049008|FG003|Overall Study|Physician Decision|1|||
143472188|NCT03684642|517275143|FG000|Overall Study|Other than specified|62|||
143472189|NCT03684642|517275144|FG001|Overall Study|Other than specified|60|||
143472190|NCT03684642|517275145|FG002|Overall Study|Other than specified|67|||
143472191|NCT03684642|517275143|FG000|Overall Study|Randomized and not treated|0|||
143136962|NCT01712516|516049005|FG000|Overall Study|Withdrawal by Subject|3|||
143136963|NCT01712516|516049006|FG001|Overall Study|Withdrawal by Subject|9|||
143136964|NCT01712516|516049007|FG002|Overall Study|Withdrawal by Subject|3|||
143136965|NCT01712516|516049008|FG003|Overall Study|Withdrawal by Subject|9|||
143136966|NCT01251952|516049011|FG000|Overall Study|Adverse Event|1|||
143136967|NCT02308046|516049012|FG000|Overall Study|Negative yeast culture at Baseline|32|||
143136968|NCT02308046|516049013|FG001|Overall Study|Negative yeast culture at Baseline|33|||
143136969|NCT02308046|516049012|FG000|Overall Study|Positive for STD at Baseline|1|||
143136970|NCT02308046|516049013|FG001|Overall Study|Positive for STD at Baseline|2|||
143136971|NCT02308046|516049012|FG000|Overall Study|Lost to Follow-up|1|||
143136972|NCT02308046|516049013|FG001|Overall Study|Lost to Follow-up|3|||
143136973|NCT02579629|516049019|FG000|Overall Study|Withdrawal by Subject|0|||
143136974|NCT02579629|516049020|FG001|Overall Study|Withdrawal by Subject|1|||
143136975|NCT02579629|516049021|FG002|Overall Study|Withdrawal by Subject|0|||
143136976|NCT02579629|516049019|FG000|Overall Study|Screen Failure|2|||
143136977|NCT02579629|516049020|FG001|Overall Study|Screen Failure|0|||
143136978|NCT02579629|516049021|FG002|Overall Study|Screen Failure|2|||
143136979|NCT01190891|516049024|FG000|Overall Study|Protocol Violation|1|||
143136980|NCT01190891|516049025|FG001|Overall Study|Protocol Violation|0|||
143136981|NCT01190891|516049024|FG000|Overall Study|Withdrawal by Subject|5|||
143136982|NCT01190891|516049025|FG001|Overall Study|Withdrawal by Subject|0|||
143136983|NCT01926028|516049026|FG000|Overall Study|Lost to Follow-up|7|||
143136984|NCT01926028|516049027|FG001|Overall Study|Lost to Follow-up|6|||
143136985|NCT01926028|516049028|FG002|Overall Study|Lost to Follow-up|0|||
143136986|NCT01926028|516049026|FG000|Overall Study|Physician Decision|1|||
143136987|NCT01926028|516049027|FG001|Overall Study|Physician Decision|5|||
143136988|NCT01926028|516049028|FG002|Overall Study|Physician Decision|0|||
143136989|NCT01926028|516049026|FG000|Overall Study|Withdrawal by Subject|9|||
143136990|NCT01926028|516049027|FG001|Overall Study|Withdrawal by Subject|9|||
143136991|NCT01926028|516049028|FG002|Overall Study|Withdrawal by Subject|2|||
143136992|NCT01926028|516049026|FG000|Overall Study|Non compliance or other reasons|4|||
143136993|NCT01926028|516049027|FG001|Overall Study|Non compliance or other reasons|2|||
143136994|NCT01926028|516049028|FG002|Overall Study|Non compliance or other reasons|0|||
143136995|NCT01130272|516049029|FG000|Overall Study|Adverse Event|2|||
143136996|NCT01130272|516049030|FG001|Overall Study|Adverse Event|5|||
143136997|NCT01130272|516049031|FG002|Overall Study|Adverse Event|6|||
143136998|NCT01130272|516049032|FG003|Overall Study|Adverse Event|22|||
143136999|NCT01130272|516049033|FG004|Overall Study|Adverse Event|7|||
143137000|NCT01130272|516049029|FG000|Overall Study|IVRS-confirmed constipation|0|||
143137001|NCT01130272|516049030|FG001|Overall Study|IVRS-confirmed constipation|1|||
143137002|NCT01130272|516049031|FG002|Overall Study|IVRS-confirmed constipation|1|||
143137003|NCT01130272|516049032|FG003|Overall Study|IVRS-confirmed constipation|2|||
143137004|NCT01130272|516049033|FG004|Overall Study|IVRS-confirmed constipation|0|||
143137005|NCT01130272|516049029|FG000|Overall Study|Rescue medications due to diarrhea|3|||
143137006|NCT01130272|516049030|FG001|Overall Study|Rescue medications due to diarrhea|5|||
143137007|NCT01130272|516049031|FG002|Overall Study|Rescue medications due to diarrhea|8|||
143137008|NCT01130272|516049032|FG003|Overall Study|Rescue medications due to diarrhea|8|||
143137009|NCT01130272|516049033|FG004|Overall Study|Rescue medications due to diarrhea|6|||
143137010|NCT01130272|516049029|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
143137011|NCT01130272|516049030|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
143137012|NCT01130272|516049031|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
143137013|NCT01130272|516049032|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
143137014|NCT01130272|516049033|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
143137015|NCT01130272|516049029|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
143137016|NCT01130272|516049030|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
143137017|NCT01130272|516049031|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
143137018|NCT01130272|516049032|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
143137019|NCT01130272|516049033|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
143137020|NCT01130272|516049029|FG000|Overall Study|Protocol Violation|0|||
143137021|NCT01130272|516049030|FG001|Overall Study|Protocol Violation|0|||
143137022|NCT01130272|516049031|FG002|Overall Study|Protocol Violation|3|||
143137023|NCT01130272|516049032|FG003|Overall Study|Protocol Violation|5|||
143361531|NCT03302910|516865658|FG000|Overall Study|Protocol Violation|1|||
143137024|NCT01130272|516049033|FG004|Overall Study|Protocol Violation|5|||
143137025|NCT01130272|516049029|FG000|Overall Study|Lost to Follow-up|4|||
143137026|NCT01130272|516049030|FG001|Overall Study|Lost to Follow-up|3|||
143137027|NCT01130272|516049031|FG002|Overall Study|Lost to Follow-up|4|||
143137028|NCT01130272|516049032|FG003|Overall Study|Lost to Follow-up|7|||
143361532|NCT03302910|516865659|FG001|Overall Study|Protocol Violation|0|||
143361533|NCT00953160|516865670|FG000|Overall Study|Lost to Follow-up|23|||
143361534|NCT00953160|516865670|FG000|Overall Study|Withdrawal by Subject|4|||
143361535|NCT02724020|516865671|FG000|Overall Study|Death|16|||
143361536|NCT02724020|516865672|FG001|Overall Study|Death|18|||
143361537|NCT02724020|516865673|FG002|Overall Study|Death|19|||
143361538|NCT02724020|516865671|FG000|Overall Study|Lost to Follow-up|0|||
143137029|NCT01130272|516049033|FG004|Overall Study|Lost to Follow-up|6|||
143137030|NCT01130272|516049029|FG000|Overall Study|Withdrawal by Subject|4|||
143137031|NCT01130272|516049030|FG001|Overall Study|Withdrawal by Subject|11|||
143137032|NCT01130272|516049031|FG002|Overall Study|Withdrawal by Subject|10|||
143137033|NCT01130272|516049032|FG003|Overall Study|Withdrawal by Subject|9|||
143137034|NCT01130272|516049033|FG004|Overall Study|Withdrawal by Subject|8|||
143137035|NCT01130272|516049029|FG000|Overall Study|Physician Decision|1|||
143137036|NCT01130272|516049030|FG001|Overall Study|Physician Decision|1|||
143137037|NCT01130272|516049031|FG002|Overall Study|Physician Decision|0|||
143137038|NCT01130272|516049032|FG003|Overall Study|Physician Decision|1|||
143137039|NCT01130272|516049033|FG004|Overall Study|Physician Decision|2|||
143137040|NCT01130272|516049029|FG000|Overall Study|Sponsor decision|6|||
143137041|NCT01130272|516049030|FG001|Overall Study|Sponsor decision|15|||
143137042|NCT01130272|516049031|FG002|Overall Study|Sponsor decision|16|||
143137043|NCT01130272|516049032|FG003|Overall Study|Sponsor decision|13|||
143137044|NCT01130272|516049033|FG004|Overall Study|Sponsor decision|16|||
143137045|NCT01130272|516049029|FG000|Overall Study|Study arm discontinued|38|||
143137046|NCT01130272|516049030|FG001|Overall Study|Study arm discontinued|0|||
143137047|NCT01130272|516049031|FG002|Overall Study|Study arm discontinued|0|||
143137048|NCT01130272|516049032|FG003|Overall Study|Study arm discontinued|0|||
143137049|NCT01130272|516049033|FG004|Overall Study|Study arm discontinued|0|||
143137050|NCT00301834|516049034|FG000|Overall Study|Death|1|||
143137051|NCT02870868|516049035|FG000|Overall Study|Withdrawal by Subject|2|||
143137052|NCT02870868|516049036|FG001|Overall Study|Withdrawal by Subject|1|||
143137053|NCT01309386|516049037|FG000|Overall Study|Other|2|||
143137054|NCT01309386|516049038|FG001|Overall Study|Other|0|||
143137055|NCT01309386|516049037|FG000|Overall Study|Withdrawal by Subject|2|||
143137056|NCT01309386|516049038|FG001|Overall Study|Withdrawal by Subject|0|||
143137057|NCT01309386|516049037|FG000|Overall Study|Progressive disease|9|||
143137058|NCT01309386|516049038|FG001|Overall Study|Progressive disease|11|||
143137059|NCT01309386|516049037|FG000|Overall Study|Physician Decision|1|||
143137060|NCT01309386|516049038|FG001|Overall Study|Physician Decision|1|||
143137061|NCT01309386|516049037|FG000|Overall Study|Lack of Efficacy|3|||
143137062|NCT01309386|516049038|FG001|Overall Study|Lack of Efficacy|1|||
143137063|NCT01309386|516049037|FG000|Overall Study|Adverse Event|5|||
143137064|NCT01309386|516049038|FG001|Overall Study|Adverse Event|8|||
143137065|NCT02062437|516049039|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
143137066|NCT02062437|516049039|FG000|Overall Study|Patient not available for the 2y visit|18|||
143137067|NCT02062437|516049039|FG000|Overall Study|Death|2|||
143137068|NCT02062437|516049039|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
143137069|NCT00723229|516049040|FG000|First Intervention|Lost to Follow-up|7|||
143137070|NCT00723229|516049041|FG001|First Intervention|Lost to Follow-up|3|||
143137071|NCT02900352|516049042|FG000|Overall Study|Lost to Follow-up|28|||
143137072|NCT02900352|516049043|FG001|Overall Study|Lost to Follow-up|17|||
143137073|NCT03074695|516049044|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
143137074|NCT03074695|516049045|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
143137075|NCT03074695|516049044|FG000|Overall Study|Research staff not available|1|||
143137076|NCT03074695|516049045|FG001|Overall Study|Research staff not available|2|||
143137077|NCT03074695|516049044|FG000|Overall Study|Did not receive neuraxial block|2|||
143137078|NCT03074695|516049045|FG001|Overall Study|Did not receive neuraxial block|2|||
143137079|NCT01774981|516049046|FG000|Overall Study|Adverse Event|0|||
143137080|NCT01774981|516049047|FG001|Overall Study|Adverse Event|0|||
143137081|NCT01774981|516049048|FG002|Overall Study|Adverse Event|0|||
143137082|NCT01774981|516049049|FG003|Overall Study|Adverse Event|0|||
143137083|NCT01774981|516049050|FG004|Overall Study|Adverse Event|0|||
143137084|NCT01774981|516049051|FG005|Overall Study|Adverse Event|1|||
143137085|NCT01774981|516049052|FG006|Overall Study|Adverse Event|0|||
143137086|NCT01774981|516049053|FG007|Overall Study|Adverse Event|0|||
143137087|NCT01774981|516049046|FG000|Overall Study|Withdrawal by Subject|0|||
143137088|NCT01774981|516049047|FG001|Overall Study|Withdrawal by Subject|0|||
143137089|NCT01774981|516049048|FG002|Overall Study|Withdrawal by Subject|0|||
143137090|NCT01774981|516049049|FG003|Overall Study|Withdrawal by Subject|0|||
143137091|NCT01774981|516049050|FG004|Overall Study|Withdrawal by Subject|0|||
143137092|NCT01774981|516049051|FG005|Overall Study|Withdrawal by Subject|0|||
143361539|NCT02724020|516865672|FG001|Overall Study|Lost to Follow-up|3|||
143361540|NCT02724020|516865673|FG002|Overall Study|Lost to Follow-up|0|||
143361541|NCT02724020|516865671|FG000|Overall Study|Site Terminated by Sponsor|15|||
143361542|NCT02724020|516865672|FG001|Overall Study|Site Terminated by Sponsor|8|||
143361543|NCT02724020|516865673|FG002|Overall Study|Site Terminated by Sponsor|8|||
143361544|NCT02724020|516865671|FG000|Overall Study|Withdrawal by Subject|1|||
143361545|NCT02724020|516865672|FG001|Overall Study|Withdrawal by Subject|3|||
143361546|NCT02724020|516865673|FG002|Overall Study|Withdrawal by Subject|5|||
143361547|NCT03023332|516865679|FG000|Overall Study|Withdrawal by Subject|10|||
143361548|NCT03023332|516865680|FG001|Overall Study|Withdrawal by Subject|5|||
143361549|NCT03023332|516865681|FG002|Overall Study|Withdrawal by Subject|4|||
143361550|NCT03023332|516865682|FG003|Overall Study|Withdrawal by Subject|7|||
143137093|NCT01774981|516049052|FG006|Overall Study|Withdrawal by Subject|0|||
143137094|NCT01774981|516049053|FG007|Overall Study|Withdrawal by Subject|1|||
143137095|NCT01774981|516049046|FG000|Overall Study|Death|0|||
143137096|NCT01774981|516049047|FG001|Overall Study|Death|0|||
143137097|NCT01774981|516049048|FG002|Overall Study|Death|0|||
143137098|NCT01774981|516049049|FG003|Overall Study|Death|0|||
143137099|NCT01774981|516049050|FG004|Overall Study|Death|1|||
143137100|NCT01774981|516049051|FG005|Overall Study|Death|0|||
143137101|NCT01774981|516049052|FG006|Overall Study|Death|0|||
143137102|NCT01774981|516049053|FG007|Overall Study|Death|0|||
143137103|NCT01324102|516049056|FG000|Overall Study|illness|1|||
143137104|NCT01324102|516049057|FG001|Overall Study|illness|6|||
143137105|NCT00902577|516049060|FG000|Overall Study|Withdrawal by Subject|6|||
143137106|NCT00902577|516049060|FG000|Overall Study|FMISO production failure|2|||
143137107|NCT03322293|516049063|FG000|Overall Study|Lost to Follow-up|0|||
143137108|NCT03322293|516049064|FG001|Overall Study|Lost to Follow-up|0|||
143137109|NCT03322293|516049065|FG002|Overall Study|Lost to Follow-up|1|||
143137110|NCT00083915|516049066|FG000|Overall Study|Death|6|||
143137111|NCT00083915|516049067|FG001|Overall Study|Death|3|||
143137112|NCT00083915|516049066|FG000|Overall Study|Physician Decision|11|||
143137113|NCT00083915|516049067|FG001|Overall Study|Physician Decision|6|||
143137114|NCT00083915|516049066|FG000|Overall Study|Withdrawal by Subject|8|||
143137115|NCT00083915|516049067|FG001|Overall Study|Withdrawal by Subject|3|||
143137116|NCT00083915|516049066|FG000|Overall Study|disease progression|18|||
143137117|NCT00083915|516049067|FG001|Overall Study|disease progression|23|||
143137118|NCT00083915|516049066|FG000|Overall Study|Failure to collect|3|||
143137119|NCT00083915|516049067|FG001|Overall Study|Failure to collect|0|||
143137120|NCT00083915|516049066|FG000|Overall Study|No response|3|||
143137121|NCT00083915|516049067|FG001|Overall Study|No response|1|||
143137122|NCT00083915|516049066|FG000|Overall Study|Insurance issues|1|||
143137123|NCT00083915|516049067|FG001|Overall Study|Insurance issues|1|||
143137124|NCT01239797|516049068|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
143137125|NCT01239797|516049069|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
143137126|NCT01239797|516049068|FG000|Randomized Participants|Participant withdrew consent|1|||
143361551|NCT03023332|516865679|FG000|Overall Study|Lost to Follow-up|13|||
143361552|NCT03023332|516865680|FG001|Overall Study|Lost to Follow-up|16|||
143361553|NCT03023332|516865681|FG002|Overall Study|Lost to Follow-up|8|||
143361554|NCT03023332|516865682|FG003|Overall Study|Lost to Follow-up|13|||
143361555|NCT03023332|516865679|FG000|Overall Study|Death|1|||
143361556|NCT03023332|516865680|FG001|Overall Study|Death|0|||
143361557|NCT03023332|516865681|FG002|Overall Study|Death|0|||
143361558|NCT03023332|516865682|FG003|Overall Study|Death|0|||
143361559|NCT02240680|516865683|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
143361560|NCT02240680|516865684|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
143361561|NCT02240680|516865685|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
143361562|NCT02240680|516865686|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
143361563|NCT02240680|516865683|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
143361564|NCT02240680|516865684|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
143361565|NCT02240680|516865685|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
143361566|NCT02240680|516865686|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
143361567|NCT02240680|516865683|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
143361568|NCT02240680|516865684|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
143361569|NCT02240680|516865685|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
143361570|NCT02240680|516865686|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
143361571|NCT02240680|516865683|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
143361572|NCT02240680|516865684|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
143361573|NCT02240680|516865685|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
143361574|NCT02240680|516865686|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
143361575|NCT02240680|516865683|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
143361576|NCT02240680|516865684|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
143361577|NCT02240680|516865685|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
143361578|NCT02240680|516865686|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
143361579|NCT02240680|516865683|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
143361580|NCT02240680|516865684|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
143361581|NCT02240680|516865685|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
143361582|NCT02240680|516865686|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
143361583|NCT02240680|516865683|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
143361584|NCT02240680|516865684|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
143472192|NCT03684642|517275144|FG001|Overall Study|Randomized and not treated|0|||
143137127|NCT01239797|516049069|FG001|Randomized Participants|Participant withdrew consent|7|||
143137128|NCT01239797|516049068|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
143137129|NCT01239797|516049069|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
143137130|NCT01239797|516049068|FG000|Treated Participants|Disease progression|185|||
143137131|NCT01239797|516049069|FG001|Treated Participants|Disease progression|185|||
143137132|NCT01239797|516049068|FG000|Treated Participants|Study drug toxicity|39|||
143137133|NCT01239797|516049069|FG001|Treated Participants|Study drug toxicity|45|||
143472193|NCT03684642|517275145|FG002|Overall Study|Randomized and not treated|1|||
143472194|NCT03684642|517275143|FG000|Overall Study|Missing completion status but alive at last contact|0|||
143472195|NCT03684642|517275144|FG001|Overall Study|Missing completion status but alive at last contact|1|||
143472196|NCT03684642|517275145|FG002|Overall Study|Missing completion status but alive at last contact|2|||
143472197|NCT00999713|517275147|FG000|Overall Study|Physician Decision|2|||
143472198|NCT00999713|517275148|FG001|Overall Study|Physician Decision|0|||
143472199|NCT01840605|517275149|FG000|Overall Study|Adverse Event|0|||
143472200|NCT01840605|517275150|FG001|Overall Study|Adverse Event|1|||
143472201|NCT01840605|517275149|FG000|Overall Study|Physician Decision|2|||
143472202|NCT01840605|517275150|FG001|Overall Study|Physician Decision|1|||
143472203|NCT04435782|517275160|FG000|Overall Study|Study terminated by sponsor|4|||
143472204|NCT03672461|517275161|FG000|Overall Study|COVID Related|4|||
143472205|NCT03672461|517275162|FG001|Overall Study|COVID Related|2|||
143472206|NCT03672461|517275161|FG000|Overall Study|Adverse Event|2|||
143472207|NCT03672461|517275162|FG001|Overall Study|Adverse Event|0|||
143472208|NCT03672461|517275161|FG000|Overall Study|Serious Adverse Event|0|||
143472209|NCT03672461|517275162|FG001|Overall Study|Serious Adverse Event|1|||
143472210|NCT03672461|517275161|FG000|Overall Study|Too Busy|3|||
143472211|NCT03672461|517275162|FG001|Overall Study|Too Busy|1|||
143472212|NCT03672461|517275161|FG000|Overall Study|Lost to Follow-up|1|||
143137134|NCT01239797|516049068|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
143137135|NCT01239797|516049069|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
143137136|NCT01239797|516049068|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
143137137|NCT01239797|516049069|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
143137138|NCT01239797|516049068|FG000|Treated Participants|Administrative reason by sponsor|13|||
143137139|NCT01239797|516049069|FG001|Treated Participants|Administrative reason by sponsor|4|||
143137140|NCT01239797|516049068|FG000|Treated Participants|Other reasons|14|||
143137141|NCT01239797|516049069|FG001|Treated Participants|Other reasons|14|||
143137142|NCT01239797|516049068|FG000|Treated Participants|Participant withdrew consent|6|||
143137143|NCT01239797|516049069|FG001|Treated Participants|Participant withdrew consent|11|||
143137144|NCT01239797|516049068|FG000|Treated Participants|Death|1|||
143137145|NCT01239797|516049069|FG001|Treated Participants|Death|1|||
143137146|NCT01239797|516049068|FG000|Treated Participants|Participant no longer meets study criteria|1|||
143137147|NCT01239797|516049069|FG001|Treated Participants|Participant no longer meets study criteria|1|||
143137148|NCT01239797|516049068|FG000|Treated Participants|Poor/non-compliance|0|||
143137149|NCT01239797|516049069|FG001|Treated Participants|Poor/non-compliance|1|||
143137150|NCT02914834|516049076|FG000|Overall Study|Study halted due to COVID|1|||
143137151|NCT02914834|516049077|FG001|Overall Study|Study halted due to COVID|1|||
143137152|NCT02914834|516049076|FG000|Overall Study|1 subject withdrew|0|||
143137153|NCT02914834|516049077|FG001|Overall Study|1 subject withdrew|1|||
143137154|NCT03439137|516049078|FG000|Overall Study|Adverse Event|16|||
143137155|NCT03439137|516049079|FG001|Overall Study|Adverse Event|12|||
143137156|NCT03439137|516049078|FG000|Overall Study|Physician Decision|0|||
143137157|NCT03439137|516049079|FG001|Overall Study|Physician Decision|5|||
143137158|NCT03439137|516049078|FG000|Overall Study|Withdrawal by Subject|14|||
143137159|NCT03439137|516049079|FG001|Overall Study|Withdrawal by Subject|4|||
143137160|NCT03439137|516049078|FG000|Overall Study|Conducting rescue therapy|2|||
143137161|NCT03439137|516049079|FG001|Overall Study|Conducting rescue therapy|1|||
143137162|NCT03439137|516049078|FG000|Overall Study|Difficult to control Hb|10|||
143137163|NCT03439137|516049079|FG001|Overall Study|Difficult to control Hb|2|||
143137164|NCT03439137|516049078|FG000|Overall Study|Initiation of a renal transplant|0|||
143137165|NCT03439137|516049079|FG001|Overall Study|Initiation of a renal transplant|2|||
143137166|NCT00719901|516049080|FG000|Overall Study|Adverse Event|5|||
143137167|NCT00719901|516049080|FG000|Overall Study|Withdrawal by Subject|1|||
143137168|NCT00719901|516049080|FG000|Overall Study|Alternate Treatment|1|||
143137169|NCT00719901|516049080|FG000|Overall Study|Disease Progression|3|||
143137170|NCT00719901|516049080|FG000|Overall Study|Availability of Study Drug|1|||
143137171|NCT00473083|516049083|FG000|Overall Study|Adverse Event|1|||
143137172|NCT00473083|516049084|FG001|Overall Study|Adverse Event|0|||
143137173|NCT00473083|516049085|FG002|Overall Study|Adverse Event|0|||
143137174|NCT02915835|516049086|FG000|Overall Study|Physician Decision|1|||
143472213|NCT03672461|517275162|FG001|Overall Study|Lost to Follow-up|2|||
143472214|NCT03672461|517275161|FG000|Overall Study|Family|2|||
143472215|NCT03672461|517275162|FG001|Overall Study|Family|2|||
143137175|NCT02915835|516049087|FG001|Overall Study|Physician Decision|0|||
143137176|NCT02915835|516049086|FG000|Overall Study|Withdrawal by Subject|0|||
143137177|NCT02915835|516049087|FG001|Overall Study|Withdrawal by Subject|1|||
143137178|NCT03426345|516049088|FG000|Overall Study|Adverse Event|4|||
143137179|NCT03426345|516049089|FG001|Overall Study|Adverse Event|4|||
143137180|NCT03426345|516049088|FG000|Overall Study|Lack of Efficacy|1|||
143137181|NCT03426345|516049089|FG001|Overall Study|Lack of Efficacy|0|||
143014023|NCT01537549|515591579|FG000|Overall Study|Lost to Follow-up|1|||
143137182|NCT03426345|516049088|FG000|Overall Study|Withdrawal by Subject|5|||
143472216|NCT03672461|517275161|FG000|Overall Study|No remote technology access|0|||
143472217|NCT03672461|517275162|FG001|Overall Study|No remote technology access|1|||
143472218|NCT03672461|517275161|FG000|Overall Study|Withdrawal by Subject|1|||
143472219|NCT03672461|517275162|FG001|Overall Study|Withdrawal by Subject|0|||
143472220|NCT03672461|517275161|FG000|Overall Study|Cannot tolerate intervention|1|||
143472221|NCT03672461|517275162|FG001|Overall Study|Cannot tolerate intervention|0|||
143472222|NCT03672461|517275161|FG000|Overall Study|Incomplete outcome data|6|||
143472223|NCT03672461|517275162|FG001|Overall Study|Incomplete outcome data|1|||
143472224|NCT04313153|517276868|FG000|Overall Study|Adverse Event (includes Death)|14|||
143472225|NCT04313153|517276869|FG001|Overall Study|Adverse Event (includes Death)|19|||
143472226|NCT04313153|517276870|FG002|Overall Study|Adverse Event (includes Death)|10|||
143361585|NCT02240680|516865685|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
143361586|NCT02240680|516865686|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
143361587|NCT02240680|516865683|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
143361588|NCT02240680|516865684|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
143014024|NCT01537549|515591579|FG000|Overall Study|Withdrawal by Subject|2|||
143014025|NCT00883740|515591582|FG000|First Intervention|Lost to Follow-up|1|||
143014026|NCT00883740|515591583|FG001|First Intervention|Lost to Follow-up|0|||
143014027|NCT00883740|515591582|FG000|First Intervention|No longer willing to participate|2|||
143014028|NCT00883740|515591583|FG001|First Intervention|No longer willing to participate|0|||
143014029|NCT00883740|515591582|FG000|First Intervention|Protocol Violation|3|||
143014030|NCT00883740|515591583|FG001|First Intervention|Protocol Violation|6|||
143014031|NCT00883740|515591582|FG000|First Intervention|Adverse Event|1|||
143361589|NCT02240680|516865685|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
143361590|NCT02240680|516865686|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
143361591|NCT01657682|516865687|FG000|Overall Study|Lost to Follow-up|1|||
143361592|NCT01657682|516865688|FG001|Overall Study|Lost to Follow-up|0|||
143361593|NCT01657682|516865689|FG002|Overall Study|Lost to Follow-up|0|||
143361594|NCT01657682|516865687|FG000|Overall Study|Withdrawal by Subject|0|||
143361595|NCT01657682|516865688|FG001|Overall Study|Withdrawal by Subject|1|||
143361596|NCT01657682|516865689|FG002|Overall Study|Withdrawal by Subject|1|||
143361597|NCT01657682|516865687|FG000|Overall Study|Adverse Event|0|||
143472227|NCT04313153|517276868|FG000|Overall Study|Physician Decision|4|||
143472228|NCT04313153|517276869|FG001|Overall Study|Physician Decision|2|||
143472229|NCT04313153|517276870|FG002|Overall Study|Physician Decision|1|||
143014032|NCT00883740|515591583|FG001|First Intervention|Adverse Event|2|||
143014033|NCT00883740|515591582|FG000|Second Intervention|Protocol Violation|1|||
143014034|NCT00883740|515591583|FG001|Second Intervention|Protocol Violation|0|||
143014035|NCT00883740|515591582|FG000|Second Intervention|No longer willing to participate|0|||
143014036|NCT00883740|515591583|FG001|Second Intervention|No longer willing to participate|1|||
143014037|NCT01286207|515591586|FG000|Overall Study|Adverse Event|27|||
143014038|NCT01286207|515591587|FG001|Overall Study|Adverse Event|41|||
143014039|NCT01286207|515591588|FG002|Overall Study|Adverse Event|8|||
143014040|NCT01286207|515591586|FG000|Overall Study|Lost to Follow-up|49|||
143014041|NCT01286207|515591587|FG001|Overall Study|Lost to Follow-up|43|||
143014042|NCT01286207|515591588|FG002|Overall Study|Lost to Follow-up|20|||
143014043|NCT01286207|515591586|FG000|Overall Study|Withdrawal by Subject|93|||
143014044|NCT01286207|515591587|FG001|Overall Study|Withdrawal by Subject|79|||
143014045|NCT01286207|515591588|FG002|Overall Study|Withdrawal by Subject|41|||
143014046|NCT01286207|515591586|FG000|Overall Study|Lack of Response|92|||
143014047|NCT01286207|515591587|FG001|Overall Study|Lack of Response|38|||
143014048|NCT01286207|515591588|FG002|Overall Study|Lack of Response|8|||
143014049|NCT01286207|515591586|FG000|Overall Study|Other|37|||
143014050|NCT01286207|515591587|FG001|Overall Study|Other|47|||
143014051|NCT01286207|515591588|FG002|Overall Study|Other|13|||
143014052|NCT00981409|515591589|FG000|Overall Study|Adverse Event|4|||
143137183|NCT03426345|516049089|FG001|Overall Study|Withdrawal by Subject|6|||
143137184|NCT03426345|516049088|FG000|Overall Study|Lost to Follow-up|3|||
143137185|NCT03426345|516049089|FG001|Overall Study|Lost to Follow-up|1|||
143137186|NCT03426345|516049088|FG000|Overall Study|Protocol Deviation|3|||
143137187|NCT03426345|516049089|FG001|Overall Study|Protocol Deviation|4|||
143137188|NCT03426345|516049088|FG000|Overall Study|Reason Not Specified|1|||
143137189|NCT03426345|516049089|FG001|Overall Study|Reason Not Specified|2|||
143137190|NCT03426345|516049088|FG000|Overall Study|Missing Completion Status|1|||
143137191|NCT03426345|516049089|FG001|Overall Study|Missing Completion Status|0|||
143137192|NCT02446691|516049090|FG000|Overall Study|Withdrawal by Subject|2|||
143137193|NCT02446691|516049090|FG000|Overall Study|Lost to Follow-up|8|||
143137194|NCT02446691|516049090|FG000|Overall Study|Protocol Violation|1|||
143137195|NCT00192114|516049091|FG000|Overall Study|Objective Tumor Progression|19|||
143137196|NCT00192114|516049091|FG000|Overall Study|Adverse Event|2|||
143137197|NCT00192114|516049091|FG000|Overall Study|Clinical Progression|2|||
143137198|NCT00192114|516049091|FG000|Overall Study|Death|1|||
143361598|NCT01657682|516865688|FG001|Overall Study|Adverse Event|1|||
143361599|NCT01657682|516865689|FG002|Overall Study|Adverse Event|0|||
143361600|NCT00562965|516865690|FG000|Overall Study|Withdrawal by Subject|0|||
143361601|NCT00562965|516865691|FG001|Overall Study|Withdrawal by Subject|1|||
143361602|NCT00562965|516865690|FG000|Overall Study|Death|2|||
143472230|NCT04313153|517276868|FG000|Overall Study|Withdrawal by Subject|7|||
143137199|NCT02643693|516049092|FG000|Overall Study|Physician Decision|0|||
143137200|NCT02643693|516049093|FG001|Overall Study|Physician Decision|1|||
143137201|NCT02643693|516049094|FG002|Overall Study|Physician Decision|0|||
143137202|NCT02643693|516049095|FG003|Overall Study|Physician Decision|0|||
143137203|NCT02643693|516049096|FG004|Overall Study|Physician Decision|0|||
143137204|NCT02643693|516049097|FG005|Overall Study|Physician Decision|0|||
143137205|NCT02643693|516049092|FG000|Overall Study|Withdrawal by Subject|0|||
143137206|NCT02643693|516049093|FG001|Overall Study|Withdrawal by Subject|1|||
143137207|NCT02643693|516049094|FG002|Overall Study|Withdrawal by Subject|0|||
143137208|NCT02643693|516049095|FG003|Overall Study|Withdrawal by Subject|0|||
143137209|NCT02643693|516049096|FG004|Overall Study|Withdrawal by Subject|0|||
143137210|NCT02643693|516049097|FG005|Overall Study|Withdrawal by Subject|0|||
143137211|NCT02643693|516049092|FG000|Overall Study|Protocol Adherence Issues|2|||
143137212|NCT02643693|516049093|FG001|Overall Study|Protocol Adherence Issues|0|||
143137213|NCT02643693|516049094|FG002|Overall Study|Protocol Adherence Issues|1|||
143137214|NCT02643693|516049095|FG003|Overall Study|Protocol Adherence Issues|0|||
143137215|NCT02643693|516049096|FG004|Overall Study|Protocol Adherence Issues|0|||
143137216|NCT02643693|516049097|FG005|Overall Study|Protocol Adherence Issues|1|||
143137217|NCT00492297|516049098|FG000|Treatment|Death|2|||
143137218|NCT00492297|516049098|FG000|Treatment|Study terminated by sponsor|3|||
143137219|NCT00492297|516049098|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
143137220|NCT00492297|516049098|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
143137221|NCT00492297|516049098|FG000|Survival Only Follow-up|Death|46|||
143137222|NCT00492297|516049098|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
143137223|NCT00492297|516049098|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
143137224|NCT00113607|516049099|FG000|Overall Study|Adverse Event|40|||
143137225|NCT00113607|516049100|FG001|Overall Study|Adverse Event|71|||
143137226|NCT00113607|516049099|FG000|Overall Study|Death|8|||
143137227|NCT00113607|516049100|FG001|Overall Study|Death|8|||
143137228|NCT00113607|516049099|FG000|Overall Study|Withdrawal by Subject|50|||
143137229|NCT00113607|516049100|FG001|Overall Study|Withdrawal by Subject|58|||
143137230|NCT00113607|516049099|FG000|Overall Study|Lost to Follow-up|0|||
143137231|NCT00113607|516049100|FG001|Overall Study|Lost to Follow-up|2|||
143137232|NCT00113607|516049099|FG000|Overall Study|Disease Progression|180|||
143137233|NCT00113607|516049100|FG001|Overall Study|Disease Progression|142|||
143137234|NCT00113607|516049099|FG000|Overall Study|Complete Response (Confirmed)|14|||
143137235|NCT00113607|516049100|FG001|Overall Study|Complete Response (Confirmed)|24|||
143137236|NCT00113607|516049099|FG000|Overall Study|Other|43|||
143137237|NCT00113607|516049100|FG001|Overall Study|Other|32|||
143137238|NCT03885908|516049101|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
143137239|NCT03885908|516049102|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
143137240|NCT03885908|516049101|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
143137241|NCT03885908|516049102|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
143137242|NCT03885908|516049101|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
143137243|NCT03885908|516049102|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
143137244|NCT03885908|516049101|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
143137245|NCT03885908|516049102|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
143137246|NCT03669549|516049103|FG000|Overall Study|Adverse Event|4|||
143137247|NCT03669549|516049103|FG000|Overall Study|Withdrawal by Subject|1|||
143137248|NCT03669549|516049103|FG000|Overall Study|Study terminated by the Sponsor|1|||
143137249|NCT00749398|516049106|FG000|Overall Study|Lack of Efficacy|7|||
143137250|NCT00749398|516049106|FG000|Overall Study|Adverse Event|4|||
143137251|NCT00749398|516049106|FG000|Overall Study|Serious adverse event|11|||
143137252|NCT00749398|516049106|FG000|Overall Study|Withdrawal by Subject|17|||
143137253|NCT00749398|516049106|FG000|Overall Study|Lost to Follow-up|11|||
143137254|NCT00749398|516049106|FG000|Overall Study|Reason not specified|2|||
143137255|NCT00749398|516049106|FG000|Overall Study|Unknown reason|1|||
143137256|NCT01103323|516049109|FG000|Without/Before Drug Switch|Adverse Event|50|||
143137257|NCT01103323|516049110|FG001|Without/Before Drug Switch|Adverse Event|7|||
143137258|NCT01103323|516049109|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
143137259|NCT01103323|516049110|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
143137260|NCT01103323|516049109|FG000|Without/Before Drug Switch|Protocol Violation|2|||
143137261|NCT01103323|516049110|FG001|Without/Before Drug Switch|Protocol Violation|0|||
143137262|NCT01103323|516049109|FG000|Without/Before Drug Switch|Physician Decision|2|||
143137263|NCT01103323|516049110|FG001|Without/Before Drug Switch|Physician Decision|0|||
143137264|NCT01103323|516049109|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
143137265|NCT01103323|516049110|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
143137266|NCT01103323|516049109|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
143137267|NCT01103323|516049110|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
143137268|NCT01103323|516049109|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
143137269|NCT01103323|516049110|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
143137270|NCT00069264|516049114|FG000|Overall Study|Adverse Event|3|||
143137271|NCT00069264|516049114|FG000|Overall Study|Progressive Disease|23|||
143137272|NCT00069264|516049114|FG000|Overall Study|Withdrawal by Subject|3|||
143137273|NCT00069264|516049114|FG000|Overall Study|Discon Therapy|3|||
143137274|NCT00577317|516049117|FG000|Overall Study|Study Terminated|0|||
143137275|NCT00577317|516049118|FG001|Overall Study|Study Terminated|2|||
143137276|NCT00846586|516049121|FG000|Overall Study|Adverse Event|20|||
143137277|NCT00846586|516049122|FG001|Overall Study|Adverse Event|10|||
143137278|NCT00846586|516049121|FG000|Overall Study|Subject withdrew consent|8|||
143137279|NCT00846586|516049122|FG001|Overall Study|Subject withdrew consent|10|||
143137280|NCT00846586|516049121|FG000|Overall Study|Administrative problems|5|||
143137281|NCT00846586|516049122|FG001|Overall Study|Administrative problems|4|||
143137282|NCT00846586|516049121|FG000|Overall Study|Death|2|||
143137283|NCT00846586|516049122|FG001|Overall Study|Death|0|||
143137284|NCT00846586|516049121|FG000|Overall Study|Protocol deviation|2|||
143137285|NCT00846586|516049122|FG001|Overall Study|Protocol deviation|6|||
143137286|NCT00846586|516049121|FG000|Overall Study|Abnormal test procedure result(s)|1|||
143137287|NCT00846586|516049122|FG001|Overall Study|Abnormal test procedure result(s)|0|||
143137288|NCT00846586|516049121|FG000|Overall Study|Lost to Follow-up|1|||
143137289|NCT00846586|516049122|FG001|Overall Study|Lost to Follow-up|4|||
143137290|NCT00846586|516049121|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
143137291|NCT00846586|516049122|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
143137292|NCT00780975|516049123|FG000|Overall Study|Progressive disease|3|||
143137293|NCT00780975|516049123|FG000|Overall Study|Toxicity|5|||
143137294|NCT03106077|516049124|FG000|Overall Study|Screen Failure|94|||
143137295|NCT03106077|516049125|FG001|Overall Study|Screen Failure|0|||
143137296|NCT01274533|516049126|FG000|Overall Study|Withdrawal by Subject|1|||
143137297|NCT01274533|516049126|FG000|Overall Study|Non-compliance|1|||
143137298|NCT01274533|516049126|FG000|Overall Study|Disease progression|2|||
143137299|NCT03669588|516049127|FG000|Overall Study|Adverse Event|1|||
143137300|NCT03669588|516049128|FG001|Overall Study|Adverse Event|0|||
143137301|NCT03669588|516049127|FG000|Overall Study|Physician Decision|0|||
143137302|NCT03669588|516049128|FG001|Overall Study|Physician Decision|1|||
143137303|NCT03669588|516049127|FG000|Overall Study|Protocol Violation|1|||
143137304|NCT03669588|516049128|FG001|Overall Study|Protocol Violation|0|||
143137305|NCT03669588|516049127|FG000|Overall Study|Sponsor Decision|1|||
143137306|NCT03669588|516049128|FG001|Overall Study|Sponsor Decision|1|||
143137307|NCT03669588|516049127|FG000|Overall Study|Withdrawal by Subject|1|||
143137308|NCT03669588|516049128|FG001|Overall Study|Withdrawal by Subject|4|||
143137309|NCT03669588|516049127|FG000|Overall Study|Rescue Therapy Needed|0|||
143137310|NCT03669588|516049128|FG001|Overall Study|Rescue Therapy Needed|1|||
143137311|NCT00492726|516049129|FG000|Overall Study|Adverse Event|10|||
143137312|NCT00492726|516049130|FG001|Overall Study|Adverse Event|6|||
143137313|NCT00492726|516049129|FG000|Overall Study|Death|7|||
143137314|NCT00492726|516049130|FG001|Overall Study|Death|2|||
143137315|NCT00492726|516049129|FG000|Overall Study|Lack of Efficacy|0|||
143137316|NCT00492726|516049130|FG001|Overall Study|Lack of Efficacy|2|||
143137317|NCT00492726|516049129|FG000|Overall Study|Lost to Follow-up|27|||
143137318|NCT00492726|516049130|FG001|Overall Study|Lost to Follow-up|19|||
143137319|NCT00492726|516049129|FG000|Overall Study|Physician Decision|0|||
143137320|NCT00492726|516049130|FG001|Overall Study|Physician Decision|1|||
143137321|NCT00492726|516049129|FG000|Overall Study|Withdrawal by Subject|6|||
143137322|NCT00492726|516049130|FG001|Overall Study|Withdrawal by Subject|3|||
143137323|NCT00492726|516049129|FG000|Overall Study|Non compliant with study medication|0|||
143137324|NCT00492726|516049130|FG001|Overall Study|Non compliant with study medication|3|||
143137325|NCT01100502|516049131|FG000|Overall Study|Withdrawal by Subject|18|||
143137326|NCT01100502|516049132|FG001|Overall Study|Withdrawal by Subject|25|||
143137327|NCT01100502|516049131|FG000|Overall Study|Lost to Follow-up|13|||
143137328|NCT01100502|516049132|FG001|Overall Study|Lost to Follow-up|28|||
143137329|NCT01100502|516049131|FG000|Overall Study|Site request to end participation in study|0|||
143137330|NCT01100502|516049132|FG001|Overall Study|Site request to end participation in study|1|||
143137331|NCT01100502|516049131|FG000|Overall Study|Death|45|||
143137332|NCT01100502|516049132|FG001|Overall Study|Death|40|||
143137333|NCT05158140|516049133|FG000|Overall Study|Death|0|||
143137334|NCT05158140|516049134|FG001|Overall Study|Death|0|||
143137335|NCT05158140|516049135|FG002|Overall Study|Death|0|||
143137336|NCT05158140|516049136|FG003|Overall Study|Death|1|||
143137337|NCT05158140|516049133|FG000|Overall Study|Lost to Follow-up|3|||
143137338|NCT05158140|516049134|FG001|Overall Study|Lost to Follow-up|6|||
143137339|NCT05158140|516049135|FG002|Overall Study|Lost to Follow-up|4|||
143137340|NCT05158140|516049136|FG003|Overall Study|Lost to Follow-up|3|||
143137341|NCT05158140|516049133|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
143137342|NCT05158140|516049134|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
143137343|NCT05158140|516049135|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
143137344|NCT05158140|516049136|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
143137345|NCT05158140|516049133|FG000|Overall Study|Withdrawal by Subject|3|||
143137346|NCT05158140|516049134|FG001|Overall Study|Withdrawal by Subject|7|||
143137347|NCT05158140|516049135|FG002|Overall Study|Withdrawal by Subject|3|||
143137348|NCT05158140|516049136|FG003|Overall Study|Withdrawal by Subject|7|||
143137349|NCT00807365|516049140|FG000|Overall Study|Study Terminated|5|||
143137350|NCT01121263|516049142|FG000|Overall Study|Death|3|||
143137351|NCT01121263|516049143|FG001|Overall Study|Death|2|||
143137352|NCT01121263|516049142|FG000|Overall Study|Lost to Follow-up|22|||
143137353|NCT01121263|516049143|FG001|Overall Study|Lost to Follow-up|12|||
143137354|NCT01121263|516049142|FG000|Overall Study|Withdrawal by Subject|0|||
143137355|NCT01121263|516049143|FG001|Overall Study|Withdrawal by Subject|1|||
143137356|NCT04194814|516049148|FG000|Overall Study|Physician Decision|3|||
143137357|NCT04194814|516049149|FG001|Overall Study|Physician Decision|0|||
143137358|NCT04194814|516049148|FG000|Overall Study|Withdrawal by Subject|0|||
143137359|NCT04194814|516049149|FG001|Overall Study|Withdrawal by Subject|2|||
143137360|NCT05630196|516050877|FG000|Overall Study|Adverse Event|2|||
143137361|NCT05630196|516050878|FG001|Overall Study|Adverse Event|1|||
143137362|NCT05630196|516050877|FG000|Overall Study|Lost to Follow-up|1|||
143137363|NCT05630196|516050878|FG001|Overall Study|Lost to Follow-up|1|||
143137364|NCT05630196|516050877|FG000|Overall Study|Protocol Violation|2|||
143137365|NCT05630196|516050878|FG001|Overall Study|Protocol Violation|3|||
143137366|NCT05630196|516050877|FG000|Overall Study|Physician Decision|1|||
143137367|NCT05630196|516050878|FG001|Overall Study|Physician Decision|0|||
143137368|NCT05630196|516050877|FG000|Overall Study|Withdrawal by Subject|3|||
143137369|NCT05630196|516050878|FG001|Overall Study|Withdrawal by Subject|4|||
143137370|NCT01655901|516050880|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
143137371|NCT01655901|516050881|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
143137372|NCT01655901|516050882|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
143137373|NCT01655901|516050883|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
143137374|NCT01655901|516050884|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
143137375|NCT01655901|516050885|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
143137376|NCT00352118|516050886|FG000|Overall Study|Physician Decision|4|||
143137377|NCT00922636|516050887|FG000|Overall Study|Adverse Event|3|||
143137378|NCT00922636|516050888|FG001|Overall Study|Adverse Event|3|||
143137379|NCT00922636|516050889|FG002|Overall Study|Adverse Event|2|||
143137380|NCT00922636|516050890|FG003|Overall Study|Adverse Event|3|||
143137381|NCT00922636|516050891|FG004|Overall Study|Adverse Event|2|||
143137382|NCT00922636|516050887|FG000|Overall Study|Lack of Efficacy|1|||
143137383|NCT00922636|516050888|FG001|Overall Study|Lack of Efficacy|7|||
143137384|NCT00922636|516050889|FG002|Overall Study|Lack of Efficacy|3|||
143137385|NCT00922636|516050890|FG003|Overall Study|Lack of Efficacy|2|||
143137386|NCT00922636|516050891|FG004|Overall Study|Lack of Efficacy|4|||
143137387|NCT00922636|516050887|FG000|Overall Study|Sponsor Decision|0|||
143137388|NCT00922636|516050888|FG001|Overall Study|Sponsor Decision|0|||
143137389|NCT00922636|516050889|FG002|Overall Study|Sponsor Decision|2|||
143137390|NCT00922636|516050890|FG003|Overall Study|Sponsor Decision|0|||
143137391|NCT00922636|516050891|FG004|Overall Study|Sponsor Decision|0|||
143137392|NCT00922636|516050887|FG000|Overall Study|Withdrawal by Subject|0|||
143137393|NCT00922636|516050888|FG001|Overall Study|Withdrawal by Subject|0|||
143137394|NCT00922636|516050889|FG002|Overall Study|Withdrawal by Subject|5|||
143137395|NCT00922636|516050890|FG003|Overall Study|Withdrawal by Subject|2|||
143137396|NCT00922636|516050891|FG004|Overall Study|Withdrawal by Subject|4|||
143137397|NCT00922636|516050887|FG000|Overall Study|Protocol Violation|0|||
143137398|NCT00922636|516050888|FG001|Overall Study|Protocol Violation|0|||
143137399|NCT00922636|516050889|FG002|Overall Study|Protocol Violation|2|||
143137400|NCT00922636|516050890|FG003|Overall Study|Protocol Violation|2|||
143137401|NCT00922636|516050891|FG004|Overall Study|Protocol Violation|0|||
143137402|NCT00922636|516050887|FG000|Overall Study|Entry Criteria Not Met|0|||
143137403|NCT00922636|516050888|FG001|Overall Study|Entry Criteria Not Met|0|||
143137404|NCT00922636|516050889|FG002|Overall Study|Entry Criteria Not Met|1|||
143137405|NCT00922636|516050890|FG003|Overall Study|Entry Criteria Not Met|1|||
143137406|NCT00922636|516050891|FG004|Overall Study|Entry Criteria Not Met|0|||
143137407|NCT00922636|516050887|FG000|Overall Study|Parent/Caregiver Decision|2|||
143137408|NCT00922636|516050888|FG001|Overall Study|Parent/Caregiver Decision|4|||
143137409|NCT00922636|516050889|FG002|Overall Study|Parent/Caregiver Decision|3|||
143137410|NCT00922636|516050890|FG003|Overall Study|Parent/Caregiver Decision|5|||
143361603|NCT00562965|516865691|FG001|Overall Study|Death|4|||
143361604|NCT00562965|516865690|FG000|Overall Study|Lost to Follow-up|1|||
143361605|NCT00562965|516865691|FG001|Overall Study|Lost to Follow-up|0|||
143361606|NCT00562965|516865690|FG000|Overall Study|Other|0|||
143361607|NCT00562965|516865691|FG001|Overall Study|Other|1|||
143361608|NCT02839681|516865695|FG000|Overall Study|Death|2|||
143361609|NCT03582137|516865698|FG000|Overall Study|Adverse Event|1|||
143361610|NCT03582137|516865699|FG001|Overall Study|Adverse Event|0|||
143361611|NCT03704298|516865701|FG000|Overall Study|Death|3|||
143361612|NCT03704298|516865702|FG001|Overall Study|Death|1|||
143361613|NCT03704298|516865703|FG002|Overall Study|Death|1|||
143137411|NCT00922636|516050891|FG004|Overall Study|Parent/Caregiver Decision|2|||
143137412|NCT00922636|516050887|FG000|Overall Study|Lost to Follow-up|1|||
143137413|NCT00922636|516050888|FG001|Overall Study|Lost to Follow-up|2|||
143137414|NCT00922636|516050889|FG002|Overall Study|Lost to Follow-up|2|||
143137415|NCT00922636|516050890|FG003|Overall Study|Lost to Follow-up|2|||
143137416|NCT00922636|516050891|FG004|Overall Study|Lost to Follow-up|4|||
143137417|NCT01181167|516050892|FG000|Overall Study|Adverse Event|11|||
143137418|NCT01181167|516050893|FG001|Overall Study|Adverse Event|21|||
143137419|NCT01181167|516050892|FG000|Overall Study|Lost to Follow-up|1|||
143137420|NCT01181167|516050893|FG001|Overall Study|Lost to Follow-up|0|||
143137421|NCT01181167|516050892|FG000|Overall Study|Physician Decision|2|||
143472231|NCT04313153|517276869|FG001|Overall Study|Withdrawal by Subject|6|||
143472232|NCT04313153|517276870|FG002|Overall Study|Withdrawal by Subject|2|||
143472233|NCT04313153|517276868|FG000|Overall Study|Lack of Efficacy|3|||
143472234|NCT04313153|517276869|FG001|Overall Study|Lack of Efficacy|3|||
143472235|NCT04313153|517276870|FG002|Overall Study|Lack of Efficacy|0|||
143472236|NCT04313153|517276868|FG000|Overall Study|Lost to Follow-up|1|||
143472237|NCT04313153|517276869|FG001|Overall Study|Lost to Follow-up|0|||
143472238|NCT04313153|517276870|FG002|Overall Study|Lost to Follow-up|2|||
143472239|NCT04313153|517276868|FG000|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|0|||
143472240|NCT04313153|517276869|FG001|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|2|||
143472241|NCT04313153|517276870|FG002|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|3|||
143472242|NCT04313153|517276868|FG000|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|16|||
143472243|NCT04313153|517276869|FG001|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|20|||
143472244|NCT04313153|517276870|FG002|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|19|||
143472245|NCT04313153|517276868|FG000|Overall Study|Change in Dialysis Modality|0|||
143472246|NCT04313153|517276869|FG001|Overall Study|Change in Dialysis Modality|1|||
143472247|NCT04313153|517276870|FG002|Overall Study|Change in Dialysis Modality|2|||
143472248|NCT04313153|517276868|FG000|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|1|||
143472249|NCT04313153|517276869|FG001|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
143472250|NCT04313153|517276870|FG002|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
143472251|NCT04313153|517276868|FG000|Overall Study|Other|5|||
143472252|NCT04313153|517276869|FG001|Overall Study|Other|3|||
143472253|NCT04313153|517276870|FG002|Overall Study|Other|2|||
143472254|NCT05586269|517276871|FG000|First Intervention (6 Weeks)|Lost to Follow-up|4|||
143472255|NCT05586269|517276872|FG001|First Intervention (6 Weeks)|Lost to Follow-up|4|||
143472256|NCT05586269|517276873|FG002|First Intervention (6 Weeks)|Lost to Follow-up|3|||
143472257|NCT05586269|517276874|FG003|First Intervention (6 Weeks)|Lost to Follow-up|3|||
143472258|NCT05586269|517276871|FG000|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
143472259|NCT05586269|517276872|FG001|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
143472260|NCT05586269|517276873|FG002|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
143137422|NCT01181167|516050893|FG001|Overall Study|Physician Decision|3|||
143137423|NCT01181167|516050892|FG000|Overall Study|Protocol Violation|3|||
143137424|NCT01181167|516050893|FG001|Overall Study|Protocol Violation|0|||
143137425|NCT01181167|516050892|FG000|Overall Study|Withdrawal by Subject|6|||
143137426|NCT01181167|516050893|FG001|Overall Study|Withdrawal by Subject|8|||
143137427|NCT02812186|516050894|FG000|Period 1|Post randomization screen failure|5|||
143137428|NCT02812186|516050895|FG001|Period 1|Post randomization screen failure|9|||
143137429|NCT02812186|516050894|FG000|Period 1|nonevaluable data sets|6|||
143137430|NCT02812186|516050895|FG001|Period 1|nonevaluable data sets|6|||
143137431|NCT00161213|516050896|FG000|Overall Study|Withdrawal by Subject|1|||
143137432|NCT00161213|516050896|FG000|Overall Study|Evaluable for toxicity but not response|1|||
143137433|NCT03103503|516050897|FG000|Overall Study|Death|64|||
143137434|NCT03103503|516050897|FG000|Overall Study|Physician Decision|57|||
143137435|NCT03103503|516050897|FG000|Overall Study|Withdrawal by Subject|10|||
143137436|NCT03103503|516050897|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
143137437|NCT03103503|516050897|FG000|Overall Study|Lost to Follow-up|3|||
143137438|NCT03103503|516050897|FG000|Overall Study|Study Closure|757|||
143137439|NCT03342001|516050903|FG000|Overall Study|Adverse Event|1|||
143137440|NCT03342001|516050903|FG000|Overall Study|Lost to Follow-up|1|||
143137441|NCT01433159|516050904|FG000|Overall Study|Adverse Event|1|||
143137442|NCT01433159|516050905|FG001|Overall Study|Adverse Event|0|||
143137443|NCT01433159|516050904|FG000|Overall Study|Physician Decision|1|||
143137444|NCT01433159|516050905|FG001|Overall Study|Physician Decision|0|||
143137445|NCT01433159|516050904|FG000|Overall Study|Protocol Violation|0|||
143137446|NCT01433159|516050905|FG001|Overall Study|Protocol Violation|1|||
143137447|NCT04635839|516050908|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
143137448|NCT04635839|516050909|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
143137449|NCT02737358|516050910|FG000|Overall Study|Withdrawal by Subject|7|||
143137450|NCT02737358|516050911|FG001|Overall Study|Withdrawal by Subject|12|||
143137451|NCT02737358|516050910|FG000|Overall Study|Lost to Follow-up|2|||
143137452|NCT02737358|516050911|FG001|Overall Study|Lost to Follow-up|3|||
143137453|NCT00744939|516050913|FG000|Overall Study|Withdrawal by Subject|9|||
143137454|NCT00744939|516050913|FG000|Overall Study|Protocol Violation|13|||
143137455|NCT00744939|516050913|FG000|Overall Study|Death|24|||
143137456|NCT00744939|516050913|FG000|Overall Study|distance|4|||
143137457|NCT00744939|516050913|FG000|Overall Study|Lost to Follow-up|12|||
143137458|NCT00744939|516050913|FG000|Overall Study|Medical history exclusionary|1|||
143137459|NCT00744939|516050913|FG000|Overall Study|Did not receive Magnevist|7|||
143137460|NCT00744939|516050913|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
143137461|NCT00744939|516050913|FG000|Overall Study|coma|1|||
143137462|NCT00744939|516050913|FG000|Overall Study|incorrect race|1|||
143137463|NCT01739335|516050914|FG000|Overall Study|Lost to Follow-up|7|||
143137464|NCT01739335|516050915|FG001|Overall Study|Lost to Follow-up|4|||
143137465|NCT01739335|516050914|FG000|Overall Study|Ineligible patient randomized|0|||
143472261|NCT05586269|517276874|FG003|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
143472262|NCT04752475|517276875|FG000|Overall Study|Withdrawal by Subject|1|||
143472263|NCT04752475|517276876|FG001|Overall Study|Withdrawal by Subject|1|||
143472264|NCT00523718|517276882|FG000|Overall Study|Withdrawal by Subject|1|||
143472265|NCT00523718|517276883|FG001|Overall Study|Withdrawal by Subject|0|||
143472266|NCT00523718|517276882|FG000|Overall Study|Protocol Violation|2|||
143137466|NCT01739335|516050915|FG001|Overall Study|Ineligible patient randomized|1|||
143137467|NCT00288912|516050916|FG000|Overall Study|Developed exclusion criterion|4|||
143137468|NCT00288912|516050917|FG001|Overall Study|Developed exclusion criterion|6|||
143137469|NCT00288912|516050918|FG002|Overall Study|Developed exclusion criterion|7|||
143137470|NCT00288912|516050916|FG000|Overall Study|Lost to Follow-up|9|||
143137471|NCT00288912|516050917|FG001|Overall Study|Lost to Follow-up|6|||
143137472|NCT00288912|516050918|FG002|Overall Study|Lost to Follow-up|9|||
143137473|NCT00288912|516050916|FG000|Overall Study|Withdrawal by Subject|4|||
143137474|NCT00288912|516050917|FG001|Overall Study|Withdrawal by Subject|5|||
143137475|NCT00288912|516050918|FG002|Overall Study|Withdrawal by Subject|12|||
143137476|NCT00183430|516050921|FG000|Overall Study|Adverse Event|1|||
143472267|NCT00523718|517276883|FG001|Overall Study|Protocol Violation|0|||
143472268|NCT01310803|517276884|FG000|Overall Study|Subject terminated by Sponsor|1|||
143472269|NCT01310803|517276885|FG001|Overall Study|Subject terminated by Sponsor|0|||
143472270|NCT00332839|517276886|FG000|Core (Months 0 - 12)|Administrative problems|1|||
143137477|NCT00183430|516050922|FG001|Overall Study|Adverse Event|0|||
143472271|NCT00332839|517276887|FG001|Core (Months 0 - 12)|Administrative problems|1|||
143472272|NCT00332839|517276886|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
143472273|NCT00332839|517276887|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
143472274|NCT00332839|517276886|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
143472275|NCT00332839|517276887|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
143472276|NCT00332839|517276886|FG000|Core (Months 0 - 12)|Adverse Event|5|||
143472277|NCT00332839|517276887|FG001|Core (Months 0 - 12)|Adverse Event|15|||
143472278|NCT00332839|517276886|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
143472279|NCT00332839|517276887|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
143472280|NCT00332839|517276886|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
143472281|NCT00332839|517276887|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
143472282|NCT00332839|517276886|FG000|Follow-up (Months 12 - 60)|Death|1|||
143472283|NCT00332839|517276887|FG001|Follow-up (Months 12 - 60)|Death|1|||
143137478|NCT00183430|516050921|FG000|Overall Study|Lost to Follow-up|3|||
143137479|NCT00183430|516050922|FG001|Overall Study|Lost to Follow-up|0|||
143137480|NCT00183430|516050921|FG000|Overall Study|did not meet inclusion criteria|1|||
143137481|NCT00183430|516050922|FG001|Overall Study|did not meet inclusion criteria|0|||
143137482|NCT00183430|516050921|FG000|Overall Study|Withdrawal by Subject|1|||
143137483|NCT00183430|516050922|FG001|Overall Study|Withdrawal by Subject|0|||
143137484|NCT00883181|516050929|FG000|Overall Study|Hematological Adverse Event|26|||
143137485|NCT00883181|516050929|FG000|Overall Study|Non-hematological Adverse Event|55|||
143137486|NCT00883181|516050929|FG000|Overall Study|Disease Progression|94|||
143137487|NCT00883181|516050929|FG000|Overall Study|Administrative Reason|24|||
143137488|NCT00883181|516050929|FG000|Overall Study|Withdrawal by Subject|4|||
143137489|NCT00883181|516050929|FG000|Overall Study|Death|31|||
143137490|NCT00883181|516050929|FG000|Overall Study|Other|38|||
143137491|NCT00883181|516050929|FG000|Overall Study|Protocol Deviation|3|||
143137492|NCT00883181|516050929|FG000|Overall Study|Noncompliance|3|||
143137493|NCT04040439|516050930|FG000|Overall Study|Invalid registration|11|||
143137494|NCT04040439|516050930|FG000|Overall Study|No IC* on publication of study results|2|||
143137495|NCT01248455|516050937|FG000|Overall Study|switched to alternate treatment|1|||
143137496|NCT00426270|516050938|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
143137497|NCT00426270|516050938|FG000|Overall Study|Adverse Event|5|||
143137498|NCT01587885|516050939|FG000|Treatment Period 1|Failure to Return|0|||
143137499|NCT01587885|516050940|FG001|Treatment Period 1|Failure to Return|1|||
143137500|NCT01587885|516050939|FG000|Treatment Period 1|Protocol Violation|0|||
143137501|NCT01587885|516050940|FG001|Treatment Period 1|Protocol Violation|2|||
143137502|NCT01117870|516050942|FG000|Overall Study|Inability to place needle|1|||
143472284|NCT00594516|517276890|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
143472285|NCT00594516|517276891|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
143472286|NCT00594516|517276892|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
143472287|NCT00594516|517276890|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
143472288|NCT00594516|517276891|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
143472289|NCT00594516|517276892|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
143137503|NCT01117870|516050943|FG001|Overall Study|Inability to place needle|0|||
143137504|NCT01674725|516050944|FG000|Overall Study|Adverse Event|1|||
143361614|NCT03704298|516865704|FG003|Overall Study|Death|0|||
143361615|NCT03704298|516865701|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
143361616|NCT03704298|516865702|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
143361617|NCT03704298|516865703|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
143361618|NCT03704298|516865704|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
143361619|NCT03704298|516865701|FG000|Overall Study|Withdrawal by Subject|1|||
143361620|NCT03704298|516865702|FG001|Overall Study|Withdrawal by Subject|0|||
143361621|NCT03704298|516865703|FG002|Overall Study|Withdrawal by Subject|0|||
143361622|NCT03704298|516865704|FG003|Overall Study|Withdrawal by Subject|0|||
143361623|NCT03704298|516865701|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
143361624|NCT03704298|516865702|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
143361625|NCT03704298|516865703|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
143361626|NCT03704298|516865704|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
143361627|NCT02303574|516865707|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
143361628|NCT02303574|516865708|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
143361629|NCT02303574|516865709|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
143361630|NCT02303574|516865710|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
143361631|NCT02303574|516865711|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
143361632|NCT02303574|516865712|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
143361633|NCT02303574|516865713|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
143361634|NCT02303574|516865714|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
143361635|NCT02303574|516865715|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
143361636|NCT02303574|516865716|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
143361637|NCT02303574|516865707|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
143361638|NCT02303574|516865708|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
143361639|NCT02303574|516865709|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
143361640|NCT02303574|516865710|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
143361641|NCT02303574|516865711|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
143361642|NCT02303574|516865712|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
143361643|NCT02303574|516865713|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
143361644|NCT02303574|516865714|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
143361645|NCT02303574|516865715|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
143361646|NCT02303574|516865716|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
143361647|NCT00410384|516865717|FG000|Overall Study|Withdrawal by Subject|28|||
143361648|NCT00410384|516865718|FG001|Overall Study|Withdrawal by Subject|17|||
143361649|NCT00410384|516865719|FG002|Overall Study|Withdrawal by Subject|20|||
143361650|NCT00410384|516865717|FG000|Overall Study|Adverse Event|23|||
143361651|NCT00410384|516865718|FG001|Overall Study|Adverse Event|18|||
143361652|NCT00410384|516865719|FG002|Overall Study|Adverse Event|23|||
143361653|NCT00410384|516865717|FG000|Overall Study|Lack of Efficacy|20|||
143361654|NCT00410384|516865718|FG001|Overall Study|Lack of Efficacy|12|||
143361655|NCT00410384|516865719|FG002|Overall Study|Lack of Efficacy|17|||
143361656|NCT00410384|516865717|FG000|Overall Study|Lack of Compliance|2|||
143361657|NCT00410384|516865718|FG001|Overall Study|Lack of Compliance|2|||
143361658|NCT00410384|516865719|FG002|Overall Study|Lack of Compliance|2|||
143361659|NCT00410384|516865717|FG000|Overall Study|Lost to Follow-up|4|||
143361660|NCT00410384|516865718|FG001|Overall Study|Lost to Follow-up|6|||
143361661|NCT00410384|516865719|FG002|Overall Study|Lost to Follow-up|6|||
143361662|NCT00410384|516865717|FG000|Overall Study|Protocol Violation|6|||
143361663|NCT00410384|516865718|FG001|Overall Study|Protocol Violation|6|||
143361664|NCT00410384|516865719|FG002|Overall Study|Protocol Violation|6|||
143361665|NCT00410384|516865717|FG000|Overall Study|Physician Decision|3|||
143361666|NCT00410384|516865718|FG001|Overall Study|Physician Decision|3|||
143361667|NCT00410384|516865719|FG002|Overall Study|Physician Decision|4|||
143361668|NCT00410384|516865717|FG000|Overall Study|Other|3|||
143361669|NCT00410384|516865718|FG001|Overall Study|Other|8|||
143361670|NCT00410384|516865719|FG002|Overall Study|Other|4|||
143361671|NCT01253200|516865720|FG000|Overall Study|Death|1|||
143361672|NCT01253200|516865721|FG001|Overall Study|Death|0|||
143361673|NCT01253200|516865722|FG002|Overall Study|Death|0|||
143361674|NCT01253200|516865723|FG003|Overall Study|Death|0|||
143361675|NCT01253200|516865724|FG004|Overall Study|Death|0|||
143361676|NCT01253200|516865720|FG000|Overall Study|Lost to Follow-up|1|||
143361677|NCT01253200|516865721|FG001|Overall Study|Lost to Follow-up|1|||
143361678|NCT01253200|516865722|FG002|Overall Study|Lost to Follow-up|0|||
143361679|NCT01253200|516865723|FG003|Overall Study|Lost to Follow-up|0|||
143361680|NCT01253200|516865724|FG004|Overall Study|Lost to Follow-up|0|||
143361681|NCT01253200|516865720|FG000|Overall Study|Withdrawal by Subject|2|||
143361682|NCT01253200|516865721|FG001|Overall Study|Withdrawal by Subject|0|||
143361683|NCT01253200|516865722|FG002|Overall Study|Withdrawal by Subject|0|||
143361684|NCT01253200|516865723|FG003|Overall Study|Withdrawal by Subject|0|||
143361685|NCT01253200|516865724|FG004|Overall Study|Withdrawal by Subject|0|||
143361686|NCT01253200|516865720|FG000|Overall Study|Protocol Violation|1|||
143472290|NCT00594516|517276890|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
143137505|NCT01674725|516050945|FG001|Overall Study|Adverse Event|0|||
143137506|NCT01674725|516050944|FG000|Overall Study|Did not receive study drug|1|||
143137507|NCT01674725|516050945|FG001|Overall Study|Did not receive study drug|0|||
143137508|NCT01674725|516050944|FG000|Overall Study|Withdrawal by Subject|1|||
143137509|NCT01674725|516050945|FG001|Overall Study|Withdrawal by Subject|0|||
143137510|NCT01674725|516050944|FG000|Overall Study|Lost to Follow-up|0|||
143137511|NCT01674725|516050945|FG001|Overall Study|Lost to Follow-up|1|||
143137512|NCT02709746|516050946|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
143137513|NCT02709746|516050947|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
143137514|NCT02709746|516050948|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
143137515|NCT02709746|516050949|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
143137516|NCT02709746|516050950|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
143137517|NCT02709746|516050946|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
143137518|NCT02709746|516050947|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
143137519|NCT02709746|516050948|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
143137520|NCT02709746|516050949|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
143137521|NCT02709746|516050950|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
143137522|NCT02709746|516050946|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
143137523|NCT02709746|516050947|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
143137524|NCT02709746|516050948|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
143137525|NCT02709746|516050949|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
143137526|NCT02709746|516050950|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
143137527|NCT02709746|516050946|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
143137528|NCT02709746|516050947|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
143137529|NCT02709746|516050948|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
143137530|NCT02709746|516050949|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
143137531|NCT02709746|516050950|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
143137532|NCT02709746|516050946|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
143137533|NCT02709746|516050947|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
143137534|NCT02709746|516050948|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
143137535|NCT02709746|516050949|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
143137536|NCT02709746|516050950|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
143137537|NCT02709746|516050946|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
143137538|NCT02709746|516050947|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
143137539|NCT02709746|516050948|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
143137540|NCT02709746|516050949|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
143137541|NCT02709746|516050950|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
143137542|NCT02709746|516050946|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
143137543|NCT02709746|516050947|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
143137544|NCT02709746|516050948|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
143137545|NCT02709746|516050949|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
143137546|NCT02709746|516050950|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
143137547|NCT02709746|516050946|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
143137548|NCT02709746|516050947|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
143137549|NCT02709746|516050948|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
143137550|NCT02709746|516050949|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
143137551|NCT02709746|516050950|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
143137552|NCT02709746|516050946|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
143137553|NCT02709746|516050947|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
143137554|NCT02709746|516050948|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
143137555|NCT02709746|516050949|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
143137556|NCT02709746|516050950|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
143137557|NCT02709746|516050946|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
143137558|NCT02709746|516050947|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
143137559|NCT02709746|516050948|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
143137560|NCT02709746|516050949|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
143472291|NCT00594516|517276891|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
143472292|NCT00594516|517276892|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
143472293|NCT00594516|517276890|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
143472294|NCT00594516|517276891|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
143137561|NCT02709746|516050950|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
143137562|NCT02709746|516050946|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
143137563|NCT02709746|516050947|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
143472295|NCT00594516|517276892|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
143137564|NCT02709746|516050948|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
143137565|NCT02709746|516050949|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
143137566|NCT02709746|516050950|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
143137567|NCT02709746|516050946|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
143137568|NCT02709746|516050947|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
143137569|NCT02709746|516050948|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
143137570|NCT02709746|516050949|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
143137571|NCT02709746|516050950|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
143137572|NCT02709746|516050946|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
143137573|NCT02709746|516050947|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
143137574|NCT02709746|516050948|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
143137575|NCT02709746|516050949|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
143137576|NCT02709746|516050950|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
143137577|NCT02709746|516050946|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
143137578|NCT02709746|516050947|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
143137579|NCT02709746|516050948|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
143137580|NCT02709746|516050949|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
143137581|NCT02709746|516050950|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
143137582|NCT02709746|516050946|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
143137583|NCT02709746|516050947|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
143137584|NCT02709746|516050948|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
143137585|NCT02709746|516050949|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
143137586|NCT02709746|516050950|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
143137587|NCT02709746|516050946|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
143137588|NCT02709746|516050947|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
143137589|NCT02709746|516050948|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
143137590|NCT02709746|516050949|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
143137591|NCT02709746|516050950|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
143137592|NCT02709746|516050946|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
143137593|NCT02709746|516050947|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
143137594|NCT02709746|516050948|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
143137595|NCT02709746|516050949|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
143137596|NCT02709746|516050950|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
143137597|NCT00752089|516050955|FG000|Overall Study|Adverse Event|1|||
143137598|NCT00752089|516050955|FG000|Overall Study|Protocol Deviation|2|||
143137599|NCT00752089|516050955|FG000|Overall Study|Could not attend visit 9|1|||
143137600|NCT00752089|516050955|FG000|Overall Study|Not capable of wearing partial denture|1|||
143137601|NCT00752089|516050955|FG000|Overall Study|Cannot continue the study|1|||
143137602|NCT00960193|516050956|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
143137603|NCT00386334|516050957|FG000|Double Blind Period|Adverse Event|9|||
143137604|NCT00386334|516050958|FG001|Double Blind Period|Adverse Event|14|||
143137605|NCT00386334|516050957|FG000|Double Blind Period|Protocol Violation|1|||
143137606|NCT00386334|516050958|FG001|Double Blind Period|Protocol Violation|1|||
143137607|NCT00386334|516050957|FG000|Double Blind Period|Withdrawal by Subject|9|||
143137608|NCT00386334|516050958|FG001|Double Blind Period|Withdrawal by Subject|13|||
143137609|NCT00386334|516050957|FG000|Double Blind Period|Lack of Efficacy|20|||
143137610|NCT00386334|516050958|FG001|Double Blind Period|Lack of Efficacy|11|||
143137611|NCT00386334|516050957|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
143137612|NCT00386334|516050958|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
143137613|NCT00386334|516050957|FG000|Double Blind Period|Other|3|||
143137614|NCT00386334|516050958|FG001|Double Blind Period|Other|3|||
143137615|NCT00386334|516050957|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
143137616|NCT00386334|516050958|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
143137617|NCT03238417|516050959|FG000|Overall|non-response|955|||
143137618|NCT03238417|516050960|FG001|Overall|non-response|1920|||
143137619|NCT03238417|516050959|FG000|Overall|partial completion|48|||
143137620|NCT03238417|516050960|FG001|Overall|partial completion|68|||
143137621|NCT03238417|516050959|FG000|Baseline|Partial completion|17|||
143361687|NCT01253200|516865721|FG001|Overall Study|Protocol Violation|4|||
143361688|NCT01253200|516865722|FG002|Overall Study|Protocol Violation|0|||
143361689|NCT01253200|516865723|FG003|Overall Study|Protocol Violation|0|||
143361690|NCT01253200|516865724|FG004|Overall Study|Protocol Violation|5|||
143137622|NCT03238417|516050960|FG001|Baseline|Partial completion|48|||
143137623|NCT03238417|516050959|FG000|Baseline|non-response|372|||
143137624|NCT03238417|516050960|FG001|Baseline|non-response|669|||
143137625|NCT03238417|516050959|FG000|12-month|non-response|296|||
143137626|NCT03238417|516050960|FG001|12-month|non-response|669|||
143137627|NCT03238417|516050959|FG000|12-month|partial completion|23|||
143137628|NCT03238417|516050960|FG001|12-month|partial completion|37|||
143361691|NCT01253200|516865720|FG000|Overall Study|intents|10|||
143137629|NCT03238417|516050959|FG000|24-month|non-response|287|||
143137630|NCT03238417|516050960|FG001|24-month|non-response|594|||
143137631|NCT03238417|516050959|FG000|24-month|partial completion|8|||
143137632|NCT03238417|516050960|FG001|24-month|partial completion|31|||
143137633|NCT02089347|516050961|FG000|Overall Study|Protocol Violation|1|||
143137634|NCT02089347|516050962|FG001|Overall Study|Protocol Violation|0|||
143137635|NCT00001566|516050963|FG000|Overall Study|patients' choice to discontinue protocol|3|||
143137636|NCT00001566|516050963|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
143361692|NCT01253200|516865721|FG001|Overall Study|intents|10|||
143361693|NCT01253200|516865722|FG002|Overall Study|intents|1|||
143361694|NCT01253200|516865723|FG003|Overall Study|intents|3|||
143361695|NCT01253200|516865724|FG004|Overall Study|intents|0|||
143361696|NCT01253200|516865720|FG000|Overall Study|Attempts|6|||
143361697|NCT01253200|516865721|FG001|Overall Study|Attempts|4|||
143361698|NCT01253200|516865722|FG002|Overall Study|Attempts|1|||
143361699|NCT01253200|516865723|FG003|Overall Study|Attempts|2|||
143361700|NCT01253200|516865724|FG004|Overall Study|Attempts|0|||
143361701|NCT02049437|516865725|FG000|Period 1|Adverse Event|1|||
143361702|NCT02049437|516865726|FG001|Period 1|Adverse Event|1|||
143361703|NCT02049437|516865725|FG000|Period 1|Adverse Event|1|||
143361704|NCT02049437|516865726|FG001|Period 1|Adverse Event|0|||
143361705|NCT00630539|516865727|FG000|Overall Study|Adverse Event|1|||
143361706|NCT00630539|516865728|FG001|Overall Study|Adverse Event|3|||
143361707|NCT00630539|516865729|FG002|Overall Study|Adverse Event|1|||
143361708|NCT00630539|516865730|FG003|Overall Study|Adverse Event|2|||
143361709|NCT00630539|516865727|FG000|Overall Study|Withdrawal by Subject|0|||
143361710|NCT00630539|516865728|FG001|Overall Study|Withdrawal by Subject|1|||
143361711|NCT00630539|516865729|FG002|Overall Study|Withdrawal by Subject|0|||
143361712|NCT00630539|516865730|FG003|Overall Study|Withdrawal by Subject|1|||
143361713|NCT00577629|516865738|FG000|Treatment Period|Death|1|||
143361714|NCT00577629|516865738|FG000|Long Term Follow-Up|Death|15|||
143361715|NCT00577629|516865738|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
143361716|NCT00577629|516865738|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
143361717|NCT00577629|516865738|FG000|Long Term Follow-Up|Physician Decision|1|||
143361718|NCT01605136|516865739|FG000|Study Period|Withdrawal by Subject|2|||
143361719|NCT01605136|516865740|FG001|Study Period|Withdrawal by Subject|0|||
143361720|NCT01605136|516865739|FG000|Study Period|Physician Decision|1|||
143361721|NCT01605136|516865740|FG001|Study Period|Physician Decision|1|||
143361722|NCT01605136|516865739|FG000|Study Period|Lost to Follow-up|0|||
143361723|NCT01605136|516865740|FG001|Study Period|Lost to Follow-up|2|||
143361724|NCT01605136|516865739|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
143361725|NCT01605136|516865740|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
143361726|NCT01027871|516865741|FG000|Overall Study|Physician Decision|1|||
143361727|NCT01027871|516865742|FG001|Overall Study|Physician Decision|5|||
143361728|NCT01027871|516865743|FG002|Overall Study|Physician Decision|0|||
143361729|NCT01027871|516865741|FG000|Overall Study|Protocol Violation|0|||
143361730|NCT01027871|516865742|FG001|Overall Study|Protocol Violation|2|||
143361731|NCT01027871|516865743|FG002|Overall Study|Protocol Violation|2|||
143361732|NCT01027871|516865741|FG000|Overall Study|Withdrawal by Subject|1|||
143361733|NCT01027871|516865742|FG001|Overall Study|Withdrawal by Subject|2|||
143361734|NCT01027871|516865743|FG002|Overall Study|Withdrawal by Subject|2|||
143361735|NCT01027871|516865741|FG000|Overall Study|Adverse Event|0|||
143361736|NCT01027871|516865742|FG001|Overall Study|Adverse Event|2|||
143361737|NCT01027871|516865743|FG002|Overall Study|Adverse Event|2|||
143361738|NCT01027871|516865741|FG000|Overall Study|Sponsor Decision|0|||
143361739|NCT01027871|516865742|FG001|Overall Study|Sponsor Decision|2|||
143361740|NCT01027871|516865743|FG002|Overall Study|Sponsor Decision|0|||
143361741|NCT01027871|516865741|FG000|Overall Study|Discontinued Prior to Treatment|0|||
143361742|NCT01027871|516865742|FG001|Overall Study|Discontinued Prior to Treatment|0|||
143361743|NCT01027871|516865743|FG002|Overall Study|Discontinued Prior to Treatment|1|||
143361744|NCT03008122|516865744|FG000|Overall Study|Physician Decision|3|||
143361745|NCT03008122|516865745|FG001|Overall Study|Physician Decision|2|||
143361746|NCT03008122|516865746|FG002|Overall Study|Physician Decision|0|||
143361747|NCT03008122|516865744|FG000|Overall Study|Withdrawal by Subject|1|||
143361748|NCT03008122|516865745|FG001|Overall Study|Withdrawal by Subject|3|||
143361749|NCT03008122|516865746|FG002|Overall Study|Withdrawal by Subject|0|||
143361750|NCT03008122|516865744|FG000|Overall Study|Lost to Follow-up|4|||
143361751|NCT03008122|516865745|FG001|Overall Study|Lost to Follow-up|8|||
143361752|NCT03008122|516865746|FG002|Overall Study|Lost to Follow-up|3|||
143361753|NCT03008122|516865744|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
143137637|NCT00001566|516050963|FG000|Overall Study|Death|13|||
143137638|NCT00001566|516050963|FG000|Overall Study|Lost to Follow-up|1|||
143361754|NCT03008122|516865745|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
143361755|NCT03008122|516865746|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
143361756|NCT03008122|516865744|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
143361757|NCT03008122|516865745|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
143361758|NCT03008122|516865746|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
143361759|NCT03008122|516865744|FG000|Overall Study|Death|0|||
143137639|NCT00001566|516050963|FG000|Overall Study|unable to complete initial apheresis|1|||
143137640|NCT01249131|516050973|FG000|Washout Period of 10 Days|Adverse Event|0|||
143137641|NCT01249131|516050974|FG001|Washout Period of 10 Days|Adverse Event|0|||
143137642|NCT01249131|516050975|FG002|Washout Period of 10 Days|Adverse Event|0|||
143137643|NCT01249131|516050976|FG003|Washout Period of 10 Days|Adverse Event|0|||
143137644|NCT01249131|516050977|FG004|Washout Period of 10 Days|Adverse Event|1|||
143137645|NCT01249131|516050978|FG005|Washout Period of 10 Days|Adverse Event|0|||
143137646|NCT01245101|516050979|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
143137647|NCT01245101|516050980|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
143137648|NCT01245101|516050979|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
143137649|NCT01245101|516050980|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
143137650|NCT01245101|516050979|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
143137651|NCT01245101|516050980|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
143137652|NCT01225549|516050981|FG000|Period 4 - Washout|Disallowed medication|0|||
143137653|NCT01225549|516050982|FG001|Period 4 - Washout|Disallowed medication|1|||
143137654|NCT01225549|516050983|FG002|Period 4 - Washout|Disallowed medication|0|||
143137655|NCT01225549|516050984|FG003|Period 4 - Washout|Disallowed medication|0|||
143137656|NCT01225549|516050985|FG004|Period 4 - Washout|Disallowed medication|0|||
143137657|NCT01225549|516050986|FG005|Period 4 - Washout|Disallowed medication|0|||
143137658|NCT01225549|516050987|FG006|Period 4 - Washout|Disallowed medication|0|||
143137659|NCT01225549|516050988|FG007|Period 4 - Washout|Disallowed medication|0|||
143137660|NCT01225549|516050989|FG008|Period 4 - Washout|Disallowed medication|0|||
143137661|NCT01225549|516050990|FG009|Period 4 - Washout|Disallowed medication|0|||
143137662|NCT01225549|516050981|FG000|Period 6 - Washout|Disallowed medication|0|||
143137663|NCT01225549|516050982|FG001|Period 6 - Washout|Disallowed medication|0|||
143137664|NCT01225549|516050983|FG002|Period 6 - Washout|Disallowed medication|0|||
143137665|NCT01225549|516050984|FG003|Period 6 - Washout|Disallowed medication|1|||
143137666|NCT01225549|516050985|FG004|Period 6 - Washout|Disallowed medication|0|||
143137667|NCT01225549|516050986|FG005|Period 6 - Washout|Disallowed medication|0|||
143137668|NCT01225549|516050987|FG006|Period 6 - Washout|Disallowed medication|0|||
143137669|NCT01225549|516050988|FG007|Period 6 - Washout|Disallowed medication|0|||
143137670|NCT01225549|516050989|FG008|Period 6 - Washout|Disallowed medication|0|||
143137671|NCT01225549|516050990|FG009|Period 6 - Washout|Disallowed medication|0|||
143137672|NCT01122173|516050991|FG000|Overall Study|Lost to Follow-up|3|||
143137673|NCT01122173|516050991|FG000|Overall Study|Withdrawal by Subject|3|||
143137674|NCT01122173|516050991|FG000|Overall Study|Left study for other reasons|3|||
143137675|NCT01184872|516050992|FG000|Overall Study|Adverse Event|3|||
143137676|NCT01184872|516050993|FG001|Overall Study|Adverse Event|4|||
143137677|NCT01184872|516050992|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
143137678|NCT01184872|516050993|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
143137679|NCT01184872|516050992|FG000|Overall Study|Withdrawal by Subject|2|||
143137680|NCT01184872|516050993|FG001|Overall Study|Withdrawal by Subject|0|||
143137681|NCT01184872|516050992|FG000|Overall Study|Lost to Follow-up|0|||
143137682|NCT01184872|516050993|FG001|Overall Study|Lost to Follow-up|1|||
143137683|NCT01184872|516050992|FG000|Overall Study|Administrative problems|1|||
143137684|NCT01184872|516050993|FG001|Overall Study|Administrative problems|1|||
143137685|NCT01184872|516050992|FG000|Overall Study|Protocol deviation|1|||
143137686|NCT01184872|516050993|FG001|Overall Study|Protocol deviation|0|||
143137687|NCT00433836|516050994|FG000|Overall Study|Adverse Event|7|||
143137688|NCT00433836|516050995|FG001|Overall Study|Adverse Event|0|||
143137689|NCT00433836|516050994|FG000|Overall Study|Lost to Follow-up|3|||
143137690|NCT00433836|516050995|FG001|Overall Study|Lost to Follow-up|0|||
143137691|NCT00433836|516050994|FG000|Overall Study|Withdrawal by Subject|2|||
143137692|NCT00433836|516050995|FG001|Overall Study|Withdrawal by Subject|1|||
143137693|NCT00433836|516050994|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
143137694|NCT00433836|516050995|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
143137695|NCT00433836|516050994|FG000|Overall Study|Protocol Violation|0|||
143137696|NCT00433836|516050995|FG001|Overall Study|Protocol Violation|2|||
143137697|NCT00433836|516050994|FG000|Overall Study|Condition no longer requires study drug|0|||
143137698|NCT00433836|516050995|FG001|Overall Study|Condition no longer requires study drug|1|||
143137699|NCT00433836|516050994|FG000|Overall Study|Abnormal laboratory values|0|||
143137700|NCT00433836|516050995|FG001|Overall Study|Abnormal laboratory values|1|||
143137701|NCT02133508|516050996|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
143137702|NCT02133508|516050996|FG000|Overall Study|Death|12|||
143137703|NCT02133508|516050996|FG000|Overall Study|Lost to Follow-up|2|||
143137704|NCT03093181|516050997|FG000|Overall Study|Withdrawal by Subject|2|||
143137705|NCT03093181|516050998|FG001|Overall Study|Withdrawal by Subject|1|||
143137706|NCT03093181|516050999|FG002|Overall Study|Withdrawal by Subject|2|||
143137707|NCT03093181|516050997|FG000|Overall Study|Other (Not specified)|1|||
143137708|NCT03093181|516050998|FG001|Overall Study|Other (Not specified)|0|||
143137709|NCT03093181|516050999|FG002|Overall Study|Other (Not specified)|0|||
143137710|NCT03093181|516050997|FG000|Overall Study|Adverse Event|0|||
143137711|NCT03093181|516050998|FG001|Overall Study|Adverse Event|1|||
143137712|NCT03093181|516050999|FG002|Overall Study|Adverse Event|0|||
143137713|NCT03093181|516050997|FG000|Overall Study|Other (Protocol violation)|0|||
143137714|NCT03093181|516050998|FG001|Overall Study|Other (Protocol violation)|0|||
143137715|NCT03093181|516050999|FG002|Overall Study|Other (Protocol violation)|1|||
143137716|NCT01159574|516051000|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
143137717|NCT01159574|516051000|FG000|Treatment Phase|Adverse Event|3|||
143137718|NCT01159574|516051000|FG000|Treatment Phase|Death|6|||
143137719|NCT01159574|516051000|FG000|Treatment Phase|Physician Decision|2|||
143472296|NCT00594516|517276890|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
143472297|NCT00594516|517276891|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
143472298|NCT00594516|517276892|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
143472299|NCT00594516|517276890|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
143472300|NCT00594516|517276891|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
143472301|NCT00594516|517276892|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
143472302|NCT00594516|517276890|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
143472303|NCT00594516|517276891|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
143472304|NCT00594516|517276892|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
143472305|NCT00594516|517276890|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
143472306|NCT00594516|517276891|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
143472307|NCT00594516|517276892|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
143472308|NCT00594516|517276890|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
143472309|NCT00594516|517276891|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
143472310|NCT00594516|517276892|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
143472311|NCT02462928|517276893|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
143472312|NCT02462928|517276894|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
143472313|NCT02462928|517276895|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
143472314|NCT02462928|517276893|FG000|Overall Study|Adverse Event|47|||
143472315|NCT02462928|517276894|FG001|Overall Study|Adverse Event|51|||
143472316|NCT02462928|517276895|FG002|Overall Study|Adverse Event|25|||
143472317|NCT02462928|517276893|FG000|Overall Study|Lack of Efficacy|3|||
143472318|NCT02462928|517276894|FG001|Overall Study|Lack of Efficacy|8|||
143472319|NCT02462928|517276895|FG002|Overall Study|Lack of Efficacy|3|||
143472320|NCT02462928|517276893|FG000|Overall Study|Lost to Follow-up|4|||
143472321|NCT02462928|517276894|FG001|Overall Study|Lost to Follow-up|4|||
143472322|NCT02462928|517276895|FG002|Overall Study|Lost to Follow-up|1|||
143472323|NCT02462928|517276893|FG000|Overall Study|Withdrawal by Patient|31|||
143472324|NCT02462928|517276894|FG001|Overall Study|Withdrawal by Patient|21|||
143472325|NCT02462928|517276895|FG002|Overall Study|Withdrawal by Patient|21|||
143472326|NCT02462928|517276893|FG000|Overall Study|Protocol Violation|0|||
143472327|NCT02462928|517276894|FG001|Overall Study|Protocol Violation|1|||
143472328|NCT02462928|517276895|FG002|Overall Study|Protocol Violation|0|||
143472329|NCT02462928|517276893|FG000|Overall Study|Reason not Specified|4|||
143472330|NCT02462928|517276894|FG001|Overall Study|Reason not Specified|6|||
143472331|NCT02462928|517276895|FG002|Overall Study|Reason not Specified|5|||
143137720|NCT01159574|516051000|FG000|Treatment Phase|Withdrawal by Subject|7|||
143472332|NCT04641299|517276896|FG000|Overall Study|Adverse Event|0|||
143472333|NCT04641299|517276897|FG001|Overall Study|Adverse Event|0|||
143472334|NCT04641299|517276898|FG002|Overall Study|Adverse Event|2|||
143472335|NCT04641299|517276899|FG003|Overall Study|Adverse Event|0|||
143472336|NCT04641299|517276896|FG000|Overall Study|Lost to Follow-up|0|||
143472337|NCT04641299|517276897|FG001|Overall Study|Lost to Follow-up|1|||
143472338|NCT04641299|517276898|FG002|Overall Study|Lost to Follow-up|0|||
143472339|NCT04641299|517276899|FG003|Overall Study|Lost to Follow-up|0|||
143472340|NCT04641299|517276896|FG000|Overall Study|Withdrawal by Subject|1|||
143472341|NCT04641299|517276897|FG001|Overall Study|Withdrawal by Subject|0|||
143472342|NCT04641299|517276898|FG002|Overall Study|Withdrawal by Subject|0|||
143472343|NCT04641299|517276899|FG003|Overall Study|Withdrawal by Subject|0|||
143472344|NCT04641299|517276896|FG000|Overall Study|Reason not given|1|||
143472345|NCT04641299|517276897|FG001|Overall Study|Reason not given|0|||
143472346|NCT04641299|517276898|FG002|Overall Study|Reason not given|0|||
143472347|NCT04641299|517276899|FG003|Overall Study|Reason not given|0|||
143472348|NCT00702845|517276903|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
143472349|NCT00702845|517276904|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
143472350|NCT00702845|517276903|FG000|Overall Study|Too high ovarian response|5|||
143472351|NCT00702845|517276904|FG001|Overall Study|Too high ovarian response|1|||
143472352|NCT00702845|517276903|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
143472353|NCT00702845|517276904|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
143472354|NCT00702845|517276903|FG000|Overall Study|Insufficient ovarian response|1|||
143472355|NCT00702845|517276904|FG001|Overall Study|Insufficient ovarian response|0|||
143137721|NCT01159574|516051000|FG000|Treatment Phase|still on treatment|2|||
143137722|NCT01159574|516051000|FG000|Follow Up Phase|Lost to Follow-up|2|||
143137723|NCT01159574|516051000|FG000|Follow Up Phase|still being followed for overall surviva|18|||
143472356|NCT00702845|517276903|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
143137724|NCT03555149|516051001|FG000|Overall Study|Death|18|||
143137725|NCT03555149|516051002|FG001|Overall Study|Death|15|||
143472357|NCT00702845|517276904|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
143137726|NCT03555149|516051003|FG002|Overall Study|Death|15|||
143137727|NCT03555149|516051004|FG003|Overall Study|Death|4|||
143137728|NCT03555149|516051005|FG004|Overall Study|Death|4|||
143137729|NCT03555149|516051006|FG005|Overall Study|Death|11|||
143137730|NCT03555149|516051007|FG006|Overall Study|Death|12|||
143137731|NCT03555149|516051008|FG007|Overall Study|Death|1|||
143137732|NCT03555149|516051001|FG000|Overall Study|Lost to Follow-up|1|||
143137733|NCT03555149|516051002|FG001|Overall Study|Lost to Follow-up|0|||
143137734|NCT03555149|516051003|FG002|Overall Study|Lost to Follow-up|0|||
143137735|NCT03555149|516051004|FG003|Overall Study|Lost to Follow-up|0|||
143137736|NCT03555149|516051005|FG004|Overall Study|Lost to Follow-up|0|||
143137737|NCT03555149|516051006|FG005|Overall Study|Lost to Follow-up|1|||
143137738|NCT03555149|516051007|FG006|Overall Study|Lost to Follow-up|0|||
143137739|NCT03555149|516051008|FG007|Overall Study|Lost to Follow-up|0|||
143137740|NCT03555149|516051001|FG000|Overall Study|Physician Decision|1|||
143137741|NCT03555149|516051002|FG001|Overall Study|Physician Decision|0|||
143137742|NCT03555149|516051003|FG002|Overall Study|Physician Decision|0|||
143137743|NCT03555149|516051004|FG003|Overall Study|Physician Decision|0|||
143137744|NCT03555149|516051005|FG004|Overall Study|Physician Decision|0|||
143137745|NCT03555149|516051006|FG005|Overall Study|Physician Decision|0|||
143137746|NCT03555149|516051007|FG006|Overall Study|Physician Decision|0|||
143137747|NCT03555149|516051008|FG007|Overall Study|Physician Decision|0|||
143137748|NCT03555149|516051001|FG000|Overall Study|Study Terminated By Sponsor|1|||
143137749|NCT03555149|516051002|FG001|Overall Study|Study Terminated By Sponsor|0|||
143137750|NCT03555149|516051003|FG002|Overall Study|Study Terminated By Sponsor|0|||
143137751|NCT03555149|516051004|FG003|Overall Study|Study Terminated By Sponsor|0|||
143137752|NCT03555149|516051005|FG004|Overall Study|Study Terminated By Sponsor|0|||
143137753|NCT03555149|516051006|FG005|Overall Study|Study Terminated By Sponsor|2|||
143137754|NCT03555149|516051007|FG006|Overall Study|Study Terminated By Sponsor|3|||
143137755|NCT03555149|516051008|FG007|Overall Study|Study Terminated By Sponsor|1|||
143137756|NCT03555149|516051001|FG000|Overall Study|Withdrawal by Subject|3|||
143137757|NCT03555149|516051002|FG001|Overall Study|Withdrawal by Subject|0|||
143137758|NCT03555149|516051003|FG002|Overall Study|Withdrawal by Subject|0|||
143137759|NCT03555149|516051004|FG003|Overall Study|Withdrawal by Subject|2|||
143137760|NCT03555149|516051005|FG004|Overall Study|Withdrawal by Subject|0|||
143137761|NCT03555149|516051006|FG005|Overall Study|Withdrawal by Subject|1|||
143137762|NCT03555149|516051007|FG006|Overall Study|Withdrawal by Subject|0|||
143137763|NCT03555149|516051008|FG007|Overall Study|Withdrawal by Subject|0|||
143137764|NCT04386902|516051012|FG000|Overall Study|Withdrawal by Subject|5|||
143137765|NCT04386902|516051012|FG000|Overall Study|Technical problems in the recording|5|||
143137766|NCT00721799|516051013|FG000|Overall Study|Withdrawal by Subject|7|||
143137767|NCT00721799|516051013|FG000|Overall Study|withdraw by subject after scan 1|1|||
143137768|NCT02033759|516051015|FG000|Overall Study|Withdrawal by Subject|2|||
143137769|NCT02033759|516051016|FG001|Overall Study|Withdrawal by Subject|1|||
143137770|NCT02033759|516051015|FG000|Overall Study|Protocol Violation|1|||
143137771|NCT02033759|516051016|FG001|Overall Study|Protocol Violation|1|||
143137772|NCT02100124|516051017|FG000|Overall Study|Lost to Follow-up|5|||
143137773|NCT02100124|516051018|FG001|Overall Study|Lost to Follow-up|11|||
143137774|NCT02100124|516051019|FG002|Overall Study|Lost to Follow-up|3|||
143137775|NCT02100124|516051017|FG000|Overall Study|Withdrawal by Subject|1|||
143137776|NCT02100124|516051018|FG001|Overall Study|Withdrawal by Subject|0|||
143137777|NCT02100124|516051019|FG002|Overall Study|Withdrawal by Subject|0|||
143137778|NCT01450813|516052921|FG000|Overall Study|Physician Decision|1|||
143137779|NCT01450813|516052922|FG001|Overall Study|Physician Decision|1|||
143137780|NCT01450813|516052923|FG002|Overall Study|Physician Decision|0|||
143137781|NCT01450813|516052924|FG003|Overall Study|Physician Decision|3|||
143137782|NCT00785356|516052927|FG000|Overall Study|Study prematurely terminated|8|||
143137783|NCT02051296|516052929|FG000|Overall Study|Lost to Follow-up|1|||
143137784|NCT02051296|516052930|FG001|Overall Study|Lost to Follow-up|2|||
143137785|NCT02051296|516052929|FG000|Overall Study|withdraw prior to treatment|7|||
143361760|NCT03008122|516865745|FG001|Overall Study|Death|0|||
143361761|NCT03008122|516865746|FG002|Overall Study|Death|1|||
143361762|NCT04159896|516865749|FG000|Overall Study|Lack of Efficacy|7|||
143361763|NCT04159896|516865749|FG000|Overall Study|Withdrawal by Subject|1|||
143361764|NCT04159896|516865749|FG000|Overall Study|Adverse Event|1|||
143361765|NCT04159896|516865749|FG000|Overall Study|A transient ischaemic attack|1|||
143472358|NCT00702845|517276903|FG000|Overall Study|No or abnormal fertilization|4|||
143137786|NCT02051296|516052930|FG001|Overall Study|withdraw prior to treatment|7|||
143137787|NCT05379920|516052931|FG000|Overall Study|Lost to Follow-up|0|||
143361766|NCT02338609|516865750|FG000|Overall Study|Physician Decision|1|||
143361767|NCT02338609|516865750|FG000|Overall Study|Death|1|||
143137788|NCT05379920|516052932|FG001|Overall Study|Lost to Follow-up|5|||
143137789|NCT05379920|516052933|FG002|Overall Study|Lost to Follow-up|0|||
143137790|NCT05379920|516052934|FG003|Overall Study|Lost to Follow-up|0|||
143137791|NCT02265510|516052935|FG000|Overall Study|Withdrawal by Subject|1|||
143361768|NCT05705167|516865751|FG000|Overall Study|Randomised but not Treated|0|||
143361769|NCT05705167|516865752|FG001|Overall Study|Randomised but not Treated|2|||
143137792|NCT02265510|516052936|FG001|Overall Study|Withdrawal by Subject|1|||
143137793|NCT02265510|516052937|FG002|Overall Study|Withdrawal by Subject|2|||
143137794|NCT02265510|516052938|FG003|Overall Study|Withdrawal by Subject|1|||
143137795|NCT02265510|516052939|FG004|Overall Study|Withdrawal by Subject|0|||
143137796|NCT02265510|516052940|FG005|Overall Study|Withdrawal by Subject|2|||
143137797|NCT02265510|516052941|FG006|Overall Study|Withdrawal by Subject|0|||
143137798|NCT02265510|516052942|FG007|Overall Study|Withdrawal by Subject|2|||
143137799|NCT02265510|516052943|FG008|Overall Study|Withdrawal by Subject|0|||
143137800|NCT02265510|516052944|FG009|Overall Study|Withdrawal by Subject|0|||
143137801|NCT02265510|516052945|FG010|Overall Study|Withdrawal by Subject|0|||
143137802|NCT02265510|516052946|FG011|Overall Study|Withdrawal by Subject|0|||
143137803|NCT02265510|516052947|FG012|Overall Study|Withdrawal by Subject|1|||
143137804|NCT02265510|516052948|FG013|Overall Study|Withdrawal by Subject|0|||
143137805|NCT02265510|516052935|FG000|Overall Study|Disease Progression|0|||
143137806|NCT02265510|516052936|FG001|Overall Study|Disease Progression|1|||
143137807|NCT02265510|516052937|FG002|Overall Study|Disease Progression|2|||
143137808|NCT02265510|516052938|FG003|Overall Study|Disease Progression|1|||
143137809|NCT02265510|516052939|FG004|Overall Study|Disease Progression|1|||
143137810|NCT02265510|516052940|FG005|Overall Study|Disease Progression|0|||
143137811|NCT02265510|516052941|FG006|Overall Study|Disease Progression|0|||
143137812|NCT02265510|516052942|FG007|Overall Study|Disease Progression|0|||
143137813|NCT02265510|516052943|FG008|Overall Study|Disease Progression|0|||
143137814|NCT02265510|516052944|FG009|Overall Study|Disease Progression|0|||
143137815|NCT02265510|516052945|FG010|Overall Study|Disease Progression|0|||
143137816|NCT02265510|516052946|FG011|Overall Study|Disease Progression|0|||
143137817|NCT02265510|516052947|FG012|Overall Study|Disease Progression|0|||
143137818|NCT02265510|516052948|FG013|Overall Study|Disease Progression|0|||
143137819|NCT02265510|516052935|FG000|Overall Study|Death|2|||
143137820|NCT02265510|516052936|FG001|Overall Study|Death|0|||
143137821|NCT02265510|516052937|FG002|Overall Study|Death|2|||
143137822|NCT02265510|516052938|FG003|Overall Study|Death|2|||
143137823|NCT02265510|516052939|FG004|Overall Study|Death|1|||
143137824|NCT02265510|516052940|FG005|Overall Study|Death|3|||
143137825|NCT02265510|516052941|FG006|Overall Study|Death|2|||
143137826|NCT02265510|516052942|FG007|Overall Study|Death|1|||
143137827|NCT02265510|516052943|FG008|Overall Study|Death|3|||
143137828|NCT02265510|516052944|FG009|Overall Study|Death|3|||
143137829|NCT02265510|516052945|FG010|Overall Study|Death|4|||
143137830|NCT02265510|516052946|FG011|Overall Study|Death|12|||
143137831|NCT02265510|516052947|FG012|Overall Study|Death|7|||
143137832|NCT02265510|516052948|FG013|Overall Study|Death|6|||
143137833|NCT02265510|516052935|FG000|Overall Study|Lost to Follow-up|0|||
143137834|NCT02265510|516052936|FG001|Overall Study|Lost to Follow-up|0|||
143137835|NCT02265510|516052937|FG002|Overall Study|Lost to Follow-up|0|||
143137836|NCT02265510|516052938|FG003|Overall Study|Lost to Follow-up|0|||
143137837|NCT02265510|516052939|FG004|Overall Study|Lost to Follow-up|1|||
143137838|NCT02265510|516052940|FG005|Overall Study|Lost to Follow-up|0|||
143137839|NCT02265510|516052941|FG006|Overall Study|Lost to Follow-up|0|||
143137840|NCT02265510|516052942|FG007|Overall Study|Lost to Follow-up|0|||
143137841|NCT02265510|516052943|FG008|Overall Study|Lost to Follow-up|0|||
143137842|NCT02265510|516052944|FG009|Overall Study|Lost to Follow-up|2|||
143137843|NCT02265510|516052945|FG010|Overall Study|Lost to Follow-up|0|||
143137844|NCT02265510|516052946|FG011|Overall Study|Lost to Follow-up|0|||
143137845|NCT02265510|516052947|FG012|Overall Study|Lost to Follow-up|0|||
143137846|NCT02265510|516052948|FG013|Overall Study|Lost to Follow-up|2|||
143137847|NCT02265510|516052935|FG000|Overall Study|Other|0|||
143137848|NCT02265510|516052936|FG001|Overall Study|Other|1|||
143137849|NCT02265510|516052937|FG002|Overall Study|Other|0|||
143137850|NCT02265510|516052938|FG003|Overall Study|Other|0|||
143137851|NCT02265510|516052939|FG004|Overall Study|Other|0|||
143137852|NCT02265510|516052940|FG005|Overall Study|Other|0|||
143137853|NCT02265510|516052941|FG006|Overall Study|Other|0|||
143137854|NCT02265510|516052942|FG007|Overall Study|Other|0|||
143137855|NCT02265510|516052943|FG008|Overall Study|Other|0|||
143137856|NCT02265510|516052944|FG009|Overall Study|Other|0|||
143137857|NCT02265510|516052945|FG010|Overall Study|Other|0|||
143137858|NCT02265510|516052946|FG011|Overall Study|Other|0|||
143137859|NCT02265510|516052947|FG012|Overall Study|Other|0|||
143137860|NCT02265510|516052948|FG013|Overall Study|Other|0|||
143137861|NCT02265510|516052935|FG000|Overall Study|Study Terminated by Sponsor|0|||
143137862|NCT02265510|516052936|FG001|Overall Study|Study Terminated by Sponsor|0|||
143137863|NCT02265510|516052937|FG002|Overall Study|Study Terminated by Sponsor|0|||
143137864|NCT02265510|516052938|FG003|Overall Study|Study Terminated by Sponsor|0|||
143137865|NCT02265510|516052939|FG004|Overall Study|Study Terminated by Sponsor|0|||
143137866|NCT02265510|516052940|FG005|Overall Study|Study Terminated by Sponsor|1|||
143137867|NCT02265510|516052941|FG006|Overall Study|Study Terminated by Sponsor|1|||
143137868|NCT02265510|516052942|FG007|Overall Study|Study Terminated by Sponsor|1|||
143137869|NCT02265510|516052943|FG008|Overall Study|Study Terminated by Sponsor|1|||
143137870|NCT02265510|516052944|FG009|Overall Study|Study Terminated by Sponsor|2|||
143137871|NCT02265510|516052945|FG010|Overall Study|Study Terminated by Sponsor|1|||
143137872|NCT02265510|516052946|FG011|Overall Study|Study Terminated by Sponsor|4|||
143361770|NCT05705167|516865753|FG002|Overall Study|Randomised but not Treated|0|||
143361771|NCT05705167|516865754|FG003|Overall Study|Randomised but not Treated|7|||
143361772|NCT05705167|516865755|FG004|Overall Study|Randomised but not Treated|0|||
143361773|NCT05705167|516865756|FG005|Overall Study|Randomised but not Treated|0|||
143361774|NCT05705167|516865757|FG006|Overall Study|Randomised but not Treated|0|||
143361775|NCT05705167|516865751|FG000|Overall Study|Death|0|||
143361776|NCT05705167|516865752|FG001|Overall Study|Death|0|||
143361777|NCT05705167|516865753|FG002|Overall Study|Death|3|||
143361778|NCT05705167|516865754|FG003|Overall Study|Death|0|||
143361779|NCT05705167|516865755|FG004|Overall Study|Death|1|||
143361780|NCT05705167|516865756|FG005|Overall Study|Death|1|||
143361781|NCT05705167|516865757|FG006|Overall Study|Death|1|||
143361782|NCT05705167|516865751|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
143361783|NCT05705167|516865752|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
143361784|NCT05705167|516865753|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
143361785|NCT05705167|516865754|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
143361786|NCT05705167|516865755|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
143361787|NCT05705167|516865756|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
143361788|NCT05705167|516865757|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
143361789|NCT04736056|516865759|FG000|Overall Study|Death|0|||
143361790|NCT04736056|516865760|FG001|Overall Study|Death|0|||
143361791|NCT04736056|516865761|FG002|Overall Study|Death|0|||
143361792|NCT04736056|516865762|FG003|Overall Study|Death|1|||
143361793|NCT04736056|516865759|FG000|Overall Study|Lost to Follow-up|1|||
143361794|NCT04736056|516865760|FG001|Overall Study|Lost to Follow-up|0|||
143361795|NCT04736056|516865761|FG002|Overall Study|Lost to Follow-up|1|||
143361796|NCT04736056|516865762|FG003|Overall Study|Lost to Follow-up|1|||
143361797|NCT04736056|516865759|FG000|Overall Study|Withdrawal by Subject|2|||
143361798|NCT04736056|516865760|FG001|Overall Study|Withdrawal by Subject|0|||
143361799|NCT04736056|516865761|FG002|Overall Study|Withdrawal by Subject|0|||
143361800|NCT04736056|516865762|FG003|Overall Study|Withdrawal by Subject|0|||
143361801|NCT04736056|516865759|FG000|Overall Study|Physician Decision|1|||
143361802|NCT04736056|516865760|FG001|Overall Study|Physician Decision|0|||
143361803|NCT04736056|516865761|FG002|Overall Study|Physician Decision|1|||
143361804|NCT04736056|516865762|FG003|Overall Study|Physician Decision|0|||
143361805|NCT02148718|516865765|FG000|Overall Study|Protocol Violation|26|||
143361806|NCT02148718|516865765|FG000|Overall Study|Discontinued Study Prematurely|5|||
143361807|NCT00333788|516865768|FG000|Overall Study|Adverse Event|44|||
143361808|NCT00333788|516865768|FG000|Overall Study|Lack of Efficacy|80|||
143361809|NCT00333788|516865768|FG000|Overall Study|Lost to Follow-up|2|||
143361810|NCT00333788|516865768|FG000|Overall Study|Withdrawal by Subject|24|||
143361811|NCT00333788|516865768|FG000|Overall Study|Other: Non-compliance|2|||
143361812|NCT00333788|516865768|FG000|Overall Study|Other: Moved|2|||
143361813|NCT00333788|516865768|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
143361814|NCT00333788|516865768|FG000|Overall Study|Other: Investigator decision|1|||
143361815|NCT00333788|516865768|FG000|Overall Study|Other: Quality of life concern|1|||
143361816|NCT00333788|516865768|FG000|Overall Study|Other: Sponsor decision|1|||
143361817|NCT00333788|516865768|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
143361818|NCT00333788|516865768|FG000|Overall Study|Other: Medical monitor decision|1|||
143361819|NCT00333788|516865768|FG000|Overall Study|Other: Physician decision|1|||
143361820|NCT00333788|516865768|FG000|Overall Study|Other: Signed consent for another study|1|||
143361821|NCT01007552|516865769|FG000|Overall Study|Withdrawal by Subject|1|||
143361822|NCT00663962|516865776|FG000|Overall Study|somnolence|1|||
143361823|NCT00663962|516865777|FG001|Overall Study|somnolence|0|||
143361824|NCT01354106|516865778|FG000|Overall Study|Withdrawal by Subject|2|||
143361825|NCT02491411|516867170|FG000|Overall Study|Physician Decision|4|||
143361826|NCT04034238|516867171|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
143361827|NCT04034238|516867172|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
143361828|NCT04034238|516867173|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
143361829|NCT04034238|516867174|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
143361830|NCT04034238|516867171|FG000|Dose Escalation Phase|Screen failures|0|||
143361831|NCT04034238|516867172|FG001|Dose Escalation Phase|Screen failures|0|||
143361832|NCT04034238|516867173|FG002|Dose Escalation Phase|Screen failures|0|||
143361833|NCT04034238|516867174|FG003|Dose Escalation Phase|Screen failures|2|||
143361834|NCT04034238|516867171|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
143361835|NCT04034238|516867172|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
143361836|NCT04034238|516867173|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
143361837|NCT04034238|516867174|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
143361838|NCT04034238|516867171|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
143361839|NCT04034238|516867172|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
143361840|NCT04034238|516867173|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
143361841|NCT04034238|516867174|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
143361842|NCT01598987|516867175|FG000|Baseline to Month 12|Administrative problems|2|||
143137873|NCT02265510|516052947|FG012|Overall Study|Study Terminated by Sponsor|1|||
143137874|NCT02265510|516052948|FG013|Overall Study|Study Terminated by Sponsor|2|||
143137875|NCT00644059|516052949|FG000|Overall Study|Lost to Follow-up|37|||
143137876|NCT00644059|516052950|FG001|Overall Study|Lost to Follow-up|34|||
143137877|NCT00644059|516052951|FG002|Overall Study|Lost to Follow-up|16|||
143137878|NCT00644059|516052949|FG000|Overall Study|Withdrawal by Subject|52|||
143137879|NCT00644059|516052950|FG001|Overall Study|Withdrawal by Subject|60|||
143137880|NCT00644059|516052951|FG002|Overall Study|Withdrawal by Subject|30|||
143137881|NCT00644059|516052949|FG000|Overall Study|Adverse Event|8|||
143137882|NCT00644059|516052950|FG001|Overall Study|Adverse Event|5|||
143137883|NCT00644059|516052951|FG002|Overall Study|Adverse Event|1|||
143137884|NCT00644059|516052949|FG000|Overall Study|Inappropriate Enrollment|1|||
143137885|NCT00644059|516052950|FG001|Overall Study|Inappropriate Enrollment|3|||
143137886|NCT00644059|516052951|FG002|Overall Study|Inappropriate Enrollment|0|||
143137887|NCT00644059|516052949|FG000|Overall Study|Protocol Deviation/violation|20|||
143137888|NCT00644059|516052950|FG001|Overall Study|Protocol Deviation/violation|19|||
143137889|NCT00644059|516052951|FG002|Overall Study|Protocol Deviation/violation|15|||
143137890|NCT00644059|516052949|FG000|Overall Study|Unable to classify|6|||
143137891|NCT00644059|516052950|FG001|Overall Study|Unable to classify|2|||
143137892|NCT00644059|516052951|FG002|Overall Study|Unable to classify|3|||
143137893|NCT04210986|516052954|FG000|Overall Study|Lost to Follow-up|5|||
143137894|NCT04210986|516052955|FG001|Overall Study|Lost to Follow-up|2|||
143137895|NCT04210986|516052954|FG000|Overall Study|Withdrawal by Subject|3|||
143137896|NCT04210986|516052955|FG001|Overall Study|Withdrawal by Subject|1|||
143137897|NCT04210986|516052954|FG000|Overall Study|Protocol Violation|1|||
143137898|NCT04210986|516052955|FG001|Overall Study|Protocol Violation|1|||
143137899|NCT04210986|516052954|FG000|Overall Study|Physician Decision|0|||
143137900|NCT04210986|516052955|FG001|Overall Study|Physician Decision|1|||
143137901|NCT02378662|516052956|FG000|Overall Study|Early Discontinuation|2|||
143137902|NCT02378662|516052957|FG001|Overall Study|Early Discontinuation|0|||
143137903|NCT01701245|516052958|FG000|Overall Study|Protocol Violation|1|||
143137904|NCT01701245|516052959|FG001|Overall Study|Protocol Violation|3|||
143137905|NCT01701245|516052958|FG000|Overall Study|Did not complete the open label period|11|||
143137906|NCT01701245|516052959|FG001|Overall Study|Did not complete the open label period|12|||
143137907|NCT02147626|516052970|FG000|Overall Study|Lost to Follow-up|4|||
143137908|NCT02147626|516052971|FG001|Overall Study|Lost to Follow-up|4|||
143137909|NCT02147626|516052970|FG000|Overall Study|Pregnancy|1|||
143137910|NCT02147626|516052971|FG001|Overall Study|Pregnancy|2|||
143137911|NCT02147626|516052970|FG000|Overall Study|Withdrawal by Subject|0|||
143137912|NCT02147626|516052971|FG001|Overall Study|Withdrawal by Subject|1|||
143137913|NCT03504917|516052972|FG000|Blinded Treatment Period|Protocol Violation|1|||
143137914|NCT03504917|516052973|FG001|Blinded Treatment Period|Protocol Violation|0|||
143137915|NCT03504917|516052972|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
143137916|NCT03504917|516052973|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
143137917|NCT03504917|516052972|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
143137918|NCT03504917|516052973|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
143137919|NCT03504917|516052972|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
143137920|NCT03504917|516052973|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
143137921|NCT03504917|516052972|FG000|Blinded Treatment Period|Adverse Event|4|||
143137922|NCT03504917|516052973|FG001|Blinded Treatment Period|Adverse Event|4|||
143137923|NCT03504917|516052972|FG000|Blinded Treatment Period|Physician Decision|1|||
143137924|NCT03504917|516052973|FG001|Blinded Treatment Period|Physician Decision|0|||
143137925|NCT03504917|516052972|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
143137926|NCT03504917|516052973|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
143137927|NCT03504917|516052972|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
143137928|NCT03504917|516052973|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
143137929|NCT03504917|516052972|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
143137930|NCT03504917|516052973|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
143137931|NCT03504917|516052972|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
143137932|NCT03504917|516052973|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
143137933|NCT03504917|516052972|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
143137934|NCT03504917|516052973|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
143137935|NCT03504917|516052972|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
143137936|NCT03504917|516052973|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
143137937|NCT03504917|516052972|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
143137938|NCT03504917|516052973|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
143137939|NCT03504917|516052972|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
143137940|NCT03504917|516052973|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
143137941|NCT03504917|516052972|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
143137942|NCT03504917|516052973|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
143361843|NCT01598987|516867175|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
143472359|NCT00702845|517276904|FG001|Overall Study|No or abnormal fertilization|2|||
143472360|NCT00702845|517276903|FG000|Overall Study|Patient's decision|2|||
143472361|NCT00702845|517276904|FG001|Overall Study|Patient's decision|1|||
143472362|NCT00702845|517276903|FG000|Overall Study|Not randomized|0|||
143472363|NCT00702845|517276904|FG001|Overall Study|Not randomized|1|||
143472364|NCT02973425|517276909|FG000|Overall Study|Lost to Follow-up|49|||
143472365|NCT02973425|517276910|FG001|Overall Study|Lost to Follow-up|53|||
143472366|NCT03876171|517276915|FG000|Overall Study|Withdrawal by Subject|3|||
143472367|NCT03876171|517276916|FG001|Overall Study|Withdrawal by Subject|3|||
143472368|NCT03876171|517276915|FG000|Overall Study|Re-arrest|0|||
143472369|NCT03876171|517276916|FG001|Overall Study|Re-arrest|4|||
143472370|NCT02012296|517276917|FG000|Overall Study|Lack of Efficacy|0|||
143472371|NCT02012296|517276918|FG001|Overall Study|Lack of Efficacy|0|||
143472372|NCT02012296|517276919|FG002|Overall Study|Lack of Efficacy|15|||
143472373|NCT02012296|517276917|FG000|Overall Study|Adverse Event|0|||
143472374|NCT02012296|517276918|FG001|Overall Study|Adverse Event|0|||
143472375|NCT02012296|517276919|FG002|Overall Study|Adverse Event|2|||
143472376|NCT02012296|517276917|FG000|Overall Study|Early study closure|0|||
143472377|NCT02012296|517276918|FG001|Overall Study|Early study closure|0|||
143472378|NCT02012296|517276919|FG002|Overall Study|Early study closure|5|||
143472379|NCT02012296|517276917|FG000|Overall Study|Protocol Violation|0|||
143472380|NCT02012296|517276918|FG001|Overall Study|Protocol Violation|1|||
143472381|NCT02012296|517276919|FG002|Overall Study|Protocol Violation|0|||
143472382|NCT01448213|517276920|FG000|Overall Study|Lost to Follow-up|12|||
143472383|NCT01448213|517276921|FG001|Overall Study|Lost to Follow-up|10|||
143472384|NCT01448213|517276920|FG000|Overall Study|Adverse Event|4|||
143472385|NCT01448213|517276921|FG001|Overall Study|Adverse Event|10|||
143472386|NCT01448213|517276920|FG000|Overall Study|Protocol Violation|1|||
143472387|NCT01448213|517276921|FG001|Overall Study|Protocol Violation|2|||
143472388|NCT01330914|517276922|FG000|Overall Study|Withdrawal by Subject|4|||
143472389|NCT01330914|517276922|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
143472390|NCT03503513|517276923|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
143472391|NCT03503513|517276923|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
143472392|NCT03503513|517276923|FG000|Overall Study|Physician Decision|3|||
143472393|NCT03503513|517276923|FG000|Overall Study|Withdrawal by Subject|2|||
143472394|NCT03503513|517276923|FG000|Overall Study|Lost to Follow-up|1|||
143472395|NCT01170039|517276928|FG000|Overall Study|Withdrawal by Subject|5|||
143472396|NCT01170039|517276929|FG001|Overall Study|Withdrawal by Subject|3|||
143472397|NCT01170039|517276928|FG000|Overall Study|Lack of funding, drug not available|3|||
143472398|NCT01170039|517276929|FG001|Overall Study|Lack of funding, drug not available|3|||
143472399|NCT00908583|517276930|FG000|Phase 1|Withdrawal by Subject|1|||
143472400|NCT00908583|517276930|FG000|Phase 1|Adverse Event|4|||
143472401|NCT00908583|517276930|FG000|Phase 2|Physician Decision|1|||
143472402|NCT00908583|517276930|FG000|Phase 2|Adverse Event|1|||
143472403|NCT00908583|517276930|FG000|Phase 3|Adverse Event|2|||
143472404|NCT00908583|517276930|FG000|Phase 4|Adverse Event|1|||
143472405|NCT00908583|517276930|FG000|Phase 4|Physician Decision|1|||
143472406|NCT00908583|517276930|FG000|Phase 5|Adverse Event|3|||
143472407|NCT00993954|517276931|FG000|Overall Study|Protocol Violation|21|||
143472408|NCT00993954|517276932|FG001|Overall Study|Protocol Violation|2|||
143472409|NCT00860951|517276933|FG000|Overall Study|Withdrawal by Subject|2|||
143472410|NCT00860951|517276933|FG000|Overall Study|Lost to Follow-up|5|||
143472411|NCT00727649|517276934|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
143472412|NCT00727649|517276935|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
143472413|NCT00727649|517276934|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
143472414|NCT00727649|517276935|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
143472415|NCT00727649|517276934|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
143472416|NCT00727649|517276935|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
143472417|NCT00727649|517276934|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
143472418|NCT00727649|517276935|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
143472419|NCT00727649|517276934|FG000|Second Intervention (4-weeks)|Death|1|||
143472420|NCT00727649|517276935|FG001|Second Intervention (4-weeks)|Death|0|||
143472421|NCT00727649|517276934|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
143472422|NCT00727649|517276935|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
143472423|NCT00727649|517276934|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
143472424|NCT00727649|517276935|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
143472425|NCT01830855|517276938|FG000|Overall Study|Other|7|||
143014053|NCT00981409|515591590|FG001|Overall Study|Adverse Event|0|||
143137943|NCT03504917|516052972|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
143137944|NCT03504917|516052973|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
143137945|NCT00572832|516052974|FG000|Overall Study|Lost to Follow-up|0|||
143137946|NCT00572832|516052975|FG001|Overall Study|Lost to Follow-up|11|||
143137947|NCT00572832|516052974|FG000|Overall Study|Pregnancy|0|||
143472426|NCT01830855|517276939|FG001|Overall Study|Other|1|||
143472427|NCT01830855|517276940|FG002|Overall Study|Other|4|||
143472428|NCT01830855|517276941|FG003|Overall Study|Other|4|||
143472429|NCT01830855|517276938|FG000|Overall Study|Medication error without associated AE|1|||
143472430|NCT01830855|517276939|FG001|Overall Study|Medication error without associated AE|0|||
143472431|NCT01830855|517276940|FG002|Overall Study|Medication error without associated AE|0|||
143472432|NCT01830855|517276941|FG003|Overall Study|Medication error without associated AE|1|||
143472433|NCT01830855|517276938|FG000|Overall Study|Pregnancy|3|||
143472434|NCT01830855|517276939|FG001|Overall Study|Pregnancy|1|||
143472435|NCT01830855|517276940|FG002|Overall Study|Pregnancy|2|||
143472436|NCT01830855|517276941|FG003|Overall Study|Pregnancy|1|||
143472437|NCT01830855|517276938|FG000|Overall Study|No longer meets eligibility criteria|11|||
143472438|NCT01830855|517276939|FG001|Overall Study|No longer meets eligibility criteria|2|||
143472439|NCT01830855|517276940|FG002|Overall Study|No longer meets eligibility criteria|3|||
143014054|NCT00981409|515591589|FG000|Overall Study|Protocol Violation|0|||
143014055|NCT00981409|515591590|FG001|Overall Study|Protocol Violation|1|||
143014056|NCT00981409|515591589|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
143014057|NCT00981409|515591590|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
143014058|NCT00450177|515591592|FG000|Overall Study|Adverse Event|7|||
143014059|NCT00450177|515591593|FG001|Overall Study|Adverse Event|4|||
143014060|NCT00450177|515591592|FG000|Overall Study|Withdrawal by Subject|1|||
143014061|NCT00450177|515591593|FG001|Overall Study|Withdrawal by Subject|6|||
143014062|NCT00450177|515591592|FG000|Overall Study|Withdrawal by Primary Team|1|||
143014063|NCT00450177|515591593|FG001|Overall Study|Withdrawal by Primary Team|1|||
143014064|NCT02923115|515591594|FG000|Overall Study|Lost to Follow-up|0|||
143014065|NCT02923115|515591595|FG001|Overall Study|Lost to Follow-up|0|||
143014066|NCT02923115|515591596|FG002|Overall Study|Lost to Follow-up|0|||
143014067|NCT02923115|515591597|FG003|Overall Study|Lost to Follow-up|1|||
143014068|NCT02923115|515591598|FG004|Overall Study|Lost to Follow-up|0|||
143014069|NCT02923115|515591599|FG005|Overall Study|Lost to Follow-up|0|||
143472440|NCT01830855|517276941|FG003|Overall Study|No longer meets eligibility criteria|5|||
143472441|NCT01830855|517276938|FG000|Overall Study|Adverse Event|11|||
143472442|NCT01830855|517276939|FG001|Overall Study|Adverse Event|5|||
143472443|NCT01830855|517276940|FG002|Overall Study|Adverse Event|6|||
143472444|NCT01830855|517276941|FG003|Overall Study|Adverse Event|3|||
143472445|NCT01830855|517276938|FG000|Overall Study|Protocol deviation|10|||
143472446|NCT01830855|517276939|FG001|Overall Study|Protocol deviation|5|||
143472447|NCT01830855|517276940|FG002|Overall Study|Protocol deviation|6|||
143472448|NCT01830855|517276941|FG003|Overall Study|Protocol deviation|6|||
143472449|NCT01830855|517276938|FG000|Overall Study|Withdrawal by Subject|33|||
143472450|NCT01830855|517276939|FG001|Overall Study|Withdrawal by Subject|14|||
143472451|NCT01830855|517276940|FG002|Overall Study|Withdrawal by Subject|10|||
143472452|NCT01830855|517276941|FG003|Overall Study|Withdrawal by Subject|12|||
143472453|NCT01830855|517276938|FG000|Overall Study|No longer willing to participate|32|||
143472454|NCT01830855|517276939|FG001|Overall Study|No longer willing to participate|13|||
143472455|NCT01830855|517276940|FG002|Overall Study|No longer willing to participate|12|||
143472456|NCT01830855|517276941|FG003|Overall Study|No longer willing to participate|17|||
143472457|NCT01830855|517276938|FG000|Overall Study|Lost to Follow-up|47|||
143472458|NCT01830855|517276939|FG001|Overall Study|Lost to Follow-up|20|||
143472459|NCT01830855|517276940|FG002|Overall Study|Lost to Follow-up|23|||
143472460|NCT01830855|517276941|FG003|Overall Study|Lost to Follow-up|33|||
143472461|NCT01667081|517276942|FG000|Overall Study|Death|43|||
143472462|NCT01667081|517276943|FG001|Overall Study|Death|3|||
143472463|NCT01667081|517276942|FG000|Overall Study|Lost to Follow-up|99|||
143472464|NCT01667081|517276943|FG001|Overall Study|Lost to Follow-up|48|||
143472465|NCT01667081|517276942|FG000|Overall Study|Physician Decision|16|||
143472466|NCT01667081|517276943|FG001|Overall Study|Physician Decision|2|||
143472467|NCT01667081|517276942|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
143472468|NCT01667081|517276943|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
143472469|NCT01667081|517276942|FG000|Overall Study|Withdrawal by Subject|90|||
143472470|NCT01667081|517276943|FG001|Overall Study|Withdrawal by Subject|35|||
143472471|NCT03034460|517276944|FG000|Overall Study|Adverse Event|0|||
143472472|NCT03034460|517276945|FG001|Overall Study|Adverse Event|1|||
143472473|NCT03034460|517276944|FG000|Overall Study|Withdrawal by Subject|2|||
143472474|NCT03034460|517276945|FG001|Overall Study|Withdrawal by Subject|2|||
143472475|NCT03034460|517276944|FG000|Overall Study|Personal Reasons|1|||
143472476|NCT03034460|517276945|FG001|Overall Study|Personal Reasons|0|||
143472477|NCT00295633|517276948|FG000|Overall Study|Lack of Efficacy|19|||
143472478|NCT00295633|517276949|FG001|Overall Study|Lack of Efficacy|7|||
143472479|NCT00295633|517276950|FG002|Overall Study|Lack of Efficacy|16|||
143472480|NCT00295633|517276948|FG000|Overall Study|Withdrawal of consent by subject|16|||
143472481|NCT00295633|517276949|FG001|Overall Study|Withdrawal of consent by subject|16|||
143472482|NCT00295633|517276950|FG002|Overall Study|Withdrawal of consent by subject|26|||
143014070|NCT02923115|515591594|FG000|Overall Study|Withdrawal by Subject|0|||
143014071|NCT02923115|515591595|FG001|Overall Study|Withdrawal by Subject|1|||
143014072|NCT02923115|515591596|FG002|Overall Study|Withdrawal by Subject|0|||
143014073|NCT02923115|515591597|FG003|Overall Study|Withdrawal by Subject|0|||
143472483|NCT00295633|517276948|FG000|Overall Study|Adverse Event|9|||
143472484|NCT00295633|517276949|FG001|Overall Study|Adverse Event|17|||
143472485|NCT00295633|517276950|FG002|Overall Study|Adverse Event|9|||
143472486|NCT00295633|517276948|FG000|Overall Study|Lost to Follow-up|6|||
143472487|NCT00295633|517276949|FG001|Overall Study|Lost to Follow-up|11|||
143472488|NCT00295633|517276950|FG002|Overall Study|Lost to Follow-up|7|||
143472489|NCT00295633|517276948|FG000|Overall Study|Physician Decision|9|||
143472490|NCT00295633|517276949|FG001|Overall Study|Physician Decision|10|||
143472491|NCT00295633|517276950|FG002|Overall Study|Physician Decision|8|||
143472492|NCT00295633|517276948|FG000|Overall Study|Poor/Noncompliance|2|||
143472493|NCT00295633|517276949|FG001|Overall Study|Poor/Noncompliance|2|||
143472494|NCT00295633|517276950|FG002|Overall Study|Poor/Noncompliance|6|||
143472495|NCT00295633|517276948|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
143472496|NCT00295633|517276949|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
143472497|NCT00295633|517276950|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
143472498|NCT00295633|517276948|FG000|Overall Study|Death|1|||
143472499|NCT00295633|517276949|FG001|Overall Study|Death|1|||
143472500|NCT00295633|517276950|FG002|Overall Study|Death|0|||
143137948|NCT00572832|516052975|FG001|Overall Study|Pregnancy|1|||
143137949|NCT04079790|516052976|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
143137950|NCT04079790|516052977|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
143137951|NCT04079790|516052978|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
143137952|NCT04079790|516052979|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
143137953|NCT04079790|516052976|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
143137954|NCT04079790|516052977|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
143137955|NCT04079790|516052978|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
143137956|NCT04079790|516052979|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
143137957|NCT04079790|516052976|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
143472501|NCT00295633|517276948|FG000|Overall Study|Administrative reason by sponsor|0|||
143472502|NCT00295633|517276949|FG001|Overall Study|Administrative reason by sponsor|0|||
143472503|NCT00295633|517276950|FG002|Overall Study|Administrative reason by sponsor|1|||
143472504|NCT01754857|517276951|FG000|Overall Study|Adverse Event|7|||
143472505|NCT01754857|517276951|FG000|Overall Study|Disease progression|3|||
143472506|NCT01754857|517276951|FG000|Overall Study|Physician Decision|2|||
143472507|NCT01754857|517276951|FG000|Overall Study|Withdrawal by Subject|3|||
143472508|NCT01754857|517276951|FG000|Overall Study|other complicating disease|1|||
143472509|NCT01754857|517276951|FG000|Overall Study|ineligible to continue onto maintenance|1|||
143472510|NCT01754857|517276951|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
143472511|NCT01754857|517276951|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
143472512|NCT01399190|517276952|FG000|Overall Study|Not Eligible for Final Analysis|5|||
143472513|NCT01399190|517276952|FG000|Overall Study|Adverse Event|8|||
143472514|NCT01399190|517276952|FG000|Overall Study|Participant's Request|5|||
143472515|NCT01399190|517276952|FG000|Overall Study|Physician Decision|2|||
143472516|NCT03842163|517276954|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
143472517|NCT03842163|517276954|FG000|Overall Study|Scintigraphy was not performed|44|||
143472518|NCT03083847|517276955|FG000|Main|Physician Decision|0|||
143472519|NCT03083847|517276956|FG001|Main|Physician Decision|0|||
143472520|NCT03083847|517276957|FG002|Main|Physician Decision|0|||
143472521|NCT03083847|517276958|FG003|Main|Physician Decision|0|||
143472522|NCT03083847|517276959|FG004|Main|Physician Decision|0|||
143472523|NCT03083847|517276960|FG005|Main|Physician Decision|1|||
143472524|NCT03083847|517276961|FG006|Main|Physician Decision|0|||
143472525|NCT03083847|517276962|FG007|Main|Physician Decision|0|||
143472526|NCT03083847|517276963|FG008|Main|Physician Decision|0|||
143472527|NCT03083847|517276964|FG009|Main|Physician Decision|0|||
143472528|NCT03083847|517276955|FG000|Main|Pregnancy|0|||
143472529|NCT03083847|517276956|FG001|Main|Pregnancy|0|||
143472530|NCT03083847|517276957|FG002|Main|Pregnancy|0|||
143472531|NCT03083847|517276958|FG003|Main|Pregnancy|0|||
143472532|NCT03083847|517276959|FG004|Main|Pregnancy|0|||
143472533|NCT03083847|517276960|FG005|Main|Pregnancy|0|||
143472534|NCT03083847|517276961|FG006|Main|Pregnancy|0|||
143472535|NCT03083847|517276962|FG007|Main|Pregnancy|1|||
143472536|NCT03083847|517276963|FG008|Main|Pregnancy|0|||
143472537|NCT03083847|517276964|FG009|Main|Pregnancy|0|||
143472538|NCT03083847|517276955|FG000|Main|Adverse Event|0|||
143472539|NCT03083847|517276956|FG001|Main|Adverse Event|0|||
143472540|NCT03083847|517276957|FG002|Main|Adverse Event|0|||
143472541|NCT03083847|517276958|FG003|Main|Adverse Event|0|||
143472542|NCT03083847|517276959|FG004|Main|Adverse Event|0|||
143472543|NCT03083847|517276960|FG005|Main|Adverse Event|0|||
143472544|NCT03083847|517276961|FG006|Main|Adverse Event|0|||
143472545|NCT03083847|517276962|FG007|Main|Adverse Event|2|||
143472546|NCT03083847|517276963|FG008|Main|Adverse Event|0|||
143472547|NCT03083847|517276964|FG009|Main|Adverse Event|0|||
143472548|NCT03083847|517276955|FG000|Main|Withdrawal by Subject|0|||
143472549|NCT03083847|517276956|FG001|Main|Withdrawal by Subject|0|||
143472550|NCT03083847|517276957|FG002|Main|Withdrawal by Subject|0|||
143472551|NCT03083847|517276958|FG003|Main|Withdrawal by Subject|0|||
143472552|NCT03083847|517276959|FG004|Main|Withdrawal by Subject|0|||
143472553|NCT03083847|517276960|FG005|Main|Withdrawal by Subject|0|||
143472554|NCT03083847|517276961|FG006|Main|Withdrawal by Subject|1|||
143137958|NCT04079790|516052977|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
143137959|NCT04079790|516052978|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
143137960|NCT04079790|516052979|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
143137961|NCT00390689|516052980|FG000|Overall Study|Adverse Event|2|||
143472555|NCT03083847|517276962|FG007|Main|Withdrawal by Subject|1|||
143137962|NCT00390689|516052981|FG001|Overall Study|Adverse Event|5|||
143137963|NCT00390689|516052982|FG002|Overall Study|Adverse Event|2|||
143137964|NCT00390689|516052980|FG000|Overall Study|Lack of Efficacy|0|||
143137965|NCT00390689|516052981|FG001|Overall Study|Lack of Efficacy|0|||
143137966|NCT00390689|516052982|FG002|Overall Study|Lack of Efficacy|1|||
143137967|NCT00390689|516052980|FG000|Overall Study|Protocol Violation|1|||
143137968|NCT00390689|516052981|FG001|Overall Study|Protocol Violation|0|||
143137969|NCT00390689|516052982|FG002|Overall Study|Protocol Violation|0|||
143137970|NCT00390689|516052980|FG000|Overall Study|Investigator's judgement|2|||
143137971|NCT00390689|516052981|FG001|Overall Study|Investigator's judgement|0|||
143137972|NCT00390689|516052982|FG002|Overall Study|Investigator's judgement|0|||
143137973|NCT01253161|516052983|FG000|Overall Study|Adverse Event|1|||
143137974|NCT03101020|516052985|FG000|Overall Study|Lack of time to participate|1|||
143137975|NCT03101020|516052986|FG001|Overall Study|Lack of time to participate|0|||
143137976|NCT03101020|516052985|FG000|Overall Study|Ran over by a car|0|||
143137977|NCT03101020|516052986|FG001|Overall Study|Ran over by a car|1|||
143137978|NCT03101020|516052985|FG000|Overall Study|Withdrawal by Subject|0|||
143137979|NCT03101020|516052986|FG001|Overall Study|Withdrawal by Subject|2|||
143137980|NCT05817669|516052987|FG000|Overall Study|Prohibited medication used|1|||
143137981|NCT05817669|516052988|FG001|Overall Study|Prohibited medication used|2|||
143137982|NCT05817669|516052987|FG000|Overall Study|Adverse Event|1|||
143137983|NCT05817669|516052988|FG001|Overall Study|Adverse Event|0|||
143137984|NCT05817669|516052987|FG000|Overall Study|Withdrawal by Subject|1|||
143137985|NCT05817669|516052988|FG001|Overall Study|Withdrawal by Subject|2|||
143137986|NCT03055936|516052990|FG000|Overall Study|Adverse Event|0|||
143137987|NCT03055936|516052991|FG001|Overall Study|Adverse Event|1|||
143137988|NCT03055936|516052992|FG002|Overall Study|Adverse Event|1|||
143137989|NCT03055936|516052993|FG003|Overall Study|Adverse Event|1|||
143137990|NCT03055936|516052990|FG000|Overall Study|Personal reason|2|||
143137991|NCT03055936|516052991|FG001|Overall Study|Personal reason|0|||
143137992|NCT03055936|516052992|FG002|Overall Study|Personal reason|1|||
143137993|NCT03055936|516052993|FG003|Overall Study|Personal reason|0|||
143137994|NCT03167242|516052997|FG000|Overall Study|Patient/Guardian Decision|0|||
143137995|NCT03167242|516052998|FG001|Overall Study|Patient/Guardian Decision|1|||
143137996|NCT03167242|516052999|FG002|Overall Study|Patient/Guardian Decision|2|||
143137997|NCT03167242|516053000|FG003|Overall Study|Patient/Guardian Decision|1|||
143137998|NCT03167242|516053001|FG004|Overall Study|Patient/Guardian Decision|1|||
143137999|NCT03167242|516053002|FG005|Overall Study|Patient/Guardian Decision|1|||
143138000|NCT03167242|516053003|FG006|Overall Study|Patient/Guardian Decision|0|||
143138001|NCT03167242|516053004|FG007|Overall Study|Patient/Guardian Decision|0|||
143138002|NCT03167242|516053005|FG008|Overall Study|Patient/Guardian Decision|0|||
143138003|NCT03167242|516053006|FG009|Overall Study|Patient/Guardian Decision|0|||
143138004|NCT03167242|516053007|FG010|Overall Study|Patient/Guardian Decision|1|||
143138005|NCT03167242|516053008|FG011|Overall Study|Patient/Guardian Decision|0|||
143138006|NCT03167242|516052997|FG000|Overall Study|Lost to Follow-up|0|||
143138007|NCT03167242|516052998|FG001|Overall Study|Lost to Follow-up|0|||
143138008|NCT03167242|516052999|FG002|Overall Study|Lost to Follow-up|1|||
143138009|NCT03167242|516053000|FG003|Overall Study|Lost to Follow-up|0|||
143138010|NCT03167242|516053001|FG004|Overall Study|Lost to Follow-up|0|||
143138011|NCT03167242|516053002|FG005|Overall Study|Lost to Follow-up|1|||
143472556|NCT03083847|517276963|FG008|Main|Withdrawal by Subject|0|||
143472557|NCT03083847|517276964|FG009|Main|Withdrawal by Subject|0|||
143472558|NCT01296035|517276965|FG000|Overall Study|Withdrawal by Subject|1|||
143472559|NCT03085758|517276970|FG000|Overall Study|Death|26|||
143138012|NCT03167242|516053003|FG006|Overall Study|Lost to Follow-up|2|||
143138013|NCT03167242|516053004|FG007|Overall Study|Lost to Follow-up|1|||
143138014|NCT03167242|516053005|FG008|Overall Study|Lost to Follow-up|0|||
143138015|NCT03167242|516053006|FG009|Overall Study|Lost to Follow-up|0|||
143138016|NCT03167242|516053007|FG010|Overall Study|Lost to Follow-up|1|||
143138017|NCT03167242|516053008|FG011|Overall Study|Lost to Follow-up|1|||
143138018|NCT03167242|516052997|FG000|Overall Study|Reason not provided|0|||
143138019|NCT03167242|516052998|FG001|Overall Study|Reason not provided|0|||
143138020|NCT03167242|516052999|FG002|Overall Study|Reason not provided|0|||
143138021|NCT03167242|516053000|FG003|Overall Study|Reason not provided|0|||
143138022|NCT03167242|516053001|FG004|Overall Study|Reason not provided|0|||
143138023|NCT03167242|516053002|FG005|Overall Study|Reason not provided|0|||
143138024|NCT03167242|516053003|FG006|Overall Study|Reason not provided|0|||
143014074|NCT02923115|515591598|FG004|Overall Study|Withdrawal by Subject|0|||
143138025|NCT03167242|516053004|FG007|Overall Study|Reason not provided|0|||
143138026|NCT03167242|516053005|FG008|Overall Study|Reason not provided|1|||
143138027|NCT03167242|516053006|FG009|Overall Study|Reason not provided|0|||
143138028|NCT03167242|516053007|FG010|Overall Study|Reason not provided|0|||
143138029|NCT03167242|516053008|FG011|Overall Study|Reason not provided|0|||
143472560|NCT03085758|517276971|FG001|Overall Study|Death|24|||
143138030|NCT01038687|516053012|FG000|Overall Study|Adverse Event|0|||
143138031|NCT01038687|516053013|FG001|Overall Study|Adverse Event|2|||
143138032|NCT01038687|516053014|FG002|Overall Study|Adverse Event|1|||
143138033|NCT05401565|516053015|FG000|Overall Study|Lost to Follow-up|1|||
143138034|NCT05401565|516053016|FG001|Overall Study|Lost to Follow-up|0|||
143138035|NCT05401565|516053015|FG000|Overall Study|Adverse Event|2|||
143138036|NCT05401565|516053016|FG001|Overall Study|Adverse Event|0|||
143138037|NCT02144701|516053023|FG000|Overall Study|development of relapse, GVHD or death|9|||
143138038|NCT02144701|516053024|FG001|Overall Study|development of relapse, GVHD or death|3|||
143138039|NCT03327324|516053025|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
143138040|NCT03327324|516053026|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
143138041|NCT03327324|516053027|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
143138042|NCT03327324|516053028|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
143138043|NCT03327324|516053029|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
143138044|NCT03327324|516053030|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
143138045|NCT03327324|516053025|FG000|Baseline (Month 0-Month 3)|Refused|0|||
143138046|NCT03327324|516053026|FG001|Baseline (Month 0-Month 3)|Refused|0|||
143138047|NCT03327324|516053027|FG002|Baseline (Month 0-Month 3)|Refused|0|||
143138048|NCT03327324|516053028|FG003|Baseline (Month 0-Month 3)|Refused|0|||
143138049|NCT03327324|516053029|FG004|Baseline (Month 0-Month 3)|Refused|1|||
143138050|NCT03327324|516053030|FG005|Baseline (Month 0-Month 3)|Refused|0|||
143138051|NCT03327324|516053025|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
143138052|NCT03327324|516053026|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
143138053|NCT03327324|516053027|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
143138054|NCT03327324|516053028|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
143138055|NCT03327324|516053029|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
143138056|NCT03327324|516053030|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
143138057|NCT03327324|516053025|FG000|Baseline (Month 0-Month 3)|Death|0|||
143361844|NCT01598987|516867175|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
143361845|NCT01598987|516867175|FG000|Baseline to 24 Month|Administrative problems|2|||
143361846|NCT01598987|516867175|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
143361847|NCT01450943|516867176|FG000|Overall Study|Screen failure, loss to follow-up|2|||
143361848|NCT01450943|516867177|FG001|Overall Study|Screen failure, loss to follow-up|7|||
143361849|NCT01450943|516867178|FG002|Overall Study|Screen failure, loss to follow-up|6|||
143361850|NCT03303105|516867181|FG000|Overall Study|Adverse Event|0|||
143361851|NCT03303105|516867182|FG001|Overall Study|Adverse Event|2|||
143361852|NCT03303105|516867181|FG000|Overall Study|Lack of Efficacy|1|||
143361853|NCT03303105|516867182|FG001|Overall Study|Lack of Efficacy|0|||
143361854|NCT03303105|516867181|FG000|Overall Study|Protocol Violation|1|||
143361855|NCT03303105|516867182|FG001|Overall Study|Protocol Violation|0|||
143361856|NCT03303105|516867181|FG000|Overall Study|Withdrawal by Subject|0|||
143361857|NCT03303105|516867182|FG001|Overall Study|Withdrawal by Subject|2|||
143361858|NCT00465361|516867185|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
143361859|NCT01333943|516867186|FG000|Overall Study|Known neuropathy|1|||
143361860|NCT01333943|516867187|FG001|Overall Study|Known neuropathy|0|||
143361861|NCT01244763|516867195|FG000|Overall Study|Adverse Event|1|||
143361862|NCT01244763|516867196|FG001|Overall Study|Adverse Event|0|||
143361863|NCT01244763|516867197|FG002|Overall Study|Adverse Event|0|||
143361864|NCT01244763|516867198|FG003|Overall Study|Adverse Event|0|||
143361865|NCT01244763|516867199|FG004|Overall Study|Adverse Event|0|||
143361866|NCT01244763|516867200|FG005|Overall Study|Adverse Event|1|||
143361867|NCT01244763|516867195|FG000|Overall Study|Death|1|||
143361868|NCT01244763|516867196|FG001|Overall Study|Death|0|||
143361869|NCT01244763|516867197|FG002|Overall Study|Death|1|||
143361870|NCT01244763|516867198|FG003|Overall Study|Death|0|||
143361871|NCT01244763|516867199|FG004|Overall Study|Death|2|||
143361872|NCT01244763|516867200|FG005|Overall Study|Death|0|||
143361873|NCT01244763|516867195|FG000|Overall Study|Physician Decision|0|||
143361874|NCT01244763|516867196|FG001|Overall Study|Physician Decision|0|||
143361875|NCT01244763|516867197|FG002|Overall Study|Physician Decision|1|||
143361876|NCT01244763|516867198|FG003|Overall Study|Physician Decision|0|||
143361877|NCT01244763|516867199|FG004|Overall Study|Physician Decision|0|||
143361878|NCT01244763|516867200|FG005|Overall Study|Physician Decision|0|||
143361879|NCT01244763|516867195|FG000|Overall Study|Withdrawal by Subject|1|||
143361880|NCT01244763|516867196|FG001|Overall Study|Withdrawal by Subject|2|||
143361881|NCT01244763|516867197|FG002|Overall Study|Withdrawal by Subject|0|||
143361882|NCT01244763|516867198|FG003|Overall Study|Withdrawal by Subject|1|||
143138058|NCT03327324|516053026|FG001|Baseline (Month 0-Month 3)|Death|0|||
143138059|NCT03327324|516053027|FG002|Baseline (Month 0-Month 3)|Death|0|||
143361883|NCT01244763|516867199|FG004|Overall Study|Withdrawal by Subject|1|||
143361884|NCT01244763|516867200|FG005|Overall Study|Withdrawal by Subject|2|||
143361885|NCT01244763|516867195|FG000|Overall Study|Lost to Follow-up|0|||
143361886|NCT01244763|516867196|FG001|Overall Study|Lost to Follow-up|1|||
143472561|NCT03085758|517276972|FG002|Overall Study|Death|53|||
143472562|NCT03085758|517276970|FG000|Overall Study|Lost to Follow-up|1|||
143472563|NCT03085758|517276971|FG001|Overall Study|Lost to Follow-up|1|||
143472564|NCT03085758|517276972|FG002|Overall Study|Lost to Follow-up|1|||
143472565|NCT03085758|517276970|FG000|Overall Study|Withdrawal by Subject|2|||
143472566|NCT03085758|517276971|FG001|Overall Study|Withdrawal by Subject|2|||
143472567|NCT03085758|517276972|FG002|Overall Study|Withdrawal by Subject|1|||
143472568|NCT03085758|517276970|FG000|Overall Study|Refusal to recall it up to day 90|0|||
143472569|NCT03085758|517276971|FG001|Overall Study|Refusal to recall it up to day 90|0|||
143472570|NCT03085758|517276972|FG002|Overall Study|Refusal to recall it up to day 90|1|||
143472571|NCT03085758|517276970|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
143472572|NCT03085758|517276971|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
143472573|NCT03085758|517276972|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
143472574|NCT00056862|517276973|FG000|Overall Study|Protocol Violation|1|||
143472575|NCT00056862|517276974|FG001|Overall Study|Protocol Violation|0|||
143472576|NCT01109173|517276978|FG000|Overall Study|Adverse Event|15|||
143472577|NCT01109173|517276979|FG001|Overall Study|Adverse Event|17|||
143472578|NCT01109173|517276980|FG002|Overall Study|Adverse Event|9|||
143472579|NCT01109173|517276981|FG003|Overall Study|Adverse Event|6|||
143472580|NCT01109173|517276978|FG000|Overall Study|Lost to Follow-up|0|||
143472581|NCT01109173|517276979|FG001|Overall Study|Lost to Follow-up|1|||
143472582|NCT01109173|517276980|FG002|Overall Study|Lost to Follow-up|0|||
143472583|NCT01109173|517276981|FG003|Overall Study|Lost to Follow-up|0|||
143472584|NCT01109173|517276978|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
143472585|NCT01109173|517276979|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
143472586|NCT01109173|517276980|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
143472587|NCT01109173|517276981|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
143472588|NCT01109173|517276978|FG000|Overall Study|Noncompliance|0|||
143472589|NCT01109173|517276979|FG001|Overall Study|Noncompliance|1|||
143472590|NCT01109173|517276980|FG002|Overall Study|Noncompliance|0|||
143472591|NCT01109173|517276981|FG003|Overall Study|Noncompliance|0|||
143472592|NCT01109173|517276978|FG000|Overall Study|Treatment Failure|25|||
143472593|NCT01109173|517276979|FG001|Overall Study|Treatment Failure|32|||
143472594|NCT01109173|517276980|FG002|Overall Study|Treatment Failure|69|||
143472595|NCT01109173|517276981|FG003|Overall Study|Treatment Failure|64|||
143472596|NCT01109173|517276978|FG000|Overall Study|Protocol Violation|4|||
143472597|NCT01109173|517276979|FG001|Overall Study|Protocol Violation|5|||
143472598|NCT01109173|517276980|FG002|Overall Study|Protocol Violation|1|||
143472599|NCT01109173|517276981|FG003|Overall Study|Protocol Violation|2|||
143472600|NCT01109173|517276978|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
143472601|NCT01109173|517276979|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
143472602|NCT01109173|517276980|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
143472603|NCT01109173|517276981|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
143472604|NCT01109173|517276978|FG000|Overall Study|Not Specifiied|5|||
143472605|NCT01109173|517276979|FG001|Overall Study|Not Specifiied|4|||
143472606|NCT01109173|517276980|FG002|Overall Study|Not Specifiied|9|||
143472607|NCT01109173|517276981|FG003|Overall Study|Not Specifiied|14|||
143472608|NCT01132612|517276985|FG000|Overall Study|Death|0|||
143472609|NCT01132612|517276986|FG001|Overall Study|Death|0|||
143472610|NCT01132612|517276987|FG002|Overall Study|Death|1|||
143472611|NCT01132612|517276985|FG000|Overall Study|Protocol deviation|0|||
143472612|NCT01132612|517276986|FG001|Overall Study|Protocol deviation|0|||
143472613|NCT01132612|517276987|FG002|Overall Study|Protocol deviation|3|||
143472614|NCT01132612|517276985|FG000|Overall Study|Lost to Follow-up|2|||
143472615|NCT01132612|517276986|FG001|Overall Study|Lost to Follow-up|2|||
143472616|NCT01132612|517276987|FG002|Overall Study|Lost to Follow-up|7|||
143472617|NCT01132612|517276985|FG000|Overall Study|Adverse Event|5|||
143472618|NCT01132612|517276986|FG001|Overall Study|Adverse Event|2|||
143472619|NCT01132612|517276987|FG002|Overall Study|Adverse Event|15|||
143472620|NCT01132612|517276985|FG000|Overall Study|Withdrawal by Subject|5|||
143472621|NCT01132612|517276986|FG001|Overall Study|Withdrawal by Subject|8|||
143472622|NCT01132612|517276987|FG002|Overall Study|Withdrawal by Subject|19|||
143472623|NCT01132612|517276985|FG000|Overall Study|Administrative problems|5|||
143472624|NCT01132612|517276986|FG001|Overall Study|Administrative problems|1|||
143472625|NCT01132612|517276987|FG002|Overall Study|Administrative problems|52|||
143472626|NCT01132612|517276985|FG000|Overall Study|Lack of Efficacy|23|||
143472627|NCT01132612|517276986|FG001|Overall Study|Lack of Efficacy|22|||
143472628|NCT01132612|517276987|FG002|Overall Study|Lack of Efficacy|73|||
143472629|NCT02252536|517276988|FG000|Overall Study|Lost to Follow-up|5|||
143472630|NCT02252536|517276989|FG001|Overall Study|Lost to Follow-up|3|||
143472631|NCT00006392|517276995|FG000|Overall Study|Ineligible|11|||
143472632|NCT00006392|517276996|FG001|Overall Study|Ineligible|3|||
143472633|NCT00006392|517276997|FG002|Overall Study|Ineligible|5|||
143472634|NCT00006392|517276998|FG003|Overall Study|Ineligible|5|||
143138060|NCT03327324|516053028|FG003|Baseline (Month 0-Month 3)|Death|0|||
143138061|NCT03327324|516053029|FG004|Baseline (Month 0-Month 3)|Death|1|||
143472635|NCT00006392|517276995|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
143472636|NCT00006392|517276996|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
143138062|NCT03327324|516053030|FG005|Baseline (Month 0-Month 3)|Death|0|||
143472637|NCT00006392|517276997|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
143138063|NCT03327324|516053025|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
143472638|NCT00006392|517276998|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
143472639|NCT01186796|517276999|FG000|Overall Study|Adverse Event|3|||
143472640|NCT01186796|517277000|FG001|Overall Study|Adverse Event|0|||
143472641|NCT01186796|517276999|FG000|Overall Study|Withdrawal by Subject|1|||
143472642|NCT01186796|517277000|FG001|Overall Study|Withdrawal by Subject|1|||
143138064|NCT03327324|516053026|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
143138065|NCT03327324|516053027|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
143138066|NCT03327324|516053028|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
143472643|NCT01186796|517276999|FG000|Overall Study|Protocol Violation|0|||
143472644|NCT01186796|517277000|FG001|Overall Study|Protocol Violation|1|||
143472645|NCT03838198|517277003|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
143472646|NCT03838198|517277004|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
143138067|NCT03327324|516053029|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
143138068|NCT03327324|516053030|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
143138069|NCT03327324|516053025|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
143138070|NCT03327324|516053026|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
143138071|NCT03327324|516053027|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
143138072|NCT03327324|516053028|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
143138073|NCT03327324|516053029|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
143138074|NCT03327324|516053030|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
143138075|NCT03327324|516053025|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
143138076|NCT03327324|516053026|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
143138077|NCT03327324|516053027|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
143138078|NCT03327324|516053028|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
143138079|NCT03327324|516053029|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
143138080|NCT03327324|516053030|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
143138081|NCT03327324|516053025|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
143138082|NCT03327324|516053026|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
143138083|NCT03327324|516053027|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
143138084|NCT03327324|516053028|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
143138085|NCT03327324|516053029|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
143138086|NCT03327324|516053030|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
143138087|NCT03327324|516053025|FG000|Intervention (Month 3-Month 6)|Death|1|||
143138088|NCT03327324|516053026|FG001|Intervention (Month 3-Month 6)|Death|0|||
143138089|NCT03327324|516053027|FG002|Intervention (Month 3-Month 6)|Death|1|||
143138090|NCT03327324|516053028|FG003|Intervention (Month 3-Month 6)|Death|1|||
143138091|NCT03327324|516053029|FG004|Intervention (Month 3-Month 6)|Death|1|||
143138092|NCT03327324|516053030|FG005|Intervention (Month 3-Month 6)|Death|0|||
143138093|NCT03327324|516053025|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
143138094|NCT03327324|516053026|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
143138095|NCT03327324|516053027|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
143138096|NCT03327324|516053028|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
143138097|NCT03327324|516053029|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
143138098|NCT03327324|516053030|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
143138099|NCT03327324|516053025|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
143138100|NCT03327324|516053026|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
143138101|NCT03327324|516053027|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
143138102|NCT03327324|516053028|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
143472647|NCT03838198|517277005|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
143472648|NCT03838198|517277006|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
143472649|NCT03838198|517277003|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
143472650|NCT03838198|517277004|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
143138103|NCT03327324|516053029|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
143138104|NCT03327324|516053030|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
143138105|NCT03327324|516053025|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
143138106|NCT03327324|516053026|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
143138107|NCT03327324|516053027|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
143138108|NCT03327324|516053028|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
143138109|NCT03327324|516053029|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
143138110|NCT03327324|516053030|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
143138111|NCT03327324|516053025|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
143138112|NCT03327324|516053026|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
143138113|NCT03327324|516053027|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
143138114|NCT03327324|516053028|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
143138115|NCT03327324|516053029|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
143138116|NCT03327324|516053030|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
143138117|NCT03327324|516053025|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
143138118|NCT03327324|516053026|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
143138119|NCT03327324|516053027|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
143138120|NCT03327324|516053028|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
143138121|NCT03327324|516053029|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
143138122|NCT03327324|516053030|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
143138123|NCT03327324|516053025|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
143138124|NCT03327324|516053026|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
143138125|NCT03327324|516053027|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
143138126|NCT03327324|516053028|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
143138127|NCT03327324|516053029|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
143138128|NCT03327324|516053030|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
143138129|NCT03327324|516053025|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
143138130|NCT03327324|516053026|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
143138131|NCT03327324|516053027|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
143138132|NCT03327324|516053028|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
143138133|NCT03327324|516053029|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
143138134|NCT03327324|516053030|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
143138135|NCT02314728|516053036|FG000|Overall Study|Protocol Violation|1|||
143138136|NCT02314728|516053037|FG001|Overall Study|Protocol Violation|0|||
143138137|NCT02314728|516053036|FG000|Overall Study|Lost to Follow-up|0|||
143138138|NCT02314728|516053037|FG001|Overall Study|Lost to Follow-up|1|||
143138139|NCT01791595|516053038|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
143138140|NCT01791595|516053039|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
143138141|NCT01791595|516053040|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
143138142|NCT01791595|516053041|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
143138143|NCT01791595|516053042|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
143138144|NCT01791595|516053043|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
143138145|NCT01791595|516053044|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
143138146|NCT01791595|516053038|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
143138147|NCT01791595|516053039|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
143138148|NCT01791595|516053040|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
143138149|NCT01791595|516053041|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
143138150|NCT01791595|516053042|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
143138151|NCT01791595|516053043|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
143138152|NCT01791595|516053044|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
143138153|NCT01791595|516053038|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
143138154|NCT01791595|516053039|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
143138155|NCT01791595|516053040|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
143138156|NCT01791595|516053041|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
143138157|NCT01791595|516053042|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
143138158|NCT01791595|516053043|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
143138159|NCT01791595|516053044|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
143138160|NCT01791595|516053038|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
143138161|NCT01791595|516053039|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
143138162|NCT01791595|516053040|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
143138163|NCT01791595|516053041|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
143138164|NCT01791595|516053042|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
143138165|NCT01791595|516053043|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
143138166|NCT01791595|516053044|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
143138167|NCT01791595|516053038|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
143472651|NCT03838198|517277005|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
143472652|NCT03838198|517277006|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
143472653|NCT01287364|517277008|FG000|Overall Study|Adverse Event|0|||
143472654|NCT01287364|517277009|FG001|Overall Study|Adverse Event|3|||
143472655|NCT01287364|517277008|FG000|Overall Study|Protocol Violation|5|||
143472656|NCT01287364|517277009|FG001|Overall Study|Protocol Violation|5|||
143472657|NCT01287364|517277008|FG000|Overall Study|Other Reason|4|||
143472658|NCT01287364|517277009|FG001|Overall Study|Other Reason|2|||
143472659|NCT00770770|517277022|FG000|Overall Study|Lost to Follow-up|1|||
143472660|NCT00770770|517277023|FG001|Overall Study|Lost to Follow-up|0|||
143472661|NCT00770770|517277022|FG000|Overall Study|Withdrawal by Subject|1|||
143472662|NCT00770770|517277023|FG001|Overall Study|Withdrawal by Subject|0|||
143472663|NCT00770770|517277022|FG000|Overall Study|Death|0|||
143472664|NCT00770770|517277023|FG001|Overall Study|Death|1|||
143472665|NCT00770770|517277022|FG000|Overall Study|Study Terminated|8|||
143472666|NCT00770770|517277023|FG001|Overall Study|Study Terminated|0|||
143472667|NCT05372653|517277024|FG000|Overall Study|Study treatment terminated by parent/guardian|1|||
143472668|NCT05372653|517277025|FG001|Overall Study|Study treatment terminated by parent/guardian|3|||
143472669|NCT05372653|517277024|FG000|Overall Study|Adverse Event|0|||
143472670|NCT05372653|517277025|FG001|Overall Study|Adverse Event|1|||
143472671|NCT00117507|517277026|FG000|Overall Study|Adverse Event|4|||
143472672|NCT00117507|517277026|FG000|Overall Study|Abnormal laboratory values|3|||
143472673|NCT00117507|517277026|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
143472674|NCT00117507|517277026|FG000|Overall Study|Patient withdrew consent|4|||
143472675|NCT00117507|517277026|FG000|Overall Study|Death|3|||
143472676|NCT00711529|517277027|FG000|Overall Study|Protocol Violation|2|||
143472677|NCT00711529|517277028|FG001|Overall Study|Protocol Violation|0|||
143472678|NCT00711529|517277027|FG000|Overall Study|Withdrawal by Subject|2|||
143472679|NCT00711529|517277028|FG001|Overall Study|Withdrawal by Subject|6|||
143472680|NCT03740997|517277031|FG000|Overall Study|Withdrawal by Subject|1|||
143472681|NCT03740997|517277032|FG001|Overall Study|Withdrawal by Subject|0|||
143472682|NCT03740997|517277031|FG000|Overall Study|Participant was unable to complete study procedures|1|||
143472683|NCT03740997|517277032|FG001|Overall Study|Participant was unable to complete study procedures|0|||
143472684|NCT01003990|517277033|FG000|Overall Study|Adverse Event|8|||
143472685|NCT01003990|517277034|FG001|Overall Study|Adverse Event|5|||
143472686|NCT01003990|517277035|FG002|Overall Study|Adverse Event|11|||
143138168|NCT01791595|516053039|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
143138169|NCT01791595|516053040|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
143138170|NCT01791595|516053041|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
143138171|NCT01791595|516053042|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
143138172|NCT01791595|516053043|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
143138173|NCT01791595|516053044|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
143138174|NCT01791595|516053038|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
143138175|NCT01791595|516053039|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
143138176|NCT01791595|516053040|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
143138177|NCT01791595|516053041|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
143138178|NCT01791595|516053042|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
143138179|NCT01791595|516053043|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
143138180|NCT01791595|516053044|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
143138181|NCT01791595|516053038|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
143138182|NCT01791595|516053039|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
143138183|NCT01791595|516053040|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
143138184|NCT01791595|516053041|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
143138185|NCT01791595|516053042|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
143138186|NCT01791595|516053043|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
143138187|NCT01791595|516053044|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
143138188|NCT01791595|516053038|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
143138189|NCT01791595|516053039|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
143138190|NCT01791595|516053040|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
143472687|NCT01003990|517277033|FG000|Overall Study|Death|0|||
143472688|NCT01003990|517277034|FG001|Overall Study|Death|8|||
143472689|NCT01003990|517277035|FG002|Overall Study|Death|1|||
143472690|NCT01003990|517277033|FG000|Overall Study|Lack of Efficacy|10|||
143472691|NCT01003990|517277034|FG001|Overall Study|Lack of Efficacy|2|||
143472692|NCT01003990|517277035|FG002|Overall Study|Lack of Efficacy|3|||
143472693|NCT01003990|517277033|FG000|Overall Study|Lost to Follow-up|30|||
143472694|NCT01003990|517277034|FG001|Overall Study|Lost to Follow-up|12|||
143472695|NCT01003990|517277035|FG002|Overall Study|Lost to Follow-up|7|||
143138191|NCT01791595|516053041|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
143138192|NCT01791595|516053042|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
143138193|NCT01791595|516053043|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
143138194|NCT01791595|516053044|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
143138195|NCT01791595|516053038|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
143138196|NCT01791595|516053039|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
143138197|NCT01791595|516053040|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
143138198|NCT01791595|516053041|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
143138199|NCT01791595|516053042|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
143138200|NCT01791595|516053043|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
143138201|NCT01791595|516053044|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
143138202|NCT01791595|516053038|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
143138203|NCT01791595|516053039|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
143138204|NCT01791595|516053040|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
143138205|NCT01791595|516053041|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
143138206|NCT01791595|516053042|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
143138207|NCT01791595|516053043|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
143138208|NCT01791595|516053044|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
143138209|NCT01791595|516053038|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
143138210|NCT01791595|516053039|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
143138211|NCT01791595|516053040|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
143138212|NCT01791595|516053041|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
143138213|NCT01791595|516053042|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
143138214|NCT01791595|516053043|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
143138215|NCT01791595|516053044|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
143138216|NCT01791595|516053038|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
143138217|NCT01791595|516053039|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
143138218|NCT01791595|516053040|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
143138219|NCT01791595|516053041|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
143138220|NCT01791595|516053042|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
143138221|NCT01791595|516053043|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
143138222|NCT01791595|516053044|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
143138223|NCT01791595|516053038|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
143138224|NCT01791595|516053039|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
143138225|NCT01791595|516053040|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
143138226|NCT01791595|516053041|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
143138227|NCT01791595|516053042|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
143138228|NCT01791595|516053043|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
143138229|NCT01791595|516053044|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
143138230|NCT01791595|516053038|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
143138231|NCT01791595|516053039|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
143138232|NCT01791595|516053040|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
143138233|NCT01791595|516053041|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
143138234|NCT01791595|516053042|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
143138235|NCT01791595|516053043|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
143138236|NCT01791595|516053044|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
143138237|NCT01791595|516053038|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
143138238|NCT01791595|516053039|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
143138239|NCT01791595|516053040|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
143138240|NCT01791595|516053041|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
143138241|NCT01791595|516053042|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
143138242|NCT01791595|516053043|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
143138243|NCT01791595|516053044|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
143138244|NCT01791595|516053038|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
143138245|NCT01791595|516053039|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
143138246|NCT01791595|516053040|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
143361887|NCT01244763|516867197|FG002|Overall Study|Lost to Follow-up|0|||
143361888|NCT01244763|516867198|FG003|Overall Study|Lost to Follow-up|0|||
143361889|NCT01244763|516867199|FG004|Overall Study|Lost to Follow-up|0|||
143361890|NCT01244763|516867200|FG005|Overall Study|Lost to Follow-up|0|||
143361891|NCT01244763|516867195|FG000|Overall Study|Enrolled into the Extension Study|0|||
143361892|NCT01244763|516867196|FG001|Overall Study|Enrolled into the Extension Study|0|||
143361893|NCT01244763|516867197|FG002|Overall Study|Enrolled into the Extension Study|0|||
143361894|NCT01244763|516867198|FG003|Overall Study|Enrolled into the Extension Study|0|||
143361895|NCT01244763|516867199|FG004|Overall Study|Enrolled into the Extension Study|0|||
143472696|NCT01003990|517277033|FG000|Overall Study|Reasons Not Identified|14|||
143138247|NCT01791595|516053041|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
143138248|NCT01791595|516053042|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
143138249|NCT01791595|516053043|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
143138250|NCT01791595|516053044|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
143138251|NCT01791595|516053038|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
143138252|NCT01791595|516053039|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
143138253|NCT01791595|516053040|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
143138254|NCT01791595|516053041|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
143138255|NCT01791595|516053042|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
143138256|NCT01791595|516053043|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
143138257|NCT01791595|516053044|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
143138258|NCT01791595|516053038|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
143138259|NCT01791595|516053039|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
143138260|NCT01791595|516053040|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
143138261|NCT01791595|516053041|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
143138262|NCT01791595|516053042|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
143138263|NCT01791595|516053043|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
143138264|NCT01791595|516053044|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
143138265|NCT03118934|516053045|FG000|Overall Study|Adverse Event|0|||
143138266|NCT03118934|516053046|FG001|Overall Study|Adverse Event|0|||
143138267|NCT03118934|516053047|FG002|Overall Study|Adverse Event|0|||
143138268|NCT03118934|516053048|FG003|Overall Study|Adverse Event|0|||
143138269|NCT03118934|516053049|FG004|Overall Study|Adverse Event|0|||
143138270|NCT03118934|516053050|FG005|Overall Study|Adverse Event|1|||
143138271|NCT03118934|516053045|FG000|Overall Study|Physician Decision|0|||
143138272|NCT03118934|516053046|FG001|Overall Study|Physician Decision|0|||
143138273|NCT03118934|516053047|FG002|Overall Study|Physician Decision|0|||
143138274|NCT03118934|516053048|FG003|Overall Study|Physician Decision|0|||
143138275|NCT03118934|516053049|FG004|Overall Study|Physician Decision|0|||
143138276|NCT03118934|516053050|FG005|Overall Study|Physician Decision|1|||
143138277|NCT03118934|516053045|FG000|Overall Study|Discontinued prior to exposure|0|||
143138278|NCT03118934|516053046|FG001|Overall Study|Discontinued prior to exposure|1|||
143138279|NCT03118934|516053047|FG002|Overall Study|Discontinued prior to exposure|1|||
143138280|NCT03118934|516053048|FG003|Overall Study|Discontinued prior to exposure|1|||
143138281|NCT03118934|516053049|FG004|Overall Study|Discontinued prior to exposure|2|||
143138282|NCT03118934|516053050|FG005|Overall Study|Discontinued prior to exposure|0|||
143138283|NCT03080935|516053051|FG000|Overall Study|Death|34|||
143138284|NCT03080935|516053052|FG001|Overall Study|Death|50|||
143138285|NCT03080935|516053051|FG000|Overall Study|Lost to Follow-up|5|||
143138286|NCT03080935|516053052|FG001|Overall Study|Lost to Follow-up|4|||
143138287|NCT03080935|516053051|FG000|Overall Study|Withdrawal by Subject|11|||
143138288|NCT03080935|516053052|FG001|Overall Study|Withdrawal by Subject|15|||
143138289|NCT02175121|516053063|FG000|Overall Study|Lack of Efficacy|1|||
143138290|NCT02175121|516053064|FG001|Overall Study|Lack of Efficacy|0|||
143138291|NCT02175121|516053065|FG002|Overall Study|Lack of Efficacy|0|||
143138292|NCT02175121|516053066|FG003|Overall Study|Lack of Efficacy|0|||
143138293|NCT02175121|516053067|FG004|Overall Study|Lack of Efficacy|0|||
143138294|NCT02175121|516053063|FG000|Overall Study|Lost to Follow-up|0|||
143138295|NCT02175121|516053064|FG001|Overall Study|Lost to Follow-up|1|||
143138296|NCT02175121|516053065|FG002|Overall Study|Lost to Follow-up|0|||
143138297|NCT02175121|516053066|FG003|Overall Study|Lost to Follow-up|1|||
143138298|NCT02175121|516053067|FG004|Overall Study|Lost to Follow-up|0|||
143138299|NCT02175121|516053063|FG000|Overall Study|Personal emergency|0|||
143138300|NCT02175121|516053064|FG001|Overall Study|Personal emergency|0|||
143138301|NCT02175121|516053065|FG002|Overall Study|Personal emergency|0|||
143138302|NCT02175121|516053066|FG003|Overall Study|Personal emergency|0|||
143138303|NCT02175121|516053067|FG004|Overall Study|Personal emergency|1|||
143138304|NCT02175121|516053063|FG000|Overall Study|Schedule conflict|0|||
143361896|NCT01244763|516867200|FG005|Overall Study|Enrolled into the Extension Study|1|||
143361897|NCT02459964|516867204|FG000|Overall Study|Withdrawal by Subject|0|||
143361898|NCT02459964|516867205|FG001|Overall Study|Withdrawal by Subject|0|||
143361899|NCT02459964|516867206|FG002|Overall Study|Withdrawal by Subject|1|||
143361900|NCT02459964|516867204|FG000|Overall Study|Abnormal EKG changes|0|||
143361901|NCT02459964|516867205|FG001|Overall Study|Abnormal EKG changes|0|||
143361902|NCT02459964|516867206|FG002|Overall Study|Abnormal EKG changes|1|||
143361903|NCT01175707|516867207|FG000|Overall Study|Adverse Event|4|||
143361904|NCT01175707|516867208|FG001|Overall Study|Adverse Event|6|||
143138305|NCT02175121|516053064|FG001|Overall Study|Schedule conflict|0|||
143138306|NCT02175121|516053065|FG002|Overall Study|Schedule conflict|1|||
143138307|NCT02175121|516053066|FG003|Overall Study|Schedule conflict|0|||
143138308|NCT02175121|516053067|FG004|Overall Study|Schedule conflict|0|||
143138309|NCT02175121|516053063|FG000|Overall Study|Time issues|0|||
143138310|NCT02175121|516053064|FG001|Overall Study|Time issues|0|||
143138311|NCT02175121|516053065|FG002|Overall Study|Time issues|1|||
143138312|NCT02175121|516053066|FG003|Overall Study|Time issues|0|||
143138313|NCT02175121|516053067|FG004|Overall Study|Time issues|0|||
143138314|NCT00249834|516053068|FG000|Overall Study|Ovarian stimulation failed|1|||
143138315|NCT00249834|516053069|FG001|Overall Study|Ovarian stimulation failed|0|||
143138316|NCT00249834|516053070|FG002|Overall Study|Ovarian stimulation failed|0|||
143138317|NCT00249834|516053071|FG003|Overall Study|Ovarian stimulation failed|0|||
143138318|NCT00249834|516053072|FG004|Overall Study|Ovarian stimulation failed|0|||
143138319|NCT00249834|516053073|FG005|Overall Study|Ovarian stimulation failed|0|||
143138320|NCT00249834|516053074|FG006|Overall Study|Ovarian stimulation failed|0|||
143138321|NCT00249834|516053075|FG007|Overall Study|Ovarian stimulation failed|0|||
143138322|NCT00249834|516053068|FG000|Overall Study|Failure of down-regulation|0|||
143138323|NCT00249834|516053069|FG001|Overall Study|Failure of down-regulation|0|||
143138324|NCT00249834|516053070|FG002|Overall Study|Failure of down-regulation|0|||
143138325|NCT00249834|516053071|FG003|Overall Study|Failure of down-regulation|0|||
143138326|NCT00249834|516053072|FG004|Overall Study|Failure of down-regulation|0|||
143138327|NCT00249834|516053073|FG005|Overall Study|Failure of down-regulation|0|||
143138328|NCT00249834|516053074|FG006|Overall Study|Failure of down-regulation|1|||
143138329|NCT00249834|516053075|FG007|Overall Study|Failure of down-regulation|0|||
143138330|NCT00249834|516053068|FG000|Overall Study|Protocol Violation|0|||
143138331|NCT00249834|516053069|FG001|Overall Study|Protocol Violation|19|||
143138332|NCT00249834|516053070|FG002|Overall Study|Protocol Violation|14|||
143138333|NCT00249834|516053071|FG003|Overall Study|Protocol Violation|8|||
143138334|NCT00249834|516053072|FG004|Overall Study|Protocol Violation|5|||
143138335|NCT00249834|516053073|FG005|Overall Study|Protocol Violation|2|||
143138336|NCT00249834|516053074|FG006|Overall Study|Protocol Violation|0|||
143138337|NCT00249834|516053075|FG007|Overall Study|Protocol Violation|0|||
143138338|NCT02027025|516053081|FG000|Overall Study|Adverse Event|0|||
143138339|NCT02027025|516053082|FG001|Overall Study|Adverse Event|1|||
143138340|NCT02027025|516053083|FG002|Overall Study|Adverse Event|1|||
143138341|NCT02027025|516053081|FG000|Overall Study|Protocol Violation|1|||
143138342|NCT02027025|516053082|FG001|Overall Study|Protocol Violation|0|||
143138343|NCT02027025|516053083|FG002|Overall Study|Protocol Violation|0|||
143138344|NCT02027025|516053081|FG000|Overall Study|Lost to Follow-up|0|||
143138345|NCT02027025|516053082|FG001|Overall Study|Lost to Follow-up|2|||
143138346|NCT02027025|516053083|FG002|Overall Study|Lost to Follow-up|0|||
143138347|NCT02027025|516053081|FG000|Overall Study|Withdrawal by Subject|0|||
143138348|NCT02027025|516053082|FG001|Overall Study|Withdrawal by Subject|1|||
143138349|NCT02027025|516053083|FG002|Overall Study|Withdrawal by Subject|0|||
143138350|NCT02027025|516053081|FG000|Overall Study|Sponsor's decision|0|||
143138351|NCT02027025|516053082|FG001|Overall Study|Sponsor's decision|1|||
143138352|NCT02027025|516053083|FG002|Overall Study|Sponsor's decision|0|||
143138353|NCT03886272|516053086|FG000|Period 1|Withdrawal by Subject|0|||
143138354|NCT03886272|516053087|FG001|Period 1|Withdrawal by Subject|0|||
143138355|NCT03886272|516053088|FG002|Period 1|Withdrawal by Subject|0|||
143138356|NCT03886272|516053089|FG003|Period 1|Withdrawal by Subject|0|||
143138357|NCT03886272|516053090|FG004|Period 1|Withdrawal by Subject|0|||
143138358|NCT03886272|516053091|FG005|Period 1|Withdrawal by Subject|1|||
143138359|NCT03886272|516053092|FG006|Period 1|Withdrawal by Subject|0|||
143138360|NCT02895347|516053095|FG000|Overall Study|Withdrawal by Subject|3|||
143138361|NCT02895347|516053096|FG001|Overall Study|Withdrawal by Subject|1|||
143138362|NCT03177148|516053100|FG000|Overall Study|Lost to Follow-up|50|||
143138363|NCT03177148|516053101|FG001|Overall Study|Lost to Follow-up|1|||
143138364|NCT03177148|516053100|FG000|Overall Study|Death|1|||
143138365|NCT03177148|516053101|FG001|Overall Study|Death|0|||
143138366|NCT02848664|516053102|FG000|Overall Study|Withdrawal by Subject|2|||
143138367|NCT02848664|516053102|FG000|Overall Study|Adverse Event|1|||
143138368|NCT02848664|516053102|FG000|Overall Study|no assistance for device training|1|||
143138369|NCT00732069|516053103|FG000|Washout After First Study Drug|Adverse Event|1|||
143138370|NCT00732069|516053104|FG001|Washout After First Study Drug|Adverse Event|0|||
143361905|NCT00751790|516867212|FG000|Overall Study|Lost to Follow-up|1|||
143361906|NCT00751790|516867212|FG000|Overall Study|Death|3|||
143361907|NCT00751790|516867212|FG000|Overall Study|Withdrawal by Subject|1|||
143361908|NCT00180674|516867215|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
143361909|NCT00180674|516867215|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
143361910|NCT04170023|516867216|FG000|LTE Period|Withdrawal by Subject|1|||
143361911|NCT04170023|516867217|FG001|LTE Period|Withdrawal by Subject|0|||
143361912|NCT04170023|516867218|FG002|LTE Period|Withdrawal by Subject|0|||
143361913|NCT04170023|516867216|FG000|LTE Period|Study Termination|11|||
143361914|NCT04170023|516867217|FG001|LTE Period|Study Termination|11|||
143138371|NCT00732069|516053105|FG002|Washout After First Study Drug|Adverse Event|0|||
143138372|NCT00732069|516053106|FG003|Washout After First Study Drug|Adverse Event|0|||
143138373|NCT00732069|516053107|FG004|Washout After First Study Drug|Adverse Event|0|||
143138374|NCT00732069|516053108|FG005|Washout After First Study Drug|Adverse Event|0|||
143138375|NCT00402727|516053109|FG000|Overall Study|Adverse Event|10|||
143138376|NCT00402727|516053110|FG001|Overall Study|Adverse Event|6|||
143138377|NCT00402727|516053109|FG000|Overall Study|Death|1|||
143138378|NCT00402727|516053110|FG001|Overall Study|Death|0|||
143138379|NCT00402727|516053109|FG000|Overall Study|Lack of Efficacy|1|||
143472697|NCT01003990|517277034|FG001|Overall Study|Reasons Not Identified|13|||
143472698|NCT01003990|517277035|FG002|Overall Study|Reasons Not Identified|8|||
143472699|NCT01003990|517277033|FG000|Overall Study|Poor/Non-compliance|4|||
143472700|NCT01003990|517277034|FG001|Overall Study|Poor/Non-compliance|3|||
143472701|NCT01003990|517277035|FG002|Overall Study|Poor/Non-compliance|2|||
143472702|NCT01003990|517277033|FG000|Overall Study|Pregnancy|10|||
143472703|NCT01003990|517277034|FG001|Overall Study|Pregnancy|2|||
143472704|NCT01003990|517277035|FG002|Overall Study|Pregnancy|4|||
143138380|NCT00402727|516053110|FG001|Overall Study|Lack of Efficacy|3|||
143138381|NCT00402727|516053109|FG000|Overall Study|Lost to Follow-up|24|||
143138382|NCT00402727|516053110|FG001|Overall Study|Lost to Follow-up|11|||
143138383|NCT00402727|516053109|FG000|Overall Study|Physician Decision|1|||
143138384|NCT00402727|516053110|FG001|Overall Study|Physician Decision|1|||
143138385|NCT00402727|516053109|FG000|Overall Study|Protocol Violation|0|||
143138386|NCT00402727|516053110|FG001|Overall Study|Protocol Violation|4|||
143138387|NCT00402727|516053109|FG000|Overall Study|Withdrawal by Subject|3|||
143138388|NCT00402727|516053110|FG001|Overall Study|Withdrawal by Subject|7|||
143138389|NCT00402727|516053109|FG000|Overall Study|supply problems|2|||
143138390|NCT00402727|516053110|FG001|Overall Study|supply problems|1|||
143138391|NCT00402727|516053109|FG000|Overall Study|non-compliance|0|||
143138392|NCT00402727|516053110|FG001|Overall Study|non-compliance|1|||
143138393|NCT01405898|516053112|FG000|Overall Study|Withdrawal by Subject|2|||
143138394|NCT01405898|516053113|FG001|Overall Study|Withdrawal by Subject|2|||
143138395|NCT01687218|516053115|FG000|Overall Study|Withdrawal by Subject|2|||
143138396|NCT01687218|516053116|FG001|Overall Study|Withdrawal by Subject|3|||
143138397|NCT01687218|516053117|FG002|Overall Study|Withdrawal by Subject|0|||
143138398|NCT01687218|516053118|FG003|Overall Study|Withdrawal by Subject|1|||
143138399|NCT01687218|516053119|FG004|Overall Study|Withdrawal by Subject|1|||
143138400|NCT01687218|516053120|FG005|Overall Study|Withdrawal by Subject|0|||
143138401|NCT01687218|516053115|FG000|Overall Study|Relocated, no follow-up planned|1|||
143138402|NCT01687218|516053116|FG001|Overall Study|Relocated, no follow-up planned|0|||
143138403|NCT01687218|516053117|FG002|Overall Study|Relocated, no follow-up planned|1|||
143138404|NCT01687218|516053118|FG003|Overall Study|Relocated, no follow-up planned|1|||
143138405|NCT01687218|516053119|FG004|Overall Study|Relocated, no follow-up planned|0|||
143138406|NCT01687218|516053120|FG005|Overall Study|Relocated, no follow-up planned|0|||
143138407|NCT00875810|516053127|FG000|Overall Study|Withdrawal by Subject|1|||
143138408|NCT00875810|516053127|FG000|Overall Study|Physician Decision|3|||
143138409|NCT00875810|516053127|FG000|Overall Study|Lost to Follow-up|39|||
143138410|NCT00875810|516053127|FG000|Overall Study|Patient enroled but not implanted|2|||
143138411|NCT00875810|516053127|FG000|Overall Study|Device explanted|1|||
143138412|NCT02563899|516053130|FG000|Overall Study|Protocol Violation|1|||
143138413|NCT02563899|516053131|FG001|Overall Study|Protocol Violation|0|||
143138414|NCT02563899|516053132|FG002|Overall Study|Protocol Violation|0|||
143138415|NCT02563899|516053133|FG003|Overall Study|Protocol Violation|0|||
143138416|NCT02563899|516053130|FG000|Overall Study|Withdrawal by Subject|0|||
143138417|NCT02563899|516053131|FG001|Overall Study|Withdrawal by Subject|0|||
143138418|NCT02563899|516053132|FG002|Overall Study|Withdrawal by Subject|1|||
143138419|NCT02563899|516053133|FG003|Overall Study|Withdrawal by Subject|0|||
143138420|NCT02008526|516053134|FG000|Overall Study|Death|0|||
143138421|NCT02008526|516053135|FG001|Overall Study|Death|2|||
143138422|NCT02008526|516053136|FG002|Overall Study|Death|1|||
143138423|NCT02008526|516053134|FG000|Overall Study|Withdrawal by Subject|3|||
143138424|NCT02008526|516053135|FG001|Overall Study|Withdrawal by Subject|3|||
143138425|NCT02008526|516053136|FG002|Overall Study|Withdrawal by Subject|2|||
143138426|NCT02008526|516053134|FG000|Overall Study|Lost to Follow-up|5|||
143138427|NCT02008526|516053135|FG001|Overall Study|Lost to Follow-up|9|||
143138428|NCT02008526|516053136|FG002|Overall Study|Lost to Follow-up|6|||
143138429|NCT01814007|516053146|FG000|Overall Study|Withdrawal by Subject|1|||
143138430|NCT02873689|516054680|FG000|Overall Study|Lack of Efficacy|1|||
143138431|NCT02873689|516054681|FG001|Overall Study|Lack of Efficacy|0|||
143138432|NCT02873689|516054680|FG000|Overall Study|Withdrawal by Subject|2|||
143138433|NCT02873689|516054681|FG001|Overall Study|Withdrawal by Subject|2|||
143138434|NCT02873689|516054680|FG000|Overall Study|Protocol Violation|1|||
143138435|NCT02873689|516054681|FG001|Overall Study|Protocol Violation|0|||
143138436|NCT02873689|516054680|FG000|Overall Study|Adverse Event|2|||
143138437|NCT02873689|516054681|FG001|Overall Study|Adverse Event|2|||
143138438|NCT02873689|516054680|FG000|Overall Study|Randomized but not Treated|1|||
143138439|NCT02873689|516054681|FG001|Overall Study|Randomized but not Treated|1|||
143138440|NCT02997163|516054686|FG000|Overall Study|Adverse Event|1|||
143472705|NCT01003990|517277033|FG000|Overall Study|No Longer Met Study Criteria|4|||
143472706|NCT01003990|517277034|FG001|Overall Study|No Longer Met Study Criteria|1|||
143472707|NCT01003990|517277035|FG002|Overall Study|No Longer Met Study Criteria|0|||
143138441|NCT02997163|516054687|FG001|Overall Study|Adverse Event|0|||
143138442|NCT02997163|516054688|FG002|Overall Study|Adverse Event|0|||
143472708|NCT01003990|517277033|FG000|Overall Study|Subject Withdrew Consent|12|||
143472709|NCT01003990|517277034|FG001|Overall Study|Subject Withdrew Consent|5|||
143138443|NCT02997163|516054689|FG003|Overall Study|Adverse Event|1|||
143472710|NCT01003990|517277035|FG002|Overall Study|Subject Withdrew Consent|7|||
143138444|NCT02337764|516054690|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
143138445|NCT02337764|516054690|FG000|Overall Study|Voluntary Withdrawal|12|||
143138446|NCT02337764|516054690|FG000|Overall Study|Lack of Efficacy|2|||
143138447|NCT03630393|516054691|FG000|Overall Study|Death|1|||
143138448|NCT03630393|516054692|FG001|Overall Study|Death|0|||
143138449|NCT00408499|516054693|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
143138450|NCT00408499|516054694|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
143138451|NCT00408499|516054695|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
143138452|NCT00408499|516054696|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
143138453|NCT00408499|516054697|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
143138454|NCT00408499|516054693|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
143138455|NCT00408499|516054694|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
143138456|NCT00408499|516054695|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
143138457|NCT00408499|516054696|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
143138458|NCT00408499|516054697|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
143138459|NCT00408499|516054693|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
143138460|NCT00408499|516054694|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
143138461|NCT00408499|516054695|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
143138462|NCT00408499|516054696|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
143138463|NCT00408499|516054697|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
143138464|NCT00408499|516054693|FG000|Phase II- MTD Expansion|Adverse Event|0|||
143138465|NCT00408499|516054694|FG001|Phase II- MTD Expansion|Adverse Event|0|||
143138466|NCT00408499|516054695|FG002|Phase II- MTD Expansion|Adverse Event|0|||
143138467|NCT00408499|516054696|FG003|Phase II- MTD Expansion|Adverse Event|0|||
143138468|NCT00408499|516054697|FG004|Phase II- MTD Expansion|Adverse Event|9|||
143138469|NCT00408499|516054693|FG000|Phase II- MTD Expansion|Death|0|||
143138470|NCT00408499|516054694|FG001|Phase II- MTD Expansion|Death|0|||
143138471|NCT00408499|516054695|FG002|Phase II- MTD Expansion|Death|0|||
143138472|NCT00408499|516054696|FG003|Phase II- MTD Expansion|Death|0|||
143138473|NCT00408499|516054697|FG004|Phase II- MTD Expansion|Death|2|||
143138474|NCT00408499|516054693|FG000|Phase II- MTD Expansion|Physician Decision|0|||
143138475|NCT00408499|516054694|FG001|Phase II- MTD Expansion|Physician Decision|0|||
143138476|NCT00408499|516054695|FG002|Phase II- MTD Expansion|Physician Decision|0|||
143138477|NCT00408499|516054696|FG003|Phase II- MTD Expansion|Physician Decision|0|||
143138478|NCT00408499|516054697|FG004|Phase II- MTD Expansion|Physician Decision|1|||
143138479|NCT00408499|516054693|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
143138480|NCT00408499|516054694|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
143138481|NCT00408499|516054695|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
143138482|NCT00408499|516054696|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
143138483|NCT00408499|516054697|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
143138484|NCT00408499|516054693|FG000|Phase II- MTD Expansion|treatment delay|0|||
143138485|NCT00408499|516054694|FG001|Phase II- MTD Expansion|treatment delay|0|||
143138486|NCT00408499|516054695|FG002|Phase II- MTD Expansion|treatment delay|0|||
143138487|NCT00408499|516054696|FG003|Phase II- MTD Expansion|treatment delay|0|||
143138488|NCT00408499|516054697|FG004|Phase II- MTD Expansion|treatment delay|3|||
143138489|NCT01586195|516054699|FG000|Overall Study|Death|11|||
143138490|NCT01586195|516054699|FG000|Overall Study|Withdrawal of Consent|5|||
143138491|NCT01586195|516054699|FG000|Overall Study|Started new anti-melanoma therapy|1|||
143138492|NCT01586195|516054699|FG000|Overall Study|Reason not specified|9|||
143138493|NCT00975416|516054700|FG000|Overall Study|early discharge from tx|3|||
143138494|NCT00975416|516054701|FG001|Overall Study|early discharge from tx|5|||
143138495|NCT02497469|516054706|FG000|Overall Study|Randomized but not Treated|0|||
143138496|NCT02497469|516054707|FG001|Overall Study|Randomized but not Treated|2|||
143138497|NCT02497469|516054706|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
143138498|NCT02497469|516054707|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
143138499|NCT02497469|516054706|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
143138500|NCT02497469|516054707|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
143138501|NCT02497469|516054706|FG000|Overall Study|Significant Protocol Deviation|4|||
143138502|NCT02497469|516054707|FG001|Overall Study|Significant Protocol Deviation|5|||
143138503|NCT02497469|516054706|FG000|Overall Study|Lost to Follow-up|14|||
143138504|NCT02497469|516054707|FG001|Overall Study|Lost to Follow-up|4|||
143138505|NCT02497469|516054706|FG000|Overall Study|Voluntary Withdrawal|39|||
143138506|NCT02497469|516054707|FG001|Overall Study|Voluntary Withdrawal|41|||
143138507|NCT02497469|516054706|FG000|Overall Study|Pregnancy|1|||
143138508|NCT02497469|516054707|FG001|Overall Study|Pregnancy|1|||
143138509|NCT02497469|516054706|FG000|Overall Study|Lack of Efficacy|86|||
143361915|NCT04170023|516867218|FG002|LTE Period|Study Termination|5|||
143361916|NCT03836664|516867223|FG000|Overall Study|Didn't complete forms and lost drug|3|||
143361917|NCT03836664|516867224|FG001|Overall Study|Didn't complete forms and lost drug|3|||
143361918|NCT03566680|516867225|FG000|Overall Study|Pregnancy|1|||
143361919|NCT03566680|516867225|FG000|Overall Study|Lost to Follow-up|13|||
143361920|NCT03566680|516867225|FG000|Overall Study|Withdrawal by Subject|3|||
143361921|NCT04337489|516867226|FG000|Overall Study|Withdrawal by Subject|1|||
143472711|NCT01271803|517277036|FG000|Overall Study|Progressive disease|0|||
143472712|NCT01271803|517277037|FG001|Overall Study|Progressive disease|0|||
143138510|NCT02497469|516054707|FG001|Overall Study|Lack of Efficacy|40|||
143138511|NCT02497469|516054706|FG000|Overall Study|Reason not Specified|6|||
143138512|NCT02497469|516054707|FG001|Overall Study|Reason not Specified|6|||
143138513|NCT03558516|516054708|FG000|Overall Study|Protocol Violation|2|||
143138514|NCT03558516|516054709|FG001|Overall Study|Protocol Violation|2|||
143138515|NCT00472420|516054710|FG000|Induction Treatment Period|Physician Decision|9|||
143138516|NCT00472420|516054710|FG000|Induction Treatment Period|Adverse Event|3|||
143138517|NCT00472420|516054710|FG000|Induction Treatment Period|Non-compliance|1|||
143138518|NCT00472420|516054710|FG000|Induction Treatment Period|Death|3|||
143138519|NCT00472420|516054710|FG000|Follow-up Period|Death|5|||
143138520|NCT00472420|516054710|FG000|Follow-up Period|Physician Decision|9|||
143138521|NCT00472420|516054710|FG000|Follow-up Period|Lost to Follow-up|2|||
143138522|NCT00472420|516054710|FG000|Follow-up Period|Protocol Violation|1|||
143138523|NCT01026493|516054713|FG000|Overall Study|Protocol Violation|0|||
143138524|NCT01026493|516054714|FG001|Overall Study|Protocol Violation|1|||
143138525|NCT01026493|516054715|FG002|Overall Study|Protocol Violation|0|||
143138526|NCT01026493|516054716|FG003|Overall Study|Protocol Violation|0|||
143138527|NCT01026493|516054717|FG004|Overall Study|Protocol Violation|2|||
143138528|NCT01026493|516054718|FG005|Overall Study|Protocol Violation|3|||
143138529|NCT01026493|516054719|FG006|Overall Study|Protocol Violation|4|||
143138530|NCT01026493|516054720|FG007|Overall Study|Protocol Violation|1|||
143138531|NCT02662569|516054721|FG000|Overall Study|Withdrawal by Subject|6|||
143138532|NCT02662569|516054722|FG001|Overall Study|Withdrawal by Subject|1|||
143138533|NCT02662569|516054723|FG002|Overall Study|Withdrawal by Subject|6|||
143138534|NCT02662569|516054724|FG003|Overall Study|Withdrawal by Subject|4|||
143138535|NCT02662569|516054721|FG000|Overall Study|Lost to Follow-up|1|||
143138536|NCT02662569|516054722|FG001|Overall Study|Lost to Follow-up|0|||
143138537|NCT02662569|516054723|FG002|Overall Study|Lost to Follow-up|0|||
143138538|NCT02662569|516054724|FG003|Overall Study|Lost to Follow-up|0|||
143138539|NCT04076917|516054727|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
143138540|NCT04076917|516054727|FG000|Overall Study|Study closure|13|||
143138541|NCT04076917|516054727|FG000|Overall Study|Physician Decision|3|||
143138542|NCT04076917|516054727|FG000|Overall Study|Death|1|||
143138543|NCT04076917|516054727|FG000|Overall Study|Lost to Follow-up|1|||
143138544|NCT04076917|516054727|FG000|Overall Study|Withdrawal by Subject|1|||
143138545|NCT04076917|516054727|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
143138546|NCT01774591|516054730|FG000|Overall Study|Physician Decision|1|||
143138547|NCT01774591|516054731|FG001|Overall Study|Physician Decision|1|||
143138548|NCT01774591|516054730|FG000|Overall Study|Withdrawal by Subject|0|||
143138549|NCT01774591|516054731|FG001|Overall Study|Withdrawal by Subject|1|||
143138550|NCT01774591|516054730|FG000|Overall Study|Adverse Event|0|||
143138551|NCT01774591|516054731|FG001|Overall Study|Adverse Event|2|||
143138552|NCT02666222|516054734|FG000|Overall Study|Death|2|||
143138553|NCT00630916|516054735|FG000|Overall Study|Death|110|||
143138554|NCT00630916|516054735|FG000|Overall Study|Explant|8|||
143138555|NCT00630916|516054735|FG000|Overall Study|Lost to Follow-up|5|||
143138556|NCT00630916|516054735|FG000|Overall Study|Withdrawal by Subject|30|||
143138557|NCT00630916|516054735|FG000|Overall Study|Protocol Violation|7|||
143138558|NCT00630916|516054735|FG000|Overall Study|Physician Decision|47|||
143138559|NCT00630916|516054735|FG000|Overall Study|Lack of Efficacy|3|||
143138560|NCT01474486|516054739|FG000|Overall Study|Death|2|||
143138561|NCT01474486|516054739|FG000|Overall Study|Withdrawal by Subject|4|||
143138562|NCT01474486|516054739|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
143138563|NCT02295644|516054741|FG000|Overall Study|Did not meet inclusion criterion|0|||
143138564|NCT02295644|516054742|FG001|Overall Study|Did not meet inclusion criterion|0|||
143138565|NCT02295644|516054743|FG002|Overall Study|Did not meet inclusion criterion|1|||
143138566|NCT02295644|516054744|FG003|Overall Study|Did not meet inclusion criterion|2|||
143138567|NCT04219189|516054745|FG000|Overall Study|Withdrawal by Subject|1|||
143138568|NCT04219189|516054746|FG001|Overall Study|Withdrawal by Subject|2|||
143138569|NCT04219189|516054745|FG000|Overall Study|Protocol Violation|0|||
143138570|NCT04219189|516054746|FG001|Overall Study|Protocol Violation|1|||
143138571|NCT04219189|516054745|FG000|Overall Study|Lost to Follow-up|0|||
143138572|NCT04219189|516054746|FG001|Overall Study|Lost to Follow-up|1|||
143138573|NCT04219189|516054745|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
143138574|NCT04219189|516054746|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
143138575|NCT03863353|516054747|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
143138576|NCT03863353|516054748|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
143138577|NCT01299584|516054749|FG000|Overall Study|Protocol Violation|9|||
143138578|NCT00324155|516054753|FG000|Enrolled and Randomized|No longer met study criteria|3|||
143138579|NCT00324155|516054754|FG001|Enrolled and Randomized|No longer met study criteria|0|||
143138580|NCT00324155|516054753|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
143138581|NCT00324155|516054754|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
143138582|NCT00324155|516054753|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
143138583|NCT00324155|516054754|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
143138584|NCT00324155|516054753|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
143138585|NCT00324155|516054754|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
143138586|NCT00324155|516054753|FG000|Received Treatment in Induction Phase|Death|8|||
143138587|NCT00324155|516054754|FG001|Received Treatment in Induction Phase|Death|15|||
143138588|NCT00324155|516054753|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
143138589|NCT00324155|516054754|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
143138590|NCT00324155|516054753|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
143138591|NCT00324155|516054754|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
143138592|NCT00324155|516054753|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
143138593|NCT00324155|516054754|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
143138594|NCT00324155|516054753|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
143138595|NCT00324155|516054754|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
143138596|NCT00324155|516054753|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
143138597|NCT00324155|516054754|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
143138598|NCT00324155|516054753|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
143138599|NCT00324155|516054754|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
143138600|NCT00324155|516054753|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
143138601|NCT00324155|516054754|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
143138602|NCT00324155|516054753|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
143138603|NCT00324155|516054754|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
143138604|NCT00324155|516054753|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
143138605|NCT00324155|516054754|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
143138606|NCT00324155|516054753|FG000|Follow-up Phase|On-going participants still on drug|11|||
143138607|NCT00324155|516054754|FG001|Follow-up Phase|On-going participants still on drug|6|||
143138608|NCT01924533|516054755|FG000|Overall Study|Death|181|||
143138609|NCT01924533|516054756|FG001|Overall Study|Death|200|||
143138610|NCT01924533|516054755|FG000|Overall Study|Lost to Follow-up|0|||
143138611|NCT01924533|516054756|FG001|Overall Study|Lost to Follow-up|1|||
143138612|NCT01924533|516054755|FG000|Overall Study|Withdrawal by Subject|7|||
143138613|NCT01924533|516054756|FG001|Overall Study|Withdrawal by Subject|3|||
143138614|NCT01924533|516054755|FG000|Overall Study|Other Eligibility criteria|1|||
143138615|NCT01924533|516054756|FG001|Overall Study|Other Eligibility criteria|1|||
143138616|NCT04233879|516054757|FG000|Overall Study|Death|2|||
143138617|NCT04233879|516054758|FG001|Overall Study|Death|0|||
143138618|NCT04233879|516054757|FG000|Overall Study|Lost to Follow-up|3|||
143138619|NCT04233879|516054758|FG001|Overall Study|Lost to Follow-up|8|||
143138620|NCT04233879|516054757|FG000|Overall Study|Physician Decision|4|||
143138621|NCT04233879|516054758|FG001|Overall Study|Physician Decision|4|||
143138622|NCT04233879|516054757|FG000|Overall Study|Withdrawal by Subject|7|||
143138623|NCT04233879|516054758|FG001|Overall Study|Withdrawal by Subject|10|||
143138624|NCT04233879|516054757|FG000|Overall Study|Other|281|||
143138625|NCT04233879|516054758|FG001|Overall Study|Other|279|||
143138626|NCT03292016|516054759|FG000|Second Washout|Adverse Event|0|||
143138627|NCT03292016|516054760|FG001|Second Washout|Adverse Event|1|||
143138628|NCT03292016|516054761|FG002|Second Washout|Adverse Event|0|||
143138629|NCT03292016|516054762|FG003|Second Washout|Adverse Event|0|||
143138630|NCT03292016|516054763|FG004|Second Washout|Adverse Event|0|||
143138631|NCT03292016|516054764|FG005|Second Washout|Adverse Event|0|||
143138632|NCT03810183|516054765|FG000|Overall Study|Study terminated by Sponsor|2|||
143138633|NCT03810183|516054766|FG001|Overall Study|Study terminated by Sponsor|1|||
143138634|NCT00323063|516054768|FG000|Overall Study|Adverse Event|1|||
143138635|NCT00323063|516054769|FG001|Overall Study|Adverse Event|0|||
143138636|NCT00323063|516054768|FG000|Overall Study|brain mets discovered prior to treatment|1|||
143138637|NCT00323063|516054769|FG001|Overall Study|brain mets discovered prior to treatment|0|||
143138638|NCT04275336|516054770|FG000|Overall Study|First venipuncture failed|4|||
143138639|NCT04275336|516054771|FG001|Overall Study|First venipuncture failed|6|||
143138640|NCT04275336|516054772|FG002|Overall Study|First venipuncture failed|5|||
143138641|NCT04275336|516054770|FG000|Overall Study|Unscheduled venipuncture|9|||
143138642|NCT04275336|516054771|FG001|Overall Study|Unscheduled venipuncture|13|||
143138643|NCT04275336|516054772|FG002|Overall Study|Unscheduled venipuncture|7|||
143138644|NCT04275336|516054770|FG000|Overall Study|Failed specimen of saliva|4|||
143138645|NCT04275336|516054771|FG001|Overall Study|Failed specimen of saliva|3|||
143361922|NCT04537949|516867229|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
143361923|NCT04537949|516867230|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
143361924|NCT04537949|516867231|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
143361925|NCT04537949|516867232|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
143361926|NCT04537949|516867233|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
143138646|NCT04275336|516054772|FG002|Overall Study|Failed specimen of saliva|4|||
143138647|NCT03786380|516054773|FG000|Overall Study|Adverse Event|1|||
143138648|NCT03786380|516054774|FG001|Overall Study|Adverse Event|0|||
143138649|NCT03786380|516054775|FG002|Overall Study|Adverse Event|0|||
143138650|NCT03786380|516054776|FG003|Overall Study|Adverse Event|3|||
143138651|NCT03786380|516054777|FG004|Overall Study|Adverse Event|1|||
143138652|NCT03786380|516054773|FG000|Overall Study|Lack of Efficacy|0|||
143138653|NCT03786380|516054774|FG001|Overall Study|Lack of Efficacy|0|||
143138654|NCT03786380|516054775|FG002|Overall Study|Lack of Efficacy|0|||
143138655|NCT03786380|516054776|FG003|Overall Study|Lack of Efficacy|0|||
143138656|NCT03786380|516054777|FG004|Overall Study|Lack of Efficacy|1|||
143138657|NCT03786380|516054773|FG000|Overall Study|Withdrawal by Subject|1|||
143138658|NCT03786380|516054774|FG001|Overall Study|Withdrawal by Subject|2|||
143138659|NCT03786380|516054775|FG002|Overall Study|Withdrawal by Subject|2|||
143138660|NCT03786380|516054776|FG003|Overall Study|Withdrawal by Subject|1|||
143138661|NCT03786380|516054777|FG004|Overall Study|Withdrawal by Subject|2|||
143138662|NCT03786380|516054773|FG000|Overall Study|Lost to Follow-up|3|||
143138663|NCT03786380|516054774|FG001|Overall Study|Lost to Follow-up|0|||
143138664|NCT03786380|516054775|FG002|Overall Study|Lost to Follow-up|1|||
143138665|NCT03786380|516054776|FG003|Overall Study|Lost to Follow-up|2|||
143138666|NCT03786380|516054777|FG004|Overall Study|Lost to Follow-up|0|||
143138667|NCT03786380|516054773|FG000|Overall Study|Physician Decision|0|||
143138668|NCT03786380|516054774|FG001|Overall Study|Physician Decision|0|||
143138669|NCT03786380|516054775|FG002|Overall Study|Physician Decision|1|||
143138670|NCT03786380|516054776|FG003|Overall Study|Physician Decision|0|||
143138671|NCT03786380|516054777|FG004|Overall Study|Physician Decision|0|||
143138672|NCT03786380|516054773|FG000|Overall Study|Study Terminated by the Sponsor|30|||
143138673|NCT03786380|516054774|FG001|Overall Study|Study Terminated by the Sponsor|20|||
143138674|NCT03786380|516054775|FG002|Overall Study|Study Terminated by the Sponsor|50|||
143138675|NCT03786380|516054776|FG003|Overall Study|Study Terminated by the Sponsor|57|||
143138676|NCT03786380|516054777|FG004|Overall Study|Study Terminated by the Sponsor|23|||
143138677|NCT03786380|516054773|FG000|Overall Study|Reason Not Specified|0|||
143138678|NCT03786380|516054774|FG001|Overall Study|Reason Not Specified|0|||
143138679|NCT03786380|516054775|FG002|Overall Study|Reason Not Specified|0|||
143138680|NCT03786380|516054776|FG003|Overall Study|Reason Not Specified|0|||
143138681|NCT03786380|516054777|FG004|Overall Study|Reason Not Specified|1|||
143138682|NCT05222880|516054784|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
143138683|NCT05222880|516054784|FG000|Overall Study|Withdrew Consent during Study|1|||
143138684|NCT05222880|516054784|FG000|Overall Study|COVID-19 Related|1|||
143138685|NCT03139552|516054801|FG000|Overall Study|unable to attend tasting due to schedule|3|||
143138686|NCT00887484|516054814|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
143138687|NCT00887484|516054814|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
143138688|NCT00887484|516054814|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
143138689|NCT03122171|516054820|FG000|Overall Study|Withdrawal by Subject|1|||
143138690|NCT03044314|516054821|FG000|Overall Study|Physician Decision|2|||
143138691|NCT03044314|516054821|FG000|Overall Study|Withdrawal by Subject|1|||
143138692|NCT03044314|516054821|FG000|Overall Study|Connector tubing not available|1|||
143138693|NCT00264147|516054822|FG000|Treatment I Period|Adverse Event|3|||
143138694|NCT00264147|516054823|FG001|Treatment I Period|Adverse Event|6|||
143138695|NCT00264147|516054824|FG002|Treatment I Period|Adverse Event|3|||
143138696|NCT00264147|516054825|FG003|Treatment I Period|Adverse Event|5|||
143138697|NCT00264147|516054826|FG004|Treatment I Period|Adverse Event|7|||
143138698|NCT00264147|516054827|FG005|Treatment I Period|Adverse Event|0|||
143138699|NCT00264147|516054822|FG000|Treatment I Period|Laboratory Adverse Event|0|||
143138700|NCT00264147|516054823|FG001|Treatment I Period|Laboratory Adverse Event|0|||
143138701|NCT00264147|516054824|FG002|Treatment I Period|Laboratory Adverse Event|0|||
143138702|NCT00264147|516054825|FG003|Treatment I Period|Laboratory Adverse Event|1|||
143138703|NCT00264147|516054826|FG004|Treatment I Period|Laboratory Adverse Event|0|||
143138704|NCT00264147|516054827|FG005|Treatment I Period|Laboratory Adverse Event|0|||
143138705|NCT00264147|516054822|FG000|Treatment I Period|Lack of Efficacy|6|||
143138706|NCT00264147|516054823|FG001|Treatment I Period|Lack of Efficacy|2|||
143138707|NCT00264147|516054824|FG002|Treatment I Period|Lack of Efficacy|8|||
143138708|NCT00264147|516054825|FG003|Treatment I Period|Lack of Efficacy|0|||
143138709|NCT00264147|516054826|FG004|Treatment I Period|Lack of Efficacy|1|||
143138710|NCT00264147|516054827|FG005|Treatment I Period|Lack of Efficacy|0|||
143138711|NCT00264147|516054822|FG000|Treatment I Period|Lost to Follow-up|1|||
143138712|NCT00264147|516054823|FG001|Treatment I Period|Lost to Follow-up|0|||
143138713|NCT00264147|516054824|FG002|Treatment I Period|Lost to Follow-up|0|||
143138714|NCT00264147|516054825|FG003|Treatment I Period|Lost to Follow-up|1|||
143138715|NCT00264147|516054826|FG004|Treatment I Period|Lost to Follow-up|1|||
143138716|NCT00264147|516054827|FG005|Treatment I Period|Lost to Follow-up|0|||
143138717|NCT00264147|516054822|FG000|Treatment I Period|Protocol Violation|2|||
143138718|NCT00264147|516054823|FG001|Treatment I Period|Protocol Violation|2|||
143138719|NCT00264147|516054824|FG002|Treatment I Period|Protocol Violation|0|||
143138720|NCT00264147|516054825|FG003|Treatment I Period|Protocol Violation|0|||
143138721|NCT00264147|516054826|FG004|Treatment I Period|Protocol Violation|0|||
143138722|NCT00264147|516054827|FG005|Treatment I Period|Protocol Violation|0|||
143138723|NCT00264147|516054822|FG000|Treatment I Period|Withdrawal by Subject|2|||
143138724|NCT00264147|516054823|FG001|Treatment I Period|Withdrawal by Subject|0|||
143138725|NCT00264147|516054824|FG002|Treatment I Period|Withdrawal by Subject|0|||
143138726|NCT00264147|516054825|FG003|Treatment I Period|Withdrawal by Subject|2|||
143138727|NCT00264147|516054826|FG004|Treatment I Period|Withdrawal by Subject|2|||
143138728|NCT00264147|516054827|FG005|Treatment I Period|Withdrawal by Subject|0|||
143138729|NCT00264147|516054822|FG000|Treatment I Period|Patient out of town for an extended time|0|||
143138730|NCT00264147|516054823|FG001|Treatment I Period|Patient out of town for an extended time|1|||
143138731|NCT00264147|516054824|FG002|Treatment I Period|Patient out of town for an extended time|0|||
143138732|NCT00264147|516054825|FG003|Treatment I Period|Patient out of town for an extended time|0|||
143138733|NCT00264147|516054826|FG004|Treatment I Period|Patient out of town for an extended time|0|||
143138734|NCT00264147|516054827|FG005|Treatment I Period|Patient out of town for an extended time|0|||
143138735|NCT00264147|516054822|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
143138736|NCT00264147|516054823|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
143138737|NCT00264147|516054824|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
143138738|NCT00264147|516054825|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
143138739|NCT00264147|516054826|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
143138740|NCT00264147|516054827|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
143138741|NCT00264147|516054822|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
143138742|NCT00264147|516054823|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
143138743|NCT00264147|516054824|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
143138744|NCT00264147|516054825|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
143138745|NCT00264147|516054826|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
143138746|NCT00264147|516054827|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
143138747|NCT00264147|516054822|FG000|Treatment II Period|Adverse Event|0|||
143138748|NCT00264147|516054823|FG001|Treatment II Period|Adverse Event|0|||
143138749|NCT00264147|516054824|FG002|Treatment II Period|Adverse Event|0|||
143472713|NCT01271803|517277038|FG002|Overall Study|Progressive disease|2|||
143472714|NCT01271803|517277036|FG000|Overall Study|Death|53|||
143472715|NCT01271803|517277037|FG001|Overall Study|Death|34|||
143472716|NCT01271803|517277038|FG002|Overall Study|Death|0|||
143472717|NCT01271803|517277036|FG000|Overall Study|Withdrawal by Subject|1|||
143472718|NCT01271803|517277037|FG001|Overall Study|Withdrawal by Subject|5|||
143472719|NCT01271803|517277038|FG002|Overall Study|Withdrawal by Subject|0|||
143138750|NCT00264147|516054825|FG003|Treatment II Period|Adverse Event|0|||
143472720|NCT01271803|517277036|FG000|Overall Study|Lost to Follow-up|1|||
143472721|NCT01271803|517277037|FG001|Overall Study|Lost to Follow-up|0|||
143472722|NCT01271803|517277038|FG002|Overall Study|Lost to Follow-up|0|||
143472723|NCT00728481|517277041|FG000|Overall Study|Withdrawal by Subject|0|||
143472724|NCT00728481|517277042|FG001|Overall Study|Withdrawal by Subject|1|||
143472725|NCT00728481|517277041|FG000|Overall Study|Adverse Event|0|||
143472726|NCT00728481|517277042|FG001|Overall Study|Adverse Event|1|||
143472727|NCT00728481|517277041|FG000|Overall Study|Study medication non-compliance|0|||
143472728|NCT00728481|517277042|FG001|Overall Study|Study medication non-compliance|2|||
143472729|NCT00728481|517277041|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
143472730|NCT00728481|517277042|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
143472731|NCT01436071|517278709|FG000|Overall Study|Adverse Event|1|||
143472732|NCT01436071|517278710|FG001|Overall Study|Adverse Event|0|||
143138751|NCT00264147|516054826|FG004|Treatment II Period|Adverse Event|9|||
143138752|NCT00264147|516054827|FG005|Treatment II Period|Adverse Event|9|||
143138753|NCT00264147|516054822|FG000|Treatment II Period|Laboratory Adverse Event|0|||
143138754|NCT00264147|516054823|FG001|Treatment II Period|Laboratory Adverse Event|0|||
143138755|NCT00264147|516054824|FG002|Treatment II Period|Laboratory Adverse Event|0|||
143138756|NCT00264147|516054825|FG003|Treatment II Period|Laboratory Adverse Event|0|||
143138757|NCT00264147|516054826|FG004|Treatment II Period|Laboratory Adverse Event|0|||
143138758|NCT00264147|516054827|FG005|Treatment II Period|Laboratory Adverse Event|1|||
143138759|NCT00264147|516054822|FG000|Treatment II Period|Lack of Efficacy|0|||
143138760|NCT00264147|516054823|FG001|Treatment II Period|Lack of Efficacy|0|||
143138761|NCT00264147|516054824|FG002|Treatment II Period|Lack of Efficacy|0|||
143138762|NCT00264147|516054825|FG003|Treatment II Period|Lack of Efficacy|0|||
143138763|NCT00264147|516054826|FG004|Treatment II Period|Lack of Efficacy|20|||
143138764|NCT00264147|516054827|FG005|Treatment II Period|Lack of Efficacy|19|||
143138765|NCT00264147|516054822|FG000|Treatment II Period|Lost to Follow-up|0|||
143472733|NCT01436071|517278709|FG000|Overall Study|Lack of Efficacy|16|||
143472734|NCT01436071|517278710|FG001|Overall Study|Lack of Efficacy|7|||
143138766|NCT00264147|516054823|FG001|Treatment II Period|Lost to Follow-up|0|||
143138767|NCT00264147|516054824|FG002|Treatment II Period|Lost to Follow-up|0|||
143138768|NCT00264147|516054825|FG003|Treatment II Period|Lost to Follow-up|0|||
143472735|NCT01436071|517278709|FG000|Overall Study|Protocol Violation|0|||
143472736|NCT01436071|517278710|FG001|Overall Study|Protocol Violation|1|||
143472737|NCT01436071|517278709|FG000|Overall Study|Lost to Follow-up|3|||
143472738|NCT01436071|517278710|FG001|Overall Study|Lost to Follow-up|1|||
143472739|NCT01436071|517278709|FG000|Overall Study|Physician Decision|1|||
143472740|NCT01436071|517278710|FG001|Overall Study|Physician Decision|0|||
143472741|NCT01436071|517278709|FG000|Overall Study|Withdrawal by Subject|2|||
143138769|NCT00264147|516054826|FG004|Treatment II Period|Lost to Follow-up|1|||
143138770|NCT00264147|516054827|FG005|Treatment II Period|Lost to Follow-up|1|||
143138771|NCT00264147|516054822|FG000|Treatment II Period|Withdrawal by Subject|0|||
143138772|NCT00264147|516054823|FG001|Treatment II Period|Withdrawal by Subject|0|||
143138773|NCT00264147|516054824|FG002|Treatment II Period|Withdrawal by Subject|0|||
143138774|NCT00264147|516054825|FG003|Treatment II Period|Withdrawal by Subject|0|||
143138775|NCT00264147|516054826|FG004|Treatment II Period|Withdrawal by Subject|3|||
143138776|NCT00264147|516054827|FG005|Treatment II Period|Withdrawal by Subject|2|||
143138777|NCT00264147|516054822|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
143361927|NCT04537949|516867234|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
143361928|NCT04537949|516867235|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
143361929|NCT04537949|516867236|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
143361930|NCT04537949|516867229|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
143361931|NCT04537949|516867230|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
143361932|NCT04537949|516867231|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
143361933|NCT04537949|516867232|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
143361934|NCT04537949|516867233|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
143361935|NCT04537949|516867234|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
143361936|NCT04537949|516867235|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
143361937|NCT04537949|516867236|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
143361938|NCT04537949|516867229|FG000|Follow-up Phase|Lost to Follow-up|0|||
143361939|NCT04537949|516867230|FG001|Follow-up Phase|Lost to Follow-up|3|||
143361940|NCT04537949|516867231|FG002|Follow-up Phase|Lost to Follow-up|0|||
143361941|NCT04537949|516867232|FG003|Follow-up Phase|Lost to Follow-up|0|||
143361942|NCT04537949|516867233|FG004|Follow-up Phase|Lost to Follow-up|0|||
143361943|NCT04537949|516867234|FG005|Follow-up Phase|Lost to Follow-up|0|||
143361944|NCT04537949|516867235|FG006|Follow-up Phase|Lost to Follow-up|0|||
143361945|NCT04537949|516867236|FG007|Follow-up Phase|Lost to Follow-up|0|||
143361946|NCT04537949|516867229|FG000|Follow-up Phase|personal reasons|0|||
143361947|NCT04537949|516867230|FG001|Follow-up Phase|personal reasons|0|||
143361948|NCT04537949|516867231|FG002|Follow-up Phase|personal reasons|0|||
143361949|NCT04537949|516867232|FG003|Follow-up Phase|personal reasons|1|||
143361950|NCT04537949|516867233|FG004|Follow-up Phase|personal reasons|1|||
143361951|NCT04537949|516867234|FG005|Follow-up Phase|personal reasons|0|||
143361952|NCT04537949|516867235|FG006|Follow-up Phase|personal reasons|0|||
143361953|NCT04537949|516867236|FG007|Follow-up Phase|personal reasons|0|||
143361954|NCT04537949|516867229|FG000|Follow-up Phase|Withdrawal by Subject|0|||
143361955|NCT04537949|516867230|FG001|Follow-up Phase|Withdrawal by Subject|0|||
143361956|NCT04537949|516867231|FG002|Follow-up Phase|Withdrawal by Subject|0|||
143361957|NCT04537949|516867232|FG003|Follow-up Phase|Withdrawal by Subject|0|||
143361958|NCT04537949|516867233|FG004|Follow-up Phase|Withdrawal by Subject|1|||
143361959|NCT04537949|516867234|FG005|Follow-up Phase|Withdrawal by Subject|0|||
143361960|NCT04537949|516867235|FG006|Follow-up Phase|Withdrawal by Subject|0|||
143361961|NCT04537949|516867236|FG007|Follow-up Phase|Withdrawal by Subject|0|||
143361962|NCT01113463|516867239|FG000|Overall Study|Physician Decision|5|||
143361963|NCT01719861|516867240|FG000|Cycle 1|Death|4|||
143361964|NCT01719861|516867240|FG000|Cycle 2|Death|1|||
143361965|NCT03379233|516867244|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
143361966|NCT03379233|516867245|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
143361967|NCT00965484|516867246|FG000|Overall Study|Protocol Violation|1|||
143361968|NCT00965484|516867246|FG000|Overall Study|Withdrawal by Subject|1|||
143361969|NCT00848211|516867247|FG000|Overall Study|Protocol Violation|0|||
143361970|NCT00848211|516867248|FG001|Overall Study|Protocol Violation|1|||
143361971|NCT00848211|516867249|FG002|Overall Study|Protocol Violation|1|||
143361972|NCT00848211|516867250|FG003|Overall Study|Protocol Violation|0|||
143361973|NCT00848211|516867247|FG000|Overall Study|Adverse Event|0|||
143361974|NCT00848211|516867248|FG001|Overall Study|Adverse Event|0|||
143361975|NCT00848211|516867249|FG002|Overall Study|Adverse Event|0|||
143361976|NCT00848211|516867250|FG003|Overall Study|Adverse Event|0|||
143361977|NCT02531438|516867251|FG000|Overall Study|Adverse Event|7|||
143361978|NCT02531438|516867252|FG001|Overall Study|Adverse Event|9|||
143361979|NCT02531438|516867251|FG000|Overall Study|Lost to Follow-up|0|||
143361980|NCT02531438|516867252|FG001|Overall Study|Lost to Follow-up|3|||
143361981|NCT02531438|516867251|FG000|Overall Study|Withdrawal by Subject|7|||
143361982|NCT02531438|516867252|FG001|Overall Study|Withdrawal by Subject|8|||
143361983|NCT02531438|516867251|FG000|Overall Study|Physician Decision|0|||
143361984|NCT02531438|516867252|FG001|Overall Study|Physician Decision|1|||
143361985|NCT02531438|516867251|FG000|Overall Study|Death|6|||
143361986|NCT02531438|516867252|FG001|Overall Study|Death|3|||
143361987|NCT02531438|516867251|FG000|Overall Study|Randomized, but Not Treated|4|||
143361988|NCT02531438|516867252|FG001|Overall Study|Randomized, but Not Treated|0|||
143361989|NCT02531438|516867251|FG000|Overall Study|Missed EOT/PTE Visit|5|||
143138778|NCT00264147|516054823|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
143138779|NCT00264147|516054824|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
143361990|NCT02531438|516867252|FG001|Overall Study|Missed EOT/PTE Visit|2|||
143361991|NCT02531438|516867251|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
143138780|NCT00264147|516054825|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
143138781|NCT00264147|516054826|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
143138782|NCT00264147|516054827|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
143138783|NCT01316224|516054828|FG000|Overall Study|Protocol Violation|3|||
143138784|NCT01316224|516054828|FG000|Overall Study|Adverse Event|3|||
143138785|NCT01316224|516054828|FG000|Overall Study|Lack of Efficacy|1|||
143138786|NCT01316224|516054828|FG000|Overall Study|Withdrawal by Subject|1|||
143138787|NCT01316224|516054828|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
143138788|NCT01316224|516054828|FG000|Overall Study|Other|1|||
143138789|NCT00449163|516054831|FG000|Overall Study|Physician Decision|3|||
143138790|NCT02949947|516054849|FG000|Overall Study|Non Compliance|0|||
143138791|NCT02949947|516054850|FG001|Overall Study|Non Compliance|1|||
143138792|NCT02949947|516054849|FG000|Overall Study|Insurance change|1|||
143138793|NCT02949947|516054850|FG001|Overall Study|Insurance change|0|||
143138794|NCT02247466|516054853|FG000|Overall Study|Procedure changed to open surgery|0|||
143138795|NCT02247466|516054854|FG001|Overall Study|Procedure changed to open surgery|3|||
143138796|NCT02230891|516054856|FG000|Baseline|Did not meet inclusion|0|||
143138797|NCT02230891|516054857|FG001|Baseline|Did not meet inclusion|1|||
143138798|NCT02230891|516054858|FG002|Baseline|Did not meet inclusion|1|||
143138799|NCT02230891|516054856|FG000|2 Week|Withdrawal by Subject|2|||
143138800|NCT02230891|516054857|FG001|2 Week|Withdrawal by Subject|2|||
143138801|NCT02230891|516054858|FG002|2 Week|Withdrawal by Subject|0|||
143138802|NCT02230891|516054856|FG000|2 Week|Consent withdrawn|1|||
143138803|NCT02230891|516054857|FG001|2 Week|Consent withdrawn|0|||
143138804|NCT02230891|516054858|FG002|2 Week|Consent withdrawn|0|||
143138805|NCT02230891|516054856|FG000|6 Month|Withdrawal by Subject|1|||
143138806|NCT02230891|516054857|FG001|6 Month|Withdrawal by Subject|1|||
143138807|NCT02230891|516054858|FG002|6 Month|Withdrawal by Subject|1|||
143138808|NCT02230891|516054856|FG000|6 Month|Physician Decision|0|||
143138809|NCT02230891|516054857|FG001|6 Month|Physician Decision|2|||
143138810|NCT02230891|516054858|FG002|6 Month|Physician Decision|0|||
143138811|NCT02230891|516054856|FG000|12 Month|Death|1|||
143138812|NCT02230891|516054857|FG001|12 Month|Death|0|||
143138813|NCT02230891|516054858|FG002|12 Month|Death|0|||
143138814|NCT02230891|516054856|FG000|12 Month|Lost to Follow-up|0|||
143138815|NCT02230891|516054857|FG001|12 Month|Lost to Follow-up|1|||
143138816|NCT02230891|516054858|FG002|12 Month|Lost to Follow-up|0|||
143138817|NCT02230891|516054856|FG000|12 Month|Withdrawal by Subject|0|||
143138818|NCT02230891|516054857|FG001|12 Month|Withdrawal by Subject|2|||
143138819|NCT02230891|516054858|FG002|12 Month|Withdrawal by Subject|0|||
143138820|NCT02230891|516054856|FG000|18 Month End of Study|Death|0|||
143138821|NCT02230891|516054857|FG001|18 Month End of Study|Death|0|||
143138822|NCT02230891|516054858|FG002|18 Month End of Study|Death|1|||
143138823|NCT02230891|516054856|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
143138824|NCT02230891|516054857|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
143138825|NCT02230891|516054858|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
143138826|NCT04158219|516054861|FG000|Overall Study|Lost to Follow-up|1|||
143138827|NCT01324947|516054862|FG000|Overall Study|Adverse Event|7|||
143138828|NCT01324947|516054862|FG000|Overall Study|Death|10|||
143138829|NCT01324947|516054862|FG000|Overall Study|Other|3|||
143138830|NCT01324947|516054862|FG000|Overall Study|Progressive Disease|50|||
143138831|NCT01324947|516054862|FG000|Overall Study|Withdrawal by Subject|3|||
143361992|NCT02531438|516867252|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
143361993|NCT01124617|516867253|FG000|Overall Study|Adverse Event|5|||
143361994|NCT01124617|516867254|FG001|Overall Study|Adverse Event|2|||
143361995|NCT01124617|516867253|FG000|Overall Study|Lack of Efficacy|2|||
143361996|NCT01124617|516867254|FG001|Overall Study|Lack of Efficacy|1|||
143361997|NCT01124617|516867253|FG000|Overall Study|Protocol Violation|1|||
143361998|NCT01124617|516867254|FG001|Overall Study|Protocol Violation|1|||
143361999|NCT01124617|516867253|FG000|Overall Study|Withdrawal by Subject|9|||
143362000|NCT01124617|516867254|FG001|Overall Study|Withdrawal by Subject|1|||
143362001|NCT01124617|516867253|FG000|Overall Study|Other|2|||
143362002|NCT01124617|516867254|FG001|Overall Study|Other|1|||
143362003|NCT00945477|516867255|FG000|Overall Study|Adverse Event|3|||
143362004|NCT00945477|516867255|FG000|Overall Study|Lack of Efficacy|2|||
143362005|NCT00945477|516867255|FG000|Overall Study|Withdrawal by Subject|1|||
143362006|NCT01653743|516867256|FG000|Overall Study|Withdrawal by Subject|1|||
143362007|NCT01653743|516867257|FG001|Overall Study|Withdrawal by Subject|0|||
143362008|NCT01653743|516867256|FG000|Overall Study|Investigator discretion|3|||
143362009|NCT01653743|516867257|FG001|Overall Study|Investigator discretion|0|||
143362010|NCT02825043|516867259|FG000|Overall Study|Lost to Follow-up|4|||
143362011|NCT04796935|516867263|FG000|Overall Study|Withdrawal by Subject|0|||
143362012|NCT04796935|516867264|FG001|Overall Study|Withdrawal by Subject|1|||
143362013|NCT04796935|516867263|FG000|Overall Study|Physician Decision|0|||
143362014|NCT04796935|516867264|FG001|Overall Study|Physician Decision|1|||
143138832|NCT01324947|516054862|FG000|Overall Study|1 discontinued before starting drug|1|||
143362015|NCT04796935|516867263|FG000|Overall Study|Device not available|1|||
143138833|NCT00350545|516057265|FG000|Overall Study|Withdrawal by Subject|2|||
143362016|NCT04796935|516867264|FG001|Overall Study|Device not available|0|||
143138834|NCT00434252|516057269|FG000|Overall Study|Lack of Efficacy|50|||
143472742|NCT01436071|517278710|FG001|Overall Study|Withdrawal by Subject|2|||
143472743|NCT01436071|517278709|FG000|Overall Study|Did Not Receive Trial Medication|3|||
143472744|NCT01436071|517278710|FG001|Overall Study|Did Not Receive Trial Medication|3|||
143472745|NCT03047551|517278714|FG000|Overall Study|Did not receive TAS|1|||
143472746|NCT03047551|517278715|FG001|Overall Study|Did not receive TAS|0|||
143472747|NCT03047551|517278714|FG000|Overall Study|Physician Decision|1|||
143472748|NCT03047551|517278715|FG001|Overall Study|Physician Decision|0|||
143472749|NCT03047551|517278714|FG000|Overall Study|Withdrawal by Subject|0|||
143138835|NCT00434252|516057270|FG001|Overall Study|Lack of Efficacy|100|||
143138836|NCT00434252|516057269|FG000|Overall Study|Adverse Event|6|||
143138837|NCT00434252|516057270|FG001|Overall Study|Adverse Event|13|||
143138838|NCT00434252|516057269|FG000|Overall Study|Death|1|||
143138839|NCT00434252|516057270|FG001|Overall Study|Death|2|||
143138840|NCT00434252|516057269|FG000|Overall Study|Lost to Follow-up|0|||
143138841|NCT00434252|516057270|FG001|Overall Study|Lost to Follow-up|1|||
143138842|NCT00434252|516057269|FG000|Overall Study|Physician Decision|4|||
143138843|NCT00434252|516057270|FG001|Overall Study|Physician Decision|8|||
143138844|NCT00434252|516057269|FG000|Overall Study|Withdrawal by Subject|3|||
143138845|NCT00434252|516057270|FG001|Overall Study|Withdrawal by Subject|7|||
143138846|NCT00266708|516057310|FG000|Overall Study|No renal function|1|||
143138847|NCT00266708|516057311|FG001|Overall Study|No renal function|1|||
143138848|NCT00266708|516057310|FG000|Overall Study|Refused biopsy|3|||
143138849|NCT00266708|516057311|FG001|Overall Study|Refused biopsy|6|||
143138850|NCT00266708|516057310|FG000|Overall Study|Asthma|0|||
143138851|NCT00266708|516057311|FG001|Overall Study|Asthma|2|||
143138852|NCT02351934|516057312|FG000|Allocation|POD weight<pre-op weight|3|||
143138853|NCT02351934|516057313|FG001|Allocation|POD weight<pre-op weight|0|||
143138854|NCT02351934|516057312|FG000|Allocation|Hypotension preventing administration|2|||
143138855|NCT02351934|516057313|FG001|Allocation|Hypotension preventing administration|0|||
143138856|NCT02351934|516057312|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
143138857|NCT02351934|516057313|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
143138858|NCT02351934|516057312|FG000|Follow-Up|POD weight<pre-op weight|3|||
143138859|NCT02351934|516057313|FG001|Follow-Up|POD weight<pre-op weight|0|||
143138860|NCT02351934|516057312|FG000|Follow-Up|Acute Kidney Injury|1|||
143138861|NCT02351934|516057313|FG001|Follow-Up|Acute Kidney Injury|0|||
143138862|NCT02351934|516057312|FG000|Follow-Up|Early dismissal|3|||
143138863|NCT02351934|516057313|FG001|Follow-Up|Early dismissal|0|||
143138864|NCT02351934|516057312|FG000|Follow-Up|Hypotension|3|||
143138865|NCT02351934|516057313|FG001|Follow-Up|Hypotension|0|||
143138866|NCT02351934|516057312|FG000|Follow-Up|No documentation|2|||
143138867|NCT02351934|516057313|FG001|Follow-Up|No documentation|0|||
143138868|NCT02351934|516057312|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
143138869|NCT02351934|516057313|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
143138870|NCT02351934|516057312|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
143138871|NCT02351934|516057313|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
143138872|NCT02683109|516057314|FG000|Overall Study|Adverse Event|1|||
143138873|NCT02683109|516057315|FG001|Overall Study|Adverse Event|0|||
143138874|NCT00368251|516057316|FG000|Overall Study|SAE, non-fatal|1|||
143138875|NCT00368251|516057317|FG001|Overall Study|SAE, non-fatal|0|||
143138876|NCT00368251|516057318|FG002|Overall Study|SAE, non-fatal|0|||
143138877|NCT00368251|516057316|FG000|Overall Study|AE, non-serious non-fatal|0|||
143138878|NCT00368251|516057317|FG001|Overall Study|AE, non-serious non-fatal|0|||
143138879|NCT00368251|516057318|FG002|Overall Study|AE, non-serious non-fatal|1|||
143138880|NCT00499122|516057320|FG000|Overall Study|Withdrawal by Subject|2|||
143138881|NCT03312738|516057321|FG000|Overall Study|Progressive disease|58|||
143138882|NCT03312738|516057322|FG001|Overall Study|Progressive disease|67|||
143138883|NCT03312738|516057321|FG000|Overall Study|Patient/guardian decision|13|||
143138884|NCT03312738|516057322|FG001|Overall Study|Patient/guardian decision|5|||
143138885|NCT03312738|516057321|FG000|Overall Study|Adverse Event|5|||
143138886|NCT03312738|516057322|FG001|Overall Study|Adverse Event|3|||
143138887|NCT03312738|516057321|FG000|Overall Study|Protocol deviation|2|||
143138888|NCT03312738|516057322|FG001|Overall Study|Protocol deviation|0|||
143138889|NCT03312738|516057321|FG000|Overall Study|Technical problems|0|||
143138890|NCT03312738|516057322|FG001|Overall Study|Technical problems|1|||
143138891|NCT03312738|516057321|FG000|Overall Study|Physician Decision|2|||
143138892|NCT03312738|516057322|FG001|Overall Study|Physician Decision|3|||
143138893|NCT02466399|516057329|FG000|Overall Study|Adverse Event|1|||
143138894|NCT02466399|516057330|FG001|Overall Study|Adverse Event|0|||
143138895|NCT02466399|516057329|FG000|Overall Study|Early exit due to family emergency|1|||
143138896|NCT02466399|516057330|FG001|Overall Study|Early exit due to family emergency|0|||
143138897|NCT01373164|516057331|FG000|Overall Study|Lost to Follow-up|0|||
143138898|NCT01373164|516057332|FG001|Overall Study|Lost to Follow-up|0|||
143138899|NCT01373164|516057333|FG002|Overall Study|Lost to Follow-up|1|||
143138900|NCT01373164|516057334|FG003|Overall Study|Lost to Follow-up|2|||
143138901|NCT01373164|516057335|FG004|Overall Study|Lost to Follow-up|0|||
143138902|NCT01373164|516057331|FG000|Overall Study|Withdrawal by Subject|0|||
143138903|NCT01373164|516057332|FG001|Overall Study|Withdrawal by Subject|1|||
143138904|NCT01373164|516057333|FG002|Overall Study|Withdrawal by Subject|0|||
143138905|NCT01373164|516057334|FG003|Overall Study|Withdrawal by Subject|10|||
143138906|NCT01373164|516057335|FG004|Overall Study|Withdrawal by Subject|2|||
143138907|NCT01799941|516057336|FG000|Overall Study|Adverse Event|34|||
143138908|NCT01799941|516057336|FG000|Overall Study|Withdrawal by Subject|21|||
143138909|NCT01799941|516057336|FG000|Overall Study|Death|2|||
143138910|NCT01799941|516057336|FG000|Overall Study|Investigator Decision|4|||
143138911|NCT01799941|516057336|FG000|Overall Study|Lack of Efficacy|3|||
143138912|NCT01799941|516057336|FG000|Overall Study|Lost to Follow-up|17|||
143472750|NCT03047551|517278715|FG001|Overall Study|Withdrawal by Subject|1|||
143472751|NCT03047551|517278714|FG000|Overall Study|Probe malfunction|0|||
143472752|NCT03047551|517278715|FG001|Overall Study|Probe malfunction|1|||
143472753|NCT03047551|517278714|FG000|Overall Study|Ineligible|0|||
143472754|NCT03047551|517278715|FG001|Overall Study|Ineligible|1|||
143472755|NCT01493557|517278717|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
143472756|NCT01493557|517278718|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
143472757|NCT01493557|517278719|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
143472758|NCT01493557|517278717|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
143472759|NCT01493557|517278718|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
143472760|NCT01493557|517278719|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
143472761|NCT01493557|517278717|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
143362017|NCT04796935|516867263|FG000|Overall Study|Trained provider not available|1|||
143362018|NCT04796935|516867264|FG001|Overall Study|Trained provider not available|0|||
143362019|NCT00783718|516867265|FG000|Induction Phase|Adverse Event|4|||
143362020|NCT00783718|516867266|FG001|Induction Phase|Adverse Event|0|||
143362021|NCT00783718|516867267|FG002|Induction Phase|Adverse Event|7|||
143362022|NCT00783718|516867268|FG003|Induction Phase|Adverse Event|0|||
143362023|NCT00783718|516867269|FG004|Induction Phase|Adverse Event|0|||
143362024|NCT00783718|516867270|FG005|Induction Phase|Adverse Event|0|||
143472762|NCT01493557|517278718|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
143472763|NCT01493557|517278719|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
143472764|NCT01493557|517278717|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
143472765|NCT01493557|517278718|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
143472766|NCT01493557|517278719|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
143472767|NCT01493557|517278717|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
143472768|NCT01493557|517278718|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
143472769|NCT01493557|517278719|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
143138913|NCT01799941|516057336|FG000|Overall Study|Other|15|||
143138914|NCT02669849|516057337|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
143138915|NCT02669849|516057338|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
143138916|NCT02669849|516057339|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
143138917|NCT02669849|516057337|FG000|Overall Study|Lost to Follow-up|1|||
143138918|NCT02669849|516057338|FG001|Overall Study|Lost to Follow-up|0|||
143138919|NCT02669849|516057339|FG002|Overall Study|Lost to Follow-up|3|||
143138920|NCT02669849|516057337|FG000|Overall Study|Death|1|||
143138921|NCT02669849|516057338|FG001|Overall Study|Death|1|||
143138922|NCT02669849|516057339|FG002|Overall Study|Death|2|||
143138923|NCT02669849|516057337|FG000|Overall Study|Study terminated by sponsor|16|||
143138924|NCT02669849|516057338|FG001|Overall Study|Study terminated by sponsor|1|||
143138925|NCT02669849|516057339|FG002|Overall Study|Study terminated by sponsor|14|||
143138926|NCT02669849|516057337|FG000|Overall Study|Other|0|||
143138927|NCT02669849|516057338|FG001|Overall Study|Other|0|||
143138928|NCT02669849|516057339|FG002|Overall Study|Other|2|||
143138929|NCT04745351|516057346|FG000|Overall Study|Death|51|||
143138930|NCT04745351|516057347|FG001|Overall Study|Death|25|||
143138931|NCT04745351|516057346|FG000|Overall Study|Lost to Follow-up|9|||
143138932|NCT04745351|516057347|FG001|Overall Study|Lost to Follow-up|3|||
143138933|NCT04745351|516057346|FG000|Overall Study|Randomized but Never Treated|3|||
143138934|NCT04745351|516057347|FG001|Overall Study|Randomized but Never Treated|3|||
143362025|NCT00783718|516867271|FG006|Induction Phase|Adverse Event|0|||
143362026|NCT00783718|516867265|FG000|Induction Phase|Protocol Violation|1|||
143362027|NCT00783718|516867266|FG001|Induction Phase|Protocol Violation|1|||
143362028|NCT00783718|516867267|FG002|Induction Phase|Protocol Violation|6|||
143362029|NCT00783718|516867268|FG003|Induction Phase|Protocol Violation|0|||
143138935|NCT04745351|516057346|FG000|Overall Study|Adverse Event|4|||
143138936|NCT04745351|516057347|FG001|Overall Study|Adverse Event|0|||
143138937|NCT04745351|516057346|FG000|Overall Study|Withdrew Consent|1|||
143138938|NCT04745351|516057347|FG001|Overall Study|Withdrew Consent|2|||
143138939|NCT04745351|516057346|FG000|Overall Study|Investigator's Discretion|2|||
143138940|NCT04745351|516057347|FG001|Overall Study|Investigator's Discretion|0|||
143138941|NCT04745351|516057346|FG000|Overall Study|Protocol Violation|1|||
143362030|NCT00783718|516867269|FG004|Induction Phase|Protocol Violation|0|||
143362031|NCT00783718|516867270|FG005|Induction Phase|Protocol Violation|0|||
143362032|NCT00783718|516867271|FG006|Induction Phase|Protocol Violation|0|||
143138942|NCT04745351|516057347|FG001|Overall Study|Protocol Violation|0|||
143472770|NCT01493557|517278717|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
143472771|NCT01493557|517278718|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
143472772|NCT01493557|517278719|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
143472773|NCT01493557|517278717|FG000|Not Randomized to Management Strategies|Early termination|0|||
143472774|NCT01493557|517278718|FG001|Not Randomized to Management Strategies|Early termination|0|||
143472775|NCT01493557|517278719|FG002|Not Randomized to Management Strategies|Early termination|34|||
143472776|NCT01493557|517278717|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
143472777|NCT01493557|517278718|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
143472778|NCT01493557|517278719|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
143472779|NCT01493557|517278717|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
143472780|NCT01493557|517278718|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
143472781|NCT01493557|517278719|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
143472782|NCT01493557|517278717|FG000|Randomized to Management Strategies|Other adverse event|8|||
143472783|NCT01493557|517278718|FG001|Randomized to Management Strategies|Other adverse event|5|||
143472784|NCT01493557|517278719|FG002|Randomized to Management Strategies|Other adverse event|0|||
143472785|NCT01493557|517278717|FG000|Randomized to Management Strategies|Protocol Violation|3|||
143472786|NCT01493557|517278718|FG001|Randomized to Management Strategies|Protocol Violation|0|||
143138943|NCT01863771|516057348|FG000|Induction Phase|Adverse Event|9|||
143138944|NCT01863771|516057349|FG001|Induction Phase|Adverse Event|0|||
143138945|NCT01863771|516057350|FG002|Induction Phase|Adverse Event|0|||
143138946|NCT01863771|516057351|FG003|Induction Phase|Adverse Event|0|||
143138947|NCT01863771|516057348|FG000|Induction Phase|Lack of Efficacy|10|||
143138948|NCT01863771|516057349|FG001|Induction Phase|Lack of Efficacy|0|||
143138949|NCT01863771|516057350|FG002|Induction Phase|Lack of Efficacy|0|||
143138950|NCT01863771|516057351|FG003|Induction Phase|Lack of Efficacy|0|||
143138951|NCT01863771|516057348|FG000|Induction Phase|Withdrawal by Subject|2|||
143138952|NCT01863771|516057349|FG001|Induction Phase|Withdrawal by Subject|0|||
143138953|NCT01863771|516057350|FG002|Induction Phase|Withdrawal by Subject|0|||
143138954|NCT01863771|516057351|FG003|Induction Phase|Withdrawal by Subject|0|||
143138955|NCT01863771|516057348|FG000|Maintenance Phase|Adverse Event|0|||
143138956|NCT01863771|516057349|FG001|Maintenance Phase|Adverse Event|0|||
143138957|NCT01863771|516057350|FG002|Maintenance Phase|Adverse Event|1|||
143138958|NCT01863771|516057351|FG003|Maintenance Phase|Adverse Event|1|||
143138959|NCT01863771|516057348|FG000|Maintenance Phase|Lack of Efficacy|0|||
143138960|NCT01863771|516057349|FG001|Maintenance Phase|Lack of Efficacy|3|||
143138961|NCT01863771|516057350|FG002|Maintenance Phase|Lack of Efficacy|7|||
143138962|NCT01863771|516057351|FG003|Maintenance Phase|Lack of Efficacy|38|||
143138963|NCT01863771|516057348|FG000|Maintenance Phase|Physician Decision|0|||
143138964|NCT01863771|516057349|FG001|Maintenance Phase|Physician Decision|0|||
143138965|NCT01863771|516057350|FG002|Maintenance Phase|Physician Decision|2|||
143138966|NCT01863771|516057351|FG003|Maintenance Phase|Physician Decision|1|||
143138967|NCT01863771|516057348|FG000|Maintenance Phase|Pregnancy|0|||
143138968|NCT01863771|516057349|FG001|Maintenance Phase|Pregnancy|1|||
143138969|NCT01863771|516057350|FG002|Maintenance Phase|Pregnancy|0|||
143138970|NCT01863771|516057351|FG003|Maintenance Phase|Pregnancy|0|||
143138971|NCT01863771|516057348|FG000|Maintenance Phase|Withdrawal by Subject|0|||
143138972|NCT01863771|516057349|FG001|Maintenance Phase|Withdrawal by Subject|1|||
143138973|NCT01863771|516057350|FG002|Maintenance Phase|Withdrawal by Subject|2|||
143138974|NCT01863771|516057351|FG003|Maintenance Phase|Withdrawal by Subject|3|||
143138975|NCT03499795|516057352|FG000|Overall Study|Adverse Event|1|||
143138976|NCT03499795|516057352|FG000|Overall Study|Lost to Follow-up|1|||
143138977|NCT03636256|516057353|FG000|Overall Study|Lost to Follow-up|3|||
143138978|NCT03636256|516057354|FG001|Overall Study|Lost to Follow-up|0|||
143138979|NCT03636256|516057355|FG002|Overall Study|Lost to Follow-up|2|||
143138980|NCT03636256|516057356|FG003|Overall Study|Lost to Follow-up|1|||
143138981|NCT03636256|516057357|FG004|Overall Study|Lost to Follow-up|0|||
143138982|NCT03636256|516057358|FG005|Overall Study|Lost to Follow-up|4|||
143138983|NCT03636256|516057359|FG006|Overall Study|Lost to Follow-up|2|||
143138984|NCT03636256|516057360|FG007|Overall Study|Lost to Follow-up|0|||
143138985|NCT03636256|516057361|FG008|Overall Study|Lost to Follow-up|4|||
143138986|NCT03636256|516057353|FG000|Overall Study|Withdrawal by Subject|0|||
143138987|NCT03636256|516057354|FG001|Overall Study|Withdrawal by Subject|0|||
143138988|NCT03636256|516057355|FG002|Overall Study|Withdrawal by Subject|0|||
143138989|NCT03636256|516057356|FG003|Overall Study|Withdrawal by Subject|0|||
143138990|NCT03636256|516057357|FG004|Overall Study|Withdrawal by Subject|0|||
143138991|NCT03636256|516057358|FG005|Overall Study|Withdrawal by Subject|0|||
143138992|NCT03636256|516057359|FG006|Overall Study|Withdrawal by Subject|0|||
143138993|NCT03636256|516057360|FG007|Overall Study|Withdrawal by Subject|0|||
143138994|NCT03636256|516057361|FG008|Overall Study|Withdrawal by Subject|1|||
143138995|NCT01218308|516057362|FG000|Overall Study|Adverse Event|1|||
143138996|NCT01218308|516057363|FG001|Overall Study|Adverse Event|2|||
143138997|NCT01218308|516057362|FG000|Overall Study|Protocol Violation|0|||
143138998|NCT01218308|516057363|FG001|Overall Study|Protocol Violation|2|||
143138999|NCT01218308|516057362|FG000|Overall Study|Withdrawal by Subject|61|||
143139000|NCT01218308|516057363|FG001|Overall Study|Withdrawal by Subject|64|||
143139001|NCT01218308|516057362|FG000|Overall Study|Lost to Follow-up|27|||
143139002|NCT01218308|516057363|FG001|Overall Study|Lost to Follow-up|31|||
143139003|NCT01218308|516057362|FG000|Overall Study|Other|14|||
143139004|NCT01218308|516057363|FG001|Overall Study|Other|21|||
143139005|NCT04748718|516057366|FG000|Overall Study|Lost to Follow-up|50|||
143139006|NCT01935089|516057368|FG000|Overall Study|Adverse Event|2|||
143139007|NCT01935089|516057368|FG000|Overall Study|Withdrawal by Subject|1|||
143139008|NCT02932943|516057369|FG000|Overall Study|Lost to Follow-up|0|||
143139009|NCT02932943|516057370|FG001|Overall Study|Lost to Follow-up|2|||
143139010|NCT02932943|516057369|FG000|Overall Study|Adverse Event|2|||
143139011|NCT02932943|516057370|FG001|Overall Study|Adverse Event|2|||
143139012|NCT02932943|516057369|FG000|Overall Study|Withdrawal by Subject|3|||
143139013|NCT02932943|516057370|FG001|Overall Study|Withdrawal by Subject|3|||
143139014|NCT00958074|516057371|FG000|Overall Study|Withdrawal by Subject|0|||
143139015|NCT00958074|516057372|FG001|Overall Study|Withdrawal by Subject|1|||
143139016|NCT01483118|516057375|FG000|Overall Study|Lost to Follow-up|12|||
143139017|NCT01483118|516057376|FG001|Overall Study|Lost to Follow-up|16|||
143139018|NCT01079780|516057377|FG000|Overall Study|Disease progression|43|||
143139019|NCT01079780|516057378|FG001|Overall Study|Disease progression|7|||
143139020|NCT01079780|516057379|FG002|Overall Study|Disease progression|31|||
143139021|NCT01079780|516057377|FG000|Overall Study|Adverse Event|13|||
143139022|NCT01079780|516057378|FG001|Overall Study|Adverse Event|5|||
143139023|NCT01079780|516057379|FG002|Overall Study|Adverse Event|7|||
143139024|NCT01079780|516057377|FG000|Overall Study|Death|2|||
143139025|NCT01079780|516057378|FG001|Overall Study|Death|0|||
143139026|NCT01079780|516057379|FG002|Overall Study|Death|2|||
143139027|NCT01079780|516057377|FG000|Overall Study|Withdrawal by Subject|6|||
143139028|NCT01079780|516057378|FG001|Overall Study|Withdrawal by Subject|4|||
143139029|NCT01079780|516057379|FG002|Overall Study|Withdrawal by Subject|4|||
143139030|NCT01079780|516057377|FG000|Overall Study|Alternative therapy|2|||
143139031|NCT01079780|516057378|FG001|Overall Study|Alternative therapy|0|||
143139032|NCT01079780|516057379|FG002|Overall Study|Alternative therapy|2|||
143139033|NCT01079780|516057377|FG000|Overall Study|Physician Decision|1|||
143139034|NCT01079780|516057378|FG001|Overall Study|Physician Decision|0|||
143139035|NCT01079780|516057379|FG002|Overall Study|Physician Decision|1|||
143139036|NCT01079780|516057377|FG000|Overall Study|Error made in lesion measurement|1|||
143139037|NCT01079780|516057378|FG001|Overall Study|Error made in lesion measurement|0|||
143139038|NCT01079780|516057379|FG002|Overall Study|Error made in lesion measurement|0|||
143139039|NCT01079780|516057377|FG000|Overall Study|Patient had surgery|1|||
143139040|NCT01079780|516057378|FG001|Overall Study|Patient had surgery|0|||
143139041|NCT01079780|516057379|FG002|Overall Study|Patient had surgery|0|||
143139042|NCT01079780|516057377|FG000|Overall Study|Treatment cycle delay|0|||
143139043|NCT01079780|516057378|FG001|Overall Study|Treatment cycle delay|0|||
143139044|NCT01079780|516057379|FG002|Overall Study|Treatment cycle delay|1|||
143139045|NCT01079780|516057377|FG000|Overall Study|Never started treatment|1|||
143139046|NCT01079780|516057378|FG001|Overall Study|Never started treatment|0|||
143139047|NCT01079780|516057379|FG002|Overall Study|Never started treatment|2|||
143139048|NCT01178294|516057385|FG000|Overall Study|Adverse Event|4|||
143139049|NCT01178294|516057385|FG000|Overall Study|Lost to Follow-up|2|||
143139050|NCT01178294|516057385|FG000|Overall Study|Lack of Efficacy|1|||
143139051|NCT01178294|516057385|FG000|Overall Study|Death|1|||
143139052|NCT01178294|516057385|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
143139053|NCT01178294|516057385|FG000|Overall Study|Subject status is terminal|1|||
143139054|NCT01178294|516057385|FG000|Overall Study|Completion status could not be verified|1|||
143139055|NCT03176771|516057388|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
143139056|NCT03176771|516057389|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
143139057|NCT03176771|516057390|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
143139058|NCT03176771|516057391|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
143139059|NCT03176771|516057392|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
143139060|NCT03176771|516057388|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
143139061|NCT03176771|516057389|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
143139062|NCT03176771|516057390|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
143139063|NCT03176771|516057391|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
143139064|NCT03176771|516057392|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
143139065|NCT03176771|516057388|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
143139066|NCT03176771|516057389|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
143139067|NCT03176771|516057390|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
143362033|NCT00783718|516867265|FG000|Induction Phase|Lack of Efficacy|5|||
143139068|NCT03176771|516057391|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
143139069|NCT03176771|516057392|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
143139070|NCT03176771|516057388|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
143139071|NCT03176771|516057389|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
143362034|NCT00783718|516867266|FG001|Induction Phase|Lack of Efficacy|2|||
143362035|NCT00783718|516867267|FG002|Induction Phase|Lack of Efficacy|14|||
143139072|NCT03176771|516057390|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
143139073|NCT03176771|516057391|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
143139074|NCT03176771|516057392|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
143139075|NCT03176771|516057388|FG000|Double-Blind Extension Period|Adverse Event|0|||
143139076|NCT03176771|516057389|FG001|Double-Blind Extension Period|Adverse Event|0|||
143139077|NCT03176771|516057390|FG002|Double-Blind Extension Period|Adverse Event|0|||
143139078|NCT03176771|516057391|FG003|Double-Blind Extension Period|Adverse Event|15|||
143139079|NCT03176771|516057392|FG004|Double-Blind Extension Period|Adverse Event|18|||
143139080|NCT03176771|516057388|FG000|Double-Blind Extension Period|Death|0|||
143139081|NCT03176771|516057389|FG001|Double-Blind Extension Period|Death|0|||
143139082|NCT03176771|516057390|FG002|Double-Blind Extension Period|Death|0|||
143139083|NCT03176771|516057391|FG003|Double-Blind Extension Period|Death|3|||
143139084|NCT03176771|516057392|FG004|Double-Blind Extension Period|Death|4|||
143139085|NCT03176771|516057388|FG000|Double-Blind Extension Period|Physician Decision|0|||
143139086|NCT03176771|516057389|FG001|Double-Blind Extension Period|Physician Decision|0|||
143139087|NCT03176771|516057390|FG002|Double-Blind Extension Period|Physician Decision|0|||
143139088|NCT03176771|516057391|FG003|Double-Blind Extension Period|Physician Decision|3|||
143139089|NCT03176771|516057392|FG004|Double-Blind Extension Period|Physician Decision|1|||
143139090|NCT03176771|516057388|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
143139091|NCT03176771|516057389|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
143139092|NCT03176771|516057390|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
143139093|NCT03176771|516057391|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
143139094|NCT03176771|516057392|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
143139095|NCT00106002|516057393|FG000|Overall Study|Did not take any study drug|1|||
143139096|NCT00106002|516057393|FG000|Overall Study|Ineligible after Registration|1|||
143139097|NCT00116142|516057397|FG000|Overall Study|Adverse Event|8|||
143139098|NCT00116142|516057398|FG001|Overall Study|Adverse Event|7|||
143139099|NCT00116142|516057397|FG000|Overall Study|Protocol Violation|2|||
143139100|NCT00116142|516057398|FG001|Overall Study|Protocol Violation|1|||
143139101|NCT00116142|516057397|FG000|Overall Study|Withdrawal by Subject|5|||
143139102|NCT00116142|516057398|FG001|Overall Study|Withdrawal by Subject|5|||
143139103|NCT00116142|516057397|FG000|Overall Study|Physician Decision|3|||
143139104|NCT00116142|516057398|FG001|Overall Study|Physician Decision|1|||
143139105|NCT00116142|516057397|FG000|Overall Study|Delayed Radiation Therapy|1|||
143139106|NCT00116142|516057398|FG001|Overall Study|Delayed Radiation Therapy|0|||
143139107|NCT00116142|516057397|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
143139108|NCT00116142|516057398|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
143139109|NCT00116142|516057397|FG000|Overall Study|Patient stopped due to depression|0|||
143139110|NCT00116142|516057398|FG001|Overall Study|Patient stopped due to depression|1|||
143139111|NCT00116142|516057397|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
143139112|NCT00116142|516057398|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
143139113|NCT00116142|516057397|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
143139114|NCT00116142|516057398|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
143139115|NCT00116142|516057397|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
143139116|NCT00116142|516057398|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
143139117|NCT03154086|516057408|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
143139118|NCT03154086|516057409|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
143139119|NCT03154086|516057410|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
143139120|NCT03154086|516057411|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
143139121|NCT03154086|516057412|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
143139122|NCT03154086|516057413|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
143139123|NCT03154086|516057414|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
143139124|NCT03154086|516057415|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
143139125|NCT03154086|516057416|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
143139126|NCT03154086|516057417|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
143139127|NCT03154086|516057418|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
143139128|NCT03154086|516057419|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
143139129|NCT03154086|516057420|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
143139130|NCT03154086|516057421|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
143139131|NCT03154086|516057422|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
143139132|NCT03154086|516057408|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
143139133|NCT03154086|516057409|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
143139134|NCT03154086|516057410|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
143139135|NCT03154086|516057411|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
143139136|NCT03154086|516057412|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
143139137|NCT03154086|516057413|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
143139138|NCT03154086|516057414|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
143139139|NCT03154086|516057415|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
143139140|NCT03154086|516057416|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
143472787|NCT01493557|517278719|FG002|Randomized to Management Strategies|Protocol Violation|0|||
143139141|NCT03154086|516057417|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
143139142|NCT03154086|516057418|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
143139143|NCT03154086|516057419|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
143139144|NCT03154086|516057420|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
143139145|NCT03154086|516057421|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
143139146|NCT03154086|516057422|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
143139147|NCT03154086|516057408|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
143139148|NCT03154086|516057409|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
143139149|NCT03154086|516057410|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
143139150|NCT03154086|516057411|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
143139151|NCT03154086|516057412|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
143139152|NCT03154086|516057413|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
143139153|NCT03154086|516057414|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
143139154|NCT03154086|516057415|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
143139155|NCT03154086|516057416|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
143139156|NCT03154086|516057417|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
143139157|NCT03154086|516057418|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
143139158|NCT03154086|516057419|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
143139159|NCT03154086|516057420|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
143139160|NCT03154086|516057421|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
143139161|NCT03154086|516057422|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
143139162|NCT03154086|516057408|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
143139163|NCT03154086|516057409|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
143139164|NCT03154086|516057410|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
143139165|NCT03154086|516057411|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
143139166|NCT03154086|516057412|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
143139167|NCT03154086|516057413|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
143139168|NCT03154086|516057414|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
143139169|NCT03154086|516057415|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
143139170|NCT03154086|516057416|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
143139171|NCT03154086|516057417|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
143139172|NCT03154086|516057418|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
143139173|NCT03154086|516057419|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
143139174|NCT03154086|516057420|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
143139175|NCT03154086|516057421|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
143139176|NCT03154086|516057422|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
143139177|NCT03154086|516057408|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
143139178|NCT03154086|516057409|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
143139179|NCT03154086|516057410|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
143139180|NCT03154086|516057411|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
143139181|NCT03154086|516057412|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
143139182|NCT03154086|516057413|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
143139183|NCT03154086|516057414|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
143139184|NCT03154086|516057415|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
143139185|NCT03154086|516057416|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
143139186|NCT03154086|516057417|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
143139187|NCT03154086|516057418|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
143139188|NCT03154086|516057419|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
143139189|NCT03154086|516057420|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
143139190|NCT03154086|516057421|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
143139191|NCT03154086|516057422|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
143139192|NCT03154086|516057408|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
143139193|NCT03154086|516057409|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
143139194|NCT03154086|516057410|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
143139195|NCT03154086|516057411|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
143139196|NCT03154086|516057412|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
143139197|NCT03154086|516057413|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
143139198|NCT03154086|516057414|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
143139199|NCT03154086|516057415|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
143139200|NCT03154086|516057416|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
143139201|NCT03154086|516057417|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
143139202|NCT03154086|516057418|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
143139203|NCT03154086|516057419|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
143139204|NCT03154086|516057420|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
143139205|NCT03154086|516057421|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
143139206|NCT03154086|516057422|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
143139207|NCT03154086|516057408|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
143139208|NCT03154086|516057409|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
143139209|NCT03154086|516057410|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
143139210|NCT03154086|516057411|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
143139211|NCT03154086|516057412|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
143139212|NCT03154086|516057413|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
143139213|NCT03154086|516057414|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
143139214|NCT03154086|516057415|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
143139215|NCT03154086|516057416|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
143139216|NCT03154086|516057417|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
143139217|NCT03154086|516057418|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
143139218|NCT03154086|516057419|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
143139219|NCT03154086|516057420|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
143139220|NCT03154086|516057421|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
143139221|NCT03154086|516057422|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
143139222|NCT01704261|516057423|FG000|Overall Study|Withdrawal by Subject|12|||
143139223|NCT01704261|516057424|FG001|Overall Study|Withdrawal by Subject|15|||
143139224|NCT01704261|516057423|FG000|Overall Study|Lost to Follow-up|1|||
143472788|NCT01493557|517278717|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
143472789|NCT01493557|517278718|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
143472790|NCT01493557|517278719|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
143472791|NCT01493557|517278717|FG000|Randomized to Management Strategies|Other than stated above|1|||
143472792|NCT01493557|517278718|FG001|Randomized to Management Strategies|Other than stated above|3|||
143472793|NCT01493557|517278719|FG002|Randomized to Management Strategies|Other than stated above|0|||
143472794|NCT01493557|517278717|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
143472795|NCT01493557|517278718|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
143472796|NCT01493557|517278719|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
143472797|NCT01493557|517278717|FG000|Adding the Second Strategy|Other adverse event|1|||
143472798|NCT01493557|517278718|FG001|Adding the Second Strategy|Other adverse event|2|||
143472799|NCT01493557|517278719|FG002|Adding the Second Strategy|Other adverse event|0|||
143472800|NCT01493557|517278717|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
143472801|NCT01493557|517278718|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
143472802|NCT01493557|517278719|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
143472803|NCT00404066|517278723|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
143472804|NCT00404066|517278723|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
143472805|NCT01118325|517278732|FG000|Overall Study|Adverse Event|1|||
143472806|NCT01118325|517278733|FG001|Overall Study|Adverse Event|0|||
143472807|NCT01118325|517278734|FG002|Overall Study|Adverse Event|1|||
143472808|NCT03678103|517278739|FG000|Overall Study|Withdrawn prior to completion|4|||
143472809|NCT05395104|517278746|FG000|Overall Study|Met Liver Stopping Criteria|1|||
143472810|NCT05395104|517278746|FG000|Overall Study|Withdrawal by Subject|1|||
143472811|NCT00381563|517278747|FG000|Overall Study|Withdrawal by Subject|5|||
143472812|NCT00381563|517278748|FG001|Overall Study|Withdrawal by Subject|5|||
143472813|NCT00381563|517278747|FG000|Overall Study|Lost to Follow-up|2|||
143139225|NCT01704261|516057424|FG001|Overall Study|Lost to Follow-up|0|||
143139226|NCT01909804|516057425|FG000|Overall Study|Randomized but Never Treated|0|||
143139227|NCT01909804|516057426|FG001|Overall Study|Randomized but Never Treated|0|||
143139228|NCT01909804|516057427|FG002|Overall Study|Randomized but Never Treated|0|||
143139229|NCT01909804|516057428|FG003|Overall Study|Randomized but Never Treated|0|||
143139230|NCT01909804|516057429|FG004|Overall Study|Randomized but Never Treated|0|||
143139231|NCT01909804|516057430|FG005|Overall Study|Randomized but Never Treated|0|||
143139232|NCT01909804|516057431|FG006|Overall Study|Randomized but Never Treated|1|||
143139233|NCT01909804|516057432|FG007|Overall Study|Randomized but Never Treated|0|||
143139234|NCT01909804|516057433|FG008|Overall Study|Randomized but Never Treated|0|||
143139235|NCT01909804|516057434|FG009|Overall Study|Randomized but Never Treated|0|||
143139236|NCT01909804|516057435|FG010|Overall Study|Randomized but Never Treated|0|||
143139237|NCT01909804|516057436|FG011|Overall Study|Randomized but Never Treated|1|||
143139238|NCT01909804|516057425|FG000|Overall Study|Death|0|||
143139239|NCT01909804|516057426|FG001|Overall Study|Death|0|||
143139240|NCT01909804|516057427|FG002|Overall Study|Death|0|||
143139241|NCT01909804|516057428|FG003|Overall Study|Death|0|||
143139242|NCT01909804|516057429|FG004|Overall Study|Death|0|||
143472814|NCT00381563|517278748|FG001|Overall Study|Lost to Follow-up|0|||
143472815|NCT00381563|517278747|FG000|Overall Study|Protocol Violation|0|||
143139243|NCT01909804|516057430|FG005|Overall Study|Death|0|||
143139244|NCT01909804|516057431|FG006|Overall Study|Death|0|||
143139245|NCT01909804|516057432|FG007|Overall Study|Death|0|||
143139246|NCT01909804|516057433|FG008|Overall Study|Death|0|||
143139247|NCT01909804|516057434|FG009|Overall Study|Death|0|||
143139248|NCT01909804|516057435|FG010|Overall Study|Death|1|||
143139249|NCT01909804|516057436|FG011|Overall Study|Death|0|||
143139250|NCT01909804|516057425|FG000|Overall Study|Lack of Efficacy|4|||
143139251|NCT01909804|516057426|FG001|Overall Study|Lack of Efficacy|1|||
143139252|NCT01909804|516057427|FG002|Overall Study|Lack of Efficacy|0|||
143139253|NCT01909804|516057428|FG003|Overall Study|Lack of Efficacy|0|||
143139254|NCT01909804|516057429|FG004|Overall Study|Lack of Efficacy|7|||
143139255|NCT01909804|516057430|FG005|Overall Study|Lack of Efficacy|3|||
143139256|NCT01909804|516057431|FG006|Overall Study|Lack of Efficacy|1|||
143139257|NCT01909804|516057432|FG007|Overall Study|Lack of Efficacy|1|||
143139258|NCT01909804|516057433|FG008|Overall Study|Lack of Efficacy|0|||
143139259|NCT01909804|516057434|FG009|Overall Study|Lack of Efficacy|1|||
143139260|NCT01909804|516057435|FG010|Overall Study|Lack of Efficacy|0|||
143139261|NCT01909804|516057436|FG011|Overall Study|Lack of Efficacy|1|||
143139262|NCT01909804|516057425|FG000|Overall Study|Withdrew Consent|0|||
143139263|NCT01909804|516057426|FG001|Overall Study|Withdrew Consent|0|||
143139264|NCT01909804|516057427|FG002|Overall Study|Withdrew Consent|0|||
143139265|NCT01909804|516057428|FG003|Overall Study|Withdrew Consent|0|||
143139266|NCT01909804|516057429|FG004|Overall Study|Withdrew Consent|1|||
143139267|NCT01909804|516057430|FG005|Overall Study|Withdrew Consent|1|||
143139268|NCT01909804|516057431|FG006|Overall Study|Withdrew Consent|0|||
143139269|NCT01909804|516057432|FG007|Overall Study|Withdrew Consent|0|||
143139270|NCT01909804|516057433|FG008|Overall Study|Withdrew Consent|0|||
143139271|NCT01909804|516057434|FG009|Overall Study|Withdrew Consent|0|||
143139272|NCT01909804|516057435|FG010|Overall Study|Withdrew Consent|0|||
143139273|NCT01909804|516057436|FG011|Overall Study|Withdrew Consent|0|||
143139274|NCT01909804|516057425|FG000|Overall Study|Protocol Violation|0|||
143139275|NCT01909804|516057426|FG001|Overall Study|Protocol Violation|0|||
143139276|NCT01909804|516057427|FG002|Overall Study|Protocol Violation|0|||
143139277|NCT01909804|516057428|FG003|Overall Study|Protocol Violation|0|||
143139278|NCT01909804|516057429|FG004|Overall Study|Protocol Violation|0|||
143139279|NCT01909804|516057430|FG005|Overall Study|Protocol Violation|0|||
143139280|NCT01909804|516057431|FG006|Overall Study|Protocol Violation|0|||
143139281|NCT01909804|516057432|FG007|Overall Study|Protocol Violation|0|||
143139282|NCT01909804|516057433|FG008|Overall Study|Protocol Violation|0|||
143139283|NCT01909804|516057434|FG009|Overall Study|Protocol Violation|0|||
143139284|NCT01909804|516057435|FG010|Overall Study|Protocol Violation|0|||
143139285|NCT01909804|516057436|FG011|Overall Study|Protocol Violation|1|||
143139286|NCT01673178|516057439|FG000|Overall Study|Lost to Follow-up|0|||
143139287|NCT01673178|516057440|FG001|Overall Study|Lost to Follow-up|1|||
143139288|NCT01673178|516057441|FG002|Overall Study|Lost to Follow-up|0|||
143139289|NCT01673178|516057442|FG003|Overall Study|Lost to Follow-up|0|||
143139290|NCT01673178|516057443|FG004|Overall Study|Lost to Follow-up|0|||
143139291|NCT01673178|516057439|FG000|Overall Study|Withdrawal by Subject|0|||
143139292|NCT01673178|516057440|FG001|Overall Study|Withdrawal by Subject|0|||
143139293|NCT01673178|516057441|FG002|Overall Study|Withdrawal by Subject|1|||
143139294|NCT01673178|516057442|FG003|Overall Study|Withdrawal by Subject|4|||
143139295|NCT01673178|516057443|FG004|Overall Study|Withdrawal by Subject|2|||
143139296|NCT01673178|516057439|FG000|Overall Study|Protocol Violation|1|||
143362036|NCT00783718|516867268|FG003|Induction Phase|Lack of Efficacy|0|||
143362037|NCT00783718|516867269|FG004|Induction Phase|Lack of Efficacy|0|||
143362038|NCT00783718|516867270|FG005|Induction Phase|Lack of Efficacy|0|||
143362039|NCT00783718|516867271|FG006|Induction Phase|Lack of Efficacy|0|||
143362040|NCT00783718|516867265|FG000|Induction Phase|Withdrawal by Subject|3|||
143362041|NCT00783718|516867266|FG001|Induction Phase|Withdrawal by Subject|4|||
143362042|NCT00783718|516867267|FG002|Induction Phase|Withdrawal by Subject|8|||
143362043|NCT00783718|516867268|FG003|Induction Phase|Withdrawal by Subject|0|||
143362044|NCT00783718|516867269|FG004|Induction Phase|Withdrawal by Subject|0|||
143362045|NCT00783718|516867270|FG005|Induction Phase|Withdrawal by Subject|0|||
143362046|NCT00783718|516867271|FG006|Induction Phase|Withdrawal by Subject|0|||
143362047|NCT00783718|516867265|FG000|Induction Phase|Lost to Follow-up|1|||
143362048|NCT00783718|516867266|FG001|Induction Phase|Lost to Follow-up|0|||
143362049|NCT00783718|516867267|FG002|Induction Phase|Lost to Follow-up|1|||
143362050|NCT00783718|516867268|FG003|Induction Phase|Lost to Follow-up|0|||
143362051|NCT00783718|516867269|FG004|Induction Phase|Lost to Follow-up|0|||
143362052|NCT00783718|516867270|FG005|Induction Phase|Lost to Follow-up|0|||
143139297|NCT01673178|516057440|FG001|Overall Study|Protocol Violation|1|||
143139298|NCT01673178|516057441|FG002|Overall Study|Protocol Violation|0|||
143139299|NCT01673178|516057442|FG003|Overall Study|Protocol Violation|1|||
143139300|NCT01673178|516057443|FG004|Overall Study|Protocol Violation|0|||
143139301|NCT01673178|516057439|FG000|Overall Study|Adverse Event|1|||
143139302|NCT01673178|516057440|FG001|Overall Study|Adverse Event|0|||
143139303|NCT01673178|516057441|FG002|Overall Study|Adverse Event|0|||
143139304|NCT01673178|516057442|FG003|Overall Study|Adverse Event|2|||
143362053|NCT00783718|516867271|FG006|Induction Phase|Lost to Follow-up|0|||
143362054|NCT00783718|516867265|FG000|Maintenance Phase|Adverse Event|12|||
143362055|NCT00783718|516867266|FG001|Maintenance Phase|Adverse Event|0|||
143139305|NCT01673178|516057443|FG004|Overall Study|Adverse Event|0|||
143362056|NCT00783718|516867267|FG002|Maintenance Phase|Adverse Event|0|||
143139306|NCT01673178|516057439|FG000|Overall Study|Other|1|||
143139307|NCT01673178|516057440|FG001|Overall Study|Other|0|||
143139308|NCT01673178|516057441|FG002|Overall Study|Other|2|||
143139309|NCT01673178|516057442|FG003|Overall Study|Other|1|||
143139310|NCT01673178|516057443|FG004|Overall Study|Other|0|||
143139311|NCT02557399|516057444|FG000|Overall Study|Adverse Event|6|||
143139312|NCT02557399|516057445|FG001|Overall Study|Adverse Event|5|||
143139313|NCT02557399|516057444|FG000|Overall Study|Protocol Violation|0|||
143139314|NCT02557399|516057445|FG001|Overall Study|Protocol Violation|1|||
143139315|NCT02557399|516057444|FG000|Overall Study|Protocol-defined stopping criteria|0|||
143139316|NCT02557399|516057445|FG001|Overall Study|Protocol-defined stopping criteria|1|||
143139317|NCT02557399|516057444|FG000|Overall Study|Withdrawal by Subject|1|||
143139318|NCT02557399|516057445|FG001|Overall Study|Withdrawal by Subject|1|||
143139319|NCT00931632|516057447|FG000|Overall Study|Withdrawal by Subject|2|||
143139320|NCT00931632|516057448|FG001|Overall Study|Withdrawal by Subject|3|||
143139321|NCT00931632|516057447|FG000|Overall Study|Adverse Event|19|||
143139322|NCT00931632|516057448|FG001|Overall Study|Adverse Event|15|||
143139323|NCT01419314|516057449|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
143139324|NCT01419314|516057450|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
143139325|NCT01419314|516057449|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
143472816|NCT00381563|517278748|FG001|Overall Study|Protocol Violation|1|||
143472817|NCT03974334|517278749|FG000|Overall Study|Lost to Follow-up|1|||
143472818|NCT02092350|517278750|FG000|Overall Study|Adverse Event|0|||
143472819|NCT02092350|517278751|FG001|Overall Study|Adverse Event|3|||
143472820|NCT02092350|517278750|FG000|Overall Study|Death|2|||
143472821|NCT02092350|517278751|FG001|Overall Study|Death|5|||
143472822|NCT02092350|517278750|FG000|Overall Study|Lost to Follow-up|3|||
143472823|NCT02092350|517278751|FG001|Overall Study|Lost to Follow-up|1|||
143472824|NCT02092350|517278750|FG000|Overall Study|Protocol Violation|1|||
143472825|NCT02092350|517278751|FG001|Overall Study|Protocol Violation|0|||
143472826|NCT02092350|517278750|FG000|Overall Study|Physician Decision|1|||
143472827|NCT02092350|517278751|FG001|Overall Study|Physician Decision|1|||
143472828|NCT02092350|517278750|FG000|Overall Study|Screen Failure|1|||
143014075|NCT02923115|515591599|FG005|Overall Study|Withdrawal by Subject|0|||
143139326|NCT01419314|516057450|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
143139327|NCT01419314|516057449|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
143139328|NCT01419314|516057450|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
143139329|NCT03372798|516057454|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
143139330|NCT03372798|516057455|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
143139331|NCT03372798|516057454|FG000|Overall Study|Failure of imaging probe|0|||
143139332|NCT03372798|516057455|FG001|Overall Study|Failure of imaging probe|1|||
143139333|NCT03234465|516057456|FG000|Overall Study|Adverse Event|4|||
143139334|NCT03234465|516057457|FG001|Overall Study|Adverse Event|2|||
143139335|NCT03234465|516057456|FG000|Overall Study|Death|0|||
143139336|NCT03234465|516057457|FG001|Overall Study|Death|1|||
143139337|NCT03234465|516057456|FG000|Overall Study|Lost to Follow-up|1|||
143139338|NCT03234465|516057457|FG001|Overall Study|Lost to Follow-up|1|||
143139339|NCT03234465|516057456|FG000|Overall Study|Withdrawal by Subject|12|||
143139340|NCT03234465|516057457|FG001|Overall Study|Withdrawal by Subject|27|||
143139341|NCT03234465|516057456|FG000|Overall Study|Symptomatic deterioration|0|||
143139342|NCT03234465|516057457|FG001|Overall Study|Symptomatic deterioration|1|||
143139343|NCT03234465|516057456|FG000|Overall Study|Non-compliance|2|||
143139344|NCT03234465|516057457|FG001|Overall Study|Non-compliance|0|||
143139345|NCT03234465|516057456|FG000|Overall Study|Other|14|||
143139346|NCT03234465|516057457|FG001|Overall Study|Other|8|||
143139347|NCT00606307|516057460|FG000|Overall Study|Adverse Event|2|||
143139348|NCT00606307|516057460|FG000|Overall Study|Withdrawal by Subject|2|||
143139349|NCT00606307|516057460|FG000|Overall Study|Disease progression|6|||
143139350|NCT00606307|516057460|FG000|Overall Study|QTc prolongation|1|||
143139351|NCT03368807|516057461|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
143139352|NCT03368807|516057461|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
143139353|NCT03368807|516057461|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
143139354|NCT03368807|516057461|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
143139355|NCT01118052|516057470|FG000|Overall Study|Never treated|2|||
143139356|NCT00369343|516057471|FG000|Double-blind Phase|Adverse Event|19|||
143139357|NCT00369343|516057472|FG001|Double-blind Phase|Adverse Event|4|||
143139358|NCT00369343|516057471|FG000|Double-blind Phase|Failed to return|2|||
143139359|NCT00369343|516057472|FG001|Double-blind Phase|Failed to return|0|||
143014076|NCT02923115|515591594|FG000|Overall Study|Randomized, but not dosed|0|||
143139360|NCT00369343|516057471|FG000|Double-blind Phase|Lost to Follow-up|9|||
143139361|NCT00369343|516057472|FG001|Double-blind Phase|Lost to Follow-up|2|||
143139362|NCT00369343|516057471|FG000|Double-blind Phase|Protocol Violation|2|||
143472829|NCT02092350|517278751|FG001|Overall Study|Screen Failure|0|||
143472830|NCT02092350|517278750|FG000|Overall Study|Withdrawal by Subject|2|||
143472831|NCT02092350|517278751|FG001|Overall Study|Withdrawal by Subject|2|||
143472832|NCT00931944|517278752|FG000|Overall Study|Adverse Event|4|||
143472833|NCT00931944|517278752|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
143139363|NCT00369343|516057472|FG001|Double-blind Phase|Protocol Violation|0|||
143139364|NCT00369343|516057471|FG000|Double-blind Phase|Withdrawal by Subject|8|||
143139365|NCT00369343|516057472|FG001|Double-blind Phase|Withdrawal by Subject|6|||
143139366|NCT00369343|516057471|FG000|Double-blind Phase|Lack of Efficacy|0|||
143139367|NCT00369343|516057472|FG001|Double-blind Phase|Lack of Efficacy|4|||
143139368|NCT00369343|516057471|FG000|Double-blind Phase|Protocol deviation|4|||
143139369|NCT00369343|516057472|FG001|Double-blind Phase|Protocol deviation|0|||
143139370|NCT00369343|516057471|FG000|Open-label Phase|Adverse Event|19|||
143139371|NCT00369343|516057472|FG001|Open-label Phase|Adverse Event|7|||
143139372|NCT00369343|516057471|FG000|Open-label Phase|Failed to return|4|||
143139373|NCT00369343|516057472|FG001|Open-label Phase|Failed to return|0|||
143139374|NCT00369343|516057471|FG000|Open-label Phase|Physician Decision|2|||
143139375|NCT00369343|516057472|FG001|Open-label Phase|Physician Decision|0|||
143139376|NCT00369343|516057471|FG000|Open-label Phase|Lost to Follow-up|5|||
143139377|NCT00369343|516057472|FG001|Open-label Phase|Lost to Follow-up|3|||
143139378|NCT00369343|516057471|FG000|Open-label Phase|inadvertently reported study completers|3|||
143139379|NCT00369343|516057472|FG001|Open-label Phase|inadvertently reported study completers|2|||
143139380|NCT00369343|516057471|FG000|Open-label Phase|Protocol Violation|1|||
143139381|NCT00369343|516057472|FG001|Open-label Phase|Protocol Violation|3|||
143139382|NCT00369343|516057471|FG000|Open-label Phase|Withdrawal by Subject|15|||
143139383|NCT00369343|516057472|FG001|Open-label Phase|Withdrawal by Subject|6|||
143139384|NCT00369343|516057471|FG000|Open-label Phase|Lack of Efficacy|4|||
143139385|NCT00369343|516057472|FG001|Open-label Phase|Lack of Efficacy|3|||
143139386|NCT00369343|516057471|FG000|Open-label Phase|Lack of continuance tolerability|3|||
143139387|NCT00369343|516057472|FG001|Open-label Phase|Lack of continuance tolerability|4|||
143139388|NCT00369343|516057471|FG000|Open-label Phase|did not take study drug|1|||
143139389|NCT00369343|516057472|FG001|Open-label Phase|did not take study drug|2|||
143139390|NCT00794664|516057473|FG000|Treatment Period|Withdrawal by Subject|0|||
143139391|NCT00794664|516057474|FG001|Treatment Period|Withdrawal by Subject|2|||
143139392|NCT00794664|516057473|FG000|Treatment Period|Protocol non-compliance|0|||
143139393|NCT00794664|516057474|FG001|Treatment Period|Protocol non-compliance|1|||
143139394|NCT00794664|516057473|FG000|Treatment Period|Other|0|||
143139395|NCT00794664|516057474|FG001|Treatment Period|Other|1|||
143139396|NCT00794664|516057473|FG000|Treatment Period|Adverse Event|1|||
143139397|NCT00794664|516057474|FG001|Treatment Period|Adverse Event|8|||
143139398|NCT00794664|516057473|FG000|Follow-up Period|Other|1|||
143139399|NCT00794664|516057474|FG001|Follow-up Period|Other|2|||
143139400|NCT00794664|516057473|FG000|Follow-up Period|Withdrawal by Subject|0|||
143139401|NCT00794664|516057474|FG001|Follow-up Period|Withdrawal by Subject|2|||
143139402|NCT00794664|516057473|FG000|Follow-up Period|Protocol non-compliance|0|||
143139403|NCT00794664|516057474|FG001|Follow-up Period|Protocol non-compliance|1|||
143139404|NCT01973218|516057475|FG000|Overall Study|Adverse Event|1|||
143139405|NCT01973218|516057476|FG001|Overall Study|Adverse Event|0|||
143139406|NCT01973218|516057475|FG000|Overall Study|Withdrawal by Subject|1|||
143139407|NCT01973218|516057476|FG001|Overall Study|Withdrawal by Subject|0|||
143139408|NCT02404545|516057479|FG000|Overall Study|Sponsor Termination|6|||
143139409|NCT02404545|516057480|FG001|Overall Study|Sponsor Termination|6|||
143139410|NCT00720278|516058946|FG000|Overall Study|Adverse Event|5|||
143139411|NCT00720278|516058947|FG001|Overall Study|Adverse Event|3|||
143139412|NCT00720278|516058948|FG002|Overall Study|Adverse Event|4|||
143139413|NCT00720278|516058946|FG000|Overall Study|Withdrawal by Subject|0|||
143139414|NCT00720278|516058947|FG001|Overall Study|Withdrawal by Subject|1|||
143139415|NCT00720278|516058948|FG002|Overall Study|Withdrawal by Subject|0|||
143139416|NCT00720278|516058946|FG000|Overall Study|Lost to Follow-up|0|||
143362057|NCT00783718|516867268|FG003|Maintenance Phase|Adverse Event|15|||
143362058|NCT00783718|516867269|FG004|Maintenance Phase|Adverse Event|7|||
143362059|NCT00783718|516867270|FG005|Maintenance Phase|Adverse Event|6|||
143362060|NCT00783718|516867271|FG006|Maintenance Phase|Adverse Event|16|||
143362061|NCT00783718|516867265|FG000|Maintenance Phase|Protocol Violation|1|||
143362062|NCT00783718|516867266|FG001|Maintenance Phase|Protocol Violation|0|||
143362063|NCT00783718|516867267|FG002|Maintenance Phase|Protocol Violation|0|||
143362064|NCT00783718|516867268|FG003|Maintenance Phase|Protocol Violation|0|||
143362065|NCT00783718|516867269|FG004|Maintenance Phase|Protocol Violation|0|||
143362066|NCT00783718|516867270|FG005|Maintenance Phase|Protocol Violation|0|||
143362067|NCT00783718|516867271|FG006|Maintenance Phase|Protocol Violation|2|||
143362068|NCT00783718|516867265|FG000|Maintenance Phase|Lack of Efficacy|83|||
143362069|NCT00783718|516867266|FG001|Maintenance Phase|Lack of Efficacy|0|||
143362070|NCT00783718|516867267|FG002|Maintenance Phase|Lack of Efficacy|0|||
143362071|NCT00783718|516867268|FG003|Maintenance Phase|Lack of Efficacy|61|||
143362072|NCT00783718|516867269|FG004|Maintenance Phase|Lack of Efficacy|31|||
143362073|NCT00783718|516867270|FG005|Maintenance Phase|Lack of Efficacy|33|||
143362074|NCT00783718|516867271|FG006|Maintenance Phase|Lack of Efficacy|155|||
143362075|NCT00783718|516867265|FG000|Maintenance Phase|Withdrawal by Subject|6|||
143362076|NCT00783718|516867266|FG001|Maintenance Phase|Withdrawal by Subject|0|||
143362077|NCT00783718|516867267|FG002|Maintenance Phase|Withdrawal by Subject|0|||
143362078|NCT00783718|516867268|FG003|Maintenance Phase|Withdrawal by Subject|2|||
143362079|NCT00783718|516867269|FG004|Maintenance Phase|Withdrawal by Subject|5|||
143472834|NCT00931944|517278752|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
143139417|NCT00720278|516058947|FG001|Overall Study|Lost to Follow-up|0|||
143139418|NCT00720278|516058948|FG002|Overall Study|Lost to Follow-up|1|||
143139419|NCT00720278|516058946|FG000|Overall Study|Non-compliance|1|||
143139420|NCT00720278|516058947|FG001|Overall Study|Non-compliance|0|||
143139421|NCT00720278|516058948|FG002|Overall Study|Non-compliance|0|||
143139422|NCT00720278|516058946|FG000|Overall Study|eligibility criteria violation|1|||
143139423|NCT00720278|516058947|FG001|Overall Study|eligibility criteria violation|0|||
143139424|NCT00720278|516058948|FG002|Overall Study|eligibility criteria violation|1|||
143139425|NCT00997334|516058951|FG000|Overall Study|still on therapy|12|||
143139426|NCT00997334|516058951|FG000|Overall Study|Adverse Event|3|||
143139427|NCT00997334|516058951|FG000|Overall Study|Patient non-compliance|1|||
143139428|NCT00997334|516058951|FG000|Overall Study|Withdrawal by Subject|3|||
143139429|NCT00997334|516058951|FG000|Overall Study|Death|2|||
143139430|NCT00997334|516058951|FG000|Overall Study|Urgent Palliative Care|2|||
143139431|NCT00997334|516058951|FG000|Overall Study|No lesion amenable|1|||
143139432|NCT00997334|516058951|FG000|Overall Study|Ineligible|1|||
143139433|NCT02791269|516058952|FG000|Overall Study|Lost to Follow-up|0|||
143139434|NCT02791269|516058953|FG001|Overall Study|Lost to Follow-up|1|||
143139435|NCT00607893|516058954|FG000|Overall Study|Lost to Follow-up|4|||
143139436|NCT00607893|516058955|FG001|Overall Study|Lost to Follow-up|0|||
143139437|NCT00607893|516058954|FG000|Overall Study|withdrew due to loss of interest|0|||
143139438|NCT00607893|516058955|FG001|Overall Study|withdrew due to loss of interest|1|||
143139439|NCT00607893|516058954|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
143139440|NCT00607893|516058955|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
143139441|NCT00607893|516058954|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
143139442|NCT00607893|516058955|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
143139443|NCT00607893|516058954|FG000|Overall Study|Declined to be treated|1|||
143139444|NCT00607893|516058955|FG001|Overall Study|Declined to be treated|0|||
143139445|NCT00607893|516058954|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
143139446|NCT00607893|516058955|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
143139447|NCT03408899|516058960|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
143139448|NCT00606008|516058961|FG000|Overall Study|Adverse Event|1|||
143139449|NCT00606008|516058961|FG000|Overall Study|Withdrawal by Subject|4|||
143139450|NCT02014272|516058974|FG000|Intervention Period 1|Withdrawal by Subject|1|||
143139451|NCT02014272|516058975|FG001|Intervention Period 1|Withdrawal by Subject|0|||
143139452|NCT02014272|516058974|FG000|Intervention Period 1|Adverse Event|0|||
143139453|NCT02014272|516058975|FG001|Intervention Period 1|Adverse Event|1|||
143139454|NCT01458587|516058978|FG000|Overall Study|Withdrawal by Subject|1|||
143139455|NCT01458587|516058979|FG001|Overall Study|Withdrawal by Subject|0|||
143139456|NCT02337491|516058981|FG000|Overall Study|Death|1|||
143139457|NCT02337491|516058982|FG001|Overall Study|Death|1|||
143139458|NCT02337491|516058981|FG000|Overall Study|Adverse Event|0|||
143139459|NCT02337491|516058982|FG001|Overall Study|Adverse Event|1|||
143139460|NCT02337491|516058981|FG000|Overall Study|Withdrawal by Subject|3|||
143139461|NCT02337491|516058982|FG001|Overall Study|Withdrawal by Subject|0|||
143139462|NCT02337491|516058981|FG000|Overall Study|Progressive Disease|44|||
143139463|NCT02337491|516058982|FG001|Overall Study|Progressive Disease|28|||
143362080|NCT00783718|516867270|FG005|Maintenance Phase|Withdrawal by Subject|2|||
143362081|NCT00783718|516867271|FG006|Maintenance Phase|Withdrawal by Subject|20|||
143362082|NCT00783718|516867265|FG000|Maintenance Phase|Lost to Follow-up|3|||
143362083|NCT00783718|516867266|FG001|Maintenance Phase|Lost to Follow-up|0|||
143362084|NCT00783718|516867267|FG002|Maintenance Phase|Lost to Follow-up|0|||
143362085|NCT00783718|516867268|FG003|Maintenance Phase|Lost to Follow-up|0|||
143362086|NCT00783718|516867269|FG004|Maintenance Phase|Lost to Follow-up|2|||
143362087|NCT00783718|516867270|FG005|Maintenance Phase|Lost to Follow-up|0|||
143362088|NCT00783718|516867271|FG006|Maintenance Phase|Lost to Follow-up|2|||
143362089|NCT01072929|516867274|FG000|Overall Study|Adverse Event|8|||
143362090|NCT01072929|516867275|FG001|Overall Study|Adverse Event|11|||
143362091|NCT01072929|516867276|FG002|Overall Study|Adverse Event|2|||
143362092|NCT01072929|516867274|FG000|Overall Study|Lack of Efficacy|7|||
143362093|NCT01072929|516867275|FG001|Overall Study|Lack of Efficacy|4|||
143362094|NCT01072929|516867276|FG002|Overall Study|Lack of Efficacy|0|||
143362095|NCT01072929|516867274|FG000|Overall Study|Withdrawal by Subject|7|||
143362096|NCT01072929|516867275|FG001|Overall Study|Withdrawal by Subject|15|||
143362097|NCT01072929|516867276|FG002|Overall Study|Withdrawal by Subject|3|||
143472835|NCT00931944|517278752|FG000|Overall Study|Death|28|||
143139464|NCT02337491|516058981|FG000|Overall Study|On Treatment|2|||
143139465|NCT02337491|516058982|FG001|Overall Study|On Treatment|0|||
143139466|NCT00095979|516058985|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
143139467|NCT02783066|516058987|FG000|Overall Study|Withdrawal by Subject|13|||
143139468|NCT00551369|516058988|FG000|Overall Study|Protocol Violation|5|||
143362098|NCT01072929|516867274|FG000|Overall Study|Protocol Violation|13|||
143362099|NCT01072929|516867275|FG001|Overall Study|Protocol Violation|11|||
143139469|NCT00551369|516058988|FG000|Overall Study|Withdrawal by Subject|1|||
143472836|NCT00931944|517278752|FG000|Overall Study|Other|2|||
143472837|NCT01829425|517278763|FG000|Overall Study|Withdrawal by Subject|4|||
143139470|NCT00551369|516058988|FG000|Overall Study|Not treated per protocol and re|1|||
143139471|NCT03530293|516058992|FG000|Pre-randomization|Adverse Event|12|||
143139472|NCT03530293|516058993|FG001|Pre-randomization|Adverse Event|0|||
143139473|NCT03530293|516058994|FG002|Pre-randomization|Adverse Event|0|||
143139474|NCT03530293|516058992|FG000|Pre-randomization|Protocol Violation|2|||
143139475|NCT03530293|516058993|FG001|Pre-randomization|Protocol Violation|0|||
143139476|NCT03530293|516058994|FG002|Pre-randomization|Protocol Violation|0|||
143139477|NCT03530293|516058992|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
143139478|NCT03530293|516058993|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
143139479|NCT03530293|516058994|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
143139480|NCT03530293|516058992|FG000|Pre-randomization|Withdrawal by Subject|5|||
143139481|NCT03530293|516058993|FG001|Pre-randomization|Withdrawal by Subject|0|||
143139482|NCT03530293|516058994|FG002|Pre-randomization|Withdrawal by Subject|0|||
143139483|NCT03530293|516058992|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
143139484|NCT03530293|516058993|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
143139485|NCT03530293|516058994|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
143139486|NCT03530293|516058992|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
143472838|NCT01829425|517278764|FG001|Overall Study|Withdrawal by Subject|3|||
143139487|NCT03530293|516058993|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
143139488|NCT03530293|516058994|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
143139489|NCT03530293|516058992|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
143139490|NCT03530293|516058993|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
143139491|NCT03530293|516058994|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
143139492|NCT03530293|516058992|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
143139493|NCT03530293|516058993|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
143139494|NCT03530293|516058994|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
143139495|NCT03530293|516058992|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
143139496|NCT03530293|516058993|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
143139497|NCT03530293|516058994|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
143139498|NCT01663623|516058995|FG000|Overall Study|Adverse Event|3|||
143139499|NCT01663623|516058996|FG001|Overall Study|Adverse Event|7|||
143139500|NCT01663623|516058995|FG000|Overall Study|Lack of Efficacy|5|||
143139501|NCT01663623|516058996|FG001|Overall Study|Lack of Efficacy|6|||
143139502|NCT01663623|516058995|FG000|Overall Study|Protocol Violation|0|||
143139503|NCT01663623|516058996|FG001|Overall Study|Protocol Violation|1|||
143139504|NCT01663623|516058995|FG000|Overall Study|Other-Study closed/terminated|1|||
143139505|NCT01663623|516058996|FG001|Overall Study|Other-Study closed/terminated|1|||
143139506|NCT01663623|516058995|FG000|Overall Study|Physician Decision|1|||
143139507|NCT01663623|516058996|FG001|Overall Study|Physician Decision|4|||
143139508|NCT01663623|516058995|FG000|Overall Study|Withdrawal by Subject|2|||
143139509|NCT01663623|516058996|FG001|Overall Study|Withdrawal by Subject|1|||
143139510|NCT02251275|516058997|FG000|Overall Study|Adverse Event|23|||
143139511|NCT02251275|516058998|FG001|Overall Study|Adverse Event|60|||
143139512|NCT02251275|516058999|FG002|Overall Study|Adverse Event|28|||
143139513|NCT02251275|516059000|FG003|Overall Study|Adverse Event|0|||
143139514|NCT02251275|516059001|FG004|Overall Study|Adverse Event|0|||
143139515|NCT02251275|516058997|FG000|Overall Study|Lost to Follow-up|5|||
143139516|NCT02251275|516058998|FG001|Overall Study|Lost to Follow-up|6|||
143139517|NCT02251275|516058999|FG002|Overall Study|Lost to Follow-up|4|||
143139518|NCT02251275|516059000|FG003|Overall Study|Lost to Follow-up|0|||
143139519|NCT02251275|516059001|FG004|Overall Study|Lost to Follow-up|0|||
143139520|NCT02251275|516058997|FG000|Overall Study|Physician Decision|19|||
143139521|NCT02251275|516058998|FG001|Overall Study|Physician Decision|30|||
143139522|NCT02251275|516058999|FG002|Overall Study|Physician Decision|26|||
143139523|NCT02251275|516059000|FG003|Overall Study|Physician Decision|0|||
143139524|NCT02251275|516059001|FG004|Overall Study|Physician Decision|1|||
143139525|NCT02251275|516058997|FG000|Overall Study|Protocol Deviation|0|||
143139526|NCT02251275|516058998|FG001|Overall Study|Protocol Deviation|0|||
143139527|NCT02251275|516058999|FG002|Overall Study|Protocol Deviation|1|||
143139528|NCT02251275|516059000|FG003|Overall Study|Protocol Deviation|0|||
143139529|NCT02251275|516059001|FG004|Overall Study|Protocol Deviation|0|||
143139530|NCT02251275|516058997|FG000|Overall Study|Withdrawal by Subject|25|||
143139531|NCT02251275|516058998|FG001|Overall Study|Withdrawal by Subject|51|||
143139532|NCT02251275|516058999|FG002|Overall Study|Withdrawal by Subject|35|||
143139533|NCT02251275|516059000|FG003|Overall Study|Withdrawal by Subject|1|||
143139534|NCT02251275|516059001|FG004|Overall Study|Withdrawal by Subject|0|||
143139535|NCT01004614|516059003|FG000|Washout|Withdrawal by Subject|0|||
143472839|NCT01829425|517278763|FG000|Overall Study|Lost to Follow-up|2|||
143472840|NCT01829425|517278764|FG001|Overall Study|Lost to Follow-up|1|||
143472841|NCT05211739|517278765|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
143139536|NCT01004614|516059004|FG001|Washout|Withdrawal by Subject|1|||
143139537|NCT01004614|516059005|FG002|Washout|Withdrawal by Subject|0|||
143139538|NCT01004614|516059006|FG003|Washout|Withdrawal by Subject|0|||
143472842|NCT05211739|517278766|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
143139539|NCT02530385|516059007|FG000|Overall Study|Withdrawal by Subject|0|||
143139540|NCT02530385|516059008|FG001|Overall Study|Withdrawal by Subject|1|||
143139541|NCT01569022|516059010|FG000|First Intervention|Lost to Follow-up|2|||
143139542|NCT01569022|516059011|FG001|First Intervention|Lost to Follow-up|1|||
143139543|NCT01569022|516059010|FG000|Second Intervention|Lost to Follow-up|2|||
143139544|NCT01569022|516059011|FG001|Second Intervention|Lost to Follow-up|2|||
143139545|NCT02111083|516059016|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
143139546|NCT02111083|516059017|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
143139547|NCT01302899|516059018|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
143139548|NCT01302899|516059019|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
143139549|NCT01302899|516059018|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
143139550|NCT01302899|516059019|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
143139551|NCT01462942|516059022|FG000|Overall Study|Adverse Event|7|||
143139552|NCT01462942|516059023|FG001|Overall Study|Adverse Event|12|||
143139553|NCT01462942|516059024|FG002|Overall Study|Adverse Event|10|||
143139554|NCT01462942|516059025|FG003|Overall Study|Adverse Event|11|||
143139555|NCT01462942|516059026|FG004|Overall Study|Adverse Event|11|||
143139556|NCT01462942|516059022|FG000|Overall Study|Other, including COPD exacerbation|3|||
143139557|NCT01462942|516059023|FG001|Overall Study|Other, including COPD exacerbation|5|||
143139558|NCT01462942|516059024|FG002|Overall Study|Other, including COPD exacerbation|2|||
143139559|NCT01462942|516059025|FG003|Overall Study|Other, including COPD exacerbation|8|||
143139560|NCT01462942|516059026|FG004|Overall Study|Other, including COPD exacerbation|5|||
143139561|NCT01462942|516059022|FG000|Overall Study|Withdrawal by Subject|14|||
143139562|NCT01462942|516059023|FG001|Overall Study|Withdrawal by Subject|10|||
143139563|NCT01462942|516059024|FG002|Overall Study|Withdrawal by Subject|14|||
143139564|NCT01462942|516059025|FG003|Overall Study|Withdrawal by Subject|16|||
143472843|NCT05211739|517278765|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
143472844|NCT05211739|517278766|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
143139565|NCT01462942|516059026|FG004|Overall Study|Withdrawal by Subject|19|||
143139566|NCT01462942|516059022|FG000|Overall Study|Lack of Efficacy|6|||
143139567|NCT01462942|516059023|FG001|Overall Study|Lack of Efficacy|0|||
143139568|NCT01462942|516059024|FG002|Overall Study|Lack of Efficacy|4|||
143139569|NCT01462942|516059025|FG003|Overall Study|Lack of Efficacy|5|||
143139570|NCT01462942|516059026|FG004|Overall Study|Lack of Efficacy|3|||
143139571|NCT01462942|516059022|FG000|Overall Study|Lost to Follow-up|0|||
143139572|NCT01462942|516059023|FG001|Overall Study|Lost to Follow-up|1|||
143139573|NCT01462942|516059024|FG002|Overall Study|Lost to Follow-up|1|||
143139574|NCT01462942|516059025|FG003|Overall Study|Lost to Follow-up|1|||
143139575|NCT01462942|516059026|FG004|Overall Study|Lost to Follow-up|1|||
143139576|NCT01462942|516059022|FG000|Overall Study|Protocol Violation|4|||
143472845|NCT05211739|517278765|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
143472846|NCT05211739|517278766|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
143472847|NCT05211739|517278765|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
143472848|NCT05211739|517278766|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
143472849|NCT03681951|517278767|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
143472850|NCT03681951|517278768|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
143472851|NCT03681951|517278769|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
143472852|NCT03681951|517278770|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
143139577|NCT01462942|516059023|FG001|Overall Study|Protocol Violation|6|||
143139578|NCT01462942|516059024|FG002|Overall Study|Protocol Violation|9|||
143139579|NCT01462942|516059025|FG003|Overall Study|Protocol Violation|9|||
143139580|NCT01462942|516059026|FG004|Overall Study|Protocol Violation|6|||
143139581|NCT02737722|516059029|FG000|Overall Study|Physician Decision|0|||
143139582|NCT02737722|516059030|FG001|Overall Study|Physician Decision|0|||
143139583|NCT02737722|516059031|FG002|Overall Study|Physician Decision|1|||
143139584|NCT02737722|516059032|FG003|Overall Study|Physician Decision|0|||
143139585|NCT02785939|516059043|FG000|Overall Study|Progression|25|||
143139586|NCT02785939|516059044|FG001|Overall Study|Progression|8|||
143139587|NCT02785939|516059043|FG000|Overall Study|Adverse Event|3|||
143139588|NCT02785939|516059044|FG001|Overall Study|Adverse Event|1|||
143139589|NCT02785939|516059043|FG000|Overall Study|Death|1|||
143139590|NCT02785939|516059044|FG001|Overall Study|Death|0|||
143139591|NCT02785939|516059043|FG000|Overall Study|Refusal|1|||
143139592|NCT02785939|516059044|FG001|Overall Study|Refusal|0|||
143139593|NCT02785939|516059043|FG000|Overall Study|Deteriorating health|1|||
143139594|NCT02785939|516059044|FG001|Overall Study|Deteriorating health|0|||
143139595|NCT02785939|516059043|FG000|Overall Study|Not protocol specified|0|||
143139596|NCT02785939|516059044|FG001|Overall Study|Not protocol specified|1|||
143139597|NCT01787552|516059047|FG000|Overall Study|Withdrawal by Subject|2|||
143139598|NCT01787552|516059048|FG001|Overall Study|Withdrawal by Subject|0|||
143139599|NCT01787552|516059049|FG002|Overall Study|Withdrawal by Subject|0|||
143139600|NCT01787552|516059050|FG003|Overall Study|Withdrawal by Subject|4|||
143139601|NCT01787552|516059047|FG000|Overall Study|Physician Decision|2|||
143139602|NCT01787552|516059048|FG001|Overall Study|Physician Decision|2|||
143139603|NCT01787552|516059049|FG002|Overall Study|Physician Decision|1|||
143139604|NCT01787552|516059050|FG003|Overall Study|Physician Decision|2|||
143139605|NCT01787552|516059047|FG000|Overall Study|Death|0|||
143139606|NCT01787552|516059048|FG001|Overall Study|Death|0|||
143139607|NCT01787552|516059049|FG002|Overall Study|Death|0|||
143139608|NCT01787552|516059050|FG003|Overall Study|Death|1|||
143139609|NCT01787552|516059047|FG000|Overall Study|Adverse Event|2|||
143139610|NCT01787552|516059048|FG001|Overall Study|Adverse Event|5|||
143139611|NCT01787552|516059049|FG002|Overall Study|Adverse Event|2|||
143139612|NCT01787552|516059050|FG003|Overall Study|Adverse Event|16|||
143139613|NCT01787552|516059047|FG000|Overall Study|Study terminated by Sponsor|0|||
143139614|NCT01787552|516059048|FG001|Overall Study|Study terminated by Sponsor|0|||
143139615|NCT01787552|516059049|FG002|Overall Study|Study terminated by Sponsor|1|||
143139616|NCT01787552|516059050|FG003|Overall Study|Study terminated by Sponsor|3|||
143139617|NCT01787552|516059047|FG000|Overall Study|Progressive Disease|2|||
143139618|NCT01787552|516059048|FG001|Overall Study|Progressive Disease|2|||
143139619|NCT01787552|516059049|FG002|Overall Study|Progressive Disease|1|||
143139620|NCT01787552|516059050|FG003|Overall Study|Progressive Disease|1|||
143139621|NCT05412134|516059052|FG000|Overall Study|Lost to Follow-up|2|||
143139622|NCT05412134|516059053|FG001|Overall Study|Lost to Follow-up|0|||
143139623|NCT00830128|516059055|FG000|Overall Study|Adverse Event|5|||
143139624|NCT00830128|516059055|FG000|Overall Study|Lack of Efficacy|7|||
143139625|NCT00830128|516059055|FG000|Overall Study|Protocol Violation|1|||
143139626|NCT00830128|516059055|FG000|Overall Study|Withdrawal by Subject|2|||
143139627|NCT00830128|516059055|FG000|Overall Study|Family obligation|1|||
143139628|NCT00830128|516059055|FG000|Overall Study|Relocation|1|||
143139629|NCT00830128|516059055|FG000|Overall Study|Work obligation|1|||
143139630|NCT00830128|516059055|FG000|Overall Study|Operating a vehicle|1|||
143139631|NCT00467519|516059064|FG000|Overall Study|Protocol Violation|8|||
143139632|NCT00467519|516059065|FG001|Overall Study|Protocol Violation|4|||
143139633|NCT00467519|516059064|FG000|Overall Study|Lost to Follow-up|2|||
143139634|NCT00467519|516059065|FG001|Overall Study|Lost to Follow-up|9|||
143139635|NCT00467519|516059064|FG000|Overall Study|Withdrawal by Subject|4|||
143139636|NCT00467519|516059065|FG001|Overall Study|Withdrawal by Subject|10|||
143139637|NCT01218802|516059067|FG000|Overall Study|Lost to Follow-up|5|||
143139638|NCT01218802|516059068|FG001|Overall Study|Lost to Follow-up|6|||
143139639|NCT01218802|516059067|FG000|Overall Study|Withdrawal by Subject|3|||
143139640|NCT01218802|516059068|FG001|Overall Study|Withdrawal by Subject|10|||
143139641|NCT01218802|516059067|FG000|Overall Study|Adverse Event|0|||
143139642|NCT01218802|516059068|FG001|Overall Study|Adverse Event|2|||
143139643|NCT01218802|516059067|FG000|Overall Study|Incarcerated|2|||
143139644|NCT01218802|516059068|FG001|Overall Study|Incarcerated|0|||
143139645|NCT04249427|516059077|FG000|Overall Study|Adverse Event|3|||
143139646|NCT04249427|516059078|FG001|Overall Study|Adverse Event|1|||
143139647|NCT04249427|516059077|FG000|Overall Study|Lack of Efficacy|0|||
143139648|NCT04249427|516059078|FG001|Overall Study|Lack of Efficacy|1|||
143139649|NCT04249427|516059077|FG000|Overall Study|Withdrawal by Subject|1|||
143139650|NCT04249427|516059078|FG001|Overall Study|Withdrawal by Subject|2|||
143139651|NCT02577029|516059081|FG000|Overall Study|Adverse Event|1|||
143139652|NCT02577029|516059082|FG001|Overall Study|Adverse Event|0|||
143139653|NCT02577029|516059083|FG002|Overall Study|Adverse Event|2|||
143139654|NCT02577029|516059084|FG003|Overall Study|Adverse Event|0|||
143139655|NCT02577029|516059085|FG004|Overall Study|Adverse Event|1|||
143139656|NCT02577029|516059086|FG005|Overall Study|Adverse Event|0|||
143139657|NCT02577029|516059087|FG006|Overall Study|Adverse Event|0|||
143139658|NCT02577029|516059088|FG007|Overall Study|Adverse Event|0|||
143139659|NCT02577029|516059081|FG000|Overall Study|Withdrawal by Subject|0|||
143139660|NCT02577029|516059082|FG001|Overall Study|Withdrawal by Subject|0|||
143139661|NCT02577029|516059083|FG002|Overall Study|Withdrawal by Subject|0|||
143139662|NCT02577029|516059084|FG003|Overall Study|Withdrawal by Subject|0|||
143139663|NCT02577029|516059085|FG004|Overall Study|Withdrawal by Subject|0|||
143139664|NCT02577029|516059086|FG005|Overall Study|Withdrawal by Subject|1|||
143139665|NCT02577029|516059087|FG006|Overall Study|Withdrawal by Subject|0|||
143139666|NCT02577029|516059088|FG007|Overall Study|Withdrawal by Subject|0|||
143139667|NCT02577029|516059081|FG000|Overall Study|Sponsor Termination of the Study|9|||
143139668|NCT02577029|516059082|FG001|Overall Study|Sponsor Termination of the Study|2|||
143139669|NCT02577029|516059083|FG002|Overall Study|Sponsor Termination of the Study|5|||
143139670|NCT02577029|516059084|FG003|Overall Study|Sponsor Termination of the Study|12|||
143139671|NCT02577029|516059085|FG004|Overall Study|Sponsor Termination of the Study|10|||
143139672|NCT02577029|516059086|FG005|Overall Study|Sponsor Termination of the Study|12|||
143139673|NCT02577029|516059087|FG006|Overall Study|Sponsor Termination of the Study|12|||
143139674|NCT02577029|516059088|FG007|Overall Study|Sponsor Termination of the Study|12|||
143139675|NCT02078817|516059089|FG000|Overall Study|Withdrawal by Subject|1|||
143139676|NCT02003144|516059090|FG000|Open Label Maintenance Phase|Other than specified|2|||
143139677|NCT02003144|516059091|FG001|Open Label Maintenance Phase|Other than specified|4|||
143139678|NCT02003144|516059090|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
143139679|NCT02003144|516059091|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
143139680|NCT02003144|516059090|FG000|Open Label Maintenance Phase|Pregnancy|0|||
143139681|NCT02003144|516059091|FG001|Open Label Maintenance Phase|Pregnancy|2|||
143139682|NCT02003144|516059090|FG000|Open Label Maintenance Phase|Physician Decision|1|||
143139683|NCT02003144|516059091|FG001|Open Label Maintenance Phase|Physician Decision|1|||
143139684|NCT02003144|516059090|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
143139685|NCT02003144|516059091|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
143139686|NCT02003144|516059090|FG000|Open Label Maintenance Phase|Adverse Event|2|||
143139687|NCT02003144|516059091|FG001|Open Label Maintenance Phase|Adverse Event|1|||
143139688|NCT01125930|516060977|FG000|Overall Study|Adverse Event|0|||
143139689|NCT01125930|516060978|FG001|Overall Study|Adverse Event|1|||
143139690|NCT01125930|516060977|FG000|Overall Study|Withdrawal by Subject|1|||
143139691|NCT01125930|516060978|FG001|Overall Study|Withdrawal by Subject|6|||
143139692|NCT01125930|516060977|FG000|Overall Study|Protocol Violation|0|||
143139693|NCT01125930|516060978|FG001|Overall Study|Protocol Violation|1|||
143139694|NCT01125930|516060977|FG000|Overall Study|Lost to Follow-up|0|||
143139695|NCT01125930|516060978|FG001|Overall Study|Lost to Follow-up|2|||
143139696|NCT00547339|516060979|FG000|Overall Study|Physician Decision|0|||
143139697|NCT00547339|516060980|FG001|Overall Study|Physician Decision|0|||
143139698|NCT00547339|516060981|FG002|Overall Study|Physician Decision|1|||
143139699|NCT00547339|516060982|FG003|Overall Study|Physician Decision|0|||
143139700|NCT01516216|516060983|FG000|Overall Study|Adverse Event|2|||
143139701|NCT01516216|516060984|FG001|Overall Study|Adverse Event|4|||
143139702|NCT01516216|516060983|FG000|Overall Study|Disease Progression|38|||
143139703|NCT01516216|516060984|FG001|Overall Study|Disease Progression|34|||
143139704|NCT01516216|516060983|FG000|Overall Study|Withdrawal by Subject|9|||
143139705|NCT01516216|516060984|FG001|Overall Study|Withdrawal by Subject|11|||
143139706|NCT01516216|516060983|FG000|Overall Study|Potentially Curative Resection|6|||
143139707|NCT01516216|516060984|FG001|Overall Study|Potentially Curative Resection|12|||
143139708|NCT01516216|516060983|FG000|Overall Study|Nonadherence|2|||
143139709|NCT01516216|516060984|FG001|Overall Study|Nonadherence|3|||
143139710|NCT01516216|516060983|FG000|Overall Study|Physician Decision|6|||
143139711|NCT01516216|516060984|FG001|Overall Study|Physician Decision|3|||
143139712|NCT01516216|516060983|FG000|Overall Study|Prolonged Treatment Delay|5|||
143139713|NCT01516216|516060984|FG001|Overall Study|Prolonged Treatment Delay|1|||
143139714|NCT01516216|516060983|FG000|Overall Study|Intercurrent Illness|1|||
143139715|NCT01516216|516060984|FG001|Overall Study|Intercurrent Illness|0|||
143139716|NCT01516216|516060983|FG000|Overall Study|Death|1|||
143139717|NCT01516216|516060984|FG001|Overall Study|Death|1|||
143139718|NCT03098979|516060985|FG000|Overall Study|Adverse Event|1|||
143139719|NCT03098979|516060986|FG001|Overall Study|Adverse Event|0|||
143139720|NCT03098979|516060987|FG002|Overall Study|Adverse Event|1|||
143139721|NCT03098979|516060988|FG003|Overall Study|Adverse Event|4|||
143139722|NCT03098979|516060989|FG004|Overall Study|Adverse Event|6|||
143139723|NCT03098979|516060990|FG005|Overall Study|Adverse Event|1|||
143139724|NCT03098979|516060985|FG000|Overall Study|Withdrawal by Subject|2|||
143139725|NCT03098979|516060986|FG001|Overall Study|Withdrawal by Subject|1|||
143139726|NCT03098979|516060987|FG002|Overall Study|Withdrawal by Subject|1|||
143139727|NCT03098979|516060988|FG003|Overall Study|Withdrawal by Subject|1|||
143139728|NCT03098979|516060989|FG004|Overall Study|Withdrawal by Subject|2|||
143139729|NCT03098979|516060990|FG005|Overall Study|Withdrawal by Subject|1|||
143139730|NCT03098979|516060985|FG000|Overall Study|Death|1|||
143139731|NCT03098979|516060986|FG001|Overall Study|Death|0|||
143472853|NCT03681951|517278771|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
143472854|NCT03681951|517278772|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
143472855|NCT03681951|517278773|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
143472856|NCT03681951|517278774|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
143472857|NCT03681951|517278767|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
143472858|NCT03681951|517278768|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
143472859|NCT03681951|517278769|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
143472860|NCT03681951|517278770|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
143472861|NCT03681951|517278771|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
143472862|NCT03681951|517278772|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
143472863|NCT03681951|517278773|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
143472864|NCT03681951|517278774|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
143139732|NCT03098979|516060987|FG002|Overall Study|Death|2|||
143139733|NCT03098979|516060988|FG003|Overall Study|Death|0|||
143139734|NCT03098979|516060989|FG004|Overall Study|Death|1|||
143139735|NCT03098979|516060990|FG005|Overall Study|Death|0|||
143139736|NCT03098979|516060985|FG000|Overall Study|Physician Decision|2|||
143139737|NCT03098979|516060986|FG001|Overall Study|Physician Decision|1|||
143139738|NCT03098979|516060987|FG002|Overall Study|Physician Decision|0|||
143139739|NCT03098979|516060988|FG003|Overall Study|Physician Decision|0|||
143139740|NCT03098979|516060989|FG004|Overall Study|Physician Decision|0|||
143139741|NCT03098979|516060990|FG005|Overall Study|Physician Decision|0|||
143139742|NCT03098979|516060985|FG000|Overall Study|Non-compliance|0|||
143139743|NCT03098979|516060986|FG001|Overall Study|Non-compliance|0|||
143139744|NCT03098979|516060987|FG002|Overall Study|Non-compliance|0|||
143139745|NCT03098979|516060988|FG003|Overall Study|Non-compliance|0|||
143139746|NCT03098979|516060989|FG004|Overall Study|Non-compliance|0|||
143139747|NCT03098979|516060990|FG005|Overall Study|Non-compliance|1|||
143139748|NCT03098979|516060985|FG000|Overall Study|Protocol Violation|0|||
143139749|NCT03098979|516060986|FG001|Overall Study|Protocol Violation|0|||
143139750|NCT03098979|516060987|FG002|Overall Study|Protocol Violation|0|||
143139751|NCT03098979|516060988|FG003|Overall Study|Protocol Violation|0|||
143139752|NCT03098979|516060989|FG004|Overall Study|Protocol Violation|0|||
143139753|NCT03098979|516060990|FG005|Overall Study|Protocol Violation|1|||
143139754|NCT02426684|516060991|FG000|Overall Study|Physician Decision|1|||
143139755|NCT03736967|516060992|FG000|Overall Study|Withdrawal by Subject|26|||
143139756|NCT03736967|516060993|FG001|Overall Study|Withdrawal by Subject|25|||
143139757|NCT03736967|516060994|FG002|Overall Study|Withdrawal by Subject|23|||
143139758|NCT03736967|516060995|FG003|Overall Study|Withdrawal by Subject|26|||
143139759|NCT03736967|516060992|FG000|Overall Study|Lost to Follow-up|3|||
143139760|NCT03736967|516060993|FG001|Overall Study|Lost to Follow-up|2|||
143139761|NCT03736967|516060994|FG002|Overall Study|Lost to Follow-up|1|||
143139762|NCT03736967|516060995|FG003|Overall Study|Lost to Follow-up|1|||
143139763|NCT03736967|516060992|FG000|Overall Study|Physician Decision|1|||
143139764|NCT03736967|516060993|FG001|Overall Study|Physician Decision|0|||
143139765|NCT03736967|516060994|FG002|Overall Study|Physician Decision|0|||
143139766|NCT03736967|516060995|FG003|Overall Study|Physician Decision|1|||
143139767|NCT03736967|516060992|FG000|Overall Study|Adverse Event|0|||
143139768|NCT03736967|516060993|FG001|Overall Study|Adverse Event|1|||
143139769|NCT03736967|516060994|FG002|Overall Study|Adverse Event|0|||
143139770|NCT03736967|516060995|FG003|Overall Study|Adverse Event|1|||
143139771|NCT03736967|516060992|FG000|Overall Study|Death|0|||
143139772|NCT03736967|516060993|FG001|Overall Study|Death|0|||
143139773|NCT03736967|516060994|FG002|Overall Study|Death|0|||
143139774|NCT03736967|516060995|FG003|Overall Study|Death|1|||
143139775|NCT03736967|516060992|FG000|Overall Study|Randomized but never treated|1|||
143139776|NCT03736967|516060993|FG001|Overall Study|Randomized but never treated|0|||
143139777|NCT03736967|516060994|FG002|Overall Study|Randomized but never treated|0|||
143139778|NCT03736967|516060995|FG003|Overall Study|Randomized but never treated|0|||
143139779|NCT02369653|516060996|FG000|Overall Study|Lost to Follow-up|0|||
143139780|NCT02369653|516060997|FG001|Overall Study|Lost to Follow-up|1|||
143139781|NCT02369653|516060996|FG000|Overall Study|Administrative reason by sponsor|0|||
143139782|NCT02369653|516060997|FG001|Overall Study|Administrative reason by sponsor|1|||
143139783|NCT02369653|516060996|FG000|Overall Study|Death|1|||
143139784|NCT02369653|516060997|FG001|Overall Study|Death|2|||
143139785|NCT02369653|516060996|FG000|Overall Study|Participant withdrew consent|13|||
143139786|NCT02369653|516060997|FG001|Overall Study|Participant withdrew consent|3|||
143139787|NCT02419807|516060998|FG000|Overall Study|Withdrawal by Subject|4|||
143139788|NCT02419807|516060998|FG000|Overall Study|Physician Decision|1|||
143139789|NCT02419807|516060998|FG000|Overall Study|Protocol Violation|5|||
143139790|NCT03587636|516060999|FG000|Overall Study|Lost to Follow-up|2|||
143139791|NCT03587636|516061000|FG001|Overall Study|Lost to Follow-up|5|||
143139792|NCT01603602|516061001|FG000|Overall Study|Adverse Event|1|||
143139793|NCT01603602|516061002|FG001|Overall Study|Adverse Event|0|||
143139794|NCT01603602|516061003|FG002|Overall Study|Adverse Event|0|||
143139795|NCT01603602|516061001|FG000|Overall Study|Personal Reasons|1|||
143139796|NCT01603602|516061002|FG001|Overall Study|Personal Reasons|0|||
143139797|NCT01603602|516061003|FG002|Overall Study|Personal Reasons|1|||
143139798|NCT00316004|516061004|FG000|Overall Study|Subject was not given study fluid.|14|||
143139799|NCT00316004|516061005|FG001|Overall Study|Subject was not given study fluid.|14|||
143139800|NCT00316004|516061006|FG002|Overall Study|Subject was not given study fluid.|21|||
143139801|NCT01065818|516061007|FG000|Overall Study|Withdrawal by Subject|1|||
143139802|NCT01065818|516061007|FG000|Overall Study|Not a candidate for surgery|1|||
143139803|NCT01118299|516061010|FG000|Overall Study|Death|7|||
143139804|NCT01118299|516061011|FG001|Overall Study|Death|5|||
143139805|NCT01118299|516061010|FG000|Overall Study|Withdrawal by Subject|8|||
143139806|NCT01118299|516061011|FG001|Overall Study|Withdrawal by Subject|8|||
143014077|NCT02923115|515591595|FG001|Overall Study|Randomized, but not dosed|0|||
143014078|NCT02923115|515591596|FG002|Overall Study|Randomized, but not dosed|3|||
143139807|NCT01118299|516061010|FG000|Overall Study|Lost to Follow-up|2|||
143139808|NCT01118299|516061011|FG001|Overall Study|Lost to Follow-up|1|||
143139809|NCT01118299|516061010|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
143139810|NCT01118299|516061011|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
143139811|NCT04459338|516061012|FG000|Overall Study|Loss of IV during study|1|||
143139812|NCT04459338|516061013|FG001|Overall Study|Loss of IV during study|0|||
143139813|NCT02665117|516061014|FG000|Overall Study|Physician Decision|1|||
143139814|NCT02665117|516061015|FG001|Overall Study|Physician Decision|0|||
143139815|NCT03712280|516061016|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
143139816|NCT03712280|516061017|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
143139817|NCT03712280|516061018|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
143139818|NCT03712280|516061019|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
143139819|NCT03712280|516061016|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
143139820|NCT03712280|516061017|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
143139821|NCT03712280|516061018|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
143139822|NCT03712280|516061019|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
143139823|NCT03712280|516061016|FG000|Overall Study|Adverse Event|0|||
143139824|NCT03712280|516061017|FG001|Overall Study|Adverse Event|0|||
143139825|NCT03712280|516061018|FG002|Overall Study|Adverse Event|1|||
143139826|NCT03712280|516061019|FG003|Overall Study|Adverse Event|0|||
143139827|NCT02152007|516061020|FG000|Overall Study|Withdrawal by Subject|1|||
143139828|NCT03502798|516061021|FG000|Overall Study|equipment failure|0|||
143139829|NCT03502798|516061022|FG001|Overall Study|equipment failure|7|||
143139830|NCT01603277|516061024|FG000|Overall Study|Adverse Event|1|||
143139831|NCT01603277|516061025|FG001|Overall Study|Adverse Event|2|||
143139832|NCT01603277|516061024|FG000|Overall Study|Physician Decision|0|||
143139833|NCT01603277|516061025|FG001|Overall Study|Physician Decision|1|||
143139834|NCT01603277|516061024|FG000|Overall Study|Protocol Violation|6|||
143139835|NCT01603277|516061025|FG001|Overall Study|Protocol Violation|10|||
143362100|NCT01072929|516867276|FG002|Overall Study|Protocol Violation|2|||
143362101|NCT01072929|516867274|FG000|Overall Study|Lost to Follow-up|8|||
143362102|NCT01072929|516867275|FG001|Overall Study|Lost to Follow-up|4|||
143362103|NCT01072929|516867276|FG002|Overall Study|Lost to Follow-up|1|||
143362104|NCT01072929|516867274|FG000|Overall Study|Noncompliance with study medication|0|||
143472865|NCT03681951|517278767|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
143472866|NCT03681951|517278768|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
143362105|NCT01072929|516867275|FG001|Overall Study|Noncompliance with study medication|3|||
143362106|NCT01072929|516867276|FG002|Overall Study|Noncompliance with study medication|0|||
143362107|NCT01072929|516867274|FG000|Overall Study|Noncompliance with study procedures|1|||
143362108|NCT01072929|516867275|FG001|Overall Study|Noncompliance with study procedures|0|||
143472867|NCT03681951|517278769|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
143472868|NCT03681951|517278770|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
143472869|NCT03681951|517278771|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
143139836|NCT01603277|516061024|FG000|Overall Study|Withdrawal by Subject|5|||
143139837|NCT01603277|516061025|FG001|Overall Study|Withdrawal by Subject|4|||
143139838|NCT01603277|516061024|FG000|Overall Study|Non-Compliance|2|||
143139839|NCT01603277|516061025|FG001|Overall Study|Non-Compliance|1|||
143139840|NCT01692119|516061026|FG000|Overall Study|Protocol Violation|3|||
143139841|NCT01692119|516061027|FG001|Overall Study|Protocol Violation|1|||
143139842|NCT01692119|516061026|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
143139843|NCT01692119|516061027|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
143139844|NCT00112957|516061028|FG000|Overall Study|Progressive disease|18|||
143139845|NCT00112957|516061028|FG000|Overall Study|Physician Decision|1|||
143472870|NCT03681951|517278772|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
143472871|NCT03681951|517278773|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
143139846|NCT03307174|516061029|FG000|Overall Study|Unplanned ICU Administrion|5|||
143139847|NCT03307174|516061030|FG001|Overall Study|Unplanned ICU Administrion|3|||
143139848|NCT03307174|516061029|FG000|Overall Study|Aborted Surgery|1|||
143139849|NCT03307174|516061030|FG001|Overall Study|Aborted Surgery|2|||
143139850|NCT03307174|516061029|FG000|Overall Study|Hypotension|6|||
143139851|NCT03307174|516061030|FG001|Overall Study|Hypotension|0|||
143139852|NCT03307174|516061029|FG000|Overall Study|Nonfunctional epidural|1|||
143139853|NCT03307174|516061030|FG001|Overall Study|Nonfunctional epidural|1|||
143139854|NCT03307174|516061029|FG000|Overall Study|Planned epidural removal|1|||
143139855|NCT03307174|516061030|FG001|Overall Study|Planned epidural removal|0|||
143139856|NCT03307174|516061029|FG000|Overall Study|Intrathecal catheter placement|0|||
143139857|NCT03307174|516061030|FG001|Overall Study|Intrathecal catheter placement|1|||
143139858|NCT03444584|516061033|FG000|Overall Study|Withdrawal by Subject|0|||
143139859|NCT03444584|516061034|FG001|Overall Study|Withdrawal by Subject|1|||
143139860|NCT03444584|516061033|FG000|Overall Study|Other|0|||
143139861|NCT03444584|516061034|FG001|Overall Study|Other|1|||
143139862|NCT03451045|516061035|FG000|Overall Study|Lack of Efficacy|3|||
143139863|NCT03451045|516061036|FG001|Overall Study|Lack of Efficacy|2|||
143139864|NCT03451045|516061037|FG002|Overall Study|Lack of Efficacy|2|||
143139865|NCT03451045|516061035|FG000|Overall Study|Physician Decision|1|||
143139866|NCT03451045|516061036|FG001|Overall Study|Physician Decision|1|||
143139867|NCT03451045|516061037|FG002|Overall Study|Physician Decision|1|||
143139868|NCT03451045|516061035|FG000|Overall Study|Withdrawal by Subject|4|||
143139869|NCT03451045|516061036|FG001|Overall Study|Withdrawal by Subject|0|||
143139870|NCT03451045|516061037|FG002|Overall Study|Withdrawal by Subject|5|||
143139871|NCT03451045|516061035|FG000|Overall Study|Pregnancy|0|||
143139872|NCT03451045|516061036|FG001|Overall Study|Pregnancy|0|||
143362109|NCT01072929|516867276|FG002|Overall Study|Noncompliance with study procedures|1|||
143139873|NCT03451045|516061037|FG002|Overall Study|Pregnancy|2|||
143139874|NCT03451045|516061035|FG000|Overall Study|Adverse Event|7|||
143139875|NCT03451045|516061036|FG001|Overall Study|Adverse Event|1|||
143139876|NCT03451045|516061037|FG002|Overall Study|Adverse Event|3|||
143362110|NCT01072929|516867274|FG000|Overall Study|Other|0|||
143139877|NCT03451045|516061035|FG000|Overall Study|Non-compliance with study|2|||
143139878|NCT03451045|516061036|FG001|Overall Study|Non-compliance with study|0|||
143139879|NCT03451045|516061037|FG002|Overall Study|Non-compliance with study|1|||
143139880|NCT03451045|516061035|FG000|Overall Study|any other reason|10|||
143139881|NCT03451045|516061036|FG001|Overall Study|any other reason|2|||
143139882|NCT03451045|516061037|FG002|Overall Study|any other reason|13|||
143139883|NCT01142336|516061038|FG000|Overall Study|Adverse Event|1|||
143139884|NCT01142336|516061039|FG001|Overall Study|Adverse Event|1|||
143139885|NCT01142336|516061038|FG000|Overall Study|Lost to Follow-up|0|||
143139886|NCT01142336|516061039|FG001|Overall Study|Lost to Follow-up|1|||
143139887|NCT00423046|516061040|FG000|Overall Study|Other|340|||
143139888|NCT00423046|516061041|FG001|Overall Study|Other|345|||
143139889|NCT02722967|516061042|FG000|Overall Study|Adverse Event|1|||
143139890|NCT02722967|516061043|FG001|Overall Study|Adverse Event|0|||
143139891|NCT02722967|516061044|FG002|Overall Study|Adverse Event|0|||
143139892|NCT02722967|516061042|FG000|Overall Study|Lost to Follow-up|0|||
143139893|NCT02722967|516061043|FG001|Overall Study|Lost to Follow-up|1|||
143139894|NCT02722967|516061044|FG002|Overall Study|Lost to Follow-up|0|||
143139895|NCT02722967|516061042|FG000|Overall Study|Non-compliance with patch wearing|2|||
143139896|NCT02722967|516061043|FG001|Overall Study|Non-compliance with patch wearing|1|||
143139897|NCT02722967|516061044|FG002|Overall Study|Non-compliance with patch wearing|1|||
143139898|NCT02722967|516061042|FG000|Overall Study|Withdrawal by Subject|1|||
143139899|NCT02722967|516061043|FG001|Overall Study|Withdrawal by Subject|0|||
143139900|NCT02722967|516061044|FG002|Overall Study|Withdrawal by Subject|1|||
143139901|NCT02722967|516061042|FG000|Overall Study|Physician Decision|1|||
143139902|NCT02722967|516061043|FG001|Overall Study|Physician Decision|0|||
143139903|NCT02722967|516061044|FG002|Overall Study|Physician Decision|0|||
143139904|NCT02722967|516061042|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
143139905|NCT02722967|516061043|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
143362111|NCT01072929|516867275|FG001|Overall Study|Other|3|||
143362112|NCT01072929|516867276|FG002|Overall Study|Other|0|||
143362113|NCT04833855|516867277|FG000|Overall Study|Decision by sponsor|0|||
143362114|NCT04833855|516867278|FG001|Overall Study|Decision by sponsor|1|||
143362115|NCT04833855|516867279|FG002|Overall Study|Decision by sponsor|0|||
143362116|NCT04833855|516867280|FG003|Overall Study|Decision by sponsor|0|||
143362117|NCT04833855|516867277|FG000|Overall Study|Withdrawal by Subject|4|||
143362118|NCT04833855|516867278|FG001|Overall Study|Withdrawal by Subject|1|||
143362119|NCT04833855|516867279|FG002|Overall Study|Withdrawal by Subject|3|||
143362120|NCT04833855|516867280|FG003|Overall Study|Withdrawal by Subject|1|||
143362121|NCT04833855|516867277|FG000|Overall Study|Lost to Follow-up|1|||
143362122|NCT04833855|516867278|FG001|Overall Study|Lost to Follow-up|0|||
143362123|NCT04833855|516867279|FG002|Overall Study|Lost to Follow-up|2|||
143362124|NCT04833855|516867280|FG003|Overall Study|Lost to Follow-up|2|||
143362125|NCT04833855|516867277|FG000|Overall Study|Protocol specified criteria|0|||
143362126|NCT04833855|516867278|FG001|Overall Study|Protocol specified criteria|0|||
143362127|NCT04833855|516867279|FG002|Overall Study|Protocol specified criteria|2|||
143362128|NCT04833855|516867280|FG003|Overall Study|Protocol specified criteria|1|||
143362129|NCT03782727|516867281|FG000|Overall Study|Lost to Follow-up|32|||
143362130|NCT03289455|516867284|FG000|Overall Study|Death|1|||
143362131|NCT03289455|516867285|FG001|Overall Study|Death|0|||
143362132|NCT03289455|516867286|FG002|Overall Study|Death|0|||
143362133|NCT03289455|516867284|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
143362134|NCT03289455|516867285|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
143362135|NCT03289455|516867286|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
143362136|NCT03289455|516867284|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
143362137|NCT03289455|516867285|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
143362138|NCT03289455|516867286|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
143362139|NCT03289455|516867284|FG000|Overall Study|Progressive disease|3|||
143362140|NCT03289455|516867285|FG001|Overall Study|Progressive disease|4|||
143362141|NCT03289455|516867286|FG002|Overall Study|Progressive disease|5|||
143362142|NCT00604786|516867287|FG000|Overall Study|Lost to Follow-up|2|||
143362143|NCT00604786|516867288|FG001|Overall Study|Lost to Follow-up|0|||
143362144|NCT00665561|516867293|FG000|Overall Study|Death recorded on subject summary pages|75|||
143362145|NCT00665561|516867294|FG001|Overall Study|Death recorded on subject summary pages|75|||
143362146|NCT00665561|516867293|FG000|Overall Study|Does not meet entrance criteria|19|||
143362147|NCT00665561|516867294|FG001|Overall Study|Does not meet entrance criteria|21|||
143362148|NCT00665561|516867293|FG000|Overall Study|Lost to Follow-up|203|||
143362149|NCT00665561|516867294|FG001|Overall Study|Lost to Follow-up|264|||
143362150|NCT00665561|516867293|FG000|Overall Study|Withdrawal by Subject|74|||
143362151|NCT00665561|516867294|FG001|Overall Study|Withdrawal by Subject|65|||
143362152|NCT00665561|516867293|FG000|Overall Study|Other|123|||
143362153|NCT00665561|516867294|FG001|Overall Study|Other|108|||
143139906|NCT02722967|516061044|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
143362154|NCT00665561|516867293|FG000|Overall Study|Site closed|8|||
143139907|NCT02391337|516061045|FG000|6 Months Follow-up|Death|5|||
143139908|NCT02391337|516061046|FG001|6 Months Follow-up|Death|4|||
143139909|NCT02391337|516061045|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
143139910|NCT02391337|516061046|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
143139911|NCT02391337|516061045|FG000|12 Months Follow-up|Death|2|||
143139912|NCT02391337|516061046|FG001|12 Months Follow-up|Death|0|||
143139913|NCT02391337|516061045|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
143139914|NCT02391337|516061046|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
143139915|NCT02391337|516061045|FG000|12 Months Follow-up|Lost to Follow-up|0|||
143139916|NCT02391337|516061046|FG001|12 Months Follow-up|Lost to Follow-up|2|||
143139917|NCT01286129|516061048|FG000|Overall Study|Withdrawal by Subject|4|||
143139918|NCT01286129|516061049|FG001|Overall Study|Withdrawal by Subject|1|||
143139919|NCT01286129|516061048|FG000|Overall Study|Could not comply with study requirements|4|||
143139920|NCT01286129|516061049|FG001|Overall Study|Could not comply with study requirements|4|||
143139921|NCT04142242|516061054|FG000|Stage I|Non-compliance with the protocol|1|||
143139922|NCT04142242|516061055|FG001|Stage I|Non-compliance with the protocol|0|||
143139923|NCT04142242|516061056|FG002|Stage I|Non-compliance with the protocol|0|||
143139924|NCT04142242|516061057|FG003|Stage I|Non-compliance with the protocol|0|||
143139925|NCT04142242|516061058|FG004|Stage I|Non-compliance with the protocol|0|||
143139926|NCT04142242|516061059|FG005|Stage I|Non-compliance with the protocol|1|||
143139927|NCT04142242|516061054|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
143139928|NCT04142242|516061055|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
143139929|NCT04142242|516061056|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
143139930|NCT04142242|516061057|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
143139931|NCT04142242|516061058|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
143139932|NCT04142242|516061059|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
143139933|NCT04142242|516061054|FG000|Stage II|Non-compliance with the protocol|0|||
143139934|NCT04142242|516061055|FG001|Stage II|Non-compliance with the protocol|0|||
143139935|NCT04142242|516061056|FG002|Stage II|Non-compliance with the protocol|0|||
143139936|NCT04142242|516061057|FG003|Stage II|Non-compliance with the protocol|2|||
143139937|NCT04142242|516061058|FG004|Stage II|Non-compliance with the protocol|0|||
143139938|NCT04142242|516061059|FG005|Stage II|Non-compliance with the protocol|0|||
143139939|NCT04142242|516061054|FG000|Stage II|Lost to Follow-up|0|||
143139940|NCT04142242|516061055|FG001|Stage II|Lost to Follow-up|0|||
143139941|NCT04142242|516061056|FG002|Stage II|Lost to Follow-up|1|||
143139942|NCT04142242|516061057|FG003|Stage II|Lost to Follow-up|2|||
143139943|NCT04142242|516061058|FG004|Stage II|Lost to Follow-up|0|||
143139944|NCT04142242|516061059|FG005|Stage II|Lost to Follow-up|0|||
143139945|NCT04142242|516061054|FG000|Stage II|Withdrawal by Subject|0|||
143139946|NCT04142242|516061055|FG001|Stage II|Withdrawal by Subject|0|||
143362155|NCT00665561|516867294|FG001|Overall Study|Site closed|0|||
143362156|NCT00665561|516867293|FG000|Overall Study|Withdrawn due to pregnancy|0|||
143362157|NCT00665561|516867294|FG001|Overall Study|Withdrawn due to pregnancy|1|||
143362158|NCT02337361|516867295|FG000|3-month Follow-up|Lost to Follow-up|19|||
143362159|NCT02337361|516867296|FG001|3-month Follow-up|Lost to Follow-up|14|||
143362160|NCT02337361|516867295|FG000|6-month Follow-up|Lost to Follow-up|2|||
143362161|NCT02337361|516867296|FG001|6-month Follow-up|Lost to Follow-up|4|||
143362162|NCT01101542|516867297|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
143362163|NCT01101542|516867297|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
143362164|NCT01101542|516867297|FG000|Year 4 Surveillance Period|Other|287|||
143362165|NCT01101542|516867297|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
143362166|NCT01101542|516867297|FG000|Year 5 Surveillance Period|Pregnancy|1|||
143362167|NCT01101542|516867297|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
143362168|NCT01101542|516867297|FG000|Year 6 Surveillance Period|Pregnancy|1|||
143362169|NCT01101542|516867297|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
143362170|NCT03015740|516867298|FG000|Overall Study|Adverse Event|1|||
143362171|NCT03015740|516867299|FG001|Overall Study|Adverse Event|0|||
143362172|NCT03015740|516867300|FG002|Overall Study|Adverse Event|0|||
143362173|NCT03015740|516867298|FG000|Overall Study|Death|3|||
143362174|NCT03015740|516867299|FG001|Overall Study|Death|5|||
143362175|NCT03015740|516867300|FG002|Overall Study|Death|0|||
143362176|NCT03015740|516867298|FG000|Overall Study|Withdrawal by Subject|2|||
143362177|NCT03015740|516867299|FG001|Overall Study|Withdrawal by Subject|0|||
143362178|NCT03015740|516867300|FG002|Overall Study|Withdrawal by Subject|0|||
143362179|NCT03253653|516867305|FG000|Overall Study|Withdrawal by Subject|4|||
143362180|NCT03253653|516867306|FG001|Overall Study|Withdrawal by Subject|1|||
143362181|NCT03253653|516867305|FG000|Overall Study|Protocol Violation|0|||
143362182|NCT03253653|516867306|FG001|Overall Study|Protocol Violation|5|||
143362183|NCT02206685|516869603|FG000|Overall Study|Surgery cancelled/changed|2|||
143362184|NCT02206685|516869604|FG001|Overall Study|Surgery cancelled/changed|3|||
143362185|NCT02206685|516869603|FG000|Overall Study|Withdrawal by Subject|1|||
143362186|NCT02206685|516869604|FG001|Overall Study|Withdrawal by Subject|2|||
143362187|NCT02206685|516869603|FG000|Overall Study|Protocol Violation|2|||
143362188|NCT02206685|516869604|FG001|Overall Study|Protocol Violation|2|||
143139947|NCT04142242|516061056|FG002|Stage II|Withdrawal by Subject|5|||
143139948|NCT04142242|516061057|FG003|Stage II|Withdrawal by Subject|9|||
143139949|NCT04142242|516061058|FG004|Stage II|Withdrawal by Subject|0|||
143139950|NCT04142242|516061059|FG005|Stage II|Withdrawal by Subject|0|||
143362189|NCT01345292|516869605|FG000|Overall Study|Withdrawal by Subject|2|||
143139951|NCT00846053|516061062|FG000|Overall Study|Physician Decision|3|||
143139952|NCT00846053|516061063|FG001|Overall Study|Physician Decision|0|||
143139953|NCT02783911|516061064|FG000|Overall Study|Lost to Follow-up|3|||
143139954|NCT02783911|516061065|FG001|Overall Study|Lost to Follow-up|32|||
143139955|NCT00062166|516061068|FG000|Overall Study|Withdrawal by Subject|6|||
143139956|NCT01041859|516061071|FG000|Open-Label Titration|Adverse Event|69|||
143139957|NCT01041859|516061072|FG001|Open-Label Titration|Adverse Event|0|||
143139958|NCT01041859|516061073|FG002|Open-Label Titration|Adverse Event|0|||
143139959|NCT01041859|516061071|FG000|Open-Label Titration|Lack of Efficacy|3|||
143139960|NCT01041859|516061072|FG001|Open-Label Titration|Lack of Efficacy|0|||
143139961|NCT01041859|516061073|FG002|Open-Label Titration|Lack of Efficacy|0|||
143139962|NCT01041859|516061071|FG000|Open-Label Titration|Lost to Follow-up|1|||
143139963|NCT01041859|516061072|FG001|Open-Label Titration|Lost to Follow-up|0|||
143139964|NCT01041859|516061073|FG002|Open-Label Titration|Lost to Follow-up|0|||
143139965|NCT01041859|516061071|FG000|Open-Label Titration|Physician Decision|1|||
143139966|NCT01041859|516061072|FG001|Open-Label Titration|Physician Decision|0|||
143139967|NCT01041859|516061073|FG002|Open-Label Titration|Physician Decision|0|||
143139968|NCT01041859|516061071|FG000|Open-Label Titration|Protocol Violation|1|||
143139969|NCT01041859|516061072|FG001|Open-Label Titration|Protocol Violation|0|||
143139970|NCT01041859|516061073|FG002|Open-Label Titration|Protocol Violation|0|||
143139971|NCT01041859|516061071|FG000|Open-Label Titration|Other|7|||
143139972|NCT01041859|516061072|FG001|Open-Label Titration|Other|0|||
143139973|NCT01041859|516061073|FG002|Open-Label Titration|Other|0|||
143139974|NCT01041859|516061071|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
143139975|NCT01041859|516061072|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
143139976|NCT01041859|516061073|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
143139977|NCT01041859|516061071|FG000|Open-Label Titration|Withdrawal by Subject|11|||
143139978|NCT01041859|516061072|FG001|Open-Label Titration|Withdrawal by Subject|0|||
143139979|NCT01041859|516061073|FG002|Open-Label Titration|Withdrawal by Subject|0|||
143139980|NCT01041859|516061071|FG000|Double-Blind Maintenance|Adverse Event|0|||
143139981|NCT01041859|516061072|FG001|Double-Blind Maintenance|Adverse Event|23|||
143139982|NCT01041859|516061073|FG002|Double-Blind Maintenance|Adverse Event|13|||
143139983|NCT01041859|516061071|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
143139984|NCT01041859|516061072|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
143139985|NCT01041859|516061073|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
143139986|NCT01041859|516061071|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
143139987|NCT01041859|516061072|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
143139988|NCT01041859|516061073|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
143139989|NCT01041859|516061071|FG000|Double-Blind Maintenance|Physician Decision|0|||
143139990|NCT01041859|516061072|FG001|Double-Blind Maintenance|Physician Decision|2|||
143139991|NCT01041859|516061073|FG002|Double-Blind Maintenance|Physician Decision|1|||
143139992|NCT01041859|516061071|FG000|Double-Blind Maintenance|Protocol Violation|0|||
143139993|NCT01041859|516061072|FG001|Double-Blind Maintenance|Protocol Violation|1|||
143139994|NCT01041859|516061073|FG002|Double-Blind Maintenance|Protocol Violation|3|||
143139995|NCT01041859|516061071|FG000|Double-Blind Maintenance|Other|0|||
143139996|NCT01041859|516061072|FG001|Double-Blind Maintenance|Other|6|||
143139997|NCT01041859|516061073|FG002|Double-Blind Maintenance|Other|2|||
143139998|NCT01041859|516061071|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
143139999|NCT01041859|516061072|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
143140000|NCT01041859|516061073|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
143140001|NCT01041859|516061071|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
143140002|NCT01041859|516061072|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
143140003|NCT01041859|516061073|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
143140004|NCT03329885|516061076|FG000|Overall Study|Sponsor discontinued the study early|0|||
143140005|NCT03329885|516061077|FG001|Overall Study|Sponsor discontinued the study early|0|||
143140006|NCT03329885|516061078|FG002|Overall Study|Sponsor discontinued the study early|0|||
143140007|NCT03329885|516061079|FG003|Overall Study|Sponsor discontinued the study early|0|||
143140008|NCT03329885|516061080|FG004|Overall Study|Sponsor discontinued the study early|0|||
143140009|NCT03329885|516061081|FG005|Overall Study|Sponsor discontinued the study early|0|||
143140010|NCT03329885|516061082|FG006|Overall Study|Sponsor discontinued the study early|1|||
143140011|NCT03329885|516061083|FG007|Overall Study|Sponsor discontinued the study early|1|||
143140012|NCT03329885|516061084|FG008|Overall Study|Sponsor discontinued the study early|0|||
143140013|NCT03608826|516061085|FG000|Overall Study|Death|3|||
143140014|NCT03608826|516061085|FG000|Overall Study|Heart Transplant|3|||
143140015|NCT03608826|516061085|FG000|Overall Study|Physician Decision|4|||
143140016|NCT00843492|516061086|FG000|Overall Study|Adverse Event|0|||
143140017|NCT00843492|516061087|FG001|Overall Study|Adverse Event|3|||
143140018|NCT00843492|516061086|FG000|Overall Study|Lost to Follow-up|4|||
143140019|NCT00843492|516061087|FG001|Overall Study|Lost to Follow-up|4|||
143140020|NCT00843492|516061086|FG000|Overall Study|Withdrawal by Subject|0|||
143140021|NCT00843492|516061087|FG001|Overall Study|Withdrawal by Subject|4|||
143140022|NCT00843492|516061086|FG000|Overall Study|Immobilization Stopped|1|||
143140023|NCT00843492|516061087|FG001|Overall Study|Immobilization Stopped|0|||
143140024|NCT00843492|516061086|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
143140025|NCT00843492|516061087|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
143140026|NCT00843492|516061086|FG000|Overall Study|Orthopedic Surgery|0|||
143140027|NCT00843492|516061087|FG001|Overall Study|Orthopedic Surgery|2|||
143140028|NCT00843492|516061086|FG000|Overall Study|Visit Not Performed|1|||
143140029|NCT00843492|516061087|FG001|Overall Study|Visit Not Performed|0|||
143140030|NCT00843492|516061086|FG000|Overall Study|Deep-vein Thrombosis|1|||
143140031|NCT00843492|516061087|FG001|Overall Study|Deep-vein Thrombosis|0|||
143140032|NCT01677741|516061088|FG000|Overall Study|Death|0|||
143140033|NCT01677741|516061089|FG001|Overall Study|Death|0|||
143140034|NCT01677741|516061090|FG002|Overall Study|Death|0|||
143140035|NCT01677741|516061091|FG003|Overall Study|Death|1|||
143140036|NCT01677741|516061092|FG004|Overall Study|Death|0|||
143140037|NCT01677741|516061093|FG005|Overall Study|Death|1|||
143140038|NCT01677741|516061094|FG006|Overall Study|Death|0|||
143140039|NCT01677741|516061095|FG007|Overall Study|Death|0|||
143140040|NCT01677741|516061088|FG000|Overall Study|Withdrawal by Subject|2|||
143140041|NCT01677741|516061089|FG001|Overall Study|Withdrawal by Subject|7|||
143140042|NCT01677741|516061090|FG002|Overall Study|Withdrawal by Subject|5|||
143140043|NCT01677741|516061091|FG003|Overall Study|Withdrawal by Subject|4|||
143140044|NCT01677741|516061092|FG004|Overall Study|Withdrawal by Subject|11|||
143140045|NCT01677741|516061093|FG005|Overall Study|Withdrawal by Subject|20|||
143140046|NCT01677741|516061094|FG006|Overall Study|Withdrawal by Subject|4|||
143140047|NCT01677741|516061095|FG007|Overall Study|Withdrawal by Subject|2|||
143140048|NCT01677741|516061088|FG000|Overall Study|Enrolled in a rollover study|0|||
143140049|NCT01677741|516061089|FG001|Overall Study|Enrolled in a rollover study|3|||
143140050|NCT01677741|516061090|FG002|Overall Study|Enrolled in a rollover study|2|||
143140051|NCT01677741|516061091|FG003|Overall Study|Enrolled in a rollover study|1|||
143140052|NCT01677741|516061092|FG004|Overall Study|Enrolled in a rollover study|6|||
143140053|NCT01677741|516061093|FG005|Overall Study|Enrolled in a rollover study|6|||
143140054|NCT01677741|516061094|FG006|Overall Study|Enrolled in a rollover study|7|||
143140055|NCT01677741|516061095|FG007|Overall Study|Enrolled in a rollover study|0|||
143140056|NCT01677741|516061088|FG000|Overall Study|Progressive disease|1|||
143140057|NCT01677741|516061089|FG001|Overall Study|Progressive disease|0|||
143140058|NCT01677741|516061090|FG002|Overall Study|Progressive disease|1|||
143140059|NCT01677741|516061091|FG003|Overall Study|Progressive disease|0|||
143140060|NCT01677741|516061092|FG004|Overall Study|Progressive disease|0|||
143140061|NCT01677741|516061093|FG005|Overall Study|Progressive disease|1|||
143140062|NCT01677741|516061094|FG006|Overall Study|Progressive disease|0|||
143140063|NCT01677741|516061095|FG007|Overall Study|Progressive disease|0|||
143140064|NCT00720499|516061096|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
143140065|NCT00720499|516061097|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
143140066|NCT00720499|516061096|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
143140067|NCT00720499|516061097|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
143140068|NCT00720499|516061096|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
143140069|NCT00720499|516061097|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
143140070|NCT00828711|516061099|FG000|Overall Study|Lost to Follow-up|1|||
143140071|NCT00828711|516061100|FG001|Overall Study|Lost to Follow-up|0|||
143140072|NCT00828711|516061101|FG002|Overall Study|Lost to Follow-up|0|||
143140073|NCT01618968|516061102|FG000|Overall Study|Adverse Event|1|||
143140074|NCT01618968|516061103|FG001|Overall Study|Adverse Event|0|||
143140075|NCT01618968|516061104|FG002|Overall Study|Adverse Event|0|||
143140076|NCT01618968|516061105|FG003|Overall Study|Adverse Event|0|||
143140077|NCT01618968|516061102|FG000|Overall Study|Death|0|||
143140078|NCT01618968|516061103|FG001|Overall Study|Death|0|||
143140079|NCT01618968|516061104|FG002|Overall Study|Death|0|||
143140080|NCT01618968|516061105|FG003|Overall Study|Death|1|||
143140081|NCT01326871|516061106|FG000|Overall Study|Major surgery|0|||
143140082|NCT01326871|516061107|FG001|Overall Study|Major surgery|1|||
143140083|NCT01326871|516061108|FG002|Overall Study|Major surgery|0|||
143140084|NCT01326871|516061106|FG000|Overall Study|SAE and death|0|||
143140085|NCT01326871|516061107|FG001|Overall Study|SAE and death|2|||
143140086|NCT01326871|516061108|FG002|Overall Study|SAE and death|0|||
143140087|NCT01326871|516061106|FG000|Overall Study|Physician decision and decreased performance status|0|||
143140088|NCT01326871|516061107|FG001|Overall Study|Physician decision and decreased performance status|1|||
143140089|NCT01326871|516061108|FG002|Overall Study|Physician decision and decreased performance status|0|||
143362190|NCT01345292|516869606|FG001|Overall Study|Withdrawal by Subject|0|||
143362191|NCT01345292|516869607|FG002|Overall Study|Withdrawal by Subject|1|||
143362192|NCT02703532|516869616|FG000|Overall Study|Withdrawal by Subject|0|||
143362193|NCT02703532|516869617|FG001|Overall Study|Withdrawal by Subject|1|||
143140090|NCT01326871|516061106|FG000|Overall Study|Disease progression|0|||
143140091|NCT01326871|516061107|FG001|Overall Study|Disease progression|11|||
143140092|NCT01326871|516061108|FG002|Overall Study|Disease progression|5|||
143140093|NCT01326871|516061106|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
143140094|NCT01326871|516061107|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
143140095|NCT01326871|516061108|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
143140096|NCT01326871|516061106|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
143140097|NCT01326871|516061107|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
143140098|NCT01326871|516061108|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
143140099|NCT01326871|516061106|FG000|Overall Study|Withdrawal by Subject|0|||
143140100|NCT01326871|516061107|FG001|Overall Study|Withdrawal by Subject|1|||
143140101|NCT01326871|516061108|FG002|Overall Study|Withdrawal by Subject|0|||
143140102|NCT01326871|516061106|FG000|Overall Study|DLT|0|||
143140103|NCT01326871|516061107|FG001|Overall Study|DLT|2|||
143140104|NCT01326871|516061108|FG002|Overall Study|DLT|0|||
143140105|NCT01326871|516061106|FG000|Overall Study|SAE, disease progression and subject decision|0|||
143140106|NCT01326871|516061107|FG001|Overall Study|SAE, disease progression and subject decision|1|||
143140107|NCT01326871|516061108|FG002|Overall Study|SAE, disease progression and subject decision|0|||
143140108|NCT01326871|516061106|FG000|Overall Study|Death|0|||
143140109|NCT01326871|516061107|FG001|Overall Study|Death|1|||
143140110|NCT01326871|516061108|FG002|Overall Study|Death|0|||
143140111|NCT01326871|516061106|FG000|Overall Study|Other|0|||
143140112|NCT01326871|516061107|FG001|Overall Study|Other|3|||
143140113|NCT01326871|516061108|FG002|Overall Study|Other|0|||
143140114|NCT01326871|516061106|FG000|Overall Study|SAE and disease progression|0|||
143140115|NCT01326871|516061107|FG001|Overall Study|SAE and disease progression|0|||
143140116|NCT01326871|516061108|FG002|Overall Study|SAE and disease progression|1|||
143140117|NCT01326871|516061106|FG000|Overall Study|SAE and physician decision|0|||
143140118|NCT01326871|516061107|FG001|Overall Study|SAE and physician decision|0|||
143140119|NCT01326871|516061108|FG002|Overall Study|SAE and physician decision|1|||
143140120|NCT01326871|516061106|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
143140121|NCT01326871|516061107|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
143140122|NCT01326871|516061108|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
143140123|NCT01326871|516061106|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
143140124|NCT01326871|516061107|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
143140125|NCT01326871|516061108|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
143140126|NCT01326871|516061106|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
143140127|NCT01326871|516061107|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
143140128|NCT01326871|516061108|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
143140129|NCT01326871|516061106|FG000|Overall Study|Physician Decision|0|||
143140130|NCT01326871|516061107|FG001|Overall Study|Physician Decision|0|||
143140131|NCT01326871|516061108|FG002|Overall Study|Physician Decision|1|||
143140132|NCT01326871|516061106|FG000|Overall Study|SAE|0|||
143140133|NCT01326871|516061107|FG001|Overall Study|SAE|0|||
143140134|NCT01326871|516061108|FG002|Overall Study|SAE|1|||
143140135|NCT01326871|516061106|FG000|Overall Study|Disease progression and death|0|||
143140136|NCT01326871|516061107|FG001|Overall Study|Disease progression and death|0|||
143140137|NCT01326871|516061108|FG002|Overall Study|Disease progression and death|1|||
143140138|NCT01326871|516061106|FG000|Overall Study|Subject decision|0|||
143140139|NCT01326871|516061107|FG001|Overall Study|Subject decision|0|||
143140140|NCT01326871|516061108|FG002|Overall Study|Subject decision|1|||
143140141|NCT01387269|516061112|FG000|Overall Study|Death|38|||
143140142|NCT01387269|516061113|FG001|Overall Study|Death|20|||
143140143|NCT01387269|516061112|FG000|Overall Study|Other|8|||
143140144|NCT01387269|516061113|FG001|Overall Study|Other|7|||
143140145|NCT01387269|516061112|FG000|Overall Study|Unrelated AE|12|||
143140146|NCT01387269|516061113|FG001|Overall Study|Unrelated AE|3|||
143140147|NCT01387269|516061112|FG000|Overall Study|Withdrawal by patient|32|||
143140148|NCT01387269|516061113|FG001|Overall Study|Withdrawal by patient|10|||
143140149|NCT01387269|516061112|FG000|Overall Study|Study drug-related AE|1|||
143140150|NCT01387269|516061113|FG001|Overall Study|Study drug-related AE|0|||
143140151|NCT01387269|516061112|FG000|Overall Study|Lost to Follow-up|1|||
143140152|NCT01387269|516061113|FG001|Overall Study|Lost to Follow-up|0|||
143140153|NCT01200329|516061114|FG000|Overall Study|Lack of financial coverage|2|||
143140154|NCT01200329|516061114|FG000|Overall Study|Progressive disease|1|||
143140155|NCT03087058|516061116|FG000|Overall Study|Withdrawal by Subject|2|||
143140156|NCT03087058|516061117|FG001|Overall Study|Withdrawal by Subject|0|||
143362194|NCT02703532|516869618|FG002|Overall Study|Withdrawal by Subject|0|||
143362195|NCT02703532|516869619|FG003|Overall Study|Withdrawal by Subject|1|||
143362196|NCT02703532|516869616|FG000|Overall Study|Lost to Follow-up|2|||
143362197|NCT02703532|516869617|FG001|Overall Study|Lost to Follow-up|0|||
143362198|NCT02703532|516869618|FG002|Overall Study|Lost to Follow-up|2|||
143362199|NCT02703532|516869619|FG003|Overall Study|Lost to Follow-up|0|||
143362200|NCT03738241|516869623|FG000|Overall Study|Withdrawal by Subject|0|||
143362201|NCT03738241|516869624|FG001|Overall Study|Withdrawal by Subject|0|||
143472872|NCT03681951|517278774|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
143140157|NCT03087058|516061118|FG002|Overall Study|Withdrawal by Subject|0|||
143140158|NCT00855218|516061119|FG000|Overall Study|Adverse Event|43|||
143140159|NCT00855218|516061120|FG001|Overall Study|Adverse Event|27|||
143362202|NCT03738241|516869625|FG002|Overall Study|Withdrawal by Subject|0|||
143362203|NCT03738241|516869626|FG003|Overall Study|Withdrawal by Subject|0|||
143362204|NCT03738241|516869627|FG004|Overall Study|Withdrawal by Subject|0|||
143362205|NCT03738241|516869628|FG005|Overall Study|Withdrawal by Subject|0|||
143362206|NCT03738241|516869629|FG006|Overall Study|Withdrawal by Subject|0|||
143362207|NCT03738241|516869630|FG007|Overall Study|Withdrawal by Subject|0|||
143140160|NCT00855218|516061119|FG000|Overall Study|Withdrawal by Subject|10|||
143140161|NCT00855218|516061120|FG001|Overall Study|Withdrawal by Subject|6|||
143140162|NCT00855218|516061119|FG000|Overall Study|Physician Decision|18|||
143140163|NCT00855218|516061120|FG001|Overall Study|Physician Decision|11|||
143140164|NCT00855218|516061119|FG000|Overall Study|Lost to Follow-up|0|||
143140165|NCT00855218|516061120|FG001|Overall Study|Lost to Follow-up|1|||
143140166|NCT00855218|516061119|FG000|Overall Study|Protocol Violation|5|||
143140167|NCT00855218|516061120|FG001|Overall Study|Protocol Violation|9|||
143140168|NCT00855218|516061119|FG000|Overall Study|non-compliant with study drug|3|||
143140169|NCT00855218|516061120|FG001|Overall Study|non-compliant with study drug|1|||
143140170|NCT00855218|516061119|FG000|Overall Study|patient convenience|2|||
143140171|NCT00855218|516061120|FG001|Overall Study|patient convenience|0|||
143140172|NCT00855218|516061119|FG000|Overall Study|technical problems|2|||
143140173|NCT00855218|516061120|FG001|Overall Study|technical problems|1|||
143140174|NCT00855218|516061119|FG000|Overall Study|Still treated with study medication|0|||
143140175|NCT00855218|516061120|FG001|Overall Study|Still treated with study medication|1|||
143140176|NCT00855218|516061119|FG000|Overall Study|Untreatable disease progression|54|||
143140177|NCT00855218|516061120|FG001|Overall Study|Untreatable disease progression|67|||
143140178|NCT00855218|516061119|FG000|Overall Study|Second malignancy|0|||
143140179|NCT00855218|516061120|FG001|Overall Study|Second malignancy|1|||
143140180|NCT00855218|516061119|FG000|Overall Study|Progression measurement proven|7|||
143140181|NCT00855218|516061120|FG001|Overall Study|Progression measurement proven|15|||
143140182|NCT00855218|516061119|FG000|Overall Study|Clinical endpoint reached|10|||
143140183|NCT00855218|516061120|FG001|Overall Study|Clinical endpoint reached|13|||
143140184|NCT03191552|516061126|FG000|Overall Study|Lost to Follow-up|1|||
143140185|NCT03191552|516061127|FG001|Overall Study|Lost to Follow-up|0|||
143140186|NCT03191552|516061128|FG002|Overall Study|Lost to Follow-up|0|||
143140187|NCT03191552|516061126|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
143140188|NCT03191552|516061127|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
143140189|NCT03191552|516061128|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
143140190|NCT01441973|516061129|FG000|Overall Study|Disease progression|8|||
143140191|NCT01441973|516061130|FG001|Overall Study|Disease progression|6|||
143140192|NCT01441973|516061129|FG000|Overall Study|Adverse event unrelated to study drug|3|||
143140193|NCT01441973|516061130|FG001|Overall Study|Adverse event unrelated to study drug|2|||
143140194|NCT01441973|516061129|FG000|Overall Study|Participant request to discontinue|1|||
143140195|NCT01441973|516061130|FG001|Overall Study|Participant request to discontinue|1|||
143140196|NCT01441973|516061129|FG000|Overall Study|Poor compliance/noncompliance|0|||
143140197|NCT01441973|516061130|FG001|Overall Study|Poor compliance/noncompliance|1|||
143140198|NCT01441973|516061129|FG000|Overall Study|Administrative reason by sponsor|3|||
143140199|NCT01441973|516061130|FG001|Overall Study|Administrative reason by sponsor|5|||
143140200|NCT01441973|516061129|FG000|Overall Study|Participant withdrew consent|0|||
143140201|NCT01441973|516061130|FG001|Overall Study|Participant withdrew consent|1|||
143140202|NCT02370511|516061131|FG000|Overall Study|Death|10|||
143140203|NCT02370511|516061132|FG001|Overall Study|Death|7|||
143140204|NCT02370511|516061133|FG002|Overall Study|Death|1|||
143140205|NCT02370511|516061131|FG000|Overall Study|Withdrawal by Subject|2|||
143140206|NCT02370511|516061132|FG001|Overall Study|Withdrawal by Subject|0|||
143140207|NCT02370511|516061133|FG002|Overall Study|Withdrawal by Subject|0|||
143140208|NCT02370511|516061131|FG000|Overall Study|Lost to Follow-up|0|||
143140209|NCT02370511|516061132|FG001|Overall Study|Lost to Follow-up|4|||
143140210|NCT02370511|516061133|FG002|Overall Study|Lost to Follow-up|0|||
143140211|NCT04356937|516061136|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
143140212|NCT04356937|516061137|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
143140213|NCT00617279|516061143|FG000|Overall Study|Study terminated by Sponsor|10|||
143140214|NCT00617279|516061144|FG001|Overall Study|Study terminated by Sponsor|15|||
143140215|NCT00617279|516061143|FG000|Overall Study|Graft abandonment|2|||
143362208|NCT03738241|516869631|FG008|Overall Study|Withdrawal by Subject|0|||
143140216|NCT00617279|516061144|FG001|Overall Study|Graft abandonment|0|||
143140217|NCT00617279|516061143|FG000|Overall Study|Lost to Follow-up|1|||
143140218|NCT00617279|516061144|FG001|Overall Study|Lost to Follow-up|0|||
143140219|NCT00617279|516061143|FG000|Overall Study|Death|1|||
143140220|NCT00617279|516061144|FG001|Overall Study|Death|2|||
143140221|NCT03882918|516061151|FG000|Overall Study|Study terminated by sponsor|98|||
143140222|NCT03882918|516061151|FG000|Overall Study|Protocol Violation|1|||
143362209|NCT03738241|516869632|FG009|Overall Study|Withdrawal by Subject|1|||
143362210|NCT03738241|516869623|FG000|Overall Study|Physician Decision|0|||
143140223|NCT03882918|516061151|FG000|Overall Study|Other|9|||
143140224|NCT03882918|516061151|FG000|Overall Study|Lack of Efficacy|14|||
143140225|NCT03882918|516061151|FG000|Overall Study|Adverse Event|13|||
143140226|NCT03882918|516061151|FG000|Overall Study|Withdrawal by Subject|5|||
143140227|NCT05117060|516061152|FG000|Overall Study|Adverse Event|3|||
143140228|NCT05117060|516061153|FG001|Overall Study|Adverse Event|5|||
143140229|NCT05117060|516061154|FG002|Overall Study|Adverse Event|6|||
143140230|NCT05117060|516061155|FG003|Overall Study|Adverse Event|1|||
143140231|NCT05117060|516061152|FG000|Overall Study|Lost to Follow-up|0|||
143140232|NCT05117060|516061153|FG001|Overall Study|Lost to Follow-up|0|||
143140233|NCT05117060|516061154|FG002|Overall Study|Lost to Follow-up|0|||
143140234|NCT05117060|516061155|FG003|Overall Study|Lost to Follow-up|1|||
143140235|NCT05117060|516061152|FG000|Overall Study|Lack of Efficacy|4|||
143140236|NCT05117060|516061153|FG001|Overall Study|Lack of Efficacy|5|||
143140237|NCT05117060|516061154|FG002|Overall Study|Lack of Efficacy|2|||
143140238|NCT05117060|516061155|FG003|Overall Study|Lack of Efficacy|6|||
143140239|NCT05117060|516061152|FG000|Overall Study|Withdrawal by Subject|8|||
143140240|NCT05117060|516061153|FG001|Overall Study|Withdrawal by Subject|5|||
143140241|NCT05117060|516061154|FG002|Overall Study|Withdrawal by Subject|5|||
143140242|NCT05117060|516061155|FG003|Overall Study|Withdrawal by Subject|6|||
143140243|NCT05117060|516061152|FG000|Overall Study|Other|2|||
143140244|NCT05117060|516061153|FG001|Overall Study|Other|1|||
143140245|NCT05117060|516061154|FG002|Overall Study|Other|3|||
143140246|NCT05117060|516061155|FG003|Overall Study|Other|1|||
143140247|NCT02160626|516061159|FG000|Overall Study|Adverse Event|1|||
143140248|NCT02160626|516061160|FG001|Overall Study|Adverse Event|0|||
143140249|NCT02160626|516061161|FG002|Overall Study|Adverse Event|0|||
143140250|NCT02160626|516061159|FG000|Overall Study|Schedule not conducive to study visits|0|||
143140251|NCT02160626|516061160|FG001|Overall Study|Schedule not conducive to study visits|0|||
143140252|NCT02160626|516061161|FG002|Overall Study|Schedule not conducive to study visits|1|||
143140253|NCT02160626|516061159|FG000|Overall Study|Withdrawal by Subject|0|||
143140254|NCT02160626|516061160|FG001|Overall Study|Withdrawal by Subject|1|||
143140255|NCT02160626|516061161|FG002|Overall Study|Withdrawal by Subject|0|||
143140256|NCT02034006|516063212|FG000|Overall Study|Withdrawal by Subject|7|||
143140257|NCT02034006|516063212|FG000|Overall Study|Lost to Follow-up|5|||
143140258|NCT02034006|516063212|FG000|Overall Study|Death|1|||
143140259|NCT02034006|516063212|FG000|Overall Study|Pregnancy|1|||
143140260|NCT01855958|516063216|FG000|Overall Study|Withdrawal by Subject|1|||
143140261|NCT01855958|516063217|FG001|Overall Study|Withdrawal by Subject|0|||
143140262|NCT04539275|516063220|FG000|Overall Study|Death|2|||
143140263|NCT04539275|516063221|FG001|Overall Study|Death|4|||
143140264|NCT04539275|516063220|FG000|Overall Study|Lost to Follow-up|1|||
143140265|NCT04539275|516063221|FG001|Overall Study|Lost to Follow-up|1|||
143140266|NCT04539275|516063220|FG000|Overall Study|Withdrawal by Subject|3|||
143140267|NCT04539275|516063221|FG001|Overall Study|Withdrawal by Subject|0|||
143140268|NCT01715831|516063224|FG000|Overall Study|Adverse Event|1|||
143140269|NCT03261401|516063225|FG000|Overall Study|Withdrawal by Subject|0|||
143140270|NCT03261401|516063226|FG001|Overall Study|Withdrawal by Subject|0|||
143140271|NCT03261401|516063227|FG002|Overall Study|Withdrawal by Subject|0|||
143140272|NCT03261401|516063228|FG003|Overall Study|Withdrawal by Subject|0|||
143140273|NCT03261401|516063229|FG004|Overall Study|Withdrawal by Subject|0|||
143140274|NCT03261401|516063230|FG005|Overall Study|Withdrawal by Subject|1|||
143140275|NCT03261401|516063231|FG006|Overall Study|Withdrawal by Subject|0|||
143140276|NCT03261401|516063232|FG007|Overall Study|Withdrawal by Subject|0|||
143140277|NCT03261401|516063233|FG008|Overall Study|Withdrawal by Subject|0|||
143140278|NCT03261401|516063234|FG009|Overall Study|Withdrawal by Subject|0|||
143140279|NCT03261401|516063235|FG010|Overall Study|Withdrawal by Subject|0|||
143140280|NCT03261401|516063236|FG011|Overall Study|Withdrawal by Subject|0|||
143140281|NCT03261401|516063237|FG012|Overall Study|Withdrawal by Subject|0|||
143140282|NCT03261401|516063225|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
143140283|NCT03261401|516063226|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
143140284|NCT03261401|516063227|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
143140285|NCT03261401|516063228|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
143140286|NCT03261401|516063229|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
143140287|NCT03261401|516063230|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
143140288|NCT03261401|516063231|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
143140289|NCT03261401|516063232|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
143140290|NCT03261401|516063233|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
143140291|NCT03261401|516063234|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
143140292|NCT03261401|516063235|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
143140293|NCT03261401|516063236|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
143140294|NCT03261401|516063237|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
143140295|NCT00941928|516063244|FG000|Overall Study|Withdrawal by Subject|1|||
143140296|NCT00941928|516063244|FG000|Overall Study|Disease Progression|1|||
143140297|NCT01670292|516063245|FG000|Overall Study|Lost to Follow-up|14|||
143140298|NCT00087178|516063248|FG000|Overall Study|No follow up data|5|||
143140299|NCT00087178|516063249|FG001|Overall Study|No follow up data|15|||
143140300|NCT00087178|516063248|FG000|Overall Study|No clinical assessment|1|||
143140301|NCT00087178|516063249|FG001|Overall Study|No clinical assessment|2|||
143140302|NCT00087178|516063248|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
143140303|NCT00087178|516063249|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
143140304|NCT04494646|516063250|FG000|Overall Study|Adverse Event|0|||
143140305|NCT04494646|516063251|FG001|Overall Study|Adverse Event|1|||
143140306|NCT04494646|516063250|FG000|Overall Study|Withdrawal by Subject|0|||
143140307|NCT04494646|516063251|FG001|Overall Study|Withdrawal by Subject|1|||
143140308|NCT04465422|516063264|FG000|Overall Study|Lost to Follow-up|0|||
143140309|NCT04465422|516063265|FG001|Overall Study|Lost to Follow-up|2|||
143140310|NCT00863707|516063278|FG000|Overall Study|Randomized, but drug not received|4|||
143140311|NCT00863707|516063279|FG001|Overall Study|Randomized, but drug not received|3|||
143140312|NCT03704064|516063280|FG000|Overall Study|Lost to Follow-up|8|||
143140313|NCT03704064|516063281|FG001|Overall Study|Lost to Follow-up|4|||
143140314|NCT03704064|516063280|FG000|Overall Study|Withdrawal by Subject|1|||
143140315|NCT03704064|516063281|FG001|Overall Study|Withdrawal by Subject|1|||
143140316|NCT03704064|516063280|FG000|Overall Study|No longer available for study visits|0|||
143140317|NCT03704064|516063281|FG001|Overall Study|No longer available for study visits|1|||
143140318|NCT03704064|516063280|FG000|Overall Study|Censoring event|1|||
143140319|NCT03704064|516063281|FG001|Overall Study|Censoring event|0|||
143140320|NCT00289276|516063282|FG000|Second Part of FAST Study (Expansion)|Death|0|||
143140321|NCT00289276|516063283|FG001|Second Part of FAST Study (Expansion)|Death|2|||
143140322|NCT00289276|516063282|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
143140323|NCT00289276|516063283|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
143140324|NCT00111761|516063284|FG000|Part 1|Physician Decision|0|||
143140325|NCT00111761|516063285|FG001|Part 1|Physician Decision|1|||
143140326|NCT00111761|516063284|FG000|Part 1|Death|0|||
143140327|NCT00111761|516063285|FG001|Part 1|Death|2|||
143140328|NCT00111761|516063284|FG000|Part 1|Other|0|||
143140329|NCT00111761|516063285|FG001|Part 1|Other|1|||
143140330|NCT00111761|516063284|FG000|Part 1|Withdrawal by Subject|0|||
143140331|NCT00111761|516063285|FG001|Part 1|Withdrawal by Subject|1|||
143140332|NCT00111761|516063284|FG000|Part 2|Adverse Event|1|||
143140333|NCT00111761|516063285|FG001|Part 2|Adverse Event|0|||
143140334|NCT00111761|516063284|FG000|Part 2|Physician Decision|1|||
143140335|NCT00111761|516063285|FG001|Part 2|Physician Decision|0|||
143140336|NCT00111761|516063284|FG000|Part 2|Death|1|||
143140337|NCT00111761|516063285|FG001|Part 2|Death|0|||
143140338|NCT00111761|516063284|FG000|Part 2|Disease progression|3|||
143140339|NCT00111761|516063285|FG001|Part 2|Disease progression|0|||
143140340|NCT00111761|516063284|FG000|Part 2|Protocol-specified criteria|1|||
143140341|NCT00111761|516063285|FG001|Part 2|Protocol-specified criteria|0|||
143140342|NCT00111761|516063284|FG000|Part 2|Other|1|||
143140343|NCT00111761|516063285|FG001|Part 2|Other|0|||
143140344|NCT00726609|516063286|FG000|Overall Study|Adverse Event|10|||
143140345|NCT00726609|516063286|FG000|Overall Study|Withdrawal by Subject|2|||
143140346|NCT00726609|516063286|FG000|Overall Study|Lack of Efficacy|25|||
143140347|NCT00726609|516063286|FG000|Overall Study|Other|16|||
143140348|NCT00726609|516063286|FG000|Overall Study|Missing|42|||
143140349|NCT00726609|516063286|FG000|Overall Study|Other|3|||
143140350|NCT02475369|516063290|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
143140351|NCT02475369|516063291|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
143140352|NCT03883386|516063297|FG000|First Assignment|Lost to Follow-up|1|||
143140353|NCT03883386|516063298|FG001|First Assignment|Lost to Follow-up|0|||
143140354|NCT03883386|516063297|FG000|First Assignment|Withdrawal by Subject|1|||
143140355|NCT03883386|516063298|FG001|First Assignment|Withdrawal by Subject|1|||
143140356|NCT00251758|516063299|FG000|Overall Study|Adverse Event|7|||
143140357|NCT00251758|516063300|FG001|Overall Study|Adverse Event|9|||
143140358|NCT00251758|516063301|FG002|Overall Study|Adverse Event|11|||
143140359|NCT00251758|516063299|FG000|Overall Study|Lost to Follow-up|4|||
143140360|NCT00251758|516063300|FG001|Overall Study|Lost to Follow-up|2|||
143140361|NCT00251758|516063301|FG002|Overall Study|Lost to Follow-up|5|||
143140362|NCT00251758|516063299|FG000|Overall Study|Withdrawal by Subject|13|||
143140363|NCT00251758|516063300|FG001|Overall Study|Withdrawal by Subject|7|||
143140364|NCT00251758|516063301|FG002|Overall Study|Withdrawal by Subject|3|||
143140365|NCT00251758|516063299|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
143140366|NCT00251758|516063300|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
143140367|NCT00251758|516063301|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
143140368|NCT00251758|516063299|FG000|Overall Study|Lack of Efficacy|3|||
143140369|NCT00251758|516063300|FG001|Overall Study|Lack of Efficacy|0|||
143140370|NCT00251758|516063301|FG002|Overall Study|Lack of Efficacy|0|||
143140371|NCT00251758|516063299|FG000|Overall Study|Noncompliant|0|||
143140372|NCT00251758|516063300|FG001|Overall Study|Noncompliant|2|||
143140373|NCT00251758|516063301|FG002|Overall Study|Noncompliant|2|||
143140374|NCT00251758|516063299|FG000|Overall Study|Pregnancy|0|||
143140375|NCT00251758|516063300|FG001|Overall Study|Pregnancy|1|||
143140376|NCT00251758|516063301|FG002|Overall Study|Pregnancy|0|||
143140377|NCT00251758|516063299|FG000|Overall Study|Per Subject Request|0|||
143140378|NCT00251758|516063300|FG001|Overall Study|Per Subject Request|0|||
143140379|NCT00251758|516063301|FG002|Overall Study|Per Subject Request|1|||
143140380|NCT00251758|516063299|FG000|Overall Study|Per Investigator Request|1|||
143140381|NCT00251758|516063300|FG001|Overall Study|Per Investigator Request|0|||
143140382|NCT00251758|516063301|FG002|Overall Study|Per Investigator Request|0|||
143140383|NCT03641508|516063305|FG000|First Injection|Lost to Follow-up|2|||
143140384|NCT03641508|516063306|FG001|First Injection|Lost to Follow-up|0|||
143140385|NCT00769561|516063309|FG000|Overall Study|Withdrawal by Subject|2|||
143140386|NCT00769561|516063310|FG001|Overall Study|Withdrawal by Subject|2|||
143140387|NCT00769561|516063309|FG000|Overall Study|Lost to Follow-up|1|||
143140388|NCT00769561|516063310|FG001|Overall Study|Lost to Follow-up|3|||
143140389|NCT03824561|516063318|FG000|Overall Study|Protocol Violation|19|||
143140390|NCT01149655|516063319|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
143140391|NCT01149655|516063320|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
143140392|NCT01149655|516063321|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
143140393|NCT01149655|516063322|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
143140394|NCT01149655|516063319|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
143140395|NCT01149655|516063320|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
143140396|NCT01149655|516063321|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
143140397|NCT01149655|516063322|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
143140398|NCT01149655|516063319|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
143140399|NCT01149655|516063320|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
143140400|NCT01149655|516063321|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
143140401|NCT01149655|516063322|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
143140402|NCT01149655|516063319|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
143140403|NCT01149655|516063320|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
143140404|NCT01149655|516063321|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
143140405|NCT01149655|516063322|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
143140406|NCT01149655|516063319|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
143140407|NCT01149655|516063320|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
143140408|NCT01149655|516063321|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
143140409|NCT01149655|516063322|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
143140410|NCT01149655|516063319|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
143140411|NCT01149655|516063320|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
143140412|NCT01149655|516063321|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
143140413|NCT01149655|516063322|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
143140414|NCT01149655|516063319|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
143140415|NCT01149655|516063320|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
143140416|NCT01149655|516063321|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
143140417|NCT01149655|516063322|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
143140418|NCT01149655|516063319|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
143140419|NCT01149655|516063320|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
143140420|NCT01149655|516063321|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
143140421|NCT01149655|516063322|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
143140422|NCT01149655|516063319|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
143140423|NCT01149655|516063320|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
143140424|NCT01149655|516063321|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
143140425|NCT01149655|516063322|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
143140426|NCT01149655|516063319|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
143140427|NCT01149655|516063320|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
143140428|NCT01149655|516063321|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
143140429|NCT01149655|516063322|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
143140430|NCT01149655|516063319|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
143140431|NCT01149655|516063320|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
143140432|NCT01149655|516063321|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
143140433|NCT01149655|516063322|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
143140434|NCT01149655|516063319|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
143140435|NCT01149655|516063320|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
143140436|NCT01149655|516063321|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
143140437|NCT01149655|516063322|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
143140438|NCT01149655|516063319|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
143140439|NCT01149655|516063320|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
143140440|NCT01149655|516063321|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
143140441|NCT01149655|516063322|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
143140442|NCT01149655|516063319|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
143140443|NCT01149655|516063320|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
143140444|NCT01149655|516063321|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
143140445|NCT01149655|516063322|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
143140446|NCT01149655|516063319|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
143140447|NCT01149655|516063320|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
143140448|NCT01149655|516063321|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
143140449|NCT01149655|516063322|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
143140450|NCT01149655|516063319|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
143140451|NCT01149655|516063320|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
143140452|NCT01149655|516063321|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
143140453|NCT01149655|516063322|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
143140454|NCT01265498|516063323|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
143140455|NCT01265498|516063324|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
143140456|NCT00921024|516063326|FG000|Overall Study|Lost to Follow-up|2|||
143140457|NCT00921024|516063327|FG001|Overall Study|Lost to Follow-up|0|||
143140458|NCT00921024|516063326|FG000|Overall Study|Received concomittant therapy|2|||
143140459|NCT00921024|516063327|FG001|Overall Study|Received concomittant therapy|0|||
143140460|NCT00921024|516063326|FG000|Overall Study|Withdrawal by Subject|0|||
143140461|NCT00921024|516063327|FG001|Overall Study|Withdrawal by Subject|3|||
143140462|NCT01499810|516063328|FG000|Overall Study|Lost to Follow-up|10|||
143140463|NCT01499810|516063328|FG000|Overall Study|Protocol Violation|1|||
143140464|NCT01499810|516063328|FG000|Overall Study|Withdrawal by Subject|1|||
143140465|NCT06996301|516063329|FG000|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
143140466|NCT06996301|516063330|FG001|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
143140467|NCT06996301|516063329|FG000|Overall Study|Patients with discordant diagnostic results|107|||
143140468|NCT06996301|516063330|FG001|Overall Study|Patients with discordant diagnostic results|90|||
143140469|NCT06996301|516063329|FG000|Overall Study|Lost to Follow-up|31|||
143140470|NCT06996301|516063330|FG001|Overall Study|Lost to Follow-up|56|||
143140471|NCT06996301|516063329|FG000|Overall Study|Withdrawal by Subject|12|||
143140472|NCT06996301|516063330|FG001|Overall Study|Withdrawal by Subject|7|||
143140473|NCT04030598|516063331|FG000|Overall Study|Voluntary Withdrawal|0|||
143140474|NCT04030598|516063332|FG001|Overall Study|Voluntary Withdrawal|1|||
143140475|NCT04030598|516063333|FG002|Overall Study|Voluntary Withdrawal|0|||
143140476|NCT03141359|516063336|FG000|Overall Study|Death|32|||
143140477|NCT03141359|516063336|FG000|Overall Study|Still On Study (in follow up)|29|||
143140478|NCT05079321|516063337|FG000|Overall Study|Withdrawal by Subject|2|||
143140479|NCT05079321|516063338|FG001|Overall Study|Withdrawal by Subject|2|||
143140480|NCT05079321|516063337|FG000|Overall Study|Lost to Follow-up|0|||
143140481|NCT05079321|516063338|FG001|Overall Study|Lost to Follow-up|1|||
143140482|NCT01884597|516063339|FG000|Overall Study|Adverse Event|0|||
143140483|NCT01884597|516063340|FG001|Overall Study|Adverse Event|0|||
143140484|NCT01884597|516063341|FG002|Overall Study|Adverse Event|1|||
143140485|NCT01884597|516063339|FG000|Overall Study|Lack of Efficacy|1|||
143140486|NCT01884597|516063340|FG001|Overall Study|Lack of Efficacy|0|||
143140487|NCT01884597|516063341|FG002|Overall Study|Lack of Efficacy|0|||
143140488|NCT01884597|516063339|FG000|Overall Study|Death|0|||
143140489|NCT01884597|516063340|FG001|Overall Study|Death|1|||
143140490|NCT01884597|516063341|FG002|Overall Study|Death|0|||
143140491|NCT02097823|516063342|FG000|Overall Study|Withdrawal by Subject|1|||
143140492|NCT02097823|516063343|FG001|Overall Study|Withdrawal by Subject|1|||
143140493|NCT01081626|516063344|FG000|Overall Study|Dosing error|1|||
143140494|NCT01081626|516063345|FG001|Overall Study|Dosing error|1|||
143140495|NCT01081626|516063344|FG000|Overall Study|Missing Estradiol|25|||
143140496|NCT01081626|516063345|FG001|Overall Study|Missing Estradiol|28|||
143140497|NCT01081626|516063344|FG000|Overall Study|Low antral follicle count|1|||
143140498|NCT01081626|516063345|FG001|Overall Study|Low antral follicle count|0|||
143140499|NCT01081626|516063344|FG000|Overall Study|Overstimulation|0|||
143140500|NCT01081626|516063345|FG001|Overall Study|Overstimulation|1|||
143140501|NCT01081626|516063344|FG000|Overall Study|Lost to Follow-up|0|||
143140502|NCT01081626|516063345|FG001|Overall Study|Lost to Follow-up|1|||
143140503|NCT01081626|516063344|FG000|Overall Study|Other|33|||
143140504|NCT01081626|516063345|FG001|Overall Study|Other|30|||
143140505|NCT01419535|516063347|FG000|Overall Study|could not maintain iv line|1|||
143140506|NCT01419535|516063348|FG001|Overall Study|could not maintain iv line|1|||
143140507|NCT01419535|516063347|FG000|Overall Study|Withdrawal by Subject|0|||
143140508|NCT01419535|516063348|FG001|Overall Study|Withdrawal by Subject|1|||
143140509|NCT05965752|516063351|FG000|Overall Study|Adverse Event|0|||
143140510|NCT05965752|516063352|FG001|Overall Study|Adverse Event|1|||
143140511|NCT05965752|516063353|FG002|Overall Study|Adverse Event|0|||
143140512|NCT05965752|516063354|FG003|Overall Study|Adverse Event|1|||
143140513|NCT05965752|516063355|FG004|Overall Study|Adverse Event|3|||
143140514|NCT05965752|516063351|FG000|Overall Study|Lost to Follow-up|2|||
143140515|NCT05965752|516063352|FG001|Overall Study|Lost to Follow-up|0|||
143140516|NCT05965752|516063353|FG002|Overall Study|Lost to Follow-up|1|||
143140517|NCT05965752|516063354|FG003|Overall Study|Lost to Follow-up|1|||
143140518|NCT05965752|516063355|FG004|Overall Study|Lost to Follow-up|1|||
143140519|NCT05965752|516063351|FG000|Overall Study|Withdrawal by Subject|2|||
143140520|NCT05965752|516063352|FG001|Overall Study|Withdrawal by Subject|2|||
143140521|NCT05965752|516063353|FG002|Overall Study|Withdrawal by Subject|1|||
143140522|NCT05965752|516063354|FG003|Overall Study|Withdrawal by Subject|5|||
143140523|NCT05965752|516063355|FG004|Overall Study|Withdrawal by Subject|0|||
143140524|NCT05965752|516063351|FG000|Overall Study|Disease Relapse|1|||
143472873|NCT02187809|517278775|FG000|Overall Study|The study was terminated|3|||
143472874|NCT01020448|517278776|FG000|Pre-assignment|Adverse Event|6|||
143140525|NCT05965752|516063352|FG001|Overall Study|Disease Relapse|0|||
143140526|NCT05965752|516063353|FG002|Overall Study|Disease Relapse|1|||
143140527|NCT05965752|516063354|FG003|Overall Study|Disease Relapse|0|||
143140528|NCT05965752|516063355|FG004|Overall Study|Disease Relapse|0|||
143140529|NCT05965752|516063351|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
143140530|NCT05965752|516063352|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
143140531|NCT05965752|516063353|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
143140532|NCT05965752|516063354|FG003|Overall Study|Failure to Meet Randomization Criteria|1|||
143140533|NCT05965752|516063355|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
143140534|NCT05965752|516063351|FG000|Overall Study|Unable to Return for Study Visits|0|||
143140535|NCT05965752|516063352|FG001|Overall Study|Unable to Return for Study Visits|1|||
143140536|NCT05965752|516063353|FG002|Overall Study|Unable to Return for Study Visits|0|||
143140537|NCT05965752|516063354|FG003|Overall Study|Unable to Return for Study Visits|3|||
143140538|NCT05965752|516063355|FG004|Overall Study|Unable to Return for Study Visits|1|||
143140539|NCT05965752|516063351|FG000|Overall Study|Early Termination|0|||
143140540|NCT05965752|516063352|FG001|Overall Study|Early Termination|0|||
143140541|NCT05965752|516063353|FG002|Overall Study|Early Termination|1|||
143140542|NCT05965752|516063354|FG003|Overall Study|Early Termination|0|||
143140543|NCT05965752|516063355|FG004|Overall Study|Early Termination|0|||
143140544|NCT05965752|516063351|FG000|Overall Study|Reported Unwanted Symptoms|0|||
143140545|NCT05965752|516063352|FG001|Overall Study|Reported Unwanted Symptoms|0|||
143140546|NCT05965752|516063353|FG002|Overall Study|Reported Unwanted Symptoms|0|||
143140547|NCT05965752|516063354|FG003|Overall Study|Reported Unwanted Symptoms|0|||
143140548|NCT05965752|516063355|FG004|Overall Study|Reported Unwanted Symptoms|1|||
143140549|NCT05965752|516063351|FG000|Overall Study|Did Not Want to be Randomized to Intervention|0|||
143140550|NCT05965752|516063352|FG001|Overall Study|Did Not Want to be Randomized to Intervention|0|||
143140551|NCT05965752|516063353|FG002|Overall Study|Did Not Want to be Randomized to Intervention|0|||
143140552|NCT05965752|516063354|FG003|Overall Study|Did Not Want to be Randomized to Intervention|0|||
143140553|NCT05965752|516063355|FG004|Overall Study|Did Not Want to be Randomized to Intervention|1|||
143140554|NCT02074514|516063356|FG000|Overall Study|Lack of Efficacy|3|||
143140555|NCT02074514|516063357|FG001|Overall Study|Lack of Efficacy|2|||
143140556|NCT02074514|516063356|FG000|Overall Study|Lost to Follow-up|0|||
143140557|NCT02074514|516063357|FG001|Overall Study|Lost to Follow-up|1|||
143140558|NCT02074514|516063356|FG000|Overall Study|Withdrew Consent|0|||
143140559|NCT02074514|516063357|FG001|Overall Study|Withdrew Consent|1|||
143140560|NCT01274351|516063358|FG000|Overall Study|Lost to Follow-up|1|||
143140561|NCT01274351|516063358|FG000|Overall Study|patient not compliant with the protocol|1|||
143140562|NCT01274351|516063358|FG000|Overall Study|Pregnancy|1|||
143140563|NCT01274351|516063358|FG000|Overall Study|Death|2|||
143140564|NCT01274351|516063358|FG000|Overall Study|Withdrawal by Subject|3|||
143140565|NCT01274351|516063358|FG000|Overall Study|Adverse Event|8|||
143140566|NCT01274351|516063358|FG000|Overall Study|progression of disease|3|||
143140567|NCT01274351|516063358|FG000|Overall Study|hospitalization|1|||
143140568|NCT03082729|516063359|FG000|Overall Study|Lost to Follow-up|7|||
143140569|NCT03082729|516063359|FG000|Overall Study|Physician Decision|2|||
143140570|NCT03082729|516063359|FG000|Overall Study|Withdrawal by Subject|1|||
143140571|NCT03082729|516063359|FG000|Overall Study|Lack of Efficacy|9|||
143140572|NCT03082729|516063359|FG000|Overall Study|Adverse Event|4|||
143140573|NCT03082729|516063359|FG000|Overall Study|Protocol Violation|6|||
143140574|NCT03082729|516063359|FG000|Overall Study|Fear of study procedure|1|||
143140575|NCT03082729|516063359|FG000|Overall Study|Scheduling conflict|1|||
143140576|NCT01296412|516063360|FG000|Overall Study|Adverse Event|8|||
143140577|NCT01296412|516063361|FG001|Overall Study|Adverse Event|29|||
143140578|NCT01296412|516063360|FG000|Overall Study|Lack of Efficacy|1|||
143140579|NCT01296412|516063361|FG001|Overall Study|Lack of Efficacy|0|||
143140580|NCT01296412|516063360|FG000|Overall Study|Lost to Follow-up|10|||
143140581|NCT01296412|516063361|FG001|Overall Study|Lost to Follow-up|7|||
143140582|NCT01296412|516063360|FG000|Overall Study|Non-compliance with study drug|1|||
143472875|NCT01020448|517278776|FG000|Pre-assignment|Withdrawal by Subject|5|||
143140583|NCT01296412|516063361|FG001|Overall Study|Non-compliance with study drug|2|||
143140584|NCT01296412|516063360|FG000|Overall Study|Other reason not specified|20|||
143140585|NCT01296412|516063361|FG001|Overall Study|Other reason not specified|15|||
143140586|NCT01296412|516063360|FG000|Overall Study|Physician Decision|1|||
143140587|NCT01296412|516063361|FG001|Overall Study|Physician Decision|3|||
143140588|NCT01296412|516063360|FG000|Overall Study|Pregnancy|0|||
143140589|NCT01296412|516063361|FG001|Overall Study|Pregnancy|1|||
143140590|NCT01296412|516063360|FG000|Overall Study|Withdrawal by Subject|10|||
143140591|NCT01296412|516063361|FG001|Overall Study|Withdrawal by Subject|13|||
143140592|NCT04239924|516063368|FG000|Overall Study|Lost to Follow-up|2|||
143140593|NCT00666237|516063369|FG000|Overall Study|Death|5|||
143140594|NCT00666237|516063370|FG001|Overall Study|Death|5|||
143140595|NCT00666237|516063369|FG000|Overall Study|Lost to Follow-up|29|||
143140596|NCT00666237|516063370|FG001|Overall Study|Lost to Follow-up|25|||
143140597|NCT01898078|516065428|FG000|Overall Study|Progressive Disease|1|||
143140598|NCT01898078|516065429|FG001|Overall Study|Progressive Disease|5|||
143140599|NCT01898078|516065428|FG000|Overall Study|Adverse Event|2|||
143140600|NCT01898078|516065429|FG001|Overall Study|Adverse Event|1|||
143140601|NCT01898078|516065428|FG000|Overall Study|Withdrawal by Subject|1|||
143140602|NCT01898078|516065429|FG001|Overall Study|Withdrawal by Subject|1|||
143140603|NCT01898078|516065428|FG000|Overall Study|Symptomatic Deterioration|2|||
143140604|NCT01898078|516065429|FG001|Overall Study|Symptomatic Deterioration|0|||
143140605|NCT01898078|516065428|FG000|Overall Study|Reason not Specified|0|||
143140606|NCT01898078|516065429|FG001|Overall Study|Reason not Specified|1|||
143140607|NCT00761319|516065430|FG000|Overall Study|Protocol Violation|21|||
143140608|NCT00761319|516065431|FG001|Overall Study|Protocol Violation|14|||
143140609|NCT00761319|516065430|FG000|Overall Study|Adverse Event|11|||
143140610|NCT00761319|516065431|FG001|Overall Study|Adverse Event|7|||
143140611|NCT00761319|516065430|FG000|Overall Study|Withdrawal by Subject|8|||
143140612|NCT00761319|516065431|FG001|Overall Study|Withdrawal by Subject|7|||
143140613|NCT00761319|516065430|FG000|Overall Study|Noncompliance|4|||
143140614|NCT00761319|516065431|FG001|Overall Study|Noncompliance|3|||
143140615|NCT00761319|516065430|FG000|Overall Study|Lost to Follow-up|1|||
143140616|NCT00761319|516065431|FG001|Overall Study|Lost to Follow-up|1|||
143140617|NCT00761319|516065430|FG000|Overall Study|Nonspecified|2|||
143140618|NCT00761319|516065431|FG001|Overall Study|Nonspecified|2|||
143140619|NCT00761319|516065430|FG000|Overall Study|Missing|1|||
143140620|NCT00761319|516065431|FG001|Overall Study|Missing|0|||
143140621|NCT00900562|516065432|FG000|Overall Study|Progressive disease|9|||
143140622|NCT00900562|516065433|FG001|Overall Study|Progressive disease|5|||
143140623|NCT00900562|516065432|FG000|Overall Study|Toxicity|1|||
143140624|NCT00900562|516065433|FG001|Overall Study|Toxicity|0|||
143140625|NCT00900562|516065432|FG000|Overall Study|Death|1|||
143140626|NCT00900562|516065433|FG001|Overall Study|Death|1|||
143140627|NCT00900562|516065432|FG000|Overall Study|Withdrawal by Subject|0|||
143140628|NCT00900562|516065433|FG001|Overall Study|Withdrawal by Subject|1|||
143140629|NCT00900562|516065432|FG000|Overall Study|Unrelated adverse event|1|||
143140630|NCT00900562|516065433|FG001|Overall Study|Unrelated adverse event|0|||
143140631|NCT01006629|516065434|FG000|Overall Study|Adverse Event|1|||
143140632|NCT01006629|516065434|FG000|Overall Study|Parent refused to continue participation|1|||
143140633|NCT01006629|516065434|FG000|Overall Study|Parent unable to perform site visit|4|||
143140634|NCT03157089|516065435|FG000|Overall Study|Treated only with pembrolizumab|1|||
143140635|NCT03157089|516065436|FG001|Overall Study|Treated only with pembrolizumab|0|||
143140636|NCT03157089|516065435|FG000|Overall Study|Adverse Event|5|||
143140637|NCT03157089|516065436|FG001|Overall Study|Adverse Event|4|||
143140638|NCT03157089|516065435|FG000|Overall Study|Progressive disease|6|||
143140639|NCT03157089|516065436|FG001|Overall Study|Progressive disease|8|||
143140640|NCT00977197|516065441|FG000|Overall Study|Withdrawal by Subject|3|||
143140641|NCT00977197|516065442|FG001|Overall Study|Withdrawal by Subject|4|||
143140642|NCT00977197|516065441|FG000|Overall Study|Adverse Event|3|||
143140643|NCT00977197|516065442|FG001|Overall Study|Adverse Event|1|||
143140644|NCT00977197|516065441|FG000|Overall Study|Lack of Efficacy|1|||
143140645|NCT00977197|516065442|FG001|Overall Study|Lack of Efficacy|0|||
143140646|NCT00977197|516065441|FG000|Overall Study|Lost to Follow-up|1|||
143140647|NCT00977197|516065442|FG001|Overall Study|Lost to Follow-up|3|||
143140648|NCT00977197|516065441|FG000|Overall Study|Nonadherence|1|||
143140649|NCT00977197|516065442|FG001|Overall Study|Nonadherence|1|||
143140650|NCT01432951|516065443|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
143140651|NCT00784875|516065444|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
143140652|NCT00784875|516065445|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
143140653|NCT00784875|516065446|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
143140654|NCT00784875|516065447|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
143140655|NCT00784875|516065444|FG000|Period A - Baseline|Adverse Event|0|||
143140656|NCT00784875|516065445|FG001|Period A - Baseline|Adverse Event|0|||
143140657|NCT00784875|516065446|FG002|Period A - Baseline|Adverse Event|0|||
143140658|NCT00784875|516065447|FG003|Period A - Baseline|Adverse Event|8|||
143140659|NCT00784875|516065444|FG000|Period A - Baseline|Protocol Violation|0|||
143140660|NCT00784875|516065445|FG001|Period A - Baseline|Protocol Violation|0|||
143140661|NCT00784875|516065446|FG002|Period A - Baseline|Protocol Violation|0|||
143140662|NCT00784875|516065447|FG003|Period A - Baseline|Protocol Violation|25|||
143140663|NCT00784875|516065444|FG000|Period A - Baseline|Withdrawal by Subject|0|||
143140664|NCT00784875|516065445|FG001|Period A - Baseline|Withdrawal by Subject|0|||
143140665|NCT00784875|516065446|FG002|Period A - Baseline|Withdrawal by Subject|0|||
143140666|NCT00784875|516065447|FG003|Period A - Baseline|Withdrawal by Subject|27|||
143140667|NCT00784875|516065444|FG000|Period A - Baseline|Physician Decision|0|||
143140668|NCT00784875|516065445|FG001|Period A - Baseline|Physician Decision|0|||
143140669|NCT00784875|516065446|FG002|Period A - Baseline|Physician Decision|0|||
143140670|NCT00784875|516065447|FG003|Period A - Baseline|Physician Decision|2|||
143140671|NCT00784875|516065444|FG000|Period A - Baseline|Sponsor Decision|0|||
143140672|NCT00784875|516065445|FG001|Period A - Baseline|Sponsor Decision|0|||
143140673|NCT00784875|516065446|FG002|Period A - Baseline|Sponsor Decision|0|||
143140674|NCT00784875|516065447|FG003|Period A - Baseline|Sponsor Decision|113|||
143140675|NCT00784875|516065444|FG000|Period A - Baseline|Lost to Follow-up|0|||
143140676|NCT00784875|516065445|FG001|Period A - Baseline|Lost to Follow-up|0|||
143140677|NCT00784875|516065446|FG002|Period A - Baseline|Lost to Follow-up|0|||
143140678|NCT00784875|516065447|FG003|Period A - Baseline|Lost to Follow-up|2|||
143140679|NCT00784875|516065444|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
143140680|NCT00784875|516065445|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
143140681|NCT00784875|516065446|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
143140682|NCT00784875|516065447|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
143140683|NCT00784875|516065444|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
143140684|NCT00784875|516065445|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
143140685|NCT00784875|516065446|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
143140686|NCT00784875|516065447|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
143140687|NCT00784875|516065444|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
143140688|NCT00784875|516065445|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
143140689|NCT00784875|516065446|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
143140690|NCT00784875|516065447|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
143140691|NCT00784875|516065444|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
143140692|NCT00784875|516065445|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
143140693|NCT00784875|516065446|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
143140694|NCT00784875|516065447|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
143140695|NCT00784875|516065444|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
143140696|NCT00784875|516065445|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
143140697|NCT00784875|516065446|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
143140698|NCT00784875|516065447|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
143140699|NCT00784875|516065444|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
143140700|NCT00784875|516065445|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
143140701|NCT00784875|516065446|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
143140702|NCT00784875|516065447|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
143140703|NCT00784875|516065444|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
143140704|NCT00784875|516065445|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
143140705|NCT00784875|516065446|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
143140706|NCT00784875|516065447|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
143140707|NCT00784875|516065444|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
143472876|NCT01020448|517278776|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
143472877|NCT01020448|517278776|FG000|Treatment|Adverse Event|11|||
143472878|NCT01020448|517278776|FG000|Treatment|Consent Withdrawn|3|||
143472879|NCT01020448|517278776|FG000|Treatment|Disease Progression|2|||
143472880|NCT01020448|517278776|FG000|Treatment|Lack of Efficacy|8|||
143472881|NCT01020448|517278776|FG000|Treatment|Lost to Follow-up|2|||
143472882|NCT01505010|517278777|FG000|Overall Study|Protocol Violation|0|||
143472883|NCT01505010|517278778|FG001|Overall Study|Protocol Violation|1|||
143472884|NCT01505010|517278777|FG000|Overall Study|Lost to Follow-up|0|||
143140708|NCT00784875|516065445|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
143140709|NCT00784875|516065446|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
143140710|NCT00784875|516065447|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
143140711|NCT00784875|516065444|FG000|Period C|Adverse Event|1|||
143140712|NCT00784875|516065445|FG001|Period C|Adverse Event|0|||
143140713|NCT00784875|516065446|FG002|Period C|Adverse Event|4|||
143140714|NCT00784875|516065447|FG003|Period C|Adverse Event|2|||
143140715|NCT00784875|516065444|FG000|Period C|Protocol Violation|0|||
143140716|NCT00784875|516065445|FG001|Period C|Protocol Violation|0|||
143140717|NCT00784875|516065446|FG002|Period C|Protocol Violation|1|||
143140718|NCT00784875|516065447|FG003|Period C|Protocol Violation|2|||
143140719|NCT00784875|516065444|FG000|Period C|Lack of Efficacy|0|||
143140720|NCT00784875|516065445|FG001|Period C|Lack of Efficacy|0|||
143140721|NCT00784875|516065446|FG002|Period C|Lack of Efficacy|1|||
143140722|NCT00784875|516065447|FG003|Period C|Lack of Efficacy|0|||
143472885|NCT01505010|517278778|FG001|Overall Study|Lost to Follow-up|1|||
143140723|NCT00784875|516065444|FG000|Period C|Withdrawal by Subject|1|||
143140724|NCT00784875|516065445|FG001|Period C|Withdrawal by Subject|1|||
143140725|NCT00784875|516065446|FG002|Period C|Withdrawal by Subject|2|||
143140726|NCT00784875|516065447|FG003|Period C|Withdrawal by Subject|0|||
143140727|NCT00784875|516065444|FG000|Period C|Physician Decision|0|||
143140728|NCT00784875|516065445|FG001|Period C|Physician Decision|0|||
143140729|NCT00784875|516065446|FG002|Period C|Physician Decision|1|||
143140730|NCT00784875|516065447|FG003|Period C|Physician Decision|1|||
143140731|NCT00784875|516065444|FG000|Period C|Sponsor Decision|5|||
143140732|NCT00784875|516065445|FG001|Period C|Sponsor Decision|5|||
143140733|NCT00784875|516065446|FG002|Period C|Sponsor Decision|4|||
143140734|NCT00784875|516065447|FG003|Period C|Sponsor Decision|2|||
143140735|NCT00784875|516065444|FG000|Period D|Adverse Event|0|||
143140736|NCT00784875|516065445|FG001|Period D|Adverse Event|2|||
143140737|NCT00784875|516065446|FG002|Period D|Adverse Event|2|||
143140738|NCT00784875|516065447|FG003|Period D|Adverse Event|0|||
143472886|NCT01006265|517278787|FG000|Overall Study|Lost to Follow-up|1|||
143472887|NCT01006265|517278788|FG001|Overall Study|Lost to Follow-up|0|||
143472888|NCT01006265|517278789|FG002|Overall Study|Lost to Follow-up|1|||
143140739|NCT00784875|516065444|FG000|Period D|Protocol Violation|1|||
143140740|NCT00784875|516065445|FG001|Period D|Protocol Violation|0|||
143472889|NCT01006265|517278790|FG003|Overall Study|Lost to Follow-up|0|||
143140741|NCT00784875|516065446|FG002|Period D|Protocol Violation|0|||
143140742|NCT00784875|516065447|FG003|Period D|Protocol Violation|0|||
143140743|NCT00784875|516065444|FG000|Period D|Withdrawal by Subject|2|||
143140744|NCT00784875|516065445|FG001|Period D|Withdrawal by Subject|0|||
143140745|NCT00784875|516065446|FG002|Period D|Withdrawal by Subject|2|||
143140746|NCT00784875|516065447|FG003|Period D|Withdrawal by Subject|0|||
143140747|NCT00784875|516065444|FG000|Period D|Physician Decision|0|||
143140748|NCT00784875|516065445|FG001|Period D|Physician Decision|1|||
143140749|NCT00784875|516065446|FG002|Period D|Physician Decision|0|||
143140750|NCT00784875|516065447|FG003|Period D|Physician Decision|0|||
143140751|NCT00784875|516065444|FG000|Period D|Sponsor Decision|1|||
143140752|NCT00784875|516065445|FG001|Period D|Sponsor Decision|1|||
143140753|NCT00784875|516065446|FG002|Period D|Sponsor Decision|1|||
143140754|NCT00784875|516065447|FG003|Period D|Sponsor Decision|0|||
143140755|NCT00784875|516065444|FG000|Period D|Lost to Follow-up|1|||
143140756|NCT00784875|516065445|FG001|Period D|Lost to Follow-up|0|||
143140757|NCT00784875|516065446|FG002|Period D|Lost to Follow-up|1|||
143140758|NCT00784875|516065447|FG003|Period D|Lost to Follow-up|1|||
143140759|NCT00853385|516065448|FG000|Overall Study|Death|0|||
143140760|NCT00853385|516065449|FG001|Overall Study|Death|0|||
143140761|NCT00853385|516065450|FG002|Overall Study|Death|0|||
143140762|NCT00853385|516065451|FG003|Overall Study|Death|0|||
143140763|NCT00853385|516065452|FG004|Overall Study|Death|1|||
143140764|NCT00853385|516065448|FG000|Overall Study|Adverse Event|24|||
143140765|NCT00853385|516065449|FG001|Overall Study|Adverse Event|24|||
143140766|NCT00853385|516065450|FG002|Overall Study|Adverse Event|2|||
143140767|NCT00853385|516065451|FG003|Overall Study|Adverse Event|5|||
143140768|NCT00853385|516065452|FG004|Overall Study|Adverse Event|22|||
143140769|NCT00853385|516065448|FG000|Overall Study|Lack of Efficacy|6|||
143140770|NCT00853385|516065449|FG001|Overall Study|Lack of Efficacy|7|||
143140771|NCT00853385|516065450|FG002|Overall Study|Lack of Efficacy|3|||
143140772|NCT00853385|516065451|FG003|Overall Study|Lack of Efficacy|3|||
143140773|NCT00853385|516065452|FG004|Overall Study|Lack of Efficacy|6|||
143140774|NCT00853385|516065448|FG000|Overall Study|Lost to Follow-up|2|||
143140775|NCT00853385|516065449|FG001|Overall Study|Lost to Follow-up|1|||
143140776|NCT00853385|516065450|FG002|Overall Study|Lost to Follow-up|0|||
143140777|NCT00853385|516065451|FG003|Overall Study|Lost to Follow-up|0|||
143140778|NCT00853385|516065452|FG004|Overall Study|Lost to Follow-up|0|||
143140779|NCT00853385|516065448|FG000|Overall Study|Withdrawal by Subject|4|||
143140780|NCT00853385|516065449|FG001|Overall Study|Withdrawal by Subject|2|||
143140781|NCT00853385|516065450|FG002|Overall Study|Withdrawal by Subject|0|||
143140782|NCT00853385|516065451|FG003|Overall Study|Withdrawal by Subject|1|||
143140783|NCT00853385|516065452|FG004|Overall Study|Withdrawal by Subject|1|||
143140784|NCT00853385|516065448|FG000|Overall Study|Other|18|||
143140785|NCT00853385|516065449|FG001|Overall Study|Other|9|||
143140786|NCT00853385|516065450|FG002|Overall Study|Other|4|||
143140787|NCT00853385|516065451|FG003|Overall Study|Other|4|||
143140788|NCT00853385|516065452|FG004|Overall Study|Other|12|||
143140789|NCT03248037|516065455|FG000|Overall Study|Withdrawal by Subject|6|||
143140790|NCT03248037|516065456|FG001|Overall Study|Withdrawal by Subject|9|||
143140791|NCT03248037|516065455|FG000|Overall Study|Adverse Event|15|||
143140792|NCT03248037|516065456|FG001|Overall Study|Adverse Event|0|||
143140793|NCT02300610|516065457|FG000|Overall Study|Withdrawal by Subject|1|||
143140794|NCT02300610|516065458|FG001|Overall Study|Withdrawal by Subject|0|||
143140795|NCT02300610|516065459|FG002|Overall Study|Withdrawal by Subject|1|||
143140796|NCT02897349|516065463|FG000|Overall Study|Lost to Follow-up|2|||
143140797|NCT02897349|516065464|FG001|Overall Study|Lost to Follow-up|2|||
143140798|NCT02897349|516065463|FG000|Overall Study|Adverse Event|3|||
143140799|NCT02897349|516065464|FG001|Overall Study|Adverse Event|3|||
143140800|NCT02897349|516065463|FG000|Overall Study|Other than listed above|0|||
143140801|NCT02897349|516065464|FG001|Overall Study|Other than listed above|1|||
143140802|NCT01829347|516065466|FG000|VTI-210|Death|5|||
143140803|NCT01829347|516065467|FG001|VTI-210|Death|3|||
143140804|NCT01829347|516065466|FG000|VTI-210|Withdrawal by Subject|1|||
143362211|NCT03738241|516869624|FG001|Overall Study|Physician Decision|0|||
143362212|NCT03738241|516869625|FG002|Overall Study|Physician Decision|0|||
143362213|NCT03738241|516869626|FG003|Overall Study|Physician Decision|0|||
143362214|NCT03738241|516869627|FG004|Overall Study|Physician Decision|0|||
143362215|NCT03738241|516869628|FG005|Overall Study|Physician Decision|0|||
143362216|NCT03738241|516869629|FG006|Overall Study|Physician Decision|0|||
143362217|NCT03738241|516869630|FG007|Overall Study|Physician Decision|0|||
143362218|NCT03738241|516869631|FG008|Overall Study|Physician Decision|1|||
143140805|NCT01829347|516065467|FG001|VTI-210|Withdrawal by Subject|0|||
143140806|NCT01829347|516065466|FG000|VTI-210E|Death|2|||
143140807|NCT01829347|516065467|FG001|VTI-210E|Death|1|||
143140808|NCT01829347|516065466|FG000|VTI-210E|Study terminated prematurely|1|||
143362219|NCT03738241|516869632|FG009|Overall Study|Physician Decision|0|||
143140809|NCT01829347|516065467|FG001|VTI-210E|Study terminated prematurely|5|||
143140810|NCT03435055|516065469|FG000|Screening|Physician Decision|2|||
143140811|NCT03435055|516065469|FG000|Received Intervention|Did not complete nitrous administration|3|||
143140812|NCT04018066|516065474|FG000|Overall Study|participants started taking medications during the study period|3|||
143140813|NCT04018066|516065474|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
143140814|NCT02732639|516065480|FG000|Overall Study|Lost to Follow-up|1|||
143140815|NCT00856180|516065481|FG000|Overall Study|Adverse Event|4|||
143140816|NCT00856180|516065481|FG000|Overall Study|Progressive Disease|16|||
143140817|NCT01668797|516065482|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
143140818|NCT01668797|516065483|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
143140819|NCT01668797|516065484|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
143140820|NCT01668797|516065485|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
143140821|NCT01668797|516065482|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
143140822|NCT01668797|516065483|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
143140823|NCT01668797|516065484|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
143140824|NCT01668797|516065485|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
143140825|NCT01668797|516065482|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
143140826|NCT01668797|516065483|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
143140827|NCT01668797|516065484|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
143140828|NCT01668797|516065485|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
143140829|NCT01668797|516065482|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
143140830|NCT01668797|516065483|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
143140831|NCT01668797|516065484|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
143140832|NCT01668797|516065485|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
143140833|NCT01668797|516065482|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
143140834|NCT01668797|516065483|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
143140835|NCT01668797|516065484|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
143140836|NCT01668797|516065485|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
143140837|NCT01668797|516065482|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
143140838|NCT01668797|516065483|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
143140839|NCT01668797|516065484|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
143140840|NCT01668797|516065485|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
143140841|NCT01668797|516065482|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
143140842|NCT01668797|516065483|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
143140843|NCT01668797|516065484|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
143140844|NCT01668797|516065485|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
143140845|NCT01668797|516065482|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
143362220|NCT03738241|516869623|FG000|Overall Study|Adverse Event|1|||
143362221|NCT03738241|516869624|FG001|Overall Study|Adverse Event|0|||
143362222|NCT03738241|516869625|FG002|Overall Study|Adverse Event|0|||
143362223|NCT03738241|516869626|FG003|Overall Study|Adverse Event|0|||
143362224|NCT03738241|516869627|FG004|Overall Study|Adverse Event|0|||
143362225|NCT03738241|516869628|FG005|Overall Study|Adverse Event|0|||
143362226|NCT03738241|516869629|FG006|Overall Study|Adverse Event|0|||
143362227|NCT03738241|516869630|FG007|Overall Study|Adverse Event|0|||
143362228|NCT03738241|516869631|FG008|Overall Study|Adverse Event|0|||
143362229|NCT03738241|516869632|FG009|Overall Study|Adverse Event|0|||
143362230|NCT02271594|516869633|FG000|Overall Study|Study closed; recruiting failure|19|||
143362231|NCT02271594|516869634|FG001|Overall Study|Study closed; recruiting failure|12|||
143362232|NCT00495469|516869635|FG000|Overall Study|Adverse Event|0|||
143362233|NCT00495469|516869636|FG001|Overall Study|Adverse Event|1|||
143362234|NCT00495469|516869637|FG002|Overall Study|Adverse Event|3|||
143362235|NCT00495469|516869638|FG003|Overall Study|Adverse Event|0|||
143362236|NCT00495469|516869639|FG004|Overall Study|Adverse Event|1|||
143362237|NCT00495469|516869640|FG005|Overall Study|Adverse Event|1|||
143362238|NCT00495469|516869641|FG006|Overall Study|Adverse Event|1|||
143362239|NCT00495469|516869635|FG000|Overall Study|Lost to Follow-up|1|||
143362240|NCT00495469|516869636|FG001|Overall Study|Lost to Follow-up|1|||
143362241|NCT00495469|516869637|FG002|Overall Study|Lost to Follow-up|3|||
143362242|NCT00495469|516869638|FG003|Overall Study|Lost to Follow-up|1|||
143362243|NCT00495469|516869639|FG004|Overall Study|Lost to Follow-up|0|||
143362244|NCT00495469|516869640|FG005|Overall Study|Lost to Follow-up|0|||
143362245|NCT00495469|516869641|FG006|Overall Study|Lost to Follow-up|0|||
143362246|NCT00495469|516869635|FG000|Overall Study|Protocol Violation|0|||
143362247|NCT00495469|516869636|FG001|Overall Study|Protocol Violation|0|||
143362248|NCT00495469|516869637|FG002|Overall Study|Protocol Violation|0|||
143362249|NCT00495469|516869638|FG003|Overall Study|Protocol Violation|0|||
143362250|NCT00495469|516869639|FG004|Overall Study|Protocol Violation|1|||
143362251|NCT00495469|516869640|FG005|Overall Study|Protocol Violation|2|||
143362252|NCT00495469|516869641|FG006|Overall Study|Protocol Violation|0|||
143362253|NCT00495469|516869635|FG000|Overall Study|Withdrawal by Subject|5|||
143362254|NCT00495469|516869636|FG001|Overall Study|Withdrawal by Subject|3|||
143362255|NCT00495469|516869637|FG002|Overall Study|Withdrawal by Subject|1|||
143362256|NCT00495469|516869638|FG003|Overall Study|Withdrawal by Subject|3|||
143362257|NCT00495469|516869639|FG004|Overall Study|Withdrawal by Subject|3|||
143362258|NCT00495469|516869640|FG005|Overall Study|Withdrawal by Subject|2|||
143362259|NCT00495469|516869641|FG006|Overall Study|Withdrawal by Subject|3|||
143362260|NCT00495469|516869635|FG000|Overall Study|Lack of Efficacy|0|||
143362261|NCT00495469|516869636|FG001|Overall Study|Lack of Efficacy|0|||
143362262|NCT00495469|516869637|FG002|Overall Study|Lack of Efficacy|0|||
143140846|NCT01668797|516065483|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
143140847|NCT01668797|516065484|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
143140848|NCT01668797|516065485|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
143140849|NCT01668797|516065482|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
143140850|NCT01668797|516065483|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
143140851|NCT01668797|516065484|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
143140852|NCT01668797|516065485|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
143140853|NCT01668797|516065482|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
143140854|NCT01668797|516065483|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
143140855|NCT01668797|516065484|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
143140856|NCT01668797|516065485|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
143140857|NCT01668797|516065482|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
143140858|NCT01668797|516065483|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
143140859|NCT01668797|516065484|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
143140860|NCT01668797|516065485|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
143140861|NCT01668797|516065482|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
143140862|NCT01668797|516065483|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
143140863|NCT01668797|516065484|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
143140864|NCT01668797|516065485|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
143140865|NCT01668797|516065482|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
143140866|NCT01668797|516065483|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
143140867|NCT01668797|516065484|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
143140868|NCT01668797|516065485|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
143140869|NCT01668797|516065482|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
143140870|NCT01668797|516065483|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
143140871|NCT01668797|516065484|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
143140872|NCT01668797|516065485|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
143140873|NCT01668797|516065482|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
143140874|NCT01668797|516065483|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
143140875|NCT01668797|516065484|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
143140876|NCT01668797|516065485|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
143140877|NCT01668797|516065482|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
143140878|NCT01668797|516065483|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
143140879|NCT01668797|516065484|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
143140880|NCT01668797|516065485|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
143140881|NCT01668797|516065482|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
143140882|NCT01668797|516065483|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
143140883|NCT01668797|516065484|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
143140884|NCT01668797|516065485|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
143140885|NCT01668797|516065482|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
143140886|NCT01668797|516065483|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
143140887|NCT01668797|516065484|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
143140888|NCT01668797|516065485|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
143140889|NCT01668797|516065482|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
143140890|NCT01668797|516065483|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
143140891|NCT01668797|516065484|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
143140892|NCT01668797|516065485|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
143140893|NCT01668797|516065482|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
143140894|NCT01668797|516065483|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
143140895|NCT01668797|516065484|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
143140896|NCT01668797|516065485|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
143140897|NCT01668797|516065482|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
143140898|NCT01668797|516065483|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
143140899|NCT01668797|516065484|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
143140900|NCT01668797|516065485|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
143140901|NCT01668797|516065482|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
143140902|NCT01668797|516065483|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
143140903|NCT01668797|516065484|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
143140904|NCT01668797|516065485|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
143140905|NCT01668797|516065482|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
143140906|NCT01668797|516065483|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
143362263|NCT00495469|516869638|FG003|Overall Study|Lack of Efficacy|0|||
143140907|NCT01668797|516065484|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
143140908|NCT01668797|516065485|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
143140909|NCT01668797|516065482|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
143140910|NCT01668797|516065483|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
143140911|NCT01668797|516065484|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
143140912|NCT01668797|516065485|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
143140913|NCT01668797|516065482|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
143140914|NCT01668797|516065483|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
143140915|NCT01668797|516065484|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
143140916|NCT01668797|516065485|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
143140917|NCT00671749|516065486|FG000|Overall Study|Adverse Event|2|||
143140918|NCT00671749|516065486|FG000|Overall Study|Withdrawal by Subject|4|||
143140919|NCT00671749|516065486|FG000|Overall Study|Protocol Violation|1|||
143140920|NCT00671749|516065486|FG000|Overall Study|Lost to Follow-up|1|||
143140921|NCT02515227|516065487|FG000|Overall Study|Adverse Event|0|||
143140922|NCT02515227|516065488|FG001|Overall Study|Adverse Event|2|||
143140923|NCT02515227|516065487|FG000|Overall Study|Progressive disease|2|||
143140924|NCT02515227|516065488|FG001|Overall Study|Progressive disease|9|||
143140925|NCT02834975|516065493|FG000|Overall Study|Physician Decision|2|||
143140926|NCT02834975|516065493|FG000|Overall Study|Adverse Event|1|||
143140927|NCT02834975|516065493|FG000|Overall Study|Withdrawal by Subject|1|||
143140928|NCT02834975|516065493|FG000|Overall Study|Lack of Efficacy|1|||
143140929|NCT00929669|516065500|FG000|Overall Study|elevated glucose levels|1|||
143140930|NCT02714153|516065501|FG000|Overall Study|Death|1|||
143140931|NCT00686972|516065502|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
143140932|NCT01901185|516065503|FG000|Overall Study|Withdrawal by Subject|2|||
143140933|NCT00250588|516065504|FG000|Overall Study|Withdrawal by Subject|3|||
143140934|NCT00250588|516065505|FG001|Overall Study|Withdrawal by Subject|6|||
143140935|NCT00250588|516065506|FG002|Overall Study|Withdrawal by Subject|0|||
143140936|NCT00250588|516065504|FG000|Overall Study|Lost to Follow-up|6|||
143140937|NCT00250588|516065505|FG001|Overall Study|Lost to Follow-up|13|||
143140938|NCT00250588|516065506|FG002|Overall Study|Lost to Follow-up|13|||
143140939|NCT00706797|516065509|FG000|Overall Study|Lack of Efficacy|3|||
143140940|NCT00706797|516065510|FG001|Overall Study|Lack of Efficacy|0|||
143140941|NCT00706797|516065509|FG000|Overall Study|Adverse Event|0|||
143140942|NCT00706797|516065510|FG001|Overall Study|Adverse Event|3|||
143140943|NCT00706797|516065509|FG000|Overall Study|Withdrawal by Subject|8|||
143140944|NCT00706797|516065510|FG001|Overall Study|Withdrawal by Subject|1|||
143140945|NCT00706797|516065509|FG000|Overall Study|Death|1|||
143140946|NCT00706797|516065510|FG001|Overall Study|Death|0|||
143140947|NCT00706797|516065509|FG000|Overall Study|Discontinuation of study by sponsor|52|||
143140948|NCT00706797|516065510|FG001|Overall Study|Discontinuation of study by sponsor|63|||
143140949|NCT00706797|516065509|FG000|Overall Study|Protocol Violation|3|||
143140950|NCT00706797|516065510|FG001|Overall Study|Protocol Violation|2|||
143140951|NCT00706797|516065509|FG000|Overall Study|Lost to Follow-up|1|||
143140952|NCT00706797|516065510|FG001|Overall Study|Lost to Follow-up|2|||
143140953|NCT00706797|516065509|FG000|Overall Study|Other|1|||
143140954|NCT00706797|516065510|FG001|Overall Study|Other|0|||
143140955|NCT00485303|516065512|FG000|Overall Study|Adverse Event|5|||
143140956|NCT00485303|516065512|FG000|Overall Study|Progressive Disease|44|||
143140957|NCT00485303|516065512|FG000|Overall Study|Other|3|||
143140958|NCT00485303|516065512|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
143140959|NCT00485303|516065512|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
143140960|NCT00296335|516065513|FG000|Overall Study|Recurrence|3|||
143140961|NCT00296335|516065514|FG001|Overall Study|Recurrence|51|||
143140962|NCT00296335|516065513|FG000|Overall Study|Adverse Event|17|||
143140963|NCT00296335|516065514|FG001|Overall Study|Adverse Event|27|||
143140964|NCT00296335|516065513|FG000|Overall Study|Lost to Follow-up|7|||
143140965|NCT00296335|516065514|FG001|Overall Study|Lost to Follow-up|33|||
143140966|NCT00296335|516065513|FG000|Overall Study|Physician Decision|3|||
143140967|NCT00296335|516065514|FG001|Overall Study|Physician Decision|11|||
143140968|NCT01027845|516065515|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
143140969|NCT01027845|516065516|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
143140970|NCT01027845|516065517|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
143140971|NCT01027845|516065518|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
143140972|NCT01027845|516065515|FG000|Primary Vaccination Phase|Adverse Event|1|||
143140973|NCT01027845|516065516|FG001|Primary Vaccination Phase|Adverse Event|0|||
143140974|NCT01027845|516065517|FG002|Primary Vaccination Phase|Adverse Event|0|||
143140975|NCT01027845|516065518|FG003|Primary Vaccination Phase|Adverse Event|0|||
143140976|NCT01027845|516065515|FG000|Primary Vaccination Phase|Protocol Violation|1|||
143472890|NCT01006265|517278787|FG000|Overall Study|Withdrawal by Subject|4|||
143140977|NCT01027845|516065516|FG001|Primary Vaccination Phase|Protocol Violation|0|||
143140978|NCT01027845|516065517|FG002|Primary Vaccination Phase|Protocol Violation|0|||
143140979|NCT01027845|516065518|FG003|Primary Vaccination Phase|Protocol Violation|0|||
143140980|NCT01027845|516065515|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
143140981|NCT01027845|516065516|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
143140982|NCT01027845|516065517|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
143140983|NCT01027845|516065518|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
143140984|NCT01027845|516065515|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
143140985|NCT01027845|516065516|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
143140986|NCT01027845|516065517|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
143140987|NCT01027845|516065518|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
143140988|NCT01027845|516065515|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
143140989|NCT01027845|516065516|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
143140990|NCT01027845|516065517|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
143140991|NCT01027845|516065518|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
143140992|NCT00368550|516065519|FG000|Overall Study|Adverse Event|7|||
143140993|NCT00368550|516065520|FG001|Overall Study|Adverse Event|4|||
143140994|NCT00368550|516065519|FG000|Overall Study|Lack of Efficacy|4|||
143140995|NCT00368550|516065520|FG001|Overall Study|Lack of Efficacy|9|||
143140996|NCT00368550|516065519|FG000|Overall Study|Withdrawal by Subject|17|||
143140997|NCT00368550|516065520|FG001|Overall Study|Withdrawal by Subject|10|||
143140998|NCT01401322|516065521|FG000|Overall Study|Withdrawal by Subject|1|||
143140999|NCT01401322|516065521|FG000|Overall Study|Physician Decision|1|||
143141000|NCT00746551|516065522|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
143141001|NCT00746551|516065523|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
143141002|NCT00746551|516065522|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
143141003|NCT00746551|516065523|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
143141004|NCT00746551|516065522|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
143141005|NCT00746551|516065523|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
143141006|NCT01123655|516065524|FG000|Overall Study|Medication for RA had to be changed|1|||
143141007|NCT01123655|516065525|FG001|Overall Study|Medication for RA had to be changed|0|||
143141008|NCT01123655|516065526|FG002|Overall Study|Medication for RA had to be changed|0|||
143141009|NCT01123655|516065524|FG000|Overall Study|new illness|0|||
143141010|NCT01123655|516065525|FG001|Overall Study|new illness|1|||
143141011|NCT01123655|516065526|FG002|Overall Study|new illness|0|||
143141012|NCT01123655|516065524|FG000|Overall Study|began prohibitive drug|0|||
143141013|NCT01123655|516065525|FG001|Overall Study|began prohibitive drug|0|||
143141014|NCT01123655|516065526|FG002|Overall Study|began prohibitive drug|1|||
143141015|NCT01776554|516065527|FG000|Overall Study|Adverse Event|1|||
143141016|NCT01776554|516065528|FG001|Overall Study|Adverse Event|0|||
143141017|NCT01776554|516065527|FG000|Overall Study|Withdrawal by Subject|3|||
143141018|NCT01776554|516065528|FG001|Overall Study|Withdrawal by Subject|8|||
143141019|NCT01776554|516065527|FG000|Overall Study|Lost to Follow-up|6|||
143141020|NCT01776554|516065528|FG001|Overall Study|Lost to Follow-up|9|||
143141021|NCT01776554|516065527|FG000|Overall Study|Administrative Reason|2|||
143141022|NCT01776554|516065528|FG001|Overall Study|Administrative Reason|5|||
143141023|NCT01776554|516065527|FG000|Overall Study|Protocol Violation|1|||
143141024|NCT01776554|516065528|FG001|Overall Study|Protocol Violation|0|||
143141025|NCT01776554|516065527|FG000|Overall Study|Unclassified|4|||
143141026|NCT01776554|516065528|FG001|Overall Study|Unclassified|1|||
143141027|NCT01991795|516065529|FG000|Overall Study|Lost to Follow-up|6|||
143141028|NCT01991795|516065530|FG001|Overall Study|Lost to Follow-up|4|||
143141029|NCT01991795|516065529|FG000|Overall Study|Withdrawal by Subject|117|||
143141030|NCT01991795|516065530|FG001|Overall Study|Withdrawal by Subject|94|||
143141031|NCT01991795|516065529|FG000|Overall Study|Site prematurely closed by sponsor|26|||
143141032|NCT01991795|516065530|FG001|Overall Study|Site prematurely closed by sponsor|25|||
143141033|NCT04798027|516065531|FG000|Overall Study|Protocol Violation|0|||
143141034|NCT04798027|516065532|FG001|Overall Study|Protocol Violation|0|||
143141035|NCT04798027|516065533|FG002|Overall Study|Protocol Violation|0|||
143141036|NCT04798027|516065534|FG003|Overall Study|Protocol Violation|0|||
143141037|NCT04798027|516065535|FG004|Overall Study|Protocol Violation|1|||
143141038|NCT04798027|516065536|FG005|Overall Study|Protocol Violation|0|||
143141039|NCT04798027|516065537|FG006|Overall Study|Protocol Violation|0|||
143141040|NCT04798027|516065538|FG007|Overall Study|Protocol Violation|1|||
143141041|NCT04798027|516065539|FG008|Overall Study|Protocol Violation|0|||
143141042|NCT04798027|516065531|FG000|Overall Study|Withdrawal by Subject|1|||
143141043|NCT04798027|516065532|FG001|Overall Study|Withdrawal by Subject|0|||
143141044|NCT04798027|516065533|FG002|Overall Study|Withdrawal by Subject|1|||
143141045|NCT04798027|516065534|FG003|Overall Study|Withdrawal by Subject|1|||
143141046|NCT04798027|516065535|FG004|Overall Study|Withdrawal by Subject|1|||
143141047|NCT04798027|516065536|FG005|Overall Study|Withdrawal by Subject|1|||
143141048|NCT04798027|516065537|FG006|Overall Study|Withdrawal by Subject|3|||
143141049|NCT04798027|516065538|FG007|Overall Study|Withdrawal by Subject|2|||
143362264|NCT00495469|516869639|FG004|Overall Study|Lack of Efficacy|0|||
143141050|NCT04798027|516065539|FG008|Overall Study|Withdrawal by Subject|2|||
143141051|NCT04798027|516065531|FG000|Overall Study|Lost to Follow-up|1|||
143141052|NCT04798027|516065532|FG001|Overall Study|Lost to Follow-up|3|||
143141053|NCT04798027|516065533|FG002|Overall Study|Lost to Follow-up|0|||
143141054|NCT04798027|516065534|FG003|Overall Study|Lost to Follow-up|0|||
143141055|NCT04798027|516065535|FG004|Overall Study|Lost to Follow-up|0|||
143141056|NCT04798027|516065536|FG005|Overall Study|Lost to Follow-up|1|||
143141057|NCT04798027|516065537|FG006|Overall Study|Lost to Follow-up|0|||
143141058|NCT04798027|516065538|FG007|Overall Study|Lost to Follow-up|0|||
143141059|NCT04798027|516065539|FG008|Overall Study|Lost to Follow-up|1|||
143141060|NCT04798027|516065531|FG000|Overall Study|Withdrawal by Sponsor|8|||
143141061|NCT04798027|516065532|FG001|Overall Study|Withdrawal by Sponsor|22|||
143141062|NCT04798027|516065533|FG002|Overall Study|Withdrawal by Sponsor|9|||
143141063|NCT04798027|516065534|FG003|Overall Study|Withdrawal by Sponsor|26|||
143141064|NCT04798027|516065535|FG004|Overall Study|Withdrawal by Sponsor|24|||
143141065|NCT04798027|516065536|FG005|Overall Study|Withdrawal by Sponsor|11|||
143141066|NCT04798027|516065537|FG006|Overall Study|Withdrawal by Sponsor|25|||
143141067|NCT04798027|516065538|FG007|Overall Study|Withdrawal by Sponsor|26|||
143141068|NCT04798027|516065539|FG008|Overall Study|Withdrawal by Sponsor|11|||
143141069|NCT00269152|516065540|FG000|Overall Study|Adverse Event|9|||
143141070|NCT00269152|516065541|FG001|Overall Study|Adverse Event|3|||
143141071|NCT00269152|516065540|FG000|Overall Study|Withdrawal by Subject|7|||
143141072|NCT00269152|516065541|FG001|Overall Study|Withdrawal by Subject|3|||
143141073|NCT00269152|516065540|FG000|Overall Study|Physician Decision|2|||
143141074|NCT00269152|516065541|FG001|Overall Study|Physician Decision|3|||
143141075|NCT00269152|516065540|FG000|Overall Study|Protocol Violation|0|||
143141076|NCT00269152|516065541|FG001|Overall Study|Protocol Violation|1|||
143141077|NCT02121210|516065542|FG000|Overall Study|Adverse Event|5|||
143141078|NCT02121210|516065543|FG001|Overall Study|Adverse Event|7|||
143141079|NCT02121210|516065542|FG000|Overall Study|Lack of Efficacy|2|||
143141080|NCT02121210|516065543|FG001|Overall Study|Lack of Efficacy|0|||
143141081|NCT02121210|516065542|FG000|Overall Study|Other than specified above|0|||
143141082|NCT02121210|516065543|FG001|Overall Study|Other than specified above|2|||
143141083|NCT04609514|516065544|FG000|Overall Study|Lost to Follow-up|5|||
143141084|NCT04609514|516065545|FG001|Overall Study|Lost to Follow-up|4|||
143141085|NCT04609514|516065544|FG000|Overall Study|Withdrawal by PI|0|||
143141086|NCT04609514|516065545|FG001|Overall Study|Withdrawal by PI|2|||
143141087|NCT00909870|516065546|FG000|Overall Study|Adverse Event|13|||
143141088|NCT00909870|516065547|FG001|Overall Study|Adverse Event|7|||
143141089|NCT00909870|516065546|FG000|Overall Study|Protocol Violation|1|||
143141090|NCT00909870|516065547|FG001|Overall Study|Protocol Violation|2|||
143141091|NCT00909870|516065546|FG000|Overall Study|Withdrawal by Subject|5|||
143141092|NCT00909870|516065547|FG001|Overall Study|Withdrawal by Subject|8|||
143141093|NCT00909870|516065546|FG000|Overall Study|Lost to Follow-up|3|||
143141094|NCT00909870|516065547|FG001|Overall Study|Lost to Follow-up|3|||
143141095|NCT00909870|516065546|FG000|Overall Study|Physician Decision|0|||
143141096|NCT00909870|516065547|FG001|Overall Study|Physician Decision|2|||
143141097|NCT00909870|516065546|FG000|Overall Study|Other|1|||
143141098|NCT00909870|516065547|FG001|Overall Study|Other|5|||
143141099|NCT00885118|516065548|FG000|Overall Study|Adverse Event|1|||
143141100|NCT00885118|516065549|FG001|Overall Study|Adverse Event|0|||
143141101|NCT00885118|516065550|FG002|Overall Study|Adverse Event|0|||
143141102|NCT00885118|516065551|FG003|Overall Study|Adverse Event|0|||
143141103|NCT00885118|516065552|FG004|Overall Study|Adverse Event|0|||
143141104|NCT00885118|516065548|FG000|Overall Study|Withdrawal by Subject|0|||
143141105|NCT00885118|516065549|FG001|Overall Study|Withdrawal by Subject|0|||
143141106|NCT00885118|516065550|FG002|Overall Study|Withdrawal by Subject|0|||
143141107|NCT00885118|516065551|FG003|Overall Study|Withdrawal by Subject|0|||
143141108|NCT00885118|516065552|FG004|Overall Study|Withdrawal by Subject|1|||
143141109|NCT00885118|516065548|FG000|Overall Study|Other reason not defined above|0|||
143141110|NCT00885118|516065549|FG001|Overall Study|Other reason not defined above|0|||
143141111|NCT00885118|516065550|FG002|Overall Study|Other reason not defined above|1|||
143141112|NCT00885118|516065551|FG003|Overall Study|Other reason not defined above|0|||
143141113|NCT00885118|516065552|FG004|Overall Study|Other reason not defined above|0|||
143141114|NCT01981616|516065558|FG000|Overall Study|Adverse Event|0|||
143141115|NCT01981616|516065559|FG001|Overall Study|Adverse Event|1|||
143141116|NCT01981616|516065558|FG000|Overall Study|Protocol Violation|1|||
143141117|NCT01981616|516065559|FG001|Overall Study|Protocol Violation|0|||
143141118|NCT03642990|516065560|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
143141119|NCT03642990|516065560|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
143141120|NCT00094445|516065561|FG000|Overall Study|Withdrawal by Subject|3|||
143141121|NCT00094445|516065561|FG000|Overall Study|Lost to Follow-up|1|||
143141122|NCT00094445|516065561|FG000|Overall Study|Progressive Disease|2|||
143141123|NCT02717195|516065562|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
143141124|NCT02717195|516065563|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
143141125|NCT02717195|516065564|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
143141126|NCT02717195|516065565|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
143141127|NCT02717195|516065566|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
143141128|NCT02717195|516065562|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
143141129|NCT02717195|516065563|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
143141130|NCT02717195|516065564|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
143141131|NCT02717195|516065565|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
143141132|NCT02717195|516065566|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
143141133|NCT02717195|516065562|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
143141134|NCT02717195|516065563|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
143141135|NCT02717195|516065564|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
143141136|NCT02717195|516065565|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
143141137|NCT02717195|516065566|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
143141138|NCT02717195|516065562|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
143141139|NCT02717195|516065563|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
143141140|NCT02717195|516065564|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
143141141|NCT02717195|516065565|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
143141142|NCT02717195|516065566|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
143141143|NCT02717195|516065562|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
143141144|NCT02717195|516065563|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
143141145|NCT02717195|516065564|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
143141146|NCT02717195|516065565|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
143141147|NCT02717195|516065566|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
143141148|NCT02717195|516065562|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
143141149|NCT02717195|516065563|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
143141150|NCT02717195|516065564|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
143141151|NCT02717195|516065565|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
143141152|NCT02717195|516065566|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
143141153|NCT02717195|516065562|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
143141154|NCT02717195|516065563|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
143141155|NCT02717195|516065564|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
143141156|NCT02717195|516065565|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
143141157|NCT02717195|516065566|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
143141158|NCT02717195|516065562|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
143141159|NCT02717195|516065563|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
143141160|NCT02717195|516065564|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
143141161|NCT02717195|516065565|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
143141162|NCT02717195|516065566|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
143141163|NCT02717195|516065562|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
143141164|NCT02717195|516065563|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
143141165|NCT02717195|516065564|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
143141166|NCT02717195|516065565|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
143141167|NCT02717195|516065566|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
143141168|NCT02717195|516065562|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
143141169|NCT02717195|516065563|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
143141170|NCT02717195|516065564|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
143141171|NCT02717195|516065565|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
143141172|NCT02717195|516065566|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
143141173|NCT02717195|516065562|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
143141174|NCT02717195|516065563|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
143141175|NCT02717195|516065564|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
143141176|NCT02717195|516065565|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
143141177|NCT02717195|516065566|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
143141178|NCT02717195|516065562|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
143141179|NCT02717195|516065563|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
143141180|NCT02717195|516065564|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
143141181|NCT02717195|516065565|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
143141182|NCT02717195|516065566|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
143141183|NCT02717195|516065562|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
143141184|NCT02717195|516065563|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
143141185|NCT02717195|516065564|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
143141186|NCT02717195|516065565|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
143141187|NCT02717195|516065566|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
143141188|NCT02717195|516065562|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
143141189|NCT02717195|516065563|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
143141190|NCT02717195|516065564|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
143141191|NCT02717195|516065565|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
143141192|NCT02717195|516065566|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
143141193|NCT02717195|516065562|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
143141194|NCT02717195|516065563|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
143141195|NCT02717195|516065564|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
143141196|NCT02717195|516065565|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
143141197|NCT02717195|516065566|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
143141198|NCT02717195|516065562|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
143141199|NCT02717195|516065563|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
143141200|NCT02717195|516065564|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
143141201|NCT02717195|516065565|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
143141202|NCT02717195|516065566|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
143141203|NCT02717195|516065562|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
143141204|NCT02717195|516065563|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
143141205|NCT02717195|516065564|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
143141206|NCT02717195|516065565|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
143141207|NCT02717195|516065566|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
143141208|NCT02717195|516065562|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
143141209|NCT02717195|516065563|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
143141210|NCT02717195|516065564|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
143141211|NCT02717195|516065565|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
143141212|NCT02717195|516065566|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
143141213|NCT02717195|516065562|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
143141214|NCT02717195|516065563|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
143141215|NCT02717195|516065564|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
143141216|NCT02717195|516065565|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
143141217|NCT02717195|516065566|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
143141218|NCT02717195|516065562|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
143141219|NCT02717195|516065563|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
143141220|NCT02717195|516065564|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
143141221|NCT02717195|516065565|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
143141222|NCT02717195|516065566|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
143141223|NCT02717195|516065562|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
143141224|NCT02717195|516065563|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
143141225|NCT02717195|516065564|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
143141226|NCT02717195|516065565|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
143141227|NCT02717195|516065566|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
143141228|NCT02717195|516065562|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
143141229|NCT02717195|516065563|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
143141230|NCT02717195|516065564|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
143141231|NCT02717195|516065565|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
143141232|NCT02717195|516065566|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
143141233|NCT02717195|516065562|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
143141234|NCT02717195|516065563|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
143141235|NCT02717195|516065564|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
143141236|NCT02717195|516065565|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
143141237|NCT02717195|516065566|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
143141238|NCT02717195|516065562|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
143141239|NCT02717195|516065563|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
143141240|NCT02717195|516065564|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
143141241|NCT02717195|516065565|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
143141242|NCT02717195|516065566|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
143141243|NCT02717195|516065562|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
143141244|NCT02717195|516065563|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
143141245|NCT02717195|516065564|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
143141246|NCT02717195|516065565|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
143141247|NCT02717195|516065566|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
143141248|NCT02717195|516065562|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
143141249|NCT02717195|516065563|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
143141250|NCT02717195|516065564|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
143141251|NCT02717195|516065565|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
143141252|NCT02717195|516065566|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
143141253|NCT02717195|516065562|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
143141254|NCT02717195|516065563|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
143362265|NCT00495469|516869640|FG005|Overall Study|Lack of Efficacy|0|||
143141255|NCT02717195|516065564|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
143141256|NCT02717195|516065565|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
143141257|NCT02717195|516065566|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
143141258|NCT02717195|516065562|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
143141259|NCT02717195|516065563|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
143141260|NCT02717195|516065564|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
143141261|NCT02717195|516065565|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
143141262|NCT02717195|516065566|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
143141263|NCT02717195|516065562|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
143141264|NCT02717195|516065563|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
143141265|NCT02717195|516065564|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
143141266|NCT02717195|516065565|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
143141267|NCT02717195|516065566|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
143141268|NCT02717195|516065562|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
143141269|NCT02717195|516065563|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
143141270|NCT02717195|516065564|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
143141271|NCT02717195|516065565|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
143141272|NCT02717195|516065566|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
143141273|NCT02717195|516065562|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
143141274|NCT02717195|516065563|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
143141275|NCT02717195|516065564|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
143141276|NCT02717195|516065565|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
143362266|NCT00495469|516869641|FG006|Overall Study|Lack of Efficacy|1|||
143141277|NCT02717195|516065566|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
143141278|NCT02717195|516065562|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
143141279|NCT02717195|516065563|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
143141280|NCT02717195|516065564|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
143141281|NCT02717195|516065565|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
143141282|NCT02717195|516065566|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
143141283|NCT02717195|516065562|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
143141284|NCT02717195|516065563|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
143141285|NCT02717195|516065564|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
143141286|NCT02717195|516065565|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
143141287|NCT02717195|516065566|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
143141288|NCT02717195|516065562|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
143141289|NCT02717195|516065563|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
143141290|NCT02717195|516065564|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
143141291|NCT02717195|516065565|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
143141292|NCT02717195|516065566|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
143141293|NCT02717195|516065562|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
143141294|NCT02717195|516065563|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
143141295|NCT02717195|516065564|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
143141296|NCT02717195|516065565|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
143141297|NCT02717195|516065566|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
143141298|NCT02717195|516065562|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
143141299|NCT02717195|516065563|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
143141300|NCT02717195|516065564|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
143141301|NCT02717195|516065565|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
143141302|NCT02717195|516065566|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
143141303|NCT01420536|516065567|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
143141304|NCT01420536|516065568|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
143141305|NCT00764790|516065569|FG000|Overall Study|Protocol Violation|0|||
143141306|NCT00764790|516065570|FG001|Overall Study|Protocol Violation|0|||
143141307|NCT00764790|516065571|FG002|Overall Study|Protocol Violation|1|||
143141308|NCT00764790|516065569|FG000|Overall Study|Withdrawal by Subject|10|||
143141309|NCT00764790|516065570|FG001|Overall Study|Withdrawal by Subject|12|||
143141310|NCT00764790|516065571|FG002|Overall Study|Withdrawal by Subject|6|||
143141311|NCT00764790|516065569|FG000|Overall Study|Lost to Follow-up|28|||
143362267|NCT00495469|516869635|FG000|Overall Study|Liver function test abnormality|0|||
143362268|NCT00495469|516869636|FG001|Overall Study|Liver function test abnormality|1|||
143362269|NCT00495469|516869637|FG002|Overall Study|Liver function test abnormality|0|||
143362270|NCT00495469|516869638|FG003|Overall Study|Liver function test abnormality|0|||
143362271|NCT00495469|516869639|FG004|Overall Study|Liver function test abnormality|0|||
143362272|NCT00495469|516869640|FG005|Overall Study|Liver function test abnormality|0|||
143362273|NCT00495469|516869641|FG006|Overall Study|Liver function test abnormality|0|||
143362274|NCT00495469|516869635|FG000|Overall Study|ST depression at randomisation in ECG|0|||
143141312|NCT00764790|516065570|FG001|Overall Study|Lost to Follow-up|29|||
143141313|NCT00764790|516065571|FG002|Overall Study|Lost to Follow-up|23|||
143141314|NCT01773928|516065574|FG000|Overall Study|Adverse Event|0|||
143141315|NCT01773928|516065575|FG001|Overall Study|Adverse Event|0|||
143141316|NCT01773928|516065576|FG002|Overall Study|Adverse Event|0|||
143141317|NCT01773928|516065577|FG003|Overall Study|Adverse Event|0|||
143141318|NCT01773928|516065578|FG004|Overall Study|Adverse Event|0|||
143141319|NCT01773928|516065579|FG005|Overall Study|Adverse Event|0|||
143141320|NCT01773928|516065580|FG006|Overall Study|Adverse Event|0|||
143472891|NCT01006265|517278788|FG001|Overall Study|Withdrawal by Subject|7|||
143472892|NCT01006265|517278789|FG002|Overall Study|Withdrawal by Subject|5|||
143141321|NCT01773928|516065581|FG007|Overall Study|Adverse Event|1|||
143141322|NCT01773928|516065582|FG008|Overall Study|Adverse Event|0|||
143141323|NCT01773928|516065574|FG000|Overall Study|Physician Decision|0|||
143141324|NCT01773928|516065575|FG001|Overall Study|Physician Decision|0|||
143141325|NCT01773928|516065576|FG002|Overall Study|Physician Decision|0|||
143141326|NCT01773928|516065577|FG003|Overall Study|Physician Decision|1|||
143141327|NCT01773928|516065578|FG004|Overall Study|Physician Decision|0|||
143141328|NCT01773928|516065579|FG005|Overall Study|Physician Decision|0|||
143141329|NCT01773928|516065580|FG006|Overall Study|Physician Decision|0|||
143141330|NCT01773928|516065581|FG007|Overall Study|Physician Decision|0|||
143141331|NCT01773928|516065582|FG008|Overall Study|Physician Decision|0|||
143141332|NCT01773928|516065574|FG000|Overall Study|Withdrawal by Subject|5|||
143472893|NCT01006265|517278790|FG003|Overall Study|Withdrawal by Subject|5|||
143472894|NCT01006265|517278787|FG000|Overall Study|Administrative reason|1|||
143472895|NCT01006265|517278788|FG001|Overall Study|Administrative reason|2|||
143472896|NCT01006265|517278789|FG002|Overall Study|Administrative reason|3|||
143472897|NCT01006265|517278790|FG003|Overall Study|Administrative reason|0|||
143472898|NCT03606980|517278791|FG000|Overall Study|Lost to Follow-up|3|||
143472899|NCT03606980|517278792|FG001|Overall Study|Lost to Follow-up|2|||
143472900|NCT03606980|517278793|FG002|Overall Study|Lost to Follow-up|3|||
143472901|NCT03606980|517278791|FG000|Overall Study|Withdrawal by Subject|1|||
143472902|NCT03606980|517278792|FG001|Overall Study|Withdrawal by Subject|0|||
143472903|NCT03606980|517278793|FG002|Overall Study|Withdrawal by Subject|4|||
143472904|NCT00387764|517278797|FG000|Overall Study|Adverse Event|12|||
143472905|NCT00387764|517278797|FG000|Overall Study|Withdrawal by Subject|8|||
143472906|NCT00387764|517278797|FG000|Overall Study|Sponsor Terminated Study|1|||
143472907|NCT00387764|517278797|FG000|Overall Study|Physician Decision|1|||
143472908|NCT00387764|517278797|FG000|Overall Study|Other|2|||
143472909|NCT00387764|517278797|FG000|Overall Study|Death|7|||
143472910|NCT01326728|517278798|FG000|Overall Study|Death|13|||
143472911|NCT01326728|517278799|FG001|Overall Study|Death|0|||
143141333|NCT01773928|516065575|FG001|Overall Study|Withdrawal by Subject|4|||
143141334|NCT01773928|516065576|FG002|Overall Study|Withdrawal by Subject|4|||
143141335|NCT01773928|516065577|FG003|Overall Study|Withdrawal by Subject|4|||
143141336|NCT01773928|516065578|FG004|Overall Study|Withdrawal by Subject|7|||
143141337|NCT01773928|516065579|FG005|Overall Study|Withdrawal by Subject|1|||
143141338|NCT01773928|516065580|FG006|Overall Study|Withdrawal by Subject|0|||
143141339|NCT01773928|516065581|FG007|Overall Study|Withdrawal by Subject|0|||
143141340|NCT01773928|516065582|FG008|Overall Study|Withdrawal by Subject|1|||
143141341|NCT01773928|516065574|FG000|Overall Study|Lost to Follow-up|0|||
143141342|NCT01773928|516065575|FG001|Overall Study|Lost to Follow-up|0|||
143141343|NCT01773928|516065576|FG002|Overall Study|Lost to Follow-up|0|||
143141344|NCT01773928|516065577|FG003|Overall Study|Lost to Follow-up|0|||
143141345|NCT01773928|516065578|FG004|Overall Study|Lost to Follow-up|0|||
143141346|NCT01773928|516065579|FG005|Overall Study|Lost to Follow-up|1|||
143141347|NCT01773928|516065580|FG006|Overall Study|Lost to Follow-up|0|||
143141348|NCT01773928|516065581|FG007|Overall Study|Lost to Follow-up|0|||
143232179|NCT00537394|516402036|FG000|First Year of Follow-up|Severe debilitation|1|||
143232180|NCT00537394|516402037|FG001|First Year of Follow-up|Severe debilitation|0|||
143232181|NCT00537394|516402038|FG002|First Year of Follow-up|Severe debilitation|1|||
143232182|NCT00537394|516402036|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
143141349|NCT01773928|516065582|FG008|Overall Study|Lost to Follow-up|0|||
143141350|NCT01773928|516065574|FG000|Overall Study|Subject misrepresented age|0|||
143141351|NCT01773928|516065575|FG001|Overall Study|Subject misrepresented age|1|||
143232183|NCT00537394|516402037|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
143472912|NCT01326728|517278798|FG000|Overall Study|Early closure of study|34|||
143141352|NCT01773928|516065576|FG002|Overall Study|Subject misrepresented age|0|||
143141353|NCT01773928|516065577|FG003|Overall Study|Subject misrepresented age|0|||
143232184|NCT00537394|516402038|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
143232185|NCT00537394|516402036|FG000|First Year of Follow-up|Lost to Follow-up|1|||
143472913|NCT01326728|517278799|FG001|Overall Study|Early closure of study|9|||
143472914|NCT02966223|517278800|FG000|Overall Study|Physician Decision|3|||
143472915|NCT02966223|517278800|FG000|Overall Study|Withdrawal by Subject|11|||
143472916|NCT02966223|517278800|FG000|Overall Study|Lost to Follow-up|1|||
143472917|NCT01184053|517278801|FG000|Overall Study|progression while on treatment|3|||
143141354|NCT01773928|516065578|FG004|Overall Study|Subject misrepresented age|0|||
143232186|NCT00537394|516402037|FG001|First Year of Follow-up|Lost to Follow-up|5|||
143141355|NCT01773928|516065579|FG005|Overall Study|Subject misrepresented age|0|||
143141356|NCT01773928|516065580|FG006|Overall Study|Subject misrepresented age|0|||
143141357|NCT01773928|516065581|FG007|Overall Study|Subject misrepresented age|0|||
143141358|NCT01773928|516065582|FG008|Overall Study|Subject misrepresented age|0|||
143141359|NCT01773928|516065574|FG000|Overall Study|Subject met exclusion criteria|0|||
143141360|NCT01773928|516065575|FG001|Overall Study|Subject met exclusion criteria|0|||
143141361|NCT01773928|516065576|FG002|Overall Study|Subject met exclusion criteria|0|||
143141362|NCT01773928|516065577|FG003|Overall Study|Subject met exclusion criteria|0|||
143141363|NCT01773928|516065578|FG004|Overall Study|Subject met exclusion criteria|0|||
143141364|NCT01773928|516065579|FG005|Overall Study|Subject met exclusion criteria|0|||
143141365|NCT01773928|516065580|FG006|Overall Study|Subject met exclusion criteria|0|||
143141366|NCT01773928|516065581|FG007|Overall Study|Subject met exclusion criteria|0|||
143141367|NCT01773928|516065582|FG008|Overall Study|Subject met exclusion criteria|1|||
143141368|NCT01773928|516065574|FG000|Overall Study|Randomized, had to leave, never returned|0|||
143141369|NCT01773928|516065575|FG001|Overall Study|Randomized, had to leave, never returned|0|||
143141370|NCT01773928|516065576|FG002|Overall Study|Randomized, had to leave, never returned|0|||
143141371|NCT01773928|516065577|FG003|Overall Study|Randomized, had to leave, never returned|1|||
143141372|NCT01773928|516065578|FG004|Overall Study|Randomized, had to leave, never returned|0|||
143141373|NCT01773928|516065579|FG005|Overall Study|Randomized, had to leave, never returned|0|||
143141374|NCT01773928|516065580|FG006|Overall Study|Randomized, had to leave, never returned|0|||
143141375|NCT01773928|516065581|FG007|Overall Study|Randomized, had to leave, never returned|0|||
143141376|NCT01773928|516065582|FG008|Overall Study|Randomized, had to leave, never returned|0|||
143141377|NCT01773928|516065574|FG000|Overall Study|Refused vaccine, withdrew consent|0|||
143141378|NCT01773928|516065575|FG001|Overall Study|Refused vaccine, withdrew consent|0|||
143141379|NCT01773928|516065576|FG002|Overall Study|Refused vaccine, withdrew consent|0|||
143141380|NCT01773928|516065577|FG003|Overall Study|Refused vaccine, withdrew consent|0|||
143141381|NCT01773928|516065578|FG004|Overall Study|Refused vaccine, withdrew consent|1|||
143141382|NCT01773928|516065579|FG005|Overall Study|Refused vaccine, withdrew consent|0|||
143141383|NCT01773928|516065580|FG006|Overall Study|Refused vaccine, withdrew consent|0|||
143141384|NCT01773928|516065581|FG007|Overall Study|Refused vaccine, withdrew consent|0|||
143141385|NCT01773928|516065582|FG008|Overall Study|Refused vaccine, withdrew consent|0|||
143141386|NCT03054428|516065583|FG000|Overall Study|Physician Decision|0|||
143141387|NCT03054428|516065584|FG001|Overall Study|Physician Decision|1|||
143141388|NCT03054428|516065585|FG002|Overall Study|Physician Decision|1|||
143141389|NCT03054428|516065583|FG000|Overall Study|Lack of Efficacy|3|||
143141390|NCT03054428|516065584|FG001|Overall Study|Lack of Efficacy|1|||
143141391|NCT03054428|516065585|FG002|Overall Study|Lack of Efficacy|0|||
143362275|NCT00495469|516869636|FG001|Overall Study|ST depression at randomisation in ECG|1|||
143362276|NCT00495469|516869637|FG002|Overall Study|ST depression at randomisation in ECG|0|||
143362277|NCT00495469|516869638|FG003|Overall Study|ST depression at randomisation in ECG|0|||
143362278|NCT00495469|516869639|FG004|Overall Study|ST depression at randomisation in ECG|0|||
143362279|NCT00495469|516869640|FG005|Overall Study|ST depression at randomisation in ECG|0|||
143362280|NCT00495469|516869641|FG006|Overall Study|ST depression at randomisation in ECG|0|||
143362281|NCT01106976|516869648|FG000|Overall Study|Lost to Follow-up|8|||
143362282|NCT00051311|516869652|FG000|Overall Study|Starting new study|0|||
143362283|NCT00051311|516869653|FG001|Overall Study|Starting new study|1|||
143362284|NCT00051311|516869652|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
143362285|NCT00051311|516869653|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
143362286|NCT00051311|516869652|FG000|Overall Study|Death of recipient|8|||
143362287|NCT00051311|516869653|FG001|Overall Study|Death of recipient|8|||
143362288|NCT00051311|516869652|FG000|Overall Study|Recipient taken off study|4|||
143362289|NCT00051311|516869653|FG001|Overall Study|Recipient taken off study|4|||
143362290|NCT01427907|516869655|FG000|Overall Study|Withdrawal by Subject|3|||
143362291|NCT01427907|516869656|FG001|Overall Study|Withdrawal by Subject|4|||
143362292|NCT02374957|516869657|FG000|Overall Study|Patient did not complete forms correctly|1|||
143362293|NCT02374957|516869658|FG001|Overall Study|Patient did not complete forms correctly|0|||
143362294|NCT00972543|516869659|FG000|Overall Study|Adverse Event|1|||
143362295|NCT00972543|516869660|FG001|Overall Study|Adverse Event|0|||
143362296|NCT00972543|516869659|FG000|Overall Study|Early study termination by sponsor|4|||
143362297|NCT00972543|516869660|FG001|Overall Study|Early study termination by sponsor|1|||
143362298|NCT00335153|516869661|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
143362299|NCT00335153|516869661|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
143362300|NCT00335153|516869661|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
143362301|NCT00335153|516869661|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
143362302|NCT00335153|516869661|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
143362303|NCT00335153|516869661|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
143362304|NCT00335153|516869661|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
143362305|NCT00335153|516869661|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
143362306|NCT00335153|516869661|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
143362307|NCT00335153|516869661|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
143141392|NCT03054428|516065583|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
143141393|NCT03054428|516065584|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
143141394|NCT03054428|516065585|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
143141395|NCT03054428|516065583|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
143141396|NCT03054428|516065584|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
143141397|NCT03054428|516065585|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
143141398|NCT03054428|516065583|FG000|Overall Study|Transitioned to OLE study|76|||
143141399|NCT03054428|516065584|FG001|Overall Study|Transitioned to OLE study|76|||
143141400|NCT03054428|516065585|FG002|Overall Study|Transitioned to OLE study|73|||
143141401|NCT03054428|516065583|FG000|Overall Study|Withdrawal by Subject|3|||
143141402|NCT03054428|516065584|FG001|Overall Study|Withdrawal by Subject|2|||
143141403|NCT03054428|516065585|FG002|Overall Study|Withdrawal by Subject|3|||
143141404|NCT03054428|516065583|FG000|Overall Study|Lost to Follow-up|0|||
143141405|NCT03054428|516065584|FG001|Overall Study|Lost to Follow-up|0|||
143141406|NCT03054428|516065585|FG002|Overall Study|Lost to Follow-up|1|||
143141407|NCT03092752|516065586|FG000|Overall Study|Aged <40 years|14209|||
143141408|NCT03092752|516065586|FG000|Overall Study|At least one claim with T2DM|61299|||
143141409|NCT03092752|516065586|FG000|Overall Study|Having no claim of study drugs|29282|||
143141410|NCT03092752|516065586|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
143141411|NCT03092752|516065586|FG000|Overall Study|<6 month history|245900|||
143141412|NCT01652690|516065587|FG000|Overall Study|Withdrawal by Subject|16|||
143141413|NCT01652690|516065588|FG001|Overall Study|Withdrawal by Subject|4|||
143141414|NCT01652690|516065587|FG000|Overall Study|Other|8|||
143141415|NCT01652690|516065588|FG001|Overall Study|Other|9|||
143141416|NCT01652690|516065587|FG000|Overall Study|Lost to Follow-up|6|||
143141417|NCT01652690|516065588|FG001|Overall Study|Lost to Follow-up|6|||
143141418|NCT01652690|516065587|FG000|Overall Study|Death|5|||
143141419|NCT01652690|516065588|FG001|Overall Study|Death|2|||
143141420|NCT05399680|516067323|FG000|Overall Study|Lost to Follow-up|1|||
143141421|NCT05399680|516067324|FG001|Overall Study|Lost to Follow-up|0|||
143141422|NCT05399680|516067323|FG000|Overall Study|Death|0|||
143141423|NCT05399680|516067324|FG001|Overall Study|Death|1|||
143141424|NCT02659865|516067325|FG000|Period 1|Withdrawal by Subject|1|||
143141425|NCT02659865|516067326|FG001|Period 1|Withdrawal by Subject|0|||
143141426|NCT02659865|516067327|FG002|Period 1|Withdrawal by Subject|0|||
143141427|NCT02659865|516067328|FG003|Period 1|Withdrawal by Subject|0|||
143141428|NCT02659865|516067329|FG004|Period 1|Withdrawal by Subject|0|||
143141429|NCT02659865|516067325|FG000|Period 1|Adverse Event|0|||
143141430|NCT02659865|516067326|FG001|Period 1|Adverse Event|0|||
143141431|NCT02659865|516067327|FG002|Period 1|Adverse Event|0|||
143141432|NCT02659865|516067328|FG003|Period 1|Adverse Event|0|||
143141433|NCT02659865|516067329|FG004|Period 1|Adverse Event|1|||
143141434|NCT03370172|516067330|FG000|Overall Study|Withdrawal by Subject|0|||
143141435|NCT03370172|516067331|FG001|Overall Study|Withdrawal by Subject|1|||
143141436|NCT00753519|516067333|FG000|Overall Study|Withdrawal by Subject|0|||
143141437|NCT00753519|516067334|FG001|Overall Study|Withdrawal by Subject|2|||
143141438|NCT00959751|516067335|FG000|Overall Study|Lost to Follow-up|2|||
143141439|NCT00959751|516067336|FG001|Overall Study|Lost to Follow-up|3|||
143141440|NCT00959751|516067335|FG000|Overall Study|Consent Withdrawn|0|||
143141441|NCT00959751|516067336|FG001|Overall Study|Consent Withdrawn|1|||
143141442|NCT00959751|516067335|FG000|Overall Study|Non-compliance to Study Procedures|0|||
143141443|NCT00959751|516067336|FG001|Overall Study|Non-compliance to Study Procedures|1|||
143141444|NCT00959751|516067335|FG000|Overall Study|No migraine headache without aura|7|||
143141445|NCT00959751|516067336|FG001|Overall Study|No migraine headache without aura|7|||
143141446|NCT01171534|516067341|FG000|Overall Study|Lost to Follow-up|0|||
143141447|NCT01171534|516067342|FG001|Overall Study|Lost to Follow-up|2|||
143141448|NCT01171534|516067341|FG000|Overall Study|screen failure|0|||
143141449|NCT01171534|516067342|FG001|Overall Study|screen failure|1|||
143141450|NCT03861039|516067343|FG000|Overall Study|Adverse Event|2|||
143141451|NCT03861039|516067344|FG001|Overall Study|Adverse Event|5|||
143141452|NCT03861039|516067345|FG002|Overall Study|Adverse Event|11|||
143141453|NCT03861039|516067343|FG000|Overall Study|Withdrawal by Subject|1|||
143141454|NCT03861039|516067344|FG001|Overall Study|Withdrawal by Subject|3|||
143141455|NCT03861039|516067345|FG002|Overall Study|Withdrawal by Subject|4|||
143141456|NCT01113749|516067346|FG000|Overall Study|Lost to Follow-up|1|||
143141457|NCT01113749|516067347|FG001|Overall Study|Lost to Follow-up|2|||
143141458|NCT03427892|516067349|FG000|Overall Study|Lost to Follow-up|2|||
143141459|NCT00548327|516067350|FG000|Overall Study|Adverse Event|0|||
143141460|NCT00548327|516067351|FG001|Overall Study|Adverse Event|1|||
143141461|NCT01673386|516067352|FG000|Overall Study|Study terminated by sponsor|16|||
143141462|NCT01673386|516067353|FG001|Overall Study|Study terminated by sponsor|22|||
143141463|NCT01673386|516067352|FG000|Overall Study|Adverse Event|5|||
143362308|NCT02478359|516869662|FG000|Overall Study|Disenrolled from health plan|106|||
143362309|NCT02478359|516869663|FG001|Overall Study|Disenrolled from health plan|65|||
143362310|NCT02412761|516869664|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
143362311|NCT02412761|516869665|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
143362312|NCT02412761|516869666|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
143141464|NCT01673386|516067353|FG001|Overall Study|Adverse Event|2|||
143141465|NCT01673386|516067352|FG000|Overall Study|Progressive disease|4|||
143141466|NCT01673386|516067353|FG001|Overall Study|Progressive disease|1|||
143141467|NCT01673386|516067352|FG000|Overall Study|Withdrawal by Subject|0|||
143141468|NCT01673386|516067353|FG001|Overall Study|Withdrawal by Subject|2|||
143141469|NCT03255187|516067354|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
143141470|NCT03255187|516067355|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
143362313|NCT02412761|516869667|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
143362314|NCT02412761|516869668|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
143362315|NCT02412761|516869669|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
143362316|NCT01818700|516869670|FG000|Overall Study|Adverse Event|67|||
143362317|NCT01818700|516869670|FG000|Overall Study|Lack of Efficacy|2|||
143362318|NCT01818700|516869670|FG000|Overall Study|Lost to Follow-up|5|||
143362319|NCT01818700|516869670|FG000|Overall Study|Withdrawal by Subject|27|||
143362320|NCT01818700|516869670|FG000|Overall Study|Protocol Violation|2|||
143362321|NCT01818700|516869670|FG000|Overall Study|Other|1|||
143362322|NCT02820051|516869679|FG000|Overall Study|Lost to Follow-up|7|||
143362323|NCT02820051|516869680|FG001|Overall Study|Lost to Follow-up|4|||
143362324|NCT01222247|516869684|FG000|Overall Study|Lost to Follow-up|2|||
143362325|NCT01222247|516869685|FG001|Overall Study|Lost to Follow-up|2|||
143362326|NCT02084082|516869686|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
143362327|NCT02084082|516869687|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
143362328|NCT02084082|516869688|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
143362329|NCT02084082|516869689|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
143362330|NCT02084082|516869686|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
143362331|NCT02084082|516869687|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
143362332|NCT02084082|516869688|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
143362333|NCT02084082|516869689|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
143362334|NCT01767909|516869690|FG000|Overall Study|Withdrawal by Subject|4|||
143362335|NCT01767909|516869691|FG001|Overall Study|Withdrawal by Subject|7|||
143362336|NCT01767909|516869690|FG000|Overall Study|Adverse Event|3|||
143362337|NCT01767909|516869691|FG001|Overall Study|Adverse Event|1|||
143362338|NCT01767909|516869690|FG000|Overall Study|Withdrawal by Study Partner|3|||
143362339|NCT01767909|516869691|FG001|Overall Study|Withdrawal by Study Partner|1|||
143362340|NCT01767909|516869690|FG000|Overall Study|Non-Compliance|2|||
143362341|NCT01767909|516869691|FG001|Overall Study|Non-Compliance|0|||
143362342|NCT01767909|516869690|FG000|Overall Study|Perceived Lack of Efficacy|1|||
143362343|NCT01767909|516869691|FG001|Overall Study|Perceived Lack of Efficacy|0|||
143362344|NCT01767909|516869690|FG000|Overall Study|Investigator Recommendation|0|||
143362345|NCT01767909|516869691|FG001|Overall Study|Investigator Recommendation|1|||
143362346|NCT01767909|516869690|FG000|Overall Study|Lost to Follow-up|0|||
143362347|NCT01767909|516869691|FG001|Overall Study|Lost to Follow-up|1|||
143362348|NCT01767909|516869690|FG000|Overall Study|LP uncessessful|0|||
143362349|NCT01767909|516869691|FG001|Overall Study|LP uncessessful|1|||
143362350|NCT03285711|516869695|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
143362351|NCT03285711|516869696|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
143362352|NCT03285711|516869697|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
143362353|NCT03285711|516869698|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
143362354|NCT03285711|516869695|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
143362355|NCT03285711|516869696|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
143362356|NCT03285711|516869697|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
143362357|NCT03285711|516869698|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
143362358|NCT03285711|516869695|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
143362359|NCT03285711|516869696|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
143362360|NCT03285711|516869697|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
143362361|NCT03285711|516869698|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
143362362|NCT03285711|516869695|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
143362363|NCT03285711|516869696|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
143362364|NCT03285711|516869697|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
143362365|NCT03285711|516869698|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
143362366|NCT02431533|516869702|FG000|Overall Study|Withdrawal by Subject|1|||
143362367|NCT02431533|516869703|FG001|Overall Study|Withdrawal by Subject|3|||
143362368|NCT02431533|516869702|FG000|Overall Study|Developed Exclusionary criteria|1|||
143362369|NCT02431533|516869703|FG001|Overall Study|Developed Exclusionary criteria|0|||
143362370|NCT00235495|516869706|FG000|Overall Study|Death|52|||
143362371|NCT00235495|516869707|FG001|Overall Study|Death|42|||
143362372|NCT00235495|516869706|FG000|Overall Study|Withdrawal by Subject|5|||
143362373|NCT00235495|516869707|FG001|Overall Study|Withdrawal by Subject|3|||
143362374|NCT00235495|516869706|FG000|Overall Study|Lost to Follow-up|11|||
143362375|NCT00235495|516869707|FG001|Overall Study|Lost to Follow-up|13|||
143362376|NCT00235495|516869706|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
143472918|NCT03785678|517278802|FG000|Overall Study|Death|44|||
143141471|NCT03255187|516067354|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
143141472|NCT03255187|516067355|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
143472919|NCT03785678|517278803|FG001|Overall Study|Death|42|||
143472920|NCT03785678|517278802|FG000|Overall Study|Lost to Follow-up|4|||
143472921|NCT03785678|517278803|FG001|Overall Study|Lost to Follow-up|2|||
143472922|NCT03785678|517278802|FG000|Overall Study|Physician Decision|0|||
143472923|NCT03785678|517278803|FG001|Overall Study|Physician Decision|2|||
143472924|NCT03785678|517278802|FG000|Overall Study|Withdrawal by Subject|5|||
143472925|NCT03785678|517278803|FG001|Overall Study|Withdrawal by Subject|3|||
143472926|NCT04399122|517278804|FG000|Overall Study|Lost to Follow-up|2|||
143472927|NCT04399122|517278805|FG001|Overall Study|Lost to Follow-up|0|||
143472928|NCT04399122|517278804|FG000|Overall Study|Withdrawal by Subject|1|||
143472929|NCT04399122|517278805|FG001|Overall Study|Withdrawal by Subject|0|||
143472930|NCT02536755|517278809|FG000|Overall Study|Adverse Event|4|||
143472931|NCT02301936|517278810|FG000|Overall Study|Lost to Follow-up|1|||
143472932|NCT02301936|517278811|FG001|Overall Study|Lost to Follow-up|0|||
143472933|NCT03065023|517278812|FG000|Overall Study|Progressive Disease|0|||
143472934|NCT03065023|517278813|FG001|Overall Study|Progressive Disease|1|||
143472935|NCT03065023|517278814|FG002|Overall Study|Progressive Disease|0|||
143472936|NCT03065023|517278815|FG003|Overall Study|Progressive Disease|0|||
143472937|NCT03065023|517278816|FG004|Overall Study|Progressive Disease|0|||
143472938|NCT03065023|517278812|FG000|Overall Study|Death|2|||
143472939|NCT03065023|517278813|FG001|Overall Study|Death|0|||
143472940|NCT03065023|517278814|FG002|Overall Study|Death|1|||
143472941|NCT03065023|517278815|FG003|Overall Study|Death|1|||
143472942|NCT03065023|517278816|FG004|Overall Study|Death|0|||
143472943|NCT03065023|517278812|FG000|Overall Study|Lost to Follow-up|0|||
143141473|NCT00109343|516067356|FG000|Overall Study|Adverse Event|1|||
143141474|NCT00109343|516067357|FG001|Overall Study|Adverse Event|0|||
143141475|NCT00109343|516067358|FG002|Overall Study|Adverse Event|2|||
143141476|NCT00109343|516067356|FG000|Overall Study|Lack of Efficacy|1|||
143141477|NCT00109343|516067357|FG001|Overall Study|Lack of Efficacy|0|||
143141478|NCT00109343|516067358|FG002|Overall Study|Lack of Efficacy|0|||
143141479|NCT00109343|516067356|FG000|Overall Study|Lost to Follow-up|35|||
143141480|NCT00109343|516067357|FG001|Overall Study|Lost to Follow-up|20|||
143141481|NCT00109343|516067358|FG002|Overall Study|Lost to Follow-up|14|||
143141482|NCT00109343|516067356|FG000|Overall Study|Protocol Violation|1|||
143141483|NCT00109343|516067357|FG001|Overall Study|Protocol Violation|2|||
143141484|NCT00109343|516067358|FG002|Overall Study|Protocol Violation|2|||
143141485|NCT00109343|516067356|FG000|Overall Study|Withdrawal by Subject|15|||
143141486|NCT00109343|516067357|FG001|Overall Study|Withdrawal by Subject|11|||
143141487|NCT00109343|516067358|FG002|Overall Study|Withdrawal by Subject|10|||
143141488|NCT00109343|516067356|FG000|Overall Study|Subject Moved|6|||
143141489|NCT00109343|516067357|FG001|Overall Study|Subject Moved|2|||
143141490|NCT00109343|516067358|FG002|Overall Study|Subject Moved|1|||
143141491|NCT00109343|516067356|FG000|Overall Study|Other|5|||
143141492|NCT00109343|516067357|FG001|Overall Study|Other|2|||
143141493|NCT00109343|516067358|FG002|Overall Study|Other|1|||
143141494|NCT00750269|516067359|FG000|Overall Study|Protocol Violation|0|||
143141495|NCT00750269|516067360|FG001|Overall Study|Protocol Violation|1|||
143141496|NCT00750269|516067361|FG002|Overall Study|Protocol Violation|1|||
143141497|NCT00750269|516067362|FG003|Overall Study|Protocol Violation|2|||
143141498|NCT00750269|516067363|FG004|Overall Study|Protocol Violation|4|||
143141499|NCT00750269|516067359|FG000|Overall Study|Withdrawal by Subject|0|||
143141500|NCT00750269|516067360|FG001|Overall Study|Withdrawal by Subject|0|||
143141501|NCT00750269|516067361|FG002|Overall Study|Withdrawal by Subject|2|||
143141502|NCT00750269|516067362|FG003|Overall Study|Withdrawal by Subject|2|||
143141503|NCT00750269|516067363|FG004|Overall Study|Withdrawal by Subject|2|||
143141504|NCT00750269|516067359|FG000|Overall Study|Physician Decision|0|||
143141505|NCT00750269|516067360|FG001|Overall Study|Physician Decision|0|||
143141506|NCT00750269|516067361|FG002|Overall Study|Physician Decision|0|||
143141507|NCT00750269|516067362|FG003|Overall Study|Physician Decision|0|||
143141508|NCT00750269|516067363|FG004|Overall Study|Physician Decision|2|||
143141509|NCT00750269|516067359|FG000|Overall Study|Patient too large for positioning|0|||
143141510|NCT00750269|516067360|FG001|Overall Study|Patient too large for positioning|0|||
143141511|NCT00750269|516067361|FG002|Overall Study|Patient too large for positioning|1|||
143141512|NCT00750269|516067362|FG003|Overall Study|Patient too large for positioning|0|||
143141513|NCT00750269|516067363|FG004|Overall Study|Patient too large for positioning|0|||
143141514|NCT00750269|516067359|FG000|Overall Study|Site error|0|||
143141515|NCT00750269|516067360|FG001|Overall Study|Site error|0|||
143141516|NCT00750269|516067361|FG002|Overall Study|Site error|0|||
143141517|NCT00750269|516067362|FG003|Overall Study|Site error|1|||
143141518|NCT00750269|516067363|FG004|Overall Study|Site error|0|||
143141519|NCT00750269|516067359|FG000|Overall Study|SBRT plan could not be drawn|0|||
143141520|NCT00750269|516067360|FG001|Overall Study|SBRT plan could not be drawn|0|||
143141521|NCT00750269|516067361|FG002|Overall Study|SBRT plan could not be drawn|0|||
143141522|NCT00750269|516067362|FG003|Overall Study|SBRT plan could not be drawn|0|||
143141523|NCT00750269|516067363|FG004|Overall Study|SBRT plan could not be drawn|1|||
143141524|NCT00750269|516067359|FG000|Overall Study|Fiducials could not be placed|0|||
143141525|NCT00750269|516067360|FG001|Overall Study|Fiducials could not be placed|0|||
143141526|NCT00750269|516067361|FG002|Overall Study|Fiducials could not be placed|0|||
143472944|NCT03065023|517278813|FG001|Overall Study|Lost to Follow-up|1|||
143472945|NCT03065023|517278814|FG002|Overall Study|Lost to Follow-up|0|||
143141527|NCT00750269|516067362|FG003|Overall Study|Fiducials could not be placed|0|||
143141528|NCT00750269|516067363|FG004|Overall Study|Fiducials could not be placed|1|||
143141529|NCT02934178|516067364|FG000|Received Vaccination 2|Death|0|||
143141530|NCT02934178|516067365|FG001|Received Vaccination 2|Death|1|||
143141531|NCT02934178|516067364|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
143141532|NCT02934178|516067365|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
143141533|NCT01075048|516067370|FG000|Overall Study|Death|4|||
143141534|NCT01075048|516067371|FG001|Overall Study|Death|17|||
143141535|NCT01075048|516067372|FG002|Overall Study|Death|12|||
143141536|NCT01075048|516067370|FG000|Overall Study|Start of other or new therapy|4|||
143141537|NCT01075048|516067371|FG001|Overall Study|Start of other or new therapy|36|||
143141538|NCT01075048|516067372|FG002|Overall Study|Start of other or new therapy|46|||
143141539|NCT01075048|516067370|FG000|Overall Study|Withdrawal by Subject|1|||
143141540|NCT01075048|516067371|FG001|Overall Study|Withdrawal by Subject|6|||
143141541|NCT01075048|516067372|FG002|Overall Study|Withdrawal by Subject|3|||
143141542|NCT01075048|516067370|FG000|Overall Study|Lost to Follow-up|0|||
143141543|NCT01075048|516067371|FG001|Overall Study|Lost to Follow-up|1|||
143141544|NCT01075048|516067372|FG002|Overall Study|Lost to Follow-up|1|||
143141545|NCT00296244|516067377|FG000|Overall Study|Underwent retransplant|0|||
143141546|NCT00296244|516067378|FG001|Overall Study|Underwent retransplant|1|||
143141547|NCT00420745|516067379|FG000|Overall Study|Adverse Event|2|||
143141548|NCT00420745|516067380|FG001|Overall Study|Adverse Event|2|||
143141549|NCT00420745|516067379|FG000|Overall Study|Lost to Follow-up|10|||
143141550|NCT00420745|516067380|FG001|Overall Study|Lost to Follow-up|2|||
143141551|NCT00420745|516067379|FG000|Overall Study|Protocol Violation|1|||
143141552|NCT00420745|516067380|FG001|Overall Study|Protocol Violation|0|||
143141553|NCT00420745|516067379|FG000|Overall Study|Physician Decision|1|||
143141554|NCT00420745|516067380|FG001|Overall Study|Physician Decision|1|||
143141555|NCT00420745|516067379|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
143141556|NCT00420745|516067380|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
143141557|NCT00420745|516067379|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
143141558|NCT00420745|516067380|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
143141559|NCT03617588|516067381|FG000|Overall Study|Withdrawal by Subject|1|||
143141560|NCT03617588|516067382|FG001|Overall Study|Withdrawal by Subject|0|||
143141561|NCT03817528|516067383|FG000|Overall Study|Withdrawal by Subject|1|||
143141562|NCT03817528|516067383|FG000|Overall Study|Adverse Event|2|||
143141563|NCT01027949|516067384|FG000|Overall Study|Death|174|||
143141564|NCT01027949|516067384|FG000|Overall Study|Progressive Disease|163|||
143141565|NCT01027949|516067384|FG000|Overall Study|Adverse Event|172|||
143141566|NCT01027949|516067384|FG000|Overall Study|Withdrawal by Subject|113|||
143141567|NCT01027949|516067384|FG000|Overall Study|Lost to Follow-up|17|||
143141568|NCT01027949|516067384|FG000|Overall Study|Protocol Violation|13|||
143141569|NCT01027949|516067384|FG000|Overall Study|PI Decision|8|||
143141570|NCT01027949|516067384|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
143141571|NCT01027949|516067384|FG000|Overall Study|Non-compliance with Study Procedures|7|||
143141572|NCT01027949|516067384|FG000|Overall Study|Lung Transplant|5|||
143141573|NCT01027949|516067384|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
143141574|NCT01027949|516067384|FG000|Overall Study|Use of Excluded Medication|2|||
143141575|NCT01027949|516067384|FG000|Overall Study|Patient Self-discontinuation|1|||
143141576|NCT01027949|516067384|FG000|Overall Study|Pregnancy|1|||
143141577|NCT01027949|516067384|FG000|Overall Study|Surgery|1|||
143141578|NCT01200355|516067385|FG000|Overall Study|Death|7|||
143141579|NCT01200355|516067386|FG001|Overall Study|Death|2|||
143141580|NCT00486044|516067388|FG000|Overall Study|Withdrawal by Subject|2|||
143141581|NCT00486044|516067389|FG001|Overall Study|Withdrawal by Subject|1|||
143141582|NCT00486044|516067388|FG000|Overall Study|Adverse Event|0|||
143141583|NCT00486044|516067389|FG001|Overall Study|Adverse Event|1|||
143141584|NCT00486044|516067388|FG000|Overall Study|Lost to Follow-up|0|||
143141585|NCT00486044|516067389|FG001|Overall Study|Lost to Follow-up|1|||
143472946|NCT03065023|517278815|FG003|Overall Study|Lost to Follow-up|0|||
143141586|NCT00997893|516067391|FG000|Overall Study|Adverse Event|1|||
143141587|NCT00997893|516067392|FG001|Overall Study|Adverse Event|0|||
143141588|NCT00997893|516067393|FG002|Overall Study|Adverse Event|0|||
143141589|NCT00997893|516067391|FG000|Overall Study|Unable to meet study timelines|1|||
143141590|NCT00997893|516067392|FG001|Overall Study|Unable to meet study timelines|0|||
143141591|NCT00997893|516067393|FG002|Overall Study|Unable to meet study timelines|0|||
143141592|NCT00997893|516067391|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
143141593|NCT00997893|516067392|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
143141594|NCT00997893|516067393|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
143141595|NCT02309359|516067394|FG000|Overall Study|Adverse Event|4|||
143141596|NCT02309359|516067395|FG001|Overall Study|Adverse Event|5|||
143141597|NCT02309359|516067396|FG002|Overall Study|Adverse Event|5|||
143141598|NCT02309359|516067397|FG003|Overall Study|Adverse Event|4|||
143141599|NCT02309359|516067398|FG004|Overall Study|Adverse Event|4|||
143141600|NCT02309359|516067394|FG000|Overall Study|Death|1|||
143141601|NCT02309359|516067395|FG001|Overall Study|Death|0|||
143141602|NCT02309359|516067396|FG002|Overall Study|Death|0|||
143141603|NCT02309359|516067397|FG003|Overall Study|Death|0|||
143141604|NCT02309359|516067398|FG004|Overall Study|Death|0|||
143141605|NCT02309359|516067394|FG000|Overall Study|Withdrawal by Subject|2|||
143141606|NCT02309359|516067395|FG001|Overall Study|Withdrawal by Subject|2|||
143141607|NCT02309359|516067396|FG002|Overall Study|Withdrawal by Subject|4|||
143141608|NCT02309359|516067397|FG003|Overall Study|Withdrawal by Subject|4|||
143141609|NCT02309359|516067398|FG004|Overall Study|Withdrawal by Subject|0|||
143141610|NCT02309359|516067394|FG000|Overall Study|Lack of Efficacy|3|||
143141611|NCT02309359|516067395|FG001|Overall Study|Lack of Efficacy|1|||
143141612|NCT02309359|516067396|FG002|Overall Study|Lack of Efficacy|0|||
143141613|NCT02309359|516067397|FG003|Overall Study|Lack of Efficacy|0|||
143141614|NCT02309359|516067398|FG004|Overall Study|Lack of Efficacy|3|||
143141615|NCT02309359|516067394|FG000|Overall Study|Lost to Follow-up|0|||
143141616|NCT02309359|516067395|FG001|Overall Study|Lost to Follow-up|0|||
143141617|NCT02309359|516067396|FG002|Overall Study|Lost to Follow-up|0|||
143141618|NCT02309359|516067397|FG003|Overall Study|Lost to Follow-up|1|||
143141619|NCT02309359|516067398|FG004|Overall Study|Lost to Follow-up|0|||
143141620|NCT02309359|516067394|FG000|Overall Study|Other|2|||
143141621|NCT02309359|516067395|FG001|Overall Study|Other|0|||
143141622|NCT02309359|516067396|FG002|Overall Study|Other|2|||
143141623|NCT02309359|516067397|FG003|Overall Study|Other|3|||
143141624|NCT02309359|516067398|FG004|Overall Study|Other|2|||
143141625|NCT00701363|516067400|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
143141626|NCT00701363|516067401|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
143141627|NCT00701363|516067402|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
143141628|NCT00701363|516067403|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
143141629|NCT00701363|516067400|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
143141630|NCT00701363|516067401|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
143141631|NCT00701363|516067402|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
143141632|NCT00701363|516067403|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
143141633|NCT00701363|516067400|FG000|Treatment Phase 1|Adverse Event|7|||
143141634|NCT00701363|516067401|FG001|Treatment Phase 1|Adverse Event|0|||
143141635|NCT00701363|516067402|FG002|Treatment Phase 1|Adverse Event|0|||
143141636|NCT00701363|516067403|FG003|Treatment Phase 1|Adverse Event|0|||
143141637|NCT00701363|516067400|FG000|Treatment Phase 1|Protocol Violation|1|||
143141638|NCT00701363|516067401|FG001|Treatment Phase 1|Protocol Violation|0|||
143141639|NCT00701363|516067402|FG002|Treatment Phase 1|Protocol Violation|0|||
143141640|NCT00701363|516067403|FG003|Treatment Phase 1|Protocol Violation|0|||
143141641|NCT00701363|516067400|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
143141642|NCT00701363|516067401|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
143141643|NCT00701363|516067402|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
143141644|NCT00701363|516067403|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
143141645|NCT00701363|516067400|FG000|Treatment Phase 1|Lack of Efficacy|1|||
143141646|NCT00701363|516067401|FG001|Treatment Phase 1|Lack of Efficacy|0|||
143141647|NCT00701363|516067402|FG002|Treatment Phase 1|Lack of Efficacy|0|||
143141648|NCT00701363|516067403|FG003|Treatment Phase 1|Lack of Efficacy|0|||
143141649|NCT00701363|516067400|FG000|Treatment Phase 2|Adverse Event|0|||
143141650|NCT00701363|516067401|FG001|Treatment Phase 2|Adverse Event|0|||
143141651|NCT00701363|516067402|FG002|Treatment Phase 2|Adverse Event|1|||
143141652|NCT00701363|516067403|FG003|Treatment Phase 2|Adverse Event|0|||
143141653|NCT00701363|516067400|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
143141654|NCT00701363|516067401|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
143141655|NCT00701363|516067402|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
143141656|NCT00701363|516067403|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
143141657|NCT04759131|516067404|FG000|Overall Study|Investigator's discretion|1|||
143141658|NCT04759131|516067405|FG001|Overall Study|Investigator's discretion|0|||
143141659|NCT04759131|516067404|FG000|Overall Study|Subject withdrawal|1|||
143141660|NCT04759131|516067405|FG001|Overall Study|Subject withdrawal|0|||
143141661|NCT05144945|516067406|FG000|Overall Study|Withdrawal by Subject|1|||
143141662|NCT05144945|516067407|FG001|Overall Study|Withdrawal by Subject|0|||
143141663|NCT01192815|516067408|FG000|Overall Study|Withdrawal by Subject|1|||
143141664|NCT01192815|516067408|FG000|Overall Study|Lack of Efficacy|1|||
143141665|NCT02592824|516067410|FG000|Overall Study|Protocol Violation|5|||
143141666|NCT02592824|516067411|FG001|Overall Study|Protocol Violation|3|||
143141667|NCT02592824|516067410|FG000|Overall Study|Lost to Follow-up|2|||
143141668|NCT02592824|516067411|FG001|Overall Study|Lost to Follow-up|1|||
143141669|NCT01604785|516067414|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
143141670|NCT01604785|516067415|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
143141671|NCT02029417|516067418|FG000|Overall Study|Death|1|||
143141672|NCT02029417|516067418|FG000|Overall Study|Adverse Event|1|||
143141673|NCT03040726|516067419|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
143141674|NCT03040726|516067420|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
143141675|NCT03040726|516067419|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
143141676|NCT03040726|516067420|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
143472947|NCT03065023|517278816|FG004|Overall Study|Lost to Follow-up|0|||
143472948|NCT03065023|517278812|FG000|Overall Study|Participant Decision|0|||
143472949|NCT03065023|517278813|FG001|Overall Study|Participant Decision|0|||
143472950|NCT03065023|517278814|FG002|Overall Study|Participant Decision|0|||
143472951|NCT03065023|517278815|FG003|Overall Study|Participant Decision|1|||
143472952|NCT03065023|517278816|FG004|Overall Study|Participant Decision|0|||
143472953|NCT03065023|517278812|FG000|Overall Study|Withdrawal by Subject|0|||
143472954|NCT03065023|517278813|FG001|Overall Study|Withdrawal by Subject|0|||
143472955|NCT03065023|517278814|FG002|Overall Study|Withdrawal by Subject|0|||
143472956|NCT03065023|517278815|FG003|Overall Study|Withdrawal by Subject|1|||
143472957|NCT03065023|517278816|FG004|Overall Study|Withdrawal by Subject|0|||
143472958|NCT00705432|517278817|FG000|Treatment Period|Adverse Event|45|||
143472959|NCT00705432|517278818|FG001|Treatment Period|Adverse Event|37|||
143472960|NCT00705432|517278819|FG002|Treatment Period|Adverse Event|51|||
143472961|NCT00705432|517278820|FG003|Treatment Period|Adverse Event|12|||
143472962|NCT00705432|517278821|FG004|Treatment Period|Adverse Event|8|||
143472963|NCT00705432|517278822|FG005|Treatment Period|Adverse Event|9|||
143472964|NCT00705432|517278817|FG000|Treatment Period|Treatment failure|92|||
143472965|NCT00705432|517278818|FG001|Treatment Period|Treatment failure|42|||
143472966|NCT00705432|517278819|FG002|Treatment Period|Treatment failure|33|||
143472967|NCT00705432|517278820|FG003|Treatment Period|Treatment failure|25|||
143472968|NCT00705432|517278821|FG004|Treatment Period|Treatment failure|13|||
143472969|NCT00705432|517278822|FG005|Treatment Period|Treatment failure|14|||
143472970|NCT00705432|517278817|FG000|Treatment Period|Non medical reason|26|||
143472971|NCT00705432|517278818|FG001|Treatment Period|Non medical reason|32|||
143472972|NCT00705432|517278819|FG002|Treatment Period|Non medical reason|37|||
143472973|NCT00705432|517278820|FG003|Treatment Period|Non medical reason|4|||
143472974|NCT00705432|517278821|FG004|Treatment Period|Non medical reason|7|||
143472975|NCT00705432|517278822|FG005|Treatment Period|Non medical reason|7|||
143472976|NCT00705432|517278817|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
143472977|NCT00705432|517278818|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
143141677|NCT03040726|516067419|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
143141678|NCT03040726|516067420|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
143141679|NCT03040726|516067419|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
143141680|NCT03040726|516067420|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
143141681|NCT03040726|516067419|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
143141682|NCT03040726|516067420|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
143141683|NCT00465179|516067423|FG000|Overall Study|Adverse Event|4|||
143141684|NCT00465179|516067423|FG000|Overall Study|Withdrawal by Subject|2|||
143141685|NCT00465179|516067423|FG000|Overall Study|Progression of Disease|47|||
143141686|NCT00833755|516067426|FG000|Overall Study|Physician Decision|4|||
143141687|NCT00833755|516067427|FG001|Overall Study|Physician Decision|4|||
143141688|NCT00833755|516067428|FG002|Overall Study|Physician Decision|2|||
143141689|NCT00833755|516067429|FG003|Overall Study|Physician Decision|6|||
143141690|NCT00833755|516067426|FG000|Overall Study|Subject had scheduling issues|0|||
143141691|NCT00833755|516067427|FG001|Overall Study|Subject had scheduling issues|1|||
143141692|NCT00833755|516067428|FG002|Overall Study|Subject had scheduling issues|0|||
143141693|NCT00833755|516067429|FG003|Overall Study|Subject had scheduling issues|0|||
143141694|NCT00262925|516067430|FG000|Overall Study|Lack of Efficacy|3|||
143141695|NCT00262925|516067430|FG000|Overall Study|Adverse Event|4|||
143141696|NCT00262925|516067430|FG000|Overall Study|Death|2|||
143141697|NCT00262925|516067430|FG000|Overall Study|alternative therapy|1|||
143141698|NCT00262925|516067430|FG000|Overall Study|Other|1|||
143141699|NCT04682301|516067431|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
143141700|NCT04682301|516067431|FG000|Overall Study|Death|2|||
143141701|NCT05219162|516067432|FG000|Overall Study|Meet exclusion criterion or did not meet inclusion criteria|6|||
143141702|NCT05219162|516067432|FG000|Overall Study|Withdrawal by Subject|23|||
143141703|NCT02187783|516067441|FG000|Overall Study|Adverse Event|8|||
143141704|NCT02187783|516067441|FG000|Overall Study|Death|3|||
143141705|NCT02187783|516067441|FG000|Overall Study|Progressive disease|80|||
143141706|NCT02187783|516067441|FG000|Overall Study|Protocol Violation|3|||
143141707|NCT02187783|516067441|FG000|Overall Study|Physician Decision|2|||
143141708|NCT02187783|516067441|FG000|Overall Study|Withdrawal by Subject|9|||
143141709|NCT02187783|516067441|FG000|Overall Study|Study terminated by sponsor|1|||
143141710|NCT00171249|516067442|FG000|Overall Study|Withdrawal by Subject|2|||
143141711|NCT00171249|516067443|FG001|Overall Study|Withdrawal by Subject|0|||
143141712|NCT00171249|516067444|FG002|Overall Study|Withdrawal by Subject|0|||
143141713|NCT00171249|516067445|FG003|Overall Study|Withdrawal by Subject|6|||
143141714|NCT00171249|516067446|FG004|Overall Study|Withdrawal by Subject|0|||
143472978|NCT00705432|517278819|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
143472979|NCT00705432|517278820|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
143472980|NCT00705432|517278821|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
143472981|NCT00705432|517278822|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
143472982|NCT00705432|517278817|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
143472983|NCT00705432|517278818|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
143141715|NCT00171249|516067447|FG005|Overall Study|Withdrawal by Subject|0|||
143141716|NCT00171249|516067448|FG006|Overall Study|Withdrawal by Subject|0|||
143141717|NCT00171249|516067442|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
143141718|NCT00171249|516067443|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
143472984|NCT00705432|517278819|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
143472985|NCT00705432|517278820|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
143472986|NCT00705432|517278821|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
143472987|NCT00705432|517278822|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
143472988|NCT01102803|517278823|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
143472989|NCT01102803|517278824|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
143472990|NCT01102803|517278823|FG000|Post to Follow-Up|Lost to Follow-up|1|||
143472991|NCT01102803|517278824|FG001|Post to Follow-Up|Lost to Follow-up|3|||
143472992|NCT03427125|517278825|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
143472993|NCT03427125|517278826|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
143472994|NCT03427125|517278827|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
143472995|NCT02684279|517278828|FG000|Overall Study|Adverse Event|87|||
143472996|NCT02684279|517278828|FG000|Overall Study|Lack of Efficacy|4|||
143472997|NCT02684279|517278828|FG000|Overall Study|Lost to Follow-up|61|||
143472998|NCT02684279|517278828|FG000|Overall Study|Protocol Violation|6|||
143472999|NCT02684279|517278828|FG000|Overall Study|Pregnancy|8|||
143473000|NCT02684279|517278828|FG000|Overall Study|Withdrawal by Subject|92|||
143473001|NCT02684279|517278828|FG000|Overall Study|non-compliance with study drug|9|||
143473002|NCT02684279|517278828|FG000|Overall Study|non compliance with study visits|2|||
143473003|NCT02684279|517278828|FG000|Overall Study|subject to have surgery|1|||
143473004|NCT02684279|517278828|FG000|Overall Study|family emergency|1|||
143473005|NCT02684279|517278828|FG000|Overall Study|Site closures|7|||
143473006|NCT02684279|517278828|FG000|Overall Study|Physician Decision|1|||
143473007|NCT05975840|517278829|FG000|Overall Study|Other|1|||
143473008|NCT05975840|517278830|FG001|Overall Study|Other|0|||
143473009|NCT05975840|517278831|FG002|Overall Study|Other|0|||
143473010|NCT05975840|517278832|FG003|Overall Study|Other|0|||
143473011|NCT05975840|517278833|FG004|Overall Study|Other|1|||
143473012|NCT05975840|517278834|FG005|Overall Study|Other|0|||
143473013|NCT05975840|517278835|FG006|Overall Study|Other|0|||
143473014|NCT05975840|517278836|FG007|Overall Study|Other|0|||
143473015|NCT05975840|517278829|FG000|Overall Study|Lost to Follow-up|3|||
143473016|NCT05975840|517278830|FG001|Overall Study|Lost to Follow-up|6|||
143473017|NCT05975840|517278831|FG002|Overall Study|Lost to Follow-up|3|||
143473018|NCT05975840|517278832|FG003|Overall Study|Lost to Follow-up|1|||
143473019|NCT05975840|517278833|FG004|Overall Study|Lost to Follow-up|4|||
143473020|NCT05975840|517278834|FG005|Overall Study|Lost to Follow-up|1|||
143473021|NCT05975840|517278835|FG006|Overall Study|Lost to Follow-up|2|||
143473022|NCT05975840|517278836|FG007|Overall Study|Lost to Follow-up|4|||
143473023|NCT05975840|517278829|FG000|Overall Study|Migrated/moved from the study area|1|||
143473024|NCT05975840|517278830|FG001|Overall Study|Migrated/moved from the study area|0|||
143473025|NCT05975840|517278831|FG002|Overall Study|Migrated/moved from the study area|0|||
143473026|NCT05975840|517278832|FG003|Overall Study|Migrated/moved from the study area|0|||
143473027|NCT05975840|517278833|FG004|Overall Study|Migrated/moved from the study area|0|||
143473028|NCT05975840|517278834|FG005|Overall Study|Migrated/moved from the study area|0|||
143473029|NCT05975840|517278835|FG006|Overall Study|Migrated/moved from the study area|0|||
143473030|NCT05975840|517278836|FG007|Overall Study|Migrated/moved from the study area|0|||
143473031|NCT05975840|517278829|FG000|Overall Study|Withdrawal by Subject|0|||
143473032|NCT05975840|517278830|FG001|Overall Study|Withdrawal by Subject|5|||
143473033|NCT05975840|517278831|FG002|Overall Study|Withdrawal by Subject|2|||
143473034|NCT05975840|517278832|FG003|Overall Study|Withdrawal by Subject|2|||
143473035|NCT05975840|517278833|FG004|Overall Study|Withdrawal by Subject|0|||
143473036|NCT05975840|517278834|FG005|Overall Study|Withdrawal by Subject|2|||
143473037|NCT05975840|517278835|FG006|Overall Study|Withdrawal by Subject|2|||
143473038|NCT05975840|517278836|FG007|Overall Study|Withdrawal by Subject|1|||
143473039|NCT05975840|517278829|FG000|Overall Study|Protocol Violation|0|||
143473040|NCT05975840|517278830|FG001|Overall Study|Protocol Violation|1|||
143473041|NCT05975840|517278831|FG002|Overall Study|Protocol Violation|0|||
143473042|NCT05975840|517278832|FG003|Overall Study|Protocol Violation|0|||
143473043|NCT05975840|517278833|FG004|Overall Study|Protocol Violation|0|||
143473044|NCT05975840|517278834|FG005|Overall Study|Protocol Violation|0|||
143473045|NCT05975840|517278835|FG006|Overall Study|Protocol Violation|0|||
143473046|NCT05975840|517278836|FG007|Overall Study|Protocol Violation|0|||
143473047|NCT05975840|517278829|FG000|Overall Study|Adverse Event|0|||
143473048|NCT05975840|517278830|FG001|Overall Study|Adverse Event|0|||
143473049|NCT05975840|517278831|FG002|Overall Study|Adverse Event|0|||
143473050|NCT05975840|517278832|FG003|Overall Study|Adverse Event|1|||
143473051|NCT05975840|517278833|FG004|Overall Study|Adverse Event|0|||
143473052|NCT05975840|517278834|FG005|Overall Study|Adverse Event|0|||
143473053|NCT05975840|517278835|FG006|Overall Study|Adverse Event|0|||
143473054|NCT05975840|517278836|FG007|Overall Study|Adverse Event|0|||
143473055|NCT05975840|517278829|FG000|Overall Study|Death|0|||
143473056|NCT05975840|517278830|FG001|Overall Study|Death|1|||
143473057|NCT05975840|517278831|FG002|Overall Study|Death|0|||
143473058|NCT05975840|517278832|FG003|Overall Study|Death|0|||
143473059|NCT05975840|517278833|FG004|Overall Study|Death|0|||
143473060|NCT05975840|517278834|FG005|Overall Study|Death|0|||
143473061|NCT05975840|517278835|FG006|Overall Study|Death|0|||
143473062|NCT05975840|517278836|FG007|Overall Study|Death|1|||
143473063|NCT04448756|517278839|FG000|Overall Study|Adverse Event|0|||
143473064|NCT04448756|517278840|FG001|Overall Study|Adverse Event|1|||
143473065|NCT04448756|517278841|FG002|Overall Study|Adverse Event|0|||
143473066|NCT04448756|517278839|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
143473067|NCT04448756|517278840|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
143473068|NCT04448756|517278841|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
143473069|NCT04448756|517278839|FG000|Overall Study|Withdrawal by Subject|0|||
143473070|NCT04448756|517278840|FG001|Overall Study|Withdrawal by Subject|3|||
143473071|NCT04448756|517278841|FG002|Overall Study|Withdrawal by Subject|1|||
143473072|NCT04448756|517278839|FG000|Overall Study|Death|2|||
143473073|NCT04448756|517278840|FG001|Overall Study|Death|1|||
143473074|NCT04448756|517278841|FG002|Overall Study|Death|0|||
143473075|NCT02733185|517278842|FG000|Overall Study|Withdrawal by Subject|12|||
143473076|NCT02733185|517278843|FG001|Overall Study|Withdrawal by Subject|10|||
143473077|NCT02733185|517278844|FG002|Overall Study|Withdrawal by Subject|17|||
143473078|NCT02733185|517278845|FG003|Overall Study|Withdrawal by Subject|21|||
143473079|NCT02733185|517278842|FG000|Overall Study|Death|46|||
143473080|NCT02733185|517278843|FG001|Overall Study|Death|34|||
143473081|NCT02733185|517278844|FG002|Overall Study|Death|35|||
143473082|NCT02733185|517278845|FG003|Overall Study|Death|43|||
143473083|NCT02733185|517278842|FG000|Overall Study|Lost to Follow-up|17|||
143473084|NCT02733185|517278843|FG001|Overall Study|Lost to Follow-up|18|||
143473085|NCT02733185|517278844|FG002|Overall Study|Lost to Follow-up|16|||
143473086|NCT02733185|517278845|FG003|Overall Study|Lost to Follow-up|11|||
143473087|NCT04252287|517278846|FG000|Overall Study|Death|5|||
143473088|NCT04252287|517278847|FG001|Overall Study|Death|3|||
143141719|NCT00171249|516067444|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
143141720|NCT00171249|516067445|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
143141721|NCT00171249|516067446|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
143141722|NCT00171249|516067447|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
143141723|NCT00171249|516067448|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
143141724|NCT00171249|516067442|FG000|Overall Study|Death|7|||
143141725|NCT00171249|516067443|FG001|Overall Study|Death|1|||
143141726|NCT00171249|516067444|FG002|Overall Study|Death|0|||
143141727|NCT00171249|516067445|FG003|Overall Study|Death|4|||
143141728|NCT00171249|516067446|FG004|Overall Study|Death|0|||
143141729|NCT00171249|516067447|FG005|Overall Study|Death|3|||
143141730|NCT00171249|516067448|FG006|Overall Study|Death|1|||
143141731|NCT00171249|516067442|FG000|Overall Study|Other|10|||
143141732|NCT00171249|516067443|FG001|Overall Study|Other|0|||
143141733|NCT00171249|516067444|FG002|Overall Study|Other|0|||
143141734|NCT00171249|516067445|FG003|Overall Study|Other|43|||
143141735|NCT00171249|516067446|FG004|Overall Study|Other|0|||
143141736|NCT00171249|516067447|FG005|Overall Study|Other|2|||
143141737|NCT00171249|516067448|FG006|Overall Study|Other|0|||
143141738|NCT00171249|516067442|FG000|Overall Study|No Longer Requires Study Drug|4|||
143141739|NCT00171249|516067443|FG001|Overall Study|No Longer Requires Study Drug|0|||
143141740|NCT00171249|516067444|FG002|Overall Study|No Longer Requires Study Drug|0|||
143141741|NCT00171249|516067445|FG003|Overall Study|No Longer Requires Study Drug|3|||
143141742|NCT00171249|516067446|FG004|Overall Study|No Longer Requires Study Drug|0|||
143141743|NCT00171249|516067447|FG005|Overall Study|No Longer Requires Study Drug|5|||
143141744|NCT00171249|516067448|FG006|Overall Study|No Longer Requires Study Drug|0|||
143141745|NCT00171249|516067442|FG000|Overall Study|Administrative Problems|1|||
143141746|NCT00171249|516067443|FG001|Overall Study|Administrative Problems|0|||
143141747|NCT00171249|516067444|FG002|Overall Study|Administrative Problems|0|||
143141748|NCT00171249|516067445|FG003|Overall Study|Administrative Problems|2|||
143141749|NCT00171249|516067446|FG004|Overall Study|Administrative Problems|0|||
143141750|NCT00171249|516067447|FG005|Overall Study|Administrative Problems|0|||
143141751|NCT00171249|516067448|FG006|Overall Study|Administrative Problems|0|||
143141752|NCT00171249|516067442|FG000|Overall Study|Adverse Event|3|||
143141753|NCT00171249|516067443|FG001|Overall Study|Adverse Event|1|||
143141754|NCT00171249|516067444|FG002|Overall Study|Adverse Event|0|||
143141755|NCT00171249|516067445|FG003|Overall Study|Adverse Event|15|||
143141756|NCT00171249|516067446|FG004|Overall Study|Adverse Event|0|||
143141757|NCT00171249|516067447|FG005|Overall Study|Adverse Event|2|||
143141758|NCT00171249|516067448|FG006|Overall Study|Adverse Event|0|||
143141759|NCT00171249|516067442|FG000|Overall Study|Lost to Follow-up|5|||
143141760|NCT00171249|516067443|FG001|Overall Study|Lost to Follow-up|0|||
143473089|NCT04252287|517278846|FG000|Overall Study|Lost to Follow-up|4|||
143473090|NCT04252287|517278847|FG001|Overall Study|Lost to Follow-up|6|||
143473091|NCT04252287|517278846|FG000|Overall Study|Withdrawal by Subject|19|||
143141761|NCT00171249|516067444|FG002|Overall Study|Lost to Follow-up|0|||
143141762|NCT00171249|516067445|FG003|Overall Study|Lost to Follow-up|9|||
143141763|NCT00171249|516067446|FG004|Overall Study|Lost to Follow-up|0|||
143141764|NCT00171249|516067447|FG005|Overall Study|Lost to Follow-up|0|||
143141765|NCT00171249|516067448|FG006|Overall Study|Lost to Follow-up|0|||
143141766|NCT00471497|516067449|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
143141767|NCT00471497|516067450|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
143141768|NCT00471497|516067451|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
143141769|NCT00471497|516067449|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
143141770|NCT00471497|516067450|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
143141771|NCT00471497|516067451|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
143141772|NCT00471497|516067449|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
143141773|NCT00471497|516067450|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
143141774|NCT00471497|516067451|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
143141775|NCT00471497|516067449|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
143141776|NCT00471497|516067450|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
143141777|NCT00471497|516067451|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
143473092|NCT04252287|517278847|FG001|Overall Study|Withdrawal by Subject|16|||
143473093|NCT04252287|517278846|FG000|Overall Study|Protocol Violation|3|||
143473094|NCT04252287|517278847|FG001|Overall Study|Protocol Violation|4|||
143473095|NCT01791803|517278849|FG000|Overall Study|Withdrawal by Subject|0|||
143141778|NCT00471497|516067449|FG000|Core Treatment Phase|Lost to Follow-up|6|||
143141779|NCT00471497|516067450|FG001|Core Treatment Phase|Lost to Follow-up|6|||
143141780|NCT00471497|516067451|FG002|Core Treatment Phase|Lost to Follow-up|3|||
143141781|NCT00471497|516067449|FG000|Core Treatment Phase|Death|3|||
143141782|NCT00471497|516067450|FG001|Core Treatment Phase|Death|9|||
143141783|NCT00471497|516067451|FG002|Core Treatment Phase|Death|3|||
143141784|NCT00471497|516067449|FG000|Core Treatment Phase|Disease Progression|10|||
143141785|NCT00471497|516067450|FG001|Core Treatment Phase|Disease Progression|2|||
143141786|NCT00471497|516067451|FG002|Core Treatment Phase|Disease Progression|4|||
143141787|NCT00471497|516067449|FG000|Core Treatment Phase|Protocol Violation|6|||
143141788|NCT00471497|516067450|FG001|Core Treatment Phase|Protocol Violation|15|||
143141789|NCT00471497|516067451|FG002|Core Treatment Phase|Protocol Violation|11|||
143141790|NCT00471497|516067449|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
143141791|NCT00471497|516067450|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
143141792|NCT00471497|516067451|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
143141793|NCT00471497|516067449|FG000|Core Treatment Phase|Administrative problems|14|||
143141794|NCT00471497|516067450|FG001|Core Treatment Phase|Administrative problems|14|||
143141795|NCT00471497|516067451|FG002|Core Treatment Phase|Administrative problems|12|||
143141796|NCT00471497|516067449|FG000|Core Treatment Phase|Adverse Event|43|||
143141797|NCT00471497|516067450|FG001|Core Treatment Phase|Adverse Event|53|||
143141798|NCT00471497|516067451|FG002|Core Treatment Phase|Adverse Event|89|||
143141799|NCT00471497|516067449|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
143141800|NCT00471497|516067450|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
143141801|NCT00471497|516067451|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
143141802|NCT00471497|516067449|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
143141803|NCT00471497|516067450|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
143141804|NCT00471497|516067451|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
143141805|NCT00471497|516067449|FG000|Extension Phase|Adverse Event|9|||
143141806|NCT00471497|516067450|FG001|Extension Phase|Adverse Event|5|||
143141807|NCT00471497|516067451|FG002|Extension Phase|Adverse Event|1|||
143141808|NCT00471497|516067449|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
143141809|NCT00471497|516067450|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
143141810|NCT00471497|516067451|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
143141811|NCT00471497|516067449|FG000|Extension Phase|Withdrawal by Subject|3|||
143141812|NCT00471497|516067450|FG001|Extension Phase|Withdrawal by Subject|1|||
143141813|NCT00471497|516067451|FG002|Extension Phase|Withdrawal by Subject|0|||
143141814|NCT00471497|516067449|FG000|Extension Phase|Lost to Follow-up|2|||
143141815|NCT00471497|516067450|FG001|Extension Phase|Lost to Follow-up|0|||
143141816|NCT00471497|516067451|FG002|Extension Phase|Lost to Follow-up|0|||
143141817|NCT00471497|516067449|FG000|Extension Phase|Death|1|||
143141818|NCT00471497|516067450|FG001|Extension Phase|Death|0|||
143141819|NCT00471497|516067451|FG002|Extension Phase|Death|0|||
143141820|NCT00471497|516067449|FG000|Extension Phase|Disease progression|2|||
143141821|NCT00471497|516067450|FG001|Extension Phase|Disease progression|0|||
143141822|NCT00471497|516067451|FG002|Extension Phase|Disease progression|0|||
143141823|NCT00471497|516067449|FG000|Extension Phase|Protocol Violation|2|||
143141824|NCT00471497|516067450|FG001|Extension Phase|Protocol Violation|2|||
143141825|NCT00471497|516067451|FG002|Extension Phase|Protocol Violation|0|||
143141826|NCT00392223|516067452|FG000|Overall Study|Adverse Event|5|||
143473096|NCT01791803|517278850|FG001|Overall Study|Withdrawal by Subject|0|||
143473097|NCT01791803|517278851|FG002|Overall Study|Withdrawal by Subject|0|||
143473098|NCT01791803|517278852|FG003|Overall Study|Withdrawal by Subject|2|||
143141827|NCT00392223|516067453|FG001|Overall Study|Adverse Event|4|||
143473099|NCT01791803|517278849|FG000|Overall Study|Physician Decision|0|||
143141828|NCT00392223|516067452|FG000|Overall Study|Lost to Follow-up|1|||
143141829|NCT00392223|516067453|FG001|Overall Study|Lost to Follow-up|4|||
143141830|NCT00392223|516067452|FG000|Overall Study|Protocol Violation|0|||
143141831|NCT00392223|516067453|FG001|Overall Study|Protocol Violation|3|||
143141832|NCT00392223|516067452|FG000|Overall Study|Withdrawal by Subject|3|||
143141833|NCT00392223|516067453|FG001|Overall Study|Withdrawal by Subject|2|||
143141834|NCT02908347|516067456|FG000|Overall Study|Adverse Event|0|||
143141835|NCT02908347|516067457|FG001|Overall Study|Adverse Event|1|||
143141836|NCT02908347|516067456|FG000|Overall Study|Lost to Follow-up|1|||
143141837|NCT02908347|516067457|FG001|Overall Study|Lost to Follow-up|0|||
143141838|NCT03344757|516067458|FG000|Overall Study|Withdrawal by Subject|18|||
143141839|NCT03344757|516067459|FG001|Overall Study|Withdrawal by Subject|16|||
143141840|NCT03344757|516067458|FG000|Overall Study|Lost to Follow-up|0|||
143141841|NCT03344757|516067459|FG001|Overall Study|Lost to Follow-up|2|||
143141842|NCT03104374|516067460|FG000|Period 1|Adverse Event|7|||
143141843|NCT03104374|516067461|FG001|Period 1|Adverse Event|7|||
143141844|NCT03104374|516067462|FG002|Period 1|Adverse Event|12|||
143141845|NCT03104374|516067463|FG003|Period 1|Adverse Event|14|||
143141846|NCT03104374|516067460|FG000|Period 1|Withdrawal by Subject|18|||
143141847|NCT03104374|516067461|FG001|Period 1|Withdrawal by Subject|9|||
143141848|NCT03104374|516067462|FG002|Period 1|Withdrawal by Subject|10|||
143141849|NCT03104374|516067463|FG003|Period 1|Withdrawal by Subject|17|||
143141850|NCT03104374|516067460|FG000|Period 1|Lost to Follow-up|4|||
143141851|NCT03104374|516067461|FG001|Period 1|Lost to Follow-up|4|||
143141852|NCT03104374|516067462|FG002|Period 1|Lost to Follow-up|6|||
143141853|NCT03104374|516067463|FG003|Period 1|Lost to Follow-up|8|||
143141854|NCT03104374|516067460|FG000|Period 1|Lack of Efficacy|6|||
143141855|NCT03104374|516067461|FG001|Period 1|Lack of Efficacy|7|||
143141856|NCT03104374|516067462|FG002|Period 1|Lack of Efficacy|12|||
143141857|NCT03104374|516067463|FG003|Period 1|Lack of Efficacy|6|||
143141858|NCT03104374|516067460|FG000|Period 1|Other|2|||
143141859|NCT03104374|516067461|FG001|Period 1|Other|2|||
143362377|NCT00235495|516869707|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
143141860|NCT03104374|516067462|FG002|Period 1|Other|4|||
143141861|NCT03104374|516067463|FG003|Period 1|Other|7|||
143141862|NCT03104374|516067460|FG000|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
143141863|NCT03104374|516067461|FG001|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
143141864|NCT03104374|516067462|FG002|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
143141865|NCT03104374|516067463|FG003|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|1|||
143141866|NCT03104374|516067460|FG000|Period 2|Adverse Event|4|||
143141867|NCT03104374|516067461|FG001|Period 2|Adverse Event|7|||
143141868|NCT03104374|516067462|FG002|Period 2|Adverse Event|10|||
143141869|NCT03104374|516067463|FG003|Period 2|Adverse Event|10|||
143141870|NCT03104374|516067460|FG000|Period 2|Withdrawal by Subject|3|||
143141871|NCT03104374|516067461|FG001|Period 2|Withdrawal by Subject|7|||
143141872|NCT03104374|516067462|FG002|Period 2|Withdrawal by Subject|13|||
143141873|NCT03104374|516067463|FG003|Period 2|Withdrawal by Subject|16|||
143141874|NCT03104374|516067460|FG000|Period 2|Lost to Follow-up|2|||
143141875|NCT03104374|516067461|FG001|Period 2|Lost to Follow-up|2|||
143141876|NCT03104374|516067462|FG002|Period 2|Lost to Follow-up|3|||
143362378|NCT02234310|516869708|FG000|Overall Study|Physician Decision|1|||
143362379|NCT02234310|516869708|FG000|Overall Study|Adverse Event|1|||
143362380|NCT02234310|516869708|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
143362381|NCT02234310|516869708|FG000|Overall Study|Withdrawal by Subject|2|||
143362382|NCT03251378|516869711|FG000|Overall Study|Death|3|||
143362383|NCT03251378|516869712|FG001|Overall Study|Death|2|||
143362384|NCT03251378|516869713|FG002|Overall Study|Death|3|||
143362385|NCT03251378|516869714|FG003|Overall Study|Death|30|||
143362386|NCT03251378|516869715|FG004|Overall Study|Death|24|||
143362387|NCT03251378|516869716|FG005|Overall Study|Death|12|||
143362388|NCT03251378|516869717|FG006|Overall Study|Death|12|||
143362389|NCT03251378|516869711|FG000|Overall Study|Lost to Follow-up|0|||
143362390|NCT03251378|516869712|FG001|Overall Study|Lost to Follow-up|0|||
143362391|NCT03251378|516869713|FG002|Overall Study|Lost to Follow-up|1|||
143141877|NCT03104374|516067463|FG003|Period 2|Lost to Follow-up|5|||
143141878|NCT03104374|516067460|FG000|Period 2|Lack of Efficacy|2|||
143141879|NCT03104374|516067461|FG001|Period 2|Lack of Efficacy|4|||
143141880|NCT03104374|516067462|FG002|Period 2|Lack of Efficacy|7|||
143141881|NCT03104374|516067463|FG003|Period 2|Lack of Efficacy|4|||
143362392|NCT03251378|516869714|FG003|Overall Study|Lost to Follow-up|3|||
143362393|NCT03251378|516869715|FG004|Overall Study|Lost to Follow-up|0|||
143362394|NCT03251378|516869716|FG005|Overall Study|Lost to Follow-up|0|||
143141882|NCT03104374|516067460|FG000|Period 2|COVID-19 Infection|0|||
143141883|NCT03104374|516067461|FG001|Period 2|COVID-19 Infection|0|||
143141884|NCT03104374|516067462|FG002|Period 2|COVID-19 Infection|1|||
143141885|NCT03104374|516067463|FG003|Period 2|COVID-19 Infection|0|||
143141886|NCT03104374|516067460|FG000|Period 2|Other|3|||
143141887|NCT03104374|516067461|FG001|Period 2|Other|2|||
143141888|NCT03104374|516067462|FG002|Period 2|Other|2|||
143141889|NCT03104374|516067463|FG003|Period 2|Other|4|||
143141890|NCT03533751|516067468|FG000|Overall Study|Withdrawal by Subject|12|||
143141891|NCT03533751|516067469|FG001|Overall Study|Withdrawal by Subject|6|||
143141892|NCT03533751|516067470|FG002|Overall Study|Withdrawal by Subject|11|||
143141893|NCT03533751|516067471|FG003|Overall Study|Withdrawal by Subject|9|||
143141894|NCT03533751|516067472|FG004|Overall Study|Withdrawal by Subject|10|||
143141895|NCT03533751|516067468|FG000|Overall Study|Adverse Event|4|||
143141896|NCT03533751|516067469|FG001|Overall Study|Adverse Event|7|||
143141897|NCT03533751|516067470|FG002|Overall Study|Adverse Event|2|||
143141898|NCT03533751|516067471|FG003|Overall Study|Adverse Event|4|||
143141899|NCT03533751|516067472|FG004|Overall Study|Adverse Event|5|||
143141900|NCT03533751|516067468|FG000|Overall Study|Physician Decision|0|||
143141901|NCT03533751|516067469|FG001|Overall Study|Physician Decision|2|||
143141902|NCT03533751|516067470|FG002|Overall Study|Physician Decision|1|||
143141903|NCT03533751|516067471|FG003|Overall Study|Physician Decision|2|||
143141904|NCT03533751|516067472|FG004|Overall Study|Physician Decision|1|||
143141905|NCT03533751|516067468|FG000|Overall Study|Sponsor Decision|0|||
143141906|NCT03533751|516067469|FG001|Overall Study|Sponsor Decision|0|||
143141907|NCT03533751|516067470|FG002|Overall Study|Sponsor Decision|1|||
143141908|NCT03533751|516067471|FG003|Overall Study|Sponsor Decision|1|||
143141909|NCT03533751|516067472|FG004|Overall Study|Sponsor Decision|0|||
143141910|NCT03533751|516067468|FG000|Overall Study|Lost to Follow-up|3|||
143141911|NCT03533751|516067469|FG001|Overall Study|Lost to Follow-up|7|||
143141912|NCT03533751|516067470|FG002|Overall Study|Lost to Follow-up|6|||
143141913|NCT03533751|516067471|FG003|Overall Study|Lost to Follow-up|4|||
143141914|NCT03533751|516067472|FG004|Overall Study|Lost to Follow-up|3|||
143141915|NCT03533751|516067468|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
143141916|NCT03533751|516067469|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
143141917|NCT03533751|516067470|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
143141918|NCT03533751|516067471|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
143141919|NCT03533751|516067472|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
143141920|NCT03533751|516067468|FG000|Overall Study|Other|0|||
143141921|NCT03533751|516067469|FG001|Overall Study|Other|2|||
143141922|NCT03533751|516067470|FG002|Overall Study|Other|1|||
143141923|NCT03533751|516067471|FG003|Overall Study|Other|0|||
143141924|NCT03533751|516067472|FG004|Overall Study|Other|3|||
143141925|NCT03225287|516067473|FG000|Overall Study|Adverse Event|0|||
143141926|NCT03225287|516067474|FG001|Overall Study|Adverse Event|0|||
143141927|NCT03225287|516067475|FG002|Overall Study|Adverse Event|1|||
143141928|NCT03225287|516067473|FG000|Overall Study|Protocol non-compliance|0|||
143141929|NCT03225287|516067474|FG001|Overall Study|Protocol non-compliance|0|||
143141930|NCT03225287|516067475|FG002|Overall Study|Protocol non-compliance|1|||
143141931|NCT03225287|516067473|FG000|Overall Study|Subject withdraws consent|3|||
143141932|NCT03225287|516067474|FG001|Overall Study|Subject withdraws consent|0|||
143141933|NCT03225287|516067475|FG002|Overall Study|Subject withdraws consent|0|||
143141934|NCT03225287|516067473|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
143141935|NCT03225287|516067474|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
143141936|NCT03225287|516067475|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
143141937|NCT03225287|516067473|FG000|Overall Study|Trial drug not effective|0|||
143141938|NCT03225287|516067474|FG001|Overall Study|Trial drug not effective|1|||
143141939|NCT03225287|516067475|FG002|Overall Study|Trial drug not effective|0|||
143141940|NCT03225287|516067473|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
143141941|NCT03225287|516067474|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
143141942|NCT03225287|516067475|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
143141943|NCT03225287|516067473|FG000|Overall Study|Stem cell transplantation|0|||
143141944|NCT03225287|516067474|FG001|Overall Study|Stem cell transplantation|1|||
143141945|NCT03225287|516067475|FG002|Overall Study|Stem cell transplantation|0|||
143141946|NCT03415178|516067479|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
143141947|NCT03415178|516067480|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
143141948|NCT03415178|516067479|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
143141949|NCT03415178|516067480|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
143141950|NCT02807259|516069194|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
143141951|NCT02807259|516069195|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
143141952|NCT02807259|516069194|FG000|Midline (3 Months)|migration, refusal, not available|30|||
143141953|NCT02807259|516069195|FG001|Midline (3 Months)|migration, refusal, not available|34|||
143141954|NCT02807259|516069194|FG000|Endline (3 Months)|migration, refusal, not available|35|||
143141955|NCT02807259|516069195|FG001|Endline (3 Months)|migration, refusal, not available|87|||
143141956|NCT00849056|516069196|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
143141957|NCT00849056|516069197|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
143141958|NCT00849056|516069196|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
143141959|NCT00849056|516069197|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
143362395|NCT03251378|516869717|FG006|Overall Study|Lost to Follow-up|0|||
143362396|NCT03251378|516869711|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
143362397|NCT03251378|516869712|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
143141960|NCT00849056|516069196|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
143141961|NCT00849056|516069197|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
143141962|NCT00849056|516069196|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
143141963|NCT00849056|516069197|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
143141964|NCT00849056|516069196|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
143141965|NCT00849056|516069197|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
143141966|NCT00849056|516069196|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
143141967|NCT00849056|516069197|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
143141968|NCT00849056|516069196|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
143141969|NCT00849056|516069197|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
143141970|NCT00849056|516069196|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
143362398|NCT03251378|516869713|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
143362399|NCT03251378|516869714|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
143362400|NCT03251378|516869715|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
143362401|NCT03251378|516869716|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
143362402|NCT03251378|516869717|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
143362403|NCT03251378|516869711|FG000|Overall Study|Progressive disease|2|||
143362404|NCT03251378|516869712|FG001|Overall Study|Progressive disease|0|||
143362405|NCT03251378|516869713|FG002|Overall Study|Progressive disease|0|||
143362406|NCT03251378|516869714|FG003|Overall Study|Progressive disease|1|||
143362407|NCT03251378|516869715|FG004|Overall Study|Progressive disease|0|||
143362408|NCT03251378|516869716|FG005|Overall Study|Progressive disease|0|||
143362409|NCT03251378|516869717|FG006|Overall Study|Progressive disease|0|||
143362410|NCT03251378|516869711|FG000|Overall Study|Physician Decision|0|||
143362411|NCT03251378|516869712|FG001|Overall Study|Physician Decision|2|||
143362412|NCT03251378|516869713|FG002|Overall Study|Physician Decision|0|||
143362413|NCT03251378|516869714|FG003|Overall Study|Physician Decision|0|||
143362414|NCT03251378|516869715|FG004|Overall Study|Physician Decision|0|||
143362415|NCT03251378|516869716|FG005|Overall Study|Physician Decision|0|||
143362416|NCT03251378|516869717|FG006|Overall Study|Physician Decision|0|||
143362417|NCT03251378|516869711|FG000|Overall Study|Other|2|||
143362418|NCT03251378|516869712|FG001|Overall Study|Other|3|||
143362419|NCT03251378|516869713|FG002|Overall Study|Other|2|||
143362420|NCT03251378|516869714|FG003|Overall Study|Other|0|||
143362421|NCT03251378|516869715|FG004|Overall Study|Other|1|||
143362422|NCT03251378|516869716|FG005|Overall Study|Other|1|||
143362423|NCT03251378|516869717|FG006|Overall Study|Other|1|||
143362424|NCT03251378|516869711|FG000|Overall Study|Other|0|||
143362425|NCT03251378|516869712|FG001|Overall Study|Other|0|||
143362426|NCT03251378|516869713|FG002|Overall Study|Other|0|||
143362427|NCT03251378|516869714|FG003|Overall Study|Other|4|||
143362428|NCT03251378|516869715|FG004|Overall Study|Other|13|||
143362429|NCT03251378|516869716|FG005|Overall Study|Other|0|||
143362430|NCT03251378|516869717|FG006|Overall Study|Other|0|||
143362431|NCT02956967|516869723|FG000|Overall Study|Adverse Event|3|||
143362432|NCT02956967|516869723|FG000|Overall Study|Reason non-related to neutropenia|10|||
143362433|NCT02956967|516869723|FG000|Overall Study|Lost to Follow-up|5|||
143362434|NCT02956967|516869723|FG000|Overall Study|Missing|1|||
143362435|NCT02956967|516869723|FG000|Overall Study|Termination of Nivestim administration|29|||
143362436|NCT02322775|516869724|FG000|Overall Study|Adverse Event|1|||
143362437|NCT02322775|516869725|FG001|Overall Study|Adverse Event|0|||
143362438|NCT02322775|516869724|FG000|Overall Study|Lost to Follow-up|0|||
143362439|NCT02322775|516869725|FG001|Overall Study|Lost to Follow-up|1|||
143362440|NCT02322775|516869724|FG000|Overall Study|Protocol Violation|1|||
143362441|NCT02322775|516869725|FG001|Overall Study|Protocol Violation|0|||
143362442|NCT02322775|516869724|FG000|Overall Study|Withdrawal by Subject|3|||
143362443|NCT02322775|516869725|FG001|Overall Study|Withdrawal by Subject|4|||
143362444|NCT02322775|516869724|FG000|Overall Study|Not willing to perform all FU visits|0|||
143362445|NCT02322775|516869725|FG001|Overall Study|Not willing to perform all FU visits|1|||
143362446|NCT04739423|516869730|FG000|Overall Study|Protocol Violation|0|||
143362447|NCT04739423|516869731|FG001|Overall Study|Protocol Violation|1|||
143362448|NCT04739423|516869732|FG002|Overall Study|Protocol Violation|0|||
143362449|NCT04739423|516869733|FG003|Overall Study|Protocol Violation|0|||
143362450|NCT04739423|516869734|FG004|Overall Study|Protocol Violation|0|||
143362451|NCT04739423|516869735|FG005|Overall Study|Protocol Violation|0|||
143362452|NCT04739423|516869730|FG000|Overall Study|Adverse Event|0|||
143362453|NCT04739423|516869731|FG001|Overall Study|Adverse Event|0|||
143362454|NCT04739423|516869732|FG002|Overall Study|Adverse Event|1|||
143362455|NCT04739423|516869733|FG003|Overall Study|Adverse Event|0|||
143362456|NCT04739423|516869734|FG004|Overall Study|Adverse Event|1|||
143362457|NCT04739423|516869735|FG005|Overall Study|Adverse Event|0|||
143362458|NCT04739423|516869730|FG000|Overall Study|Withdrawal by Subject|0|||
143362459|NCT04739423|516869731|FG001|Overall Study|Withdrawal by Subject|0|||
143362460|NCT04739423|516869732|FG002|Overall Study|Withdrawal by Subject|0|||
143362461|NCT04739423|516869733|FG003|Overall Study|Withdrawal by Subject|0|||
143141971|NCT00849056|516069197|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
143141972|NCT00849056|516069196|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
143141973|NCT00849056|516069197|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
143141974|NCT00849056|516069196|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
143473100|NCT01791803|517278850|FG001|Overall Study|Physician Decision|2|||
143473101|NCT01791803|517278851|FG002|Overall Study|Physician Decision|0|||
143473102|NCT01791803|517278852|FG003|Overall Study|Physician Decision|1|||
143473103|NCT01791803|517278849|FG000|Overall Study|Death|0|||
143473104|NCT01791803|517278850|FG001|Overall Study|Death|0|||
143473105|NCT01791803|517278851|FG002|Overall Study|Death|2|||
143473106|NCT01791803|517278852|FG003|Overall Study|Death|2|||
143473107|NCT04572854|517278853|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
143473108|NCT04572854|517278854|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
143473109|NCT04572854|517278855|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
143473110|NCT04572854|517278856|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
143473111|NCT04572854|517278853|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
143473112|NCT04572854|517278854|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
143473113|NCT04572854|517278855|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
143473114|NCT04572854|517278856|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
143473115|NCT00972777|517278857|FG000|Overall Study|Adverse Event|3|||
143473116|NCT00972777|517278858|FG001|Overall Study|Adverse Event|2|||
143141975|NCT00849056|516069197|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
143141976|NCT00849056|516069196|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
143141977|NCT00849056|516069197|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
143141978|NCT00849056|516069196|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
143141979|NCT00849056|516069197|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
143141980|NCT00849056|516069196|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
143141981|NCT00849056|516069197|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
143141982|NCT00849056|516069196|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
143141983|NCT00849056|516069197|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
143141984|NCT00849056|516069196|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
143141985|NCT00849056|516069197|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
143141986|NCT00849056|516069196|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
143141987|NCT00849056|516069197|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
143141988|NCT02100631|516069200|FG000|Overall Study|Withdrawal by Subject|1|||
143141989|NCT02100631|516069201|FG001|Overall Study|Withdrawal by Subject|0|||
143141990|NCT02100631|516069202|FG002|Overall Study|Withdrawal by Subject|0|||
143141991|NCT02100631|516069200|FG000|Overall Study|Lost to Follow-up|3|||
143141992|NCT02100631|516069201|FG001|Overall Study|Lost to Follow-up|4|||
143141993|NCT02100631|516069202|FG002|Overall Study|Lost to Follow-up|0|||
143141994|NCT02100631|516069200|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
143141995|NCT02100631|516069201|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
143141996|NCT02100631|516069202|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
143141997|NCT03944616|516069203|FG000|Overall Study|Lost to Follow-up|0|||
143141998|NCT03944616|516069204|FG001|Overall Study|Lost to Follow-up|2|||
143141999|NCT01287936|516069205|FG000|Overall Study|Lost to Follow-up|0|||
143142000|NCT01287936|516069206|FG001|Overall Study|Lost to Follow-up|1|||
143142001|NCT01287936|516069207|FG002|Overall Study|Lost to Follow-up|1|||
143142002|NCT01648764|516069208|FG000|Overall Study|Progressive Disease|0|||
143142003|NCT01648764|516069209|FG001|Overall Study|Progressive Disease|1|||
143142004|NCT01648764|516069210|FG002|Overall Study|Progressive Disease|0|||
143142005|NCT01648764|516069211|FG003|Overall Study|Progressive Disease|0|||
143142006|NCT01648764|516069212|FG004|Overall Study|Progressive Disease|0|||
143142007|NCT01648764|516069213|FG005|Overall Study|Progressive Disease|1|||
143142008|NCT01648764|516069214|FG006|Overall Study|Progressive Disease|1|||
143142009|NCT01648764|516069215|FG007|Overall Study|Progressive Disease|0|||
143473117|NCT00972777|517278857|FG000|Overall Study|Lost to Follow-up|0|||
143473118|NCT00972777|517278858|FG001|Overall Study|Lost to Follow-up|4|||
143473119|NCT00972777|517278857|FG000|Overall Study|Withdrawal by Subject|4|||
143142010|NCT01648764|516069216|FG008|Overall Study|Progressive Disease|0|||
143142011|NCT01648764|516069217|FG009|Overall Study|Progressive Disease|2|||
143142012|NCT01648764|516069218|FG010|Overall Study|Progressive Disease|0|||
143142013|NCT01648764|516069219|FG011|Overall Study|Progressive Disease|1|||
143142014|NCT01648764|516069220|FG012|Overall Study|Progressive Disease|2|||
143142015|NCT01648764|516069221|FG013|Overall Study|Progressive Disease|1|||
143142016|NCT01648764|516069208|FG000|Overall Study|Adverse Event|0|||
143473120|NCT00972777|517278858|FG001|Overall Study|Withdrawal by Subject|5|||
143473121|NCT00972777|517278857|FG000|Overall Study|Physician Decision|4|||
143142017|NCT01648764|516069209|FG001|Overall Study|Adverse Event|0|||
143142018|NCT01648764|516069210|FG002|Overall Study|Adverse Event|0|||
143142019|NCT01648764|516069211|FG003|Overall Study|Adverse Event|0|||
143473122|NCT00972777|517278858|FG001|Overall Study|Physician Decision|0|||
143473123|NCT00972777|517278857|FG000|Overall Study|Protocol Violation|0|||
143473124|NCT00972777|517278858|FG001|Overall Study|Protocol Violation|2|||
143473125|NCT00972777|517278857|FG000|Overall Study|Screening Failure|2|||
143473126|NCT00972777|517278858|FG001|Overall Study|Screening Failure|1|||
143473127|NCT00972777|517278857|FG000|Overall Study|Missed visit|1|||
143473128|NCT00972777|517278858|FG001|Overall Study|Missed visit|0|||
143473129|NCT01093326|517278859|FG000|Overall Study|Death|0|||
143473130|NCT01093326|517278860|FG001|Overall Study|Death|1|||
143473131|NCT01093326|517278861|FG002|Overall Study|Death|0|||
143473132|NCT01093326|517278859|FG000|Overall Study|Lack of Efficacy|7|||
143473133|NCT01093326|517278860|FG001|Overall Study|Lack of Efficacy|6|||
143473134|NCT01093326|517278861|FG002|Overall Study|Lack of Efficacy|3|||
143473135|NCT01093326|517278859|FG000|Overall Study|Lost to Follow-up|2|||
143473136|NCT01093326|517278860|FG001|Overall Study|Lost to Follow-up|5|||
143473137|NCT01093326|517278861|FG002|Overall Study|Lost to Follow-up|4|||
143142020|NCT01648764|516069212|FG004|Overall Study|Adverse Event|0|||
143473138|NCT01093326|517278859|FG000|Overall Study|Physician Decision|3|||
143473139|NCT01093326|517278860|FG001|Overall Study|Physician Decision|1|||
143473140|NCT01093326|517278861|FG002|Overall Study|Physician Decision|3|||
143473141|NCT01093326|517278859|FG000|Overall Study|Withdrawal by Subject|30|||
143473142|NCT01093326|517278860|FG001|Overall Study|Withdrawal by Subject|27|||
143473143|NCT01093326|517278861|FG002|Overall Study|Withdrawal by Subject|26|||
143473144|NCT01093326|517278859|FG000|Overall Study|Adverse Event|2|||
143473145|NCT01093326|517278860|FG001|Overall Study|Adverse Event|1|||
143473146|NCT01093326|517278861|FG002|Overall Study|Adverse Event|4|||
143473147|NCT01093326|517278859|FG000|Overall Study|Other|0|||
143473148|NCT01093326|517278860|FG001|Overall Study|Other|0|||
143473149|NCT01093326|517278861|FG002|Overall Study|Other|1|||
143473150|NCT02246582|517280799|FG000|Overall Study|Withdrawal by Subject|3|||
143473151|NCT02246582|517280800|FG001|Overall Study|Withdrawal by Subject|4|||
143473152|NCT03441334|517280804|FG000|Overall Study|Withdrawal by Subject|1|||
143473153|NCT03441334|517280805|FG001|Overall Study|Withdrawal by Subject|0|||
143473154|NCT02592551|517280812|FG000|Overall Study|Not evaluable|1|||
143473155|NCT02592551|517280813|FG001|Overall Study|Not evaluable|3|||
143473156|NCT02592551|517280814|FG002|Overall Study|Not evaluable|0|||
143473157|NCT01876251|517280815|FG000|Overall Study|Clinical progression|1|||
143473158|NCT01876251|517280816|FG001|Overall Study|Clinical progression|0|||
143473159|NCT01876251|517280817|FG002|Overall Study|Clinical progression|0|||
143473160|NCT01876251|517280815|FG000|Overall Study|Death|2|||
143473161|NCT01876251|517280816|FG001|Overall Study|Death|0|||
143473162|NCT01876251|517280817|FG002|Overall Study|Death|1|||
143473163|NCT01876251|517280815|FG000|Overall Study|Participant started new treatment|1|||
143473164|NCT01876251|517280816|FG001|Overall Study|Participant started new treatment|0|||
143473165|NCT01876251|517280817|FG002|Overall Study|Participant started new treatment|1|||
143473166|NCT01876251|517280815|FG000|Overall Study|Participant refused further follow-up|0|||
143473167|NCT01876251|517280816|FG001|Overall Study|Participant refused further follow-up|0|||
143473168|NCT01876251|517280817|FG002|Overall Study|Participant refused further follow-up|1|||
143473169|NCT01876251|517280815|FG000|Overall Study|Study terminated|1|||
143473170|NCT01876251|517280816|FG001|Overall Study|Study terminated|0|||
143473171|NCT01876251|517280817|FG002|Overall Study|Study terminated|0|||
143473172|NCT01876251|517280815|FG000|Overall Study|Objective progression or relapse|10|||
143473173|NCT01876251|517280816|FG001|Overall Study|Objective progression or relapse|3|||
143142021|NCT01648764|516069213|FG005|Overall Study|Adverse Event|1|||
143142022|NCT01648764|516069214|FG006|Overall Study|Adverse Event|0|||
143142023|NCT01648764|516069215|FG007|Overall Study|Adverse Event|0|||
143142024|NCT01648764|516069216|FG008|Overall Study|Adverse Event|0|||
143142025|NCT01648764|516069217|FG009|Overall Study|Adverse Event|1|||
143142026|NCT01648764|516069218|FG010|Overall Study|Adverse Event|0|||
143142027|NCT01648764|516069219|FG011|Overall Study|Adverse Event|3|||
143142028|NCT01648764|516069220|FG012|Overall Study|Adverse Event|1|||
143142029|NCT01648764|516069221|FG013|Overall Study|Adverse Event|1|||
143142030|NCT01648764|516069208|FG000|Overall Study|Death|0|||
143142031|NCT01648764|516069209|FG001|Overall Study|Death|0|||
143142032|NCT01648764|516069210|FG002|Overall Study|Death|0|||
143142033|NCT01648764|516069211|FG003|Overall Study|Death|0|||
143142034|NCT01648764|516069212|FG004|Overall Study|Death|0|||
143142035|NCT01648764|516069213|FG005|Overall Study|Death|0|||
143142036|NCT01648764|516069214|FG006|Overall Study|Death|1|||
143142037|NCT01648764|516069215|FG007|Overall Study|Death|0|||
143142038|NCT01648764|516069216|FG008|Overall Study|Death|0|||
143142039|NCT01648764|516069217|FG009|Overall Study|Death|0|||
143473174|NCT01876251|517280817|FG002|Overall Study|Objective progression or relapse|8|||
143473175|NCT03335163|517280828|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
143142040|NCT01648764|516069218|FG010|Overall Study|Death|0|||
143142041|NCT01648764|516069219|FG011|Overall Study|Death|0|||
143142042|NCT01648764|516069220|FG012|Overall Study|Death|0|||
143473176|NCT03335163|517280828|FG000|Overall Study|Withdrawal by Subject|18|||
143473177|NCT02020863|517280830|FG000|Overall Study|Discovery of Metastatic disease|4|||
143473178|NCT02020863|517280830|FG000|Overall Study|Team chose not to place an a line|1|||
143473179|NCT01920594|517280831|FG000|Overall Study|Adverse Event|4|||
143473180|NCT01920594|517280832|FG001|Overall Study|Adverse Event|2|||
143362462|NCT04739423|516869734|FG004|Overall Study|Withdrawal by Subject|0|||
143362463|NCT04739423|516869735|FG005|Overall Study|Withdrawal by Subject|1|||
143362464|NCT04482855|516869742|FG000|Overall Study|Lost to Follow-up|1|||
143362465|NCT04482855|516869743|FG001|Overall Study|Lost to Follow-up|0|||
143362466|NCT04482855|516869742|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
143362467|NCT04482855|516869743|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
143362468|NCT04482855|516869742|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
143362469|NCT04482855|516869743|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
143362470|NCT00764868|516869744|FG000|Overall Study|Adverse Event|18|||
143362471|NCT00764868|516869744|FG000|Overall Study|Withdrawal by Subject|31|||
143362472|NCT00764868|516869744|FG000|Overall Study|Non-compliance|16|||
143362473|NCT00764868|516869744|FG000|Overall Study|Lost to Follow-up|25|||
143362474|NCT00764868|516869744|FG000|Overall Study|Lack of Efficacy|5|||
143362475|NCT00764868|516869744|FG000|Overall Study|Subject moved|7|||
143362476|NCT00764868|516869744|FG000|Overall Study|Pregnancy|3|||
143362477|NCT00764868|516869744|FG000|Overall Study|Prohibited medication|1|||
143362478|NCT00764868|516869744|FG000|Overall Study|Out of town|1|||
143362479|NCT00764868|516869744|FG000|Overall Study|Misuse and compliance of study drug|1|||
143362480|NCT00764868|516869744|FG000|Overall Study|Subject sent to boarding school|1|||
143362481|NCT00764868|516869744|FG000|Overall Study|Met an exclusion criteria|1|||
143362482|NCT00764868|516869744|FG000|Overall Study|Positive drug screen|2|||
143362483|NCT00764868|516869744|FG000|Overall Study|Sponsor requested withdrawal|1|||
143362484|NCT00819234|516869753|FG000|Overall Study|Withdrawal by Subject|8|||
143362485|NCT00819234|516869754|FG001|Overall Study|Withdrawal by Subject|13|||
143362486|NCT00819234|516869755|FG002|Overall Study|Withdrawal by Subject|6|||
143362487|NCT00819234|516869756|FG003|Overall Study|Withdrawal by Subject|3|||
143362488|NCT00819234|516869757|FG004|Overall Study|Withdrawal by Subject|0|||
143362489|NCT00819234|516869758|FG005|Overall Study|Withdrawal by Subject|4|||
143362490|NCT00819234|516869759|FG006|Overall Study|Withdrawal by Subject|4|||
143362491|NCT00819234|516869760|FG007|Overall Study|Withdrawal by Subject|8|||
143362492|NCT00819234|516869761|FG008|Overall Study|Withdrawal by Subject|5|||
143362493|NCT00819234|516869762|FG009|Overall Study|Withdrawal by Subject|3|||
143362494|NCT00819234|516869753|FG000|Overall Study|Adverse Event|0|||
143362495|NCT00819234|516869754|FG001|Overall Study|Adverse Event|0|||
143362496|NCT00819234|516869755|FG002|Overall Study|Adverse Event|1|||
143362497|NCT00819234|516869756|FG003|Overall Study|Adverse Event|0|||
143362498|NCT00819234|516869757|FG004|Overall Study|Adverse Event|0|||
143362499|NCT00819234|516869758|FG005|Overall Study|Adverse Event|2|||
143362500|NCT00819234|516869759|FG006|Overall Study|Adverse Event|0|||
143362501|NCT00819234|516869760|FG007|Overall Study|Adverse Event|0|||
143362502|NCT00819234|516869761|FG008|Overall Study|Adverse Event|0|||
143362503|NCT00819234|516869762|FG009|Overall Study|Adverse Event|0|||
143362504|NCT00819234|516869753|FG000|Overall Study|Physician Decision|0|||
143362505|NCT00819234|516869754|FG001|Overall Study|Physician Decision|0|||
143362506|NCT00819234|516869755|FG002|Overall Study|Physician Decision|0|||
143362507|NCT00819234|516869756|FG003|Overall Study|Physician Decision|1|||
143362508|NCT00819234|516869757|FG004|Overall Study|Physician Decision|0|||
143362509|NCT00819234|516869758|FG005|Overall Study|Physician Decision|0|||
143362510|NCT00819234|516869759|FG006|Overall Study|Physician Decision|0|||
143362511|NCT00819234|516869760|FG007|Overall Study|Physician Decision|0|||
143362512|NCT00819234|516869761|FG008|Overall Study|Physician Decision|0|||
143362513|NCT00819234|516869762|FG009|Overall Study|Physician Decision|2|||
143362514|NCT00819234|516869753|FG000|Overall Study|Protocol Violation|0|||
143362515|NCT00819234|516869754|FG001|Overall Study|Protocol Violation|0|||
143362516|NCT00819234|516869755|FG002|Overall Study|Protocol Violation|1|||
143362517|NCT00819234|516869756|FG003|Overall Study|Protocol Violation|0|||
143362518|NCT00819234|516869757|FG004|Overall Study|Protocol Violation|0|||
143362519|NCT00819234|516869758|FG005|Overall Study|Protocol Violation|0|||
143362520|NCT00819234|516869759|FG006|Overall Study|Protocol Violation|0|||
143362521|NCT00819234|516869760|FG007|Overall Study|Protocol Violation|0|||
143362522|NCT00819234|516869761|FG008|Overall Study|Protocol Violation|0|||
143362523|NCT00819234|516869762|FG009|Overall Study|Protocol Violation|0|||
143362524|NCT00819234|516869753|FG000|Overall Study|Lost to Follow-up|2|||
143362525|NCT00819234|516869754|FG001|Overall Study|Lost to Follow-up|2|||
143362526|NCT00819234|516869755|FG002|Overall Study|Lost to Follow-up|0|||
143362527|NCT00819234|516869756|FG003|Overall Study|Lost to Follow-up|2|||
143362528|NCT00819234|516869757|FG004|Overall Study|Lost to Follow-up|1|||
143362529|NCT00819234|516869758|FG005|Overall Study|Lost to Follow-up|1|||
143362530|NCT00819234|516869759|FG006|Overall Study|Lost to Follow-up|1|||
143362531|NCT00819234|516869760|FG007|Overall Study|Lost to Follow-up|1|||
143362532|NCT00819234|516869761|FG008|Overall Study|Lost to Follow-up|1|||
143362533|NCT00819234|516869762|FG009|Overall Study|Lost to Follow-up|2|||
143362534|NCT04438785|516869763|FG000|Overall Study|change of weight, give up intervention|2|||
143362535|NCT04438785|516869764|FG001|Overall Study|change of weight, give up intervention|10|||
143362536|NCT04011033|516869765|FG000|Overall Study|Physician Decision|2|||
143362537|NCT04011033|516869766|FG001|Overall Study|Physician Decision|3|||
143473181|NCT01920594|517280831|FG000|Overall Study|Lost to Follow-up|1|||
143142043|NCT01648764|516069221|FG013|Overall Study|Death|1|||
143142044|NCT01648764|516069208|FG000|Overall Study|Withdrawal by Subject|0|||
143142045|NCT01648764|516069209|FG001|Overall Study|Withdrawal by Subject|0|||
143142046|NCT01648764|516069210|FG002|Overall Study|Withdrawal by Subject|0|||
143142047|NCT01648764|516069211|FG003|Overall Study|Withdrawal by Subject|0|||
143142048|NCT01648764|516069212|FG004|Overall Study|Withdrawal by Subject|0|||
143142049|NCT01648764|516069213|FG005|Overall Study|Withdrawal by Subject|0|||
143142050|NCT01648764|516069214|FG006|Overall Study|Withdrawal by Subject|2|||
143142051|NCT01648764|516069215|FG007|Overall Study|Withdrawal by Subject|0|||
143142052|NCT01648764|516069216|FG008|Overall Study|Withdrawal by Subject|0|||
143142053|NCT01648764|516069217|FG009|Overall Study|Withdrawal by Subject|0|||
143473182|NCT01920594|517280832|FG001|Overall Study|Lost to Follow-up|0|||
143473183|NCT01920594|517280831|FG000|Overall Study|Recovery|2|||
143473184|NCT01920594|517280832|FG001|Overall Study|Recovery|0|||
143473185|NCT01920594|517280831|FG000|Overall Study|Investigator discretion|0|||
143473186|NCT01920594|517280832|FG001|Overall Study|Investigator discretion|1|||
143473187|NCT02460497|517280837|FG000|Overall Study|Participant Requested Withdrawal|4|||
143473188|NCT02460497|517280837|FG000|Overall Study|Non-Compliance|1|||
143473189|NCT02460497|517280837|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
143473190|NCT02460497|517280837|FG000|Overall Study|Lost to Follow-up|2|||
143473191|NCT02460497|517280837|FG000|Overall Study|Investigator Decision|1|||
143473192|NCT01650285|517280840|FG000|Overall Study|Adverse Event|1|||
143473193|NCT00659529|517280841|FG000|Overall Study|Withdrawal by Subject|4|||
143473194|NCT00659529|517280841|FG000|Overall Study|Protocol Violation|3|||
143473195|NCT00659529|517280841|FG000|Overall Study|Screen failure|9|||
143473196|NCT03627767|517280844|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
143473197|NCT03627767|517280845|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
143473198|NCT03627767|517280846|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
143473199|NCT03627767|517280847|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
143142054|NCT01648764|516069218|FG010|Overall Study|Withdrawal by Subject|0|||
143142055|NCT01648764|516069219|FG011|Overall Study|Withdrawal by Subject|0|||
143142056|NCT01648764|516069220|FG012|Overall Study|Withdrawal by Subject|1|||
143142057|NCT01648764|516069221|FG013|Overall Study|Withdrawal by Subject|0|||
143142058|NCT01648764|516069208|FG000|Overall Study|Investigator Decision|0|||
143142059|NCT01648764|516069209|FG001|Overall Study|Investigator Decision|0|||
143142060|NCT01648764|516069210|FG002|Overall Study|Investigator Decision|0|||
143142061|NCT01648764|516069211|FG003|Overall Study|Investigator Decision|0|||
143142062|NCT01648764|516069212|FG004|Overall Study|Investigator Decision|0|||
143142063|NCT01648764|516069213|FG005|Overall Study|Investigator Decision|0|||
143142064|NCT01648764|516069214|FG006|Overall Study|Investigator Decision|1|||
143142065|NCT01648764|516069215|FG007|Overall Study|Investigator Decision|0|||
143142066|NCT01648764|516069216|FG008|Overall Study|Investigator Decision|0|||
143142067|NCT01648764|516069217|FG009|Overall Study|Investigator Decision|0|||
143142068|NCT01648764|516069218|FG010|Overall Study|Investigator Decision|0|||
143142069|NCT01648764|516069219|FG011|Overall Study|Investigator Decision|1|||
143142070|NCT01648764|516069220|FG012|Overall Study|Investigator Decision|0|||
143142071|NCT01648764|516069221|FG013|Overall Study|Investigator Decision|0|||
143142072|NCT00076570|516069222|FG000|Overall Study|Drug intolerance|8|||
143142073|NCT00076570|516069223|FG001|Overall Study|Drug intolerance|8|||
143142074|NCT00903968|516069224|FG000|Overall Study|Adverse Event|0|||
143142075|NCT00903968|516069225|FG001|Overall Study|Adverse Event|0|||
143142076|NCT00903968|516069226|FG002|Overall Study|Adverse Event|0|||
143142077|NCT00903968|516069227|FG003|Overall Study|Adverse Event|0|||
143142078|NCT00903968|516069228|FG004|Overall Study|Adverse Event|0|||
143142079|NCT00903968|516069229|FG005|Overall Study|Adverse Event|0|||
143142080|NCT00903968|516069230|FG006|Overall Study|Adverse Event|1|||
143142081|NCT00903968|516069231|FG007|Overall Study|Adverse Event|8|||
143142082|NCT00903968|516069224|FG000|Overall Study|DLT|0|||
143142083|NCT00903968|516069225|FG001|Overall Study|DLT|0|||
143142084|NCT00903968|516069226|FG002|Overall Study|DLT|0|||
143142085|NCT00903968|516069227|FG003|Overall Study|DLT|0|||
143142086|NCT00903968|516069228|FG004|Overall Study|DLT|0|||
143142087|NCT00903968|516069229|FG005|Overall Study|DLT|0|||
143142088|NCT00903968|516069230|FG006|Overall Study|DLT|2|||
143142089|NCT00903968|516069231|FG007|Overall Study|DLT|0|||
143142090|NCT00903968|516069224|FG000|Overall Study|Withdrawal by Subject|1|||
143142091|NCT00903968|516069225|FG001|Overall Study|Withdrawal by Subject|0|||
143142092|NCT00903968|516069226|FG002|Overall Study|Withdrawal by Subject|1|||
143142093|NCT00903968|516069227|FG003|Overall Study|Withdrawal by Subject|0|||
143142094|NCT00903968|516069228|FG004|Overall Study|Withdrawal by Subject|1|||
143142095|NCT00903968|516069229|FG005|Overall Study|Withdrawal by Subject|1|||
143142096|NCT00903968|516069230|FG006|Overall Study|Withdrawal by Subject|0|||
143473200|NCT03627767|517280848|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
143473201|NCT03627767|517280844|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
143142097|NCT00903968|516069231|FG007|Overall Study|Withdrawal by Subject|4|||
143142098|NCT00903968|516069224|FG000|Overall Study|Non-Compliance|0|||
143142099|NCT00903968|516069225|FG001|Overall Study|Non-Compliance|0|||
143142100|NCT00903968|516069226|FG002|Overall Study|Non-Compliance|0|||
143142101|NCT00903968|516069227|FG003|Overall Study|Non-Compliance|0|||
143142102|NCT00903968|516069228|FG004|Overall Study|Non-Compliance|0|||
143142103|NCT00903968|516069229|FG005|Overall Study|Non-Compliance|1|||
143142104|NCT00903968|516069230|FG006|Overall Study|Non-Compliance|0|||
143142105|NCT00903968|516069231|FG007|Overall Study|Non-Compliance|0|||
143142106|NCT00903968|516069224|FG000|Overall Study|Physician Decision|0|||
143142107|NCT00903968|516069225|FG001|Overall Study|Physician Decision|0|||
143142108|NCT00903968|516069226|FG002|Overall Study|Physician Decision|0|||
143142109|NCT00903968|516069227|FG003|Overall Study|Physician Decision|0|||
143142110|NCT00903968|516069228|FG004|Overall Study|Physician Decision|0|||
143142111|NCT00903968|516069229|FG005|Overall Study|Physician Decision|1|||
143142112|NCT00903968|516069230|FG006|Overall Study|Physician Decision|0|||
143142113|NCT00903968|516069231|FG007|Overall Study|Physician Decision|0|||
143142114|NCT00903968|516069224|FG000|Overall Study|Progressive Disease|2|||
143142115|NCT00903968|516069225|FG001|Overall Study|Progressive Disease|3|||
143142116|NCT00903968|516069226|FG002|Overall Study|Progressive Disease|2|||
143142117|NCT00903968|516069227|FG003|Overall Study|Progressive Disease|3|||
143142118|NCT00903968|516069228|FG004|Overall Study|Progressive Disease|3|||
143142119|NCT00903968|516069229|FG005|Overall Study|Progressive Disease|3|||
143142120|NCT00903968|516069230|FG006|Overall Study|Progressive Disease|0|||
143142121|NCT00903968|516069231|FG007|Overall Study|Progressive Disease|18|||
143142122|NCT00903968|516069224|FG000|Overall Study|Lack of Efficacy|0|||
143142123|NCT00903968|516069225|FG001|Overall Study|Lack of Efficacy|0|||
143142124|NCT00903968|516069226|FG002|Overall Study|Lack of Efficacy|0|||
143473202|NCT03627767|517280845|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
143473203|NCT03627767|517280846|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
143473204|NCT03627767|517280847|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
143473205|NCT03627767|517280848|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
143473206|NCT03627767|517280844|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
143473207|NCT03627767|517280845|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
143473208|NCT03627767|517280846|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
143473209|NCT03627767|517280847|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
143473210|NCT03627767|517280848|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
143473211|NCT03627767|517280844|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
143473212|NCT03627767|517280845|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
143473213|NCT03627767|517280846|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
143473214|NCT03627767|517280847|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
143473215|NCT03627767|517280848|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
143473216|NCT03627767|517280844|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
143473217|NCT03627767|517280845|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
143473218|NCT03627767|517280846|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
143473219|NCT03627767|517280847|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
143142125|NCT00903968|516069227|FG003|Overall Study|Lack of Efficacy|0|||
143142126|NCT00903968|516069228|FG004|Overall Study|Lack of Efficacy|0|||
143142127|NCT00903968|516069229|FG005|Overall Study|Lack of Efficacy|0|||
143142128|NCT00903968|516069230|FG006|Overall Study|Lack of Efficacy|0|||
143142129|NCT00903968|516069231|FG007|Overall Study|Lack of Efficacy|3|||
143142130|NCT01294046|516069232|FG000|Overall Study|Infection and surgical explant|1|||
143142131|NCT01294046|516069232|FG000|Overall Study|Eligibility criteria expanded|1|||
143142132|NCT01294046|516069232|FG000|Overall Study|Stimulation response inadqequate|1|||
143142133|NCT00998946|516069235|FG000|Overall Study|Lost to Follow-up|1|||
143142134|NCT00998946|516069235|FG000|Overall Study|Withdrawal by Subject|1|||
143142135|NCT00998946|516069235|FG000|Overall Study|Death|2|||
143142136|NCT00998946|516069235|FG000|Overall Study|Reason Unspecified|3|||
143142137|NCT00998946|516069235|FG000|Overall Study|Enrolled but not Dosed|2|||
143142138|NCT01454284|516069238|FG000|Overall Study|Adverse Event|20|||
143142139|NCT01454284|516069239|FG001|Overall Study|Adverse Event|7|||
143142140|NCT01454284|516069238|FG000|Overall Study|Death|0|||
143142141|NCT01454284|516069239|FG001|Overall Study|Death|3|||
143142142|NCT01454284|516069238|FG000|Overall Study|Lost to Follow-up|13|||
143142143|NCT01454284|516069239|FG001|Overall Study|Lost to Follow-up|8|||
143142144|NCT01454284|516069238|FG000|Overall Study|Protocol Violation|9|||
143142145|NCT01454284|516069239|FG001|Overall Study|Protocol Violation|6|||
143142146|NCT01454284|516069238|FG000|Overall Study|Withdrawal by Subject|58|||
143142147|NCT01454284|516069239|FG001|Overall Study|Withdrawal by Subject|36|||
143142148|NCT01454284|516069238|FG000|Overall Study|Physician Decision|16|||
143142149|NCT01454284|516069239|FG001|Overall Study|Physician Decision|11|||
143473220|NCT03627767|517280848|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
143142150|NCT01454284|516069238|FG000|Overall Study|Sponsor Decision|0|||
143142151|NCT01454284|516069239|FG001|Overall Study|Sponsor Decision|2|||
143142152|NCT01432327|516069240|FG000|Posttest 3 Months|depression|3|||
143142153|NCT01432327|516069241|FG001|Posttest 3 Months|depression|0|||
143142154|NCT01432327|516069242|FG002|Posttest 3 Months|depression|0|||
143142155|NCT01432327|516069243|FG003|Posttest 3 Months|depression|0|||
143142156|NCT01432327|516069240|FG000|Posttest 3 Months|Lost to Follow-up|1|||
143142157|NCT01432327|516069241|FG001|Posttest 3 Months|Lost to Follow-up|0|||
143142158|NCT01432327|516069242|FG002|Posttest 3 Months|Lost to Follow-up|2|||
143142159|NCT01432327|516069243|FG003|Posttest 3 Months|Lost to Follow-up|1|||
143142160|NCT01432327|516069240|FG000|Posttest 3 Months|Allergic reaction|0|||
143142161|NCT01432327|516069241|FG001|Posttest 3 Months|Allergic reaction|2|||
143142162|NCT01432327|516069242|FG002|Posttest 3 Months|Allergic reaction|0|||
143142163|NCT01432327|516069243|FG003|Posttest 3 Months|Allergic reaction|0|||
143142164|NCT01432327|516069240|FG000|Posttest 6 Months|Lost to Follow-up|0|||
143142165|NCT01432327|516069241|FG001|Posttest 6 Months|Lost to Follow-up|0|||
143142166|NCT01432327|516069242|FG002|Posttest 6 Months|Lost to Follow-up|3|||
143142167|NCT01432327|516069243|FG003|Posttest 6 Months|Lost to Follow-up|2|||
143142168|NCT01432327|516069240|FG000|Posttest 6 Months|Allergic reaction|0|||
143142169|NCT01432327|516069241|FG001|Posttest 6 Months|Allergic reaction|0|||
143142170|NCT01432327|516069242|FG002|Posttest 6 Months|Allergic reaction|1|||
143142171|NCT01432327|516069243|FG003|Posttest 6 Months|Allergic reaction|0|||
143142172|NCT01432327|516069240|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
143142173|NCT01432327|516069241|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
143142174|NCT01432327|516069242|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
143142175|NCT01432327|516069243|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
143142176|NCT01432327|516069240|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
143142177|NCT01432327|516069241|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
143142178|NCT01432327|516069242|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
143142179|NCT01432327|516069243|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
143142180|NCT01432327|516069240|FG000|Posttest 1 Year|Lost to Follow-up|0|||
143142181|NCT01432327|516069241|FG001|Posttest 1 Year|Lost to Follow-up|0|||
143142182|NCT01432327|516069242|FG002|Posttest 1 Year|Lost to Follow-up|4|||
143142183|NCT01432327|516069243|FG003|Posttest 1 Year|Lost to Follow-up|2|||
143142184|NCT01432327|516069240|FG000|Posttest 1 Year|Allergic reaction|0|||
143142185|NCT01432327|516069241|FG001|Posttest 1 Year|Allergic reaction|0|||
143142186|NCT01432327|516069242|FG002|Posttest 1 Year|Allergic reaction|1|||
143142187|NCT01432327|516069243|FG003|Posttest 1 Year|Allergic reaction|1|||
143142188|NCT00577408|516069244|FG000|Overall Study|Stopped attending study visits|9|||
143142189|NCT00577408|516069245|FG001|Overall Study|Stopped attending study visits|11|||
143142190|NCT00577408|516069244|FG000|Overall Study|Continued opioid use|3|||
143142191|NCT00577408|516069245|FG001|Overall Study|Continued opioid use|2|||
143142192|NCT00577408|516069244|FG000|Overall Study|Non-compliance with study meds|0|||
143142193|NCT00577408|516069245|FG001|Overall Study|Non-compliance with study meds|3|||
143362538|NCT04011033|516869765|FG000|Overall Study|Withdrawal by Subject|1|||
143362539|NCT04011033|516869766|FG001|Overall Study|Withdrawal by Subject|0|||
143362540|NCT01823341|516869767|FG000|Overall Study|Failed run-in|7|||
143362541|NCT01823341|516869767|FG000|Overall Study|Withdrawal by Subject|7|||
143362542|NCT01823341|516869767|FG000|Overall Study|Adverse Event|1|||
143362543|NCT02027935|516869768|FG000|Overall Study|Death|1|||
143362544|NCT02027935|516869768|FG000|Overall Study|Lack of Efficacy|5|||
143362545|NCT02027935|516869768|FG000|Overall Study|Study Closure|1|||
143362546|NCT00689104|516869769|FG000|Overall Study|Eligibility criterion not met|5|||
143362547|NCT00689104|516869770|FG001|Overall Study|Eligibility criterion not met|8|||
143362548|NCT00689104|516869771|FG002|Overall Study|Eligibility criterion not met|0|||
143362549|NCT00689104|516869772|FG003|Overall Study|Eligibility criterion not met|4|||
143362550|NCT00689104|516869769|FG000|Overall Study|Adverse Event|13|||
143362551|NCT00689104|516869770|FG001|Overall Study|Adverse Event|25|||
143362552|NCT00689104|516869771|FG002|Overall Study|Adverse Event|16|||
143362553|NCT00689104|516869772|FG003|Overall Study|Adverse Event|24|||
143362554|NCT00689104|516869769|FG000|Overall Study|Lack of Efficacy|5|||
143362555|NCT00689104|516869770|FG001|Overall Study|Lack of Efficacy|6|||
143362556|NCT00689104|516869771|FG002|Overall Study|Lack of Efficacy|2|||
143362557|NCT00689104|516869772|FG003|Overall Study|Lack of Efficacy|3|||
143362558|NCT00689104|516869769|FG000|Overall Study|Withdrawal by Subject|12|||
143362559|NCT00689104|516869770|FG001|Overall Study|Withdrawal by Subject|11|||
143362560|NCT00689104|516869771|FG002|Overall Study|Withdrawal by Subject|18|||
143362561|NCT00689104|516869772|FG003|Overall Study|Withdrawal by Subject|11|||
143362562|NCT00689104|516869769|FG000|Overall Study|Lost to Follow-up|4|||
143362563|NCT00689104|516869770|FG001|Overall Study|Lost to Follow-up|3|||
143362564|NCT00689104|516869771|FG002|Overall Study|Lost to Follow-up|2|||
143362565|NCT00689104|516869772|FG003|Overall Study|Lost to Follow-up|5|||
143362566|NCT00689104|516869769|FG000|Overall Study|Protocol Violation|2|||
143362567|NCT00689104|516869770|FG001|Overall Study|Protocol Violation|3|||
143362568|NCT00689104|516869771|FG002|Overall Study|Protocol Violation|5|||
143362569|NCT00689104|516869772|FG003|Overall Study|Protocol Violation|3|||
143362570|NCT00689104|516869769|FG000|Overall Study|Randomized but never received study drug|2|||
143142194|NCT00577408|516069244|FG000|Overall Study|Refused Oral Naltrexone|0|||
143142195|NCT00577408|516069245|FG001|Overall Study|Refused Oral Naltrexone|1|||
143362571|NCT00689104|516869770|FG001|Overall Study|Randomized but never received study drug|1|||
143362572|NCT00689104|516869771|FG002|Overall Study|Randomized but never received study drug|1|||
143142196|NCT00577408|516069244|FG000|Overall Study|Moved out of state|0|||
143142197|NCT00577408|516069245|FG001|Overall Study|Moved out of state|1|||
143142198|NCT00577408|516069244|FG000|Overall Study|Scheduling Issues|0|||
143142199|NCT00577408|516069245|FG001|Overall Study|Scheduling Issues|3|||
143142200|NCT00577408|516069244|FG000|Overall Study|Death|0|||
143142201|NCT00577408|516069245|FG001|Overall Study|Death|1|||
143142202|NCT00577408|516069244|FG000|Overall Study|Psychiatric hospitalization|0|||
143142203|NCT00577408|516069245|FG001|Overall Study|Psychiatric hospitalization|1|||
143142204|NCT02765035|516069253|FG000|First Intervention (90 Days)|Adverse Event|1|||
143142205|NCT02765035|516069254|FG001|First Intervention (90 Days)|Adverse Event|1|||
143142206|NCT02765035|516069253|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
143142207|NCT02765035|516069254|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
143142208|NCT01259245|516069263|FG000|Overall Study|Withdrawal by Subject|27|||
143142209|NCT01259245|516069264|FG001|Overall Study|Withdrawal by Subject|24|||
143142210|NCT01259245|516069263|FG000|Overall Study|Death|1|||
143142211|NCT01259245|516069264|FG001|Overall Study|Death|2|||
143142212|NCT03451071|516069265|FG000|First Vaccine|Withdrawal by Subject|1|||
143142213|NCT03451071|516069265|FG000|Second Vaccine|Lost to Follow-up|19|||
143142214|NCT03451071|516069265|FG000|Third Vaccine|Lost to Follow-up|22|||
143142215|NCT03451071|516069265|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
143142216|NCT03363906|516069266|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
143142217|NCT03363906|516069267|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
143142218|NCT03363906|516069266|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
143142219|NCT03363906|516069267|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
143142220|NCT03363906|516069266|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
143142221|NCT03363906|516069267|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
143142222|NCT03363906|516069266|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
143142223|NCT03363906|516069267|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
143142224|NCT02065557|516069270|FG000|Induction Period|Withdrawal by Subject|2|||
143142225|NCT02065557|516069271|FG001|Induction Period|Withdrawal by Subject|1|||
143142226|NCT02065557|516069272|FG002|Induction Period|Withdrawal by Subject|0|||
143142227|NCT02065557|516069273|FG003|Induction Period|Withdrawal by Subject|0|||
143142228|NCT02065557|516069274|FG004|Induction Period|Withdrawal by Subject|0|||
143142229|NCT02065557|516069275|FG005|Induction Period|Withdrawal by Subject|0|||
143142230|NCT02065557|516069270|FG000|Induction Period|Lack of Efficacy|2|||
143142231|NCT02065557|516069271|FG001|Induction Period|Lack of Efficacy|1|||
143142232|NCT02065557|516069272|FG002|Induction Period|Lack of Efficacy|1|||
143142233|NCT02065557|516069273|FG003|Induction Period|Lack of Efficacy|0|||
143142234|NCT02065557|516069274|FG004|Induction Period|Lack of Efficacy|0|||
143142235|NCT02065557|516069275|FG005|Induction Period|Lack of Efficacy|0|||
143142236|NCT02065557|516069270|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
143142237|NCT02065557|516069271|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
143142238|NCT02065557|516069272|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
143142239|NCT02065557|516069273|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
143142240|NCT02065557|516069274|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
143142241|NCT02065557|516069275|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
143142242|NCT02065557|516069270|FG000|Induction Period|Non-Responder at Week 8|4|||
143142243|NCT02065557|516069271|FG001|Induction Period|Non-Responder at Week 8|4|||
143142244|NCT02065557|516069272|FG002|Induction Period|Non-Responder at Week 8|0|||
143142245|NCT02065557|516069273|FG003|Induction Period|Non-Responder at Week 8|0|||
143142246|NCT02065557|516069274|FG004|Induction Period|Non-Responder at Week 8|0|||
143473221|NCT03627767|517280844|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
143473222|NCT03627767|517280845|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
143473223|NCT03627767|517280846|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
143473224|NCT03627767|517280847|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
143473225|NCT03627767|517280848|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
143473226|NCT03627767|517280844|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
143473227|NCT03627767|517280845|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
143142247|NCT02065557|516069275|FG005|Induction Period|Non-Responder at Week 8|0|||
143142248|NCT02065557|516069270|FG000|Induction Period|Adverse Event|1|||
143142249|NCT02065557|516069271|FG001|Induction Period|Adverse Event|1|||
143473228|NCT03627767|517280846|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
143473229|NCT03627767|517280847|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
143473230|NCT03627767|517280848|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
143473231|NCT03627767|517280844|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
143473232|NCT03627767|517280845|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
143473233|NCT03627767|517280846|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
143142250|NCT02065557|516069272|FG002|Induction Period|Adverse Event|0|||
143142251|NCT02065557|516069273|FG003|Induction Period|Adverse Event|0|||
143142252|NCT02065557|516069274|FG004|Induction Period|Adverse Event|0|||
143142253|NCT02065557|516069275|FG005|Induction Period|Adverse Event|0|||
143142254|NCT02065557|516069270|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
143142255|NCT02065557|516069271|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
143142256|NCT02065557|516069272|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
143142257|NCT02065557|516069273|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
143142258|NCT02065557|516069274|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
143142259|NCT02065557|516069275|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
143142260|NCT02065557|516069270|FG000|Maintenance Period|Withdrawal by Subject|0|||
143142261|NCT02065557|516069271|FG001|Maintenance Period|Withdrawal by Subject|0|||
143362573|NCT00689104|516869772|FG003|Overall Study|Randomized but never received study drug|0|||
143362574|NCT00689104|516869769|FG000|Overall Study|Physician Decision|1|||
143362575|NCT00689104|516869770|FG001|Overall Study|Physician Decision|0|||
143362576|NCT00689104|516869771|FG002|Overall Study|Physician Decision|0|||
143362577|NCT00689104|516869772|FG003|Overall Study|Physician Decision|0|||
143362578|NCT00689104|516869769|FG000|Overall Study|Non-compliance with study procedures|0|||
143362579|NCT00689104|516869770|FG001|Overall Study|Non-compliance with study procedures|0|||
143362580|NCT00689104|516869771|FG002|Overall Study|Non-compliance with study procedures|1|||
143362581|NCT00689104|516869772|FG003|Overall Study|Non-compliance with study procedures|0|||
143362582|NCT04873817|516869773|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
143362583|NCT04873817|516869773|FG000|Overall Study|Lost to Follow-up|4|||
143362584|NCT04873817|516869773|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
143362585|NCT04873817|516869773|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
143362586|NCT04873817|516869773|FG000|Overall Study|Other Reasons|3|||
143362587|NCT00924560|516869777|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
143362588|NCT00924560|516869778|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
143362589|NCT00924560|516869779|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
143362590|NCT00924560|516869777|FG000|Overall Study|Non Compliance with the Protocol|20|||
143362591|NCT00924560|516869778|FG001|Overall Study|Non Compliance with the Protocol|15|||
143362592|NCT00924560|516869779|FG002|Overall Study|Non Compliance with the Protocol|4|||
143362593|NCT00924560|516869777|FG000|Overall Study|Physician Decision|2|||
143362594|NCT00924560|516869778|FG001|Overall Study|Physician Decision|3|||
143362595|NCT00924560|516869779|FG002|Overall Study|Physician Decision|4|||
143362596|NCT00924560|516869777|FG000|Overall Study|Withdrawal by Subject|50|||
143362597|NCT00924560|516869778|FG001|Overall Study|Withdrawal by Subject|44|||
143362598|NCT00924560|516869779|FG002|Overall Study|Withdrawal by Subject|18|||
143362599|NCT00924560|516869777|FG000|Overall Study|Adverse Event|39|||
143362600|NCT00924560|516869778|FG001|Overall Study|Adverse Event|33|||
143362601|NCT00924560|516869779|FG002|Overall Study|Adverse Event|0|||
143362602|NCT00924560|516869777|FG000|Overall Study|Pregnancy|5|||
143362603|NCT00924560|516869778|FG001|Overall Study|Pregnancy|7|||
143362604|NCT00924560|516869779|FG002|Overall Study|Pregnancy|1|||
143362605|NCT00924560|516869777|FG000|Overall Study|Lost to Follow-up|78|||
143362606|NCT00924560|516869778|FG001|Overall Study|Lost to Follow-up|94|||
143362607|NCT00924560|516869779|FG002|Overall Study|Lost to Follow-up|45|||
143362608|NCT00924560|516869777|FG000|Overall Study|Miscellaneous Reasons|13|||
143362609|NCT00924560|516869778|FG001|Overall Study|Miscellaneous Reasons|10|||
143362610|NCT00924560|516869779|FG002|Overall Study|Miscellaneous Reasons|10|||
143362611|NCT00701311|516869780|FG000|Overall Study|Lack of Efficacy|3|||
143362612|NCT00701311|516869780|FG000|Overall Study|Adverse Event|3|||
143362613|NCT00701311|516869780|FG000|Overall Study|Withdrawal by Subject|2|||
143362614|NCT01449929|516869781|FG000|Randomization Phase 96 Week|Adverse Event|5|||
143362615|NCT01449929|516869782|FG001|Randomization Phase 96 Week|Adverse Event|13|||
143362616|NCT01449929|516869783|FG002|Randomization Phase 96 Week|Adverse Event|0|||
143362617|NCT01449929|516869781|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
143362618|NCT01449929|516869782|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
143362619|NCT01449929|516869783|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
143362620|NCT01449929|516869781|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
143362621|NCT01449929|516869782|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
143362622|NCT01449929|516869783|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
143362623|NCT01449929|516869781|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
143362624|NCT01449929|516869782|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
143362625|NCT01449929|516869783|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
143362626|NCT01449929|516869781|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
143362627|NCT01449929|516869782|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
143362628|NCT01449929|516869783|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
143362629|NCT01449929|516869781|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
143362630|NCT01449929|516869782|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
143362631|NCT01449929|516869783|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
143362632|NCT01449929|516869781|FG000|Randomization Phase 96 Week|Physician Decision|2|||
143362633|NCT01449929|516869782|FG001|Randomization Phase 96 Week|Physician Decision|3|||
143362634|NCT01449929|516869783|FG002|Randomization Phase 96 Week|Physician Decision|0|||
143362635|NCT01449929|516869781|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
143473234|NCT03627767|517280847|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
143473235|NCT03627767|517280848|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
143473236|NCT03627767|517280844|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
143473237|NCT03627767|517280845|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
143473238|NCT03627767|517280846|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
143473239|NCT03627767|517280847|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
143473240|NCT03627767|517280848|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
143473241|NCT03627767|517280844|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
143473242|NCT03627767|517280845|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
143473243|NCT03627767|517280846|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
143473244|NCT03627767|517280847|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
143473245|NCT03627767|517280848|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
143473246|NCT03627767|517280844|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
143473247|NCT03627767|517280845|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
143473248|NCT03627767|517280846|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
143473249|NCT03627767|517280847|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
143473250|NCT03627767|517280848|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
143473251|NCT03627767|517280844|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
143473252|NCT03627767|517280845|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
143473253|NCT03627767|517280846|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
143473254|NCT03627767|517280847|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
143473255|NCT03627767|517280848|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
143473256|NCT03627767|517280844|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
143473257|NCT03627767|517280845|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
143473258|NCT03627767|517280846|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
143473259|NCT03627767|517280847|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
143473260|NCT03627767|517280848|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
143473261|NCT03627767|517280844|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
143473262|NCT03627767|517280845|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
143473263|NCT03627767|517280846|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
143473264|NCT03627767|517280847|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
143473265|NCT03627767|517280848|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
143473266|NCT03627767|517280844|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
143473267|NCT03627767|517280845|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
143473268|NCT03627767|517280846|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
143473269|NCT03627767|517280847|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
143473270|NCT03627767|517280848|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
143473271|NCT03627767|517280844|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
143473272|NCT03627767|517280845|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
143473273|NCT03627767|517280846|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
143473274|NCT03627767|517280847|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
143473275|NCT03627767|517280848|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
143473276|NCT03627767|517280844|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
143473277|NCT03627767|517280845|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
143473278|NCT03627767|517280846|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
143473279|NCT03627767|517280847|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
143473280|NCT03627767|517280848|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
143473281|NCT03627767|517280844|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
143473282|NCT03627767|517280845|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
143473283|NCT03627767|517280846|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
143473284|NCT03627767|517280847|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
143473285|NCT03627767|517280848|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
143473286|NCT03627767|517280844|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
143473287|NCT03627767|517280845|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
143473288|NCT03627767|517280846|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
143473289|NCT03627767|517280847|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
143473290|NCT03627767|517280848|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
143473291|NCT03627767|517280844|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
143473292|NCT03627767|517280845|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
143473293|NCT03627767|517280846|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
143473294|NCT03627767|517280847|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
143473295|NCT03627767|517280848|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
143473296|NCT04163900|517280851|FG000|Overall Study|Radiological disease progression|112|||
143473297|NCT04163900|517280852|FG001|Overall Study|Radiological disease progression|127|||
143473298|NCT04163900|517280851|FG000|Overall Study|Study closure|98|||
143473299|NCT04163900|517280852|FG001|Overall Study|Study closure|133|||
143473300|NCT04163900|517280851|FG000|Overall Study|Adverse Event|78|||
143473301|NCT04163900|517280852|FG001|Overall Study|Adverse Event|32|||
143473302|NCT04163900|517280851|FG000|Overall Study|Withdrawal by Subject|37|||
143473303|NCT04163900|517280852|FG001|Overall Study|Withdrawal by Subject|34|||
143473304|NCT04163900|517280851|FG000|Overall Study|Death|29|||
143473305|NCT04163900|517280852|FG001|Overall Study|Death|16|||
143473306|NCT04163900|517280851|FG000|Overall Study|Physician Decision|17|||
143473307|NCT04163900|517280852|FG001|Overall Study|Physician Decision|25|||
143473308|NCT04163900|517280851|FG000|Overall Study|Clinical disease progression|14|||
143473309|NCT04163900|517280852|FG001|Overall Study|Clinical disease progression|13|||
143142262|NCT02065557|516069272|FG002|Maintenance Period|Withdrawal by Subject|0|||
143473310|NCT04163900|517280851|FG000|Overall Study|Protocol Violation|3|||
143473311|NCT04163900|517280852|FG001|Overall Study|Protocol Violation|4|||
143473312|NCT04163900|517280851|FG000|Overall Study|Lost to Follow-up|0|||
143473313|NCT04163900|517280852|FG001|Overall Study|Lost to Follow-up|1|||
143473314|NCT00283049|517280853|FG000|Overall Study|Adverse Event|6|||
143473315|NCT00283049|517280854|FG001|Overall Study|Adverse Event|1|||
143473316|NCT00283049|517280855|FG002|Overall Study|Adverse Event|4|||
143473317|NCT00283049|517280853|FG000|Overall Study|Protocol Violation|3|||
143473318|NCT00283049|517280854|FG001|Overall Study|Protocol Violation|0|||
143473319|NCT00283049|517280855|FG002|Overall Study|Protocol Violation|3|||
143473320|NCT00283049|517280853|FG000|Overall Study|Death|1|||
143473321|NCT00283049|517280854|FG001|Overall Study|Death|1|||
143473322|NCT00283049|517280855|FG002|Overall Study|Death|1|||
143473323|NCT00283049|517280853|FG000|Overall Study|Lack of Efficacy|0|||
143473324|NCT00283049|517280854|FG001|Overall Study|Lack of Efficacy|1|||
143473325|NCT00283049|517280855|FG002|Overall Study|Lack of Efficacy|1|||
143473326|NCT00283049|517280853|FG000|Overall Study|Lost to Follow-up|4|||
143473327|NCT00283049|517280854|FG001|Overall Study|Lost to Follow-up|2|||
143473328|NCT00283049|517280855|FG002|Overall Study|Lost to Follow-up|5|||
143473329|NCT00283049|517280853|FG000|Overall Study|Withdrawal by Subject|26|||
143473330|NCT00283049|517280854|FG001|Overall Study|Withdrawal by Subject|24|||
143473331|NCT00283049|517280855|FG002|Overall Study|Withdrawal by Subject|19|||
143473332|NCT00283049|517280853|FG000|Overall Study|Discontinuation of Study|18|||
143473333|NCT00283049|517280854|FG001|Overall Study|Discontinuation of Study|16|||
143473334|NCT00283049|517280855|FG002|Overall Study|Discontinuation of Study|20|||
143473335|NCT00283049|517280853|FG000|Overall Study|No longer requires study treatment|0|||
143473336|NCT00283049|517280854|FG001|Overall Study|No longer requires study treatment|0|||
143473337|NCT00283049|517280855|FG002|Overall Study|No longer requires study treatment|1|||
143473338|NCT01873417|517280856|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
143473339|NCT01873417|517280856|FG000|Overall Study|Adverse Event|24|||
143473340|NCT01873417|517280856|FG000|Overall Study|Lost to Follow-up|2|||
143473341|NCT01873417|517280856|FG000|Overall Study|Withdrawal by Subject|2|||
143473342|NCT01873417|517280856|FG000|Overall Study|Physician Decision|3|||
143473343|NCT00785044|517280857|FG000|Overall Study|Dosed at non-participating sites|152|||
143473344|NCT00785044|517280857|FG000|Overall Study|Death|77|||
143473345|NCT00785044|517280857|FG000|Overall Study|Lost to Follow-up|266|||
143473346|NCT00785044|517280857|FG000|Overall Study|Withdrawal by Subject|1|||
143473347|NCT01628107|517280858|FG000|Overall Study|Withdrawal by Subject|17|||
143473348|NCT01628107|517280858|FG000|Overall Study|Lost to Follow-up|4|||
143473349|NCT01628107|517280858|FG000|Overall Study|Adverse Event|33|||
143473350|NCT01628107|517280858|FG000|Overall Study|Physician Decision|2|||
143473351|NCT01628107|517280858|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
143473352|NCT01628107|517280858|FG000|Overall Study|Non-compliant with Study Procedures|10|||
143473353|NCT01628107|517280858|FG000|Overall Study|Not Treated|8|||
143473354|NCT01628107|517280858|FG000|Overall Study|Sponsor Decision|11|||
143473355|NCT01628107|517280858|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
143473356|NCT01628107|517280858|FG000|Overall Study|Relocated|8|||
143473357|NCT01628107|517280858|FG000|Overall Study|Kidney Transplant|9|||
143473358|NCT01628107|517280858|FG000|Overall Study|Use of Standard of Care|9|||
143473359|NCT01086410|517280859|FG000|Overall Study|Adverse Event|1|||
143014079|NCT02923115|515591597|FG003|Overall Study|Randomized, but not dosed|1|||
143014080|NCT02923115|515591598|FG004|Overall Study|Randomized, but not dosed|5|||
143014081|NCT02923115|515591599|FG005|Overall Study|Randomized, but not dosed|0|||
143014082|NCT05354206|515591606|FG000|Overall Study|Withdrawal by Subject|1|||
143142263|NCT02065557|516069273|FG003|Maintenance Period|Withdrawal by Subject|0|||
143142264|NCT02065557|516069274|FG004|Maintenance Period|Withdrawal by Subject|2|||
143473360|NCT01086410|517280860|FG001|Overall Study|Adverse Event|0|||
143473361|NCT01086410|517280861|FG002|Overall Study|Adverse Event|0|||
143473362|NCT01086410|517280862|FG003|Overall Study|Adverse Event|2|||
143473363|NCT01086410|517280859|FG000|Overall Study|Lack of Efficacy|1|||
143473364|NCT01086410|517280860|FG001|Overall Study|Lack of Efficacy|1|||
143473365|NCT01086410|517280861|FG002|Overall Study|Lack of Efficacy|0|||
143473366|NCT01086410|517280862|FG003|Overall Study|Lack of Efficacy|0|||
143473367|NCT01086410|517280859|FG000|Overall Study|Protocol Violation|1|||
143473368|NCT01086410|517280860|FG001|Overall Study|Protocol Violation|1|||
143473369|NCT01086410|517280861|FG002|Overall Study|Protocol Violation|0|||
143473370|NCT01086410|517280862|FG003|Overall Study|Protocol Violation|0|||
143473371|NCT01086410|517280859|FG000|Overall Study|Lost to Follow-up|0|||
143473372|NCT01086410|517280860|FG001|Overall Study|Lost to Follow-up|0|||
143473373|NCT01086410|517280861|FG002|Overall Study|Lost to Follow-up|1|||
143473374|NCT01086410|517280862|FG003|Overall Study|Lost to Follow-up|0|||
143473375|NCT02953639|517280863|FG000|Overall Study|Adverse Event|2|||
143473376|NCT02953639|517280864|FG001|Overall Study|Adverse Event|0|||
143473377|NCT02953639|517280865|FG002|Overall Study|Adverse Event|1|||
143473378|NCT02953639|517280863|FG000|Overall Study|Lost to Follow-up|8|||
143473379|NCT02953639|517280864|FG001|Overall Study|Lost to Follow-up|4|||
143473380|NCT02953639|517280865|FG002|Overall Study|Lost to Follow-up|3|||
143473381|NCT02953639|517280863|FG000|Overall Study|Non-Compliance With Study Drug|0|||
143473382|NCT02953639|517280864|FG001|Overall Study|Non-Compliance With Study Drug|2|||
143473383|NCT02953639|517280865|FG002|Overall Study|Non-Compliance With Study Drug|1|||
143473384|NCT02953639|517280863|FG000|Overall Study|Multiple Reasons|1|||
143473385|NCT02953639|517280864|FG001|Overall Study|Multiple Reasons|0|||
143473386|NCT02953639|517280865|FG002|Overall Study|Multiple Reasons|1|||
143473387|NCT02953639|517280863|FG000|Overall Study|Physician Decision|1|||
143473388|NCT02953639|517280864|FG001|Overall Study|Physician Decision|0|||
143473389|NCT02953639|517280865|FG002|Overall Study|Physician Decision|0|||
143473390|NCT02953639|517280863|FG000|Overall Study|Withdrawal by Subject|7|||
143473391|NCT02953639|517280864|FG001|Overall Study|Withdrawal by Subject|8|||
143473392|NCT02953639|517280865|FG002|Overall Study|Withdrawal by Subject|10|||
143473393|NCT02953639|517280863|FG000|Overall Study|Completed or Discontinued information is missing|1|||
143473394|NCT02953639|517280864|FG001|Overall Study|Completed or Discontinued information is missing|0|||
143473395|NCT02953639|517280865|FG002|Overall Study|Completed or Discontinued information is missing|0|||
143473396|NCT04196803|517280866|FG000|Overall Study|Withdrawal by Subject|1|||
143473397|NCT04196803|517280867|FG001|Overall Study|Withdrawal by Subject|3|||
143473398|NCT04196803|517280866|FG000|Overall Study|Adverse Event|4|||
143473399|NCT04196803|517280867|FG001|Overall Study|Adverse Event|2|||
143473400|NCT04196803|517280866|FG000|Overall Study|Lost to Follow-up|0|||
143473401|NCT04196803|517280867|FG001|Overall Study|Lost to Follow-up|1|||
143473402|NCT01022996|517280868|FG000|Overall Study|Adverse Event|14|||
143473403|NCT01022996|517280868|FG000|Overall Study|Withdrawal by Subject|3|||
143473404|NCT01022996|517280868|FG000|Overall Study|Lost to Follow-up|1|||
143473405|NCT01022996|517280868|FG000|Overall Study|Administrative problems|6|||
143473406|NCT01022996|517280868|FG000|Overall Study|Disease Progression|32|||
143142265|NCT02065557|516069275|FG005|Maintenance Period|Withdrawal by Subject|1|||
143142266|NCT02065557|516069270|FG000|Maintenance Period|Lack of Efficacy|0|||
143142267|NCT02065557|516069271|FG001|Maintenance Period|Lack of Efficacy|0|||
143142268|NCT02065557|516069272|FG002|Maintenance Period|Lack of Efficacy|0|||
143142269|NCT02065557|516069273|FG003|Maintenance Period|Lack of Efficacy|0|||
143142270|NCT02065557|516069274|FG004|Maintenance Period|Lack of Efficacy|5|||
143142271|NCT02065557|516069275|FG005|Maintenance Period|Lack of Efficacy|2|||
143142272|NCT02065557|516069270|FG000|Maintenance Period|Subject Non-Compliance|0|||
143362636|NCT01449929|516869782|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
143362637|NCT01449929|516869783|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
143362638|NCT01449929|516869781|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
143362639|NCT01449929|516869782|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
143362640|NCT01449929|516869783|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
143362641|NCT01449929|516869781|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
143362642|NCT01449929|516869782|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
143362643|NCT01449929|516869783|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
143362644|NCT01449929|516869781|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
143362645|NCT01449929|516869782|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
143362646|NCT01449929|516869783|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
143362647|NCT00231179|516871484|FG000|Overall Study|Lost to Follow-up|21|||
143362648|NCT00231179|516871485|FG001|Overall Study|Lost to Follow-up|21|||
143362649|NCT00231179|516871484|FG000|Overall Study|Withdrawal by Subject|3|||
143362650|NCT00231179|516871485|FG001|Overall Study|Withdrawal by Subject|3|||
143362651|NCT05406791|516871486|FG000|Overall Study|Lost to Follow-up|13|||
143362652|NCT05406791|516871487|FG001|Overall Study|Lost to Follow-up|10|||
143362653|NCT00367237|516871488|FG000|Overall Study|Adverse Event|7|||
143362654|NCT00367237|516871489|FG001|Overall Study|Adverse Event|2|||
143362655|NCT00367237|516871488|FG000|Overall Study|Lost to Follow-up|1|||
143362656|NCT00367237|516871489|FG001|Overall Study|Lost to Follow-up|0|||
143362657|NCT00367237|516871488|FG000|Overall Study|Withdrawal by Subject|0|||
143362658|NCT00367237|516871489|FG001|Overall Study|Withdrawal by Subject|4|||
143362659|NCT00367237|516871488|FG000|Overall Study|Protocol Violation|2|||
143362660|NCT00367237|516871489|FG001|Overall Study|Protocol Violation|5|||
143473407|NCT01022996|517280868|FG000|Overall Study|Protocol Violation|1|||
143473408|NCT00930722|517280869|FG000|Overall Study|Lost to Follow-up|16|||
143142273|NCT02065557|516069271|FG001|Maintenance Period|Subject Non-Compliance|0|||
143362661|NCT01403987|516871490|FG000|Overall Study|Residents forgot their secret PIN|18|||
143473409|NCT00930722|517280869|FG000|Overall Study|No longer willing to participate|9|||
143142274|NCT02065557|516069272|FG002|Maintenance Period|Subject Non-Compliance|0|||
143473410|NCT00930722|517280869|FG000|Overall Study|Study terminated by sponsor|2|||
143473411|NCT03523728|517280870|FG000|Stage 1 (24 Months)|Adverse Event|2|||
143473412|NCT03523728|517280871|FG001|Stage 1 (24 Months)|Adverse Event|2|||
143473413|NCT03523728|517280872|FG002|Stage 1 (24 Months)|Adverse Event|4|||
143473414|NCT03523728|517280873|FG003|Stage 1 (24 Months)|Adverse Event|0|||
143473415|NCT03523728|517280874|FG004|Stage 1 (24 Months)|Adverse Event|0|||
143473416|NCT03523728|517280870|FG000|Stage 1 (24 Months)|Progressive disease|0|||
143473417|NCT03523728|517280871|FG001|Stage 1 (24 Months)|Progressive disease|0|||
143473418|NCT03523728|517280872|FG002|Stage 1 (24 Months)|Progressive disease|1|||
143473419|NCT03523728|517280873|FG003|Stage 1 (24 Months)|Progressive disease|0|||
143473420|NCT03523728|517280874|FG004|Stage 1 (24 Months)|Progressive disease|0|||
143473421|NCT03523728|517280870|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
143142275|NCT02065557|516069273|FG003|Maintenance Period|Subject Non-Compliance|0|||
143142276|NCT02065557|516069274|FG004|Maintenance Period|Subject Non-Compliance|0|||
143142277|NCT02065557|516069275|FG005|Maintenance Period|Subject Non-Compliance|1|||
143142278|NCT01281306|516069279|FG000|Overall Study|Lack of Efficacy|0|||
143142279|NCT01281306|516069280|FG001|Overall Study|Lack of Efficacy|1|||
143142280|NCT01281306|516069281|FG002|Overall Study|Lack of Efficacy|3|||
143142281|NCT01281306|516069282|FG003|Overall Study|Lack of Efficacy|0|||
143142282|NCT01281306|516069283|FG004|Overall Study|Lack of Efficacy|2|||
143142283|NCT01281306|516069284|FG005|Overall Study|Lack of Efficacy|0|||
143142284|NCT01281306|516069285|FG006|Overall Study|Lack of Efficacy|1|||
143142285|NCT01281306|516069279|FG000|Overall Study|Withdrawal by Subject|1|||
143142286|NCT01281306|516069280|FG001|Overall Study|Withdrawal by Subject|0|||
143142287|NCT01281306|516069281|FG002|Overall Study|Withdrawal by Subject|2|||
143473422|NCT03523728|517280871|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
143473423|NCT03523728|517280872|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
143473424|NCT03523728|517280873|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
143473425|NCT03523728|517280874|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
143473426|NCT03523728|517280870|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
143473427|NCT03523728|517280871|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
143473428|NCT03523728|517280872|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
143473429|NCT03523728|517280873|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
143473430|NCT03523728|517280874|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
143473431|NCT03523728|517280870|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
143473432|NCT03523728|517280871|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
143473433|NCT03523728|517280872|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
143473434|NCT03523728|517280873|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
143473435|NCT03523728|517280874|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
143473436|NCT03523728|517280870|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
143473437|NCT03523728|517280871|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
143473438|NCT03523728|517280872|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
143473439|NCT03523728|517280873|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
143473440|NCT03523728|517280874|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
143473441|NCT03523728|517280870|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
143473442|NCT03523728|517280871|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
143473443|NCT03523728|517280872|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
143473444|NCT03523728|517280873|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
143473445|NCT03523728|517280874|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
143473446|NCT03523728|517280870|FG000|Stage 2 (24 Months)|Adverse Event|0|||
143473447|NCT03523728|517280871|FG001|Stage 2 (24 Months)|Adverse Event|0|||
143473448|NCT03523728|517280872|FG002|Stage 2 (24 Months)|Adverse Event|0|||
143473449|NCT03523728|517280873|FG003|Stage 2 (24 Months)|Adverse Event|1|||
143473450|NCT03523728|517280874|FG004|Stage 2 (24 Months)|Adverse Event|2|||
143473451|NCT03523728|517280870|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
143473452|NCT03523728|517280871|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
143473453|NCT03523728|517280872|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
143473454|NCT03523728|517280873|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
143473455|NCT03523728|517280874|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
143473456|NCT03523728|517280870|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
143142288|NCT01281306|516069282|FG003|Overall Study|Withdrawal by Subject|4|||
143473457|NCT03523728|517280871|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
143473458|NCT03523728|517280872|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
143473459|NCT03523728|517280873|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
143473460|NCT03523728|517280874|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
143473461|NCT03523728|517280870|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
143473462|NCT03523728|517280871|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
143473463|NCT03523728|517280872|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
143473464|NCT03523728|517280873|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
143473465|NCT03523728|517280874|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
143142289|NCT01281306|516069283|FG004|Overall Study|Withdrawal by Subject|1|||
143142290|NCT01281306|516069284|FG005|Overall Study|Withdrawal by Subject|3|||
143142291|NCT01281306|516069285|FG006|Overall Study|Withdrawal by Subject|1|||
143142292|NCT01281306|516069279|FG000|Overall Study|Protocol deviation|0|||
143142293|NCT01281306|516069280|FG001|Overall Study|Protocol deviation|1|||
143142294|NCT01281306|516069281|FG002|Overall Study|Protocol deviation|1|||
143142295|NCT01281306|516069282|FG003|Overall Study|Protocol deviation|1|||
143142296|NCT01281306|516069283|FG004|Overall Study|Protocol deviation|1|||
143473466|NCT03523728|517280870|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
143473467|NCT03523728|517280871|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
143473468|NCT03523728|517280872|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
143473469|NCT03523728|517280873|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
143473470|NCT03523728|517280874|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
143473471|NCT00621751|517280875|FG000|Overall Study|Adverse Event|0|||
143473472|NCT00621751|517280876|FG001|Overall Study|Adverse Event|1|||
143473473|NCT00419120|517280878|FG000|Long Term Follow up Period|study ongoing|10|||
143473474|NCT01950247|517280879|FG000|Overall Study|Withdrawal by Subject|28|||
143473475|NCT01950247|517280880|FG001|Overall Study|Withdrawal by Subject|13|||
143473476|NCT01950247|517280879|FG000|Overall Study|Lost to Follow-up|18|||
143473477|NCT01950247|517280880|FG001|Overall Study|Lost to Follow-up|16|||
143473478|NCT01950247|517280879|FG000|Overall Study|Physician Decision|3|||
143473479|NCT01950247|517280880|FG001|Overall Study|Physician Decision|4|||
143473480|NCT01950247|517280879|FG000|Overall Study|Adverse Event|3|||
143473481|NCT01950247|517280880|FG001|Overall Study|Adverse Event|2|||
143473482|NCT01950247|517280879|FG000|Overall Study|Death|1|||
143473483|NCT01950247|517280880|FG001|Overall Study|Death|1|||
143473484|NCT01950247|517280879|FG000|Overall Study|Not Defined|4|||
143473485|NCT01950247|517280880|FG001|Overall Study|Not Defined|10|||
143473486|NCT01798992|517280881|FG000|Overall Study|Administrative withdrawal|0|||
143473487|NCT01798992|517280882|FG001|Overall Study|Administrative withdrawal|1|||
143473488|NCT01798992|517280883|FG002|Overall Study|Administrative withdrawal|0|||
143473489|NCT01798992|517280884|FG003|Overall Study|Administrative withdrawal|1|||
143473490|NCT01798992|517280881|FG000|Overall Study|Lost to Follow-up|0|||
143473491|NCT01798992|517280882|FG001|Overall Study|Lost to Follow-up|1|||
143473492|NCT01798992|517280883|FG002|Overall Study|Lost to Follow-up|1|||
143473493|NCT01798992|517280884|FG003|Overall Study|Lost to Follow-up|0|||
143473494|NCT01798992|517280881|FG000|Overall Study|Insufficient biopsy tissue|0|||
143473495|NCT01798992|517280882|FG001|Overall Study|Insufficient biopsy tissue|0|||
143473496|NCT01798992|517280883|FG002|Overall Study|Insufficient biopsy tissue|1|||
143473497|NCT01798992|517280884|FG003|Overall Study|Insufficient biopsy tissue|0|||
143473498|NCT01069120|517280885|FG000|Overall Study|Study prematurely terminated|27|||
143473499|NCT00763971|517280886|FG000|Overall Study|Adverse Event|5|||
143473500|NCT00763971|517280887|FG001|Overall Study|Adverse Event|2|||
143473501|NCT00763971|517280888|FG002|Overall Study|Adverse Event|4|||
143362662|NCT01403987|516871491|FG001|Overall Study|Residents forgot their secret PIN|17|||
143362663|NCT01403987|516871492|FG002|Overall Study|Residents forgot their secret PIN|18|||
143362664|NCT01094743|516871493|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
143362665|NCT02851511|516871494|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
143362666|NCT02851511|516871495|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
143362667|NCT02851511|516871496|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
143362668|NCT02851511|516871497|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
143362669|NCT02851511|516871494|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
143362670|NCT02851511|516871495|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
143362671|NCT02851511|516871496|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
143362672|NCT02851511|516871497|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
143362673|NCT02851511|516871494|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
143362674|NCT02851511|516871495|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
143362675|NCT02851511|516871496|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
143362676|NCT02851511|516871497|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
143362677|NCT02851511|516871494|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
143362678|NCT02851511|516871495|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
143362679|NCT02851511|516871496|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
143362680|NCT02851511|516871497|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
143362681|NCT02851511|516871494|FG000|Phase I|Physician Decision|0|||
143362682|NCT02851511|516871495|FG001|Phase I|Physician Decision|0|||
143362683|NCT02851511|516871496|FG002|Phase I|Physician Decision|0|||
143362684|NCT02851511|516871497|FG003|Phase I|Physician Decision|1|||
143362685|NCT02851511|516871494|FG000|Phase I|Withdrawal by Subject|2|||
143362686|NCT02851511|516871495|FG001|Phase I|Withdrawal by Subject|1|||
143362687|NCT02851511|516871496|FG002|Phase I|Withdrawal by Subject|0|||
143362688|NCT02851511|516871497|FG003|Phase I|Withdrawal by Subject|3|||
143362689|NCT02851511|516871494|FG000|Phase II|Physician Decision|18|||
143362690|NCT02851511|516871495|FG001|Phase II|Physician Decision|16|||
143362691|NCT02851511|516871496|FG002|Phase II|Physician Decision|0|||
143362692|NCT02851511|516871497|FG003|Phase II|Physician Decision|0|||
143473502|NCT00763971|517280886|FG000|Overall Study|Protocol Violation|3|||
143473503|NCT00763971|517280887|FG001|Overall Study|Protocol Violation|3|||
143473504|NCT00763971|517280888|FG002|Overall Study|Protocol Violation|2|||
143473505|NCT00763971|517280886|FG000|Overall Study|Withdrawal by Subject|4|||
143473506|NCT00763971|517280887|FG001|Overall Study|Withdrawal by Subject|5|||
143473507|NCT00763971|517280888|FG002|Overall Study|Withdrawal by Subject|5|||
143473508|NCT00763971|517280886|FG000|Overall Study|Lost to Follow-up|0|||
143473509|NCT00763971|517280887|FG001|Overall Study|Lost to Follow-up|1|||
143473510|NCT00763971|517280888|FG002|Overall Study|Lost to Follow-up|0|||
143473511|NCT00763971|517280886|FG000|Overall Study|Lack of Efficacy|11|||
143473512|NCT00763971|517280887|FG001|Overall Study|Lack of Efficacy|22|||
143473513|NCT00763971|517280888|FG002|Overall Study|Lack of Efficacy|54|||
143473514|NCT00763971|517280886|FG000|Overall Study|Unable to swallow capsule|2|||
143473515|NCT00763971|517280887|FG001|Overall Study|Unable to swallow capsule|1|||
143473516|NCT00763971|517280888|FG002|Overall Study|Unable to swallow capsule|1|||
143473517|NCT00763971|517280886|FG000|Overall Study|Personal reason|3|||
143473518|NCT00763971|517280887|FG001|Overall Study|Personal reason|0|||
143473519|NCT00763971|517280888|FG002|Overall Study|Personal reason|0|||
143473520|NCT00763971|517280886|FG000|Overall Study|Exclusion criteria met|1|||
143473521|NCT00763971|517280887|FG001|Overall Study|Exclusion criteria met|0|||
143473522|NCT00763971|517280888|FG002|Overall Study|Exclusion criteria met|0|||
143473523|NCT00763971|517280886|FG000|Overall Study|Sponsor decision|1|||
143473524|NCT00763971|517280887|FG001|Overall Study|Sponsor decision|0|||
143473525|NCT00763971|517280888|FG002|Overall Study|Sponsor decision|0|||
143473526|NCT00763971|517280886|FG000|Overall Study|Due to holiday season|2|||
143473527|NCT00763971|517280887|FG001|Overall Study|Due to holiday season|0|||
143473528|NCT00763971|517280888|FG002|Overall Study|Due to holiday season|1|||
143473529|NCT00763971|517280886|FG000|Overall Study|Randomization error|0|||
143473530|NCT00763971|517280887|FG001|Overall Study|Randomization error|0|||
143473531|NCT00763971|517280888|FG002|Overall Study|Randomization error|1|||
143473532|NCT00763971|517280886|FG000|Overall Study|Medical monitor decision|0|||
143473533|NCT00763971|517280887|FG001|Overall Study|Medical monitor decision|0|||
143473534|NCT00763971|517280888|FG002|Overall Study|Medical monitor decision|1|||
143473535|NCT00763971|517280886|FG000|Overall Study|Moved to another country|0|||
143473536|NCT00763971|517280887|FG001|Overall Study|Moved to another country|1|||
143473537|NCT00763971|517280888|FG002|Overall Study|Moved to another country|0|||
143473538|NCT00763971|517280886|FG000|Overall Study|Subject wanted dose reduction|0|||
143473539|NCT00763971|517280887|FG001|Overall Study|Subject wanted dose reduction|1|||
143473540|NCT00763971|517280888|FG002|Overall Study|Subject wanted dose reduction|0|||
143473541|NCT00763971|517280886|FG000|Overall Study|Lack of availability|0|||
143473542|NCT00763971|517280887|FG001|Overall Study|Lack of availability|1|||
143473543|NCT00763971|517280888|FG002|Overall Study|Lack of availability|0|||
143473544|NCT00763971|517280886|FG000|Overall Study|Performed final visit on phone|0|||
143473545|NCT00763971|517280887|FG001|Overall Study|Performed final visit on phone|1|||
143473546|NCT00763971|517280888|FG002|Overall Study|Performed final visit on phone|0|||
143473547|NCT00763971|517280886|FG000|Overall Study|Participation in 489-326 required|1|||
143473548|NCT00763971|517280887|FG001|Overall Study|Participation in 489-326 required|0|||
143473549|NCT00763971|517280888|FG002|Overall Study|Participation in 489-326 required|0|||
143473550|NCT00710879|517280889|FG000|Overall Study|Lost to Follow-up|2|||
143473551|NCT00710879|517280890|FG001|Overall Study|Lost to Follow-up|1|||
143014083|NCT05354206|515591607|FG001|Overall Study|Withdrawal by Subject|0|||
143142297|NCT01281306|516069284|FG005|Overall Study|Protocol deviation|0|||
143142298|NCT01281306|516069285|FG006|Overall Study|Protocol deviation|0|||
143142299|NCT01281306|516069279|FG000|Overall Study|Condition no longer requires study drug|1|||
143142300|NCT01281306|516069280|FG001|Overall Study|Condition no longer requires study drug|0|||
143142301|NCT01281306|516069281|FG002|Overall Study|Condition no longer requires study drug|0|||
143142302|NCT01281306|516069282|FG003|Overall Study|Condition no longer requires study drug|0|||
143142303|NCT01281306|516069283|FG004|Overall Study|Condition no longer requires study drug|0|||
143142304|NCT01281306|516069284|FG005|Overall Study|Condition no longer requires study drug|1|||
143142305|NCT01281306|516069285|FG006|Overall Study|Condition no longer requires study drug|1|||
143142306|NCT01281306|516069279|FG000|Overall Study|Lost to Follow-up|1|||
143142307|NCT01281306|516069280|FG001|Overall Study|Lost to Follow-up|0|||
143142308|NCT01281306|516069281|FG002|Overall Study|Lost to Follow-up|0|||
143142309|NCT01281306|516069282|FG003|Overall Study|Lost to Follow-up|2|||
143142310|NCT01281306|516069283|FG004|Overall Study|Lost to Follow-up|0|||
143142311|NCT01281306|516069284|FG005|Overall Study|Lost to Follow-up|0|||
143142312|NCT01281306|516069285|FG006|Overall Study|Lost to Follow-up|1|||
143142313|NCT01281306|516069279|FG000|Overall Study|Death|1|||
143142314|NCT01281306|516069280|FG001|Overall Study|Death|0|||
143142315|NCT01281306|516069281|FG002|Overall Study|Death|0|||
143142316|NCT01281306|516069282|FG003|Overall Study|Death|0|||
143142317|NCT01281306|516069283|FG004|Overall Study|Death|0|||
143142318|NCT01281306|516069284|FG005|Overall Study|Death|0|||
143142319|NCT01281306|516069285|FG006|Overall Study|Death|0|||
143142320|NCT01281306|516069279|FG000|Overall Study|Adverse Event|3|||
143142321|NCT01281306|516069280|FG001|Overall Study|Adverse Event|2|||
143142322|NCT01281306|516069281|FG002|Overall Study|Adverse Event|2|||
143142323|NCT01281306|516069282|FG003|Overall Study|Adverse Event|3|||
143142324|NCT01281306|516069283|FG004|Overall Study|Adverse Event|5|||
143142325|NCT01281306|516069284|FG005|Overall Study|Adverse Event|3|||
143473552|NCT00710879|517280889|FG000|Overall Study|Protocol Violation|0|||
143473553|NCT00710879|517280890|FG001|Overall Study|Protocol Violation|3|||
143473554|NCT01516970|517280891|FG000|Overall Study|Lost to Follow-up|7|||
143473555|NCT01516970|517280892|FG001|Overall Study|Lost to Follow-up|8|||
143473556|NCT01516970|517280891|FG000|Overall Study|Adverse Event|1|||
143473557|NCT01516970|517280892|FG001|Overall Study|Adverse Event|5|||
143473558|NCT01516970|517280891|FG000|Overall Study|Withdrawal by Subject|1|||
143473559|NCT01516970|517280892|FG001|Overall Study|Withdrawal by Subject|1|||
143473560|NCT01516970|517280891|FG000|Overall Study|Other|9|||
143473561|NCT01516970|517280892|FG001|Overall Study|Other|7|||
143473562|NCT00434421|517280893|FG000|Overall Study|Withdrawal by Subject|1|||
143473563|NCT00434421|517280893|FG000|Overall Study|Non-compliance with study treatment|1|||
143473564|NCT01205438|517280894|FG000|Overall Study|Adverse Event|19|||
143473565|NCT01205438|517280895|FG001|Overall Study|Adverse Event|17|||
143473566|NCT01205438|517280896|FG002|Overall Study|Adverse Event|24|||
143473567|NCT01205438|517280894|FG000|Overall Study|Death|1|||
143473568|NCT01205438|517280895|FG001|Overall Study|Death|1|||
143473569|NCT01205438|517280896|FG002|Overall Study|Death|3|||
143473570|NCT01205438|517280894|FG000|Overall Study|Entry Criteria Not Met|16|||
143473571|NCT01205438|517280895|FG001|Overall Study|Entry Criteria Not Met|15|||
143473572|NCT01205438|517280896|FG002|Overall Study|Entry Criteria Not Met|13|||
143473573|NCT01205438|517280894|FG000|Overall Study|Lack of Efficacy|14|||
143473574|NCT01205438|517280895|FG001|Overall Study|Lack of Efficacy|11|||
143473575|NCT01205438|517280896|FG002|Overall Study|Lack of Efficacy|14|||
143473576|NCT01205438|517280894|FG000|Overall Study|Lost to Follow-up|6|||
143473577|NCT01205438|517280895|FG001|Overall Study|Lost to Follow-up|7|||
143473578|NCT01205438|517280896|FG002|Overall Study|Lost to Follow-up|8|||
143473579|NCT01205438|517280894|FG000|Overall Study|Withdrawal by Subject|19|||
143473580|NCT01205438|517280895|FG001|Overall Study|Withdrawal by Subject|25|||
143473581|NCT01205438|517280896|FG002|Overall Study|Withdrawal by Subject|19|||
143473582|NCT01205438|517280894|FG000|Overall Study|Physician Decision|0|||
143473583|NCT01205438|517280895|FG001|Overall Study|Physician Decision|3|||
143473584|NCT01205438|517280896|FG002|Overall Study|Physician Decision|2|||
143473585|NCT01205438|517280894|FG000|Overall Study|Protocol Violation|2|||
143473586|NCT01205438|517280895|FG001|Overall Study|Protocol Violation|7|||
143473587|NCT01205438|517280896|FG002|Overall Study|Protocol Violation|4|||
143473588|NCT01205438|517280894|FG000|Overall Study|Sponsor Decision|0|||
143473589|NCT01205438|517280895|FG001|Overall Study|Sponsor Decision|1|||
143473590|NCT01205438|517280896|FG002|Overall Study|Sponsor Decision|1|||
143473591|NCT03823404|517280897|FG000|Overall Study|Lost to Follow-up|1|||
143473592|NCT03823404|517280898|FG001|Overall Study|Lost to Follow-up|2|||
143473593|NCT03823404|517280899|FG002|Overall Study|Lost to Follow-up|3|||
143473594|NCT03823404|517280897|FG000|Overall Study|Protocol Violation|2|||
143473595|NCT03823404|517280898|FG001|Overall Study|Protocol Violation|0|||
143473596|NCT03823404|517280899|FG002|Overall Study|Protocol Violation|2|||
143473597|NCT03823404|517280897|FG000|Overall Study|Adverse Event|35|||
143473598|NCT03823404|517280898|FG001|Overall Study|Adverse Event|38|||
143473599|NCT03823404|517280899|FG002|Overall Study|Adverse Event|8|||
143473600|NCT03823404|517280897|FG000|Overall Study|Withdrawal by Subject|38|||
143473601|NCT03823404|517280898|FG001|Overall Study|Withdrawal by Subject|40|||
143473602|NCT03823404|517280899|FG002|Overall Study|Withdrawal by Subject|35|||
143473603|NCT03823404|517280897|FG000|Overall Study|Death|4|||
143473604|NCT03823404|517280898|FG001|Overall Study|Death|0|||
143473605|NCT03823404|517280899|FG002|Overall Study|Death|0|||
143473606|NCT03823404|517280897|FG000|Overall Study|Other: Various reasons provided|5|||
143473607|NCT03823404|517280898|FG001|Overall Study|Other: Various reasons provided|5|||
143473608|NCT03823404|517280899|FG002|Overall Study|Other: Various reasons provided|6|||
143473609|NCT03631667|517280907|FG000|Overall Study|Withdrawal by Subject|3|||
143473610|NCT03383289|517280910|FG000|Overall Study|Death|83|||
143473611|NCT03383289|517280911|FG001|Overall Study|Death|78|||
143473612|NCT03383289|517280910|FG000|Overall Study|discharge from facility|84|||
143473613|NCT03383289|517280911|FG001|Overall Study|discharge from facility|84|||
143142326|NCT01281306|516069285|FG006|Overall Study|Adverse Event|3|||
143142327|NCT01281306|516069279|FG000|Overall Study|Randomized in error|1|||
143473614|NCT03383289|517280910|FG000|Overall Study|Withdrawal by Subject|4|||
143473615|NCT03383289|517280911|FG001|Overall Study|Withdrawal by Subject|1|||
143473616|NCT00884325|517280912|FG000|Overall Study|Lost to Follow-up|1|||
143473617|NCT00884325|517280913|FG001|Overall Study|Lost to Follow-up|2|||
143473618|NCT00884325|517280912|FG000|Overall Study|Lack of Efficacy|0|||
143473619|NCT00884325|517280913|FG001|Overall Study|Lack of Efficacy|1|||
143473620|NCT00884325|517280912|FG000|Overall Study|Withdrawal by Subject|1|||
143473621|NCT00884325|517280913|FG001|Overall Study|Withdrawal by Subject|1|||
143473622|NCT00884325|517280912|FG000|Overall Study|Not provided|1|||
143473623|NCT00884325|517280913|FG001|Overall Study|Not provided|0|||
143473624|NCT00832117|517280914|FG000|Overall Study|Death|1|||
143473625|NCT00832117|517280914|FG000|Overall Study|Disease Progression|11|||
143473626|NCT04439071|517280915|FG000|Overall Study|Lost to Follow-up|0|||
143473627|NCT04439071|517280916|FG001|Overall Study|Lost to Follow-up|3|||
143473628|NCT04439071|517280915|FG000|Overall Study|Withdrawal by Subject|3|||
143473629|NCT04439071|517280916|FG001|Overall Study|Withdrawal by Subject|8|||
143142328|NCT01281306|516069280|FG001|Overall Study|Randomized in error|0|||
143473630|NCT04439071|517280915|FG000|Overall Study|Death|6|||
143473631|NCT04439071|517280916|FG001|Overall Study|Death|4|||
143473632|NCT04439071|517280915|FG000|Overall Study|Other than specified|3|||
143473633|NCT04439071|517280916|FG001|Overall Study|Other than specified|3|||
143473634|NCT04439071|517280915|FG000|Overall Study|Randomized but not treated|2|||
143473635|NCT04439071|517280916|FG001|Overall Study|Randomized but not treated|0|||
143473636|NCT00892177|517280917|FG000|Phase II|Ineligible|0|||
143473637|NCT00892177|517280918|FG001|Phase II|Ineligible|0|||
143473638|NCT00892177|517280919|FG002|Phase II|Ineligible|0|||
143473639|NCT00892177|517280920|FG003|Phase II|Ineligible|0|||
143473640|NCT00892177|517280921|FG004|Phase II|Ineligible|1|||
143473641|NCT00892177|517280922|FG005|Phase II|Ineligible|1|||
143473642|NCT00892177|517280917|FG000|Phase II|Withdrawal by Subject|0|||
143473643|NCT00892177|517280918|FG001|Phase II|Withdrawal by Subject|0|||
143473644|NCT00892177|517280919|FG002|Phase II|Withdrawal by Subject|0|||
143473645|NCT00892177|517280920|FG003|Phase II|Withdrawal by Subject|0|||
143473646|NCT00892177|517280921|FG004|Phase II|Withdrawal by Subject|4|||
143473647|NCT00892177|517280922|FG005|Phase II|Withdrawal by Subject|1|||
143473648|NCT01087957|517280931|FG000|Overall Study|Death|2|||
143473649|NCT01087957|517280932|FG001|Overall Study|Death|2|||
143473650|NCT01087957|517280931|FG000|Overall Study|Lost to Follow-up|3|||
143473651|NCT01087957|517280932|FG001|Overall Study|Lost to Follow-up|4|||
143473652|NCT01087957|517280931|FG000|Overall Study|Protocol Violation|13|||
143473653|NCT01087957|517280932|FG001|Overall Study|Protocol Violation|25|||
143473654|NCT01087957|517280931|FG000|Overall Study|Withdrawal by Subject|18|||
143473655|NCT01087957|517280932|FG001|Overall Study|Withdrawal by Subject|15|||
143473656|NCT01087957|517280931|FG000|Overall Study|Physician Decision|5|||
143473657|NCT01087957|517280932|FG001|Overall Study|Physician Decision|9|||
143473658|NCT01186939|517280933|FG000|Overall Study|Death|7|||
143473659|NCT01186939|517280933|FG000|Overall Study|Withdrawal by Subject|2|||
143473660|NCT01186939|517280933|FG000|Overall Study|No longer receiving clinical benefit|17|||
143473661|NCT01186939|517280933|FG000|Overall Study|Program closed|5|||
143473662|NCT01186939|517280933|FG000|Overall Study|Sponsor decision|4|||
143473663|NCT01186939|517280933|FG000|Overall Study|Started additional treatment|1|||
143473664|NCT01186939|517280933|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
143473665|NCT01186939|517280933|FG000|Overall Study|Myocardial infarction|1|||
143473666|NCT01186939|517280933|FG000|Overall Study|Bone marrow transplant|1|||
143473667|NCT01186939|517280933|FG000|Overall Study|Transformation to AML|1|||
143473668|NCT03945591|517280934|FG000|Overall Study|Participant not transplanted|1|||
143473669|NCT03945591|517280934|FG000|Overall Study|Change in treatment plan|3|||
143473670|NCT03945591|517280934|FG000|Overall Study|Adverse Event|1|||
143473671|NCT00375219|517280938|FG000|Overall Study|Failure to achieve a response|16|||
143473672|NCT00375219|517280939|FG001|Overall Study|Failure to achieve a response|2|||
143473673|NCT00375219|517280940|FG002|Overall Study|Failure to achieve a response|0|||
143473674|NCT00375219|517280938|FG000|Overall Study|Adverse Event|8|||
143473675|NCT00375219|517280939|FG001|Overall Study|Adverse Event|2|||
143473676|NCT00375219|517280940|FG002|Overall Study|Adverse Event|1|||
143473677|NCT00375219|517280938|FG000|Overall Study|Protocol Violation|1|||
143473678|NCT00375219|517280939|FG001|Overall Study|Protocol Violation|0|||
143473679|NCT00375219|517280940|FG002|Overall Study|Protocol Violation|1|||
143473680|NCT00375219|517280938|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
143473681|NCT00375219|517280939|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
143473682|NCT00375219|517280940|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
143473683|NCT00375219|517280938|FG000|Overall Study|Lost to Follow-up|1|||
143473684|NCT00375219|517280939|FG001|Overall Study|Lost to Follow-up|1|||
143473685|NCT00375219|517280940|FG002|Overall Study|Lost to Follow-up|0|||
143473686|NCT00375219|517280938|FG000|Overall Study|Disease progression|18|||
143473687|NCT00375219|517280939|FG001|Overall Study|Disease progression|9|||
143473688|NCT00375219|517280940|FG002|Overall Study|Disease progression|12|||
143473689|NCT00375219|517280938|FG000|Overall Study|Death|4|||
143142329|NCT01281306|516069281|FG002|Overall Study|Randomized in error|0|||
143142330|NCT01281306|516069282|FG003|Overall Study|Randomized in error|1|||
143142331|NCT01281306|516069283|FG004|Overall Study|Randomized in error|0|||
143142332|NCT01281306|516069284|FG005|Overall Study|Randomized in error|0|||
143473690|NCT00375219|517280939|FG001|Overall Study|Death|3|||
143473691|NCT00375219|517280940|FG002|Overall Study|Death|7|||
143473692|NCT00375219|517280938|FG000|Overall Study|Hematologic resistance|1|||
143473693|NCT00375219|517280939|FG001|Overall Study|Hematologic resistance|0|||
143473694|NCT00375219|517280940|FG002|Overall Study|Hematologic resistance|0|||
143473695|NCT00375219|517280938|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
143473696|NCT00375219|517280939|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
143473697|NCT00375219|517280940|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
143014084|NCT01414062|515591608|FG000|Overall Study|Lost to Follow-up|3|||
143473698|NCT00375219|517280938|FG000|Overall Study|Allograft|2|||
143473699|NCT00375219|517280939|FG001|Overall Study|Allograft|0|||
143473700|NCT00375219|517280940|FG002|Overall Study|Allograft|0|||
143473701|NCT00375219|517280938|FG000|Overall Study|Cord blood transplantation|1|||
143473702|NCT00375219|517280939|FG001|Overall Study|Cord blood transplantation|0|||
143473703|NCT00375219|517280940|FG002|Overall Study|Cord blood transplantation|0|||
143473704|NCT00375219|517280938|FG000|Overall Study|Withdrawal by Subject|1|||
143473705|NCT00375219|517280939|FG001|Overall Study|Withdrawal by Subject|0|||
143473706|NCT00375219|517280940|FG002|Overall Study|Withdrawal by Subject|0|||
143473707|NCT01667107|517280941|FG000|Overall Study|Adverse Event|4|||
143473708|NCT01667107|517280942|FG001|Overall Study|Adverse Event|3|||
143473709|NCT01667107|517280941|FG000|Overall Study|Tolerability issues|0|||
143473710|NCT01667107|517280942|FG001|Overall Study|Tolerability issues|2|||
143473711|NCT01667107|517280941|FG000|Overall Study|Protocol Violation|0|||
143473712|NCT01667107|517280942|FG001|Overall Study|Protocol Violation|1|||
143473713|NCT01667107|517280941|FG000|Overall Study|Lack of Efficacy|0|||
143473714|NCT01667107|517280942|FG001|Overall Study|Lack of Efficacy|1|||
143473715|NCT01162239|517280945|FG000|Treatment Phase|Withdrawal by Subject|1|||
143473716|NCT01162239|517280946|FG001|Treatment Phase|Withdrawal by Subject|3|||
143473717|NCT01162239|517280947|FG002|Treatment Phase|Withdrawal by Subject|2|||
143473718|NCT01162239|517280948|FG003|Treatment Phase|Withdrawal by Subject|3|||
143142333|NCT01281306|516069285|FG006|Overall Study|Randomized in error|0|||
143142334|NCT03185208|516069286|FG000|Overall Study|Did not start study medication|0|||
143142335|NCT03185208|516069287|FG001|Overall Study|Did not start study medication|3|||
143142336|NCT02410629|516069288|FG000|Overall Study|Family cannot commit to the study|2|||
143473719|NCT01162239|517280945|FG000|Treatment Phase|Death|0|||
143473720|NCT01162239|517280946|FG001|Treatment Phase|Death|0|||
143473721|NCT01162239|517280947|FG002|Treatment Phase|Death|0|||
143473722|NCT01162239|517280948|FG003|Treatment Phase|Death|1|||
143473723|NCT01162239|517280945|FG000|Treatment Phase|Lost to Follow-up|5|||
143473724|NCT01162239|517280946|FG001|Treatment Phase|Lost to Follow-up|4|||
143473725|NCT01162239|517280947|FG002|Treatment Phase|Lost to Follow-up|2|||
143473726|NCT01162239|517280948|FG003|Treatment Phase|Lost to Follow-up|1|||
143473727|NCT01162239|517280945|FG000|Extended Follow-up|Lost to Follow-up|8|||
143473728|NCT01162239|517280946|FG001|Extended Follow-up|Lost to Follow-up|13|||
143473729|NCT01162239|517280947|FG002|Extended Follow-up|Lost to Follow-up|8|||
143473730|NCT01162239|517280948|FG003|Extended Follow-up|Lost to Follow-up|6|||
143473731|NCT02877927|517280951|FG000|Overall Study|Adverse Event|1|||
143473732|NCT02877927|517280952|FG001|Overall Study|Adverse Event|0|||
143473733|NCT02877927|517280951|FG000|Overall Study|Lost to Follow-up|37|||
143473734|NCT02877927|517280952|FG001|Overall Study|Lost to Follow-up|38|||
143473735|NCT02877927|517280951|FG000|Overall Study|Withdrawal by Subject|11|||
143473736|NCT02877927|517280952|FG001|Overall Study|Withdrawal by Subject|12|||
143473737|NCT02877927|517280951|FG000|Overall Study|Physician Decision|0|||
143473738|NCT02877927|517280952|FG001|Overall Study|Physician Decision|1|||
143473739|NCT02877927|517280951|FG000|Overall Study|Missed EOT/PTE Visit|5|||
143473740|NCT02877927|517280952|FG001|Overall Study|Missed EOT/PTE Visit|6|||
143473741|NCT00601250|517280953|FG000|Overall Study|Adverse Event|3|||
143473742|NCT00601250|517280954|FG001|Overall Study|Adverse Event|9|||
143473743|NCT00601250|517280953|FG000|Overall Study|Protocol Violation|3|||
143473744|NCT00601250|517280954|FG001|Overall Study|Protocol Violation|2|||
143473745|NCT00601250|517280953|FG000|Overall Study|Lost to Follow-up|2|||
143473746|NCT00601250|517280954|FG001|Overall Study|Lost to Follow-up|6|||
143473747|NCT00601250|517280953|FG000|Overall Study|Withdrawal by Subject|4|||
143473748|NCT00601250|517280954|FG001|Overall Study|Withdrawal by Subject|13|||
143473749|NCT00601250|517280953|FG000|Overall Study|Other incl. lack of efficacy|2|||
143473750|NCT00601250|517280954|FG001|Overall Study|Other incl. lack of efficacy|9|||
143473751|NCT01810016|517280955|FG000|Overall Study|Progressive disease|1|||
143473752|NCT01810016|517280956|FG001|Overall Study|Progressive disease|1|||
143473753|NCT01810016|517280957|FG002|Overall Study|Progressive disease|0|||
143473754|NCT01810016|517280955|FG000|Overall Study|Death|0|||
143473755|NCT01810016|517280956|FG001|Overall Study|Death|0|||
143473756|NCT01810016|517280957|FG002|Overall Study|Death|1|||
143142337|NCT02410629|516069289|FG001|Overall Study|Family cannot commit to the study|1|||
143142338|NCT02410629|516069288|FG000|Overall Study|Subject returned to work|1|||
143142339|NCT02410629|516069289|FG001|Overall Study|Subject returned to work|0|||
143142340|NCT02410629|516069288|FG000|Overall Study|Subject moved back to home country|0|||
143142341|NCT02410629|516069289|FG001|Overall Study|Subject moved back to home country|1|||
143142342|NCT02410629|516069288|FG000|Overall Study|Subject underwent heart surgery|0|||
143142343|NCT02410629|516069289|FG001|Overall Study|Subject underwent heart surgery|1|||
143142344|NCT02701634|516069290|FG000|Overall Study|Adverse Event|2|||
143142345|NCT02701634|516069291|FG001|Overall Study|Adverse Event|3|||
143142346|NCT02701634|516069290|FG000|Overall Study|Death|1|||
143473757|NCT04223791|517280962|FG000|Overall Study|Lost to Follow-up|0|||
143473758|NCT04223791|517280963|FG001|Overall Study|Lost to Follow-up|4|||
143473759|NCT04223791|517280962|FG000|Overall Study|Physician Decision|5|||
143473760|NCT04223791|517280963|FG001|Overall Study|Physician Decision|1|||
143473761|NCT04223791|517280962|FG000|Overall Study|Protocol Violation|1|||
143473762|NCT04223791|517280963|FG001|Overall Study|Protocol Violation|1|||
143473763|NCT04223791|517280962|FG000|Overall Study|Withdrawal by Subject|10|||
143142347|NCT02701634|516069291|FG001|Overall Study|Death|0|||
143473764|NCT04223791|517280963|FG001|Overall Study|Withdrawal by Subject|12|||
143473765|NCT04223791|517280962|FG000|Overall Study|Pregnancy|1|||
143473766|NCT04223791|517280963|FG001|Overall Study|Pregnancy|1|||
143473767|NCT04223791|517280962|FG000|Overall Study|Ongoing in Study|305|||
143473768|NCT04223791|517280963|FG001|Overall Study|Ongoing in Study|302|||
143473769|NCT00698204|517282424|FG000|Overall Study|Withdrawal by Subject|1|||
143473770|NCT00698204|517282425|FG001|Overall Study|Withdrawal by Subject|0|||
143473771|NCT01179672|517282426|FG000|Overall Study|Adverse Event|17|||
143473772|NCT01179672|517282427|FG001|Overall Study|Adverse Event|8|||
143473773|NCT01179672|517282426|FG000|Overall Study|Withdrawal by Subject|10|||
143473774|NCT01179672|517282427|FG001|Overall Study|Withdrawal by Subject|12|||
143473775|NCT01179672|517282426|FG000|Overall Study|Entry Criteria Not Met|0|||
143473776|NCT01179672|517282427|FG001|Overall Study|Entry Criteria Not Met|2|||
143473777|NCT01179672|517282426|FG000|Overall Study|Lost to Follow-up|0|||
143473778|NCT01179672|517282427|FG001|Overall Study|Lost to Follow-up|1|||
143473779|NCT01179672|517282426|FG000|Overall Study|Protocol Violation|2|||
143473780|NCT01179672|517282427|FG001|Overall Study|Protocol Violation|2|||
143473781|NCT01179672|517282426|FG000|Overall Study|Physician Decision|1|||
143473782|NCT01179672|517282427|FG001|Overall Study|Physician Decision|1|||
143473783|NCT00314249|517282429|FG000|Overall Study|Adverse Event|73|||
143473784|NCT00314249|517282430|FG001|Overall Study|Adverse Event|94|||
143473785|NCT00314249|517282429|FG000|Overall Study|Lack of Efficacy|33|||
143473786|NCT00314249|517282430|FG001|Overall Study|Lack of Efficacy|24|||
143473787|NCT00314249|517282429|FG000|Overall Study|Withdrawal by Subject|21|||
143473788|NCT00314249|517282430|FG001|Overall Study|Withdrawal by Subject|28|||
143473789|NCT00314249|517282429|FG000|Overall Study|Lost to Follow-up|15|||
143473790|NCT00314249|517282430|FG001|Overall Study|Lost to Follow-up|9|||
143473791|NCT00314249|517282429|FG000|Overall Study|Physician Decision|1|||
143473792|NCT00314249|517282430|FG001|Overall Study|Physician Decision|1|||
143473793|NCT00314249|517282429|FG000|Overall Study|Withdrawn for other reasons|4|||
143473794|NCT00314249|517282430|FG001|Overall Study|Withdrawn for other reasons|1|||
143473795|NCT00314249|517282429|FG000|Overall Study|Non-Compliant|5|||
143473796|NCT00314249|517282430|FG001|Overall Study|Non-Compliant|6|||
143473797|NCT01949155|517282431|FG000|Overall Study|Lost to Follow-up|1|||
143473798|NCT01949155|517282432|FG001|Overall Study|Lost to Follow-up|0|||
143473799|NCT01949155|517282431|FG000|Overall Study|Protocol Violation|1|||
143473800|NCT01949155|517282432|FG001|Overall Study|Protocol Violation|0|||
143473801|NCT00210184|517282433|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
143473802|NCT03334409|517282434|FG000|Overall Study|Did not meet inclusion criteria|1|||
143473803|NCT03334409|517282435|FG001|Overall Study|Did not meet inclusion criteria|0|||
143473804|NCT00975715|517282436|FG000|Titration Period|Adverse Event|6|||
143473805|NCT00975715|517282437|FG001|Titration Period|Adverse Event|0|||
143473806|NCT00975715|517282436|FG000|Titration Period|Protocol Violation|1|||
143473807|NCT00975715|517282437|FG001|Titration Period|Protocol Violation|0|||
143473808|NCT00975715|517282436|FG000|Maintenance Period|Adverse Event|2|||
143473809|NCT00975715|517282437|FG001|Maintenance Period|Adverse Event|1|||
143473810|NCT01674712|517282442|FG000|Overall Study|Adverse Event|5|||
143473811|NCT01674712|517282443|FG001|Overall Study|Adverse Event|6|||
143473812|NCT01674712|517282444|FG002|Overall Study|Adverse Event|3|||
143473813|NCT01674712|517282445|FG003|Overall Study|Adverse Event|4|||
143473814|NCT01674712|517282446|FG004|Overall Study|Adverse Event|6|||
143473815|NCT01674712|517282442|FG000|Overall Study|Lost to Follow-up|1|||
143473816|NCT01674712|517282443|FG001|Overall Study|Lost to Follow-up|0|||
143473817|NCT01674712|517282444|FG002|Overall Study|Lost to Follow-up|0|||
143473818|NCT01674712|517282445|FG003|Overall Study|Lost to Follow-up|0|||
143473819|NCT01674712|517282446|FG004|Overall Study|Lost to Follow-up|0|||
143473820|NCT01674712|517282442|FG000|Overall Study|Protocol Violation|2|||
143473821|NCT01674712|517282443|FG001|Overall Study|Protocol Violation|0|||
143473822|NCT01674712|517282444|FG002|Overall Study|Protocol Violation|0|||
143473823|NCT01674712|517282445|FG003|Overall Study|Protocol Violation|0|||
143473824|NCT01674712|517282446|FG004|Overall Study|Protocol Violation|0|||
143473825|NCT01674712|517282442|FG000|Overall Study|Withdrawal by Subject|2|||
143014085|NCT01414062|515591609|FG001|Overall Study|Lost to Follow-up|2|||
143142348|NCT02701634|516069290|FG000|Overall Study|Investigator's Discretion|7|||
143142349|NCT02701634|516069291|FG001|Overall Study|Investigator's Discretion|4|||
143142350|NCT02701634|516069290|FG000|Overall Study|Study terminated by Sponsor|15|||
143142351|NCT02701634|516069291|FG001|Overall Study|Study terminated by Sponsor|17|||
143142352|NCT02701634|516069290|FG000|Overall Study|Withdrew Consent|6|||
143142353|NCT02701634|516069291|FG001|Overall Study|Withdrew Consent|7|||
143142354|NCT02701634|516069290|FG000|Overall Study|Randomized but not treated|1|||
143473826|NCT01674712|517282443|FG001|Overall Study|Withdrawal by Subject|2|||
143473827|NCT01674712|517282444|FG002|Overall Study|Withdrawal by Subject|5|||
143473828|NCT01674712|517282445|FG003|Overall Study|Withdrawal by Subject|4|||
143473829|NCT01674712|517282446|FG004|Overall Study|Withdrawal by Subject|3|||
143473830|NCT01674712|517282442|FG000|Overall Study|Administrative|0|||
143473831|NCT01674712|517282443|FG001|Overall Study|Administrative|1|||
143473832|NCT01674712|517282444|FG002|Overall Study|Administrative|0|||
143473833|NCT01674712|517282445|FG003|Overall Study|Administrative|0|||
143473834|NCT01674712|517282446|FG004|Overall Study|Administrative|1|||
143473835|NCT01674712|517282442|FG000|Overall Study|Lack of Efficacy|0|||
143473836|NCT01674712|517282443|FG001|Overall Study|Lack of Efficacy|0|||
143473837|NCT01674712|517282444|FG002|Overall Study|Lack of Efficacy|1|||
143473838|NCT01674712|517282445|FG003|Overall Study|Lack of Efficacy|0|||
143473839|NCT01674712|517282446|FG004|Overall Study|Lack of Efficacy|1|||
143473840|NCT04004429|517282447|FG000|Overall Study|Protocol Violation|1|||
143473841|NCT04004429|517282448|FG001|Overall Study|Protocol Violation|0|||
143473842|NCT04004429|517282449|FG002|Overall Study|Protocol Violation|0|||
143473843|NCT04004429|517282447|FG000|Overall Study|Physician Decision|0|||
143473844|NCT04004429|517282448|FG001|Overall Study|Physician Decision|1|||
143473845|NCT04004429|517282449|FG002|Overall Study|Physician Decision|1|||
143473846|NCT04004429|517282447|FG000|Overall Study|Withdrawal by Subject|1|||
143473847|NCT04004429|517282448|FG001|Overall Study|Withdrawal by Subject|1|||
143473848|NCT04004429|517282449|FG002|Overall Study|Withdrawal by Subject|1|||
143473849|NCT02606461|517282450|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
143473850|NCT02606461|517282451|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
143473851|NCT02606461|517282452|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
143142355|NCT02701634|516069291|FG001|Overall Study|Randomized but not treated|0|||
143142356|NCT01206764|516069292|FG000|Overall Study|Adverse Event|20|||
143142357|NCT01206764|516069292|FG000|Overall Study|Abnormal laboratory value|2|||
143142358|NCT01206764|516069292|FG000|Overall Study|Abnormal test procedure result|1|||
143142359|NCT01206764|516069292|FG000|Overall Study|Patient withdrew consent|5|||
143142360|NCT01206764|516069292|FG000|Overall Study|Lost to Follow-up|6|||
143142361|NCT01206764|516069292|FG000|Overall Study|Death|11|||
143362693|NCT02851511|516871494|FG000|Phase II|Withdrawal by Subject|18|||
143142362|NCT01206764|516069292|FG000|Overall Study|New cancer therapy|2|||
143362694|NCT02851511|516871495|FG001|Phase II|Withdrawal by Subject|16|||
143362695|NCT02851511|516871496|FG002|Phase II|Withdrawal by Subject|0|||
143362696|NCT02851511|516871497|FG003|Phase II|Withdrawal by Subject|0|||
143362697|NCT02851511|516871494|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
143362698|NCT02851511|516871495|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
143362699|NCT02851511|516871496|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
143362700|NCT02851511|516871497|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
143362701|NCT02851511|516871494|FG000|Phase II|Lost to Follow-up|0|||
143362702|NCT02851511|516871495|FG001|Phase II|Lost to Follow-up|1|||
143362703|NCT02851511|516871496|FG002|Phase II|Lost to Follow-up|0|||
143362704|NCT02851511|516871497|FG003|Phase II|Lost to Follow-up|0|||
143362705|NCT00303303|516871498|FG000|Overall Study|Withdrawal by Subject|0|||
143362706|NCT00303303|516871499|FG001|Overall Study|Withdrawal by Subject|0|||
143362707|NCT00303303|516871500|FG002|Overall Study|Withdrawal by Subject|1|||
143362708|NCT03255941|516871502|FG000|Overall Study|Not eligible or refused injection|37|||
143362709|NCT03255941|516871503|FG001|Overall Study|Not eligible or refused injection|44|||
143362710|NCT03255941|516871504|FG002|Overall Study|Not eligible or refused injection|5|||
143362711|NCT03255941|516871505|FG003|Overall Study|Not eligible or refused injection|6|||
143362712|NCT03255941|516871502|FG000|Overall Study|Did not complete exit interview|1|||
143362713|NCT03255941|516871503|FG001|Overall Study|Did not complete exit interview|2|||
143362714|NCT03255941|516871504|FG002|Overall Study|Did not complete exit interview|0|||
143362715|NCT03255941|516871505|FG003|Overall Study|Did not complete exit interview|0|||
143362716|NCT01417000|516871506|FG000|Overall Study|Death|59|||
143362717|NCT01417000|516871507|FG001|Overall Study|Death|28|||
143362718|NCT01417000|516871506|FG000|Overall Study|Lost to Follow-up|1|||
143362719|NCT01417000|516871507|FG001|Overall Study|Lost to Follow-up|0|||
143362720|NCT01417000|516871506|FG000|Overall Study|Study Terminated by Sponsor|1|||
143362721|NCT01417000|516871507|FG001|Overall Study|Study Terminated by Sponsor|1|||
143362722|NCT00958009|516871508|FG000|Overall Study|Adverse Event|1|||
143362723|NCT00958009|516871508|FG000|Overall Study|Subject found device difficult to use|1|||
143362724|NCT01813422|516871512|FG000|Overall Study|Withdrawal by Subject|14|||
143362725|NCT01813422|516871513|FG001|Overall Study|Withdrawal by Subject|8|||
143362726|NCT01813422|516871512|FG000|Overall Study|Death|2|||
143362727|NCT01813422|516871513|FG001|Overall Study|Death|3|||
143362728|NCT01813422|516871512|FG000|Overall Study|Sponsor Decision|2|||
143362729|NCT01813422|516871513|FG001|Overall Study|Sponsor Decision|1|||
143362730|NCT01813422|516871512|FG000|Overall Study|Lost to Follow-up|2|||
143362731|NCT01813422|516871513|FG001|Overall Study|Lost to Follow-up|4|||
143362732|NCT00558753|516871520|FG000|Overall Study|Lost to Follow-up|5|||
143362733|NCT00558753|516871521|FG001|Overall Study|Lost to Follow-up|7|||
143362734|NCT00797225|516871524|FG000|Weeks 1 to 12|Adverse Event|0|||
143362735|NCT00797225|516871525|FG001|Weeks 1 to 12|Adverse Event|0|||
143362736|NCT00797225|516871526|FG002|Weeks 1 to 12|Adverse Event|1|||
143362737|NCT00797225|516871527|FG003|Weeks 1 to 12|Adverse Event|0|||
143362738|NCT00797225|516871528|FG004|Weeks 1 to 12|Adverse Event|0|||
143362739|NCT00797225|516871529|FG005|Weeks 1 to 12|Adverse Event|0|||
143362740|NCT00797225|516871530|FG006|Weeks 1 to 12|Adverse Event|0|||
143362741|NCT00797225|516871531|FG007|Weeks 1 to 12|Adverse Event|0|||
143362742|NCT00797225|516871524|FG000|Weeks 1 to 12|Non-compliance|0|||
143362743|NCT00797225|516871525|FG001|Weeks 1 to 12|Non-compliance|1|||
143362744|NCT00797225|516871526|FG002|Weeks 1 to 12|Non-compliance|0|||
143362745|NCT00797225|516871527|FG003|Weeks 1 to 12|Non-compliance|0|||
143142363|NCT01206764|516069292|FG000|Overall Study|Disease progression|88|||
143142364|NCT01206764|516069292|FG000|Overall Study|Protocol deviation|3|||
143142365|NCT05853120|516069295|FG000|Overall Study|Lost to Follow-up|4|||
143142366|NCT05853120|516069296|FG001|Overall Study|Lost to Follow-up|4|||
143142367|NCT05853120|516069295|FG000|Overall Study|Physician Decision|3|||
143142368|NCT05853120|516069296|FG001|Overall Study|Physician Decision|0|||
143142369|NCT05853120|516069295|FG000|Overall Study|Withdrawal by Subject|5|||
143142370|NCT05853120|516069296|FG001|Overall Study|Withdrawal by Subject|2|||
143142371|NCT00465517|516069302|FG000|Overall Study|Adverse Event|7|||
143142372|NCT00465517|516069303|FG001|Overall Study|Adverse Event|3|||
143142373|NCT00465517|516069302|FG000|Overall Study|Lost to Follow-up|1|||
143142374|NCT00465517|516069303|FG001|Overall Study|Lost to Follow-up|0|||
143142375|NCT00465517|516069302|FG000|Overall Study|Withdrawal by Subject|4|||
143142376|NCT00465517|516069303|FG001|Overall Study|Withdrawal by Subject|1|||
143142377|NCT00071981|516069305|FG000|Overall Study|Lack of Efficacy|37|||
143142378|NCT00071981|516069306|FG001|Overall Study|Lack of Efficacy|29|||
143142379|NCT00071981|516069307|FG002|Overall Study|Lack of Efficacy|30|||
143142380|NCT00071981|516069308|FG003|Overall Study|Lack of Efficacy|43|||
143142381|NCT00071981|516069305|FG000|Overall Study|Adverse Event|4|||
143142382|NCT00071981|516069306|FG001|Overall Study|Adverse Event|4|||
143362746|NCT00797225|516871528|FG004|Weeks 1 to 12|Non-compliance|0|||
143362747|NCT00797225|516871529|FG005|Weeks 1 to 12|Non-compliance|0|||
143362748|NCT00797225|516871530|FG006|Weeks 1 to 12|Non-compliance|0|||
143362749|NCT00797225|516871531|FG007|Weeks 1 to 12|Non-compliance|0|||
143362750|NCT00797225|516871524|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
143362751|NCT00797225|516871525|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
143362752|NCT00797225|516871526|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
143362753|NCT00797225|516871527|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
143362754|NCT00797225|516871528|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
143362755|NCT00797225|516871529|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
143362756|NCT00797225|516871530|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
143362757|NCT00797225|516871531|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
143362758|NCT00797225|516871524|FG000|Weeks 1 to 12|Sponsor Decision|1|||
143362759|NCT00797225|516871525|FG001|Weeks 1 to 12|Sponsor Decision|0|||
143362760|NCT00797225|516871526|FG002|Weeks 1 to 12|Sponsor Decision|0|||
143362761|NCT00797225|516871527|FG003|Weeks 1 to 12|Sponsor Decision|0|||
143362762|NCT00797225|516871528|FG004|Weeks 1 to 12|Sponsor Decision|0|||
143362763|NCT00797225|516871529|FG005|Weeks 1 to 12|Sponsor Decision|0|||
143362764|NCT00797225|516871530|FG006|Weeks 1 to 12|Sponsor Decision|0|||
143362765|NCT00797225|516871531|FG007|Weeks 1 to 12|Sponsor Decision|0|||
143362766|NCT00797225|516871524|FG000|Weeks 13 to 24|Non-compliance|0|||
143362767|NCT00797225|516871525|FG001|Weeks 13 to 24|Non-compliance|2|||
143362768|NCT00797225|516871526|FG002|Weeks 13 to 24|Non-compliance|0|||
143362769|NCT00797225|516871527|FG003|Weeks 13 to 24|Non-compliance|0|||
143362770|NCT00797225|516871528|FG004|Weeks 13 to 24|Non-compliance|0|||
143362771|NCT00797225|516871529|FG005|Weeks 13 to 24|Non-compliance|0|||
143362772|NCT00797225|516871530|FG006|Weeks 13 to 24|Non-compliance|0|||
143362773|NCT00797225|516871531|FG007|Weeks 13 to 24|Non-compliance|0|||
143362774|NCT00797225|516871524|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
143362775|NCT00797225|516871525|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
143362776|NCT00797225|516871526|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
143362777|NCT00797225|516871527|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
143362778|NCT00797225|516871528|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
143362779|NCT00797225|516871529|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
143362780|NCT00797225|516871530|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
143362781|NCT00797225|516871531|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
143362782|NCT00797225|516871524|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
143362783|NCT00797225|516871525|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
143362784|NCT00797225|516871526|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
143362785|NCT00797225|516871527|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
143362786|NCT00797225|516871528|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
143362787|NCT00797225|516871529|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
143362788|NCT00797225|516871530|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
143362789|NCT00797225|516871531|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
143362790|NCT00797225|516871524|FG000|Weeks 13 to 24|Adverse Event|0|||
143362791|NCT00797225|516871525|FG001|Weeks 13 to 24|Adverse Event|1|||
143362792|NCT00797225|516871526|FG002|Weeks 13 to 24|Adverse Event|0|||
143362793|NCT00797225|516871527|FG003|Weeks 13 to 24|Adverse Event|0|||
143362794|NCT00797225|516871528|FG004|Weeks 13 to 24|Adverse Event|0|||
143362795|NCT00797225|516871529|FG005|Weeks 13 to 24|Adverse Event|0|||
143362796|NCT00797225|516871530|FG006|Weeks 13 to 24|Adverse Event|1|||
143362797|NCT00797225|516871531|FG007|Weeks 13 to 24|Adverse Event|0|||
143362798|NCT00797225|516871524|FG000|Weeks 13 to 24|Sponsor Decision|0|||
143362799|NCT00797225|516871525|FG001|Weeks 13 to 24|Sponsor Decision|0|||
143362800|NCT00797225|516871526|FG002|Weeks 13 to 24|Sponsor Decision|0|||
143142383|NCT00071981|516069307|FG002|Overall Study|Adverse Event|3|||
143142384|NCT00071981|516069308|FG003|Overall Study|Adverse Event|1|||
143142385|NCT00071981|516069305|FG000|Overall Study|Death|0|||
143362801|NCT00797225|516871527|FG003|Weeks 13 to 24|Sponsor Decision|0|||
143362802|NCT00797225|516871528|FG004|Weeks 13 to 24|Sponsor Decision|0|||
143473852|NCT02606461|517282453|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
143473853|NCT02606461|517282454|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
143473854|NCT02606461|517282455|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
143473855|NCT00024167|517282456|FG000|Overall Study|Death|53|||
143473856|NCT00024167|517282457|FG001|Overall Study|Death|47|||
143473857|NCT00851682|517282463|FG000|Overall Study|screen failure|5|||
143473858|NCT00851682|517282464|FG001|Overall Study|screen failure|0|||
143473859|NCT01379573|517282476|FG000|Overall Study|Lost to Follow-up|1|||
143473860|NCT01379573|517282476|FG000|Overall Study|Screen Failure|10|||
143473861|NCT00962390|517282477|FG000|Overall Study|Adverse Event|0|||
143473862|NCT00962390|517282478|FG001|Overall Study|Adverse Event|0|||
143473863|NCT00962390|517282479|FG002|Overall Study|Adverse Event|3|||
143473864|NCT00962390|517282480|FG003|Overall Study|Adverse Event|1|||
143142386|NCT00071981|516069306|FG001|Overall Study|Death|0|||
143142387|NCT00071981|516069307|FG002|Overall Study|Death|1|||
143142388|NCT00071981|516069308|FG003|Overall Study|Death|1|||
143142389|NCT00071981|516069305|FG000|Overall Study|Withdrawal by Subject|3|||
143142390|NCT00071981|516069306|FG001|Overall Study|Withdrawal by Subject|1|||
143142391|NCT00071981|516069307|FG002|Overall Study|Withdrawal by Subject|0|||
143142392|NCT00071981|516069308|FG003|Overall Study|Withdrawal by Subject|0|||
143142393|NCT00071981|516069305|FG000|Overall Study|No protocol therapy|2|||
143142394|NCT00071981|516069306|FG001|Overall Study|No protocol therapy|5|||
143142395|NCT00071981|516069307|FG002|Overall Study|No protocol therapy|1|||
143142396|NCT00071981|516069308|FG003|Overall Study|No protocol therapy|0|||
143142397|NCT00071981|516069305|FG000|Overall Study|others (not specified in the study)|0|||
143142398|NCT00071981|516069306|FG001|Overall Study|others (not specified in the study)|2|||
143142399|NCT00071981|516069307|FG002|Overall Study|others (not specified in the study)|2|||
143142400|NCT00071981|516069308|FG003|Overall Study|others (not specified in the study)|0|||
143142401|NCT01232283|516069316|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
143142402|NCT01232283|516069317|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
143142403|NCT01232283|516069318|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
143142404|NCT01232283|516069319|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
143142405|NCT01232283|516069320|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
143142406|NCT01232283|516069321|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
143142407|NCT01232283|516069322|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
143142408|NCT01232283|516069323|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
143142409|NCT01232283|516069324|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
143142410|NCT01232283|516069325|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
143142411|NCT01232283|516069316|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
143142412|NCT01232283|516069317|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
143142413|NCT01232283|516069318|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
143142414|NCT01232283|516069319|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
143142415|NCT01232283|516069320|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
143142416|NCT01232283|516069321|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
143142417|NCT01232283|516069322|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
143142418|NCT01232283|516069323|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
143142419|NCT01232283|516069324|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
143142420|NCT01232283|516069325|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
143142421|NCT01232283|516069316|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
143142422|NCT01232283|516069317|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
143142423|NCT01232283|516069318|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
143142424|NCT01232283|516069319|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
143142425|NCT01232283|516069320|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
143142426|NCT01232283|516069321|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
143142427|NCT01232283|516069322|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
143142428|NCT01232283|516069323|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
143142429|NCT01232283|516069324|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
143142430|NCT01232283|516069325|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
143142431|NCT01232283|516069316|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
143142432|NCT01232283|516069317|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
143142433|NCT01232283|516069318|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
143142434|NCT01232283|516069319|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
143142435|NCT01232283|516069320|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
143142436|NCT01232283|516069321|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
143142437|NCT01232283|516069322|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
143473865|NCT00962390|517282477|FG000|Overall Study|Lost to Follow-up|2|||
143473866|NCT00962390|517282478|FG001|Overall Study|Lost to Follow-up|2|||
143473867|NCT00962390|517282479|FG002|Overall Study|Lost to Follow-up|0|||
143473868|NCT00962390|517282480|FG003|Overall Study|Lost to Follow-up|0|||
143473869|NCT00962390|517282477|FG000|Overall Study|Protocol Violation|1|||
143473870|NCT00962390|517282478|FG001|Overall Study|Protocol Violation|0|||
143473871|NCT00962390|517282479|FG002|Overall Study|Protocol Violation|0|||
143473872|NCT00962390|517282480|FG003|Overall Study|Protocol Violation|0|||
143473873|NCT00962390|517282477|FG000|Overall Study|Withdrawal by Subject|1|||
143473874|NCT00962390|517282478|FG001|Overall Study|Withdrawal by Subject|1|||
143473875|NCT00962390|517282479|FG002|Overall Study|Withdrawal by Subject|1|||
143473876|NCT00962390|517282480|FG003|Overall Study|Withdrawal by Subject|0|||
143473877|NCT02613884|517282481|FG000|Overall Study|Death|1|||
143473878|NCT02613884|517282481|FG000|Overall Study|Lost to Follow-up|1|||
143473879|NCT02844920|517282484|FG000|Overall Study|Lost to Follow-up|2|||
143473880|NCT00800436|517282485|FG000|Overall Study|Withdrawal by Subject|0|||
143473881|NCT00800436|517282486|FG001|Overall Study|Withdrawal by Subject|0|||
143473882|NCT00800436|517282487|FG002|Overall Study|Withdrawal by Subject|1|||
143473883|NCT00800436|517282488|FG003|Overall Study|Withdrawal by Subject|1|||
143473884|NCT00800436|517282489|FG004|Overall Study|Withdrawal by Subject|0|||
143473885|NCT00800436|517282490|FG005|Overall Study|Withdrawal by Subject|0|||
143473886|NCT00800436|517282491|FG006|Overall Study|Withdrawal by Subject|0|||
143473887|NCT01910116|517282492|FG000|Overall Study|Adverse Event|0|||
143473888|NCT01910116|517282493|FG001|Overall Study|Adverse Event|3|||
143142438|NCT01232283|516069323|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
143142439|NCT01232283|516069324|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
143142440|NCT01232283|516069325|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
143142441|NCT01232283|516069316|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
143142442|NCT01232283|516069317|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
143473889|NCT01910116|517282492|FG000|Overall Study|Lack of Efficacy|3|||
143473890|NCT01910116|517282493|FG001|Overall Study|Lack of Efficacy|4|||
143473891|NCT01910116|517282492|FG000|Overall Study|Lost to Follow-up|1|||
143473892|NCT01910116|517282493|FG001|Overall Study|Lost to Follow-up|0|||
143473893|NCT01910116|517282492|FG000|Overall Study|Protocol Violation|1|||
143473894|NCT01910116|517282493|FG001|Overall Study|Protocol Violation|2|||
143473895|NCT01910116|517282492|FG000|Overall Study|Withdrawal by Subject|8|||
143473896|NCT01910116|517282493|FG001|Overall Study|Withdrawal by Subject|3|||
143473897|NCT01910116|517282492|FG000|Overall Study|uncertain allocation|1|||
143473898|NCT01910116|517282493|FG001|Overall Study|uncertain allocation|3|||
143473899|NCT01910116|517282492|FG000|Overall Study|incomplete data|0|||
143473900|NCT01910116|517282493|FG001|Overall Study|incomplete data|1|||
143473901|NCT01849497|517282494|FG000|Overall Study|Withdrawal by Subject|1|||
143473902|NCT01849497|517282495|FG001|Overall Study|Withdrawal by Subject|2|||
143473903|NCT01849497|517282494|FG000|Overall Study|Sponsor Decision|0|||
143473904|NCT01849497|517282495|FG001|Overall Study|Sponsor Decision|1|||
143473905|NCT01849497|517282494|FG000|Overall Study|Lost to Follow-up|0|||
143473906|NCT01849497|517282495|FG001|Overall Study|Lost to Follow-up|1|||
143473907|NCT02729740|517282498|FG000|Overall Study|Early Termination|130|||
143473908|NCT02729740|517282498|FG000|Overall Study|Other|1|||
143142443|NCT01232283|516069318|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
143142444|NCT01232283|516069319|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
143142445|NCT01232283|516069320|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
143473909|NCT00307333|517282499|FG000|Overall Study|Lost to Follow-up|11|||
143473910|NCT00307333|517282500|FG001|Overall Study|Lost to Follow-up|3|||
143142446|NCT01232283|516069321|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
143142447|NCT01232283|516069322|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
143142448|NCT01232283|516069323|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
143142449|NCT01232283|516069324|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
143142450|NCT01232283|516069325|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
143142451|NCT01232283|516069316|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
143142452|NCT01232283|516069317|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
143142453|NCT01232283|516069318|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
143142454|NCT01232283|516069319|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
143142455|NCT01232283|516069320|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
143142456|NCT01232283|516069321|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
143142457|NCT01232283|516069322|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
143142458|NCT01232283|516069323|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
143142459|NCT01232283|516069324|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
143142460|NCT01232283|516069325|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
143142461|NCT01232283|516069316|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
143473911|NCT00698932|517282501|FG000|Overall Study|Adverse Event|0|||
143473912|NCT00698932|517282502|FG001|Overall Study|Adverse Event|2|||
143142462|NCT01232283|516069317|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
143473913|NCT00698932|517282501|FG000|Overall Study|Incorrect enrollment|0|||
143473914|NCT00698932|517282502|FG001|Overall Study|Incorrect enrollment|2|||
143473915|NCT00698932|517282501|FG000|Overall Study|Study specific discontinuation criteria|3|||
143473916|NCT00698932|517282502|FG001|Overall Study|Study specific discontinuation criteria|4|||
143473917|NCT00698932|517282501|FG000|Overall Study|Withdrawal by Subject|11|||
143473918|NCT00698932|517282502|FG001|Overall Study|Withdrawal by Subject|23|||
143473919|NCT00698932|517282501|FG000|Overall Study|Lost to Follow-up|6|||
143473920|NCT00698932|517282502|FG001|Overall Study|Lost to Follow-up|1|||
143473921|NCT00698932|517282501|FG000|Overall Study|Severe non-compliance to protocol|1|||
143473922|NCT00698932|517282502|FG001|Overall Study|Severe non-compliance to protocol|2|||
143473923|NCT00698932|517282501|FG000|Overall Study|Safety reasons|0|||
143473924|NCT00698932|517282502|FG001|Overall Study|Safety reasons|2|||
143473925|NCT00698932|517282501|FG000|Overall Study|Death|1|||
143473926|NCT00698932|517282502|FG001|Overall Study|Death|0|||
143473927|NCT01245387|517282503|FG000|Overall Study|Lost to Follow-up|106|||
143473928|NCT01245387|517282503|FG000|Overall Study|Lack of Efficacy|195|||
143473929|NCT01245387|517282503|FG000|Overall Study|Adverse Event|9|||
143473930|NCT01245387|517282503|FG000|Overall Study|Death|3|||
143473931|NCT01245387|517282503|FG000|Overall Study|Other|131|||
143473932|NCT01245387|517282503|FG000|Overall Study|Missing discontinuation status|369|||
143473933|NCT00757003|517282504|FG000|Overall Study|Death|33|||
143473934|NCT00757003|517282504|FG000|Overall Study|Lost to Follow-up|9|||
143473935|NCT00757003|517282504|FG000|Overall Study|Withdrawal by Subject|4|||
143473936|NCT00757003|517282504|FG000|Overall Study|Surgically explanted|2|||
143473937|NCT00757003|517282504|FG000|Overall Study|Not implanted|1|||
143473938|NCT00601705|517282505|FG000|Overall Study|Withdrawal by Subject|1|||
143473939|NCT02146599|517282509|FG000|Overall Study|Failed to meet inclusion criteria|5|||
143473940|NCT04246801|517282510|FG000|Overall Study|Adverse Event|1|||
143473941|NCT04246801|517282511|FG001|Overall Study|Adverse Event|1|||
143473942|NCT04246801|517282510|FG000|Overall Study|Protocol Violation|1|||
143473943|NCT04246801|517282511|FG001|Overall Study|Protocol Violation|1|||
143473944|NCT04246801|517282510|FG000|Overall Study|Lack of Efficacy|0|||
143473945|NCT04246801|517282511|FG001|Overall Study|Lack of Efficacy|2|||
143473946|NCT04246801|517282510|FG000|Overall Study|Lost to Follow-up|1|||
143473947|NCT04246801|517282511|FG001|Overall Study|Lost to Follow-up|1|||
143473948|NCT04246801|517282510|FG000|Overall Study|Withdrawal by Subject|2|||
143473949|NCT04246801|517282511|FG001|Overall Study|Withdrawal by Subject|1|||
143473950|NCT02101021|517282512|FG000|Overall Study|Death|4|||
143473951|NCT02101021|517282513|FG001|Overall Study|Death|3|||
143473952|NCT02101021|517282514|FG002|Overall Study|Death|6|||
143473953|NCT02101021|517282515|FG003|Overall Study|Death|0|||
143473954|NCT02101021|517282516|FG004|Overall Study|Death|3|||
143473955|NCT02101021|517282512|FG000|Overall Study|Withdrew Consent from study|1|||
143473956|NCT02101021|517282513|FG001|Overall Study|Withdrew Consent from study|1|||
143473957|NCT02101021|517282514|FG002|Overall Study|Withdrew Consent from study|0|||
143473958|NCT02101021|517282515|FG003|Overall Study|Withdrew Consent from study|2|||
143473959|NCT02101021|517282516|FG004|Overall Study|Withdrew Consent from study|0|||
143473960|NCT02101021|517282512|FG000|Overall Study|Lost to Follow-up|1|||
143473961|NCT02101021|517282513|FG001|Overall Study|Lost to Follow-up|0|||
143473962|NCT02101021|517282514|FG002|Overall Study|Lost to Follow-up|0|||
143473963|NCT02101021|517282515|FG003|Overall Study|Lost to Follow-up|0|||
143473964|NCT02101021|517282516|FG004|Overall Study|Lost to Follow-up|0|||
143473965|NCT02101021|517282512|FG000|Overall Study|Study Terminated by Sponsor|1|||
143473966|NCT02101021|517282513|FG001|Overall Study|Study Terminated by Sponsor|0|||
143473967|NCT02101021|517282514|FG002|Overall Study|Study Terminated by Sponsor|1|||
143473968|NCT02101021|517282515|FG003|Overall Study|Study Terminated by Sponsor|1|||
143473969|NCT02101021|517282516|FG004|Overall Study|Study Terminated by Sponsor|1|||
143473970|NCT01621542|517282517|FG000|Overall Study|Adverse Event|0|||
143473971|NCT01621542|517282518|FG001|Overall Study|Adverse Event|0|||
143473972|NCT01621542|517282519|FG002|Overall Study|Adverse Event|1|||
143473973|NCT01621542|517282520|FG003|Overall Study|Adverse Event|3|||
143473974|NCT01621542|517282521|FG004|Overall Study|Adverse Event|0|||
143473975|NCT01621542|517282522|FG005|Overall Study|Adverse Event|0|||
143473976|NCT01621542|517282517|FG000|Overall Study|Death|0|||
143473977|NCT01621542|517282518|FG001|Overall Study|Death|1|||
143473978|NCT01621542|517282519|FG002|Overall Study|Death|0|||
143473979|NCT01621542|517282520|FG003|Overall Study|Death|0|||
143473980|NCT01621542|517282521|FG004|Overall Study|Death|0|||
143473981|NCT01621542|517282522|FG005|Overall Study|Death|0|||
143473982|NCT01621542|517282517|FG000|Overall Study|Physician Decision|1|||
143473983|NCT01621542|517282518|FG001|Overall Study|Physician Decision|0|||
143473984|NCT01621542|517282519|FG002|Overall Study|Physician Decision|1|||
143473985|NCT01621542|517282520|FG003|Overall Study|Physician Decision|13|||
143473986|NCT01621542|517282521|FG004|Overall Study|Physician Decision|3|||
143473987|NCT01621542|517282522|FG005|Overall Study|Physician Decision|1|||
143473988|NCT01621542|517282517|FG000|Overall Study|Withdrawal by Subject|2|||
143473989|NCT01621542|517282518|FG001|Overall Study|Withdrawal by Subject|0|||
143473990|NCT01621542|517282519|FG002|Overall Study|Withdrawal by Subject|1|||
143473991|NCT01621542|517282520|FG003|Overall Study|Withdrawal by Subject|3|||
143473992|NCT01621542|517282521|FG004|Overall Study|Withdrawal by Subject|3|||
143473993|NCT01621542|517282522|FG005|Overall Study|Withdrawal by Subject|3|||
143473994|NCT01621542|517282517|FG000|Overall Study|progression/treatment failure|2|||
143473995|NCT01621542|517282518|FG001|Overall Study|progression/treatment failure|4|||
143473996|NCT01621542|517282519|FG002|Overall Study|progression/treatment failure|3|||
143142463|NCT01232283|516069318|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
143142464|NCT01232283|516069319|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
143142465|NCT01232283|516069320|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
143142466|NCT01232283|516069321|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
143142467|NCT01232283|516069322|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
143142468|NCT01232283|516069323|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
143142469|NCT01232283|516069324|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
143362803|NCT00797225|516871529|FG005|Weeks 13 to 24|Sponsor Decision|0|||
143362804|NCT00797225|516871530|FG006|Weeks 13 to 24|Sponsor Decision|1|||
143362805|NCT00797225|516871531|FG007|Weeks 13 to 24|Sponsor Decision|0|||
143362806|NCT00578227|516871533|FG000|Overall Study|Lost to Follow-up|0|||
143362807|NCT00578227|516871534|FG001|Overall Study|Lost to Follow-up|1|||
143362808|NCT00578227|516871535|FG002|Overall Study|Lost to Follow-up|1|||
143362809|NCT00578227|516871533|FG000|Overall Study|Withdrawal by Subject|5|||
143362810|NCT00578227|516871534|FG001|Overall Study|Withdrawal by Subject|1|||
143362811|NCT00578227|516871535|FG002|Overall Study|Withdrawal by Subject|3|||
143362812|NCT02929108|516871541|FG000|Overall Study|Hospice patient death|100|||
143362813|NCT02929108|516871542|FG001|Overall Study|Hospice patient death|64|||
143362814|NCT02929108|516871543|FG002|Overall Study|Hospice patient death|28|||
143362815|NCT02929108|516871544|FG003|Overall Study|Hospice patient death|46|||
143362816|NCT02929108|516871545|FG004|Overall Study|Hospice patient death|55|||
143362817|NCT02929108|516871546|FG005|Overall Study|Hospice patient death|28|||
143362818|NCT02929108|516871547|FG006|Overall Study|Hospice patient death|78|||
143362819|NCT00052962|516871548|FG000|Overall Study|Not evaluable|0|||
143362820|NCT00052962|516871549|FG001|Overall Study|Not evaluable|2|||
143362821|NCT00052962|516871548|FG000|Overall Study|Not randomized/not evaluable|1|||
143362822|NCT00052962|516871549|FG001|Overall Study|Not randomized/not evaluable|0|||
143362823|NCT01414166|516871551|FG000|Overall Study|Adverse Event|10|||
143362824|NCT01414166|516871552|FG001|Overall Study|Adverse Event|2|||
143362825|NCT01414166|516871551|FG000|Overall Study|Lost to Follow-up|4|||
143362826|NCT01414166|516871552|FG001|Overall Study|Lost to Follow-up|1|||
143362827|NCT01414166|516871551|FG000|Overall Study|Non-compliance with study drug|2|||
143362828|NCT01414166|516871552|FG001|Overall Study|Non-compliance with study drug|0|||
143362829|NCT01414166|516871551|FG000|Overall Study|Physician Decision|2|||
143362830|NCT01414166|516871552|FG001|Overall Study|Physician Decision|0|||
143362831|NCT01414166|516871551|FG000|Overall Study|Protocol Violation|2|||
143362832|NCT01414166|516871552|FG001|Overall Study|Protocol Violation|0|||
143362833|NCT01414166|516871551|FG000|Overall Study|Study terminated by Sponsor|68|||
143362834|NCT01414166|516871552|FG001|Overall Study|Study terminated by Sponsor|75|||
143362835|NCT01414166|516871551|FG000|Overall Study|Withdrawal by Subject|3|||
143362836|NCT01414166|516871552|FG001|Overall Study|Withdrawal by Subject|5|||
143362837|NCT03682536|516871553|FG000|Randomization|Withdrawal by Subject|0|||
143362838|NCT03682536|516871554|FG001|Randomization|Withdrawal by Subject|2|||
143362839|NCT03682536|516871553|FG000|Treatment|Other Reasons|8|||
143362840|NCT03682536|516871554|FG001|Treatment|Other Reasons|7|||
143362841|NCT03682536|516871553|FG000|Treatment|Physician Decision|5|||
143362842|NCT03682536|516871554|FG001|Treatment|Physician Decision|5|||
143362843|NCT03682536|516871553|FG000|Treatment|Protocol Violation|1|||
143362844|NCT03682536|516871554|FG001|Treatment|Protocol Violation|0|||
143362845|NCT03682536|516871553|FG000|Treatment|Study Terminated by Sponsor|1|||
143362846|NCT03682536|516871554|FG001|Treatment|Study Terminated by Sponsor|2|||
143362847|NCT03682536|516871553|FG000|Treatment|Lost to Follow-up|0|||
143362848|NCT03682536|516871554|FG001|Treatment|Lost to Follow-up|1|||
143362849|NCT03682536|516871553|FG000|Treatment|Withdrawal by Subject|16|||
143362850|NCT03682536|516871554|FG001|Treatment|Withdrawal by Subject|18|||
143362851|NCT03682536|516871553|FG000|Treatment|Lack of Efficacy|41|||
143362852|NCT03682536|516871554|FG001|Treatment|Lack of Efficacy|68|||
143362853|NCT03682536|516871553|FG000|Treatment|Disease Progression|9|||
143362854|NCT03682536|516871554|FG001|Treatment|Disease Progression|7|||
143362855|NCT03682536|516871553|FG000|Treatment|Adverse Event|9|||
143362856|NCT03682536|516871554|FG001|Treatment|Adverse Event|5|||
143362857|NCT03682536|516871553|FG000|Treatment|Death|14|||
143362858|NCT03682536|516871554|FG001|Treatment|Death|13|||
143362859|NCT04824131|516871555|FG000|CAB LA Oral Phase|Adverse Event|1|||
143362860|NCT04824131|516871555|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
143362861|NCT04824131|516871555|FG000|Step 3|Withdrawal by Subject|2|||
143362862|NCT05489224|516871556|FG000|Treatment Period I|Withdrawal by Subject|6|||
143362863|NCT05489224|516871557|FG001|Treatment Period I|Withdrawal by Subject|5|||
143362864|NCT05489224|516871558|FG002|Treatment Period I|Withdrawal by Subject|0|||
143362865|NCT05489224|516871556|FG000|Treatment Period I|Adverse Event|3|||
143362866|NCT05489224|516871557|FG001|Treatment Period I|Adverse Event|11|||
143362867|NCT05489224|516871558|FG002|Treatment Period I|Adverse Event|0|||
143362868|NCT05489224|516871556|FG000|Treatment Period I|Lost to Follow-up|0|||
143473997|NCT01621542|517282520|FG003|Overall Study|progression/treatment failure|7|||
143362869|NCT05489224|516871557|FG001|Treatment Period I|Lost to Follow-up|1|||
143362870|NCT05489224|516871558|FG002|Treatment Period I|Lost to Follow-up|0|||
143362871|NCT05489224|516871556|FG000|Treatment Period I|Physician Decision|0|||
143362872|NCT05489224|516871557|FG001|Treatment Period I|Physician Decision|1|||
143142470|NCT01232283|516069325|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
143142471|NCT01232283|516069316|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
143142472|NCT01232283|516069317|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
143142473|NCT01232283|516069318|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
143142474|NCT01232283|516069319|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
143142475|NCT01232283|516069320|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
143142476|NCT01232283|516069321|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
143142477|NCT01232283|516069322|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
143142478|NCT01232283|516069323|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
143142479|NCT01232283|516069324|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
143142480|NCT01232283|516069325|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
143142481|NCT01232283|516069316|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
143142482|NCT01232283|516069317|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
143142483|NCT01232283|516069318|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
143142484|NCT01232283|516069319|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
143362873|NCT05489224|516871558|FG002|Treatment Period I|Physician Decision|0|||
143142485|NCT01232283|516069320|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
143142486|NCT01232283|516069321|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
143142487|NCT01232283|516069322|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
143142488|NCT01232283|516069323|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
143142489|NCT01232283|516069324|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
143142490|NCT01232283|516069325|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
143362874|NCT05489224|516871556|FG000|Treatment Period II up to Week 32|Ongoing|222|||
143362875|NCT05489224|516871557|FG001|Treatment Period II up to Week 32|Ongoing|107|||
143362876|NCT05489224|516871558|FG002|Treatment Period II up to Week 32|Ongoing|107|||
143362877|NCT05489224|516871556|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
143362878|NCT05489224|516871557|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
143362879|NCT05489224|516871558|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
143362880|NCT05489224|516871556|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
143362881|NCT05489224|516871557|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
143362882|NCT05489224|516871558|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
143362883|NCT03686384|516871559|FG000|Overall Study|Lack of Efficacy|4|||
143362884|NCT03686384|516871560|FG001|Overall Study|Lack of Efficacy|13|||
143362885|NCT03686384|516871559|FG000|Overall Study|Lost to Follow-up|3|||
143362886|NCT03686384|516871560|FG001|Overall Study|Lost to Follow-up|0|||
143362887|NCT03686384|516871559|FG000|Overall Study|Physician Decision|0|||
143362888|NCT03686384|516871560|FG001|Overall Study|Physician Decision|1|||
143362889|NCT03686384|516871559|FG000|Overall Study|Took prohibited medication|0|||
143362890|NCT03686384|516871560|FG001|Overall Study|Took prohibited medication|1|||
143362891|NCT04887285|516871561|FG000|Overall Study|Lost to Follow-up|0|||
143362892|NCT04887285|516871562|FG001|Overall Study|Lost to Follow-up|2|||
143362893|NCT04887285|516871563|FG002|Overall Study|Lost to Follow-up|3|||
143362894|NCT04640571|516871564|FG000|Overall Study|Withdrawal by Subject|0|||
143362895|NCT04640571|516871565|FG001|Overall Study|Withdrawal by Subject|0|||
143362896|NCT04640571|516871566|FG002|Overall Study|Withdrawal by Subject|0|||
143362897|NCT04640571|516871567|FG003|Overall Study|Withdrawal by Subject|0|||
143362898|NCT04640571|516871568|FG004|Overall Study|Withdrawal by Subject|0|||
143362899|NCT04640571|516871569|FG005|Overall Study|Withdrawal by Subject|2|||
143362900|NCT01723774|516871574|FG000|Neoadjuvant|Ki67 > 10%|4|||
143362901|NCT01723774|516871575|FG001|Neoadjuvant|Ki67 > 10%|0|||
143362902|NCT01723774|516871576|FG002|Neoadjuvant|Ki67 > 10%|10|||
143362903|NCT01723774|516871577|FG003|Neoadjuvant|Ki67 > 10%|0|||
143362904|NCT01723774|516871574|FG000|Neoadjuvant|Withdrawal by Subject|3|||
143362905|NCT01723774|516871575|FG001|Neoadjuvant|Withdrawal by Subject|1|||
143362906|NCT01723774|516871576|FG002|Neoadjuvant|Withdrawal by Subject|0|||
143362907|NCT01723774|516871577|FG003|Neoadjuvant|Withdrawal by Subject|0|||
143362908|NCT01723774|516871574|FG000|Neoadjuvant|Disease progression|0|||
143362909|NCT01723774|516871575|FG001|Neoadjuvant|Disease progression|1|||
143362910|NCT01723774|516871576|FG002|Neoadjuvant|Disease progression|1|||
143362911|NCT01723774|516871577|FG003|Neoadjuvant|Disease progression|0|||
143362912|NCT01723774|516871574|FG000|Neoadjuvant|Adverse Event|0|||
143362913|NCT01723774|516871575|FG001|Neoadjuvant|Adverse Event|1|||
143362914|NCT01723774|516871576|FG002|Neoadjuvant|Adverse Event|2|||
143362915|NCT01723774|516871577|FG003|Neoadjuvant|Adverse Event|0|||
143362916|NCT01723774|516871574|FG000|Neoadjuvant|High estradiol|0|||
143362917|NCT01723774|516871575|FG001|Neoadjuvant|High estradiol|1|||
143362918|NCT01723774|516871576|FG002|Neoadjuvant|High estradiol|0|||
143362919|NCT01723774|516871577|FG003|Neoadjuvant|High estradiol|0|||
143362920|NCT05174065|516871580|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
143362921|NCT05174065|516871581|FG001|Placebo-controlled Period|Withdrawal by Subject|0|||
143362922|NCT05174065|516871582|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
143362923|NCT05174065|516871580|FG000|Placebo-controlled Period|Other|0|||
143362924|NCT05174065|516871581|FG001|Placebo-controlled Period|Other|1|||
143362925|NCT05174065|516871582|FG002|Placebo-controlled Period|Other|0|||
143362926|NCT05174065|516871580|FG000|Placebo-controlled Period|Adverse Event|1|||
143362927|NCT05174065|516871581|FG001|Placebo-controlled Period|Adverse Event|1|||
143473998|NCT01621542|517282521|FG004|Overall Study|progression/treatment failure|3|||
143473999|NCT01621542|517282522|FG005|Overall Study|progression/treatment failure|5|||
143474000|NCT01621542|517282517|FG000|Overall Study|Protocol Violation|0|||
143474001|NCT01621542|517282518|FG001|Overall Study|Protocol Violation|0|||
143474002|NCT01621542|517282519|FG002|Overall Study|Protocol Violation|0|||
143474003|NCT01621542|517282520|FG003|Overall Study|Protocol Violation|1|||
143474004|NCT01621542|517282521|FG004|Overall Study|Protocol Violation|0|||
143474005|NCT01621542|517282522|FG005|Overall Study|Protocol Violation|0|||
143474006|NCT01621542|517282517|FG000|Overall Study|study stopped by sponsor|0|||
143474007|NCT01621542|517282518|FG001|Overall Study|study stopped by sponsor|0|||
143474008|NCT01621542|517282519|FG002|Overall Study|study stopped by sponsor|0|||
143474009|NCT01621542|517282520|FG003|Overall Study|study stopped by sponsor|1|||
143474010|NCT01621542|517282521|FG004|Overall Study|study stopped by sponsor|0|||
143474011|NCT01621542|517282522|FG005|Overall Study|study stopped by sponsor|0|||
143474012|NCT01368042|517282523|FG000|Overall Study|Death|14|||
143474013|NCT01368042|517282523|FG000|Overall Study|Protocol Violation|11|||
143474014|NCT01368042|517282523|FG000|Overall Study|Lost to Follow-up|4|||
143014086|NCT01414062|515591608|FG000|Overall Study|Left Country|1|||
143362928|NCT05174065|516871582|FG002|Placebo-controlled Period|Adverse Event|0|||
143362929|NCT05174065|516871580|FG000|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
143362930|NCT05174065|516871581|FG001|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
143362931|NCT05174065|516871582|FG002|Apremilast Active Treatment Period|Withdrawal by Subject|3|||
143362932|NCT05174065|516871580|FG000|Apremilast Active Treatment Period|Protocol Violation|0|||
143362933|NCT05174065|516871581|FG001|Apremilast Active Treatment Period|Protocol Violation|0|||
143362934|NCT05174065|516871582|FG002|Apremilast Active Treatment Period|Protocol Violation|1|||
143362935|NCT05174065|516871580|FG000|Apremilast Active Treatment Period|Adverse Event|0|||
143362936|NCT05174065|516871581|FG001|Apremilast Active Treatment Period|Adverse Event|0|||
143362937|NCT05174065|516871582|FG002|Apremilast Active Treatment Period|Adverse Event|4|||
143362938|NCT01221181|516871593|FG000|Overall Study|Lost to Follow-up|1|||
143362939|NCT00429793|516871594|FG000|Overall Study|Improper pre-protocol treatment|3|||
143362940|NCT00429793|516871594|FG000|Overall Study|Required test not done|1|||
143362941|NCT00429793|516871594|FG000|Overall Study|Never treated|1|||
143362942|NCT00429793|516871594|FG000|Overall Study|Non-measurable|1|||
143362943|NCT03073005|516871595|FG000|Overall Study|Death|6|||
143362944|NCT03073005|516871596|FG001|Overall Study|Death|0|||
143362945|NCT03073005|516871597|FG002|Overall Study|Death|7|||
143362946|NCT03073005|516871598|FG003|Overall Study|Death|0|||
143362947|NCT03073005|516871595|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
143362948|NCT03073005|516871596|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
143362949|NCT03073005|516871597|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
143362950|NCT03073005|516871598|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
143362951|NCT03073005|516871595|FG000|Overall Study|Lost to Follow-up|2|||
143362952|NCT03073005|516871596|FG001|Overall Study|Lost to Follow-up|2|||
143362953|NCT03073005|516871597|FG002|Overall Study|Lost to Follow-up|1|||
143362954|NCT03073005|516871598|FG003|Overall Study|Lost to Follow-up|2|||
143362955|NCT03073005|516871595|FG000|Overall Study|Withdrawal by Subject|0|||
143362956|NCT03073005|516871596|FG001|Overall Study|Withdrawal by Subject|4|||
143362957|NCT03073005|516871597|FG002|Overall Study|Withdrawal by Subject|4|||
143362958|NCT03073005|516871598|FG003|Overall Study|Withdrawal by Subject|4|||
143362959|NCT02427646|516871599|FG000|Overall Study|Lack of Efficacy|2|||
143362960|NCT02427646|516871600|FG001|Overall Study|Lack of Efficacy|3|||
143362961|NCT02427646|516871599|FG000|Overall Study|Physician Decision|1|||
143362962|NCT02427646|516871600|FG001|Overall Study|Physician Decision|4|||
143362963|NCT02427646|516871599|FG000|Overall Study|Protocol Violation|3|||
143362964|NCT02427646|516871600|FG001|Overall Study|Protocol Violation|3|||
143362965|NCT02427646|516871599|FG000|Overall Study|Bothersome hand weakness|2|||
143362966|NCT02427646|516871600|FG001|Overall Study|Bothersome hand weakness|4|||
143362967|NCT03824236|516871601|FG000|Overall Study|Lost to Follow-up|0|||
143362968|NCT03824236|516871602|FG001|Overall Study|Lost to Follow-up|0|||
143362969|NCT03824236|516871603|FG002|Overall Study|Lost to Follow-up|1|||
143362970|NCT01290094|516871604|FG000|Overall Study|Withdrawal by Subject|1|||
143362971|NCT01290094|516871604|FG000|Overall Study|Lost to Follow-up|5|||
143362972|NCT01641861|516871605|FG000|Overall Study|Lost to Follow-up|21|||
143362973|NCT01641861|516871606|FG001|Overall Study|Lost to Follow-up|16|||
143362974|NCT01641861|516871605|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
143362975|NCT01641861|516871606|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
143362976|NCT01641861|516871605|FG000|Overall Study|Died due to drowning|0|||
143362977|NCT01641861|516871606|FG001|Overall Study|Died due to drowning|1|||
143362978|NCT00814489|516871636|FG000|Overall Study|Other|2|||
143362979|NCT00814489|516871637|FG001|Overall Study|Other|0|||
143362980|NCT00814489|516871638|FG002|Overall Study|Other|1|||
143362981|NCT01866917|516871639|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
143362982|NCT01866917|516871640|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
143362983|NCT01712685|516871644|FG000|Overall Study|pt declined to participate before trmt|1|||
143362984|NCT01140347|516871648|FG000|Overall Study|Lost to Follow-up|5|||
143362985|NCT01140347|516871649|FG001|Overall Study|Lost to Follow-up|6|||
143474015|NCT01368042|517282523|FG000|Overall Study|Transplanted|1|||
143474016|NCT00760669|517282524|FG000|Overall Study|Not assessed for overall improvement|18|||
143474017|NCT00760669|517282524|FG000|Overall Study|Participants missing efficacy assessment|6|||
143474018|NCT00760669|517282524|FG000|Overall Study|Participants with overlapping cases|1|||
143474019|NCT00760669|517282524|FG000|Overall Study|Took drug before entering in contract|5|||
143474020|NCT02632721|517282528|FG000|Overall Study|Adverse Event|0|||
143474021|NCT02632721|517282529|FG001|Overall Study|Adverse Event|0|||
143474022|NCT02632721|517282530|FG002|Overall Study|Adverse Event|2|||
143474023|NCT02632721|517282531|FG003|Overall Study|Adverse Event|5|||
143474024|NCT02632721|517282532|FG004|Overall Study|Adverse Event|3|||
143474025|NCT02632721|517282528|FG000|Overall Study|Dose limiting toxicity|0|||
143474026|NCT02632721|517282529|FG001|Overall Study|Dose limiting toxicity|0|||
143474027|NCT02632721|517282530|FG002|Overall Study|Dose limiting toxicity|0|||
143474028|NCT02632721|517282531|FG003|Overall Study|Dose limiting toxicity|1|||
143474029|NCT02632721|517282532|FG004|Overall Study|Dose limiting toxicity|0|||
143474030|NCT02632721|517282528|FG000|Overall Study|Progressive disease|3|||
143474031|NCT02632721|517282529|FG001|Overall Study|Progressive disease|0|||
143474032|NCT02632721|517282530|FG002|Overall Study|Progressive disease|4|||
143474033|NCT02632721|517282531|FG003|Overall Study|Progressive disease|6|||
143474034|NCT02632721|517282532|FG004|Overall Study|Progressive disease|5|||
143474035|NCT02632721|517282528|FG000|Overall Study|Refused to continue taking trial medication|0|||
143474036|NCT02632721|517282529|FG001|Overall Study|Refused to continue taking trial medication|1|||
143474037|NCT02632721|517282530|FG002|Overall Study|Refused to continue taking trial medication|1|||
143474038|NCT02632721|517282531|FG003|Overall Study|Refused to continue taking trial medication|1|||
143474039|NCT02632721|517282532|FG004|Overall Study|Refused to continue taking trial medication|2|||
143474040|NCT02632721|517282528|FG000|Overall Study|Inadequate clinical condition|0|||
143474041|NCT02632721|517282529|FG001|Overall Study|Inadequate clinical condition|0|||
143474042|NCT02632721|517282530|FG002|Overall Study|Inadequate clinical condition|0|||
143474043|NCT02632721|517282531|FG003|Overall Study|Inadequate clinical condition|0|||
143474044|NCT02632721|517282532|FG004|Overall Study|Inadequate clinical condition|1|||
143474045|NCT02632721|517282528|FG000|Overall Study|No meet eligibility|0|||
143474046|NCT02632721|517282529|FG001|Overall Study|No meet eligibility|0|||
143474047|NCT02632721|517282530|FG002|Overall Study|No meet eligibility|0|||
143474048|NCT02632721|517282531|FG003|Overall Study|No meet eligibility|0|||
143474049|NCT02632721|517282532|FG004|Overall Study|No meet eligibility|1|||
143474050|NCT02632721|517282528|FG000|Overall Study|Allergic reaction|0|||
143474051|NCT02632721|517282529|FG001|Overall Study|Allergic reaction|0|||
143474052|NCT02632721|517282530|FG002|Overall Study|Allergic reaction|0|||
143474053|NCT02632721|517282531|FG003|Overall Study|Allergic reaction|1|||
143474054|NCT02632721|517282532|FG004|Overall Study|Allergic reaction|0|||
143474055|NCT02632721|517282528|FG000|Overall Study|Receiving Decitabine locally|0|||
143474056|NCT02632721|517282529|FG001|Overall Study|Receiving Decitabine locally|0|||
143474057|NCT02632721|517282530|FG002|Overall Study|Receiving Decitabine locally|1|||
143474058|NCT02632721|517282531|FG003|Overall Study|Receiving Decitabine locally|0|||
143474059|NCT02632721|517282532|FG004|Overall Study|Receiving Decitabine locally|0|||
143474060|NCT02632721|517282528|FG000|Overall Study|No benefit from study treatment|1|||
143474061|NCT02632721|517282529|FG001|Overall Study|No benefit from study treatment|1|||
143474062|NCT02632721|517282530|FG002|Overall Study|No benefit from study treatment|0|||
143474063|NCT02632721|517282531|FG003|Overall Study|No benefit from study treatment|0|||
143474064|NCT02632721|517282532|FG004|Overall Study|No benefit from study treatment|1|||
143474065|NCT02632721|517282528|FG000|Overall Study|Patient wish for other treatment|0|||
143474066|NCT02632721|517282529|FG001|Overall Study|Patient wish for other treatment|1|||
143474067|NCT02632721|517282530|FG002|Overall Study|Patient wish for other treatment|0|||
143474068|NCT02632721|517282531|FG003|Overall Study|Patient wish for other treatment|0|||
143474069|NCT02632721|517282532|FG004|Overall Study|Patient wish for other treatment|0|||
143474070|NCT02632721|517282528|FG000|Overall Study|Relapsed Pneumonia|0|||
143474071|NCT02632721|517282529|FG001|Overall Study|Relapsed Pneumonia|0|||
143474072|NCT02632721|517282530|FG002|Overall Study|Relapsed Pneumonia|0|||
143474073|NCT02632721|517282531|FG003|Overall Study|Relapsed Pneumonia|0|||
143474074|NCT02632721|517282532|FG004|Overall Study|Relapsed Pneumonia|1|||
143474075|NCT02632721|517282528|FG000|Overall Study|Therapy refractory AML|0|||
143474076|NCT02632721|517282529|FG001|Overall Study|Therapy refractory AML|0|||
143474077|NCT02632721|517282530|FG002|Overall Study|Therapy refractory AML|0|||
143474078|NCT02632721|517282531|FG003|Overall Study|Therapy refractory AML|0|||
143474079|NCT02632721|517282532|FG004|Overall Study|Therapy refractory AML|1|||
143474080|NCT02632721|517282528|FG000|Overall Study|Increase of white blood cell count|0|||
143474081|NCT02632721|517282529|FG001|Overall Study|Increase of white blood cell count|0|||
143474082|NCT02632721|517282530|FG002|Overall Study|Increase of white blood cell count|0|||
143474083|NCT02632721|517282531|FG003|Overall Study|Increase of white blood cell count|0|||
143474084|NCT02632721|517282532|FG004|Overall Study|Increase of white blood cell count|1|||
143474085|NCT02632721|517282528|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
143474086|NCT02632721|517282529|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
143474087|NCT02632721|517282530|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
143362986|NCT01140347|516871648|FG000|Overall Study|Withdrawal by Subject|13|||
143362987|NCT01140347|516871649|FG001|Overall Study|Withdrawal by Subject|8|||
143362988|NCT01515319|516871650|FG000|Overall Study|Withdrawal by Subject|0|||
143362989|NCT01515319|516871651|FG001|Overall Study|Withdrawal by Subject|0|||
143362990|NCT01515319|516871652|FG002|Overall Study|Withdrawal by Subject|0|||
143362991|NCT01515319|516871653|FG003|Overall Study|Withdrawal by Subject|0|||
143362992|NCT01515319|516871654|FG004|Overall Study|Withdrawal by Subject|0|||
143362993|NCT01515319|516871655|FG005|Overall Study|Withdrawal by Subject|0|||
143362994|NCT01515319|516871656|FG006|Overall Study|Withdrawal by Subject|1|||
143362995|NCT01515319|516871657|FG007|Overall Study|Withdrawal by Subject|0|||
143362996|NCT01515319|516871658|FG008|Overall Study|Withdrawal by Subject|0|||
143362997|NCT01515319|516871659|FG009|Overall Study|Withdrawal by Subject|0|||
143362998|NCT01515319|516871650|FG000|Overall Study|Adverse Event|0|||
143362999|NCT01515319|516871651|FG001|Overall Study|Adverse Event|0|||
143363000|NCT01515319|516871652|FG002|Overall Study|Adverse Event|0|||
143363001|NCT01515319|516871653|FG003|Overall Study|Adverse Event|0|||
143363002|NCT01515319|516871654|FG004|Overall Study|Adverse Event|0|||
143363003|NCT01515319|516871655|FG005|Overall Study|Adverse Event|0|||
143363004|NCT01515319|516871656|FG006|Overall Study|Adverse Event|0|||
143363005|NCT01515319|516871657|FG007|Overall Study|Adverse Event|0|||
143363006|NCT01515319|516871658|FG008|Overall Study|Adverse Event|3|||
143363007|NCT01515319|516871659|FG009|Overall Study|Adverse Event|0|||
143363008|NCT01515319|516871650|FG000|Overall Study|Protocol Violation|0|||
143363009|NCT01515319|516871651|FG001|Overall Study|Protocol Violation|0|||
143363010|NCT01515319|516871652|FG002|Overall Study|Protocol Violation|0|||
143363011|NCT01515319|516871653|FG003|Overall Study|Protocol Violation|0|||
143363012|NCT01515319|516871654|FG004|Overall Study|Protocol Violation|0|||
143363013|NCT01515319|516871655|FG005|Overall Study|Protocol Violation|0|||
143363014|NCT01515319|516871656|FG006|Overall Study|Protocol Violation|0|||
143363015|NCT01515319|516871657|FG007|Overall Study|Protocol Violation|0|||
143363016|NCT01515319|516871658|FG008|Overall Study|Protocol Violation|2|||
143363017|NCT01515319|516871659|FG009|Overall Study|Protocol Violation|0|||
143363018|NCT00901485|516871660|FG000|Overall Study|Lack of Efficacy|0|||
143363019|NCT00901485|516871661|FG001|Overall Study|Lack of Efficacy|2|||
143363020|NCT00901485|516871660|FG000|Overall Study|Withdrawal by Subject|1|||
143363021|NCT00901485|516871661|FG001|Overall Study|Withdrawal by Subject|2|||
143363022|NCT01871285|516871662|FG000|First Intervention (1 Day)|Adverse Event|1|||
143363023|NCT01871285|516871663|FG001|First Intervention (1 Day)|Adverse Event|0|||
143363024|NCT01871285|516871664|FG002|First Intervention (1 Day)|Adverse Event|0|||
143363025|NCT01871285|516871665|FG003|First Intervention (1 Day)|Adverse Event|0|||
143363026|NCT01871285|516871662|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
143363027|NCT01871285|516871663|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
143142491|NCT01232283|516069316|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
143142492|NCT01232283|516069317|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
143142493|NCT01232283|516069318|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
143142494|NCT01232283|516069319|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
143142495|NCT01232283|516069320|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
143142496|NCT01232283|516069321|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
143363028|NCT01871285|516871664|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
143363029|NCT01871285|516871665|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
143363030|NCT01959880|516871666|FG000|Overall Study|Withdrawal by Subject|11|||
143363031|NCT01959880|516871667|FG001|Overall Study|Withdrawal by Subject|13|||
143363032|NCT01959880|516871668|FG002|Overall Study|Withdrawal by Subject|8|||
143363033|NCT01959880|516871669|FG003|Overall Study|Withdrawal by Subject|7|||
143363034|NCT01959880|516871666|FG000|Overall Study|Death|1|||
143363035|NCT01959880|516871667|FG001|Overall Study|Death|10|||
143363036|NCT01959880|516871668|FG002|Overall Study|Death|1|||
143363037|NCT01959880|516871669|FG003|Overall Study|Death|2|||
143363038|NCT01959880|516871666|FG000|Overall Study|Lost to Follow-up|95|||
143363039|NCT01959880|516871667|FG001|Overall Study|Lost to Follow-up|18|||
143363040|NCT01959880|516871668|FG002|Overall Study|Lost to Follow-up|15|||
143363041|NCT01959880|516871669|FG003|Overall Study|Lost to Follow-up|8|||
143363042|NCT01959880|516871666|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
143363043|NCT01959880|516871667|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
143142497|NCT01232283|516069322|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
143363044|NCT01959880|516871668|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
143363045|NCT01959880|516871669|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
143363046|NCT01959880|516871666|FG000|Overall Study|Study completed early-FDA approved|1003|||
143363047|NCT01959880|516871667|FG001|Overall Study|Study completed early-FDA approved|311|||
143363048|NCT01959880|516871668|FG002|Overall Study|Study completed early-FDA approved|179|||
143363049|NCT01959880|516871669|FG003|Overall Study|Study completed early-FDA approved|152|||
143363050|NCT01919619|516871670|FG000|Overall Study|Physician Decision|1|||
143363051|NCT01919619|516871671|FG001|Overall Study|Physician Decision|1|||
143363052|NCT02624778|516873620|FG000|Overall Study|Lost to Follow-up|0|||
143363053|NCT02624778|516873621|FG001|Overall Study|Lost to Follow-up|0|||
143474088|NCT02632721|517282531|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
143474089|NCT02632721|517282532|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
143474090|NCT00544648|517282536|FG000|Overall Study|Withdrawal by Subject|1|||
143474091|NCT00544648|517282537|FG001|Overall Study|Withdrawal by Subject|0|||
143474092|NCT00544648|517282536|FG000|Overall Study|Adverse Event|1|||
143474093|NCT00544648|517282537|FG001|Overall Study|Adverse Event|1|||
143474094|NCT00544648|517282536|FG000|Overall Study|progression of disease|1|||
143474095|NCT00544648|517282537|FG001|Overall Study|progression of disease|0|||
143474096|NCT02663271|517282538|FG000|Overall Study|Withdrawal by Subject|5|||
143474097|NCT02663271|517282538|FG000|Overall Study|Lack of Efficacy|1|||
143474098|NCT01572675|517282539|FG000|Overall Study|End of prescribed treatment|140|||
143474099|NCT01572675|517282540|FG001|Overall Study|End of prescribed treatment|118|||
143474100|NCT01572675|517282539|FG000|Overall Study|Recovery|16|||
143474101|NCT01572675|517282540|FG001|Overall Study|Recovery|23|||
143474102|NCT01572675|517282539|FG000|Overall Study|Lack of Efficacy|31|||
143474103|NCT01572675|517282540|FG001|Overall Study|Lack of Efficacy|31|||
143474104|NCT01572675|517282539|FG000|Overall Study|Intolerance|6|||
143474105|NCT01572675|517282540|FG001|Overall Study|Intolerance|5|||
143474106|NCT01572675|517282539|FG000|Overall Study|Improved symptoms|8|||
143474107|NCT01572675|517282540|FG001|Overall Study|Improved symptoms|2|||
143474108|NCT01572675|517282539|FG000|Overall Study|Surgical intervention|3|||
143474109|NCT01572675|517282540|FG001|Overall Study|Surgical intervention|6|||
143474110|NCT01572675|517282539|FG000|Overall Study|Withdrawal by Subject|5|||
143474111|NCT01572675|517282540|FG001|Overall Study|Withdrawal by Subject|1|||
143474112|NCT01572675|517282539|FG000|Overall Study|Physician Decision|2|||
143474113|NCT01572675|517282540|FG001|Overall Study|Physician Decision|2|||
143474114|NCT01572675|517282539|FG000|Overall Study|Death unrelated to coxibs|1|||
143474115|NCT01572675|517282540|FG001|Overall Study|Death unrelated to coxibs|1|||
143474116|NCT01572675|517282539|FG000|Overall Study|Other disease detected|1|||
143474117|NCT01572675|517282540|FG001|Overall Study|Other disease detected|1|||
143474118|NCT01572675|517282539|FG000|Overall Study|Unknown reason|1|||
143474119|NCT01572675|517282540|FG001|Overall Study|Unknown reason|1|||
143474120|NCT01572675|517282539|FG000|Overall Study|Rheumatologist new evaluation|0|||
143474121|NCT01572675|517282540|FG001|Overall Study|Rheumatologist new evaluation|1|||
143474122|NCT01572675|517282539|FG000|Overall Study|Missing data|1|||
143474123|NCT01572675|517282540|FG001|Overall Study|Missing data|4|||
143474124|NCT01572675|517282539|FG000|Overall Study|Lost to Follow-up|22|||
143474125|NCT01572675|517282540|FG001|Overall Study|Lost to Follow-up|27|||
143474126|NCT03346057|517282541|FG000|Overall Study|Death|1|||
143474127|NCT03346057|517282542|FG001|Overall Study|Death|2|||
143474128|NCT03346057|517282543|FG002|Overall Study|Death|0|||
143474129|NCT03346057|517282544|FG003|Overall Study|Death|0|||
143474130|NCT03346057|517282541|FG000|Overall Study|Lost to Follow-up|0|||
143474131|NCT03346057|517282542|FG001|Overall Study|Lost to Follow-up|2|||
143474132|NCT03346057|517282543|FG002|Overall Study|Lost to Follow-up|1|||
143474133|NCT03346057|517282544|FG003|Overall Study|Lost to Follow-up|0|||
143474134|NCT03346057|517282541|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
143474135|NCT03346057|517282542|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
143474136|NCT03346057|517282543|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
143474137|NCT03346057|517282544|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
143474138|NCT03346057|517282541|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
143474139|NCT03346057|517282542|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
143474140|NCT03346057|517282543|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
143474141|NCT03346057|517282544|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
143474142|NCT03346057|517282541|FG000|Overall Study|Physician Decision|3|||
143474143|NCT03346057|517282542|FG001|Overall Study|Physician Decision|2|||
143474144|NCT03346057|517282543|FG002|Overall Study|Physician Decision|0|||
143474145|NCT03346057|517282544|FG003|Overall Study|Physician Decision|2|||
143474146|NCT03346057|517282541|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
143474147|NCT03346057|517282542|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
143474148|NCT03346057|517282543|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
143474149|NCT03346057|517282544|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
143474150|NCT03346057|517282541|FG000|Overall Study|Withdrawal by Subject|1|||
143474151|NCT03346057|517282542|FG001|Overall Study|Withdrawal by Subject|0|||
143474152|NCT03346057|517282543|FG002|Overall Study|Withdrawal by Subject|0|||
143474153|NCT03346057|517282544|FG003|Overall Study|Withdrawal by Subject|0|||
143474154|NCT02921269|517282545|FG000|Overall Study|Did not complete DLT period|1|||
143474155|NCT00504153|517282555|FG000|Overall Study|Withdrawal by Subject|1|||
143474156|NCT00504153|517282555|FG000|Overall Study|Adverse Event|4|||
143474157|NCT00504153|517282555|FG000|Overall Study|Death|1|||
143474158|NCT02322229|517282556|FG000|Overall Study|Physician Decision|2|||
143474159|NCT00521053|517282557|FG000|Observation Phase|Disease Progression|55|||
143474160|NCT00521053|517282557|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
143474161|NCT00521053|517282557|FG000|Observation Phase|Death|2|||
143474162|NCT00521053|517282557|FG000|Observation Phase|Adverse Event|1|||
143474163|NCT00521053|517282557|FG000|Observation Phase|Other non-study melanoma treatment|1|||
143474164|NCT00521053|517282557|FG000|Observation Phase|Physician Decision|1|||
143474165|NCT04029961|517282558|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
143474166|NCT04029961|517282559|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
143474167|NCT04029961|517282558|FG000|Overall Study|Change in Treatment Course|0|||
143474168|NCT04029961|517282559|FG001|Overall Study|Change in Treatment Course|1|||
143474169|NCT02281357|517282560|FG000|Overall Study|Adverse Event|2|||
143474170|NCT02281357|517282561|FG001|Overall Study|Adverse Event|1|||
143474171|NCT02281357|517282560|FG000|Overall Study|Lost to Follow-up|1|||
143474172|NCT02281357|517282561|FG001|Overall Study|Lost to Follow-up|0|||
143474173|NCT02281357|517282560|FG000|Overall Study|Withdrawal by Subject|4|||
143474174|NCT02281357|517282561|FG001|Overall Study|Withdrawal by Subject|3|||
143474175|NCT00228566|517282562|FG000|Overall Study|Adverse Event|31|||
143474176|NCT00228566|517282562|FG000|Overall Study|Lack of Efficacy|14|||
143474177|NCT00228566|517282562|FG000|Overall Study|Lost to Follow-up|16|||
143474178|NCT00228566|517282562|FG000|Overall Study|Physician Decision|5|||
143474179|NCT00228566|517282562|FG000|Overall Study|Withdrawal by Subject|4|||
143474180|NCT00228566|517282562|FG000|Overall Study|Miscellaneous|1|||
143474181|NCT02553265|517283869|FG000|Enrollment|Death|0|||
143474182|NCT02553265|517283870|FG001|Enrollment|Death|0|||
143474183|NCT02553265|517283871|FG002|Enrollment|Death|1|||
143474184|NCT02553265|517283869|FG000|First Intervention (28 Days)|Adverse Event|1|||
143474185|NCT02553265|517283870|FG001|First Intervention (28 Days)|Adverse Event|0|||
143474186|NCT02553265|517283871|FG002|First Intervention (28 Days)|Adverse Event|0|||
143474187|NCT02553265|517283869|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
143474188|NCT02553265|517283870|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
143363054|NCT02624778|516873622|FG002|Overall Study|Lost to Follow-up|1|||
143363055|NCT02624778|516873623|FG003|Overall Study|Lost to Follow-up|0|||
143363056|NCT02624778|516873624|FG004|Overall Study|Lost to Follow-up|0|||
143363057|NCT02624778|516873625|FG005|Overall Study|Lost to Follow-up|0|||
143363058|NCT02624778|516873626|FG006|Overall Study|Lost to Follow-up|0|||
143363059|NCT02624778|516873627|FG007|Overall Study|Lost to Follow-up|0|||
143363060|NCT02624778|516873628|FG008|Overall Study|Lost to Follow-up|0|||
143363061|NCT02624778|516873620|FG000|Overall Study|Withdrawal by Subject|0|||
143363062|NCT02624778|516873621|FG001|Overall Study|Withdrawal by Subject|1|||
143363063|NCT02624778|516873622|FG002|Overall Study|Withdrawal by Subject|0|||
143363064|NCT02624778|516873623|FG003|Overall Study|Withdrawal by Subject|0|||
143363065|NCT02624778|516873624|FG004|Overall Study|Withdrawal by Subject|0|||
143363066|NCT02624778|516873625|FG005|Overall Study|Withdrawal by Subject|1|||
143363067|NCT02624778|516873626|FG006|Overall Study|Withdrawal by Subject|1|||
143363068|NCT02624778|516873627|FG007|Overall Study|Withdrawal by Subject|1|||
143363069|NCT02624778|516873628|FG008|Overall Study|Withdrawal by Subject|1|||
143363070|NCT02624778|516873620|FG000|Overall Study|Adverse Event|0|||
143363071|NCT02624778|516873621|FG001|Overall Study|Adverse Event|0|||
143363072|NCT02624778|516873622|FG002|Overall Study|Adverse Event|0|||
143363073|NCT02624778|516873623|FG003|Overall Study|Adverse Event|0|||
143363074|NCT02624778|516873624|FG004|Overall Study|Adverse Event|0|||
143363075|NCT02624778|516873625|FG005|Overall Study|Adverse Event|0|||
143363076|NCT02624778|516873626|FG006|Overall Study|Adverse Event|0|||
143363077|NCT02624778|516873627|FG007|Overall Study|Adverse Event|0|||
143363078|NCT02624778|516873628|FG008|Overall Study|Adverse Event|2|||
143363079|NCT02624778|516873620|FG000|Overall Study|Death|0|||
143363080|NCT02624778|516873621|FG001|Overall Study|Death|0|||
143363081|NCT02624778|516873622|FG002|Overall Study|Death|0|||
143363082|NCT02624778|516873623|FG003|Overall Study|Death|0|||
143363083|NCT02624778|516873624|FG004|Overall Study|Death|0|||
143363084|NCT02624778|516873625|FG005|Overall Study|Death|0|||
143363085|NCT02624778|516873626|FG006|Overall Study|Death|1|||
143363086|NCT02624778|516873627|FG007|Overall Study|Death|0|||
143363087|NCT02624778|516873628|FG008|Overall Study|Death|0|||
143363088|NCT02624778|516873620|FG000|Overall Study|Physician Decision|0|||
143363089|NCT02624778|516873621|FG001|Overall Study|Physician Decision|0|||
143363090|NCT02624778|516873622|FG002|Overall Study|Physician Decision|0|||
143363091|NCT02624778|516873623|FG003|Overall Study|Physician Decision|0|||
143363092|NCT02624778|516873624|FG004|Overall Study|Physician Decision|0|||
143363093|NCT02624778|516873625|FG005|Overall Study|Physician Decision|0|||
143363094|NCT02624778|516873626|FG006|Overall Study|Physician Decision|0|||
143363095|NCT02624778|516873627|FG007|Overall Study|Physician Decision|3|||
143363096|NCT02624778|516873628|FG008|Overall Study|Physician Decision|3|||
143363097|NCT04091672|516873629|FG000|Overall Study|Death|6|||
143363098|NCT04091672|516873630|FG001|Overall Study|Death|6|||
143363099|NCT04091672|516873629|FG000|Overall Study|Lost to Follow-up|7|||
143363100|NCT04091672|516873630|FG001|Overall Study|Lost to Follow-up|7|||
143363101|NCT04091672|516873629|FG000|Overall Study|Withdrawal by Subject|3|||
143363102|NCT04091672|516873630|FG001|Overall Study|Withdrawal by Subject|3|||
143363103|NCT04091672|516873629|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
143363104|NCT04091672|516873630|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
143363105|NCT02268396|516873631|FG000|Overall Study|Adverse Event|3|||
143363106|NCT02268396|516873631|FG000|Overall Study|Administrative|2|||
143363107|NCT02268396|516873631|FG000|Overall Study|Withdrawal by Subject|1|||
143474189|NCT02553265|517283871|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
143474190|NCT02553265|517283869|FG000|Second Intervention (28 Days)|Adverse Event|1|||
143474191|NCT02553265|517283870|FG001|Second Intervention (28 Days)|Adverse Event|0|||
143474192|NCT02553265|517283871|FG002|Second Intervention (28 Days)|Adverse Event|0|||
143474193|NCT02553265|517283869|FG000|Third Intervention (28 Days)|Adverse Event|1|||
143474194|NCT02553265|517283870|FG001|Third Intervention (28 Days)|Adverse Event|0|||
143474195|NCT02553265|517283871|FG002|Third Intervention (28 Days)|Adverse Event|0|||
143474196|NCT02553265|517283869|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
143474197|NCT02553265|517283870|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
143142498|NCT01232283|516069323|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
143142499|NCT01232283|516069324|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
143142500|NCT01232283|516069325|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
143142501|NCT01232283|516069316|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
143363108|NCT02268396|516873631|FG000|Overall Study|Lost to Follow-up|2|||
143363109|NCT02268396|516873631|FG000|Overall Study|Protocol-Specified Criteria|2|||
143363110|NCT02268396|516873631|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
143363111|NCT04610684|516873632|FG000|Study Treatment|Withdrawal by Subject|1|||
143363112|NCT04610684|516873632|FG000|Study Treatment|Disease Progression|2|||
143363113|NCT04610684|516873632|FG000|Follow up|Death|2|||
143363114|NCT04610684|516873632|FG000|Follow up|Withdrawal by Subject|1|||
143363115|NCT02153788|516873633|FG000|Overall Study|Physician Decision|2|||
143363116|NCT02153788|516873634|FG001|Overall Study|Physician Decision|1|||
143363117|NCT00079937|516873635|FG000|Overall Study|Adverse Event|2|||
143363118|NCT00079937|516873636|FG001|Overall Study|Adverse Event|1|||
143363119|NCT00079937|516873635|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
143363120|NCT00079937|516873636|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
143363121|NCT00079937|516873635|FG000|Overall Study|Subject no longer requires study drug|3|||
143363122|NCT00079937|516873636|FG001|Overall Study|Subject no longer requires study drug|0|||
143363123|NCT00079937|516873635|FG000|Overall Study|Protocol Violation|8|||
143363124|NCT00079937|516873636|FG001|Overall Study|Protocol Violation|6|||
143363125|NCT00079937|516873635|FG000|Overall Study|Withdrawal by Subject|21|||
143363126|NCT00079937|516873636|FG001|Overall Study|Withdrawal by Subject|7|||
143363127|NCT00079937|516873635|FG000|Overall Study|Lost to Follow-up|12|||
143363128|NCT00079937|516873636|FG001|Overall Study|Lost to Follow-up|5|||
143363129|NCT00079937|516873635|FG000|Overall Study|Administrative problems|22|||
143363130|NCT00079937|516873636|FG001|Overall Study|Administrative problems|11|||
143363131|NCT02949271|516873637|FG000|Overall Study|Lack of Efficacy|5|||
143363132|NCT02949271|516873638|FG001|Overall Study|Lack of Efficacy|4|||
143363133|NCT02949271|516873637|FG000|Overall Study|Lost to Follow-up|3|||
143363134|NCT02949271|516873638|FG001|Overall Study|Lost to Follow-up|6|||
143363135|NCT02949271|516873637|FG000|Overall Study|Physician Decision|5|||
143363136|NCT02949271|516873638|FG001|Overall Study|Physician Decision|5|||
143363137|NCT02949271|516873637|FG000|Overall Study|Protocol Violation|6|||
143363138|NCT02949271|516873638|FG001|Overall Study|Protocol Violation|3|||
143363139|NCT02949271|516873637|FG000|Overall Study|Withdrawal by Subject|1|||
143363140|NCT02949271|516873638|FG001|Overall Study|Withdrawal by Subject|0|||
143363141|NCT02949271|516873637|FG000|Overall Study|Delivered prior to intervention|7|||
143363142|NCT02949271|516873638|FG001|Overall Study|Delivered prior to intervention|9|||
143363143|NCT02949271|516873637|FG000|Overall Study|Outside the window for cervical dilation|2|||
143363144|NCT02949271|516873638|FG001|Overall Study|Outside the window for cervical dilation|3|||
143363145|NCT05458102|516873641|FG000|Overall Study|Withdrew consent|2|||
143363146|NCT05458102|516873642|FG001|Overall Study|Withdrew consent|0|||
143363147|NCT05458102|516873641|FG000|Overall Study|Adverse Event|1|||
143363148|NCT05458102|516873642|FG001|Overall Study|Adverse Event|0|||
143363149|NCT05458102|516873641|FG000|Overall Study|Enrolled but never treated|1|||
143363150|NCT05458102|516873642|FG001|Overall Study|Enrolled but never treated|0|||
143363151|NCT05458102|516873641|FG000|Overall Study|Protocol Violation|1|||
143363152|NCT05458102|516873642|FG001|Overall Study|Protocol Violation|0|||
143363153|NCT00852475|516873651|FG000|Overall Study|Lost to Follow-up|3|||
143363154|NCT00852475|516873652|FG001|Overall Study|Lost to Follow-up|4|||
143363155|NCT00515086|516873653|FG000|Overall Study|Adverse Event|1|||
143363156|NCT00515086|516873654|FG001|Overall Study|Adverse Event|1|||
143363157|NCT00515086|516873655|FG002|Overall Study|Adverse Event|2|||
143363158|NCT00515086|516873656|FG003|Overall Study|Adverse Event|3|||
143363159|NCT00515086|516873653|FG000|Overall Study|Administrative|1|||
143363160|NCT00515086|516873654|FG001|Overall Study|Administrative|1|||
143363161|NCT00515086|516873655|FG002|Overall Study|Administrative|0|||
143363162|NCT00515086|516873656|FG003|Overall Study|Administrative|0|||
143363163|NCT00515086|516873653|FG000|Overall Study|Withdrawal by Subject|1|||
143363164|NCT00515086|516873654|FG001|Overall Study|Withdrawal by Subject|0|||
143363165|NCT00515086|516873655|FG002|Overall Study|Withdrawal by Subject|0|||
143363166|NCT00515086|516873656|FG003|Overall Study|Withdrawal by Subject|1|||
143363167|NCT00515086|516873653|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
143474198|NCT02553265|517283871|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
143474199|NCT01809132|517283872|FG000|Overall Study|Withdrawal by Subject|0|||
143474200|NCT01809132|517283873|FG001|Overall Study|Withdrawal by Subject|0|||
143474201|NCT01809132|517283874|FG002|Overall Study|Withdrawal by Subject|1|||
143474202|NCT03583450|517283875|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
143474203|NCT03583450|517283876|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
143474204|NCT01446016|517283877|FG000|Overall Study|Lost to Follow-up|3|||
143474205|NCT01446016|517283877|FG000|Overall Study|Withdrawal by Subject|1|||
143474206|NCT01446016|517283877|FG000|Overall Study|Toxicity|3|||
143474207|NCT00791258|517283878|FG000|Overall Study|Adverse Event|87|||
143474208|NCT00791258|517283878|FG000|Overall Study|Lost to Follow-up|18|||
143474209|NCT00791258|517283878|FG000|Overall Study|Protocol Violation|109|||
143474210|NCT00791258|517283878|FG000|Overall Study|Withdrawal by Subject|40|||
143474211|NCT00791258|517283878|FG000|Overall Study|Did not take medication for >3 days|1|||
143474212|NCT00791258|517283878|FG000|Overall Study|subject left area|2|||
143474213|NCT00791258|517283878|FG000|Overall Study|non-compliance|3|||
143474214|NCT00791258|517283878|FG000|Overall Study|Subject incarcerated|1|||
143474215|NCT00791258|517283878|FG000|Overall Study|Subject required restricted medication|1|||
143474216|NCT00791258|517283878|FG000|Overall Study|Lack of Efficacy|1|||
143474217|NCT00041080|517283879|FG000|Overall Study|Adverse Event|21|||
143474218|NCT00041080|517283880|FG001|Overall Study|Adverse Event|1|||
143474219|NCT00041080|517283879|FG000|Overall Study|Withdrawal by Subject|6|||
143474220|NCT00041080|517283880|FG001|Overall Study|Withdrawal by Subject|6|||
143474221|NCT00041080|517283879|FG000|Overall Study|Concommitant Illness/Other|1|||
143474222|NCT00041080|517283880|FG001|Overall Study|Concommitant Illness/Other|2|||
143474223|NCT00041080|517283879|FG000|Overall Study|Did not start therapy|1|||
143474224|NCT00041080|517283880|FG001|Overall Study|Did not start therapy|1|||
143474225|NCT00041080|517283879|FG000|Overall Study|Ineligible|1|||
143474226|NCT00041080|517283880|FG001|Overall Study|Ineligible|0|||
143474227|NCT00436618|517283881|FG000|Overall Study|Withdrawal by Subject|5|||
143474228|NCT00436618|517283882|FG001|Overall Study|Withdrawal by Subject|8|||
143474229|NCT00436618|517283883|FG002|Overall Study|Withdrawal by Subject|11|||
143474230|NCT00436618|517283881|FG000|Overall Study|Adverse Event|8|||
143474231|NCT00436618|517283882|FG001|Overall Study|Adverse Event|8|||
143474232|NCT00436618|517283883|FG002|Overall Study|Adverse Event|9|||
143474233|NCT00436618|517283881|FG000|Overall Study|Alternate Treatment|3|||
143474234|NCT00436618|517283882|FG001|Overall Study|Alternate Treatment|4|||
143474235|NCT00436618|517283883|FG002|Overall Study|Alternate Treatment|12|||
143474236|NCT00436618|517283881|FG000|Overall Study|Other Medical Problems|3|||
143474237|NCT00436618|517283882|FG001|Overall Study|Other Medical Problems|1|||
143474238|NCT00436618|517283883|FG002|Overall Study|Other Medical Problems|7|||
143474239|NCT00436618|517283881|FG000|Overall Study|Death|4|||
143474240|NCT00436618|517283882|FG001|Overall Study|Death|2|||
143474241|NCT00436618|517283883|FG002|Overall Study|Death|3|||
143142502|NCT01232283|516069317|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
143142503|NCT01232283|516069318|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
143142504|NCT01232283|516069319|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
143142505|NCT01232283|516069320|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
143142506|NCT01232283|516069321|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
143142507|NCT01232283|516069322|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
143142508|NCT01232283|516069323|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
143142509|NCT01232283|516069324|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
143142510|NCT01232283|516069325|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
143142511|NCT01232283|516069316|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
143142512|NCT01232283|516069317|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
143142513|NCT01232283|516069318|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
143142514|NCT01232283|516069319|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
143474242|NCT00436618|517283881|FG000|Overall Study|New Primary or Other Reasons|6|||
143474243|NCT00436618|517283882|FG001|Overall Study|New Primary or Other Reasons|2|||
143474244|NCT00436618|517283883|FG002|Overall Study|New Primary or Other Reasons|12|||
143142515|NCT01232283|516069320|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
143142516|NCT01232283|516069321|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
143142517|NCT01232283|516069322|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
143474245|NCT00436618|517283881|FG000|Overall Study|Still on treatment|1|||
143474246|NCT00436618|517283882|FG001|Overall Study|Still on treatment|2|||
143474247|NCT00436618|517283883|FG002|Overall Study|Still on treatment|7|||
143474248|NCT01011439|517283884|FG000|Overall Study|Death|37|||
143474249|NCT01011439|517283884|FG000|Overall Study|Lost to Follow-up|4|||
143474250|NCT01011439|517283884|FG000|Overall Study|Withdrawal by Subject|1|||
143474251|NCT01011439|517283884|FG000|Overall Study|Sponsor's decision|15|||
143474252|NCT05418673|517283885|FG000|Overall Study|Study Terminated by Sponsor|2|||
143474253|NCT05418673|517283886|FG001|Overall Study|Study Terminated by Sponsor|4|||
143474254|NCT05418673|517283885|FG000|Overall Study|Lost to Follow-up|1|||
143474255|NCT05418673|517283886|FG001|Overall Study|Lost to Follow-up|0|||
143474256|NCT02316340|517283887|FG000|First Progression|Clinical progression|2|||
143474257|NCT02316340|517283888|FG001|First Progression|Clinical progression|1|||
143474258|NCT02316340|517283887|FG000|First Progression|Withdrawal by Subject|1|||
143474259|NCT02316340|517283888|FG001|First Progression|Withdrawal by Subject|0|||
143474260|NCT01835015|517283889|FG000|Overall Study|Adverse Event|0|||
143474261|NCT01835015|517283890|FG001|Overall Study|Adverse Event|0|||
143474262|NCT01835015|517283891|FG002|Overall Study|Adverse Event|1|||
143474263|NCT01835015|517283892|FG003|Overall Study|Adverse Event|0|||
143474264|NCT01835015|517283893|FG004|Overall Study|Adverse Event|0|||
143474265|NCT01986920|517283896|FG000|A- 101 25%|Withdrawal by Subject|1|||
143474266|NCT01986920|517283897|FG001|A- 101 25%|Withdrawal by Subject|0|||
143474267|NCT01986920|517283898|FG002|A- 101 25%|Withdrawal by Subject|0|||
143474268|NCT01986920|517283899|FG003|A- 101 25%|Withdrawal by Subject|0|||
143474269|NCT01986920|517283896|FG000|A-101 32.5%|Withdrawal by Subject|0|||
143474270|NCT01986920|517283897|FG001|A-101 32.5%|Withdrawal by Subject|1|||
143474271|NCT01986920|517283898|FG002|A-101 32.5%|Withdrawal by Subject|0|||
143474272|NCT01986920|517283899|FG003|A-101 32.5%|Withdrawal by Subject|0|||
143474273|NCT01986920|517283896|FG000|A-101 40%|Withdrawal by Subject|0|||
143474274|NCT01986920|517283897|FG001|A-101 40%|Withdrawal by Subject|0|||
143474275|NCT01986920|517283898|FG002|A-101 40%|Withdrawal by Subject|1|||
143474276|NCT01986920|517283899|FG003|A-101 40%|Withdrawal by Subject|0|||
143474277|NCT01986920|517283896|FG000|Placebo|Withdrawal by Subject|0|||
143474278|NCT01986920|517283897|FG001|Placebo|Withdrawal by Subject|0|||
143474279|NCT01986920|517283898|FG002|Placebo|Withdrawal by Subject|0|||
143474280|NCT01986920|517283899|FG003|Placebo|Withdrawal by Subject|1|||
143474281|NCT01241552|517283904|FG000|Overall Study|Lack of Efficacy|1|||
143474282|NCT01241552|517283905|FG001|Overall Study|Lack of Efficacy|0|||
143474283|NCT01241552|517283906|FG002|Overall Study|Lack of Efficacy|0|||
143474284|NCT01241552|517283907|FG003|Overall Study|Lack of Efficacy|0|||
143474285|NCT01241552|517283904|FG000|Overall Study|Death|26|||
143474286|NCT01241552|517283905|FG001|Overall Study|Death|30|||
143474287|NCT01241552|517283906|FG002|Overall Study|Death|20|||
143474288|NCT01241552|517283907|FG003|Overall Study|Death|25|||
143474289|NCT01241552|517283904|FG000|Overall Study|Adverse Event|1|||
143474290|NCT01241552|517283905|FG001|Overall Study|Adverse Event|1|||
143474291|NCT01241552|517283906|FG002|Overall Study|Adverse Event|0|||
143474292|NCT01241552|517283907|FG003|Overall Study|Adverse Event|0|||
143474293|NCT01241552|517283904|FG000|Overall Study|Technical Problems|2|||
143474294|NCT01241552|517283905|FG001|Overall Study|Technical Problems|0|||
143474295|NCT01241552|517283906|FG002|Overall Study|Technical Problems|2|||
143474296|NCT01241552|517283907|FG003|Overall Study|Technical Problems|2|||
143474297|NCT01241552|517283904|FG000|Overall Study|Progressive Disease|0|||
143474298|NCT01241552|517283905|FG001|Overall Study|Progressive Disease|0|||
143474299|NCT01241552|517283906|FG002|Overall Study|Progressive Disease|1|||
143474300|NCT01241552|517283907|FG003|Overall Study|Progressive Disease|2|||
143474301|NCT01241552|517283904|FG000|Overall Study|Protocol Violation|0|||
143474302|NCT01241552|517283905|FG001|Overall Study|Protocol Violation|2|||
143474303|NCT01241552|517283906|FG002|Overall Study|Protocol Violation|6|||
143474304|NCT01241552|517283907|FG003|Overall Study|Protocol Violation|1|||
143474305|NCT01241552|517283904|FG000|Overall Study|Withdrawal by Subject|7|||
143474306|NCT01241552|517283905|FG001|Overall Study|Withdrawal by Subject|15|||
143474307|NCT01241552|517283906|FG002|Overall Study|Withdrawal by Subject|14|||
143474308|NCT01241552|517283907|FG003|Overall Study|Withdrawal by Subject|15|||
143474309|NCT01241552|517283904|FG000|Overall Study|Physician Decision|2|||
143474310|NCT01241552|517283905|FG001|Overall Study|Physician Decision|4|||
143474311|NCT01241552|517283906|FG002|Overall Study|Physician Decision|2|||
143474312|NCT01241552|517283907|FG003|Overall Study|Physician Decision|3|||
143474313|NCT01241552|517283904|FG000|Overall Study|Lost to Follow-up|2|||
143474314|NCT01241552|517283905|FG001|Overall Study|Lost to Follow-up|11|||
143474315|NCT01241552|517283906|FG002|Overall Study|Lost to Follow-up|15|||
143474316|NCT01241552|517283907|FG003|Overall Study|Lost to Follow-up|16|||
143474317|NCT00874770|517283910|FG000|Overall Study|Lack of Efficacy|2|||
143474318|NCT00874770|517283911|FG001|Overall Study|Lack of Efficacy|0|||
143474319|NCT00874770|517283912|FG002|Overall Study|Lack of Efficacy|0|||
143142518|NCT01232283|516069323|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
143474320|NCT00874770|517283913|FG003|Overall Study|Lack of Efficacy|2|||
143474321|NCT00874770|517283910|FG000|Overall Study|Adverse Event|1|||
143474322|NCT00874770|517283911|FG001|Overall Study|Adverse Event|1|||
143474323|NCT00874770|517283912|FG002|Overall Study|Adverse Event|4|||
143474324|NCT00874770|517283913|FG003|Overall Study|Adverse Event|2|||
143474325|NCT00874770|517283910|FG000|Overall Study|Lost to Follow-up|1|||
143474326|NCT00874770|517283911|FG001|Overall Study|Lost to Follow-up|0|||
143474327|NCT00874770|517283912|FG002|Overall Study|Lost to Follow-up|0|||
143142519|NCT01232283|516069324|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
143142520|NCT01232283|516069325|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
143474328|NCT00874770|517283913|FG003|Overall Study|Lost to Follow-up|1|||
143474329|NCT00874770|517283910|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
143474330|NCT00874770|517283911|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
143474331|NCT00874770|517283912|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
143474332|NCT00874770|517283913|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
143474333|NCT05215262|517283914|FG000|Overall Study|Lost to Follow-up|12|||
143474334|NCT05215262|517283915|FG001|Overall Study|Lost to Follow-up|0|||
143474335|NCT00718549|517283917|FG000|Induction Phase|Disease Progression|1|||
143474336|NCT00718549|517283918|FG001|Induction Phase|Disease Progression|0|||
143474337|NCT00718549|517283919|FG002|Induction Phase|Disease Progression|0|||
143474338|NCT00718549|517283917|FG000|Induction Phase|Eligibility Criteria Violation|2|||
143474339|NCT00718549|517283918|FG001|Induction Phase|Eligibility Criteria Violation|0|||
143474340|NCT00718549|517283919|FG002|Induction Phase|Eligibility Criteria Violation|0|||
143474341|NCT00718549|517283917|FG000|Induction Phase|Early Termination - No Additional Info|59|||
143474342|NCT00718549|517283918|FG001|Induction Phase|Early Termination - No Additional Info|0|||
143474343|NCT00718549|517283919|FG002|Induction Phase|Early Termination - No Additional Info|0|||
143474344|NCT00718549|517283917|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
143474345|NCT00718549|517283918|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
143474346|NCT00718549|517283919|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
143474347|NCT00718549|517283917|FG000|Maintenance/ Observation Phase|Death|0|||
143474348|NCT00718549|517283918|FG001|Maintenance/ Observation Phase|Death|1|||
143474349|NCT00718549|517283919|FG002|Maintenance/ Observation Phase|Death|2|||
143474350|NCT00718549|517283917|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
143474351|NCT00718549|517283918|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
143474352|NCT00718549|517283919|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
143474353|NCT00718549|517283917|FG000|Maintenance/ Observation Phase|Progression|0|||
143474354|NCT00718549|517283918|FG001|Maintenance/ Observation Phase|Progression|5|||
143474355|NCT00718549|517283919|FG002|Maintenance/ Observation Phase|Progression|14|||
143474356|NCT00718549|517283917|FG000|Maintenance/ Observation Phase|Relapse|0|||
143474357|NCT00718549|517283918|FG001|Maintenance/ Observation Phase|Relapse|3|||
143474358|NCT00718549|517283919|FG002|Maintenance/ Observation Phase|Relapse|2|||
143474359|NCT01353508|517283920|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
143474360|NCT01353508|517283921|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
143474361|NCT01353508|517283922|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
143474362|NCT01353508|517283923|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
143474363|NCT01353508|517283920|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
143474364|NCT01353508|517283921|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
143474365|NCT01353508|517283922|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
143474366|NCT01353508|517283923|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
143474367|NCT00646906|517283924|FG000|Crossover Period 1|Withdrawal by Subject|1|||
143474368|NCT00646906|517283925|FG001|Crossover Period 1|Withdrawal by Subject|0|||
143142521|NCT01232283|516069316|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
143142522|NCT01232283|516069317|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
143142523|NCT01232283|516069318|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
143142524|NCT01232283|516069319|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
143142525|NCT01232283|516069320|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
143142526|NCT01232283|516069321|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
143142527|NCT01232283|516069322|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
143142528|NCT01232283|516069323|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
143474369|NCT00646906|517283926|FG002|Crossover Period 1|Withdrawal by Subject|0|||
143474370|NCT00646906|517283927|FG003|Crossover Period 1|Withdrawal by Subject|0|||
143474371|NCT00646906|517283928|FG004|Crossover Period 1|Withdrawal by Subject|0|||
143474372|NCT00646906|517283929|FG005|Crossover Period 1|Withdrawal by Subject|1|||
143474373|NCT00646906|517283930|FG006|Crossover Period 1|Withdrawal by Subject|0|||
143474374|NCT00646906|517283924|FG000|Crossover Period 2|Withdrawal by Subject|0|||
143474375|NCT00646906|517283925|FG001|Crossover Period 2|Withdrawal by Subject|1|||
143474376|NCT00646906|517283926|FG002|Crossover Period 2|Withdrawal by Subject|2|||
143474377|NCT00646906|517283927|FG003|Crossover Period 2|Withdrawal by Subject|1|||
143474378|NCT00646906|517283928|FG004|Crossover Period 2|Withdrawal by Subject|0|||
143474379|NCT00646906|517283929|FG005|Crossover Period 2|Withdrawal by Subject|0|||
143474380|NCT00646906|517283930|FG006|Crossover Period 2|Withdrawal by Subject|0|||
143474381|NCT00646906|517283924|FG000|Crossover Period 2|Physician Decision|0|||
143474382|NCT00646906|517283925|FG001|Crossover Period 2|Physician Decision|0|||
143474383|NCT00646906|517283926|FG002|Crossover Period 2|Physician Decision|0|||
143474384|NCT00646906|517283927|FG003|Crossover Period 2|Physician Decision|0|||
143474385|NCT00646906|517283928|FG004|Crossover Period 2|Physician Decision|0|||
143474386|NCT00646906|517283929|FG005|Crossover Period 2|Physician Decision|0|||
143474387|NCT00646906|517283930|FG006|Crossover Period 2|Physician Decision|1|||
143474388|NCT02448225|517283931|FG000|Overall Study|Withdrawal by Subject|1|||
143474389|NCT02448225|517283931|FG000|Overall Study|Did not get FSPG scan|18|||
143474390|NCT02448225|517283931|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
143474391|NCT04060563|517283932|FG000|Overall Study|Lost to Follow-up|1|||
143474392|NCT04060563|517283933|FG001|Overall Study|Lost to Follow-up|1|||
143474393|NCT04060563|517283932|FG000|Overall Study|Physician Decision|0|||
143474394|NCT04060563|517283933|FG001|Overall Study|Physician Decision|1|||
143142529|NCT01232283|516069324|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
143142530|NCT01232283|516069325|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
143474395|NCT04422990|517283936|FG000|Overall Study|Withdrawal by Subject|0|||
143474396|NCT04422990|517283937|FG001|Overall Study|Withdrawal by Subject|1|||
143474397|NCT04422990|517283936|FG000|Overall Study|Travel|3|||
143474398|NCT04422990|517283937|FG001|Overall Study|Travel|0|||
143474399|NCT00433914|517283938|FG000|Overall Study|Withdrawal by Subject|0|||
143474400|NCT00433914|517283939|FG001|Overall Study|Withdrawal by Subject|2|||
143474401|NCT00433914|517283938|FG000|Overall Study|Lost to Follow-up|0|||
143474402|NCT00433914|517283939|FG001|Overall Study|Lost to Follow-up|1|||
143474403|NCT02486653|517283940|FG000|Overall Study|Withdrawal by Subject|1|||
143474404|NCT02486653|517283941|FG001|Overall Study|Withdrawal by Subject|3|||
143474405|NCT02486653|517283940|FG000|Overall Study|Protocol Violation|1|||
143474406|NCT02486653|517283941|FG001|Overall Study|Protocol Violation|0|||
143474407|NCT02486653|517283940|FG000|Overall Study|surgery cancelled|4|||
143474408|NCT02486653|517283941|FG001|Overall Study|surgery cancelled|1|||
143474409|NCT00766090|517283942|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
143474410|NCT00766090|517283943|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
143474411|NCT00766090|517283944|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
143474412|NCT00766090|517283945|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
143474413|NCT00766090|517283946|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
143474414|NCT00766090|517283947|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
143474415|NCT00766090|517283948|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
143474416|NCT00766090|517283949|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
143474417|NCT00766090|517283950|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
143474418|NCT00766090|517283951|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
143474419|NCT00766090|517283952|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
143474420|NCT00766090|517283953|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
143474421|NCT00766090|517283942|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
143474422|NCT00766090|517283943|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
143474423|NCT00766090|517283944|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
143474424|NCT00766090|517283945|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
143474425|NCT00766090|517283946|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
143474426|NCT00766090|517283947|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
143474427|NCT00766090|517283948|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
143474428|NCT00766090|517283949|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
143474429|NCT00766090|517283950|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
143474430|NCT00766090|517283951|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
143474431|NCT00766090|517283952|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
143474432|NCT00766090|517283953|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
143474433|NCT00766090|517283942|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
143474434|NCT00766090|517283943|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
143474435|NCT00766090|517283944|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
143474436|NCT00766090|517283945|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
143474437|NCT00766090|517283946|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
143474438|NCT00766090|517283947|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
143474439|NCT00766090|517283948|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
143474440|NCT00766090|517283949|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
143474441|NCT00766090|517283950|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
143474442|NCT00766090|517283951|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
143474443|NCT00766090|517283952|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
143474444|NCT00766090|517283953|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
143474445|NCT00766090|517283942|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
143474446|NCT00766090|517283943|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
143474447|NCT00766090|517283944|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
143474448|NCT00766090|517283945|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
143474449|NCT00766090|517283946|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
143474450|NCT00766090|517283947|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
143474451|NCT00766090|517283948|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
143474452|NCT00766090|517283949|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
143474453|NCT00766090|517283950|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
143474454|NCT00766090|517283951|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
143474455|NCT00766090|517283952|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
143474456|NCT00766090|517283953|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
143474457|NCT00766090|517283942|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
143474458|NCT00766090|517283943|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
143474459|NCT00766090|517283944|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
143474460|NCT00766090|517283945|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
143474461|NCT00766090|517283946|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
143474462|NCT00766090|517283947|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
143474463|NCT00766090|517283948|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
143474464|NCT00766090|517283949|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
143474465|NCT00766090|517283950|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
143014087|NCT01414062|515591609|FG001|Overall Study|Left Country|1|||
143474466|NCT00766090|517283951|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
143474467|NCT00766090|517283952|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
143142531|NCT01232283|516069316|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
143142532|NCT01232283|516069317|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
143474468|NCT00766090|517283953|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
143474469|NCT00766090|517283942|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
143474470|NCT00766090|517283943|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
143474471|NCT00766090|517283944|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
143474472|NCT00766090|517283945|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
143474473|NCT00766090|517283946|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
143474474|NCT00766090|517283947|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
143474475|NCT00766090|517283948|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
143474476|NCT00766090|517283949|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
143474477|NCT00766090|517283950|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
143474478|NCT00766090|517283951|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
143474479|NCT00766090|517283952|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
143474480|NCT00766090|517283953|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
143474481|NCT00766090|517283942|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
143474482|NCT00766090|517283943|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
143474483|NCT00766090|517283944|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
143474484|NCT00766090|517283945|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
143474485|NCT00766090|517283946|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
143474486|NCT00766090|517283947|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
143474487|NCT00766090|517283948|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
143474488|NCT00766090|517283949|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
143474489|NCT00766090|517283950|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
143474490|NCT00766090|517283951|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
143474491|NCT00766090|517283952|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
143474492|NCT00766090|517283953|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
143474493|NCT00766090|517283942|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
143474494|NCT00766090|517283943|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
143474495|NCT00766090|517283944|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
143474496|NCT00766090|517283945|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
143474497|NCT00766090|517283946|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
143474498|NCT00766090|517283947|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
143474499|NCT00766090|517283948|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
143474500|NCT00766090|517283949|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
143474501|NCT00766090|517283950|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
143474502|NCT00766090|517283951|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
143474503|NCT00766090|517283952|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
143474504|NCT00766090|517283953|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
143474505|NCT00766090|517283942|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
143474506|NCT00766090|517283943|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
143474507|NCT00766090|517283944|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
143474508|NCT00766090|517283945|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
143474509|NCT00766090|517283946|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
143474510|NCT00766090|517283947|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
143474511|NCT00766090|517283948|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
143474512|NCT00766090|517283949|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
143474513|NCT00766090|517283950|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
143474514|NCT00766090|517283951|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
143474515|NCT00766090|517283952|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
143474516|NCT00766090|517283953|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
143474517|NCT00766090|517283942|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
143474518|NCT00766090|517283943|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
143474519|NCT00766090|517283944|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
143474520|NCT00766090|517283945|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
143474521|NCT00766090|517283946|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
143474522|NCT00766090|517283947|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
143474523|NCT00766090|517283948|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
143474524|NCT00766090|517283949|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
143142533|NCT01232283|516069318|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
143474525|NCT00766090|517283950|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
143142534|NCT01232283|516069319|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
143474526|NCT00766090|517283951|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
143142535|NCT01232283|516069320|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
143142536|NCT01232283|516069321|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
143142537|NCT01232283|516069322|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
143474527|NCT00766090|517283952|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
143474528|NCT00766090|517283953|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
143142538|NCT01232283|516069323|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
143142539|NCT01232283|516069324|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
143474529|NCT01230554|517283957|FG000|Overall Study|Lost to Follow-up|2|||
143474530|NCT01230554|517283957|FG000|Overall Study|Inability to maintain visit schedule|1|||
143142540|NCT01232283|516069325|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
143142541|NCT01232283|516069316|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
143474531|NCT00911625|517283958|FG000|Overall Study|Lost to Follow-up|7|||
143474532|NCT00911625|517283959|FG001|Overall Study|Lost to Follow-up|0|||
143474533|NCT01289821|517283960|FG000|Treatment Period|Withdrawal by Subject|1|||
143474534|NCT01289821|517283960|FG000|Treatment Period|Physician Decision|3|||
143474535|NCT01289821|517283960|FG000|Treatment Period|Adverse Event|4|||
143474536|NCT01289821|517283960|FG000|Treatment Period|Radiological Progression|43|||
143474537|NCT01289821|517283960|FG000|Treatment Period|Clinical Progression|2|||
143474538|NCT01289821|517283960|FG000|Treatment Period|Therapeutic procedure required|1|||
143474539|NCT01289821|517283960|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
143474540|NCT01289821|517283960|FG000|Safety Follow-up Period|Protocol Violation|3|||
143474541|NCT01289821|517283960|FG000|Safety Follow-up Period|Unspecified reason|1|||
143474542|NCT01289821|517283960|FG000|Survival Follow-up Period|Protocol Violation|1|||
143474543|NCT01289821|517283960|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
143474544|NCT01289821|517283960|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
143474545|NCT03061175|517283977|FG000|Baseline|Participant was deemed ineligible|1|||
143474546|NCT03061175|517283978|FG001|Baseline|Participant was deemed ineligible|0|||
143474547|NCT03061175|517283977|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
143474548|NCT03061175|517283978|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
143474549|NCT03061175|517283977|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
143474550|NCT03061175|517283978|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
143474551|NCT03061175|517283977|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
143474552|NCT03061175|517283978|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
143474553|NCT04166383|517283980|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
143474554|NCT04166383|517283980|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
143474555|NCT04166383|517283980|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
143474556|NCT03044886|517283982|FG000|Overall Study|Lost to Follow-up|15|||
143474557|NCT03044886|517283983|FG001|Overall Study|Lost to Follow-up|10|||
143474558|NCT03044886|517283984|FG002|Overall Study|Lost to Follow-up|12|||
143474559|NCT01174238|517283986|FG000|Overall Study|Lost to Follow-up|2|||
143474560|NCT00732251|517283994|FG000|Overall Study|Lost to Follow-up|3|||
143474561|NCT00732251|517283994|FG000|Overall Study|Withdrawal by Subject|3|||
143474562|NCT00732251|517283994|FG000|Overall Study|Early Term due to Site Closure|1|||
143474563|NCT00805025|517283995|FG000|Overall Study|Screened but not enrolled/treated|42|||
143474564|NCT00805025|517283995|FG000|Overall Study|Adverse Event|4|||
143474565|NCT00805025|517283995|FG000|Overall Study|Withdrawal by Subject|2|||
143474566|NCT00805025|517283995|FG000|Overall Study|Physician Decision|1|||
143474567|NCT03007979|517283999|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
143474568|NCT01624259|517284000|FG000|Overall Study|Adverse Event|18|||
143474569|NCT01624259|517284001|FG001|Overall Study|Adverse Event|18|||
143474570|NCT01624259|517284000|FG000|Overall Study|Protocol Violation|1|||
143474571|NCT01624259|517284001|FG001|Overall Study|Protocol Violation|2|||
143474572|NCT01624259|517284000|FG000|Overall Study|Withdrawal by Subject|5|||
143474573|NCT01624259|517284001|FG001|Overall Study|Withdrawal by Subject|7|||
143474574|NCT01624259|517284000|FG000|Overall Study|Physician Decision|1|||
143474575|NCT01624259|517284001|FG001|Overall Study|Physician Decision|1|||
143474576|NCT01624259|517284000|FG000|Overall Study|Lost to Follow-up|2|||
143474577|NCT01624259|517284001|FG001|Overall Study|Lost to Follow-up|3|||
143474578|NCT01624259|517284000|FG000|Overall Study|Abnormal laboratory measure|3|||
143474579|NCT01624259|517284001|FG001|Overall Study|Abnormal laboratory measure|0|||
143474580|NCT00232141|517284002|FG000|Overall Study|Adverse Event|9|||
143474581|NCT00232141|517284003|FG001|Overall Study|Adverse Event|4|||
143474582|NCT00232141|517284002|FG000|Overall Study|Lack of Efficacy|0|||
143474583|NCT00232141|517284003|FG001|Overall Study|Lack of Efficacy|3|||
143474584|NCT00232141|517284002|FG000|Overall Study|Lost to Follow-up|9|||
143474585|NCT00232141|517284003|FG001|Overall Study|Lost to Follow-up|6|||
143474586|NCT00232141|517284002|FG000|Overall Study|Other|8|||
143474587|NCT00232141|517284003|FG001|Overall Study|Other|10|||
143474588|NCT00232141|517284002|FG000|Overall Study|Withdrawal by Subject|5|||
143474589|NCT00232141|517284003|FG001|Overall Study|Withdrawal by Subject|3|||
143474590|NCT02273726|517284004|FG000|Overall Study|Death|70|||
143474591|NCT02273726|517284005|FG001|Overall Study|Death|62|||
143474592|NCT02273726|517284004|FG000|Overall Study|Withdrawal by Subject|41|||
143474593|NCT02273726|517284005|FG001|Overall Study|Withdrawal by Subject|29|||
143474594|NCT02273726|517284004|FG000|Overall Study|Kidney transplant|31|||
143474595|NCT02273726|517284005|FG001|Overall Study|Kidney transplant|39|||
143474596|NCT02273726|517284004|FG000|Overall Study|Physician Decision|30|||
143474597|NCT02273726|517284005|FG001|Overall Study|Physician Decision|15|||
143474598|NCT02273726|517284004|FG000|Overall Study|Adverse Event|27|||
143474599|NCT02273726|517284005|FG001|Overall Study|Adverse Event|9|||
143474600|NCT02273726|517284004|FG000|Overall Study|Lost to Follow-up|6|||
143474601|NCT02273726|517284005|FG001|Overall Study|Lost to Follow-up|3|||
143474602|NCT02273726|517284004|FG000|Overall Study|Lack of Efficacy|6|||
143474603|NCT02273726|517284005|FG001|Overall Study|Lack of Efficacy|1|||
143474604|NCT02273726|517284004|FG000|Overall Study|Protocol Violation|4|||
143474605|NCT02273726|517284005|FG001|Overall Study|Protocol Violation|0|||
143474606|NCT02273726|517284004|FG000|Overall Study|Other than specified|28|||
143474607|NCT02273726|517284005|FG001|Overall Study|Other than specified|30|||
143474608|NCT01479829|517284009|FG000|Overall Study|Withdrawal by Subject|8|||
143474609|NCT01479829|517284010|FG001|Overall Study|Withdrawal by Subject|10|||
143474610|NCT04263896|517284012|FG000|Overall Study|Withdrawal by Subject|2|||
143474611|NCT04263896|517284013|FG001|Overall Study|Withdrawal by Subject|4|||
143474612|NCT04263896|517284012|FG000|Overall Study|converted to open procedure|0|||
143474613|NCT04263896|517284013|FG001|Overall Study|converted to open procedure|1|||
143474614|NCT04263896|517284012|FG000|Overall Study|Lost to Follow-up|9|||
143474615|NCT04263896|517284013|FG001|Overall Study|Lost to Follow-up|11|||
143474616|NCT04263896|517284012|FG000|Overall Study|surveys lost in mail|5|||
143474617|NCT04263896|517284013|FG001|Overall Study|surveys lost in mail|3|||
143474618|NCT04263896|517284012|FG000|Overall Study|excluded from analysis|1|||
143474619|NCT04263896|517284013|FG001|Overall Study|excluded from analysis|0|||
143474620|NCT02229539|517285795|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
143474621|NCT02229539|517285796|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
143474622|NCT02229539|517285797|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
143474623|NCT02229539|517285795|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
143474624|NCT02229539|517285796|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
143474625|NCT02229539|517285797|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
143474626|NCT02229539|517285795|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
143474627|NCT02229539|517285796|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
143474628|NCT02229539|517285797|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
143474629|NCT02229539|517285795|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
143474630|NCT02229539|517285796|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
143474631|NCT02229539|517285797|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|8|||
143474632|NCT02229539|517285795|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
143474633|NCT02229539|517285796|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
143474634|NCT02229539|517285797|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
143474635|NCT02229539|517285795|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
143474636|NCT02229539|517285796|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
143474637|NCT02229539|517285797|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|2|||
143474638|NCT02060383|517285798|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
143474639|NCT02060383|517285799|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
143474640|NCT02060383|517285800|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
143474641|NCT02060383|517285801|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
143474642|NCT02060383|517285802|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
143474643|NCT02060383|517285798|FG000|Core Phase|Adverse Event|2|||
143474644|NCT02060383|517285799|FG001|Core Phase|Adverse Event|0|||
143474645|NCT02060383|517285800|FG002|Core Phase|Adverse Event|0|||
143474646|NCT02060383|517285801|FG003|Core Phase|Adverse Event|2|||
143474647|NCT02060383|517285802|FG004|Core Phase|Adverse Event|6|||
143474648|NCT02060383|517285798|FG000|Core Phase|Administrative problems|0|||
143474649|NCT02060383|517285799|FG001|Core Phase|Administrative problems|1|||
143474650|NCT02060383|517285800|FG002|Core Phase|Administrative problems|0|||
143474651|NCT02060383|517285801|FG003|Core Phase|Administrative problems|0|||
143474652|NCT02060383|517285802|FG004|Core Phase|Administrative problems|0|||
143474653|NCT02060383|517285798|FG000|Core Phase|Protocol Violation|0|||
143474654|NCT02060383|517285799|FG001|Core Phase|Protocol Violation|0|||
143474655|NCT02060383|517285800|FG002|Core Phase|Protocol Violation|0|||
143474656|NCT02060383|517285801|FG003|Core Phase|Protocol Violation|1|||
143474657|NCT02060383|517285802|FG004|Core Phase|Protocol Violation|0|||
143474658|NCT02060383|517285798|FG000|Core Phase|Withdrawal by Subject|0|||
143474659|NCT02060383|517285799|FG001|Core Phase|Withdrawal by Subject|0|||
143474660|NCT02060383|517285800|FG002|Core Phase|Withdrawal by Subject|0|||
143474661|NCT02060383|517285801|FG003|Core Phase|Withdrawal by Subject|4|||
143474662|NCT02060383|517285802|FG004|Core Phase|Withdrawal by Subject|2|||
143474663|NCT02060383|517285798|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
143142542|NCT01232283|516069317|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
143474664|NCT02060383|517285799|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
143474665|NCT02060383|517285800|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
143474666|NCT02060383|517285801|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
143474667|NCT02060383|517285802|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
143474668|NCT02060383|517285798|FG000|Extension Phase|Adverse Event|1|||
143474669|NCT02060383|517285799|FG001|Extension Phase|Adverse Event|1|||
143142543|NCT01232283|516069318|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
143474670|NCT02060383|517285800|FG002|Extension Phase|Adverse Event|2|||
143474671|NCT02060383|517285801|FG003|Extension Phase|Adverse Event|0|||
143474672|NCT02060383|517285802|FG004|Extension Phase|Adverse Event|1|||
143474673|NCT02060383|517285798|FG000|Extension Phase|Withdrawal by Subject|0|||
143474674|NCT02060383|517285799|FG001|Extension Phase|Withdrawal by Subject|1|||
143474675|NCT02060383|517285800|FG002|Extension Phase|Withdrawal by Subject|0|||
143474676|NCT02060383|517285801|FG003|Extension Phase|Withdrawal by Subject|0|||
143474677|NCT02060383|517285802|FG004|Extension Phase|Withdrawal by Subject|2|||
143474678|NCT02060383|517285798|FG000|Extension Phase|Administrative problems|1|||
143474679|NCT02060383|517285799|FG001|Extension Phase|Administrative problems|0|||
143474680|NCT02060383|517285800|FG002|Extension Phase|Administrative problems|0|||
143474681|NCT02060383|517285801|FG003|Extension Phase|Administrative problems|0|||
143474682|NCT02060383|517285802|FG004|Extension Phase|Administrative problems|0|||
143474683|NCT02060383|517285798|FG000|Extension Phase|Death|0|||
143474684|NCT02060383|517285799|FG001|Extension Phase|Death|0|||
143474685|NCT02060383|517285800|FG002|Extension Phase|Death|1|||
143474686|NCT02060383|517285801|FG003|Extension Phase|Death|0|||
143474687|NCT02060383|517285802|FG004|Extension Phase|Death|1|||
143474688|NCT02060383|517285798|FG000|Extension Phase|Protocol Violation|0|||
143474689|NCT02060383|517285799|FG001|Extension Phase|Protocol Violation|0|||
143474690|NCT02060383|517285800|FG002|Extension Phase|Protocol Violation|0|||
143474691|NCT02060383|517285801|FG003|Extension Phase|Protocol Violation|0|||
143474692|NCT02060383|517285802|FG004|Extension Phase|Protocol Violation|1|||
143474693|NCT00088907|517285803|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
143474694|NCT00088907|517285804|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
143474695|NCT00088907|517285803|FG000|Randomized Study (Step 1)|Adverse Event|14|||
143474696|NCT00088907|517285804|FG001|Randomized Study (Step 1)|Adverse Event|19|||
143474697|NCT00088907|517285803|FG000|Randomized Study (Step 1)|Death|11|||
143474698|NCT00088907|517285804|FG001|Randomized Study (Step 1)|Death|12|||
143474699|NCT00088907|517285803|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
143474700|NCT00088907|517285804|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
143474701|NCT00088907|517285803|FG000|Randomized Study (Step 1)|complicating disease|3|||
143474702|NCT00088907|517285804|FG001|Randomized Study (Step 1)|complicating disease|1|||
143474703|NCT00088907|517285803|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
143474704|NCT00088907|517285804|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
143474705|NCT00088907|517285803|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
143474706|NCT00088907|517285804|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
143474707|NCT00088907|517285803|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
143474708|NCT00088907|517285804|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
143474709|NCT00088907|517285803|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
143474710|NCT00088907|517285804|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
143474711|NCT00088907|517285803|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
143474712|NCT00088907|517285804|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
143474713|NCT00088907|517285803|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
143474714|NCT00088907|517285804|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
143474715|NCT03426787|517285805|FG000|Overall Study|Withdrawal by Subject|6|||
143474716|NCT03426787|517285805|FG000|Overall Study|Lost to Follow-up|7|||
143474717|NCT03426787|517285805|FG000|Overall Study|Unrelated to intervention death|1|||
143474718|NCT00395863|517285806|FG000|Overall Study|Patients did not complete both exams|2|||
143474719|NCT00395863|517285807|FG001|Overall Study|Patients did not complete both exams|3|||
143474720|NCT04050670|517285810|FG000|Period 3|Physician Decision|0|||
143474721|NCT04050670|517285811|FG001|Period 3|Physician Decision|1|||
143474722|NCT04050670|517285812|FG002|Period 3|Physician Decision|0|||
143474723|NCT00761306|517285813|FG000|Overall Study|Adverse Event|5|||
143474724|NCT00761306|517285813|FG000|Overall Study|Lack of Efficacy|4|||
143474725|NCT00761306|517285813|FG000|Overall Study|Protocol Violation|2|||
143474726|NCT00761306|517285813|FG000|Overall Study|Withdrawal of Consent|3|||
143474727|NCT00761306|517285813|FG000|Overall Study|Lost to Follow-up|1|||
143474728|NCT00761306|517285813|FG000|Overall Study|Administrative or Other Reasons|5|||
143474729|NCT00268437|517285814|FG000|Overall Study|Ineligible|1|||
143474730|NCT05162027|517285815|FG000|Overall Study|Adverse Event|1|||
143474731|NCT05162027|517285816|FG001|Overall Study|Adverse Event|0|||
143474732|NCT02615470|517285818|FG000|Overall Study|Lost to Follow-up|21|||
143474733|NCT02615470|517285819|FG001|Overall Study|Lost to Follow-up|32|||
143474734|NCT03713034|517285820|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
143474735|NCT03713034|517285821|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
143474736|NCT02982239|517285824|FG000|Overall Study|Lost to Follow-up|3|||
143474737|NCT02982239|517285825|FG001|Overall Study|Lost to Follow-up|2|||
143474738|NCT00907257|517285830|FG000|Overall Study|Adverse Event|0|||
143474739|NCT00907257|517285831|FG001|Overall Study|Adverse Event|4|||
143142544|NCT01232283|516069319|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
143474740|NCT00907257|517285830|FG000|Overall Study|Protocol Violation|1|||
143474741|NCT00907257|517285831|FG001|Overall Study|Protocol Violation|2|||
143474742|NCT00907257|517285830|FG000|Overall Study|Lost to Follow-up|3|||
143474743|NCT00907257|517285831|FG001|Overall Study|Lost to Follow-up|3|||
143474744|NCT00907257|517285830|FG000|Overall Study|Withdrawal by Subject|1|||
143474745|NCT00907257|517285831|FG001|Overall Study|Withdrawal by Subject|2|||
143474746|NCT00907257|517285830|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
143474747|NCT00907257|517285831|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
143474748|NCT00907257|517285830|FG000|Overall Study|Moved|1|||
143474749|NCT00907257|517285831|FG001|Overall Study|Moved|0|||
143474750|NCT00907257|517285830|FG000|Overall Study|Personal Reasons|6|||
143474751|NCT00907257|517285831|FG001|Overall Study|Personal Reasons|1|||
143474752|NCT00880555|517285832|FG000|Overall Study|Physician Decision|0|||
143474753|NCT00880555|517285833|FG001|Overall Study|Physician Decision|8|||
143474754|NCT00880555|517285834|FG002|Overall Study|Physician Decision|0|||
143474755|NCT00880555|517285835|FG003|Overall Study|Physician Decision|2|||
143474756|NCT00880555|517285836|FG004|Overall Study|Physician Decision|1|||
143474757|NCT00880555|517285837|FG005|Overall Study|Physician Decision|0|||
143474758|NCT00880555|517285832|FG000|Overall Study|Withdrawal by Subject|1|||
143474759|NCT00880555|517285833|FG001|Overall Study|Withdrawal by Subject|1|||
143474760|NCT00880555|517285834|FG002|Overall Study|Withdrawal by Subject|0|||
143474761|NCT00880555|517285835|FG003|Overall Study|Withdrawal by Subject|0|||
143474762|NCT00880555|517285836|FG004|Overall Study|Withdrawal by Subject|0|||
143474763|NCT00880555|517285837|FG005|Overall Study|Withdrawal by Subject|0|||
143474764|NCT00880555|517285832|FG000|Overall Study|Lack of resources (hired rater)|9|||
143474765|NCT00880555|517285833|FG001|Overall Study|Lack of resources (hired rater)|7|||
143474766|NCT00880555|517285834|FG002|Overall Study|Lack of resources (hired rater)|5|||
143474767|NCT00880555|517285835|FG003|Overall Study|Lack of resources (hired rater)|0|||
143474768|NCT00880555|517285836|FG004|Overall Study|Lack of resources (hired rater)|0|||
143474769|NCT00880555|517285837|FG005|Overall Study|Lack of resources (hired rater)|0|||
143474770|NCT00880555|517285832|FG000|Overall Study|Death|0|||
143474771|NCT00880555|517285833|FG001|Overall Study|Death|0|||
143474772|NCT00880555|517285834|FG002|Overall Study|Death|0|||
143474773|NCT00880555|517285835|FG003|Overall Study|Death|0|||
143474774|NCT00880555|517285836|FG004|Overall Study|Death|0|||
143474775|NCT00880555|517285837|FG005|Overall Study|Death|1|||
143474776|NCT00880555|517285832|FG000|Overall Study|Lost to Follow-up|0|||
143474777|NCT00880555|517285833|FG001|Overall Study|Lost to Follow-up|1|||
143474778|NCT00880555|517285834|FG002|Overall Study|Lost to Follow-up|0|||
143474779|NCT00880555|517285835|FG003|Overall Study|Lost to Follow-up|0|||
143474780|NCT00880555|517285836|FG004|Overall Study|Lost to Follow-up|0|||
143474781|NCT00880555|517285837|FG005|Overall Study|Lost to Follow-up|0|||
143474782|NCT01168973|517285841|FG000|Overall Study|Progressive Disease|341|||
143474783|NCT01168973|517285842|FG001|Overall Study|Progressive Disease|429|||
143474784|NCT01168973|517285841|FG000|Overall Study|Adverse Event|94|||
143474785|NCT01168973|517285842|FG001|Overall Study|Adverse Event|55|||
143474786|NCT01168973|517285841|FG000|Overall Study|Withdrawal by Subject|90|||
143474787|NCT01168973|517285842|FG001|Overall Study|Withdrawal by Subject|53|||
143474788|NCT01168973|517285841|FG000|Overall Study|Death|42|||
143474789|NCT01168973|517285842|FG001|Overall Study|Death|45|||
143474790|NCT01168973|517285841|FG000|Overall Study|Physician Decision|37|||
143474791|NCT01168973|517285842|FG001|Overall Study|Physician Decision|19|||
143474792|NCT01168973|517285841|FG000|Overall Study|Sponsor Decision|2|||
143474793|NCT01168973|517285842|FG001|Overall Study|Sponsor Decision|1|||
143474794|NCT01168973|517285841|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
143474795|NCT01168973|517285842|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
143474796|NCT02767323|517285843|FG000|Overall Study|Withdrawal by Subject|17|||
143474797|NCT02767323|517285844|FG001|Overall Study|Withdrawal by Subject|5|||
143474798|NCT02767323|517285845|FG002|Overall Study|Withdrawal by Subject|13|||
143474799|NCT02767323|517285846|FG003|Overall Study|Withdrawal by Subject|0|||
143474800|NCT02767323|517285843|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
143474801|NCT02767323|517285844|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
143474802|NCT02767323|517285845|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
143474803|NCT02767323|517285846|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
143474804|NCT02230254|517285847|FG000|Overall Study|Lost to Follow-up|3|||
143474805|NCT02023242|517285849|FG000|Overall Study|Lost to Follow-up|3|||
143474806|NCT02023242|517285850|FG001|Overall Study|Lost to Follow-up|1|||
143474807|NCT02023242|517285849|FG000|Overall Study|Death|0|||
143474808|NCT02023242|517285850|FG001|Overall Study|Death|1|||
143474809|NCT04854434|517285856|FG000|Overall Study|Death|1|||
143474810|NCT04854434|517285857|FG001|Overall Study|Death|3|||
143474811|NCT04854434|517285858|FG002|Overall Study|Death|4|||
143474812|NCT04854434|517285856|FG000|Overall Study|Study Terminated by Sponsor|2|||
143474813|NCT04854434|517285857|FG001|Overall Study|Study Terminated by Sponsor|0|||
143474814|NCT04854434|517285858|FG002|Overall Study|Study Terminated by Sponsor|0|||
143474815|NCT04854434|517285856|FG000|Overall Study|Other|1|||
143474816|NCT04854434|517285857|FG001|Overall Study|Other|1|||
143474817|NCT04854434|517285858|FG002|Overall Study|Other|0|||
143474818|NCT03349775|517285859|FG000|Overall Study|Side Effects|1|||
143474819|NCT03349775|517285860|FG001|Overall Study|Side Effects|2|||
143474820|NCT03349775|517285859|FG000|Overall Study|Withdrawal by Subject|1|||
143474821|NCT03349775|517285860|FG001|Overall Study|Withdrawal by Subject|1|||
143474822|NCT03349775|517285859|FG000|Overall Study|No primary outcome measurements|0|||
143474823|NCT03349775|517285860|FG001|Overall Study|No primary outcome measurements|1|||
143474824|NCT02667275|517285861|FG000|Overall Study|Protocol Violation|11|||
143474825|NCT02667275|517285862|FG001|Overall Study|Protocol Violation|7|||
143474826|NCT02667275|517285861|FG000|Overall Study|Lost to Follow-up|0|||
143474827|NCT02667275|517285862|FG001|Overall Study|Lost to Follow-up|2|||
143474828|NCT02667275|517285861|FG000|Overall Study|Withdrawal by Subject|0|||
143474829|NCT02667275|517285862|FG001|Overall Study|Withdrawal by Subject|5|||
143474830|NCT02667275|517285861|FG000|Overall Study|Discontinued early without completing|0|||
143474831|NCT02667275|517285862|FG001|Overall Study|Discontinued early without completing|1|||
143474832|NCT01756040|517285863|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
143474833|NCT01756040|517285863|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
143474834|NCT01756040|517285863|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
143474835|NCT01274715|517285864|FG000|Overall Study|Lost to Follow-up|1|||
143474836|NCT01274715|517285864|FG000|Overall Study|After consent, met exclusion criteria.|1|||
143474837|NCT01274715|517285864|FG000|Overall Study|After consent, met exclusion criteria.|1|||
143474838|NCT01274715|517285864|FG000|Overall Study|After consent, met exclusion criteria.|1|||
143474839|NCT04479436|517285865|FG000|Overall Study|Progressive disease|26|||
143474840|NCT04479436|517285866|FG001|Overall Study|Progressive disease|1|||
143474841|NCT04479436|517285865|FG000|Overall Study|Adverse Event|6|||
143474842|NCT04479436|517285866|FG001|Overall Study|Adverse Event|0|||
143474843|NCT04479436|517285865|FG000|Overall Study|Withdrawal by Subject|5|||
143474844|NCT04479436|517285866|FG001|Overall Study|Withdrawal by Subject|0|||
143474845|NCT04479436|517285865|FG000|Overall Study|Clinical progression|1|||
143474846|NCT04479436|517285866|FG001|Overall Study|Clinical progression|0|||
143474847|NCT04479436|517285865|FG000|Overall Study|Physician Decision|1|||
143474848|NCT04479436|517285866|FG001|Overall Study|Physician Decision|0|||
143474849|NCT02357134|517285867|FG000|Overall Study|Lost to Follow-up|1|||
143474850|NCT02357134|517285868|FG001|Overall Study|Lost to Follow-up|0|||
143474851|NCT02357134|517285869|FG002|Overall Study|Lost to Follow-up|0|||
143474852|NCT02357134|517285870|FG003|Overall Study|Lost to Follow-up|0|||
143474853|NCT01301456|517285871|FG000|Stage 1|Withdrawal by Subject|0|||
143474854|NCT01301456|517285872|FG001|Stage 1|Withdrawal by Subject|0|||
143474855|NCT01301456|517285873|FG002|Stage 1|Withdrawal by Subject|1|||
143474856|NCT01301456|517285874|FG003|Stage 1|Withdrawal by Subject|0|||
143474857|NCT01301456|517285875|FG004|Stage 1|Withdrawal by Subject|1|||
143474858|NCT01301456|517285876|FG005|Stage 1|Withdrawal by Subject|0|||
143474859|NCT01301456|517285877|FG006|Stage 1|Withdrawal by Subject|0|||
143474860|NCT01301456|517285878|FG007|Stage 1|Withdrawal by Subject|0|||
143474861|NCT01301456|517285879|FG008|Stage 1|Withdrawal by Subject|0|||
143474862|NCT01301456|517285880|FG009|Stage 1|Withdrawal by Subject|0|||
143474863|NCT01301456|517285881|FG010|Stage 1|Withdrawal by Subject|0|||
143474864|NCT01301456|517285882|FG011|Stage 1|Withdrawal by Subject|0|||
143474865|NCT01301456|517285871|FG000|Stage 1|Randomized but not treated|0|||
143474866|NCT01301456|517285872|FG001|Stage 1|Randomized but not treated|0|||
143474867|NCT01301456|517285873|FG002|Stage 1|Randomized but not treated|0|||
143474868|NCT01301456|517285874|FG003|Stage 1|Randomized but not treated|0|||
143474869|NCT01301456|517285875|FG004|Stage 1|Randomized but not treated|0|||
143474870|NCT01301456|517285876|FG005|Stage 1|Randomized but not treated|0|||
143474871|NCT01301456|517285877|FG006|Stage 1|Randomized but not treated|1|||
143474872|NCT01301456|517285878|FG007|Stage 1|Randomized but not treated|0|||
143474873|NCT01301456|517285879|FG008|Stage 1|Randomized but not treated|0|||
143474874|NCT01301456|517285880|FG009|Stage 1|Randomized but not treated|0|||
143474875|NCT01301456|517285881|FG010|Stage 1|Randomized but not treated|0|||
143474876|NCT01301456|517285882|FG011|Stage 1|Randomized but not treated|0|||
143474877|NCT01301456|517285871|FG000|Stage 2|Adverse Event|0|||
143474878|NCT01301456|517285872|FG001|Stage 2|Adverse Event|0|||
143474879|NCT01301456|517285873|FG002|Stage 2|Adverse Event|0|||
143474880|NCT01301456|517285874|FG003|Stage 2|Adverse Event|0|||
143474881|NCT01301456|517285875|FG004|Stage 2|Adverse Event|0|||
143474882|NCT01301456|517285876|FG005|Stage 2|Adverse Event|0|||
143474883|NCT01301456|517285877|FG006|Stage 2|Adverse Event|0|||
143474884|NCT01301456|517285878|FG007|Stage 2|Adverse Event|0|||
143474885|NCT01301456|517285879|FG008|Stage 2|Adverse Event|0|||
143474886|NCT01301456|517285880|FG009|Stage 2|Adverse Event|0|||
143474887|NCT01301456|517285881|FG010|Stage 2|Adverse Event|1|||
143474888|NCT01301456|517285882|FG011|Stage 2|Adverse Event|0|||
143474889|NCT00616434|517285885|FG000|Overall Study|Adverse Event|5|||
143474890|NCT00616434|517285886|FG001|Overall Study|Adverse Event|2|||
143474891|NCT00616434|517285885|FG000|Overall Study|Physician Decision|0|||
143474892|NCT00616434|517285886|FG001|Overall Study|Physician Decision|4|||
143474893|NCT00616434|517285885|FG000|Overall Study|Withdrawal by Subject|1|||
143474894|NCT00616434|517285886|FG001|Overall Study|Withdrawal by Subject|1|||
143474895|NCT00616434|517285885|FG000|Overall Study|Protocol deviation|0|||
143474896|NCT00616434|517285886|FG001|Overall Study|Protocol deviation|1|||
143474897|NCT05097716|517285887|FG000|Period 1|Adverse Event|1|||
143474898|NCT05097716|517285887|FG000|Period 1|Close contact with highly-transmissible infection|1|||
143474899|NCT00467779|517285890|FG000|Stage 1|Adverse Event|1|||
143474900|NCT00467779|517285891|FG001|Stage 1|Adverse Event|0|||
143474901|NCT00467779|517285892|FG002|Stage 1|Adverse Event|0|||
143474902|NCT00467779|517285893|FG003|Stage 1|Adverse Event|0|||
143474903|NCT00467779|517285894|FG004|Stage 1|Adverse Event|0|||
143474904|NCT00467779|517285895|FG005|Stage 1|Adverse Event|1|||
143474905|NCT00467779|517285896|FG006|Stage 1|Adverse Event|2|||
143474906|NCT00467779|517285897|FG007|Stage 1|Adverse Event|1|||
143474907|NCT00467779|517285898|FG008|Stage 1|Adverse Event|0|||
143474908|NCT00467779|517285899|FG009|Stage 1|Adverse Event|0|||
143474909|NCT00467779|517285900|FG010|Stage 1|Adverse Event|0|||
143474910|NCT00467779|517285901|FG011|Stage 1|Adverse Event|0|||
143474911|NCT00467779|517285902|FG012|Stage 1|Adverse Event|0|||
143474912|NCT00467779|517285903|FG013|Stage 1|Adverse Event|0|||
143474913|NCT00467779|517285904|FG014|Stage 1|Adverse Event|0|||
143474914|NCT00467779|517285890|FG000|Stage 1|Disease Progression|2|||
143474915|NCT00467779|517285891|FG001|Stage 1|Disease Progression|2|||
143474916|NCT00467779|517285892|FG002|Stage 1|Disease Progression|2|||
143474917|NCT00467779|517285893|FG003|Stage 1|Disease Progression|3|||
143474918|NCT00467779|517285894|FG004|Stage 1|Disease Progression|2|||
143474919|NCT00467779|517285895|FG005|Stage 1|Disease Progression|2|||
143474920|NCT00467779|517285896|FG006|Stage 1|Disease Progression|4|||
143474921|NCT00467779|517285897|FG007|Stage 1|Disease Progression|5|||
143474922|NCT00467779|517285898|FG008|Stage 1|Disease Progression|0|||
143474923|NCT00467779|517285899|FG009|Stage 1|Disease Progression|0|||
143474924|NCT00467779|517285900|FG010|Stage 1|Disease Progression|0|||
143474925|NCT00467779|517285901|FG011|Stage 1|Disease Progression|0|||
143474926|NCT00467779|517285902|FG012|Stage 1|Disease Progression|0|||
143474927|NCT00467779|517285903|FG013|Stage 1|Disease Progression|0|||
143474928|NCT00467779|517285904|FG014|Stage 1|Disease Progression|0|||
143474929|NCT00467779|517285890|FG000|Stage 1|Unspecified Reason|1|||
143474930|NCT00467779|517285891|FG001|Stage 1|Unspecified Reason|0|||
143474931|NCT00467779|517285892|FG002|Stage 1|Unspecified Reason|1|||
143474932|NCT00467779|517285893|FG003|Stage 1|Unspecified Reason|0|||
143474933|NCT00467779|517285894|FG004|Stage 1|Unspecified Reason|1|||
143474934|NCT00467779|517285895|FG005|Stage 1|Unspecified Reason|2|||
143474935|NCT00467779|517285896|FG006|Stage 1|Unspecified Reason|0|||
143474936|NCT00467779|517285897|FG007|Stage 1|Unspecified Reason|0|||
143474937|NCT00467779|517285898|FG008|Stage 1|Unspecified Reason|0|||
143474938|NCT00467779|517285899|FG009|Stage 1|Unspecified Reason|0|||
143474939|NCT00467779|517285900|FG010|Stage 1|Unspecified Reason|0|||
143474940|NCT00467779|517285901|FG011|Stage 1|Unspecified Reason|0|||
143474941|NCT00467779|517285902|FG012|Stage 1|Unspecified Reason|0|||
143474942|NCT00467779|517285903|FG013|Stage 1|Unspecified Reason|0|||
143474943|NCT00467779|517285904|FG014|Stage 1|Unspecified Reason|0|||
143474944|NCT00467779|517285890|FG000|Stage 1|Physician Decision|0|||
143474945|NCT00467779|517285891|FG001|Stage 1|Physician Decision|1|||
143474946|NCT00467779|517285892|FG002|Stage 1|Physician Decision|0|||
143474947|NCT00467779|517285893|FG003|Stage 1|Physician Decision|0|||
143474948|NCT00467779|517285894|FG004|Stage 1|Physician Decision|0|||
143474949|NCT00467779|517285895|FG005|Stage 1|Physician Decision|0|||
143474950|NCT00467779|517285896|FG006|Stage 1|Physician Decision|0|||
143474951|NCT00467779|517285897|FG007|Stage 1|Physician Decision|0|||
143474952|NCT00467779|517285898|FG008|Stage 1|Physician Decision|0|||
143474953|NCT00467779|517285899|FG009|Stage 1|Physician Decision|0|||
143474954|NCT00467779|517285900|FG010|Stage 1|Physician Decision|0|||
143474955|NCT00467779|517285901|FG011|Stage 1|Physician Decision|0|||
143474956|NCT00467779|517285902|FG012|Stage 1|Physician Decision|0|||
143474957|NCT00467779|517285903|FG013|Stage 1|Physician Decision|0|||
143474958|NCT00467779|517285904|FG014|Stage 1|Physician Decision|0|||
143474959|NCT00467779|517285890|FG000|Stage 1|Withdrawal by Subject|0|||
143474960|NCT00467779|517285891|FG001|Stage 1|Withdrawal by Subject|0|||
143474961|NCT00467779|517285892|FG002|Stage 1|Withdrawal by Subject|0|||
143474962|NCT00467779|517285893|FG003|Stage 1|Withdrawal by Subject|0|||
143474963|NCT00467779|517285894|FG004|Stage 1|Withdrawal by Subject|0|||
143474964|NCT00467779|517285895|FG005|Stage 1|Withdrawal by Subject|0|||
143474965|NCT00467779|517285896|FG006|Stage 1|Withdrawal by Subject|1|||
143474966|NCT00467779|517285897|FG007|Stage 1|Withdrawal by Subject|1|||
143474967|NCT00467779|517285898|FG008|Stage 1|Withdrawal by Subject|0|||
143474968|NCT00467779|517285899|FG009|Stage 1|Withdrawal by Subject|0|||
143474969|NCT00467779|517285900|FG010|Stage 1|Withdrawal by Subject|0|||
143474970|NCT00467779|517285901|FG011|Stage 1|Withdrawal by Subject|0|||
143474971|NCT00467779|517285902|FG012|Stage 1|Withdrawal by Subject|0|||
143474972|NCT00467779|517285903|FG013|Stage 1|Withdrawal by Subject|0|||
143474973|NCT00467779|517285904|FG014|Stage 1|Withdrawal by Subject|0|||
143474974|NCT00467779|517285890|FG000|Stage 1A|Adverse Event|0|||
143474975|NCT00467779|517285891|FG001|Stage 1A|Adverse Event|0|||
143474976|NCT00467779|517285892|FG002|Stage 1A|Adverse Event|0|||
143474977|NCT00467779|517285893|FG003|Stage 1A|Adverse Event|0|||
143474978|NCT00467779|517285894|FG004|Stage 1A|Adverse Event|0|||
143474979|NCT00467779|517285895|FG005|Stage 1A|Adverse Event|0|||
143474980|NCT00467779|517285896|FG006|Stage 1A|Adverse Event|0|||
143474981|NCT00467779|517285897|FG007|Stage 1A|Adverse Event|0|||
143474982|NCT00467779|517285898|FG008|Stage 1A|Adverse Event|0|||
143474983|NCT00467779|517285899|FG009|Stage 1A|Adverse Event|0|||
143474984|NCT00467779|517285900|FG010|Stage 1A|Adverse Event|0|||
143474985|NCT00467779|517285901|FG011|Stage 1A|Adverse Event|0|||
143474986|NCT00467779|517285902|FG012|Stage 1A|Adverse Event|1|||
143474987|NCT00467779|517285903|FG013|Stage 1A|Adverse Event|0|||
143474988|NCT00467779|517285904|FG014|Stage 1A|Adverse Event|0|||
143474989|NCT00467779|517285890|FG000|Stage 1A|Death|0|||
143474990|NCT00467779|517285891|FG001|Stage 1A|Death|0|||
143474991|NCT00467779|517285892|FG002|Stage 1A|Death|0|||
143474992|NCT00467779|517285893|FG003|Stage 1A|Death|0|||
143474993|NCT00467779|517285894|FG004|Stage 1A|Death|0|||
143474994|NCT00467779|517285895|FG005|Stage 1A|Death|0|||
143474995|NCT00467779|517285896|FG006|Stage 1A|Death|0|||
143474996|NCT00467779|517285897|FG007|Stage 1A|Death|0|||
143474997|NCT00467779|517285898|FG008|Stage 1A|Death|0|||
143474998|NCT00467779|517285899|FG009|Stage 1A|Death|0|||
143474999|NCT00467779|517285900|FG010|Stage 1A|Death|0|||
143475000|NCT00467779|517285901|FG011|Stage 1A|Death|1|||
143475001|NCT00467779|517285902|FG012|Stage 1A|Death|1|||
143475002|NCT00467779|517285903|FG013|Stage 1A|Death|0|||
143475003|NCT00467779|517285904|FG014|Stage 1A|Death|0|||
143475004|NCT00467779|517285890|FG000|Stage 1A|Disease Progression|0|||
143475005|NCT00467779|517285891|FG001|Stage 1A|Disease Progression|0|||
143475006|NCT00467779|517285892|FG002|Stage 1A|Disease Progression|0|||
143475007|NCT00467779|517285893|FG003|Stage 1A|Disease Progression|0|||
143475008|NCT00467779|517285894|FG004|Stage 1A|Disease Progression|0|||
143475009|NCT00467779|517285895|FG005|Stage 1A|Disease Progression|0|||
143475010|NCT00467779|517285896|FG006|Stage 1A|Disease Progression|0|||
143475011|NCT00467779|517285897|FG007|Stage 1A|Disease Progression|0|||
143475012|NCT00467779|517285898|FG008|Stage 1A|Disease Progression|0|||
143475013|NCT00467779|517285899|FG009|Stage 1A|Disease Progression|2|||
143475014|NCT00467779|517285900|FG010|Stage 1A|Disease Progression|2|||
143475015|NCT00467779|517285901|FG011|Stage 1A|Disease Progression|5|||
143475016|NCT00467779|517285902|FG012|Stage 1A|Disease Progression|2|||
143475017|NCT00467779|517285903|FG013|Stage 1A|Disease Progression|0|||
143475018|NCT00467779|517285904|FG014|Stage 1A|Disease Progression|0|||
143475019|NCT00467779|517285890|FG000|Stage 1A|Physician Decision|0|||
143475020|NCT00467779|517285891|FG001|Stage 1A|Physician Decision|0|||
143475021|NCT00467779|517285892|FG002|Stage 1A|Physician Decision|0|||
143475022|NCT00467779|517285893|FG003|Stage 1A|Physician Decision|0|||
143475023|NCT00467779|517285894|FG004|Stage 1A|Physician Decision|0|||
143475024|NCT00467779|517285895|FG005|Stage 1A|Physician Decision|0|||
143475025|NCT00467779|517285896|FG006|Stage 1A|Physician Decision|0|||
143475026|NCT00467779|517285897|FG007|Stage 1A|Physician Decision|0|||
143475027|NCT00467779|517285898|FG008|Stage 1A|Physician Decision|0|||
143475028|NCT00467779|517285899|FG009|Stage 1A|Physician Decision|1|||
143475029|NCT00467779|517285900|FG010|Stage 1A|Physician Decision|0|||
143475030|NCT00467779|517285901|FG011|Stage 1A|Physician Decision|0|||
143475031|NCT00467779|517285902|FG012|Stage 1A|Physician Decision|0|||
143475032|NCT00467779|517285903|FG013|Stage 1A|Physician Decision|0|||
143475033|NCT00467779|517285904|FG014|Stage 1A|Physician Decision|0|||
143475034|NCT00467779|517285890|FG000|Stage 1A|Withdrawal by Subject|0|||
143475035|NCT00467779|517285891|FG001|Stage 1A|Withdrawal by Subject|0|||
143475036|NCT00467779|517285892|FG002|Stage 1A|Withdrawal by Subject|0|||
143475037|NCT00467779|517285893|FG003|Stage 1A|Withdrawal by Subject|0|||
143475038|NCT00467779|517285894|FG004|Stage 1A|Withdrawal by Subject|0|||
143475039|NCT00467779|517285895|FG005|Stage 1A|Withdrawal by Subject|0|||
143475040|NCT00467779|517285896|FG006|Stage 1A|Withdrawal by Subject|0|||
143475041|NCT00467779|517285897|FG007|Stage 1A|Withdrawal by Subject|0|||
143475042|NCT00467779|517285898|FG008|Stage 1A|Withdrawal by Subject|0|||
143475043|NCT00467779|517285899|FG009|Stage 1A|Withdrawal by Subject|0|||
143475044|NCT00467779|517285900|FG010|Stage 1A|Withdrawal by Subject|1|||
143475045|NCT00467779|517285901|FG011|Stage 1A|Withdrawal by Subject|1|||
143475046|NCT00467779|517285902|FG012|Stage 1A|Withdrawal by Subject|1|||
143475047|NCT00467779|517285903|FG013|Stage 1A|Withdrawal by Subject|0|||
143475048|NCT00467779|517285904|FG014|Stage 1A|Withdrawal by Subject|0|||
143475049|NCT00467779|517285890|FG000|Stage 1A|Unspecified Reason|0|||
143475050|NCT00467779|517285891|FG001|Stage 1A|Unspecified Reason|0|||
143475051|NCT00467779|517285892|FG002|Stage 1A|Unspecified Reason|0|||
143475052|NCT00467779|517285893|FG003|Stage 1A|Unspecified Reason|0|||
143475053|NCT00467779|517285894|FG004|Stage 1A|Unspecified Reason|0|||
143475054|NCT00467779|517285895|FG005|Stage 1A|Unspecified Reason|0|||
143475055|NCT00467779|517285896|FG006|Stage 1A|Unspecified Reason|0|||
143475056|NCT00467779|517285897|FG007|Stage 1A|Unspecified Reason|0|||
143475057|NCT00467779|517285898|FG008|Stage 1A|Unspecified Reason|0|||
143475058|NCT00467779|517285899|FG009|Stage 1A|Unspecified Reason|0|||
143475059|NCT00467779|517285900|FG010|Stage 1A|Unspecified Reason|0|||
143475060|NCT00467779|517285901|FG011|Stage 1A|Unspecified Reason|1|||
143475061|NCT00467779|517285902|FG012|Stage 1A|Unspecified Reason|1|||
143475062|NCT00467779|517285903|FG013|Stage 1A|Unspecified Reason|0|||
143475063|NCT00467779|517285904|FG014|Stage 1A|Unspecified Reason|0|||
143475064|NCT00467779|517285890|FG000|Stage 2|Adverse Event|0|||
143475065|NCT00467779|517285891|FG001|Stage 2|Adverse Event|0|||
143475066|NCT00467779|517285892|FG002|Stage 2|Adverse Event|0|||
143475067|NCT00467779|517285893|FG003|Stage 2|Adverse Event|0|||
143475068|NCT00467779|517285894|FG004|Stage 2|Adverse Event|0|||
143475069|NCT00467779|517285895|FG005|Stage 2|Adverse Event|0|||
143475070|NCT00467779|517285896|FG006|Stage 2|Adverse Event|0|||
143475071|NCT00467779|517285897|FG007|Stage 2|Adverse Event|0|||
143475072|NCT00467779|517285898|FG008|Stage 2|Adverse Event|1|||
143475073|NCT00467779|517285899|FG009|Stage 2|Adverse Event|0|||
143475074|NCT00467779|517285900|FG010|Stage 2|Adverse Event|0|||
143475075|NCT00467779|517285901|FG011|Stage 2|Adverse Event|0|||
143475076|NCT00467779|517285902|FG012|Stage 2|Adverse Event|0|||
143475077|NCT00467779|517285903|FG013|Stage 2|Adverse Event|0|||
143475078|NCT00467779|517285904|FG014|Stage 2|Adverse Event|0|||
143475079|NCT00467779|517285890|FG000|Stage 2|Death|0|||
143475080|NCT00467779|517285891|FG001|Stage 2|Death|0|||
143475081|NCT00467779|517285892|FG002|Stage 2|Death|0|||
143475082|NCT00467779|517285893|FG003|Stage 2|Death|0|||
143475083|NCT00467779|517285894|FG004|Stage 2|Death|0|||
143475084|NCT00467779|517285895|FG005|Stage 2|Death|0|||
143475085|NCT00467779|517285896|FG006|Stage 2|Death|0|||
143475086|NCT00467779|517285897|FG007|Stage 2|Death|0|||
143475087|NCT00467779|517285898|FG008|Stage 2|Death|1|||
143475088|NCT00467779|517285899|FG009|Stage 2|Death|0|||
143475089|NCT00467779|517285900|FG010|Stage 2|Death|0|||
143475090|NCT00467779|517285901|FG011|Stage 2|Death|0|||
143475091|NCT00467779|517285902|FG012|Stage 2|Death|0|||
143475092|NCT00467779|517285903|FG013|Stage 2|Death|0|||
143475093|NCT00467779|517285904|FG014|Stage 2|Death|0|||
143475094|NCT00467779|517285890|FG000|Stage 2|Disease Progression|0|||
143475095|NCT00467779|517285891|FG001|Stage 2|Disease Progression|0|||
143475096|NCT00467779|517285892|FG002|Stage 2|Disease Progression|0|||
143475097|NCT00467779|517285893|FG003|Stage 2|Disease Progression|0|||
143475098|NCT00467779|517285894|FG004|Stage 2|Disease Progression|0|||
143475099|NCT00467779|517285895|FG005|Stage 2|Disease Progression|0|||
143475100|NCT00467779|517285896|FG006|Stage 2|Disease Progression|0|||
143475101|NCT00467779|517285897|FG007|Stage 2|Disease Progression|0|||
143475102|NCT00467779|517285898|FG008|Stage 2|Disease Progression|16|||
143475103|NCT00467779|517285899|FG009|Stage 2|Disease Progression|0|||
143475104|NCT00467779|517285900|FG010|Stage 2|Disease Progression|0|||
143475105|NCT00467779|517285901|FG011|Stage 2|Disease Progression|0|||
143475106|NCT00467779|517285902|FG012|Stage 2|Disease Progression|0|||
143475107|NCT00467779|517285903|FG013|Stage 2|Disease Progression|0|||
143475108|NCT00467779|517285904|FG014|Stage 2|Disease Progression|0|||
143475109|NCT00467779|517285890|FG000|Stage 2|Unspecified Reason|0|||
143475110|NCT00467779|517285891|FG001|Stage 2|Unspecified Reason|0|||
143475111|NCT00467779|517285892|FG002|Stage 2|Unspecified Reason|0|||
143475112|NCT00467779|517285893|FG003|Stage 2|Unspecified Reason|0|||
143475113|NCT00467779|517285894|FG004|Stage 2|Unspecified Reason|0|||
143475114|NCT00467779|517285895|FG005|Stage 2|Unspecified Reason|0|||
143475115|NCT00467779|517285896|FG006|Stage 2|Unspecified Reason|0|||
143475116|NCT00467779|517285897|FG007|Stage 2|Unspecified Reason|0|||
143475117|NCT00467779|517285898|FG008|Stage 2|Unspecified Reason|3|||
143475118|NCT00467779|517285899|FG009|Stage 2|Unspecified Reason|0|||
143475119|NCT00467779|517285900|FG010|Stage 2|Unspecified Reason|0|||
143475120|NCT00467779|517285901|FG011|Stage 2|Unspecified Reason|0|||
143475121|NCT00467779|517285902|FG012|Stage 2|Unspecified Reason|0|||
143475122|NCT00467779|517285903|FG013|Stage 2|Unspecified Reason|0|||
143475123|NCT00467779|517285904|FG014|Stage 2|Unspecified Reason|0|||
143475124|NCT00467779|517285890|FG000|Stage 2A|Adverse Event|0|||
143475125|NCT00467779|517285891|FG001|Stage 2A|Adverse Event|0|||
143475126|NCT00467779|517285892|FG002|Stage 2A|Adverse Event|0|||
143475127|NCT00467779|517285893|FG003|Stage 2A|Adverse Event|0|||
143475128|NCT00467779|517285894|FG004|Stage 2A|Adverse Event|0|||
143475129|NCT00467779|517285895|FG005|Stage 2A|Adverse Event|0|||
143475130|NCT00467779|517285896|FG006|Stage 2A|Adverse Event|0|||
143475131|NCT00467779|517285897|FG007|Stage 2A|Adverse Event|0|||
143475132|NCT00467779|517285898|FG008|Stage 2A|Adverse Event|0|||
143475133|NCT00467779|517285899|FG009|Stage 2A|Adverse Event|0|||
143475134|NCT00467779|517285900|FG010|Stage 2A|Adverse Event|0|||
143475135|NCT00467779|517285901|FG011|Stage 2A|Adverse Event|0|||
143475136|NCT00467779|517285902|FG012|Stage 2A|Adverse Event|0|||
143475137|NCT00467779|517285903|FG013|Stage 2A|Adverse Event|2|||
143475138|NCT00467779|517285904|FG014|Stage 2A|Adverse Event|0|||
143475139|NCT00467779|517285890|FG000|Stage 2A|Death|0|||
143475140|NCT00467779|517285891|FG001|Stage 2A|Death|0|||
143475141|NCT00467779|517285892|FG002|Stage 2A|Death|0|||
143475142|NCT00467779|517285893|FG003|Stage 2A|Death|0|||
143475143|NCT00467779|517285894|FG004|Stage 2A|Death|0|||
143475144|NCT00467779|517285895|FG005|Stage 2A|Death|0|||
143475145|NCT00467779|517285896|FG006|Stage 2A|Death|0|||
143475146|NCT00467779|517285897|FG007|Stage 2A|Death|0|||
143475147|NCT00467779|517285898|FG008|Stage 2A|Death|0|||
143475148|NCT00467779|517285899|FG009|Stage 2A|Death|0|||
143475149|NCT00467779|517285900|FG010|Stage 2A|Death|0|||
143475150|NCT00467779|517285901|FG011|Stage 2A|Death|0|||
143475151|NCT00467779|517285902|FG012|Stage 2A|Death|0|||
143475152|NCT00467779|517285903|FG013|Stage 2A|Death|1|||
143475153|NCT00467779|517285904|FG014|Stage 2A|Death|0|||
143475154|NCT00467779|517285890|FG000|Stage 2A|Disease Progression|0|||
143475155|NCT00467779|517285891|FG001|Stage 2A|Disease Progression|0|||
143475156|NCT00467779|517285892|FG002|Stage 2A|Disease Progression|0|||
143475157|NCT00467779|517285893|FG003|Stage 2A|Disease Progression|0|||
143475158|NCT00467779|517285894|FG004|Stage 2A|Disease Progression|0|||
143475159|NCT00467779|517285895|FG005|Stage 2A|Disease Progression|0|||
143475160|NCT00467779|517285896|FG006|Stage 2A|Disease Progression|0|||
143475161|NCT00467779|517285897|FG007|Stage 2A|Disease Progression|0|||
143475162|NCT00467779|517285898|FG008|Stage 2A|Disease Progression|0|||
143475163|NCT00467779|517285899|FG009|Stage 2A|Disease Progression|0|||
143475164|NCT00467779|517285900|FG010|Stage 2A|Disease Progression|0|||
143475165|NCT00467779|517285901|FG011|Stage 2A|Disease Progression|0|||
143475166|NCT00467779|517285902|FG012|Stage 2A|Disease Progression|0|||
143475167|NCT00467779|517285903|FG013|Stage 2A|Disease Progression|10|||
143475168|NCT00467779|517285904|FG014|Stage 2A|Disease Progression|0|||
143475169|NCT00467779|517285890|FG000|Stage 2A|Unspecified Reason|0|||
143475170|NCT00467779|517285891|FG001|Stage 2A|Unspecified Reason|0|||
143475171|NCT00467779|517285892|FG002|Stage 2A|Unspecified Reason|0|||
143475172|NCT00467779|517285893|FG003|Stage 2A|Unspecified Reason|0|||
143475173|NCT00467779|517285894|FG004|Stage 2A|Unspecified Reason|0|||
143475174|NCT00467779|517285895|FG005|Stage 2A|Unspecified Reason|0|||
143475175|NCT00467779|517285896|FG006|Stage 2A|Unspecified Reason|0|||
143475176|NCT00467779|517285897|FG007|Stage 2A|Unspecified Reason|0|||
143475177|NCT00467779|517285898|FG008|Stage 2A|Unspecified Reason|0|||
143475178|NCT00467779|517285899|FG009|Stage 2A|Unspecified Reason|0|||
143475179|NCT00467779|517285900|FG010|Stage 2A|Unspecified Reason|0|||
143475180|NCT00467779|517285901|FG011|Stage 2A|Unspecified Reason|0|||
143475181|NCT00467779|517285902|FG012|Stage 2A|Unspecified Reason|0|||
143475182|NCT00467779|517285903|FG013|Stage 2A|Unspecified Reason|7|||
143475183|NCT00467779|517285904|FG014|Stage 2A|Unspecified Reason|0|||
143475184|NCT00467779|517285890|FG000|Stage 2A|Withdrawal by Subject|0|||
143475185|NCT00467779|517285891|FG001|Stage 2A|Withdrawal by Subject|0|||
143475186|NCT00467779|517285892|FG002|Stage 2A|Withdrawal by Subject|0|||
143475187|NCT00467779|517285893|FG003|Stage 2A|Withdrawal by Subject|0|||
143475188|NCT00467779|517285894|FG004|Stage 2A|Withdrawal by Subject|0|||
143475189|NCT00467779|517285895|FG005|Stage 2A|Withdrawal by Subject|0|||
143475190|NCT00467779|517285896|FG006|Stage 2A|Withdrawal by Subject|0|||
143475191|NCT00467779|517285897|FG007|Stage 2A|Withdrawal by Subject|0|||
143475192|NCT00467779|517285898|FG008|Stage 2A|Withdrawal by Subject|0|||
143475193|NCT00467779|517285899|FG009|Stage 2A|Withdrawal by Subject|0|||
143475194|NCT00467779|517285900|FG010|Stage 2A|Withdrawal by Subject|0|||
143475195|NCT00467779|517285901|FG011|Stage 2A|Withdrawal by Subject|0|||
143475196|NCT00467779|517285902|FG012|Stage 2A|Withdrawal by Subject|0|||
143475197|NCT00467779|517285903|FG013|Stage 2A|Withdrawal by Subject|1|||
143475198|NCT00467779|517285904|FG014|Stage 2A|Withdrawal by Subject|0|||
143475199|NCT00467779|517285890|FG000|Stage 3|Adverse Event|0|||
143475200|NCT00467779|517285891|FG001|Stage 3|Adverse Event|0|||
143475201|NCT00467779|517285892|FG002|Stage 3|Adverse Event|0|||
143475202|NCT00467779|517285893|FG003|Stage 3|Adverse Event|0|||
143475203|NCT00467779|517285894|FG004|Stage 3|Adverse Event|0|||
143475204|NCT00467779|517285895|FG005|Stage 3|Adverse Event|0|||
143475205|NCT00467779|517285896|FG006|Stage 3|Adverse Event|0|||
143475206|NCT00467779|517285897|FG007|Stage 3|Adverse Event|0|||
143475207|NCT00467779|517285898|FG008|Stage 3|Adverse Event|0|||
143475208|NCT00467779|517285899|FG009|Stage 3|Adverse Event|0|||
143475209|NCT00467779|517285900|FG010|Stage 3|Adverse Event|0|||
143475210|NCT00467779|517285901|FG011|Stage 3|Adverse Event|0|||
143475211|NCT00467779|517285902|FG012|Stage 3|Adverse Event|0|||
143475212|NCT00467779|517285903|FG013|Stage 3|Adverse Event|0|||
143475213|NCT00467779|517285904|FG014|Stage 3|Adverse Event|2|||
143475214|NCT00467779|517285890|FG000|Stage 3|Death|0|||
143475215|NCT00467779|517285891|FG001|Stage 3|Death|0|||
143475216|NCT00467779|517285892|FG002|Stage 3|Death|0|||
143475217|NCT00467779|517285893|FG003|Stage 3|Death|0|||
143475218|NCT00467779|517285894|FG004|Stage 3|Death|0|||
143475219|NCT00467779|517285895|FG005|Stage 3|Death|0|||
143475220|NCT00467779|517285896|FG006|Stage 3|Death|0|||
143475221|NCT00467779|517285897|FG007|Stage 3|Death|0|||
143475222|NCT00467779|517285898|FG008|Stage 3|Death|0|||
143475223|NCT00467779|517285899|FG009|Stage 3|Death|0|||
143475224|NCT00467779|517285900|FG010|Stage 3|Death|0|||
143475225|NCT00467779|517285901|FG011|Stage 3|Death|0|||
143475226|NCT00467779|517285902|FG012|Stage 3|Death|0|||
143475227|NCT00467779|517285903|FG013|Stage 3|Death|0|||
143475228|NCT00467779|517285904|FG014|Stage 3|Death|1|||
143475229|NCT00467779|517285890|FG000|Stage 3|Disease Progression|0|||
143475230|NCT00467779|517285891|FG001|Stage 3|Disease Progression|0|||
143475231|NCT00467779|517285892|FG002|Stage 3|Disease Progression|0|||
143475232|NCT00467779|517285893|FG003|Stage 3|Disease Progression|0|||
143475233|NCT00467779|517285894|FG004|Stage 3|Disease Progression|0|||
143475234|NCT00467779|517285895|FG005|Stage 3|Disease Progression|0|||
143475235|NCT00467779|517285896|FG006|Stage 3|Disease Progression|0|||
143475236|NCT00467779|517285897|FG007|Stage 3|Disease Progression|0|||
143475237|NCT00467779|517285898|FG008|Stage 3|Disease Progression|0|||
143475238|NCT00467779|517285899|FG009|Stage 3|Disease Progression|0|||
143475239|NCT00467779|517285900|FG010|Stage 3|Disease Progression|0|||
143475240|NCT00467779|517285901|FG011|Stage 3|Disease Progression|0|||
143475241|NCT00467779|517285902|FG012|Stage 3|Disease Progression|0|||
143475242|NCT00467779|517285903|FG013|Stage 3|Disease Progression|0|||
143475243|NCT00467779|517285904|FG014|Stage 3|Disease Progression|9|||
143475244|NCT00467779|517285890|FG000|Stage 3|Unspecified Reason|0|||
143475245|NCT00467779|517285891|FG001|Stage 3|Unspecified Reason|0|||
143475246|NCT00467779|517285892|FG002|Stage 3|Unspecified Reason|0|||
143475247|NCT00467779|517285893|FG003|Stage 3|Unspecified Reason|0|||
143475248|NCT00467779|517285894|FG004|Stage 3|Unspecified Reason|0|||
143475249|NCT00467779|517285895|FG005|Stage 3|Unspecified Reason|0|||
143475250|NCT00467779|517285896|FG006|Stage 3|Unspecified Reason|0|||
143475251|NCT00467779|517285897|FG007|Stage 3|Unspecified Reason|0|||
143475252|NCT00467779|517285898|FG008|Stage 3|Unspecified Reason|0|||
143475253|NCT00467779|517285899|FG009|Stage 3|Unspecified Reason|0|||
143475254|NCT00467779|517285900|FG010|Stage 3|Unspecified Reason|0|||
143475255|NCT00467779|517285901|FG011|Stage 3|Unspecified Reason|0|||
143475256|NCT00467779|517285902|FG012|Stage 3|Unspecified Reason|0|||
143475257|NCT00467779|517285903|FG013|Stage 3|Unspecified Reason|0|||
143475258|NCT00467779|517285904|FG014|Stage 3|Unspecified Reason|5|||
143475259|NCT01509079|517285905|FG000|Overall Study|Lack of Efficacy|0|||
143475260|NCT01509079|517285906|FG001|Overall Study|Lack of Efficacy|2|||
143475261|NCT01509079|517285905|FG000|Overall Study|started an excluded medication|0|||
143475262|NCT01509079|517285906|FG001|Overall Study|started an excluded medication|1|||
143475263|NCT05111041|517285907|FG000|Overall Study|Lost to Follow-up|6|||
143475264|NCT05111041|517285908|FG001|Overall Study|Lost to Follow-up|7|||
143475265|NCT05111041|517285907|FG000|Overall Study|Withdrawal by Subject|1|||
143475266|NCT05111041|517285908|FG001|Overall Study|Withdrawal by Subject|0|||
143475267|NCT04667377|517285909|FG000|Dose Escalation Period|Other not specified below|3|||
143475268|NCT04667377|517285910|FG001|Dose Escalation Period|Other not specified below|3|||
143475269|NCT04667377|517285911|FG002|Dose Escalation Period|Other not specified below|2|||
143475270|NCT04667377|517285912|FG003|Dose Escalation Period|Other not specified below|1|||
143475271|NCT04667377|517285913|FG004|Dose Escalation Period|Other not specified below|3|||
143475272|NCT04667377|517285909|FG000|Dose Escalation Period|Protocol Violation|2|||
143475273|NCT04667377|517285910|FG001|Dose Escalation Period|Protocol Violation|2|||
143475274|NCT04667377|517285911|FG002|Dose Escalation Period|Protocol Violation|0|||
143475275|NCT04667377|517285912|FG003|Dose Escalation Period|Protocol Violation|2|||
143475276|NCT04667377|517285913|FG004|Dose Escalation Period|Protocol Violation|1|||
143475277|NCT04667377|517285909|FG000|Dose Escalation Period|Burden of study procedures|2|||
143475278|NCT04667377|517285910|FG001|Dose Escalation Period|Burden of study procedures|1|||
143475279|NCT04667377|517285911|FG002|Dose Escalation Period|Burden of study procedures|1|||
143475280|NCT04667377|517285912|FG003|Dose Escalation Period|Burden of study procedures|1|||
143475281|NCT04667377|517285913|FG004|Dose Escalation Period|Burden of study procedures|5|||
143475282|NCT04667377|517285909|FG000|Dose Escalation Period|Change of residence|0|||
143475283|NCT04667377|517285910|FG001|Dose Escalation Period|Change of residence|0|||
143475284|NCT04667377|517285911|FG002|Dose Escalation Period|Change of residence|1|||
143475285|NCT04667377|517285912|FG003|Dose Escalation Period|Change of residence|0|||
143475286|NCT04667377|517285913|FG004|Dose Escalation Period|Change of residence|0|||
143475287|NCT04667377|517285909|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
143475288|NCT04667377|517285910|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
143475289|NCT04667377|517285911|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
143475290|NCT04667377|517285912|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
143475291|NCT04667377|517285913|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
143475292|NCT04667377|517285909|FG000|Dose Escalation Period|Adverse Event|9|||
143475293|NCT04667377|517285910|FG001|Dose Escalation Period|Adverse Event|10|||
143475294|NCT04667377|517285911|FG002|Dose Escalation Period|Adverse Event|12|||
143475295|NCT04667377|517285912|FG003|Dose Escalation Period|Adverse Event|17|||
143475296|NCT04667377|517285913|FG004|Dose Escalation Period|Adverse Event|3|||
143475297|NCT04667377|517285909|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
143475298|NCT04667377|517285910|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
143475299|NCT04667377|517285911|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
143475300|NCT04667377|517285912|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
143475301|NCT04667377|517285913|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
143475302|NCT04667377|517285909|FG000|Dose Escalation Period|Not treated|1|||
143475303|NCT04667377|517285910|FG001|Dose Escalation Period|Not treated|0|||
143475304|NCT04667377|517285911|FG002|Dose Escalation Period|Not treated|0|||
143475305|NCT04667377|517285912|FG003|Dose Escalation Period|Not treated|0|||
143475306|NCT04667377|517285913|FG004|Dose Escalation Period|Not treated|0|||
143475307|NCT04667377|517285909|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
143475308|NCT04667377|517285910|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
143475309|NCT04667377|517285911|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
143475310|NCT04667377|517285912|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
143475311|NCT04667377|517285913|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
143475312|NCT04667377|517285909|FG000|Dose Escalation Period|Lost to Follow-up|0|||
143475313|NCT04667377|517285910|FG001|Dose Escalation Period|Lost to Follow-up|1|||
143475314|NCT04667377|517285911|FG002|Dose Escalation Period|Lost to Follow-up|0|||
143475315|NCT04667377|517285912|FG003|Dose Escalation Period|Lost to Follow-up|0|||
143475316|NCT04667377|517285913|FG004|Dose Escalation Period|Lost to Follow-up|0|||
143475317|NCT04667377|517285909|FG000|Maintenance Period|Perceived lack of efficacy|0|||
143475318|NCT04667377|517285910|FG001|Maintenance Period|Perceived lack of efficacy|2|||
143475319|NCT04667377|517285911|FG002|Maintenance Period|Perceived lack of efficacy|1|||
143475320|NCT04667377|517285912|FG003|Maintenance Period|Perceived lack of efficacy|0|||
143475321|NCT04667377|517285913|FG004|Maintenance Period|Perceived lack of efficacy|1|||
143475322|NCT04667377|517285909|FG000|Maintenance Period|Adverse Event|2|||
143475323|NCT04667377|517285910|FG001|Maintenance Period|Adverse Event|8|||
143475324|NCT04667377|517285911|FG002|Maintenance Period|Adverse Event|5|||
143475325|NCT04667377|517285912|FG003|Maintenance Period|Adverse Event|4|||
143475326|NCT04667377|517285913|FG004|Maintenance Period|Adverse Event|1|||
143475327|NCT04667377|517285909|FG000|Maintenance Period|Adverse event: COVID infection|0|||
143475328|NCT04667377|517285910|FG001|Maintenance Period|Adverse event: COVID infection|1|||
143475329|NCT04667377|517285911|FG002|Maintenance Period|Adverse event: COVID infection|0|||
143475330|NCT04667377|517285912|FG003|Maintenance Period|Adverse event: COVID infection|0|||
143475331|NCT04667377|517285913|FG004|Maintenance Period|Adverse event: COVID infection|0|||
143475332|NCT04667377|517285909|FG000|Maintenance Period|COVID-related|0|||
143475333|NCT04667377|517285910|FG001|Maintenance Period|COVID-related|0|||
143475334|NCT04667377|517285911|FG002|Maintenance Period|COVID-related|1|||
143475335|NCT04667377|517285912|FG003|Maintenance Period|COVID-related|1|||
143475336|NCT04667377|517285913|FG004|Maintenance Period|COVID-related|0|||
143475337|NCT04667377|517285909|FG000|Maintenance Period|Protocol Violation|1|||
143475338|NCT04667377|517285910|FG001|Maintenance Period|Protocol Violation|0|||
143475339|NCT04667377|517285911|FG002|Maintenance Period|Protocol Violation|0|||
143475340|NCT04667377|517285912|FG003|Maintenance Period|Protocol Violation|0|||
143475341|NCT04667377|517285913|FG004|Maintenance Period|Protocol Violation|1|||
143475342|NCT04667377|517285909|FG000|Maintenance Period|Burden of study procedures|1|||
143475343|NCT04667377|517285910|FG001|Maintenance Period|Burden of study procedures|2|||
143475344|NCT04667377|517285911|FG002|Maintenance Period|Burden of study procedures|0|||
143475345|NCT04667377|517285912|FG003|Maintenance Period|Burden of study procedures|1|||
143475346|NCT04667377|517285913|FG004|Maintenance Period|Burden of study procedures|0|||
143475347|NCT04667377|517285909|FG000|Maintenance Period|Change of residence|0|||
143475348|NCT04667377|517285910|FG001|Maintenance Period|Change of residence|1|||
143475349|NCT04667377|517285911|FG002|Maintenance Period|Change of residence|0|||
143475350|NCT04667377|517285912|FG003|Maintenance Period|Change of residence|0|||
143475351|NCT04667377|517285913|FG004|Maintenance Period|Change of residence|1|||
143475352|NCT04667377|517285909|FG000|Maintenance Period|Missing|1|||
143475353|NCT04667377|517285910|FG001|Maintenance Period|Missing|0|||
143475354|NCT04667377|517285911|FG002|Maintenance Period|Missing|0|||
143475355|NCT04667377|517285912|FG003|Maintenance Period|Missing|0|||
143475356|NCT04667377|517285913|FG004|Maintenance Period|Missing|0|||
143475357|NCT04667377|517285909|FG000|Maintenance Period|Other than listed above|2|||
143475358|NCT04667377|517285910|FG001|Maintenance Period|Other than listed above|0|||
143475359|NCT04667377|517285911|FG002|Maintenance Period|Other than listed above|3|||
143475360|NCT04667377|517285912|FG003|Maintenance Period|Other than listed above|2|||
143475361|NCT04667377|517285913|FG004|Maintenance Period|Other than listed above|6|||
143475362|NCT04667377|517285909|FG000|Maintenance Period|Withdrawal by Subject|0|||
143475363|NCT04667377|517285910|FG001|Maintenance Period|Withdrawal by Subject|1|||
143475364|NCT04667377|517285911|FG002|Maintenance Period|Withdrawal by Subject|0|||
143475365|NCT04667377|517285912|FG003|Maintenance Period|Withdrawal by Subject|0|||
143475366|NCT04667377|517285913|FG004|Maintenance Period|Withdrawal by Subject|0|||
143475367|NCT04667377|517285909|FG000|Maintenance Period|Lost to Follow-up|1|||
143475368|NCT04667377|517285910|FG001|Maintenance Period|Lost to Follow-up|0|||
143475369|NCT04667377|517285911|FG002|Maintenance Period|Lost to Follow-up|1|||
143475370|NCT04667377|517285912|FG003|Maintenance Period|Lost to Follow-up|0|||
143475371|NCT04667377|517285913|FG004|Maintenance Period|Lost to Follow-up|1|||
143475372|NCT02066311|517285914|FG000|Overall Study|Adverse Event|4|||
143475373|NCT02066311|517285914|FG000|Overall Study|Withdrawal by Subject|1|||
143475374|NCT00359021|517285915|FG000|Overall Study|Adverse Event|26|||
143475375|NCT00359021|517285916|FG001|Overall Study|Adverse Event|8|||
143475376|NCT00359021|517285915|FG000|Overall Study|Subject Non-Compliant|1|||
143475377|NCT00359021|517285916|FG001|Overall Study|Subject Non-Compliant|2|||
143475378|NCT00359021|517285915|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
143475379|NCT00359021|517285916|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
143475380|NCT00359021|517285915|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
143475381|NCT00359021|517285916|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
143475382|NCT00359021|517285915|FG000|Overall Study|Withdrawal by Subject|2|||
143475383|NCT00359021|517285916|FG001|Overall Study|Withdrawal by Subject|9|||
143475384|NCT00359021|517285915|FG000|Overall Study|Lost to Follow-up|1|||
143475385|NCT00359021|517285916|FG001|Overall Study|Lost to Follow-up|0|||
143475386|NCT00359021|517285915|FG000|Overall Study|Other|4|||
143475387|NCT00359021|517285916|FG001|Overall Study|Other|1|||
143475388|NCT00359021|517285915|FG000|Overall Study|Pregnancy|1|||
143475389|NCT00359021|517285916|FG001|Overall Study|Pregnancy|0|||
143475390|NCT01526551|517285922|FG000|Overall Study|Lack of returned parental consent form|424|||
143475391|NCT04880447|517285923|FG000|Overall Study|No vaccination information|1|||
143475392|NCT04880447|517285923|FG000|Overall Study|No adverse event information (missing information)|1|||
143475393|NCT04880447|517285923|FG000|Overall Study|Disease not covered in this study|35|||
143475394|NCT01576172|517285925|FG000|Overall Study|Ineligible|2|||
143475395|NCT01576172|517285926|FG001|Overall Study|Ineligible|1|||
143475396|NCT01576172|517285925|FG000|Overall Study|Withdrawal by Subject|2|||
143475397|NCT01576172|517285926|FG001|Overall Study|Withdrawal by Subject|0|||
143475398|NCT01576172|517285925|FG000|Overall Study|Insurance issue|1|||
143475399|NCT01576172|517285926|FG001|Overall Study|Insurance issue|0|||
143475400|NCT00239226|517285931|FG000|Overall Study|permAF during stabilization period|0|||
143475401|NCT00239226|517285932|FG001|Overall Study|permAF during stabilization period|0|||
143475402|NCT00239226|517285933|FG002|Overall Study|permAF during stabilization period|0|||
143475403|NCT00239226|517285934|FG003|Overall Study|permAF during stabilization period|3|||
143475404|NCT00239226|517285931|FG000|Overall Study|Lost to Follow-up|1|||
143475405|NCT00239226|517285932|FG001|Overall Study|Lost to Follow-up|0|||
143475406|NCT00239226|517285933|FG002|Overall Study|Lost to Follow-up|1|||
143475407|NCT00239226|517285934|FG003|Overall Study|Lost to Follow-up|0|||
143475408|NCT03044249|517285947|FG000|Overall Study|Adverse Event|4|||
143475409|NCT03044249|517285948|FG001|Overall Study|Adverse Event|9|||
143475410|NCT03044249|517285947|FG000|Overall Study|Lost to Follow-up|1|||
143475411|NCT03044249|517285948|FG001|Overall Study|Lost to Follow-up|0|||
143475412|NCT03044249|517285947|FG000|Overall Study|Non-compliance with Study Drug|1|||
143475413|NCT03044249|517285948|FG001|Overall Study|Non-compliance with Study Drug|0|||
143475414|NCT03044249|517285947|FG000|Overall Study|Study Terminated by Sponsor|2|||
143475415|NCT03044249|517285948|FG001|Overall Study|Study Terminated by Sponsor|0|||
143475416|NCT03044249|517285947|FG000|Overall Study|Withdrawal by Subject|2|||
143475417|NCT03044249|517285948|FG001|Overall Study|Withdrawal by Subject|5|||
143475418|NCT02456662|517285951|FG000|Overall Study|Lost to Follow-up|2|||
143475419|NCT02456662|517285952|FG001|Overall Study|Lost to Follow-up|1|||
143475420|NCT03828292|517285953|FG000|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
143475421|NCT03828292|517285954|FG001|Main Study: Part 1 (Up to 141 Weeks)|Death|1|||
143475422|NCT03828292|517285955|FG002|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
143475423|NCT03828292|517285956|FG003|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
143475424|NCT03828292|517285957|FG004|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
143475425|NCT03828292|517285958|FG005|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
143475426|NCT03828292|517285953|FG000|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
143475427|NCT03828292|517285954|FG001|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
143475428|NCT03828292|517285955|FG002|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|1|||
143475429|NCT03828292|517285956|FG003|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
143475430|NCT03828292|517285957|FG004|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
143475431|NCT03828292|517285958|FG005|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
143475432|NCT03828292|517285953|FG000|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
143475433|NCT03828292|517285954|FG001|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
143475434|NCT03828292|517285955|FG002|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
143475435|NCT03828292|517285956|FG003|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|1|||
143475436|NCT03828292|517285957|FG004|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
143475437|NCT03828292|517285958|FG005|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
143475438|NCT03828292|517285953|FG000|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
143475439|NCT03828292|517285954|FG001|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
143475440|NCT03828292|517285955|FG002|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
143475441|NCT03828292|517285956|FG003|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|1|||
143475442|NCT03828292|517285957|FG004|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
143475443|NCT03828292|517285958|FG005|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
143475444|NCT03828292|517285953|FG000|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
143475445|NCT03828292|517285954|FG001|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
143475446|NCT03828292|517285955|FG002|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
143475447|NCT03828292|517285956|FG003|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
143475448|NCT03828292|517285957|FG004|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
143475449|NCT03828292|517285958|FG005|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
143475450|NCT01444456|517285959|FG000|Overall Study|Withdrawal by Subject|21|||
143475451|NCT01444456|517285959|FG000|Overall Study|Physician Decision|9|||
143475452|NCT01444456|517285959|FG000|Overall Study|Lost to Follow-up|37|||
143475453|NCT01444456|517285959|FG000|Overall Study|Death|73|||
143475454|NCT01444456|517285959|FG000|Overall Study|Ineligibility determined|23|||
143475455|NCT01444456|517285959|FG000|Overall Study|Other|18|||
143475456|NCT01444456|517285959|FG000|Overall Study|Not treated|104|||
143475457|NCT04376827|517285963|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
143475458|NCT04376827|517285964|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
143475459|NCT04376827|517285963|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
143475460|NCT04376827|517285964|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
143475461|NCT04376827|517285963|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
143475462|NCT04376827|517285964|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
143475463|NCT04376827|517285963|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
143475464|NCT04376827|517285964|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
143475465|NCT04376827|517285963|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
143475466|NCT04376827|517285964|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
143475467|NCT03023059|517287458|FG000|Overall Study|Withdrawal by Subject|5|||
143475468|NCT03781323|517287459|FG000|Overall Study|Withdrawal by Subject|1|||
143475469|NCT01338415|517287460|FG000|Core + Extension|Adverse Event|8|||
143475470|NCT01338415|517287461|FG001|Core + Extension|Adverse Event|6|||
143475471|NCT01338415|517287462|FG002|Core + Extension|Adverse Event|0|||
143475472|NCT01338415|517287460|FG000|Core + Extension|Withdrawal by Subject|1|||
143475473|NCT01338415|517287461|FG001|Core + Extension|Withdrawal by Subject|1|||
143475474|NCT01338415|517287462|FG002|Core + Extension|Withdrawal by Subject|0|||
143475475|NCT01338415|517287460|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
143475476|NCT01338415|517287461|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
143475477|NCT01338415|517287462|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
143475478|NCT01338415|517287460|FG000|Core + Extension|Other (administrative reason)|1|||
143475479|NCT01338415|517287461|FG001|Core + Extension|Other (administrative reason)|0|||
143475480|NCT01338415|517287462|FG002|Core + Extension|Other (administrative reason)|0|||
143475481|NCT01338415|517287460|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
143475482|NCT01338415|517287461|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
143475483|NCT01338415|517287462|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
143475484|NCT01338415|517287460|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
143475485|NCT01338415|517287461|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
143475486|NCT01338415|517287462|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
143475487|NCT01338415|517287460|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
143475488|NCT01338415|517287461|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
143475489|NCT01338415|517287462|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
143475490|NCT01338415|517287460|FG000|Exceptional Use Treatment Period|Death|0|||
143475491|NCT01338415|517287461|FG001|Exceptional Use Treatment Period|Death|0|||
143475492|NCT01338415|517287462|FG002|Exceptional Use Treatment Period|Death|1|||
143475493|NCT00233363|517287463|FG000|Overall Study|Adverse Event|1|||
143475494|NCT00233363|517287464|FG001|Overall Study|Adverse Event|2|||
143475495|NCT00233363|517287463|FG000|Overall Study|Lack of Efficacy|0|||
143475496|NCT00233363|517287464|FG001|Overall Study|Lack of Efficacy|2|||
143475497|NCT00233363|517287463|FG000|Overall Study|Withdrawal by Subject|1|||
143475498|NCT00233363|517287464|FG001|Overall Study|Withdrawal by Subject|1|||
143475499|NCT00233363|517287463|FG000|Overall Study|Aggravation of complication|1|||
143475500|NCT00233363|517287464|FG001|Overall Study|Aggravation of complication|0|||
143475501|NCT01303965|517287469|FG000|Overall Study|Adverse Event|1|||
143475502|NCT01303965|517287470|FG001|Overall Study|Adverse Event|1|||
143475503|NCT01303965|517287469|FG000|Overall Study|Death|0|||
143475504|NCT01303965|517287470|FG001|Overall Study|Death|3|||
143475505|NCT01303965|517287469|FG000|Overall Study|Withdrawal by Subject|1|||
143475506|NCT01303965|517287470|FG001|Overall Study|Withdrawal by Subject|0|||
143475507|NCT01303965|517287469|FG000|Overall Study|Disease Progression|1|||
143475508|NCT01303965|517287470|FG001|Overall Study|Disease Progression|6|||
143475509|NCT04534491|517287472|FG000|Overall Study|Not completed end-of-study interview|24|||
143475510|NCT04534491|517287472|FG000|Overall Study|Non-users|70|||
143475511|NCT04534491|517287472|FG000|Overall Study|Non-verifiable users|58|||
143475512|NCT03024970|517287482|FG000|First Intervention|Adverse Event|1|||
143475513|NCT03024970|517287483|FG001|First Intervention|Adverse Event|0|||
143475514|NCT03024970|517287482|FG000|Second Intervention|Lost to Follow-up|1|||
143475515|NCT03024970|517287483|FG001|Second Intervention|Lost to Follow-up|0|||
143475516|NCT00131469|517287484|FG000|Overall Study|Withdrawal by Subject|3|||
143475517|NCT00131469|517287485|FG001|Overall Study|Withdrawal by Subject|4|||
143475518|NCT00131469|517287484|FG000|Overall Study|Protocol Violation|3|||
143475519|NCT00131469|517287485|FG001|Overall Study|Protocol Violation|1|||
143475520|NCT00131469|517287484|FG000|Overall Study|Death|0|||
143475521|NCT00131469|517287485|FG001|Overall Study|Death|1|||
143475522|NCT00131469|517287484|FG000|Overall Study|Lost to Follow-up|0|||
143475523|NCT00131469|517287485|FG001|Overall Study|Lost to Follow-up|1|||
143475524|NCT00131469|517287484|FG000|Overall Study|scan not analyzable|3|||
143475525|NCT00131469|517287485|FG001|Overall Study|scan not analyzable|6|||
143475526|NCT01106027|517287486|FG000|Overall Study|Lost graft early, discontinued|1|||
143475527|NCT02871778|517287487|FG000|Part A: Treatment Period 1|Adverse Event|1|||
143475528|NCT02871778|517287488|FG001|Part A: Treatment Period 1|Adverse Event|1|||
143475529|NCT02871778|517287489|FG002|Part A: Treatment Period 1|Adverse Event|1|||
143475530|NCT02871778|517287490|FG003|Part A: Treatment Period 1|Adverse Event|0|||
143475531|NCT02871778|517287491|FG004|Part A: Treatment Period 1|Adverse Event|0|||
143475532|NCT02871778|517287492|FG005|Part A: Treatment Period 1|Adverse Event|0|||
143475533|NCT02871778|517287493|FG006|Part A: Treatment Period 1|Adverse Event|0|||
143475534|NCT02871778|517287494|FG007|Part A: Treatment Period 1|Adverse Event|0|||
143475535|NCT02871778|517287487|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
143475536|NCT02871778|517287488|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
143475537|NCT02871778|517287489|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
143475538|NCT02871778|517287490|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
143475539|NCT02871778|517287491|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
143475540|NCT02871778|517287492|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
143475541|NCT02871778|517287493|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
143475542|NCT02871778|517287494|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
143475543|NCT02871778|517287487|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
143475544|NCT02871778|517287488|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
143475545|NCT02871778|517287489|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
143475546|NCT02871778|517287490|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
143475547|NCT02871778|517287491|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
143475548|NCT02871778|517287492|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
143475549|NCT02871778|517287493|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
143475550|NCT02871778|517287494|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
143475551|NCT02871778|517287487|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
143475552|NCT02871778|517287488|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
143475553|NCT02871778|517287489|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
143475554|NCT02871778|517287490|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
143475555|NCT02871778|517287491|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
143475556|NCT02871778|517287492|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
143475557|NCT02871778|517287493|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
143475558|NCT02871778|517287494|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
143475559|NCT02871778|517287487|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
143475560|NCT02871778|517287488|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
143475561|NCT02871778|517287489|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
143475562|NCT02871778|517287490|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
143475563|NCT02871778|517287491|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
143475564|NCT02871778|517287492|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
143475565|NCT02871778|517287493|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
143475566|NCT02871778|517287494|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
143475567|NCT02871778|517287487|FG000|Part A: Treatment Period 2|Adverse Event|2|||
143475568|NCT02871778|517287488|FG001|Part A: Treatment Period 2|Adverse Event|2|||
143475569|NCT02871778|517287489|FG002|Part A: Treatment Period 2|Adverse Event|0|||
143475570|NCT02871778|517287490|FG003|Part A: Treatment Period 2|Adverse Event|0|||
143475571|NCT02871778|517287491|FG004|Part A: Treatment Period 2|Adverse Event|0|||
143475572|NCT02871778|517287492|FG005|Part A: Treatment Period 2|Adverse Event|0|||
143475573|NCT02871778|517287493|FG006|Part A: Treatment Period 2|Adverse Event|0|||
143475574|NCT02871778|517287494|FG007|Part A: Treatment Period 2|Adverse Event|0|||
143475575|NCT02871778|517287487|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
143475576|NCT02871778|517287488|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
143475577|NCT02871778|517287489|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
143475578|NCT02871778|517287490|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
143475579|NCT02871778|517287491|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
143475580|NCT02871778|517287492|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
143475581|NCT02871778|517287493|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
143475582|NCT02871778|517287494|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
143475583|NCT02871778|517287487|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
143475584|NCT02871778|517287488|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
143475585|NCT02871778|517287489|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
143475586|NCT02871778|517287490|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
143475587|NCT02871778|517287491|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
143475588|NCT02871778|517287492|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
143475589|NCT02871778|517287493|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
143475590|NCT02871778|517287494|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
143475591|NCT02871778|517287487|FG000|Part B: Treatment Period 3|Adverse Event|0|||
143475592|NCT02871778|517287488|FG001|Part B: Treatment Period 3|Adverse Event|0|||
143142545|NCT01232283|516069320|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
143475593|NCT02871778|517287489|FG002|Part B: Treatment Period 3|Adverse Event|0|||
143475594|NCT02871778|517287490|FG003|Part B: Treatment Period 3|Adverse Event|0|||
143475595|NCT02871778|517287491|FG004|Part B: Treatment Period 3|Adverse Event|1|||
143475596|NCT02871778|517287492|FG005|Part B: Treatment Period 3|Adverse Event|1|||
143475597|NCT02871778|517287493|FG006|Part B: Treatment Period 3|Adverse Event|1|||
143475598|NCT02871778|517287494|FG007|Part B: Treatment Period 3|Adverse Event|0|||
143475599|NCT02653300|517287496|FG000|Overall Study|Withdrawal by Subject|2|||
143475600|NCT02678416|517287497|FG000|Part 1|Withdrawal by Subject|1|||
143475601|NCT02678416|517287497|FG000|Part 2|Adverse Event|2|||
143475602|NCT02678416|517287497|FG000|Part 2|Withdrawal by Subject|1|||
143475603|NCT01848353|517287498|FG000|Phase 1|Withdrawal by Subject|3|||
143475604|NCT01848353|517287499|FG001|Phase 1|Withdrawal by Subject|1|||
143475605|NCT01848353|517287500|FG002|Phase 1|Withdrawal by Subject|0|||
143475606|NCT01848353|517287501|FG003|Phase 1|Withdrawal by Subject|0|||
143475607|NCT01848353|517287498|FG000|Phase 2|Withdrawal by Subject|3|||
143475608|NCT01848353|517287499|FG001|Phase 2|Withdrawal by Subject|2|||
143475609|NCT01848353|517287500|FG002|Phase 2|Withdrawal by Subject|0|||
143475610|NCT01848353|517287501|FG003|Phase 2|Withdrawal by Subject|0|||
143475611|NCT01848353|517287498|FG000|Phase 3|Withdrawal by Subject|1|||
143475612|NCT01848353|517287499|FG001|Phase 3|Withdrawal by Subject|1|||
143475613|NCT01848353|517287500|FG002|Phase 3|Withdrawal by Subject|0|||
143475614|NCT01848353|517287501|FG003|Phase 3|Withdrawal by Subject|0|||
143475615|NCT00935272|517287502|FG000|Overall Study|Lost to Follow-up|10|||
143475616|NCT00935272|517287503|FG001|Overall Study|Lost to Follow-up|3|||
143475617|NCT00935272|517287502|FG000|Overall Study|Withdrawal by Subject|8|||
143475618|NCT00935272|517287503|FG001|Overall Study|Withdrawal by Subject|2|||
143475619|NCT00935272|517287502|FG000|Overall Study|Physician Decision|1|||
143475620|NCT00935272|517287503|FG001|Overall Study|Physician Decision|0|||
143475621|NCT00935272|517287502|FG000|Overall Study|Protocol Violation|0|||
143475622|NCT00935272|517287503|FG001|Overall Study|Protocol Violation|1|||
143475623|NCT01390272|517287506|FG000|Overall Study|Death|3|||
143475624|NCT01390272|517287507|FG001|Overall Study|Death|2|||
143475625|NCT01390272|517287506|FG000|Overall Study|Withdrawal by Subject|9|||
143475626|NCT01390272|517287507|FG001|Overall Study|Withdrawal by Subject|5|||
143475627|NCT01390272|517287506|FG000|Overall Study|Patient moved, no longer eligible|5|||
143475628|NCT01390272|517287507|FG001|Overall Study|Patient moved, no longer eligible|8|||
143475629|NCT01177384|517287508|FG000|Overall Study|Adverse Event|6|||
143475630|NCT01177384|517287509|FG001|Overall Study|Adverse Event|4|||
143475631|NCT01177384|517287508|FG000|Overall Study|Lack of Efficacy|0|||
143475632|NCT01177384|517287509|FG001|Overall Study|Lack of Efficacy|1|||
143475633|NCT01177384|517287508|FG000|Overall Study|Lost to Follow-up|3|||
143475634|NCT01177384|517287509|FG001|Overall Study|Lost to Follow-up|4|||
143475635|NCT01177384|517287508|FG000|Overall Study|Physician Decision|0|||
143475636|NCT01177384|517287509|FG001|Overall Study|Physician Decision|3|||
143475637|NCT01177384|517287508|FG000|Overall Study|Protocol Violation|0|||
143475638|NCT01177384|517287509|FG001|Overall Study|Protocol Violation|2|||
143475639|NCT01177384|517287508|FG000|Overall Study|Withdrawal by Subject|5|||
143475640|NCT01177384|517287509|FG001|Overall Study|Withdrawal by Subject|12|||
143475641|NCT00590044|517287540|FG000|Overall Study|Withdrawal by Subject|2|||
143475642|NCT00590044|517287541|FG001|Overall Study|Withdrawal by Subject|2|||
143475643|NCT00590044|517287540|FG000|Overall Study|wrong insulin arm assigned|1|||
143475644|NCT00590044|517287541|FG001|Overall Study|wrong insulin arm assigned|0|||
143475645|NCT00590044|517287540|FG000|Overall Study|Protocol Violation|1|||
143475646|NCT00590044|517287541|FG001|Overall Study|Protocol Violation|0|||
143475647|NCT01514136|517287545|FG000|Test Period 1; Test A|Protocol Violation|1|||
143475648|NCT01514136|517287546|FG001|Test Period 1; Test A|Protocol Violation|0|||
143475649|NCT01514136|517287547|FG002|Test Period 1; Test A|Protocol Violation|0|||
143475650|NCT01514136|517287548|FG003|Test Period 1; Test A|Protocol Violation|0|||
143475651|NCT01514136|517287549|FG004|Test Period 1; Test A|Protocol Violation|0|||
143475652|NCT01514136|517287550|FG005|Test Period 1; Test A|Protocol Violation|0|||
143475653|NCT01514136|517287551|FG006|Test Period 1; Test A|Protocol Violation|0|||
143475654|NCT01514136|517287552|FG007|Test Period 1; Test A|Protocol Violation|0|||
143475655|NCT01514136|517287545|FG000|Test Period 1; Test A|Break from study holiday|2|||
143475656|NCT01514136|517287546|FG001|Test Period 1; Test A|Break from study holiday|0|||
143475657|NCT01514136|517287547|FG002|Test Period 1; Test A|Break from study holiday|0|||
143475658|NCT01514136|517287548|FG003|Test Period 1; Test A|Break from study holiday|0|||
143475659|NCT01514136|517287549|FG004|Test Period 1; Test A|Break from study holiday|0|||
143475660|NCT01514136|517287550|FG005|Test Period 1; Test A|Break from study holiday|0|||
143475661|NCT01514136|517287551|FG006|Test Period 1; Test A|Break from study holiday|0|||
143475662|NCT01514136|517287552|FG007|Test Period 1; Test A|Break from study holiday|0|||
143475663|NCT01514136|517287545|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
143475664|NCT01514136|517287546|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
143475665|NCT01514136|517287547|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
143475666|NCT01514136|517287548|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
143475667|NCT01514136|517287549|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
143475668|NCT01514136|517287550|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
143475669|NCT01514136|517287551|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
143475670|NCT01514136|517287552|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
143475671|NCT01514136|517287545|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
143475672|NCT01514136|517287546|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
143475673|NCT01514136|517287547|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
143475674|NCT01514136|517287548|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
143475675|NCT01514136|517287549|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
143475676|NCT01514136|517287550|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
143475677|NCT01514136|517287551|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
143475678|NCT01514136|517287552|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
143475679|NCT01514136|517287545|FG000|Test Period 2; Test A*|Adverse Event|0|||
143475680|NCT01514136|517287546|FG001|Test Period 2; Test A*|Adverse Event|0|||
143475681|NCT01514136|517287547|FG002|Test Period 2; Test A*|Adverse Event|0|||
143475682|NCT01514136|517287548|FG003|Test Period 2; Test A*|Adverse Event|0|||
143475683|NCT01514136|517287549|FG004|Test Period 2; Test A*|Adverse Event|1|||
143475684|NCT01514136|517287550|FG005|Test Period 2; Test A*|Adverse Event|0|||
143475685|NCT01514136|517287551|FG006|Test Period 2; Test A*|Adverse Event|0|||
143475686|NCT01514136|517287552|FG007|Test Period 2; Test A*|Adverse Event|0|||
143475687|NCT01514136|517287545|FG000|Test Period 2; Test A*|Holiday|0|||
143475688|NCT01514136|517287546|FG001|Test Period 2; Test A*|Holiday|0|||
143475689|NCT01514136|517287547|FG002|Test Period 2; Test A*|Holiday|0|||
143475690|NCT01514136|517287548|FG003|Test Period 2; Test A*|Holiday|0|||
143475691|NCT01514136|517287549|FG004|Test Period 2; Test A*|Holiday|1|||
143475692|NCT01514136|517287550|FG005|Test Period 2; Test A*|Holiday|0|||
143475693|NCT01514136|517287551|FG006|Test Period 2; Test A*|Holiday|0|||
143475694|NCT01514136|517287552|FG007|Test Period 2; Test A*|Holiday|0|||
143475695|NCT01514136|517287545|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
143475696|NCT01514136|517287546|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
143475697|NCT01514136|517287547|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
143475698|NCT01514136|517287548|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
143475699|NCT01514136|517287549|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
143475700|NCT01514136|517287550|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
143475701|NCT01514136|517287551|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
143475702|NCT01514136|517287552|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
143475703|NCT01514136|517287545|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
143475704|NCT01514136|517287546|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
143475705|NCT01514136|517287547|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
143475706|NCT01514136|517287548|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
143475707|NCT01514136|517287549|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
143475708|NCT01514136|517287550|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
143475709|NCT01514136|517287551|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
143475710|NCT01514136|517287552|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
143475711|NCT01514136|517287545|FG000|Test Period 2; Test C*|holiday|0|||
143475712|NCT01514136|517287546|FG001|Test Period 2; Test C*|holiday|0|||
143475713|NCT01514136|517287547|FG002|Test Period 2; Test C*|holiday|0|||
143475714|NCT01514136|517287548|FG003|Test Period 2; Test C*|holiday|0|||
143475715|NCT01514136|517287549|FG004|Test Period 2; Test C*|holiday|0|||
143475716|NCT01514136|517287550|FG005|Test Period 2; Test C*|holiday|0|||
143475717|NCT01514136|517287551|FG006|Test Period 2; Test C*|holiday|1|||
143475718|NCT01514136|517287552|FG007|Test Period 2; Test C*|holiday|0|||
143475719|NCT01514136|517287545|FG000|Test Period 2; Test C*|Protocol Violation|0|||
143475720|NCT01514136|517287546|FG001|Test Period 2; Test C*|Protocol Violation|0|||
143475721|NCT01514136|517287547|FG002|Test Period 2; Test C*|Protocol Violation|0|||
143475722|NCT01514136|517287548|FG003|Test Period 2; Test C*|Protocol Violation|0|||
143475723|NCT01514136|517287549|FG004|Test Period 2; Test C*|Protocol Violation|0|||
143475724|NCT01514136|517287550|FG005|Test Period 2; Test C*|Protocol Violation|0|||
143475725|NCT01514136|517287551|FG006|Test Period 2; Test C*|Protocol Violation|1|||
143475726|NCT01514136|517287552|FG007|Test Period 2; Test C*|Protocol Violation|0|||
143475727|NCT01010633|517287553|FG000|Overall Study|Adverse Event|1|||
143475728|NCT01010633|517287554|FG001|Overall Study|Adverse Event|1|||
143475729|NCT01010633|517287553|FG000|Overall Study|Protocol Violation|1|||
143475730|NCT01010633|517287554|FG001|Overall Study|Protocol Violation|2|||
143475731|NCT01010633|517287553|FG000|Overall Study|Withdrawal by Subject|2|||
143475732|NCT01010633|517287554|FG001|Overall Study|Withdrawal by Subject|1|||
143475733|NCT01010633|517287553|FG000|Overall Study|Investigator decision|0|||
143475734|NCT01010633|517287554|FG001|Overall Study|Investigator decision|1|||
143475735|NCT02941926|517287557|FG000|Core Phase|Progressive disease|1109|||
143475736|NCT02941926|517287557|FG000|Core Phase|Adverse Event|504|||
143475737|NCT02941926|517287557|FG000|Core Phase|Subject/guardian decision|127|||
143475738|NCT02941926|517287557|FG000|Core Phase|Physician Decision|112|||
143475739|NCT02941926|517287557|FG000|Core Phase|Death|46|||
143475740|NCT02941926|517287557|FG000|Core Phase|Protocol deviation|34|||
143475741|NCT02941926|517287557|FG000|Core Phase|Lost to Follow-up|8|||
143475742|NCT02941926|517287557|FG000|Core Phase|Technical problems|5|||
143475743|NCT02941926|517287557|FG000|Extension Phase|Physician Decision|155|||
143475744|NCT02941926|517287557|FG000|Extension Phase|Progressive disease|115|||
143475745|NCT02941926|517287557|FG000|Extension Phase|Adverse Event|13|||
143475746|NCT02941926|517287557|FG000|Extension Phase|Subject/Guardian decision|12|||
143475747|NCT02941926|517287557|FG000|Extension Phase|Death|6|||
143475748|NCT00888381|517287558|FG000|Overall Study|Lost to Follow-up|0|||
143475749|NCT00888381|517287559|FG001|Overall Study|Lost to Follow-up|1|||
143475750|NCT00097773|517287560|FG000|Overall Study|Lost to Follow-up|2|||
143475751|NCT00097773|517287561|FG001|Overall Study|Lost to Follow-up|2|||
143475752|NCT00097773|517287562|FG002|Overall Study|Lost to Follow-up|0|||
143475753|NCT00097773|517287563|FG003|Overall Study|Lost to Follow-up|1|||
143475754|NCT00097773|517287560|FG000|Overall Study|Physician Decision|2|||
143363168|NCT00515086|516873654|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
143363169|NCT00515086|516873655|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
143363170|NCT00515086|516873656|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
143363171|NCT00515086|516873653|FG000|Overall Study|Lost to Follow-up|1|||
143363172|NCT00515086|516873654|FG001|Overall Study|Lost to Follow-up|0|||
143363173|NCT00515086|516873655|FG002|Overall Study|Lost to Follow-up|0|||
143363174|NCT00515086|516873656|FG003|Overall Study|Lost to Follow-up|0|||
143363175|NCT00515086|516873653|FG000|Overall Study|Study drug no longer required|0|||
143363176|NCT00515086|516873654|FG001|Overall Study|Study drug no longer required|1|||
143363177|NCT00515086|516873655|FG002|Overall Study|Study drug no longer required|0|||
143363178|NCT00515086|516873656|FG003|Overall Study|Study drug no longer required|0|||
143363179|NCT00515086|516873653|FG000|Overall Study|Death|2|||
143363180|NCT00515086|516873654|FG001|Overall Study|Death|0|||
143363181|NCT00515086|516873655|FG002|Overall Study|Death|0|||
143363182|NCT00515086|516873656|FG003|Overall Study|Death|0|||
143363183|NCT02373813|516873657|FG000|Run-In Period|Other, Not Specified|5|||
143363184|NCT02373813|516873658|FG001|Run-In Period|Other, Not Specified|0|||
143363185|NCT02373813|516873659|FG002|Run-In Period|Other, Not Specified|0|||
143363186|NCT02373813|516873660|FG003|Run-In Period|Other, Not Specified|0|||
143363187|NCT02373813|516873657|FG000|Run-In Period|Withdrawal by Subject|16|||
143363188|NCT02373813|516873658|FG001|Run-In Period|Withdrawal by Subject|0|||
143363189|NCT02373813|516873659|FG002|Run-In Period|Withdrawal by Subject|0|||
143363190|NCT02373813|516873660|FG003|Run-In Period|Withdrawal by Subject|0|||
143363191|NCT02373813|516873657|FG000|Run-In Period|Decision by Sponsor|11|||
143363192|NCT02373813|516873658|FG001|Run-In Period|Decision by Sponsor|0|||
143363193|NCT02373813|516873659|FG002|Run-In Period|Decision by Sponsor|0|||
143363194|NCT02373813|516873660|FG003|Run-In Period|Decision by Sponsor|0|||
143363195|NCT02373813|516873657|FG000|Run-In Period|Protocol Violation|75|||
143363196|NCT02373813|516873658|FG001|Run-In Period|Protocol Violation|0|||
143363197|NCT02373813|516873659|FG002|Run-In Period|Protocol Violation|0|||
143363198|NCT02373813|516873660|FG003|Run-In Period|Protocol Violation|0|||
143363199|NCT02373813|516873657|FG000|Run-In Period|Lost to Follow-up|2|||
143363200|NCT02373813|516873658|FG001|Run-In Period|Lost to Follow-up|0|||
143363201|NCT02373813|516873659|FG002|Run-In Period|Lost to Follow-up|0|||
143363202|NCT02373813|516873660|FG003|Run-In Period|Lost to Follow-up|0|||
143363203|NCT02373813|516873657|FG000|Run-In Period|Adverse Event|3|||
143363204|NCT02373813|516873658|FG001|Run-In Period|Adverse Event|0|||
143363205|NCT02373813|516873659|FG002|Run-In Period|Adverse Event|0|||
143363206|NCT02373813|516873660|FG003|Run-In Period|Adverse Event|0|||
143363207|NCT02373813|516873657|FG000|Run-In Period|Noncompliance|1|||
143363208|NCT02373813|516873658|FG001|Run-In Period|Noncompliance|0|||
143363209|NCT02373813|516873659|FG002|Run-In Period|Noncompliance|0|||
143363210|NCT02373813|516873660|FG003|Run-In Period|Noncompliance|0|||
143363211|NCT02373813|516873657|FG000|Run-In Period|Ineligibility Determined|3|||
143363212|NCT02373813|516873658|FG001|Run-In Period|Ineligibility Determined|0|||
143363213|NCT02373813|516873659|FG002|Run-In Period|Ineligibility Determined|0|||
143363214|NCT02373813|516873660|FG003|Run-In Period|Ineligibility Determined|0|||
143363215|NCT02373813|516873657|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
143363216|NCT02373813|516873658|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
143363217|NCT02373813|516873659|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
143363218|NCT02373813|516873660|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
143363219|NCT02373813|516873657|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
143363220|NCT02373813|516873658|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
143363221|NCT02373813|516873659|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
143363222|NCT02373813|516873660|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
143363223|NCT02373813|516873657|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
143363224|NCT02373813|516873658|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
143363225|NCT02373813|516873659|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
143363226|NCT02373813|516873660|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
143363227|NCT02373813|516873657|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
143363228|NCT02373813|516873658|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
143363229|NCT02373813|516873659|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
143363230|NCT02373813|516873660|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
143363231|NCT01764386|516873663|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
143363232|NCT01764386|516873664|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
143363233|NCT01764386|516873663|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
143363234|NCT01764386|516873664|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
143475755|NCT00097773|517287561|FG001|Overall Study|Physician Decision|2|||
143475756|NCT00097773|517287562|FG002|Overall Study|Physician Decision|3|||
143475757|NCT00097773|517287563|FG003|Overall Study|Physician Decision|1|||
143475758|NCT00097773|517287560|FG000|Overall Study|Withdrawal by Subject|3|||
143475759|NCT00097773|517287561|FG001|Overall Study|Withdrawal by Subject|3|||
143475760|NCT00097773|517287562|FG002|Overall Study|Withdrawal by Subject|3|||
143475761|NCT00097773|517287563|FG003|Overall Study|Withdrawal by Subject|1|||
143475762|NCT00097773|517287560|FG000|Overall Study|Adverse Event|0|||
143475763|NCT00097773|517287561|FG001|Overall Study|Adverse Event|1|||
143475764|NCT00097773|517287562|FG002|Overall Study|Adverse Event|0|||
143475765|NCT00097773|517287563|FG003|Overall Study|Adverse Event|0|||
143475766|NCT00097773|517287560|FG000|Overall Study|Other|1|||
143475767|NCT00097773|517287561|FG001|Overall Study|Other|0|||
143475768|NCT00097773|517287562|FG002|Overall Study|Other|2|||
143475769|NCT00097773|517287563|FG003|Overall Study|Other|0|||
143475770|NCT02243865|517287570|FG000|Overall Study|Protocol Violation|1|||
143475771|NCT02243865|517287571|FG001|Overall Study|Protocol Violation|3|||
143475772|NCT02243865|517287570|FG000|Overall Study|Lost to Follow-up|1|||
143475773|NCT02243865|517287571|FG001|Overall Study|Lost to Follow-up|1|||
143475774|NCT02243865|517287570|FG000|Overall Study|Withdrawal by Subject|1|||
143475775|NCT02243865|517287571|FG001|Overall Study|Withdrawal by Subject|0|||
143475776|NCT02243865|517287570|FG000|Overall Study|Adverse Event|1|||
143475777|NCT02243865|517287571|FG001|Overall Study|Adverse Event|1|||
143475778|NCT00955279|517287572|FG000|Overall Study|Other|0|||
143475779|NCT00955279|517287573|FG001|Overall Study|Other|0|||
143475780|NCT00955279|517287574|FG002|Overall Study|Other|3|||
143475781|NCT00955279|517287572|FG000|Overall Study|Death|1|||
143475782|NCT00955279|517287573|FG001|Overall Study|Death|1|||
143475783|NCT00955279|517287574|FG002|Overall Study|Death|1|||
143475784|NCT00955279|517287572|FG000|Overall Study|Lost to Follow-up|0|||
143475785|NCT00955279|517287573|FG001|Overall Study|Lost to Follow-up|3|||
143475786|NCT00955279|517287574|FG002|Overall Study|Lost to Follow-up|1|||
143475787|NCT00955279|517287572|FG000|Overall Study|Withdrawal by Subject|2|||
143475788|NCT00955279|517287573|FG001|Overall Study|Withdrawal by Subject|0|||
143475789|NCT00955279|517287574|FG002|Overall Study|Withdrawal by Subject|3|||
143475790|NCT01235793|517287575|FG000|Overall Study|Death|6|||
143475791|NCT02003014|517287578|FG000|Overall Study|Case report forms uncollected|9|||
143475792|NCT02003014|517287578|FG000|Overall Study|Treatment started after contract period|1|||
143475793|NCT02003014|517287578|FG000|Overall Study|Patient did not visit the study site|5|||
143475794|NCT02003014|517287578|FG000|Overall Study|Investigator's transfer|4|||
143475795|NCT01660451|517287579|FG000|Overall Study|Protocol Violation|0|||
143475796|NCT01660451|517287580|FG001|Overall Study|Protocol Violation|1|||
143475797|NCT01660451|517287581|FG002|Overall Study|Protocol Violation|1|||
143475798|NCT01660451|517287579|FG000|Overall Study|AE not associated with clinical disease progression|13|||
143475799|NCT01660451|517287580|FG001|Overall Study|AE not associated with clinical disease progression|10|||
143475800|NCT01660451|517287581|FG002|Overall Study|AE not associated with clinical disease progression|40|||
143475801|NCT01660451|517287579|FG000|Overall Study|AE associated with clinical disease progression|1|||
143475802|NCT01660451|517287580|FG001|Overall Study|AE associated with clinical disease progression|3|||
143475803|NCT01660451|517287581|FG002|Overall Study|AE associated with clinical disease progression|11|||
143475804|NCT01660451|517287579|FG000|Overall Study|Sponsor Decision|0|||
143475805|NCT01660451|517287580|FG001|Overall Study|Sponsor Decision|0|||
143475806|NCT01660451|517287581|FG002|Overall Study|Sponsor Decision|1|||
143475807|NCT01660451|517287579|FG000|Overall Study|Protocol Deviation|0|||
143475808|NCT01660451|517287580|FG001|Overall Study|Protocol Deviation|0|||
143475809|NCT01660451|517287581|FG002|Overall Study|Protocol Deviation|1|||
143475810|NCT01660451|517287579|FG000|Overall Study|Physician Decision|1|||
143475811|NCT01660451|517287580|FG001|Overall Study|Physician Decision|2|||
143475812|NCT01660451|517287581|FG002|Overall Study|Physician Decision|5|||
143475813|NCT01660451|517287579|FG000|Overall Study|Withdrawal by Subject|1|||
143475814|NCT01660451|517287580|FG001|Overall Study|Withdrawal by Subject|1|||
143475815|NCT01660451|517287581|FG002|Overall Study|Withdrawal by Subject|20|||
143475816|NCT01660451|517287579|FG000|Overall Study|Trial closure.|0|||
143475817|NCT01660451|517287580|FG001|Overall Study|Trial closure.|0|||
143475818|NCT01660451|517287581|FG002|Overall Study|Trial closure.|1|||
143475819|NCT01660451|517287579|FG000|Overall Study|Switching to other therapy|0|||
143475820|NCT01660451|517287580|FG001|Overall Study|Switching to other therapy|1|||
143475821|NCT01660451|517287581|FG002|Overall Study|Switching to other therapy|1|||
143475822|NCT01660451|517287579|FG000|Overall Study|Progressive disease - clinical progression|4|||
143475823|NCT01660451|517287580|FG001|Overall Study|Progressive disease - clinical progression|10|||
143475824|NCT01660451|517287581|FG002|Overall Study|Progressive disease - clinical progression|9|||
143475825|NCT01660451|517287579|FG000|Overall Study|Progressive disease - radiological progression|12|||
143475826|NCT01660451|517287580|FG001|Overall Study|Progressive disease - radiological progression|23|||
143475827|NCT01660451|517287581|FG002|Overall Study|Progressive disease - radiological progression|50|||
143475828|NCT01660451|517287579|FG000|Overall Study|Death|1|||
143475829|NCT01660451|517287580|FG001|Overall Study|Death|0|||
143475830|NCT01660451|517287581|FG002|Overall Study|Death|1|||
143475831|NCT01660451|517287579|FG000|Overall Study|Other|0|||
143475832|NCT01660451|517287580|FG001|Overall Study|Other|0|||
143475833|NCT01660451|517287581|FG002|Overall Study|Other|1|||
143475834|NCT01159912|517287582|FG000|Overall Study|Adverse Event|2|||
143475835|NCT01159912|517287583|FG001|Overall Study|Adverse Event|2|||
143475836|NCT01159912|517287584|FG002|Overall Study|Adverse Event|3|||
143475837|NCT01159912|517287582|FG000|Overall Study|Lack of Efficacy|23|||
143475838|NCT01159912|517287583|FG001|Overall Study|Lack of Efficacy|15|||
143475839|NCT01159912|517287584|FG002|Overall Study|Lack of Efficacy|14|||
143475840|NCT01159912|517287582|FG000|Overall Study|Protocol Violation|1|||
143475841|NCT01159912|517287583|FG001|Overall Study|Protocol Violation|2|||
143475842|NCT01159912|517287584|FG002|Overall Study|Protocol Violation|3|||
143475843|NCT01159912|517287582|FG000|Overall Study|Lost to Follow-up|4|||
143475844|NCT01159912|517287583|FG001|Overall Study|Lost to Follow-up|0|||
143475845|NCT01159912|517287584|FG002|Overall Study|Lost to Follow-up|0|||
143475846|NCT01159912|517287582|FG000|Overall Study|Physician Decision|0|||
143475847|NCT01159912|517287583|FG001|Overall Study|Physician Decision|0|||
143475848|NCT01159912|517287584|FG002|Overall Study|Physician Decision|3|||
143475849|NCT01159912|517287582|FG000|Overall Study|Withdrawal by Subject|10|||
143475850|NCT01159912|517287583|FG001|Overall Study|Withdrawal by Subject|3|||
143475851|NCT01159912|517287584|FG002|Overall Study|Withdrawal by Subject|3|||
143475852|NCT02374021|517287587|FG000|Overall Study|Adverse Event|1|||
143475853|NCT02374021|517287588|FG001|Overall Study|Adverse Event|0|||
143475854|NCT02374021|517287587|FG000|Overall Study|Lost to Follow-up|3|||
143475855|NCT02374021|517287588|FG001|Overall Study|Lost to Follow-up|2|||
143475856|NCT02374021|517287587|FG000|Overall Study|Physician Decision|0|||
143475857|NCT02374021|517287588|FG001|Overall Study|Physician Decision|3|||
143475858|NCT02374021|517287587|FG000|Overall Study|Withdrawal by Subject|6|||
143475859|NCT02374021|517287588|FG001|Overall Study|Withdrawal by Subject|5|||
143475860|NCT02374021|517287587|FG000|Overall Study|Poor Adherence|0|||
143475861|NCT02374021|517287588|FG001|Overall Study|Poor Adherence|1|||
143475862|NCT02374021|517287587|FG000|Overall Study|Scan protocol not followed|0|||
143475863|NCT02374021|517287588|FG001|Overall Study|Scan protocol not followed|1|||
143475864|NCT02374021|517287587|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
143475865|NCT02374021|517287588|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
143475866|NCT00074581|517287590|FG000|Overall Study|Death|15|||
143475867|NCT00074581|517287591|FG001|Overall Study|Death|16|||
143475868|NCT00074581|517287590|FG000|Overall Study|Withdrawal by Subject|50|||
143475869|NCT00074581|517287591|FG001|Overall Study|Withdrawal by Subject|49|||
143475870|NCT00074581|517287590|FG000|Overall Study|Unable to adhere to visit schedule|13|||
143475871|NCT00074581|517287591|FG001|Overall Study|Unable to adhere to visit schedule|14|||
143475872|NCT00074581|517287590|FG000|Overall Study|Relocated|14|||
143475873|NCT00074581|517287591|FG001|Overall Study|Relocated|9|||
143475874|NCT00074581|517287590|FG000|Overall Study|Were withdrawn by investigator|5|||
143475875|NCT00074581|517287591|FG001|Overall Study|Were withdrawn by investigator|2|||
143475876|NCT00074581|517287590|FG000|Overall Study|Lost to Follow-up|16|||
143475877|NCT00074581|517287591|FG001|Overall Study|Lost to Follow-up|11|||
143475878|NCT00074581|517287590|FG000|Overall Study|Ended relationship w. index participant|117|||
143475879|NCT00074581|517287591|FG001|Overall Study|Ended relationship w. index participant|106|||
143475880|NCT00074581|517287590|FG000|Overall Study|Other|14|||
143475881|NCT00074581|517287591|FG001|Overall Study|Other|19|||
143475882|NCT04411628|517287593|FG000|Overall Study|Withdrawal by Subject|1|||
143475883|NCT04411628|517287594|FG001|Overall Study|Withdrawal by Subject|1|||
143475884|NCT04411628|517287595|FG002|Overall Study|Withdrawal by Subject|2|||
143475885|NCT04411628|517287596|FG003|Overall Study|Withdrawal by Subject|0|||
143475886|NCT04411628|517287593|FG000|Overall Study|Lost to Follow-up|0|||
143475887|NCT04411628|517287594|FG001|Overall Study|Lost to Follow-up|1|||
143475888|NCT04411628|517287595|FG002|Overall Study|Lost to Follow-up|0|||
143475889|NCT04411628|517287596|FG003|Overall Study|Lost to Follow-up|0|||
143475890|NCT00682448|517289138|FG000|Overall Study|Adverse Event|1|||
143475891|NCT00682448|517289139|FG001|Overall Study|Adverse Event|2|||
143475892|NCT00682448|517289138|FG000|Overall Study|Lack of Efficacy|1|||
143475893|NCT00682448|517289139|FG001|Overall Study|Lack of Efficacy|0|||
143475894|NCT00682448|517289138|FG000|Overall Study|Lost to Follow-up|1|||
143475895|NCT00682448|517289139|FG001|Overall Study|Lost to Follow-up|3|||
143475896|NCT00682448|517289138|FG000|Overall Study|Pregnancy|0|||
143475897|NCT00682448|517289139|FG001|Overall Study|Pregnancy|1|||
143475898|NCT00682448|517289138|FG000|Overall Study|Withdrawal by Subject|2|||
143475899|NCT00682448|517289139|FG001|Overall Study|Withdrawal by Subject|0|||
143475900|NCT00257166|517289143|FG000|Overall Study|Adverse Event|18|||
143475901|NCT00257166|517289144|FG001|Overall Study|Adverse Event|13|||
143475902|NCT00257166|517289143|FG000|Overall Study|Laboratory abnormality|1|||
143475903|NCT00257166|517289144|FG001|Overall Study|Laboratory abnormality|0|||
143475904|NCT00257166|517289143|FG000|Overall Study|Lost to Follow-up|8|||
143475905|NCT00257166|517289144|FG001|Overall Study|Lost to Follow-up|1|||
143475906|NCT00257166|517289143|FG000|Overall Study|Withdrawal by Subject|9|||
143475907|NCT00257166|517289144|FG001|Overall Study|Withdrawal by Subject|2|||
143475908|NCT00257166|517289143|FG000|Overall Study|Other|16|||
143475909|NCT00257166|517289144|FG001|Overall Study|Other|21|||
143475910|NCT00257166|517289143|FG000|Overall Study|Randomized, but not treated|1|||
143475911|NCT00257166|517289144|FG001|Overall Study|Randomized, but not treated|0|||
143475912|NCT00525044|517289147|FG000|Overall Study|Lost to Follow-up|0|||
143475913|NCT00525044|517289148|FG001|Overall Study|Lost to Follow-up|1|||
143475914|NCT02142738|517289149|FG000|Overall Study|Adverse Event|13|||
143475915|NCT02142738|517289150|FG001|Overall Study|Adverse Event|9|||
143475916|NCT02142738|517289149|FG000|Overall Study|Death|92|||
143475917|NCT02142738|517289150|FG001|Overall Study|Death|112|||
143475918|NCT02142738|517289149|FG000|Overall Study|Lost to Follow-up|0|||
143475919|NCT02142738|517289150|FG001|Overall Study|Lost to Follow-up|3|||
143475920|NCT02142738|517289149|FG000|Overall Study|Withdrawal by Subject|6|||
143475921|NCT02142738|517289150|FG001|Overall Study|Withdrawal by Subject|7|||
143475922|NCT02142738|517289149|FG000|Overall Study|Follow up ended by sponsor|43|||
143475923|NCT02142738|517289150|FG001|Overall Study|Follow up ended by sponsor|20|||
143475924|NCT03688880|517289151|FG000|Overall Study|Withdrawal by Subject|0|||
143475925|NCT03688880|517289152|FG001|Overall Study|Withdrawal by Subject|2|||
143475926|NCT03688880|517289151|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
143475927|NCT03688880|517289152|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
143475928|NCT03688880|517289151|FG000|Overall Study|Lost to Follow-up|4|||
143475929|NCT03688880|517289152|FG001|Overall Study|Lost to Follow-up|7|||
143475930|NCT03688880|517289151|FG000|Overall Study|Adverse Event|0|||
143475931|NCT03688880|517289152|FG001|Overall Study|Adverse Event|2|||
143475932|NCT03688880|517289151|FG000|Overall Study|Device deficiencies|0|||
143475933|NCT03688880|517289152|FG001|Overall Study|Device deficiencies|2|||
143475934|NCT03688880|517289151|FG000|Overall Study|Other|10|||
143475935|NCT03688880|517289152|FG001|Overall Study|Other|16|||
143475936|NCT01704287|517289153|FG000|Initial Treatment Period|Death|139|||
143475937|NCT01704287|517289154|FG001|Initial Treatment Period|Death|129|||
143475938|NCT01704287|517289155|FG002|Initial Treatment Period|Death|71|||
143475939|NCT01704287|517289156|FG003|Initial Treatment Period|Death|0|||
143475940|NCT01704287|517289157|FG004|Initial Treatment Period|Death|0|||
143475941|NCT01704287|517289153|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
143475942|NCT01704287|517289154|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
143475943|NCT01704287|517289155|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
143475944|NCT01704287|517289156|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
143475945|NCT01704287|517289157|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
143142546|NCT01232283|516069321|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
143363235|NCT01764386|516873663|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
143363236|NCT01764386|516873664|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
143363237|NCT01764386|516873663|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
143363238|NCT01764386|516873664|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
143363239|NCT01764386|516873663|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
143363240|NCT01764386|516873664|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
143363241|NCT01764386|516873663|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
143363242|NCT01764386|516873664|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
143363243|NCT01764386|516873663|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
143363244|NCT01764386|516873664|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
143363245|NCT01764386|516873663|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
143363246|NCT01764386|516873664|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
143363247|NCT04454567|516873665|FG000|Overall Study|Study Terminated by Sponsor|1|||
143363248|NCT04454567|516873666|FG001|Overall Study|Study Terminated by Sponsor|1|||
143363249|NCT01123161|516873667|FG000|Overall Study|Lost to Follow-up|1|||
143363250|NCT01123161|516873668|FG001|Overall Study|Lost to Follow-up|0|||
143363251|NCT01123161|516873667|FG000|Overall Study|Withdrawal by Subject|1|||
143363252|NCT01123161|516873668|FG001|Overall Study|Withdrawal by Subject|0|||
143363253|NCT04531540|516873672|FG000|Overall Study|Adverse Event|1|||
143363254|NCT04531540|516873672|FG000|Overall Study|Protocol Violation|3|||
143363255|NCT04531540|516873672|FG000|Overall Study|Withdrawal by Subject|4|||
143363256|NCT04531540|516873672|FG000|Overall Study|Found to be Ineligible|1|||
143363257|NCT03239210|516873673|FG000|Overall Study|Lost to Follow-up|2|||
143363258|NCT03239210|516873674|FG001|Overall Study|Lost to Follow-up|2|||
143363259|NCT03239210|516873673|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
143363260|NCT03239210|516873674|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
143363261|NCT03239210|516873673|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
143363262|NCT03239210|516873674|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
143363263|NCT03606460|516873675|FG000|Overall Study|Lost to Follow-up|1|||
143363264|NCT03606460|516873676|FG001|Overall Study|Lost to Follow-up|8|||
143363265|NCT02256969|516873677|FG000|Overall Study|Screenfailed or withdrew|2|||
143363266|NCT02256969|516873678|FG001|Overall Study|Screenfailed or withdrew|1|||
143363267|NCT02256969|516873679|FG002|Overall Study|Screenfailed or withdrew|1|||
143363268|NCT03085017|516873683|FG000|Overall Study|Death|0|||
143363269|NCT03085017|516873684|FG001|Overall Study|Death|3|||
143363270|NCT00688688|516873685|FG000|Overall Study|Eligibility criterion not met|7|||
143363271|NCT00688688|516873686|FG001|Overall Study|Eligibility criterion not met|7|||
143363272|NCT00688688|516873687|FG002|Overall Study|Eligibility criterion not met|10|||
143363273|NCT00688688|516873685|FG000|Overall Study|Adverse Event|52|||
143475946|NCT01704287|517289153|FG000|Initial Treatment Period|Lost to Follow-up|5|||
143475947|NCT01704287|517289154|FG001|Initial Treatment Period|Lost to Follow-up|3|||
143475948|NCT01704287|517289155|FG002|Initial Treatment Period|Lost to Follow-up|0|||
143475949|NCT01704287|517289156|FG003|Initial Treatment Period|Lost to Follow-up|0|||
143475950|NCT01704287|517289157|FG004|Initial Treatment Period|Lost to Follow-up|0|||
143475951|NCT01704287|517289153|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
143475952|NCT01704287|517289154|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
143475953|NCT01704287|517289155|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
143475954|NCT01704287|517289156|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
143475955|NCT01704287|517289157|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
143475956|NCT01704287|517289153|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
143475957|NCT01704287|517289154|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
143475958|NCT01704287|517289155|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
143475959|NCT01704287|517289156|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
143475960|NCT01704287|517289157|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
143475961|NCT01704287|517289153|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
143363274|NCT00688688|516873686|FG001|Overall Study|Adverse Event|51|||
143363275|NCT00688688|516873687|FG002|Overall Study|Adverse Event|50|||
143363276|NCT00688688|516873685|FG000|Overall Study|Lack of Efficacy|34|||
143363277|NCT00688688|516873686|FG001|Overall Study|Lack of Efficacy|25|||
143363278|NCT00688688|516873687|FG002|Overall Study|Lack of Efficacy|45|||
143363279|NCT00688688|516873685|FG000|Overall Study|Withdrawal by Subject|66|||
143363280|NCT00688688|516873686|FG001|Overall Study|Withdrawal by Subject|75|||
143363281|NCT00688688|516873687|FG002|Overall Study|Withdrawal by Subject|65|||
143363282|NCT00688688|516873685|FG000|Overall Study|Lost to Follow-up|14|||
143363283|NCT00688688|516873686|FG001|Overall Study|Lost to Follow-up|7|||
143363284|NCT00688688|516873687|FG002|Overall Study|Lost to Follow-up|7|||
143363285|NCT00688688|516873685|FG000|Overall Study|Protocol Violation|6|||
143363286|NCT00688688|516873686|FG001|Overall Study|Protocol Violation|9|||
143363287|NCT00688688|516873687|FG002|Overall Study|Protocol Violation|11|||
143363288|NCT00688688|516873685|FG000|Overall Study|Randomized but never received study drug|1|||
143363289|NCT00688688|516873686|FG001|Overall Study|Randomized but never received study drug|0|||
143363290|NCT00688688|516873687|FG002|Overall Study|Randomized but never received study drug|0|||
143363291|NCT00688688|516873685|FG000|Overall Study|Non-compliance with study procedures|5|||
143363292|NCT00688688|516873686|FG001|Overall Study|Non-compliance with study procedures|3|||
143363293|NCT00688688|516873687|FG002|Overall Study|Non-compliance with study procedures|4|||
143363294|NCT00688688|516873685|FG000|Overall Study|Taking exclusionary medications|1|||
143475962|NCT01704287|517289154|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
143475963|NCT01704287|517289155|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
143475964|NCT01704287|517289156|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
143475965|NCT01704287|517289157|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
143475966|NCT01704287|517289153|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
143475967|NCT01704287|517289154|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
143475968|NCT01704287|517289155|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
143475969|NCT01704287|517289156|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
143475970|NCT01704287|517289157|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
143475971|NCT04024228|517289159|FG000|Overall Study|Adverse Event|1|||
143475972|NCT04024228|517289160|FG001|Overall Study|Adverse Event|0|||
143475973|NCT04024228|517289159|FG000|Overall Study|Protocol Deviation|0|||
143475974|NCT04024228|517289160|FG001|Overall Study|Protocol Deviation|2|||
143475975|NCT04024228|517289159|FG000|Overall Study|Withdrawal by Subject|3|||
143475976|NCT04024228|517289160|FG001|Overall Study|Withdrawal by Subject|4|||
143475977|NCT02982590|517289161|FG000|Overall Study|Lost to Follow-up|0|||
143475978|NCT02982590|517289162|FG001|Overall Study|Lost to Follow-up|1|||
143475979|NCT02982590|517289161|FG000|Overall Study|Death|4|||
143475980|NCT02982590|517289162|FG001|Overall Study|Death|0|||
143475981|NCT02713542|517289170|FG000|Overall Study|Use of prohibited medication|14|||
143475982|NCT02713542|517289171|FG001|Overall Study|Use of prohibited medication|5|||
143475983|NCT02713542|517289170|FG000|Overall Study|Withdrawal by Subject|4|||
143475984|NCT02713542|517289171|FG001|Overall Study|Withdrawal by Subject|1|||
143475985|NCT00709111|517289184|FG000|Overall Study|Withdrawal by Subject|1|||
143475986|NCT00709111|517289184|FG000|Overall Study|Unable to attend clinic visits|1|||
143475987|NCT01383096|517289189|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
143475988|NCT01383096|517289190|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
143363295|NCT00688688|516873686|FG001|Overall Study|Taking exclusionary medications|0|||
143363296|NCT00688688|516873687|FG002|Overall Study|Taking exclusionary medications|0|||
143475989|NCT01383096|517289191|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
143475990|NCT01383096|517289189|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
143363297|NCT00688688|516873685|FG000|Overall Study|Site closure|0|||
143475991|NCT01383096|517289190|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
143014088|NCT01414062|515591608|FG000|Overall Study|Family Disapproval|1|||
143363298|NCT00688688|516873686|FG001|Overall Study|Site closure|1|||
143475992|NCT01383096|517289191|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
143475993|NCT01383096|517289189|FG000|Third Intervention (8 Days)|Elevated AST|0|||
143475994|NCT01383096|517289190|FG001|Third Intervention (8 Days)|Elevated AST|1|||
143475995|NCT01383096|517289191|FG002|Third Intervention (8 Days)|Elevated AST|0|||
143475996|NCT01383096|517289189|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
143475997|NCT01383096|517289190|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
143475998|NCT01383096|517289191|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
143475999|NCT01383096|517289189|FG000|Third Intervention (8 Days)|Adverse Event|1|||
143476000|NCT01383096|517289190|FG001|Third Intervention (8 Days)|Adverse Event|0|||
143476001|NCT01383096|517289191|FG002|Third Intervention (8 Days)|Adverse Event|0|||
143476002|NCT01383096|517289189|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
143476003|NCT01383096|517289190|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
143476004|NCT01383096|517289191|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
143476005|NCT01383096|517289189|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
143476006|NCT01383096|517289190|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
143476007|NCT01383096|517289191|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
143476008|NCT01383096|517289189|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
143476009|NCT01383096|517289190|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
143476010|NCT01383096|517289191|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
143476011|NCT01383096|517289189|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
143476012|NCT01383096|517289190|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
143476013|NCT01383096|517289191|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
143476014|NCT01383096|517289189|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
143476015|NCT01383096|517289190|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
143476016|NCT01383096|517289191|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
143476017|NCT01383096|517289189|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
143476018|NCT01383096|517289190|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
143476019|NCT01383096|517289191|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
143476020|NCT01994382|517289195|FG000|Overall Study|Informed consent withdrawn|0|||
143363299|NCT00688688|516873687|FG002|Overall Study|Site closure|0|||
143363300|NCT00688688|516873685|FG000|Overall Study|Violation of exclusion criterion|0|||
143363301|NCT00688688|516873686|FG001|Overall Study|Violation of exclusion criterion|1|||
143363302|NCT00688688|516873687|FG002|Overall Study|Violation of exclusion criterion|0|||
143363303|NCT00372060|516873691|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
143363304|NCT00372060|516873692|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
143363305|NCT00372060|516873691|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
143363306|NCT00372060|516873692|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
143363307|NCT00372060|516873691|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
143363308|NCT00372060|516873692|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
143363309|NCT00372060|516873691|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
143363310|NCT00372060|516873692|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
143363311|NCT00372060|516873691|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
143363312|NCT00372060|516873692|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
143363313|NCT00372060|516873691|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
143363314|NCT00372060|516873692|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
143363315|NCT01004263|516873693|FG000|Overall Study|Adverse Event|15|||
143363316|NCT01004263|516873693|FG000|Overall Study|Withdrawal by Subject|58|||
143363317|NCT01004263|516873693|FG000|Overall Study|Protocol Violation|10|||
143363318|NCT01004263|516873693|FG000|Overall Study|Lost to Follow-up|64|||
143363319|NCT01004263|516873693|FG000|Overall Study|Lack of Efficacy|13|||
143363320|NCT01004263|516873693|FG000|Overall Study|Pregnancy|2|||
143363321|NCT01004263|516873693|FG000|Overall Study|Physician Decision|15|||
143363322|NCT01004263|516873693|FG000|Overall Study|Lack of Qualifying Event|2|||
143363323|NCT00372528|516873694|FG000|Overall Study|Lack of Efficacy|1|||
143363324|NCT00372528|516873694|FG000|Overall Study|Adverse Event|1|||
143363325|NCT00372528|516873694|FG000|Overall Study|Study Terminated by Sponsor|18|||
143363326|NCT00372528|516873694|FG000|Overall Study|Other|1|||
143363327|NCT05124899|516873695|FG000|Overall Study|Lost to Follow-up|3|||
143363328|NCT03432533|516873696|FG000|Overall Study|Lost to Follow-up|1|||
143363329|NCT03432533|516873697|FG001|Overall Study|Lost to Follow-up|2|||
143363330|NCT03432533|516873696|FG000|Overall Study|Withdrawal by Subject|14|||
143363331|NCT03432533|516873697|FG001|Overall Study|Withdrawal by Subject|9|||
143363332|NCT01648283|516873698|FG000|Overall Study|Withdrawal by Subject|14|||
143363333|NCT04956692|516873706|FG000|Overall Study|Death|115|||
143363334|NCT04956692|516873707|FG001|Overall Study|Death|47|||
143363335|NCT04956692|516873706|FG000|Overall Study|Lost to Follow-up|0|||
143363336|NCT04956692|516873707|FG001|Overall Study|Lost to Follow-up|1|||
143476021|NCT01994382|517289196|FG001|Overall Study|Informed consent withdrawn|0|||
143476022|NCT01994382|517289197|FG002|Overall Study|Informed consent withdrawn|0|||
143476023|NCT01994382|517289198|FG003|Overall Study|Informed consent withdrawn|0|||
143476024|NCT01994382|517289199|FG004|Overall Study|Informed consent withdrawn|0|||
143476025|NCT01994382|517289200|FG005|Overall Study|Informed consent withdrawn|0|||
143476026|NCT01994382|517289201|FG006|Overall Study|Informed consent withdrawn|1|||
143476027|NCT01994382|517289202|FG007|Overall Study|Informed consent withdrawn|0|||
143476028|NCT01994382|517289203|FG008|Overall Study|Informed consent withdrawn|0|||
143476029|NCT01994382|517289204|FG009|Overall Study|Informed consent withdrawn|0|||
143476030|NCT01994382|517289205|FG010|Overall Study|Informed consent withdrawn|0|||
143476031|NCT01994382|517289206|FG011|Overall Study|Informed consent withdrawn|0|||
143476032|NCT01994382|517289207|FG012|Overall Study|Informed consent withdrawn|0|||
143476033|NCT01994382|517289208|FG013|Overall Study|Informed consent withdrawn|0|||
143476034|NCT01994382|517289209|FG014|Overall Study|Informed consent withdrawn|0|||
143476035|NCT01994382|517289210|FG015|Overall Study|Informed consent withdrawn|0|||
143476036|NCT01994382|517289211|FG016|Overall Study|Informed consent withdrawn|0|||
143476037|NCT01994382|517289195|FG000|Overall Study|Progressive disease|3|||
143476038|NCT01994382|517289196|FG001|Overall Study|Progressive disease|4|||
143476039|NCT01994382|517289197|FG002|Overall Study|Progressive disease|4|||
143476040|NCT01994382|517289198|FG003|Overall Study|Progressive disease|3|||
143476041|NCT01994382|517289199|FG004|Overall Study|Progressive disease|2|||
143476042|NCT01994382|517289200|FG005|Overall Study|Progressive disease|3|||
143476043|NCT01994382|517289201|FG006|Overall Study|Progressive disease|3|||
143476044|NCT01994382|517289202|FG007|Overall Study|Progressive disease|6|||
143476045|NCT01994382|517289203|FG008|Overall Study|Progressive disease|2|||
143476046|NCT01994382|517289204|FG009|Overall Study|Progressive disease|2|||
143476047|NCT01994382|517289205|FG010|Overall Study|Progressive disease|13|||
143476048|NCT01994382|517289206|FG011|Overall Study|Progressive disease|8|||
143476049|NCT01994382|517289207|FG012|Overall Study|Progressive disease|7|||
143476050|NCT01994382|517289208|FG013|Overall Study|Progressive disease|3|||
143476051|NCT01994382|517289209|FG014|Overall Study|Progressive disease|6|||
143476052|NCT01994382|517289210|FG015|Overall Study|Progressive disease|44|||
143476053|NCT01994382|517289211|FG016|Overall Study|Progressive disease|28|||
143476054|NCT01994382|517289195|FG000|Overall Study|Physician Decision|0|||
143476055|NCT01994382|517289196|FG001|Overall Study|Physician Decision|1|||
143476056|NCT01994382|517289197|FG002|Overall Study|Physician Decision|0|||
143476057|NCT01994382|517289198|FG003|Overall Study|Physician Decision|0|||
143476058|NCT01994382|517289199|FG004|Overall Study|Physician Decision|0|||
143476059|NCT01994382|517289200|FG005|Overall Study|Physician Decision|0|||
143476060|NCT01994382|517289201|FG006|Overall Study|Physician Decision|0|||
143476061|NCT01994382|517289202|FG007|Overall Study|Physician Decision|0|||
143476062|NCT01994382|517289203|FG008|Overall Study|Physician Decision|0|||
143476063|NCT01994382|517289204|FG009|Overall Study|Physician Decision|0|||
143476064|NCT01994382|517289205|FG010|Overall Study|Physician Decision|3|||
143476065|NCT01994382|517289206|FG011|Overall Study|Physician Decision|1|||
143476066|NCT01994382|517289207|FG012|Overall Study|Physician Decision|1|||
143476067|NCT01994382|517289208|FG013|Overall Study|Physician Decision|0|||
143476068|NCT01994382|517289209|FG014|Overall Study|Physician Decision|1|||
143476069|NCT01994382|517289210|FG015|Overall Study|Physician Decision|4|||
143476070|NCT01994382|517289211|FG016|Overall Study|Physician Decision|2|||
143476071|NCT01994382|517289195|FG000|Overall Study|Death|0|||
143476072|NCT01994382|517289196|FG001|Overall Study|Death|0|||
143476073|NCT01994382|517289197|FG002|Overall Study|Death|0|||
143476074|NCT01994382|517289198|FG003|Overall Study|Death|0|||
143476075|NCT01994382|517289199|FG004|Overall Study|Death|1|||
143476076|NCT01994382|517289200|FG005|Overall Study|Death|0|||
143476077|NCT01994382|517289201|FG006|Overall Study|Death|0|||
143476078|NCT01994382|517289202|FG007|Overall Study|Death|0|||
143476079|NCT01994382|517289203|FG008|Overall Study|Death|1|||
143476080|NCT01994382|517289204|FG009|Overall Study|Death|1|||
143476081|NCT01994382|517289205|FG010|Overall Study|Death|0|||
143476082|NCT01994382|517289206|FG011|Overall Study|Death|0|||
143476083|NCT01994382|517289207|FG012|Overall Study|Death|0|||
143476084|NCT01994382|517289208|FG013|Overall Study|Death|0|||
143476085|NCT01994382|517289209|FG014|Overall Study|Death|0|||
143142547|NCT01232283|516069322|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
143142548|NCT01232283|516069323|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
143142549|NCT01232283|516069324|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
143142550|NCT01232283|516069325|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
143476086|NCT01994382|517289210|FG015|Overall Study|Death|1|||
143476087|NCT01994382|517289211|FG016|Overall Study|Death|0|||
143476088|NCT01994382|517289195|FG000|Overall Study|Adverse Event|0|||
143476089|NCT01994382|517289196|FG001|Overall Study|Adverse Event|1|||
143476090|NCT01994382|517289197|FG002|Overall Study|Adverse Event|2|||
143476091|NCT01994382|517289198|FG003|Overall Study|Adverse Event|0|||
143476092|NCT01994382|517289199|FG004|Overall Study|Adverse Event|0|||
143476093|NCT01994382|517289200|FG005|Overall Study|Adverse Event|0|||
143476094|NCT01994382|517289201|FG006|Overall Study|Adverse Event|0|||
143476095|NCT01994382|517289202|FG007|Overall Study|Adverse Event|0|||
143476096|NCT01994382|517289203|FG008|Overall Study|Adverse Event|0|||
143476097|NCT01994382|517289204|FG009|Overall Study|Adverse Event|0|||
143476098|NCT01994382|517289205|FG010|Overall Study|Adverse Event|15|||
143476099|NCT01994382|517289206|FG011|Overall Study|Adverse Event|2|||
143476100|NCT01994382|517289207|FG012|Overall Study|Adverse Event|7|||
143476101|NCT01994382|517289208|FG013|Overall Study|Adverse Event|3|||
143476102|NCT01994382|517289209|FG014|Overall Study|Adverse Event|17|||
143476103|NCT01994382|517289210|FG015|Overall Study|Adverse Event|6|||
143476104|NCT01994382|517289211|FG016|Overall Study|Adverse Event|3|||
143476105|NCT01994382|517289195|FG000|Overall Study|Other than specified|0|||
143476106|NCT01994382|517289196|FG001|Overall Study|Other than specified|0|||
143476107|NCT01994382|517289197|FG002|Overall Study|Other than specified|0|||
143476108|NCT01994382|517289198|FG003|Overall Study|Other than specified|0|||
143476109|NCT01994382|517289199|FG004|Overall Study|Other than specified|0|||
143476110|NCT01994382|517289200|FG005|Overall Study|Other than specified|0|||
143476111|NCT01994382|517289201|FG006|Overall Study|Other than specified|0|||
143476112|NCT01994382|517289202|FG007|Overall Study|Other than specified|0|||
143476113|NCT01994382|517289203|FG008|Overall Study|Other than specified|0|||
143476114|NCT01994382|517289204|FG009|Overall Study|Other than specified|0|||
143476115|NCT01994382|517289205|FG010|Overall Study|Other than specified|2|||
143476116|NCT01994382|517289206|FG011|Overall Study|Other than specified|0|||
143476117|NCT01994382|517289207|FG012|Overall Study|Other than specified|2|||
143476118|NCT01994382|517289208|FG013|Overall Study|Other than specified|0|||
143476119|NCT01994382|517289209|FG014|Overall Study|Other than specified|0|||
143476120|NCT01994382|517289210|FG015|Overall Study|Other than specified|4|||
143476121|NCT01994382|517289211|FG016|Overall Study|Other than specified|4|||
143476122|NCT01994382|517289195|FG000|Overall Study|Withdrawal by Subject|0|||
143476123|NCT01994382|517289196|FG001|Overall Study|Withdrawal by Subject|0|||
143476124|NCT01994382|517289197|FG002|Overall Study|Withdrawal by Subject|0|||
143476125|NCT01994382|517289198|FG003|Overall Study|Withdrawal by Subject|0|||
143476126|NCT01994382|517289199|FG004|Overall Study|Withdrawal by Subject|0|||
143476127|NCT01994382|517289200|FG005|Overall Study|Withdrawal by Subject|0|||
143476128|NCT01994382|517289201|FG006|Overall Study|Withdrawal by Subject|0|||
143476129|NCT01994382|517289202|FG007|Overall Study|Withdrawal by Subject|0|||
143476130|NCT01994382|517289203|FG008|Overall Study|Withdrawal by Subject|0|||
143476131|NCT01994382|517289204|FG009|Overall Study|Withdrawal by Subject|0|||
143476132|NCT01994382|517289205|FG010|Overall Study|Withdrawal by Subject|6|||
143476133|NCT01994382|517289206|FG011|Overall Study|Withdrawal by Subject|0|||
143476134|NCT01994382|517289207|FG012|Overall Study|Withdrawal by Subject|2|||
143476135|NCT01994382|517289208|FG013|Overall Study|Withdrawal by Subject|0|||
143476136|NCT01994382|517289209|FG014|Overall Study|Withdrawal by Subject|4|||
143476137|NCT01994382|517289210|FG015|Overall Study|Withdrawal by Subject|3|||
143476138|NCT01994382|517289211|FG016|Overall Study|Withdrawal by Subject|0|||
143476139|NCT01994382|517289195|FG000|Overall Study|Lost to Follow-up|0|||
143476140|NCT01994382|517289196|FG001|Overall Study|Lost to Follow-up|0|||
143476141|NCT01994382|517289197|FG002|Overall Study|Lost to Follow-up|0|||
143476142|NCT01994382|517289198|FG003|Overall Study|Lost to Follow-up|0|||
143476143|NCT01994382|517289199|FG004|Overall Study|Lost to Follow-up|0|||
143476144|NCT01994382|517289200|FG005|Overall Study|Lost to Follow-up|0|||
143476145|NCT01994382|517289201|FG006|Overall Study|Lost to Follow-up|0|||
143476146|NCT01994382|517289202|FG007|Overall Study|Lost to Follow-up|0|||
143476147|NCT01994382|517289203|FG008|Overall Study|Lost to Follow-up|0|||
143476148|NCT01994382|517289204|FG009|Overall Study|Lost to Follow-up|0|||
143476149|NCT01994382|517289205|FG010|Overall Study|Lost to Follow-up|1|||
143476150|NCT01994382|517289206|FG011|Overall Study|Lost to Follow-up|0|||
143476151|NCT01994382|517289207|FG012|Overall Study|Lost to Follow-up|0|||
143476152|NCT01994382|517289208|FG013|Overall Study|Lost to Follow-up|0|||
143476153|NCT01994382|517289209|FG014|Overall Study|Lost to Follow-up|0|||
143476154|NCT01994382|517289210|FG015|Overall Study|Lost to Follow-up|0|||
143476155|NCT01994382|517289211|FG016|Overall Study|Lost to Follow-up|0|||
143476156|NCT01994382|517289195|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
143476157|NCT01994382|517289196|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
143476158|NCT01994382|517289197|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
143476159|NCT01994382|517289198|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
143476160|NCT01994382|517289199|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
143476161|NCT01994382|517289200|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
143476162|NCT01994382|517289201|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
143476163|NCT01994382|517289202|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
143476164|NCT01994382|517289203|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
143476165|NCT01994382|517289204|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
143476166|NCT01994382|517289205|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
143476167|NCT01994382|517289206|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
143476168|NCT01994382|517289207|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
143476169|NCT01994382|517289208|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
143476170|NCT01994382|517289209|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
143476171|NCT01994382|517289210|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
143476172|NCT01994382|517289211|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
143476173|NCT01994382|517289195|FG000|Overall Study|Protocol violation/noncompliance|0|||
143476174|NCT01994382|517289196|FG001|Overall Study|Protocol violation/noncompliance|0|||
143476175|NCT01994382|517289197|FG002|Overall Study|Protocol violation/noncompliance|0|||
143476176|NCT01994382|517289198|FG003|Overall Study|Protocol violation/noncompliance|0|||
143476177|NCT01994382|517289199|FG004|Overall Study|Protocol violation/noncompliance|0|||
143476178|NCT01994382|517289200|FG005|Overall Study|Protocol violation/noncompliance|0|||
143476179|NCT01994382|517289201|FG006|Overall Study|Protocol violation/noncompliance|0|||
143476180|NCT01994382|517289202|FG007|Overall Study|Protocol violation/noncompliance|0|||
143476181|NCT01994382|517289203|FG008|Overall Study|Protocol violation/noncompliance|0|||
143476182|NCT01994382|517289204|FG009|Overall Study|Protocol violation/noncompliance|0|||
143476183|NCT01994382|517289205|FG010|Overall Study|Protocol violation/noncompliance|0|||
143476184|NCT01994382|517289206|FG011|Overall Study|Protocol violation/noncompliance|1|||
143476185|NCT01994382|517289207|FG012|Overall Study|Protocol violation/noncompliance|0|||
143476186|NCT01994382|517289208|FG013|Overall Study|Protocol violation/noncompliance|0|||
143476187|NCT01994382|517289209|FG014|Overall Study|Protocol violation/noncompliance|0|||
143476188|NCT01994382|517289210|FG015|Overall Study|Protocol violation/noncompliance|0|||
143476189|NCT01994382|517289211|FG016|Overall Study|Protocol violation/noncompliance|2|||
143476190|NCT01994382|517289195|FG000|Overall Study|Rolled over to Phase 2a|0|||
143476191|NCT01994382|517289196|FG001|Overall Study|Rolled over to Phase 2a|0|||
143476192|NCT01994382|517289197|FG002|Overall Study|Rolled over to Phase 2a|1|||
143476193|NCT01994382|517289198|FG003|Overall Study|Rolled over to Phase 2a|0|||
143476194|NCT01994382|517289199|FG004|Overall Study|Rolled over to Phase 2a|0|||
143476195|NCT01994382|517289200|FG005|Overall Study|Rolled over to Phase 2a|0|||
143476196|NCT01994382|517289201|FG006|Overall Study|Rolled over to Phase 2a|0|||
143476197|NCT01994382|517289202|FG007|Overall Study|Rolled over to Phase 2a|0|||
143476198|NCT01994382|517289203|FG008|Overall Study|Rolled over to Phase 2a|0|||
143476199|NCT01994382|517289204|FG009|Overall Study|Rolled over to Phase 2a|2|||
143476200|NCT01994382|517289205|FG010|Overall Study|Rolled over to Phase 2a|0|||
143476201|NCT01994382|517289206|FG011|Overall Study|Rolled over to Phase 2a|0|||
143476202|NCT01994382|517289207|FG012|Overall Study|Rolled over to Phase 2a|0|||
143476203|NCT01994382|517289208|FG013|Overall Study|Rolled over to Phase 2a|0|||
143476204|NCT01994382|517289209|FG014|Overall Study|Rolled over to Phase 2a|0|||
143476205|NCT01994382|517289210|FG015|Overall Study|Rolled over to Phase 2a|0|||
143476206|NCT01994382|517289211|FG016|Overall Study|Rolled over to Phase 2a|0|||
143476207|NCT02428855|517289212|FG000|Overall Study|Withdrawal by Subject|2|||
143476208|NCT03198520|517289215|FG000|Overall Study|Physician Decision|2|||
143476209|NCT03198520|517289215|FG000|Overall Study|Protocol Violation|2|||
143476210|NCT03198520|517289215|FG000|Overall Study|Withdrawal by Subject|1|||
143476211|NCT03198520|517289215|FG000|Overall Study|Study Ended|1|||
143476212|NCT01670539|517289216|FG000|Overall Study|Death|3|||
143476213|NCT01670539|517289217|FG001|Overall Study|Death|5|||
143476214|NCT01670539|517289216|FG000|Overall Study|Withdrawal by Subject|3|||
143476215|NCT01670539|517289217|FG001|Overall Study|Withdrawal by Subject|0|||
143476216|NCT00823823|517289220|FG000|Overall Study|Lost to Follow-up|3|||
143476217|NCT00823823|517289221|FG001|Overall Study|Lost to Follow-up|1|||
143476218|NCT00823823|517289220|FG000|Overall Study|Protocol Violation|5|||
143476219|NCT00823823|517289221|FG001|Overall Study|Protocol Violation|5|||
143476220|NCT02170779|517289236|FG000|Overall Study|Withdrawal by Subject|1|||
143476221|NCT02170779|517289237|FG001|Overall Study|Withdrawal by Subject|0|||
143476222|NCT02170779|517289236|FG000|Overall Study|Lost to Follow-up|0|||
143476223|NCT02170779|517289237|FG001|Overall Study|Lost to Follow-up|1|||
143476224|NCT00800683|517289238|FG000|Overall Study|Adverse Event|11|||
143476225|NCT00800683|517289239|FG001|Overall Study|Adverse Event|8|||
143476226|NCT00800683|517289238|FG000|Overall Study|Lost to Follow-up|3|||
143476227|NCT00800683|517289239|FG001|Overall Study|Lost to Follow-up|1|||
143476228|NCT00800683|517289238|FG000|Overall Study|Withdrawal by Subject|1|||
143476229|NCT00800683|517289239|FG001|Overall Study|Withdrawal by Subject|7|||
143476230|NCT00800683|517289238|FG000|Overall Study|Lack of Efficacy|1|||
143476231|NCT00800683|517289239|FG001|Overall Study|Lack of Efficacy|1|||
143476232|NCT00800683|517289238|FG000|Overall Study|Other|1|||
143476233|NCT00800683|517289239|FG001|Overall Study|Other|2|||
143476234|NCT03492554|517289247|FG000|Overall Study|Protocol Violation|0|||
143476235|NCT03492554|517289248|FG001|Overall Study|Protocol Violation|14|||
143476236|NCT00736034|517289249|FG000|Overall Study|Adverse Event|2|||
143476237|NCT01478360|517289252|FG000|Overall Study|Lost to Follow-up|1|||
143476238|NCT01478360|517289253|FG001|Overall Study|Lost to Follow-up|0|||
143476239|NCT01478360|517289252|FG000|Overall Study|Adverse Event|0|||
143476240|NCT01478360|517289253|FG001|Overall Study|Adverse Event|1|||
143476241|NCT01478360|517289252|FG000|Overall Study|Administrative problems|1|||
143476242|NCT01478360|517289253|FG001|Overall Study|Administrative problems|2|||
143476243|NCT02289352|517289254|FG000|Overall Study|Withdrawal by Subject|1|||
143476244|NCT02289352|517289255|FG001|Overall Study|Withdrawal by Subject|1|||
143476245|NCT02289352|517289256|FG002|Overall Study|Withdrawal by Subject|0|||
143476246|NCT03716050|517289260|FG000|Overall Study|Lost to Follow-up|0|||
143476247|NCT03716050|517289261|FG001|Overall Study|Lost to Follow-up|0|||
143476248|NCT03716050|517289262|FG002|Overall Study|Lost to Follow-up|1|||
143476249|NCT03716050|517289263|FG003|Overall Study|Lost to Follow-up|0|||
143476250|NCT03716050|517289264|FG004|Overall Study|Lost to Follow-up|0|||
143476251|NCT03716050|517289265|FG005|Overall Study|Lost to Follow-up|0|||
143476252|NCT03716050|517289266|FG006|Overall Study|Lost to Follow-up|0|||
143476253|NCT03716050|517289267|FG007|Overall Study|Lost to Follow-up|0|||
143476254|NCT03716050|517289260|FG000|Overall Study|Physician Decision|0|||
143476255|NCT03716050|517289261|FG001|Overall Study|Physician Decision|0|||
143476256|NCT03716050|517289262|FG002|Overall Study|Physician Decision|0|||
143476257|NCT03716050|517289263|FG003|Overall Study|Physician Decision|1|||
143476258|NCT03716050|517289264|FG004|Overall Study|Physician Decision|0|||
143476259|NCT03716050|517289265|FG005|Overall Study|Physician Decision|0|||
143476260|NCT03716050|517289266|FG006|Overall Study|Physician Decision|0|||
143476261|NCT03716050|517289267|FG007|Overall Study|Physician Decision|0|||
143476262|NCT03716050|517289260|FG000|Overall Study|Protocol Violation|0|||
143476263|NCT03716050|517289261|FG001|Overall Study|Protocol Violation|0|||
143476264|NCT03716050|517289262|FG002|Overall Study|Protocol Violation|0|||
143476265|NCT03716050|517289263|FG003|Overall Study|Protocol Violation|1|||
143476266|NCT03716050|517289264|FG004|Overall Study|Protocol Violation|0|||
143476267|NCT03716050|517289265|FG005|Overall Study|Protocol Violation|0|||
143476268|NCT03716050|517289266|FG006|Overall Study|Protocol Violation|0|||
143476269|NCT03716050|517289267|FG007|Overall Study|Protocol Violation|2|||
143476270|NCT03123250|517289268|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
143476271|NCT04340557|517289269|FG000|Overall Study|Transferred to ICU and/or death|1|||
143476272|NCT04340557|517289270|FG001|Overall Study|Transferred to ICU and/or death|2|||
143476273|NCT01221727|517289271|FG000|Overall Study|Physician Decision|2|||
143476274|NCT01221727|517289272|FG001|Overall Study|Physician Decision|0|||
143476275|NCT01221727|517289271|FG000|Overall Study|Withdrawal by Subject|1|||
143476276|NCT01221727|517289272|FG001|Overall Study|Withdrawal by Subject|1|||
143476277|NCT00529451|517289273|FG000|Overall Study|Subject withdrew consent|16|||
143476278|NCT00529451|517289274|FG001|Overall Study|Subject withdrew consent|21|||
143476279|NCT00529451|517289275|FG002|Overall Study|Subject withdrew consent|13|||
143476280|NCT00529451|517289276|FG003|Overall Study|Subject withdrew consent|12|||
143476281|NCT00529451|517289273|FG000|Overall Study|Adverse Event|9|||
143476282|NCT00529451|517289274|FG001|Overall Study|Adverse Event|16|||
143476283|NCT00529451|517289275|FG002|Overall Study|Adverse Event|14|||
143476284|NCT00529451|517289276|FG003|Overall Study|Adverse Event|8|||
143476285|NCT00529451|517289273|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
143476286|NCT00529451|517289274|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
143476287|NCT00529451|517289275|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
143476288|NCT00529451|517289276|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
143476289|NCT00529451|517289273|FG000|Overall Study|Lost to Follow-up|4|||
143476290|NCT00529451|517289274|FG001|Overall Study|Lost to Follow-up|7|||
143476291|NCT00529451|517289275|FG002|Overall Study|Lost to Follow-up|4|||
143476292|NCT00529451|517289276|FG003|Overall Study|Lost to Follow-up|4|||
143476293|NCT00529451|517289273|FG000|Overall Study|Protocol deviation|1|||
143476294|NCT00529451|517289274|FG001|Overall Study|Protocol deviation|1|||
143476295|NCT00529451|517289275|FG002|Overall Study|Protocol deviation|4|||
143476296|NCT00529451|517289276|FG003|Overall Study|Protocol deviation|1|||
143476297|NCT00529451|517289273|FG000|Overall Study|Administrative problems|1|||
143476298|NCT00529451|517289274|FG001|Overall Study|Administrative problems|1|||
143476299|NCT00529451|517289275|FG002|Overall Study|Administrative problems|0|||
143476300|NCT00529451|517289276|FG003|Overall Study|Administrative problems|2|||
143476301|NCT00773136|517289277|FG000|Overall Study|Physician Decision|2|||
143476302|NCT02463071|517289280|FG000|Overall Study|Adverse Event|3|||
143476303|NCT02463071|517289281|FG001|Overall Study|Adverse Event|5|||
143476304|NCT02463071|517289282|FG002|Overall Study|Adverse Event|1|||
143476305|NCT02463071|517289280|FG000|Overall Study|Death|1|||
143476306|NCT02463071|517289281|FG001|Overall Study|Death|0|||
143476307|NCT02463071|517289282|FG002|Overall Study|Death|0|||
143476308|NCT02463071|517289280|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
143476309|NCT02463071|517289281|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
143476310|NCT02463071|517289282|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
143476311|NCT02463071|517289280|FG000|Overall Study|Reason not specified|7|||
143476312|NCT02463071|517289281|FG001|Overall Study|Reason not specified|9|||
143476313|NCT02463071|517289282|FG002|Overall Study|Reason not specified|4|||
143476314|NCT02463071|517289280|FG000|Overall Study|Protocol Violation|0|||
143476315|NCT02463071|517289281|FG001|Overall Study|Protocol Violation|2|||
143476316|NCT02463071|517289282|FG002|Overall Study|Protocol Violation|0|||
143476317|NCT02463071|517289280|FG000|Overall Study|Lost to Follow-up|0|||
143476318|NCT02463071|517289281|FG001|Overall Study|Lost to Follow-up|0|||
143476319|NCT02463071|517289282|FG002|Overall Study|Lost to Follow-up|1|||
143476320|NCT01009034|517289283|FG000|Overall Study|Lost to Follow-up|2|||
143476321|NCT01009034|517289283|FG000|Overall Study|Withdrawal by Subject|2|||
143476322|NCT01494350|517289284|FG000|Overall Study|Worsening of lesion|1|||
143476323|NCT00175877|517289285|FG000|Overall Study|Adverse Event|136|||
143476324|NCT00175877|517289285|FG000|Overall Study|Withdrawal by Subject|141|||
143476325|NCT00175877|517289285|FG000|Overall Study|Lost to Follow-up|9|||
143476326|NCT00175877|517289285|FG000|Overall Study|Lack of Efficacy|26|||
143476327|NCT00175877|517289285|FG000|Overall Study|Protocol Violation|15|||
143476328|NCT00175877|517289285|FG000|Overall Study|Other Reason|20|||
143476329|NCT00175877|517289285|FG000|Overall Study|AE & Other|1|||
143476330|NCT00175877|517289285|FG000|Overall Study|Withdrawal by subject & Other|1|||
143476331|NCT04305275|517289286|FG000|Overall Study|Adverse Event|4|||
143476332|NCT04305275|517289287|FG001|Overall Study|Adverse Event|0|||
143476333|NCT04305275|517289286|FG000|Overall Study|Lost to Follow-up|1|||
143476334|NCT04305275|517289287|FG001|Overall Study|Lost to Follow-up|1|||
143476335|NCT04305275|517289286|FG000|Overall Study|Withdrawal by Participant|8|||
143476336|NCT04305275|517289287|FG001|Overall Study|Withdrawal by Participant|1|||
143476337|NCT00199836|517289289|FG000|Overall Study|Progressive Disease|5|||
143476338|NCT00199836|517289289|FG000|Overall Study|Death|1|||
143476339|NCT05093322|517289297|FG000|Overall Study|Death|6|||
143476340|NCT05093322|517289298|FG001|Overall Study|Death|2|||
143476341|NCT05093322|517289297|FG000|Overall Study|Other|4|||
143476342|NCT05093322|517289298|FG001|Overall Study|Other|1|||
143476343|NCT00617604|517289300|FG000|Overall Study|Death|2|||
143476344|NCT00617604|517289301|FG001|Overall Study|Death|1|||
143476345|NCT00617604|517289300|FG000|Overall Study|Lost to Follow-up|1|||
143476346|NCT00617604|517289301|FG001|Overall Study|Lost to Follow-up|0|||
143476347|NCT00617604|517289300|FG000|Overall Study|Miscellaneous Reasons|8|||
143476348|NCT00617604|517289301|FG001|Overall Study|Miscellaneous Reasons|10|||
143476349|NCT00617604|517289300|FG000|Overall Study|Withdrawal by Subject|4|||
143476350|NCT00617604|517289301|FG001|Overall Study|Withdrawal by Subject|6|||
143476351|NCT00617604|517289300|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
143476352|NCT00617604|517289301|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
143476353|NCT00932425|517289307|FG000|Overall Study|Lost to Follow-up|0|||
143476354|NCT00932425|517289308|FG001|Overall Study|Lost to Follow-up|1|||
143476355|NCT00932425|517289307|FG000|Overall Study|Withdrawal by Subject|0|||
143476356|NCT00932425|517289308|FG001|Overall Study|Withdrawal by Subject|1|||
143476357|NCT00382720|517290913|FG000|Overall Study|Adverse Event|21|||
143476358|NCT00382720|517290914|FG001|Overall Study|Adverse Event|23|||
143476359|NCT00382720|517290915|FG002|Overall Study|Adverse Event|15|||
143476360|NCT00382720|517290913|FG000|Overall Study|Protocol Violation|2|||
143476361|NCT00382720|517290914|FG001|Overall Study|Protocol Violation|5|||
143476362|NCT00382720|517290915|FG002|Overall Study|Protocol Violation|1|||
143476363|NCT00382720|517290913|FG000|Overall Study|Death|0|||
143476364|NCT00382720|517290914|FG001|Overall Study|Death|1|||
143476365|NCT00382720|517290915|FG002|Overall Study|Death|2|||
143476366|NCT00382720|517290913|FG000|Overall Study|Progressive disease|37|||
143476367|NCT00382720|517290914|FG001|Overall Study|Progressive disease|28|||
143476368|NCT00382720|517290915|FG002|Overall Study|Progressive disease|38|||
143476369|NCT00382720|517290913|FG000|Overall Study|Withdrew consent|1|||
143476370|NCT00382720|517290914|FG001|Overall Study|Withdrew consent|1|||
143476371|NCT00382720|517290915|FG002|Overall Study|Withdrew consent|2|||
143476372|NCT00382720|517290913|FG000|Overall Study|Withdrawal by Subject|11|||
143476373|NCT00382720|517290914|FG001|Overall Study|Withdrawal by Subject|20|||
143476374|NCT00382720|517290915|FG002|Overall Study|Withdrawal by Subject|12|||
143476375|NCT00382720|517290913|FG000|Overall Study|Surgery|1|||
143476376|NCT00382720|517290914|FG001|Overall Study|Surgery|1|||
143476377|NCT00382720|517290915|FG002|Overall Study|Surgery|4|||
143476378|NCT00382720|517290913|FG000|Overall Study|Patient did not receive study medication|1|||
143476379|NCT00382720|517290914|FG001|Overall Study|Patient did not receive study medication|1|||
143476380|NCT00382720|517290915|FG002|Overall Study|Patient did not receive study medication|4|||
143476381|NCT00382720|517290913|FG000|Overall Study|Clinically progressive disease|0|||
143476382|NCT00382720|517290914|FG001|Overall Study|Clinically progressive disease|1|||
143476383|NCT00382720|517290915|FG002|Overall Study|Clinically progressive disease|0|||
143476384|NCT00382720|517290913|FG000|Overall Study|Good prognosis|0|||
143476385|NCT00382720|517290914|FG001|Overall Study|Good prognosis|1|||
143476386|NCT00382720|517290915|FG002|Overall Study|Good prognosis|0|||
143476387|NCT00382720|517290913|FG000|Overall Study|Investigator/Clinical decision|5|||
143476388|NCT00382720|517290914|FG001|Overall Study|Investigator/Clinical decision|6|||
143476389|NCT00382720|517290915|FG002|Overall Study|Investigator/Clinical decision|6|||
143476390|NCT00382720|517290913|FG000|Overall Study|Discontinued at end of study|0|||
143476391|NCT00382720|517290914|FG001|Overall Study|Discontinued at end of study|1|||
143476392|NCT00382720|517290915|FG002|Overall Study|Discontinued at end of study|2|||
143476393|NCT02737852|517290918|FG000|Overall Study|Withdrawal by Subject|2|||
143476394|NCT04042740|517290920|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
143476395|NCT04042740|517290920|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
143476396|NCT04490395|517290921|FG000|Overall Study|Lost to Follow-up|0|||
143476397|NCT04490395|517290922|FG001|Overall Study|Lost to Follow-up|1|||
143476398|NCT02163187|517290925|FG000|Overall Study|Device removed|1|||
143476399|NCT02163187|517290926|FG001|Overall Study|Device removed|0|||
143476400|NCT02163187|517290925|FG000|Overall Study|Progressive disease|1|||
143476401|NCT02163187|517290926|FG001|Overall Study|Progressive disease|0|||
143476402|NCT03281668|517290927|FG000|Overall Study|Physician Decision|1|||
143476403|NCT03281668|517290927|FG000|Overall Study|scheduling conflict, family circumstance|2|||
143476404|NCT03281668|517290927|FG000|Overall Study|Withdrawal by Subject|4|||
143476405|NCT03281668|517290927|FG000|Overall Study|Lost to Follow-up|1|||
143476406|NCT00762892|517290934|FG000|Overall Study|Lost to Follow-up|2|||
143476407|NCT00762892|517290935|FG001|Overall Study|Lost to Follow-up|5|||
143476408|NCT00762892|517290934|FG000|Overall Study|Withdrawal by Subject|0|||
143476409|NCT00762892|517290935|FG001|Overall Study|Withdrawal by Subject|1|||
143476410|NCT00762892|517290934|FG000|Overall Study|Death|1|||
143476411|NCT00762892|517290935|FG001|Overall Study|Death|0|||
143476412|NCT00762892|517290934|FG000|Overall Study|Pregnancy|1|||
143476413|NCT00762892|517290935|FG001|Overall Study|Pregnancy|0|||
143476414|NCT00762892|517290934|FG000|Overall Study|Incarceration|1|||
143476415|NCT00762892|517290935|FG001|Overall Study|Incarceration|0|||
143476416|NCT01841749|517290942|FG000|Overall Study|Protocol Violation|1|||
143476417|NCT02285920|517290943|FG000|Overall Study|Kidney transplantation|2|||
143476418|NCT02285920|517290944|FG001|Overall Study|Kidney transplantation|2|||
143476419|NCT02285920|517290945|FG002|Overall Study|Kidney transplantation|2|||
143476420|NCT02285920|517290946|FG003|Overall Study|Kidney transplantation|0|||
143476421|NCT02285920|517290943|FG000|Overall Study|Change to peritoneal dialysis|0|||
143476422|NCT02285920|517290944|FG001|Overall Study|Change to peritoneal dialysis|0|||
143476423|NCT02285920|517290945|FG002|Overall Study|Change to peritoneal dialysis|1|||
143476424|NCT02285920|517290946|FG003|Overall Study|Change to peritoneal dialysis|0|||
143476425|NCT02285920|517290943|FG000|Overall Study|Transfer to non-participating unit|0|||
143476426|NCT02285920|517290944|FG001|Overall Study|Transfer to non-participating unit|1|||
143476427|NCT02285920|517290945|FG002|Overall Study|Transfer to non-participating unit|0|||
143476428|NCT02285920|517290946|FG003|Overall Study|Transfer to non-participating unit|0|||
143476429|NCT02285920|517290943|FG000|Overall Study|Dialysis discontinuation|0|||
143476430|NCT02285920|517290944|FG001|Overall Study|Dialysis discontinuation|1|||
143476431|NCT02285920|517290945|FG002|Overall Study|Dialysis discontinuation|0|||
143476432|NCT02285920|517290946|FG003|Overall Study|Dialysis discontinuation|0|||
143476433|NCT02285920|517290943|FG000|Overall Study|Death|2|||
143476434|NCT02285920|517290944|FG001|Overall Study|Death|0|||
143476435|NCT02285920|517290945|FG002|Overall Study|Death|2|||
143476436|NCT02285920|517290946|FG003|Overall Study|Death|1|||
143476437|NCT00677820|517290947|FG000|Overall Study|Lost to Follow-up|1|||
143476438|NCT00677820|517290948|FG001|Overall Study|Lost to Follow-up|0|||
143476439|NCT01641237|517290956|FG000|Period II|Withdrawal by Subject|1|||
143476440|NCT01641237|517290957|FG001|Period II|Withdrawal by Subject|0|||
143476441|NCT01641237|517290958|FG002|Period II|Withdrawal by Subject|0|||
143476442|NCT01641237|517290959|FG003|Period II|Withdrawal by Subject|0|||
143476443|NCT01641237|517290956|FG000|Period III|Lost to Follow-up|1|||
143476444|NCT01641237|517290957|FG001|Period III|Lost to Follow-up|0|||
143476445|NCT01641237|517290958|FG002|Period III|Lost to Follow-up|0|||
143476446|NCT01641237|517290959|FG003|Period III|Lost to Follow-up|0|||
143476447|NCT02716675|517290960|FG000|Overall Study|Death|2|||
143476448|NCT02716675|517290961|FG001|Overall Study|Death|3|||
143476449|NCT02716675|517290962|FG002|Overall Study|Death|0|||
143476450|NCT02716675|517290960|FG000|Overall Study|Physician Decision|2|||
143476451|NCT02716675|517290961|FG001|Overall Study|Physician Decision|1|||
143476452|NCT02716675|517290962|FG002|Overall Study|Physician Decision|1|||
143476453|NCT02716675|517290960|FG000|Overall Study|Lost to Follow-up|100|||
143476454|NCT02716675|517290961|FG001|Overall Study|Lost to Follow-up|87|||
143476455|NCT02716675|517290962|FG002|Overall Study|Lost to Follow-up|99|||
143476456|NCT02716675|517290960|FG000|Overall Study|Withdrawal by Subject|22|||
143476457|NCT02716675|517290961|FG001|Overall Study|Withdrawal by Subject|25|||
143476458|NCT02716675|517290962|FG002|Overall Study|Withdrawal by Subject|20|||
143476459|NCT02716675|517290960|FG000|Overall Study|Protocol Violation|0|||
143476460|NCT02716675|517290961|FG001|Overall Study|Protocol Violation|3|||
143476461|NCT02716675|517290962|FG002|Overall Study|Protocol Violation|1|||
143476462|NCT02716675|517290960|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
143476463|NCT02716675|517290961|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
143476464|NCT02716675|517290962|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
143476465|NCT02716675|517290960|FG000|Overall Study|Other|38|||
143476466|NCT02716675|517290961|FG001|Overall Study|Other|47|||
143476467|NCT02716675|517290962|FG002|Overall Study|Other|48|||
143476468|NCT00290290|517290963|FG000|Overall Study|Death|3|||
143476469|NCT00290290|517290964|FG001|Overall Study|Death|4|||
143476470|NCT00290290|517290963|FG000|Overall Study|Withdrawal by Subject|2|||
143476471|NCT00290290|517290964|FG001|Overall Study|Withdrawal by Subject|2|||
143476472|NCT00290290|517290963|FG000|Overall Study|Underwent clean surgical procedure|13|||
143476473|NCT00290290|517290964|FG001|Overall Study|Underwent clean surgical procedure|12|||
143476474|NCT00915772|517290967|FG000|Overall Study|Adverse Event|12|||
143476475|NCT00915772|517290968|FG001|Overall Study|Adverse Event|13|||
143476476|NCT00915772|517290969|FG002|Overall Study|Adverse Event|11|||
143476477|NCT00915772|517290967|FG000|Overall Study|Protocol Violation|4|||
143476478|NCT00915772|517290968|FG001|Overall Study|Protocol Violation|1|||
143476479|NCT00915772|517290969|FG002|Overall Study|Protocol Violation|2|||
143476480|NCT00915772|517290967|FG000|Overall Study|Lost to Follow-up|1|||
143476481|NCT00915772|517290968|FG001|Overall Study|Lost to Follow-up|2|||
143476482|NCT00915772|517290969|FG002|Overall Study|Lost to Follow-up|2|||
143476483|NCT00915772|517290967|FG000|Overall Study|Lack of Efficacy|9|||
143476484|NCT00915772|517290968|FG001|Overall Study|Lack of Efficacy|15|||
143476485|NCT00915772|517290969|FG002|Overall Study|Lack of Efficacy|3|||
143476486|NCT00915772|517290967|FG000|Overall Study|Refused to continue trial medication|6|||
143476487|NCT00915772|517290968|FG001|Overall Study|Refused to continue trial medication|8|||
143476488|NCT00915772|517290969|FG002|Overall Study|Refused to continue trial medication|4|||
143476489|NCT00915772|517290967|FG000|Overall Study|Any other reason|4|||
143476490|NCT00915772|517290968|FG001|Overall Study|Any other reason|7|||
143476491|NCT00915772|517290969|FG002|Overall Study|Any other reason|7|||
143476492|NCT03374995|517290970|FG000|Overall Study|Withdrawal by Subject|0|||
143476493|NCT03374995|517290971|FG001|Overall Study|Withdrawal by Subject|1|||
143476494|NCT01211535|517290974|FG000|Overall Study|Adverse Event|0|||
143476495|NCT01211535|517290975|FG001|Overall Study|Adverse Event|1|||
143476496|NCT00549939|517290981|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
143476497|NCT00549939|517290982|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
143476498|NCT00549939|517290983|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
143476499|NCT00549939|517290981|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
143476500|NCT00549939|517290982|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
143476501|NCT00549939|517290983|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
143476502|NCT00549939|517290981|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
143476503|NCT00549939|517290982|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
143476504|NCT00549939|517290983|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
143476505|NCT00549939|517290981|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
143476506|NCT00549939|517290982|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
143476507|NCT00549939|517290983|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
143476508|NCT00549939|517290981|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
143476509|NCT00549939|517290982|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
143476510|NCT00549939|517290983|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
143476511|NCT00549939|517290981|FG000|40-week Open Label Treatment Period|Other|0|||
143476512|NCT00549939|517290982|FG001|40-week Open Label Treatment Period|Other|1|||
143476513|NCT00549939|517290983|FG002|40-week Open Label Treatment Period|Other|4|||
143476514|NCT03593850|517290986|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
143476515|NCT03593850|517290987|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
143476516|NCT00003895|517290988|FG000|Overall Study|Adverse Event|4|||
143476517|NCT00003895|517290989|FG001|Overall Study|Adverse Event|0|||
143476518|NCT00003895|517290988|FG000|Overall Study|Lack of Efficacy|1|||
143476519|NCT00003895|517290989|FG001|Overall Study|Lack of Efficacy|1|||
143476520|NCT00003895|517290988|FG000|Overall Study|Patient Vacation|2|||
143476521|NCT00003895|517290989|FG001|Overall Study|Patient Vacation|0|||
143476522|NCT00003895|517290988|FG000|Overall Study|Withdrawal by Subject|0|||
143476523|NCT00003895|517290989|FG001|Overall Study|Withdrawal by Subject|3|||
143476524|NCT01735279|517290992|FG000|Overall Study|Lost to Follow-up|11|||
143476525|NCT01735279|517290993|FG001|Overall Study|Lost to Follow-up|8|||
143476526|NCT01380730|517290994|FG000|Overall Study|Death|0|||
143476527|NCT01380730|517290995|FG001|Overall Study|Death|0|||
143476528|NCT01380730|517290996|FG002|Overall Study|Death|0|||
143476529|NCT01380730|517290997|FG003|Overall Study|Death|0|||
143476530|NCT01380730|517290998|FG004|Overall Study|Death|1|||
143476531|NCT01380730|517290999|FG005|Overall Study|Death|0|||
143476532|NCT01380730|517291000|FG006|Overall Study|Death|0|||
143476533|NCT01380730|517291001|FG007|Overall Study|Death|0|||
143476534|NCT01195090|517291007|FG000|Overall Study|Adverse Event|1|||
143476535|NCT01195090|517291008|FG001|Overall Study|Adverse Event|2|||
143476536|NCT01195090|517291007|FG000|Overall Study|Lost to Follow-up|2|||
143476537|NCT01195090|517291008|FG001|Overall Study|Lost to Follow-up|2|||
143476538|NCT01195090|517291007|FG000|Overall Study|Protocol Violation|3|||
143476539|NCT01195090|517291008|FG001|Overall Study|Protocol Violation|4|||
143476540|NCT01205230|517291011|FG000|Overall Study|Adverse Event|4|||
143476541|NCT01205230|517291012|FG001|Overall Study|Adverse Event|0|||
143476542|NCT01205230|517291011|FG000|Overall Study|Physician Decision|1|||
143476543|NCT01205230|517291012|FG001|Overall Study|Physician Decision|0|||
143476544|NCT00922480|517291013|FG000|Main Study|Protocol Violation|3|||
143476545|NCT00922480|517291014|FG001|Main Study|Protocol Violation|6|||
143476546|NCT00922480|517291013|FG000|Main Study|Adverse Event|6|||
143476547|NCT00922480|517291014|FG001|Main Study|Adverse Event|7|||
143476548|NCT00922480|517291013|FG000|Main Study|Lack of Efficacy|3|||
143476549|NCT00922480|517291014|FG001|Main Study|Lack of Efficacy|0|||
143476550|NCT00922480|517291013|FG000|Main Study|Withdrawal by Subject|20|||
143476551|NCT00922480|517291014|FG001|Main Study|Withdrawal by Subject|15|||
143476552|NCT00922480|517291013|FG000|Main Study|Lost to Follow-up|5|||
143476553|NCT00922480|517291014|FG001|Main Study|Lost to Follow-up|0|||
143476554|NCT00922480|517291013|FG000|Main Study|Physician Decision|0|||
143476555|NCT00922480|517291014|FG001|Main Study|Physician Decision|1|||
143476556|NCT00922480|517291013|FG000|Extension Study|Protocol Violation|3|||
143476557|NCT00922480|517291014|FG001|Extension Study|Protocol Violation|0|||
143476558|NCT00922480|517291013|FG000|Extension Study|Adverse Event|1|||
143476559|NCT00922480|517291014|FG001|Extension Study|Adverse Event|1|||
143476560|NCT00922480|517291013|FG000|Extension Study|Withdrawal by Subject|1|||
143476561|NCT00922480|517291014|FG001|Extension Study|Withdrawal by Subject|1|||
143476562|NCT00922480|517291013|FG000|Extension Study|Others|0|||
143476563|NCT00922480|517291014|FG001|Extension Study|Others|1|||
143476564|NCT04784897|517291015|FG000|Overall Study|Death|4|||
143476565|NCT04784897|517291016|FG001|Overall Study|Death|2|||
143476566|NCT04784897|517291017|FG002|Overall Study|Death|1|||
143476567|NCT04784897|517291015|FG000|Overall Study|Withdrawal by Subject|0|||
143476568|NCT04784897|517291016|FG001|Overall Study|Withdrawal by Subject|0|||
143476569|NCT04784897|517291017|FG002|Overall Study|Withdrawal by Subject|1|||
143476570|NCT00058552|517291018|FG000|Overall Study|Died prior to receiving treatment|4|||
143476571|NCT00058552|517291019|FG001|Overall Study|Died prior to receiving treatment|2|||
143476572|NCT00058552|517291018|FG000|Overall Study|Disease progression|52|||
143476573|NCT00058552|517291019|FG001|Overall Study|Disease progression|44|||
143476574|NCT00058552|517291018|FG000|Overall Study|Adverse Event|4|||
143476575|NCT00058552|517291019|FG001|Overall Study|Adverse Event|2|||
143476576|NCT00058552|517291018|FG000|Overall Study|Withdrawal by Subject|3|||
143476577|NCT00058552|517291019|FG001|Overall Study|Withdrawal by Subject|5|||
143476578|NCT00058552|517291018|FG000|Overall Study|Physician Decision|2|||
143476579|NCT00058552|517291019|FG001|Overall Study|Physician Decision|5|||
143476580|NCT00058552|517291018|FG000|Overall Study|Clinical disease progression|0|||
143476581|NCT00058552|517291019|FG001|Overall Study|Clinical disease progression|4|||
143476582|NCT03861936|517291020|FG000|Overall Study|Withdrawal by Subject|4|||
143476583|NCT03861936|517291021|FG001|Overall Study|Withdrawal by Subject|1|||
143476584|NCT03861936|517291022|FG002|Overall Study|Withdrawal by Subject|3|||
143476585|NCT03861936|517291020|FG000|Overall Study|Lost to Follow-up|5|||
143476586|NCT03861936|517291021|FG001|Overall Study|Lost to Follow-up|3|||
143476587|NCT03861936|517291022|FG002|Overall Study|Lost to Follow-up|3|||
143476588|NCT03861936|517291020|FG000|Overall Study|Physician Decision|0|||
143476589|NCT03861936|517291021|FG001|Overall Study|Physician Decision|1|||
143476590|NCT03861936|517291022|FG002|Overall Study|Physician Decision|0|||
143476591|NCT03861936|517291020|FG000|Overall Study|Protocol Deviation|0|||
143476592|NCT03861936|517291021|FG001|Overall Study|Protocol Deviation|0|||
143476593|NCT03861936|517291022|FG002|Overall Study|Protocol Deviation|1|||
143476594|NCT03861936|517291020|FG000|Overall Study|Reason not Specified|5|||
143476595|NCT03861936|517291021|FG001|Overall Study|Reason not Specified|5|||
143476596|NCT03861936|517291022|FG002|Overall Study|Reason not Specified|3|||
143476597|NCT02319668|517291023|FG000|Overall Study|Other (Not specified)|0|||
143476598|NCT02319668|517291024|FG001|Overall Study|Other (Not specified)|2|||
143476599|NCT04353596|517291029|FG000|Overall Study|Protocol Violation|4|||
143476600|NCT04353596|517291030|FG001|Overall Study|Protocol Violation|4|||
143476601|NCT04353596|517291029|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
143476602|NCT04353596|517291030|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
143476603|NCT01236573|517291031|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
143476604|NCT01236573|517291032|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
143476605|NCT01236573|517291033|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
143476606|NCT01236573|517291034|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
143476607|NCT01236573|517291035|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
143476608|NCT01236573|517291036|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
143476609|NCT01236573|517291037|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
143476610|NCT01236573|517291038|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
143476611|NCT01236573|517291039|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
143476612|NCT01236573|517291040|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
143476613|NCT01236573|517291041|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
143476614|NCT01236573|517291031|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
143476615|NCT01236573|517291032|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
143476616|NCT01236573|517291033|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
143476617|NCT01236573|517291034|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
143476618|NCT01236573|517291035|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
143476619|NCT01236573|517291036|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
143476620|NCT01236573|517291037|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
143476621|NCT01236573|517291038|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
143476622|NCT01236573|517291039|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
143476623|NCT01236573|517291040|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
143476624|NCT01236573|517291041|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
143476625|NCT01236573|517291031|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
143476626|NCT01236573|517291032|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
143476627|NCT01236573|517291033|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
143476628|NCT01236573|517291034|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
143476629|NCT01236573|517291035|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
143476630|NCT01236573|517291036|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
143476631|NCT01236573|517291037|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
143476632|NCT01236573|517291038|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
143476633|NCT01236573|517291039|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
143476634|NCT01236573|517291040|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
143476635|NCT01236573|517291041|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
143476636|NCT02665052|517291042|FG000|Overall Study|Lost to Follow-up|1|||
143476637|NCT02665052|517291043|FG001|Overall Study|Lost to Follow-up|0|||
143476638|NCT02665052|517291044|FG002|Overall Study|Lost to Follow-up|0|||
143476639|NCT02665052|517291045|FG003|Overall Study|Lost to Follow-up|0|||
143476640|NCT02665052|517291042|FG000|Overall Study|Withdrawal by Subject|1|||
143476641|NCT02665052|517291043|FG001|Overall Study|Withdrawal by Subject|1|||
143476642|NCT02665052|517291044|FG002|Overall Study|Withdrawal by Subject|0|||
143476643|NCT02665052|517291045|FG003|Overall Study|Withdrawal by Subject|5|||
143476644|NCT02665052|517291042|FG000|Overall Study|Adverse Event|1|||
143476645|NCT02665052|517291043|FG001|Overall Study|Adverse Event|1|||
143476646|NCT02665052|517291044|FG002|Overall Study|Adverse Event|0|||
143476647|NCT02665052|517291045|FG003|Overall Study|Adverse Event|0|||
143476648|NCT02234284|517291046|FG000|Overall Study|Death|4|||
143476649|NCT02234284|517291047|FG001|Overall Study|Death|2|||
143476650|NCT02234284|517291046|FG000|Overall Study|Withdrawal by Subject|1|||
143476651|NCT02234284|517291047|FG001|Overall Study|Withdrawal by Subject|0|||
143476652|NCT02234284|517291046|FG000|Overall Study|Lost to Follow-up|20|||
143476653|NCT02234284|517291047|FG001|Overall Study|Lost to Follow-up|7|||
143476654|NCT00536809|517291049|FG000|Phase II|Adverse Event|1|||
143476655|NCT00536809|517291049|FG000|Phase II|Referred for surgical resection|1|||
143476656|NCT04569032|517291050|FG000|Overall Study|Death|10|||
143476657|NCT04569032|517291051|FG001|Overall Study|Death|13|||
143476658|NCT04569032|517291050|FG000|Overall Study|Withdrawal by Subject|2|||
143476659|NCT04569032|517291051|FG001|Overall Study|Withdrawal by Subject|0|||
143476660|NCT04569032|517291050|FG000|Overall Study|Lost to Follow-up|0|||
143476661|NCT04569032|517291051|FG001|Overall Study|Lost to Follow-up|1|||
143476662|NCT04569032|517291050|FG000|Overall Study|In long term follow up|22|||
143476663|NCT04569032|517291051|FG001|Overall Study|In long term follow up|34|||
143476664|NCT00873366|517291052|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
143476665|NCT00873366|517291052|FG000|Overall Study|Off tamoxifen due to side effects|2|||
143476666|NCT00873366|517291052|FG000|Overall Study|Refused to continue DM-BT testing|3|||
143476667|NCT01970488|517291053|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
143476668|NCT01970488|517291054|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
143476669|NCT01970488|517291055|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
143476670|NCT01970488|517291056|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
143476671|NCT01970488|517291057|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
143476672|NCT01970488|517291053|FG000|Part 1: Through Week 16|Protocol Violation|1|||
143476673|NCT01970488|517291054|FG001|Part 1: Through Week 16|Protocol Violation|2|||
143476674|NCT01970488|517291055|FG002|Part 1: Through Week 16|Protocol Violation|0|||
143476675|NCT01970488|517291056|FG003|Part 1: Through Week 16|Protocol Violation|0|||
143476676|NCT01970488|517291057|FG004|Part 1: Through Week 16|Protocol Violation|0|||
143476677|NCT01970488|517291053|FG000|Part 1: Through Week 16|Adverse Event|6|||
143476678|NCT01970488|517291054|FG001|Part 1: Through Week 16|Adverse Event|5|||
143476679|NCT01970488|517291055|FG002|Part 1: Through Week 16|Adverse Event|0|||
143476680|NCT01970488|517291056|FG003|Part 1: Through Week 16|Adverse Event|0|||
143476681|NCT01970488|517291057|FG004|Part 1: Through Week 16|Adverse Event|0|||
143476682|NCT01970488|517291053|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
143476683|NCT01970488|517291054|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
143476684|NCT01970488|517291055|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
143476685|NCT01970488|517291056|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
143476686|NCT01970488|517291057|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
143476687|NCT01970488|517291053|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
143476688|NCT01970488|517291054|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
143476689|NCT01970488|517291055|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
143476690|NCT01970488|517291056|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
143476691|NCT01970488|517291057|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
143476692|NCT01970488|517291053|FG000|Part 2: Post Week 16|Physician Decision|0|||
143476693|NCT01970488|517291054|FG001|Part 2: Post Week 16|Physician Decision|0|||
143476694|NCT01970488|517291055|FG002|Part 2: Post Week 16|Physician Decision|0|||
143476695|NCT01970488|517291056|FG003|Part 2: Post Week 16|Physician Decision|0|||
143476696|NCT01970488|517291057|FG004|Part 2: Post Week 16|Physician Decision|1|||
143476697|NCT01970488|517291053|FG000|Part 2: Post Week 16|Non-compliance|0|||
143476698|NCT01970488|517291054|FG001|Part 2: Post Week 16|Non-compliance|0|||
143476699|NCT01970488|517291055|FG002|Part 2: Post Week 16|Non-compliance|1|||
143476700|NCT01970488|517291056|FG003|Part 2: Post Week 16|Non-compliance|0|||
143476701|NCT01970488|517291057|FG004|Part 2: Post Week 16|Non-compliance|0|||
143476702|NCT01970488|517291053|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
143476703|NCT01970488|517291054|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
143476704|NCT01970488|517291055|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
143476705|NCT01970488|517291056|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
143476706|NCT01970488|517291057|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
143476707|NCT01970488|517291053|FG000|Part 2: Post Week 16|Adverse Event|0|||
143476708|NCT01970488|517291054|FG001|Part 2: Post Week 16|Adverse Event|0|||
143476709|NCT01970488|517291055|FG002|Part 2: Post Week 16|Adverse Event|5|||
143476710|NCT01970488|517291056|FG003|Part 2: Post Week 16|Adverse Event|1|||
143476711|NCT01970488|517291057|FG004|Part 2: Post Week 16|Adverse Event|1|||
143476712|NCT01970488|517291053|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
143476713|NCT01970488|517291054|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
143476714|NCT01970488|517291055|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
143476715|NCT01970488|517291056|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
143476716|NCT01970488|517291057|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
143476717|NCT01970488|517291053|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
143476718|NCT01970488|517291054|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
143476719|NCT01970488|517291055|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
143476720|NCT01970488|517291056|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
143476721|NCT01970488|517291057|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
143476722|NCT00356889|517291059|FG000|Overall Study|Protocol Violation|2|||
143476723|NCT00356889|517291059|FG000|Overall Study|Adverse Event|1|||
143476724|NCT01721876|517291063|FG000|Overall Study|Not treated|1|||
143476725|NCT01721876|517291064|FG001|Overall Study|Not treated|4|||
143476726|NCT01721876|517291063|FG000|Overall Study|Disease progression / relapse|123|||
143476727|NCT01721876|517291064|FG001|Overall Study|Disease progression / relapse|156|||
143476728|NCT01721876|517291063|FG000|Overall Study|Death|6|||
143476729|NCT01721876|517291064|FG001|Overall Study|Death|13|||
143476730|NCT01721876|517291063|FG000|Overall Study|Adverse Event|41|||
143476731|NCT01721876|517291064|FG001|Overall Study|Adverse Event|165|||
143476732|NCT01721876|517291063|FG000|Overall Study|Protocol Violation|2|||
143476733|NCT01721876|517291064|FG001|Overall Study|Protocol Violation|1|||
143476734|NCT01721876|517291063|FG000|Overall Study|Withdrawal by Subject|15|||
143476735|NCT01721876|517291064|FG001|Overall Study|Withdrawal by Subject|38|||
143476736|NCT01721876|517291063|FG000|Overall Study|Reason not listed|34|||
143476737|NCT01721876|517291064|FG001|Overall Study|Reason not listed|63|||
143476738|NCT01721876|517291063|FG000|Overall Study|Sponsor terminated trial|0|||
143476739|NCT01721876|517291064|FG001|Overall Study|Sponsor terminated trial|4|||
143476740|NCT05293743|517291067|FG000|Overall Study|Withdrawal by Subject|1|||
143476741|NCT05293743|517291068|FG001|Overall Study|Withdrawal by Subject|0|||
143476742|NCT03734016|517291071|FG000|Overall Study|Sponsor Ended Study|225|||
143476743|NCT03734016|517291072|FG001|Overall Study|Sponsor Ended Study|200|||
143476744|NCT03734016|517291071|FG000|Overall Study|Death|69|||
143476745|NCT03734016|517291072|FG001|Overall Study|Death|83|||
143476746|NCT03734016|517291071|FG000|Overall Study|Withdrawal by Subject|21|||
143476747|NCT03734016|517291072|FG001|Overall Study|Withdrawal by Subject|27|||
143476748|NCT03734016|517291071|FG000|Overall Study|Physician Decision|1|||
143476749|NCT03734016|517291072|FG001|Overall Study|Physician Decision|12|||
143476750|NCT03734016|517291071|FG000|Overall Study|Lost to Follow-up|6|||
143476751|NCT03734016|517291072|FG001|Overall Study|Lost to Follow-up|2|||
143476752|NCT03734016|517291071|FG000|Overall Study|Miscellaneous|5|||
143476753|NCT03734016|517291072|FG001|Overall Study|Miscellaneous|1|||
143476754|NCT01979835|517291073|FG000|Primary Outcome SA Measurment|failed insertion|18|||
143476755|NCT01979835|517291073|FG000|Follow-up|Lost to Follow-up|32|||
143476756|NCT01428661|517291076|FG000|Double-Masked Phase|Protocol Violation|9|||
143476757|NCT01428661|517291077|FG001|Double-Masked Phase|Protocol Violation|4|||
143476758|NCT01428661|517291078|FG002|Double-Masked Phase|Protocol Violation|0|||
143476759|NCT01428661|517291076|FG000|Double-Masked Phase|Adverse Event|13|||
143476760|NCT01428661|517291077|FG001|Double-Masked Phase|Adverse Event|4|||
143476761|NCT01428661|517291078|FG002|Double-Masked Phase|Adverse Event|0|||
143476762|NCT01428661|517291076|FG000|Double-Masked Phase|Lost to Follow-up|14|||
143476763|NCT01428661|517291077|FG001|Double-Masked Phase|Lost to Follow-up|14|||
143476764|NCT01428661|517291078|FG002|Double-Masked Phase|Lost to Follow-up|0|||
143476765|NCT01428661|517291076|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
143476766|NCT01428661|517291077|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
143476767|NCT01428661|517291078|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
143476768|NCT01428661|517291076|FG000|Double-Masked Phase|Lack of Efficacy|2|||
143476769|NCT01428661|517291077|FG001|Double-Masked Phase|Lack of Efficacy|1|||
143476770|NCT01428661|517291078|FG002|Double-Masked Phase|Lack of Efficacy|0|||
143476771|NCT01428661|517291076|FG000|Double-Masked Phase|*Various|1|||
143476772|NCT01428661|517291077|FG001|Double-Masked Phase|*Various|6|||
143476773|NCT01428661|517291078|FG002|Double-Masked Phase|*Various|0|||
143476774|NCT01428661|517291076|FG000|Open Label Extension|Protocol Violation|0|||
143476775|NCT01428661|517291077|FG001|Open Label Extension|Protocol Violation|0|||
143476776|NCT01428661|517291078|FG002|Open Label Extension|Protocol Violation|9|||
143476777|NCT01428661|517291076|FG000|Open Label Extension|Adverse Event|0|||
143476778|NCT01428661|517291077|FG001|Open Label Extension|Adverse Event|0|||
143476779|NCT01428661|517291078|FG002|Open Label Extension|Adverse Event|15|||
143476780|NCT01428661|517291076|FG000|Open Label Extension|Lost to Follow-up|0|||
143476781|NCT01428661|517291077|FG001|Open Label Extension|Lost to Follow-up|0|||
143476782|NCT01428661|517291078|FG002|Open Label Extension|Lost to Follow-up|38|||
143476783|NCT01428661|517291076|FG000|Open Label Extension|Withdrawal by Subject|0|||
143476784|NCT01428661|517291077|FG001|Open Label Extension|Withdrawal by Subject|0|||
143476785|NCT01428661|517291078|FG002|Open Label Extension|Withdrawal by Subject|49|||
143476786|NCT01428661|517291076|FG000|Open Label Extension|Lack of Efficacy|0|||
143476787|NCT01428661|517291077|FG001|Open Label Extension|Lack of Efficacy|0|||
143476788|NCT01428661|517291078|FG002|Open Label Extension|Lack of Efficacy|24|||
143476789|NCT01428661|517291076|FG000|Open Label Extension|**Various|0|||
143476790|NCT01428661|517291077|FG001|Open Label Extension|**Various|0|||
143476791|NCT01428661|517291078|FG002|Open Label Extension|**Various|185|||
143476792|NCT02490475|517293095|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
143476793|NCT02490475|517293096|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
143476794|NCT02490475|517293097|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
143476795|NCT02490475|517293098|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
143476796|NCT02490475|517293095|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
143476797|NCT02490475|517293096|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
143476798|NCT02490475|517293097|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
143476799|NCT02490475|517293098|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
143476800|NCT02490475|517293095|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
143476801|NCT02490475|517293096|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
143476802|NCT02490475|517293097|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
143476803|NCT02490475|517293098|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
143476804|NCT02490475|517293095|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
143476805|NCT02490475|517293096|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
143476806|NCT02490475|517293097|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
143476807|NCT02490475|517293098|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
143476808|NCT02490475|517293095|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
143476809|NCT02490475|517293096|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
143476810|NCT02490475|517293097|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
143476811|NCT02490475|517293098|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
143476812|NCT02490475|517293095|FG000|Period 2: Extension Phase|Refused Treatment|0|||
143476813|NCT02490475|517293096|FG001|Period 2: Extension Phase|Refused Treatment|0|||
143476814|NCT02490475|517293097|FG002|Period 2: Extension Phase|Refused Treatment|0|||
143476815|NCT02490475|517293098|FG003|Period 2: Extension Phase|Refused Treatment|1|||
143476816|NCT02490475|517293095|FG000|Period 2: Extension Phase|Adverse Event|0|||
143476817|NCT02490475|517293096|FG001|Period 2: Extension Phase|Adverse Event|0|||
143476818|NCT02490475|517293097|FG002|Period 2: Extension Phase|Adverse Event|1|||
143476819|NCT02490475|517293098|FG003|Period 2: Extension Phase|Adverse Event|0|||
143476820|NCT01372150|517293099|FG000|Overall Study|Lack of Efficacy|3|||
143476821|NCT01372150|517293100|FG001|Overall Study|Lack of Efficacy|0|||
143476822|NCT01372150|517293101|FG002|Overall Study|Lack of Efficacy|1|||
143476823|NCT01372150|517293099|FG000|Overall Study|Lost to Follow-up|4|||
143476824|NCT01372150|517293100|FG001|Overall Study|Lost to Follow-up|5|||
143476825|NCT01372150|517293101|FG002|Overall Study|Lost to Follow-up|6|||
143476826|NCT01372150|517293099|FG000|Overall Study|Protocol Violation|1|||
143476827|NCT01372150|517293100|FG001|Overall Study|Protocol Violation|0|||
143476828|NCT01372150|517293101|FG002|Overall Study|Protocol Violation|3|||
143476829|NCT01372150|517293099|FG000|Overall Study|Withdrawal by Subject|2|||
143476830|NCT01372150|517293100|FG001|Overall Study|Withdrawal by Subject|7|||
143476831|NCT01372150|517293101|FG002|Overall Study|Withdrawal by Subject|2|||
143476832|NCT01372150|517293099|FG000|Overall Study|Other|1|||
143476833|NCT01372150|517293100|FG001|Overall Study|Other|0|||
143476834|NCT01372150|517293101|FG002|Overall Study|Other|2|||
143476835|NCT01372150|517293099|FG000|Overall Study|Adverse Event|2|||
143476836|NCT01372150|517293100|FG001|Overall Study|Adverse Event|1|||
143476837|NCT01372150|517293101|FG002|Overall Study|Adverse Event|2|||
143476838|NCT01372150|517293099|FG000|Overall Study|Randomized but not treated|0|||
143476839|NCT01372150|517293100|FG001|Overall Study|Randomized but not treated|1|||
143476840|NCT01372150|517293101|FG002|Overall Study|Randomized but not treated|0|||
143476841|NCT01490814|517293108|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
143476842|NCT01490814|517293109|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
143476843|NCT01490814|517293108|FG000|Overall Study|Physician Decision|1|||
143476844|NCT01490814|517293109|FG001|Overall Study|Physician Decision|0|||
143476845|NCT01490814|517293108|FG000|Overall Study|Withdrawal by Subject|0|||
143476846|NCT01490814|517293109|FG001|Overall Study|Withdrawal by Subject|5|||
143476847|NCT01537198|517293110|FG000|Overall Study|RSV infection|2|||
143476848|NCT01537198|517293110|FG000|Overall Study|Adverse Event|4|||
143476849|NCT01537198|517293110|FG000|Overall Study|No Further Visits to the Clinic|37|||
143476850|NCT01537198|517293110|FG000|Overall Study|Other|111|||
143476851|NCT00113074|517293111|FG000|Overall Study|Lost to Follow-up|10|||
143142551|NCT01232283|516069316|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
143142552|NCT01232283|516069317|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
143142553|NCT01232283|516069318|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
143142554|NCT01232283|516069319|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
143142555|NCT01232283|516069320|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
143142556|NCT01232283|516069321|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
143142557|NCT01232283|516069322|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
143142558|NCT01232283|516069323|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
143142559|NCT01232283|516069324|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
143142560|NCT01232283|516069325|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
143142561|NCT01232283|516069316|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
143142562|NCT01232283|516069317|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
143142563|NCT01232283|516069318|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
143142564|NCT01232283|516069319|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
143142565|NCT01232283|516069320|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
143142566|NCT01232283|516069321|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
143142567|NCT01232283|516069322|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
143142568|NCT01232283|516069323|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
143142569|NCT01232283|516069324|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
143142570|NCT01232283|516069325|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
143142571|NCT01232283|516069316|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
143476852|NCT00113074|517293112|FG001|Overall Study|Lost to Follow-up|10|||
143476853|NCT00113074|517293113|FG002|Overall Study|Lost to Follow-up|14|||
143476854|NCT03680911|517293114|FG000|At Home Treatment|Study Termination|3|||
143476855|NCT03680911|517293115|FG001|At Home Treatment|Study Termination|0|||
143476856|NCT03680911|517293114|FG000|At Home Treatment|Lost to Follow-up|0|||
143476857|NCT03680911|517293115|FG001|At Home Treatment|Lost to Follow-up|1|||
143476858|NCT03680911|517293114|FG000|At Home Treatment|Withdrawal by Subject|0|||
143476859|NCT03680911|517293115|FG001|At Home Treatment|Withdrawal by Subject|2|||
143476860|NCT03680911|517293114|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
143476861|NCT03680911|517293115|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
143476862|NCT03962738|517293118|FG000|Overall Study|Protocol Deviation|3|||
143476863|NCT03962738|517293119|FG001|Overall Study|Protocol Deviation|0|||
143476864|NCT03962738|517293120|FG002|Overall Study|Protocol Deviation|1|||
143476865|NCT03962738|517293121|FG003|Overall Study|Protocol Deviation|1|||
143476866|NCT03962738|517293118|FG000|Overall Study|Withdrawal by Subject|4|||
143476867|NCT03962738|517293119|FG001|Overall Study|Withdrawal by Subject|0|||
143476868|NCT03962738|517293120|FG002|Overall Study|Withdrawal by Subject|0|||
143476869|NCT03962738|517293121|FG003|Overall Study|Withdrawal by Subject|0|||
143476870|NCT03962738|517293118|FG000|Overall Study|Lost to Follow-up|0|||
143476871|NCT03962738|517293119|FG001|Overall Study|Lost to Follow-up|0|||
143476872|NCT03962738|517293120|FG002|Overall Study|Lost to Follow-up|1|||
143476873|NCT03962738|517293121|FG003|Overall Study|Lost to Follow-up|0|||
143476874|NCT00574288|517293122|FG000|Overall Study|Adverse Event|2|||
143476875|NCT00574288|517293123|FG001|Overall Study|Adverse Event|0|||
143476876|NCT00574288|517293124|FG002|Overall Study|Adverse Event|0|||
143476877|NCT00574288|517293125|FG003|Overall Study|Adverse Event|0|||
143476878|NCT00574288|517293126|FG004|Overall Study|Adverse Event|1|||
143476879|NCT00574288|517293127|FG005|Overall Study|Adverse Event|0|||
143476880|NCT00574288|517293128|FG006|Overall Study|Adverse Event|0|||
143476881|NCT00574288|517293122|FG000|Overall Study|Death|0|||
143476882|NCT00574288|517293123|FG001|Overall Study|Death|0|||
143476883|NCT00574288|517293124|FG002|Overall Study|Death|0|||
143476884|NCT00574288|517293125|FG003|Overall Study|Death|0|||
143476885|NCT00574288|517293126|FG004|Overall Study|Death|0|||
143476886|NCT00574288|517293127|FG005|Overall Study|Death|25|||
143476887|NCT00574288|517293128|FG006|Overall Study|Death|21|||
143476888|NCT00574288|517293122|FG000|Overall Study|Lost to Follow-up|0|||
143476889|NCT00574288|517293123|FG001|Overall Study|Lost to Follow-up|0|||
143476890|NCT00574288|517293124|FG002|Overall Study|Lost to Follow-up|0|||
143476891|NCT00574288|517293125|FG003|Overall Study|Lost to Follow-up|0|||
143476892|NCT00574288|517293126|FG004|Overall Study|Lost to Follow-up|0|||
143476893|NCT00574288|517293127|FG005|Overall Study|Lost to Follow-up|1|||
143476894|NCT00574288|517293128|FG006|Overall Study|Lost to Follow-up|2|||
143476895|NCT00574288|517293122|FG000|Overall Study|Study Terminated By Sponsor|0|||
143476896|NCT00574288|517293123|FG001|Overall Study|Study Terminated By Sponsor|0|||
143476897|NCT00574288|517293124|FG002|Overall Study|Study Terminated By Sponsor|0|||
143476898|NCT00574288|517293125|FG003|Overall Study|Study Terminated By Sponsor|0|||
143476899|NCT00574288|517293126|FG004|Overall Study|Study Terminated By Sponsor|0|||
143476900|NCT00574288|517293127|FG005|Overall Study|Study Terminated By Sponsor|0|||
143476901|NCT00574288|517293128|FG006|Overall Study|Study Terminated By Sponsor|5|||
143476902|NCT00574288|517293122|FG000|Overall Study|Progressive Disease|17|||
143476903|NCT00574288|517293123|FG001|Overall Study|Progressive Disease|2|||
143476904|NCT00574288|517293124|FG002|Overall Study|Progressive Disease|3|||
143476905|NCT00574288|517293125|FG003|Overall Study|Progressive Disease|2|||
143142572|NCT01232283|516069317|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
143142573|NCT01232283|516069318|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
143142574|NCT01232283|516069319|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
143142575|NCT01232283|516069320|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
143142576|NCT01232283|516069321|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
143142577|NCT01232283|516069322|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
143142578|NCT01232283|516069323|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
143142579|NCT01232283|516069324|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
143142580|NCT01232283|516069325|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
143142581|NCT01232283|516069316|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
143142582|NCT01232283|516069317|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
143142583|NCT01232283|516069318|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
143142584|NCT01232283|516069319|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
143142585|NCT01232283|516069320|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
143142586|NCT01232283|516069321|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
143142587|NCT01232283|516069322|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
143142588|NCT01232283|516069323|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
143142589|NCT01232283|516069324|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
143142590|NCT01232283|516069325|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
143142591|NCT01232283|516069316|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
143142592|NCT01232283|516069317|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
143142593|NCT01232283|516069318|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
143142594|NCT01232283|516069319|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
143142595|NCT01232283|516069320|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
143142596|NCT01232283|516069321|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
143142597|NCT01232283|516069322|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
143142598|NCT01232283|516069323|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
143142599|NCT01232283|516069324|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
143142600|NCT01232283|516069325|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
143142601|NCT01232283|516069316|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
143142602|NCT01232283|516069317|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
143142603|NCT01232283|516069318|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
143142604|NCT01232283|516069319|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
143142605|NCT01232283|516069320|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
143142606|NCT01232283|516069321|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
143142607|NCT01232283|516069322|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
143142608|NCT01232283|516069323|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
143142609|NCT01232283|516069324|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
143142610|NCT01232283|516069325|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
143142611|NCT01232283|516069316|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
143142612|NCT01232283|516069317|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
143142613|NCT01232283|516069318|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
143142614|NCT01232283|516069319|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
143142615|NCT01232283|516069320|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
143142616|NCT01232283|516069321|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
143142617|NCT01232283|516069322|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
143142618|NCT01232283|516069323|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
143142619|NCT01232283|516069324|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
143142620|NCT01232283|516069325|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
143142621|NCT01232283|516069316|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
143142622|NCT01232283|516069317|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
143142623|NCT01232283|516069318|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
143142624|NCT01232283|516069319|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
143142625|NCT01232283|516069320|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
143142626|NCT01232283|516069321|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
143142627|NCT01232283|516069322|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
143142628|NCT01232283|516069323|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
143142629|NCT01232283|516069324|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
143142630|NCT01232283|516069325|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
143142631|NCT01232283|516069316|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
143142632|NCT01232283|516069317|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
143142633|NCT01232283|516069318|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
143142634|NCT01232283|516069319|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
143142635|NCT01232283|516069320|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
143476906|NCT00574288|517293126|FG004|Overall Study|Progressive Disease|1|||
143142636|NCT01232283|516069321|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
143142637|NCT01232283|516069322|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
143142638|NCT01232283|516069323|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
143142639|NCT01232283|516069324|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
143142640|NCT01232283|516069325|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
143142641|NCT01232283|516069316|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
143142642|NCT01232283|516069317|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
143142643|NCT01232283|516069318|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
143142644|NCT01232283|516069319|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
143142645|NCT01232283|516069320|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
143142646|NCT01232283|516069321|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
143142647|NCT01232283|516069322|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
143142648|NCT01232283|516069323|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
143142649|NCT01232283|516069324|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
143142650|NCT01232283|516069325|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
143142651|NCT01232283|516069316|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
143142652|NCT01232283|516069317|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
143142653|NCT01232283|516069318|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
143142654|NCT01232283|516069319|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
143142655|NCT01232283|516069320|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
143142656|NCT01232283|516069321|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
143142657|NCT01232283|516069322|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
143142658|NCT01232283|516069323|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
143142659|NCT01232283|516069324|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
143142660|NCT01232283|516069325|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
143142661|NCT01232283|516069316|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
143142662|NCT01232283|516069317|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
143142663|NCT01232283|516069318|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
143142664|NCT01232283|516069319|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
143142665|NCT01232283|516069320|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
143142666|NCT01232283|516069321|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
143142667|NCT01232283|516069322|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
143142668|NCT01232283|516069323|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
143142669|NCT01232283|516069324|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
143142670|NCT01232283|516069325|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
143142671|NCT01232283|516069316|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
143142672|NCT01232283|516069317|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
143142673|NCT01232283|516069318|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
143142674|NCT01232283|516069319|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
143142675|NCT01232283|516069320|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
143142676|NCT01232283|516069321|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
143142677|NCT01232283|516069322|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
143142678|NCT01232283|516069323|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
143142679|NCT01232283|516069324|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
143142680|NCT01232283|516069325|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
143142681|NCT00402831|516069326|FG000|Overall Study|Lost to Follow-up|1|||
143142682|NCT00402831|516069327|FG001|Overall Study|Lost to Follow-up|2|||
143142683|NCT00402831|516069326|FG000|Overall Study|Non-compliance with protocol|0|||
143142684|NCT00402831|516069327|FG001|Overall Study|Non-compliance with protocol|1|||
143142685|NCT00671788|516069330|FG000|Overall Study|Adverse Event|8|||
143142686|NCT00671788|516069330|FG000|Overall Study|Refused further treatment|3|||
143142687|NCT00671788|516069330|FG000|Overall Study|Ineligible|1|||
143142688|NCT00671788|516069330|FG000|Overall Study|MD Decision|1|||
143142689|NCT00671788|516069330|FG000|Overall Study|Other|1|||
143142690|NCT02792504|516069333|FG000|Overall Study|Lost to Follow-up|24|||
143142691|NCT02792504|516069333|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
143142692|NCT01035138|516069340|FG000|Overall Study|Adverse Event|4|||
143142693|NCT01035138|516069341|FG001|Overall Study|Adverse Event|0|||
143142694|NCT01035138|516069342|FG002|Overall Study|Adverse Event|2|||
143142695|NCT01035138|516069340|FG000|Overall Study|Caregiver Decision|2|||
143142696|NCT01035138|516069341|FG001|Overall Study|Caregiver Decision|0|||
143142697|NCT01035138|516069342|FG002|Overall Study|Caregiver Decision|1|||
143142698|NCT01035138|516069340|FG000|Overall Study|Withdrawal by Subject|1|||
143142699|NCT01035138|516069341|FG001|Overall Study|Withdrawal by Subject|0|||
143142700|NCT01035138|516069342|FG002|Overall Study|Withdrawal by Subject|0|||
143142701|NCT01035138|516069340|FG000|Overall Study|Physician Decision|0|||
143142702|NCT01035138|516069341|FG001|Overall Study|Physician Decision|0|||
143142703|NCT01035138|516069342|FG002|Overall Study|Physician Decision|1|||
143476907|NCT00574288|517293127|FG005|Overall Study|Progressive Disease|0|||
143142704|NCT01035138|516069340|FG000|Overall Study|Sponsor Decision|66|||
143142705|NCT01035138|516069341|FG001|Overall Study|Sponsor Decision|60|||
143142706|NCT01035138|516069342|FG002|Overall Study|Sponsor Decision|42|||
143142707|NCT01035138|516069340|FG000|Overall Study|Lost to Follow-up|0|||
143142708|NCT01035138|516069341|FG001|Overall Study|Lost to Follow-up|0|||
143142709|NCT01035138|516069342|FG002|Overall Study|Lost to Follow-up|1|||
143142710|NCT00848497|516069343|FG000|Overall Study|Screen failure|2|||
143142711|NCT00848497|516069344|FG001|Overall Study|Screen failure|0|||
143142712|NCT00848497|516069343|FG000|Overall Study|Withdrawal by Subject|0|||
143142713|NCT00848497|516069344|FG001|Overall Study|Withdrawal by Subject|1|||
143142714|NCT01832766|516069345|FG000|Washout|Lost to Follow-up|0|||
143142715|NCT01832766|516069346|FG001|Washout|Lost to Follow-up|1|||
143142716|NCT01114724|516069347|FG000|Overall Study|Death|8|||
143142717|NCT01114724|516069347|FG000|Overall Study|Lost to Follow-up|1|||
143142718|NCT01114724|516069347|FG000|Overall Study|Withdrawal by Subject|1|||
143142719|NCT04711005|516069357|FG000|Overall Study|Withdrawal by Subject|0|||
143142720|NCT04711005|516069358|FG001|Overall Study|Withdrawal by Subject|0|||
143142721|NCT04711005|516069359|FG002|Overall Study|Withdrawal by Subject|0|||
143142722|NCT04711005|516069360|FG003|Overall Study|Withdrawal by Subject|0|||
143142723|NCT04711005|516069361|FG004|Overall Study|Withdrawal by Subject|0|||
143142724|NCT04711005|516069362|FG005|Overall Study|Withdrawal by Subject|0|||
143142725|NCT04711005|516069363|FG006|Overall Study|Withdrawal by Subject|0|||
143142726|NCT04711005|516069364|FG007|Overall Study|Withdrawal by Subject|1|||
143142727|NCT04711005|516069365|FG008|Overall Study|Withdrawal by Subject|0|||
143142728|NCT04711005|516069366|FG009|Overall Study|Withdrawal by Subject|0|||
143142729|NCT04711005|516069357|FG000|Overall Study|Physician Decision|0|||
143142730|NCT04711005|516069358|FG001|Overall Study|Physician Decision|0|||
143476908|NCT00574288|517293128|FG006|Overall Study|Progressive Disease|0|||
143476909|NCT00574288|517293122|FG000|Overall Study|Other|1|||
143476910|NCT00574288|517293123|FG001|Overall Study|Other|1|||
143476911|NCT00574288|517293124|FG002|Overall Study|Other|0|||
143476912|NCT00574288|517293125|FG003|Overall Study|Other|0|||
143476913|NCT00574288|517293126|FG004|Overall Study|Other|0|||
143476914|NCT00574288|517293127|FG005|Overall Study|Other|0|||
143476915|NCT00574288|517293128|FG006|Overall Study|Other|0|||
143476916|NCT00369785|517293140|FG000|Overall Study|Physician Decision|3|||
143476917|NCT00369785|517293141|FG001|Overall Study|Physician Decision|2|||
143476918|NCT00369785|517293140|FG000|Overall Study|Death|1|||
143476919|NCT00369785|517293141|FG001|Overall Study|Death|2|||
143476920|NCT00369785|517293140|FG000|Overall Study|Withdrawal by Subject|7|||
143476921|NCT00369785|517293141|FG001|Overall Study|Withdrawal by Subject|6|||
143476922|NCT00369785|517293140|FG000|Overall Study|Toxicity|6|||
143476923|NCT00369785|517293141|FG001|Overall Study|Toxicity|4|||
143476924|NCT00369785|517293140|FG000|Overall Study|Never started|0|||
143476925|NCT00369785|517293141|FG001|Overall Study|Never started|2|||
143476926|NCT00369785|517293140|FG000|Overall Study|Progression|4|||
143476927|NCT00369785|517293141|FG001|Overall Study|Progression|4|||
143476928|NCT00369785|517293140|FG000|Overall Study|Multiple reasons|6|||
143476929|NCT00369785|517293141|FG001|Overall Study|Multiple reasons|5|||
143476930|NCT02247960|517293143|FG000|Patient Consent and Randomization|Physician Decision|2|||
143476931|NCT02247960|517293144|FG001|Patient Consent and Randomization|Physician Decision|2|||
143476932|NCT02247960|517293143|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
143476933|NCT02247960|517293144|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
143476934|NCT02247960|517293143|FG000|Catheter Removed|Lost to Follow-up|7|||
143476935|NCT02247960|517293144|FG001|Catheter Removed|Lost to Follow-up|10|||
143476936|NCT00702325|517293147|FG000|Overall Study|Adverse Event|1|||
143476937|NCT00702325|517293148|FG001|Overall Study|Adverse Event|0|||
143476938|NCT00702325|517293147|FG000|Overall Study|Withdrawal by Subject|7|||
143476939|NCT00702325|517293148|FG001|Overall Study|Withdrawal by Subject|7|||
143476940|NCT00702325|517293147|FG000|Overall Study|Lost to Follow-up|3|||
143476941|NCT00702325|517293148|FG001|Overall Study|Lost to Follow-up|4|||
143476942|NCT00702325|517293147|FG000|Overall Study|Incorrect enrollment|5|||
143142731|NCT04711005|516069359|FG002|Overall Study|Physician Decision|0|||
143142732|NCT04711005|516069360|FG003|Overall Study|Physician Decision|0|||
143142733|NCT04711005|516069361|FG004|Overall Study|Physician Decision|0|||
143142734|NCT04711005|516069362|FG005|Overall Study|Physician Decision|0|||
143142735|NCT04711005|516069363|FG006|Overall Study|Physician Decision|0|||
143142736|NCT04711005|516069364|FG007|Overall Study|Physician Decision|2|||
143142737|NCT04711005|516069365|FG008|Overall Study|Physician Decision|1|||
143142738|NCT04711005|516069366|FG009|Overall Study|Physician Decision|0|||
143142739|NCT02781324|516069371|FG000|Overall Study|Withdrawal by Subject|1|||
143142740|NCT02781324|516069372|FG001|Overall Study|Withdrawal by Subject|0|||
143142741|NCT02781324|516069371|FG000|Overall Study|Physician Decision|1|||
143142742|NCT02781324|516069372|FG001|Overall Study|Physician Decision|2|||
143476943|NCT00702325|517293148|FG001|Overall Study|Incorrect enrollment|7|||
143476944|NCT00702325|517293147|FG000|Overall Study|Developed study discontinuation criteria|18|||
143476945|NCT00702325|517293148|FG001|Overall Study|Developed study discontinuation criteria|28|||
143476946|NCT00702325|517293147|FG000|Overall Study|Severe noncompliance to protocol|3|||
143476947|NCT00702325|517293148|FG001|Overall Study|Severe noncompliance to protocol|3|||
143476948|NCT00702325|517293147|FG000|Overall Study|Termination due to lab results|1|||
143476949|NCT00702325|517293148|FG001|Overall Study|Termination due to lab results|0|||
143476950|NCT00702325|517293147|FG000|Overall Study|Didn't follow study medication dosage|0|||
143476951|NCT00702325|517293148|FG001|Overall Study|Didn't follow study medication dosage|2|||
143476952|NCT00702325|517293147|FG000|Overall Study|Withdrew consent|0|||
143476953|NCT00702325|517293148|FG001|Overall Study|Withdrew consent|1|||
143476954|NCT00702325|517293147|FG000|Overall Study|Incorrectly Discontinued|0|||
143476955|NCT00702325|517293148|FG001|Overall Study|Incorrectly Discontinued|1|||
143476956|NCT04556136|517293152|FG000|Overall Study|Lost to Follow-up|6|||
143476957|NCT04556136|517293153|FG001|Overall Study|Lost to Follow-up|6|||
143476958|NCT04556136|517293152|FG000|Overall Study|Physician Decision|2|||
143476959|NCT04556136|517293153|FG001|Overall Study|Physician Decision|1|||
143476960|NCT04556136|517293152|FG000|Overall Study|Withdrawal by Subject|2|||
143476961|NCT04556136|517293153|FG001|Overall Study|Withdrawal by Subject|1|||
143476962|NCT01022502|517293156|FG000|Overall Study|Adverse Event|1|||
143476963|NCT01022502|517293156|FG000|Overall Study|employment related reasons|1|||
143476964|NCT01022502|517293156|FG000|Overall Study|Withdrawal by Subject|1|||
143476965|NCT02361944|517293157|FG000|Overall Study|surgery cancellation|0|||
143476966|NCT02361944|517293158|FG001|Overall Study|surgery cancellation|1|||
143476967|NCT02566577|517293159|FG000|Overall Study|Withdrawal by Subject|1|||
143476968|NCT02566577|517293160|FG001|Overall Study|Withdrawal by Subject|1|||
143476969|NCT02566577|517293159|FG000|Overall Study|Equipment failure|1|||
143476970|NCT02566577|517293160|FG001|Overall Study|Equipment failure|1|||
143476971|NCT02566577|517293159|FG000|Overall Study|Physical limitation|1|||
143476972|NCT02566577|517293160|FG001|Overall Study|Physical limitation|0|||
143476973|NCT00073528|517293171|FG000|Overall Study|Death|488|||
143476974|NCT00073528|517293172|FG001|Overall Study|Death|473|||
143476975|NCT00073528|517293171|FG000|Overall Study|Lost to Follow-up|52|||
143476976|NCT00073528|517293172|FG001|Overall Study|Lost to Follow-up|45|||
143476977|NCT00073528|517293171|FG000|Overall Study|Withdrawal by Subject|50|||
143476978|NCT00073528|517293172|FG001|Overall Study|Withdrawal by Subject|45|||
143476979|NCT00073528|517293171|FG000|Overall Study|Study terminated by Sponsor|10|||
143476980|NCT00073528|517293172|FG001|Overall Study|Study terminated by Sponsor|29|||
143476981|NCT00073528|517293171|FG000|Overall Study|Other|18|||
143476982|NCT00073528|517293172|FG001|Overall Study|Other|19|||
143476983|NCT00073528|517293171|FG000|Overall Study|Other|9|||
143476984|NCT00073528|517293172|FG001|Overall Study|Other|12|||
143476985|NCT00073528|517293171|FG000|Overall Study|Protocol Violation|3|||
143476986|NCT00073528|517293172|FG001|Overall Study|Protocol Violation|5|||
143476987|NCT03086057|517293173|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
143476988|NCT03086057|517293174|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
143476989|NCT03086057|517293175|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
143476990|NCT03086057|517293176|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
143476991|NCT03086057|517293173|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
143476992|NCT03086057|517293174|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
143476993|NCT03086057|517293175|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
143476994|NCT03086057|517293176|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
143476995|NCT03086057|517293173|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
143476996|NCT03086057|517293174|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
143476997|NCT03086057|517293175|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
143476998|NCT03086057|517293176|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
143476999|NCT03086057|517293173|FG000|Stage 1: PrEP Uptake|Death|1|||
143477000|NCT03086057|517293174|FG001|Stage 1: PrEP Uptake|Death|0|||
143477001|NCT03086057|517293175|FG002|Stage 1: PrEP Uptake|Death|0|||
143477002|NCT03086057|517293176|FG003|Stage 1: PrEP Uptake|Death|0|||
143477003|NCT03086057|517293173|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
143477004|NCT03086057|517293174|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
143477005|NCT03086057|517293175|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
143477006|NCT03086057|517293176|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
143477007|NCT03086057|517293173|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
143477008|NCT03086057|517293174|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
143477009|NCT03086057|517293175|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
143477010|NCT03086057|517293176|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
143477011|NCT03086057|517293173|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
143477012|NCT03086057|517293174|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
143477013|NCT03086057|517293175|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
143477014|NCT03086057|517293176|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
143477015|NCT00003702|517293179|FG000|Overall Study|Ineligible cell types|2|||
143477016|NCT00003702|517293180|FG001|Overall Study|Ineligible cell types|2|||
143477017|NCT00003702|517293179|FG000|Overall Study|Did not meet criteria for persistence|8|||
143477018|NCT00003702|517293180|FG001|Overall Study|Did not meet criteria for persistence|5|||
143477019|NCT00003702|517293179|FG000|Overall Study|WHO score > 6|2|||
143477020|NCT00003702|517293180|FG001|Overall Study|WHO score > 6|1|||
143477021|NCT00003702|517293179|FG000|Overall Study|Inadequate documentation of disease|1|||
143477022|NCT00003702|517293180|FG001|Overall Study|Inadequate documentation of disease|3|||
143477023|NCT01786603|517293181|FG000|Overall Study|Death|5|||
143477024|NCT01786603|517293182|FG001|Overall Study|Death|1|||
143142743|NCT00834041|516069373|FG000|Overall Study|Withdrawal by Subject|1|||
143142744|NCT00834041|516069374|FG001|Overall Study|Withdrawal by Subject|0|||
143142745|NCT00834041|516069373|FG000|Overall Study|Lost to Follow-up|0|||
143142746|NCT00834041|516069374|FG001|Overall Study|Lost to Follow-up|1|||
143142747|NCT00274456|516070634|FG000|Overall Study|Still on treatment|2|||
143142748|NCT00274456|516070635|FG001|Overall Study|Still on treatment|3|||
143142749|NCT00274456|516070636|FG002|Overall Study|Still on treatment|5|||
143142750|NCT00274456|516070637|FG003|Overall Study|Still on treatment|1|||
143142751|NCT00274456|516070634|FG000|Overall Study|Unacceptable toxicity|10|||
143142752|NCT00274456|516070635|FG001|Overall Study|Unacceptable toxicity|5|||
143142753|NCT00274456|516070636|FG002|Overall Study|Unacceptable toxicity|12|||
143142754|NCT00274456|516070637|FG003|Overall Study|Unacceptable toxicity|16|||
143363337|NCT04956692|516873706|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
143363338|NCT04956692|516873707|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
143363339|NCT04956692|516873706|FG000|Overall Study|Withdrawal by Subject|5|||
143363340|NCT04956692|516873707|FG001|Overall Study|Withdrawal by Subject|2|||
143363341|NCT04956692|516873706|FG000|Overall Study|Ongoing in Study|236|||
143363342|NCT04956692|516873707|FG001|Overall Study|Ongoing in Study|123|||
143363343|NCT04639947|516873708|FG000|Overall Study|Screen fail|1|||
143363344|NCT02696785|516873714|FG000|Blinded Treatment Period|Adverse Event|0|||
143363345|NCT02696785|516873715|FG001|Blinded Treatment Period|Adverse Event|1|||
143363346|NCT02696785|516873716|FG002|Blinded Treatment Period|Adverse Event|3|||
143363347|NCT02696785|516873717|FG003|Blinded Treatment Period|Adverse Event|0|||
143363348|NCT02696785|516873714|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
143363349|NCT02696785|516873715|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
143363350|NCT02696785|516873716|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
143363351|NCT02696785|516873717|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
143363352|NCT02696785|516873714|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
143363353|NCT02696785|516873715|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
143363354|NCT02696785|516873716|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
143363355|NCT02696785|516873717|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
143363356|NCT02696785|516873714|FG000|Blinded Treatment Period|Screen Failure|1|||
143363357|NCT02696785|516873715|FG001|Blinded Treatment Period|Screen Failure|0|||
143363358|NCT02696785|516873716|FG002|Blinded Treatment Period|Screen Failure|0|||
143363359|NCT02696785|516873717|FG003|Blinded Treatment Period|Screen Failure|0|||
143363360|NCT02696785|516873714|FG000|Washout Period|Withdrawal by Subject|0|||
143363361|NCT02696785|516873715|FG001|Washout Period|Withdrawal by Subject|1|||
143363362|NCT02696785|516873716|FG002|Washout Period|Withdrawal by Subject|0|||
143363363|NCT02696785|516873717|FG003|Washout Period|Withdrawal by Subject|0|||
143363364|NCT02696785|516873714|FG000|Washout Period|Lack of Efficacy|0|||
143363365|NCT02696785|516873715|FG001|Washout Period|Lack of Efficacy|1|||
143363366|NCT02696785|516873716|FG002|Washout Period|Lack of Efficacy|0|||
143363367|NCT02696785|516873717|FG003|Washout Period|Lack of Efficacy|0|||
143363368|NCT02696785|516873714|FG000|Extended Treatment Period|Adverse Event|2|||
143363369|NCT02696785|516873715|FG001|Extended Treatment Period|Adverse Event|3|||
143363370|NCT02696785|516873716|FG002|Extended Treatment Period|Adverse Event|2|||
143363371|NCT02696785|516873717|FG003|Extended Treatment Period|Adverse Event|1|||
143363372|NCT02696785|516873714|FG000|Extended Treatment Period|Lack of Efficacy|0|||
143363373|NCT02696785|516873715|FG001|Extended Treatment Period|Lack of Efficacy|1|||
143363374|NCT02696785|516873716|FG002|Extended Treatment Period|Lack of Efficacy|0|||
143363375|NCT02696785|516873717|FG003|Extended Treatment Period|Lack of Efficacy|0|||
143363376|NCT02696785|516873714|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
143363377|NCT02696785|516873715|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
143363378|NCT02696785|516873716|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
143363379|NCT02696785|516873717|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
143363380|NCT02696785|516873714|FG000|Follow-up Period|Adverse Event|0|||
143363381|NCT02696785|516873715|FG001|Follow-up Period|Adverse Event|0|||
143363382|NCT02696785|516873716|FG002|Follow-up Period|Adverse Event|8|||
143363383|NCT02696785|516873717|FG003|Follow-up Period|Adverse Event|2|||
143363384|NCT02696785|516873714|FG000|Follow-up Period|Lost to Follow-up|0|||
143363385|NCT02696785|516873715|FG001|Follow-up Period|Lost to Follow-up|0|||
143363386|NCT02696785|516873716|FG002|Follow-up Period|Lost to Follow-up|0|||
143363387|NCT02696785|516873717|FG003|Follow-up Period|Lost to Follow-up|1|||
143363388|NCT02696785|516873714|FG000|Follow-up Period|Lack of Efficacy|0|||
143363389|NCT02696785|516873715|FG001|Follow-up Period|Lack of Efficacy|0|||
143363390|NCT02696785|516873716|FG002|Follow-up Period|Lack of Efficacy|0|||
143363391|NCT02696785|516873717|FG003|Follow-up Period|Lack of Efficacy|1|||
143363392|NCT02696785|516873714|FG000|Follow-up Period|Withdrawal by Subject|1|||
143363393|NCT02696785|516873715|FG001|Follow-up Period|Withdrawal by Subject|0|||
143363394|NCT02696785|516873716|FG002|Follow-up Period|Withdrawal by Subject|5|||
143363395|NCT02696785|516873717|FG003|Follow-up Period|Withdrawal by Subject|4|||
143363396|NCT05780047|516873727|FG000|Overall Study|Did not submit baseline urine test kit|226|||
143363397|NCT05780047|516873727|FG000|Overall Study|Lost to Follow-up|34|||
143142755|NCT00274456|516070634|FG000|Overall Study|Adverse Event|0|||
143142756|NCT00274456|516070635|FG001|Overall Study|Adverse Event|1|||
143142757|NCT00274456|516070636|FG002|Overall Study|Adverse Event|2|||
143477025|NCT01786603|517293181|FG000|Overall Study|Adverse Event|6|||
143477026|NCT01786603|517293182|FG001|Overall Study|Adverse Event|2|||
143477027|NCT01786603|517293181|FG000|Overall Study|Physician decision to withdraw|6|||
143477028|NCT01786603|517293182|FG001|Overall Study|Physician decision to withdraw|7|||
143477029|NCT01786603|517293181|FG000|Overall Study|Lost to Follow-up|1|||
143477030|NCT01786603|517293182|FG001|Overall Study|Lost to Follow-up|2|||
143477031|NCT01226459|517293183|FG000|Overall Study|Adverse Event|2|||
143477032|NCT01226459|517293184|FG001|Overall Study|Adverse Event|8|||
143477033|NCT01226459|517293183|FG000|Overall Study|Protocol Violation|4|||
143477034|NCT01226459|517293184|FG001|Overall Study|Protocol Violation|3|||
143477035|NCT01226459|517293183|FG000|Overall Study|Withdrawal by Subject|10|||
143477036|NCT01226459|517293184|FG001|Overall Study|Withdrawal by Subject|13|||
143477037|NCT01226459|517293183|FG000|Overall Study|Lost to Follow-up|4|||
143477038|NCT01226459|517293184|FG001|Overall Study|Lost to Follow-up|8|||
143477039|NCT01226459|517293183|FG000|Overall Study|Pregnancy|1|||
143477040|NCT01226459|517293184|FG001|Overall Study|Pregnancy|0|||
143477041|NCT00474708|517293185|FG000|Overall Study|Lack of Efficacy|11|||
143477042|NCT00474708|517293186|FG001|Overall Study|Lack of Efficacy|5|||
143477043|NCT00474708|517293185|FG000|Overall Study|Suicide ideation/behavior|0|||
143142758|NCT00274456|516070637|FG003|Overall Study|Adverse Event|2|||
143142759|NCT00274456|516070634|FG000|Overall Study|Physician Decision|7|||
143477044|NCT00474708|517293186|FG001|Overall Study|Suicide ideation/behavior|1|||
143477045|NCT00474708|517293185|FG000|Overall Study|Withdrawal by Subject|7|||
143477046|NCT00474708|517293186|FG001|Overall Study|Withdrawal by Subject|0|||
143477047|NCT00474708|517293185|FG000|Overall Study|Lack of compliance|12|||
143477048|NCT00474708|517293186|FG001|Overall Study|Lack of compliance|4|||
143477049|NCT00474708|517293185|FG000|Overall Study|Lost to Follow-up|18|||
143477050|NCT00474708|517293186|FG001|Overall Study|Lost to Follow-up|9|||
143477051|NCT00474708|517293185|FG000|Overall Study|Physician Decision|9|||
143477052|NCT00474708|517293186|FG001|Overall Study|Physician Decision|6|||
143477053|NCT00117598|517293191|FG000|Prior to Treatment Cross Over|Death|40|||
143477054|NCT00117598|517293192|FG001|Prior to Treatment Cross Over|Death|41|||
143477055|NCT00117598|517293193|FG002|Prior to Treatment Cross Over|Death|37|||
143477056|NCT00117598|517293194|FG003|Prior to Treatment Cross Over|Death|0|||
143477057|NCT00117598|517293195|FG004|Prior to Treatment Cross Over|Death|0|||
143477058|NCT00117598|517293191|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
143477059|NCT00117598|517293192|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
143477060|NCT00117598|517293193|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
143477061|NCT00117598|517293194|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
143477062|NCT00117598|517293195|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
143477063|NCT00117598|517293191|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
143477064|NCT00117598|517293192|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
143477065|NCT00117598|517293193|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
143477066|NCT00117598|517293194|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
143477067|NCT00117598|517293195|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
143477068|NCT00117598|517293191|FG000|Prior to Treatment Cross Over|Other|15|||
143477069|NCT00117598|517293192|FG001|Prior to Treatment Cross Over|Other|9|||
143477070|NCT00117598|517293193|FG002|Prior to Treatment Cross Over|Other|9|||
143477071|NCT00117598|517293194|FG003|Prior to Treatment Cross Over|Other|0|||
143477072|NCT00117598|517293195|FG004|Prior to Treatment Cross Over|Other|0|||
143477073|NCT00117598|517293191|FG000|After Treament Cross Over|Death|0|||
143477074|NCT00117598|517293192|FG001|After Treament Cross Over|Death|0|||
143142760|NCT00274456|516070635|FG001|Overall Study|Physician Decision|5|||
143142761|NCT00274456|516070636|FG002|Overall Study|Physician Decision|6|||
143142762|NCT00274456|516070637|FG003|Overall Study|Physician Decision|13|||
143142763|NCT00274456|516070634|FG000|Overall Study|Lost to Follow-up|0|||
143142764|NCT00274456|516070635|FG001|Overall Study|Lost to Follow-up|0|||
143142765|NCT00274456|516070636|FG002|Overall Study|Lost to Follow-up|1|||
143142766|NCT00274456|516070637|FG003|Overall Study|Lost to Follow-up|0|||
143142767|NCT00274456|516070634|FG000|Overall Study|Withdrawal by Subject|18|||
143142768|NCT00274456|516070635|FG001|Overall Study|Withdrawal by Subject|13|||
143142769|NCT00274456|516070636|FG002|Overall Study|Withdrawal by Subject|9|||
143142770|NCT00274456|516070637|FG003|Overall Study|Withdrawal by Subject|13|||
143142771|NCT00375752|516070638|FG000|Overall Study|Lack of Efficacy|4|||
143142772|NCT00375752|516070639|FG001|Overall Study|Lack of Efficacy|4|||
143142773|NCT00375752|516070638|FG000|Overall Study|Adverse Event|1|||
143142774|NCT00375752|516070639|FG001|Overall Study|Adverse Event|6|||
143477075|NCT00117598|517293193|FG002|After Treament Cross Over|Death|0|||
143477076|NCT00117598|517293194|FG003|After Treament Cross Over|Death|1|||
143477077|NCT00117598|517293195|FG004|After Treament Cross Over|Death|2|||
143477078|NCT00117598|517293191|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
143477079|NCT00117598|517293192|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
143477080|NCT00117598|517293193|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
143477081|NCT00117598|517293194|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
143477082|NCT00117598|517293195|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
143142775|NCT00375752|516070638|FG000|Overall Study|Withdrawal by Subject|6|||
143142776|NCT00375752|516070639|FG001|Overall Study|Withdrawal by Subject|1|||
143142777|NCT00375752|516070638|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
143142778|NCT00375752|516070639|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
143142779|NCT00375752|516070638|FG000|Overall Study|Protocol Violation|0|||
143142780|NCT00375752|516070639|FG001|Overall Study|Protocol Violation|2|||
143142781|NCT00375752|516070638|FG000|Overall Study|Administrative Problems|0|||
143142782|NCT00375752|516070639|FG001|Overall Study|Administrative Problems|1|||
143142783|NCT01140906|516070644|FG000|Overall Study|Adverse Event|7|||
143142784|NCT01140906|516070645|FG001|Overall Study|Adverse Event|10|||
143142785|NCT01140906|516070646|FG002|Overall Study|Adverse Event|17|||
143142786|NCT01140906|516070647|FG003|Overall Study|Adverse Event|7|||
143142787|NCT01140906|516070644|FG000|Overall Study|Lack of Efficacy|6|||
143142788|NCT01140906|516070645|FG001|Overall Study|Lack of Efficacy|8|||
143142789|NCT01140906|516070646|FG002|Overall Study|Lack of Efficacy|2|||
143142790|NCT01140906|516070647|FG003|Overall Study|Lack of Efficacy|1|||
143142791|NCT01140906|516070644|FG000|Overall Study|Non-compliance|0|||
143142792|NCT01140906|516070645|FG001|Overall Study|Non-compliance|1|||
143477083|NCT00117598|517293191|FG000|After Treament Cross Over|Other|0|||
143477084|NCT00117598|517293192|FG001|After Treament Cross Over|Other|0|||
143477085|NCT00117598|517293193|FG002|After Treament Cross Over|Other|0|||
143477086|NCT00117598|517293194|FG003|After Treament Cross Over|Other|1|||
143477087|NCT00117598|517293195|FG004|After Treament Cross Over|Other|2|||
143477088|NCT03098836|517293201|FG000|Overall Study|Adverse Event|1|||
143477089|NCT03098836|517293202|FG001|Overall Study|Adverse Event|3|||
143477090|NCT03098836|517293201|FG000|Overall Study|Lack of Efficacy|30|||
143363398|NCT05780047|516873727|FG000|Overall Study|Did not submit second urine test kit|124|||
143363399|NCT00783692|516873737|FG000|Induction Phase|Adverse Event|7|||
143363400|NCT00783692|516873738|FG001|Induction Phase|Adverse Event|9|||
143363401|NCT00783692|516873739|FG002|Induction Phase|Adverse Event|24|||
143363402|NCT00783692|516873740|FG003|Induction Phase|Adverse Event|0|||
143363403|NCT00783692|516873741|FG004|Induction Phase|Adverse Event|0|||
143363404|NCT00783692|516873742|FG005|Induction Phase|Adverse Event|0|||
143363405|NCT00783692|516873743|FG006|Induction Phase|Adverse Event|0|||
143363406|NCT00783692|516873737|FG000|Induction Phase|Protocol Violation|0|||
143363407|NCT00783692|516873738|FG001|Induction Phase|Protocol Violation|0|||
143363408|NCT00783692|516873739|FG002|Induction Phase|Protocol Violation|1|||
143363409|NCT00783692|516873740|FG003|Induction Phase|Protocol Violation|0|||
143363410|NCT00783692|516873741|FG004|Induction Phase|Protocol Violation|0|||
143363411|NCT00783692|516873742|FG005|Induction Phase|Protocol Violation|0|||
143363412|NCT00783692|516873743|FG006|Induction Phase|Protocol Violation|0|||
143363413|NCT00783692|516873737|FG000|Induction Phase|Lack of Efficacy|1|||
143363414|NCT00783692|516873738|FG001|Induction Phase|Lack of Efficacy|3|||
143363415|NCT00783692|516873739|FG002|Induction Phase|Lack of Efficacy|28|||
143363416|NCT00783692|516873740|FG003|Induction Phase|Lack of Efficacy|0|||
143363417|NCT00783692|516873741|FG004|Induction Phase|Lack of Efficacy|0|||
143363418|NCT00783692|516873742|FG005|Induction Phase|Lack of Efficacy|0|||
143363419|NCT00783692|516873743|FG006|Induction Phase|Lack of Efficacy|0|||
143363420|NCT00783692|516873737|FG000|Induction Phase|Withdrawal by Subject|3|||
143363421|NCT00783692|516873738|FG001|Induction Phase|Withdrawal by Subject|9|||
143363422|NCT00783692|516873739|FG002|Induction Phase|Withdrawal by Subject|16|||
143363423|NCT00783692|516873740|FG003|Induction Phase|Withdrawal by Subject|0|||
143363424|NCT00783692|516873741|FG004|Induction Phase|Withdrawal by Subject|0|||
143363425|NCT00783692|516873742|FG005|Induction Phase|Withdrawal by Subject|0|||
143363426|NCT00783692|516873743|FG006|Induction Phase|Withdrawal by Subject|0|||
143363427|NCT00783692|516873737|FG000|Induction Phase|Lost to Follow-up|0|||
143363428|NCT00783692|516873738|FG001|Induction Phase|Lost to Follow-up|0|||
143363429|NCT00783692|516873739|FG002|Induction Phase|Lost to Follow-up|3|||
143363430|NCT00783692|516873740|FG003|Induction Phase|Lost to Follow-up|0|||
143363431|NCT00783692|516873741|FG004|Induction Phase|Lost to Follow-up|0|||
143363432|NCT00783692|516873742|FG005|Induction Phase|Lost to Follow-up|0|||
143363433|NCT00783692|516873743|FG006|Induction Phase|Lost to Follow-up|0|||
143363434|NCT00783692|516873737|FG000|Induction Phase|Other|0|||
143363435|NCT00783692|516873738|FG001|Induction Phase|Other|0|||
143363436|NCT00783692|516873739|FG002|Induction Phase|Other|2|||
143363437|NCT00783692|516873740|FG003|Induction Phase|Other|0|||
143363438|NCT00783692|516873741|FG004|Induction Phase|Other|0|||
143363439|NCT00783692|516873742|FG005|Induction Phase|Other|0|||
143363440|NCT00783692|516873743|FG006|Induction Phase|Other|0|||
143363441|NCT00783692|516873737|FG000|Maintenance Phase|Adverse Event|7|||
143363442|NCT00783692|516873738|FG001|Maintenance Phase|Adverse Event|0|||
143363443|NCT00783692|516873739|FG002|Maintenance Phase|Adverse Event|0|||
143477091|NCT03098836|517293202|FG001|Overall Study|Lack of Efficacy|15|||
143142793|NCT01140906|516070646|FG002|Overall Study|Non-compliance|0|||
143363444|NCT00783692|516873740|FG003|Maintenance Phase|Adverse Event|15|||
143142794|NCT01140906|516070647|FG003|Overall Study|Non-compliance|1|||
143142795|NCT01140906|516070644|FG000|Overall Study|Protocol Violation|5|||
143142796|NCT01140906|516070645|FG001|Overall Study|Protocol Violation|3|||
143142797|NCT01140906|516070646|FG002|Overall Study|Protocol Violation|2|||
143142798|NCT01140906|516070647|FG003|Overall Study|Protocol Violation|1|||
143363445|NCT00783692|516873741|FG004|Maintenance Phase|Adverse Event|12|||
143477092|NCT03098836|517293201|FG000|Overall Study|Physician Decision|2|||
143477093|NCT03098836|517293202|FG001|Overall Study|Physician Decision|1|||
143477094|NCT03098836|517293201|FG000|Overall Study|Withdrawal by Subject|3|||
143477095|NCT03098836|517293202|FG001|Overall Study|Withdrawal by Subject|2|||
143477096|NCT03986866|517293203|FG000|Overall Study|Withdrawal by Subject|0|||
143477097|NCT03986866|517293204|FG001|Overall Study|Withdrawal by Subject|3|||
143477098|NCT03986866|517293203|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
143477099|NCT03986866|517293204|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
143142799|NCT01140906|516070644|FG000|Overall Study|Withdrawal of consent|6|||
143142800|NCT01140906|516070645|FG001|Overall Study|Withdrawal of consent|6|||
143142801|NCT01140906|516070646|FG002|Overall Study|Withdrawal of consent|2|||
143142802|NCT01140906|516070647|FG003|Overall Study|Withdrawal of consent|2|||
143142803|NCT01140906|516070644|FG000|Overall Study|Lost to Follow-up|1|||
143142804|NCT01140906|516070645|FG001|Overall Study|Lost to Follow-up|1|||
143142805|NCT01140906|516070646|FG002|Overall Study|Lost to Follow-up|0|||
143142806|NCT01140906|516070647|FG003|Overall Study|Lost to Follow-up|2|||
143142807|NCT01140906|516070644|FG000|Overall Study|Administrative or other reason|0|||
143142808|NCT01140906|516070645|FG001|Overall Study|Administrative or other reason|5|||
143142809|NCT01140906|516070646|FG002|Overall Study|Administrative or other reason|3|||
143142810|NCT01140906|516070647|FG003|Overall Study|Administrative or other reason|2|||
143142811|NCT01721798|516070648|FG000|Overall Study|Death|0|||
143142812|NCT01721798|516070649|FG001|Overall Study|Death|0|||
143142813|NCT01721798|516070650|FG002|Overall Study|Death|1|||
143142814|NCT01721798|516070651|FG003|Overall Study|Death|1|||
143142815|NCT01721798|516070648|FG000|Overall Study|Lost to Follow-up|2|||
143142816|NCT01721798|516070649|FG001|Overall Study|Lost to Follow-up|2|||
143142817|NCT01721798|516070650|FG002|Overall Study|Lost to Follow-up|9|||
143142818|NCT01721798|516070651|FG003|Overall Study|Lost to Follow-up|9|||
143142819|NCT01721798|516070648|FG000|Overall Study|Pregnancy|0|||
143142820|NCT01721798|516070649|FG001|Overall Study|Pregnancy|0|||
143142821|NCT01721798|516070650|FG002|Overall Study|Pregnancy|1|||
143142822|NCT01721798|516070651|FG003|Overall Study|Pregnancy|1|||
143142823|NCT01721798|516070648|FG000|Overall Study|Withdrawal by Subject|1|||
143142824|NCT01721798|516070649|FG001|Overall Study|Withdrawal by Subject|0|||
143142825|NCT01721798|516070650|FG002|Overall Study|Withdrawal by Subject|2|||
143142826|NCT01721798|516070651|FG003|Overall Study|Withdrawal by Subject|1|||
143142827|NCT01721798|516070648|FG000|Overall Study|Not eligible for 24 month visit|1|||
143142828|NCT01721798|516070649|FG001|Overall Study|Not eligible for 24 month visit|0|||
143142829|NCT01721798|516070650|FG002|Overall Study|Not eligible for 24 month visit|8|||
143142830|NCT01721798|516070651|FG003|Overall Study|Not eligible for 24 month visit|7|||
143142831|NCT00703534|516070652|FG000|Overall Study|Adverse Event|14|||
143142832|NCT00703534|516070653|FG001|Overall Study|Adverse Event|3|||
143142833|NCT00703534|516070652|FG000|Overall Study|Withdrawal by Subject|8|||
143142834|NCT00703534|516070653|FG001|Overall Study|Withdrawal by Subject|7|||
143142835|NCT00703534|516070652|FG000|Overall Study|Incorrect Enrollment|6|||
143142836|NCT00703534|516070653|FG001|Overall Study|Incorrect Enrollment|6|||
143142837|NCT00703534|516070652|FG000|Overall Study|Lost to Follow-up|1|||
143142838|NCT00703534|516070653|FG001|Overall Study|Lost to Follow-up|4|||
143142839|NCT00703534|516070652|FG000|Overall Study|Severe Non Compliance|1|||
143142840|NCT00703534|516070653|FG001|Overall Study|Severe Non Compliance|5|||
143142841|NCT00427934|516070654|FG000|Overall Study|Adverse Event|1|||
143142842|NCT00427934|516070655|FG001|Overall Study|Adverse Event|0|||
143142843|NCT00427934|516070656|FG002|Overall Study|Adverse Event|5|||
143142844|NCT00427934|516070657|FG003|Overall Study|Adverse Event|4|||
143142845|NCT00427934|516070654|FG000|Overall Study|Lack of Efficacy|0|||
143142846|NCT00427934|516070655|FG001|Overall Study|Lack of Efficacy|0|||
143142847|NCT00427934|516070656|FG002|Overall Study|Lack of Efficacy|5|||
143142848|NCT00427934|516070657|FG003|Overall Study|Lack of Efficacy|2|||
143142849|NCT00427934|516070654|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
143142850|NCT00427934|516070655|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
143142851|NCT00427934|516070656|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
143142852|NCT00427934|516070657|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
143142853|NCT00427934|516070654|FG000|Overall Study|Other|0|||
143142854|NCT00427934|516070655|FG001|Overall Study|Other|0|||
143142855|NCT00427934|516070656|FG002|Overall Study|Other|11|||
143142856|NCT00427934|516070657|FG003|Overall Study|Other|5|||
143142857|NCT00427934|516070654|FG000|Overall Study|Withdrawal by Subject|0|||
143142858|NCT00427934|516070655|FG001|Overall Study|Withdrawal by Subject|0|||
143142859|NCT00427934|516070656|FG002|Overall Study|Withdrawal by Subject|1|||
143142860|NCT00427934|516070657|FG003|Overall Study|Withdrawal by Subject|3|||
143142861|NCT00336544|516070658|FG000|Overall Study|Lack of Efficacy|8|||
143142862|NCT00336544|516070659|FG001|Overall Study|Lack of Efficacy|5|||
143142863|NCT00336544|516070658|FG000|Overall Study|Adverse Event|4|||
143142864|NCT00336544|516070659|FG001|Overall Study|Adverse Event|9|||
143142865|NCT00336544|516070658|FG000|Overall Study|Withdrawal by Subject|4|||
143142866|NCT00336544|516070659|FG001|Overall Study|Withdrawal by Subject|3|||
143142867|NCT00336544|516070658|FG000|Overall Study|Other|3|||
143142868|NCT00336544|516070659|FG001|Overall Study|Other|5|||
143142869|NCT01649765|516070660|FG000|Overall Study|Adverse Event|5|||
143142870|NCT01649765|516070661|FG001|Overall Study|Adverse Event|3|||
143363446|NCT00783692|516873742|FG005|Maintenance Phase|Adverse Event|9|||
143363447|NCT00783692|516873743|FG006|Maintenance Phase|Adverse Event|38|||
143142871|NCT01649765|516070660|FG000|Overall Study|Lack of Efficacy|1|||
143363448|NCT00783692|516873737|FG000|Maintenance Phase|Protocol Violation|0|||
143363449|NCT00783692|516873738|FG001|Maintenance Phase|Protocol Violation|0|||
143363450|NCT00783692|516873739|FG002|Maintenance Phase|Protocol Violation|0|||
143363451|NCT00783692|516873740|FG003|Maintenance Phase|Protocol Violation|1|||
143363452|NCT00783692|516873741|FG004|Maintenance Phase|Protocol Violation|2|||
143363453|NCT00783692|516873742|FG005|Maintenance Phase|Protocol Violation|3|||
143363454|NCT00783692|516873743|FG006|Maintenance Phase|Protocol Violation|4|||
143363455|NCT00783692|516873737|FG000|Maintenance Phase|Lack of Efficacy|79|||
143363456|NCT00783692|516873738|FG001|Maintenance Phase|Lack of Efficacy|0|||
143363457|NCT00783692|516873739|FG002|Maintenance Phase|Lack of Efficacy|0|||
143363458|NCT00783692|516873740|FG003|Maintenance Phase|Lack of Efficacy|64|||
143363459|NCT00783692|516873741|FG004|Maintenance Phase|Lack of Efficacy|58|||
143363460|NCT00783692|516873742|FG005|Maintenance Phase|Lack of Efficacy|48|||
143363461|NCT00783692|516873743|FG006|Maintenance Phase|Lack of Efficacy|177|||
143363462|NCT00783692|516873737|FG000|Maintenance Phase|Withdrawal by Subject|7|||
143363463|NCT00783692|516873738|FG001|Maintenance Phase|Withdrawal by Subject|0|||
143363464|NCT00783692|516873739|FG002|Maintenance Phase|Withdrawal by Subject|0|||
143363465|NCT00783692|516873740|FG003|Maintenance Phase|Withdrawal by Subject|7|||
143363466|NCT00783692|516873741|FG004|Maintenance Phase|Withdrawal by Subject|6|||
143363467|NCT00783692|516873742|FG005|Maintenance Phase|Withdrawal by Subject|9|||
143363468|NCT00783692|516873743|FG006|Maintenance Phase|Withdrawal by Subject|24|||
143363469|NCT00783692|516873737|FG000|Maintenance Phase|Lost to Follow-up|2|||
143363470|NCT00783692|516873738|FG001|Maintenance Phase|Lost to Follow-up|0|||
143363471|NCT00783692|516873739|FG002|Maintenance Phase|Lost to Follow-up|0|||
143363472|NCT00783692|516873740|FG003|Maintenance Phase|Lost to Follow-up|1|||
143363473|NCT00783692|516873741|FG004|Maintenance Phase|Lost to Follow-up|3|||
143363474|NCT00783692|516873742|FG005|Maintenance Phase|Lost to Follow-up|2|||
143363475|NCT00783692|516873743|FG006|Maintenance Phase|Lost to Follow-up|5|||
143363476|NCT00783692|516873737|FG000|Maintenance Phase|Other|0|||
143363477|NCT00783692|516873738|FG001|Maintenance Phase|Other|0|||
143363478|NCT00783692|516873739|FG002|Maintenance Phase|Other|0|||
143363479|NCT00783692|516873740|FG003|Maintenance Phase|Other|1|||
143363480|NCT00783692|516873741|FG004|Maintenance Phase|Other|0|||
143363481|NCT00783692|516873742|FG005|Maintenance Phase|Other|1|||
143363482|NCT00783692|516873743|FG006|Maintenance Phase|Other|1|||
143363483|NCT03005288|516873746|FG000|Overall Study|Withdrawal by Subject|7|||
143363484|NCT03005288|516873747|FG001|Overall Study|Withdrawal by Subject|5|||
143363485|NCT03005288|516873746|FG000|Overall Study|Lost to Follow-up|0|||
143363486|NCT03005288|516873747|FG001|Overall Study|Lost to Follow-up|1|||
143363487|NCT03005288|516873746|FG000|Overall Study|Adverse Event|5|||
143363488|NCT03005288|516873747|FG001|Overall Study|Adverse Event|0|||
143363489|NCT03005288|516873746|FG000|Overall Study|Protocol deviation|0|||
143363490|NCT03005288|516873747|FG001|Overall Study|Protocol deviation|1|||
143363491|NCT03005288|516873746|FG000|Overall Study|Physician Decision|0|||
143363492|NCT03005288|516873747|FG001|Overall Study|Physician Decision|1|||
143363493|NCT00209274|516873748|FG000|Overall Study|Missed visit|3|||
143363494|NCT00209274|516873749|FG001|Overall Study|Missed visit|2|||
143363495|NCT00209274|516873748|FG000|Overall Study|Death|32|||
143363496|NCT00209274|516873749|FG001|Overall Study|Death|15|||
143363497|NCT00209274|516873748|FG000|Overall Study|Withdrawal by Subject|30|||
143363498|NCT00209274|516873749|FG001|Overall Study|Withdrawal by Subject|15|||
143363499|NCT00209274|516873748|FG000|Overall Study|Randomized not treated (RNT)|6|||
143363500|NCT00209274|516873749|FG001|Overall Study|Randomized not treated (RNT)|15|||
143363501|NCT02753530|516873750|FG000|Overall Study|Adverse Event|7|||
143363502|NCT02753530|516873751|FG001|Overall Study|Adverse Event|1|||
143363503|NCT02753530|516873750|FG000|Overall Study|Death|0|||
143363504|NCT02753530|516873751|FG001|Overall Study|Death|1|||
143363505|NCT02753530|516873750|FG000|Overall Study|Physician Decision|0|||
143363506|NCT02753530|516873751|FG001|Overall Study|Physician Decision|1|||
143363507|NCT02753530|516873750|FG000|Overall Study|Protocol Violation|1|||
143363508|NCT02753530|516873751|FG001|Overall Study|Protocol Violation|0|||
143363509|NCT02753530|516873750|FG000|Overall Study|Withdrawal by Subject|4|||
143363510|NCT02753530|516873751|FG001|Overall Study|Withdrawal by Subject|3|||
143363511|NCT03590743|516873752|FG000|Overall Study|Withdrawal by Subject|0|||
143363512|NCT03590743|516873753|FG001|Overall Study|Withdrawal by Subject|1|||
143363513|NCT02696226|516873754|FG000|Overall Study|Study terminated - lack of enrollment|1|||
143363514|NCT02696226|516873755|FG001|Overall Study|Study terminated - lack of enrollment|0|||
143363515|NCT02696226|516873756|FG002|Overall Study|Study terminated - lack of enrollment|2|||
143363516|NCT02696226|516873757|FG003|Overall Study|Study terminated - lack of enrollment|0|||
143363517|NCT02909101|516873758|FG000|Overall Study|Lost to Follow-up|1|||
143363518|NCT02909101|516873759|FG001|Overall Study|Lost to Follow-up|1|||
143477100|NCT03250832|517293205|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
143477101|NCT03250832|517293206|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
143477102|NCT03250832|517293207|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
143477103|NCT03250832|517293208|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
143477104|NCT03250832|517293209|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
143477105|NCT03250832|517293210|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
143477106|NCT03250832|517293211|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
143477107|NCT03250832|517293212|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
143477108|NCT03250832|517293213|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
143477109|NCT03250832|517293214|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
143477110|NCT03250832|517293215|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
143477111|NCT03250832|517293216|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
143477112|NCT03250832|517293205|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
143477113|NCT03250832|517293206|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
143477114|NCT03250832|517293207|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
143477115|NCT03250832|517293208|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
143477116|NCT03250832|517293209|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
143477117|NCT03250832|517293210|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
143477118|NCT03250832|517293211|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
143477119|NCT03250832|517293212|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
143477120|NCT03250832|517293213|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
143477121|NCT03250832|517293214|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
143477122|NCT03250832|517293215|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
143477123|NCT03250832|517293216|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
143477124|NCT03250832|517293205|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
143477125|NCT03250832|517293206|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
143477126|NCT03250832|517293207|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
143477127|NCT03250832|517293208|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
143477128|NCT03250832|517293209|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
143477129|NCT03250832|517293210|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
143477130|NCT03250832|517293211|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
143477131|NCT03250832|517293212|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
143477132|NCT03250832|517293213|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
143477133|NCT03250832|517293214|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
143477134|NCT03250832|517293215|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
143477135|NCT03250832|517293216|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
143477136|NCT03250832|517293205|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
143477137|NCT03250832|517293206|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
143477138|NCT03250832|517293207|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
143477139|NCT03250832|517293208|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
143477140|NCT03250832|517293209|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
143477141|NCT03250832|517293210|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
143477142|NCT03250832|517293211|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
143477143|NCT03250832|517293212|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
143477144|NCT03250832|517293213|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
143477145|NCT03250832|517293214|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
143477146|NCT03250832|517293215|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
143477147|NCT03250832|517293216|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
143477148|NCT03250832|517293205|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
143477149|NCT03250832|517293206|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
143477150|NCT03250832|517293207|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
143477151|NCT03250832|517293208|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
143477152|NCT03250832|517293209|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
143477153|NCT03250832|517293210|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
143477154|NCT03250832|517293211|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
143477155|NCT03250832|517293212|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
143477156|NCT03250832|517293213|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
143477157|NCT03250832|517293214|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
143477158|NCT03250832|517293215|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
143477159|NCT03250832|517293216|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
143477160|NCT03250832|517293205|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
143142872|NCT01649765|516070661|FG001|Overall Study|Lack of Efficacy|1|||
143142873|NCT01649765|516070660|FG000|Overall Study|Physician Decision|0|||
143142874|NCT01649765|516070661|FG001|Overall Study|Physician Decision|3|||
143142875|NCT01649765|516070660|FG000|Overall Study|Protocol Violation|1|||
143142876|NCT01649765|516070661|FG001|Overall Study|Protocol Violation|0|||
143142877|NCT01649765|516070660|FG000|Overall Study|Withdrawal by Subject|2|||
143477161|NCT03250832|517293206|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
143477162|NCT03250832|517293207|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
143477163|NCT03250832|517293208|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
143477164|NCT03250832|517293209|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
143477165|NCT03250832|517293210|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
143477166|NCT03250832|517293211|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
143477167|NCT03250832|517293212|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
143477168|NCT03250832|517293213|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
143477169|NCT03250832|517293214|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
143477170|NCT03250832|517293215|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
143477171|NCT03250832|517293216|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
143477172|NCT03250832|517293205|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
143477173|NCT03250832|517293206|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
143477174|NCT03250832|517293207|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
143477175|NCT03250832|517293208|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
143477176|NCT03250832|517293209|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
143477177|NCT03250832|517293210|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
143477178|NCT03250832|517293211|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
143477179|NCT03250832|517293212|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
143477180|NCT03250832|517293213|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
143477181|NCT03250832|517293214|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
143477182|NCT03250832|517293215|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
143477183|NCT03250832|517293216|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
143477184|NCT03250832|517293205|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
143477185|NCT03250832|517293206|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
143142878|NCT01649765|516070661|FG001|Overall Study|Withdrawal by Subject|1|||
143142879|NCT02194465|516070662|FG000|Overall Study|Adverse Event|6|||
143142880|NCT02194465|516070663|FG001|Overall Study|Adverse Event|1|||
143142881|NCT02194465|516070664|FG002|Overall Study|Adverse Event|4|||
143142882|NCT02194465|516070665|FG003|Overall Study|Adverse Event|4|||
143142883|NCT02194465|516070666|FG004|Overall Study|Adverse Event|4|||
143142884|NCT02194465|516070667|FG005|Overall Study|Adverse Event|2|||
143142885|NCT02194465|516070668|FG006|Overall Study|Adverse Event|0|||
143142886|NCT02194465|516070662|FG000|Overall Study|Lost to Follow-up|0|||
143142887|NCT02194465|516070663|FG001|Overall Study|Lost to Follow-up|0|||
143142888|NCT02194465|516070664|FG002|Overall Study|Lost to Follow-up|0|||
143142889|NCT02194465|516070665|FG003|Overall Study|Lost to Follow-up|1|||
143142890|NCT02194465|516070666|FG004|Overall Study|Lost to Follow-up|0|||
143142891|NCT02194465|516070667|FG005|Overall Study|Lost to Follow-up|1|||
143142892|NCT02194465|516070668|FG006|Overall Study|Lost to Follow-up|0|||
143142893|NCT02194465|516070662|FG000|Overall Study|Physician Decision|1|||
143142894|NCT02194465|516070663|FG001|Overall Study|Physician Decision|0|||
143142895|NCT02194465|516070664|FG002|Overall Study|Physician Decision|0|||
143142896|NCT02194465|516070665|FG003|Overall Study|Physician Decision|0|||
143142897|NCT02194465|516070666|FG004|Overall Study|Physician Decision|0|||
143142898|NCT02194465|516070667|FG005|Overall Study|Physician Decision|0|||
143142899|NCT02194465|516070668|FG006|Overall Study|Physician Decision|0|||
143142900|NCT02194465|516070662|FG000|Overall Study|Protocol Violation|1|||
143142901|NCT02194465|516070663|FG001|Overall Study|Protocol Violation|1|||
143142902|NCT02194465|516070664|FG002|Overall Study|Protocol Violation|2|||
143142903|NCT02194465|516070665|FG003|Overall Study|Protocol Violation|1|||
143142904|NCT02194465|516070666|FG004|Overall Study|Protocol Violation|1|||
143142905|NCT02194465|516070667|FG005|Overall Study|Protocol Violation|0|||
143142906|NCT02194465|516070668|FG006|Overall Study|Protocol Violation|0|||
143142907|NCT02194465|516070662|FG000|Overall Study|Withdrawal by Subject|1|||
143142908|NCT02194465|516070663|FG001|Overall Study|Withdrawal by Subject|3|||
143142909|NCT02194465|516070664|FG002|Overall Study|Withdrawal by Subject|1|||
143142910|NCT02194465|516070665|FG003|Overall Study|Withdrawal by Subject|2|||
143142911|NCT02194465|516070666|FG004|Overall Study|Withdrawal by Subject|2|||
143142912|NCT02194465|516070667|FG005|Overall Study|Withdrawal by Subject|1|||
143142913|NCT02194465|516070668|FG006|Overall Study|Withdrawal by Subject|2|||
143142914|NCT02194465|516070662|FG000|Overall Study|Discontinued follow-up period|0|||
143142915|NCT02194465|516070663|FG001|Overall Study|Discontinued follow-up period|2|||
143142916|NCT02194465|516070664|FG002|Overall Study|Discontinued follow-up period|1|||
143142917|NCT02194465|516070665|FG003|Overall Study|Discontinued follow-up period|0|||
143142918|NCT02194465|516070666|FG004|Overall Study|Discontinued follow-up period|2|||
143142919|NCT02194465|516070667|FG005|Overall Study|Discontinued follow-up period|0|||
143142920|NCT02194465|516070668|FG006|Overall Study|Discontinued follow-up period|0|||
143363519|NCT02698436|516873764|FG000|Overall Study|Adverse Event|1|||
143142921|NCT00961064|516070669|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
143363520|NCT02698436|516873765|FG001|Overall Study|Adverse Event|0|||
143142922|NCT00961064|516070669|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
143477186|NCT03250832|517293207|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
143477187|NCT03250832|517293208|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
143477188|NCT03250832|517293209|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
143477189|NCT03250832|517293210|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
143477190|NCT03250832|517293211|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
143477191|NCT03250832|517293212|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
143477192|NCT03250832|517293213|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
143477193|NCT03250832|517293214|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
143477194|NCT03250832|517293215|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
143477195|NCT03250832|517293216|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
143477196|NCT03250832|517293205|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
143477197|NCT03250832|517293206|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
143477198|NCT03250832|517293207|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
143477199|NCT03250832|517293208|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
143477200|NCT03250832|517293209|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
143477201|NCT03250832|517293210|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
143477202|NCT03250832|517293211|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
143477203|NCT03250832|517293212|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
143477204|NCT03250832|517293213|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
143477205|NCT03250832|517293214|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
143477206|NCT03250832|517293215|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
143477207|NCT03250832|517293216|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
143477208|NCT03250832|517293205|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
143477209|NCT03250832|517293206|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
143477210|NCT03250832|517293207|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
143477211|NCT03250832|517293208|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
143477212|NCT03250832|517293209|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
143477213|NCT03250832|517293210|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
143477214|NCT03250832|517293211|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
143477215|NCT03250832|517293212|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
143477216|NCT03250832|517293213|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
143477217|NCT03250832|517293214|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
143477218|NCT03250832|517293215|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
143477219|NCT03250832|517293216|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
143477220|NCT03250832|517293205|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
143477221|NCT03250832|517293206|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
143477222|NCT03250832|517293207|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
143477223|NCT03250832|517293208|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
143477224|NCT03250832|517293209|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
143477225|NCT03250832|517293210|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
143477226|NCT03250832|517293211|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
143477227|NCT03250832|517293212|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
143477228|NCT03250832|517293213|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
143477229|NCT03250832|517293214|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
143477230|NCT03250832|517293215|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
143477231|NCT03250832|517293216|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
143477232|NCT03250832|517293205|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
143477233|NCT03250832|517293206|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
143477234|NCT03250832|517293207|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
143477235|NCT03250832|517293208|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
143477236|NCT03250832|517293209|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
143477237|NCT03250832|517293210|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
143477238|NCT03250832|517293211|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
143477239|NCT03250832|517293212|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
143477240|NCT03250832|517293213|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
143477241|NCT03250832|517293214|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
143142923|NCT00961064|516070669|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
143477242|NCT03250832|517293215|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
143477243|NCT03250832|517293216|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
143142924|NCT00961064|516070669|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
143142925|NCT00961064|516070669|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
143142926|NCT00961064|516070669|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
143142927|NCT00961064|516070669|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
143142928|NCT00961064|516070669|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
143142929|NCT01408641|516070670|FG000|Overall Study|Physician Decision|1|||
143142930|NCT01408641|516070671|FG001|Overall Study|Physician Decision|0|||
143142931|NCT00715208|516070672|FG000|Overall Study|Withdrawal by Subject|1|||
143142932|NCT00715208|516070673|FG001|Overall Study|Withdrawal by Subject|1|||
143142933|NCT00715208|516070672|FG000|Overall Study|Adverse Event|0|||
143142934|NCT00715208|516070673|FG001|Overall Study|Adverse Event|6|||
143142935|NCT00715208|516070672|FG000|Overall Study|Lack of Efficacy|0|||
143142936|NCT00715208|516070673|FG001|Overall Study|Lack of Efficacy|2|||
143142937|NCT00576758|516070674|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
143142938|NCT00576758|516070675|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
143142939|NCT00576758|516070674|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
143142940|NCT00576758|516070675|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
143477244|NCT02303704|517293217|FG000|Overall Study|Protocol Violation|5|||
143477245|NCT02303704|517293218|FG001|Overall Study|Protocol Violation|9|||
143477246|NCT01034540|517293219|FG000|Overall Study|Adverse Event|0|||
143477247|NCT01034540|517293220|FG001|Overall Study|Adverse Event|1|||
143477248|NCT00430482|517293226|FG000|Completed Treatment|Insufficient Treatment|7|||
143477249|NCT00430482|517293227|FG001|Completed Treatment|Insufficient Treatment|11|||
143477250|NCT00555477|517293228|FG000|Overall Study|Adverse Event|0|||
143477251|NCT00555477|517293229|FG001|Overall Study|Adverse Event|9|||
143477252|NCT00555477|517293228|FG000|Overall Study|Withdrawal by Subject|1|||
143477253|NCT00555477|517293229|FG001|Overall Study|Withdrawal by Subject|2|||
143477254|NCT00555477|517293228|FG000|Overall Study|Physician Decision|1|||
143477255|NCT00555477|517293229|FG001|Overall Study|Physician Decision|2|||
143477256|NCT00545402|517293230|FG000|Overall Study|Discontinuation of treatment|17|||
143477257|NCT00545402|517293231|FG001|Overall Study|Discontinuation of treatment|9|||
143477258|NCT00545402|517293230|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
143477259|NCT00545402|517293231|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
143477260|NCT00545402|517293230|FG000|Overall Study|Death|5|||
143477261|NCT00545402|517293231|FG001|Overall Study|Death|7|||
143477262|NCT00545402|517293230|FG000|Overall Study|Graft loss|2|||
143477263|NCT00545402|517293231|FG001|Overall Study|Graft loss|4|||
143477264|NCT00545402|517293230|FG000|Overall Study|Withdrawal by Subject|0|||
143477265|NCT00545402|517293231|FG001|Overall Study|Withdrawal by Subject|1|||
143477266|NCT00545402|517293230|FG000|Overall Study|Protocol Violation|1|||
143477267|NCT00545402|517293231|FG001|Overall Study|Protocol Violation|0|||
143477268|NCT00545402|517293230|FG000|Overall Study|Reason not specified|1|||
143477269|NCT00545402|517293231|FG001|Overall Study|Reason not specified|1|||
143477270|NCT00397033|517293232|FG000|Overall Study|Adverse Event|7|||
143477271|NCT00397033|517293233|FG001|Overall Study|Adverse Event|10|||
143477272|NCT00397033|517293234|FG002|Overall Study|Adverse Event|4|||
143477273|NCT00397033|517293232|FG000|Overall Study|Lack of Efficacy|22|||
143477274|NCT00397033|517293233|FG001|Overall Study|Lack of Efficacy|12|||
143477275|NCT00397033|517293234|FG002|Overall Study|Lack of Efficacy|9|||
143477276|NCT00397033|517293232|FG000|Overall Study|Lost to Follow-up|3|||
143477277|NCT00397033|517293233|FG001|Overall Study|Lost to Follow-up|3|||
143477278|NCT00397033|517293234|FG002|Overall Study|Lost to Follow-up|3|||
143477279|NCT00397033|517293232|FG000|Overall Study|Withdrawal by Subject|12|||
143477280|NCT00397033|517293233|FG001|Overall Study|Withdrawal by Subject|7|||
143477281|NCT00397033|517293234|FG002|Overall Study|Withdrawal by Subject|5|||
143477282|NCT00397033|517293232|FG000|Overall Study|Other|0|||
143477283|NCT00397033|517293233|FG001|Overall Study|Other|5|||
143477284|NCT00397033|517293234|FG002|Overall Study|Other|2|||
143477285|NCT03519867|517293235|FG000|Overall Study|Adverse Event|1|||
143477286|NCT03519867|517293236|FG001|Overall Study|Adverse Event|1|||
143477287|NCT03519867|517293237|FG002|Overall Study|Adverse Event|0|||
143477288|NCT03519867|517293238|FG003|Overall Study|Adverse Event|0|||
143477289|NCT03519867|517293239|FG004|Overall Study|Adverse Event|0|||
143477290|NCT03519867|517293240|FG005|Overall Study|Adverse Event|0|||
143477291|NCT03519867|517293241|FG006|Overall Study|Adverse Event|0|||
143477292|NCT03519867|517293242|FG007|Overall Study|Adverse Event|0|||
143477293|NCT03519867|517293243|FG008|Overall Study|Adverse Event|0|||
143477294|NCT03519867|517293244|FG009|Overall Study|Adverse Event|0|||
143477295|NCT03519867|517293235|FG000|Overall Study|Protocol Violation|0|||
143477296|NCT03519867|517293236|FG001|Overall Study|Protocol Violation|0|||
143477297|NCT03519867|517293237|FG002|Overall Study|Protocol Violation|0|||
143477298|NCT03519867|517293238|FG003|Overall Study|Protocol Violation|0|||
143477299|NCT03519867|517293239|FG004|Overall Study|Protocol Violation|0|||
143142941|NCT00576758|516070674|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
143142942|NCT00576758|516070675|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
143142943|NCT00576758|516070674|FG000|Induction Treatment Period|Death|1|||
143477300|NCT03519867|517293240|FG005|Overall Study|Protocol Violation|1|||
143477301|NCT03519867|517293241|FG006|Overall Study|Protocol Violation|0|||
143477302|NCT03519867|517293242|FG007|Overall Study|Protocol Violation|0|||
143477303|NCT03519867|517293243|FG008|Overall Study|Protocol Violation|0|||
143477304|NCT03519867|517293244|FG009|Overall Study|Protocol Violation|0|||
143477305|NCT03519867|517293235|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
143477306|NCT03519867|517293236|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
143477307|NCT03519867|517293237|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
143142944|NCT00576758|516070675|FG001|Induction Treatment Period|Death|0|||
143142945|NCT00576758|516070674|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
143142946|NCT00576758|516070675|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
143477308|NCT03519867|517293238|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
143477309|NCT03519867|517293239|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
143477310|NCT03519867|517293240|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
143477311|NCT03519867|517293241|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
143477312|NCT03519867|517293242|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
143477313|NCT03519867|517293243|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
143477314|NCT03519867|517293244|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
143477315|NCT03519867|517293235|FG000|Overall Study|Admin. of other reversal agent|1|||
143477316|NCT03519867|517293236|FG001|Overall Study|Admin. of other reversal agent|1|||
143477317|NCT03519867|517293237|FG002|Overall Study|Admin. of other reversal agent|0|||
143477318|NCT03519867|517293238|FG003|Overall Study|Admin. of other reversal agent|0|||
143477319|NCT03519867|517293239|FG004|Overall Study|Admin. of other reversal agent|0|||
143477320|NCT03519867|517293240|FG005|Overall Study|Admin. of other reversal agent|1|||
143477321|NCT03519867|517293241|FG006|Overall Study|Admin. of other reversal agent|0|||
143477322|NCT03519867|517293242|FG007|Overall Study|Admin. of other reversal agent|0|||
143477323|NCT03519867|517293243|FG008|Overall Study|Admin. of other reversal agent|0|||
143477324|NCT03519867|517293244|FG009|Overall Study|Admin. of other reversal agent|0|||
143477325|NCT03519867|517293235|FG000|Overall Study|Reason not provided|1|||
143477326|NCT03519867|517293236|FG001|Overall Study|Reason not provided|1|||
143477327|NCT03519867|517293237|FG002|Overall Study|Reason not provided|1|||
143477328|NCT03519867|517293238|FG003|Overall Study|Reason not provided|1|||
143477329|NCT03519867|517293239|FG004|Overall Study|Reason not provided|0|||
143477330|NCT03519867|517293240|FG005|Overall Study|Reason not provided|1|||
143477331|NCT03519867|517293241|FG006|Overall Study|Reason not provided|0|||
143477332|NCT03519867|517293242|FG007|Overall Study|Reason not provided|1|||
143477333|NCT03519867|517293243|FG008|Overall Study|Reason not provided|1|||
143477334|NCT03519867|517293244|FG009|Overall Study|Reason not provided|0|||
143477335|NCT01721057|517293245|FG000|Treatment Period|Withdrawal by Subject|11|||
143477336|NCT01721057|517293246|FG001|Treatment Period|Withdrawal by Subject|5|||
143477337|NCT01721057|517293247|FG002|Treatment Period|Withdrawal by Subject|8|||
143477338|NCT01721057|517293248|FG003|Treatment Period|Withdrawal by Subject|0|||
143477339|NCT01721057|517293249|FG004|Treatment Period|Withdrawal by Subject|0|||
143477340|NCT01721057|517293250|FG005|Treatment Period|Withdrawal by Subject|0|||
143477341|NCT01721057|517293251|FG006|Treatment Period|Withdrawal by Subject|0|||
143477342|NCT01721057|517293245|FG000|Treatment Period|Adverse Event|7|||
143477343|NCT01721057|517293246|FG001|Treatment Period|Adverse Event|10|||
143477344|NCT01721057|517293247|FG002|Treatment Period|Adverse Event|12|||
143477345|NCT01721057|517293248|FG003|Treatment Period|Adverse Event|0|||
143477346|NCT01721057|517293249|FG004|Treatment Period|Adverse Event|0|||
143477347|NCT01721057|517293250|FG005|Treatment Period|Adverse Event|0|||
143477348|NCT01721057|517293251|FG006|Treatment Period|Adverse Event|0|||
143477349|NCT01721057|517293245|FG000|Treatment Period|Lack of Efficacy|7|||
143477350|NCT01721057|517293246|FG001|Treatment Period|Lack of Efficacy|3|||
143477351|NCT01721057|517293247|FG002|Treatment Period|Lack of Efficacy|0|||
143477352|NCT01721057|517293248|FG003|Treatment Period|Lack of Efficacy|0|||
143477353|NCT01721057|517293249|FG004|Treatment Period|Lack of Efficacy|0|||
143477354|NCT01721057|517293250|FG005|Treatment Period|Lack of Efficacy|0|||
143477355|NCT01721057|517293251|FG006|Treatment Period|Lack of Efficacy|0|||
143477356|NCT01721057|517293245|FG000|Treatment Period|Lost to Follow-up|1|||
143477357|NCT01721057|517293246|FG001|Treatment Period|Lost to Follow-up|0|||
143477358|NCT01721057|517293247|FG002|Treatment Period|Lost to Follow-up|0|||
143477359|NCT01721057|517293248|FG003|Treatment Period|Lost to Follow-up|0|||
143477360|NCT01721057|517293249|FG004|Treatment Period|Lost to Follow-up|0|||
143142947|NCT00576758|516070674|FG000|Induction Treatment Period|Withdrew consent|1|||
143142948|NCT00576758|516070675|FG001|Induction Treatment Period|Withdrew consent|0|||
143142949|NCT00576758|516070674|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
143142950|NCT00576758|516070675|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
143363521|NCT02698436|516873764|FG000|Overall Study|Withdrawal by Subject|3|||
143477361|NCT01721057|517293250|FG005|Treatment Period|Lost to Follow-up|0|||
143142951|NCT00576758|516070674|FG000|Extension Treatment Period|Death|1|||
143142952|NCT00576758|516070675|FG001|Extension Treatment Period|Death|1|||
143363522|NCT02698436|516873765|FG001|Overall Study|Withdrawal by Subject|3|||
143363523|NCT02698436|516873764|FG000|Overall Study|Lost to Follow-up|2|||
143363524|NCT02698436|516873765|FG001|Overall Study|Lost to Follow-up|4|||
143363525|NCT02698436|516873764|FG000|Overall Study|Non-compliance with study regimen|1|||
143363526|NCT02698436|516873765|FG001|Overall Study|Non-compliance with study regimen|0|||
143363527|NCT01394991|516873766|FG000|Overall Study|Adverse Event|0|||
143477362|NCT01721057|517293251|FG006|Treatment Period|Lost to Follow-up|0|||
143477363|NCT01721057|517293245|FG000|Treatment Period|Physician Decision|0|||
143477364|NCT01721057|517293246|FG001|Treatment Period|Physician Decision|1|||
143477365|NCT01721057|517293247|FG002|Treatment Period|Physician Decision|3|||
143477366|NCT01721057|517293248|FG003|Treatment Period|Physician Decision|0|||
143477367|NCT01721057|517293249|FG004|Treatment Period|Physician Decision|0|||
143477368|NCT01721057|517293250|FG005|Treatment Period|Physician Decision|0|||
143477369|NCT01721057|517293251|FG006|Treatment Period|Physician Decision|0|||
143477370|NCT01721057|517293245|FG000|Treatment Period|Death|2|||
143477371|NCT01721057|517293246|FG001|Treatment Period|Death|0|||
143477372|NCT01721057|517293247|FG002|Treatment Period|Death|0|||
143477373|NCT01721057|517293248|FG003|Treatment Period|Death|0|||
143477374|NCT01721057|517293249|FG004|Treatment Period|Death|0|||
143477375|NCT01721057|517293250|FG005|Treatment Period|Death|0|||
143477376|NCT01721057|517293251|FG006|Treatment Period|Death|0|||
143477377|NCT01721057|517293245|FG000|Rescue Period|Adverse Event|0|||
143477378|NCT01721057|517293246|FG001|Rescue Period|Adverse Event|0|||
143477379|NCT01721057|517293247|FG002|Rescue Period|Adverse Event|0|||
143477380|NCT01721057|517293248|FG003|Rescue Period|Adverse Event|1|||
143477381|NCT01721057|517293249|FG004|Rescue Period|Adverse Event|0|||
143477382|NCT01721057|517293250|FG005|Rescue Period|Adverse Event|0|||
143477383|NCT01721057|517293251|FG006|Rescue Period|Adverse Event|0|||
143477384|NCT01721057|517293245|FG000|Rescue Period|Lack of Efficacy|0|||
143477385|NCT01721057|517293246|FG001|Rescue Period|Lack of Efficacy|0|||
143477386|NCT01721057|517293247|FG002|Rescue Period|Lack of Efficacy|0|||
143477387|NCT01721057|517293248|FG003|Rescue Period|Lack of Efficacy|2|||
143477388|NCT01721057|517293249|FG004|Rescue Period|Lack of Efficacy|0|||
143477389|NCT01721057|517293250|FG005|Rescue Period|Lack of Efficacy|0|||
143477390|NCT01721057|517293251|FG006|Rescue Period|Lack of Efficacy|0|||
143477391|NCT01202279|517293254|FG000|Overall Study|Adverse Event|8|||
143477392|NCT01202279|517293255|FG001|Overall Study|Adverse Event|6|||
143477393|NCT01202279|517293254|FG000|Overall Study|Withdrawal by Subject|13|||
143477394|NCT01202279|517293255|FG001|Overall Study|Withdrawal by Subject|10|||
143477395|NCT01202279|517293254|FG000|Overall Study|Physician Decision|0|||
143477396|NCT01202279|517293255|FG001|Overall Study|Physician Decision|1|||
143477397|NCT01202279|517293254|FG000|Overall Study|Lost to Follow-up|10|||
143477398|NCT01202279|517293255|FG001|Overall Study|Lost to Follow-up|7|||
143142953|NCT00576758|516070674|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
143477399|NCT01202279|517293254|FG000|Overall Study|Protocol Violation|1|||
143477400|NCT01202279|517293255|FG001|Overall Study|Protocol Violation|1|||
143477401|NCT01202279|517293254|FG000|Overall Study|study compliance|5|||
143477402|NCT01202279|517293255|FG001|Overall Study|study compliance|2|||
143477403|NCT03805750|517293256|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
143477404|NCT03805750|517293257|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
143477405|NCT01984164|517293258|FG000|Overall Study|Withdrawal by Subject|4|||
143477406|NCT01984164|517293259|FG001|Overall Study|Withdrawal by Subject|3|||
143477407|NCT01984164|517293258|FG000|Overall Study|Adverse Event|5|||
143477408|NCT01984164|517293259|FG001|Overall Study|Adverse Event|19|||
143477409|NCT01984164|517293258|FG000|Overall Study|Lost to Follow-up|1|||
143477410|NCT01984164|517293259|FG001|Overall Study|Lost to Follow-up|3|||
143477411|NCT02811549|517293260|FG000|Overall Study|Lost to Follow-up|1|||
143477412|NCT02811549|517293260|FG000|Overall Study|Withdrawal by Subject|3|||
143477413|NCT02811549|517293260|FG000|Overall Study|Subject screen failed|4|||
143477414|NCT02811549|517293260|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
143477415|NCT03472924|517293261|FG000|Overall Study|Adverse Event|1|||
143477416|NCT03472924|517293262|FG001|Overall Study|Adverse Event|0|||
143477417|NCT02546765|517293266|FG000|Overall Study|Withdrawal by Subject|0|||
143477418|NCT02546765|517293267|FG001|Overall Study|Withdrawal by Subject|1|||
143477419|NCT02546765|517293268|FG002|Overall Study|Withdrawal by Subject|0|||
143477420|NCT02546765|517293269|FG003|Overall Study|Withdrawal by Subject|0|||
143477421|NCT00475722|517293270|FG000|Overall Study|Withdrawal by Subject|12|||
143477422|NCT00475722|517293271|FG001|Overall Study|Withdrawal by Subject|12|||
143477423|NCT00475722|517293270|FG000|Overall Study|Protocol Violation|3|||
143477424|NCT00475722|517293271|FG001|Overall Study|Protocol Violation|0|||
143477425|NCT00916279|517293272|FG000|Overall Study|Death|2|||
143477426|NCT00916279|517293272|FG000|Overall Study|Lost to Follow-up|2|||
143477427|NCT02064920|517293273|FG000|Overall Study|Adverse Event|0|||
143142954|NCT00576758|516070675|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
143142955|NCT00576758|516070674|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
143142956|NCT00576758|516070675|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
143477428|NCT02064920|517293274|FG001|Overall Study|Adverse Event|4|||
143477429|NCT02064920|517293273|FG000|Overall Study|Physician Decision|0|||
143477430|NCT02064920|517293274|FG001|Overall Study|Physician Decision|1|||
143477431|NCT02064920|517293273|FG000|Overall Study|Technical Problems|0|||
143477432|NCT02064920|517293274|FG001|Overall Study|Technical Problems|1|||
143477433|NCT02064920|517293273|FG000|Overall Study|Withdrawal by Subject|1|||
143477434|NCT02064920|517293274|FG001|Overall Study|Withdrawal by Subject|3|||
143477435|NCT02109562|517293275|FG000|Overall Study|Insufficient clinical response|2|||
143477436|NCT02109562|517293276|FG001|Overall Study|Insufficient clinical response|0|||
143477437|NCT02109562|517293277|FG002|Overall Study|Insufficient clinical response|4|||
143477438|NCT02109562|517293275|FG000|Overall Study|Adverse Event|0|||
143477439|NCT02109562|517293276|FG001|Overall Study|Adverse Event|2|||
143477440|NCT02109562|517293277|FG002|Overall Study|Adverse Event|3|||
143477441|NCT02109562|517293275|FG000|Overall Study|Lost to Follow-up|1|||
143477442|NCT02109562|517293276|FG001|Overall Study|Lost to Follow-up|0|||
143477443|NCT02109562|517293277|FG002|Overall Study|Lost to Follow-up|1|||
143477444|NCT02109562|517293275|FG000|Overall Study|Protocol Violation|0|||
143477445|NCT02109562|517293276|FG001|Overall Study|Protocol Violation|3|||
143477446|NCT02109562|517293277|FG002|Overall Study|Protocol Violation|1|||
143477447|NCT02109562|517293275|FG000|Overall Study|Withdrawal by Subject|20|||
143477448|NCT02109562|517293276|FG001|Overall Study|Withdrawal by Subject|25|||
143477449|NCT02109562|517293277|FG002|Overall Study|Withdrawal by Subject|21|||
143477450|NCT02109562|517293275|FG000|Overall Study|Physician Decision|3|||
143477451|NCT02109562|517293276|FG001|Overall Study|Physician Decision|4|||
143477452|NCT02109562|517293277|FG002|Overall Study|Physician Decision|5|||
143477453|NCT00310804|517293278|FG000|Overall Study|Lost to Follow-up|2|||
143477454|NCT00310804|517293279|FG001|Overall Study|Lost to Follow-up|0|||
143477455|NCT00310804|517293278|FG000|Overall Study|Withdrawal by Subject|3|||
143477456|NCT00310804|517293279|FG001|Overall Study|Withdrawal by Subject|0|||
143477457|NCT00688155|517293284|FG000|Overall Study|Withdrawal by Subject|2|||
143477458|NCT00688155|517293285|FG001|Overall Study|Withdrawal by Subject|2|||
143477459|NCT00688155|517293286|FG002|Overall Study|Withdrawal by Subject|1|||
143477460|NCT00688155|517293287|FG003|Overall Study|Withdrawal by Subject|1|||
143477461|NCT01889238|517293291|FG000|Overall Study|Death|1|||
143477462|NCT01889238|517293291|FG000|Overall Study|Withdrawal by Subject|1|||
143477463|NCT01889238|517293291|FG000|Overall Study|Adverse Event|6|||
143477464|NCT01889238|517293291|FG000|Overall Study|Disease Progression|104|||
143477465|NCT01889238|517293291|FG000|Overall Study|Other|6|||
143477466|NCT04136184|517293292|FG000|Overall Study|Lost to Follow-up|0|||
143477467|NCT04136184|517293293|FG001|Overall Study|Lost to Follow-up|3|||
143477468|NCT04136184|517293292|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
143477469|NCT04136184|517293293|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
143477470|NCT03318978|517293297|FG000|Overall Study|Withdrawal by Subject|1|||
143477471|NCT02844816|517293298|FG000|Overall Study|No protocol treatment received|5|||
143477472|NCT02844816|517293299|FG001|Overall Study|No protocol treatment received|1|||
143477473|NCT02844816|517293298|FG000|Overall Study|Ineligible|22|||
143477474|NCT02844816|517293299|FG001|Overall Study|Ineligible|15|||
143477475|NCT02844816|517293298|FG000|Overall Study|Participant refusal|5|||
143477476|NCT02844816|517293299|FG001|Overall Study|Participant refusal|5|||
143477477|NCT02844816|517293298|FG000|Overall Study|Adverse Event|5|||
143477478|NCT02844816|517293299|FG001|Overall Study|Adverse Event|4|||
143477479|NCT02844816|517293298|FG000|Overall Study|Death|0|||
143477480|NCT02844816|517293299|FG001|Overall Study|Death|1|||
143477481|NCT02844816|517293298|FG000|Overall Study|Disease progression/recurrence|50|||
143477482|NCT02844816|517293299|FG001|Overall Study|Disease progression/recurrence|24|||
143477483|NCT02844816|517293298|FG000|Overall Study|Physician Decision|1|||
143477484|NCT02844816|517293299|FG001|Overall Study|Physician Decision|1|||
143477485|NCT01200238|517293303|FG000|Overall Study|Adverse Event|2|||
143477486|NCT01200238|517293304|FG001|Overall Study|Adverse Event|1|||
143477487|NCT01200238|517293303|FG000|Overall Study|Progressive Disease|5|||
143477488|NCT01200238|517293304|FG001|Overall Study|Progressive Disease|8|||
143477489|NCT01200238|517293303|FG000|Overall Study|Withdrawal by Subject|0|||
143477490|NCT01200238|517293304|FG001|Overall Study|Withdrawal by Subject|1|||
143477491|NCT02717754|517293305|FG000|Overall Study|Incorrect Infusion Duration|0|||
143477492|NCT02717754|517293306|FG001|Overall Study|Incorrect Infusion Duration|0|||
143477493|NCT02717754|517293307|FG002|Overall Study|Incorrect Infusion Duration|0|||
143477494|NCT02717754|517293308|FG003|Overall Study|Incorrect Infusion Duration|10|||
143477495|NCT02717754|517293309|FG004|Overall Study|Incorrect Infusion Duration|20|||
143477496|NCT02717754|517293310|FG005|Overall Study|Incorrect Infusion Duration|20|||
143477497|NCT00482703|517293311|FG000|Overall Study|Poor compliance|1|||
143477498|NCT00482703|517293312|FG001|Overall Study|Poor compliance|0|||
143477499|NCT00667823|517293314|FG000|Overall Study|Lost to Follow-up|5|||
143477500|NCT00667823|517293314|FG000|Overall Study|Adverse Event|7|||
143477501|NCT00667823|517293314|FG000|Overall Study|Death|182|||
143477502|NCT00667823|517293314|FG000|Overall Study|Withdrawal by Subject|12|||
143477503|NCT00667823|517293314|FG000|Overall Study|Other|8|||
143477504|NCT00667823|517293314|FG000|Overall Study|Missing (completion page missing)|2|||
143477505|NCT02592018|517293315|FG000|Overall Study|Adverse Event|1|||
143477506|NCT02592018|517293315|FG000|Overall Study|Lost to Follow-up|1|||
143477507|NCT01717287|517294535|FG000|Overall Study|Lost to Follow-up|0|||
143477508|NCT01717287|517294536|FG001|Overall Study|Lost to Follow-up|2|||
143477509|NCT01717287|517294535|FG000|Overall Study|Protocol Violation|0|||
143477510|NCT01717287|517294536|FG001|Overall Study|Protocol Violation|1|||
143477511|NCT00938717|517294537|FG000|Overall Study|Adverse Event|10|||
143477512|NCT00938717|517294538|FG001|Overall Study|Adverse Event|41|||
143477513|NCT00938717|517294537|FG000|Overall Study|Protocol Violation|11|||
143477514|NCT00938717|517294538|FG001|Overall Study|Protocol Violation|8|||
143477515|NCT00938717|517294537|FG000|Overall Study|Withdrawal by Subject|26|||
143477516|NCT00938717|517294538|FG001|Overall Study|Withdrawal by Subject|24|||
143477517|NCT00938717|517294537|FG000|Overall Study|Lost to Follow-up|13|||
143477518|NCT00938717|517294538|FG001|Overall Study|Lost to Follow-up|18|||
143142957|NCT00576758|516070674|FG000|Extension Treatment Period|Administrative/Other|3|||
143142958|NCT00576758|516070675|FG001|Extension Treatment Period|Administrative/Other|1|||
143142959|NCT00576758|516070674|FG000|Follow-up Period|Administrative/Other|6|||
143142960|NCT00576758|516070675|FG001|Follow-up Period|Administrative/Other|8|||
143142961|NCT00576758|516070674|FG000|Follow-up Period|Death|3|||
143142962|NCT00576758|516070675|FG001|Follow-up Period|Death|3|||
143142963|NCT00576758|516070674|FG000|Follow-up Period|Insufficient therapeutic response|16|||
143142964|NCT00576758|516070675|FG001|Follow-up Period|Insufficient therapeutic response|5|||
143142965|NCT00576758|516070674|FG000|Follow-up Period|Withdrew consent|2|||
143142966|NCT00576758|516070675|FG001|Follow-up Period|Withdrew consent|1|||
143477519|NCT00938717|517294537|FG000|Overall Study|Lack of Efficacy|33|||
143477520|NCT00938717|517294538|FG001|Overall Study|Lack of Efficacy|15|||
143477521|NCT00938717|517294537|FG000|Overall Study|Other reason|5|||
143477522|NCT00938717|517294538|FG001|Overall Study|Other reason|2|||
143477523|NCT00388505|517294541|FG000|Overall Study|Adverse Event or Death|43|||
143477524|NCT00388505|517294542|FG001|Overall Study|Adverse Event or Death|17|||
143477525|NCT00388505|517294541|FG000|Overall Study|Withdrawal by Subject|24|||
143477526|NCT00388505|517294542|FG001|Overall Study|Withdrawal by Subject|9|||
143477527|NCT00388505|517294541|FG000|Overall Study|Lost to Follow-up|5|||
143477528|NCT00388505|517294542|FG001|Overall Study|Lost to Follow-up|3|||
143477529|NCT00388505|517294541|FG000|Overall Study|Inappropriate Enrollment|0|||
143477530|NCT00388505|517294542|FG001|Overall Study|Inappropriate Enrollment|1|||
143477531|NCT00388505|517294541|FG000|Overall Study|Administrative Reason|1|||
143477532|NCT00388505|517294542|FG001|Overall Study|Administrative Reason|0|||
143477533|NCT00388505|517294541|FG000|Overall Study|Protocol Violation|6|||
143477534|NCT00388505|517294542|FG001|Overall Study|Protocol Violation|5|||
143477535|NCT00388505|517294541|FG000|Overall Study|Unable to classify|4|||
143477536|NCT00388505|517294542|FG001|Overall Study|Unable to classify|3|||
143477537|NCT05092919|517294543|FG000|Overall Study|Lost to Follow-up|7|||
143477538|NCT05092919|517294543|FG000|Overall Study|Withdrawal by Subject|2|||
143477539|NCT01942148|517294545|FG000|Overall Study|Adverse Event|4|||
143477540|NCT01942148|517294545|FG000|Overall Study|Lack of Efficacy|2|||
143477541|NCT01942148|517294545|FG000|Overall Study|Physician Decision|11|||
143477542|NCT01942148|517294545|FG000|Overall Study|Protocol Violation|1|||
143477543|NCT01942148|517294545|FG000|Overall Study|Withdrawal by Subject|8|||
143477544|NCT01942148|517294545|FG000|Overall Study|Use of the prohibition medicine|1|||
143477545|NCT02248259|517294546|FG000|Treatment Period 1|Adverse Event|0|||
143477546|NCT02248259|517294547|FG001|Treatment Period 1|Adverse Event|0|||
143477547|NCT02248259|517294548|FG002|Treatment Period 1|Adverse Event|1|||
143477548|NCT02248259|517294549|FG003|Treatment Period 1|Adverse Event|0|||
143477549|NCT02369848|517294552|FG000|Overall Study|Death|1|||
143477550|NCT02369848|517294552|FG000|Overall Study|Withdrawal by Subject|2|||
143477551|NCT02369848|517294552|FG000|Overall Study|Lost to Follow-up|1|||
143477552|NCT00096785|517294556|FG000|Overall Study|Lost to Follow-up|1|||
143477553|NCT00096785|517294557|FG001|Overall Study|Lost to Follow-up|0|||
143477554|NCT00096785|517294556|FG000|Overall Study|Withdrawal by Subject|0|||
143477555|NCT00096785|517294557|FG001|Overall Study|Withdrawal by Subject|1|||
143477556|NCT00096785|517294556|FG000|Overall Study|Relocated|1|||
143477557|NCT00096785|517294557|FG001|Overall Study|Relocated|0|||
143477558|NCT00257725|517294558|FG000|Overall Study|Adverse Event|3|||
143477559|NCT02573870|517294559|FG000|Overall Study|Adverse Event|0|||
143477560|NCT02573870|517294560|FG001|Overall Study|Adverse Event|2|||
143477561|NCT02573870|517294559|FG000|Overall Study|Lack of Efficacy|0|||
143477562|NCT02573870|517294560|FG001|Overall Study|Lack of Efficacy|1|||
143477563|NCT02573870|517294559|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
143477564|NCT02573870|517294560|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
143477565|NCT02573870|517294559|FG000|Overall Study|Lost to Follow-up|0|||
143477566|NCT02573870|517294560|FG001|Overall Study|Lost to Follow-up|1|||
143477567|NCT02573870|517294559|FG000|Overall Study|Other: Fail to Meet Visit|0|||
143477568|NCT02573870|517294560|FG001|Overall Study|Other: Fail to Meet Visit|2|||
143477569|NCT01858532|517294561|FG000|Overall Study|Adverse Event|58|||
143477570|NCT01858532|517294562|FG001|Overall Study|Adverse Event|50|||
143477571|NCT01858532|517294563|FG002|Overall Study|Adverse Event|23|||
143477572|NCT01858532|517294564|FG003|Overall Study|Adverse Event|28|||
143477573|NCT01858532|517294561|FG000|Overall Study|Withdrew consent|71|||
143477574|NCT01858532|517294562|FG001|Overall Study|Withdrew consent|93|||
143477575|NCT01858532|517294563|FG002|Overall Study|Withdrew consent|46|||
143477576|NCT01858532|517294564|FG003|Overall Study|Withdrew consent|27|||
143477577|NCT01858532|517294561|FG000|Overall Study|Lost to Follow-up|17|||
143477578|NCT01858532|517294562|FG001|Overall Study|Lost to Follow-up|26|||
143477579|NCT01858532|517294563|FG002|Overall Study|Lost to Follow-up|11|||
143477580|NCT01858532|517294564|FG003|Overall Study|Lost to Follow-up|14|||
143477581|NCT01858532|517294561|FG000|Overall Study|Deterioration of medical status|3|||
143477582|NCT01858532|517294562|FG001|Overall Study|Deterioration of medical status|4|||
143477583|NCT01858532|517294563|FG002|Overall Study|Deterioration of medical status|3|||
143014089|NCT01414062|515591609|FG001|Overall Study|Family Disapproval|0|||
143477584|NCT01858532|517294564|FG003|Overall Study|Deterioration of medical status|7|||
143477585|NCT01858532|517294561|FG000|Overall Study|Investigator request|3|||
143477586|NCT01858532|517294562|FG001|Overall Study|Investigator request|4|||
143477587|NCT01858532|517294563|FG002|Overall Study|Investigator request|2|||
143477588|NCT01858532|517294564|FG003|Overall Study|Investigator request|6|||
143142967|NCT01316614|516070676|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
143142968|NCT01316614|516070676|FG000|Overall Study|Cytology slides not available for review|4|||
143142969|NCT01316614|516070676|FG000|Overall Study|Cystic lesion|5|||
143142970|NCT01316614|516070676|FG000|Overall Study|Inadequate number of passes|2|||
143477589|NCT01858532|517294561|FG000|Overall Study|Other, not specified|29|||
143477590|NCT01858532|517294562|FG001|Overall Study|Other, not specified|15|||
143477591|NCT01858532|517294563|FG002|Overall Study|Other, not specified|13|||
143477592|NCT01858532|517294564|FG003|Overall Study|Other, not specified|11|||
143142971|NCT01316614|516070676|FG000|Overall Study|Medically unstable|1|||
143142972|NCT03427411|516070677|FG000|Overall Study|Screen failure - platelets too low|0|||
143142973|NCT03427411|516070678|FG001|Overall Study|Screen failure - platelets too low|1|||
143142974|NCT03738696|516070679|FG000|Overall Study|Withdrawal by Subject|0|||
143142975|NCT03738696|516070680|FG001|Overall Study|Withdrawal by Subject|1|||
143142976|NCT03738696|516070679|FG000|Overall Study|Lost to Follow-up|8|||
143142977|NCT03738696|516070680|FG001|Overall Study|Lost to Follow-up|14|||
143142978|NCT01715298|516070686|FG000|Overall Study|Lost to Follow-up|0|||
143142979|NCT01715298|516070687|FG001|Overall Study|Lost to Follow-up|2|||
143142980|NCT01715298|516070686|FG000|Overall Study|Patient/guardian decision|7|||
143142981|NCT01715298|516070687|FG001|Overall Study|Patient/guardian decision|9|||
143142982|NCT02058095|516070690|FG000|Overall Study|Adverse Event|1|||
143142983|NCT02058095|516070691|FG001|Overall Study|Adverse Event|0|||
143142984|NCT01499511|516070692|FG000|Overall Study|Death|1|||
143142985|NCT01499511|516070693|FG001|Overall Study|Death|0|||
143142986|NCT00726453|516070695|FG000|Primary Enrollment Group|Death|18|||
143142987|NCT00726453|516070696|FG001|Primary Enrollment Group|Death|0|||
143142988|NCT00726453|516070695|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
143142989|NCT00726453|516070696|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
143142990|NCT00726453|516070695|FG000|38 mm Length Group|Death|0|||
143142991|NCT00726453|516070696|FG001|38 mm Length Group|Death|3|||
143142992|NCT02690727|516070698|FG000|Overall Study|Adverse Event|2|||
143142993|NCT02690727|516070699|FG001|Overall Study|Adverse Event|2|||
143142994|NCT02842866|516070702|FG000|Overall Study|Serious Adverse Event|0|||
143142995|NCT02842866|516070703|FG001|Overall Study|Serious Adverse Event|1|||
143142996|NCT02842866|516070702|FG000|Overall Study|Protocol Violation|4|||
143142997|NCT02842866|516070703|FG001|Overall Study|Protocol Violation|2|||
143142998|NCT02842866|516070702|FG000|Overall Study|Lost to Follow-up|2|||
143142999|NCT02842866|516070703|FG001|Overall Study|Lost to Follow-up|0|||
143143000|NCT02842866|516070702|FG000|Overall Study|Withdrawal by Subject|1|||
143143001|NCT02842866|516070703|FG001|Overall Study|Withdrawal by Subject|0|||
143143002|NCT00676143|516070706|FG000|Overall Study|Adverse Event|34|||
143143003|NCT00676143|516070707|FG001|Overall Study|Adverse Event|60|||
143143004|NCT00676143|516070706|FG000|Overall Study|Death|4|||
143143005|NCT00676143|516070707|FG001|Overall Study|Death|4|||
143143006|NCT00676143|516070706|FG000|Overall Study|Lack of Efficacy|0|||
143143007|NCT00676143|516070707|FG001|Overall Study|Lack of Efficacy|6|||
143143008|NCT00676143|516070706|FG000|Overall Study|Lost to Follow-up|0|||
143143009|NCT00676143|516070707|FG001|Overall Study|Lost to Follow-up|13|||
143143010|NCT00676143|516070706|FG000|Overall Study|Physician Decision|5|||
143143011|NCT00676143|516070707|FG001|Overall Study|Physician Decision|8|||
143143012|NCT00676143|516070706|FG000|Overall Study|Protocol Violation|4|||
143143013|NCT00676143|516070707|FG001|Overall Study|Protocol Violation|8|||
143143014|NCT00676143|516070706|FG000|Overall Study|Withdrawal by Subject|24|||
143143015|NCT00676143|516070707|FG001|Overall Study|Withdrawal by Subject|42|||
143143016|NCT00676143|516070706|FG000|Overall Study|Discontinuation of study by sponsor|65|||
143143017|NCT00676143|516070707|FG001|Overall Study|Discontinuation of study by sponsor|88|||
143143018|NCT00676143|516070706|FG000|Overall Study|Failed to return|2|||
143143019|NCT00676143|516070707|FG001|Overall Study|Failed to return|1|||
143477593|NCT00514514|517294565|FG000|Pre-phase|Death|10|||
143477594|NCT00514514|517294566|FG001|Pre-phase|Death|0|||
143143020|NCT00676143|516070706|FG000|Overall Study|Loss of caregiver|5|||
143143021|NCT00676143|516070707|FG001|Overall Study|Loss of caregiver|3|||
143143022|NCT00676143|516070706|FG000|Overall Study|Other|11|||
143143023|NCT00676143|516070707|FG001|Overall Study|Other|20|||
143477595|NCT00514514|517294567|FG002|Pre-phase|Death|0|||
143477596|NCT00514514|517294565|FG000|Pre-phase|administrative problems|2|||
143477597|NCT00514514|517294566|FG001|Pre-phase|administrative problems|0|||
143143024|NCT00676143|516070706|FG000|Overall Study|Participant participation unknown|1|||
143143025|NCT00676143|516070707|FG001|Overall Study|Participant participation unknown|4|||
143143026|NCT00676143|516070706|FG000|Overall Study|Vasogenic edema recurrence|1|||
143143027|NCT00676143|516070707|FG001|Overall Study|Vasogenic edema recurrence|3|||
143143028|NCT03937778|516070708|FG000|Overall Study|Withdrawal by Subject|1|||
143477598|NCT00514514|517294567|FG002|Pre-phase|administrative problems|0|||
143477599|NCT00514514|517294565|FG000|Pre-phase|Protocol Violation|6|||
143143029|NCT03937778|516070708|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
143143030|NCT04810962|516070711|FG000|Overall Study|Adverse Event|0|||
143143031|NCT04810962|516070712|FG001|Overall Study|Adverse Event|1|||
143143032|NCT04810962|516070711|FG000|Overall Study|Lost to Follow-up|2|||
143143033|NCT04810962|516070712|FG001|Overall Study|Lost to Follow-up|1|||
143143034|NCT04810962|516070711|FG000|Overall Study|Physician Decision|1|||
143143035|NCT04810962|516070712|FG001|Overall Study|Physician Decision|0|||
143143036|NCT04810962|516070711|FG000|Overall Study|Withdrawal by Subject|1|||
143143037|NCT04810962|516070712|FG001|Overall Study|Withdrawal by Subject|3|||
143143038|NCT04810962|516070711|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
143143039|NCT04810962|516070712|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
143143040|NCT02412657|516070718|FG000|Overall Study|Lost to Follow-up|1|||
143143041|NCT02412657|516070719|FG001|Overall Study|Lost to Follow-up|0|||
143143042|NCT02412657|516070720|FG002|Overall Study|Lost to Follow-up|0|||
143143043|NCT02412657|516070718|FG000|Overall Study|Protocol Violation|0|||
143143044|NCT02412657|516070719|FG001|Overall Study|Protocol Violation|2|||
143143045|NCT02412657|516070720|FG002|Overall Study|Protocol Violation|3|||
143143046|NCT03426878|516070724|FG000|Overall Study|Did not return saliva sample to laboratory|126|||
143143047|NCT03426878|516070724|FG000|Overall Study|DNA extraction and sequencing was not successful|14|||
143143048|NCT03426878|516070724|FG000|Overall Study|Declined to receive results|3|||
143143049|NCT03426878|516070724|FG000|Overall Study|Received negative results by mailed letter|65|||
143143050|NCT03426878|516070724|FG000|Overall Study|Lost to Follow-up|177|||
143143051|NCT02855268|516070725|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
143143052|NCT02855268|516070726|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
143143053|NCT02855268|516070725|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
143143054|NCT02855268|516070726|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
143143055|NCT02855268|516070725|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
143143056|NCT02855268|516070726|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
143143057|NCT02855268|516070725|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
143143058|NCT02855268|516070726|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
143143059|NCT02855268|516070725|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
143143060|NCT02855268|516070726|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
143143061|NCT02855268|516070725|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
143143062|NCT02855268|516070726|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
143143063|NCT05233761|516070729|FG000|Treatment Period A|Withdrawal by Subject|12|||
143143064|NCT05233761|516070730|FG001|Treatment Period A|Withdrawal by Subject|10|||
143143065|NCT05233761|516070729|FG000|Treatment Period A|Lost to Follow-up|6|||
143143066|NCT05233761|516070730|FG001|Treatment Period A|Lost to Follow-up|12|||
143143067|NCT05233761|516070729|FG000|Treatment Period A|Protocol Violation|8|||
143143068|NCT05233761|516070730|FG001|Treatment Period A|Protocol Violation|15|||
143143069|NCT00869960|516070731|FG000|Overall Study|Lost to Follow-up|2|||
143143070|NCT01394276|516070737|FG000|Overall Study|Related Adverse event (AEs)|15|||
143143071|NCT01394276|516070737|FG000|Overall Study|Not related AEs|9|||
143143072|NCT01394276|516070737|FG000|Overall Study|Remission of disease|2|||
143143073|NCT01394276|516070737|FG000|Overall Study|Insufficient therapeutic effect|17|||
143143074|NCT01394276|516070737|FG000|Overall Study|Insufficient compliance|9|||
143143075|NCT01394276|516070737|FG000|Overall Study|Lost to Follow-up|5|||
143143076|NCT01394276|516070737|FG000|Overall Study|Participant moved to another site|1|||
143143077|NCT01394276|516070737|FG000|Overall Study|Pregnancy|1|||
143143078|NCT01394276|516070737|FG000|Overall Study|unavailability of drug at the Hospital|2|||
143143079|NCT01394276|516070737|FG000|Overall Study|Symptoms of concurrent diseases|1|||
143143080|NCT00560404|516070739|FG000|Overall Study|Adverse Event|2|||
143143081|NCT00560404|516070740|FG001|Overall Study|Adverse Event|3|||
143143082|NCT00560404|516070739|FG000|Overall Study|Death|3|||
143143083|NCT00560404|516070740|FG001|Overall Study|Death|3|||
143143084|NCT00560404|516070739|FG000|Overall Study|Protocol Violation|12|||
143143085|NCT00560404|516070740|FG001|Overall Study|Protocol Violation|7|||
143143086|NCT00560404|516070739|FG000|Overall Study|Administrative Reasons|1|||
143143087|NCT00560404|516070740|FG001|Overall Study|Administrative Reasons|1|||
143143088|NCT00560404|516070739|FG000|Overall Study|Withdrew Consent|4|||
143143089|NCT00560404|516070740|FG001|Overall Study|Withdrew Consent|0|||
143143090|NCT00560404|516070739|FG000|Overall Study|Failure to return|1|||
143143091|NCT00560404|516070740|FG001|Overall Study|Failure to return|2|||
143143092|NCT00560404|516070739|FG000|Overall Study|Other withdrawal reason|13|||
143143093|NCT00560404|516070740|FG001|Overall Study|Other withdrawal reason|5|||
143143094|NCT01316575|516070741|FG000|Overall Study|Withdrawal by Subject|2|||
143143095|NCT01316575|516070742|FG001|Overall Study|Withdrawal by Subject|0|||
143143096|NCT01316575|516070741|FG000|Overall Study|Required alternate treatment|0|||
143143097|NCT01316575|516070742|FG001|Overall Study|Required alternate treatment|1|||
143143098|NCT02814526|516070743|FG000|Overall Study|Adverse Event|4|||
143143099|NCT02814526|516070744|FG001|Overall Study|Adverse Event|3|||
143143100|NCT02814526|516070743|FG000|Overall Study|Death|1|||
143143101|NCT02814526|516070744|FG001|Overall Study|Death|1|||
143143102|NCT02814526|516070743|FG000|Overall Study|Lost to Follow-up|3|||
143143103|NCT02814526|516070744|FG001|Overall Study|Lost to Follow-up|4|||
143143104|NCT02814526|516070743|FG000|Overall Study|non site physician decision|1|||
143363528|NCT01394991|516873767|FG001|Overall Study|Adverse Event|4|||
143477600|NCT00514514|517294566|FG001|Pre-phase|Protocol Violation|0|||
143477601|NCT00514514|517294567|FG002|Pre-phase|Protocol Violation|0|||
143477602|NCT00514514|517294565|FG000|Pre-phase|condition no longer requires study drug|7|||
143477603|NCT00514514|517294566|FG001|Pre-phase|condition no longer requires study drug|0|||
143477604|NCT00514514|517294567|FG002|Pre-phase|condition no longer requires study drug|0|||
143477605|NCT00514514|517294565|FG000|Pre-phase|abnormal test procedure results|15|||
143477606|NCT00514514|517294566|FG001|Pre-phase|abnormal test procedure results|0|||
143477607|NCT00514514|517294567|FG002|Pre-phase|abnormal test procedure results|0|||
143477608|NCT00514514|517294565|FG000|Pre-phase|Lost to Follow-up|2|||
143477609|NCT00514514|517294566|FG001|Pre-phase|Lost to Follow-up|0|||
143477610|NCT00514514|517294567|FG002|Pre-phase|Lost to Follow-up|0|||
143477611|NCT00514514|517294565|FG000|Pre-phase|abnormal lab values|23|||
143477612|NCT00514514|517294566|FG001|Pre-phase|abnormal lab values|0|||
143477613|NCT00514514|517294567|FG002|Pre-phase|abnormal lab values|0|||
143477614|NCT00514514|517294565|FG000|Pre-phase|Lack of Efficacy|35|||
143477615|NCT00514514|517294566|FG001|Pre-phase|Lack of Efficacy|0|||
143143105|NCT02814526|516070744|FG001|Overall Study|non site physician decision|0|||
143143106|NCT02814526|516070743|FG000|Overall Study|participant noncompliance|1|||
143143107|NCT02814526|516070744|FG001|Overall Study|participant noncompliance|1|||
143143108|NCT02814526|516070743|FG000|Overall Study|Withdrawal by Subject|20|||
143143109|NCT02814526|516070744|FG001|Overall Study|Withdrawal by Subject|14|||
143143110|NCT02814526|516070743|FG000|Overall Study|safety risk|2|||
143143111|NCT02814526|516070744|FG001|Overall Study|safety risk|1|||
143143112|NCT02814526|516070743|FG000|Overall Study|early termination-study terminated|1|||
143143113|NCT02814526|516070744|FG001|Overall Study|early termination-study terminated|2|||
143143114|NCT02814526|516070743|FG000|Overall Study|Other|0|||
143143115|NCT02814526|516070744|FG001|Overall Study|Other|4|||
143143116|NCT03573297|516070745|FG000|Open Label Treatment Period|Adverse Event|67|||
143143117|NCT03573297|516070746|FG001|Open Label Treatment Period|Adverse Event|0|||
143143118|NCT03573297|516070747|FG002|Open Label Treatment Period|Adverse Event|0|||
143143119|NCT03573297|516070748|FG003|Open Label Treatment Period|Adverse Event|0|||
143143120|NCT03573297|516070745|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
143143121|NCT03573297|516070746|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
143143122|NCT03573297|516070747|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
143143123|NCT03573297|516070748|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
143143124|NCT03573297|516070745|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
143143125|NCT03573297|516070746|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
143143126|NCT03573297|516070747|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
143143127|NCT03573297|516070748|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
143143128|NCT03573297|516070745|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
143143129|NCT03573297|516070746|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
143143130|NCT03573297|516070747|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
143143131|NCT03573297|516070748|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
143143132|NCT03573297|516070745|FG000|Open Label Treatment Period|Pregnancy|1|||
143143133|NCT03573297|516070746|FG001|Open Label Treatment Period|Pregnancy|0|||
143143134|NCT03573297|516070747|FG002|Open Label Treatment Period|Pregnancy|0|||
143143135|NCT03573297|516070748|FG003|Open Label Treatment Period|Pregnancy|0|||
143143136|NCT03573297|516070745|FG000|Open Label Treatment Period|Protocol Violation|17|||
143143137|NCT03573297|516070746|FG001|Open Label Treatment Period|Protocol Violation|0|||
143143138|NCT03573297|516070747|FG002|Open Label Treatment Period|Protocol Violation|0|||
143143139|NCT03573297|516070748|FG003|Open Label Treatment Period|Protocol Violation|0|||
143143140|NCT03573297|516070745|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
143143141|NCT03573297|516070746|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
143143142|NCT03573297|516070747|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
143143143|NCT03573297|516070748|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
143143144|NCT03573297|516070745|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
143143145|NCT03573297|516070746|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
143143146|NCT03573297|516070747|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
143143147|NCT03573297|516070748|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
143143148|NCT03573297|516070745|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
143143149|NCT03573297|516070746|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
143143150|NCT03573297|516070747|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
143143151|NCT03573297|516070748|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
143143152|NCT03573297|516070745|FG000|Open Label Treatment Period|Other, Not Specified|7|||
143143153|NCT03573297|516070746|FG001|Open Label Treatment Period|Other, Not Specified|0|||
143143154|NCT03573297|516070747|FG002|Open Label Treatment Period|Other, Not Specified|0|||
143477616|NCT00514514|517294567|FG002|Pre-phase|Lack of Efficacy|0|||
143477617|NCT00514514|517294565|FG000|Pre-phase|Adverse Event|137|||
143477618|NCT00514514|517294566|FG001|Pre-phase|Adverse Event|0|||
143477619|NCT00514514|517294567|FG002|Pre-phase|Adverse Event|0|||
143477620|NCT00514514|517294565|FG000|Pre-phase|Withdrawal by Subject|66|||
143477621|NCT00514514|517294566|FG001|Pre-phase|Withdrawal by Subject|0|||
143477622|NCT00514514|517294567|FG002|Pre-phase|Withdrawal by Subject|0|||
143477623|NCT00514514|517294565|FG000|Randomized - 9 Month|Death|3|||
143477624|NCT00514514|517294566|FG001|Randomized - 9 Month|Death|2|||
143477625|NCT00514514|517294567|FG002|Randomized - 9 Month|Death|2|||
143477626|NCT00514514|517294565|FG000|Randomized - 9 Month|Administrative problems|1|||
143477627|NCT00514514|517294566|FG001|Randomized - 9 Month|Administrative problems|1|||
143143155|NCT03573297|516070748|FG003|Open Label Treatment Period|Other, Not Specified|0|||
143143156|NCT03573297|516070745|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
143143157|NCT03573297|516070746|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
143143158|NCT03573297|516070747|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
143143159|NCT03573297|516070748|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
143143160|NCT03573297|516070745|FG000|Double-Blind Treatment Period|Adverse Event|0|||
143143161|NCT03573297|516070746|FG001|Double-Blind Treatment Period|Adverse Event|1|||
143143162|NCT03573297|516070747|FG002|Double-Blind Treatment Period|Adverse Event|5|||
143143163|NCT03573297|516070748|FG003|Double-Blind Treatment Period|Adverse Event|1|||
143143164|NCT03573297|516070745|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
143143165|NCT03573297|516070746|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
143143166|NCT03573297|516070747|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
143143167|NCT03573297|516070748|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
143143168|NCT03573297|516070745|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
143143169|NCT03573297|516070746|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
143143170|NCT03573297|516070747|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
143143171|NCT03573297|516070748|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
143143172|NCT03573297|516070745|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
143143173|NCT03573297|516070746|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
143143174|NCT03573297|516070747|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
143143175|NCT03573297|516070748|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
143143176|NCT03573297|516070745|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
143143177|NCT03573297|516070746|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
143143178|NCT03573297|516070747|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
143143179|NCT03573297|516070748|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
143143180|NCT03573297|516070745|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
143143181|NCT03573297|516070746|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
143143182|NCT03573297|516070747|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
143143183|NCT03573297|516070748|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
143143184|NCT03573297|516070745|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
143143185|NCT03573297|516070746|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
143143186|NCT03573297|516070747|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
143143187|NCT03573297|516070748|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
143143188|NCT01093846|516070751|FG000|Overall Study|Adverse Event|0|||
143143189|NCT01093846|516070752|FG001|Overall Study|Adverse Event|0|||
143143190|NCT01093846|516070753|FG002|Overall Study|Adverse Event|1|||
143143191|NCT01093846|516070751|FG000|Overall Study|Lack of Efficacy|0|||
143143192|NCT01093846|516070752|FG001|Overall Study|Lack of Efficacy|0|||
143143193|NCT01093846|516070753|FG002|Overall Study|Lack of Efficacy|4|||
143143194|NCT01093846|516070751|FG000|Overall Study|Condition no longer required study drug|1|||
143143195|NCT01093846|516070752|FG001|Overall Study|Condition no longer required study drug|1|||
143143196|NCT01093846|516070753|FG002|Overall Study|Condition no longer required study drug|1|||
143143197|NCT01093846|516070751|FG000|Overall Study|Administrative Problems|18|||
143143198|NCT01093846|516070752|FG001|Overall Study|Administrative Problems|17|||
143143199|NCT01093846|516070753|FG002|Overall Study|Administrative Problems|15|||
143143200|NCT00661388|516070759|FG000|Overall Study|Adverse Event|14|||
143143201|NCT00661388|516070759|FG000|Overall Study|Protocol Violation|7|||
143143202|NCT00661388|516070759|FG000|Overall Study|Renal transplantation|1|||
143143203|NCT00661388|516070759|FG000|Overall Study|Dialysis initiation|1|||
143143204|NCT00661388|516070759|FG000|Overall Study|Administrative reasons|1|||
143143205|NCT04530630|516072720|FG000|Overall Study|Physician Decision|1|||
143143206|NCT03675308|516072723|FG000|Overall Study|Adverse Event|3|||
143143207|NCT03675308|516072724|FG001|Overall Study|Adverse Event|2|||
143143208|NCT03675308|516072723|FG000|Overall Study|Withdrawal by Subject|6|||
143477628|NCT00514514|517294567|FG002|Randomized - 9 Month|Administrative problems|2|||
143477629|NCT00514514|517294565|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
143477630|NCT00514514|517294566|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
143477631|NCT00514514|517294567|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
143477632|NCT00514514|517294565|FG000|Randomized - 9 Month|Protocol Violation|1|||
143143209|NCT03675308|516072724|FG001|Overall Study|Withdrawal by Subject|4|||
143143210|NCT03675308|516072723|FG000|Overall Study|Lost to Follow-up|3|||
143143211|NCT03675308|516072724|FG001|Overall Study|Lost to Follow-up|0|||
143143212|NCT03675308|516072723|FG000|Overall Study|Lack of Efficacy|1|||
143143213|NCT03675308|516072724|FG001|Overall Study|Lack of Efficacy|1|||
143143214|NCT03675308|516072723|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
143363529|NCT01394991|516873766|FG000|Overall Study|Lack of Efficacy|5|||
143477633|NCT00514514|517294566|FG001|Randomized - 9 Month|Protocol Violation|1|||
143477634|NCT00514514|517294567|FG002|Randomized - 9 Month|Protocol Violation|0|||
143477635|NCT00514514|517294565|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
143477636|NCT00514514|517294566|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
143477637|NCT00514514|517294567|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
143477638|NCT00514514|517294565|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
143477639|NCT00514514|517294566|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
143477640|NCT00514514|517294567|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
143477641|NCT00514514|517294565|FG000|Randomized - 9 Month|Adverse Event|25|||
143477642|NCT00514514|517294566|FG001|Randomized - 9 Month|Adverse Event|44|||
143477643|NCT00514514|517294567|FG002|Randomized - 9 Month|Adverse Event|27|||
143477644|NCT00514514|517294565|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
143477645|NCT00514514|517294566|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
143477646|NCT00514514|517294567|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
143477647|NCT00514514|517294565|FG000|Extension - 4 Years|Lost to Follow-up|12|||
143477648|NCT00514514|517294566|FG001|Extension - 4 Years|Lost to Follow-up|10|||
143477649|NCT00514514|517294567|FG002|Extension - 4 Years|Lost to Follow-up|9|||
143477650|NCT00514514|517294565|FG000|Extension - 4 Years|Administrative problems|3|||
143477651|NCT00514514|517294566|FG001|Extension - 4 Years|Administrative problems|1|||
143477652|NCT00514514|517294567|FG002|Extension - 4 Years|Administrative problems|1|||
143477653|NCT00514514|517294565|FG000|Extension - 4 Years|Death|8|||
143477654|NCT00514514|517294566|FG001|Extension - 4 Years|Death|3|||
143477655|NCT00514514|517294567|FG002|Extension - 4 Years|Death|6|||
143143215|NCT03675308|516072724|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
143143216|NCT03675308|516072723|FG000|Overall Study|Other|0|||
143143217|NCT03675308|516072724|FG001|Overall Study|Other|1|||
143143218|NCT00089648|516072726|FG000|Overall Study|Adverse Event|7|||
143143219|NCT00089648|516072726|FG000|Overall Study|Withdrawal by Subject|1|||
143143220|NCT00089648|516072726|FG000|Overall Study|Lack of Efficacy|33|||
143143221|NCT00423605|516072727|FG000|Overall Study|Adverse Event|129|||
143143222|NCT00423605|516072727|FG000|Overall Study|Withdrawal by Subject|36|||
143143223|NCT00423605|516072727|FG000|Overall Study|Lost to Follow-up|15|||
143143224|NCT00423605|516072727|FG000|Overall Study|Lack of Efficacy|38|||
143143225|NCT00423605|516072727|FG000|Overall Study|Sponsor Decision|3|||
143143226|NCT00423605|516072727|FG000|Overall Study|Physician Decision|8|||
143143227|NCT00423605|516072727|FG000|Overall Study|Protocol Violation|7|||
143143228|NCT00423605|516072727|FG000|Overall Study|Not one of the pre-specified options|5|||
143143229|NCT03183908|516072731|FG000|Overall Study|Missing Symptom Diary Data|0|||
143143230|NCT03183908|516072732|FG001|Overall Study|Missing Symptom Diary Data|2|||
143143231|NCT04889040|516072733|FG000|Overall Study|Withdrawal by Subject|3|||
143143232|NCT04889040|516072734|FG001|Overall Study|Withdrawal by Subject|3|||
143143233|NCT04889040|516072733|FG000|Overall Study|Lost to Follow-up|0|||
143143234|NCT04889040|516072734|FG001|Overall Study|Lost to Follow-up|1|||
143143235|NCT04889040|516072733|FG000|Overall Study|Adverse Event|2|||
143143236|NCT04889040|516072734|FG001|Overall Study|Adverse Event|1|||
143143237|NCT00915525|516072735|FG000|Overall Study|Protocol Violation|9|||
143143238|NCT00915525|516072736|FG001|Overall Study|Protocol Violation|4|||
143143239|NCT00915525|516072735|FG000|Overall Study|Withdrawal by Subject|59|||
143143240|NCT00915525|516072736|FG001|Overall Study|Withdrawal by Subject|21|||
143143241|NCT00915525|516072735|FG000|Overall Study|Lost to Follow-up|27|||
143143242|NCT00915525|516072736|FG001|Overall Study|Lost to Follow-up|16|||
143143243|NCT00915525|516072735|FG000|Overall Study|Pregnancy|2|||
143143244|NCT00915525|516072736|FG001|Overall Study|Pregnancy|0|||
143143245|NCT00915525|516072735|FG000|Overall Study|Lack of Efficacy|15|||
143143246|NCT00915525|516072736|FG001|Overall Study|Lack of Efficacy|32|||
143143247|NCT00915525|516072735|FG000|Overall Study|Adverse Event|29|||
143143248|NCT00915525|516072736|FG001|Overall Study|Adverse Event|13|||
143143249|NCT00915525|516072735|FG000|Overall Study|Missing|12|||
143143250|NCT00915525|516072736|FG001|Overall Study|Missing|1|||
143143251|NCT00915525|516072735|FG000|Overall Study|Other Reason|35|||
143143252|NCT00915525|516072736|FG001|Overall Study|Other Reason|12|||
143143253|NCT00915525|516072735|FG000|Overall Study|Site Closed|27|||
143143254|NCT00915525|516072736|FG001|Overall Study|Site Closed|9|||
143143255|NCT00915525|516072735|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
143477656|NCT00514514|517294565|FG000|Extension - 4 Years|Adverse Event|9|||
143477657|NCT00514514|517294566|FG001|Extension - 4 Years|Adverse Event|6|||
143477658|NCT00514514|517294567|FG002|Extension - 4 Years|Adverse Event|3|||
143477659|NCT03785925|517294568|FG000|Overall Study|Withdrawal by Subject|15|||
143014090|NCT01414062|515591608|FG000|Overall Study|Withdrawal by Subject|0|||
143014091|NCT01414062|515591609|FG001|Overall Study|Withdrawal by Subject|1|||
143143256|NCT00915525|516072736|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
143143257|NCT00915525|516072735|FG000|Overall Study|Study Burden|28|||
143143258|NCT00915525|516072736|FG001|Overall Study|Study Burden|12|||
143143259|NCT00915525|516072735|FG000|Overall Study|Non-Compliance|3|||
143143260|NCT00915525|516072736|FG001|Overall Study|Non-Compliance|1|||
143143261|NCT00915525|516072735|FG000|Overall Study|Patient Moved|15|||
143143262|NCT00915525|516072736|FG001|Overall Study|Patient Moved|9|||
143143263|NCT01712178|516072739|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
143477660|NCT03785925|517294568|FG000|Overall Study|Lost to Follow-up|1|||
143477661|NCT00957528|517294570|FG000|Overall Study|Protocol Violation|0|||
143477662|NCT00957528|517294571|FG001|Overall Study|Protocol Violation|1|||
143477663|NCT00957528|517294572|FG002|Overall Study|Protocol Violation|0|||
143477664|NCT00957528|517294570|FG000|Overall Study|Withdrawal by Subject|0|||
143477665|NCT00957528|517294571|FG001|Overall Study|Withdrawal by Subject|0|||
143477666|NCT00957528|517294572|FG002|Overall Study|Withdrawal by Subject|1|||
143477667|NCT01848288|517294574|FG000|Overall Study|Death|1|||
143477668|NCT01848288|517294574|FG000|Overall Study|Protocol Violation|1|||
143477669|NCT01848288|517294574|FG000|Overall Study|Withdrawal by Subject|1|||
143477670|NCT01101438|517294575|FG000|Overall Study|Withdrawal by Subject|8|||
143477671|NCT01101438|517294576|FG001|Overall Study|Withdrawal by Subject|9|||
143477672|NCT01480284|517294582|FG000|Overall Study|Withdrawal by Subject|2|||
143477673|NCT01480284|517294583|FG001|Overall Study|Withdrawal by Subject|0|||
143477674|NCT01480284|517294582|FG000|Overall Study|Adverse Event|1|||
143477675|NCT01480284|517294583|FG001|Overall Study|Adverse Event|0|||
143477676|NCT01480284|517294582|FG000|Overall Study|Study closed/terminated|3|||
143477677|NCT01480284|517294583|FG001|Overall Study|Study closed/terminated|0|||
143477678|NCT01480284|517294582|FG000|Overall Study|Lost to Follow-up|1|||
143477679|NCT01480284|517294583|FG001|Overall Study|Lost to Follow-up|0|||
143477680|NCT01480284|517294582|FG000|Overall Study|Physician Decision|1|||
143477681|NCT01480284|517294583|FG001|Overall Study|Physician Decision|0|||
143477682|NCT00066742|517294586|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
143477683|NCT00066742|517294586|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
143477684|NCT00066742|517294586|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
143477685|NCT00066742|517294586|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
143477686|NCT00066742|517294586|FG000|Induction Chemoradiotherapy|Ineligible|3|||
143477687|NCT00066742|517294586|FG000|Consolidation Chemotherapy|not protocol specified|1|||
143477688|NCT00066742|517294586|FG000|Consolidation Chemotherapy|Ineligible|2|||
143477689|NCT03677596|517294593|FG000|Overall Study|Adverse Event|0|||
143477690|NCT03677596|517294594|FG001|Overall Study|Adverse Event|1|||
143477691|NCT03677596|517294593|FG000|Overall Study|Death|10|||
143477692|NCT03677596|517294594|FG001|Overall Study|Death|6|||
143477693|NCT03677596|517294593|FG000|Overall Study|Lost to Follow-up|0|||
143477694|NCT03677596|517294594|FG001|Overall Study|Lost to Follow-up|1|||
143477695|NCT03677596|517294593|FG000|Overall Study|Progressive Disease|8|||
143477696|NCT03677596|517294594|FG001|Overall Study|Progressive Disease|8|||
143477697|NCT03677596|517294593|FG000|Overall Study|Withdrawal by Subject|3|||
143477698|NCT03677596|517294594|FG001|Overall Study|Withdrawal by Subject|0|||
143477699|NCT03677596|517294593|FG000|Overall Study|Disease Relapse|2|||
143477700|NCT03677596|517294594|FG001|Overall Study|Disease Relapse|2|||
143477701|NCT03677596|517294593|FG000|Overall Study|Other|0|||
143477702|NCT03677596|517294594|FG001|Overall Study|Other|1|||
143477703|NCT00806195|517294595|FG000|Overall Study|Death|6|||
143477704|NCT00806195|517294596|FG001|Overall Study|Death|0|||
143477705|NCT00806195|517294597|FG002|Overall Study|Death|1|||
143477706|NCT00806195|517294598|FG003|Overall Study|Death|0|||
143143264|NCT01712178|516072740|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
143143265|NCT01712178|516072739|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
143143266|NCT01712178|516072740|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
143143267|NCT01712178|516072739|FG000|Overall Study|Lost to Follow-up|0|||
143143268|NCT01712178|516072740|FG001|Overall Study|Lost to Follow-up|1|||
143143269|NCT00091819|516072741|FG000|Overall Study|Adverse Event|1|||
143143270|NCT00091819|516072742|FG001|Overall Study|Adverse Event|1|||
143143271|NCT00091819|516072741|FG000|Overall Study|Death|4|||
143143272|NCT00091819|516072742|FG001|Overall Study|Death|5|||
143143273|NCT00091819|516072741|FG000|Overall Study|Lost to Follow-up|26|||
143143274|NCT00091819|516072742|FG001|Overall Study|Lost to Follow-up|23|||
143143275|NCT00091819|516072741|FG000|Overall Study|Withdrawal by Subject|5|||
143143276|NCT00091819|516072742|FG001|Overall Study|Withdrawal by Subject|8|||
143143277|NCT00091819|516072741|FG000|Overall Study|Protocol Violation|1|||
143143278|NCT00091819|516072742|FG001|Overall Study|Protocol Violation|2|||
143143279|NCT00091819|516072741|FG000|Overall Study|Other|2|||
143143280|NCT00091819|516072742|FG001|Overall Study|Other|3|||
143477707|NCT00806195|517294595|FG000|Overall Study|Adverse Event|25|||
143477708|NCT00806195|517294596|FG001|Overall Study|Adverse Event|5|||
143477709|NCT00806195|517294597|FG002|Overall Study|Adverse Event|11|||
143143281|NCT00091819|516072741|FG000|Overall Study|Never received study treatment|3|||
143143282|NCT00091819|516072742|FG001|Overall Study|Never received study treatment|4|||
143477710|NCT00806195|517294598|FG003|Overall Study|Adverse Event|2|||
143477711|NCT00806195|517294595|FG000|Overall Study|Withdrawal by Subject|119|||
143477712|NCT00806195|517294596|FG001|Overall Study|Withdrawal by Subject|31|||
143477713|NCT00806195|517294597|FG002|Overall Study|Withdrawal by Subject|76|||
143477714|NCT00806195|517294598|FG003|Overall Study|Withdrawal by Subject|35|||
143477715|NCT00806195|517294595|FG000|Overall Study|Lost to Follow-up|217|||
143477716|NCT00806195|517294596|FG001|Overall Study|Lost to Follow-up|66|||
143477717|NCT00806195|517294597|FG002|Overall Study|Lost to Follow-up|90|||
143477718|NCT00806195|517294598|FG003|Overall Study|Lost to Follow-up|34|||
143477719|NCT00806195|517294595|FG000|Overall Study|Inappropriate Enrollment|0|||
143477720|NCT00806195|517294596|FG001|Overall Study|Inappropriate Enrollment|1|||
143477721|NCT00806195|517294597|FG002|Overall Study|Inappropriate Enrollment|0|||
143477722|NCT00806195|517294598|FG003|Overall Study|Inappropriate Enrollment|0|||
143477723|NCT00806195|517294595|FG000|Overall Study|Administrative Reason|113|||
143477724|NCT00806195|517294596|FG001|Overall Study|Administrative Reason|35|||
143477725|NCT00806195|517294597|FG002|Overall Study|Administrative Reason|66|||
143477726|NCT00806195|517294598|FG003|Overall Study|Administrative Reason|26|||
143477727|NCT00806195|517294595|FG000|Overall Study|Protocol Violation|34|||
143477728|NCT00806195|517294596|FG001|Overall Study|Protocol Violation|24|||
143477729|NCT00806195|517294597|FG002|Overall Study|Protocol Violation|26|||
143477730|NCT00806195|517294598|FG003|Overall Study|Protocol Violation|9|||
143477731|NCT04912245|517294599|FG000|Overall Study|Withdrawal by Subject|21|||
143477732|NCT04912245|517294600|FG001|Overall Study|Withdrawal by Subject|4|||
143477733|NCT04912245|517294599|FG000|Overall Study|Lost to Follow-up|5|||
143477734|NCT04912245|517294600|FG001|Overall Study|Lost to Follow-up|11|||
143477735|NCT02752035|517294601|FG000|Safety Cohort: Approximately 5 Years|Miscellaneous|2|||
143477736|NCT02752035|517294602|FG001|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
143477737|NCT02752035|517294603|FG002|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
143477738|NCT02752035|517294604|FG003|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
143477739|NCT02752035|517294601|FG000|Safety Cohort: Approximately 5 Years|Disease relapse|5|||
143477740|NCT02752035|517294602|FG001|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
143477741|NCT02752035|517294603|FG002|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
143477742|NCT02752035|517294604|FG003|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
143477743|NCT02752035|517294601|FG000|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|1|||
143477744|NCT02752035|517294602|FG001|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
143477745|NCT02752035|517294603|FG002|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
143477746|NCT02752035|517294604|FG003|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
143477747|NCT02752035|517294601|FG000|Safety Cohort: Approximately 5 Years|Lack of Efficacy|1|||
143477748|NCT02752035|517294602|FG001|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
143477749|NCT02752035|517294603|FG002|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
143477750|NCT02752035|517294604|FG003|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
143477751|NCT02752035|517294601|FG000|Safety Cohort: Approximately 5 Years|Death|5|||
143477752|NCT02752035|517294602|FG001|Safety Cohort: Approximately 5 Years|Death|0|||
143477753|NCT02752035|517294603|FG002|Safety Cohort: Approximately 5 Years|Death|0|||
143477754|NCT02752035|517294604|FG003|Safety Cohort: Approximately 5 Years|Death|0|||
143477755|NCT02752035|517294601|FG000|Safety Cohort: Approximately 5 Years|Adverse Event|1|||
143477756|NCT02752035|517294602|FG001|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
143477757|NCT02752035|517294603|FG002|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
143477758|NCT02752035|517294604|FG003|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
143143283|NCT00827567|516072743|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
143143284|NCT03482024|516072748|FG000|Overall Study|Physician Decision|1|||
143143285|NCT03482024|516072749|FG001|Overall Study|Physician Decision|0|||
143143286|NCT03482024|516072750|FG002|Overall Study|Physician Decision|0|||
143143287|NCT03482024|516072751|FG003|Overall Study|Physician Decision|0|||
143143288|NCT03482024|516072752|FG004|Overall Study|Physician Decision|0|||
143143289|NCT05001620|516072755|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
143143290|NCT05001620|516072756|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
143143291|NCT00481676|516072759|FG000|Overall Study|Adverse Event|0|||
143143292|NCT00481676|516072760|FG001|Overall Study|Adverse Event|1|||
143143293|NCT00481676|516072759|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
143143294|NCT00481676|516072760|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
143143295|NCT00481676|516072759|FG000|Overall Study|Administrative problem|1|||
143143296|NCT00481676|516072760|FG001|Overall Study|Administrative problem|0|||
143143297|NCT00819039|516072761|FG000|Overall Study|Physician Decision|1|||
143143298|NCT00819039|516072762|FG001|Overall Study|Physician Decision|0|||
143143299|NCT00819039|516072763|FG002|Overall Study|Physician Decision|1|||
143477759|NCT02752035|517294601|FG000|Randomization: Approximately 3 Years|Miscellaneous|0|||
143143300|NCT00819039|516072761|FG000|Overall Study|Protocol Violation|1|||
143143301|NCT00819039|516072762|FG001|Overall Study|Protocol Violation|0|||
143143302|NCT00819039|516072763|FG002|Overall Study|Protocol Violation|0|||
143477760|NCT02752035|517294602|FG001|Randomization: Approximately 3 Years|Miscellaneous|7|||
143477761|NCT02752035|517294603|FG002|Randomization: Approximately 3 Years|Miscellaneous|4|||
143477762|NCT02752035|517294604|FG003|Randomization: Approximately 3 Years|Miscellaneous|1|||
143477763|NCT02752035|517294601|FG000|Randomization: Approximately 3 Years|Disease Relapse|0|||
143477764|NCT02752035|517294602|FG001|Randomization: Approximately 3 Years|Disease Relapse|22|||
143477765|NCT02752035|517294603|FG002|Randomization: Approximately 3 Years|Disease Relapse|16|||
143477766|NCT02752035|517294604|FG003|Randomization: Approximately 3 Years|Disease Relapse|6|||
143143303|NCT04796415|516072764|FG000|Overall Study|not interested|12|||
143143304|NCT04796415|516072764|FG000|Overall Study|health issue|8|||
143014092|NCT04285983|515591610|FG000|Overall Study|Protocol Violation|6|||
143477767|NCT02752035|517294601|FG000|Randomization: Approximately 3 Years|Physician Decision|0|||
143477768|NCT02752035|517294602|FG001|Randomization: Approximately 3 Years|Physician Decision|3|||
143477769|NCT02752035|517294603|FG002|Randomization: Approximately 3 Years|Physician Decision|1|||
143477770|NCT02752035|517294604|FG003|Randomization: Approximately 3 Years|Physician Decision|1|||
143477771|NCT02752035|517294601|FG000|Randomization: Approximately 3 Years|Withdrawal by Subject|0|||
143477772|NCT02752035|517294602|FG001|Randomization: Approximately 3 Years|Withdrawal by Subject|14|||
143477773|NCT02752035|517294603|FG002|Randomization: Approximately 3 Years|Withdrawal by Subject|7|||
143477774|NCT02752035|517294604|FG003|Randomization: Approximately 3 Years|Withdrawal by Subject|4|||
143477775|NCT02752035|517294601|FG000|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
143477776|NCT02752035|517294602|FG001|Randomization: Approximately 3 Years|Lack of Efficacy|4|||
143477777|NCT02752035|517294603|FG002|Randomization: Approximately 3 Years|Lack of Efficacy|14|||
143477778|NCT02752035|517294604|FG003|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
143477779|NCT02752035|517294601|FG000|Randomization: Approximately 3 Years|Death|0|||
143477780|NCT02752035|517294602|FG001|Randomization: Approximately 3 Years|Death|25|||
143477781|NCT02752035|517294603|FG002|Randomization: Approximately 3 Years|Death|13|||
143477782|NCT02752035|517294604|FG003|Randomization: Approximately 3 Years|Death|4|||
143477783|NCT02752035|517294601|FG000|Randomization: Approximately 3 Years|Adverse Event|0|||
143477784|NCT02752035|517294602|FG001|Randomization: Approximately 3 Years|Adverse Event|14|||
143477785|NCT02752035|517294603|FG002|Randomization: Approximately 3 Years|Adverse Event|2|||
143477786|NCT02752035|517294604|FG003|Randomization: Approximately 3 Years|Adverse Event|6|||
143477787|NCT02752035|517294601|FG000|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
143477788|NCT02752035|517294602|FG001|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
143477789|NCT02752035|517294603|FG002|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
143477790|NCT02752035|517294604|FG003|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
143477791|NCT02752035|517294601|FG000|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
143477792|NCT02752035|517294602|FG001|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
143477793|NCT02752035|517294603|FG002|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
143477794|NCT02752035|517294604|FG003|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
143477795|NCT02752035|517294601|FG000|Long-term Follow-up: up to 3 Years|Death|5|||
143477796|NCT02752035|517294602|FG001|Long-term Follow-up: up to 3 Years|Death|26|||
143477797|NCT02752035|517294603|FG002|Long-term Follow-up: up to 3 Years|Death|30|||
143477798|NCT02752035|517294604|FG003|Long-term Follow-up: up to 3 Years|Death|10|||
143477799|NCT02752035|517294601|FG000|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
143477800|NCT02752035|517294602|FG001|Long-term Follow-up: up to 3 Years|Miscellaneous|3|||
143477801|NCT02752035|517294603|FG002|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
143477802|NCT02752035|517294604|FG003|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
143477803|NCT01519934|517294609|FG000|Overall Study|Lost to Follow-up|3|||
143143305|NCT04796415|516072764|FG000|Overall Study|Other|4|||
143143306|NCT04796415|516072764|FG000|Overall Study|discharged from home health service|3|||
143143307|NCT04796415|516072764|FG000|Overall Study|re-hospitalization|2|||
143143308|NCT04796415|516072764|FG000|Overall Study|moving to nursing home|1|||
143143309|NCT04796415|516072764|FG000|Overall Study|lost contact|1|||
143143310|NCT01240694|516072765|FG000|Overall Study|Adverse Event|9|||
143143311|NCT01240694|516072765|FG000|Overall Study|Lack of Efficacy|6|||
143143312|NCT01240694|516072765|FG000|Overall Study|Withdrawal by Subject|6|||
143143313|NCT01240694|516072765|FG000|Overall Study|Protocol Violation|2|||
143143314|NCT01240694|516072765|FG000|Overall Study|Lost to Follow-up|2|||
143143315|NCT01240694|516072765|FG000|Overall Study|Other than specified|3|||
143143316|NCT01240694|516072765|FG000|Overall Study|Withdrawn due to early study termination|107|||
143143317|NCT02110693|516072766|FG000|Overall Study|Withdrawal by Subject|6|||
143143318|NCT02110693|516072767|FG001|Overall Study|Withdrawal by Subject|7|||
143143319|NCT02110693|516072766|FG000|Overall Study|skipped assessment|15|||
143143320|NCT02110693|516072767|FG001|Overall Study|skipped assessment|18|||
143143321|NCT02110693|516072766|FG000|Overall Study|technical difficulties|6|||
143143322|NCT02110693|516072767|FG001|Overall Study|technical difficulties|4|||
143143323|NCT02110693|516072766|FG000|Overall Study|Other|1|||
143143324|NCT02110693|516072767|FG001|Overall Study|Other|0|||
143143325|NCT01881425|516072768|FG000|Overall Study|Death|5|||
143477804|NCT02161575|517294617|FG000|Overall Study|Protocol Violation|8|||
143477805|NCT02161575|517294617|FG000|Overall Study|Lack of Efficacy|1|||
143477806|NCT02161575|517294617|FG000|Overall Study|Adverse Event|2|||
143014093|NCT04936334|515591611|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
143143326|NCT01881425|516072769|FG001|Overall Study|Death|1|||
143143327|NCT01881425|516072768|FG000|Overall Study|Withdrawal by Subject|8|||
143143328|NCT01881425|516072769|FG001|Overall Study|Withdrawal by Subject|3|||
143143329|NCT01881425|516072768|FG000|Overall Study|Physician Decision|2|||
143143330|NCT01881425|516072769|FG001|Overall Study|Physician Decision|1|||
143143331|NCT01881425|516072768|FG000|Overall Study|Adverse Event|3|||
143143332|NCT01881425|516072769|FG001|Overall Study|Adverse Event|0|||
143143333|NCT01881425|516072768|FG000|Overall Study|General Anesthesia panic attack|0|||
143143334|NCT01881425|516072769|FG001|Overall Study|General Anesthesia panic attack|1|||
143143335|NCT01881425|516072768|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
143477807|NCT04754802|517294622|FG000|Overall Study|Lost to Follow-up|0|||
143477808|NCT04754802|517294623|FG001|Overall Study|Lost to Follow-up|2|||
143477809|NCT04754802|517294622|FG000|Overall Study|Withdrawal by Subject|2|||
143477810|NCT04754802|517294623|FG001|Overall Study|Withdrawal by Subject|0|||
143477811|NCT01231659|517294626|FG000|Overall Study|Adverse Event|9|||
143477812|NCT01231659|517294626|FG000|Overall Study|Disease Progression|48|||
143477813|NCT01231659|517294626|FG000|Overall Study|Death|2|||
143477814|NCT01231659|517294626|FG000|Overall Study|Patient refused to complete study visit|1|||
143477815|NCT01231659|517294626|FG000|Overall Study|Other protocol defined criteria|12|||
143477816|NCT00496730|517294627|FG000|Overall Study|Lost to Follow-up|4|||
143477817|NCT00496730|517294628|FG001|Overall Study|Lost to Follow-up|3|||
143477818|NCT00496730|517294627|FG000|Overall Study|Withdrawal by Subject|2|||
143143336|NCT01881425|516072769|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
143143337|NCT01881425|516072768|FG000|Overall Study|Lost to Follow-up|7|||
143143338|NCT01881425|516072769|FG001|Overall Study|Lost to Follow-up|2|||
143143339|NCT03834350|516072775|FG000|Overall Study|Withdrawal by Subject|1|||
143143340|NCT03416179|516072780|FG000|Overall Study|Death|90|||
143143341|NCT03416179|516072781|FG001|Overall Study|Death|87|||
143143342|NCT03416179|516072782|FG002|Overall Study|Death|117|||
143143343|NCT03416179|516072783|FG003|Overall Study|Death|113|||
143143344|NCT03416179|516072780|FG000|Overall Study|Withdrawal by Subject|15|||
143143345|NCT03416179|516072781|FG001|Overall Study|Withdrawal by Subject|20|||
143143346|NCT03416179|516072782|FG002|Overall Study|Withdrawal by Subject|6|||
143143347|NCT03416179|516072783|FG003|Overall Study|Withdrawal by Subject|9|||
143143348|NCT03416179|516072780|FG000|Overall Study|Lost to Follow-up|1|||
143143349|NCT03416179|516072781|FG001|Overall Study|Lost to Follow-up|1|||
143143350|NCT03416179|516072782|FG002|Overall Study|Lost to Follow-up|0|||
143143351|NCT03416179|516072783|FG003|Overall Study|Lost to Follow-up|3|||
143143352|NCT03416179|516072780|FG000|Overall Study|Study participation terminated by Sponsor|93|||
143143353|NCT03416179|516072781|FG001|Overall Study|Study participation terminated by Sponsor|91|||
143143354|NCT03416179|516072782|FG002|Overall Study|Study participation terminated by Sponsor|26|||
143143355|NCT03416179|516072783|FG003|Overall Study|Study participation terminated by Sponsor|31|||
143143356|NCT03416179|516072780|FG000|Overall Study|Other|2|||
143143357|NCT03416179|516072781|FG001|Overall Study|Other|3|||
143143358|NCT03416179|516072782|FG002|Overall Study|Other|1|||
143143359|NCT03416179|516072783|FG003|Overall Study|Other|0|||
143143360|NCT00961415|516072785|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
143143361|NCT00961415|516072786|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
143143362|NCT00961415|516072787|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
143143363|NCT00961415|516072785|FG000|Induction Treatment Phase|Death|77|||
143143364|NCT00961415|516072786|FG001|Induction Treatment Phase|Death|0|||
143143365|NCT00961415|516072787|FG002|Induction Treatment Phase|Death|0|||
143143366|NCT00961415|516072785|FG000|Induction Treatment Phase|Protocol Violation|1|||
143143367|NCT00961415|516072786|FG001|Induction Treatment Phase|Protocol Violation|0|||
143143368|NCT00961415|516072787|FG002|Induction Treatment Phase|Protocol Violation|0|||
143143369|NCT00961415|516072785|FG000|Induction Treatment Phase|Physician Decision|2|||
143143370|NCT00961415|516072786|FG001|Induction Treatment Phase|Physician Decision|0|||
143143371|NCT00961415|516072787|FG002|Induction Treatment Phase|Physician Decision|0|||
143143372|NCT00961415|516072785|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
143143373|NCT00961415|516072786|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
143143374|NCT00961415|516072787|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
143143375|NCT00961415|516072785|FG000|Induction Treatment Phase|Other Reason|5|||
143143376|NCT00961415|516072786|FG001|Induction Treatment Phase|Other Reason|0|||
143143377|NCT00961415|516072787|FG002|Induction Treatment Phase|Other Reason|0|||
143143378|NCT00961415|516072785|FG000|Maintenance Treatment Phase|Death|0|||
143143379|NCT00961415|516072786|FG001|Maintenance Treatment Phase|Death|42|||
143143380|NCT00961415|516072787|FG002|Maintenance Treatment Phase|Death|34|||
143143381|NCT00961415|516072785|FG000|Maintenance Treatment Phase|Investigators decision|0|||
143143382|NCT00961415|516072786|FG001|Maintenance Treatment Phase|Investigators decision|2|||
143143383|NCT00961415|516072787|FG002|Maintenance Treatment Phase|Investigators decision|0|||
143143384|NCT00961415|516072785|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
143143385|NCT00961415|516072786|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
143477819|NCT00496730|517294628|FG001|Overall Study|Withdrawal by Subject|2|||
143477820|NCT01092143|517294629|FG000|Overall Study|Adverse Event|10|||
143477821|NCT01092143|517294630|FG001|Overall Study|Adverse Event|5|||
143477822|NCT01092143|517294631|FG002|Overall Study|Adverse Event|1|||
143143386|NCT00961415|516072787|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
143143387|NCT00961415|516072785|FG000|Maintenance Treatment Phase|Other reason|0|||
143143388|NCT00961415|516072786|FG001|Maintenance Treatment Phase|Other reason|1|||
143143389|NCT00961415|516072787|FG002|Maintenance Treatment Phase|Other reason|3|||
143143390|NCT00226655|516072788|FG000|Overall Study|Death|13|||
143143391|NCT00226655|516072788|FG000|Overall Study|Withdrawal by Subject|15|||
143143392|NCT00226655|516072788|FG000|Overall Study|Adverse Event|35|||
143143393|NCT00226655|516072788|FG000|Overall Study|Physician Decision|6|||
143477823|NCT01092143|517294632|FG003|Overall Study|Adverse Event|4|||
143143394|NCT00226655|516072788|FG000|Overall Study|Clinical deterioration|10|||
143143395|NCT01311661|516072791|FG000|Overall Study|Adverse Event|2|||
143143396|NCT01311661|516072791|FG000|Overall Study|Protocol Violation|3|||
143143397|NCT01311661|516072791|FG000|Overall Study|Withdrawal by Subject|2|||
143143398|NCT00284856|516072792|FG000|Overall Study|Adverse Event|3|||
143143399|NCT00284856|516072793|FG001|Overall Study|Adverse Event|3|||
143143400|NCT00284856|516072794|FG002|Overall Study|Adverse Event|3|||
143143401|NCT00284856|516072792|FG000|Overall Study|Lack of Efficacy|2|||
143143402|NCT00284856|516072793|FG001|Overall Study|Lack of Efficacy|1|||
143143403|NCT00284856|516072794|FG002|Overall Study|Lack of Efficacy|8|||
143143404|NCT00284856|516072792|FG000|Overall Study|Lost to Follow-up|25|||
143143405|NCT00284856|516072793|FG001|Overall Study|Lost to Follow-up|21|||
143143406|NCT00284856|516072794|FG002|Overall Study|Lost to Follow-up|22|||
143143407|NCT00284856|516072792|FG000|Overall Study|Protocol Violation|5|||
143143408|NCT00284856|516072793|FG001|Overall Study|Protocol Violation|4|||
143143409|NCT00284856|516072794|FG002|Overall Study|Protocol Violation|5|||
143143410|NCT00284856|516072792|FG000|Overall Study|Withdrawal by Subject|12|||
143143411|NCT00284856|516072793|FG001|Overall Study|Withdrawal by Subject|16|||
143143412|NCT00284856|516072794|FG002|Overall Study|Withdrawal by Subject|18|||
143143413|NCT00284856|516072792|FG000|Overall Study|Other|4|||
143143414|NCT00284856|516072793|FG001|Overall Study|Other|5|||
143143415|NCT00284856|516072794|FG002|Overall Study|Other|4|||
143143416|NCT03692949|516072795|FG000|Overall Study|Lost to Follow-up|0|||
143143417|NCT03692949|516072796|FG001|Overall Study|Lost to Follow-up|0|||
143143418|NCT03692949|516072797|FG002|Overall Study|Lost to Follow-up|0|||
143143419|NCT03692949|516072798|FG003|Overall Study|Lost to Follow-up|0|||
143143420|NCT03692949|516072799|FG004|Overall Study|Lost to Follow-up|0|||
143143421|NCT03692949|516072800|FG005|Overall Study|Lost to Follow-up|0|||
143143422|NCT03692949|516072801|FG006|Overall Study|Lost to Follow-up|0|||
143143423|NCT03692949|516072802|FG007|Overall Study|Lost to Follow-up|1|||
143143424|NCT01933594|516072806|FG000|Overall Study|Lost to Follow-up|1|||
143143425|NCT01933594|516072807|FG001|Overall Study|Lost to Follow-up|0|||
143143426|NCT01933594|516072808|FG002|Overall Study|Lost to Follow-up|0|||
143143427|NCT01933594|516072809|FG003|Overall Study|Lost to Follow-up|0|||
143143428|NCT01933594|516072810|FG004|Overall Study|Lost to Follow-up|1|||
143143429|NCT01933594|516072811|FG005|Overall Study|Lost to Follow-up|0|||
143143430|NCT01933594|516072806|FG000|Overall Study|Ineligible for subsequent study step|0|||
143143431|NCT01933594|516072807|FG001|Overall Study|Ineligible for subsequent study step|0|||
143143432|NCT01933594|516072808|FG002|Overall Study|Ineligible for subsequent study step|0|||
143143433|NCT01933594|516072809|FG003|Overall Study|Ineligible for subsequent study step|0|||
143143434|NCT01933594|516072810|FG004|Overall Study|Ineligible for subsequent study step|1|||
143143435|NCT01933594|516072811|FG005|Overall Study|Ineligible for subsequent study step|0|||
143143436|NCT04513366|516072812|FG000|Treatment Phase|Withdrawal by Subject|6|||
143143437|NCT04513366|516072813|FG001|Treatment Phase|Withdrawal by Subject|8|||
143143438|NCT04513366|516072814|FG002|Treatment Phase|Withdrawal by Subject|3|||
143143439|NCT04513366|516072812|FG000|Treatment Phase|Lost to Follow-up|1|||
143143440|NCT04513366|516072813|FG001|Treatment Phase|Lost to Follow-up|2|||
143143441|NCT04513366|516072814|FG002|Treatment Phase|Lost to Follow-up|5|||
143143442|NCT04513366|516072812|FG000|Treatment Phase|Other than Specified|1|||
143143443|NCT04513366|516072813|FG001|Treatment Phase|Other than Specified|0|||
143143444|NCT04513366|516072814|FG002|Treatment Phase|Other than Specified|2|||
143143445|NCT04513366|516072812|FG000|Treatment Phase|Physician Decision|2|||
143143446|NCT04513366|516072813|FG001|Treatment Phase|Physician Decision|0|||
143143447|NCT04513366|516072814|FG002|Treatment Phase|Physician Decision|0|||
143143448|NCT04513366|516072812|FG000|Treatment Phase|Adverse Event|0|||
143143449|NCT04513366|516072813|FG001|Treatment Phase|Adverse Event|1|||
143143450|NCT04513366|516072814|FG002|Treatment Phase|Adverse Event|1|||
143143451|NCT04513366|516072812|FG000|Extension Phase|Withdrawal by Subject|3|||
143143452|NCT04513366|516072813|FG001|Extension Phase|Withdrawal by Subject|1|||
143143453|NCT04513366|516072814|FG002|Extension Phase|Withdrawal by Subject|1|||
143143454|NCT04513366|516072812|FG000|Extension Phase|Other than Specified|4|||
143143455|NCT04513366|516072813|FG001|Extension Phase|Other than Specified|0|||
143143456|NCT04513366|516072814|FG002|Extension Phase|Other than Specified|1|||
143143457|NCT04513366|516072812|FG000|Extension Phase|Lost to Follow-up|1|||
143143458|NCT04513366|516072813|FG001|Extension Phase|Lost to Follow-up|1|||
143143459|NCT04513366|516072814|FG002|Extension Phase|Lost to Follow-up|1|||
143143460|NCT04513366|516072812|FG000|Extension Phase|Sponsor Decision|0|||
143143461|NCT04513366|516072813|FG001|Extension Phase|Sponsor Decision|1|||
143143462|NCT04513366|516072814|FG002|Extension Phase|Sponsor Decision|0|||
143143463|NCT04513366|516072812|FG000|Extension Phase|Death|0|||
143143464|NCT04513366|516072813|FG001|Extension Phase|Death|1|||
143143465|NCT04513366|516072814|FG002|Extension Phase|Death|0|||
143143466|NCT04513366|516072812|FG000|Extension Phase|Adverse Event|0|||
143143467|NCT04513366|516072813|FG001|Extension Phase|Adverse Event|0|||
143143468|NCT04513366|516072814|FG002|Extension Phase|Adverse Event|1|||
143143469|NCT01654276|516072815|FG000|Overall Study|Lack of Efficacy|1|||
143143470|NCT01654276|516072815|FG000|Overall Study|Lost to Follow-up|4|||
143143471|NCT01654276|516072815|FG000|Overall Study|Withdrawal by Subject|1|||
143363530|NCT01394991|516873767|FG001|Overall Study|Lack of Efficacy|7|||
143143472|NCT02966834|516072819|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
143143473|NCT02966834|516072820|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
143143474|NCT02966834|516072821|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
143143475|NCT02966834|516072822|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
143143476|NCT02966834|516072823|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
143143477|NCT02966834|516072824|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
143143478|NCT02966834|516072819|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
143143479|NCT02966834|516072820|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
143143480|NCT02966834|516072821|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
143143481|NCT02966834|516072822|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
143143482|NCT02966834|516072823|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
143143483|NCT02966834|516072824|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
143143484|NCT02966834|516072819|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
143143485|NCT02966834|516072820|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
143143486|NCT02966834|516072821|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
143143487|NCT02966834|516072822|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
143143488|NCT02966834|516072823|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
143143489|NCT02966834|516072824|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
143143490|NCT02966834|516072819|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
143143491|NCT02966834|516072820|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
143143492|NCT02966834|516072821|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
143143493|NCT02966834|516072822|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
143143494|NCT02966834|516072823|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
143143495|NCT02966834|516072824|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
143143496|NCT02966834|516072819|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
143143497|NCT02966834|516072820|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
143143498|NCT02966834|516072821|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
143143499|NCT02966834|516072822|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
143143500|NCT02966834|516072823|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
143143501|NCT02966834|516072824|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
143143502|NCT02966834|516072819|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
143143503|NCT02966834|516072820|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
143143504|NCT02966834|516072821|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
143143505|NCT02966834|516072822|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
143143506|NCT02966834|516072823|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
143143507|NCT02966834|516072824|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
143143508|NCT01020123|516072828|FG000|Main Period|Withdrawal by Subject|6|||
143143509|NCT01020123|516072829|FG001|Main Period|Withdrawal by Subject|5|||
143143510|NCT01020123|516072830|FG002|Main Period|Withdrawal by Subject|3|||
143143511|NCT01020123|516072831|FG003|Main Period|Withdrawal by Subject|1|||
143143512|NCT01020123|516072832|FG004|Main Period|Withdrawal by Subject|6|||
143143513|NCT01020123|516072833|FG005|Main Period|Withdrawal by Subject|3|||
143143514|NCT01020123|516072834|FG006|Main Period|Withdrawal by Subject|2|||
143143515|NCT01020123|516072828|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
143143516|NCT01020123|516072829|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
143143517|NCT01020123|516072830|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
143143518|NCT01020123|516072831|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
143143519|NCT01020123|516072832|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
143143520|NCT01020123|516072833|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
143143521|NCT01020123|516072834|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
143143522|NCT01020123|516072828|FG000|Main Period|Adverse Event|5|||
143143523|NCT01020123|516072829|FG001|Main Period|Adverse Event|2|||
143143524|NCT01020123|516072830|FG002|Main Period|Adverse Event|2|||
143143525|NCT01020123|516072831|FG003|Main Period|Adverse Event|1|||
143143526|NCT01020123|516072832|FG004|Main Period|Adverse Event|1|||
143143527|NCT01020123|516072833|FG005|Main Period|Adverse Event|2|||
143143528|NCT01020123|516072834|FG006|Main Period|Adverse Event|1|||
143143529|NCT01020123|516072828|FG000|Main Period|Protocol Violation|4|||
143143530|NCT01020123|516072829|FG001|Main Period|Protocol Violation|4|||
143143531|NCT01020123|516072830|FG002|Main Period|Protocol Violation|2|||
143143532|NCT01020123|516072831|FG003|Main Period|Protocol Violation|5|||
143143533|NCT01020123|516072832|FG004|Main Period|Protocol Violation|2|||
143143534|NCT01020123|516072833|FG005|Main Period|Protocol Violation|3|||
143143535|NCT01020123|516072834|FG006|Main Period|Protocol Violation|2|||
143143536|NCT01020123|516072828|FG000|Main Period|Lost to Follow-up|0|||
143143537|NCT01020123|516072829|FG001|Main Period|Lost to Follow-up|2|||
143143538|NCT01020123|516072830|FG002|Main Period|Lost to Follow-up|0|||
143363531|NCT01394991|516873766|FG000|Overall Study|Lost to Follow-up|6|||
143143539|NCT01020123|516072831|FG003|Main Period|Lost to Follow-up|0|||
143143540|NCT01020123|516072832|FG004|Main Period|Lost to Follow-up|0|||
143143541|NCT01020123|516072833|FG005|Main Period|Lost to Follow-up|0|||
143143542|NCT01020123|516072834|FG006|Main Period|Lost to Follow-up|0|||
143143543|NCT01020123|516072828|FG000|Main Period|Unclasified|2|||
143143544|NCT01020123|516072829|FG001|Main Period|Unclasified|0|||
143143545|NCT01020123|516072830|FG002|Main Period|Unclasified|1|||
143143546|NCT01020123|516072831|FG003|Main Period|Unclasified|0|||
143143547|NCT01020123|516072832|FG004|Main Period|Unclasified|1|||
143143548|NCT01020123|516072833|FG005|Main Period|Unclasified|3|||
143143549|NCT01020123|516072834|FG006|Main Period|Unclasified|6|||
143143550|NCT01020123|516072828|FG000|Extention Period|Withdrawal by Subject|2|||
143143551|NCT01020123|516072829|FG001|Extention Period|Withdrawal by Subject|1|||
143143552|NCT01020123|516072830|FG002|Extention Period|Withdrawal by Subject|1|||
143143553|NCT01020123|516072831|FG003|Extention Period|Withdrawal by Subject|0|||
143143554|NCT01020123|516072832|FG004|Extention Period|Withdrawal by Subject|0|||
143143555|NCT01020123|516072833|FG005|Extention Period|Withdrawal by Subject|0|||
143143556|NCT01020123|516072834|FG006|Extention Period|Withdrawal by Subject|0|||
143143557|NCT01020123|516072828|FG000|Extention Period|Adverse Event|0|||
143143558|NCT01020123|516072829|FG001|Extention Period|Adverse Event|0|||
143143559|NCT01020123|516072830|FG002|Extention Period|Adverse Event|0|||
143143560|NCT01020123|516072831|FG003|Extention Period|Adverse Event|1|||
143143561|NCT01020123|516072832|FG004|Extention Period|Adverse Event|0|||
143143562|NCT01020123|516072833|FG005|Extention Period|Adverse Event|0|||
143143563|NCT01020123|516072834|FG006|Extention Period|Adverse Event|0|||
143143564|NCT01020123|516072828|FG000|Extention Period|Protocol Violation|1|||
143143565|NCT01020123|516072829|FG001|Extention Period|Protocol Violation|1|||
143143566|NCT01020123|516072830|FG002|Extention Period|Protocol Violation|1|||
143143567|NCT01020123|516072831|FG003|Extention Period|Protocol Violation|0|||
143143568|NCT01020123|516072832|FG004|Extention Period|Protocol Violation|0|||
143143569|NCT01020123|516072833|FG005|Extention Period|Protocol Violation|0|||
143143570|NCT01020123|516072834|FG006|Extention Period|Protocol Violation|1|||
143143571|NCT01020123|516072828|FG000|Extention Period|Lost to Follow-up|0|||
143143572|NCT01020123|516072829|FG001|Extention Period|Lost to Follow-up|0|||
143143573|NCT01020123|516072830|FG002|Extention Period|Lost to Follow-up|0|||
143143574|NCT01020123|516072831|FG003|Extention Period|Lost to Follow-up|0|||
143143575|NCT01020123|516072832|FG004|Extention Period|Lost to Follow-up|0|||
143143576|NCT01020123|516072833|FG005|Extention Period|Lost to Follow-up|2|||
143143577|NCT01020123|516072834|FG006|Extention Period|Lost to Follow-up|0|||
143143578|NCT00655889|516072835|FG000|Overall Study|Inadequate cell growth|1|||
143143579|NCT00655889|516072835|FG000|Overall Study|Protocol Violation|1|||
143143580|NCT01047319|516072836|FG000|Overall Study|Teva requested participant withdrawal|3|||
143143581|NCT01047319|516072837|FG001|Overall Study|Teva requested participant withdrawal|0|||
143143582|NCT01047319|516072838|FG002|Overall Study|Teva requested participant withdrawal|1|||
143143583|NCT01047319|516072836|FG000|Overall Study|Protocol Violation|3|||
143143584|NCT01047319|516072837|FG001|Overall Study|Protocol Violation|2|||
143143585|NCT01047319|516072838|FG002|Overall Study|Protocol Violation|4|||
143143586|NCT01047319|516072836|FG000|Overall Study|Lack of Efficacy|4|||
143477824|NCT01092143|517294633|FG004|Overall Study|Adverse Event|3|||
143477825|NCT01092143|517294629|FG000|Overall Study|Lost to Follow-up|1|||
143477826|NCT01092143|517294630|FG001|Overall Study|Lost to Follow-up|0|||
143477827|NCT01092143|517294631|FG002|Overall Study|Lost to Follow-up|1|||
143477828|NCT01092143|517294632|FG003|Overall Study|Lost to Follow-up|0|||
143477829|NCT01092143|517294633|FG004|Overall Study|Lost to Follow-up|0|||
143477830|NCT01092143|517294629|FG000|Overall Study|Consent withdrawn|2|||
143477831|NCT01092143|517294630|FG001|Overall Study|Consent withdrawn|1|||
143477832|NCT01092143|517294631|FG002|Overall Study|Consent withdrawn|0|||
143477833|NCT01092143|517294632|FG003|Overall Study|Consent withdrawn|1|||
143477834|NCT01092143|517294633|FG004|Overall Study|Consent withdrawn|3|||
143477835|NCT01092143|517294629|FG000|Overall Study|Not treated|0|||
143477836|NCT01092143|517294630|FG001|Overall Study|Not treated|0|||
143477837|NCT01092143|517294631|FG002|Overall Study|Not treated|1|||
143477838|NCT01092143|517294632|FG003|Overall Study|Not treated|0|||
143477839|NCT01092143|517294633|FG004|Overall Study|Not treated|0|||
143477840|NCT01092143|517294629|FG000|Overall Study|did not reversibility criteria|0|||
143143587|NCT01047319|516072837|FG001|Overall Study|Lack of Efficacy|3|||
143143588|NCT01047319|516072838|FG002|Overall Study|Lack of Efficacy|3|||
143143589|NCT01047319|516072836|FG000|Overall Study|Death|5|||
143143590|NCT01047319|516072837|FG001|Overall Study|Death|1|||
143143591|NCT01047319|516072838|FG002|Overall Study|Death|5|||
143477841|NCT01092143|517294630|FG001|Overall Study|did not reversibility criteria|0|||
143477842|NCT01092143|517294631|FG002|Overall Study|did not reversibility criteria|1|||
143477843|NCT01092143|517294632|FG003|Overall Study|did not reversibility criteria|0|||
143143592|NCT01047319|516072836|FG000|Overall Study|Pregnancy|13|||
143143593|NCT01047319|516072837|FG001|Overall Study|Pregnancy|8|||
143143594|NCT01047319|516072838|FG002|Overall Study|Pregnancy|8|||
143143595|NCT01047319|516072836|FG000|Overall Study|Physician Decision|12|||
143143596|NCT01047319|516072837|FG001|Overall Study|Physician Decision|9|||
143143597|NCT01047319|516072838|FG002|Overall Study|Physician Decision|10|||
143143598|NCT01047319|516072836|FG000|Overall Study|Lost to Follow-up|14|||
143143599|NCT01047319|516072837|FG001|Overall Study|Lost to Follow-up|10|||
143143600|NCT01047319|516072838|FG002|Overall Study|Lost to Follow-up|10|||
143143601|NCT01047319|516072836|FG000|Overall Study|Adverse Event|16|||
143477844|NCT01092143|517294633|FG004|Overall Study|did not reversibility criteria|0|||
143477845|NCT01092143|517294629|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
143477846|NCT01092143|517294630|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
143477847|NCT01092143|517294631|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
143477848|NCT01092143|517294632|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
143477849|NCT01092143|517294633|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
143477850|NCT01092143|517294629|FG000|Overall Study|Ineligible patient|1|||
143477851|NCT01092143|517294630|FG001|Overall Study|Ineligible patient|0|||
143477852|NCT01092143|517294631|FG002|Overall Study|Ineligible patient|0|||
143477853|NCT01092143|517294632|FG003|Overall Study|Ineligible patient|0|||
143477854|NCT01092143|517294633|FG004|Overall Study|Ineligible patient|0|||
143477855|NCT01092143|517294629|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
143477856|NCT01092143|517294630|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
143477857|NCT01092143|517294631|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
143477858|NCT01092143|517294632|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
143477859|NCT01092143|517294633|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
143477860|NCT01092143|517294629|FG000|Overall Study|Patient travel|0|||
143477861|NCT01092143|517294630|FG001|Overall Study|Patient travel|0|||
143477862|NCT01092143|517294631|FG002|Overall Study|Patient travel|0|||
143477863|NCT01092143|517294632|FG003|Overall Study|Patient travel|0|||
143143602|NCT01047319|516072837|FG001|Overall Study|Adverse Event|27|||
143143603|NCT01047319|516072838|FG002|Overall Study|Adverse Event|21|||
143143604|NCT01047319|516072836|FG000|Overall Study|Withdrawal by Subject|77|||
143143605|NCT01047319|516072837|FG001|Overall Study|Withdrawal by Subject|75|||
143143606|NCT01047319|516072838|FG002|Overall Study|Withdrawal by Subject|87|||
143143607|NCT01047319|516072836|FG000|Overall Study|Study terminated by Sponsor|198|||
143143608|NCT01047319|516072837|FG001|Overall Study|Study terminated by Sponsor|215|||
143143609|NCT01047319|516072838|FG002|Overall Study|Study terminated by Sponsor|203|||
143143610|NCT04585893|516072839|FG000|Overall Study|Death|1|||
143143611|NCT04585893|516072840|FG001|Overall Study|Death|0|||
143143612|NCT01277861|516072842|FG000|Overall Study|Physician Decision|2|||
143143613|NCT01277861|516072843|FG001|Overall Study|Physician Decision|2|||
143143614|NCT02696798|516072844|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
143143615|NCT02696798|516072845|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
143143616|NCT02696798|516072846|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
143143617|NCT02696798|516072844|FG000|Blinded Treatment Dosing Period|Death|0|||
143143618|NCT02696798|516072845|FG001|Blinded Treatment Dosing Period|Death|0|||
143143619|NCT02696798|516072846|FG002|Blinded Treatment Dosing Period|Death|1|||
143143620|NCT02696798|516072844|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
143143621|NCT02696798|516072845|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
143143622|NCT02696798|516072846|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
143143623|NCT02696798|516072844|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
143143624|NCT02696798|516072845|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
143143625|NCT02696798|516072846|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
143143626|NCT02696798|516072844|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
143143627|NCT02696798|516072845|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
143143628|NCT02696798|516072846|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
143143629|NCT02696798|516072844|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
143143630|NCT02696798|516072845|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
143143631|NCT02696798|516072846|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
143143632|NCT02696798|516072844|FG000|Extended Treatment Period|Adverse Event|1|||
143143633|NCT02696798|516072845|FG001|Extended Treatment Period|Adverse Event|4|||
143143634|NCT02696798|516072846|FG002|Extended Treatment Period|Adverse Event|5|||
143143635|NCT02696798|516072844|FG000|Extended Treatment Period|Lack of Efficacy|7|||
143143636|NCT02696798|516072845|FG001|Extended Treatment Period|Lack of Efficacy|2|||
143143637|NCT02696798|516072846|FG002|Extended Treatment Period|Lack of Efficacy|2|||
143143638|NCT02696798|516072844|FG000|Extended Treatment Period|Lost to Follow-up|1|||
143143639|NCT02696798|516072845|FG001|Extended Treatment Period|Lost to Follow-up|0|||
143143640|NCT02696798|516072846|FG002|Extended Treatment Period|Lost to Follow-up|0|||
143143641|NCT02696798|516072844|FG000|Extended Treatment Period|Physician Decision|0|||
143143642|NCT02696798|516072845|FG001|Extended Treatment Period|Physician Decision|1|||
143143643|NCT02696798|516072846|FG002|Extended Treatment Period|Physician Decision|0|||
143143644|NCT02696798|516072844|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
143143645|NCT02696798|516072845|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
143143646|NCT02696798|516072846|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
143477864|NCT01092143|517294633|FG004|Overall Study|Patient travel|1|||
143477865|NCT01092143|517294629|FG000|Overall Study|Non compliance with study medication|0|||
143477866|NCT01092143|517294630|FG001|Overall Study|Non compliance with study medication|0|||
143477867|NCT01092143|517294631|FG002|Overall Study|Non compliance with study medication|0|||
143477868|NCT01092143|517294632|FG003|Overall Study|Non compliance with study medication|0|||
143143647|NCT02696798|516072844|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
143143648|NCT02696798|516072845|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
143143649|NCT02696798|516072846|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
143143650|NCT02696798|516072844|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
143477869|NCT01092143|517294633|FG004|Overall Study|Non compliance with study medication|1|||
143477870|NCT01092143|517294629|FG000|Overall Study|Randomized by mistake|0|||
143477871|NCT01092143|517294630|FG001|Overall Study|Randomized by mistake|0|||
143477872|NCT01092143|517294631|FG002|Overall Study|Randomized by mistake|0|||
143477873|NCT01092143|517294632|FG003|Overall Study|Randomized by mistake|1|||
143143651|NCT02696798|516072845|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
143143652|NCT02696798|516072846|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
143143653|NCT02696798|516072844|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
143143654|NCT02696798|516072845|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
143143655|NCT02696798|516072846|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
143143656|NCT02696798|516072844|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
143143657|NCT02696798|516072845|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
143143658|NCT02696798|516072846|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
143143659|NCT02696798|516072844|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
143143660|NCT02696798|516072845|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
143143661|NCT02696798|516072846|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
143143662|NCT02696798|516072844|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
143143663|NCT02696798|516072845|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
143143664|NCT02696798|516072846|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
143143665|NCT01366092|516072847|FG000|Overall Study|Progressive cGVHD|2|||
143143666|NCT01366092|516072847|FG000|Overall Study|Physician Decision|1|||
143143667|NCT01366092|516072847|FG000|Overall Study|Withdrawal by Subject|1|||
143143668|NCT02273167|516072849|FG000|Overall Study|Adverse Event|1|||
143143669|NCT02273167|516072850|FG001|Overall Study|Adverse Event|0|||
143143670|NCT02273167|516072851|FG002|Overall Study|Adverse Event|0|||
143143671|NCT02273167|516072849|FG000|Overall Study|Protocol Violation|3|||
143143672|NCT02273167|516072850|FG001|Overall Study|Protocol Violation|1|||
143143673|NCT02273167|516072851|FG002|Overall Study|Protocol Violation|1|||
143143674|NCT02273167|516072849|FG000|Overall Study|Lost to Follow-up|0|||
143143675|NCT02273167|516072850|FG001|Overall Study|Lost to Follow-up|1|||
143143676|NCT02273167|516072851|FG002|Overall Study|Lost to Follow-up|1|||
143143677|NCT02273167|516072849|FG000|Overall Study|Withdrawal by Subject|10|||
143143678|NCT02273167|516072850|FG001|Overall Study|Withdrawal by Subject|12|||
143143679|NCT02273167|516072851|FG002|Overall Study|Withdrawal by Subject|11|||
143143680|NCT02273167|516072849|FG000|Overall Study|Various|10|||
143143681|NCT02273167|516072850|FG001|Overall Study|Various|9|||
143143682|NCT02273167|516072851|FG002|Overall Study|Various|8|||
143143683|NCT03074500|516072857|FG000|Overall Study|Lost to Follow-up|1|||
143143684|NCT03074500|516072858|FG001|Overall Study|Lost to Follow-up|0|||
143143685|NCT03074500|516072859|FG002|Overall Study|Lost to Follow-up|0|||
143143686|NCT03074500|516072857|FG000|Overall Study|Lack of Efficacy|0|||
143143687|NCT03074500|516072858|FG001|Overall Study|Lack of Efficacy|1|||
143143688|NCT03074500|516072859|FG002|Overall Study|Lack of Efficacy|0|||
143143689|NCT03074500|516072857|FG000|Overall Study|Adverse Event|0|||
143143690|NCT03074500|516072858|FG001|Overall Study|Adverse Event|0|||
143143691|NCT03074500|516072859|FG002|Overall Study|Adverse Event|1|||
143143692|NCT03321721|516072860|FG000|Overall Study|Lost to Follow-up|4|||
143143693|NCT03321721|516072861|FG001|Overall Study|Lost to Follow-up|8|||
143143694|NCT03321721|516072862|FG002|Overall Study|Lost to Follow-up|11|||
143143695|NCT01416571|516072865|FG000|Overall Study|Lost to Follow-up|2|||
143143696|NCT03608163|516072866|FG000|2nd Intervention (2 Days)|Physician Decision|0|||
143143697|NCT03608163|516072867|FG001|2nd Intervention (2 Days)|Physician Decision|1|||
143143698|NCT03353220|516072868|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
143143699|NCT03353220|516072869|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
143143700|NCT04006457|516073937|FG000|Main Study: Treatment Period 1|Adverse Event|26|||
143143701|NCT04006457|516073938|FG001|Main Study: Treatment Period 1|Adverse Event|36|||
143143702|NCT04006457|516073939|FG002|Main Study: Treatment Period 1|Adverse Event|0|||
143143703|NCT04006457|516073937|FG000|Main Study: Treatment Period 1|Death|1|||
143143704|NCT04006457|516073938|FG001|Main Study: Treatment Period 1|Death|1|||
143143705|NCT04006457|516073939|FG002|Main Study: Treatment Period 1|Death|0|||
143477874|NCT01092143|517294633|FG004|Overall Study|Randomized by mistake|0|||
143014094|NCT00422058|515591612|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
143143706|NCT04006457|516073937|FG000|Main Study: Treatment Period 1|Lack of Efficacy|27|||
143143707|NCT04006457|516073938|FG001|Main Study: Treatment Period 1|Lack of Efficacy|79|||
143143708|NCT04006457|516073939|FG002|Main Study: Treatment Period 1|Lack of Efficacy|0|||
143143709|NCT04006457|516073937|FG000|Main Study: Treatment Period 1|Lost to Follow-up|22|||
143143710|NCT04006457|516073938|FG001|Main Study: Treatment Period 1|Lost to Follow-up|17|||
143143711|NCT04006457|516073939|FG002|Main Study: Treatment Period 1|Lost to Follow-up|0|||
143143712|NCT04006457|516073937|FG000|Main Study: Treatment Period 1|Non-Compliance with Study Drug|4|||
143143713|NCT04006457|516073938|FG001|Main Study: Treatment Period 1|Non-Compliance with Study Drug|1|||
143143714|NCT04006457|516073939|FG002|Main Study: Treatment Period 1|Non-Compliance with Study Drug|0|||
143143715|NCT04006457|516073937|FG000|Main Study: Treatment Period 1|Physician Decision|3|||
143143716|NCT04006457|516073938|FG001|Main Study: Treatment Period 1|Physician Decision|0|||
143143717|NCT04006457|516073939|FG002|Main Study: Treatment Period 1|Physician Decision|0|||
143143718|NCT04006457|516073937|FG000|Main Study: Treatment Period 1|Pregnancy|8|||
143143719|NCT04006457|516073938|FG001|Main Study: Treatment Period 1|Pregnancy|8|||
143143720|NCT04006457|516073939|FG002|Main Study: Treatment Period 1|Pregnancy|0|||
143143721|NCT04006457|516073937|FG000|Main Study: Treatment Period 1|Withdrawal by Subject|41|||
143143722|NCT04006457|516073938|FG001|Main Study: Treatment Period 1|Withdrawal by Subject|57|||
143143723|NCT04006457|516073939|FG002|Main Study: Treatment Period 1|Withdrawal by Subject|0|||
143143724|NCT04006457|516073937|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|14|||
143143725|NCT04006457|516073938|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|29|||
143143726|NCT04006457|516073939|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|0|||
143143727|NCT04006457|516073937|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|4|||
143143728|NCT04006457|516073938|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|2|||
143143729|NCT04006457|516073939|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|0|||
143143730|NCT04006457|516073937|FG000|Main Study: Treatment Period 1|Other|10|||
143143731|NCT04006457|516073938|FG001|Main Study: Treatment Period 1|Other|4|||
143143732|NCT04006457|516073939|FG002|Main Study: Treatment Period 1|Other|0|||
143143733|NCT04006457|516073937|FG000|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
143143734|NCT04006457|516073938|FG001|Main Study: Treatment Period 1|Approved Drug Available For Indication|37|||
143477875|NCT01092143|517294629|FG000|Overall Study|Pregnancy|0|||
143477876|NCT01092143|517294630|FG001|Overall Study|Pregnancy|0|||
143477877|NCT01092143|517294631|FG002|Overall Study|Pregnancy|0|||
143143735|NCT04006457|516073939|FG002|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
143143736|NCT04006457|516073937|FG000|Main Study: Treatment Period 2|Adverse Event|2|||
143143737|NCT04006457|516073938|FG001|Main Study: Treatment Period 2|Adverse Event|2|||
143143738|NCT04006457|516073939|FG002|Main Study: Treatment Period 2|Adverse Event|0|||
143143739|NCT04006457|516073937|FG000|Main Study: Treatment Period 2|Lack of Efficacy|7|||
143143740|NCT04006457|516073938|FG001|Main Study: Treatment Period 2|Lack of Efficacy|0|||
143143741|NCT04006457|516073939|FG002|Main Study: Treatment Period 2|Lack of Efficacy|0|||
143143742|NCT04006457|516073937|FG000|Main Study: Treatment Period 2|Lost to Follow-up|2|||
143143743|NCT04006457|516073938|FG001|Main Study: Treatment Period 2|Lost to Follow-up|1|||
143143744|NCT04006457|516073939|FG002|Main Study: Treatment Period 2|Lost to Follow-up|0|||
143143745|NCT04006457|516073937|FG000|Main Study: Treatment Period 2|Protocol Violation|3|||
143143746|NCT04006457|516073938|FG001|Main Study: Treatment Period 2|Protocol Violation|1|||
143143747|NCT04006457|516073939|FG002|Main Study: Treatment Period 2|Protocol Violation|0|||
143143748|NCT04006457|516073937|FG000|Main Study: Treatment Period 2|Withdrawal by Subject|8|||
143143749|NCT04006457|516073938|FG001|Main Study: Treatment Period 2|Withdrawal by Subject|7|||
143143750|NCT04006457|516073939|FG002|Main Study: Treatment Period 2|Withdrawal by Subject|0|||
143143751|NCT04006457|516073937|FG000|Main Study: Treatment Period 2|Other|2|||
143143752|NCT04006457|516073938|FG001|Main Study: Treatment Period 2|Other|3|||
143143753|NCT04006457|516073939|FG002|Main Study: Treatment Period 2|Other|0|||
143143754|NCT04006457|516073937|FG000|Main Study: Treatment Period 2|Approved Drug Available For Indication|179|||
143143755|NCT04006457|516073938|FG001|Main Study: Treatment Period 2|Approved Drug Available For Indication|222|||
143143756|NCT04006457|516073939|FG002|Main Study: Treatment Period 2|Approved Drug Available For Indication|0|||
143143757|NCT04006457|516073937|FG000|Main Study: Treatment Period 2|Ongoing|86|||
143143758|NCT04006457|516073938|FG001|Main Study: Treatment Period 2|Ongoing|96|||
143143759|NCT04006457|516073939|FG002|Main Study: Treatment Period 2|Ongoing|0|||
143143760|NCT04006457|516073937|FG000|Main Study Observation Period|Adverse Event|1|||
143143761|NCT04006457|516073938|FG001|Main Study Observation Period|Adverse Event|1|||
143143762|NCT04006457|516073939|FG002|Main Study Observation Period|Adverse Event|0|||
143143763|NCT04006457|516073937|FG000|Main Study Observation Period|Lost to Follow-up|0|||
143143764|NCT04006457|516073938|FG001|Main Study Observation Period|Lost to Follow-up|1|||
143143765|NCT04006457|516073939|FG002|Main Study Observation Period|Lost to Follow-up|0|||
143143766|NCT04006457|516073937|FG000|Main Study Observation Period|Pregnancy|1|||
143143767|NCT04006457|516073938|FG001|Main Study Observation Period|Pregnancy|0|||
143143768|NCT04006457|516073939|FG002|Main Study Observation Period|Pregnancy|0|||
143143769|NCT04006457|516073937|FG000|Main Study Observation Period|Withdrawal by Subject|10|||
143143770|NCT04006457|516073938|FG001|Main Study Observation Period|Withdrawal by Subject|14|||
143143771|NCT04006457|516073939|FG002|Main Study Observation Period|Withdrawal by Subject|0|||
143143772|NCT04006457|516073937|FG000|Main Study Observation Period|Other|8|||
143477878|NCT01092143|517294632|FG003|Overall Study|Pregnancy|1|||
143477879|NCT01092143|517294633|FG004|Overall Study|Pregnancy|0|||
143477880|NCT02054325|517294635|FG000|Overall Study|Lost to Follow-up|8|||
143477881|NCT02054325|517294636|FG001|Overall Study|Lost to Follow-up|5|||
143143773|NCT04006457|516073938|FG001|Main Study Observation Period|Other|16|||
143143774|NCT04006457|516073939|FG002|Main Study Observation Period|Other|0|||
143143775|NCT04006457|516073937|FG000|Main Study Observation Period|Approved Drug Available For Indication|6|||
143143776|NCT04006457|516073938|FG001|Main Study Observation Period|Approved Drug Available For Indication|9|||
143143777|NCT04006457|516073939|FG002|Main Study Observation Period|Approved Drug Available For Indication|0|||
143143778|NCT04006457|516073937|FG000|Main Study Observation Period|Ongoing|2|||
143143779|NCT04006457|516073938|FG001|Main Study Observation Period|Ongoing|1|||
143143780|NCT04006457|516073939|FG002|Main Study Observation Period|Ongoing|0|||
143143781|NCT04006457|516073937|FG000|Vaccine Sub Study|Withdrawal by Subject|0|||
143143782|NCT04006457|516073938|FG001|Vaccine Sub Study|Withdrawal by Subject|0|||
143143783|NCT04006457|516073939|FG002|Vaccine Sub Study|Withdrawal by Subject|1|||
143143784|NCT03729362|516073940|FG000|Overall Study|Withdrawal by Subject|2|||
143143785|NCT03729362|516073941|FG001|Overall Study|Withdrawal by Subject|0|||
143143786|NCT03729362|516073940|FG000|Overall Study|Physician Decision|1|||
143143787|NCT03729362|516073941|FG001|Overall Study|Physician Decision|0|||
143143788|NCT03729362|516073940|FG000|Overall Study|COVID-19 Pandemic|1|||
143143789|NCT03729362|516073941|FG001|Overall Study|COVID-19 Pandemic|0|||
143143790|NCT03729362|516073940|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
143143791|NCT03729362|516073941|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
143143792|NCT03729362|516073940|FG000|Overall Study|Adverse Event|0|||
143143793|NCT03729362|516073941|FG001|Overall Study|Adverse Event|1|||
143143794|NCT03729362|516073940|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
143143795|NCT03729362|516073941|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
143143796|NCT03979313|516073942|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
143143797|NCT03979313|516073943|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
143143798|NCT03979313|516073942|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
143143799|NCT03979313|516073943|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
143143800|NCT03979313|516073942|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
143143801|NCT03979313|516073943|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
143143802|NCT03979313|516073942|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
143143803|NCT03979313|516073943|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
143143804|NCT03979313|516073942|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
143143805|NCT03979313|516073943|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
143143806|NCT03979313|516073942|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
143143807|NCT03979313|516073943|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
143143808|NCT03979313|516073942|FG000|All Subjects|Any Other Reason|16|||
143143809|NCT03979313|516073943|FG001|All Subjects|Any Other Reason|23|||
143143810|NCT03979313|516073942|FG000|All Subjects|Covid-19|1|||
143143811|NCT03979313|516073943|FG001|All Subjects|Covid-19|3|||
143143812|NCT03979313|516073942|FG000|All Subjects|Withdrawal by Subject|35|||
143143813|NCT03979313|516073943|FG001|All Subjects|Withdrawal by Subject|44|||
143143814|NCT03979313|516073942|FG000|All Subjects|Death|0|||
143143815|NCT03979313|516073943|FG001|All Subjects|Death|5|||
143143816|NCT03979313|516073942|FG000|All Subjects|Lost to Follow-up|28|||
143143817|NCT03979313|516073943|FG001|All Subjects|Lost to Follow-up|61|||
143143818|NCT01294514|516073946|FG000|Overall Study|Excluded due to Arrhythmia|1|||
143143819|NCT01588509|516073947|FG000|Overall Study|Lost to Follow-up|1|||
143143820|NCT01588509|516073948|FG001|Overall Study|Lost to Follow-up|0|||
143143821|NCT03345004|516073949|FG000|Overall Study|Physician Decision|1|||
143143822|NCT03345004|516073950|FG001|Overall Study|Physician Decision|0|||
143143823|NCT03345004|516073949|FG000|Overall Study|Withdrawal by Subject|0|||
143143824|NCT03345004|516073950|FG001|Overall Study|Withdrawal by Subject|1|||
143143825|NCT01983930|516073953|FG000|Overall Study|Withdrawal by Subject|9|||
143143826|NCT01983930|516073954|FG001|Overall Study|Withdrawal by Subject|8|||
143143827|NCT01983930|516073953|FG000|Overall Study|Adverse Event|0|||
143143828|NCT01983930|516073954|FG001|Overall Study|Adverse Event|1|||
143143829|NCT00393367|516073955|FG000|Overall Study|Protocol Violation|2|||
143143830|NCT00393367|516073956|FG001|Overall Study|Protocol Violation|5|||
143143831|NCT00393367|516073955|FG000|Overall Study|Withdrawal by Subject|0|||
143143832|NCT00393367|516073956|FG001|Overall Study|Withdrawal by Subject|2|||
143143833|NCT03286504|516073957|FG000|Overall Study|Lost to Follow-up|19|||
143143834|NCT03286504|516073958|FG001|Overall Study|Lost to Follow-up|16|||
143143835|NCT00656617|516073959|FG000|Overall Study|Adverse Event|1|||
143143836|NCT00656617|516073959|FG000|Overall Study|Death|2|||
143143837|NCT00656617|516073959|FG000|Overall Study|Insurance Issues|2|||
143143838|NCT00656617|516073959|FG000|Overall Study|Move to different clinical trial|2|||
143143839|NCT02030600|516073960|FG000|Treatment Period 1|Adverse Event|5|||
143143840|NCT02030600|516073961|FG001|Treatment Period 1|Adverse Event|7|||
143143841|NCT02030600|516073960|FG000|Treatment Period 1|Lack of Efficacy|0|||
143143842|NCT02030600|516073961|FG001|Treatment Period 1|Lack of Efficacy|1|||
143143843|NCT02030600|516073960|FG000|Treatment Period 1|Lost to Follow-up|11|||
143143844|NCT02030600|516073961|FG001|Treatment Period 1|Lost to Follow-up|3|||
143143845|NCT02030600|516073960|FG000|Treatment Period 1|Protocol Violation|22|||
143143846|NCT02030600|516073961|FG001|Treatment Period 1|Protocol Violation|17|||
143143847|NCT02030600|516073960|FG000|Treatment Period 1|Withdrawal by Subject|13|||
143143848|NCT02030600|516073961|FG001|Treatment Period 1|Withdrawal by Subject|17|||
143143849|NCT02030600|516073960|FG000|Treatment Period 1|Casebook Unsigned|1|||
143143850|NCT02030600|516073961|FG001|Treatment Period 1|Casebook Unsigned|0|||
143143851|NCT02030600|516073960|FG000|Treatment Period 1|Unclassified|1|||
143143852|NCT02030600|516073961|FG001|Treatment Period 1|Unclassified|0|||
143477882|NCT00898443|517294637|FG000|Overall Study|Withdrawal by Subject|1|||
143477883|NCT00898443|517294638|FG001|Overall Study|Withdrawal by Subject|0|||
143143853|NCT02030600|516073960|FG000|Treatment Period 2|Adverse Event|4|||
143143854|NCT02030600|516073961|FG001|Treatment Period 2|Adverse Event|4|||
143143855|NCT02030600|516073960|FG000|Treatment Period 2|Lack of Efficacy|2|||
143143856|NCT02030600|516073961|FG001|Treatment Period 2|Lack of Efficacy|1|||
143143857|NCT02030600|516073960|FG000|Treatment Period 2|Lost to Follow-up|4|||
143143858|NCT02030600|516073961|FG001|Treatment Period 2|Lost to Follow-up|2|||
143143859|NCT02030600|516073960|FG000|Treatment Period 2|Protocol Violation|1|||
143143860|NCT02030600|516073961|FG001|Treatment Period 2|Protocol Violation|2|||
143143861|NCT02030600|516073960|FG000|Treatment Period 2|Withdrawal by Subject|13|||
143143862|NCT02030600|516073961|FG001|Treatment Period 2|Withdrawal by Subject|9|||
143143863|NCT02030600|516073960|FG000|Treatment Period 2|Unclassified|1|||
143143864|NCT02030600|516073961|FG001|Treatment Period 2|Unclassified|0|||
143143865|NCT00634504|516073966|FG000|Overall Study|Protocol Violation|1|||
143143866|NCT00634504|516073967|FG001|Overall Study|Protocol Violation|0|||
143143867|NCT02736617|516073968|FG000|Treatment|Adverse Event|1|||
143143868|NCT02736617|516073968|FG000|Treatment|Lack of Efficacy|1|||
143143869|NCT02736617|516073968|FG000|Treatment|Withdrawal by Subject|1|||
143143870|NCT02736617|516073968|FG000|Maintenance|Lack of Efficacy|4|||
143143871|NCT02736617|516073968|FG000|Maintenance|Physician Decision|1|||
143143872|NCT02911116|516073969|FG000|Overall Study|Insufficient Therapeutic Response|1|||
143143873|NCT02911116|516073970|FG001|Overall Study|Insufficient Therapeutic Response|0|||
143143874|NCT02911116|516073969|FG000|Overall Study|Lost to Follow-up|0|||
143143875|NCT02911116|516073970|FG001|Overall Study|Lost to Follow-up|1|||
143143876|NCT01513590|516073971|FG000|Overall Study|Adverse Event|2|||
143143877|NCT01513590|516073972|FG001|Overall Study|Adverse Event|3|||
143143878|NCT01513590|516073971|FG000|Overall Study|Withdrawal Criteria|3|||
143143879|NCT01513590|516073972|FG001|Overall Study|Withdrawal Criteria|0|||
143143880|NCT01513590|516073971|FG000|Overall Study|Unclassified|5|||
143143881|NCT01513590|516073972|FG001|Overall Study|Unclassified|10|||
143143882|NCT01056276|516073973|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
143143883|NCT01056276|516073974|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
143143884|NCT01056276|516073973|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
143143885|NCT01056276|516073974|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
143143886|NCT01056276|516073973|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
143143887|NCT01056276|516073974|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
143143888|NCT01056276|516073973|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
143143889|NCT01056276|516073974|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
143143890|NCT01056276|516073973|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
143143891|NCT01056276|516073974|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
143143892|NCT01056276|516073973|FG000|Treatment Period-Cycles 1-8|Death|3|||
143143893|NCT01056276|516073974|FG001|Treatment Period-Cycles 1-8|Death|1|||
143143894|NCT01056276|516073973|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
143143895|NCT01056276|516073974|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
143143896|NCT01056276|516073973|FG000|Maintenance Therapy|Toxicity|0|||
143143897|NCT01056276|516073974|FG001|Maintenance Therapy|Toxicity|2|||
143143898|NCT01056276|516073973|FG000|Maintenance Therapy|Progressive Disease|0|||
143143899|NCT01056276|516073974|FG001|Maintenance Therapy|Progressive Disease|9|||
143143900|NCT01056276|516073973|FG000|Maintenance Therapy|Physician Decision|0|||
143143901|NCT01056276|516073974|FG001|Maintenance Therapy|Physician Decision|1|||
143143902|NCT01056276|516073973|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
143143903|NCT01056276|516073974|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
143143904|NCT01056276|516073973|FG000|Maintenance Therapy|Intercurrent Illness|0|||
143143905|NCT01056276|516073974|FG001|Maintenance Therapy|Intercurrent Illness|1|||
143143906|NCT01056276|516073973|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
143143907|NCT01056276|516073974|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
143143908|NCT04154956|516073977|FG000|Overall Study|Death|109|||
143143909|NCT04154956|516073978|FG001|Overall Study|Death|110|||
143143910|NCT04154956|516073977|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
143143911|NCT04154956|516073978|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
143143912|NCT04154956|516073977|FG000|Overall Study|Withdrawal by Subject|1|||
143143913|NCT04154956|516073978|FG001|Overall Study|Withdrawal by Subject|7|||
143143914|NCT04154956|516073977|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
143363532|NCT01394991|516873767|FG001|Overall Study|Lost to Follow-up|8|||
143477884|NCT01770912|517294641|FG000|Overall Study|Lost to Follow-up|2|||
143477885|NCT01770912|517294642|FG001|Overall Study|Lost to Follow-up|0|||
143477886|NCT01708291|517294643|FG000|Overall Study|fighting|2|||
143143915|NCT04154956|516073978|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
143143916|NCT04424901|516073979|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
143363533|NCT01394991|516873766|FG000|Overall Study|Physician Decision|1|||
143477887|NCT01708291|517294644|FG001|Overall Study|fighting|1|||
143143917|NCT04424901|516073980|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
143143918|NCT00147238|516073981|FG000|Overall Study|Inevaluable|8|||
143143919|NCT01348269|516073982|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
143143920|NCT01348269|516073983|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
143143921|NCT01348269|516073982|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
143143922|NCT01348269|516073983|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
143143923|NCT01348269|516073982|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
143477888|NCT01536951|517294646|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
143477889|NCT01536951|517294647|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
143477890|NCT01536951|517294648|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
143477891|NCT01536951|517294649|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
143477892|NCT01536951|517294650|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
143477893|NCT01536951|517294651|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
143477894|NCT01536951|517294652|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
143477895|NCT01536951|517294653|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
143477896|NCT01536951|517294654|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
143477897|NCT01536951|517294646|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
143143924|NCT01348269|516073983|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
143143925|NCT00805532|516073984|FG000|Overall Study|invalid data|0|||
143143926|NCT00805532|516073985|FG001|Overall Study|invalid data|1|||
143143927|NCT01859741|516073986|FG000|Overall Study|Death|3|||
143143928|NCT01859741|516073987|FG001|Overall Study|Death|2|||
143143929|NCT01859741|516073988|FG002|Overall Study|Death|4|||
143143930|NCT01859741|516073989|FG003|Overall Study|Death|3|||
143143931|NCT01859741|516073990|FG004|Overall Study|Death|5|||
143143932|NCT01859741|516073991|FG005|Overall Study|Death|4|||
143143933|NCT01859741|516073992|FG006|Overall Study|Death|51|||
143143934|NCT01859741|516073993|FG007|Overall Study|Death|51|||
143143935|NCT01859741|516073986|FG000|Overall Study|Lost to Follow-up|0|||
143143936|NCT01859741|516073987|FG001|Overall Study|Lost to Follow-up|0|||
143143937|NCT01859741|516073988|FG002|Overall Study|Lost to Follow-up|0|||
143143938|NCT01859741|516073989|FG003|Overall Study|Lost to Follow-up|0|||
143143939|NCT01859741|516073990|FG004|Overall Study|Lost to Follow-up|0|||
143143940|NCT01859741|516073991|FG005|Overall Study|Lost to Follow-up|1|||
143143941|NCT01859741|516073992|FG006|Overall Study|Lost to Follow-up|0|||
143143942|NCT01859741|516073993|FG007|Overall Study|Lost to Follow-up|4|||
143143943|NCT01859741|516073986|FG000|Overall Study|Withdrawal by Subject|0|||
143143944|NCT01859741|516073987|FG001|Overall Study|Withdrawal by Subject|1|||
143143945|NCT01859741|516073988|FG002|Overall Study|Withdrawal by Subject|2|||
143143946|NCT01859741|516073989|FG003|Overall Study|Withdrawal by Subject|0|||
143143947|NCT01859741|516073990|FG004|Overall Study|Withdrawal by Subject|0|||
143143948|NCT01859741|516073991|FG005|Overall Study|Withdrawal by Subject|1|||
143143949|NCT01859741|516073992|FG006|Overall Study|Withdrawal by Subject|1|||
143143950|NCT01859741|516073993|FG007|Overall Study|Withdrawal by Subject|1|||
143143951|NCT01859741|516073986|FG000|Overall Study|Study Terminated by Sponsor|0|||
143143952|NCT01859741|516073987|FG001|Overall Study|Study Terminated by Sponsor|0|||
143143953|NCT01859741|516073988|FG002|Overall Study|Study Terminated by Sponsor|0|||
143143954|NCT01859741|516073989|FG003|Overall Study|Study Terminated by Sponsor|0|||
143143955|NCT01859741|516073990|FG004|Overall Study|Study Terminated by Sponsor|1|||
143143956|NCT01859741|516073991|FG005|Overall Study|Study Terminated by Sponsor|0|||
143143957|NCT01859741|516073992|FG006|Overall Study|Study Terminated by Sponsor|16|||
143143958|NCT01859741|516073993|FG007|Overall Study|Study Terminated by Sponsor|14|||
143143959|NCT01859741|516073986|FG000|Overall Study|Other|0|||
143143960|NCT01859741|516073987|FG001|Overall Study|Other|0|||
143143961|NCT01859741|516073988|FG002|Overall Study|Other|0|||
143143962|NCT01859741|516073989|FG003|Overall Study|Other|0|||
143143963|NCT01859741|516073990|FG004|Overall Study|Other|0|||
143143964|NCT01859741|516073991|FG005|Overall Study|Other|0|||
143143965|NCT01859741|516073992|FG006|Overall Study|Other|2|||
143143966|NCT01859741|516073993|FG007|Overall Study|Other|0|||
143143967|NCT02606253|516073994|FG000|Overall Study|Adverse Event|2|||
143477898|NCT01536951|517294647|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
143477899|NCT01536951|517294648|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
143477900|NCT01536951|517294649|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
143143968|NCT02606253|516073995|FG001|Overall Study|Adverse Event|0|||
143143969|NCT02606253|516073996|FG002|Overall Study|Adverse Event|0|||
143143970|NCT02606253|516073994|FG000|Overall Study|Protocol Violation|2|||
143143971|NCT02606253|516073995|FG001|Overall Study|Protocol Violation|1|||
143143972|NCT02606253|516073996|FG002|Overall Study|Protocol Violation|0|||
143143973|NCT02606253|516073994|FG000|Overall Study|Physician Decision|1|||
143143974|NCT02606253|516073995|FG001|Overall Study|Physician Decision|1|||
143143975|NCT02606253|516073996|FG002|Overall Study|Physician Decision|0|||
143143976|NCT02765165|516073999|FG000|Treatment Period|Progressive disease|3|||
143143977|NCT02765165|516074000|FG001|Treatment Period|Progressive disease|2|||
143143978|NCT02765165|516074001|FG002|Treatment Period|Progressive disease|3|||
143143979|NCT02765165|516074002|FG003|Treatment Period|Progressive disease|3|||
143143980|NCT02765165|516074003|FG004|Treatment Period|Progressive disease|4|||
143143981|NCT02765165|516074004|FG005|Treatment Period|Progressive disease|2|||
143143982|NCT02765165|516074005|FG006|Treatment Period|Progressive disease|2|||
143143983|NCT02765165|516073999|FG000|Treatment Period|Physician Decision|0|||
143143984|NCT02765165|516074000|FG001|Treatment Period|Physician Decision|1|||
143143985|NCT02765165|516074001|FG002|Treatment Period|Physician Decision|0|||
143143986|NCT02765165|516074002|FG003|Treatment Period|Physician Decision|0|||
143143987|NCT02765165|516074003|FG004|Treatment Period|Physician Decision|0|||
143143988|NCT02765165|516074004|FG005|Treatment Period|Physician Decision|0|||
143143989|NCT02765165|516074005|FG006|Treatment Period|Physician Decision|0|||
143143990|NCT02765165|516073999|FG000|Treatment Period|Adverse Event|0|||
143143991|NCT02765165|516074000|FG001|Treatment Period|Adverse Event|1|||
143143992|NCT02765165|516074001|FG002|Treatment Period|Adverse Event|0|||
143143993|NCT02765165|516074002|FG003|Treatment Period|Adverse Event|0|||
143143994|NCT02765165|516074003|FG004|Treatment Period|Adverse Event|0|||
143143995|NCT02765165|516074004|FG005|Treatment Period|Adverse Event|0|||
143143996|NCT02765165|516074005|FG006|Treatment Period|Adverse Event|0|||
143143997|NCT02765165|516073999|FG000|Treatment Period|Withdrawal by Subject|0|||
143143998|NCT02765165|516074000|FG001|Treatment Period|Withdrawal by Subject|0|||
143143999|NCT02765165|516074001|FG002|Treatment Period|Withdrawal by Subject|0|||
143144000|NCT02765165|516074002|FG003|Treatment Period|Withdrawal by Subject|0|||
143144001|NCT02765165|516074003|FG004|Treatment Period|Withdrawal by Subject|2|||
143144002|NCT02765165|516074004|FG005|Treatment Period|Withdrawal by Subject|0|||
143144003|NCT02765165|516074005|FG006|Treatment Period|Withdrawal by Subject|0|||
143144004|NCT02765165|516073999|FG000|Treatment Period|Study terminated|0|||
143144005|NCT02765165|516074000|FG001|Treatment Period|Study terminated|0|||
143144006|NCT02765165|516074001|FG002|Treatment Period|Study terminated|0|||
143144007|NCT02765165|516074002|FG003|Treatment Period|Study terminated|0|||
143144008|NCT02765165|516074003|FG004|Treatment Period|Study terminated|0|||
143144009|NCT02765165|516074004|FG005|Treatment Period|Study terminated|1|||
143144010|NCT02765165|516074005|FG006|Treatment Period|Study terminated|2|||
143144011|NCT02765165|516073999|FG000|Post-treatment Follow-up|Death|1|||
143144012|NCT02765165|516074000|FG001|Post-treatment Follow-up|Death|2|||
143144013|NCT02765165|516074001|FG002|Post-treatment Follow-up|Death|1|||
143144014|NCT02765165|516074002|FG003|Post-treatment Follow-up|Death|1|||
143144015|NCT02765165|516074003|FG004|Post-treatment Follow-up|Death|1|||
143144016|NCT02765165|516074004|FG005|Post-treatment Follow-up|Death|1|||
143144017|NCT02765165|516074005|FG006|Post-treatment Follow-up|Death|0|||
143144018|NCT02765165|516073999|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
143144019|NCT02765165|516074000|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
143144020|NCT02765165|516074001|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
143144021|NCT02765165|516074002|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
143144022|NCT02765165|516074003|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
143144023|NCT02765165|516074004|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
143144024|NCT02765165|516074005|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
143144025|NCT02765165|516073999|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
143144026|NCT02765165|516074000|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
143144027|NCT02765165|516074001|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
143144028|NCT02765165|516074002|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
143144029|NCT02765165|516074003|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
143144030|NCT02765165|516074004|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
143144031|NCT02765165|516074005|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
143144032|NCT02765165|516073999|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
143144033|NCT02765165|516074000|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
143144034|NCT02765165|516074001|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
143144035|NCT02765165|516074002|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
143144036|NCT02765165|516074003|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
143144037|NCT02765165|516074004|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
143144038|NCT02765165|516074005|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
143363534|NCT01394991|516873767|FG001|Overall Study|Physician Decision|3|||
143363535|NCT01394991|516873766|FG000|Overall Study|Protocol Violation|1|||
143144039|NCT02765165|516073999|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
143144040|NCT02765165|516074000|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
143144041|NCT02765165|516074001|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
143144042|NCT02765165|516074002|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
143144043|NCT02765165|516074003|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
143144044|NCT02765165|516074004|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
143144045|NCT02765165|516074005|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
143144046|NCT02765165|516073999|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
143144047|NCT02765165|516074000|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
143144048|NCT02765165|516074001|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
143144049|NCT02765165|516074002|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
143363536|NCT01394991|516873767|FG001|Overall Study|Protocol Violation|1|||
143363537|NCT01394991|516873766|FG000|Overall Study|Withdrawal by Subject|20|||
143363538|NCT01394991|516873767|FG001|Overall Study|Withdrawal by Subject|17|||
143477901|NCT01536951|517294650|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
143477902|NCT01536951|517294651|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
143144050|NCT02765165|516074003|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
143144051|NCT02765165|516074004|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
143144052|NCT02765165|516074005|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
143144053|NCT01186770|516074006|FG000|Overall Study|Ineligibility|0|||
143144054|NCT01186770|516074007|FG001|Overall Study|Ineligibility|0|||
143144055|NCT01186770|516074008|FG002|Overall Study|Ineligibility|2|||
143144056|NCT01186770|516074009|FG003|Overall Study|Ineligibility|0|||
143144057|NCT01186770|516074006|FG000|Overall Study|Protocol Violation|7|||
143144058|NCT01186770|516074007|FG001|Overall Study|Protocol Violation|9|||
143144059|NCT01186770|516074008|FG002|Overall Study|Protocol Violation|12|||
143144060|NCT01186770|516074009|FG003|Overall Study|Protocol Violation|14|||
143144061|NCT01186770|516074006|FG000|Overall Study|Adverse Event|2|||
143144062|NCT01186770|516074007|FG001|Overall Study|Adverse Event|9|||
143144063|NCT01186770|516074008|FG002|Overall Study|Adverse Event|7|||
143144064|NCT01186770|516074009|FG003|Overall Study|Adverse Event|9|||
143144065|NCT01186770|516074006|FG000|Overall Study|Withdrawal by Subject|15|||
143144066|NCT01186770|516074007|FG001|Overall Study|Withdrawal by Subject|13|||
143144067|NCT01186770|516074008|FG002|Overall Study|Withdrawal by Subject|11|||
143144068|NCT01186770|516074009|FG003|Overall Study|Withdrawal by Subject|17|||
143144069|NCT01186770|516074006|FG000|Overall Study|Lost to Follow-up|10|||
143144070|NCT01186770|516074007|FG001|Overall Study|Lost to Follow-up|6|||
143144071|NCT01186770|516074008|FG002|Overall Study|Lost to Follow-up|14|||
143144072|NCT01186770|516074009|FG003|Overall Study|Lost to Follow-up|9|||
143144073|NCT01186770|516074006|FG000|Overall Study|Insufficient response to treatment|7|||
143144074|NCT01186770|516074007|FG001|Overall Study|Insufficient response to treatment|8|||
143144075|NCT01186770|516074008|FG002|Overall Study|Insufficient response to treatment|5|||
143144076|NCT01186770|516074009|FG003|Overall Study|Insufficient response to treatment|7|||
143144077|NCT01186770|516074006|FG000|Overall Study|Other than specified|0|||
143144078|NCT01186770|516074007|FG001|Overall Study|Other than specified|1|||
143144079|NCT01186770|516074008|FG002|Overall Study|Other than specified|1|||
143144080|NCT01186770|516074009|FG003|Overall Study|Other than specified|2|||
143144081|NCT02567188|516074010|FG000|Overall Study|Death|10|||
143144082|NCT02567188|516074010|FG000|Overall Study|Terminated Mircera Treatment|9|||
143144083|NCT02567188|516074010|FG000|Overall Study|Lost to Follow-up|5|||
143144084|NCT02567188|516074010|FG000|Overall Study|Adverse Event|1|||
143144085|NCT02567188|516074010|FG000|Overall Study|Withdrawal by Subject|1|||
143144086|NCT02567188|516074010|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
143144087|NCT02567188|516074010|FG000|Overall Study|Moved and Changed Clinic|1|||
143144088|NCT02567188|516074010|FG000|Overall Study|Started Hemodialysis|2|||
143144089|NCT02567188|516074010|FG000|Overall Study|Protocol Violation|5|||
143144090|NCT01189266|516074011|FG000|Overall Study|Adverse Event|1|||
143144091|NCT01189266|516074012|FG001|Overall Study|Adverse Event|0|||
143144092|NCT01189266|516074013|FG002|Overall Study|Adverse Event|5|||
143144093|NCT01189266|516074011|FG000|Overall Study|Death|0|||
143144094|NCT01189266|516074012|FG001|Overall Study|Death|0|||
143144095|NCT01189266|516074013|FG002|Overall Study|Death|5|||
143144096|NCT01189266|516074011|FG000|Overall Study|Lack of Efficacy|4|||
143144097|NCT01189266|516074012|FG001|Overall Study|Lack of Efficacy|5|||
143144098|NCT01189266|516074013|FG002|Overall Study|Lack of Efficacy|44|||
143144099|NCT01189266|516074011|FG000|Overall Study|Physician Decision|0|||
143144100|NCT01189266|516074012|FG001|Overall Study|Physician Decision|0|||
143144101|NCT01189266|516074013|FG002|Overall Study|Physician Decision|1|||
143144102|NCT01189266|516074011|FG000|Overall Study|Protocol Violation|0|||
143144103|NCT01189266|516074012|FG001|Overall Study|Protocol Violation|1|||
143144104|NCT01189266|516074013|FG002|Overall Study|Protocol Violation|1|||
143144105|NCT01189266|516074011|FG000|Overall Study|Withdrawal by Subject|0|||
143144106|NCT01189266|516074012|FG001|Overall Study|Withdrawal by Subject|0|||
143144107|NCT01189266|516074013|FG002|Overall Study|Withdrawal by Subject|1|||
143144108|NCT01189266|516074011|FG000|Overall Study|Patient refuses further therapy|1|||
143144109|NCT01189266|516074012|FG001|Overall Study|Patient refuses further therapy|0|||
143144110|NCT01189266|516074013|FG002|Overall Study|Patient refuses further therapy|7|||
143144111|NCT01189266|516074011|FG000|Overall Study|No treatment|0|||
143144112|NCT01189266|516074012|FG001|Overall Study|No treatment|0|||
143144113|NCT01189266|516074013|FG002|Overall Study|No treatment|1|||
143144114|NCT00410163|516074014|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
143144115|NCT00410163|516074015|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
143144116|NCT00410163|516074014|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
143144117|NCT00410163|516074015|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
143144118|NCT00410163|516074014|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
143144119|NCT00410163|516074015|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
143144120|NCT00410163|516074014|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
143144121|NCT00410163|516074015|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
143144122|NCT00410163|516074014|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
143144123|NCT00410163|516074015|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
143144124|NCT00410163|516074014|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
143144125|NCT00410163|516074015|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
143144126|NCT00410163|516074014|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
143144127|NCT00410163|516074015|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
143144128|NCT00410163|516074014|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
143144129|NCT00410163|516074015|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
143144130|NCT00410163|516074014|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
143144131|NCT00410163|516074015|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
143144132|NCT00410163|516074014|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
143144133|NCT00410163|516074015|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
143144134|NCT00410163|516074014|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
143144135|NCT00410163|516074015|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
143144136|NCT00410163|516074014|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
143144137|NCT00410163|516074015|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
143144138|NCT00410163|516074014|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
143144139|NCT00410163|516074015|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
143144140|NCT00410163|516074014|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
143144141|NCT00410163|516074015|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
143144142|NCT02472353|516074017|FG000|Overall Study|Lost to Follow-up|1|||
143144143|NCT02472353|516074018|FG001|Overall Study|Lost to Follow-up|1|||
143144144|NCT02472353|516074017|FG000|Overall Study|Withdrawal by Subject|2|||
143144145|NCT02472353|516074018|FG001|Overall Study|Withdrawal by Subject|1|||
143144146|NCT02472353|516074017|FG000|Overall Study|Study Termination|1|||
143144147|NCT02472353|516074018|FG001|Overall Study|Study Termination|4|||
143144148|NCT00797563|516074019|FG000|Overall Study|Adverse Event|1|||
143144149|NCT00844519|516074021|FG000|Overall Study|Withdrawal by Subject|1|||
143477903|NCT01536951|517294652|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
143477904|NCT01536951|517294653|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
143144150|NCT00844519|516074022|FG001|Overall Study|Withdrawal by Subject|1|||
143144151|NCT00844519|516074021|FG000|Overall Study|Adverse Event|1|||
143144152|NCT00844519|516074022|FG001|Overall Study|Adverse Event|0|||
143144153|NCT01925417|516074033|FG000|Overall Study|Withdrawal by Subject|2|||
143144154|NCT01925417|516074033|FG000|Overall Study|Death|1|||
143144155|NCT01157845|516074034|FG000|Overall Study|Lost to Follow-up|5|||
143144156|NCT01157845|516074034|FG000|Overall Study|Withdrawal by Subject|12|||
143144157|NCT01157845|516074034|FG000|Overall Study|Physician Decision|3|||
143144158|NCT01157845|516074034|FG000|Overall Study|Protocol Violation|13|||
143144159|NCT01157845|516074034|FG000|Overall Study|Study was ended|1|||
143144160|NCT01157845|516074034|FG000|Overall Study|Device malfunction|1|||
143144161|NCT03311555|516074035|FG000|Overall Study|Adverse Event|1|||
143144162|NCT03454555|516076122|FG000|Overall Study|Death|6|||
143144163|NCT03454555|516076123|FG001|Overall Study|Death|6|||
143144164|NCT03454555|516076122|FG000|Overall Study|Lost to Follow-up|31|||
143144165|NCT03454555|516076123|FG001|Overall Study|Lost to Follow-up|12|||
143144166|NCT03454555|516076122|FG000|Overall Study|Physician Decision|2|||
143144167|NCT03454555|516076123|FG001|Overall Study|Physician Decision|6|||
143144168|NCT03454555|516076122|FG000|Overall Study|Withdrawal by Subject|34|||
143144169|NCT03454555|516076123|FG001|Overall Study|Withdrawal by Subject|5|||
143144170|NCT03454555|516076122|FG000|Overall Study|Ineligible|1|||
143144171|NCT03454555|516076123|FG001|Overall Study|Ineligible|5|||
143144172|NCT01288430|516076127|FG000|Part 1|Progressive disease|2|||
143144173|NCT01288430|516076128|FG001|Part 1|Progressive disease|1|||
143477905|NCT01536951|517294654|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
143477906|NCT03697720|517295964|FG000|Overall Study|Lost to Follow-up|7|||
143477907|NCT05050318|517295965|FG000|Overall Study|Protocol Deviation|1|||
143477908|NCT05050318|517295966|FG001|Overall Study|Protocol Deviation|0|||
143477909|NCT05050318|517295967|FG002|Overall Study|Protocol Deviation|0|||
143477910|NCT03496012|517295973|FG000|Overall Study|Withdrawal by Subject|2|||
143477911|NCT03496012|517295974|FG001|Overall Study|Withdrawal by Subject|0|||
143477912|NCT03496012|517295975|FG002|Overall Study|Withdrawal by Subject|2|||
143144174|NCT01288430|516076129|FG002|Part 1|Progressive disease|1|||
143144175|NCT01288430|516076130|FG003|Part 1|Progressive disease|6|||
143144176|NCT01288430|516076131|FG004|Part 1|Progressive disease|2|||
143144177|NCT01288430|516076132|FG005|Part 1|Progressive disease|4|||
143144178|NCT01288430|516076133|FG006|Part 1|Progressive disease|2|||
143477913|NCT03496012|517295973|FG000|Overall Study|Adverse Event|0|||
143144179|NCT01288430|516076134|FG007|Part 1|Progressive disease|0|||
143144180|NCT01288430|516076135|FG008|Part 1|Progressive disease|0|||
143144181|NCT01288430|516076136|FG009|Part 1|Progressive disease|0|||
143144182|NCT01288430|516076127|FG000|Part 1|Clinical disease progression|0|||
143477914|NCT03496012|517295974|FG001|Overall Study|Adverse Event|0|||
143477915|NCT03496012|517295975|FG002|Overall Study|Adverse Event|1|||
143144183|NCT01288430|516076128|FG001|Part 1|Clinical disease progression|0|||
143144184|NCT01288430|516076129|FG002|Part 1|Clinical disease progression|1|||
143144185|NCT01288430|516076130|FG003|Part 1|Clinical disease progression|0|||
143144186|NCT01288430|516076131|FG004|Part 1|Clinical disease progression|0|||
143144187|NCT01288430|516076132|FG005|Part 1|Clinical disease progression|2|||
143144188|NCT01288430|516076133|FG006|Part 1|Clinical disease progression|2|||
143144189|NCT01288430|516076134|FG007|Part 1|Clinical disease progression|0|||
143144190|NCT01288430|516076135|FG008|Part 1|Clinical disease progression|0|||
143144191|NCT01288430|516076136|FG009|Part 1|Clinical disease progression|0|||
143144192|NCT01288430|516076127|FG000|Part 1|Death due to disease progression|0|||
143144193|NCT01288430|516076128|FG001|Part 1|Death due to disease progression|0|||
143144194|NCT01288430|516076129|FG002|Part 1|Death due to disease progression|0|||
143144195|NCT01288430|516076130|FG003|Part 1|Death due to disease progression|0|||
143144196|NCT01288430|516076131|FG004|Part 1|Death due to disease progression|1|||
143144197|NCT01288430|516076132|FG005|Part 1|Death due to disease progression|0|||
143144198|NCT01288430|516076133|FG006|Part 1|Death due to disease progression|0|||
143144199|NCT01288430|516076134|FG007|Part 1|Death due to disease progression|0|||
143144200|NCT01288430|516076135|FG008|Part 1|Death due to disease progression|0|||
143144201|NCT01288430|516076136|FG009|Part 1|Death due to disease progression|0|||
143144202|NCT01288430|516076127|FG000|Part 1|Adverse Event|0|||
143144203|NCT01288430|516076128|FG001|Part 1|Adverse Event|0|||
143144204|NCT01288430|516076129|FG002|Part 1|Adverse Event|3|||
143144205|NCT01288430|516076130|FG003|Part 1|Adverse Event|1|||
143144206|NCT01288430|516076131|FG004|Part 1|Adverse Event|0|||
143144207|NCT01288430|516076132|FG005|Part 1|Adverse Event|0|||
143144208|NCT01288430|516076133|FG006|Part 1|Adverse Event|2|||
143144209|NCT01288430|516076134|FG007|Part 1|Adverse Event|0|||
143144210|NCT01288430|516076135|FG008|Part 1|Adverse Event|0|||
143144211|NCT01288430|516076136|FG009|Part 1|Adverse Event|0|||
143144212|NCT01288430|516076127|FG000|Part 1|Other|0|||
143144213|NCT01288430|516076128|FG001|Part 1|Other|2|||
143144214|NCT01288430|516076129|FG002|Part 1|Other|0|||
143144215|NCT01288430|516076130|FG003|Part 1|Other|0|||
143144216|NCT01288430|516076131|FG004|Part 1|Other|0|||
143144217|NCT01288430|516076132|FG005|Part 1|Other|0|||
143144218|NCT01288430|516076133|FG006|Part 1|Other|1|||
143144219|NCT01288430|516076134|FG007|Part 1|Other|0|||
143144220|NCT01288430|516076135|FG008|Part 1|Other|0|||
143144221|NCT01288430|516076136|FG009|Part 1|Other|0|||
143144222|NCT01288430|516076127|FG000|Part 2|Progressive disease|0|||
143144223|NCT01288430|516076128|FG001|Part 2|Progressive disease|0|||
143144224|NCT01288430|516076129|FG002|Part 2|Progressive disease|0|||
143144225|NCT01288430|516076130|FG003|Part 2|Progressive disease|0|||
143144226|NCT01288430|516076131|FG004|Part 2|Progressive disease|0|||
143144227|NCT01288430|516076132|FG005|Part 2|Progressive disease|0|||
143144228|NCT01288430|516076133|FG006|Part 2|Progressive disease|0|||
143144229|NCT01288430|516076134|FG007|Part 2|Progressive disease|8|||
143144230|NCT01288430|516076135|FG008|Part 2|Progressive disease|7|||
143144231|NCT01288430|516076136|FG009|Part 2|Progressive disease|2|||
143144232|NCT01288430|516076127|FG000|Part 2|Clinical disease progression|0|||
143144233|NCT01288430|516076128|FG001|Part 2|Clinical disease progression|0|||
143144234|NCT01288430|516076129|FG002|Part 2|Clinical disease progression|0|||
143144235|NCT01288430|516076130|FG003|Part 2|Clinical disease progression|0|||
143144236|NCT01288430|516076131|FG004|Part 2|Clinical disease progression|0|||
143477916|NCT03496012|517295973|FG000|Overall Study|Reason Not Specified|2|||
143477917|NCT03496012|517295974|FG001|Overall Study|Reason Not Specified|0|||
143477918|NCT03496012|517295975|FG002|Overall Study|Reason Not Specified|1|||
143477919|NCT00574145|517295976|FG000|Overall Study|Withdrawal by Subject|2|||
143477920|NCT00574145|517295977|FG001|Overall Study|Withdrawal by Subject|1|||
143477921|NCT03227471|517295978|FG000|Overall Study|Withdrawal by Subject|0|||
143477922|NCT03227471|517295979|FG001|Overall Study|Withdrawal by Subject|0|||
143477923|NCT03227471|517295980|FG002|Overall Study|Withdrawal by Subject|0|||
143477924|NCT03227471|517295981|FG003|Overall Study|Withdrawal by Subject|0|||
143144237|NCT01288430|516076132|FG005|Part 2|Clinical disease progression|0|||
143144238|NCT01288430|516076133|FG006|Part 2|Clinical disease progression|0|||
143144239|NCT01288430|516076134|FG007|Part 2|Clinical disease progression|2|||
143144240|NCT01288430|516076135|FG008|Part 2|Clinical disease progression|0|||
143144241|NCT01288430|516076136|FG009|Part 2|Clinical disease progression|0|||
143144242|NCT01288430|516076127|FG000|Part 2|Withdrawal by Subject|0|||
143144243|NCT01288430|516076128|FG001|Part 2|Withdrawal by Subject|0|||
143144244|NCT01288430|516076129|FG002|Part 2|Withdrawal by Subject|0|||
143144245|NCT01288430|516076130|FG003|Part 2|Withdrawal by Subject|0|||
143144246|NCT01288430|516076131|FG004|Part 2|Withdrawal by Subject|0|||
143477925|NCT03227471|517295982|FG004|Overall Study|Withdrawal by Subject|1|||
143477926|NCT03227471|517295983|FG005|Overall Study|Withdrawal by Subject|0|||
143144247|NCT01288430|516076132|FG005|Part 2|Withdrawal by Subject|0|||
143144248|NCT01288430|516076133|FG006|Part 2|Withdrawal by Subject|0|||
143144249|NCT01288430|516076134|FG007|Part 2|Withdrawal by Subject|1|||
143144250|NCT01288430|516076135|FG008|Part 2|Withdrawal by Subject|4|||
143144251|NCT01288430|516076136|FG009|Part 2|Withdrawal by Subject|0|||
143144252|NCT01288430|516076127|FG000|Part 2|Adverse Event|0|||
143144253|NCT01288430|516076128|FG001|Part 2|Adverse Event|0|||
143144254|NCT01288430|516076129|FG002|Part 2|Adverse Event|0|||
143144255|NCT01288430|516076130|FG003|Part 2|Adverse Event|0|||
143144256|NCT01288430|516076131|FG004|Part 2|Adverse Event|0|||
143144257|NCT01288430|516076132|FG005|Part 2|Adverse Event|0|||
143144258|NCT01288430|516076133|FG006|Part 2|Adverse Event|0|||
143144259|NCT01288430|516076134|FG007|Part 2|Adverse Event|1|||
143144260|NCT01288430|516076135|FG008|Part 2|Adverse Event|1|||
143144261|NCT01288430|516076136|FG009|Part 2|Adverse Event|0|||
143144262|NCT01288430|516076127|FG000|Part 2|Other|0|||
143144263|NCT01288430|516076128|FG001|Part 2|Other|0|||
143144264|NCT01288430|516076129|FG002|Part 2|Other|0|||
143144265|NCT01288430|516076130|FG003|Part 2|Other|0|||
143144266|NCT01288430|516076131|FG004|Part 2|Other|0|||
143144267|NCT01288430|516076132|FG005|Part 2|Other|0|||
143144268|NCT01288430|516076133|FG006|Part 2|Other|0|||
143144269|NCT01288430|516076134|FG007|Part 2|Other|0|||
143144270|NCT01288430|516076135|FG008|Part 2|Other|0|||
143144271|NCT01288430|516076136|FG009|Part 2|Other|1|||
143144272|NCT05172609|516076137|FG000|Time 3|Elected not to continue with study due to time constraints|1|||
143144273|NCT05172609|516076138|FG001|Time 3|Elected not to continue with study due to time constraints|1|||
143144274|NCT05172609|516076137|FG000|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|1|||
143144275|NCT05172609|516076138|FG001|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|0|||
143144276|NCT05172609|516076137|FG000|Time 4|Elected not to continue with study due to time constraints|0|||
143144277|NCT05172609|516076138|FG001|Time 4|Elected not to continue with study due to time constraints|1|||
143144278|NCT03737994|516076139|FG000|Overall Study|Withdrawal by Subject|0|||
143144279|NCT03737994|516076140|FG001|Overall Study|Withdrawal by Subject|0|||
143144280|NCT03737994|516076141|FG002|Overall Study|Withdrawal by Subject|0|||
143144281|NCT03737994|516076142|FG003|Overall Study|Withdrawal by Subject|0|||
143144282|NCT03737994|516076143|FG004|Overall Study|Withdrawal by Subject|0|||
143144283|NCT03737994|516076144|FG005|Overall Study|Withdrawal by Subject|0|||
143144284|NCT03737994|516076145|FG006|Overall Study|Withdrawal by Subject|1|||
143144285|NCT02332707|516076150|FG000|Overall Study|Adverse Event|0|||
143144286|NCT02332707|516076151|FG001|Overall Study|Adverse Event|0|||
143144287|NCT02332707|516076152|FG002|Overall Study|Adverse Event|0|||
143144288|NCT02332707|516076153|FG003|Overall Study|Adverse Event|0|||
143144289|NCT02332707|516076154|FG004|Overall Study|Adverse Event|0|||
143144290|NCT02332707|516076155|FG005|Overall Study|Adverse Event|0|||
143144291|NCT02332707|516076156|FG006|Overall Study|Adverse Event|0|||
143144292|NCT02332707|516076157|FG007|Overall Study|Adverse Event|0|||
143144293|NCT02332707|516076158|FG008|Overall Study|Adverse Event|0|||
143144294|NCT02332707|516076159|FG009|Overall Study|Adverse Event|0|||
143144295|NCT02332707|516076160|FG010|Overall Study|Adverse Event|0|||
143144296|NCT02332707|516076161|FG011|Overall Study|Adverse Event|0|||
143144297|NCT02332707|516076162|FG012|Overall Study|Adverse Event|1|||
143144298|NCT02332707|516076163|FG013|Overall Study|Adverse Event|0|||
143144299|NCT02332707|516076164|FG014|Overall Study|Adverse Event|0|||
143144300|NCT02332707|516076165|FG015|Overall Study|Adverse Event|0|||
143144301|NCT02332707|516076166|FG016|Overall Study|Adverse Event|0|||
143144302|NCT02332707|516076167|FG017|Overall Study|Adverse Event|0|||
143144303|NCT02332707|516076150|FG000|Overall Study|Lost to Follow-up|0|||
143144304|NCT02332707|516076151|FG001|Overall Study|Lost to Follow-up|0|||
143144305|NCT02332707|516076152|FG002|Overall Study|Lost to Follow-up|0|||
143144306|NCT02332707|516076153|FG003|Overall Study|Lost to Follow-up|0|||
143144307|NCT02332707|516076154|FG004|Overall Study|Lost to Follow-up|0|||
143144308|NCT02332707|516076155|FG005|Overall Study|Lost to Follow-up|1|||
143144309|NCT02332707|516076156|FG006|Overall Study|Lost to Follow-up|0|||
143144310|NCT02332707|516076157|FG007|Overall Study|Lost to Follow-up|0|||
143144311|NCT02332707|516076158|FG008|Overall Study|Lost to Follow-up|0|||
143144312|NCT02332707|516076159|FG009|Overall Study|Lost to Follow-up|0|||
143144313|NCT02332707|516076160|FG010|Overall Study|Lost to Follow-up|2|||
143144314|NCT02332707|516076161|FG011|Overall Study|Lost to Follow-up|0|||
143144315|NCT02332707|516076162|FG012|Overall Study|Lost to Follow-up|3|||
143144316|NCT02332707|516076163|FG013|Overall Study|Lost to Follow-up|0|||
143144317|NCT02332707|516076164|FG014|Overall Study|Lost to Follow-up|0|||
143144318|NCT02332707|516076165|FG015|Overall Study|Lost to Follow-up|0|||
143144319|NCT02332707|516076166|FG016|Overall Study|Lost to Follow-up|0|||
143144320|NCT02332707|516076167|FG017|Overall Study|Lost to Follow-up|0|||
143144321|NCT02332707|516076150|FG000|Overall Study|Physician Decision|0|||
143144322|NCT02332707|516076151|FG001|Overall Study|Physician Decision|0|||
143144323|NCT02332707|516076152|FG002|Overall Study|Physician Decision|0|||
143144324|NCT02332707|516076153|FG003|Overall Study|Physician Decision|1|||
143144325|NCT02332707|516076154|FG004|Overall Study|Physician Decision|0|||
143144326|NCT02332707|516076155|FG005|Overall Study|Physician Decision|0|||
143144327|NCT02332707|516076156|FG006|Overall Study|Physician Decision|0|||
143144328|NCT02332707|516076157|FG007|Overall Study|Physician Decision|0|||
143144329|NCT02332707|516076158|FG008|Overall Study|Physician Decision|0|||
143144330|NCT02332707|516076159|FG009|Overall Study|Physician Decision|0|||
143144331|NCT02332707|516076160|FG010|Overall Study|Physician Decision|0|||
143144332|NCT02332707|516076161|FG011|Overall Study|Physician Decision|0|||
143144333|NCT02332707|516076162|FG012|Overall Study|Physician Decision|1|||
143144334|NCT02332707|516076163|FG013|Overall Study|Physician Decision|0|||
143144335|NCT02332707|516076164|FG014|Overall Study|Physician Decision|0|||
143144336|NCT02332707|516076165|FG015|Overall Study|Physician Decision|0|||
143144337|NCT02332707|516076166|FG016|Overall Study|Physician Decision|0|||
143144338|NCT02332707|516076167|FG017|Overall Study|Physician Decision|0|||
143144339|NCT02332707|516076150|FG000|Overall Study|Withdrawal by Subject|0|||
143144340|NCT02332707|516076151|FG001|Overall Study|Withdrawal by Subject|0|||
143144341|NCT02332707|516076152|FG002|Overall Study|Withdrawal by Subject|1|||
143144342|NCT02332707|516076153|FG003|Overall Study|Withdrawal by Subject|0|||
143144343|NCT02332707|516076154|FG004|Overall Study|Withdrawal by Subject|0|||
143144344|NCT02332707|516076155|FG005|Overall Study|Withdrawal by Subject|0|||
143144345|NCT02332707|516076156|FG006|Overall Study|Withdrawal by Subject|0|||
143144346|NCT02332707|516076157|FG007|Overall Study|Withdrawal by Subject|0|||
143144347|NCT02332707|516076158|FG008|Overall Study|Withdrawal by Subject|0|||
143144348|NCT02332707|516076159|FG009|Overall Study|Withdrawal by Subject|3|||
143144349|NCT02332707|516076160|FG010|Overall Study|Withdrawal by Subject|0|||
143144350|NCT02332707|516076161|FG011|Overall Study|Withdrawal by Subject|0|||
143144351|NCT02332707|516076162|FG012|Overall Study|Withdrawal by Subject|0|||
143144352|NCT02332707|516076163|FG013|Overall Study|Withdrawal by Subject|0|||
143144353|NCT02332707|516076164|FG014|Overall Study|Withdrawal by Subject|0|||
143144354|NCT02332707|516076165|FG015|Overall Study|Withdrawal by Subject|0|||
143144355|NCT02332707|516076166|FG016|Overall Study|Withdrawal by Subject|0|||
143144356|NCT02332707|516076167|FG017|Overall Study|Withdrawal by Subject|0|||
143144357|NCT01473134|516076168|FG000|Overall Study|Lost to Follow-up|21|||
143144358|NCT01473134|516076169|FG001|Overall Study|Lost to Follow-up|13|||
143144359|NCT01473134|516076168|FG000|Overall Study|Protocol Violation|32|||
143144360|NCT01473134|516076169|FG001|Overall Study|Protocol Violation|19|||
143144361|NCT01473134|516076168|FG000|Overall Study|Withdrawal by Subject|1|||
143144362|NCT01473134|516076169|FG001|Overall Study|Withdrawal by Subject|2|||
143144363|NCT01473134|516076168|FG000|Overall Study|Death|0|||
143144364|NCT01473134|516076169|FG001|Overall Study|Death|1|||
143144365|NCT01473134|516076168|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
143144366|NCT01473134|516076169|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
143144367|NCT04761822|516076174|FG000|Overall Study|Adverse Event|3|||
143144368|NCT04761822|516076175|FG001|Overall Study|Adverse Event|1|||
143144369|NCT04761822|516076176|FG002|Overall Study|Adverse Event|1|||
143144370|NCT04761822|516076177|FG003|Overall Study|Adverse Event|3|||
143144371|NCT04761822|516076174|FG000|Overall Study|Lost to Follow-up|1|||
143144372|NCT04761822|516076175|FG001|Overall Study|Lost to Follow-up|0|||
143144373|NCT04761822|516076176|FG002|Overall Study|Lost to Follow-up|2|||
143144374|NCT04761822|516076177|FG003|Overall Study|Lost to Follow-up|3|||
143144375|NCT04761822|516076174|FG000|Overall Study|Physician Decision|0|||
143144376|NCT04761822|516076175|FG001|Overall Study|Physician Decision|1|||
143144377|NCT04761822|516076176|FG002|Overall Study|Physician Decision|0|||
143144378|NCT04761822|516076177|FG003|Overall Study|Physician Decision|0|||
143144379|NCT04761822|516076174|FG000|Overall Study|Withdrawal by Subject|3|||
143144380|NCT04761822|516076175|FG001|Overall Study|Withdrawal by Subject|8|||
143144381|NCT04761822|516076176|FG002|Overall Study|Withdrawal by Subject|1|||
143144382|NCT04761822|516076177|FG003|Overall Study|Withdrawal by Subject|11|||
143144383|NCT04761822|516076174|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
143144384|NCT04761822|516076175|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
143144385|NCT04761822|516076176|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
143144386|NCT04761822|516076177|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
143144387|NCT04761822|516076174|FG000|Overall Study|Participant requested unblinding|0|||
143144388|NCT04761822|516076175|FG001|Overall Study|Participant requested unblinding|0|||
143144389|NCT04761822|516076176|FG002|Overall Study|Participant requested unblinding|0|||
143144390|NCT04761822|516076177|FG003|Overall Study|Participant requested unblinding|1|||
143144391|NCT05020015|516076178|FG000|Overall Study|Ongoing on study|1|||
143144392|NCT05020015|516076179|FG001|Overall Study|Ongoing on study|3|||
143144393|NCT05020015|516076180|FG002|Overall Study|Ongoing on study|4|||
143144394|NCT05020015|516076181|FG003|Overall Study|Ongoing on study|7|||
143144395|NCT05020015|516076178|FG000|Overall Study|Death|2|||
143144396|NCT05020015|516076179|FG001|Overall Study|Death|3|||
143144397|NCT05020015|516076180|FG002|Overall Study|Death|4|||
143144398|NCT05020015|516076181|FG003|Overall Study|Death|0|||
143144399|NCT05020015|516076178|FG000|Overall Study|Withdrawal by Subject|0|||
143144400|NCT05020015|516076179|FG001|Overall Study|Withdrawal by Subject|0|||
143144401|NCT05020015|516076180|FG002|Overall Study|Withdrawal by Subject|1|||
143144402|NCT05020015|516076181|FG003|Overall Study|Withdrawal by Subject|0|||
143144403|NCT05020015|516076178|FG000|Overall Study|Reason Not Specified|0|||
143144404|NCT05020015|516076179|FG001|Overall Study|Reason Not Specified|0|||
143144405|NCT05020015|516076180|FG002|Overall Study|Reason Not Specified|2|||
143144406|NCT05020015|516076181|FG003|Overall Study|Reason Not Specified|0|||
143144407|NCT02233413|516076182|FG000|Overall Study|Lost to Follow-up|7|||
143144408|NCT02233413|516076183|FG001|Overall Study|Lost to Follow-up|9|||
143477927|NCT03227471|517295984|FG006|Overall Study|Withdrawal by Subject|0|||
143477928|NCT03227471|517295985|FG007|Overall Study|Withdrawal by Subject|0|||
143477929|NCT03227471|517295986|FG008|Overall Study|Withdrawal by Subject|0|||
143477930|NCT03227471|517295987|FG009|Overall Study|Withdrawal by Subject|0|||
143477931|NCT03227471|517295988|FG010|Overall Study|Withdrawal by Subject|0|||
143477932|NCT03227471|517295989|FG011|Overall Study|Withdrawal by Subject|0|||
143477933|NCT03227471|517295990|FG012|Overall Study|Withdrawal by Subject|1|||
143477934|NCT03227471|517295991|FG013|Overall Study|Withdrawal by Subject|0|||
143477935|NCT03227471|517295992|FG014|Overall Study|Withdrawal by Subject|0|||
143477936|NCT03227471|517295978|FG000|Overall Study|Randomized, Never Dosed|0|||
143477937|NCT03227471|517295979|FG001|Overall Study|Randomized, Never Dosed|0|||
143477938|NCT03227471|517295980|FG002|Overall Study|Randomized, Never Dosed|0|||
143144409|NCT02233413|516076182|FG000|Overall Study|Withdrawal by Subject|4|||
143144410|NCT02233413|516076183|FG001|Overall Study|Withdrawal by Subject|5|||
143144411|NCT00090103|516076186|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
143144412|NCT00090103|516076187|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
143144413|NCT00090103|516076188|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
143144414|NCT00090103|516076186|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
143144415|NCT00090103|516076187|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
143144416|NCT00090103|516076188|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
143144417|NCT00090103|516076186|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
143477939|NCT03227471|517295981|FG003|Overall Study|Randomized, Never Dosed|0|||
143477940|NCT03227471|517295982|FG004|Overall Study|Randomized, Never Dosed|0|||
143477941|NCT03227471|517295983|FG005|Overall Study|Randomized, Never Dosed|0|||
143477942|NCT03227471|517295984|FG006|Overall Study|Randomized, Never Dosed|0|||
143477943|NCT03227471|517295985|FG007|Overall Study|Randomized, Never Dosed|0|||
143477944|NCT03227471|517295986|FG008|Overall Study|Randomized, Never Dosed|0|||
143477945|NCT03227471|517295987|FG009|Overall Study|Randomized, Never Dosed|0|||
143477946|NCT03227471|517295988|FG010|Overall Study|Randomized, Never Dosed|0|||
143477947|NCT03227471|517295989|FG011|Overall Study|Randomized, Never Dosed|0|||
143477948|NCT03227471|517295990|FG012|Overall Study|Randomized, Never Dosed|0|||
143477949|NCT03227471|517295991|FG013|Overall Study|Randomized, Never Dosed|0|||
143144418|NCT00090103|516076187|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
143144419|NCT00090103|516076188|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
143144420|NCT00090103|516076186|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
143144421|NCT00090103|516076187|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
143144422|NCT00090103|516076188|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
143144423|NCT00090103|516076186|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
143144424|NCT00090103|516076187|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
143144425|NCT00090103|516076188|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
143144426|NCT00090103|516076186|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
143144427|NCT00090103|516076187|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
143144428|NCT00090103|516076188|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
143144429|NCT00090103|516076186|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
143144430|NCT00090103|516076187|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
143144431|NCT00090103|516076188|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
143144432|NCT00090103|516076186|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
143144433|NCT00090103|516076187|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
143144434|NCT00090103|516076188|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
143144435|NCT00090103|516076186|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
143144436|NCT00090103|516076187|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
143144437|NCT00090103|516076188|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
143144438|NCT00090103|516076186|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
143144439|NCT00090103|516076187|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
143144440|NCT00090103|516076188|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
143144441|NCT00090103|516076186|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
143144442|NCT00090103|516076187|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
143144443|NCT00090103|516076188|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
143144444|NCT00090103|516076186|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
143144445|NCT00090103|516076187|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
143144446|NCT00090103|516076188|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
143144447|NCT00090103|516076186|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
143144448|NCT00090103|516076187|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
143477950|NCT03227471|517295992|FG014|Overall Study|Randomized, Never Dosed|1|||
143477951|NCT02322125|517295993|FG000|Overall Study|Withdrawal by Subject|2|||
143477952|NCT00766038|517295996|FG000|Overall Study|Lost to Follow-up|15|||
143144449|NCT00090103|516076188|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
143144450|NCT00090103|516076186|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
143144451|NCT00090103|516076187|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
143144452|NCT00090103|516076188|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
143144453|NCT00090103|516076186|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
143144454|NCT00090103|516076187|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
143144455|NCT00090103|516076188|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
143144456|NCT00090103|516076186|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
143144457|NCT00090103|516076187|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
143144458|NCT00090103|516076188|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
143144459|NCT00090103|516076186|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
143144460|NCT00090103|516076187|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
143144461|NCT00090103|516076188|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
143144462|NCT00090103|516076186|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
143144463|NCT00090103|516076187|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
143144464|NCT00090103|516076188|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
143144465|NCT00090103|516076186|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
143144466|NCT00090103|516076187|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
143144467|NCT00090103|516076188|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
143144468|NCT00090103|516076186|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
143144469|NCT00090103|516076187|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
143144470|NCT00090103|516076188|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
143144471|NCT00090103|516076186|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
143144472|NCT00090103|516076187|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
143144473|NCT00090103|516076188|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
143144474|NCT00090103|516076186|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
143144475|NCT00090103|516076187|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
143144476|NCT00090103|516076188|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
143144477|NCT00090103|516076186|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
143144478|NCT00090103|516076187|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
143144479|NCT00090103|516076188|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
143144480|NCT00090103|516076186|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
143144481|NCT00090103|516076187|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
143144482|NCT00090103|516076188|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
143144483|NCT00090103|516076186|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
143144484|NCT00090103|516076187|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
143144485|NCT00090103|516076188|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
143144486|NCT00090103|516076186|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
143144487|NCT00090103|516076187|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
143144488|NCT00090103|516076188|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
143144489|NCT00090103|516076186|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
143144490|NCT00090103|516076187|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
143144491|NCT00090103|516076188|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
143144492|NCT00090103|516076186|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
143144493|NCT00090103|516076187|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
143144494|NCT00090103|516076188|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
143144495|NCT00090103|516076186|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
143144496|NCT00090103|516076187|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
143144497|NCT00090103|516076188|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
143144498|NCT00090103|516076186|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
143144499|NCT00090103|516076187|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
143144500|NCT00090103|516076188|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
143144501|NCT00090103|516076186|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
143144502|NCT00090103|516076187|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
143144503|NCT00090103|516076188|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
143144504|NCT00090103|516076186|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
143144505|NCT00090103|516076187|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
143144506|NCT00090103|516076188|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
143144507|NCT00090103|516076186|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
143144508|NCT00090103|516076187|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
143477953|NCT00766038|517295997|FG001|Overall Study|Lost to Follow-up|14|||
143477954|NCT00449670|517295998|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
143477955|NCT00449670|517295999|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
143477956|NCT00449670|517295998|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
143477957|NCT00449670|517295999|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
143477958|NCT00449670|517295998|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
143477959|NCT00449670|517295999|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
143477960|NCT00449670|517295998|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
143477961|NCT00449670|517295999|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
143477962|NCT00449670|517295998|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
143477963|NCT00449670|517295999|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
143477964|NCT00449670|517295998|FG000|Booster Phase (Study no.109873)|Other|0|||
143477965|NCT00449670|517295999|FG001|Booster Phase (Study no.109873)|Other|2|||
143477966|NCT04183790|517296000|FG000|Overall Study|Participants did not rollover to Part B|12|||
143477967|NCT04183790|517296001|FG001|Overall Study|Participants did not rollover to Part B|0|||
143477968|NCT04183790|517296000|FG000|Overall Study|Withdrawal of consent (not due to AE)|6|||
143144509|NCT00090103|516076188|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
143144510|NCT00090103|516076186|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
143144511|NCT00090103|516076187|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
143144512|NCT00090103|516076188|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
143144513|NCT00090103|516076186|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
143144514|NCT00090103|516076187|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
143144515|NCT00090103|516076188|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
143144516|NCT00090103|516076186|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
143144517|NCT00090103|516076187|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
143144518|NCT00090103|516076188|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
143144519|NCT00090103|516076186|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
143144520|NCT00090103|516076187|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
143144521|NCT00090103|516076188|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
143144522|NCT00090103|516076186|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
143144523|NCT00090103|516076187|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
143144524|NCT00090103|516076188|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
143144525|NCT00090103|516076186|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
143144526|NCT00090103|516076187|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
143144527|NCT00090103|516076188|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
143144528|NCT00090103|516076186|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
143144529|NCT00090103|516076187|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
143144530|NCT00090103|516076188|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
143144531|NCT00090103|516076186|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
143144532|NCT00090103|516076187|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
143144533|NCT00090103|516076188|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
143144534|NCT00090103|516076186|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
143144535|NCT00090103|516076187|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
143144536|NCT00090103|516076188|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
143144537|NCT00090103|516076186|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
143144538|NCT00090103|516076187|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
143144539|NCT00090103|516076188|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
143144540|NCT00090103|516076186|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
143144541|NCT00090103|516076187|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
143144542|NCT00090103|516076188|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
143144543|NCT00090103|516076186|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
143144544|NCT00090103|516076187|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
143144545|NCT00090103|516076188|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
143144546|NCT00090103|516076186|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
143144547|NCT00090103|516076187|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
143144548|NCT00090103|516076188|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
143144549|NCT00090103|516076186|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
143144550|NCT00090103|516076187|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
143144551|NCT00090103|516076188|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
143144552|NCT00090103|516076186|FG000|16-Week Safety Follow-up Period|Death|1|||
143144553|NCT00090103|516076187|FG001|16-Week Safety Follow-up Period|Death|0|||
143144554|NCT00090103|516076188|FG002|16-Week Safety Follow-up Period|Death|1|||
143477969|NCT04183790|517296001|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
143477970|NCT04183790|517296000|FG000|Overall Study|Commercial drug is available for participant|6|||
143477971|NCT04183790|517296001|FG001|Overall Study|Commercial drug is available for participant|0|||
143477972|NCT04183790|517296000|FG000|Overall Study|Adverse Event|1|||
143477973|NCT04183790|517296001|FG001|Overall Study|Adverse Event|0|||
143144555|NCT00090103|516076186|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
143477974|NCT04183790|517296000|FG000|Overall Study|Not enrolled in 107 study|0|||
143477975|NCT04183790|517296001|FG001|Overall Study|Not enrolled in 107 study|2|||
143477976|NCT01251653|517296002|FG000|Overall Study|Progressive Disease|1|||
143477977|NCT01251653|517296003|FG001|Overall Study|Progressive Disease|7|||
143477978|NCT01251653|517296004|FG002|Overall Study|Progressive Disease|16|||
143477979|NCT01251653|517296005|FG003|Overall Study|Progressive Disease|4|||
143477980|NCT01251653|517296006|FG004|Overall Study|Progressive Disease|0|||
143477981|NCT01251653|517296007|FG005|Overall Study|Progressive Disease|17|||
143477982|NCT01251653|517296008|FG006|Overall Study|Progressive Disease|14|||
143477983|NCT01251653|517296009|FG007|Overall Study|Progressive Disease|7|||
143477984|NCT01251653|517296010|FG008|Overall Study|Progressive Disease|5|||
143477985|NCT01251653|517296002|FG000|Overall Study|Dose-limiting toxicity|0|||
143477986|NCT01251653|517296003|FG001|Overall Study|Dose-limiting toxicity|1|||
143477987|NCT01251653|517296004|FG002|Overall Study|Dose-limiting toxicity|1|||
143477988|NCT01251653|517296005|FG003|Overall Study|Dose-limiting toxicity|1|||
143477989|NCT01251653|517296006|FG004|Overall Study|Dose-limiting toxicity|0|||
143477990|NCT01251653|517296007|FG005|Overall Study|Dose-limiting toxicity|0|||
143477991|NCT01251653|517296008|FG006|Overall Study|Dose-limiting toxicity|2|||
143477992|NCT01251653|517296009|FG007|Overall Study|Dose-limiting toxicity|0|||
143477993|NCT01251653|517296010|FG008|Overall Study|Dose-limiting toxicity|0|||
143477994|NCT01251653|517296002|FG000|Overall Study|Adverse Event|1|||
143477995|NCT01251653|517296003|FG001|Overall Study|Adverse Event|0|||
143477996|NCT01251653|517296004|FG002|Overall Study|Adverse Event|2|||
143477997|NCT01251653|517296005|FG003|Overall Study|Adverse Event|1|||
143477998|NCT01251653|517296006|FG004|Overall Study|Adverse Event|1|||
143477999|NCT01251653|517296007|FG005|Overall Study|Adverse Event|0|||
143478000|NCT01251653|517296008|FG006|Overall Study|Adverse Event|2|||
143478001|NCT01251653|517296009|FG007|Overall Study|Adverse Event|2|||
143478002|NCT01251653|517296010|FG008|Overall Study|Adverse Event|1|||
143478003|NCT01251653|517296002|FG000|Overall Study|Withdrawal by Subject|1|||
143478004|NCT01251653|517296003|FG001|Overall Study|Withdrawal by Subject|0|||
143478005|NCT01251653|517296004|FG002|Overall Study|Withdrawal by Subject|1|||
143478006|NCT01251653|517296005|FG003|Overall Study|Withdrawal by Subject|0|||
143478007|NCT01251653|517296006|FG004|Overall Study|Withdrawal by Subject|1|||
143144556|NCT00090103|516076187|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
143144557|NCT00090103|516076188|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
143144558|NCT00090103|516076186|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
143144559|NCT00090103|516076187|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
143144560|NCT00090103|516076188|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
143144561|NCT00090103|516076186|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
143144562|NCT00090103|516076187|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
143144563|NCT00090103|516076188|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
143144564|NCT00090103|516076186|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
143144565|NCT00090103|516076187|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
143144566|NCT00090103|516076188|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
143144567|NCT00090103|516076186|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
143144568|NCT00090103|516076187|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
143144569|NCT00090103|516076188|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
143144570|NCT00090103|516076186|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
143144571|NCT00090103|516076187|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
143144572|NCT00090103|516076188|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
143144573|NCT00090103|516076186|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
143144574|NCT00090103|516076187|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
143144575|NCT00090103|516076188|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
143144576|NCT00090103|516076186|FG000|16-Week Safety Follow-up Period|Depression|0|||
143144577|NCT00090103|516076187|FG001|16-Week Safety Follow-up Period|Depression|1|||
143144578|NCT00090103|516076188|FG002|16-Week Safety Follow-up Period|Depression|0|||
143144579|NCT00090103|516076186|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
143144580|NCT00090103|516076187|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
143144581|NCT00090103|516076188|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
143144582|NCT00090103|516076186|FG000|16-Week Safety Follow-up Period|Jailed|0|||
143144583|NCT00090103|516076187|FG001|16-Week Safety Follow-up Period|Jailed|1|||
143144584|NCT00090103|516076188|FG002|16-Week Safety Follow-up Period|Jailed|0|||
143144585|NCT00090103|516076186|FG000|16-Week Safety Follow-up Period|Other|0|||
143144586|NCT00090103|516076187|FG001|16-Week Safety Follow-up Period|Other|1|||
143478008|NCT01251653|517296007|FG005|Overall Study|Withdrawal by Subject|1|||
143478009|NCT01251653|517296008|FG006|Overall Study|Withdrawal by Subject|0|||
143478010|NCT01251653|517296009|FG007|Overall Study|Withdrawal by Subject|1|||
143478011|NCT01251653|517296010|FG008|Overall Study|Withdrawal by Subject|0|||
143478012|NCT01251653|517296002|FG000|Overall Study|Other reason not mentioned above|0|||
143478013|NCT01251653|517296003|FG001|Overall Study|Other reason not mentioned above|0|||
143478014|NCT01251653|517296004|FG002|Overall Study|Other reason not mentioned above|0|||
143478015|NCT01251653|517296005|FG003|Overall Study|Other reason not mentioned above|0|||
143478016|NCT01251653|517296006|FG004|Overall Study|Other reason not mentioned above|0|||
143478017|NCT01251653|517296007|FG005|Overall Study|Other reason not mentioned above|0|||
143478018|NCT01251653|517296008|FG006|Overall Study|Other reason not mentioned above|0|||
143478019|NCT01251653|517296009|FG007|Overall Study|Other reason not mentioned above|2|||
143478020|NCT01251653|517296010|FG008|Overall Study|Other reason not mentioned above|0|||
143478021|NCT01183143|517296012|FG000|Overall Study|Protocol Violation|115|||
143478022|NCT01183143|517296012|FG000|Overall Study|Withdrawal by Subject|19|||
143478023|NCT01183143|517296012|FG000|Overall Study|Subject Questionnaires not returned|5|||
143478024|NCT01183143|517296012|FG000|Overall Study|Subjects enrolled, but not treated|11|||
143014095|NCT00422058|515591613|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
143144587|NCT00090103|516076188|FG002|16-Week Safety Follow-up Period|Other|0|||
143144588|NCT01799889|516076189|FG000|Overall Study|Adverse Event|4|||
143144589|NCT01799889|516076190|FG001|Overall Study|Adverse Event|4|||
143144590|NCT01799889|516076191|FG002|Overall Study|Adverse Event|5|||
143144591|NCT01799889|516076192|FG003|Overall Study|Adverse Event|1|||
143144592|NCT01799889|516076193|FG004|Overall Study|Adverse Event|11|||
143144593|NCT01799889|516076194|FG005|Overall Study|Adverse Event|1|||
143144594|NCT01799889|516076195|FG006|Overall Study|Adverse Event|5|||
143144595|NCT01799889|516076196|FG007|Overall Study|Adverse Event|2|||
143144596|NCT01799889|516076197|FG008|Overall Study|Adverse Event|3|||
143144597|NCT01799889|516076198|FG009|Overall Study|Adverse Event|1|||
143144598|NCT01799889|516076199|FG010|Overall Study|Adverse Event|1|||
143144599|NCT01799889|516076200|FG011|Overall Study|Adverse Event|0|||
143144600|NCT01799889|516076189|FG000|Overall Study|Death|1|||
143144601|NCT01799889|516076190|FG001|Overall Study|Death|0|||
143144602|NCT01799889|516076191|FG002|Overall Study|Death|5|||
143144603|NCT01799889|516076192|FG003|Overall Study|Death|3|||
143144604|NCT01799889|516076193|FG004|Overall Study|Death|1|||
143144605|NCT01799889|516076194|FG005|Overall Study|Death|0|||
143144606|NCT01799889|516076195|FG006|Overall Study|Death|0|||
143144607|NCT01799889|516076196|FG007|Overall Study|Death|0|||
143144608|NCT01799889|516076197|FG008|Overall Study|Death|1|||
143144609|NCT01799889|516076198|FG009|Overall Study|Death|0|||
143144610|NCT01799889|516076199|FG010|Overall Study|Death|1|||
143144611|NCT01799889|516076200|FG011|Overall Study|Death|0|||
143144612|NCT01799889|516076189|FG000|Overall Study|Lack of Efficacy|1|||
143144613|NCT01799889|516076190|FG001|Overall Study|Lack of Efficacy|1|||
143144614|NCT01799889|516076191|FG002|Overall Study|Lack of Efficacy|0|||
143144615|NCT01799889|516076192|FG003|Overall Study|Lack of Efficacy|1|||
143144616|NCT01799889|516076193|FG004|Overall Study|Lack of Efficacy|2|||
143144617|NCT01799889|516076194|FG005|Overall Study|Lack of Efficacy|2|||
143144618|NCT01799889|516076195|FG006|Overall Study|Lack of Efficacy|0|||
143144619|NCT01799889|516076196|FG007|Overall Study|Lack of Efficacy|0|||
143144620|NCT01799889|516076197|FG008|Overall Study|Lack of Efficacy|2|||
143144621|NCT01799889|516076198|FG009|Overall Study|Lack of Efficacy|0|||
143144622|NCT01799889|516076199|FG010|Overall Study|Lack of Efficacy|1|||
143144623|NCT01799889|516076200|FG011|Overall Study|Lack of Efficacy|0|||
143144624|NCT01799889|516076189|FG000|Overall Study|Lost to Follow-up|0|||
143144625|NCT01799889|516076190|FG001|Overall Study|Lost to Follow-up|1|||
143144626|NCT01799889|516076191|FG002|Overall Study|Lost to Follow-up|0|||
143144627|NCT01799889|516076192|FG003|Overall Study|Lost to Follow-up|0|||
143144628|NCT01799889|516076193|FG004|Overall Study|Lost to Follow-up|0|||
143144629|NCT01799889|516076194|FG005|Overall Study|Lost to Follow-up|0|||
143144630|NCT01799889|516076195|FG006|Overall Study|Lost to Follow-up|0|||
143144631|NCT01799889|516076196|FG007|Overall Study|Lost to Follow-up|0|||
143144632|NCT01799889|516076197|FG008|Overall Study|Lost to Follow-up|0|||
143144633|NCT01799889|516076198|FG009|Overall Study|Lost to Follow-up|0|||
143144634|NCT01799889|516076199|FG010|Overall Study|Lost to Follow-up|0|||
143144635|NCT01799889|516076200|FG011|Overall Study|Lost to Follow-up|0|||
143144636|NCT01799889|516076189|FG000|Overall Study|Physician Decision|3|||
143144637|NCT01799889|516076190|FG001|Overall Study|Physician Decision|2|||
143144638|NCT01799889|516076191|FG002|Overall Study|Physician Decision|4|||
143144639|NCT01799889|516076192|FG003|Overall Study|Physician Decision|4|||
143144640|NCT01799889|516076193|FG004|Overall Study|Physician Decision|5|||
143144641|NCT01799889|516076194|FG005|Overall Study|Physician Decision|5|||
143144642|NCT01799889|516076195|FG006|Overall Study|Physician Decision|5|||
143478025|NCT04096274|517296013|FG000|Phase I|Lost to Follow-up|5|||
143478026|NCT04096274|517296014|FG001|Phase I|Lost to Follow-up|5|||
143144643|NCT01799889|516076196|FG007|Overall Study|Physician Decision|2|||
143144644|NCT01799889|516076197|FG008|Overall Study|Physician Decision|6|||
143144645|NCT01799889|516076198|FG009|Overall Study|Physician Decision|0|||
143144646|NCT01799889|516076199|FG010|Overall Study|Physician Decision|0|||
143478027|NCT04096274|517296013|FG000|Phase II|Lost to Follow-up|11|||
143478028|NCT04096274|517296014|FG001|Phase II|Lost to Follow-up|11|||
143014096|NCT00422058|515591614|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
143144647|NCT01799889|516076200|FG011|Overall Study|Physician Decision|1|||
143144648|NCT01799889|516076189|FG000|Overall Study|Progressive Disease|30|||
143144649|NCT01799889|516076190|FG001|Overall Study|Progressive Disease|26|||
143144650|NCT01799889|516076191|FG002|Overall Study|Progressive Disease|25|||
143144651|NCT01799889|516076192|FG003|Overall Study|Progressive Disease|30|||
143144652|NCT01799889|516076193|FG004|Overall Study|Progressive Disease|23|||
143478029|NCT02081534|517296022|FG000|Overall Study|Adverse Event|5|||
143478030|NCT02081534|517296023|FG001|Overall Study|Adverse Event|4|||
143478031|NCT02081534|517296024|FG002|Overall Study|Adverse Event|3|||
143478032|NCT02081534|517296025|FG003|Overall Study|Adverse Event|10|||
143478033|NCT02081534|517296026|FG004|Overall Study|Adverse Event|2|||
143478034|NCT02081534|517296027|FG005|Overall Study|Adverse Event|8|||
143478035|NCT02081534|517296028|FG006|Overall Study|Adverse Event|2|||
143478036|NCT02081534|517296022|FG000|Overall Study|Withdrawal by Subject|0|||
143478037|NCT02081534|517296023|FG001|Overall Study|Withdrawal by Subject|1|||
143478038|NCT02081534|517296024|FG002|Overall Study|Withdrawal by Subject|1|||
143478039|NCT02081534|517296025|FG003|Overall Study|Withdrawal by Subject|1|||
143478040|NCT02081534|517296026|FG004|Overall Study|Withdrawal by Subject|1|||
143478041|NCT02081534|517296027|FG005|Overall Study|Withdrawal by Subject|0|||
143478042|NCT02081534|517296028|FG006|Overall Study|Withdrawal by Subject|1|||
143478043|NCT02081534|517296022|FG000|Overall Study|Protocol Violation|0|||
143478044|NCT02081534|517296023|FG001|Overall Study|Protocol Violation|3|||
143478045|NCT02081534|517296024|FG002|Overall Study|Protocol Violation|0|||
143478046|NCT02081534|517296025|FG003|Overall Study|Protocol Violation|0|||
143478047|NCT02081534|517296026|FG004|Overall Study|Protocol Violation|0|||
143478048|NCT02081534|517296027|FG005|Overall Study|Protocol Violation|0|||
143478049|NCT02081534|517296028|FG006|Overall Study|Protocol Violation|1|||
143478050|NCT02081534|517296022|FG000|Overall Study|Lost to Follow-up|0|||
143478051|NCT02081534|517296023|FG001|Overall Study|Lost to Follow-up|0|||
143478052|NCT02081534|517296024|FG002|Overall Study|Lost to Follow-up|0|||
143478053|NCT02081534|517296025|FG003|Overall Study|Lost to Follow-up|2|||
143478054|NCT02081534|517296026|FG004|Overall Study|Lost to Follow-up|1|||
143478055|NCT02081534|517296027|FG005|Overall Study|Lost to Follow-up|1|||
143478056|NCT02081534|517296028|FG006|Overall Study|Lost to Follow-up|0|||
143478057|NCT01007032|517296029|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
143478058|NCT01007032|517296030|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
143144653|NCT01799889|516076194|FG005|Overall Study|Progressive Disease|9|||
143144654|NCT01799889|516076195|FG006|Overall Study|Progressive Disease|8|||
143478059|NCT01007032|517296031|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
143478060|NCT01007032|517296032|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
143478061|NCT01007032|517296029|FG000|Overall Study|Withdrawal by Subject|0|||
143014097|NCT00422058|515591615|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
143144655|NCT01799889|516076196|FG007|Overall Study|Progressive Disease|13|||
143144656|NCT01799889|516076197|FG008|Overall Study|Progressive Disease|18|||
143144657|NCT01799889|516076198|FG009|Overall Study|Progressive Disease|5|||
143144658|NCT01799889|516076199|FG010|Overall Study|Progressive Disease|3|||
143144659|NCT01799889|516076200|FG011|Overall Study|Progressive Disease|1|||
143144660|NCT01799889|516076189|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
143144661|NCT01799889|516076190|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
143144662|NCT01799889|516076191|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
143144663|NCT01799889|516076192|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
143144664|NCT01799889|516076193|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
143144665|NCT01799889|516076194|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
143144666|NCT01799889|516076195|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
143144667|NCT01799889|516076196|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
143144668|NCT01799889|516076197|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
143144669|NCT01799889|516076198|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
143144670|NCT01799889|516076199|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
143144671|NCT01799889|516076200|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
143144672|NCT01799889|516076189|FG000|Overall Study|Study Terminated By Sponsor|1|||
143144673|NCT01799889|516076190|FG001|Overall Study|Study Terminated By Sponsor|0|||
143144674|NCT01799889|516076191|FG002|Overall Study|Study Terminated By Sponsor|0|||
143144675|NCT01799889|516076192|FG003|Overall Study|Study Terminated By Sponsor|0|||
143144676|NCT01799889|516076193|FG004|Overall Study|Study Terminated By Sponsor|2|||
143144677|NCT01799889|516076194|FG005|Overall Study|Study Terminated By Sponsor|1|||
143144678|NCT01799889|516076195|FG006|Overall Study|Study Terminated By Sponsor|0|||
143144679|NCT01799889|516076196|FG007|Overall Study|Study Terminated By Sponsor|2|||
143144680|NCT01799889|516076197|FG008|Overall Study|Study Terminated By Sponsor|1|||
143144681|NCT01799889|516076198|FG009|Overall Study|Study Terminated By Sponsor|1|||
143144682|NCT01799889|516076199|FG010|Overall Study|Study Terminated By Sponsor|0|||
143144683|NCT01799889|516076200|FG011|Overall Study|Study Terminated By Sponsor|0|||
143144684|NCT01799889|516076189|FG000|Overall Study|Withdrawal by Subject|1|||
143144685|NCT01799889|516076190|FG001|Overall Study|Withdrawal by Subject|6|||
143144686|NCT01799889|516076191|FG002|Overall Study|Withdrawal by Subject|4|||
143478062|NCT01007032|517296030|FG001|Overall Study|Withdrawal by Subject|0|||
143478063|NCT01007032|517296031|FG002|Overall Study|Withdrawal by Subject|0|||
143478064|NCT01007032|517296032|FG003|Overall Study|Withdrawal by Subject|1|||
143478065|NCT03794583|517296033|FG000|Overall Study|Death|8|||
143478066|NCT03794583|517296033|FG000|Overall Study|Study Terminated by Sponsor|24|||
143478067|NCT03794583|517296033|FG000|Overall Study|Withdrawal by Subject|9|||
143478068|NCT01161043|517296036|FG000|Overall Study|Withdrawal by Subject|3|||
143014098|NCT00422058|515591616|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
143478069|NCT02164929|517296037|FG000|Overall Study|Converted to open procedure|1|||
143144687|NCT01799889|516076192|FG003|Overall Study|Withdrawal by Subject|0|||
143144688|NCT01799889|516076193|FG004|Overall Study|Withdrawal by Subject|5|||
143478070|NCT02164929|517296038|FG001|Overall Study|Converted to open procedure|0|||
143144689|NCT01799889|516076194|FG005|Overall Study|Withdrawal by Subject|1|||
143144690|NCT01799889|516076195|FG006|Overall Study|Withdrawal by Subject|3|||
143144691|NCT01799889|516076196|FG007|Overall Study|Withdrawal by Subject|1|||
143144692|NCT01799889|516076197|FG008|Overall Study|Withdrawal by Subject|2|||
143144693|NCT01799889|516076198|FG009|Overall Study|Withdrawal by Subject|1|||
143144694|NCT01799889|516076199|FG010|Overall Study|Withdrawal by Subject|1|||
143144695|NCT01799889|516076200|FG011|Overall Study|Withdrawal by Subject|1|||
143144696|NCT01799889|516076189|FG000|Overall Study|Non-Compliance With Study Drug|0|||
143144697|NCT01799889|516076190|FG001|Overall Study|Non-Compliance With Study Drug|0|||
143144698|NCT01799889|516076191|FG002|Overall Study|Non-Compliance With Study Drug|0|||
143144699|NCT01799889|516076192|FG003|Overall Study|Non-Compliance With Study Drug|0|||
143144700|NCT01799889|516076193|FG004|Overall Study|Non-Compliance With Study Drug|0|||
143144701|NCT01799889|516076194|FG005|Overall Study|Non-Compliance With Study Drug|1|||
143144702|NCT01799889|516076195|FG006|Overall Study|Non-Compliance With Study Drug|0|||
143144703|NCT01799889|516076196|FG007|Overall Study|Non-Compliance With Study Drug|0|||
143144704|NCT01799889|516076197|FG008|Overall Study|Non-Compliance With Study Drug|0|||
143144705|NCT01799889|516076198|FG009|Overall Study|Non-Compliance With Study Drug|0|||
143144706|NCT01799889|516076199|FG010|Overall Study|Non-Compliance With Study Drug|0|||
143144707|NCT01799889|516076200|FG011|Overall Study|Non-Compliance With Study Drug|0|||
143144708|NCT00300053|516076205|FG000|Overall Study|Patient/Caregiver Preference|2|||
143144709|NCT00300053|516076206|FG001|Overall Study|Patient/Caregiver Preference|2|||
143144710|NCT00300053|516076207|FG002|Overall Study|Patient/Caregiver Preference|3|||
143144711|NCT00300053|516076205|FG000|Overall Study|Death|0|||
143144712|NCT00300053|516076206|FG001|Overall Study|Death|0|||
143144713|NCT00300053|516076207|FG002|Overall Study|Death|3|||
143144714|NCT00300053|516076205|FG000|Overall Study|Lost to Follow-up|0|||
143144715|NCT00300053|516076206|FG001|Overall Study|Lost to Follow-up|1|||
143478071|NCT02164929|517296039|FG002|Overall Study|Converted to open procedure|0|||
143478072|NCT02164929|517296040|FG003|Overall Study|Converted to open procedure|2|||
143478073|NCT02164929|517296037|FG000|Overall Study|Failed regional block|0|||
143478074|NCT02164929|517296038|FG001|Overall Study|Failed regional block|0|||
143478075|NCT02164929|517296039|FG002|Overall Study|Failed regional block|1|||
143478076|NCT02164929|517296040|FG003|Overall Study|Failed regional block|0|||
143478077|NCT00701090|517296048|FG000|Overall Study|Adverse Event|11|||
143144716|NCT00300053|516076207|FG002|Overall Study|Lost to Follow-up|0|||
143144717|NCT02566005|516076208|FG000|Overall Study|vaginal bleeding|0|||
143144718|NCT02566005|516076209|FG001|Overall Study|vaginal bleeding|1|||
143144719|NCT02566005|516076208|FG000|Overall Study|received foley|8|||
143144720|NCT02566005|516076209|FG001|Overall Study|received foley|0|||
143144721|NCT02566005|516076208|FG000|Overall Study|did not receive foley|0|||
143144722|NCT02566005|516076209|FG001|Overall Study|did not receive foley|1|||
143144723|NCT02566005|516076208|FG000|Overall Study|labor after randomization|0|||
143144724|NCT02566005|516076209|FG001|Overall Study|labor after randomization|4|||
143144725|NCT01963611|516076212|FG000|Overall Study|Adverse Event|1|||
143144726|NCT01963611|516076213|FG001|Overall Study|Adverse Event|1|||
143144727|NCT01963611|516076214|FG002|Overall Study|Adverse Event|3|||
143144728|NCT01963611|516076215|FG003|Overall Study|Adverse Event|4|||
143144729|NCT01963611|516076216|FG004|Overall Study|Adverse Event|3|||
143144730|NCT01963611|516076212|FG000|Overall Study|Protocol Violation|0|||
143144731|NCT01963611|516076213|FG001|Overall Study|Protocol Violation|0|||
143144732|NCT01963611|516076214|FG002|Overall Study|Protocol Violation|0|||
143144733|NCT01963611|516076215|FG003|Overall Study|Protocol Violation|1|||
143144734|NCT01963611|516076216|FG004|Overall Study|Protocol Violation|0|||
143144735|NCT01963611|516076212|FG000|Overall Study|Lack of Efficacy|0|||
143144736|NCT01963611|516076213|FG001|Overall Study|Lack of Efficacy|0|||
143144737|NCT01963611|516076214|FG002|Overall Study|Lack of Efficacy|0|||
143144738|NCT01963611|516076215|FG003|Overall Study|Lack of Efficacy|1|||
143144739|NCT01963611|516076216|FG004|Overall Study|Lack of Efficacy|0|||
143144740|NCT01963611|516076212|FG000|Overall Study|Withdrawal by Subject|3|||
143144741|NCT01963611|516076213|FG001|Overall Study|Withdrawal by Subject|2|||
143144742|NCT01963611|516076214|FG002|Overall Study|Withdrawal by Subject|1|||
143144743|NCT01963611|516076215|FG003|Overall Study|Withdrawal by Subject|1|||
143144744|NCT01963611|516076216|FG004|Overall Study|Withdrawal by Subject|3|||
143144745|NCT01963611|516076212|FG000|Overall Study|Other|47|||
143144746|NCT01963611|516076213|FG001|Overall Study|Other|46|||
143144747|NCT01963611|516076214|FG002|Overall Study|Other|48|||
143144748|NCT01963611|516076215|FG003|Overall Study|Other|45|||
143144749|NCT01963611|516076216|FG004|Overall Study|Other|45|||
143478078|NCT00701090|517296049|FG001|Overall Study|Adverse Event|2|||
143144750|NCT03801252|516076217|FG000|Overall Study|Protocol Violation|1|||
143144751|NCT03801252|516076218|FG001|Overall Study|Protocol Violation|2|||
143144752|NCT02471183|516076219|FG000|Main Treatment Period|Adverse Event|1|||
143478079|NCT00701090|517296048|FG000|Overall Study|Death|0|||
143478080|NCT00701090|517296049|FG001|Overall Study|Death|1|||
143478081|NCT00701090|517296048|FG000|Overall Study|Lack of Efficacy|5|||
143478082|NCT00701090|517296049|FG001|Overall Study|Lack of Efficacy|4|||
143478083|NCT00701090|517296048|FG000|Overall Study|Lost to Follow-up|9|||
143478084|NCT00701090|517296049|FG001|Overall Study|Lost to Follow-up|9|||
143478085|NCT00701090|517296048|FG000|Overall Study|Physician Decision|3|||
143478086|NCT00701090|517296049|FG001|Overall Study|Physician Decision|4|||
143478087|NCT00701090|517296048|FG000|Overall Study|Protocol Violation|2|||
143478088|NCT00701090|517296049|FG001|Overall Study|Protocol Violation|3|||
143478089|NCT00701090|517296048|FG000|Overall Study|Withdrawal by Subject|11|||
143478090|NCT00701090|517296049|FG001|Overall Study|Withdrawal by Subject|16|||
143478091|NCT00701090|517296048|FG000|Overall Study|Other|7|||
143478092|NCT00701090|517296049|FG001|Overall Study|Other|12|||
143478093|NCT01299376|517296054|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
143478094|NCT01299376|517296055|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
143478095|NCT01299376|517296054|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
143144753|NCT02471183|516076219|FG000|Main Treatment Period|Withdrawal by Subject|1|||
143478096|NCT01299376|517296055|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
143478097|NCT01299376|517296054|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
143478098|NCT01299376|517296055|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
143478099|NCT01299376|517296054|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
143478100|NCT01299376|517296055|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
143144754|NCT02471183|516076219|FG000|Extended Treatment Period|Lack of Efficacy|1|||
143144755|NCT00614393|516076224|FG000|Overall Study|Adverse Event|20|||
143144756|NCT00614393|516076225|FG001|Overall Study|Adverse Event|2|||
143144757|NCT00614393|516076226|FG002|Overall Study|Adverse Event|3|||
143144758|NCT00614393|516076227|FG003|Overall Study|Adverse Event|13|||
143144759|NCT00614393|516076228|FG004|Overall Study|Adverse Event|21|||
143144760|NCT00614393|516076224|FG000|Overall Study|Lost to Follow-up|0|||
143144761|NCT00614393|516076225|FG001|Overall Study|Lost to Follow-up|0|||
143144762|NCT00614393|516076226|FG002|Overall Study|Lost to Follow-up|0|||
143144763|NCT00614393|516076227|FG003|Overall Study|Lost to Follow-up|1|||
143144764|NCT00614393|516076228|FG004|Overall Study|Lost to Follow-up|2|||
143144765|NCT00614393|516076224|FG000|Overall Study|Physician Decision|17|||
143144766|NCT00614393|516076225|FG001|Overall Study|Physician Decision|0|||
143144767|NCT00614393|516076226|FG002|Overall Study|Physician Decision|1|||
143144768|NCT00614393|516076227|FG003|Overall Study|Physician Decision|8|||
143144769|NCT00614393|516076228|FG004|Overall Study|Physician Decision|9|||
143144770|NCT00614393|516076224|FG000|Overall Study|Progressive Disease|118|||
143144771|NCT00614393|516076225|FG001|Overall Study|Progressive Disease|5|||
143144772|NCT00614393|516076226|FG002|Overall Study|Progressive Disease|5|||
143144773|NCT00614393|516076227|FG003|Overall Study|Progressive Disease|138|||
143144774|NCT00614393|516076228|FG004|Overall Study|Progressive Disease|130|||
143144775|NCT00614393|516076224|FG000|Overall Study|Protocol Violation|1|||
143144776|NCT00614393|516076225|FG001|Overall Study|Protocol Violation|0|||
143144777|NCT00614393|516076226|FG002|Overall Study|Protocol Violation|0|||
143144778|NCT00614393|516076227|FG003|Overall Study|Protocol Violation|0|||
143144779|NCT00614393|516076228|FG004|Overall Study|Protocol Violation|0|||
143144780|NCT00614393|516076224|FG000|Overall Study|Terminated by Sponsor|0|||
143144781|NCT00614393|516076225|FG001|Overall Study|Terminated by Sponsor|0|||
143144782|NCT00614393|516076226|FG002|Overall Study|Terminated by Sponsor|0|||
143144783|NCT00614393|516076227|FG003|Overall Study|Terminated by Sponsor|0|||
143144784|NCT00614393|516076228|FG004|Overall Study|Terminated by Sponsor|1|||
143144785|NCT00614393|516076224|FG000|Overall Study|Withdrawal by Subject|20|||
143144786|NCT00614393|516076225|FG001|Overall Study|Withdrawal by Subject|1|||
143144787|NCT00614393|516076226|FG002|Overall Study|Withdrawal by Subject|1|||
143144788|NCT00614393|516076227|FG003|Overall Study|Withdrawal by Subject|16|||
143144789|NCT00614393|516076228|FG004|Overall Study|Withdrawal by Subject|13|||
143144790|NCT00614393|516076224|FG000|Overall Study|Other|4|||
143144791|NCT00614393|516076225|FG001|Overall Study|Other|0|||
143144792|NCT00614393|516076226|FG002|Overall Study|Other|0|||
143144793|NCT00614393|516076227|FG003|Overall Study|Other|4|||
143144794|NCT00614393|516076228|FG004|Overall Study|Other|2|||
143144795|NCT00614393|516076224|FG000|Overall Study|Not Treated|0|||
143144796|NCT00614393|516076225|FG001|Overall Study|Not Treated|0|||
143144797|NCT00614393|516076226|FG002|Overall Study|Not Treated|0|||
143478101|NCT01299376|517296054|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
143144798|NCT00614393|516076227|FG003|Overall Study|Not Treated|0|||
143478102|NCT01299376|517296055|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
143478103|NCT01299376|517296054|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
143144799|NCT00614393|516076228|FG004|Overall Study|Not Treated|2|||
143144800|NCT02328105|516076229|FG000|Overall Study|Death|6|||
143144801|NCT02328105|516076229|FG000|Overall Study|Withdrawal by Subject|1|||
143144802|NCT02328105|516076229|FG000|Overall Study|Still On Study in Follow-Up|4|||
143144803|NCT00855582|516076230|FG000|Overall Study|Adverse Event|2|||
143144804|NCT00855582|516076231|FG001|Overall Study|Adverse Event|6|||
143144805|NCT00855582|516076232|FG002|Overall Study|Adverse Event|3|||
143144806|NCT00855582|516076230|FG000|Overall Study|Death|1|||
143478104|NCT01299376|517296055|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
143478105|NCT01299376|517296054|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
143478106|NCT01299376|517296055|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
143144807|NCT00855582|516076231|FG001|Overall Study|Death|0|||
143144808|NCT00855582|516076232|FG002|Overall Study|Death|0|||
143144809|NCT00855582|516076230|FG000|Overall Study|Lack of Efficacy|1|||
143144810|NCT00855582|516076231|FG001|Overall Study|Lack of Efficacy|3|||
143144811|NCT00855582|516076232|FG002|Overall Study|Lack of Efficacy|8|||
143144812|NCT00855582|516076230|FG000|Overall Study|Lost to Follow-up|1|||
143144813|NCT00855582|516076231|FG001|Overall Study|Lost to Follow-up|3|||
143144814|NCT00855582|516076232|FG002|Overall Study|Lost to Follow-up|1|||
143144815|NCT00855582|516076230|FG000|Overall Study|Physician Decision|0|||
143144816|NCT00855582|516076231|FG001|Overall Study|Physician Decision|0|||
143144817|NCT00855582|516076232|FG002|Overall Study|Physician Decision|1|||
143144818|NCT00855582|516076230|FG000|Overall Study|Protocol Violation|6|||
143144819|NCT00855582|516076231|FG001|Overall Study|Protocol Violation|2|||
143144820|NCT00855582|516076232|FG002|Overall Study|Protocol Violation|6|||
143144821|NCT00855582|516076230|FG000|Overall Study|Entry Criteria Not Met|8|||
143144822|NCT00855582|516076231|FG001|Overall Study|Entry Criteria Not Met|6|||
143144823|NCT00855582|516076232|FG002|Overall Study|Entry Criteria Not Met|3|||
143144824|NCT00855582|516076230|FG000|Overall Study|Withdrawal by Subject|7|||
143144825|NCT00855582|516076231|FG001|Overall Study|Withdrawal by Subject|4|||
143144826|NCT00855582|516076232|FG002|Overall Study|Withdrawal by Subject|8|||
143144827|NCT02349386|516076258|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
143144828|NCT02349386|516076259|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
143144829|NCT02349386|516076260|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
143144830|NCT02349386|516076261|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
143144831|NCT02349386|516076258|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
143144832|NCT02349386|516076259|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
143144833|NCT02349386|516076260|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
143144834|NCT02349386|516076261|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
143144835|NCT02349386|516076258|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
143144836|NCT02349386|516076259|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
143144837|NCT02349386|516076260|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
143144838|NCT02349386|516076261|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
143144839|NCT02349386|516076258|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
143363539|NCT01394991|516873766|FG000|Overall Study|Chemotherapy Termination|10|||
143363540|NCT01394991|516873767|FG001|Overall Study|Chemotherapy Termination|15|||
143363541|NCT01394991|516873766|FG000|Overall Study|Disease Progression|7|||
143363542|NCT01394991|516873767|FG001|Overall Study|Disease Progression|7|||
143363543|NCT01394991|516873766|FG000|Overall Study|Prematurely Termination of Trial|9|||
143363544|NCT01394991|516873767|FG001|Overall Study|Prematurely Termination of Trial|10|||
143363545|NCT00097370|516873768|FG000|Stage 1|Adverse Event|3|||
143363546|NCT00097370|516873768|FG000|Stage 1|Withdrawal by Subject|1|||
143363547|NCT00097370|516873768|FG000|Stage 1|Lack of Efficacy|2|||
143363548|NCT00097370|516873768|FG000|Stage 2|Adverse Event|5|||
143363549|NCT00097370|516873768|FG000|Stage 2|Withdrawal by Subject|1|||
143363550|NCT00097370|516873768|FG000|Stage 2|Lack of Efficacy|3|||
143363551|NCT00097370|516873768|FG000|Stage 2|Pregnancy|1|||
143363552|NCT00097370|516873768|FG000|Stage 2|Sponsor Terminated Study|2|||
143363553|NCT00097370|516873768|FG000|Stage 2|Lost to Follow-up|1|||
143363554|NCT00097370|516873768|FG000|Stage 3|Adverse Event|2|||
143363555|NCT00097370|516873768|FG000|Stage 3|Withdrawal by Subject|3|||
143363556|NCT00097370|516873768|FG000|Stage 3|Lack of Efficacy|1|||
143363557|NCT00097370|516873768|FG000|Stage 3|Sponsor Terminated Study|52|||
143363558|NCT00097370|516873768|FG000|Stage 3|Lost to Follow-up|1|||
143363559|NCT01734811|516873778|FG000|Overall Study|Lost to Follow-up|2|||
143363560|NCT01734811|516873779|FG001|Overall Study|Lost to Follow-up|3|||
143363561|NCT01734811|516873778|FG000|Overall Study|Withdrawal by Subject|2|||
143363562|NCT01734811|516873779|FG001|Overall Study|Withdrawal by Subject|0|||
143363563|NCT00062868|516873780|FG000|Dose Level 1|Death|2|||
143363564|NCT00062868|516873781|FG001|Dose Level 1|Death|0|||
143363565|NCT00062868|516873782|FG002|Dose Level 1|Death|0|||
143363566|NCT00062868|516873783|FG003|Dose Level 1|Death|2|||
143363567|NCT00062868|516873784|FG004|Dose Level 1|Death|0|||
143363568|NCT00062868|516873785|FG005|Dose Level 1|Death|0|||
143478107|NCT01299376|517296054|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
143363569|NCT00062868|516873786|FG006|Dose Level 1|Death|3|||
143144840|NCT02349386|516076259|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
143363570|NCT00062868|516873787|FG007|Dose Level 1|Death|0|||
143363571|NCT00062868|516873788|FG008|Dose Level 1|Death|0|||
143363572|NCT00062868|516873789|FG009|Dose Level 1|Death|0|||
143363573|NCT00062868|516873790|FG010|Dose Level 1|Death|0|||
143363574|NCT00062868|516873791|FG011|Dose Level 1|Death|0|||
143363575|NCT00062868|516873792|FG012|Dose Level 1|Death|0|||
143363576|NCT00062868|516873793|FG013|Dose Level 1|Death|0|||
143363577|NCT00062868|516873794|FG014|Dose Level 1|Death|0|||
143478108|NCT01299376|517296055|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
143478109|NCT01299376|517296054|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
143478110|NCT01299376|517296055|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
143478111|NCT01299376|517296054|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
143478112|NCT01299376|517296055|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
143478113|NCT01299376|517296054|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
143478114|NCT01299376|517296055|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
143478115|NCT00509067|517296058|FG000|Overall Study|Lost to Follow-up|1|||
143478116|NCT00509067|517296059|FG001|Overall Study|Lost to Follow-up|1|||
143478117|NCT00509067|517296058|FG000|Overall Study|Adverse Event|3|||
143478118|NCT00509067|517296059|FG001|Overall Study|Adverse Event|1|||
143478119|NCT00509067|517296058|FG000|Overall Study|Protocol Violation|0|||
143478120|NCT00509067|517296059|FG001|Overall Study|Protocol Violation|3|||
143478121|NCT02790138|517296062|FG000|Overall Study|Adverse Event|5|||
143478122|NCT02790138|517296063|FG001|Overall Study|Adverse Event|2|||
143478123|NCT02790138|517296062|FG000|Overall Study|Significant Protocol Deviation|0|||
143478124|NCT02790138|517296063|FG001|Overall Study|Significant Protocol Deviation|1|||
143478125|NCT02790138|517296062|FG000|Overall Study|Lost to Follow-up|1|||
143478126|NCT02790138|517296063|FG001|Overall Study|Lost to Follow-up|0|||
143478127|NCT02790138|517296062|FG000|Overall Study|Voluntary Withdrawal|8|||
143478128|NCT02790138|517296063|FG001|Overall Study|Voluntary Withdrawal|9|||
143478129|NCT02790138|517296062|FG000|Overall Study|Lack of Efficacy|6|||
143478130|NCT02790138|517296063|FG001|Overall Study|Lack of Efficacy|7|||
143478131|NCT02790138|517296062|FG000|Overall Study|Reason not Specified|1|||
143478132|NCT02790138|517296063|FG001|Overall Study|Reason not Specified|0|||
143478133|NCT03199040|517296064|FG000|Overall Study|Lack of Efficacy|2|||
143478134|NCT03199040|517296065|FG001|Overall Study|Lack of Efficacy|0|||
143478135|NCT03199040|517296064|FG000|Overall Study|Withdrawal by Subject|2|||
143478136|NCT03199040|517296065|FG001|Overall Study|Withdrawal by Subject|0|||
143478137|NCT03199040|517296064|FG000|Overall Study|Adverse Event|0|||
143478138|NCT03199040|517296065|FG001|Overall Study|Adverse Event|1|||
143478139|NCT03199040|517296064|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
143478140|NCT03199040|517296065|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
143478141|NCT03700320|517296066|FG000|Overall Study|Adverse Event|5|||
143478142|NCT03700320|517296067|FG001|Overall Study|Adverse Event|31|||
143478143|NCT03700320|517296066|FG000|Overall Study|Lack of Efficacy|2|||
143478144|NCT03700320|517296067|FG001|Overall Study|Lack of Efficacy|5|||
143478145|NCT03700320|517296066|FG000|Overall Study|Withdrawal by Subject|29|||
143478146|NCT03700320|517296067|FG001|Overall Study|Withdrawal by Subject|75|||
143478147|NCT03700320|517296066|FG000|Overall Study|Lost to Follow-up|16|||
143478148|NCT03700320|517296067|FG001|Overall Study|Lost to Follow-up|23|||
143478149|NCT03700320|517296066|FG000|Overall Study|Pregnancy|2|||
143478150|NCT03700320|517296067|FG001|Overall Study|Pregnancy|4|||
143478151|NCT03700320|517296066|FG000|Overall Study|Protocol Deviation|7|||
143478152|NCT03700320|517296067|FG001|Overall Study|Protocol Deviation|31|||
143478153|NCT03700320|517296066|FG000|Overall Study|Non-compliance with Study Drug|1|||
143478154|NCT03700320|517296067|FG001|Overall Study|Non-compliance with Study Drug|3|||
143478155|NCT03700320|517296066|FG000|Overall Study|Reason not Specified|0|||
143478156|NCT03700320|517296067|FG001|Overall Study|Reason not Specified|1|||
143478157|NCT03654976|517296075|FG000|Overall Study|Withdrawal by Subject|12|||
143478158|NCT03654976|517296076|FG001|Overall Study|Withdrawal by Subject|11|||
143478159|NCT03654976|517296075|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
143478160|NCT03654976|517296076|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
143478161|NCT03654976|517296075|FG000|Overall Study|Adverse Event|5|||
143478162|NCT03654976|517296076|FG001|Overall Study|Adverse Event|0|||
143478163|NCT03654976|517296075|FG000|Overall Study|Lost to Follow-up|2|||
143478164|NCT03654976|517296076|FG001|Overall Study|Lost to Follow-up|0|||
143478165|NCT03654976|517296075|FG000|Overall Study|Lack of Efficacy|0|||
143478166|NCT03654976|517296076|FG001|Overall Study|Lack of Efficacy|1|||
143478167|NCT01854645|517296077|FG000|Overall Study|Protocol-Specified Criteria|13|||
143478168|NCT01854645|517296078|FG001|Overall Study|Protocol-Specified Criteria|10|||
143478169|NCT01854645|517296079|FG002|Overall Study|Protocol-Specified Criteria|8|||
143478170|NCT01854645|517296080|FG003|Overall Study|Protocol-Specified Criteria|5|||
143478171|NCT01854645|517296081|FG004|Overall Study|Protocol-Specified Criteria|7|||
143478172|NCT01854645|517296077|FG000|Overall Study|Administrative Reasons / Missing|0|||
143478173|NCT01854645|517296078|FG001|Overall Study|Administrative Reasons / Missing|0|||
143478174|NCT01854645|517296079|FG002|Overall Study|Administrative Reasons / Missing|0|||
143478175|NCT01854645|517296080|FG003|Overall Study|Administrative Reasons / Missing|1|||
143478176|NCT01854645|517296081|FG004|Overall Study|Administrative Reasons / Missing|1|||
143478177|NCT01854645|517296077|FG000|Overall Study|Protocol Violation|3|||
143478178|NCT01854645|517296078|FG001|Overall Study|Protocol Violation|0|||
143478179|NCT01854645|517296079|FG002|Overall Study|Protocol Violation|5|||
143478180|NCT01854645|517296080|FG003|Overall Study|Protocol Violation|4|||
143478181|NCT01854645|517296081|FG004|Overall Study|Protocol Violation|1|||
143478182|NCT01854645|517296077|FG000|Overall Study|Lost to Follow-up|10|||
143478183|NCT01854645|517296078|FG001|Overall Study|Lost to Follow-up|7|||
143478184|NCT01854645|517296079|FG002|Overall Study|Lost to Follow-up|8|||
143478185|NCT01854645|517296080|FG003|Overall Study|Lost to Follow-up|5|||
143144841|NCT02349386|516076260|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
143144842|NCT02349386|516076261|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
143144843|NCT02349386|516076258|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
143144844|NCT02349386|516076259|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
143144845|NCT02349386|516076260|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
143144846|NCT02349386|516076261|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
143144847|NCT02349386|516076258|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
143144848|NCT02349386|516076259|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
143144849|NCT02349386|516076260|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
143144850|NCT02349386|516076261|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
143144851|NCT02471339|516076262|FG000|Overall Study|Did not provide follow-up data|2|||
143144852|NCT02471339|516076263|FG001|Overall Study|Did not provide follow-up data|0|||
143144853|NCT00984867|516076264|FG000|Overall Study|Adverse Event|3|||
143144854|NCT00984867|516076265|FG001|Overall Study|Adverse Event|7|||
143144855|NCT00984867|516076264|FG000|Overall Study|Death|1|||
143144856|NCT00984867|516076265|FG001|Overall Study|Death|0|||
143144857|NCT00984867|516076264|FG000|Overall Study|Withdrawal by Subject|13|||
143144858|NCT00984867|516076265|FG001|Overall Study|Withdrawal by Subject|4|||
143144859|NCT00984867|516076264|FG000|Overall Study|Lost to Follow-up|3|||
143144860|NCT00984867|516076265|FG001|Overall Study|Lost to Follow-up|4|||
143144861|NCT00984867|516076264|FG000|Overall Study|Poor/non-compliance|0|||
143144862|NCT00984867|516076265|FG001|Overall Study|Poor/non-compliance|1|||
143144863|NCT00984867|516076264|FG000|Overall Study|Subject no longer meets study criteria|1|||
143144864|NCT00984867|516076265|FG001|Overall Study|Subject no longer meets study criteria|1|||
143144865|NCT00984867|516076264|FG000|Overall Study|site closing|1|||
143144866|NCT00984867|516076265|FG001|Overall Study|site closing|0|||
143144867|NCT00984867|516076264|FG000|Overall Study|lack of efficacy and subject compliance|1|||
143144868|NCT00984867|516076265|FG001|Overall Study|lack of efficacy and subject compliance|0|||
143144869|NCT06057064|516076266|FG000|Overall Study|Death|2|||
143144870|NCT06057064|516076267|FG001|Overall Study|Death|0|||
143144871|NCT06057064|516076266|FG000|Overall Study|Physician Decision|1|||
143144872|NCT06057064|516076267|FG001|Overall Study|Physician Decision|0|||
143144873|NCT06057064|516076266|FG000|Overall Study|Withdrawal by Subject|1|||
143144874|NCT06057064|516076267|FG001|Overall Study|Withdrawal by Subject|1|||
143144875|NCT00626639|516076275|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
143144876|NCT00626639|516076276|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
143144877|NCT01461551|516076277|FG000|Overall Study|Physician Decision|2|||
143144878|NCT01461551|516076278|FG001|Overall Study|Physician Decision|1|||
143144879|NCT01461551|516076279|FG002|Overall Study|Physician Decision|2|||
143144880|NCT01155141|516076280|FG000|Overall Study|Withdrawal by Subject|1|||
143144881|NCT01155141|516076280|FG000|Overall Study|Screen Failure|1|||
143144882|NCT00785629|516076284|FG000|Overall Study|Adverse Event|2|||
143144883|NCT00785629|516076285|FG001|Overall Study|Adverse Event|1|||
143144884|NCT00785629|516076286|FG002|Overall Study|Adverse Event|1|||
143144885|NCT00785629|516076287|FG003|Overall Study|Adverse Event|5|||
143144886|NCT00785629|516076284|FG000|Overall Study|Protocol Violation|1|||
143144887|NCT00785629|516076285|FG001|Overall Study|Protocol Violation|2|||
143144888|NCT00785629|516076286|FG002|Overall Study|Protocol Violation|4|||
143144889|NCT00785629|516076287|FG003|Overall Study|Protocol Violation|5|||
143144890|NCT00785629|516076284|FG000|Overall Study|administrative decision|5|||
143144891|NCT00785629|516076285|FG001|Overall Study|administrative decision|1|||
143144892|NCT00785629|516076286|FG002|Overall Study|administrative decision|3|||
143144893|NCT00785629|516076287|FG003|Overall Study|administrative decision|4|||
143144894|NCT00785629|516076284|FG000|Overall Study|Withdrawal by Subject|0|||
143144895|NCT00785629|516076285|FG001|Overall Study|Withdrawal by Subject|1|||
143144896|NCT00785629|516076286|FG002|Overall Study|Withdrawal by Subject|2|||
143144897|NCT00785629|516076287|FG003|Overall Study|Withdrawal by Subject|2|||
143144898|NCT00851591|516076288|FG000|Overall Study|Withdrawal by Subject|2|||
143144899|NCT00851591|516076289|FG001|Overall Study|Withdrawal by Subject|0|||
143144900|NCT02326883|516076291|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
143144901|NCT02326883|516076292|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
143144902|NCT02326883|516076293|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
143144903|NCT02107898|516076296|FG000|Overall Study|Adverse Event|4|||
143144904|NCT02107898|516076297|FG001|Overall Study|Adverse Event|7|||
143144905|NCT02107898|516076296|FG000|Overall Study|Poor compliance to protocol|0|||
143144906|NCT02107898|516076297|FG001|Overall Study|Poor compliance to protocol|1|||
143144907|NCT02107898|516076296|FG000|Overall Study|Participant moved|0|||
143144908|NCT02107898|516076297|FG001|Overall Study|Participant moved|2|||
143144909|NCT02107898|516076296|FG000|Overall Study|Consent withdrawn by participant|2|||
143144910|NCT02107898|516076297|FG001|Overall Study|Consent withdrawn by participant|1|||
143144911|NCT02107898|516076296|FG000|Overall Study|Randomized but not treated|0|||
143144912|NCT02107898|516076297|FG001|Overall Study|Randomized but not treated|1|||
143144913|NCT03329989|516076298|FG000|Overall Study|Withdrawal by Subject|9|||
143144914|NCT03329989|516076298|FG000|Overall Study|Lost to Follow-up|8|||
143144915|NCT03329989|516076298|FG000|Overall Study|Adverse Event|5|||
143144916|NCT03329989|516076298|FG000|Overall Study|Protocol Violation|1|||
143144917|NCT01898130|516076299|FG000|Treatment|Withdrawal by Subject|2|||
143144918|NCT01898130|516076299|FG000|Treatment|Progressive Disease|4|||
143144919|NCT01898130|516076299|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
143144920|NCT00142415|516076300|FG000|Overall Study|Physician Decision|0|||
143144921|NCT00142415|516076301|FG001|Overall Study|Physician Decision|0|||
143144922|NCT00142415|516076302|FG002|Overall Study|Physician Decision|0|||
143144923|NCT00142415|516076303|FG003|Overall Study|Physician Decision|0|||
143144924|NCT00142415|516076304|FG004|Overall Study|Physician Decision|1|||
143144925|NCT00142415|516076305|FG005|Overall Study|Physician Decision|2|||
143144926|NCT00537277|516076308|FG000|Overall Study|Adverse Event|1|||
143144927|NCT00537277|516076308|FG000|Overall Study|Lack of Efficacy|2|||
143144928|NCT00537277|516076308|FG000|Overall Study|Lost to Follow-up|12|||
143144929|NCT00537277|516076308|FG000|Overall Study|Protocol Violation|11|||
143144930|NCT00537277|516076308|FG000|Overall Study|Unclassified|4|||
143144931|NCT00537277|516076308|FG000|Overall Study|Inability to tolerate trial medication|4|||
143144932|NCT00537277|516076308|FG000|Overall Study|Non-compliance with trial procedures|15|||
143144933|NCT03620162|516076309|FG000|Overall Study|Physician Decision|4|||
143144934|NCT03620162|516076310|FG001|Overall Study|Physician Decision|0|||
143144935|NCT03620162|516076311|FG002|Overall Study|Physician Decision|1|||
143144936|NCT03620162|516076312|FG003|Overall Study|Physician Decision|0|||
143144937|NCT03620162|516076313|FG004|Overall Study|Physician Decision|2|||
143144938|NCT03620162|516076309|FG000|Overall Study|Lost to Follow-up|2|||
143478186|NCT01854645|517296081|FG004|Overall Study|Lost to Follow-up|0|||
143478187|NCT01854645|517296077|FG000|Overall Study|Physician Decision|1|||
143144939|NCT03620162|516076310|FG001|Overall Study|Lost to Follow-up|6|||
143144940|NCT03620162|516076311|FG002|Overall Study|Lost to Follow-up|7|||
143144941|NCT03620162|516076312|FG003|Overall Study|Lost to Follow-up|3|||
143144942|NCT03620162|516076313|FG004|Overall Study|Lost to Follow-up|2|||
143144943|NCT03620162|516076309|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
143144944|NCT03620162|516076310|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
143144945|NCT03620162|516076311|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
143144946|NCT03620162|516076312|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
143144947|NCT03620162|516076313|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
143144948|NCT04009837|516076316|FG000|Overall Study|Withdrawal by Subject|5|||
143144949|NCT04009837|516076317|FG001|Overall Study|Withdrawal by Subject|4|||
143144950|NCT04009837|516076316|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
143144951|NCT04009837|516076317|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
143144952|NCT01572792|516076320|FG000|Lead-in Study|Lost to Follow-up|5|||
143144953|NCT01572792|516076321|FG001|Lead-in Study|Lost to Follow-up|9|||
143144954|NCT01572792|516076322|FG002|Lead-in Study|Lost to Follow-up|4|||
143144955|NCT01572792|516076323|FG003|Lead-in Study|Lost to Follow-up|2|||
143144956|NCT01572792|516076324|FG004|Lead-in Study|Lost to Follow-up|4|||
143144957|NCT01572792|516076320|FG000|Lead-in Study|Withdrawal by Subject|22|||
143144958|NCT01572792|516076321|FG001|Lead-in Study|Withdrawal by Subject|11|||
143144959|NCT01572792|516076322|FG002|Lead-in Study|Withdrawal by Subject|12|||
143144960|NCT01572792|516076323|FG003|Lead-in Study|Withdrawal by Subject|24|||
143144961|NCT01572792|516076324|FG004|Lead-in Study|Withdrawal by Subject|11|||
143478188|NCT01854645|517296078|FG001|Overall Study|Physician Decision|5|||
143478189|NCT01854645|517296079|FG002|Overall Study|Physician Decision|3|||
143478190|NCT01854645|517296080|FG003|Overall Study|Physician Decision|3|||
143478191|NCT01854645|517296081|FG004|Overall Study|Physician Decision|7|||
143478192|NCT01854645|517296077|FG000|Overall Study|Withdrawal by Subject|31|||
143478193|NCT01854645|517296078|FG001|Overall Study|Withdrawal by Subject|41|||
143478194|NCT01854645|517296079|FG002|Overall Study|Withdrawal by Subject|30|||
143144962|NCT01572792|516076320|FG000|Lead-in Study|Protocol Violation|19|||
143144963|NCT01572792|516076321|FG001|Lead-in Study|Protocol Violation|10|||
143144964|NCT01572792|516076322|FG002|Lead-in Study|Protocol Violation|12|||
143144965|NCT01572792|516076323|FG003|Lead-in Study|Protocol Violation|13|||
143478195|NCT01854645|517296080|FG003|Overall Study|Withdrawal by Subject|21|||
143144966|NCT01572792|516076324|FG004|Lead-in Study|Protocol Violation|21|||
143144967|NCT01572792|516076320|FG000|Lead-in Study|Lack of Efficacy|20|||
143144968|NCT01572792|516076321|FG001|Lead-in Study|Lack of Efficacy|5|||
143144969|NCT01572792|516076322|FG002|Lead-in Study|Lack of Efficacy|4|||
143144970|NCT01572792|516076323|FG003|Lead-in Study|Lack of Efficacy|8|||
143144971|NCT01572792|516076324|FG004|Lead-in Study|Lack of Efficacy|10|||
143144972|NCT01572792|516076320|FG000|Lead-in Study|Adverse Event|21|||
143478196|NCT01854645|517296081|FG004|Overall Study|Withdrawal by Subject|24|||
143478197|NCT01854645|517296077|FG000|Overall Study|Lack of Efficacy|7|||
143478198|NCT01854645|517296078|FG001|Overall Study|Lack of Efficacy|12|||
143478199|NCT01854645|517296079|FG002|Overall Study|Lack of Efficacy|9|||
143144973|NCT01572792|516076321|FG001|Lead-in Study|Adverse Event|21|||
143144974|NCT01572792|516076322|FG002|Lead-in Study|Adverse Event|22|||
143144975|NCT01572792|516076323|FG003|Lead-in Study|Adverse Event|16|||
143478200|NCT01854645|517296080|FG003|Overall Study|Lack of Efficacy|3|||
143478201|NCT01854645|517296081|FG004|Overall Study|Lack of Efficacy|9|||
143478202|NCT01854645|517296077|FG000|Overall Study|Adverse Event|33|||
143478203|NCT01854645|517296078|FG001|Overall Study|Adverse Event|31|||
143478204|NCT01854645|517296079|FG002|Overall Study|Adverse Event|19|||
143144976|NCT01572792|516076324|FG004|Lead-in Study|Adverse Event|14|||
143144977|NCT01572792|516076320|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
143144978|NCT01572792|516076321|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
143144979|NCT01572792|516076322|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
143144980|NCT01572792|516076323|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
143144981|NCT01572792|516076324|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
143144982|NCT01572792|516076320|FG000|Extension Study|Lost to Follow-up|6|||
143144983|NCT01572792|516076321|FG001|Extension Study|Lost to Follow-up|2|||
143144984|NCT01572792|516076322|FG002|Extension Study|Lost to Follow-up|0|||
143144985|NCT01572792|516076323|FG003|Extension Study|Lost to Follow-up|3|||
143144986|NCT01572792|516076324|FG004|Extension Study|Lost to Follow-up|3|||
143144987|NCT01572792|516076320|FG000|Extension Study|Withdrawal by Subject|7|||
143144988|NCT01572792|516076321|FG001|Extension Study|Withdrawal by Subject|6|||
143144989|NCT01572792|516076322|FG002|Extension Study|Withdrawal by Subject|11|||
143144990|NCT01572792|516076323|FG003|Extension Study|Withdrawal by Subject|8|||
143144991|NCT01572792|516076324|FG004|Extension Study|Withdrawal by Subject|14|||
143144992|NCT01572792|516076320|FG000|Extension Study|Protocol Violation|0|||
143144993|NCT01572792|516076321|FG001|Extension Study|Protocol Violation|4|||
143144994|NCT01572792|516076322|FG002|Extension Study|Protocol Violation|3|||
143144995|NCT01572792|516076323|FG003|Extension Study|Protocol Violation|4|||
143144996|NCT01572792|516076324|FG004|Extension Study|Protocol Violation|3|||
143144997|NCT01572792|516076320|FG000|Extension Study|Lack of Efficacy|2|||
143144998|NCT01572792|516076321|FG001|Extension Study|Lack of Efficacy|3|||
143144999|NCT01572792|516076322|FG002|Extension Study|Lack of Efficacy|3|||
143145000|NCT01572792|516076323|FG003|Extension Study|Lack of Efficacy|2|||
143145001|NCT01572792|516076324|FG004|Extension Study|Lack of Efficacy|2|||
143145002|NCT01572792|516076320|FG000|Extension Study|Adverse Event|7|||
143145003|NCT01572792|516076321|FG001|Extension Study|Adverse Event|6|||
143145004|NCT01572792|516076322|FG002|Extension Study|Adverse Event|5|||
143145005|NCT01572792|516076323|FG003|Extension Study|Adverse Event|6|||
143145006|NCT01572792|516076324|FG004|Extension Study|Adverse Event|4|||
143145007|NCT01572792|516076320|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
143145008|NCT01572792|516076321|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
143145009|NCT01572792|516076322|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
143145010|NCT01572792|516076323|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
143145011|NCT01572792|516076324|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
143145012|NCT02101294|516076325|FG000|Overall Study|Withdrawal by Subject|5|||
143145013|NCT02101294|516076325|FG000|Overall Study|Lost to Follow-up|6|||
143145014|NCT00688597|516076328|FG000|Overall Study|Adverse Event|2|||
143145015|NCT00688597|516076329|FG001|Overall Study|Adverse Event|0|||
143145016|NCT00688597|516076330|FG002|Overall Study|Adverse Event|0|||
143145017|NCT00688597|516076328|FG000|Overall Study|Physician Decision|1|||
143145018|NCT00688597|516076329|FG001|Overall Study|Physician Decision|0|||
143145019|NCT00688597|516076330|FG002|Overall Study|Physician Decision|0|||
143145020|NCT06438601|516076331|FG000|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|1|||
143145021|NCT06438601|516076332|FG001|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|0|||
143145022|NCT06438601|516076331|FG000|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|1|||
143145023|NCT06438601|516076332|FG001|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|0|||
143145024|NCT01056536|516076333|FG000|Overall Study|Lost to Follow-up|202|||
143145025|NCT01056536|516076334|FG001|Overall Study|Lost to Follow-up|116|||
143145026|NCT01056536|516076335|FG002|Overall Study|Lost to Follow-up|248|||
143145027|NCT04058717|516076344|FG000|Randomization Period|Lost to Follow-up|2|||
143145028|NCT04058717|516076345|FG001|Randomization Period|Lost to Follow-up|3|||
143145029|NCT04058717|516076346|FG002|Randomization Period|Lost to Follow-up|4|||
143145030|NCT04058717|516076347|FG003|Randomization Period|Lost to Follow-up|4|||
143145031|NCT04058717|516076344|FG000|Randomization Period|Withdrawal by Subject|1|||
143145032|NCT04058717|516076345|FG001|Randomization Period|Withdrawal by Subject|3|||
143145033|NCT04058717|516076346|FG002|Randomization Period|Withdrawal by Subject|3|||
143478205|NCT01854645|517296080|FG003|Overall Study|Adverse Event|20|||
143478206|NCT01854645|517296081|FG004|Overall Study|Adverse Event|11|||
143478207|NCT01817751|517296084|FG000|Overall Study|Physician Decision|1|||
143478208|NCT00382018|517296085|FG000|Overall Study|Progression|0|||
143478209|NCT00382018|517296086|FG001|Overall Study|Progression|136|||
143145034|NCT04058717|516076347|FG003|Randomization Period|Withdrawal by Subject|3|||
143145035|NCT04058717|516076344|FG000|Randomization Period|PI decision|0|||
143145036|NCT04058717|516076345|FG001|Randomization Period|PI decision|1|||
143145037|NCT04058717|516076346|FG002|Randomization Period|PI decision|0|||
143145038|NCT04058717|516076347|FG003|Randomization Period|PI decision|0|||
143145039|NCT04486716|516077933|FG000|Core Phase|Subject decision|6|||
143145040|NCT04486716|516077933|FG000|Core Phase|Adverse Event|5|||
143145041|NCT04486716|516077933|FG000|Core Phase|Lost to Follow-up|1|||
143478210|NCT00382018|517296087|FG002|Overall Study|Progression|51|||
143145042|NCT04486716|516077933|FG000|Core Phase|Physician Decision|1|||
143145043|NCT04486716|516077933|FG000|Core Phase|Enrolled subjects not treated|9|||
143145044|NCT03405870|516077934|FG000|Overall Study|Withdrawal|1|||
143145045|NCT03405870|516077935|FG001|Overall Study|Withdrawal|0|||
143145046|NCT03405870|516077936|FG002|Overall Study|Withdrawal|1|||
143145047|NCT03405870|516077937|FG003|Overall Study|Withdrawal|0|||
143145048|NCT03405870|516077938|FG004|Overall Study|Withdrawal|0|||
143145049|NCT03405870|516077939|FG005|Overall Study|Withdrawal|0|||
143145050|NCT03405870|516077940|FG006|Overall Study|Withdrawal|1|||
143145051|NCT03405870|516077941|FG007|Overall Study|Withdrawal|0|||
143478211|NCT00382018|517296088|FG003|Overall Study|Progression|43|||
143478212|NCT00382018|517296085|FG000|Overall Study|Death|0|||
143478213|NCT00382018|517296086|FG001|Overall Study|Death|9|||
143478214|NCT00382018|517296087|FG002|Overall Study|Death|7|||
143478215|NCT00382018|517296088|FG003|Overall Study|Death|11|||
143478216|NCT00382018|517296085|FG000|Overall Study|Withdrawal by Subject|0|||
143014099|NCT00422058|515591617|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
143145052|NCT03846479|516077942|FG000|Overall Study|Death|8|||
143145053|NCT03846479|516077942|FG000|Overall Study|Lost to Follow-up|1|||
143145054|NCT00362232|516077943|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
143145055|NCT00362232|516077944|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
143145056|NCT00362232|516077943|FG000|Treatment (12 +/- 2 Days)|Death|1|||
143145057|NCT00362232|516077944|FG001|Treatment (12 +/- 2 Days)|Death|3|||
143145058|NCT00362232|516077943|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
143145059|NCT00362232|516077944|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
143145060|NCT00362232|516077943|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
143145061|NCT00362232|516077944|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
143145062|NCT00362232|516077943|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
143145063|NCT00362232|516077944|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
143145064|NCT00362232|516077943|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
143145065|NCT00362232|516077944|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
143145066|NCT00362232|516077943|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
143145067|NCT00362232|516077944|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
143145068|NCT00362232|516077943|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
143145069|NCT00362232|516077944|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
143145070|NCT00362232|516077943|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
143145071|NCT00362232|516077944|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
143145072|NCT00362232|516077943|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
143145073|NCT00362232|516077944|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
143145074|NCT00362232|516077943|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
143145075|NCT00362232|516077944|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
143145076|NCT00362232|516077943|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
143145077|NCT00362232|516077944|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
143145078|NCT00362232|516077943|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
143145079|NCT00362232|516077944|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
143145080|NCT04476043|516077953|FG000|Overall Study|Withdrawal by Subject|1|||
143145081|NCT04476043|516077954|FG001|Overall Study|Withdrawal by Subject|3|||
143145082|NCT04476043|516077955|FG002|Overall Study|Withdrawal by Subject|4|||
143145083|NCT04476043|516077956|FG003|Overall Study|Withdrawal by Subject|1|||
143145084|NCT04476043|516077953|FG000|Overall Study|Lost to Follow-up|1|||
143145085|NCT04476043|516077954|FG001|Overall Study|Lost to Follow-up|1|||
143145086|NCT04476043|516077955|FG002|Overall Study|Lost to Follow-up|2|||
143145087|NCT04476043|516077956|FG003|Overall Study|Lost to Follow-up|1|||
143145088|NCT04476043|516077953|FG000|Overall Study|Adverse Event|2|||
143145089|NCT04476043|516077954|FG001|Overall Study|Adverse Event|0|||
143145090|NCT04476043|516077955|FG002|Overall Study|Adverse Event|1|||
143145091|NCT04476043|516077956|FG003|Overall Study|Adverse Event|0|||
143145092|NCT04476043|516077953|FG000|Overall Study|Protocol Violation|0|||
143145093|NCT04476043|516077954|FG001|Overall Study|Protocol Violation|1|||
143145094|NCT04476043|516077955|FG002|Overall Study|Protocol Violation|0|||
143145095|NCT04476043|516077956|FG003|Overall Study|Protocol Violation|0|||
143145096|NCT06217380|516077957|FG000|Overall Study|Death: Unrelated to the device. The subject was enrolled but did not start any study activities|1|||
143145097|NCT06217380|516077957|FG000|Overall Study|Physician Decision|1|||
143145098|NCT06217380|516077957|FG000|Overall Study|Withdrawal by Subject|2|||
143145099|NCT06633965|516077958|FG000|Overall Study|Withdrawal by Subject|0|||
143145100|NCT06633965|516077959|FG001|Overall Study|Withdrawal by Subject|1|||
143145101|NCT02469233|516077960|FG000|Overall Study|Death|1|||
143145102|NCT02469233|516077961|FG001|Overall Study|Death|1|||
143145103|NCT02469233|516077960|FG000|Overall Study|Lost to post or 6 month follow up|7|||
143145104|NCT02469233|516077961|FG001|Overall Study|Lost to post or 6 month follow up|2|||
143145105|NCT01013753|516077962|FG000|Overall Study|Adverse Event|8|||
143145106|NCT01013753|516077962|FG000|Overall Study|Protocol Violation|3|||
143145107|NCT01013753|516077962|FG000|Overall Study|Lost to Follow-up|1|||
143145108|NCT01013753|516077962|FG000|Overall Study|Withdrawal by Subject|2|||
143145109|NCT01013753|516077962|FG000|Overall Study|Other|2|||
143145110|NCT04757636|516077963|FG000|Overall Study|Adverse Event|25|||
143478217|NCT00382018|517296086|FG001|Overall Study|Withdrawal by Subject|4|||
143478218|NCT00382018|517296087|FG002|Overall Study|Withdrawal by Subject|3|||
143478219|NCT00382018|517296088|FG003|Overall Study|Withdrawal by Subject|4|||
143478220|NCT00382018|517296085|FG000|Overall Study|Other, not protocol specified|0|||
143145111|NCT04757636|516077964|FG001|Overall Study|Adverse Event|8|||
143145112|NCT04757636|516077965|FG002|Overall Study|Adverse Event|11|||
143145113|NCT04757636|516077963|FG000|Overall Study|Death|9|||
143145114|NCT04757636|516077964|FG001|Overall Study|Death|12|||
143145115|NCT04757636|516077965|FG002|Overall Study|Death|6|||
143145116|NCT04757636|516077963|FG000|Overall Study|Lack of Efficacy|2|||
143145117|NCT04757636|516077964|FG001|Overall Study|Lack of Efficacy|0|||
143145118|NCT04757636|516077965|FG002|Overall Study|Lack of Efficacy|0|||
143145119|NCT04757636|516077963|FG000|Overall Study|Lost to Follow-up|1|||
143145120|NCT04757636|516077964|FG001|Overall Study|Lost to Follow-up|6|||
143145121|NCT04757636|516077965|FG002|Overall Study|Lost to Follow-up|7|||
143145122|NCT04757636|516077963|FG000|Overall Study|Physician Decision|1|||
143145123|NCT04757636|516077964|FG001|Overall Study|Physician Decision|3|||
143145124|NCT04757636|516077965|FG002|Overall Study|Physician Decision|4|||
143145125|NCT04757636|516077963|FG000|Overall Study|Withdrawal by Subject|20|||
143145126|NCT04757636|516077964|FG001|Overall Study|Withdrawal by Subject|23|||
143145127|NCT04757636|516077965|FG002|Overall Study|Withdrawal by Subject|18|||
143145128|NCT04757636|516077963|FG000|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
143145129|NCT04757636|516077964|FG001|Overall Study|Discontinued Study Treatment at or prior to Week 52|1|||
143145130|NCT04757636|516077965|FG002|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
143145131|NCT04757636|516077963|FG000|Overall Study|Study Terminated by Sponsor|103|||
143145132|NCT04757636|516077964|FG001|Overall Study|Study Terminated by Sponsor|104|||
143145133|NCT04757636|516077965|FG002|Overall Study|Study Terminated by Sponsor|114|||
143145134|NCT04757636|516077963|FG000|Overall Study|Sponsor Decision|0|||
143145135|NCT04757636|516077964|FG001|Overall Study|Sponsor Decision|0|||
143145136|NCT04757636|516077965|FG002|Overall Study|Sponsor Decision|1|||
143145137|NCT04757636|516077963|FG000|Overall Study|Randomized in Error|0|||
143145138|NCT04757636|516077964|FG001|Overall Study|Randomized in Error|0|||
143145139|NCT04757636|516077965|FG002|Overall Study|Randomized in Error|2|||
143145140|NCT00141921|516077967|FG000|Overall Study|Remain on Study|28|||
143145141|NCT00141921|516077967|FG000|Overall Study|Withdrawal by Subject|42|||
143145142|NCT00141921|516077967|FG000|Overall Study|Lost to Follow-up|19|||
143145143|NCT00141921|516077967|FG000|Overall Study|Noncompliance|17|||
143145144|NCT00141921|516077967|FG000|Overall Study|Disease Progression|7|||
143145145|NCT00141921|516077967|FG000|Overall Study|Protocol Deviation|7|||
143145146|NCT00141921|516077967|FG000|Overall Study|Adverse Event|5|||
143145147|NCT00141921|516077967|FG000|Overall Study|Administrative Decision|2|||
143145148|NCT00141921|516077967|FG000|Overall Study|Pregnancy|4|||
143145149|NCT00141921|516077967|FG000|Overall Study|Ineligibility Determined|2|||
143145150|NCT00141921|516077967|FG000|Overall Study|Other|8|||
143145151|NCT00671060|516077968|FG000|Overall Study|Protocol Violation|1|||
143145152|NCT00671060|516077969|FG001|Overall Study|Protocol Violation|0|||
143145153|NCT00671060|516077968|FG000|Overall Study|Physician Decision|0|||
143145154|NCT00671060|516077969|FG001|Overall Study|Physician Decision|1|||
143145155|NCT01541748|516077970|FG000|Overall Study|Lost to Follow-up|17|||
143145156|NCT01541748|516077970|FG000|Overall Study|Moved out of state|1|||
143145157|NCT01541748|516077970|FG000|Overall Study|Withdrawal by Subject|7|||
143145158|NCT01541748|516077970|FG000|Overall Study|Screen failure|5|||
143145159|NCT01541748|516077970|FG000|Overall Study|Did not receive study device|1|||
143145160|NCT00303186|516077971|FG000|Overall Study|Other|52|||
143145161|NCT03473197|516077972|FG000|Overall Study|Adverse Event|4|||
143145162|NCT03473197|516077972|FG000|Overall Study|Lost to Follow-up|1|||
143145163|NCT03473197|516077972|FG000|Overall Study|Withdrawal by Subject|5|||
143145164|NCT01283386|516077977|FG000|Overall Study|Death|2|||
143145165|NCT01283386|516077978|FG001|Overall Study|Death|0|||
143145166|NCT01283386|516077977|FG000|Overall Study|Withdrawal by Subject|2|||
143145167|NCT01283386|516077978|FG001|Overall Study|Withdrawal by Subject|1|||
143145168|NCT01283386|516077977|FG000|Overall Study|Relapse of underlying disease|1|||
143145169|NCT01283386|516077978|FG001|Overall Study|Relapse of underlying disease|3|||
143145170|NCT01283386|516077977|FG000|Overall Study|Progression of underlying disease|2|||
143145171|NCT01283386|516077978|FG001|Overall Study|Progression of underlying disease|7|||
143145172|NCT01283386|516077977|FG000|Overall Study|Reason not specified|1|||
143145173|NCT01283386|516077978|FG001|Overall Study|Reason not specified|0|||
143145174|NCT01283386|516077977|FG000|Overall Study|Protocol Violation|0|||
143363578|NCT00062868|516873795|FG015|Dose Level 1|Death|0|||
143145175|NCT01283386|516077978|FG001|Overall Study|Protocol Violation|1|||
143145176|NCT02469857|516077979|FG000|Overall Study|Death|24|||
143363579|NCT00062868|516873796|FG016|Dose Level 1|Death|0|||
143145177|NCT02469857|516077980|FG001|Overall Study|Death|29|||
143145178|NCT02469857|516077979|FG000|Overall Study|Discontinuation|1|||
143145179|NCT02469857|516077980|FG001|Overall Study|Discontinuation|3|||
143145180|NCT00937950|516077981|FG000|Overall Study|Withdrawal by Subject|23|||
143145181|NCT00937950|516077981|FG000|Overall Study|Migrated/moved from study area|27|||
143363580|NCT00062868|516873797|FG017|Dose Level 1|Death|0|||
143145182|NCT00937950|516077981|FG000|Overall Study|Lost to Follow-up|144|||
143363581|NCT00062868|516873798|FG018|Dose Level 1|Death|7|||
143478221|NCT00382018|517296086|FG001|Overall Study|Other, not protocol specified|16|||
143478222|NCT00382018|517296087|FG002|Overall Study|Other, not protocol specified|3|||
143478223|NCT00382018|517296088|FG003|Overall Study|Other, not protocol specified|1|||
143145183|NCT00937950|516077981|FG000|Overall Study|Missing confirmed|4|||
143145184|NCT00937950|516077981|FG000|Overall Study|Other|18|||
143145185|NCT01137786|516077982|FG000|Overall Study|Lost to Follow-up|0|||
143145186|NCT01137786|516077983|FG001|Overall Study|Lost to Follow-up|2|||
143145187|NCT01137786|516077982|FG000|Overall Study|Withdrawal by Subject|1|||
143145188|NCT01137786|516077983|FG001|Overall Study|Withdrawal by Subject|1|||
143145189|NCT01531153|516077984|FG000|Overall Study|Withdrawal by Subject|10|||
143145190|NCT01531153|516077985|FG001|Overall Study|Withdrawal by Subject|9|||
143145191|NCT01531153|516077986|FG002|Overall Study|Withdrawal by Subject|15|||
143145192|NCT00770367|516077987|FG000|First Intervention|Withdrawal by Subject|0|||
143145193|NCT00770367|516077988|FG001|First Intervention|Withdrawal by Subject|2|||
143145194|NCT00770367|516077987|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
143145195|NCT00770367|516077988|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
143145196|NCT00770367|516077987|FG000|Second Intervention|Lost to Follow-up|2|||
143145197|NCT00770367|516077988|FG001|Second Intervention|Lost to Follow-up|0|||
143145198|NCT04727749|516077990|FG000|Overall Study|Lost to Follow-up|10|||
143145199|NCT04727749|516077991|FG001|Overall Study|Lost to Follow-up|3|||
143145200|NCT02378181|516077992|FG000|Overall Study|Lost to Follow-up|2|||
143145201|NCT02378181|516077993|FG001|Overall Study|Lost to Follow-up|5|||
143145202|NCT02378181|516077992|FG000|Overall Study|Withdrawal by Subject|1|||
143145203|NCT02378181|516077993|FG001|Overall Study|Withdrawal by Subject|1|||
143145204|NCT02378181|516077992|FG000|Overall Study|Incarcerated|0|||
143145205|NCT02378181|516077993|FG001|Overall Study|Incarcerated|1|||
143145206|NCT00297167|516077995|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
143145207|NCT00297167|516077996|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
143145208|NCT00297167|516077997|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
143145209|NCT00297167|516077995|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
143145210|NCT00297167|516077996|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
143145211|NCT00297167|516077997|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
143145212|NCT00920816|516077998|FG000|Overall Study|Death|116|||
143145213|NCT00920816|516077999|FG001|Overall Study|Death|63|||
143145214|NCT00920816|516078000|FG002|Overall Study|Death|8|||
143145215|NCT00920816|516078001|FG003|Overall Study|Death|3|||
143145216|NCT00920816|516077998|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
143145217|NCT00920816|516077999|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
143145218|NCT00920816|516078000|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
143145219|NCT00920816|516078001|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
143145220|NCT00920816|516077998|FG000|Overall Study|Global deterioration of health status|2|||
143145221|NCT00920816|516077999|FG001|Overall Study|Global deterioration of health status|0|||
143145222|NCT00920816|516078000|FG002|Overall Study|Global deterioration of health status|0|||
143145223|NCT00920816|516078001|FG003|Overall Study|Global deterioration of health status|0|||
143145224|NCT00920816|516077998|FG000|Overall Study|Objective progression or relapse|6|||
143145225|NCT00920816|516077999|FG001|Overall Study|Objective progression or relapse|2|||
143145226|NCT00920816|516078000|FG002|Overall Study|Objective progression or relapse|0|||
143145227|NCT00920816|516078001|FG003|Overall Study|Objective progression or relapse|0|||
143145228|NCT00920816|516077998|FG000|Overall Study|Other|26|||
143145229|NCT00920816|516077999|FG001|Overall Study|Other|15|||
143145230|NCT00920816|516078000|FG002|Overall Study|Other|1|||
143145231|NCT00920816|516078001|FG003|Overall Study|Other|2|||
143145232|NCT00920816|516077998|FG000|Overall Study|Lost to Follow-up|11|||
143145233|NCT00920816|516077999|FG001|Overall Study|Lost to Follow-up|2|||
143145234|NCT00920816|516078000|FG002|Overall Study|Lost to Follow-up|0|||
143145235|NCT00920816|516078001|FG003|Overall Study|Lost to Follow-up|0|||
143145236|NCT00920816|516077998|FG000|Overall Study|Adverse Event|1|||
143145237|NCT00920816|516077999|FG001|Overall Study|Adverse Event|1|||
143145238|NCT00920816|516078000|FG002|Overall Study|Adverse Event|1|||
143145239|NCT00920816|516078001|FG003|Overall Study|Adverse Event|0|||
143145240|NCT00920816|516077998|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
143145241|NCT00920816|516077999|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
143145242|NCT00920816|516078000|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
143145243|NCT00920816|516078001|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
143145244|NCT00920816|516077998|FG000|Overall Study|Randomized but not treated|3|||
143145245|NCT00920816|516077999|FG001|Overall Study|Randomized but not treated|0|||
143145246|NCT00920816|516078000|FG002|Overall Study|Randomized but not treated|0|||
143145247|NCT00920816|516078001|FG003|Overall Study|Randomized but not treated|0|||
143145248|NCT01033136|516078002|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
143478224|NCT01846624|517296089|FG000|Overall Study|Died during induction, no midostaurin|1|||
143478225|NCT01252810|517296090|FG000|Overall Study|Withdrawal by Subject|4|||
143478226|NCT01252810|517296091|FG001|Overall Study|Withdrawal by Subject|1|||
143478227|NCT01252810|517296090|FG000|Overall Study|Lost to Follow-up|0|||
143478228|NCT01252810|517296091|FG001|Overall Study|Lost to Follow-up|1|||
143478229|NCT01252810|517296090|FG000|Overall Study|Physician Decision|2|||
143478230|NCT01252810|517296091|FG001|Overall Study|Physician Decision|1|||
143478231|NCT01252810|517296090|FG000|Overall Study|Various reasons|8|||
143478232|NCT01252810|517296091|FG001|Overall Study|Various reasons|0|||
143478233|NCT00427349|517296095|FG000|Overall Study|Lack of Efficacy|23|||
143478234|NCT00427349|517296095|FG000|Overall Study|Adverse Event|14|||
143145249|NCT01033136|516078003|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
143145250|NCT00630292|516078004|FG000|Overall Study|Withdrawal by Subject|1|||
143145251|NCT02382939|516078005|FG000|Overall Study|Adverse Event|1|||
143145252|NCT02382939|516078006|FG001|Overall Study|Adverse Event|1|||
143145253|NCT02382939|516078005|FG000|Overall Study|Withdrawal by Subject|2|||
143145254|NCT02382939|516078006|FG001|Overall Study|Withdrawal by Subject|2|||
143145255|NCT00321763|516078010|FG000|Overall Study|Adverse Event|1|||
143145256|NCT00321763|516078011|FG001|Overall Study|Adverse Event|1|||
143145257|NCT00321763|516078012|FG002|Overall Study|Adverse Event|0|||
143145258|NCT00321763|516078013|FG003|Overall Study|Adverse Event|1|||
143145259|NCT00321763|516078010|FG000|Overall Study|Withdrawal by Subject|2|||
143145260|NCT00321763|516078011|FG001|Overall Study|Withdrawal by Subject|0|||
143145261|NCT00321763|516078012|FG002|Overall Study|Withdrawal by Subject|1|||
143145262|NCT00321763|516078013|FG003|Overall Study|Withdrawal by Subject|0|||
143145263|NCT00321763|516078010|FG000|Overall Study|Lost to Follow-up|3|||
143145264|NCT00321763|516078011|FG001|Overall Study|Lost to Follow-up|1|||
143145265|NCT00321763|516078012|FG002|Overall Study|Lost to Follow-up|5|||
143145266|NCT00321763|516078013|FG003|Overall Study|Lost to Follow-up|4|||
143145267|NCT01553851|516078014|FG000|Overall Study|Adverse Event|2|||
143145268|NCT01553851|516078014|FG000|Overall Study|constipation|1|||
143145269|NCT03530696|516078015|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
143145270|NCT03530696|516078016|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
143145271|NCT01551173|516078017|FG000|Overall Study|Withdrawal by Subject|11|||
143145272|NCT01551173|516078018|FG001|Overall Study|Withdrawal by Subject|16|||
143145273|NCT01551173|516078017|FG000|Overall Study|Adverse Event|7|||
143145274|NCT01551173|516078018|FG001|Overall Study|Adverse Event|6|||
143145275|NCT01551173|516078017|FG000|Overall Study|Lost to Follow-up|5|||
143145276|NCT01551173|516078018|FG001|Overall Study|Lost to Follow-up|7|||
143145277|NCT01551173|516078017|FG000|Overall Study|Other|5|||
143145278|NCT01551173|516078018|FG001|Overall Study|Other|3|||
143145279|NCT04530344|516078019|FG000|Overall Study|Lost to Follow-up|3|||
143145280|NCT04530344|516078020|FG001|Overall Study|Lost to Follow-up|3|||
143145281|NCT04530344|516078021|FG002|Overall Study|Lost to Follow-up|3|||
143145282|NCT04530344|516078022|FG003|Overall Study|Lost to Follow-up|10|||
143145283|NCT04530344|516078019|FG000|Overall Study|Withdrawal by Subject|14|||
143145284|NCT04530344|516078020|FG001|Overall Study|Withdrawal by Subject|5|||
143145285|NCT04530344|516078021|FG002|Overall Study|Withdrawal by Subject|18|||
143145286|NCT04530344|516078022|FG003|Overall Study|Withdrawal by Subject|33|||
143145287|NCT04530344|516078019|FG000|Overall Study|Adverse Event|0|||
143145288|NCT04530344|516078020|FG001|Overall Study|Adverse Event|0|||
143145289|NCT04530344|516078021|FG002|Overall Study|Adverse Event|0|||
143145290|NCT04530344|516078022|FG003|Overall Study|Adverse Event|1|||
143145291|NCT04530344|516078019|FG000|Overall Study|Lack of Efficacy|0|||
143145292|NCT04530344|516078020|FG001|Overall Study|Lack of Efficacy|0|||
143145293|NCT04530344|516078021|FG002|Overall Study|Lack of Efficacy|0|||
143145294|NCT04530344|516078022|FG003|Overall Study|Lack of Efficacy|1|||
143145295|NCT04530344|516078019|FG000|Overall Study|Physician Decision|0|||
143145296|NCT04530344|516078020|FG001|Overall Study|Physician Decision|0|||
143145297|NCT04530344|516078021|FG002|Overall Study|Physician Decision|1|||
143145298|NCT04530344|516078022|FG003|Overall Study|Physician Decision|1|||
143145299|NCT04530344|516078019|FG000|Overall Study|Pregnancy|0|||
143145300|NCT04530344|516078020|FG001|Overall Study|Pregnancy|0|||
143145301|NCT04530344|516078021|FG002|Overall Study|Pregnancy|2|||
143145302|NCT04530344|516078022|FG003|Overall Study|Pregnancy|1|||
143145303|NCT04530344|516078019|FG000|Overall Study|Protocol Violation|0|||
143145304|NCT04530344|516078020|FG001|Overall Study|Protocol Violation|0|||
143145305|NCT04530344|516078021|FG002|Overall Study|Protocol Violation|0|||
143145306|NCT04530344|516078022|FG003|Overall Study|Protocol Violation|1|||
143145307|NCT04530344|516078019|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
143145308|NCT04530344|516078020|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
143145309|NCT04530344|516078021|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
143145310|NCT04530344|516078022|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
143145311|NCT04530344|516078019|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
143145312|NCT04530344|516078020|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
143145313|NCT04530344|516078021|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
143145314|NCT04530344|516078022|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
143145315|NCT04530344|516078019|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
143145316|NCT04530344|516078020|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
143478235|NCT00427349|517296095|FG000|Overall Study|Death|1|||
143478236|NCT00427349|517296095|FG000|Overall Study|Withdrawal by Subject|3|||
143478237|NCT00427349|517296095|FG000|Overall Study|Alternative therapy|1|||
143478238|NCT00427349|517296095|FG000|Overall Study|Other|2|||
143478239|NCT00427349|517296095|FG000|Overall Study|Ineligible|1|||
143478240|NCT00427349|517296095|FG000|Overall Study|Never started therapy|1|||
143478241|NCT00698997|517296096|FG000|Overall Study|Lost to Follow-up|3|||
143478242|NCT00698997|517296097|FG001|Overall Study|Lost to Follow-up|0|||
143478243|NCT00698997|517296096|FG000|Overall Study|Withdrawal by Subject|7|||
143478244|NCT00698997|517296097|FG001|Overall Study|Withdrawal by Subject|27|||
143478245|NCT05082376|517296098|FG000|Overall Study|Lost to Follow-up|2|||
143478246|NCT00493220|517296099|FG000|Third Intervention|Withdrawal by Subject|1|||
143478247|NCT00493220|517296100|FG001|Third Intervention|Withdrawal by Subject|0|||
143478248|NCT00493220|517296101|FG002|Third Intervention|Withdrawal by Subject|0|||
143478249|NCT00493220|517296102|FG003|Third Intervention|Withdrawal by Subject|0|||
143478250|NCT00493220|517296103|FG004|Third Intervention|Withdrawal by Subject|0|||
143478251|NCT00493220|517296104|FG005|Third Intervention|Withdrawal by Subject|0|||
143478252|NCT02625233|517296105|FG000|Overall Study|Adverse Event|2|||
143478253|NCT02625233|517296106|FG001|Overall Study|Adverse Event|0|||
143478254|NCT04425720|517296112|FG000|Overall Study|Withdrawal by Subject|0|||
143478255|NCT04425720|517296113|FG001|Overall Study|Withdrawal by Subject|20|||
143478256|NCT00445224|517296114|FG000|Specific Exercises|Withdrawal by Subject|3|||
143478257|NCT00445224|517296115|FG001|Specific Exercises|Withdrawal by Subject|3|||
143478258|NCT00445224|517296114|FG000|Specific Exercises|Withdrawal by Subject|1|||
143478259|NCT00445224|517296115|FG001|Specific Exercises|Withdrawal by Subject|0|||
143478260|NCT01490450|517297783|FG000|Period 1|Lack of Efficacy|2|||
143478261|NCT01490450|517297784|FG001|Period 1|Lack of Efficacy|0|||
143478262|NCT01490450|517297785|FG002|Period 1|Lack of Efficacy|3|||
143478263|NCT01490450|517297786|FG003|Period 1|Lack of Efficacy|0|||
143478264|NCT01490450|517297783|FG000|Period 1|Adverse Event|0|||
143478265|NCT01490450|517297784|FG001|Period 1|Adverse Event|0|||
143478266|NCT01490450|517297785|FG002|Period 1|Adverse Event|0|||
143478267|NCT01490450|517297786|FG003|Period 1|Adverse Event|5|||
143478268|NCT01490450|517297783|FG000|Period 1|Request to discontinue treatment|1|||
143478269|NCT01490450|517297784|FG001|Period 1|Request to discontinue treatment|0|||
143478270|NCT01490450|517297785|FG002|Period 1|Request to discontinue treatment|0|||
143478271|NCT01490450|517297786|FG003|Period 1|Request to discontinue treatment|0|||
143478272|NCT01490450|517297783|FG000|Period 1|Withdrawal by Subject|0|||
143478273|NCT01490450|517297784|FG001|Period 1|Withdrawal by Subject|0|||
143478274|NCT01490450|517297785|FG002|Period 1|Withdrawal by Subject|0|||
143478275|NCT01490450|517297786|FG003|Period 1|Withdrawal by Subject|3|||
143478276|NCT01490450|517297783|FG000|Period 1|No longer met study criteria|0|||
143478277|NCT01490450|517297784|FG001|Period 1|No longer met study criteria|1|||
143478278|NCT01490450|517297785|FG002|Period 1|No longer met study criteria|1|||
143478279|NCT01490450|517297786|FG003|Period 1|No longer met study criteria|0|||
143478280|NCT01490450|517297783|FG000|Period 2|Lack of Efficacy|0|||
143145317|NCT04530344|516078021|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
143145318|NCT04530344|516078022|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
143145319|NCT04530344|516078019|FG000|Overall Study|Personal Reasons|0|||
143145320|NCT04530344|516078020|FG001|Overall Study|Personal Reasons|0|||
143145321|NCT04530344|516078021|FG002|Overall Study|Personal Reasons|0|||
143145322|NCT04530344|516078022|FG003|Overall Study|Personal Reasons|1|||
143145323|NCT04530344|516078019|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
143145324|NCT04530344|516078020|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
143145325|NCT04530344|516078021|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
143145326|NCT04530344|516078022|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
143145327|NCT05049122|516078023|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
143145328|NCT05049122|516078023|FG000|Overall Study|Participant moved|1|||
143145329|NCT05049122|516078023|FG000|Overall Study|At the direction of the doctor|1|||
143145330|NCT05722015|516078024|FG000|Overall Study|Death|57|||
143145331|NCT05722015|516078025|FG001|Overall Study|Death|37|||
143145332|NCT05722015|516078024|FG000|Overall Study|Lost to Follow-up|1|||
143145333|NCT05722015|516078025|FG001|Overall Study|Lost to Follow-up|0|||
143145334|NCT05722015|516078024|FG000|Overall Study|Withdrawal by Subject|5|||
143478281|NCT01490450|517297784|FG001|Period 2|Lack of Efficacy|0|||
143478282|NCT01490450|517297785|FG002|Period 2|Lack of Efficacy|0|||
143478283|NCT01490450|517297786|FG003|Period 2|Lack of Efficacy|1|||
143478284|NCT01490450|517297783|FG000|Period 2|Adverse Event|1|||
143478285|NCT01490450|517297784|FG001|Period 2|Adverse Event|1|||
143478286|NCT01490450|517297785|FG002|Period 2|Adverse Event|0|||
143478287|NCT01490450|517297786|FG003|Period 2|Adverse Event|1|||
143145335|NCT05722015|516078025|FG001|Overall Study|Withdrawal by Subject|1|||
143145336|NCT05722015|516078024|FG000|Overall Study|Participants Ongoing|188|||
143145337|NCT05722015|516078025|FG001|Overall Study|Participants Ongoing|88|||
143478288|NCT01490450|517297783|FG000|Period 2|Withdrawal by Subject|1|||
143478289|NCT01490450|517297784|FG001|Period 2|Withdrawal by Subject|0|||
143478290|NCT01490450|517297785|FG002|Period 2|Withdrawal by Subject|0|||
143478291|NCT01490450|517297786|FG003|Period 2|Withdrawal by Subject|0|||
143478292|NCT01490450|517297783|FG000|Period 2|Lost to Follow-up|0|||
143478293|NCT01490450|517297784|FG001|Period 2|Lost to Follow-up|0|||
143145338|NCT02657551|516078026|FG000|Overall Study|Adverse Event|2|||
143145339|NCT02657551|516078026|FG000|Overall Study|Withdrawal by Subject|1|||
143145340|NCT02657551|516078026|FG000|Overall Study|Non-Compliance|1|||
143145341|NCT02657551|516078026|FG000|Overall Study|Progression / Relapse|4|||
143478294|NCT01490450|517297785|FG002|Period 2|Lost to Follow-up|0|||
143478295|NCT01490450|517297786|FG003|Period 2|Lost to Follow-up|2|||
143478296|NCT03197493|517297787|FG000|Overall Study|Withdrawal by Subject|5|||
143478297|NCT01462435|517297788|FG000|Overall Study|Lack of Efficacy|1|||
143478298|NCT01462435|517297789|FG001|Overall Study|Lack of Efficacy|0|||
143478299|NCT01462435|517297790|FG002|Overall Study|Lack of Efficacy|0|||
143478300|NCT01462435|517297791|FG003|Overall Study|Lack of Efficacy|3|||
143478301|NCT01462435|517297788|FG000|Overall Study|Physician Decision|0|||
143478302|NCT01462435|517297789|FG001|Overall Study|Physician Decision|0|||
143478303|NCT01462435|517297790|FG002|Overall Study|Physician Decision|1|||
143478304|NCT01462435|517297791|FG003|Overall Study|Physician Decision|0|||
143478305|NCT01462435|517297788|FG000|Overall Study|Withdrawal by Subject|0|||
143478306|NCT01462435|517297789|FG001|Overall Study|Withdrawal by Subject|0|||
143478307|NCT01462435|517297790|FG002|Overall Study|Withdrawal by Subject|0|||
143478308|NCT01462435|517297791|FG003|Overall Study|Withdrawal by Subject|1|||
143478309|NCT01462435|517297788|FG000|Overall Study|Lost to Follow-up|0|||
143478310|NCT01462435|517297789|FG001|Overall Study|Lost to Follow-up|0|||
143478311|NCT01462435|517297790|FG002|Overall Study|Lost to Follow-up|0|||
143478312|NCT01462435|517297791|FG003|Overall Study|Lost to Follow-up|1|||
143478313|NCT02807480|517297796|FG000|Overall Study|Withdrawal by Subject|14|||
143145342|NCT04478266|516078027|FG000|Overall Study|Adverse Event|20|||
143145343|NCT04478266|516078028|FG001|Overall Study|Adverse Event|21|||
143145344|NCT04478266|516078027|FG000|Overall Study|Progressive disease|146|||
143145345|NCT04478266|516078028|FG001|Overall Study|Progressive disease|168|||
143145346|NCT04478266|516078027|FG000|Overall Study|Poor compliance to protocol|1|||
143145347|NCT04478266|516078028|FG001|Overall Study|Poor compliance to protocol|0|||
143145348|NCT04478266|516078027|FG000|Overall Study|Withdrawal by Subject|19|||
143145349|NCT04478266|516078028|FG001|Overall Study|Withdrawal by Subject|16|||
143145350|NCT04478266|516078027|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
143145351|NCT04478266|516078028|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
143145352|NCT04478266|516078027|FG000|Overall Study|Study terminated by sponsor|33|||
143145353|NCT04478266|516078028|FG001|Overall Study|Study terminated by sponsor|35|||
143145354|NCT04478266|516078027|FG000|Overall Study|Other: unspecified|5|||
143145355|NCT04478266|516078028|FG001|Overall Study|Other: unspecified|7|||
143145356|NCT04478266|516078027|FG000|Overall Study|Randomized but not treated|1|||
143145357|NCT04478266|516078028|FG001|Overall Study|Randomized but not treated|1|||
143145358|NCT01977846|516078031|FG000|Total Study - Prospective|Death|0|||
143145359|NCT01977846|516078032|FG001|Total Study - Prospective|Death|1|||
143145360|NCT01977846|516078031|FG000|Total Study - Prospective|Lost to Follow-up|0|||
143145361|NCT01977846|516078032|FG001|Total Study - Prospective|Lost to Follow-up|8|||
143145362|NCT01977846|516078031|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
143145363|NCT01977846|516078032|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
143145364|NCT01977846|516078031|FG000|Total Study - Prospective|Not available at time of visit|0|||
143145365|NCT01977846|516078032|FG001|Total Study - Prospective|Not available at time of visit|5|||
143145366|NCT01977846|516078031|FG000|Total Study - Prospective|No show|0|||
143145367|NCT01977846|516078032|FG001|Total Study - Prospective|No show|1|||
143145368|NCT01977846|516078031|FG000|Total Study - Prospective|Protocol Violation|0|||
143145369|NCT01977846|516078032|FG001|Total Study - Prospective|Protocol Violation|1|||
143145370|NCT00596635|516078033|FG000|Overall Study|Lost to Follow-up|0|||
143145371|NCT00596635|516078034|FG001|Overall Study|Lost to Follow-up|2|||
143145372|NCT00596635|516078035|FG002|Overall Study|Lost to Follow-up|0|||
143145373|NCT00596635|516078033|FG000|Overall Study|Treatment for symptomatic UTI|4|||
143145374|NCT00596635|516078034|FG001|Overall Study|Treatment for symptomatic UTI|6|||
143478314|NCT02807480|517297797|FG001|Overall Study|Withdrawal by Subject|10|||
143478315|NCT01543152|517297800|FG000|Overall Study|Withdrawal by Subject|0|||
143145375|NCT00596635|516078035|FG002|Overall Study|Treatment for symptomatic UTI|3|||
143145376|NCT00596635|516078033|FG000|Overall Study|Hip fracture|2|||
143145377|NCT00596635|516078034|FG001|Overall Study|Hip fracture|3|||
143145378|NCT00596635|516078035|FG002|Overall Study|Hip fracture|3|||
143145379|NCT00596635|516078033|FG000|Overall Study|Could not provide urine specimen|1|||
143145380|NCT00596635|516078034|FG001|Overall Study|Could not provide urine specimen|2|||
143145381|NCT00596635|516078035|FG002|Overall Study|Could not provide urine specimen|2|||
143145382|NCT01101178|516078036|FG000|Period 1|Withdrawal by Subject|1|||
143145383|NCT01101178|516078037|FG001|Period 1|Withdrawal by Subject|2|||
143145384|NCT01101178|516078036|FG000|Period 1|Positive drug screen|1|||
143145385|NCT01101178|516078037|FG001|Period 1|Positive drug screen|1|||
143478316|NCT01543152|517297801|FG001|Overall Study|Withdrawal by Subject|2|||
143478317|NCT01543152|517297802|FG002|Overall Study|Withdrawal by Subject|0|||
143478318|NCT01543152|517297803|FG003|Overall Study|Withdrawal by Subject|0|||
143478319|NCT01543152|517297804|FG004|Overall Study|Withdrawal by Subject|0|||
143478320|NCT02053168|517297807|FG000|Overall Study|Withdrawal by Subject|1|||
143478321|NCT02053168|517297807|FG000|Overall Study|Physician Decision|1|||
143478322|NCT02053168|517297807|FG000|Overall Study|Lost to Follow-up|1|||
143478323|NCT02687542|517297808|FG000|Overall Study|Medication error without associated AEs|0|||
143478324|NCT02687542|517297809|FG001|Overall Study|Medication error without associated AEs|0|||
143478325|NCT02687542|517297810|FG002|Overall Study|Medication error without associated AEs|0|||
143478326|NCT02687542|517297811|FG003|Overall Study|Medication error without associated AEs|0|||
143478327|NCT02687542|517297812|FG004|Overall Study|Medication error without associated AEs|1|||
143478328|NCT02687542|517297808|FG000|Overall Study|Lost to Follow-up|0|||
143478329|NCT02687542|517297809|FG001|Overall Study|Lost to Follow-up|0|||
143478330|NCT02687542|517297810|FG002|Overall Study|Lost to Follow-up|0|||
143478331|NCT02687542|517297811|FG003|Overall Study|Lost to Follow-up|0|||
143478332|NCT02687542|517297812|FG004|Overall Study|Lost to Follow-up|1|||
143478333|NCT02687542|517297808|FG000|Overall Study|Protocol Violation|0|||
143478334|NCT02687542|517297809|FG001|Overall Study|Protocol Violation|1|||
143145386|NCT01101178|516078036|FG000|Period 1|Adverse Event|2|||
143145387|NCT01101178|516078037|FG001|Period 1|Adverse Event|1|||
143145388|NCT01101178|516078036|FG000|Period 2|Withdrawal by Subject|0|||
143145389|NCT01101178|516078037|FG001|Period 2|Withdrawal by Subject|1|||
143145390|NCT01850641|516078038|FG000|Overall Study|Physician Decision|1|||
143145391|NCT01850641|516078038|FG000|Overall Study|Decrease in serum phosphorus|1|||
143145392|NCT01850641|516078038|FG000|Overall Study|Decrease in serum calcium|2|||
143145393|NCT01850641|516078038|FG000|Overall Study|Increase in serum ferritin|1|||
143145394|NCT00127803|516078039|FG000|Overall Study|Adverse Event|2|||
143145395|NCT00127803|516078040|FG001|Overall Study|Adverse Event|0|||
143145396|NCT00127803|516078041|FG002|Overall Study|Adverse Event|0|||
143145397|NCT00127803|516078042|FG003|Overall Study|Adverse Event|0|||
143145398|NCT00127803|516078039|FG000|Overall Study|Withdrawal by Subject|1|||
143145399|NCT00127803|516078040|FG001|Overall Study|Withdrawal by Subject|0|||
143145400|NCT00127803|516078041|FG002|Overall Study|Withdrawal by Subject|0|||
143145401|NCT00127803|516078042|FG003|Overall Study|Withdrawal by Subject|0|||
143145402|NCT00127803|516078039|FG000|Overall Study|Lost to Follow-up|0|||
143145403|NCT00127803|516078040|FG001|Overall Study|Lost to Follow-up|0|||
143145404|NCT00127803|516078041|FG002|Overall Study|Lost to Follow-up|0|||
143145405|NCT00127803|516078042|FG003|Overall Study|Lost to Follow-up|1|||
143145406|NCT02774889|516078043|FG000|Overall Study|Lost to Follow-up|2|||
143145407|NCT02774889|516078044|FG001|Overall Study|Lost to Follow-up|1|||
143145408|NCT00846365|516078047|FG000|Overall Study|Adverse Event|20|||
143145409|NCT00846365|516078048|FG001|Overall Study|Adverse Event|30|||
143145410|NCT00846365|516078049|FG002|Overall Study|Adverse Event|11|||
143145411|NCT00846365|516078047|FG000|Overall Study|Protocol Violation|5|||
143145412|NCT00846365|516078048|FG001|Overall Study|Protocol Violation|4|||
143145413|NCT00846365|516078049|FG002|Overall Study|Protocol Violation|0|||
143145414|NCT00846365|516078047|FG000|Overall Study|Lost to Follow-up|8|||
143145415|NCT00846365|516078048|FG001|Overall Study|Lost to Follow-up|2|||
143145416|NCT00846365|516078049|FG002|Overall Study|Lost to Follow-up|5|||
143145417|NCT00846365|516078047|FG000|Overall Study|Withdrawal by Subject|11|||
143145418|NCT00846365|516078048|FG001|Overall Study|Withdrawal by Subject|11|||
143145419|NCT00846365|516078049|FG002|Overall Study|Withdrawal by Subject|9|||
143145420|NCT00846365|516078047|FG000|Overall Study|Pregnancy|1|||
143145421|NCT00846365|516078048|FG001|Overall Study|Pregnancy|0|||
143145422|NCT00846365|516078049|FG002|Overall Study|Pregnancy|0|||
143145423|NCT00846365|516078047|FG000|Overall Study|Lack of Efficacy|1|||
143145424|NCT00846365|516078048|FG001|Overall Study|Lack of Efficacy|1|||
143145425|NCT00846365|516078049|FG002|Overall Study|Lack of Efficacy|2|||
143145426|NCT00846365|516078047|FG000|Overall Study|Other|9|||
143145427|NCT00846365|516078048|FG001|Overall Study|Other|1|||
143145428|NCT00846365|516078049|FG002|Overall Study|Other|6|||
143145429|NCT00720759|516078054|FG000|Overall Study|Lost to Follow-up|0|||
143145430|NCT00720759|516078055|FG001|Overall Study|Lost to Follow-up|1|||
143145431|NCT00720759|516078056|FG002|Overall Study|Lost to Follow-up|1|||
143145432|NCT00720759|516078057|FG003|Overall Study|Lost to Follow-up|0|||
143145433|NCT02318940|516078058|FG000|Overall Study|lost the record|1|||
143478335|NCT02687542|517297810|FG002|Overall Study|Protocol Violation|0|||
143478336|NCT02687542|517297811|FG003|Overall Study|Protocol Violation|0|||
143145434|NCT02318940|516078059|FG001|Overall Study|lost the record|0|||
143145435|NCT00857389|516078066|FG000|Overall Study|Did not proceed to transplant|2|||
143363582|NCT00062868|516873799|FG019|Dose Level 1|Death|0|||
143478337|NCT02687542|517297812|FG004|Overall Study|Protocol Violation|0|||
143145436|NCT03836053|516079698|FG000|Overall Study|Protocol-specified criteria|0|||
143363583|NCT00062868|516873800|FG020|Dose Level 1|Death|1|||
143363584|NCT00062868|516873780|FG000|Dose Level 1|Lost to Follow-up|0|||
143363585|NCT00062868|516873781|FG001|Dose Level 1|Lost to Follow-up|0|||
143145437|NCT03836053|516079699|FG001|Overall Study|Protocol-specified criteria|2|||
143145438|NCT03836053|516079700|FG002|Overall Study|Protocol-specified criteria|1|||
143145439|NCT03836053|516079698|FG000|Overall Study|Death|1|||
143145440|NCT03836053|516079699|FG001|Overall Study|Death|6|||
143145441|NCT03836053|516079700|FG002|Overall Study|Death|4|||
143145442|NCT03836053|516079698|FG000|Overall Study|Withdrawal of consent from study|0|||
143145443|NCT03836053|516079699|FG001|Overall Study|Withdrawal of consent from study|0|||
143145444|NCT03836053|516079700|FG002|Overall Study|Withdrawal of consent from study|1|||
143145445|NCT03836053|516079698|FG000|Overall Study|Decision by sponsor|0|||
143145446|NCT03836053|516079699|FG001|Overall Study|Decision by sponsor|2|||
143145447|NCT03836053|516079700|FG002|Overall Study|Decision by sponsor|4|||
143145448|NCT00788671|516079701|FG000|Overall Study|Death|2|||
143145449|NCT00788671|516079701|FG000|Overall Study|Unable to biopsy|1|||
143478338|NCT02687542|517297808|FG000|Overall Study|Other|5|||
143478339|NCT02687542|517297809|FG001|Overall Study|Other|9|||
143478340|NCT02687542|517297810|FG002|Overall Study|Other|10|||
143145450|NCT00788671|516079701|FG000|Overall Study|Withdrawal by Subject|4|||
143145451|NCT00788671|516079701|FG000|Overall Study|IUD expulsed|1|||
143145452|NCT00788671|516079701|FG000|Overall Study|Lost to follow up|2|||
143145453|NCT06125964|516079702|FG000|Overall Study|Lost to Follow-up|0|||
143145454|NCT06125964|516079703|FG001|Overall Study|Lost to Follow-up|1|||
143145455|NCT06125964|516079704|FG002|Overall Study|Lost to Follow-up|0|||
143145456|NCT06125964|516079705|FG003|Overall Study|Lost to Follow-up|0|||
143145457|NCT00947544|516079706|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
143145458|NCT00947544|516079707|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
143145459|NCT03095287|516079711|FG000|Overall Study|Treatment Failure|1|||
143145460|NCT03095287|516079711|FG000|Overall Study|Adverse Event|1|||
143145461|NCT00782067|516079712|FG000|Overall Study|Adverse Event|35|||
143145462|NCT00782067|516079712|FG000|Overall Study|Subject withdrew consent|11|||
143145463|NCT00782067|516079712|FG000|Overall Study|Lost to Follow-up|2|||
143145464|NCT00782067|516079712|FG000|Overall Study|Administrative problems|14|||
143145465|NCT00782067|516079712|FG000|Overall Study|Death|9|||
143145466|NCT00782067|516079712|FG000|Overall Study|Disease progression|43|||
143145467|NCT00782067|516079712|FG000|Overall Study|Protocol deviation|2|||
143145468|NCT01134042|516079713|FG000|Overall Study|Adverse Event|3|||
143145469|NCT01134042|516079714|FG001|Overall Study|Adverse Event|7|||
143145470|NCT01134042|516079715|FG002|Overall Study|Adverse Event|2|||
143145471|NCT01134042|516079713|FG000|Overall Study|Lack of Efficacy|21|||
143145472|NCT01134042|516079714|FG001|Overall Study|Lack of Efficacy|6|||
143145473|NCT01134042|516079715|FG002|Overall Study|Lack of Efficacy|18|||
143145474|NCT01134042|516079713|FG000|Overall Study|Protocol Violation|5|||
143145475|NCT01134042|516079714|FG001|Overall Study|Protocol Violation|3|||
143145476|NCT01134042|516079715|FG002|Overall Study|Protocol Violation|5|||
143145477|NCT01134042|516079713|FG000|Overall Study|Lost to Follow-up|2|||
143145478|NCT01134042|516079714|FG001|Overall Study|Lost to Follow-up|0|||
143145479|NCT01134042|516079715|FG002|Overall Study|Lost to Follow-up|1|||
143145480|NCT01134042|516079713|FG000|Overall Study|Physician Decision|4|||
143145481|NCT01134042|516079714|FG001|Overall Study|Physician Decision|8|||
143145482|NCT01134042|516079715|FG002|Overall Study|Physician Decision|1|||
143145483|NCT01134042|516079713|FG000|Overall Study|Withdrawal by Subject|13|||
143145484|NCT01134042|516079714|FG001|Overall Study|Withdrawal by Subject|4|||
143145485|NCT01134042|516079715|FG002|Overall Study|Withdrawal by Subject|7|||
143145486|NCT05350423|516079719|FG000|Overall Study|Lost to Follow-up|3|||
143145487|NCT05350423|516079720|FG001|Overall Study|Lost to Follow-up|3|||
143145488|NCT05350423|516079719|FG000|Overall Study|screen failure|5|||
143145489|NCT05350423|516079720|FG001|Overall Study|screen failure|6|||
143145490|NCT03320369|516079725|FG000|Overall Study|Adverse Event|1|||
143145491|NCT03320369|516079725|FG000|Overall Study|Withdrawal by Subject|2|||
143145492|NCT03813654|516079726|FG000|Overall Study|Protocol Violation|0|||
143145493|NCT03813654|516079727|FG001|Overall Study|Protocol Violation|1|||
143478341|NCT02687542|517297811|FG003|Overall Study|Other|6|||
143478342|NCT02687542|517297812|FG004|Overall Study|Other|5|||
143478343|NCT02687542|517297808|FG000|Overall Study|Adverse Event|3|||
143478344|NCT02687542|517297809|FG001|Overall Study|Adverse Event|1|||
143478345|NCT02687542|517297810|FG002|Overall Study|Adverse Event|3|||
143478346|NCT02687542|517297811|FG003|Overall Study|Adverse Event|2|||
143478347|NCT02687542|517297812|FG004|Overall Study|Adverse Event|9|||
143478348|NCT02687542|517297808|FG000|Overall Study|Withdrawal by Subject|0|||
143478349|NCT02687542|517297809|FG001|Overall Study|Withdrawal by Subject|1|||
143478350|NCT02687542|517297810|FG002|Overall Study|Withdrawal by Subject|1|||
143478351|NCT02687542|517297811|FG003|Overall Study|Withdrawal by Subject|2|||
143145494|NCT03813654|516079728|FG002|Overall Study|Protocol Violation|2|||
143145495|NCT03813654|516079726|FG000|Overall Study|Withdrawal by Subject|1|||
143145496|NCT03813654|516079727|FG001|Overall Study|Withdrawal by Subject|0|||
143478352|NCT02687542|517297812|FG004|Overall Study|Withdrawal by Subject|4|||
143478353|NCT00636675|517297814|FG000|Overall Study|Lost to Follow-up|121|||
143478354|NCT00636675|517297815|FG001|Overall Study|Lost to Follow-up|31|||
143145497|NCT03813654|516079728|FG002|Overall Study|Withdrawal by Subject|0|||
143145498|NCT01155323|516079729|FG000|First Intervention|exclusion criteria|1|||
143145499|NCT01155323|516079730|FG001|First Intervention|exclusion criteria|1|||
143145500|NCT01155323|516079729|FG000|Second Intervention|Lost to Follow-up|1|||
143145501|NCT01155323|516079730|FG001|Second Intervention|Lost to Follow-up|1|||
143145502|NCT01208051|516079731|FG000|Total Enrollment|Withdrawal by Subject|0|||
143145503|NCT01208051|516079732|FG001|Total Enrollment|Withdrawal by Subject|1|||
143145504|NCT01208051|516079733|FG002|Total Enrollment|Withdrawal by Subject|0|||
143145505|NCT01208051|516079734|FG003|Total Enrollment|Withdrawal by Subject|0|||
143145506|NCT01208051|516079735|FG004|Total Enrollment|Withdrawal by Subject|2|||
143478355|NCT00636675|517297814|FG000|Overall Study|Withdrawal by Subject|19|||
143478356|NCT00636675|517297815|FG001|Overall Study|Withdrawal by Subject|10|||
143478357|NCT01838616|517297816|FG000|Titration Period|Adverse Event|18|||
143478358|NCT01838616|517297817|FG001|Titration Period|Adverse Event|48|||
143478359|NCT01838616|517297816|FG000|Titration Period|Lack of Efficacy|5|||
143478360|NCT01838616|517297817|FG001|Titration Period|Lack of Efficacy|12|||
143478361|NCT01838616|517297816|FG000|Titration Period|Withdrawal by Subject|5|||
143478362|NCT01838616|517297817|FG001|Titration Period|Withdrawal by Subject|5|||
143478363|NCT01838616|517297816|FG000|Titration Period|Technical problems|1|||
143145507|NCT01208051|516079731|FG000|Total Enrollment|Brain metastases|0|||
143145508|NCT01208051|516079732|FG001|Total Enrollment|Brain metastases|0|||
143145509|NCT01208051|516079733|FG002|Total Enrollment|Brain metastases|1|||
143145510|NCT01208051|516079734|FG003|Total Enrollment|Brain metastases|0|||
143145511|NCT01208051|516079735|FG004|Total Enrollment|Brain metastases|0|||
143145512|NCT00973973|516079737|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
143145513|NCT00973973|516079738|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
143145514|NCT00973973|516079737|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
143145515|NCT00973973|516079738|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
143145516|NCT00973973|516079737|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
143145517|NCT00973973|516079738|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
143145518|NCT00973973|516079737|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
143145519|NCT00973973|516079738|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
143145520|NCT00973973|516079737|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
143145521|NCT00973973|516079738|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
143145522|NCT00973973|516079737|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
143145523|NCT00973973|516079738|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
143145524|NCT00973973|516079737|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
143145525|NCT00973973|516079738|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
143145526|NCT00973973|516079737|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
143145527|NCT00973973|516079738|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
143145528|NCT00973973|516079737|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
143145529|NCT00973973|516079738|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
143145530|NCT00973973|516079737|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
143145531|NCT00973973|516079738|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
143145532|NCT00973973|516079737|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
143145533|NCT00973973|516079738|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
143145534|NCT00973973|516079737|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
143145535|NCT00973973|516079738|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
143145536|NCT02832037|516079739|FG000|Overall Study|Administrative reasons|0|||
143145537|NCT02832037|516079740|FG001|Overall Study|Administrative reasons|0|||
143145538|NCT02832037|516079741|FG002|Overall Study|Administrative reasons|1|||
143145539|NCT02832037|516079742|FG003|Overall Study|Administrative reasons|0|||
143145540|NCT02832037|516079743|FG004|Overall Study|Administrative reasons|0|||
143145541|NCT02832037|516079739|FG000|Overall Study|Protocol Violation|3|||
143145542|NCT02832037|516079740|FG001|Overall Study|Protocol Violation|0|||
143145543|NCT02832037|516079741|FG002|Overall Study|Protocol Violation|4|||
143145544|NCT02832037|516079742|FG003|Overall Study|Protocol Violation|1|||
143145545|NCT02832037|516079743|FG004|Overall Study|Protocol Violation|2|||
143145546|NCT02832037|516079739|FG000|Overall Study|Lost to Follow-up|2|||
143145547|NCT02832037|516079740|FG001|Overall Study|Lost to Follow-up|0|||
143145548|NCT02832037|516079741|FG002|Overall Study|Lost to Follow-up|3|||
143145549|NCT02832037|516079742|FG003|Overall Study|Lost to Follow-up|0|||
143145550|NCT02832037|516079743|FG004|Overall Study|Lost to Follow-up|5|||
143145551|NCT02832037|516079739|FG000|Overall Study|Withdrawal by Subject|9|||
143145552|NCT02832037|516079740|FG001|Overall Study|Withdrawal by Subject|8|||
143145553|NCT02832037|516079741|FG002|Overall Study|Withdrawal by Subject|0|||
143145554|NCT02832037|516079742|FG003|Overall Study|Withdrawal by Subject|4|||
143145555|NCT02832037|516079743|FG004|Overall Study|Withdrawal by Subject|8|||
143145556|NCT02832037|516079739|FG000|Overall Study|Adverse Event|5|||
143145557|NCT02832037|516079740|FG001|Overall Study|Adverse Event|4|||
143145558|NCT02832037|516079741|FG002|Overall Study|Adverse Event|0|||
143145559|NCT02832037|516079742|FG003|Overall Study|Adverse Event|2|||
143145560|NCT02832037|516079743|FG004|Overall Study|Adverse Event|4|||
143145561|NCT03483103|516079745|FG000|Pre-Treatment Phase|Other reasons|1|||
143145562|NCT03483103|516079745|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
143145563|NCT03483103|516079745|FG000|Pre-Treatment Phase|Disease-related complications|1|||
143145564|NCT03483103|516079745|FG000|Pre-Treatment Phase|Death|5|||
143145565|NCT03483103|516079745|FG000|Treatment Phase|Withdrawal by Subject|7|||
143478364|NCT01838616|517297817|FG001|Titration Period|Technical problems|0|||
143478365|NCT01838616|517297816|FG000|Titration Period|Other|1|||
143145566|NCT03483103|516079745|FG000|Treatment Phase|Other reasons|1|||
143145567|NCT03483103|516079745|FG000|Treatment Phase|Death|23|||
143478366|NCT01838616|517297817|FG001|Titration Period|Other|0|||
143478367|NCT01838616|517297816|FG000|Titration Period|Protocol Violation|0|||
143478368|NCT01838616|517297817|FG001|Titration Period|Protocol Violation|1|||
143478369|NCT01838616|517297816|FG000|Continuation Period|Lack of Efficacy|3|||
143478370|NCT01838616|517297817|FG001|Continuation Period|Lack of Efficacy|5|||
143478371|NCT01838616|517297816|FG000|Continuation Period|Adverse Event|8|||
143478372|NCT01838616|517297817|FG001|Continuation Period|Adverse Event|4|||
143478373|NCT01838616|517297816|FG000|Continuation Period|Protocol Violation|2|||
143478374|NCT01838616|517297817|FG001|Continuation Period|Protocol Violation|0|||
143478375|NCT01838616|517297816|FG000|Continuation Period|Lost to Follow-up|1|||
143478376|NCT01838616|517297817|FG001|Continuation Period|Lost to Follow-up|0|||
143478377|NCT01838616|517297816|FG000|Continuation Period|Withdrawal by Subject|0|||
143478378|NCT01838616|517297817|FG001|Continuation Period|Withdrawal by Subject|4|||
143145568|NCT03483103|516079745|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
143145569|NCT03483103|516079745|FG000|Treatment Phase|Received nonconforming product|1|||
143145570|NCT02239328|516079746|FG000|Overall Study|Benign disease noted at time of surgery|6|||
143145571|NCT02239328|516079746|FG000|Overall Study|Equipment or website malfunction|2|||
143145572|NCT00435942|516079747|FG000|Overall Study|Death|17|||
143145573|NCT00435942|516079748|FG001|Overall Study|Death|10|||
143145574|NCT00435942|516079747|FG000|Overall Study|Withdrawal by Subject|2|||
143145575|NCT00435942|516079748|FG001|Overall Study|Withdrawal by Subject|0|||
143145576|NCT00435942|516079747|FG000|Overall Study|Lost to Follow-up|0|||
143145577|NCT00435942|516079748|FG001|Overall Study|Lost to Follow-up|16|||
143145578|NCT00435942|516079747|FG000|Overall Study|Conversion to Open Repair|1|||
143145579|NCT00435942|516079748|FG001|Overall Study|Conversion to Open Repair|0|||
143145580|NCT00435942|516079747|FG000|Overall Study|Technical Failure|3|||
143145581|NCT00435942|516079748|FG001|Overall Study|Technical Failure|0|||
143145582|NCT00435942|516079747|FG000|Overall Study|Other|0|||
143145583|NCT00435942|516079748|FG001|Overall Study|Other|1|||
143145584|NCT00460798|516079749|FG000|Overall Study|Death|59|||
143145585|NCT00460798|516079749|FG000|Overall Study|Adverse Event|27|||
143145586|NCT00460798|516079749|FG000|Overall Study|Lost to Follow-up|19|||
143145587|NCT00460798|516079749|FG000|Overall Study|Progressive Disease|99|||
143145588|NCT00460798|516079749|FG000|Overall Study|Other|27|||
143145589|NCT00460798|516079749|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
143145590|NCT00460798|516079749|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
143145591|NCT01180777|516079750|FG000|Overall Study|Protocol Violation|6|||
143145592|NCT01180777|516079750|FG000|Overall Study|Poor lens fit|4|||
143145593|NCT01180777|516079750|FG000|Overall Study|Lost to Follow-up|1|||
143145594|NCT01180777|516079750|FG000|Overall Study|Adverse Event|1|||
143145595|NCT04491994|516079751|FG000|Overall Study|Withdrawal by Subject|10|||
143145596|NCT04491994|516079752|FG001|Overall Study|Withdrawal by Subject|5|||
143145597|NCT04491994|516079751|FG000|Overall Study|developed fever > 3 days|4|||
143145598|NCT04491994|516079752|FG001|Overall Study|developed fever > 3 days|1|||
143145599|NCT04491994|516079751|FG000|Overall Study|Protocol Violation|11|||
143145600|NCT04491994|516079752|FG001|Overall Study|Protocol Violation|2|||
143145601|NCT04491994|516079751|FG000|Overall Study|Lost to Follow-up|4|||
143145602|NCT04491994|516079752|FG001|Overall Study|Lost to Follow-up|3|||
143145603|NCT04167462|516079760|FG000|Overall Study|Other reasons|3|||
143145604|NCT04167462|516079761|FG001|Overall Study|Other reasons|2|||
143145605|NCT04167462|516079760|FG000|Overall Study|Withdrawal by Subject|6|||
143145606|NCT04167462|516079761|FG001|Overall Study|Withdrawal by Subject|7|||
143145607|NCT04167462|516079760|FG000|Overall Study|Adverse Event|4|||
143145608|NCT04167462|516079761|FG001|Overall Study|Adverse Event|0|||
143145609|NCT04167462|516079760|FG000|Overall Study|Pregnancy|1|||
143145610|NCT04167462|516079761|FG001|Overall Study|Pregnancy|0|||
143145611|NCT04167462|516079760|FG000|Overall Study|Lack of Efficacy|0|||
143145612|NCT04167462|516079761|FG001|Overall Study|Lack of Efficacy|1|||
143145613|NCT02320396|516079762|FG000|Overall Study|Adverse Event|2|||
143145614|NCT02320396|516079763|FG001|Overall Study|Adverse Event|2|||
143145615|NCT02320396|516079762|FG000|Overall Study|Pregnancy|0|||
143145616|NCT02320396|516079763|FG001|Overall Study|Pregnancy|1|||
143145617|NCT02320396|516079762|FG000|Overall Study|Protocol Violation|0|||
143145618|NCT02320396|516079763|FG001|Overall Study|Protocol Violation|1|||
143145619|NCT02320396|516079762|FG000|Overall Study|Withdrawal by Subject|2|||
143145620|NCT02320396|516079763|FG001|Overall Study|Withdrawal by Subject|0|||
143145621|NCT03331562|516079764|FG000|Overall Study|Adverse Event|2|||
143145622|NCT03331562|516079765|FG001|Overall Study|Adverse Event|0|||
143478379|NCT01838616|517297816|FG000|Continuation Period|Technical problems|0|||
143145623|NCT03331562|516079764|FG000|Overall Study|Death|1|||
143145624|NCT03331562|516079765|FG001|Overall Study|Death|0|||
143145625|NCT03718000|516079766|FG000|Overall Study|Relocation|2|||
143145626|NCT03718000|516079767|FG001|Overall Study|Relocation|4|||
143145627|NCT03718000|516079766|FG000|Overall Study|Pregnancy|0|||
143145628|NCT03718000|516079767|FG001|Overall Study|Pregnancy|1|||
143145629|NCT02475213|516079770|FG000|Overall Study|Adverse Event|2|||
143145630|NCT02475213|516079771|FG001|Overall Study|Adverse Event|0|||
143145631|NCT02475213|516079772|FG002|Overall Study|Adverse Event|0|||
143145632|NCT02475213|516079773|FG003|Overall Study|Adverse Event|1|||
143145633|NCT02475213|516079774|FG004|Overall Study|Adverse Event|1|||
143145634|NCT02475213|516079775|FG005|Overall Study|Adverse Event|4|||
143145635|NCT02475213|516079776|FG006|Overall Study|Adverse Event|6|||
143145636|NCT02475213|516079777|FG007|Overall Study|Adverse Event|2|||
143145637|NCT02475213|516079770|FG000|Overall Study|Physician Decision|1|||
143145638|NCT02475213|516079771|FG001|Overall Study|Physician Decision|1|||
143145639|NCT02475213|516079772|FG002|Overall Study|Physician Decision|1|||
143145640|NCT02475213|516079773|FG003|Overall Study|Physician Decision|0|||
143145641|NCT02475213|516079774|FG004|Overall Study|Physician Decision|0|||
143145642|NCT02475213|516079775|FG005|Overall Study|Physician Decision|1|||
143145643|NCT02475213|516079776|FG006|Overall Study|Physician Decision|4|||
143145644|NCT02475213|516079777|FG007|Overall Study|Physician Decision|0|||
143145645|NCT02475213|516079770|FG000|Overall Study|Progressive Disease|3|||
143145646|NCT02475213|516079771|FG001|Overall Study|Progressive Disease|2|||
143145647|NCT02475213|516079772|FG002|Overall Study|Progressive Disease|2|||
143145648|NCT02475213|516079773|FG003|Overall Study|Progressive Disease|13|||
143145649|NCT02475213|516079774|FG004|Overall Study|Progressive Disease|15|||
143145650|NCT02475213|516079775|FG005|Overall Study|Progressive Disease|25|||
143145651|NCT02475213|516079776|FG006|Overall Study|Progressive Disease|30|||
143145652|NCT02475213|516079777|FG007|Overall Study|Progressive Disease|10|||
143145653|NCT02475213|516079770|FG000|Overall Study|Death|0|||
143145654|NCT02475213|516079771|FG001|Overall Study|Death|0|||
143145655|NCT02475213|516079772|FG002|Overall Study|Death|0|||
143145656|NCT02475213|516079773|FG003|Overall Study|Death|0|||
143145657|NCT02475213|516079774|FG004|Overall Study|Death|0|||
143145658|NCT02475213|516079775|FG005|Overall Study|Death|4|||
143145659|NCT02475213|516079776|FG006|Overall Study|Death|1|||
143145660|NCT02475213|516079777|FG007|Overall Study|Death|0|||
143145661|NCT02475213|516079770|FG000|Overall Study|Protocol Violation|0|||
143145662|NCT02475213|516079771|FG001|Overall Study|Protocol Violation|0|||
143145663|NCT02475213|516079772|FG002|Overall Study|Protocol Violation|0|||
143145664|NCT02475213|516079773|FG003|Overall Study|Protocol Violation|0|||
143478380|NCT01838616|517297817|FG001|Continuation Period|Technical problems|1|||
143145665|NCT02475213|516079774|FG004|Overall Study|Protocol Violation|1|||
143145666|NCT02475213|516079775|FG005|Overall Study|Protocol Violation|0|||
143145667|NCT02475213|516079776|FG006|Overall Study|Protocol Violation|0|||
143145668|NCT02475213|516079777|FG007|Overall Study|Protocol Violation|0|||
143478381|NCT01838616|517297816|FG000|Pick-up Arm|Lack of Efficacy|4|||
143478382|NCT01838616|517297817|FG001|Pick-up Arm|Lack of Efficacy|0|||
143478383|NCT01838616|517297816|FG000|Pick-up Arm|Adverse Event|9|||
143478384|NCT01838616|517297817|FG001|Pick-up Arm|Adverse Event|0|||
143478385|NCT01838616|517297816|FG000|Pick-up Arm|Withdrawal by Subject|1|||
143478386|NCT01838616|517297817|FG001|Pick-up Arm|Withdrawal by Subject|0|||
143145669|NCT02475213|516079770|FG000|Overall Study|Withdrawal by Subject|0|||
143145670|NCT02475213|516079771|FG001|Overall Study|Withdrawal by Subject|0|||
143145671|NCT02475213|516079772|FG002|Overall Study|Withdrawal by Subject|0|||
143145672|NCT02475213|516079773|FG003|Overall Study|Withdrawal by Subject|1|||
143145673|NCT02475213|516079774|FG004|Overall Study|Withdrawal by Subject|0|||
143145674|NCT02475213|516079775|FG005|Overall Study|Withdrawal by Subject|2|||
143145675|NCT02475213|516079776|FG006|Overall Study|Withdrawal by Subject|2|||
143145676|NCT02475213|516079777|FG007|Overall Study|Withdrawal by Subject|0|||
143145677|NCT02475213|516079770|FG000|Overall Study|Other|0|||
143145678|NCT02475213|516079771|FG001|Overall Study|Other|0|||
143145679|NCT02475213|516079772|FG002|Overall Study|Other|0|||
143145680|NCT02475213|516079773|FG003|Overall Study|Other|1|||
143145681|NCT02475213|516079774|FG004|Overall Study|Other|3|||
143145682|NCT02475213|516079775|FG005|Overall Study|Other|1|||
143145683|NCT02475213|516079776|FG006|Overall Study|Other|0|||
143478387|NCT01838616|517297816|FG000|Pick-up Arm|Technical problems|1|||
143478388|NCT01838616|517297817|FG001|Pick-up Arm|Technical problems|0|||
143478389|NCT00176605|517297819|FG000|Overall Study|Withdrawal by Subject|2|||
143478390|NCT01321710|517297820|FG000|Overall Study|Lost to Follow-up|4|||
143478391|NCT01321710|517297821|FG001|Overall Study|Lost to Follow-up|5|||
143478392|NCT01321710|517297822|FG002|Overall Study|Lost to Follow-up|0|||
143478393|NCT00833053|517297824|FG000|Overall Study|Adverse Event|4|||
143478394|NCT00833053|517297825|FG001|Overall Study|Adverse Event|0|||
143478395|NCT00833053|517297824|FG000|Overall Study|Treatment Failure|3|||
143478396|NCT00833053|517297825|FG001|Overall Study|Treatment Failure|1|||
143478397|NCT00833053|517297824|FG000|Overall Study|Withdrawal by Subject|0|||
143145684|NCT02475213|516079777|FG007|Overall Study|Other|0|||
143145685|NCT00505921|516079778|FG000|Overall Study|Ineligible|1|||
143145686|NCT00505921|516079778|FG000|Overall Study|Failed to Mobilize|8|||
143145687|NCT02441283|516079779|FG000|Overall Study|Withdrew consent|15|||
143478398|NCT00833053|517297825|FG001|Overall Study|Withdrawal by Subject|1|||
143478399|NCT00833053|517297824|FG000|Overall Study|Protocol Violation|2|||
143145688|NCT02441283|516079779|FG000|Overall Study|Lost to Follow-up|42|||
143145689|NCT02441283|516079779|FG000|Overall Study|Death|1|||
143145690|NCT02441283|516079779|FG000|Overall Study|Other, not specified|32|||
143145691|NCT05383209|516079780|FG000|Overall Study|Adverse Event: Non-ocular|0|||
143145692|NCT05383209|516079781|FG001|Overall Study|Adverse Event: Non-ocular|1|||
143145693|NCT05383209|516079782|FG002|Overall Study|Adverse Event: Non-ocular|0|||
143478400|NCT00833053|517297825|FG001|Overall Study|Protocol Violation|1|||
143478401|NCT02187471|517297826|FG000|Overall Study|Protocol Violation|4|||
143145694|NCT05383209|516079780|FG000|Overall Study|Lost to Follow-up|2|||
143145695|NCT05383209|516079781|FG001|Overall Study|Lost to Follow-up|1|||
143145696|NCT05383209|516079782|FG002|Overall Study|Lost to Follow-up|4|||
143145697|NCT05383209|516079780|FG000|Overall Study|Withdrawal by Subject|2|||
143145698|NCT05383209|516079781|FG001|Overall Study|Withdrawal by Subject|0|||
143145699|NCT05383209|516079782|FG002|Overall Study|Withdrawal by Subject|1|||
143145700|NCT05383209|516079780|FG000|Overall Study|Death|1|||
143145701|NCT05383209|516079781|FG001|Overall Study|Death|0|||
143145702|NCT05383209|516079782|FG002|Overall Study|Death|0|||
143145703|NCT05383209|516079780|FG000|Overall Study|Other|0|||
143145704|NCT05383209|516079781|FG001|Overall Study|Other|1|||
143145705|NCT05383209|516079782|FG002|Overall Study|Other|0|||
143145706|NCT00717886|516079783|FG000|Overall Study|Withdrawal by Subject|3|||
143145707|NCT00717886|516079783|FG000|Overall Study|Treatment Failure|1|||
143145708|NCT00716417|516079784|FG000|Overall Study|Adverse Event|0|||
143145709|NCT00716417|516079785|FG001|Overall Study|Adverse Event|0|||
143145710|NCT00716417|516079786|FG002|Overall Study|Adverse Event|2|||
143145711|NCT00716417|516079787|FG003|Overall Study|Adverse Event|1|||
143145712|NCT00716417|516079788|FG004|Overall Study|Adverse Event|0|||
143145713|NCT00716417|516079789|FG005|Overall Study|Adverse Event|0|||
143145714|NCT00716417|516079790|FG006|Overall Study|Adverse Event|3|||
143145715|NCT00716417|516079791|FG007|Overall Study|Adverse Event|1|||
143145716|NCT00716417|516079792|FG008|Overall Study|Adverse Event|0|||
143145717|NCT00716417|516079793|FG009|Overall Study|Adverse Event|3|||
143145718|NCT00716417|516079784|FG000|Overall Study|Withdrawal by Subject|0|||
143145719|NCT00716417|516079785|FG001|Overall Study|Withdrawal by Subject|1|||
143145720|NCT00716417|516079786|FG002|Overall Study|Withdrawal by Subject|0|||
143145721|NCT00716417|516079787|FG003|Overall Study|Withdrawal by Subject|2|||
143145722|NCT00716417|516079788|FG004|Overall Study|Withdrawal by Subject|0|||
143145723|NCT00716417|516079789|FG005|Overall Study|Withdrawal by Subject|0|||
143145724|NCT00716417|516079790|FG006|Overall Study|Withdrawal by Subject|1|||
143145725|NCT00716417|516079791|FG007|Overall Study|Withdrawal by Subject|0|||
143145726|NCT00716417|516079792|FG008|Overall Study|Withdrawal by Subject|0|||
143145727|NCT00716417|516079793|FG009|Overall Study|Withdrawal by Subject|0|||
143145728|NCT00716417|516079784|FG000|Overall Study|Progressive disease|3|||
143145729|NCT00716417|516079785|FG001|Overall Study|Progressive disease|5|||
143145730|NCT00716417|516079786|FG002|Overall Study|Progressive disease|3|||
143145731|NCT00716417|516079787|FG003|Overall Study|Progressive disease|8|||
143145732|NCT00716417|516079788|FG004|Overall Study|Progressive disease|0|||
143145733|NCT00716417|516079789|FG005|Overall Study|Progressive disease|3|||
143145734|NCT00716417|516079790|FG006|Overall Study|Progressive disease|3|||
143145735|NCT00716417|516079791|FG007|Overall Study|Progressive disease|1|||
143145736|NCT00716417|516079792|FG008|Overall Study|Progressive disease|5|||
143145737|NCT00716417|516079793|FG009|Overall Study|Progressive disease|0|||
143145738|NCT00716417|516079784|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
143145739|NCT00716417|516079785|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
143145740|NCT00716417|516079786|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
143145741|NCT00716417|516079787|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
143145742|NCT00716417|516079788|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
143145743|NCT00716417|516079789|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
143145744|NCT00716417|516079790|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
143145745|NCT00716417|516079791|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
143145746|NCT00716417|516079792|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
143145747|NCT00716417|516079793|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
143145748|NCT00716417|516079784|FG000|Overall Study|On patient request due to toxicities|0|||
143145749|NCT00716417|516079785|FG001|Overall Study|On patient request due to toxicities|0|||
143145750|NCT00716417|516079786|FG002|Overall Study|On patient request due to toxicities|0|||
143145751|NCT00716417|516079787|FG003|Overall Study|On patient request due to toxicities|0|||
143145752|NCT00716417|516079788|FG004|Overall Study|On patient request due to toxicities|0|||
143145753|NCT00716417|516079789|FG005|Overall Study|On patient request due to toxicities|0|||
143145754|NCT00716417|516079790|FG006|Overall Study|On patient request due to toxicities|0|||
143145755|NCT00716417|516079791|FG007|Overall Study|On patient request due to toxicities|1|||
143145756|NCT00716417|516079792|FG008|Overall Study|On patient request due to toxicities|0|||
143145757|NCT00716417|516079793|FG009|Overall Study|On patient request due to toxicities|0|||
143145758|NCT01129128|516079795|FG000|Overall Study|Lost to Follow-up|2|||
143145759|NCT01129128|516079796|FG001|Overall Study|Lost to Follow-up|2|||
143145760|NCT01129128|516079797|FG002|Overall Study|Lost to Follow-up|1|||
143145761|NCT01129128|516079795|FG000|Overall Study|Protocol Violation|0|||
143145762|NCT01129128|516079796|FG001|Overall Study|Protocol Violation|1|||
143145763|NCT01129128|516079797|FG002|Overall Study|Protocol Violation|0|||
143145764|NCT01129128|516079795|FG000|Overall Study|Withdrawal by Subject|0|||
143145765|NCT01129128|516079796|FG001|Overall Study|Withdrawal by Subject|1|||
143145766|NCT01129128|516079797|FG002|Overall Study|Withdrawal by Subject|3|||
143145767|NCT01129128|516079795|FG000|Overall Study|Physician Decision|1|||
143145768|NCT01129128|516079796|FG001|Overall Study|Physician Decision|0|||
143145769|NCT01129128|516079797|FG002|Overall Study|Physician Decision|0|||
143478402|NCT02187471|517297827|FG001|Overall Study|Protocol Violation|5|||
143478403|NCT02187471|517297828|FG002|Overall Study|Protocol Violation|4|||
143478404|NCT02187471|517297829|FG003|Overall Study|Protocol Violation|4|||
143478405|NCT02187471|517297826|FG000|Overall Study|Missing|0|||
143478406|NCT02187471|517297827|FG001|Overall Study|Missing|0|||
143478407|NCT02187471|517297828|FG002|Overall Study|Missing|0|||
143478408|NCT02187471|517297829|FG003|Overall Study|Missing|1|||
143478409|NCT02187471|517297826|FG000|Overall Study|Lack of Efficacy|18|||
143478410|NCT02187471|517297827|FG001|Overall Study|Lack of Efficacy|9|||
143478411|NCT02187471|517297828|FG002|Overall Study|Lack of Efficacy|13|||
143478412|NCT02187471|517297829|FG003|Overall Study|Lack of Efficacy|11|||
143478413|NCT02187471|517297826|FG000|Overall Study|Adverse Event|24|||
143145770|NCT03822416|516079804|FG000|Overall Study|Lost to Follow-up|1|||
143145771|NCT03822416|516079805|FG001|Overall Study|Lost to Follow-up|0|||
143145772|NCT03822416|516079804|FG000|Overall Study|Withdrawal by Subject|0|||
143145773|NCT03822416|516079805|FG001|Overall Study|Withdrawal by Subject|1|||
143145774|NCT04666298|516079806|FG000|Overall Study|Subject decision|1|||
143145775|NCT04666298|516079807|FG001|Overall Study|Subject decision|0|||
143145776|NCT04666298|516079808|FG002|Overall Study|Subject decision|0|||
143145777|NCT04666298|516079809|FG003|Overall Study|Subject decision|2|||
143145778|NCT04666298|516079806|FG000|Overall Study|Death|1|||
143145779|NCT04666298|516079807|FG001|Overall Study|Death|0|||
143145780|NCT04666298|516079808|FG002|Overall Study|Death|0|||
143145781|NCT04666298|516079809|FG003|Overall Study|Death|0|||
143145782|NCT04666298|516079806|FG000|Overall Study|Lost to Follow-up|0|||
143145783|NCT04666298|516079807|FG001|Overall Study|Lost to Follow-up|0|||
143145784|NCT04666298|516079808|FG002|Overall Study|Lost to Follow-up|0|||
143145785|NCT04666298|516079809|FG003|Overall Study|Lost to Follow-up|1|||
143145786|NCT04666298|516079806|FG000|Overall Study|Physician Decision|0|||
143145787|NCT04666298|516079807|FG001|Overall Study|Physician Decision|0|||
143145788|NCT04666298|516079808|FG002|Overall Study|Physician Decision|0|||
143145789|NCT04666298|516079809|FG003|Overall Study|Physician Decision|1|||
143145790|NCT04666298|516079806|FG000|Overall Study|Protocol deviation|0|||
143145791|NCT04666298|516079807|FG001|Overall Study|Protocol deviation|0|||
143145792|NCT04666298|516079808|FG002|Overall Study|Protocol deviation|1|||
143145793|NCT04666298|516079809|FG003|Overall Study|Protocol deviation|0|||
143145794|NCT01303419|516079810|FG000|Overall Study|Discontinuation of study|60|||
143145795|NCT01303419|516079810|FG000|Overall Study|Did not complete both imaging methods|5|||
143145796|NCT01303419|516079810|FG000|Overall Study|Did not meet all I/E after screening|31|||
143145797|NCT02755090|516079816|FG000|Overall Study|equipment malfunction|1|||
143145798|NCT02755090|516079817|FG001|Overall Study|equipment malfunction|0|||
143145799|NCT03197129|516079818|FG000|Overall Study|did not answer the VPT: shyness|4|||
143145800|NCT03197129|516079819|FG001|Overall Study|did not answer the VPT: shyness|5|||
143145801|NCT01564407|516079820|FG000|Overall Study|Lost to Follow-up|0|||
143145802|NCT01564407|516079821|FG001|Overall Study|Lost to Follow-up|1|||
143145803|NCT01564407|516079822|FG002|Overall Study|Lost to Follow-up|0|||
143145804|NCT01564407|516079823|FG003|Overall Study|Lost to Follow-up|0|||
143145805|NCT01564407|516079824|FG004|Overall Study|Lost to Follow-up|0|||
143145806|NCT01564407|516079820|FG000|Overall Study|Withdrawal by Subject|0|||
143145807|NCT01564407|516079821|FG001|Overall Study|Withdrawal by Subject|1|||
143145808|NCT01564407|516079822|FG002|Overall Study|Withdrawal by Subject|0|||
143145809|NCT01564407|516079823|FG003|Overall Study|Withdrawal by Subject|0|||
143145810|NCT01564407|516079824|FG004|Overall Study|Withdrawal by Subject|0|||
143145811|NCT01564407|516079820|FG000|Overall Study|funding lost, study ended|0|||
143145812|NCT01564407|516079821|FG001|Overall Study|funding lost, study ended|0|||
143145813|NCT01564407|516079822|FG002|Overall Study|funding lost, study ended|0|||
143145814|NCT01564407|516079823|FG003|Overall Study|funding lost, study ended|1|||
143145815|NCT01564407|516079824|FG004|Overall Study|funding lost, study ended|0|||
143145816|NCT01285518|516079827|FG000|Overall Study|Lost to Follow-up|0|||
143145817|NCT01285518|516079828|FG001|Overall Study|Lost to Follow-up|0|||
143145818|NCT01285518|516079829|FG002|Overall Study|Lost to Follow-up|0|||
143145819|NCT01285518|516079830|FG003|Overall Study|Lost to Follow-up|0|||
143145820|NCT01285518|516079831|FG004|Overall Study|Lost to Follow-up|0|||
143145821|NCT01285518|516079832|FG005|Overall Study|Lost to Follow-up|1|||
143145822|NCT01285518|516079833|FG006|Overall Study|Lost to Follow-up|0|||
143145823|NCT01285518|516079834|FG007|Overall Study|Lost to Follow-up|0|||
143145824|NCT00639509|516079837|FG000|Overall Study|Death|1|||
143145825|NCT05493111|516081264|FG000|Overall Study|Adverse Event|3|||
143145826|NCT05493111|516081265|FG001|Overall Study|Adverse Event|4|||
143145827|NCT05493111|516081264|FG000|Overall Study|Withdrawal of Consent|19|||
143145828|NCT05493111|516081265|FG001|Overall Study|Withdrawal of Consent|10|||
143145829|NCT05493111|516081264|FG000|Overall Study|Non-compliance|1|||
143145830|NCT05493111|516081265|FG001|Overall Study|Non-compliance|1|||
143145831|NCT05493111|516081264|FG000|Overall Study|Lost to Follow-up|8|||
143145832|NCT05493111|516081265|FG001|Overall Study|Lost to Follow-up|1|||
143145833|NCT05493111|516081264|FG000|Overall Study|Disallowed Concurrent Treatment|1|||
143478414|NCT02187471|517297827|FG001|Overall Study|Adverse Event|34|||
143478415|NCT02187471|517297828|FG002|Overall Study|Adverse Event|44|||
143145834|NCT05493111|516081265|FG001|Overall Study|Disallowed Concurrent Treatment|0|||
143478416|NCT02187471|517297829|FG003|Overall Study|Adverse Event|36|||
143478417|NCT02187471|517297826|FG000|Overall Study|Withdrawal by Subject|23|||
143478418|NCT02187471|517297827|FG001|Overall Study|Withdrawal by Subject|29|||
143478419|NCT02187471|517297828|FG002|Overall Study|Withdrawal by Subject|22|||
143478420|NCT02187471|517297829|FG003|Overall Study|Withdrawal by Subject|24|||
143478421|NCT02187471|517297826|FG000|Overall Study|Other|7|||
143478422|NCT02187471|517297827|FG001|Overall Study|Other|5|||
143145835|NCT05493111|516081264|FG000|Overall Study|Withdrawal by Subject|1|||
143145836|NCT05493111|516081265|FG001|Overall Study|Withdrawal by Subject|1|||
143145837|NCT01787838|516081267|FG000|Overall Study|refused|1413|||
143145838|NCT01240746|516081268|FG000|Overall Study|Adverse Event|2|||
143145839|NCT01240746|516081269|FG001|Overall Study|Adverse Event|0|||
143145840|NCT01240746|516081270|FG002|Overall Study|Adverse Event|10|||
143145841|NCT01240746|516081268|FG000|Overall Study|Lost to Follow-up|23|||
143145842|NCT01240746|516081269|FG001|Overall Study|Lost to Follow-up|20|||
143145843|NCT01240746|516081270|FG002|Overall Study|Lost to Follow-up|102|||
143145844|NCT01240746|516081268|FG000|Overall Study|Protocol Violation|24|||
143145845|NCT01240746|516081269|FG001|Overall Study|Protocol Violation|15|||
143145846|NCT01240746|516081270|FG002|Overall Study|Protocol Violation|72|||
143145847|NCT01240746|516081268|FG000|Overall Study|Withdrawal by Subject|10|||
143145848|NCT01240746|516081269|FG001|Overall Study|Withdrawal by Subject|13|||
143145849|NCT01240746|516081270|FG002|Overall Study|Withdrawal by Subject|59|||
143145850|NCT02472405|516081271|FG000|Overall Study|Lost to Follow-up|9|||
143145851|NCT02472405|516081271|FG000|Overall Study|Adverse Event|1|||
143145852|NCT01431976|516081272|FG000|Overall Study|Adverse Event|6|||
143145853|NCT01431976|516081272|FG000|Overall Study|Lack of Efficacy|2|||
143145854|NCT01431976|516081272|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
143145855|NCT01431976|516081272|FG000|Overall Study|Physician Decision|1|||
143145856|NCT01431976|516081272|FG000|Overall Study|Withdrawal by Subject|1|||
143145857|NCT02394275|516081280|FG000|Overall Study|Adverse Event|22|||
143145858|NCT02394275|516081280|FG000|Overall Study|Lost to Follow-up|7|||
143145859|NCT02097277|516081286|FG000|Overall Study|Subject no longer meets study criteria|0|||
143145860|NCT02097277|516081287|FG001|Overall Study|Subject no longer meets study criteria|1|||
143145861|NCT02097277|516081288|FG002|Overall Study|Subject no longer meets study criteria|0|||
143145862|NCT02097277|516081289|FG003|Overall Study|Subject no longer meets study criteria|1|||
143145863|NCT02097277|516081290|FG004|Overall Study|Subject no longer meets study criteria|0|||
143145864|NCT02097277|516081286|FG000|Overall Study|Subject request to discontinue treatment|0|||
143145865|NCT02097277|516081287|FG001|Overall Study|Subject request to discontinue treatment|0|||
143145866|NCT02097277|516081288|FG002|Overall Study|Subject request to discontinue treatment|0|||
143145867|NCT02097277|516081289|FG003|Overall Study|Subject request to discontinue treatment|0|||
143145868|NCT02097277|516081290|FG004|Overall Study|Subject request to discontinue treatment|1|||
143145869|NCT02097277|516081286|FG000|Overall Study|Lost to Follow-up|0|||
143145870|NCT02097277|516081287|FG001|Overall Study|Lost to Follow-up|1|||
143145871|NCT02097277|516081288|FG002|Overall Study|Lost to Follow-up|1|||
143145872|NCT02097277|516081289|FG003|Overall Study|Lost to Follow-up|0|||
143145873|NCT02097277|516081290|FG004|Overall Study|Lost to Follow-up|0|||
143145874|NCT02097277|516081286|FG000|Overall Study|Withdrawal by Subject|2|||
143145875|NCT02097277|516081287|FG001|Overall Study|Withdrawal by Subject|1|||
143145876|NCT02097277|516081288|FG002|Overall Study|Withdrawal by Subject|0|||
143145877|NCT02097277|516081289|FG003|Overall Study|Withdrawal by Subject|1|||
143145878|NCT02097277|516081290|FG004|Overall Study|Withdrawal by Subject|0|||
143145879|NCT02097277|516081286|FG000|Overall Study|Adverse Event|0|||
143145880|NCT02097277|516081287|FG001|Overall Study|Adverse Event|0|||
143145881|NCT02097277|516081288|FG002|Overall Study|Adverse Event|1|||
143145882|NCT02097277|516081289|FG003|Overall Study|Adverse Event|2|||
143145883|NCT02097277|516081290|FG004|Overall Study|Adverse Event|0|||
143145884|NCT01091259|516081292|FG000|Overall Study|Adverse Event|3|||
143145885|NCT01091259|516081292|FG000|Overall Study|Lack of Efficacy|2|||
143145886|NCT01732692|516081296|FG000|Overall Study|Adverse Event|0|||
143145887|NCT01732692|516081297|FG001|Overall Study|Adverse Event|1|||
143145888|NCT02020941|516081298|FG000|Overall Study|Adverse Event|1|||
143145889|NCT02020941|516081298|FG000|Overall Study|Physician Decision|2|||
143145890|NCT02020941|516081298|FG000|Overall Study|Withdrawal by Subject|1|||
143145891|NCT02020941|516081298|FG000|Overall Study|Disease Progression|4|||
143145892|NCT03881371|516081312|FG000|Overall Study|Adverse Event|8|||
143145893|NCT03881371|516081313|FG001|Overall Study|Adverse Event|9|||
143145894|NCT03881371|516081312|FG000|Overall Study|Death|1|||
143145895|NCT03881371|516081313|FG001|Overall Study|Death|0|||
143145896|NCT03881371|516081312|FG000|Overall Study|Lost to Follow-up|1|||
143145897|NCT03881371|516081313|FG001|Overall Study|Lost to Follow-up|0|||
143145898|NCT03881371|516081312|FG000|Overall Study|Non-Compliance with Study Drug|0|||
143145899|NCT03881371|516081313|FG001|Overall Study|Non-Compliance with Study Drug|2|||
143145900|NCT03881371|516081312|FG000|Overall Study|Physician Decision|3|||
143145901|NCT03881371|516081313|FG001|Overall Study|Physician Decision|3|||
143145902|NCT03881371|516081312|FG000|Overall Study|Withdrawal by Subject|2|||
143145903|NCT03881371|516081313|FG001|Overall Study|Withdrawal by Subject|10|||
143363586|NCT00062868|516873782|FG002|Dose Level 1|Lost to Follow-up|0|||
143478423|NCT02187471|517297828|FG002|Overall Study|Other|3|||
143478424|NCT02187471|517297829|FG003|Overall Study|Other|4|||
143478425|NCT02236520|517297830|FG000|Overall Study|Physician Decision|0|||
143478426|NCT02236520|517297831|FG001|Overall Study|Physician Decision|5|||
143478427|NCT02236520|517297832|FG002|Overall Study|Physician Decision|0|||
143478428|NCT02236520|517297833|FG003|Overall Study|Physician Decision|0|||
143478429|NCT02236520|517297830|FG000|Overall Study|Withdrawal by Subject|1|||
143478430|NCT02236520|517297831|FG001|Overall Study|Withdrawal by Subject|0|||
143478431|NCT02236520|517297832|FG002|Overall Study|Withdrawal by Subject|0|||
143478432|NCT02236520|517297833|FG003|Overall Study|Withdrawal by Subject|1|||
143478433|NCT02236520|517297830|FG000|Overall Study|Pregnancy|1|||
143478434|NCT02236520|517297831|FG001|Overall Study|Pregnancy|0|||
143478435|NCT02236520|517297832|FG002|Overall Study|Pregnancy|0|||
143478436|NCT02236520|517297833|FG003|Overall Study|Pregnancy|0|||
143478437|NCT01785160|517297834|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
143478438|NCT01785160|517297834|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
143478439|NCT02234479|517297835|FG000|Overall Study|Withdrawal by Subject|1|||
143478440|NCT02234479|517297836|FG001|Overall Study|Withdrawal by Subject|3|||
143478441|NCT02318667|517297837|FG000|Overall Study|Adverse Event|1|||
143478442|NCT02318667|517297837|FG000|Overall Study|Lack of Efficacy|6|||
143478443|NCT02318667|517297837|FG000|Overall Study|Protocol Violation|2|||
143478444|NCT01033734|517297838|FG000|Overall Study|Withdrawal by Subject|1|||
143478445|NCT00139776|517297847|FG000|Period I|Did not enter Period II|575|||
143478446|NCT00139776|517297848|FG001|Period I|Did not enter Period II|0|||
143478447|NCT00139776|517297849|FG002|Period I|Did not enter Period II|0|||
143478448|NCT00139776|517297850|FG003|Period I|Did not enter Period II|0|||
143478449|NCT00139776|517297847|FG000|Period II|Not Randomized into Period III|0|||
143478450|NCT00139776|517297848|FG001|Period II|Not Randomized into Period III|322|||
143478451|NCT00139776|517297849|FG002|Period II|Not Randomized into Period III|0|||
143478452|NCT00139776|517297850|FG003|Period II|Not Randomized into Period III|0|||
143478453|NCT00139776|517297847|FG000|Period III|Adverse Event|0|||
143478454|NCT00139776|517297848|FG001|Period III|Adverse Event|0|||
143478455|NCT00139776|517297849|FG002|Period III|Adverse Event|22|||
143478456|NCT00139776|517297850|FG003|Period III|Adverse Event|23|||
143478457|NCT00139776|517297847|FG000|Period III|Other|0|||
143478458|NCT00139776|517297848|FG001|Period III|Other|0|||
143478459|NCT00139776|517297849|FG002|Period III|Other|23|||
143478460|NCT00139776|517297850|FG003|Period III|Other|34|||
143478461|NCT00139776|517297847|FG000|Period III|Lack of Efficacy|0|||
143478462|NCT00139776|517297848|FG001|Period III|Lack of Efficacy|0|||
143478463|NCT00139776|517297849|FG002|Period III|Lack of Efficacy|10|||
143478464|NCT00139776|517297850|FG003|Period III|Lack of Efficacy|24|||
143478465|NCT00139776|517297847|FG000|Period III|Lost to Follow-up|0|||
143478466|NCT00139776|517297848|FG001|Period III|Lost to Follow-up|0|||
143478467|NCT00139776|517297849|FG002|Period III|Lost to Follow-up|5|||
143478468|NCT00139776|517297850|FG003|Period III|Lost to Follow-up|4|||
143478469|NCT00139776|517297847|FG000|Period III|Withdrawal by Subject|0|||
143478470|NCT00139776|517297848|FG001|Period III|Withdrawal by Subject|0|||
143478471|NCT00139776|517297849|FG002|Period III|Withdrawal by Subject|16|||
143478472|NCT00139776|517297850|FG003|Period III|Withdrawal by Subject|21|||
143478473|NCT00111800|517297858|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
143478474|NCT00111800|517297859|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
143478475|NCT00111800|517297860|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
143478476|NCT00111800|517297861|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
143478477|NCT00111800|517297862|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
143478478|NCT00111800|517297863|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
143478479|NCT00111800|517297858|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
143478480|NCT00111800|517297859|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
143478481|NCT00111800|517297860|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
143478482|NCT00111800|517297861|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
143478483|NCT00111800|517297862|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
143478484|NCT00111800|517297863|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
143478485|NCT00111800|517297858|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
143478486|NCT00111800|517297859|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
143478487|NCT00111800|517297860|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
143478488|NCT00111800|517297861|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
143478489|NCT00111800|517297862|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
143478490|NCT00111800|517297863|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
143478491|NCT00111800|517297858|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
143478492|NCT00111800|517297859|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
143478493|NCT00111800|517297860|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
143478494|NCT00111800|517297861|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
143478495|NCT00111800|517297862|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
143478496|NCT00111800|517297863|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
143478497|NCT00111800|517297858|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
143478498|NCT00111800|517297859|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
143478499|NCT00111800|517297860|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
143478500|NCT00111800|517297861|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
143478501|NCT00111800|517297862|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
143478502|NCT00111800|517297863|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
143478503|NCT00111800|517297858|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
143478504|NCT00111800|517297859|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
143478505|NCT00111800|517297860|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
143478506|NCT00111800|517297861|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
143478507|NCT00111800|517297862|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
143478508|NCT00111800|517297863|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
143478509|NCT00111800|517297858|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
143478510|NCT00111800|517297859|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
143478511|NCT00111800|517297860|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
143478512|NCT00111800|517297861|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
143478513|NCT00111800|517297862|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
143478514|NCT00111800|517297863|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
143478515|NCT00111800|517297858|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
143478516|NCT00111800|517297859|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
143478517|NCT00111800|517297860|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
143478518|NCT00111800|517297861|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
143478519|NCT00111800|517297862|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
143478520|NCT00111800|517297863|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
143478521|NCT00111800|517297858|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
143478522|NCT00111800|517297859|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
143478523|NCT00111800|517297860|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
143478524|NCT00111800|517297861|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
143478525|NCT00111800|517297862|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
143478526|NCT00111800|517297863|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
143145904|NCT03881371|516081312|FG000|Overall Study|Discontinuation from Study|1|||
143478527|NCT00111800|517297858|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
143478528|NCT00111800|517297859|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
143478529|NCT00111800|517297860|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
143145905|NCT03881371|516081313|FG001|Overall Study|Discontinuation from Study|0|||
143145906|NCT03329001|516081316|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
143145907|NCT03329001|516081317|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
143145908|NCT03329001|516081318|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
143145909|NCT03329001|516081319|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
143145910|NCT03329001|516081320|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
143145911|NCT03329001|516081321|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
143145912|NCT03329001|516081322|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
143363587|NCT00062868|516873783|FG003|Dose Level 1|Lost to Follow-up|0|||
143478530|NCT00111800|517297861|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
143478531|NCT00111800|517297862|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
143478532|NCT00111800|517297863|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
143478533|NCT00111800|517297858|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
143478534|NCT00111800|517297859|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
143478535|NCT00111800|517297860|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
143478536|NCT00111800|517297861|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
143478537|NCT00111800|517297862|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
143478538|NCT00111800|517297863|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
143478539|NCT00111800|517297858|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
143478540|NCT00111800|517297859|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
143478541|NCT00111800|517297860|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
143478542|NCT00111800|517297861|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
143478543|NCT00111800|517297862|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
143478544|NCT00111800|517297863|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
143478545|NCT00111800|517297858|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
143478546|NCT00111800|517297859|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
143478547|NCT00111800|517297860|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
143478548|NCT00111800|517297861|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
143478549|NCT00111800|517297862|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
143478550|NCT00111800|517297863|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
143478551|NCT00111800|517297858|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
143478552|NCT00111800|517297859|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
143478553|NCT00111800|517297860|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
143478554|NCT00111800|517297861|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
143478555|NCT00111800|517297862|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
143478556|NCT00111800|517297863|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
143478557|NCT00111800|517297858|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
143478558|NCT00111800|517297859|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
143478559|NCT00111800|517297860|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
143478560|NCT00111800|517297861|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
143478561|NCT00111800|517297862|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
143478562|NCT00111800|517297863|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
143478563|NCT00111800|517297858|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
143478564|NCT00111800|517297859|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
143478565|NCT00111800|517297860|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
143478566|NCT00111800|517297861|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
143478567|NCT00111800|517297862|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
143478568|NCT00111800|517297863|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
143478569|NCT00111800|517297858|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
143478570|NCT00111800|517297859|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
143478571|NCT00111800|517297860|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
143478572|NCT00111800|517297861|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
143478573|NCT00111800|517297862|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
143478574|NCT00111800|517297863|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
143478575|NCT00111800|517297858|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
143478576|NCT00111800|517297859|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
143478577|NCT00111800|517297860|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
143478578|NCT00111800|517297861|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
143478579|NCT00111800|517297862|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
143478580|NCT00111800|517297863|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
143478581|NCT00111800|517297858|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
143478582|NCT00111800|517297859|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
143478583|NCT00111800|517297860|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
143478584|NCT00111800|517297861|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
143478585|NCT00111800|517297862|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
143478586|NCT00111800|517297863|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
143478587|NCT00111800|517297858|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
143478588|NCT00111800|517297859|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
143478589|NCT00111800|517297860|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
143478590|NCT00111800|517297861|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
143478591|NCT00111800|517297862|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
143478592|NCT00111800|517297863|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
143478593|NCT00111800|517297858|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
143478594|NCT00111800|517297859|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
143478595|NCT00111800|517297860|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
143478596|NCT00111800|517297861|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
143478597|NCT00111800|517297862|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
143478598|NCT00111800|517297863|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
143478599|NCT00111800|517297858|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
143478600|NCT00111800|517297859|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
143478601|NCT00111800|517297860|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
143478602|NCT00111800|517297861|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
143478603|NCT00111800|517297862|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
143363588|NCT00062868|516873784|FG004|Dose Level 1|Lost to Follow-up|0|||
143478604|NCT00111800|517297863|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
143478605|NCT00111800|517297858|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
143478606|NCT00111800|517297859|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
143478607|NCT00111800|517297860|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
143478608|NCT00111800|517297861|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
143478609|NCT00111800|517297862|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
143478610|NCT00111800|517297863|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
143478611|NCT00111800|517297858|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
143478612|NCT00111800|517297859|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
143478613|NCT00111800|517297860|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
143478614|NCT00111800|517297861|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
143478615|NCT00111800|517297862|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
143478616|NCT00111800|517297863|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
143478617|NCT00111800|517297858|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
143478618|NCT00111800|517297859|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
143478619|NCT00111800|517297860|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
143478620|NCT00111800|517297861|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
143478621|NCT00111800|517297862|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
143478622|NCT00111800|517297863|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
143478623|NCT00111800|517297858|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
143478624|NCT00111800|517297859|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
143478625|NCT00111800|517297860|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
143478626|NCT00111800|517297861|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
143478627|NCT00111800|517297862|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
143478628|NCT00111800|517297863|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
143478629|NCT00914927|517297865|FG000|Overall Study|Adverse Event|0|||
143478630|NCT00914927|517297866|FG001|Overall Study|Adverse Event|0|||
143478631|NCT00914927|517297867|FG002|Overall Study|Adverse Event|0|||
143478632|NCT00914927|517297868|FG003|Overall Study|Adverse Event|0|||
143478633|NCT00914927|517297869|FG004|Overall Study|Adverse Event|1|||
143478634|NCT00914927|517297870|FG005|Overall Study|Adverse Event|0|||
143478635|NCT00914927|517297871|FG006|Overall Study|Adverse Event|0|||
143478636|NCT00914927|517297865|FG000|Overall Study|Withdrawal by Subject|0|||
143478637|NCT00914927|517297866|FG001|Overall Study|Withdrawal by Subject|1|||
143478638|NCT00914927|517297867|FG002|Overall Study|Withdrawal by Subject|0|||
143478639|NCT00914927|517297868|FG003|Overall Study|Withdrawal by Subject|1|||
143478640|NCT00914927|517297869|FG004|Overall Study|Withdrawal by Subject|0|||
143478641|NCT00914927|517297870|FG005|Overall Study|Withdrawal by Subject|0|||
143478642|NCT00914927|517297871|FG006|Overall Study|Withdrawal by Subject|0|||
143478643|NCT00914927|517297865|FG000|Overall Study|Lost to Follow-up|0|||
143478644|NCT00914927|517297866|FG001|Overall Study|Lost to Follow-up|0|||
143478645|NCT00914927|517297867|FG002|Overall Study|Lost to Follow-up|0|||
143478646|NCT00914927|517297868|FG003|Overall Study|Lost to Follow-up|1|||
143478647|NCT00914927|517297869|FG004|Overall Study|Lost to Follow-up|0|||
143478648|NCT00914927|517297870|FG005|Overall Study|Lost to Follow-up|0|||
143478649|NCT00914927|517297871|FG006|Overall Study|Lost to Follow-up|0|||
143478650|NCT00914927|517297865|FG000|Overall Study|Administrative/Other|2|||
143478651|NCT00914927|517297866|FG001|Overall Study|Administrative/Other|1|||
143478652|NCT00914927|517297867|FG002|Overall Study|Administrative/Other|0|||
143478653|NCT00914927|517297868|FG003|Overall Study|Administrative/Other|0|||
143478654|NCT00914927|517297869|FG004|Overall Study|Administrative/Other|1|||
143478655|NCT00914927|517297870|FG005|Overall Study|Administrative/Other|0|||
143478656|NCT00914927|517297871|FG006|Overall Study|Administrative/Other|0|||
143478657|NCT00365456|517297872|FG000|Trial Period I (12 Months)|Adverse Event|84|||
143478658|NCT00365456|517297873|FG001|Trial Period I (12 Months)|Adverse Event|0|||
143478659|NCT00365456|517297872|FG000|Trial Period I (12 Months)|Non-compliance|3|||
143478660|NCT00365456|517297873|FG001|Trial Period I (12 Months)|Non-compliance|0|||
143478661|NCT00365456|517297872|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
143478662|NCT00365456|517297873|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
143478663|NCT00365456|517297872|FG000|Trial Period I (12 Months)|Other|11|||
143478664|NCT00365456|517297873|FG001|Trial Period I (12 Months)|Other|0|||
143478665|NCT00365456|517297872|FG000|Trial Period II (12 Months)|Adverse Event|0|||
143478666|NCT00365456|517297873|FG001|Trial Period II (12 Months)|Adverse Event|6|||
143478667|NCT00365456|517297872|FG000|Trial Period II (12 Months)|Non-compliance|0|||
143478668|NCT00365456|517297873|FG001|Trial Period II (12 Months)|Non-compliance|2|||
143478669|NCT00365456|517297872|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
143478670|NCT00365456|517297873|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
143478671|NCT00365456|517297872|FG000|Trial Period II (12 Months)|Other|0|||
143478672|NCT00365456|517297873|FG001|Trial Period II (12 Months)|Other|1|||
143478673|NCT00365456|517297872|FG000|Trial Period III (12 Months)|Adverse Event|13|||
143478674|NCT00365456|517297873|FG001|Trial Period III (12 Months)|Adverse Event|3|||
143478675|NCT00365456|517297872|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
143478676|NCT00365456|517297873|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
143478677|NCT00365456|517297872|FG000|Trial Period III (12 Months)|Other|1|||
143478678|NCT00365456|517297873|FG001|Trial Period III (12 Months)|Other|1|||
143478679|NCT00424749|517297874|FG000|Overall Study|Withdrawal by Subject|1|||
143478680|NCT04109222|517297875|FG000|Overall Study|Adverse Event|1|||
143478681|NCT04109222|517297876|FG001|Overall Study|Adverse Event|0|||
143478682|NCT04109222|517297877|FG002|Overall Study|Adverse Event|0|||
143478683|NCT02577406|517297878|FG000|Randomized Period|Death|1|||
143478684|NCT02577406|517297879|FG001|Randomized Period|Death|0|||
143478685|NCT02577406|517297878|FG000|Randomized Period|Other reasons|0|||
143478686|NCT02577406|517297879|FG001|Randomized Period|Other reasons|20|||
143478687|NCT02577406|517297878|FG000|Treatment Period|Death|38|||
143478688|NCT02577406|517297879|FG001|Treatment Period|Death|23|||
143478689|NCT02577406|517297878|FG000|Treatment Period|Adverse Event|17|||
143478690|NCT02577406|517297879|FG001|Treatment Period|Adverse Event|12|||
143478691|NCT02577406|517297878|FG000|Treatment Period|Progressive Disease|53|||
143478692|NCT02577406|517297879|FG001|Treatment Period|Progressive Disease|37|||
143478693|NCT02577406|517297878|FG000|Treatment Period|Withdrawal by Subject|10|||
143478694|NCT02577406|517297879|FG001|Treatment Period|Withdrawal by Subject|24|||
143478695|NCT02577406|517297878|FG000|Treatment Period|Lost to Follow-up|0|||
143478696|NCT02577406|517297879|FG001|Treatment Period|Lost to Follow-up|1|||
143478697|NCT02577406|517297878|FG000|Treatment Period|Transition to commercially available treatment|1|||
143478698|NCT02577406|517297879|FG001|Treatment Period|Transition to commercially available treatment|1|||
143478699|NCT02577406|517297878|FG000|Treatment Period|Physician Decision|1|||
143478700|NCT02577406|517297879|FG001|Treatment Period|Physician Decision|0|||
143478701|NCT02577406|517297878|FG000|Treatment Period|Disease Relapse|28|||
143145913|NCT03329001|516081323|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
143478702|NCT02577406|517297879|FG001|Treatment Period|Disease Relapse|1|||
143478703|NCT02577406|517297878|FG000|Treatment Period|Protocol Violation|0|||
143478704|NCT02577406|517297879|FG001|Treatment Period|Protocol Violation|1|||
143478705|NCT02577406|517297878|FG000|Treatment Period|Other Reasons|3|||
143478706|NCT02577406|517297879|FG001|Treatment Period|Other Reasons|39|||
143478707|NCT02577406|517297878|FG000|Treatment Period|Hematopoietic Stem Cell Transplantation|6|||
143478708|NCT02577406|517297879|FG001|Treatment Period|Hematopoietic Stem Cell Transplantation|2|||
143478709|NCT05525689|517297883|FG000|Overall Study|Lost to Follow-up|1|||
143478710|NCT05525689|517297884|FG001|Overall Study|Lost to Follow-up|0|||
143478711|NCT03000179|517297887|FG000|Overall Study|Lost to Follow-up|2|||
143478712|NCT04688775|517297888|FG000|Placebo-controlled Period|Randomized, not treated|1|||
143478713|NCT04688775|517297889|FG001|Placebo-controlled Period|Randomized, not treated|1|||
143478714|NCT04688775|517297890|FG002|Placebo-controlled Period|Randomized, not treated|0|||
143478715|NCT04688775|517297891|FG003|Placebo-controlled Period|Randomized, not treated|0|||
143478716|NCT04688775|517297888|FG000|Placebo-controlled Period|Adverse Event|2|||
143478717|NCT04688775|517297889|FG001|Placebo-controlled Period|Adverse Event|0|||
143478718|NCT04688775|517297890|FG002|Placebo-controlled Period|Adverse Event|0|||
143478719|NCT04688775|517297891|FG003|Placebo-controlled Period|Adverse Event|0|||
143478720|NCT04688775|517297888|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
143478721|NCT04688775|517297889|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
143478722|NCT04688775|517297890|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
143478723|NCT04688775|517297891|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
143478724|NCT04688775|517297888|FG000|Placebo-controlled Period|Protocol Violation|0|||
143478725|NCT04688775|517297889|FG001|Placebo-controlled Period|Protocol Violation|1|||
143478726|NCT04688775|517297890|FG002|Placebo-controlled Period|Protocol Violation|0|||
143478727|NCT04688775|517297891|FG003|Placebo-controlled Period|Protocol Violation|0|||
143478728|NCT04688775|517297888|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
143478729|NCT04688775|517297889|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
143478730|NCT04688775|517297890|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
143478731|NCT04688775|517297891|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
143478732|NCT04688775|517297888|FG000|Placebo-controlled Period|Other reasons|0|||
143478733|NCT04688775|517297889|FG001|Placebo-controlled Period|Other reasons|1|||
143478734|NCT04688775|517297890|FG002|Placebo-controlled Period|Other reasons|0|||
143478735|NCT04688775|517297891|FG003|Placebo-controlled Period|Other reasons|0|||
143478736|NCT04688775|517297888|FG000|Delayed Start Period|Adverse Event|0|||
143478737|NCT04688775|517297889|FG001|Delayed Start Period|Adverse Event|0|||
143478738|NCT04688775|517297890|FG002|Delayed Start Period|Adverse Event|1|||
143478739|NCT04688775|517297891|FG003|Delayed Start Period|Adverse Event|0|||
143145914|NCT03329001|516081316|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
143145915|NCT03329001|516081317|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
143145916|NCT03329001|516081318|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
143145917|NCT03329001|516081319|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
143145918|NCT03329001|516081320|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
143145919|NCT03329001|516081321|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
143478740|NCT04688775|517297888|FG000|Delayed Start Period|Lack of Efficacy|0|||
143478741|NCT04688775|517297889|FG001|Delayed Start Period|Lack of Efficacy|0|||
143478742|NCT04688775|517297890|FG002|Delayed Start Period|Lack of Efficacy|0|||
143478743|NCT04688775|517297891|FG003|Delayed Start Period|Lack of Efficacy|3|||
143478744|NCT04688775|517297888|FG000|Delayed Start Period|Withdrawal by Subject|0|||
143478745|NCT04688775|517297889|FG001|Delayed Start Period|Withdrawal by Subject|0|||
143478746|NCT04688775|517297890|FG002|Delayed Start Period|Withdrawal by Subject|2|||
143478747|NCT04688775|517297891|FG003|Delayed Start Period|Withdrawal by Subject|4|||
143145920|NCT03329001|516081322|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
143145921|NCT03329001|516081323|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
143145922|NCT03329001|516081316|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
143145923|NCT03329001|516081317|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
143145924|NCT03329001|516081318|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
143145925|NCT03329001|516081319|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
143145926|NCT03329001|516081320|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
143145927|NCT03329001|516081321|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
143145928|NCT03329001|516081322|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
143145929|NCT03329001|516081323|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
143478748|NCT04688775|517297888|FG000|Delayed Start Period|Lost to Follow-up|0|||
143478749|NCT04688775|517297889|FG001|Delayed Start Period|Lost to Follow-up|0|||
143478750|NCT04688775|517297890|FG002|Delayed Start Period|Lost to Follow-up|2|||
143478751|NCT04688775|517297891|FG003|Delayed Start Period|Lost to Follow-up|1|||
143478752|NCT04688775|517297888|FG000|Delayed Start Period|other reasons|0|||
143478753|NCT04688775|517297889|FG001|Delayed Start Period|other reasons|0|||
143478754|NCT04688775|517297890|FG002|Delayed Start Period|other reasons|1|||
143478755|NCT04688775|517297891|FG003|Delayed Start Period|other reasons|0|||
143478756|NCT01843972|517297892|FG000|Overall Study|Withdrawal by Subject|0|||
143478757|NCT01843972|517297893|FG001|Overall Study|Withdrawal by Subject|0|||
143478758|NCT01843972|517297894|FG002|Overall Study|Withdrawal by Subject|0|||
143478759|NCT01843972|517297895|FG003|Overall Study|Withdrawal by Subject|0|||
143478760|NCT01843972|517297896|FG004|Overall Study|Withdrawal by Subject|1|||
143478761|NCT01843972|517297897|FG005|Overall Study|Withdrawal by Subject|0|||
143478762|NCT01843972|517297898|FG006|Overall Study|Withdrawal by Subject|0|||
143478763|NCT01843972|517297899|FG007|Overall Study|Withdrawal by Subject|0|||
143478764|NCT01843972|517297900|FG008|Overall Study|Withdrawal by Subject|0|||
143478765|NCT01843972|517297901|FG009|Overall Study|Withdrawal by Subject|0|||
143478766|NCT04702737|517297904|FG000|Overall Study|Decision by Sponsor|1|||
143478767|NCT04702737|517297904|FG000|Overall Study|Withdrawal of Consent from Study|3|||
143478768|NCT04702737|517297904|FG000|Overall Study|Lost to Follow-up|1|||
143478769|NCT04702737|517297904|FG000|Overall Study|Death|35|||
143478770|NCT01177683|517297905|FG000|Study Treatment|Disease Progressions during treatment|2|||
143478771|NCT01177683|517297906|FG001|Study Treatment|Disease Progressions during treatment|0|||
143478772|NCT01177683|517297907|FG002|Study Treatment|Disease Progressions during treatment|3|||
143478773|NCT01177683|517297905|FG000|Study Treatment|Adverse Event|0|||
143478774|NCT01177683|517297906|FG001|Study Treatment|Adverse Event|1|||
143478775|NCT01177683|517297907|FG002|Study Treatment|Adverse Event|12|||
143478776|NCT01177683|517297905|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
143478777|NCT01177683|517297906|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
143478778|NCT01177683|517297907|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
143478779|NCT01177683|517297905|FG000|Study Treatment|Alternative therapy|0|||
143478780|NCT01177683|517297906|FG001|Study Treatment|Alternative therapy|0|||
143478781|NCT01177683|517297907|FG002|Study Treatment|Alternative therapy|4|||
143478782|NCT01177683|517297905|FG000|Study Treatment|Physician Decision|1|||
143478783|NCT01177683|517297906|FG001|Study Treatment|Physician Decision|0|||
143478784|NCT01177683|517297907|FG002|Study Treatment|Physician Decision|1|||
143478785|NCT01177683|517297905|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
143478786|NCT01177683|517297906|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
143478787|NCT01177683|517297907|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
143478788|NCT01177683|517297905|FG000|Study Treatment|Symptomatic Deterioration|0|||
143478789|NCT01177683|517297906|FG001|Study Treatment|Symptomatic Deterioration|0|||
143478790|NCT01177683|517297907|FG002|Study Treatment|Symptomatic Deterioration|1|||
143478791|NCT01177683|517297905|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
143478792|NCT01177683|517297906|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
143478793|NCT01177683|517297907|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
143478794|NCT01177683|517297905|FG000|Follow up|Patient lost to follow up|0|||
143478795|NCT01177683|517297906|FG001|Follow up|Patient lost to follow up|0|||
143478796|NCT01177683|517297907|FG002|Follow up|Patient lost to follow up|2|||
143478797|NCT01177683|517297905|FG000|Follow up|Death|2|||
143478798|NCT01177683|517297906|FG001|Follow up|Death|1|||
143478799|NCT01177683|517297907|FG002|Follow up|Death|7|||
143478800|NCT01177683|517297905|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
143478801|NCT01177683|517297906|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
143145930|NCT03329001|516081316|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
143145931|NCT03329001|516081317|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
143363589|NCT00062868|516873785|FG005|Dose Level 1|Lost to Follow-up|0|||
143478802|NCT01177683|517297907|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
143478803|NCT01977820|517297910|FG000|Overall Study|Sponsor terminated the study|1|||
143478804|NCT01977820|517297911|FG001|Overall Study|Sponsor terminated the study|1|||
143145932|NCT03329001|516081318|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
143145933|NCT03329001|516081319|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
143145934|NCT03329001|516081320|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
143145935|NCT03329001|516081321|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
143145936|NCT03329001|516081322|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
143145937|NCT03329001|516081323|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
143145938|NCT03329001|516081316|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
143145939|NCT03329001|516081317|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
143145940|NCT03329001|516081318|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
143145941|NCT03329001|516081319|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
143145942|NCT03329001|516081320|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
143145943|NCT03329001|516081321|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
143145944|NCT03329001|516081322|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
143145945|NCT03329001|516081323|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
143363590|NCT00062868|516873786|FG006|Dose Level 1|Lost to Follow-up|0|||
143363591|NCT00062868|516873787|FG007|Dose Level 1|Lost to Follow-up|0|||
143145946|NCT03329001|516081316|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
143145947|NCT03329001|516081317|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
143145948|NCT03329001|516081318|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
143145949|NCT03329001|516081319|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
143145950|NCT03329001|516081320|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
143145951|NCT03329001|516081321|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
143145952|NCT03329001|516081322|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
143145953|NCT03329001|516081323|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
143145954|NCT03329001|516081316|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
143145955|NCT03329001|516081317|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
143145956|NCT03329001|516081318|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
143145957|NCT03329001|516081319|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
143145958|NCT03329001|516081320|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
143145959|NCT03329001|516081321|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
143145960|NCT03329001|516081322|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
143145961|NCT03329001|516081323|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
143145962|NCT03329001|516081316|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
143145963|NCT03329001|516081317|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
143145964|NCT03329001|516081318|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
143145965|NCT03329001|516081319|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
143145966|NCT03329001|516081320|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
143145967|NCT03329001|516081321|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
143145968|NCT03329001|516081322|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
143145969|NCT03329001|516081323|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
143145970|NCT03329001|516081316|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
143145971|NCT03329001|516081317|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
143145972|NCT03329001|516081318|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
143145973|NCT03329001|516081319|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
143145974|NCT03329001|516081320|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
143145975|NCT03329001|516081321|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
143145976|NCT03329001|516081322|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
143145977|NCT03329001|516081323|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
143145978|NCT03329001|516081316|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
143145979|NCT03329001|516081317|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
143145980|NCT03329001|516081318|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
143363592|NCT00062868|516873788|FG008|Dose Level 1|Lost to Follow-up|0|||
143363593|NCT00062868|516873789|FG009|Dose Level 1|Lost to Follow-up|0|||
143145981|NCT03329001|516081319|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
143145982|NCT03329001|516081320|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
143145983|NCT03329001|516081321|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
143145984|NCT03329001|516081322|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
143145985|NCT03329001|516081323|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
143145986|NCT03329001|516081316|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
143145987|NCT03329001|516081317|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
143145988|NCT03329001|516081318|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
143145989|NCT03329001|516081319|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
143145990|NCT03329001|516081320|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
143145991|NCT03329001|516081321|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
143145992|NCT03329001|516081322|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
143145993|NCT03329001|516081323|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
143145994|NCT03329001|516081316|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
143145995|NCT03329001|516081317|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
143145996|NCT03329001|516081318|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
143145997|NCT03329001|516081319|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
143145998|NCT03329001|516081320|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
143145999|NCT03329001|516081321|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
143014100|NCT00422058|515591612|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
143014101|NCT00422058|515591613|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
143014102|NCT00422058|515591614|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
143014103|NCT00422058|515591615|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
143014104|NCT00422058|515591616|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
143014105|NCT00422058|515591617|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
143014106|NCT00422058|515591612|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
143014107|NCT00422058|515591613|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
143014108|NCT00422058|515591614|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
143014109|NCT00422058|515591615|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
143014110|NCT00422058|515591616|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
143014111|NCT00422058|515591617|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
143014112|NCT00422058|515591612|FG000|Double-Blind, Week 0-20|Other|11|||
143014113|NCT00422058|515591613|FG001|Double-Blind, Week 0-20|Other|3|||
143014114|NCT00422058|515591614|FG002|Double-Blind, Week 0-20|Other|8|||
143014115|NCT00422058|515591615|FG003|Double-Blind, Week 0-20|Other|8|||
143014116|NCT00422058|515591616|FG004|Double-Blind, Week 0-20|Other|4|||
143014117|NCT00422058|515591617|FG005|Double-Blind, Week 0-20|Other|10|||
143014118|NCT00422058|515591612|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
143014119|NCT00422058|515591613|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
143014120|NCT00422058|515591614|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
143014121|NCT00422058|515591615|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
143014122|NCT00422058|515591616|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
143014123|NCT00422058|515591617|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
143014124|NCT00422058|515591612|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
143014125|NCT00422058|515591613|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
143014126|NCT00422058|515591614|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
143014127|NCT00422058|515591615|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
143014128|NCT00422058|515591616|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
143014129|NCT00422058|515591617|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
143014130|NCT00422058|515591612|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
143014131|NCT00422058|515591613|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
143014132|NCT00422058|515591614|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
143014133|NCT00422058|515591615|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
143014134|NCT00422058|515591616|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
143014135|NCT00422058|515591617|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
143014136|NCT00422058|515591612|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
143014137|NCT00422058|515591613|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
143014138|NCT00422058|515591614|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
143014139|NCT00422058|515591615|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
143014140|NCT00422058|515591616|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
143014141|NCT00422058|515591617|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
143014142|NCT00422058|515591612|FG000|Open-Label Extension, Week 20-104|Other|13|||
143014143|NCT00422058|515591613|FG001|Open-Label Extension, Week 20-104|Other|14|||
143014144|NCT00422058|515591614|FG002|Open-Label Extension, Week 20-104|Other|6|||
143014145|NCT00422058|515591615|FG003|Open-Label Extension, Week 20-104|Other|13|||
143014146|NCT00422058|515591616|FG004|Open-Label Extension, Week 20-104|Other|16|||
143014147|NCT00422058|515591617|FG005|Open-Label Extension, Week 20-104|Other|18|||
143146000|NCT03329001|516081322|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
143146001|NCT03329001|516081323|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
143146002|NCT03329001|516081316|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
143146003|NCT03329001|516081317|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
143146004|NCT03329001|516081318|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
143146005|NCT03329001|516081319|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
143146006|NCT03329001|516081320|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
143146007|NCT03329001|516081321|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
143146008|NCT03329001|516081322|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
143146009|NCT03329001|516081323|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
143146010|NCT03329001|516081316|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
143146011|NCT03329001|516081317|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
143146012|NCT03329001|516081318|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
143146013|NCT03329001|516081319|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
143146014|NCT03329001|516081320|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
143146015|NCT03329001|516081321|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
143146016|NCT03329001|516081322|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
143146017|NCT03329001|516081323|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
143146018|NCT03329001|516081316|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
143146019|NCT03329001|516081317|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
143146020|NCT03329001|516081318|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
143146021|NCT03329001|516081319|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
143146022|NCT03329001|516081320|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
143146023|NCT03329001|516081321|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
143146024|NCT03329001|516081322|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
143146025|NCT03329001|516081323|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
143146026|NCT03329001|516081316|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
143146027|NCT03329001|516081317|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
143146028|NCT03329001|516081318|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
143146029|NCT03329001|516081319|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
143146030|NCT03329001|516081320|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
143146031|NCT03329001|516081321|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
143146032|NCT03329001|516081322|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
143146033|NCT03329001|516081323|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
143146034|NCT03329001|516081316|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
143146035|NCT03329001|516081317|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
143146036|NCT03329001|516081318|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
143146037|NCT03329001|516081319|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
143146038|NCT03329001|516081320|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
143146039|NCT03329001|516081321|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
143146040|NCT03329001|516081322|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
143146041|NCT03329001|516081323|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
143146042|NCT03329001|516081316|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
143146043|NCT03329001|516081317|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
143146044|NCT03329001|516081318|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
143146045|NCT03329001|516081319|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
143146046|NCT03329001|516081320|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
143146047|NCT03329001|516081321|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
143146048|NCT03329001|516081322|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
143146049|NCT03329001|516081323|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
143146050|NCT03329001|516081316|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
143146051|NCT03329001|516081317|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
143146052|NCT03329001|516081318|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
143146053|NCT03329001|516081319|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
143146054|NCT03329001|516081320|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
143146055|NCT03329001|516081321|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
143146056|NCT03329001|516081322|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
143478805|NCT02568475|517297915|FG000|Overall Study|Lost to Follow-up|40|||
143478806|NCT02568475|517297916|FG001|Overall Study|Lost to Follow-up|39|||
143478807|NCT02568475|517297915|FG000|Overall Study|Withdrawal by Subject|2|||
143478808|NCT02568475|517297916|FG001|Overall Study|Withdrawal by Subject|0|||
143478809|NCT02568475|517297915|FG000|Overall Study|Discharged home|4|||
143478810|NCT02568475|517297916|FG001|Overall Study|Discharged home|4|||
143478811|NCT02568475|517297915|FG000|Overall Study|Short-term: Discharge location unknown|4|||
143478812|NCT02568475|517297916|FG001|Overall Study|Short-term: Discharge location unknown|0|||
143478813|NCT02568475|517297915|FG000|Overall Study|Transferred to another facility|1|||
143478814|NCT02568475|517297916|FG001|Overall Study|Transferred to another facility|0|||
143478815|NCT00290186|517297921|FG000|Overall Study|Adverse Event|1|||
143478816|NCT00290186|517297922|FG001|Overall Study|Adverse Event|1|||
143478817|NCT00290186|517297921|FG000|Overall Study|Lost to Follow-up|3|||
143478818|NCT00290186|517297922|FG001|Overall Study|Lost to Follow-up|2|||
143478819|NCT00290186|517297921|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
143478820|NCT00290186|517297922|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
143146057|NCT03329001|516081323|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
143146058|NCT03329001|516081316|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
143146059|NCT03329001|516081317|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
143146060|NCT03329001|516081318|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
143146061|NCT03329001|516081319|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
143146062|NCT03329001|516081320|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
143146063|NCT03329001|516081321|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
143146064|NCT03329001|516081322|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
143146065|NCT03329001|516081323|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
143146066|NCT03329001|516081316|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
143146067|NCT03329001|516081317|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
143146068|NCT03329001|516081318|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
143146069|NCT03329001|516081319|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
143146070|NCT03329001|516081320|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
143146071|NCT03329001|516081321|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
143146072|NCT03329001|516081322|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
143146073|NCT03329001|516081323|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
143146074|NCT03329001|516081316|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
143146075|NCT03329001|516081317|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
143146076|NCT03329001|516081318|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
143146077|NCT03329001|516081319|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
143146078|NCT03329001|516081320|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
143146079|NCT03329001|516081321|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
143146080|NCT03329001|516081322|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
143146081|NCT03329001|516081323|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
143146082|NCT03329001|516081316|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
143146083|NCT03329001|516081317|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
143146084|NCT03329001|516081318|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
143146085|NCT03329001|516081319|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
143146086|NCT03329001|516081320|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
143146087|NCT03329001|516081321|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
143146088|NCT03329001|516081322|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
143146089|NCT03329001|516081323|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
143146090|NCT03329001|516081316|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
143146091|NCT03329001|516081317|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
143146092|NCT03329001|516081318|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
143146093|NCT03329001|516081319|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
143146094|NCT03329001|516081320|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
143146095|NCT03329001|516081321|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
143146096|NCT03329001|516081322|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
143146097|NCT03329001|516081323|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
143146098|NCT03329001|516081316|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
143146099|NCT03329001|516081317|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
143146100|NCT03329001|516081318|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
143146101|NCT03329001|516081319|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
143146102|NCT03329001|516081320|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
143146103|NCT03329001|516081321|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
143146104|NCT03329001|516081322|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
143181185|NCT00707993|516210488|FG001|Overall Study|Withdrawal by Subject|16|||
143478821|NCT00290186|517297921|FG000|Overall Study|Withdrawal by Subject|0|||
143478822|NCT00290186|517297922|FG001|Overall Study|Withdrawal by Subject|1|||
143478823|NCT03184077|517297925|FG000|Overall Study|Lost to Follow-up|21|||
143478824|NCT03184077|517297926|FG001|Overall Study|Lost to Follow-up|21|||
143478825|NCT00262522|517297927|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
143478826|NCT00262522|517297928|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
143478827|NCT00262522|517297929|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
143478828|NCT00262522|517297930|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
143478829|NCT00262522|517297927|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
143478830|NCT00262522|517297928|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
143478831|NCT00262522|517297929|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
143478832|NCT00262522|517297930|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
143478833|NCT00262522|517297927|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
143478834|NCT00262522|517297928|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
143478835|NCT00262522|517297929|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
143478836|NCT00262522|517297930|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
143478837|NCT00262522|517297927|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
143478838|NCT00262522|517297928|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
143478839|NCT00262522|517297929|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
143478840|NCT00262522|517297930|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
143478841|NCT00262522|517297927|FG000|Study Start Through 8 Weeks|Death|1|||
143478842|NCT00262522|517297928|FG001|Study Start Through 8 Weeks|Death|0|||
143478843|NCT00262522|517297929|FG002|Study Start Through 8 Weeks|Death|0|||
143478844|NCT00262522|517297930|FG003|Study Start Through 8 Weeks|Death|0|||
143478845|NCT00262522|517297927|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
143478846|NCT00262522|517297928|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
143478847|NCT00262522|517297929|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
143478848|NCT00262522|517297930|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
143478849|NCT00262522|517297927|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
143478850|NCT00262522|517297928|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
143478851|NCT00262522|517297929|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
143478852|NCT00262522|517297930|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
143478853|NCT00262522|517297927|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
143478854|NCT00262522|517297928|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
143478855|NCT00262522|517297929|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
143478856|NCT00262522|517297930|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
143478857|NCT00262522|517297927|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
143478858|NCT00262522|517297928|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
143478859|NCT00262522|517297929|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
143478860|NCT00262522|517297930|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
143478861|NCT00262522|517297927|FG000|Study Start Through 48 Weeks|Death|2|||
143478862|NCT00262522|517297928|FG001|Study Start Through 48 Weeks|Death|0|||
143478863|NCT00262522|517297929|FG002|Study Start Through 48 Weeks|Death|1|||
143478864|NCT00262522|517297930|FG003|Study Start Through 48 Weeks|Death|0|||
143478865|NCT00262522|517297927|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
143478866|NCT00262522|517297928|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
143478867|NCT00262522|517297929|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
143146105|NCT03329001|516081323|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
143146106|NCT03329001|516081316|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
143146107|NCT03329001|516081317|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
143146108|NCT03329001|516081318|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
143146109|NCT03329001|516081319|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
143146110|NCT03329001|516081320|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
143146111|NCT03329001|516081321|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
143146112|NCT03329001|516081322|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
143146113|NCT03329001|516081323|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
143146114|NCT03329001|516081316|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
143478868|NCT00262522|517297930|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
143478869|NCT00262522|517297927|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
143478870|NCT00262522|517297928|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
143478871|NCT00262522|517297929|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
143478872|NCT00262522|517297930|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
143478873|NCT00262522|517297927|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
143478874|NCT00262522|517297928|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
143478875|NCT00262522|517297929|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
143478876|NCT00262522|517297930|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
143014148|NCT00713830|515591618|FG000|Overall Study|Adverse Event|23|||
143014149|NCT00713830|515591619|FG001|Overall Study|Adverse Event|71|||
143146115|NCT03329001|516081317|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
143146116|NCT03329001|516081318|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
143146117|NCT03329001|516081319|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
143478877|NCT00262522|517297927|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
143478878|NCT00262522|517297928|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
143478879|NCT00262522|517297929|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
143478880|NCT00262522|517297930|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
143478881|NCT00262522|517297927|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
143478882|NCT00262522|517297928|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
143478883|NCT00262522|517297929|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
143478884|NCT00262522|517297930|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
143478885|NCT00262522|517297927|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
143146118|NCT03329001|516081320|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
143146119|NCT03329001|516081321|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
143146120|NCT03329001|516081322|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
143146121|NCT03329001|516081323|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
143146122|NCT03329001|516081316|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
143146123|NCT03329001|516081317|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
143146124|NCT03329001|516081318|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
143146125|NCT03329001|516081319|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
143146126|NCT03329001|516081320|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
143146127|NCT03329001|516081321|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
143146128|NCT03329001|516081322|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
143146129|NCT03329001|516081323|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
143146130|NCT03329001|516081316|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
143146131|NCT03329001|516081317|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
143146132|NCT03329001|516081318|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
143146133|NCT03329001|516081319|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
143146134|NCT03329001|516081320|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
143146135|NCT03329001|516081321|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
143146136|NCT03329001|516081322|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
143146137|NCT03329001|516081323|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
143146138|NCT02178956|516081324|FG000|Overall Study|Lost to Follow-up|4|||
143146139|NCT02178956|516081325|FG001|Overall Study|Lost to Follow-up|4|||
143146140|NCT02178956|516081324|FG000|Overall Study|Sponsor terminated study|49|||
143146141|NCT02178956|516081325|FG001|Overall Study|Sponsor terminated study|58|||
143146142|NCT02178956|516081324|FG000|Overall Study|Withdrawal by Subject|15|||
143146143|NCT02178956|516081325|FG001|Overall Study|Withdrawal by Subject|11|||
143146144|NCT02178956|516081324|FG000|Overall Study|Various Reasons|3|||
143146145|NCT02178956|516081325|FG001|Overall Study|Various Reasons|5|||
143146146|NCT01138046|516081328|FG000|Overall Study|Withdrawal due to death|6|||
143146147|NCT02709369|516081330|FG000|Overall Study|Lost to Follow-up|15|||
143146148|NCT02709369|516081330|FG000|Overall Study|Withdrawal by Subject|10|||
143146149|NCT02709369|516081330|FG000|Overall Study|Did not received intervention|2|||
143146150|NCT00963235|516081331|FG000|Overall Study|Withdrawal by Subject|22|||
143146151|NCT00963235|516081331|FG000|Overall Study|Lost to Follow-up|14|||
143146152|NCT00963235|516081331|FG000|Overall Study|Failed to return|9|||
143146153|NCT00963235|516081331|FG000|Overall Study|Protocol Violation|7|||
143146154|NCT00963235|516081331|FG000|Overall Study|Adverse Event|5|||
143146155|NCT00963235|516081331|FG000|Overall Study|Physician Decision|2|||
143146156|NCT00963235|516081331|FG000|Overall Study|Other|1|||
143146157|NCT01900314|516081332|FG000|Overall Study|Lost to Follow-up|1|||
143146158|NCT01900314|516081333|FG001|Overall Study|Lost to Follow-up|0|||
143146159|NCT01900314|516081332|FG000|Overall Study|Protocol Violation|0|||
143146160|NCT01900314|516081333|FG001|Overall Study|Protocol Violation|1|||
143146161|NCT01900314|516081332|FG000|Overall Study|Withdrawal by Subject|3|||
143146162|NCT01900314|516081333|FG001|Overall Study|Withdrawal by Subject|3|||
143146163|NCT01104766|516081334|FG000|Overall Study|Did not meet inc/exc criteria|1|||
143146164|NCT01104766|516081335|FG001|Overall Study|Did not meet inc/exc criteria|0|||
143146165|NCT01104766|516081336|FG002|Overall Study|Did not meet inc/exc criteria|0|||
143146166|NCT01104766|516081337|FG003|Overall Study|Did not meet inc/exc criteria|0|||
143146167|NCT01104766|516081334|FG000|Overall Study|Adverse Event|17|||
143146168|NCT01104766|516081335|FG001|Overall Study|Adverse Event|15|||
143146169|NCT01104766|516081336|FG002|Overall Study|Adverse Event|20|||
143146170|NCT01104766|516081337|FG003|Overall Study|Adverse Event|14|||
143146171|NCT01104766|516081334|FG000|Overall Study|Lack of Efficacy|20|||
143146172|NCT01104766|516081335|FG001|Overall Study|Lack of Efficacy|15|||
143146173|NCT01104766|516081336|FG002|Overall Study|Lack of Efficacy|14|||
143146174|NCT01104766|516081337|FG003|Overall Study|Lack of Efficacy|8|||
143146175|NCT01104766|516081334|FG000|Overall Study|Protocol Violation|2|||
143146176|NCT01104766|516081335|FG001|Overall Study|Protocol Violation|0|||
143146177|NCT01104766|516081336|FG002|Overall Study|Protocol Violation|0|||
143146178|NCT01104766|516081337|FG003|Overall Study|Protocol Violation|0|||
143146179|NCT01104766|516081334|FG000|Overall Study|Withdrawal by Subject|17|||
143146180|NCT01104766|516081335|FG001|Overall Study|Withdrawal by Subject|19|||
143014150|NCT00713830|515591618|FG000|Overall Study|Lack of Efficacy|24|||
143146181|NCT01104766|516081336|FG002|Overall Study|Withdrawal by Subject|25|||
143146182|NCT01104766|516081337|FG003|Overall Study|Withdrawal by Subject|15|||
143146183|NCT01104766|516081334|FG000|Overall Study|Lost to Follow-up|1|||
143146184|NCT01104766|516081335|FG001|Overall Study|Lost to Follow-up|2|||
143146185|NCT01104766|516081336|FG002|Overall Study|Lost to Follow-up|1|||
143146186|NCT01104766|516081337|FG003|Overall Study|Lost to Follow-up|1|||
143146187|NCT01341470|516081339|FG000|Overall Study|Sponsor decision|0|||
143146188|NCT01341470|516081340|FG001|Overall Study|Sponsor decision|0|||
143146189|NCT01341470|516081341|FG002|Overall Study|Sponsor decision|1|||
143146190|NCT01341470|516081342|FG003|Overall Study|Sponsor decision|1|||
143146191|NCT01341470|516081343|FG004|Overall Study|Sponsor decision|0|||
143146192|NCT01341470|516081344|FG005|Overall Study|Sponsor decision|1|||
143146193|NCT01136915|516081346|FG000|Overall Study|Lost to Follow-up|2|||
143146194|NCT01136915|516081347|FG001|Overall Study|Lost to Follow-up|0|||
143146195|NCT01136915|516081346|FG000|Overall Study|Exclusion criterion met|0|||
143146196|NCT01136915|516081347|FG001|Overall Study|Exclusion criterion met|1|||
143146197|NCT01756235|516081348|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
143146198|NCT03282097|516081351|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
143146199|NCT03282097|516081352|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
143146200|NCT03282097|516081351|FG000|Intervention Visit Complete|Patient Death|13|||
143146201|NCT03282097|516081352|FG001|Intervention Visit Complete|Patient Death|15|||
143146202|NCT03282097|516081351|FG000|Intervention Visit Complete|Caregiver Death|0|||
143146203|NCT03282097|516081352|FG001|Intervention Visit Complete|Caregiver Death|3|||
143146204|NCT03282097|516081351|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
143146205|NCT03282097|516081352|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
143146206|NCT03282097|516081351|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
143146207|NCT03282097|516081352|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
143146208|NCT03282097|516081351|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
143146209|NCT03282097|516081352|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
143146210|NCT03282097|516081351|FG000|Primary Outcome Data Collection Complete|Missing|2|||
143146211|NCT03282097|516081352|FG001|Primary Outcome Data Collection Complete|Missing|3|||
143146212|NCT03282097|516081351|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
143146213|NCT03282097|516081352|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
143146214|NCT03282097|516081351|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
143146215|NCT03282097|516081352|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
143146216|NCT03282097|516081351|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
143146217|NCT03282097|516081352|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
143146218|NCT03188822|516081354|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
143146219|NCT03188822|516081354|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
143146220|NCT03806296|516081355|FG000|T1: Laboratory: 1 Week|Withdrawal by Subject|6|||
143146221|NCT03806296|516081356|FG001|T1: Laboratory: 1 Week|Withdrawal by Subject|1|||
143146222|NCT03806296|516081357|FG002|T1: Laboratory: 1 Week|Withdrawal by Subject|3|||
143146223|NCT03806296|516081355|FG000|T1: Laboratory: 1 Week|Lost to Follow-up|7|||
143146224|NCT03806296|516081356|FG001|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
143146225|NCT03806296|516081357|FG002|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
143146226|NCT03806296|516081355|FG000|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|1|||
143146227|NCT03806296|516081356|FG001|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
143146228|NCT03806296|516081357|FG002|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
143146229|NCT02401230|516081365|FG000|Overall Study|Adverse Event|3|||
143146230|NCT02401230|516081366|FG001|Overall Study|Adverse Event|2|||
143146231|NCT02401230|516081367|FG002|Overall Study|Adverse Event|0|||
143146232|NCT02401230|516081365|FG000|Overall Study|Withdrawal by Subject|2|||
143146233|NCT02401230|516081366|FG001|Overall Study|Withdrawal by Subject|1|||
143363594|NCT00062868|516873790|FG010|Dose Level 1|Lost to Follow-up|0|||
143478886|NCT00262522|517297928|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
143478887|NCT00262522|517297929|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
143478888|NCT00262522|517297930|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
143478889|NCT00262522|517297927|FG000|Study Start Through 96 Weeks|Death|2|||
143478890|NCT00262522|517297928|FG001|Study Start Through 96 Weeks|Death|0|||
143478891|NCT00262522|517297929|FG002|Study Start Through 96 Weeks|Death|2|||
143478892|NCT00262522|517297930|FG003|Study Start Through 96 Weeks|Death|0|||
143478893|NCT00262522|517297927|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
143478894|NCT00262522|517297928|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
143478895|NCT00262522|517297929|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
143478896|NCT00262522|517297930|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
143478897|NCT00262522|517297927|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
143478898|NCT00262522|517297928|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
143478899|NCT00262522|517297929|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
143478900|NCT00262522|517297930|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
143146234|NCT02401230|516081367|FG002|Overall Study|Withdrawal by Subject|1|||
143146235|NCT02401230|516081365|FG000|Overall Study|Lost to Follow-up|1|||
143146236|NCT02401230|516081366|FG001|Overall Study|Lost to Follow-up|3|||
143146237|NCT02401230|516081367|FG002|Overall Study|Lost to Follow-up|3|||
143146238|NCT00830765|516081368|FG000|Overall Study|Protocol Violation|3|||
143363595|NCT00062868|516873791|FG011|Dose Level 1|Lost to Follow-up|0|||
143363596|NCT00062868|516873792|FG012|Dose Level 1|Lost to Follow-up|1|||
143363597|NCT00062868|516873793|FG013|Dose Level 1|Lost to Follow-up|0|||
143478901|NCT03159091|517297931|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
143478902|NCT03159091|517297932|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
143478903|NCT03159091|517297931|FG000|Overall Study|Patient has taken no dose of study drug|0|||
143478904|NCT03159091|517297932|FG001|Overall Study|Patient has taken no dose of study drug|1|||
143478905|NCT00943579|517297934|FG000|Overall Study|Adverse Event|4|||
143478906|NCT00943579|517297935|FG001|Overall Study|Adverse Event|3|||
143478907|NCT00943579|517297934|FG000|Overall Study|Lack of Efficacy|2|||
143478908|NCT00943579|517297935|FG001|Overall Study|Lack of Efficacy|2|||
143478909|NCT02710136|517297936|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
143478910|NCT02710136|517297937|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
143478911|NCT00418665|517297938|FG000|Treatment Period|Ineligibility determined|1|||
143478912|NCT00418665|517297939|FG001|Treatment Period|Ineligibility determined|1|||
143478913|NCT00418665|517297940|FG002|Treatment Period|Ineligibility determined|0|||
143478914|NCT00418665|517297938|FG000|Treatment Period|Adverse Event|2|||
143478915|NCT00418665|517297939|FG001|Treatment Period|Adverse Event|2|||
143478916|NCT00418665|517297940|FG002|Treatment Period|Adverse Event|0|||
143478917|NCT00418665|517297938|FG000|Treatment Period|Withdrawal by Subject|0|||
143478918|NCT00418665|517297939|FG001|Treatment Period|Withdrawal by Subject|3|||
143478919|NCT00418665|517297940|FG002|Treatment Period|Withdrawal by Subject|1|||
143478920|NCT00418665|517297938|FG000|Treatment Period|Requirement for alternative therapy|1|||
143478921|NCT00418665|517297939|FG001|Treatment Period|Requirement for alternative therapy|0|||
143478922|NCT00418665|517297940|FG002|Treatment Period|Requirement for alternative therapy|0|||
143478923|NCT00418665|517297938|FG000|Treatment Period|Physician Decision|1|||
143478924|NCT00418665|517297939|FG001|Treatment Period|Physician Decision|0|||
143478925|NCT00418665|517297940|FG002|Treatment Period|Physician Decision|3|||
143478926|NCT00418665|517297938|FG000|Treatment Extension|Adverse Event|1|||
143478927|NCT00418665|517297939|FG001|Treatment Extension|Adverse Event|0|||
143478928|NCT00418665|517297940|FG002|Treatment Extension|Adverse Event|0|||
143478929|NCT00418665|517297938|FG000|Treatment Extension|Withdrawal by Subject|1|||
143478930|NCT00418665|517297939|FG001|Treatment Extension|Withdrawal by Subject|0|||
143478931|NCT00418665|517297940|FG002|Treatment Extension|Withdrawal by Subject|0|||
143478932|NCT00418665|517297938|FG000|Treatment Extension|Requirement for alternative therapy|2|||
143478933|NCT00418665|517297939|FG001|Treatment Extension|Requirement for alternative therapy|2|||
143478934|NCT00418665|517297940|FG002|Treatment Extension|Requirement for alternative therapy|0|||
143478935|NCT00418665|517297938|FG000|Treatment Extension|Physician Decision|2|||
143478936|NCT00418665|517297939|FG001|Treatment Extension|Physician Decision|2|||
143478937|NCT00418665|517297940|FG002|Treatment Extension|Physician Decision|1|||
143478938|NCT00418665|517297938|FG000|Treatment Extension|Death|0|||
143478939|NCT00418665|517297939|FG001|Treatment Extension|Death|0|||
143478940|NCT00418665|517297940|FG002|Treatment Extension|Death|1|||
143478941|NCT01133379|517297941|FG000|Overall Study|Withdrawal by Subject|0|||
143478942|NCT01133379|517297942|FG001|Overall Study|Withdrawal by Subject|1|||
143478943|NCT01133379|517297943|FG002|Overall Study|Withdrawal by Subject|1|||
143478944|NCT01133379|517297941|FG000|Overall Study|Lost to Follow-up|1|||
143478945|NCT01133379|517297942|FG001|Overall Study|Lost to Follow-up|1|||
143478946|NCT01133379|517297943|FG002|Overall Study|Lost to Follow-up|1|||
143478947|NCT06156215|517297952|FG000|Overall Study|Withdrawal by Subject|2|||
143478948|NCT06156215|517297953|FG001|Overall Study|Withdrawal by Subject|4|||
143478949|NCT06156215|517297954|FG002|Overall Study|Withdrawal by Subject|4|||
143478950|NCT06156215|517297955|FG003|Overall Study|Withdrawal by Subject|0|||
143478951|NCT06156215|517297956|FG004|Overall Study|Withdrawal by Subject|2|||
143478952|NCT06156215|517297957|FG005|Overall Study|Withdrawal by Subject|2|||
143478953|NCT06156215|517297952|FG000|Overall Study|Left ED without completing study|9|||
143478954|NCT06156215|517297953|FG001|Overall Study|Left ED without completing study|3|||
143478955|NCT06156215|517297954|FG002|Overall Study|Left ED without completing study|9|||
143478956|NCT06156215|517297955|FG003|Overall Study|Left ED without completing study|0|||
143478957|NCT06156215|517297956|FG004|Overall Study|Left ED without completing study|8|||
143478958|NCT06156215|517297957|FG005|Overall Study|Left ED without completing study|16|||
143014151|NCT00713830|515591619|FG001|Overall Study|Lack of Efficacy|16|||
143146239|NCT00830765|516081369|FG001|Overall Study|Protocol Violation|2|||
143363598|NCT00062868|516873794|FG014|Dose Level 1|Lost to Follow-up|0|||
143363599|NCT00062868|516873795|FG015|Dose Level 1|Lost to Follow-up|0|||
143478959|NCT06156215|517297952|FG000|Overall Study|Physician Decision|1|||
143478960|NCT06156215|517297953|FG001|Overall Study|Physician Decision|0|||
143478961|NCT06156215|517297954|FG002|Overall Study|Physician Decision|0|||
143478962|NCT06156215|517297955|FG003|Overall Study|Physician Decision|0|||
143478963|NCT06156215|517297956|FG004|Overall Study|Physician Decision|0|||
143478964|NCT06156215|517297957|FG005|Overall Study|Physician Decision|0|||
143478965|NCT06156215|517297952|FG000|Overall Study|Became or found ineligible|2|||
143478966|NCT06156215|517297953|FG001|Overall Study|Became or found ineligible|0|||
143146240|NCT00315445|516081370|FG000|Overall Study|Adverse Event|7|||
143146241|NCT00315445|516081371|FG001|Overall Study|Adverse Event|12|||
143146242|NCT00315445|516081372|FG002|Overall Study|Adverse Event|15|||
143146243|NCT00315445|516081370|FG000|Overall Study|Lack of Efficacy|16|||
143146244|NCT00315445|516081371|FG001|Overall Study|Lack of Efficacy|1|||
143146245|NCT00315445|516081372|FG002|Overall Study|Lack of Efficacy|7|||
143146246|NCT00315445|516081370|FG000|Overall Study|Lost to Follow-up|1|||
143146247|NCT00315445|516081371|FG001|Overall Study|Lost to Follow-up|0|||
143146248|NCT00315445|516081372|FG002|Overall Study|Lost to Follow-up|1|||
143146249|NCT00315445|516081370|FG000|Overall Study|Protocol Violation|2|||
143146250|NCT00315445|516081371|FG001|Overall Study|Protocol Violation|0|||
143146251|NCT00315445|516081372|FG002|Overall Study|Protocol Violation|1|||
143146252|NCT00315445|516081370|FG000|Overall Study|Other|1|||
143146253|NCT00315445|516081371|FG001|Overall Study|Other|3|||
143146254|NCT00315445|516081372|FG002|Overall Study|Other|0|||
143146255|NCT02340949|516081373|FG000|Overall Study|Adverse Event|4|||
143146256|NCT02340949|516081374|FG001|Overall Study|Adverse Event|2|||
143146257|NCT02340949|516081373|FG000|Overall Study|Withdrawal by Subject|2|||
143146258|NCT02340949|516081374|FG001|Overall Study|Withdrawal by Subject|0|||
143146259|NCT02340949|516081373|FG000|Overall Study|Progression disease|6|||
143146260|NCT02340949|516081374|FG001|Overall Study|Progression disease|2|||
143146261|NCT02340949|516081373|FG000|Overall Study|Death|3|||
143146262|NCT02340949|516081374|FG001|Overall Study|Death|0|||
143146263|NCT02340949|516081373|FG000|Overall Study|Physician Decision|1|||
143146264|NCT02340949|516081374|FG001|Overall Study|Physician Decision|0|||
143146265|NCT00296517|516081375|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
143146266|NCT00296517|516081376|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
143146267|NCT00296517|516081375|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
143146268|NCT00296517|516081376|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
143146269|NCT00296517|516081375|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
143146270|NCT00296517|516081376|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
143146271|NCT00296517|516081375|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
143146272|NCT00296517|516081376|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
143146273|NCT00296517|516081375|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
143146274|NCT00296517|516081376|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
143146275|NCT00296517|516081375|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
143146276|NCT00296517|516081376|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
143146277|NCT00296517|516081375|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
143146278|NCT00296517|516081376|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
143146279|NCT00296517|516081375|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
143146280|NCT00296517|516081376|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
143146281|NCT00296517|516081375|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
143146282|NCT00296517|516081376|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
143146283|NCT03479905|516081385|FG000|Overall Study|Other airway method used|4|||
143146284|NCT03479905|516081386|FG001|Overall Study|Other airway method used|5|||
143146285|NCT03479905|516081387|FG002|Overall Study|Other airway method used|5|||
143146286|NCT00862992|516081388|FG000|Overall Study|Adverse Event|2|||
143146287|NCT00862992|516081389|FG001|Overall Study|Adverse Event|1|||
143146288|NCT00862992|516081390|FG002|Overall Study|Adverse Event|1|||
143146289|NCT00862992|516081388|FG000|Overall Study|Physician Decision|1|||
143146290|NCT00862992|516081389|FG001|Overall Study|Physician Decision|0|||
143146291|NCT00862992|516081390|FG002|Overall Study|Physician Decision|0|||
143146292|NCT00862992|516081388|FG000|Overall Study|Withdrawal by Subject|0|||
143146293|NCT00862992|516081389|FG001|Overall Study|Withdrawal by Subject|0|||
143146294|NCT00862992|516081390|FG002|Overall Study|Withdrawal by Subject|2|||
143146295|NCT05032196|516081398|FG000|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
143146296|NCT05032196|516081399|FG001|Period 1 (Single Ascending Dose)|Withdrawal by Subject|1|||
143146297|NCT05032196|516081400|FG002|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
143146298|NCT05032196|516081401|FG003|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
143363600|NCT00062868|516873796|FG016|Dose Level 1|Lost to Follow-up|0|||
143478967|NCT06156215|517297954|FG002|Overall Study|Became or found ineligible|2|||
143146299|NCT05032196|516081402|FG004|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
143146300|NCT05032196|516081403|FG005|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
143146301|NCT05032196|516081398|FG000|Period 1 (Single Ascending Dose)|Adverse Event|0|||
143146302|NCT05032196|516081399|FG001|Period 1 (Single Ascending Dose)|Adverse Event|0|||
143146303|NCT05032196|516081400|FG002|Period 1 (Single Ascending Dose)|Adverse Event|0|||
143146304|NCT05032196|516081401|FG003|Period 1 (Single Ascending Dose)|Adverse Event|1|||
143146305|NCT05032196|516081402|FG004|Period 1 (Single Ascending Dose)|Adverse Event|0|||
143146306|NCT05032196|516081403|FG005|Period 1 (Single Ascending Dose)|Adverse Event|0|||
143146307|NCT05032196|516081398|FG000|Period 2 (Multidose)|Physician Decision|0|||
143146308|NCT05032196|516081399|FG001|Period 2 (Multidose)|Physician Decision|0|||
143146309|NCT05032196|516081400|FG002|Period 2 (Multidose)|Physician Decision|0|||
143146310|NCT05032196|516081401|FG003|Period 2 (Multidose)|Physician Decision|0|||
143146311|NCT05032196|516081402|FG004|Period 2 (Multidose)|Physician Decision|1|||
143478968|NCT06156215|517297955|FG003|Overall Study|Became or found ineligible|0|||
143478969|NCT06156215|517297956|FG004|Overall Study|Became or found ineligible|1|||
143478970|NCT06156215|517297957|FG005|Overall Study|Became or found ineligible|2|||
143478971|NCT02833974|517299322|FG000|Overall Study|Lost to Follow-up|1|||
143478972|NCT02833974|517299323|FG001|Overall Study|Lost to Follow-up|0|||
143478973|NCT02833974|517299322|FG000|Overall Study|Adverse Event|0|||
143478974|NCT02833974|517299323|FG001|Overall Study|Adverse Event|3|||
143478975|NCT01524198|517299324|FG000|Overall Study|Protocol Violation|8|||
143478976|NCT01524198|517299325|FG001|Overall Study|Protocol Violation|6|||
143478977|NCT01524198|517299324|FG000|Overall Study|Withdrawal by Subject|15|||
143478978|NCT01524198|517299325|FG001|Overall Study|Withdrawal by Subject|10|||
143478979|NCT02232802|517299326|FG000|Period 1|Sponsor request|1|||
143478980|NCT02232802|517299327|FG001|Period 1|Sponsor request|0|||
143478981|NCT02232802|517299326|FG000|Period 1|Adverse Event|1|||
143478982|NCT02232802|517299327|FG001|Period 1|Adverse Event|1|||
143478983|NCT00885703|517299333|FG000|Overall Study|Death|9|||
143478984|NCT00885703|517299334|FG001|Overall Study|Death|7|||
143478985|NCT00885703|517299335|FG002|Overall Study|Death|8|||
143478986|NCT00885703|517299336|FG003|Overall Study|Death|7|||
143478987|NCT00885703|517299337|FG004|Overall Study|Death|7|||
143478988|NCT00885703|517299338|FG005|Overall Study|Death|8|||
143478989|NCT00885703|517299339|FG006|Overall Study|Death|4|||
143478990|NCT00885703|517299333|FG000|Overall Study|Lost to Follow-up|0|||
143478991|NCT00885703|517299334|FG001|Overall Study|Lost to Follow-up|0|||
143478992|NCT00885703|517299335|FG002|Overall Study|Lost to Follow-up|1|||
143478993|NCT00885703|517299336|FG003|Overall Study|Lost to Follow-up|0|||
143478994|NCT00885703|517299337|FG004|Overall Study|Lost to Follow-up|0|||
143478995|NCT00885703|517299338|FG005|Overall Study|Lost to Follow-up|1|||
143478996|NCT00885703|517299339|FG006|Overall Study|Lost to Follow-up|0|||
143478997|NCT00885703|517299333|FG000|Overall Study|Withdrawal by Subject|0|||
143478998|NCT00885703|517299334|FG001|Overall Study|Withdrawal by Subject|0|||
143478999|NCT00885703|517299335|FG002|Overall Study|Withdrawal by Subject|0|||
143479000|NCT00885703|517299336|FG003|Overall Study|Withdrawal by Subject|1|||
143146312|NCT05032196|516081403|FG005|Period 2 (Multidose)|Physician Decision|0|||
143146313|NCT05260008|516081404|FG000|Overall Study|Physician Decision|0|||
143146314|NCT05260008|516081405|FG001|Overall Study|Physician Decision|1|||
143146315|NCT05260008|516081406|FG002|Overall Study|Physician Decision|0|||
143146316|NCT05260008|516081407|FG003|Overall Study|Physician Decision|0|||
143146317|NCT04584788|516081409|FG000|Overall Study|Physician Decision|8|||
143146318|NCT04584788|516081409|FG000|Overall Study|Withdrawal by Subject|1|||
143146319|NCT04584788|516081409|FG000|Overall Study|Adverse Event|3|||
143181186|NCT00707993|516210487|FG000|Overall Study|Hyperglycemic Rescue|55|||
143181187|NCT00707993|516210488|FG001|Overall Study|Hyperglycemic Rescue|47|||
143181188|NCT00707993|516210487|FG000|Overall Study|Other|2|||
143181189|NCT00707993|516210488|FG001|Overall Study|Other|0|||
143181190|NCT03654274|516210493|FG000|Overall Study|Adverse Event|19|||
143479001|NCT00885703|517299337|FG004|Overall Study|Withdrawal by Subject|3|||
143479002|NCT00885703|517299338|FG005|Overall Study|Withdrawal by Subject|1|||
143479003|NCT00885703|517299339|FG006|Overall Study|Withdrawal by Subject|1|||
143479004|NCT00885703|517299333|FG000|Overall Study|Ineligible (no CM)|1|||
143479005|NCT00885703|517299334|FG001|Overall Study|Ineligible (no CM)|3|||
143479006|NCT00885703|517299335|FG002|Overall Study|Ineligible (no CM)|2|||
143479007|NCT00885703|517299336|FG003|Overall Study|Ineligible (no CM)|1|||
143479008|NCT00885703|517299337|FG004|Overall Study|Ineligible (no CM)|2|||
143479009|NCT00885703|517299338|FG005|Overall Study|Ineligible (no CM)|3|||
143479010|NCT00885703|517299339|FG006|Overall Study|Ineligible (no CM)|1|||
143479011|NCT01502709|517299340|FG000|Overall Study|Lost to Follow-up|4|||
143479012|NCT01502709|517299341|FG001|Overall Study|Lost to Follow-up|0|||
143479013|NCT00307151|517299342|FG000|Overall Study|Death|4|||
143479014|NCT00307151|517299343|FG001|Overall Study|Death|3|||
143479015|NCT00307151|517299344|FG002|Overall Study|Death|10|||
143479016|NCT00307151|517299345|FG003|Overall Study|Death|3|||
143479017|NCT00307151|517299342|FG000|Overall Study|Severe debilitation, unable to continue|1|||
143479018|NCT00307151|517299343|FG001|Overall Study|Severe debilitation, unable to continue|0|||
143479019|NCT00307151|517299344|FG002|Overall Study|Severe debilitation, unable to continue|0|||
143479020|NCT00307151|517299345|FG003|Overall Study|Severe debilitation, unable to continue|0|||
143479021|NCT00307151|517299342|FG000|Overall Study|Subject unable to get to clinic|1|||
143479022|NCT00307151|517299343|FG001|Overall Study|Subject unable to get to clinic|0|||
143479023|NCT00307151|517299344|FG002|Overall Study|Subject unable to get to clinic|6|||
143479024|NCT00307151|517299345|FG003|Overall Study|Subject unable to get to clinic|2|||
143479025|NCT00307151|517299342|FG000|Overall Study|Withdrew consent|0|||
143479026|NCT00307151|517299343|FG001|Overall Study|Withdrew consent|1|||
143479027|NCT00307151|517299344|FG002|Overall Study|Withdrew consent|1|||
143181191|NCT03654274|516210494|FG001|Overall Study|Adverse Event|23|||
143181192|NCT03654274|516210495|FG002|Overall Study|Adverse Event|24|||
143181193|NCT03654274|516210493|FG000|Overall Study|Protocol Deviation|0|||
143181194|NCT03654274|516210494|FG001|Overall Study|Protocol Deviation|2|||
143181195|NCT03654274|516210495|FG002|Overall Study|Protocol Deviation|0|||
143479028|NCT00307151|517299345|FG003|Overall Study|Withdrew consent|3|||
143479029|NCT00307151|517299342|FG000|Overall Study|Not willing to adhere to study reqs|2|||
143479030|NCT00307151|517299343|FG001|Overall Study|Not willing to adhere to study reqs|0|||
143479031|NCT00307151|517299344|FG002|Overall Study|Not willing to adhere to study reqs|2|||
143479032|NCT00307151|517299345|FG003|Overall Study|Not willing to adhere to study reqs|2|||
143479033|NCT00307151|517299342|FG000|Overall Study|Clinic unable to contact subject|3|||
143479034|NCT00307151|517299343|FG001|Overall Study|Clinic unable to contact subject|3|||
143479035|NCT00307151|517299344|FG002|Overall Study|Clinic unable to contact subject|1|||
143479036|NCT00307151|517299345|FG003|Overall Study|Clinic unable to contact subject|1|||
143479037|NCT02966509|517299349|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
143479038|NCT02966509|517299350|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
143479039|NCT02966509|517299349|FG000|Baseline Satisfaction Survey|Death|0|||
143479040|NCT02966509|517299350|FG001|Baseline Satisfaction Survey|Death|1|||
143479041|NCT02966509|517299349|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
143479042|NCT02966509|517299350|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
143479043|NCT02966509|517299349|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
143479044|NCT02966509|517299350|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
143479045|NCT02966509|517299349|FG000|6 Month Satisfaction Decision Survey|Death|22|||
143479046|NCT02966509|517299350|FG001|6 Month Satisfaction Decision Survey|Death|25|||
143479047|NCT02966509|517299349|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
143479048|NCT02966509|517299350|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
143479049|NCT02966509|517299349|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
143479050|NCT02966509|517299350|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
143479051|NCT02966509|517299349|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
143479052|NCT02966509|517299350|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
143479053|NCT02966509|517299349|FG000|6 Month Satisfaction Survey|Death|36|||
143479054|NCT02966509|517299350|FG001|6 Month Satisfaction Survey|Death|33|||
143479055|NCT02966509|517299349|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
143479056|NCT02966509|517299350|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
143479057|NCT02966509|517299349|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
143479058|NCT02966509|517299350|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
143479059|NCT02966509|517299349|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
143479060|NCT02966509|517299350|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
143479061|NCT02966509|517299349|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
143479062|NCT02966509|517299350|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
143479063|NCT02966509|517299349|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
143479064|NCT02966509|517299350|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
143479065|NCT01566773|517299351|FG000|Overall Study|Protocol specified criteria|4|||
143479066|NCT01566773|517299351|FG000|Overall Study|Protocol Violation|4|||
143479067|NCT01566773|517299351|FG000|Overall Study|Withdrawal by Subject|9|||
143479068|NCT01566773|517299351|FG000|Overall Study|Administrative reason|1|||
143479069|NCT01566773|517299351|FG000|Overall Study|Adverse Event|10|||
143479070|NCT01566773|517299351|FG000|Overall Study|Physician Decision|2|||
143479071|NCT02289742|517299352|FG000|First Wear Period|Adverse event prior to treatment|0|||
143479072|NCT02289742|517299353|FG001|First Wear Period|Adverse event prior to treatment|1|||
143479073|NCT02289742|517299354|FG002|First Wear Period|Adverse event prior to treatment|0|||
143479074|NCT02289742|517299355|FG003|First Wear Period|Adverse event prior to treatment|0|||
143479075|NCT02289742|517299352|FG000|First Wear Period|Adverse Event|0|||
143479076|NCT02289742|517299353|FG001|First Wear Period|Adverse Event|0|||
143479077|NCT02289742|517299354|FG002|First Wear Period|Adverse Event|1|||
143479078|NCT02289742|517299355|FG003|First Wear Period|Adverse Event|0|||
143479079|NCT02289742|517299352|FG000|First Wear Period|Other prior to treatment|0|||
143479080|NCT02289742|517299353|FG001|First Wear Period|Other prior to treatment|0|||
143479081|NCT02289742|517299354|FG002|First Wear Period|Other prior to treatment|0|||
143479082|NCT02289742|517299355|FG003|First Wear Period|Other prior to treatment|1|||
143479083|NCT02289742|517299352|FG000|Third Wear Period|Adverse Event|0|||
143479084|NCT02289742|517299353|FG001|Third Wear Period|Adverse Event|1|||
143479085|NCT02289742|517299354|FG002|Third Wear Period|Adverse Event|0|||
143479086|NCT02289742|517299355|FG003|Third Wear Period|Adverse Event|0|||
143479087|NCT02289742|517299352|FG000|Third Wear Period|Reason not given|0|||
143479088|NCT02289742|517299353|FG001|Third Wear Period|Reason not given|0|||
143479089|NCT02289742|517299354|FG002|Third Wear Period|Reason not given|0|||
143479090|NCT02289742|517299355|FG003|Third Wear Period|Reason not given|1|||
143479091|NCT02865018|517299357|FG000|Overall Study|Withdrawal by Subject|1|||
143479092|NCT01365039|517299358|FG000|Overall Study|Study related symptoms and complaints|1|||
143479093|NCT01365039|517299359|FG001|Overall Study|Study related symptoms and complaints|0|||
143479094|NCT00971178|517299364|FG000|Overall Study|Lost to Follow-up|2|||
143479095|NCT00971178|517299365|FG001|Overall Study|Lost to Follow-up|2|||
143479096|NCT00971178|517299366|FG002|Overall Study|Lost to Follow-up|2|||
143479097|NCT01263483|517299368|FG000|Overall Study|Adverse Event|4|||
143479098|NCT01263483|517299369|FG001|Overall Study|Adverse Event|0|||
143479099|NCT01263483|517299370|FG002|Overall Study|Adverse Event|3|||
143479100|NCT01263483|517299368|FG000|Overall Study|Withdrawal by Subject|1|||
143479101|NCT01263483|517299369|FG001|Overall Study|Withdrawal by Subject|0|||
143479102|NCT01263483|517299370|FG002|Overall Study|Withdrawal by Subject|0|||
143479103|NCT01263483|517299368|FG000|Overall Study|Lack of Efficacy|2|||
143479104|NCT01263483|517299369|FG001|Overall Study|Lack of Efficacy|0|||
143479105|NCT01263483|517299370|FG002|Overall Study|Lack of Efficacy|0|||
143479106|NCT01263483|517299368|FG000|Overall Study|Protocol Violation|0|||
143479107|NCT01263483|517299369|FG001|Overall Study|Protocol Violation|1|||
143479108|NCT01263483|517299370|FG002|Overall Study|Protocol Violation|1|||
143479109|NCT01263483|517299368|FG000|Overall Study|Participant Unavailability|0|||
143479110|NCT01263483|517299369|FG001|Overall Study|Participant Unavailability|1|||
143479111|NCT01263483|517299370|FG002|Overall Study|Participant Unavailability|1|||
143479112|NCT00714285|517299371|FG000|Overall Study|Lost to Follow-up|0|||
143479113|NCT00714285|517299372|FG001|Overall Study|Lost to Follow-up|2|||
143479114|NCT00714285|517299373|FG002|Overall Study|Lost to Follow-up|0|||
143479115|NCT00714285|517299374|FG003|Overall Study|Lost to Follow-up|1|||
143479116|NCT00714285|517299371|FG000|Overall Study|Migrated/moved from study area|0|||
143479117|NCT00714285|517299372|FG001|Overall Study|Migrated/moved from study area|1|||
143479118|NCT00714285|517299373|FG002|Overall Study|Migrated/moved from study area|0|||
143479119|NCT00714285|517299374|FG003|Overall Study|Migrated/moved from study area|0|||
143479120|NCT01131676|517299375|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
143479121|NCT01131676|517299376|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
143479122|NCT01131676|517299377|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
143479123|NCT01131676|517299375|FG000|Discontinuation From Treatment|Not treated|4|||
143479124|NCT01131676|517299376|FG001|Discontinuation From Treatment|Not treated|2|||
143479125|NCT01131676|517299377|FG002|Discontinuation From Treatment|Not treated|2|||
143479126|NCT01131676|517299375|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
143479127|NCT01131676|517299376|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
143479128|NCT01131676|517299377|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
143479129|NCT01131676|517299375|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
143479130|NCT01131676|517299376|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
143479131|NCT01131676|517299377|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
143479132|NCT01131676|517299375|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
143479133|NCT01131676|517299376|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
143479134|NCT01131676|517299377|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
143479135|NCT01131676|517299375|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
143479136|NCT01131676|517299376|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
143479137|NCT01131676|517299377|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
143479138|NCT01131676|517299375|FG000|Discontinuation From Treatment|Other than those specified|162|||
143479139|NCT01131676|517299376|FG001|Discontinuation From Treatment|Other than those specified|142|||
143479140|NCT01131676|517299377|FG002|Discontinuation From Treatment|Other than those specified|125|||
143479141|NCT01131676|517299375|FG000|Discontinuation From Treatment|Adverse Event|303|||
143479142|NCT01131676|517299376|FG001|Discontinuation From Treatment|Adverse Event|267|||
143479143|NCT01131676|517299377|FG002|Discontinuation From Treatment|Adverse Event|273|||
143479144|NCT01131676|517299375|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
143479145|NCT01131676|517299376|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
143479146|NCT01131676|517299377|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
143479147|NCT01131676|517299375|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
143479148|NCT01131676|517299376|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
143479149|NCT01131676|517299377|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
143479150|NCT01131676|517299375|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
143479151|NCT01131676|517299376|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
143479152|NCT01131676|517299377|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
143479153|NCT01131676|517299375|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
143479154|NCT01131676|517299376|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
143479155|NCT01131676|517299377|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
143479156|NCT01131676|517299375|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
143479157|NCT01131676|517299376|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
143479158|NCT01131676|517299377|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
143479159|NCT01131676|517299375|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
143479160|NCT01131676|517299376|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
143479161|NCT01131676|517299377|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
143479162|NCT02138617|517299378|FG000|Overall Study|Death|1|||
143479163|NCT02138617|517299379|FG001|Overall Study|Death|2|||
143479164|NCT02138617|517299380|FG002|Overall Study|Death|2|||
143479165|NCT02138617|517299378|FG000|Overall Study|Adverse Event|8|||
143479166|NCT02138617|517299379|FG001|Overall Study|Adverse Event|5|||
143014152|NCT00713830|515591618|FG000|Overall Study|Lost to Follow-up|2|||
143479167|NCT02138617|517299380|FG002|Overall Study|Adverse Event|2|||
143479168|NCT02138617|517299378|FG000|Overall Study|Disease Progression|20|||
143479169|NCT02138617|517299379|FG001|Overall Study|Disease Progression|13|||
143479170|NCT02138617|517299380|FG002|Overall Study|Disease Progression|4|||
143479171|NCT02138617|517299378|FG000|Overall Study|Withdrawal by Subject|7|||
143146320|NCT04817410|516083459|FG000|Overall Study|Withdrawal by Subject|5|||
143146321|NCT04817410|516083459|FG000|Overall Study|Physician Decision|3|||
143146322|NCT00549055|516083470|FG000|Overall Study|Adverse Event|4|||
143146323|NCT00549055|516083470|FG000|Overall Study|Lack of Efficacy|18|||
143146324|NCT00549055|516083470|FG000|Overall Study|Stabilization|5|||
143146325|NCT00549055|516083470|FG000|Overall Study|Progression to fibrosis|2|||
143146326|NCT00549055|516083470|FG000|Overall Study|Decrease of size|1|||
143479172|NCT02138617|517299379|FG001|Overall Study|Withdrawal by Subject|10|||
143146327|NCT00549055|516083470|FG000|Overall Study|Active choroidal neovascula increased|1|||
143146328|NCT00549055|516083470|FG000|Overall Study|Vitreous hemorrhage|1|||
143146329|NCT00549055|516083470|FG000|Overall Study|Growth choroidal neovascularisation|1|||
143146330|NCT00549055|516083470|FG000|Overall Study|Choroidal neovascularization|1|||
143146331|NCT00549055|516083470|FG000|Overall Study|Very low visual acuity (VA)|1|||
143146332|NCT01126424|516083475|FG000|Overall Study|Adverse Event|0|||
143146333|NCT01126424|516083476|FG001|Overall Study|Adverse Event|0|||
143146334|NCT01126424|516083477|FG002|Overall Study|Adverse Event|0|||
143146335|NCT01126424|516083478|FG003|Overall Study|Adverse Event|0|||
143146336|NCT01126424|516083479|FG004|Overall Study|Adverse Event|1|||
143146337|NCT01126424|516083480|FG005|Overall Study|Adverse Event|0|||
143146338|NCT01126424|516083475|FG000|Overall Study|Withdrawal by Subject|0|||
143146339|NCT01126424|516083476|FG001|Overall Study|Withdrawal by Subject|0|||
143146340|NCT01126424|516083477|FG002|Overall Study|Withdrawal by Subject|1|||
143146341|NCT01126424|516083478|FG003|Overall Study|Withdrawal by Subject|3|||
143146342|NCT01126424|516083479|FG004|Overall Study|Withdrawal by Subject|1|||
143146343|NCT01126424|516083480|FG005|Overall Study|Withdrawal by Subject|0|||
143146344|NCT02127671|516083481|FG000|Overall Study|Death|2|||
143146345|NCT02127671|516083482|FG001|Overall Study|Death|2|||
143146346|NCT02127671|516083481|FG000|Overall Study|Lost to Follow-up|4|||
143146347|NCT02127671|516083482|FG001|Overall Study|Lost to Follow-up|2|||
143146348|NCT02127671|516083481|FG000|Overall Study|Physician Decision|1|||
143146349|NCT02127671|516083482|FG001|Overall Study|Physician Decision|0|||
143146350|NCT02127671|516083481|FG000|Overall Study|incarceration|0|||
143146351|NCT02127671|516083482|FG001|Overall Study|incarceration|1|||
143146352|NCT02127671|516083481|FG000|Overall Study|Did not have full Framingham risk score measured|1|||
143146353|NCT02127671|516083482|FG001|Overall Study|Did not have full Framingham risk score measured|0|||
143146354|NCT01970371|516083486|FG000|Overall Study|Death|8|||
143146355|NCT01970371|516083487|FG001|Overall Study|Death|13|||
143146356|NCT01970371|516083488|FG002|Overall Study|Death|12|||
143146357|NCT01970371|516083486|FG000|Overall Study|Lost to Follow-up|0|||
143146358|NCT01970371|516083487|FG001|Overall Study|Lost to Follow-up|0|||
143146359|NCT01970371|516083488|FG002|Overall Study|Lost to Follow-up|1|||
143146360|NCT04115059|516083491|FG000|Overall Study|Withdrawal by Subject|1|||
143146361|NCT04115059|516083491|FG000|Overall Study|Lack of Efficacy|2|||
143146362|NCT03517137|516083492|FG000|Overall Study|Lack of Efficacy|1|||
143146363|NCT03517137|516083492|FG000|Overall Study|Adverse Event|2|||
143146364|NCT03517137|516083492|FG000|Overall Study|Withdrawal by Subject|2|||
143146365|NCT03517137|516083492|FG000|Overall Study|Poor therapy tolerance, ineligibility, AE, error in treatment administration|4|||
143146366|NCT03575364|516083493|FG000|Overall Study|Death|45|||
143146367|NCT03575364|516083493|FG000|Overall Study|Lost to Follow-up|114|||
143146368|NCT03575364|516083493|FG000|Overall Study|Withdrawal by Subject|21|||
143146369|NCT03575364|516083493|FG000|Overall Study|Physician Decision|11|||
143146370|NCT03575364|516083493|FG000|Overall Study|Subject Refused Follow-up|13|||
143146371|NCT03575364|516083493|FG000|Overall Study|Hospital Administration decision, Research department closed|6|||
143146372|NCT03575364|516083493|FG000|Overall Study|Patient moved out of the state|1|||
143146373|NCT03575364|516083493|FG000|Overall Study|Patient no longer has insurance, will not return to clinic.|1|||
143146374|NCT03575364|516083493|FG000|Overall Study|Patient is lost to follow up|1|||
143146375|NCT03575364|516083493|FG000|Overall Study|Patient was unable to get to the clinic due to health problems and transportation difficulties|1|||
143146376|NCT05522751|516083495|FG000|Overall Study|Adverse Event|1|||
143146377|NCT06420232|516083496|FG000|Overall Study|Withdrawal by Subject|3|||
143146378|NCT01369433|516083504|FG000|Overall Study|Adverse Event|31|||
143479173|NCT02138617|517299380|FG002|Overall Study|Withdrawal by Subject|2|||
143479174|NCT02138617|517299378|FG000|Overall Study|other complicating disease|0|||
143014153|NCT00713830|515591619|FG001|Overall Study|Lost to Follow-up|9|||
143146379|NCT01369433|516083505|FG001|Overall Study|Adverse Event|1|||
143146380|NCT01369433|516083504|FG000|Overall Study|Required significant surgical procedure|1|||
143146381|NCT01369433|516083505|FG001|Overall Study|Required significant surgical procedure|0|||
143146382|NCT01369433|516083504|FG000|Overall Study|Non-compliance|1|||
143146383|NCT01369433|516083505|FG001|Overall Study|Non-compliance|0|||
143146384|NCT01369433|516083504|FG000|Overall Study|Withdrawal by Subject|5|||
143146385|NCT01369433|516083505|FG001|Overall Study|Withdrawal by Subject|2|||
143146386|NCT01369433|516083504|FG000|Overall Study|Study terminated by Sponsor|67|||
143146387|NCT01369433|516083505|FG001|Overall Study|Study terminated by Sponsor|0|||
143146388|NCT01369433|516083504|FG000|Overall Study|Lost to Follow-up|1|||
143479175|NCT02138617|517299379|FG001|Overall Study|other complicating disease|2|||
143479176|NCT02138617|517299380|FG002|Overall Study|other complicating disease|0|||
143479177|NCT02138617|517299378|FG000|Overall Study|Protocol Violation|1|||
143479178|NCT02138617|517299379|FG001|Overall Study|Protocol Violation|0|||
143479179|NCT02138617|517299380|FG002|Overall Study|Protocol Violation|0|||
143479180|NCT02138617|517299378|FG000|Overall Study|Physician Decision|7|||
143479181|NCT02138617|517299379|FG001|Overall Study|Physician Decision|6|||
143479182|NCT02138617|517299380|FG002|Overall Study|Physician Decision|0|||
143479183|NCT02138617|517299378|FG000|Overall Study|financial reason|0|||
143479184|NCT02138617|517299379|FG001|Overall Study|financial reason|1|||
143479185|NCT02138617|517299380|FG002|Overall Study|financial reason|0|||
143479186|NCT02138617|517299378|FG000|Overall Study|other therapy|3|||
143479187|NCT02138617|517299379|FG001|Overall Study|other therapy|4|||
143479188|NCT02138617|517299380|FG002|Overall Study|other therapy|0|||
143479189|NCT01111851|517299383|FG000|Overall Study|All planned PET scans were not obtained.|2|||
143479190|NCT01111851|517299384|FG001|Overall Study|All planned PET scans were not obtained.|0|||
143479191|NCT05500274|517299385|FG000|Overall Study|Not able to complete the session and follow-up visits.|7|||
143479192|NCT05500274|517299386|FG001|Overall Study|Not able to complete the session and follow-up visits.|15|||
143479193|NCT05500274|517299385|FG000|Overall Study|Lost to Follow-up|76|||
143479194|NCT05500274|517299386|FG001|Overall Study|Lost to Follow-up|51|||
143479195|NCT05807464|517299389|FG000|Overall Study|Adverse Event|1|||
143479196|NCT04451161|517299390|FG000|Overall Study|Lost to Follow-up|28|||
143479197|NCT04451161|517299391|FG001|Overall Study|Lost to Follow-up|37|||
143479198|NCT04451161|517299392|FG002|Overall Study|Lost to Follow-up|22|||
143479199|NCT04451161|517299393|FG003|Overall Study|Lost to Follow-up|13|||
143479200|NCT04451161|517299394|FG004|Overall Study|Lost to Follow-up|11|||
143479201|NCT04451161|517299395|FG005|Overall Study|Lost to Follow-up|14|||
143479202|NCT04451161|517299390|FG000|Overall Study|Withdrawal by Subject|3|||
143479203|NCT04451161|517299391|FG001|Overall Study|Withdrawal by Subject|0|||
143479204|NCT04451161|517299392|FG002|Overall Study|Withdrawal by Subject|0|||
143479205|NCT04451161|517299393|FG003|Overall Study|Withdrawal by Subject|0|||
143479206|NCT04451161|517299394|FG004|Overall Study|Withdrawal by Subject|2|||
143479207|NCT04451161|517299395|FG005|Overall Study|Withdrawal by Subject|4|||
143479208|NCT03596866|517299397|FG000|Overall Study|Site terminated by Sponsor|64|||
143479209|NCT03596866|517299398|FG001|Overall Study|Site terminated by Sponsor|65|||
143479210|NCT03596866|517299397|FG000|Overall Study|Death|37|||
143479211|NCT03596866|517299398|FG001|Overall Study|Death|24|||
143479212|NCT03596866|517299397|FG000|Overall Study|Withdrawal by Subject|4|||
143479213|NCT03596866|517299398|FG001|Overall Study|Withdrawal by Subject|6|||
143479214|NCT03596866|517299397|FG000|Overall Study|Missing|0|||
143479215|NCT03596866|517299398|FG001|Overall Study|Missing|6|||
143479216|NCT03596866|517299397|FG000|Overall Study|Lost to Follow-up|2|||
143479217|NCT03596866|517299398|FG001|Overall Study|Lost to Follow-up|3|||
143479218|NCT03596866|517299397|FG000|Overall Study|Protocol Violation|1|||
143479219|NCT03596866|517299398|FG001|Overall Study|Protocol Violation|0|||
143479220|NCT03596866|517299397|FG000|Overall Study|Reason Not Specified|14|||
143479221|NCT03596866|517299398|FG001|Overall Study|Reason Not Specified|13|||
143479222|NCT01961349|517299399|FG000|Overall Study|Withdrawal by Subject|1|||
143479223|NCT01961349|517299400|FG001|Overall Study|Withdrawal by Subject|4|||
143479224|NCT01961349|517299401|FG002|Overall Study|Withdrawal by Subject|0|||
143479225|NCT01961349|517299399|FG000|Overall Study|Adverse Event|0|||
143479226|NCT01961349|517299400|FG001|Overall Study|Adverse Event|0|||
143479227|NCT01961349|517299401|FG002|Overall Study|Adverse Event|1|||
143479228|NCT01961349|517299399|FG000|Overall Study|registration error, personal reason etc|2|||
143479229|NCT01961349|517299400|FG001|Overall Study|registration error, personal reason etc|2|||
143479230|NCT01961349|517299401|FG002|Overall Study|registration error, personal reason etc|1|||
143479231|NCT00596947|517299402|FG000|Overall Study|study halted due to low enrollment|5|||
143479232|NCT00596947|517299403|FG001|Overall Study|study halted due to low enrollment|3|||
143479233|NCT00596947|517299402|FG000|Overall Study|Lost to Follow-up|1|||
143479234|NCT00596947|517299403|FG001|Overall Study|Lost to Follow-up|0|||
143479235|NCT00829179|517299404|FG000|Overall Study|Withdrawal by Subject|1|||
143479236|NCT02343159|517299405|FG000|Overall Study|Early Study Termination|16|||
143479237|NCT02343159|517299406|FG001|Overall Study|Early Study Termination|19|||
143479238|NCT02343159|517299407|FG002|Overall Study|Early Study Termination|23|||
143014154|NCT00713830|515591618|FG000|Overall Study|Withdrawal by Subject|13|||
143479239|NCT02343159|517299405|FG000|Overall Study|Physician Decision|2|||
143479240|NCT02343159|517299406|FG001|Overall Study|Physician Decision|0|||
143479241|NCT02343159|517299407|FG002|Overall Study|Physician Decision|1|||
143479242|NCT02343159|517299405|FG000|Overall Study|Withdrawal by Subject|3|||
143479243|NCT02343159|517299406|FG001|Overall Study|Withdrawal by Subject|0|||
143479244|NCT02343159|517299407|FG002|Overall Study|Withdrawal by Subject|2|||
143479245|NCT02343159|517299405|FG000|Overall Study|Lost to Follow-up|0|||
143479246|NCT02343159|517299406|FG001|Overall Study|Lost to Follow-up|2|||
143479247|NCT02343159|517299407|FG002|Overall Study|Lost to Follow-up|2|||
143479248|NCT02343159|517299405|FG000|Overall Study|Adverse Event|4|||
143479249|NCT02343159|517299406|FG001|Overall Study|Adverse Event|4|||
143479250|NCT02343159|517299407|FG002|Overall Study|Adverse Event|2|||
143479251|NCT02343159|517299405|FG000|Overall Study|Sponsor Decision|0|||
143479252|NCT02343159|517299406|FG001|Overall Study|Sponsor Decision|1|||
143479253|NCT02343159|517299407|FG002|Overall Study|Sponsor Decision|0|||
143479254|NCT02343159|517299405|FG000|Overall Study|Enrollment Error|1|||
143479255|NCT02343159|517299406|FG001|Overall Study|Enrollment Error|0|||
143479256|NCT02343159|517299407|FG002|Overall Study|Enrollment Error|0|||
143479257|NCT02044133|517299411|FG000|Overall Study|Lost to Follow-up|1|||
143479258|NCT02044133|517299412|FG001|Overall Study|Lost to Follow-up|1|||
143479259|NCT02044133|517299411|FG000|Overall Study|Death|1|||
143479260|NCT02044133|517299412|FG001|Overall Study|Death|0|||
143479261|NCT02044133|517299411|FG000|Overall Study|Release|3|||
143479262|NCT02044133|517299412|FG001|Overall Study|Release|4|||
143479263|NCT02044133|517299411|FG000|Overall Study|Transfer|1|||
143479264|NCT02044133|517299412|FG001|Overall Study|Transfer|0|||
143479265|NCT02044133|517299411|FG000|Overall Study|refusal of blood sampling|0|||
143479266|NCT02044133|517299412|FG001|Overall Study|refusal of blood sampling|1|||
143479267|NCT04085523|517299413|FG000|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
143479268|NCT04085523|517299414|FG001|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
143479269|NCT04085523|517299415|FG002|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
143479270|NCT04085523|517299416|FG003|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
143479271|NCT04085523|517299417|FG004|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
143479272|NCT04085523|517299418|FG005|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|2|||
143479273|NCT05318937|517299423|FG000|Overall Study|Non-Compliance with Study Drug|1|||
143479274|NCT05318937|517299424|FG001|Overall Study|Non-Compliance with Study Drug|0|||
143479275|NCT05318937|517299423|FG000|Overall Study|Lost to Follow-up|0|||
143479276|NCT05318937|517299424|FG001|Overall Study|Lost to Follow-up|1|||
143479277|NCT05318937|517299423|FG000|Overall Study|Withdrawal by Subject|0|||
143479278|NCT05318937|517299424|FG001|Overall Study|Withdrawal by Subject|2|||
143479279|NCT05318937|517299423|FG000|Overall Study|Protocol Violation|0|||
143479280|NCT05318937|517299424|FG001|Overall Study|Protocol Violation|1|||
143479281|NCT04722042|517299425|FG000|Overall Study|Withdrawal by Subject|2|||
143479282|NCT04722042|517299426|FG001|Overall Study|Withdrawal by Subject|1|||
143479283|NCT04722042|517299427|FG002|Overall Study|Withdrawal by Subject|0|||
143479284|NCT04490018|517299428|FG000|Overall Study|Protocol Violation|0|||
143479285|NCT04490018|517299429|FG001|Overall Study|Protocol Violation|2|||
143479286|NCT04490018|517299430|FG002|Overall Study|Protocol Violation|1|||
143479287|NCT04490018|517299428|FG000|Overall Study|Lost to Follow-up|2|||
143479288|NCT04490018|517299429|FG001|Overall Study|Lost to Follow-up|2|||
143479289|NCT04490018|517299430|FG002|Overall Study|Lost to Follow-up|0|||
143479290|NCT04490018|517299428|FG000|Overall Study|Withdrawal by Subject|2|||
143479291|NCT04490018|517299429|FG001|Overall Study|Withdrawal by Subject|1|||
143479292|NCT04490018|517299430|FG002|Overall Study|Withdrawal by Subject|0|||
143479293|NCT04490018|517299428|FG000|Overall Study|Withdrawal by parent/guardian|2|||
143479294|NCT04490018|517299429|FG001|Overall Study|Withdrawal by parent/guardian|3|||
143479295|NCT04490018|517299430|FG002|Overall Study|Withdrawal by parent/guardian|0|||
143479296|NCT01401842|517299432|FG000|Overall Study|Withdrawal by Subject|3|||
143479297|NCT01401842|517299433|FG001|Overall Study|Withdrawal by Subject|2|||
143479298|NCT01401842|517299432|FG000|Overall Study|academic reason|4|||
143479299|NCT01401842|517299433|FG001|Overall Study|academic reason|1|||
143479300|NCT01401842|517299432|FG000|Overall Study|changed companies|20|||
143479301|NCT01401842|517299433|FG001|Overall Study|changed companies|34|||
143479302|NCT01401842|517299432|FG000|Overall Study|discharged from US Army|3|||
143479303|NCT01401842|517299433|FG001|Overall Study|discharged from US Army|4|||
143479304|NCT01401842|517299432|FG000|Overall Study|invalid follow-up strength data|1|||
143479305|NCT01401842|517299433|FG001|Overall Study|invalid follow-up strength data|4|||
143479306|NCT01401842|517299432|FG000|Overall Study|on profile|9|||
143479307|NCT01401842|517299433|FG001|Overall Study|on profile|5|||
143479308|NCT01401842|517299432|FG000|Overall Study|other/unknown|28|||
143479309|NCT01401842|517299433|FG001|Overall Study|other/unknown|17|||
143479310|NCT00583024|517299442|FG000|Overall Study|Lost to Follow-up|4|||
143479311|NCT03977974|517299445|FG000|Period 2|Adverse Event|0|||
143479312|NCT03977974|517299446|FG001|Period 2|Adverse Event|0|||
143479313|NCT03977974|517299447|FG002|Period 2|Adverse Event|0|||
143479314|NCT03977974|517299448|FG003|Period 2|Adverse Event|0|||
143479315|NCT03977974|517299449|FG004|Period 2|Adverse Event|1|||
143479316|NCT03977974|517299450|FG005|Period 2|Adverse Event|0|||
143479317|NCT03977974|517299451|FG006|Period 2|Adverse Event|0|||
143479318|NCT03977974|517299452|FG007|Period 2|Adverse Event|0|||
143479319|NCT03977974|517299453|FG008|Period 2|Adverse Event|0|||
143479320|NCT03977974|517299454|FG009|Period 2|Adverse Event|0|||
143479321|NCT03977974|517299455|FG010|Period 2|Adverse Event|0|||
143479322|NCT03977974|517299456|FG011|Period 2|Adverse Event|0|||
143479323|NCT03977974|517299457|FG012|Period 2|Adverse Event|0|||
143479324|NCT00404820|517300697|FG000|Overall Study|Adverse Event|4|||
143479325|NCT00404820|517300698|FG001|Overall Study|Adverse Event|16|||
143479326|NCT00404820|517300697|FG000|Overall Study|Withdrawal by Subject|5|||
143479327|NCT00404820|517300698|FG001|Overall Study|Withdrawal by Subject|3|||
143146389|NCT01369433|516083505|FG001|Overall Study|Lost to Follow-up|0|||
143146390|NCT01369433|516083504|FG000|Overall Study|Death|5|||
143146391|NCT01369433|516083505|FG001|Overall Study|Death|0|||
143146392|NCT01369433|516083504|FG000|Overall Study|Investigator discretion|6|||
143146393|NCT01369433|516083505|FG001|Overall Study|Investigator discretion|1|||
143146394|NCT01369433|516083504|FG000|Overall Study|Progressive Disease|92|||
143146395|NCT01369433|516083505|FG001|Overall Study|Progressive Disease|12|||
143146396|NCT00487188|516083506|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
143146397|NCT00487188|516083507|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
143146398|NCT00487188|516083508|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
143146399|NCT00487188|516083506|FG000|Induction Phase|Adverse Event|5|||
143146400|NCT00487188|516083507|FG001|Induction Phase|Adverse Event|0|||
143146401|NCT00487188|516083508|FG002|Induction Phase|Adverse Event|0|||
143146402|NCT00487188|516083506|FG000|Induction Phase|Lack of Efficacy|0|||
143146403|NCT00487188|516083507|FG001|Induction Phase|Lack of Efficacy|1|||
143146404|NCT00487188|516083508|FG002|Induction Phase|Lack of Efficacy|0|||
143146405|NCT00487188|516083506|FG000|Induction Phase|Protocol Violation|1|||
143146406|NCT00487188|516083507|FG001|Induction Phase|Protocol Violation|0|||
143146407|NCT00487188|516083508|FG002|Induction Phase|Protocol Violation|0|||
143146408|NCT00487188|516083506|FG000|Induction Phase|Refused Treatment|1|||
143146409|NCT00487188|516083507|FG001|Induction Phase|Refused Treatment|2|||
143146410|NCT00487188|516083508|FG002|Induction Phase|Refused Treatment|0|||
143146411|NCT00487188|516083506|FG000|Induction Phase|Lost to Follow-up|2|||
143146412|NCT00487188|516083507|FG001|Induction Phase|Lost to Follow-up|2|||
143146413|NCT00487188|516083508|FG002|Induction Phase|Lost to Follow-up|0|||
143146414|NCT00487188|516083506|FG000|Induction Phase|Administrative|0|||
143146415|NCT00487188|516083507|FG001|Induction Phase|Administrative|1|||
143146416|NCT00487188|516083508|FG002|Induction Phase|Administrative|0|||
143146417|NCT00487188|516083506|FG000|Maintenance Phase|Adverse Event|1|||
143146418|NCT00487188|516083507|FG001|Maintenance Phase|Adverse Event|0|||
143146419|NCT00487188|516083508|FG002|Maintenance Phase|Adverse Event|0|||
143146420|NCT00487188|516083506|FG000|Maintenance Phase|Death|1|||
143146421|NCT00487188|516083507|FG001|Maintenance Phase|Death|0|||
143146422|NCT00487188|516083508|FG002|Maintenance Phase|Death|0|||
143146423|NCT00487188|516083506|FG000|Maintenance Phase|Lost to Follow-up|1|||
143146424|NCT00487188|516083507|FG001|Maintenance Phase|Lost to Follow-up|0|||
143146425|NCT00487188|516083508|FG002|Maintenance Phase|Lost to Follow-up|0|||
143146426|NCT00487188|516083506|FG000|Maintenance Phase|Administrative|0|||
143146427|NCT00487188|516083507|FG001|Maintenance Phase|Administrative|0|||
143479328|NCT00404820|517300697|FG000|Overall Study|Lost to Follow-up|7|||
143479329|NCT00404820|517300698|FG001|Overall Study|Lost to Follow-up|3|||
143146428|NCT00487188|516083508|FG002|Maintenance Phase|Administrative|1|||
143146429|NCT01838876|516083509|FG000|Overall Study|Adverse Event|49|||
143146430|NCT01838876|516083509|FG000|Overall Study|Insufficient Therapeutic Response|10|||
143146431|NCT01838876|516083509|FG000|Overall Study|Protocol Violation|34|||
143146432|NCT01838876|516083509|FG000|Overall Study|Withdrawal of Consent|33|||
143146433|NCT01838876|516083509|FG000|Overall Study|Lost to Follow-up|21|||
143146434|NCT01838876|516083509|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
143146435|NCT01838876|516083509|FG000|Overall Study|Reason not Specified|7|||
143146436|NCT01838876|516083509|FG000|Overall Study|Did not meet eligibility criteria|78|||
143146437|NCT02313155|516083510|FG000|Overall Study|Lost to Follow-up|0|||
143146438|NCT02313155|516083511|FG001|Overall Study|Lost to Follow-up|1|||
143146439|NCT01682031|516083512|FG000|Overall Study|Withdrawal by Subject|0|||
143146440|NCT01682031|516083513|FG001|Overall Study|Withdrawal by Subject|1|||
143146441|NCT01682031|516083512|FG000|Overall Study|Adverse Event|0|||
143146442|NCT01682031|516083513|FG001|Overall Study|Adverse Event|2|||
143146443|NCT01682031|516083512|FG000|Overall Study|MRI results indicate increased nodul|0|||
143146444|NCT01682031|516083513|FG001|Overall Study|MRI results indicate increased nodul|1|||
143146445|NCT01682031|516083512|FG000|Overall Study|Patient could not swallow tablets|1|||
143146446|NCT01682031|516083513|FG001|Overall Study|Patient could not swallow tablets|0|||
143146447|NCT01682031|516083512|FG000|Overall Study|Patient stopped selenium on his own|0|||
143146448|NCT01682031|516083513|FG001|Overall Study|Patient stopped selenium on his own|1|||
143146449|NCT00933933|516083515|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
143146450|NCT00933933|516083516|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
143146451|NCT00933933|516083517|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
143146452|NCT00933933|516083515|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
143479330|NCT00404820|517300697|FG000|Overall Study|Administrative problems|2|||
143146453|NCT00933933|516083516|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
143146454|NCT00933933|516083517|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
143146455|NCT04797169|516083518|FG000|Overall Study|Lost to Follow-up|84|||
143146456|NCT04797169|516083519|FG001|Overall Study|Lost to Follow-up|67|||
143146457|NCT04797169|516083518|FG000|Overall Study|Pregnancy|1|||
143146458|NCT04797169|516083519|FG001|Overall Study|Pregnancy|3|||
143146459|NCT04797169|516083518|FG000|Overall Study|Withdrawal by Subject|27|||
143146460|NCT04797169|516083519|FG001|Overall Study|Withdrawal by Subject|35|||
143146461|NCT00390013|516083523|FG000|Phase 1|tired|0|||
143479331|NCT00404820|517300698|FG001|Overall Study|Administrative problems|0|||
143479332|NCT00404820|517300697|FG000|Overall Study|Death|1|||
143479333|NCT00404820|517300698|FG001|Overall Study|Death|0|||
143479334|NCT00404820|517300697|FG000|Overall Study|Other|0|||
143479335|NCT00404820|517300698|FG001|Overall Study|Other|2|||
143479336|NCT00003535|517300699|FG000|Overall Study|Not evaluable|5|||
143479337|NCT02181816|517300703|FG000|Overall Study|Case Report Forms Uncollected|38|||
143479338|NCT02181816|517300703|FG000|Overall Study|Protocol Deviation|21|||
143479339|NCT03807349|517300706|FG000|Overall Study|Early Study Termination|9|||
143479340|NCT00294060|517300707|FG000|Overall Study|Death|225|||
143479341|NCT00294060|517300707|FG000|Overall Study|Other|59|||
143479342|NCT00294060|517300707|FG000|Overall Study|Lost to Follow-up|55|||
143479343|NCT00294060|517300707|FG000|Overall Study|Withdrawal by Subject|11|||
143479344|NCT00294060|517300707|FG000|Overall Study|Physician Decision|797|||
143479345|NCT00294060|517300707|FG000|Overall Study|Medical condition|3|||
143479346|NCT00294060|517300707|FG000|Overall Study|Device explanted/not replaced|23|||
143479347|NCT01360554|517300708|FG000|Overall Study|Death|359|||
143479348|NCT01360554|517300709|FG001|Overall Study|Death|371|||
143479349|NCT01360554|517300708|FG000|Overall Study|Lost to Follow-up|4|||
143479350|NCT01360554|517300709|FG001|Overall Study|Lost to Follow-up|4|||
143479351|NCT01360554|517300708|FG000|Overall Study|Withdrawal by Subject|23|||
143479352|NCT01360554|517300709|FG001|Overall Study|Withdrawal by Subject|24|||
143479353|NCT01360554|517300708|FG000|Overall Study|Study terminated by sponsor|49|||
143479354|NCT01360554|517300709|FG001|Overall Study|Study terminated by sponsor|37|||
143479355|NCT01360554|517300708|FG000|Overall Study|Other, not specified|1|||
143479356|NCT01360554|517300709|FG001|Overall Study|Other, not specified|0|||
143479357|NCT01360554|517300708|FG000|Overall Study|Randomized but not treated.|3|||
143479358|NCT01360554|517300709|FG001|Overall Study|Randomized but not treated.|3|||
143479359|NCT00187096|517300710|FG000|Overall Study|unacceptable toxicity|0|||
143479360|NCT00187096|517300711|FG001|Overall Study|unacceptable toxicity|0|||
143479361|NCT00187096|517300712|FG002|Overall Study|unacceptable toxicity|1|||
143479362|NCT00253643|517300713|FG000|Overall Study|Withdrawal by Subject|0|||
143479363|NCT00253643|517300714|FG001|Overall Study|Withdrawal by Subject|0|||
143479364|NCT00253643|517300715|FG002|Overall Study|Withdrawal by Subject|1|||
143479365|NCT00253643|517300716|FG003|Overall Study|Withdrawal by Subject|1|||
143479366|NCT00253643|517300713|FG000|Overall Study|Non-Compliance|0|||
143479367|NCT00253643|517300714|FG001|Overall Study|Non-Compliance|0|||
143479368|NCT00253643|517300715|FG002|Overall Study|Non-Compliance|0|||
143479369|NCT00253643|517300716|FG003|Overall Study|Non-Compliance|2|||
143479370|NCT01368536|517300717|FG000|Overall Study|Adverse Event|5|||
143479371|NCT01368536|517300718|FG001|Overall Study|Adverse Event|6|||
143479372|NCT01368536|517300719|FG002|Overall Study|Adverse Event|8|||
143479373|NCT01368536|517300717|FG000|Overall Study|Abnormal laboratory value(s)|0|||
143479374|NCT01368536|517300718|FG001|Overall Study|Abnormal laboratory value(s)|1|||
143479375|NCT01368536|517300719|FG002|Overall Study|Abnormal laboratory value(s)|2|||
143479376|NCT01368536|517300717|FG000|Overall Study|Abnormal test procedure result(s)|0|||
143479377|NCT01368536|517300718|FG001|Overall Study|Abnormal test procedure result(s)|0|||
143479378|NCT01368536|517300719|FG002|Overall Study|Abnormal test procedure result(s)|1|||
143479379|NCT01368536|517300717|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
143479380|NCT01368536|517300718|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
143479381|NCT01368536|517300719|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
143479382|NCT01368536|517300717|FG000|Overall Study|No longer required study medication|0|||
143479383|NCT01368536|517300718|FG001|Overall Study|No longer required study medication|0|||
143479384|NCT01368536|517300719|FG002|Overall Study|No longer required study medication|1|||
143479385|NCT01368536|517300717|FG000|Overall Study|Withdrawal by Subject|2|||
143479386|NCT01368536|517300718|FG001|Overall Study|Withdrawal by Subject|5|||
143479387|NCT01368536|517300719|FG002|Overall Study|Withdrawal by Subject|4|||
143479388|NCT01368536|517300717|FG000|Overall Study|Lost to Follow-up|3|||
143479389|NCT01368536|517300718|FG001|Overall Study|Lost to Follow-up|3|||
143479390|NCT01368536|517300719|FG002|Overall Study|Lost to Follow-up|5|||
143479391|NCT01368536|517300717|FG000|Overall Study|Administrative problems|34|||
143479392|NCT01368536|517300718|FG001|Overall Study|Administrative problems|39|||
143479393|NCT01368536|517300719|FG002|Overall Study|Administrative problems|35|||
143479394|NCT01368536|517300717|FG000|Overall Study|Protocol deviation|0|||
143479395|NCT01368536|517300718|FG001|Overall Study|Protocol deviation|3|||
143479396|NCT01368536|517300719|FG002|Overall Study|Protocol deviation|1|||
143479397|NCT03668600|517300726|FG000|Overall Study|Study Terminated by the Sponsor|157|||
143479398|NCT03668600|517300726|FG000|Overall Study|Protocol Violation|1|||
143479399|NCT03668600|517300726|FG000|Overall Study|Pregnancy|1|||
143479400|NCT03668600|517300726|FG000|Overall Study|Lost to Follow-up|7|||
143479401|NCT03668600|517300726|FG000|Overall Study|Withdrawal by Subject|56|||
143479402|NCT03668600|517300726|FG000|Overall Study|Lack of Efficacy|7|||
143479403|NCT03668600|517300726|FG000|Overall Study|Adverse Event|1|||
143479404|NCT02636582|517300727|FG000|Overall Study|Surgical Pathology|1|||
143479405|NCT02636582|517300728|FG001|Overall Study|Surgical Pathology|0|||
143479406|NCT00326209|517300729|FG000|Overall Study|Adverse Event|28|||
143479407|NCT00326209|517300729|FG000|Overall Study|Withdrawal by Subject|22|||
143479408|NCT00326209|517300729|FG000|Overall Study|Lack of Efficacy|31|||
143479409|NCT00326209|517300729|FG000|Overall Study|Lost to Follow-up|18|||
143479410|NCT00326209|517300729|FG000|Overall Study|Participant non-compliant|6|||
143479411|NCT00326209|517300729|FG000|Overall Study|Sponsor closed study|173|||
143146462|NCT00390013|516083524|FG001|Phase 1|tired|0|||
143146463|NCT00390013|516083525|FG002|Phase 1|tired|0|||
143146464|NCT00390013|516083526|FG003|Phase 1|tired|1|||
143146465|NCT00390013|516083523|FG000|Phase 2 First Treatment|tired|1|||
143146466|NCT00390013|516083524|FG001|Phase 2 First Treatment|tired|0|||
143146467|NCT00390013|516083525|FG002|Phase 2 First Treatment|tired|0|||
143146468|NCT00390013|516083526|FG003|Phase 2 First Treatment|tired|0|||
143146469|NCT00390013|516083523|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
143146470|NCT00390013|516083524|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
143146471|NCT00390013|516083525|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
143146472|NCT00390013|516083526|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
143146473|NCT03839641|516083527|FG000|Overall Study|Withdrawal by Subject|1|||
143146474|NCT03839641|516083528|FG001|Overall Study|Withdrawal by Subject|1|||
143146475|NCT04221490|516083529|FG000|At 30 Days Follow-up|Death|7|||
143146476|NCT04221490|516083529|FG000|At 30 Days Follow-up|Missed Visit|4|||
143146477|NCT04221490|516083529|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
143146478|NCT04221490|516083529|FG000|At 6 Months Follow-up|Death|9|||
143146479|NCT04221490|516083529|FG000|At 6 Months Follow-up|Physician Decision|1|||
143146480|NCT04221490|516083529|FG000|At 6 Months Follow-up|Missed Visit|8|||
143146481|NCT04221490|516083529|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
143146482|NCT03765073|516083530|FG000|Stage 1|Lost to Follow-up|1|||
143146483|NCT03765073|516083531|FG001|Stage 1|Lost to Follow-up|0|||
143146484|NCT03765073|516083532|FG002|Stage 1|Lost to Follow-up|0|||
143146485|NCT03765073|516083533|FG003|Stage 1|Lost to Follow-up|0|||
143146486|NCT03765073|516083534|FG004|Stage 1|Lost to Follow-up|0|||
143146487|NCT03765073|516083535|FG005|Stage 1|Lost to Follow-up|0|||
143146488|NCT03765073|516083536|FG006|Stage 1|Lost to Follow-up|0|||
143146489|NCT03765073|516083537|FG007|Stage 1|Lost to Follow-up|0|||
143146490|NCT03765073|516083538|FG008|Stage 1|Lost to Follow-up|0|||
143146491|NCT03765073|516083539|FG009|Stage 1|Lost to Follow-up|0|||
143146492|NCT03765073|516083540|FG010|Stage 1|Lost to Follow-up|0|||
143146493|NCT03765073|516083541|FG011|Stage 1|Lost to Follow-up|0|||
143146494|NCT03765073|516083542|FG012|Stage 1|Lost to Follow-up|0|||
143146495|NCT03765073|516083543|FG013|Stage 1|Lost to Follow-up|0|||
143146496|NCT03765073|516083544|FG014|Stage 1|Lost to Follow-up|0|||
143146497|NCT03765073|516083545|FG015|Stage 1|Lost to Follow-up|0|||
143146498|NCT03765073|516083546|FG016|Stage 1|Lost to Follow-up|0|||
143146499|NCT03765073|516083547|FG017|Stage 1|Lost to Follow-up|0|||
143146500|NCT03765073|516083548|FG018|Stage 1|Lost to Follow-up|0|||
143146501|NCT03765073|516083549|FG019|Stage 1|Lost to Follow-up|0|||
143146502|NCT03765073|516083550|FG020|Stage 1|Lost to Follow-up|0|||
143146503|NCT03765073|516083530|FG000|Stage 1|Withdrawal by participant|0|||
143146504|NCT03765073|516083531|FG001|Stage 1|Withdrawal by participant|1|||
143146505|NCT03765073|516083532|FG002|Stage 1|Withdrawal by participant|0|||
143146506|NCT03765073|516083533|FG003|Stage 1|Withdrawal by participant|0|||
143146507|NCT03765073|516083534|FG004|Stage 1|Withdrawal by participant|0|||
143146508|NCT03765073|516083535|FG005|Stage 1|Withdrawal by participant|0|||
143146509|NCT03765073|516083536|FG006|Stage 1|Withdrawal by participant|0|||
143146510|NCT03765073|516083537|FG007|Stage 1|Withdrawal by participant|0|||
143146511|NCT03765073|516083538|FG008|Stage 1|Withdrawal by participant|0|||
143146512|NCT03765073|516083539|FG009|Stage 1|Withdrawal by participant|0|||
143146513|NCT03765073|516083540|FG010|Stage 1|Withdrawal by participant|0|||
143146514|NCT03765073|516083541|FG011|Stage 1|Withdrawal by participant|0|||
143146515|NCT03765073|516083542|FG012|Stage 1|Withdrawal by participant|0|||
143146516|NCT03765073|516083543|FG013|Stage 1|Withdrawal by participant|0|||
143146517|NCT03765073|516083544|FG014|Stage 1|Withdrawal by participant|0|||
143479412|NCT00326209|517300729|FG000|Overall Study|Prohibited medication use|1|||
143363601|NCT00062868|516873797|FG017|Dose Level 1|Lost to Follow-up|0|||
143146518|NCT03765073|516083545|FG015|Stage 1|Withdrawal by participant|0|||
143146519|NCT03765073|516083546|FG016|Stage 1|Withdrawal by participant|0|||
143146520|NCT03765073|516083547|FG017|Stage 1|Withdrawal by participant|0|||
143146521|NCT03765073|516083548|FG018|Stage 1|Withdrawal by participant|0|||
143146522|NCT03765073|516083549|FG019|Stage 1|Withdrawal by participant|0|||
143146523|NCT03765073|516083550|FG020|Stage 1|Withdrawal by participant|0|||
143146524|NCT03765073|516083530|FG000|Stage 2|Death|0|||
143146525|NCT03765073|516083531|FG001|Stage 2|Death|0|||
143146526|NCT03765073|516083532|FG002|Stage 2|Death|0|||
143146527|NCT03765073|516083533|FG003|Stage 2|Death|0|||
143146528|NCT03765073|516083534|FG004|Stage 2|Death|0|||
143146529|NCT03765073|516083535|FG005|Stage 2|Death|0|||
143363602|NCT00062868|516873798|FG018|Dose Level 1|Lost to Follow-up|2|||
143014155|NCT00713830|515591619|FG001|Overall Study|Withdrawal by Subject|23|||
143146530|NCT03765073|516083536|FG006|Stage 2|Death|0|||
143479413|NCT00326209|517300729|FG000|Overall Study|Violation of entry criteria|1|||
143146531|NCT03765073|516083537|FG007|Stage 2|Death|0|||
143146532|NCT03765073|516083538|FG008|Stage 2|Death|0|||
143146533|NCT03765073|516083539|FG009|Stage 2|Death|1|||
143146534|NCT03765073|516083540|FG010|Stage 2|Death|0|||
143146535|NCT03765073|516083541|FG011|Stage 2|Death|1|||
143146536|NCT03765073|516083542|FG012|Stage 2|Death|0|||
143479414|NCT00326209|517300729|FG000|Overall Study|Withdrawn in error|1|||
143479415|NCT00326209|517300729|FG000|Overall Study|Pregnancy|1|||
143479416|NCT01555151|517300730|FG000|Overall Study|Withdrawal by Subject|6|||
143479417|NCT01555151|517300731|FG001|Overall Study|Withdrawal by Subject|2|||
143479418|NCT01555151|517300732|FG002|Overall Study|Withdrawal by Subject|0|||
143479419|NCT01555151|517300733|FG003|Overall Study|Withdrawal by Subject|2|||
143479420|NCT01555151|517300730|FG000|Overall Study|Administrative|3|||
143479421|NCT01555151|517300731|FG001|Overall Study|Administrative|1|||
143146537|NCT03765073|516083543|FG013|Stage 2|Death|0|||
143146538|NCT03765073|516083544|FG014|Stage 2|Death|0|||
143146539|NCT03765073|516083545|FG015|Stage 2|Death|0|||
143146540|NCT03765073|516083546|FG016|Stage 2|Death|2|||
143146541|NCT03765073|516083547|FG017|Stage 2|Death|0|||
143146542|NCT03765073|516083548|FG018|Stage 2|Death|0|||
143146543|NCT03765073|516083549|FG019|Stage 2|Death|0|||
143146544|NCT03765073|516083550|FG020|Stage 2|Death|0|||
143146545|NCT03765073|516083530|FG000|Stage 2|Lost to Follow-up|0|||
143146546|NCT03765073|516083531|FG001|Stage 2|Lost to Follow-up|0|||
143146547|NCT03765073|516083532|FG002|Stage 2|Lost to Follow-up|0|||
143146548|NCT03765073|516083533|FG003|Stage 2|Lost to Follow-up|5|||
143146549|NCT03765073|516083534|FG004|Stage 2|Lost to Follow-up|1|||
143146550|NCT03765073|516083535|FG005|Stage 2|Lost to Follow-up|0|||
143146551|NCT03765073|516083536|FG006|Stage 2|Lost to Follow-up|3|||
143146552|NCT03765073|516083537|FG007|Stage 2|Lost to Follow-up|3|||
143146553|NCT03765073|516083538|FG008|Stage 2|Lost to Follow-up|1|||
143146554|NCT03765073|516083539|FG009|Stage 2|Lost to Follow-up|6|||
143146555|NCT03765073|516083540|FG010|Stage 2|Lost to Follow-up|5|||
143146556|NCT03765073|516083541|FG011|Stage 2|Lost to Follow-up|1|||
143146557|NCT03765073|516083542|FG012|Stage 2|Lost to Follow-up|1|||
143146558|NCT03765073|516083543|FG013|Stage 2|Lost to Follow-up|3|||
143146559|NCT03765073|516083544|FG014|Stage 2|Lost to Follow-up|3|||
143146560|NCT03765073|516083545|FG015|Stage 2|Lost to Follow-up|1|||
143146561|NCT03765073|516083546|FG016|Stage 2|Lost to Follow-up|6|||
143146562|NCT03765073|516083547|FG017|Stage 2|Lost to Follow-up|0|||
143146563|NCT03765073|516083548|FG018|Stage 2|Lost to Follow-up|0|||
143146564|NCT03765073|516083549|FG019|Stage 2|Lost to Follow-up|0|||
143146565|NCT03765073|516083550|FG020|Stage 2|Lost to Follow-up|0|||
143146566|NCT03765073|516083530|FG000|Stage 2|Other|0|||
143146567|NCT03765073|516083531|FG001|Stage 2|Other|0|||
143146568|NCT03765073|516083532|FG002|Stage 2|Other|0|||
143146569|NCT03765073|516083533|FG003|Stage 2|Other|0|||
143146570|NCT03765073|516083534|FG004|Stage 2|Other|0|||
143146571|NCT03765073|516083535|FG005|Stage 2|Other|0|||
143146572|NCT03765073|516083536|FG006|Stage 2|Other|0|||
143146573|NCT03765073|516083537|FG007|Stage 2|Other|1|||
143146574|NCT03765073|516083538|FG008|Stage 2|Other|1|||
143146575|NCT03765073|516083539|FG009|Stage 2|Other|3|||
143146576|NCT03765073|516083540|FG010|Stage 2|Other|0|||
143146577|NCT03765073|516083541|FG011|Stage 2|Other|0|||
143146578|NCT03765073|516083542|FG012|Stage 2|Other|0|||
143146579|NCT03765073|516083543|FG013|Stage 2|Other|0|||
143146580|NCT03765073|516083544|FG014|Stage 2|Other|0|||
143146581|NCT03765073|516083545|FG015|Stage 2|Other|1|||
143146582|NCT03765073|516083546|FG016|Stage 2|Other|2|||
143146583|NCT03765073|516083547|FG017|Stage 2|Other|0|||
143146584|NCT03765073|516083548|FG018|Stage 2|Other|0|||
143146585|NCT03765073|516083549|FG019|Stage 2|Other|0|||
143146586|NCT03765073|516083550|FG020|Stage 2|Other|0|||
143146587|NCT03765073|516083530|FG000|Stage 2|Withdrawal by parent/guardian|0|||
143146588|NCT03765073|516083531|FG001|Stage 2|Withdrawal by parent/guardian|0|||
143146589|NCT03765073|516083532|FG002|Stage 2|Withdrawal by parent/guardian|0|||
143146590|NCT03765073|516083533|FG003|Stage 2|Withdrawal by parent/guardian|0|||
143146591|NCT03765073|516083534|FG004|Stage 2|Withdrawal by parent/guardian|0|||
143479422|NCT01555151|517300732|FG002|Overall Study|Administrative|2|||
143479423|NCT01555151|517300733|FG003|Overall Study|Administrative|0|||
143479424|NCT01555151|517300730|FG000|Overall Study|Protocol Violation|3|||
143479425|NCT01555151|517300731|FG001|Overall Study|Protocol Violation|3|||
143479426|NCT01555151|517300732|FG002|Overall Study|Protocol Violation|3|||
143146592|NCT03765073|516083535|FG005|Stage 2|Withdrawal by parent/guardian|0|||
143146593|NCT03765073|516083536|FG006|Stage 2|Withdrawal by parent/guardian|0|||
143146594|NCT03765073|516083537|FG007|Stage 2|Withdrawal by parent/guardian|0|||
143146595|NCT03765073|516083538|FG008|Stage 2|Withdrawal by parent/guardian|0|||
143146596|NCT03765073|516083539|FG009|Stage 2|Withdrawal by parent/guardian|0|||
143146597|NCT03765073|516083540|FG010|Stage 2|Withdrawal by parent/guardian|3|||
143146598|NCT03765073|516083541|FG011|Stage 2|Withdrawal by parent/guardian|3|||
143146599|NCT03765073|516083542|FG012|Stage 2|Withdrawal by parent/guardian|3|||
143479427|NCT01555151|517300733|FG003|Overall Study|Protocol Violation|5|||
143479428|NCT01555151|517300730|FG000|Overall Study|Adverse Event|1|||
143146600|NCT03765073|516083543|FG013|Stage 2|Withdrawal by parent/guardian|1|||
143146601|NCT03765073|516083544|FG014|Stage 2|Withdrawal by parent/guardian|1|||
143146602|NCT03765073|516083545|FG015|Stage 2|Withdrawal by parent/guardian|0|||
143146603|NCT03765073|516083546|FG016|Stage 2|Withdrawal by parent/guardian|3|||
143146604|NCT03765073|516083547|FG017|Stage 2|Withdrawal by parent/guardian|0|||
143146605|NCT03765073|516083548|FG018|Stage 2|Withdrawal by parent/guardian|0|||
143146606|NCT03765073|516083549|FG019|Stage 2|Withdrawal by parent/guardian|0|||
143146607|NCT03765073|516083550|FG020|Stage 2|Withdrawal by parent/guardian|0|||
143479429|NCT01555151|517300731|FG001|Overall Study|Adverse Event|2|||
143479430|NCT01555151|517300732|FG002|Overall Study|Adverse Event|1|||
143479431|NCT01555151|517300733|FG003|Overall Study|Adverse Event|2|||
143479432|NCT01555151|517300730|FG000|Overall Study|Lost to Follow-up|0|||
143479433|NCT01555151|517300731|FG001|Overall Study|Lost to Follow-up|0|||
143479434|NCT01555151|517300732|FG002|Overall Study|Lost to Follow-up|0|||
143479435|NCT01555151|517300733|FG003|Overall Study|Lost to Follow-up|1|||
143479436|NCT01816061|517300734|FG000|Overall Study|Lost to Follow-up|13|||
143479437|NCT01816061|517300735|FG001|Overall Study|Lost to Follow-up|24|||
143479438|NCT01671111|517300737|FG000|Overall Study|Adverse Event|2|||
143479439|NCT01671111|517300737|FG000|Overall Study|Lack of Efficacy|1|||
143479440|NCT01671111|517300737|FG000|Overall Study|Withdrawal by Subject|2|||
143479441|NCT01671111|517300737|FG000|Overall Study|Physician Decision|1|||
143479442|NCT01671111|517300737|FG000|Overall Study|Other|24|||
143479443|NCT02114268|517300740|FG000|Overall Study|Lost to Follow-up|4|||
143479444|NCT02114268|517300741|FG001|Overall Study|Lost to Follow-up|1|||
143479445|NCT02114268|517300742|FG002|Overall Study|Lost to Follow-up|1|||
143479446|NCT02114268|517300743|FG003|Overall Study|Lost to Follow-up|0|||
143479447|NCT02114268|517300744|FG004|Overall Study|Lost to Follow-up|0|||
143479448|NCT02114268|517300745|FG005|Overall Study|Lost to Follow-up|2|||
143479449|NCT02114268|517300740|FG000|Overall Study|Withdrawal by Subject|1|||
143479450|NCT02114268|517300741|FG001|Overall Study|Withdrawal by Subject|0|||
143479451|NCT02114268|517300742|FG002|Overall Study|Withdrawal by Subject|0|||
143479452|NCT02114268|517300743|FG003|Overall Study|Withdrawal by Subject|0|||
143479453|NCT02114268|517300744|FG004|Overall Study|Withdrawal by Subject|0|||
143479454|NCT02114268|517300745|FG005|Overall Study|Withdrawal by Subject|1|||
143479455|NCT02114268|517300740|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
143479456|NCT02114268|517300741|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
143479457|NCT02114268|517300742|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
143479458|NCT02114268|517300743|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
143479459|NCT02114268|517300744|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
143479460|NCT02114268|517300745|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
143479461|NCT01075412|517300750|FG000|Overall Study|Withdrawal by Subject|0|||
143479462|NCT01075412|517300751|FG001|Overall Study|Withdrawal by Subject|1|||
143479463|NCT00865904|517300754|FG000|Overall Study|Randomized but not Treated|2|||
143479464|NCT00865904|517300755|FG001|Overall Study|Randomized but not Treated|0|||
143479465|NCT00865904|517300756|FG002|Overall Study|Randomized but not Treated|0|||
143479466|NCT00865904|517300757|FG003|Overall Study|Randomized but not Treated|1|||
143479467|NCT00865904|517300758|FG004|Overall Study|Randomized but not Treated|1|||
143479468|NCT00545064|517300759|FG000|Overall Study|Lost to Follow-up|3|||
143479469|NCT00545064|517300759|FG000|Overall Study|Withdrawal by Subject|2|||
143479470|NCT00545064|517300759|FG000|Overall Study|did not complete course of treatment|1|||
143146608|NCT03765073|516083530|FG000|Stage 2|Withdrawal by Subject|0|||
143146609|NCT03765073|516083531|FG001|Stage 2|Withdrawal by Subject|0|||
143146610|NCT03765073|516083532|FG002|Stage 2|Withdrawal by Subject|0|||
143146611|NCT03765073|516083533|FG003|Stage 2|Withdrawal by Subject|3|||
143479471|NCT00545064|517300759|FG000|Overall Study|cancel all appointments, no rebooking|1|||
143479472|NCT00545064|517300759|FG000|Overall Study|inclement weather|1|||
143479473|NCT01506960|517300762|FG000|Overall Study|Did not meet angiographic criteria|47|||
143479474|NCT00789880|517300764|FG000|Overall Study|Adverse Event|0|||
143479475|NCT00789880|517300765|FG001|Overall Study|Adverse Event|0|||
143479476|NCT00789880|517300766|FG002|Overall Study|Adverse Event|0|||
143146612|NCT03765073|516083534|FG004|Stage 2|Withdrawal by Subject|3|||
143146613|NCT03765073|516083535|FG005|Stage 2|Withdrawal by Subject|3|||
143146614|NCT03765073|516083536|FG006|Stage 2|Withdrawal by Subject|0|||
143146615|NCT03765073|516083537|FG007|Stage 2|Withdrawal by Subject|1|||
143146616|NCT03765073|516083538|FG008|Stage 2|Withdrawal by Subject|0|||
143146617|NCT03765073|516083539|FG009|Stage 2|Withdrawal by Subject|5|||
143146618|NCT03765073|516083540|FG010|Stage 2|Withdrawal by Subject|0|||
143146619|NCT03765073|516083541|FG011|Stage 2|Withdrawal by Subject|0|||
143146620|NCT03765073|516083542|FG012|Stage 2|Withdrawal by Subject|0|||
143479477|NCT00789880|517300767|FG003|Overall Study|Adverse Event|0|||
143479478|NCT00789880|517300768|FG004|Overall Study|Adverse Event|1|||
143479479|NCT00789880|517300769|FG005|Overall Study|Adverse Event|0|||
143479480|NCT00789880|517300764|FG000|Overall Study|Protocol Violation|0|||
143479481|NCT00789880|517300765|FG001|Overall Study|Protocol Violation|1|||
143479482|NCT00789880|517300766|FG002|Overall Study|Protocol Violation|0|||
143479483|NCT00789880|517300767|FG003|Overall Study|Protocol Violation|1|||
143479484|NCT00789880|517300768|FG004|Overall Study|Protocol Violation|0|||
143479485|NCT00789880|517300769|FG005|Overall Study|Protocol Violation|0|||
143479486|NCT00789880|517300764|FG000|Overall Study|Withdrawal by Subject|1|||
143146621|NCT03765073|516083543|FG013|Stage 2|Withdrawal by Subject|0|||
143146622|NCT03765073|516083544|FG014|Stage 2|Withdrawal by Subject|0|||
143146623|NCT03765073|516083545|FG015|Stage 2|Withdrawal by Subject|0|||
143479487|NCT00789880|517300765|FG001|Overall Study|Withdrawal by Subject|0|||
143479488|NCT00789880|517300766|FG002|Overall Study|Withdrawal by Subject|0|||
143479489|NCT00789880|517300767|FG003|Overall Study|Withdrawal by Subject|0|||
143479490|NCT00789880|517300768|FG004|Overall Study|Withdrawal by Subject|2|||
143479491|NCT00789880|517300769|FG005|Overall Study|Withdrawal by Subject|0|||
143479492|NCT00609986|517300770|FG000|Overall Study|Did not receive transplant or treatment|8|||
143479493|NCT00609986|517300771|FG001|Overall Study|Did not receive transplant or treatment|3|||
143479494|NCT04814823|517300773|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
143146624|NCT03765073|516083546|FG016|Stage 2|Withdrawal by Subject|0|||
143146625|NCT03765073|516083547|FG017|Stage 2|Withdrawal by Subject|0|||
143146626|NCT03765073|516083548|FG018|Stage 2|Withdrawal by Subject|0|||
143146627|NCT03765073|516083549|FG019|Stage 2|Withdrawal by Subject|0|||
143146628|NCT03765073|516083550|FG020|Stage 2|Withdrawal by Subject|0|||
143146629|NCT03765073|516083530|FG000|Stage 3|Adverse Event|0|||
143146630|NCT03765073|516083531|FG001|Stage 3|Adverse Event|0|||
143146631|NCT03765073|516083532|FG002|Stage 3|Adverse Event|0|||
143146632|NCT03765073|516083533|FG003|Stage 3|Adverse Event|0|||
143146633|NCT03765073|516083534|FG004|Stage 3|Adverse Event|0|||
143146634|NCT03765073|516083535|FG005|Stage 3|Adverse Event|0|||
143146635|NCT03765073|516083536|FG006|Stage 3|Adverse Event|0|||
143146636|NCT03765073|516083537|FG007|Stage 3|Adverse Event|0|||
143146637|NCT03765073|516083538|FG008|Stage 3|Adverse Event|0|||
143146638|NCT03765073|516083539|FG009|Stage 3|Adverse Event|0|||
143146639|NCT03765073|516083540|FG010|Stage 3|Adverse Event|0|||
143146640|NCT03765073|516083541|FG011|Stage 3|Adverse Event|0|||
143146641|NCT03765073|516083542|FG012|Stage 3|Adverse Event|0|||
143146642|NCT03765073|516083543|FG013|Stage 3|Adverse Event|0|||
143146643|NCT03765073|516083544|FG014|Stage 3|Adverse Event|0|||
143146644|NCT03765073|516083545|FG015|Stage 3|Adverse Event|0|||
143146645|NCT03765073|516083546|FG016|Stage 3|Adverse Event|0|||
143146646|NCT03765073|516083547|FG017|Stage 3|Adverse Event|0|||
143146647|NCT03765073|516083548|FG018|Stage 3|Adverse Event|1|||
143146648|NCT03765073|516083549|FG019|Stage 3|Adverse Event|0|||
143146649|NCT03765073|516083550|FG020|Stage 3|Adverse Event|0|||
143146650|NCT03765073|516083530|FG000|Stage 3|Death|0|||
143146651|NCT03765073|516083531|FG001|Stage 3|Death|0|||
143146652|NCT03765073|516083532|FG002|Stage 3|Death|0|||
143146653|NCT03765073|516083533|FG003|Stage 3|Death|0|||
143146654|NCT03765073|516083534|FG004|Stage 3|Death|0|||
143146655|NCT03765073|516083535|FG005|Stage 3|Death|0|||
143146656|NCT03765073|516083536|FG006|Stage 3|Death|0|||
143146657|NCT03765073|516083537|FG007|Stage 3|Death|0|||
143146658|NCT03765073|516083538|FG008|Stage 3|Death|0|||
143146659|NCT03765073|516083539|FG009|Stage 3|Death|0|||
143146660|NCT03765073|516083540|FG010|Stage 3|Death|0|||
143146661|NCT03765073|516083541|FG011|Stage 3|Death|0|||
143146662|NCT03765073|516083542|FG012|Stage 3|Death|0|||
143146663|NCT03765073|516083543|FG013|Stage 3|Death|0|||
143146664|NCT03765073|516083544|FG014|Stage 3|Death|0|||
143146665|NCT03765073|516083545|FG015|Stage 3|Death|0|||
143146666|NCT03765073|516083546|FG016|Stage 3|Death|0|||
143146667|NCT03765073|516083547|FG017|Stage 3|Death|0|||
143146668|NCT03765073|516083548|FG018|Stage 3|Death|0|||
143146669|NCT03765073|516083549|FG019|Stage 3|Death|3|||
143146670|NCT03765073|516083550|FG020|Stage 3|Death|2|||
143146671|NCT03765073|516083530|FG000|Stage 3|Lost to Follow-up|0|||
143146672|NCT03765073|516083531|FG001|Stage 3|Lost to Follow-up|0|||
143146673|NCT03765073|516083532|FG002|Stage 3|Lost to Follow-up|0|||
143146674|NCT03765073|516083533|FG003|Stage 3|Lost to Follow-up|0|||
143146675|NCT03765073|516083534|FG004|Stage 3|Lost to Follow-up|0|||
143146676|NCT03765073|516083535|FG005|Stage 3|Lost to Follow-up|0|||
143146677|NCT03765073|516083536|FG006|Stage 3|Lost to Follow-up|0|||
143146678|NCT03765073|516083537|FG007|Stage 3|Lost to Follow-up|0|||
143146679|NCT03765073|516083538|FG008|Stage 3|Lost to Follow-up|0|||
143146680|NCT03765073|516083539|FG009|Stage 3|Lost to Follow-up|0|||
143146681|NCT03765073|516083540|FG010|Stage 3|Lost to Follow-up|0|||
143479495|NCT01877915|517300781|FG000|Overall Study|Lost to Follow-up|10|||
143146682|NCT03765073|516083541|FG011|Stage 3|Lost to Follow-up|0|||
143146683|NCT03765073|516083542|FG012|Stage 3|Lost to Follow-up|0|||
143146684|NCT03765073|516083543|FG013|Stage 3|Lost to Follow-up|0|||
143146685|NCT03765073|516083544|FG014|Stage 3|Lost to Follow-up|0|||
143146686|NCT03765073|516083545|FG015|Stage 3|Lost to Follow-up|0|||
143146687|NCT03765073|516083546|FG016|Stage 3|Lost to Follow-up|0|||
143146688|NCT03765073|516083547|FG017|Stage 3|Lost to Follow-up|8|||
143146689|NCT03765073|516083548|FG018|Stage 3|Lost to Follow-up|5|||
143146690|NCT03765073|516083549|FG019|Stage 3|Lost to Follow-up|7|||
143146691|NCT03765073|516083550|FG020|Stage 3|Lost to Follow-up|4|||
143146692|NCT03765073|516083530|FG000|Stage 3|No longer meets eligibility criteria|0|||
143146693|NCT03765073|516083531|FG001|Stage 3|No longer meets eligibility criteria|0|||
143146694|NCT03765073|516083532|FG002|Stage 3|No longer meets eligibility criteria|0|||
143146695|NCT03765073|516083533|FG003|Stage 3|No longer meets eligibility criteria|0|||
143146696|NCT03765073|516083534|FG004|Stage 3|No longer meets eligibility criteria|0|||
143146697|NCT03765073|516083535|FG005|Stage 3|No longer meets eligibility criteria|0|||
143146698|NCT03765073|516083536|FG006|Stage 3|No longer meets eligibility criteria|0|||
143146699|NCT03765073|516083537|FG007|Stage 3|No longer meets eligibility criteria|0|||
143146700|NCT03765073|516083538|FG008|Stage 3|No longer meets eligibility criteria|0|||
143146701|NCT03765073|516083539|FG009|Stage 3|No longer meets eligibility criteria|0|||
143146702|NCT03765073|516083540|FG010|Stage 3|No longer meets eligibility criteria|0|||
143146703|NCT03765073|516083541|FG011|Stage 3|No longer meets eligibility criteria|0|||
143479496|NCT01877915|517300782|FG001|Overall Study|Lost to Follow-up|9|||
143479497|NCT01877915|517300781|FG000|Overall Study|Withdrawal by Subject|42|||
143479498|NCT01877915|517300782|FG001|Overall Study|Withdrawal by Subject|55|||
143479499|NCT01877915|517300781|FG000|Overall Study|Other|2|||
143479500|NCT01877915|517300782|FG001|Overall Study|Other|4|||
143479501|NCT05678257|517300787|FG000|Overall Study|Withdrawal by Subject|2|||
143479502|NCT05678257|517300788|FG001|Overall Study|Withdrawal by Subject|0|||
143479503|NCT05678257|517300789|FG002|Overall Study|Withdrawal by Subject|5|||
143479504|NCT05678257|517300787|FG000|Overall Study|Physician Decision|1|||
143479505|NCT05678257|517300788|FG001|Overall Study|Physician Decision|0|||
143479506|NCT05678257|517300789|FG002|Overall Study|Physician Decision|1|||
143479507|NCT05678257|517300787|FG000|Overall Study|Adverse Event|1|||
143479508|NCT05678257|517300788|FG001|Overall Study|Adverse Event|3|||
143146704|NCT03765073|516083542|FG012|Stage 3|No longer meets eligibility criteria|0|||
143146705|NCT03765073|516083543|FG013|Stage 3|No longer meets eligibility criteria|0|||
143479509|NCT05678257|517300789|FG002|Overall Study|Adverse Event|1|||
143479510|NCT05678257|517300787|FG000|Overall Study|Progressive disease|11|||
143479511|NCT05678257|517300788|FG001|Overall Study|Progressive disease|18|||
143146706|NCT03765073|516083544|FG014|Stage 3|No longer meets eligibility criteria|0|||
143146707|NCT03765073|516083545|FG015|Stage 3|No longer meets eligibility criteria|0|||
143146708|NCT03765073|516083546|FG016|Stage 3|No longer meets eligibility criteria|0|||
143146709|NCT03765073|516083547|FG017|Stage 3|No longer meets eligibility criteria|0|||
143146710|NCT03765073|516083548|FG018|Stage 3|No longer meets eligibility criteria|1|||
143146711|NCT03765073|516083549|FG019|Stage 3|No longer meets eligibility criteria|0|||
143146712|NCT03765073|516083550|FG020|Stage 3|No longer meets eligibility criteria|1|||
143146713|NCT03765073|516083530|FG000|Stage 3|Other|0|||
143146714|NCT03765073|516083531|FG001|Stage 3|Other|0|||
143146715|NCT03765073|516083532|FG002|Stage 3|Other|0|||
143146716|NCT03765073|516083533|FG003|Stage 3|Other|0|||
143146717|NCT03765073|516083534|FG004|Stage 3|Other|0|||
143146718|NCT03765073|516083535|FG005|Stage 3|Other|0|||
143146719|NCT03765073|516083536|FG006|Stage 3|Other|0|||
143146720|NCT03765073|516083537|FG007|Stage 3|Other|0|||
143146721|NCT03765073|516083538|FG008|Stage 3|Other|0|||
143146722|NCT03765073|516083539|FG009|Stage 3|Other|0|||
143146723|NCT03765073|516083540|FG010|Stage 3|Other|0|||
143146724|NCT03765073|516083541|FG011|Stage 3|Other|0|||
143146725|NCT03765073|516083542|FG012|Stage 3|Other|0|||
143146726|NCT03765073|516083543|FG013|Stage 3|Other|0|||
143146727|NCT03765073|516083544|FG014|Stage 3|Other|0|||
143146728|NCT03765073|516083545|FG015|Stage 3|Other|0|||
143146729|NCT03765073|516083546|FG016|Stage 3|Other|0|||
143146730|NCT03765073|516083547|FG017|Stage 3|Other|1|||
143146731|NCT03765073|516083548|FG018|Stage 3|Other|2|||
143146732|NCT03765073|516083549|FG019|Stage 3|Other|2|||
143146733|NCT03765073|516083550|FG020|Stage 3|Other|2|||
143146734|NCT03765073|516083530|FG000|Stage 3|Withdrawal by parent/guardian|0|||
143146735|NCT03765073|516083531|FG001|Stage 3|Withdrawal by parent/guardian|0|||
143146736|NCT03765073|516083532|FG002|Stage 3|Withdrawal by parent/guardian|0|||
143146737|NCT03765073|516083533|FG003|Stage 3|Withdrawal by parent/guardian|0|||
143146738|NCT03765073|516083534|FG004|Stage 3|Withdrawal by parent/guardian|0|||
143146739|NCT03765073|516083535|FG005|Stage 3|Withdrawal by parent/guardian|0|||
143146740|NCT03765073|516083536|FG006|Stage 3|Withdrawal by parent/guardian|0|||
143146741|NCT03765073|516083537|FG007|Stage 3|Withdrawal by parent/guardian|0|||
143146742|NCT03765073|516083538|FG008|Stage 3|Withdrawal by parent/guardian|0|||
143146743|NCT03765073|516083539|FG009|Stage 3|Withdrawal by parent/guardian|0|||
143146744|NCT03765073|516083540|FG010|Stage 3|Withdrawal by parent/guardian|0|||
143146745|NCT03765073|516083541|FG011|Stage 3|Withdrawal by parent/guardian|0|||
143146746|NCT03765073|516083542|FG012|Stage 3|Withdrawal by parent/guardian|0|||
143146747|NCT03765073|516083543|FG013|Stage 3|Withdrawal by parent/guardian|0|||
143146748|NCT03765073|516083544|FG014|Stage 3|Withdrawal by parent/guardian|0|||
143479512|NCT05678257|517300789|FG002|Overall Study|Progressive disease|7|||
143479513|NCT05678257|517300787|FG000|Overall Study|No longer clinically benefitting|2|||
143479514|NCT05678257|517300788|FG001|Overall Study|No longer clinically benefitting|1|||
143479515|NCT05678257|517300789|FG002|Overall Study|No longer clinically benefitting|0|||
143479516|NCT05678257|517300787|FG000|Overall Study|Sponsor decision|5|||
143479517|NCT05678257|517300788|FG001|Overall Study|Sponsor decision|9|||
143146749|NCT03765073|516083545|FG015|Stage 3|Withdrawal by parent/guardian|0|||
143146750|NCT03765073|516083546|FG016|Stage 3|Withdrawal by parent/guardian|0|||
143146751|NCT03765073|516083547|FG017|Stage 3|Withdrawal by parent/guardian|0|||
143146752|NCT03765073|516083548|FG018|Stage 3|Withdrawal by parent/guardian|0|||
143146753|NCT03765073|516083549|FG019|Stage 3|Withdrawal by parent/guardian|6|||
143479518|NCT05678257|517300789|FG002|Overall Study|Sponsor decision|8|||
143146754|NCT03765073|516083550|FG020|Stage 3|Withdrawal by parent/guardian|9|||
143146755|NCT03765073|516083530|FG000|Stage 3|Withdrawal by Subject|0|||
143146756|NCT03765073|516083531|FG001|Stage 3|Withdrawal by Subject|0|||
143146757|NCT03765073|516083532|FG002|Stage 3|Withdrawal by Subject|0|||
143146758|NCT03765073|516083533|FG003|Stage 3|Withdrawal by Subject|0|||
143479519|NCT05678257|517300787|FG000|Overall Study|Protocol Violation|0|||
143479520|NCT05678257|517300788|FG001|Overall Study|Protocol Violation|0|||
143479521|NCT05678257|517300789|FG002|Overall Study|Protocol Violation|1|||
143479522|NCT05678257|517300787|FG000|Overall Study|Patient non-compliance|0|||
143479523|NCT05678257|517300788|FG001|Overall Study|Patient non-compliance|0|||
143479524|NCT05678257|517300789|FG002|Overall Study|Patient non-compliance|3|||
143479525|NCT02046096|517300790|FG000|Overall Study|Death|28|||
143479526|NCT02046096|517300791|FG001|Overall Study|Death|45|||
143479527|NCT02046096|517300790|FG000|Overall Study|Lost to Follow-up|9|||
143479528|NCT02046096|517300791|FG001|Overall Study|Lost to Follow-up|20|||
143479529|NCT02046096|517300790|FG000|Overall Study|Withdrawal by Subject|5|||
143479530|NCT02046096|517300791|FG001|Overall Study|Withdrawal by Subject|17|||
143479531|NCT02046096|517300790|FG000|Overall Study|Other endpoint|2|||
143479532|NCT02046096|517300791|FG001|Overall Study|Other endpoint|19|||
143479533|NCT03520959|517300792|FG000|Overall Study|Study terminated by Sponsor|0|||
143479534|NCT03520959|517300793|FG001|Overall Study|Study terminated by Sponsor|1|||
143479535|NCT01449461|517300794|FG000|Overall Study|Adverse Event|0|||
143479536|NCT01449461|517300795|FG001|Overall Study|Adverse Event|3|||
143479537|NCT01449461|517300796|FG002|Overall Study|Adverse Event|2|||
143479538|NCT01449461|517300797|FG003|Overall Study|Adverse Event|3|||
143479539|NCT01449461|517300798|FG004|Overall Study|Adverse Event|4|||
143479540|NCT01449461|517300799|FG005|Overall Study|Adverse Event|4|||
143479541|NCT01449461|517300794|FG000|Overall Study|Death|0|||
143479542|NCT01449461|517300795|FG001|Overall Study|Death|2|||
143479543|NCT01449461|517300796|FG002|Overall Study|Death|0|||
143479544|NCT01449461|517300797|FG003|Overall Study|Death|0|||
143479545|NCT01449461|517300798|FG004|Overall Study|Death|7|||
143479546|NCT01449461|517300799|FG005|Overall Study|Death|1|||
143479547|NCT01449461|517300794|FG000|Overall Study|Physician Decision|0|||
143479548|NCT01449461|517300795|FG001|Overall Study|Physician Decision|1|||
143479549|NCT01449461|517300796|FG002|Overall Study|Physician Decision|0|||
143479550|NCT01449461|517300797|FG003|Overall Study|Physician Decision|4|||
143479551|NCT01449461|517300798|FG004|Overall Study|Physician Decision|1|||
143479552|NCT01449461|517300799|FG005|Overall Study|Physician Decision|0|||
143479553|NCT01449461|517300794|FG000|Overall Study|Documented Progressive Disease|4|||
143479554|NCT01449461|517300795|FG001|Overall Study|Documented Progressive Disease|7|||
143479555|NCT01449461|517300796|FG002|Overall Study|Documented Progressive Disease|14|||
143479556|NCT01449461|517300797|FG003|Overall Study|Documented Progressive Disease|15|||
143479557|NCT01449461|517300798|FG004|Overall Study|Documented Progressive Disease|24|||
143479558|NCT01449461|517300799|FG005|Overall Study|Documented Progressive Disease|5|||
143479559|NCT01449461|517300794|FG000|Overall Study|Clinical Progressive Disease|2|||
143479560|NCT01449461|517300795|FG001|Overall Study|Clinical Progressive Disease|2|||
143479561|NCT01449461|517300796|FG002|Overall Study|Clinical Progressive Disease|0|||
143479562|NCT01449461|517300797|FG003|Overall Study|Clinical Progressive Disease|3|||
143479563|NCT01449461|517300798|FG004|Overall Study|Clinical Progressive Disease|4|||
143479564|NCT01449461|517300799|FG005|Overall Study|Clinical Progressive Disease|2|||
143479565|NCT01449461|517300794|FG000|Overall Study|Protocol Violation|0|||
143479566|NCT01449461|517300795|FG001|Overall Study|Protocol Violation|0|||
143479567|NCT01449461|517300796|FG002|Overall Study|Protocol Violation|0|||
143479568|NCT01449461|517300797|FG003|Overall Study|Protocol Violation|1|||
143479569|NCT01449461|517300798|FG004|Overall Study|Protocol Violation|0|||
143479570|NCT01449461|517300799|FG005|Overall Study|Protocol Violation|0|||
143479571|NCT01449461|517300794|FG000|Overall Study|Site Terminated by Sponsor|0|||
143146759|NCT03765073|516083534|FG004|Stage 3|Withdrawal by Subject|0|||
143146760|NCT03765073|516083535|FG005|Stage 3|Withdrawal by Subject|0|||
143146761|NCT03765073|516083536|FG006|Stage 3|Withdrawal by Subject|0|||
143146762|NCT03765073|516083537|FG007|Stage 3|Withdrawal by Subject|0|||
143146763|NCT03765073|516083538|FG008|Stage 3|Withdrawal by Subject|0|||
143146764|NCT03765073|516083539|FG009|Stage 3|Withdrawal by Subject|0|||
143146765|NCT03765073|516083540|FG010|Stage 3|Withdrawal by Subject|0|||
143146766|NCT03765073|516083541|FG011|Stage 3|Withdrawal by Subject|0|||
143146767|NCT03765073|516083542|FG012|Stage 3|Withdrawal by Subject|0|||
143146768|NCT03765073|516083543|FG013|Stage 3|Withdrawal by Subject|0|||
143146769|NCT03765073|516083544|FG014|Stage 3|Withdrawal by Subject|0|||
143146770|NCT03765073|516083545|FG015|Stage 3|Withdrawal by Subject|0|||
143479572|NCT01449461|517300795|FG001|Overall Study|Site Terminated by Sponsor|1|||
143479573|NCT01449461|517300796|FG002|Overall Study|Site Terminated by Sponsor|2|||
143479574|NCT01449461|517300797|FG003|Overall Study|Site Terminated by Sponsor|3|||
143479575|NCT01449461|517300798|FG004|Overall Study|Site Terminated by Sponsor|4|||
143479576|NCT01449461|517300799|FG005|Overall Study|Site Terminated by Sponsor|1|||
143479577|NCT01449461|517300794|FG000|Overall Study|Withdrawal by Subject|0|||
143479578|NCT01449461|517300795|FG001|Overall Study|Withdrawal by Subject|1|||
143479579|NCT01449461|517300796|FG002|Overall Study|Withdrawal by Subject|0|||
143479580|NCT01449461|517300797|FG003|Overall Study|Withdrawal by Subject|0|||
143479581|NCT01449461|517300798|FG004|Overall Study|Withdrawal by Subject|2|||
143479582|NCT01449461|517300799|FG005|Overall Study|Withdrawal by Subject|1|||
143479583|NCT01449461|517300794|FG000|Overall Study|Reason not Specified|0|||
143146771|NCT03765073|516083546|FG016|Stage 3|Withdrawal by Subject|0|||
143479584|NCT01449461|517300795|FG001|Overall Study|Reason not Specified|1|||
143479585|NCT01449461|517300796|FG002|Overall Study|Reason not Specified|0|||
143479586|NCT01449461|517300797|FG003|Overall Study|Reason not Specified|3|||
143146772|NCT03765073|516083547|FG017|Stage 3|Withdrawal by Subject|8|||
143146773|NCT03765073|516083548|FG018|Stage 3|Withdrawal by Subject|11|||
143146774|NCT03765073|516083549|FG019|Stage 3|Withdrawal by Subject|0|||
143146775|NCT03765073|516083550|FG020|Stage 3|Withdrawal by Subject|0|||
143146776|NCT02763566|516083559|FG000|Overall Study|Lost to Follow-up|1|||
143146777|NCT02763566|516083560|FG001|Overall Study|Lost to Follow-up|4|||
143146778|NCT02763566|516083561|FG002|Overall Study|Lost to Follow-up|0|||
143146779|NCT02763566|516083562|FG003|Overall Study|Lost to Follow-up|1|||
143146780|NCT02763566|516083559|FG000|Overall Study|On study treatment at study conclusion|114|||
143146781|NCT02763566|516083560|FG001|Overall Study|On study treatment at study conclusion|34|||
143146782|NCT02763566|516083561|FG002|Overall Study|On study treatment at study conclusion|54|||
143146783|NCT02763566|516083562|FG003|Overall Study|On study treatment at study conclusion|13|||
143146784|NCT02763566|516083559|FG000|Overall Study|Withdrawal by Subject|3|||
143146785|NCT02763566|516083560|FG001|Overall Study|Withdrawal by Subject|1|||
143146786|NCT02763566|516083561|FG002|Overall Study|Withdrawal by Subject|0|||
143146787|NCT02763566|516083562|FG003|Overall Study|Withdrawal by Subject|0|||
143146788|NCT04896385|516083563|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
143146789|NCT04896385|516083564|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
143146790|NCT04896385|516083565|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
143146791|NCT04896385|516083566|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
143146792|NCT04896385|516083563|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
143146793|NCT04896385|516083564|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
143146794|NCT04896385|516083565|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
143146795|NCT04896385|516083566|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
143146796|NCT04896385|516083563|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
143146797|NCT04896385|516083564|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
143146798|NCT04896385|516083565|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
143146799|NCT04896385|516083566|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
143146800|NCT04896385|516083563|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
143146801|NCT04896385|516083564|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
143146802|NCT04896385|516083565|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
143146803|NCT04896385|516083566|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
143146804|NCT04896385|516083563|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
143146805|NCT04896385|516083564|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
143146806|NCT04896385|516083565|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
143146807|NCT04896385|516083566|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
143146808|NCT04896385|516083563|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
143146809|NCT04896385|516083564|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
143146810|NCT04896385|516083565|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
143146811|NCT04896385|516083566|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
143146812|NCT00790036|516083567|FG000|Overall Study|Abnormal lab values|3|||
143146813|NCT00790036|516083568|FG001|Overall Study|Abnormal lab values|2|||
143146814|NCT00790036|516083567|FG000|Overall Study|Administrative problems|5|||
143146815|NCT00790036|516083568|FG001|Overall Study|Administrative problems|9|||
143146816|NCT00790036|516083567|FG000|Overall Study|Adverse Event|113|||
143146817|NCT00790036|516083568|FG001|Overall Study|Adverse Event|44|||
143146818|NCT00790036|516083567|FG000|Overall Study|Death|1|||
143146819|NCT00790036|516083568|FG001|Overall Study|Death|0|||
143146820|NCT00790036|516083567|FG000|Overall Study|Disease progression|24|||
143146821|NCT00790036|516083568|FG001|Overall Study|Disease progression|48|||
143146822|NCT00790036|516083567|FG000|Overall Study|Lost to Follow-up|1|||
143146823|NCT00790036|516083568|FG001|Overall Study|Lost to Follow-up|2|||
143146824|NCT00790036|516083567|FG000|Overall Study|Protocol Violation|10|||
143146825|NCT00790036|516083568|FG001|Overall Study|Protocol Violation|2|||
143146826|NCT00790036|516083567|FG000|Overall Study|Withdrawal by Subject|18|||
143146827|NCT00790036|516083568|FG001|Overall Study|Withdrawal by Subject|7|||
143146828|NCT00790036|516083567|FG000|Overall Study|Subject/guardian decision|20|||
143146829|NCT00790036|516083568|FG001|Overall Study|Subject/guardian decision|7|||
143146830|NCT02442349|516083569|FG000|Overall Study|Death|95|||
143146831|NCT02442349|516083569|FG000|Overall Study|Withdrawal by Subject|27|||
143146832|NCT02442349|516083569|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
143146833|NCT02442349|516083569|FG000|Overall Study|Lost to Follow-up|1|||
143146834|NCT00879658|516083570|FG000|Overall Study|Abnormal laboratory value(s)|3|||
143146835|NCT00879658|516083571|FG001|Overall Study|Abnormal laboratory value(s)|0|||
143146836|NCT00879658|516083572|FG002|Overall Study|Abnormal laboratory value(s)|0|||
143146837|NCT00879658|516083573|FG003|Overall Study|Abnormal laboratory value(s)|1|||
143146838|NCT00879658|516083574|FG004|Overall Study|Abnormal laboratory value(s)|0|||
143146839|NCT00879658|516083575|FG005|Overall Study|Abnormal laboratory value(s)|0|||
143146840|NCT00879658|516083576|FG006|Overall Study|Abnormal laboratory value(s)|0|||
143146841|NCT00879658|516083570|FG000|Overall Study|Administrative problems|2|||
143146842|NCT00879658|516083571|FG001|Overall Study|Administrative problems|1|||
143146843|NCT00879658|516083572|FG002|Overall Study|Administrative problems|0|||
143479587|NCT01449461|517300798|FG004|Overall Study|Reason not Specified|2|||
143479588|NCT01449461|517300799|FG005|Overall Study|Reason not Specified|1|||
143479589|NCT05314517|517300801|FG000|Double-blind Period|Adverse Event|4|||
143479590|NCT05314517|517300802|FG001|Double-blind Period|Adverse Event|0|||
143479591|NCT05314517|517300803|FG002|Double-blind Period|Adverse Event|0|||
143479592|NCT05314517|517300804|FG003|Double-blind Period|Adverse Event|0|||
143479593|NCT05314517|517300801|FG000|Double-blind Period|Noncompliance|0|||
143479594|NCT05314517|517300802|FG001|Double-blind Period|Noncompliance|1|||
143479595|NCT05314517|517300803|FG002|Double-blind Period|Noncompliance|0|||
143479596|NCT05314517|517300804|FG003|Double-blind Period|Noncompliance|0|||
143479597|NCT05314517|517300801|FG000|Double-blind Period|Randomized, not treated|1|||
143479598|NCT05314517|517300802|FG001|Double-blind Period|Randomized, not treated|0|||
143479599|NCT05314517|517300803|FG002|Double-blind Period|Randomized, not treated|0|||
143479600|NCT05314517|517300804|FG003|Double-blind Period|Randomized, not treated|0|||
143479601|NCT05314517|517300801|FG000|Open-label Extension|Adverse Event|0|||
143479602|NCT05314517|517300802|FG001|Open-label Extension|Adverse Event|0|||
143479603|NCT05314517|517300803|FG002|Open-label Extension|Adverse Event|1|||
143479604|NCT05314517|517300804|FG003|Open-label Extension|Adverse Event|2|||
143479605|NCT05314517|517300801|FG000|Open-label Extension|Investigator decision|0|||
143479606|NCT05314517|517300802|FG001|Open-label Extension|Investigator decision|0|||
143479607|NCT05314517|517300803|FG002|Open-label Extension|Investigator decision|1|||
143479608|NCT05314517|517300804|FG003|Open-label Extension|Investigator decision|0|||
143479609|NCT05314517|517300801|FG000|Open-label Extension|Lost to Follow-up|0|||
143479610|NCT05314517|517300802|FG001|Open-label Extension|Lost to Follow-up|0|||
143479611|NCT05314517|517300803|FG002|Open-label Extension|Lost to Follow-up|0|||
143146844|NCT00879658|516083573|FG003|Overall Study|Administrative problems|1|||
143146845|NCT00879658|516083574|FG004|Overall Study|Administrative problems|0|||
143146846|NCT00879658|516083575|FG005|Overall Study|Administrative problems|0|||
143146847|NCT00879658|516083576|FG006|Overall Study|Administrative problems|0|||
143146848|NCT00879658|516083570|FG000|Overall Study|Adverse Event|6|||
143146849|NCT00879658|516083571|FG001|Overall Study|Adverse Event|4|||
143146850|NCT00879658|516083572|FG002|Overall Study|Adverse Event|3|||
143146851|NCT00879658|516083573|FG003|Overall Study|Adverse Event|1|||
143479612|NCT05314517|517300804|FG003|Open-label Extension|Lost to Follow-up|1|||
143479613|NCT05314517|517300801|FG000|Open-label Extension|Withdrawal by Subject|0|||
143479614|NCT05314517|517300802|FG001|Open-label Extension|Withdrawal by Subject|0|||
143479615|NCT05314517|517300803|FG002|Open-label Extension|Withdrawal by Subject|1|||
143479616|NCT05314517|517300804|FG003|Open-label Extension|Withdrawal by Subject|2|||
143479617|NCT05314517|517300801|FG000|Open-label Extension|Use of prohibited medication|0|||
143479618|NCT05314517|517300802|FG001|Open-label Extension|Use of prohibited medication|0|||
143479619|NCT05314517|517300803|FG002|Open-label Extension|Use of prohibited medication|1|||
143479620|NCT05314517|517300804|FG003|Open-label Extension|Use of prohibited medication|0|||
143479621|NCT05314517|517300801|FG000|Open-label Extension|Sponsor decision to terminate study|0|||
143479622|NCT05314517|517300802|FG001|Open-label Extension|Sponsor decision to terminate study|0|||
143479623|NCT05314517|517300803|FG002|Open-label Extension|Sponsor decision to terminate study|13|||
143479624|NCT05314517|517300804|FG003|Open-label Extension|Sponsor decision to terminate study|15|||
143479625|NCT04969276|517300805|FG000|Overall Study|Protocol Deviation|0|||
143479626|NCT04969276|517300806|FG001|Overall Study|Protocol Deviation|1|||
143479627|NCT04969276|517300807|FG002|Overall Study|Protocol Deviation|0|||
143479628|NCT04969276|517300805|FG000|Overall Study|Withdrawal by Subject|1|||
143479629|NCT04969276|517300806|FG001|Overall Study|Withdrawal by Subject|10|||
143146852|NCT00879658|516083574|FG004|Overall Study|Adverse Event|2|||
143146853|NCT00879658|516083575|FG005|Overall Study|Adverse Event|0|||
143479630|NCT04969276|517300807|FG002|Overall Study|Withdrawal by Subject|0|||
143479631|NCT04969276|517300805|FG000|Overall Study|Lost to Follow-up|0|||
143479632|NCT04969276|517300806|FG001|Overall Study|Lost to Follow-up|1|||
143479633|NCT04969276|517300807|FG002|Overall Study|Lost to Follow-up|0|||
143479634|NCT05248295|517300811|FG000|Overall Study|found ineligible|4|||
143479635|NCT05248295|517300812|FG001|Overall Study|found ineligible|1|||
143479636|NCT05248295|517300811|FG000|Overall Study|Withdrawal by Subject|0|||
143479637|NCT05248295|517300812|FG001|Overall Study|Withdrawal by Subject|1|||
143479638|NCT05248295|517300811|FG000|Overall Study|Data loss: audio recording error|1|||
143479639|NCT05248295|517300812|FG001|Overall Study|Data loss: audio recording error|1|||
143479640|NCT04655144|517300813|FG000|Overall Study|Consumed THC|1|||
143146854|NCT00879658|516083576|FG006|Overall Study|Adverse Event|0|||
143479641|NCT04655144|517300814|FG001|Overall Study|Consumed THC|0|||
143479642|NCT04655144|517300813|FG000|Overall Study|Unilateral embolization|0|||
143479643|NCT04655144|517300814|FG001|Overall Study|Unilateral embolization|1|||
143479644|NCT01484977|517300817|FG000|Overall Study|Adverse Event|8|||
143479645|NCT01484977|517300817|FG000|Overall Study|Lack of Efficacy|4|||
143479646|NCT01484977|517300817|FG000|Overall Study|Protocol Violation|6|||
143479647|NCT01484977|517300817|FG000|Overall Study|Lost to Follow-up|1|||
143479648|NCT01484977|517300817|FG000|Overall Study|Withdrawal by Subject|4|||
143146855|NCT00879658|516083570|FG000|Overall Study|Protocol Violation|1|||
143146856|NCT00879658|516083571|FG001|Overall Study|Protocol Violation|0|||
143146857|NCT00879658|516083572|FG002|Overall Study|Protocol Violation|0|||
143479649|NCT01484977|517300817|FG000|Overall Study|Subject Protocol Non-compliant|1|||
143479650|NCT01484977|517300817|FG000|Overall Study|Moving Overseas|1|||
143479651|NCT01484977|517300817|FG000|Overall Study|Low White Blood Cell Count|1|||
143479652|NCT01484977|517300817|FG000|Overall Study|Lack of Compliance|1|||
143479653|NCT00591214|517300820|FG000|Overall Study|Physician Decision|7|||
143479654|NCT00591214|517300820|FG000|Overall Study|Withdrawal by Subject|1|||
143479655|NCT04857996|517300823|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
143479656|NCT04857996|517300824|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
143479657|NCT04857996|517300823|FG000|Overall Study|Lost to Follow-up|1|||
143479658|NCT04857996|517300824|FG001|Overall Study|Lost to Follow-up|3|||
143479659|NCT04857996|517300823|FG000|Overall Study|Site Closure|1|||
143479660|NCT04857996|517300824|FG001|Overall Study|Site Closure|0|||
143479661|NCT04857996|517300823|FG000|Overall Study|Withdrawal by Subject|1|||
143479662|NCT04857996|517300824|FG001|Overall Study|Withdrawal by Subject|0|||
143479663|NCT02269787|517300826|FG000|Overall Study|Lost to Follow-up|20|||
143479664|NCT02269787|517300827|FG001|Overall Study|Lost to Follow-up|6|||
143479665|NCT02269787|517300826|FG000|Overall Study|Death|2|||
143479666|NCT02269787|517300827|FG001|Overall Study|Death|3|||
143479667|NCT02269787|517300826|FG000|Overall Study|Incapacitated|0|||
143479668|NCT02269787|517300827|FG001|Overall Study|Incapacitated|1|||
143479669|NCT00798135|517300828|FG000|Overall Study|Disease progression, relapse|11|||
143479670|NCT00798135|517300828|FG000|Overall Study|Disease progression, refractory|1|||
143479671|NCT00798135|517300828|FG000|Overall Study|Physician Decision|1|||
143479672|NCT01129921|517300829|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
143479673|NCT01129921|517300830|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
143479674|NCT01129921|517300829|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
143479675|NCT01129921|517300830|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
143479676|NCT01129921|517300829|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
143479677|NCT01129921|517300830|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
143479678|NCT01129921|517300829|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
143479679|NCT01129921|517300830|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
143479680|NCT00687440|517300831|FG000|Overall Study|Adverse Event|3|||
143479681|NCT00687440|517300831|FG000|Overall Study|Lost to Follow-up|3|||
143479682|NCT00687440|517300831|FG000|Overall Study|Lack of Efficacy|2|||
143479683|NCT00687440|517300831|FG000|Overall Study|Death|2|||
143479684|NCT00687440|517300831|FG000|Overall Study|Other|1|||
143479685|NCT00687440|517300831|FG000|Overall Study|Missing|1|||
143479686|NCT02228720|517300832|FG000|Open Label - Day 30|Lost to Follow-up|1|||
143479687|NCT00282295|517300835|FG000|Overall Study|Adverse Event|0|||
143479688|NCT00282295|517300836|FG001|Overall Study|Adverse Event|1|||
143479689|NCT00282295|517300837|FG002|Overall Study|Adverse Event|0|||
143479690|NCT00282295|517300835|FG000|Overall Study|Serious Adverse Events|0|||
143479691|NCT00282295|517300836|FG001|Overall Study|Serious Adverse Events|0|||
143479692|NCT00282295|517300837|FG002|Overall Study|Serious Adverse Events|1|||
143479693|NCT00282295|517300835|FG000|Overall Study|Protocol Violation|0|||
143479694|NCT00282295|517300836|FG001|Overall Study|Protocol Violation|2|||
143479695|NCT00282295|517300837|FG002|Overall Study|Protocol Violation|1|||
143479696|NCT00282295|517300835|FG000|Overall Study|Withdrawal by Subject|2|||
143479697|NCT00282295|517300836|FG001|Overall Study|Withdrawal by Subject|6|||
143479698|NCT00282295|517300837|FG002|Overall Study|Withdrawal by Subject|4|||
143479699|NCT00282295|517300835|FG000|Overall Study|Lost to Follow-up|1|||
143479700|NCT00282295|517300836|FG001|Overall Study|Lost to Follow-up|7|||
143479701|NCT00282295|517300837|FG002|Overall Study|Lost to Follow-up|2|||
143479702|NCT00282295|517300835|FG000|Overall Study|Other|0|||
143479703|NCT00282295|517300836|FG001|Overall Study|Other|1|||
143479704|NCT00282295|517300837|FG002|Overall Study|Other|0|||
143479705|NCT03337542|517300838|FG000|Overall Study|Withdrew Consent|17|||
143479706|NCT03337542|517300838|FG000|Overall Study|Allergic Adverse Event|1|||
143479707|NCT03337542|517300838|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
143479708|NCT03337542|517300838|FG000|Overall Study|Lost to Follow-up|1|||
143479709|NCT03337542|517300838|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
143479710|NCT01392677|517300841|FG000|Overall Study|Adverse Event|3|||
143479711|NCT01392677|517300842|FG001|Overall Study|Adverse Event|1|||
143479712|NCT01392677|517300841|FG000|Overall Study|Withdrawal by Subject|0|||
143479713|NCT01392677|517300842|FG001|Overall Study|Withdrawal by Subject|2|||
143479714|NCT01392677|517300841|FG000|Overall Study|Incorrect enrollment|2|||
143479715|NCT01392677|517300842|FG001|Overall Study|Incorrect enrollment|3|||
143479716|NCT01392677|517300841|FG000|Overall Study|Other reason|3|||
143479717|NCT01392677|517300842|FG001|Overall Study|Other reason|2|||
143479718|NCT00121108|517300843|FG000|Overall Study|Lost to Follow-up|10|||
143146858|NCT00879658|516083573|FG003|Overall Study|Protocol Violation|0|||
143479719|NCT00121108|517300844|FG001|Overall Study|Lost to Follow-up|22|||
143479720|NCT00121108|517300843|FG000|Overall Study|Withdrawal by Subject|106|||
143479721|NCT00121108|517300844|FG001|Overall Study|Withdrawal by Subject|195|||
143479722|NCT00121108|517300843|FG000|Overall Study|Death|5|||
143479723|NCT00121108|517300844|FG001|Overall Study|Death|8|||
143146859|NCT00879658|516083574|FG004|Overall Study|Protocol Violation|0|||
143146860|NCT00879658|516083575|FG005|Overall Study|Protocol Violation|0|||
143146861|NCT00879658|516083576|FG006|Overall Study|Protocol Violation|0|||
143146862|NCT00879658|516083570|FG000|Overall Study|Withdrawal by Subject|3|||
143146863|NCT00879658|516083571|FG001|Overall Study|Withdrawal by Subject|0|||
143146864|NCT00879658|516083572|FG002|Overall Study|Withdrawal by Subject|2|||
143146865|NCT00879658|516083573|FG003|Overall Study|Withdrawal by Subject|0|||
143146866|NCT00879658|516083574|FG004|Overall Study|Withdrawal by Subject|0|||
143146867|NCT00879658|516083575|FG005|Overall Study|Withdrawal by Subject|1|||
143146868|NCT00879658|516083576|FG006|Overall Study|Withdrawal by Subject|0|||
143146869|NCT00879658|516083570|FG000|Overall Study|Lack of Efficacy|0|||
143146870|NCT00879658|516083571|FG001|Overall Study|Lack of Efficacy|0|||
143146871|NCT00879658|516083572|FG002|Overall Study|Lack of Efficacy|2|||
143146872|NCT00879658|516083573|FG003|Overall Study|Lack of Efficacy|0|||
143146873|NCT00879658|516083574|FG004|Overall Study|Lack of Efficacy|0|||
143146874|NCT00879658|516083575|FG005|Overall Study|Lack of Efficacy|0|||
143146875|NCT00879658|516083576|FG006|Overall Study|Lack of Efficacy|0|||
143146876|NCT00879658|516083570|FG000|Overall Study|misrandomized (never received study med)|0|||
143146877|NCT00879658|516083571|FG001|Overall Study|misrandomized (never received study med)|0|||
143146878|NCT00879658|516083572|FG002|Overall Study|misrandomized (never received study med)|0|||
143146879|NCT00879658|516083573|FG003|Overall Study|misrandomized (never received study med)|1|||
143146880|NCT00879658|516083574|FG004|Overall Study|misrandomized (never received study med)|0|||
143146881|NCT00879658|516083575|FG005|Overall Study|misrandomized (never received study med)|0|||
143146882|NCT00879658|516083576|FG006|Overall Study|misrandomized (never received study med)|0|||
143146883|NCT00294658|516083577|FG000|Overall Study|Death|0|||
143146884|NCT00294658|516083578|FG001|Overall Study|Death|1|||
143146885|NCT00294658|516083577|FG000|Overall Study|Lost to Follow-up|4|||
143146886|NCT00294658|516083578|FG001|Overall Study|Lost to Follow-up|0|||
143146887|NCT00294658|516083577|FG000|Overall Study|Physician Decision|1|||
143146888|NCT00294658|516083578|FG001|Overall Study|Physician Decision|2|||
143146889|NCT00294658|516083577|FG000|Overall Study|Pregnancy|0|||
143146890|NCT00294658|516083578|FG001|Overall Study|Pregnancy|1|||
143146891|NCT00294658|516083577|FG000|Overall Study|Withdrawal by Subject|0|||
143146892|NCT00294658|516083578|FG001|Overall Study|Withdrawal by Subject|4|||
143146893|NCT00294658|516083577|FG000|Overall Study|Found to have invasive thymoma|1|||
143146894|NCT00294658|516083578|FG001|Overall Study|Found to have invasive thymoma|0|||
143146895|NCT00294658|516083577|FG000|Overall Study|Patient and family were not satisfied|0|||
143146896|NCT00294658|516083578|FG001|Overall Study|Patient and family were not satisfied|1|||
143146897|NCT00580840|516083579|FG000|Run-in|Adverse Event|17|||
143146898|NCT00580840|516083580|FG001|Run-in|Adverse Event|0|||
143146899|NCT00580840|516083581|FG002|Run-in|Adverse Event|0|||
143146900|NCT00580840|516083582|FG003|Run-in|Adverse Event|0|||
143146901|NCT00580840|516083579|FG000|Run-in|Lack of Efficacy|93|||
143146902|NCT00580840|516083580|FG001|Run-in|Lack of Efficacy|0|||
143146903|NCT00580840|516083581|FG002|Run-in|Lack of Efficacy|0|||
143146904|NCT00580840|516083582|FG003|Run-in|Lack of Efficacy|0|||
143146905|NCT00580840|516083579|FG000|Run-in|Loss of Efficacy|1|||
143146906|NCT00580840|516083580|FG001|Run-in|Loss of Efficacy|0|||
143146907|NCT00580840|516083581|FG002|Run-in|Loss of Efficacy|0|||
143146908|NCT00580840|516083582|FG003|Run-in|Loss of Efficacy|0|||
143146909|NCT00580840|516083579|FG000|Run-in|Lost to Follow-up|4|||
143146910|NCT00580840|516083580|FG001|Run-in|Lost to Follow-up|0|||
143146911|NCT00580840|516083581|FG002|Run-in|Lost to Follow-up|0|||
143146912|NCT00580840|516083582|FG003|Run-in|Lost to Follow-up|0|||
143146913|NCT00580840|516083579|FG000|Run-in|Withdrawal by Subject|5|||
143146914|NCT00580840|516083580|FG001|Run-in|Withdrawal by Subject|0|||
143146915|NCT00580840|516083581|FG002|Run-in|Withdrawal by Subject|0|||
143479724|NCT01380379|517300847|FG000|Overall Study|Pregnancy|1|||
143479725|NCT01357577|517300850|FG000|Overall Study|Lost to Follow-up|20|||
143146916|NCT00580840|516083582|FG003|Run-in|Withdrawal by Subject|0|||
143363603|NCT00062868|516873799|FG019|Dose Level 1|Lost to Follow-up|0|||
143479726|NCT01357577|517300851|FG001|Overall Study|Lost to Follow-up|16|||
143479727|NCT01357577|517300850|FG000|Overall Study|Withdrawal by Subject|16|||
143146917|NCT00580840|516083579|FG000|Run-in|Other: Per Sponsor Request|2|||
143146918|NCT00580840|516083580|FG001|Run-in|Other: Per Sponsor Request|0|||
143146919|NCT00580840|516083581|FG002|Run-in|Other: Per Sponsor Request|0|||
143146920|NCT00580840|516083582|FG003|Run-in|Other: Per Sponsor Request|0|||
143146921|NCT00580840|516083579|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
143146922|NCT00580840|516083580|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
143146923|NCT00580840|516083581|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
143146924|NCT00580840|516083582|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
143146925|NCT00580840|516083579|FG000|Run-in|Other: Exclusionary Lab Value|1|||
143146926|NCT00580840|516083580|FG001|Run-in|Other: Exclusionary Lab Value|0|||
143146927|NCT00580840|516083581|FG002|Run-in|Other: Exclusionary Lab Value|0|||
143146928|NCT00580840|516083582|FG003|Run-in|Other: Exclusionary Lab Value|0|||
143146929|NCT00580840|516083579|FG000|Double-Blind|Adverse Event|0|||
143479728|NCT01357577|517300851|FG001|Overall Study|Withdrawal by Subject|8|||
143479729|NCT01357577|517300850|FG000|Overall Study|look at data in database?|1|||
143479730|NCT01357577|517300851|FG001|Overall Study|look at data in database?|2|||
143479731|NCT04360551|517302199|FG000|Overall Study|Withdrawal by Subject|1|||
143479732|NCT04360551|517302200|FG001|Overall Study|Withdrawal by Subject|0|||
143479733|NCT00736255|517302201|FG000|Overall Study|Adverse Event|1|||
143146930|NCT00580840|516083580|FG001|Double-Blind|Adverse Event|3|||
143146931|NCT00580840|516083581|FG002|Double-Blind|Adverse Event|4|||
143146932|NCT00580840|516083582|FG003|Double-Blind|Adverse Event|1|||
143146933|NCT00580840|516083579|FG000|Double-Blind|Loss of Efficacy|0|||
143146934|NCT00580840|516083580|FG001|Double-Blind|Loss of Efficacy|1|||
143146935|NCT00580840|516083581|FG002|Double-Blind|Loss of Efficacy|2|||
143146936|NCT00580840|516083582|FG003|Double-Blind|Loss of Efficacy|10|||
143146937|NCT00580840|516083579|FG000|Double-Blind|Lost to Follow-up|0|||
143146938|NCT00580840|516083580|FG001|Double-Blind|Lost to Follow-up|1|||
143146939|NCT00580840|516083581|FG002|Double-Blind|Lost to Follow-up|0|||
143146940|NCT00580840|516083582|FG003|Double-Blind|Lost to Follow-up|2|||
143146941|NCT00580840|516083579|FG000|Double-Blind|Withdrawal by Subject|0|||
143146942|NCT00580840|516083580|FG001|Double-Blind|Withdrawal by Subject|1|||
143146943|NCT00580840|516083581|FG002|Double-Blind|Withdrawal by Subject|2|||
143146944|NCT00580840|516083582|FG003|Double-Blind|Withdrawal by Subject|2|||
143146945|NCT00580840|516083579|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
143146946|NCT00580840|516083580|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
143146947|NCT00580840|516083581|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
143146948|NCT00580840|516083582|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
143146949|NCT00580840|516083579|FG000|Double-Blind|Other: Forbidden Medication|0|||
143146950|NCT00580840|516083580|FG001|Double-Blind|Other: Forbidden Medication|0|||
143146951|NCT00580840|516083581|FG002|Double-Blind|Other: Forbidden Medication|1|||
143146952|NCT00580840|516083582|FG003|Double-Blind|Other: Forbidden Medication|0|||
143146953|NCT01402700|516083584|FG000|Overall Study|Death|3|||
143146954|NCT01402700|516083584|FG000|Overall Study|Withdrawal by Subject|3|||
143146955|NCT01402700|516083584|FG000|Overall Study|Missed Visit|1|||
143146956|NCT03507790|516083585|FG000|Overall Study|Adverse Event|0|||
143146957|NCT03507790|516083586|FG001|Overall Study|Adverse Event|11|||
143146958|NCT03507790|516083587|FG002|Overall Study|Adverse Event|3|||
143146959|NCT03507790|516083585|FG000|Overall Study|Withdrawal by Subject|2|||
143146960|NCT03507790|516083586|FG001|Overall Study|Withdrawal by Subject|0|||
143146961|NCT03507790|516083587|FG002|Overall Study|Withdrawal by Subject|0|||
143146962|NCT03507790|516083585|FG000|Overall Study|Subject moved to another location|1|||
143146963|NCT03507790|516083586|FG001|Overall Study|Subject moved to another location|2|||
143146964|NCT03507790|516083587|FG002|Overall Study|Subject moved to another location|0|||
143146965|NCT03507790|516083585|FG000|Overall Study|Non-compliance with study drug|0|||
143146966|NCT03507790|516083586|FG001|Overall Study|Non-compliance with study drug|0|||
143146967|NCT03507790|516083587|FG002|Overall Study|Non-compliance with study drug|1|||
143146968|NCT03507790|516083585|FG000|Overall Study|COVID 19 Pandemic|0|||
143146969|NCT03507790|516083586|FG001|Overall Study|COVID 19 Pandemic|1|||
143146970|NCT03507790|516083587|FG002|Overall Study|COVID 19 Pandemic|0|||
143146971|NCT03507790|516083585|FG000|Overall Study|Lost to Follow-up|0|||
143146972|NCT03507790|516083586|FG001|Overall Study|Lost to Follow-up|1|||
143146973|NCT03507790|516083587|FG002|Overall Study|Lost to Follow-up|0|||
143146974|NCT03507790|516083585|FG000|Overall Study|Discontinuation of the trial at the site|1|||
143146975|NCT03507790|516083586|FG001|Overall Study|Discontinuation of the trial at the site|1|||
143146976|NCT03507790|516083587|FG002|Overall Study|Discontinuation of the trial at the site|0|||
143146977|NCT03507790|516083585|FG000|Overall Study|Randomized in error|0|||
143146978|NCT03507790|516083586|FG001|Overall Study|Randomized in error|0|||
143146979|NCT03507790|516083587|FG002|Overall Study|Randomized in error|1|||
143146980|NCT03805841|516083589|FG000|Overall Study|Clinical Progression|2|||
143146981|NCT03805841|516083590|FG001|Overall Study|Clinical Progression|0|||
143146982|NCT03805841|516083591|FG002|Overall Study|Clinical Progression|0|||
143146983|NCT03805841|516083589|FG000|Overall Study|Death|0|||
143146984|NCT03805841|516083590|FG001|Overall Study|Death|3|||
143146985|NCT03805841|516083591|FG002|Overall Study|Death|1|||
143146986|NCT03805841|516083589|FG000|Overall Study|Lost to Follow-up|0|||
143146987|NCT03805841|516083590|FG001|Overall Study|Lost to Follow-up|0|||
143146988|NCT03805841|516083591|FG002|Overall Study|Lost to Follow-up|1|||
143146989|NCT03805841|516083589|FG000|Overall Study|Withdrawal by Subject|2|||
143146990|NCT03805841|516083590|FG001|Overall Study|Withdrawal by Subject|3|||
143146991|NCT03805841|516083591|FG002|Overall Study|Withdrawal by Subject|0|||
143146992|NCT03805841|516083589|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
143146993|NCT03805841|516083590|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
143146994|NCT03805841|516083591|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
143146995|NCT00157755|516083592|FG000|Overall Study|Death|2|||
143146996|NCT00157755|516083593|FG001|Overall Study|Death|3|||
143146997|NCT00157755|516083594|FG002|Overall Study|Death|3|||
143146998|NCT00157755|516083595|FG003|Overall Study|Death|2|||
143146999|NCT00157755|516083596|FG004|Overall Study|Death|0|||
143147000|NCT00157755|516083597|FG005|Overall Study|Death|0|||
143479734|NCT00736255|517302202|FG001|Overall Study|Adverse Event|0|||
143147001|NCT00157755|516083592|FG000|Overall Study|Lost to Follow-up|0|||
143147002|NCT00157755|516083593|FG001|Overall Study|Lost to Follow-up|0|||
143147003|NCT00157755|516083594|FG002|Overall Study|Lost to Follow-up|1|||
143147004|NCT00157755|516083595|FG003|Overall Study|Lost to Follow-up|0|||
143147005|NCT00157755|516083596|FG004|Overall Study|Lost to Follow-up|0|||
143147006|NCT00157755|516083597|FG005|Overall Study|Lost to Follow-up|0|||
143147007|NCT00157755|516083592|FG000|Overall Study|Withdrawal by Subject|0|||
143147008|NCT00157755|516083593|FG001|Overall Study|Withdrawal by Subject|0|||
143147009|NCT00157755|516083594|FG002|Overall Study|Withdrawal by Subject|1|||
143147010|NCT00157755|516083595|FG003|Overall Study|Withdrawal by Subject|1|||
143147011|NCT00157755|516083596|FG004|Overall Study|Withdrawal by Subject|1|||
143147012|NCT00157755|516083597|FG005|Overall Study|Withdrawal by Subject|2|||
143147013|NCT00157755|516083592|FG000|Overall Study|Explant due to infection|0|||
143147014|NCT00157755|516083593|FG001|Overall Study|Explant due to infection|0|||
143147015|NCT00157755|516083594|FG002|Overall Study|Explant due to infection|1|||
143147016|NCT00157755|516083595|FG003|Overall Study|Explant due to infection|0|||
143147017|NCT00157755|516083596|FG004|Overall Study|Explant due to infection|0|||
143147018|NCT00157755|516083597|FG005|Overall Study|Explant due to infection|0|||
143147019|NCT00157755|516083592|FG000|Overall Study|Medical reason|0|||
143147020|NCT00157755|516083593|FG001|Overall Study|Medical reason|0|||
143147021|NCT00157755|516083594|FG002|Overall Study|Medical reason|1|||
143147022|NCT00157755|516083595|FG003|Overall Study|Medical reason|1|||
143147023|NCT00157755|516083596|FG004|Overall Study|Medical reason|0|||
143147024|NCT00157755|516083597|FG005|Overall Study|Medical reason|0|||
143147025|NCT00157755|516083592|FG000|Overall Study|Study site closure|0|||
143147026|NCT00157755|516083593|FG001|Overall Study|Study site closure|1|||
143147027|NCT00157755|516083594|FG002|Overall Study|Study site closure|0|||
143147028|NCT00157755|516083595|FG003|Overall Study|Study site closure|0|||
143147029|NCT00157755|516083596|FG004|Overall Study|Study site closure|0|||
143147030|NCT00157755|516083597|FG005|Overall Study|Study site closure|0|||
143147031|NCT00157755|516083592|FG000|Overall Study|Subject non-compliance|0|||
143147032|NCT00157755|516083593|FG001|Overall Study|Subject non-compliance|0|||
143147033|NCT00157755|516083594|FG002|Overall Study|Subject non-compliance|0|||
143147034|NCT00157755|516083595|FG003|Overall Study|Subject non-compliance|0|||
143147035|NCT00157755|516083596|FG004|Overall Study|Subject non-compliance|0|||
143147036|NCT00157755|516083597|FG005|Overall Study|Subject non-compliance|1|||
143147037|NCT00157755|516083592|FG000|Overall Study|Study completion|0|||
143147038|NCT00157755|516083593|FG001|Overall Study|Study completion|0|||
143147039|NCT00157755|516083594|FG002|Overall Study|Study completion|0|||
143147040|NCT00157755|516083595|FG003|Overall Study|Study completion|0|||
143147041|NCT00157755|516083596|FG004|Overall Study|Study completion|1|||
143147042|NCT00157755|516083597|FG005|Overall Study|Study completion|2|||
143147043|NCT01910441|516083600|FG000|Overall Study|Sponsor decision|0|||
143147044|NCT01910441|516083601|FG001|Overall Study|Sponsor decision|2|||
143147045|NCT01910441|516083600|FG000|Overall Study|Lost to Follow-up|6|||
143147046|NCT01910441|516083601|FG001|Overall Study|Lost to Follow-up|5|||
143147047|NCT01910441|516083600|FG000|Overall Study|Withdrawal by Subject|0|||
143147048|NCT01910441|516083601|FG001|Overall Study|Withdrawal by Subject|1|||
143147049|NCT01910441|516083600|FG000|Overall Study|Non-compliance|0|||
143147050|NCT01910441|516083601|FG001|Overall Study|Non-compliance|1|||
143147051|NCT01910441|516083600|FG000|Overall Study|Adverse Event|1|||
143147052|NCT01910441|516083601|FG001|Overall Study|Adverse Event|0|||
143147053|NCT01910441|516083600|FG000|Overall Study|Physician Decision|0|||
143147054|NCT01910441|516083601|FG001|Overall Study|Physician Decision|1|||
143147055|NCT05168800|516083605|FG000|Time 1 Survey|Did not start T1 survey|182|||
143147056|NCT05168800|516083606|FG001|Time 1 Survey|Did not start T1 survey|150|||
143147057|NCT05168800|516083607|FG002|Time 1 Survey|Did not start T1 survey|140|||
143147058|NCT05168800|516083605|FG000|Time 1 Survey|Completed T1 survey outside window|18|||
143147059|NCT05168800|516083606|FG001|Time 1 Survey|Completed T1 survey outside window|21|||
143147060|NCT05168800|516083607|FG002|Time 1 Survey|Completed T1 survey outside window|13|||
143147061|NCT05168800|516083605|FG000|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
143147062|NCT05168800|516083606|FG001|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|6|||
143147063|NCT05168800|516083607|FG002|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
143147064|NCT05168800|516083605|FG000|Time 1 Survey|Failed verification, did not start Time 1 survey|221|||
143147065|NCT05168800|516083606|FG001|Time 1 Survey|Failed verification, did not start Time 1 survey|200|||
143147066|NCT05168800|516083607|FG002|Time 1 Survey|Failed verification, did not start Time 1 survey|220|||
143147067|NCT05168800|516083605|FG000|Time 1 Survey|Failed verification, did complete time 1 survey|23|||
143147068|NCT05168800|516083606|FG001|Time 1 Survey|Failed verification, did complete time 1 survey|24|||
143147069|NCT05168800|516083607|FG002|Time 1 Survey|Failed verification, did complete time 1 survey|16|||
143147070|NCT05168800|516083605|FG000|Time 1 Survey|Withdrawal by Subject|6|||
143147071|NCT05168800|516083606|FG001|Time 1 Survey|Withdrawal by Subject|3|||
143147072|NCT05168800|516083607|FG002|Time 1 Survey|Withdrawal by Subject|2|||
143147073|NCT05168800|516083605|FG000|Time 2 Survey|Already excluded at Time 1|228|||
143147074|NCT05168800|516083606|FG001|Time 2 Survey|Already excluded at Time 1|202|||
143147075|NCT05168800|516083607|FG002|Time 2 Survey|Already excluded at Time 1|173|||
143181196|NCT03654274|516210493|FG000|Overall Study|Lost to Follow-up|8|||
143479735|NCT00736255|517302201|FG000|Overall Study|Physician Decision|1|||
143479736|NCT00736255|517302202|FG001|Overall Study|Physician Decision|0|||
143479737|NCT00736255|517302201|FG000|Overall Study|Non-compliance|1|||
143479738|NCT00736255|517302202|FG001|Overall Study|Non-compliance|1|||
143479739|NCT00980200|517302214|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
143479740|NCT00980200|517302215|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
143479741|NCT00980200|517302216|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
143479742|NCT00980200|517302217|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
143479743|NCT00980200|517302218|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
143479744|NCT00980200|517302214|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
143479745|NCT00980200|517302215|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
143479746|NCT00980200|517302216|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
143479747|NCT00980200|517302217|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
143479748|NCT00980200|517302218|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
143479749|NCT04179734|517302222|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
143479750|NCT04179734|517302223|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
143479751|NCT04179734|517302222|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
143479752|NCT04179734|517302223|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
143479753|NCT00937937|517302224|FG000|Overall Study|Adverse Event|6|||
143479754|NCT00937937|517302224|FG000|Overall Study|Withdrawal by Subject|2|||
143479755|NCT00937937|517302224|FG000|Overall Study|Progression/relapse|61|||
143479756|NCT00937937|517302224|FG000|Overall Study|Death|1|||
143479757|NCT00937937|517302224|FG000|Overall Study|Other|2|||
143479758|NCT00054704|517302225|FG000|Overall Study|Lack of Efficacy|2|||
143479759|NCT00054704|517302226|FG001|Overall Study|Lack of Efficacy|3|||
143479760|NCT00054704|517302225|FG000|Overall Study|Adverse Event|3|||
143479761|NCT00054704|517302226|FG001|Overall Study|Adverse Event|1|||
143479762|NCT00054704|517302225|FG000|Overall Study|Lost to Follow-up|0|||
143479763|NCT00054704|517302226|FG001|Overall Study|Lost to Follow-up|1|||
143479764|NCT00362414|517302227|FG000|Overall Study|Death|2|||
143479765|NCT00362414|517302227|FG000|Overall Study|Adverse Event|1|||
143479766|NCT01761292|517302228|FG000|Part 1|Adverse Event|1|||
143479767|NCT01761292|517302228|FG000|Part 1|not receiving treatment in Part 1|1|||
143479768|NCT01761292|517302228|FG000|Extension 1|Withdrawal by Subject|1|||
143479769|NCT00383084|517302229|FG000|Overall Study|Withdrawal by Subject|12|||
143479770|NCT00383084|517302230|FG001|Overall Study|Withdrawal by Subject|10|||
143479771|NCT02113436|517302231|FG000|Period 1: 8 Weeks|Adverse Event|1|||
143479772|NCT02113436|517302232|FG001|Period 1: 8 Weeks|Adverse Event|0|||
143479773|NCT02113436|517302233|FG002|Period 1: 8 Weeks|Adverse Event|0|||
143479774|NCT02113436|517302234|FG003|Period 1: 8 Weeks|Adverse Event|0|||
143479775|NCT02113436|517302231|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
143479776|NCT02113436|517302232|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
143479777|NCT02113436|517302233|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
143479778|NCT02113436|517302234|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
143479779|NCT02113436|517302231|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
143479780|NCT02113436|517302232|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
143479781|NCT02113436|517302233|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
143479782|NCT02113436|517302234|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
143479783|NCT02113436|517302231|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
143479784|NCT02113436|517302232|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
143479785|NCT02113436|517302233|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
143479786|NCT02113436|517302234|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
143479787|NCT02113436|517302231|FG000|Period 2: 16 Weeks|Adverse Event|0|||
143479788|NCT02113436|517302232|FG001|Period 2: 16 Weeks|Adverse Event|0|||
143479789|NCT02113436|517302233|FG002|Period 2: 16 Weeks|Adverse Event|4|||
143479790|NCT02113436|517302234|FG003|Period 2: 16 Weeks|Adverse Event|5|||
143147076|NCT05168800|516083605|FG000|Time 2 Survey|Did not start Time 2 survey|31|||
143479791|NCT02113436|517302231|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
143479792|NCT02113436|517302232|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
143479793|NCT02113436|517302233|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
143479794|NCT02113436|517302234|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
143479795|NCT02113436|517302231|FG000|Period 2: 16 Weeks|Physician Decision|0|||
143479796|NCT02113436|517302232|FG001|Period 2: 16 Weeks|Physician Decision|0|||
143479797|NCT02113436|517302233|FG002|Period 2: 16 Weeks|Physician Decision|2|||
143479798|NCT02113436|517302234|FG003|Period 2: 16 Weeks|Physician Decision|0|||
143479799|NCT02113436|517302231|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
143479800|NCT02113436|517302232|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
143479801|NCT02113436|517302233|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
143147077|NCT05168800|516083606|FG001|Time 2 Survey|Did not start Time 2 survey|26|||
143479802|NCT02113436|517302234|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
143479803|NCT01648790|517302235|FG000|Treatment 3|Withdrawal by Subject|0|||
143479804|NCT01648790|517302236|FG001|Treatment 3|Withdrawal by Subject|0|||
143479805|NCT01648790|517302237|FG002|Treatment 3|Withdrawal by Subject|0|||
143479806|NCT01648790|517302238|FG003|Treatment 3|Withdrawal by Subject|1|||
143479807|NCT01648790|517302239|FG004|Treatment 3|Withdrawal by Subject|0|||
143479808|NCT02159729|517302240|FG000|Overall Study|Adverse Event|0|||
143479809|NCT02159729|517302241|FG001|Overall Study|Adverse Event|1|||
143479810|NCT02159729|517302240|FG000|Overall Study|Subject's Request|13|||
143479811|NCT02159729|517302241|FG001|Overall Study|Subject's Request|10|||
143479812|NCT02159729|517302240|FG000|Overall Study|Lost to Follow-up|24|||
143479813|NCT02159729|517302241|FG001|Overall Study|Lost to Follow-up|9|||
143479814|NCT02159729|517302240|FG000|Overall Study|Non compliance|2|||
143479815|NCT02159729|517302241|FG001|Overall Study|Non compliance|0|||
143479816|NCT02159729|517302240|FG000|Overall Study|Other Unspecified|3|||
143479817|NCT02159729|517302241|FG001|Overall Study|Other Unspecified|1|||
143479818|NCT02953340|517302242|FG000|Overall Study|Death|0|||
143479819|NCT02953340|517302243|FG001|Overall Study|Death|1|||
143479820|NCT02953340|517302242|FG000|Overall Study|Investigator Decision|3|||
143479821|NCT02953340|517302243|FG001|Overall Study|Investigator Decision|3|||
143479822|NCT02953340|517302242|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
143479823|NCT02953340|517302243|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
143479824|NCT02953340|517302242|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
143479825|NCT02953340|517302243|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
143479826|NCT02953340|517302242|FG000|Overall Study|Withdrawal by Subject|9|||
143479827|NCT02953340|517302243|FG001|Overall Study|Withdrawal by Subject|9|||
143479828|NCT02953340|517302242|FG000|Overall Study|Sponsor decision|0|||
143479829|NCT02953340|517302243|FG001|Overall Study|Sponsor decision|2|||
143479830|NCT02953340|517302242|FG000|Overall Study|Lost to Follow-up|3|||
143479831|NCT02953340|517302243|FG001|Overall Study|Lost to Follow-up|2|||
143479832|NCT02953340|517302242|FG000|Overall Study|Reason not specified|2|||
143479833|NCT02953340|517302243|FG001|Overall Study|Reason not specified|2|||
143479834|NCT04712110|517302244|FG000|Overall Study|Lost to Follow-up|0|||
143479835|NCT04712110|517302245|FG001|Overall Study|Lost to Follow-up|1|||
143479836|NCT04712110|517302244|FG000|Overall Study|Withdrawal by Subject|0|||
143479837|NCT04712110|517302245|FG001|Overall Study|Withdrawal by Subject|4|||
143479838|NCT04712110|517302244|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
143479839|NCT04712110|517302245|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
143479840|NCT01197521|517302246|FG000|Overall Study|Not reported|24|||
143479841|NCT01197521|517302247|FG001|Overall Study|Not reported|25|||
143479842|NCT01197521|517302248|FG002|Overall Study|Not reported|21|||
143479843|NCT01197521|517302246|FG000|Overall Study|Enrolment in long term extension|42|||
143479844|NCT01197521|517302247|FG001|Overall Study|Enrolment in long term extension|36|||
143479845|NCT01197521|517302248|FG002|Overall Study|Enrolment in long term extension|87|||
143479846|NCT01197521|517302246|FG000|Overall Study|Severe non-compliance to protocol|1|||
143479847|NCT01197521|517302247|FG001|Overall Study|Severe non-compliance to protocol|3|||
143479848|NCT01197521|517302248|FG002|Overall Study|Severe non-compliance to protocol|3|||
143479849|NCT01197521|517302246|FG000|Overall Study|Lack of therapeutic response|2|||
143479850|NCT01197521|517302247|FG001|Overall Study|Lack of therapeutic response|3|||
143479851|NCT01197521|517302248|FG002|Overall Study|Lack of therapeutic response|4|||
143479852|NCT01197521|517302246|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
143479853|NCT01197521|517302247|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
143479854|NCT01197521|517302248|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
143479855|NCT01197521|517302246|FG000|Overall Study|Lost to Follow-up|3|||
143479856|NCT01197521|517302247|FG001|Overall Study|Lost to Follow-up|2|||
143479857|NCT01197521|517302248|FG002|Overall Study|Lost to Follow-up|2|||
143479858|NCT01197521|517302246|FG000|Overall Study|Adverse Event|25|||
143479859|NCT01197521|517302247|FG001|Overall Study|Adverse Event|28|||
143479860|NCT01197521|517302248|FG002|Overall Study|Adverse Event|24|||
143479861|NCT04707157|517302255|FG000|Overall Study|Adverse Event|12|||
143479862|NCT04707157|517302256|FG001|Overall Study|Adverse Event|3|||
143479863|NCT04707157|517302255|FG000|Overall Study|Lost to Follow-up|2|||
143479864|NCT04707157|517302256|FG001|Overall Study|Lost to Follow-up|0|||
143479865|NCT04707157|517302255|FG000|Overall Study|Sponsor's decision|1|||
143479866|NCT04707157|517302256|FG001|Overall Study|Sponsor's decision|0|||
143479867|NCT04707157|517302255|FG000|Overall Study|Physician Decision|8|||
143479868|NCT04707157|517302256|FG001|Overall Study|Physician Decision|5|||
143479869|NCT04707157|517302255|FG000|Overall Study|Protocol Deviation|1|||
143479870|NCT04707157|517302256|FG001|Overall Study|Protocol Deviation|0|||
143479871|NCT04707157|517302255|FG000|Overall Study|Withdrawal by Subject|1|||
143479872|NCT04707157|517302256|FG001|Overall Study|Withdrawal by Subject|1|||
143479873|NCT03625687|517302264|FG000|Overall Study|Death|1|||
143479874|NCT01431274|517302265|FG000|Overall Study|Adverse Event|51|||
143479875|NCT01431274|517302266|FG001|Overall Study|Adverse Event|37|||
143479876|NCT01431274|517302267|FG002|Overall Study|Adverse Event|43|||
143479877|NCT01431274|517302268|FG003|Overall Study|Adverse Event|30|||
143479878|NCT01431274|517302269|FG004|Overall Study|Adverse Event|37|||
143479879|NCT01431274|517302265|FG000|Overall Study|Consent withdrawn not due to AE|29|||
143479880|NCT01431274|517302266|FG001|Overall Study|Consent withdrawn not due to AE|20|||
143479881|NCT01431274|517302267|FG002|Overall Study|Consent withdrawn not due to AE|17|||
143479882|NCT01431274|517302268|FG003|Overall Study|Consent withdrawn not due to AE|20|||
143479883|NCT01431274|517302269|FG004|Overall Study|Consent withdrawn not due to AE|11|||
143479884|NCT01431274|517302265|FG000|Overall Study|Non compliant with protocol|5|||
143479885|NCT01431274|517302266|FG001|Overall Study|Non compliant with protocol|8|||
143479886|NCT01431274|517302267|FG002|Overall Study|Non compliant with protocol|4|||
143479887|NCT01431274|517302268|FG003|Overall Study|Non compliant with protocol|4|||
143479888|NCT01431274|517302269|FG004|Overall Study|Non compliant with protocol|4|||
143479889|NCT01431274|517302265|FG000|Overall Study|Lost to Follow-up|6|||
143479890|NCT01431274|517302266|FG001|Overall Study|Lost to Follow-up|7|||
143479891|NCT01431274|517302267|FG002|Overall Study|Lost to Follow-up|1|||
143479892|NCT01431274|517302268|FG003|Overall Study|Lost to Follow-up|4|||
143479893|NCT01431274|517302269|FG004|Overall Study|Lost to Follow-up|0|||
143479894|NCT01431274|517302265|FG000|Overall Study|Other reason not stated above|6|||
143479895|NCT01431274|517302266|FG001|Overall Study|Other reason not stated above|5|||
143479896|NCT01431274|517302267|FG002|Overall Study|Other reason not stated above|7|||
143479897|NCT01431274|517302268|FG003|Overall Study|Other reason not stated above|2|||
143479898|NCT01431274|517302269|FG004|Overall Study|Other reason not stated above|4|||
143479899|NCT05879107|517302274|FG000|Overall Study|Withdrawal by participant, not due to an adverse event|5|||
143479900|NCT05879107|517302275|FG001|Overall Study|Withdrawal by participant, not due to an adverse event|7|||
143479901|NCT05879107|517302274|FG000|Overall Study|Migrated / moved from the study area|1|||
143479902|NCT05879107|517302275|FG001|Overall Study|Migrated / moved from the study area|1|||
143479903|NCT05879107|517302274|FG000|Overall Study|Lost to Follow-up|8|||
143479904|NCT05879107|517302275|FG001|Overall Study|Lost to Follow-up|13|||
143479905|NCT05879107|517302274|FG000|Overall Study|Death|0|||
143479906|NCT05879107|517302275|FG001|Overall Study|Death|2|||
143479907|NCT05879107|517302274|FG000|Overall Study|Other|0|||
143479908|NCT05879107|517302275|FG001|Overall Study|Other|3|||
143479909|NCT00589420|517302278|FG000|Overall Study|screen failure|1|||
143479910|NCT00243386|517302279|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
143479911|NCT00243386|517302280|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
143479912|NCT00243386|517302281|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
143479913|NCT00243386|517302279|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
143479914|NCT00243386|517302280|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
143479915|NCT00243386|517302281|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
143479916|NCT00243386|517302279|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
143479917|NCT00243386|517302280|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
143479918|NCT00243386|517302281|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
143479919|NCT00243386|517302279|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
143479920|NCT00243386|517302280|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
143479921|NCT00243386|517302281|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
143479922|NCT00243386|517302279|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
143479923|NCT00243386|517302280|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
143479924|NCT00243386|517302281|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
143479925|NCT00243386|517302279|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
143479926|NCT00243386|517302280|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
143479927|NCT00243386|517302281|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
143479928|NCT00243386|517302279|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
143479929|NCT00243386|517302280|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
143479930|NCT00243386|517302281|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
143479931|NCT00243386|517302279|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
143479932|NCT00243386|517302280|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
143479933|NCT00243386|517302281|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
143479934|NCT04037748|517302282|FG000|Treatment Period 1|Withdrawal by Subject|3|||
143479935|NCT04037748|517302283|FG001|Treatment Period 1|Withdrawal by Subject|0|||
143479936|NCT04037748|517302282|FG000|Treatment Period 1|Adverse Event|1|||
143479937|NCT04037748|517302283|FG001|Treatment Period 1|Adverse Event|1|||
143479938|NCT04037748|517302282|FG000|Treatment Period 1|Protocol Violation|4|||
143479939|NCT04037748|517302283|FG001|Treatment Period 1|Protocol Violation|5|||
143479940|NCT04037748|517302282|FG000|Treatment Period 2|Adverse Event|0|||
143479941|NCT04037748|517302283|FG001|Treatment Period 2|Adverse Event|1|||
143479942|NCT04037748|517302282|FG000|Treatment Period 2|Protocol Violation|2|||
143479943|NCT04037748|517302283|FG001|Treatment Period 2|Protocol Violation|0|||
143479944|NCT00133991|517302284|FG000|Overall Study|Death|4|||
143479945|NCT01378858|517302288|FG000|Overall Study|Withdrawal by Subject|4|||
143479946|NCT01378858|517302289|FG001|Overall Study|Withdrawal by Subject|4|||
143479947|NCT02664272|517302290|FG000|Overall Study|Fluoroscopic images not made available|2|||
143479948|NCT03073980|517302291|FG000|Overall Study|Lost to Follow-up|10|||
143479949|NCT03073980|517302292|FG001|Overall Study|Lost to Follow-up|2|||
143479950|NCT03073980|517302293|FG002|Overall Study|Lost to Follow-up|9|||
143479951|NCT03073980|517302291|FG000|Overall Study|No post-procedure data|0|||
143479952|NCT03073980|517302292|FG001|Overall Study|No post-procedure data|0|||
143479953|NCT03073980|517302293|FG002|Overall Study|No post-procedure data|2|||
143479954|NCT01358760|517302294|FG000|Overall Study|Adverse Event|3|||
143479955|NCT01358760|517302295|FG001|Overall Study|Adverse Event|4|||
143479956|NCT01358760|517302296|FG002|Overall Study|Adverse Event|3|||
143479957|NCT01358760|517302294|FG000|Overall Study|Lost to Follow-up|1|||
143479958|NCT01358760|517302295|FG001|Overall Study|Lost to Follow-up|1|||
143479959|NCT01358760|517302296|FG002|Overall Study|Lost to Follow-up|3|||
143479960|NCT01358760|517302294|FG000|Overall Study|Withdrawal by Subject|5|||
143479961|NCT01358760|517302295|FG001|Overall Study|Withdrawal by Subject|3|||
143479962|NCT01358760|517302296|FG002|Overall Study|Withdrawal by Subject|2|||
143479963|NCT01358760|517302294|FG000|Overall Study|Physician Decision|1|||
143479964|NCT01358760|517302295|FG001|Overall Study|Physician Decision|0|||
143479965|NCT01358760|517302296|FG002|Overall Study|Physician Decision|1|||
143479966|NCT01358760|517302294|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
143479967|NCT01358760|517302295|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
143479968|NCT01358760|517302296|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
143479969|NCT04695392|517302297|FG000|Overall Study|Withdrawn by parent/guardian|0|||
143479970|NCT04695392|517302298|FG001|Overall Study|Withdrawn by parent/guardian|1|||
143479971|NCT04695392|517302297|FG000|Overall Study|Withdrawn by physician|0|||
143479972|NCT04695392|517302298|FG001|Overall Study|Withdrawn by physician|1|||
143479973|NCT00450723|517302300|FG000|Overall Study|Physician Decision|5|||
143479974|NCT02047253|517302303|FG000|Overall Study|Lost to Follow-up|8|||
143479975|NCT03574753|517302304|FG000|Overall Study|Adverse Event|3|||
143147078|NCT05168800|516083607|FG002|Time 2 Survey|Did not start Time 2 survey|45|||
143147079|NCT05168800|516083605|FG000|Time 2 Survey|Completed Time 2 survey outside window|10|||
143147080|NCT05168800|516083606|FG001|Time 2 Survey|Completed Time 2 survey outside window|15|||
143147081|NCT05168800|516083607|FG002|Time 2 Survey|Completed Time 2 survey outside window|9|||
143147082|NCT05168800|516083605|FG000|Time 2 Survey|Missing primary outcome data at Time 2|0|||
143147083|NCT05168800|516083606|FG001|Time 2 Survey|Missing primary outcome data at Time 2|1|||
143147084|NCT05168800|516083607|FG002|Time 2 Survey|Missing primary outcome data at Time 2|1|||
143147085|NCT05168800|516083605|FG000|Time 2 Survey|Withdrawal by Subject|1|||
143147086|NCT05168800|516083606|FG001|Time 2 Survey|Withdrawal by Subject|0|||
143147087|NCT05168800|516083607|FG002|Time 2 Survey|Withdrawal by Subject|1|||
143147088|NCT05168800|516083605|FG000|Time 3 Survey|Already excluded at Time 1|228|||
143147089|NCT05168800|516083606|FG001|Time 3 Survey|Already excluded at Time 1|200|||
143147090|NCT05168800|516083607|FG002|Time 3 Survey|Already excluded at Time 1|173|||
143147091|NCT05168800|516083605|FG000|Time 3 Survey|Did not start Time 3 survey|48|||
143147092|NCT05168800|516083606|FG001|Time 3 Survey|Did not start Time 3 survey|48|||
143147093|NCT05168800|516083607|FG002|Time 3 Survey|Did not start Time 3 survey|51|||
143147094|NCT05168800|516083605|FG000|Time 3 Survey|Completed Time 3 survey outside window|1|||
143147095|NCT05168800|516083606|FG001|Time 3 Survey|Completed Time 3 survey outside window|6|||
143147096|NCT05168800|516083607|FG002|Time 3 Survey|Completed Time 3 survey outside window|8|||
143147097|NCT05168800|516083605|FG000|Time 3 Survey|Missing primary outcome data at Time 3|0|||
143147098|NCT05168800|516083606|FG001|Time 3 Survey|Missing primary outcome data at Time 3|1|||
143147099|NCT05168800|516083607|FG002|Time 3 Survey|Missing primary outcome data at Time 3|0|||
143147100|NCT04958707|516083608|FG000|Post Intervention|Withdrawal by Subject|1|||
143147101|NCT04958707|516083609|FG001|Post Intervention|Withdrawal by Subject|0|||
143147102|NCT04958707|516083610|FG002|Post Intervention|Withdrawal by Subject|0|||
143147103|NCT04958707|516083608|FG000|3 Months Follow- up|Lost to Follow-up|0|||
143147104|NCT04958707|516083609|FG001|3 Months Follow- up|Lost to Follow-up|3|||
143147105|NCT04958707|516083610|FG002|3 Months Follow- up|Lost to Follow-up|0|||
143147106|NCT04958707|516083608|FG000|3 Months Follow- up|Withdrawal by Subject|2|||
143147107|NCT04958707|516083609|FG001|3 Months Follow- up|Withdrawal by Subject|0|||
143147108|NCT04958707|516083610|FG002|3 Months Follow- up|Withdrawal by Subject|0|||
143147109|NCT00831844|516083611|FG000|Overall Study|Adverse Event|2|||
143147110|NCT00831844|516083612|FG001|Overall Study|Adverse Event|0|||
143147111|NCT00831844|516083613|FG002|Overall Study|Adverse Event|0|||
143147112|NCT00831844|516083614|FG003|Overall Study|Adverse Event|0|||
143147113|NCT00831844|516083615|FG004|Overall Study|Adverse Event|1|||
143147114|NCT00831844|516083616|FG005|Overall Study|Adverse Event|1|||
143147115|NCT00831844|516083617|FG006|Overall Study|Adverse Event|2|||
143147116|NCT00831844|516083618|FG007|Overall Study|Adverse Event|0|||
143147117|NCT00831844|516083619|FG008|Overall Study|Adverse Event|0|||
143147118|NCT00831844|516083620|FG009|Overall Study|Adverse Event|0|||
143147119|NCT00831844|516083611|FG000|Overall Study|Death|0|||
143147120|NCT00831844|516083612|FG001|Overall Study|Death|0|||
143147121|NCT00831844|516083613|FG002|Overall Study|Death|0|||
143147122|NCT00831844|516083614|FG003|Overall Study|Death|1|||
143479976|NCT03574753|517302304|FG000|Overall Study|Progression/relapse|19|||
143479977|NCT03574753|517302304|FG000|Overall Study|Death|1|||
143147123|NCT00831844|516083615|FG004|Overall Study|Death|0|||
143147124|NCT00831844|516083616|FG005|Overall Study|Death|0|||
143147125|NCT00831844|516083617|FG006|Overall Study|Death|0|||
143147126|NCT00831844|516083618|FG007|Overall Study|Death|0|||
143147127|NCT00831844|516083619|FG008|Overall Study|Death|0|||
143479978|NCT03710486|517302305|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
143479979|NCT03710486|517302306|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
143479980|NCT03710486|517302305|FG000|Overall Study|Missing|0|||
143147128|NCT00831844|516083620|FG009|Overall Study|Death|0|||
143479981|NCT03710486|517302306|FG001|Overall Study|Missing|2|||
143147129|NCT00831844|516083611|FG000|Overall Study|Lack of Efficacy|8|||
143147130|NCT00831844|516083612|FG001|Overall Study|Lack of Efficacy|10|||
143147131|NCT00831844|516083613|FG002|Overall Study|Lack of Efficacy|15|||
143147132|NCT00831844|516083614|FG003|Overall Study|Lack of Efficacy|8|||
143147133|NCT00831844|516083615|FG004|Overall Study|Lack of Efficacy|11|||
143147134|NCT00831844|516083616|FG005|Overall Study|Lack of Efficacy|17|||
143147135|NCT00831844|516083617|FG006|Overall Study|Lack of Efficacy|8|||
143147136|NCT00831844|516083618|FG007|Overall Study|Lack of Efficacy|9|||
143147137|NCT00831844|516083619|FG008|Overall Study|Lack of Efficacy|7|||
143147138|NCT00831844|516083620|FG009|Overall Study|Lack of Efficacy|0|||
143147139|NCT00831844|516083611|FG000|Overall Study|Physician Decision|0|||
143147140|NCT00831844|516083612|FG001|Overall Study|Physician Decision|1|||
143147141|NCT00831844|516083613|FG002|Overall Study|Physician Decision|3|||
143147142|NCT00831844|516083614|FG003|Overall Study|Physician Decision|1|||
143147143|NCT00831844|516083615|FG004|Overall Study|Physician Decision|1|||
143147144|NCT00831844|516083616|FG005|Overall Study|Physician Decision|1|||
143147145|NCT00831844|516083617|FG006|Overall Study|Physician Decision|0|||
143147146|NCT00831844|516083618|FG007|Overall Study|Physician Decision|0|||
143147147|NCT00831844|516083619|FG008|Overall Study|Physician Decision|1|||
143147148|NCT00831844|516083620|FG009|Overall Study|Physician Decision|0|||
143147149|NCT00831844|516083611|FG000|Overall Study|Withdrawal by Subject|0|||
143147150|NCT00831844|516083612|FG001|Overall Study|Withdrawal by Subject|0|||
143147151|NCT00831844|516083613|FG002|Overall Study|Withdrawal by Subject|1|||
143147152|NCT00831844|516083614|FG003|Overall Study|Withdrawal by Subject|0|||
143147153|NCT00831844|516083615|FG004|Overall Study|Withdrawal by Subject|0|||
143147154|NCT00831844|516083616|FG005|Overall Study|Withdrawal by Subject|0|||
143147155|NCT00831844|516083617|FG006|Overall Study|Withdrawal by Subject|0|||
143147156|NCT00831844|516083618|FG007|Overall Study|Withdrawal by Subject|1|||
143147157|NCT00831844|516083619|FG008|Overall Study|Withdrawal by Subject|1|||
143147158|NCT00831844|516083620|FG009|Overall Study|Withdrawal by Subject|0|||
143147159|NCT00831844|516083611|FG000|Overall Study|Ineligible|0|||
143147160|NCT00831844|516083612|FG001|Overall Study|Ineligible|1|||
143147161|NCT00831844|516083613|FG002|Overall Study|Ineligible|1|||
143147162|NCT00831844|516083614|FG003|Overall Study|Ineligible|0|||
143147163|NCT00831844|516083615|FG004|Overall Study|Ineligible|1|||
143147164|NCT00831844|516083616|FG005|Overall Study|Ineligible|0|||
143147165|NCT00831844|516083617|FG006|Overall Study|Ineligible|0|||
143147166|NCT00831844|516083618|FG007|Overall Study|Ineligible|0|||
143147167|NCT00831844|516083619|FG008|Overall Study|Ineligible|0|||
143147168|NCT00831844|516083620|FG009|Overall Study|Ineligible|0|||
143147169|NCT01299909|516083623|FG000|Overall Study|Lost to Follow-up|22|||
143147170|NCT01299909|516083624|FG001|Overall Study|Lost to Follow-up|18|||
143147171|NCT01299909|516083625|FG002|Overall Study|Lost to Follow-up|17|||
143147172|NCT01192178|516083626|FG000|Overall Study|Withdrawal by Subject|6|||
143147173|NCT01192178|516083627|FG001|Overall Study|Withdrawal by Subject|10|||
143147174|NCT01192178|516083626|FG000|Overall Study|Protocol Violation|10|||
143147175|NCT01192178|516083627|FG001|Overall Study|Protocol Violation|3|||
143147176|NCT01192178|516083626|FG000|Overall Study|Physician Decision|2|||
143147177|NCT01192178|516083627|FG001|Overall Study|Physician Decision|4|||
143147178|NCT01192178|516083626|FG000|Overall Study|Lost to Follow-up|3|||
143147179|NCT01192178|516083627|FG001|Overall Study|Lost to Follow-up|3|||
143147180|NCT01192178|516083626|FG000|Overall Study|Adverse Event|2|||
143147181|NCT01192178|516083627|FG001|Overall Study|Adverse Event|1|||
143147182|NCT01192178|516083626|FG000|Overall Study|Lack of Efficacy|1|||
143147183|NCT01192178|516083627|FG001|Overall Study|Lack of Efficacy|2|||
143147184|NCT02460289|516083628|FG000|Overall Study|Adverse Event|1|||
143147185|NCT02460289|516083628|FG000|Overall Study|Withdrawal by Subject|8|||
143147186|NCT02460289|516083628|FG000|Overall Study|Lost to Follow-up|1|||
143147187|NCT01155570|516083629|FG000|Overall Study|Adverse Event|39|||
143147188|NCT01155570|516083629|FG000|Overall Study|Lack of Efficacy|46|||
143147189|NCT01155570|516083629|FG000|Overall Study|Participant's Economic Reasons|17|||
143147190|NCT01155570|516083629|FG000|Overall Study|No Hospital Visits|7|||
143147191|NCT01155570|516083629|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
143147192|NCT01155570|516083629|FG000|Overall Study|Adverse Event + Other Reasons|7|||
143147193|NCT01155570|516083629|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
143147194|NCT01155570|516083629|FG000|Overall Study|Other Reasons|23|||
143147195|NCT02164916|516083630|FG000|Overall Study|Adverse Event|3|||
143147196|NCT02164916|516083631|FG001|Overall Study|Adverse Event|8|||
143147197|NCT02164916|516083630|FG000|Overall Study|Death|1|||
143147198|NCT02164916|516083631|FG001|Overall Study|Death|1|||
143147199|NCT02164916|516083630|FG000|Overall Study|Refusal unrelated to adverse event|3|||
143147200|NCT02164916|516083631|FG001|Overall Study|Refusal unrelated to adverse event|7|||
143147201|NCT02164916|516083630|FG000|Overall Study|Progression|37|||
143147202|NCT02164916|516083631|FG001|Overall Study|Progression|26|||
143147203|NCT02164916|516083630|FG000|Overall Study|Not protocol specified|5|||
143147204|NCT02164916|516083631|FG001|Overall Study|Not protocol specified|1|||
143147205|NCT02164916|516083630|FG000|Overall Study|Reason under review|1|||
143147206|NCT02164916|516083631|FG001|Overall Study|Reason under review|6|||
143147207|NCT02164916|516083630|FG000|Overall Study|Not eligible|2|||
143147208|NCT02164916|516083631|FG001|Overall Study|Not eligible|5|||
143479982|NCT01987960|517302307|FG000|Period 1|Adverse Event|24|||
143479983|NCT01987960|517302308|FG001|Period 1|Adverse Event|0|||
143479984|NCT01987960|517302309|FG002|Period 1|Adverse Event|0|||
143479985|NCT01987960|517302310|FG003|Period 1|Adverse Event|0|||
143479986|NCT01987960|517302307|FG000|Period 1|Lack of Efficacy|4|||
143479987|NCT01987960|517302308|FG001|Period 1|Lack of Efficacy|0|||
143479988|NCT01987960|517302309|FG002|Period 1|Lack of Efficacy|0|||
143479989|NCT01987960|517302310|FG003|Period 1|Lack of Efficacy|0|||
143479990|NCT01987960|517302307|FG000|Period 1|Non-compliance with IMP|6|||
143479991|NCT01987960|517302308|FG001|Period 1|Non-compliance with IMP|0|||
143479992|NCT01987960|517302309|FG002|Period 1|Non-compliance with IMP|0|||
143479993|NCT01987960|517302310|FG003|Period 1|Non-compliance with IMP|0|||
143479994|NCT01987960|517302307|FG000|Period 1|Protocol Violation|12|||
143147209|NCT00964782|516083635|FG000|Overall Study|Lost to Follow-up|1|||
143147210|NCT00964782|516083636|FG001|Overall Study|Lost to Follow-up|0|||
143147211|NCT01143324|516083642|FG000|Overall Study|Lost to Follow-up|11|||
143147212|NCT01143324|516083642|FG000|Overall Study|Withdrawal by Subject|4|||
143147213|NCT01143324|516083642|FG000|Overall Study|Explant of the device|4|||
143147214|NCT00770809|516086139|FG000|Overall Study|Adverse Event|9|||
143147215|NCT00770809|516086140|FG001|Overall Study|Adverse Event|1|||
143147216|NCT00770809|516086141|FG002|Overall Study|Adverse Event|12|||
143147217|NCT00770809|516086139|FG000|Overall Study|Death|1|||
143147218|NCT00770809|516086140|FG001|Overall Study|Death|0|||
143147219|NCT00770809|516086141|FG002|Overall Study|Death|0|||
143147220|NCT00770809|516086139|FG000|Overall Study|Withdrawal by Subject|3|||
143147221|NCT00770809|516086140|FG001|Overall Study|Withdrawal by Subject|3|||
143147222|NCT00770809|516086141|FG002|Overall Study|Withdrawal by Subject|7|||
143147223|NCT00770809|516086139|FG000|Overall Study|Progression|2|||
143147224|NCT00770809|516086140|FG001|Overall Study|Progression|2|||
143147225|NCT00770809|516086141|FG002|Overall Study|Progression|0|||
143147226|NCT00770809|516086139|FG000|Overall Study|Complicating illness|0|||
143147227|NCT00770809|516086140|FG001|Overall Study|Complicating illness|0|||
143147228|NCT00770809|516086141|FG002|Overall Study|Complicating illness|1|||
143147229|NCT00770809|516086139|FG000|Overall Study|Other Medical Reasons|2|||
143147230|NCT00770809|516086140|FG001|Overall Study|Other Medical Reasons|4|||
143147231|NCT00770809|516086141|FG002|Overall Study|Other Medical Reasons|3|||
143147232|NCT00690898|516086142|FG000|SCREENING|Screen failure|18|||
143147233|NCT00690898|516086142|FG000|TREATMENT|Adverse Event|3|||
143147234|NCT00690898|516086142|FG000|TREATMENT|Lack of Efficacy|18|||
143147235|NCT00690898|516086142|FG000|TREATMENT|Withdrawal by Subject|4|||
143147236|NCT00690898|516086142|FG000|TREATMENT|Other (not otherwise specified)|1|||
143147237|NCT05977868|516086143|FG000|Overall Study|Withdrawal by Subject|1|||
143147238|NCT05977868|516086144|FG001|Overall Study|Withdrawal by Subject|2|||
143147239|NCT05977868|516086143|FG000|Overall Study|Transitioned to comfort care|1|||
143147240|NCT05977868|516086144|FG001|Overall Study|Transitioned to comfort care|0|||
143147241|NCT01136954|516086149|FG000|Overall Study|Adverse Event|3|||
143147242|NCT01136954|516086150|FG001|Overall Study|Adverse Event|2|||
143147243|NCT01136954|516086149|FG000|Overall Study|Withdrawal by Subject|6|||
143147244|NCT01136954|516086150|FG001|Overall Study|Withdrawal by Subject|2|||
143147245|NCT01136954|516086149|FG000|Overall Study|Lack of Efficacy|14|||
143147246|NCT01136954|516086150|FG001|Overall Study|Lack of Efficacy|13|||
143147247|NCT01136954|516086149|FG000|Overall Study|Physician Decision|0|||
143147248|NCT01136954|516086150|FG001|Overall Study|Physician Decision|1|||
143147249|NCT01136954|516086149|FG000|Overall Study|Other|1|||
143147250|NCT01136954|516086150|FG001|Overall Study|Other|3|||
143147251|NCT00764517|516086153|FG000|Overall Study|Adverse Event|9|||
143147252|NCT00764517|516086154|FG001|Overall Study|Adverse Event|3|||
143147253|NCT00764517|516086153|FG000|Overall Study|Death|3|||
143147254|NCT00764517|516086154|FG001|Overall Study|Death|11|||
143147255|NCT00764517|516086153|FG000|Overall Study|Physician Decision|3|||
143147256|NCT00764517|516086154|FG001|Overall Study|Physician Decision|0|||
143147257|NCT00620542|516086161|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
143147258|NCT00620542|516086162|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
143147259|NCT00620542|516086163|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
143147260|NCT00620542|516086164|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
143147261|NCT00620542|516086161|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
143147262|NCT00620542|516086162|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
143479995|NCT01987960|517302308|FG001|Period 1|Protocol Violation|0|||
143479996|NCT01987960|517302309|FG002|Period 1|Protocol Violation|0|||
143479997|NCT01987960|517302310|FG003|Period 1|Protocol Violation|0|||
143147263|NCT00620542|516086163|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
143147264|NCT00620542|516086164|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
143147265|NCT00620542|516086161|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
143147266|NCT00620542|516086162|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
143147267|NCT00620542|516086163|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
143147268|NCT00620542|516086164|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
143147269|NCT00620542|516086161|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
143147270|NCT00620542|516086162|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
143479998|NCT01987960|517302307|FG000|Period 1|Withdrawal by Subject|21|||
143479999|NCT01987960|517302308|FG001|Period 1|Withdrawal by Subject|0|||
143480000|NCT01987960|517302309|FG002|Period 1|Withdrawal by Subject|0|||
143480001|NCT01987960|517302310|FG003|Period 1|Withdrawal by Subject|0|||
143480002|NCT01987960|517302307|FG000|Period 1|Lost to Follow-up|40|||
143480003|NCT01987960|517302308|FG001|Period 1|Lost to Follow-up|0|||
143480004|NCT01987960|517302309|FG002|Period 1|Lost to Follow-up|0|||
143480005|NCT01987960|517302310|FG003|Period 1|Lost to Follow-up|0|||
143480006|NCT01987960|517302307|FG000|Period 1|administrative or other reason|75|||
143480007|NCT01987960|517302308|FG001|Period 1|administrative or other reason|0|||
143480008|NCT01987960|517302309|FG002|Period 1|administrative or other reason|0|||
143480009|NCT01987960|517302310|FG003|Period 1|administrative or other reason|0|||
143480010|NCT01987960|517302307|FG000|Period 1|Withdrawal of consent before treatment|4|||
143480011|NCT01987960|517302308|FG001|Period 1|Withdrawal of consent before treatment|0|||
143480012|NCT01987960|517302309|FG002|Period 1|Withdrawal of consent before treatment|0|||
143480013|NCT01987960|517302310|FG003|Period 1|Withdrawal of consent before treatment|0|||
143480014|NCT01987960|517302307|FG000|Period 2|Adverse Event|0|||
143480015|NCT01987960|517302308|FG001|Period 2|Adverse Event|0|||
143480016|NCT01987960|517302309|FG002|Period 2|Adverse Event|1|||
143480017|NCT01987960|517302310|FG003|Period 2|Adverse Event|0|||
143480018|NCT01987960|517302307|FG000|Period 2|Withdrawal by Subject|0|||
143480019|NCT01987960|517302308|FG001|Period 2|Withdrawal by Subject|0|||
143480020|NCT01987960|517302309|FG002|Period 2|Withdrawal by Subject|1|||
143480021|NCT01987960|517302310|FG003|Period 2|Withdrawal by Subject|0|||
143480022|NCT01987960|517302307|FG000|Period 2|Administrative or other reason|0|||
143480023|NCT01987960|517302308|FG001|Period 2|Administrative or other reason|5|||
143480024|NCT01987960|517302309|FG002|Period 2|Administrative or other reason|7|||
143480025|NCT01987960|517302310|FG003|Period 2|Administrative or other reason|0|||
143480026|NCT01987960|517302307|FG000|Period 3|Adverse Event|0|||
143480027|NCT01987960|517302308|FG001|Period 3|Adverse Event|0|||
143480028|NCT01987960|517302309|FG002|Period 3|Adverse Event|0|||
143480029|NCT01987960|517302310|FG003|Period 3|Adverse Event|7|||
143480030|NCT01987960|517302307|FG000|Period 3|Non-compliance with IMP|0|||
143480031|NCT01987960|517302308|FG001|Period 3|Non-compliance with IMP|0|||
143480032|NCT01987960|517302309|FG002|Period 3|Non-compliance with IMP|0|||
143480033|NCT01987960|517302310|FG003|Period 3|Non-compliance with IMP|1|||
143480034|NCT01987960|517302307|FG000|Period 3|Protocol Violation|0|||
143480035|NCT01987960|517302308|FG001|Period 3|Protocol Violation|0|||
143480036|NCT01987960|517302309|FG002|Period 3|Protocol Violation|0|||
143480037|NCT01987960|517302310|FG003|Period 3|Protocol Violation|6|||
143480038|NCT01987960|517302307|FG000|Period 3|Withdrawal by Subject|0|||
143480039|NCT01987960|517302308|FG001|Period 3|Withdrawal by Subject|0|||
143480040|NCT01987960|517302309|FG002|Period 3|Withdrawal by Subject|0|||
143480041|NCT01987960|517302310|FG003|Period 3|Withdrawal by Subject|9|||
143480042|NCT01987960|517302307|FG000|Period 3|Lost to Follow-up|0|||
143480043|NCT01987960|517302308|FG001|Period 3|Lost to Follow-up|0|||
143480044|NCT01987960|517302309|FG002|Period 3|Lost to Follow-up|0|||
143480045|NCT01987960|517302310|FG003|Period 3|Lost to Follow-up|5|||
143480046|NCT01987960|517302307|FG000|Period 3|Administrative or other reason|0|||
143480047|NCT01987960|517302308|FG001|Period 3|Administrative or other reason|0|||
143480048|NCT01987960|517302309|FG002|Period 3|Administrative or other reason|0|||
143480049|NCT01987960|517302310|FG003|Period 3|Administrative or other reason|43|||
143480050|NCT01279850|517302315|FG000|Overall Study|Protocol Violation|50|||
143480051|NCT01279850|517302315|FG000|Overall Study|No Drug Administration Information|7|||
143480052|NCT01279850|517302315|FG000|Overall Study|No Visit After Treatment|34|||
143480053|NCT01131520|517302316|FG000|Overall Study|Computer problem|1|||
143480054|NCT01131520|517302317|FG001|Overall Study|Computer problem|0|||
143480055|NCT01131520|517302316|FG000|Overall Study|Counselor not available|0|||
143147271|NCT00620542|516086163|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
143147272|NCT00620542|516086164|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
143147273|NCT00620542|516086161|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
143147274|NCT00620542|516086162|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
143147275|NCT00620542|516086163|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
143147276|NCT00620542|516086164|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
143480056|NCT01131520|517302317|FG001|Overall Study|Counselor not available|3|||
143147277|NCT00620542|516086161|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
143147278|NCT00620542|516086162|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
143480057|NCT01131520|517302316|FG000|Overall Study|Subject changed history after enrollment|0|||
143480058|NCT01131520|517302317|FG001|Overall Study|Subject changed history after enrollment|1|||
143480059|NCT01436084|517302320|FG000|Overall Study|Disease Progression|2|||
143480060|NCT01436084|517302320|FG000|Overall Study|Withdrawal by Subject|1|||
143480061|NCT01436084|517302320|FG000|Overall Study|Early Closure of Study|1|||
143147279|NCT00620542|516086163|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
143147280|NCT00620542|516086164|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
143480062|NCT01744665|517302321|FG000|Monitoring Phase|Adverse Event|4|||
143480063|NCT01744665|517302321|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
143480064|NCT01744665|517302321|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
143480065|NCT01744665|517302321|FG000|Monitoring Phase|Withdrawal by Subject|5|||
143480066|NCT01744665|517302321|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
143480067|NCT01744665|517302321|FG000|Consolidation Phase|Adverse Event|2|||
143480068|NCT01744665|517302321|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
143480069|NCT01744665|517302321|FG000|Consolidation Phase|Withdrawal by Subject|4|||
143480070|NCT01744665|517302321|FG000|Consolidation Phase|Administrative problems|9|||
143480071|NCT01744665|517302321|FG000|Re-initiation Phase|Administrative problems|10|||
143480072|NCT01744665|517302321|FG000|Re-initiation Phase|Adverse Event|1|||
143480073|NCT01744665|517302321|FG000|Re-initiation Phase|No longer required treatment|1|||
143480074|NCT01744665|517302321|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
143480075|NCT00807742|517302322|FG000|Overall Study|Death|9|||
143480076|NCT00807742|517302323|FG001|Overall Study|Death|2|||
143480077|NCT00807742|517302322|FG000|Overall Study|Withdrawal by Subject|2|||
143480078|NCT00807742|517302323|FG001|Overall Study|Withdrawal by Subject|1|||
143480079|NCT00807742|517302322|FG000|Overall Study|Lost to Follow-up|35|||
143480080|NCT00807742|517302323|FG001|Overall Study|Lost to Follow-up|51|||
143480081|NCT00847145|517303486|FG000|Overall Study|AE or Death|0|||
143480082|NCT00847145|517303487|FG001|Overall Study|AE or Death|1|||
143480083|NCT00847145|517303488|FG002|Overall Study|AE or Death|1|||
143480084|NCT00847145|517303489|FG003|Overall Study|AE or Death|0|||
143480085|NCT00847145|517303490|FG004|Overall Study|AE or Death|0|||
143480086|NCT00847145|517303491|FG005|Overall Study|AE or Death|0|||
143480087|NCT00847145|517303492|FG006|Overall Study|AE or Death|0|||
143480088|NCT00847145|517303493|FG007|Overall Study|AE or Death|0|||
143480089|NCT00847145|517303486|FG000|Overall Study|Withdrawal by Subject|3|||
143480090|NCT00847145|517303487|FG001|Overall Study|Withdrawal by Subject|4|||
143480091|NCT00847145|517303488|FG002|Overall Study|Withdrawal by Subject|6|||
143480092|NCT00847145|517303489|FG003|Overall Study|Withdrawal by Subject|1|||
143480093|NCT00847145|517303490|FG004|Overall Study|Withdrawal by Subject|0|||
143480094|NCT00847145|517303491|FG005|Overall Study|Withdrawal by Subject|0|||
143147281|NCT00620542|516086161|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
143147282|NCT00620542|516086162|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
143147283|NCT00620542|516086163|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
143147284|NCT00620542|516086164|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
143147285|NCT00620542|516086161|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
143147286|NCT00620542|516086162|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
143147287|NCT00620542|516086163|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
143147288|NCT00620542|516086164|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
143147289|NCT00620542|516086161|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
143147290|NCT00620542|516086162|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
143147291|NCT00620542|516086163|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
143147292|NCT00620542|516086164|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
143147293|NCT00620542|516086161|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
143147294|NCT00620542|516086162|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
143147295|NCT00620542|516086163|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
143147296|NCT00620542|516086164|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
143147297|NCT00620542|516086161|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
143147298|NCT00620542|516086162|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
143147299|NCT00620542|516086163|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
143147300|NCT00620542|516086164|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
143147301|NCT00620542|516086161|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
143147302|NCT00620542|516086162|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
143147303|NCT00620542|516086163|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
143147304|NCT00620542|516086164|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
143147305|NCT00620542|516086161|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
143147306|NCT00620542|516086162|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
143147307|NCT00620542|516086163|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
143147308|NCT00620542|516086164|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
143147309|NCT00620542|516086161|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
143147310|NCT00620542|516086162|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
143147311|NCT00620542|516086163|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
143147312|NCT00620542|516086164|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
143147313|NCT00620542|516086161|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
143147314|NCT00620542|516086162|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
143147315|NCT00620542|516086163|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
143147316|NCT00620542|516086164|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
143147317|NCT01582451|516086168|FG000|Overall Study|Adverse Event|1|||
143147318|NCT01582451|516086169|FG001|Overall Study|Adverse Event|3|||
143147319|NCT01582451|516086168|FG000|Overall Study|Death|3|||
143480095|NCT00847145|517303492|FG006|Overall Study|Withdrawal by Subject|1|||
143480096|NCT00847145|517303493|FG007|Overall Study|Withdrawal by Subject|1|||
143480097|NCT00847145|517303486|FG000|Overall Study|Lost to Follow-up|3|||
143480098|NCT00847145|517303487|FG001|Overall Study|Lost to Follow-up|1|||
143480099|NCT00847145|517303488|FG002|Overall Study|Lost to Follow-up|1|||
143480100|NCT00847145|517303489|FG003|Overall Study|Lost to Follow-up|0|||
143480101|NCT00847145|517303490|FG004|Overall Study|Lost to Follow-up|4|||
143480102|NCT00847145|517303491|FG005|Overall Study|Lost to Follow-up|4|||
143480103|NCT00847145|517303492|FG006|Overall Study|Lost to Follow-up|8|||
143480104|NCT00847145|517303493|FG007|Overall Study|Lost to Follow-up|2|||
143480105|NCT00847145|517303486|FG000|Overall Study|Inappropriate enrollment|0|||
143480106|NCT00847145|517303487|FG001|Overall Study|Inappropriate enrollment|0|||
143480107|NCT00847145|517303488|FG002|Overall Study|Inappropriate enrollment|0|||
143480108|NCT00847145|517303489|FG003|Overall Study|Inappropriate enrollment|0|||
143147320|NCT01582451|516086169|FG001|Overall Study|Death|3|||
143147321|NCT01582451|516086168|FG000|Overall Study|Lost to Follow-up|0|||
143147322|NCT01582451|516086169|FG001|Overall Study|Lost to Follow-up|2|||
143147323|NCT01582451|516086168|FG000|Overall Study|Protocol Violation|11|||
143147324|NCT01582451|516086169|FG001|Overall Study|Protocol Violation|3|||
143147325|NCT01582451|516086168|FG000|Overall Study|Withdrawal by Subject|13|||
143147326|NCT01582451|516086169|FG001|Overall Study|Withdrawal by Subject|9|||
143147327|NCT01582451|516086168|FG000|Overall Study|Physician Decision|3|||
143147328|NCT01582451|516086169|FG001|Overall Study|Physician Decision|0|||
143147329|NCT01582451|516086168|FG000|Overall Study|Sponsor Decision|1|||
143147330|NCT01582451|516086169|FG001|Overall Study|Sponsor Decision|0|||
143147331|NCT00689936|516086170|FG000|Active Treatment Phase|Adverse Event|68|||
143147332|NCT00689936|516086171|FG001|Active Treatment Phase|Adverse Event|71|||
143147333|NCT00689936|516086172|FG002|Active Treatment Phase|Adverse Event|76|||
143363604|NCT00062868|516873800|FG020|Dose Level 1|Lost to Follow-up|1|||
143480109|NCT00847145|517303490|FG004|Overall Study|Inappropriate enrollment|1|||
143480110|NCT00847145|517303491|FG005|Overall Study|Inappropriate enrollment|0|||
143480111|NCT00847145|517303492|FG006|Overall Study|Inappropriate enrollment|0|||
143480112|NCT00847145|517303493|FG007|Overall Study|Inappropriate enrollment|0|||
143480113|NCT00847145|517303486|FG000|Overall Study|Protocol Violation|0|||
143480114|NCT00847145|517303487|FG001|Overall Study|Protocol Violation|0|||
143480115|NCT00847145|517303488|FG002|Overall Study|Protocol Violation|3|||
143480116|NCT00847145|517303489|FG003|Overall Study|Protocol Violation|0|||
143480117|NCT00847145|517303490|FG004|Overall Study|Protocol Violation|1|||
143480118|NCT00847145|517303491|FG005|Overall Study|Protocol Violation|0|||
143480119|NCT00847145|517303492|FG006|Overall Study|Protocol Violation|0|||
143480120|NCT00847145|517303493|FG007|Overall Study|Protocol Violation|1|||
143480121|NCT04419610|517303500|FG000|Overall Study|Withdrawal by Subject|3|||
143480122|NCT04419610|517303501|FG001|Overall Study|Withdrawal by Subject|1|||
143480123|NCT04419610|517303500|FG000|Overall Study|Adverse Event|1|||
143480124|NCT04419610|517303501|FG001|Overall Study|Adverse Event|0|||
143480125|NCT04419610|517303500|FG000|Overall Study|discharged early|1|||
143480126|NCT04419610|517303501|FG001|Overall Study|discharged early|1|||
143480127|NCT01439282|517303502|FG000|Overall Study|Adverse Event|5|||
143480128|NCT01439282|517303503|FG001|Overall Study|Adverse Event|0|||
143480129|NCT01439282|517303502|FG000|Overall Study|Withdrawal by Subject|2|||
143480130|NCT01439282|517303503|FG001|Overall Study|Withdrawal by Subject|0|||
143480131|NCT01439282|517303502|FG000|Overall Study|Other|1|||
143480132|NCT01439282|517303503|FG001|Overall Study|Other|1|||
143480133|NCT00346073|517303504|FG000|Overall Study|Serious Adverse Event|2|||
143480134|NCT00346073|517303505|FG001|Overall Study|Serious Adverse Event|0|||
143480135|NCT00346073|517303504|FG000|Overall Study|Lost to Follow-up|39|||
143480136|NCT00346073|517303505|FG001|Overall Study|Lost to Follow-up|24|||
143480137|NCT02603120|517303506|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
143480138|NCT02603120|517303507|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
143480139|NCT02603120|517303506|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
143480140|NCT02603120|517303507|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
143480141|NCT02603120|517303506|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
143480142|NCT02603120|517303507|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
143480143|NCT02603120|517303506|FG000|Double-Blind Treatment Phase|Death|2|||
143480144|NCT02603120|517303507|FG001|Double-Blind Treatment Phase|Death|0|||
143480145|NCT02603120|517303506|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
143480146|NCT02603120|517303507|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
143480147|NCT02603120|517303506|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
143480148|NCT02603120|517303507|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
143480149|NCT02603120|517303506|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
143480150|NCT02603120|517303507|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
143480151|NCT02603120|517303506|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
143480152|NCT02603120|517303507|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
143480153|NCT02603120|517303506|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
143480154|NCT02603120|517303507|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
143480155|NCT02603120|517303506|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
143480156|NCT02603120|517303507|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
143480157|NCT02603120|517303506|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
143147334|NCT00689936|516086170|FG000|Active Treatment Phase|Disease Progression|273|||
143147335|NCT00689936|516086171|FG001|Active Treatment Phase|Disease Progression|362|||
143147336|NCT00689936|516086172|FG002|Active Treatment Phase|Disease Progression|339|||
143480158|NCT02603120|517303507|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
143480159|NCT02603120|517303506|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
143480160|NCT02603120|517303507|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
143480161|NCT02603120|517303506|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
143480162|NCT02603120|517303507|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
143480163|NCT02603120|517303506|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
143480164|NCT02603120|517303507|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
143480165|NCT01469182|517303510|FG000|Overall Study|Adverse Event|21|||
143480166|NCT01469182|517303511|FG001|Overall Study|Adverse Event|3|||
143480167|NCT01469182|517303510|FG000|Overall Study|Lost to Follow-up|3|||
143480168|NCT01469182|517303511|FG001|Overall Study|Lost to Follow-up|0|||
143480169|NCT01469182|517303510|FG000|Overall Study|Withdrawal by Subject|4|||
143480170|NCT01469182|517303511|FG001|Overall Study|Withdrawal by Subject|1|||
143480171|NCT01469182|517303510|FG000|Overall Study|Protocol Violation|4|||
143480172|NCT01469182|517303511|FG001|Overall Study|Protocol Violation|2|||
143480173|NCT01469182|517303510|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
143480174|NCT01469182|517303511|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
143480175|NCT01227187|517303514|FG000|Overall Study|Physician Decision|0|||
143480176|NCT01227187|517303515|FG001|Overall Study|Physician Decision|0|||
143480177|NCT01227187|517303516|FG002|Overall Study|Physician Decision|0|||
143480178|NCT01227187|517303517|FG003|Overall Study|Physician Decision|1|||
143147337|NCT00689936|516086170|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
143147338|NCT00689936|516086171|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
143147339|NCT00689936|516086172|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
143147340|NCT00689936|516086170|FG000|Active Treatment Phase|Death|60|||
143147341|NCT00689936|516086171|FG001|Active Treatment Phase|Death|28|||
143147342|NCT00689936|516086172|FG002|Active Treatment Phase|Death|37|||
143147343|NCT00689936|516086170|FG000|Active Treatment Phase|Lost to Follow-up|0|||
143147344|NCT00689936|516086171|FG001|Active Treatment Phase|Lost to Follow-up|2|||
143147345|NCT00689936|516086172|FG002|Active Treatment Phase|Lost to Follow-up|2|||
143147346|NCT00689936|516086170|FG000|Active Treatment Phase|Protocol Violation|2|||
143147347|NCT00689936|516086171|FG001|Active Treatment Phase|Protocol Violation|2|||
143147348|NCT00689936|516086172|FG002|Active Treatment Phase|Protocol Violation|4|||
143147349|NCT00689936|516086170|FG000|Active Treatment Phase|Study Close Out|64|||
143147350|NCT00689936|516086171|FG001|Active Treatment Phase|Study Close Out|26|||
143147351|NCT00689936|516086172|FG002|Active Treatment Phase|Study Close Out|21|||
143147352|NCT00689936|516086170|FG000|Active Treatment Phase|Miscellaneous|52|||
143147353|NCT00689936|516086171|FG001|Active Treatment Phase|Miscellaneous|34|||
143147354|NCT00689936|516086172|FG002|Active Treatment Phase|Miscellaneous|47|||
143147355|NCT00689936|516086170|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
143147356|NCT00689936|516086171|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
143147357|NCT00689936|516086172|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
143147358|NCT01995201|516086177|FG000|From Baseline Until Week 24|Adverse Event|4|||
143147359|NCT01995201|516086178|FG001|From Baseline Until Week 24|Adverse Event|15|||
143147360|NCT01995201|516086179|FG002|From Baseline Until Week 24|Adverse Event|0|||
143147361|NCT01995201|516086180|FG003|From Baseline Until Week 24|Adverse Event|0|||
143147362|NCT01995201|516086181|FG004|From Baseline Until Week 24|Adverse Event|0|||
143147363|NCT01995201|516086182|FG005|From Baseline Until Week 24|Adverse Event|0|||
143147364|NCT01995201|516086183|FG006|From Baseline Until Week 24|Adverse Event|0|||
143147365|NCT01995201|516086177|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
143147366|NCT01995201|516086178|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
143147367|NCT01995201|516086179|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
143147368|NCT01995201|516086180|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
143147369|NCT01995201|516086181|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
143147370|NCT01995201|516086182|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
143147371|NCT01995201|516086183|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
143147372|NCT01995201|516086177|FG000|From Baseline Until Week 24|Death|0|||
143147373|NCT01995201|516086178|FG001|From Baseline Until Week 24|Death|1|||
143147374|NCT01995201|516086179|FG002|From Baseline Until Week 24|Death|0|||
143147375|NCT01995201|516086180|FG003|From Baseline Until Week 24|Death|0|||
143147376|NCT01995201|516086181|FG004|From Baseline Until Week 24|Death|0|||
143147377|NCT01995201|516086182|FG005|From Baseline Until Week 24|Death|0|||
143147378|NCT01995201|516086183|FG006|From Baseline Until Week 24|Death|0|||
143147379|NCT01995201|516086177|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
143480179|NCT00840086|517303518|FG000|Overall Study|Adverse Event|1|||
143480180|NCT00840086|517303518|FG000|Overall Study|Protocol Violation|2|||
143147380|NCT01995201|516086178|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
143147381|NCT01995201|516086179|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
143480181|NCT00840086|517303518|FG000|Overall Study|Lost to Follow-up|1|||
143147382|NCT01995201|516086180|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
143480182|NCT03332498|517303519|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
143480183|NCT03332498|517303520|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
143480184|NCT03332498|517303521|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
143480185|NCT02349048|517303522|FG000|Overall Study|Withdrawal by Subject|4|||
143480186|NCT02349048|517303523|FG001|Overall Study|Withdrawal by Subject|0|||
143480187|NCT02349048|517303522|FG000|Overall Study|Lost to Follow-up|1|||
143480188|NCT02349048|517303523|FG001|Overall Study|Lost to Follow-up|0|||
143480189|NCT04206605|517303532|FG000|Overall Study|Adverse Event|0|||
143480190|NCT04206605|517303533|FG001|Overall Study|Adverse Event|1|||
143480191|NCT04206605|517303532|FG000|Overall Study|Withdrawal by Subject|1|||
143480192|NCT04206605|517303533|FG001|Overall Study|Withdrawal by Subject|0|||
143480193|NCT00827606|517303534|FG000|Overall Study|Protocol Violation|4|||
143480194|NCT00827606|517303535|FG001|Overall Study|Protocol Violation|3|||
143480195|NCT00827606|517303534|FG000|Overall Study|Lost to Follow-up|3|||
143480196|NCT00827606|517303535|FG001|Overall Study|Lost to Follow-up|1|||
143480197|NCT00827606|517303534|FG000|Overall Study|Withdrawal by Subject|7|||
143480198|NCT00827606|517303535|FG001|Overall Study|Withdrawal by Subject|6|||
143480199|NCT00827606|517303534|FG000|Overall Study|Pregnancy|0|||
143480200|NCT00827606|517303535|FG001|Overall Study|Pregnancy|1|||
143480201|NCT00827606|517303534|FG000|Overall Study|Other|5|||
143480202|NCT00827606|517303535|FG001|Overall Study|Other|13|||
143480203|NCT00827606|517303534|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
143480204|NCT00827606|517303535|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
143480205|NCT00827606|517303534|FG000|Overall Study|Adverse Event|4|||
143480206|NCT00827606|517303535|FG001|Overall Study|Adverse Event|2|||
143480207|NCT00942175|517303536|FG000|Overall Study|Adverse Event|2|||
143480208|NCT00942175|517303537|FG001|Overall Study|Adverse Event|1|||
143480209|NCT00942175|517303538|FG002|Overall Study|Adverse Event|0|||
143480210|NCT00942175|517303539|FG003|Overall Study|Adverse Event|0|||
143480211|NCT00942175|517303536|FG000|Overall Study|Protocol Violation|0|||
143480212|NCT00942175|517303537|FG001|Overall Study|Protocol Violation|1|||
143480213|NCT00942175|517303538|FG002|Overall Study|Protocol Violation|2|||
143480214|NCT00942175|517303539|FG003|Overall Study|Protocol Violation|0|||
143480215|NCT00942175|517303536|FG000|Overall Study|Pregnancy|0|||
143480216|NCT00942175|517303537|FG001|Overall Study|Pregnancy|0|||
143480217|NCT00942175|517303538|FG002|Overall Study|Pregnancy|0|||
143480218|NCT00942175|517303539|FG003|Overall Study|Pregnancy|1|||
143480219|NCT00942175|517303536|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
143480220|NCT00942175|517303537|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
143480221|NCT00942175|517303538|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
143480222|NCT00942175|517303539|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
143480223|NCT00942175|517303536|FG000|Overall Study|Low Platelet Count|0|||
143480224|NCT00942175|517303537|FG001|Overall Study|Low Platelet Count|2|||
143480225|NCT00942175|517303538|FG002|Overall Study|Low Platelet Count|0|||
143480226|NCT00942175|517303539|FG003|Overall Study|Low Platelet Count|0|||
143480227|NCT01066585|517303540|FG000|Overall Study|Protocol Violation|1|||
143480228|NCT01066585|517303541|FG001|Overall Study|Protocol Violation|0|||
143480229|NCT01066585|517303540|FG000|Overall Study|Withdrawal by Subject|0|||
143480230|NCT01066585|517303541|FG001|Overall Study|Withdrawal by Subject|3|||
143480231|NCT00884273|517303544|FG000|Overall Study|Adverse Event|0|||
143480232|NCT00884273|517303545|FG001|Overall Study|Adverse Event|2|||
143480233|NCT00884273|517303544|FG000|Overall Study|Protocol Violation|1|||
143480234|NCT00884273|517303545|FG001|Overall Study|Protocol Violation|3|||
143480235|NCT00884273|517303544|FG000|Overall Study|Practical reasons|1|||
143480236|NCT00884273|517303545|FG001|Overall Study|Practical reasons|0|||
143480237|NCT01940471|517303546|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
143480238|NCT01940471|517303547|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
143480239|NCT01940471|517303548|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
143480240|NCT01940471|517303549|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
143480241|NCT01940471|517303546|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
143480242|NCT01940471|517303547|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
143480243|NCT01940471|517303548|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
143480244|NCT01940471|517303549|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
143480245|NCT01940471|517303546|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
143480246|NCT01940471|517303547|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
143363605|NCT00062868|516873780|FG000|Dose Level 2|Death|0|||
143480247|NCT01940471|517303548|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
143480248|NCT01940471|517303549|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
143480249|NCT01940471|517303546|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
143480250|NCT01940471|517303547|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
143363606|NCT00062868|516873781|FG001|Dose Level 2|Death|3|||
143480251|NCT01940471|517303548|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
143480252|NCT01940471|517303549|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
143480253|NCT01940471|517303546|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
143480254|NCT01940471|517303547|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
143480255|NCT01940471|517303548|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
143480256|NCT01940471|517303549|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
143480257|NCT01940471|517303546|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
143480258|NCT01940471|517303547|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
143480259|NCT01940471|517303548|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
143147383|NCT01995201|516086181|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
143147384|NCT01995201|516086182|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
143147385|NCT01995201|516086183|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
143147386|NCT01995201|516086177|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
143147387|NCT01995201|516086178|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
143147388|NCT01995201|516086179|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
143147389|NCT01995201|516086180|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
143147390|NCT01995201|516086181|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
143147391|NCT01995201|516086182|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
143147392|NCT01995201|516086183|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
143147393|NCT01995201|516086177|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
143147394|NCT01995201|516086178|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
143147395|NCT01995201|516086179|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
143147396|NCT01995201|516086180|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
143147397|NCT01995201|516086181|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
143147398|NCT01995201|516086182|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
143147399|NCT01995201|516086183|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
143147400|NCT01995201|516086177|FG000|From Baseline Until Week 24|Physician Decision|0|||
143147401|NCT01995201|516086178|FG001|From Baseline Until Week 24|Physician Decision|2|||
143147402|NCT01995201|516086179|FG002|From Baseline Until Week 24|Physician Decision|0|||
143147403|NCT01995201|516086180|FG003|From Baseline Until Week 24|Physician Decision|0|||
143147404|NCT01995201|516086181|FG004|From Baseline Until Week 24|Physician Decision|0|||
143147405|NCT01995201|516086182|FG005|From Baseline Until Week 24|Physician Decision|0|||
143147406|NCT01995201|516086183|FG006|From Baseline Until Week 24|Physician Decision|0|||
143147407|NCT01995201|516086177|FG000|From Baseline Until Week 24|Protocol Violation|0|||
143147408|NCT01995201|516086178|FG001|From Baseline Until Week 24|Protocol Violation|9|||
143147409|NCT01995201|516086179|FG002|From Baseline Until Week 24|Protocol Violation|0|||
143147410|NCT01995201|516086180|FG003|From Baseline Until Week 24|Protocol Violation|0|||
143147411|NCT01995201|516086181|FG004|From Baseline Until Week 24|Protocol Violation|0|||
143147412|NCT01995201|516086182|FG005|From Baseline Until Week 24|Protocol Violation|0|||
143147413|NCT01995201|516086183|FG006|From Baseline Until Week 24|Protocol Violation|0|||
143147414|NCT01995201|516086177|FG000|From Week 24 Until Week 48|Adverse Event|0|||
143147415|NCT01995201|516086178|FG001|From Week 24 Until Week 48|Adverse Event|0|||
143147416|NCT01995201|516086179|FG002|From Week 24 Until Week 48|Adverse Event|2|||
143147417|NCT01995201|516086180|FG003|From Week 24 Until Week 48|Adverse Event|1|||
143147418|NCT01995201|516086181|FG004|From Week 24 Until Week 48|Adverse Event|1|||
143147419|NCT01995201|516086182|FG005|From Week 24 Until Week 48|Adverse Event|3|||
143147420|NCT01995201|516086183|FG006|From Week 24 Until Week 48|Adverse Event|1|||
143147421|NCT01995201|516086177|FG000|From Week 24 Until Week 48|Death|0|||
143147422|NCT01995201|516086178|FG001|From Week 24 Until Week 48|Death|0|||
143147423|NCT01995201|516086179|FG002|From Week 24 Until Week 48|Death|0|||
143147424|NCT01995201|516086180|FG003|From Week 24 Until Week 48|Death|0|||
143147425|NCT01995201|516086181|FG004|From Week 24 Until Week 48|Death|0|||
143147426|NCT01995201|516086182|FG005|From Week 24 Until Week 48|Death|2|||
143147427|NCT01995201|516086183|FG006|From Week 24 Until Week 48|Death|0|||
143147428|NCT01995201|516086177|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
143147429|NCT01995201|516086178|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
143147430|NCT01995201|516086179|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
143147431|NCT01995201|516086180|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
143147432|NCT01995201|516086181|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
143147433|NCT01995201|516086182|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
143147434|NCT01995201|516086183|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
143147435|NCT01995201|516086177|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
143147436|NCT01995201|516086178|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
143147437|NCT01995201|516086179|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
143147438|NCT01995201|516086180|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
143147439|NCT01995201|516086181|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
143147440|NCT01995201|516086182|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
143147441|NCT01995201|516086183|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
143147442|NCT01995201|516086177|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
143147443|NCT01995201|516086178|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
143147444|NCT01995201|516086179|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
143147445|NCT01995201|516086180|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
143147446|NCT01995201|516086181|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
143147447|NCT01995201|516086182|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
143147448|NCT01995201|516086183|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
143147449|NCT01995201|516086177|FG000|From Week 24 Until Week 48|Physician Decision|0|||
143363607|NCT00062868|516873782|FG002|Dose Level 2|Death|0|||
143480260|NCT01940471|517303549|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
143480261|NCT01940471|517303546|FG000|Period 1: Double-blind Phase|Death|2|||
143480262|NCT01940471|517303547|FG001|Period 1: Double-blind Phase|Death|1|||
143480263|NCT01940471|517303548|FG002|Period 1: Double-blind Phase|Death|0|||
143480264|NCT01940471|517303549|FG003|Period 1: Double-blind Phase|Death|0|||
143480265|NCT01940471|517303546|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
143480266|NCT01940471|517303547|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
143480267|NCT01940471|517303548|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
143480268|NCT01940471|517303549|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
143480269|NCT01940471|517303546|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
143480270|NCT01940471|517303547|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
143480271|NCT01940471|517303548|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
143480272|NCT01940471|517303549|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
143480273|NCT01940471|517303546|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
143480274|NCT01940471|517303547|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
143480275|NCT01940471|517303548|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
143480276|NCT01940471|517303549|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
143480277|NCT01940471|517303546|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
143480278|NCT01940471|517303547|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
143480279|NCT01940471|517303548|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
143480280|NCT01940471|517303549|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
143480281|NCT01940471|517303546|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
143480282|NCT01940471|517303547|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
143480283|NCT01940471|517303548|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
143480284|NCT01940471|517303549|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
143480285|NCT01940471|517303546|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
143480286|NCT01940471|517303547|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
143480287|NCT01940471|517303548|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
143480288|NCT01940471|517303549|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
143480289|NCT01940471|517303546|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
143480290|NCT01940471|517303547|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
143480291|NCT01940471|517303548|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
143480292|NCT01940471|517303549|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
143480293|NCT01940471|517303546|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
143480294|NCT01940471|517303547|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
143480295|NCT01940471|517303548|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
143480296|NCT01940471|517303549|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
143480297|NCT01940471|517303546|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
143480298|NCT01940471|517303547|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
143480299|NCT01940471|517303548|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
143480300|NCT01940471|517303549|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
143480301|NCT01940471|517303546|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
143480302|NCT01940471|517303547|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
143480303|NCT01940471|517303548|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
143480304|NCT01940471|517303549|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
143480305|NCT01940471|517303546|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
143480306|NCT01940471|517303547|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
143480307|NCT01940471|517303548|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
143480308|NCT01940471|517303549|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
143480309|NCT01940471|517303546|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
143480310|NCT01940471|517303547|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
143480311|NCT01940471|517303548|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
143480312|NCT01940471|517303549|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
143480313|NCT01940471|517303546|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
143480314|NCT01940471|517303547|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
143480315|NCT01940471|517303548|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
143480316|NCT01940471|517303549|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
143480317|NCT01940471|517303546|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
143480318|NCT01940471|517303547|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
143480319|NCT01940471|517303548|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
143480320|NCT01940471|517303549|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
143480321|NCT00258674|517303550|FG000|Overall Study|Death|32|||
143480322|NCT00258674|517303551|FG001|Overall Study|Death|53|||
143480323|NCT00258674|517303552|FG002|Overall Study|Death|34|||
143480324|NCT03715153|517303553|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
143480325|NCT03715153|517303554|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
143480326|NCT03715153|517303553|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
143480327|NCT03715153|517303554|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
143480328|NCT03715153|517303553|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
143480329|NCT03715153|517303554|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
143480330|NCT03715153|517303553|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
143480331|NCT03715153|517303554|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
143480332|NCT03715153|517303553|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
143480333|NCT03715153|517303554|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
143480334|NCT03715153|517303553|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
143480335|NCT03715153|517303554|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
143480336|NCT02973087|517303557|FG000|Overall Study|Withdrawal by Subject|2|||
143480337|NCT02973087|517303558|FG001|Overall Study|Withdrawal by Subject|1|||
143480338|NCT02973087|517303557|FG000|Overall Study|Adverse Event|1|||
143480339|NCT02973087|517303558|FG001|Overall Study|Adverse Event|0|||
143480340|NCT02973087|517303557|FG000|Overall Study|other|1|||
143480341|NCT02973087|517303558|FG001|Overall Study|other|1|||
143480342|NCT02090413|517303562|FG000|Overall Study|Adverse Event|11|||
143480343|NCT02090413|517303563|FG001|Overall Study|Adverse Event|15|||
143480344|NCT02090413|517303564|FG002|Overall Study|Adverse Event|20|||
143480345|NCT02090413|517303562|FG000|Overall Study|Flushing event|2|||
143480346|NCT02090413|517303563|FG001|Overall Study|Flushing event|0|||
143480347|NCT02090413|517303564|FG002|Overall Study|Flushing event|1|||
143480348|NCT02090413|517303562|FG000|Overall Study|Withdrawal by Subject|2|||
143480349|NCT02090413|517303563|FG001|Overall Study|Withdrawal by Subject|2|||
143480350|NCT02090413|517303564|FG002|Overall Study|Withdrawal by Subject|2|||
143480351|NCT02090413|517303562|FG000|Overall Study|Investigator Decision|1|||
143480352|NCT02090413|517303563|FG001|Overall Study|Investigator Decision|1|||
143480353|NCT02090413|517303564|FG002|Overall Study|Investigator Decision|0|||
143480354|NCT02090413|517303562|FG000|Overall Study|Other|2|||
143480355|NCT02090413|517303563|FG001|Overall Study|Other|1|||
143480356|NCT02090413|517303564|FG002|Overall Study|Other|0|||
143480357|NCT02090413|517303562|FG000|Overall Study|Lost to Follow-up|1|||
143480358|NCT02090413|517303563|FG001|Overall Study|Lost to Follow-up|1|||
143480359|NCT02090413|517303564|FG002|Overall Study|Lost to Follow-up|0|||
143480360|NCT05419128|517303565|FG000|Overall Study|Withdrawal by Subject|1|||
143480361|NCT05419128|517303566|FG001|Overall Study|Withdrawal by Subject|1|||
143480362|NCT05419128|517303567|FG002|Overall Study|Withdrawal by Subject|0|||
143480363|NCT05419128|517303568|FG003|Overall Study|Withdrawal by Subject|1|||
143480364|NCT05419128|517303569|FG004|Overall Study|Withdrawal by Subject|1|||
143480365|NCT05419128|517303570|FG005|Overall Study|Withdrawal by Subject|0|||
143480366|NCT05419128|517303565|FG000|Overall Study|Lost to Follow-up|0|||
143480367|NCT05419128|517303566|FG001|Overall Study|Lost to Follow-up|0|||
143480368|NCT05419128|517303567|FG002|Overall Study|Lost to Follow-up|1|||
143480369|NCT05419128|517303568|FG003|Overall Study|Lost to Follow-up|0|||
143480370|NCT05419128|517303569|FG004|Overall Study|Lost to Follow-up|0|||
143480371|NCT05419128|517303570|FG005|Overall Study|Lost to Follow-up|1|||
143480372|NCT03834519|517303571|FG000|Overall Study|Lost to Follow-up|2|||
143480373|NCT03834519|517303572|FG001|Overall Study|Lost to Follow-up|1|||
143480374|NCT03834519|517303571|FG000|Overall Study|Withdrawal by Subject|5|||
143480375|NCT03834519|517303572|FG001|Overall Study|Withdrawal by Subject|8|||
143480376|NCT03834519|517303571|FG000|Overall Study|Death|368|||
143480377|NCT03834519|517303572|FG001|Overall Study|Death|174|||
143480378|NCT03834519|517303571|FG000|Overall Study|Physician Decision|5|||
143480379|NCT03834519|517303572|FG001|Overall Study|Physician Decision|1|||
143480380|NCT03834519|517303571|FG000|Overall Study|Sponsor decision|149|||
143480381|NCT03834519|517303572|FG001|Overall Study|Sponsor decision|80|||
143480382|NCT00853749|517303573|FG000|Overall Study|Lost to Follow-up|0|||
143480383|NCT00853749|517303574|FG001|Overall Study|Lost to Follow-up|1|||
143480384|NCT03996876|517303577|FG000|Overall Study|Incomplete Data|2|||
143480385|NCT03996876|517303578|FG001|Overall Study|Incomplete Data|4|||
143480386|NCT01538628|517303581|FG000|Overall Study|Withdrawal by Subject|1|||
143480387|NCT01538628|517303582|FG001|Overall Study|Withdrawal by Subject|1|||
143480388|NCT01538628|517303581|FG000|Overall Study|Lost to Follow-up|0|||
143480389|NCT01538628|517303582|FG001|Overall Study|Lost to Follow-up|1|||
143480390|NCT03080883|517303585|FG000|Overall Study|Withdrawal by Subject|11|||
143480391|NCT03080883|517303586|FG001|Overall Study|Withdrawal by Subject|15|||
143480392|NCT03080883|517303585|FG000|Overall Study|Adverse Event|22|||
143480393|NCT03080883|517303586|FG001|Overall Study|Adverse Event|22|||
143480394|NCT03080883|517303585|FG000|Overall Study|Alternative Therapy|0|||
143480395|NCT03080883|517303586|FG001|Overall Study|Alternative Therapy|3|||
143480396|NCT03080883|517303585|FG000|Overall Study|Other Complicating Disease|9|||
143480397|NCT03080883|517303586|FG001|Overall Study|Other Complicating Disease|5|||
143480398|NCT03080883|517303585|FG000|Overall Study|Death|21|||
143480399|NCT03080883|517303586|FG001|Overall Study|Death|16|||
143480400|NCT03080883|517303585|FG000|Overall Study|Physician Decision|2|||
143480401|NCT03080883|517303586|FG001|Overall Study|Physician Decision|2|||
143480402|NCT03080883|517303585|FG000|Overall Study|Disease Progression|2|||
143480403|NCT03080883|517303586|FG001|Overall Study|Disease Progression|8|||
143480404|NCT03080883|517303585|FG000|Overall Study|Lost to Follow-up|1|||
143480405|NCT03080883|517303586|FG001|Overall Study|Lost to Follow-up|1|||
143480406|NCT03703882|517305294|FG000|Overall Study|Adverse Event|1|||
143480407|NCT03703882|517305295|FG001|Overall Study|Adverse Event|0|||
143480408|NCT03703882|517305294|FG000|Overall Study|Lost to Follow-up|0|||
143480409|NCT03703882|517305295|FG001|Overall Study|Lost to Follow-up|2|||
143480410|NCT03703882|517305294|FG000|Overall Study|Non-compliance with study drug|0|||
143480411|NCT03703882|517305295|FG001|Overall Study|Non-compliance with study drug|1|||
143480412|NCT03703882|517305294|FG000|Overall Study|Physician Decision|0|||
143480413|NCT03703882|517305295|FG001|Overall Study|Physician Decision|1|||
143480414|NCT03703882|517305294|FG000|Overall Study|Progressive disease|1|||
143480415|NCT03703882|517305295|FG001|Overall Study|Progressive disease|0|||
143480416|NCT03703882|517305294|FG000|Overall Study|Withdrawal by parent/guardian|1|||
143480417|NCT03703882|517305295|FG001|Overall Study|Withdrawal by parent/guardian|0|||
143480418|NCT03703882|517305294|FG000|Overall Study|Starting another treatment|0|||
143480419|NCT03703882|517305295|FG001|Overall Study|Starting another treatment|1|||
143480420|NCT03703882|517305294|FG000|Overall Study|noncompliance with study procedures|0|||
143480421|NCT03703882|517305295|FG001|Overall Study|noncompliance with study procedures|1|||
143480422|NCT03670953|517305296|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
143480423|NCT03670953|517305297|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
143480424|NCT03670953|517305298|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
143480425|NCT03670953|517305299|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
143480426|NCT03670953|517305296|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
143480427|NCT03670953|517305297|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
143480428|NCT03670953|517305298|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
143480429|NCT03670953|517305299|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
143480430|NCT03670953|517305296|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
143480431|NCT03670953|517305297|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
143480432|NCT03670953|517305298|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
143480433|NCT03670953|517305299|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
143480434|NCT03670953|517305296|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
143147450|NCT01995201|516086178|FG001|From Week 24 Until Week 48|Physician Decision|0|||
143147451|NCT01995201|516086179|FG002|From Week 24 Until Week 48|Physician Decision|0|||
143147452|NCT01995201|516086180|FG003|From Week 24 Until Week 48|Physician Decision|0|||
143147453|NCT01995201|516086181|FG004|From Week 24 Until Week 48|Physician Decision|1|||
143147454|NCT01995201|516086182|FG005|From Week 24 Until Week 48|Physician Decision|0|||
143147455|NCT01995201|516086183|FG006|From Week 24 Until Week 48|Physician Decision|0|||
143147456|NCT01995201|516086177|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
143147457|NCT01995201|516086178|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
143147458|NCT01995201|516086179|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
143147459|NCT01995201|516086180|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
143147460|NCT01995201|516086181|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
143147461|NCT01995201|516086182|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
143147462|NCT01995201|516086183|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
143147463|NCT05376358|516086187|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
143147464|NCT05376358|516086188|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|15|||
143147465|NCT05376358|516086187|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
143147466|NCT05376358|516086188|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
143147467|NCT05376358|516086187|FG000|3 Month Timepoint Data Collection|Lost to Follow-up|3|||
143147468|NCT05376358|516086188|FG001|3 Month Timepoint Data Collection|Lost to Follow-up|5|||
143147469|NCT05376358|516086187|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|14|||
143147470|NCT05376358|516086188|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
143147471|NCT05376358|516086187|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|1|||
143147472|NCT05376358|516086188|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|5|||
143147473|NCT05376358|516086187|FG000|6 Month Timepoint Data Collection|Lost to Follow-up|8|||
143147474|NCT05376358|516086188|FG001|6 Month Timepoint Data Collection|Lost to Follow-up|6|||
143147475|NCT04225832|516086189|FG000|Overall Study|No longer eligible (e.g., seroconversion)|6|||
143147476|NCT04225832|516086190|FG001|Overall Study|No longer eligible (e.g., seroconversion)|3|||
143147477|NCT04225832|516086189|FG000|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|36|||
143147478|NCT04225832|516086190|FG001|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|5|||
143147479|NCT00311168|516086191|FG000|First Intervention|Withdrawal by Subject|2|||
143480435|NCT03670953|517305297|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
143480436|NCT03670953|517305298|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
143480437|NCT03670953|517305299|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
143480438|NCT03670953|517305296|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
143147480|NCT00311168|516086192|FG001|First Intervention|Withdrawal by Subject|2|||
143147481|NCT00311168|516086191|FG000|First Intervention|Lost to Follow-up|1|||
143147482|NCT00311168|516086192|FG001|First Intervention|Lost to Follow-up|1|||
143147483|NCT00311168|516086191|FG000|First Intervention|Protocol Violation|1|||
143147484|NCT00311168|516086192|FG001|First Intervention|Protocol Violation|1|||
143147485|NCT00311168|516086191|FG000|First Intervention|Adverse Event|1|||
143147486|NCT00311168|516086192|FG001|First Intervention|Adverse Event|0|||
143147487|NCT00311168|516086191|FG000|First Intervention|Other|2|||
143147488|NCT00311168|516086192|FG001|First Intervention|Other|2|||
143147489|NCT00311168|516086191|FG000|Second Intervention|Lost to Follow-up|9|||
143147490|NCT00311168|516086192|FG001|Second Intervention|Lost to Follow-up|2|||
143147491|NCT00311168|516086191|FG000|Second Intervention|Withdrawal by Subject|0|||
143147492|NCT00311168|516086192|FG001|Second Intervention|Withdrawal by Subject|1|||
143147493|NCT00311168|516086191|FG000|Second Intervention|Other|1|||
143147494|NCT00311168|516086192|FG001|Second Intervention|Other|1|||
143147495|NCT03323502|516086195|FG000|Overall Study|Resident could not be linked to CMS data|594|||
143147496|NCT03323502|516086196|FG001|Overall Study|Resident could not be linked to CMS data|435|||
143147497|NCT03323502|516086195|FG000|Overall Study|Resident cognitive status could not be determined from CMS data|6551|||
143147498|NCT03323502|516086196|FG001|Overall Study|Resident cognitive status could not be determined from CMS data|6426|||
143147499|NCT03323502|516086195|FG000|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|247|||
143147500|NCT03323502|516086196|FG001|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|260|||
143147501|NCT03323502|516086195|FG000|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|896|||
143147502|NCT03323502|516086196|FG001|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|573|||
143147503|NCT03323502|516086195|FG000|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8386|||
143147504|NCT03323502|516086196|FG001|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8196|||
143147505|NCT02213926|516086197|FG000|Overall Study|Death|59|||
143147506|NCT02213926|516086197|FG000|Overall Study|Withdrawal by Subject|10|||
143147507|NCT02213926|516086197|FG000|Overall Study|study terminated by sponsor|51|||
143147508|NCT02213926|516086197|FG000|Overall Study|Lost to Follow-up|3|||
143147509|NCT02213926|516086197|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
143147510|NCT03965923|516086200|FG000|Overall Study|Withdrawal by Subject|1|||
143147511|NCT03965923|516086201|FG001|Overall Study|Withdrawal by Subject|2|||
143147512|NCT03965923|516086202|FG002|Overall Study|Withdrawal by Subject|3|||
143147513|NCT03965923|516086203|FG003|Overall Study|Withdrawal by Subject|1|||
143147514|NCT03965923|516086204|FG004|Overall Study|Withdrawal by Subject|2|||
143147515|NCT03965923|516086205|FG005|Overall Study|Withdrawal by Subject|0|||
143147516|NCT03965923|516086206|FG006|Overall Study|Withdrawal by Subject|4|||
143147517|NCT03965923|516086207|FG007|Overall Study|Withdrawal by Subject|3|||
143147518|NCT03965923|516086208|FG008|Overall Study|Withdrawal by Subject|4|||
143147519|NCT03965923|516086209|FG009|Overall Study|Withdrawal by Subject|0|||
143147520|NCT03965923|516086210|FG010|Overall Study|Withdrawal by Subject|2|||
143147521|NCT03965923|516086211|FG011|Overall Study|Withdrawal by Subject|0|||
143147522|NCT03965923|516086200|FG000|Overall Study|Lost to Follow-up|2|||
143147523|NCT03965923|516086201|FG001|Overall Study|Lost to Follow-up|1|||
143147524|NCT03965923|516086202|FG002|Overall Study|Lost to Follow-up|1|||
143147525|NCT03965923|516086203|FG003|Overall Study|Lost to Follow-up|0|||
143147526|NCT03965923|516086204|FG004|Overall Study|Lost to Follow-up|2|||
143147527|NCT03965923|516086205|FG005|Overall Study|Lost to Follow-up|1|||
143147528|NCT03965923|516086206|FG006|Overall Study|Lost to Follow-up|2|||
143480439|NCT03670953|517305297|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
143480440|NCT03670953|517305298|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
143480441|NCT03670953|517305299|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
143480442|NCT03670953|517305296|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
143480443|NCT03670953|517305297|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
143480444|NCT03670953|517305298|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
143480445|NCT03670953|517305299|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
143480446|NCT03670953|517305296|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
143480447|NCT03670953|517305297|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
143480448|NCT03670953|517305298|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
143480449|NCT03670953|517305299|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
143480450|NCT03670953|517305296|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
143480451|NCT03670953|517305297|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
143480452|NCT03670953|517305298|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
143147529|NCT03965923|516086207|FG007|Overall Study|Lost to Follow-up|1|||
143147530|NCT03965923|516086208|FG008|Overall Study|Lost to Follow-up|0|||
143147531|NCT03965923|516086209|FG009|Overall Study|Lost to Follow-up|2|||
143147532|NCT03965923|516086210|FG010|Overall Study|Lost to Follow-up|0|||
143147533|NCT03965923|516086211|FG011|Overall Study|Lost to Follow-up|0|||
143147534|NCT03965923|516086200|FG000|Overall Study|Death|0|||
143147535|NCT03965923|516086201|FG001|Overall Study|Death|0|||
143147536|NCT03965923|516086202|FG002|Overall Study|Death|0|||
143480453|NCT03670953|517305299|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
143480454|NCT03670953|517305296|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
143480455|NCT03670953|517305297|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
143480456|NCT03670953|517305298|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
143480457|NCT03670953|517305299|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
143480458|NCT03670953|517305296|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
143480459|NCT03670953|517305297|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
143480460|NCT03670953|517305298|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
143480461|NCT03670953|517305299|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
143480462|NCT03670953|517305296|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
143480463|NCT03670953|517305297|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
143480464|NCT03670953|517305298|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
143480465|NCT03670953|517305299|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
143480466|NCT03670953|517305296|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
143480467|NCT03670953|517305297|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
143480468|NCT03670953|517305298|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
143480469|NCT03670953|517305299|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
143480470|NCT03670953|517305296|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
143480471|NCT03670953|517305297|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
143480472|NCT03670953|517305298|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
143480473|NCT03670953|517305299|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
143480474|NCT03670953|517305296|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
143480475|NCT03670953|517305297|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
143480476|NCT03670953|517305298|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
143480477|NCT03670953|517305299|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
143480478|NCT03670953|517305296|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
143480479|NCT03670953|517305297|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
143480480|NCT03670953|517305298|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
143480481|NCT03670953|517305299|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
143480482|NCT03670953|517305296|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
143480483|NCT03670953|517305297|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
143480484|NCT03670953|517305298|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
143480485|NCT03670953|517305299|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
143480486|NCT03670953|517305296|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
143480487|NCT03670953|517305297|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
143480488|NCT03670953|517305298|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
143480489|NCT03670953|517305299|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
143480490|NCT03670953|517305296|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
143014156|NCT00713830|515591618|FG000|Overall Study|Poor Compliance to Protocol|7|||
143014157|NCT00713830|515591619|FG001|Overall Study|Poor Compliance to Protocol|14|||
143014158|NCT00713830|515591618|FG000|Overall Study|Familial and Personal Reasons|9|||
143014159|NCT00713830|515591619|FG001|Overall Study|Familial and Personal Reasons|34|||
143014160|NCT00713830|515591618|FG000|Overall Study|Sponsor Decision|4|||
143014161|NCT00713830|515591619|FG001|Overall Study|Sponsor Decision|10|||
143014162|NCT00902265|515591624|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
143014163|NCT00902265|515591624|FG000|Overall Study|Adverse Event|2|||
143014164|NCT00902265|515591624|FG000|Overall Study|Lack of Efficacy|2|||
143014165|NCT00902265|515591624|FG000|Overall Study|Protocol Violation|1|||
143014166|NCT02866695|515591627|FG000|Overall Study|Adverse Event|1|||
143014167|NCT02866695|515591627|FG000|Overall Study|Lost to Follow-up|1|||
143014168|NCT03224234|515591628|FG000|Main Study|Lost to Follow-up|5|||
143014169|NCT03224234|515591629|FG001|Main Study|Lost to Follow-up|5|||
143014170|NCT05016765|515591630|FG000|Overall Study|Lost to Follow-up|4|||
143014171|NCT05144477|515591633|FG000|Overall Study|Withdrawal by Subject|1|||
143014172|NCT05144477|515591634|FG001|Overall Study|Withdrawal by Subject|1|||
143014173|NCT02149199|515591646|FG000|Overall Study|Study specific withdrawal criteria|4|||
143014174|NCT02149199|515591647|FG001|Overall Study|Study specific withdrawal criteria|21|||
143014175|NCT02149199|515591648|FG002|Overall Study|Study specific withdrawal criteria|6|||
143014176|NCT02149199|515591646|FG000|Overall Study|Other|20|||
143014177|NCT02149199|515591647|FG001|Overall Study|Other|25|||
143014178|NCT02149199|515591648|FG002|Overall Study|Other|20|||
143014179|NCT02149199|515591646|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
143014180|NCT02149199|515591647|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
143014181|NCT02149199|515591648|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
143014182|NCT02149199|515591646|FG000|Overall Study|Withdrawal by Subject|75|||
143014183|NCT02149199|515591647|FG001|Overall Study|Withdrawal by Subject|93|||
143014184|NCT02149199|515591648|FG002|Overall Study|Withdrawal by Subject|77|||
143014185|NCT02149199|515591646|FG000|Overall Study|Protocol Violation|16|||
143014186|NCT02149199|515591647|FG001|Overall Study|Protocol Violation|13|||
143014187|NCT02149199|515591648|FG002|Overall Study|Protocol Violation|15|||
143147537|NCT03965923|516086203|FG003|Overall Study|Death|0|||
143480491|NCT03670953|517305297|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
143480492|NCT03670953|517305298|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
143480493|NCT03670953|517305299|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
143480494|NCT02982954|517305302|FG000|Overall Study|Death|55|||
143480495|NCT02982954|517305303|FG001|Overall Study|Death|29|||
143480496|NCT02982954|517305304|FG002|Overall Study|Death|15|||
143480497|NCT02982954|517305305|FG003|Overall Study|Death|20|||
143480498|NCT02982954|517305302|FG000|Overall Study|Lost to Follow-up|2|||
143480499|NCT02982954|517305303|FG001|Overall Study|Lost to Follow-up|1|||
143480500|NCT02982954|517305304|FG002|Overall Study|Lost to Follow-up|0|||
143480501|NCT02982954|517305305|FG003|Overall Study|Lost to Follow-up|0|||
143480502|NCT02982954|517305302|FG000|Overall Study|Participant withdrew consent|7|||
143480503|NCT02982954|517305303|FG001|Overall Study|Participant withdrew consent|5|||
143480504|NCT02982954|517305304|FG002|Overall Study|Participant withdrew consent|1|||
143480505|NCT02982954|517305305|FG003|Overall Study|Participant withdrew consent|1|||
143480506|NCT02982954|517305302|FG000|Overall Study|Other reasons|42|||
143480507|NCT02982954|517305303|FG001|Overall Study|Other reasons|17|||
143480508|NCT02982954|517305304|FG002|Overall Study|Other reasons|12|||
143480509|NCT02982954|517305305|FG003|Overall Study|Other reasons|3|||
143480510|NCT02982954|517305302|FG000|Overall Study|Premature site closure|0|||
143480511|NCT02982954|517305303|FG001|Overall Study|Premature site closure|0|||
143480512|NCT02982954|517305304|FG002|Overall Study|Premature site closure|0|||
143480513|NCT02982954|517305305|FG003|Overall Study|Premature site closure|1|||
143480514|NCT00516048|517305306|FG000|Overall Study|Death|0|||
143480515|NCT00516048|517305307|FG001|Overall Study|Death|0|||
143480516|NCT00516048|517305308|FG002|Overall Study|Death|1|||
143480517|NCT00516048|517305306|FG000|Overall Study|Subject Decision|0|||
143480518|NCT00516048|517305307|FG001|Overall Study|Subject Decision|2|||
143480519|NCT00516048|517305308|FG002|Overall Study|Subject Decision|0|||
143480520|NCT02263079|517305309|FG000|Overall Study|Physician Decision|1|||
143480521|NCT02263079|517305310|FG001|Overall Study|Physician Decision|0|||
143480522|NCT02263079|517305311|FG002|Overall Study|Physician Decision|0|||
143480523|NCT02263079|517305309|FG000|Overall Study|Withdrawal by Subject|2|||
143480524|NCT02263079|517305310|FG001|Overall Study|Withdrawal by Subject|8|||
143480525|NCT02263079|517305311|FG002|Overall Study|Withdrawal by Subject|0|||
143480526|NCT02554019|517305312|FG000|Overall Study|Withdrawal by Subject|1|||
143480527|NCT02554019|517305313|FG001|Overall Study|Withdrawal by Subject|0|||
143480528|NCT02554019|517305314|FG002|Overall Study|Withdrawal by Subject|2|||
143480529|NCT02554019|517305312|FG000|Overall Study|Adverse Event|1|||
143480530|NCT02554019|517305313|FG001|Overall Study|Adverse Event|0|||
143480531|NCT02554019|517305314|FG002|Overall Study|Adverse Event|0|||
143480532|NCT02463409|517305315|FG000|Overall Study|Withdrawal by Subject|1|||
143480533|NCT02463409|517305315|FG000|Overall Study|Screen failure|1|||
143480534|NCT00916357|517305316|FG000|Period 1|Withdrawal by Subject|1|||
143480535|NCT00916357|517305317|FG001|Period 1|Withdrawal by Subject|0|||
143480536|NCT00916357|517305318|FG002|Period 1|Withdrawal by Subject|0|||
143480537|NCT00916357|517305319|FG003|Period 1|Withdrawal by Subject|0|||
143480538|NCT00916357|517305320|FG004|Period 1|Withdrawal by Subject|0|||
143480539|NCT00916357|517305321|FG005|Period 1|Withdrawal by Subject|0|||
143480540|NCT00916357|517305316|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
143480541|NCT00916357|517305317|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
143480542|NCT00916357|517305318|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
143480543|NCT00916357|517305319|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
143480544|NCT00916357|517305320|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
143480545|NCT00916357|517305321|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
143480546|NCT03577730|517305322|FG000|Overall Study|Physician Decision|3|||
143480547|NCT03577730|517305323|FG001|Overall Study|Physician Decision|1|||
143480548|NCT03577730|517305322|FG000|Overall Study|Did not receive allocated intervention|1|||
143480549|NCT03577730|517305323|FG001|Overall Study|Did not receive allocated intervention|0|||
143480550|NCT00909181|517305325|FG000|Overall Study|Lost to Follow-up|39|||
143480551|NCT00909181|517305326|FG001|Overall Study|Lost to Follow-up|18|||
143480552|NCT00909181|517305327|FG002|Overall Study|Lost to Follow-up|33|||
143480553|NCT04353284|517305328|FG000|Overall Study|Adverse Event|1|||
143480554|NCT04353284|517305329|FG001|Overall Study|Adverse Event|1|||
143480555|NCT04353284|517305328|FG000|Overall Study|Lost to Follow-up|1|||
143480556|NCT04353284|517305329|FG001|Overall Study|Lost to Follow-up|0|||
143480557|NCT02830880|517305330|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
143480558|NCT02830880|517305330|FG000|Overall Study|Death|1|||
143480559|NCT02830880|517305330|FG000|Overall Study|Physician Decision|1|||
143480560|NCT01549275|517305337|FG000|Overall Study|Lost to Follow-up|1|||
143480561|NCT01549275|517305338|FG001|Overall Study|Lost to Follow-up|0|||
143480562|NCT01040351|517305339|FG000|Overall Study|poor ovarian response|1|||
143480563|NCT01040351|517305340|FG001|Overall Study|poor ovarian response|2|||
143480564|NCT04773106|517305341|FG000|Overall Study|Withdrawal by Subject|3|||
143480565|NCT04773106|517305341|FG000|Overall Study|Death|1|||
143480566|NCT02819635|517305346|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
143480567|NCT02819635|517305347|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
143014188|NCT02149199|515591646|FG000|Overall Study|Lost to Follow-up|3|||
143480568|NCT02819635|517305348|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
143480569|NCT02819635|517305349|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
143480570|NCT02819635|517305350|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
143480571|NCT02819635|517305351|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
143480572|NCT02819635|517305352|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
143480573|NCT02819635|517305353|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
143480574|NCT02819635|517305354|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
143480575|NCT02819635|517305355|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
143480576|NCT02819635|517305356|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
143480577|NCT02819635|517305357|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
143480578|NCT02819635|517305346|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
143480579|NCT02819635|517305347|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
143480580|NCT02819635|517305348|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
143480581|NCT02819635|517305349|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
143480582|NCT02819635|517305350|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
143480583|NCT02819635|517305351|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
143480584|NCT02819635|517305352|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
143480585|NCT02819635|517305353|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
143480586|NCT02819635|517305354|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
143480587|NCT02819635|517305355|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
143480588|NCT02819635|517305356|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
143480589|NCT02819635|517305357|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
143480590|NCT02819635|517305346|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
143480591|NCT02819635|517305347|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
143480592|NCT02819635|517305348|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
143480593|NCT02819635|517305349|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
143480594|NCT02819635|517305350|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
143480595|NCT02819635|517305351|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
143480596|NCT02819635|517305352|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
143480597|NCT02819635|517305353|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
143480598|NCT02819635|517305354|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
143480599|NCT02819635|517305355|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
143480600|NCT02819635|517305356|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
143480601|NCT02819635|517305357|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
143480602|NCT02819635|517305346|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
143480603|NCT02819635|517305347|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
143480604|NCT02819635|517305348|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
143480605|NCT02819635|517305349|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
143480606|NCT02819635|517305350|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
143480607|NCT02819635|517305351|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
143480608|NCT02819635|517305352|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
143480609|NCT02819635|517305353|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
143480610|NCT02819635|517305354|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
143480611|NCT02819635|517305355|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
143480612|NCT02819635|517305356|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
143480613|NCT02819635|517305357|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
143480614|NCT02819635|517305346|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
143480615|NCT02819635|517305347|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
143480616|NCT02819635|517305348|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
143480617|NCT02819635|517305349|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
143480618|NCT02819635|517305350|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
143480619|NCT02819635|517305351|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
143480620|NCT02819635|517305352|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
143480621|NCT02819635|517305353|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
143147538|NCT03965923|516086204|FG004|Overall Study|Death|0|||
143147539|NCT03965923|516086205|FG005|Overall Study|Death|0|||
143147540|NCT03965923|516086206|FG006|Overall Study|Death|0|||
143147541|NCT03965923|516086207|FG007|Overall Study|Death|1|||
143147542|NCT03965923|516086208|FG008|Overall Study|Death|4|||
143147543|NCT03965923|516086209|FG009|Overall Study|Death|0|||
143147544|NCT03965923|516086210|FG010|Overall Study|Death|4|||
143147545|NCT03965923|516086211|FG011|Overall Study|Death|0|||
143147546|NCT03965923|516086200|FG000|Overall Study|Other reason|0|||
143147547|NCT03965923|516086201|FG001|Overall Study|Other reason|0|||
143147548|NCT03965923|516086202|FG002|Overall Study|Other reason|0|||
143147549|NCT03965923|516086203|FG003|Overall Study|Other reason|1|||
143147550|NCT03965923|516086204|FG004|Overall Study|Other reason|0|||
143480622|NCT02819635|517305354|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
143480623|NCT02819635|517305355|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
143480624|NCT02819635|517305356|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
143480625|NCT02819635|517305357|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
143480626|NCT02819635|517305346|FG000|Substudy 2, Part 2|Adverse Event|0|||
143480627|NCT02819635|517305347|FG001|Substudy 2, Part 2|Adverse Event|0|||
143480628|NCT02819635|517305348|FG002|Substudy 2, Part 2|Adverse Event|0|||
143147551|NCT03965923|516086205|FG005|Overall Study|Other reason|0|||
143147552|NCT03965923|516086206|FG006|Overall Study|Other reason|0|||
143147553|NCT03965923|516086207|FG007|Overall Study|Other reason|0|||
143147554|NCT03965923|516086208|FG008|Overall Study|Other reason|0|||
143147555|NCT03965923|516086209|FG009|Overall Study|Other reason|0|||
143147556|NCT03965923|516086210|FG010|Overall Study|Other reason|2|||
143147557|NCT03965923|516086211|FG011|Overall Study|Other reason|0|||
143147558|NCT02452190|516086212|FG000|Overall Study|Withdrawal by Sponsor|1|||
143147559|NCT02452190|516086213|FG001|Overall Study|Withdrawal by Sponsor|3|||
143147560|NCT02452190|516086212|FG000|Overall Study|Pregnancy|1|||
143147561|NCT02452190|516086213|FG001|Overall Study|Pregnancy|0|||
143147562|NCT02452190|516086212|FG000|Overall Study|Investigator's Decision|2|||
143147563|NCT02452190|516086213|FG001|Overall Study|Investigator's Decision|0|||
143147564|NCT02452190|516086212|FG000|Overall Study|Lack of Efficacy|3|||
143147565|NCT02452190|516086213|FG001|Overall Study|Lack of Efficacy|1|||
143147566|NCT02452190|516086212|FG000|Overall Study|Lost to Follow-up|4|||
143147567|NCT02452190|516086213|FG001|Overall Study|Lost to Follow-up|3|||
143147568|NCT02452190|516086212|FG000|Overall Study|Adverse Event|2|||
143147569|NCT02452190|516086213|FG001|Overall Study|Adverse Event|5|||
143147570|NCT02452190|516086212|FG000|Overall Study|Withdrawal by Subject|20|||
143147571|NCT02452190|516086213|FG001|Overall Study|Withdrawal by Subject|11|||
143147572|NCT02452190|516086212|FG000|Overall Study|Noncompliance with study drug|1|||
143147573|NCT02452190|516086213|FG001|Overall Study|Noncompliance with study drug|0|||
143147574|NCT02452190|516086212|FG000|Overall Study|Participant traveled abroad|1|||
143147575|NCT02452190|516086213|FG001|Overall Study|Participant traveled abroad|0|||
143147576|NCT02452190|516086212|FG000|Overall Study|Death|0|||
143147577|NCT02452190|516086213|FG001|Overall Study|Death|1|||
143147578|NCT02327078|516086216|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
143147579|NCT02327078|516086217|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
143147580|NCT02327078|516086218|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
143147581|NCT02327078|516086219|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
143147582|NCT02327078|516086220|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
143147583|NCT02327078|516086221|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
143147584|NCT02327078|516086222|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
143147585|NCT02327078|516086223|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
143147586|NCT02327078|516086224|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
143147587|NCT02327078|516086216|FG000|Overall Study|Death|2|||
143147588|NCT02327078|516086217|FG001|Overall Study|Death|4|||
143147589|NCT02327078|516086218|FG002|Overall Study|Death|10|||
143147590|NCT02327078|516086219|FG003|Overall Study|Death|6|||
143147591|NCT02327078|516086220|FG004|Overall Study|Death|4|||
143147592|NCT02327078|516086221|FG005|Overall Study|Death|3|||
143147593|NCT02327078|516086222|FG006|Overall Study|Death|2|||
143147594|NCT02327078|516086223|FG007|Overall Study|Death|51|||
143147595|NCT02327078|516086224|FG008|Overall Study|Death|97|||
143147596|NCT02327078|516086216|FG000|Overall Study|Lost to Follow-up|0|||
143147597|NCT02327078|516086217|FG001|Overall Study|Lost to Follow-up|1|||
143147598|NCT02327078|516086218|FG002|Overall Study|Lost to Follow-up|1|||
143147599|NCT02327078|516086219|FG003|Overall Study|Lost to Follow-up|0|||
143147600|NCT02327078|516086220|FG004|Overall Study|Lost to Follow-up|0|||
143147601|NCT02327078|516086221|FG005|Overall Study|Lost to Follow-up|0|||
143147602|NCT02327078|516086222|FG006|Overall Study|Lost to Follow-up|0|||
143147603|NCT02327078|516086223|FG007|Overall Study|Lost to Follow-up|2|||
143147604|NCT02327078|516086224|FG008|Overall Study|Lost to Follow-up|5|||
143147605|NCT02327078|516086216|FG000|Overall Study|Site Terminated by Sponsor|1|||
143147606|NCT02327078|516086217|FG001|Overall Study|Site Terminated by Sponsor|0|||
143147607|NCT02327078|516086218|FG002|Overall Study|Site Terminated by Sponsor|1|||
143147608|NCT02327078|516086219|FG003|Overall Study|Site Terminated by Sponsor|4|||
143480629|NCT02819635|517305349|FG003|Substudy 2, Part 2|Adverse Event|0|||
143147609|NCT02327078|516086220|FG004|Overall Study|Site Terminated by Sponsor|0|||
143147610|NCT02327078|516086221|FG005|Overall Study|Site Terminated by Sponsor|0|||
143147611|NCT02327078|516086222|FG006|Overall Study|Site Terminated by Sponsor|0|||
143147612|NCT02327078|516086223|FG007|Overall Study|Site Terminated by Sponsor|11|||
143147613|NCT02327078|516086224|FG008|Overall Study|Site Terminated by Sponsor|25|||
143147614|NCT02327078|516086216|FG000|Overall Study|Physician Decision|0|||
143147615|NCT02327078|516086217|FG001|Overall Study|Physician Decision|0|||
143480630|NCT02819635|517305350|FG004|Substudy 2, Part 2|Adverse Event|0|||
143014189|NCT02149199|515591647|FG001|Overall Study|Lost to Follow-up|12|||
143480631|NCT02819635|517305351|FG005|Substudy 2, Part 2|Adverse Event|4|||
143480632|NCT02819635|517305352|FG006|Substudy 2, Part 2|Adverse Event|0|||
143480633|NCT02819635|517305353|FG007|Substudy 2, Part 2|Adverse Event|0|||
143480634|NCT02819635|517305354|FG008|Substudy 2, Part 2|Adverse Event|0|||
143480635|NCT02819635|517305355|FG009|Substudy 2, Part 2|Adverse Event|0|||
143480636|NCT02819635|517305356|FG010|Substudy 2, Part 2|Adverse Event|0|||
143480637|NCT02819635|517305357|FG011|Substudy 2, Part 2|Adverse Event|0|||
143480638|NCT02819635|517305346|FG000|Substudy 2, Part 2|Withdrew consent|0|||
143480639|NCT02819635|517305347|FG001|Substudy 2, Part 2|Withdrew consent|0|||
143480640|NCT02819635|517305348|FG002|Substudy 2, Part 2|Withdrew consent|0|||
143480641|NCT02819635|517305349|FG003|Substudy 2, Part 2|Withdrew consent|0|||
143480642|NCT02819635|517305350|FG004|Substudy 2, Part 2|Withdrew consent|0|||
143480643|NCT02819635|517305351|FG005|Substudy 2, Part 2|Withdrew consent|3|||
143480644|NCT02819635|517305352|FG006|Substudy 2, Part 2|Withdrew consent|1|||
143480645|NCT02819635|517305353|FG007|Substudy 2, Part 2|Withdrew consent|0|||
143480646|NCT02819635|517305354|FG008|Substudy 2, Part 2|Withdrew consent|0|||
143480647|NCT02819635|517305355|FG009|Substudy 2, Part 2|Withdrew consent|0|||
143480648|NCT02819635|517305356|FG010|Substudy 2, Part 2|Withdrew consent|0|||
143480649|NCT02819635|517305357|FG011|Substudy 2, Part 2|Withdrew consent|0|||
143480650|NCT02819635|517305346|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
143480651|NCT02819635|517305347|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
143480652|NCT02819635|517305348|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
143480653|NCT02819635|517305349|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
143480654|NCT02819635|517305350|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
143480655|NCT02819635|517305351|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
143480656|NCT02819635|517305352|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
143480657|NCT02819635|517305353|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
143480658|NCT02819635|517305354|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
143480659|NCT02819635|517305355|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
143480660|NCT02819635|517305356|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
143480661|NCT02819635|517305357|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
143480662|NCT02819635|517305346|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
143480663|NCT02819635|517305347|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
143480664|NCT02819635|517305348|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
143480665|NCT02819635|517305349|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
143480666|NCT02819635|517305350|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
143480667|NCT02819635|517305351|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
143480668|NCT02819635|517305352|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
143480669|NCT02819635|517305353|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
143480670|NCT02819635|517305354|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
143480671|NCT02819635|517305355|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
143480672|NCT02819635|517305356|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
143480673|NCT02819635|517305357|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
143480674|NCT02819635|517305346|FG000|Substudy 2, Part 2|Other, not specified|0|||
143480675|NCT02819635|517305347|FG001|Substudy 2, Part 2|Other, not specified|0|||
143480676|NCT02819635|517305348|FG002|Substudy 2, Part 2|Other, not specified|0|||
143480677|NCT02819635|517305349|FG003|Substudy 2, Part 2|Other, not specified|0|||
143480678|NCT02819635|517305350|FG004|Substudy 2, Part 2|Other, not specified|0|||
143480679|NCT02819635|517305351|FG005|Substudy 2, Part 2|Other, not specified|4|||
143480680|NCT02819635|517305352|FG006|Substudy 2, Part 2|Other, not specified|8|||
143480681|NCT02819635|517305353|FG007|Substudy 2, Part 2|Other, not specified|0|||
143480682|NCT02819635|517305354|FG008|Substudy 2, Part 2|Other, not specified|0|||
143480683|NCT02819635|517305355|FG009|Substudy 2, Part 2|Other, not specified|0|||
143147616|NCT02327078|516086218|FG002|Overall Study|Physician Decision|0|||
143480684|NCT02819635|517305356|FG010|Substudy 2, Part 2|Other, not specified|0|||
143480685|NCT02819635|517305357|FG011|Substudy 2, Part 2|Other, not specified|0|||
143480686|NCT02819635|517305346|FG000|Substudy 3|Adverse Event|0|||
143480687|NCT02819635|517305347|FG001|Substudy 3|Adverse Event|0|||
143480688|NCT02819635|517305348|FG002|Substudy 3|Adverse Event|0|||
143480689|NCT02819635|517305349|FG003|Substudy 3|Adverse Event|0|||
143480690|NCT02819635|517305350|FG004|Substudy 3|Adverse Event|0|||
143480691|NCT02819635|517305351|FG005|Substudy 3|Adverse Event|0|||
143480692|NCT02819635|517305352|FG006|Substudy 3|Adverse Event|0|||
143480693|NCT02819635|517305353|FG007|Substudy 3|Adverse Event|0|||
143480694|NCT02819635|517305354|FG008|Substudy 3|Adverse Event|32|||
143480695|NCT02819635|517305355|FG009|Substudy 3|Adverse Event|3|||
143480696|NCT02819635|517305356|FG010|Substudy 3|Adverse Event|12|||
143480697|NCT02819635|517305357|FG011|Substudy 3|Adverse Event|18|||
143480698|NCT02819635|517305346|FG000|Substudy 3|Withdrew consent|0|||
143480699|NCT02819635|517305347|FG001|Substudy 3|Withdrew consent|0|||
143147617|NCT02327078|516086219|FG003|Overall Study|Physician Decision|1|||
143480700|NCT02819635|517305348|FG002|Substudy 3|Withdrew consent|0|||
143480701|NCT02819635|517305349|FG003|Substudy 3|Withdrew consent|0|||
143480702|NCT02819635|517305350|FG004|Substudy 3|Withdrew consent|0|||
143480703|NCT02819635|517305351|FG005|Substudy 3|Withdrew consent|0|||
143480704|NCT02819635|517305352|FG006|Substudy 3|Withdrew consent|0|||
143480705|NCT02819635|517305353|FG007|Substudy 3|Withdrew consent|0|||
143480706|NCT02819635|517305354|FG008|Substudy 3|Withdrew consent|11|||
143480707|NCT02819635|517305355|FG009|Substudy 3|Withdrew consent|1|||
143480708|NCT02819635|517305356|FG010|Substudy 3|Withdrew consent|4|||
143480709|NCT02819635|517305357|FG011|Substudy 3|Withdrew consent|9|||
143480710|NCT02819635|517305346|FG000|Substudy 3|Lost to Follow-up|0|||
143147618|NCT02327078|516086220|FG004|Overall Study|Physician Decision|0|||
143147619|NCT02327078|516086221|FG005|Overall Study|Physician Decision|0|||
143147620|NCT02327078|516086222|FG006|Overall Study|Physician Decision|0|||
143147621|NCT02327078|516086223|FG007|Overall Study|Physician Decision|0|||
143147622|NCT02327078|516086224|FG008|Overall Study|Physician Decision|1|||
143147623|NCT02327078|516086216|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
143147624|NCT02327078|516086217|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
143147625|NCT02327078|516086218|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
143147626|NCT02327078|516086219|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
143147627|NCT02327078|516086220|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
143147628|NCT02327078|516086221|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
143147629|NCT02327078|516086222|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
143147630|NCT02327078|516086223|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
143147631|NCT02327078|516086224|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
143147632|NCT02327078|516086216|FG000|Overall Study|Reason not Specified|0|||
143147633|NCT02327078|516086217|FG001|Overall Study|Reason not Specified|0|||
143147634|NCT02327078|516086218|FG002|Overall Study|Reason not Specified|0|||
143147635|NCT02327078|516086219|FG003|Overall Study|Reason not Specified|0|||
143147636|NCT02327078|516086220|FG004|Overall Study|Reason not Specified|0|||
143147637|NCT02327078|516086221|FG005|Overall Study|Reason not Specified|0|||
143147638|NCT02327078|516086222|FG006|Overall Study|Reason not Specified|0|||
143147639|NCT02327078|516086223|FG007|Overall Study|Reason not Specified|5|||
143147640|NCT02327078|516086224|FG008|Overall Study|Reason not Specified|12|||
143147641|NCT06001021|516086225|FG000|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
143147642|NCT06001021|516086226|FG001|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
143147643|NCT06001021|516086227|FG002|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
143147644|NCT06001021|516086228|FG003|15 August 2023 to 30 September 2023|Withdrawal by Subject|8|||
143147645|NCT06001021|516086229|FG004|15 August 2023 to 30 September 2023|Withdrawal by Subject|6|||
143147646|NCT06001021|516086230|FG005|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
143147647|NCT06001021|516086231|FG006|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
143147648|NCT06001021|516086225|FG000|1 October 2023 to 28 October 2023)|Withdrawal by Subject|14|||
143147649|NCT06001021|516086226|FG001|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
143147650|NCT06001021|516086227|FG002|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
143147651|NCT06001021|516086228|FG003|1 October 2023 to 28 October 2023)|Withdrawal by Subject|8|||
143147652|NCT06001021|516086229|FG004|1 October 2023 to 28 October 2023)|Withdrawal by Subject|10|||
143147653|NCT06001021|516086230|FG005|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
143147654|NCT06001021|516086231|FG006|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
143147655|NCT06001866|516086234|FG000|Overall Study|Withdrawal by Subject|0|||
143147656|NCT06001866|516086235|FG001|Overall Study|Withdrawal by Subject|2|||
143147657|NCT06001866|516086234|FG000|Overall Study|Protocol Violation|0|||
143147658|NCT06001866|516086235|FG001|Overall Study|Protocol Violation|2|||
143147659|NCT02337829|516086236|FG000|Overall Study|Death|0|||
143147660|NCT02337829|516086237|FG001|Overall Study|Death|1|||
143147661|NCT02337829|516086238|FG002|Overall Study|Death|0|||
143147662|NCT02337829|516086239|FG003|Overall Study|Death|0|||
143147663|NCT02337829|516086236|FG000|Overall Study|Study terminated by sponsor|12|||
143147664|NCT02337829|516086237|FG001|Overall Study|Study terminated by sponsor|10|||
143147665|NCT02337829|516086238|FG002|Overall Study|Study terminated by sponsor|5|||
143147666|NCT02337829|516086239|FG003|Overall Study|Study terminated by sponsor|6|||
143147667|NCT02337829|516086236|FG000|Overall Study|discontinued for other reasons|6|||
143147668|NCT02337829|516086237|FG001|Overall Study|discontinued for other reasons|3|||
143147669|NCT02337829|516086238|FG002|Overall Study|discontinued for other reasons|1|||
143147670|NCT02337829|516086239|FG003|Overall Study|discontinued for other reasons|4|||
143147671|NCT03330197|516086240|FG000|Overall Study|Adverse Event|0|||
143147672|NCT03330197|516086241|FG001|Overall Study|Adverse Event|1|||
143147673|NCT03330197|516086240|FG000|Overall Study|Withdrawal by Subject|0|||
143147674|NCT03330197|516086241|FG001|Overall Study|Withdrawal by Subject|1|||
143147675|NCT04537299|516086250|FG000|Overall Study|Withdrawal by Subject|2|||
143147676|NCT04537299|516086251|FG001|Overall Study|Withdrawal by Subject|0|||
143147677|NCT04537299|516086250|FG000|Overall Study|Protocol Violation|1|||
143147678|NCT04537299|516086251|FG001|Overall Study|Protocol Violation|1|||
143147679|NCT03034967|516086256|FG000|Overall Study|Withdrawal by Subject|9|||
143480711|NCT02819635|517305347|FG001|Substudy 3|Lost to Follow-up|0|||
143147680|NCT03034967|516086257|FG001|Overall Study|Withdrawal by Subject|2|||
143147681|NCT03034967|516086258|FG002|Overall Study|Withdrawal by Subject|6|||
143147682|NCT03034967|516086259|FG003|Overall Study|Withdrawal by Subject|6|||
143480712|NCT02819635|517305348|FG002|Substudy 3|Lost to Follow-up|0|||
143480713|NCT02819635|517305349|FG003|Substudy 3|Lost to Follow-up|0|||
143147683|NCT03034967|516086260|FG004|Overall Study|Withdrawal by Subject|9|||
143147684|NCT03034967|516086261|FG005|Overall Study|Withdrawal by Subject|2|||
143147685|NCT03034967|516086256|FG000|Overall Study|Physician Decision|1|||
143147686|NCT03034967|516086257|FG001|Overall Study|Physician Decision|0|||
143147687|NCT03034967|516086258|FG002|Overall Study|Physician Decision|1|||
143147688|NCT03034967|516086259|FG003|Overall Study|Physician Decision|1|||
143147689|NCT03034967|516086260|FG004|Overall Study|Physician Decision|1|||
143147690|NCT03034967|516086261|FG005|Overall Study|Physician Decision|0|||
143147691|NCT03034967|516086256|FG000|Overall Study|Lost to Follow-up|0|||
143147692|NCT03034967|516086257|FG001|Overall Study|Lost to Follow-up|0|||
143147693|NCT03034967|516086258|FG002|Overall Study|Lost to Follow-up|0|||
143147694|NCT03034967|516086259|FG003|Overall Study|Lost to Follow-up|1|||
143147695|NCT03034967|516086260|FG004|Overall Study|Lost to Follow-up|0|||
143147696|NCT03034967|516086261|FG005|Overall Study|Lost to Follow-up|2|||
143147697|NCT03034967|516086256|FG000|Overall Study|Liver function test abnormality|0|||
143147698|NCT03034967|516086257|FG001|Overall Study|Liver function test abnormality|0|||
143147699|NCT03034967|516086258|FG002|Overall Study|Liver function test abnormality|1|||
143147700|NCT03034967|516086259|FG003|Overall Study|Liver function test abnormality|0|||
143147701|NCT03034967|516086260|FG004|Overall Study|Liver function test abnormality|0|||
143147702|NCT03034967|516086261|FG005|Overall Study|Liver function test abnormality|0|||
143147703|NCT03034967|516086256|FG000|Overall Study|Protocol Violation|1|||
143480714|NCT02819635|517305350|FG004|Substudy 3|Lost to Follow-up|0|||
143480715|NCT02819635|517305351|FG005|Substudy 3|Lost to Follow-up|0|||
143480716|NCT02819635|517305352|FG006|Substudy 3|Lost to Follow-up|0|||
143480717|NCT02819635|517305353|FG007|Substudy 3|Lost to Follow-up|0|||
143480718|NCT02819635|517305354|FG008|Substudy 3|Lost to Follow-up|1|||
143480719|NCT02819635|517305355|FG009|Substudy 3|Lost to Follow-up|0|||
143480720|NCT02819635|517305356|FG010|Substudy 3|Lost to Follow-up|1|||
143480721|NCT02819635|517305357|FG011|Substudy 3|Lost to Follow-up|1|||
143480722|NCT02819635|517305346|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
143480723|NCT02819635|517305347|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
143480724|NCT02819635|517305348|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
143480725|NCT02819635|517305349|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
143480726|NCT02819635|517305350|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
143480727|NCT02819635|517305351|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
143480728|NCT02819635|517305352|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
143480729|NCT02819635|517305353|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
143480730|NCT02819635|517305354|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
143480731|NCT02819635|517305355|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
143480732|NCT02819635|517305356|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
143480733|NCT02819635|517305357|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
143480734|NCT02819635|517305346|FG000|Substudy 3|Other, not specified|0|||
143480735|NCT02819635|517305347|FG001|Substudy 3|Other, not specified|0|||
143480736|NCT02819635|517305348|FG002|Substudy 3|Other, not specified|0|||
143480737|NCT02819635|517305349|FG003|Substudy 3|Other, not specified|0|||
143480738|NCT02819635|517305350|FG004|Substudy 3|Other, not specified|0|||
143480739|NCT02819635|517305351|FG005|Substudy 3|Other, not specified|0|||
143480740|NCT02819635|517305352|FG006|Substudy 3|Other, not specified|0|||
143480741|NCT02819635|517305353|FG007|Substudy 3|Other, not specified|0|||
143480742|NCT02819635|517305354|FG008|Substudy 3|Other, not specified|202|||
143480743|NCT02819635|517305355|FG009|Substudy 3|Other, not specified|5|||
143480744|NCT02819635|517305356|FG010|Substudy 3|Other, not specified|89|||
143480745|NCT02819635|517305357|FG011|Substudy 3|Other, not specified|39|||
143480746|NCT00573430|517305361|FG000|Overall Study|Incorrect enrollment of randomization|0|||
143480747|NCT00573430|517305362|FG001|Overall Study|Incorrect enrollment of randomization|4|||
143480748|NCT00573430|517305363|FG002|Overall Study|Incorrect enrollment of randomization|3|||
143480749|NCT00573430|517305361|FG000|Overall Study|Adverse Event|0|||
143480750|NCT00573430|517305362|FG001|Overall Study|Adverse Event|0|||
143480751|NCT00573430|517305363|FG002|Overall Study|Adverse Event|2|||
143480752|NCT00573430|517305361|FG000|Overall Study|Withdrawal by Subject|1|||
143480753|NCT00573430|517305362|FG001|Overall Study|Withdrawal by Subject|0|||
143480754|NCT00573430|517305363|FG002|Overall Study|Withdrawal by Subject|1|||
143480755|NCT00573430|517305361|FG000|Overall Study|Protocol Violation|0|||
143147704|NCT03034967|516086257|FG001|Overall Study|Protocol Violation|0|||
143147705|NCT03034967|516086258|FG002|Overall Study|Protocol Violation|0|||
143147706|NCT03034967|516086259|FG003|Overall Study|Protocol Violation|0|||
143147707|NCT03034967|516086260|FG004|Overall Study|Protocol Violation|0|||
143147708|NCT03034967|516086261|FG005|Overall Study|Protocol Violation|2|||
143147709|NCT03034967|516086256|FG000|Overall Study|Lack of Efficacy|0|||
143480756|NCT00573430|517305362|FG001|Overall Study|Protocol Violation|1|||
143480757|NCT00573430|517305363|FG002|Overall Study|Protocol Violation|1|||
143480758|NCT00573430|517305361|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
143480759|NCT00573430|517305362|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
143480760|NCT00573430|517305363|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
143480761|NCT01278745|517305364|FG000|Overall Study|Death|2|||
143147710|NCT03034967|516086257|FG001|Overall Study|Lack of Efficacy|1|||
143147711|NCT03034967|516086258|FG002|Overall Study|Lack of Efficacy|2|||
143480762|NCT01278745|517305365|FG001|Overall Study|Death|5|||
143480763|NCT01278745|517305366|FG002|Overall Study|Death|7|||
143480764|NCT01278745|517305367|FG003|Overall Study|Death|0|||
143480765|NCT01278745|517305364|FG000|Overall Study|Physician Decision|1|||
143480766|NCT01278745|517305365|FG001|Overall Study|Physician Decision|0|||
143480767|NCT01278745|517305366|FG002|Overall Study|Physician Decision|0|||
143480768|NCT01278745|517305367|FG003|Overall Study|Physician Decision|9|||
143480769|NCT01278745|517305364|FG000|Overall Study|Withdrawal by Subject|1|||
143480770|NCT01278745|517305365|FG001|Overall Study|Withdrawal by Subject|1|||
143480771|NCT01278745|517305366|FG002|Overall Study|Withdrawal by Subject|5|||
143480772|NCT01278745|517305367|FG003|Overall Study|Withdrawal by Subject|1|||
143480773|NCT01278745|517305364|FG000|Overall Study|Sponsor Decision|1|||
143480774|NCT01278745|517305365|FG001|Overall Study|Sponsor Decision|0|||
143480775|NCT01278745|517305366|FG002|Overall Study|Sponsor Decision|62|||
143480776|NCT01278745|517305367|FG003|Overall Study|Sponsor Decision|6|||
143147712|NCT03034967|516086259|FG003|Overall Study|Lack of Efficacy|1|||
143147713|NCT03034967|516086260|FG004|Overall Study|Lack of Efficacy|1|||
143147714|NCT03034967|516086261|FG005|Overall Study|Lack of Efficacy|0|||
143147715|NCT03034967|516086256|FG000|Overall Study|Adverse Event, non-fatal|3|||
143147716|NCT03034967|516086257|FG001|Overall Study|Adverse Event, non-fatal|1|||
143147717|NCT03034967|516086258|FG002|Overall Study|Adverse Event, non-fatal|2|||
143147718|NCT03034967|516086259|FG003|Overall Study|Adverse Event, non-fatal|0|||
143147719|NCT03034967|516086260|FG004|Overall Study|Adverse Event, non-fatal|2|||
143147720|NCT03034967|516086261|FG005|Overall Study|Adverse Event, non-fatal|8|||
143147721|NCT03034967|516086256|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
143147722|NCT03034967|516086257|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
143147723|NCT03034967|516086258|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
143147724|NCT03034967|516086259|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
143147725|NCT03034967|516086260|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
143147726|NCT03034967|516086261|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
143147727|NCT02225587|516086274|FG000|Overall Study|Adverse Event|5|||
143147728|NCT02225587|516086275|FG001|Overall Study|Adverse Event|5|||
143147729|NCT02225587|516086274|FG000|Overall Study|Lost to Follow-up|5|||
143147730|NCT02225587|516086275|FG001|Overall Study|Lost to Follow-up|5|||
143147731|NCT02225587|516086274|FG000|Overall Study|Non-Compliance With Study Drug|1|||
143147732|NCT02225587|516086275|FG001|Overall Study|Non-Compliance With Study Drug|0|||
143147733|NCT02225587|516086274|FG000|Overall Study|Physician Decision|2|||
143147734|NCT02225587|516086275|FG001|Overall Study|Physician Decision|0|||
143147735|NCT02225587|516086274|FG000|Overall Study|Protocol Violation|1|||
143147736|NCT02225587|516086275|FG001|Overall Study|Protocol Violation|0|||
143147737|NCT02225587|516086274|FG000|Overall Study|Participant Moved|1|||
143147738|NCT02225587|516086275|FG001|Overall Study|Participant Moved|0|||
143147739|NCT02225587|516086274|FG000|Overall Study|Withdrawal by Subject|13|||
143147740|NCT02225587|516086275|FG001|Overall Study|Withdrawal by Subject|28|||
143147741|NCT01901562|516086276|FG000|Overall Study|Protocol Violation|5|||
143147742|NCT01901562|516086276|FG000|Overall Study|Excluded intraoperatively|4|||
143147743|NCT02612155|516086277|FG000|Overall Study|Death|1|||
143147744|NCT02612155|516086278|FG001|Overall Study|Death|1|||
143147745|NCT02612155|516086277|FG000|Overall Study|Lost to Follow-up|2|||
143147746|NCT02612155|516086278|FG001|Overall Study|Lost to Follow-up|2|||
143147747|NCT03126110|516086279|FG000|Phase 1|Death|2|||
143147748|NCT03126110|516086280|FG001|Phase 1|Death|2|||
143147749|NCT03126110|516086281|FG002|Phase 1|Death|4|||
143147750|NCT03126110|516086282|FG003|Phase 1|Death|3|||
143147751|NCT03126110|516086283|FG004|Phase 1|Death|4|||
143147752|NCT03126110|516086284|FG005|Phase 1|Death|4|||
143147753|NCT03126110|516086285|FG006|Phase 1|Death|3|||
143147754|NCT03126110|516086286|FG007|Phase 1|Death|4|||
143147755|NCT03126110|516086287|FG008|Phase 1|Death|5|||
143147756|NCT03126110|516086288|FG009|Phase 1|Death|2|||
143147757|NCT03126110|516086289|FG010|Phase 1|Death|6|||
143147758|NCT03126110|516086290|FG011|Phase 1|Death|0|||
143147759|NCT03126110|516086291|FG012|Phase 1|Death|0|||
143147760|NCT03126110|516086292|FG013|Phase 1|Death|0|||
143147761|NCT03126110|516086293|FG014|Phase 1|Death|0|||
143147762|NCT03126110|516086294|FG015|Phase 1|Death|0|||
143480777|NCT01278745|517305364|FG000|Overall Study|Ineligible|0|||
143480778|NCT01278745|517305365|FG001|Overall Study|Ineligible|0|||
143147763|NCT03126110|516086295|FG016|Phase 1|Death|0|||
143147764|NCT03126110|516086279|FG000|Phase 1|Lost to Follow-up|0|||
143147765|NCT03126110|516086280|FG001|Phase 1|Lost to Follow-up|1|||
143147766|NCT03126110|516086281|FG002|Phase 1|Lost to Follow-up|0|||
143147767|NCT03126110|516086282|FG003|Phase 1|Lost to Follow-up|0|||
143147768|NCT03126110|516086283|FG004|Phase 1|Lost to Follow-up|0|||
143147769|NCT03126110|516086284|FG005|Phase 1|Lost to Follow-up|0|||
143480779|NCT01278745|517305366|FG002|Overall Study|Ineligible|42|||
143147770|NCT03126110|516086285|FG006|Phase 1|Lost to Follow-up|0|||
143147771|NCT03126110|516086286|FG007|Phase 1|Lost to Follow-up|0|||
143147772|NCT03126110|516086287|FG008|Phase 1|Lost to Follow-up|1|||
143147773|NCT03126110|516086288|FG009|Phase 1|Lost to Follow-up|0|||
143147774|NCT03126110|516086289|FG010|Phase 1|Lost to Follow-up|0|||
143480780|NCT01278745|517305367|FG003|Overall Study|Ineligible|61|||
143480781|NCT01278745|517305364|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
143147775|NCT03126110|516086290|FG011|Phase 1|Lost to Follow-up|0|||
143147776|NCT03126110|516086291|FG012|Phase 1|Lost to Follow-up|0|||
143147777|NCT03126110|516086292|FG013|Phase 1|Lost to Follow-up|0|||
143147778|NCT03126110|516086293|FG014|Phase 1|Lost to Follow-up|0|||
143147779|NCT03126110|516086294|FG015|Phase 1|Lost to Follow-up|0|||
143147780|NCT03126110|516086295|FG016|Phase 1|Lost to Follow-up|0|||
143147781|NCT03126110|516086279|FG000|Phase 1|Withdrawal by Subject|1|||
143147782|NCT03126110|516086280|FG001|Phase 1|Withdrawal by Subject|0|||
143147783|NCT03126110|516086281|FG002|Phase 1|Withdrawal by Subject|0|||
143147784|NCT03126110|516086282|FG003|Phase 1|Withdrawal by Subject|1|||
143147785|NCT03126110|516086283|FG004|Phase 1|Withdrawal by Subject|1|||
143480782|NCT01278745|517305365|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
143480783|NCT01278745|517305366|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
143480784|NCT01278745|517305367|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
143480785|NCT01148537|517305368|FG000|Overall Study|Withdrawal by Subject|1|||
143147786|NCT03126110|516086284|FG005|Phase 1|Withdrawal by Subject|0|||
143147787|NCT03126110|516086285|FG006|Phase 1|Withdrawal by Subject|0|||
143147788|NCT03126110|516086286|FG007|Phase 1|Withdrawal by Subject|0|||
143147789|NCT03126110|516086287|FG008|Phase 1|Withdrawal by Subject|2|||
143147790|NCT03126110|516086288|FG009|Phase 1|Withdrawal by Subject|1|||
143147791|NCT03126110|516086289|FG010|Phase 1|Withdrawal by Subject|0|||
143147792|NCT03126110|516086290|FG011|Phase 1|Withdrawal by Subject|0|||
143147793|NCT03126110|516086291|FG012|Phase 1|Withdrawal by Subject|0|||
143147794|NCT03126110|516086292|FG013|Phase 1|Withdrawal by Subject|0|||
143147795|NCT03126110|516086293|FG014|Phase 1|Withdrawal by Subject|0|||
143147796|NCT03126110|516086294|FG015|Phase 1|Withdrawal by Subject|0|||
143147797|NCT03126110|516086295|FG016|Phase 1|Withdrawal by Subject|0|||
143147798|NCT03126110|516086279|FG000|Phase 1|Safety follow-up no longer necessary|1|||
143147799|NCT03126110|516086280|FG001|Phase 1|Safety follow-up no longer necessary|0|||
143147800|NCT03126110|516086281|FG002|Phase 1|Safety follow-up no longer necessary|0|||
143147801|NCT03126110|516086282|FG003|Phase 1|Safety follow-up no longer necessary|0|||
143147802|NCT03126110|516086283|FG004|Phase 1|Safety follow-up no longer necessary|0|||
143147803|NCT03126110|516086284|FG005|Phase 1|Safety follow-up no longer necessary|0|||
143147804|NCT03126110|516086285|FG006|Phase 1|Safety follow-up no longer necessary|0|||
143147805|NCT03126110|516086286|FG007|Phase 1|Safety follow-up no longer necessary|0|||
143147806|NCT03126110|516086287|FG008|Phase 1|Safety follow-up no longer necessary|0|||
143147807|NCT03126110|516086288|FG009|Phase 1|Safety follow-up no longer necessary|0|||
143147808|NCT03126110|516086289|FG010|Phase 1|Safety follow-up no longer necessary|0|||
143147809|NCT03126110|516086290|FG011|Phase 1|Safety follow-up no longer necessary|0|||
143147810|NCT03126110|516086291|FG012|Phase 1|Safety follow-up no longer necessary|0|||
143147811|NCT03126110|516086292|FG013|Phase 1|Safety follow-up no longer necessary|0|||
143147812|NCT03126110|516086293|FG014|Phase 1|Safety follow-up no longer necessary|0|||
143147813|NCT03126110|516086294|FG015|Phase 1|Safety follow-up no longer necessary|0|||
143147814|NCT03126110|516086295|FG016|Phase 1|Safety follow-up no longer necessary|0|||
143147815|NCT03126110|516086279|FG000|Phase 1|Survival follow-up no longer necessary|0|||
143147816|NCT03126110|516086280|FG001|Phase 1|Survival follow-up no longer necessary|0|||
143147817|NCT03126110|516086281|FG002|Phase 1|Survival follow-up no longer necessary|1|||
143147818|NCT03126110|516086282|FG003|Phase 1|Survival follow-up no longer necessary|0|||
143147819|NCT03126110|516086283|FG004|Phase 1|Survival follow-up no longer necessary|0|||
143147820|NCT03126110|516086284|FG005|Phase 1|Survival follow-up no longer necessary|0|||
143480786|NCT01148537|517305369|FG001|Overall Study|Withdrawal by Subject|0|||
143480787|NCT01148537|517305370|FG002|Overall Study|Withdrawal by Subject|2|||
143480788|NCT01148537|517305368|FG000|Overall Study|Adverse Event|2|||
143480789|NCT01148537|517305369|FG001|Overall Study|Adverse Event|0|||
143480790|NCT01148537|517305370|FG002|Overall Study|Adverse Event|1|||
143480791|NCT01471015|517305371|FG000|Overall Study|Death|0|||
143147821|NCT03126110|516086285|FG006|Phase 1|Survival follow-up no longer necessary|0|||
143147822|NCT03126110|516086286|FG007|Phase 1|Survival follow-up no longer necessary|0|||
143147823|NCT03126110|516086287|FG008|Phase 1|Survival follow-up no longer necessary|0|||
143147824|NCT03126110|516086288|FG009|Phase 1|Survival follow-up no longer necessary|0|||
143147825|NCT03126110|516086289|FG010|Phase 1|Survival follow-up no longer necessary|0|||
143147826|NCT03126110|516086290|FG011|Phase 1|Survival follow-up no longer necessary|0|||
143147827|NCT03126110|516086291|FG012|Phase 1|Survival follow-up no longer necessary|0|||
143147828|NCT03126110|516086292|FG013|Phase 1|Survival follow-up no longer necessary|0|||
143147829|NCT03126110|516086293|FG014|Phase 1|Survival follow-up no longer necessary|0|||
143147830|NCT03126110|516086294|FG015|Phase 1|Survival follow-up no longer necessary|0|||
143147831|NCT03126110|516086295|FG016|Phase 1|Survival follow-up no longer necessary|0|||
143147832|NCT03126110|516086279|FG000|Phase 2|Study terminated by the sponsor|0|||
143147833|NCT03126110|516086280|FG001|Phase 2|Study terminated by the sponsor|0|||
143147834|NCT03126110|516086281|FG002|Phase 2|Study terminated by the sponsor|0|||
143147835|NCT03126110|516086282|FG003|Phase 2|Study terminated by the sponsor|0|||
143147836|NCT03126110|516086283|FG004|Phase 2|Study terminated by the sponsor|0|||
143147837|NCT03126110|516086284|FG005|Phase 2|Study terminated by the sponsor|0|||
143480792|NCT01471015|517305372|FG001|Overall Study|Death|1|||
143480793|NCT01471015|517305373|FG002|Overall Study|Death|1|||
143480794|NCT01843842|517305379|FG000|Overall Study|Do not meet inclusion criteria|1|||
143480795|NCT01843842|517305380|FG001|Overall Study|Do not meet inclusion criteria|1|||
143480796|NCT01376778|517305381|FG000|Overall Study|Lost to Follow-up|3|||
143147838|NCT03126110|516086285|FG006|Phase 2|Study terminated by the sponsor|0|||
143147839|NCT03126110|516086286|FG007|Phase 2|Study terminated by the sponsor|0|||
143147840|NCT03126110|516086287|FG008|Phase 2|Study terminated by the sponsor|0|||
143147841|NCT03126110|516086288|FG009|Phase 2|Study terminated by the sponsor|0|||
143147842|NCT03126110|516086289|FG010|Phase 2|Study terminated by the sponsor|0|||
143147843|NCT03126110|516086290|FG011|Phase 2|Study terminated by the sponsor|0|||
143147844|NCT03126110|516086291|FG012|Phase 2|Study terminated by the sponsor|0|||
143147845|NCT03126110|516086292|FG013|Phase 2|Study terminated by the sponsor|4|||
143147846|NCT03126110|516086293|FG014|Phase 2|Study terminated by the sponsor|0|||
143147847|NCT03126110|516086294|FG015|Phase 2|Study terminated by the sponsor|0|||
143147848|NCT03126110|516086295|FG016|Phase 2|Study terminated by the sponsor|0|||
143147849|NCT03126110|516086279|FG000|Phase 2|Withdrawal by Subject|0|||
143147850|NCT03126110|516086280|FG001|Phase 2|Withdrawal by Subject|0|||
143147851|NCT03126110|516086281|FG002|Phase 2|Withdrawal by Subject|0|||
143147852|NCT03126110|516086282|FG003|Phase 2|Withdrawal by Subject|0|||
143147853|NCT03126110|516086283|FG004|Phase 2|Withdrawal by Subject|0|||
143147854|NCT03126110|516086284|FG005|Phase 2|Withdrawal by Subject|0|||
143147855|NCT03126110|516086285|FG006|Phase 2|Withdrawal by Subject|0|||
143147856|NCT03126110|516086286|FG007|Phase 2|Withdrawal by Subject|0|||
143147857|NCT03126110|516086287|FG008|Phase 2|Withdrawal by Subject|0|||
143147858|NCT03126110|516086288|FG009|Phase 2|Withdrawal by Subject|0|||
143147859|NCT03126110|516086289|FG010|Phase 2|Withdrawal by Subject|0|||
143147860|NCT03126110|516086290|FG011|Phase 2|Withdrawal by Subject|1|||
143147861|NCT03126110|516086291|FG012|Phase 2|Withdrawal by Subject|3|||
143147862|NCT03126110|516086292|FG013|Phase 2|Withdrawal by Subject|3|||
143147863|NCT03126110|516086293|FG014|Phase 2|Withdrawal by Subject|2|||
143147864|NCT03126110|516086294|FG015|Phase 2|Withdrawal by Subject|1|||
143147865|NCT03126110|516086295|FG016|Phase 2|Withdrawal by Subject|0|||
143147866|NCT03126110|516086279|FG000|Phase 2|Lost to Follow-up|0|||
143147867|NCT03126110|516086280|FG001|Phase 2|Lost to Follow-up|0|||
143147868|NCT03126110|516086281|FG002|Phase 2|Lost to Follow-up|0|||
143147869|NCT03126110|516086282|FG003|Phase 2|Lost to Follow-up|0|||
143147870|NCT03126110|516086283|FG004|Phase 2|Lost to Follow-up|0|||
143147871|NCT03126110|516086284|FG005|Phase 2|Lost to Follow-up|0|||
143147872|NCT03126110|516086285|FG006|Phase 2|Lost to Follow-up|0|||
143147873|NCT03126110|516086286|FG007|Phase 2|Lost to Follow-up|0|||
143147874|NCT03126110|516086287|FG008|Phase 2|Lost to Follow-up|0|||
143147875|NCT03126110|516086288|FG009|Phase 2|Lost to Follow-up|0|||
143147876|NCT03126110|516086289|FG010|Phase 2|Lost to Follow-up|0|||
143147877|NCT03126110|516086290|FG011|Phase 2|Lost to Follow-up|1|||
143147878|NCT03126110|516086291|FG012|Phase 2|Lost to Follow-up|1|||
143147879|NCT03126110|516086292|FG013|Phase 2|Lost to Follow-up|1|||
143147880|NCT03126110|516086293|FG014|Phase 2|Lost to Follow-up|2|||
143147881|NCT03126110|516086294|FG015|Phase 2|Lost to Follow-up|0|||
143147882|NCT03126110|516086295|FG016|Phase 2|Lost to Follow-up|0|||
143147883|NCT03126110|516086279|FG000|Phase 2|Death|0|||
143147884|NCT03126110|516086280|FG001|Phase 2|Death|0|||
143147885|NCT03126110|516086281|FG002|Phase 2|Death|0|||
143147886|NCT03126110|516086282|FG003|Phase 2|Death|0|||
143147887|NCT03126110|516086283|FG004|Phase 2|Death|0|||
143147888|NCT03126110|516086284|FG005|Phase 2|Death|0|||
143147889|NCT03126110|516086285|FG006|Phase 2|Death|0|||
143147890|NCT03126110|516086286|FG007|Phase 2|Death|0|||
143147891|NCT03126110|516086287|FG008|Phase 2|Death|0|||
143147892|NCT03126110|516086288|FG009|Phase 2|Death|0|||
143147893|NCT03126110|516086289|FG010|Phase 2|Death|0|||
143147894|NCT03126110|516086290|FG011|Phase 2|Death|6|||
143147895|NCT03126110|516086291|FG012|Phase 2|Death|12|||
143480797|NCT01376778|517305382|FG001|Overall Study|Lost to Follow-up|2|||
143480798|NCT00454857|517305384|FG000|Overall Study|Withdrawal by Subject|15|||
143480799|NCT00454857|517305384|FG000|Overall Study|Lost to Follow-up|16|||
143480800|NCT00454857|517305384|FG000|Overall Study|Noncompliance|6|||
143147896|NCT03126110|516086292|FG013|Phase 2|Death|25|||
143147897|NCT03126110|516086293|FG014|Phase 2|Death|11|||
143147898|NCT03126110|516086294|FG015|Phase 2|Death|3|||
143147899|NCT03126110|516086295|FG016|Phase 2|Death|2|||
143147900|NCT03126110|516086279|FG000|Phase 2|Progressive Disease|0|||
143147901|NCT03126110|516086280|FG001|Phase 2|Progressive Disease|0|||
143147902|NCT03126110|516086281|FG002|Phase 2|Progressive Disease|0|||
143147903|NCT03126110|516086282|FG003|Phase 2|Progressive Disease|0|||
143147904|NCT03126110|516086283|FG004|Phase 2|Progressive Disease|0|||
143147905|NCT03126110|516086284|FG005|Phase 2|Progressive Disease|0|||
143147906|NCT03126110|516086285|FG006|Phase 2|Progressive Disease|0|||
143147907|NCT03126110|516086286|FG007|Phase 2|Progressive Disease|0|||
143147908|NCT03126110|516086287|FG008|Phase 2|Progressive Disease|0|||
143147909|NCT03126110|516086288|FG009|Phase 2|Progressive Disease|0|||
143480801|NCT00454857|517305384|FG000|Overall Study|Death|5|||
143147910|NCT03126110|516086289|FG010|Phase 2|Progressive Disease|0|||
143147911|NCT03126110|516086290|FG011|Phase 2|Progressive Disease|0|||
143147912|NCT03126110|516086291|FG012|Phase 2|Progressive Disease|0|||
143147913|NCT03126110|516086292|FG013|Phase 2|Progressive Disease|1|||
143480802|NCT00454857|517305384|FG000|Overall Study|Other|11|||
143480803|NCT00454857|517305384|FG000|Overall Study|Reason unknown|1|||
143480804|NCT00632099|517305387|FG000|Overall Study|Lost to Follow-up|3|||
143480805|NCT00632099|517305388|FG001|Overall Study|Lost to Follow-up|3|||
143480806|NCT01923285|517305397|FG000|Overall Study|Withdrawal by Subject|7|||
143480807|NCT01923285|517305398|FG001|Overall Study|Withdrawal by Subject|6|||
143480808|NCT03374189|517305399|FG000|Overall Study|Lost to Follow-up|1|||
143480809|NCT03374189|517305400|FG001|Overall Study|Lost to Follow-up|0|||
143480810|NCT02375724|517305401|FG000|Overall Study|Lack of Efficacy|1|||
143480811|NCT02375724|517305402|FG001|Overall Study|Lack of Efficacy|1|||
143480812|NCT02375724|517305401|FG000|Overall Study|Withdrawal by Subject|1|||
143480813|NCT02375724|517305402|FG001|Overall Study|Withdrawal by Subject|1|||
143480814|NCT02375724|517305401|FG000|Overall Study|Lost to Follow-up|1|||
143480815|NCT02375724|517305402|FG001|Overall Study|Lost to Follow-up|0|||
143480816|NCT02375724|517305401|FG000|Overall Study|Protocol Violation|1|||
143480817|NCT02375724|517305402|FG001|Overall Study|Protocol Violation|0|||
143480818|NCT02375724|517305401|FG000|Overall Study|Adverse Event|2|||
143480819|NCT02375724|517305402|FG001|Overall Study|Adverse Event|4|||
143480820|NCT01517893|517305405|FG000|Overall Study|Withdrawal by Subject|3|||
143480821|NCT01517893|517305406|FG001|Overall Study|Withdrawal by Subject|0|||
143480822|NCT03462576|517305407|FG000|Overall Study|Protocol Violation|5|||
143480823|NCT03462576|517305408|FG001|Overall Study|Protocol Violation|11|||
143480824|NCT03462576|517305409|FG002|Overall Study|Protocol Violation|7|||
143480825|NCT03462576|517305407|FG000|Overall Study|Device Malfunction|0|||
143480826|NCT03462576|517305408|FG001|Overall Study|Device Malfunction|0|||
143480827|NCT03462576|517305409|FG002|Overall Study|Device Malfunction|1|||
143480828|NCT02285777|517305410|FG000|Overall Study|Withdrawal by Subject|1|||
143480829|NCT02285777|517305411|FG001|Overall Study|Withdrawal by Subject|1|||
143480830|NCT02285777|517305410|FG000|Overall Study|Lost to Follow-up|4|||
143480831|NCT02285777|517305411|FG001|Overall Study|Lost to Follow-up|2|||
143480832|NCT03962101|517305412|FG000|Overall Study|Adverse Event|1|||
143480833|NCT03962101|517305412|FG000|Overall Study|Physician Decision|2|||
143480834|NCT03962101|517305412|FG000|Overall Study|Not related to medical events|1|||
143480835|NCT00271596|517305413|FG000|Overall Study|Protocol Violation|1|||
143480836|NCT00271596|517305414|FG001|Overall Study|Protocol Violation|0|||
143480837|NCT00271596|517305413|FG000|Overall Study|Withdrawal by Subject|0|||
143480838|NCT00271596|517305414|FG001|Overall Study|Withdrawal by Subject|1|||
143480839|NCT01543828|517305415|FG000|Treatment 2|Lost to Follow-up|1|||
143480840|NCT01543828|517305416|FG001|Treatment 2|Lost to Follow-up|0|||
143480841|NCT01069172|517305417|FG000|Overall Study|Withdrawal by Subject|1|||
143480842|NCT01069172|517305418|FG001|Overall Study|Withdrawal by Subject|0|||
143480843|NCT00711425|517305422|FG000|Overall Study|Protocol Violation|1|||
143480844|NCT00711425|517305422|FG000|Overall Study|Death|2|||
143480845|NCT00711425|517305422|FG000|Overall Study|Lost to Follow-up|1|||
143480846|NCT03901079|517305425|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
143480847|NCT00843518|517305426|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
143480848|NCT00843518|517305427|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
143480849|NCT00843518|517305426|FG000|Period 2 (Double-blind Treatment)|Death|0|||
143480850|NCT00843518|517305427|FG001|Period 2 (Double-blind Treatment)|Death|1|||
143480851|NCT00843518|517305426|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
143480852|NCT00843518|517305427|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
143480853|NCT00843518|517305426|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
143480854|NCT00843518|517305427|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
143480855|NCT00843518|517305426|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
143480856|NCT00843518|517305427|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
143480857|NCT00843518|517305426|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
143480858|NCT00843518|517305427|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
143480859|NCT00843518|517305426|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
143480860|NCT00843518|517305427|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
143480861|NCT04607148|517305432|FG000|Overall Study|Withdrawal by Subject|0|||
143480862|NCT04607148|517305433|FG001|Overall Study|Withdrawal by Subject|4|||
143480863|NCT04607148|517305434|FG002|Overall Study|Withdrawal by Subject|2|||
143480864|NCT04607148|517305435|FG003|Overall Study|Withdrawal by Subject|8|||
143480865|NCT04607148|517305432|FG000|Overall Study|Study Terminated by Sponsor|14|||
143480866|NCT04607148|517305433|FG001|Overall Study|Study Terminated by Sponsor|59|||
143480867|NCT04607148|517305434|FG002|Overall Study|Study Terminated by Sponsor|9|||
143480868|NCT04607148|517305435|FG003|Overall Study|Study Terminated by Sponsor|39|||
143480869|NCT04607148|517305432|FG000|Overall Study|Sponsor Decision|0|||
143480870|NCT04607148|517305433|FG001|Overall Study|Sponsor Decision|0|||
143480871|NCT04607148|517305434|FG002|Overall Study|Sponsor Decision|1|||
143480872|NCT04607148|517305435|FG003|Overall Study|Sponsor Decision|0|||
143480873|NCT04607148|517305432|FG000|Overall Study|Non-Compliance With Study Drug|0|||
143480874|NCT04607148|517305433|FG001|Overall Study|Non-Compliance With Study Drug|1|||
143480875|NCT04607148|517305434|FG002|Overall Study|Non-Compliance With Study Drug|0|||
143480876|NCT04607148|517305435|FG003|Overall Study|Non-Compliance With Study Drug|0|||
143480877|NCT04607148|517305432|FG000|Overall Study|Lost to Follow-up|0|||
143480878|NCT04607148|517305433|FG001|Overall Study|Lost to Follow-up|2|||
143014190|NCT02149199|515591648|FG002|Overall Study|Lost to Follow-up|11|||
143014191|NCT02149199|515591646|FG000|Overall Study|Death|0|||
143014192|NCT02149199|515591647|FG001|Overall Study|Death|0|||
143014193|NCT02149199|515591648|FG002|Overall Study|Death|1|||
143147914|NCT03126110|516086293|FG014|Phase 2|Progressive Disease|0|||
143147915|NCT03126110|516086294|FG015|Phase 2|Progressive Disease|0|||
143147916|NCT03126110|516086295|FG016|Phase 2|Progressive Disease|0|||
143147917|NCT03126110|516086279|FG000|Phase 2|Started new treatment|0|||
143147918|NCT03126110|516086280|FG001|Phase 2|Started new treatment|0|||
143147919|NCT03126110|516086281|FG002|Phase 2|Started new treatment|0|||
143147920|NCT03126110|516086282|FG003|Phase 2|Started new treatment|0|||
143147921|NCT03126110|516086283|FG004|Phase 2|Started new treatment|0|||
143147922|NCT03126110|516086284|FG005|Phase 2|Started new treatment|0|||
143147923|NCT03126110|516086285|FG006|Phase 2|Started new treatment|0|||
143147924|NCT03126110|516086286|FG007|Phase 2|Started new treatment|0|||
143147925|NCT03126110|516086287|FG008|Phase 2|Started new treatment|0|||
143147926|NCT03126110|516086288|FG009|Phase 2|Started new treatment|0|||
143147927|NCT03126110|516086289|FG010|Phase 2|Started new treatment|0|||
143147928|NCT03126110|516086290|FG011|Phase 2|Started new treatment|0|||
143147929|NCT03126110|516086291|FG012|Phase 2|Started new treatment|0|||
143147930|NCT03126110|516086292|FG013|Phase 2|Started new treatment|0|||
143147931|NCT03126110|516086293|FG014|Phase 2|Started new treatment|1|||
143147932|NCT03126110|516086294|FG015|Phase 2|Started new treatment|0|||
143147933|NCT03126110|516086295|FG016|Phase 2|Started new treatment|0|||
143147934|NCT04435626|516086298|FG000|Overall Study|Lost to Follow-up|1|||
143147935|NCT04435626|516086299|FG001|Overall Study|Lost to Follow-up|5|||
143147936|NCT04435626|516086298|FG000|Overall Study|Withdrawal by Subject|6|||
143147937|NCT04435626|516086299|FG001|Overall Study|Withdrawal by Subject|7|||
143147938|NCT04435626|516086298|FG000|Overall Study|major GCP violations|8|||
143147939|NCT04435626|516086299|FG001|Overall Study|major GCP violations|7|||
143147940|NCT01160614|516086302|FG000|Overall Study|Withdrawal by Subject|0|||
143147941|NCT01160614|516086303|FG001|Overall Study|Withdrawal by Subject|2|||
143147942|NCT03314935|516086305|FG000|Phase 1|Death|4|||
143147943|NCT03314935|516086306|FG001|Phase 1|Death|2|||
143147944|NCT03314935|516086307|FG002|Phase 1|Death|5|||
143147945|NCT03314935|516086308|FG003|Phase 1|Death|4|||
143147946|NCT03314935|516086309|FG004|Phase 1|Death|3|||
143147947|NCT03314935|516086310|FG005|Phase 1|Death|4|||
143147948|NCT03314935|516086311|FG006|Phase 1|Death|5|||
143147949|NCT03314935|516086312|FG007|Phase 1|Death|4|||
143147950|NCT03314935|516086313|FG008|Phase 1|Death|3|||
143147951|NCT03314935|516086314|FG009|Phase 1|Death|0|||
143147952|NCT03314935|516086315|FG010|Phase 1|Death|0|||
143147953|NCT03314935|516086316|FG011|Phase 1|Death|0|||
143147954|NCT03314935|516086317|FG012|Phase 1|Death|0|||
143147955|NCT03314935|516086318|FG013|Phase 1|Death|0|||
143147956|NCT03314935|516086319|FG014|Phase 1|Death|0|||
143480879|NCT04607148|517305434|FG002|Overall Study|Lost to Follow-up|0|||
143147957|NCT03314935|516086305|FG000|Phase 1|Withdrawal by Subject|2|||
143147958|NCT03314935|516086306|FG001|Phase 1|Withdrawal by Subject|1|||
143147959|NCT03314935|516086307|FG002|Phase 1|Withdrawal by Subject|1|||
143147960|NCT03314935|516086308|FG003|Phase 1|Withdrawal by Subject|2|||
143147961|NCT03314935|516086309|FG004|Phase 1|Withdrawal by Subject|1|||
143147962|NCT03314935|516086310|FG005|Phase 1|Withdrawal by Subject|0|||
143480880|NCT04607148|517305435|FG003|Overall Study|Lost to Follow-up|0|||
143480881|NCT04607148|517305432|FG000|Overall Study|Death|0|||
143480882|NCT04607148|517305433|FG001|Overall Study|Death|3|||
143147963|NCT03314935|516086311|FG006|Phase 1|Withdrawal by Subject|1|||
143480883|NCT04607148|517305434|FG002|Overall Study|Death|0|||
143014194|NCT02149199|515591646|FG000|Overall Study|Adverse Event|6|||
143014195|NCT02149199|515591647|FG001|Overall Study|Adverse Event|15|||
143014196|NCT02149199|515591648|FG002|Overall Study|Adverse Event|9|||
143014197|NCT01500434|515591651|FG000|Overall Study|Death|1|||
143147964|NCT03314935|516086312|FG007|Phase 1|Withdrawal by Subject|0|||
143014198|NCT01500434|515591651|FG000|Overall Study|Withdrawal by Subject|1|||
143147965|NCT03314935|516086313|FG008|Phase 1|Withdrawal by Subject|1|||
143147966|NCT03314935|516086314|FG009|Phase 1|Withdrawal by Subject|0|||
143147967|NCT03314935|516086315|FG010|Phase 1|Withdrawal by Subject|0|||
143147968|NCT03314935|516086316|FG011|Phase 1|Withdrawal by Subject|0|||
143147969|NCT03314935|516086317|FG012|Phase 1|Withdrawal by Subject|0|||
143147970|NCT03314935|516086318|FG013|Phase 1|Withdrawal by Subject|0|||
143147971|NCT03314935|516086319|FG014|Phase 1|Withdrawal by Subject|0|||
143147972|NCT03314935|516086305|FG000|Phase 1|Progressive Disease|2|||
143147973|NCT03314935|516086306|FG001|Phase 1|Progressive Disease|0|||
143147974|NCT03314935|516086307|FG002|Phase 1|Progressive Disease|0|||
143147975|NCT03314935|516086308|FG003|Phase 1|Progressive Disease|1|||
143147976|NCT03314935|516086309|FG004|Phase 1|Progressive Disease|0|||
143147977|NCT03314935|516086310|FG005|Phase 1|Progressive Disease|0|||
143147978|NCT03314935|516086311|FG006|Phase 1|Progressive Disease|0|||
143147979|NCT03314935|516086312|FG007|Phase 1|Progressive Disease|0|||
143480884|NCT04607148|517305435|FG003|Overall Study|Death|1|||
143480885|NCT04607148|517305432|FG000|Overall Study|Adverse Event|0|||
143480886|NCT04607148|517305433|FG001|Overall Study|Adverse Event|1|||
143480887|NCT04607148|517305434|FG002|Overall Study|Adverse Event|0|||
143480888|NCT04607148|517305435|FG003|Overall Study|Adverse Event|0|||
143480889|NCT00916149|517305436|FG000|Overall Study|Lost to Follow-up|3|||
143480890|NCT00916149|517305437|FG001|Overall Study|Lost to Follow-up|2|||
143480891|NCT00916149|517305438|FG002|Overall Study|Lost to Follow-up|0|||
143480892|NCT00916149|517305436|FG000|Overall Study|Unable to place scalp EEG leads|1|||
143480893|NCT00916149|517305437|FG001|Overall Study|Unable to place scalp EEG leads|0|||
143480894|NCT00916149|517305438|FG002|Overall Study|Unable to place scalp EEG leads|0|||
143480895|NCT00912028|517305439|FG000|Overall Study|Lost to Follow-up|2|||
143480896|NCT00912028|517305440|FG001|Overall Study|Lost to Follow-up|3|||
143480897|NCT00912028|517305441|FG002|Overall Study|Lost to Follow-up|0|||
143480898|NCT00912028|517305442|FG003|Overall Study|Lost to Follow-up|1|||
143480899|NCT00912028|517305443|FG004|Overall Study|Lost to Follow-up|3|||
143480900|NCT00912028|517305439|FG000|Overall Study|Withdrawal by Subject|3|||
143480901|NCT00912028|517305440|FG001|Overall Study|Withdrawal by Subject|0|||
143147980|NCT03314935|516086313|FG008|Phase 1|Progressive Disease|0|||
143147981|NCT03314935|516086314|FG009|Phase 1|Progressive Disease|0|||
143147982|NCT03314935|516086315|FG010|Phase 1|Progressive Disease|0|||
143147983|NCT03314935|516086316|FG011|Phase 1|Progressive Disease|0|||
143147984|NCT03314935|516086317|FG012|Phase 1|Progressive Disease|0|||
143147985|NCT03314935|516086318|FG013|Phase 1|Progressive Disease|0|||
143147986|NCT03314935|516086319|FG014|Phase 1|Progressive Disease|0|||
143147987|NCT03314935|516086305|FG000|Phase 1|Study Terminated by Sponsor|0|||
143147988|NCT03314935|516086306|FG001|Phase 1|Study Terminated by Sponsor|1|||
143147989|NCT03314935|516086307|FG002|Phase 1|Study Terminated by Sponsor|0|||
143147990|NCT03314935|516086308|FG003|Phase 1|Study Terminated by Sponsor|0|||
143147991|NCT03314935|516086309|FG004|Phase 1|Study Terminated by Sponsor|0|||
143147992|NCT03314935|516086310|FG005|Phase 1|Study Terminated by Sponsor|0|||
143147993|NCT03314935|516086311|FG006|Phase 1|Study Terminated by Sponsor|0|||
143147994|NCT03314935|516086312|FG007|Phase 1|Study Terminated by Sponsor|0|||
143147995|NCT03314935|516086313|FG008|Phase 1|Study Terminated by Sponsor|1|||
143147996|NCT03314935|516086314|FG009|Phase 1|Study Terminated by Sponsor|0|||
143147997|NCT03314935|516086315|FG010|Phase 1|Study Terminated by Sponsor|0|||
143147998|NCT03314935|516086316|FG011|Phase 1|Study Terminated by Sponsor|0|||
143147999|NCT03314935|516086317|FG012|Phase 1|Study Terminated by Sponsor|0|||
143148000|NCT03314935|516086318|FG013|Phase 1|Study Terminated by Sponsor|0|||
143148001|NCT03314935|516086319|FG014|Phase 1|Study Terminated by Sponsor|0|||
143148002|NCT03314935|516086305|FG000|Phase 1|"Captured as Other in Database"|0|||
143148003|NCT03314935|516086306|FG001|Phase 1|"Captured as Other in Database"|2|||
143148004|NCT03314935|516086307|FG002|Phase 1|"Captured as Other in Database"|0|||
143148005|NCT03314935|516086308|FG003|Phase 1|"Captured as Other in Database"|0|||
143148006|NCT03314935|516086309|FG004|Phase 1|"Captured as Other in Database"|0|||
143148007|NCT03314935|516086310|FG005|Phase 1|"Captured as Other in Database"|0|||
143148008|NCT03314935|516086311|FG006|Phase 1|"Captured as Other in Database"|1|||
143148009|NCT03314935|516086312|FG007|Phase 1|"Captured as Other in Database"|1|||
143148010|NCT03314935|516086313|FG008|Phase 1|"Captured as Other in Database"|1|||
143148011|NCT03314935|516086314|FG009|Phase 1|"Captured as Other in Database"|0|||
143148012|NCT03314935|516086315|FG010|Phase 1|"Captured as Other in Database"|0|||
143148013|NCT03314935|516086316|FG011|Phase 1|"Captured as Other in Database"|0|||
143148014|NCT03314935|516086317|FG012|Phase 1|"Captured as Other in Database"|0|||
143148015|NCT03314935|516086318|FG013|Phase 1|"Captured as Other in Database"|0|||
143148016|NCT03314935|516086319|FG014|Phase 1|"Captured as Other in Database"|0|||
143148017|NCT03314935|516086305|FG000|Phase 1|Lost to Follow-up|0|||
143148018|NCT03314935|516086306|FG001|Phase 1|Lost to Follow-up|0|||
143148019|NCT03314935|516086307|FG002|Phase 1|Lost to Follow-up|0|||
143148020|NCT03314935|516086308|FG003|Phase 1|Lost to Follow-up|0|||
143148021|NCT03314935|516086309|FG004|Phase 1|Lost to Follow-up|0|||
143148022|NCT03314935|516086310|FG005|Phase 1|Lost to Follow-up|0|||
143148023|NCT03314935|516086311|FG006|Phase 1|Lost to Follow-up|0|||
143148024|NCT03314935|516086312|FG007|Phase 1|Lost to Follow-up|0|||
143148025|NCT03314935|516086313|FG008|Phase 1|Lost to Follow-up|1|||
143148026|NCT03314935|516086314|FG009|Phase 1|Lost to Follow-up|0|||
143148027|NCT03314935|516086315|FG010|Phase 1|Lost to Follow-up|0|||
143148028|NCT03314935|516086316|FG011|Phase 1|Lost to Follow-up|0|||
143148029|NCT03314935|516086317|FG012|Phase 1|Lost to Follow-up|0|||
143148030|NCT03314935|516086318|FG013|Phase 1|Lost to Follow-up|0|||
143148031|NCT03314935|516086319|FG014|Phase 1|Lost to Follow-up|0|||
143148032|NCT03314935|516086305|FG000|Phase 2|Death|0|||
143148033|NCT03314935|516086306|FG001|Phase 2|Death|0|||
143148034|NCT03314935|516086307|FG002|Phase 2|Death|0|||
143148035|NCT03314935|516086308|FG003|Phase 2|Death|0|||
143148036|NCT03314935|516086309|FG004|Phase 2|Death|0|||
143148037|NCT03314935|516086310|FG005|Phase 2|Death|0|||
143148038|NCT03314935|516086311|FG006|Phase 2|Death|0|||
143148039|NCT03314935|516086312|FG007|Phase 2|Death|0|||
143148040|NCT03314935|516086313|FG008|Phase 2|Death|0|||
143148041|NCT03314935|516086314|FG009|Phase 2|Death|5|||
143480902|NCT00912028|517305441|FG002|Overall Study|Withdrawal by Subject|0|||
143480903|NCT00912028|517305442|FG003|Overall Study|Withdrawal by Subject|0|||
143480904|NCT00912028|517305443|FG004|Overall Study|Withdrawal by Subject|0|||
143480905|NCT03002155|517305444|FG000|Overall Study|Lost to Follow-up|1|||
143480906|NCT03002155|517305445|FG001|Overall Study|Lost to Follow-up|2|||
143480907|NCT03002155|517305444|FG000|Overall Study|Withdrawal by Subject|1|||
143480908|NCT03002155|517305445|FG001|Overall Study|Withdrawal by Subject|0|||
143480909|NCT03002155|517305444|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
143480910|NCT03002155|517305445|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
143480911|NCT03451084|517305448|FG000|Overall Study|Withdrawal by Subject|2|||
143480912|NCT03451084|517305449|FG001|Overall Study|Withdrawal by Subject|1|||
143480913|NCT03451084|517305450|FG002|Overall Study|Withdrawal by Subject|2|||
143480914|NCT03451084|517305451|FG003|Overall Study|Withdrawal by Subject|1|||
143480915|NCT03451084|517305448|FG000|Overall Study|Disease recurrence|0|||
143480916|NCT03451084|517305449|FG001|Overall Study|Disease recurrence|2|||
143480917|NCT03451084|517305450|FG002|Overall Study|Disease recurrence|0|||
143480918|NCT03451084|517305451|FG003|Overall Study|Disease recurrence|0|||
143480919|NCT03451084|517305448|FG000|Overall Study|Lack of Efficacy|0|||
143480920|NCT03451084|517305449|FG001|Overall Study|Lack of Efficacy|3|||
143480921|NCT03451084|517305450|FG002|Overall Study|Lack of Efficacy|0|||
143480922|NCT03451084|517305451|FG003|Overall Study|Lack of Efficacy|1|||
143480923|NCT03451084|517305448|FG000|Overall Study|Death|1|||
143480924|NCT03451084|517305449|FG001|Overall Study|Death|0|||
143480925|NCT03451084|517305450|FG002|Overall Study|Death|2|||
143480926|NCT03451084|517305451|FG003|Overall Study|Death|0|||
143480927|NCT03451084|517305448|FG000|Overall Study|Physician Decision|0|||
143480928|NCT03451084|517305449|FG001|Overall Study|Physician Decision|0|||
143480929|NCT03451084|517305450|FG002|Overall Study|Physician Decision|2|||
143480930|NCT03451084|517305451|FG003|Overall Study|Physician Decision|2|||
143480931|NCT03451084|517305448|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
143480932|NCT03451084|517305449|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
143480933|NCT03451084|517305450|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
143480934|NCT03451084|517305451|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
143480935|NCT04995055|517305452|FG000|Period 1|COVID-19 Related|1|||
143480936|NCT04995055|517305453|FG001|Period 1|COVID-19 Related|0|||
143480937|NCT04995055|517305452|FG000|Period 1|Withdrawal by Subject|0|||
143480938|NCT04995055|517305453|FG001|Period 1|Withdrawal by Subject|1|||
143480939|NCT04995055|517305452|FG000|Period 1|Subject discontinued due to timing|4|||
143480940|NCT04995055|517305453|FG001|Period 1|Subject discontinued due to timing|4|||
143480941|NCT03418129|517305456|FG000|Overall Study|Lost to Follow-up|11|||
143480942|NCT03418129|517305457|FG001|Overall Study|Lost to Follow-up|20|||
143480943|NCT03418129|517305458|FG002|Overall Study|Lost to Follow-up|15|||
143480944|NCT03418129|517305456|FG000|Overall Study|Withdrawal by Subject|3|||
143480945|NCT03418129|517305457|FG001|Overall Study|Withdrawal by Subject|6|||
143480946|NCT03418129|517305458|FG002|Overall Study|Withdrawal by Subject|4|||
143480947|NCT01617070|517305470|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
143480948|NCT05289570|517305471|FG000|Overall Study|Physician Decision|1|||
143480949|NCT04544475|517305472|FG000|Overall Study|Withdrawal by Subject|1|||
143480950|NCT04544475|517305473|FG001|Overall Study|Withdrawal by Subject|3|||
143148042|NCT03314935|516086315|FG010|Phase 2|Death|20|||
143148043|NCT03314935|516086316|FG011|Phase 2|Death|6|||
143148044|NCT03314935|516086317|FG012|Phase 2|Death|7|||
143148045|NCT03314935|516086318|FG013|Phase 2|Death|6|||
143148046|NCT03314935|516086319|FG014|Phase 2|Death|17|||
143148047|NCT03314935|516086305|FG000|Phase 2|Withdrawal by Subject|0|||
143148048|NCT03314935|516086306|FG001|Phase 2|Withdrawal by Subject|0|||
143148049|NCT03314935|516086307|FG002|Phase 2|Withdrawal by Subject|0|||
143148050|NCT03314935|516086308|FG003|Phase 2|Withdrawal by Subject|0|||
143148051|NCT03314935|516086309|FG004|Phase 2|Withdrawal by Subject|0|||
143148052|NCT03314935|516086310|FG005|Phase 2|Withdrawal by Subject|0|||
143148053|NCT03314935|516086311|FG006|Phase 2|Withdrawal by Subject|0|||
143148054|NCT03314935|516086312|FG007|Phase 2|Withdrawal by Subject|0|||
143148055|NCT03314935|516086313|FG008|Phase 2|Withdrawal by Subject|0|||
143148056|NCT03314935|516086314|FG009|Phase 2|Withdrawal by Subject|1|||
143148057|NCT03314935|516086315|FG010|Phase 2|Withdrawal by Subject|4|||
143148058|NCT03314935|516086316|FG011|Phase 2|Withdrawal by Subject|0|||
143148059|NCT03314935|516086317|FG012|Phase 2|Withdrawal by Subject|1|||
143148060|NCT03314935|516086318|FG013|Phase 2|Withdrawal by Subject|0|||
143148061|NCT03314935|516086319|FG014|Phase 2|Withdrawal by Subject|1|||
143148062|NCT03314935|516086305|FG000|Phase 2|Progressive Disease|0|||
143148063|NCT03314935|516086306|FG001|Phase 2|Progressive Disease|0|||
143148064|NCT03314935|516086307|FG002|Phase 2|Progressive Disease|0|||
143148065|NCT03314935|516086308|FG003|Phase 2|Progressive Disease|0|||
143148066|NCT03314935|516086309|FG004|Phase 2|Progressive Disease|0|||
143480951|NCT00808236|517305474|FG000|Overall Study|Was not resuscitated|50|||
143480952|NCT00808236|517305475|FG001|Overall Study|Was not resuscitated|56|||
143480953|NCT00808236|517305474|FG000|Overall Study|Pre-defined exclusion|13|||
143480954|NCT00808236|517305475|FG001|Overall Study|Pre-defined exclusion|3|||
143480955|NCT00808236|517305474|FG000|Overall Study|Lost to Follow-up|1|||
143480956|NCT00808236|517305475|FG001|Overall Study|Lost to Follow-up|1|||
143480957|NCT00808236|517305474|FG000|Overall Study|Physician Decision|0|||
143480958|NCT00808236|517305475|FG001|Overall Study|Physician Decision|1|||
143480959|NCT00808236|517305474|FG000|Overall Study|Death|18|||
143480960|NCT00808236|517305475|FG001|Overall Study|Death|30|||
143480961|NCT01147744|517305476|FG000|Overall Study|Protocol Violation|1|||
143480962|NCT01147744|517305477|FG001|Overall Study|Protocol Violation|0|||
143480963|NCT01147744|517305478|FG002|Overall Study|Protocol Violation|1|||
143480964|NCT01147744|517305479|FG003|Overall Study|Protocol Violation|0|||
143480965|NCT01147744|517305480|FG004|Overall Study|Protocol Violation|1|||
143480966|NCT01147744|517305481|FG005|Overall Study|Protocol Violation|3|||
143480967|NCT01147744|517305482|FG006|Overall Study|Protocol Violation|1|||
143480968|NCT01147744|517305476|FG000|Overall Study|Physician Decision|0|||
143480969|NCT01147744|517305477|FG001|Overall Study|Physician Decision|1|||
143480970|NCT01147744|517305478|FG002|Overall Study|Physician Decision|1|||
143480971|NCT01147744|517305479|FG003|Overall Study|Physician Decision|0|||
143480972|NCT01147744|517305480|FG004|Overall Study|Physician Decision|0|||
143480973|NCT01147744|517305481|FG005|Overall Study|Physician Decision|0|||
143480974|NCT01147744|517305482|FG006|Overall Study|Physician Decision|1|||
143480975|NCT01147744|517305476|FG000|Overall Study|Lack of Efficacy|11|||
143480976|NCT01147744|517305477|FG001|Overall Study|Lack of Efficacy|11|||
143480977|NCT01147744|517305478|FG002|Overall Study|Lack of Efficacy|9|||
143480978|NCT01147744|517305479|FG003|Overall Study|Lack of Efficacy|11|||
143480979|NCT01147744|517305480|FG004|Overall Study|Lack of Efficacy|13|||
143480980|NCT01147744|517305481|FG005|Overall Study|Lack of Efficacy|8|||
143480981|NCT01147744|517305482|FG006|Overall Study|Lack of Efficacy|7|||
143148067|NCT03314935|516086310|FG005|Phase 2|Progressive Disease|0|||
143148068|NCT03314935|516086311|FG006|Phase 2|Progressive Disease|0|||
143148069|NCT03314935|516086312|FG007|Phase 2|Progressive Disease|0|||
143148070|NCT03314935|516086313|FG008|Phase 2|Progressive Disease|0|||
143480982|NCT01147744|517305476|FG000|Overall Study|Adverse Event|1|||
143480983|NCT01147744|517305477|FG001|Overall Study|Adverse Event|2|||
143480984|NCT01147744|517305478|FG002|Overall Study|Adverse Event|3|||
143480985|NCT01147744|517305479|FG003|Overall Study|Adverse Event|0|||
143480986|NCT01147744|517305480|FG004|Overall Study|Adverse Event|2|||
143480987|NCT01147744|517305481|FG005|Overall Study|Adverse Event|1|||
143480988|NCT01147744|517305482|FG006|Overall Study|Adverse Event|2|||
143480989|NCT01147744|517305476|FG000|Overall Study|Withdrawal by Subject|8|||
143480990|NCT01147744|517305477|FG001|Overall Study|Withdrawal by Subject|4|||
143480991|NCT01147744|517305478|FG002|Overall Study|Withdrawal by Subject|2|||
143480992|NCT01147744|517305479|FG003|Overall Study|Withdrawal by Subject|2|||
143480993|NCT01147744|517305480|FG004|Overall Study|Withdrawal by Subject|2|||
143480994|NCT01147744|517305481|FG005|Overall Study|Withdrawal by Subject|5|||
143480995|NCT01147744|517305482|FG006|Overall Study|Withdrawal by Subject|2|||
143480996|NCT01147744|517305476|FG000|Overall Study|Lost to Follow-up|0|||
143480997|NCT01147744|517305477|FG001|Overall Study|Lost to Follow-up|1|||
143480998|NCT01147744|517305478|FG002|Overall Study|Lost to Follow-up|0|||
143480999|NCT01147744|517305479|FG003|Overall Study|Lost to Follow-up|0|||
143481000|NCT01147744|517305480|FG004|Overall Study|Lost to Follow-up|0|||
143481001|NCT01147744|517305481|FG005|Overall Study|Lost to Follow-up|0|||
143481002|NCT01147744|517305482|FG006|Overall Study|Lost to Follow-up|0|||
143481003|NCT01147744|517305476|FG000|Overall Study|Sponsor decision to amend protocol|7|||
143481004|NCT01147744|517305477|FG001|Overall Study|Sponsor decision to amend protocol|4|||
143481005|NCT01147744|517305478|FG002|Overall Study|Sponsor decision to amend protocol|2|||
143481006|NCT01147744|517305479|FG003|Overall Study|Sponsor decision to amend protocol|5|||
143481007|NCT01147744|517305480|FG004|Overall Study|Sponsor decision to amend protocol|7|||
143481008|NCT01147744|517305481|FG005|Overall Study|Sponsor decision to amend protocol|2|||
143481009|NCT01147744|517305482|FG006|Overall Study|Sponsor decision to amend protocol|6|||
143481010|NCT01147744|517305476|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
143481011|NCT01147744|517305477|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
143481012|NCT01147744|517305478|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
143481013|NCT01147744|517305479|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
143481014|NCT01147744|517305480|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
143481015|NCT01147744|517305481|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
143481016|NCT01147744|517305482|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
143481017|NCT01342484|517305491|FG000|Overall Study|Other Reasons|1|||
143481018|NCT01342484|517305492|FG001|Overall Study|Other Reasons|0|||
143481019|NCT01342484|517305493|FG002|Overall Study|Other Reasons|0|||
143481020|NCT01342484|517305491|FG000|Overall Study|Protocol Violation|0|||
143148071|NCT03314935|516086314|FG009|Phase 2|Progressive Disease|1|||
143481021|NCT01342484|517305492|FG001|Overall Study|Protocol Violation|0|||
143481022|NCT01342484|517305493|FG002|Overall Study|Protocol Violation|1|||
143481023|NCT01342484|517305491|FG000|Overall Study|Withdrawal by Subject|1|||
143481024|NCT01342484|517305492|FG001|Overall Study|Withdrawal by Subject|0|||
143148072|NCT03314935|516086315|FG010|Phase 2|Progressive Disease|1|||
143481025|NCT01342484|517305493|FG002|Overall Study|Withdrawal by Subject|0|||
143481026|NCT00388973|517307333|FG000|Overall Study|Adverse Event|16|||
143481027|NCT00388973|517307334|FG001|Overall Study|Adverse Event|6|||
143481028|NCT00388973|517307333|FG000|Overall Study|Lack of Efficacy|1|||
143481029|NCT00388973|517307334|FG001|Overall Study|Lack of Efficacy|12|||
143481030|NCT00388973|517307333|FG000|Overall Study|Protocol Violation|3|||
143481031|NCT00388973|517307334|FG001|Overall Study|Protocol Violation|0|||
143481032|NCT00388973|517307333|FG000|Overall Study|Withdrawal by Subject|14|||
143481033|NCT00388973|517307334|FG001|Overall Study|Withdrawal by Subject|17|||
143481034|NCT00388973|517307333|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
143481035|NCT00388973|517307334|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
143481036|NCT00388973|517307333|FG000|Overall Study|Did not complete 61 days of treatment|5|||
143481037|NCT00388973|517307334|FG001|Overall Study|Did not complete 61 days of treatment|4|||
143481038|NCT00388973|517307333|FG000|Overall Study|Left region|0|||
143481039|NCT00388973|517307334|FG001|Overall Study|Left region|1|||
143481040|NCT00388973|517307333|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
143481041|NCT00388973|517307334|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
143481042|NCT01617460|517307344|FG000|Overall Study|Adverse Event|10|||
143481043|NCT01617460|517307344|FG000|Overall Study|Physician Decision|16|||
143481044|NCT01617460|517307344|FG000|Overall Study|Protocol Violation|5|||
143481045|NCT01617460|517307344|FG000|Overall Study|Withdrawal by Subject|9|||
143481046|NCT00457015|517307348|FG000|Overall Study|Left study site against medical advice|0|||
143481047|NCT00457015|517307349|FG001|Overall Study|Left study site against medical advice|1|||
143481048|NCT00075023|517307350|FG000|Pilot Study|Physician Decision|1|||
143481049|NCT00075023|517307351|FG001|Pilot Study|Physician Decision|2|||
143481050|NCT00075023|517307350|FG000|Pilot Study|Withdrawal by Subject|1|||
143481051|NCT00075023|517307351|FG001|Pilot Study|Withdrawal by Subject|0|||
143481052|NCT04342871|517307352|FG000|Overall Study|Death|4|||
143481053|NCT04342871|517307352|FG000|Overall Study|Clinical deterioration/illness progression|2|||
143481054|NCT04342871|517307352|FG000|Overall Study|Did not complete baseline assessments|5|||
143481055|NCT04342871|517307352|FG000|Overall Study|Lost to Follow-up|13|||
143481056|NCT00666458|517307353|FG000|Overall Study|Adverse Event|8|||
143481057|NCT00666458|517307354|FG001|Overall Study|Adverse Event|7|||
143481058|NCT00666458|517307353|FG000|Overall Study|Withdrawal by Subject|5|||
143481059|NCT00666458|517307354|FG001|Overall Study|Withdrawal by Subject|4|||
143481060|NCT00666458|517307353|FG000|Overall Study|Lost to Follow-up|0|||
143481061|NCT00666458|517307354|FG001|Overall Study|Lost to Follow-up|3|||
143481062|NCT00666458|517307353|FG000|Overall Study|Administrative reason by sponsor|1|||
143481063|NCT00666458|517307354|FG001|Overall Study|Administrative reason by sponsor|1|||
143481064|NCT00666458|517307353|FG000|Overall Study|Incorrect enrollment|7|||
143481065|NCT00666458|517307354|FG001|Overall Study|Incorrect enrollment|1|||
143481066|NCT00666458|517307353|FG000|Overall Study|Study specific discontinuation criteria|14|||
143481067|NCT00666458|517307354|FG001|Overall Study|Study specific discontinuation criteria|7|||
143481068|NCT00666458|517307353|FG000|Overall Study|Severe non-compliance to the protocol|1|||
143481069|NCT00666458|517307354|FG001|Overall Study|Severe non-compliance to the protocol|1|||
143481070|NCT00666458|517307353|FG000|Overall Study|Safety reasons|1|||
143481071|NCT00666458|517307354|FG001|Overall Study|Safety reasons|0|||
143481072|NCT00666458|517307353|FG000|Overall Study|Medical history of anemia|1|||
143481073|NCT00666458|517307354|FG001|Overall Study|Medical history of anemia|0|||
143481074|NCT02222207|517307355|FG000|Overall Study|Death|1|||
143481075|NCT02222207|517307355|FG000|Overall Study|Other reasons|2|||
143481076|NCT02222207|517307355|FG000|Overall Study|Adverse Event|1|||
143481077|NCT01429584|517307359|FG000|Overall Study|Withdrawal by Subject|1|||
143481078|NCT01429584|517307360|FG001|Overall Study|Withdrawal by Subject|0|||
143481079|NCT01429584|517307359|FG000|Overall Study|Protocol Violation|0|||
143481080|NCT01429584|517307360|FG001|Overall Study|Protocol Violation|1|||
143481081|NCT00747643|517307361|FG000|Overall Study|Withdrawal by Subject|36|||
143481082|NCT00747643|517307362|FG001|Overall Study|Withdrawal by Subject|27|||
143481083|NCT00750698|517307363|FG000|Overall Study|Withdrawal by Subject|1|||
143481084|NCT00750698|517307364|FG001|Overall Study|Withdrawal by Subject|0|||
143481085|NCT00750698|517307363|FG000|Overall Study|Progressive disease|5|||
143481086|NCT00750698|517307364|FG001|Overall Study|Progressive disease|2|||
143481087|NCT01999465|517307365|FG000|Overall Study|Lost to Follow-up|0|||
143481088|NCT01999465|517307366|FG001|Overall Study|Lost to Follow-up|2|||
143481089|NCT01999465|517307365|FG000|Overall Study|Protocol Violation|0|||
143481090|NCT01999465|517307366|FG001|Overall Study|Protocol Violation|1|||
143481091|NCT01308008|517307373|FG000|4 Weeks|Illness, disinterest, time|9|||
143481092|NCT01308008|517307374|FG001|4 Weeks|Illness, disinterest, time|2|||
143481093|NCT01417195|517307375|FG000|Overall Study|Stimulation failure|1|||
143481094|NCT01417195|517307376|FG001|Overall Study|Stimulation failure|0|||
143481095|NCT01417195|517307375|FG000|Overall Study|No embryos for transfer|0|||
143481096|NCT01417195|517307376|FG001|Overall Study|No embryos for transfer|1|||
143148073|NCT03314935|516086316|FG011|Phase 2|Progressive Disease|1|||
143481097|NCT01417195|517307375|FG000|Overall Study|No transfer due to risk of OHSS|1|||
143481098|NCT01417195|517307376|FG001|Overall Study|No transfer due to risk of OHSS|0|||
143481099|NCT01417195|517307375|FG000|Overall Study|No transfer due to elevated progesterone|1|||
143481100|NCT01417195|517307376|FG001|Overall Study|No transfer due to elevated progesterone|0|||
143481101|NCT03357731|517307377|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
143481102|NCT03357731|517307378|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
143481103|NCT03357731|517307379|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
143481104|NCT03357731|517307380|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
143481105|NCT03357731|517307381|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
143481106|NCT03357731|517307382|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
143481107|NCT03357731|517307377|FG000|Overall Study|Acute bradycardia and hypotension|0|||
143481108|NCT03357731|517307378|FG001|Overall Study|Acute bradycardia and hypotension|0|||
143481109|NCT03357731|517307379|FG002|Overall Study|Acute bradycardia and hypotension|0|||
143481110|NCT03357731|517307380|FG003|Overall Study|Acute bradycardia and hypotension|1|||
143481111|NCT03357731|517307381|FG004|Overall Study|Acute bradycardia and hypotension|0|||
143481112|NCT03357731|517307382|FG005|Overall Study|Acute bradycardia and hypotension|0|||
143481113|NCT03357731|517307377|FG000|Overall Study|Adverse Event|0|||
143481114|NCT03357731|517307378|FG001|Overall Study|Adverse Event|0|||
143481115|NCT03357731|517307379|FG002|Overall Study|Adverse Event|0|||
143481116|NCT03357731|517307380|FG003|Overall Study|Adverse Event|0|||
143481117|NCT03357731|517307381|FG004|Overall Study|Adverse Event|0|||
143481118|NCT03357731|517307382|FG005|Overall Study|Adverse Event|1|||
143481119|NCT03357731|517307377|FG000|Overall Study|Hypotension|0|||
143481120|NCT03357731|517307378|FG001|Overall Study|Hypotension|0|||
143481121|NCT03357731|517307379|FG002|Overall Study|Hypotension|1|||
143148074|NCT03314935|516086317|FG012|Phase 2|Progressive Disease|2|||
143481122|NCT03357731|517307380|FG003|Overall Study|Hypotension|1|||
143481123|NCT03357731|517307381|FG004|Overall Study|Hypotension|0|||
143481124|NCT03357731|517307382|FG005|Overall Study|Hypotension|0|||
143481125|NCT03357731|517307377|FG000|Overall Study|Lost to Follow-up|0|||
143481126|NCT03357731|517307378|FG001|Overall Study|Lost to Follow-up|0|||
143481127|NCT03357731|517307379|FG002|Overall Study|Lost to Follow-up|0|||
143481128|NCT03357731|517307380|FG003|Overall Study|Lost to Follow-up|1|||
143481129|NCT03357731|517307381|FG004|Overall Study|Lost to Follow-up|0|||
143481130|NCT03357731|517307382|FG005|Overall Study|Lost to Follow-up|0|||
143481131|NCT04036708|517307383|FG000|Overall Study|Lost to Follow-up|14|||
143481132|NCT04036708|517307384|FG001|Overall Study|Lost to Follow-up|4|||
143481133|NCT04036708|517307385|FG002|Overall Study|Lost to Follow-up|14|||
143481134|NCT04036708|517307386|FG003|Overall Study|Lost to Follow-up|4|||
143481135|NCT04766021|517307387|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
143481136|NCT04766021|517307387|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
143481137|NCT02634151|517307389|FG000|Overall Study|Withdrawal by Subject|1|||
143481138|NCT02634151|517307390|FG001|Overall Study|Withdrawal by Subject|0|||
143481139|NCT02634151|517307389|FG000|Overall Study|Non-Compliance|0|||
143481140|NCT02634151|517307390|FG001|Overall Study|Non-Compliance|1|||
143481141|NCT02634151|517307389|FG000|Overall Study|Other|0|||
143481142|NCT02634151|517307390|FG001|Overall Study|Other|1|||
143481143|NCT02347098|517307392|FG000|Overall Study|Death|1|||
143481144|NCT02347098|517307393|FG001|Overall Study|Death|0|||
143481145|NCT02347098|517307392|FG000|Overall Study|Withdrawal by Subject|1|||
143481146|NCT02347098|517307393|FG001|Overall Study|Withdrawal by Subject|0|||
143481147|NCT02347098|517307392|FG000|Overall Study|Lost to Follow-up|2|||
143481148|NCT02347098|517307393|FG001|Overall Study|Lost to Follow-up|2|||
143481149|NCT02347098|517307392|FG000|Overall Study|Refuse Follow-up Visit|1|||
143481150|NCT02347098|517307393|FG001|Overall Study|Refuse Follow-up Visit|5|||
143481151|NCT02347098|517307392|FG000|Overall Study|no visit due to illness|2|||
143148075|NCT03314935|516086318|FG013|Phase 2|Progressive Disease|0|||
143148076|NCT03314935|516086319|FG014|Phase 2|Progressive Disease|1|||
143148077|NCT03314935|516086305|FG000|Phase 2|Study Terminated by Sponsor|0|||
143148078|NCT03314935|516086306|FG001|Phase 2|Study Terminated by Sponsor|0|||
143148079|NCT03314935|516086307|FG002|Phase 2|Study Terminated by Sponsor|0|||
143148080|NCT03314935|516086308|FG003|Phase 2|Study Terminated by Sponsor|0|||
143148081|NCT03314935|516086309|FG004|Phase 2|Study Terminated by Sponsor|0|||
143148082|NCT03314935|516086310|FG005|Phase 2|Study Terminated by Sponsor|0|||
143148083|NCT03314935|516086311|FG006|Phase 2|Study Terminated by Sponsor|0|||
143148084|NCT03314935|516086312|FG007|Phase 2|Study Terminated by Sponsor|0|||
143148085|NCT03314935|516086313|FG008|Phase 2|Study Terminated by Sponsor|0|||
143148086|NCT03314935|516086314|FG009|Phase 2|Study Terminated by Sponsor|0|||
143148087|NCT03314935|516086315|FG010|Phase 2|Study Terminated by Sponsor|7|||
143148088|NCT03314935|516086316|FG011|Phase 2|Study Terminated by Sponsor|2|||
143148089|NCT03314935|516086317|FG012|Phase 2|Study Terminated by Sponsor|1|||
143481152|NCT02347098|517307393|FG001|Overall Study|no visit due to illness|1|||
143481153|NCT01444742|517307394|FG000|Overall Study|Death|1|||
143481154|NCT02187172|517307395|FG000|Overall Study|Lost to Follow-up|1|||
143481155|NCT02187172|517307396|FG001|Overall Study|Lost to Follow-up|2|||
143481156|NCT02187172|517307395|FG000|Overall Study|Lack of Efficacy|1|||
143481157|NCT02187172|517307396|FG001|Overall Study|Lack of Efficacy|2|||
143481158|NCT02187172|517307395|FG000|Overall Study|Adverse Event|0|||
143481159|NCT02187172|517307396|FG001|Overall Study|Adverse Event|1|||
143481160|NCT02187172|517307395|FG000|Overall Study|Physician Decision|1|||
143481161|NCT02187172|517307396|FG001|Overall Study|Physician Decision|1|||
143481162|NCT02535715|517307401|FG000|Overall Study|Withdrawal by Subject|0|||
143481163|NCT02535715|517307402|FG001|Overall Study|Withdrawal by Subject|0|||
143481164|NCT02535715|517307403|FG002|Overall Study|Withdrawal by Subject|1|||
143481165|NCT00094770|517307409|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
143481166|NCT00094770|517307410|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
143481167|NCT00094770|517307409|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
143481168|NCT00094770|517307410|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
143481169|NCT00094770|517307409|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
143481170|NCT00094770|517307410|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
143481171|NCT00094770|517307409|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
143481172|NCT00094770|517307410|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
143481173|NCT00094770|517307409|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
143481174|NCT00094770|517307410|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
143481175|NCT00094770|517307409|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
143481176|NCT00094770|517307410|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
143481177|NCT00094770|517307409|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
143481178|NCT00094770|517307410|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
143481179|NCT00094770|517307409|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
143481180|NCT00094770|517307410|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
143481181|NCT00094770|517307409|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
143481182|NCT00094770|517307410|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
143481183|NCT00094770|517307409|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
143481184|NCT00094770|517307410|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
143481185|NCT00094770|517307409|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
143481186|NCT00094770|517307410|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
143481187|NCT00094770|517307409|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
143481188|NCT00094770|517307410|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
143481189|NCT00094770|517307409|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
143481190|NCT00094770|517307410|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
143481191|NCT00094770|517307409|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
143014199|NCT01500434|515591651|FG000|Overall Study|Missed 12-month follow-up|5|||
143014200|NCT00752895|515591655|FG000|Overall Study|Withdrawal by Subject|8|||
143014201|NCT00752895|515591656|FG001|Overall Study|Withdrawal by Subject|3|||
143014202|NCT00633217|515591657|FG000|Overall Study|Adverse Event|5|||
143014203|NCT00633217|515591658|FG001|Overall Study|Adverse Event|9|||
143014204|NCT00633217|515591657|FG000|Overall Study|Lack of Efficacy|0|||
143014205|NCT00633217|515591658|FG001|Overall Study|Lack of Efficacy|2|||
143014206|NCT00633217|515591657|FG000|Overall Study|Protocol Violation|3|||
143014207|NCT00633217|515591658|FG001|Overall Study|Protocol Violation|7|||
143014208|NCT00633217|515591657|FG000|Overall Study|Lost to Follow-up|2|||
143481192|NCT00094770|517307410|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
143481193|NCT00094770|517307409|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
143481194|NCT00094770|517307410|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
143481195|NCT00094770|517307409|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
143481196|NCT00094770|517307410|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
143481197|NCT00094770|517307409|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
143481198|NCT00094770|517307410|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
143481199|NCT00094770|517307409|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
143014209|NCT00633217|515591658|FG001|Overall Study|Lost to Follow-up|2|||
143014210|NCT00633217|515591657|FG000|Overall Study|Investigator Discretion|2|||
143014211|NCT00633217|515591658|FG001|Overall Study|Investigator Discretion|0|||
143014212|NCT00633217|515591657|FG000|Overall Study|Withdrew Consent|3|||
143148090|NCT03314935|516086318|FG013|Phase 2|Study Terminated by Sponsor|4|||
143148091|NCT03314935|516086319|FG014|Phase 2|Study Terminated by Sponsor|4|||
143481200|NCT00094770|517307410|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
143481201|NCT01911442|517307411|FG000|Overall Study|Adverse Event|2|||
143481202|NCT01911442|517307412|FG001|Overall Study|Adverse Event|2|||
143481203|NCT01911442|517307413|FG002|Overall Study|Adverse Event|4|||
143481204|NCT01911442|517307411|FG000|Overall Study|Lack of Efficacy|1|||
143481205|NCT01911442|517307412|FG001|Overall Study|Lack of Efficacy|1|||
143481206|NCT01911442|517307413|FG002|Overall Study|Lack of Efficacy|1|||
143481207|NCT01911442|517307411|FG000|Overall Study|Lost to Follow-up|2|||
143481208|NCT01911442|517307412|FG001|Overall Study|Lost to Follow-up|0|||
143481209|NCT01911442|517307413|FG002|Overall Study|Lost to Follow-up|1|||
143481210|NCT01911442|517307411|FG000|Overall Study|Withdrawal by Subject|1|||
143481211|NCT01911442|517307412|FG001|Overall Study|Withdrawal by Subject|0|||
143481212|NCT01911442|517307413|FG002|Overall Study|Withdrawal by Subject|6|||
143481213|NCT01911442|517307411|FG000|Overall Study|Mother's Work Schedule|0|||
143481214|NCT01911442|517307412|FG001|Overall Study|Mother's Work Schedule|1|||
143481215|NCT01911442|517307413|FG002|Overall Study|Mother's Work Schedule|0|||
143481216|NCT00122681|517307423|FG000|Overall Study|Adverse Event|20|||
143481217|NCT00122681|517307424|FG001|Overall Study|Adverse Event|16|||
143481218|NCT00122681|517307423|FG000|Overall Study|Lost to Follow-up|1080|||
143481219|NCT00122681|517307424|FG001|Overall Study|Lost to Follow-up|1097|||
143481220|NCT00122681|517307423|FG000|Overall Study|Protocol Violation|7|||
143481221|NCT00122681|517307424|FG001|Overall Study|Protocol Violation|10|||
143014213|NCT00633217|515591658|FG001|Overall Study|Withdrew Consent|3|||
143014214|NCT00314262|515591659|FG000|Overall Study|Adverse Event|2|||
143148092|NCT03314935|516086305|FG000|Phase 2|Lost to Follow-up|0|||
143481222|NCT00122681|517307423|FG000|Overall Study|Withdrawal by Subject|257|||
143481223|NCT00122681|517307424|FG001|Overall Study|Withdrawal by Subject|251|||
143481224|NCT00122681|517307423|FG000|Overall Study|Personal reasons|150|||
143481225|NCT00122681|517307424|FG001|Overall Study|Personal reasons|147|||
143481226|NCT03179891|517307428|FG000|First Intervention|Withdrawal by Subject|1|||
143481227|NCT03179891|517307429|FG001|First Intervention|Withdrawal by Subject|1|||
143481228|NCT03179891|517307428|FG000|First Intervention|Unspecified reason|1|||
143481229|NCT03179891|517307429|FG001|First Intervention|Unspecified reason|0|||
143481230|NCT03179891|517307428|FG000|First Intervention|Protocol Violation|0|||
143481231|NCT03179891|517307429|FG001|First Intervention|Protocol Violation|1|||
143481232|NCT00530894|517307430|FG000|Overall Study|Death|84|||
143481233|NCT00530894|517307431|FG001|Overall Study|Death|89|||
143481234|NCT00530894|517307432|FG002|Overall Study|Death|55|||
143481235|NCT00530894|517307433|FG003|Overall Study|Death|89|||
143481236|NCT00530894|517307430|FG000|Overall Study|Lost to Follow-up|1|||
143481237|NCT00530894|517307431|FG001|Overall Study|Lost to Follow-up|3|||
143481238|NCT00530894|517307432|FG002|Overall Study|Lost to Follow-up|0|||
143481239|NCT00530894|517307433|FG003|Overall Study|Lost to Follow-up|0|||
143481240|NCT00530894|517307430|FG000|Overall Study|Withdrawal by Subject|1|||
143481241|NCT00530894|517307431|FG001|Overall Study|Withdrawal by Subject|23|||
143481242|NCT00530894|517307432|FG002|Overall Study|Withdrawal by Subject|0|||
143481243|NCT00530894|517307433|FG003|Overall Study|Withdrawal by Subject|5|||
143481244|NCT00530894|517307430|FG000|Overall Study|Alive and censored prior to 1 year|2|||
143481245|NCT00530894|517307431|FG001|Overall Study|Alive and censored prior to 1 year|0|||
143481246|NCT00530894|517307432|FG002|Overall Study|Alive and censored prior to 1 year|0|||
143481247|NCT00530894|517307433|FG003|Overall Study|Alive and censored prior to 1 year|0|||
143481248|NCT01349465|517307434|FG000|Overall Study|Adverse Event|1|||
143481249|NCT01349465|517307435|FG001|Overall Study|Adverse Event|0|||
143481250|NCT01349465|517307434|FG000|Overall Study|Death|3|||
143481251|NCT01349465|517307435|FG001|Overall Study|Death|0|||
143481252|NCT01349465|517307434|FG000|Overall Study|Lost to Follow-up|10|||
143481253|NCT01349465|517307435|FG001|Overall Study|Lost to Follow-up|1|||
143481254|NCT01349465|517307434|FG000|Overall Study|Withdrawal by Subject|4|||
143481255|NCT01349465|517307435|FG001|Overall Study|Withdrawal by Subject|2|||
143481256|NCT01349465|517307434|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
143481257|NCT01349465|517307435|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
143481258|NCT02969187|517307438|FG000|Overall Study|Physician Decision|12|||
143481259|NCT02969187|517307439|FG001|Overall Study|Physician Decision|13|||
143481260|NCT01486927|517307440|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
143481261|NCT01486927|517307440|FG000|Overall Study|Physician Decision|1|||
143481262|NCT01486927|517307440|FG000|Overall Study|50 Exposure days not reached|2|||
143481263|NCT01486927|517307440|FG000|Overall Study|Withdrawal by Subject|8|||
143481264|NCT01486927|517307440|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
143481265|NCT03719690|517307444|FG000|Overall Study|Withdrawal by Subject|5|||
143481266|NCT03719690|517307445|FG001|Overall Study|Withdrawal by Subject|10|||
143481267|NCT03719690|517307444|FG000|Overall Study|Death|40|||
143481268|NCT03719690|517307445|FG001|Overall Study|Death|149|||
143481269|NCT03719690|517307444|FG000|Overall Study|Miscellaneous|12|||
143481270|NCT03719690|517307445|FG001|Overall Study|Miscellaneous|56|||
143481271|NCT03719690|517307444|FG000|Overall Study|Lost to Follow-up|2|||
143481272|NCT03719690|517307445|FG001|Overall Study|Lost to Follow-up|18|||
143481273|NCT03719690|517307444|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
143481274|NCT03719690|517307445|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
143481275|NCT03972969|517307449|FG000|3-month Follow-up|Death|1|||
143481276|NCT03972969|517307450|FG001|3-month Follow-up|Death|1|||
143481277|NCT03972969|517307451|FG002|3-month Follow-up|Death|0|||
143481278|NCT03972969|517307449|FG000|6-month Follow-up|Death|1|||
143481279|NCT03972969|517307450|FG001|6-month Follow-up|Death|1|||
143481280|NCT03972969|517307451|FG002|6-month Follow-up|Death|1|||
143481281|NCT03972969|517307449|FG000|6-month Follow-up|Lost to Follow-up|2|||
143481282|NCT03972969|517307450|FG001|6-month Follow-up|Lost to Follow-up|2|||
143481283|NCT03972969|517307451|FG002|6-month Follow-up|Lost to Follow-up|2|||
143481284|NCT00804570|517307452|FG000|Overall Study|Adverse Event|14|||
143481285|NCT00804570|517307453|FG001|Overall Study|Adverse Event|7|||
143481286|NCT00804570|517307452|FG000|Overall Study|Lack of Efficacy|0|||
143481287|NCT00804570|517307453|FG001|Overall Study|Lack of Efficacy|1|||
143481288|NCT00804570|517307452|FG000|Overall Study|Lost to Follow-up|18|||
143481289|NCT00804570|517307453|FG001|Overall Study|Lost to Follow-up|21|||
143481290|NCT00804570|517307452|FG000|Overall Study|Entry criteria not met|5|||
143481291|NCT00804570|517307453|FG001|Overall Study|Entry criteria not met|5|||
143481292|NCT00804570|517307452|FG000|Overall Study|Protocol Violation|12|||
143481293|NCT00804570|517307453|FG001|Overall Study|Protocol Violation|16|||
143481294|NCT00804570|517307452|FG000|Overall Study|Physician Decision|1|||
143481295|NCT00804570|517307453|FG001|Overall Study|Physician Decision|2|||
143481296|NCT00804570|517307452|FG000|Overall Study|Sponsor decision|1|||
143481297|NCT00804570|517307453|FG001|Overall Study|Sponsor decision|4|||
143481298|NCT00804570|517307452|FG000|Overall Study|Withdrawal by Subject|21|||
143481299|NCT00804570|517307453|FG001|Overall Study|Withdrawal by Subject|38|||
143481300|NCT00978029|517307454|FG000|Overall Study|Adverse Event|1|||
143481301|NCT00978029|517307455|FG001|Overall Study|Adverse Event|2|||
143481302|NCT00978029|517307456|FG002|Overall Study|Adverse Event|5|||
143481303|NCT00978029|517307454|FG000|Overall Study|Withdrawal by Subject|0|||
143481304|NCT00978029|517307455|FG001|Overall Study|Withdrawal by Subject|0|||
143481305|NCT00978029|517307456|FG002|Overall Study|Withdrawal by Subject|1|||
143481306|NCT00978029|517307454|FG000|Overall Study|Protocol Violation|0|||
143481307|NCT00978029|517307455|FG001|Overall Study|Protocol Violation|1|||
143481308|NCT00978029|517307456|FG002|Overall Study|Protocol Violation|0|||
143481309|NCT01793142|517307459|FG000|Overall Study|Randomized not treated|7|||
143481310|NCT01840579|517307460|FG000|Overall Study|Status not recorded|0|||
143481311|NCT01840579|517307461|FG001|Overall Study|Status not recorded|0|||
143481312|NCT01840579|517307462|FG002|Overall Study|Status not recorded|2|||
143481313|NCT01840579|517307463|FG003|Overall Study|Status not recorded|3|||
143481314|NCT01840579|517307464|FG004|Overall Study|Status not recorded|4|||
143481315|NCT01840579|517307465|FG005|Overall Study|Status not recorded|3|||
143481316|NCT01840579|517307466|FG006|Overall Study|Status not recorded|0|||
143481317|NCT01840579|517307467|FG007|Overall Study|Status not recorded|3|||
143481318|NCT01840579|517307468|FG008|Overall Study|Status not recorded|3|||
143481319|NCT01840579|517307469|FG009|Overall Study|Status not recorded|3|||
143481320|NCT01840579|517307460|FG000|Overall Study|Progressive disease|3|||
143481321|NCT01840579|517307461|FG001|Overall Study|Progressive disease|5|||
143481322|NCT01840579|517307462|FG002|Overall Study|Progressive disease|0|||
143481323|NCT01840579|517307463|FG003|Overall Study|Progressive disease|0|||
143481324|NCT01840579|517307464|FG004|Overall Study|Progressive disease|0|||
143481325|NCT01840579|517307465|FG005|Overall Study|Progressive disease|0|||
143481326|NCT01840579|517307466|FG006|Overall Study|Progressive disease|0|||
143481327|NCT01840579|517307467|FG007|Overall Study|Progressive disease|0|||
143481328|NCT01840579|517307468|FG008|Overall Study|Progressive disease|0|||
143481329|NCT01840579|517307469|FG009|Overall Study|Progressive disease|0|||
143481330|NCT01840579|517307460|FG000|Overall Study|Ongoing in study|0|||
143481331|NCT01840579|517307461|FG001|Overall Study|Ongoing in study|1|||
143481332|NCT01840579|517307462|FG002|Overall Study|Ongoing in study|0|||
143481333|NCT01840579|517307463|FG003|Overall Study|Ongoing in study|0|||
143481334|NCT01840579|517307464|FG004|Overall Study|Ongoing in study|0|||
143481335|NCT01840579|517307465|FG005|Overall Study|Ongoing in study|0|||
143481336|NCT01840579|517307466|FG006|Overall Study|Ongoing in study|0|||
143481337|NCT01840579|517307467|FG007|Overall Study|Ongoing in study|0|||
143481338|NCT01840579|517307468|FG008|Overall Study|Ongoing in study|0|||
143481339|NCT01840579|517307469|FG009|Overall Study|Ongoing in study|0|||
143481340|NCT01840579|517307460|FG000|Overall Study|Death|0|||
143481341|NCT01840579|517307461|FG001|Overall Study|Death|0|||
143481342|NCT01840579|517307462|FG002|Overall Study|Death|0|||
143481343|NCT01840579|517307463|FG003|Overall Study|Death|0|||
143481344|NCT01840579|517307464|FG004|Overall Study|Death|0|||
143481345|NCT01840579|517307465|FG005|Overall Study|Death|1|||
143481346|NCT01840579|517307466|FG006|Overall Study|Death|0|||
143481347|NCT01840579|517307467|FG007|Overall Study|Death|0|||
143481348|NCT01840579|517307468|FG008|Overall Study|Death|0|||
143481349|NCT01840579|517307469|FG009|Overall Study|Death|0|||
143481350|NCT01840579|517307460|FG000|Overall Study|Adverse Event|0|||
143481351|NCT01840579|517307461|FG001|Overall Study|Adverse Event|1|||
143481352|NCT01840579|517307462|FG002|Overall Study|Adverse Event|0|||
143481353|NCT01840579|517307463|FG003|Overall Study|Adverse Event|0|||
143481354|NCT01840579|517307464|FG004|Overall Study|Adverse Event|0|||
143481355|NCT01840579|517307465|FG005|Overall Study|Adverse Event|0|||
143481356|NCT01840579|517307466|FG006|Overall Study|Adverse Event|0|||
143148093|NCT03314935|516086306|FG001|Phase 2|Lost to Follow-up|0|||
143148094|NCT03314935|516086307|FG002|Phase 2|Lost to Follow-up|0|||
143148095|NCT03314935|516086308|FG003|Phase 2|Lost to Follow-up|0|||
143148096|NCT03314935|516086309|FG004|Phase 2|Lost to Follow-up|0|||
143148097|NCT03314935|516086310|FG005|Phase 2|Lost to Follow-up|0|||
143148098|NCT03314935|516086311|FG006|Phase 2|Lost to Follow-up|0|||
143148099|NCT03314935|516086312|FG007|Phase 2|Lost to Follow-up|0|||
143148100|NCT03314935|516086313|FG008|Phase 2|Lost to Follow-up|0|||
143481357|NCT01840579|517307467|FG007|Overall Study|Adverse Event|0|||
143481358|NCT01840579|517307468|FG008|Overall Study|Adverse Event|0|||
143481359|NCT01840579|517307469|FG009|Overall Study|Adverse Event|0|||
143481360|NCT01840579|517307460|FG000|Overall Study|Follow-up ended by Sponsor|0|||
143481361|NCT01840579|517307461|FG001|Overall Study|Follow-up ended by Sponsor|0|||
143148101|NCT03314935|516086314|FG009|Phase 2|Lost to Follow-up|1|||
143148102|NCT03314935|516086315|FG010|Phase 2|Lost to Follow-up|0|||
143148103|NCT03314935|516086316|FG011|Phase 2|Lost to Follow-up|0|||
143481362|NCT01840579|517307462|FG002|Overall Study|Follow-up ended by Sponsor|0|||
143481363|NCT01840579|517307463|FG003|Overall Study|Follow-up ended by Sponsor|0|||
143481364|NCT01840579|517307464|FG004|Overall Study|Follow-up ended by Sponsor|0|||
143481365|NCT01840579|517307465|FG005|Overall Study|Follow-up ended by Sponsor|0|||
143148104|NCT03314935|516086317|FG012|Phase 2|Lost to Follow-up|0|||
143148105|NCT03314935|516086318|FG013|Phase 2|Lost to Follow-up|0|||
143481366|NCT01840579|517307466|FG006|Overall Study|Follow-up ended by Sponsor|2|||
143481367|NCT01840579|517307467|FG007|Overall Study|Follow-up ended by Sponsor|0|||
143481368|NCT01840579|517307468|FG008|Overall Study|Follow-up ended by Sponsor|0|||
143481369|NCT01840579|517307469|FG009|Overall Study|Follow-up ended by Sponsor|0|||
143481370|NCT03302975|517307471|FG000|Overall Study|Lost to Follow-up|4|||
143481371|NCT05003622|517307473|FG000|Overall Study|Progressive disease|2|||
143481372|NCT05003622|517307473|FG000|Overall Study|Withdrawal by Subject|1|||
143481373|NCT01045798|517307477|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
143481374|NCT01045798|517307478|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
143481375|NCT01045798|517307477|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
143481376|NCT01045798|517307478|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
143481377|NCT01045798|517307477|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
143481378|NCT01045798|517307478|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
143148106|NCT03314935|516086319|FG014|Phase 2|Lost to Follow-up|1|||
143148107|NCT03314935|516086305|FG000|Phase 2|Physician Decision|0|||
143148108|NCT03314935|516086306|FG001|Phase 2|Physician Decision|0|||
143148109|NCT03314935|516086307|FG002|Phase 2|Physician Decision|0|||
143148110|NCT03314935|516086308|FG003|Phase 2|Physician Decision|0|||
143148111|NCT03314935|516086309|FG004|Phase 2|Physician Decision|0|||
143148112|NCT03314935|516086310|FG005|Phase 2|Physician Decision|0|||
143148113|NCT03314935|516086311|FG006|Phase 2|Physician Decision|0|||
143148114|NCT03314935|516086312|FG007|Phase 2|Physician Decision|0|||
143148115|NCT03314935|516086313|FG008|Phase 2|Physician Decision|0|||
143148116|NCT03314935|516086314|FG009|Phase 2|Physician Decision|0|||
143148117|NCT03314935|516086315|FG010|Phase 2|Physician Decision|1|||
143148118|NCT03314935|516086316|FG011|Phase 2|Physician Decision|0|||
143148119|NCT03314935|516086317|FG012|Phase 2|Physician Decision|0|||
143148120|NCT03314935|516086318|FG013|Phase 2|Physician Decision|0|||
143148121|NCT03314935|516086319|FG014|Phase 2|Physician Decision|0|||
143363608|NCT00062868|516873783|FG003|Dose Level 2|Death|0|||
143363609|NCT00062868|516873784|FG004|Dose Level 2|Death|2|||
143481379|NCT01045798|517307477|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
143481380|NCT01045798|517307478|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
143481381|NCT04066491|517307479|FG000|Overall Study|Randomized, not treated|0|||
143481382|NCT04066491|517307480|FG001|Overall Study|Randomized, not treated|0|||
143481383|NCT04066491|517307481|FG002|Overall Study|Randomized, not treated|2|||
143481384|NCT04506086|517307482|FG000|Overall Study|Withdrawal by Subject|2|||
143481385|NCT02321930|517307490|FG000|Overall Study|Lost to Follow-up|1|||
143481386|NCT01293968|517307491|FG000|Overall Study|non-cooperation|3|||
143481387|NCT01293968|517307492|FG001|Overall Study|non-cooperation|3|||
143481388|NCT00597753|517307494|FG000|Overall Study|Adverse Event|6|||
143481389|NCT00597753|517307495|FG001|Overall Study|Adverse Event|2|||
143481390|NCT00597753|517307494|FG000|Overall Study|Death|55|||
143481391|NCT00597753|517307495|FG001|Overall Study|Death|29|||
143481392|NCT00597753|517307494|FG000|Overall Study|Lack of Efficacy|2|||
143481393|NCT00597753|517307495|FG001|Overall Study|Lack of Efficacy|0|||
143481394|NCT00597753|517307494|FG000|Overall Study|Lost to Follow-up|10|||
143481395|NCT00597753|517307495|FG001|Overall Study|Lost to Follow-up|3|||
143481396|NCT00597753|517307494|FG000|Overall Study|Physician Decision|5|||
143481397|NCT00597753|517307495|FG001|Overall Study|Physician Decision|1|||
143481398|NCT00597753|517307494|FG000|Overall Study|Pregnancy|1|||
143481399|NCT00597753|517307495|FG001|Overall Study|Pregnancy|0|||
143481400|NCT00597753|517307494|FG000|Overall Study|Withdrawal by Subject|35|||
143481401|NCT00597753|517307495|FG001|Overall Study|Withdrawal by Subject|12|||
143481402|NCT00597753|517307494|FG000|Overall Study|Discontinued Dialysis|0|||
143481403|NCT00597753|517307495|FG001|Overall Study|Discontinued Dialysis|1|||
143481404|NCT00597753|517307494|FG000|Overall Study|Never dosed|2|||
143481405|NCT00597753|517307495|FG001|Overall Study|Never dosed|0|||
143481406|NCT00597753|517307494|FG000|Overall Study|Noncompliance|2|||
143481407|NCT00597753|517307495|FG001|Overall Study|Noncompliance|1|||
143481408|NCT00597753|517307494|FG000|Overall Study|Relocation|17|||
143481409|NCT00597753|517307495|FG001|Overall Study|Relocation|6|||
143481410|NCT00597753|517307494|FG000|Overall Study|Renal transplant|10|||
143481411|NCT00597753|517307495|FG001|Overall Study|Renal transplant|3|||
143481412|NCT00597753|517307494|FG000|Overall Study|Site closed by sponsor|19|||
143481413|NCT00597753|517307495|FG001|Overall Study|Site closed by sponsor|7|||
143481414|NCT00597753|517307494|FG000|Overall Study|Site elected to close|2|||
143481415|NCT00597753|517307495|FG001|Overall Study|Site elected to close|4|||
143481416|NCT05885737|517307496|FG000|DB Period|Adverse Event|4|||
143481417|NCT05885737|517307497|FG001|DB Period|Adverse Event|4|||
143481418|NCT05885737|517307496|FG000|DB Period|Lost to Follow-up|0|||
143481419|NCT05885737|517307497|FG001|DB Period|Lost to Follow-up|1|||
143481420|NCT05885737|517307496|FG000|DB Period|Physician Decision|2|||
143481421|NCT05885737|517307497|FG001|DB Period|Physician Decision|0|||
143481422|NCT05885737|517307496|FG000|DB Period|Withdrawal by Subject|12|||
143481423|NCT05885737|517307497|FG001|DB Period|Withdrawal by Subject|6|||
143481424|NCT05885737|517307496|FG000|DB Period|Other: Unspecified|2|||
143148122|NCT05845619|516086320|FG000|Overall Study|duplicate enrollment|2|||
143148123|NCT05845619|516086321|FG001|Overall Study|duplicate enrollment|2|||
143148124|NCT05845619|516086322|FG002|Overall Study|duplicate enrollment|1|||
143363610|NCT00062868|516873785|FG005|Dose Level 2|Death|0|||
143148125|NCT03636477|516086323|FG000|Overall Study|Adverse Event|0|||
143481425|NCT05885737|517307497|FG001|DB Period|Other: Unspecified|2|||
143481426|NCT05885737|517307496|FG000|OLE Period|Adverse Event|3|||
143481427|NCT05885737|517307497|FG001|OLE Period|Adverse Event|2|||
143481428|NCT05885737|517307496|FG000|OLE Period|Physician Decision|1|||
143481429|NCT05885737|517307497|FG001|OLE Period|Physician Decision|0|||
143481430|NCT05885737|517307496|FG000|OLE Period|Withdrawal by Subject|5|||
143481431|NCT05885737|517307497|FG001|OLE Period|Withdrawal by Subject|5|||
143148126|NCT03636477|516086324|FG001|Overall Study|Adverse Event|0|||
143148127|NCT03636477|516086325|FG002|Overall Study|Adverse Event|1|||
143148128|NCT04279522|516086326|FG000|Period 1: Double Blind Phase|Lost to Follow-up|0|||
143148129|NCT04279522|516086327|FG001|Period 1: Double Blind Phase|Lost to Follow-up|1|||
143148130|NCT04279522|516086326|FG000|Period 1: Double Blind Phase|Withdrawal by Subject|10|||
143148131|NCT04279522|516086327|FG001|Period 1: Double Blind Phase|Withdrawal by Subject|8|||
143148132|NCT04279522|516086326|FG000|Period 1: Double Blind Phase|Protocol Violation|1|||
143148133|NCT04279522|516086327|FG001|Period 1: Double Blind Phase|Protocol Violation|0|||
143148134|NCT04279522|516086326|FG000|Period 2: Open Label Phase|Lost to Follow-up|1|||
143481432|NCT05885737|517307496|FG000|OLE Period|Other: Unspecified|2|||
143481433|NCT05885737|517307497|FG001|OLE Period|Other: Unspecified|1|||
143481434|NCT00402649|517309218|FG000|Overall Study|Lost to Follow-up|1|||
143481435|NCT00402649|517309218|FG000|Overall Study|Withdrawal by Subject|1|||
143481436|NCT01773109|517309220|FG000|Overall Study|Symptomatic Progression|2|||
143481437|NCT01773109|517309220|FG000|Overall Study|Death|1|||
143148135|NCT04279522|516086327|FG001|Period 2: Open Label Phase|Lost to Follow-up|1|||
143148136|NCT04279522|516086326|FG000|Period 2: Open Label Phase|Withdrawal by Subject|2|||
143148137|NCT04279522|516086327|FG001|Period 2: Open Label Phase|Withdrawal by Subject|2|||
143148138|NCT04279522|516086326|FG000|Period 2: Open Label Phase|Physician Decision|0|||
143148139|NCT04279522|516086327|FG001|Period 2: Open Label Phase|Physician Decision|3|||
143148140|NCT04279522|516086326|FG000|Period 2: Open Label Phase|Adverse Event|0|||
143148141|NCT04279522|516086327|FG001|Period 2: Open Label Phase|Adverse Event|1|||
143148142|NCT04279522|516086326|FG000|Period 2: Open Label Phase|Protocol Violation|1|||
143481438|NCT01239342|517309221|FG000|Overall Study|Adverse Event|1|||
143481439|NCT01239342|517309222|FG001|Overall Study|Adverse Event|0|||
143481440|NCT01239342|517309221|FG000|Overall Study|Withdrawal by Subject|1|||
143481441|NCT01239342|517309222|FG001|Overall Study|Withdrawal by Subject|5|||
143481442|NCT01239342|517309221|FG000|Overall Study|Reason Unknown|1|||
143481443|NCT01239342|517309222|FG001|Overall Study|Reason Unknown|1|||
143481444|NCT02325219|517309225|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
143481445|NCT02325219|517309226|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
143481446|NCT02325219|517309227|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
143481447|NCT02325219|517309228|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
143481448|NCT02325219|517309229|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
143481449|NCT02325219|517309225|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
143481450|NCT02325219|517309226|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
143481451|NCT02325219|517309227|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
143481452|NCT02325219|517309228|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
143481453|NCT02325219|517309229|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
143481454|NCT02325219|517309225|FG000|Controlled Period (Week 0 - 16)|Other|0|||
143481455|NCT02325219|517309226|FG001|Controlled Period (Week 0 - 16)|Other|0|||
143481456|NCT02325219|517309227|FG002|Controlled Period (Week 0 - 16)|Other|1|||
143481457|NCT02325219|517309228|FG003|Controlled Period (Week 0 - 16)|Other|0|||
143481458|NCT02325219|517309229|FG004|Controlled Period (Week 0 - 16)|Other|0|||
143481459|NCT02325219|517309225|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
143148143|NCT04279522|516086327|FG001|Period 2: Open Label Phase|Protocol Violation|0|||
143148144|NCT02629159|516086330|FG000|Overall Study|Adverse Event|17|||
143481460|NCT02325219|517309226|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
143481461|NCT02325219|517309227|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
143481462|NCT02325219|517309228|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
143481463|NCT02325219|517309229|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
143481464|NCT02325219|517309225|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
143481465|NCT02325219|517309226|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
143481466|NCT02325219|517309227|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
143481467|NCT02325219|517309228|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
143481468|NCT02325219|517309229|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
143148145|NCT02629159|516086331|FG001|Overall Study|Adverse Event|20|||
143148146|NCT02629159|516086332|FG002|Overall Study|Adverse Event|22|||
143481469|NCT02325219|517309225|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
143481470|NCT02325219|517309226|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
143481471|NCT02325219|517309227|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
143148147|NCT02629159|516086330|FG000|Overall Study|Withdrawal by Subject|22|||
143148148|NCT02629159|516086331|FG001|Overall Study|Withdrawal by Subject|11|||
143148149|NCT02629159|516086332|FG002|Overall Study|Withdrawal by Subject|15|||
143148150|NCT02629159|516086330|FG000|Overall Study|Lost to Follow-up|7|||
143481472|NCT02325219|517309228|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
143481473|NCT02325219|517309229|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
143481474|NCT04640272|517309230|FG000|Overall Study|Subject moved out of area|1|||
143481475|NCT04329702|517309238|FG000|Overall Study|illness|3|||
143481476|NCT04329702|517309239|FG001|Overall Study|illness|4|||
143481477|NCT04329702|517309240|FG002|Overall Study|illness|0|||
143481478|NCT04329702|517309238|FG000|Overall Study|Lost to Follow-up|0|||
143481479|NCT04329702|517309239|FG001|Overall Study|Lost to Follow-up|0|||
143481480|NCT04329702|517309240|FG002|Overall Study|Lost to Follow-up|2|||
143481481|NCT04329702|517309238|FG000|Overall Study|Death|0|||
143481482|NCT04329702|517309239|FG001|Overall Study|Death|2|||
143481483|NCT04329702|517309240|FG002|Overall Study|Death|0|||
143481484|NCT00766532|517309241|FG000|Overall Study|Protocol Violation|2|||
143481485|NCT01438489|517309242|FG000|Overall Study|Lost to Follow-up|4|||
143481486|NCT01438489|517309243|FG001|Overall Study|Lost to Follow-up|2|||
143481487|NCT01438489|517309244|FG002|Overall Study|Lost to Follow-up|2|||
143481488|NCT01438489|517309242|FG000|Overall Study|Withdrawal by Subject|11|||
143481489|NCT01438489|517309243|FG001|Overall Study|Withdrawal by Subject|3|||
143481490|NCT01438489|517309244|FG002|Overall Study|Withdrawal by Subject|8|||
143481491|NCT01438489|517309242|FG000|Overall Study|Death|0|||
143481492|NCT01438489|517309243|FG001|Overall Study|Death|0|||
143481493|NCT01438489|517309244|FG002|Overall Study|Death|1|||
143481494|NCT01438489|517309242|FG000|Overall Study|Sponsor decision|4|||
143481495|NCT01438489|517309243|FG001|Overall Study|Sponsor decision|1|||
143481496|NCT01438489|517309244|FG002|Overall Study|Sponsor decision|4|||
143481497|NCT01438489|517309242|FG000|Overall Study|Subject choice/Subject moved|2|||
143481498|NCT01438489|517309243|FG001|Overall Study|Subject choice/Subject moved|1|||
143481499|NCT01438489|517309244|FG002|Overall Study|Subject choice/Subject moved|1|||
143481500|NCT01438489|517309242|FG000|Overall Study|Investigator decision|0|||
143481501|NCT01438489|517309243|FG001|Overall Study|Investigator decision|1|||
143148151|NCT02629159|516086331|FG001|Overall Study|Lost to Follow-up|4|||
143148152|NCT02629159|516086332|FG002|Overall Study|Lost to Follow-up|5|||
143481502|NCT01438489|517309244|FG002|Overall Study|Investigator decision|0|||
143481503|NCT01438489|517309242|FG000|Overall Study|AE/SAEs|2|||
143481504|NCT01438489|517309243|FG001|Overall Study|AE/SAEs|1|||
143481505|NCT01438489|517309244|FG002|Overall Study|AE/SAEs|1|||
143481506|NCT01438489|517309242|FG000|Overall Study|Received prohibited medication|1|||
143481507|NCT01438489|517309243|FG001|Overall Study|Received prohibited medication|0|||
143481508|NCT01438489|517309244|FG002|Overall Study|Received prohibited medication|0|||
143481509|NCT01438489|517309242|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
143148153|NCT02629159|516086330|FG000|Overall Study|Lack of Efficacy|4|||
143148154|NCT02629159|516086331|FG001|Overall Study|Lack of Efficacy|0|||
143148155|NCT02629159|516086332|FG002|Overall Study|Lack of Efficacy|1|||
143148156|NCT02629159|516086330|FG000|Overall Study|Other|6|||
143481510|NCT01438489|517309243|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
143481511|NCT01438489|517309244|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
143481512|NCT01438489|517309242|FG000|Overall Study|Inadequate venous access|0|||
143481513|NCT01438489|517309243|FG001|Overall Study|Inadequate venous access|2|||
143481514|NCT01438489|517309244|FG002|Overall Study|Inadequate venous access|0|||
143481515|NCT01476475|517309246|FG000|Overall Study|Adverse Event|6|||
143481516|NCT01476475|517309247|FG001|Overall Study|Adverse Event|0|||
143481517|NCT01476475|517309246|FG000|Overall Study|Poor compliance to protocol|1|||
143481518|NCT01476475|517309247|FG001|Overall Study|Poor compliance to protocol|1|||
143481519|NCT01476475|517309246|FG000|Overall Study|Other reasons|4|||
143481520|NCT01476475|517309247|FG001|Overall Study|Other reasons|2|||
143481521|NCT00751400|517309253|FG000|Overall Study|Lost to Follow-up|10|||
143481522|NCT01372384|517309254|FG000|Overall Study|Progression of disease|3|||
143481523|NCT00661531|517309260|FG000|Overall Study|Withdrawal by Subject|3|||
143481524|NCT03134599|517309261|FG000|Week 1|Lost to Follow-up|0|||
143148157|NCT02629159|516086331|FG001|Overall Study|Other|4|||
143148158|NCT02629159|516086332|FG002|Overall Study|Other|8|||
143481525|NCT03134599|517309262|FG001|Week 1|Lost to Follow-up|0|||
143481526|NCT03134599|517309263|FG002|Week 1|Lost to Follow-up|0|||
143481527|NCT03134599|517309264|FG003|Week 1|Lost to Follow-up|0|||
143481528|NCT03134599|517309265|FG004|Week 1|Lost to Follow-up|1|||
143481529|NCT03134599|517309266|FG005|Week 1|Lost to Follow-up|0|||
143148159|NCT05352399|516086340|FG000|Overall Study|Discontinued intervention|6|||
143148160|NCT05523297|516086341|FG000|Overall Study|Death|7|||
143481530|NCT03134599|517309261|FG000|Week 2|Lost to Follow-up|1|||
143481531|NCT03134599|517309262|FG001|Week 2|Lost to Follow-up|0|||
143481532|NCT03134599|517309263|FG002|Week 2|Lost to Follow-up|0|||
143481533|NCT03134599|517309264|FG003|Week 2|Lost to Follow-up|1|||
143481534|NCT03134599|517309265|FG004|Week 2|Lost to Follow-up|1|||
143481535|NCT03134599|517309266|FG005|Week 2|Lost to Follow-up|0|||
143481536|NCT03134599|517309261|FG000|Week 3|Lost to Follow-up|0|||
143148161|NCT05523297|516086342|FG001|Overall Study|Death|8|||
143148162|NCT05523297|516086341|FG000|Overall Study|Lost to Follow-up|2|||
143148163|NCT05523297|516086342|FG001|Overall Study|Lost to Follow-up|1|||
143181197|NCT03654274|516210494|FG001|Overall Study|Lost to Follow-up|6|||
143481537|NCT03134599|517309262|FG001|Week 3|Lost to Follow-up|0|||
143481538|NCT03134599|517309263|FG002|Week 3|Lost to Follow-up|0|||
143148164|NCT01811238|516086348|FG000|Overall Study|Withdrawal by Subject|42|||
143148165|NCT01811238|516086348|FG000|Overall Study|Adverse Event|25|||
143148166|NCT01811238|516086348|FG000|Overall Study|Protocol Violation|4|||
143148167|NCT01811238|516086348|FG000|Overall Study|Lack of Efficacy|4|||
143481539|NCT03134599|517309264|FG003|Week 3|Lost to Follow-up|1|||
143481540|NCT03134599|517309265|FG004|Week 3|Lost to Follow-up|0|||
143481541|NCT03134599|517309266|FG005|Week 3|Lost to Follow-up|1|||
143481542|NCT01265615|517309267|FG000|Overall Study|Protocol Violation|2|||
143481543|NCT01265615|517309268|FG001|Overall Study|Protocol Violation|2|||
143481544|NCT01265615|517309269|FG002|Overall Study|Protocol Violation|4|||
143481545|NCT01265615|517309270|FG003|Overall Study|Protocol Violation|3|||
143481546|NCT02576444|517309271|FG000|Overall Study|Death|1|||
143481547|NCT02576444|517309272|FG001|Overall Study|Death|1|||
143481548|NCT02576444|517309273|FG002|Overall Study|Death|0|||
143481549|NCT02576444|517309274|FG003|Overall Study|Death|0|||
143481550|NCT02576444|517309271|FG000|Overall Study|Withdrawal by Subject|0|||
143481551|NCT02576444|517309272|FG001|Overall Study|Withdrawal by Subject|0|||
143481552|NCT02576444|517309273|FG002|Overall Study|Withdrawal by Subject|2|||
143148168|NCT01811238|516086348|FG000|Overall Study|subject refused study medication|6|||
143481553|NCT02576444|517309274|FG003|Overall Study|Withdrawal by Subject|0|||
143481554|NCT02576444|517309271|FG000|Overall Study|Adverse Event|0|||
143481555|NCT02576444|517309272|FG001|Overall Study|Adverse Event|0|||
143481556|NCT02576444|517309273|FG002|Overall Study|Adverse Event|1|||
143481557|NCT02576444|517309274|FG003|Overall Study|Adverse Event|0|||
143481558|NCT02576444|517309271|FG000|Overall Study|Physician Decision|0|||
143481559|NCT02576444|517309272|FG001|Overall Study|Physician Decision|0|||
143481560|NCT02576444|517309273|FG002|Overall Study|Physician Decision|1|||
143481561|NCT02576444|517309274|FG003|Overall Study|Physician Decision|0|||
143481562|NCT03370120|517309278|FG000|Overall Study|Adverse event, non-fatal|24|||
143481563|NCT03370120|517309278|FG000|Overall Study|Withdrawal by Subject|6|||
143481564|NCT03370120|517309278|FG000|Overall Study|Lost to Follow-up|1|||
143481565|NCT03370120|517309278|FG000|Overall Study|Lack of Efficacy|37|||
143481566|NCT03370120|517309278|FG000|Overall Study|Per sponsor's instructions|1|||
143481567|NCT03370120|517309278|FG000|Overall Study|Study was terminated by parent company UCB|2|||
143481568|NCT03370120|517309278|FG000|Overall Study|The study was ended by the promoter|3|||
143481569|NCT03370120|517309278|FG000|Overall Study|Discontinuation of drug development|3|||
143481570|NCT03370120|517309278|FG000|Overall Study|End of project|2|||
143481571|NCT03370120|517309278|FG000|Overall Study|Premature study closure|2|||
143481572|NCT03370120|517309278|FG000|Overall Study|Premature program termination|1|||
143481573|NCT03370120|517309278|FG000|Overall Study|Premature study termination|7|||
143481574|NCT03370120|517309278|FG000|Overall Study|Trial terminated by sponsor|2|||
143481575|NCT03370120|517309278|FG000|Overall Study|Trial discontinued by sponsor|2|||
143481576|NCT03370120|517309278|FG000|Overall Study|Study ended|15|||
143481577|NCT03370120|517309278|FG000|Overall Study|Clinical trial has been cancelled|1|||
143481578|NCT03370120|517309278|FG000|Overall Study|End of study per sponsor decision|2|||
143481579|NCT03370120|517309278|FG000|Overall Study|Promoter's decision|2|||
143481580|NCT03370120|517309278|FG000|Overall Study|The trial has been suspended|3|||
143481581|NCT03370120|517309278|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
143481582|NCT03370120|517309278|FG000|Overall Study|Early termination by order of sponsor|2|||
143481583|NCT03370120|517309278|FG000|Overall Study|Discontinuation of the study|5|||
143481584|NCT03370120|517309278|FG000|Overall Study|End of clinical trial discontinuation|1|||
143481585|NCT03370120|517309278|FG000|Overall Study|Because the clinical trial ended halfway|4|||
143481586|NCT03370120|517309278|FG000|Overall Study|Development discontinued|5|||
143481587|NCT03370120|517309278|FG000|Overall Study|Padsenovil program closed|3|||
143481588|NCT03370120|517309278|FG000|Overall Study|End of project|2|||
143481589|NCT03370120|517309278|FG000|Overall Study|Termination of project|1|||
143481590|NCT03370120|517309278|FG000|Overall Study|The study was interrupted by sponsor|4|||
143481591|NCT03370120|517309278|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
143481592|NCT03370120|517309278|FG000|Overall Study|End of sponsor decision|1|||
143481593|NCT03370120|517309278|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
143481594|NCT03370120|517309278|FG000|Overall Study|Early termination of studies|5|||
143481595|NCT03370120|517309278|FG000|Overall Study|This study is ended early|1|||
143481596|NCT03370120|517309278|FG000|Overall Study|End of padsevonil program|2|||
143481597|NCT03370120|517309278|FG000|Overall Study|Decision of sponsor|6|||
143481598|NCT03370120|517309278|FG000|Overall Study|Asked by the sponsor|3|||
143481599|NCT03370120|517309278|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
143481600|NCT03370120|517309278|FG000|Overall Study|PI decision poor compliance from participant|1|||
143481601|NCT03370120|517309278|FG000|Overall Study|Promoter ended the study|3|||
143481602|NCT03370120|517309278|FG000|Overall Study|Premature study close by sponsor's decision|4|||
143481603|NCT03370120|517309278|FG000|Overall Study|Study terminated by sponsor|33|||
143481604|NCT03370120|517309278|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
143481605|NCT03370120|517309278|FG000|Overall Study|Sponsor decision to terminate study|63|||
143481606|NCT03370120|517309278|FG000|Overall Study|Program closure|3|||
143481607|NCT03370120|517309278|FG000|Overall Study|Study ended prematurely|1|||
143148169|NCT02916927|516086349|FG000|Overall Study|Discharged prior to study drug receipt|0|||
143481608|NCT03370120|517309278|FG000|Overall Study|Study stopped by sponsor|2|||
143481609|NCT03370120|517309278|FG000|Overall Study|Program termination|55|||
143481610|NCT03370120|517309278|FG000|Overall Study|Sponsor decision|62|||
143481611|NCT03370120|517309278|FG000|Overall Study|Sponsor study closure|10|||
143481612|NCT02700412|517309279|FG000|Overall Study|Adverse Event|6|||
143481613|NCT02700412|517309279|FG000|Overall Study|Death|1|||
143481614|NCT02700412|517309279|FG000|Overall Study|Lack of Efficacy|19|||
143481615|NCT02700412|517309279|FG000|Overall Study|Protocol Violation|5|||
143481616|NCT02700412|517309279|FG000|Overall Study|Withdrawal by Subject|2|||
143481617|NCT00928889|517309280|FG000|Overall Study|Lost to Follow-up|3|||
143481618|NCT00928889|517309281|FG001|Overall Study|Lost to Follow-up|1|||
143481619|NCT00928889|517309280|FG000|Overall Study|Protocol Violation|0|||
143481620|NCT00928889|517309281|FG001|Overall Study|Protocol Violation|1|||
143481621|NCT00928889|517309280|FG000|Overall Study|Adverse Event|1|||
143481622|NCT00928889|517309281|FG001|Overall Study|Adverse Event|0|||
143481623|NCT00928889|517309280|FG000|Overall Study|Other|1|||
143481624|NCT00928889|517309281|FG001|Overall Study|Other|0|||
143481625|NCT04206020|517309282|FG000|Overall Study|Adverse Event|1|||
143481626|NCT04206020|517309283|FG001|Overall Study|Adverse Event|4|||
143481627|NCT04206020|517309282|FG000|Overall Study|Protocol Violation|2|||
143481628|NCT04206020|517309283|FG001|Overall Study|Protocol Violation|0|||
143481629|NCT04206020|517309282|FG000|Overall Study|Withdrawal by Subject|2|||
143481630|NCT04206020|517309283|FG001|Overall Study|Withdrawal by Subject|0|||
143481631|NCT04206020|517309282|FG000|Overall Study|Lost to Follow-up|2|||
143481632|NCT04206020|517309283|FG001|Overall Study|Lost to Follow-up|0|||
143481633|NCT04206020|517309282|FG000|Overall Study|Pregnancy|0|||
143481634|NCT04206020|517309283|FG001|Overall Study|Pregnancy|1|||
143481635|NCT04206020|517309282|FG000|Overall Study|Unable to attend visits|1|||
143481636|NCT04206020|517309283|FG001|Overall Study|Unable to attend visits|2|||
143481637|NCT04416555|517309284|FG000|Overall Study|Withdrawal by Subject|0|||
143481638|NCT04416555|517309285|FG001|Overall Study|Withdrawal by Subject|3|||
143481639|NCT01356407|517309292|FG000|Overall Study|Lost to Follow-up|2|||
143481640|NCT01356407|517309293|FG001|Overall Study|Lost to Follow-up|0|||
143481641|NCT01356407|517309292|FG000|Overall Study|Patient Withdrew Consent|2|||
143481642|NCT01356407|517309293|FG001|Overall Study|Patient Withdrew Consent|1|||
143481643|NCT01356407|517309292|FG000|Overall Study|Could not afford IMP administration|0|||
143481644|NCT01356407|517309293|FG001|Overall Study|Could not afford IMP administration|1|||
143481645|NCT01356407|517309292|FG000|Overall Study|Not complete Endoscopy|2|||
143481646|NCT01356407|517309293|FG001|Overall Study|Not complete Endoscopy|2|||
143481647|NCT01309659|517309294|FG000|Overall Study|Protocol Violation|0|||
143481648|NCT01309659|517309295|FG001|Overall Study|Protocol Violation|1|||
143481649|NCT02018822|517309296|FG000|Overall Study|filling replaced by crown|0|||
143481650|NCT02018822|517309297|FG001|Overall Study|filling replaced by crown|1|||
143481651|NCT02018822|517309298|FG002|Overall Study|filling replaced by crown|0|||
143481652|NCT02018822|517309296|FG000|Overall Study|Physician Decision|0|||
143481653|NCT02018822|517309297|FG001|Overall Study|Physician Decision|1|||
143481654|NCT02018822|517309298|FG002|Overall Study|Physician Decision|1|||
143481655|NCT02018822|517309296|FG000|Overall Study|Lost to Follow-up|6|||
143481656|NCT02018822|517309297|FG001|Overall Study|Lost to Follow-up|6|||
143481657|NCT02018822|517309298|FG002|Overall Study|Lost to Follow-up|5|||
143481658|NCT03201458|517309299|FG000|Overall Study|No longer eligible|2|||
143481659|NCT03201458|517309300|FG001|Overall Study|No longer eligible|5|||
143481660|NCT03201458|517309299|FG000|Overall Study|Health event before starting|1|||
143481661|NCT03201458|517309300|FG001|Overall Study|Health event before starting|0|||
143481662|NCT03201458|517309299|FG000|Overall Study|Physician Decision|1|||
143481663|NCT03201458|517309300|FG001|Overall Study|Physician Decision|0|||
143481664|NCT00715026|517309301|FG000|Overall Study|Withdrawal by Subject|5|||
143481665|NCT00715026|517309301|FG000|Overall Study|Lost to Follow-up|3|||
143481666|NCT00715026|517309301|FG000|Overall Study|Protocol Violation|1|||
143481667|NCT00715026|517309301|FG000|Overall Study|Surgery done on non-study consented hip|1|||
143481668|NCT02614859|517309302|FG000|Overall Study|Physician Decision|0|||
143481669|NCT02614859|517309303|FG001|Overall Study|Physician Decision|1|||
143481670|NCT01399788|517309307|FG000|First Intervention Period|Adverse Event|1|||
143481671|NCT01399788|517309308|FG001|First Intervention Period|Adverse Event|0|||
143481672|NCT03699007|517309310|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
143481673|NCT03699007|517309311|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
143481674|NCT03699007|517309310|FG000|6-month Follow Up|Lost to Follow-up|2|||
143481675|NCT03699007|517309311|FG001|6-month Follow Up|Lost to Follow-up|3|||
143481676|NCT03259074|517309312|FG000|Overall Study|Adverse Event|9|||
143481677|NCT03259074|517309313|FG001|Overall Study|Adverse Event|12|||
143481678|NCT03259074|517309314|FG002|Overall Study|Adverse Event|8|||
143481679|NCT03259074|517309312|FG000|Overall Study|Death|1|||
143481680|NCT03259074|517309313|FG001|Overall Study|Death|1|||
143481681|NCT03259074|517309314|FG002|Overall Study|Death|3|||
143481682|NCT03259074|517309312|FG000|Overall Study|Lost to Follow-up|2|||
143481683|NCT03259074|517309313|FG001|Overall Study|Lost to Follow-up|4|||
143481684|NCT03259074|517309314|FG002|Overall Study|Lost to Follow-up|3|||
143481685|NCT03259074|517309312|FG000|Overall Study|New Therapy For Study Indication|1|||
143481686|NCT03259074|517309313|FG001|Overall Study|New Therapy For Study Indication|2|||
143481687|NCT03259074|517309314|FG002|Overall Study|New Therapy For Study Indication|2|||
143481688|NCT03259074|517309312|FG000|Overall Study|Physician Decision|4|||
143481689|NCT03259074|517309313|FG001|Overall Study|Physician Decision|12|||
143481690|NCT03259074|517309314|FG002|Overall Study|Physician Decision|10|||
143481691|NCT03259074|517309312|FG000|Overall Study|Pregnancy|1|||
143481692|NCT03259074|517309313|FG001|Overall Study|Pregnancy|1|||
143481693|NCT03259074|517309314|FG002|Overall Study|Pregnancy|0|||
143481694|NCT03259074|517309312|FG000|Overall Study|Progressive Disease|1|||
143481695|NCT03259074|517309313|FG001|Overall Study|Progressive Disease|0|||
143481696|NCT03259074|517309314|FG002|Overall Study|Progressive Disease|0|||
143481697|NCT03259074|517309312|FG000|Overall Study|Protocol Deviation|1|||
143481698|NCT03259074|517309313|FG001|Overall Study|Protocol Deviation|1|||
143481699|NCT03259074|517309314|FG002|Overall Study|Protocol Deviation|3|||
143481700|NCT03259074|517309312|FG000|Overall Study|Subject/Guardian Decision|13|||
143481701|NCT03259074|517309313|FG001|Overall Study|Subject/Guardian Decision|16|||
143481702|NCT03259074|517309314|FG002|Overall Study|Subject/Guardian Decision|14|||
143014215|NCT00314262|515591659|FG000|Overall Study|Withdrawal by Subject|2|||
143014216|NCT00314262|515591659|FG000|Overall Study|Physician Decision|1|||
143014217|NCT04881448|515591660|FG000|Overall Study|Study cancelled by sponsor|220|||
143014218|NCT04881448|515591660|FG000|Overall Study|Withdrawal by Subject|2|||
143014219|NCT04881448|515591660|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
143014220|NCT01966107|515591661|FG000|Overall Study|excluded from FAS|21|||
143014221|NCT01966107|515591662|FG001|Overall Study|excluded from FAS|20|||
143014222|NCT01966107|515591661|FG000|Overall Study|discontinued treatment|345|||
143014223|NCT01966107|515591662|FG001|Overall Study|discontinued treatment|372|||
143014224|NCT01966107|515591661|FG000|Overall Study|due to study closure|164|||
143014225|NCT01966107|515591662|FG001|Overall Study|due to study closure|186|||
143014226|NCT01966107|515591661|FG000|Overall Study|withdrew from the study|272|||
143014227|NCT01966107|515591662|FG001|Overall Study|withdrew from the study|303|||
143014228|NCT00532779|515591663|FG000|Overall Study|Adverse Event|122|||
143014229|NCT00532779|515591664|FG001|Overall Study|Adverse Event|112|||
143014230|NCT00532779|515591665|FG002|Overall Study|Adverse Event|56|||
143014231|NCT00532779|515591663|FG000|Overall Study|Lost to Follow-up|76|||
143014232|NCT00532779|515591664|FG001|Overall Study|Lost to Follow-up|65|||
143014233|NCT00532779|515591665|FG002|Overall Study|Lost to Follow-up|66|||
143014234|NCT00532779|515591663|FG000|Overall Study|Withdrawal by Subject|63|||
143014235|NCT00532779|515591664|FG001|Overall Study|Withdrawal by Subject|60|||
143014236|NCT00532779|515591665|FG002|Overall Study|Withdrawal by Subject|90|||
143014237|NCT00532779|515591663|FG000|Overall Study|Lack of Efficacy|12|||
143014238|NCT00532779|515591664|FG001|Overall Study|Lack of Efficacy|12|||
143014239|NCT00532779|515591665|FG002|Overall Study|Lack of Efficacy|40|||
143014240|NCT00532779|515591663|FG000|Overall Study|Protocol Violation|5|||
143014241|NCT00532779|515591664|FG001|Overall Study|Protocol Violation|9|||
143014242|NCT00532779|515591665|FG002|Overall Study|Protocol Violation|7|||
143014243|NCT00532779|515591663|FG000|Overall Study|Pregnancy|2|||
143481703|NCT00705783|517309317|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
143481704|NCT00705783|517309318|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
143481705|NCT00705783|517309319|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
143481706|NCT00705783|517309317|FG000|Conversion Phase|Lost to Follow-up|13|||
143014244|NCT00532779|515591664|FG001|Overall Study|Pregnancy|5|||
143014245|NCT00532779|515591665|FG002|Overall Study|Pregnancy|3|||
143014246|NCT00532779|515591663|FG000|Overall Study|Death|0|||
143014247|NCT00532779|515591664|FG001|Overall Study|Death|1|||
143014248|NCT00532779|515591665|FG002|Overall Study|Death|0|||
143014249|NCT00532779|515591663|FG000|Overall Study|Drug noncompliance, moved, other|14|||
143014250|NCT00532779|515591664|FG001|Overall Study|Drug noncompliance, moved, other|23|||
143014251|NCT00532779|515591665|FG002|Overall Study|Drug noncompliance, moved, other|29|||
143014252|NCT02662556|515591666|FG000|Overall Study|Adverse Event|4|||
143014253|NCT02662556|515591666|FG000|Overall Study|Lack of Efficacy|4|||
143148170|NCT02916927|516086350|FG001|Overall Study|Discharged prior to study drug receipt|2|||
143148171|NCT02916927|516086349|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
143148172|NCT02916927|516086350|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
143148173|NCT02916927|516086349|FG000|Overall Study|Withdrawal before first time point|1|||
143481707|NCT00705783|517309318|FG001|Conversion Phase|Lost to Follow-up|0|||
143014254|NCT00689273|515591671|FG000|Overall Study|Adverse Event|3|||
143148174|NCT02916927|516086350|FG001|Overall Study|Withdrawal before first time point|0|||
143148175|NCT00141817|516086351|FG000|Overall Study|Protocol Violation|0|||
143481708|NCT00705783|517309319|FG002|Conversion Phase|Lost to Follow-up|0|||
143481709|NCT00705783|517309317|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
143014255|NCT00689273|515591672|FG001|Overall Study|Adverse Event|1|||
143014256|NCT00689273|515591671|FG000|Overall Study|Lack of Efficacy|3|||
143014257|NCT00689273|515591672|FG001|Overall Study|Lack of Efficacy|0|||
143014258|NCT00689273|515591671|FG000|Overall Study|Lost to Follow-up|0|||
143014259|NCT00689273|515591672|FG001|Overall Study|Lost to Follow-up|2|||
143014260|NCT00689273|515591671|FG000|Overall Study|Other|6|||
143014261|NCT00689273|515591672|FG001|Overall Study|Other|2|||
143481710|NCT00705783|517309318|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
143014262|NCT00689273|515591671|FG000|Overall Study|Randomized but not Treated|1|||
143014263|NCT00689273|515591672|FG001|Overall Study|Randomized but not Treated|0|||
143014264|NCT02531698|515591677|FG000|Overall Study|Adverse Event|2|||
143014265|NCT02531698|515591678|FG001|Overall Study|Adverse Event|1|||
143014266|NCT02531698|515591677|FG000|Overall Study|Withdrawal by Subject|6|||
143014267|NCT02531698|515591678|FG001|Overall Study|Withdrawal by Subject|1|||
143014268|NCT02531698|515591677|FG000|Overall Study|Protocol Violation|2|||
143014269|NCT02531698|515591678|FG001|Overall Study|Protocol Violation|0|||
143014270|NCT02531698|515591677|FG000|Overall Study|Lost to Follow-up|1|||
143014271|NCT02531698|515591678|FG001|Overall Study|Lost to Follow-up|0|||
143014272|NCT02395536|515591679|FG000|Overall Study|Lost to Follow-up|4|||
143014273|NCT02395536|515591680|FG001|Overall Study|Lost to Follow-up|4|||
143014274|NCT02395536|515591679|FG000|Overall Study|Death|2|||
143014275|NCT02395536|515591680|FG001|Overall Study|Death|0|||
143014276|NCT02395536|515591679|FG000|Overall Study|Physician Decision|4|||
143014277|NCT02395536|515591680|FG001|Overall Study|Physician Decision|6|||
143014278|NCT02395536|515591679|FG000|Overall Study|Withdrawal by Subject|9|||
143014279|NCT02395536|515591680|FG001|Overall Study|Withdrawal by Subject|17|||
143014280|NCT02395536|515591679|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
143014281|NCT02395536|515591680|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
143014282|NCT02395536|515591679|FG000|Overall Study|Insurance issue|0|||
143014283|NCT02395536|515591680|FG001|Overall Study|Insurance issue|1|||
143014284|NCT01211613|515593580|FG000|Overall Study|Lost to Follow-up|2|||
143014285|NCT01211613|515593581|FG001|Overall Study|Lost to Follow-up|2|||
143014286|NCT01211613|515593582|FG002|Overall Study|Lost to Follow-up|2|||
143014287|NCT01211613|515593580|FG000|Overall Study|Withdrawal by Subject|1|||
143014288|NCT01211613|515593581|FG001|Overall Study|Withdrawal by Subject|0|||
143014289|NCT01211613|515593582|FG002|Overall Study|Withdrawal by Subject|0|||
143014290|NCT03853213|515593583|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
143014291|NCT03853213|515593584|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
143014292|NCT03853213|515593583|FG000|Overall Study|Other (e.g., too busy)|0|||
143014293|NCT03853213|515593584|FG001|Overall Study|Other (e.g., too busy)|2|||
143014294|NCT03302299|515593585|FG000|Overall Study|Protocol Violation|1|||
143014295|NCT00021229|515593586|FG000|Overall Study|Adverse Event|10|||
143014296|NCT00021229|515593587|FG001|Overall Study|Adverse Event|5|||
143014297|NCT00021229|515593588|FG002|Overall Study|Adverse Event|2|||
143014298|NCT00021229|515593586|FG000|Overall Study|Death|0|||
143014299|NCT00021229|515593587|FG001|Overall Study|Death|1|||
143014300|NCT00021229|515593588|FG002|Overall Study|Death|0|||
143014301|NCT00021229|515593586|FG000|Overall Study|Withdrawal by Subject|7|||
143014302|NCT00021229|515593587|FG001|Overall Study|Withdrawal by Subject|7|||
143014303|NCT00021229|515593588|FG002|Overall Study|Withdrawal by Subject|1|||
143014304|NCT00021229|515593586|FG000|Overall Study|Progressive Disease|15|||
143014305|NCT00021229|515593587|FG001|Overall Study|Progressive Disease|19|||
143014306|NCT00021229|515593588|FG002|Overall Study|Progressive Disease|12|||
143014307|NCT00021229|515593586|FG000|Overall Study|Protocol Violation|1|||
143014308|NCT00021229|515593587|FG001|Overall Study|Protocol Violation|1|||
143014309|NCT00021229|515593588|FG002|Overall Study|Protocol Violation|0|||
143014310|NCT00021229|515593586|FG000|Overall Study|Physician Decision|0|||
143014311|NCT00021229|515593587|FG001|Overall Study|Physician Decision|0|||
143014312|NCT00021229|515593588|FG002|Overall Study|Physician Decision|1|||
143014313|NCT00021229|515593586|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
143014314|NCT00021229|515593587|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
143014315|NCT00021229|515593588|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
143014316|NCT01901146|515593592|FG000|Neoadjuvant Phase|Death|1|||
143014317|NCT01901146|515593593|FG001|Neoadjuvant Phase|Death|2|||
143014318|NCT01901146|515593594|FG002|Neoadjuvant Phase|Death|0|||
143014319|NCT01901146|515593595|FG003|Neoadjuvant Phase|Death|0|||
143014320|NCT01901146|515593596|FG004|Neoadjuvant Phase|Death|0|||
143014321|NCT01901146|515593592|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
143014322|NCT01901146|515593593|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
143014323|NCT01901146|515593594|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
143014324|NCT01901146|515593595|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
143014325|NCT01901146|515593596|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
143481711|NCT00705783|517309319|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
143481712|NCT00705783|517309317|FG000|Conversion Phase|Withdrawn by Investigator|4|||
143014326|NCT01901146|515593592|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
143014327|NCT01901146|515593593|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
143014328|NCT01901146|515593594|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
143014329|NCT01901146|515593595|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
143014330|NCT01901146|515593596|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
143014331|NCT01901146|515593592|FG000|Neoadjuvant Phase|Physician Decision|1|||
143014332|NCT01901146|515593593|FG001|Neoadjuvant Phase|Physician Decision|2|||
143014333|NCT01901146|515593594|FG002|Neoadjuvant Phase|Physician Decision|0|||
143014334|NCT01901146|515593595|FG003|Neoadjuvant Phase|Physician Decision|0|||
143014335|NCT01901146|515593596|FG004|Neoadjuvant Phase|Physician Decision|0|||
143014336|NCT01901146|515593592|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
143148176|NCT00141817|516086352|FG001|Overall Study|Protocol Violation|0|||
143148177|NCT00141817|516086353|FG002|Overall Study|Protocol Violation|1|||
143148178|NCT00141817|516086354|FG003|Overall Study|Protocol Violation|0|||
143148179|NCT00141817|516086351|FG000|Overall Study|Parent request|1|||
143148180|NCT00141817|516086352|FG001|Overall Study|Parent request|0|||
143481713|NCT00705783|517309318|FG001|Conversion Phase|Withdrawn by Investigator|0|||
143481714|NCT00705783|517309319|FG002|Conversion Phase|Withdrawn by Investigator|0|||
143481715|NCT00705783|517309317|FG000|Conversion Phase|Withdrew Consent|24|||
143481716|NCT00705783|517309318|FG001|Conversion Phase|Withdrew Consent|0|||
143481717|NCT00705783|517309319|FG002|Conversion Phase|Withdrew Consent|0|||
143481718|NCT00705783|517309317|FG000|Conversion Phase|Protocol Deviation|2|||
143481719|NCT00705783|517309318|FG001|Conversion Phase|Protocol Deviation|0|||
143481720|NCT00705783|517309319|FG002|Conversion Phase|Protocol Deviation|0|||
143481721|NCT00705783|517309317|FG000|Conversion Phase|Adverse Event|11|||
143481722|NCT00705783|517309318|FG001|Conversion Phase|Adverse Event|0|||
143481723|NCT00705783|517309319|FG002|Conversion Phase|Adverse Event|0|||
143481724|NCT00705783|517309317|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
143481725|NCT00705783|517309318|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
143481726|NCT00705783|517309319|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
143481727|NCT00705783|517309317|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
143481728|NCT00705783|517309318|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
143481729|NCT00705783|517309319|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
143481730|NCT00705783|517309317|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
143481731|NCT00705783|517309318|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
143481732|NCT00705783|517309319|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
143481733|NCT00705783|517309317|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
143481734|NCT00705783|517309318|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
143481735|NCT00705783|517309319|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
143481736|NCT00705783|517309317|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
143481737|NCT00705783|517309318|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
143481738|NCT00705783|517309319|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
143481739|NCT00705783|517309317|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
143481740|NCT00705783|517309318|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
143481741|NCT00705783|517309319|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
143481742|NCT00705783|517309317|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
143481743|NCT00705783|517309318|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
143481744|NCT00705783|517309319|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
143481745|NCT00705783|517309317|FG000|Oral Stabilization Phase|Adverse Event|14|||
143481746|NCT00705783|517309318|FG001|Oral Stabilization Phase|Adverse Event|0|||
143481747|NCT00705783|517309319|FG002|Oral Stabilization Phase|Adverse Event|0|||
143481748|NCT00705783|517309317|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
143481749|NCT00705783|517309318|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
143481750|NCT00705783|517309319|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
143481751|NCT00705783|517309317|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
143481752|NCT00705783|517309318|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
143481753|NCT00705783|517309319|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
143481754|NCT00705783|517309317|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
143481755|NCT00705783|517309318|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
143481756|NCT00705783|517309319|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
143481757|NCT00705783|517309317|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
143481758|NCT00705783|517309318|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
143481759|NCT00705783|517309319|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
143481760|NCT00705783|517309317|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
143481761|NCT00705783|517309318|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
143481762|NCT00705783|517309319|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
143481763|NCT00705783|517309317|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
143481764|NCT00705783|517309318|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
143481765|NCT00705783|517309319|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
143481766|NCT00705783|517309317|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
143481767|NCT00705783|517309318|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
143481768|NCT00705783|517309319|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
143481769|NCT00705783|517309317|FG000|Depot Stabilization Phase|Adverse Event|17|||
143481770|NCT00705783|517309318|FG001|Depot Stabilization Phase|Adverse Event|0|||
143481771|NCT00705783|517309319|FG002|Depot Stabilization Phase|Adverse Event|0|||
143481772|NCT00705783|517309317|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
143481773|NCT00705783|517309318|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
143481774|NCT00705783|517309319|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
143481775|NCT00705783|517309317|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
143148181|NCT00141817|516086353|FG002|Overall Study|Parent request|0|||
143148182|NCT00141817|516086354|FG003|Overall Study|Parent request|0|||
143014337|NCT01901146|515593593|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
143014338|NCT01901146|515593594|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
143014339|NCT01901146|515593595|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
143014340|NCT01901146|515593596|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
143014341|NCT01901146|515593592|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
143014342|NCT01901146|515593593|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
143014343|NCT01901146|515593594|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
143481776|NCT00705783|517309318|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
143481777|NCT00705783|517309319|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
143481778|NCT00705783|517309317|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
143481779|NCT00705783|517309318|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
143481780|NCT00705783|517309319|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
143481781|NCT00705783|517309317|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
143481782|NCT00705783|517309318|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
143481783|NCT00705783|517309319|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
143481784|NCT00705783|517309317|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
143481785|NCT00705783|517309318|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
143481786|NCT00705783|517309319|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
143481787|NCT00705783|517309317|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
143481788|NCT00705783|517309318|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
143481789|NCT00705783|517309319|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
143481790|NCT00705783|517309317|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
143481791|NCT00705783|517309318|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
143481792|NCT00705783|517309319|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
143481793|NCT00705783|517309317|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
143481794|NCT00705783|517309318|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
143481795|NCT00705783|517309319|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
143481796|NCT00705783|517309317|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
143481797|NCT00705783|517309318|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
143481798|NCT00705783|517309319|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
143481799|NCT00705783|517309317|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
143481800|NCT00705783|517309318|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
143481801|NCT00705783|517309319|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
143481802|NCT00705783|517309317|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
143481803|NCT00705783|517309318|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
143481804|NCT00705783|517309319|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
143481805|NCT04251910|517309320|FG000|Overall Study|Covid 19 lockdown|0|||
143481806|NCT04251910|517309321|FG001|Overall Study|Covid 19 lockdown|5|||
143481807|NCT04251910|517309322|FG002|Overall Study|Covid 19 lockdown|0|||
143481808|NCT04251910|517309323|FG003|Overall Study|Covid 19 lockdown|4|||
143481809|NCT04251910|517309324|FG004|Overall Study|Covid 19 lockdown|0|||
143481810|NCT04251910|517309325|FG005|Overall Study|Covid 19 lockdown|0|||
143481811|NCT04251910|517309320|FG000|Overall Study|Assisted living facility was closed|0|||
143481812|NCT04251910|517309321|FG001|Overall Study|Assisted living facility was closed|0|||
143481813|NCT04251910|517309322|FG002|Overall Study|Assisted living facility was closed|0|||
143481814|NCT04251910|517309323|FG003|Overall Study|Assisted living facility was closed|0|||
143481815|NCT04251910|517309324|FG004|Overall Study|Assisted living facility was closed|1|||
143481816|NCT04251910|517309325|FG005|Overall Study|Assisted living facility was closed|0|||
143481817|NCT00290342|517309326|FG000|Overall Study|Other|0|||
143481818|NCT00290342|517309327|FG001|Overall Study|Other|1|||
143481819|NCT00290342|517309326|FG000|Overall Study|Withdrawal by Subject|6|||
143481820|NCT00290342|517309327|FG001|Overall Study|Withdrawal by Subject|4|||
143481821|NCT00290342|517309326|FG000|Overall Study|Lost to Follow-up|1|||
143481822|NCT00290342|517309327|FG001|Overall Study|Lost to Follow-up|0|||
143481823|NCT01056510|517309330|FG000|Overall Study|Dropout Before Start of Treatment|1|||
143481824|NCT01056510|517309331|FG001|Overall Study|Dropout Before Start of Treatment|1|||
143481825|NCT01056510|517309330|FG000|Overall Study|Withdrawal by Subject|4|||
143481826|NCT01056510|517309331|FG001|Overall Study|Withdrawal by Subject|2|||
143481827|NCT01056510|517309330|FG000|Overall Study|Death|29|||
143481828|NCT01056510|517309331|FG001|Overall Study|Death|34|||
143481829|NCT01056510|517309330|FG000|Overall Study|Noncompliance|1|||
143481830|NCT01056510|517309331|FG001|Overall Study|Noncompliance|3|||
143481831|NCT01056510|517309330|FG000|Overall Study|Physician Decision|4|||
143481832|NCT01056510|517309331|FG001|Overall Study|Physician Decision|5|||
143481833|NCT01056510|517309330|FG000|Overall Study|Lost to Follow-up|5|||
143481834|NCT01056510|517309331|FG001|Overall Study|Lost to Follow-up|6|||
143481835|NCT01056510|517309330|FG000|Overall Study|Other|10|||
143481836|NCT01056510|517309331|FG001|Overall Study|Other|12|||
143481837|NCT01056510|517309330|FG000|Overall Study|Missing|0|||
143481838|NCT01056510|517309331|FG001|Overall Study|Missing|1|||
143481839|NCT02285998|517309334|FG000|Overall Study|Adverse Event|9|||
143481840|NCT02285998|517309335|FG001|Overall Study|Adverse Event|8|||
143481841|NCT02285998|517309334|FG000|Overall Study|Physician Decision|1|||
143481842|NCT02285998|517309335|FG001|Overall Study|Physician Decision|2|||
143481843|NCT02285998|517309334|FG000|Overall Study|Lost to Follow-up|176|||
143481844|NCT02285998|517309335|FG001|Overall Study|Lost to Follow-up|172|||
143481845|NCT02285998|517309334|FG000|Overall Study|Withdrawal by Subject|53|||
143481846|NCT02285998|517309335|FG001|Overall Study|Withdrawal by Subject|61|||
143481847|NCT02285998|517309334|FG000|Overall Study|Other Reasons|7|||
143481848|NCT02285998|517309335|FG001|Overall Study|Other Reasons|10|||
143481849|NCT00841568|517309336|FG000|Overall Study|Adverse Event|1|||
143481850|NCT00841568|517309336|FG000|Overall Study|Death|1|||
143481851|NCT00841568|517309336|FG000|Overall Study|Withdrawal by Subject|2|||
143481852|NCT00841568|517309336|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
143481853|NCT00545298|517309337|FG000|Overall Study|Issues with Standard of Care|2|||
143481854|NCT00545298|517309338|FG001|Overall Study|Issues with Standard of Care|0|||
143481855|NCT00545298|517309339|FG002|Overall Study|Issues with Standard of Care|1|||
143481856|NCT02830776|517309340|FG000|Overall Study|Lost to Follow-up|1|||
143481857|NCT01820364|517309341|FG000|Part I: LGX818|Death|1|||
143481858|NCT01820364|517309342|FG001|Part I: LGX818|Death|0|||
143481859|NCT01820364|517309341|FG000|Part I: LGX818|Administrative Problems|3|||
143481860|NCT01820364|517309342|FG001|Part I: LGX818|Administrative Problems|0|||
143481861|NCT01820364|517309341|FG000|Part I: LGX818|Adverse Event|6|||
143481862|NCT01820364|517309342|FG001|Part I: LGX818|Adverse Event|0|||
143481863|NCT01820364|517309341|FG000|Part I: LGX818|Disease Progression|4|||
143481864|NCT01820364|517309342|FG001|Part I: LGX818|Disease Progression|0|||
143481865|NCT01820364|517309341|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
143481866|NCT01820364|517309342|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
143481867|NCT01087775|517309346|FG000|Overall Study|failed inclusion criteria|2|||
143481868|NCT01553188|517309349|FG000|Overall Study|Patient choice|1|||
143481869|NCT01553188|517309350|FG001|Overall Study|Patient choice|0|||
143481870|NCT01553188|517309351|FG002|Overall Study|Patient choice|0|||
143481871|NCT01553188|517309352|FG003|Overall Study|Patient choice|0|||
143481872|NCT01553188|517309349|FG000|Overall Study|Intercurrent illness and adverse event|0|||
143481873|NCT01553188|517309350|FG001|Overall Study|Intercurrent illness and adverse event|1|||
143481874|NCT01553188|517309351|FG002|Overall Study|Intercurrent illness and adverse event|2|||
143481875|NCT01553188|517309352|FG003|Overall Study|Intercurrent illness and adverse event|0|||
143481876|NCT04744207|517309354|FG000|Treatment|Withdrawal by Subject|2|||
143481877|NCT04744207|517309355|FG001|Treatment|Withdrawal by Subject|0|||
143481878|NCT04744207|517309354|FG000|Treatment|Adverse Event|1|||
143481879|NCT04744207|517309355|FG001|Treatment|Adverse Event|2|||
143481880|NCT00777101|517309363|FG000|Overall Study|Death|48|||
143481881|NCT00777101|517309364|FG001|Overall Study|Death|43|||
143481882|NCT00777101|517309363|FG000|Overall Study|Withdrawal by Subject|11|||
143481883|NCT00777101|517309364|FG001|Overall Study|Withdrawal by Subject|6|||
143481884|NCT00777101|517309363|FG000|Overall Study|Lost to Follow-up|2|||
143481885|NCT00777101|517309364|FG001|Overall Study|Lost to Follow-up|1|||
143481886|NCT00777101|517309363|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
143481887|NCT00777101|517309364|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
143481888|NCT00777101|517309363|FG000|Overall Study|Failed to Return|0|||
143481889|NCT00777101|517309364|FG001|Overall Study|Failed to Return|1|||
143481890|NCT00961220|517309365|FG000|Overall Study|Adverse Event|3|||
143481891|NCT00961220|517309365|FG000|Overall Study|Lack of Efficacy|1|||
143481892|NCT00961220|517309365|FG000|Overall Study|No IV access for O6BG|1|||
143481893|NCT00961220|517309365|FG000|Overall Study|O6BG no longer supplied|1|||
143481894|NCT00961220|517309365|FG000|Overall Study|Complete Response prior to 12 courses|1|||
143481895|NCT01301950|517309373|FG000|Overall Study|Surgery was cancelled by patient|0|||
143481896|NCT01301950|517309374|FG001|Overall Study|Surgery was cancelled by patient|1|||
143481897|NCT04041284|517309377|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
143481898|NCT04041284|517309378|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
143481899|NCT04041284|517309377|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
143481900|NCT04041284|517309378|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
143481901|NCT04041284|517309377|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
143481902|NCT04041284|517309378|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
143481903|NCT04041284|517309377|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
143481904|NCT04041284|517309378|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
143481905|NCT04041284|517309377|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
143481906|NCT04041284|517309378|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
143481907|NCT04041284|517309377|FG000|DB Phase (12 Weeks)|Other than specified|1|||
143481908|NCT04041284|517309378|FG001|DB Phase (12 Weeks)|Other than specified|0|||
143481909|NCT04041284|517309377|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
143481910|NCT04041284|517309378|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
143481911|NCT04041284|517309377|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
143481912|NCT04041284|517309378|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
143481913|NCT04041284|517309377|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
143481914|NCT04041284|517309378|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
143481915|NCT04041284|517309377|FG000|OL Phase (12 Weeks)|Other than specified|6|||
143481916|NCT04041284|517309378|FG001|OL Phase (12 Weeks)|Other than specified|2|||
143481917|NCT00825162|517309379|FG000|Overall Study|Withdrawal by Subject|11|||
143481918|NCT00825162|517309380|FG001|Overall Study|Withdrawal by Subject|13|||
143481919|NCT00825162|517309381|FG002|Overall Study|Withdrawal by Subject|3|||
143481920|NCT00825162|517309379|FG000|Overall Study|Lost to Follow-up|9|||
143481921|NCT00825162|517309380|FG001|Overall Study|Lost to Follow-up|6|||
143481922|NCT00825162|517309381|FG002|Overall Study|Lost to Follow-up|3|||
143481923|NCT00825162|517309379|FG000|Overall Study|Physician Decision|2|||
143481924|NCT00825162|517309380|FG001|Overall Study|Physician Decision|0|||
143481925|NCT00825162|517309381|FG002|Overall Study|Physician Decision|0|||
143481926|NCT00825162|517309379|FG000|Overall Study|Move away from the study area|1|||
143481927|NCT00825162|517309380|FG001|Overall Study|Move away from the study area|0|||
143481928|NCT00825162|517309381|FG002|Overall Study|Move away from the study area|0|||
143481929|NCT00825162|517309379|FG000|Overall Study|Unable to attend the study visit|5|||
143481930|NCT00825162|517309380|FG001|Overall Study|Unable to attend the study visit|2|||
143481931|NCT00825162|517309381|FG002|Overall Study|Unable to attend the study visit|0|||
143481932|NCT00964743|517309385|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
143481933|NCT00492752|517309386|FG000|Double Blind Treatment|Death|13|||
143481934|NCT00492752|517309387|FG001|Double Blind Treatment|Death|0|||
143481935|NCT00492752|517309388|FG002|Double Blind Treatment|Death|2|||
143481936|NCT00492752|517309389|FG003|Double Blind Treatment|Death|0|||
143481937|NCT00492752|517309386|FG000|Double Blind Treatment|Adverse Event|1|||
143481938|NCT00492752|517309387|FG001|Double Blind Treatment|Adverse Event|0|||
143481939|NCT00492752|517309388|FG002|Double Blind Treatment|Adverse Event|0|||
143481940|NCT00492752|517309389|FG003|Double Blind Treatment|Adverse Event|0|||
143481941|NCT00492752|517309386|FG000|Double Blind Treatment|Protocol Violation|0|||
143481942|NCT00492752|517309387|FG001|Double Blind Treatment|Protocol Violation|0|||
143481943|NCT00492752|517309388|FG002|Double Blind Treatment|Protocol Violation|1|||
143481944|NCT00492752|517309389|FG003|Double Blind Treatment|Protocol Violation|0|||
143481945|NCT00492752|517309386|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
143481946|NCT00492752|517309387|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
143481947|NCT00492752|517309388|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
143481948|NCT00492752|517309389|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
143481949|NCT00492752|517309386|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
143481950|NCT00492752|517309387|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
143481951|NCT00492752|517309388|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
143481952|NCT00492752|517309389|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
143481953|NCT00492752|517309386|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
143481954|NCT00492752|517309387|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
143481955|NCT00492752|517309388|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
143481956|NCT00492752|517309389|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
143481957|NCT00492752|517309386|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
143481958|NCT00492752|517309387|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
143481959|NCT00492752|517309388|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
143481960|NCT00492752|517309389|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
143481961|NCT00492752|517309386|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
143481962|NCT00492752|517309387|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
143481963|NCT00492752|517309388|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
143481964|NCT00492752|517309389|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
143481965|NCT00492752|517309386|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
143481966|NCT00492752|517309387|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
143481967|NCT00492752|517309388|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
143481968|NCT00492752|517309389|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
143481969|NCT00492752|517309386|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
143481970|NCT00492752|517309387|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
143481971|NCT00492752|517309388|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
143481972|NCT00492752|517309389|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
143481973|NCT00492752|517309386|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
143481974|NCT00492752|517309387|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
143481975|NCT00492752|517309388|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
143481976|NCT00492752|517309389|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
143481977|NCT00219284|517309390|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
143481978|NCT00219284|517309391|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
143481979|NCT00219284|517309390|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
143481980|NCT00219284|517309391|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
143014344|NCT01901146|515593595|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
143014345|NCT01901146|515593596|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
143481981|NCT00219284|517309390|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
143481982|NCT00219284|517309391|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
143014346|NCT01901146|515593592|FG000|Adjuvant Phase|Other|0|||
143014347|NCT01901146|515593593|FG001|Adjuvant Phase|Other|0|||
143014348|NCT01901146|515593594|FG002|Adjuvant Phase|Other|1|||
143014349|NCT01901146|515593595|FG003|Adjuvant Phase|Other|0|||
143014350|NCT01901146|515593596|FG004|Adjuvant Phase|Other|0|||
143148183|NCT01349595|516086364|FG000|Overall Study|Lack of funding|2|||
143148184|NCT01349595|516086365|FG001|Overall Study|Lack of funding|2|||
143148185|NCT03595748|516087679|FG000|Overall Study|Death|11|||
143481983|NCT00219284|517309390|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
143481984|NCT00219284|517309391|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
143014351|NCT01901146|515593592|FG000|Adjuvant Phase|Death|0|||
143014352|NCT01901146|515593593|FG001|Adjuvant Phase|Death|0|||
143014353|NCT01901146|515593594|FG002|Adjuvant Phase|Death|0|||
143014354|NCT01901146|515593595|FG003|Adjuvant Phase|Death|0|||
143014355|NCT01901146|515593596|FG004|Adjuvant Phase|Death|3|||
143014356|NCT01901146|515593592|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
143014357|NCT01901146|515593593|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
143014358|NCT01901146|515593594|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
143014359|NCT01901146|515593595|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
143014360|NCT01901146|515593596|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
143014361|NCT01901146|515593592|FG000|Adjuvant Phase|Physician Decision|0|||
143014362|NCT01901146|515593593|FG001|Adjuvant Phase|Physician Decision|0|||
143014363|NCT01901146|515593594|FG002|Adjuvant Phase|Physician Decision|9|||
143014364|NCT01901146|515593595|FG003|Adjuvant Phase|Physician Decision|2|||
143014365|NCT01901146|515593596|FG004|Adjuvant Phase|Physician Decision|4|||
143014366|NCT01901146|515593592|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
143014367|NCT01901146|515593593|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
143014368|NCT01901146|515593594|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
143014369|NCT01901146|515593595|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
143014370|NCT01901146|515593596|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
143014371|NCT00297492|515593597|FG000|Set Quit Date|Lost to Follow-up|7|||
143014372|NCT00297492|515593598|FG001|Set Quit Date|Lost to Follow-up|13|||
143014373|NCT00297492|515593599|FG002|Set Quit Date|Lost to Follow-up|5|||
143014374|NCT00297492|515593597|FG000|6 Month Follow-up|Lost to Follow-up|63|||
143014375|NCT00297492|515593598|FG001|6 Month Follow-up|Lost to Follow-up|49|||
143014376|NCT00297492|515593599|FG002|6 Month Follow-up|Lost to Follow-up|27|||
143014377|NCT03724968|515593600|FG000|Overall Study|Insurance issues|0|||
143014378|NCT03724968|515593601|FG001|Overall Study|Insurance issues|1|||
143014379|NCT03724968|515593600|FG000|Overall Study|Study closed|0|||
143014380|NCT03724968|515593601|FG001|Overall Study|Study closed|1|||
143014381|NCT01858558|515593602|FG000|Overall Study|Death|1|||
143014382|NCT01858558|515593603|FG001|Overall Study|Death|1|||
143014383|NCT01858558|515593602|FG000|Overall Study|Lost to Follow-up|1|||
143014384|NCT01858558|515593603|FG001|Overall Study|Lost to Follow-up|0|||
143014385|NCT01858558|515593602|FG000|Overall Study|Disease progression|3|||
143014386|NCT01858558|515593603|FG001|Overall Study|Disease progression|1|||
143014387|NCT01858558|515593602|FG000|Overall Study|Product contamination|2|||
143014388|NCT01858558|515593603|FG001|Overall Study|Product contamination|0|||
143014389|NCT01858558|515593602|FG000|Overall Study|Failed expansion of cell product|2|||
143014390|NCT01858558|515593603|FG001|Overall Study|Failed expansion of cell product|0|||
143014391|NCT01336608|515593604|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
143014392|NCT01336608|515593605|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
143014393|NCT01336608|515593606|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
143014394|NCT01336608|515593607|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
143014395|NCT01336608|515593604|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
143014396|NCT01336608|515593605|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
143014397|NCT01336608|515593606|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
143014398|NCT01336608|515593607|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
143363611|NCT00062868|516873786|FG006|Dose Level 2|Death|0|||
143481985|NCT00219284|517309390|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
143481986|NCT00219284|517309391|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
143481987|NCT00219284|517309390|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
143481988|NCT00219284|517309391|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
143481989|NCT00219284|517309390|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
143481990|NCT00219284|517309391|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
143481991|NCT00219284|517309390|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
143014399|NCT01336608|515593604|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
143014400|NCT01336608|515593605|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
143014401|NCT01336608|515593606|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
143014402|NCT01336608|515593607|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
143014403|NCT01336608|515593604|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
143014404|NCT01336608|515593605|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
143014405|NCT01336608|515593606|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
143363612|NCT00062868|516873787|FG007|Dose Level 2|Death|0|||
143148186|NCT03595748|516087680|FG001|Overall Study|Death|12|||
143148187|NCT03595748|516087679|FG000|Overall Study|Withdrawal by Subject|28|||
143148188|NCT03595748|516087680|FG001|Overall Study|Withdrawal by Subject|29|||
143148189|NCT03595748|516087679|FG000|Overall Study|Protocol Violation|0|||
143148190|NCT03595748|516087680|FG001|Overall Study|Protocol Violation|1|||
143148191|NCT04809974|516087681|FG000|Lead-in Phase|Withdrawal by Subject|3|||
143148192|NCT04809974|516087682|FG001|Lead-in Phase|Withdrawal by Subject|0|||
143148193|NCT04809974|516087683|FG002|Lead-in Phase|Withdrawal by Subject|0|||
143148194|NCT04809974|516087681|FG000|Lead-in Phase|No longer eligible|11|||
143148195|NCT04809974|516087682|FG001|Lead-in Phase|No longer eligible|0|||
143148196|NCT04809974|516087683|FG002|Lead-in Phase|No longer eligible|0|||
143148197|NCT04809974|516087681|FG000|Randomized Phase|Lost to Follow-up|0|||
143148198|NCT04809974|516087682|FG001|Randomized Phase|Lost to Follow-up|1|||
143148199|NCT04809974|516087683|FG002|Randomized Phase|Lost to Follow-up|5|||
143481992|NCT00219284|517309391|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
143481993|NCT00219284|517309390|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
143481994|NCT00219284|517309391|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
143481995|NCT01357655|517309392|FG000|Overall Study|Administrative Reason by Sponsor|45|||
143481996|NCT01357655|517309393|FG001|Overall Study|Administrative Reason by Sponsor|0|||
143481997|NCT01357655|517309392|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
143481998|NCT01357655|517309393|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
143481999|NCT01357655|517309392|FG000|Overall Study|Disease Progression|1|||
143482000|NCT01357655|517309393|FG001|Overall Study|Disease Progression|0|||
143482001|NCT01357655|517309392|FG000|Overall Study|Lost to Follow-up|2|||
143482002|NCT01357655|517309393|FG001|Overall Study|Lost to Follow-up|0|||
143482003|NCT01357655|517309392|FG000|Overall Study|Maximum Clinical Benefit|2|||
143482004|NCT01357655|517309393|FG001|Overall Study|Maximum Clinical Benefit|0|||
143482005|NCT01357655|517309392|FG000|Overall Study|Reason Unspecified|1|||
143482006|NCT01357655|517309393|FG001|Overall Study|Reason Unspecified|0|||
143482007|NCT01357655|517309392|FG000|Overall Study|Study Drug Toxicity|11|||
143482008|NCT01357655|517309393|FG001|Overall Study|Study Drug Toxicity|0|||
143482009|NCT01357655|517309392|FG000|Overall Study|Subject Withdrew Consent|1|||
143482010|NCT01357655|517309393|FG001|Overall Study|Subject Withdrew Consent|0|||
143482011|NCT01652885|517310800|FG000|Overall Study|Adverse Event|1|||
143482012|NCT00075400|517310801|FG000|Overall Study|Ineligible: wrong primary|1|||
143482013|NCT00075400|517310801|FG000|Overall Study|Never treated|2|||
143482014|NCT03723707|517310802|FG000|Overall Study|Death|32|||
143482015|NCT03723707|517310803|FG001|Overall Study|Death|32|||
143482016|NCT03723707|517310802|FG000|Overall Study|Admitted to long term care|12|||
143482017|NCT03723707|517310803|FG001|Overall Study|Admitted to long term care|12|||
143482018|NCT03723707|517310802|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
143482019|NCT03723707|517310803|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
143482020|NCT03723707|517310802|FG000|Overall Study|Lost to Follow-up|40|||
143482021|NCT03723707|517310803|FG001|Overall Study|Lost to Follow-up|22|||
143482022|NCT03723707|517310802|FG000|Overall Study|Discontinued after study closure|24|||
143482023|NCT03723707|517310803|FG001|Overall Study|Discontinued after study closure|12|||
143482024|NCT04682405|517310805|FG000|Overall Study|Adverse Event|0|||
143482025|NCT04682405|517310806|FG001|Overall Study|Adverse Event|1|||
143482026|NCT03557281|517310807|FG000|Overall Study|Investigator discretion|0|||
143482027|NCT03557281|517310808|FG001|Overall Study|Investigator discretion|0|||
143482028|NCT03557281|517310809|FG002|Overall Study|Investigator discretion|1|||
143482029|NCT03557281|517310810|FG003|Overall Study|Investigator discretion|0|||
143482030|NCT03557281|517310811|FG004|Overall Study|Investigator discretion|0|||
143482031|NCT03557281|517310807|FG000|Overall Study|Withdrawal by Subject|0|||
143482032|NCT03557281|517310808|FG001|Overall Study|Withdrawal by Subject|1|||
143482033|NCT03557281|517310809|FG002|Overall Study|Withdrawal by Subject|1|||
143482034|NCT03557281|517310810|FG003|Overall Study|Withdrawal by Subject|1|||
143482035|NCT03557281|517310811|FG004|Overall Study|Withdrawal by Subject|2|||
143482036|NCT03557281|517310807|FG000|Overall Study|Randomized, but did not receive treatment|0|||
143482037|NCT03557281|517310808|FG001|Overall Study|Randomized, but did not receive treatment|0|||
143482038|NCT03557281|517310809|FG002|Overall Study|Randomized, but did not receive treatment|0|||
143482039|NCT03557281|517310810|FG003|Overall Study|Randomized, but did not receive treatment|0|||
143482040|NCT03557281|517310811|FG004|Overall Study|Randomized, but did not receive treatment|1|||
143482041|NCT01199042|517310812|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
143482042|NCT01199042|517310812|FG000|At Home (3 Months)|Lost to Follow-up|1|||
143482043|NCT00390546|517310816|FG000|Overall Study|Renal impairment|1|||
143482044|NCT00390546|517310817|FG001|Overall Study|Renal impairment|0|||
143482045|NCT00390546|517310816|FG000|Overall Study|Physician Decision|5|||
143482046|NCT00390546|517310817|FG001|Overall Study|Physician Decision|5|||
143482047|NCT02918864|517310818|FG000|Overall Study|Withdrawal by Subject|1|||
143482048|NCT02918864|517310819|FG001|Overall Study|Withdrawal by Subject|1|||
143482049|NCT02918864|517310818|FG000|Overall Study|Lost to Follow-up|3|||
143482050|NCT02918864|517310819|FG001|Overall Study|Lost to Follow-up|2|||
143482051|NCT02257372|517310825|FG000|Overall Study|Adverse Event|3|||
143148200|NCT04809974|516087681|FG000|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|0|||
143482052|NCT02257372|517310826|FG001|Overall Study|Adverse Event|7|||
143482053|NCT02257372|517310825|FG000|Overall Study|Lack of Efficacy|2|||
143482054|NCT02257372|517310826|FG001|Overall Study|Lack of Efficacy|1|||
143482055|NCT02257372|517310825|FG000|Overall Study|Protocol Violation|1|||
143482056|NCT02257372|517310826|FG001|Overall Study|Protocol Violation|1|||
143482057|NCT02257372|517310825|FG000|Overall Study|Lost to Follow-up|0|||
143482058|NCT02257372|517310826|FG001|Overall Study|Lost to Follow-up|1|||
143482059|NCT02257372|517310825|FG000|Overall Study|Withdrew consent|1|||
143482060|NCT02257372|517310826|FG001|Overall Study|Withdrew consent|0|||
143482061|NCT01849874|517310828|FG000|Overall Study|Death|89|||
143482062|NCT01849874|517310829|FG001|Overall Study|Death|42|||
143482063|NCT01849874|517310828|FG000|Overall Study|Withdrawal by Subject|17|||
143482064|NCT01849874|517310829|FG001|Overall Study|Withdrawal by Subject|16|||
143482065|NCT01849874|517310828|FG000|Overall Study|Lost to Follow-up|3|||
143482066|NCT01849874|517310829|FG001|Overall Study|Lost to Follow-up|2|||
143482067|NCT01849874|517310828|FG000|Overall Study|Study Termination By Sponsor|93|||
143482068|NCT01849874|517310829|FG001|Overall Study|Study Termination By Sponsor|48|||
143482069|NCT01849874|517310828|FG000|Overall Study|Completed as per protocol amendment 6|3|||
143482070|NCT01849874|517310829|FG001|Overall Study|Completed as per protocol amendment 6|0|||
143482071|NCT01849874|517310828|FG000|Overall Study|Physician Decision|7|||
143482072|NCT01849874|517310829|FG001|Overall Study|Physician Decision|1|||
143482073|NCT01849874|517310828|FG000|Overall Study|Other|16|||
143482074|NCT01849874|517310829|FG001|Overall Study|Other|4|||
143482075|NCT02104583|517310830|FG000|Overall Study|New ICD or CRT-D implanted|2|||
143482076|NCT02104583|517310831|FG001|Overall Study|New ICD or CRT-D implanted|0|||
143482077|NCT02104583|517310832|FG002|Overall Study|New ICD or CRT-D implanted|1|||
143482078|NCT02104583|517310833|FG003|Overall Study|New ICD or CRT-D implanted|0|||
143482079|NCT02104583|517310834|FG004|Overall Study|New ICD or CRT-D implanted|0|||
143482080|NCT02104583|517310830|FG000|Overall Study|Death|2|||
143482081|NCT02104583|517310831|FG001|Overall Study|Death|1|||
143482082|NCT02104583|517310832|FG002|Overall Study|Death|3|||
143482083|NCT02104583|517310833|FG003|Overall Study|Death|3|||
143482084|NCT02104583|517310834|FG004|Overall Study|Death|5|||
143014406|NCT01336608|515593607|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
143014407|NCT01336608|515593604|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
143014408|NCT01336608|515593605|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
143482085|NCT02104583|517310830|FG000|Overall Study|Subject required cardiac ablation|6|||
143482086|NCT02104583|517310831|FG001|Overall Study|Subject required cardiac ablation|4|||
143482087|NCT02104583|517310832|FG002|Overall Study|Subject required cardiac ablation|4|||
143482088|NCT02104583|517310833|FG003|Overall Study|Subject required cardiac ablation|5|||
143482089|NCT02104583|517310834|FG004|Overall Study|Subject required cardiac ablation|4|||
143482090|NCT02104583|517310830|FG000|Overall Study|Subject required prohibited medication|0|||
143482091|NCT02104583|517310831|FG001|Overall Study|Subject required prohibited medication|1|||
143482092|NCT02104583|517310832|FG002|Overall Study|Subject required prohibited medication|1|||
143482093|NCT02104583|517310833|FG003|Overall Study|Subject required prohibited medication|0|||
143482094|NCT02104583|517310834|FG004|Overall Study|Subject required prohibited medication|1|||
143482095|NCT02104583|517310830|FG000|Overall Study|Withdrew Consent|3|||
143482096|NCT02104583|517310831|FG001|Overall Study|Withdrew Consent|2|||
143482097|NCT02104583|517310832|FG002|Overall Study|Withdrew Consent|0|||
143482098|NCT02104583|517310833|FG003|Overall Study|Withdrew Consent|2|||
143482099|NCT02104583|517310834|FG004|Overall Study|Withdrew Consent|1|||
143482100|NCT02104583|517310830|FG000|Overall Study|Investigator's Discretion|1|||
143482101|NCT02104583|517310831|FG001|Overall Study|Investigator's Discretion|0|||
143482102|NCT02104583|517310832|FG002|Overall Study|Investigator's Discretion|0|||
143482103|NCT02104583|517310833|FG003|Overall Study|Investigator's Discretion|0|||
143482104|NCT02104583|517310834|FG004|Overall Study|Investigator's Discretion|0|||
143482105|NCT02104583|517310830|FG000|Overall Study|Protocol Violation|0|||
143482106|NCT02104583|517310831|FG001|Overall Study|Protocol Violation|0|||
143482107|NCT02104583|517310832|FG002|Overall Study|Protocol Violation|1|||
143482108|NCT02104583|517310833|FG003|Overall Study|Protocol Violation|0|||
143482109|NCT02104583|517310834|FG004|Overall Study|Protocol Violation|0|||
143482110|NCT02104583|517310830|FG000|Overall Study|Adverse Event|3|||
143482111|NCT02104583|517310831|FG001|Overall Study|Adverse Event|3|||
143482112|NCT02104583|517310832|FG002|Overall Study|Adverse Event|6|||
143482113|NCT02104583|517310833|FG003|Overall Study|Adverse Event|6|||
143482114|NCT02104583|517310834|FG004|Overall Study|Adverse Event|1|||
143482115|NCT02104583|517310830|FG000|Overall Study|Lost to Follow-up|1|||
143482116|NCT02104583|517310831|FG001|Overall Study|Lost to Follow-up|0|||
143482117|NCT02104583|517310832|FG002|Overall Study|Lost to Follow-up|0|||
143482118|NCT02104583|517310833|FG003|Overall Study|Lost to Follow-up|0|||
143482119|NCT02104583|517310834|FG004|Overall Study|Lost to Follow-up|0|||
143482120|NCT02104583|517310830|FG000|Overall Study|Randomized but Never Treated|0|||
143482121|NCT02104583|517310831|FG001|Overall Study|Randomized but Never Treated|0|||
143181198|NCT03654274|516210495|FG002|Overall Study|Lost to Follow-up|5|||
143482122|NCT02104583|517310832|FG002|Overall Study|Randomized but Never Treated|0|||
143482123|NCT02104583|517310833|FG003|Overall Study|Randomized but Never Treated|1|||
143482124|NCT02104583|517310834|FG004|Overall Study|Randomized but Never Treated|0|||
143014409|NCT01336608|515593606|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
143014410|NCT01336608|515593607|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
143014411|NCT01336608|515593604|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
143014412|NCT01336608|515593605|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
143014413|NCT01336608|515593606|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
143014414|NCT01336608|515593607|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
143014415|NCT01336608|515593604|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
143014416|NCT01336608|515593605|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
143014417|NCT01336608|515593606|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
143014418|NCT01336608|515593607|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
143014419|NCT01336608|515593604|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
143014420|NCT01336608|515593605|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
143014421|NCT01336608|515593606|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
143014422|NCT01336608|515593607|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
143014423|NCT01336608|515593604|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
143014424|NCT01336608|515593605|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
143014425|NCT01336608|515593606|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
143014426|NCT01336608|515593607|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
143014427|NCT01336608|515593604|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
143482125|NCT00880399|517310838|FG000|Overall Study|Adverse Event|4|||
143014428|NCT01336608|515593605|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
143014429|NCT01336608|515593606|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
143482126|NCT00880399|517310839|FG001|Overall Study|Adverse Event|6|||
143482127|NCT00880399|517310840|FG002|Overall Study|Adverse Event|5|||
143482128|NCT00880399|517310838|FG000|Overall Study|Lack of Efficacy|1|||
143482129|NCT00880399|517310839|FG001|Overall Study|Lack of Efficacy|4|||
143482130|NCT00880399|517310840|FG002|Overall Study|Lack of Efficacy|2|||
143482131|NCT00880399|517310838|FG000|Overall Study|Protocol Violation|4|||
143482132|NCT00880399|517310839|FG001|Overall Study|Protocol Violation|4|||
143482133|NCT00880399|517310840|FG002|Overall Study|Protocol Violation|6|||
143482134|NCT00880399|517310838|FG000|Overall Study|Study closed/terminated|3|||
143482135|NCT00880399|517310839|FG001|Overall Study|Study closed/terminated|7|||
143482136|NCT00880399|517310840|FG002|Overall Study|Study closed/terminated|4|||
143482137|NCT00880399|517310838|FG000|Overall Study|Lost to Follow-up|8|||
143482138|NCT00880399|517310839|FG001|Overall Study|Lost to Follow-up|5|||
143482139|NCT00880399|517310840|FG002|Overall Study|Lost to Follow-up|3|||
143482140|NCT00880399|517310838|FG000|Overall Study|Physician Decision|5|||
143482141|NCT00880399|517310839|FG001|Overall Study|Physician Decision|0|||
143482142|NCT00880399|517310840|FG002|Overall Study|Physician Decision|3|||
143482143|NCT00880399|517310838|FG000|Overall Study|Withdrawal by Subject|6|||
143482144|NCT00880399|517310839|FG001|Overall Study|Withdrawal by Subject|3|||
143482145|NCT00880399|517310840|FG002|Overall Study|Withdrawal by Subject|3|||
143482146|NCT01230307|517310841|FG000|Overall Study|LVAD Placement|0|||
143482147|NCT01230307|517310842|FG001|Overall Study|LVAD Placement|2|||
143482148|NCT02256540|517310846|FG000|Overall Study|Withdrawal by Subject|0|||
143482149|NCT02256540|517310847|FG001|Overall Study|Withdrawal by Subject|1|||
143482150|NCT02256540|517310848|FG002|Overall Study|Withdrawal by Subject|1|||
143482151|NCT02256540|517310846|FG000|Overall Study|Back pain preventing exercise|0|||
143482152|NCT02256540|517310847|FG001|Overall Study|Back pain preventing exercise|0|||
143482153|NCT02256540|517310848|FG002|Overall Study|Back pain preventing exercise|1|||
143482154|NCT01918007|517310849|FG000|Overall Study|Baseline oximetry not acceptable|11|||
143482155|NCT01918007|517310850|FG001|Overall Study|Baseline oximetry not acceptable|7|||
143482156|NCT01918007|517310849|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
143482157|NCT01918007|517310850|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
143482158|NCT01918007|517310849|FG000|Overall Study|Lost to Follow-up|4|||
143482159|NCT01918007|517310850|FG001|Overall Study|Lost to Follow-up|7|||
143482160|NCT01140451|517310851|FG000|Overall Study|Withdrawal by Subject|26|||
143482161|NCT01140451|517310852|FG001|Overall Study|Withdrawal by Subject|33|||
143482162|NCT01140451|517310851|FG000|Overall Study|Adverse Event|2|||
143482163|NCT01140451|517310852|FG001|Overall Study|Adverse Event|6|||
143482164|NCT01140451|517310851|FG000|Overall Study|Physician Decision|5|||
143148201|NCT04809974|516087682|FG001|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|2|||
143181199|NCT03654274|516210493|FG000|Overall Study|Withdrawal by Subject|46|||
143482165|NCT01140451|517310852|FG001|Overall Study|Physician Decision|3|||
143482166|NCT01140451|517310851|FG000|Overall Study|Lost to Follow-up|2|||
143482167|NCT01140451|517310852|FG001|Overall Study|Lost to Follow-up|0|||
143482168|NCT01140451|517310851|FG000|Overall Study|Participants Planning Pregnancy|3|||
143482169|NCT01140451|517310852|FG001|Overall Study|Participants Planning Pregnancy|0|||
143482170|NCT00441974|517310853|FG000|Overall Study|Adverse Event|6|||
143482171|NCT00441974|517310853|FG000|Overall Study|Consent Withdrawn|35|||
143482172|NCT00441974|517310853|FG000|Overall Study|Lost to Follow-up|80|||
143014430|NCT01336608|515593607|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
143014431|NCT01336608|515593604|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
143014432|NCT01336608|515593605|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
143014433|NCT01336608|515593606|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
143482173|NCT00441974|517310853|FG000|Overall Study|Protocol Violation|7|||
143482174|NCT02004262|517310856|FG000|Overall Study|Death|67|||
143482175|NCT02004262|517310857|FG001|Overall Study|Death|64|||
143482176|NCT02004262|517310858|FG002|Overall Study|Death|66|||
143482177|NCT02004262|517310859|FG003|Overall Study|Death|28|||
143482178|NCT02004262|517310860|FG004|Overall Study|Death|29|||
143482179|NCT02004262|517310861|FG005|Overall Study|Death|22|||
143482180|NCT02004262|517310856|FG000|Overall Study|Withdrawal by Subject|1|||
143014434|NCT01336608|515593607|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
143014435|NCT01336608|515593604|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
143014436|NCT01336608|515593605|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
143014437|NCT01336608|515593606|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
143014438|NCT01336608|515593607|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
143014439|NCT01336608|515593604|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
143014440|NCT01336608|515593605|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
143014441|NCT01336608|515593606|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
143014442|NCT01336608|515593607|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
143014443|NCT00569231|515593608|FG000|Overall Study|Study unrelated surgery|1|||
143014444|NCT00569231|515593608|FG000|Overall Study|Airfare expense|2|||
143482181|NCT02004262|517310857|FG001|Overall Study|Withdrawal by Subject|0|||
143482182|NCT02004262|517310858|FG002|Overall Study|Withdrawal by Subject|4|||
143482183|NCT02004262|517310859|FG003|Overall Study|Withdrawal by Subject|0|||
143482184|NCT02004262|517310860|FG004|Overall Study|Withdrawal by Subject|1|||
143482185|NCT02004262|517310861|FG005|Overall Study|Withdrawal by Subject|3|||
143482186|NCT02004262|517310856|FG000|Overall Study|Lost to Follow-up|1|||
143482187|NCT02004262|517310857|FG001|Overall Study|Lost to Follow-up|1|||
143482188|NCT02004262|517310858|FG002|Overall Study|Lost to Follow-up|0|||
143482189|NCT02004262|517310859|FG003|Overall Study|Lost to Follow-up|0|||
143482190|NCT02004262|517310860|FG004|Overall Study|Lost to Follow-up|0|||
143482191|NCT02004262|517310861|FG005|Overall Study|Lost to Follow-up|0|||
143482192|NCT02004262|517310856|FG000|Overall Study|Study Terminated by Sponsor|4|||
143482193|NCT02004262|517310857|FG001|Overall Study|Study Terminated by Sponsor|3|||
143014445|NCT00569231|515593608|FG000|Overall Study|Withdrawal by Subject|1|||
143014446|NCT00569231|515593608|FG000|Overall Study|Car accident injury|1|||
143014447|NCT00569231|515593608|FG000|Overall Study|Non-compliance|2|||
143014448|NCT01614925|515593609|FG000|Overall Study|Withdrawal by Subject|1|||
143014449|NCT01614925|515593610|FG001|Overall Study|Withdrawal by Subject|0|||
143014450|NCT01614925|515593609|FG000|Overall Study|Protocol Violation|3|||
143014451|NCT01614925|515593610|FG001|Overall Study|Protocol Violation|2|||
143014452|NCT02437890|515593615|FG000|Overall Study|Non-compliance to study drug|0|||
143014453|NCT02437890|515593616|FG001|Overall Study|Non-compliance to study drug|1|||
143014454|NCT02437890|515593617|FG002|Overall Study|Non-compliance to study drug|0|||
143014455|NCT02437890|515593618|FG003|Overall Study|Non-compliance to study drug|0|||
143014456|NCT02437890|515593619|FG004|Overall Study|Non-compliance to study drug|1|||
143014457|NCT02437890|515593615|FG000|Overall Study|Sponsor's decision|1|||
143014458|NCT02437890|515593616|FG001|Overall Study|Sponsor's decision|1|||
143014459|NCT02437890|515593617|FG002|Overall Study|Sponsor's decision|4|||
143014460|NCT02437890|515593618|FG003|Overall Study|Sponsor's decision|0|||
143014461|NCT02437890|515593619|FG004|Overall Study|Sponsor's decision|2|||
143014462|NCT02437890|515593615|FG000|Overall Study|Physician Decision|0|||
143014463|NCT02437890|515593616|FG001|Overall Study|Physician Decision|0|||
143014464|NCT02437890|515593617|FG002|Overall Study|Physician Decision|0|||
143014465|NCT02437890|515593618|FG003|Overall Study|Physician Decision|1|||
143014466|NCT02437890|515593619|FG004|Overall Study|Physician Decision|0|||
143014467|NCT02437890|515593615|FG000|Overall Study|Unable to attend visit(s)|1|||
143014468|NCT02437890|515593616|FG001|Overall Study|Unable to attend visit(s)|0|||
143014469|NCT02437890|515593617|FG002|Overall Study|Unable to attend visit(s)|0|||
143014470|NCT02437890|515593618|FG003|Overall Study|Unable to attend visit(s)|0|||
143014471|NCT02437890|515593619|FG004|Overall Study|Unable to attend visit(s)|0|||
143482194|NCT02004262|517310858|FG002|Overall Study|Study Terminated by Sponsor|2|||
143482195|NCT02004262|517310859|FG003|Overall Study|Study Terminated by Sponsor|1|||
143014472|NCT02437890|515593615|FG000|Overall Study|Lack of Efficacy|1|||
143014473|NCT02437890|515593616|FG001|Overall Study|Lack of Efficacy|3|||
143014474|NCT02437890|515593617|FG002|Overall Study|Lack of Efficacy|0|||
143014475|NCT02437890|515593618|FG003|Overall Study|Lack of Efficacy|3|||
143014476|NCT02437890|515593619|FG004|Overall Study|Lack of Efficacy|1|||
143482196|NCT02004262|517310860|FG004|Overall Study|Study Terminated by Sponsor|1|||
143482197|NCT02004262|517310861|FG005|Overall Study|Study Terminated by Sponsor|5|||
143482198|NCT00552175|517310864|FG000|Overall Study|Lack of Efficacy|2|||
143482199|NCT00552175|517310865|FG001|Overall Study|Lack of Efficacy|0|||
143482200|NCT00552175|517310866|FG002|Overall Study|Lack of Efficacy|1|||
143014477|NCT02437890|515593615|FG000|Overall Study|Adverse Event|4|||
143014478|NCT02437890|515593616|FG001|Overall Study|Adverse Event|9|||
143014479|NCT02437890|515593617|FG002|Overall Study|Adverse Event|5|||
143014480|NCT02437890|515593618|FG003|Overall Study|Adverse Event|11|||
143014481|NCT02437890|515593619|FG004|Overall Study|Adverse Event|7|||
143014482|NCT02437890|515593615|FG000|Overall Study|Withdrawal by Subject|1|||
143014483|NCT02437890|515593616|FG001|Overall Study|Withdrawal by Subject|2|||
143014484|NCT02437890|515593617|FG002|Overall Study|Withdrawal by Subject|6|||
143014485|NCT02437890|515593618|FG003|Overall Study|Withdrawal by Subject|5|||
143014486|NCT02437890|515593619|FG004|Overall Study|Withdrawal by Subject|5|||
143014487|NCT02437890|515593615|FG000|Overall Study|Death|0|||
143014488|NCT02437890|515593616|FG001|Overall Study|Death|0|||
143014489|NCT02437890|515593617|FG002|Overall Study|Death|0|||
143014490|NCT02437890|515593618|FG003|Overall Study|Death|2|||
143014491|NCT02437890|515593619|FG004|Overall Study|Death|0|||
143014492|NCT02328547|515593620|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
143014493|NCT02328547|515593621|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
143014494|NCT02328547|515593620|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
143014495|NCT02328547|515593621|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
143014496|NCT03543046|515593624|FG000|Overall Study|Adverse Event|1|||
143014497|NCT03543046|515593625|FG001|Overall Study|Adverse Event|1|||
143014498|NCT03543046|515593624|FG000|Overall Study|Physician Decision|1|||
143014499|NCT03543046|515593625|FG001|Overall Study|Physician Decision|1|||
143014500|NCT03543046|515593624|FG000|Overall Study|Protocol Violation|1|||
143014501|NCT03543046|515593625|FG001|Overall Study|Protocol Violation|0|||
143014502|NCT00520494|515593635|FG000|Overall Study|Withdrawal by Subject|1|||
143014503|NCT04247594|515593636|FG000|Overall Study|Withdrawal by Subject|4|||
143014504|NCT02748616|515593645|FG000|Overall Study|Lost to Follow-up|1|||
143014505|NCT02748616|515593645|FG000|Overall Study|Withdrawal by Subject|2|||
143482201|NCT00552175|517310864|FG000|Overall Study|Adverse Event|9|||
143482202|NCT00552175|517310865|FG001|Overall Study|Adverse Event|9|||
143482203|NCT00552175|517310866|FG002|Overall Study|Adverse Event|10|||
143482204|NCT00552175|517310864|FG000|Overall Study|Withdrawal by Subject|2|||
143482205|NCT00552175|517310865|FG001|Overall Study|Withdrawal by Subject|2|||
143482206|NCT00552175|517310866|FG002|Overall Study|Withdrawal by Subject|1|||
143482207|NCT00552175|517310864|FG000|Overall Study|Lost to Follow-up|0|||
143482208|NCT00552175|517310865|FG001|Overall Study|Lost to Follow-up|0|||
143482209|NCT00552175|517310866|FG002|Overall Study|Lost to Follow-up|1|||
143482210|NCT00552175|517310864|FG000|Overall Study|Entry Criteria Not Met|1|||
143482211|NCT00552175|517310865|FG001|Overall Study|Entry Criteria Not Met|1|||
143482212|NCT00552175|517310866|FG002|Overall Study|Entry Criteria Not Met|0|||
143482213|NCT00552175|517310864|FG000|Overall Study|Reason Not Specified|3|||
143482214|NCT00552175|517310865|FG001|Overall Study|Reason Not Specified|1|||
143482215|NCT00552175|517310866|FG002|Overall Study|Reason Not Specified|1|||
143482216|NCT00750737|517310867|FG000|Overall Study|Withdrawal by Subject|3|||
143482217|NCT00750737|517310868|FG001|Overall Study|Withdrawal by Subject|3|||
143482218|NCT02919436|517310869|FG000|Overall Study|Did not undergo surgery|16|||
143482219|NCT02919436|517310870|FG001|Overall Study|Did not undergo surgery|20|||
143482220|NCT02919436|517310869|FG000|Overall Study|Enrolled before trial registration|44|||
143482221|NCT02919436|517310870|FG001|Overall Study|Enrolled before trial registration|33|||
143482222|NCT01389752|517310871|FG000|Study Period 1|Sponsor decision|0|||
143482223|NCT01389752|517310872|FG001|Study Period 1|Sponsor decision|2|||
143482224|NCT01389752|517310871|FG000|Study Period 2|Sponsor decision|1|||
143482225|NCT01389752|517310872|FG001|Study Period 2|Sponsor decision|0|||
143482226|NCT00053417|517310883|FG000|Overall Study|Adverse Event|1|||
143482227|NCT00053417|517310884|FG001|Overall Study|Adverse Event|0|||
143482228|NCT00053417|517310885|FG002|Overall Study|Adverse Event|1|||
143482229|NCT00053417|517310886|FG003|Overall Study|Adverse Event|5|||
143482230|NCT00053417|517310883|FG000|Overall Study|Non-Compliance|0|||
143482231|NCT00053417|517310884|FG001|Overall Study|Non-Compliance|0|||
143482232|NCT00053417|517310885|FG002|Overall Study|Non-Compliance|0|||
143482233|NCT00053417|517310886|FG003|Overall Study|Non-Compliance|1|||
143482234|NCT00053417|517310883|FG000|Overall Study|Withdrawal by Subject|0|||
143482235|NCT00053417|517310884|FG001|Overall Study|Withdrawal by Subject|1|||
143482236|NCT00053417|517310885|FG002|Overall Study|Withdrawal by Subject|0|||
143482237|NCT00053417|517310886|FG003|Overall Study|Withdrawal by Subject|0|||
143482238|NCT00053417|517310883|FG000|Overall Study|Lost to Follow-up|1|||
143482239|NCT00053417|517310884|FG001|Overall Study|Lost to Follow-up|1|||
143482240|NCT00053417|517310885|FG002|Overall Study|Lost to Follow-up|0|||
143482241|NCT00053417|517310886|FG003|Overall Study|Lost to Follow-up|0|||
143482242|NCT02409290|517310887|FG000|Overall Study|Protocol Violation|3|||
143482243|NCT02409290|517310888|FG001|Overall Study|Protocol Violation|6|||
143482244|NCT02409290|517310889|FG002|Overall Study|Protocol Violation|9|||
143482245|NCT02409290|517310890|FG003|Overall Study|Protocol Violation|4|||
143482246|NCT02409290|517310887|FG000|Overall Study|No positive culture/no baseline sample|3|||
143482247|NCT02409290|517310888|FG001|Overall Study|No positive culture/no baseline sample|9|||
143014506|NCT02748616|515593645|FG000|Overall Study|Physician Decision|2|||
143014507|NCT02748616|515593645|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
143482248|NCT02409290|517310889|FG002|Overall Study|No positive culture/no baseline sample|6|||
143482249|NCT02409290|517310890|FG003|Overall Study|No positive culture/no baseline sample|5|||
143482250|NCT02409290|517310887|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
143482251|NCT02409290|517310888|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
143482252|NCT02409290|517310889|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
143482253|NCT02409290|517310890|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
143482254|NCT02230384|517310894|FG000|Phase 1|Lost to Follow-up|1|||
143482255|NCT02230384|517310895|FG001|Phase 1|Lost to Follow-up|0|||
143482256|NCT02230384|517310894|FG000|Phase 1|Physician Decision|0|||
143482257|NCT02230384|517310895|FG001|Phase 1|Physician Decision|1|||
143482258|NCT02230384|517310894|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
143482259|NCT02230384|517310895|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
143482260|NCT02230384|517310894|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
143482261|NCT02230384|517310895|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
143482262|NCT02230384|517310894|FG000|Phase 2 - Switch|Adverse Event|2|||
143482263|NCT02230384|517310895|FG001|Phase 2 - Switch|Adverse Event|0|||
143482264|NCT05376215|517310896|FG000|Overall Study|Withdrawal by Subject|2|||
143482265|NCT05376215|517310897|FG001|Overall Study|Withdrawal by Subject|1|||
143482266|NCT05376215|517310896|FG000|Overall Study|Lost to Follow-up|0|||
143482267|NCT05376215|517310897|FG001|Overall Study|Lost to Follow-up|1|||
143482268|NCT00282334|517310899|FG000|Overall Study|Withdrawal by Subject|8|||
143482269|NCT00282334|517310900|FG001|Overall Study|Withdrawal by Subject|5|||
143482270|NCT00781911|517310907|FG000|Overall Study|Adverse Event|4|||
143482271|NCT00781911|517310908|FG001|Overall Study|Adverse Event|4|||
143482272|NCT00781911|517310907|FG000|Overall Study|Withdrawal by Subject|1|||
143482273|NCT00781911|517310908|FG001|Overall Study|Withdrawal by Subject|2|||
143482274|NCT00781911|517310907|FG000|Overall Study|Physician Decision|0|||
143482275|NCT00781911|517310908|FG001|Overall Study|Physician Decision|2|||
143482276|NCT00781911|517310907|FG000|Overall Study|Sponsor Decision|1|||
143482277|NCT00781911|517310908|FG001|Overall Study|Sponsor Decision|0|||
143482278|NCT03317795|517310913|FG000|Overall Study|IUD Expulsion|1|||
143482279|NCT03317795|517310914|FG001|Overall Study|IUD Expulsion|0|||
143482280|NCT03317795|517310913|FG000|Overall Study|Lost to Follow-up|1|||
143482281|NCT03317795|517310914|FG001|Overall Study|Lost to Follow-up|3|||
143482282|NCT03317795|517310913|FG000|Overall Study|Treatment change|0|||
143482283|NCT03317795|517310914|FG001|Overall Study|Treatment change|3|||
143482284|NCT03317795|517310913|FG000|Overall Study|Intolerance of medication|0|||
143482285|NCT03317795|517310914|FG001|Overall Study|Intolerance of medication|1|||
143482286|NCT00939783|517310916|FG000|Overall Study|Death|6|||
143482287|NCT00939783|517310916|FG000|Overall Study|Adverse Event|39|||
143482288|NCT00939783|517310916|FG000|Overall Study|Study Terminated by Sponsor|498|||
143482289|NCT00939783|517310916|FG000|Overall Study|Withdrawal by Subject|78|||
143482290|NCT00939783|517310916|FG000|Overall Study|Other|16|||
143482291|NCT00939783|517310916|FG000|Overall Study|Lost to Follow-up|8|||
143482292|NCT00939783|517310916|FG000|Overall Study|Protocol Violation|3|||
143482293|NCT00939783|517310916|FG000|Overall Study|Enrolled but not treated|1|||
143482294|NCT01549002|517310919|FG000|Overall Study|Excessive pain|0|||
143482295|NCT01549002|517310920|FG001|Overall Study|Excessive pain|2|||
143482296|NCT01549002|517310919|FG000|Overall Study|Moderate sedation required|0|||
143482297|NCT01549002|517310920|FG001|Overall Study|Moderate sedation required|2|||
143482298|NCT00501007|517310921|FG000|Overall Study|Inclusion criteria not met.|29|||
143482299|NCT00501007|517310922|FG001|Overall Study|Inclusion criteria not met.|25|||
143482300|NCT05264740|517310930|FG000|Baseline|Withdrawal by Subject|0|||
143482301|NCT05264740|517310931|FG001|Baseline|Withdrawal by Subject|1|||
143482302|NCT05264740|517310930|FG000|Follow Up 1|Lost to Follow-up|1|||
143482303|NCT05264740|517310931|FG001|Follow Up 1|Lost to Follow-up|1|||
143482304|NCT05264740|517310930|FG000|Follow Up 1|Withdrawal by Subject|0|||
143482305|NCT05264740|517310931|FG001|Follow Up 1|Withdrawal by Subject|1|||
143482306|NCT05264740|517310930|FG000|Follow Up 2|Lost to Follow-up|1|||
143482307|NCT05264740|517310931|FG001|Follow Up 2|Lost to Follow-up|4|||
143482308|NCT05264740|517310930|FG000|Follow Up 3|Lost to Follow-up|7|||
143482309|NCT05264740|517310931|FG001|Follow Up 3|Lost to Follow-up|4|||
143482310|NCT02663453|517310932|FG000|Overall Study|Death|4|||
143482311|NCT02663453|517310933|FG001|Overall Study|Death|4|||
143482312|NCT02663453|517310932|FG000|Overall Study|Withdrawal by Subject|1|||
143482313|NCT02663453|517310933|FG001|Overall Study|Withdrawal by Subject|0|||
143482314|NCT03709654|517312012|FG000|Overall Study|Lost to Follow-up|1|||
143482315|NCT03709654|517312013|FG001|Overall Study|Lost to Follow-up|1|||
143482316|NCT03709654|517312012|FG000|Overall Study|Withdrawal by Subject|1|||
143482317|NCT03709654|517312013|FG001|Overall Study|Withdrawal by Subject|1|||
143482318|NCT03709654|517312012|FG000|Overall Study|Adverse Event|1|||
143482319|NCT03709654|517312013|FG001|Overall Study|Adverse Event|0|||
143482320|NCT01902966|517312014|FG000|Overall Study|Death|1|||
143482321|NCT01902966|517312014|FG000|Overall Study|Physician Decision|1|||
143482322|NCT01902966|517312014|FG000|Overall Study|Withdrawal by Subject|1|||
143482323|NCT01230242|517312015|FG000|Overall Study|Physician Decision|2|||
143482324|NCT01230242|517312015|FG000|Overall Study|Withdrawal by Subject|1|||
143014508|NCT01875991|515593651|FG000|Overall Study|Withdrawal by Subject|6|||
143014509|NCT01875991|515593652|FG001|Overall Study|Withdrawal by Subject|6|||
143014510|NCT01875991|515593651|FG000|Overall Study|Sponsor Decision|1|||
143014511|NCT01875991|515593652|FG001|Overall Study|Sponsor Decision|0|||
143014512|NCT02787785|515593653|FG000|Overall Study|Death|3|||
143014513|NCT02787785|515593654|FG001|Overall Study|Death|4|||
143014514|NCT02787785|515593653|FG000|Overall Study|Lost to Follow-up|1|||
143014515|NCT02787785|515593654|FG001|Overall Study|Lost to Follow-up|1|||
143014516|NCT02787785|515593653|FG000|Overall Study|Withdrawal by Subject|0|||
143014517|NCT02787785|515593654|FG001|Overall Study|Withdrawal by Subject|5|||
143014518|NCT02030834|515593655|FG000|Overall Study|Death|4|||
143014519|NCT02030834|515593656|FG001|Overall Study|Death|0|||
143014520|NCT02030834|515593657|FG002|Overall Study|Death|0|||
143014521|NCT02030834|515593655|FG000|Overall Study|Manufacturing failure|2|||
143014522|NCT02030834|515593656|FG001|Overall Study|Manufacturing failure|0|||
143014523|NCT02030834|515593657|FG002|Overall Study|Manufacturing failure|1|||
143014524|NCT02030834|515593655|FG000|Overall Study|Disease progression|2|||
143014525|NCT02030834|515593656|FG001|Overall Study|Disease progression|0|||
143014526|NCT02030834|515593657|FG002|Overall Study|Disease progression|2|||
143014527|NCT02030834|515593655|FG000|Overall Study|Lost to Follow-up|1|||
143014528|NCT02030834|515593656|FG001|Overall Study|Lost to Follow-up|0|||
143014529|NCT02030834|515593657|FG002|Overall Study|Lost to Follow-up|0|||
143014530|NCT02030834|515593655|FG000|Overall Study|Withdrawal by Subject|1|||
143014531|NCT02030834|515593656|FG001|Overall Study|Withdrawal by Subject|0|||
143014532|NCT02030834|515593657|FG002|Overall Study|Withdrawal by Subject|0|||
143014533|NCT02030834|515593655|FG000|Overall Study|Lack of funding|1|||
143363613|NCT00062868|516873788|FG008|Dose Level 2|Death|0|||
143482325|NCT03923426|517312016|FG000|Overall Study|Other|19|||
143482326|NCT03923426|517312016|FG000|Overall Study|Lost to Follow-up|16|||
143482327|NCT03923426|517312016|FG000|Overall Study|Death|107|||
143482328|NCT03923426|517312016|FG000|Overall Study|Incomplete response to question|13|||
143482329|NCT04962022|517312024|FG000|Period 1|Withdrawal by Subject|1|||
143148202|NCT04809974|516087683|FG002|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|8|||
143482330|NCT04962022|517312025|FG001|Period 1|Withdrawal by Subject|0|||
143482331|NCT00530270|517312026|FG000|Overall Study|Protocol Violation|1|||
143482332|NCT00530270|517312027|FG001|Overall Study|Protocol Violation|0|||
143482333|NCT00732303|517312037|FG000|Overall Study|Study Terminated|2|||
143482334|NCT00283595|517312038|FG000|Overall Study|Withdrawal by Subject|1|||
143482335|NCT00283595|517312039|FG001|Overall Study|Withdrawal by Subject|2|||
143482336|NCT01709435|517312040|FG000|Overall Study|Adverse Event|1|||
143482337|NCT01709435|517312041|FG001|Overall Study|Adverse Event|1|||
143482338|NCT01709435|517312042|FG002|Overall Study|Adverse Event|1|||
143482339|NCT01709435|517312043|FG003|Overall Study|Adverse Event|0|||
143482340|NCT01709435|517312044|FG004|Overall Study|Adverse Event|0|||
143482341|NCT01709435|517312045|FG005|Overall Study|Adverse Event|1|||
143482342|NCT01709435|517312040|FG000|Overall Study|Lack of Efficacy|5|||
143482343|NCT01709435|517312041|FG001|Overall Study|Lack of Efficacy|7|||
143482344|NCT01709435|517312042|FG002|Overall Study|Lack of Efficacy|2|||
143482345|NCT01709435|517312043|FG003|Overall Study|Lack of Efficacy|2|||
143482346|NCT01709435|517312044|FG004|Overall Study|Lack of Efficacy|6|||
143482347|NCT01709435|517312045|FG005|Overall Study|Lack of Efficacy|3|||
143482348|NCT01709435|517312040|FG000|Overall Study|Physician Decision|0|||
143482349|NCT01709435|517312041|FG001|Overall Study|Physician Decision|1|||
143482350|NCT01709435|517312042|FG002|Overall Study|Physician Decision|0|||
143482351|NCT01709435|517312043|FG003|Overall Study|Physician Decision|1|||
143482352|NCT01709435|517312044|FG004|Overall Study|Physician Decision|2|||
143482353|NCT01709435|517312045|FG005|Overall Study|Physician Decision|0|||
143482354|NCT01709435|517312040|FG000|Overall Study|Withdrawal by Subject|0|||
143482355|NCT01709435|517312041|FG001|Overall Study|Withdrawal by Subject|0|||
143482356|NCT01709435|517312042|FG002|Overall Study|Withdrawal by Subject|3|||
143482357|NCT01709435|517312043|FG003|Overall Study|Withdrawal by Subject|0|||
143482358|NCT01709435|517312044|FG004|Overall Study|Withdrawal by Subject|2|||
143482359|NCT01709435|517312045|FG005|Overall Study|Withdrawal by Subject|2|||
143148203|NCT04809974|516087681|FG000|Randomized Phase|Adverse Event|0|||
143148204|NCT04809974|516087682|FG001|Randomized Phase|Adverse Event|1|||
143148205|NCT04809974|516087683|FG002|Randomized Phase|Adverse Event|4|||
143148206|NCT04809974|516087681|FG000|Randomized Phase|Withdrawal by Subject|0|||
143148207|NCT04809974|516087682|FG001|Randomized Phase|Withdrawal by Subject|0|||
143148208|NCT04809974|516087683|FG002|Randomized Phase|Withdrawal by Subject|5|||
143363614|NCT00062868|516873789|FG009|Dose Level 2|Death|0|||
143482360|NCT03917823|517312047|FG000|Overall Study|Lost to Follow-up|1|||
143482361|NCT03917823|517312048|FG001|Overall Study|Lost to Follow-up|1|||
143014534|NCT02030834|515593656|FG001|Overall Study|Lack of funding|0|||
143014535|NCT02030834|515593657|FG002|Overall Study|Lack of funding|0|||
143014536|NCT03959137|515593658|FG000|Overall Study|Protocol Violation|6|||
143014537|NCT04529096|515593660|FG000|Overall Study|Adverse Event|6|||
143014538|NCT04529096|515593661|FG001|Overall Study|Adverse Event|1|||
143014539|NCT04529096|515593660|FG000|Overall Study|Lack of Efficacy|1|||
143482362|NCT03917823|517312047|FG000|Overall Study|Withdrawal by Subject|0|||
143014540|NCT04529096|515593661|FG001|Overall Study|Lack of Efficacy|0|||
143014541|NCT04529096|515593660|FG000|Overall Study|Lost to Follow-up|1|||
143014542|NCT04529096|515593661|FG001|Overall Study|Lost to Follow-up|1|||
143014543|NCT04529096|515593660|FG000|Overall Study|Non-Compliance With Study Drug|0|||
143014544|NCT04529096|515593661|FG001|Overall Study|Non-Compliance With Study Drug|1|||
143014545|NCT04529096|515593660|FG000|Overall Study|Physician Decision|1|||
143014546|NCT04529096|515593661|FG001|Overall Study|Physician Decision|3|||
143014547|NCT04529096|515593660|FG000|Overall Study|Withdrawal by Subject|5|||
143014548|NCT04529096|515593661|FG001|Overall Study|Withdrawal by Subject|0|||
143014549|NCT00995488|515593662|FG000|Overall Study|Withdrawal by Subject|1|||
143014550|NCT01289990|515593663|FG000|Overall Study|Death|0|||
143014551|NCT01289990|515593664|FG001|Overall Study|Death|0|||
143014552|NCT01289990|515593665|FG002|Overall Study|Death|0|||
143014553|NCT01289990|515593666|FG003|Overall Study|Death|1|||
143014554|NCT01289990|515593667|FG004|Overall Study|Death|2|||
143014555|NCT01289990|515593668|FG005|Overall Study|Death|1|||
143014556|NCT01289990|515593669|FG006|Overall Study|Death|0|||
143014557|NCT01289990|515593670|FG007|Overall Study|Death|0|||
143014558|NCT01289990|515593671|FG008|Overall Study|Death|0|||
143014559|NCT01289990|515593672|FG009|Overall Study|Death|0|||
143014560|NCT01289990|515593673|FG010|Overall Study|Death|0|||
143014561|NCT01289990|515593674|FG011|Overall Study|Death|1|||
143014562|NCT01289990|515593675|FG012|Overall Study|Death|0|||
143014563|NCT01289990|515593663|FG000|Overall Study|Lost to Follow-up|3|||
143014564|NCT01289990|515593664|FG001|Overall Study|Lost to Follow-up|2|||
143014565|NCT01289990|515593665|FG002|Overall Study|Lost to Follow-up|5|||
143014566|NCT01289990|515593666|FG003|Overall Study|Lost to Follow-up|5|||
143014567|NCT01289990|515593667|FG004|Overall Study|Lost to Follow-up|3|||
143014568|NCT01289990|515593668|FG005|Overall Study|Lost to Follow-up|4|||
143014569|NCT01289990|515593669|FG006|Overall Study|Lost to Follow-up|2|||
143014570|NCT01289990|515593670|FG007|Overall Study|Lost to Follow-up|2|||
143014571|NCT01289990|515593671|FG008|Overall Study|Lost to Follow-up|1|||
143014572|NCT01289990|515593672|FG009|Overall Study|Lost to Follow-up|4|||
143014573|NCT01289990|515593673|FG010|Overall Study|Lost to Follow-up|2|||
143014574|NCT01289990|515593674|FG011|Overall Study|Lost to Follow-up|1|||
143014575|NCT01289990|515593675|FG012|Overall Study|Lost to Follow-up|2|||
143014576|NCT01289990|515593663|FG000|Overall Study|Withdrawal by Subject|15|||
143014577|NCT01289990|515593664|FG001|Overall Study|Withdrawal by Subject|14|||
143014578|NCT01289990|515593665|FG002|Overall Study|Withdrawal by Subject|12|||
143014579|NCT01289990|515593666|FG003|Overall Study|Withdrawal by Subject|13|||
143014580|NCT01289990|515593667|FG004|Overall Study|Withdrawal by Subject|8|||
143014581|NCT01289990|515593668|FG005|Overall Study|Withdrawal by Subject|7|||
143014582|NCT01289990|515593669|FG006|Overall Study|Withdrawal by Subject|13|||
143014583|NCT01289990|515593670|FG007|Overall Study|Withdrawal by Subject|9|||
143014584|NCT01289990|515593671|FG008|Overall Study|Withdrawal by Subject|12|||
143014585|NCT01289990|515593672|FG009|Overall Study|Withdrawal by Subject|13|||
143014586|NCT01289990|515593673|FG010|Overall Study|Withdrawal by Subject|11|||
143014587|NCT01289990|515593674|FG011|Overall Study|Withdrawal by Subject|13|||
143014588|NCT01289990|515593675|FG012|Overall Study|Withdrawal by Subject|16|||
143014589|NCT01289990|515593663|FG000|Overall Study|discontinued in preceding trial|18|||
143014590|NCT01289990|515593664|FG001|Overall Study|discontinued in preceding trial|20|||
143014591|NCT01289990|515593665|FG002|Overall Study|discontinued in preceding trial|41|||
143014592|NCT01289990|515593666|FG003|Overall Study|discontinued in preceding trial|17|||
143014593|NCT01289990|515593667|FG004|Overall Study|discontinued in preceding trial|11|||
143014594|NCT01289990|515593668|FG005|Overall Study|discontinued in preceding trial|12|||
143014595|NCT01289990|515593669|FG006|Overall Study|discontinued in preceding trial|18|||
143363615|NCT00062868|516873790|FG010|Dose Level 2|Death|1|||
143482363|NCT03917823|517312048|FG001|Overall Study|Withdrawal by Subject|1|||
143482364|NCT00135668|517312049|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
143482365|NCT00135668|517312050|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
143014596|NCT01289990|515593670|FG007|Overall Study|discontinued in preceding trial|8|||
143014597|NCT01289990|515593671|FG008|Overall Study|discontinued in preceding trial|17|||
143014598|NCT01289990|515593672|FG009|Overall Study|discontinued in preceding trial|21|||
143014599|NCT01289990|515593673|FG010|Overall Study|discontinued in preceding trial|17|||
143014600|NCT01289990|515593674|FG011|Overall Study|discontinued in preceding trial|17|||
143014601|NCT01289990|515593675|FG012|Overall Study|discontinued in preceding trial|24|||
143014602|NCT01289990|515593663|FG000|Overall Study|did not continue in extension|41|||
143014603|NCT01289990|515593664|FG001|Overall Study|did not continue in extension|45|||
143014604|NCT01289990|515593665|FG002|Overall Study|did not continue in extension|51|||
143014605|NCT01289990|515593666|FG003|Overall Study|did not continue in extension|51|||
143363616|NCT00062868|516873791|FG011|Dose Level 2|Death|0|||
143014606|NCT01289990|515593667|FG004|Overall Study|did not continue in extension|48|||
143014607|NCT01289990|515593668|FG005|Overall Study|did not continue in extension|50|||
143014608|NCT01289990|515593669|FG006|Overall Study|did not continue in extension|54|||
143363617|NCT00062868|516873792|FG012|Dose Level 2|Death|0|||
143014609|NCT01289990|515593670|FG007|Overall Study|did not continue in extension|36|||
143363618|NCT00062868|516873793|FG013|Dose Level 2|Death|0|||
143482366|NCT00135668|517312051|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
143482367|NCT00135668|517312052|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
143482368|NCT02424253|517312055|FG000|Overall Study|Other, unspecified|1|||
143482369|NCT02424253|517312056|FG001|Overall Study|Other, unspecified|0|||
143482370|NCT02424253|517312055|FG000|Overall Study|Compliance problems|1|||
143482371|NCT02424253|517312056|FG001|Overall Study|Compliance problems|0|||
143482372|NCT02424253|517312055|FG000|Overall Study|Physician Decision|2|||
143482373|NCT02424253|517312056|FG001|Overall Study|Physician Decision|0|||
143482374|NCT02424253|517312055|FG000|Overall Study|Lack of Efficacy|0|||
143482375|NCT02424253|517312056|FG001|Overall Study|Lack of Efficacy|7|||
143482376|NCT02424253|517312055|FG000|Overall Study|Adverse Event|2|||
143482377|NCT02424253|517312056|FG001|Overall Study|Adverse Event|0|||
143482378|NCT02424253|517312055|FG000|Overall Study|Consent withdrawn by subject|4|||
143482379|NCT02424253|517312056|FG001|Overall Study|Consent withdrawn by subject|1|||
143482380|NCT02424253|517312055|FG000|Overall Study|Lost to Follow-up|1|||
143482381|NCT02424253|517312056|FG001|Overall Study|Lost to Follow-up|1|||
143482382|NCT02290873|517312059|FG000|Overall Study|Withdrawal by Subject|0|||
143482383|NCT02290873|517312060|FG001|Overall Study|Withdrawal by Subject|1|||
143482384|NCT02290873|517312061|FG002|Overall Study|Withdrawal by Subject|1|||
143482385|NCT02290873|517312059|FG000|Overall Study|Nellcor device error|1|||
143482386|NCT02290873|517312060|FG001|Overall Study|Nellcor device error|0|||
143482387|NCT02290873|517312061|FG002|Overall Study|Nellcor device error|0|||
143482388|NCT02290873|517312059|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
143482389|NCT02290873|517312060|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
143482390|NCT02290873|517312061|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
143482391|NCT02290873|517312059|FG000|Overall Study|Protocol Violation|0|||
143482392|NCT02290873|517312060|FG001|Overall Study|Protocol Violation|0|||
143482393|NCT02290873|517312061|FG002|Overall Study|Protocol Violation|1|||
143482394|NCT02700997|517312064|FG000|Overall Study|Did not undergo CT imaging|1|||
143482395|NCT02700997|517312064|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
143482396|NCT00078325|517312067|FG000|Overall Study|Adverse Event|15|||
143482397|NCT00078325|517312068|FG001|Overall Study|Adverse Event|10|||
143482398|NCT00078325|517312069|FG002|Overall Study|Adverse Event|5|||
143482399|NCT00078325|517312067|FG000|Overall Study|Protocol Violation|2|||
143482400|NCT00078325|517312068|FG001|Overall Study|Protocol Violation|2|||
143482401|NCT00078325|517312069|FG002|Overall Study|Protocol Violation|0|||
143482402|NCT00078325|517312067|FG000|Overall Study|Withdrawal by Subject|1|||
143482403|NCT00078325|517312068|FG001|Overall Study|Withdrawal by Subject|5|||
143482404|NCT00078325|517312069|FG002|Overall Study|Withdrawal by Subject|3|||
143482405|NCT00078325|517312067|FG000|Overall Study|Lost to Follow-up|0|||
143482406|NCT00078325|517312068|FG001|Overall Study|Lost to Follow-up|1|||
143482407|NCT00078325|517312069|FG002|Overall Study|Lost to Follow-up|1|||
143482408|NCT00078325|517312067|FG000|Overall Study|Physician Decision|2|||
143482409|NCT00078325|517312068|FG001|Overall Study|Physician Decision|0|||
143482410|NCT00078325|517312069|FG002|Overall Study|Physician Decision|1|||
143482411|NCT00078325|517312067|FG000|Overall Study|Miscellaneous|1|||
143482412|NCT00078325|517312068|FG001|Overall Study|Miscellaneous|1|||
143482413|NCT00078325|517312069|FG002|Overall Study|Miscellaneous|1|||
143014610|NCT01289990|515593671|FG008|Overall Study|did not continue in extension|44|||
143014611|NCT01289990|515593672|FG009|Overall Study|did not continue in extension|48|||
143014612|NCT01289990|515593673|FG010|Overall Study|did not continue in extension|45|||
143148209|NCT01481779|516087684|FG000|Overall Study|Adverse Event|23|||
143482414|NCT04126083|517312073|FG000|Overall Study|Withdrawal by Subject|1|||
143482415|NCT00578136|517312074|FG000|Overall Study|Not given intervention|1|||
143482416|NCT00578136|517312075|FG001|Overall Study|Not given intervention|1|||
143482417|NCT00932360|517312077|FG000|Washout (One Week)|Withdrawal by Subject|0|||
143482418|NCT00932360|517312078|FG001|Washout (One Week)|Withdrawal by Subject|0|||
143482419|NCT00932360|517312079|FG002|Washout (One Week)|Withdrawal by Subject|0|||
143482420|NCT00932360|517312080|FG003|Washout (One Week)|Withdrawal by Subject|0|||
143482421|NCT00932360|517312081|FG004|Washout (One Week)|Withdrawal by Subject|2|||
143482422|NCT00932360|517312082|FG005|Washout (One Week)|Withdrawal by Subject|0|||
143482423|NCT02536313|517312083|FG000|Overall Study|Lack of Efficacy|0|||
143148210|NCT01481779|516087685|FG001|Overall Study|Adverse Event|5|||
143148211|NCT01481779|516087684|FG000|Overall Study|Lost to Follow-up|3|||
143482424|NCT02536313|517312084|FG001|Overall Study|Lack of Efficacy|1|||
143482425|NCT01892163|517312091|FG000|Overall Study|Death|1|||
143482426|NCT01892163|517312092|FG001|Overall Study|Death|1|||
143482427|NCT01892163|517312091|FG000|Overall Study|Lost to Follow-up|1|||
143148212|NCT01481779|516087685|FG001|Overall Study|Lost to Follow-up|2|||
143482428|NCT01892163|517312092|FG001|Overall Study|Lost to Follow-up|0|||
143014613|NCT01289990|515593674|FG011|Overall Study|did not continue in extension|34|||
143482429|NCT00432042|517312095|FG000|Overall Study|Protocol Violation|2|||
143482430|NCT00432042|517312096|FG001|Overall Study|Protocol Violation|0|||
143482431|NCT00432042|517312097|FG002|Overall Study|Protocol Violation|0|||
143482432|NCT00432042|517312095|FG000|Overall Study|Withdrawal by Subject|0|||
143482433|NCT00432042|517312096|FG001|Overall Study|Withdrawal by Subject|0|||
143482434|NCT00432042|517312097|FG002|Overall Study|Withdrawal by Subject|2|||
143148213|NCT01481779|516087684|FG000|Overall Study|Protocol Violation|2|||
143148214|NCT01481779|516087685|FG001|Overall Study|Protocol Violation|3|||
143148215|NCT01481779|516087684|FG000|Overall Study|Withdrawal by Subject|26|||
143148216|NCT01481779|516087685|FG001|Overall Study|Withdrawal by Subject|13|||
143148217|NCT01481779|516087684|FG000|Overall Study|Physician Decision|13|||
143148218|NCT01481779|516087685|FG001|Overall Study|Physician Decision|4|||
143148219|NCT01481779|516087684|FG000|Overall Study|Sponsor Decision|3|||
143148220|NCT01481779|516087685|FG001|Overall Study|Sponsor Decision|1|||
143148221|NCT01697579|516087693|FG000|Base Study-Cycle 1|Adverse Event|1|||
143148222|NCT01697579|516087694|FG001|Base Study-Cycle 1|Adverse Event|0|||
143148223|NCT01697579|516087695|FG002|Base Study-Cycle 1|Adverse Event|0|||
143148224|NCT01697579|516087696|FG003|Base Study-Cycle 1|Adverse Event|0|||
143148225|NCT01697579|516087697|FG004|Base Study-Cycle 1|Adverse Event|0|||
143148226|NCT01697579|516087698|FG005|Base Study-Cycle 1|Adverse Event|0|||
143482435|NCT00432042|517312095|FG000|Overall Study|Lost to Follow-up|5|||
143482436|NCT00432042|517312096|FG001|Overall Study|Lost to Follow-up|1|||
143482437|NCT00432042|517312097|FG002|Overall Study|Lost to Follow-up|0|||
143482438|NCT01585272|517312099|FG000|Overall Study|Adverse Event|22|||
143482439|NCT01585272|517312099|FG000|Overall Study|Protocol Violation|7|||
143482440|NCT01585272|517312099|FG000|Overall Study|Withdrawal by Subject|10|||
143482441|NCT00993265|517312104|FG000|Overall Study|Adverse Event|1|||
143482442|NCT00993265|517312105|FG001|Overall Study|Adverse Event|0|||
143482443|NCT00993265|517312104|FG000|Overall Study|Changed dose of concomitant drug|2|||
143482444|NCT00993265|517312105|FG001|Overall Study|Changed dose of concomitant drug|0|||
143482445|NCT00993265|517312104|FG000|Overall Study|Non-compliant with study medication|1|||
143482446|NCT00993265|517312105|FG001|Overall Study|Non-compliant with study medication|0|||
143482447|NCT03803059|517312108|FG000|Overall Study|Protocol Violation|2|||
143482448|NCT03803059|517312108|FG000|Overall Study|Lost to Follow-up|1|||
143482449|NCT00517751|517312109|FG000|Overall Study|Death|3|||
143482450|NCT00517751|517312109|FG000|Overall Study|Withdrawal by Subject|37|||
143482451|NCT00517751|517312109|FG000|Overall Study|Lost to Follow-up|4|||
143482452|NCT00517751|517312109|FG000|Overall Study|patient not over due|6|||
143482453|NCT00517751|517312109|FG000|Overall Study|Patient not due for visit|76|||
143482454|NCT00517751|517312109|FG000|Overall Study|Missing|3|||
143482455|NCT03021499|517312110|FG000|Overall Study|Adverse Event|1|||
143482456|NCT03021499|517312111|FG001|Overall Study|Adverse Event|0|||
143482457|NCT03021499|517312110|FG000|Overall Study|Death|1|||
143482458|NCT03021499|517312111|FG001|Overall Study|Death|5|||
143482459|NCT03021499|517312110|FG000|Overall Study|Lack of Efficacy|0|||
143482460|NCT03021499|517312111|FG001|Overall Study|Lack of Efficacy|1|||
143482461|NCT03021499|517312110|FG000|Overall Study|Lost to Follow-up|1|||
143482462|NCT03021499|517312111|FG001|Overall Study|Lost to Follow-up|3|||
143482463|NCT03021499|517312110|FG000|Overall Study|Physician Decision|2|||
143482464|NCT03021499|517312111|FG001|Overall Study|Physician Decision|3|||
143482465|NCT03021499|517312110|FG000|Overall Study|Pregnancy|1|||
143482466|NCT03021499|517312111|FG001|Overall Study|Pregnancy|0|||
143482467|NCT03021499|517312110|FG000|Overall Study|Withdrawal by Subject|7|||
143482468|NCT03021499|517312111|FG001|Overall Study|Withdrawal by Subject|14|||
143482469|NCT03021499|517312110|FG000|Overall Study|Prohibited medication required|1|||
143482470|NCT03021499|517312111|FG001|Overall Study|Prohibited medication required|0|||
143482471|NCT03021499|517312110|FG000|Overall Study|Protocol non-compliance|1|||
143482472|NCT03021499|517312111|FG001|Overall Study|Protocol non-compliance|1|||
143482473|NCT03021499|517312110|FG000|Overall Study|None of the above|0|||
143482474|NCT03021499|517312111|FG001|Overall Study|None of the above|4|||
143482475|NCT03021499|517312110|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
143482476|NCT03021499|517312111|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
143482477|NCT01210690|517312112|FG000|Overall Study|Adverse Event|7|||
143482478|NCT01210690|517312112|FG000|Overall Study|Lack of Efficacy|12|||
143482479|NCT01210690|517312112|FG000|Overall Study|Lost to Follow-up|3|||
143482480|NCT01210690|517312112|FG000|Overall Study|Disease Remission|1|||
143482481|NCT01210690|517312112|FG000|Overall Study|Withdrawal by Subject|1|||
143482482|NCT01210690|517312112|FG000|Overall Study|Patient refused to swallow|1|||
143482483|NCT01210690|517312112|FG000|Overall Study|Patient could not take glucose|1|||
143482484|NCT00495820|517312113|FG000|Overall Study|Adverse Event|1|||
143482485|NCT00495820|517312114|FG001|Overall Study|Adverse Event|1|||
143482486|NCT00820950|517312115|FG000|Overall Study|Scheduling Conflict|0|||
143482487|NCT00820950|517312116|FG001|Overall Study|Scheduling Conflict|0|||
143482488|NCT00820950|517312117|FG002|Overall Study|Scheduling Conflict|0|||
143482489|NCT00820950|517312118|FG003|Overall Study|Scheduling Conflict|0|||
143482490|NCT00820950|517312119|FG004|Overall Study|Scheduling Conflict|0|||
143482491|NCT00820950|517312120|FG005|Overall Study|Scheduling Conflict|0|||
143482492|NCT00820950|517312121|FG006|Overall Study|Scheduling Conflict|1|||
143363619|NCT00062868|516873794|FG014|Dose Level 2|Death|0|||
143482493|NCT00820950|517312122|FG007|Overall Study|Scheduling Conflict|1|||
143148227|NCT01697579|516087699|FG006|Base Study-Cycle 1|Adverse Event|0|||
143148228|NCT01697579|516087693|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
143482494|NCT00820950|517312123|FG008|Overall Study|Scheduling Conflict|0|||
143482495|NCT00820950|517312124|FG009|Overall Study|Scheduling Conflict|0|||
143482496|NCT00820950|517312115|FG000|Overall Study|Protocol Violation|1|||
143014614|NCT01289990|515593675|FG012|Overall Study|did not continue in extension|56|||
143014615|NCT01289990|515593663|FG000|Overall Study|Not treated|0|||
143014616|NCT01289990|515593664|FG001|Overall Study|Not treated|0|||
143014617|NCT01289990|515593665|FG002|Overall Study|Not treated|0|||
143014618|NCT01289990|515593666|FG003|Overall Study|Not treated|0|||
143014619|NCT01289990|515593667|FG004|Overall Study|Not treated|0|||
143014620|NCT01289990|515593668|FG005|Overall Study|Not treated|0|||
143014621|NCT01289990|515593669|FG006|Overall Study|Not treated|1|||
143014622|NCT01289990|515593670|FG007|Overall Study|Not treated|0|||
143014623|NCT01289990|515593671|FG008|Overall Study|Not treated|1|||
143482497|NCT00820950|517312116|FG001|Overall Study|Protocol Violation|1|||
143482498|NCT00820950|517312117|FG002|Overall Study|Protocol Violation|0|||
143482499|NCT00820950|517312118|FG003|Overall Study|Protocol Violation|0|||
143482500|NCT00820950|517312119|FG004|Overall Study|Protocol Violation|0|||
143482501|NCT00820950|517312120|FG005|Overall Study|Protocol Violation|0|||
143014624|NCT01289990|515593672|FG009|Overall Study|Not treated|0|||
143014625|NCT01289990|515593673|FG010|Overall Study|Not treated|1|||
143014626|NCT01289990|515593674|FG011|Overall Study|Not treated|2|||
143014627|NCT01289990|515593675|FG012|Overall Study|Not treated|0|||
143014628|NCT00683904|515593676|FG000|Dose Level 1|Disease progression|2|||
143014629|NCT00683904|515593677|FG001|Dose Level 1|Disease progression|0|||
143014630|NCT00683904|515593676|FG000|Dose Level 1|Adverse Event|1|||
143014631|NCT00683904|515593677|FG001|Dose Level 1|Adverse Event|0|||
143014632|NCT00683904|515593676|FG000|Dose Level 2|Adverse Event|0|||
143014633|NCT00683904|515593677|FG001|Dose Level 2|Adverse Event|2|||
143014634|NCT00758706|515593678|FG000|Overall Study|Adverse Event|4|||
143014635|NCT00758706|515593679|FG001|Overall Study|Adverse Event|4|||
143014636|NCT05789420|515593680|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
143014637|NCT05789420|515593680|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
143014638|NCT01220128|515593681|FG000|Overall Study|Progressive disease|0|||
143014639|NCT01220128|515593682|FG001|Overall Study|Progressive disease|0|||
143014640|NCT01220128|515593683|FG002|Overall Study|Progressive disease|2|||
143014641|NCT01220128|515593684|FG003|Overall Study|Progressive disease|0|||
143014642|NCT01220128|515593685|FG004|Overall Study|Progressive disease|0|||
143014643|NCT01220128|515593686|FG005|Overall Study|Progressive disease|0|||
143014644|NCT01220128|515593687|FG006|Overall Study|Progressive disease|0|||
143014645|NCT01220128|515593681|FG000|Overall Study|Sponsor study termination|0|||
143014646|NCT01220128|515593682|FG001|Overall Study|Sponsor study termination|1|||
143014647|NCT01220128|515593683|FG002|Overall Study|Sponsor study termination|0|||
143014648|NCT01220128|515593684|FG003|Overall Study|Sponsor study termination|0|||
143014649|NCT01220128|515593685|FG004|Overall Study|Sponsor study termination|0|||
143482502|NCT00820950|517312121|FG006|Overall Study|Protocol Violation|0|||
143014650|NCT01220128|515593686|FG005|Overall Study|Sponsor study termination|0|||
143014651|NCT01220128|515593687|FG006|Overall Study|Sponsor study termination|1|||
143014652|NCT01220128|515593681|FG000|Overall Study|Adverse event, serious fatal|2|||
143363620|NCT00062868|516873795|FG015|Dose Level 2|Death|0|||
143363621|NCT00062868|516873796|FG016|Dose Level 2|Death|2|||
143363622|NCT00062868|516873797|FG017|Dose Level 2|Death|0|||
143482503|NCT00820950|517312122|FG007|Overall Study|Protocol Violation|0|||
143482504|NCT00820950|517312123|FG008|Overall Study|Protocol Violation|0|||
143482505|NCT00820950|517312124|FG009|Overall Study|Protocol Violation|0|||
143482506|NCT00470054|517312125|FG000|Overall Study|Ineligible|1|||
143482507|NCT00528021|517312131|FG000|Overall Study|Lack of Efficacy|17|||
143482508|NCT00528021|517312132|FG001|Overall Study|Lack of Efficacy|13|||
143482509|NCT00528021|517312133|FG002|Overall Study|Lack of Efficacy|7|||
143482510|NCT00528021|517312134|FG003|Overall Study|Lack of Efficacy|9|||
143482511|NCT04050982|517312135|FG000|Overall Study|Did not meet eligibility criteria|0|||
143482512|NCT04050982|517312136|FG001|Overall Study|Did not meet eligibility criteria|1|||
143482513|NCT04050982|517312137|FG002|Overall Study|Did not meet eligibility criteria|0|||
143482514|NCT04050982|517312135|FG000|Overall Study|Withdrawal by Subject|1|||
143014653|NCT01220128|515593682|FG001|Overall Study|Adverse event, serious fatal|0|||
143014654|NCT01220128|515593683|FG002|Overall Study|Adverse event, serious fatal|0|||
143014655|NCT01220128|515593684|FG003|Overall Study|Adverse event, serious fatal|0|||
143014656|NCT01220128|515593685|FG004|Overall Study|Adverse event, serious fatal|0|||
143482515|NCT04050982|517312136|FG001|Overall Study|Withdrawal by Subject|0|||
143014657|NCT01220128|515593686|FG005|Overall Study|Adverse event, serious fatal|0|||
143014658|NCT01220128|515593687|FG006|Overall Study|Adverse event, serious fatal|1|||
143014659|NCT01220128|515593681|FG000|Overall Study|Adverse event, non-fatal|1|||
143482516|NCT04050982|517312137|FG002|Overall Study|Withdrawal by Subject|0|||
143014660|NCT01220128|515593682|FG001|Overall Study|Adverse event, non-fatal|0|||
143014661|NCT01220128|515593683|FG002|Overall Study|Adverse event, non-fatal|0|||
143148229|NCT01697579|516087694|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
143014662|NCT01220128|515593684|FG003|Overall Study|Adverse event, non-fatal|0|||
143014663|NCT01220128|515593685|FG004|Overall Study|Adverse event, non-fatal|0|||
143014664|NCT01220128|515593686|FG005|Overall Study|Adverse event, non-fatal|0|||
143363623|NCT00062868|516873798|FG018|Dose Level 2|Death|0|||
143363624|NCT00062868|516873799|FG019|Dose Level 2|Death|0|||
143482517|NCT04050982|517312135|FG000|Overall Study|Unable to enroll on platform|1|||
143482518|NCT04050982|517312136|FG001|Overall Study|Unable to enroll on platform|0|||
143482519|NCT04050982|517312137|FG002|Overall Study|Unable to enroll on platform|0|||
143482520|NCT01423851|517312140|FG000|Whole Study|Disease progression|2|||
143482521|NCT01423851|517312141|FG001|Whole Study|Disease progression|1|||
143482522|NCT01423851|517312142|FG002|Whole Study|Disease progression|1|||
143482523|NCT01423851|517312143|FG003|Whole Study|Disease progression|4|||
143482524|NCT01423851|517312144|FG004|Whole Study|Disease progression|1|||
143482525|NCT01423851|517312145|FG005|Whole Study|Disease progression|3|||
143482526|NCT01423851|517312146|FG006|Whole Study|Disease progression|1|||
143482527|NCT01423851|517312147|FG007|Whole Study|Disease progression|4|||
143482528|NCT01423851|517312148|FG008|Whole Study|Disease progression|0|||
143482529|NCT01423851|517312149|FG009|Whole Study|Disease progression|2|||
143482530|NCT01423851|517312150|FG010|Whole Study|Disease progression|10|||
143482531|NCT01423851|517312140|FG000|Whole Study|Physician Decision|0|||
143482532|NCT01423851|517312141|FG001|Whole Study|Physician Decision|1|||
143482533|NCT01423851|517312142|FG002|Whole Study|Physician Decision|2|||
143482534|NCT01423851|517312143|FG003|Whole Study|Physician Decision|0|||
143482535|NCT01423851|517312144|FG004|Whole Study|Physician Decision|2|||
143482536|NCT01423851|517312145|FG005|Whole Study|Physician Decision|0|||
143482537|NCT01423851|517312146|FG006|Whole Study|Physician Decision|2|||
143482538|NCT01423851|517312147|FG007|Whole Study|Physician Decision|1|||
143482539|NCT01423851|517312148|FG008|Whole Study|Physician Decision|3|||
143482540|NCT01423851|517312149|FG009|Whole Study|Physician Decision|4|||
143482541|NCT01423851|517312150|FG010|Whole Study|Physician Decision|12|||
143482542|NCT01423851|517312140|FG000|Whole Study|Withdrawal by Subject|1|||
143482543|NCT01423851|517312141|FG001|Whole Study|Withdrawal by Subject|1|||
143482544|NCT01423851|517312142|FG002|Whole Study|Withdrawal by Subject|0|||
143482545|NCT01423851|517312143|FG003|Whole Study|Withdrawal by Subject|0|||
143482546|NCT01423851|517312144|FG004|Whole Study|Withdrawal by Subject|0|||
143482547|NCT01423851|517312145|FG005|Whole Study|Withdrawal by Subject|0|||
143482548|NCT01423851|517312146|FG006|Whole Study|Withdrawal by Subject|0|||
143482549|NCT01423851|517312147|FG007|Whole Study|Withdrawal by Subject|0|||
143482550|NCT01423851|517312148|FG008|Whole Study|Withdrawal by Subject|2|||
143482551|NCT01423851|517312149|FG009|Whole Study|Withdrawal by Subject|0|||
143482552|NCT01423851|517312150|FG010|Whole Study|Withdrawal by Subject|4|||
143482553|NCT01423851|517312140|FG000|Whole Study|Adverse Event|0|||
143482554|NCT01423851|517312141|FG001|Whole Study|Adverse Event|0|||
143482555|NCT01423851|517312142|FG002|Whole Study|Adverse Event|0|||
143482556|NCT01423851|517312143|FG003|Whole Study|Adverse Event|2|||
143482557|NCT01423851|517312144|FG004|Whole Study|Adverse Event|0|||
143482558|NCT01423851|517312145|FG005|Whole Study|Adverse Event|0|||
143482559|NCT01423851|517312146|FG006|Whole Study|Adverse Event|0|||
143482560|NCT01423851|517312147|FG007|Whole Study|Adverse Event|3|||
143482561|NCT01423851|517312148|FG008|Whole Study|Adverse Event|3|||
143482562|NCT01423851|517312149|FG009|Whole Study|Adverse Event|2|||
143482563|NCT01423851|517312150|FG010|Whole Study|Adverse Event|3|||
143482564|NCT00733954|517312154|FG000|Overall Study|Lost to Follow-up|5|||
143014665|NCT01220128|515593687|FG006|Overall Study|Adverse event, non-fatal|3|||
143014666|NCT01220128|515593681|FG000|Overall Study|Other|0|||
143014667|NCT01220128|515593682|FG001|Overall Study|Other|0|||
143014668|NCT01220128|515593683|FG002|Overall Study|Other|1|||
143014669|NCT01220128|515593684|FG003|Overall Study|Other|0|||
143014670|NCT01220128|515593685|FG004|Overall Study|Other|0|||
143014671|NCT01220128|515593686|FG005|Overall Study|Other|0|||
143014672|NCT01220128|515593687|FG006|Overall Study|Other|0|||
143014673|NCT01220128|515593681|FG000|Overall Study|Consent withdrawn by subject|1|||
143014674|NCT01220128|515593682|FG001|Overall Study|Consent withdrawn by subject|0|||
143014675|NCT01220128|515593683|FG002|Overall Study|Consent withdrawn by subject|0|||
143014676|NCT01220128|515593684|FG003|Overall Study|Consent withdrawn by subject|0|||
143014677|NCT01220128|515593685|FG004|Overall Study|Consent withdrawn by subject|0|||
143014678|NCT01220128|515593686|FG005|Overall Study|Consent withdrawn by subject|0|||
143482565|NCT00733954|517312155|FG001|Overall Study|Lost to Follow-up|2|||
143482566|NCT00733954|517312154|FG000|Overall Study|Protocol Violation|1|||
143482567|NCT00733954|517312155|FG001|Overall Study|Protocol Violation|0|||
143482568|NCT00733954|517312154|FG000|Overall Study|Withdrawal by Subject|2|||
143014679|NCT01220128|515593687|FG006|Overall Study|Consent withdrawn by subject|0|||
143014680|NCT05473247|515593688|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
143148230|NCT01697579|516087695|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
143148231|NCT01697579|516087696|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
143482569|NCT00733954|517312155|FG001|Overall Study|Withdrawal by Subject|0|||
143482570|NCT03416153|517312156|FG000|Overall Study|Physician Decision|1|||
143482571|NCT03416153|517312157|FG001|Overall Study|Physician Decision|1|||
143482572|NCT03416153|517312156|FG000|Overall Study|Withdrawal by Subject|1|||
143482573|NCT03416153|517312157|FG001|Overall Study|Withdrawal by Subject|0|||
143482574|NCT02037295|517313562|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
143482575|NCT02037295|517313563|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
143482576|NCT02037295|517313564|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
143482577|NCT02037295|517313565|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
143482578|NCT01146873|517313571|FG000|Overall Study|Transfer out|0|||
143014681|NCT02392559|515593689|FG000|Overall Study|Withdrawal by Subject|0|||
143014682|NCT02392559|515593690|FG001|Overall Study|Withdrawal by Subject|1|||
143014683|NCT02340078|515593696|FG000|Overall Study|Protocol Violation|1|||
143014684|NCT00883129|515593702|FG000|Overall Study|Adverse Event|7|||
143014685|NCT00883129|515593703|FG001|Overall Study|Adverse Event|15|||
143014686|NCT00883129|515593702|FG000|Overall Study|Withdrawal by Subject|8|||
143014687|NCT00883129|515593703|FG001|Overall Study|Withdrawal by Subject|9|||
143014688|NCT00883129|515593702|FG000|Overall Study|Non-compliance|3|||
143014689|NCT00883129|515593703|FG001|Overall Study|Non-compliance|6|||
143014690|NCT00883129|515593702|FG000|Overall Study|Lost to Follow-up|1|||
143014691|NCT00883129|515593703|FG001|Overall Study|Lost to Follow-up|2|||
143014692|NCT00883129|515593702|FG000|Overall Study|Death|1|||
143014693|NCT00883129|515593703|FG001|Overall Study|Death|2|||
143014694|NCT00883129|515593702|FG000|Overall Study|Defined Treatment Failure|0|||
143014695|NCT00883129|515593703|FG001|Overall Study|Defined Treatment Failure|2|||
143014696|NCT03273257|515593704|FG000|Overall Study|Death|0|||
143014697|NCT03273257|515593705|FG001|Overall Study|Death|1|||
143014698|NCT03273257|515593704|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
143014699|NCT03273257|515593705|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
143014700|NCT03273257|515593704|FG000|Overall Study|Study terminated|3|||
143014701|NCT03273257|515593705|FG001|Overall Study|Study terminated|2|||
143014702|NCT01185639|515593707|FG000|Overall Study|Progressed and didn't receive therapy|2|||
143482579|NCT01146873|517313572|FG001|Overall Study|Transfer out|6|||
143482580|NCT01967628|517313573|FG000|Overall Study|Withdrawal by Subject|2|||
143482581|NCT01967628|517313574|FG001|Overall Study|Withdrawal by Subject|0|||
143482582|NCT01967628|517313573|FG000|Overall Study|Unable to complete bronchoscopy|4|||
143482583|NCT01967628|517313574|FG001|Overall Study|Unable to complete bronchoscopy|6|||
143482584|NCT01967628|517313573|FG000|Overall Study|Lost to Follow-up|1|||
143482585|NCT01967628|517313574|FG001|Overall Study|Lost to Follow-up|0|||
143482586|NCT01967628|517313573|FG000|Overall Study|Low protein concentration in sample|20|||
143482587|NCT01967628|517313574|FG001|Overall Study|Low protein concentration in sample|25|||
143482588|NCT00838331|517313575|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
143482589|NCT03200366|517313578|FG000|Patient Navigation Intervention Given|Death|0|||
143482590|NCT03200366|517313579|FG001|Patient Navigation Intervention Given|Death|2|||
143482591|NCT03200366|517313580|FG002|Patient Navigation Intervention Given|Death|0|||
143482592|NCT03200366|517313578|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
143014703|NCT02200614|515593708|FG000|Double Blind Treatment|Adverse Event|86|||
143014704|NCT02200614|515593709|FG001|Double Blind Treatment|Adverse Event|48|||
143014705|NCT02200614|515593708|FG000|Double Blind Treatment|Confirmed metastasis|120|||
143014706|NCT02200614|515593709|FG001|Double Blind Treatment|Confirmed metastasis|140|||
143014707|NCT02200614|515593708|FG000|Double Blind Treatment|Judgment of the investigator|59|||
143014708|NCT02200614|515593709|FG001|Double Blind Treatment|Judgment of the investigator|99|||
143014709|NCT02200614|515593708|FG000|Double Blind Treatment|Metastasis by local reading|1|||
143014710|NCT02200614|515593709|FG001|Double Blind Treatment|Metastasis by local reading|3|||
143014711|NCT02200614|515593708|FG000|Double Blind Treatment|Other reason|6|||
143014712|NCT02200614|515593709|FG001|Double Blind Treatment|Other reason|2|||
143014713|NCT02200614|515593708|FG000|Double Blind Treatment|Personal reason|77|||
143014714|NCT02200614|515593709|FG001|Double Blind Treatment|Personal reason|85|||
143014715|NCT02200614|515593708|FG000|Double Blind Treatment|Protocol deviation|14|||
143014716|NCT02200614|515593709|FG001|Double Blind Treatment|Protocol deviation|7|||
143014717|NCT02200614|515593708|FG000|Double Blind Treatment|Not treated|1|||
143014718|NCT02200614|515593709|FG001|Double Blind Treatment|Not treated|0|||
143014719|NCT02200614|515593708|FG000|Open Label|Adverse Event|41|||
143014720|NCT02200614|515593709|FG001|Open Label|Adverse Event|11|||
143014721|NCT02200614|515593708|FG000|Open Label|Confirmed metastasis|1|||
143482593|NCT03200366|517313579|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
143482594|NCT03200366|517313580|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
143482595|NCT03200366|517313578|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
143482596|NCT03200366|517313579|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
143482597|NCT03200366|517313580|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
143482598|NCT03200366|517313578|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
143014722|NCT02200614|515593709|FG001|Open Label|Confirmed metastasis|0|||
143014723|NCT02200614|515593708|FG000|Open Label|Judgment of the investigator|29|||
143014724|NCT02200614|515593709|FG001|Open Label|Judgment of the investigator|2|||
143482599|NCT03200366|517313579|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
143014725|NCT02200614|515593708|FG000|Open Label|Metastasis by local reading|138|||
143014726|NCT02200614|515593709|FG001|Open Label|Metastasis by local reading|27|||
143014727|NCT02200614|515593708|FG000|Open Label|Other reason|22|||
143014728|NCT02200614|515593709|FG001|Open Label|Other reason|4|||
143014729|NCT02200614|515593708|FG000|Open Label|Personal reason|60|||
143014730|NCT02200614|515593709|FG001|Open Label|Personal reason|8|||
143014731|NCT02200614|515593708|FG000|Open Label|Protocol deviation|3|||
143014732|NCT02200614|515593709|FG001|Open Label|Protocol deviation|2|||
143014733|NCT02200614|515593708|FG000|Open Label|Missing|2|||
143014734|NCT02200614|515593709|FG001|Open Label|Missing|2|||
143014735|NCT01898884|515593710|FG000|Multiple Dose Period|Adverse Event|0|||
143482600|NCT03200366|517313580|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
143014736|NCT01898884|515593711|FG001|Multiple Dose Period|Adverse Event|0|||
143014737|NCT01898884|515593712|FG002|Multiple Dose Period|Adverse Event|0|||
143014738|NCT01898884|515593713|FG003|Multiple Dose Period|Adverse Event|0|||
143014739|NCT01898884|515593714|FG004|Multiple Dose Period|Adverse Event|0|||
143014740|NCT01898884|515593715|FG005|Multiple Dose Period|Adverse Event|0|||
143014741|NCT01898884|515593716|FG006|Multiple Dose Period|Adverse Event|1|||
143014742|NCT01898884|515593717|FG007|Multiple Dose Period|Adverse Event|0|||
143014743|NCT01898884|515593718|FG008|Multiple Dose Period|Adverse Event|0|||
143014744|NCT01898884|515593710|FG000|Multiple Dose Period|Randomized Not Treated|0|||
143014745|NCT01898884|515593711|FG001|Multiple Dose Period|Randomized Not Treated|0|||
143014746|NCT01898884|515593712|FG002|Multiple Dose Period|Randomized Not Treated|0|||
143014747|NCT01898884|515593713|FG003|Multiple Dose Period|Randomized Not Treated|0|||
143014748|NCT01898884|515593714|FG004|Multiple Dose Period|Randomized Not Treated|0|||
143014749|NCT01898884|515593715|FG005|Multiple Dose Period|Randomized Not Treated|0|||
143014750|NCT01898884|515593716|FG006|Multiple Dose Period|Randomized Not Treated|0|||
143014751|NCT01898884|515593717|FG007|Multiple Dose Period|Randomized Not Treated|0|||
143014752|NCT01898884|515593718|FG008|Multiple Dose Period|Randomized Not Treated|1|||
143014753|NCT00759759|515593719|FG000|Overall Study|didn't return for period 2|1|||
143014754|NCT00759759|515593720|FG001|Overall Study|didn't return for period 2|0|||
143014755|NCT00759759|515593719|FG000|Overall Study|Didn't receive drug in period 2|1|||
143014756|NCT00759759|515593720|FG001|Overall Study|Didn't receive drug in period 2|0|||
143014757|NCT00759759|515593719|FG000|Overall Study|Withdrawal by Subject|2|||
143014758|NCT00759759|515593720|FG001|Overall Study|Withdrawal by Subject|1|||
143014759|NCT01556165|515593729|FG000|Overall Study|Adverse Event|5|||
143014760|NCT01556165|515593730|FG001|Overall Study|Adverse Event|3|||
143014761|NCT01556165|515593729|FG000|Overall Study|Protocol Violation|0|||
143014762|NCT01556165|515593730|FG001|Overall Study|Protocol Violation|3|||
143014763|NCT01556165|515593729|FG000|Overall Study|Withdrawal of Consent|7|||
143014764|NCT01556165|515593730|FG001|Overall Study|Withdrawal of Consent|1|||
143014765|NCT00701558|515593736|FG000|Overall Study|Death|7|||
143014766|NCT00701558|515593736|FG000|Overall Study|Lost to Follow-up|8|||
143014767|NCT01640964|515593739|FG000|Overall Study|Lost to Follow-up|0|||
143014768|NCT01640964|515593740|FG001|Overall Study|Lost to Follow-up|0|||
143014769|NCT01640964|515593741|FG002|Overall Study|Lost to Follow-up|1|||
143014770|NCT01640964|515593739|FG000|Overall Study|Protocol Deviation|1|||
143014771|NCT01640964|515593740|FG001|Overall Study|Protocol Deviation|1|||
143014772|NCT01640964|515593741|FG002|Overall Study|Protocol Deviation|2|||
143014773|NCT02787746|515593742|FG000|Overall Study|Adverse Event|42|||
143014774|NCT02787746|515593742|FG000|Overall Study|Withdrawal by Subject|65|||
143014775|NCT02787746|515593742|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
143014776|NCT04822701|515593743|FG000|Overall Study|Not treated|2|||
143014777|NCT04822701|515593744|FG001|Overall Study|Not treated|0|||
143148232|NCT01697579|516087697|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
143148233|NCT01697579|516087698|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
143148234|NCT01697579|516087699|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
143148235|NCT01697579|516087693|FG000|Base Study-Cycle 1|Protocol Violation|0|||
143482601|NCT03200366|517313578|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
143482602|NCT03200366|517313579|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
143482603|NCT03200366|517313580|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
143482604|NCT03200366|517313578|FG000|6 Month Post-Baseline Interview|Death|1|||
143482605|NCT03200366|517313579|FG001|6 Month Post-Baseline Interview|Death|1|||
143482606|NCT03200366|517313580|FG002|6 Month Post-Baseline Interview|Death|1|||
143482607|NCT03200366|517313578|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
143482608|NCT03200366|517313579|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
143482609|NCT03200366|517313580|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
143482610|NCT03200366|517313578|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
143482611|NCT03200366|517313579|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
143482612|NCT03200366|517313580|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
143014778|NCT04822701|515593743|FG000|Overall Study|Lost to Follow-up|1|||
143014779|NCT04822701|515593744|FG001|Overall Study|Lost to Follow-up|0|||
143014780|NCT04822701|515593743|FG000|Overall Study|Withdrawal by Subject|1|||
143014781|NCT04822701|515593744|FG001|Overall Study|Withdrawal by Subject|0|||
143014782|NCT01458132|515595503|FG000|Overall Study|Other|15|||
143014783|NCT01458132|515595504|FG001|Overall Study|Other|3|||
143014784|NCT00344305|515595513|FG000|Overall Study|Lost to Follow-up|2|||
143014785|NCT00344305|515595514|FG001|Overall Study|Lost to Follow-up|0|||
143148236|NCT01697579|516087694|FG001|Base Study-Cycle 1|Protocol Violation|0|||
143014786|NCT00344305|515595513|FG000|Overall Study|Participant was not contacted in window|0|||
143014787|NCT00344305|515595514|FG001|Overall Study|Participant was not contacted in window|1|||
143482613|NCT03200366|517313578|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
143482614|NCT03200366|517313579|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
143482615|NCT03200366|517313580|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
143482616|NCT03200366|517313578|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
143482617|NCT03200366|517313579|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
143482618|NCT03200366|517313580|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
143482619|NCT03200366|517313578|FG000|9 Month Post-Baseline Interview|Death|1|||
143482620|NCT03200366|517313579|FG001|9 Month Post-Baseline Interview|Death|1|||
143482621|NCT03200366|517313580|FG002|9 Month Post-Baseline Interview|Death|1|||
143482622|NCT03200366|517313578|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
143482623|NCT03200366|517313579|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
143482624|NCT03200366|517313580|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
143482625|NCT03200366|517313578|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
143482626|NCT03200366|517313579|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
143482627|NCT03200366|517313580|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
143482628|NCT03200366|517313578|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
143482629|NCT03200366|517313579|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
143482630|NCT03200366|517313580|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
143482631|NCT04677959|517313581|FG000|Overall Study|Adverse Event|1|||
143482632|NCT04677959|517313582|FG001|Overall Study|Adverse Event|9|||
143482633|NCT04677959|517313581|FG000|Overall Study|Withdrawal by Subject|2|||
143482634|NCT04677959|517313582|FG001|Overall Study|Withdrawal by Subject|15|||
143482635|NCT04677959|517313581|FG000|Overall Study|Withdrawal by parent/guardian|0|||
143482636|NCT04677959|517313582|FG001|Overall Study|Withdrawal by parent/guardian|1|||
143482637|NCT04677959|517313581|FG000|Overall Study|Non-compliance with study drug|0|||
143482638|NCT04677959|517313582|FG001|Overall Study|Non-compliance with study drug|2|||
143482639|NCT04677959|517313581|FG000|Overall Study|Protocol deviation|0|||
143482640|NCT04677959|517313582|FG001|Overall Study|Protocol deviation|11|||
143482641|NCT04677959|517313581|FG000|Overall Study|Lost to Follow-up|9|||
143482642|NCT04677959|517313582|FG001|Overall Study|Lost to Follow-up|13|||
143482643|NCT04677959|517313581|FG000|Overall Study|Other than specified|0|||
143482644|NCT04677959|517313582|FG001|Overall Study|Other than specified|8|||
143482645|NCT00264875|517313583|FG000|Overall Study|Adverse Event|6|||
143482646|NCT00264875|517313583|FG000|Overall Study|Lost to Follow-up|6|||
143482647|NCT00264875|517313583|FG000|Overall Study|Protocol Violation|11|||
143482648|NCT00264875|517313583|FG000|Overall Study|Withdrawal by Subject|7|||
143482649|NCT01074190|517313584|FG000|Overall Study|Emergency Cesarean Delivery|1|||
143482650|NCT01074190|517313585|FG001|Overall Study|Emergency Cesarean Delivery|2|||
143482651|NCT01074190|517313586|FG002|Overall Study|Emergency Cesarean Delivery|1|||
143482652|NCT01074190|517313584|FG000|Overall Study|Protocol Violation|2|||
143482653|NCT01074190|517313585|FG001|Overall Study|Protocol Violation|1|||
143482654|NCT01074190|517313586|FG002|Overall Study|Protocol Violation|0|||
143482655|NCT01074190|517313584|FG000|Overall Study|Delivered in under 90 minutes|0|||
143482656|NCT01074190|517313585|FG001|Overall Study|Delivered in under 90 minutes|2|||
143482657|NCT01074190|517313586|FG002|Overall Study|Delivered in under 90 minutes|1|||
143482658|NCT01074190|517313584|FG000|Overall Study|Subject withdrew consent|1|||
143482659|NCT01074190|517313585|FG001|Overall Study|Subject withdrew consent|1|||
143482660|NCT01074190|517313586|FG002|Overall Study|Subject withdrew consent|1|||
143482661|NCT01500278|517313587|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
143482662|NCT01500278|517313588|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
143482663|NCT01500278|517313587|FG000|Week 0 - Week 12|Protocol Violation|10|||
143482664|NCT01500278|517313588|FG001|Week 0 - Week 12|Protocol Violation|16|||
143482665|NCT01500278|517313587|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
143482666|NCT01500278|517313588|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
143482667|NCT01500278|517313587|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
143482668|NCT01500278|517313588|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
143482669|NCT01500278|517313587|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
143482670|NCT01500278|517313588|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
143482671|NCT01500278|517313587|FG000|Week 0 - Week 12|Patient decision|1|||
143482672|NCT01500278|517313588|FG001|Week 0 - Week 12|Patient decision|0|||
143482673|NCT01500278|517313587|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
143482674|NCT01500278|517313588|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
143482675|NCT01500278|517313587|FG000|Week 0 - Week 12|Investigator decision|1|||
143482676|NCT01500278|517313588|FG001|Week 0 - Week 12|Investigator decision|0|||
143482677|NCT01500278|517313587|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
143482678|NCT01500278|517313588|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
143482679|NCT01500278|517313587|FG000|Week 0 - Week 12|Sponsor decision|1|||
143482680|NCT01500278|517313588|FG001|Week 0 - Week 12|Sponsor decision|0|||
143482681|NCT01500278|517313587|FG000|Week 0 - Week 12|Personal reason|0|||
143482682|NCT01500278|517313588|FG001|Week 0 - Week 12|Personal reason|1|||
143482683|NCT01500278|517313587|FG000|Week 0 - Week 12|Other serious disease|0|||
143482684|NCT01500278|517313588|FG001|Week 0 - Week 12|Other serious disease|1|||
143482685|NCT01500278|517313587|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
143014788|NCT01190098|515595515|FG000|Overall Study|Adverse Event|2|||
143014789|NCT01190098|515595516|FG001|Overall Study|Adverse Event|0|||
143014790|NCT01190098|515595515|FG000|Overall Study|Patient coomorbidity|0|||
143014791|NCT01190098|515595516|FG001|Overall Study|Patient coomorbidity|1|||
143014792|NCT01190098|515595515|FG000|Overall Study|Lack of transportation|1|||
143014793|NCT01190098|515595516|FG001|Overall Study|Lack of transportation|0|||
143014794|NCT01190098|515595515|FG000|Overall Study|Other|0|||
143014795|NCT01190098|515595516|FG001|Overall Study|Other|1|||
143014796|NCT04723173|515595521|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
143014797|NCT02996448|515595522|FG000|Overall Study|Study terminated due to adverse effects|3|||
143014798|NCT01422720|515595523|FG000|Overall Study|Adverse Event|16|||
143014799|NCT01422720|515595523|FG000|Overall Study|Lack of Efficacy|1|||
143014800|NCT01422720|515595523|FG000|Overall Study|Withdrawal by Subject|4|||
143014801|NCT01422720|515595523|FG000|Overall Study|Ineligibility|1|||
143014802|NCT00303316|515595528|FG000|Overall Study|Protocol Violation|1|||
143014803|NCT00303316|515595529|FG001|Overall Study|Protocol Violation|0|||
143014804|NCT00303316|515595528|FG000|Overall Study|Lost to Follow-up|0|||
143014805|NCT00303316|515595529|FG001|Overall Study|Lost to Follow-up|1|||
143014806|NCT00303316|515595528|FG000|Overall Study|Withdrawal by Subject|1|||
143014807|NCT00303316|515595529|FG001|Overall Study|Withdrawal by Subject|2|||
143148237|NCT01697579|516087695|FG002|Base Study-Cycle 1|Protocol Violation|0|||
143148238|NCT01697579|516087696|FG003|Base Study-Cycle 1|Protocol Violation|0|||
143148239|NCT01697579|516087697|FG004|Base Study-Cycle 1|Protocol Violation|3|||
143148240|NCT01697579|516087698|FG005|Base Study-Cycle 1|Protocol Violation|0|||
143482686|NCT01500278|517313588|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
143482687|NCT01500278|517313587|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
143482688|NCT01500278|517313588|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
143482689|NCT01500278|517313587|FG000|Week 13 - Week 104|Protocol Violation|6|||
143482690|NCT01500278|517313588|FG001|Week 13 - Week 104|Protocol Violation|6|||
143482691|NCT01500278|517313587|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
143482692|NCT01500278|517313588|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
143482693|NCT01500278|517313587|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
143482694|NCT01500278|517313588|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
143482695|NCT01500278|517313587|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
143482696|NCT01500278|517313588|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
143482697|NCT01500278|517313587|FG000|Week 13 - Week 104|Non/bad compliance|7|||
143482698|NCT01500278|517313588|FG001|Week 13 - Week 104|Non/bad compliance|5|||
143482699|NCT01500278|517313587|FG000|Week 13 - Week 104|Recurrent infections|1|||
143482700|NCT01500278|517313588|FG001|Week 13 - Week 104|Recurrent infections|0|||
143482701|NCT01500278|517313587|FG000|Week 13 - Week 104|False positive test|1|||
143482702|NCT01500278|517313588|FG001|Week 13 - Week 104|False positive test|2|||
143482703|NCT01500278|517313587|FG000|Week 13 - Week 104|Sponsor request|4|||
143482704|NCT01500278|517313588|FG001|Week 13 - Week 104|Sponsor request|0|||
143482705|NCT01500278|517313587|FG000|Week 13 - Week 104|Withdrawn in error|1|||
143482706|NCT01500278|517313588|FG001|Week 13 - Week 104|Withdrawn in error|0|||
143482707|NCT01500278|517313587|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
143482708|NCT01500278|517313588|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
143482709|NCT01500278|517313587|FG000|Week 13 - Week 104|Protocol deviation|1|||
143482710|NCT01500278|517313588|FG001|Week 13 - Week 104|Protocol deviation|0|||
143014808|NCT01726335|515595530|FG000|Overall Study|Lost to Follow-up|2|||
143014809|NCT01726335|515595530|FG000|Overall Study|Withdrawal by Subject|15|||
143148241|NCT01697579|516087699|FG006|Base Study-Cycle 1|Protocol Violation|0|||
143148242|NCT01697579|516087693|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
143148243|NCT01697579|516087694|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
143148244|NCT01697579|516087695|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
143148245|NCT01697579|516087696|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
143148246|NCT01697579|516087697|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
143148247|NCT01697579|516087698|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
143148248|NCT01697579|516087699|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
143148249|NCT01697579|516087693|FG000|Base Study-Cycle 1|Technical Problems|0|||
143148250|NCT01697579|516087694|FG001|Base Study-Cycle 1|Technical Problems|0|||
143148251|NCT01697579|516087695|FG002|Base Study-Cycle 1|Technical Problems|1|||
143148252|NCT01697579|516087696|FG003|Base Study-Cycle 1|Technical Problems|1|||
143148253|NCT01697579|516087697|FG004|Base Study-Cycle 1|Technical Problems|0|||
143148254|NCT01697579|516087698|FG005|Base Study-Cycle 1|Technical Problems|0|||
143482711|NCT01500278|517313587|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
143014810|NCT01726335|515595530|FG000|Overall Study|Adverse Event|4|||
143014811|NCT01726335|515595530|FG000|Overall Study|Lost to Follow-up|2|||
143148255|NCT01697579|516087699|FG006|Base Study-Cycle 1|Technical Problems|0|||
143482712|NCT01500278|517313588|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
143482713|NCT01500278|517313587|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
143482714|NCT01500278|517313588|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
143014812|NCT01726335|515595530|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
143482715|NCT01500278|517313587|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
143482716|NCT01500278|517313588|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
143482717|NCT01500278|517313587|FG000|Week 13 - Week 104|Relocation|0|||
143482718|NCT01500278|517313588|FG001|Week 13 - Week 104|Relocation|1|||
143482719|NCT01500278|517313587|FG000|Week 13 - Week 104|Sponsor decision|0|||
143482720|NCT01500278|517313588|FG001|Week 13 - Week 104|Sponsor decision|2|||
143482721|NCT01500278|517313587|FG000|Week 13 - Week 104|Medical monitor decision|0|||
143482722|NCT01500278|517313588|FG001|Week 13 - Week 104|Medical monitor decision|2|||
143482723|NCT01500278|517313587|FG000|Week 13 - Week 104|Personal reason|0|||
143482724|NCT01500278|517313588|FG001|Week 13 - Week 104|Personal reason|1|||
143482725|NCT01500278|517313587|FG000|Week 13 - Week 104|Not completed|0|||
143482726|NCT01500278|517313588|FG001|Week 13 - Week 104|Not completed|1|||
143482727|NCT01500278|517313587|FG000|Week 13 - Week 104|Death|2|||
143482728|NCT01500278|517313588|FG001|Week 13 - Week 104|Death|4|||
143482729|NCT01500278|517313587|FG000|Week 13 - Week 104|Adverse Event|54|||
143482730|NCT01500278|517313588|FG001|Week 13 - Week 104|Adverse Event|54|||
143482731|NCT04718974|517313592|FG000|Overall Study|Death|0|||
143482732|NCT04718974|517313593|FG001|Overall Study|Death|2|||
143482733|NCT04718974|517313592|FG000|Overall Study|Lost to Follow-up|10|||
143482734|NCT04718974|517313593|FG001|Overall Study|Lost to Follow-up|20|||
143482735|NCT04718974|517313592|FG000|Overall Study|Transferred out|2|||
143482736|NCT04718974|517313593|FG001|Overall Study|Transferred out|4|||
143482737|NCT02184195|517313596|FG000|Overall Study|Patient decision|5|||
143482738|NCT02184195|517313597|FG001|Overall Study|Patient decision|2|||
143482739|NCT02184195|517313596|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
143482740|NCT02184195|517313597|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
143482741|NCT02184195|517313596|FG000|Overall Study|Death|67|||
143482742|NCT02184195|517313597|FG001|Overall Study|Death|44|||
143482743|NCT02184195|517313596|FG000|Overall Study|Lost to Follow-up|1|||
143482744|NCT02184195|517313597|FG001|Overall Study|Lost to Follow-up|5|||
143482745|NCT02184195|517313596|FG000|Overall Study|Other|0|||
143482746|NCT02184195|517313597|FG001|Overall Study|Other|3|||
143482747|NCT03029143|517313598|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
143482748|NCT03029143|517313599|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
143482749|NCT03029143|517313600|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
143482750|NCT03029143|517313598|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
143482751|NCT03029143|517313599|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
143482752|NCT03029143|517313600|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
143482753|NCT03029143|517313598|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
143482754|NCT03029143|517313599|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
143482755|NCT03029143|517313600|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
143482756|NCT03029143|517313598|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
143482757|NCT03029143|517313599|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
143482758|NCT03029143|517313600|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
143482759|NCT03029143|517313598|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
143482760|NCT03029143|517313599|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
143482761|NCT03029143|517313600|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
143482762|NCT03029143|517313598|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
143482763|NCT03029143|517313599|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
143482764|NCT03029143|517313600|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
143014813|NCT01074307|515595537|FG000|Overall Study|No primary endpoint evaluation|14|||
143014814|NCT01074307|515595538|FG001|Overall Study|No primary endpoint evaluation|6|||
143014815|NCT01074307|515595537|FG000|Overall Study|Exclusion criterion|0|||
143014816|NCT01074307|515595538|FG001|Overall Study|Exclusion criterion|1|||
143014817|NCT01074307|515595537|FG000|Overall Study|Protocol Violation|8|||
143014818|NCT01074307|515595538|FG001|Overall Study|Protocol Violation|5|||
143014819|NCT02162511|515595544|FG000|Overall Study|Lack of Efficacy|0|||
143014820|NCT02162511|515595545|FG001|Overall Study|Lack of Efficacy|0|||
143482765|NCT03029143|517313598|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
143482766|NCT03029143|517313599|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
143482767|NCT03029143|517313600|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
143482768|NCT03029143|517313598|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
143482769|NCT03029143|517313599|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
143482770|NCT03029143|517313600|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
143482771|NCT03029143|517313598|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
143014821|NCT02162511|515595546|FG002|Overall Study|Lack of Efficacy|2|||
143482772|NCT03029143|517313599|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
143482773|NCT03029143|517313600|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
143482774|NCT03029143|517313598|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
143482775|NCT03029143|517313599|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
143482776|NCT03029143|517313600|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
143014822|NCT01160198|515595547|FG000|Overall Study|Withdrawal by Subject|2|||
143014823|NCT01160198|515595548|FG001|Overall Study|Withdrawal by Subject|1|||
143014824|NCT01160198|515595549|FG002|Overall Study|Withdrawal by Subject|0|||
143014825|NCT01160198|515595547|FG000|Overall Study|Adverse Event|0|||
143014826|NCT01160198|515595548|FG001|Overall Study|Adverse Event|1|||
143014827|NCT01160198|515595549|FG002|Overall Study|Adverse Event|0|||
143014828|NCT01160198|515595547|FG000|Overall Study|Lost to Follow-up|0|||
143014829|NCT01160198|515595548|FG001|Overall Study|Lost to Follow-up|1|||
143014830|NCT01160198|515595549|FG002|Overall Study|Lost to Follow-up|0|||
143014831|NCT01160198|515595547|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
143014832|NCT01160198|515595548|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
143014833|NCT01160198|515595549|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
143014834|NCT01796860|515595551|FG000|Overall Study|Withdrawal by Subject|3|||
143014835|NCT01408576|515595553|FG000|Overall Study|Lack of Efficacy|17|||
143014836|NCT01408576|515595554|FG001|Overall Study|Lack of Efficacy|30|||
143014837|NCT01408576|515595555|FG002|Overall Study|Lack of Efficacy|48|||
143014838|NCT01408576|515595553|FG000|Overall Study|Protocol Violation|1|||
143014839|NCT01408576|515595554|FG001|Overall Study|Protocol Violation|2|||
143014840|NCT01408576|515595555|FG002|Overall Study|Protocol Violation|2|||
143014841|NCT01408576|515595553|FG000|Overall Study|Lost to Follow-up|10|||
143014842|NCT01408576|515595554|FG001|Overall Study|Lost to Follow-up|9|||
143014843|NCT01408576|515595555|FG002|Overall Study|Lost to Follow-up|17|||
143014844|NCT01408576|515595553|FG000|Overall Study|Withdrawal by Subject|34|||
143014845|NCT01408576|515595554|FG001|Overall Study|Withdrawal by Subject|60|||
143014846|NCT01408576|515595555|FG002|Overall Study|Withdrawal by Subject|66|||
143014847|NCT01408576|515595553|FG000|Overall Study|Sponsor terminated study|89|||
143014848|NCT01408576|515595554|FG001|Overall Study|Sponsor terminated study|333|||
143014849|NCT01408576|515595555|FG002|Overall Study|Sponsor terminated study|330|||
143014850|NCT01408576|515595553|FG000|Overall Study|AE, serious fatal|4|||
143014851|NCT01408576|515595554|FG001|Overall Study|AE, serious fatal|4|||
143014852|NCT01408576|515595555|FG002|Overall Study|AE, serious fatal|1|||
143148256|NCT01697579|516087693|FG000|Optional Extension-Cycles 2-6|Death|0|||
143148257|NCT01697579|516087694|FG001|Optional Extension-Cycles 2-6|Death|0|||
143148258|NCT01697579|516087695|FG002|Optional Extension-Cycles 2-6|Death|0|||
143148259|NCT01697579|516087696|FG003|Optional Extension-Cycles 2-6|Death|0|||
143014853|NCT01408576|515595553|FG000|Overall Study|SAE, non-fatal|11|||
143014854|NCT01408576|515595554|FG001|Overall Study|SAE, non-fatal|23|||
143014855|NCT01408576|515595555|FG002|Overall Study|SAE, non-fatal|14|||
143014856|NCT01408576|515595553|FG000|Overall Study|AE, non-serious non-fatal|12|||
143014857|NCT01408576|515595554|FG001|Overall Study|AE, non-serious non-fatal|19|||
143014858|NCT01408576|515595555|FG002|Overall Study|AE, non-serious non-fatal|11|||
143014859|NCT01408576|515595553|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
143148260|NCT01697579|516087697|FG004|Optional Extension-Cycles 2-6|Death|0|||
143148261|NCT01697579|516087698|FG005|Optional Extension-Cycles 2-6|Death|0|||
143148262|NCT01697579|516087699|FG006|Optional Extension-Cycles 2-6|Death|2|||
143482777|NCT03029143|517313598|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
143482778|NCT03029143|517313599|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
143482779|NCT03029143|517313600|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
143482780|NCT02121262|517313601|FG000|Overall Study|Adverse Event|6|||
143482781|NCT02121262|517313602|FG001|Overall Study|Adverse Event|3|||
143482782|NCT02121262|517313601|FG000|Overall Study|Lack of Efficacy|3|||
143482783|NCT02121262|517313602|FG001|Overall Study|Lack of Efficacy|0|||
143482784|NCT02121262|517313601|FG000|Overall Study|Personal Reasons|19|||
143482785|NCT02121262|517313602|FG001|Overall Study|Personal Reasons|5|||
143482786|NCT02121262|517313601|FG000|Overall Study|Protocol Violation|1|||
143482787|NCT02121262|517313602|FG001|Overall Study|Protocol Violation|1|||
143482788|NCT02121262|517313601|FG000|Overall Study|Participant Dropped-out|0|||
143482789|NCT02121262|517313602|FG001|Overall Study|Participant Dropped-out|1|||
143482790|NCT02121262|517313601|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
143482791|NCT02121262|517313602|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
143482792|NCT02121262|517313601|FG000|Overall Study|Consent Withdrawn|1|||
143482793|NCT02121262|517313602|FG001|Overall Study|Consent Withdrawn|0|||
143482794|NCT03223428|517313603|FG000|Overall Study|No longer taking Xermelo|27|||
143482795|NCT03223428|517313603|FG000|Overall Study|Declined Consent|1|||
143482796|NCT03223428|517313603|FG000|Overall Study|Non-responders|56|||
143482797|NCT03223428|517313603|FG000|Overall Study|Withdrawal by Subject|14|||
143014860|NCT01408576|515595554|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
143014861|NCT01408576|515595555|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
143148263|NCT01697579|516087693|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
143148264|NCT01697579|516087694|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
143482798|NCT02025907|517313604|FG000|Overall Study|Lack of Efficacy|1|||
143482799|NCT02025907|517313605|FG001|Overall Study|Lack of Efficacy|0|||
143482800|NCT02025907|517313604|FG000|Overall Study|Withdrawal by Subject|15|||
143014862|NCT01408576|515595553|FG000|Overall Study|AE, unknown type|0|||
143014863|NCT01408576|515595554|FG001|Overall Study|AE, unknown type|1|||
143014864|NCT01408576|515595555|FG002|Overall Study|AE, unknown type|0|||
143014865|NCT01408576|515595553|FG000|Overall Study|Other|10|||
143482801|NCT02025907|517313605|FG001|Overall Study|Withdrawal by Subject|8|||
143482802|NCT02025907|517313604|FG000|Overall Study|Protocol Violation|2|||
143482803|NCT02025907|517313605|FG001|Overall Study|Protocol Violation|0|||
143482804|NCT02025907|517313604|FG000|Overall Study|Physician Decision|2|||
143482805|NCT02025907|517313605|FG001|Overall Study|Physician Decision|0|||
143482806|NCT02025907|517313604|FG000|Overall Study|Lost to Follow-up|2|||
143482807|NCT02025907|517313605|FG001|Overall Study|Lost to Follow-up|2|||
143482808|NCT02025907|517313604|FG000|Overall Study|Adverse Event|3|||
143482809|NCT02025907|517313605|FG001|Overall Study|Adverse Event|1|||
143482810|NCT02025907|517313604|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
143482811|NCT02025907|517313605|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
143482812|NCT02411539|517313609|FG000|Overall Study|Lost to Follow-up|2|||
143482813|NCT02411539|517313610|FG001|Overall Study|Lost to Follow-up|0|||
143482814|NCT02411539|517313609|FG000|Overall Study|Confounding medical condition|0|||
143482815|NCT02411539|517313610|FG001|Overall Study|Confounding medical condition|1|||
143482816|NCT03631732|517313618|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
143482817|NCT03631732|517313619|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
143482818|NCT03631732|517313618|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
143482819|NCT03631732|517313619|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
143482820|NCT03631732|517313618|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
143482821|NCT03631732|517313619|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
143482822|NCT03631732|517313618|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
143482823|NCT03631732|517313619|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
143482824|NCT03631732|517313618|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
143482825|NCT03631732|517313619|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
143482826|NCT03631732|517313618|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
143482827|NCT03631732|517313619|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
143482828|NCT03631732|517313618|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
143482829|NCT03631732|517313619|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
143482830|NCT03631732|517313618|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
143482831|NCT03631732|517313619|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
143482832|NCT03631732|517313618|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
143482833|NCT03631732|517313619|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
143482834|NCT03631732|517313618|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
143482835|NCT03631732|517313619|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
143482836|NCT00886600|517313620|FG000|Double-blind Monotherapy|Adverse Event|1|||
143482837|NCT00886600|517313621|FG001|Double-blind Monotherapy|Adverse Event|1|||
143482838|NCT00886600|517313622|FG002|Double-blind Monotherapy|Adverse Event|1|||
143482839|NCT00886600|517313623|FG003|Double-blind Monotherapy|Adverse Event|1|||
143482840|NCT00886600|517313620|FG000|Double-blind Monotherapy|Protocol Violation|0|||
143482841|NCT00886600|517313621|FG001|Double-blind Monotherapy|Protocol Violation|0|||
143482842|NCT00886600|517313622|FG002|Double-blind Monotherapy|Protocol Violation|0|||
143482843|NCT00886600|517313623|FG003|Double-blind Monotherapy|Protocol Violation|1|||
143482844|NCT00886600|517313620|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
143482845|NCT00886600|517313621|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
143482846|NCT00886600|517313622|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
143482847|NCT00886600|517313623|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
143482848|NCT00886600|517313620|FG000|Combination Therapy Period|Adverse Event|0|||
143482849|NCT00886600|517313621|FG001|Combination Therapy Period|Adverse Event|0|||
143482850|NCT00886600|517313622|FG002|Combination Therapy Period|Adverse Event|1|||
143482851|NCT00886600|517313623|FG003|Combination Therapy Period|Adverse Event|0|||
143482852|NCT00886600|517313620|FG000|Combination Therapy Period|Protocol Violation|0|||
143482853|NCT00886600|517313621|FG001|Combination Therapy Period|Protocol Violation|0|||
143482854|NCT00886600|517313622|FG002|Combination Therapy Period|Protocol Violation|1|||
143482855|NCT00886600|517313623|FG003|Combination Therapy Period|Protocol Violation|0|||
143482856|NCT01251367|517313624|FG000|Overall Study|Protocol Violation|1|||
143482857|NCT01251367|517313624|FG000|Overall Study|Lack of Efficacy|2|||
143482858|NCT01251367|517313624|FG000|Overall Study|Adverse Event|19|||
143482859|NCT01251367|517313624|FG000|Overall Study|Withdrawal by Subject|36|||
143482860|NCT01251367|517313624|FG000|Overall Study|Lost to Follow-up|5|||
143482861|NCT01251367|517313624|FG000|Overall Study|Subject Required Alternative Treatment|7|||
143482862|NCT01251367|517313624|FG000|Overall Study|No Study Drug Available|1|||
143482863|NCT01251367|517313624|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
143482864|NCT01251367|517313624|FG000|Overall Study|End of Study Visit Performed in Error|1|||
143482865|NCT02016820|517313627|FG000|Overall Study|Lost to Follow-up|2|||
143482866|NCT02016820|517313628|FG001|Overall Study|Lost to Follow-up|4|||
143482867|NCT00473343|517313629|FG000|Overall Study|Adverse Event|9|||
143482868|NCT00473343|517313629|FG000|Overall Study|Lost to Follow-up|8|||
143482869|NCT00473343|517313629|FG000|Overall Study|Treatment failure|27|||
143482870|NCT00473343|517313629|FG000|Overall Study|Withdrew consent|3|||
143482871|NCT00473343|517313629|FG000|Overall Study|Other un-specified reason|3|||
143482872|NCT02370615|517313630|FG000|Overall Study|Adverse Event|1|||
143148265|NCT01697579|516087695|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
143148266|NCT01697579|516087696|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
143148267|NCT01697579|516087697|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
143148268|NCT01697579|516087698|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
143148269|NCT01697579|516087699|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
143148270|NCT01697579|516087693|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
143148271|NCT01697579|516087694|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
143148272|NCT01697579|516087695|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
143148273|NCT01697579|516087696|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
143148274|NCT01697579|516087697|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
143148275|NCT01697579|516087698|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
143148276|NCT01697579|516087699|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
143148277|NCT01697579|516087693|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
143148278|NCT01697579|516087694|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
143148279|NCT01697579|516087695|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
143148280|NCT01697579|516087696|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
143148281|NCT01697579|516087697|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
143014866|NCT01408576|515595554|FG001|Overall Study|Other|16|||
143014867|NCT01408576|515595555|FG002|Overall Study|Other|18|||
143014868|NCT00802529|515595556|FG000|Overall Study|Lost to Follow-up|0|||
143014869|NCT00802529|515595557|FG001|Overall Study|Lost to Follow-up|1|||
143014870|NCT02703454|515595561|FG000|Overall Study|Not treated|1|||
143014871|NCT02703454|515595562|FG001|Overall Study|Not treated|3|||
143014872|NCT02703454|515595561|FG000|Overall Study|Withdrawal by Subject|4|||
143014873|NCT02703454|515595562|FG001|Overall Study|Withdrawal by Subject|3|||
143014874|NCT02703454|515595561|FG000|Overall Study|Lost to Follow-up|1|||
143014875|NCT02703454|515595562|FG001|Overall Study|Lost to Follow-up|2|||
143014876|NCT02703454|515595561|FG000|Overall Study|Study discontinuation|5|||
143014877|NCT02703454|515595562|FG001|Overall Study|Study discontinuation|8|||
143014878|NCT02284373|515595563|FG000|Overall Study|Withdrawal by Subject|0|||
143014879|NCT02284373|515595564|FG001|Overall Study|Withdrawal by Subject|1|||
143014880|NCT02284373|515595565|FG002|Overall Study|Withdrawal by Subject|0|||
143014881|NCT02284373|515595563|FG000|Overall Study|Other|0|||
143014882|NCT02284373|515595564|FG001|Overall Study|Other|1|||
143014883|NCT02284373|515595565|FG002|Overall Study|Other|0|||
143014884|NCT02284373|515595563|FG000|Overall Study|Lost to Follow-up|0|||
143014885|NCT02284373|515595564|FG001|Overall Study|Lost to Follow-up|1|||
143014886|NCT02284373|515595565|FG002|Overall Study|Lost to Follow-up|0|||
143014887|NCT02016755|515595567|FG000|Overall Study|Major amputation of index limb|2|||
143014888|NCT02016755|515595567|FG000|Overall Study|Adverse Event|2|||
143014889|NCT02016755|515595567|FG000|Overall Study|Physician Decision|1|||
143014890|NCT02016755|515595567|FG000|Overall Study|Death|2|||
143014891|NCT02499406|515595569|FG000|Overall Study|missed 3 treatment sessions|4|||
143014892|NCT00552617|515595573|FG000|Overall Study|Not Treated|0|||
143014893|NCT00552617|515595574|FG001|Overall Study|Not Treated|0|||
143014894|NCT00552617|515595575|FG002|Overall Study|Not Treated|1|||
143014895|NCT00552617|515595576|FG003|Overall Study|Not Treated|0|||
143014896|NCT00552617|515595577|FG004|Overall Study|Not Treated|0|||
143014897|NCT00552617|515595578|FG005|Overall Study|Not Treated|0|||
143014898|NCT00552617|515595579|FG006|Overall Study|Not Treated|0|||
143014899|NCT00552617|515595580|FG007|Overall Study|Not Treated|0|||
143014900|NCT00552617|515595581|FG008|Overall Study|Not Treated|0|||
143014901|NCT00552617|515595582|FG009|Overall Study|Not Treated|1|||
143014902|NCT00552617|515595573|FG000|Overall Study|Lost to Follow-up|0|||
143014903|NCT00552617|515595574|FG001|Overall Study|Lost to Follow-up|0|||
143148282|NCT01697579|516087698|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
143148283|NCT01697579|516087699|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
143148284|NCT01697579|516087693|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
143148285|NCT01697579|516087694|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
143148286|NCT01697579|516087695|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
143148287|NCT01697579|516087696|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
143148288|NCT01697579|516087697|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
143482873|NCT02370615|517313631|FG001|Overall Study|Adverse Event|0|||
143482874|NCT01378104|517313632|FG000|Overall Study|Adverse Event|8|||
143014904|NCT00552617|515595575|FG002|Overall Study|Lost to Follow-up|0|||
143014905|NCT00552617|515595576|FG003|Overall Study|Lost to Follow-up|1|||
143014906|NCT00552617|515595577|FG004|Overall Study|Lost to Follow-up|0|||
143014907|NCT00552617|515595578|FG005|Overall Study|Lost to Follow-up|2|||
143014908|NCT00552617|515595579|FG006|Overall Study|Lost to Follow-up|0|||
143014909|NCT00552617|515595580|FG007|Overall Study|Lost to Follow-up|0|||
143014910|NCT00552617|515595581|FG008|Overall Study|Lost to Follow-up|2|||
143014911|NCT00552617|515595582|FG009|Overall Study|Lost to Follow-up|0|||
143014912|NCT04651218|515595583|FG000|Overall Study|Withdrawal by Subject|0|||
143014913|NCT04651218|515595584|FG001|Overall Study|Withdrawal by Subject|2|||
143148289|NCT01697579|516087698|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
143482875|NCT01378104|517313633|FG001|Overall Study|Adverse Event|8|||
143014914|NCT01399125|515595594|FG000|Overall Study|Adverse Event|32|||
143482876|NCT01378104|517313632|FG000|Overall Study|Lack of Efficacy|7|||
143482877|NCT01378104|517313633|FG001|Overall Study|Lack of Efficacy|5|||
143482878|NCT01378104|517313632|FG000|Overall Study|Withdrawal by Subject|12|||
143482879|NCT01378104|517313633|FG001|Overall Study|Withdrawal by Subject|13|||
143482880|NCT00455013|517313635|FG000|Short Term Period|Adverse Event|2|||
143482881|NCT00455013|517313636|FG001|Short Term Period|Adverse Event|5|||
143482882|NCT00455013|517313637|FG002|Short Term Period|Adverse Event|0|||
143482883|NCT00455013|517313635|FG000|Short Term Period|Withdrawal by Subject|0|||
143482884|NCT00455013|517313636|FG001|Short Term Period|Withdrawal by Subject|0|||
143482885|NCT00455013|517313637|FG002|Short Term Period|Withdrawal by Subject|1|||
143482886|NCT00455013|517313635|FG000|Short Term Period|Lack of Efficacy|4|||
143482887|NCT00455013|517313636|FG001|Short Term Period|Lack of Efficacy|0|||
143482888|NCT00455013|517313637|FG002|Short Term Period|Lack of Efficacy|0|||
143482889|NCT00455013|517313635|FG000|Short Term Period|Other|0|||
143482890|NCT00455013|517313636|FG001|Short Term Period|Other|0|||
143482891|NCT00455013|517313637|FG002|Short Term Period|Other|1|||
143482892|NCT00455013|517313635|FG000|Long Term Extension (LTE)|Adverse Event|0|||
143482893|NCT00455013|517313636|FG001|Long Term Extension (LTE)|Adverse Event|1|||
143482894|NCT00455013|517313637|FG002|Long Term Extension (LTE)|Adverse Event|1|||
143482895|NCT00455013|517313635|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
143482896|NCT00455013|517313636|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
143482897|NCT00455013|517313637|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
143482898|NCT00455013|517313635|FG000|Long Term Extension (LTE)|Death|1|||
143482899|NCT00455013|517313636|FG001|Long Term Extension (LTE)|Death|1|||
143482900|NCT00455013|517313637|FG002|Long Term Extension (LTE)|Death|0|||
143482901|NCT00455013|517313635|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
143482902|NCT00455013|517313636|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
143482903|NCT00455013|517313637|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
143482904|NCT00455013|517313635|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
143482905|NCT00455013|517313636|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
143482906|NCT00455013|517313637|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
143482907|NCT00455013|517313635|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
143482908|NCT00455013|517313636|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
143482909|NCT00455013|517313637|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
143482910|NCT00455013|517313635|FG000|Long Term Extension (LTE)|non-specified|0|||
143482911|NCT00455013|517313636|FG001|Long Term Extension (LTE)|non-specified|0|||
143482912|NCT00455013|517313637|FG002|Long Term Extension (LTE)|non-specified|1|||
143148290|NCT01697579|516087699|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
143148291|NCT01697579|516087693|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
143148292|NCT01697579|516087694|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
143148293|NCT01697579|516087695|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
143148294|NCT01697579|516087696|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
143148295|NCT01697579|516087697|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
143148296|NCT01697579|516087698|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
143148297|NCT01697579|516087699|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
143148298|NCT01697579|516087693|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
143482913|NCT01445951|517313638|FG000|Overall Study|Adverse Event|16|||
143482914|NCT01445951|517313639|FG001|Overall Study|Adverse Event|9|||
143482915|NCT01445951|517313640|FG002|Overall Study|Adverse Event|0|||
143482916|NCT01445951|517313638|FG000|Overall Study|Protocol Violation|2|||
143482917|NCT01445951|517313639|FG001|Overall Study|Protocol Violation|2|||
143482918|NCT01445951|517313640|FG002|Overall Study|Protocol Violation|2|||
143482919|NCT01445951|517313638|FG000|Overall Study|Withdrawal by Subject|21|||
143482920|NCT01445951|517313639|FG001|Overall Study|Withdrawal by Subject|16|||
143482921|NCT01445951|517313640|FG002|Overall Study|Withdrawal by Subject|8|||
143482922|NCT01445951|517313638|FG000|Overall Study|Physician Decision|3|||
143482923|NCT01445951|517313639|FG001|Overall Study|Physician Decision|1|||
143482924|NCT01445951|517313640|FG002|Overall Study|Physician Decision|0|||
143482925|NCT01445951|517313638|FG000|Overall Study|Lost to Follow-up|1|||
143482926|NCT01445951|517313639|FG001|Overall Study|Lost to Follow-up|2|||
143148299|NCT01697579|516087694|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
143148300|NCT01697579|516087695|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
143148301|NCT01697579|516087696|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
143148302|NCT01697579|516087697|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
143148303|NCT01697579|516087698|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
143148304|NCT01697579|516087699|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
143148305|NCT01697579|516087693|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
143181200|NCT03654274|516210494|FG001|Overall Study|Withdrawal by Subject|25|||
143482927|NCT01445951|517313640|FG002|Overall Study|Lost to Follow-up|4|||
143482928|NCT01445951|517313638|FG000|Overall Study|Pregnancy|0|||
143482929|NCT01445951|517313639|FG001|Overall Study|Pregnancy|1|||
143482930|NCT01445951|517313640|FG002|Overall Study|Pregnancy|4|||
143482931|NCT01445951|517313638|FG000|Overall Study|Death|0|||
143014915|NCT01399125|515595595|FG001|Overall Study|Adverse Event|30|||
143014916|NCT01399125|515595594|FG000|Overall Study|Abnormal Lab values|0|||
143014917|NCT01399125|515595595|FG001|Overall Study|Abnormal Lab values|1|||
143014918|NCT01399125|515595594|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
143014919|NCT01399125|515595595|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
143014920|NCT01399125|515595594|FG000|Overall Study|Withdrawal by Subject|5|||
143014921|NCT01399125|515595595|FG001|Overall Study|Withdrawal by Subject|8|||
143014922|NCT01399125|515595594|FG000|Overall Study|Lost to Follow-up|2|||
143014923|NCT01399125|515595595|FG001|Overall Study|Lost to Follow-up|3|||
143014924|NCT01399125|515595594|FG000|Overall Study|Administrative Problems|7|||
143014925|NCT01399125|515595595|FG001|Overall Study|Administrative Problems|11|||
143014926|NCT01399125|515595594|FG000|Overall Study|Death|0|||
143014927|NCT01399125|515595595|FG001|Overall Study|Death|1|||
143148306|NCT01697579|516087694|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
143148307|NCT01697579|516087695|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
143148308|NCT01697579|516087696|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
143148309|NCT01697579|516087697|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
143148310|NCT01697579|516087698|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
143148311|NCT01697579|516087699|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
143148312|NCT01697579|516087693|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
143148313|NCT01697579|516087694|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
143148314|NCT01697579|516087695|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
143148315|NCT01697579|516087696|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
143148316|NCT01697579|516087697|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
143148317|NCT01697579|516087698|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
143148318|NCT01697579|516087699|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
143148319|NCT01697579|516087693|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
143148320|NCT01697579|516087694|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
143148321|NCT01697579|516087695|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
143148322|NCT01697579|516087696|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
143148323|NCT01697579|516087697|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
143148324|NCT01697579|516087698|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
143148325|NCT01697579|516087699|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
143148326|NCT01697579|516087693|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
143148327|NCT01697579|516087694|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
143482932|NCT01445951|517313639|FG001|Overall Study|Death|0|||
143482933|NCT01445951|517313640|FG002|Overall Study|Death|1|||
143482934|NCT01445951|517313638|FG000|Overall Study|Non-compliance with study drug|1|||
143014928|NCT01399125|515595594|FG000|Overall Study|Protocol Deviation|5|||
143014929|NCT01399125|515595595|FG001|Overall Study|Protocol Deviation|2|||
143014930|NCT00647426|515595596|FG000|Overall Study|Withdrawal by Subject|2|||
143014931|NCT00563524|515595597|FG000|Overall Study|Adverse Event|0|||
143014932|NCT00563524|515595598|FG001|Overall Study|Adverse Event|1|||
143014933|NCT00563524|515595599|FG002|Overall Study|Adverse Event|0|||
143014934|NCT00563524|515595600|FG003|Overall Study|Adverse Event|0|||
143014935|NCT00563524|515595601|FG004|Overall Study|Adverse Event|2|||
143014936|NCT00563524|515595602|FG005|Overall Study|Adverse Event|0|||
143014937|NCT00563524|515595597|FG000|Overall Study|Lost to Follow-up|1|||
143014938|NCT00563524|515595598|FG001|Overall Study|Lost to Follow-up|0|||
143014939|NCT00563524|515595599|FG002|Overall Study|Lost to Follow-up|0|||
143014940|NCT00563524|515595600|FG003|Overall Study|Lost to Follow-up|0|||
143014941|NCT00563524|515595601|FG004|Overall Study|Lost to Follow-up|0|||
143014942|NCT00563524|515595602|FG005|Overall Study|Lost to Follow-up|0|||
143014943|NCT00563524|515595597|FG000|Overall Study|Protocol Violation|0|||
143014944|NCT00563524|515595598|FG001|Overall Study|Protocol Violation|1|||
143014945|NCT00563524|515595599|FG002|Overall Study|Protocol Violation|0|||
143014946|NCT00563524|515595600|FG003|Overall Study|Protocol Violation|0|||
143014947|NCT00563524|515595601|FG004|Overall Study|Protocol Violation|0|||
143014948|NCT00563524|515595602|FG005|Overall Study|Protocol Violation|0|||
143014949|NCT00563524|515595597|FG000|Overall Study|Withdrawal by Subject|1|||
143014950|NCT00563524|515595598|FG001|Overall Study|Withdrawal by Subject|1|||
143014951|NCT00563524|515595599|FG002|Overall Study|Withdrawal by Subject|3|||
143014952|NCT00563524|515595600|FG003|Overall Study|Withdrawal by Subject|0|||
143014953|NCT00563524|515595601|FG004|Overall Study|Withdrawal by Subject|0|||
143014954|NCT00563524|515595602|FG005|Overall Study|Withdrawal by Subject|1|||
143014955|NCT02766088|515595606|FG000|Overall Study|Sponsor study termination|498|||
143014956|NCT02766088|515595606|FG000|Overall Study|Migrated/moved from the study area|1|||
143014957|NCT02766088|515595606|FG000|Overall Study|Lost to Follow-up|5|||
143014958|NCT02766088|515595606|FG000|Overall Study|Other|1|||
143014959|NCT02766088|515595606|FG000|Overall Study|Death|1|||
143014960|NCT01222715|515595607|FG000|Overall Study|Adverse Event|0|||
143014961|NCT01222715|515595608|FG001|Overall Study|Adverse Event|4|||
143014962|NCT01222715|515595607|FG000|Overall Study|Death|0|||
143014963|NCT01222715|515595608|FG001|Overall Study|Death|1|||
143482935|NCT01445951|517313639|FG001|Overall Study|Non-compliance with study drug|2|||
143482936|NCT01445951|517313640|FG002|Overall Study|Non-compliance with study drug|0|||
143482937|NCT01445951|517313638|FG000|Overall Study|Non-compliance with protocol|0|||
143482938|NCT01445951|517313639|FG001|Overall Study|Non-compliance with protocol|1|||
143482939|NCT01445951|517313640|FG002|Overall Study|Non-compliance with protocol|0|||
143482940|NCT01445951|517313638|FG000|Overall Study|Sponsor decision - subject travel|0|||
143482941|NCT01445951|517313639|FG001|Overall Study|Sponsor decision - subject travel|1|||
143482942|NCT01445951|517313640|FG002|Overall Study|Sponsor decision - subject travel|0|||
143482943|NCT01445951|517313638|FG000|Overall Study|Cough|0|||
143482944|NCT01445951|517313639|FG001|Overall Study|Cough|1|||
143482945|NCT01445951|517313640|FG002|Overall Study|Cough|0|||
143482946|NCT01473563|517313643|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
143482947|NCT01519765|517313644|FG000|Overall Study|Adverse Event|0|||
143482948|NCT01519765|517313645|FG001|Overall Study|Adverse Event|1|||
143482949|NCT01519765|517313644|FG000|Overall Study|Lack of Efficacy|2|||
143482950|NCT01519765|517313645|FG001|Overall Study|Lack of Efficacy|0|||
143482951|NCT01519765|517313644|FG000|Overall Study|Protocol Violation|1|||
143482952|NCT01519765|517313645|FG001|Overall Study|Protocol Violation|0|||
143482953|NCT01519765|517313644|FG000|Overall Study|Withdrawal by Subject|0|||
143482954|NCT01519765|517313645|FG001|Overall Study|Withdrawal by Subject|1|||
143482955|NCT03610724|517313646|FG000|Overall Study|Death|17|||
143482956|NCT03610724|517313646|FG000|Overall Study|Lost to Follow-up|1|||
143482957|NCT03610724|517313646|FG000|Overall Study|Physician Decision|1|||
143482958|NCT03610724|517313646|FG000|Overall Study|Died prior to infusion|1|||
143482959|NCT02354222|517313647|FG000|Overall Study|Adverse Event|0|||
143482960|NCT02354222|517313648|FG001|Overall Study|Adverse Event|3|||
143482961|NCT02354222|517313647|FG000|Overall Study|Physician Decision|1|||
143482962|NCT02354222|517313648|FG001|Overall Study|Physician Decision|1|||
143482963|NCT02354222|517313647|FG000|Overall Study|Pregnancy|1|||
143482964|NCT02354222|517313648|FG001|Overall Study|Pregnancy|0|||
143482965|NCT02354222|517313647|FG000|Overall Study|Withdrawal by Subject|2|||
143482966|NCT02354222|517313648|FG001|Overall Study|Withdrawal by Subject|3|||
143482967|NCT02354222|517313647|FG000|Overall Study|Conflict with the stopping criteria|0|||
143482968|NCT02354222|517313648|FG001|Overall Study|Conflict with the stopping criteria|4|||
143482969|NCT02739620|517313649|FG000|Overall Study|Lost to Follow-up|3|||
143482970|NCT02739620|517313650|FG001|Overall Study|Lost to Follow-up|1|||
143482971|NCT02739620|517313649|FG000|Overall Study|Adverse Event|0|||
143482972|NCT02739620|517313650|FG001|Overall Study|Adverse Event|1|||
143482973|NCT00786565|517313651|FG000|Enrollment Prior to Surgery|Site Closed|3|||
143482974|NCT00786565|517313651|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
143482975|NCT00786565|517313651|FG000|Post Surgery|Abnormal macular pucker|1|||
143482976|NCT00786565|517313651|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
143482977|NCT00754793|517313655|FG000|Overall Study|voluntary withdrawn from study|0|||
143482978|NCT00754793|517313656|FG001|Overall Study|voluntary withdrawn from study|1|||
143482979|NCT02437864|517313660|FG000|Overall Study|Protocol Violation|4|||
143482980|NCT02437864|517313661|FG001|Overall Study|Protocol Violation|0|||
143148328|NCT01697579|516087695|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
143148329|NCT01697579|516087696|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
143148330|NCT01697579|516087697|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
143148331|NCT01697579|516087698|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
143148332|NCT01697579|516087699|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
143148333|NCT01697579|516087693|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
143148334|NCT01697579|516087694|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
143148335|NCT01697579|516087695|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
143148336|NCT01697579|516087696|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
143148337|NCT01697579|516087697|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
143148338|NCT01697579|516087698|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
143148339|NCT01697579|516087699|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
143148340|NCT01697579|516087693|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
143363625|NCT00062868|516873800|FG020|Dose Level 2|Death|0|||
143482981|NCT01924182|517313662|FG000|Overall Study|Withdrawal by Subject|1|||
143482982|NCT01924182|517313663|FG001|Overall Study|Withdrawal by Subject|0|||
143482983|NCT00645593|517313664|FG000|Overall Study|Later found to be ineligible|1|||
143482984|NCT00645593|517313665|FG001|Overall Study|Later found to be ineligible|0|||
143482985|NCT02577146|517313666|FG000|Overall Study|Lost to Follow-up|8|||
143482986|NCT02577146|517313666|FG000|Overall Study|Physician Decision|3|||
143482987|NCT02577146|517313666|FG000|Overall Study|Screen Failure|17|||
143482988|NCT03765138|517313667|FG000|Overall Study|Lost to Follow-up|1|||
143482989|NCT00361270|517313668|FG000|Overall Study|Death|0|||
143482990|NCT00361270|517313669|FG001|Overall Study|Death|0|||
143482991|NCT00361270|517313670|FG002|Overall Study|Death|0|||
143482992|NCT00361270|517313671|FG003|Overall Study|Death|2|||
143482993|NCT00361270|517313668|FG000|Overall Study|Lost to Follow-up|4|||
143482994|NCT00361270|517313669|FG001|Overall Study|Lost to Follow-up|1|||
143482995|NCT00361270|517313670|FG002|Overall Study|Lost to Follow-up|0|||
143482996|NCT00361270|517313671|FG003|Overall Study|Lost to Follow-up|0|||
143482997|NCT00361270|517313668|FG000|Overall Study|Physician Decision|0|||
143482998|NCT00361270|517313669|FG001|Overall Study|Physician Decision|0|||
143482999|NCT00361270|517313670|FG002|Overall Study|Physician Decision|1|||
143483000|NCT00361270|517313671|FG003|Overall Study|Physician Decision|0|||
143483001|NCT00361270|517313668|FG000|Overall Study|Protocol Violation|9|||
143483002|NCT00361270|517313669|FG001|Overall Study|Protocol Violation|4|||
143483003|NCT00361270|517313670|FG002|Overall Study|Protocol Violation|5|||
143483004|NCT00361270|517313671|FG003|Overall Study|Protocol Violation|4|||
143483005|NCT00361270|517313668|FG000|Overall Study|Withdrawal by Subject|6|||
143483006|NCT00361270|517313669|FG001|Overall Study|Withdrawal by Subject|6|||
143483007|NCT00361270|517313670|FG002|Overall Study|Withdrawal by Subject|3|||
143483008|NCT00361270|517313671|FG003|Overall Study|Withdrawal by Subject|7|||
143483009|NCT00361270|517313668|FG000|Overall Study|Afraid of Hypnosis|1|||
143483010|NCT00361270|517313669|FG001|Overall Study|Afraid of Hypnosis|2|||
143483011|NCT00361270|517313670|FG002|Overall Study|Afraid of Hypnosis|0|||
143483012|NCT00361270|517313671|FG003|Overall Study|Afraid of Hypnosis|0|||
143483013|NCT00361270|517313668|FG000|Overall Study|Problems with Transportation|4|||
143483014|NCT00361270|517313669|FG001|Overall Study|Problems with Transportation|0|||
143483015|NCT00361270|517313670|FG002|Overall Study|Problems with Transportation|0|||
143483016|NCT00361270|517313671|FG003|Overall Study|Problems with Transportation|0|||
143483017|NCT00361270|517313668|FG000|Overall Study|Adverse Event|0|||
143483018|NCT00361270|517313669|FG001|Overall Study|Adverse Event|1|||
143483019|NCT00361270|517313670|FG002|Overall Study|Adverse Event|1|||
143483020|NCT00361270|517313671|FG003|Overall Study|Adverse Event|0|||
143483021|NCT03116698|517313675|FG000|Overall Study|Adverse Event|1|||
143483022|NCT03116698|517313676|FG001|Overall Study|Adverse Event|1|||
143483023|NCT03116698|517313677|FG002|Overall Study|Adverse Event|1|||
143483024|NCT03116698|517313678|FG003|Overall Study|Adverse Event|0|||
143483025|NCT03116698|517313675|FG000|Overall Study|Withdrawal by Subject|1|||
143483026|NCT03116698|517313676|FG001|Overall Study|Withdrawal by Subject|4|||
143483027|NCT03116698|517313677|FG002|Overall Study|Withdrawal by Subject|5|||
143483028|NCT03116698|517313678|FG003|Overall Study|Withdrawal by Subject|2|||
143483029|NCT03116698|517313675|FG000|Overall Study|Lost to Follow-up|2|||
143483030|NCT03116698|517313676|FG001|Overall Study|Lost to Follow-up|0|||
143483031|NCT03116698|517313677|FG002|Overall Study|Lost to Follow-up|0|||
143483032|NCT03116698|517313678|FG003|Overall Study|Lost to Follow-up|0|||
143483033|NCT03116698|517313675|FG000|Overall Study|Physician Decision|1|||
143483034|NCT03116698|517313676|FG001|Overall Study|Physician Decision|1|||
143483035|NCT03116698|517313677|FG002|Overall Study|Physician Decision|0|||
143483036|NCT03116698|517313678|FG003|Overall Study|Physician Decision|0|||
143483037|NCT03116698|517313675|FG000|Overall Study|Protocol Violation|1|||
143483038|NCT03116698|517313676|FG001|Overall Study|Protocol Violation|0|||
143483039|NCT03116698|517313677|FG002|Overall Study|Protocol Violation|0|||
143483040|NCT03116698|517313678|FG003|Overall Study|Protocol Violation|0|||
143483041|NCT03116698|517313675|FG000|Overall Study|Death|0|||
143483042|NCT03116698|517313676|FG001|Overall Study|Death|0|||
143483043|NCT03116698|517313677|FG002|Overall Study|Death|2|||
143483044|NCT03116698|517313678|FG003|Overall Study|Death|0|||
143483045|NCT00788372|517313679|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
143483046|NCT00788372|517313679|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
143483047|NCT00788372|517313679|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
143483048|NCT00788372|517313679|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
143483049|NCT00788372|517313679|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
143483050|NCT00788372|517313679|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
143483051|NCT00788372|517313679|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
143483052|NCT02258451|517313680|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
143483053|NCT02258451|517313681|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
143483054|NCT02258451|517313680|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
143483055|NCT02258451|517313681|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
143483056|NCT02258451|517313680|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
143483057|NCT02258451|517313681|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
143483058|NCT02258451|517313680|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
143483059|NCT02258451|517313681|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
143483060|NCT02258451|517313680|FG000|Overall Study|Discontinuation all treatment due to death|4|||
143483061|NCT02258451|517313681|FG001|Overall Study|Discontinuation all treatment due to death|3|||
143483062|NCT02258451|517313680|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
143483063|NCT02258451|517313681|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
143483064|NCT02258451|517313680|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
143483065|NCT02258451|517313681|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
143483066|NCT02258451|517313680|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
143483067|NCT02258451|517313681|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
143483068|NCT02258451|517313680|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
143483069|NCT02258451|517313681|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
143483070|NCT02258451|517313680|FG000|Overall Study|Other reason|1|||
143483071|NCT02258451|517313681|FG001|Overall Study|Other reason|1|||
143483072|NCT02258451|517313680|FG000|Overall Study|Never treated|2|||
143483073|NCT02258451|517313681|FG001|Overall Study|Never treated|3|||
143483074|NCT03099187|517313684|FG000|Double-blind Treatment|Adverse Event|19|||
143483075|NCT03099187|517313685|FG001|Double-blind Treatment|Adverse Event|1|||
143483076|NCT03099187|517313686|FG002|Double-blind Treatment|Adverse Event|0|||
143483077|NCT03099187|517313687|FG003|Double-blind Treatment|Adverse Event|0|||
143483078|NCT03099187|517313684|FG000|Double-blind Treatment|Death|1|||
143483079|NCT03099187|517313685|FG001|Double-blind Treatment|Death|3|||
143483080|NCT03099187|517313686|FG002|Double-blind Treatment|Death|0|||
143483081|NCT03099187|517313687|FG003|Double-blind Treatment|Death|0|||
143483082|NCT03099187|517313684|FG000|Double-blind Treatment|Lack of Efficacy|1|||
143483083|NCT03099187|517313685|FG001|Double-blind Treatment|Lack of Efficacy|0|||
143483084|NCT03099187|517313686|FG002|Double-blind Treatment|Lack of Efficacy|0|||
143483085|NCT03099187|517313687|FG003|Double-blind Treatment|Lack of Efficacy|0|||
143483086|NCT03099187|517313684|FG000|Double-blind Treatment|Physician Decision|2|||
143483087|NCT03099187|517313685|FG001|Double-blind Treatment|Physician Decision|1|||
143483088|NCT03099187|517313686|FG002|Double-blind Treatment|Physician Decision|0|||
143483089|NCT03099187|517313687|FG003|Double-blind Treatment|Physician Decision|0|||
143483090|NCT03099187|517313684|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
143483091|NCT03099187|517313685|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
143483092|NCT03099187|517313686|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
143483093|NCT03099187|517313687|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
143483094|NCT03099187|517313684|FG000|Double-blind Treatment|Lung transplantation|0|||
143483095|NCT03099187|517313685|FG001|Double-blind Treatment|Lung transplantation|1|||
143483096|NCT03099187|517313686|FG002|Double-blind Treatment|Lung transplantation|0|||
143483097|NCT03099187|517313687|FG003|Double-blind Treatment|Lung transplantation|0|||
143483098|NCT03099187|517313684|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
143483099|NCT03099187|517313685|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
143014964|NCT01222715|515595607|FG000|Overall Study|Lack of Efficacy|22|||
143148341|NCT01697579|516087694|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
143148342|NCT01697579|516087695|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
143148343|NCT01697579|516087696|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
143148344|NCT01697579|516087697|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
143148345|NCT01697579|516087698|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
143148346|NCT01697579|516087699|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
143148347|NCT03112603|516087703|FG000|End of Randomization Period|Lost to Follow-up|3|||
143148348|NCT03112603|516087704|FG001|End of Randomization Period|Lost to Follow-up|0|||
143148349|NCT03112603|516087705|FG002|End of Randomization Period|Lost to Follow-up|0|||
143148350|NCT03112603|516087703|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
143148351|NCT03112603|516087704|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
143148352|NCT03112603|516087705|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
143148353|NCT03112603|516087703|FG000|End of Randomization Period|Physician Decision|43|||
143148354|NCT03112603|516087704|FG001|End of Randomization Period|Physician Decision|18|||
143148355|NCT03112603|516087705|FG002|End of Randomization Period|Physician Decision|0|||
143148356|NCT03112603|516087703|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
143148357|NCT03112603|516087704|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
143148358|NCT03112603|516087705|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
143148359|NCT03112603|516087703|FG000|End of Randomization Period|Death|10|||
143148360|NCT03112603|516087704|FG001|End of Randomization Period|Death|7|||
143148361|NCT03112603|516087705|FG002|End of Randomization Period|Death|0|||
143148362|NCT03112603|516087703|FG000|End of Randomization Period|Disease Relapse|12|||
143148363|NCT03112603|516087704|FG001|End of Randomization Period|Disease Relapse|7|||
143148364|NCT03112603|516087705|FG002|End of Randomization Period|Disease Relapse|0|||
143148365|NCT03112603|516087703|FG000|End of Randomization Period|Lack of Efficacy|25|||
143148366|NCT03112603|516087704|FG001|End of Randomization Period|Lack of Efficacy|77|||
143148367|NCT03112603|516087705|FG002|End of Randomization Period|Lack of Efficacy|0|||
143148368|NCT03112603|516087703|FG000|End of Randomization Period|Adverse Event|32|||
143148369|NCT03112603|516087704|FG001|End of Randomization Period|Adverse Event|12|||
143483100|NCT03099187|517313686|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
143483101|NCT03099187|517313687|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
143483102|NCT03099187|517313684|FG000|Double-blind Treatment|Disease progression|0|||
143148370|NCT03112603|516087705|FG002|End of Randomization Period|Adverse Event|0|||
143483103|NCT03099187|517313685|FG001|Double-blind Treatment|Disease progression|1|||
143483104|NCT03099187|517313686|FG002|Double-blind Treatment|Disease progression|0|||
143014965|NCT01222715|515595608|FG001|Overall Study|Lack of Efficacy|14|||
143014966|NCT01222715|515595607|FG000|Overall Study|Physician Decision|12|||
143014967|NCT01222715|515595608|FG001|Overall Study|Physician Decision|2|||
143014968|NCT01222715|515595607|FG000|Overall Study|Refusal of further protocol therapy|0|||
143014969|NCT01222715|515595608|FG001|Overall Study|Refusal of further protocol therapy|4|||
143014970|NCT01222715|515595607|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
143014971|NCT01222715|515595608|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
143014972|NCT01222715|515595607|FG000|Overall Study|Ineligible|0|||
143014973|NCT01222715|515595608|FG001|Overall Study|Ineligible|1|||
143014974|NCT01222715|515595607|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
143014975|NCT01222715|515595608|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
143014976|NCT01392170|515595609|FG000|Overall Study|Withdrawal by Subject|1|||
143014977|NCT01392170|515595609|FG000|Overall Study|Ineligible|1|||
143014978|NCT04333199|515595617|FG000|Evaluated Patients|Lost to Follow-up|0|||
143014979|NCT04333199|515595618|FG001|Evaluated Patients|Lost to Follow-up|1|||
143014980|NCT04333199|515595619|FG002|Evaluated Patients|Lost to Follow-up|2|||
143014981|NCT00854607|515595620|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
143014982|NCT00965263|515595628|FG000|Overall Study|Physician Decision|2|||
143014983|NCT00965263|515595629|FG001|Overall Study|Physician Decision|0|||
143014984|NCT00965263|515595628|FG000|Overall Study|Family emergency|0|||
143483105|NCT03099187|517313687|FG003|Double-blind Treatment|Disease progression|0|||
143014985|NCT00965263|515595629|FG001|Overall Study|Family emergency|1|||
143483106|NCT03099187|517313684|FG000|Double-blind Treatment|Randomization error|0|||
143483107|NCT03099187|517313685|FG001|Double-blind Treatment|Randomization error|2|||
143483108|NCT03099187|517313686|FG002|Double-blind Treatment|Randomization error|0|||
143483109|NCT03099187|517313687|FG003|Double-blind Treatment|Randomization error|0|||
143483110|NCT03099187|517313684|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
143483111|NCT03099187|517313685|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
143483112|NCT03099187|517313686|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
143483113|NCT03099187|517313687|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
143483114|NCT03099187|517313684|FG000|12-month Safety Follow-up|Adverse Event|0|||
143483115|NCT03099187|517313685|FG001|12-month Safety Follow-up|Adverse Event|0|||
143483116|NCT03099187|517313686|FG002|12-month Safety Follow-up|Adverse Event|5|||
143483117|NCT03099187|517313687|FG003|12-month Safety Follow-up|Adverse Event|12|||
143483118|NCT03099187|517313684|FG000|12-month Safety Follow-up|Death|0|||
143483119|NCT03099187|517313685|FG001|12-month Safety Follow-up|Death|0|||
143483120|NCT03099187|517313686|FG002|12-month Safety Follow-up|Death|7|||
143483121|NCT03099187|517313687|FG003|12-month Safety Follow-up|Death|9|||
143483122|NCT03099187|517313684|FG000|12-month Safety Follow-up|Lung transplantation|0|||
143483123|NCT03099187|517313685|FG001|12-month Safety Follow-up|Lung transplantation|0|||
143483124|NCT03099187|517313686|FG002|12-month Safety Follow-up|Lung transplantation|2|||
143483125|NCT03099187|517313687|FG003|12-month Safety Follow-up|Lung transplantation|1|||
143483126|NCT03099187|517313684|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
143483127|NCT03099187|517313685|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
143483128|NCT03099187|517313686|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
143483129|NCT03099187|517313687|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
143483130|NCT03099187|517313684|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
143483131|NCT03099187|517313685|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
143483132|NCT03099187|517313686|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
143483133|NCT03099187|517313687|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
143483134|NCT03099187|517313684|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
143483135|NCT03099187|517313685|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
143483136|NCT03099187|517313686|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
143483137|NCT03099187|517313687|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
143483138|NCT03099187|517313684|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
143483139|NCT03099187|517313685|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
143483140|NCT03099187|517313686|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
143483141|NCT03099187|517313687|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
143483142|NCT01439555|517313692|FG000|Overall Study|Protocol Violation|1|||
143483143|NCT01246583|517313696|FG000|Overall Study|Lost to Follow-up|0|||
143014986|NCT00965263|515595628|FG000|Overall Study|Protocol Violation|0|||
143014987|NCT00965263|515595629|FG001|Overall Study|Protocol Violation|2|||
143014988|NCT01494649|515595637|FG000|Overall Study|Lost to Follow-up|0|||
143014989|NCT01494649|515595638|FG001|Overall Study|Lost to Follow-up|1|||
143014990|NCT03467971|515595639|FG000|Treatment Period 2|Withdrawal by Subject|0|||
143014991|NCT03467971|515595640|FG001|Treatment Period 2|Withdrawal by Subject|1|||
143014992|NCT01656967|515595641|FG000|Overall Study|faulty monitor|1|||
143148371|NCT03112603|516087703|FG000|End of Cross Over Period|Death|0|||
143483144|NCT01246583|517313697|FG001|Overall Study|Lost to Follow-up|0|||
143483145|NCT01246583|517313698|FG002|Overall Study|Lost to Follow-up|0|||
143483146|NCT01246583|517313699|FG003|Overall Study|Lost to Follow-up|1|||
143483147|NCT01246583|517313696|FG000|Overall Study|Protocol Violation|0|||
143483148|NCT01246583|517313697|FG001|Overall Study|Protocol Violation|0|||
143483149|NCT01246583|517313698|FG002|Overall Study|Protocol Violation|1|||
143483150|NCT01246583|517313699|FG003|Overall Study|Protocol Violation|0|||
143483151|NCT01246583|517313696|FG000|Overall Study|Withdrawal by Subject|1|||
143483152|NCT01246583|517313697|FG001|Overall Study|Withdrawal by Subject|0|||
143483153|NCT01246583|517313698|FG002|Overall Study|Withdrawal by Subject|0|||
143483154|NCT01246583|517313699|FG003|Overall Study|Withdrawal by Subject|0|||
143483155|NCT02116777|517313700|FG000|Overall Study|Adverse Event|0|||
143483156|NCT02116777|517313701|FG001|Overall Study|Adverse Event|0|||
143483157|NCT02116777|517313702|FG002|Overall Study|Adverse Event|0|||
143483158|NCT02116777|517313703|FG003|Overall Study|Adverse Event|0|||
143483159|NCT02116777|517313704|FG004|Overall Study|Adverse Event|2|||
143483160|NCT02116777|517313705|FG005|Overall Study|Adverse Event|2|||
143483161|NCT02116777|517313706|FG006|Overall Study|Adverse Event|0|||
143483162|NCT02116777|517313700|FG000|Overall Study|Death|0|||
143483163|NCT02116777|517313701|FG001|Overall Study|Death|0|||
143483164|NCT02116777|517313702|FG002|Overall Study|Death|0|||
143483165|NCT02116777|517313703|FG003|Overall Study|Death|1|||
143483166|NCT02116777|517313704|FG004|Overall Study|Death|0|||
143483167|NCT02116777|517313705|FG005|Overall Study|Death|0|||
143483168|NCT02116777|517313706|FG006|Overall Study|Death|0|||
143483169|NCT02116777|517313700|FG000|Overall Study|Lack of Efficacy|3|||
143014993|NCT01656967|515595642|FG001|Overall Study|faulty monitor|0|||
143014994|NCT01656967|515595641|FG000|Overall Study|unsuccessful ETT insertion|3|||
143014995|NCT01656967|515595642|FG001|Overall Study|unsuccessful ETT insertion|2|||
143014996|NCT01345058|515595643|FG000|Overall Study|Withdrawal by Subject|1|||
143014997|NCT01345058|515595644|FG001|Overall Study|Withdrawal by Subject|0|||
143014998|NCT01345058|515595643|FG000|Overall Study|Participant Reported Increase in Events|1|||
143014999|NCT01345058|515595644|FG001|Overall Study|Participant Reported Increase in Events|0|||
143483170|NCT02116777|517313701|FG001|Overall Study|Lack of Efficacy|3|||
143483171|NCT02116777|517313702|FG002|Overall Study|Lack of Efficacy|3|||
143483172|NCT02116777|517313703|FG003|Overall Study|Lack of Efficacy|8|||
143015000|NCT01345058|515595643|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
143483173|NCT02116777|517313704|FG004|Overall Study|Lack of Efficacy|4|||
143483174|NCT02116777|517313705|FG005|Overall Study|Lack of Efficacy|1|||
143015001|NCT01345058|515595644|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
143015002|NCT01345058|515595643|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
143015003|NCT01345058|515595644|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
143015004|NCT01345058|515595643|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
143015005|NCT01345058|515595644|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
143483175|NCT02116777|517313706|FG006|Overall Study|Lack of Efficacy|9|||
143483176|NCT02116777|517313700|FG000|Overall Study|Physician Decision|0|||
143483177|NCT02116777|517313701|FG001|Overall Study|Physician Decision|0|||
143015006|NCT00000135|515595645|FG000|Overall Study|Death|27|||
143015007|NCT00000135|515595646|FG001|Overall Study|Death|14|||
143015008|NCT01311505|515595647|FG000|First Intervention Period|Protocol Violation|0|||
143015009|NCT01311505|515595648|FG001|First Intervention Period|Protocol Violation|1|||
143015010|NCT00567996|515595649|FG000|Overall Study|Adverse Event|18|||
143015011|NCT00567996|515595650|FG001|Overall Study|Adverse Event|16|||
143015012|NCT00567996|515595651|FG002|Overall Study|Adverse Event|13|||
143015013|NCT00567996|515595649|FG000|Overall Study|Protocol Deviation|9|||
143015014|NCT00567996|515595650|FG001|Overall Study|Protocol Deviation|11|||
143015015|NCT00567996|515595651|FG002|Overall Study|Protocol Deviation|13|||
143015016|NCT00567996|515595649|FG000|Overall Study|Withdrawal by Subject|8|||
143148372|NCT03112603|516087704|FG001|End of Cross Over Period|Death|0|||
143148373|NCT03112603|516087705|FG002|End of Cross Over Period|Death|2|||
143148374|NCT03112603|516087703|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
143148375|NCT03112603|516087704|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
143148376|NCT03112603|516087705|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
143483178|NCT02116777|517313702|FG002|Overall Study|Physician Decision|0|||
143483179|NCT02116777|517313703|FG003|Overall Study|Physician Decision|2|||
143148377|NCT03112603|516087703|FG000|End of Cross Over Period|Physician Decision|0|||
143483180|NCT02116777|517313704|FG004|Overall Study|Physician Decision|0|||
143483181|NCT02116777|517313705|FG005|Overall Study|Physician Decision|0|||
143015017|NCT00567996|515595650|FG001|Overall Study|Withdrawal by Subject|12|||
143015018|NCT00567996|515595651|FG002|Overall Study|Withdrawal by Subject|22|||
143015019|NCT00567996|515595649|FG000|Overall Study|Abnormal Lab value(s)|2|||
143015020|NCT00567996|515595650|FG001|Overall Study|Abnormal Lab value(s)|1|||
143148378|NCT03112603|516087704|FG001|End of Cross Over Period|Physician Decision|0|||
143148379|NCT03112603|516087705|FG002|End of Cross Over Period|Physician Decision|29|||
143483182|NCT02116777|517313706|FG006|Overall Study|Physician Decision|0|||
143483183|NCT02116777|517313700|FG000|Overall Study|Protocol Violation|0|||
143483184|NCT02116777|517313701|FG001|Overall Study|Protocol Violation|0|||
143483185|NCT02116777|517313702|FG002|Overall Study|Protocol Violation|0|||
143483186|NCT02116777|517313703|FG003|Overall Study|Protocol Violation|1|||
143483187|NCT02116777|517313704|FG004|Overall Study|Protocol Violation|0|||
143483188|NCT02116777|517313705|FG005|Overall Study|Protocol Violation|0|||
143015021|NCT00567996|515595651|FG002|Overall Study|Abnormal Lab value(s)|2|||
143148380|NCT03112603|516087703|FG000|End of Cross Over Period|Lack of Efficacy|0|||
143148381|NCT03112603|516087704|FG001|End of Cross Over Period|Lack of Efficacy|0|||
143148382|NCT03112603|516087705|FG002|End of Cross Over Period|Lack of Efficacy|8|||
143148383|NCT03112603|516087703|FG000|End of Cross Over Period|Adverse Event|0|||
143148384|NCT03112603|516087704|FG001|End of Cross Over Period|Adverse Event|0|||
143148385|NCT03112603|516087705|FG002|End of Cross Over Period|Adverse Event|6|||
143148386|NCT03112603|516087703|FG000|End of Cross Over Period|Disease Relapse|0|||
143148387|NCT03112603|516087704|FG001|End of Cross Over Period|Disease Relapse|0|||
143148388|NCT03112603|516087705|FG002|End of Cross Over Period|Disease Relapse|2|||
143148389|NCT00207740|516087706|FG000|Overall Study|Adverse Event|4|||
143148390|NCT00207740|516087707|FG001|Overall Study|Adverse Event|14|||
143148391|NCT00207740|516087708|FG002|Overall Study|Adverse Event|14|||
143148392|NCT00207740|516087709|FG003|Overall Study|Adverse Event|11|||
143148393|NCT00207740|516087706|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
143148394|NCT00207740|516087707|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
143148395|NCT00207740|516087708|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
143148396|NCT00207740|516087709|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
143148397|NCT00207740|516087706|FG000|Overall Study|Lost to Follow-up|0|||
143148398|NCT00207740|516087707|FG001|Overall Study|Lost to Follow-up|2|||
143148399|NCT00207740|516087708|FG002|Overall Study|Lost to Follow-up|1|||
143148400|NCT00207740|516087709|FG003|Overall Study|Lost to Follow-up|1|||
143148401|NCT00207740|516087706|FG000|Overall Study|Death|0|||
143148402|NCT00207740|516087707|FG001|Overall Study|Death|0|||
143483189|NCT02116777|517313706|FG006|Overall Study|Protocol Violation|0|||
143483190|NCT02116777|517313700|FG000|Overall Study|Withdrawal by Subject|0|||
143483191|NCT02116777|517313701|FG001|Overall Study|Withdrawal by Subject|0|||
143148403|NCT00207740|516087708|FG002|Overall Study|Death|0|||
143148404|NCT00207740|516087709|FG003|Overall Study|Death|1|||
143148405|NCT00207740|516087706|FG000|Overall Study|Sponsor Directive|22|||
143148406|NCT00207740|516087707|FG001|Overall Study|Sponsor Directive|15|||
143148407|NCT00207740|516087708|FG002|Overall Study|Sponsor Directive|16|||
143148408|NCT00207740|516087709|FG003|Overall Study|Sponsor Directive|21|||
143148409|NCT00207740|516087706|FG000|Overall Study|Other|2|||
143148410|NCT00207740|516087707|FG001|Overall Study|Other|10|||
143148411|NCT00207740|516087708|FG002|Overall Study|Other|7|||
143148412|NCT00207740|516087709|FG003|Overall Study|Other|5|||
143148413|NCT03916926|516087711|FG000|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|51|||
143148414|NCT03916926|516087712|FG001|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|35|||
143148415|NCT03916926|516087711|FG000|26 Week Follow-Up Visit|Withdrawal by Subject|11|||
143148416|NCT03916926|516087712|FG001|26 Week Follow-Up Visit|Withdrawal by Subject|2|||
143148417|NCT03916926|516087711|FG000|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|22|||
143148418|NCT03916926|516087712|FG001|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|13|||
143148419|NCT03916926|516087711|FG000|52 Week Follow-Up Visit|Withdrawal by Subject|22|||
143148420|NCT03916926|516087712|FG001|52 Week Follow-Up Visit|Withdrawal by Subject|12|||
143148421|NCT04725188|516087713|FG000|Overall Study|Death|72|||
143148422|NCT04725188|516087714|FG001|Overall Study|Death|69|||
143148423|NCT04725188|516087715|FG002|Overall Study|Death|76|||
143148424|NCT04725188|516087713|FG000|Overall Study|Lost to Follow-up|1|||
143148425|NCT04725188|516087714|FG001|Overall Study|Lost to Follow-up|0|||
143148426|NCT04725188|516087715|FG002|Overall Study|Lost to Follow-up|1|||
143148427|NCT04725188|516087713|FG000|Overall Study|Withdrawal by Subject|2|||
143148428|NCT04725188|516087714|FG001|Overall Study|Withdrawal by Subject|2|||
143148429|NCT04725188|516087715|FG002|Overall Study|Withdrawal by Subject|1|||
143148430|NCT04725188|516087713|FG000|Overall Study|Sponsor Decision|12|||
143483192|NCT02116777|517313702|FG002|Overall Study|Withdrawal by Subject|0|||
143483193|NCT02116777|517313703|FG003|Overall Study|Withdrawal by Subject|1|||
143483194|NCT02116777|517313704|FG004|Overall Study|Withdrawal by Subject|0|||
143483195|NCT02116777|517313705|FG005|Overall Study|Withdrawal by Subject|0|||
143483196|NCT02116777|517313706|FG006|Overall Study|Withdrawal by Subject|0|||
143483197|NCT00490568|517315013|FG000|Overall Study|Adverse Event|116|||
143483198|NCT00490568|517315013|FG000|Overall Study|Lost to Follow-up|13|||
143483199|NCT00490568|517315013|FG000|Overall Study|Protocol Violation|45|||
143483200|NCT00490568|517315013|FG000|Overall Study|Withdrawal by Subject|135|||
143483201|NCT00490568|517315013|FG000|Overall Study|Still in the study at termination|974|||
143148431|NCT04725188|516087714|FG001|Overall Study|Sponsor Decision|12|||
143148432|NCT04725188|516087715|FG002|Overall Study|Sponsor Decision|7|||
143148433|NCT00975923|516087724|FG000|Overall Study|Withdrawal by Subject|0|||
143148434|NCT00975923|516087725|FG001|Overall Study|Withdrawal by Subject|1|||
143148435|NCT00876343|516087727|FG000|Overall Study|Adverse Event|7|||
143148436|NCT00876343|516087728|FG001|Overall Study|Adverse Event|8|||
143483202|NCT00490568|517315013|FG000|Overall Study|Other|1|||
143483203|NCT00490568|517315013|FG000|Overall Study|Exclusion criteria met|1|||
143148437|NCT00876343|516087729|FG002|Overall Study|Adverse Event|2|||
143148438|NCT00876343|516087727|FG000|Overall Study|Withdrawal by Subject|4|||
143148439|NCT00876343|516087728|FG001|Overall Study|Withdrawal by Subject|4|||
143148440|NCT00876343|516087729|FG002|Overall Study|Withdrawal by Subject|3|||
143148441|NCT00876343|516087727|FG000|Overall Study|Lack of Efficacy|0|||
143483204|NCT00490568|517315013|FG000|Overall Study|Caregiver related|20|||
143483205|NCT00490568|517315013|FG000|Overall Study|Abnormal ECG|25|||
143483206|NCT00490568|517315013|FG000|Overall Study|Participant refused follow-up|9|||
143483207|NCT00490568|517315013|FG000|Overall Study|Legal representative withdrew consent|1|||
143483208|NCT00490568|517315013|FG000|Overall Study|Disease progression|4|||
143483209|NCT00490568|517315013|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
143483210|NCT00490568|517315013|FG000|Overall Study|Investigator decision|3|||
143483211|NCT00490568|517315013|FG000|Overall Study|Non-Compliance|7|||
143483212|NCT00490568|517315013|FG000|Overall Study|Efficacy related|3|||
143483213|NCT00490568|517315013|FG000|Overall Study|Participant died|1|||
143483214|NCT00490568|517315013|FG000|Overall Study|Participant withdrawal due to surgery|1|||
143483215|NCT00105443|517315014|FG000|Double-Blind Treatment|Adverse Event|1|||
143483216|NCT00105443|517315015|FG001|Double-Blind Treatment|Adverse Event|0|||
143483217|NCT00105443|517315016|FG002|Double-Blind Treatment|Adverse Event|0|||
143483218|NCT00105443|517315017|FG003|Double-Blind Treatment|Adverse Event|0|||
143483219|NCT00105443|517315014|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
143483220|NCT00105443|517315015|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
143483221|NCT00105443|517315016|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
143483222|NCT00105443|517315017|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
143483223|NCT00105443|517315014|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
143483224|NCT00105443|517315015|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
143483225|NCT00105443|517315016|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
143483226|NCT00105443|517315017|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
143483227|NCT00105443|517315014|FG000|Double-Blind Treatment|Physician Decision|1|||
143483228|NCT00105443|517315015|FG001|Double-Blind Treatment|Physician Decision|0|||
143483229|NCT00105443|517315016|FG002|Double-Blind Treatment|Physician Decision|2|||
143483230|NCT00105443|517315017|FG003|Double-Blind Treatment|Physician Decision|0|||
143483231|NCT00105443|517315014|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
143483232|NCT00105443|517315015|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
143483233|NCT00105443|517315016|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
143483234|NCT00105443|517315017|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
143483235|NCT00105443|517315014|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
143483236|NCT00105443|517315015|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
143483237|NCT00105443|517315016|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
143483238|NCT00105443|517315017|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
143483239|NCT00105443|517315014|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
143483240|NCT00105443|517315015|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
143483241|NCT00105443|517315016|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
143483242|NCT00105443|517315017|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
143483243|NCT00105443|517315014|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
143483244|NCT00105443|517315015|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
143483245|NCT00105443|517315016|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
143483246|NCT00105443|517315017|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
143483247|NCT00105443|517315014|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
143483248|NCT00105443|517315015|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
143483249|NCT00105443|517315016|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
143483250|NCT00105443|517315017|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
143483251|NCT00105443|517315014|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
143483252|NCT00105443|517315015|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
143483253|NCT00105443|517315016|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
143483254|NCT00105443|517315017|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
143483255|NCT00105443|517315014|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
143483256|NCT00105443|517315015|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
143483257|NCT00105443|517315016|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
143483258|NCT00105443|517315017|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
143483259|NCT00105443|517315014|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
143483260|NCT00105443|517315015|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
143483261|NCT00105443|517315016|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
143483262|NCT00105443|517315017|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
143483263|NCT00105443|517315014|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
143483264|NCT00105443|517315015|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
143483265|NCT00105443|517315016|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
143483266|NCT00105443|517315017|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
143483267|NCT00105443|517315014|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
143483268|NCT00105443|517315015|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
143483269|NCT00105443|517315016|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
143483270|NCT00105443|517315017|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
143483271|NCT00105443|517315014|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
143483272|NCT00105443|517315015|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
143483273|NCT00105443|517315016|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
143483274|NCT00105443|517315017|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
143483275|NCT00105443|517315014|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
143483276|NCT00105443|517315015|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
143483277|NCT00105443|517315016|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
143483278|NCT00105443|517315017|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
143483279|NCT00105443|517315014|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
143483280|NCT00105443|517315015|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
143483281|NCT00105443|517315016|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
143483282|NCT00105443|517315017|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
143483283|NCT00105443|517315014|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
143483284|NCT00105443|517315015|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
143483285|NCT00105443|517315016|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
143483286|NCT00105443|517315017|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
143483287|NCT00105443|517315014|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
143483288|NCT00105443|517315015|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
143483289|NCT00105443|517315016|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
143483290|NCT00105443|517315017|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
143483291|NCT01157078|517315018|FG000|Overall Study|Withdrawal by Subject|12|||
143483292|NCT01157078|517315019|FG001|Overall Study|Withdrawal by Subject|14|||
143483293|NCT01157078|517315018|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
143483294|NCT01157078|517315019|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
143483295|NCT01157078|517315018|FG000|Overall Study|Adverse Event|6|||
143483296|NCT01157078|517315019|FG001|Overall Study|Adverse Event|6|||
143483297|NCT01157078|517315018|FG000|Overall Study|Severe non-compliance to protocol|2|||
143483298|NCT01157078|517315019|FG001|Overall Study|Severe non-compliance to protocol|4|||
143483299|NCT01157078|517315018|FG000|Overall Study|Condition under investigation worsened|0|||
143483300|NCT01157078|517315019|FG001|Overall Study|Condition under investigation worsened|1|||
143483301|NCT01157078|517315018|FG000|Overall Study|Lack of Efficacy|2|||
143483302|NCT01157078|517315019|FG001|Overall Study|Lack of Efficacy|0|||
143483303|NCT01157078|517315018|FG000|Overall Study|Study-specific withdrawal criteria|2|||
143483304|NCT01157078|517315019|FG001|Overall Study|Study-specific withdrawal criteria|2|||
143483305|NCT01157078|517315018|FG000|Overall Study|Lost to Follow-up|7|||
143483306|NCT01157078|517315019|FG001|Overall Study|Lost to Follow-up|5|||
143483307|NCT01157078|517315018|FG000|Overall Study|Other|2|||
143483308|NCT01157078|517315019|FG001|Overall Study|Other|4|||
143483309|NCT00129766|517315020|FG000|Overall Study|Death|3|||
143483310|NCT00129766|517315021|FG001|Overall Study|Death|8|||
143483311|NCT00129766|517315020|FG000|Overall Study|Withdrawal of consent|31|||
143483312|NCT00129766|517315021|FG001|Overall Study|Withdrawal of consent|30|||
143483313|NCT00129766|517315020|FG000|Overall Study|Lost to Follow-up|26|||
143483314|NCT00129766|517315021|FG001|Overall Study|Lost to Follow-up|21|||
143483315|NCT02699892|517315027|FG000|Overall Study|Other|36|||
143483316|NCT02770547|517315028|FG000|Overall Study|Patient non-compliant|1|||
143483317|NCT02770547|517315029|FG001|Overall Study|Patient non-compliant|0|||
143483318|NCT02770547|517315028|FG000|Overall Study|Adverse Event|0|||
143483319|NCT02770547|517315029|FG001|Overall Study|Adverse Event|1|||
143483320|NCT00847912|517315035|FG000|Overall Study|Protocol Violation|6|||
143483321|NCT00847912|517315036|FG001|Overall Study|Protocol Violation|7|||
143483322|NCT00847912|517315035|FG000|Overall Study|Withdrawal by Subject|3|||
143483323|NCT00847912|517315036|FG001|Overall Study|Withdrawal by Subject|6|||
143483324|NCT01324232|517315037|FG000|Overall Study|Protocol Violation|0|||
143483325|NCT01324232|517315038|FG001|Overall Study|Protocol Violation|0|||
143483326|NCT01324232|517315039|FG002|Overall Study|Protocol Violation|0|||
143483327|NCT01324232|517315040|FG003|Overall Study|Protocol Violation|2|||
143483328|NCT01324232|517315037|FG000|Overall Study|Missing|0|||
143483329|NCT01324232|517315038|FG001|Overall Study|Missing|0|||
143483330|NCT01324232|517315039|FG002|Overall Study|Missing|1|||
143483331|NCT01324232|517315040|FG003|Overall Study|Missing|0|||
143483332|NCT01324232|517315037|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
143483333|NCT01324232|517315038|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
143148442|NCT00876343|516087728|FG001|Overall Study|Lack of Efficacy|0|||
143483334|NCT01324232|517315039|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
143483335|NCT01324232|517315040|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
143483336|NCT01324232|517315037|FG000|Overall Study|Lack of Efficacy|2|||
143483337|NCT01324232|517315038|FG001|Overall Study|Lack of Efficacy|1|||
143483338|NCT01324232|517315039|FG002|Overall Study|Lack of Efficacy|2|||
143483339|NCT01324232|517315040|FG003|Overall Study|Lack of Efficacy|2|||
143483340|NCT01324232|517315037|FG000|Overall Study|Participant Refused Medication|0|||
143483341|NCT01324232|517315038|FG001|Overall Study|Participant Refused Medication|1|||
143483342|NCT01324232|517315039|FG002|Overall Study|Participant Refused Medication|0|||
143483343|NCT01324232|517315040|FG003|Overall Study|Participant Refused Medication|0|||
143483344|NCT01324232|517315037|FG000|Overall Study|Intercurrent illness|0|||
143483345|NCT01324232|517315038|FG001|Overall Study|Intercurrent illness|0|||
143483346|NCT01324232|517315039|FG002|Overall Study|Intercurrent illness|0|||
143483347|NCT01324232|517315040|FG003|Overall Study|Intercurrent illness|1|||
143483348|NCT01324232|517315037|FG000|Overall Study|Adverse Event|2|||
143483349|NCT01324232|517315038|FG001|Overall Study|Adverse Event|5|||
143483350|NCT01324232|517315039|FG002|Overall Study|Adverse Event|6|||
143483351|NCT01324232|517315040|FG003|Overall Study|Adverse Event|6|||
143483352|NCT01324232|517315037|FG000|Overall Study|Withdrawal by Subject|0|||
143483353|NCT01324232|517315038|FG001|Overall Study|Withdrawal by Subject|3|||
143483354|NCT01324232|517315039|FG002|Overall Study|Withdrawal by Subject|4|||
143483355|NCT01324232|517315040|FG003|Overall Study|Withdrawal by Subject|0|||
143483356|NCT01324232|517315037|FG000|Overall Study|Lost to Follow-up|1|||
143483357|NCT01324232|517315038|FG001|Overall Study|Lost to Follow-up|0|||
143483358|NCT01324232|517315039|FG002|Overall Study|Lost to Follow-up|0|||
143483359|NCT01324232|517315040|FG003|Overall Study|Lost to Follow-up|0|||
143483360|NCT05440539|517315042|FG000|Overall Study|Lost to Follow-up|4|||
143483361|NCT05440539|517315043|FG001|Overall Study|Lost to Follow-up|4|||
143483362|NCT05440539|517315042|FG000|Overall Study|Fetal demise, no longer pregnant|3|||
143483363|NCT05440539|517315043|FG001|Overall Study|Fetal demise, no longer pregnant|4|||
143483364|NCT00393887|517315044|FG000|Overall Study|Physician Decision|5|||
143483365|NCT00393887|517315045|FG001|Overall Study|Physician Decision|0|||
143483366|NCT00393887|517315044|FG000|Overall Study|Lost to Follow-up|11|||
143483367|NCT00393887|517315045|FG001|Overall Study|Lost to Follow-up|9|||
143483368|NCT02055820|517315048|FG000|Phase I: Dose-Finding|Death|1|||
143483369|NCT02055820|517315049|FG001|Phase I: Dose-Finding|Death|0|||
143483370|NCT02055820|517315050|FG002|Phase I: Dose-Finding|Death|1|||
143483371|NCT02055820|517315051|FG003|Phase I: Dose-Finding|Death|2|||
143483372|NCT02055820|517315052|FG004|Phase I: Dose-Finding|Death|0|||
143483373|NCT02055820|517315053|FG005|Phase I: Dose-Finding|Death|1|||
143483374|NCT02055820|517315054|FG006|Phase I: Dose-Finding|Death|1|||
143483375|NCT02055820|517315055|FG007|Phase I: Dose-Finding|Death|0|||
143483376|NCT02055820|517315056|FG008|Phase I: Dose-Finding|Death|0|||
143483377|NCT02055820|517315057|FG009|Phase I: Dose-Finding|Death|0|||
143483378|NCT02055820|517315048|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
143483379|NCT02055820|517315049|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
143483380|NCT02055820|517315050|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
143483381|NCT02055820|517315051|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
143483382|NCT02055820|517315052|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
143483383|NCT02055820|517315053|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
143483384|NCT02055820|517315054|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
143483385|NCT02055820|517315055|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
143483386|NCT02055820|517315056|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
143483387|NCT02055820|517315057|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
143483388|NCT02055820|517315048|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
143483389|NCT02055820|517315049|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
143483390|NCT02055820|517315050|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
143483391|NCT02055820|517315051|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
143483392|NCT02055820|517315052|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
143483393|NCT02055820|517315053|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
143483394|NCT02055820|517315054|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
143483395|NCT02055820|517315055|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
143483396|NCT02055820|517315056|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
143483397|NCT02055820|517315057|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
143483398|NCT02055820|517315048|FG000|Phase II: Expansion|Death|0|||
143483399|NCT02055820|517315049|FG001|Phase II: Expansion|Death|0|||
143148443|NCT00876343|516087729|FG002|Overall Study|Lack of Efficacy|1|||
143148444|NCT00876343|516087727|FG000|Overall Study|Protocol Violation|4|||
143148445|NCT00876343|516087728|FG001|Overall Study|Protocol Violation|1|||
143148446|NCT00876343|516087729|FG002|Overall Study|Protocol Violation|1|||
143148447|NCT00876343|516087727|FG000|Overall Study|Physician Decision|0|||
143148448|NCT00876343|516087728|FG001|Overall Study|Physician Decision|1|||
143148449|NCT00876343|516087729|FG002|Overall Study|Physician Decision|1|||
143148450|NCT00876343|516087727|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
143148451|NCT00876343|516087728|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
143148452|NCT00876343|516087729|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
143148453|NCT00876343|516087727|FG000|Overall Study|Change of residence or other commitments|2|||
143483400|NCT02055820|517315050|FG002|Phase II: Expansion|Death|0|||
143483401|NCT02055820|517315051|FG003|Phase II: Expansion|Death|0|||
143483402|NCT02055820|517315052|FG004|Phase II: Expansion|Death|33|||
143483403|NCT02055820|517315053|FG005|Phase II: Expansion|Death|0|||
143483404|NCT02055820|517315054|FG006|Phase II: Expansion|Death|0|||
143483405|NCT02055820|517315055|FG007|Phase II: Expansion|Death|0|||
143483406|NCT02055820|517315056|FG008|Phase II: Expansion|Death|0|||
143483407|NCT02055820|517315057|FG009|Phase II: Expansion|Death|0|||
143483408|NCT02055820|517315048|FG000|Phase II: Expansion|Lost to Follow-up|0|||
143483409|NCT02055820|517315049|FG001|Phase II: Expansion|Lost to Follow-up|0|||
143483410|NCT02055820|517315050|FG002|Phase II: Expansion|Lost to Follow-up|0|||
143483411|NCT02055820|517315051|FG003|Phase II: Expansion|Lost to Follow-up|0|||
143483412|NCT02055820|517315052|FG004|Phase II: Expansion|Lost to Follow-up|4|||
143483413|NCT02055820|517315053|FG005|Phase II: Expansion|Lost to Follow-up|0|||
143483414|NCT02055820|517315054|FG006|Phase II: Expansion|Lost to Follow-up|0|||
143483415|NCT02055820|517315055|FG007|Phase II: Expansion|Lost to Follow-up|0|||
143483416|NCT02055820|517315056|FG008|Phase II: Expansion|Lost to Follow-up|0|||
143483417|NCT02055820|517315057|FG009|Phase II: Expansion|Lost to Follow-up|0|||
143483418|NCT02055820|517315048|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
143483419|NCT02055820|517315049|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
143483420|NCT02055820|517315050|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
143483421|NCT02055820|517315051|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
143483422|NCT02055820|517315052|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
143483423|NCT02055820|517315053|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
143483424|NCT02055820|517315054|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
143483425|NCT02055820|517315055|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
143483426|NCT02055820|517315056|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
143483427|NCT02055820|517315057|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
143483428|NCT00930761|517315058|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
143483429|NCT00930761|517315059|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
143483430|NCT00930761|517315058|FG000|Overall Study|less than 3 music therapy sessions|0|||
143483431|NCT00930761|517315059|FG001|Overall Study|less than 3 music therapy sessions|3|||
143483432|NCT03571646|517315061|FG000|Overall Study|Adverse Event|1|||
143483433|NCT03571646|517315062|FG001|Overall Study|Adverse Event|0|||
143483434|NCT03571646|517315061|FG000|Overall Study|Withdrawal by Subject|1|||
143483435|NCT03571646|517315062|FG001|Overall Study|Withdrawal by Subject|1|||
143483436|NCT03548935|517315063|FG000|Overall Study|Withdrawal by Subject|26|||
143483437|NCT03548935|517315064|FG001|Overall Study|Withdrawal by Subject|17|||
143483438|NCT03548935|517315063|FG000|Overall Study|Lost to Follow-up|39|||
143483439|NCT03548935|517315064|FG001|Overall Study|Lost to Follow-up|28|||
143483440|NCT03548935|517315063|FG000|Overall Study|Death|1|||
143483441|NCT03548935|517315064|FG001|Overall Study|Death|1|||
143483442|NCT01970995|517315065|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
143483443|NCT01970995|517315066|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
143483444|NCT01970995|517315067|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
143483445|NCT01970995|517315065|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
143483446|NCT01970995|517315066|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
143483447|NCT01970995|517315067|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
143483448|NCT01157364|517315070|FG000|Overall Study|Other Reasons|1|||
143483449|NCT01157364|517315071|FG001|Overall Study|Other Reasons|1|||
143483450|NCT01157364|517315072|FG002|Overall Study|Other Reasons|2|||
143483451|NCT01157364|517315073|FG003|Overall Study|Other Reasons|1|||
143483452|NCT01157364|517315074|FG004|Overall Study|Other Reasons|0|||
143483453|NCT01157364|517315075|FG005|Overall Study|Other Reasons|0|||
143483454|NCT01157364|517315070|FG000|Overall Study|Personal Reasons|0|||
143483455|NCT01157364|517315071|FG001|Overall Study|Personal Reasons|2|||
143483456|NCT01157364|517315072|FG002|Overall Study|Personal Reasons|0|||
143483457|NCT01157364|517315073|FG003|Overall Study|Personal Reasons|0|||
143483458|NCT01157364|517315074|FG004|Overall Study|Personal Reasons|1|||
143483459|NCT01157364|517315075|FG005|Overall Study|Personal Reasons|1|||
143483460|NCT01157364|517315070|FG000|Overall Study|Lost to Follow-up|1|||
143483461|NCT01157364|517315071|FG001|Overall Study|Lost to Follow-up|0|||
143483462|NCT01157364|517315072|FG002|Overall Study|Lost to Follow-up|1|||
143483463|NCT01157364|517315073|FG003|Overall Study|Lost to Follow-up|0|||
143483464|NCT01157364|517315074|FG004|Overall Study|Lost to Follow-up|0|||
143483465|NCT01157364|517315075|FG005|Overall Study|Lost to Follow-up|0|||
143483466|NCT01157364|517315070|FG000|Overall Study|Lack of Efficacy|0|||
143483467|NCT01157364|517315071|FG001|Overall Study|Lack of Efficacy|0|||
143483468|NCT01157364|517315072|FG002|Overall Study|Lack of Efficacy|0|||
143483469|NCT01157364|517315073|FG003|Overall Study|Lack of Efficacy|1|||
143483470|NCT01157364|517315074|FG004|Overall Study|Lack of Efficacy|0|||
143483471|NCT01157364|517315075|FG005|Overall Study|Lack of Efficacy|0|||
143483472|NCT01157364|517315070|FG000|Overall Study|Adverse Event|0|||
143483473|NCT01157364|517315071|FG001|Overall Study|Adverse Event|1|||
143483474|NCT01157364|517315072|FG002|Overall Study|Adverse Event|1|||
143483475|NCT01157364|517315073|FG003|Overall Study|Adverse Event|0|||
143483476|NCT01157364|517315074|FG004|Overall Study|Adverse Event|1|||
143483477|NCT01157364|517315075|FG005|Overall Study|Adverse Event|0|||
143483478|NCT01780662|517315076|FG000|Overall Study|Adverse Event|1|||
143483479|NCT01780662|517315077|FG001|Overall Study|Adverse Event|0|||
143483480|NCT01780662|517315078|FG002|Overall Study|Adverse Event|2|||
143483481|NCT01780662|517315076|FG000|Overall Study|Physician Decision|0|||
143483482|NCT01780662|517315077|FG001|Overall Study|Physician Decision|5|||
143483483|NCT01780662|517315078|FG002|Overall Study|Physician Decision|7|||
143483484|NCT01780662|517315076|FG000|Overall Study|Protocol Violation|0|||
143363626|NCT00062868|516873780|FG000|Dose Level 2|Lost to Follow-up|0|||
143363627|NCT00062868|516873781|FG001|Dose Level 2|Lost to Follow-up|0|||
143483485|NCT01780662|517315077|FG001|Overall Study|Protocol Violation|1|||
143483486|NCT01780662|517315078|FG002|Overall Study|Protocol Violation|0|||
143483487|NCT01780662|517315076|FG000|Overall Study|Ineligible|0|||
143483488|NCT01780662|517315077|FG001|Overall Study|Ineligible|0|||
143483489|NCT01780662|517315078|FG002|Overall Study|Ineligible|1|||
143483490|NCT01263639|517315079|FG000|Overall Study|Lost to Follow-up|66|||
143483491|NCT01263639|517315080|FG001|Overall Study|Lost to Follow-up|70|||
143148454|NCT00876343|516087728|FG001|Overall Study|Change of residence or other commitments|2|||
143148455|NCT00876343|516087729|FG002|Overall Study|Change of residence or other commitments|3|||
143148456|NCT02550795|516087730|FG000|Overall Study|Physician Decision|0|||
143148457|NCT02550795|516087731|FG001|Overall Study|Physician Decision|1|||
143148458|NCT02550795|516087732|FG002|Overall Study|Physician Decision|0|||
143148459|NCT02802228|516087733|FG000|Overall Study|Withdrawal by Subject|2|||
143148460|NCT02802228|516087734|FG001|Overall Study|Withdrawal by Subject|0|||
143148461|NCT02802228|516087733|FG000|Overall Study|Lost to Follow-up|1|||
143148462|NCT02802228|516087734|FG001|Overall Study|Lost to Follow-up|0|||
143148463|NCT02802228|516087733|FG000|Overall Study|Adverse Event|1|||
143148464|NCT02802228|516087734|FG001|Overall Study|Adverse Event|0|||
143148465|NCT02802228|516087733|FG000|Overall Study|Physician Decision|1|||
143148466|NCT02802228|516087734|FG001|Overall Study|Physician Decision|0|||
143148467|NCT00695019|516087735|FG000|Overall Study|Withdrawal by Subject|8|||
143148468|NCT00695019|516087736|FG001|Overall Study|Withdrawal by Subject|6|||
143148469|NCT00695019|516087737|FG002|Overall Study|Withdrawal by Subject|4|||
143148470|NCT00695019|516087735|FG000|Overall Study|Protocol Violation|1|||
143148471|NCT00695019|516087736|FG001|Overall Study|Protocol Violation|3|||
143148472|NCT00695019|516087737|FG002|Overall Study|Protocol Violation|1|||
143148473|NCT00695019|516087735|FG000|Overall Study|Lack of Efficacy|0|||
143148474|NCT00695019|516087736|FG001|Overall Study|Lack of Efficacy|0|||
143148475|NCT00695019|516087737|FG002|Overall Study|Lack of Efficacy|1|||
143148476|NCT00695019|516087735|FG000|Overall Study|Various|4|||
143148477|NCT00695019|516087736|FG001|Overall Study|Various|5|||
143148478|NCT00695019|516087737|FG002|Overall Study|Various|4|||
143148479|NCT00924898|516087738|FG000|Overall Study|Withdrawal by Subject|2|||
143148480|NCT05291689|516087744|FG000|Overall Study|Adverse Event|3|||
143148481|NCT05291689|516087744|FG000|Overall Study|Lack of Efficacy|10|||
143148482|NCT05291689|516087744|FG000|Overall Study|Withdrawal by Subject|4|||
143148483|NCT01931098|516087745|FG000|Overall Study|Withdrawal by Subject|0|||
143148484|NCT01931098|516087746|FG001|Overall Study|Withdrawal by Subject|1|||
143148485|NCT01931098|516087745|FG000|Overall Study|Enrolled in different protocol|0|||
143148486|NCT01931098|516087746|FG001|Overall Study|Enrolled in different protocol|1|||
143148487|NCT01931098|516087745|FG000|Overall Study|Unable to begin trmt:active infection|0|||
143148488|NCT01931098|516087746|FG001|Overall Study|Unable to begin trmt:active infection|1|||
143148489|NCT01931098|516087745|FG000|Overall Study|Refused further treatment|0|||
143148490|NCT01931098|516087746|FG001|Overall Study|Refused further treatment|1|||
143148491|NCT02278354|516087750|FG000|Overall Study|Lost to Follow-up|2|||
143148492|NCT02278354|516087751|FG001|Overall Study|Lost to Follow-up|2|||
143148493|NCT02278354|516087750|FG000|Overall Study|Withdrawal by Subject|0|||
143148494|NCT02278354|516087751|FG001|Overall Study|Withdrawal by Subject|1|||
143148495|NCT02278354|516087750|FG000|Overall Study|<10 professional fights|2|||
143148496|NCT02278354|516087751|FG001|Overall Study|<10 professional fights|0|||
143148497|NCT01925794|516087753|FG000|180 Days|Death|2|||
143148498|NCT01925794|516087753|FG000|180 Days|Withdrawal by Subject|2|||
143148499|NCT01925794|516087753|FG000|270 Days|Death|2|||
143148500|NCT01925794|516087753|FG000|270 Days|Protocol Violation|3|||
143148501|NCT02879695|516087757|FG000|Overall Study|Did not start study treatment|2|||
143148502|NCT02879695|516087758|FG001|Overall Study|Did not start study treatment|0|||
143148503|NCT02879695|516087759|FG002|Overall Study|Did not start study treatment|3|||
143148504|NCT02879695|516087760|FG003|Overall Study|Did not start study treatment|0|||
143363628|NCT00062868|516873782|FG002|Dose Level 2|Lost to Follow-up|0|||
143363629|NCT00062868|516873783|FG003|Dose Level 2|Lost to Follow-up|0|||
143483492|NCT01263639|517315079|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
143148505|NCT04235374|516087762|FG000|Overall Study|Death|91|||
143148506|NCT04235374|516087763|FG001|Overall Study|Death|91|||
143148507|NCT04235374|516087762|FG000|Overall Study|Refused|2|||
143148508|NCT04235374|516087763|FG001|Overall Study|Refused|2|||
143148509|NCT04235374|516087762|FG000|Overall Study|Unavailable|12|||
143148510|NCT04235374|516087763|FG001|Overall Study|Unavailable|3|||
143148511|NCT04235374|516087762|FG000|Overall Study|Withdrawal by Subject|0|||
143148512|NCT04235374|516087763|FG001|Overall Study|Withdrawal by Subject|1|||
143148513|NCT04235374|516087762|FG000|Overall Study|Withdrawal by Legally Authorized Representative|10|||
143148514|NCT04235374|516087763|FG001|Overall Study|Withdrawal by Legally Authorized Representative|9|||
143148515|NCT00314145|516087764|FG000|Overall Study|Withdrawal by Subject|8|||
143148516|NCT00314145|516087765|FG001|Overall Study|Withdrawal by Subject|10|||
143483493|NCT01263639|517315080|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
143148517|NCT00314145|516087764|FG000|Overall Study|Lost to Follow-up|5|||
143363630|NCT00062868|516873784|FG004|Dose Level 2|Lost to Follow-up|0|||
143148518|NCT00314145|516087765|FG001|Overall Study|Lost to Follow-up|12|||
143148519|NCT00314145|516087764|FG000|Overall Study|Physician Decision|3|||
143148520|NCT00314145|516087765|FG001|Overall Study|Physician Decision|4|||
143148521|NCT00314145|516087764|FG000|Overall Study|Adverse Event|0|||
143148522|NCT00314145|516087765|FG001|Overall Study|Adverse Event|3|||
143148523|NCT00314145|516087764|FG000|Overall Study|Protocol Violation|3|||
143148524|NCT00314145|516087765|FG001|Overall Study|Protocol Violation|0|||
143148525|NCT00314145|516087764|FG000|Overall Study|Sponsor Decision|2|||
143148526|NCT00314145|516087765|FG001|Overall Study|Sponsor Decision|0|||
143148527|NCT02572167|516087766|FG000|Overall Study|Withdrawal by Subject|0|||
143148528|NCT02572167|516087767|FG001|Overall Study|Withdrawal by Subject|3|||
143148529|NCT02572167|516087768|FG002|Overall Study|Withdrawal by Subject|0|||
143148530|NCT02572167|516087766|FG000|Overall Study|Lost to Follow-up|2|||
143148531|NCT02572167|516087767|FG001|Overall Study|Lost to Follow-up|5|||
143148532|NCT02572167|516087768|FG002|Overall Study|Lost to Follow-up|3|||
143148533|NCT02572167|516087766|FG000|Overall Study|Death|0|||
143148534|NCT02572167|516087767|FG001|Overall Study|Death|8|||
143148535|NCT02572167|516087768|FG002|Overall Study|Death|3|||
143148536|NCT02572167|516087766|FG000|Overall Study|Did not meet inclusion criteria|0|||
143148537|NCT02572167|516087767|FG001|Overall Study|Did not meet inclusion criteria|0|||
143148538|NCT02572167|516087768|FG002|Overall Study|Did not meet inclusion criteria|1|||
143148539|NCT02572167|516087766|FG000|Overall Study|Study closure by Sponsor|4|||
143148540|NCT02572167|516087767|FG001|Overall Study|Study closure by Sponsor|40|||
143148541|NCT02572167|516087768|FG002|Overall Study|Study closure by Sponsor|24|||
143148542|NCT00976027|516087769|FG000|Overall Study|Serious Adverse Event|36|||
143148543|NCT00976027|516087770|FG001|Overall Study|Serious Adverse Event|17|||
143148544|NCT00976027|516087769|FG000|Overall Study|Adverse Event|0|||
143148545|NCT00976027|516087770|FG001|Overall Study|Adverse Event|2|||
143148546|NCT00976027|516087769|FG000|Overall Study|Protocol Violation|60|||
143148547|NCT00976027|516087770|FG001|Overall Study|Protocol Violation|27|||
143148548|NCT00976027|516087769|FG000|Overall Study|Lost to Follow-up|208|||
143148549|NCT00976027|516087770|FG001|Overall Study|Lost to Follow-up|103|||
143148550|NCT00976027|516087769|FG000|Overall Study|Withdrawal by Subject|107|||
143148551|NCT00976027|516087770|FG001|Overall Study|Withdrawal by Subject|66|||
143148552|NCT01771107|516087780|FG000|Overall Study|Adverse Event|1|||
143148553|NCT01771107|516087781|FG001|Overall Study|Adverse Event|3|||
143148554|NCT01771107|516087780|FG000|Overall Study|Withdrawal by Subject|0|||
143148555|NCT01771107|516087781|FG001|Overall Study|Withdrawal by Subject|2|||
143148556|NCT01771107|516087780|FG000|Overall Study|Lost to Follow-up|0|||
143148557|NCT01771107|516087781|FG001|Overall Study|Lost to Follow-up|1|||
143148558|NCT01771107|516087780|FG000|Overall Study|participant moved|0|||
143148559|NCT01771107|516087781|FG001|Overall Study|participant moved|1|||
143148560|NCT01771107|516087780|FG000|Overall Study|Other|0|||
143148561|NCT01771107|516087781|FG001|Overall Study|Other|1|||
143148562|NCT01802281|516087782|FG000|Overall Study|Death|1|||
143148563|NCT01802281|516087783|FG001|Overall Study|Death|2|||
143148564|NCT01802281|516087782|FG000|Overall Study|Withdrawal by Subject|2|||
143148565|NCT01802281|516087783|FG001|Overall Study|Withdrawal by Subject|1|||
143148566|NCT01802281|516087782|FG000|Overall Study|Ineligible|5|||
143148567|NCT01802281|516087783|FG001|Overall Study|Ineligible|3|||
143148568|NCT02246777|516087784|FG000|Overall Study|Adverse Event|2|||
143148569|NCT02246777|516087784|FG000|Overall Study|Change of residence|1|||
143148570|NCT04133909|516087785|FG000|Overall Study|Death|11|||
143148571|NCT04133909|516087786|FG001|Overall Study|Death|11|||
143148572|NCT04133909|516087785|FG000|Overall Study|Adverse Event|4|||
143148573|NCT04133909|516087786|FG001|Overall Study|Adverse Event|5|||
143148574|NCT04133909|516087785|FG000|Overall Study|Lost to Follow-up|3|||
143148575|NCT04133909|516087786|FG001|Overall Study|Lost to Follow-up|5|||
143148576|NCT04133909|516087785|FG000|Overall Study|Physician Decision|4|||
143148577|NCT04133909|516087786|FG001|Overall Study|Physician Decision|7|||
143148578|NCT04133909|516087785|FG000|Overall Study|Withdrawal by Subject|40|||
143148579|NCT04133909|516087786|FG001|Overall Study|Withdrawal by Subject|35|||
143148580|NCT04133909|516087785|FG000|Overall Study|Lack of Efficacy|2|||
143148581|NCT04133909|516087786|FG001|Overall Study|Lack of Efficacy|7|||
143148582|NCT04133909|516087785|FG000|Overall Study|Randomized in error|1|||
143148583|NCT04133909|516087786|FG001|Overall Study|Randomized in error|1|||
143148584|NCT00858988|516087787|FG000|Analysis|Lactulose unable to be detected in urine|2|||
143148585|NCT00858988|516087788|FG001|Analysis|Lactulose unable to be detected in urine|1|||
143148586|NCT00658528|516087789|FG000|Overall Study|Adverse Event|5|||
143148587|NCT00658528|516087790|FG001|Overall Study|Adverse Event|7|||
143148588|NCT00658528|516087789|FG000|Overall Study|Lost to Follow-up|14|||
143148589|NCT00658528|516087790|FG001|Overall Study|Lost to Follow-up|22|||
143148590|NCT00658528|516087789|FG000|Overall Study|Withdrawal by Subject|8|||
143148591|NCT00658528|516087790|FG001|Overall Study|Withdrawal by Subject|6|||
143148592|NCT00658528|516087789|FG000|Overall Study|Withdrawal of consent|5|||
143148593|NCT00658528|516087790|FG001|Overall Study|Withdrawal of consent|6|||
143148594|NCT00658528|516087789|FG000|Overall Study|Other|8|||
143148595|NCT00658528|516087790|FG001|Overall Study|Other|4|||
143148596|NCT01706328|516087792|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
143363631|NCT00062868|516873785|FG005|Dose Level 2|Lost to Follow-up|0|||
143483494|NCT01576549|517315081|FG000|Overall Study|Sponsor Decision|2|||
143483495|NCT03975920|517315084|FG000|Overall Study|Lost to Follow-up|1|||
143483496|NCT03975920|517315085|FG001|Overall Study|Lost to Follow-up|2|||
143483497|NCT03975920|517315084|FG000|Overall Study|Protocol Violation|1|||
143483498|NCT03975920|517315085|FG001|Overall Study|Protocol Violation|1|||
143483499|NCT03975920|517315084|FG000|Overall Study|Did not complete survey|2|||
143483500|NCT03975920|517315085|FG001|Overall Study|Did not complete survey|1|||
143483501|NCT00586495|517315086|FG000|Treatment Period|Adverse Event|11|||
143483502|NCT00586495|517315086|FG000|Treatment Period|Death|1|||
143483503|NCT00586495|517315086|FG000|Treatment Period|Protocol Violation|1|||
143483504|NCT00586495|517315086|FG000|Treatment Period|Withdrawal by Subject|1|||
143483505|NCT00586495|517315086|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
143483506|NCT00586495|517315086|FG000|Treatment Period|Switch to commercial drug|10|||
143483507|NCT00586495|517315086|FG000|Follow-up|Death|40|||
143483508|NCT00586495|517315086|FG000|Follow-up|Lost to Follow-up|1|||
143483509|NCT00586495|517315086|FG000|Follow-up|Withdrawal by Subject|4|||
143483510|NCT00586495|517315086|FG000|Follow-up|Protocol driven decision point|37|||
143483511|NCT00586495|517315086|FG000|Follow-up|Switch to commercial drug|10|||
143483512|NCT02182687|517315090|FG000|Overall Study|Withdrawal by Subject|4|||
143483513|NCT02182687|517315091|FG001|Overall Study|Withdrawal by Subject|0|||
143483514|NCT02182687|517315090|FG000|Overall Study|Adverse Event|1|||
143483515|NCT02182687|517315091|FG001|Overall Study|Adverse Event|0|||
143483516|NCT02182687|517315090|FG000|Overall Study|Lost to Follow-up|0|||
143483517|NCT02182687|517315091|FG001|Overall Study|Lost to Follow-up|1|||
143483518|NCT03882970|517315096|FG000|Overall Study|Adverse Event|5|||
143483519|NCT03882970|517315097|FG001|Overall Study|Adverse Event|7|||
143483520|NCT03882970|517315098|FG002|Overall Study|Adverse Event|3|||
143483521|NCT03882970|517315099|FG003|Overall Study|Adverse Event|1|||
143483522|NCT03882970|517315096|FG000|Overall Study|Death|1|||
143483523|NCT03882970|517315097|FG001|Overall Study|Death|2|||
143483524|NCT03882970|517315098|FG002|Overall Study|Death|1|||
143483525|NCT03882970|517315099|FG003|Overall Study|Death|1|||
143483526|NCT03882970|517315096|FG000|Overall Study|Lost to Follow-up|8|||
143483527|NCT03882970|517315097|FG001|Overall Study|Lost to Follow-up|9|||
143483528|NCT03882970|517315098|FG002|Overall Study|Lost to Follow-up|5|||
143483529|NCT03882970|517315099|FG003|Overall Study|Lost to Follow-up|5|||
143483530|NCT03882970|517315096|FG000|Overall Study|Physician Decision|0|||
143483531|NCT03882970|517315097|FG001|Overall Study|Physician Decision|2|||
143483532|NCT03882970|517315098|FG002|Overall Study|Physician Decision|2|||
143483533|NCT03882970|517315099|FG003|Overall Study|Physician Decision|2|||
143483534|NCT03882970|517315096|FG000|Overall Study|Protocol Violation|2|||
143483535|NCT03882970|517315097|FG001|Overall Study|Protocol Violation|0|||
143483536|NCT03882970|517315098|FG002|Overall Study|Protocol Violation|0|||
143483537|NCT03882970|517315099|FG003|Overall Study|Protocol Violation|0|||
143483538|NCT03882970|517315096|FG000|Overall Study|Withdrawal by Subject|8|||
143483539|NCT03882970|517315097|FG001|Overall Study|Withdrawal by Subject|17|||
143483540|NCT03882970|517315098|FG002|Overall Study|Withdrawal by Subject|7|||
143483541|NCT03882970|517315099|FG003|Overall Study|Withdrawal by Subject|22|||
143483542|NCT03882970|517315096|FG000|Overall Study|Personal Reason|2|||
143483543|NCT03882970|517315097|FG001|Overall Study|Personal Reason|3|||
143483544|NCT03882970|517315098|FG002|Overall Study|Personal Reason|1|||
143483545|NCT03882970|517315099|FG003|Overall Study|Personal Reason|3|||
143483546|NCT00974675|517315100|FG000|Overall Study|Adverse Event|2|||
143483547|NCT00974675|517315101|FG001|Overall Study|Adverse Event|1|||
143483548|NCT00974675|517315102|FG002|Overall Study|Adverse Event|1|||
143483549|NCT00974675|517315103|FG003|Overall Study|Adverse Event|1|||
143483550|NCT00974675|517315100|FG000|Overall Study|Physician Decision|0|||
143483551|NCT00974675|517315101|FG001|Overall Study|Physician Decision|0|||
143483552|NCT00974675|517315102|FG002|Overall Study|Physician Decision|1|||
143483553|NCT00974675|517315103|FG003|Overall Study|Physician Decision|0|||
143483554|NCT00974675|517315100|FG000|Overall Study|Participant on holiday; unable to attend|0|||
143483555|NCT00974675|517315101|FG001|Overall Study|Participant on holiday; unable to attend|0|||
143483556|NCT00974675|517315102|FG002|Overall Study|Participant on holiday; unable to attend|0|||
143483557|NCT00974675|517315103|FG003|Overall Study|Participant on holiday; unable to attend|1|||
143483558|NCT01394627|517315105|FG000|First Intervention (1 Day)|poor intravenous access|0|||
143483559|NCT01394627|517315106|FG001|First Intervention (1 Day)|poor intravenous access|1|||
143483560|NCT01394627|517315105|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
143483561|NCT01394627|517315106|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
143483562|NCT01765920|517315111|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
143483563|NCT01765920|517315112|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
143483564|NCT01765920|517315111|FG000|Overall Study|Patient code disclosure|0|||
143483565|NCT01765920|517315112|FG001|Overall Study|Patient code disclosure|1|||
143483566|NCT01081249|517315113|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
143483567|NCT01081249|517315114|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
143483568|NCT01439204|517315117|FG000|Overall Study|Withdrawal by Subject|0|||
143363632|NCT00062868|516873786|FG006|Dose Level 2|Lost to Follow-up|0|||
143483569|NCT01439204|517315118|FG001|Overall Study|Withdrawal by Subject|1|||
143148597|NCT01706328|516087793|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
143148598|NCT01706328|516087794|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
143148599|NCT01706328|516087792|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
143148600|NCT01706328|516087793|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
143148601|NCT01706328|516087794|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
143148602|NCT01706328|516087792|FG000|2-week Run-in Period|Physician Decision|4|||
143148603|NCT01706328|516087793|FG001|2-week Run-in Period|Physician Decision|0|||
143148604|NCT01706328|516087794|FG002|2-week Run-in Period|Physician Decision|0|||
143148605|NCT01706328|516087792|FG000|2-week Run-in Period|Adverse Event|4|||
143148606|NCT01706328|516087793|FG001|2-week Run-in Period|Adverse Event|0|||
143148607|NCT01706328|516087794|FG002|2-week Run-in Period|Adverse Event|0|||
143148608|NCT01706328|516087792|FG000|2-week Run-in Period|Lost to Follow-up|2|||
143148609|NCT01706328|516087793|FG001|2-week Run-in Period|Lost to Follow-up|0|||
143148610|NCT01706328|516087794|FG002|2-week Run-in Period|Lost to Follow-up|0|||
143148611|NCT01706328|516087792|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
143148612|NCT01706328|516087793|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
143148613|NCT01706328|516087794|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
143148614|NCT01706328|516087792|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
143148615|NCT01706328|516087793|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
143148616|NCT01706328|516087794|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
143148617|NCT01706328|516087792|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
143148618|NCT01706328|516087793|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
143148619|NCT01706328|516087794|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
143148620|NCT01706328|516087792|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
143148621|NCT01706328|516087793|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
143148622|NCT01706328|516087794|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
143148623|NCT01706328|516087792|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
143148624|NCT01706328|516087793|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
143148625|NCT01706328|516087794|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
143148626|NCT01706328|516087792|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
143148627|NCT01706328|516087793|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
143148628|NCT01706328|516087794|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
143148629|NCT01706328|516087792|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
143148630|NCT01706328|516087793|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
143148631|NCT01706328|516087794|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
143148632|NCT04835441|516087795|FG000|Overall Study|Physician Decision|4|||
143148633|NCT04835441|516087796|FG001|Overall Study|Physician Decision|4|||
143148634|NCT04835441|516087795|FG000|Overall Study|Other|1|||
143148635|NCT04835441|516087796|FG001|Overall Study|Other|1|||
143148636|NCT04835441|516087795|FG000|Overall Study|Lost to Follow-up|0|||
143148637|NCT04835441|516087796|FG001|Overall Study|Lost to Follow-up|1|||
143148638|NCT00177671|516089149|FG000|Overall Study|Withdrawal by Subject|5|||
143148639|NCT00177671|516089150|FG001|Overall Study|Withdrawal by Subject|6|||
143148640|NCT00177671|516089149|FG000|Overall Study|medical complications|2|||
143148641|NCT00177671|516089150|FG001|Overall Study|medical complications|0|||
143148642|NCT00177671|516089149|FG000|Overall Study|Adverse Event|6|||
143148643|NCT00177671|516089150|FG001|Overall Study|Adverse Event|0|||
143148644|NCT00177671|516089149|FG000|Overall Study|Physician Decision|12|||
143148645|NCT00177671|516089150|FG001|Overall Study|Physician Decision|8|||
143148646|NCT05696847|516089159|FG000|Overall Study|Withdrawal by Subject|1|||
143148647|NCT05696847|516089160|FG001|Overall Study|Withdrawal by Subject|0|||
143148648|NCT05696847|516089161|FG002|Overall Study|Withdrawal by Subject|0|||
143148649|NCT05696847|516089162|FG003|Overall Study|Withdrawal by Subject|0|||
143148650|NCT05696847|516089163|FG004|Overall Study|Withdrawal by Subject|0|||
143148651|NCT05696847|516089164|FG005|Overall Study|Withdrawal by Subject|0|||
143148652|NCT05696847|516089159|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
143148653|NCT05696847|516089160|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
143148654|NCT05696847|516089161|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
143148655|NCT05696847|516089162|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
143148656|NCT05696847|516089163|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
143148657|NCT05696847|516089164|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
143148658|NCT05696847|516089159|FG000|Overall Study|Adverse Event|0|||
143148659|NCT05696847|516089160|FG001|Overall Study|Adverse Event|0|||
143148660|NCT05696847|516089161|FG002|Overall Study|Adverse Event|0|||
143148661|NCT05696847|516089162|FG003|Overall Study|Adverse Event|0|||
143148662|NCT05696847|516089163|FG004|Overall Study|Adverse Event|0|||
143148663|NCT05696847|516089164|FG005|Overall Study|Adverse Event|1|||
143148664|NCT05696847|516089159|FG000|Overall Study|Sponsor Decision|0|||
143148665|NCT05696847|516089160|FG001|Overall Study|Sponsor Decision|0|||
143148666|NCT05696847|516089161|FG002|Overall Study|Sponsor Decision|0|||
143148667|NCT05696847|516089162|FG003|Overall Study|Sponsor Decision|1|||
143148668|NCT05696847|516089163|FG004|Overall Study|Sponsor Decision|0|||
143148669|NCT05696847|516089164|FG005|Overall Study|Sponsor Decision|0|||
143148670|NCT01044498|516089165|FG000|Overall Study|Withdrew consent|1|||
143148671|NCT01044498|516089166|FG001|Overall Study|Withdrew consent|1|||
143148672|NCT01044498|516089165|FG000|Overall Study|Adverse Event|1|||
143148673|NCT01044498|516089166|FG001|Overall Study|Adverse Event|1|||
143148674|NCT01044498|516089165|FG000|Overall Study|Other|1|||
143148675|NCT01044498|516089166|FG001|Overall Study|Other|0|||
143148676|NCT02903914|516089169|FG000|Overall Study|Adverse Event|0|||
143148677|NCT02903914|516089170|FG001|Overall Study|Adverse Event|0|||
143148678|NCT02903914|516089171|FG002|Overall Study|Adverse Event|1|||
143148679|NCT02903914|516089172|FG003|Overall Study|Adverse Event|0|||
143483570|NCT01439204|517315117|FG000|Overall Study|Lost to Follow-up|0|||
143483571|NCT01439204|517315118|FG001|Overall Study|Lost to Follow-up|2|||
143483572|NCT01439204|517315117|FG000|Overall Study|No longer meets study criteria|1|||
143483573|NCT01439204|517315118|FG001|Overall Study|No longer meets study criteria|0|||
143483574|NCT01439204|517315117|FG000|Overall Study|poor/non-compliance|3|||
143483575|NCT01439204|517315118|FG001|Overall Study|poor/non-compliance|0|||
143483576|NCT03775421|517315119|FG000|Overall Study|Lost to Follow-up|2|||
143483577|NCT03775421|517315119|FG000|Overall Study|Withdrawal by Subject|10|||
143483578|NCT03775421|517315119|FG000|Overall Study|Physician Decision|3|||
143483579|NCT03775421|517315119|FG000|Overall Study|Death|1|||
143483580|NCT03775421|517315119|FG000|Overall Study|Study Terminated by Sponsor|94|||
143483581|NCT02287623|517315125|FG000|Overall Study|Protocol Violation|0|||
143483582|NCT02287623|517315126|FG001|Overall Study|Protocol Violation|1|||
143483583|NCT00506883|517315129|FG000|Overall Study|Lost to Follow-up|1|||
143483584|NCT00506883|517315130|FG001|Overall Study|Lost to Follow-up|1|||
143483585|NCT00506883|517315131|FG002|Overall Study|Lost to Follow-up|1|||
143483586|NCT00506883|517315129|FG000|Overall Study|Withdrawal by Subject|1|||
143483587|NCT00506883|517315130|FG001|Overall Study|Withdrawal by Subject|0|||
143483588|NCT00506883|517315131|FG002|Overall Study|Withdrawal by Subject|1|||
143483589|NCT00506883|517315129|FG000|Overall Study|Lack of Efficacy|0|||
143483590|NCT00506883|517315130|FG001|Overall Study|Lack of Efficacy|1|||
143483591|NCT00506883|517315131|FG002|Overall Study|Lack of Efficacy|1|||
143483592|NCT00506883|517315129|FG000|Overall Study|Other|5|||
143483593|NCT00506883|517315130|FG001|Overall Study|Other|1|||
143148680|NCT02903914|516089173|FG004|Overall Study|Adverse Event|0|||
143148681|NCT02903914|516089174|FG005|Overall Study|Adverse Event|0|||
143148682|NCT02903914|516089175|FG006|Overall Study|Adverse Event|2|||
143148683|NCT02903914|516089176|FG007|Overall Study|Adverse Event|0|||
143148684|NCT02903914|516089169|FG000|Overall Study|Withdrawal by Subject|3|||
143148685|NCT02903914|516089170|FG001|Overall Study|Withdrawal by Subject|1|||
143148686|NCT02903914|516089171|FG002|Overall Study|Withdrawal by Subject|28|||
143148687|NCT02903914|516089172|FG003|Overall Study|Withdrawal by Subject|0|||
143148688|NCT02903914|516089173|FG004|Overall Study|Withdrawal by Subject|1|||
143148689|NCT02903914|516089174|FG005|Overall Study|Withdrawal by Subject|2|||
143148690|NCT02903914|516089175|FG006|Overall Study|Withdrawal by Subject|12|||
143148691|NCT02903914|516089176|FG007|Overall Study|Withdrawal by Subject|0|||
143148692|NCT02903914|516089169|FG000|Overall Study|Progressive Disease|1|||
143148693|NCT02903914|516089170|FG001|Overall Study|Progressive Disease|0|||
143148694|NCT02903914|516089171|FG002|Overall Study|Progressive Disease|4|||
143148695|NCT02903914|516089172|FG003|Overall Study|Progressive Disease|0|||
143148696|NCT02903914|516089173|FG004|Overall Study|Progressive Disease|0|||
143148697|NCT02903914|516089174|FG005|Overall Study|Progressive Disease|0|||
143148698|NCT02903914|516089175|FG006|Overall Study|Progressive Disease|2|||
143148699|NCT02903914|516089176|FG007|Overall Study|Progressive Disease|0|||
143148700|NCT02903914|516089169|FG000|Overall Study|Death|0|||
143148701|NCT02903914|516089170|FG001|Overall Study|Death|0|||
143148702|NCT02903914|516089171|FG002|Overall Study|Death|9|||
143148703|NCT02903914|516089172|FG003|Overall Study|Death|0|||
143148704|NCT02903914|516089173|FG004|Overall Study|Death|1|||
143148705|NCT02903914|516089174|FG005|Overall Study|Death|3|||
143148706|NCT02903914|516089175|FG006|Overall Study|Death|24|||
143148707|NCT02903914|516089176|FG007|Overall Study|Death|2|||
143148708|NCT02903914|516089169|FG000|Overall Study|Lost to Follow-up|0|||
143148709|NCT02903914|516089170|FG001|Overall Study|Lost to Follow-up|1|||
143483594|NCT00506883|517315131|FG002|Overall Study|Other|1|||
143483595|NCT04143009|517315132|FG000|Pilot Trial|Lost to Follow-up|0|||
143148710|NCT02903914|516089171|FG002|Overall Study|Lost to Follow-up|0|||
143483596|NCT04143009|517315133|FG001|Pilot Trial|Lost to Follow-up|1|||
143483597|NCT04143009|517315134|FG002|Pilot Trial|Lost to Follow-up|1|||
143483598|NCT04013529|517315139|FG000|Overall Study|Withdrawal by Subject|1|||
143483599|NCT04013529|517315140|FG001|Overall Study|Withdrawal by Subject|1|||
143483600|NCT04869345|517315141|FG000|Overall Study|Lost to Follow-up|8|||
143483601|NCT04869345|517315142|FG001|Overall Study|Lost to Follow-up|3|||
143148711|NCT02903914|516089172|FG003|Overall Study|Lost to Follow-up|0|||
143148712|NCT02903914|516089173|FG004|Overall Study|Lost to Follow-up|2|||
143148713|NCT02903914|516089174|FG005|Overall Study|Lost to Follow-up|0|||
143148714|NCT02903914|516089175|FG006|Overall Study|Lost to Follow-up|1|||
143148715|NCT02903914|516089176|FG007|Overall Study|Lost to Follow-up|0|||
143483602|NCT02581202|517315149|FG000|Overall Study|Lack of Efficacy|2|||
143483603|NCT02581202|517315149|FG000|Overall Study|Withdrawal by Subject|4|||
143483604|NCT02581202|517315149|FG000|Overall Study|Lost to Follow-up|5|||
143483605|NCT02581202|517315149|FG000|Overall Study|Pregnancy|3|||
143483606|NCT05054114|517315155|FG000|Overall Study|Protocol Violation|13|||
143483607|NCT05054114|517315156|FG001|Overall Study|Protocol Violation|1|||
143483608|NCT05054114|517315155|FG000|Overall Study|Pregnancy|0|||
143483609|NCT05054114|517315156|FG001|Overall Study|Pregnancy|1|||
143483610|NCT01806779|517315157|FG000|Overall Study|Physician Decision|2|||
143483611|NCT01806779|517315158|FG001|Overall Study|Physician Decision|0|||
143483612|NCT01806779|517315159|FG002|Overall Study|Physician Decision|1|||
143483613|NCT01806779|517315157|FG000|Overall Study|Lack of Efficacy|1|||
143483614|NCT01806779|517315158|FG001|Overall Study|Lack of Efficacy|1|||
143483615|NCT01806779|517315159|FG002|Overall Study|Lack of Efficacy|0|||
143483616|NCT01806779|517315157|FG000|Overall Study|Lost to Follow-up|19|||
143483617|NCT01806779|517315158|FG001|Overall Study|Lost to Follow-up|20|||
143483618|NCT01806779|517315159|FG002|Overall Study|Lost to Follow-up|0|||
143483619|NCT01806779|517315157|FG000|Overall Study|Withdrawal by Subject|20|||
143483620|NCT01806779|517315158|FG001|Overall Study|Withdrawal by Subject|23|||
143483621|NCT01806779|517315159|FG002|Overall Study|Withdrawal by Subject|22|||
143483622|NCT02595450|517315160|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
143483623|NCT02595450|517315160|FG000|Overall Study|Enrolled, but not treated|8|||
143483624|NCT00609791|517316448|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
143483625|NCT04218201|517316449|FG000|Overall Study|Death|0|||
143483626|NCT04218201|517316450|FG001|Overall Study|Death|0|||
143483627|NCT04218201|517316451|FG002|Overall Study|Death|2|||
143483628|NCT04218201|517316452|FG003|Overall Study|Death|0|||
143483629|NCT04218201|517316449|FG000|Overall Study|Unable to contact participant|4|||
143483630|NCT04218201|517316450|FG001|Overall Study|Unable to contact participant|0|||
143483631|NCT04218201|517316451|FG002|Overall Study|Unable to contact participant|3|||
143483632|NCT04218201|517316452|FG003|Overall Study|Unable to contact participant|0|||
143483633|NCT04218201|517316449|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
143483634|NCT04218201|517316450|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
143483635|NCT04218201|517316451|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
143483636|NCT04218201|517316452|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
143483637|NCT04218201|517316449|FG000|Overall Study|Withdrawal by Subject|2|||
143483638|NCT04218201|517316450|FG001|Overall Study|Withdrawal by Subject|0|||
143483639|NCT04218201|517316451|FG002|Overall Study|Withdrawal by Subject|0|||
143483640|NCT04218201|517316452|FG003|Overall Study|Withdrawal by Subject|0|||
143483641|NCT04218201|517316449|FG000|Overall Study|PCP plans to leave practice|0|||
143483642|NCT04218201|517316450|FG001|Overall Study|PCP plans to leave practice|8|||
143483643|NCT04218201|517316451|FG002|Overall Study|PCP plans to leave practice|0|||
143483644|NCT04218201|517316452|FG003|Overall Study|PCP plans to leave practice|5|||
143483645|NCT04218201|517316449|FG000|Overall Study|Reduced panel|0|||
143483646|NCT04218201|517316450|FG001|Overall Study|Reduced panel|0|||
143483647|NCT04218201|517316451|FG002|Overall Study|Reduced panel|0|||
143483648|NCT04218201|517316452|FG003|Overall Study|Reduced panel|1|||
143483649|NCT04218201|517316449|FG000|Overall Study|No longer interested in participating|0|||
143483650|NCT04218201|517316450|FG001|Overall Study|No longer interested in participating|1|||
143483651|NCT04218201|517316451|FG002|Overall Study|No longer interested in participating|0|||
143483652|NCT04218201|517316452|FG003|Overall Study|No longer interested in participating|0|||
143483653|NCT04649255|517316454|FG000|Overall Study|Death|9|||
143483654|NCT04649255|517316454|FG000|Overall Study|Withdrawal by Subject|1|||
143483655|NCT02484911|517316455|FG000|Overall Study|Withdrawal by Subject|2|||
143483656|NCT02484911|517316456|FG001|Overall Study|Withdrawal by Subject|1|||
143483657|NCT02484911|517316455|FG000|Overall Study|Protocol Violation|2|||
143483658|NCT02484911|517316456|FG001|Overall Study|Protocol Violation|1|||
143483659|NCT01908101|517316469|FG000|Overall Study|Physician Decision|1|||
143483660|NCT01908101|517316469|FG000|Overall Study|Withdrawal by Subject|1|||
143483661|NCT01908101|517316469|FG000|Overall Study|Incorrect Diagnosis|2|||
143483662|NCT01908101|517316469|FG000|Overall Study|Incorrect Starting Dose|1|||
143483663|NCT01908101|517316469|FG000|Overall Study|Did not complete the first cycle|4|||
143483664|NCT02495844|517316470|FG000|Overall Study|Lack of Efficacy|1|||
143483665|NCT02495844|517316471|FG001|Overall Study|Lack of Efficacy|2|||
143483666|NCT02495844|517316470|FG000|Overall Study|AE, non-fatal|0|||
143483667|NCT02495844|517316471|FG001|Overall Study|AE, non-fatal|1|||
143483668|NCT02495844|517316470|FG000|Overall Study|Hepatitis Positivity|0|||
143483669|NCT02495844|517316471|FG001|Overall Study|Hepatitis Positivity|1|||
143483670|NCT00789529|517316472|FG000|Overall Study|Withdrawal by Subject|0|||
143483671|NCT00789529|517316473|FG001|Overall Study|Withdrawal by Subject|1|||
143483672|NCT00789529|517316472|FG000|Overall Study|Other Reason|1|||
143483673|NCT00789529|517316473|FG001|Overall Study|Other Reason|0|||
143483674|NCT01081912|517316476|FG000|Conversion/Titration|Adverse Event|47|||
143483675|NCT01081912|517316477|FG001|Conversion/Titration|Adverse Event|0|||
143483676|NCT01081912|517316478|FG002|Conversion/Titration|Adverse Event|0|||
143483677|NCT01081912|517316476|FG000|Conversion/Titration|Lack of Efficacy|17|||
143483678|NCT01081912|517316477|FG001|Conversion/Titration|Lack of Efficacy|0|||
143483679|NCT01081912|517316478|FG002|Conversion/Titration|Lack of Efficacy|0|||
143148716|NCT02903914|516089169|FG000|Overall Study|Physician Decision|0|||
143148717|NCT02903914|516089170|FG001|Overall Study|Physician Decision|0|||
143148718|NCT02903914|516089171|FG002|Overall Study|Physician Decision|1|||
143148719|NCT02903914|516089172|FG003|Overall Study|Physician Decision|0|||
143148720|NCT02903914|516089173|FG004|Overall Study|Physician Decision|0|||
143148721|NCT02903914|516089174|FG005|Overall Study|Physician Decision|0|||
143148722|NCT02903914|516089175|FG006|Overall Study|Physician Decision|1|||
143148723|NCT02903914|516089176|FG007|Overall Study|Physician Decision|0|||
143148724|NCT02903914|516089169|FG000|Overall Study|Symptomatic Deterioration|0|||
143148725|NCT02903914|516089170|FG001|Overall Study|Symptomatic Deterioration|0|||
143148726|NCT02903914|516089171|FG002|Overall Study|Symptomatic Deterioration|1|||
143148727|NCT02903914|516089172|FG003|Overall Study|Symptomatic Deterioration|0|||
143148728|NCT02903914|516089173|FG004|Overall Study|Symptomatic Deterioration|0|||
143148729|NCT02903914|516089174|FG005|Overall Study|Symptomatic Deterioration|0|||
143148730|NCT02903914|516089175|FG006|Overall Study|Symptomatic Deterioration|0|||
143148731|NCT02903914|516089176|FG007|Overall Study|Symptomatic Deterioration|0|||
143148732|NCT02903914|516089169|FG000|Overall Study|New Cancer Therapy|2|||
143148733|NCT02903914|516089170|FG001|Overall Study|New Cancer Therapy|2|||
143148734|NCT02903914|516089171|FG002|Overall Study|New Cancer Therapy|21|||
143148735|NCT02903914|516089172|FG003|Overall Study|New Cancer Therapy|4|||
143148736|NCT02903914|516089173|FG004|Overall Study|New Cancer Therapy|3|||
143148737|NCT02903914|516089174|FG005|Overall Study|New Cancer Therapy|6|||
143148738|NCT02903914|516089175|FG006|Overall Study|New Cancer Therapy|56|||
143148739|NCT02903914|516089176|FG007|Overall Study|New Cancer Therapy|3|||
143148740|NCT02903914|516089169|FG000|Overall Study|Didn't Return to Site|1|||
143148741|NCT02903914|516089170|FG001|Overall Study|Didn't Return to Site|0|||
143148742|NCT02903914|516089171|FG002|Overall Study|Didn't Return to Site|1|||
143148743|NCT02903914|516089172|FG003|Overall Study|Didn't Return to Site|1|||
143148744|NCT02903914|516089173|FG004|Overall Study|Didn't Return to Site|0|||
143148745|NCT02903914|516089174|FG005|Overall Study|Didn't Return to Site|0|||
143148746|NCT02903914|516089175|FG006|Overall Study|Didn't Return to Site|2|||
143148747|NCT02903914|516089176|FG007|Overall Study|Didn't Return to Site|0|||
143148748|NCT02903914|516089169|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
143148749|NCT02903914|516089170|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
143148750|NCT02903914|516089171|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
143148751|NCT02903914|516089172|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
143148752|NCT02903914|516089173|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
143148753|NCT02903914|516089174|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
143148754|NCT02903914|516089175|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
143148755|NCT02903914|516089176|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
143148756|NCT02903914|516089169|FG000|Overall Study|Follow-up Did Not Occur|0|||
143148757|NCT02903914|516089170|FG001|Overall Study|Follow-up Did Not Occur|1|||
143148758|NCT02903914|516089171|FG002|Overall Study|Follow-up Did Not Occur|1|||
143148759|NCT02903914|516089172|FG003|Overall Study|Follow-up Did Not Occur|0|||
143148760|NCT02903914|516089173|FG004|Overall Study|Follow-up Did Not Occur|2|||
143148761|NCT02903914|516089174|FG005|Overall Study|Follow-up Did Not Occur|0|||
143148762|NCT02903914|516089175|FG006|Overall Study|Follow-up Did Not Occur|8|||
143148763|NCT02903914|516089176|FG007|Overall Study|Follow-up Did Not Occur|0|||
143148764|NCT02903914|516089169|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
143148765|NCT02903914|516089170|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
143148766|NCT02903914|516089171|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
143148767|NCT02903914|516089172|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
143148768|NCT02903914|516089173|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
143148769|NCT02903914|516089174|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
143148770|NCT02903914|516089175|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
143148771|NCT02903914|516089176|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
143148772|NCT02903914|516089169|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
143148773|NCT02903914|516089170|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
143148774|NCT02903914|516089171|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
143148775|NCT02903914|516089172|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
143148776|NCT02903914|516089173|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
143483680|NCT01081912|517316476|FG000|Conversion/Titration|Lost to Follow-up|5|||
143483681|NCT01081912|517316477|FG001|Conversion/Titration|Lost to Follow-up|0|||
143483682|NCT01081912|517316478|FG002|Conversion/Titration|Lost to Follow-up|0|||
143483683|NCT01081912|517316476|FG000|Conversion/Titration|Physician Decision|2|||
143483684|NCT01081912|517316477|FG001|Conversion/Titration|Physician Decision|0|||
143483685|NCT01081912|517316478|FG002|Conversion/Titration|Physician Decision|0|||
143148777|NCT02903914|516089174|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
143148778|NCT02903914|516089175|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
143483686|NCT01081912|517316476|FG000|Conversion/Titration|Protocol Violation|67|||
143483687|NCT01081912|517316477|FG001|Conversion/Titration|Protocol Violation|0|||
143148779|NCT02903914|516089176|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
143483688|NCT01081912|517316478|FG002|Conversion/Titration|Protocol Violation|0|||
143483689|NCT01081912|517316476|FG000|Conversion/Titration|Withdrawal by Subject|23|||
143483690|NCT01081912|517316477|FG001|Conversion/Titration|Withdrawal by Subject|0|||
143483691|NCT01081912|517316478|FG002|Conversion/Titration|Withdrawal by Subject|0|||
143483692|NCT01081912|517316476|FG000|Conversion/Titration|Non-Compliance|47|||
143483693|NCT01081912|517316477|FG001|Conversion/Titration|Non-Compliance|0|||
143483694|NCT01081912|517316478|FG002|Conversion/Titration|Non-Compliance|0|||
143483695|NCT01081912|517316476|FG000|Maintenance Treatment|Adverse Event|0|||
143483696|NCT01081912|517316477|FG001|Maintenance Treatment|Adverse Event|2|||
143483697|NCT01081912|517316478|FG002|Maintenance Treatment|Adverse Event|12|||
143483698|NCT01081912|517316476|FG000|Maintenance Treatment|Lack of Efficacy|0|||
143483699|NCT01081912|517316477|FG001|Maintenance Treatment|Lack of Efficacy|14|||
143483700|NCT01081912|517316478|FG002|Maintenance Treatment|Lack of Efficacy|64|||
143483701|NCT01081912|517316476|FG000|Maintenance Treatment|Lost to Follow-up|0|||
143483702|NCT01081912|517316477|FG001|Maintenance Treatment|Lost to Follow-up|1|||
143483703|NCT01081912|517316478|FG002|Maintenance Treatment|Lost to Follow-up|0|||
143483704|NCT01081912|517316476|FG000|Maintenance Treatment|Physician Decision|0|||
143483705|NCT01081912|517316477|FG001|Maintenance Treatment|Physician Decision|0|||
143483706|NCT01081912|517316478|FG002|Maintenance Treatment|Physician Decision|1|||
143483707|NCT01081912|517316476|FG000|Maintenance Treatment|Protocol Violation|0|||
143483708|NCT01081912|517316477|FG001|Maintenance Treatment|Protocol Violation|1|||
143483709|NCT01081912|517316478|FG002|Maintenance Treatment|Protocol Violation|2|||
143483710|NCT01081912|517316476|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
143483711|NCT01081912|517316477|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
143483712|NCT01081912|517316478|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
143483713|NCT01081912|517316476|FG000|Maintenance Treatment|Non-Compliance|0|||
143483714|NCT01081912|517316477|FG001|Maintenance Treatment|Non-Compliance|4|||
143483715|NCT01081912|517316478|FG002|Maintenance Treatment|Non-Compliance|7|||
143483716|NCT01081912|517316476|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
143483717|NCT01081912|517316477|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
143483718|NCT01081912|517316478|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
143483719|NCT01650636|517316479|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
143483720|NCT01650636|517316480|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
143483721|NCT01650636|517316479|FG000|Washout up to 5 Months|Physician Decision|2|||
143483722|NCT01650636|517316480|FG001|Washout up to 5 Months|Physician Decision|2|||
143483723|NCT01650636|517316479|FG000|Washout up to 5 Months|Death|1|||
143483724|NCT01650636|517316480|FG001|Washout up to 5 Months|Death|0|||
143483725|NCT01650636|517316479|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
143148780|NCT02903914|516089169|FG000|Overall Study|Clinical Disease Progression|0|||
143148781|NCT02903914|516089170|FG001|Overall Study|Clinical Disease Progression|0|||
143148782|NCT02903914|516089171|FG002|Overall Study|Clinical Disease Progression|2|||
143483726|NCT01650636|517316480|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
143483727|NCT01650636|517316479|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
143483728|NCT01650636|517316480|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
143483729|NCT01650636|517316479|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
143483730|NCT01650636|517316480|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
143483731|NCT00631020|517316481|FG000|Overall Study|Lost to Follow-up|7|||
143483732|NCT00631020|517316481|FG000|Overall Study|Incarcerated|1|||
143483733|NCT04081363|517316488|FG000|Overall Study|Withdrawal by Subject|1|||
143483734|NCT04081363|517316489|FG001|Overall Study|Withdrawal by Subject|0|||
143483735|NCT00708500|517316490|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
143483736|NCT00708500|517316491|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
143483737|NCT00708500|517316492|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
143483738|NCT00708500|517316490|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
143483739|NCT00708500|517316491|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
143483740|NCT00708500|517316492|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
143483741|NCT00708500|517316490|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
143483742|NCT00708500|517316491|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
143483743|NCT00708500|517316492|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
143483744|NCT00708500|517316490|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
143483745|NCT00708500|517316491|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
143483746|NCT00708500|517316492|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
143483747|NCT00708500|517316490|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
143483748|NCT00708500|517316491|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
143483749|NCT00708500|517316492|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
143483750|NCT00708500|517316490|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
143483751|NCT00708500|517316491|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
143483752|NCT00708500|517316492|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
143483753|NCT00708500|517316490|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
143483754|NCT00708500|517316491|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
143148783|NCT02903914|516089172|FG003|Overall Study|Clinical Disease Progression|0|||
143483755|NCT00708500|517316492|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
143483756|NCT00708500|517316490|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
143483757|NCT00708500|517316491|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
143483758|NCT00708500|517316492|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
143483759|NCT00708500|517316490|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
143483760|NCT00708500|517316491|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
143483761|NCT00708500|517316492|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
143483762|NCT00708500|517316490|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
143483763|NCT00708500|517316491|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
143483764|NCT00708500|517316492|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
143483765|NCT00708500|517316490|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
143483766|NCT00708500|517316491|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
143483767|NCT00708500|517316492|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
143483768|NCT00708500|517316490|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
143483769|NCT00708500|517316491|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
143483770|NCT00708500|517316492|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
143483771|NCT00708500|517316490|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
143483772|NCT00708500|517316491|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
143483773|NCT00708500|517316492|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
143483774|NCT00708500|517316490|FG000|FOLLOWUP|Adverse Event|0|||
143483775|NCT00708500|517316491|FG001|FOLLOWUP|Adverse Event|1|||
143483776|NCT00708500|517316492|FG002|FOLLOWUP|Adverse Event|0|||
143483777|NCT00708500|517316490|FG000|FOLLOWUP|Lost to Follow-up|1|||
143483778|NCT00708500|517316491|FG001|FOLLOWUP|Lost to Follow-up|6|||
143483779|NCT00708500|517316492|FG002|FOLLOWUP|Lost to Follow-up|4|||
143483780|NCT00708500|517316490|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
143483781|NCT00708500|517316491|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
143483782|NCT00708500|517316492|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
143483783|NCT00708500|517316490|FG000|FOLLOWUP|Subject withdrew consent|31|||
143483784|NCT00708500|517316491|FG001|FOLLOWUP|Subject withdrew consent|4|||
143483785|NCT00708500|517316492|FG002|FOLLOWUP|Subject withdrew consent|5|||
143483786|NCT00708500|517316490|FG000|FOLLOWUP|Non-compliance with protocol|5|||
143483787|NCT00708500|517316491|FG001|FOLLOWUP|Non-compliance with protocol|0|||
143483788|NCT00708500|517316492|FG002|FOLLOWUP|Non-compliance with protocol|1|||
143148784|NCT02903914|516089173|FG004|Overall Study|Clinical Disease Progression|0|||
143148785|NCT02903914|516089174|FG005|Overall Study|Clinical Disease Progression|0|||
143148786|NCT02903914|516089175|FG006|Overall Study|Clinical Disease Progression|0|||
143148787|NCT02903914|516089176|FG007|Overall Study|Clinical Disease Progression|0|||
143148788|NCT02903914|516089169|FG000|Overall Study|Completed Follow-up Period|0|||
143148789|NCT02903914|516089170|FG001|Overall Study|Completed Follow-up Period|0|||
143148790|NCT02903914|516089171|FG002|Overall Study|Completed Follow-up Period|6|||
143148791|NCT02903914|516089172|FG003|Overall Study|Completed Follow-up Period|2|||
143148792|NCT02903914|516089173|FG004|Overall Study|Completed Follow-up Period|1|||
143148793|NCT02903914|516089174|FG005|Overall Study|Completed Follow-up Period|0|||
143148794|NCT02903914|516089175|FG006|Overall Study|Completed Follow-up Period|9|||
143148795|NCT02903914|516089176|FG007|Overall Study|Completed Follow-up Period|1|||
143148796|NCT02903914|516089169|FG000|Overall Study|Taken off Treatment per Protocol|0|||
143148797|NCT02903914|516089170|FG001|Overall Study|Taken off Treatment per Protocol|0|||
143148798|NCT02903914|516089171|FG002|Overall Study|Taken off Treatment per Protocol|0|||
143148799|NCT02903914|516089172|FG003|Overall Study|Taken off Treatment per Protocol|0|||
143148800|NCT02903914|516089173|FG004|Overall Study|Taken off Treatment per Protocol|0|||
143148801|NCT02903914|516089174|FG005|Overall Study|Taken off Treatment per Protocol|1|||
143148802|NCT02903914|516089175|FG006|Overall Study|Taken off Treatment per Protocol|0|||
143148803|NCT02903914|516089176|FG007|Overall Study|Taken off Treatment per Protocol|0|||
143148804|NCT02903914|516089169|FG000|Overall Study|Refused Further Treatment/Contact|0|||
143148805|NCT02903914|516089170|FG001|Overall Study|Refused Further Treatment/Contact|0|||
143148806|NCT02903914|516089171|FG002|Overall Study|Refused Further Treatment/Contact|0|||
143148807|NCT02903914|516089172|FG003|Overall Study|Refused Further Treatment/Contact|0|||
143148808|NCT02903914|516089173|FG004|Overall Study|Refused Further Treatment/Contact|0|||
143148809|NCT02903914|516089174|FG005|Overall Study|Refused Further Treatment/Contact|0|||
143148810|NCT02903914|516089175|FG006|Overall Study|Refused Further Treatment/Contact|1|||
143148811|NCT02903914|516089176|FG007|Overall Study|Refused Further Treatment/Contact|0|||
143148812|NCT02903914|516089169|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
143148813|NCT02903914|516089170|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
143148814|NCT02903914|516089171|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
143148815|NCT02903914|516089172|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
143148816|NCT02903914|516089173|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
143148817|NCT02903914|516089174|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
143148818|NCT02903914|516089175|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
143483789|NCT02716987|517316513|FG000|Overall Study|Ligand synthesis failure|0|||
143483790|NCT02716987|517316514|FG001|Overall Study|Ligand synthesis failure|0|||
143483791|NCT02716987|517316515|FG002|Overall Study|Ligand synthesis failure|1|||
143483792|NCT02716987|517316516|FG003|Overall Study|Ligand synthesis failure|0|||
143483793|NCT02716987|517316517|FG004|Overall Study|Ligand synthesis failure|0|||
143483794|NCT02716987|517316518|FG005|Overall Study|Ligand synthesis failure|0|||
143483795|NCT02716987|517316513|FG000|Overall Study|Withdrawal by Subject|0|||
143483796|NCT02716987|517316514|FG001|Overall Study|Withdrawal by Subject|0|||
143483797|NCT02716987|517316515|FG002|Overall Study|Withdrawal by Subject|0|||
143483798|NCT02716987|517316516|FG003|Overall Study|Withdrawal by Subject|0|||
143483799|NCT02716987|517316517|FG004|Overall Study|Withdrawal by Subject|1|||
143483800|NCT02716987|517316518|FG005|Overall Study|Withdrawal by Subject|1|||
143483801|NCT02829138|517316519|FG000|Overall Study|Withdrawal by Subject|1|||
143483802|NCT02829138|517316520|FG001|Overall Study|Withdrawal by Subject|0|||
143483803|NCT02255409|517316521|FG000|Overall Study|Administrative Reason|3|||
143483804|NCT02255409|517316522|FG001|Overall Study|Administrative Reason|7|||
143483805|NCT02255409|517316521|FG000|Overall Study|Withdrawal by Subject|1|||
143483806|NCT02255409|517316522|FG001|Overall Study|Withdrawal by Subject|5|||
143483807|NCT02255409|517316521|FG000|Overall Study|Lost to Follow-up|10|||
143483808|NCT02255409|517316522|FG001|Overall Study|Lost to Follow-up|19|||
143483809|NCT01227044|517316526|FG000|Overall Study|Lost to Follow-up|5|||
143483810|NCT01227044|517316527|FG001|Overall Study|Lost to Follow-up|7|||
143483811|NCT01227044|517316526|FG000|Overall Study|Discontinued Intervention|1|||
143483812|NCT01227044|517316527|FG001|Overall Study|Discontinued Intervention|2|||
143483813|NCT00205855|517316538|FG000|Overall Study|Only received temporary implants|16|||
143483814|NCT00205855|517316538|FG000|Overall Study|Withdrawal by Subject|5|||
143483815|NCT02943564|517316539|FG000|Overall Study|Miscellaneous Reasons|0|||
143483816|NCT02943564|517316540|FG001|Overall Study|Miscellaneous Reasons|0|||
143483817|NCT02943564|517316541|FG002|Overall Study|Miscellaneous Reasons|3|||
143483818|NCT02943564|517316539|FG000|Overall Study|Site terminated by sponsor|0|||
143483819|NCT02943564|517316540|FG001|Overall Study|Site terminated by sponsor|1|||
143483820|NCT02943564|517316541|FG002|Overall Study|Site terminated by sponsor|0|||
143483821|NCT02943564|517316539|FG000|Overall Study|Non-compliance with study drug|0|||
143483822|NCT02943564|517316540|FG001|Overall Study|Non-compliance with study drug|1|||
143483823|NCT02943564|517316541|FG002|Overall Study|Non-compliance with study drug|0|||
143483824|NCT02943564|517316539|FG000|Overall Study|Pregnancy|0|||
143483825|NCT02943564|517316540|FG001|Overall Study|Pregnancy|1|||
143483826|NCT02943564|517316541|FG002|Overall Study|Pregnancy|1|||
143483827|NCT02943564|517316539|FG000|Overall Study|Protocol Violation|2|||
143483828|NCT02943564|517316540|FG001|Overall Study|Protocol Violation|2|||
143483829|NCT02943564|517316541|FG002|Overall Study|Protocol Violation|2|||
143483830|NCT02943564|517316539|FG000|Overall Study|Lost to Follow-up|1|||
143483831|NCT02943564|517316540|FG001|Overall Study|Lost to Follow-up|0|||
143483832|NCT02943564|517316541|FG002|Overall Study|Lost to Follow-up|0|||
143483833|NCT02943564|517316539|FG000|Overall Study|Withdrawal by Subject|6|||
143483834|NCT02943564|517316540|FG001|Overall Study|Withdrawal by Subject|5|||
143483835|NCT02943564|517316541|FG002|Overall Study|Withdrawal by Subject|2|||
143483836|NCT02943564|517316539|FG000|Overall Study|Adverse Event|1|||
143483837|NCT02943564|517316540|FG001|Overall Study|Adverse Event|2|||
143483838|NCT02943564|517316541|FG002|Overall Study|Adverse Event|1|||
143483839|NCT02943564|517316539|FG000|Overall Study|Lack of Efficacy|0|||
143483840|NCT02943564|517316540|FG001|Overall Study|Lack of Efficacy|1|||
143483841|NCT02943564|517316541|FG002|Overall Study|Lack of Efficacy|0|||
143483842|NCT01073267|517316544|FG000|Overall Study|Disease Progression|3|||
143483843|NCT00917150|517316545|FG000|Overall Study|Adverse Event|12|||
143483844|NCT00917150|517316546|FG001|Overall Study|Adverse Event|7|||
143483845|NCT00917150|517316547|FG002|Overall Study|Adverse Event|12|||
143483846|NCT00917150|517316548|FG003|Overall Study|Adverse Event|11|||
143483847|NCT00917150|517316545|FG000|Overall Study|Death|1|||
143483848|NCT00917150|517316546|FG001|Overall Study|Death|4|||
143483849|NCT00917150|517316547|FG002|Overall Study|Death|3|||
143148819|NCT02903914|516089176|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
143483850|NCT00917150|517316548|FG003|Overall Study|Death|2|||
143483851|NCT00917150|517316545|FG000|Overall Study|Lost to Follow-up|1|||
143483852|NCT00917150|517316546|FG001|Overall Study|Lost to Follow-up|0|||
143483853|NCT00917150|517316547|FG002|Overall Study|Lost to Follow-up|4|||
143483854|NCT00917150|517316548|FG003|Overall Study|Lost to Follow-up|2|||
143483855|NCT00917150|517316545|FG000|Overall Study|Physician Decision|0|||
143148820|NCT04225039|516089177|FG000|Overall Study|Withdrawal by Subject|1|||
143148821|NCT04225039|516089178|FG001|Overall Study|Withdrawal by Subject|0|||
143148822|NCT04225039|516089179|FG002|Overall Study|Withdrawal by Subject|0|||
143483856|NCT00917150|517316546|FG001|Overall Study|Physician Decision|2|||
143483857|NCT00917150|517316547|FG002|Overall Study|Physician Decision|0|||
143483858|NCT00917150|517316548|FG003|Overall Study|Physician Decision|1|||
143483859|NCT00917150|517316545|FG000|Overall Study|Protocol Violation|5|||
143483860|NCT00917150|517316546|FG001|Overall Study|Protocol Violation|5|||
143483861|NCT00917150|517316547|FG002|Overall Study|Protocol Violation|3|||
143148823|NCT04225039|516089180|FG003|Overall Study|Withdrawal by Subject|1|||
143148824|NCT04225039|516089177|FG000|Overall Study|Currently active on study treatment|0|||
143148825|NCT04225039|516089178|FG001|Overall Study|Currently active on study treatment|1|||
143148826|NCT04225039|516089179|FG002|Overall Study|Currently active on study treatment|0|||
143148827|NCT04225039|516089180|FG003|Overall Study|Currently active on study treatment|0|||
143148828|NCT04225039|516089177|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
143148829|NCT04225039|516089178|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
143148830|NCT04225039|516089179|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
143148831|NCT04225039|516089180|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
143148832|NCT04225039|516089177|FG000|Overall Study|Ineligible for treatment|0|||
143148833|NCT04225039|516089178|FG001|Overall Study|Ineligible for treatment|0|||
143148834|NCT04225039|516089179|FG002|Overall Study|Ineligible for treatment|0|||
143148835|NCT04225039|516089180|FG003|Overall Study|Ineligible for treatment|4|||
143148836|NCT00088153|516089183|FG000|Overall Study|Physician Decision|3|||
143148837|NCT00088153|516089184|FG001|Overall Study|Physician Decision|3|||
143148838|NCT00088153|516089183|FG000|Overall Study|Withdrawal by Subject|10|||
143148839|NCT00088153|516089184|FG001|Overall Study|Withdrawal by Subject|10|||
143148840|NCT00088153|516089183|FG000|Overall Study|Lost to Follow-up|11|||
143148841|NCT00088153|516089184|FG001|Overall Study|Lost to Follow-up|12|||
143148842|NCT02296125|516089189|FG000|Overall Study|Withdrawal by Subject|18|||
143148843|NCT02296125|516089190|FG001|Overall Study|Withdrawal by Subject|8|||
143148844|NCT02296125|516089191|FG002|Overall Study|Withdrawal by Subject|6|||
143148845|NCT02296125|516089192|FG003|Overall Study|Withdrawal by Subject|2|||
143148846|NCT02296125|516089189|FG000|Overall Study|Adverse Event|41|||
143148847|NCT02296125|516089190|FG001|Overall Study|Adverse Event|52|||
143148848|NCT02296125|516089191|FG002|Overall Study|Adverse Event|9|||
143148849|NCT02296125|516089192|FG003|Overall Study|Adverse Event|4|||
143148850|NCT02296125|516089189|FG000|Overall Study|Severe non-compliance to protocol|0|||
143148851|NCT02296125|516089190|FG001|Overall Study|Severe non-compliance to protocol|1|||
143148852|NCT02296125|516089191|FG002|Overall Study|Severe non-compliance to protocol|0|||
143148853|NCT02296125|516089192|FG003|Overall Study|Severe non-compliance to protocol|0|||
143148854|NCT02296125|516089189|FG000|Overall Study|Condition under investigation worsened|153|||
143148855|NCT02296125|516089190|FG001|Overall Study|Condition under investigation worsened|199|||
143148856|NCT02296125|516089191|FG002|Overall Study|Condition under investigation worsened|39|||
143148857|NCT02296125|516089192|FG003|Overall Study|Condition under investigation worsened|56|||
143148858|NCT02296125|516089189|FG000|Overall Study|Any reason not specifically recorded|6|||
143148859|NCT02296125|516089190|FG001|Overall Study|Any reason not specifically recorded|4|||
143148860|NCT02296125|516089191|FG002|Overall Study|Any reason not specifically recorded|2|||
143148861|NCT02296125|516089192|FG003|Overall Study|Any reason not specifically recorded|0|||
143148862|NCT05248386|516089193|FG000|Overall Study|Technical problems|0|||
143148863|NCT05248386|516089194|FG001|Overall Study|Technical problems|1|||
143148864|NCT05248386|516089193|FG000|Overall Study|Withdrawal by Subject|15|||
143148865|NCT05248386|516089194|FG001|Overall Study|Withdrawal by Subject|10|||
143148866|NCT05248386|516089193|FG000|Overall Study|Physician Decision|0|||
143148867|NCT05248386|516089194|FG001|Overall Study|Physician Decision|1|||
143148868|NCT05248386|516089193|FG000|Overall Study|Adverse Event|2|||
143148869|NCT05248386|516089194|FG001|Overall Study|Adverse Event|4|||
143483862|NCT00917150|517316548|FG003|Overall Study|Protocol Violation|5|||
143483863|NCT00917150|517316545|FG000|Overall Study|Withdrawal by Subject|15|||
143483864|NCT00917150|517316546|FG001|Overall Study|Withdrawal by Subject|16|||
143483865|NCT00917150|517316547|FG002|Overall Study|Withdrawal by Subject|18|||
143483866|NCT00917150|517316548|FG003|Overall Study|Withdrawal by Subject|11|||
143483867|NCT00917150|517316545|FG000|Overall Study|Other than specified|3|||
143483868|NCT00917150|517316546|FG001|Overall Study|Other than specified|3|||
143483869|NCT00917150|517316547|FG002|Overall Study|Other than specified|2|||
143483870|NCT00917150|517316548|FG003|Overall Study|Other than specified|2|||
143483871|NCT03891264|517316549|FG000|Overall Study|Adverse Event|1|||
143483872|NCT03891264|517316549|FG000|Overall Study|Withdrawal by Subject|2|||
143483873|NCT03891264|517316549|FG000|Overall Study|Physician Decision|2|||
143483874|NCT01505634|517316550|FG000|Overall Study|Withdrawal by Subject|2|||
143483875|NCT01505634|517316551|FG001|Overall Study|Withdrawal by Subject|5|||
143483876|NCT01505634|517316552|FG002|Overall Study|Withdrawal by Subject|1|||
143483877|NCT01505634|517316550|FG000|Overall Study|Physician Decision|1|||
143483878|NCT01505634|517316551|FG001|Overall Study|Physician Decision|1|||
143483879|NCT01505634|517316552|FG002|Overall Study|Physician Decision|0|||
143483880|NCT01505634|517316550|FG000|Overall Study|Adverse Event|1|||
143483881|NCT01505634|517316551|FG001|Overall Study|Adverse Event|0|||
143148870|NCT05248386|516089193|FG000|Overall Study|Other|1|||
143363633|NCT00062868|516873787|FG007|Dose Level 2|Lost to Follow-up|0|||
143483882|NCT01505634|517316552|FG002|Overall Study|Adverse Event|0|||
143483883|NCT01505634|517316550|FG000|Overall Study|Insufficient supply of drug at site|1|||
143483884|NCT01505634|517316551|FG001|Overall Study|Insufficient supply of drug at site|0|||
143148871|NCT05248386|516089194|FG001|Overall Study|Other|0|||
143148872|NCT05248386|516089193|FG000|Overall Study|Lack of Efficacy|14|||
143148873|NCT05248386|516089194|FG001|Overall Study|Lack of Efficacy|12|||
143148874|NCT02864992|516089195|FG000|Overall Study|still on treatment|15|||
143483885|NCT01505634|517316552|FG002|Overall Study|Insufficient supply of drug at site|0|||
143483886|NCT01505634|517316550|FG000|Overall Study|Protocol Violation|2|||
143483887|NCT01505634|517316551|FG001|Overall Study|Protocol Violation|0|||
143483888|NCT01505634|517316552|FG002|Overall Study|Protocol Violation|0|||
143483889|NCT01505634|517316550|FG000|Overall Study|Lost to Follow-up|1|||
143483890|NCT01505634|517316551|FG001|Overall Study|Lost to Follow-up|4|||
143483891|NCT01505634|517316552|FG002|Overall Study|Lost to Follow-up|4|||
143483892|NCT01505634|517316550|FG000|Overall Study|Death|1|||
143483893|NCT01505634|517316551|FG001|Overall Study|Death|0|||
143483894|NCT01505634|517316552|FG002|Overall Study|Death|0|||
143483895|NCT01505634|517316550|FG000|Overall Study|In a conflict zone|0|||
143483896|NCT01505634|517316551|FG001|Overall Study|In a conflict zone|0|||
143483897|NCT01505634|517316552|FG002|Overall Study|In a conflict zone|1|||
143483898|NCT01624662|517316556|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
143148875|NCT02864992|516089196|FG001|Overall Study|still on treatment|1|||
143148876|NCT02864992|516089197|FG002|Overall Study|still on treatment|33|||
143148877|NCT03621592|516089198|FG000|Overall Study|Lost to Follow-up|1|||
143483899|NCT01624662|517316557|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
143148878|NCT03621592|516089199|FG001|Overall Study|Lost to Follow-up|0|||
143148879|NCT03621592|516089198|FG000|Overall Study|Lack of Improvement|1|||
143148880|NCT03621592|516089199|FG001|Overall Study|Lack of Improvement|0|||
143148881|NCT03621592|516089198|FG000|Overall Study|Preference to receive wound care closer to home|1|||
143148882|NCT03621592|516089199|FG001|Overall Study|Preference to receive wound care closer to home|0|||
143148883|NCT03621592|516089198|FG000|Overall Study|Lack of healing|0|||
143148884|NCT03621592|516089199|FG001|Overall Study|Lack of healing|2|||
143148885|NCT04967222|516089201|FG000|Randomized|Lost to Follow-up|0|||
143148886|NCT04967222|516089202|FG001|Randomized|Lost to Follow-up|1|||
143148887|NCT04967222|516089203|FG002|Randomized|Lost to Follow-up|1|||
143148888|NCT04967222|516089201|FG000|Randomized|Physician Decision|0|||
143148889|NCT04967222|516089202|FG001|Randomized|Physician Decision|0|||
143483900|NCT01624662|517316558|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
143483901|NCT01624662|517316559|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
143483902|NCT01624662|517316556|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
143483903|NCT01624662|517316557|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
143483904|NCT01624662|517316558|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
143483905|NCT01624662|517316559|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
143483906|NCT01624662|517316556|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
143483907|NCT01624662|517316557|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
143483908|NCT01624662|517316558|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
143483909|NCT01624662|517316559|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
143483910|NCT01624662|517316556|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
143483911|NCT01624662|517316557|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
143483912|NCT01624662|517316558|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
143483913|NCT01624662|517316559|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
143483914|NCT01624662|517316556|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
143483915|NCT01624662|517316557|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
143483916|NCT01624662|517316558|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
143483917|NCT01624662|517316559|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
143483918|NCT01624662|517316556|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
143483919|NCT01624662|517316557|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
143483920|NCT01624662|517316558|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
143483921|NCT01624662|517316559|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
143483922|NCT01624662|517316556|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
143483923|NCT01624662|517316557|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
143483924|NCT01624662|517316558|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
143483925|NCT01624662|517316559|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
143483926|NCT00278993|517316562|FG000|Overall Study|Adverse Event|24|||
143483927|NCT00278993|517316562|FG000|Overall Study|Withdrawal by Subject|5|||
143483928|NCT00278993|517316562|FG000|Overall Study|Progressive Disease|65|||
143483929|NCT00278993|517316562|FG000|Overall Study|Physician Decision|9|||
143483930|NCT00278993|517316562|FG000|Overall Study|Not Otherwise Specified|4|||
143483931|NCT03077685|517316570|FG000|Overall Study|Lost to Follow-up|0|||
143483932|NCT03077685|517316571|FG001|Overall Study|Lost to Follow-up|0|||
143015022|NCT00567996|515595649|FG000|Overall Study|Abnormal test procedure result(s)|2|||
143015023|NCT00567996|515595650|FG001|Overall Study|Abnormal test procedure result(s)|1|||
143148890|NCT04967222|516089203|FG002|Randomized|Physician Decision|1|||
143148891|NCT04967222|516089201|FG000|Randomized|Withdrawal by Subject|0|||
143148892|NCT04967222|516089202|FG001|Randomized|Withdrawal by Subject|0|||
143148893|NCT04967222|516089203|FG002|Randomized|Withdrawal by Subject|2|||
143148894|NCT04967222|516089201|FG000|Randomized|abnormal finding in MRI|0|||
143148895|NCT04967222|516089202|FG001|Randomized|abnormal finding in MRI|2|||
143148896|NCT04967222|516089203|FG002|Randomized|abnormal finding in MRI|0|||
143483933|NCT03077685|517316572|FG002|Overall Study|Lost to Follow-up|0|||
143483934|NCT03077685|517316573|FG003|Overall Study|Lost to Follow-up|0|||
143483935|NCT03077685|517316574|FG004|Overall Study|Lost to Follow-up|1|||
143483936|NCT03077685|517316570|FG000|Overall Study|Death|0|||
143483937|NCT03077685|517316571|FG001|Overall Study|Death|0|||
143483938|NCT03077685|517316572|FG002|Overall Study|Death|1|||
143483939|NCT03077685|517316573|FG003|Overall Study|Death|1|||
143483940|NCT03077685|517316574|FG004|Overall Study|Death|3|||
143483941|NCT03077685|517316570|FG000|Overall Study|Withdrawal by Subject|0|||
143483942|NCT03077685|517316571|FG001|Overall Study|Withdrawal by Subject|0|||
143483943|NCT03077685|517316572|FG002|Overall Study|Withdrawal by Subject|0|||
143483944|NCT03077685|517316573|FG003|Overall Study|Withdrawal by Subject|2|||
143483945|NCT03077685|517316574|FG004|Overall Study|Withdrawal by Subject|1|||
143483946|NCT03077685|517316570|FG000|Overall Study|Physician Decision|0|||
143483947|NCT03077685|517316571|FG001|Overall Study|Physician Decision|0|||
143483948|NCT03077685|517316572|FG002|Overall Study|Physician Decision|1|||
143483949|NCT03077685|517316573|FG003|Overall Study|Physician Decision|0|||
143483950|NCT03077685|517316574|FG004|Overall Study|Physician Decision|3|||
143483951|NCT03077685|517316570|FG000|Overall Study|Disease Progression|1|||
143483952|NCT03077685|517316571|FG001|Overall Study|Disease Progression|0|||
143483953|NCT03077685|517316572|FG002|Overall Study|Disease Progression|0|||
143483954|NCT03077685|517316573|FG003|Overall Study|Disease Progression|2|||
143483955|NCT03077685|517316574|FG004|Overall Study|Disease Progression|1|||
143483956|NCT03077685|517316570|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
143483957|NCT03077685|517316571|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
143483958|NCT03077685|517316572|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
143483959|NCT03077685|517316573|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
143483960|NCT03077685|517316574|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
143483961|NCT03077685|517316570|FG000|Overall Study|Subject entered hospice care|0|||
143483962|NCT03077685|517316571|FG001|Overall Study|Subject entered hospice care|0|||
143483963|NCT03077685|517316572|FG002|Overall Study|Subject entered hospice care|0|||
143483964|NCT03077685|517316573|FG003|Overall Study|Subject entered hospice care|0|||
143483965|NCT03077685|517316574|FG004|Overall Study|Subject entered hospice care|1|||
143483966|NCT01979536|517316575|FG000|Overall Study|Physician Decision|2|||
143483967|NCT01979536|517316576|FG001|Overall Study|Physician Decision|3|||
143483968|NCT01979536|517316575|FG000|Overall Study|Withdrawal by Subject|0|||
143483969|NCT01979536|517316576|FG001|Overall Study|Withdrawal by Subject|1|||
143483970|NCT01979536|517316575|FG000|Overall Study|Refusal|0|||
143483971|NCT01979536|517316576|FG001|Overall Study|Refusal|1|||
143483972|NCT01979536|517316575|FG000|Overall Study|Relapse|0|||
143483973|NCT01979536|517316576|FG001|Overall Study|Relapse|1|||
143483974|NCT01979536|517316575|FG000|Overall Study|Study terminated by Sponsor|0|||
143483975|NCT01979536|517316576|FG001|Overall Study|Study terminated by Sponsor|1|||
143483976|NCT01979536|517316575|FG000|Overall Study|Did not start treatment|0|||
143148897|NCT02382380|516089204|FG000|Overall Study|Withdrawal by Subject|2|||
143148898|NCT02382380|516089205|FG001|Overall Study|Withdrawal by Subject|2|||
143148899|NCT02382380|516089204|FG000|Overall Study|Lost to Follow-up|0|||
143148900|NCT02382380|516089205|FG001|Overall Study|Lost to Follow-up|1|||
143148901|NCT01295944|516089206|FG000|Overall Study|Switched to alternative treatment|1|||
143148902|NCT01295944|516089206|FG000|Overall Study|Ineligible|9|||
143148903|NCT01295944|516089206|FG000|Overall Study|Withdrawal by Subject|1|||
143148904|NCT01295944|516089206|FG000|Overall Study|Participant chose to be treated in Peru|1|||
143148905|NCT01295944|516089206|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
143148906|NCT01295944|516089206|FG000|Overall Study|Physician Decision|1|||
143148907|NCT01295944|516089206|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
143148908|NCT01295944|516089206|FG000|Overall Study|Disease progression|4|||
143148909|NCT01295944|516089206|FG000|Overall Study|Transferred care before starting new treatment|1|||
143148910|NCT03785366|516089214|FG000|Overall Study|Non-Menstrual Pelvic Pain|1|||
143148911|NCT03785366|516089215|FG001|Overall Study|Non-Menstrual Pelvic Pain|0|||
143148912|NCT03785366|516089214|FG000|Overall Study|Lost to Follow-up|1|||
143148913|NCT03785366|516089215|FG001|Overall Study|Lost to Follow-up|0|||
143148914|NCT03785366|516089214|FG000|Overall Study|Partial IUD Expulsion|0|||
143148915|NCT03785366|516089215|FG001|Overall Study|Partial IUD Expulsion|2|||
143148916|NCT03785366|516089214|FG000|Overall Study|Unsuccessful IUD Insertion|0|||
143148917|NCT03785366|516089215|FG001|Overall Study|Unsuccessful IUD Insertion|1|||
143148918|NCT03240874|516089216|FG000|Overall Study|Lost to Follow-up|0|||
143148919|NCT03240874|516089217|FG001|Overall Study|Lost to Follow-up|2|||
143148920|NCT03240874|516089218|FG002|Overall Study|Lost to Follow-up|4|||
143148921|NCT03240874|516089219|FG003|Overall Study|Lost to Follow-up|1|||
143148922|NCT05252702|516089220|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
143148923|NCT05252702|516089220|FG000|Overall Study|Death|16|||
143148924|NCT05252702|516089220|FG000|Overall Study|System explant|5|||
143148925|NCT05252702|516089220|FG000|Overall Study|Lost to Follow-up|1|||
143483977|NCT01979536|517316576|FG001|Overall Study|Did not start treatment|1|||
143483978|NCT04294901|517316587|FG000|Overall Study|Death|86|||
143148926|NCT05252702|516089220|FG000|Overall Study|Withdrawn by investigator|1|||
143483979|NCT04294901|517316588|FG001|Overall Study|Death|110|||
143483980|NCT04294901|517316587|FG000|Overall Study|Provider did not have historical control patients|581|||
143483981|NCT04294901|517316588|FG001|Overall Study|Provider did not have historical control patients|0|||
143483982|NCT04294901|517316587|FG000|Overall Study|Provider did not have intervention patients|0|||
143483983|NCT04294901|517316588|FG001|Overall Study|Provider did not have intervention patients|98|||
143483984|NCT01934556|517316590|FG000|Overall Study|Withdrawal by Subject|0|||
143483985|NCT01934556|517316591|FG001|Overall Study|Withdrawal by Subject|1|||
143483986|NCT01934556|517316592|FG002|Overall Study|Withdrawal by Subject|1|||
143483987|NCT01934556|517316590|FG000|Overall Study|Lost to Follow-up|4|||
143483988|NCT01934556|517316591|FG001|Overall Study|Lost to Follow-up|10|||
143483989|NCT01934556|517316592|FG002|Overall Study|Lost to Follow-up|7|||
143483990|NCT01934556|517316590|FG000|Overall Study|Death|1|||
143483991|NCT01934556|517316591|FG001|Overall Study|Death|5|||
143483992|NCT01934556|517316592|FG002|Overall Study|Death|2|||
143483993|NCT00102960|517316595|FG000|Overall Study|Death|23|||
143483994|NCT00102960|517316596|FG001|Overall Study|Death|11|||
143483995|NCT00102960|517316597|FG002|Overall Study|Death|11|||
143483996|NCT00102960|517316595|FG000|Overall Study|Lost to Follow-up|6|||
143148927|NCT05252702|516089220|FG000|Overall Study|Visit not due|306|||
143148928|NCT05252702|516089220|FG000|Overall Study|Visit within window but not completed|92|||
143148929|NCT05252702|516089220|FG000|Overall Study|Unsuccessful implant|1|||
143148930|NCT04153864|516089221|FG000|Overall Study|Withdrawal by Subject|21|||
143148931|NCT04153864|516089222|FG001|Overall Study|Withdrawal by Subject|7|||
143148932|NCT04153864|516089223|FG002|Overall Study|Withdrawal by Subject|23|||
143148933|NCT04153864|516089224|FG003|Overall Study|Withdrawal by Subject|2|||
143148934|NCT04153864|516089221|FG000|Overall Study|Lost to Follow-up|4|||
143148935|NCT04153864|516089222|FG001|Overall Study|Lost to Follow-up|0|||
143148936|NCT04153864|516089223|FG002|Overall Study|Lost to Follow-up|3|||
143148937|NCT04153864|516089224|FG003|Overall Study|Lost to Follow-up|0|||
143148938|NCT04153864|516089221|FG000|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|28|||
143148939|NCT04153864|516089222|FG001|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|10|||
143483997|NCT00102960|517316596|FG001|Overall Study|Lost to Follow-up|12|||
143483998|NCT00102960|517316597|FG002|Overall Study|Lost to Follow-up|16|||
143483999|NCT00102960|517316595|FG000|Overall Study|Withdrawal by Subject|1|||
143484000|NCT00102960|517316596|FG001|Overall Study|Withdrawal by Subject|0|||
143484001|NCT00102960|517316597|FG002|Overall Study|Withdrawal by Subject|1|||
143484002|NCT04129528|517318565|FG000|Overall Study|Adverse Event|1|||
143484003|NCT04129528|517318566|FG001|Overall Study|Adverse Event|0|||
143484004|NCT04129528|517318565|FG000|Overall Study|Physician Decision|1|||
143484005|NCT04129528|517318566|FG001|Overall Study|Physician Decision|1|||
143484006|NCT04129528|517318565|FG000|Overall Study|Withdrawal by Subject|1|||
143484007|NCT04129528|517318566|FG001|Overall Study|Withdrawal by Subject|1|||
143484008|NCT01395394|517318567|FG000|Baseline Study Visit|Protocol Violation|1|||
143484009|NCT01395394|517318568|FG001|Baseline Study Visit|Protocol Violation|0|||
143484010|NCT01395394|517318569|FG002|Baseline Study Visit|Protocol Violation|0|||
143484011|NCT05121480|517318570|FG000|Overall Study|Lack of Efficacy|2|||
143484012|NCT05121480|517318571|FG001|Overall Study|Lack of Efficacy|2|||
143484013|NCT05121480|517318572|FG002|Overall Study|Lack of Efficacy|1|||
143484014|NCT05121480|517318573|FG003|Overall Study|Lack of Efficacy|4|||
143484015|NCT05121480|517318574|FG004|Overall Study|Lack of Efficacy|0|||
143484016|NCT05121480|517318575|FG005|Overall Study|Lack of Efficacy|1|||
143484017|NCT05121480|517318576|FG006|Overall Study|Lack of Efficacy|0|||
143484018|NCT05121480|517318577|FG007|Overall Study|Lack of Efficacy|2|||
143484019|NCT05121480|517318570|FG000|Overall Study|Treatment Failure|0|||
143484020|NCT05121480|517318571|FG001|Overall Study|Treatment Failure|2|||
143484021|NCT05121480|517318572|FG002|Overall Study|Treatment Failure|0|||
143484022|NCT05121480|517318573|FG003|Overall Study|Treatment Failure|1|||
143484023|NCT05121480|517318574|FG004|Overall Study|Treatment Failure|0|||
143484024|NCT05121480|517318575|FG005|Overall Study|Treatment Failure|0|||
143484025|NCT05121480|517318576|FG006|Overall Study|Treatment Failure|0|||
143484026|NCT05121480|517318577|FG007|Overall Study|Treatment Failure|0|||
143484027|NCT05121480|517318570|FG000|Overall Study|Adverse Event|0|||
143484028|NCT05121480|517318571|FG001|Overall Study|Adverse Event|1|||
143484029|NCT05121480|517318572|FG002|Overall Study|Adverse Event|0|||
143484030|NCT05121480|517318573|FG003|Overall Study|Adverse Event|5|||
143484031|NCT05121480|517318574|FG004|Overall Study|Adverse Event|3|||
143484032|NCT05121480|517318575|FG005|Overall Study|Adverse Event|2|||
143484033|NCT05121480|517318576|FG006|Overall Study|Adverse Event|0|||
143484034|NCT05121480|517318577|FG007|Overall Study|Adverse Event|4|||
143484035|NCT05121480|517318570|FG000|Overall Study|Withdrawal by Subject|4|||
143484036|NCT05121480|517318571|FG001|Overall Study|Withdrawal by Subject|9|||
143484037|NCT05121480|517318572|FG002|Overall Study|Withdrawal by Subject|1|||
143148940|NCT04153864|516089223|FG002|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|26|||
143148941|NCT04153864|516089224|FG003|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|8|||
143148942|NCT03036254|516089225|FG000|Overall Study|Adverse Event|6|||
143484038|NCT05121480|517318573|FG003|Overall Study|Withdrawal by Subject|8|||
143484039|NCT05121480|517318574|FG004|Overall Study|Withdrawal by Subject|0|||
143148943|NCT03036254|516089226|FG001|Overall Study|Adverse Event|4|||
143148944|NCT03036254|516089225|FG000|Overall Study|Death|3|||
143148945|NCT03036254|516089226|FG001|Overall Study|Death|1|||
143148946|NCT03036254|516089225|FG000|Overall Study|Lack of Efficacy|5|||
143148947|NCT03036254|516089226|FG001|Overall Study|Lack of Efficacy|1|||
143148948|NCT03036254|516089225|FG000|Overall Study|Withdrawal by Subject|3|||
143148949|NCT03036254|516089226|FG001|Overall Study|Withdrawal by Subject|5|||
143148950|NCT02783274|516089234|FG000|Overall Study|Withdrawal by Subject|16|||
143148951|NCT02783274|516089234|FG000|Overall Study|Physician Decision|6|||
143148952|NCT02783274|516089234|FG000|Overall Study|Death|9|||
143148953|NCT02783274|516089234|FG000|Overall Study|Lost to Follow-up|22|||
143148954|NCT02783274|516089234|FG000|Overall Study|Other|22|||
143148955|NCT04132050|516089238|FG000|Period I (Double-blind Period)|Adverse Event|3|||
143148956|NCT04132050|516089239|FG001|Period I (Double-blind Period)|Adverse Event|0|||
143148957|NCT04132050|516089238|FG000|Period I (Double-blind Period)|Lack of Efficacy|9|||
143148958|NCT04132050|516089239|FG001|Period I (Double-blind Period)|Lack of Efficacy|8|||
143148959|NCT04132050|516089238|FG000|R788 Treatment Period|Adverse Event|5|||
143148960|NCT04132050|516089239|FG001|R788 Treatment Period|Adverse Event|0|||
143148961|NCT04132050|516089238|FG000|R788 Treatment Period|Lack of Efficacy|5|||
143148962|NCT04132050|516089239|FG001|R788 Treatment Period|Lack of Efficacy|0|||
143148963|NCT04132050|516089238|FG000|R788 Treatment Period|Withdrawal by Subject|1|||
143148964|NCT04132050|516089239|FG001|R788 Treatment Period|Withdrawal by Subject|0|||
143148965|NCT01063114|516089240|FG000|Overall Study|Lost to Follow-up|1|||
143148966|NCT04635423|516089241|FG000|Overall Study|Ongoing|493|||
143148967|NCT04635423|516089242|FG001|Overall Study|Ongoing|501|||
143148968|NCT04635423|516089241|FG000|Overall Study|Withdrawal by Subject|36|||
143148969|NCT04635423|516089242|FG001|Overall Study|Withdrawal by Subject|29|||
143148970|NCT05556057|516089243|FG000|Overall Study|Lost to Follow-up|5|||
143148971|NCT05556057|516089244|FG001|Overall Study|Lost to Follow-up|4|||
143148972|NCT05556057|516089243|FG000|Overall Study|Withdrawal by Subject|0|||
143148973|NCT05556057|516089244|FG001|Overall Study|Withdrawal by Subject|2|||
143148974|NCT05020743|516089254|FG000|Overall Study|Enrollment in Interventional Study|2|||
143148975|NCT05020743|516089255|FG001|Overall Study|Enrollment in Interventional Study|9|||
143148976|NCT05020743|516089256|FG002|Overall Study|Enrollment in Interventional Study|0|||
143148977|NCT05020743|516089254|FG000|Overall Study|Withdrawal by Subject|0|||
143148978|NCT05020743|516089255|FG001|Overall Study|Withdrawal by Subject|3|||
143148979|NCT05020743|516089256|FG002|Overall Study|Withdrawal by Subject|1|||
143148980|NCT05020743|516089254|FG000|Overall Study|Lost to Follow-up|1|||
143148981|NCT05020743|516089255|FG001|Overall Study|Lost to Follow-up|0|||
143148982|NCT05020743|516089256|FG002|Overall Study|Lost to Follow-up|0|||
143148983|NCT05020743|516089254|FG000|Overall Study|Study Termination by Sponsor|10|||
143148984|NCT05020743|516089255|FG001|Overall Study|Study Termination by Sponsor|11|||
143148985|NCT05020743|516089256|FG002|Overall Study|Study Termination by Sponsor|10|||
143148986|NCT02390284|516089257|FG000|Overall Study|Physician Decision|0|||
143148987|NCT02390284|516089258|FG001|Overall Study|Physician Decision|0|||
143148988|NCT02390284|516089259|FG002|Overall Study|Physician Decision|9|||
143148989|NCT03980223|516089260|FG000|Overall Study|Lost to Follow-up|3|||
143148990|NCT03980223|516089261|FG001|Overall Study|Lost to Follow-up|7|||
143148991|NCT03980223|516089262|FG002|Overall Study|Lost to Follow-up|10|||
143484040|NCT05121480|517318575|FG005|Overall Study|Withdrawal by Subject|9|||
143148992|NCT03980223|516089263|FG003|Overall Study|Lost to Follow-up|8|||
143148993|NCT03980223|516089260|FG000|Overall Study|Withdrawal by Subject|0|||
143148994|NCT03980223|516089261|FG001|Overall Study|Withdrawal by Subject|0|||
143148995|NCT03980223|516089262|FG002|Overall Study|Withdrawal by Subject|1|||
143484041|NCT05121480|517318576|FG006|Overall Study|Withdrawal by Subject|0|||
143484042|NCT05121480|517318577|FG007|Overall Study|Withdrawal by Subject|4|||
143484043|NCT05121480|517318570|FG000|Overall Study|Non-compliance with the protocol|0|||
143148996|NCT03980223|516089263|FG003|Overall Study|Withdrawal by Subject|2|||
143148997|NCT03980223|516089260|FG000|Overall Study|Physician Decision|0|||
143148998|NCT03980223|516089261|FG001|Overall Study|Physician Decision|0|||
143148999|NCT03980223|516089262|FG002|Overall Study|Physician Decision|1|||
143484044|NCT05121480|517318571|FG001|Overall Study|Non-compliance with the protocol|0|||
143484045|NCT05121480|517318572|FG002|Overall Study|Non-compliance with the protocol|0|||
143484046|NCT05121480|517318573|FG003|Overall Study|Non-compliance with the protocol|0|||
143484047|NCT05121480|517318574|FG004|Overall Study|Non-compliance with the protocol|1|||
143484048|NCT05121480|517318575|FG005|Overall Study|Non-compliance with the protocol|6|||
143484049|NCT05121480|517318576|FG006|Overall Study|Non-compliance with the protocol|0|||
143484050|NCT05121480|517318577|FG007|Overall Study|Non-compliance with the protocol|1|||
143484051|NCT05121480|517318570|FG000|Overall Study|Lost to Follow-up|0|||
143149000|NCT03980223|516089263|FG003|Overall Study|Physician Decision|0|||
143149001|NCT03980223|516089260|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
143149002|NCT03980223|516089261|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
143149003|NCT03980223|516089262|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
143149004|NCT03980223|516089263|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
143149005|NCT01922934|516089267|FG000|Eligible Patients|Death|0|||
143149006|NCT01922934|516089268|FG001|Eligible Patients|Death|7|||
143149007|NCT01922934|516089267|FG000|Eligible Patients|Physician Decision|17|||
143149008|NCT01922934|516089268|FG001|Eligible Patients|Physician Decision|0|||
143149009|NCT01922934|516089267|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
143149010|NCT01922934|516089268|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
143149011|NCT01922934|516089267|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
143149012|NCT01922934|516089268|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
143149013|NCT01922934|516089267|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
143149014|NCT01922934|516089268|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
143149015|NCT01922934|516089267|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
143149016|NCT01922934|516089268|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
143149017|NCT01069939|516089273|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
143149018|NCT01069939|516089274|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
143149019|NCT01069939|516089273|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
143149020|NCT01069939|516089274|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
143149021|NCT01069939|516089273|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
143149022|NCT01069939|516089274|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
143484052|NCT05121480|517318571|FG001|Overall Study|Lost to Follow-up|4|||
143484053|NCT05121480|517318572|FG002|Overall Study|Lost to Follow-up|1|||
143484054|NCT05121480|517318573|FG003|Overall Study|Lost to Follow-up|3|||
143484055|NCT05121480|517318574|FG004|Overall Study|Lost to Follow-up|1|||
143484056|NCT05121480|517318575|FG005|Overall Study|Lost to Follow-up|1|||
143484057|NCT05121480|517318576|FG006|Overall Study|Lost to Follow-up|1|||
143484058|NCT05121480|517318577|FG007|Overall Study|Lost to Follow-up|4|||
143484059|NCT05121480|517318570|FG000|Overall Study|Physician Decision|0|||
143484060|NCT05121480|517318571|FG001|Overall Study|Physician Decision|0|||
143484061|NCT05121480|517318572|FG002|Overall Study|Physician Decision|0|||
143484062|NCT05121480|517318573|FG003|Overall Study|Physician Decision|0|||
143484063|NCT05121480|517318574|FG004|Overall Study|Physician Decision|0|||
143484064|NCT05121480|517318575|FG005|Overall Study|Physician Decision|1|||
143484065|NCT05121480|517318576|FG006|Overall Study|Physician Decision|0|||
143484066|NCT05121480|517318577|FG007|Overall Study|Physician Decision|1|||
143484067|NCT05121480|517318570|FG000|Overall Study|Other Reason|0|||
143484068|NCT05121480|517318571|FG001|Overall Study|Other Reason|0|||
143484069|NCT05121480|517318572|FG002|Overall Study|Other Reason|0|||
143484070|NCT05121480|517318573|FG003|Overall Study|Other Reason|0|||
143484071|NCT05121480|517318574|FG004|Overall Study|Other Reason|0|||
143484072|NCT05121480|517318575|FG005|Overall Study|Other Reason|1|||
143484073|NCT05121480|517318576|FG006|Overall Study|Other Reason|1|||
143484074|NCT05121480|517318577|FG007|Overall Study|Other Reason|1|||
143484075|NCT02356562|517318580|FG000|Overall Study|Withdrawal by Subject|0|||
143484076|NCT02356562|517318581|FG001|Overall Study|Withdrawal by Subject|1|||
143484077|NCT02356562|517318580|FG000|Overall Study|Re-entered treatment in a previous study|1|||
143484078|NCT02356562|517318581|FG001|Overall Study|Re-entered treatment in a previous study|0|||
143484079|NCT02356562|517318580|FG000|Overall Study|site closure|1|||
143484080|NCT02356562|517318581|FG001|Overall Study|site closure|0|||
143484081|NCT00150592|517318583|FG000|Overall Study|Adverse Event|4|||
143484082|NCT00150592|517318584|FG001|Overall Study|Adverse Event|1|||
143484083|NCT00150592|517318583|FG000|Overall Study|Protocol Violation|1|||
143484084|NCT00150592|517318584|FG001|Overall Study|Protocol Violation|0|||
143484085|NCT00150592|517318583|FG000|Overall Study|Withdrawal by Subject|1|||
143484086|NCT00150592|517318584|FG001|Overall Study|Withdrawal by Subject|2|||
143484087|NCT00150592|517318583|FG000|Overall Study|Non-compliance|1|||
143484088|NCT00150592|517318584|FG001|Overall Study|Non-compliance|0|||
143484089|NCT00412750|517318585|FG000|Overall Study|Abnormal laboratory value(s)|1|||
143484090|NCT00412750|517318586|FG001|Overall Study|Abnormal laboratory value(s)|0|||
143484091|NCT00412750|517318587|FG002|Overall Study|Abnormal laboratory value(s)|0|||
143484092|NCT00412750|517318585|FG000|Overall Study|Administrative problems|21|||
143484093|NCT00412750|517318586|FG001|Overall Study|Administrative problems|17|||
143484094|NCT00412750|517318587|FG002|Overall Study|Administrative problems|14|||
143484095|NCT00412750|517318585|FG000|Overall Study|Adverse Event|8|||
143484096|NCT00412750|517318586|FG001|Overall Study|Adverse Event|3|||
143484097|NCT00412750|517318587|FG002|Overall Study|Adverse Event|3|||
143484098|NCT00412750|517318585|FG000|Overall Study|Lost to Follow-up|1|||
143484099|NCT00412750|517318586|FG001|Overall Study|Lost to Follow-up|0|||
143484100|NCT00412750|517318587|FG002|Overall Study|Lost to Follow-up|1|||
143149023|NCT01069939|516089273|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
143484101|NCT00412750|517318585|FG000|Overall Study|Withdrawal by Subject|0|||
143484102|NCT00412750|517318586|FG001|Overall Study|Withdrawal by Subject|1|||
143484103|NCT00412750|517318587|FG002|Overall Study|Withdrawal by Subject|2|||
143149024|NCT01069939|516089274|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
143484104|NCT00412750|517318585|FG000|Overall Study|Lack of Efficacy|0|||
143484105|NCT00412750|517318586|FG001|Overall Study|Lack of Efficacy|0|||
143484106|NCT00412750|517318587|FG002|Overall Study|Lack of Efficacy|3|||
143149025|NCT01069939|516089273|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
143149026|NCT01069939|516089274|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
143149027|NCT01069939|516089273|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
143149028|NCT01069939|516089274|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
143149029|NCT01069939|516089273|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
143149030|NCT01069939|516089274|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
143149031|NCT01069939|516089273|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
143149032|NCT01069939|516089274|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
143149033|NCT01069939|516089273|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
143149034|NCT01069939|516089274|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
143149035|NCT01069939|516089273|FG000|Randomised and Included in the Analyses|Removal|1|||
143149036|NCT01069939|516089274|FG001|Randomised and Included in the Analyses|Removal|0|||
143149037|NCT00724945|516089275|FG000|Period 1|non-compliance|1|||
143149038|NCT00724945|516089276|FG001|Period 1|non-compliance|0|||
143149039|NCT00724945|516089275|FG000|Period 1|Adverse Event|1|||
143149040|NCT00724945|516089276|FG001|Period 1|Adverse Event|1|||
143149041|NCT00724945|516089275|FG000|Period 1|Lost to Follow-up|1|||
143149042|NCT00724945|516089276|FG001|Period 1|Lost to Follow-up|0|||
143149043|NCT00724945|516089275|FG000|Period 2|lens comfort issue|3|||
143149044|NCT00724945|516089276|FG001|Period 2|lens comfort issue|0|||
143149045|NCT00724945|516089275|FG000|Period 2|lens physiology issue|1|||
143149046|NCT00724945|516089276|FG001|Period 2|lens physiology issue|0|||
143149047|NCT05166876|516089277|FG000|Overall Study|Withdrawal by Subject|1|||
143149048|NCT05166876|516089278|FG001|Overall Study|Withdrawal by Subject|0|||
143149049|NCT05166876|516089279|FG002|Overall Study|Withdrawal by Subject|0|||
143149050|NCT01147458|516089280|FG000|First Intervention|Study terminated by sponsor|8|||
143149051|NCT01147458|516089281|FG001|First Intervention|Study terminated by sponsor|8|||
143149052|NCT01147458|516089282|FG002|First Intervention|Study terminated by sponsor|7|||
143149053|NCT01147458|516089283|FG003|First Intervention|Study terminated by sponsor|8|||
143149054|NCT01147458|516089280|FG000|First Intervention|Protocol Violation|2|||
143149055|NCT01147458|516089281|FG001|First Intervention|Protocol Violation|3|||
143149056|NCT01147458|516089282|FG002|First Intervention|Protocol Violation|2|||
143149057|NCT01147458|516089283|FG003|First Intervention|Protocol Violation|3|||
143149058|NCT01147458|516089280|FG000|First Intervention|Withdrawal by Subject|3|||
143149059|NCT01147458|516089281|FG001|First Intervention|Withdrawal by Subject|0|||
143149060|NCT01147458|516089282|FG002|First Intervention|Withdrawal by Subject|1|||
143149061|NCT01147458|516089283|FG003|First Intervention|Withdrawal by Subject|0|||
143149062|NCT01147458|516089280|FG000|First Intervention|Adverse Event|0|||
143149063|NCT01147458|516089281|FG001|First Intervention|Adverse Event|3|||
143149064|NCT01147458|516089282|FG002|First Intervention|Adverse Event|2|||
143149065|NCT01147458|516089283|FG003|First Intervention|Adverse Event|3|||
143149066|NCT01147458|516089280|FG000|First Intervention|Other|1|||
143149067|NCT01147458|516089281|FG001|First Intervention|Other|2|||
143149068|NCT01147458|516089282|FG002|First Intervention|Other|0|||
143149069|NCT01147458|516089283|FG003|First Intervention|Other|0|||
143149070|NCT01147458|516089280|FG000|Second Intervention|Study terminated by sponsor|7|||
143149071|NCT01147458|516089281|FG001|Second Intervention|Study terminated by sponsor|5|||
143149072|NCT01147458|516089282|FG002|Second Intervention|Study terminated by sponsor|5|||
143149073|NCT01147458|516089283|FG003|Second Intervention|Study terminated by sponsor|3|||
143149074|NCT01147458|516089280|FG000|Second Intervention|Protocol Violation|0|||
143149075|NCT01147458|516089281|FG001|Second Intervention|Protocol Violation|1|||
143149076|NCT01147458|516089282|FG002|Second Intervention|Protocol Violation|1|||
143149077|NCT01147458|516089283|FG003|Second Intervention|Protocol Violation|0|||
143149078|NCT01147458|516089280|FG000|Second Intervention|Withdrawal by Subject|0|||
143149079|NCT01147458|516089281|FG001|Second Intervention|Withdrawal by Subject|1|||
143149080|NCT01147458|516089282|FG002|Second Intervention|Withdrawal by Subject|0|||
143149081|NCT01147458|516089283|FG003|Second Intervention|Withdrawal by Subject|0|||
143232187|NCT00537394|516402038|FG002|First Year of Follow-up|Lost to Follow-up|1|||
143232188|NCT00537394|516402036|FG000|2nd Year of Follow-up|Death|4|||
143232189|NCT00537394|516402037|FG001|2nd Year of Follow-up|Death|1|||
143232190|NCT00537394|516402038|FG002|2nd Year of Follow-up|Death|2|||
143232191|NCT00537394|516402036|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
143232192|NCT00537394|516402037|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
143232193|NCT00537394|516402038|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
143232194|NCT00537394|516402036|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
143484107|NCT00874120|517318594|FG000|First Intervention|Adverse Event|0|||
143484108|NCT00874120|517318595|FG001|First Intervention|Adverse Event|1|||
143484109|NCT00874120|517318594|FG000|First Intervention|Withdrawal by Subject|2|||
143232195|NCT00537394|516402037|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
143232196|NCT00537394|516402038|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
143232197|NCT00537394|516402036|FG000|2nd Year of Follow-up|Clinic site closure|1|||
143232198|NCT00537394|516402037|FG001|2nd Year of Follow-up|Clinic site closure|0|||
143484110|NCT00874120|517318595|FG001|First Intervention|Withdrawal by Subject|0|||
143484111|NCT00874120|517318594|FG000|First Intervention|Lost to Follow-up|0|||
143149082|NCT01147458|516089280|FG000|Second Intervention|Adverse Event|2|||
143149083|NCT01147458|516089281|FG001|Second Intervention|Adverse Event|0|||
143149084|NCT01147458|516089282|FG002|Second Intervention|Adverse Event|1|||
143149085|NCT01147458|516089283|FG003|Second Intervention|Adverse Event|1|||
143149086|NCT01147458|516089280|FG000|Second Intervention|Other|0|||
143149087|NCT01147458|516089281|FG001|Second Intervention|Other|0|||
143149088|NCT01147458|516089282|FG002|Second Intervention|Other|1|||
143149089|NCT01147458|516089283|FG003|Second Intervention|Other|0|||
143149090|NCT00832975|516089290|FG000|Overall Study|Lost to Follow-up|7|||
143149091|NCT00832975|516089290|FG000|Overall Study|Protocol Violation|6|||
143149092|NCT00832975|516089290|FG000|Overall Study|Death|5|||
143149093|NCT00832975|516089290|FG000|Overall Study|Physician Decision|4|||
143149094|NCT00832975|516089290|FG000|Overall Study|Withdrawal by Subject|3|||
143149095|NCT00832975|516089290|FG000|Overall Study|Other reasons|14|||
143149096|NCT04603066|516089294|FG000|Wash-out (3 Weeks)|Protocol Violation|1|||
143149097|NCT04603066|516089295|FG001|Wash-out (3 Weeks)|Protocol Violation|0|||
143149098|NCT01525589|516089296|FG000|Overall Study|Non-treatment-related AE|1|||
143484112|NCT00874120|517318595|FG001|First Intervention|Lost to Follow-up|1|||
143484113|NCT00874120|517318594|FG000|First Intervention|Protocol Violation|3|||
143484114|NCT00874120|517318595|FG001|First Intervention|Protocol Violation|0|||
143149099|NCT01525589|516089297|FG001|Overall Study|Non-treatment-related AE|0|||
143149100|NCT01525589|516089298|FG002|Overall Study|Non-treatment-related AE|0|||
143149101|NCT01525589|516089296|FG000|Overall Study|Progressive disease|48|||
143149102|NCT01525589|516089297|FG001|Overall Study|Progressive disease|15|||
143149103|NCT01525589|516089298|FG002|Overall Study|Progressive disease|29|||
143149104|NCT01525589|516089296|FG000|Overall Study|Never treated|2|||
143149105|NCT01525589|516089297|FG001|Overall Study|Never treated|0|||
143149106|NCT01525589|516089298|FG002|Overall Study|Never treated|0|||
143149107|NCT01525589|516089296|FG000|Overall Study|Physician Decision|4|||
143149108|NCT01525589|516089297|FG001|Overall Study|Physician Decision|2|||
143149109|NCT01525589|516089298|FG002|Overall Study|Physician Decision|2|||
143149110|NCT01525589|516089296|FG000|Overall Study|Death|0|||
143149111|NCT01525589|516089297|FG001|Overall Study|Death|0|||
143149112|NCT01525589|516089298|FG002|Overall Study|Death|2|||
143149113|NCT01525589|516089296|FG000|Overall Study|Treatment-related AE|1|||
143149114|NCT01525589|516089297|FG001|Overall Study|Treatment-related AE|1|||
143149115|NCT01525589|516089298|FG002|Overall Study|Treatment-related AE|2|||
143149116|NCT01525589|516089296|FG000|Overall Study|Other reasons|0|||
143149117|NCT01525589|516089297|FG001|Overall Study|Other reasons|1|||
143149118|NCT01525589|516089298|FG002|Overall Study|Other reasons|0|||
143149119|NCT01525589|516089296|FG000|Overall Study|Withdrawal by Subject|0|||
143149120|NCT01525589|516089297|FG001|Overall Study|Withdrawal by Subject|1|||
143149121|NCT01525589|516089298|FG002|Overall Study|Withdrawal by Subject|0|||
143149122|NCT04409002|516089299|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
143149123|NCT02924376|516089300|FG000|Overall Study|Progressive Disease|4|||
143149124|NCT02924376|516089301|FG001|Overall Study|Progressive Disease|0|||
143149125|NCT02924376|516089302|FG002|Overall Study|Progressive Disease|1|||
143149126|NCT02924376|516089303|FG003|Overall Study|Progressive Disease|0|||
143149127|NCT02924376|516089300|FG000|Overall Study|Death|73|||
143149128|NCT02924376|516089301|FG001|Overall Study|Death|18|||
143149129|NCT02924376|516089302|FG002|Overall Study|Death|15|||
143149130|NCT02924376|516089303|FG003|Overall Study|Death|2|||
143149131|NCT02924376|516089300|FG000|Overall Study|Lost to Follow-up|3|||
143149132|NCT02924376|516089301|FG001|Overall Study|Lost to Follow-up|0|||
143149133|NCT02924376|516089302|FG002|Overall Study|Lost to Follow-up|0|||
143149134|NCT02924376|516089303|FG003|Overall Study|Lost to Follow-up|0|||
143149135|NCT02924376|516089300|FG000|Overall Study|Study Terminated by Sponsor|19|||
143149136|NCT02924376|516089301|FG001|Overall Study|Study Terminated by Sponsor|0|||
143149137|NCT02924376|516089302|FG002|Overall Study|Study Terminated by Sponsor|0|||
143149138|NCT02924376|516089303|FG003|Overall Study|Study Terminated by Sponsor|0|||
143484115|NCT00874120|517318594|FG000|First Intervention|positive drug test|1|||
143484116|NCT00874120|517318595|FG001|First Intervention|positive drug test|0|||
143484117|NCT00874120|517318594|FG000|Second Intervention|Withdrawal by Subject|1|||
143149139|NCT02924376|516089300|FG000|Overall Study|Physician Decision|1|||
143149140|NCT02924376|516089301|FG001|Overall Study|Physician Decision|0|||
143149141|NCT02924376|516089302|FG002|Overall Study|Physician Decision|0|||
143149142|NCT02924376|516089303|FG003|Overall Study|Physician Decision|0|||
143484118|NCT00874120|517318595|FG001|Second Intervention|Withdrawal by Subject|0|||
143149143|NCT02924376|516089300|FG000|Overall Study|Withdrawal by Subject|7|||
143149144|NCT02924376|516089301|FG001|Overall Study|Withdrawal by Subject|2|||
143149145|NCT02924376|516089302|FG002|Overall Study|Withdrawal by Subject|1|||
143149146|NCT02924376|516089303|FG003|Overall Study|Withdrawal by Subject|0|||
143149147|NCT02924376|516089300|FG000|Overall Study|Rolled Over to Another Study|1|||
143149148|NCT02924376|516089301|FG001|Overall Study|Rolled Over to Another Study|0|||
143149149|NCT02924376|516089302|FG002|Overall Study|Rolled Over to Another Study|0|||
143149150|NCT02924376|516089303|FG003|Overall Study|Rolled Over to Another Study|0|||
143149151|NCT06481579|516089305|FG000|Overall Study|Death|1|||
143149152|NCT06481579|516089306|FG001|Overall Study|Death|0|||
143149153|NCT06481579|516089305|FG000|Overall Study|Withdrawal by Subject|3|||
143484119|NCT00874120|517318594|FG000|Second Intervention|Protocol Violation|1|||
143484120|NCT00874120|517318595|FG001|Second Intervention|Protocol Violation|0|||
143484121|NCT02135692|517318603|FG000|Overall Study|Adverse Event|3|||
143484122|NCT02135692|517318603|FG000|Overall Study|Lack of Efficacy|2|||
143484123|NCT02135692|517318603|FG000|Overall Study|Protocol Violation|2|||
143484124|NCT02135692|517318603|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
143484125|NCT02135692|517318603|FG000|Overall Study|Product commercially available|159|||
143484126|NCT02135692|517318603|FG000|Overall Study|Study closed/terminated|153|||
143484127|NCT02135692|517318603|FG000|Overall Study|Lost to Follow-up|4|||
143484128|NCT02135692|517318603|FG000|Overall Study|Withdrawal by Subject|15|||
143149154|NCT06481579|516089306|FG001|Overall Study|Withdrawal by Subject|0|||
143149155|NCT06481579|516089305|FG000|Overall Study|Other|1|||
143149156|NCT06481579|516089306|FG001|Overall Study|Other|1|||
143149157|NCT05253807|516089307|FG000|Overall Study|Death|1|||
143149158|NCT05253807|516089308|FG001|Overall Study|Death|4|||
143149159|NCT05253807|516089307|FG000|Overall Study|Withdrawal by Subject|1|||
143484129|NCT01611974|517318606|FG000|Overall Study|Death|10|||
143484130|NCT01611974|517318607|FG001|Overall Study|Death|12|||
143484131|NCT01611974|517318608|FG002|Overall Study|Death|10|||
143484132|NCT01611974|517318606|FG000|Overall Study|Lost to Follow-up|0|||
143484133|NCT01611974|517318607|FG001|Overall Study|Lost to Follow-up|1|||
143484134|NCT01611974|517318608|FG002|Overall Study|Lost to Follow-up|0|||
143484135|NCT01611974|517318606|FG000|Overall Study|Physician Decision|5|||
143484136|NCT01611974|517318607|FG001|Overall Study|Physician Decision|1|||
143484137|NCT01611974|517318608|FG002|Overall Study|Physician Decision|2|||
143484138|NCT01611974|517318606|FG000|Overall Study|Withdrawal by Subject|0|||
143484139|NCT01611974|517318607|FG001|Overall Study|Withdrawal by Subject|1|||
143484140|NCT01611974|517318608|FG002|Overall Study|Withdrawal by Subject|4|||
143484141|NCT01097746|517318609|FG000|Overall Study|Adverse Event|4|||
143484142|NCT01097746|517318609|FG000|Overall Study|taken off study before any treatment given|1|||
143484143|NCT00522431|517318610|FG000|Overall Study|Adverse Event|5|||
143484144|NCT00522431|517318610|FG000|Overall Study|Protocol Violation|2|||
143484145|NCT00522431|517318610|FG000|Overall Study|Withdrawal by Subject|2|||
143484146|NCT00522431|517318610|FG000|Overall Study|Subject non-compliance|1|||
143484147|NCT00522431|517318610|FG000|Overall Study|Other/unknown|1|||
143484148|NCT00772954|517318611|FG000|Overall Study|Adverse Event|0|||
143484149|NCT00772954|517318612|FG001|Overall Study|Adverse Event|0|||
143484150|NCT00772954|517318613|FG002|Overall Study|Adverse Event|1|||
143484151|NCT01732796|517318617|FG000|Overall Study|Adverse Event|16|||
143484152|NCT01732796|517318618|FG001|Overall Study|Adverse Event|16|||
143484153|NCT01732796|517318619|FG002|Overall Study|Adverse Event|4|||
143484154|NCT01732796|517318617|FG000|Overall Study|Lack of Efficacy|21|||
143484155|NCT01732796|517318618|FG001|Overall Study|Lack of Efficacy|18|||
143484156|NCT01732796|517318619|FG002|Overall Study|Lack of Efficacy|5|||
143484157|NCT01732796|517318617|FG000|Overall Study|Lost to Follow-up|2|||
143484158|NCT01732796|517318618|FG001|Overall Study|Lost to Follow-up|0|||
143484159|NCT01732796|517318619|FG002|Overall Study|Lost to Follow-up|0|||
143484160|NCT01732796|517318617|FG000|Overall Study|Withdrawal by Subject|6|||
143484161|NCT01732796|517318618|FG001|Overall Study|Withdrawal by Subject|8|||
143484162|NCT01732796|517318619|FG002|Overall Study|Withdrawal by Subject|2|||
143484163|NCT01732796|517318617|FG000|Overall Study|Other reason not defined above|1|||
143484164|NCT01732796|517318618|FG001|Overall Study|Other reason not defined above|0|||
143484165|NCT01732796|517318619|FG002|Overall Study|Other reason not defined above|2|||
143484166|NCT01379274|517318622|FG000|Overall Study|funding withdrawn|1|||
143484167|NCT03287219|517318626|FG000|Overall Study|Protocol Violation|0|||
143484168|NCT03287219|517318627|FG001|Overall Study|Protocol Violation|2|||
143484169|NCT00794677|517318630|FG000|First Intervention|Withdrawal by Subject|2|||
143484170|NCT00794677|517318631|FG001|First Intervention|Withdrawal by Subject|0|||
143484171|NCT02863809|517318632|FG000|Overall Study|Adverse Event|8|||
143484172|NCT02863809|517318633|FG001|Overall Study|Adverse Event|8|||
143484173|NCT02863809|517318632|FG000|Overall Study|Withdrawal by Subject|0|||
143484174|NCT02863809|517318633|FG001|Overall Study|Withdrawal by Subject|1|||
143484175|NCT02863809|517318632|FG000|Overall Study|Lost to Follow-up|1|||
143484176|NCT02863809|517318633|FG001|Overall Study|Lost to Follow-up|1|||
143484177|NCT02863809|517318632|FG000|Overall Study|Death|1|||
143484178|NCT02863809|517318633|FG001|Overall Study|Death|0|||
143484179|NCT00607386|517318634|FG000|Overall Study|Physician Decision|1|||
143363634|NCT00062868|516873788|FG008|Dose Level 2|Lost to Follow-up|0|||
143484180|NCT01422915|517318637|FG000|Overall Study|Adverse Event|1|||
143484181|NCT01265797|517318638|FG000|Run-in Month|Withdrawal by Subject|0|||
143484182|NCT01265797|517318639|FG001|Run-in Month|Withdrawal by Subject|4|||
143484183|NCT01265797|517318638|FG000|Run-in Month|1st seizure during run-in month|0|||
143484184|NCT01265797|517318639|FG001|Run-in Month|1st seizure during run-in month|1|||
143484185|NCT01265797|517318638|FG000|Blinded Month|Lack of Efficacy|5|||
143149160|NCT05253807|516089308|FG001|Overall Study|Withdrawal by Subject|0|||
143149161|NCT05253807|516089307|FG000|Overall Study|Study Terminated by Sponsor|1|||
143363635|NCT00062868|516873789|FG009|Dose Level 2|Lost to Follow-up|0|||
143484186|NCT01265797|517318639|FG001|Blinded Month|Lack of Efficacy|0|||
143484187|NCT01265797|517318638|FG000|Blinded Month|Lost to Follow-up|1|||
143149162|NCT05253807|516089308|FG001|Overall Study|Study Terminated by Sponsor|1|||
143149163|NCT02293499|516090251|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
143149164|NCT02293499|516090252|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
143149165|NCT02293499|516090253|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
143149166|NCT02293499|516090251|FG000|Intervention - Camp|Withdrawal by Subject|3|||
143149167|NCT02293499|516090252|FG001|Intervention - Camp|Withdrawal by Subject|6|||
143232199|NCT00537394|516402038|FG002|2nd Year of Follow-up|Clinic site closure|0|||
143232200|NCT01283139|516402039|FG000|Overall Study|Lost to Follow-up|5|||
143232201|NCT01283139|516402040|FG001|Overall Study|Lost to Follow-up|2|||
143232202|NCT01283139|516402041|FG002|Overall Study|Lost to Follow-up|3|||
143232203|NCT01283139|516402042|FG003|Overall Study|Lost to Follow-up|1|||
143232204|NCT01283139|516402039|FG000|Overall Study|Withdrawal by Subject|8|||
143232205|NCT01283139|516402040|FG001|Overall Study|Withdrawal by Subject|8|||
143232206|NCT01283139|516402041|FG002|Overall Study|Withdrawal by Subject|6|||
143232207|NCT01283139|516402042|FG003|Overall Study|Withdrawal by Subject|8|||
143232208|NCT01283139|516402039|FG000|Overall Study|Death|2|||
143232209|NCT01283139|516402040|FG001|Overall Study|Death|0|||
143232210|NCT01283139|516402041|FG002|Overall Study|Death|2|||
143232211|NCT01283139|516402042|FG003|Overall Study|Death|2|||
143232212|NCT01283139|516402039|FG000|Overall Study|Lack of Efficacy|1|||
143232213|NCT01283139|516402040|FG001|Overall Study|Lack of Efficacy|2|||
143232214|NCT01283139|516402041|FG002|Overall Study|Lack of Efficacy|2|||
143232215|NCT01283139|516402042|FG003|Overall Study|Lack of Efficacy|1|||
143232216|NCT01283139|516402039|FG000|Overall Study|Early termination due to AE/SAE|1|||
143232217|NCT01283139|516402040|FG001|Overall Study|Early termination due to AE/SAE|1|||
143232218|NCT01283139|516402041|FG002|Overall Study|Early termination due to AE/SAE|0|||
143232219|NCT01283139|516402042|FG003|Overall Study|Early termination due to AE/SAE|0|||
143232220|NCT01283139|516402039|FG000|Overall Study|Participant's refusal to continue|0|||
143232221|NCT01283139|516402040|FG001|Overall Study|Participant's refusal to continue|3|||
143232222|NCT01283139|516402041|FG002|Overall Study|Participant's refusal to continue|1|||
143232223|NCT01283139|516402042|FG003|Overall Study|Participant's refusal to continue|1|||
143232224|NCT01283139|516402039|FG000|Overall Study|Pregnancy|0|||
143232225|NCT01283139|516402040|FG001|Overall Study|Pregnancy|1|||
143232226|NCT01283139|516402041|FG002|Overall Study|Pregnancy|1|||
143232227|NCT01283139|516402042|FG003|Overall Study|Pregnancy|0|||
143232228|NCT01283139|516402039|FG000|Overall Study|Missed follow-up visit|0|||
143232229|NCT01283139|516402040|FG001|Overall Study|Missed follow-up visit|1|||
143232230|NCT01283139|516402041|FG002|Overall Study|Missed follow-up visit|2|||
143232231|NCT01283139|516402042|FG003|Overall Study|Missed follow-up visit|2|||
143232232|NCT01283139|516402039|FG000|Overall Study|Participant randomized in error|0|||
143232233|NCT01283139|516402040|FG001|Overall Study|Participant randomized in error|0|||
143232234|NCT01283139|516402041|FG002|Overall Study|Participant randomized in error|1|||
143232235|NCT01283139|516402042|FG003|Overall Study|Participant randomized in error|0|||
143232236|NCT03668873|516402043|FG000|Overall Study|Lost to Follow-up|6|||
143232237|NCT03668873|516402044|FG001|Overall Study|Lost to Follow-up|3|||
143232238|NCT00784563|516402045|FG000|Years 1 & 2|Withdrawal by Subject|3|||
143232239|NCT00784563|516402046|FG001|Years 1 & 2|Withdrawal by Subject|2|||
143232240|NCT00784563|516402047|FG002|Years 1 & 2|Withdrawal by Subject|0|||
143232241|NCT00784563|516402045|FG000|Years 1 & 2|Adverse Event|0|||
143232242|NCT00784563|516402046|FG001|Years 1 & 2|Adverse Event|3|||
143232243|NCT00784563|516402047|FG002|Years 1 & 2|Adverse Event|0|||
143232244|NCT00784563|516402045|FG000|Year 3|Withdrawal by Subject|0|||
143232245|NCT00784563|516402046|FG001|Year 3|Withdrawal by Subject|0|||
143232246|NCT00784563|516402047|FG002|Year 3|Withdrawal by Subject|2|||
143232247|NCT00784563|516402045|FG000|Year 3|Adverse Event|0|||
143232248|NCT00784563|516402046|FG001|Year 3|Adverse Event|0|||
143232249|NCT00784563|516402047|FG002|Year 3|Adverse Event|1|||
143232250|NCT00762164|516402049|FG000|Overall Study|Lost to Follow-up|1|||
143232251|NCT00762164|516402050|FG001|Overall Study|Lost to Follow-up|1|||
143232252|NCT00762164|516402049|FG000|Overall Study|Discontinued medication|2|||
143232253|NCT00762164|516402050|FG001|Overall Study|Discontinued medication|0|||
143232254|NCT00762164|516402049|FG000|Overall Study|Withdrawal by Subject|0|||
143232255|NCT00762164|516402050|FG001|Overall Study|Withdrawal by Subject|1|||
143232256|NCT02954536|516402055|FG000|Overall Study|Adverse Event|2|||
143232257|NCT02954536|516402055|FG000|Overall Study|Death|12|||
143232258|NCT03914417|516402062|FG000|Overall Study|Withdrawal by Subject|2|||
143232259|NCT03836625|516402067|FG000|Overall Study|Lost to Follow-up|9|||
143232260|NCT03836625|516402068|FG001|Overall Study|Lost to Follow-up|9|||
143232261|NCT03836625|516402067|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
143232262|NCT03836625|516402068|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
143484188|NCT01265797|517318639|FG001|Blinded Month|Lost to Follow-up|0|||
143232263|NCT03836625|516402067|FG000|Overall Study|Death|0|||
143232264|NCT03836625|516402068|FG001|Overall Study|Death|1|||
143232265|NCT03836625|516402067|FG000|Overall Study|Refused follow-up|0|||
143232266|NCT03836625|516402068|FG001|Overall Study|Refused follow-up|1|||
143232267|NCT00517296|516402069|FG000|Overall Study|Withdrawal by Subject|1|||
143232268|NCT00517296|516402070|FG001|Overall Study|Withdrawal by Subject|0|||
143232269|NCT01420861|516402073|FG000|Overall Study|Adverse Event|2|||
143232270|NCT01420861|516402073|FG000|Overall Study|Study terminated by Sponsor|7|||
143232271|NCT01420861|516402073|FG000|Overall Study|Screen failure|7|||
143232272|NCT01420861|516402073|FG000|Overall Study|Randomized not Treated|2|||
143232273|NCT03361137|516402074|FG000|Overall Study|Reason not specified|1|||
143232274|NCT03361137|516402075|FG001|Overall Study|Reason not specified|0|||
143484189|NCT01265797|517318638|FG000|Blinded Month|Protocol Violation|2|||
143484190|NCT01265797|517318639|FG001|Blinded Month|Protocol Violation|1|||
143484191|NCT01265797|517318638|FG000|Blinded Month|Adverse Event|2|||
143484192|NCT01265797|517318639|FG001|Blinded Month|Adverse Event|0|||
143484193|NCT01265797|517318638|FG000|Blinded Month|Diary data incomplete|0|||
143484194|NCT01265797|517318639|FG001|Blinded Month|Diary data incomplete|1|||
143484195|NCT01265797|517318638|FG000|Open Label Month|Lost to Follow-up|0|||
143484196|NCT01265797|517318639|FG001|Open Label Month|Lost to Follow-up|1|||
143484197|NCT00879645|517318640|FG000|Overall Study|Adverse Event|1|||
143484198|NCT00879645|517318641|FG001|Overall Study|Adverse Event|0|||
143484199|NCT00879645|517318642|FG002|Overall Study|Adverse Event|0|||
143484200|NCT00879645|517318643|FG003|Overall Study|Adverse Event|0|||
143484201|NCT04288154|517318644|FG000|Overall Study|Withdrawal by Subject|9|||
143484202|NCT04288154|517318645|FG001|Overall Study|Withdrawal by Subject|9|||
143484203|NCT00996944|517318646|FG000|Double-blind Treatment Period|Adverse Event|2|||
143484204|NCT00996944|517318647|FG001|Double-blind Treatment Period|Adverse Event|1|||
143484205|NCT00996944|517318646|FG000|Double-blind Treatment Period|Protocol Violation|1|||
143484206|NCT00996944|517318647|FG001|Double-blind Treatment Period|Protocol Violation|0|||
143484207|NCT00996944|517318646|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
143484208|NCT00996944|517318647|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
143484209|NCT00996944|517318646|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
143484210|NCT00996944|517318647|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
143484211|NCT00996944|517318646|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
143484212|NCT00996944|517318647|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
143484213|NCT00769184|517318648|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
143484214|NCT00769184|517318649|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
143484215|NCT00769184|517318648|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
143484216|NCT00769184|517318649|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
143484217|NCT00769184|517318648|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
143484218|NCT00769184|517318649|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
143484219|NCT00385255|517318650|FG000|Overall Study|Serious Adverse Event|1|||
143484220|NCT00385255|517318651|FG001|Overall Study|Serious Adverse Event|2|||
143484221|NCT00385255|517318650|FG000|Overall Study|Protocol Violation|0|||
143484222|NCT00385255|517318651|FG001|Overall Study|Protocol Violation|4|||
143484223|NCT00385255|517318650|FG000|Overall Study|Withdrawal by Subject|0|||
143484224|NCT00385255|517318651|FG001|Overall Study|Withdrawal by Subject|8|||
143484225|NCT00385255|517318650|FG000|Overall Study|Migrated/moved from study area|0|||
143484226|NCT00385255|517318651|FG001|Overall Study|Migrated/moved from study area|1|||
143484227|NCT00385255|517318650|FG000|Overall Study|Lost to Follow-up|20|||
143484228|NCT00385255|517318651|FG001|Overall Study|Lost to Follow-up|58|||
143484229|NCT00583362|517318652|FG000|Overall Study|Adverse Event|44|||
143484230|NCT00583362|517318652|FG000|Overall Study|Lack of Efficacy|22|||
143484231|NCT00583362|517318652|FG000|Overall Study|Lost to Follow-up|4|||
143484232|NCT00583362|517318652|FG000|Overall Study|Non-compliance with study drug|28|||
143484233|NCT00583362|517318652|FG000|Overall Study|Pregnancy|7|||
143484234|NCT00583362|517318652|FG000|Overall Study|Miscommunication of visit window|5|||
143484235|NCT00583362|517318652|FG000|Overall Study|Current site closed|7|||
143484236|NCT00583362|517318652|FG000|Overall Study|Subject not dosed in LBSL99|1|||
143484237|NCT00583362|517318652|FG000|Overall Study|Subject moved out of the country/state|2|||
143484238|NCT00583362|517318652|FG000|Overall Study|Missed visits due to staff changes|1|||
143484239|NCT00583362|517318652|FG000|Overall Study|Misunderstanding of protocol|1|||
143484240|NCT00583362|517318652|FG000|Overall Study|Behavioral problems and non-compliance|1|||
143484241|NCT00583362|517318652|FG000|Overall Study|Sponsor request due to missed doses|1|||
143484242|NCT00583362|517318652|FG000|Overall Study|Physician Decision|19|||
143484243|NCT00583362|517318652|FG000|Overall Study|Protocol Violation|2|||
143484244|NCT00583362|517318652|FG000|Overall Study|Withdrawal by Subject|57|||
143484245|NCT04247061|517318653|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
143484246|NCT04247061|517318653|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
143484247|NCT04247061|517318653|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
143484248|NCT01136655|517318658|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
143484249|NCT01136655|517318658|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
143484250|NCT01136655|517318658|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
143484251|NCT01136655|517318658|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
143232275|NCT03361137|516402076|FG002|Overall Study|Reason not specified|0|||
143232276|NCT03361137|516402077|FG003|Overall Study|Reason not specified|0|||
143232277|NCT03361137|516402078|FG004|Overall Study|Reason not specified|0|||
143484252|NCT02873936|517318659|FG000|Overall Study|Withdrew Consent|4|||
143484253|NCT02873936|517318660|FG001|Overall Study|Withdrew Consent|11|||
143484254|NCT02873936|517318661|FG002|Overall Study|Withdrew Consent|20|||
143232278|NCT00791934|516402079|FG000|Overall Study|Withdrawal by Subject|2|||
143232279|NCT00791934|516402079|FG000|Overall Study|Did not consent for extended follow-up|13|||
143232280|NCT04905134|516402081|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
143232281|NCT04905134|516402081|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
143232282|NCT03009058|516402082|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
143232283|NCT03221556|516402083|FG000|Allocation|post-randomization exclusion|0|||
143232284|NCT03221556|516402084|FG001|Allocation|post-randomization exclusion|1|||
143232285|NCT03221556|516402083|FG000|Follow-Up|Withdrawal by Subject|0|||
143232286|NCT03221556|516402084|FG001|Follow-Up|Withdrawal by Subject|1|||
143232287|NCT01486966|516402087|FG000|Overall Study|Adverse Event|0|||
143232288|NCT01486966|516402088|FG001|Overall Study|Adverse Event|1|||
143232289|NCT01486966|516402087|FG000|Overall Study|Withdrawal by Subject|0|||
143232290|NCT01486966|516402088|FG001|Overall Study|Withdrawal by Subject|1|||
143232291|NCT02234843|516402089|FG000|Overall Study|Death|1|||
143232292|NCT02234843|516402090|FG001|Overall Study|Death|0|||
143232293|NCT02234843|516402091|FG002|Overall Study|Death|0|||
143232294|NCT02234843|516402092|FG003|Overall Study|Death|0|||
143232295|NCT02234843|516402093|FG004|Overall Study|Death|0|||
143232296|NCT02234843|516402094|FG005|Overall Study|Death|0|||
143232297|NCT02234843|516402095|FG006|Overall Study|Death|0|||
143232298|NCT02234843|516402096|FG007|Overall Study|Death|0|||
143232299|NCT02234843|516402097|FG008|Overall Study|Death|0|||
143232300|NCT02234843|516402098|FG009|Overall Study|Death|0|||
143232301|NCT02234843|516402089|FG000|Overall Study|Protocol Violation|1|||
143232302|NCT02234843|516402090|FG001|Overall Study|Protocol Violation|0|||
143232303|NCT02234843|516402091|FG002|Overall Study|Protocol Violation|1|||
143232304|NCT02234843|516402092|FG003|Overall Study|Protocol Violation|0|||
143232305|NCT02234843|516402093|FG004|Overall Study|Protocol Violation|0|||
143232306|NCT02234843|516402094|FG005|Overall Study|Protocol Violation|0|||
143232307|NCT02234843|516402095|FG006|Overall Study|Protocol Violation|0|||
143232308|NCT02234843|516402096|FG007|Overall Study|Protocol Violation|0|||
143232309|NCT02234843|516402097|FG008|Overall Study|Protocol Violation|0|||
143232310|NCT02234843|516402098|FG009|Overall Study|Protocol Violation|0|||
143232311|NCT02234843|516402089|FG000|Overall Study|Efficacy outcome reached|2|||
143232312|NCT02234843|516402090|FG001|Overall Study|Efficacy outcome reached|0|||
143232313|NCT02234843|516402091|FG002|Overall Study|Efficacy outcome reached|0|||
143232314|NCT02234843|516402092|FG003|Overall Study|Efficacy outcome reached|0|||
143232315|NCT02234843|516402093|FG004|Overall Study|Efficacy outcome reached|0|||
143232316|NCT02234843|516402094|FG005|Overall Study|Efficacy outcome reached|2|||
143232317|NCT02234843|516402095|FG006|Overall Study|Efficacy outcome reached|0|||
143232318|NCT02234843|516402096|FG007|Overall Study|Efficacy outcome reached|0|||
143232319|NCT02234843|516402097|FG008|Overall Study|Efficacy outcome reached|0|||
143232320|NCT02234843|516402098|FG009|Overall Study|Efficacy outcome reached|0|||
143232321|NCT02234843|516402089|FG000|Overall Study|Patient convenience|2|||
143232322|NCT02234843|516402090|FG001|Overall Study|Patient convenience|0|||
143232323|NCT02234843|516402091|FG002|Overall Study|Patient convenience|0|||
143232324|NCT02234843|516402092|FG003|Overall Study|Patient convenience|0|||
143484255|NCT02873936|517318659|FG000|Overall Study|Investigator's Discretion|3|||
143484256|NCT02873936|517318660|FG001|Overall Study|Investigator's Discretion|5|||
143484257|NCT02873936|517318661|FG002|Overall Study|Investigator's Discretion|4|||
143484258|NCT02873936|517318659|FG000|Overall Study|Adverse Event|3|||
143484259|NCT02873936|517318660|FG001|Overall Study|Adverse Event|5|||
143484260|NCT02873936|517318661|FG002|Overall Study|Adverse Event|3|||
143484261|NCT02873936|517318659|FG000|Overall Study|Protocol Violation|0|||
143232325|NCT02234843|516402093|FG004|Overall Study|Patient convenience|0|||
143484262|NCT02873936|517318660|FG001|Overall Study|Protocol Violation|1|||
143484263|NCT02873936|517318661|FG002|Overall Study|Protocol Violation|3|||
143484264|NCT02873936|517318659|FG000|Overall Study|Lost to Follow-up|1|||
143232326|NCT02234843|516402094|FG005|Overall Study|Patient convenience|1|||
143484265|NCT02873936|517318660|FG001|Overall Study|Lost to Follow-up|1|||
143484266|NCT02873936|517318661|FG002|Overall Study|Lost to Follow-up|1|||
143484267|NCT02873936|517318659|FG000|Overall Study|Non-compliance With Study Drug|1|||
143232327|NCT02234843|516402095|FG006|Overall Study|Patient convenience|0|||
143232328|NCT02234843|516402096|FG007|Overall Study|Patient convenience|0|||
143232329|NCT02234843|516402097|FG008|Overall Study|Patient convenience|0|||
143232330|NCT02234843|516402098|FG009|Overall Study|Patient convenience|0|||
143232331|NCT02234843|516402089|FG000|Overall Study|Withdrawal by Subject|5|||
143232332|NCT02234843|516402090|FG001|Overall Study|Withdrawal by Subject|1|||
143232333|NCT02234843|516402091|FG002|Overall Study|Withdrawal by Subject|1|||
143232334|NCT02234843|516402092|FG003|Overall Study|Withdrawal by Subject|0|||
143232335|NCT02234843|516402093|FG004|Overall Study|Withdrawal by Subject|0|||
143232336|NCT02234843|516402094|FG005|Overall Study|Withdrawal by Subject|7|||
143232337|NCT02234843|516402095|FG006|Overall Study|Withdrawal by Subject|0|||
143484268|NCT02873936|517318660|FG001|Overall Study|Non-compliance With Study Drug|0|||
143484269|NCT02873936|517318661|FG002|Overall Study|Non-compliance With Study Drug|1|||
143484270|NCT02873936|517318659|FG000|Overall Study|Randomized but not Dosed|1|||
143484271|NCT02873936|517318660|FG001|Overall Study|Randomized but not Dosed|0|||
143484272|NCT02873936|517318661|FG002|Overall Study|Randomized but not Dosed|0|||
143484273|NCT05513625|517318662|FG000|Overall Study|Withdrawal by Subject|1|||
143484274|NCT01015768|517318663|FG000|Overall Study|Some subject data unuseable|4|||
143484275|NCT01015768|517318664|FG001|Overall Study|Some subject data unuseable|4|||
143484276|NCT01225731|517318666|FG000|Part 1|Did not meet eligibility criteria|1|||
143484277|NCT01225731|517318667|FG001|Part 1|Did not meet eligibility criteria|0|||
143484278|NCT01225731|517318668|FG002|Part 1|Did not meet eligibility criteria|0|||
143484279|NCT01225731|517318669|FG003|Part 1|Did not meet eligibility criteria|0|||
143484280|NCT01225731|517318670|FG004|Part 1|Did not meet eligibility criteria|1|||
143484281|NCT01225731|517318671|FG005|Part 1|Did not meet eligibility criteria|0|||
143484282|NCT01225731|517318672|FG006|Part 1|Did not meet eligibility criteria|0|||
143484283|NCT01225731|517318673|FG007|Part 1|Did not meet eligibility criteria|0|||
143484284|NCT01225731|517318674|FG008|Part 1|Did not meet eligibility criteria|0|||
143484285|NCT01225731|517318675|FG009|Part 1|Did not meet eligibility criteria|0|||
143484286|NCT01225731|517318676|FG010|Part 1|Did not meet eligibility criteria|0|||
143484287|NCT01225731|517318677|FG011|Part 1|Did not meet eligibility criteria|0|||
143484288|NCT01225731|517318678|FG012|Part 1|Did not meet eligibility criteria|0|||
143484289|NCT01225731|517318666|FG000|Part 1|Adverse Event|1|||
143484290|NCT01225731|517318667|FG001|Part 1|Adverse Event|2|||
143484291|NCT01225731|517318668|FG002|Part 1|Adverse Event|1|||
143484292|NCT01225731|517318669|FG003|Part 1|Adverse Event|1|||
143484293|NCT01225731|517318670|FG004|Part 1|Adverse Event|1|||
143484294|NCT01225731|517318671|FG005|Part 1|Adverse Event|0|||
143484295|NCT01225731|517318672|FG006|Part 1|Adverse Event|0|||
143484296|NCT01225731|517318673|FG007|Part 1|Adverse Event|0|||
143484297|NCT01225731|517318674|FG008|Part 1|Adverse Event|0|||
143484298|NCT01225731|517318675|FG009|Part 1|Adverse Event|0|||
143484299|NCT01225731|517318676|FG010|Part 1|Adverse Event|0|||
143484300|NCT01225731|517318677|FG011|Part 1|Adverse Event|0|||
143484301|NCT01225731|517318678|FG012|Part 1|Adverse Event|0|||
143484302|NCT01225731|517318666|FG000|Part 1|Withdrawal by Subject|0|||
143484303|NCT01225731|517318667|FG001|Part 1|Withdrawal by Subject|3|||
143484304|NCT01225731|517318668|FG002|Part 1|Withdrawal by Subject|0|||
143484305|NCT01225731|517318669|FG003|Part 1|Withdrawal by Subject|0|||
143484306|NCT01225731|517318670|FG004|Part 1|Withdrawal by Subject|4|||
143484307|NCT01225731|517318671|FG005|Part 1|Withdrawal by Subject|0|||
143484308|NCT01225731|517318672|FG006|Part 1|Withdrawal by Subject|0|||
143484309|NCT01225731|517318673|FG007|Part 1|Withdrawal by Subject|0|||
143484310|NCT01225731|517318674|FG008|Part 1|Withdrawal by Subject|0|||
143484311|NCT01225731|517318675|FG009|Part 1|Withdrawal by Subject|0|||
143484312|NCT01225731|517318676|FG010|Part 1|Withdrawal by Subject|0|||
143484313|NCT01225731|517318677|FG011|Part 1|Withdrawal by Subject|0|||
143484314|NCT01225731|517318678|FG012|Part 1|Withdrawal by Subject|0|||
143484315|NCT01225731|517318666|FG000|Part 1|Protocol Violation|0|||
143484316|NCT01225731|517318667|FG001|Part 1|Protocol Violation|0|||
143484317|NCT01225731|517318668|FG002|Part 1|Protocol Violation|0|||
143484318|NCT01225731|517318669|FG003|Part 1|Protocol Violation|1|||
143484319|NCT01225731|517318670|FG004|Part 1|Protocol Violation|0|||
143484320|NCT01225731|517318671|FG005|Part 1|Protocol Violation|0|||
143484321|NCT01225731|517318672|FG006|Part 1|Protocol Violation|0|||
143484322|NCT01225731|517318673|FG007|Part 1|Protocol Violation|0|||
143484323|NCT01225731|517318674|FG008|Part 1|Protocol Violation|0|||
143484324|NCT01225731|517318675|FG009|Part 1|Protocol Violation|0|||
143484325|NCT01225731|517318676|FG010|Part 1|Protocol Violation|0|||
143484326|NCT01225731|517318677|FG011|Part 1|Protocol Violation|0|||
143484327|NCT01225731|517318678|FG012|Part 1|Protocol Violation|0|||
143484328|NCT01225731|517318666|FG000|Part 2|Protocol Violation|0|||
143484329|NCT01225731|517318667|FG001|Part 2|Protocol Violation|0|||
143484330|NCT01225731|517318668|FG002|Part 2|Protocol Violation|0|||
143484331|NCT01225731|517318669|FG003|Part 2|Protocol Violation|0|||
143484332|NCT01225731|517318670|FG004|Part 2|Protocol Violation|0|||
143484333|NCT01225731|517318671|FG005|Part 2|Protocol Violation|1|||
143015024|NCT00567996|515595651|FG002|Overall Study|Abnormal test procedure result(s)|1|||
143484334|NCT01225731|517318672|FG006|Part 2|Protocol Violation|0|||
143484335|NCT01225731|517318673|FG007|Part 2|Protocol Violation|0|||
143484336|NCT01225731|517318674|FG008|Part 2|Protocol Violation|1|||
143015025|NCT00567996|515595649|FG000|Overall Study|Lost to Follow-up|2|||
143484337|NCT01225731|517318675|FG009|Part 2|Protocol Violation|0|||
143484338|NCT01225731|517318676|FG010|Part 2|Protocol Violation|0|||
143484339|NCT01225731|517318677|FG011|Part 2|Protocol Violation|0|||
143484340|NCT01225731|517318678|FG012|Part 2|Protocol Violation|0|||
143484341|NCT01225731|517318666|FG000|Part 2|Adverse Event|0|||
143484342|NCT01225731|517318667|FG001|Part 2|Adverse Event|0|||
143484343|NCT01225731|517318668|FG002|Part 2|Adverse Event|0|||
143484344|NCT01225731|517318669|FG003|Part 2|Adverse Event|0|||
143484345|NCT01225731|517318670|FG004|Part 2|Adverse Event|0|||
143484346|NCT01225731|517318671|FG005|Part 2|Adverse Event|0|||
143484347|NCT01225731|517318672|FG006|Part 2|Adverse Event|4|||
143484348|NCT01225731|517318673|FG007|Part 2|Adverse Event|4|||
143484349|NCT01225731|517318674|FG008|Part 2|Adverse Event|2|||
143484350|NCT01225731|517318675|FG009|Part 2|Adverse Event|0|||
143484351|NCT01225731|517318676|FG010|Part 2|Adverse Event|0|||
143484352|NCT01225731|517318677|FG011|Part 2|Adverse Event|0|||
143484353|NCT01225731|517318678|FG012|Part 2|Adverse Event|0|||
143484354|NCT01225731|517318666|FG000|Part 2|Lack of Efficacy|0|||
143484355|NCT01225731|517318667|FG001|Part 2|Lack of Efficacy|0|||
143484356|NCT01225731|517318668|FG002|Part 2|Lack of Efficacy|0|||
143484357|NCT01225731|517318669|FG003|Part 2|Lack of Efficacy|0|||
143484358|NCT01225731|517318670|FG004|Part 2|Lack of Efficacy|0|||
143484359|NCT01225731|517318671|FG005|Part 2|Lack of Efficacy|1|||
143484360|NCT01225731|517318672|FG006|Part 2|Lack of Efficacy|0|||
143484361|NCT01225731|517318673|FG007|Part 2|Lack of Efficacy|12|||
143484362|NCT01225731|517318674|FG008|Part 2|Lack of Efficacy|3|||
143484363|NCT01225731|517318675|FG009|Part 2|Lack of Efficacy|0|||
143484364|NCT01225731|517318676|FG010|Part 2|Lack of Efficacy|0|||
143484365|NCT01225731|517318677|FG011|Part 2|Lack of Efficacy|0|||
143484366|NCT01225731|517318678|FG012|Part 2|Lack of Efficacy|0|||
143484367|NCT01225731|517318666|FG000|Part 2|Pregnancy|0|||
143484368|NCT01225731|517318667|FG001|Part 2|Pregnancy|0|||
143484369|NCT01225731|517318668|FG002|Part 2|Pregnancy|0|||
143484370|NCT01225731|517318669|FG003|Part 2|Pregnancy|0|||
143484371|NCT01225731|517318670|FG004|Part 2|Pregnancy|0|||
143484372|NCT01225731|517318671|FG005|Part 2|Pregnancy|0|||
143484373|NCT01225731|517318672|FG006|Part 2|Pregnancy|1|||
143484374|NCT01225731|517318673|FG007|Part 2|Pregnancy|0|||
143484375|NCT01225731|517318674|FG008|Part 2|Pregnancy|1|||
143484376|NCT01225731|517318675|FG009|Part 2|Pregnancy|0|||
143484377|NCT01225731|517318676|FG010|Part 2|Pregnancy|0|||
143484378|NCT01225731|517318677|FG011|Part 2|Pregnancy|0|||
143484379|NCT01225731|517318678|FG012|Part 2|Pregnancy|0|||
143484380|NCT01225731|517318666|FG000|Part 2|Lost to Follow-up|0|||
143484381|NCT01225731|517318667|FG001|Part 2|Lost to Follow-up|0|||
143484382|NCT01225731|517318668|FG002|Part 2|Lost to Follow-up|0|||
143484383|NCT01225731|517318669|FG003|Part 2|Lost to Follow-up|0|||
143484384|NCT01225731|517318670|FG004|Part 2|Lost to Follow-up|0|||
143484385|NCT01225731|517318671|FG005|Part 2|Lost to Follow-up|0|||
143484386|NCT01225731|517318672|FG006|Part 2|Lost to Follow-up|0|||
143484387|NCT01225731|517318673|FG007|Part 2|Lost to Follow-up|3|||
143484388|NCT01225731|517318674|FG008|Part 2|Lost to Follow-up|1|||
143484389|NCT01225731|517318675|FG009|Part 2|Lost to Follow-up|0|||
143484390|NCT01225731|517318676|FG010|Part 2|Lost to Follow-up|0|||
143484391|NCT01225731|517318677|FG011|Part 2|Lost to Follow-up|0|||
143484392|NCT01225731|517318678|FG012|Part 2|Lost to Follow-up|0|||
143484393|NCT01225731|517318666|FG000|Part 2|Physician Decision|0|||
143484394|NCT01225731|517318667|FG001|Part 2|Physician Decision|0|||
143484395|NCT01225731|517318668|FG002|Part 2|Physician Decision|0|||
143484396|NCT01225731|517318669|FG003|Part 2|Physician Decision|0|||
143484397|NCT01225731|517318670|FG004|Part 2|Physician Decision|0|||
143484398|NCT01225731|517318671|FG005|Part 2|Physician Decision|0|||
143484399|NCT01225731|517318672|FG006|Part 2|Physician Decision|0|||
143484400|NCT01225731|517318673|FG007|Part 2|Physician Decision|2|||
143484401|NCT01225731|517318674|FG008|Part 2|Physician Decision|2|||
143484402|NCT01225731|517318675|FG009|Part 2|Physician Decision|0|||
143484403|NCT01225731|517318676|FG010|Part 2|Physician Decision|0|||
143484404|NCT01225731|517318677|FG011|Part 2|Physician Decision|0|||
143484405|NCT01225731|517318678|FG012|Part 2|Physician Decision|0|||
143484406|NCT01225731|517318666|FG000|Part 2|Withdrawal by Subject|0|||
143484407|NCT01225731|517318667|FG001|Part 2|Withdrawal by Subject|0|||
143484408|NCT01225731|517318668|FG002|Part 2|Withdrawal by Subject|0|||
143484409|NCT01225731|517318669|FG003|Part 2|Withdrawal by Subject|0|||
143484410|NCT01225731|517318670|FG004|Part 2|Withdrawal by Subject|0|||
143484411|NCT01225731|517318671|FG005|Part 2|Withdrawal by Subject|1|||
143484412|NCT01225731|517318672|FG006|Part 2|Withdrawal by Subject|3|||
143484413|NCT01225731|517318673|FG007|Part 2|Withdrawal by Subject|4|||
143484414|NCT01225731|517318674|FG008|Part 2|Withdrawal by Subject|1|||
143484415|NCT01225731|517318675|FG009|Part 2|Withdrawal by Subject|0|||
143484416|NCT01225731|517318676|FG010|Part 2|Withdrawal by Subject|0|||
143484417|NCT01225731|517318677|FG011|Part 2|Withdrawal by Subject|0|||
143484418|NCT01225731|517318678|FG012|Part 2|Withdrawal by Subject|0|||
143484419|NCT01225731|517318666|FG000|Part 3|Adverse Event|0|||
143484420|NCT01225731|517318667|FG001|Part 3|Adverse Event|0|||
143484421|NCT01225731|517318668|FG002|Part 3|Adverse Event|0|||
143484422|NCT01225731|517318669|FG003|Part 3|Adverse Event|0|||
143484423|NCT01225731|517318670|FG004|Part 3|Adverse Event|0|||
143484424|NCT01225731|517318671|FG005|Part 3|Adverse Event|0|||
143484425|NCT01225731|517318672|FG006|Part 3|Adverse Event|0|||
143484426|NCT01225731|517318673|FG007|Part 3|Adverse Event|0|||
143484427|NCT01225731|517318674|FG008|Part 3|Adverse Event|0|||
143484428|NCT01225731|517318675|FG009|Part 3|Adverse Event|0|||
143484429|NCT01225731|517318676|FG010|Part 3|Adverse Event|1|||
143484430|NCT01225731|517318677|FG011|Part 3|Adverse Event|1|||
143484431|NCT01225731|517318678|FG012|Part 3|Adverse Event|0|||
143484432|NCT01225731|517318666|FG000|Part 3|Lost to Follow-up|0|||
143484433|NCT01225731|517318667|FG001|Part 3|Lost to Follow-up|0|||
143484434|NCT01225731|517318668|FG002|Part 3|Lost to Follow-up|0|||
143484435|NCT01225731|517318669|FG003|Part 3|Lost to Follow-up|0|||
143484436|NCT01225731|517318670|FG004|Part 3|Lost to Follow-up|0|||
143484437|NCT01225731|517318671|FG005|Part 3|Lost to Follow-up|0|||
143484438|NCT01225731|517318672|FG006|Part 3|Lost to Follow-up|0|||
143484439|NCT01225731|517318673|FG007|Part 3|Lost to Follow-up|0|||
143484440|NCT01225731|517318674|FG008|Part 3|Lost to Follow-up|0|||
143484441|NCT01225731|517318675|FG009|Part 3|Lost to Follow-up|0|||
143484442|NCT01225731|517318676|FG010|Part 3|Lost to Follow-up|1|||
143484443|NCT01225731|517318677|FG011|Part 3|Lost to Follow-up|2|||
143484444|NCT01225731|517318678|FG012|Part 3|Lost to Follow-up|1|||
143484445|NCT01225731|517318666|FG000|Part 3|Physician Decision|0|||
143484446|NCT01225731|517318667|FG001|Part 3|Physician Decision|0|||
143484447|NCT01225731|517318668|FG002|Part 3|Physician Decision|0|||
143484448|NCT01225731|517318669|FG003|Part 3|Physician Decision|0|||
143484449|NCT01225731|517318670|FG004|Part 3|Physician Decision|0|||
143484450|NCT01225731|517318671|FG005|Part 3|Physician Decision|0|||
143484451|NCT01225731|517318672|FG006|Part 3|Physician Decision|0|||
143484452|NCT01225731|517318673|FG007|Part 3|Physician Decision|0|||
143484453|NCT01225731|517318674|FG008|Part 3|Physician Decision|0|||
143484454|NCT01225731|517318675|FG009|Part 3|Physician Decision|0|||
143484455|NCT01225731|517318676|FG010|Part 3|Physician Decision|0|||
143484456|NCT01225731|517318677|FG011|Part 3|Physician Decision|1|||
143484457|NCT01225731|517318678|FG012|Part 3|Physician Decision|2|||
143484458|NCT01225731|517318666|FG000|Part 3|Withdrawal by Subject|0|||
143149168|NCT02293499|516090253|FG002|Intervention - Camp|Withdrawal by Subject|2|||
143149169|NCT02293499|516090251|FG000|Intervention - Camp|these are those not showing up at camp|24|||
143149170|NCT02293499|516090252|FG001|Intervention - Camp|these are those not showing up at camp|28|||
143149171|NCT02293499|516090253|FG002|Intervention - Camp|these are those not showing up at camp|4|||
143149172|NCT02293499|516090251|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
143149173|NCT02293499|516090252|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
143149174|NCT02293499|516090253|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
143149175|NCT02293499|516090251|FG000|3 Month Follow Up|Lost to Follow-up|14|||
143149176|NCT02293499|516090252|FG001|3 Month Follow Up|Lost to Follow-up|15|||
143149177|NCT02293499|516090253|FG002|3 Month Follow Up|Lost to Follow-up|6|||
143149178|NCT02293499|516090251|FG000|6 Month Follow Up|Lost to Follow-up|17|||
143149179|NCT02293499|516090252|FG001|6 Month Follow Up|Lost to Follow-up|27|||
143149180|NCT02293499|516090253|FG002|6 Month Follow Up|Lost to Follow-up|6|||
143149181|NCT02293499|516090251|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
143149182|NCT02293499|516090252|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
143149183|NCT02293499|516090253|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
143149184|NCT02293499|516090251|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
143149185|NCT02293499|516090252|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
143149186|NCT02293499|516090253|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
143149187|NCT02293499|516090251|FG000|9 Month Follow Up|Lost to Follow-up|24|||
143149188|NCT02293499|516090252|FG001|9 Month Follow Up|Lost to Follow-up|28|||
143149189|NCT02293499|516090253|FG002|9 Month Follow Up|Lost to Follow-up|4|||
143149190|NCT02293499|516090251|FG000|12 Month Follow Up|Lost to Follow-up|26|||
143149191|NCT02293499|516090252|FG001|12 Month Follow Up|Lost to Follow-up|25|||
143149192|NCT02293499|516090253|FG002|12 Month Follow Up|Lost to Follow-up|6|||
143149193|NCT02293499|516090251|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
143149194|NCT02293499|516090252|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
143149195|NCT02293499|516090253|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
143149196|NCT02293499|516090251|FG000|15 Month Follow Up|Lost to Follow-up|22|||
143149197|NCT02293499|516090252|FG001|15 Month Follow Up|Lost to Follow-up|22|||
143149198|NCT02293499|516090253|FG002|15 Month Follow Up|Lost to Follow-up|7|||
143149199|NCT03317496|516090254|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
143149200|NCT03317496|516090255|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
143149201|NCT03317496|516090256|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
143149202|NCT03317496|516090257|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
143149203|NCT03317496|516090258|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
143149204|NCT03317496|516090254|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
143149205|NCT03317496|516090255|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
143149206|NCT03317496|516090256|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
143149207|NCT03317496|516090257|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
143149208|NCT03317496|516090258|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
143484459|NCT01225731|517318667|FG001|Part 3|Withdrawal by Subject|0|||
143484460|NCT01225731|517318668|FG002|Part 3|Withdrawal by Subject|0|||
143015026|NCT00567996|515595650|FG001|Overall Study|Lost to Follow-up|5|||
143149209|NCT03317496|516090254|FG000|Phase 1b Lead-in: Treatment|Death|0|||
143149210|NCT03317496|516090255|FG001|Phase 1b Lead-in: Treatment|Death|0|||
143149211|NCT03317496|516090256|FG002|Phase 1b Lead-in: Treatment|Death|1|||
143149212|NCT03317496|516090257|FG003|Phase 1b Lead-in: Treatment|Death|0|||
143149213|NCT03317496|516090258|FG004|Phase 1b Lead-in: Treatment|Death|0|||
143149214|NCT03317496|516090254|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
143149215|NCT03317496|516090255|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
143149216|NCT03317496|516090256|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
143484461|NCT01225731|517318669|FG003|Part 3|Withdrawal by Subject|0|||
143484462|NCT01225731|517318670|FG004|Part 3|Withdrawal by Subject|0|||
143484463|NCT01225731|517318671|FG005|Part 3|Withdrawal by Subject|0|||
143484464|NCT01225731|517318672|FG006|Part 3|Withdrawal by Subject|0|||
143484465|NCT01225731|517318673|FG007|Part 3|Withdrawal by Subject|0|||
143484466|NCT01225731|517318674|FG008|Part 3|Withdrawal by Subject|0|||
143484467|NCT01225731|517318675|FG009|Part 3|Withdrawal by Subject|0|||
143484468|NCT01225731|517318676|FG010|Part 3|Withdrawal by Subject|4|||
143015027|NCT00567996|515595651|FG002|Overall Study|Lost to Follow-up|2|||
143149217|NCT03317496|516090257|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
143149218|NCT03317496|516090258|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
143149219|NCT03317496|516090254|FG000|Phase 1b Lead-in: Treatment|Other|2|||
143149220|NCT03317496|516090255|FG001|Phase 1b Lead-in: Treatment|Other|1|||
143149221|NCT03317496|516090256|FG002|Phase 1b Lead-in: Treatment|Other|0|||
143149222|NCT03317496|516090257|FG003|Phase 1b Lead-in: Treatment|Other|0|||
143149223|NCT03317496|516090258|FG004|Phase 1b Lead-in: Treatment|Other|0|||
143149224|NCT03317496|516090254|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
143149225|NCT03317496|516090255|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
143149226|NCT03317496|516090256|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
143149227|NCT03317496|516090257|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
143149228|NCT03317496|516090258|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
143149229|NCT03317496|516090254|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
143149230|NCT03317496|516090255|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
143149231|NCT03317496|516090256|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
143149232|NCT03317496|516090257|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
143149233|NCT03317496|516090258|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
143149234|NCT03317496|516090254|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
143149235|NCT03317496|516090255|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
143149236|NCT03317496|516090256|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
143149237|NCT03317496|516090257|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
143149238|NCT03317496|516090258|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
143149239|NCT03317496|516090254|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
143149240|NCT03317496|516090255|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
143149241|NCT03317496|516090256|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
143149242|NCT03317496|516090257|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
143149243|NCT03317496|516090258|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
143149244|NCT03317496|516090254|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
143149245|NCT03317496|516090255|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
143149246|NCT03317496|516090256|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
143149247|NCT03317496|516090257|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
143149248|NCT03317496|516090258|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
143149249|NCT03317496|516090254|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
143149250|NCT03317496|516090255|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
143149251|NCT03317496|516090256|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
143149252|NCT03317496|516090257|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
143149253|NCT03317496|516090258|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
143149254|NCT03317496|516090254|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
143149255|NCT03317496|516090255|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
143149256|NCT03317496|516090256|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
143149257|NCT03317496|516090257|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
143149258|NCT03317496|516090258|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
143149259|NCT03317496|516090254|FG000|Phase 2: Treatment|Adverse Event|0|||
143149260|NCT03317496|516090255|FG001|Phase 2: Treatment|Adverse Event|0|||
143149261|NCT03317496|516090256|FG002|Phase 2: Treatment|Adverse Event|0|||
143149262|NCT03317496|516090257|FG003|Phase 2: Treatment|Adverse Event|0|||
143149263|NCT03317496|516090258|FG004|Phase 2: Treatment|Adverse Event|6|||
143149264|NCT03317496|516090254|FG000|Phase 2: Treatment|Progressive disease|0|||
143149265|NCT03317496|516090255|FG001|Phase 2: Treatment|Progressive disease|0|||
143149266|NCT03317496|516090256|FG002|Phase 2: Treatment|Progressive disease|0|||
143149267|NCT03317496|516090257|FG003|Phase 2: Treatment|Progressive disease|0|||
143149268|NCT03317496|516090258|FG004|Phase 2: Treatment|Progressive disease|22|||
143149269|NCT03317496|516090254|FG000|Phase 2: Treatment|Other|0|||
143149270|NCT03317496|516090255|FG001|Phase 2: Treatment|Other|0|||
143149271|NCT03317496|516090256|FG002|Phase 2: Treatment|Other|0|||
143149272|NCT03317496|516090257|FG003|Phase 2: Treatment|Other|0|||
143149273|NCT03317496|516090258|FG004|Phase 2: Treatment|Other|4|||
143149274|NCT03317496|516090254|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
143149275|NCT03317496|516090255|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
143149276|NCT03317496|516090256|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
143149277|NCT03317496|516090257|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
143149278|NCT03317496|516090258|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
143149279|NCT03317496|516090254|FG000|Phase 2: Treatment|Physician Decision|0|||
143149280|NCT03317496|516090255|FG001|Phase 2: Treatment|Physician Decision|0|||
143149281|NCT03317496|516090256|FG002|Phase 2: Treatment|Physician Decision|0|||
143149282|NCT03317496|516090257|FG003|Phase 2: Treatment|Physician Decision|0|||
143149283|NCT03317496|516090258|FG004|Phase 2: Treatment|Physician Decision|1|||
143149284|NCT03317496|516090254|FG000|Phase 2: Treatment|Death|0|||
143149285|NCT03317496|516090255|FG001|Phase 2: Treatment|Death|0|||
143149286|NCT03317496|516090256|FG002|Phase 2: Treatment|Death|0|||
143484469|NCT01225731|517318677|FG011|Part 3|Withdrawal by Subject|6|||
143149287|NCT03317496|516090257|FG003|Phase 2: Treatment|Death|0|||
143149288|NCT03317496|516090258|FG004|Phase 2: Treatment|Death|1|||
143149289|NCT03317496|516090254|FG000|Phase 2: Follow-up|Death|0|||
143149290|NCT03317496|516090255|FG001|Phase 2: Follow-up|Death|0|||
143149291|NCT03317496|516090256|FG002|Phase 2: Follow-up|Death|0|||
143149292|NCT03317496|516090257|FG003|Phase 2: Follow-up|Death|0|||
143149293|NCT03317496|516090258|FG004|Phase 2: Follow-up|Death|24|||
143149294|NCT03317496|516090254|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
143149295|NCT03317496|516090255|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
143149296|NCT03317496|516090256|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
143149297|NCT03317496|516090257|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
143149298|NCT03317496|516090258|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
143149299|NCT03317496|516090254|FG000|Phase 2: Follow-up|Other|0|||
143149300|NCT03317496|516090255|FG001|Phase 2: Follow-up|Other|0|||
143149301|NCT03317496|516090256|FG002|Phase 2: Follow-up|Other|0|||
143149302|NCT03317496|516090257|FG003|Phase 2: Follow-up|Other|0|||
143149303|NCT03317496|516090258|FG004|Phase 2: Follow-up|Other|1|||
143149304|NCT03317496|516090254|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
143149305|NCT03317496|516090255|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
143149306|NCT03317496|516090256|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
143149307|NCT03317496|516090257|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
143149308|NCT03317496|516090258|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
143149309|NCT04919161|516090259|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
143149310|NCT04919161|516090260|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
143149311|NCT04919161|516090259|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
143149312|NCT04919161|516090260|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
143149313|NCT04919161|516090259|FG000|Overall Study|Acute ankle sprain after session 1|0|||
143149314|NCT04919161|516090260|FG001|Overall Study|Acute ankle sprain after session 1|1|||
143149315|NCT05513950|516090261|FG000|Overall Study|Not treated due to technical reasons|0|||
143149316|NCT05513950|516090262|FG001|Overall Study|Not treated due to technical reasons|0|||
143149317|NCT05513950|516090263|FG002|Overall Study|Not treated due to technical reasons|1|||
143149318|NCT05513950|516090264|FG003|Overall Study|Not treated due to technical reasons|0|||
143149319|NCT04717557|516090275|FG000|Overall Study|Withdrawal by Subject|2|||
143149320|NCT04717557|516090276|FG001|Overall Study|Withdrawal by Subject|0|||
143149321|NCT04717557|516090275|FG000|Overall Study|Death|1|||
143149322|NCT04717557|516090276|FG001|Overall Study|Death|0|||
143149323|NCT06354257|516090277|FG000|Treatment Period 1|Withdrawal by Subject|1|||
143149324|NCT06354257|516090277|FG000|Treatment Period 2|Adverse Event|1|||
143149325|NCT02685735|516090278|FG000|Overall Study|Surgery Cancelled|4|||
143149326|NCT02685735|516090279|FG001|Overall Study|Surgery Cancelled|9|||
143149327|NCT02685735|516090278|FG000|Overall Study|Adverse Event|10|||
143149328|NCT02685735|516090279|FG001|Overall Study|Adverse Event|3|||
143149329|NCT02685735|516090278|FG000|Overall Study|Preop testing found to be incomplete|2|||
143149330|NCT02685735|516090279|FG001|Overall Study|Preop testing found to be incomplete|2|||
143149331|NCT02685735|516090278|FG000|Overall Study|Withdrawal by Subject|1|||
143149332|NCT02685735|516090279|FG001|Overall Study|Withdrawal by Subject|2|||
143149333|NCT02685735|516090278|FG000|Overall Study|Death|1|||
143149334|NCT02685735|516090279|FG001|Overall Study|Death|0|||
143149335|NCT00927472|516090287|FG000|Overall Study|Withdrawal by Subject|10|||
143149336|NCT00927472|516090288|FG001|Overall Study|Withdrawal by Subject|11|||
143149337|NCT00927472|516090287|FG000|Overall Study|Lost to Follow-up|1|||
143149338|NCT00927472|516090288|FG001|Overall Study|Lost to Follow-up|6|||
143149339|NCT00927472|516090287|FG000|Overall Study|Protocol Violation|0|||
143149340|NCT00927472|516090288|FG001|Overall Study|Protocol Violation|1|||
143149341|NCT00927472|516090287|FG000|Overall Study|Post treatment Assessment out of window|0|||
143149342|NCT00927472|516090288|FG001|Overall Study|Post treatment Assessment out of window|4|||
143149343|NCT00433537|516090289|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
143149344|NCT00433537|516090290|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
143149345|NCT00433537|516090291|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
143149346|NCT00433537|516090289|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
143149347|NCT00433537|516090290|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
143149348|NCT00433537|516090291|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
143149349|NCT00433537|516090289|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
143149350|NCT00433537|516090290|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
143232338|NCT02234843|516402096|FG007|Overall Study|Withdrawal by Subject|0|||
143149351|NCT00433537|516090291|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
143149352|NCT00433537|516090289|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
143149353|NCT00433537|516090290|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
143149354|NCT00433537|516090291|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
143149355|NCT00433537|516090289|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
143149356|NCT00433537|516090290|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
143149357|NCT00433537|516090291|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
143149358|NCT00433537|516090289|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
143232339|NCT02234843|516402097|FG008|Overall Study|Withdrawal by Subject|0|||
143232340|NCT02234843|516402098|FG009|Overall Study|Withdrawal by Subject|0|||
143232341|NCT02234843|516402089|FG000|Overall Study|Recovery|1|||
143232342|NCT02234843|516402090|FG001|Overall Study|Recovery|0|||
143232343|NCT02234843|516402091|FG002|Overall Study|Recovery|0|||
143232344|NCT02234843|516402092|FG003|Overall Study|Recovery|0|||
143232345|NCT02234843|516402093|FG004|Overall Study|Recovery|0|||
143232346|NCT02234843|516402094|FG005|Overall Study|Recovery|0|||
143232347|NCT02234843|516402095|FG006|Overall Study|Recovery|0|||
143232348|NCT02234843|516402096|FG007|Overall Study|Recovery|0|||
143232349|NCT02234843|516402097|FG008|Overall Study|Recovery|0|||
143232350|NCT02234843|516402098|FG009|Overall Study|Recovery|0|||
143232351|NCT02234843|516402089|FG000|Overall Study|Other|0|||
143232352|NCT02234843|516402090|FG001|Overall Study|Other|2|||
143232353|NCT02234843|516402091|FG002|Overall Study|Other|0|||
143232354|NCT02234843|516402092|FG003|Overall Study|Other|1|||
143232355|NCT02234843|516402093|FG004|Overall Study|Other|0|||
143232356|NCT02234843|516402094|FG005|Overall Study|Other|1|||
143232357|NCT02234843|516402095|FG006|Overall Study|Other|0|||
143232358|NCT02234843|516402096|FG007|Overall Study|Other|1|||
143232359|NCT02234843|516402097|FG008|Overall Study|Other|0|||
143232360|NCT02234843|516402098|FG009|Overall Study|Other|0|||
143232361|NCT02234843|516402089|FG000|Overall Study|Physician Decision|4|||
143232362|NCT02234843|516402090|FG001|Overall Study|Physician Decision|1|||
143232363|NCT02234843|516402091|FG002|Overall Study|Physician Decision|0|||
143232364|NCT02234843|516402092|FG003|Overall Study|Physician Decision|1|||
143232365|NCT02234843|516402093|FG004|Overall Study|Physician Decision|0|||
143232366|NCT02234843|516402094|FG005|Overall Study|Physician Decision|0|||
143232367|NCT02234843|516402095|FG006|Overall Study|Physician Decision|0|||
143232368|NCT02234843|516402096|FG007|Overall Study|Physician Decision|1|||
143232369|NCT02234843|516402097|FG008|Overall Study|Physician Decision|0|||
143232370|NCT02234843|516402098|FG009|Overall Study|Physician Decision|0|||
143232371|NCT02234843|516402089|FG000|Overall Study|Adverse Event|5|||
143232372|NCT02234843|516402090|FG001|Overall Study|Adverse Event|1|||
143232373|NCT02234843|516402091|FG002|Overall Study|Adverse Event|1|||
143232374|NCT02234843|516402092|FG003|Overall Study|Adverse Event|3|||
143232375|NCT02234843|516402093|FG004|Overall Study|Adverse Event|2|||
143232376|NCT02234843|516402094|FG005|Overall Study|Adverse Event|1|||
143232377|NCT02234843|516402095|FG006|Overall Study|Adverse Event|0|||
143232378|NCT02234843|516402096|FG007|Overall Study|Adverse Event|0|||
143232379|NCT02234843|516402097|FG008|Overall Study|Adverse Event|1|||
143232380|NCT02234843|516402098|FG009|Overall Study|Adverse Event|0|||
143232381|NCT02234843|516402089|FG000|Overall Study|Non-compliance with study drug|1|||
143232382|NCT02234843|516402090|FG001|Overall Study|Non-compliance with study drug|0|||
143232383|NCT02234843|516402091|FG002|Overall Study|Non-compliance with study drug|0|||
143232384|NCT02234843|516402092|FG003|Overall Study|Non-compliance with study drug|0|||
143232385|NCT02234843|516402093|FG004|Overall Study|Non-compliance with study drug|0|||
143232386|NCT02234843|516402094|FG005|Overall Study|Non-compliance with study drug|1|||
143232387|NCT02234843|516402095|FG006|Overall Study|Non-compliance with study drug|1|||
143232388|NCT02234843|516402096|FG007|Overall Study|Non-compliance with study drug|0|||
143232389|NCT02234843|516402097|FG008|Overall Study|Non-compliance with study drug|0|||
143232390|NCT02234843|516402098|FG009|Overall Study|Non-compliance with study drug|0|||
143232391|NCT02234843|516402089|FG000|Overall Study|Lost to Follow-up|0|||
143232392|NCT02234843|516402090|FG001|Overall Study|Lost to Follow-up|1|||
143232393|NCT02234843|516402091|FG002|Overall Study|Lost to Follow-up|0|||
143232394|NCT02234843|516402092|FG003|Overall Study|Lost to Follow-up|0|||
143232395|NCT02234843|516402093|FG004|Overall Study|Lost to Follow-up|0|||
143232396|NCT02234843|516402094|FG005|Overall Study|Lost to Follow-up|0|||
143232397|NCT02234843|516402095|FG006|Overall Study|Lost to Follow-up|1|||
143232398|NCT02234843|516402096|FG007|Overall Study|Lost to Follow-up|0|||
143232399|NCT02234843|516402097|FG008|Overall Study|Lost to Follow-up|0|||
143232400|NCT02234843|516402098|FG009|Overall Study|Lost to Follow-up|0|||
143232401|NCT00506350|516402099|FG000|Overall Study|Serious Adverse Event|1|||
143232402|NCT00506350|516402100|FG001|Overall Study|Serious Adverse Event|0|||
143484470|NCT01225731|517318678|FG012|Part 3|Withdrawal by Subject|4|||
143484471|NCT00577642|517318679|FG000|Overall Study|Clinical Disease Progression|1|||
143232403|NCT00506350|516402101|FG002|Overall Study|Serious Adverse Event|0|||
143232404|NCT00506350|516402102|FG003|Overall Study|Serious Adverse Event|0|||
143232405|NCT00506350|516402103|FG004|Overall Study|Serious Adverse Event|0|||
143232406|NCT00506350|516402104|FG005|Overall Study|Serious Adverse Event|0|||
143232407|NCT00506350|516402105|FG006|Overall Study|Serious Adverse Event|0|||
143232408|NCT00506350|516402106|FG007|Overall Study|Serious Adverse Event|0|||
143232409|NCT00506350|516402107|FG008|Overall Study|Serious Adverse Event|0|||
143232410|NCT00506350|516402099|FG000|Overall Study|Adverse Event|0|||
143484472|NCT02039375|517318684|FG000|Overall Study|Lost to Follow-up|2|||
143232411|NCT00506350|516402100|FG001|Overall Study|Adverse Event|0|||
143232412|NCT00506350|516402101|FG002|Overall Study|Adverse Event|0|||
143232413|NCT00506350|516402102|FG003|Overall Study|Adverse Event|0|||
143232414|NCT00506350|516402103|FG004|Overall Study|Adverse Event|0|||
143232415|NCT00506350|516402104|FG005|Overall Study|Adverse Event|0|||
143484473|NCT00542269|517318695|FG000|Overall Study|Adverse Event|10|||
143484474|NCT00542269|517318696|FG001|Overall Study|Adverse Event|4|||
143232416|NCT00506350|516402105|FG006|Overall Study|Adverse Event|0|||
143232417|NCT00506350|516402106|FG007|Overall Study|Adverse Event|1|||
143232418|NCT00506350|516402107|FG008|Overall Study|Adverse Event|1|||
143232419|NCT00506350|516402099|FG000|Overall Study|Protocol Violation|0|||
143232420|NCT00506350|516402100|FG001|Overall Study|Protocol Violation|0|||
143232421|NCT00506350|516402101|FG002|Overall Study|Protocol Violation|1|||
143232422|NCT00506350|516402102|FG003|Overall Study|Protocol Violation|0|||
143232423|NCT00506350|516402103|FG004|Overall Study|Protocol Violation|0|||
143232424|NCT00506350|516402104|FG005|Overall Study|Protocol Violation|0|||
143232425|NCT00506350|516402105|FG006|Overall Study|Protocol Violation|1|||
143232426|NCT00506350|516402106|FG007|Overall Study|Protocol Violation|0|||
143232427|NCT00506350|516402107|FG008|Overall Study|Protocol Violation|0|||
143232428|NCT00506350|516402099|FG000|Overall Study|Withdrawal by Subject|0|||
143232429|NCT00506350|516402100|FG001|Overall Study|Withdrawal by Subject|1|||
143232430|NCT00506350|516402101|FG002|Overall Study|Withdrawal by Subject|1|||
143232431|NCT00506350|516402102|FG003|Overall Study|Withdrawal by Subject|1|||
143232432|NCT00506350|516402103|FG004|Overall Study|Withdrawal by Subject|4|||
143232433|NCT00506350|516402104|FG005|Overall Study|Withdrawal by Subject|1|||
143232434|NCT00506350|516402105|FG006|Overall Study|Withdrawal by Subject|1|||
143232435|NCT00506350|516402106|FG007|Overall Study|Withdrawal by Subject|2|||
143232436|NCT00506350|516402107|FG008|Overall Study|Withdrawal by Subject|0|||
143232437|NCT00506350|516402099|FG000|Overall Study|Lost to Follow-up|1|||
143232438|NCT00506350|516402100|FG001|Overall Study|Lost to Follow-up|1|||
143232439|NCT00506350|516402101|FG002|Overall Study|Lost to Follow-up|1|||
143232440|NCT00506350|516402102|FG003|Overall Study|Lost to Follow-up|1|||
143232441|NCT00506350|516402103|FG004|Overall Study|Lost to Follow-up|2|||
143232442|NCT00506350|516402104|FG005|Overall Study|Lost to Follow-up|1|||
143484475|NCT00542269|517318697|FG002|Overall Study|Adverse Event|5|||
143232443|NCT00506350|516402105|FG006|Overall Study|Lost to Follow-up|0|||
143232444|NCT00506350|516402106|FG007|Overall Study|Lost to Follow-up|0|||
143232445|NCT00506350|516402107|FG008|Overall Study|Lost to Follow-up|2|||
143232446|NCT00506350|516402099|FG000|Overall Study|Medical Reason|0|||
143232447|NCT00506350|516402100|FG001|Overall Study|Medical Reason|0|||
143232448|NCT00506350|516402101|FG002|Overall Study|Medical Reason|0|||
143232449|NCT00506350|516402102|FG003|Overall Study|Medical Reason|0|||
143232450|NCT00506350|516402103|FG004|Overall Study|Medical Reason|1|||
143232451|NCT00506350|516402104|FG005|Overall Study|Medical Reason|0|||
143232452|NCT00506350|516402105|FG006|Overall Study|Medical Reason|0|||
143232453|NCT00506350|516402106|FG007|Overall Study|Medical Reason|0|||
143232454|NCT00506350|516402107|FG008|Overall Study|Medical Reason|0|||
143232455|NCT00506350|516402099|FG000|Overall Study|Other|1|||
143232456|NCT00506350|516402100|FG001|Overall Study|Other|1|||
143232457|NCT00506350|516402101|FG002|Overall Study|Other|3|||
143232458|NCT00506350|516402102|FG003|Overall Study|Other|0|||
143232459|NCT00506350|516402103|FG004|Overall Study|Other|3|||
143232460|NCT00506350|516402104|FG005|Overall Study|Other|0|||
143232461|NCT00506350|516402105|FG006|Overall Study|Other|0|||
143232462|NCT00506350|516402106|FG007|Overall Study|Other|2|||
143232463|NCT00506350|516402107|FG008|Overall Study|Other|2|||
143232464|NCT04886154|516402108|FG000|Overall Study|Adverse Event|0|||
143232465|NCT04886154|516402109|FG001|Overall Study|Adverse Event|0|||
143232466|NCT04886154|516402110|FG002|Overall Study|Adverse Event|0|||
143232467|NCT04886154|516402111|FG003|Overall Study|Adverse Event|0|||
143232468|NCT04886154|516402112|FG004|Overall Study|Adverse Event|1|||
143232469|NCT04886154|516402113|FG005|Overall Study|Adverse Event|0|||
143232470|NCT04886154|516402114|FG006|Overall Study|Adverse Event|0|||
143484476|NCT00542269|517318695|FG000|Overall Study|Protocol Violation|1|||
143484477|NCT00542269|517318696|FG001|Overall Study|Protocol Violation|1|||
143484478|NCT00542269|517318697|FG002|Overall Study|Protocol Violation|0|||
143015028|NCT00567996|515595649|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
143232471|NCT04886154|516402115|FG007|Overall Study|Adverse Event|1|||
143232472|NCT04886154|516402116|FG008|Overall Study|Adverse Event|1|||
143232473|NCT04886154|516402117|FG009|Overall Study|Adverse Event|0|||
143232474|NCT04886154|516402118|FG010|Overall Study|Adverse Event|0|||
143232475|NCT04886154|516402119|FG011|Overall Study|Adverse Event|1|||
143232476|NCT04886154|516402120|FG012|Overall Study|Adverse Event|0|||
143232477|NCT04886154|516402121|FG013|Overall Study|Adverse Event|0|||
143232478|NCT04886154|516402122|FG014|Overall Study|Adverse Event|3|||
143232479|NCT04886154|516402108|FG000|Overall Study|Lost to Follow-up|1|||
143484479|NCT00542269|517318695|FG000|Overall Study|Withdrawal by Subject|1|||
143484480|NCT00542269|517318696|FG001|Overall Study|Withdrawal by Subject|0|||
143484481|NCT00542269|517318697|FG002|Overall Study|Withdrawal by Subject|0|||
143015029|NCT00567996|515595650|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
143232480|NCT04886154|516402109|FG001|Overall Study|Lost to Follow-up|0|||
143232481|NCT04886154|516402110|FG002|Overall Study|Lost to Follow-up|2|||
143232482|NCT04886154|516402111|FG003|Overall Study|Lost to Follow-up|0|||
143232483|NCT04886154|516402112|FG004|Overall Study|Lost to Follow-up|17|||
143232484|NCT04886154|516402113|FG005|Overall Study|Lost to Follow-up|7|||
143232485|NCT04886154|516402114|FG006|Overall Study|Lost to Follow-up|8|||
143484482|NCT00542269|517318695|FG000|Overall Study|Administrative problems|1|||
143484483|NCT00542269|517318696|FG001|Overall Study|Administrative problems|1|||
143484484|NCT00542269|517318697|FG002|Overall Study|Administrative problems|1|||
143484485|NCT03873714|517318698|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
143484486|NCT00794157|517318699|FG000|Overall Study|Adverse Event|4|||
143484487|NCT00794157|517318700|FG001|Overall Study|Adverse Event|1|||
143484488|NCT00794157|517318701|FG002|Overall Study|Adverse Event|8|||
143484489|NCT00794157|517318699|FG000|Overall Study|Subject withdrew consent|2|||
143149359|NCT00433537|516090290|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
143149360|NCT00433537|516090291|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
143149361|NCT00433537|516090289|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
143149362|NCT00433537|516090290|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
143149363|NCT00433537|516090291|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
143149364|NCT00433537|516090289|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
143149365|NCT00433537|516090290|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
143149366|NCT00433537|516090291|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
143149367|NCT00433537|516090289|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
143149368|NCT00433537|516090290|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
143149369|NCT00433537|516090291|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
143149370|NCT05436613|516090292|FG000|Overall Study|Lost to Follow-up|9|||
143149371|NCT05436613|516090292|FG000|Overall Study|Withdrawal by Subject|3|||
143149372|NCT05317546|516090295|FG000|First Wash-Out Period|Withdrawal by Subject|1|||
143149373|NCT05317546|516090296|FG001|First Wash-Out Period|Withdrawal by Subject|2|||
143149374|NCT03331250|516090297|FG000|Overall Study|Withdrawal by Subject|1|||
143149375|NCT05350202|516090298|FG000|Visit 1 - Baseline|Not-treated|18|||
143149376|NCT05350202|516090299|FG001|Visit 1 - Baseline|Not-treated|0|||
143149377|NCT05350202|516090298|FG000|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|25|||
143149378|NCT05350202|516090299|FG001|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|0|||
143149379|NCT05350202|516090298|FG000|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|36|||
143149380|NCT05350202|516090299|FG001|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|0|||
143149381|NCT05350202|516090298|FG000|Visit 1 to Visit 2 - 24 Weeks|Death|45|||
143149382|NCT05350202|516090299|FG001|Visit 1 to Visit 2 - 24 Weeks|Death|0|||
143149383|NCT05350202|516090298|FG000|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|7|||
143149384|NCT05350202|516090299|FG001|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|0|||
143149385|NCT05350202|516090298|FG000|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|6|||
143149386|NCT05350202|516090299|FG001|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|0|||
143149387|NCT05350202|516090298|FG000|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|38|||
143149388|NCT05350202|516090299|FG001|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|0|||
143149389|NCT03488524|516090300|FG000|Overall Study|Withdrawal by Subject|51|||
143149390|NCT03488524|516090300|FG000|Overall Study|Death|19|||
143149391|NCT03488524|516090300|FG000|Overall Study|Study Sponsor|11|||
143149392|NCT03488524|516090300|FG000|Overall Study|Physician Decision|4|||
143149393|NCT03488524|516090300|FG000|Overall Study|Lost to Follow-up|3|||
143149394|NCT01937299|516090301|FG000|Overall Study|Adverse Event|13|||
143149395|NCT01937299|516090302|FG001|Overall Study|Adverse Event|0|||
143149396|NCT01937299|516090301|FG000|Overall Study|Lack of Efficacy|0|||
143149397|NCT01937299|516090302|FG001|Overall Study|Lack of Efficacy|4|||
143149398|NCT01937299|516090301|FG000|Overall Study|Withdrawal by Subject|1|||
143149399|NCT01937299|516090302|FG001|Overall Study|Withdrawal by Subject|0|||
143149400|NCT05759338|516090309|FG000|Overall Study|Withdrawal by Subject|3|||
143149401|NCT04611126|516090310|FG000|Overall Study|TIL expansion unsuccessful|1|||
143149402|NCT04611126|516090311|FG001|Overall Study|TIL expansion unsuccessful|0|||
143149403|NCT03459846|516090312|FG000|Overall Study|Death|52|||
143149404|NCT03459846|516090313|FG001|Overall Study|Death|46|||
143149405|NCT03459846|516090312|FG000|Overall Study|Study terminated by sponsor|24|||
143149406|NCT03459846|516090313|FG001|Overall Study|Study terminated by sponsor|28|||
143149407|NCT03459846|516090312|FG000|Overall Study|Withdrawal by Subject|2|||
143149408|NCT03459846|516090313|FG001|Overall Study|Withdrawal by Subject|2|||
143149409|NCT06455111|516090314|FG000|Overall Study|Withdrawal by Subject|11|||
143149410|NCT06455111|516090315|FG001|Overall Study|Withdrawal by Subject|4|||
143149411|NCT03069989|516090319|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
143149412|NCT03069989|516090320|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
143149413|NCT06717399|516090321|FG000|Overall Study|Death|1|||
143149414|NCT02145390|516090322|FG000|Overall Study|Withdrawal by Subject|1|||
143149415|NCT05578872|516090323|FG000|Overall Study|Withdrawal by Subject|2|||
143149416|NCT05578872|516090324|FG001|Overall Study|Withdrawal by Subject|1|||
143149417|NCT05578872|516090323|FG000|Overall Study|Adverse Event|1|||
143484490|NCT00794157|517318700|FG001|Overall Study|Subject withdrew consent|0|||
143484491|NCT00794157|517318701|FG002|Overall Study|Subject withdrew consent|3|||
143149418|NCT05578872|516090324|FG001|Overall Study|Adverse Event|1|||
143149419|NCT05578872|516090323|FG000|Overall Study|Physician Decision|1|||
143149420|NCT05578872|516090324|FG001|Overall Study|Physician Decision|2|||
143149421|NCT05578872|516090323|FG000|Overall Study|Progressive disease|10|||
143149422|NCT05578872|516090324|FG001|Overall Study|Progressive disease|9|||
143149423|NCT05578872|516090323|FG000|Overall Study|Sponsor decision|0|||
143149424|NCT05578872|516090324|FG001|Overall Study|Sponsor decision|1|||
143149425|NCT05578872|516090323|FG000|Overall Study|Toxicity and Patient's decision|0|||
143149426|NCT05578872|516090324|FG001|Overall Study|Toxicity and Patient's decision|1|||
143149427|NCT01991314|516091536|FG000|Overall Study|Adverse Event|5|||
143149428|NCT01991314|516091537|FG001|Overall Study|Adverse Event|1|||
143149429|NCT01991314|516091536|FG000|Overall Study|Lost to Follow-up|6|||
143149430|NCT01991314|516091537|FG001|Overall Study|Lost to Follow-up|10|||
143149431|NCT02034591|516091546|FG000|Overall Study|Withdrawal by Subject|0|||
143149432|NCT02034591|516091547|FG001|Overall Study|Withdrawal by Subject|0|||
143149433|NCT02034591|516091548|FG002|Overall Study|Withdrawal by Subject|0|||
143149434|NCT02034591|516091549|FG003|Overall Study|Withdrawal by Subject|0|||
143149435|NCT02034591|516091550|FG004|Overall Study|Withdrawal by Subject|1|||
143149436|NCT02034591|516091551|FG005|Overall Study|Withdrawal by Subject|0|||
143149437|NCT00817063|516091552|FG000|Overall Study|Adverse Event|32|||
143149438|NCT00817063|516091553|FG001|Overall Study|Adverse Event|13|||
143149439|NCT00817063|516091552|FG000|Overall Study|Death|1|||
143149440|NCT00817063|516091553|FG001|Overall Study|Death|1|||
143149441|NCT00817063|516091552|FG000|Overall Study|Lack of Efficacy|33|||
143149442|NCT00817063|516091553|FG001|Overall Study|Lack of Efficacy|86|||
143149443|NCT00817063|516091552|FG000|Overall Study|Failure to Return|13|||
143149444|NCT00817063|516091553|FG001|Overall Study|Failure to Return|12|||
143149445|NCT00817063|516091552|FG000|Overall Study|Violation of Selection at Entry|7|||
143149446|NCT00817063|516091553|FG001|Overall Study|Violation of Selection at Entry|4|||
143149447|NCT00817063|516091552|FG000|Overall Study|Protocol Violation|3|||
143149448|NCT00817063|516091553|FG001|Overall Study|Protocol Violation|8|||
143149449|NCT00817063|516091552|FG000|Overall Study|Withdrawal by Subject|17|||
143149450|NCT00817063|516091553|FG001|Overall Study|Withdrawal by Subject|37|||
143149451|NCT00817063|516091552|FG000|Overall Study|Early Improvement|19|||
143149452|NCT00817063|516091553|FG001|Overall Study|Early Improvement|4|||
143149453|NCT00817063|516091552|FG000|Overall Study|Administrative|10|||
143149454|NCT00817063|516091553|FG001|Overall Study|Administrative|4|||
143149455|NCT00817063|516091552|FG000|Overall Study|Abnormality of Laboratory Test|2|||
143149456|NCT00817063|516091553|FG001|Overall Study|Abnormality of Laboratory Test|1|||
143149457|NCT01496456|516091554|FG000|Overall Study|Protocol Violation|1|||
143149458|NCT01496456|516091554|FG000|Overall Study|Lost to Follow-up|7|||
143149459|NCT02489773|516091555|FG000|Overall Study|Lost to Follow-up|4|||
143149460|NCT02489773|516091556|FG001|Overall Study|Lost to Follow-up|1|||
143149461|NCT02489773|516091555|FG000|Overall Study|Physician Decision|1|||
143149462|NCT02489773|516091556|FG001|Overall Study|Physician Decision|0|||
143149463|NCT02489773|516091555|FG000|Overall Study|Withdrawal by Subject|1|||
143149464|NCT02489773|516091556|FG001|Overall Study|Withdrawal by Subject|0|||
143149465|NCT02489773|516091555|FG000|Overall Study|Leave the country or the state|1|||
143149466|NCT02489773|516091556|FG001|Overall Study|Leave the country or the state|1|||
143149467|NCT00712920|516091557|FG000|Overall Study|Adverse Event|3|||
143149468|NCT00712920|516091558|FG001|Overall Study|Adverse Event|4|||
143149469|NCT00712920|516091559|FG002|Overall Study|Adverse Event|7|||
143149470|NCT00712920|516091557|FG000|Overall Study|Withdrawal by Subject|4|||
143149471|NCT00712920|516091558|FG001|Overall Study|Withdrawal by Subject|2|||
143149472|NCT00712920|516091559|FG002|Overall Study|Withdrawal by Subject|1|||
143149473|NCT00712920|516091557|FG000|Overall Study|Lost to Follow-up|1|||
143232486|NCT04886154|516402115|FG007|Overall Study|Lost to Follow-up|7|||
143232487|NCT04886154|516402116|FG008|Overall Study|Lost to Follow-up|8|||
143232488|NCT04886154|516402117|FG009|Overall Study|Lost to Follow-up|0|||
143232489|NCT04886154|516402118|FG010|Overall Study|Lost to Follow-up|2|||
143232490|NCT04886154|516402119|FG011|Overall Study|Lost to Follow-up|0|||
143232491|NCT04886154|516402120|FG012|Overall Study|Lost to Follow-up|0|||
143232492|NCT04886154|516402121|FG013|Overall Study|Lost to Follow-up|0|||
143232493|NCT04886154|516402122|FG014|Overall Study|Lost to Follow-up|0|||
143232494|NCT04886154|516402108|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
143232495|NCT04886154|516402109|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
143232496|NCT04886154|516402110|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
143232497|NCT04886154|516402111|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
143149474|NCT00712920|516091558|FG001|Overall Study|Lost to Follow-up|4|||
143149475|NCT00712920|516091559|FG002|Overall Study|Lost to Follow-up|0|||
143149476|NCT00712920|516091557|FG000|Overall Study|Lack of Efficacy|1|||
143149477|NCT00712920|516091558|FG001|Overall Study|Lack of Efficacy|0|||
143149478|NCT00712920|516091559|FG002|Overall Study|Lack of Efficacy|1|||
143149479|NCT00712920|516091557|FG000|Overall Study|Other|5|||
143149480|NCT00712920|516091558|FG001|Overall Study|Other|7|||
143149481|NCT00712920|516091559|FG002|Overall Study|Other|3|||
143149482|NCT00712920|516091557|FG000|Overall Study|Non-compliance|3|||
143149483|NCT00712920|516091558|FG001|Overall Study|Non-compliance|0|||
143149484|NCT00712920|516091559|FG002|Overall Study|Non-compliance|0|||
143149485|NCT02696616|516091560|FG000|Overall Study|Adverse Event|0|||
143149486|NCT02696616|516091561|FG001|Overall Study|Adverse Event|1|||
143484492|NCT00794157|517318699|FG000|Overall Study|Lost to Follow-up|2|||
143484493|NCT00794157|517318700|FG001|Overall Study|Lost to Follow-up|0|||
143484494|NCT00794157|517318701|FG002|Overall Study|Lost to Follow-up|1|||
143484495|NCT00794157|517318699|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
143484496|NCT00794157|517318700|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
143484497|NCT00794157|517318701|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
143484498|NCT00794157|517318699|FG000|Overall Study|Administrative problems|1|||
143484499|NCT00794157|517318700|FG001|Overall Study|Administrative problems|7|||
143484500|NCT00794157|517318701|FG002|Overall Study|Administrative problems|4|||
143484501|NCT00794157|517318699|FG000|Overall Study|Abnormal test procedure result(s)|0|||
143484502|NCT00794157|517318700|FG001|Overall Study|Abnormal test procedure result(s)|1|||
143484503|NCT00794157|517318701|FG002|Overall Study|Abnormal test procedure result(s)|0|||
143484504|NCT00794157|517318699|FG000|Overall Study|Protocol deviation|0|||
143484505|NCT00794157|517318700|FG001|Overall Study|Protocol deviation|1|||
143484506|NCT00794157|517318701|FG002|Overall Study|Protocol deviation|1|||
143484507|NCT01970501|517318702|FG000|Overall Study|Discontinuation of study by sponsor|16|||
143484508|NCT01970501|517318703|FG001|Overall Study|Discontinuation of study by sponsor|14|||
143484509|NCT01970501|517318702|FG000|Overall Study|Withdrawal by Subject|6|||
143484510|NCT01970501|517318703|FG001|Overall Study|Withdrawal by Subject|7|||
143484511|NCT01970501|517318702|FG000|Overall Study|Adverse Event|2|||
143484512|NCT01970501|517318703|FG001|Overall Study|Adverse Event|4|||
143484513|NCT01970501|517318702|FG000|Overall Study|Death|1|||
143484514|NCT01970501|517318703|FG001|Overall Study|Death|3|||
143484515|NCT01970501|517318702|FG000|Overall Study|Physician Decision|2|||
143484516|NCT01970501|517318703|FG001|Overall Study|Physician Decision|0|||
143484517|NCT01692275|517318704|FG000|Overall Study|Lost to Follow-up|57|||
143484518|NCT01692275|517318705|FG001|Overall Study|Lost to Follow-up|48|||
143484519|NCT01692275|517318704|FG000|Overall Study|Withdrawal by Subject|9|||
143484520|NCT01692275|517318705|FG001|Overall Study|Withdrawal by Subject|11|||
143484521|NCT00950664|517318710|FG000|First Intervention|Lost to Follow-up|1|||
143484522|NCT00950664|517318711|FG001|First Intervention|Lost to Follow-up|3|||
143484523|NCT00950664|517318710|FG000|First Intervention|Withdrawal by Subject|2|||
143484524|NCT00950664|517318711|FG001|First Intervention|Withdrawal by Subject|2|||
143484525|NCT00677014|517318712|FG000|Overall Study|Lost to Follow-up|20|||
143484526|NCT00677014|517318713|FG001|Overall Study|Lost to Follow-up|12|||
143484527|NCT00677014|517318714|FG002|Overall Study|Lost to Follow-up|24|||
143484528|NCT00677014|517318712|FG000|Overall Study|Death|6|||
143484529|NCT00677014|517318713|FG001|Overall Study|Death|15|||
143484530|NCT00677014|517318714|FG002|Overall Study|Death|7|||
143484531|NCT00677014|517318712|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
143484532|NCT00677014|517318713|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
143484533|NCT00677014|517318714|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
143484534|NCT00640328|517318715|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
143484535|NCT00640328|517318716|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
143484536|NCT00640328|517318717|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
143484537|NCT00640328|517318718|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
143484538|NCT00640328|517318719|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
143232498|NCT04886154|516402112|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
143232499|NCT04886154|516402113|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
143232500|NCT04886154|516402114|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
143232501|NCT04886154|516402115|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
143232502|NCT04886154|516402116|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
143232503|NCT04886154|516402117|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
143484539|NCT00640328|517318720|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
143484540|NCT00640328|517318715|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
143484541|NCT00640328|517318716|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
143484542|NCT00640328|517318717|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
143484543|NCT00640328|517318718|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
143484544|NCT00640328|517318719|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
143484545|NCT00640328|517318720|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
143484546|NCT00640328|517318715|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
143232504|NCT04886154|516402118|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
143232505|NCT04886154|516402119|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
143484547|NCT00640328|517318716|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
143484548|NCT00640328|517318717|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
143484549|NCT00640328|517318718|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
143484550|NCT00640328|517318719|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
143484551|NCT00640328|517318720|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
143484552|NCT00640328|517318715|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
143484553|NCT00640328|517318716|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
143484554|NCT00640328|517318717|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
143484555|NCT00640328|517318718|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
143484556|NCT00640328|517318719|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
143484557|NCT00640328|517318720|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
143484558|NCT01714687|517318723|FG000|Overall Study|Withdrawal by Subject|1|||
143232506|NCT04886154|516402120|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
143149487|NCT02696616|516091562|FG002|Overall Study|Adverse Event|0|||
143149488|NCT02696616|516091563|FG003|Overall Study|Adverse Event|0|||
143149489|NCT02696616|516091564|FG004|Overall Study|Adverse Event|0|||
143149490|NCT02696616|516091565|FG005|Overall Study|Adverse Event|0|||
143149491|NCT02696616|516091566|FG006|Overall Study|Adverse Event|0|||
143149492|NCT01732783|516091569|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
143149493|NCT01732783|516091570|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
143149494|NCT01732783|516091571|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
143149495|NCT01732783|516091569|FG000|Overall Study|Death|13|||
143149496|NCT01732783|516091570|FG001|Overall Study|Death|4|||
143149497|NCT01732783|516091571|FG002|Overall Study|Death|1|||
143149498|NCT01732783|516091569|FG000|Overall Study|Lost to Follow-up|7|||
143149499|NCT01732783|516091570|FG001|Overall Study|Lost to Follow-up|1|||
143149500|NCT01732783|516091571|FG002|Overall Study|Lost to Follow-up|1|||
143149501|NCT01732783|516091569|FG000|Overall Study|Administrative Decision|8|||
143149502|NCT01732783|516091570|FG001|Overall Study|Administrative Decision|2|||
143149503|NCT01732783|516091571|FG002|Overall Study|Administrative Decision|1|||
143149504|NCT01732783|516091569|FG000|Overall Study|Withdrawal by Subject|1|||
143149505|NCT01732783|516091570|FG001|Overall Study|Withdrawal by Subject|0|||
143149506|NCT01732783|516091571|FG002|Overall Study|Withdrawal by Subject|0|||
143149507|NCT01500083|516091572|FG000|Overall Study|Adverse Event|4|||
143149508|NCT01500083|516091573|FG001|Overall Study|Adverse Event|17|||
143149509|NCT01500083|516091572|FG000|Overall Study|Death|0|||
143149510|NCT01500083|516091573|FG001|Overall Study|Death|2|||
143149511|NCT01500083|516091572|FG000|Overall Study|Lost to Follow-up|1|||
143149512|NCT01500083|516091573|FG001|Overall Study|Lost to Follow-up|0|||
143149513|NCT01500083|516091572|FG000|Overall Study|Withdrawal of Consent|0|||
143149514|NCT01500083|516091573|FG001|Overall Study|Withdrawal of Consent|1|||
143149515|NCT01500083|516091572|FG000|Overall Study|Disease Progression|2|||
143149516|NCT01500083|516091573|FG001|Overall Study|Disease Progression|10|||
143149517|NCT01500083|516091572|FG000|Overall Study|Investigator Discretion|3|||
143149518|NCT01500083|516091573|FG001|Overall Study|Investigator Discretion|8|||
143149519|NCT01500083|516091572|FG000|Overall Study|Other Reasons|2|||
143149520|NCT01500083|516091573|FG001|Overall Study|Other Reasons|5|||
143149521|NCT01555931|516091574|FG000|Overall Study|Lost to Follow-up|2|||
143149522|NCT01555931|516091575|FG001|Overall Study|Lost to Follow-up|5|||
143149523|NCT02299167|516091578|FG000|Overall Study|patients were excluded from the study|11|||
143149524|NCT03600428|516091579|FG000|Overall Study|Not eligible|0|||
143149525|NCT03600428|516091580|FG001|Overall Study|Not eligible|1|||
143149526|NCT03600428|516091579|FG000|Overall Study|Lost to Follow-up|5|||
143149527|NCT03600428|516091580|FG001|Overall Study|Lost to Follow-up|4|||
143149528|NCT04092777|516091582|FG000|Overall Study|Lost to Follow-up|28|||
143149529|NCT04092777|516091583|FG001|Overall Study|Lost to Follow-up|46|||
143149530|NCT04092777|516091582|FG000|Overall Study|Withdrawal by Subject|8|||
143149531|NCT04092777|516091583|FG001|Overall Study|Withdrawal by Subject|5|||
143149532|NCT03168672|516091597|FG000|Overall Study|Withdrawal by Subject|13|||
143149533|NCT03168672|516091597|FG000|Overall Study|Death|3|||
143149534|NCT03168672|516091597|FG000|Overall Study|Investigator's Decision|137|||
143149535|NCT03168672|516091597|FG000|Overall Study|Adverse Event|1|||
143149536|NCT03168672|516091597|FG000|Overall Study|Other|2|||
143149537|NCT03168672|516091597|FG000|Overall Study|Started but not treated with GLOBAL ICON|15|||
143149538|NCT03462680|516091598|FG000|Overall Study|Withdrawal by Subject|3|||
143149539|NCT03462680|516091599|FG001|Overall Study|Withdrawal by Subject|5|||
143149540|NCT01757847|516091600|FG000|Overall Study|Withdrawal by Subject|3|||
143149541|NCT01757847|516091601|FG001|Overall Study|Withdrawal by Subject|4|||
143484559|NCT01714687|517318724|FG001|Overall Study|Withdrawal by Subject|0|||
143484560|NCT01714687|517318723|FG000|Overall Study|Lost to Follow-up|2|||
143484561|NCT01714687|517318724|FG001|Overall Study|Lost to Follow-up|4|||
143484562|NCT02457637|517318730|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
143149542|NCT04556097|516091602|FG000|Overall Study|Death|0|||
143149543|NCT04556097|516091603|FG001|Overall Study|Death|5|||
143149544|NCT04556097|516091604|FG002|Overall Study|Death|0|||
143149545|NCT04556097|516091605|FG003|Overall Study|Death|0|||
143149546|NCT04556097|516091602|FG000|Overall Study|No caregiver|43|||
143149547|NCT04556097|516091603|FG001|Overall Study|No caregiver|53|||
143149548|NCT04556097|516091604|FG002|Overall Study|No caregiver|0|||
143149549|NCT04556097|516091605|FG003|Overall Study|No caregiver|0|||
143149550|NCT04556097|516091602|FG000|Overall Study|Ineligible, SNF|2|||
143149551|NCT04556097|516091603|FG001|Overall Study|Ineligible, SNF|2|||
143149552|NCT04556097|516091604|FG002|Overall Study|Ineligible, SNF|0|||
143149553|NCT04556097|516091605|FG003|Overall Study|Ineligible, SNF|0|||
143149554|NCT04556097|516091602|FG000|Overall Study|Ineligible, health|3|||
143149555|NCT04556097|516091603|FG001|Overall Study|Ineligible, health|4|||
143232507|NCT04886154|516402121|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
143232508|NCT04886154|516402122|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
143232509|NCT04886154|516402108|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143232510|NCT04886154|516402109|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143232511|NCT04886154|516402110|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143232512|NCT04886154|516402111|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143232513|NCT04886154|516402112|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
143232514|NCT04886154|516402113|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143232515|NCT04886154|516402114|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
143232516|NCT04886154|516402115|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
143232517|NCT04886154|516402116|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143484563|NCT00159861|517318732|FG000|Core Study - 16 Weeks|Death|3|||
143484564|NCT00159861|517318733|FG001|Core Study - 16 Weeks|Death|0|||
143484565|NCT00159861|517318732|FG000|Core Study - 16 Weeks|Adverse Event|12|||
143484566|NCT00159861|517318733|FG001|Core Study - 16 Weeks|Adverse Event|6|||
143484567|NCT00159861|517318732|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
143149556|NCT04556097|516091604|FG002|Overall Study|Ineligible, health|0|||
143149557|NCT04556097|516091605|FG003|Overall Study|Ineligible, health|0|||
143149558|NCT04556097|516091602|FG000|Overall Study|Ineligible, language|0|||
143149559|NCT04556097|516091603|FG001|Overall Study|Ineligible, language|1|||
143149560|NCT04556097|516091604|FG002|Overall Study|Ineligible, language|0|||
143149561|NCT04556097|516091605|FG003|Overall Study|Ineligible, language|0|||
143149562|NCT04556097|516091602|FG000|Overall Study|Ineligible, no longer in care management|0|||
143149563|NCT04556097|516091603|FG001|Overall Study|Ineligible, no longer in care management|2|||
143149564|NCT04556097|516091604|FG002|Overall Study|Ineligible, no longer in care management|1|||
143149565|NCT04556097|516091605|FG003|Overall Study|Ineligible, no longer in care management|0|||
143149566|NCT04556097|516091602|FG000|Overall Study|No dementia|13|||
143149567|NCT04556097|516091603|FG001|Overall Study|No dementia|3|||
143149568|NCT04556097|516091604|FG002|Overall Study|No dementia|0|||
143149569|NCT04556097|516091605|FG003|Overall Study|No dementia|0|||
143149570|NCT04556097|516091602|FG000|Overall Study|Missing identifier|2|||
143149571|NCT04556097|516091603|FG001|Overall Study|Missing identifier|4|||
143149572|NCT04556097|516091604|FG002|Overall Study|Missing identifier|0|||
143149573|NCT04556097|516091605|FG003|Overall Study|Missing identifier|0|||
143149574|NCT04556097|516091602|FG000|Overall Study|Did not have at least 1 member month in pre and post period|17|||
143149575|NCT04556097|516091603|FG001|Overall Study|Did not have at least 1 member month in pre and post period|8|||
143149576|NCT04556097|516091604|FG002|Overall Study|Did not have at least 1 member month in pre and post period|0|||
143149577|NCT04556097|516091605|FG003|Overall Study|Did not have at least 1 member month in pre and post period|0|||
143149578|NCT02516241|516091606|FG000|Overall Study|Death|255|||
143149579|NCT02516241|516091607|FG001|Overall Study|Death|262|||
143149580|NCT02516241|516091608|FG002|Overall Study|Death|270|||
143149581|NCT02516241|516091606|FG000|Overall Study|Lost to Follow-up|1|||
143149582|NCT02516241|516091607|FG001|Overall Study|Lost to Follow-up|1|||
143149583|NCT02516241|516091608|FG002|Overall Study|Lost to Follow-up|3|||
143149584|NCT02516241|516091606|FG000|Overall Study|Withdrawal by Subject|2|||
143149585|NCT02516241|516091607|FG001|Overall Study|Withdrawal by Subject|7|||
143149586|NCT02516241|516091608|FG002|Overall Study|Withdrawal by Subject|12|||
143149587|NCT02516241|516091606|FG000|Overall Study|participants ongoing at data cut-off|84|||
143149588|NCT02516241|516091607|FG001|Overall Study|participants ongoing at data cut-off|76|||
143149589|NCT02516241|516091608|FG002|Overall Study|participants ongoing at data cut-off|59|||
143149590|NCT04590963|516091609|FG000|Overall Study|Death|118|||
143149591|NCT04590963|516091610|FG001|Overall Study|Death|59|||
143149592|NCT04590963|516091609|FG000|Overall Study|Lost to Follow-up|1|||
143149593|NCT04590963|516091610|FG001|Overall Study|Lost to Follow-up|1|||
143149594|NCT04590963|516091609|FG000|Overall Study|Progressive disease|0|||
143149595|NCT04590963|516091610|FG001|Overall Study|Progressive disease|1|||
143149596|NCT04590963|516091609|FG000|Overall Study|Study terminated by sponsor|103|||
143149597|NCT04590963|516091610|FG001|Overall Study|Study terminated by sponsor|50|||
143149598|NCT04590963|516091609|FG000|Overall Study|Withdrawal by Subject|15|||
143149599|NCT04590963|516091610|FG001|Overall Study|Withdrawal by Subject|8|||
143232518|NCT04886154|516402117|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143232519|NCT04886154|516402118|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143232520|NCT04886154|516402119|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143363636|NCT00062868|516873790|FG010|Dose Level 2|Lost to Follow-up|0|||
143484568|NCT00159861|517318733|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
143149600|NCT04590963|516091609|FG000|Overall Study|Ongoing at data cut-off|9|||
143149601|NCT04590963|516091610|FG001|Overall Study|Ongoing at data cut-off|4|||
143149602|NCT04590963|516091609|FG000|Overall Study|Screen failure|1|||
143149603|NCT04590963|516091610|FG001|Overall Study|Screen failure|0|||
143149604|NCT04057365|516091611|FG000|Overall Study|Withdrawal by Subject|2|||
143149605|NCT04057365|516091612|FG001|Overall Study|Withdrawal by Subject|0|||
143149606|NCT04738487|516091613|FG000|Overall Study|Participant Ongoing in Study|298|||
143149607|NCT04738487|516091614|FG001|Overall Study|Participant Ongoing in Study|297|||
143484569|NCT00159861|517318732|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
143484570|NCT00159861|517318733|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
143484571|NCT00159861|517318732|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
143484572|NCT00159861|517318733|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
143484573|NCT00159861|517318732|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
143484574|NCT00159861|517318733|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
143484575|NCT00159861|517318732|FG000|Extension Study - up to 3 Years|Death|24|||
143484576|NCT00159861|517318733|FG001|Extension Study - up to 3 Years|Death|28|||
143484577|NCT00159861|517318732|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
143484578|NCT00159861|517318733|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
143484579|NCT00159861|517318732|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
143484580|NCT00159861|517318733|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
143484581|NCT00159861|517318732|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
143484582|NCT00159861|517318733|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
143484583|NCT00159861|517318732|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
143484584|NCT00159861|517318733|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
143484585|NCT01553136|517318735|FG000|Overall Study|Adverse Event|3|||
143484586|NCT01553136|517318736|FG001|Overall Study|Adverse Event|2|||
143484587|NCT01553136|517318735|FG000|Overall Study|Withdrawal by Subject|2|||
143484588|NCT01553136|517318736|FG001|Overall Study|Withdrawal by Subject|3|||
143484589|NCT01553136|517318735|FG000|Overall Study|Lost to Follow-up|4|||
143484590|NCT01553136|517318736|FG001|Overall Study|Lost to Follow-up|10|||
143484591|NCT01553136|517318735|FG000|Overall Study|Physician Decision|2|||
143484592|NCT01553136|517318736|FG001|Overall Study|Physician Decision|3|||
143484593|NCT01553136|517318735|FG000|Overall Study|Scheduling Difficulties|5|||
143484594|NCT01553136|517318736|FG001|Overall Study|Scheduling Difficulties|4|||
143484595|NCT03349099|517318739|FG000|Overall Study|Physician Decision|3|||
143484596|NCT03349099|517318740|FG001|Overall Study|Physician Decision|4|||
143484597|NCT03349099|517318739|FG000|Overall Study|Stone migrated from the kidney|1|||
143484598|NCT03349099|517318740|FG001|Overall Study|Stone migrated from the kidney|0|||
143484599|NCT04194528|517318741|FG000|Overall Study|Adverse Event|1|||
143484600|NCT03921424|517318744|FG000|Overall Study|Lost to Follow-up|0|||
143484601|NCT03921424|517318745|FG001|Overall Study|Lost to Follow-up|1|||
143484602|NCT03921424|517318744|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
143484603|NCT03921424|517318745|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
143484604|NCT05038020|517318746|FG000|Overall Study|Early Termination|3|||
143149608|NCT04738487|516091613|FG000|Overall Study|Withdrawal by Subject|7|||
143149609|NCT04738487|516091614|FG001|Overall Study|Withdrawal by Subject|9|||
143149610|NCT04738487|516091613|FG000|Overall Study|Lost to Follow-up|2|||
143149611|NCT04738487|516091614|FG001|Overall Study|Lost to Follow-up|0|||
143149612|NCT04738487|516091613|FG000|Overall Study|Death|287|||
143149613|NCT04738487|516091614|FG001|Overall Study|Death|306|||
143149614|NCT00325416|516091637|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
143149615|NCT00325416|516091638|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
143149616|NCT00325416|516091637|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
143149617|NCT00325416|516091638|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
143149618|NCT00325416|516091637|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
143149619|NCT00325416|516091638|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
143149620|NCT00325416|516091637|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
143149621|NCT00325416|516091638|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
143149622|NCT00325416|516091637|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
143149623|NCT00325416|516091638|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
143149624|NCT00325416|516091637|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
143149625|NCT00325416|516091638|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
143149626|NCT06239610|516091639|FG000|Overall Study|no usable migration data for minimum of one day|11|||
143149627|NCT04589650|516091640|FG000|Overall Study|Subject decision|6|||
143149628|NCT04589650|516091641|FG001|Overall Study|Subject decision|2|||
143149629|NCT04589650|516091642|FG002|Overall Study|Subject decision|2|||
143149630|NCT04589650|516091643|FG003|Overall Study|Subject decision|0|||
143484605|NCT05038020|517318747|FG001|Overall Study|Early Termination|0|||
143484606|NCT01049035|517320932|FG000|Overall Study|Serious adverse event|0|||
143484607|NCT01049035|517320933|FG001|Overall Study|Serious adverse event|1|||
143149631|NCT04589650|516091644|FG004|Overall Study|Subject decision|0|||
143484608|NCT01049035|517320934|FG002|Overall Study|Serious adverse event|1|||
143484609|NCT01049035|517320935|FG003|Overall Study|Serious adverse event|2|||
143149632|NCT04589650|516091645|FG005|Overall Study|Subject decision|0|||
143149633|NCT04589650|516091640|FG000|Overall Study|Adverse Event|3|||
143149634|NCT04589650|516091641|FG001|Overall Study|Adverse Event|1|||
143232521|NCT04886154|516402120|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143484610|NCT01049035|517320936|FG004|Overall Study|Serious adverse event|0|||
143484611|NCT01049035|517320937|FG005|Overall Study|Serious adverse event|0|||
143484612|NCT01049035|517320938|FG006|Overall Study|Serious adverse event|0|||
143484613|NCT01049035|517320932|FG000|Overall Study|Other adverse event (AE)|0|||
143484614|NCT01049035|517320933|FG001|Overall Study|Other adverse event (AE)|0|||
143484615|NCT01049035|517320934|FG002|Overall Study|Other adverse event (AE)|0|||
143484616|NCT01049035|517320935|FG003|Overall Study|Other adverse event (AE)|1|||
143232522|NCT04886154|516402121|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143232523|NCT04886154|516402122|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
143232524|NCT04886154|516402108|FG000|Overall Study|Other, Not Specified|0|||
143232525|NCT04886154|516402109|FG001|Overall Study|Other, Not Specified|0|||
143232526|NCT04886154|516402110|FG002|Overall Study|Other, Not Specified|0|||
143232527|NCT04886154|516402111|FG003|Overall Study|Other, Not Specified|0|||
143232528|NCT04886154|516402112|FG004|Overall Study|Other, Not Specified|11|||
143232529|NCT04886154|516402113|FG005|Overall Study|Other, Not Specified|8|||
143149635|NCT04589650|516091642|FG002|Overall Study|Adverse Event|1|||
143149636|NCT04589650|516091643|FG003|Overall Study|Adverse Event|1|||
143149637|NCT04589650|516091644|FG004|Overall Study|Adverse Event|0|||
143149638|NCT04589650|516091645|FG005|Overall Study|Adverse Event|1|||
143149639|NCT04589650|516091640|FG000|Overall Study|Physician Decision|1|||
143149640|NCT04589650|516091641|FG001|Overall Study|Physician Decision|1|||
143149641|NCT04589650|516091642|FG002|Overall Study|Physician Decision|0|||
143149642|NCT04589650|516091643|FG003|Overall Study|Physician Decision|0|||
143149643|NCT04589650|516091644|FG004|Overall Study|Physician Decision|0|||
143149644|NCT04589650|516091645|FG005|Overall Study|Physician Decision|0|||
143149645|NCT04589650|516091640|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
143149646|NCT04589650|516091641|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
143149647|NCT04589650|516091642|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
143149648|NCT04589650|516091643|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
143149649|NCT04589650|516091644|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
143149650|NCT04589650|516091645|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
143149651|NCT04589650|516091640|FG000|Overall Study|Death|0|||
143149652|NCT04589650|516091641|FG001|Overall Study|Death|0|||
143149653|NCT04589650|516091642|FG002|Overall Study|Death|0|||
143149654|NCT04589650|516091643|FG003|Overall Study|Death|1|||
143149655|NCT04589650|516091644|FG004|Overall Study|Death|0|||
143149656|NCT04589650|516091645|FG005|Overall Study|Death|0|||
143149657|NCT04589650|516091640|FG000|Overall Study|Guardian Decision|0|||
143149658|NCT04589650|516091641|FG001|Overall Study|Guardian Decision|0|||
143149659|NCT04589650|516091642|FG002|Overall Study|Guardian Decision|0|||
143149660|NCT04589650|516091643|FG003|Overall Study|Guardian Decision|1|||
143149661|NCT04589650|516091644|FG004|Overall Study|Guardian Decision|0|||
143149662|NCT04589650|516091645|FG005|Overall Study|Guardian Decision|0|||
143149663|NCT04017962|516091649|FG000|Overall Study|Death|2|||
143149664|NCT04017962|516091650|FG001|Overall Study|Death|0|||
143149665|NCT04017962|516091649|FG000|Overall Study|Lost to Follow-up|2|||
143149666|NCT04017962|516091650|FG001|Overall Study|Lost to Follow-up|0|||
143149667|NCT04017962|516091649|FG000|Overall Study|Physician Decision|1|||
143149668|NCT04017962|516091650|FG001|Overall Study|Physician Decision|0|||
143149669|NCT04017962|516091649|FG000|Overall Study|Discontinued LTV|5|||
143149670|NCT04017962|516091650|FG001|Overall Study|Discontinued LTV|0|||
143149671|NCT01164475|516091651|FG000|Overall Study|Lack of Efficacy|1|||
143149672|NCT01164475|516091652|FG001|Overall Study|Lack of Efficacy|0|||
143149673|NCT01164475|516091651|FG000|Overall Study|Other|0|||
143149674|NCT01164475|516091652|FG001|Overall Study|Other|1|||
143149675|NCT01164475|516091651|FG000|Overall Study|Progressive disease|0|||
143149676|NCT01164475|516091652|FG001|Overall Study|Progressive disease|1|||
143149677|NCT01164475|516091651|FG000|Overall Study|Protocol Violation|1|||
143149678|NCT01164475|516091652|FG001|Overall Study|Protocol Violation|0|||
143149679|NCT00143507|516092658|FG000|Overall Study|Death|572|||
143149680|NCT00143507|516092659|FG001|Overall Study|Death|547|||
143149681|NCT00143507|516092658|FG000|Overall Study|Withdrawal by Subject|114|||
143149682|NCT00143507|516092659|FG001|Overall Study|Withdrawal by Subject|102|||
143149683|NCT00143507|516092658|FG000|Overall Study|Lost to Follow-up|1|||
143149684|NCT00143507|516092659|FG001|Overall Study|Lost to Follow-up|0|||
143149685|NCT00143507|516092658|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
143149686|NCT00143507|516092659|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
143149687|NCT00876395|516092660|FG000|Overall Study|Untreated|8|||
143232530|NCT04886154|516402114|FG006|Overall Study|Other, Not Specified|9|||
143232531|NCT04886154|516402115|FG007|Overall Study|Other, Not Specified|10|||
143232532|NCT04886154|516402116|FG008|Overall Study|Other, Not Specified|6|||
143232533|NCT04886154|516402117|FG009|Overall Study|Other, Not Specified|1|||
143149688|NCT00876395|516092661|FG001|Overall Study|Untreated|1|||
143149689|NCT00876395|516092660|FG000|Overall Study|Adverse Event|63|||
143149690|NCT00876395|516092661|FG001|Overall Study|Adverse Event|11|||
143149691|NCT00876395|516092660|FG000|Overall Study|Abnormal test procedure result(s)|1|||
143149692|NCT00876395|516092661|FG001|Overall Study|Abnormal test procedure result(s)|0|||
143149693|NCT00876395|516092660|FG000|Overall Study|Disease progression|259|||
143149694|NCT00876395|516092661|FG001|Overall Study|Disease progression|162|||
143232534|NCT04886154|516402118|FG010|Overall Study|Other, Not Specified|1|||
143149695|NCT00876395|516092660|FG000|Overall Study|New cancer therapy|25|||
143149696|NCT00876395|516092661|FG001|Overall Study|New cancer therapy|7|||
143149697|NCT00876395|516092660|FG000|Overall Study|Protocol Violation|5|||
143149698|NCT00876395|516092661|FG001|Overall Study|Protocol Violation|2|||
143232535|NCT04886154|516402119|FG011|Overall Study|Other, Not Specified|2|||
143232536|NCT04886154|516402120|FG012|Overall Study|Other, Not Specified|1|||
143232537|NCT04886154|516402121|FG013|Overall Study|Other, Not Specified|2|||
143232538|NCT04886154|516402122|FG014|Overall Study|Other, Not Specified|3|||
143232539|NCT03919773|516402123|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
143232540|NCT03919773|516402124|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
143232541|NCT03919773|516402123|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
143232542|NCT03919773|516402124|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
143232543|NCT02336282|516402128|FG000|Overall Study|Unrelated illness|1|||
143232544|NCT02336282|516402128|FG000|Overall Study|Uncomfortable with technology|1|||
143232545|NCT02336282|516402128|FG000|Overall Study|Lost to Follow-up|1|||
143232546|NCT02336282|516402128|FG000|Overall Study|Not enough time to complete sessions|2|||
143232547|NCT04875975|516402130|FG000|Overall Study|Adverse Event|1|||
143232548|NCT04875975|516402131|FG001|Overall Study|Adverse Event|2|||
143232549|NCT04875975|516402130|FG000|Overall Study|Lack of Efficacy|2|||
143232550|NCT04875975|516402131|FG001|Overall Study|Lack of Efficacy|2|||
143232551|NCT04875975|516402130|FG000|Overall Study|Permanently left due to seizure recurrence|1|||
143232552|NCT04875975|516402131|FG001|Overall Study|Permanently left due to seizure recurrence|0|||
143232553|NCT04875975|516402130|FG000|Overall Study|Relapse With Insults|0|||
143232554|NCT04875975|516402131|FG001|Overall Study|Relapse With Insults|1|||
143149699|NCT00876395|516092660|FG000|Overall Study|Withdrawal by Subject|66|||
143149700|NCT00876395|516092661|FG001|Overall Study|Withdrawal by Subject|33|||
143149701|NCT00876395|516092660|FG000|Overall Study|Lost to Follow-up|2|||
143149702|NCT00876395|516092661|FG001|Overall Study|Lost to Follow-up|0|||
143149703|NCT00876395|516092660|FG000|Overall Study|Administrative problems|39|||
143149704|NCT00876395|516092661|FG001|Overall Study|Administrative problems|23|||
143149705|NCT00876395|516092660|FG000|Overall Study|Death|12|||
143149706|NCT00876395|516092661|FG001|Overall Study|Death|0|||
143149707|NCT00662259|516092663|FG000|Overall Study|Adverse Event|2|||
143149708|NCT00662259|516092664|FG001|Overall Study|Adverse Event|0|||
143149709|NCT01750346|516092665|FG000|Overall Study|Adverse Event|1|||
143149710|NCT01750346|516092666|FG001|Overall Study|Adverse Event|0|||
143149711|NCT01750346|516092667|FG002|Overall Study|Adverse Event|0|||
143149712|NCT00599313|516092668|FG000|Overall Study|Adverse Event|19|||
143149713|NCT00599313|516092668|FG000|Overall Study|Disease Progression|12|||
143149714|NCT00599313|516092668|FG000|Overall Study|Patient Request|4|||
143149715|NCT00599313|516092668|FG000|Overall Study|Ineligible|1|||
143149716|NCT01121926|516092671|FG000|First Intervention Period|Adverse Event|1|||
143149717|NCT01121926|516092672|FG001|First Intervention Period|Adverse Event|0|||
143149718|NCT01121926|516092671|FG000|Washout Period|Adverse Event|0|||
143149719|NCT01121926|516092672|FG001|Washout Period|Adverse Event|1|||
143149720|NCT01121926|516092671|FG000|Washout Period|Positive pregnancy test|0|||
143149721|NCT01121926|516092672|FG001|Washout Period|Positive pregnancy test|1|||
143149722|NCT02362451|516092680|FG000|Overall Study|Withdrawal by Subject|0|||
143149723|NCT02362451|516092681|FG001|Overall Study|Withdrawal by Subject|1|||
143149724|NCT02362451|516092680|FG000|Overall Study|Lack of Efficacy|2|||
143149725|NCT02362451|516092681|FG001|Overall Study|Lack of Efficacy|0|||
143149726|NCT02362451|516092680|FG000|Overall Study|Progression|1|||
143149727|NCT02362451|516092681|FG001|Overall Study|Progression|0|||
143149728|NCT02362451|516092680|FG000|Overall Study|Participant chose other therapy.|1|||
143149729|NCT02362451|516092681|FG001|Overall Study|Participant chose other therapy.|0|||
143149730|NCT01879852|516092682|FG000|Overall Study|Withdrawal by Subject|2|||
143149731|NCT01879852|516092683|FG001|Overall Study|Withdrawal by Subject|0|||
143149732|NCT04398134|516092684|FG000|Overall Study|Adverse Event|0|||
143149733|NCT04398134|516092685|FG001|Overall Study|Adverse Event|0|||
143149734|NCT04398134|516092686|FG002|Overall Study|Adverse Event|1|||
143149735|NCT04398134|516092687|FG003|Overall Study|Adverse Event|0|||
143149736|NCT04398134|516092684|FG000|Overall Study|Withdrawal by Subject|2|||
143149737|NCT04398134|516092685|FG001|Overall Study|Withdrawal by Subject|0|||
143149738|NCT04398134|516092686|FG002|Overall Study|Withdrawal by Subject|0|||
143232555|NCT04875975|516402130|FG000|Overall Study|Permanently left due to new seizure recurrence|0|||
143232556|NCT04875975|516402131|FG001|Overall Study|Permanently left due to new seizure recurrence|1|||
143232557|NCT05472090|516402132|FG000|Overall Study|Adverse Event|2|||
143232558|NCT05472090|516402133|FG001|Overall Study|Adverse Event|3|||
143149739|NCT04398134|516092687|FG003|Overall Study|Withdrawal by Subject|1|||
143232559|NCT05472090|516402132|FG000|Overall Study|Lack of Efficacy|1|||
143149740|NCT04398134|516092684|FG000|Overall Study|Study Terminated by Sponsor|30|||
143149741|NCT04398134|516092685|FG001|Overall Study|Study Terminated by Sponsor|11|||
143149742|NCT04398134|516092686|FG002|Overall Study|Study Terminated by Sponsor|32|||
143232560|NCT05472090|516402133|FG001|Overall Study|Lack of Efficacy|0|||
143232561|NCT05472090|516402132|FG000|Overall Study|Physician Decision|1|||
143149743|NCT04398134|516092687|FG003|Overall Study|Study Terminated by Sponsor|11|||
143149744|NCT00005047|516092689|FG000|Overall Study|Withdrawal by Subject|12|||
143149745|NCT00005047|516092690|FG001|Overall Study|Withdrawal by Subject|0|||
143149746|NCT00005047|516092691|FG002|Overall Study|Withdrawal by Subject|0|||
143149747|NCT00005047|516092692|FG003|Overall Study|Withdrawal by Subject|0|||
143232562|NCT05472090|516402133|FG001|Overall Study|Physician Decision|0|||
143232563|NCT05472090|516402132|FG000|Overall Study|Withdrawal by Subject|2|||
143232564|NCT05472090|516402133|FG001|Overall Study|Withdrawal by Subject|0|||
143232565|NCT05472090|516402132|FG000|Overall Study|Lost to Follow-up|0|||
143232566|NCT05472090|516402133|FG001|Overall Study|Lost to Follow-up|3|||
143232567|NCT02177695|516403340|FG000|ITT Analysis|Ineligible|5|||
143232568|NCT02177695|516403341|FG001|ITT Analysis|Ineligible|5|||
143232569|NCT02177695|516403340|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
143232570|NCT02177695|516403341|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
143232571|NCT02177695|516403340|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
143232572|NCT02177695|516403341|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
143232573|NCT02177695|516403340|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
143149748|NCT00005047|516092689|FG000|Overall Study|Adverse Event|5|||
143149749|NCT00005047|516092690|FG001|Overall Study|Adverse Event|0|||
143149750|NCT00005047|516092691|FG002|Overall Study|Adverse Event|0|||
143149751|NCT00005047|516092692|FG003|Overall Study|Adverse Event|0|||
143149752|NCT00005047|516092689|FG000|Overall Study|Lost to Follow-up|1|||
143232574|NCT02177695|516403341|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
143232575|NCT00248625|516403342|FG000|Overall Study|Withdrawal by Subject|0|||
143232576|NCT00248625|516403343|FG001|Overall Study|Withdrawal by Subject|2|||
143232577|NCT05176314|516403346|FG000|Overall Study|Lost to Follow-up|2|||
143232578|NCT05176314|516403346|FG000|Overall Study|Physician Decision|1|||
143232579|NCT05176314|516403346|FG000|Overall Study|Adverse Event|1|||
143232580|NCT02118584|516403347|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
143232581|NCT02118584|516403348|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
143232582|NCT02118584|516403349|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
143232583|NCT02118584|516403347|FG000|Part 1: Open Label Extension Period|Death|9|||
143232584|NCT02118584|516403348|FG001|Part 1: Open Label Extension Period|Death|0|||
143232585|NCT02118584|516403349|FG002|Part 1: Open Label Extension Period|Death|0|||
143232586|NCT02118584|516403347|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
143232587|NCT02118584|516403348|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
143232588|NCT02118584|516403349|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
143232589|NCT02118584|516403347|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
143232590|NCT02118584|516403348|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
143232591|NCT02118584|516403349|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
143232592|NCT02118584|516403347|FG000|Part 1: Open Label Extension Period|Other|135|||
143232593|NCT02118584|516403348|FG001|Part 1: Open Label Extension Period|Other|0|||
143232594|NCT02118584|516403349|FG002|Part 1: Open Label Extension Period|Other|0|||
143232595|NCT02118584|516403347|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
143232596|NCT02118584|516403348|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
143232597|NCT02118584|516403349|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
143232598|NCT02118584|516403347|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
143232599|NCT02118584|516403348|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
143015030|NCT00567996|515595651|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
143149753|NCT00005047|516092690|FG001|Overall Study|Lost to Follow-up|0|||
143149754|NCT00005047|516092691|FG002|Overall Study|Lost to Follow-up|0|||
143149755|NCT00005047|516092692|FG003|Overall Study|Lost to Follow-up|0|||
143149756|NCT00005047|516092689|FG000|Overall Study|Lack of Efficacy|1|||
143149757|NCT00005047|516092690|FG001|Overall Study|Lack of Efficacy|0|||
143149758|NCT00005047|516092691|FG002|Overall Study|Lack of Efficacy|0|||
143149759|NCT00005047|516092692|FG003|Overall Study|Lack of Efficacy|0|||
143149760|NCT03506477|516092693|FG000|Overall Study|Withdrawal by Subject|1|||
143149761|NCT03506477|516092694|FG001|Overall Study|Withdrawal by Subject|0|||
143149762|NCT02324153|516092699|FG000|Overall Study|Withdrawal by Subject|4|||
143149763|NCT02324153|516092700|FG001|Overall Study|Withdrawal by Subject|1|||
143149764|NCT02324153|516092699|FG000|Overall Study|Surgery postponed after randomization|3|||
143149765|NCT02324153|516092700|FG001|Overall Study|Surgery postponed after randomization|0|||
143149766|NCT02324153|516092699|FG000|Overall Study|Developed delirium preoperatively|1|||
143149767|NCT02324153|516092700|FG001|Overall Study|Developed delirium preoperatively|0|||
143149768|NCT00385840|516092701|FG000|Overall Study|Adverse Event|1|||
143149769|NCT00385840|516092702|FG001|Overall Study|Adverse Event|1|||
143149770|NCT00385840|516092701|FG000|Overall Study|Lost to Follow-up|3|||
143149771|NCT00385840|516092702|FG001|Overall Study|Lost to Follow-up|13|||
143484617|NCT01049035|517320936|FG004|Overall Study|Other adverse event (AE)|0|||
143149772|NCT01260948|516092703|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
143149773|NCT01260948|516092704|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
143149774|NCT01260948|516092703|FG000|Second Intervention|Emesis|0|||
143149775|NCT01260948|516092704|FG001|Second Intervention|Emesis|1|||
143232600|NCT02118584|516403349|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
143232601|NCT02118584|516403347|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
143232602|NCT02118584|516403348|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
143232603|NCT02118584|516403349|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
143232604|NCT02118584|516403347|FG000|Part 1: Open Label Extension Period|Other|3|||
143232605|NCT02118584|516403348|FG001|Part 1: Open Label Extension Period|Other|0|||
143015031|NCT00567996|515595649|FG000|Overall Study|Administrative problems|1|||
143149776|NCT00462462|516092705|FG000|Overall Study|Physician Decision|0|||
143149777|NCT00462462|516092706|FG001|Overall Study|Physician Decision|1|||
143149778|NCT02555878|516092707|FG000|Overall Study|Lost to Follow-up|2|||
143149779|NCT02555878|516092708|FG001|Overall Study|Lost to Follow-up|3|||
143149780|NCT02555878|516092707|FG000|Overall Study|Withdrawal by Subject|48|||
143149781|NCT02555878|516092708|FG001|Overall Study|Withdrawal by Subject|48|||
143149782|NCT02555878|516092707|FG000|Overall Study|Adverse Event|12|||
143149783|NCT02555878|516092708|FG001|Overall Study|Adverse Event|8|||
143149784|NCT02555878|516092707|FG000|Overall Study|Death|74|||
143149785|NCT02555878|516092708|FG001|Overall Study|Death|59|||
143149786|NCT02555878|516092707|FG000|Overall Study|Protocol Violation|1|||
143149787|NCT02555878|516092708|FG001|Overall Study|Protocol Violation|2|||
143149788|NCT02555878|516092707|FG000|Overall Study|Physician Decision|12|||
143149789|NCT02555878|516092708|FG001|Overall Study|Physician Decision|13|||
143149790|NCT02555878|516092707|FG000|Overall Study|Other|17|||
143149791|NCT02555878|516092708|FG001|Overall Study|Other|17|||
143149792|NCT00765076|516092709|FG000|Overall Study|Adverse Event|1|||
143149793|NCT00765076|516092710|FG001|Overall Study|Adverse Event|0|||
143149794|NCT00765076|516092711|FG002|Overall Study|Adverse Event|0|||
143149795|NCT00765076|516092709|FG000|Overall Study|Withdrawal by Subject|0|||
143149796|NCT00765076|516092710|FG001|Overall Study|Withdrawal by Subject|0|||
143149797|NCT00765076|516092711|FG002|Overall Study|Withdrawal by Subject|1|||
143149798|NCT01163617|516092712|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
143149799|NCT01163617|516092713|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
143149800|NCT01163617|516092714|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
143149801|NCT01163617|516092715|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
143149802|NCT01163617|516092716|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
143149803|NCT01163617|516092717|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
143149804|NCT01163617|516092718|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
143149805|NCT01163617|516092719|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
143149806|NCT01163617|516092712|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
143149807|NCT01163617|516092713|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
143149808|NCT01163617|516092714|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
143149809|NCT01163617|516092715|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
143149810|NCT01163617|516092716|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
143149811|NCT01163617|516092717|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
143149812|NCT01163617|516092718|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
143149813|NCT01163617|516092719|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
143149814|NCT01163617|516092712|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
143149815|NCT01163617|516092713|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
143149816|NCT01163617|516092714|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
143149817|NCT01163617|516092715|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
143149818|NCT01163617|516092716|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
143149819|NCT01163617|516092717|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
143149820|NCT01163617|516092718|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
143149821|NCT01163617|516092719|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
143149822|NCT02875080|516092720|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
143149823|NCT02875080|516092721|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
143149824|NCT02875080|516092722|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
143149825|NCT02394756|516092723|FG000|Period 1|Lens Discomfort|0|||
143149826|NCT02394756|516092724|FG001|Period 1|Lens Discomfort|0|||
143149827|NCT02394756|516092725|FG002|Period 1|Lens Discomfort|0|||
143149828|NCT02394756|516092726|FG003|Period 1|Lens Discomfort|0|||
143149829|NCT02394756|516092727|FG004|Period 1|Lens Discomfort|0|||
143149830|NCT02394756|516092728|FG005|Period 1|Lens Discomfort|1|||
143149831|NCT02394756|516092723|FG000|Period 1|Withdrawal by Subject|0|||
143149832|NCT02394756|516092724|FG001|Period 1|Withdrawal by Subject|1|||
143149833|NCT02394756|516092725|FG002|Period 1|Withdrawal by Subject|1|||
143149834|NCT02394756|516092726|FG003|Period 1|Withdrawal by Subject|1|||
143149835|NCT02394756|516092727|FG004|Period 1|Withdrawal by Subject|0|||
143149836|NCT02394756|516092728|FG005|Period 1|Withdrawal by Subject|0|||
143149837|NCT02394756|516092723|FG000|Period 2|Unsatisfactory Visual Response|0|||
143149838|NCT02394756|516092724|FG001|Period 2|Unsatisfactory Visual Response|0|||
143149839|NCT02394756|516092725|FG002|Period 2|Unsatisfactory Visual Response|0|||
143149840|NCT02394756|516092726|FG003|Period 2|Unsatisfactory Visual Response|0|||
143149841|NCT02394756|516092727|FG004|Period 2|Unsatisfactory Visual Response|1|||
143149842|NCT02394756|516092728|FG005|Period 2|Unsatisfactory Visual Response|0|||
143149843|NCT00768053|516092729|FG000|Overall Study|Adverse Event|10|||
143015032|NCT00567996|515595650|FG001|Overall Study|Administrative problems|1|||
143149844|NCT00768053|516092729|FG000|Overall Study|Lost to Follow-up|1|||
143149845|NCT02335944|516092730|FG000|Treatment Phase|Progressive Disease|2|||
143149846|NCT02335944|516092731|FG001|Treatment Phase|Progressive Disease|5|||
143149847|NCT02335944|516092732|FG002|Treatment Phase|Progressive Disease|2|||
143149848|NCT02335944|516092733|FG003|Treatment Phase|Progressive Disease|11|||
143149849|NCT02335944|516092734|FG004|Treatment Phase|Progressive Disease|4|||
143149850|NCT02335944|516092735|FG005|Treatment Phase|Progressive Disease|25|||
143149851|NCT02335944|516092736|FG006|Treatment Phase|Progressive Disease|2|||
143149852|NCT02335944|516092737|FG007|Treatment Phase|Progressive Disease|30|||
143149853|NCT02335944|516092738|FG008|Treatment Phase|Progressive Disease|27|||
143149854|NCT02335944|516092739|FG009|Treatment Phase|Progressive Disease|0|||
143149855|NCT02335944|516092730|FG000|Treatment Phase|Adverse Event|2|||
143149856|NCT02335944|516092731|FG001|Treatment Phase|Adverse Event|0|||
143149857|NCT02335944|516092732|FG002|Treatment Phase|Adverse Event|0|||
143149858|NCT02335944|516092733|FG003|Treatment Phase|Adverse Event|2|||
143149859|NCT02335944|516092734|FG004|Treatment Phase|Adverse Event|1|||
143149860|NCT02335944|516092735|FG005|Treatment Phase|Adverse Event|15|||
143149861|NCT02335944|516092736|FG006|Treatment Phase|Adverse Event|0|||
143149862|NCT02335944|516092737|FG007|Treatment Phase|Adverse Event|5|||
143149863|NCT02335944|516092738|FG008|Treatment Phase|Adverse Event|7|||
143149864|NCT02335944|516092739|FG009|Treatment Phase|Adverse Event|0|||
143149865|NCT02335944|516092730|FG000|Treatment Phase|Physician Decision|0|||
143149866|NCT02335944|516092731|FG001|Treatment Phase|Physician Decision|0|||
143149867|NCT02335944|516092732|FG002|Treatment Phase|Physician Decision|0|||
143149868|NCT02335944|516092733|FG003|Treatment Phase|Physician Decision|1|||
143149869|NCT02335944|516092734|FG004|Treatment Phase|Physician Decision|0|||
143149870|NCT02335944|516092735|FG005|Treatment Phase|Physician Decision|6|||
143149871|NCT02335944|516092736|FG006|Treatment Phase|Physician Decision|1|||
143149872|NCT02335944|516092737|FG007|Treatment Phase|Physician Decision|2|||
143149873|NCT02335944|516092738|FG008|Treatment Phase|Physician Decision|1|||
143149874|NCT02335944|516092739|FG009|Treatment Phase|Physician Decision|0|||
143149875|NCT02335944|516092730|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
143149876|NCT02335944|516092731|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
143149877|NCT02335944|516092732|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
143149878|NCT02335944|516092733|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
143149879|NCT02335944|516092734|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
143149880|NCT02335944|516092735|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
143149881|NCT02335944|516092736|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
143149882|NCT02335944|516092737|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
143149883|NCT02335944|516092738|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
143149884|NCT02335944|516092739|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
143149885|NCT02335944|516092730|FG000|Treatment Phase|Subject/Guardian Decision|0|||
143149886|NCT02335944|516092731|FG001|Treatment Phase|Subject/Guardian Decision|0|||
143149887|NCT02335944|516092732|FG002|Treatment Phase|Subject/Guardian Decision|1|||
143149888|NCT02335944|516092733|FG003|Treatment Phase|Subject/Guardian Decision|0|||
143149889|NCT02335944|516092734|FG004|Treatment Phase|Subject/Guardian Decision|0|||
143149890|NCT02335944|516092735|FG005|Treatment Phase|Subject/Guardian Decision|1|||
143149891|NCT02335944|516092736|FG006|Treatment Phase|Subject/Guardian Decision|0|||
143149892|NCT02335944|516092737|FG007|Treatment Phase|Subject/Guardian Decision|4|||
143149893|NCT02335944|516092738|FG008|Treatment Phase|Subject/Guardian Decision|0|||
143149894|NCT02335944|516092739|FG009|Treatment Phase|Subject/Guardian Decision|0|||
143149895|NCT02335944|516092730|FG000|Post-treatment Follow-up|Progressive Disease|0|||
143149896|NCT02335944|516092731|FG001|Post-treatment Follow-up|Progressive Disease|0|||
143149897|NCT02335944|516092732|FG002|Post-treatment Follow-up|Progressive Disease|0|||
143149898|NCT02335944|516092733|FG003|Post-treatment Follow-up|Progressive Disease|1|||
143149899|NCT02335944|516092734|FG004|Post-treatment Follow-up|Progressive Disease|0|||
143149900|NCT02335944|516092735|FG005|Post-treatment Follow-up|Progressive Disease|9|||
143149901|NCT02335944|516092736|FG006|Post-treatment Follow-up|Progressive Disease|0|||
143149902|NCT02335944|516092737|FG007|Post-treatment Follow-up|Progressive Disease|2|||
143149903|NCT02335944|516092738|FG008|Post-treatment Follow-up|Progressive Disease|3|||
143149904|NCT02335944|516092739|FG009|Post-treatment Follow-up|Progressive Disease|0|||
143149905|NCT02335944|516092730|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
143149906|NCT02335944|516092731|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
143149907|NCT02335944|516092732|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
143149908|NCT02335944|516092733|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
143149909|NCT02335944|516092734|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
143149910|NCT02335944|516092735|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
143149911|NCT02335944|516092736|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
143149912|NCT02335944|516092737|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
143149913|NCT02335944|516092738|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
143149914|NCT02335944|516092739|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
143149915|NCT02335944|516092730|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
143149916|NCT02335944|516092731|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
143232606|NCT02118584|516403349|FG002|Part 1: Open Label Extension Period|Other|0|||
143232607|NCT02118584|516403347|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
143232608|NCT02118584|516403348|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
143232609|NCT02118584|516403349|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
143232610|NCT02118584|516403347|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
143232611|NCT02118584|516403348|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
143232612|NCT02118584|516403349|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
143232613|NCT02118584|516403347|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
143232614|NCT02118584|516403348|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
143232615|NCT02118584|516403349|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
143232616|NCT02118584|516403347|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
143232617|NCT02118584|516403348|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
143232618|NCT02118584|516403349|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
143232619|NCT02118584|516403347|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
143149917|NCT02335944|516092732|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
143149918|NCT02335944|516092733|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
143149919|NCT02335944|516092734|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
143149920|NCT02335944|516092735|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
143149921|NCT02335944|516092736|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
143149922|NCT02335944|516092737|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
143149923|NCT02335944|516092738|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
143149924|NCT02335944|516092739|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
143149925|NCT02335944|516092730|FG000|Post-treatment Follow-up|Adverse Event|0|||
143149926|NCT02335944|516092731|FG001|Post-treatment Follow-up|Adverse Event|0|||
143149927|NCT02335944|516092732|FG002|Post-treatment Follow-up|Adverse Event|0|||
143149928|NCT02335944|516092733|FG003|Post-treatment Follow-up|Adverse Event|0|||
143149929|NCT02335944|516092734|FG004|Post-treatment Follow-up|Adverse Event|0|||
143149930|NCT02335944|516092735|FG005|Post-treatment Follow-up|Adverse Event|1|||
143149931|NCT02335944|516092736|FG006|Post-treatment Follow-up|Adverse Event|0|||
143149932|NCT02335944|516092737|FG007|Post-treatment Follow-up|Adverse Event|0|||
143149933|NCT02335944|516092738|FG008|Post-treatment Follow-up|Adverse Event|0|||
143149934|NCT02335944|516092739|FG009|Post-treatment Follow-up|Adverse Event|0|||
143149935|NCT02335944|516092730|FG000|Post-treatment Follow-up|Death|0|||
143149936|NCT02335944|516092731|FG001|Post-treatment Follow-up|Death|0|||
143149937|NCT02335944|516092732|FG002|Post-treatment Follow-up|Death|0|||
143149938|NCT02335944|516092733|FG003|Post-treatment Follow-up|Death|1|||
143149939|NCT02335944|516092734|FG004|Post-treatment Follow-up|Death|0|||
143149940|NCT02335944|516092735|FG005|Post-treatment Follow-up|Death|1|||
143149941|NCT02335944|516092736|FG006|Post-treatment Follow-up|Death|0|||
143149942|NCT02335944|516092737|FG007|Post-treatment Follow-up|Death|0|||
143149943|NCT02335944|516092738|FG008|Post-treatment Follow-up|Death|0|||
143149944|NCT02335944|516092739|FG009|Post-treatment Follow-up|Death|0|||
143149945|NCT02335944|516092730|FG000|Post-treatment Follow-up|Physician Decision|1|||
143149946|NCT02335944|516092731|FG001|Post-treatment Follow-up|Physician Decision|0|||
143149947|NCT02335944|516092732|FG002|Post-treatment Follow-up|Physician Decision|0|||
143149948|NCT02335944|516092733|FG003|Post-treatment Follow-up|Physician Decision|0|||
143149949|NCT02335944|516092734|FG004|Post-treatment Follow-up|Physician Decision|0|||
143149950|NCT02335944|516092735|FG005|Post-treatment Follow-up|Physician Decision|0|||
143149951|NCT02335944|516092736|FG006|Post-treatment Follow-up|Physician Decision|0|||
143149952|NCT02335944|516092737|FG007|Post-treatment Follow-up|Physician Decision|1|||
143149953|NCT02335944|516092738|FG008|Post-treatment Follow-up|Physician Decision|0|||
143149954|NCT02335944|516092739|FG009|Post-treatment Follow-up|Physician Decision|0|||
143149955|NCT01202591|516092740|FG000|Overall Study|Adverse Event|2|||
143149956|NCT01202591|516092741|FG001|Overall Study|Adverse Event|1|||
143149957|NCT01202591|516092742|FG002|Overall Study|Adverse Event|4|||
143149958|NCT01202591|516092743|FG003|Overall Study|Adverse Event|4|||
143149959|NCT01202591|516092744|FG004|Overall Study|Adverse Event|0|||
143149960|NCT01202591|516092745|FG005|Overall Study|Adverse Event|0|||
143149961|NCT01202591|516092740|FG000|Overall Study|Other reason as per investigator|3|||
143149962|NCT01202591|516092741|FG001|Overall Study|Other reason as per investigator|4|||
143149963|NCT01202591|516092742|FG002|Overall Study|Other reason as per investigator|7|||
143149964|NCT01202591|516092743|FG003|Overall Study|Other reason as per investigator|3|||
143149965|NCT01202591|516092744|FG004|Overall Study|Other reason as per investigator|1|||
143232620|NCT02118584|516403348|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
143149966|NCT01202591|516092745|FG005|Overall Study|Other reason as per investigator|3|||
143149967|NCT01202591|516092740|FG000|Overall Study|Withdrawal by Subject|0|||
143149968|NCT01202591|516092741|FG001|Overall Study|Withdrawal by Subject|0|||
143149969|NCT01202591|516092742|FG002|Overall Study|Withdrawal by Subject|0|||
143149970|NCT01202591|516092743|FG003|Overall Study|Withdrawal by Subject|0|||
143149971|NCT01202591|516092744|FG004|Overall Study|Withdrawal by Subject|2|||
143149972|NCT01202591|516092745|FG005|Overall Study|Withdrawal by Subject|1|||
143232621|NCT02118584|516403349|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
143363637|NCT00062868|516873791|FG011|Dose Level 2|Lost to Follow-up|0|||
143232622|NCT02118584|516403347|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
143232623|NCT02118584|516403348|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
143232624|NCT02118584|516403349|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
143232625|NCT02118584|516403347|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
143232626|NCT02118584|516403348|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
143232627|NCT02118584|516403349|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
143232628|NCT02118584|516403347|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
143232629|NCT02118584|516403348|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
143232630|NCT02118584|516403349|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
143232631|NCT02118584|516403347|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
143232632|NCT02118584|516403348|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
143232633|NCT02118584|516403349|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
143232634|NCT02939287|516403353|FG000|Overall Study|met exclusion criteria|1|||
143015033|NCT00567996|515595651|FG002|Overall Study|Administrative problems|0|||
143232635|NCT02939287|516403354|FG001|Overall Study|met exclusion criteria|1|||
143232636|NCT02939287|516403355|FG002|Overall Study|met exclusion criteria|1|||
143232637|NCT02939287|516403353|FG000|Overall Study|Did not complete survey|2|||
143232638|NCT02939287|516403354|FG001|Overall Study|Did not complete survey|2|||
143232639|NCT02939287|516403355|FG002|Overall Study|Did not complete survey|0|||
143484618|NCT01049035|517320937|FG005|Overall Study|Other adverse event (AE)|0|||
143015034|NCT00567996|515595649|FG000|Overall Study|Death|1|||
143015035|NCT00567996|515595650|FG001|Overall Study|Death|0|||
143015036|NCT00567996|515595651|FG002|Overall Study|Death|2|||
143015037|NCT00567996|515595649|FG000|Overall Study|Patient's inability to use the device|0|||
143015038|NCT00567996|515595650|FG001|Overall Study|Patient's inability to use the device|1|||
143015039|NCT00567996|515595651|FG002|Overall Study|Patient's inability to use the device|0|||
143015040|NCT02956005|515595652|FG000|Overall Study|Not eligible|1|||
143015041|NCT02956005|515595652|FG000|Overall Study|Withdrawal by Subject|3|||
143015042|NCT02956005|515595652|FG000|Overall Study|Physician Decision|12|||
143015043|NCT02524665|515595653|FG000|Overall Study|Lost to Follow-up|1|||
143015044|NCT01066039|515595654|FG000|Overall Study|Adverse Event|6|||
143015045|NCT01066039|515595654|FG000|Overall Study|Withdrawal by Subject|17|||
143015046|NCT01066039|515595654|FG000|Overall Study|Protocol Violation|2|||
143015047|NCT01066039|515595654|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
143015048|NCT01066039|515595654|FG000|Overall Study|Investigator's Request|1|||
143015049|NCT01066039|515595654|FG000|Overall Study|Dropout due to Insulin Administration|1|||
143015050|NCT01066039|515595654|FG000|Overall Study|Additional Antihypertensive Required|4|||
143015051|NCT01066039|515595654|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
143015052|NCT01066039|515595654|FG000|Overall Study|Failure to Control Blood Pressure|1|||
143015053|NCT01066039|515595654|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
143015054|NCT03022799|515595658|FG000|Overall Study|Adverse Event|0|||
143015055|NCT03022799|515595659|FG001|Overall Study|Adverse Event|0|||
143015056|NCT03022799|515595660|FG002|Overall Study|Adverse Event|0|||
143015057|NCT03022799|515595661|FG003|Overall Study|Adverse Event|0|||
143015058|NCT03022799|515595662|FG004|Overall Study|Adverse Event|0|||
143015059|NCT03022799|515595663|FG005|Overall Study|Adverse Event|0|||
143015060|NCT03022799|515595664|FG006|Overall Study|Adverse Event|0|||
143015061|NCT03022799|515595665|FG007|Overall Study|Adverse Event|0|||
143015062|NCT03022799|515595666|FG008|Overall Study|Adverse Event|0|||
143015063|NCT03022799|515595667|FG009|Overall Study|Adverse Event|1|||
143015064|NCT03022799|515595668|FG010|Overall Study|Adverse Event|1|||
143015065|NCT03022799|515595669|FG011|Overall Study|Adverse Event|0|||
143015066|NCT03022799|515595670|FG012|Overall Study|Adverse Event|0|||
143015067|NCT01999322|515595673|FG000|Overall Study|Adverse Event|1|||
143015068|NCT01999322|515595674|FG001|Overall Study|Adverse Event|0|||
143015069|NCT00434148|515595675|FG000|Overall Study|Adverse Event|18|||
143015070|NCT00434148|515595676|FG001|Overall Study|Adverse Event|18|||
143015071|NCT00434148|515595675|FG000|Overall Study|Lack of Efficacy|25|||
143015072|NCT00434148|515595676|FG001|Overall Study|Lack of Efficacy|28|||
143015073|NCT00434148|515595675|FG000|Overall Study|Withdrawal by Subject|15|||
143015074|NCT00434148|515595676|FG001|Overall Study|Withdrawal by Subject|15|||
143015075|NCT00434148|515595675|FG000|Overall Study|Protocol Violation|4|||
143015076|NCT00434148|515595676|FG001|Overall Study|Protocol Violation|0|||
143015077|NCT00434148|515595675|FG000|Overall Study|Administrative problems|6|||
143015078|NCT00434148|515595676|FG001|Overall Study|Administrative problems|10|||
143015079|NCT00434148|515595675|FG000|Overall Study|Lost to Follow-up|0|||
143015080|NCT00434148|515595676|FG001|Overall Study|Lost to Follow-up|1|||
143015081|NCT00434148|515595675|FG000|Overall Study|Condition no longer requires study drug|1|||
143015082|NCT00434148|515595676|FG001|Overall Study|Condition no longer requires study drug|0|||
143232640|NCT02939287|516403353|FG000|Overall Study|Withdrawal by Subject|1|||
143015083|NCT00434148|515595675|FG000|Overall Study|Abnormal test procedure result|0|||
143015084|NCT00434148|515595676|FG001|Overall Study|Abnormal test procedure result|1|||
143015085|NCT00700310|515597311|FG000|Overall Study|Adverse Event|6|||
143015086|NCT00700310|515597312|FG001|Overall Study|Adverse Event|10|||
143232641|NCT02939287|516403354|FG001|Overall Study|Withdrawal by Subject|1|||
143232642|NCT02939287|516403355|FG002|Overall Study|Withdrawal by Subject|0|||
143232643|NCT00671658|516403361|FG000|Overall Study|Physician Decision|5|||
143232644|NCT01527149|516403363|FG000|Overall Study|Death|2|||
143232645|NCT01680341|516403365|FG000|Overall Study|Adverse Event|3|||
143232646|NCT01680341|516403366|FG001|Overall Study|Adverse Event|2|||
143232647|NCT01680341|516403365|FG000|Overall Study|Unclassified|18|||
143232648|NCT01680341|516403366|FG001|Overall Study|Unclassified|15|||
143232649|NCT02587221|516403368|FG000|Overall Study|Adverse Event|3|||
143232650|NCT02587221|516403369|FG001|Overall Study|Adverse Event|3|||
143232651|NCT02587221|516403368|FG000|Overall Study|Death|33|||
143232652|NCT02587221|516403369|FG001|Overall Study|Death|34|||
143232653|NCT02587221|516403368|FG000|Overall Study|Withdrawal by Subject|66|||
143232654|NCT02587221|516403369|FG001|Overall Study|Withdrawal by Subject|61|||
143232655|NCT02587221|516403368|FG000|Overall Study|Lost to Follow-up|21|||
143232656|NCT02587221|516403369|FG001|Overall Study|Lost to Follow-up|19|||
143232657|NCT02587221|516403368|FG000|Overall Study|Protocol Violation|6|||
143232658|NCT02587221|516403369|FG001|Overall Study|Protocol Violation|5|||
143232659|NCT02587221|516403368|FG000|Overall Study|Other Reason or Unspecified|2|||
143232660|NCT02587221|516403369|FG001|Overall Study|Other Reason or Unspecified|1|||
143149973|NCT01202591|516092740|FG000|Overall Study|Objective Disease Progression|0|||
143149974|NCT01202591|516092741|FG001|Overall Study|Objective Disease Progression|0|||
143149975|NCT01202591|516092742|FG002|Overall Study|Objective Disease Progression|0|||
143149976|NCT01202591|516092743|FG003|Overall Study|Objective Disease Progression|0|||
143149977|NCT01202591|516092744|FG004|Overall Study|Objective Disease Progression|2|||
143149978|NCT01202591|516092745|FG005|Overall Study|Objective Disease Progression|0|||
143149979|NCT03018938|516092746|FG000|Overall Study|Death|0|||
143149980|NCT03018938|516092747|FG001|Overall Study|Death|1|||
143149981|NCT03018938|516092746|FG000|Overall Study|Lost to Follow-up|21|||
143149982|NCT03018938|516092747|FG001|Overall Study|Lost to Follow-up|32|||
143149983|NCT03018938|516092746|FG000|Overall Study|Withdrawal by Subject|38|||
143149984|NCT03018938|516092747|FG001|Overall Study|Withdrawal by Subject|45|||
143149985|NCT03018938|516092746|FG000|Overall Study|Physician Decision|3|||
143149986|NCT03018938|516092747|FG001|Overall Study|Physician Decision|2|||
143149987|NCT03018938|516092746|FG000|Overall Study|Sponsor Decision|0|||
143149988|NCT03018938|516092747|FG001|Overall Study|Sponsor Decision|1|||
143149989|NCT03018938|516092746|FG000|Overall Study|Screen failure-After randomization|4|||
143149990|NCT03018938|516092747|FG001|Overall Study|Screen failure-After randomization|2|||
143149991|NCT03018938|516092746|FG000|Overall Study|Not recorded|0|||
143149992|NCT03018938|516092747|FG001|Overall Study|Not recorded|2|||
143149993|NCT02811159|516092748|FG000|Treatment Course 1|Lost to Follow-up|1|||
143149994|NCT00191100|516092751|FG000|Overall Study|Adverse Event|18|||
143149995|NCT00191100|516092752|FG001|Overall Study|Adverse Event|1|||
143149996|NCT00191100|516092751|FG000|Overall Study|Lost to Follow-up|2|||
143149997|NCT00191100|516092752|FG001|Overall Study|Lost to Follow-up|0|||
143149998|NCT00191100|516092751|FG000|Overall Study|Patient Moved|0|||
143149999|NCT00191100|516092752|FG001|Overall Study|Patient Moved|1|||
143150000|NCT00191100|516092751|FG000|Overall Study|Withdrawal by Subject|9|||
143150001|NCT00191100|516092752|FG001|Overall Study|Withdrawal by Subject|3|||
143150002|NCT00191100|516092751|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
143150003|NCT00191100|516092752|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
143150004|NCT00191100|516092751|FG000|Overall Study|Clinical Relapse|2|||
143150005|NCT00191100|516092752|FG001|Overall Study|Clinical Relapse|1|||
143150006|NCT00191100|516092751|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
143150007|NCT00191100|516092752|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
143150008|NCT00191100|516092751|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
143150009|NCT00191100|516092752|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
143150010|NCT00191100|516092751|FG000|Overall Study|Physician Decision|3|||
143150011|NCT00191100|516092752|FG001|Overall Study|Physician Decision|1|||
143150012|NCT00191100|516092751|FG000|Overall Study|Death from Study Drug Toxicity|2|||
143150013|NCT00191100|516092752|FG001|Overall Study|Death from Study Drug Toxicity|0|||
143150014|NCT00191100|516092751|FG000|Overall Study|Protocol Violation|1|||
143150015|NCT00191100|516092752|FG001|Overall Study|Protocol Violation|1|||
143150016|NCT00191100|516092751|FG000|Overall Study|Death from Other Cause|1|||
143150017|NCT00191100|516092752|FG001|Overall Study|Death from Other Cause|0|||
143150018|NCT00191100|516092751|FG000|Overall Study|Reason Not Specified|0|||
143150019|NCT00191100|516092752|FG001|Overall Study|Reason Not Specified|1|||
143150020|NCT02406612|516092753|FG000|Overall Study|Screening Failure|3|||
143150021|NCT02406612|516092754|FG001|Overall Study|Screening Failure|0|||
143232661|NCT00499486|516403370|FG000|Overall Study|Withdrawal by Subject|16|||
143232662|NCT03796728|516403375|FG000|Overall Study|Lost to Follow-up|8|||
143232663|NCT03796728|516403375|FG000|Overall Study|Reason not Specified|16|||
143232664|NCT00333775|516403377|FG000|Overall Study|Death|144|||
143232665|NCT00333775|516403378|FG001|Overall Study|Death|149|||
143232666|NCT00333775|516403379|FG002|Overall Study|Death|143|||
143232667|NCT00333775|516403377|FG000|Overall Study|In Follow-up When Study Stopped|87|||
143232668|NCT00333775|516403378|FG001|Overall Study|In Follow-up When Study Stopped|92|||
143232669|NCT00333775|516403379|FG002|Overall Study|In Follow-up When Study Stopped|96|||
143232670|NCT00333775|516403377|FG000|Overall Study|Lost to Follow-up|10|||
143232671|NCT00333775|516403378|FG001|Overall Study|Lost to Follow-up|7|||
143232672|NCT00333775|516403379|FG002|Overall Study|Lost to Follow-up|8|||
143232673|NCT01383928|516403383|FG000|Overall Study|Initiation of ASCT|2|||
143232674|NCT01383928|516403384|FG001|Overall Study|Initiation of ASCT|1|||
143232675|NCT01383928|516403385|FG002|Overall Study|Initiation of ASCT|18|||
143232676|NCT01383928|516403383|FG000|Overall Study|Adverse Event|1|||
143232677|NCT01383928|516403384|FG001|Overall Study|Adverse Event|2|||
143232678|NCT01383928|516403385|FG002|Overall Study|Adverse Event|8|||
143232679|NCT01383928|516403383|FG000|Overall Study|Other|1|||
143232680|NCT01383928|516403384|FG001|Overall Study|Other|3|||
143232681|NCT01383928|516403385|FG002|Overall Study|Other|4|||
143232682|NCT01383928|516403383|FG000|Overall Study|Progressive Disease|1|||
143232683|NCT01383928|516403384|FG001|Overall Study|Progressive Disease|1|||
143232684|NCT01383928|516403385|FG002|Overall Study|Progressive Disease|5|||
143232685|NCT01383928|516403383|FG000|Overall Study|Withdrawal by Subject|0|||
143232686|NCT01383928|516403384|FG001|Overall Study|Withdrawal by Subject|0|||
143232687|NCT01383928|516403385|FG002|Overall Study|Withdrawal by Subject|4|||
143232688|NCT01383928|516403383|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
143150022|NCT02406612|516092753|FG000|Overall Study|Intra-procedural Exclusion|1|||
143150023|NCT02406612|516092754|FG001|Overall Study|Intra-procedural Exclusion|3|||
143150024|NCT02406612|516092753|FG000|Overall Study|Guidewire Failure|0|||
143150025|NCT02406612|516092754|FG001|Overall Study|Guidewire Failure|1|||
143150026|NCT02916771|516092759|FG000|Overall Study|Withdrawal by Subject|9|||
143150027|NCT02916771|516092759|FG000|Overall Study|Physician Decision|1|||
143150028|NCT02916771|516092759|FG000|Overall Study|Began treatment for another active malignancy|1|||
143150029|NCT00970944|516093755|FG000|Overall Study|Death|1|||
143150030|NCT00970944|516093756|FG001|Overall Study|Death|0|||
143150031|NCT00970944|516093755|FG000|Overall Study|Physician Decision|0|||
143150032|NCT00970944|516093756|FG001|Overall Study|Physician Decision|2|||
143150033|NCT02008370|516093757|FG000|Overall Study|Lost to Follow-up|7|||
143150034|NCT00972738|516093758|FG000|Overall Study|Adverse Event|7|||
143150035|NCT00972738|516093759|FG001|Overall Study|Adverse Event|1|||
143150036|NCT00972738|516093760|FG002|Overall Study|Adverse Event|8|||
143150037|NCT00972738|516093758|FG000|Overall Study|Protocol Violation|2|||
143150038|NCT00972738|516093759|FG001|Overall Study|Protocol Violation|1|||
143150039|NCT00972738|516093760|FG002|Overall Study|Protocol Violation|3|||
143150040|NCT00972738|516093758|FG000|Overall Study|Lost to Follow-up|1|||
143150041|NCT00972738|516093759|FG001|Overall Study|Lost to Follow-up|0|||
143150042|NCT00972738|516093760|FG002|Overall Study|Lost to Follow-up|1|||
143150043|NCT00972738|516093758|FG000|Overall Study|Lack of Efficacy|5|||
143150044|NCT00972738|516093759|FG001|Overall Study|Lack of Efficacy|1|||
143150045|NCT00972738|516093760|FG002|Overall Study|Lack of Efficacy|11|||
143150046|NCT00972738|516093758|FG000|Overall Study|Withdrawal by Subject|5|||
143150047|NCT00972738|516093759|FG001|Overall Study|Withdrawal by Subject|1|||
143150048|NCT00972738|516093760|FG002|Overall Study|Withdrawal by Subject|4|||
143150049|NCT00972738|516093758|FG000|Overall Study|Moved|0|||
143150050|NCT00972738|516093759|FG001|Overall Study|Moved|0|||
143150051|NCT00972738|516093760|FG002|Overall Study|Moved|1|||
143150052|NCT00972738|516093758|FG000|Overall Study|Other|1|||
143150053|NCT00972738|516093759|FG001|Overall Study|Other|2|||
143150054|NCT00972738|516093760|FG002|Overall Study|Other|1|||
143150055|NCT03915067|516093762|FG000|Overall Study|Adverse Event|0|||
143150056|NCT03915067|516093763|FG001|Overall Study|Adverse Event|0|||
143150057|NCT03915067|516093764|FG002|Overall Study|Adverse Event|1|||
143150058|NCT03915067|516093762|FG000|Overall Study|Withdrawal by Subject|4|||
143150059|NCT03915067|516093763|FG001|Overall Study|Withdrawal by Subject|3|||
143150060|NCT03915067|516093764|FG002|Overall Study|Withdrawal by Subject|0|||
143150061|NCT03915067|516093762|FG000|Overall Study|Lost to Follow-up|3|||
143150062|NCT03915067|516093763|FG001|Overall Study|Lost to Follow-up|2|||
143150063|NCT03915067|516093764|FG002|Overall Study|Lost to Follow-up|0|||
143150064|NCT03915067|516093762|FG000|Overall Study|Protocol Deviation|0|||
143150065|NCT03915067|516093763|FG001|Overall Study|Protocol Deviation|0|||
143150066|NCT03915067|516093764|FG002|Overall Study|Protocol Deviation|1|||
143150067|NCT03915067|516093762|FG000|Overall Study|Covid-19 Related Issues|2|||
143150068|NCT03915067|516093763|FG001|Overall Study|Covid-19 Related Issues|4|||
143150069|NCT03915067|516093764|FG002|Overall Study|Covid-19 Related Issues|4|||
143232689|NCT01383928|516403384|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
143232690|NCT01383928|516403385|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
143232691|NCT02491684|516403386|FG000|Treatment Phase|Adverse Event|2|||
143232692|NCT02491684|516403387|FG001|Treatment Phase|Adverse Event|2|||
143232693|NCT02491684|516403386|FG000|Treatment Phase|Incorrect randomisation|1|||
143232694|NCT02491684|516403387|FG001|Treatment Phase|Incorrect randomisation|0|||
143232695|NCT02491684|516403386|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
143232696|NCT02491684|516403387|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
143232697|NCT00771914|516403390|FG000|Overall Study|Physician Decision|0|||
143232698|NCT00771914|516403391|FG001|Overall Study|Physician Decision|0|||
143232699|NCT00771914|516403392|FG002|Overall Study|Physician Decision|0|||
143232700|NCT00771914|516403393|FG003|Overall Study|Physician Decision|1|||
143232701|NCT00771914|516403390|FG000|Overall Study|Lost to Follow-up|0|||
143232702|NCT00771914|516403391|FG001|Overall Study|Lost to Follow-up|0|||
143232703|NCT00771914|516403392|FG002|Overall Study|Lost to Follow-up|0|||
143232704|NCT00771914|516403393|FG003|Overall Study|Lost to Follow-up|1|||
143232705|NCT01521117|516403394|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
143232706|NCT01521117|516403395|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
143232707|NCT01521117|516403394|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
143232708|NCT01521117|516403395|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
143232709|NCT01521117|516403394|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
143232710|NCT01521117|516403395|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
143232711|NCT00004563|516403396|FG000|Overall Study|Withdrawal by Subject|20|||
143232712|NCT00004563|516403397|FG001|Overall Study|Withdrawal by Subject|16|||
143232713|NCT00004563|516403396|FG000|Overall Study|Lack of Efficacy|3|||
143232714|NCT00004563|516403397|FG001|Overall Study|Lack of Efficacy|5|||
143150070|NCT03915067|516093762|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
143150071|NCT03915067|516093763|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
143150072|NCT03915067|516093764|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
143150073|NCT02693418|516093765|FG000|Overall Study|Lost to Follow-up|1|||
143150074|NCT02693418|516093766|FG001|Overall Study|Lost to Follow-up|2|||
143150075|NCT02693418|516093767|FG002|Overall Study|Lost to Follow-up|0|||
143150076|NCT02693418|516093768|FG003|Overall Study|Lost to Follow-up|0|||
143150077|NCT02693418|516093769|FG004|Overall Study|Lost to Follow-up|0|||
143150078|NCT02693418|516093765|FG000|Overall Study|Menses during study period|0|||
143150079|NCT02693418|516093766|FG001|Overall Study|Menses during study period|0|||
143150080|NCT02693418|516093767|FG002|Overall Study|Menses during study period|2|||
143150081|NCT02693418|516093768|FG003|Overall Study|Menses during study period|0|||
143150082|NCT02693418|516093769|FG004|Overall Study|Menses during study period|0|||
143150083|NCT01001104|516093771|FG000|Overall Study|Adverse Event|2|||
143150084|NCT01001104|516093772|FG001|Overall Study|Adverse Event|1|||
143150085|NCT01001104|516093773|FG002|Overall Study|Adverse Event|0|||
143150086|NCT01001104|516093774|FG003|Overall Study|Adverse Event|0|||
143150087|NCT01001104|516093771|FG000|Overall Study|Lost to Follow-up|0|||
143150088|NCT01001104|516093772|FG001|Overall Study|Lost to Follow-up|0|||
143150089|NCT01001104|516093773|FG002|Overall Study|Lost to Follow-up|1|||
143150090|NCT01001104|516093774|FG003|Overall Study|Lost to Follow-up|0|||
143150091|NCT01001104|516093771|FG000|Overall Study|Entry Criteria Not Met|0|||
143150092|NCT01001104|516093772|FG001|Overall Study|Entry Criteria Not Met|0|||
143150093|NCT01001104|516093773|FG002|Overall Study|Entry Criteria Not Met|0|||
143150094|NCT01001104|516093774|FG003|Overall Study|Entry Criteria Not Met|1|||
143150095|NCT01001104|516093771|FG000|Overall Study|Withdrawal by Subject|0|||
143150096|NCT01001104|516093772|FG001|Overall Study|Withdrawal by Subject|0|||
143150097|NCT01001104|516093773|FG002|Overall Study|Withdrawal by Subject|0|||
143150098|NCT01001104|516093774|FG003|Overall Study|Withdrawal by Subject|2|||
143150099|NCT01793935|516093775|FG000|Overall Study|Pregnancy|1|||
143150100|NCT01793935|516093776|FG001|Overall Study|Pregnancy|0|||
143150101|NCT01793935|516093775|FG000|Overall Study|Protocol Violation|2|||
143150102|NCT01793935|516093776|FG001|Overall Study|Protocol Violation|1|||
143150103|NCT01793935|516093775|FG000|Overall Study|Adverse Event|2|||
143150104|NCT01793935|516093776|FG001|Overall Study|Adverse Event|0|||
143150105|NCT01793935|516093775|FG000|Overall Study|Patient did not take study medication|1|||
143150106|NCT01793935|516093776|FG001|Overall Study|Patient did not take study medication|1|||
143150107|NCT01793935|516093775|FG000|Overall Study|Lost to Follow-up|0|||
143150108|NCT01793935|516093776|FG001|Overall Study|Lost to Follow-up|1|||
143150109|NCT02782468|516093777|FG000|Overall Study|Progressive Disease|2|||
143150110|NCT02782468|516093778|FG001|Overall Study|Progressive Disease|5|||
143150111|NCT02782468|516093779|FG002|Overall Study|Progressive Disease|0|||
143150112|NCT02782468|516093780|FG003|Overall Study|Progressive Disease|4|||
143150113|NCT02782468|516093777|FG000|Overall Study|Adverse Event|0|||
143150114|NCT02782468|516093778|FG001|Overall Study|Adverse Event|2|||
143150115|NCT02782468|516093779|FG002|Overall Study|Adverse Event|2|||
143150116|NCT02782468|516093780|FG003|Overall Study|Adverse Event|3|||
143150117|NCT02782468|516093777|FG000|Overall Study|Other|0|||
143150118|NCT02782468|516093778|FG001|Overall Study|Other|0|||
143150119|NCT02782468|516093779|FG002|Overall Study|Other|1|||
143150120|NCT02782468|516093780|FG003|Overall Study|Other|1|||
143150121|NCT02782468|516093777|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
143150122|NCT02782468|516093778|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
143150123|NCT02782468|516093779|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
143150124|NCT02782468|516093780|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
143150125|NCT02782468|516093777|FG000|Overall Study|Symptomatic Deterioration|0|||
143150126|NCT02782468|516093778|FG001|Overall Study|Symptomatic Deterioration|0|||
143150127|NCT02782468|516093779|FG002|Overall Study|Symptomatic Deterioration|0|||
143232715|NCT00004563|516403396|FG000|Overall Study|Death|2|||
143232716|NCT00004563|516403397|FG001|Overall Study|Death|3|||
143232717|NCT01668784|516403400|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
143232718|NCT01668784|516403401|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
143232719|NCT01668784|516403400|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
143232720|NCT01668784|516403401|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
143232721|NCT01668784|516403400|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
143232722|NCT01668784|516403401|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
143232723|NCT01668784|516403400|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
143232724|NCT01668784|516403401|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
143232725|NCT01668784|516403400|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
143232726|NCT01668784|516403401|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
143232727|NCT01668784|516403400|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
143232728|NCT01668784|516403401|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
143232729|NCT01668784|516403400|FG000|Treatment Period|Disease Progression|316|||
143232730|NCT01668784|516403401|FG001|Treatment Period|Disease Progression|293|||
143232731|NCT01668784|516403400|FG000|Treatment Period|Study Drug Toxicity|46|||
143232732|NCT01668784|516403401|FG001|Treatment Period|Study Drug Toxicity|53|||
143232733|NCT01668784|516403400|FG000|Treatment Period|Death|1|||
143232734|NCT01668784|516403401|FG001|Treatment Period|Death|1|||
143232735|NCT01668784|516403400|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
143232736|NCT01668784|516403401|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
143232737|NCT01668784|516403400|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
143232738|NCT01668784|516403401|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
143232739|NCT01668784|516403400|FG000|Treatment Period|Withdrawal by Subject|5|||
143232740|NCT01668784|516403401|FG001|Treatment Period|Withdrawal by Subject|3|||
143232741|NCT01668784|516403400|FG000|Treatment Period|Maximal Clinical Benefit|3|||
143232742|NCT01668784|516403401|FG001|Treatment Period|Maximal Clinical Benefit|3|||
143232743|NCT01668784|516403400|FG000|Treatment Period|Other|2|||
143232744|NCT01668784|516403401|FG001|Treatment Period|Other|8|||
143232745|NCT01668784|516403400|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
143232746|NCT01668784|516403401|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
143232747|NCT00685165|516403404|FG000|Washout Period of 14 Days|Adverse Event|1|||
143232748|NCT00685165|516403405|FG001|Washout Period of 14 Days|Adverse Event|0|||
143232749|NCT05135871|516403412|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
143232750|NCT05135871|516403413|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
143232751|NCT05135871|516403414|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
143232752|NCT05135871|516403415|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
143232753|NCT04576988|516403419|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
143232754|NCT04576988|516403420|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
143232755|NCT04576988|516403419|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
143232756|NCT04576988|516403420|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
143232757|NCT04576988|516403419|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
143232758|NCT04576988|516403420|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
143232759|NCT04576988|516403419|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
143232760|NCT04576988|516403420|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
143232761|NCT04576988|516403419|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
143232762|NCT04576988|516403420|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
143232763|NCT04576988|516403419|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
143232764|NCT04576988|516403420|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
143232765|NCT04576988|516403419|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
143232766|NCT04576988|516403420|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
143232767|NCT04576988|516403419|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
143232768|NCT04576988|516403420|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
143232769|NCT04576988|516403419|FG000|Long Term Double Blind (LTDB)|Death|2|||
143232770|NCT04576988|516403420|FG001|Long Term Double Blind (LTDB)|Death|1|||
143232771|NCT04576988|516403419|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
143232772|NCT04576988|516403420|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
143232773|NCT01576341|516403423|FG000|Overall Study|Withdrawal by Subject|24|||
143232774|NCT01576341|516403423|FG000|Overall Study|Adverse Event|10|||
143232775|NCT01576341|516403423|FG000|Overall Study|Death|21|||
143232776|NCT01576341|516403423|FG000|Overall Study|Physician Decision|2|||
143232777|NCT01576341|516403423|FG000|Overall Study|Lost to Follow-up|2|||
143232778|NCT01576341|516403423|FG000|Overall Study|Kidney transplantation|10|||
143232779|NCT01576341|516403423|FG000|Overall Study|Protocol Violation|12|||
143232780|NCT01576341|516403423|FG000|Overall Study|Other|12|||
143232781|NCT01844765|516403424|FG000|Overall Study|Adverse Event|6|||
143232782|NCT01844765|516403425|FG001|Overall Study|Adverse Event|8|||
143232783|NCT01844765|516403424|FG000|Overall Study|Withdrawal by Subject|2|||
143232784|NCT01844765|516403425|FG001|Overall Study|Withdrawal by Subject|3|||
143232785|NCT01844765|516403424|FG000|Overall Study|Disease progression|1|||
143232786|NCT01844765|516403425|FG001|Overall Study|Disease progression|0|||
143232787|NCT01844765|516403424|FG000|Overall Study|Administrative problems|3|||
143232788|NCT01844765|516403425|FG001|Overall Study|Administrative problems|4|||
143232789|NCT01844765|516403424|FG000|Overall Study|Protocol deviation|2|||
143232790|NCT01844765|516403425|FG001|Overall Study|Protocol deviation|0|||
143232791|NCT01844765|516403424|FG000|Overall Study|Untreated|1|||
143232792|NCT01844765|516403425|FG001|Overall Study|Untreated|0|||
143232793|NCT00556075|516403434|FG000|Overall Study|Lost to Follow-up|3|||
143232794|NCT00556075|516403435|FG001|Overall Study|Lost to Follow-up|0|||
143232795|NCT00556075|516403436|FG002|Overall Study|Lost to Follow-up|3|||
143232796|NCT00556075|516403434|FG000|Overall Study|Withdrawal by Subject|3|||
143232797|NCT00556075|516403435|FG001|Overall Study|Withdrawal by Subject|3|||
143232798|NCT00556075|516403436|FG002|Overall Study|Withdrawal by Subject|0|||
143232799|NCT00556075|516403434|FG000|Overall Study|Protocol Violation|1|||
143232800|NCT00556075|516403435|FG001|Overall Study|Protocol Violation|1|||
143232801|NCT00556075|516403436|FG002|Overall Study|Protocol Violation|3|||
143232802|NCT00556075|516403434|FG000|Overall Study|Not eligible|1|||
143232803|NCT00556075|516403435|FG001|Overall Study|Not eligible|1|||
143232804|NCT00556075|516403436|FG002|Overall Study|Not eligible|2|||
143232805|NCT00556075|516403434|FG000|Overall Study|Adverse Event|1|||
143232806|NCT00556075|516403435|FG001|Overall Study|Adverse Event|2|||
143232807|NCT00556075|516403436|FG002|Overall Study|Adverse Event|0|||
143232808|NCT00556075|516403434|FG000|Overall Study|Personal issues|4|||
143232809|NCT00556075|516403435|FG001|Overall Study|Personal issues|1|||
143232810|NCT00556075|516403436|FG002|Overall Study|Personal issues|0|||
143232811|NCT00556075|516403434|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
143232812|NCT00556075|516403435|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
143232813|NCT00556075|516403436|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
143232814|NCT02485691|516403437|FG000|Overall Study|Adverse Event|25|||
143232815|NCT02485691|516403438|FG001|Overall Study|Adverse Event|11|||
143232816|NCT02485691|516403437|FG000|Overall Study|Poor compliance to protocol|0|||
143232817|NCT02485691|516403438|FG001|Overall Study|Poor compliance to protocol|1|||
143232818|NCT02485691|516403437|FG000|Overall Study|Disease progression|57|||
143232819|NCT02485691|516403438|FG001|Overall Study|Disease progression|92|||
143232820|NCT02485691|516403437|FG000|Overall Study|Investigator's decision|23|||
143232821|NCT02485691|516403438|FG001|Overall Study|Investigator's decision|5|||
143232822|NCT02485691|516403437|FG000|Overall Study|Participant's request|13|||
143232823|NCT02485691|516403438|FG001|Overall Study|Participant's request|6|||
143232824|NCT02485691|516403437|FG000|Overall Study|Other reason|8|||
143232825|NCT02485691|516403438|FG001|Overall Study|Other reason|9|||
143232826|NCT02485691|516403437|FG000|Overall Study|Randomized and not treated|3|||
143232827|NCT02485691|516403438|FG001|Overall Study|Randomized and not treated|2|||
143232828|NCT00604565|516403439|FG000|Overall Study|Study terminated|0|||
143232829|NCT00604565|516403440|FG001|Overall Study|Study terminated|3|||
143232830|NCT04292535|516403442|FG000|Overall Study|Withdrawal by Subject|0|||
143232831|NCT04292535|516403443|FG001|Overall Study|Withdrawal by Subject|0|||
143232832|NCT04292535|516403444|FG002|Overall Study|Withdrawal by Subject|0|||
143232833|NCT04292535|516403445|FG003|Overall Study|Withdrawal by Subject|0|||
143232834|NCT04292535|516403446|FG004|Overall Study|Withdrawal by Subject|0|||
143150128|NCT02782468|516093780|FG003|Overall Study|Symptomatic Deterioration|1|||
143150129|NCT02782468|516093777|FG000|Overall Study|Withdrawal by Subject|1|||
143150130|NCT02782468|516093778|FG001|Overall Study|Withdrawal by Subject|0|||
143150131|NCT02782468|516093779|FG002|Overall Study|Withdrawal by Subject|0|||
143150132|NCT02782468|516093780|FG003|Overall Study|Withdrawal by Subject|0|||
143150133|NCT00313170|516093781|FG000|Overall Study|Death|2|||
143150134|NCT00313170|516093782|FG001|Overall Study|Death|4|||
143150135|NCT00313170|516093783|FG002|Overall Study|Death|2|||
143150136|NCT00313170|516093781|FG000|Overall Study|Adverse Event|1|||
143150137|NCT00313170|516093782|FG001|Overall Study|Adverse Event|2|||
143150138|NCT00313170|516093783|FG002|Overall Study|Adverse Event|0|||
143150139|NCT00313170|516093781|FG000|Overall Study|Disease progression|31|||
143150140|NCT00313170|516093782|FG001|Overall Study|Disease progression|26|||
143150141|NCT00313170|516093783|FG002|Overall Study|Disease progression|27|||
143150142|NCT00313170|516093781|FG000|Overall Study|Withdrawal by Subject|1|||
143150143|NCT00313170|516093782|FG001|Overall Study|Withdrawal by Subject|0|||
143150144|NCT00313170|516093783|FG002|Overall Study|Withdrawal by Subject|1|||
143363638|NCT00062868|516873792|FG012|Dose Level 2|Lost to Follow-up|0|||
143232835|NCT04292535|516403447|FG005|Overall Study|Withdrawal by Subject|0|||
143232836|NCT04292535|516403448|FG006|Overall Study|Withdrawal by Subject|0|||
143150145|NCT00313170|516093781|FG000|Overall Study|Incorrect enrollment|0|||
143150146|NCT00313170|516093782|FG001|Overall Study|Incorrect enrollment|2|||
143150147|NCT00313170|516093783|FG002|Overall Study|Incorrect enrollment|1|||
143150148|NCT00313170|516093781|FG000|Overall Study|Lost to Follow-up|0|||
143150149|NCT00313170|516093782|FG001|Overall Study|Lost to Follow-up|0|||
143232837|NCT04292535|516403449|FG007|Overall Study|Withdrawal by Subject|1|||
143232838|NCT04292535|516403450|FG008|Overall Study|Withdrawal by Subject|0|||
143232839|NCT04292535|516403451|FG009|Overall Study|Withdrawal by Subject|0|||
143232840|NCT04292535|516403452|FG010|Overall Study|Withdrawal by Subject|0|||
143232841|NCT04292535|516403453|FG011|Overall Study|Withdrawal by Subject|0|||
143232842|NCT04292535|516403454|FG012|Overall Study|Withdrawal by Subject|0|||
143232843|NCT04292535|516403455|FG013|Overall Study|Withdrawal by Subject|0|||
143232844|NCT04292535|516403442|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
143232845|NCT04292535|516403443|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
143232846|NCT04292535|516403444|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
143232847|NCT04292535|516403445|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
143232848|NCT04292535|516403446|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
143232849|NCT04292535|516403447|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
143232850|NCT04292535|516403448|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
143232851|NCT04292535|516403449|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
143232852|NCT04292535|516403450|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
143232853|NCT04292535|516403451|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
143232854|NCT04292535|516403452|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
143232855|NCT04292535|516403453|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
143232856|NCT04292535|516403454|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
143232857|NCT04292535|516403455|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
143232858|NCT04292535|516403442|FG000|Overall Study|Report of Dizziness|0|||
143232859|NCT04292535|516403443|FG001|Overall Study|Report of Dizziness|0|||
143232860|NCT04292535|516403444|FG002|Overall Study|Report of Dizziness|0|||
143232861|NCT04292535|516403445|FG003|Overall Study|Report of Dizziness|0|||
143232862|NCT04292535|516403446|FG004|Overall Study|Report of Dizziness|0|||
143232863|NCT04292535|516403447|FG005|Overall Study|Report of Dizziness|0|||
143232864|NCT04292535|516403448|FG006|Overall Study|Report of Dizziness|0|||
143232865|NCT04292535|516403449|FG007|Overall Study|Report of Dizziness|0|||
143232866|NCT04292535|516403450|FG008|Overall Study|Report of Dizziness|0|||
143232867|NCT04292535|516403451|FG009|Overall Study|Report of Dizziness|0|||
143232868|NCT04292535|516403452|FG010|Overall Study|Report of Dizziness|0|||
143232869|NCT04292535|516403453|FG011|Overall Study|Report of Dizziness|0|||
143232870|NCT04292535|516403454|FG012|Overall Study|Report of Dizziness|0|||
143232871|NCT04292535|516403455|FG013|Overall Study|Report of Dizziness|1|||
143232872|NCT04292535|516403442|FG000|Overall Study|Equipment Failure|0|||
143232873|NCT04292535|516403443|FG001|Overall Study|Equipment Failure|0|||
143232874|NCT04292535|516403444|FG002|Overall Study|Equipment Failure|0|||
143232875|NCT04292535|516403445|FG003|Overall Study|Equipment Failure|0|||
143232876|NCT04292535|516403446|FG004|Overall Study|Equipment Failure|0|||
143232877|NCT04292535|516403447|FG005|Overall Study|Equipment Failure|0|||
143232878|NCT04292535|516403448|FG006|Overall Study|Equipment Failure|0|||
143232879|NCT04292535|516403449|FG007|Overall Study|Equipment Failure|0|||
143232880|NCT04292535|516403450|FG008|Overall Study|Equipment Failure|0|||
143232881|NCT04292535|516403451|FG009|Overall Study|Equipment Failure|0|||
143232882|NCT04292535|516403452|FG010|Overall Study|Equipment Failure|0|||
143232883|NCT04292535|516403453|FG011|Overall Study|Equipment Failure|1|||
143232884|NCT04292535|516403454|FG012|Overall Study|Equipment Failure|0|||
143232885|NCT04292535|516403455|FG013|Overall Study|Equipment Failure|0|||
143232886|NCT04659044|516403458|FG000|Induction|Physician Decision|1|||
143232887|NCT04659044|516403458|FG000|Induction|Adverse Event|2|||
143232888|NCT00668148|516403473|FG000|Overall Study|Adverse Event|5|||
143232889|NCT00668148|516403473|FG000|Overall Study|Subject Non-compliance|1|||
143232890|NCT00668148|516403473|FG000|Overall Study|Progressive Disease Before Treatment|2|||
143232891|NCT00668148|516403473|FG000|Overall Study|Withdrawal of Consent|2|||
143232892|NCT00904969|516404820|FG000|Overall Study|Lost to Follow-up|4|||
143232893|NCT00904969|516404820|FG000|Overall Study|Withdrawal by Subject|3|||
143232894|NCT00904969|516404820|FG000|Overall Study|Additional Treatments|11|||
143232895|NCT00904969|516404820|FG000|Overall Study|Case Aborted; Subject Exited|1|||
143232896|NCT01702311|516404827|FG000|Overall Study|Withdrawal by Subject|3|||
143232897|NCT01702311|516404828|FG001|Overall Study|Withdrawal by Subject|2|||
143232898|NCT01702311|516404827|FG000|Overall Study|Discharge less than 24 hours|10|||
143232899|NCT01702311|516404828|FG001|Overall Study|Discharge less than 24 hours|7|||
143015087|NCT00700310|515597313|FG002|Overall Study|Adverse Event|5|||
143015088|NCT00700310|515597314|FG003|Overall Study|Adverse Event|11|||
143232900|NCT01702311|516404827|FG000|Overall Study|Physician Decision|3|||
143232901|NCT01702311|516404828|FG001|Overall Study|Physician Decision|4|||
143232902|NCT00804908|516404836|FG000|Overall Study|Other|115|||
143232903|NCT00804908|516404837|FG001|Overall Study|Other|116|||
143232904|NCT00804908|516404838|FG002|Overall Study|Other|114|||
143232905|NCT01280903|516404839|FG000|Overall Study|Lost to Follow-up|23|||
143232906|NCT01280903|516404840|FG001|Overall Study|Lost to Follow-up|16|||
143232907|NCT00726063|516404844|FG000|Overall Study|Adverse Event|9|||
143232908|NCT00726063|516404845|FG001|Overall Study|Adverse Event|7|||
143232909|NCT02007096|516404846|FG000|Overall Study|medication not available|2|||
143232910|NCT02007096|516404847|FG001|Overall Study|medication not available|0|||
143232911|NCT02007096|516404846|FG000|Overall Study|did not inject saline|0|||
143232912|NCT02007096|516404847|FG001|Overall Study|did not inject saline|3|||
143232913|NCT02007096|516404846|FG000|Overall Study|did not follow postoperative protocol|8|||
143232914|NCT02007096|516404847|FG001|Overall Study|did not follow postoperative protocol|11|||
143015089|NCT00700310|515597311|FG000|Overall Study|Lost to Follow-up|4|||
143232915|NCT02007096|516404846|FG000|Overall Study|converted to open surgery|1|||
143232916|NCT02007096|516404847|FG001|Overall Study|converted to open surgery|1|||
143232917|NCT02007096|516404846|FG000|Overall Study|no mesh placed|0|||
143232918|NCT02007096|516404847|FG001|Overall Study|no mesh placed|1|||
143232919|NCT01231984|516404853|FG000|Study Period 1|Withdrawal by Subject|0|||
143232920|NCT01231984|516404854|FG001|Study Period 1|Withdrawal by Subject|0|||
143232921|NCT01231984|516404855|FG002|Study Period 1|Withdrawal by Subject|0|||
143232922|NCT01231984|516404856|FG003|Study Period 1|Withdrawal by Subject|1|||
143232923|NCT01231984|516404853|FG000|Study Period 1|Lost to Follow-up|1|||
143232924|NCT01231984|516404854|FG001|Study Period 1|Lost to Follow-up|1|||
143232925|NCT01231984|516404855|FG002|Study Period 1|Lost to Follow-up|1|||
143232926|NCT01231984|516404856|FG003|Study Period 1|Lost to Follow-up|0|||
143232927|NCT01231984|516404853|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
143232928|NCT01231984|516404854|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
143232929|NCT01231984|516404855|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
143232930|NCT01231984|516404856|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
143232931|NCT01231984|516404853|FG000|Study Period 1|Screen Failure|0|||
143232932|NCT01231984|516404854|FG001|Study Period 1|Screen Failure|0|||
143232933|NCT01231984|516404855|FG002|Study Period 1|Screen Failure|0|||
143232934|NCT01231984|516404856|FG003|Study Period 1|Screen Failure|1|||
143232935|NCT01231984|516404853|FG000|Study Period 1|Non-compliance with study requirements|5|||
143232936|NCT01231984|516404854|FG001|Study Period 1|Non-compliance with study requirements|0|||
143232937|NCT01231984|516404855|FG002|Study Period 1|Non-compliance with study requirements|2|||
143232938|NCT01231984|516404856|FG003|Study Period 1|Non-compliance with study requirements|1|||
143232939|NCT01231984|516404853|FG000|Study Period 1|Protocol Violation|3|||
143232940|NCT01231984|516404854|FG001|Study Period 1|Protocol Violation|4|||
143232941|NCT01231984|516404855|FG002|Study Period 1|Protocol Violation|2|||
143232942|NCT01231984|516404856|FG003|Study Period 1|Protocol Violation|3|||
143232943|NCT01231984|516404853|FG000|Study Period 1|Adverse Event|1|||
143232944|NCT01231984|516404854|FG001|Study Period 1|Adverse Event|0|||
143232945|NCT01231984|516404855|FG002|Study Period 1|Adverse Event|0|||
143232946|NCT01231984|516404856|FG003|Study Period 1|Adverse Event|0|||
143232947|NCT01231984|516404853|FG000|Study Period 1|Other|0|||
143232948|NCT01231984|516404854|FG001|Study Period 1|Other|0|||
143232949|NCT01231984|516404855|FG002|Study Period 1|Other|0|||
143232950|NCT01231984|516404856|FG003|Study Period 1|Other|1|||
143232951|NCT01231984|516404853|FG000|Study Period 2|Withdrawal by Subject|1|||
143232952|NCT01231984|516404854|FG001|Study Period 2|Withdrawal by Subject|1|||
143232953|NCT01231984|516404855|FG002|Study Period 2|Withdrawal by Subject|0|||
143232954|NCT01231984|516404856|FG003|Study Period 2|Withdrawal by Subject|0|||
143232955|NCT01231984|516404853|FG000|Study Period 2|Lost to Follow-up|1|||
143232956|NCT01231984|516404854|FG001|Study Period 2|Lost to Follow-up|0|||
143232957|NCT01231984|516404855|FG002|Study Period 2|Lost to Follow-up|0|||
143232958|NCT01231984|516404856|FG003|Study Period 2|Lost to Follow-up|3|||
143232959|NCT01231984|516404853|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
143232960|NCT01231984|516404854|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
143232961|NCT01231984|516404855|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
143232962|NCT01231984|516404856|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
143232963|NCT02182895|516404857|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
143232964|NCT02182895|516404858|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
143232965|NCT03103542|516404859|FG000|Overall Study|Physician Decision|2|||
143232966|NCT03103542|516404859|FG000|Overall Study|Adverse Event|2|||
143232967|NCT03103542|516404859|FG000|Overall Study|Other|2|||
143232968|NCT03103542|516404859|FG000|Overall Study|Withdrawal by Subject|1|||
143232969|NCT04026113|516404860|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
143232970|NCT04026113|516404861|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
143232971|NCT04026113|516404862|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
143232972|NCT04026113|516404863|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
143232973|NCT04026113|516404860|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
143232974|NCT04026113|516404861|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
143232975|NCT04026113|516404862|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
143232976|NCT04026113|516404863|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
143232977|NCT04026113|516404860|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
143232978|NCT04026113|516404861|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
143232979|NCT04026113|516404862|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
143232980|NCT04026113|516404863|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
143015090|NCT00700310|515597312|FG001|Overall Study|Lost to Follow-up|1|||
143232981|NCT04026113|516404860|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
143232982|NCT04026113|516404861|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
143232983|NCT04026113|516404862|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
143232984|NCT04026113|516404863|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
143232985|NCT04026113|516404860|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
143232986|NCT04026113|516404861|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
143232987|NCT04026113|516404862|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
143232988|NCT04026113|516404863|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
143232989|NCT04026113|516404860|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
143232990|NCT04026113|516404861|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
143232991|NCT04026113|516404862|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
143232992|NCT04026113|516404863|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
143232993|NCT04026113|516404860|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
143232994|NCT04026113|516404861|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
143232995|NCT04026113|516404862|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
143232996|NCT04026113|516404863|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
143232997|NCT04026113|516404860|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
143232998|NCT04026113|516404861|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
143232999|NCT04026113|516404862|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
143233000|NCT04026113|516404863|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
143233001|NCT04026113|516404860|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
143233002|NCT04026113|516404861|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
143233003|NCT04026113|516404862|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
143233004|NCT04026113|516404863|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
143233005|NCT04613362|516404864|FG000|3 Month Follow-up|Lost to Follow-up|1|||
143233006|NCT04613362|516404865|FG001|3 Month Follow-up|Lost to Follow-up|2|||
143233007|NCT04613362|516404864|FG000|6 Month Follow-up|Lost to Follow-up|0|||
143233008|NCT04613362|516404865|FG001|6 Month Follow-up|Lost to Follow-up|1|||
143233009|NCT03406780|516404866|FG000|Overall Study|Withdrawal by Subject|1|||
143233010|NCT03406780|516404867|FG001|Overall Study|Withdrawal by Subject|1|||
143233011|NCT03406780|516404866|FG000|Overall Study|Other|0|||
143233012|NCT03406780|516404867|FG001|Overall Study|Other|2|||
143233013|NCT01488045|516404868|FG000|Overall Study|Withdrawal by Subject|6|||
143233014|NCT01488045|516404869|FG001|Overall Study|Withdrawal by Subject|11|||
143233015|NCT01488045|516404868|FG000|Overall Study|Failure to present for colonoscopy|3|||
143233016|NCT01488045|516404869|FG001|Overall Study|Failure to present for colonoscopy|6|||
143233017|NCT01488045|516404868|FG000|Overall Study|Failure to report exclusion criteria|0|||
143233018|NCT01488045|516404869|FG001|Overall Study|Failure to report exclusion criteria|1|||
143233019|NCT05365217|516404871|FG000|Treatment Period 1|Withdrawal by Subject|1|||
143233020|NCT05365217|516404872|FG001|Treatment Period 1|Withdrawal by Subject|0|||
143233021|NCT02230410|516404873|FG000|Overall Study|Screen Failure|3|||
143233022|NCT00656513|516404877|FG000|Overall Study|Protocol Violation|1|||
143233023|NCT00656513|516404878|FG001|Overall Study|Protocol Violation|0|||
143233024|NCT00656513|516404879|FG002|Overall Study|Protocol Violation|2|||
143233025|NCT00656513|516404877|FG000|Overall Study|Withdrawal by Subject|0|||
143233026|NCT00656513|516404878|FG001|Overall Study|Withdrawal by Subject|11|||
143233027|NCT00656513|516404879|FG002|Overall Study|Withdrawal by Subject|4|||
143233028|NCT00656513|516404877|FG000|Overall Study|Death|0|||
143233029|NCT00656513|516404878|FG001|Overall Study|Death|0|||
143233030|NCT00656513|516404879|FG002|Overall Study|Death|1|||
143233031|NCT00656513|516404877|FG000|Overall Study|Missing data|0|||
143233032|NCT00656513|516404878|FG001|Overall Study|Missing data|11|||
143233033|NCT00656513|516404879|FG002|Overall Study|Missing data|9|||
143233034|NCT00656513|516404877|FG000|Overall Study|Incomplete treatment|3|||
143233035|NCT00656513|516404878|FG001|Overall Study|Incomplete treatment|0|||
143233036|NCT00656513|516404879|FG002|Overall Study|Incomplete treatment|0|||
143233037|NCT00656513|516404877|FG000|Overall Study|Treatment completed outside of timeframe|0|||
143150150|NCT00313170|516093783|FG002|Overall Study|Lost to Follow-up|1|||
143150151|NCT00313170|516093781|FG000|Overall Study|Progression (investigators opinion)|1|||
143150152|NCT00313170|516093782|FG001|Overall Study|Progression (investigators opinion)|0|||
143150153|NCT00313170|516093783|FG002|Overall Study|Progression (investigators opinion)|0|||
143150154|NCT00356590|516093784|FG000|Overall Study|Adverse Event|54|||
143150155|NCT00356590|516093784|FG000|Overall Study|Death|10|||
143150156|NCT00356590|516093784|FG000|Overall Study|Lost to Follow-up|35|||
143150157|NCT00356590|516093784|FG000|Overall Study|Physician Decision|46|||
143233038|NCT00656513|516404878|FG001|Overall Study|Treatment completed outside of timeframe|3|||
143233039|NCT00656513|516404879|FG002|Overall Study|Treatment completed outside of timeframe|1|||
143233040|NCT00656513|516404877|FG000|Overall Study|Missing baseline form|0|||
143233041|NCT00656513|516404878|FG001|Overall Study|Missing baseline form|5|||
143233042|NCT00656513|516404879|FG002|Overall Study|Missing baseline form|5|||
143233043|NCT03199976|516404880|FG000|Overall Study|Lack of Efficacy|3|||
143233044|NCT03199976|516404881|FG001|Overall Study|Lack of Efficacy|6|||
143233045|NCT03199976|516404882|FG002|Overall Study|Lack of Efficacy|13|||
143150158|NCT00356590|516093784|FG000|Overall Study|Withdrawal by Subject|41|||
143363639|NCT00062868|516873793|FG013|Dose Level 2|Lost to Follow-up|1|||
143363640|NCT00062868|516873794|FG014|Dose Level 2|Lost to Follow-up|0|||
143150159|NCT00356590|516093784|FG000|Overall Study|Completed month 12 only|2|||
143233046|NCT03199976|516404880|FG000|Overall Study|Withdrawal by Subject|1|||
143233047|NCT03199976|516404881|FG001|Overall Study|Withdrawal by Subject|0|||
143233048|NCT03199976|516404882|FG002|Overall Study|Withdrawal by Subject|0|||
143233049|NCT03199976|516404880|FG000|Overall Study|Lost to Follow-up|0|||
143233050|NCT03199976|516404881|FG001|Overall Study|Lost to Follow-up|1|||
143233051|NCT03199976|516404882|FG002|Overall Study|Lost to Follow-up|1|||
143233052|NCT01761877|516404883|FG000|Overall Study|Adverse Event|7|||
143233053|NCT01761877|516404884|FG001|Overall Study|Adverse Event|0|||
143233054|NCT01761877|516404883|FG000|Overall Study|Withdrawal by Subject|6|||
143233055|NCT01761877|516404884|FG001|Overall Study|Withdrawal by Subject|4|||
143233056|NCT01761877|516404883|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
143233057|NCT01761877|516404884|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
143233058|NCT01761877|516404883|FG000|Overall Study|Death|0|||
143233059|NCT01761877|516404884|FG001|Overall Study|Death|1|||
143233060|NCT01761877|516404883|FG000|Overall Study|MRI intolerant|1|||
143233061|NCT01761877|516404884|FG001|Overall Study|MRI intolerant|6|||
143233062|NCT04739982|516404886|FG000|Overall Study|Lost to Follow-up|176|||
143233063|NCT04739982|516404887|FG001|Overall Study|Lost to Follow-up|65|||
143233064|NCT04739982|516404886|FG000|Overall Study|Withdrawal by Subject|19|||
143233065|NCT04739982|516404887|FG001|Overall Study|Withdrawal by Subject|0|||
143233066|NCT04739982|516404886|FG000|Overall Study|Protocol Violation|0|||
143233067|NCT04739982|516404887|FG001|Overall Study|Protocol Violation|5|||
143233068|NCT03651765|516404888|FG000|Overall Study|Adverse Event|6|||
143233069|NCT03651765|516404888|FG000|Overall Study|Lack of Efficacy|18|||
143233070|NCT03651765|516404888|FG000|Overall Study|Lost to Follow-up|5|||
143233071|NCT03651765|516404888|FG000|Overall Study|Non-Compliance with Study Drug|4|||
143233072|NCT03651765|516404888|FG000|Overall Study|Physician Decision|6|||
143233073|NCT03651765|516404888|FG000|Overall Study|Pregnancy|1|||
143233074|NCT03651765|516404888|FG000|Overall Study|Discontinued by Sponsor|40|||
143233075|NCT03651765|516404888|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
143233076|NCT03651765|516404888|FG000|Overall Study|Withdrawal by Subject|24|||
143233077|NCT03651765|516404888|FG000|Overall Study|Miscellaneous|6|||
143233078|NCT00551759|516404891|FG000|Overall Study|Adverse Event|7|||
143233079|NCT00551759|516404891|FG000|Overall Study|Death|5|||
143233080|NCT00551759|516404891|FG000|Overall Study|Ineligible|1|||
143233081|NCT03279081|516404892|FG000|Overall Study|Withdrawal by Subject|12|||
143233082|NCT03279081|516404893|FG001|Overall Study|Withdrawal by Subject|20|||
143233083|NCT03279081|516404892|FG000|Overall Study|Physician Decision|4|||
143233084|NCT03279081|516404893|FG001|Overall Study|Physician Decision|1|||
143233085|NCT03279081|516404892|FG000|Overall Study|Lost to Follow-up|8|||
143233086|NCT03279081|516404893|FG001|Overall Study|Lost to Follow-up|8|||
143233087|NCT03279081|516404892|FG000|Overall Study|Death|0|||
143233088|NCT03279081|516404893|FG001|Overall Study|Death|1|||
143233089|NCT03279081|516404892|FG000|Overall Study|Adverse Event|1|||
143233090|NCT03279081|516404893|FG001|Overall Study|Adverse Event|0|||
143484619|NCT01049035|517320938|FG006|Overall Study|Other adverse event (AE)|0|||
143484620|NCT01049035|517320932|FG000|Overall Study|Non-compliance with the protocol|12|||
143484621|NCT01049035|517320933|FG001|Overall Study|Non-compliance with the protocol|6|||
143484622|NCT01049035|517320934|FG002|Overall Study|Non-compliance with the protocol|14|||
143150160|NCT00356590|516093784|FG000|Overall Study|Protocol issues|6|||
143150161|NCT00356590|516093784|FG000|Overall Study|Response status|28|||
143150162|NCT00356590|516093784|FG000|Overall Study|Other|52|||
143150163|NCT03439514|516093790|FG000|Double-Blind Treatment Period|Other|4|||
143150164|NCT03439514|516093791|FG001|Double-Blind Treatment Period|Other|1|||
143150165|NCT03439514|516093790|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
143150166|NCT03439514|516093791|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
143150167|NCT03439514|516093790|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
143150168|NCT03439514|516093791|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
143150169|NCT03439514|516093790|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
143150170|NCT03439514|516093791|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
143150171|NCT03439514|516093790|FG000|Double-Blind Treatment Period|Death|1|||
143150172|NCT03439514|516093791|FG001|Double-Blind Treatment Period|Death|2|||
143150173|NCT02175758|516093792|FG000|Treatment Phase|Lost to Follow-up|0|||
143150174|NCT02175758|516093793|FG001|Treatment Phase|Lost to Follow-up|1|||
143150175|NCT02175758|516093794|FG002|Treatment Phase|Lost to Follow-up|0|||
143233091|NCT03279081|516404892|FG000|Overall Study|Reason not Specified|14|||
143150176|NCT02175758|516093795|FG003|Treatment Phase|Lost to Follow-up|0|||
143233092|NCT03279081|516404893|FG001|Overall Study|Reason not Specified|4|||
143233093|NCT03521570|516404894|FG000|Overall Study|Not eligible|11|||
143233094|NCT00322881|516404896|FG000|Overall Study|Death|2|||
143233095|NCT00322881|516404896|FG000|Overall Study|Adverse Event|1|||
143233096|NCT00322881|516404896|FG000|Overall Study|Disease Progression|2|||
143233097|NCT04842747|516404900|FG000|Overall Study|Withdrawal by Subject|6|||
143150177|NCT02175758|516093796|FG004|Treatment Phase|Lost to Follow-up|0|||
143233098|NCT04842747|516404901|FG001|Overall Study|Withdrawal by Subject|2|||
143233099|NCT04842747|516404900|FG000|Overall Study|Lost to Follow-up|1|||
143233100|NCT04842747|516404901|FG001|Overall Study|Lost to Follow-up|2|||
143150178|NCT02175758|516093797|FG005|Treatment Phase|Lost to Follow-up|0|||
143150179|NCT02175758|516093792|FG000|Treatment Phase|Adverse Event|0|||
143150180|NCT02175758|516093793|FG001|Treatment Phase|Adverse Event|0|||
143150181|NCT02175758|516093794|FG002|Treatment Phase|Adverse Event|0|||
143150182|NCT02175758|516093795|FG003|Treatment Phase|Adverse Event|0|||
143150183|NCT02175758|516093796|FG004|Treatment Phase|Adverse Event|1|||
143150184|NCT02175758|516093797|FG005|Treatment Phase|Adverse Event|0|||
143150185|NCT01913353|516093802|FG000|Overall Study|Adverse Event|2|||
143150186|NCT01913353|516093803|FG001|Overall Study|Adverse Event|0|||
143150187|NCT01913353|516093802|FG000|Overall Study|Physician Decision|0|||
143150188|NCT01913353|516093803|FG001|Overall Study|Physician Decision|2|||
143150189|NCT01913353|516093802|FG000|Overall Study|Withdrawal by Subject|20|||
143150190|NCT01913353|516093803|FG001|Overall Study|Withdrawal by Subject|6|||
143150191|NCT01913353|516093802|FG000|Overall Study|multiple reasons|10|||
143150192|NCT01913353|516093803|FG001|Overall Study|multiple reasons|7|||
143150193|NCT06170827|516093805|FG000|Overall Study|Withdrawal by Subject|1|||
143150194|NCT06170827|516093806|FG001|Overall Study|Withdrawal by Subject|1|||
143150195|NCT02115386|516094448|FG000|Overall Study|Protocol Violation|1|||
143150196|NCT02115386|516094448|FG000|Overall Study|Administrative - trial was terminated|6|||
143150197|NCT02493855|516094449|FG000|Overall Study|Non-compliance|1|||
143150198|NCT02493855|516094450|FG001|Overall Study|Non-compliance|0|||
143150199|NCT02493855|516094451|FG002|Overall Study|Non-compliance|0|||
143150200|NCT02493855|516094449|FG000|Overall Study|Adverse Event|0|||
143150201|NCT02493855|516094450|FG001|Overall Study|Adverse Event|1|||
143150202|NCT02493855|516094451|FG002|Overall Study|Adverse Event|0|||
143150203|NCT02493855|516094449|FG000|Overall Study|Withdrawal by Subject|1|||
143150204|NCT02493855|516094450|FG001|Overall Study|Withdrawal by Subject|0|||
143150205|NCT02493855|516094451|FG002|Overall Study|Withdrawal by Subject|0|||
143150206|NCT02453048|516094454|FG000|Overall Study|Only part of initial 6 mo. study|0|||
143150207|NCT02453048|516094455|FG001|Overall Study|Only part of initial 6 mo. study|0|||
143150208|NCT02453048|516094456|FG002|Overall Study|Only part of initial 6 mo. study|0|||
143150209|NCT02453048|516094457|FG003|Overall Study|Only part of initial 6 mo. study|0|||
143150210|NCT02453048|516094458|FG004|Overall Study|Only part of initial 6 mo. study|6|||
143150211|NCT02453048|516094454|FG000|Overall Study|Lost to Follow-up|0|||
143150212|NCT02453048|516094455|FG001|Overall Study|Lost to Follow-up|1|||
143150213|NCT02453048|516094456|FG002|Overall Study|Lost to Follow-up|2|||
143150214|NCT02453048|516094457|FG003|Overall Study|Lost to Follow-up|0|||
143150215|NCT02453048|516094458|FG004|Overall Study|Lost to Follow-up|0|||
143150216|NCT01482221|516094460|FG000|Overall Study|Lack of Efficacy|1|||
143150217|NCT01482221|516094461|FG001|Overall Study|Lack of Efficacy|0|||
143150218|NCT01482221|516094462|FG002|Overall Study|Lack of Efficacy|1|||
143150219|NCT01482221|516094460|FG000|Overall Study|Lost to Follow-up|3|||
143150220|NCT01482221|516094461|FG001|Overall Study|Lost to Follow-up|2|||
143150221|NCT01482221|516094462|FG002|Overall Study|Lost to Follow-up|1|||
143150222|NCT01482221|516094460|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
143150223|NCT01482221|516094461|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
143150224|NCT01482221|516094462|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
143150225|NCT01482221|516094460|FG000|Overall Study|Condition under Investigation Worsened|3|||
143150226|NCT01482221|516094461|FG001|Overall Study|Condition under Investigation Worsened|2|||
143150227|NCT01482221|516094462|FG002|Overall Study|Condition under Investigation Worsened|4|||
143150228|NCT01482221|516094460|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
143150229|NCT01482221|516094461|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
143150230|NCT01482221|516094462|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
143150231|NCT01482221|516094460|FG000|Overall Study|Adverse Event|1|||
143150232|NCT01482221|516094461|FG001|Overall Study|Adverse Event|7|||
143150233|NCT01482221|516094462|FG002|Overall Study|Adverse Event|3|||
143150234|NCT01482221|516094460|FG000|Overall Study|Withdrawal by Subject|10|||
143150235|NCT01482221|516094461|FG001|Overall Study|Withdrawal by Subject|7|||
143150236|NCT01482221|516094462|FG002|Overall Study|Withdrawal by Subject|12|||
143150237|NCT01482221|516094460|FG000|Overall Study|Incorrect randomization|0|||
143150238|NCT01482221|516094461|FG001|Overall Study|Incorrect randomization|1|||
143150239|NCT01482221|516094462|FG002|Overall Study|Incorrect randomization|0|||
143150240|NCT01482221|516094460|FG000|Overall Study|Physician Decision|0|||
143150241|NCT01482221|516094461|FG001|Overall Study|Physician Decision|1|||
143150242|NCT01482221|516094462|FG002|Overall Study|Physician Decision|0|||
143015091|NCT00700310|515597313|FG002|Overall Study|Lost to Follow-up|0|||
143150243|NCT03086343|516094463|FG000|Period 1|Adverse Event|7|||
143150244|NCT03086343|516094464|FG001|Period 1|Adverse Event|7|||
143150245|NCT03086343|516094465|FG002|Period 1|Adverse Event|0|||
143150246|NCT03086343|516094466|FG003|Period 1|Adverse Event|1|||
143150247|NCT03086343|516094463|FG000|Period 1|Withdrawal by Subject|6|||
143150248|NCT03086343|516094464|FG001|Period 1|Withdrawal by Subject|10|||
143150249|NCT03086343|516094465|FG002|Period 1|Withdrawal by Subject|0|||
143150250|NCT03086343|516094466|FG003|Period 1|Withdrawal by Subject|0|||
143150251|NCT03086343|516094463|FG000|Period 1|Lost to Follow-up|1|||
143150252|NCT03086343|516094464|FG001|Period 1|Lost to Follow-up|3|||
143150253|NCT03086343|516094465|FG002|Period 1|Lost to Follow-up|1|||
143150254|NCT03086343|516094466|FG003|Period 1|Lost to Follow-up|0|||
143233101|NCT04842747|516404900|FG000|Overall Study|Physician Decision|1|||
143233102|NCT04842747|516404901|FG001|Overall Study|Physician Decision|0|||
143233103|NCT04842747|516404900|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
143233104|NCT04842747|516404901|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
143233105|NCT01743469|516404902|FG000|Active Treatment Phase|Adverse Event|10|||
143233106|NCT01743469|516404903|FG001|Active Treatment Phase|Adverse Event|5|||
143233107|NCT01743469|516404904|FG002|Active Treatment Phase|Adverse Event|8|||
143233108|NCT01743469|516404905|FG003|Active Treatment Phase|Adverse Event|1|||
143233109|NCT01743469|516404902|FG000|Active Treatment Phase|Disease Progression|40|||
143233110|NCT01743469|516404903|FG001|Active Treatment Phase|Disease Progression|47|||
143233111|NCT01743469|516404904|FG002|Active Treatment Phase|Disease Progression|30|||
143233112|NCT01743469|516404905|FG003|Active Treatment Phase|Disease Progression|20|||
143233113|NCT01743469|516404902|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
143233114|NCT01743469|516404903|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
143233115|NCT01743469|516404904|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
143233116|NCT01743469|516404905|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
143233117|NCT01743469|516404902|FG000|Active Treatment Phase|Missing|1|||
143233118|NCT01743469|516404903|FG001|Active Treatment Phase|Missing|0|||
143233119|NCT01743469|516404904|FG002|Active Treatment Phase|Missing|0|||
143233120|NCT01743469|516404905|FG003|Active Treatment Phase|Missing|0|||
143233121|NCT01743469|516404902|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
143233122|NCT01743469|516404903|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
143233123|NCT01743469|516404904|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
143233124|NCT01743469|516404905|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
143233125|NCT01743469|516404902|FG000|Follow-up Period - Post-Treatment|Death|43|||
143233126|NCT01743469|516404903|FG001|Follow-up Period - Post-Treatment|Death|47|||
143233127|NCT01743469|516404904|FG002|Follow-up Period - Post-Treatment|Death|22|||
143233128|NCT01743469|516404905|FG003|Follow-up Period - Post-Treatment|Death|16|||
143233129|NCT01743469|516404902|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
143233130|NCT01743469|516404903|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
143233131|NCT01743469|516404904|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
143233132|NCT01743469|516404905|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
143233133|NCT01451606|516404906|FG000|Overall Study|Withdrawal by Subject|4|||
143233134|NCT01451606|516404907|FG001|Overall Study|Withdrawal by Subject|3|||
143233135|NCT04484961|516404910|FG000|Overall Study|Lost to Follow-up|9|||
143233136|NCT04484961|516404911|FG001|Overall Study|Lost to Follow-up|9|||
143233137|NCT00388349|516404912|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
143233138|NCT00388349|516404913|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
143233139|NCT01345240|516404917|FG000|Overall Study|Adverse Event|3|||
143233140|NCT01345240|516404918|FG001|Overall Study|Adverse Event|5|||
143233141|NCT01345240|516404919|FG002|Overall Study|Adverse Event|4|||
143233142|NCT01345240|516404920|FG003|Overall Study|Adverse Event|2|||
143233143|NCT01345240|516404921|FG004|Overall Study|Adverse Event|1|||
143233144|NCT01345240|516404917|FG000|Overall Study|Lost to Follow-up|8|||
143233145|NCT01345240|516404918|FG001|Overall Study|Lost to Follow-up|9|||
143233146|NCT01345240|516404919|FG002|Overall Study|Lost to Follow-up|14|||
143233147|NCT01345240|516404920|FG003|Overall Study|Lost to Follow-up|7|||
143233148|NCT01345240|516404921|FG004|Overall Study|Lost to Follow-up|9|||
143233149|NCT04011540|516404922|FG000|Overall Study|Lost to Follow-up|9|||
143233150|NCT04011540|516404923|FG001|Overall Study|Lost to Follow-up|6|||
143233151|NCT00976274|516404928|FG000|Overall Study|Lost to Follow-up|5|||
143233152|NCT00976274|516404929|FG001|Overall Study|Lost to Follow-up|5|||
143233153|NCT00976274|516404928|FG000|Overall Study|Withdrawal by Subject|1|||
143233154|NCT00976274|516404929|FG001|Overall Study|Withdrawal by Subject|1|||
143233155|NCT00976274|516404928|FG000|Overall Study|Physician Decision|1|||
143233156|NCT00976274|516404929|FG001|Overall Study|Physician Decision|2|||
143233157|NCT02183675|516404930|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
143233158|NCT02183675|516404931|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
143233159|NCT02183675|516404932|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
143233160|NCT02183675|516404933|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
143233161|NCT02183675|516404934|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
143233162|NCT02183675|516404935|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
143233163|NCT00627393|516404936|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
143233164|NCT00627393|516404937|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
143233165|NCT00627393|516404936|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
143233166|NCT00627393|516404937|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
143233167|NCT00627393|516404936|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
143233168|NCT00627393|516404937|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
143233169|NCT00627393|516404936|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
143233170|NCT00627393|516404937|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
143233171|NCT03337308|516404938|FG000|Overall Study|Adverse Event|2|||
143233172|NCT03337308|516404939|FG001|Overall Study|Adverse Event|3|||
143233173|NCT03337308|516404940|FG002|Overall Study|Adverse Event|3|||
143233174|NCT03337308|516404941|FG003|Overall Study|Adverse Event|1|||
143233175|NCT03337308|516404938|FG000|Overall Study|Lost to Follow-up|1|||
143233176|NCT03337308|516404939|FG001|Overall Study|Lost to Follow-up|2|||
143233177|NCT03337308|516404940|FG002|Overall Study|Lost to Follow-up|0|||
143233178|NCT03337308|516404941|FG003|Overall Study|Lost to Follow-up|0|||
143233179|NCT03337308|516404938|FG000|Overall Study|Withdrawal by Subject|2|||
143233180|NCT03337308|516404939|FG001|Overall Study|Withdrawal by Subject|1|||
143233181|NCT03337308|516404940|FG002|Overall Study|Withdrawal by Subject|2|||
143233182|NCT03337308|516404941|FG003|Overall Study|Withdrawal by Subject|1|||
143233183|NCT03337308|516404938|FG000|Overall Study|Protocol Violation|0|||
143150255|NCT03086343|516094463|FG000|Period 1|Other, Not Specified|10|||
143150256|NCT03086343|516094464|FG001|Period 1|Other, Not Specified|12|||
143150257|NCT03086343|516094465|FG002|Period 1|Other, Not Specified|2|||
143150258|NCT03086343|516094466|FG003|Period 1|Other, Not Specified|1|||
143150259|NCT03086343|516094463|FG000|Period 1|Missing|1|||
143150260|NCT03086343|516094464|FG001|Period 1|Missing|0|||
143150261|NCT03086343|516094465|FG002|Period 1|Missing|0|||
143150262|NCT03086343|516094466|FG003|Period 1|Missing|0|||
143150263|NCT03086343|516094463|FG000|Period 2|Adverse Event|20|||
143150264|NCT03086343|516094464|FG001|Period 2|Adverse Event|11|||
143150265|NCT03086343|516094465|FG002|Period 2|Adverse Event|1|||
143150266|NCT03086343|516094466|FG003|Period 2|Adverse Event|2|||
143150267|NCT03086343|516094463|FG000|Period 2|Withdrawal by Subject|15|||
143150268|NCT03086343|516094464|FG001|Period 2|Withdrawal by Subject|25|||
143150269|NCT03086343|516094465|FG002|Period 2|Withdrawal by Subject|2|||
143150270|NCT03086343|516094466|FG003|Period 2|Withdrawal by Subject|2|||
143150271|NCT03086343|516094463|FG000|Period 2|Lost to Follow-up|6|||
143150272|NCT03086343|516094464|FG001|Period 2|Lost to Follow-up|11|||
143150273|NCT03086343|516094465|FG002|Period 2|Lost to Follow-up|1|||
143150274|NCT03086343|516094466|FG003|Period 2|Lost to Follow-up|0|||
143150275|NCT03086343|516094463|FG000|Period 2|COVID-19 Infection|5|||
143150276|NCT03086343|516094464|FG001|Period 2|COVID-19 Infection|0|||
143150277|NCT03086343|516094465|FG002|Period 2|COVID-19 Infection|0|||
143150278|NCT03086343|516094466|FG003|Period 2|COVID-19 Infection|0|||
143150279|NCT03086343|516094463|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
143150280|NCT03086343|516094464|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
143150281|NCT03086343|516094465|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
143150282|NCT03086343|516094466|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
143150283|NCT03086343|516094463|FG000|Period 2|Other, Not Specified|23|||
143150284|NCT03086343|516094464|FG001|Period 2|Other, Not Specified|22|||
143150285|NCT03086343|516094465|FG002|Period 2|Other, Not Specified|2|||
143150286|NCT03086343|516094466|FG003|Period 2|Other, Not Specified|4|||
143150287|NCT00741611|516094467|FG000|Overall Study|Death|0|||
143150288|NCT00741611|516094468|FG001|Overall Study|Death|0|||
143150289|NCT00741611|516094469|FG002|Overall Study|Death|1|||
143150290|NCT00741611|516094467|FG000|Overall Study|Withdrawal by Subject|0|||
143150291|NCT00741611|516094468|FG001|Overall Study|Withdrawal by Subject|2|||
143150292|NCT00741611|516094469|FG002|Overall Study|Withdrawal by Subject|2|||
143150293|NCT04339972|516094476|FG000|Overall Study|Scheduling Issues|3|||
143150294|NCT04339972|516094477|FG001|Overall Study|Scheduling Issues|3|||
143150295|NCT04339972|516094476|FG000|Overall Study|dropout|1|||
143150296|NCT04339972|516094477|FG001|Overall Study|dropout|1|||
143150297|NCT04339972|516094476|FG000|Overall Study|Technical issues|1|||
143150298|NCT04339972|516094477|FG001|Overall Study|Technical issues|0|||
143150299|NCT04339972|516094476|FG000|Overall Study|Claustraphobia|0|||
143150300|NCT04339972|516094477|FG001|Overall Study|Claustraphobia|1|||
143150301|NCT02403271|516094478|FG000|Period 1|Other varied reasons|1|||
143150302|NCT02403271|516094479|FG001|Period 1|Other varied reasons|0|||
143150303|NCT02403271|516094478|FG000|Period 2|Withdrawal by Subject|0|||
143150304|NCT02403271|516094479|FG001|Period 2|Withdrawal by Subject|14|||
143150305|NCT02403271|516094478|FG000|Period 2|Death|0|||
143150306|NCT02403271|516094479|FG001|Period 2|Death|84|||
143150307|NCT02403271|516094478|FG000|Period 2|Lost to Follow-up|0|||
143150308|NCT02403271|516094479|FG001|Period 2|Lost to Follow-up|2|||
143233184|NCT03337308|516404939|FG001|Overall Study|Protocol Violation|1|||
143233185|NCT03337308|516404940|FG002|Overall Study|Protocol Violation|0|||
143233186|NCT03337308|516404941|FG003|Overall Study|Protocol Violation|0|||
143233187|NCT02946580|516404942|FG000|Overall Study|Withdrawal by Subject|1|||
143233188|NCT02946580|516404943|FG001|Overall Study|Withdrawal by Subject|2|||
143150309|NCT02403271|516094478|FG000|Period 2|Study Terminated by Sponsor|0|||
143150310|NCT02403271|516094479|FG001|Period 2|Study Terminated by Sponsor|14|||
143150311|NCT02403271|516094478|FG000|Period 2|Other varied reasons|0|||
143150312|NCT02403271|516094479|FG001|Period 2|Other varied reasons|10|||
143150313|NCT02989389|516094480|FG000|Period 1|Lost to Follow-up|0|||
143150314|NCT02989389|516094481|FG001|Period 1|Lost to Follow-up|1|||
143150315|NCT02989389|516094482|FG002|Period 1|Lost to Follow-up|0|||
143233189|NCT02946580|516404942|FG000|Overall Study|Adverse Event|0|||
143150316|NCT02989389|516094483|FG003|Period 1|Lost to Follow-up|0|||
143150317|NCT02989389|516094484|FG004|Period 1|Lost to Follow-up|0|||
143150318|NCT02989389|516094485|FG005|Period 1|Lost to Follow-up|0|||
143233190|NCT02946580|516404943|FG001|Overall Study|Adverse Event|2|||
143233191|NCT02946580|516404942|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
143233192|NCT02946580|516404943|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
143233193|NCT02761330|516404944|FG000|Treatment Week 1|Withdrawal by Subject|0|||
143233194|NCT02761330|516404945|FG001|Treatment Week 1|Withdrawal by Subject|0|||
143233195|NCT02761330|516404946|FG002|Treatment Week 1|Withdrawal by Subject|0|||
143233196|NCT02761330|516404947|FG003|Treatment Week 1|Withdrawal by Subject|1|||
143233197|NCT02761330|516404948|FG004|Treatment Week 1|Withdrawal by Subject|0|||
143233198|NCT02761330|516404949|FG005|Treatment Week 1|Withdrawal by Subject|1|||
143233199|NCT00888134|516404950|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
143233200|NCT00888134|516404950|FG000|Follow-up|being followed for long-term survival|1|||
143233201|NCT03043313|516404951|FG000|Overall Study|Withdrawal by Subject|5|||
143233202|NCT03043313|516404952|FG001|Overall Study|Withdrawal by Subject|1|||
143233203|NCT03043313|516404953|FG002|Overall Study|Withdrawal by Subject|1|||
143233204|NCT03043313|516404951|FG000|Overall Study|Lost to Follow-up|1|||
143233205|NCT03043313|516404952|FG001|Overall Study|Lost to Follow-up|1|||
143233206|NCT03043313|516404953|FG002|Overall Study|Lost to Follow-up|0|||
143233207|NCT03043313|516404951|FG000|Overall Study|Death|28|||
143233208|NCT03043313|516404952|FG001|Overall Study|Death|26|||
143233209|NCT03043313|516404953|FG002|Overall Study|Death|17|||
143233210|NCT03043313|516404951|FG000|Overall Study|Participation terminated by sponsor|11|||
143233211|NCT03043313|516404952|FG001|Overall Study|Participation terminated by sponsor|13|||
143233212|NCT03043313|516404953|FG002|Overall Study|Participation terminated by sponsor|13|||
143233213|NCT02657889|516404954|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
143233214|NCT02657889|516404955|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
143233215|NCT02657889|516404956|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
143233216|NCT02657889|516404957|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
143233217|NCT02657889|516404954|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
143233218|NCT02657889|516404955|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
143233219|NCT02657889|516404956|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
143233220|NCT02657889|516404957|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
143233221|NCT02657889|516404954|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
143233222|NCT02657889|516404955|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
143233223|NCT02657889|516404956|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
143233224|NCT02657889|516404957|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
143233225|NCT02657889|516404954|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
143233226|NCT02657889|516404955|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
143233227|NCT02657889|516404956|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
143233228|NCT02657889|516404957|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
143233229|NCT02657889|516404954|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
143233230|NCT02657889|516404955|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
143233231|NCT02657889|516404956|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
143233232|NCT02657889|516404957|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
143233233|NCT02657889|516404954|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
143233234|NCT02657889|516404955|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
143233235|NCT02657889|516404956|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
143233236|NCT02657889|516404957|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
143233237|NCT02657889|516404954|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
143233238|NCT02657889|516404955|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
143233239|NCT02657889|516404956|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
143233240|NCT02657889|516404957|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
143233241|NCT02657889|516404954|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
143233242|NCT02657889|516404955|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
143233243|NCT02657889|516404956|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
143233244|NCT02657889|516404957|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
143233245|NCT02657889|516404954|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
143233246|NCT02657889|516404955|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
143233247|NCT02657889|516404956|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
143233248|NCT02657889|516404957|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
143233249|NCT02657889|516404954|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
143233250|NCT02657889|516404955|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
143233251|NCT02657889|516404956|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
143233252|NCT02657889|516404957|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
143233253|NCT02657889|516404954|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
143233254|NCT02657889|516404955|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
143233255|NCT02657889|516404956|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
143233256|NCT02657889|516404957|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
143015092|NCT00700310|515597314|FG003|Overall Study|Lost to Follow-up|1|||
143015093|NCT00700310|515597311|FG000|Overall Study|Withdrawal by Subject|8|||
143015094|NCT00700310|515597312|FG001|Overall Study|Withdrawal by Subject|9|||
143015095|NCT00700310|515597313|FG002|Overall Study|Withdrawal by Subject|8|||
143015096|NCT00700310|515597314|FG003|Overall Study|Withdrawal by Subject|8|||
143015097|NCT00700310|515597311|FG000|Overall Study|Lack of Efficacy|0|||
143015098|NCT00700310|515597312|FG001|Overall Study|Lack of Efficacy|3|||
143015099|NCT00700310|515597313|FG002|Overall Study|Lack of Efficacy|0|||
143015100|NCT00700310|515597314|FG003|Overall Study|Lack of Efficacy|1|||
143015101|NCT00700310|515597311|FG000|Overall Study|Administrative/Other|1|||
143015102|NCT00700310|515597312|FG001|Overall Study|Administrative/Other|3|||
143015103|NCT00700310|515597313|FG002|Overall Study|Administrative/Other|1|||
143015104|NCT00700310|515597314|FG003|Overall Study|Administrative/Other|3|||
143015105|NCT00700310|515597311|FG000|Overall Study|Randomized, Not Treated|2|||
143015106|NCT00700310|515597312|FG001|Overall Study|Randomized, Not Treated|0|||
143015107|NCT00700310|515597313|FG002|Overall Study|Randomized, Not Treated|2|||
143015108|NCT00700310|515597314|FG003|Overall Study|Randomized, Not Treated|2|||
143015109|NCT02082262|515597315|FG000|Overall Study|Withdrawal by Subject|3|||
143015110|NCT02082262|515597315|FG000|Overall Study|Adverse Event|48|||
143015111|NCT02476851|515597317|FG000|Overall Study|Protocol Violation|1|||
143150319|NCT02989389|516094486|FG006|Period 1|Lost to Follow-up|0|||
143150320|NCT02989389|516094487|FG007|Period 1|Lost to Follow-up|0|||
143150321|NCT02989389|516094488|FG008|Period 1|Lost to Follow-up|0|||
143150322|NCT02989389|516094489|FG009|Period 1|Lost to Follow-up|0|||
143150323|NCT02989389|516094480|FG000|Period 1|Physician Decision|0|||
143150324|NCT02989389|516094481|FG001|Period 1|Physician Decision|0|||
143150325|NCT02989389|516094482|FG002|Period 1|Physician Decision|0|||
143150326|NCT02989389|516094483|FG003|Period 1|Physician Decision|0|||
143150327|NCT02989389|516094484|FG004|Period 1|Physician Decision|0|||
143150328|NCT02989389|516094485|FG005|Period 1|Physician Decision|0|||
143150329|NCT02989389|516094486|FG006|Period 1|Physician Decision|0|||
143150330|NCT02989389|516094487|FG007|Period 1|Physician Decision|0|||
143150331|NCT02989389|516094488|FG008|Period 1|Physician Decision|1|||
143150332|NCT02989389|516094489|FG009|Period 1|Physician Decision|0|||
143150333|NCT04470427|516094490|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
143150334|NCT04470427|516094491|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
143150335|NCT04470427|516094492|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
143150336|NCT04470427|516094493|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
143150337|NCT04470427|516094494|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
143150338|NCT04470427|516094495|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
143150339|NCT04470427|516094490|FG000|Part B :Open-label|Other than specified|0|||
143150340|NCT04470427|516094491|FG001|Part B :Open-label|Other than specified|0|||
143150341|NCT04470427|516094492|FG002|Part B :Open-label|Other than specified|788|||
143150342|NCT04470427|516094493|FG003|Part B :Open-label|Other than specified|0|||
143150343|NCT04470427|516094494|FG004|Part B :Open-label|Other than specified|523|||
143150344|NCT04470427|516094495|FG005|Part B :Open-label|Other than specified|0|||
143150345|NCT04470427|516094490|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
143150346|NCT04470427|516094491|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
143150347|NCT04470427|516094492|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
143150348|NCT04470427|516094493|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
143150349|NCT04470427|516094494|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
143150350|NCT04470427|516094495|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
143150351|NCT04470427|516094490|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
143150352|NCT04470427|516094491|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
143150353|NCT04470427|516094492|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
143150354|NCT04470427|516094493|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
143150355|NCT04470427|516094494|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
143150356|NCT04470427|516094495|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
143150357|NCT01018979|516094496|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
143150358|NCT01018979|516094497|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
143150359|NCT01018979|516094496|FG000|Overall Study|Not received at least one dose|0|||
143150360|NCT01018979|516094497|FG001|Overall Study|Not received at least one dose|1|||
143150361|NCT02676973|516094498|FG000|Overall Study|Withdrawal by Subject|9|||
143150362|NCT02676973|516094499|FG001|Overall Study|Withdrawal by Subject|8|||
143150363|NCT02676973|516094500|FG002|Overall Study|Withdrawal by Subject|11|||
143150364|NCT02676973|516094498|FG000|Overall Study|Lost to Follow-up|8|||
143150365|NCT02676973|516094499|FG001|Overall Study|Lost to Follow-up|12|||
143150366|NCT02676973|516094500|FG002|Overall Study|Lost to Follow-up|8|||
143150367|NCT02676973|516094498|FG000|Overall Study|Death|2|||
143150368|NCT02676973|516094499|FG001|Overall Study|Death|1|||
143150369|NCT02676973|516094500|FG002|Overall Study|Death|5|||
143150370|NCT02830087|516094501|FG000|Overall Study|No study staff to follow-up patients|4|||
143150371|NCT02830087|516094502|FG001|Overall Study|No study staff to follow-up patients|4|||
143150372|NCT02830087|516094503|FG002|Overall Study|No study staff to follow-up patients|4|||
143150373|NCT02830087|516094504|FG003|Overall Study|No study staff to follow-up patients|3|||
143233257|NCT02657889|516404954|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
143233258|NCT02657889|516404955|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
143233259|NCT02657889|516404956|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
143233260|NCT02657889|516404957|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
143233261|NCT00795535|516404958|FG000|Overall Study|incomplete data and technical problems|20|||
143233262|NCT00374140|516404960|FG000|Overall Study|Lost to Follow-up|1|||
143150374|NCT02830087|516094505|FG004|Overall Study|No study staff to follow-up patients|3|||
143233263|NCT00374140|516404960|FG000|Overall Study|Protocol Violation|1|||
143233264|NCT00617734|516404961|FG000|Overall Study|Withdrew Consent|2|||
143150375|NCT02830087|516094506|FG005|Overall Study|No study staff to follow-up patients|3|||
143150376|NCT03244189|516094507|FG000|Overall Study|Death|0|||
143150377|NCT03244189|516094508|FG001|Overall Study|Death|2|||
143150378|NCT03244189|516094507|FG000|Overall Study|Lost to Follow-up|92|||
143150379|NCT03244189|516094508|FG001|Overall Study|Lost to Follow-up|107|||
143150380|NCT03244189|516094507|FG000|Overall Study|Physician Decision|4|||
143150381|NCT03244189|516094508|FG001|Overall Study|Physician Decision|2|||
143150382|NCT03244189|516094507|FG000|Overall Study|Pregnancy|7|||
143150383|NCT03244189|516094508|FG001|Overall Study|Pregnancy|5|||
143150384|NCT03244189|516094507|FG000|Overall Study|Protocol Violation|0|||
143150385|NCT03244189|516094508|FG001|Overall Study|Protocol Violation|2|||
143150386|NCT03244189|516094507|FG000|Overall Study|Withdrawal by Subject|45|||
143150387|NCT03244189|516094508|FG001|Overall Study|Withdrawal by Subject|23|||
143150388|NCT03244189|516094507|FG000|Overall Study|Technical Problems|2|||
143150389|NCT03244189|516094508|FG001|Overall Study|Technical Problems|0|||
143150390|NCT00632359|516094509|FG000|Overall Study|Withdrawal by Subject|2|||
143150391|NCT03043573|516094510|FG000|Overall Study|Lost to Follow-up|3|||
143150392|NCT03043573|516094511|FG001|Overall Study|Lost to Follow-up|3|||
143150393|NCT03043573|516094510|FG000|Overall Study|Physician Decision|0|||
143150394|NCT03043573|516094511|FG001|Overall Study|Physician Decision|5|||
143150395|NCT03043573|516094510|FG000|Overall Study|Withdrawal by Subject|0|||
143150396|NCT03043573|516094511|FG001|Overall Study|Withdrawal by Subject|4|||
143150397|NCT02337686|516094514|FG000|Overall Study|Adverse Event|1|||
143150398|NCT00484159|516095923|FG000|Overall Study|Lost to Follow-up|1|||
143150399|NCT00484159|516095924|FG001|Overall Study|Lost to Follow-up|1|||
143150400|NCT00484159|516095925|FG002|Overall Study|Lost to Follow-up|0|||
143150401|NCT04766333|516095926|FG000|Overall Study|Lost to Follow-up|40|||
143150402|NCT04766333|516095927|FG001|Overall Study|Lost to Follow-up|826|||
143150403|NCT03234881|516095928|FG000|Overall Study|Lost to Follow-up|9|||
143150404|NCT03234881|516095929|FG001|Overall Study|Lost to Follow-up|3|||
143150405|NCT03807843|516095930|FG000|Overall Study|Lost to Follow-up|1|||
143150406|NCT03807843|516095931|FG001|Overall Study|Lost to Follow-up|0|||
143150407|NCT01312129|516095932|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
143150408|NCT01312129|516095933|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
143150409|NCT03720847|516095934|FG000|Washout|Physician Decision|1|||
143150410|NCT03720847|516095935|FG001|Washout|Physician Decision|2|||
143150411|NCT01239680|516095940|FG000|Overall Study|Withdrawal by Subject|2|||
143150412|NCT01239680|516095941|FG001|Overall Study|Withdrawal by Subject|0|||
143150413|NCT03033901|516095942|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
143150414|NCT03033901|516095942|FG000|Overall Study|Refused PSG|23|||
143150415|NCT03033901|516095942|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
143150416|NCT03033901|516095942|FG000|Overall Study|Missing Oximetry Data|3|||
143150417|NCT00729586|516095943|FG000|Overall Study|Ineligible|0|||
143150418|NCT00729586|516095944|FG001|Overall Study|Ineligible|1|||
143150419|NCT00729586|516095943|FG000|Overall Study|never treated|1|||
143150420|NCT00729586|516095944|FG001|Overall Study|never treated|0|||
143150421|NCT05177094|516095947|FG000|Overall Study|Adverse Event|5|||
143150422|NCT05177094|516095948|FG001|Overall Study|Adverse Event|5|||
143150423|NCT05177094|516095947|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
143150424|NCT05177094|516095948|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
143150425|NCT05177094|516095947|FG000|Overall Study|Protocol Deviation|3|||
143233265|NCT00617734|516404962|FG001|Overall Study|Withdrew Consent|0|||
143150426|NCT05177094|516095948|FG001|Overall Study|Protocol Deviation|0|||
143233266|NCT00617734|516404961|FG000|Overall Study|Adverse Event|4|||
143233267|NCT00617734|516404962|FG001|Overall Study|Adverse Event|1|||
143484623|NCT01049035|517320935|FG003|Overall Study|Non-compliance with the protocol|5|||
143150427|NCT05177094|516095947|FG000|Overall Study|Withdrawal by Subject|6|||
143150428|NCT05177094|516095948|FG001|Overall Study|Withdrawal by Subject|3|||
143150429|NCT05177094|516095947|FG000|Overall Study|Participant could not tolerate long study visits|1|||
143150430|NCT05177094|516095948|FG001|Overall Study|Participant could not tolerate long study visits|0|||
143150431|NCT01033942|516095951|FG000|Overall Study|Withdrawal by Subject|1|||
143150432|NCT01033942|516095952|FG001|Overall Study|Withdrawal by Subject|1|||
143150433|NCT01033942|516095953|FG002|Overall Study|Withdrawal by Subject|1|||
143150434|NCT01033942|516095951|FG000|Overall Study|Lost to Follow-up|1|||
143150435|NCT01033942|516095952|FG001|Overall Study|Lost to Follow-up|0|||
143233268|NCT00617734|516404961|FG000|Overall Study|Protocol Violation|1|||
143484624|NCT01049035|517320936|FG004|Overall Study|Non-compliance with the protocol|3|||
143150436|NCT01033942|516095953|FG002|Overall Study|Lost to Follow-up|0|||
143150437|NCT01033942|516095951|FG000|Overall Study|Enrolled in Extension Study|0|||
143150438|NCT01033942|516095952|FG001|Overall Study|Enrolled in Extension Study|3|||
143150439|NCT01033942|516095953|FG002|Overall Study|Enrolled in Extension Study|0|||
143150440|NCT02737618|516095954|FG000|Overall Study|Withdrawal by Subject|9|||
143150441|NCT02513199|516095955|FG000|Treatment|Death|1|||
143150442|NCT02513199|516095955|FG000|Treatment|Lost to Follow-up|1|||
143150443|NCT02513199|516095955|FG000|Follow-Up|Death|11|||
143150444|NCT02260986|516095963|FG000|Overall Study|Adverse Event|24|||
143150445|NCT02260986|516095964|FG001|Overall Study|Adverse Event|0|||
143150446|NCT02260986|516095965|FG002|Overall Study|Adverse Event|11|||
143150447|NCT02260986|516095963|FG000|Overall Study|Lack of Efficacy|27|||
143150448|NCT02260986|516095964|FG001|Overall Study|Lack of Efficacy|3|||
143150449|NCT02260986|516095965|FG002|Overall Study|Lack of Efficacy|0|||
143150450|NCT02260986|516095963|FG000|Overall Study|Protocol Violation|14|||
143150451|NCT02260986|516095964|FG001|Overall Study|Protocol Violation|5|||
143150452|NCT02260986|516095965|FG002|Overall Study|Protocol Violation|16|||
143150453|NCT02260986|516095963|FG000|Overall Study|Car accident|0|||
143150454|NCT02260986|516095964|FG001|Overall Study|Car accident|0|||
143150455|NCT02260986|516095965|FG002|Overall Study|Car accident|1|||
143150456|NCT02260986|516095963|FG000|Overall Study|Withdrawal by Subject|17|||
143150457|NCT02260986|516095964|FG001|Overall Study|Withdrawal by Subject|4|||
143150458|NCT02260986|516095965|FG002|Overall Study|Withdrawal by Subject|9|||
143150459|NCT02260986|516095963|FG000|Overall Study|Incorrect randomization|0|||
143150460|NCT02260986|516095964|FG001|Overall Study|Incorrect randomization|1|||
143150461|NCT02260986|516095965|FG002|Overall Study|Incorrect randomization|0|||
143150462|NCT02260986|516095963|FG000|Overall Study|Lack of investigation product supply|2|||
143150463|NCT02260986|516095964|FG001|Overall Study|Lack of investigation product supply|0|||
143150464|NCT02260986|516095965|FG002|Overall Study|Lack of investigation product supply|1|||
143150465|NCT02260986|516095963|FG000|Overall Study|Lost to Follow-up|4|||
143150466|NCT02260986|516095964|FG001|Overall Study|Lost to Follow-up|0|||
143150467|NCT02260986|516095965|FG002|Overall Study|Lost to Follow-up|3|||
143150468|NCT02260986|516095963|FG000|Overall Study|Pregnancy|2|||
143150469|NCT02260986|516095964|FG001|Overall Study|Pregnancy|0|||
143150470|NCT02260986|516095965|FG002|Overall Study|Pregnancy|0|||
143150471|NCT02397837|516095967|FG000|Overall Study|Withdrawal by Subject|6|||
143150472|NCT02397837|516095968|FG001|Overall Study|Withdrawal by Subject|5|||
143150473|NCT02397837|516095967|FG000|Overall Study|Physician Decision|1|||
143150474|NCT02397837|516095968|FG001|Overall Study|Physician Decision|1|||
143150475|NCT00407511|516095976|FG000|Overall Study|Adverse Event|9|||
143150476|NCT00407511|516095976|FG000|Overall Study|Lost to Follow-up|4|||
143150477|NCT00407511|516095976|FG000|Overall Study|Other|5|||
143150478|NCT00407511|516095976|FG000|Overall Study|Withdrawal by Subject|4|||
143150479|NCT00529035|516095977|FG000|Overall Study|Withdrawal by Subject|1|||
143150480|NCT00153920|516095980|FG000|Overall Study|Adverse Event|9|||
143150481|NCT00153920|516095980|FG000|Overall Study|Progressive Disease|9|||
143150482|NCT00153920|516095980|FG000|Overall Study|Physician Decision|3|||
143150483|NCT00153920|516095980|FG000|Overall Study|Lack of Response|3|||
143150484|NCT00153920|516095980|FG000|Overall Study|Death|2|||
143150485|NCT00153920|516095980|FG000|Overall Study|Withdrawal by Subject|1|||
143150486|NCT00153920|516095980|FG000|Overall Study|Non-Protocol Therapy|1|||
143150487|NCT00153920|516095980|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
143150488|NCT00153920|516095980|FG000|Overall Study|Progressive Disease before Trt|1|||
143150489|NCT02202616|516095981|FG000|Overall Study|Screen failed|24|||
143150490|NCT02202616|516095981|FG000|Overall Study|Adverse Event|32|||
143150491|NCT02202616|516095981|FG000|Overall Study|Protocol deviation|18|||
143150492|NCT02202616|516095981|FG000|Overall Study|Patient withdrew consent|12|||
143150493|NCT02202616|516095981|FG000|Overall Study|Lost to Follow-up|6|||
143150494|NCT02202616|516095981|FG000|Overall Study|Administrative problems|6|||
143150495|NCT02202616|516095981|FG000|Overall Study|Abnormal test procedure result|1|||
143150496|NCT02202616|516095981|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
143150497|NCT01334515|516095982|FG000|Overall Study|Adverse Event|1|||
143150498|NCT01334515|516095983|FG001|Overall Study|Adverse Event|6|||
143150499|NCT01334515|516095982|FG000|Overall Study|Death|1|||
143150500|NCT01334515|516095983|FG001|Overall Study|Death|0|||
143150501|NCT01334515|516095982|FG000|Overall Study|Lack of Efficacy|8|||
143150502|NCT01334515|516095983|FG001|Overall Study|Lack of Efficacy|21|||
143150503|NCT01334515|516095982|FG000|Overall Study|Physician Decision|1|||
143150504|NCT01334515|516095983|FG001|Overall Study|Physician Decision|1|||
143150505|NCT01334515|516095982|FG000|Overall Study|Withdrawal by Subject|1|||
143150506|NCT01334515|516095983|FG001|Overall Study|Withdrawal by Subject|1|||
143150507|NCT00776997|516095984|FG000|Overall Study|Adverse Event|2|||
143150508|NCT05221866|516095987|FG000|Overall Study|Withdrawal by Subject|5|||
143150509|NCT05221866|516095988|FG001|Overall Study|Withdrawal by Subject|7|||
143150510|NCT05221866|516095989|FG002|Overall Study|Withdrawal by Subject|6|||
143150511|NCT05221866|516095990|FG003|Overall Study|Withdrawal by Subject|4|||
143150512|NCT05221866|516095987|FG000|Overall Study|Physician Decision|3|||
143150513|NCT05221866|516095988|FG001|Overall Study|Physician Decision|2|||
143150514|NCT05221866|516095989|FG002|Overall Study|Physician Decision|1|||
143233269|NCT00617734|516404962|FG001|Overall Study|Protocol Violation|0|||
143233270|NCT00617734|516404961|FG000|Overall Study|Found Ineligible After Randomization|1|||
143233271|NCT00617734|516404962|FG001|Overall Study|Found Ineligible After Randomization|4|||
143233272|NCT00617734|516404961|FG000|Overall Study|Lost to Follow-up|0|||
143233273|NCT00617734|516404962|FG001|Overall Study|Lost to Follow-up|1|||
143233274|NCT02783690|516404963|FG000|Overall Study|Withdrawal by Subject|3|||
143233275|NCT02783690|516404964|FG001|Overall Study|Withdrawal by Subject|3|||
143233276|NCT03474588|516404965|FG000|Overall Study|Withdrawal by Subject|4|||
143233277|NCT03474588|516404966|FG001|Overall Study|Withdrawal by Subject|3|||
143233278|NCT03474588|516404965|FG000|Overall Study|Death|0|||
143233279|NCT03474588|516404966|FG001|Overall Study|Death|1|||
143233280|NCT04966013|516404968|FG000|Overall Study|Withdrawal by Subject|0|||
143233281|NCT04966013|516404969|FG001|Overall Study|Withdrawal by Subject|2|||
143233282|NCT04966013|516404970|FG002|Overall Study|Withdrawal by Subject|1|||
143233283|NCT04966013|516404968|FG000|Overall Study|Adverse Event|2|||
143233284|NCT04966013|516404969|FG001|Overall Study|Adverse Event|1|||
143233285|NCT04966013|516404970|FG002|Overall Study|Adverse Event|1|||
143233286|NCT00781768|516406920|FG000|Overall Study|Not transplanted.|0|||
143233287|NCT00781768|516406921|FG001|Overall Study|Not transplanted.|2|||
143233288|NCT02458313|516406922|FG000|Overall Study|Withdrawal by Subject|6|||
143233289|NCT02458313|516406923|FG001|Overall Study|Withdrawal by Subject|8|||
143233290|NCT02458313|516406922|FG000|Overall Study|Excluded for motion during MRI|1|||
143233291|NCT02458313|516406923|FG001|Overall Study|Excluded for motion during MRI|2|||
143233292|NCT00199381|516406924|FG000|Overall Study|Withdrawal by Subject|38|||
143233293|NCT00199381|516406924|FG000|Overall Study|Adverse Event|73|||
143233294|NCT00199381|516406924|FG000|Overall Study|Protocol Violation|6|||
143233295|NCT00199381|516406924|FG000|Overall Study|Lack of Efficacy|27|||
143233296|NCT00199381|516406924|FG000|Overall Study|Not including due to early termination|37|||
143233297|NCT00199381|516406924|FG000|Overall Study|Study termination by Sponsor|323|||
143233298|NCT04944992|516406926|FG000|Overall Study|Lost to Follow-up|1|||
143233299|NCT04944992|516406927|FG001|Overall Study|Lost to Follow-up|1|||
143233300|NCT04944992|516406926|FG000|Overall Study|Physician Decision|1|||
143150515|NCT05221866|516095990|FG003|Overall Study|Physician Decision|4|||
143150516|NCT05221866|516095987|FG000|Overall Study|Lost to Follow-up|12|||
143150517|NCT05221866|516095988|FG001|Overall Study|Lost to Follow-up|17|||
143150518|NCT05221866|516095989|FG002|Overall Study|Lost to Follow-up|14|||
143150519|NCT05221866|516095990|FG003|Overall Study|Lost to Follow-up|14|||
143150520|NCT05221866|516095987|FG000|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|7|||
143150521|NCT05221866|516095988|FG001|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|5|||
143150522|NCT05221866|516095989|FG002|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|0|||
143150523|NCT05221866|516095990|FG003|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|4|||
143150524|NCT03487445|516095991|FG000|Randomization|Not treated for administrative reasons|1|||
143150525|NCT03487445|516095992|FG001|Randomization|Not treated for administrative reasons|0|||
143150526|NCT00221104|516095993|FG000|Overall Study|Adverse Event|1|||
143150527|NCT00221104|516095994|FG001|Overall Study|Adverse Event|0|||
143150528|NCT00221104|516095993|FG000|Overall Study|Physician Decision|1|||
143150529|NCT00221104|516095994|FG001|Overall Study|Physician Decision|0|||
143150530|NCT00221104|516095993|FG000|Overall Study|Protocol Violation|2|||
143150531|NCT00221104|516095994|FG001|Overall Study|Protocol Violation|0|||
143150532|NCT00221104|516095993|FG000|Overall Study|Withdrawal by Subject|42|||
143150533|NCT00221104|516095994|FG001|Overall Study|Withdrawal by Subject|29|||
143150534|NCT00221104|516095993|FG000|Overall Study|Others|37|||
143150535|NCT00221104|516095994|FG001|Overall Study|Others|47|||
143150536|NCT01666652|516095995|FG000|Overall Study|Serious Adverse Event|0|||
143150537|NCT01666652|516095996|FG001|Overall Study|Serious Adverse Event|0|||
143150538|NCT01666652|516095997|FG002|Overall Study|Serious Adverse Event|0|||
143150539|NCT01666652|516095998|FG003|Overall Study|Serious Adverse Event|1|||
143150540|NCT01666652|516095999|FG004|Overall Study|Serious Adverse Event|0|||
143150541|NCT01666652|516095995|FG000|Overall Study|Withdrawal by Subject|0|||
143150542|NCT01666652|516095996|FG001|Overall Study|Withdrawal by Subject|0|||
143150543|NCT01666652|516095997|FG002|Overall Study|Withdrawal by Subject|0|||
143150544|NCT01666652|516095998|FG003|Overall Study|Withdrawal by Subject|0|||
143150545|NCT01666652|516095999|FG004|Overall Study|Withdrawal by Subject|1|||
143150546|NCT01666652|516095995|FG000|Overall Study|Moved from study area|1|||
143150547|NCT01666652|516095996|FG001|Overall Study|Moved from study area|0|||
143150548|NCT01666652|516095997|FG002|Overall Study|Moved from study area|0|||
143233301|NCT04944992|516406927|FG001|Overall Study|Physician Decision|0|||
143233302|NCT04944992|516406926|FG000|Overall Study|Withdrawal by Subject|6|||
143233303|NCT04944992|516406927|FG001|Overall Study|Withdrawal by Subject|1|||
143363641|NCT00062868|516873795|FG015|Dose Level 2|Lost to Follow-up|0|||
143233304|NCT01295814|516406928|FG000|Overall Study|Lack of Efficacy|0|||
143233305|NCT01295814|516406929|FG001|Overall Study|Lack of Efficacy|2|||
143233306|NCT01295814|516406928|FG000|Overall Study|Withdrawal by Subject|2|||
143363642|NCT00062868|516873796|FG016|Dose Level 2|Lost to Follow-up|1|||
143233307|NCT01295814|516406929|FG001|Overall Study|Withdrawal by Subject|0|||
143233308|NCT03414983|516406930|FG000|Pre-Treatment|Other reasons|1|||
143233309|NCT03414983|516406931|FG001|Pre-Treatment|Other reasons|0|||
143233310|NCT03414983|516406930|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
143233311|NCT03414983|516406931|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
143233312|NCT03414983|516406930|FG000|Pre-Treatment|Participant withdrew consent|1|||
143233313|NCT03414983|516406931|FG001|Pre-Treatment|Participant withdrew consent|3|||
143233314|NCT03414983|516406930|FG000|Treatment|Participant withdrew consent|4|||
143233315|NCT03414983|516406931|FG001|Treatment|Participant withdrew consent|3|||
143233316|NCT03414983|516406930|FG000|Treatment|Participant request to discontinue study treatment|8|||
143233317|NCT03414983|516406931|FG001|Treatment|Participant request to discontinue study treatment|10|||
143233318|NCT03414983|516406930|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
143233319|NCT03414983|516406931|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
143233320|NCT03414983|516406930|FG000|Treatment|Death|0|||
143233321|NCT03414983|516406931|FG001|Treatment|Death|1|||
143233322|NCT03414983|516406930|FG000|Treatment|Study Drug Toxicity|10|||
143233323|NCT03414983|516406931|FG001|Treatment|Study Drug Toxicity|5|||
143233324|NCT03414983|516406930|FG000|Treatment|Disease Progression|75|||
143233325|NCT03414983|516406931|FG001|Treatment|Disease Progression|29|||
143233326|NCT03414983|516406930|FG000|Treatment|Not reported|1|||
143233327|NCT03414983|516406931|FG001|Treatment|Not reported|0|||
143015112|NCT02476851|515597318|FG001|Overall Study|Protocol Violation|1|||
143233328|NCT03414983|516406930|FG000|Treatment|Other reasons|3|||
143233329|NCT03414983|516406931|FG001|Treatment|Other reasons|2|||
143233330|NCT03414983|516406930|FG000|Treatment|Poor/non-compliance|2|||
143015113|NCT00337129|515597321|FG000|Overall Study|Adverse Event|4|||
143015114|NCT00337129|515597321|FG000|Overall Study|Withdrawal by Subject|1|||
143015115|NCT00337129|515597321|FG000|Overall Study|Lack of Efficacy|32|||
143015116|NCT00337129|515597321|FG000|Overall Study|Death|2|||
143015117|NCT00337129|515597321|FG000|Overall Study|not protocol specified|1|||
143015118|NCT01467570|515597325|FG000|Overall Study|Lost to Follow-up|8|||
143015119|NCT01467570|515597326|FG001|Overall Study|Lost to Follow-up|9|||
143015120|NCT02626182|515597329|FG000|Overall Study|Adverse Event|2|||
143015121|NCT02626182|515597330|FG001|Overall Study|Adverse Event|0|||
143015122|NCT01084603|515597338|FG000|Baseline|Withdrawal by Subject|2|||
143015123|NCT01084603|515597338|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
143015124|NCT01084603|515597338|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
143015125|NCT01084603|515597338|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
143015126|NCT01084603|515597338|FG000|Washout Period 4|Adverse Event|1|||
143015127|NCT03836729|515597345|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
143015128|NCT00948025|515597346|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
143015129|NCT00948025|515597347|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
143015130|NCT00948025|515597346|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
143015131|NCT00948025|515597347|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
143015132|NCT00948025|515597346|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
143015133|NCT00948025|515597347|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
143015134|NCT03555890|515597356|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
143015135|NCT03555890|515597357|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
143015136|NCT03555890|515597358|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
143015137|NCT03555890|515597359|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
143015138|NCT03372369|515597360|FG000|Qualification Period|Withdrawal by Subject|16|||
143015139|NCT03372369|515597361|FG001|Qualification Period|Withdrawal by Subject|13|||
143015140|NCT03372369|515597360|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
143015141|NCT03372369|515597361|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
143015142|NCT03372369|515597360|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
143015143|NCT03372369|515597361|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
143015144|NCT02239601|515597362|FG000|Overall Study|Withdrawal by Subject|3|||
143015145|NCT02239601|515597363|FG001|Overall Study|Withdrawal by Subject|4|||
143015146|NCT02239601|515597362|FG000|Overall Study|Protocol Violation|4|||
143015147|NCT02239601|515597363|FG001|Overall Study|Protocol Violation|2|||
143015148|NCT01508325|515597364|FG000|Overall Study|Withdrawal by Subject|8|||
143015149|NCT01508325|515597365|FG001|Overall Study|Withdrawal by Subject|9|||
143015150|NCT01508325|515597364|FG000|Overall Study|Protocol Violation|0|||
143015151|NCT01508325|515597365|FG001|Overall Study|Protocol Violation|3|||
143015152|NCT01508325|515597364|FG000|Overall Study|Physician Decision|2|||
143015153|NCT01508325|515597365|FG001|Overall Study|Physician Decision|1|||
143015154|NCT01508325|515597364|FG000|Overall Study|Adverse Event|1|||
143015155|NCT01508325|515597365|FG001|Overall Study|Adverse Event|0|||
143015156|NCT01508325|515597364|FG000|Overall Study|Lost to Follow-up|5|||
143015157|NCT01508325|515597365|FG001|Overall Study|Lost to Follow-up|6|||
143015158|NCT01508325|515597364|FG000|Overall Study|Other|2|||
143015159|NCT01508325|515597365|FG001|Overall Study|Other|2|||
143233331|NCT03414983|516406931|FG001|Treatment|Poor/non-compliance|0|||
143233332|NCT03414983|516406930|FG000|Treatment|Maximum clinical benefit|5|||
143233333|NCT03414983|516406931|FG001|Treatment|Maximum clinical benefit|9|||
143233334|NCT03414983|516406930|FG000|Treatment|Lost to Follow-up|0|||
143233335|NCT03414983|516406931|FG001|Treatment|Lost to Follow-up|1|||
143150549|NCT01666652|516095998|FG003|Overall Study|Moved from study area|2|||
143150550|NCT01666652|516095999|FG004|Overall Study|Moved from study area|0|||
143150551|NCT01666652|516095995|FG000|Overall Study|Lost to Follow-up|1|||
143150552|NCT01666652|516095996|FG001|Overall Study|Lost to Follow-up|1|||
143150553|NCT01666652|516095997|FG002|Overall Study|Lost to Follow-up|1|||
143150554|NCT01666652|516095998|FG003|Overall Study|Lost to Follow-up|1|||
143150555|NCT01666652|516095999|FG004|Overall Study|Lost to Follow-up|0|||
143150556|NCT01695746|516096002|FG000|Overall Study|Adverse Event|1|||
143150557|NCT01695746|516096002|FG000|Overall Study|Non-compliance by the participant|3|||
143150558|NCT01695746|516096002|FG000|Overall Study|Protocol Violation|5|||
143150559|NCT01695746|516096002|FG000|Overall Study|Participant not willing to participate|3|||
143150560|NCT03976375|516096005|FG000|Overall Study|Death|158|||
143150561|NCT03976375|516096006|FG001|Overall Study|Death|160|||
143150562|NCT03976375|516096007|FG002|Overall Study|Death|42|||
143150563|NCT03976375|516096005|FG000|Overall Study|Lost to Follow-up|2|||
143150564|NCT03976375|516096006|FG001|Overall Study|Lost to Follow-up|1|||
143150565|NCT03976375|516096007|FG002|Overall Study|Lost to Follow-up|1|||
143150566|NCT03976375|516096005|FG000|Overall Study|Withdrawal by Subject|5|||
143150567|NCT03976375|516096006|FG001|Overall Study|Withdrawal by Subject|9|||
143150568|NCT03976375|516096007|FG002|Overall Study|Withdrawal by Subject|4|||
143150569|NCT03976375|516096005|FG000|Overall Study|Sponsor decision|20|||
143150570|NCT03976375|516096006|FG001|Overall Study|Sponsor decision|19|||
143150571|NCT03976375|516096007|FG002|Overall Study|Sponsor decision|1|||
143150572|NCT02717611|516096008|FG000|Overall Study|Death|13|||
143150573|NCT02717611|516096008|FG000|Overall Study|Withdrawal by Subject|6|||
143150574|NCT02717611|516096008|FG000|Overall Study|Active, not recruiting|40|||
143150575|NCT02717611|516096008|FG000|Overall Study|Complicating disease|1|||
143150576|NCT04598828|516096009|FG000|Overall Study|Physician Decision|1|||
143150577|NCT04598828|516096010|FG001|Overall Study|Physician Decision|0|||
143150578|NCT04598828|516096009|FG000|Overall Study|Withdrawal by Subject|0|||
143150579|NCT04598828|516096010|FG001|Overall Study|Withdrawal by Subject|1|||
143150580|NCT04598828|516096009|FG000|Overall Study|Withdrawal by Subject|0|||
143150581|NCT04598828|516096010|FG001|Overall Study|Withdrawal by Subject|1|||
143150582|NCT01078662|516096011|FG000|Overall Study|Death|41|||
143150583|NCT01078662|516096012|FG001|Overall Study|Death|103|||
143150584|NCT01078662|516096013|FG002|Overall Study|Death|18|||
143150585|NCT01078662|516096014|FG003|Overall Study|Death|5|||
143150586|NCT01078662|516096015|FG004|Overall Study|Death|8|||
143150587|NCT01078662|516096011|FG000|Overall Study|Patients reached data cut-off|12|||
143150588|NCT01078662|516096012|FG001|Overall Study|Patients reached data cut-off|53|||
143150589|NCT01078662|516096013|FG002|Overall Study|Patients reached data cut-off|2|||
143150590|NCT01078662|516096014|FG003|Overall Study|Patients reached data cut-off|2|||
143150591|NCT01078662|516096015|FG004|Overall Study|Patients reached data cut-off|3|||
143150592|NCT01078662|516096011|FG000|Overall Study|Withdrawal by Subject|4|||
143150593|NCT01078662|516096012|FG001|Overall Study|Withdrawal by Subject|11|||
143150594|NCT01078662|516096013|FG002|Overall Study|Withdrawal by Subject|1|||
143150595|NCT01078662|516096014|FG003|Overall Study|Withdrawal by Subject|0|||
143150596|NCT01078662|516096015|FG004|Overall Study|Withdrawal by Subject|0|||
143150597|NCT01078662|516096011|FG000|Overall Study|Protocol Violation|0|||
143150598|NCT01078662|516096012|FG001|Overall Study|Protocol Violation|1|||
143150599|NCT01078662|516096013|FG002|Overall Study|Protocol Violation|0|||
143150600|NCT01078662|516096014|FG003|Overall Study|Protocol Violation|0|||
143150601|NCT01078662|516096015|FG004|Overall Study|Protocol Violation|0|||
143150602|NCT01078662|516096011|FG000|Overall Study|Lost to Follow-up|1|||
143150603|NCT01078662|516096012|FG001|Overall Study|Lost to Follow-up|0|||
143150604|NCT01078662|516096013|FG002|Overall Study|Lost to Follow-up|0|||
143150605|NCT01078662|516096014|FG003|Overall Study|Lost to Follow-up|0|||
143233336|NCT03414983|516406930|FG000|Treatment|Administrative reasons by sponsor|1|||
143233337|NCT03414983|516406931|FG001|Treatment|Administrative reasons by sponsor|0|||
143150606|NCT01078662|516096015|FG004|Overall Study|Lost to Follow-up|0|||
143150607|NCT02872714|516096016|FG000|Overall Study|Progressive Disease|1|||
143150608|NCT02872714|516096017|FG001|Overall Study|Progressive Disease|2|||
143150609|NCT02872714|516096018|FG002|Overall Study|Progressive Disease|0|||
143150610|NCT02872714|516096019|FG003|Overall Study|Progressive Disease|0|||
143233338|NCT00303069|516406932|FG000|Overall Study|Lost to Follow-up|1|||
143150611|NCT02872714|516096020|FG004|Overall Study|Progressive Disease|0|||
143150612|NCT02872714|516096016|FG000|Overall Study|Death|87|||
143150613|NCT02872714|516096017|FG001|Overall Study|Death|36|||
143150614|NCT02872714|516096018|FG002|Overall Study|Death|8|||
143150615|NCT02872714|516096019|FG003|Overall Study|Death|81|||
143150616|NCT02872714|516096020|FG004|Overall Study|Death|2|||
143150617|NCT02872714|516096016|FG000|Overall Study|Lost to Follow-up|2|||
143150618|NCT02872714|516096017|FG001|Overall Study|Lost to Follow-up|1|||
143150619|NCT02872714|516096018|FG002|Overall Study|Lost to Follow-up|0|||
143150620|NCT02872714|516096019|FG003|Overall Study|Lost to Follow-up|3|||
143150621|NCT02872714|516096020|FG004|Overall Study|Lost to Follow-up|0|||
143233339|NCT00303069|516406933|FG001|Overall Study|Lost to Follow-up|0|||
143150622|NCT02872714|516096016|FG000|Overall Study|Physician Decision|0|||
143150623|NCT02872714|516096017|FG001|Overall Study|Physician Decision|0|||
143150624|NCT02872714|516096018|FG002|Overall Study|Physician Decision|0|||
143150625|NCT02872714|516096019|FG003|Overall Study|Physician Decision|1|||
143150626|NCT02872714|516096020|FG004|Overall Study|Physician Decision|0|||
143150627|NCT02872714|516096016|FG000|Overall Study|Withdrawal by Subject|1|||
143150628|NCT02872714|516096017|FG001|Overall Study|Withdrawal by Subject|3|||
143150629|NCT02872714|516096018|FG002|Overall Study|Withdrawal by Subject|0|||
143150630|NCT02872714|516096019|FG003|Overall Study|Withdrawal by Subject|2|||
143150631|NCT02872714|516096020|FG004|Overall Study|Withdrawal by Subject|0|||
143150632|NCT02872714|516096016|FG000|Overall Study|Captured as Other|2|||
143150633|NCT02872714|516096017|FG001|Overall Study|Captured as Other|0|||
143150634|NCT02872714|516096018|FG002|Overall Study|Captured as Other|0|||
143150635|NCT02872714|516096019|FG003|Overall Study|Captured as Other|1|||
143150636|NCT02872714|516096020|FG004|Overall Study|Captured as Other|0|||
143150637|NCT05800145|516096028|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|7|||
143150638|NCT05800145|516096029|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
143150639|NCT05800145|516096030|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
143150640|NCT05800145|516096031|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|3|||
143150641|NCT05800145|516096032|FG004|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
143150642|NCT05800145|516096033|FG005|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
143150643|NCT05800145|516096028|FG000|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|1|||
143150644|NCT05800145|516096029|FG001|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
143150645|NCT05800145|516096030|FG002|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
143150646|NCT05800145|516096031|FG003|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|3|||
143150647|NCT05800145|516096032|FG004|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
143150648|NCT05800145|516096033|FG005|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
143150649|NCT05800145|516096028|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
143150650|NCT05800145|516096029|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|5|||
143150651|NCT05800145|516096030|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|0|||
143150652|NCT05800145|516096031|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|3|||
143150653|NCT05800145|516096032|FG004|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
143150654|NCT05800145|516096033|FG005|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
143150655|NCT02850406|516096034|FG000|Part B (Up to 28 Weeks)|Adverse Event|0|||
143150656|NCT02850406|516096035|FG001|Part B (Up to 28 Weeks)|Adverse Event|0|||
143150657|NCT02850406|516096036|FG002|Part B (Up to 28 Weeks)|Adverse Event|0|||
143150658|NCT02850406|516096037|FG003|Part B (Up to 28 Weeks)|Adverse Event|1|||
143150659|NCT02850406|516096038|FG004|Part B (Up to 28 Weeks)|Adverse Event|0|||
143150660|NCT02850406|516096039|FG005|Part B (Up to 28 Weeks)|Adverse Event|0|||
143150661|NCT02850406|516096040|FG006|Part B (Up to 28 Weeks)|Adverse Event|0|||
143150662|NCT02850406|516096041|FG007|Part B (Up to 28 Weeks)|Adverse Event|0|||
143150663|NCT02850406|516096034|FG000|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
143150664|NCT02850406|516096035|FG001|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
143150665|NCT02850406|516096036|FG002|Part B (Up to 28 Weeks)|Withdrawal by Subject|1|||
143150666|NCT02850406|516096037|FG003|Part B (Up to 28 Weeks)|Withdrawal by Subject|2|||
143150667|NCT02850406|516096038|FG004|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
143150668|NCT02850406|516096039|FG005|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
143150669|NCT02850406|516096040|FG006|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
143150670|NCT02850406|516096041|FG007|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
143150671|NCT02850406|516096034|FG000|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
143150672|NCT02850406|516096035|FG001|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
143150673|NCT02850406|516096036|FG002|Part B (Up to 28 Weeks)|Lost to Follow-up|1|||
143150674|NCT02850406|516096037|FG003|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
143150675|NCT02850406|516096038|FG004|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
143150676|NCT02850406|516096039|FG005|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
143150677|NCT02850406|516096040|FG006|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
143150678|NCT02850406|516096041|FG007|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
143150679|NCT02850406|516096034|FG000|Part B (Up to 28 Weeks)|Non compliance|0|||
143150680|NCT02850406|516096035|FG001|Part B (Up to 28 Weeks)|Non compliance|0|||
143150681|NCT02850406|516096036|FG002|Part B (Up to 28 Weeks)|Non compliance|1|||
143150682|NCT02850406|516096037|FG003|Part B (Up to 28 Weeks)|Non compliance|0|||
143150683|NCT02850406|516096038|FG004|Part B (Up to 28 Weeks)|Non compliance|0|||
143150684|NCT02850406|516096039|FG005|Part B (Up to 28 Weeks)|Non compliance|0|||
143150685|NCT02850406|516096040|FG006|Part B (Up to 28 Weeks)|Non compliance|0|||
143150686|NCT02850406|516096041|FG007|Part B (Up to 28 Weeks)|Non compliance|0|||
143150687|NCT02850406|516096034|FG000|Part C (Up to 52 Weeks)|Adverse Event|0|||
143150688|NCT02850406|516096035|FG001|Part C (Up to 52 Weeks)|Adverse Event|0|||
143150689|NCT02850406|516096036|FG002|Part C (Up to 52 Weeks)|Adverse Event|0|||
143150690|NCT02850406|516096037|FG003|Part C (Up to 52 Weeks)|Adverse Event|0|||
143150691|NCT02850406|516096038|FG004|Part C (Up to 52 Weeks)|Adverse Event|4|||
143150692|NCT02850406|516096039|FG005|Part C (Up to 52 Weeks)|Adverse Event|2|||
143150693|NCT02850406|516096040|FG006|Part C (Up to 52 Weeks)|Adverse Event|0|||
143150694|NCT02850406|516096041|FG007|Part C (Up to 52 Weeks)|Adverse Event|0|||
143233340|NCT00303069|516406934|FG002|Overall Study|Lost to Follow-up|0|||
143363643|NCT00062868|516873797|FG017|Dose Level 2|Lost to Follow-up|0|||
143150695|NCT02850406|516096034|FG000|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
143150696|NCT02850406|516096035|FG001|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
143150697|NCT02850406|516096036|FG002|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
143150698|NCT02850406|516096037|FG003|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
143150699|NCT02850406|516096038|FG004|Part C (Up to 52 Weeks)|Withdrawal by Subject|6|||
143150700|NCT02850406|516096039|FG005|Part C (Up to 52 Weeks)|Withdrawal by Subject|3|||
143150701|NCT02850406|516096040|FG006|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
143150702|NCT02850406|516096041|FG007|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
143150703|NCT02850406|516096034|FG000|Part C (Up to 52 Weeks)|Physician Decision|0|||
143150704|NCT02850406|516096035|FG001|Part C (Up to 52 Weeks)|Physician Decision|0|||
143150705|NCT02850406|516096036|FG002|Part C (Up to 52 Weeks)|Physician Decision|0|||
143150706|NCT02850406|516096037|FG003|Part C (Up to 52 Weeks)|Physician Decision|0|||
143150707|NCT02850406|516096038|FG004|Part C (Up to 52 Weeks)|Physician Decision|1|||
143150708|NCT02850406|516096039|FG005|Part C (Up to 52 Weeks)|Physician Decision|0|||
143150709|NCT02850406|516096040|FG006|Part C (Up to 52 Weeks)|Physician Decision|0|||
143150710|NCT02850406|516096041|FG007|Part C (Up to 52 Weeks)|Physician Decision|0|||
143150711|NCT02850406|516096034|FG000|Part C (Up to 52 Weeks)|Other|0|||
143150712|NCT02850406|516096035|FG001|Part C (Up to 52 Weeks)|Other|0|||
143150713|NCT02850406|516096036|FG002|Part C (Up to 52 Weeks)|Other|0|||
143150714|NCT02850406|516096037|FG003|Part C (Up to 52 Weeks)|Other|0|||
143150715|NCT02850406|516096038|FG004|Part C (Up to 52 Weeks)|Other|1|||
143150716|NCT02850406|516096039|FG005|Part C (Up to 52 Weeks)|Other|3|||
143150717|NCT02850406|516096040|FG006|Part C (Up to 52 Weeks)|Other|0|||
143150718|NCT02850406|516096041|FG007|Part C (Up to 52 Weeks)|Other|0|||
143150719|NCT02850406|516096034|FG000|Part D (Up to 52 Weeks)|Adverse Event|0|||
143150720|NCT02850406|516096035|FG001|Part D (Up to 52 Weeks)|Adverse Event|0|||
143150721|NCT02850406|516096036|FG002|Part D (Up to 52 Weeks)|Adverse Event|0|||
143150722|NCT02850406|516096037|FG003|Part D (Up to 52 Weeks)|Adverse Event|0|||
143150723|NCT02850406|516096038|FG004|Part D (Up to 52 Weeks)|Adverse Event|0|||
143150724|NCT02850406|516096039|FG005|Part D (Up to 52 Weeks)|Adverse Event|0|||
143150725|NCT02850406|516096040|FG006|Part D (Up to 52 Weeks)|Adverse Event|1|||
143150726|NCT02850406|516096041|FG007|Part D (Up to 52 Weeks)|Adverse Event|0|||
143150727|NCT02850406|516096034|FG000|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
143150728|NCT02850406|516096035|FG001|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
143150729|NCT02850406|516096036|FG002|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
143150730|NCT02850406|516096037|FG003|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
143150731|NCT02850406|516096038|FG004|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
143150732|NCT02850406|516096039|FG005|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
143150733|NCT02850406|516096040|FG006|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
143150734|NCT02850406|516096041|FG007|Part D (Up to 52 Weeks)|Withdrawal by Subject|1|||
143150735|NCT02850406|516096034|FG000|Part D (Up to 52 Weeks)|Physician Decision|0|||
143150736|NCT02850406|516096035|FG001|Part D (Up to 52 Weeks)|Physician Decision|0|||
143150737|NCT02850406|516096036|FG002|Part D (Up to 52 Weeks)|Physician Decision|0|||
143150738|NCT02850406|516096037|FG003|Part D (Up to 52 Weeks)|Physician Decision|0|||
143150739|NCT02850406|516096038|FG004|Part D (Up to 52 Weeks)|Physician Decision|0|||
143150740|NCT02850406|516096039|FG005|Part D (Up to 52 Weeks)|Physician Decision|0|||
143150741|NCT02850406|516096040|FG006|Part D (Up to 52 Weeks)|Physician Decision|1|||
143150742|NCT02850406|516096041|FG007|Part D (Up to 52 Weeks)|Physician Decision|1|||
143150743|NCT02850406|516096034|FG000|Part D (Up to 52 Weeks)|Other|0|||
143150744|NCT02850406|516096035|FG001|Part D (Up to 52 Weeks)|Other|0|||
143150745|NCT02850406|516096036|FG002|Part D (Up to 52 Weeks)|Other|0|||
143150746|NCT02850406|516096037|FG003|Part D (Up to 52 Weeks)|Other|0|||
143150747|NCT02850406|516096038|FG004|Part D (Up to 52 Weeks)|Other|0|||
143150748|NCT02850406|516096039|FG005|Part D (Up to 52 Weeks)|Other|0|||
143150749|NCT02850406|516096040|FG006|Part D (Up to 52 Weeks)|Other|0|||
143150750|NCT02850406|516096041|FG007|Part D (Up to 52 Weeks)|Other|1|||
143150751|NCT05643794|516097599|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
143150752|NCT05643794|516097600|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|0|||
143150753|NCT05643794|516097601|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
143150754|NCT05643794|516097599|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
143150755|NCT05643794|516097600|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
143150756|NCT05643794|516097601|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
143150757|NCT05643794|516097599|FG000|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
143150758|NCT05643794|516097600|FG001|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
143150759|NCT05643794|516097601|FG002|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
143150760|NCT05643794|516097599|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
143150761|NCT05643794|516097600|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
143150762|NCT05643794|516097601|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
143150763|NCT05643794|516097599|FG000|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
143181201|NCT03654274|516210495|FG002|Overall Study|Withdrawal by Subject|33|||
143233341|NCT00303069|516406935|FG003|Overall Study|Lost to Follow-up|2|||
143233342|NCT00303069|516406932|FG000|Overall Study|subject moved|1|||
143233343|NCT00303069|516406933|FG001|Overall Study|subject moved|0|||
143233344|NCT00303069|516406934|FG002|Overall Study|subject moved|0|||
143233345|NCT00303069|516406935|FG003|Overall Study|subject moved|0|||
143233346|NCT00303069|516406932|FG000|Overall Study|Recruitment into Army Reserves|0|||
143233347|NCT00303069|516406933|FG001|Overall Study|Recruitment into Army Reserves|0|||
143233348|NCT00303069|516406934|FG002|Overall Study|Recruitment into Army Reserves|1|||
143233349|NCT00303069|516406935|FG003|Overall Study|Recruitment into Army Reserves|0|||
143233350|NCT02608684|516406936|FG000|Overall Study|Physician Decision|2|||
143233351|NCT02608684|516406936|FG000|Overall Study|Withdrawal by Subject|1|||
143233352|NCT00751296|516406938|FG000|Overall Study|Adverse Event|2|||
143233353|NCT01972217|516406939|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
143233354|NCT01972217|516406940|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
143233355|NCT01972217|516406941|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
143233356|NCT01972217|516406942|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
143233357|NCT01972217|516406939|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
143233358|NCT01972217|516406940|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
143233359|NCT01972217|516406941|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
143233360|NCT01972217|516406942|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
143233361|NCT01972217|516406939|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
143233362|NCT01972217|516406940|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
143233363|NCT01972217|516406941|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
143233364|NCT01972217|516406942|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
143233365|NCT01972217|516406939|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
143233366|NCT01972217|516406940|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
143233367|NCT01972217|516406941|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
143233368|NCT01972217|516406942|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
143233369|NCT01972217|516406939|FG000|Part B Double-blind, Randomised Period|Death|0|||
143233370|NCT01972217|516406940|FG001|Part B Double-blind, Randomised Period|Death|0|||
143233371|NCT01972217|516406941|FG002|Part B Double-blind, Randomised Period|Death|43|||
143233372|NCT01972217|516406942|FG003|Part B Double-blind, Randomised Period|Death|44|||
143233373|NCT01972217|516406939|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
143233374|NCT01972217|516406940|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
143233375|NCT01972217|516406941|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
143233376|NCT01972217|516406942|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
143233377|NCT01972217|516406939|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
143233378|NCT01972217|516406940|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
143233379|NCT01972217|516406941|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
143233380|NCT01972217|516406942|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
143015160|NCT04682639|515597366|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
143233381|NCT01972217|516406939|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
143233382|NCT01972217|516406940|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
143233383|NCT01972217|516406941|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
143363644|NCT00062868|516873798|FG018|Dose Level 2|Lost to Follow-up|0|||
143015161|NCT04682639|515597367|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
143015162|NCT04682639|515597368|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
143015163|NCT04682639|515597369|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
143015164|NCT04682639|515597370|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
143015165|NCT04682639|515597366|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
143015166|NCT04682639|515597367|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
143015167|NCT04682639|515597368|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
143015168|NCT04682639|515597369|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
143015169|NCT04682639|515597370|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
143015170|NCT04682639|515597366|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
143015171|NCT04682639|515597367|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
143015172|NCT04682639|515597368|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
143015173|NCT04682639|515597369|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
143015174|NCT04682639|515597370|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
143015175|NCT04682639|515597366|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
143015176|NCT04682639|515597367|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
143015177|NCT04682639|515597368|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
143015178|NCT04682639|515597369|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
143015179|NCT04682639|515597370|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
143233384|NCT01972217|516406942|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
143233385|NCT01972217|516406939|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
143233386|NCT01972217|516406940|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
143233387|NCT01972217|516406941|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
143233388|NCT01972217|516406942|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
143233389|NCT01775501|516406947|FG000|Overall Study|Discontinued prior to treatment|1|||
143233390|NCT02318706|516406948|FG000|Double-blind Phase|Adverse Event|7|||
143233391|NCT02318706|516406949|FG001|Double-blind Phase|Adverse Event|4|||
143233392|NCT02318706|516406950|FG002|Double-blind Phase|Adverse Event|3|||
143233393|NCT02318706|516406951|FG003|Double-blind Phase|Adverse Event|10|||
143233394|NCT02318706|516406952|FG004|Double-blind Phase|Adverse Event|0|||
143233395|NCT02318706|516406948|FG000|Double-blind Phase|Lost to Follow-up|1|||
143233396|NCT02318706|516406949|FG001|Double-blind Phase|Lost to Follow-up|0|||
143233397|NCT02318706|516406950|FG002|Double-blind Phase|Lost to Follow-up|0|||
143233398|NCT02318706|516406951|FG003|Double-blind Phase|Lost to Follow-up|0|||
143233399|NCT02318706|516406952|FG004|Double-blind Phase|Lost to Follow-up|0|||
143233400|NCT02318706|516406948|FG000|Double-blind Phase|Protocol Violation|4|||
143233401|NCT02318706|516406949|FG001|Double-blind Phase|Protocol Violation|2|||
143233402|NCT02318706|516406950|FG002|Double-blind Phase|Protocol Violation|4|||
143233403|NCT02318706|516406951|FG003|Double-blind Phase|Protocol Violation|3|||
143233404|NCT02318706|516406952|FG004|Double-blind Phase|Protocol Violation|0|||
143233405|NCT02318706|516406948|FG000|Double-blind Phase|Withdrawal by Subject|9|||
143233406|NCT02318706|516406949|FG001|Double-blind Phase|Withdrawal by Subject|5|||
143233407|NCT02318706|516406950|FG002|Double-blind Phase|Withdrawal by Subject|7|||
143233408|NCT02318706|516406951|FG003|Double-blind Phase|Withdrawal by Subject|10|||
143233409|NCT02318706|516406952|FG004|Double-blind Phase|Withdrawal by Subject|0|||
143233410|NCT02318706|516406948|FG000|Double-blind Phase|Other|4|||
143233411|NCT02318706|516406949|FG001|Double-blind Phase|Other|1|||
143233412|NCT02318706|516406950|FG002|Double-blind Phase|Other|2|||
143233413|NCT02318706|516406951|FG003|Double-blind Phase|Other|1|||
143233414|NCT02318706|516406952|FG004|Double-blind Phase|Other|0|||
143233415|NCT02318706|516406948|FG000|Double-blind Phase|Death|0|||
143233416|NCT02318706|516406949|FG001|Double-blind Phase|Death|0|||
143150764|NCT05643794|516097600|FG001|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
143150765|NCT05643794|516097601|FG002|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
143150766|NCT05643794|516097599|FG000|Treatment Period 2 (12 Weeks)|New Work Commitments|1|||
143150767|NCT05643794|516097600|FG001|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
143150768|NCT05643794|516097601|FG002|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
143150769|NCT04167670|516097604|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
143150770|NCT04167670|516097605|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
143150771|NCT04167670|516097606|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
143150772|NCT04167670|516097604|FG000|Overall Study|Significant protocol deviation|3|||
143150773|NCT04167670|516097605|FG001|Overall Study|Significant protocol deviation|1|||
143150774|NCT04167670|516097606|FG002|Overall Study|Significant protocol deviation|0|||
143150775|NCT04167670|516097604|FG000|Overall Study|Lost to Follow-up|0|||
143150776|NCT04167670|516097605|FG001|Overall Study|Lost to Follow-up|3|||
143150777|NCT04167670|516097606|FG002|Overall Study|Lost to Follow-up|3|||
143150778|NCT04167670|516097604|FG000|Overall Study|Voluntary Withdrawal|0|||
143150779|NCT04167670|516097605|FG001|Overall Study|Voluntary Withdrawal|1|||
143150780|NCT04167670|516097606|FG002|Overall Study|Voluntary Withdrawal|1|||
143150781|NCT04167670|516097604|FG000|Overall Study|Withdrawal of Consent|4|||
143150782|NCT04167670|516097605|FG001|Overall Study|Withdrawal of Consent|1|||
143150783|NCT04167670|516097606|FG002|Overall Study|Withdrawal of Consent|3|||
143150784|NCT04167670|516097604|FG000|Overall Study|Miscellaneous|7|||
143150785|NCT04167670|516097605|FG001|Overall Study|Miscellaneous|5|||
143150786|NCT04167670|516097606|FG002|Overall Study|Miscellaneous|3|||
143150787|NCT01127061|516097609|FG000|Overall Study|Lost to Follow-up|7|||
143150788|NCT01127061|516097610|FG001|Overall Study|Lost to Follow-up|10|||
143150789|NCT01127061|516097609|FG000|Overall Study|Physician Decision|3|||
143150790|NCT01127061|516097610|FG001|Overall Study|Physician Decision|3|||
143150791|NCT04827446|516097611|FG000|Overall Study|Lost to Follow-up|1|||
143150792|NCT04827446|516097612|FG001|Overall Study|Lost to Follow-up|1|||
143150793|NCT04827446|516097611|FG000|Overall Study|Death|2|||
143150794|NCT04827446|516097612|FG001|Overall Study|Death|0|||
143150795|NCT04827446|516097611|FG000|Overall Study|Withdrawal by Subject|2|||
143150796|NCT04827446|516097612|FG001|Overall Study|Withdrawal by Subject|2|||
143150797|NCT01363076|516097615|FG000|Overall Study|Withdrawal by Subject|0|||
143233417|NCT02318706|516406950|FG002|Double-blind Phase|Death|2|||
143233418|NCT02318706|516406951|FG003|Double-blind Phase|Death|0|||
143233419|NCT02318706|516406952|FG004|Double-blind Phase|Death|0|||
143233420|NCT02318706|516406948|FG000|Open-label Extension Phase|Adverse Event|0|||
143233421|NCT02318706|516406949|FG001|Open-label Extension Phase|Adverse Event|0|||
143233422|NCT02318706|516406950|FG002|Open-label Extension Phase|Adverse Event|0|||
143150798|NCT01363076|516097616|FG001|Overall Study|Withdrawal by Subject|1|||
143150799|NCT01112267|516097617|FG000|Overall Study|Adverse Event|24|||
143233423|NCT02318706|516406951|FG003|Open-label Extension Phase|Adverse Event|0|||
143233424|NCT02318706|516406952|FG004|Open-label Extension Phase|Adverse Event|21|||
143233425|NCT02318706|516406948|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
143150800|NCT01112267|516097618|FG001|Overall Study|Adverse Event|6|||
143150801|NCT01112267|516097617|FG000|Overall Study|Withdrawal by Subject|3|||
143150802|NCT01112267|516097618|FG001|Overall Study|Withdrawal by Subject|5|||
143233426|NCT02318706|516406949|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
143233427|NCT02318706|516406950|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
143233428|NCT02318706|516406951|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
143233429|NCT02318706|516406952|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
143233430|NCT02318706|516406948|FG000|Open-label Extension Phase|Death|0|||
143233431|NCT02318706|516406949|FG001|Open-label Extension Phase|Death|0|||
143233432|NCT02318706|516406950|FG002|Open-label Extension Phase|Death|0|||
143233433|NCT02318706|516406951|FG003|Open-label Extension Phase|Death|0|||
143233434|NCT02318706|516406952|FG004|Open-label Extension Phase|Death|1|||
143233435|NCT02318706|516406948|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
143233436|NCT02318706|516406949|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
143233437|NCT02318706|516406950|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
143233438|NCT02318706|516406951|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
143233439|NCT02318706|516406952|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
143233440|NCT01456039|516406953|FG000|Phase 1 (First Step)|Disease Progression|1|||
143233441|NCT01456039|516406954|FG001|Phase 1 (First Step)|Disease Progression|1|||
143233442|NCT01456039|516406955|FG002|Phase 1 (First Step)|Disease Progression|0|||
143233443|NCT01456039|516406953|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
143150803|NCT01112267|516097617|FG000|Overall Study|Protocol Violation|5|||
143150804|NCT01112267|516097618|FG001|Overall Study|Protocol Violation|3|||
143150805|NCT01112267|516097617|FG000|Overall Study|Participants not compliant|1|||
143150806|NCT01112267|516097618|FG001|Overall Study|Participants not compliant|2|||
143150807|NCT01112267|516097617|FG000|Overall Study|Participants not receive any study drug|1|||
143150808|NCT01112267|516097618|FG001|Overall Study|Participants not receive any study drug|2|||
143150809|NCT00003456|516097619|FG000|Overall Study|Not evaluable|8|||
143150810|NCT00420407|516097621|FG000|Overall Study|Lost to Follow-up|0|||
143150811|NCT00420407|516097622|FG001|Overall Study|Lost to Follow-up|3|||
143150812|NCT00420407|516097621|FG000|Overall Study|Physician Decision|2|||
143150813|NCT00420407|516097622|FG001|Overall Study|Physician Decision|1|||
143150814|NCT00420407|516097621|FG000|Overall Study|subject identified as detainee|1|||
143150815|NCT00420407|516097622|FG001|Overall Study|subject identified as detainee|0|||
143150816|NCT00420407|516097621|FG000|Overall Study|subject identified as Jehovah's witness|1|||
143150817|NCT00420407|516097622|FG001|Overall Study|subject identified as Jehovah's witness|0|||
143150818|NCT00420407|516097621|FG000|Overall Study|Withdrawal by Subject|0|||
143150819|NCT00420407|516097622|FG001|Overall Study|Withdrawal by Subject|2|||
143150820|NCT03641924|516097623|FG000|Overall Study|Withdrawal by Subject|26|||
143150821|NCT03641924|516097623|FG000|Overall Study|Lost to Follow-up|16|||
143150822|NCT03641924|516097623|FG000|Overall Study|Protocol Violation|10|||
143150823|NCT04333498|516097624|FG000|Overall Study|Lost to Follow-up|1|||
143150824|NCT04333498|516097625|FG001|Overall Study|Lost to Follow-up|0|||
143150825|NCT04333498|516097624|FG000|Overall Study|Lost to Follow-up|0|||
143150826|NCT04333498|516097625|FG001|Overall Study|Lost to Follow-up|1|||
143150827|NCT01565694|516097626|FG000|Dose-Titration Period|Adverse Event|4|||
143150828|NCT01565694|516097626|FG000|Dose-Titration Period|Protocol Violation|10|||
143150829|NCT01565694|516097626|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
143150830|NCT00479232|516097628|FG000|Overall Study|Adverse Event|0|||
143150831|NCT00479232|516097629|FG001|Overall Study|Adverse Event|0|||
143150832|NCT00479232|516097630|FG002|Overall Study|Adverse Event|5|||
143150833|NCT00479232|516097631|FG003|Overall Study|Adverse Event|0|||
143150834|NCT00479232|516097632|FG004|Overall Study|Adverse Event|0|||
143150835|NCT00479232|516097633|FG005|Overall Study|Adverse Event|10|||
143150836|NCT00479232|516097628|FG000|Overall Study|Deviation from Protocol|0|||
143150837|NCT00479232|516097629|FG001|Overall Study|Deviation from Protocol|0|||
143150838|NCT00479232|516097630|FG002|Overall Study|Deviation from Protocol|1|||
143150839|NCT00479232|516097631|FG003|Overall Study|Deviation from Protocol|0|||
143150840|NCT00479232|516097632|FG004|Overall Study|Deviation from Protocol|0|||
143150841|NCT00479232|516097633|FG005|Overall Study|Deviation from Protocol|0|||
143150842|NCT00479232|516097628|FG000|Overall Study|Lack of Efficacy|0|||
143150843|NCT00479232|516097629|FG001|Overall Study|Lack of Efficacy|0|||
143233444|NCT01456039|516406954|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
143233445|NCT01456039|516406955|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
143150844|NCT00479232|516097630|FG002|Overall Study|Lack of Efficacy|2|||
143233446|NCT01456039|516406953|FG000|Phase 1 (First Step)|Adverse Event|0|||
143233447|NCT01456039|516406954|FG001|Phase 1 (First Step)|Adverse Event|3|||
143363645|NCT00062868|516873799|FG019|Dose Level 2|Lost to Follow-up|0|||
143150845|NCT00479232|516097631|FG003|Overall Study|Lack of Efficacy|0|||
143150846|NCT00479232|516097632|FG004|Overall Study|Lack of Efficacy|0|||
143150847|NCT00479232|516097633|FG005|Overall Study|Lack of Efficacy|4|||
143150848|NCT00479232|516097628|FG000|Overall Study|Physician Decision|0|||
143150849|NCT00479232|516097629|FG001|Overall Study|Physician Decision|0|||
143150850|NCT00479232|516097630|FG002|Overall Study|Physician Decision|2|||
143150851|NCT00479232|516097631|FG003|Overall Study|Physician Decision|0|||
143150852|NCT00479232|516097632|FG004|Overall Study|Physician Decision|0|||
143150853|NCT00479232|516097633|FG005|Overall Study|Physician Decision|1|||
143150854|NCT00479232|516097628|FG000|Overall Study|Progressive Disease|3|||
143150855|NCT00479232|516097629|FG001|Overall Study|Progressive Disease|1|||
143150856|NCT00479232|516097630|FG002|Overall Study|Progressive Disease|12|||
143150857|NCT00479232|516097631|FG003|Overall Study|Progressive Disease|3|||
143150858|NCT00479232|516097632|FG004|Overall Study|Progressive Disease|3|||
143150859|NCT00479232|516097633|FG005|Overall Study|Progressive Disease|12|||
143150860|NCT00479232|516097628|FG000|Overall Study|Withdrew Consent|0|||
143150861|NCT00479232|516097629|FG001|Overall Study|Withdrew Consent|2|||
143150862|NCT00479232|516097630|FG002|Overall Study|Withdrew Consent|6|||
143150863|NCT00479232|516097631|FG003|Overall Study|Withdrew Consent|0|||
143150864|NCT00479232|516097632|FG004|Overall Study|Withdrew Consent|1|||
143150865|NCT00479232|516097633|FG005|Overall Study|Withdrew Consent|3|||
143150866|NCT05399771|516097634|FG000|Overall Study|Physician Decision|3|||
143150867|NCT05399771|516097634|FG000|Overall Study|Adverse Event|1|||
143150868|NCT01373229|516097635|FG000|Overall Study|Death|3|||
143150869|NCT01373229|516097635|FG000|Overall Study|Physician Decision|3|||
143150870|NCT01047501|516097636|FG000|Overall Study|Adverse Event|7|||
143150871|NCT01047501|516097637|FG001|Overall Study|Adverse Event|8|||
143150872|NCT01047501|516097638|FG002|Overall Study|Adverse Event|5|||
143150873|NCT01047501|516097636|FG000|Overall Study|Withdrew Consent|6|||
143150874|NCT01047501|516097637|FG001|Overall Study|Withdrew Consent|2|||
143150875|NCT01047501|516097638|FG002|Overall Study|Withdrew Consent|4|||
143150876|NCT01047501|516097636|FG000|Overall Study|Lost to Follow-up|0|||
143150877|NCT01047501|516097637|FG001|Overall Study|Lost to Follow-up|1|||
143150878|NCT01047501|516097638|FG002|Overall Study|Lost to Follow-up|1|||
143150879|NCT01047501|516097636|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
143150880|NCT01047501|516097637|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
143150881|NCT01047501|516097638|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
143150882|NCT01047501|516097636|FG000|Overall Study|Death|1|||
143233448|NCT01456039|516406955|FG002|Phase 1 (First Step)|Adverse Event|0|||
143233449|NCT01456039|516406953|FG000|Phase 1 (First Step)|Other|0|||
143233450|NCT01456039|516406954|FG001|Phase 1 (First Step)|Other|1|||
143484625|NCT01049035|517320937|FG005|Overall Study|Non-compliance with the protocol|4|||
143484626|NCT01049035|517320938|FG006|Overall Study|Non-compliance with the protocol|10|||
143484627|NCT01049035|517320932|FG000|Overall Study|Lost to Follow-up|5|||
143150883|NCT01047501|516097637|FG001|Overall Study|Death|0|||
143150884|NCT01047501|516097638|FG002|Overall Study|Death|0|||
143150885|NCT01047501|516097636|FG000|Overall Study|Other discontinuation|1|||
143150886|NCT01047501|516097637|FG001|Overall Study|Other discontinuation|0|||
143150887|NCT01047501|516097638|FG002|Overall Study|Other discontinuation|1|||
143150888|NCT01047501|516097636|FG000|Overall Study|Investigator judgement|0|||
143150889|NCT01047501|516097637|FG001|Overall Study|Investigator judgement|0|||
143150890|NCT01047501|516097638|FG002|Overall Study|Investigator judgement|1|||
143150891|NCT04602000|516097639|FG000|Overall Study|Withdrawal by Subject|3|||
143150892|NCT04602000|516097640|FG001|Overall Study|Withdrawal by Subject|6|||
143150893|NCT04602000|516097641|FG002|Overall Study|Withdrawal by Subject|3|||
143150894|NCT04602000|516097642|FG003|Overall Study|Withdrawal by Subject|27|||
143150895|NCT04602000|516097643|FG004|Overall Study|Withdrawal by Subject|39|||
143150896|NCT04602000|516097639|FG000|Overall Study|Physician Decision|1|||
143150897|NCT04602000|516097640|FG001|Overall Study|Physician Decision|0|||
143150898|NCT04602000|516097641|FG002|Overall Study|Physician Decision|0|||
143150899|NCT04602000|516097642|FG003|Overall Study|Physician Decision|2|||
143150900|NCT04602000|516097643|FG004|Overall Study|Physician Decision|2|||
143150901|NCT04602000|516097639|FG000|Overall Study|Death|0|||
143150902|NCT04602000|516097640|FG001|Overall Study|Death|1|||
143150903|NCT04602000|516097641|FG002|Overall Study|Death|0|||
143150904|NCT04602000|516097642|FG003|Overall Study|Death|1|||
143150905|NCT04602000|516097643|FG004|Overall Study|Death|2|||
143150906|NCT04602000|516097639|FG000|Overall Study|Lost to Follow-up|0|||
143150907|NCT04602000|516097640|FG001|Overall Study|Lost to Follow-up|0|||
143150908|NCT04602000|516097641|FG002|Overall Study|Lost to Follow-up|0|||
143150909|NCT04602000|516097642|FG003|Overall Study|Lost to Follow-up|3|||
143150910|NCT04602000|516097643|FG004|Overall Study|Lost to Follow-up|4|||
143233451|NCT01456039|516406955|FG002|Phase 1 (First Step)|Other|0|||
143233452|NCT01456039|516406953|FG000|Phase 2 (Second Step)|Disease Progression|0|||
143233453|NCT01456039|516406954|FG001|Phase 2 (Second Step)|Disease Progression|0|||
143150911|NCT04602000|516097639|FG000|Overall Study|Other|4|||
143150912|NCT04602000|516097640|FG001|Overall Study|Other|1|||
143150913|NCT04602000|516097641|FG002|Overall Study|Other|2|||
143150914|NCT04602000|516097642|FG003|Overall Study|Other|5|||
143150915|NCT04602000|516097643|FG004|Overall Study|Other|4|||
143233454|NCT01456039|516406955|FG002|Phase 2 (Second Step)|Disease Progression|17|||
143484628|NCT01049035|517320933|FG001|Overall Study|Lost to Follow-up|4|||
143150916|NCT04602000|516097639|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
143150917|NCT04602000|516097640|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
143150918|NCT04602000|516097641|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
143150919|NCT04602000|516097642|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
143150920|NCT04602000|516097643|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
143150921|NCT05607043|516097644|FG000|Overall Study|Lost to Follow-up|2|||
143150922|NCT00429299|516097650|FG000|Overall Study|Disease Progression|1|||
143150923|NCT00429299|516097651|FG001|Overall Study|Disease Progression|1|||
143150924|NCT00429299|516097652|FG002|Overall Study|Disease Progression|0|||
143150925|NCT00429299|516097650|FG000|Overall Study|Adverse Event|2|||
143150926|NCT00429299|516097651|FG001|Overall Study|Adverse Event|5|||
143150927|NCT00429299|516097652|FG002|Overall Study|Adverse Event|1|||
143150928|NCT00429299|516097650|FG000|Overall Study|Protocol Violation|1|||
143150929|NCT00429299|516097651|FG001|Overall Study|Protocol Violation|0|||
143150930|NCT00429299|516097652|FG002|Overall Study|Protocol Violation|0|||
143150931|NCT00429299|516097650|FG000|Overall Study|Withdrawal by Subject|0|||
143150932|NCT00429299|516097651|FG001|Overall Study|Withdrawal by Subject|1|||
143150933|NCT00429299|516097652|FG002|Overall Study|Withdrawal by Subject|3|||
143150934|NCT01510756|516097653|FG000|Overall Study|Death|1|||
143150935|NCT01510756|516097653|FG000|Overall Study|Lack of Efficacy|2|||
143150936|NCT01510756|516097653|FG000|Overall Study|Physician Decision|1|||
143150937|NCT01922011|516097654|FG000|Overall Study|Protocol Violation|0|||
143150938|NCT01922011|516097655|FG001|Overall Study|Protocol Violation|1|||
143150939|NCT01922011|516097654|FG000|Overall Study|Physician Decision|0|||
143150940|NCT01922011|516097655|FG001|Overall Study|Physician Decision|1|||
143150941|NCT01922011|516097654|FG000|Overall Study|Parent/Guardian Decision|3|||
143150942|NCT01922011|516097655|FG001|Overall Study|Parent/Guardian Decision|0|||
143150943|NCT01922011|516097654|FG000|Overall Study|Lost to Follow-up|0|||
143150944|NCT01922011|516097655|FG001|Overall Study|Lost to Follow-up|1|||
143150945|NCT01922011|516097654|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
143150946|NCT01922011|516097655|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
143150947|NCT01922011|516097654|FG000|Overall Study|Not Treated|1|||
143150948|NCT01922011|516097655|FG001|Overall Study|Not Treated|0|||
143150949|NCT01922011|516097654|FG000|Overall Study|Lack of willing home health agency|1|||
143150950|NCT01922011|516097655|FG001|Overall Study|Lack of willing home health agency|0|||
143150951|NCT01922011|516097654|FG000|Overall Study|Randomized in error|1|||
143150952|NCT01922011|516097655|FG001|Overall Study|Randomized in error|0|||
143150953|NCT04871113|516097656|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
143150954|NCT04871113|516097657|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
143150955|NCT04871113|516097658|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
143150956|NCT04871113|516097659|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
143150957|NCT04871113|516097660|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
143150958|NCT04871113|516097661|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
143150959|NCT04871113|516097662|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
143150960|NCT04871113|516097663|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
143150961|NCT04871113|516097664|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
143150962|NCT04871113|516097665|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
143150963|NCT04871113|516097656|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
143150964|NCT04871113|516097657|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
143150965|NCT04871113|516097658|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
143150966|NCT04871113|516097659|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
143150967|NCT04871113|516097660|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
143150968|NCT04871113|516097661|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
143150969|NCT04871113|516097662|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
143150970|NCT04871113|516097663|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
143150971|NCT04871113|516097664|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
143150972|NCT04871113|516097665|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
143150973|NCT02447029|516097666|FG000|Overall Study|Withdrawal by Subject|3|||
143150974|NCT02447029|516097667|FG001|Overall Study|Withdrawal by Subject|2|||
143150975|NCT01239745|516097668|FG000|Overall Study|Study terminated by sponsor|45|||
143150976|NCT01239745|516097668|FG000|Overall Study|Adverse Event|1|||
143150977|NCT00549328|516097670|FG000|Overall Study|Adverse Event|2|||
143150978|NCT00549328|516097670|FG000|Overall Study|Disease Progression|10|||
143150979|NCT00549328|516097670|FG000|Overall Study|Death|1|||
143150980|NCT00549328|516097670|FG000|Overall Study|Use of Prohibited Medication|1|||
143150981|NCT01946802|516097675|FG000|Overall Study|Death|1|||
143150982|NCT01946802|516097675|FG000|Overall Study|Withdrawal by Subject|2|||
143150983|NCT01946802|516097675|FG000|Overall Study|Combined septic shock|1|||
143150984|NCT01946802|516097675|FG000|Overall Study|Protocol Violation|1|||
143150985|NCT03384966|516097679|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
143150986|NCT03384966|516097680|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
143363646|NCT00062868|516873800|FG020|Dose Level 2|Lost to Follow-up|0|||
143150987|NCT03384966|516097681|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
143150988|NCT03384966|516097679|FG000|Follow-up Period|Adverse Event|1|||
143150989|NCT03384966|516097680|FG001|Follow-up Period|Adverse Event|0|||
143150990|NCT03384966|516097681|FG002|Follow-up Period|Adverse Event|0|||
143150991|NCT04327271|516097682|FG000|Overall Study|Death|1|||
143150992|NCT04327271|516097683|FG001|Overall Study|Death|0|||
143150993|NCT04327271|516097682|FG000|Overall Study|Withdrawal by Subject|1|||
143150994|NCT04327271|516097683|FG001|Overall Study|Withdrawal by Subject|0|||
143150995|NCT04327271|516097682|FG000|Overall Study|randomization error (data capture)|4|||
143150996|NCT04327271|516097683|FG001|Overall Study|randomization error (data capture)|3|||
143150997|NCT01479530|516097686|FG000|Overall Study|Adverse Event|5|||
143150998|NCT01479530|516097687|FG001|Overall Study|Adverse Event|6|||
143150999|NCT01479530|516097686|FG000|Overall Study|Lack of Efficacy|0|||
143151000|NCT01479530|516097687|FG001|Overall Study|Lack of Efficacy|1|||
143151001|NCT01479530|516097686|FG000|Overall Study|Protocol Violation|2|||
143151002|NCT01479530|516097687|FG001|Overall Study|Protocol Violation|3|||
143151003|NCT01479530|516097686|FG000|Overall Study|Withdrawal of Consent|3|||
143151004|NCT01479530|516097687|FG001|Overall Study|Withdrawal of Consent|2|||
143151005|NCT04795323|516097688|FG000|Overall Study|Did not interact with TARA|1|||
143151006|NCT04795323|516097689|FG001|Overall Study|Did not interact with TARA|0|||
143151007|NCT00303628|516097692|FG000|Overall Study|Disease progression|0|||
143151008|NCT00303628|516097693|FG001|Overall Study|Disease progression|1|||
143151009|NCT00303628|516097692|FG000|Overall Study|Adverse Event|26|||
143151010|NCT00303628|516097693|FG001|Overall Study|Adverse Event|36|||
143151011|NCT00303628|516097692|FG000|Overall Study|Death|0|||
143151012|NCT00303628|516097693|FG001|Overall Study|Death|1|||
143151013|NCT00303628|516097692|FG000|Overall Study|Withdrawal by Subject|11|||
143151014|NCT00303628|516097693|FG001|Overall Study|Withdrawal by Subject|20|||
143151015|NCT00303628|516097692|FG000|Overall Study|Alternative therapy|2|||
143151016|NCT00303628|516097693|FG001|Overall Study|Alternative therapy|0|||
143151017|NCT00303628|516097692|FG000|Overall Study|Other complicating disease|0|||
143151018|NCT00303628|516097693|FG001|Overall Study|Other complicating disease|1|||
143151019|NCT00303628|516097692|FG000|Overall Study|Not start protocol therapy|3|||
143151020|NCT00303628|516097693|FG001|Overall Study|Not start protocol therapy|5|||
143151021|NCT00303628|516097692|FG000|Overall Study|Other|8|||
143151022|NCT00303628|516097693|FG001|Overall Study|Other|9|||
143151023|NCT00376506|516097694|FG000|Overall Study|Death|0|||
143151024|NCT00376506|516097695|FG001|Overall Study|Death|2|||
143151025|NCT04925934|516097696|FG000|Overall Study|Adverse Event|1|||
143151026|NCT04925934|516097697|FG001|Overall Study|Adverse Event|0|||
143151027|NCT04925934|516097698|FG002|Overall Study|Adverse Event|0|||
143151028|NCT04925934|516097696|FG000|Overall Study|Lost to Follow-up|2|||
143151029|NCT04925934|516097697|FG001|Overall Study|Lost to Follow-up|0|||
143151030|NCT04925934|516097698|FG002|Overall Study|Lost to Follow-up|1|||
143151031|NCT04925934|516097696|FG000|Overall Study|Death|0|||
143151032|NCT04925934|516097697|FG001|Overall Study|Death|1|||
143151033|NCT04925934|516097698|FG002|Overall Study|Death|0|||
143151034|NCT04925934|516097696|FG000|Overall Study|Withdrawal by Subject|8|||
143151035|NCT04925934|516097697|FG001|Overall Study|Withdrawal by Subject|5|||
143151036|NCT04925934|516097698|FG002|Overall Study|Withdrawal by Subject|9|||
143151037|NCT04925934|516097696|FG000|Overall Study|Other|2|||
143151038|NCT04925934|516097697|FG001|Overall Study|Other|2|||
143151039|NCT04925934|516097698|FG002|Overall Study|Other|2|||
143151040|NCT04925934|516097696|FG000|Overall Study|Eastern European Conflict|7|||
143151041|NCT04925934|516097697|FG001|Overall Study|Eastern European Conflict|3|||
143151042|NCT04925934|516097698|FG002|Overall Study|Eastern European Conflict|2|||
143151043|NCT02948400|516097703|FG000|Overall Study|Withdrawal by Subject|17|||
143151044|NCT02948400|516097704|FG001|Overall Study|Withdrawal by Subject|10|||
143151045|NCT02948400|516097703|FG000|Overall Study|failed to attend appointments|47|||
143151046|NCT02948400|516097704|FG001|Overall Study|failed to attend appointments|34|||
143151047|NCT02948400|516097703|FG000|Overall Study|COVID-related closure|6|||
143151048|NCT02948400|516097704|FG001|Overall Study|COVID-related closure|2|||
143151049|NCT02948400|516097703|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
143151050|NCT02948400|516097704|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
143151051|NCT02948400|516097703|FG000|Overall Study|motion sickness in virtual reality|2|||
143151052|NCT02948400|516097704|FG001|Overall Study|motion sickness in virtual reality|0|||
143151053|NCT01716156|516097705|FG000|Overall Study|Protocol Violation|1|||
143151054|NCT01716156|516097706|FG001|Overall Study|Protocol Violation|0|||
143151055|NCT01716156|516097707|FG002|Overall Study|Protocol Violation|0|||
143151056|NCT01716156|516097705|FG000|Overall Study|Withdrawal by Subject|0|||
143151057|NCT01716156|516097706|FG001|Overall Study|Withdrawal by Subject|1|||
143151058|NCT01716156|516097707|FG002|Overall Study|Withdrawal by Subject|2|||
143151059|NCT01716156|516097705|FG000|Overall Study|Lost to Follow-up|1|||
143151060|NCT01716156|516097706|FG001|Overall Study|Lost to Follow-up|0|||
143151061|NCT01716156|516097707|FG002|Overall Study|Lost to Follow-up|0|||
143151062|NCT01132755|516097710|FG000|Overall Study|Procedure not done due to medical reason|23|||
143151063|NCT01132755|516097710|FG000|Overall Study|Protocol Violation|15|||
143151064|NCT01132755|516097710|FG000|Overall Study|Withdrawal by Subject|4|||
143151065|NCT02393755|516097711|FG000|Overall Study|Withdrawal by Subject|0|||
143151066|NCT02393755|516097712|FG001|Overall Study|Withdrawal by Subject|3|||
143151067|NCT02393755|516097711|FG000|Overall Study|Adverse Event|0|||
143151068|NCT02393755|516097712|FG001|Overall Study|Adverse Event|2|||
143151069|NCT02393755|516097711|FG000|Overall Study|Physician Decision|0|||
143151070|NCT02393755|516097712|FG001|Overall Study|Physician Decision|2|||
143151071|NCT02949934|516097713|FG000|Natural Drinking Period|Adverse Event|1|||
143233455|NCT01456039|516406953|FG000|Phase 2 (Second Step)|Adverse Event|0|||
143233456|NCT01456039|516406954|FG001|Phase 2 (Second Step)|Adverse Event|0|||
143233457|NCT01456039|516406955|FG002|Phase 2 (Second Step)|Adverse Event|10|||
143233458|NCT01456039|516406953|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
143233459|NCT01456039|516406954|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
143233460|NCT01456039|516406955|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
143233461|NCT01456039|516406953|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
143233462|NCT01456039|516406954|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
143233463|NCT01456039|516406955|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
143233464|NCT01456039|516406953|FG000|Phase 2 (Second Step)|Other|0|||
143233465|NCT01456039|516406954|FG001|Phase 2 (Second Step)|Other|0|||
143233466|NCT01456039|516406955|FG002|Phase 2 (Second Step)|Other|1|||
143233467|NCT00335777|516406958|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
143233468|NCT00335777|516406958|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
143233469|NCT00335777|516406958|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
143233470|NCT00335777|516406958|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
143233471|NCT00335777|516406958|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
143233472|NCT04106557|516406962|FG000|Overall Study|Physician Decision|0|||
143233473|NCT04106557|516406963|FG001|Overall Study|Physician Decision|1|||
143233474|NCT04106557|516406964|FG002|Overall Study|Physician Decision|0|||
143233475|NCT04106557|516406962|FG000|Overall Study|Protocol Violation|0|||
143151072|NCT02949934|516097714|FG001|Natural Drinking Period|Adverse Event|0|||
143151073|NCT02949934|516097715|FG002|Natural Drinking Period|Adverse Event|0|||
143151074|NCT02949934|516097716|FG003|Natural Drinking Period|Adverse Event|1|||
143151075|NCT02949934|516097717|FG004|Natural Drinking Period|Adverse Event|0|||
143151076|NCT02949934|516097718|FG005|Natural Drinking Period|Adverse Event|0|||
143151077|NCT02949934|516097713|FG000|Natural Drinking Period|Lost to Follow-up|0|||
143151078|NCT02949934|516097714|FG001|Natural Drinking Period|Lost to Follow-up|0|||
143151079|NCT02949934|516097715|FG002|Natural Drinking Period|Lost to Follow-up|0|||
143151080|NCT02949934|516097716|FG003|Natural Drinking Period|Lost to Follow-up|0|||
143151081|NCT02949934|516097717|FG004|Natural Drinking Period|Lost to Follow-up|1|||
143151082|NCT02949934|516097718|FG005|Natural Drinking Period|Lost to Follow-up|0|||
143151083|NCT02949934|516097713|FG000|Neuroimaging|Protocol Violation|2|||
143151084|NCT02949934|516097714|FG001|Neuroimaging|Protocol Violation|0|||
143151085|NCT02949934|516097715|FG002|Neuroimaging|Protocol Violation|0|||
143151086|NCT02949934|516097716|FG003|Neuroimaging|Protocol Violation|0|||
143151087|NCT02949934|516097717|FG004|Neuroimaging|Protocol Violation|1|||
143151088|NCT02949934|516097718|FG005|Neuroimaging|Protocol Violation|0|||
143151089|NCT02949934|516097713|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
143151090|NCT02949934|516097714|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
143151091|NCT02949934|516097715|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
143151092|NCT02949934|516097716|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
143151093|NCT02949934|516097717|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
143151094|NCT02949934|516097718|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
143151095|NCT02949934|516097713|FG000|Neuroimaging|Not scanned|0|||
143151096|NCT02949934|516097714|FG001|Neuroimaging|Not scanned|0|||
143151097|NCT02949934|516097715|FG002|Neuroimaging|Not scanned|1|||
143151098|NCT02949934|516097716|FG003|Neuroimaging|Not scanned|0|||
143151099|NCT02949934|516097717|FG004|Neuroimaging|Not scanned|0|||
143151100|NCT02949934|516097718|FG005|Neuroimaging|Not scanned|2|||
143151101|NCT02949934|516097713|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
143151102|NCT02949934|516097714|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
143151103|NCT02949934|516097715|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
143151104|NCT02949934|516097716|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
143151105|NCT02949934|516097717|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
143151106|NCT02949934|516097718|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
143151107|NCT02949934|516097713|FG000|Bar Laboratory|Adverse Event|1|||
143151108|NCT02949934|516097714|FG001|Bar Laboratory|Adverse Event|0|||
143151109|NCT02949934|516097715|FG002|Bar Laboratory|Adverse Event|2|||
143151110|NCT02949934|516097716|FG003|Bar Laboratory|Adverse Event|0|||
143151111|NCT02949934|516097717|FG004|Bar Laboratory|Adverse Event|1|||
143151112|NCT02949934|516097718|FG005|Bar Laboratory|Adverse Event|0|||
143151113|NCT02949934|516097713|FG000|Bar Laboratory|Protocol Violation|0|||
143151114|NCT02949934|516097714|FG001|Bar Laboratory|Protocol Violation|0|||
143151115|NCT02949934|516097715|FG002|Bar Laboratory|Protocol Violation|0|||
143151116|NCT02949934|516097716|FG003|Bar Laboratory|Protocol Violation|1|||
143151117|NCT02949934|516097717|FG004|Bar Laboratory|Protocol Violation|0|||
143151118|NCT02949934|516097718|FG005|Bar Laboratory|Protocol Violation|0|||
143151119|NCT04615507|516097719|FG000|Period 1|Covid-19 exposure|2|||
143151120|NCT04615507|516097720|FG001|Period 1|Covid-19 exposure|1|||
143151121|NCT04615507|516097719|FG000|Period 2|Covid-19 exposure|0|||
143151122|NCT04615507|516097720|FG001|Period 2|Covid-19 exposure|1|||
143151123|NCT04615507|516097719|FG000|Period 2|Protocol Violation|1|||
143151124|NCT04615507|516097720|FG001|Period 2|Protocol Violation|0|||
143151125|NCT04615507|516097719|FG000|Period 2|Withdrawal by Subject|1|||
143151126|NCT04615507|516097720|FG001|Period 2|Withdrawal by Subject|0|||
143151127|NCT04615507|516097719|FG000|Period 2|Adverse Event|0|||
143151128|NCT04615507|516097720|FG001|Period 2|Adverse Event|1|||
143151129|NCT04615507|516097719|FG000|Period 3|Covid-19 exposure|0|||
143151130|NCT04615507|516097720|FG001|Period 3|Covid-19 exposure|1|||
143151131|NCT04818112|516097723|FG000|Overall Study|Withdrawal by Subject|54|||
143151132|NCT04818112|516097724|FG001|Overall Study|Withdrawal by Subject|12|||
143151133|NCT04818112|516097723|FG000|Overall Study|Lost to Follow-up|38|||
143151134|NCT04818112|516097724|FG001|Overall Study|Lost to Follow-up|10|||
143151135|NCT03122106|516097726|FG000|Overall Study|Not enough tissue|1|||
143151136|NCT03122106|516097726|FG000|Overall Study|Disease progression during screening|2|||
143151137|NCT03122106|516097726|FG000|Overall Study|Poor RNA quality for vaccine|1|||
143151138|NCT00700635|516097727|FG000|Overall Study|Adverse Event|1|||
143151139|NCT00700635|516097728|FG001|Overall Study|Adverse Event|0|||
143151140|NCT00700635|516097729|FG002|Overall Study|Adverse Event|0|||
143151141|NCT00700635|516097727|FG000|Overall Study|Lost to Follow-up|1|||
143151142|NCT00700635|516097728|FG001|Overall Study|Lost to Follow-up|3|||
143151143|NCT00700635|516097729|FG002|Overall Study|Lost to Follow-up|0|||
143151144|NCT00700635|516097727|FG000|Overall Study|Protocol Violation|2|||
143151145|NCT00700635|516097728|FG001|Overall Study|Protocol Violation|2|||
143151146|NCT00700635|516097729|FG002|Overall Study|Protocol Violation|0|||
143151147|NCT00700635|516097727|FG000|Overall Study|Withdrawal by Subject|7|||
143151148|NCT00700635|516097728|FG001|Overall Study|Withdrawal by Subject|3|||
143151149|NCT00700635|516097729|FG002|Overall Study|Withdrawal by Subject|1|||
143151150|NCT03611946|516097732|FG000|Overall Study|Withdrawal by Subject|0|||
143151151|NCT03611946|516097733|FG001|Overall Study|Withdrawal by Subject|0|||
143151152|NCT03611946|516097734|FG002|Overall Study|Withdrawal by Subject|1|||
143151153|NCT03611946|516097735|FG003|Overall Study|Withdrawal by Subject|0|||
143151154|NCT00587457|516098681|FG000|Overall Study|Adverse Event|1|||
143151155|NCT00587457|516098682|FG001|Overall Study|Adverse Event|2|||
143151156|NCT00587457|516098683|FG002|Overall Study|Adverse Event|1|||
143151157|NCT00587457|516098681|FG000|Overall Study|Disease progression|2|||
143151158|NCT00587457|516098682|FG001|Overall Study|Disease progression|0|||
143151159|NCT00587457|516098683|FG002|Overall Study|Disease progression|2|||
143151160|NCT00587457|516098681|FG000|Overall Study|Initiation of alternative therapy|0|||
143151161|NCT00587457|516098682|FG001|Overall Study|Initiation of alternative therapy|1|||
143151162|NCT00587457|516098683|FG002|Overall Study|Initiation of alternative therapy|0|||
143151163|NCT00587457|516098681|FG000|Overall Study|Undefined|0|||
143151164|NCT00587457|516098682|FG001|Overall Study|Undefined|0|||
143151165|NCT00587457|516098683|FG002|Overall Study|Undefined|1|||
143151166|NCT00587457|516098681|FG000|Overall Study|Development of neutralizing Abs|0|||
143151167|NCT00587457|516098682|FG001|Overall Study|Development of neutralizing Abs|0|||
143151168|NCT00587457|516098683|FG002|Overall Study|Development of neutralizing Abs|1|||
143151169|NCT00541229|516098684|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
143151170|NCT00541229|516098685|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
143151171|NCT00541229|516098686|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
143151172|NCT00541229|516098687|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
143151173|NCT00541229|516098688|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
143151174|NCT00541229|516098689|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
143151175|NCT00541229|516098684|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
143151176|NCT00541229|516098685|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
143151177|NCT00541229|516098686|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
143151178|NCT00541229|516098687|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
143151179|NCT00541229|516098688|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
143151180|NCT00541229|516098689|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
143151181|NCT00541229|516098684|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
143151182|NCT00541229|516098685|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
143151183|NCT00541229|516098686|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
143151184|NCT00541229|516098687|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
143151185|NCT00541229|516098688|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
143151186|NCT00541229|516098689|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
143151187|NCT00541229|516098684|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
143151188|NCT00541229|516098685|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
143151189|NCT00541229|516098686|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
143151190|NCT00541229|516098687|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
143151191|NCT00541229|516098688|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
143151192|NCT00541229|516098689|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
143151193|NCT00541229|516098684|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
143151194|NCT00541229|516098685|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
143151195|NCT00541229|516098686|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
143151196|NCT00541229|516098687|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
143151197|NCT00541229|516098688|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
143151198|NCT00541229|516098689|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
143151199|NCT00541229|516098684|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
143151200|NCT00541229|516098685|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
143484629|NCT01049035|517320934|FG002|Overall Study|Lost to Follow-up|4|||
143484630|NCT01049035|517320935|FG003|Overall Study|Lost to Follow-up|1|||
143484631|NCT01049035|517320936|FG004|Overall Study|Lost to Follow-up|0|||
143484632|NCT01049035|517320937|FG005|Overall Study|Lost to Follow-up|3|||
143484633|NCT01049035|517320938|FG006|Overall Study|Lost to Follow-up|3|||
143484634|NCT01049035|517320932|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
143484635|NCT01049035|517320933|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
143484636|NCT01049035|517320934|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
143484637|NCT01049035|517320935|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
143484638|NCT01049035|517320936|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
143484639|NCT01049035|517320937|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
143484640|NCT01049035|517320938|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
143484641|NCT03927105|517320939|FG000|Overall Study|Death|1|||
143484642|NCT03927105|517320939|FG000|Overall Study|In observation for potential re-treatment|2|||
143484643|NCT03927105|517320939|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
143484644|NCT01135498|517320945|FG000|Overall Study|Adverse Event|20|||
143233476|NCT04106557|516406963|FG001|Overall Study|Protocol Violation|1|||
143233477|NCT04106557|516406964|FG002|Overall Study|Protocol Violation|0|||
143484645|NCT01135498|517320945|FG000|Overall Study|Progressive disease|38|||
143484646|NCT01135498|517320945|FG000|Overall Study|Investigator judgement|25|||
143484647|NCT01135498|517320945|FG000|Overall Study|Withdrawal by Subject|4|||
143484648|NCT01135498|517320945|FG000|Overall Study|Death|1|||
143484649|NCT01135498|517320945|FG000|Overall Study|Ongoing at time of analysis|2|||
143484650|NCT02145741|517320946|FG000|Overall Study|Progressive disease|3|||
143484651|NCT02145741|517320947|FG001|Overall Study|Progressive disease|6|||
143484652|NCT02145741|517320948|FG002|Overall Study|Progressive disease|6|||
143484653|NCT02145741|517320946|FG000|Overall Study|quality issue with the administered drug|3|||
143484654|NCT02145741|517320947|FG001|Overall Study|quality issue with the administered drug|0|||
143484655|NCT02145741|517320948|FG002|Overall Study|quality issue with the administered drug|0|||
143484656|NCT05634577|517320949|FG000|Overall Study|Lost to Follow-up|1|||
143233478|NCT02326155|516406965|FG000|Overall Study|Adverse Event|21|||
143233479|NCT02326155|516406966|FG001|Overall Study|Adverse Event|5|||
143233480|NCT02326155|516406965|FG000|Overall Study|Death|3|||
143233481|NCT02326155|516406966|FG001|Overall Study|Death|0|||
143233482|NCT02326155|516406965|FG000|Overall Study|Lack of Efficacy|49|||
143233483|NCT02326155|516406966|FG001|Overall Study|Lack of Efficacy|5|||
143233484|NCT02326155|516406965|FG000|Overall Study|Lost to Follow-up|14|||
143233485|NCT02326155|516406966|FG001|Overall Study|Lost to Follow-up|3|||
143233486|NCT02326155|516406965|FG000|Overall Study|Protocol Violation|2|||
143233487|NCT02326155|516406966|FG001|Overall Study|Protocol Violation|0|||
143484657|NCT05634577|517320949|FG000|Overall Study|Withdrawal by Subject|1|||
143484658|NCT01351389|517320950|FG000|Overall Study|Withdrawal by Subject|7|||
143484659|NCT01351389|517320951|FG001|Overall Study|Withdrawal by Subject|0|||
143484660|NCT01351389|517320950|FG000|Overall Study|did not complete intervention|23|||
143484661|NCT01351389|517320951|FG001|Overall Study|did not complete intervention|15|||
143484662|NCT04839978|517320952|FG000|Overall Study|Lost to Follow-up|135|||
143484663|NCT04839978|517320953|FG001|Overall Study|Lost to Follow-up|147|||
143484664|NCT02646982|517320954|FG000|Overall Study|Adverse Event|1|||
143484665|NCT02646982|517320955|FG001|Overall Study|Adverse Event|1|||
143484666|NCT02646982|517320954|FG000|Overall Study|Withdrawal by Subject|2|||
143484667|NCT02646982|517320955|FG001|Overall Study|Withdrawal by Subject|1|||
143484668|NCT00713700|517320956|FG000|Overall Study|Lost to Follow-up|3|||
143484669|NCT00713700|517320956|FG000|Overall Study|Withdrawal by Subject|1|||
143151201|NCT00541229|516098686|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
143151202|NCT00541229|516098687|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
143151203|NCT00541229|516098688|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
143151204|NCT00541229|516098689|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
143151205|NCT00541229|516098684|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
143151206|NCT00541229|516098685|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
143151207|NCT00541229|516098686|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
143151208|NCT00541229|516098687|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
143151209|NCT00541229|516098688|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
143151210|NCT00541229|516098689|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
143151211|NCT00541229|516098684|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
143233488|NCT02326155|516406965|FG000|Overall Study|Withdrawal by Subject|34|||
143233489|NCT02326155|516406966|FG001|Overall Study|Withdrawal by Subject|11|||
143233490|NCT02326155|516406965|FG000|Overall Study|Disease progression|37|||
143484670|NCT03551509|517320957|FG000|Overall Study|Lost to Follow-up|0|||
143484671|NCT03551509|517320958|FG001|Overall Study|Lost to Follow-up|1|||
143484672|NCT03551509|517320959|FG002|Overall Study|Lost to Follow-up|0|||
143484673|NCT02631200|517320962|FG000|First Period|Death|1|||
143484674|NCT02631200|517320963|FG001|First Period|Death|2|||
143233491|NCT02326155|516406966|FG001|Overall Study|Disease progression|4|||
143233492|NCT02326155|516406965|FG000|Overall Study|Study close|188|||
143233493|NCT02326155|516406966|FG001|Overall Study|Study close|21|||
143233494|NCT02326155|516406965|FG000|Overall Study|except for study close|46|||
143233495|NCT02326155|516406966|FG001|Overall Study|except for study close|13|||
143233496|NCT05024032|516406967|FG000|Overall Study|Withdrawal by Subject|0|||
143233497|NCT05024032|516406968|FG001|Overall Study|Withdrawal by Subject|3|||
143233498|NCT05024032|516406969|FG002|Overall Study|Withdrawal by Subject|4|||
143233499|NCT05024032|516406967|FG000|Overall Study|Adverse Event|0|||
143233500|NCT05024032|516406968|FG001|Overall Study|Adverse Event|1|||
143233501|NCT05024032|516406969|FG002|Overall Study|Adverse Event|0|||
143181202|NCT03654274|516210493|FG000|Overall Study|Lack of Efficacy|4|||
143181203|NCT03654274|516210494|FG001|Overall Study|Lack of Efficacy|5|||
143181204|NCT03654274|516210495|FG002|Overall Study|Lack of Efficacy|7|||
143181205|NCT03654274|516210493|FG000|Overall Study|Pregnancy|2|||
143181206|NCT03654274|516210494|FG001|Overall Study|Pregnancy|2|||
143181207|NCT03654274|516210495|FG002|Overall Study|Pregnancy|1|||
143181208|NCT03654274|516210493|FG000|Overall Study|Other|27|||
143181209|NCT03654274|516210494|FG001|Overall Study|Other|29|||
143181210|NCT03654274|516210495|FG002|Overall Study|Other|32|||
143181211|NCT03654274|516210493|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
143181212|NCT03654274|516210494|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
143181213|NCT03654274|516210495|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
143181214|NCT01265992|516210498|FG000|Overall Study|Lost to Follow-up|1|||
143181215|NCT01265992|516210498|FG000|Overall Study|Withdrawal by Subject|1|||
143181216|NCT01265992|516210498|FG000|Overall Study|Adverse Event|1|||
143181217|NCT01265992|516210498|FG000|Overall Study|Administrative reasons|2|||
143181218|NCT01265992|516210498|FG000|Overall Study|Stopped treatment|3|||
143181219|NCT01265992|516210498|FG000|Overall Study|Did not receive treatment|1|||
143181220|NCT01102491|516210499|FG000|Overall Study|Protocol Violation|11|||
143181221|NCT01102491|516210500|FG001|Overall Study|Protocol Violation|12|||
143181222|NCT02137070|516210501|FG000|Overall Study|Adverse Event|12|||
143181223|NCT02137070|516210502|FG001|Overall Study|Adverse Event|3|||
143181224|NCT02137070|516210501|FG000|Overall Study|Death|2|||
143181225|NCT02137070|516210502|FG001|Overall Study|Death|0|||
143181226|NCT02137070|516210501|FG000|Overall Study|Lost to Follow-up|24|||
143181227|NCT02137070|516210502|FG001|Overall Study|Lost to Follow-up|9|||
143181228|NCT02137070|516210501|FG000|Overall Study|Physician Decision|0|||
143181229|NCT02137070|516210502|FG001|Overall Study|Physician Decision|1|||
143181230|NCT02137070|516210501|FG000|Overall Study|Protocol Violation|18|||
143181231|NCT02137070|516210502|FG001|Overall Study|Protocol Violation|4|||
143181232|NCT02137070|516210501|FG000|Overall Study|Withdrawal by Subject|18|||
143181233|NCT02137070|516210502|FG001|Overall Study|Withdrawal by Subject|1|||
143181234|NCT03960684|516210503|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
143181235|NCT02151786|516210504|FG000|Overall Study|Unavailability of Case Report Form|26|||
143181236|NCT02151786|516210504|FG000|Overall Study|Outside the Contract Period|1|||
143181237|NCT02151786|516210504|FG000|Overall Study|Randomized, not Treated|1|||
143181238|NCT02151786|516210504|FG000|Overall Study|Unavailability of Information|8|||
143181239|NCT03533660|516210505|FG000|Overall Study|Withdrawal by Subject|2|||
143181240|NCT03533660|516210506|FG001|Overall Study|Withdrawal by Subject|2|||
143181241|NCT03533660|516210505|FG000|Overall Study|Death|2|||
143181242|NCT03533660|516210506|FG001|Overall Study|Death|4|||
143181243|NCT03533660|516210505|FG000|Overall Study|Adverse Event|0|||
143181244|NCT03533660|516210506|FG001|Overall Study|Adverse Event|2|||
143181245|NCT01444430|516210514|FG000|Overall Study|Withdrawal by Subject|53|||
143181246|NCT01444430|516210515|FG001|Overall Study|Withdrawal by Subject|72|||
143181247|NCT01444430|516210514|FG000|Overall Study|Death|6|||
143181248|NCT01444430|516210515|FG001|Overall Study|Death|8|||
143181249|NCT01444430|516210514|FG000|Overall Study|Lost to Follow-up|2|||
143181250|NCT01444430|516210515|FG001|Overall Study|Lost to Follow-up|0|||
143181251|NCT01444430|516210514|FG000|Overall Study|CRF termination module not completed.|0|||
143181252|NCT01444430|516210515|FG001|Overall Study|CRF termination module not completed.|1|||
143181253|NCT01273038|516211673|FG000|Second Intervention (14 Days)|Adverse Event|0|||
143181254|NCT01273038|516211674|FG001|Second Intervention (14 Days)|Adverse Event|1|||
143181255|NCT01273038|516211673|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
143181256|NCT01273038|516211674|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
143181257|NCT00175916|516211675|FG000|Overall Study|Death|19|||
143181258|NCT00175916|516211675|FG000|Overall Study|Adverse Event|81|||
143181259|NCT00175916|516211675|FG000|Overall Study|Lack of Efficacy|354|||
143181260|NCT00175916|516211675|FG000|Overall Study|Lost to Follow-up|17|||
143181261|NCT00175916|516211675|FG000|Overall Study|Subject Choice|98|||
143181262|NCT00175916|516211675|FG000|Overall Study|Lack of compliance|8|||
143181263|NCT00175916|516211675|FG000|Overall Study|Patient cannot record seizures|1|||
143181264|NCT00175916|516211675|FG000|Overall Study|Sponsor decision|17|||
143181265|NCT00175916|516211675|FG000|Overall Study|Vigabatrin intake|1|||
143233502|NCT05024032|516406967|FG000|Overall Study|Protocol Deviation|1|||
143233503|NCT05024032|516406968|FG001|Overall Study|Protocol Deviation|0|||
143233504|NCT05024032|516406969|FG002|Overall Study|Protocol Deviation|0|||
143233505|NCT01209689|516406970|FG000|Overall Study|Insufficient Therapeutic Response|7|||
143233506|NCT01209689|516406971|FG001|Overall Study|Insufficient Therapeutic Response|2|||
143233507|NCT01209689|516406970|FG000|Overall Study|Refused Treatment|8|||
143233508|NCT01209689|516406971|FG001|Overall Study|Refused Treatment|3|||
143233509|NCT01209689|516406970|FG000|Overall Study|Adverse Event|4|||
143233510|NCT01209689|516406971|FG001|Overall Study|Adverse Event|0|||
143233511|NCT01209689|516406970|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
143233512|NCT01209689|516406971|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
143233513|NCT01209689|516406970|FG000|Overall Study|Failure to Return|3|||
143233514|NCT01209689|516406971|FG001|Overall Study|Failure to Return|0|||
143233515|NCT01209689|516406970|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
143233516|NCT01209689|516406971|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
143151212|NCT00541229|516098685|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
143151213|NCT00541229|516098686|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
143151214|NCT00541229|516098687|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
143151215|NCT00541229|516098688|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
143151216|NCT00541229|516098689|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
143151217|NCT00541229|516098684|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
143151218|NCT00541229|516098685|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
143151219|NCT00541229|516098686|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
143151220|NCT00541229|516098687|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
143151221|NCT00541229|516098688|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
143151222|NCT00541229|516098689|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
143151223|NCT00541229|516098684|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
143151224|NCT00541229|516098685|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
143151225|NCT00541229|516098686|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
143151226|NCT00541229|516098687|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
143151227|NCT00541229|516098688|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
143151228|NCT00541229|516098689|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
143151229|NCT00541229|516098684|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
143151230|NCT00541229|516098685|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
143151231|NCT00541229|516098686|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
143151232|NCT00541229|516098687|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
143151233|NCT00541229|516098688|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
143151234|NCT00541229|516098689|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
143151235|NCT00541229|516098684|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
143151236|NCT00541229|516098685|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
143151237|NCT00541229|516098686|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
143151238|NCT00541229|516098687|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
143151239|NCT00541229|516098688|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
143151240|NCT00541229|516098689|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
143151241|NCT00541229|516098684|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
143151242|NCT00541229|516098685|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
143151243|NCT00541229|516098686|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
143151244|NCT00541229|516098687|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
143151245|NCT00541229|516098688|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
143151246|NCT00541229|516098689|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
143151247|NCT00541229|516098684|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
143151248|NCT00541229|516098685|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
143151249|NCT00541229|516098686|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
143151250|NCT00541229|516098687|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
143151251|NCT00541229|516098688|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
143151252|NCT00541229|516098689|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
143151253|NCT00541229|516098684|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
143151254|NCT00541229|516098685|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
143151255|NCT00541229|516098686|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
143151256|NCT00541229|516098687|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
143151257|NCT00541229|516098688|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
143151258|NCT00541229|516098689|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
143151259|NCT00541229|516098684|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
143233517|NCT03780244|516406972|FG000|Overall Study|Lost to Follow-up|1|||
143233518|NCT03780244|516406973|FG001|Overall Study|Lost to Follow-up|0|||
143233519|NCT03175367|516406974|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
143233520|NCT03175367|516406975|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
143233521|NCT03175367|516406976|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
143363647|NCT00062868|516873780|FG000|Dose Level 3|Death|0|||
143151260|NCT00541229|516098685|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
143151261|NCT00541229|516098686|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
143151262|NCT00541229|516098687|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
143151263|NCT00541229|516098688|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
143151264|NCT00541229|516098689|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
143151265|NCT00924651|516098690|FG000|Overall Study|Chemo started too soon|2|||
143151266|NCT00924651|516098691|FG001|Overall Study|Chemo started too soon|3|||
143151267|NCT00924651|516098690|FG000|Overall Study|No Reason|3|||
143151268|NCT00924651|516098691|FG001|Overall Study|No Reason|7|||
143151269|NCT00924651|516098690|FG000|Overall Study|Overwhelmed|6|||
143151270|NCT00924651|516098691|FG001|Overall Study|Overwhelmed|6|||
143151271|NCT00924651|516098690|FG000|Overall Study|Noncompliant|1|||
143151272|NCT00924651|516098691|FG001|Overall Study|Noncompliant|4|||
143151273|NCT00924651|516098690|FG000|Overall Study|Medical|1|||
143151274|NCT00924651|516098691|FG001|Overall Study|Medical|3|||
143233522|NCT03175367|516406977|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
143233523|NCT03175367|516406978|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
143233524|NCT03175367|516406979|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
143233525|NCT03175367|516406980|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
143233526|NCT03175367|516406974|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
143233527|NCT03175367|516406975|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
143233528|NCT03175367|516406976|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
143233529|NCT03175367|516406977|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
143233530|NCT03175367|516406978|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
143233531|NCT03175367|516406979|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
143233532|NCT03175367|516406980|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
143233533|NCT03175367|516406974|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
143233534|NCT03175367|516406975|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
143233535|NCT03175367|516406976|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
143233536|NCT03175367|516406977|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
143233537|NCT03175367|516406978|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
143233538|NCT03175367|516406979|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
143233539|NCT03175367|516406980|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
143233540|NCT03175367|516406974|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
143233541|NCT03175367|516406975|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
143233542|NCT03175367|516406976|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
143233543|NCT03175367|516406977|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
143233544|NCT03175367|516406978|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
143233545|NCT03175367|516406979|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
143233546|NCT03175367|516406980|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
143233547|NCT03175367|516406974|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
143233548|NCT03175367|516406975|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
143233549|NCT03175367|516406976|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
143233550|NCT03175367|516406977|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
143233551|NCT03175367|516406978|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
143233552|NCT03175367|516406979|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
143233553|NCT03175367|516406980|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
143233554|NCT03175367|516406974|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
143233555|NCT03175367|516406975|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
143233556|NCT03175367|516406976|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
143233557|NCT03175367|516406977|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
143233558|NCT03175367|516406978|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
143233559|NCT03175367|516406979|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
143233560|NCT03175367|516406980|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
143233561|NCT03175367|516406974|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
143233562|NCT03175367|516406975|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
143233563|NCT03175367|516406976|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
143233564|NCT03175367|516406977|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
143233565|NCT03175367|516406978|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
143363648|NCT00062868|516873781|FG001|Dose Level 3|Death|0|||
143151275|NCT00924651|516098690|FG000|Overall Study|Changed Mind|10|||
143151276|NCT00924651|516098691|FG001|Overall Study|Changed Mind|1|||
143151277|NCT00924651|516098690|FG000|Overall Study|Incomplete Form|2|||
143151278|NCT00924651|516098691|FG001|Overall Study|Incomplete Form|1|||
143233566|NCT03175367|516406979|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
143233567|NCT03175367|516406980|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
143233568|NCT03714672|516406981|FG000|Overall Study|Adverse Event|0|||
143233569|NCT03714672|516406982|FG001|Overall Study|Adverse Event|0|||
143151279|NCT01797185|516098692|FG000|Overall Study|Adverse Event|5|||
143151280|NCT01797185|516098693|FG001|Overall Study|Adverse Event|15|||
143151281|NCT01797185|516098694|FG002|Overall Study|Adverse Event|6|||
143151282|NCT01797185|516098692|FG000|Overall Study|Withdrawal by Subject|6|||
143151283|NCT01797185|516098693|FG001|Overall Study|Withdrawal by Subject|9|||
143151284|NCT01797185|516098694|FG002|Overall Study|Withdrawal by Subject|5|||
143151285|NCT01797185|516098692|FG000|Overall Study|Site terminated|8|||
143151286|NCT01797185|516098693|FG001|Overall Study|Site terminated|4|||
143151287|NCT01797185|516098694|FG002|Overall Study|Site terminated|0|||
143151288|NCT01797185|516098692|FG000|Overall Study|Lost to Follow-up|2|||
143151289|NCT01797185|516098693|FG001|Overall Study|Lost to Follow-up|6|||
143151290|NCT01797185|516098694|FG002|Overall Study|Lost to Follow-up|1|||
143233570|NCT03714672|516406983|FG002|Overall Study|Adverse Event|3|||
143151291|NCT01797185|516098692|FG000|Overall Study|Withdrawn per sponsor|5|||
143151292|NCT01797185|516098693|FG001|Overall Study|Withdrawn per sponsor|0|||
143151293|NCT01797185|516098694|FG002|Overall Study|Withdrawn per sponsor|0|||
143151294|NCT01797185|516098692|FG000|Overall Study|Physician Decision|1|||
143151295|NCT01797185|516098693|FG001|Overall Study|Physician Decision|3|||
143151296|NCT01797185|516098694|FG002|Overall Study|Physician Decision|0|||
143151297|NCT01797185|516098692|FG000|Overall Study|Protocol Violation|1|||
143151298|NCT01797185|516098693|FG001|Overall Study|Protocol Violation|1|||
143151299|NCT01797185|516098694|FG002|Overall Study|Protocol Violation|0|||
143151300|NCT00800540|516098695|FG000|Period One: 6 Weeks|Noncompliance|1|||
143151301|NCT00800540|516098696|FG001|Period One: 6 Weeks|Noncompliance|0|||
143151302|NCT00800540|516098695|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
143151303|NCT00800540|516098696|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
143151304|NCT00800540|516098695|FG000|Period 2: 6 Weeks|Adverse Event|0|||
143151305|NCT00800540|516098696|FG001|Period 2: 6 Weeks|Adverse Event|1|||
143151306|NCT00081458|516098699|FG000|Overall Study|Adverse Event|1|||
143151307|NCT00081458|516098700|FG001|Overall Study|Adverse Event|5|||
143151308|NCT00081458|516098701|FG002|Overall Study|Adverse Event|2|||
143151309|NCT00081458|516098699|FG000|Overall Study|Withdrawal by Subject|0|||
143151310|NCT00081458|516098700|FG001|Overall Study|Withdrawal by Subject|3|||
143151311|NCT00081458|516098701|FG002|Overall Study|Withdrawal by Subject|1|||
143151312|NCT00081458|516098699|FG000|Overall Study|Randomized but not dosed|0|||
143151313|NCT00081458|516098700|FG001|Overall Study|Randomized but not dosed|0|||
143151314|NCT00081458|516098701|FG002|Overall Study|Randomized but not dosed|1|||
143151315|NCT00770484|516098706|FG000|Overall Study|Withdrawal by Subject|1|||
143151316|NCT00770484|516098707|FG001|Overall Study|Withdrawal by Subject|0|||
143151317|NCT03097315|516098708|FG000|Overall Study|Withdrawal by Subject|1|||
143151318|NCT02143778|516098709|FG000|Overall Study|Withdrawal by Subject|2|||
143151319|NCT02143778|516098709|FG000|Overall Study|Device malfunction|1|||
143151320|NCT00367458|516098710|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
143151321|NCT00367458|516098711|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
143151322|NCT03637374|516098714|FG000|Overall Study|Death|2|||
143151323|NCT03637374|516098715|FG001|Overall Study|Death|0|||
143151324|NCT03158688|516098718|FG000|Overall Study|Withdrawal by Subject|14|||
143151325|NCT03158688|516098719|FG001|Overall Study|Withdrawal by Subject|28|||
143151326|NCT03158688|516098718|FG000|Overall Study|Decision by sponsor|13|||
143151327|NCT03158688|516098719|FG001|Overall Study|Decision by sponsor|37|||
143151328|NCT03158688|516098718|FG000|Overall Study|Lost to Follow-up|4|||
143151329|NCT03158688|516098719|FG001|Overall Study|Lost to Follow-up|3|||
143151330|NCT03158688|516098718|FG000|Overall Study|Death|74|||
143151331|NCT03158688|516098719|FG001|Overall Study|Death|142|||
143151332|NCT00021255|516098724|FG000|Overall Study|Death|1|||
143151333|NCT00021255|516098725|FG001|Overall Study|Death|0|||
143151334|NCT00021255|516098726|FG002|Overall Study|Death|2|||
143151335|NCT00021255|516098724|FG000|Overall Study|Breast cancer relapse|5|||
143151336|NCT00021255|516098725|FG001|Overall Study|Breast cancer relapse|18|||
143151337|NCT00021255|516098726|FG002|Overall Study|Breast cancer relapse|11|||
143151338|NCT00021255|516098724|FG000|Overall Study|Second primary malignancy|0|||
143151339|NCT00021255|516098725|FG001|Overall Study|Second primary malignancy|4|||
143151340|NCT00021255|516098726|FG002|Overall Study|Second primary malignancy|1|||
143151341|NCT00021255|516098724|FG000|Overall Study|Withdrawal by Subject|41|||
143151342|NCT00021255|516098725|FG001|Overall Study|Withdrawal by Subject|64|||
143151343|NCT00021255|516098726|FG002|Overall Study|Withdrawal by Subject|26|||
143151344|NCT00021255|516098724|FG000|Overall Study|Lost to Follow-up|0|||
143151345|NCT00021255|516098725|FG001|Overall Study|Lost to Follow-up|2|||
143151346|NCT00021255|516098726|FG002|Overall Study|Lost to Follow-up|3|||
143151347|NCT00021255|516098724|FG000|Overall Study|Cardiac toxicity|0|||
143151348|NCT00021255|516098725|FG001|Overall Study|Cardiac toxicity|61|||
143151349|NCT00021255|516098726|FG002|Overall Study|Cardiac toxicity|32|||
143233571|NCT03714672|516406984|FG003|Overall Study|Adverse Event|0|||
143151350|NCT00021255|516098724|FG000|Overall Study|Herceptin toxicity|0|||
143151351|NCT00021255|516098725|FG001|Overall Study|Herceptin toxicity|22|||
143151352|NCT00021255|516098726|FG002|Overall Study|Herceptin toxicity|6|||
143151353|NCT00021255|516098724|FG000|Overall Study|Adverse Event|46|||
143151354|NCT00021255|516098725|FG001|Overall Study|Adverse Event|30|||
143233572|NCT03714672|516406981|FG000|Overall Study|Physician Decision|0|||
143233573|NCT03714672|516406982|FG001|Overall Study|Physician Decision|1|||
143233574|NCT03714672|516406983|FG002|Overall Study|Physician Decision|0|||
143233575|NCT03714672|516406984|FG003|Overall Study|Physician Decision|0|||
143233576|NCT03714672|516406981|FG000|Overall Study|Other Reason|1|||
143233577|NCT03714672|516406982|FG001|Overall Study|Other Reason|2|||
143233578|NCT03714672|516406983|FG002|Overall Study|Other Reason|1|||
143233579|NCT03714672|516406984|FG003|Overall Study|Other Reason|1|||
143233580|NCT03714672|516406981|FG000|Overall Study|Lost to Follow-up|1|||
143233581|NCT03714672|516406982|FG001|Overall Study|Lost to Follow-up|1|||
143233582|NCT03714672|516406983|FG002|Overall Study|Lost to Follow-up|0|||
143233583|NCT03714672|516406984|FG003|Overall Study|Lost to Follow-up|0|||
143233584|NCT03453164|516406988|FG000|Overall Study|Lack of Efficacy|16|||
143233585|NCT03453164|516406988|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
143233586|NCT03085095|516406991|FG000|Overall Study|Adverse Event|23|||
143233587|NCT03085095|516406992|FG001|Overall Study|Adverse Event|8|||
143233588|NCT03085095|516406991|FG000|Overall Study|Protocol Violation|0|||
143233589|NCT03085095|516406992|FG001|Overall Study|Protocol Violation|1|||
143233590|NCT03085095|516406991|FG000|Overall Study|Lost to Follow-up|2|||
143233591|NCT03085095|516406992|FG001|Overall Study|Lost to Follow-up|1|||
143233592|NCT03085095|516406991|FG000|Overall Study|Withdrawal by Subject|17|||
143233593|NCT03085095|516406992|FG001|Overall Study|Withdrawal by Subject|6|||
143233594|NCT03085095|516406991|FG000|Overall Study|Physician Decision|9|||
143233595|NCT03085095|516406992|FG001|Overall Study|Physician Decision|3|||
143233596|NCT03085095|516406991|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
143233597|NCT03085095|516406992|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
143233598|NCT03085095|516406991|FG000|Overall Study|Did not Receive Study Drug|2|||
143233599|NCT03085095|516406992|FG001|Overall Study|Did not Receive Study Drug|2|||
143233600|NCT03085095|516406991|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
143233601|NCT03085095|516406992|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
143233602|NCT01074502|516406994|FG000|Overall Study|Withdrawal by Subject|1|||
143233603|NCT03459079|516406995|FG000|Overall Study|Adverse Event|4|||
143233604|NCT03459079|516406996|FG001|Overall Study|Adverse Event|2|||
143233605|NCT03459079|516406997|FG002|Overall Study|Adverse Event|0|||
143233606|NCT03459079|516406995|FG000|Overall Study|Withdrawal by Subject|2|||
143233607|NCT03459079|516406996|FG001|Overall Study|Withdrawal by Subject|2|||
143233608|NCT03459079|516406997|FG002|Overall Study|Withdrawal by Subject|0|||
143233609|NCT02220920|516407005|FG000|Overall Study|Adverse Event|1|||
143233610|NCT02220920|516407006|FG001|Overall Study|Adverse Event|0|||
143233611|NCT02220920|516407005|FG000|Overall Study|Lack of Efficacy|0|||
143233612|NCT02220920|516407006|FG001|Overall Study|Lack of Efficacy|1|||
143233613|NCT02220920|516407005|FG000|Overall Study|Withdrawal by Subject|1|||
143233614|NCT02220920|516407006|FG001|Overall Study|Withdrawal by Subject|0|||
143233615|NCT02220920|516407005|FG000|Overall Study|Conflict with the stopping criteria|1|||
143233616|NCT02220920|516407006|FG001|Overall Study|Conflict with the stopping criteria|2|||
143233617|NCT04945733|516407009|FG000|Overall Study|Physician Decision|1|||
143233618|NCT04945733|516407010|FG001|Overall Study|Physician Decision|3|||
143233619|NCT04945733|516407011|FG002|Overall Study|Physician Decision|0|||
143233620|NCT04945733|516407009|FG000|Overall Study|Withdrawal by Subject|3|||
143233621|NCT04945733|516407010|FG001|Overall Study|Withdrawal by Subject|3|||
143233622|NCT04945733|516407011|FG002|Overall Study|Withdrawal by Subject|0|||
143233623|NCT03566511|516407015|FG000|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|1|||
143233624|NCT03566511|516407016|FG001|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|0|||
143233625|NCT02218372|516407017|FG000|Overall Study|Adverse Event|1|||
143233626|NCT02218372|516407018|FG001|Overall Study|Adverse Event|1|||
143233627|NCT02218372|516407017|FG000|Overall Study|Miscellaneous|2|||
143233628|NCT02218372|516407018|FG001|Overall Study|Miscellaneous|1|||
143233629|NCT02218372|516407017|FG000|Overall Study|Randomized but did not receive treatment|2|||
143233630|NCT02218372|516407018|FG001|Overall Study|Randomized but did not receive treatment|3|||
143233631|NCT02218372|516407017|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
143233632|NCT02218372|516407018|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
143233633|NCT04558125|516407020|FG000|Overall Study|Death|1|||
143233634|NCT03379818|516407021|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
143233635|NCT03379818|516407022|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
143233636|NCT03379818|516407021|FG000|Overall Study|Withdrawal by Subject|2|||
143233637|NCT03379818|516407022|FG001|Overall Study|Withdrawal by Subject|3|||
143233638|NCT03379818|516407021|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
143233639|NCT03379818|516407022|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
143233640|NCT02718898|516407023|FG000|Blinded Treatment Period|Adverse Event|5|||
143233641|NCT02718898|516407024|FG001|Blinded Treatment Period|Adverse Event|1|||
143233642|NCT02718898|516407025|FG002|Blinded Treatment Period|Adverse Event|0|||
143233643|NCT02718898|516407026|FG003|Blinded Treatment Period|Adverse Event|0|||
143233644|NCT02718898|516407027|FG004|Blinded Treatment Period|Adverse Event|0|||
143233645|NCT02718898|516407028|FG005|Blinded Treatment Period|Adverse Event|0|||
143233646|NCT02718898|516407029|FG006|Blinded Treatment Period|Adverse Event|0|||
143151355|NCT00021255|516098726|FG002|Overall Study|Adverse Event|18|||
143151356|NCT00021255|516098724|FG000|Overall Study|Protocol Violation|0|||
143151357|NCT00021255|516098725|FG001|Overall Study|Protocol Violation|2|||
143151358|NCT00021255|516098726|FG002|Overall Study|Protocol Violation|0|||
143151359|NCT00021255|516098724|FG000|Overall Study|Other than specified above|0|||
143151360|NCT00021255|516098725|FG001|Overall Study|Other than specified above|38|||
143151361|NCT00021255|516098726|FG002|Overall Study|Other than specified above|19|||
143151362|NCT00021255|516098724|FG000|Overall Study|Missing|0|||
143151363|NCT00021255|516098725|FG001|Overall Study|Missing|27|||
143151364|NCT00021255|516098726|FG002|Overall Study|Missing|13|||
143151365|NCT00021255|516098724|FG000|Overall Study|Randomized but not treated|28|||
143151366|NCT00021255|516098725|FG001|Overall Study|Randomized but not treated|2|||
143151367|NCT00021255|516098726|FG002|Overall Study|Randomized but not treated|18|||
143151368|NCT02337946|516098727|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
143151369|NCT02337946|516098728|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
143151370|NCT02337946|516098729|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
143151371|NCT02337946|516098727|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
143151372|NCT02337946|516098728|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
143151373|NCT02337946|516098729|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
143151374|NCT02337946|516098727|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
143151375|NCT02337946|516098728|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
143151376|NCT02337946|516098729|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
143151377|NCT02337946|516098727|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
143151378|NCT02337946|516098728|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
143151379|NCT02337946|516098729|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
143151380|NCT02337946|516098727|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
143151381|NCT02337946|516098728|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
143151382|NCT02337946|516098729|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
143151383|NCT02337946|516098727|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
143151384|NCT02337946|516098728|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
143151385|NCT02337946|516098729|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
143151386|NCT02337946|516098727|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
143151387|NCT02337946|516098728|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
143151388|NCT02337946|516098729|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
143151389|NCT02337946|516098727|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
143151390|NCT02337946|516098728|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
143151391|NCT02337946|516098729|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
143151392|NCT02337946|516098727|FG000|In-between Period|Without Informed Consent|1|||
143151393|NCT02337946|516098728|FG001|In-between Period|Without Informed Consent|0|||
143151394|NCT02337946|516098729|FG002|In-between Period|Without Informed Consent|0|||
143151395|NCT02337946|516098727|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
143151396|NCT02337946|516098728|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
143151397|NCT02337946|516098729|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
143151398|NCT02337946|516098727|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
143151399|NCT02337946|516098728|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
143151400|NCT02337946|516098729|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
143151401|NCT02337946|516098727|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
143151402|NCT02337946|516098728|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
143151403|NCT02337946|516098729|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
143151404|NCT02337946|516098727|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
143151405|NCT02337946|516098728|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
143151406|NCT02337946|516098729|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
143151407|NCT02337946|516098727|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
143151408|NCT02337946|516098728|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
143151409|NCT02337946|516098729|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
143151410|NCT02337946|516098727|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
143151411|NCT02337946|516098728|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
143151412|NCT02337946|516098729|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
143484675|NCT02631200|517320962|FG000|First Period|Patient ill-health|2|||
143484676|NCT02631200|517320963|FG001|First Period|Patient ill-health|4|||
143484677|NCT02631200|517320962|FG000|First Period|Withdrawal by Subject|4|||
143484678|NCT02631200|517320963|FG001|First Period|Withdrawal by Subject|1|||
143484679|NCT02631200|517320962|FG000|Deferred Period|Death|0|||
143151413|NCT04069520|516098738|FG000|Overall Study|Lost to Follow-up|0|||
143151414|NCT04069520|516098739|FG001|Overall Study|Lost to Follow-up|2|||
143151415|NCT04069520|516098738|FG000|Overall Study|Withdrawal by Subject|0|||
143151416|NCT04069520|516098739|FG001|Overall Study|Withdrawal by Subject|1|||
143151417|NCT04069520|516098738|FG000|Overall Study|Prior Injury|1|||
143151418|NCT04069520|516098739|FG001|Overall Study|Prior Injury|0|||
143151419|NCT04069520|516098738|FG000|Overall Study|Orthodontia|1|||
143484680|NCT02631200|517320963|FG001|Deferred Period|Death|1|||
143233647|NCT02718898|516407023|FG000|Blinded Treatment Period|Physician Decision|1|||
143233648|NCT02718898|516407024|FG001|Blinded Treatment Period|Physician Decision|0|||
143233649|NCT02718898|516407025|FG002|Blinded Treatment Period|Physician Decision|0|||
143233650|NCT02718898|516407026|FG003|Blinded Treatment Period|Physician Decision|0|||
143233651|NCT02718898|516407027|FG004|Blinded Treatment Period|Physician Decision|0|||
143233652|NCT02718898|516407028|FG005|Blinded Treatment Period|Physician Decision|0|||
143233653|NCT02718898|516407029|FG006|Blinded Treatment Period|Physician Decision|0|||
143233654|NCT02718898|516407023|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
143233655|NCT02718898|516407024|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
143233656|NCT02718898|516407025|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
143233657|NCT02718898|516407026|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
143233658|NCT02718898|516407027|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
143233659|NCT02718898|516407028|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
143233660|NCT02718898|516407029|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
143233661|NCT02718898|516407023|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
143233662|NCT02718898|516407024|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
143233663|NCT02718898|516407025|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
143233664|NCT02718898|516407026|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
143233665|NCT02718898|516407027|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
143233666|NCT02718898|516407028|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
143233667|NCT02718898|516407029|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
143233668|NCT02718898|516407023|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
143233669|NCT02718898|516407024|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
143233670|NCT02718898|516407025|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
143233671|NCT02718898|516407026|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
143233672|NCT02718898|516407027|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
143233673|NCT02718898|516407028|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
143233674|NCT02718898|516407029|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
143233675|NCT02718898|516407023|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
143233676|NCT02718898|516407024|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
143233677|NCT02718898|516407025|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
143233678|NCT02718898|516407026|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
143233679|NCT02718898|516407027|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
143233680|NCT02718898|516407028|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
143233681|NCT02718898|516407029|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
143233682|NCT02718898|516407023|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
143233683|NCT02718898|516407024|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
143233684|NCT02718898|516407025|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
143233685|NCT02718898|516407026|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
143233686|NCT02718898|516407027|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
143233687|NCT02718898|516407028|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
143233688|NCT02718898|516407029|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
143233689|NCT02718898|516407023|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
143233690|NCT02718898|516407024|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
143233691|NCT02718898|516407025|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
143233692|NCT02718898|516407026|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
143233693|NCT02718898|516407027|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
143233694|NCT02718898|516407028|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
143233695|NCT02718898|516407029|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
143233696|NCT02718898|516407023|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
143233697|NCT02718898|516407024|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
143233698|NCT02718898|516407025|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
143233699|NCT02718898|516407026|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
143233700|NCT02718898|516407027|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
143233701|NCT02718898|516407028|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
143233702|NCT02718898|516407029|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
143233703|NCT02718898|516407023|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
143233704|NCT02718898|516407024|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
143233705|NCT02718898|516407025|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
143233706|NCT02718898|516407026|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
143233707|NCT02718898|516407027|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
143233708|NCT02718898|516407028|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
143233709|NCT02718898|516407029|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
143233710|NCT02718898|516407023|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
143233711|NCT02718898|516407024|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
143233712|NCT02718898|516407025|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
143151420|NCT04069520|516098739|FG001|Overall Study|Orthodontia|0|||
143151421|NCT04069520|516098738|FG000|Overall Study|Cut from team|0|||
143151422|NCT04069520|516098739|FG001|Overall Study|Cut from team|2|||
143151423|NCT00849472|516098740|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
143151424|NCT00849472|516098740|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
143151425|NCT00849472|516098740|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
143151426|NCT00849472|516098740|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
143151427|NCT00849472|516098740|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
143151428|NCT00849472|516098740|FG000|Weekly Paclitaxel|Disease Progression|1|||
143151429|NCT00849472|516098740|FG000|Weekly Paclitaxel|Adverse Event|11|||
143151430|NCT00849472|516098740|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
143151431|NCT00849472|516098740|FG000|Weekly Paclitaxel|Physician Decision|3|||
143151432|NCT00849472|516098740|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
143151433|NCT00849472|516098740|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
143151434|NCT00849472|516098740|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
143151435|NCT00849472|516098740|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
143151436|NCT00849472|516098740|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
143151437|NCT00849472|516098740|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
143151438|NCT00849472|516098740|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
143151439|NCT00849472|516098740|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
143151440|NCT04822194|516098741|FG000|Overall Study|Withdrawal by Subject|5|||
143151441|NCT04822194|516098742|FG001|Overall Study|Withdrawal by Subject|4|||
143151442|NCT04822194|516098741|FG000|Overall Study|Technical issues with MR scanner|1|||
143151443|NCT04822194|516098742|FG001|Overall Study|Technical issues with MR scanner|0|||
143151444|NCT04822194|516098741|FG000|Overall Study|Lost to Follow-up|5|||
143151445|NCT04822194|516098742|FG001|Overall Study|Lost to Follow-up|7|||
143151446|NCT03010501|516098749|FG000|Study Week 1|Withdrawal by Subject|2|||
143151447|NCT03010501|516098750|FG001|Study Week 1|Withdrawal by Subject|1|||
143151448|NCT03010501|516098751|FG002|Study Week 1|Withdrawal by Subject|0|||
143151449|NCT03010501|516098752|FG003|Study Week 1|Withdrawal by Subject|2|||
143151450|NCT03010501|516098753|FG004|Study Week 1|Withdrawal by Subject|0|||
143151451|NCT03010501|516098754|FG005|Study Week 1|Withdrawal by Subject|0|||
143151452|NCT03010501|516098749|FG000|Study Week 3|Withdrawal by Subject|0|||
143151453|NCT03010501|516098750|FG001|Study Week 3|Withdrawal by Subject|0|||
143151454|NCT03010501|516098751|FG002|Study Week 3|Withdrawal by Subject|0|||
143151455|NCT03010501|516098752|FG003|Study Week 3|Withdrawal by Subject|1|||
143151456|NCT03010501|516098753|FG004|Study Week 3|Withdrawal by Subject|0|||
143151457|NCT03010501|516098754|FG005|Study Week 3|Withdrawal by Subject|0|||
143151458|NCT05172570|516098755|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
143151459|NCT05172570|516098756|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
143151460|NCT05172570|516098757|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
143151461|NCT05172570|516098755|FG000|Overall Study|PI Decision due to equipment shortages|0|||
143151462|NCT05172570|516098756|FG001|Overall Study|PI Decision due to equipment shortages|0|||
143151463|NCT05172570|516098757|FG002|Overall Study|PI Decision due to equipment shortages|1|||
143151464|NCT00640289|516098760|FG000|Overall Study|Death|3|||
143151465|NCT00640289|516098760|FG000|Overall Study|Withdrawal by Subject|1|||
143151466|NCT00640289|516098760|FG000|Overall Study|Lost to Follow-up|1|||
143151467|NCT00640289|516098760|FG000|Overall Study|Data collected under different amendment|2|||
143151468|NCT00640289|516098760|FG000|Overall Study|Transferred to another center|1|||
143151469|NCT00640289|516098760|FG000|Overall Study|Missing status|5|||
143151470|NCT03550209|516098761|FG000|Overall Study|Lost to Follow-up|1|||
143151471|NCT03550209|516098762|FG001|Overall Study|Lost to Follow-up|0|||
143151472|NCT03550209|516098763|FG002|Overall Study|Lost to Follow-up|1|||
143151473|NCT03550209|516098764|FG003|Overall Study|Lost to Follow-up|0|||
143151474|NCT03550209|516098761|FG000|Overall Study|Withdrawal by Subject|0|||
143151475|NCT03550209|516098762|FG001|Overall Study|Withdrawal by Subject|3|||
143151476|NCT03550209|516098763|FG002|Overall Study|Withdrawal by Subject|1|||
143151477|NCT03550209|516098764|FG003|Overall Study|Withdrawal by Subject|2|||
143151478|NCT03550209|516098761|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
143151479|NCT03550209|516098762|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
143151480|NCT03550209|516098763|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
143151481|NCT03550209|516098764|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
143151482|NCT04937387|516098769|FG000|Overall Study|Adverse Event|1|||
143151483|NCT04937387|516098770|FG001|Overall Study|Adverse Event|0|||
143151484|NCT04937387|516098771|FG002|Overall Study|Adverse Event|2|||
143151485|NCT04937387|516098772|FG003|Overall Study|Adverse Event|0|||
143151486|NCT04937387|516098769|FG000|Overall Study|Lack of Efficacy|1|||
143151487|NCT04937387|516098770|FG001|Overall Study|Lack of Efficacy|0|||
143151488|NCT04937387|516098771|FG002|Overall Study|Lack of Efficacy|0|||
143151489|NCT04937387|516098772|FG003|Overall Study|Lack of Efficacy|1|||
143151490|NCT04937387|516098769|FG000|Overall Study|Withdrawal by Subject|1|||
143151491|NCT04937387|516098770|FG001|Overall Study|Withdrawal by Subject|0|||
143151492|NCT04937387|516098771|FG002|Overall Study|Withdrawal by Subject|1|||
143151493|NCT04937387|516098772|FG003|Overall Study|Withdrawal by Subject|1|||
143151494|NCT04937387|516098769|FG000|Overall Study|Randomized in error|0|||
143151495|NCT04937387|516098770|FG001|Overall Study|Randomized in error|0|||
143151496|NCT04937387|516098771|FG002|Overall Study|Randomized in error|0|||
143151497|NCT04937387|516098772|FG003|Overall Study|Randomized in error|1|||
143151498|NCT02583269|516098773|FG000|Overall Study|Patient hospitalized prior to start|1|||
143151499|NCT02583269|516098774|FG001|Overall Study|Patient hospitalized prior to start|0|||
143151500|NCT02583269|516098775|FG002|Overall Study|Patient hospitalized prior to start|0|||
143151501|NCT02583269|516098776|FG003|Overall Study|Patient hospitalized prior to start|0|||
143151502|NCT02583269|516098777|FG004|Overall Study|Patient hospitalized prior to start|0|||
143151503|NCT02207608|516098779|FG000|Overall Study|Adverse Event|1|||
143151504|NCT02207608|516098780|FG001|Overall Study|Adverse Event|0|||
143151505|NCT00980460|516098781|FG000|Overall Study|Death|0|||
143151506|NCT00980460|516098782|FG001|Overall Study|Death|0|||
143151507|NCT00980460|516098783|FG002|Overall Study|Death|1|||
143151508|NCT00980460|516098784|FG003|Overall Study|Death|2|||
143151509|NCT00980460|516098785|FG004|Overall Study|Death|1|||
143151510|NCT00980460|516098781|FG000|Overall Study|Lack of Efficacy|0|||
143151511|NCT00980460|516098782|FG001|Overall Study|Lack of Efficacy|0|||
143151512|NCT00980460|516098783|FG002|Overall Study|Lack of Efficacy|10|||
143151513|NCT00980460|516098784|FG003|Overall Study|Lack of Efficacy|6|||
143151514|NCT00980460|516098785|FG004|Overall Study|Lack of Efficacy|8|||
143151515|NCT00980460|516098781|FG000|Overall Study|Lost to Follow-up|0|||
143151516|NCT00980460|516098782|FG001|Overall Study|Lost to Follow-up|0|||
143151517|NCT00980460|516098783|FG002|Overall Study|Lost to Follow-up|0|||
143151518|NCT00980460|516098784|FG003|Overall Study|Lost to Follow-up|1|||
143151519|NCT00980460|516098785|FG004|Overall Study|Lost to Follow-up|0|||
143151520|NCT00980460|516098781|FG000|Overall Study|Physician Decision|0|||
143151521|NCT00980460|516098782|FG001|Overall Study|Physician Decision|0|||
143151522|NCT00980460|516098783|FG002|Overall Study|Physician Decision|11|||
143151523|NCT00980460|516098784|FG003|Overall Study|Physician Decision|5|||
143151524|NCT00980460|516098785|FG004|Overall Study|Physician Decision|3|||
143151525|NCT00980460|516098781|FG000|Overall Study|Withdrawal by Subject|0|||
143151526|NCT00980460|516098782|FG001|Overall Study|Withdrawal by Subject|0|||
143151527|NCT00980460|516098783|FG002|Overall Study|Withdrawal by Subject|1|||
143151528|NCT00980460|516098784|FG003|Overall Study|Withdrawal by Subject|0|||
143151529|NCT00980460|516098785|FG004|Overall Study|Withdrawal by Subject|0|||
143151530|NCT00980460|516098781|FG000|Overall Study|Ineligible|0|||
143151531|NCT00980460|516098782|FG001|Overall Study|Ineligible|2|||
143151532|NCT00980460|516098783|FG002|Overall Study|Ineligible|3|||
143151533|NCT00980460|516098784|FG003|Overall Study|Ineligible|1|||
143151534|NCT00980460|516098785|FG004|Overall Study|Ineligible|4|||
143151535|NCT00980460|516098781|FG000|Overall Study|Refusal of further therapy|0|||
143151536|NCT00980460|516098782|FG001|Overall Study|Refusal of further therapy|2|||
143151537|NCT00980460|516098783|FG002|Overall Study|Refusal of further therapy|3|||
143151538|NCT00980460|516098784|FG003|Overall Study|Refusal of further therapy|2|||
143151539|NCT00980460|516098785|FG004|Overall Study|Refusal of further therapy|0|||
143151540|NCT00980460|516098781|FG000|Overall Study|No therapy within 42 days of resection|0|||
143151541|NCT00980460|516098782|FG001|Overall Study|No therapy within 42 days of resection|0|||
143151542|NCT00980460|516098783|FG002|Overall Study|No therapy within 42 days of resection|3|||
143151543|NCT00980460|516098784|FG003|Overall Study|No therapy within 42 days of resection|1|||
143151544|NCT00980460|516098785|FG004|Overall Study|No therapy within 42 days of resection|0|||
143151545|NCT00980460|516098781|FG000|Overall Study|No transplant by protocol timepoints|0|||
143151546|NCT00980460|516098782|FG001|Overall Study|No transplant by protocol timepoints|0|||
143151547|NCT00980460|516098783|FG002|Overall Study|No transplant by protocol timepoints|3|||
143151548|NCT00980460|516098784|FG003|Overall Study|No transplant by protocol timepoints|0|||
143233713|NCT02718898|516407026|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
143233714|NCT02718898|516407027|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
143233715|NCT02718898|516407028|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
143151549|NCT00980460|516098785|FG004|Overall Study|No transplant by protocol timepoints|0|||
143151550|NCT01251861|516098786|FG000|Overall Study|Disease progression|6|||
143151551|NCT01251861|516098787|FG001|Overall Study|Disease progression|6|||
143151552|NCT01251861|516098786|FG000|Overall Study|Adverse Event|2|||
143151553|NCT01251861|516098787|FG001|Overall Study|Adverse Event|17|||
143151554|NCT01251861|516098786|FG000|Overall Study|Withdrawal by Subject|2|||
143151555|NCT01251861|516098787|FG001|Overall Study|Withdrawal by Subject|2|||
143151556|NCT01251861|516098786|FG000|Overall Study|Alternative therapy|1|||
143151557|NCT01251861|516098787|FG001|Overall Study|Alternative therapy|0|||
143151558|NCT01251861|516098786|FG000|Overall Study|Other complicating disease|0|||
143151559|NCT01251861|516098787|FG001|Overall Study|Other complicating disease|1|||
143151560|NCT01251861|516098786|FG000|Overall Study|Physician Decision|1|||
143151561|NCT01251861|516098787|FG001|Overall Study|Physician Decision|0|||
143151562|NCT01251861|516098786|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
143151563|NCT01251861|516098787|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
143233716|NCT02718898|516407029|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
143233717|NCT02718898|516407023|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
143233718|NCT02718898|516407024|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
143233719|NCT02718898|516407025|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
143233720|NCT02718898|516407026|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
143233721|NCT02718898|516407027|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
143233722|NCT02718898|516407028|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
143233723|NCT02718898|516407029|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
143233724|NCT02718898|516407023|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
143233725|NCT02718898|516407024|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
143233726|NCT02718898|516407025|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
143233727|NCT02718898|516407026|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
143233728|NCT02718898|516407027|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
143233729|NCT02718898|516407028|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
143233730|NCT02718898|516407029|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
143233731|NCT02559622|516407031|FG000|Overall Study|Progressive disease|0|||
143233732|NCT02559622|516407032|FG001|Overall Study|Progressive disease|1|||
143233733|NCT02559622|516407033|FG002|Overall Study|Progressive disease|0|||
143233734|NCT02559622|516407034|FG003|Overall Study|Progressive disease|0|||
143233735|NCT02559622|516407031|FG000|Overall Study|Adverse Event|0|||
143233736|NCT02559622|516407032|FG001|Overall Study|Adverse Event|2|||
143233737|NCT02559622|516407033|FG002|Overall Study|Adverse Event|2|||
143233738|NCT02559622|516407034|FG003|Overall Study|Adverse Event|2|||
143233739|NCT02559622|516407031|FG000|Overall Study|Patient/guardian decision|1|||
143233740|NCT02559622|516407032|FG001|Overall Study|Patient/guardian decision|2|||
143233741|NCT02559622|516407033|FG002|Overall Study|Patient/guardian decision|0|||
143233742|NCT02559622|516407034|FG003|Overall Study|Patient/guardian decision|1|||
143233743|NCT02163538|516407035|FG000|Overall Study|Protocol Violation|1|||
143233744|NCT02163538|516407036|FG001|Overall Study|Protocol Violation|0|||
143233745|NCT02163538|516407035|FG000|Overall Study|Physician Decision|0|||
143233746|NCT02163538|516407036|FG001|Overall Study|Physician Decision|1|||
143233747|NCT01502293|516407039|FG000|Overall Study|Progressive Disease|20|||
143233748|NCT01502293|516407040|FG001|Overall Study|Progressive Disease|12|||
143233749|NCT01502293|516407041|FG002|Overall Study|Progressive Disease|2|||
143233750|NCT01502293|516407039|FG000|Overall Study|Withdrawal by Subject|3|||
143233751|NCT01502293|516407040|FG001|Overall Study|Withdrawal by Subject|3|||
143233752|NCT01502293|516407041|FG002|Overall Study|Withdrawal by Subject|1|||
143233753|NCT01502293|516407039|FG000|Overall Study|Adverse Event|0|||
143233754|NCT01502293|516407040|FG001|Overall Study|Adverse Event|2|||
143233755|NCT01502293|516407041|FG002|Overall Study|Adverse Event|0|||
143233756|NCT01502293|516407039|FG000|Overall Study|Reason Not Specified|2|||
143233757|NCT01502293|516407040|FG001|Overall Study|Reason Not Specified|0|||
143233758|NCT01502293|516407041|FG002|Overall Study|Reason Not Specified|0|||
143233759|NCT01502293|516407039|FG000|Overall Study|Physician Decision|0|||
143233760|NCT01502293|516407040|FG001|Overall Study|Physician Decision|0|||
143233761|NCT01502293|516407041|FG002|Overall Study|Physician Decision|1|||
143233762|NCT01339832|516407046|FG000|Overall Study|Lost to Follow-up|3|||
143233763|NCT01339832|516407046|FG000|Overall Study|Death|11|||
143233764|NCT00231816|516407047|FG000|Overall Study|Adverse Event|1|||
143233765|NCT00231816|516407048|FG001|Overall Study|Adverse Event|0|||
143233766|NCT00231816|516407047|FG000|Overall Study|Lost to Follow-up|8|||
143233767|NCT00231816|516407048|FG001|Overall Study|Lost to Follow-up|5|||
143233768|NCT00231816|516407047|FG000|Overall Study|Protocol Violation|2|||
143233769|NCT00231816|516407048|FG001|Overall Study|Protocol Violation|3|||
143233770|NCT00231816|516407047|FG000|Overall Study|Withdrawal by Subject|3|||
143233771|NCT00231816|516407048|FG001|Overall Study|Withdrawal by Subject|3|||
143233772|NCT00231816|516407047|FG000|Overall Study|Other|2|||
143233773|NCT00231816|516407048|FG001|Overall Study|Other|1|||
143233774|NCT00468169|516407049|FG000|Overall Study|Withdrawal by Subject|1|||
143233775|NCT00468169|516407050|FG001|Overall Study|Withdrawal by Subject|0|||
143233776|NCT00774046|516407051|FG000|Screening|Not eligible|56|||
143233777|NCT00774046|516407051|FG000|Enrollment|Desired other therapy/refused|28|||
143233778|NCT00774046|516407051|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
143233779|NCT01056822|516407052|FG000|Overall Study|Adverse Event|0|||
143233780|NCT01056822|516407053|FG001|Overall Study|Adverse Event|1|||
143233781|NCT01056822|516407052|FG000|Overall Study|Protocol Violation|6|||
143233782|NCT01056822|516407053|FG001|Overall Study|Protocol Violation|5|||
143233783|NCT01056822|516407052|FG000|Overall Study|Withdrawal by Subject|1|||
143233784|NCT01056822|516407053|FG001|Overall Study|Withdrawal by Subject|1|||
143233785|NCT01056822|516407052|FG000|Overall Study|Lost to Follow-up|1|||
143233786|NCT01056822|516407053|FG001|Overall Study|Lost to Follow-up|0|||
143233787|NCT01614249|516407057|FG000|Overall Study|Lost to Follow-up|11|||
143233788|NCT01614249|516407058|FG001|Overall Study|Lost to Follow-up|23|||
143233789|NCT05498649|516407059|FG000|Overall Study|Lost to Follow-up|1|||
143233790|NCT03341299|516407073|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
143233791|NCT03341299|516407074|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
143363649|NCT00062868|516873782|FG002|Dose Level 3|Death|0|||
143151564|NCT01251861|516098786|FG000|Overall Study|Other|1|||
143151565|NCT01251861|516098787|FG001|Overall Study|Other|0|||
143151566|NCT01251861|516098786|FG000|Overall Study|Never started therapy|4|||
143151567|NCT01251861|516098787|FG001|Overall Study|Never started therapy|1|||
143151568|NCT01251861|516098786|FG000|Overall Study|Potential interaction of drugs|0|||
143151569|NCT01251861|516098787|FG001|Overall Study|Potential interaction of drugs|1|||
143151570|NCT03599713|516098788|FG000|Overall Study|Death|38|||
143151571|NCT03599713|516098789|FG001|Overall Study|Death|3|||
143151572|NCT03599713|516098788|FG000|Overall Study|Withdrawal by Subject|17|||
143151573|NCT03599713|516098789|FG001|Overall Study|Withdrawal by Subject|0|||
143151574|NCT03599713|516098788|FG000|Overall Study|Lost to Follow-up|4|||
143151575|NCT03599713|516098789|FG001|Overall Study|Lost to Follow-up|0|||
143151576|NCT03599713|516098788|FG000|Overall Study|Discontinued Due to End of Study|42|||
143151577|NCT03599713|516098789|FG001|Overall Study|Discontinued Due to End of Study|3|||
143151578|NCT03580928|516098794|FG000|Overall Study|Death|0|||
143151579|NCT03580928|516098795|FG001|Overall Study|Death|3|||
143151580|NCT03580928|516098794|FG000|Overall Study|Withdrawal by Subject|2|||
143151581|NCT03580928|516098795|FG001|Overall Study|Withdrawal by Subject|1|||
143151582|NCT03580928|516098794|FG000|Overall Study|Lost to Follow-up|2|||
143151583|NCT03580928|516098795|FG001|Overall Study|Lost to Follow-up|0|||
143151584|NCT03580928|516098794|FG000|Overall Study|Progressive Disease|0|||
143151585|NCT03580928|516098795|FG001|Overall Study|Progressive Disease|1|||
143151586|NCT02582632|516099445|FG000|Overall Study|Other|1|||
143151587|NCT03298061|516099446|FG000|Overall Study|Adverse Event|3|||
143151588|NCT03298061|516099446|FG000|Overall Study|Lack of Efficacy|6|||
143151589|NCT03298061|516099446|FG000|Overall Study|Protocol Violation|1|||
143151590|NCT03298061|516099446|FG000|Overall Study|Physician Decision|7|||
143151591|NCT03298061|516099446|FG000|Overall Study|Withdrawal by Subject|10|||
143151592|NCT04307394|516099450|FG000|Overall Study|Lost to Follow-up|3|||
143151593|NCT04307394|516099450|FG000|Overall Study|Withdrawal by Subject|2|||
143151594|NCT02536794|516099452|FG000|Reached 1st Response Assessment|Adverse Event|2|||
143151595|NCT02536794|516099452|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
143151596|NCT02536794|516099452|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
143151597|NCT02536794|516099452|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
143151598|NCT02536794|516099452|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
143151599|NCT02536794|516099452|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
143151600|NCT00416949|516099453|FG000|Overall Study|Patients refused to participate|5|||
143151601|NCT01410604|516099455|FG000|Overall Study|Adverse Event|2|||
143151602|NCT01410604|516099456|FG001|Overall Study|Adverse Event|1|||
143151603|NCT01410604|516099455|FG000|Overall Study|Lost to Follow-up|1|||
143151604|NCT01410604|516099456|FG001|Overall Study|Lost to Follow-up|0|||
143151605|NCT01410604|516099455|FG000|Overall Study|Physician Decision|0|||
143151606|NCT01410604|516099456|FG001|Overall Study|Physician Decision|1|||
143151607|NCT01521364|516099459|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
143151608|NCT01521364|516099459|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
143151609|NCT02636283|516099460|FG000|Overall Study|Adverse Event|2|||
143151610|NCT02636283|516099461|FG001|Overall Study|Adverse Event|0|||
143151611|NCT02636283|516099460|FG000|Overall Study|Trial Terminated Prematurely|0|||
143151612|NCT02636283|516099461|FG001|Overall Study|Trial Terminated Prematurely|3|||
143151613|NCT03418675|516099462|FG000|Overall Study|Lost to Follow-up|13|||
143151614|NCT03418675|516099463|FG001|Overall Study|Lost to Follow-up|10|||
143151615|NCT03418675|516099462|FG000|Overall Study|Adverse Event|2|||
143151616|NCT03418675|516099463|FG001|Overall Study|Adverse Event|0|||
143151617|NCT01178411|516099464|FG000|Overall Study|Adverse Event|5|||
143151618|NCT01178411|516099464|FG000|Overall Study|Withdrawal by Subject|4|||
143151619|NCT01178411|516099464|FG000|Overall Study|Protocol Violation|1|||
143151620|NCT01178411|516099464|FG000|Overall Study|Progressive disease per RECIST|32|||
143151621|NCT01178411|516099464|FG000|Overall Study|Progressive disease per clinician|9|||
143151622|NCT01178411|516099464|FG000|Overall Study|Physician Decision|6|||
143151623|NCT01178411|516099464|FG000|Overall Study|Death|1|||
143151624|NCT01178411|516099464|FG000|Overall Study|No reason provided|1|||
143151625|NCT01178411|516099464|FG000|Overall Study|Drug manufacturing ended|1|||
143151626|NCT02383173|516099468|FG000|Overall Study|Palliative Care Team withdrew|0|||
143151627|NCT02383173|516099469|FG001|Overall Study|Palliative Care Team withdrew|2|||
143151628|NCT04900272|516099470|FG000|Overall Study|Lost to Follow-up|2|||
143151629|NCT04900272|516099470|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
143151630|NCT04900272|516099470|FG000|Overall Study|Withdrawal by Subject|1|||
143151631|NCT00195429|516099471|FG000|Overall Study|Adverse Event|2|||
143151632|NCT00195429|516099472|FG001|Overall Study|Adverse Event|4|||
143151633|NCT00195429|516099471|FG000|Overall Study|Lack of Efficacy|2|||
143151634|NCT00195429|516099472|FG001|Overall Study|Lack of Efficacy|1|||
143151635|NCT00195429|516099471|FG000|Overall Study|Lost to Follow-up|1|||
143151636|NCT00195429|516099472|FG001|Overall Study|Lost to Follow-up|0|||
143151637|NCT05561140|516099474|FG000|Randomized Treatment Period|Adverse Event|1|||
143151638|NCT05561140|516099475|FG001|Randomized Treatment Period|Adverse Event|0|||
143151639|NCT05561140|516099474|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
143151640|NCT05561140|516099475|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
143151641|NCT05561140|516099474|FG000|Open Label Treatment Period|Adverse Event|6|||
143151642|NCT05561140|516099475|FG001|Open Label Treatment Period|Adverse Event|4|||
143151643|NCT05561140|516099474|FG000|Open Label Treatment Period|Lost to Follow-up|1|||
143151644|NCT05561140|516099475|FG001|Open Label Treatment Period|Lost to Follow-up|1|||
143151645|NCT05561140|516099474|FG000|Open Label Treatment Period|Physician Decision|0|||
143151646|NCT05561140|516099475|FG001|Open Label Treatment Period|Physician Decision|1|||
143151647|NCT05561140|516099474|FG000|Open Label Treatment Period|Pregnancy|1|||
143151648|NCT05561140|516099475|FG001|Open Label Treatment Period|Pregnancy|0|||
143181266|NCT00175916|516211675|FG000|Overall Study|Suicidal behaviour|1|||
143181267|NCT00175916|516211675|FG000|Overall Study|Withdrawal by Subject|1|||
143181268|NCT00175916|516211675|FG000|Overall Study|Seizure - free|4|||
143181269|NCT00175916|516211675|FG000|Overall Study|Administrative reason|1|||
143181270|NCT00175916|516211675|FG000|Overall Study|Pregnancy|1|||
143181271|NCT00175916|516211675|FG000|Overall Study|Patient's request|2|||
143181272|NCT00175916|516211675|FG000|Overall Study|Treating physiciant's choice|1|||
143181273|NCT00175916|516211675|FG000|Overall Study|Moved overseas|1|||
143181274|NCT00175916|516211675|FG000|Overall Study|Loss of job and economic burden|1|||
143181275|NCT00175916|516211675|FG000|Overall Study|Site was closed|9|||
143181276|NCT00175916|516211675|FG000|Overall Study|Patient went to prison|1|||
143181277|NCT03901963|516211676|FG000|Overall Study|Lost to Follow-up|1|||
143181278|NCT03901963|516211677|FG001|Overall Study|Lost to Follow-up|1|||
143181279|NCT03901963|516211676|FG000|Overall Study|Physician Decision|1|||
143181280|NCT03901963|516211677|FG001|Overall Study|Physician Decision|2|||
143181281|NCT03901963|516211676|FG000|Overall Study|Protocol Violation|1|||
143181282|NCT03901963|516211677|FG001|Overall Study|Protocol Violation|1|||
143181283|NCT03901963|516211676|FG000|Overall Study|Withdrawal by Subject|4|||
143181284|NCT03901963|516211677|FG001|Overall Study|Withdrawal by Subject|11|||
143181285|NCT03901963|516211676|FG000|Overall Study|Ongoing|84|||
143181286|NCT03901963|516211677|FG001|Overall Study|Ongoing|73|||
143181287|NCT03901963|516211676|FG000|Overall Study|Randomized but not treated|3|||
143181288|NCT03901963|516211677|FG001|Overall Study|Randomized but not treated|3|||
143181289|NCT01206140|516211678|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
143181290|NCT01206140|516211679|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
143181291|NCT01803880|516211680|FG000|Overall Study|Adverse Event|1|||
143181292|NCT01803880|516211681|FG001|Overall Study|Adverse Event|0|||
143181293|NCT01803880|516211682|FG002|Overall Study|Adverse Event|0|||
143181294|NCT01803880|516211680|FG000|Overall Study|Withdrawal by Subject|1|||
143181295|NCT01803880|516211681|FG001|Overall Study|Withdrawal by Subject|1|||
143181296|NCT01803880|516211682|FG002|Overall Study|Withdrawal by Subject|4|||
143181297|NCT01803880|516211680|FG000|Overall Study|Physician Decision|0|||
143181298|NCT01803880|516211681|FG001|Overall Study|Physician Decision|0|||
143181299|NCT01803880|516211682|FG002|Overall Study|Physician Decision|1|||
143181300|NCT01803880|516211680|FG000|Overall Study|Unable to return for follow-up visits|0|||
143181301|NCT01803880|516211681|FG001|Overall Study|Unable to return for follow-up visits|1|||
143181302|NCT01803880|516211682|FG002|Overall Study|Unable to return for follow-up visits|2|||
143181303|NCT01803880|516211680|FG000|Overall Study|Lost to Follow-up|1|||
143181304|NCT01803880|516211681|FG001|Overall Study|Lost to Follow-up|2|||
143181305|NCT01803880|516211682|FG002|Overall Study|Lost to Follow-up|3|||
143181306|NCT01803880|516211680|FG000|Overall Study|Protocol Violation|1|||
143181307|NCT01803880|516211681|FG001|Overall Study|Protocol Violation|0|||
143181308|NCT01803880|516211682|FG002|Overall Study|Protocol Violation|0|||
143181309|NCT01803880|516211680|FG000|Overall Study|Early study termination|0|||
143181310|NCT01803880|516211681|FG001|Overall Study|Early study termination|6|||
143181311|NCT01803880|516211682|FG002|Overall Study|Early study termination|5|||
143181312|NCT01803880|516211680|FG000|Overall Study|Incomplete data entry by sites|2|||
143181313|NCT01803880|516211681|FG001|Overall Study|Incomplete data entry by sites|0|||
143181314|NCT01803880|516211682|FG002|Overall Study|Incomplete data entry by sites|0|||
143181315|NCT01081951|516211683|FG000|Overall Study|Death|54|||
143181316|NCT01081951|516211684|FG001|Overall Study|Death|47|||
143181317|NCT01081951|516211683|FG000|Overall Study|Withdrawal by Subject|2|||
143181318|NCT01081951|516211684|FG001|Overall Study|Withdrawal by Subject|6|||
143181319|NCT01081951|516211683|FG000|Overall Study|Allocated treatment but did not take it|0|||
143181320|NCT01081951|516211684|FG001|Overall Study|Allocated treatment but did not take it|1|||
143181321|NCT01081951|516211683|FG000|Overall Study|Lost to Follow-up|0|||
143181322|NCT01081951|516211684|FG001|Overall Study|Lost to Follow-up|1|||
143181323|NCT05226598|516211685|FG000|Overall Study|Death|186|||
143181324|NCT05226598|516211686|FG001|Overall Study|Death|191|||
143181325|NCT05226598|516211685|FG000|Overall Study|Withdrawal by Subject|6|||
143181326|NCT05226598|516211686|FG001|Overall Study|Withdrawal by Subject|6|||
143181327|NCT05226598|516211685|FG000|Overall Study|Ongoing|174|||
143181328|NCT05226598|516211686|FG001|Overall Study|Ongoing|176|||
143181329|NCT02959463|516211687|FG000|Overall Study|Adverse Event|1|||
143233792|NCT03341299|516407075|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
143233793|NCT03341299|516407076|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
143233794|NCT04328077|516408844|FG000|Overall Study|Lost to Follow-up|0|||
143151649|NCT05561140|516099474|FG000|Open Label Treatment Period|Study terminated by sponsor|29|||
143151650|NCT05561140|516099475|FG001|Open Label Treatment Period|Study terminated by sponsor|30|||
143151651|NCT05561140|516099474|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
143233795|NCT04328077|516408845|FG001|Overall Study|Lost to Follow-up|1|||
143233796|NCT04328077|516408846|FG002|Overall Study|Lost to Follow-up|0|||
143233797|NCT04328077|516408847|FG003|Overall Study|Lost to Follow-up|0|||
143233798|NCT04328077|516408844|FG000|Overall Study|Withdrawal by Subject|0|||
143233799|NCT04328077|516408845|FG001|Overall Study|Withdrawal by Subject|1|||
143233800|NCT04328077|516408846|FG002|Overall Study|Withdrawal by Subject|1|||
143151652|NCT05561140|516099475|FG001|Open Label Treatment Period|Withdrawal by Subject|1|||
143151653|NCT05561140|516099474|FG000|Open Label Treatment Period|Other|1|||
143151654|NCT05561140|516099475|FG001|Open Label Treatment Period|Other|0|||
143151655|NCT03301714|516099478|FG000|Overall Study|Lost to Follow-up|10|||
143151656|NCT03301714|516099479|FG001|Overall Study|Lost to Follow-up|4|||
143151657|NCT03301714|516099480|FG002|Overall Study|Lost to Follow-up|4|||
143151658|NCT03301714|516099478|FG000|Overall Study|Did not receive allocated intervention|0|||
143151659|NCT03301714|516099479|FG001|Overall Study|Did not receive allocated intervention|2|||
143151660|NCT03301714|516099480|FG002|Overall Study|Did not receive allocated intervention|3|||
143151661|NCT02112552|516099483|FG000|Overall Study|Withdrawal by Subject|1|||
143151662|NCT02112552|516099483|FG000|Overall Study|Adverse Event|1|||
143151663|NCT05324371|516099484|FG000|Overall Study|Withdrawal by Subject|1|||
143151664|NCT05324371|516099484|FG000|Overall Study|Death|1|||
143151665|NCT01068912|516099485|FG000|Overall Study|Adverse Event|2|||
143151666|NCT01068912|516099486|FG001|Overall Study|Adverse Event|3|||
143151667|NCT01068912|516099487|FG002|Overall Study|Adverse Event|2|||
143151668|NCT01068912|516099485|FG000|Overall Study|Withdrawal by Subject|5|||
143151669|NCT01068912|516099486|FG001|Overall Study|Withdrawal by Subject|6|||
143151670|NCT01068912|516099487|FG002|Overall Study|Withdrawal by Subject|6|||
143151671|NCT01068912|516099485|FG000|Overall Study|Lost to Follow-up|3|||
143151672|NCT01068912|516099486|FG001|Overall Study|Lost to Follow-up|7|||
143151673|NCT01068912|516099487|FG002|Overall Study|Lost to Follow-up|3|||
143151674|NCT01068912|516099485|FG000|Overall Study|Protocol Violation|0|||
143151675|NCT01068912|516099486|FG001|Overall Study|Protocol Violation|2|||
143151676|NCT01068912|516099487|FG002|Overall Study|Protocol Violation|0|||
143151677|NCT01068912|516099485|FG000|Overall Study|aggravation influenza|1|||
143151678|NCT01068912|516099486|FG001|Overall Study|aggravation influenza|1|||
143151679|NCT01068912|516099487|FG002|Overall Study|aggravation influenza|1|||
143151680|NCT01068912|516099485|FG000|Overall Study|other underlying illness|0|||
143151681|NCT01068912|516099486|FG001|Overall Study|other underlying illness|3|||
143151682|NCT01068912|516099487|FG002|Overall Study|other underlying illness|3|||
143151683|NCT00825175|516099488|FG000|Overall Study|Withdrawal by Subject|0|||
143151684|NCT00825175|516099489|FG001|Overall Study|Withdrawal by Subject|5|||
143151685|NCT00118287|516099492|FG000|Overall Study|Intracranial haemorrhage|1|||
143151686|NCT00118287|516099492|FG000|Overall Study|Muscle pain|1|||
143151687|NCT03442569|516099493|FG000|Overall Study|Subject was ineligible after enrollment|1|||
143151688|NCT03091439|516099494|FG000|Overall Study|Study Terminated by the Sponsor|1|||
143151689|NCT03091439|516099495|FG001|Overall Study|Study Terminated by the Sponsor|0|||
143151690|NCT02347787|516099499|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
143151691|NCT02347787|516099500|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
143151692|NCT02347787|516099499|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
143151693|NCT02347787|516099500|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
143151694|NCT02347787|516099499|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
143151695|NCT02347787|516099500|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
143151696|NCT02347787|516099499|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
143151697|NCT02347787|516099500|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
143151698|NCT00544882|516099510|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
143151699|NCT00544882|516099511|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
143151700|NCT00544882|516099512|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
143151701|NCT00544882|516099510|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
143151702|NCT00544882|516099511|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
143151703|NCT00544882|516099512|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
143151704|NCT00544882|516099510|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
143151705|NCT00544882|516099511|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
143151706|NCT00544882|516099512|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
143151707|NCT00544882|516099510|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
143151708|NCT00544882|516099511|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
143151709|NCT00544882|516099512|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
143151710|NCT00544882|516099510|FG000|Cycle 3: Follow-up|Noncompliance|0|||
143233801|NCT04328077|516408847|FG003|Overall Study|Withdrawal by Subject|3|||
143233802|NCT00371150|516408856|FG000|Overall Study|Lost to Follow-up|3|||
143233803|NCT00371150|516408857|FG001|Overall Study|Lost to Follow-up|2|||
143233804|NCT02345070|516408859|FG000|Overall Study|Adverse Event|12|||
143233805|NCT02345070|516408860|FG001|Overall Study|Adverse Event|8|||
143233806|NCT02345070|516408861|FG002|Overall Study|Adverse Event|16|||
143233807|NCT02345070|516408859|FG000|Overall Study|Poor compliance to protocol|2|||
143151711|NCT00544882|516099511|FG001|Cycle 3: Follow-up|Noncompliance|1|||
143151712|NCT00544882|516099512|FG002|Cycle 3: Follow-up|Noncompliance|0|||
143151713|NCT00544882|516099510|FG000|Cycle 3: Follow-up|Pregnancy|0|||
143151714|NCT00544882|516099511|FG001|Cycle 3: Follow-up|Pregnancy|1|||
143151715|NCT00544882|516099512|FG002|Cycle 3: Follow-up|Pregnancy|0|||
143151716|NCT01039675|516099515|FG000|Overall Study|Adverse Event|0|||
143151717|NCT01039675|516099516|FG001|Overall Study|Adverse Event|2|||
143151718|NCT01039675|516099515|FG000|Overall Study|Lack of Efficacy|0|||
143151719|NCT01039675|516099516|FG001|Overall Study|Lack of Efficacy|2|||
143151720|NCT01039675|516099515|FG000|Overall Study|Withdrawal by Subject|0|||
143151721|NCT01039675|516099516|FG001|Overall Study|Withdrawal by Subject|1|||
143151722|NCT01039675|516099515|FG000|Overall Study|Lost to Follow-up|0|||
143151723|NCT01039675|516099516|FG001|Overall Study|Lost to Follow-up|1|||
143151724|NCT01039675|516099515|FG000|Overall Study|Physician Decision|0|||
143151725|NCT01039675|516099516|FG001|Overall Study|Physician Decision|1|||
143151726|NCT00182637|516100887|FG000|Overall Study|Adverse Event|2|||
143151727|NCT00182637|516100887|FG000|Overall Study|Disease Progression|1|||
143151728|NCT02642679|516100888|FG000|Overall Study|Withdrawal by Subject|1|||
143151729|NCT02642679|516100888|FG000|Overall Study|Physician Decision|1|||
143151730|NCT02642679|516100888|FG000|Overall Study|Physician Decision|1|||
143151731|NCT04941898|516100889|FG000|Overall Study|Protocol Violation|1|||
143151732|NCT04633447|516100892|FG000|Main Study (From Week 0 up to Week 60)|Adverse Event|8|||
143151733|NCT04633447|516100893|FG001|Main Study (From Week 0 up to Week 60)|Adverse Event|2|||
143151734|NCT04633447|516100892|FG000|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
143151735|NCT04633447|516100893|FG001|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
143151736|NCT04633447|516100892|FG000|Main Study (From Week 0 up to Week 60)|Physician Decision|0|||
143151737|NCT04633447|516100893|FG001|Main Study (From Week 0 up to Week 60)|Physician Decision|1|||
143151738|NCT04633447|516100892|FG000|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|2|||
143151739|NCT04633447|516100893|FG001|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|0|||
143151740|NCT04633447|516100892|FG000|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|3|||
143151741|NCT04633447|516100893|FG001|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|2|||
143151742|NCT04633447|516100892|FG000|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
143151743|NCT04633447|516100893|FG001|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
143151744|NCT03439839|516100897|FG000|Overall Study|Death|3|||
143151745|NCT03439839|516100898|FG001|Overall Study|Death|0|||
143151746|NCT01807520|516100899|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
143151747|NCT01807520|516100900|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
143151748|NCT01807520|516100901|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
143151749|NCT01807520|516100902|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
143151750|NCT01807520|516100903|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
143151751|NCT01807520|516100904|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
143151752|NCT01807520|516100905|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
143151753|NCT01807520|516100899|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
143151754|NCT01807520|516100900|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
143151755|NCT01807520|516100901|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
143151756|NCT01807520|516100902|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
143151757|NCT01807520|516100903|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
143151758|NCT01807520|516100904|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
143151759|NCT01807520|516100905|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
143151760|NCT01807520|516100899|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
143151761|NCT01807520|516100900|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
143151762|NCT01807520|516100901|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
143151763|NCT01807520|516100902|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
143151764|NCT01807520|516100903|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
143151765|NCT01807520|516100904|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
143151766|NCT01807520|516100905|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
143151767|NCT01807520|516100899|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
143151768|NCT01807520|516100900|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
143151769|NCT01807520|516100901|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
143233808|NCT02345070|516408860|FG001|Overall Study|Poor compliance to protocol|0|||
143233809|NCT02345070|516408861|FG002|Overall Study|Poor compliance to protocol|0|||
143233810|NCT02345070|516408859|FG000|Overall Study|Other than specified above|6|||
143233811|NCT02345070|516408860|FG001|Overall Study|Other than specified above|3|||
143233812|NCT02345070|516408861|FG002|Overall Study|Other than specified above|7|||
143151770|NCT01807520|516100902|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
143151771|NCT01807520|516100903|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
143151772|NCT01807520|516100904|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
143233813|NCT02151058|516408862|FG000|Overall Study|Withdrawal by Subject|1|||
143233814|NCT02151058|516408863|FG001|Overall Study|Withdrawal by Subject|1|||
143233815|NCT02151058|516408864|FG002|Overall Study|Withdrawal by Subject|3|||
143233816|NCT02151058|516408862|FG000|Overall Study|Lost to Follow-up|1|||
143233817|NCT02151058|516408863|FG001|Overall Study|Lost to Follow-up|0|||
143233818|NCT02151058|516408864|FG002|Overall Study|Lost to Follow-up|2|||
143233819|NCT01054885|516408865|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
143233820|NCT01054885|516408866|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
143233821|NCT01054885|516408867|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
143233822|NCT01054885|516408868|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
143233823|NCT01054885|516408869|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
143233824|NCT01054885|516408870|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
143233825|NCT01054885|516408871|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
143233826|NCT01054885|516408865|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
143233827|NCT01054885|516408866|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
143233828|NCT01054885|516408867|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
143233829|NCT01054885|516408868|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
143233830|NCT01054885|516408869|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
143233831|NCT01054885|516408870|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
143233832|NCT01054885|516408871|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
143233833|NCT01054885|516408865|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
143233834|NCT01054885|516408866|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
143233835|NCT01054885|516408867|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
143233836|NCT01054885|516408868|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
143233837|NCT01054885|516408869|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
143233838|NCT01054885|516408870|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
143233839|NCT01054885|516408871|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
143233840|NCT01054885|516408865|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
143233841|NCT01054885|516408866|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
143233842|NCT01054885|516408867|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
143233843|NCT01054885|516408868|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
143233844|NCT01054885|516408869|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
143233845|NCT01054885|516408870|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
143233846|NCT01054885|516408871|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
143233847|NCT01054885|516408865|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
143233848|NCT01054885|516408866|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
143233849|NCT01054885|516408867|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
143233850|NCT01054885|516408868|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
143233851|NCT01054885|516408869|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
143233852|NCT01054885|516408870|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
143233853|NCT01054885|516408871|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
143233854|NCT01054885|516408865|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
143233855|NCT01054885|516408866|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
143233856|NCT01054885|516408867|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
143233857|NCT01054885|516408868|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
143233858|NCT01054885|516408869|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
143233859|NCT01054885|516408870|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
143233860|NCT01054885|516408871|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
143233861|NCT01054885|516408865|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
143233862|NCT01054885|516408866|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
143233863|NCT01054885|516408867|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
143233864|NCT01054885|516408868|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
143151773|NCT01807520|516100905|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
143151774|NCT01807520|516100899|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
143151775|NCT01807520|516100900|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
143151776|NCT01807520|516100901|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
143151777|NCT01807520|516100902|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
143151778|NCT01807520|516100903|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
143151779|NCT01807520|516100904|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
143151780|NCT01807520|516100905|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
143151781|NCT01807520|516100899|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
143151782|NCT01807520|516100900|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
143151783|NCT01807520|516100901|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
143151784|NCT01807520|516100902|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
143151785|NCT01807520|516100903|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
143233865|NCT01054885|516408869|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
143363650|NCT00062868|516873783|FG003|Dose Level 3|Death|0|||
143151786|NCT01807520|516100904|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
143151787|NCT01807520|516100905|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
143151788|NCT01807520|516100899|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
143151789|NCT01807520|516100900|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
143151790|NCT01807520|516100901|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
143151791|NCT01807520|516100902|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
143151792|NCT01807520|516100903|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
143151793|NCT01807520|516100904|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
143151794|NCT01807520|516100905|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
143151795|NCT01807520|516100899|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
143151796|NCT01807520|516100900|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
143151797|NCT01807520|516100901|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
143151798|NCT01807520|516100902|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
143151799|NCT01807520|516100903|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
143151800|NCT01807520|516100904|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
143151801|NCT01807520|516100905|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
143151802|NCT01807520|516100899|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
143151803|NCT01807520|516100900|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
143151804|NCT01807520|516100901|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
143151805|NCT01807520|516100902|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
143151806|NCT01807520|516100903|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
143151807|NCT01807520|516100904|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
143151808|NCT01807520|516100905|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
143151809|NCT01807520|516100899|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
143151810|NCT01807520|516100900|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
143151811|NCT01807520|516100901|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
143151812|NCT01807520|516100902|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
143151813|NCT01807520|516100903|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
143151814|NCT01807520|516100904|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
143151815|NCT01807520|516100905|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
143151816|NCT01807520|516100899|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
143151817|NCT01807520|516100900|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
143181330|NCT02959463|516211688|FG001|Overall Study|Adverse Event|1|||
143181331|NCT02959463|516211687|FG000|Overall Study|Death|1|||
143181332|NCT02959463|516211688|FG001|Overall Study|Death|0|||
143181333|NCT02959463|516211687|FG000|Overall Study|Withdrawal by Subject|1|||
143181334|NCT02959463|516211688|FG001|Overall Study|Withdrawal by Subject|0|||
143181335|NCT02048813|516211689|FG000|Overall Study|Still on treatment|279|||
143181336|NCT02048813|516211690|FG001|Overall Study|Still on treatment|0|||
143181337|NCT02048813|516211689|FG000|Overall Study|Adverse Event|40|||
143181338|NCT02048813|516211690|FG001|Overall Study|Adverse Event|38|||
143181339|NCT02048813|516211689|FG000|Overall Study|Disease progression|13|||
143181340|NCT02048813|516211690|FG001|Overall Study|Disease progression|3|||
143181341|NCT02048813|516211689|FG000|Overall Study|Withdrawal by Subject|7|||
143181342|NCT02048813|516211690|FG001|Overall Study|Withdrawal by Subject|8|||
143181343|NCT02048813|516211689|FG000|Overall Study|Death|2|||
143181344|NCT02048813|516211690|FG001|Overall Study|Death|1|||
143181345|NCT02048813|516211689|FG000|Overall Study|Complication|2|||
143181346|NCT02048813|516211690|FG001|Overall Study|Complication|2|||
143181347|NCT02048813|516211689|FG000|Overall Study|Non-protocol therapy|0|||
143181348|NCT02048813|516211690|FG001|Overall Study|Non-protocol therapy|1|||
143181349|NCT02048813|516211689|FG000|Overall Study|Second primary cancer|2|||
143181350|NCT02048813|516211690|FG001|Overall Study|Second primary cancer|0|||
143181351|NCT02048813|516211689|FG000|Overall Study|Insurance|2|||
143181352|NCT02048813|516211690|FG001|Overall Study|Insurance|0|||
143181353|NCT02048813|516211689|FG000|Overall Study|Wound infection/healing|2|||
143181354|NCT02048813|516211690|FG001|Overall Study|Wound infection/healing|0|||
143181355|NCT02048813|516211689|FG000|Overall Study|Missed appointment|3|||
143181356|NCT02048813|516211690|FG001|Overall Study|Missed appointment|0|||
143181357|NCT02048813|516211689|FG000|Overall Study|Never started treatment|2|||
143181358|NCT02048813|516211690|FG001|Overall Study|Never started treatment|17|||
143181359|NCT04188509|516211691|FG000|Overall Study|Adverse Event|2|||
143181360|NCT04188509|516211691|FG000|Overall Study|Lost to Follow-up|1|||
143181361|NCT04188509|516211691|FG000|Overall Study|Withdrawal of Consent|1|||
143181362|NCT04188509|516211691|FG000|Overall Study|Discretion of Investigator|1|||
143181363|NCT04188509|516211691|FG000|Overall Study|Noncompliance|3|||
143181364|NCT04188509|516211691|FG000|Overall Study|Sponsor Decision|127|||
143181365|NCT04188509|516211691|FG000|Overall Study|Other|2|||
143181366|NCT01541865|516211700|FG000|Overall Study|Lost to Follow-up|11|||
143181367|NCT01541865|516211700|FG000|Overall Study|Withdrawal by Subject|9|||
143181368|NCT01541865|516211700|FG000|Overall Study|Adverse Event|1|||
143233866|NCT01054885|516408870|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
143233867|NCT01054885|516408871|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
143233868|NCT01054885|516408865|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
143233869|NCT01054885|516408866|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
143233870|NCT01054885|516408867|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
143233871|NCT01054885|516408868|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
143233872|NCT01054885|516408869|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
143233873|NCT01054885|516408870|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
143233874|NCT01054885|516408871|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
143233875|NCT01054885|516408865|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
143233876|NCT01054885|516408866|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
143233877|NCT01054885|516408867|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
143233878|NCT01054885|516408868|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
143233879|NCT01054885|516408869|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
143233880|NCT01054885|516408870|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
143233881|NCT01054885|516408871|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
143233882|NCT01054885|516408865|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
143233883|NCT01054885|516408866|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
143233884|NCT01054885|516408867|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
143233885|NCT01054885|516408868|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
143233886|NCT01054885|516408869|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
143233887|NCT01054885|516408870|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
143233888|NCT01054885|516408871|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
143233889|NCT01054885|516408865|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
143233890|NCT01054885|516408866|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
143233891|NCT01054885|516408867|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
143233892|NCT01054885|516408868|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
143233893|NCT01054885|516408869|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
143233894|NCT01054885|516408870|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
143233895|NCT01054885|516408871|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
143233896|NCT01054885|516408865|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
143233897|NCT01054885|516408866|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
143233898|NCT01054885|516408867|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
143233899|NCT01054885|516408868|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
143233900|NCT01054885|516408869|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
143233901|NCT01054885|516408870|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
143233902|NCT01054885|516408871|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
143233903|NCT01054885|516408865|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
143233904|NCT01054885|516408866|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
143233905|NCT01054885|516408867|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
143233906|NCT01054885|516408868|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
143233907|NCT01054885|516408869|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
143233908|NCT01054885|516408870|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
143233909|NCT01054885|516408871|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
143233910|NCT01054885|516408865|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
143233911|NCT01054885|516408866|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
143233912|NCT01054885|516408867|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
143233913|NCT01054885|516408868|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
143233914|NCT01054885|516408869|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
143233915|NCT01054885|516408870|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
143233916|NCT01054885|516408871|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
143233917|NCT01054885|516408865|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
143233918|NCT01054885|516408866|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
143233919|NCT01054885|516408867|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
143233920|NCT01054885|516408868|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
143233921|NCT01054885|516408869|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
143233922|NCT01054885|516408870|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
143233923|NCT01054885|516408871|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
143233924|NCT00124943|516408872|FG000|Phase II|Adverse Event|0|||
143484681|NCT02631200|517320962|FG000|Deferred Period|Received kidney transplant|0|||
143484682|NCT02631200|517320963|FG001|Deferred Period|Received kidney transplant|1|||
143484683|NCT02631200|517320962|FG000|Deferred Period|Withdrawal by Subject|0|||
143233925|NCT00124943|516408873|FG001|Phase II|Adverse Event|2|||
143233926|NCT00124943|516408874|FG002|Phase II|Adverse Event|0|||
143233927|NCT00124943|516408875|FG003|Phase II|Adverse Event|1|||
143233928|NCT00124943|516408872|FG000|Phase II|Protocol Violation|0|||
143233929|NCT00124943|516408873|FG001|Phase II|Protocol Violation|0|||
143233930|NCT00124943|516408874|FG002|Phase II|Protocol Violation|0|||
143233931|NCT00124943|516408875|FG003|Phase II|Protocol Violation|1|||
143233932|NCT00124943|516408872|FG000|Phase II|Lost to Follow-up|0|||
143233933|NCT00124943|516408873|FG001|Phase II|Lost to Follow-up|0|||
143233934|NCT00124943|516408874|FG002|Phase II|Lost to Follow-up|0|||
143233935|NCT00124943|516408875|FG003|Phase II|Lost to Follow-up|1|||
143233936|NCT00124943|516408872|FG000|Phase II|Withdrawal by Subject|0|||
143233937|NCT00124943|516408873|FG001|Phase II|Withdrawal by Subject|0|||
143233938|NCT00124943|516408874|FG002|Phase II|Withdrawal by Subject|0|||
143233939|NCT00124943|516408875|FG003|Phase II|Withdrawal by Subject|2|||
143233940|NCT02443688|516408876|FG000|Overall Study|Adverse Event|2|||
143233941|NCT02443688|516408877|FG001|Overall Study|Adverse Event|3|||
143233942|NCT02443688|516408878|FG002|Overall Study|Adverse Event|2|||
143484684|NCT02631200|517320963|FG001|Deferred Period|Withdrawal by Subject|2|||
143484685|NCT02631200|517320962|FG000|Deferred Period|Lost to Follow-up|0|||
143484686|NCT02631200|517320963|FG001|Deferred Period|Lost to Follow-up|1|||
143484687|NCT01877187|517320964|FG000|Overall Study|Death|2|||
143484688|NCT01877187|517320964|FG000|Overall Study|Withdrawal by Subject|4|||
143484689|NCT01877187|517320964|FG000|Overall Study|Lost to Follow-up|3|||
143484690|NCT01877187|517320964|FG000|Overall Study|Declining clinical status|11|||
143233943|NCT02443688|516408876|FG000|Overall Study|Lost to Follow-up|1|||
143233944|NCT02443688|516408877|FG001|Overall Study|Lost to Follow-up|0|||
143233945|NCT02443688|516408878|FG002|Overall Study|Lost to Follow-up|0|||
143233946|NCT02443688|516408876|FG000|Overall Study|Physician Decision|3|||
143233947|NCT02443688|516408877|FG001|Overall Study|Physician Decision|0|||
143484691|NCT01877187|517320964|FG000|Overall Study|Liver transplant|2|||
143484692|NCT00769002|517320966|FG000|Overall Study|Study was not completed, no data|9|||
143484693|NCT00769002|517320967|FG001|Overall Study|Study was not completed, no data|9|||
143484694|NCT00960661|517320969|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
143484695|NCT00960661|517320970|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
143484696|NCT00960661|517320971|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
143484697|NCT00960661|517320969|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
143484698|NCT00960661|517320970|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
143484699|NCT00960661|517320971|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
143484700|NCT00960661|517320969|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
143484701|NCT00960661|517320970|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
143484702|NCT00960661|517320971|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
143484703|NCT00960661|517320969|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
143484704|NCT00960661|517320970|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
143151818|NCT01807520|516100901|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
143151819|NCT01807520|516100902|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
143151820|NCT01807520|516100903|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
143151821|NCT01807520|516100904|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
143151822|NCT01807520|516100905|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
143151823|NCT01807520|516100899|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
143151824|NCT01807520|516100900|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
143151825|NCT01807520|516100901|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
143151826|NCT01807520|516100902|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
143151827|NCT01807520|516100903|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
143151828|NCT01807520|516100904|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
143151829|NCT01807520|516100905|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
143151830|NCT01807520|516100899|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
143151831|NCT01807520|516100900|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
143151832|NCT01807520|516100901|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
143151833|NCT01807520|516100902|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
143151834|NCT01807520|516100903|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
143151835|NCT01807520|516100904|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
143151836|NCT01807520|516100905|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
143151837|NCT01807520|516100899|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
143151838|NCT01807520|516100900|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
143151839|NCT01807520|516100901|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
143233948|NCT02443688|516408878|FG002|Overall Study|Physician Decision|1|||
143233949|NCT02443688|516408876|FG000|Overall Study|Pregnancy|0|||
143233950|NCT02443688|516408877|FG001|Overall Study|Pregnancy|0|||
143233951|NCT02443688|516408878|FG002|Overall Study|Pregnancy|1|||
143233952|NCT02443688|516408876|FG000|Overall Study|Withdrawal by Subject|3|||
143233953|NCT02443688|516408877|FG001|Overall Study|Withdrawal by Subject|3|||
143233954|NCT02443688|516408878|FG002|Overall Study|Withdrawal by Subject|4|||
143151840|NCT01807520|516100902|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
143151841|NCT01807520|516100903|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
143151842|NCT01807520|516100904|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
143151843|NCT01807520|516100905|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
143151844|NCT01807520|516100899|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
143151845|NCT01807520|516100900|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
143151846|NCT01807520|516100901|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
143233955|NCT02443688|516408876|FG000|Overall Study|Non-compliance with study drug|1|||
143233956|NCT02443688|516408877|FG001|Overall Study|Non-compliance with study drug|2|||
143233957|NCT02443688|516408878|FG002|Overall Study|Non-compliance with study drug|4|||
143233958|NCT02443688|516408876|FG000|Overall Study|Sponsor Request|2|||
143233959|NCT02443688|516408877|FG001|Overall Study|Sponsor Request|1|||
143233960|NCT02443688|516408878|FG002|Overall Study|Sponsor Request|0|||
143233961|NCT00408317|516408880|FG000|First Intervention Period|Adverse Event|0|||
143233962|NCT00408317|516408881|FG001|First Intervention Period|Adverse Event|1|||
143233963|NCT00408317|516408880|FG000|Second Intervention Period|Adverse Event|2|||
143233964|NCT00408317|516408881|FG001|Second Intervention Period|Adverse Event|0|||
143233965|NCT00408317|516408880|FG000|Second Intervention Period|Protocol Violation|0|||
143233966|NCT00408317|516408881|FG001|Second Intervention Period|Protocol Violation|1|||
143233967|NCT00408317|516408880|FG000|Second Intervention Period|Withdrawal of consent|0|||
143233968|NCT00408317|516408881|FG001|Second Intervention Period|Withdrawal of consent|1|||
143233969|NCT00616759|516408882|FG000|Overall Study|Physician Decision|2|||
143233970|NCT00616759|516408883|FG001|Overall Study|Physician Decision|0|||
143233971|NCT00616759|516408882|FG000|Overall Study|Withdrawal by Subject|1|||
143233972|NCT00616759|516408883|FG001|Overall Study|Withdrawal by Subject|2|||
143233973|NCT05660577|516408885|FG000|Overall Study|Discontinued|9|||
143233974|NCT01310777|516408889|FG000|Overall Study|Adverse Event|23|||
143233975|NCT01310777|516408890|FG001|Overall Study|Adverse Event|1|||
143233976|NCT01310777|516408891|FG002|Overall Study|Adverse Event|15|||
143233977|NCT01310777|516408889|FG000|Overall Study|Lost to Follow-up|0|||
143233978|NCT01310777|516408890|FG001|Overall Study|Lost to Follow-up|4|||
143233979|NCT01310777|516408891|FG002|Overall Study|Lost to Follow-up|1|||
143233980|NCT01310777|516408889|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
143233981|NCT01310777|516408890|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
143233982|NCT01310777|516408891|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
143233983|NCT01310777|516408889|FG000|Overall Study|Inadequate Control of IOP|5|||
143233984|NCT01310777|516408890|FG001|Overall Study|Inadequate Control of IOP|7|||
143233985|NCT01310777|516408891|FG002|Overall Study|Inadequate Control of IOP|10|||
143233986|NCT01310777|516408889|FG000|Overall Study|Other|4|||
143233987|NCT01310777|516408890|FG001|Overall Study|Other|1|||
143233988|NCT01310777|516408891|FG002|Overall Study|Other|2|||
143233989|NCT03962491|516408893|FG000|Overall Study|Lost to Follow-up|4|||
143233990|NCT03962491|516408894|FG001|Overall Study|Lost to Follow-up|5|||
143233991|NCT00106704|516408901|FG000|Overall Study|Adverse Event|10|||
143151847|NCT01807520|516100902|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
143151848|NCT01807520|516100903|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
143233992|NCT00106704|516408902|FG001|Overall Study|Adverse Event|7|||
143233993|NCT00106704|516408901|FG000|Overall Study|Death|2|||
143233994|NCT00106704|516408902|FG001|Overall Study|Death|1|||
143151849|NCT01807520|516100904|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
143151850|NCT01807520|516100905|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
143151851|NCT01807520|516100899|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
143151852|NCT01807520|516100900|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
143151853|NCT01807520|516100901|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
143151854|NCT01807520|516100902|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
143151855|NCT01807520|516100903|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
143151856|NCT01807520|516100904|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
143151857|NCT01807520|516100905|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
143151858|NCT01807520|516100899|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
143151859|NCT01807520|516100900|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
143151860|NCT01807520|516100901|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
143151861|NCT01807520|516100902|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
143151862|NCT01807520|516100903|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
143151863|NCT01807520|516100904|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
143233995|NCT00106704|516408901|FG000|Overall Study|Lack of Efficacy|67|||
143233996|NCT00106704|516408902|FG001|Overall Study|Lack of Efficacy|69|||
143233997|NCT00106704|516408901|FG000|Overall Study|Lost to Follow-up|7|||
143233998|NCT00106704|516408902|FG001|Overall Study|Lost to Follow-up|3|||
143151864|NCT01807520|516100905|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
143233999|NCT00106704|516408901|FG000|Overall Study|Pregnancy|1|||
143234000|NCT00106704|516408902|FG001|Overall Study|Pregnancy|0|||
143234001|NCT00106704|516408901|FG000|Overall Study|Protocol Violation|4|||
143484705|NCT00960661|517320971|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
143484706|NCT00960661|517320969|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
143151865|NCT00639379|516100906|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
143234002|NCT00106704|516408902|FG001|Overall Study|Protocol Violation|7|||
143234003|NCT00106704|516408901|FG000|Overall Study|Withdrawal by Subject|14|||
143234004|NCT00106704|516408902|FG001|Overall Study|Withdrawal by Subject|21|||
143234005|NCT00106704|516408901|FG000|Overall Study|Patient moved|1|||
143234006|NCT00106704|516408902|FG001|Overall Study|Patient moved|0|||
143234007|NCT00106704|516408901|FG000|Overall Study|Site terminated|0|||
143151866|NCT00639379|516100907|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
143151867|NCT00639379|516100906|FG000|Period 1 - 2 Weeks|lens issue|3|||
143151868|NCT00639379|516100907|FG001|Period 1 - 2 Weeks|lens issue|0|||
143151869|NCT00992836|516100908|FG000|Overall Study|Lost to Follow-up|1|||
143151870|NCT00992836|516100908|FG000|Overall Study|Withdrawal by Subject|2|||
143151871|NCT00992836|516100908|FG000|Overall Study|Protocol Violation|2|||
143151872|NCT01617967|516100912|FG000|Overall Study|Protocol Violation|0|||
143151873|NCT01617967|516100913|FG001|Overall Study|Protocol Violation|0|||
143151874|NCT01617967|516100914|FG002|Overall Study|Protocol Violation|0|||
143151875|NCT01617967|516100915|FG003|Overall Study|Protocol Violation|1|||
143151876|NCT01617967|516100916|FG004|Overall Study|Protocol Violation|0|||
143151877|NCT01617967|516100917|FG005|Overall Study|Protocol Violation|0|||
143151878|NCT01617967|516100912|FG000|Overall Study|Withdrawal by Subject|0|||
143151879|NCT01617967|516100913|FG001|Overall Study|Withdrawal by Subject|0|||
143151880|NCT01617967|516100914|FG002|Overall Study|Withdrawal by Subject|0|||
143151881|NCT01617967|516100915|FG003|Overall Study|Withdrawal by Subject|0|||
143151882|NCT01617967|516100916|FG004|Overall Study|Withdrawal by Subject|0|||
143151883|NCT01617967|516100917|FG005|Overall Study|Withdrawal by Subject|1|||
143151884|NCT01617967|516100912|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
143151885|NCT01617967|516100913|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
143151886|NCT01617967|516100914|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
143151887|NCT01617967|516100915|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
143151888|NCT01617967|516100916|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
143151889|NCT01617967|516100917|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
143151890|NCT02506036|516100918|FG000|First Intervention (4-6 Weeks)|Death|1|||
143151891|NCT02506036|516100919|FG001|First Intervention (4-6 Weeks)|Death|0|||
143151892|NCT02506036|516100918|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
143151893|NCT02506036|516100919|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
143151894|NCT02506036|516100918|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
143151895|NCT02506036|516100919|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
143151896|NCT05276804|516100922|FG000|Overall Study|screen failure|23|||
143151897|NCT05276804|516100923|FG001|Overall Study|screen failure|0|||
143151898|NCT02827708|516100924|FG000|Overall Study|Lost to Follow-up|3|||
143151899|NCT02827708|516100925|FG001|Overall Study|Lost to Follow-up|1|||
143151900|NCT02827708|516100924|FG000|Overall Study|Withdrawal by Subject|1|||
143151901|NCT02827708|516100925|FG001|Overall Study|Withdrawal by Subject|2|||
143151902|NCT02827708|516100924|FG000|Overall Study|Death|1|||
143151903|NCT02827708|516100925|FG001|Overall Study|Death|2|||
143151904|NCT00898807|516100926|FG000|Overall Study|Withdrawal by Subject|5|||
143151905|NCT00898807|516100927|FG001|Overall Study|Withdrawal by Subject|3|||
143151906|NCT00898807|516100926|FG000|Overall Study|Family pressure to discontinue|2|||
143151907|NCT00898807|516100927|FG001|Overall Study|Family pressure to discontinue|2|||
143151908|NCT00898807|516100926|FG000|Overall Study|Lost to Follow-up|1|||
143151909|NCT00898807|516100927|FG001|Overall Study|Lost to Follow-up|3|||
143151910|NCT00898807|516100926|FG000|Overall Study|Death|0|||
143151911|NCT00898807|516100927|FG001|Overall Study|Death|1|||
143151912|NCT01625182|516100928|FG000|Overall Study|Administrative problems|1|||
143151913|NCT01625182|516100929|FG001|Overall Study|Administrative problems|0|||
143151914|NCT01625182|516100928|FG000|Overall Study|Protocol deviation|0|||
143151915|NCT01625182|516100929|FG001|Overall Study|Protocol deviation|2|||
143151916|NCT01625182|516100928|FG000|Overall Study|Adverse Event|2|||
143151917|NCT01625182|516100929|FG001|Overall Study|Adverse Event|0|||
143151918|NCT01625182|516100928|FG000|Overall Study|Withdrawal by Subject|5|||
143151919|NCT01625182|516100929|FG001|Overall Study|Withdrawal by Subject|1|||
143151920|NCT01625182|516100928|FG000|Overall Study|Lack of Efficacy|12|||
143234008|NCT00106704|516408902|FG001|Overall Study|Site terminated|1|||
143234009|NCT00106704|516408901|FG000|Overall Study|Planned major surgery|1|||
143234010|NCT00106704|516408902|FG001|Overall Study|Planned major surgery|0|||
143234011|NCT00106704|516408901|FG000|Overall Study|Patient Received Glycemic Medication|22|||
143234012|NCT00106704|516408902|FG001|Overall Study|Patient Received Glycemic Medication|41|||
143151921|NCT01625182|516100929|FG001|Overall Study|Lack of Efficacy|8|||
143151922|NCT05059080|516100930|FG000|Overall Study|Withdrawal by Subject|3|||
143151923|NCT05059080|516100930|FG000|Overall Study|Study Terminated by Sponsor|64|||
143151924|NCT00263562|516100931|FG000|Overall Study|Protocol Violation|3|||
143151925|NCT00263562|516100932|FG001|Overall Study|Protocol Violation|0|||
143151926|NCT03927157|516100934|FG000|Overall Study|Adverse Event|1|||
143151927|NCT03927157|516100935|FG001|Overall Study|Adverse Event|3|||
143151928|NCT03927157|516100934|FG000|Overall Study|Protocol Violation|1|||
143151929|NCT03927157|516100935|FG001|Overall Study|Protocol Violation|2|||
143151930|NCT03927157|516100934|FG000|Overall Study|Withdrawal by Subject|8|||
143234013|NCT00106704|516408901|FG000|Overall Study|Unable to re-enter US|1|||
143234014|NCT00106704|516408902|FG001|Overall Study|Unable to re-enter US|0|||
143234015|NCT00106704|516408901|FG000|Overall Study|Laboratory test|1|||
143234016|NCT00106704|516408902|FG001|Overall Study|Laboratory test|1|||
143234017|NCT01780506|516408903|FG000|Double-Blind Phase|Randomized but not Treated|3|||
143234018|NCT01780506|516408904|FG001|Double-Blind Phase|Randomized but not Treated|2|||
143234019|NCT01780506|516408903|FG000|Double-Blind Phase|Adverse Event|4|||
143234020|NCT01780506|516408904|FG001|Double-Blind Phase|Adverse Event|14|||
143234021|NCT01780506|516408903|FG000|Double-Blind Phase|Death|1|||
143234022|NCT01780506|516408904|FG001|Double-Blind Phase|Death|2|||
143234023|NCT01780506|516408903|FG000|Double-Blind Phase|Pregnancy|2|||
143234024|NCT01780506|516408904|FG001|Double-Blind Phase|Pregnancy|1|||
143234025|NCT01780506|516408903|FG000|Double-Blind Phase|Lack of Efficacy|1|||
143234026|NCT01780506|516408904|FG001|Double-Blind Phase|Lack of Efficacy|1|||
143234027|NCT01780506|516408903|FG000|Double-Blind Phase|Investigator's Discretion|5|||
143234028|NCT01780506|516408904|FG001|Double-Blind Phase|Investigator's Discretion|2|||
143234029|NCT01780506|516408903|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
143234030|NCT01780506|516408904|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
143234031|NCT01780506|516408903|FG000|Double-Blind Phase|Protocol Violation|4|||
143234032|NCT01780506|516408904|FG001|Double-Blind Phase|Protocol Violation|3|||
143234033|NCT01780506|516408903|FG000|Double-Blind Phase|Withdrew Consent|23|||
143234034|NCT01780506|516408904|FG001|Double-Blind Phase|Withdrew Consent|24|||
143234035|NCT01780506|516408903|FG000|Double-Blind Phase|Lost to Follow-up|23|||
143234036|NCT01780506|516408904|FG001|Double-Blind Phase|Lost to Follow-up|26|||
143234037|NCT01780506|516408903|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
143234038|NCT01780506|516408904|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
143234039|NCT01867671|516408908|FG000|Overall Study|Adverse Event|5|||
143234040|NCT01867671|516408909|FG001|Overall Study|Adverse Event|3|||
143234041|NCT01867671|516408908|FG000|Overall Study|Anaphylaxis|0|||
143234042|NCT01867671|516408909|FG001|Overall Study|Anaphylaxis|1|||
143234043|NCT01867671|516408908|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
143234044|NCT01867671|516408909|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
143234045|NCT01867671|516408908|FG000|Overall Study|Lost to Follow-up|0|||
143234046|NCT01867671|516408909|FG001|Overall Study|Lost to Follow-up|1|||
143234047|NCT01867671|516408908|FG000|Overall Study|Non-compliance with Study Drug|1|||
143234048|NCT01867671|516408909|FG001|Overall Study|Non-compliance with Study Drug|2|||
143234049|NCT01867671|516408908|FG000|Overall Study|Withdrawal by Subject|21|||
143234050|NCT01867671|516408909|FG001|Overall Study|Withdrawal by Subject|21|||
143234051|NCT05236270|516408914|FG000|Overall Study|Lost to Follow-up|3|||
143234052|NCT05236270|516408915|FG001|Overall Study|Lost to Follow-up|2|||
143234053|NCT05236270|516408916|FG002|Overall Study|Lost to Follow-up|0|||
143234054|NCT05236270|516408917|FG003|Overall Study|Lost to Follow-up|0|||
143234055|NCT05236270|516408918|FG004|Overall Study|Lost to Follow-up|2|||
143234056|NCT05236270|516408919|FG005|Overall Study|Lost to Follow-up|0|||
143234057|NCT05236270|516408920|FG006|Overall Study|Lost to Follow-up|1|||
143234058|NCT05236270|516408921|FG007|Overall Study|Lost to Follow-up|3|||
143234059|NCT03486912|516408922|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
143234060|NCT03486912|516408923|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
143234061|NCT03486912|516408924|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
143234062|NCT03486912|516408925|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
143234063|NCT03486912|516408922|FG000|Treatment Period|Withdrawal by Subject|3|||
143234064|NCT03486912|516408923|FG001|Treatment Period|Withdrawal by Subject|3|||
143234065|NCT03486912|516408924|FG002|Treatment Period|Withdrawal by Subject|3|||
143234066|NCT03486912|516408925|FG003|Treatment Period|Withdrawal by Subject|2|||
143234067|NCT03486912|516408922|FG000|Treatment Period|Other Reasons|0|||
143234068|NCT03486912|516408923|FG001|Treatment Period|Other Reasons|2|||
143234069|NCT03486912|516408924|FG002|Treatment Period|Other Reasons|1|||
143234070|NCT03486912|516408925|FG003|Treatment Period|Other Reasons|1|||
143234071|NCT03486912|516408922|FG000|Treatment Period|Adverse Event|0|||
143234072|NCT03486912|516408923|FG001|Treatment Period|Adverse Event|1|||
143234073|NCT03486912|516408924|FG002|Treatment Period|Adverse Event|1|||
143484707|NCT00960661|517320970|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
143234074|NCT03486912|516408925|FG003|Treatment Period|Adverse Event|0|||
143234075|NCT03486912|516408922|FG000|Treatment Period|Lost to Follow-up|1|||
143234076|NCT03486912|516408923|FG001|Treatment Period|Lost to Follow-up|0|||
143234077|NCT03486912|516408924|FG002|Treatment Period|Lost to Follow-up|0|||
143234078|NCT03486912|516408925|FG003|Treatment Period|Lost to Follow-up|2|||
143234079|NCT00412984|516408926|FG000|Overall Study|Death|331|||
143234080|NCT00412984|516408927|FG001|Overall Study|Death|349|||
143234081|NCT00412984|516408926|FG000|Overall Study|Adverse Event|679|||
143234082|NCT00412984|516408927|FG001|Overall Study|Adverse Event|738|||
143234083|NCT00412984|516408926|FG000|Overall Study|Withdrawal by Subject|921|||
143234084|NCT00412984|516408927|FG001|Overall Study|Withdrawal by Subject|989|||
143234085|NCT00412984|516408926|FG000|Overall Study|Lost to Follow-up|51|||
143234086|NCT00412984|516408927|FG001|Overall Study|Lost to Follow-up|39|||
143234087|NCT00412984|516408926|FG000|Overall Study|Poor/Noncompliance|57|||
143234088|NCT00412984|516408927|FG001|Overall Study|Poor/Noncompliance|77|||
143234089|NCT00412984|516408926|FG000|Overall Study|Pregnancy|1|||
143234090|NCT00412984|516408927|FG001|Overall Study|Pregnancy|0|||
143234091|NCT00412984|516408926|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
143234092|NCT00412984|516408927|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
143234093|NCT00412984|516408926|FG000|Overall Study|Administrative Reason by Sponsor|11|||
143234094|NCT00412984|516408927|FG001|Overall Study|Administrative Reason by Sponsor|8|||
143234095|NCT00412984|516408926|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
143234096|NCT00412984|516408927|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
143234097|NCT00412984|516408926|FG000|Overall Study|Other Reason|80|||
143234098|NCT00412984|516408927|FG001|Overall Study|Other Reason|92|||
143234099|NCT00412984|516408926|FG000|Overall Study|Not Reported|11|||
143234100|NCT00412984|516408927|FG001|Overall Study|Not Reported|12|||
143234101|NCT01499940|516408928|FG000|Overall Study|Study was withdrawn before completion.|9|||
143234102|NCT02435212|516408930|FG000|Core Phase|Adverse Event|8|||
143234103|NCT02435212|516408931|FG001|Core Phase|Adverse Event|5|||
143234104|NCT02435212|516408930|FG000|Core Phase|Withdrawal by Subject|3|||
143234105|NCT02435212|516408931|FG001|Core Phase|Withdrawal by Subject|0|||
143234106|NCT02435212|516408930|FG000|Core Phase|Withdrawal by parent/guardian|9|||
143234107|NCT02435212|516408931|FG001|Core Phase|Withdrawal by parent/guardian|4|||
143234108|NCT02435212|516408930|FG000|Core Phase|Protocol Violation|1|||
143234109|NCT02435212|516408931|FG001|Core Phase|Protocol Violation|2|||
143234110|NCT02435212|516408930|FG000|Core Phase|Physician Decision|3|||
143234111|NCT02435212|516408931|FG001|Core Phase|Physician Decision|0|||
143234112|NCT02435212|516408930|FG000|Core Phase|Lost to Follow-up|0|||
143234113|NCT02435212|516408931|FG001|Core Phase|Lost to Follow-up|1|||
143234114|NCT02435212|516408930|FG000|Core Phase|Lack of Efficacy|0|||
143234115|NCT02435212|516408931|FG001|Core Phase|Lack of Efficacy|1|||
143234116|NCT02435212|516408930|FG000|Core Phase|Recovery|1|||
143234117|NCT02435212|516408931|FG001|Core Phase|Recovery|0|||
143234118|NCT02435212|516408930|FG000|Optional Extension Phase|Adverse Event|3|||
143234119|NCT02435212|516408931|FG001|Optional Extension Phase|Adverse Event|9|||
143234120|NCT02435212|516408930|FG000|Optional Extension Phase|Physician Decision|6|||
143234121|NCT02435212|516408931|FG001|Optional Extension Phase|Physician Decision|8|||
143234122|NCT02435212|516408930|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
143234123|NCT02435212|516408931|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
143234124|NCT02435212|516408930|FG000|Optional Extension Phase|Lack of Efficacy|2|||
143234125|NCT02435212|516408931|FG001|Optional Extension Phase|Lack of Efficacy|3|||
143234126|NCT02435212|516408930|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
143234127|NCT02435212|516408931|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
143234128|NCT02435212|516408930|FG000|Optional Extension Phase|Protocol Violation|0|||
143234129|NCT02435212|516408931|FG001|Optional Extension Phase|Protocol Violation|1|||
143234130|NCT02435212|516408930|FG000|Optional Extension Phase|Recovery|1|||
143234131|NCT02435212|516408931|FG001|Optional Extension Phase|Recovery|1|||
143234132|NCT02435212|516408930|FG000|Optional Extension Phase|Death|1|||
143234133|NCT02435212|516408931|FG001|Optional Extension Phase|Death|0|||
143234134|NCT02435212|516408930|FG000|Optional Extension Phase|Technical problems|2|||
143234135|NCT02435212|516408931|FG001|Optional Extension Phase|Technical problems|0|||
143234136|NCT04711850|516408932|FG000|Overall Study|Graft loss|2|||
143234137|NCT04711850|516408933|FG001|Overall Study|Graft loss|1|||
143234138|NCT04711850|516408932|FG000|Overall Study|Patient not eligible as no AMR in feeder trial|1|||
143234139|NCT04711850|516408933|FG001|Overall Study|Patient not eligible as no AMR in feeder trial|0|||
143234140|NCT04711850|516408932|FG000|Overall Study|Study terminated by sponsor|5|||
143234141|NCT04711850|516408933|FG001|Overall Study|Study terminated by sponsor|3|||
143234142|NCT04711850|516408932|FG000|Overall Study|Sponsor decision|0|||
143234143|NCT04711850|516408933|FG001|Overall Study|Sponsor decision|2|||
143234144|NCT04531176|516408949|FG000|Overall Study|Study was stopped early|24|||
143234145|NCT04531176|516408950|FG001|Overall Study|Study was stopped early|26|||
143234146|NCT04531176|516408951|FG002|Overall Study|Study was stopped early|24|||
143234147|NCT00561652|516408956|FG000|Overall Study|Withdrawal by Subject|0|||
143234148|NCT00561652|516408957|FG001|Overall Study|Withdrawal by Subject|1|||
143234149|NCT00317473|516408958|FG000|Overall Study|Withdrawal by Subject|2|||
143234150|NCT00317473|516408959|FG001|Overall Study|Withdrawal by Subject|1|||
143234151|NCT00317473|516408960|FG002|Overall Study|Withdrawal by Subject|2|||
143234152|NCT00317473|516408961|FG003|Overall Study|Withdrawal by Subject|1|||
143234153|NCT00317473|516408962|FG004|Overall Study|Withdrawal by Subject|3|||
143234154|NCT00317473|516408963|FG005|Overall Study|Withdrawal by Subject|1|||
143234155|NCT00317473|516408958|FG000|Overall Study|Relocation|1|||
143234156|NCT00317473|516408959|FG001|Overall Study|Relocation|0|||
143234157|NCT00317473|516408960|FG002|Overall Study|Relocation|1|||
143234158|NCT00317473|516408961|FG003|Overall Study|Relocation|1|||
143234159|NCT00317473|516408962|FG004|Overall Study|Relocation|5|||
143234160|NCT00317473|516408963|FG005|Overall Study|Relocation|2|||
143234161|NCT00317473|516408958|FG000|Overall Study|Death|1|||
143234162|NCT00317473|516408959|FG001|Overall Study|Death|0|||
143234163|NCT00317473|516408960|FG002|Overall Study|Death|0|||
143234164|NCT00317473|516408961|FG003|Overall Study|Death|0|||
143234165|NCT00317473|516408962|FG004|Overall Study|Death|0|||
143234166|NCT00317473|516408963|FG005|Overall Study|Death|0|||
143234167|NCT00317473|516408958|FG000|Overall Study|Other|0|||
143234168|NCT00317473|516408959|FG001|Overall Study|Other|2|||
143234169|NCT00317473|516408960|FG002|Overall Study|Other|0|||
143234170|NCT00317473|516408961|FG003|Overall Study|Other|0|||
143234171|NCT00317473|516408962|FG004|Overall Study|Other|0|||
143234172|NCT00317473|516408963|FG005|Overall Study|Other|0|||
143234173|NCT02285855|516408964|FG000|Overall Study|Withdrawal by Subject|2|||
143234174|NCT02285855|516408965|FG001|Overall Study|Withdrawal by Subject|1|||
143234175|NCT00528112|516408966|FG000|Treatment up to 3 Years|Adverse Event|313|||
143234176|NCT00528112|516408967|FG001|Treatment up to 3 Years|Adverse Event|278|||
143234177|NCT00528112|516408966|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
143234178|NCT00528112|516408967|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
143234179|NCT00528112|516408966|FG000|Treatment up to 3 Years|Protocol Violation|16|||
143234180|NCT00528112|516408967|FG001|Treatment up to 3 Years|Protocol Violation|16|||
143234181|NCT00528112|516408966|FG000|Treatment up to 3 Years|Death|0|||
143234182|NCT00528112|516408967|FG001|Treatment up to 3 Years|Death|1|||
143234183|NCT00528112|516408966|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
143234184|NCT00528112|516408967|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
143234185|NCT00528112|516408966|FG000|Treatment up to 3 Years|Pregnancy|9|||
143234186|NCT00528112|516408967|FG001|Treatment up to 3 Years|Pregnancy|10|||
143234187|NCT00528112|516408966|FG000|Treatment up to 3 Years|Other reasons|186|||
143234188|NCT00528112|516408967|FG001|Treatment up to 3 Years|Other reasons|186|||
143234189|NCT00528112|516408966|FG000|Extension Phase|Withdrawal by Subject|0|||
143234190|NCT00528112|516408967|FG001|Extension Phase|Withdrawal by Subject|3|||
143234191|NCT00528112|516408966|FG000|Extension Phase|Other reasons|0|||
143234192|NCT00528112|516408967|FG001|Extension Phase|Other reasons|100|||
143234193|NCT00528112|516408966|FG000|Extension Phase|Pregnancy|0|||
143234194|NCT00528112|516408967|FG001|Extension Phase|Pregnancy|3|||
143151931|NCT03927157|516100935|FG001|Overall Study|Withdrawal by Subject|21|||
143151932|NCT03927157|516100934|FG000|Overall Study|Due to COVID-19 pandemic|5|||
143151933|NCT03927157|516100935|FG001|Overall Study|Due to COVID-19 pandemic|2|||
143151934|NCT03927157|516100934|FG000|Overall Study|Protocol-specified withdrawal criterion met|0|||
143151935|NCT03927157|516100935|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
143151936|NCT03927157|516100934|FG000|Overall Study|Other than above|0|||
143151937|NCT03927157|516100935|FG001|Overall Study|Other than above|1|||
143151938|NCT00726557|516100936|FG000|Overall Study|Screening failure|4|||
143151939|NCT00726557|516100936|FG000|Overall Study|No end of treatment documentation|37|||
143151940|NCT00726557|516100936|FG000|Overall Study|No follow-up documentation available|55|||
143151941|NCT00726557|516100936|FG000|Overall Study|Treatment less than 3 months|17|||
143151942|NCT00726557|516100936|FG000|Overall Study|Inclusion criteria not met|15|||
143151943|NCT01257542|516100941|FG000|Overall Study|Protocol Violation|3|||
143151944|NCT01257542|516100942|FG001|Overall Study|Protocol Violation|5|||
143151945|NCT01257542|516100941|FG000|Overall Study|Withdrawal by Subject|0|||
143151946|NCT01257542|516100942|FG001|Overall Study|Withdrawal by Subject|2|||
143151947|NCT02541903|516100945|FG000|Overall Study|Death|1|||
143151948|NCT03880565|516100946|FG000|Overall Study|Withdrawal by Subject|1|||
143151949|NCT03880565|516100947|FG001|Overall Study|Withdrawal by Subject|0|||
143151950|NCT02969018|516100952|FG000|Overall Study|Adverse Event|2|||
143151951|NCT02969018|516100953|FG001|Overall Study|Adverse Event|4|||
143151952|NCT02969018|516100954|FG002|Overall Study|Adverse Event|1|||
143151953|NCT02969018|516100955|FG003|Overall Study|Adverse Event|2|||
143151954|NCT02969018|516100956|FG004|Overall Study|Adverse Event|0|||
143151955|NCT02969018|516100957|FG005|Overall Study|Adverse Event|1|||
143151956|NCT02969018|516100958|FG006|Overall Study|Adverse Event|2|||
143151957|NCT02969018|516100959|FG007|Overall Study|Adverse Event|0|||
143151958|NCT02969018|516100952|FG000|Overall Study|Lack of Efficacy|0|||
143151959|NCT02969018|516100953|FG001|Overall Study|Lack of Efficacy|1|||
143151960|NCT02969018|516100954|FG002|Overall Study|Lack of Efficacy|0|||
143151961|NCT02969018|516100955|FG003|Overall Study|Lack of Efficacy|0|||
143151962|NCT02969018|516100956|FG004|Overall Study|Lack of Efficacy|1|||
143151963|NCT02969018|516100957|FG005|Overall Study|Lack of Efficacy|1|||
143151964|NCT02969018|516100958|FG006|Overall Study|Lack of Efficacy|1|||
143151965|NCT02969018|516100959|FG007|Overall Study|Lack of Efficacy|1|||
143234195|NCT00528112|516408966|FG000|Extension Phase|Lost to Follow-up|0|||
143234196|NCT00528112|516408967|FG001|Extension Phase|Lost to Follow-up|12|||
143234197|NCT00528112|516408966|FG000|Extension Phase|Death|0|||
143234198|NCT00528112|516408967|FG001|Extension Phase|Death|1|||
143234199|NCT00528112|516408966|FG000|Extension Phase|Adverse Event|0|||
143151966|NCT02969018|516100952|FG000|Overall Study|Lost to Follow-up|1|||
143151967|NCT02969018|516100953|FG001|Overall Study|Lost to Follow-up|2|||
143151968|NCT02969018|516100954|FG002|Overall Study|Lost to Follow-up|2|||
143151969|NCT02969018|516100955|FG003|Overall Study|Lost to Follow-up|0|||
143151970|NCT02969018|516100956|FG004|Overall Study|Lost to Follow-up|1|||
143151971|NCT02969018|516100957|FG005|Overall Study|Lost to Follow-up|1|||
143151972|NCT02969018|516100958|FG006|Overall Study|Lost to Follow-up|0|||
143151973|NCT02969018|516100959|FG007|Overall Study|Lost to Follow-up|1|||
143234200|NCT00528112|516408967|FG001|Extension Phase|Adverse Event|36|||
143234201|NCT00528112|516408966|FG000|Extension Phase|Protocol Violation|0|||
143234202|NCT00528112|516408967|FG001|Extension Phase|Protocol Violation|2|||
143234203|NCT01126749|516408976|FG000|Phase 1b|Other|0|||
143234204|NCT01126749|516408977|FG001|Phase 1b|Other|1|||
143234205|NCT01126749|516408978|FG002|Phase 1b|Other|0|||
143234206|NCT01126749|516408979|FG003|Phase 1b|Other|0|||
143234207|NCT01126749|516408976|FG000|Phase 1b|Withdrawal by Subject|0|||
143234208|NCT01126749|516408977|FG001|Phase 1b|Withdrawal by Subject|1|||
143151974|NCT02969018|516100952|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
143151975|NCT02969018|516100953|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
143151976|NCT02969018|516100954|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
143151977|NCT02969018|516100955|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
143151978|NCT02969018|516100956|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
143151979|NCT02969018|516100957|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
143151980|NCT02969018|516100958|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
143151981|NCT02969018|516100959|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
143151982|NCT02969018|516100952|FG000|Overall Study|Non-Compliance With Study Drug|1|||
143151983|NCT02969018|516100953|FG001|Overall Study|Non-Compliance With Study Drug|0|||
143151984|NCT02969018|516100954|FG002|Overall Study|Non-Compliance With Study Drug|0|||
143151985|NCT02969018|516100955|FG003|Overall Study|Non-Compliance With Study Drug|0|||
143151986|NCT02969018|516100956|FG004|Overall Study|Non-Compliance With Study Drug|0|||
143151987|NCT02969018|516100957|FG005|Overall Study|Non-Compliance With Study Drug|0|||
143151988|NCT02969018|516100958|FG006|Overall Study|Non-Compliance With Study Drug|0|||
143151989|NCT02969018|516100959|FG007|Overall Study|Non-Compliance With Study Drug|0|||
143151990|NCT02969018|516100952|FG000|Overall Study|Other|0|||
143151991|NCT02969018|516100953|FG001|Overall Study|Other|0|||
143151992|NCT02969018|516100954|FG002|Overall Study|Other|0|||
143151993|NCT02969018|516100955|FG003|Overall Study|Other|1|||
143151994|NCT02969018|516100956|FG004|Overall Study|Other|0|||
143151995|NCT02969018|516100957|FG005|Overall Study|Other|0|||
143151996|NCT02969018|516100958|FG006|Overall Study|Other|0|||
143151997|NCT02969018|516100959|FG007|Overall Study|Other|2|||
143151998|NCT02969018|516100952|FG000|Overall Study|Pregnancy|0|||
143484708|NCT00960661|517320971|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
143484709|NCT00960661|517320969|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
143484710|NCT00960661|517320970|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
143484711|NCT00960661|517320971|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
143484712|NCT00960661|517320969|FG000|Interventional Phase|Adverse Event|0|||
143484713|NCT00960661|517320970|FG001|Interventional Phase|Adverse Event|17|||
143484714|NCT00960661|517320971|FG002|Interventional Phase|Adverse Event|8|||
143484715|NCT00960661|517320969|FG000|Interventional Phase|Death|0|||
143484716|NCT00960661|517320970|FG001|Interventional Phase|Death|1|||
143484717|NCT00960661|517320971|FG002|Interventional Phase|Death|0|||
143484718|NCT00960661|517320969|FG000|Interventional Phase|Lost to Follow-up|0|||
143484719|NCT00960661|517320970|FG001|Interventional Phase|Lost to Follow-up|0|||
143484720|NCT00960661|517320971|FG002|Interventional Phase|Lost to Follow-up|2|||
143484721|NCT00960661|517320969|FG000|Interventional Phase|entry criteria not met|0|||
143484722|NCT00960661|517320970|FG001|Interventional Phase|entry criteria not met|3|||
143484723|NCT00960661|517320971|FG002|Interventional Phase|entry criteria not met|0|||
143484724|NCT00960661|517320969|FG000|Interventional Phase|Protocol Violation|0|||
143484725|NCT00960661|517320970|FG001|Interventional Phase|Protocol Violation|7|||
143484726|NCT00960661|517320971|FG002|Interventional Phase|Protocol Violation|2|||
143484727|NCT00960661|517320969|FG000|Interventional Phase|Withdrawal by Subject|0|||
143484728|NCT00960661|517320970|FG001|Interventional Phase|Withdrawal by Subject|18|||
143484729|NCT00960661|517320971|FG002|Interventional Phase|Withdrawal by Subject|29|||
143484730|NCT00960661|517320969|FG000|Interventional Phase|Physician Decision|0|||
143484731|NCT00960661|517320970|FG001|Interventional Phase|Physician Decision|3|||
143484732|NCT00960661|517320971|FG002|Interventional Phase|Physician Decision|5|||
143484733|NCT00960661|517320969|FG000|Interventional Phase|sponsor decision|0|||
143151999|NCT02969018|516100953|FG001|Overall Study|Pregnancy|0|||
143152000|NCT02969018|516100954|FG002|Overall Study|Pregnancy|0|||
143152001|NCT02969018|516100955|FG003|Overall Study|Pregnancy|0|||
143152002|NCT02969018|516100956|FG004|Overall Study|Pregnancy|0|||
143152003|NCT02969018|516100957|FG005|Overall Study|Pregnancy|1|||
143152004|NCT02969018|516100958|FG006|Overall Study|Pregnancy|0|||
143152005|NCT02969018|516100959|FG007|Overall Study|Pregnancy|0|||
143234209|NCT01126749|516408978|FG002|Phase 1b|Withdrawal by Subject|0|||
143234210|NCT01126749|516408979|FG003|Phase 1b|Withdrawal by Subject|0|||
143152006|NCT02969018|516100952|FG000|Overall Study|Protocol Violation|0|||
143234211|NCT01126749|516408976|FG000|Phase 1b|Death|3|||
143152007|NCT02969018|516100953|FG001|Overall Study|Protocol Violation|0|||
143152008|NCT02969018|516100954|FG002|Overall Study|Protocol Violation|1|||
143152009|NCT02969018|516100955|FG003|Overall Study|Protocol Violation|1|||
143152010|NCT02969018|516100956|FG004|Overall Study|Protocol Violation|0|||
143152011|NCT02969018|516100957|FG005|Overall Study|Protocol Violation|0|||
143234212|NCT01126749|516408977|FG001|Phase 1b|Death|4|||
143234213|NCT01126749|516408978|FG002|Phase 1b|Death|0|||
143234214|NCT01126749|516408979|FG003|Phase 1b|Death|0|||
143234215|NCT01126749|516408976|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
143234216|NCT01126749|516408977|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
143234217|NCT01126749|516408978|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
143234218|NCT01126749|516408979|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
143234219|NCT01126749|516408976|FG000|Phase 2|Study Termination by Sponsor|0|||
143234220|NCT01126749|516408977|FG001|Phase 2|Study Termination by Sponsor|0|||
143234221|NCT01126749|516408978|FG002|Phase 2|Study Termination by Sponsor|12|||
143234222|NCT01126749|516408979|FG003|Phase 2|Study Termination by Sponsor|6|||
143234223|NCT01126749|516408976|FG000|Phase 2|Other|0|||
143234224|NCT01126749|516408977|FG001|Phase 2|Other|0|||
143234225|NCT01126749|516408978|FG002|Phase 2|Other|4|||
143234226|NCT01126749|516408979|FG003|Phase 2|Other|2|||
143234227|NCT01126749|516408976|FG000|Phase 2|Withdrawal by Subject|0|||
143234228|NCT01126749|516408977|FG001|Phase 2|Withdrawal by Subject|0|||
143234229|NCT01126749|516408978|FG002|Phase 2|Withdrawal by Subject|0|||
143234230|NCT01126749|516408979|FG003|Phase 2|Withdrawal by Subject|2|||
143234231|NCT01126749|516408976|FG000|Phase 2|Lost to Follow-up|0|||
143234232|NCT01126749|516408977|FG001|Phase 2|Lost to Follow-up|0|||
143234233|NCT01126749|516408978|FG002|Phase 2|Lost to Follow-up|0|||
143234234|NCT01126749|516408979|FG003|Phase 2|Lost to Follow-up|1|||
143234235|NCT01126749|516408976|FG000|Phase 2|Death|0|||
143234236|NCT01126749|516408977|FG001|Phase 2|Death|0|||
143234237|NCT01126749|516408978|FG002|Phase 2|Death|22|||
143234238|NCT01126749|516408979|FG003|Phase 2|Death|22|||
143234239|NCT01126749|516408976|FG000|Phase 2|Adverse Event|0|||
143234240|NCT01126749|516408977|FG001|Phase 2|Adverse Event|0|||
143234241|NCT01126749|516408978|FG002|Phase 2|Adverse Event|0|||
143234242|NCT01126749|516408979|FG003|Phase 2|Adverse Event|1|||
143234243|NCT04609319|516408981|FG000|Overall Study|Death|64|||
143234244|NCT04609319|516408982|FG001|Overall Study|Death|49|||
143234245|NCT04609319|516408983|FG002|Overall Study|Death|1|||
143234246|NCT04609319|516408981|FG000|Overall Study|Withdrawal of consent|15|||
143234247|NCT04609319|516408982|FG001|Overall Study|Withdrawal of consent|3|||
143234248|NCT04609319|516408983|FG002|Overall Study|Withdrawal of consent|0|||
143234249|NCT04609319|516408981|FG000|Overall Study|Lost to Follow-up|20|||
143234250|NCT04609319|516408982|FG001|Overall Study|Lost to Follow-up|33|||
143234251|NCT04609319|516408983|FG002|Overall Study|Lost to Follow-up|0|||
143234252|NCT04609319|516408981|FG000|Overall Study|Alive until end of follow-up|60|||
143234253|NCT04609319|516408982|FG001|Overall Study|Alive until end of follow-up|53|||
143234254|NCT04609319|516408983|FG002|Overall Study|Alive until end of follow-up|1|||
143234255|NCT03804528|516408984|FG000|Overall Study|Time Commitment|18|||
143152012|NCT02969018|516100958|FG006|Overall Study|Protocol Violation|0|||
143152013|NCT02969018|516100959|FG007|Overall Study|Protocol Violation|0|||
143152014|NCT02969018|516100952|FG000|Overall Study|Withdrawal by Subject|0|||
143152015|NCT02969018|516100953|FG001|Overall Study|Withdrawal by Subject|1|||
143234256|NCT03804528|516408984|FG000|Overall Study|Health Reasons|5|||
143234257|NCT04607005|516408987|FG000|Overall Study|Adverse Event|0|||
143234258|NCT04607005|516408988|FG001|Overall Study|Adverse Event|1|||
143234259|NCT04607005|516408987|FG000|Overall Study|Lack of Efficacy|1|||
143234260|NCT04607005|516408988|FG001|Overall Study|Lack of Efficacy|6|||
143234261|NCT04607005|516408987|FG000|Overall Study|Withdrawal by Subject|4|||
143234262|NCT04607005|516408988|FG001|Overall Study|Withdrawal by Subject|9|||
143234263|NCT04607005|516408987|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
143234264|NCT04607005|516408988|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
143152016|NCT02969018|516100954|FG002|Overall Study|Withdrawal by Subject|2|||
143152017|NCT02969018|516100955|FG003|Overall Study|Withdrawal by Subject|1|||
143152018|NCT02969018|516100956|FG004|Overall Study|Withdrawal by Subject|0|||
143152019|NCT02969018|516100957|FG005|Overall Study|Withdrawal by Subject|4|||
143152020|NCT02969018|516100958|FG006|Overall Study|Withdrawal by Subject|4|||
143152021|NCT02969018|516100959|FG007|Overall Study|Withdrawal by Subject|3|||
143152022|NCT02836769|516100963|FG000|Overall Study|Lost to Follow-up|10|||
143484734|NCT00960661|517320970|FG001|Interventional Phase|sponsor decision|1|||
143484735|NCT00960661|517320971|FG002|Interventional Phase|sponsor decision|0|||
143152023|NCT02836769|516100963|FG000|Overall Study|Medical withdrawal|2|||
143234265|NCT02331134|516408989|FG000|Overall Study|Withdrawal by Subject|1|||
143234266|NCT04825574|516408990|FG000|Overall Study|Commercial treatment became available|1|||
143234267|NCT04825574|516408990|FG000|Overall Study|Disease progression|1|||
143234268|NCT03518086|516408991|FG000|Overall Study|Adverse Event|23|||
143234269|NCT03518086|516408992|FG001|Overall Study|Adverse Event|15|||
143152024|NCT02836769|516100963|FG000|Overall Study|Withdrawal by Subject|3|||
143234270|NCT03518086|516408993|FG002|Overall Study|Adverse Event|3|||
143234271|NCT03518086|516408994|FG003|Overall Study|Adverse Event|2|||
143234272|NCT03518086|516408991|FG000|Overall Study|Withdrawal by Subject|8|||
143234273|NCT03518086|516408992|FG001|Overall Study|Withdrawal by Subject|5|||
143234274|NCT03518086|516408993|FG002|Overall Study|Withdrawal by Subject|1|||
143234275|NCT03518086|516408994|FG003|Overall Study|Withdrawal by Subject|0|||
143152025|NCT01944774|516100969|FG000|Overall Study|Withdrawal by Subject|2|||
143152026|NCT01944774|516100970|FG001|Overall Study|Withdrawal by Subject|3|||
143234276|NCT03518086|516408991|FG000|Overall Study|Lack of Efficacy|5|||
143152027|NCT01944774|516100971|FG002|Overall Study|Withdrawal by Subject|3|||
143234277|NCT03518086|516408992|FG001|Overall Study|Lack of Efficacy|5|||
143234278|NCT03518086|516408993|FG002|Overall Study|Lack of Efficacy|0|||
143234279|NCT03518086|516408994|FG003|Overall Study|Lack of Efficacy|2|||
143152028|NCT01944774|516100969|FG000|Overall Study|Adverse Event|3|||
143152029|NCT01944774|516100970|FG001|Overall Study|Adverse Event|2|||
143152030|NCT01944774|516100971|FG002|Overall Study|Adverse Event|3|||
143152031|NCT01944774|516100969|FG000|Overall Study|Lack of Efficacy|1|||
143152032|NCT01944774|516100970|FG001|Overall Study|Lack of Efficacy|2|||
143152033|NCT01944774|516100971|FG002|Overall Study|Lack of Efficacy|2|||
143152034|NCT01944774|516100969|FG000|Overall Study|Lost to Follow-up|0|||
143152035|NCT01944774|516100970|FG001|Overall Study|Lost to Follow-up|1|||
143152036|NCT01944774|516100971|FG002|Overall Study|Lost to Follow-up|0|||
143152037|NCT03325439|516100976|FG000|Overall Study|Ineligibility|3|||
143152038|NCT03188185|516100977|FG000|Stage 1|Adverse Event|4|||
143152039|NCT03188185|516100978|FG001|Stage 1|Adverse Event|12|||
143152040|NCT03188185|516100979|FG002|Stage 1|Adverse Event|0|||
143152041|NCT03188185|516100980|FG003|Stage 1|Adverse Event|0|||
143152042|NCT03188185|516100977|FG000|Stage 1|Lack of Efficacy|0|||
143152043|NCT03188185|516100978|FG001|Stage 1|Lack of Efficacy|2|||
143152044|NCT03188185|516100979|FG002|Stage 1|Lack of Efficacy|0|||
143152045|NCT03188185|516100980|FG003|Stage 1|Lack of Efficacy|0|||
143152046|NCT03188185|516100977|FG000|Stage 1|Lost to Follow-up|6|||
143152047|NCT03188185|516100978|FG001|Stage 1|Lost to Follow-up|1|||
143152048|NCT03188185|516100979|FG002|Stage 1|Lost to Follow-up|0|||
143152049|NCT03188185|516100980|FG003|Stage 1|Lost to Follow-up|0|||
143152050|NCT03188185|516100977|FG000|Stage 1|Withdrawal by Subject|9|||
143152051|NCT03188185|516100978|FG001|Stage 1|Withdrawal by Subject|0|||
143152052|NCT03188185|516100979|FG002|Stage 1|Withdrawal by Subject|0|||
143152053|NCT03188185|516100980|FG003|Stage 1|Withdrawal by Subject|0|||
143152054|NCT03188185|516100977|FG000|Stage 1|Identified as a professional patient|0|||
143152055|NCT03188185|516100978|FG001|Stage 1|Identified as a professional patient|1|||
143152056|NCT03188185|516100979|FG002|Stage 1|Identified as a professional patient|0|||
143152057|NCT03188185|516100980|FG003|Stage 1|Identified as a professional patient|0|||
143152058|NCT03188185|516100977|FG000|Stage 2|Adverse Event|0|||
143152059|NCT03188185|516100978|FG001|Stage 2|Adverse Event|0|||
143152060|NCT03188185|516100979|FG002|Stage 2|Adverse Event|2|||
143152061|NCT03188185|516100980|FG003|Stage 2|Adverse Event|4|||
143152062|NCT03188185|516100977|FG000|Stage 2|Lack of Efficacy|0|||
143152063|NCT03188185|516100978|FG001|Stage 2|Lack of Efficacy|0|||
143152064|NCT03188185|516100979|FG002|Stage 2|Lack of Efficacy|3|||
143152065|NCT03188185|516100980|FG003|Stage 2|Lack of Efficacy|0|||
143152066|NCT03188185|516100977|FG000|Stage 2|Lost to Follow-up|0|||
143152067|NCT03188185|516100978|FG001|Stage 2|Lost to Follow-up|0|||
143152068|NCT03188185|516100979|FG002|Stage 2|Lost to Follow-up|1|||
143152069|NCT03188185|516100980|FG003|Stage 2|Lost to Follow-up|0|||
143152070|NCT03188185|516100977|FG000|Stage 2|Physician Decision|0|||
143152071|NCT03188185|516100978|FG001|Stage 2|Physician Decision|0|||
143152072|NCT03188185|516100979|FG002|Stage 2|Physician Decision|0|||
143152073|NCT03188185|516100980|FG003|Stage 2|Physician Decision|1|||
143152074|NCT03188185|516100977|FG000|Stage 2|Withdrawal by Subject|0|||
143152075|NCT03188185|516100978|FG001|Stage 2|Withdrawal by Subject|0|||
143152076|NCT03188185|516100979|FG002|Stage 2|Withdrawal by Subject|3|||
143152077|NCT03188185|516100980|FG003|Stage 2|Withdrawal by Subject|1|||
143152078|NCT03349515|516100981|FG000|Overall Study|Lack of Efficacy|2|||
143152079|NCT03349515|516100982|FG001|Overall Study|Lack of Efficacy|0|||
143152080|NCT03349515|516100981|FG000|Overall Study|Physician Decision|3|||
143152081|NCT03349515|516100982|FG001|Overall Study|Physician Decision|1|||
143234280|NCT03518086|516408991|FG000|Overall Study|Protocol Violation|1|||
143234281|NCT03518086|516408992|FG001|Overall Study|Protocol Violation|5|||
143234282|NCT03518086|516408993|FG002|Overall Study|Protocol Violation|1|||
143234283|NCT03518086|516408994|FG003|Overall Study|Protocol Violation|3|||
143234284|NCT03518086|516408991|FG000|Overall Study|Lost to Follow-up|0|||
143152082|NCT03412890|516100989|FG000|Overall Study|Adverse Event|5|||
143152083|NCT03412890|516100990|FG001|Overall Study|Adverse Event|5|||
143152084|NCT03412890|516100991|FG002|Overall Study|Adverse Event|9|||
143152085|NCT03412890|516100989|FG000|Overall Study|Protocol deviation|2|||
143152086|NCT03412890|516100990|FG001|Overall Study|Protocol deviation|1|||
143152087|NCT03412890|516100991|FG002|Overall Study|Protocol deviation|2|||
143152088|NCT03412890|516100989|FG000|Overall Study|Lost to Follow-up|7|||
143152089|NCT03412890|516100990|FG001|Overall Study|Lost to Follow-up|10|||
143152090|NCT03412890|516100991|FG002|Overall Study|Lost to Follow-up|10|||
143152091|NCT03412890|516100989|FG000|Overall Study|Withdrawal by Subject|9|||
143152092|NCT03412890|516100990|FG001|Overall Study|Withdrawal by Subject|12|||
143152093|NCT03412890|516100991|FG002|Overall Study|Withdrawal by Subject|11|||
143152094|NCT03412890|516100989|FG000|Overall Study|Lack of Efficacy|2|||
143152095|NCT03412890|516100990|FG001|Overall Study|Lack of Efficacy|7|||
143152096|NCT03412890|516100991|FG002|Overall Study|Lack of Efficacy|5|||
143152097|NCT03412890|516100989|FG000|Overall Study|Other|5|||
143152098|NCT03412890|516100990|FG001|Overall Study|Other|6|||
143152099|NCT03412890|516100991|FG002|Overall Study|Other|5|||
143152100|NCT03412890|516100989|FG000|Overall Study|Participants who did not receive any study drug|0|||
143234285|NCT03518086|516408992|FG001|Overall Study|Lost to Follow-up|3|||
143234286|NCT03518086|516408993|FG002|Overall Study|Lost to Follow-up|0|||
143234287|NCT03518086|516408994|FG003|Overall Study|Lost to Follow-up|0|||
143234288|NCT03518086|516408991|FG000|Overall Study|Insufficient Diary Data|0|||
143234289|NCT03518086|516408992|FG001|Overall Study|Insufficient Diary Data|2|||
143234290|NCT03518086|516408993|FG002|Overall Study|Insufficient Diary Data|0|||
143234291|NCT03518086|516408994|FG003|Overall Study|Insufficient Diary Data|0|||
143234292|NCT03518086|516408991|FG000|Overall Study|Non- compliance to Protocol|0|||
143234293|NCT03518086|516408992|FG001|Overall Study|Non- compliance to Protocol|1|||
143234294|NCT03518086|516408993|FG002|Overall Study|Non- compliance to Protocol|0|||
143234295|NCT03518086|516408994|FG003|Overall Study|Non- compliance to Protocol|0|||
143234296|NCT03518086|516408991|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
143234297|NCT03518086|516408992|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
143181369|NCT01541865|516211700|FG000|Overall Study|Protocol Violation|1|||
143181370|NCT01393899|516211717|FG000|Overall Study|Study terminated by sponsor|1|||
143181371|NCT01393899|516211718|FG001|Overall Study|Study terminated by sponsor|0|||
143181372|NCT01393899|516211719|FG002|Overall Study|Study terminated by sponsor|1|||
143181373|NCT01393899|516211717|FG000|Overall Study|Other|1|||
143181374|NCT01393899|516211718|FG001|Overall Study|Other|0|||
143181375|NCT01393899|516211719|FG002|Overall Study|Other|0|||
143181376|NCT01393899|516211717|FG000|Overall Study|Withdrawal by Subject|2|||
143181377|NCT01393899|516211718|FG001|Overall Study|Withdrawal by Subject|2|||
143181378|NCT01393899|516211719|FG002|Overall Study|Withdrawal by Subject|1|||
143181379|NCT01393899|516211717|FG000|Overall Study|Lost to Follow-up|0|||
143181380|NCT01393899|516211718|FG001|Overall Study|Lost to Follow-up|0|||
143181381|NCT01393899|516211719|FG002|Overall Study|Lost to Follow-up|1|||
143181382|NCT01393899|516211717|FG000|Overall Study|Does not meet entrance criteria|1|||
143181383|NCT01393899|516211718|FG001|Overall Study|Does not meet entrance criteria|0|||
143181384|NCT01393899|516211719|FG002|Overall Study|Does not meet entrance criteria|1|||
143181385|NCT01393899|516211717|FG000|Overall Study|Lack of Efficacy|26|||
143181386|NCT01393899|516211718|FG001|Overall Study|Lack of Efficacy|21|||
143181387|NCT01393899|516211719|FG002|Overall Study|Lack of Efficacy|16|||
143181388|NCT01393899|516211717|FG000|Overall Study|Adverse Event|1|||
143181389|NCT01393899|516211718|FG001|Overall Study|Adverse Event|5|||
143181390|NCT01393899|516211719|FG002|Overall Study|Adverse Event|3|||
143181391|NCT03462719|516211722|FG000|Overall Study|Withdrawal by Subject|4|||
143181392|NCT03462719|516211723|FG001|Overall Study|Withdrawal by Subject|3|||
143181393|NCT03462719|516211722|FG000|Overall Study|Ongoing|87|||
143181394|NCT03462719|516211723|FG001|Overall Study|Ongoing|72|||
143181395|NCT04108208|516211724|FG000|Overall Study|Withdrawal by Subject|2|||
143181396|NCT04108208|516211725|FG001|Overall Study|Withdrawal by Subject|6|||
143181397|NCT04108208|516211724|FG000|Overall Study|other-ongoing|20|||
143181398|NCT04108208|516211725|FG001|Overall Study|other-ongoing|40|||
143181399|NCT04108208|516211724|FG000|Overall Study|Death|1|||
143181400|NCT04108208|516211725|FG001|Overall Study|Death|4|||
143181401|NCT04108208|516211724|FG000|Overall Study|Lost to Follow-up|2|||
143181402|NCT04108208|516211725|FG001|Overall Study|Lost to Follow-up|0|||
143181403|NCT03670355|516211726|FG000|Overall Study|Adverse Event|1|||
143181404|NCT03670355|516211727|FG001|Overall Study|Adverse Event|0|||
143181405|NCT03670355|516211726|FG000|Overall Study|Unable to comply with study procedures|0|||
143181406|NCT03670355|516211727|FG001|Overall Study|Unable to comply with study procedures|1|||
143181407|NCT03670355|516211726|FG000|Overall Study|Participant refused|0|||
143181408|NCT03670355|516211727|FG001|Overall Study|Participant refused|1|||
143181409|NCT03517436|516211728|FG000|Overall Study|Death|3|||
143181410|NCT03517436|516211728|FG000|Overall Study|Withdrawal by Subject|4|||
143181411|NCT03517436|516211728|FG000|Overall Study|Did not receive study valve.|1|||
143181412|NCT04181827|516211729|FG000|Overall Study|Ongoing|124|||
143181413|NCT04181827|516211730|FG001|Overall Study|Ongoing|157|||
143181414|NCT04181827|516211729|FG000|Overall Study|Death|82|||
143181415|NCT04181827|516211730|FG001|Overall Study|Death|50|||
143181416|NCT04181827|516211729|FG000|Overall Study|Lost to Follow-up|0|||
143181417|NCT04181827|516211730|FG001|Overall Study|Lost to Follow-up|1|||
143181418|NCT04181827|516211729|FG000|Overall Study|Withdrawal by Subject|5|||
143181419|NCT04181827|516211730|FG001|Overall Study|Withdrawal by Subject|0|||
143181420|NCT04587869|516211733|FG000|Overall Study|Death|1|||
143181421|NCT04587869|516211734|FG001|Overall Study|Death|0|||
143181422|NCT04587869|516211733|FG000|Overall Study|Lost to Follow-up|27|||
143181423|NCT04587869|516211734|FG001|Overall Study|Lost to Follow-up|34|||
143181424|NCT04587869|516211733|FG000|Overall Study|Grant Termination|13|||
143181425|NCT04587869|516211734|FG001|Overall Study|Grant Termination|25|||
143181426|NCT04587869|516211733|FG000|Overall Study|too busy|2|||
143181427|NCT04587869|516211734|FG001|Overall Study|too busy|0|||
143181428|NCT04587869|516211733|FG000|Overall Study|Withdrawal by Subject|2|||
143181429|NCT04587869|516211734|FG001|Overall Study|Withdrawal by Subject|2|||
143181430|NCT04587869|516211733|FG000|Overall Study|Other|1|||
143181431|NCT04587869|516211734|FG001|Overall Study|Other|0|||
143181432|NCT04538664|516211740|FG000|Overall Study|Withdrawal by Subject|5|||
143152101|NCT03412890|516100990|FG001|Overall Study|Participants who did not receive any study drug|1|||
143152102|NCT03412890|516100991|FG002|Overall Study|Participants who did not receive any study drug|0|||
143152103|NCT02503865|516100992|FG000|Overall Study|Moved out of area|1|||
143152104|NCT02503865|516100993|FG001|Overall Study|Moved out of area|8|||
143152105|NCT02503865|516100994|FG002|Overall Study|Moved out of area|0|||
143152106|NCT02503865|516100992|FG000|Overall Study|Refused treatment|4|||
143152107|NCT02503865|516100993|FG001|Overall Study|Refused treatment|39|||
143152108|NCT02503865|516100994|FG002|Overall Study|Refused treatment|2|||
143152109|NCT05073315|516100995|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
143152110|NCT05073315|516100996|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
143152111|NCT05073315|516100997|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
143152112|NCT05073315|516100995|FG000|Period 1 (Lead-in Period)|Death|1|||
143152113|NCT05073315|516100996|FG001|Period 1 (Lead-in Period)|Death|0|||
143152114|NCT05073315|516100997|FG002|Period 1 (Lead-in Period)|Death|0|||
143152115|NCT05073315|516100995|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
143152116|NCT05073315|516100996|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
143152117|NCT05073315|516100997|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
143152118|NCT05073315|516100995|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
143152119|NCT05073315|516100996|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
143152120|NCT05073315|516100997|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
143152121|NCT05073315|516100995|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
143152122|NCT05073315|516100996|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
143152123|NCT05073315|516100997|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
143152124|NCT05073315|516100995|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
143152125|NCT05073315|516100996|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
143152126|NCT05073315|516100997|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
143152127|NCT05073315|516100995|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
143152128|NCT05073315|516100996|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
143152129|NCT05073315|516100997|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
143152130|NCT05073315|516100995|FG000|Period 2|Adverse Event|0|||
143152131|NCT05073315|516100996|FG001|Period 2|Adverse Event|3|||
143152132|NCT05073315|516100997|FG002|Period 2|Adverse Event|6|||
143234298|NCT03518086|516408993|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
143234299|NCT03518086|516408994|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
143234300|NCT03518086|516408991|FG000|Overall Study|Site Terminated by Sponsor|0|||
143234301|NCT03518086|516408992|FG001|Overall Study|Site Terminated by Sponsor|1|||
143234302|NCT03518086|516408993|FG002|Overall Study|Site Terminated by Sponsor|0|||
143234303|NCT03518086|516408994|FG003|Overall Study|Site Terminated by Sponsor|0|||
143234304|NCT03518086|516408991|FG000|Overall Study|Pregnancy|0|||
143234305|NCT03518086|516408992|FG001|Overall Study|Pregnancy|0|||
143234306|NCT03518086|516408993|FG002|Overall Study|Pregnancy|0|||
143234307|NCT03518086|516408994|FG003|Overall Study|Pregnancy|2|||
143234308|NCT02702492|516408995|FG000|Overall Study|Disease progression|3|||
143234309|NCT02702492|516408996|FG001|Overall Study|Disease progression|3|||
143234310|NCT02702492|516408997|FG002|Overall Study|Disease progression|2|||
143234311|NCT02702492|516408998|FG003|Overall Study|Disease progression|4|||
143234312|NCT02702492|516408999|FG004|Overall Study|Disease progression|4|||
143234313|NCT02702492|516409000|FG005|Overall Study|Disease progression|1|||
143234314|NCT02702492|516409001|FG006|Overall Study|Disease progression|2|||
143234315|NCT02702492|516409002|FG007|Overall Study|Disease progression|8|||
143234316|NCT02702492|516409003|FG008|Overall Study|Disease progression|5|||
143234317|NCT02702492|516409004|FG009|Overall Study|Disease progression|1|||
143234318|NCT02702492|516409005|FG010|Overall Study|Disease progression|0|||
143234319|NCT02702492|516409006|FG011|Overall Study|Disease progression|3|||
143234320|NCT02702492|516409007|FG012|Overall Study|Disease progression|2|||
143234321|NCT02702492|516408995|FG000|Overall Study|Clinical progression|0|||
143234322|NCT02702492|516408996|FG001|Overall Study|Clinical progression|0|||
143234323|NCT02702492|516408997|FG002|Overall Study|Clinical progression|2|||
143234324|NCT02702492|516408998|FG003|Overall Study|Clinical progression|1|||
143234325|NCT02702492|516408999|FG004|Overall Study|Clinical progression|0|||
143234326|NCT02702492|516409000|FG005|Overall Study|Clinical progression|2|||
143234327|NCT02702492|516409001|FG006|Overall Study|Clinical progression|1|||
143234328|NCT02702492|516409002|FG007|Overall Study|Clinical progression|4|||
143234329|NCT02702492|516409003|FG008|Overall Study|Clinical progression|0|||
143234330|NCT02702492|516409004|FG009|Overall Study|Clinical progression|0|||
143152133|NCT05073315|516100995|FG000|Period 2|Lost to Follow-up|0|||
143152134|NCT05073315|516100996|FG001|Period 2|Lost to Follow-up|5|||
143152135|NCT05073315|516100997|FG002|Period 2|Lost to Follow-up|5|||
143152136|NCT05073315|516100995|FG000|Period 2|Withdrawal by Subject|0|||
143152137|NCT05073315|516100996|FG001|Period 2|Withdrawal by Subject|4|||
143234331|NCT02702492|516409005|FG010|Overall Study|Clinical progression|1|||
143234332|NCT02702492|516409006|FG011|Overall Study|Clinical progression|2|||
143234333|NCT02702492|516409007|FG012|Overall Study|Clinical progression|0|||
143234334|NCT02702492|516408995|FG000|Overall Study|Adverse Event|0|||
143234335|NCT02702492|516408996|FG001|Overall Study|Adverse Event|0|||
143234336|NCT02702492|516408997|FG002|Overall Study|Adverse Event|1|||
143234337|NCT02702492|516408998|FG003|Overall Study|Adverse Event|2|||
143152138|NCT05073315|516100997|FG002|Period 2|Withdrawal by Subject|9|||
143152139|NCT05073315|516100995|FG000|Period 2|Protocol Violation|0|||
143152140|NCT05073315|516100996|FG001|Period 2|Protocol Violation|0|||
143152141|NCT05073315|516100997|FG002|Period 2|Protocol Violation|1|||
143152142|NCT01529268|516100998|FG000|Overall Study|Lost to Follow-up|9|||
143152143|NCT01529268|516100999|FG001|Overall Study|Lost to Follow-up|3|||
143152144|NCT01529268|516100998|FG000|Overall Study|Moved|3|||
143152145|NCT01529268|516100999|FG001|Overall Study|Moved|0|||
143152146|NCT00303953|516101000|FG000|Overall Study|Ineligible|1|||
143152147|NCT00303953|516101000|FG000|Overall Study|Death|1|||
143152148|NCT00303953|516101000|FG000|Overall Study|Adverse Event|4|||
143152149|NCT00303953|516101000|FG000|Overall Study|Lack of Efficacy|12|||
143152150|NCT00303953|516101000|FG000|Overall Study|Physician Decision|1|||
143152151|NCT02315625|516101001|FG000|First Intervention|Disease Progression|1|||
143152152|NCT02315625|516101002|FG001|First Intervention|Disease Progression|0|||
143152153|NCT02315625|516101001|FG000|Second Intervention|Physician Decision|2|||
143152154|NCT02315625|516101002|FG001|Second Intervention|Physician Decision|1|||
143152155|NCT02315625|516101001|FG000|Second Intervention|Study closure|1|||
143152156|NCT02315625|516101002|FG001|Second Intervention|Study closure|0|||
143152157|NCT02315625|516101001|FG000|Second Intervention|Disease Progression|1|||
143152158|NCT02315625|516101002|FG001|Second Intervention|Disease Progression|0|||
143152159|NCT02232698|516101003|FG000|Overall Study|Pregnancy|1|||
143152160|NCT02232698|516101004|FG001|Overall Study|Pregnancy|1|||
143152161|NCT02232698|516101003|FG000|Overall Study|Met exclusion criteria|1|||
143152162|NCT02232698|516101004|FG001|Overall Study|Met exclusion criteria|1|||
143152163|NCT02232698|516101003|FG000|Overall Study|Had device-associated symptoms|7|||
143152164|NCT02232698|516101004|FG001|Overall Study|Had device-associated symptoms|0|||
143152165|NCT02232698|516101003|FG000|Overall Study|Non-compliance with study device|1|||
143152166|NCT02232698|516101004|FG001|Overall Study|Non-compliance with study device|4|||
143152167|NCT02232698|516101003|FG000|Overall Study|Allocated to control group|0|||
143152168|NCT02232698|516101004|FG001|Overall Study|Allocated to control group|3|||
143152169|NCT02232698|516101003|FG000|Overall Study|Withdrawal by Subject|0|||
143152170|NCT02232698|516101004|FG001|Overall Study|Withdrawal by Subject|11|||
143152171|NCT01131585|516101005|FG000|Overall Study|Adverse Event|0|||
143152172|NCT01131585|516101006|FG001|Overall Study|Adverse Event|2|||
143152173|NCT01131585|516101005|FG000|Overall Study|Abnormal laboratory value|1|||
143152174|NCT01131585|516101006|FG001|Overall Study|Abnormal laboratory value|0|||
143152175|NCT01131585|516101005|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
143152176|NCT01131585|516101006|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
143152177|NCT01131585|516101005|FG000|Overall Study|Protocol Violation|2|||
143152178|NCT01131585|516101006|FG001|Overall Study|Protocol Violation|1|||
143152179|NCT01131585|516101005|FG000|Overall Study|Withdrawal by Subject|3|||
143152180|NCT01131585|516101006|FG001|Overall Study|Withdrawal by Subject|3|||
143152181|NCT01131585|516101005|FG000|Overall Study|Lost to Follow-up|0|||
143152182|NCT01131585|516101006|FG001|Overall Study|Lost to Follow-up|1|||
143152183|NCT01131585|516101005|FG000|Overall Study|Administrative problems|1|||
143152184|NCT01131585|516101006|FG001|Overall Study|Administrative problems|1|||
143152185|NCT01131585|516101005|FG000|Overall Study|Study termination|78|||
143152186|NCT01131585|516101006|FG001|Overall Study|Study termination|32|||
143152187|NCT00927082|516101007|FG000|Overall Study|Lost to Follow-up|9|||
143152188|NCT00927082|516101008|FG001|Overall Study|Lost to Follow-up|8|||
143152189|NCT00927082|516101009|FG002|Overall Study|Lost to Follow-up|12|||
143152190|NCT00927082|516101010|FG003|Overall Study|Lost to Follow-up|16|||
143152191|NCT00927082|516101007|FG000|Overall Study|Withdrawal by Subject|3|||
143152192|NCT00927082|516101008|FG001|Overall Study|Withdrawal by Subject|2|||
143152193|NCT00927082|516101009|FG002|Overall Study|Withdrawal by Subject|7|||
143152194|NCT00927082|516101010|FG003|Overall Study|Withdrawal by Subject|2|||
143152195|NCT00927082|516101007|FG000|Overall Study|Death|0|||
143152196|NCT00927082|516101008|FG001|Overall Study|Death|0|||
143152197|NCT00927082|516101009|FG002|Overall Study|Death|1|||
143152198|NCT00927082|516101010|FG003|Overall Study|Death|0|||
143152199|NCT00927082|516101007|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
143152200|NCT00927082|516101008|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
143152201|NCT00927082|516101009|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
143152202|NCT00927082|516101010|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
143152203|NCT00812097|516101011|FG000|Overall Study|Death|3|||
143152204|NCT00812097|516101012|FG001|Overall Study|Death|10|||
143363651|NCT00062868|516873784|FG004|Dose Level 3|Death|0|||
143152205|NCT00812097|516101013|FG002|Overall Study|Death|3|||
143152206|NCT00812097|516101014|FG003|Overall Study|Death|3|||
143152207|NCT00812097|516101011|FG000|Overall Study|Withdrawal by Subject|14|||
143152208|NCT00812097|516101012|FG001|Overall Study|Withdrawal by Subject|12|||
143152209|NCT00812097|516101013|FG002|Overall Study|Withdrawal by Subject|8|||
143152210|NCT00812097|516101014|FG003|Overall Study|Withdrawal by Subject|2|||
143152211|NCT00812097|516101011|FG000|Overall Study|Lost to Follow-up|90|||
143152212|NCT00812097|516101012|FG001|Overall Study|Lost to Follow-up|14|||
143152213|NCT00812097|516101013|FG002|Overall Study|Lost to Follow-up|17|||
143152214|NCT00812097|516101014|FG003|Overall Study|Lost to Follow-up|5|||
143234338|NCT02702492|516408999|FG004|Overall Study|Adverse Event|1|||
143234339|NCT02702492|516409000|FG005|Overall Study|Adverse Event|0|||
143234340|NCT02702492|516409001|FG006|Overall Study|Adverse Event|1|||
143234341|NCT02702492|516409002|FG007|Overall Study|Adverse Event|0|||
143234342|NCT02702492|516409003|FG008|Overall Study|Adverse Event|2|||
143234343|NCT02702492|516409004|FG009|Overall Study|Adverse Event|0|||
143234344|NCT02702492|516409005|FG010|Overall Study|Adverse Event|0|||
143234345|NCT02702492|516409006|FG011|Overall Study|Adverse Event|0|||
143234346|NCT02702492|516409007|FG012|Overall Study|Adverse Event|1|||
143234347|NCT02702492|516408995|FG000|Overall Study|Other|0|||
143234348|NCT02702492|516408996|FG001|Overall Study|Other|0|||
143234349|NCT02702492|516408997|FG002|Overall Study|Other|0|||
143234350|NCT02702492|516408998|FG003|Overall Study|Other|0|||
143234351|NCT02702492|516408999|FG004|Overall Study|Other|0|||
143234352|NCT02702492|516409000|FG005|Overall Study|Other|0|||
143234353|NCT02702492|516409001|FG006|Overall Study|Other|0|||
143234354|NCT02702492|516409002|FG007|Overall Study|Other|0|||
143234355|NCT02702492|516409003|FG008|Overall Study|Other|0|||
143234356|NCT02702492|516409004|FG009|Overall Study|Other|0|||
143234357|NCT02702492|516409005|FG010|Overall Study|Other|0|||
143234358|NCT02702492|516409006|FG011|Overall Study|Other|0|||
143234359|NCT02702492|516409007|FG012|Overall Study|Other|1|||
143234360|NCT03253393|516409012|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
143234361|NCT03253393|516409013|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
143234362|NCT03253393|516409014|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
143015180|NCT04682639|515597366|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
143015181|NCT04682639|515597367|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
143015182|NCT04682639|515597368|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
143015183|NCT04682639|515597369|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
143234363|NCT03204188|516409015|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
143234364|NCT03204188|516409015|FG000|Immunotherapy Phase (1 Year)|Death|1|||
143234365|NCT03204188|516409015|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
143234366|NCT03204188|516409015|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
143234367|NCT01350999|516409017|FG000|Overall Study|Adverse Event|4|||
143234368|NCT01350999|516409018|FG001|Overall Study|Adverse Event|9|||
143234369|NCT01350999|516409019|FG002|Overall Study|Adverse Event|10|||
143234370|NCT01350999|516409017|FG000|Overall Study|Voluntary withdrawal|3|||
143234371|NCT01350999|516409018|FG001|Overall Study|Voluntary withdrawal|4|||
143234372|NCT01350999|516409019|FG002|Overall Study|Voluntary withdrawal|6|||
143234373|NCT01350999|516409017|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
143234374|NCT01350999|516409018|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
143234375|NCT01350999|516409019|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
143234376|NCT02892344|516411252|FG000|Overall Study|Protocol deviation|3|||
143234377|NCT02892344|516411253|FG001|Overall Study|Protocol deviation|4|||
143234378|NCT02892344|516411252|FG000|Overall Study|Adverse Event|1|||
143234379|NCT02892344|516411253|FG001|Overall Study|Adverse Event|8|||
143234380|NCT02892344|516411252|FG000|Overall Study|Lost to Follow-up|0|||
143234381|NCT02892344|516411253|FG001|Overall Study|Lost to Follow-up|1|||
143234382|NCT02892344|516411252|FG000|Overall Study|Non-compliance with study treatment|0|||
143234383|NCT02892344|516411253|FG001|Overall Study|Non-compliance with study treatment|1|||
143234384|NCT02892344|516411252|FG000|Overall Study|Physician Decision|0|||
143234385|NCT02892344|516411253|FG001|Overall Study|Physician Decision|2|||
143234386|NCT02892344|516411252|FG000|Overall Study|Subject/guardian decision|0|||
143234387|NCT02892344|516411253|FG001|Overall Study|Subject/guardian decision|4|||
143234388|NCT02892344|516411252|FG000|Overall Study|Technical problems|0|||
143234389|NCT02892344|516411253|FG001|Overall Study|Technical problems|1|||
143234390|NCT00674817|516411254|FG000|Period 1|Withdrawal by Subject|2|||
143234391|NCT00674817|516411254|FG000|Period 1|Protocol Violation|1|||
143234392|NCT00674817|516411254|FG000|Period 3|Adverse Event|1|||
143234393|NCT00674817|516411254|FG000|Period 3|Protocol Violation|1|||
143234394|NCT00674817|516411254|FG000|Period 4|Adverse Event|1|||
143234395|NCT03363841|516411260|FG000|Overall Study|Adverse Event|1|||
143234396|NCT03363841|516411260|FG000|Overall Study|Withdrawal by Subject|1|||
143234397|NCT03363841|516411260|FG000|Overall Study|Death|7|||
143234398|NCT03363841|516411260|FG000|Overall Study|Physician Decision|1|||
143234399|NCT02156076|516411261|FG000|Treatment Period|no longer meets study criteria|0|||
143234400|NCT02156076|516411262|FG001|Treatment Period|no longer meets study criteria|0|||
143234401|NCT02156076|516411263|FG002|Treatment Period|no longer meets study criteria|1|||
143234402|NCT02156076|516411264|FG003|Treatment Period|no longer meets study criteria|0|||
143234403|NCT02156076|516411261|FG000|Treatment Period|Poor/non-compliance|0|||
143015184|NCT04682639|515597370|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
143234404|NCT02156076|516411262|FG001|Treatment Period|Poor/non-compliance|1|||
143234405|NCT02156076|516411263|FG002|Treatment Period|Poor/non-compliance|0|||
143234406|NCT02156076|516411264|FG003|Treatment Period|Poor/non-compliance|0|||
143234407|NCT02156076|516411261|FG000|Treatment Period|Lost to Follow-up|0|||
143363652|NCT00062868|516873785|FG005|Dose Level 3|Death|0|||
143363653|NCT00062868|516873786|FG006|Dose Level 3|Death|0|||
143234408|NCT02156076|516411262|FG001|Treatment Period|Lost to Follow-up|0|||
143234409|NCT02156076|516411263|FG002|Treatment Period|Lost to Follow-up|0|||
143234410|NCT02156076|516411264|FG003|Treatment Period|Lost to Follow-up|1|||
143234411|NCT02156076|516411261|FG000|Treatment Period|Withdrawal by Subject|0|||
143234412|NCT02156076|516411262|FG001|Treatment Period|Withdrawal by Subject|0|||
143234413|NCT02156076|516411263|FG002|Treatment Period|Withdrawal by Subject|1|||
143234414|NCT02156076|516411264|FG003|Treatment Period|Withdrawal by Subject|0|||
143234415|NCT02156076|516411261|FG000|Treatment Period|Subject request to discontinue treatment|0|||
143234416|NCT02156076|516411262|FG001|Treatment Period|Subject request to discontinue treatment|1|||
143234417|NCT02156076|516411263|FG002|Treatment Period|Subject request to discontinue treatment|0|||
143234418|NCT02156076|516411264|FG003|Treatment Period|Subject request to discontinue treatment|0|||
143234419|NCT02156076|516411261|FG000|Treatment Period|Adverse Event|0|||
143234420|NCT02156076|516411262|FG001|Treatment Period|Adverse Event|0|||
143234421|NCT02156076|516411263|FG002|Treatment Period|Adverse Event|0|||
143234422|NCT02156076|516411264|FG003|Treatment Period|Adverse Event|1|||
143234423|NCT02156076|516411261|FG000|Follow-up Period|Withdrawal by Subject|1|||
143234424|NCT02156076|516411262|FG001|Follow-up Period|Withdrawal by Subject|0|||
143234425|NCT02156076|516411263|FG002|Follow-up Period|Withdrawal by Subject|0|||
143234426|NCT02156076|516411264|FG003|Follow-up Period|Withdrawal by Subject|0|||
143234427|NCT06271993|516411267|FG000|Overall Study|Not reactive to histamine|5|||
143234428|NCT06271993|516411268|FG001|Overall Study|Not reactive to histamine|5|||
143234429|NCT06271993|516411269|FG002|Overall Study|Not reactive to histamine|5|||
143234430|NCT00981656|516411275|FG000|Overall Study|Protocol Violation|1|||
143234431|NCT00981656|516411275|FG000|Overall Study|Did not start protocol treatment|2|||
143234432|NCT00687596|516411276|FG000|Overall Study|Adverse Event (AE)|10|||
143234433|NCT00687596|516411277|FG001|Overall Study|Adverse Event (AE)|3|||
143234434|NCT00687596|516411276|FG000|Overall Study|Radiological Disease Progression|6|||
143234435|NCT00687596|516411277|FG001|Overall Study|Radiological Disease Progression|2|||
143234436|NCT00687596|516411276|FG000|Overall Study|Clinical Disease Progression|1|||
143234437|NCT00687596|516411277|FG001|Overall Study|Clinical Disease Progression|3|||
143234438|NCT00687596|516411276|FG000|Overall Study|Investigator Discretion|3|||
143234439|NCT00687596|516411277|FG001|Overall Study|Investigator Discretion|1|||
143234440|NCT00687596|516411276|FG000|Overall Study|Sponsor Terminated Study|6|||
143234441|NCT00687596|516411277|FG001|Overall Study|Sponsor Terminated Study|17|||
143234442|NCT03331315|516411285|FG000|Overall Study|Physician Decision|18|||
143234443|NCT03331315|516411286|FG001|Overall Study|Physician Decision|14|||
143234444|NCT01709721|516411287|FG000|Open Label Phase|Withdrawal by Subject|0|||
143234445|NCT01709721|516411288|FG001|Open Label Phase|Withdrawal by Subject|0|||
143234446|NCT01709721|516411289|FG002|Open Label Phase|Withdrawal by Subject|5|||
143234447|NCT01709721|516411287|FG000|Open Label Phase|Adverse Event|0|||
143234448|NCT01709721|516411288|FG001|Open Label Phase|Adverse Event|0|||
143234449|NCT01709721|516411289|FG002|Open Label Phase|Adverse Event|8|||
143234450|NCT01709721|516411287|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
143234451|NCT01709721|516411288|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
143234452|NCT01709721|516411289|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
143234453|NCT01709721|516411287|FG000|Open Label Phase|Investigator Decision|0|||
143234454|NCT01709721|516411288|FG001|Open Label Phase|Investigator Decision|0|||
143234455|NCT01709721|516411289|FG002|Open Label Phase|Investigator Decision|1|||
143234456|NCT01709721|516411287|FG000|Open Label Phase|Sponsor Decision|0|||
143234457|NCT01709721|516411288|FG001|Open Label Phase|Sponsor Decision|0|||
143234458|NCT01709721|516411289|FG002|Open Label Phase|Sponsor Decision|2|||
143234459|NCT01709721|516411287|FG000|Open Label Phase|Protocol Violation|0|||
143234460|NCT01709721|516411288|FG001|Open Label Phase|Protocol Violation|0|||
143234461|NCT01709721|516411289|FG002|Open Label Phase|Protocol Violation|1|||
143234462|NCT01709721|516411287|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
143234463|NCT01709721|516411288|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
143234464|NCT01709721|516411289|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
143234465|NCT01709721|516411287|FG000|Open Label Phase|Inadequate Pain Control|0|||
143234466|NCT01709721|516411288|FG001|Open Label Phase|Inadequate Pain Control|0|||
143234467|NCT01709721|516411289|FG002|Open Label Phase|Inadequate Pain Control|37|||
143234468|NCT01709721|516411287|FG000|Open Label Phase|Other, Specify in text field in database|0|||
143234469|NCT01709721|516411288|FG001|Open Label Phase|Other, Specify in text field in database|0|||
143234470|NCT01709721|516411289|FG002|Open Label Phase|Other, Specify in text field in database|14|||
143234471|NCT01709721|516411287|FG000|Randomized Phase|Adverse Event|0|||
143234472|NCT01709721|516411288|FG001|Randomized Phase|Adverse Event|1|||
143234473|NCT01709721|516411289|FG002|Randomized Phase|Adverse Event|0|||
143234474|NCT01709721|516411287|FG000|Randomized Phase|Lost to Follow-up|1|||
143234475|NCT01709721|516411288|FG001|Randomized Phase|Lost to Follow-up|0|||
143234476|NCT01709721|516411289|FG002|Randomized Phase|Lost to Follow-up|0|||
143234477|NCT01709721|516411287|FG000|Randomized Phase|Inadequate Pain Control|1|||
143363654|NCT00062868|516873787|FG007|Dose Level 3|Death|0|||
143234478|NCT01709721|516411288|FG001|Randomized Phase|Inadequate Pain Control|2|||
143234479|NCT01709721|516411289|FG002|Randomized Phase|Inadequate Pain Control|0|||
143234480|NCT01709721|516411287|FG000|Randomized Phase|Other, Specify text field in database|1|||
143234481|NCT01709721|516411288|FG001|Randomized Phase|Other, Specify text field in database|3|||
143234482|NCT01709721|516411289|FG002|Randomized Phase|Other, Specify text field in database|0|||
143234483|NCT02558894|516411292|FG000|Overall Study|Death; any cause, entire study duration|28|||
143234484|NCT02558894|516411293|FG001|Overall Study|Death; any cause, entire study duration|31|||
143234485|NCT02558894|516411292|FG000|Overall Study|Withdrawal by Subject|2|||
143234486|NCT02558894|516411293|FG001|Overall Study|Withdrawal by Subject|1|||
143234487|NCT02558894|516411292|FG000|Overall Study|Closure of Part A|2|||
143234488|NCT02558894|516411293|FG001|Overall Study|Closure of Part A|1|||
143234489|NCT02992288|516411294|FG000|Overall Study|Adverse Event|8|||
143234490|NCT02992288|516411295|FG001|Overall Study|Adverse Event|2|||
143234491|NCT02992288|516411296|FG002|Overall Study|Adverse Event|2|||
143234492|NCT02992288|516411297|FG003|Overall Study|Adverse Event|2|||
143234493|NCT02992288|516411298|FG004|Overall Study|Adverse Event|2|||
143234494|NCT02992288|516411299|FG005|Overall Study|Adverse Event|7|||
143234495|NCT02992288|516411294|FG000|Overall Study|Non-compliance with study drug|0|||
143234496|NCT02992288|516411295|FG001|Overall Study|Non-compliance with study drug|1|||
143234497|NCT02992288|516411296|FG002|Overall Study|Non-compliance with study drug|1|||
143234498|NCT02992288|516411297|FG003|Overall Study|Non-compliance with study drug|0|||
143234499|NCT02992288|516411298|FG004|Overall Study|Non-compliance with study drug|1|||
143234500|NCT02992288|516411299|FG005|Overall Study|Non-compliance with study drug|0|||
143234501|NCT02992288|516411294|FG000|Overall Study|Physician Decision|3|||
143234502|NCT02992288|516411295|FG001|Overall Study|Physician Decision|0|||
143234503|NCT02992288|516411296|FG002|Overall Study|Physician Decision|1|||
143234504|NCT02992288|516411297|FG003|Overall Study|Physician Decision|0|||
143234505|NCT02992288|516411298|FG004|Overall Study|Physician Decision|0|||
143234506|NCT02992288|516411299|FG005|Overall Study|Physician Decision|1|||
143234507|NCT02992288|516411294|FG000|Overall Study|Death|2|||
143234508|NCT02992288|516411295|FG001|Overall Study|Death|0|||
143234509|NCT02992288|516411296|FG002|Overall Study|Death|2|||
143234510|NCT02992288|516411297|FG003|Overall Study|Death|1|||
143234511|NCT02992288|516411298|FG004|Overall Study|Death|2|||
143234512|NCT02992288|516411299|FG005|Overall Study|Death|0|||
143234513|NCT02992288|516411294|FG000|Overall Study|Lost to Follow-up|0|||
143234514|NCT02992288|516411295|FG001|Overall Study|Lost to Follow-up|0|||
143234515|NCT02992288|516411296|FG002|Overall Study|Lost to Follow-up|0|||
143234516|NCT02992288|516411297|FG003|Overall Study|Lost to Follow-up|1|||
143234517|NCT02992288|516411298|FG004|Overall Study|Lost to Follow-up|0|||
143234518|NCT02992288|516411299|FG005|Overall Study|Lost to Follow-up|0|||
143234519|NCT02992288|516411294|FG000|Overall Study|Protocol Violation|0|||
143234520|NCT02992288|516411295|FG001|Overall Study|Protocol Violation|0|||
143234521|NCT02992288|516411296|FG002|Overall Study|Protocol Violation|0|||
143234522|NCT02992288|516411297|FG003|Overall Study|Protocol Violation|0|||
143234523|NCT02992288|516411298|FG004|Overall Study|Protocol Violation|0|||
143234524|NCT02992288|516411299|FG005|Overall Study|Protocol Violation|1|||
143234525|NCT02992288|516411294|FG000|Overall Study|Withdrawal by Subject|4|||
143234526|NCT02992288|516411295|FG001|Overall Study|Withdrawal by Subject|2|||
143234527|NCT02992288|516411296|FG002|Overall Study|Withdrawal by Subject|1|||
143234528|NCT02992288|516411297|FG003|Overall Study|Withdrawal by Subject|5|||
143234529|NCT02992288|516411298|FG004|Overall Study|Withdrawal by Subject|3|||
143234530|NCT02992288|516411299|FG005|Overall Study|Withdrawal by Subject|4|||
143234531|NCT01435382|516411302|FG000|Overall Study|Lost to Follow-up|1|||
143234532|NCT01435382|516411303|FG001|Overall Study|Lost to Follow-up|0|||
143234533|NCT01435382|516411304|FG002|Overall Study|Lost to Follow-up|1|||
143234534|NCT01435382|516411305|FG003|Overall Study|Lost to Follow-up|0|||
143234535|NCT01435382|516411302|FG000|Overall Study|Withdrawal by Subject|0|||
143234536|NCT01435382|516411303|FG001|Overall Study|Withdrawal by Subject|2|||
143234537|NCT01435382|516411304|FG002|Overall Study|Withdrawal by Subject|0|||
143234538|NCT01435382|516411305|FG003|Overall Study|Withdrawal by Subject|1|||
143234539|NCT00423579|516411307|FG000|Overall Study|Lost to Follow-up|3|||
143234540|NCT00423579|516411308|FG001|Overall Study|Lost to Follow-up|0|||
143234541|NCT00423579|516411307|FG000|Overall Study|Protocol Violation|1|||
143484736|NCT00960661|517320969|FG000|Interventional Phase|Lack of Efficacy|0|||
143484737|NCT00960661|517320970|FG001|Interventional Phase|Lack of Efficacy|2|||
143234542|NCT00423579|516411308|FG001|Overall Study|Protocol Violation|3|||
143234543|NCT00423579|516411307|FG000|Overall Study|Diagnosis of diabetes|0|||
143234544|NCT00423579|516411308|FG001|Overall Study|Diagnosis of diabetes|1|||
143234545|NCT03697252|516411311|FG000|Overall Study|Adverse Event|3|||
143234546|NCT03697252|516411312|FG001|Overall Study|Adverse Event|2|||
143234547|NCT03697252|516411311|FG000|Overall Study|Withdrawal by Subject|14|||
143234548|NCT03697252|516411312|FG001|Overall Study|Withdrawal by Subject|14|||
143234549|NCT03697252|516411311|FG000|Overall Study|Lost to Follow-up|0|||
143234550|NCT03697252|516411312|FG001|Overall Study|Lost to Follow-up|1|||
143234551|NCT03697252|516411311|FG000|Overall Study|Physician Decision|1|||
143234552|NCT03697252|516411312|FG001|Overall Study|Physician Decision|1|||
143234553|NCT03697252|516411311|FG000|Overall Study|Other|0|||
143234554|NCT03697252|516411312|FG001|Overall Study|Other|1|||
143234555|NCT03125395|516411313|FG000|Overall Study|Adverse Event|2|||
143234556|NCT03125395|516411313|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
143234557|NCT03125395|516411313|FG000|Overall Study|Physician Decision|2|||
143234558|NCT03125395|516411313|FG000|Overall Study|Commercial drug is available|5|||
143234559|NCT02383576|516411315|FG000|Overall Study|Death|53|||
143234560|NCT02383576|516411316|FG001|Overall Study|Death|33|||
143234561|NCT02383576|516411315|FG000|Overall Study|Lost to Follow-up|7|||
143234562|NCT02383576|516411316|FG001|Overall Study|Lost to Follow-up|1|||
143234563|NCT02383576|516411315|FG000|Overall Study|Withdrew Consent|1|||
143234564|NCT02383576|516411316|FG001|Overall Study|Withdrew Consent|6|||
143234565|NCT02383576|516411315|FG000|Overall Study|Investigator's Decision|0|||
143234566|NCT02383576|516411316|FG001|Overall Study|Investigator's Decision|1|||
143234567|NCT02383576|516411315|FG000|Overall Study|Administrative/Other|2|||
143234568|NCT02383576|516411316|FG001|Overall Study|Administrative/Other|4|||
143234569|NCT04218240|516411317|FG000|Overall Study|Withdrawal by Subject|6|||
143234570|NCT04218240|516411318|FG001|Overall Study|Withdrawal by Subject|0|||
143234571|NCT04218240|516411317|FG000|Overall Study|Lack of Efficacy|24|||
143234572|NCT04218240|516411318|FG001|Overall Study|Lack of Efficacy|19|||
143484738|NCT00960661|517320971|FG002|Interventional Phase|Lack of Efficacy|0|||
143152215|NCT00812097|516101011|FG000|Overall Study|Explantation of study device(s)|27|||
143152216|NCT00812097|516101012|FG001|Overall Study|Explantation of study device(s)|29|||
143152217|NCT00812097|516101013|FG002|Overall Study|Explantation of study device(s)|14|||
143152218|NCT00812097|516101014|FG003|Overall Study|Explantation of study device(s)|20|||
143152219|NCT00812097|516101011|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
143152220|NCT00812097|516101012|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
143152221|NCT00812097|516101013|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
143152222|NCT00812097|516101014|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
143152223|NCT01786109|516101015|FG000|Overall Study|fail manometry barostat tube placement|1|||
143152224|NCT01786109|516101016|FG001|Overall Study|fail manometry barostat tube placement|0|||
143152225|NCT01786109|516101017|FG002|Overall Study|fail manometry barostat tube placement|0|||
143152226|NCT01786109|516101015|FG000|Overall Study|unrelated illness|0|||
143152227|NCT01786109|516101016|FG001|Overall Study|unrelated illness|0|||
143152228|NCT01786109|516101017|FG002|Overall Study|unrelated illness|1|||
143152229|NCT01786109|516101015|FG000|Overall Study|adverse effects colon preparation|0|||
143152230|NCT01786109|516101016|FG001|Overall Study|adverse effects colon preparation|0|||
143152231|NCT01786109|516101017|FG002|Overall Study|adverse effects colon preparation|1|||
143152232|NCT02762604|516101020|FG000|Overall Study|Lost to Follow-up|2|||
143152233|NCT02762604|516101021|FG001|Overall Study|Lost to Follow-up|7|||
143152234|NCT02762604|516101020|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
143152235|NCT02762604|516101021|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
143152236|NCT00308685|516101030|FG000|Overall Study|Lost to Follow-up|1|||
143152237|NCT00308685|516101031|FG001|Overall Study|Lost to Follow-up|0|||
143152238|NCT00308685|516101030|FG000|Overall Study|Need to administer prohibited medication|1|||
143152239|NCT00308685|516101031|FG001|Overall Study|Need to administer prohibited medication|2|||
143152240|NCT00308685|516101030|FG000|Overall Study|Other than specified|1|||
143152241|NCT00308685|516101031|FG001|Overall Study|Other than specified|3|||
143152242|NCT03770455|516101032|FG000|Overall Study|Screen failures|3|||
143152243|NCT03921541|516102313|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
143152244|NCT03921541|516102314|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
143152245|NCT04706403|516102317|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
143152246|NCT04706403|516102318|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
143152247|NCT04706403|516102319|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
143152248|NCT04706403|516102320|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
143152249|NCT04706403|516102321|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
143152250|NCT01653262|516102322|FG000|Overall Study|Lack of Efficacy|1|||
143152251|NCT01653262|516102322|FG000|Overall Study|SAE, non-fatal|1|||
143152252|NCT01653262|516102322|FG000|Overall Study|AE, non-serious non-fatal|1|||
143152253|NCT05417113|516102324|FG000|Overall Study|Lost to Follow-up|2|||
143152254|NCT05417113|516102325|FG001|Overall Study|Lost to Follow-up|2|||
143152255|NCT01022580|516102326|FG000|Overall Study|Death|18|||
143152256|NCT01022580|516102327|FG001|Overall Study|Death|22|||
143152257|NCT00134719|516102328|FG000|Primary Vaccination Phase|Adverse Event|4|||
143152258|NCT00134719|516102329|FG001|Primary Vaccination Phase|Adverse Event|0|||
143152259|NCT00134719|516102330|FG002|Primary Vaccination Phase|Adverse Event|0|||
143152260|NCT00134719|516102328|FG000|Primary Vaccination Phase|Protocol Violation|1|||
143152261|NCT00134719|516102329|FG001|Primary Vaccination Phase|Protocol Violation|0|||
143152262|NCT00134719|516102330|FG002|Primary Vaccination Phase|Protocol Violation|0|||
143152263|NCT00134719|516102328|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
143234573|NCT04218240|516411317|FG000|Overall Study|Physician Decision|0|||
143234574|NCT04218240|516411318|FG001|Overall Study|Physician Decision|1|||
143234575|NCT04218240|516411317|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
143234576|NCT04218240|516411318|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
143234577|NCT04097678|516411319|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
143234578|NCT04097678|516411320|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
143234579|NCT03694678|516411321|FG000|Overall Study|Withdrawal by Subject|2|||
143234580|NCT03694678|516411322|FG001|Overall Study|Withdrawal by Subject|0|||
143234581|NCT03694678|516411321|FG000|Overall Study|Lost to Follow-up|2|||
143234582|NCT03694678|516411322|FG001|Overall Study|Lost to Follow-up|3|||
143234583|NCT04852302|516411337|FG000|Overall Study|Withdrawal by Subject|2|||
143234584|NCT04852302|516411337|FG000|Overall Study|Did not complete CALM therapy.|2|||
143234585|NCT03267277|516411338|FG000|Overall Study|Withdrawal by Subject|1|||
143234586|NCT01436149|516411339|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
143234587|NCT01436149|516411340|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
143234588|NCT01436149|516411341|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
143234589|NCT01436149|516411339|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
143234590|NCT01436149|516411340|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
143234591|NCT01436149|516411341|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
143234592|NCT01436149|516411339|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
143234593|NCT01436149|516411340|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
143234594|NCT01436149|516411341|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
143234595|NCT01436149|516411339|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
143234596|NCT01436149|516411340|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
143152264|NCT00134719|516102329|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
143152265|NCT00134719|516102330|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
143234597|NCT01436149|516411341|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
143234598|NCT01436149|516411339|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
143234599|NCT01436149|516411340|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
143152266|NCT00134719|516102328|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
143152267|NCT00134719|516102329|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
143152268|NCT00134719|516102330|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
143152269|NCT00134719|516102328|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
143152270|NCT00134719|516102329|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
143152271|NCT00134719|516102330|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
143152272|NCT00134719|516102328|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
143152273|NCT00134719|516102329|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
143152274|NCT00134719|516102330|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
143152275|NCT01500096|516102333|FG000|Overall Study|Lost to Follow-up|1|||
143152276|NCT01500096|516102334|FG001|Overall Study|Lost to Follow-up|0|||
143152277|NCT01500096|516102335|FG002|Overall Study|Lost to Follow-up|0|||
143152278|NCT01500096|516102336|FG003|Overall Study|Lost to Follow-up|2|||
143152279|NCT00723944|516102342|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
143152280|NCT00723944|516102343|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
143152281|NCT00723944|516102342|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
143152282|NCT00723944|516102343|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
143152283|NCT00723944|516102342|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
143152284|NCT00723944|516102343|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
143152285|NCT01631188|516102344|FG000|Overall Study|Physician Decision|75|||
143152286|NCT03600350|516102347|FG000|Overall Study|Death|1|||
143234600|NCT01436149|516411341|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
143234601|NCT01436149|516411339|FG000|Antidepressant Lead-in Phase|Other|119|||
143234602|NCT01436149|516411340|FG001|Antidepressant Lead-in Phase|Other|0|||
143234603|NCT01436149|516411341|FG002|Antidepressant Lead-in Phase|Other|0|||
143234604|NCT01436149|516411339|FG000|Randomized Phase|Adverse Event|9|||
143234605|NCT01436149|516411340|FG001|Randomized Phase|Adverse Event|10|||
143234606|NCT01436149|516411341|FG002|Randomized Phase|Adverse Event|11|||
143234607|NCT01436149|516411339|FG000|Randomized Phase|Protocol Violation|4|||
143234608|NCT01436149|516411340|FG001|Randomized Phase|Protocol Violation|5|||
143015185|NCT04682639|515597366|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
143152287|NCT03600350|516102347|FG000|Overall Study|On Follow Up|18|||
143152288|NCT04575324|516102348|FG000|Overall Study|Lost to Follow-up|29|||
143152289|NCT04575324|516102349|FG001|Overall Study|Lost to Follow-up|25|||
143152290|NCT04575324|516102348|FG000|Overall Study|Death|1|||
143152291|NCT04575324|516102349|FG001|Overall Study|Death|2|||
143152292|NCT04575324|516102348|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
143234609|NCT01436149|516411341|FG002|Randomized Phase|Protocol Violation|0|||
143234610|NCT01436149|516411339|FG000|Randomized Phase|Withdrawal by Subject|16|||
143234611|NCT01436149|516411340|FG001|Randomized Phase|Withdrawal by Subject|10|||
143234612|NCT01436149|516411341|FG002|Randomized Phase|Withdrawal by Subject|10|||
143234613|NCT01436149|516411339|FG000|Randomized Phase|Lost to Follow-up|34|||
143234614|NCT01436149|516411340|FG001|Randomized Phase|Lost to Follow-up|5|||
143234615|NCT01436149|516411341|FG002|Randomized Phase|Lost to Follow-up|6|||
143234616|NCT01436149|516411339|FG000|Randomized Phase|Lack of Efficacy|0|||
143152293|NCT04575324|516102349|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
143152294|NCT01771913|516102356|FG000|Overall Study|Withdrawal by Subject|1|||
143015186|NCT04682639|515597367|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
143015187|NCT04682639|515597368|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
143015188|NCT04682639|515597369|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
143015189|NCT04682639|515597370|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
143015190|NCT04682639|515597366|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
143015191|NCT04682639|515597367|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
143015192|NCT04682639|515597368|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
143015193|NCT04682639|515597369|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
143015194|NCT04682639|515597370|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
143015195|NCT04682639|515597366|FG000|OLE Period (28 Weeks)|Other|1|||
143015196|NCT04682639|515597367|FG001|OLE Period (28 Weeks)|Other|2|||
143015197|NCT04682639|515597368|FG002|OLE Period (28 Weeks)|Other|0|||
143015198|NCT04682639|515597369|FG003|OLE Period (28 Weeks)|Other|0|||
143015199|NCT04682639|515597370|FG004|OLE Period (28 Weeks)|Other|1|||
143015200|NCT04682639|515597366|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
143015201|NCT04682639|515597367|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
143015202|NCT04682639|515597368|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
143015203|NCT04682639|515597369|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
143015204|NCT04682639|515597370|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
143015205|NCT04682639|515597366|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
143015206|NCT04682639|515597367|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
143015207|NCT04682639|515597368|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
143015208|NCT04682639|515597369|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
143015209|NCT04682639|515597370|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
143015210|NCT04682639|515597366|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
143015211|NCT04682639|515597367|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
143015212|NCT04682639|515597368|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
143015213|NCT04682639|515597369|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
143015214|NCT04682639|515597370|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
143015215|NCT04682639|515597366|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
143015216|NCT04682639|515597367|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
143015217|NCT04682639|515597368|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
143015218|NCT04682639|515597369|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
143015219|NCT04682639|515597370|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
143015220|NCT01383954|515597371|FG000|Overall Study|Lack of Efficacy|2|||
143015221|NCT01383954|515597371|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
143015222|NCT01383954|515597371|FG000|Overall Study|Adverse Event|1|||
143015223|NCT01383954|515597371|FG000|Overall Study|Reason Not Specified|9|||
143015224|NCT00763269|515597378|FG000|Overall Study|Lost to Follow-up|12|||
143015225|NCT00763269|515597379|FG001|Overall Study|Lost to Follow-up|13|||
143015226|NCT03174925|515597380|FG000|Overall Study|Elastographic images not retrievable|2|||
143015227|NCT03174925|515597380|FG000|Overall Study|Elastography image not interpretable|1|||
143015228|NCT01791127|515597383|FG000|Overall Study|Death|356|||
143015229|NCT01791127|515597383|FG000|Overall Study|Patient has withdrawn from study|293|||
143015230|NCT01791127|515597383|FG000|Overall Study|Lost to Follow-up|42|||
143015231|NCT01791127|515597383|FG000|Overall Study|All Siello leads are explanted|31|||
143015232|NCT01791127|515597383|FG000|Overall Study|Completion of 30 day safety registry|1|||
143015233|NCT01791127|515597383|FG000|Overall Study|Study terminated for EP Passion|749|||
143015234|NCT03471182|515597384|FG000|Overall Study|Withdrawal by Subject|1|||
143015235|NCT03471182|515597385|FG001|Overall Study|Withdrawal by Subject|1|||
143015236|NCT03471182|515597386|FG002|Overall Study|Withdrawal by Subject|0|||
143015237|NCT03471182|515597384|FG000|Overall Study|Technical failure|2|||
143015238|NCT03471182|515597385|FG001|Overall Study|Technical failure|0|||
143015239|NCT03471182|515597386|FG002|Overall Study|Technical failure|0|||
143015240|NCT04440163|515597389|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
143015241|NCT04440163|515597390|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
143015242|NCT04440163|515597391|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
143015243|NCT04440163|515597392|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
143015244|NCT04440163|515597393|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
143015245|NCT04440163|515597394|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
143015246|NCT04440163|515597395|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
143015247|NCT04440163|515597396|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
143015248|NCT04440163|515597389|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
143015249|NCT04440163|515597390|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
143015250|NCT04440163|515597391|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
143015251|NCT04440163|515597392|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
143015252|NCT04440163|515597393|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
143015253|NCT04440163|515597394|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
143015254|NCT04440163|515597395|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
143015255|NCT04440163|515597396|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
143234617|NCT01436149|516411340|FG001|Randomized Phase|Lack of Efficacy|0|||
143234618|NCT01436149|516411341|FG002|Randomized Phase|Lack of Efficacy|1|||
143234619|NCT01436149|516411339|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
143234620|NCT01436149|516411340|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
143234621|NCT01436149|516411341|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
143234622|NCT01436149|516411339|FG000|Randomized Phase|Other|12|||
143234623|NCT01436149|516411340|FG001|Randomized Phase|Other|5|||
143234624|NCT01436149|516411341|FG002|Randomized Phase|Other|11|||
143234625|NCT04849364|516411343|FG000|Overall Study|Eligibility criteria not meet|0|||
143234626|NCT04849364|516411344|FG001|Overall Study|Eligibility criteria not meet|1|||
143234627|NCT04849364|516411345|FG002|Overall Study|Eligibility criteria not meet|0|||
143234628|NCT02738801|516411354|FG000|Overall Study|Adverse Event|1|||
143234629|NCT02738801|516411355|FG001|Overall Study|Adverse Event|1|||
143234630|NCT02738801|516411354|FG000|Overall Study|Withdrawal by Subject|0|||
143234631|NCT02738801|516411355|FG001|Overall Study|Withdrawal by Subject|1|||
143234632|NCT01643668|516411356|FG000|Overall Study|Death|1|||
143234633|NCT03253796|516411367|FG000|Period 1: Run-In|Adverse Event|4|||
143234634|NCT03253796|516411368|FG001|Period 1: Run-In|Adverse Event|0|||
143234635|NCT03253796|516411369|FG002|Period 1: Run-In|Adverse Event|0|||
143234636|NCT03253796|516411370|FG003|Period 1: Run-In|Adverse Event|0|||
143234637|NCT03253796|516411371|FG004|Period 1: Run-In|Adverse Event|0|||
143234638|NCT03253796|516411367|FG000|Period 1: Run-In|Lack of Efficacy|1|||
143234639|NCT03253796|516411368|FG001|Period 1: Run-In|Lack of Efficacy|0|||
143234640|NCT03253796|516411369|FG002|Period 1: Run-In|Lack of Efficacy|0|||
143234641|NCT03253796|516411370|FG003|Period 1: Run-In|Lack of Efficacy|0|||
143234642|NCT03253796|516411371|FG004|Period 1: Run-In|Lack of Efficacy|0|||
143234643|NCT03253796|516411367|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
143234644|NCT03253796|516411368|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
143234645|NCT03253796|516411369|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
143234646|NCT03253796|516411370|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
143234647|NCT03253796|516411371|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
143234648|NCT03253796|516411367|FG000|Period 1: Run-In|Protocol Violation|5|||
143234649|NCT03253796|516411368|FG001|Period 1: Run-In|Protocol Violation|0|||
143234650|NCT03253796|516411369|FG002|Period 1: Run-In|Protocol Violation|0|||
143234651|NCT03253796|516411370|FG003|Period 1: Run-In|Protocol Violation|0|||
143234652|NCT03253796|516411371|FG004|Period 1: Run-In|Protocol Violation|0|||
143234653|NCT03253796|516411367|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
143234654|NCT03253796|516411368|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
143234655|NCT03253796|516411369|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
143234656|NCT03253796|516411370|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
143234657|NCT03253796|516411371|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
143234658|NCT03253796|516411367|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
143234659|NCT03253796|516411368|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
143234660|NCT03253796|516411369|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
143234661|NCT03253796|516411370|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
143234662|NCT03253796|516411371|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
143234663|NCT03253796|516411367|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
143234664|NCT03253796|516411368|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
143234665|NCT03253796|516411369|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
143234666|NCT03253796|516411370|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
143234667|NCT03253796|516411371|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
143234668|NCT03253796|516411367|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
143234669|NCT03253796|516411368|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
143234670|NCT03253796|516411369|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
143234671|NCT03253796|516411370|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
143234672|NCT03253796|516411371|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
143234673|NCT03253796|516411367|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
143234674|NCT03253796|516411368|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
143234675|NCT03253796|516411369|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
143234676|NCT03253796|516411370|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
143234677|NCT03253796|516411371|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
143234678|NCT03253796|516411367|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
143234679|NCT03253796|516411368|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
143234680|NCT03253796|516411369|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
143234681|NCT03253796|516411370|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
143234682|NCT03253796|516411371|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
143234683|NCT03253796|516411367|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
143234684|NCT03253796|516411368|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
143234685|NCT03253796|516411369|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
143234686|NCT03253796|516411370|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
143234687|NCT03253796|516411371|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
143234688|NCT00894803|516411372|FG000|Overall Study|Death|20|||
143234689|NCT00894803|516411373|FG001|Overall Study|Death|4|||
143234690|NCT00894803|516411372|FG000|Overall Study|Lost to Follow-up|0|||
143234691|NCT00894803|516411373|FG001|Overall Study|Lost to Follow-up|1|||
143234692|NCT01075243|516411375|FG000|Overall Study|Lost to Follow-up|5|||
143234693|NCT01075243|516411376|FG001|Overall Study|Lost to Follow-up|2|||
143234694|NCT01075243|516411377|FG002|Overall Study|Lost to Follow-up|0|||
143234695|NCT01075243|516411375|FG000|Overall Study|Withdrawal by Subject|1|||
143234696|NCT01075243|516411376|FG001|Overall Study|Withdrawal by Subject|1|||
143234697|NCT01075243|516411377|FG002|Overall Study|Withdrawal by Subject|0|||
143234698|NCT03094416|516411383|FG000|Run-in|Screening failure|8|||
143234699|NCT03094416|516411383|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
143234700|NCT03094416|516411383|FG000|Run-in|Withdrawal by Subject|3|||
143234701|NCT03094416|516411383|FG000|Treatment Period|Withdrawal by Subject|2|||
143234702|NCT03050801|516411386|FG000|Experiment 1|Lost to Follow-up|0|||
143234703|NCT03050801|516411387|FG001|Experiment 1|Lost to Follow-up|1|||
143234704|NCT03050801|516411388|FG002|Experiment 1|Lost to Follow-up|0|||
143234705|NCT03050801|516411389|FG003|Experiment 1|Lost to Follow-up|0|||
143234706|NCT03050801|516411390|FG004|Experiment 1|Lost to Follow-up|0|||
143234707|NCT03050801|516411391|FG005|Experiment 1|Lost to Follow-up|0|||
143234708|NCT03050801|516411386|FG000|Experiment 1|Physician Decision|0|||
143234709|NCT03050801|516411387|FG001|Experiment 1|Physician Decision|3|||
143234710|NCT03050801|516411388|FG002|Experiment 1|Physician Decision|0|||
143234711|NCT03050801|516411389|FG003|Experiment 1|Physician Decision|0|||
143234712|NCT03050801|516411390|FG004|Experiment 1|Physician Decision|0|||
143234713|NCT03050801|516411391|FG005|Experiment 1|Physician Decision|0|||
143234714|NCT03050801|516411386|FG000|Experiment 1|Change of experimental design|0|||
143234715|NCT03050801|516411387|FG001|Experiment 1|Change of experimental design|3|||
143234716|NCT03050801|516411388|FG002|Experiment 1|Change of experimental design|0|||
143234717|NCT03050801|516411389|FG003|Experiment 1|Change of experimental design|0|||
143234718|NCT03050801|516411390|FG004|Experiment 1|Change of experimental design|0|||
143234719|NCT03050801|516411391|FG005|Experiment 1|Change of experimental design|0|||
143234720|NCT03050801|516411386|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
143234721|NCT03050801|516411387|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
143234722|NCT03050801|516411388|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
143234723|NCT03050801|516411389|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
143234724|NCT03050801|516411390|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
143234725|NCT03050801|516411391|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
143234726|NCT03050801|516411386|FG000|Experiment 2|Lost to Follow-up|0|||
143234727|NCT03050801|516411387|FG001|Experiment 2|Lost to Follow-up|0|||
143234728|NCT03050801|516411388|FG002|Experiment 2|Lost to Follow-up|0|||
143234729|NCT03050801|516411389|FG003|Experiment 2|Lost to Follow-up|1|||
143234730|NCT03050801|516411390|FG004|Experiment 2|Lost to Follow-up|1|||
143234731|NCT03050801|516411391|FG005|Experiment 2|Lost to Follow-up|0|||
143234732|NCT03050801|516411386|FG000|Experiment 2|Physician Decision|0|||
143234733|NCT03050801|516411387|FG001|Experiment 2|Physician Decision|0|||
143234734|NCT03050801|516411388|FG002|Experiment 2|Physician Decision|0|||
143234735|NCT03050801|516411389|FG003|Experiment 2|Physician Decision|0|||
143234736|NCT03050801|516411390|FG004|Experiment 2|Physician Decision|1|||
143234737|NCT03050801|516411391|FG005|Experiment 2|Physician Decision|0|||
143234738|NCT03050801|516411386|FG000|Experiment 2|Pregnancy|0|||
143234739|NCT03050801|516411387|FG001|Experiment 2|Pregnancy|0|||
143234740|NCT03050801|516411388|FG002|Experiment 2|Pregnancy|0|||
143234741|NCT03050801|516411389|FG003|Experiment 2|Pregnancy|0|||
143234742|NCT03050801|516411390|FG004|Experiment 2|Pregnancy|1|||
143234743|NCT03050801|516411391|FG005|Experiment 2|Pregnancy|0|||
143234744|NCT03050801|516411386|FG000|Experiment 2|Withdrawal by Subject|0|||
143234745|NCT03050801|516411387|FG001|Experiment 2|Withdrawal by Subject|0|||
143234746|NCT03050801|516411388|FG002|Experiment 2|Withdrawal by Subject|0|||
143363655|NCT00062868|516873788|FG008|Dose Level 3|Death|0|||
143234747|NCT03050801|516411389|FG003|Experiment 2|Withdrawal by Subject|1|||
143234748|NCT03050801|516411390|FG004|Experiment 2|Withdrawal by Subject|0|||
143234749|NCT03050801|516411391|FG005|Experiment 2|Withdrawal by Subject|0|||
143234750|NCT03050801|516411386|FG000|Experiment 2|Poor data quality|0|||
143234751|NCT03050801|516411387|FG001|Experiment 2|Poor data quality|0|||
143234752|NCT03050801|516411388|FG002|Experiment 2|Poor data quality|0|||
143234753|NCT03050801|516411389|FG003|Experiment 2|Poor data quality|4|||
143234754|NCT03050801|516411390|FG004|Experiment 2|Poor data quality|1|||
143234755|NCT03050801|516411391|FG005|Experiment 2|Poor data quality|0|||
143234756|NCT03050801|516411386|FG000|Experiment 2|Discomfort during stimulation|0|||
143234757|NCT03050801|516411387|FG001|Experiment 2|Discomfort during stimulation|0|||
143234758|NCT03050801|516411388|FG002|Experiment 2|Discomfort during stimulation|0|||
143234759|NCT03050801|516411389|FG003|Experiment 2|Discomfort during stimulation|0|||
143234760|NCT03050801|516411390|FG004|Experiment 2|Discomfort during stimulation|0|||
143234761|NCT03050801|516411391|FG005|Experiment 2|Discomfort during stimulation|2|||
143234762|NCT03600909|516411392|FG000|Overall Study|Not treated|0|||
143234763|NCT03600909|516411393|FG001|Overall Study|Not treated|3|||
143234764|NCT03600909|516411394|FG002|Overall Study|Not treated|0|||
143234765|NCT00521079|516411395|FG000|Overall Study|Adverse Event|7|||
143234766|NCT00521079|516411396|FG001|Overall Study|Adverse Event|1|||
143234767|NCT00521079|516411395|FG000|Overall Study|Lost to Follow-up|2|||
143234768|NCT00521079|516411396|FG001|Overall Study|Lost to Follow-up|1|||
143234769|NCT00521079|516411395|FG000|Overall Study|Withdrawal by Subject|5|||
143234770|NCT00521079|516411396|FG001|Overall Study|Withdrawal by Subject|3|||
143234771|NCT02246530|516411397|FG000|Overall Study|Lost to Follow-up|4|||
143234772|NCT02246530|516411398|FG001|Overall Study|Lost to Follow-up|0|||
143234773|NCT01506596|516411399|FG000|Overall Study|ineligible pathology|1|||
143152295|NCT01771913|516102357|FG001|Overall Study|Withdrawal by Subject|0|||
143152296|NCT00552058|516102366|FG000|Overall Study|Adverse Event|8|||
143152297|NCT00552058|516102367|FG001|Overall Study|Adverse Event|7|||
143152298|NCT00552058|516102366|FG000|Overall Study|Lack of Efficacy|1|||
143152299|NCT00552058|516102367|FG001|Overall Study|Lack of Efficacy|5|||
143152300|NCT00552058|516102366|FG000|Overall Study|Lost to Follow-up|1|||
143152301|NCT00552058|516102367|FG001|Overall Study|Lost to Follow-up|0|||
143152302|NCT00552058|516102366|FG000|Overall Study|Withdrawal by Subject|4|||
143152303|NCT00552058|516102367|FG001|Overall Study|Withdrawal by Subject|4|||
143152304|NCT00552058|516102366|FG000|Overall Study|Other: Protocol Violation|0|||
143152305|NCT00552058|516102367|FG001|Overall Study|Other: Protocol Violation|1|||
143152306|NCT00552058|516102366|FG000|Overall Study|Other: Non Compliance|1|||
143152307|NCT00552058|516102367|FG001|Overall Study|Other: Non Compliance|2|||
143152308|NCT00552058|516102366|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
143152309|NCT00552058|516102367|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
143152310|NCT00552058|516102366|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
143152311|NCT00552058|516102367|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
143152312|NCT00552058|516102366|FG000|Overall Study|Other: Positive Stool Result|0|||
143152313|NCT00552058|516102367|FG001|Overall Study|Other: Positive Stool Result|1|||
143152314|NCT00552058|516102366|FG000|Overall Study|Other: Randomized in error|0|||
143152315|NCT00552058|516102367|FG001|Overall Study|Other: Randomized in error|1|||
143152316|NCT00552058|516102366|FG000|Overall Study|Other: Sponsors Decision|0|||
143152317|NCT00552058|516102367|FG001|Overall Study|Other: Sponsors Decision|1|||
143152318|NCT00552058|516102366|FG000|Overall Study|Other: Early Roll Over|1|||
143152319|NCT00552058|516102367|FG001|Overall Study|Other: Early Roll Over|0|||
143152320|NCT01471574|516102372|FG000|Treatment Period|Lack of Efficacy|12|||
143152321|NCT01471574|516102373|FG001|Treatment Period|Lack of Efficacy|4|||
143152322|NCT01471574|516102374|FG002|Treatment Period|Lack of Efficacy|14|||
143152323|NCT01471574|516102375|FG003|Treatment Period|Lack of Efficacy|1|||
143152324|NCT01471574|516102372|FG000|Treatment Period|Adverse Event|7|||
143152325|NCT01471574|516102373|FG001|Treatment Period|Adverse Event|3|||
143152326|NCT01471574|516102374|FG002|Treatment Period|Adverse Event|6|||
143152327|NCT01471574|516102375|FG003|Treatment Period|Adverse Event|1|||
143152328|NCT01471574|516102372|FG000|Treatment Period|Withdrawal by Subject|5|||
143152329|NCT01471574|516102373|FG001|Treatment Period|Withdrawal by Subject|1|||
143152330|NCT01471574|516102374|FG002|Treatment Period|Withdrawal by Subject|1|||
143152331|NCT01471574|516102375|FG003|Treatment Period|Withdrawal by Subject|0|||
143152332|NCT01471574|516102372|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
143152333|NCT01471574|516102373|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
143152334|NCT01471574|516102374|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
143152335|NCT01471574|516102375|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
143152336|NCT01471574|516102372|FG000|Treatment Period|Lost to Follow-up|1|||
143152337|NCT01471574|516102373|FG001|Treatment Period|Lost to Follow-up|2|||
143152338|NCT01471574|516102374|FG002|Treatment Period|Lost to Follow-up|2|||
143234774|NCT01488890|516411402|FG000|Overall Study|Serious adverse event|2|||
143234775|NCT01488890|516411403|FG001|Overall Study|Serious adverse event|0|||
143234776|NCT01488890|516411404|FG002|Overall Study|Serious adverse event|0|||
143234777|NCT01488890|516411405|FG003|Overall Study|Serious adverse event|0|||
143234778|NCT01488890|516411402|FG000|Overall Study|Protocol Violation|3|||
143234779|NCT01488890|516411403|FG001|Overall Study|Protocol Violation|0|||
143234780|NCT01488890|516411404|FG002|Overall Study|Protocol Violation|4|||
143234781|NCT01488890|516411405|FG003|Overall Study|Protocol Violation|0|||
143234782|NCT01488890|516411402|FG000|Overall Study|Lost to Follow-up|13|||
143234783|NCT01488890|516411403|FG001|Overall Study|Lost to Follow-up|10|||
143234784|NCT01488890|516411404|FG002|Overall Study|Lost to Follow-up|20|||
143234785|NCT01488890|516411405|FG003|Overall Study|Lost to Follow-up|3|||
143234786|NCT01488890|516411402|FG000|Overall Study|Withdrawal by Subject|14|||
143152339|NCT01471574|516102375|FG003|Treatment Period|Lost to Follow-up|0|||
143152340|NCT01471574|516102372|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
143152341|NCT01471574|516102373|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
143152342|NCT01471574|516102374|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
143152343|NCT01471574|516102375|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
143152344|NCT01471574|516102372|FG000|Treatment Period|Other|1|||
143234787|NCT01488890|516411403|FG001|Overall Study|Withdrawal by Subject|10|||
143234788|NCT01488890|516411404|FG002|Overall Study|Withdrawal by Subject|11|||
143234789|NCT01488890|516411405|FG003|Overall Study|Withdrawal by Subject|2|||
143234790|NCT05712460|516411406|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
143234791|NCT05712460|516411407|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
143234792|NCT05712460|516411408|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
143234793|NCT05712460|516411409|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
143234794|NCT05712460|516411410|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
143234795|NCT05712460|516411411|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
143234796|NCT05712460|516411412|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
143234797|NCT05712460|516411413|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
143234798|NCT05712460|516411414|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
143234799|NCT05712460|516411415|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
143234800|NCT05712460|516411416|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
143234801|NCT05712460|516411417|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
143234802|NCT04366349|516411420|FG000|Overall Study|Withdrawal by Subject|1|||
143234803|NCT04366349|516411421|FG001|Overall Study|Withdrawal by Subject|0|||
143234804|NCT04366349|516411422|FG002|Overall Study|Withdrawal by Subject|0|||
143234805|NCT04366349|516411423|FG003|Overall Study|Withdrawal by Subject|0|||
143234806|NCT04366349|516411424|FG004|Overall Study|Withdrawal by Subject|0|||
143234807|NCT04366349|516411425|FG005|Overall Study|Withdrawal by Subject|0|||
143234808|NCT05138653|516411429|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
143234809|NCT05138653|516411430|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
143234810|NCT05138653|516411431|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
143234811|NCT05138653|516411432|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
143234812|NCT05138653|516411433|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
143234813|NCT05138653|516411434|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
143234814|NCT05138653|516411435|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
143234815|NCT05138653|516411436|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
143234816|NCT05138653|516411437|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
143234817|NCT05138653|516411438|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
143234818|NCT05138653|516411439|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
143234819|NCT05138653|516411440|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
143234820|NCT05138653|516411441|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
143234821|NCT05138653|516411442|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
143234822|NCT05138653|516411443|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
143234823|NCT05138653|516411444|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
143234824|NCT05138653|516411429|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
143234825|NCT05138653|516411430|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
143234826|NCT05138653|516411431|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
143234827|NCT05138653|516411432|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
143234828|NCT05138653|516411433|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
143234829|NCT05138653|516411434|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
143234830|NCT05138653|516411435|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
143234831|NCT05138653|516411436|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
143234832|NCT05138653|516411437|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
143234833|NCT05138653|516411438|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
143234834|NCT05138653|516411439|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
143234835|NCT05138653|516411440|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
143234836|NCT05138653|516411441|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
143234837|NCT05138653|516411442|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
143152345|NCT01471574|516102373|FG001|Treatment Period|Other|0|||
143152346|NCT01471574|516102374|FG002|Treatment Period|Other|0|||
143152347|NCT01471574|516102375|FG003|Treatment Period|Other|0|||
143152348|NCT01471574|516102372|FG000|Follow-up Period|Withdrawal by Subject|3|||
143152349|NCT01471574|516102373|FG001|Follow-up Period|Withdrawal by Subject|0|||
143152350|NCT01471574|516102374|FG002|Follow-up Period|Withdrawal by Subject|3|||
143152351|NCT01471574|516102375|FG003|Follow-up Period|Withdrawal by Subject|1|||
143152352|NCT01471574|516102372|FG000|Follow-up Period|Lost to Follow-up|4|||
143234838|NCT05138653|516411443|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
143234839|NCT05138653|516411444|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
143234840|NCT05138653|516411429|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
143234841|NCT05138653|516411430|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
143234842|NCT05138653|516411431|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
143152353|NCT01471574|516102373|FG001|Follow-up Period|Lost to Follow-up|1|||
143152354|NCT01471574|516102374|FG002|Follow-up Period|Lost to Follow-up|3|||
143152355|NCT01471574|516102375|FG003|Follow-up Period|Lost to Follow-up|2|||
143152356|NCT01471574|516102372|FG000|Follow-up Period|Death|0|||
143234843|NCT05138653|516411432|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
143234844|NCT05138653|516411433|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
143234845|NCT05138653|516411434|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
143234846|NCT05138653|516411435|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
143234847|NCT05138653|516411436|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
143234848|NCT05138653|516411437|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
143234849|NCT05138653|516411438|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
143234850|NCT05138653|516411439|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
143234851|NCT05138653|516411440|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
143234852|NCT05138653|516411441|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
143234853|NCT05138653|516411442|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
143234854|NCT05138653|516411443|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
143234855|NCT05138653|516411444|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
143234856|NCT05138653|516411429|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
143234857|NCT05138653|516411430|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
143234858|NCT05138653|516411431|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
143234859|NCT05138653|516411432|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
143234860|NCT05138653|516411433|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
143234861|NCT05138653|516411434|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
143234862|NCT05138653|516411435|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
143234863|NCT05138653|516411436|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
143234864|NCT05138653|516411437|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
143234865|NCT05138653|516411438|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
143234866|NCT05138653|516411439|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
143234867|NCT05138653|516411440|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
143234868|NCT05138653|516411441|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
143234869|NCT05138653|516411442|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
143234870|NCT05138653|516411443|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
143234871|NCT05138653|516411444|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
143234872|NCT05138653|516411429|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
143234873|NCT05138653|516411430|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
143234874|NCT05138653|516411431|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
143234875|NCT05138653|516411432|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
143234876|NCT05138653|516411433|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
143234877|NCT05138653|516411434|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
143234878|NCT05138653|516411435|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
143234879|NCT05138653|516411436|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
143234880|NCT05138653|516411437|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
143234881|NCT05138653|516411438|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
143234882|NCT05138653|516411439|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
143234883|NCT05138653|516411440|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
143234884|NCT05138653|516411441|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
143234885|NCT05138653|516411442|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
143234886|NCT05138653|516411443|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
143234887|NCT05138653|516411444|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
143234888|NCT05138653|516411429|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
143234889|NCT05138653|516411430|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
143234890|NCT05138653|516411431|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
143234891|NCT05138653|516411432|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
143234892|NCT05138653|516411433|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
143234893|NCT05138653|516411434|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
143234894|NCT05138653|516411435|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
143234895|NCT05138653|516411436|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
143234896|NCT05138653|516411437|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
143234897|NCT05138653|516411438|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
143234898|NCT05138653|516411439|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
143234899|NCT05138653|516411440|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
143234900|NCT05138653|516411441|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
143234901|NCT05138653|516411442|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
143234902|NCT05138653|516411443|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
143234903|NCT05138653|516411444|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
143234904|NCT05138653|516411429|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
143234905|NCT05138653|516411430|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
143234906|NCT05138653|516411431|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
143363656|NCT00062868|516873789|FG009|Dose Level 3|Death|0|||
143234907|NCT05138653|516411432|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
143234908|NCT05138653|516411433|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
143234909|NCT05138653|516411434|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
143234910|NCT05138653|516411435|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
143234911|NCT05138653|516411436|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
143234912|NCT05138653|516411437|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
143234913|NCT05138653|516411438|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
143234914|NCT05138653|516411439|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
143234915|NCT05138653|516411440|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
143234916|NCT05138653|516411441|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
143234917|NCT05138653|516411442|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
143234918|NCT05138653|516411443|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
143234919|NCT05138653|516411444|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
143234920|NCT05967260|516411445|FG000|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|0|||
143234921|NCT05967260|516411446|FG001|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|1|||
143234922|NCT00626106|516411447|FG000|Overall Study|Withdrawal by Subject|2|||
143234923|NCT00626106|516411448|FG001|Overall Study|Withdrawal by Subject|1|||
143363657|NCT00062868|516873790|FG010|Dose Level 3|Death|0|||
143152357|NCT01471574|516102373|FG001|Follow-up Period|Death|0|||
143152358|NCT01471574|516102374|FG002|Follow-up Period|Death|1|||
143152359|NCT01471574|516102375|FG003|Follow-up Period|Death|0|||
143152360|NCT01471574|516102372|FG000|Follow-up Period|Follow-up no longer required|0|||
143152361|NCT01471574|516102373|FG001|Follow-up Period|Follow-up no longer required|1|||
143152362|NCT01471574|516102374|FG002|Follow-up Period|Follow-up no longer required|0|||
143152363|NCT01471574|516102375|FG003|Follow-up Period|Follow-up no longer required|0|||
143152364|NCT01137812|516102376|FG000|Overall Study|Adverse Event|21|||
143152365|NCT01137812|516102377|FG001|Overall Study|Adverse Event|14|||
143152366|NCT01137812|516102376|FG000|Overall Study|Lost to Follow-up|6|||
143152367|NCT01137812|516102377|FG001|Overall Study|Lost to Follow-up|8|||
143152368|NCT01137812|516102376|FG000|Overall Study|Physician Decision|25|||
143152369|NCT01137812|516102377|FG001|Overall Study|Physician Decision|17|||
143152370|NCT01137812|516102376|FG000|Overall Study|Protocol Violation|5|||
143152371|NCT01137812|516102377|FG001|Overall Study|Protocol Violation|4|||
143152372|NCT01137812|516102376|FG000|Overall Study|Withdrawal by Subject|5|||
143152373|NCT01137812|516102377|FG001|Overall Study|Withdrawal by Subject|13|||
143152374|NCT01137812|516102376|FG000|Overall Study|Death|2|||
143152375|NCT01137812|516102377|FG001|Overall Study|Death|0|||
143152376|NCT01137812|516102376|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
143152377|NCT01137812|516102377|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
143152378|NCT01137812|516102376|FG000|Overall Study|Other|19|||
143152379|NCT01137812|516102377|FG001|Overall Study|Other|27|||
143152380|NCT00845182|516102378|FG000|Overall Study|Lost to Follow-up|3|||
143152381|NCT00845182|516102379|FG001|Overall Study|Lost to Follow-up|3|||
143152382|NCT00845182|516102380|FG002|Overall Study|Lost to Follow-up|4|||
143152383|NCT00845182|516102378|FG000|Overall Study|Adverse Event|0|||
143152384|NCT00845182|516102379|FG001|Overall Study|Adverse Event|1|||
143152385|NCT00845182|516102380|FG002|Overall Study|Adverse Event|1|||
143152386|NCT00845182|516102378|FG000|Overall Study|Physician Decision|0|||
143152387|NCT00845182|516102379|FG001|Overall Study|Physician Decision|0|||
143152388|NCT00845182|516102380|FG002|Overall Study|Physician Decision|1|||
143152389|NCT04621760|516102381|FG000|Overall Study|Lost to Follow-up|2|||
143152390|NCT04621760|516102382|FG001|Overall Study|Lost to Follow-up|4|||
143152391|NCT04621760|516102381|FG000|Overall Study|Withdrawal by Subject|1|||
143152392|NCT04621760|516102382|FG001|Overall Study|Withdrawal by Subject|0|||
143152393|NCT00447278|516102385|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
143152394|NCT00447278|516102386|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
143152395|NCT00447278|516102385|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
143152396|NCT00447278|516102386|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
143152397|NCT00447278|516102385|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
143363658|NCT00062868|516873791|FG011|Dose Level 3|Death|1|||
143484739|NCT04677712|517320973|FG000|Overall Study|Lost to Follow-up|0|||
143484740|NCT04677712|517320974|FG001|Overall Study|Lost to Follow-up|1|||
143152398|NCT00447278|516102386|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
143152399|NCT00447278|516102385|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
143484741|NCT04677712|517320975|FG002|Overall Study|Lost to Follow-up|0|||
143484742|NCT04677712|517320976|FG003|Overall Study|Lost to Follow-up|0|||
143152400|NCT00447278|516102386|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
143152401|NCT00447278|516102385|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
143152402|NCT00447278|516102386|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
143152403|NCT00447278|516102385|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
143152404|NCT00447278|516102386|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
143152405|NCT00447278|516102385|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
143234924|NCT00626106|516411447|FG000|Overall Study|Lost to Follow-up|1|||
143234925|NCT00626106|516411448|FG001|Overall Study|Lost to Follow-up|4|||
143234926|NCT00626106|516411447|FG000|Overall Study|Death|64|||
143234927|NCT00626106|516411448|FG001|Overall Study|Death|19|||
143234928|NCT00079417|516413436|FG000|Overall Study|Physician Decision|2|||
143234929|NCT00079417|516413436|FG000|Overall Study|Ineligible|7|||
143234930|NCT01615939|516413437|FG000|Overall Study|Lost to Follow-up|5|||
143234931|NCT01615939|516413438|FG001|Overall Study|Lost to Follow-up|0|||
143234932|NCT02121535|516413442|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
143234933|NCT02121535|516413443|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
143234934|NCT02121535|516413442|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
143234935|NCT02121535|516413443|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
143234936|NCT00092417|516413444|FG000|Overall Study|Lost to Follow-up|2|||
143234937|NCT00092417|516413445|FG001|Overall Study|Lost to Follow-up|0|||
143234938|NCT00092417|516413444|FG000|Overall Study|Withdrawal by Subject|2|||
143234939|NCT00092417|516413445|FG001|Overall Study|Withdrawal by Subject|1|||
143234940|NCT00092417|516413444|FG000|Overall Study|Other|1|||
143234941|NCT00092417|516413445|FG001|Overall Study|Other|0|||
143234942|NCT01520506|516413446|FG000|Overall Study|Missed Visit|4|||
143234943|NCT01520506|516413446|FG000|Overall Study|Lost to Follow-up|1|||
143234944|NCT01520506|516413446|FG000|Overall Study|Withdrawal by Subject|1|||
143234945|NCT00425269|516413447|FG000|Overall Study|Pregnancy|5|||
143234946|NCT00425269|516413448|FG001|Overall Study|Pregnancy|7|||
143234947|NCT00425269|516413447|FG000|Overall Study|Lost to Follow-up|9|||
143234948|NCT00425269|516413448|FG001|Overall Study|Lost to Follow-up|9|||
143234949|NCT00425269|516413447|FG000|Overall Study|moved or medical reason|5|||
143234950|NCT00425269|516413448|FG001|Overall Study|moved or medical reason|4|||
143234951|NCT01084655|516413451|FG000|Overall Study|Radiographic disease progression|3|||
143234952|NCT01084655|516413452|FG001|Overall Study|Radiographic disease progression|2|||
143234953|NCT01084655|516413453|FG002|Overall Study|Radiographic disease progression|8|||
143234954|NCT01084655|516413451|FG000|Overall Study|Withdrawal by Subject|1|||
143234955|NCT01084655|516413452|FG001|Overall Study|Withdrawal by Subject|0|||
143234956|NCT01084655|516413453|FG002|Overall Study|Withdrawal by Subject|4|||
143234957|NCT01084655|516413451|FG000|Overall Study|Adverse Event|2|||
143234958|NCT01084655|516413452|FG001|Overall Study|Adverse Event|1|||
143152406|NCT00447278|516102386|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
143152407|NCT00447278|516102385|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
143152408|NCT00447278|516102386|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
143152409|NCT00447278|516102385|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
143234959|NCT01084655|516413453|FG002|Overall Study|Adverse Event|2|||
143234960|NCT01084655|516413451|FG000|Overall Study|Other|0|||
143234961|NCT01084655|516413452|FG001|Overall Study|Other|3|||
143152410|NCT00447278|516102386|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
143152411|NCT00447278|516102385|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
143152412|NCT00447278|516102386|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
143152413|NCT00447278|516102385|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
143152414|NCT00447278|516102386|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
143152415|NCT00447278|516102385|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
143152416|NCT00447278|516102386|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
143152417|NCT00447278|516102385|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
143152418|NCT00447278|516102386|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
143152419|NCT00447278|516102385|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
143152420|NCT00447278|516102386|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
143152421|NCT03677401|516102387|FG000|Overall Study|Adverse Event|4|||
143152422|NCT03677401|516102388|FG001|Overall Study|Adverse Event|14|||
143152423|NCT03677401|516102387|FG000|Overall Study|Lack of Efficacy|3|||
143234962|NCT01084655|516413453|FG002|Overall Study|Other|2|||
143234963|NCT01084655|516413451|FG000|Overall Study|Symptomatic deterioration|0|||
143234964|NCT01084655|516413452|FG001|Overall Study|Symptomatic deterioration|0|||
143234965|NCT01084655|516413453|FG002|Overall Study|Symptomatic deterioration|2|||
143234966|NCT01084655|516413451|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
143234967|NCT01084655|516413452|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
143234968|NCT01084655|516413453|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
143234969|NCT01256788|516413454|FG000|Overall Study|Lost to Follow-up|5|||
143234970|NCT01256788|516413455|FG001|Overall Study|Lost to Follow-up|8|||
143234971|NCT01256788|516413456|FG002|Overall Study|Lost to Follow-up|3|||
143234972|NCT00906204|516413457|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
143234973|NCT00906204|516413458|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
143234974|NCT00906204|516413457|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
143234975|NCT00906204|516413458|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
143234976|NCT00906204|516413457|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
143234977|NCT00906204|516413458|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
143234978|NCT00906204|516413457|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
143152424|NCT03677401|516102388|FG001|Overall Study|Lack of Efficacy|1|||
143152425|NCT03677401|516102387|FG000|Overall Study|Withdrawal by Subject|2|||
143152426|NCT03677401|516102388|FG001|Overall Study|Withdrawal by Subject|2|||
143152427|NCT03677401|516102387|FG000|Overall Study|Sponsor decision|0|||
143152428|NCT03677401|516102388|FG001|Overall Study|Sponsor decision|1|||
143152429|NCT03677401|516102387|FG000|Overall Study|Reason Unspecified|1|||
143152430|NCT03677401|516102388|FG001|Overall Study|Reason Unspecified|0|||
143152431|NCT01177410|516102391|FG000|Overall Study|Adverse Event|0|||
143152432|NCT01177410|516102392|FG001|Overall Study|Adverse Event|2|||
143152433|NCT01177410|516102393|FG002|Overall Study|Adverse Event|2|||
143152434|NCT01177410|516102391|FG000|Overall Study|Withdrawal by Subject|1|||
143152435|NCT01177410|516102392|FG001|Overall Study|Withdrawal by Subject|4|||
143152436|NCT01177410|516102393|FG002|Overall Study|Withdrawal by Subject|3|||
143152437|NCT01177410|516102391|FG000|Overall Study|Lost to Follow-up|0|||
143152438|NCT01177410|516102392|FG001|Overall Study|Lost to Follow-up|1|||
143152439|NCT01177410|516102393|FG002|Overall Study|Lost to Follow-up|0|||
143152440|NCT00471354|516102397|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
143152441|NCT00471354|516102397|FG000|Overall Study|Adverse Event|13|||
143152442|NCT00471354|516102397|FG000|Overall Study|Protocol Violation|12|||
143152443|NCT00471354|516102397|FG000|Overall Study|Withdrawal by Subject|1|||
143152444|NCT00471354|516102397|FG000|Overall Study|Physician Decision|4|||
143152445|NCT00471354|516102397|FG000|Overall Study|Sponsor Decision|1|||
143152446|NCT00471354|516102397|FG000|Overall Study|Lost to Follow-up|3|||
143152447|NCT00471354|516102397|FG000|Overall Study|Lack of Efficacy|5|||
143152448|NCT00471354|516102397|FG000|Overall Study|Patient/Caregiver Decision|12|||
143152449|NCT05427916|516102398|FG000|Overall Study|Adverse Event|3|||
143152450|NCT05427916|516102399|FG001|Overall Study|Adverse Event|0|||
143152451|NCT05427916|516102398|FG000|Overall Study|Lack of Efficacy|6|||
143152452|NCT05427916|516102399|FG001|Overall Study|Lack of Efficacy|0|||
143152453|NCT05427916|516102398|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
143152454|NCT05427916|516102399|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
143152455|NCT02691663|516102405|FG000|Overall Study|Screen failure after baseline|2|||
143152456|NCT02691663|516102406|FG001|Overall Study|Screen failure after baseline|2|||
143152457|NCT02691663|516102405|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
143152458|NCT02691663|516102406|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
143152459|NCT02691663|516102405|FG000|Overall Study|Withdrawn after Follow up 2|1|||
143152460|NCT02691663|516102406|FG001|Overall Study|Withdrawn after Follow up 2|1|||
143152461|NCT02691663|516102405|FG000|Overall Study|Lost to Follow-up|3|||
143152462|NCT02691663|516102406|FG001|Overall Study|Lost to Follow-up|2|||
143152463|NCT03142750|516102407|FG000|Overall Study|Lost to Follow-up|4|||
143152464|NCT03142750|516102408|FG001|Overall Study|Lost to Follow-up|1|||
143152465|NCT02942407|516102409|FG000|Overall Study|Lost to Follow-up|3|||
143152466|NCT02942407|516102410|FG001|Overall Study|Lost to Follow-up|2|||
143152467|NCT02942407|516102409|FG000|Overall Study|Withdrawal by Subject|7|||
143152468|NCT02942407|516102410|FG001|Overall Study|Withdrawal by Subject|9|||
143152469|NCT02942407|516102409|FG000|Overall Study|Death|16|||
143152470|NCT02942407|516102410|FG001|Overall Study|Death|13|||
143152471|NCT00933166|516102411|FG000|Overall Study|Lost to Follow-up|4|||
143152472|NCT00933166|516102411|FG000|Overall Study|Lack of Efficacy|9|||
143152473|NCT00933166|516102411|FG000|Overall Study|Unavailable|4|||
143152474|NCT00933166|516102411|FG000|Overall Study|Withdrawal by Subject|1|||
143152475|NCT03925220|516102412|FG000|Overall Study|Withdrawal by Subject|4|||
143152476|NCT03925220|516102413|FG001|Overall Study|Withdrawal by Subject|4|||
143152477|NCT03925220|516102414|FG002|Overall Study|Withdrawal by Subject|4|||
143152478|NCT03925220|516102415|FG003|Overall Study|Withdrawal by Subject|4|||
143152479|NCT03925220|516102412|FG000|Overall Study|Lost to Follow-up|40|||
143152480|NCT03925220|516102413|FG001|Overall Study|Lost to Follow-up|46|||
143152481|NCT03925220|516102414|FG002|Overall Study|Lost to Follow-up|37|||
143152482|NCT03925220|516102415|FG003|Overall Study|Lost to Follow-up|38|||
143152483|NCT00374868|516102416|FG000|Overall Study|Adverse Event|12|||
143152484|NCT00374868|516102416|FG000|Overall Study|Progressive Disease|7|||
143152485|NCT00374868|516102416|FG000|Overall Study|Physician Decision|13|||
143152486|NCT00374868|516102416|FG000|Overall Study|Lost to Follow-up|1|||
143152487|NCT00374868|516102416|FG000|Overall Study|Death|2|||
143152488|NCT00374868|516102416|FG000|Overall Study|Other - Not Specified|1|||
143152489|NCT00774748|516102417|FG000|Overall Study|Lost to Follow-up|3|||
143152490|NCT00866320|516102418|FG000|Overall Study|Withdrawal by Subject|4|||
143152491|NCT00866320|516102418|FG000|Overall Study|Death|2|||
143152492|NCT01327703|516102419|FG000|Second Treatment Period|Adverse Event|1|||
143152493|NCT01327703|516102420|FG001|Second Treatment Period|Adverse Event|1|||
143363659|NCT00062868|516873792|FG012|Dose Level 3|Death|0|||
143152494|NCT01327703|516102419|FG000|Second Treatment Period|Protocol Violation|0|||
143152495|NCT01327703|516102420|FG001|Second Treatment Period|Protocol Violation|1|||
143152496|NCT06038643|516102422|FG000|Overall Study|Withdrawal by Subject|9|||
143152497|NCT06038643|516102423|FG001|Overall Study|Withdrawal by Subject|4|||
143152498|NCT06038643|516102422|FG000|Overall Study|Excluded (not longer fulfilled enrollment criteria)|1|||
143152499|NCT06038643|516102423|FG001|Overall Study|Excluded (not longer fulfilled enrollment criteria)|0|||
143363660|NCT00062868|516873793|FG013|Dose Level 3|Death|0|||
143484743|NCT04677712|517320977|FG004|Overall Study|Lost to Follow-up|0|||
143484744|NCT04677712|517320978|FG005|Overall Study|Lost to Follow-up|0|||
143484745|NCT00711100|517320979|FG000|Overall Study|Lack of Efficacy|5|||
143484746|NCT00711100|517320979|FG000|Overall Study|Withdrawal by Subject|8|||
143484747|NCT00783094|517320980|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
143484748|NCT00783094|517320981|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
143484749|NCT00783094|517320982|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
143484750|NCT00783094|517320980|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
143484751|NCT00783094|517320981|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
143484752|NCT00783094|517320982|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
143484753|NCT00783094|517320980|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
143484754|NCT00783094|517320981|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
143484755|NCT00783094|517320982|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
143484756|NCT00783094|517320980|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
143484757|NCT00783094|517320981|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
143484758|NCT00783094|517320982|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
143484759|NCT00783094|517320980|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
143484760|NCT00783094|517320981|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
143484761|NCT00783094|517320982|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
143484762|NCT00783094|517320980|FG000|Open-Label Extension Period|Adverse Event|12|||
143484763|NCT00783094|517320981|FG001|Open-Label Extension Period|Adverse Event|7|||
143484764|NCT00783094|517320982|FG002|Open-Label Extension Period|Adverse Event|16|||
143484765|NCT00783094|517320980|FG000|Open-Label Extension Period|Death|0|||
143484766|NCT00783094|517320981|FG001|Open-Label Extension Period|Death|0|||
143484767|NCT00783094|517320982|FG002|Open-Label Extension Period|Death|1|||
143484768|NCT00783094|517320980|FG000|Open-Label Extension Period|Protocol Violation|4|||
143484769|NCT00783094|517320981|FG001|Open-Label Extension Period|Protocol Violation|5|||
143484770|NCT00783094|517320982|FG002|Open-Label Extension Period|Protocol Violation|7|||
143484771|NCT00783094|517320980|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
143484772|NCT00783094|517320981|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
143484773|NCT00783094|517320982|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
143484774|NCT00783094|517320980|FG000|Open-Label Extension Period|Physician Decision|4|||
143484775|NCT00783094|517320981|FG001|Open-Label Extension Period|Physician Decision|2|||
143484776|NCT00783094|517320982|FG002|Open-Label Extension Period|Physician Decision|3|||
143484777|NCT00783094|517320980|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
143484778|NCT00783094|517320981|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
143484779|NCT00783094|517320982|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
143484780|NCT02513329|517320983|FG000|Overall Study|Lost to Follow-up|5|||
143484781|NCT02513329|517320984|FG001|Overall Study|Lost to Follow-up|2|||
143484782|NCT01294670|517320985|FG000|Overall Study|Not treated|1|||
143484783|NCT01294670|517320986|FG001|Overall Study|Not treated|0|||
143484784|NCT01294670|517320987|FG002|Overall Study|Not treated|0|||
143484785|NCT01294670|517320988|FG003|Overall Study|Not treated|0|||
143484786|NCT01294670|517320989|FG004|Overall Study|Not treated|0|||
143484787|NCT03808077|517320991|FG000|Overall Study|Physician Decision|2|||
143484788|NCT03808077|517320992|FG001|Overall Study|Physician Decision|3|||
143152500|NCT02965833|516102427|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
143152501|NCT02965833|516102428|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
143152502|NCT02965833|516102427|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
143484789|NCT03808077|517320991|FG000|Overall Study|Withdrawal by Subject|1|||
143484790|NCT03808077|517320992|FG001|Overall Study|Withdrawal by Subject|0|||
143484791|NCT03808077|517320991|FG000|Overall Study|Equipment Issues|2|||
143484792|NCT03808077|517320992|FG001|Overall Study|Equipment Issues|1|||
143484793|NCT04152161|517320993|FG000|Overall Study|Death|0|||
143484794|NCT04152161|517320994|FG001|Overall Study|Death|1|||
143484795|NCT04152161|517320993|FG000|Overall Study|Physician Decision|0|||
143484796|NCT04152161|517320994|FG001|Overall Study|Physician Decision|1|||
143484797|NCT04152161|517320993|FG000|Overall Study|Lost to Follow-up|9|||
143484798|NCT04152161|517320994|FG001|Overall Study|Lost to Follow-up|3|||
143484799|NCT04152161|517320993|FG000|Overall Study|Protocol Violation|1|||
143484800|NCT04152161|517320994|FG001|Overall Study|Protocol Violation|0|||
143484801|NCT04152161|517320993|FG000|Overall Study|Withdrawal by Subject|29|||
143484802|NCT04152161|517320994|FG001|Overall Study|Withdrawal by Subject|28|||
143484803|NCT04152161|517320993|FG000|Overall Study|Sponsor termination of study|750|||
143484804|NCT04152161|517320994|FG001|Overall Study|Sponsor termination of study|755|||
143484805|NCT04152161|517320993|FG000|Overall Study|Other|20|||
143484806|NCT04152161|517320994|FG001|Overall Study|Other|18|||
143484807|NCT00001379|517320995|FG000|Initial Treatment|Disease progression|21|||
143484808|NCT00001379|517320996|FG001|Initial Treatment|Disease progression|3|||
143484809|NCT00001379|517320997|FG002|Initial Treatment|Disease progression|0|||
143484810|NCT00001379|517320998|FG003|Initial Treatment|Disease progression|0|||
143152503|NCT02965833|516102428|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
143152504|NCT02965833|516102427|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
143484811|NCT00001379|517320995|FG000|Initial Treatment|Complicating disease/intercurrent illness|6|||
143484812|NCT00001379|517320996|FG001|Initial Treatment|Complicating disease/intercurrent illness|1|||
143484813|NCT00001379|517320997|FG002|Initial Treatment|Complicating disease/intercurrent illness|0|||
143484814|NCT00001379|517320998|FG003|Initial Treatment|Complicating disease/intercurrent illness|0|||
143484815|NCT00001379|517320995|FG000|Initial Treatment|Received alternative treatment|2|||
143484816|NCT00001379|517320996|FG001|Initial Treatment|Received alternative treatment|1|||
143484817|NCT00001379|517320997|FG002|Initial Treatment|Received alternative treatment|0|||
143484818|NCT00001379|517320998|FG003|Initial Treatment|Received alternative treatment|0|||
143484819|NCT00001379|517320995|FG000|Initial Treatment|Refused further treatment|2|||
143234979|NCT00906204|516413458|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
143234980|NCT00906204|516413457|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
143234981|NCT00906204|516413458|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
143484820|NCT00001379|517320996|FG001|Initial Treatment|Refused further treatment|0|||
143484821|NCT00001379|517320997|FG002|Initial Treatment|Refused further treatment|0|||
143484822|NCT00001379|517320998|FG003|Initial Treatment|Refused further treatment|0|||
143484823|NCT00001379|517320995|FG000|Initial Treatment|Did not receive protocol treatment|0|||
143484824|NCT00001379|517320996|FG001|Initial Treatment|Did not receive protocol treatment|0|||
143484825|NCT00001379|517320997|FG002|Initial Treatment|Did not receive protocol treatment|5|||
143484826|NCT00001379|517320998|FG003|Initial Treatment|Did not receive protocol treatment|0|||
143484827|NCT00001379|517320995|FG000|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
143484828|NCT00001379|517320996|FG001|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
143484829|NCT00001379|517320997|FG002|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
143484830|NCT00001379|517320998|FG003|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|1|||
143484831|NCT00001379|517320995|FG000|Cross-Over After Initial Treatment|Disease progression|4|||
143484832|NCT00001379|517320996|FG001|Cross-Over After Initial Treatment|Disease progression|2|||
143484833|NCT00001379|517320997|FG002|Cross-Over After Initial Treatment|Disease progression|0|||
143484834|NCT00001379|517320998|FG003|Cross-Over After Initial Treatment|Disease progression|0|||
143484835|NCT00001379|517320995|FG000|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
143484836|NCT00001379|517320996|FG001|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
143484837|NCT00001379|517320997|FG002|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
143484838|NCT00001379|517320998|FG003|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
143484839|NCT00001379|517320995|FG000|Cross-Over After Initial Treatment|Received alternative treatment|4|||
143484840|NCT00001379|517320996|FG001|Cross-Over After Initial Treatment|Received alternative treatment|0|||
143484841|NCT00001379|517320997|FG002|Cross-Over After Initial Treatment|Received alternative treatment|0|||
143484842|NCT00001379|517320998|FG003|Cross-Over After Initial Treatment|Received alternative treatment|0|||
143484843|NCT00001379|517320995|FG000|Cross-Over After Initial Treatment|Refused further treatment|1|||
143484844|NCT00001379|517320996|FG001|Cross-Over After Initial Treatment|Refused further treatment|0|||
143484845|NCT00001379|517320997|FG002|Cross-Over After Initial Treatment|Refused further treatment|0|||
143484846|NCT00001379|517320998|FG003|Cross-Over After Initial Treatment|Refused further treatment|0|||
143484847|NCT03703102|517321005|FG000|Overall Study|Adverse Event|4|||
143484848|NCT03703102|517321006|FG001|Overall Study|Adverse Event|3|||
143484849|NCT03703102|517321007|FG002|Overall Study|Adverse Event|7|||
143484850|NCT03703102|517321008|FG003|Overall Study|Adverse Event|3|||
143484851|NCT03703102|517321009|FG004|Overall Study|Adverse Event|13|||
143484852|NCT03703102|517321005|FG000|Overall Study|Lack of Efficacy|4|||
143484853|NCT03703102|517321006|FG001|Overall Study|Lack of Efficacy|0|||
143484854|NCT03703102|517321007|FG002|Overall Study|Lack of Efficacy|1|||
143484855|NCT03703102|517321008|FG003|Overall Study|Lack of Efficacy|4|||
143484856|NCT03703102|517321009|FG004|Overall Study|Lack of Efficacy|1|||
143484857|NCT03703102|517321005|FG000|Overall Study|Lost to Follow-up|0|||
143484858|NCT03703102|517321006|FG001|Overall Study|Lost to Follow-up|0|||
143484859|NCT03703102|517321007|FG002|Overall Study|Lost to Follow-up|1|||
143484860|NCT03703102|517321008|FG003|Overall Study|Lost to Follow-up|2|||
143484861|NCT03703102|517321009|FG004|Overall Study|Lost to Follow-up|2|||
143484862|NCT03703102|517321005|FG000|Overall Study|Physician Decision|2|||
143484863|NCT03703102|517321006|FG001|Overall Study|Physician Decision|2|||
143484864|NCT03703102|517321007|FG002|Overall Study|Physician Decision|2|||
143484865|NCT03703102|517321008|FG003|Overall Study|Physician Decision|2|||
143484866|NCT03703102|517321009|FG004|Overall Study|Physician Decision|4|||
143484867|NCT03703102|517321005|FG000|Overall Study|Withdrawal by Subject|7|||
143484868|NCT03703102|517321006|FG001|Overall Study|Withdrawal by Subject|5|||
143484869|NCT03703102|517321007|FG002|Overall Study|Withdrawal by Subject|5|||
143484870|NCT03703102|517321008|FG003|Overall Study|Withdrawal by Subject|5|||
143484871|NCT03703102|517321009|FG004|Overall Study|Withdrawal by Subject|9|||
143484872|NCT03703102|517321005|FG000|Overall Study|Ineligibility|0|||
143484873|NCT03703102|517321006|FG001|Overall Study|Ineligibility|0|||
143484874|NCT03703102|517321007|FG002|Overall Study|Ineligibility|1|||
143484875|NCT03703102|517321008|FG003|Overall Study|Ineligibility|0|||
143484876|NCT03703102|517321009|FG004|Overall Study|Ineligibility|0|||
143152505|NCT02965833|516102428|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
143484877|NCT03703102|517321005|FG000|Overall Study|Protocol Deviation|4|||
143484878|NCT03703102|517321006|FG001|Overall Study|Protocol Deviation|4|||
143484879|NCT03703102|517321007|FG002|Overall Study|Protocol Deviation|3|||
143484880|NCT03703102|517321008|FG003|Overall Study|Protocol Deviation|0|||
143484881|NCT03703102|517321009|FG004|Overall Study|Protocol Deviation|0|||
143484882|NCT03703102|517321005|FG000|Overall Study|Non-Compliance with Study Drug|1|||
143484883|NCT03703102|517321006|FG001|Overall Study|Non-Compliance with Study Drug|1|||
143484884|NCT03703102|517321007|FG002|Overall Study|Non-Compliance with Study Drug|2|||
143484885|NCT03703102|517321008|FG003|Overall Study|Non-Compliance with Study Drug|1|||
143484886|NCT03703102|517321009|FG004|Overall Study|Non-Compliance with Study Drug|4|||
143484887|NCT02311153|517321010|FG000|Overall Study|Lost to Follow-up|5|||
143484888|NCT02311153|517321011|FG001|Overall Study|Lost to Follow-up|7|||
143484889|NCT00876187|517321012|FG000|Overall Study|Adverse Event|14|||
143484890|NCT00876187|517321013|FG001|Overall Study|Adverse Event|12|||
143484891|NCT00876187|517321014|FG002|Overall Study|Adverse Event|19|||
143484892|NCT00876187|517321015|FG003|Overall Study|Adverse Event|29|||
143484893|NCT00876187|517321016|FG004|Overall Study|Adverse Event|10|||
143484894|NCT00876187|517321012|FG000|Overall Study|Lack of Efficacy|59|||
143484895|NCT00876187|517321013|FG001|Overall Study|Lack of Efficacy|34|||
143484896|NCT00876187|517321014|FG002|Overall Study|Lack of Efficacy|45|||
143484897|NCT00876187|517321015|FG003|Overall Study|Lack of Efficacy|34|||
143484898|NCT00876187|517321016|FG004|Overall Study|Lack of Efficacy|59|||
143484899|NCT00876187|517321012|FG000|Overall Study|Lost to Follow-up|9|||
143484900|NCT00876187|517321013|FG001|Overall Study|Lost to Follow-up|10|||
143484901|NCT00876187|517321014|FG002|Overall Study|Lost to Follow-up|8|||
143484902|NCT00876187|517321015|FG003|Overall Study|Lost to Follow-up|8|||
143484903|NCT00876187|517321016|FG004|Overall Study|Lost to Follow-up|11|||
143484904|NCT00876187|517321012|FG000|Overall Study|Protocol Violation|6|||
143484905|NCT00876187|517321013|FG001|Overall Study|Protocol Violation|7|||
143484906|NCT00876187|517321014|FG002|Overall Study|Protocol Violation|7|||
143484907|NCT00876187|517321015|FG003|Overall Study|Protocol Violation|6|||
143484908|NCT00876187|517321016|FG004|Overall Study|Protocol Violation|3|||
143484909|NCT00876187|517321012|FG000|Overall Study|Withdrawal by Subject|16|||
143484910|NCT00876187|517321013|FG001|Overall Study|Withdrawal by Subject|26|||
143484911|NCT00876187|517321014|FG002|Overall Study|Withdrawal by Subject|32|||
143484912|NCT00876187|517321015|FG003|Overall Study|Withdrawal by Subject|38|||
143484913|NCT00876187|517321016|FG004|Overall Study|Withdrawal by Subject|37|||
143484914|NCT00876187|517321012|FG000|Overall Study|Entered extension study|101|||
143484915|NCT00876187|517321013|FG001|Overall Study|Entered extension study|120|||
143484916|NCT00876187|517321014|FG002|Overall Study|Entered extension study|156|||
143484917|NCT00876187|517321015|FG003|Overall Study|Entered extension study|151|||
143484918|NCT00876187|517321016|FG004|Overall Study|Entered extension study|144|||
143484919|NCT00876187|517321012|FG000|Overall Study|Randomized but not treated|3|||
143484920|NCT00876187|517321013|FG001|Overall Study|Randomized but not treated|1|||
143484921|NCT00876187|517321014|FG002|Overall Study|Randomized but not treated|3|||
143484922|NCT00876187|517321015|FG003|Overall Study|Randomized but not treated|2|||
143484923|NCT00876187|517321016|FG004|Overall Study|Randomized but not treated|3|||
143484924|NCT00876187|517321012|FG000|Overall Study|Other|2|||
143484925|NCT00876187|517321013|FG001|Overall Study|Other|5|||
143484926|NCT00876187|517321014|FG002|Overall Study|Other|9|||
143484927|NCT00876187|517321015|FG003|Overall Study|Other|7|||
143484928|NCT00876187|517321016|FG004|Overall Study|Other|4|||
143484929|NCT00405067|517321021|FG000|Overall Study|Adverse Event|4|||
143484930|NCT00405067|517321022|FG001|Overall Study|Adverse Event|9|||
143484931|NCT00405067|517321023|FG002|Overall Study|Adverse Event|4|||
143484932|NCT00405067|517321021|FG000|Overall Study|Lost to Follow-up|0|||
143484933|NCT00405067|517321022|FG001|Overall Study|Lost to Follow-up|0|||
143484934|NCT00405067|517321023|FG002|Overall Study|Lost to Follow-up|1|||
143484935|NCT01560780|517321024|FG000|Overall Study|Death|2|||
143484936|NCT01560780|517321025|FG001|Overall Study|Death|1|||
143484937|NCT01560780|517321024|FG000|Overall Study|Patient Preference|11|||
143484938|NCT01560780|517321025|FG001|Overall Study|Patient Preference|11|||
143484939|NCT01032915|517321026|FG000|Overall Study|Adverse Event|2|||
143484940|NCT01032915|517321027|FG001|Overall Study|Adverse Event|2|||
143484941|NCT01032915|517321028|FG002|Overall Study|Adverse Event|1|||
143484942|NCT01032915|517321029|FG003|Overall Study|Adverse Event|1|||
143484943|NCT01032915|517321026|FG000|Overall Study|Abnormal test procedure result|0|||
143484944|NCT01032915|517321027|FG001|Overall Study|Abnormal test procedure result|0|||
143484945|NCT01032915|517321028|FG002|Overall Study|Abnormal test procedure result|1|||
143484946|NCT01032915|517321029|FG003|Overall Study|Abnormal test procedure result|0|||
143484947|NCT01032915|517321026|FG000|Overall Study|Withdrawal by Subject|0|||
143152506|NCT02965833|516102427|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
143484948|NCT01032915|517321027|FG001|Overall Study|Withdrawal by Subject|3|||
143484949|NCT01032915|517321028|FG002|Overall Study|Withdrawal by Subject|1|||
143484950|NCT01032915|517321029|FG003|Overall Study|Withdrawal by Subject|1|||
143484951|NCT01032915|517321026|FG000|Overall Study|Administrative reasons|5|||
143484952|NCT01032915|517321027|FG001|Overall Study|Administrative reasons|6|||
143015256|NCT04440163|515597389|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
143015257|NCT04440163|515597390|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
143015258|NCT04440163|515597391|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
143015259|NCT04440163|515597392|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
143015260|NCT04440163|515597393|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
143015261|NCT04440163|515597394|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
143015262|NCT04440163|515597395|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
143015263|NCT04440163|515597396|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
143015264|NCT04440163|515597389|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
143015265|NCT04440163|515597390|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
143015266|NCT04440163|515597391|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
143015267|NCT04440163|515597392|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
143015268|NCT04440163|515597393|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
143015269|NCT04440163|515597394|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
143015270|NCT04440163|515597395|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
143015271|NCT04440163|515597396|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
143015272|NCT04440163|515597389|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
143234982|NCT00992108|516413459|FG000|Overall Study|Lost to Follow-up|0|||
143234983|NCT00992108|516413460|FG001|Overall Study|Lost to Follow-up|1|||
143234984|NCT00535496|516413461|FG000|Overall Study|Lost to Follow-up|0|||
143234985|NCT00535496|516413462|FG001|Overall Study|Lost to Follow-up|1|||
143234986|NCT00535496|516413463|FG002|Overall Study|Lost to Follow-up|0|||
143234987|NCT00535496|516413464|FG003|Overall Study|Lost to Follow-up|0|||
143234988|NCT00535496|516413461|FG000|Overall Study|Not treated with sugammadex|0|||
143234989|NCT00535496|516413462|FG001|Overall Study|Not treated with sugammadex|1|||
143234990|NCT00535496|516413463|FG002|Overall Study|Not treated with sugammadex|0|||
143234991|NCT00535496|516413464|FG003|Overall Study|Not treated with sugammadex|0|||
143234992|NCT01083771|516413468|FG000|Overall Study|non-compliant|2|||
143234993|NCT01083771|516413468|FG000|Overall Study|Withdrawal by Subject|3|||
143234994|NCT00939393|516413471|FG000|Overall Study|Withdrawal by Subject|1|||
143234995|NCT00939393|516413472|FG001|Overall Study|Withdrawal by Subject|0|||
143234996|NCT00939393|516413471|FG000|Overall Study|Lost to Follow-up|3|||
143234997|NCT00939393|516413472|FG001|Overall Study|Lost to Follow-up|0|||
143234998|NCT02851615|516413473|FG000|Overall Study|Cognitive Issue|1|||
143234999|NCT02851615|516413474|FG001|Overall Study|Cognitive Issue|0|||
143235000|NCT02851615|516413473|FG000|Overall Study|Lost to Follow-up|0|||
143235001|NCT02851615|516413474|FG001|Overall Study|Lost to Follow-up|4|||
143235002|NCT00313014|516413475|FG000|Overall Study|Withdrawal by Subject|11|||
143235003|NCT00313014|516413476|FG001|Overall Study|Withdrawal by Subject|7|||
143235004|NCT00313014|516413477|FG002|Overall Study|Withdrawal by Subject|5|||
143235005|NCT00313014|516413475|FG000|Overall Study|Adverse Event|14|||
143235006|NCT00313014|516413476|FG001|Overall Study|Adverse Event|29|||
143235007|NCT00313014|516413477|FG002|Overall Study|Adverse Event|16|||
143235008|NCT00313014|516413475|FG000|Overall Study|Lost to Follow-up|7|||
143235009|NCT00313014|516413476|FG001|Overall Study|Lost to Follow-up|6|||
143235010|NCT00313014|516413477|FG002|Overall Study|Lost to Follow-up|10|||
143235011|NCT00313014|516413475|FG000|Overall Study|Administrative|9|||
143235012|NCT00313014|516413476|FG001|Overall Study|Administrative|6|||
143235013|NCT00313014|516413477|FG002|Overall Study|Administrative|14|||
143235014|NCT00313014|516413475|FG000|Overall Study|Lack of Efficacy|52|||
143235015|NCT00313014|516413476|FG001|Overall Study|Lack of Efficacy|25|||
143235016|NCT00313014|516413477|FG002|Overall Study|Lack of Efficacy|16|||
143235017|NCT03829228|516413481|FG000|Overall Study|Protocol Violation|1|||
143235018|NCT03337477|516413482|FG000|Overall Study|not categorized into the listed ones|11|||
143235019|NCT03337477|516413483|FG001|Overall Study|not categorized into the listed ones|9|||
143235020|NCT03337477|516413482|FG000|Overall Study|Withdrawal by Subject|0|||
143235021|NCT03337477|516413483|FG001|Overall Study|Withdrawal by Subject|1|||
143235022|NCT03337477|516413482|FG000|Overall Study|Death|0|||
143235023|NCT03337477|516413483|FG001|Overall Study|Death|1|||
143235024|NCT03337477|516413482|FG000|Overall Study|Lost to Follow-up|0|||
143235025|NCT03337477|516413483|FG001|Overall Study|Lost to Follow-up|2|||
143235026|NCT00473564|516413486|FG000|Overall Study|robot surgery aborted in OR|23|||
143235027|NCT02379728|516413487|FG000|Overall Study|Lost to Follow-up|1|||
143235028|NCT02379728|516413488|FG001|Overall Study|Lost to Follow-up|0|||
143235029|NCT02379728|516413489|FG002|Overall Study|Lost to Follow-up|3|||
143235030|NCT02379728|516413490|FG003|Overall Study|Lost to Follow-up|0|||
143235031|NCT02379728|516413487|FG000|Overall Study|Withdrawal by Subject|5|||
143235032|NCT02379728|516413488|FG001|Overall Study|Withdrawal by Subject|0|||
143235033|NCT02379728|516413489|FG002|Overall Study|Withdrawal by Subject|5|||
143235034|NCT02379728|516413490|FG003|Overall Study|Withdrawal by Subject|3|||
143235035|NCT02379728|516413487|FG000|Overall Study|Protocol Violation|0|||
143235036|NCT02379728|516413488|FG001|Overall Study|Protocol Violation|0|||
143484953|NCT01032915|517321028|FG002|Overall Study|Administrative reasons|4|||
143484954|NCT01032915|517321029|FG003|Overall Study|Administrative reasons|4|||
143235037|NCT02379728|516413489|FG002|Overall Study|Protocol Violation|2|||
143015273|NCT04440163|515597390|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
143015274|NCT04440163|515597391|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
143015275|NCT04440163|515597392|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
143152507|NCT02965833|516102428|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
143152508|NCT02965833|516102427|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
143152509|NCT02965833|516102428|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
143152510|NCT03370302|516102430|FG000|Dose Escalation Phase|Other|0|||
143152511|NCT03370302|516102431|FG001|Dose Escalation Phase|Other|1|||
143152512|NCT03370302|516102432|FG002|Dose Escalation Phase|Other|1|||
143152513|NCT03370302|516102433|FG003|Dose Escalation Phase|Other|0|||
143152514|NCT03370302|516102434|FG004|Dose Escalation Phase|Other|0|||
143152515|NCT03370302|516102435|FG005|Dose Escalation Phase|Other|0|||
143152516|NCT03370302|516102430|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
143152517|NCT03370302|516102431|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
143152518|NCT03370302|516102432|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
143152519|NCT03370302|516102433|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
143152520|NCT03370302|516102434|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
143152521|NCT03370302|516102435|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
143152522|NCT03370302|516102430|FG000|Dose Escalation Phase|Adverse Event|1|||
143152523|NCT03370302|516102431|FG001|Dose Escalation Phase|Adverse Event|0|||
143152524|NCT03370302|516102432|FG002|Dose Escalation Phase|Adverse Event|2|||
143152525|NCT03370302|516102433|FG003|Dose Escalation Phase|Adverse Event|0|||
143152526|NCT03370302|516102434|FG004|Dose Escalation Phase|Adverse Event|0|||
143152527|NCT03370302|516102435|FG005|Dose Escalation Phase|Adverse Event|0|||
143152528|NCT03370302|516102430|FG000|Dose Escalation Phase|Progressive Disease|2|||
143152529|NCT03370302|516102431|FG001|Dose Escalation Phase|Progressive Disease|4|||
143152530|NCT03370302|516102432|FG002|Dose Escalation Phase|Progressive Disease|2|||
143152531|NCT03370302|516102433|FG003|Dose Escalation Phase|Progressive Disease|0|||
143152532|NCT03370302|516102434|FG004|Dose Escalation Phase|Progressive Disease|3|||
143152533|NCT03370302|516102435|FG005|Dose Escalation Phase|Progressive Disease|1|||
143152534|NCT03370302|516102430|FG000|Dose Expansion Phase|Progressive Disease|0|||
143152535|NCT03370302|516102431|FG001|Dose Expansion Phase|Progressive Disease|0|||
143152536|NCT03370302|516102432|FG002|Dose Expansion Phase|Progressive Disease|0|||
143152537|NCT03370302|516102433|FG003|Dose Expansion Phase|Progressive Disease|6|||
143152538|NCT03370302|516102434|FG004|Dose Expansion Phase|Progressive Disease|0|||
143152539|NCT03370302|516102435|FG005|Dose Expansion Phase|Progressive Disease|0|||
143152540|NCT01685437|516102439|FG000|Overall Study|Withdrawal by Subject|22|||
143152541|NCT01685437|516102439|FG000|Overall Study|Lost to Follow-up|3|||
143152542|NCT01685437|516102439|FG000|Overall Study|Adverse Event|1|||
143152543|NCT01685437|516102439|FG000|Overall Study|Protocol Violation|4|||
143152544|NCT01685437|516102439|FG000|Overall Study|Unable to make visits due to work|1|||
143152545|NCT05399485|516104097|FG000|DBT Phase|Other|6|||
143152546|NCT05399485|516104098|FG001|DBT Phase|Other|5|||
143152547|NCT05399485|516104097|FG000|DBT Phase|Protocol-specified withdrawal criterion met|1|||
143152548|NCT05399485|516104098|FG001|DBT Phase|Protocol-specified withdrawal criterion met|1|||
143152549|NCT05399485|516104097|FG000|DBT Phase|Withdrawal by Subject|3|||
143152550|NCT05399485|516104098|FG001|DBT Phase|Withdrawal by Subject|2|||
143152551|NCT05399485|516104097|FG000|DBT Phase|Protocol Violation|2|||
143152552|NCT05399485|516104098|FG001|DBT Phase|Protocol Violation|1|||
143152553|NCT05399485|516104097|FG000|DBT Phase|Physician Decision|0|||
143152554|NCT05399485|516104098|FG001|DBT Phase|Physician Decision|1|||
143152555|NCT05399485|516104097|FG000|DBT Phase|Adverse Event|2|||
143152556|NCT05399485|516104098|FG001|DBT Phase|Adverse Event|1|||
143152557|NCT05399485|516104097|FG000|OLE Phase|Protocol deviation|1|||
143152558|NCT05399485|516104098|FG001|OLE Phase|Protocol deviation|0|||
143152559|NCT05399485|516104097|FG000|OLE Phase|Other|5|||
143152560|NCT05399485|516104098|FG001|OLE Phase|Other|5|||
143152561|NCT05399485|516104097|FG000|OLE Phase|Withdrawal by Subject|12|||
143152562|NCT05399485|516104098|FG001|OLE Phase|Withdrawal by Subject|7|||
143152563|NCT05399485|516104097|FG000|OLE Phase|Pregnancy|0|||
143152564|NCT05399485|516104098|FG001|OLE Phase|Pregnancy|2|||
143152565|NCT05399485|516104097|FG000|OLE Phase|Physician Decision|3|||
143363661|NCT00062868|516873794|FG014|Dose Level 3|Death|0|||
143015276|NCT04440163|515597393|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
143152566|NCT05399485|516104098|FG001|OLE Phase|Physician Decision|0|||
143152567|NCT05399485|516104097|FG000|OLE Phase|Adverse Event|2|||
143152568|NCT05399485|516104098|FG001|OLE Phase|Adverse Event|2|||
143152576|NCT02068794|516104107|FG000|Overall Study|Withdrawal by Subject|0|||
143152577|NCT02068794|516104108|FG001|Overall Study|Withdrawal by Subject|1|||
143152578|NCT02068794|516104109|FG002|Overall Study|Withdrawal by Subject|2|||
143484955|NCT01032915|517321026|FG000|Overall Study|Protocol Violation|1|||
143484956|NCT01032915|517321027|FG001|Overall Study|Protocol Violation|0|||
143484957|NCT01032915|517321028|FG002|Overall Study|Protocol Violation|0|||
143484958|NCT01032915|517321029|FG003|Overall Study|Protocol Violation|1|||
143484959|NCT01577186|517321030|FG000|Overall Study|Adverse Event|23|||
143484960|NCT01577186|517321030|FG000|Overall Study|Death|1|||
143484961|NCT01577186|517321030|FG000|Overall Study|Lost to Follow-up|28|||
143484962|NCT01577186|517321030|FG000|Overall Study|Withdrawal by Subject|35|||
143484963|NCT01577186|517321030|FG000|Overall Study|Insufficient Response|18|||
143484964|NCT01577186|517321030|FG000|Overall Study|Ineligible to Continue|15|||
143484965|NCT01577186|517321030|FG000|Overall Study|Non-Compliant|8|||
143484966|NCT01577186|517321030|FG000|Overall Study|Other|2|||
143484967|NCT00957008|517321031|FG000|Overall Study|Withdrawal by Subject|13|||
143484968|NCT00957008|517321032|FG001|Overall Study|Withdrawal by Subject|10|||
143484969|NCT00957008|517321033|FG002|Overall Study|Withdrawal by Subject|12|||
143484970|NCT00957008|517321034|FG003|Overall Study|Withdrawal by Subject|16|||
143484971|NCT00957008|517321031|FG000|Overall Study|Lost to Follow-up|3|||
143484972|NCT00957008|517321032|FG001|Overall Study|Lost to Follow-up|1|||
143484973|NCT00957008|517321033|FG002|Overall Study|Lost to Follow-up|3|||
143484974|NCT00957008|517321034|FG003|Overall Study|Lost to Follow-up|4|||
143484975|NCT00957008|517321031|FG000|Overall Study|Physician Decision|1|||
143484976|NCT00957008|517321032|FG001|Overall Study|Physician Decision|0|||
143484977|NCT00957008|517321033|FG002|Overall Study|Physician Decision|1|||
143484978|NCT00957008|517321034|FG003|Overall Study|Physician Decision|1|||
143484979|NCT00957008|517321031|FG000|Overall Study|Relocated; Family conflict|4|||
143484980|NCT00957008|517321032|FG001|Overall Study|Relocated; Family conflict|1|||
143484981|NCT00957008|517321033|FG002|Overall Study|Relocated; Family conflict|1|||
143484982|NCT00957008|517321034|FG003|Overall Study|Relocated; Family conflict|3|||
143484983|NCT01118351|517321035|FG000|Overall Study|Adverse Event|3|||
143484984|NCT01118351|517321035|FG000|Overall Study|Withdrawal by Subject|1|||
143484985|NCT00811135|517321036|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
143484986|NCT00811135|517321036|FG000|Overall Study|Death|3|||
143484987|NCT00811135|517321036|FG000|Overall Study|Protocol Violation|2|||
143484988|NCT00811135|517321036|FG000|Overall Study|Violation of Selection Criteria|1|||
143484989|NCT00811135|517321036|FG000|Overall Study|Refused Treatment|1|||
143484990|NCT00811135|517321036|FG000|Overall Study|Withdrawal by Subject|3|||
143484991|NCT00811135|517321036|FG000|Overall Study|Administrative/Other Unspecified|11|||
143484992|NCT00811135|517321036|FG000|Overall Study|Ongoing|59|||
143484993|NCT02797808|517321040|FG000|Overall Study|Withdrawal by Subject|1|||
143152579|NCT02068794|516104107|FG000|Overall Study|Early Progression|1|||
143152580|NCT02068794|516104108|FG001|Overall Study|Early Progression|0|||
143152581|NCT02068794|516104109|FG002|Overall Study|Early Progression|1|||
143152582|NCT02068794|516104107|FG000|Overall Study|Ineligible|0|||
143152583|NCT02068794|516104108|FG001|Overall Study|Ineligible|0|||
143152584|NCT02068794|516104109|FG002|Overall Study|Ineligible|1|||
143152591|NCT04439175|516104116|FG000|Overall Study|Never started treatment|4|||
143152592|NCT04439175|516104116|FG000|Overall Study|Ineligible|5|||
143152593|NCT04439175|516104116|FG000|Overall Study|Adverse Event|6|||
143152594|NCT04439175|516104116|FG000|Overall Study|Death|4|||
143152595|NCT04439175|516104116|FG000|Overall Study|Disease progression|44|||
143152596|NCT04439175|516104116|FG000|Overall Study|Withdrawal by Subject|4|||
143152597|NCT04439175|516104116|FG000|Overall Study|Alternative Therapy|1|||
143152598|NCT04439175|516104116|FG000|Overall Study|Other|2|||
143484994|NCT02797808|517321041|FG001|Overall Study|Withdrawal by Subject|1|||
143484995|NCT02797808|517321040|FG000|Overall Study|Physician Decision|6|||
143484996|NCT02797808|517321041|FG001|Overall Study|Physician Decision|2|||
143484997|NCT02192827|517321042|FG000|Overall Study|Lost to Follow-up|25|||
143484998|NCT02192827|517321043|FG001|Overall Study|Lost to Follow-up|27|||
143235038|NCT02379728|516413490|FG003|Overall Study|Protocol Violation|0|||
143235039|NCT01112917|516413491|FG000|Overall Study|Death|2|||
143363662|NCT00062868|516873795|FG015|Dose Level 3|Death|0|||
143484999|NCT02192827|517321042|FG000|Overall Study|Given additional steroids with admission|13|||
143485000|NCT02192827|517321043|FG001|Overall Study|Given additional steroids with admission|11|||
143485001|NCT00763815|517321045|FG000|Overall Study|Adverse Event|14|||
143485002|NCT00763815|517321046|FG001|Overall Study|Adverse Event|29|||
143485003|NCT00763815|517321045|FG000|Overall Study|Lack of Efficacy|10|||
143235040|NCT01112917|516413492|FG001|Overall Study|Death|11|||
143235041|NCT01112917|516413491|FG000|Overall Study|Lost to Follow-up|1|||
143235042|NCT01112917|516413492|FG001|Overall Study|Lost to Follow-up|1|||
143235043|NCT01112917|516413491|FG000|Overall Study|Withdrawal by Subject|1|||
143235044|NCT01112917|516413492|FG001|Overall Study|Withdrawal by Subject|3|||
143235045|NCT01112917|516413491|FG000|Overall Study|Unable to Convert Filter|3|||
143235046|NCT01112917|516413492|FG001|Overall Study|Unable to Convert Filter|0|||
143235047|NCT05101122|516413493|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
143235048|NCT05101122|516413493|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
143235049|NCT05101122|516413493|FG000|AD313 80/5|Withdrawal by Subject|1|||
143235050|NCT05101122|516413493|FG000|AD313 80/10|Physician Decision|1|||
143235051|NCT03131219|516413495|FG000|Initial Evaluation Period|Adverse Event|2|||
143235052|NCT03131219|516413496|FG001|Initial Evaluation Period|Adverse Event|0|||
143235053|NCT03131219|516413495|FG000|Initial Evaluation Period|Protocol Violation|1|||
143235054|NCT03131219|516413496|FG001|Initial Evaluation Period|Protocol Violation|0|||
143235055|NCT03131219|516413495|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
143235056|NCT03131219|516413496|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
143235057|NCT03131219|516413495|FG000|Initial Evaluation Period|Physician Decision|1|||
143235058|NCT03131219|516413496|FG001|Initial Evaluation Period|Physician Decision|0|||
143485004|NCT00763815|517321046|FG001|Overall Study|Lack of Efficacy|11|||
143485005|NCT00763815|517321045|FG000|Overall Study|Poor Compliance to Protocol|6|||
143485006|NCT00763815|517321046|FG001|Overall Study|Poor Compliance to Protocol|6|||
143485007|NCT00763815|517321045|FG000|Overall Study|Lost to Follow-up|2|||
143485008|NCT00763815|517321046|FG001|Overall Study|Lost to Follow-up|4|||
143485009|NCT00763815|517321045|FG000|Overall Study|Early Termination|1|||
143485010|NCT00763815|517321046|FG001|Overall Study|Early Termination|0|||
143485011|NCT00763815|517321045|FG000|Overall Study|Familial and Personal Reasons|9|||
143485012|NCT00763815|517321046|FG001|Overall Study|Familial and Personal Reasons|16|||
143485013|NCT00763815|517321045|FG000|Overall Study|Physician Decision|1|||
143485014|NCT00763815|517321046|FG001|Overall Study|Physician Decision|0|||
143485015|NCT00763815|517321045|FG000|Overall Study|Withdrawal by Subject|7|||
143485016|NCT00763815|517321046|FG001|Overall Study|Withdrawal by Subject|12|||
143485017|NCT00763815|517321045|FG000|Overall Study|Protocol Violation|2|||
143485018|NCT00763815|517321046|FG001|Overall Study|Protocol Violation|5|||
143485019|NCT00763815|517321045|FG000|Overall Study|Sponsor's Decision|0|||
143485020|NCT00763815|517321046|FG001|Overall Study|Sponsor's Decision|1|||
143485021|NCT00845728|517321047|FG000|Overall Study|Abnormal laboratory value (s)|2|||
143485022|NCT00845728|517321048|FG001|Overall Study|Abnormal laboratory value (s)|2|||
143485023|NCT00845728|517321047|FG000|Overall Study|Patient's inability to use the device|4|||
143235059|NCT03131219|516413495|FG000|Extension Period|Physician Decision|1|||
143235060|NCT03131219|516413496|FG001|Extension Period|Physician Decision|0|||
143235061|NCT02177123|516413500|FG000|Overall Study|Lost to Follow-up|6|||
143235062|NCT02177123|516413500|FG000|Overall Study|Withdrawal by Subject|4|||
143235063|NCT02177123|516413500|FG000|Overall Study|Adverse Event|4|||
143235064|NCT02177123|516413500|FG000|Overall Study|Physician Decision|3|||
143235065|NCT02177123|516413500|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
143235066|NCT02177123|516413500|FG000|Overall Study|Excluded for medical reasons|2|||
143235067|NCT02177123|516413500|FG000|Overall Study|Death|1|||
143235068|NCT02177123|516413500|FG000|Overall Study|Other|1|||
143235069|NCT02177123|516413500|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
143235070|NCT01391546|516413501|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
143235071|NCT01391546|516413502|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
143235072|NCT02903771|516413511|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
143235073|NCT02903771|516413512|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
143235074|NCT02903771|516413513|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
143235075|NCT02903771|516413514|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
143235076|NCT02903771|516413515|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
143235077|NCT02903771|516413516|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
143235078|NCT02903771|516413517|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
143235079|NCT02903771|516413511|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
143485024|NCT00845728|517321048|FG001|Overall Study|Patient's inability to use the device|6|||
143235080|NCT02903771|516413512|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
143235081|NCT02903771|516413513|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
143235082|NCT02903771|516413514|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
143235083|NCT02903771|516413515|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
143235084|NCT02903771|516413516|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
143485025|NCT00845728|517321047|FG000|Overall Study|Abnormal test procedure result (s)|7|||
143485026|NCT00845728|517321048|FG001|Overall Study|Abnormal test procedure result (s)|2|||
143485027|NCT00845728|517321047|FG000|Overall Study|Lost to Follow-up|22|||
143485028|NCT00845728|517321048|FG001|Overall Study|Lost to Follow-up|13|||
143235085|NCT02903771|516413517|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
143235086|NCT02903771|516413511|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
143485029|NCT00845728|517321047|FG000|Overall Study|Death|24|||
143015277|NCT04440163|515597394|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
143015278|NCT04440163|515597395|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
143015279|NCT04440163|515597396|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
143015280|NCT04440163|515597389|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
143015281|NCT04440163|515597390|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
143015282|NCT04440163|515597391|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
143015283|NCT04440163|515597392|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
143015284|NCT04440163|515597393|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
143015285|NCT04440163|515597394|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
143015286|NCT04440163|515597395|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
143015287|NCT04440163|515597396|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
143015288|NCT04440163|515597389|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
143015289|NCT04440163|515597390|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
143015290|NCT04440163|515597391|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
143015291|NCT04440163|515597392|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
143015292|NCT04440163|515597393|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
143015293|NCT04440163|515597394|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
143015294|NCT04440163|515597395|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
143015295|NCT04440163|515597396|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
143015296|NCT04440163|515597389|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
143015297|NCT04440163|515597390|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
143015298|NCT04440163|515597391|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
143015299|NCT04440163|515597392|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
143015300|NCT04440163|515597393|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
143015301|NCT04440163|515597394|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
143015302|NCT04440163|515597395|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
143015303|NCT04440163|515597396|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
143015304|NCT04440163|515597389|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
143015305|NCT04440163|515597390|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
143015306|NCT04440163|515597391|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
143015307|NCT04440163|515597392|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
143015308|NCT04440163|515597393|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
143015309|NCT04440163|515597394|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
143015310|NCT04440163|515597395|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
143015311|NCT04440163|515597396|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
143015312|NCT04440163|515597389|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
143015313|NCT04440163|515597390|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
143015314|NCT04440163|515597391|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
143015315|NCT04440163|515597392|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
143015316|NCT04440163|515597393|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
143015317|NCT04440163|515597394|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
143015318|NCT04440163|515597395|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
143015319|NCT04440163|515597396|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
143363663|NCT00062868|516873796|FG016|Dose Level 3|Death|0|||
143485030|NCT00845728|517321048|FG001|Overall Study|Death|26|||
143485031|NCT00845728|517321047|FG000|Overall Study|Administrative Problems|34|||
143485032|NCT00845728|517321048|FG001|Overall Study|Administrative Problems|26|||
143485033|NCT00845728|517321047|FG000|Overall Study|Protocol Violation|36|||
143485034|NCT00845728|517321048|FG001|Overall Study|Protocol Violation|24|||
143485035|NCT00845728|517321047|FG000|Overall Study|Lack of Efficacy|51|||
143485036|NCT00845728|517321048|FG001|Overall Study|Lack of Efficacy|39|||
143485037|NCT00845728|517321047|FG000|Overall Study|Adverse Event|101|||
143485038|NCT00845728|517321048|FG001|Overall Study|Adverse Event|96|||
143485039|NCT00845728|517321047|FG000|Overall Study|Withdrawal by Subject|105|||
143485040|NCT00845728|517321048|FG001|Overall Study|Withdrawal by Subject|108|||
143485041|NCT00183274|517321051|FG000|Phase 1: Open-Label|Adverse Event|31|||
143485042|NCT00183274|517321052|FG001|Phase 1: Open-Label|Adverse Event|0|||
143485043|NCT00183274|517321053|FG002|Phase 1: Open-Label|Adverse Event|0|||
143485044|NCT00183274|517321054|FG003|Phase 1: Open-Label|Adverse Event|0|||
143015320|NCT04440163|515597389|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
143363664|NCT00062868|516873797|FG017|Dose Level 3|Death|1|||
143485045|NCT00183274|517321055|FG004|Phase 1: Open-Label|Adverse Event|0|||
143485046|NCT00183274|517321056|FG005|Phase 1: Open-Label|Adverse Event|0|||
143485047|NCT00183274|517321051|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
143485048|NCT00183274|517321052|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
143015321|NCT04440163|515597390|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
143015322|NCT04440163|515597391|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
143015323|NCT04440163|515597392|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
143015324|NCT04440163|515597393|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
143015325|NCT04440163|515597394|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
143015326|NCT04440163|515597395|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
143015327|NCT04440163|515597396|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
143015328|NCT04440163|515597389|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
143015329|NCT04440163|515597390|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
143015330|NCT04440163|515597391|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
143015331|NCT04440163|515597392|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
143015332|NCT04440163|515597393|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
143015333|NCT04440163|515597394|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
143015334|NCT04440163|515597395|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
143015335|NCT04440163|515597396|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
143015336|NCT00068406|515597399|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
143015337|NCT00068406|515597399|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
143015338|NCT02018042|515597400|FG000|Overall Study|Withdrawal by Subject|1|||
143015339|NCT00589693|515597401|FG000|Overall Study|randomized in error|12|||
143015340|NCT00589693|515597402|FG001|Overall Study|randomized in error|6|||
143015341|NCT00589693|515597401|FG000|Overall Study|Adverse Event|4|||
143015342|NCT00589693|515597402|FG001|Overall Study|Adverse Event|4|||
143015343|NCT00589693|515597401|FG000|Overall Study|Death|26|||
143015344|NCT00589693|515597402|FG001|Overall Study|Death|16|||
143015345|NCT00589693|515597401|FG000|Overall Study|Lack of Efficacy|0|||
143015346|NCT00589693|515597402|FG001|Overall Study|Lack of Efficacy|1|||
143015347|NCT00589693|515597401|FG000|Overall Study|Lost to Follow-up|1|||
143015348|NCT00589693|515597402|FG001|Overall Study|Lost to Follow-up|0|||
143015349|NCT00589693|515597401|FG000|Overall Study|Physician Decision|0|||
143015350|NCT00589693|515597402|FG001|Overall Study|Physician Decision|1|||
143015351|NCT00589693|515597401|FG000|Overall Study|Protocol Violation|1|||
143015352|NCT00589693|515597402|FG001|Overall Study|Protocol Violation|1|||
143015353|NCT03231709|515597403|FG000|Treatment Period 1|Reason not Specified|0|||
143015354|NCT03231709|515597404|FG001|Treatment Period 1|Reason not Specified|1|||
143015355|NCT03231709|515597403|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
143015356|NCT03231709|515597404|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
143015357|NCT02609178|515597405|FG000|First Crown|Withdrawal by Subject|0|||
143015358|NCT02609178|515597406|FG001|First Crown|Withdrawal by Subject|0|||
143015359|NCT02609178|515597407|FG002|First Crown|Withdrawal by Subject|1|||
143015360|NCT02609178|515597408|FG003|First Crown|Withdrawal by Subject|1|||
143485049|NCT00183274|517321053|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
143485050|NCT00183274|517321054|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
143485051|NCT00183274|517321055|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
143485052|NCT00183274|517321056|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
143485053|NCT00183274|517321051|FG000|Phase 1: Open-Label|Protocol Violation|11|||
143485054|NCT00183274|517321052|FG001|Phase 1: Open-Label|Protocol Violation|0|||
143485055|NCT00183274|517321053|FG002|Phase 1: Open-Label|Protocol Violation|0|||
143485056|NCT00183274|517321054|FG003|Phase 1: Open-Label|Protocol Violation|0|||
143485057|NCT00183274|517321055|FG004|Phase 1: Open-Label|Protocol Violation|0|||
143485058|NCT00183274|517321056|FG005|Phase 1: Open-Label|Protocol Violation|0|||
143485059|NCT00183274|517321051|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
143485060|NCT00183274|517321052|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
143485061|NCT00183274|517321053|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
143485062|NCT00183274|517321054|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
143485063|NCT00183274|517321055|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
143485064|NCT00183274|517321056|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
143485065|NCT00183274|517321051|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
143485066|NCT00183274|517321052|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
143485067|NCT00183274|517321053|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
143485068|NCT00183274|517321054|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
143485069|NCT00183274|517321055|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
143485070|NCT00183274|517321056|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
143485071|NCT00183274|517321051|FG000|Phase 1: Open-Label|Other|9|||
143485072|NCT00183274|517321052|FG001|Phase 1: Open-Label|Other|0|||
143485073|NCT00183274|517321053|FG002|Phase 1: Open-Label|Other|0|||
143485074|NCT00183274|517321054|FG003|Phase 1: Open-Label|Other|0|||
143015361|NCT02609178|515597409|FG004|First Crown|Withdrawal by Subject|0|||
143015362|NCT02609178|515597410|FG005|First Crown|Withdrawal by Subject|0|||
143015363|NCT01128153|515597411|FG000|Overall Study|Adverse Event|1|||
143015364|NCT01128153|515597412|FG001|Overall Study|Adverse Event|3|||
143015365|NCT01128153|515597411|FG000|Overall Study|Condition under investigation worsened|8|||
143015366|NCT01128153|515597412|FG001|Overall Study|Condition under investigation worsened|7|||
143485075|NCT00183274|517321055|FG004|Phase 1: Open-Label|Other|0|||
143485076|NCT00183274|517321056|FG005|Phase 1: Open-Label|Other|0|||
143485077|NCT00183274|517321051|FG000|Phase 2: Double-Blind|Relapsed|0|||
143152624|NCT01847209|516104131|FG000|Overall Study|Withdrawal by Subject|1|||
143152625|NCT01847209|516104131|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
143485078|NCT00183274|517321052|FG001|Phase 2: Double-Blind|Relapsed|8|||
143485079|NCT00183274|517321053|FG002|Phase 2: Double-Blind|Relapsed|29|||
143485080|NCT00183274|517321054|FG003|Phase 2: Double-Blind|Relapsed|0|||
143485081|NCT00183274|517321055|FG004|Phase 2: Double-Blind|Relapsed|0|||
143485082|NCT00183274|517321056|FG005|Phase 2: Double-Blind|Relapsed|0|||
143485083|NCT00183274|517321051|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
143485084|NCT00183274|517321052|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
143485085|NCT00183274|517321053|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
143485086|NCT00183274|517321054|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
143485087|NCT00183274|517321055|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
143485088|NCT00183274|517321056|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
143485089|NCT00183274|517321051|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
143485090|NCT00183274|517321052|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
143485091|NCT00183274|517321053|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
143485092|NCT00183274|517321054|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
143485093|NCT00183274|517321055|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
143485094|NCT00183274|517321056|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
143485095|NCT00183274|517321051|FG000|Phase 3: Double-Blind|Relapsed|0|||
143485096|NCT00183274|517321052|FG001|Phase 3: Double-Blind|Relapsed|0|||
143485097|NCT00183274|517321053|FG002|Phase 3: Double-Blind|Relapsed|0|||
143485098|NCT00183274|517321054|FG003|Phase 3: Double-Blind|Relapsed|1|||
143485099|NCT00183274|517321055|FG004|Phase 3: Double-Blind|Relapsed|11|||
143485100|NCT00183274|517321056|FG005|Phase 3: Double-Blind|Relapsed|2|||
143485101|NCT00618410|517321063|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
143485102|NCT00618410|517321064|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
143485103|NCT02980224|517321074|FG000|Overall Study|Adverse Event|4|||
143485104|NCT02980224|517321075|FG001|Overall Study|Adverse Event|1|||
143485105|NCT02980224|517321074|FG000|Overall Study|Withdrawal by Subject|0|||
143485106|NCT02980224|517321075|FG001|Overall Study|Withdrawal by Subject|2|||
143485107|NCT04770389|517321078|FG000|Overall Study|Adverse Event|1|||
143485108|NCT04770389|517321079|FG001|Overall Study|Adverse Event|2|||
143485109|NCT04770389|517321080|FG002|Overall Study|Adverse Event|0|||
143485110|NCT04770389|517321081|FG003|Overall Study|Adverse Event|1|||
143485111|NCT04770389|517321078|FG000|Overall Study|Withdrawal by Subject|0|||
143485112|NCT04770389|517321079|FG001|Overall Study|Withdrawal by Subject|2|||
143485113|NCT04770389|517321080|FG002|Overall Study|Withdrawal by Subject|1|||
143485114|NCT04770389|517321081|FG003|Overall Study|Withdrawal by Subject|0|||
143485115|NCT04770389|517321078|FG000|Overall Study|Failed attempt to draw blood|1|||
143485116|NCT04770389|517321079|FG001|Overall Study|Failed attempt to draw blood|0|||
143485117|NCT04770389|517321080|FG002|Overall Study|Failed attempt to draw blood|0|||
143485118|NCT04770389|517321081|FG003|Overall Study|Failed attempt to draw blood|0|||
143485119|NCT04770389|517321078|FG000|Overall Study|Left the country|0|||
143485120|NCT04770389|517321079|FG001|Overall Study|Left the country|0|||
143485121|NCT04770389|517321080|FG002|Overall Study|Left the country|1|||
143485122|NCT04770389|517321081|FG003|Overall Study|Left the country|2|||
143015367|NCT01128153|515597411|FG000|Overall Study|Withdrawal by Subject|2|||
143485123|NCT04770389|517321078|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
143485124|NCT04770389|517321079|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
143485125|NCT04770389|517321080|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
143485126|NCT04770389|517321081|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
143485127|NCT04770389|517321078|FG000|Overall Study|Lost to Follow-up|0|||
143485128|NCT04770389|517321079|FG001|Overall Study|Lost to Follow-up|0|||
143485129|NCT04770389|517321080|FG002|Overall Study|Lost to Follow-up|0|||
143485130|NCT04770389|517321081|FG003|Overall Study|Lost to Follow-up|1|||
143485131|NCT04770389|517321078|FG000|Overall Study|Moved away from study site|0|||
143485132|NCT04770389|517321079|FG001|Overall Study|Moved away from study site|1|||
143485133|NCT04770389|517321080|FG002|Overall Study|Moved away from study site|0|||
143015368|NCT01128153|515597412|FG001|Overall Study|Withdrawal by Subject|3|||
143015369|NCT01128153|515597411|FG000|Overall Study|Incorrect enrolment to study|2|||
143015370|NCT01128153|515597412|FG001|Overall Study|Incorrect enrolment to study|1|||
143015371|NCT01128153|515597411|FG000|Overall Study|Protocol Violation|2|||
143015372|NCT01128153|515597412|FG001|Overall Study|Protocol Violation|0|||
143015373|NCT01128153|515597411|FG000|Overall Study|Developed discontinuation criteria|1|||
143015374|NCT01128153|515597412|FG001|Overall Study|Developed discontinuation criteria|1|||
143015375|NCT01954082|515597413|FG000|Overall Study|Study Suspension|42|||
143485134|NCT04770389|517321081|FG003|Overall Study|Moved away from study site|0|||
143015376|NCT01954082|515597414|FG001|Overall Study|Study Suspension|36|||
143015377|NCT01954082|515597413|FG000|Overall Study|Adverse Event|10|||
143015378|NCT01954082|515597414|FG001|Overall Study|Adverse Event|4|||
143015379|NCT01954082|515597413|FG000|Overall Study|Intolerance|0|||
143015380|NCT01954082|515597414|FG001|Overall Study|Intolerance|1|||
143015381|NCT01954082|515597413|FG000|Overall Study|Non-compliance|6|||
143015382|NCT01954082|515597414|FG001|Overall Study|Non-compliance|4|||
143015383|NCT01954082|515597413|FG000|Overall Study|Physician Decision|2|||
143015384|NCT01954082|515597414|FG001|Overall Study|Physician Decision|0|||
143015385|NCT01954082|515597413|FG000|Overall Study|Parent Decision|1|||
143015386|NCT01954082|515597414|FG001|Overall Study|Parent Decision|0|||
143015387|NCT01954082|515597413|FG000|Overall Study|Withdrawal by Subject|0|||
143015388|NCT01954082|515597414|FG001|Overall Study|Withdrawal by Subject|1|||
143015389|NCT01954082|515597413|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
143015390|NCT01954082|515597414|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
143015391|NCT01954082|515597413|FG000|Overall Study|Redirection of Care|0|||
143015392|NCT01954082|515597414|FG001|Overall Study|Redirection of Care|2|||
143015393|NCT01954082|515597413|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
143015394|NCT01954082|515597414|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
143015395|NCT01954082|515597413|FG000|Overall Study|Comfort Care|0|||
143015396|NCT01954082|515597414|FG001|Overall Study|Comfort Care|1|||
143015397|NCT01954082|515597413|FG000|Overall Study|Infant Moved|0|||
143015398|NCT01954082|515597414|FG001|Overall Study|Infant Moved|1|||
143015399|NCT01954082|515597413|FG000|Overall Study|Randomized not Treated|4|||
143015400|NCT01954082|515597414|FG001|Overall Study|Randomized not Treated|2|||
143015401|NCT02419469|515597415|FG000|Overall Study|Withdrawal by Subject|1|||
143015402|NCT01682512|515597416|FG000|Overall Study|Adverse Event|6|||
143015403|NCT01682512|515597417|FG001|Overall Study|Adverse Event|5|||
143015404|NCT01682512|515597418|FG002|Overall Study|Adverse Event|2|||
143015405|NCT01682512|515597416|FG000|Overall Study|Withdrawal by Subject|2|||
143015406|NCT01682512|515597417|FG001|Overall Study|Withdrawal by Subject|6|||
143015407|NCT01682512|515597418|FG002|Overall Study|Withdrawal by Subject|3|||
143015408|NCT01682512|515597416|FG000|Overall Study|Physician Decision|0|||
143015409|NCT01682512|515597417|FG001|Overall Study|Physician Decision|2|||
143015410|NCT01682512|515597418|FG002|Overall Study|Physician Decision|0|||
143015411|NCT01682512|515597416|FG000|Overall Study|Study terminated by sponsor|46|||
143015412|NCT01682512|515597417|FG001|Overall Study|Study terminated by sponsor|43|||
143015413|NCT01682512|515597418|FG002|Overall Study|Study terminated by sponsor|0|||
143015414|NCT01682512|515597416|FG000|Overall Study|Lost to Follow-up|3|||
143015415|NCT01682512|515597417|FG001|Overall Study|Lost to Follow-up|0|||
143015416|NCT01682512|515597418|FG002|Overall Study|Lost to Follow-up|2|||
143015417|NCT01682512|515597416|FG000|Overall Study|Protocol Violation|2|||
143015418|NCT01682512|515597417|FG001|Overall Study|Protocol Violation|3|||
143015419|NCT01682512|515597418|FG002|Overall Study|Protocol Violation|2|||
143015420|NCT01682512|515597416|FG000|Overall Study|Primary lack of efficacy|10|||
143015421|NCT01682512|515597417|FG001|Overall Study|Primary lack of efficacy|7|||
143015422|NCT01682512|515597418|FG002|Overall Study|Primary lack of efficacy|7|||
143015423|NCT01682512|515597416|FG000|Overall Study|Secondary lack of efficacy|1|||
143015424|NCT01682512|515597417|FG001|Overall Study|Secondary lack of efficacy|1|||
143015425|NCT01682512|515597418|FG002|Overall Study|Secondary lack of efficacy|0|||
143015426|NCT01682512|515597416|FG000|Overall Study|Other than stated above|2|||
143015427|NCT01682512|515597417|FG001|Overall Study|Other than stated above|4|||
143015428|NCT01682512|515597418|FG002|Overall Study|Other than stated above|2|||
143015429|NCT01377233|515597419|FG000|Open-label|Adverse Event|1|||
143363665|NCT00062868|516873798|FG018|Dose Level 3|Death|0|||
143485135|NCT00708123|517321083|FG000|Period 1|Protocol Violation|0|||
143485136|NCT00708123|517321084|FG001|Period 1|Protocol Violation|1|||
143015430|NCT01377233|515597420|FG001|Open-label|Adverse Event|0|||
143015431|NCT01377233|515597421|FG002|Open-label|Adverse Event|0|||
143015432|NCT01377233|515597422|FG003|Open-label|Adverse Event|0|||
143015433|NCT01377233|515597423|FG004|Open-label|Adverse Event|0|||
143015434|NCT01377233|515597419|FG000|Open-label|Withdrawal by Subject|3|||
143015435|NCT01377233|515597420|FG001|Open-label|Withdrawal by Subject|0|||
143015436|NCT01377233|515597421|FG002|Open-label|Withdrawal by Subject|0|||
143015437|NCT01377233|515597422|FG003|Open-label|Withdrawal by Subject|0|||
143152632|NCT02965716|516104139|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
143152633|NCT02965716|516104140|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
143152634|NCT02965716|516104139|FG000|Overall Study|Progression/Relapse|8|||
143152635|NCT02965716|516104140|FG001|Overall Study|Progression/Relapse|16|||
143152636|NCT02965716|516104139|FG000|Overall Study|Death|1|||
143152637|NCT02965716|516104140|FG001|Overall Study|Death|0|||
143152638|NCT02965716|516104139|FG000|Overall Study|Not Protocol Specified|1|||
143152639|NCT02965716|516104140|FG001|Overall Study|Not Protocol Specified|3|||
143363666|NCT00062868|516873799|FG019|Dose Level 3|Death|0|||
143015438|NCT01377233|515597423|FG004|Open-label|Withdrawal by Subject|0|||
143485137|NCT00708123|517321085|FG002|Period 1|Protocol Violation|0|||
143015439|NCT01377233|515597419|FG000|Double-blind|Adverse Event|0|||
143015440|NCT01377233|515597420|FG001|Double-blind|Adverse Event|1|||
143015441|NCT01377233|515597421|FG002|Double-blind|Adverse Event|2|||
143015442|NCT01377233|515597422|FG003|Double-blind|Adverse Event|2|||
143015443|NCT01377233|515597423|FG004|Double-blind|Adverse Event|0|||
143015444|NCT01377233|515597419|FG000|Double-blind|Protocol Violation|0|||
143015445|NCT01377233|515597420|FG001|Double-blind|Protocol Violation|0|||
143015446|NCT01377233|515597421|FG002|Double-blind|Protocol Violation|0|||
143015447|NCT01377233|515597422|FG003|Double-blind|Protocol Violation|0|||
143015448|NCT01377233|515597423|FG004|Double-blind|Protocol Violation|1|||
143015449|NCT01377233|515597419|FG000|Double-blind|Withdrawal by Subject|0|||
143015450|NCT01377233|515597420|FG001|Double-blind|Withdrawal by Subject|0|||
143015451|NCT01377233|515597421|FG002|Double-blind|Withdrawal by Subject|0|||
143015452|NCT01377233|515597422|FG003|Double-blind|Withdrawal by Subject|1|||
143015453|NCT01377233|515597423|FG004|Double-blind|Withdrawal by Subject|0|||
143015454|NCT01377233|515597419|FG000|Double-blind|Administrative or other|0|||
143485138|NCT00708123|517321086|FG003|Period 1|Protocol Violation|1|||
143485139|NCT00708123|517321087|FG004|Period 1|Protocol Violation|0|||
143485140|NCT00708123|517321083|FG000|Period 1|Adverse Event|0|||
143485141|NCT00708123|517321084|FG001|Period 1|Adverse Event|0|||
143485142|NCT00708123|517321085|FG002|Period 1|Adverse Event|1|||
143485143|NCT00708123|517321086|FG003|Period 1|Adverse Event|0|||
143485144|NCT00708123|517321087|FG004|Period 1|Adverse Event|0|||
143485145|NCT00708123|517321083|FG000|Period 2|Protocol Violation|0|||
143485146|NCT00708123|517321084|FG001|Period 2|Protocol Violation|0|||
143485147|NCT00708123|517321085|FG002|Period 2|Protocol Violation|0|||
143485148|NCT00708123|517321086|FG003|Period 2|Protocol Violation|1|||
143485149|NCT00708123|517321087|FG004|Period 2|Protocol Violation|0|||
143485150|NCT00708123|517321083|FG000|Period 2|Other Reason|1|||
143485151|NCT00708123|517321084|FG001|Period 2|Other Reason|0|||
143485152|NCT00708123|517321085|FG002|Period 2|Other Reason|0|||
143485153|NCT00708123|517321086|FG003|Period 2|Other Reason|0|||
143485154|NCT00708123|517321087|FG004|Period 2|Other Reason|0|||
143485155|NCT00708123|517321083|FG000|Period 3|Lost to Follow-up|0|||
143485156|NCT00708123|517321084|FG001|Period 3|Lost to Follow-up|0|||
143485157|NCT00708123|517321085|FG002|Period 3|Lost to Follow-up|1|||
143485158|NCT00708123|517321086|FG003|Period 3|Lost to Follow-up|1|||
143485159|NCT00708123|517321087|FG004|Period 3|Lost to Follow-up|0|||
143015455|NCT01377233|515597420|FG001|Double-blind|Administrative or other|0|||
143015456|NCT01377233|515597421|FG002|Double-blind|Administrative or other|0|||
143015457|NCT01377233|515597422|FG003|Double-blind|Administrative or other|1|||
143015458|NCT01377233|515597423|FG004|Double-blind|Administrative or other|1|||
143015459|NCT01785875|515597424|FG000|Overall Study|Withdrawal by Subject|41|||
143015460|NCT01785875|515597425|FG001|Overall Study|Withdrawal by Subject|34|||
143015461|NCT01785875|515597426|FG002|Overall Study|Withdrawal by Subject|36|||
143015462|NCT01785875|515597424|FG000|Overall Study|Lost to Follow-up|19|||
143015463|NCT01785875|515597425|FG001|Overall Study|Lost to Follow-up|22|||
143015464|NCT01785875|515597426|FG002|Overall Study|Lost to Follow-up|6|||
143015465|NCT01785875|515597424|FG000|Overall Study|Death|27|||
143015466|NCT01785875|515597425|FG001|Overall Study|Death|16|||
143015467|NCT01785875|515597426|FG002|Overall Study|Death|7|||
143015468|NCT01785875|515597424|FG000|Overall Study|Sponsor Decision|0|||
143015469|NCT01785875|515597425|FG001|Overall Study|Sponsor Decision|2|||
143015470|NCT01785875|515597426|FG002|Overall Study|Sponsor Decision|0|||
143015471|NCT01785875|515597424|FG000|Overall Study|Protocol Specified Criteria|207|||
143015472|NCT01785875|515597425|FG001|Overall Study|Protocol Specified Criteria|214|||
143015473|NCT01785875|515597426|FG002|Overall Study|Protocol Specified Criteria|55|||
143015474|NCT01785875|515597424|FG000|Overall Study|Missing|0|||
143015475|NCT01785875|515597425|FG001|Overall Study|Missing|1|||
143485160|NCT00708123|517321083|FG000|Period 4|Protocol Violation|0|||
143485161|NCT00708123|517321084|FG001|Period 4|Protocol Violation|1|||
143485162|NCT00708123|517321085|FG002|Period 4|Protocol Violation|0|||
143485163|NCT00708123|517321086|FG003|Period 4|Protocol Violation|0|||
143485164|NCT00708123|517321087|FG004|Period 4|Protocol Violation|0|||
143485165|NCT00814892|517321088|FG000|Overall Study|Disease Progression|1|||
143485166|NCT00814892|517321088|FG000|Overall Study|Study Termination|1|||
143015476|NCT01785875|515597426|FG002|Overall Study|Missing|3|||
143015477|NCT00417027|515597429|FG000|Overall Study|Protocol Violation|0|||
143015478|NCT00417027|515597430|FG001|Overall Study|Protocol Violation|5|||
143015479|NCT00417027|515597431|FG002|Overall Study|Protocol Violation|5|||
143015480|NCT03137082|515597432|FG000|Overall Study|Withdrawal by Subject|1|||
143485167|NCT00845650|517321089|FG000|Overall Study|Withdrawal by Subject|0|||
143485168|NCT00845650|517321090|FG001|Overall Study|Withdrawal by Subject|0|||
143485169|NCT00845650|517321091|FG002|Overall Study|Withdrawal by Subject|0|||
143485170|NCT00845650|517321092|FG003|Overall Study|Withdrawal by Subject|0|||
143485171|NCT00845650|517321093|FG004|Overall Study|Withdrawal by Subject|2|||
143485172|NCT00845650|517321094|FG005|Overall Study|Withdrawal by Subject|0|||
143485173|NCT00845650|517321089|FG000|Overall Study|Lost to Follow-up|0|||
143485174|NCT00845650|517321090|FG001|Overall Study|Lost to Follow-up|0|||
143485175|NCT00845650|517321091|FG002|Overall Study|Lost to Follow-up|3|||
143485176|NCT00845650|517321092|FG003|Overall Study|Lost to Follow-up|1|||
143485177|NCT00845650|517321093|FG004|Overall Study|Lost to Follow-up|0|||
143485178|NCT00845650|517321094|FG005|Overall Study|Lost to Follow-up|1|||
143485179|NCT00845650|517321089|FG000|Overall Study|Sponsor hold on dosing|0|||
143485180|NCT00845650|517321090|FG001|Overall Study|Sponsor hold on dosing|0|||
143485181|NCT00845650|517321091|FG002|Overall Study|Sponsor hold on dosing|0|||
143485182|NCT00845650|517321092|FG003|Overall Study|Sponsor hold on dosing|0|||
143485183|NCT00845650|517321093|FG004|Overall Study|Sponsor hold on dosing|1|||
143485184|NCT00845650|517321094|FG005|Overall Study|Sponsor hold on dosing|1|||
143485185|NCT00845650|517321089|FG000|Overall Study|Unable to access IV line|1|||
143485186|NCT00845650|517321090|FG001|Overall Study|Unable to access IV line|0|||
143485187|NCT00845650|517321091|FG002|Overall Study|Unable to access IV line|0|||
143485188|NCT00845650|517321092|FG003|Overall Study|Unable to access IV line|0|||
143485189|NCT00845650|517321093|FG004|Overall Study|Unable to access IV line|0|||
143485190|NCT00845650|517321094|FG005|Overall Study|Unable to access IV line|0|||
143485191|NCT04486950|517321095|FG000|Overall Study|Lost to Follow-up|0|||
143485192|NCT04486950|517321096|FG001|Overall Study|Lost to Follow-up|0|||
143485193|NCT04486950|517321097|FG002|Overall Study|Lost to Follow-up|0|||
143485194|NCT04486950|517321098|FG003|Overall Study|Lost to Follow-up|0|||
143485195|NCT04486950|517321099|FG004|Overall Study|Lost to Follow-up|0|||
143485196|NCT04486950|517321100|FG005|Overall Study|Lost to Follow-up|1|||
143485197|NCT04486950|517321101|FG006|Overall Study|Lost to Follow-up|0|||
143485198|NCT00401375|517321102|FG000|Overall Study|Protocol Violation|2|||
143485199|NCT00401375|517321103|FG001|Overall Study|Protocol Violation|2|||
143485200|NCT00401375|517321104|FG002|Overall Study|Protocol Violation|1|||
143485201|NCT00401375|517321102|FG000|Overall Study|Adverse Event|6|||
143485202|NCT00401375|517321103|FG001|Overall Study|Adverse Event|11|||
143485203|NCT00401375|517321104|FG002|Overall Study|Adverse Event|10|||
143485204|NCT00401375|517321102|FG000|Overall Study|Withdrawal by Subject|9|||
143485205|NCT00401375|517321103|FG001|Overall Study|Withdrawal by Subject|7|||
143485206|NCT00401375|517321104|FG002|Overall Study|Withdrawal by Subject|7|||
143485207|NCT00401375|517321102|FG000|Overall Study|Lost to Follow-up|0|||
143485208|NCT00401375|517321103|FG001|Overall Study|Lost to Follow-up|1|||
143485209|NCT00401375|517321104|FG002|Overall Study|Lost to Follow-up|1|||
143485210|NCT00401375|517321102|FG000|Overall Study|Other than specified|2|||
143485211|NCT00401375|517321103|FG001|Overall Study|Other than specified|1|||
143485212|NCT00401375|517321104|FG002|Overall Study|Other than specified|3|||
143485213|NCT00401375|517321102|FG000|Overall Study|Randomized but not treated|3|||
143485214|NCT00401375|517321103|FG001|Overall Study|Randomized but not treated|3|||
143485215|NCT00401375|517321104|FG002|Overall Study|Randomized but not treated|3|||
143485216|NCT02821715|517321105|FG000|Overall Study|Protocol Violation|1|||
143485217|NCT02821715|517321106|FG001|Overall Study|Protocol Violation|0|||
143485218|NCT02821715|517321107|FG002|Overall Study|Protocol Violation|0|||
143485219|NCT02821715|517321108|FG003|Overall Study|Protocol Violation|0|||
143485220|NCT02821715|517321109|FG004|Overall Study|Protocol Violation|0|||
143485221|NCT02821715|517321110|FG005|Overall Study|Protocol Violation|0|||
143485222|NCT02374099|517321111|FG000|Overall Study|Adverse Event|1|||
143485223|NCT02374099|517321112|FG001|Overall Study|Adverse Event|0|||
143485224|NCT02374099|517321111|FG000|Overall Study|Progressive Disease|35|||
143485225|NCT02374099|517321112|FG001|Overall Study|Progressive Disease|40|||
143485226|NCT02374099|517321111|FG000|Overall Study|Withdrawal by Subject|5|||
143235087|NCT02903771|516413512|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
143485227|NCT02374099|517321112|FG001|Overall Study|Withdrawal by Subject|1|||
143485228|NCT02374099|517321111|FG000|Overall Study|Miscellaneous|2|||
143485229|NCT02374099|517321112|FG001|Overall Study|Miscellaneous|3|||
143235088|NCT02903771|516413513|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
143235089|NCT02903771|516413514|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
143235090|NCT02903771|516413515|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
143485230|NCT02374099|517321111|FG000|Overall Study|Randomized, but not treated|2|||
143485231|NCT02374099|517321112|FG001|Overall Study|Randomized, but not treated|1|||
143015481|NCT03137082|515597433|FG001|Overall Study|Withdrawal by Subject|1|||
143015482|NCT03137082|515597432|FG000|Overall Study|Lost to Follow-up|1|||
143485232|NCT02374099|517321111|FG000|Overall Study|Study Terminated by Sponsor|3|||
143485233|NCT02374099|517321112|FG001|Overall Study|Study Terminated by Sponsor|4|||
143485234|NCT01033825|517321113|FG000|Overall Study|Withdrawal by Subject|2|||
143485235|NCT01033825|517321114|FG001|Overall Study|Withdrawal by Subject|3|||
143485236|NCT01033825|517321115|FG002|Overall Study|Withdrawal by Subject|2|||
143485237|NCT01033825|517321116|FG003|Overall Study|Withdrawal by Subject|1|||
143485238|NCT01033825|517321117|FG004|Overall Study|Withdrawal by Subject|1|||
143485239|NCT01033825|517321118|FG005|Overall Study|Withdrawal by Subject|0|||
143235091|NCT02903771|516413516|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
143235092|NCT02903771|516413517|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
143235093|NCT02903771|516413511|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
143235094|NCT02903771|516413512|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
143235095|NCT02903771|516413513|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
143485240|NCT01033825|517321119|FG006|Overall Study|Withdrawal by Subject|0|||
143235096|NCT02903771|516413514|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
143235097|NCT02903771|516413515|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
143235098|NCT02903771|516413516|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
143235099|NCT02903771|516413517|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
143235100|NCT02903771|516413511|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
143235101|NCT02903771|516413512|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
143235102|NCT02903771|516413513|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
143235103|NCT02903771|516413514|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
143235104|NCT02903771|516413515|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
143235105|NCT02903771|516413516|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
143235106|NCT02903771|516413517|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
143485241|NCT01033825|517321113|FG000|Overall Study|Adverse Event|0|||
143485242|NCT01033825|517321114|FG001|Overall Study|Adverse Event|0|||
143485243|NCT01033825|517321115|FG002|Overall Study|Adverse Event|0|||
143485244|NCT01033825|517321116|FG003|Overall Study|Adverse Event|1|||
143485245|NCT01033825|517321117|FG004|Overall Study|Adverse Event|0|||
143485246|NCT01033825|517321118|FG005|Overall Study|Adverse Event|0|||
143485247|NCT01033825|517321119|FG006|Overall Study|Adverse Event|0|||
143485248|NCT01033825|517321113|FG000|Overall Study|Protocol Violation|1|||
143485249|NCT01033825|517321114|FG001|Overall Study|Protocol Violation|0|||
143485250|NCT01033825|517321115|FG002|Overall Study|Protocol Violation|0|||
143485251|NCT01033825|517321116|FG003|Overall Study|Protocol Violation|0|||
143485252|NCT01033825|517321117|FG004|Overall Study|Protocol Violation|0|||
143485253|NCT01033825|517321118|FG005|Overall Study|Protocol Violation|0|||
143485254|NCT01033825|517321119|FG006|Overall Study|Protocol Violation|0|||
143485255|NCT01033825|517321113|FG000|Overall Study|Other|0|||
143485256|NCT01033825|517321114|FG001|Overall Study|Other|0|||
143485257|NCT01033825|517321115|FG002|Overall Study|Other|0|||
143485258|NCT01033825|517321116|FG003|Overall Study|Other|0|||
143485259|NCT01033825|517321117|FG004|Overall Study|Other|1|||
143485260|NCT01033825|517321118|FG005|Overall Study|Other|0|||
143485261|NCT01033825|517321119|FG006|Overall Study|Other|0|||
143485262|NCT04294719|517321120|FG000|Overall Study|Withdrawal by Subject|1|||
143485263|NCT00081159|517321122|FG000|Overall Study|Withdrawal by Subject|0|||
143485264|NCT00081159|517321123|FG001|Overall Study|Withdrawal by Subject|3|||
143485265|NCT00081159|517321122|FG000|Overall Study|Myelosuppression prior to treatment|0|||
143485266|NCT00081159|517321123|FG001|Overall Study|Myelosuppression prior to treatment|1|||
143485267|NCT00081159|517321122|FG000|Overall Study|Lost to Follow-up|2|||
143485268|NCT00081159|517321123|FG001|Overall Study|Lost to Follow-up|1|||
143485269|NCT03693625|517321124|FG000|Overall Study|Adverse Event|2|||
143485270|NCT03693625|517321125|FG001|Overall Study|Adverse Event|0|||
143485271|NCT03693625|517321124|FG000|Overall Study|Study Terminated By Sponsor|20|||
143485272|NCT03693625|517321125|FG001|Overall Study|Study Terminated By Sponsor|7|||
143485273|NCT03693625|517321124|FG000|Overall Study|Withdrawal by Subject|1|||
143485274|NCT03693625|517321125|FG001|Overall Study|Withdrawal by Subject|1|||
143485275|NCT01883635|517321127|FG000|Overall Study|Withdrawal by Subject|4|||
143485276|NCT01883635|517321128|FG001|Overall Study|Withdrawal by Subject|0|||
143485277|NCT01187953|517321129|FG000|Overall Study|Death|11|||
143485278|NCT01187953|517321130|FG001|Overall Study|Death|13|||
143485279|NCT01187953|517321129|FG000|Overall Study|Adverse Event|1|||
143485280|NCT01187953|517321130|FG001|Overall Study|Adverse Event|2|||
143485281|NCT01187953|517321129|FG000|Overall Study|Lost to Follow-up|0|||
143485282|NCT01187953|517321130|FG001|Overall Study|Lost to Follow-up|3|||
143485283|NCT01187953|517321129|FG000|Overall Study|Withdrawal by Subject|3|||
143485284|NCT01187953|517321130|FG001|Overall Study|Withdrawal by Subject|3|||
143485285|NCT01464307|517321131|FG000|Main Period|Death|0|||
143235107|NCT02903771|516413511|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
143363667|NCT00062868|516873800|FG020|Dose Level 3|Death|0|||
143485286|NCT01464307|517321132|FG001|Main Period|Death|1|||
143485287|NCT01464307|517321131|FG000|Main Period|Adverse Event|6|||
143015483|NCT03137082|515597433|FG001|Overall Study|Lost to Follow-up|0|||
143235108|NCT02903771|516413512|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
143485288|NCT01464307|517321132|FG001|Main Period|Adverse Event|1|||
143485289|NCT01464307|517321131|FG000|Main Period|Lack of Efficacy|2|||
143485290|NCT01464307|517321132|FG001|Main Period|Lack of Efficacy|0|||
143485291|NCT01464307|517321131|FG000|Main Period|Withdrawal by Subject|5|||
143485292|NCT01464307|517321132|FG001|Main Period|Withdrawal by Subject|2|||
143485293|NCT01464307|517321131|FG000|Main Period|Predefined discontinuation criteria|2|||
143485294|NCT01464307|517321132|FG001|Main Period|Predefined discontinuation criteria|1|||
143485295|NCT01464307|517321131|FG000|Open-Label Extension Period|Adverse Event|15|||
143485296|NCT01464307|517321132|FG001|Open-Label Extension Period|Adverse Event|0|||
143015484|NCT00707174|515597434|FG000|Overall Study|Adverse Event|1|||
143015485|NCT00707174|515597435|FG001|Overall Study|Adverse Event|6|||
143015486|NCT00707174|515597434|FG000|Overall Study|Withdrawal by Subject|4|||
143015487|NCT00707174|515597435|FG001|Overall Study|Withdrawal by Subject|1|||
143015488|NCT00544557|515597436|FG000|Overall Study|Adverse Event|140|||
143015489|NCT00544557|515597436|FG000|Overall Study|Lack of Efficacy|196|||
143015490|NCT00544557|515597436|FG000|Overall Study|Other|98|||
143015491|NCT04057118|515597439|FG000|Overall Study|Adverse Event|1|||
143015492|NCT04057118|515597440|FG001|Overall Study|Adverse Event|0|||
143015493|NCT04057118|515597441|FG002|Overall Study|Adverse Event|1|||
143015494|NCT04057118|515597442|FG003|Overall Study|Adverse Event|1|||
143015495|NCT04057118|515597439|FG000|Overall Study|Physician Decision|0|||
143015496|NCT04057118|515597440|FG001|Overall Study|Physician Decision|0|||
143015497|NCT04057118|515597441|FG002|Overall Study|Physician Decision|1|||
143015498|NCT04057118|515597442|FG003|Overall Study|Physician Decision|1|||
143015499|NCT04057118|515597439|FG000|Overall Study|Withdrawal by Subject|2|||
143015500|NCT04057118|515597440|FG001|Overall Study|Withdrawal by Subject|2|||
143015501|NCT04057118|515597441|FG002|Overall Study|Withdrawal by Subject|0|||
143015502|NCT04057118|515597442|FG003|Overall Study|Withdrawal by Subject|2|||
143015503|NCT04057118|515597439|FG000|Overall Study|Not Specific|0|||
143015504|NCT04057118|515597440|FG001|Overall Study|Not Specific|0|||
143015505|NCT04057118|515597441|FG002|Overall Study|Not Specific|1|||
143015506|NCT04057118|515597442|FG003|Overall Study|Not Specific|1|||
143015507|NCT01850108|515597448|FG000|Overall Study|Lost to Follow-up|4|||
143015508|NCT01850108|515597448|FG000|Overall Study|Not eligible|1|||
143015509|NCT01850108|515597448|FG000|Overall Study|Failed engraftment|2|||
143015510|NCT01850108|515597448|FG000|Overall Study|Physician Decision|1|||
143015511|NCT00886782|515597452|FG000|Overall Study|Disease progression|3|||
143015512|NCT00886782|515597453|FG001|Overall Study|Disease progression|3|||
143015513|NCT00886782|515597454|FG002|Overall Study|Disease progression|3|||
143015514|NCT00886782|515597452|FG000|Overall Study|Study drug toxicity|0|||
143015515|NCT00886782|515597453|FG001|Overall Study|Study drug toxicity|0|||
143015516|NCT00886782|515597454|FG002|Overall Study|Study drug toxicity|1|||
143015517|NCT00886782|515597452|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
143015518|NCT00886782|515597453|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
143015519|NCT00886782|515597454|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
143015520|NCT05166512|515597457|FG000|Randomized|Lost to Follow-up|2|||
143015521|NCT05166512|515597458|FG001|Randomized|Lost to Follow-up|0|||
143015522|NCT05166512|515597457|FG000|Randomized|Withdrawal by Subject|1|||
143015523|NCT05166512|515597458|FG001|Randomized|Withdrawal by Subject|0|||
143015524|NCT05166512|515597457|FG000|Baseline Data Collection|Lost to Follow-up|0|||
143015525|NCT05166512|515597458|FG001|Baseline Data Collection|Lost to Follow-up|3|||
143015526|NCT05166512|515597457|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
143015527|NCT05166512|515597458|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
143015528|NCT05166512|515597457|FG000|Baseline Data Collection|Protocol Violation|2|||
143015529|NCT05166512|515597458|FG001|Baseline Data Collection|Protocol Violation|0|||
143015530|NCT05166512|515597457|FG000|4 Month Data Collection|Lost to Follow-up|1|||
143015531|NCT05166512|515597458|FG001|4 Month Data Collection|Lost to Follow-up|0|||
143015532|NCT05166512|515597457|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
143015533|NCT05166512|515597458|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
143015534|NCT05166512|515597457|FG000|12 Month Data Collection|Lost to Follow-up|3|||
143015535|NCT05166512|515597458|FG001|12 Month Data Collection|Lost to Follow-up|1|||
143015536|NCT05166512|515597457|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
143015537|NCT05166512|515597458|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
143015538|NCT00420849|515597459|FG000|Overall Study|Lack of Efficacy|154|||
143015539|NCT00420849|515597459|FG000|Overall Study|Adverse Event|107|||
143015540|NCT00420849|515597459|FG000|Overall Study|Withdrawal by Subject|28|||
143015541|NCT00420849|515597459|FG000|Overall Study|Death|18|||
143235109|NCT02903771|516413513|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
143235110|NCT02903771|516413514|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
143015542|NCT00420849|515597459|FG000|Overall Study|Other|14|||
143235111|NCT02903771|516413515|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
143485297|NCT01464307|517321131|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
143485298|NCT01464307|517321132|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
143015543|NCT00420849|515597459|FG000|Overall Study|Transplant|8|||
143015544|NCT00420849|515597459|FG000|Overall Study|Protocol Violation|1|||
143015545|NCT00420849|515597459|FG000|Overall Study|Lost to Follow-up|1|||
143015546|NCT01831596|515597460|FG000|Overall Study|Other|8|||
143015547|NCT00446134|515597461|FG000|Overall Study|Adverse Event|7|||
143015548|NCT00446134|515597462|FG001|Overall Study|Adverse Event|17|||
143015549|NCT00446134|515597463|FG002|Overall Study|Adverse Event|13|||
143485299|NCT01464307|517321131|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
143015550|NCT00446134|515597464|FG003|Overall Study|Adverse Event|18|||
143015551|NCT00446134|515597461|FG000|Overall Study|Lack of Efficacy|19|||
143015552|NCT00446134|515597462|FG001|Overall Study|Lack of Efficacy|19|||
143015553|NCT00446134|515597463|FG002|Overall Study|Lack of Efficacy|24|||
143015554|NCT00446134|515597464|FG003|Overall Study|Lack of Efficacy|19|||
143015555|NCT00446134|515597461|FG000|Overall Study|Protocol Violation|0|||
143015556|NCT00446134|515597462|FG001|Overall Study|Protocol Violation|2|||
143015557|NCT00446134|515597463|FG002|Overall Study|Protocol Violation|1|||
143015558|NCT00446134|515597464|FG003|Overall Study|Protocol Violation|0|||
143015559|NCT00446134|515597461|FG000|Overall Study|Lost to Follow-up|1|||
143015560|NCT00446134|515597462|FG001|Overall Study|Lost to Follow-up|3|||
143015561|NCT00446134|515597463|FG002|Overall Study|Lost to Follow-up|1|||
143015562|NCT00446134|515597464|FG003|Overall Study|Lost to Follow-up|1|||
143015563|NCT00446134|515597461|FG000|Overall Study|Withdrawal by Subject|3|||
143015564|NCT00446134|515597462|FG001|Overall Study|Withdrawal by Subject|3|||
143015565|NCT00446134|515597463|FG002|Overall Study|Withdrawal by Subject|1|||
143015566|NCT00446134|515597464|FG003|Overall Study|Withdrawal by Subject|3|||
143015567|NCT00446134|515597461|FG000|Overall Study|Physician Decision|0|||
143015568|NCT00446134|515597462|FG001|Overall Study|Physician Decision|0|||
143015569|NCT00446134|515597463|FG002|Overall Study|Physician Decision|0|||
143015570|NCT00446134|515597464|FG003|Overall Study|Physician Decision|2|||
143015571|NCT00446134|515597461|FG000|Overall Study|Adverse Event-Diarrhea|1|||
143015572|NCT00446134|515597462|FG001|Overall Study|Adverse Event-Diarrhea|1|||
143015573|NCT00446134|515597463|FG002|Overall Study|Adverse Event-Diarrhea|2|||
143015574|NCT00446134|515597464|FG003|Overall Study|Adverse Event-Diarrhea|0|||
143015575|NCT00446134|515597461|FG000|Overall Study|Reason Not Completed|3|||
143015576|NCT00446134|515597462|FG001|Overall Study|Reason Not Completed|0|||
143015577|NCT00446134|515597463|FG002|Overall Study|Reason Not Completed|1|||
143015578|NCT00446134|515597464|FG003|Overall Study|Reason Not Completed|2|||
143015579|NCT02602080|515597470|FG000|Overall Study|Protocol Violation|6|||
143015580|NCT02602080|515597471|FG001|Overall Study|Protocol Violation|1|||
143015581|NCT02602080|515597472|FG002|Overall Study|Protocol Violation|3|||
143015582|NCT02574260|515597476|FG000|Overall Study|Disease Progression|1|||
143015583|NCT00828516|515597478|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
143015584|NCT00833976|515599129|FG000|Overall Study|Withdrawal by Subject|5|||
143015585|NCT00833976|515599129|FG000|Overall Study|Lost to Follow-up|4|||
143015586|NCT00833976|515599129|FG000|Overall Study|Did not meet eligibility criteria|41|||
143015587|NCT00833976|515599129|FG000|Overall Study|Physician Decision|1|||
143015588|NCT01142466|515599133|FG000|Overall Study|Adverse Event|2|||
143015589|NCT01142466|515599134|FG001|Overall Study|Adverse Event|1|||
143015590|NCT01142466|515599133|FG000|Overall Study|Withdrawal by Subject|1|||
143015591|NCT01142466|515599134|FG001|Overall Study|Withdrawal by Subject|1|||
143015592|NCT02414854|515599139|FG000|Overall Study|Adverse Event|9|||
143015593|NCT02414854|515599140|FG001|Overall Study|Adverse Event|7|||
143015594|NCT02414854|515599141|FG002|Overall Study|Adverse Event|1|||
143015595|NCT02414854|515599142|FG003|Overall Study|Adverse Event|12|||
143015596|NCT02414854|515599139|FG000|Overall Study|Poor compliance to protocol|1|||
143015597|NCT02414854|515599140|FG001|Overall Study|Poor compliance to protocol|1|||
143015598|NCT02414854|515599141|FG002|Overall Study|Poor compliance to protocol|2|||
143015599|NCT02414854|515599142|FG003|Overall Study|Poor compliance to protocol|2|||
143015600|NCT02414854|515599139|FG000|Overall Study|Other than specified above|12|||
143015601|NCT02414854|515599140|FG001|Overall Study|Other than specified above|37|||
143015602|NCT02414854|515599141|FG002|Overall Study|Other than specified above|17|||
143015603|NCT02414854|515599142|FG003|Overall Study|Other than specified above|37|||
143015604|NCT03724916|515599143|FG000|Overall Study|Withdrawal by Subject|0|||
143015605|NCT03724916|515599144|FG001|Overall Study|Withdrawal by Subject|1|||
143015606|NCT03724916|515599145|FG002|Overall Study|Withdrawal by Subject|1|||
143015607|NCT03724916|515599146|FG003|Overall Study|Withdrawal by Subject|2|||
143015608|NCT03724916|515599143|FG000|Overall Study|Randomized but not Treated|1|||
143015609|NCT03724916|515599144|FG001|Overall Study|Randomized but not Treated|0|||
143015610|NCT03724916|515599145|FG002|Overall Study|Randomized but not Treated|0|||
143235112|NCT02903771|516413516|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
143235113|NCT02903771|516413517|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
143235114|NCT02903771|516413511|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
143235115|NCT02903771|516413512|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
143015611|NCT03724916|515599146|FG003|Overall Study|Randomized but not Treated|0|||
143015612|NCT04575038|515599147|FG000|Overall Study|Withdrawal by Subject|1|||
143015613|NCT04575038|515599148|FG001|Overall Study|Withdrawal by Subject|1|||
143015614|NCT00606801|515599153|FG000|Intervention|Protocol Violation|3|||
143015615|NCT00606801|515599154|FG001|Intervention|Protocol Violation|3|||
143015616|NCT03591107|515599155|FG000|Overall Study|Same patient in both arms|1|||
143015617|NCT03591107|515599156|FG001|Overall Study|Same patient in both arms|1|||
143015618|NCT03591107|515599155|FG000|Overall Study|Sought care at other clinics|0|||
143015619|NCT03591107|515599156|FG001|Overall Study|Sought care at other clinics|2|||
143015620|NCT03591107|515599155|FG000|Overall Study|Discharged from clinic|0|||
143015621|NCT03591107|515599156|FG001|Overall Study|Discharged from clinic|1|||
143015622|NCT03591107|515599155|FG000|Overall Study|Withdrawal by Subject|0|||
143015623|NCT03591107|515599156|FG001|Overall Study|Withdrawal by Subject|1|||
143015624|NCT01020305|515599161|FG000|Overall Study|Adverse Event|2|||
143015625|NCT00467818|515599162|FG000|Overall Study|Adverse Event|1|||
143015626|NCT00467818|515599163|FG001|Overall Study|Adverse Event|0|||
143363668|NCT00062868|516873780|FG000|Dose Level 3|Lost to Follow-up|0|||
143015627|NCT00467818|515599162|FG000|Overall Study|Lost to Follow-up|2|||
143015628|NCT00467818|515599163|FG001|Overall Study|Lost to Follow-up|2|||
143015629|NCT00618774|515599164|FG000|Overall Study|Adverse Event|5|||
143015630|NCT00618774|515599165|FG001|Overall Study|Adverse Event|3|||
143015631|NCT00618774|515599164|FG000|Overall Study|Withdrawal by Subject|1|||
143015632|NCT00618774|515599165|FG001|Overall Study|Withdrawal by Subject|0|||
143015633|NCT02753400|515599166|FG000|Overall Study|Adverse Event|3|||
143015634|NCT02753400|515599167|FG001|Overall Study|Adverse Event|0|||
143015635|NCT02753400|515599166|FG000|Overall Study|Withdrawal by Subject|2|||
143015636|NCT02753400|515599167|FG001|Overall Study|Withdrawal by Subject|1|||
143015637|NCT01830920|515599170|FG000|Overall Study|Adverse Event|1|||
143015638|NCT01830920|515599171|FG001|Overall Study|Adverse Event|0|||
143015639|NCT01830920|515599172|FG002|Overall Study|Adverse Event|1|||
143015640|NCT01830920|515599173|FG003|Overall Study|Adverse Event|0|||
143015641|NCT01830920|515599174|FG004|Overall Study|Adverse Event|0|||
143015642|NCT01830920|515599170|FG000|Overall Study|Withdrawal by Subject|2|||
143015643|NCT01830920|515599171|FG001|Overall Study|Withdrawal by Subject|2|||
143015644|NCT01830920|515599172|FG002|Overall Study|Withdrawal by Subject|1|||
143015645|NCT01830920|515599173|FG003|Overall Study|Withdrawal by Subject|7|||
143015646|NCT01830920|515599174|FG004|Overall Study|Withdrawal by Subject|1|||
143015647|NCT01830920|515599170|FG000|Overall Study|Death|3|||
143015648|NCT01830920|515599171|FG001|Overall Study|Death|3|||
143015649|NCT01830920|515599172|FG002|Overall Study|Death|5|||
143015650|NCT01830920|515599173|FG003|Overall Study|Death|4|||
143015651|NCT01830920|515599174|FG004|Overall Study|Death|4|||
143015652|NCT01830920|515599170|FG000|Overall Study|Other|15|||
143015653|NCT01830920|515599171|FG001|Overall Study|Other|1|||
143015654|NCT01830920|515599172|FG002|Overall Study|Other|1|||
143015655|NCT01830920|515599173|FG003|Overall Study|Other|5|||
143015656|NCT01830920|515599174|FG004|Overall Study|Other|3|||
143015657|NCT01313728|515599175|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
143015658|NCT00572156|515599183|FG000|Overall Study|Adverse Event|3|||
143015659|NCT00572156|515599184|FG001|Overall Study|Adverse Event|1|||
143015660|NCT00572156|515599185|FG002|Overall Study|Adverse Event|5|||
143015661|NCT00572156|515599186|FG003|Overall Study|Adverse Event|1|||
143015662|NCT00572156|515599183|FG000|Overall Study|Lost to Follow-up|1|||
143015663|NCT00572156|515599184|FG001|Overall Study|Lost to Follow-up|1|||
143015664|NCT00572156|515599185|FG002|Overall Study|Lost to Follow-up|1|||
143015665|NCT00572156|515599186|FG003|Overall Study|Lost to Follow-up|0|||
143015666|NCT00572156|515599183|FG000|Overall Study|Protocol Violation|1|||
143015667|NCT00572156|515599184|FG001|Overall Study|Protocol Violation|2|||
143015668|NCT00572156|515599185|FG002|Overall Study|Protocol Violation|0|||
143015669|NCT00572156|515599186|FG003|Overall Study|Protocol Violation|2|||
143015670|NCT00572156|515599183|FG000|Overall Study|Patient/Parent Decision|1|||
143015671|NCT00572156|515599184|FG001|Overall Study|Patient/Parent Decision|6|||
143015672|NCT00572156|515599185|FG002|Overall Study|Patient/Parent Decision|4|||
143015673|NCT00572156|515599186|FG003|Overall Study|Patient/Parent Decision|3|||
143015674|NCT00572156|515599183|FG000|Overall Study|Sponsor Decision|20|||
143015675|NCT00572156|515599184|FG001|Overall Study|Sponsor Decision|16|||
143015676|NCT00572156|515599185|FG002|Overall Study|Sponsor Decision|17|||
143015677|NCT00572156|515599186|FG003|Overall Study|Sponsor Decision|19|||
143015678|NCT02261974|515599187|FG000|Overall Study|Withdrawal by Subject|3|||
143015679|NCT02261974|515599188|FG001|Overall Study|Withdrawal by Subject|2|||
143015680|NCT02261974|515599187|FG000|Overall Study|Pregnancy|0|||
143015681|NCT02261974|515599188|FG001|Overall Study|Pregnancy|1|||
143485300|NCT01464307|517321132|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
143485301|NCT01464307|517321131|FG000|Open-Label Extension Period|Death|1|||
143485302|NCT01464307|517321132|FG001|Open-Label Extension Period|Death|0|||
143485303|NCT01464307|517321131|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
143485304|NCT01464307|517321132|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
143485305|NCT01464307|517321131|FG000|Open-Label Extension Period|Non-compliance|9|||
143015682|NCT02261974|515599187|FG000|Overall Study|Missed treatment cut-off date|6|||
143015683|NCT02261974|515599188|FG001|Overall Study|Missed treatment cut-off date|3|||
143015684|NCT02261974|515599187|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
143485306|NCT01464307|517321132|FG001|Open-Label Extension Period|Non-compliance|0|||
143015685|NCT02261974|515599188|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
143015686|NCT02261974|515599187|FG000|Overall Study|Lost to Follow-up|2|||
143015687|NCT02261974|515599188|FG001|Overall Study|Lost to Follow-up|0|||
143015688|NCT02261974|515599187|FG000|Overall Study|Adverse Event|1|||
143015689|NCT02261974|515599188|FG001|Overall Study|Adverse Event|0|||
143015690|NCT04736576|515599191|FG000|Overall Study|Progressive disease|3|||
143015691|NCT04736576|515599192|FG001|Overall Study|Progressive disease|1|||
143015692|NCT04736576|515599191|FG000|Overall Study|Death|1|||
143015693|NCT04736576|515599192|FG001|Overall Study|Death|0|||
143015694|NCT03273712|515599195|FG000|Overall Study|Death|5|||
143015695|NCT03273712|515599195|FG000|Overall Study|Adverse Event|1|||
143015696|NCT03273712|515599195|FG000|Overall Study|Disease Progression|1|||
143015697|NCT00190684|515599197|FG000|Overall Study|Adverse Event|86|||
143015698|NCT00190684|515599197|FG000|Overall Study|Satisfactory response|80|||
143015699|NCT00190684|515599197|FG000|Overall Study|Lack of efficacy|204|||
143015700|NCT00190684|515599197|FG000|Overall Study|Lost to Follow-up|232|||
143015701|NCT00190684|515599197|FG000|Overall Study|Patient moved|60|||
143015702|NCT00190684|515599197|FG000|Overall Study|Patient Decision|432|||
143015703|NCT00190684|515599197|FG000|Overall Study|Clinical relapse|67|||
143015704|NCT00190684|515599197|FG000|Overall Study|Sponsor's decision|17|||
143015705|NCT00190684|515599197|FG000|Overall Study|Physician Decision|84|||
143015706|NCT00190684|515599197|FG000|Overall Study|Protocol Violation|123|||
143015707|NCT00190684|515599197|FG000|Overall Study|Study Period III Completed|103|||
143015708|NCT00190684|515599197|FG000|Overall Study|Study Period V Completed|1|||
143015709|NCT02567266|515599203|FG000|Overall Study|Withdrawal by Subject|10|||
143015710|NCT02567266|515599204|FG001|Overall Study|Withdrawal by Subject|7|||
143015711|NCT02567266|515599205|FG002|Overall Study|Withdrawal by Subject|6|||
143015712|NCT02567266|515599203|FG000|Overall Study|Lost to Follow-up|13|||
143015713|NCT02567266|515599204|FG001|Overall Study|Lost to Follow-up|8|||
143015714|NCT02567266|515599205|FG002|Overall Study|Lost to Follow-up|10|||
143015715|NCT01255722|515599210|FG000|Overall Study|Adverse Event|0|||
143015716|NCT01255722|515599211|FG001|Overall Study|Adverse Event|1|||
143015717|NCT01255722|515599212|FG002|Overall Study|Adverse Event|1|||
143015718|NCT01255722|515599210|FG000|Overall Study|asymptomatic patient|1|||
143015719|NCT01255722|515599211|FG001|Overall Study|asymptomatic patient|0|||
143015720|NCT01255722|515599212|FG002|Overall Study|asymptomatic patient|0|||
143015721|NCT01255722|515599210|FG000|Overall Study|beta-blocker contraindicated|2|||
143015722|NCT01255722|515599211|FG001|Overall Study|beta-blocker contraindicated|0|||
143015723|NCT01255722|515599212|FG002|Overall Study|beta-blocker contraindicated|0|||
143015724|NCT04529499|515599213|FG000|Overall Study|Withdrawal by Subject|9|||
143015725|NCT04529499|515599214|FG001|Overall Study|Withdrawal by Subject|11|||
143015726|NCT04529499|515599213|FG000|Overall Study|Physician Decision|1|||
143015727|NCT04529499|515599214|FG001|Overall Study|Physician Decision|2|||
143015728|NCT04529499|515599213|FG000|Overall Study|Adverse Event|4|||
143015729|NCT04529499|515599214|FG001|Overall Study|Adverse Event|4|||
143015730|NCT04529499|515599213|FG000|Overall Study|Death|14|||
143015731|NCT04529499|515599214|FG001|Overall Study|Death|11|||
143015732|NCT04529499|515599213|FG000|Overall Study|Lost to Follow-up|1|||
143015733|NCT04529499|515599214|FG001|Overall Study|Lost to Follow-up|1|||
143015734|NCT04529499|515599213|FG000|Overall Study|Others|7|||
143015735|NCT04529499|515599214|FG001|Overall Study|Others|11|||
143015736|NCT02441179|515599216|FG000|Overall Study|Withdrawal by Subject|1|||
143015737|NCT02441179|515599217|FG001|Overall Study|Withdrawal by Subject|1|||
143015738|NCT02702271|515599218|FG000|Overall Study|Death|36|||
143015739|NCT02702271|515599219|FG001|Overall Study|Death|7|||
143015740|NCT02702271|515599218|FG000|Overall Study|Lost to Follow-up|12|||
143015741|NCT02702271|515599219|FG001|Overall Study|Lost to Follow-up|0|||
143015742|NCT02702271|515599218|FG000|Overall Study|Withdrawal by Subject|8|||
143015743|NCT02702271|515599219|FG001|Overall Study|Withdrawal by Subject|1|||
143485307|NCT01464307|517321131|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
143485308|NCT01464307|517321132|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
143015744|NCT02702271|515599218|FG000|Overall Study|Physician Decision|2|||
143015745|NCT02702271|515599219|FG001|Overall Study|Physician Decision|0|||
143015746|NCT02702271|515599218|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
143015747|NCT02702271|515599219|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
143015748|NCT03091400|515599220|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
143015749|NCT03091400|515599221|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
143015750|NCT00051636|515599222|FG000|Period 1 - Core|Adverse Event|2|||
143015751|NCT00051636|515599223|FG001|Period 1 - Core|Adverse Event|2|||
143015752|NCT00051636|515599222|FG000|Period 1 - Core|Protocol Violation|1|||
143363669|NCT00062868|516873781|FG001|Dose Level 3|Lost to Follow-up|0|||
143015753|NCT00051636|515599223|FG001|Period 1 - Core|Protocol Violation|0|||
143015754|NCT00051636|515599222|FG000|Period 1 - Core|Withdrawal by Subject|1|||
143015755|NCT00051636|515599223|FG001|Period 1 - Core|Withdrawal by Subject|2|||
143015756|NCT00051636|515599222|FG000|Period 1 - Core|Lost to Follow-up|0|||
143015757|NCT00051636|515599223|FG001|Period 1 - Core|Lost to Follow-up|2|||
143015758|NCT00051636|515599222|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
143015759|NCT00051636|515599223|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
143015760|NCT00051636|515599222|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
143015761|NCT00051636|515599223|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
143015762|NCT00051636|515599222|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
143015763|NCT00051636|515599223|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
143015764|NCT00051636|515599222|FG000|Period 2- Extended Observation Period|Death|4|||
143015765|NCT00051636|515599223|FG001|Period 2- Extended Observation Period|Death|5|||
143015766|NCT00051636|515599222|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
143015767|NCT00051636|515599223|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
143015768|NCT00975884|515599224|FG000|Overall Study|Adverse Event|1|||
143015769|NCT00975884|515599225|FG001|Overall Study|Adverse Event|0|||
143015770|NCT00975884|515599224|FG000|Overall Study|Lost to Follow-up|5|||
143015771|NCT00975884|515599225|FG001|Overall Study|Lost to Follow-up|3|||
143015772|NCT00975884|515599224|FG000|Overall Study|Withdrawal by Subject|9|||
143015773|NCT00975884|515599225|FG001|Overall Study|Withdrawal by Subject|9|||
143015774|NCT00975884|515599224|FG000|Overall Study|Other|1|||
143015775|NCT00975884|515599225|FG001|Overall Study|Other|3|||
143015776|NCT01174368|515599226|FG000|Overall Study|Withdrawal by Subject|1|||
143015777|NCT00479765|515599227|FG000|Overall Study|study terminated|4|||
143015778|NCT00725725|515599232|FG000|Overall Study|Adverse Event|1|||
143015779|NCT00725725|515599233|FG001|Overall Study|Adverse Event|3|||
143015780|NCT00725725|515599234|FG002|Overall Study|Adverse Event|2|||
143015781|NCT00725725|515599232|FG000|Overall Study|Lost to Follow-up|2|||
143015782|NCT00725725|515599233|FG001|Overall Study|Lost to Follow-up|0|||
143015783|NCT00725725|515599234|FG002|Overall Study|Lost to Follow-up|2|||
143015784|NCT00725725|515599232|FG000|Overall Study|Withdrawal by Subject|1|||
143015785|NCT00725725|515599233|FG001|Overall Study|Withdrawal by Subject|0|||
143015786|NCT00725725|515599234|FG002|Overall Study|Withdrawal by Subject|1|||
143015787|NCT00725725|515599232|FG000|Overall Study|Protocol Violation|0|||
143015788|NCT00725725|515599233|FG001|Overall Study|Protocol Violation|1|||
143015789|NCT00725725|515599234|FG002|Overall Study|Protocol Violation|0|||
143015790|NCT01619085|515599235|FG000|Overall Study|Adverse Event|231|||
143015791|NCT01619085|515599235|FG000|Overall Study|Protocol Violation|4|||
143015792|NCT01619085|515599235|FG000|Overall Study|Lost to Follow-up|3|||
143015793|NCT01619085|515599235|FG000|Overall Study|Withdrawal by Subject|45|||
143015794|NCT01619085|515599235|FG000|Overall Study|Other than specified|96|||
143015795|NCT01619085|515599235|FG000|Overall Study|Not treated|1|||
143015796|NCT01619085|515599235|FG000|Overall Study|Death|145|||
143015797|NCT00944125|515599238|FG000|3 to 6 Months|Withdrawal by Subject|0|||
143015798|NCT00944125|515599239|FG001|3 to 6 Months|Withdrawal by Subject|2|||
143015799|NCT00944125|515599238|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
143015800|NCT00944125|515599239|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
143015801|NCT03125629|515599240|FG000|Overall Study|Withdrawal by Subject|2|||
143015802|NCT03125629|515599240|FG000|Overall Study|Equipment malfunction|1|||
143015803|NCT00743119|515599241|FG000|Overall Study|unreliable|3|||
143015804|NCT00743119|515599241|FG000|Overall Study|Withdrawal by Subject|1|||
143015805|NCT04816877|515599242|FG000|Overall Study|Withdrawal by Subject|1|||
143015806|NCT04816877|515599243|FG001|Overall Study|Withdrawal by Subject|0|||
143015807|NCT02176642|515599246|FG000|Overall Study|Withdrawal by Subject|0|||
143015808|NCT02176642|515599247|FG001|Overall Study|Withdrawal by Subject|1|||
143015809|NCT02989610|515599248|FG000|Overall Study|Withdrawal by Subject|20|||
143015810|NCT02989610|515599248|FG000|Overall Study|Departure of PI from Site|8|||
143015811|NCT02989610|515599248|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
143015812|NCT02989610|515599248|FG000|Overall Study|Lost to Follow-up|3|||
143015813|NCT02989610|515599248|FG000|Overall Study|Death|3|||
143015814|NCT02989610|515599248|FG000|Overall Study|System Explant|3|||
143015815|NCT02989610|515599248|FG000|Overall Study|Subject Non-Compliance|2|||
143015816|NCT02989610|515599248|FG000|Overall Study|System Revision|2|||
143015817|NCT02989610|515599248|FG000|Overall Study|PI Left, Study Closing|1|||
143015818|NCT02989610|515599248|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
143015819|NCT02989610|515599248|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
143015820|NCT04508621|515599249|FG000|Overall Study|Adverse Event|39|||
143015821|NCT04508621|515599250|FG001|Overall Study|Adverse Event|16|||
143015822|NCT04508621|515599249|FG000|Overall Study|Lack of Efficacy|2|||
143015823|NCT04508621|515599250|FG001|Overall Study|Lack of Efficacy|8|||
143015824|NCT04508621|515599249|FG000|Overall Study|Physician Decision|0|||
143015825|NCT04508621|515599250|FG001|Overall Study|Physician Decision|1|||
143363670|NCT00062868|516873782|FG002|Dose Level 3|Lost to Follow-up|0|||
143015826|NCT04508621|515599249|FG000|Overall Study|Withdrawal by Subject|10|||
143015827|NCT04508621|515599250|FG001|Overall Study|Withdrawal by Subject|14|||
143015828|NCT04508621|515599249|FG000|Overall Study|Lost to Follow-up|12|||
143015829|NCT04508621|515599250|FG001|Overall Study|Lost to Follow-up|9|||
143015830|NCT04508621|515599249|FG000|Overall Study|COVID-19 related crisis|3|||
143015831|NCT04508621|515599250|FG001|Overall Study|COVID-19 related crisis|0|||
143015832|NCT04508621|515599249|FG000|Overall Study|Subject non-compliance|1|||
143015833|NCT04508621|515599250|FG001|Overall Study|Subject non-compliance|0|||
143015834|NCT00084617|515599251|FG000|Overall Study|Withdrawal by Subject|7|||
143015835|NCT00084617|515599251|FG000|Overall Study|Lack of Efficacy|1|||
143015836|NCT00084617|515599251|FG000|Overall Study|Protocol Violation|1|||
143015837|NCT04355767|515599252|FG000|Overall Study|Withdrawal by Subject|2|||
143015838|NCT04355767|515599253|FG001|Overall Study|Withdrawal by Subject|2|||
143015839|NCT04355767|515599252|FG000|Overall Study|Death|5|||
143015840|NCT04355767|515599253|FG001|Overall Study|Death|1|||
143015841|NCT01355523|515600971|FG000|Overall Study|Withdrawal by Subject|1|||
143015842|NCT01355523|515600972|FG001|Overall Study|Withdrawal by Subject|4|||
143015843|NCT01355523|515600971|FG000|Overall Study|Lost to Follow-up|0|||
143015844|NCT01355523|515600972|FG001|Overall Study|Lost to Follow-up|2|||
143015845|NCT01355523|515600971|FG000|Overall Study|Protocol Violation|0|||
143015846|NCT01355523|515600972|FG001|Overall Study|Protocol Violation|2|||
143015847|NCT01355523|515600971|FG000|Overall Study|Adverse Event|0|||
143015848|NCT01355523|515600972|FG001|Overall Study|Adverse Event|2|||
143015849|NCT02464059|515600973|FG000|Overall Study|Lost to Follow-up|6|||
143015850|NCT04335110|515600976|FG000|Overall Study|Withdrawal by Subject|1|||
143015851|NCT04335110|515600977|FG001|Overall Study|Withdrawal by Subject|1|||
143015852|NCT04335110|515600976|FG000|Overall Study|Death|0|||
143015853|NCT04335110|515600977|FG001|Overall Study|Death|1|||
143015854|NCT00350519|515600978|FG000|Overall Study|Death|0|||
143015855|NCT00350519|515600979|FG001|Overall Study|Death|1|||
143015856|NCT00350519|515600978|FG000|Overall Study|Physician Decision|0|||
143015857|NCT00350519|515600979|FG001|Overall Study|Physician Decision|1|||
143015858|NCT00350519|515600978|FG000|Overall Study|Protocol Violation|1|||
143015859|NCT00350519|515600979|FG001|Overall Study|Protocol Violation|2|||
143015860|NCT00350519|515600978|FG000|Overall Study|Withdrawal by Subject|3|||
143015861|NCT00350519|515600979|FG001|Overall Study|Withdrawal by Subject|2|||
143015862|NCT04388527|515600980|FG000|Overall Study|Death|14|||
143015863|NCT04388527|515600980|FG000|Overall Study|Withdrawal by Subject|2|||
143015864|NCT04388527|515600980|FG000|Overall Study|Lost to Follow-up|1|||
143015865|NCT01440595|515600983|FG000|Overall Study|Lost to Follow-up|0|||
143015866|NCT01440595|515600984|FG001|Overall Study|Lost to Follow-up|1|||
143015867|NCT01440595|515600985|FG002|Overall Study|Lost to Follow-up|0|||
143015868|NCT01440595|515600983|FG000|Overall Study|Study terminated by sponsor.|1|||
143015869|NCT01440595|515600984|FG001|Overall Study|Study terminated by sponsor.|2|||
143015870|NCT01440595|515600985|FG002|Overall Study|Study terminated by sponsor.|1|||
143015871|NCT01347879|515600986|FG000|Overall Study|Adverse Event|0|||
143015872|NCT01347879|515600987|FG001|Overall Study|Adverse Event|12|||
143015873|NCT01347879|515600986|FG000|Overall Study|Lost to Follow-up|2|||
143015874|NCT01347879|515600987|FG001|Overall Study|Lost to Follow-up|0|||
143015875|NCT01347879|515600986|FG000|Overall Study|Withdrawal by Subject|3|||
143015876|NCT01347879|515600987|FG001|Overall Study|Withdrawal by Subject|2|||
143015877|NCT01347879|515600986|FG000|Overall Study|Other|2|||
143015878|NCT01347879|515600987|FG001|Overall Study|Other|3|||
143015879|NCT00720304|515600990|FG000|Overall Study|Withdrawal by Subject|14|||
143015880|NCT00720304|515600991|FG001|Overall Study|Withdrawal by Subject|1|||
143015881|NCT00720304|515600990|FG000|Overall Study|Death|1|||
143015882|NCT00720304|515600991|FG001|Overall Study|Death|0|||
143015883|NCT00720304|515600990|FG000|Overall Study|Physician Decision|5|||
143015884|NCT00720304|515600991|FG001|Overall Study|Physician Decision|2|||
143015885|NCT00720304|515600990|FG000|Overall Study|Adverse Event|3|||
143015886|NCT00720304|515600991|FG001|Overall Study|Adverse Event|1|||
143015887|NCT00720304|515600990|FG000|Overall Study|Disease progression|6|||
143015888|NCT00720304|515600991|FG001|Overall Study|Disease progression|1|||
143015889|NCT04330482|515600992|FG000|Overall Study|Lost to Follow-up|2|||
143015890|NCT04330482|515600993|FG001|Overall Study|Lost to Follow-up|1|||
143015891|NCT04330482|515600992|FG000|Overall Study|Withdrawal by Subject|0|||
143015892|NCT04330482|515600993|FG001|Overall Study|Withdrawal by Subject|3|||
143015893|NCT00996918|515600994|FG000|Overall Study|Lack of Efficacy|1|||
143015894|NCT00996918|515600995|FG001|Overall Study|Lack of Efficacy|1|||
143015895|NCT00996918|515600996|FG002|Overall Study|Lack of Efficacy|2|||
143015896|NCT00996918|515600997|FG003|Overall Study|Lack of Efficacy|2|||
143015897|NCT00996918|515600998|FG004|Overall Study|Lack of Efficacy|0|||
143015898|NCT00996918|515600994|FG000|Overall Study|Adverse Event|2|||
143015899|NCT00996918|515600995|FG001|Overall Study|Adverse Event|5|||
143015900|NCT00996918|515600996|FG002|Overall Study|Adverse Event|2|||
143015901|NCT00996918|515600997|FG003|Overall Study|Adverse Event|6|||
143015902|NCT00996918|515600998|FG004|Overall Study|Adverse Event|0|||
143015903|NCT00996918|515600994|FG000|Overall Study|Withdrawal by Subject|1|||
143015904|NCT00996918|515600995|FG001|Overall Study|Withdrawal by Subject|4|||
143015905|NCT00996918|515600996|FG002|Overall Study|Withdrawal by Subject|3|||
143015906|NCT00996918|515600997|FG003|Overall Study|Withdrawal by Subject|3|||
143015907|NCT00996918|515600998|FG004|Overall Study|Withdrawal by Subject|2|||
143015908|NCT00996918|515600994|FG000|Overall Study|Physician Decision|1|||
143015909|NCT00996918|515600995|FG001|Overall Study|Physician Decision|0|||
143015910|NCT00996918|515600996|FG002|Overall Study|Physician Decision|0|||
143015911|NCT00996918|515600997|FG003|Overall Study|Physician Decision|0|||
143015912|NCT00996918|515600998|FG004|Overall Study|Physician Decision|0|||
143015913|NCT00996918|515600994|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
143015914|NCT00996918|515600995|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
143015915|NCT00996918|515600996|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
143015916|NCT00996918|515600997|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
143015917|NCT00996918|515600998|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
143015918|NCT00996918|515600994|FG000|Overall Study|Loss of Caregiver|0|||
143015919|NCT00996918|515600995|FG001|Overall Study|Loss of Caregiver|1|||
143015920|NCT00996918|515600996|FG002|Overall Study|Loss of Caregiver|0|||
143015921|NCT00996918|515600997|FG003|Overall Study|Loss of Caregiver|0|||
143015922|NCT00996918|515600998|FG004|Overall Study|Loss of Caregiver|0|||
143015923|NCT00996918|515600994|FG000|Overall Study|Other|3|||
143015924|NCT00996918|515600995|FG001|Overall Study|Other|1|||
143015925|NCT00996918|515600996|FG002|Overall Study|Other|0|||
143015926|NCT00996918|515600997|FG003|Overall Study|Other|0|||
143015927|NCT00996918|515600998|FG004|Overall Study|Other|0|||
143015928|NCT01333475|515601001|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
143015929|NCT01333475|515601002|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
143015930|NCT01333475|515601001|FG000|Overall Study|Toxicity|1|||
143015931|NCT01333475|515601002|FG001|Overall Study|Toxicity|3|||
143015932|NCT04440007|515601003|FG000|Overall Study|Adverse Event|0|||
143015933|NCT04440007|515601004|FG001|Overall Study|Adverse Event|1|||
143015934|NCT04440007|515601003|FG000|Overall Study|Lost to Follow-up|1|||
143015935|NCT04440007|515601004|FG001|Overall Study|Lost to Follow-up|3|||
143015936|NCT04440007|515601003|FG000|Overall Study|Death|7|||
143015937|NCT04440007|515601004|FG001|Overall Study|Death|2|||
143015938|NCT04440007|515601003|FG000|Overall Study|Physician Decision|1|||
143015939|NCT04440007|515601004|FG001|Overall Study|Physician Decision|1|||
143015940|NCT04440007|515601003|FG000|Overall Study|Withdrawal by Subject|2|||
143015941|NCT04440007|515601004|FG001|Overall Study|Withdrawal by Subject|1|||
143015942|NCT04440007|515601003|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
143015943|NCT04440007|515601004|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
143015944|NCT04440007|515601003|FG000|Overall Study|Discontinued prior to dosing|0|||
143015945|NCT04440007|515601004|FG001|Overall Study|Discontinued prior to dosing|2|||
143015946|NCT01466673|515601005|FG000|Overall Study|Non-compliance with study treatment|2|||
143015947|NCT01466673|515601006|FG001|Overall Study|Non-compliance with study treatment|0|||
143015948|NCT01466673|515601005|FG000|Overall Study|Lost to Follow-up|3|||
143015949|NCT01466673|515601006|FG001|Overall Study|Lost to Follow-up|5|||
143015950|NCT01466673|515601005|FG000|Overall Study|Adverse Event|2|||
143015951|NCT01466673|515601006|FG001|Overall Study|Adverse Event|1|||
143015952|NCT02725671|515601007|FG000|Overall Study|Lost to Follow-up|1|||
143015953|NCT02981602|515601008|FG000|Overall Study|Adverse Event|0|||
143015954|NCT02981602|515601009|FG001|Overall Study|Adverse Event|0|||
143015955|NCT02981602|515601010|FG002|Overall Study|Adverse Event|0|||
143015956|NCT02981602|515601011|FG003|Overall Study|Adverse Event|1|||
143015957|NCT02981602|515601012|FG004|Overall Study|Adverse Event|0|||
143235116|NCT02903771|516413513|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
143485309|NCT00761514|517321133|FG000|Overall Study|Adverse Event|1|||
143015958|NCT00666718|515601013|FG000|Overall Study|Adverse Event|0|||
143015959|NCT00666718|515601014|FG001|Overall Study|Adverse Event|1|||
143015960|NCT00666718|515601013|FG000|Overall Study|Death|1|||
143015961|NCT00666718|515601014|FG001|Overall Study|Death|0|||
143015962|NCT00666718|515601013|FG000|Overall Study|Lost to Follow-up|1|||
143015963|NCT00666718|515601014|FG001|Overall Study|Lost to Follow-up|0|||
143015964|NCT00666718|515601013|FG000|Overall Study|Entry Criteria Not Met|2|||
143015965|NCT00666718|515601014|FG001|Overall Study|Entry Criteria Not Met|0|||
143015966|NCT00666718|515601013|FG000|Overall Study|Protocol Violation|1|||
143015967|NCT00666718|515601014|FG001|Overall Study|Protocol Violation|3|||
143015968|NCT00666718|515601013|FG000|Overall Study|Withdrawal by Subject|7|||
143015969|NCT00666718|515601014|FG001|Overall Study|Withdrawal by Subject|12|||
143015970|NCT00666718|515601013|FG000|Overall Study|Physician Decision|0|||
143015971|NCT00666718|515601014|FG001|Overall Study|Physician Decision|2|||
143015972|NCT00963599|515601015|FG000|Overall Study|Adverse Event|2|||
143015973|NCT00963599|515601016|FG001|Overall Study|Adverse Event|0|||
143015974|NCT00963599|515601017|FG002|Overall Study|Adverse Event|1|||
143015975|NCT00963599|515601018|FG003|Overall Study|Adverse Event|2|||
143015976|NCT00963599|515601015|FG000|Overall Study|Lack of Efficacy|0|||
143015977|NCT00963599|515601016|FG001|Overall Study|Lack of Efficacy|2|||
143015978|NCT00963599|515601017|FG002|Overall Study|Lack of Efficacy|1|||
143015979|NCT00963599|515601018|FG003|Overall Study|Lack of Efficacy|4|||
143015980|NCT00963599|515601015|FG000|Overall Study|Lost to Follow-up|0|||
143015981|NCT00963599|515601016|FG001|Overall Study|Lost to Follow-up|1|||
143015982|NCT00963599|515601017|FG002|Overall Study|Lost to Follow-up|1|||
143015983|NCT00963599|515601018|FG003|Overall Study|Lost to Follow-up|1|||
143015984|NCT00963599|515601015|FG000|Overall Study|Protocol Violation|2|||
143015985|NCT00963599|515601016|FG001|Overall Study|Protocol Violation|2|||
143015986|NCT00963599|515601017|FG002|Overall Study|Protocol Violation|3|||
143015987|NCT00963599|515601018|FG003|Overall Study|Protocol Violation|4|||
143015988|NCT00963599|515601015|FG000|Overall Study|Withdrawal by Subject|2|||
143015989|NCT00963599|515601016|FG001|Overall Study|Withdrawal by Subject|1|||
143015990|NCT00963599|515601017|FG002|Overall Study|Withdrawal by Subject|3|||
143015991|NCT00963599|515601018|FG003|Overall Study|Withdrawal by Subject|3|||
143015992|NCT03496207|515601021|FG000|Base Study|Adverse Event|0|||
143015993|NCT03496207|515601022|FG001|Base Study|Adverse Event|0|||
143015994|NCT03496207|515601023|FG002|Base Study|Adverse Event|1|||
143015995|NCT03496207|515601024|FG003|Base Study|Adverse Event|1|||
143015996|NCT03496207|515601025|FG004|Base Study|Adverse Event|4|||
143015997|NCT03496207|515601021|FG000|Base Study|Death|0|||
143015998|NCT03496207|515601022|FG001|Base Study|Death|0|||
143015999|NCT03496207|515601023|FG002|Base Study|Death|0|||
143016000|NCT03496207|515601024|FG003|Base Study|Death|0|||
143016001|NCT03496207|515601025|FG004|Base Study|Death|1|||
143016002|NCT03496207|515601021|FG000|Base Study|Withdrawal by Subject|0|||
143016003|NCT03496207|515601022|FG001|Base Study|Withdrawal by Subject|0|||
143016004|NCT03496207|515601023|FG002|Base Study|Withdrawal by Subject|1|||
143016005|NCT03496207|515601024|FG003|Base Study|Withdrawal by Subject|0|||
143016006|NCT03496207|515601025|FG004|Base Study|Withdrawal by Subject|1|||
143016007|NCT03496207|515601021|FG000|Extension Period|Adverse Event|0|||
143016008|NCT03496207|515601022|FG001|Extension Period|Adverse Event|0|||
143016009|NCT03496207|515601023|FG002|Extension Period|Adverse Event|0|||
143016010|NCT03496207|515601024|FG003|Extension Period|Adverse Event|1|||
143016011|NCT03496207|515601025|FG004|Extension Period|Adverse Event|1|||
143016012|NCT03496207|515601021|FG000|Extension Period|Death|1|||
143016013|NCT03496207|515601022|FG001|Extension Period|Death|0|||
143016014|NCT03496207|515601023|FG002|Extension Period|Death|0|||
143016015|NCT03496207|515601024|FG003|Extension Period|Death|1|||
143016016|NCT03496207|515601025|FG004|Extension Period|Death|2|||
143016017|NCT03496207|515601021|FG000|Extension Period|Withdrawal by Subject|1|||
143016018|NCT03496207|515601022|FG001|Extension Period|Withdrawal by Subject|0|||
143016019|NCT03496207|515601023|FG002|Extension Period|Withdrawal by Subject|0|||
143016020|NCT03496207|515601024|FG003|Extension Period|Withdrawal by Subject|1|||
143485310|NCT00761514|517321133|FG000|Overall Study|Withdrawal by Subject|2|||
143016021|NCT03496207|515601025|FG004|Extension Period|Withdrawal by Subject|1|||
143016022|NCT03496207|515601021|FG000|Extension Period|Elevated hemoglobin levels|0|||
143016023|NCT03496207|515601022|FG001|Extension Period|Elevated hemoglobin levels|0|||
143016024|NCT03496207|515601023|FG002|Extension Period|Elevated hemoglobin levels|0|||
143016025|NCT03496207|515601024|FG003|Extension Period|Elevated hemoglobin levels|0|||
143016026|NCT03496207|515601025|FG004|Extension Period|Elevated hemoglobin levels|1|||
143016027|NCT00810615|515601028|FG000|Overall Study|Withdrawal by Subject|1|||
143016028|NCT00810615|515601029|FG001|Overall Study|Withdrawal by Subject|1|||
143016029|NCT02525562|515601030|FG000|Overall Study|Death|9|||
143016030|NCT02525562|515601031|FG001|Overall Study|Death|0|||
143016031|NCT02525562|515601032|FG002|Overall Study|Death|0|||
143016032|NCT02525562|515601030|FG000|Overall Study|Lost to Follow-up|19|||
143016033|NCT02525562|515601031|FG001|Overall Study|Lost to Follow-up|0|||
143016034|NCT02525562|515601032|FG002|Overall Study|Lost to Follow-up|0|||
143016035|NCT02525562|515601030|FG000|Overall Study|Withdrawal by Subject|37|||
143016036|NCT02525562|515601031|FG001|Overall Study|Withdrawal by Subject|0|||
143016037|NCT02525562|515601032|FG002|Overall Study|Withdrawal by Subject|0|||
143016038|NCT02525562|515601030|FG000|Overall Study|Revision/Removal of Study Device|4|||
143016039|NCT02525562|515601031|FG001|Overall Study|Revision/Removal of Study Device|0|||
143016040|NCT02525562|515601032|FG002|Overall Study|Revision/Removal of Study Device|0|||
143016041|NCT02525562|515601030|FG000|Overall Study|Study Closed by Sponsor|154|||
143016042|NCT02525562|515601031|FG001|Overall Study|Study Closed by Sponsor|0|||
143016043|NCT02525562|515601032|FG002|Overall Study|Study Closed by Sponsor|0|||
143016044|NCT02354976|515601034|FG000|Overall Study|Other - reason not specified|1|||
143016045|NCT02354976|515601035|FG001|Overall Study|Other - reason not specified|0|||
143016046|NCT02354976|515601036|FG002|Overall Study|Other - reason not specified|1|||
143016047|NCT02354976|515601034|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
143016048|NCT02354976|515601035|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
143016049|NCT02354976|515601036|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
143016050|NCT02354976|515601034|FG000|Overall Study|Adverse Event|1|||
143016051|NCT02354976|515601035|FG001|Overall Study|Adverse Event|0|||
143016052|NCT02354976|515601036|FG002|Overall Study|Adverse Event|2|||
143016053|NCT01706770|515601037|FG000|Overall Study|Lost to Follow-up|1|||
143016054|NCT01706770|515601038|FG001|Overall Study|Lost to Follow-up|0|||
143016055|NCT01706770|515601037|FG000|Overall Study|Physician Decision|1|||
143016056|NCT01706770|515601038|FG001|Overall Study|Physician Decision|0|||
143016057|NCT00068445|515601039|FG000|Randomization|Cancel|1|||
143016058|NCT00068445|515601040|FG001|Randomization|Cancel|3|||
143016059|NCT00068445|515601039|FG000|Randomization|Ineligible|1|||
143016060|NCT00068445|515601040|FG001|Randomization|Ineligible|1|||
143016061|NCT00068445|515601039|FG000|Treatment|Refused Further Treatment|13|||
143016062|NCT00068445|515601040|FG001|Treatment|Refused Further Treatment|10|||
143016063|NCT00068445|515601039|FG000|Treatment|Adverse Event|7|||
143016064|NCT00068445|515601040|FG001|Treatment|Adverse Event|1|||
143016065|NCT00068445|515601039|FG000|Treatment|Other (Specifics not available)|9|||
143016066|NCT00068445|515601040|FG001|Treatment|Other (Specifics not available)|5|||
143016067|NCT01155284|515601041|FG000|Overall Study|Withdrawal by Subject|4|||
143016068|NCT01155284|515601042|FG001|Overall Study|Withdrawal by Subject|3|||
143016069|NCT01155284|515601041|FG000|Overall Study|Lost to Follow-up|1|||
143016070|NCT01155284|515601042|FG001|Overall Study|Lost to Follow-up|2|||
143016071|NCT01155284|515601041|FG000|Overall Study|Physician Decision|1|||
143016072|NCT01155284|515601042|FG001|Overall Study|Physician Decision|0|||
143016073|NCT01155284|515601041|FG000|Overall Study|Adverse Event|1|||
143016074|NCT01155284|515601042|FG001|Overall Study|Adverse Event|0|||
143016075|NCT01896700|515601043|FG000|Overall Study|Adverse Event|4|||
143016076|NCT01896700|515601044|FG001|Overall Study|Adverse Event|5|||
143016077|NCT01896700|515601043|FG000|Overall Study|Withdrawal by Subject|0|||
143016078|NCT01896700|515601044|FG001|Overall Study|Withdrawal by Subject|1|||
143016079|NCT00123487|515601045|FG000|Randomized|Death prior to starting treatment|0|||
143016080|NCT00123487|515601046|FG001|Randomized|Death prior to starting treatment|1|||
143016081|NCT00123487|515601045|FG000|Randomized|SAE prior to starting treatment|1|||
143016082|NCT00123487|515601046|FG001|Randomized|SAE prior to starting treatment|0|||
143016083|NCT00123487|515601045|FG000|Treated With Study Drug|Adverse Event|23|||
143016084|NCT00123487|515601046|FG001|Treated With Study Drug|Adverse Event|22|||
143016085|NCT00123487|515601045|FG000|Treated With Study Drug|Disease Progression|141|||
143016086|NCT00123487|515601046|FG001|Treated With Study Drug|Disease Progression|122|||
143016087|NCT00123487|515601045|FG000|Treated With Study Drug|Physician Decision|8|||
143016088|NCT00123487|515601046|FG001|Treated With Study Drug|Physician Decision|9|||
143016089|NCT00123487|515601045|FG000|Treated With Study Drug|Other|59|||
143016090|NCT00123487|515601046|FG001|Treated With Study Drug|Other|58|||
143016091|NCT00123487|515601045|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
143485311|NCT00761514|517321133|FG000|Overall Study|Lost to Follow-up|1|||
143485312|NCT00761514|517321133|FG000|Overall Study|Health insurance didn't cover study drug|1|||
143485313|NCT00761514|517321133|FG000|Overall Study|Problem complying with study visit|1|||
143485314|NCT00761514|517321133|FG000|Overall Study|Unable to pay for medications|1|||
143016092|NCT00123487|515601046|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
143016093|NCT00123487|515601045|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
143016094|NCT00123487|515601046|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
143016095|NCT00123487|515601045|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
143016096|NCT00123487|515601046|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
143016097|NCT00423488|515601047|FG000|Overall Study|No evidence of study drug intake|2|||
143016098|NCT00423488|515601048|FG001|Overall Study|No evidence of study drug intake|1|||
143016099|NCT00423488|515601047|FG000|Overall Study|No post baseline data|3|||
143016100|NCT00423488|515601048|FG001|Overall Study|No post baseline data|0|||
143016101|NCT03118765|515601049|FG000|Overall Study|Withdrawal by Subject|0|||
143016102|NCT03118765|515601050|FG001|Overall Study|Withdrawal by Subject|0|||
143016103|NCT03118765|515601051|FG002|Overall Study|Withdrawal by Subject|1|||
143016104|NCT03118765|515601052|FG003|Overall Study|Withdrawal by Subject|0|||
143016105|NCT03118765|515601053|FG004|Overall Study|Withdrawal by Subject|0|||
143016106|NCT03118765|515601049|FG000|Overall Study|Adverse Event|1|||
143016107|NCT03118765|515601050|FG001|Overall Study|Adverse Event|1|||
143016108|NCT03118765|515601051|FG002|Overall Study|Adverse Event|1|||
143016109|NCT03118765|515601052|FG003|Overall Study|Adverse Event|1|||
143152790|NCT06262607|516104153|FG000|Overall Study|Physician Decision|0|||
143152791|NCT06262607|516104154|FG001|Overall Study|Physician Decision|1|||
143152792|NCT06262607|516104153|FG000|Overall Study|Withdrawal by Subject|2|||
143152793|NCT06262607|516104154|FG001|Overall Study|Withdrawal by Subject|0|||
143016110|NCT03118765|515601053|FG004|Overall Study|Adverse Event|1|||
143016111|NCT03118765|515601049|FG000|Overall Study|Non compliance with Study Procedures|0|||
143485315|NCT03885089|517321134|FG000|Overall Study|No informed consent for publication of study results|2|||
143235117|NCT02903771|516413514|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
143235118|NCT02903771|516413515|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
143235119|NCT02903771|516413516|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
143235120|NCT02903771|516413517|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
143235121|NCT02903771|516413511|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
143235122|NCT02903771|516413512|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
143235123|NCT02903771|516413513|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
143235124|NCT02903771|516413514|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
143235125|NCT02903771|516413515|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
143235126|NCT02903771|516413516|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
143235127|NCT02903771|516413517|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
143235128|NCT02903771|516413511|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
143235129|NCT02903771|516413512|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
143235130|NCT02903771|516413513|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
143235131|NCT02903771|516413514|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
143235132|NCT02903771|516413515|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
143235133|NCT02903771|516413516|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
143235134|NCT02903771|516413517|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
143235135|NCT02903771|516413511|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
143235136|NCT02903771|516413512|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
143235137|NCT02903771|516413513|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
143235138|NCT02903771|516413514|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
143235139|NCT02903771|516413515|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
143235140|NCT02903771|516413516|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
143235141|NCT02903771|516413517|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
143235142|NCT02903771|516413511|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
143235143|NCT02903771|516413512|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
143235144|NCT02903771|516413513|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
143235145|NCT02903771|516413514|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
143235146|NCT02903771|516413515|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
143235147|NCT02903771|516413516|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
143235148|NCT02903771|516413517|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
143235149|NCT04225897|516413518|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
143235150|NCT04225897|516413519|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
143235151|NCT04225897|516413520|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
143235152|NCT04225897|516413521|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
143235153|NCT04225897|516413522|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
143152798|NCT05278065|516104157|FG000|Overall Study|Withdrawal by Subject|1|||
143152799|NCT05278065|516104158|FG001|Overall Study|Withdrawal by Subject|0|||
143152800|NCT02029443|516104159|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
143152801|NCT02029443|516104160|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
143152802|NCT02029443|516104161|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
143152803|NCT02029443|516104162|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
143152804|NCT02029443|516104163|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
143152805|NCT02029443|516104159|FG000|Overall Study|Death|13|||
143152806|NCT02029443|516104160|FG001|Overall Study|Death|2|||
143152807|NCT02029443|516104161|FG002|Overall Study|Death|2|||
143152808|NCT02029443|516104162|FG003|Overall Study|Death|11|||
143152809|NCT02029443|516104163|FG004|Overall Study|Death|2|||
143152810|NCT02029443|516104159|FG000|Overall Study|Lost to Follow-up|1|||
143152811|NCT02029443|516104160|FG001|Overall Study|Lost to Follow-up|0|||
143152812|NCT02029443|516104161|FG002|Overall Study|Lost to Follow-up|1|||
143152813|NCT02029443|516104162|FG003|Overall Study|Lost to Follow-up|1|||
143152814|NCT02029443|516104163|FG004|Overall Study|Lost to Follow-up|0|||
143152815|NCT02029443|516104159|FG000|Overall Study|Started other anti-cancer therapy|17|||
143152816|NCT02029443|516104160|FG001|Overall Study|Started other anti-cancer therapy|4|||
143235154|NCT04225897|516413523|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
143235155|NCT04225897|516413524|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
143235156|NCT04225897|516413525|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
143152817|NCT02029443|516104161|FG002|Overall Study|Started other anti-cancer therapy|7|||
143016112|NCT03118765|515601050|FG001|Overall Study|Non compliance with Study Procedures|0|||
143016113|NCT03118765|515601051|FG002|Overall Study|Non compliance with Study Procedures|0|||
143016114|NCT03118765|515601052|FG003|Overall Study|Non compliance with Study Procedures|1|||
143016115|NCT03118765|515601053|FG004|Overall Study|Non compliance with Study Procedures|0|||
143016116|NCT03118765|515601049|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
143016117|NCT03118765|515601050|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
143016118|NCT03118765|515601051|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
143485316|NCT03770260|517322788|FG000|Overall Study|Disease progression|0|||
143485317|NCT03770260|517322789|FG001|Overall Study|Disease progression|1|||
143485318|NCT03770260|517322790|FG002|Overall Study|Disease progression|0|||
143485319|NCT03770260|517322791|FG003|Overall Study|Disease progression|0|||
143485320|NCT03451773|517322793|FG000|Overall Study|Death on study|1|||
143485321|NCT03451773|517322794|FG001|Overall Study|Death on study|5|||
143485322|NCT03451773|517322793|FG000|Overall Study|Death during follow-up period|0|||
143485323|NCT03451773|517322794|FG001|Overall Study|Death during follow-up period|1|||
143485324|NCT01964352|517322799|FG000|Overall Study|Adverse Event|13|||
143485325|NCT01964352|517322800|FG001|Overall Study|Adverse Event|3|||
143485326|NCT01964352|517322801|FG002|Overall Study|Adverse Event|4|||
143485327|NCT01964352|517322802|FG003|Overall Study|Adverse Event|3|||
143485328|NCT01964352|517322799|FG000|Overall Study|Lack of Efficacy|6|||
143485329|NCT01964352|517322800|FG001|Overall Study|Lack of Efficacy|0|||
143485330|NCT01964352|517322801|FG002|Overall Study|Lack of Efficacy|0|||
143485331|NCT01964352|517322802|FG003|Overall Study|Lack of Efficacy|0|||
143485332|NCT01964352|517322799|FG000|Overall Study|Protocol Violation|2|||
143485333|NCT01964352|517322800|FG001|Overall Study|Protocol Violation|4|||
143485334|NCT01964352|517322801|FG002|Overall Study|Protocol Violation|0|||
143485335|NCT01964352|517322802|FG003|Overall Study|Protocol Violation|2|||
143485336|NCT01964352|517322799|FG000|Overall Study|Lost to Follow-up|1|||
143485337|NCT01964352|517322800|FG001|Overall Study|Lost to Follow-up|0|||
143485338|NCT01964352|517322801|FG002|Overall Study|Lost to Follow-up|0|||
143485339|NCT01964352|517322802|FG003|Overall Study|Lost to Follow-up|1|||
143485340|NCT01964352|517322799|FG000|Overall Study|Withdrawal by Subject|4|||
143485341|NCT01964352|517322800|FG001|Overall Study|Withdrawal by Subject|2|||
143485342|NCT01964352|517322801|FG002|Overall Study|Withdrawal by Subject|1|||
143485343|NCT01964352|517322802|FG003|Overall Study|Withdrawal by Subject|0|||
143485344|NCT01964352|517322799|FG000|Overall Study|Other than stated above|0|||
143485345|NCT01964352|517322800|FG001|Overall Study|Other than stated above|2|||
143485346|NCT01964352|517322801|FG002|Overall Study|Other than stated above|1|||
143485347|NCT01964352|517322802|FG003|Overall Study|Other than stated above|2|||
143016119|NCT03118765|515601052|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
143152818|NCT02029443|516104162|FG003|Overall Study|Started other anti-cancer therapy|9|||
143152819|NCT02029443|516104163|FG004|Overall Study|Started other anti-cancer therapy|3|||
143152820|NCT02029443|516104159|FG000|Overall Study|Withdrawal by Subject|3|||
143152821|NCT02029443|516104160|FG001|Overall Study|Withdrawal by Subject|1|||
143152822|NCT02029443|516104161|FG002|Overall Study|Withdrawal by Subject|1|||
143152823|NCT02029443|516104162|FG003|Overall Study|Withdrawal by Subject|1|||
143152824|NCT02029443|516104163|FG004|Overall Study|Withdrawal by Subject|0|||
143152825|NCT02029443|516104159|FG000|Overall Study|Other|6|||
143152826|NCT02029443|516104160|FG001|Overall Study|Other|6|||
143152827|NCT02029443|516104161|FG002|Overall Study|Other|4|||
143152828|NCT02029443|516104162|FG003|Overall Study|Other|2|||
143152829|NCT02029443|516104163|FG004|Overall Study|Other|0|||
143152831|NCT05630755|516104167|FG000|Overall Study|Lost to Follow-up|7|||
143152832|NCT05630755|516104168|FG001|Overall Study|Lost to Follow-up|0|||
143152833|NCT05630755|516104167|FG000|Overall Study|Randomized by Mistake Without Study Treatment|1|||
143152834|NCT05630755|516104168|FG001|Overall Study|Randomized by Mistake Without Study Treatment|0|||
143152835|NCT05630755|516104167|FG000|Overall Study|Withdrawal by Subject|9|||
143152836|NCT05630755|516104168|FG001|Overall Study|Withdrawal by Subject|3|||
143152837|NCT05630755|516104167|FG000|Overall Study|Participant moved away from trial site|0|||
143152838|NCT05630755|516104168|FG001|Overall Study|Participant moved away from trial site|1|||
143152839|NCT05630755|516104167|FG000|Overall Study|Status not Recorded|316|||
143152840|NCT05630755|516104168|FG001|Overall Study|Status not Recorded|161|||
143485348|NCT03468855|517322803|FG000|Overall Study|Adverse Event|2|||
143485349|NCT03468855|517322803|FG000|Overall Study|Lost to Follow-up|5|||
143485350|NCT03468855|517322803|FG000|Overall Study|Withdrawal by Subject|3|||
143485351|NCT03468855|517322803|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
143016120|NCT03118765|515601053|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
143152841|NCT05950906|516104169|FG000|Overall Study|Adverse Event|0|||
143152842|NCT05950906|516104170|FG001|Overall Study|Adverse Event|0|||
143152843|NCT05950906|516104171|FG002|Overall Study|Adverse Event|0|||
143152844|NCT05950906|516104172|FG003|Overall Study|Adverse Event|0|||
143485352|NCT01394939|517322804|FG000|Overall Study|Adverse Event|1|||
143485353|NCT01394939|517322805|FG001|Overall Study|Adverse Event|3|||
143485354|NCT01394939|517322806|FG002|Overall Study|Adverse Event|0|||
143485355|NCT01394939|517322807|FG003|Overall Study|Adverse Event|2|||
143016121|NCT03118765|515601049|FG000|Overall Study|COPD Exacerbation|1|||
143016122|NCT03118765|515601050|FG001|Overall Study|COPD Exacerbation|0|||
143016123|NCT03118765|515601051|FG002|Overall Study|COPD Exacerbation|0|||
143016124|NCT03118765|515601052|FG003|Overall Study|COPD Exacerbation|1|||
143016125|NCT03118765|515601053|FG004|Overall Study|COPD Exacerbation|0|||
143016126|NCT03118765|515601049|FG000|Overall Study|Lost to Follow-up|1|||
143016127|NCT03118765|515601050|FG001|Overall Study|Lost to Follow-up|0|||
143016128|NCT03118765|515601051|FG002|Overall Study|Lost to Follow-up|1|||
143016129|NCT03118765|515601052|FG003|Overall Study|Lost to Follow-up|0|||
143016130|NCT03118765|515601053|FG004|Overall Study|Lost to Follow-up|0|||
143016131|NCT03118765|515601049|FG000|Overall Study|Sponsor Decision|1|||
143235157|NCT04225897|516413526|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
143485356|NCT01394939|517322804|FG000|Overall Study|Death|0|||
143016132|NCT03118765|515601050|FG001|Overall Study|Sponsor Decision|0|||
143016133|NCT03118765|515601051|FG002|Overall Study|Sponsor Decision|1|||
143016134|NCT03118765|515601052|FG003|Overall Study|Sponsor Decision|0|||
143016135|NCT03118765|515601053|FG004|Overall Study|Sponsor Decision|1|||
143016136|NCT02164539|515601054|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
143016137|NCT02164539|515601055|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
143016138|NCT02164539|515601056|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
143016139|NCT02164539|515601057|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
143016140|NCT02164539|515601058|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
143016141|NCT02164539|515601059|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
143016142|NCT02164539|515601060|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
143016143|NCT02164539|515601054|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
143016144|NCT02164539|515601055|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
143016145|NCT02164539|515601056|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
143016146|NCT02164539|515601057|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
143016147|NCT02164539|515601058|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
143016148|NCT02164539|515601059|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
143016149|NCT02164539|515601060|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
143016150|NCT02164539|515601054|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
143016151|NCT02164539|515601055|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
143016152|NCT02164539|515601056|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
143016153|NCT02164539|515601057|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
143016154|NCT02164539|515601058|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
143016155|NCT02164539|515601059|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
143016156|NCT02164539|515601060|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
143016157|NCT02164539|515601054|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
143016158|NCT02164539|515601055|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
143016159|NCT02164539|515601056|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
143016160|NCT02164539|515601057|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
143016161|NCT02164539|515601058|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
143016162|NCT02164539|515601059|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
143016163|NCT02164539|515601060|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
143016164|NCT02164539|515601054|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
143016165|NCT02164539|515601055|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
143016166|NCT02164539|515601056|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
143016167|NCT02164539|515601057|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
143016168|NCT02164539|515601058|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
143016169|NCT02164539|515601059|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
143016170|NCT02164539|515601060|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
143016171|NCT02164539|515601054|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
143016172|NCT02164539|515601055|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
143016173|NCT02164539|515601056|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
143016174|NCT02164539|515601057|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
143016175|NCT02164539|515601058|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
143016176|NCT02164539|515601059|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
143016177|NCT02164539|515601060|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
143016178|NCT02643966|515601061|FG000|First Screening Round|ineligible|1|||
143016179|NCT02643966|515601061|FG000|First Screening Round|excluded from analysis|2|||
143016180|NCT02643966|515601061|FG000|First Screening Round|Lost to Follow-up|56|||
143016181|NCT02643966|515601061|FG000|First Screening Round|Withdrawal by Subject|28|||
143016182|NCT02643966|515601061|FG000|First Screening Round|Death|1|||
143016183|NCT02643966|515601061|FG000|Between First and Second Screening|Lost to Follow-up|65|||
143016184|NCT02643966|515601061|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
143016185|NCT02643966|515601061|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
143016186|NCT02643966|515601061|FG000|Second Screening Round|Withdrawal by Subject|20|||
143016187|NCT02643966|515601061|FG000|Second Screening Round|Lost to Follow-up|57|||
143016188|NCT02643966|515601061|FG000|Second Screening Round|Physician Decision|2|||
143016189|NCT02643966|515601061|FG000|Second Screening Round|Death|4|||
143016190|NCT02643966|515601061|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
143235158|NCT04225897|516413527|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
143485357|NCT01394939|517322805|FG001|Overall Study|Death|2|||
143016191|NCT02643966|515601061|FG000|Between Second and Third Screening|Death|1|||
143016192|NCT02643966|515601061|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
143016193|NCT02643966|515601061|FG000|Third Screening Round|PI excluded|2|||
143016194|NCT02643966|515601061|FG000|Third Screening Round|Lost to Follow-up|241|||
143016195|NCT03835975|515601062|FG000|Overall Study|Lost to Follow-up|1|||
143016196|NCT03835975|515601063|FG001|Overall Study|Lost to Follow-up|1|||
143016197|NCT03835975|515601064|FG002|Overall Study|Lost to Follow-up|0|||
143016198|NCT03835975|515601065|FG003|Overall Study|Lost to Follow-up|0|||
143016199|NCT03835975|515601066|FG004|Overall Study|Lost to Follow-up|0|||
143016200|NCT03835975|515601062|FG000|Overall Study|No longer met eligibility criteria|0|||
143016201|NCT03835975|515601063|FG001|Overall Study|No longer met eligibility criteria|1|||
143016202|NCT03835975|515601064|FG002|Overall Study|No longer met eligibility criteria|0|||
143016203|NCT03835975|515601065|FG003|Overall Study|No longer met eligibility criteria|0|||
143016204|NCT03835975|515601066|FG004|Overall Study|No longer met eligibility criteria|0|||
143016205|NCT03835975|515601062|FG000|Overall Study|Protocol Violation|1|||
143016206|NCT03835975|515601063|FG001|Overall Study|Protocol Violation|1|||
143016207|NCT03835975|515601064|FG002|Overall Study|Protocol Violation|2|||
143016208|NCT03835975|515601065|FG003|Overall Study|Protocol Violation|0|||
143016209|NCT03835975|515601066|FG004|Overall Study|Protocol Violation|0|||
143016210|NCT03835975|515601062|FG000|Overall Study|Withdrawal by Subject|1|||
143016211|NCT03835975|515601063|FG001|Overall Study|Withdrawal by Subject|0|||
143016212|NCT03835975|515601064|FG002|Overall Study|Withdrawal by Subject|1|||
143016213|NCT03835975|515601065|FG003|Overall Study|Withdrawal by Subject|1|||
143016214|NCT03835975|515601066|FG004|Overall Study|Withdrawal by Subject|0|||
143016215|NCT01612702|515601069|FG000|Overall Study|Protocol Violation|11|||
143016216|NCT01612702|515601070|FG001|Overall Study|Protocol Violation|11|||
143016217|NCT03636542|515601071|FG000|Overall Study|Lost to Follow-up|1|||
143016218|NCT03636542|515601072|FG001|Overall Study|Lost to Follow-up|1|||
143016219|NCT03636542|515601071|FG000|Overall Study|Physician Decision|0|||
143016220|NCT03636542|515601072|FG001|Overall Study|Physician Decision|1|||
143152845|NCT05950906|516104173|FG004|Overall Study|Adverse Event|0|||
143152846|NCT05950906|516104174|FG005|Overall Study|Adverse Event|0|||
143152847|NCT05950906|516104175|FG006|Overall Study|Adverse Event|0|||
143152848|NCT05950906|516104176|FG007|Overall Study|Adverse Event|0|||
143152849|NCT05950906|516104177|FG008|Overall Study|Adverse Event|0|||
143152850|NCT05950906|516104178|FG009|Overall Study|Adverse Event|0|||
143152851|NCT05950906|516104179|FG010|Overall Study|Adverse Event|0|||
143152852|NCT05950906|516104180|FG011|Overall Study|Adverse Event|0|||
143152853|NCT05950906|516104181|FG012|Overall Study|Adverse Event|1|||
143152854|NCT05950906|516104182|FG013|Overall Study|Adverse Event|0|||
143152855|NCT05950906|516104169|FG000|Overall Study|Physician Decision|0|||
143152856|NCT05950906|516104170|FG001|Overall Study|Physician Decision|0|||
143152857|NCT05950906|516104171|FG002|Overall Study|Physician Decision|0|||
143152858|NCT05950906|516104172|FG003|Overall Study|Physician Decision|0|||
143152859|NCT05950906|516104173|FG004|Overall Study|Physician Decision|0|||
143152860|NCT05950906|516104174|FG005|Overall Study|Physician Decision|0|||
143152861|NCT05950906|516104175|FG006|Overall Study|Physician Decision|0|||
143152862|NCT05950906|516104176|FG007|Overall Study|Physician Decision|0|||
143152863|NCT05950906|516104177|FG008|Overall Study|Physician Decision|0|||
143152864|NCT05950906|516104178|FG009|Overall Study|Physician Decision|0|||
143152865|NCT05950906|516104179|FG010|Overall Study|Physician Decision|0|||
143152866|NCT05950906|516104180|FG011|Overall Study|Physician Decision|0|||
143152867|NCT05950906|516104181|FG012|Overall Study|Physician Decision|1|||
143152868|NCT05950906|516104182|FG013|Overall Study|Physician Decision|0|||
143152869|NCT04868682|516104183|FG000|Post-treatment|Lost to Follow-up|1|||
143152870|NCT04868682|516104184|FG001|Post-treatment|Lost to Follow-up|1|||
143152871|NCT04868682|516104183|FG000|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|1|||
143152872|NCT04868682|516104184|FG001|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|2|||
143152873|NCT04868682|516104183|FG000|Six-month Assessment|Lost to Follow-up|1|||
143152874|NCT04868682|516104184|FG001|Six-month Assessment|Lost to Follow-up|0|||
143152875|NCT04868682|516104183|FG000|Six-month Assessment|Death|1|||
143235159|NCT04225897|516413528|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
143235160|NCT04225897|516413529|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
143152876|NCT04868682|516104184|FG001|Six-month Assessment|Death|0|||
143152877|NCT04868682|516104183|FG000|Six-month Assessment|Refused|0|||
143235161|NCT04225897|516413518|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
143235162|NCT04225897|516413519|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
143152878|NCT04868682|516104184|FG001|Six-month Assessment|Refused|1|||
143152879|NCT04868682|516104183|FG000|12-month Assessment|Lost to Follow-up|2|||
143016221|NCT03636542|515601071|FG000|Overall Study|Withdrawal by Subject|1|||
143016222|NCT03636542|515601072|FG001|Overall Study|Withdrawal by Subject|0|||
143016223|NCT03070431|515601073|FG000|Overall Study|Withdrawal by Subject|2|||
143016224|NCT03070431|515601073|FG000|Overall Study|Lost to Follow-up|2|||
143016225|NCT01542736|515601076|FG000|Overall Study|Death|1|||
143016226|NCT03674827|515601077|FG000|Treatment Phase|Adverse Event|0|||
143016227|NCT03674827|515601078|FG001|Treatment Phase|Adverse Event|0|||
143016228|NCT03674827|515601079|FG002|Treatment Phase|Adverse Event|0|||
143016229|NCT03674827|515601080|FG003|Treatment Phase|Adverse Event|0|||
143016230|NCT03674827|515601081|FG004|Treatment Phase|Adverse Event|0|||
143016231|NCT03674827|515601082|FG005|Treatment Phase|Adverse Event|2|||
143016232|NCT03674827|515601077|FG000|Treatment Phase|Death|2|||
143016233|NCT03674827|515601078|FG001|Treatment Phase|Death|0|||
143016234|NCT03674827|515601079|FG002|Treatment Phase|Death|0|||
143016235|NCT03674827|515601080|FG003|Treatment Phase|Death|0|||
143016236|NCT03674827|515601081|FG004|Treatment Phase|Death|1|||
143016237|NCT03674827|515601082|FG005|Treatment Phase|Death|0|||
143016238|NCT03674827|515601077|FG000|Treatment Phase|Progressive Disease|0|||
143485358|NCT01394939|517322806|FG002|Overall Study|Death|0|||
143485359|NCT01394939|517322807|FG003|Overall Study|Death|0|||
143485360|NCT01394939|517322804|FG000|Overall Study|Physician Decision|0|||
143485361|NCT01394939|517322805|FG001|Overall Study|Physician Decision|1|||
143485362|NCT01394939|517322806|FG002|Overall Study|Physician Decision|0|||
143485363|NCT01394939|517322807|FG003|Overall Study|Physician Decision|0|||
143485364|NCT01394939|517322804|FG000|Overall Study|Withdrawal by Subject|0|||
143485365|NCT01394939|517322805|FG001|Overall Study|Withdrawal by Subject|2|||
143485366|NCT01394939|517322806|FG002|Overall Study|Withdrawal by Subject|0|||
143485367|NCT01394939|517322807|FG003|Overall Study|Withdrawal by Subject|2|||
143485368|NCT01394939|517322804|FG000|Overall Study|Others|0|||
143485369|NCT01394939|517322805|FG001|Overall Study|Others|2|||
143485370|NCT01394939|517322806|FG002|Overall Study|Others|0|||
143485371|NCT01394939|517322807|FG003|Overall Study|Others|3|||
143485372|NCT02831673|517322809|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
143485373|NCT02831673|517322810|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
143485374|NCT02831673|517322811|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
143485375|NCT02831673|517322812|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
143485376|NCT02831673|517322813|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
143016239|NCT03674827|515601078|FG001|Treatment Phase|Progressive Disease|4|||
143016240|NCT03674827|515601079|FG002|Treatment Phase|Progressive Disease|3|||
143016241|NCT03674827|515601080|FG003|Treatment Phase|Progressive Disease|4|||
143016242|NCT03674827|515601081|FG004|Treatment Phase|Progressive Disease|4|||
143016243|NCT03674827|515601082|FG005|Treatment Phase|Progressive Disease|9|||
143016244|NCT03674827|515601077|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
143016245|NCT03674827|515601078|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
143016246|NCT03674827|515601079|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
143016247|NCT03674827|515601080|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
143016248|NCT03674827|515601081|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
143016249|NCT03674827|515601082|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
143016250|NCT03674827|515601077|FG000|Treatment Phase|Withdrawal by Subject|0|||
143016251|NCT03674827|515601078|FG001|Treatment Phase|Withdrawal by Subject|0|||
143016252|NCT03674827|515601079|FG002|Treatment Phase|Withdrawal by Subject|0|||
143016253|NCT03674827|515601080|FG003|Treatment Phase|Withdrawal by Subject|0|||
143016254|NCT03674827|515601081|FG004|Treatment Phase|Withdrawal by Subject|0|||
143016255|NCT03674827|515601082|FG005|Treatment Phase|Withdrawal by Subject|1|||
143016256|NCT03674827|515601077|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
143016257|NCT03674827|515601078|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
143016258|NCT03674827|515601079|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
143016259|NCT03674827|515601080|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
143016260|NCT03674827|515601081|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
143016261|NCT03674827|515601082|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
143016262|NCT03674827|515601077|FG000|Treatment Phase|Other|0|||
143016263|NCT03674827|515601078|FG001|Treatment Phase|Other|1|||
143016264|NCT03674827|515601079|FG002|Treatment Phase|Other|0|||
143016265|NCT03674827|515601080|FG003|Treatment Phase|Other|0|||
143016266|NCT03674827|515601081|FG004|Treatment Phase|Other|0|||
143152880|NCT04868682|516104184|FG001|12-month Assessment|Lost to Follow-up|1|||
143152881|NCT04868682|516104183|FG000|12-month Assessment|Death|0|||
143152882|NCT04868682|516104184|FG001|12-month Assessment|Death|1|||
143016267|NCT03674827|515601082|FG005|Treatment Phase|Other|1|||
143485377|NCT02831673|517322809|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
143485378|NCT02831673|517322810|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
143016268|NCT03674827|515601077|FG000|Long-Term Follow-up Phase|Death|2|||
143016269|NCT03674827|515601078|FG001|Long-Term Follow-up Phase|Death|4|||
143016270|NCT03674827|515601079|FG002|Long-Term Follow-up Phase|Death|2|||
143016271|NCT03674827|515601080|FG003|Long-Term Follow-up Phase|Death|3|||
143016272|NCT03674827|515601081|FG004|Long-Term Follow-up Phase|Death|2|||
143016273|NCT03674827|515601082|FG005|Long-Term Follow-up Phase|Death|6|||
143016274|NCT03674827|515601077|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
143016275|NCT03674827|515601078|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
143016276|NCT03674827|515601079|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
143016277|NCT03674827|515601080|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
143016278|NCT03674827|515601081|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
143016279|NCT03674827|515601082|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
143016280|NCT03674827|515601077|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
143016281|NCT03674827|515601078|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
143016282|NCT03674827|515601079|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
143016283|NCT03674827|515601080|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
143016284|NCT03674827|515601081|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
143016285|NCT03674827|515601082|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
143016286|NCT00527397|515601083|FG000|Overall Study|Adverse Event|3|||
143016287|NCT00527397|515601083|FG000|Overall Study|Lack of Efficacy|1|||
143016288|NCT00527397|515601083|FG000|Overall Study|Protocol Violation|1|||
143016289|NCT00527397|515601083|FG000|Overall Study|Withdrawal by Subject|6|||
143016290|NCT00527397|515601083|FG000|Overall Study|Study terminated by sponsor|13|||
143016291|NCT01783483|515601084|FG000|Overall Study|Death|3|||
143016292|NCT01783483|515601085|FG001|Overall Study|Death|3|||
143016293|NCT01783483|515601084|FG000|Overall Study|Lost to Follow-up|14|||
143016294|NCT01783483|515601085|FG001|Overall Study|Lost to Follow-up|10|||
143016295|NCT01783483|515601084|FG000|Overall Study|Withdrawal by Subject|2|||
143016296|NCT01783483|515601085|FG001|Overall Study|Withdrawal by Subject|1|||
143016297|NCT01783483|515601084|FG000|Overall Study|Physician Decision|1|||
143016298|NCT01783483|515601085|FG001|Overall Study|Physician Decision|1|||
143016299|NCT04130919|515601088|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
143016300|NCT04130919|515601089|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
143016301|NCT04130919|515601090|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
143016302|NCT04130919|515601091|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
143016303|NCT04130919|515601092|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
143016304|NCT04130919|515601093|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
143016305|NCT04130919|515601088|FG000|Blinded Treatment Phase|Adverse Event|0|||
143016306|NCT04130919|515601089|FG001|Blinded Treatment Phase|Adverse Event|0|||
143016307|NCT04130919|515601090|FG002|Blinded Treatment Phase|Adverse Event|1|||
143016308|NCT04130919|515601091|FG003|Blinded Treatment Phase|Adverse Event|0|||
143016309|NCT04130919|515601092|FG004|Blinded Treatment Phase|Adverse Event|0|||
143016310|NCT04130919|515601093|FG005|Blinded Treatment Phase|Adverse Event|0|||
143016311|NCT04130919|515601088|FG000|Blinded Treatment Phase|Disease worsening|0|||
143016312|NCT04130919|515601089|FG001|Blinded Treatment Phase|Disease worsening|0|||
143016313|NCT04130919|515601090|FG002|Blinded Treatment Phase|Disease worsening|1|||
143016314|NCT04130919|515601091|FG003|Blinded Treatment Phase|Disease worsening|0|||
143016315|NCT04130919|515601092|FG004|Blinded Treatment Phase|Disease worsening|0|||
143016316|NCT04130919|515601093|FG005|Blinded Treatment Phase|Disease worsening|0|||
143016317|NCT04130919|515601088|FG000|Blinded Treatment Phase|Investigator's decision|0|||
143016318|NCT04130919|515601089|FG001|Blinded Treatment Phase|Investigator's decision|1|||
143016319|NCT04130919|515601090|FG002|Blinded Treatment Phase|Investigator's decision|0|||
143016320|NCT04130919|515601091|FG003|Blinded Treatment Phase|Investigator's decision|0|||
143016321|NCT04130919|515601092|FG004|Blinded Treatment Phase|Investigator's decision|0|||
143016322|NCT04130919|515601093|FG005|Blinded Treatment Phase|Investigator's decision|0|||
143016323|NCT04130919|515601088|FG000|Blinded Treatment Phase|Withdrew consent|1|||
143016324|NCT04130919|515601089|FG001|Blinded Treatment Phase|Withdrew consent|0|||
143016325|NCT04130919|515601090|FG002|Blinded Treatment Phase|Withdrew consent|0|||
143016326|NCT04130919|515601091|FG003|Blinded Treatment Phase|Withdrew consent|0|||
143016327|NCT04130919|515601092|FG004|Blinded Treatment Phase|Withdrew consent|0|||
143016328|NCT04130919|515601093|FG005|Blinded Treatment Phase|Withdrew consent|0|||
143016329|NCT04130919|515601088|FG000|Open-label Treatment Phase|Withdrew consent|0|||
143016330|NCT04130919|515601089|FG001|Open-label Treatment Phase|Withdrew consent|0|||
143016331|NCT04130919|515601090|FG002|Open-label Treatment Phase|Withdrew consent|0|||
143016332|NCT04130919|515601091|FG003|Open-label Treatment Phase|Withdrew consent|1|||
143016333|NCT04130919|515601092|FG004|Open-label Treatment Phase|Withdrew consent|1|||
143016334|NCT04130919|515601093|FG005|Open-label Treatment Phase|Withdrew consent|1|||
143016335|NCT04130919|515601088|FG000|Open-label Treatment Phase|Disease worsening|0|||
143016336|NCT04130919|515601089|FG001|Open-label Treatment Phase|Disease worsening|0|||
143016337|NCT04130919|515601090|FG002|Open-label Treatment Phase|Disease worsening|0|||
143016338|NCT04130919|515601091|FG003|Open-label Treatment Phase|Disease worsening|1|||
143016339|NCT04130919|515601092|FG004|Open-label Treatment Phase|Disease worsening|0|||
143016340|NCT04130919|515601093|FG005|Open-label Treatment Phase|Disease worsening|1|||
143485379|NCT02831673|517322811|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
143016341|NCT04130919|515601088|FG000|Open-label Treatment Phase|Investigator's decision|0|||
143016342|NCT04130919|515601089|FG001|Open-label Treatment Phase|Investigator's decision|0|||
143016343|NCT04130919|515601090|FG002|Open-label Treatment Phase|Investigator's decision|0|||
143016344|NCT04130919|515601091|FG003|Open-label Treatment Phase|Investigator's decision|1|||
143016345|NCT04130919|515601092|FG004|Open-label Treatment Phase|Investigator's decision|0|||
143016346|NCT04130919|515601093|FG005|Open-label Treatment Phase|Investigator's decision|0|||
143016347|NCT04130919|515601088|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
143016348|NCT04130919|515601089|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
143016349|NCT04130919|515601090|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
143016350|NCT04130919|515601091|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
143016351|NCT04130919|515601092|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
143016352|NCT04130919|515601093|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
143016353|NCT04130919|515601088|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
143016354|NCT04130919|515601089|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
143016355|NCT04130919|515601090|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
143016356|NCT04130919|515601091|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
143016357|NCT04130919|515601092|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
143016358|NCT04130919|515601093|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
143016359|NCT02624518|515601097|FG000|Overall Study|Physician Decision|1|||
143016360|NCT00370396|515601100|FG000|Overall Study|Withdrawal by Subject|0|||
143016361|NCT00370396|515601101|FG001|Overall Study|Withdrawal by Subject|0|||
143016362|NCT00370396|515601102|FG002|Overall Study|Withdrawal by Subject|1|||
143016363|NCT00370396|515601100|FG000|Overall Study|Lost to Follow-up|11|||
143016364|NCT00370396|515601101|FG001|Overall Study|Lost to Follow-up|1|||
143016365|NCT00370396|515601102|FG002|Overall Study|Lost to Follow-up|0|||
143016366|NCT02065791|515601103|FG000|Overall Study|Closed Site|1|||
143016367|NCT02065791|515601104|FG001|Overall Study|Closed Site|1|||
143016368|NCT02065791|515601103|FG000|Overall Study|Withdrawal by Subject|11|||
143016369|NCT02065791|515601104|FG001|Overall Study|Withdrawal by Subject|5|||
143016370|NCT02065791|515601103|FG000|Overall Study|Lost to Follow-up|13|||
143016371|NCT02065791|515601104|FG001|Overall Study|Lost to Follow-up|9|||
143016372|NCT02400905|515601105|FG000|Overall Study|Death|24|||
143016373|NCT02400905|515601105|FG000|Overall Study|Lost to Follow-up|18|||
143016374|NCT02400905|515601105|FG000|Overall Study|Withdrawal by Subject|16|||
143016375|NCT02400905|515601105|FG000|Overall Study|Physician Decision|4|||
143016376|NCT02400905|515601105|FG000|Overall Study|Other|1|||
143235163|NCT04225897|516413520|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
143235164|NCT04225897|516413521|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
143016377|NCT00295620|515601108|FG000|Overall Study|Lost to Follow-up|9|||
143016378|NCT00295620|515601109|FG001|Overall Study|Lost to Follow-up|5|||
143016379|NCT00295620|515601108|FG000|Overall Study|Withdrawal by Subject|37|||
143016380|NCT00295620|515601109|FG001|Overall Study|Withdrawal by Subject|50|||
143016381|NCT00295620|515601108|FG000|Overall Study|Death|206|||
143016382|NCT00295620|515601109|FG001|Overall Study|Death|207|||
143016383|NCT00295620|515601108|FG000|Overall Study|Other reasons|10|||
143016384|NCT00295620|515601109|FG001|Overall Study|Other reasons|9|||
143016385|NCT00295620|515601108|FG000|Overall Study|Discontinuation by sponsor|580|||
143016386|NCT00295620|515601109|FG001|Overall Study|Discontinuation by sponsor|593|||
143016387|NCT00295620|515601108|FG000|Overall Study|Protocol Violation|30|||
143016388|NCT00295620|515601109|FG001|Overall Study|Protocol Violation|32|||
143016389|NCT01625286|515601114|FG000|Overall Study|Adverse Event|0|||
143016390|NCT01625286|515601115|FG001|Overall Study|Adverse Event|0|||
143016391|NCT01625286|515601116|FG002|Overall Study|Adverse Event|0|||
143016392|NCT01625286|515601117|FG003|Overall Study|Adverse Event|0|||
143016393|NCT01625286|515601118|FG004|Overall Study|Adverse Event|1|||
143016394|NCT01625286|515601119|FG005|Overall Study|Adverse Event|2|||
143016395|NCT01625286|515601120|FG006|Overall Study|Adverse Event|1|||
143016396|NCT01625286|515601114|FG000|Overall Study|Death|0|||
143016397|NCT01625286|515601115|FG001|Overall Study|Death|0|||
143016398|NCT01625286|515601116|FG002|Overall Study|Death|1|||
143016399|NCT01625286|515601117|FG003|Overall Study|Death|1|||
143016400|NCT01625286|515601118|FG004|Overall Study|Death|0|||
143016401|NCT01625286|515601119|FG005|Overall Study|Death|11|||
143016402|NCT01625286|515601120|FG006|Overall Study|Death|16|||
143016403|NCT01625286|515601114|FG000|Overall Study|Withdrawal by Subject|0|||
143016404|NCT01625286|515601115|FG001|Overall Study|Withdrawal by Subject|1|||
143016405|NCT01625286|515601116|FG002|Overall Study|Withdrawal by Subject|0|||
143016406|NCT01625286|515601117|FG003|Overall Study|Withdrawal by Subject|1|||
143016407|NCT01625286|515601118|FG004|Overall Study|Withdrawal by Subject|0|||
143016408|NCT01625286|515601119|FG005|Overall Study|Withdrawal by Subject|0|||
143016409|NCT01625286|515601120|FG006|Overall Study|Withdrawal by Subject|1|||
143016410|NCT01625286|515601114|FG000|Overall Study|Any reason not specifically recorded|0|||
143016411|NCT01625286|515601115|FG001|Overall Study|Any reason not specifically recorded|0|||
143016412|NCT01625286|515601116|FG002|Overall Study|Any reason not specifically recorded|0|||
143016413|NCT01625286|515601117|FG003|Overall Study|Any reason not specifically recorded|0|||
143016414|NCT01625286|515601118|FG004|Overall Study|Any reason not specifically recorded|0|||
143016415|NCT01625286|515601119|FG005|Overall Study|Any reason not specifically recorded|1|||
143016416|NCT01625286|515601120|FG006|Overall Study|Any reason not specifically recorded|0|||
143016417|NCT01625286|515601114|FG000|Overall Study|Progressive disease|6|||
143016418|NCT01625286|515601115|FG001|Overall Study|Progressive disease|3|||
143016419|NCT01625286|515601116|FG002|Overall Study|Progressive disease|4|||
143016420|NCT01625286|515601117|FG003|Overall Study|Progressive disease|5|||
143016421|NCT01625286|515601118|FG004|Overall Study|Progressive disease|5|||
143016422|NCT01625286|515601119|FG005|Overall Study|Progressive disease|0|||
143016423|NCT01625286|515601120|FG006|Overall Study|Progressive disease|0|||
143016424|NCT01625286|515601114|FG000|Overall Study|Lost to Follow-up|0|||
143016425|NCT01625286|515601115|FG001|Overall Study|Lost to Follow-up|0|||
143016426|NCT01625286|515601116|FG002|Overall Study|Lost to Follow-up|0|||
143016427|NCT01625286|515601117|FG003|Overall Study|Lost to Follow-up|0|||
143016428|NCT01625286|515601118|FG004|Overall Study|Lost to Follow-up|0|||
143016429|NCT01625286|515601119|FG005|Overall Study|Lost to Follow-up|0|||
143016430|NCT01625286|515601120|FG006|Overall Study|Lost to Follow-up|1|||
143016431|NCT01861717|515601126|FG000|Overall Study|Lost to Follow-up|1|||
143016432|NCT01861717|515601126|FG000|Overall Study|Withdrawal by Subject|1|||
143016433|NCT02598622|515602655|FG000|Overall Study|Withdrawal by Subject|3|||
143485380|NCT02831673|517322812|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
143485381|NCT02831673|517322813|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
143016434|NCT02598622|515602656|FG001|Overall Study|Withdrawal by Subject|0|||
143235165|NCT04225897|516413522|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
143485382|NCT02831673|517322809|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
143016435|NCT02598622|515602655|FG000|Overall Study|Physician Decision|3|||
143016436|NCT02598622|515602656|FG001|Overall Study|Physician Decision|0|||
143016437|NCT00681824|515602660|FG000|Overall Study|withdrawn by investigator|0|||
143016438|NCT00681824|515602661|FG001|Overall Study|withdrawn by investigator|0|||
143016439|NCT00681824|515602662|FG002|Overall Study|withdrawn by investigator|1|||
143016440|NCT00681824|515602660|FG000|Overall Study|scheduling conflict|1|||
143016441|NCT00681824|515602661|FG001|Overall Study|scheduling conflict|0|||
143016442|NCT00681824|515602662|FG002|Overall Study|scheduling conflict|0|||
143016443|NCT00681824|515602660|FG000|Overall Study|Death|0|||
143016444|NCT00681824|515602661|FG001|Overall Study|Death|1|||
143016445|NCT00681824|515602662|FG002|Overall Study|Death|0|||
143016446|NCT01902134|515602665|FG000|Overall Study|Adverse Event|3|||
143016447|NCT01902134|515602666|FG001|Overall Study|Adverse Event|1|||
143016448|NCT01902134|515602667|FG002|Overall Study|Adverse Event|2|||
143016449|NCT01902134|515602668|FG003|Overall Study|Adverse Event|1|||
143016450|NCT01902134|515602669|FG004|Overall Study|Adverse Event|1|||
143016451|NCT01902134|515602670|FG005|Overall Study|Adverse Event|3|||
143016452|NCT01902134|515602665|FG000|Overall Study|Lack of Efficacy|0|||
143016453|NCT01902134|515602666|FG001|Overall Study|Lack of Efficacy|0|||
143016454|NCT01902134|515602667|FG002|Overall Study|Lack of Efficacy|2|||
143016455|NCT01902134|515602668|FG003|Overall Study|Lack of Efficacy|0|||
143016456|NCT01902134|515602669|FG004|Overall Study|Lack of Efficacy|0|||
143016457|NCT01902134|515602670|FG005|Overall Study|Lack of Efficacy|1|||
143016458|NCT01902134|515602665|FG000|Overall Study|Physician Decision|0|||
143016459|NCT01902134|515602666|FG001|Overall Study|Physician Decision|1|||
143016460|NCT01902134|515602667|FG002|Overall Study|Physician Decision|0|||
143016461|NCT01902134|515602668|FG003|Overall Study|Physician Decision|0|||
143016462|NCT01902134|515602669|FG004|Overall Study|Physician Decision|0|||
143016463|NCT01902134|515602670|FG005|Overall Study|Physician Decision|0|||
143016464|NCT01902134|515602665|FG000|Overall Study|Protocol Violation|0|||
143016465|NCT01902134|515602666|FG001|Overall Study|Protocol Violation|0|||
143016466|NCT01902134|515602667|FG002|Overall Study|Protocol Violation|0|||
143016467|NCT01902134|515602668|FG003|Overall Study|Protocol Violation|0|||
143016468|NCT01902134|515602669|FG004|Overall Study|Protocol Violation|0|||
143016469|NCT01902134|515602670|FG005|Overall Study|Protocol Violation|1|||
143016470|NCT01902134|515602665|FG000|Overall Study|Withdrawal by Subject|4|||
143016471|NCT01902134|515602666|FG001|Overall Study|Withdrawal by Subject|8|||
143016472|NCT01902134|515602667|FG002|Overall Study|Withdrawal by Subject|9|||
143016473|NCT01902134|515602668|FG003|Overall Study|Withdrawal by Subject|1|||
143016474|NCT01902134|515602669|FG004|Overall Study|Withdrawal by Subject|5|||
143016475|NCT01902134|515602670|FG005|Overall Study|Withdrawal by Subject|4|||
143016476|NCT01902134|515602665|FG000|Overall Study|no compliance|1|||
143485383|NCT02831673|517322810|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
143016477|NCT01902134|515602666|FG001|Overall Study|no compliance|0|||
143016478|NCT01902134|515602667|FG002|Overall Study|no compliance|0|||
143016479|NCT01902134|515602668|FG003|Overall Study|no compliance|0|||
143016480|NCT01902134|515602669|FG004|Overall Study|no compliance|0|||
143016481|NCT01902134|515602670|FG005|Overall Study|no compliance|0|||
143016482|NCT01902134|515602665|FG000|Overall Study|Other|0|||
143016483|NCT01902134|515602666|FG001|Overall Study|Other|1|||
143016484|NCT01902134|515602667|FG002|Overall Study|Other|2|||
143016485|NCT01902134|515602668|FG003|Overall Study|Other|0|||
143016486|NCT01902134|515602669|FG004|Overall Study|Other|1|||
143016487|NCT01902134|515602670|FG005|Overall Study|Other|0|||
143016488|NCT00305110|515602671|FG000|Overall Study|Missing data|29|||
143235166|NCT04225897|516413523|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
143235167|NCT04225897|516413524|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
143235168|NCT04225897|516413525|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
143235169|NCT04225897|516413526|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
143235170|NCT04225897|516413527|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
143235171|NCT04225897|516413528|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
143235172|NCT04225897|516413529|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
143235173|NCT04225897|516413518|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
143485384|NCT02831673|517322811|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
143485385|NCT02831673|517322812|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
143485386|NCT02831673|517322813|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
143485387|NCT02831673|517322809|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
143485388|NCT02831673|517322810|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
143485389|NCT02831673|517322811|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
143485390|NCT02831673|517322812|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
143485391|NCT02831673|517322813|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
143016489|NCT00678379|515602672|FG000|Overall Study|Injection performed after tonsillectomy|2|||
143016490|NCT00678379|515602673|FG001|Overall Study|Injection performed after tonsillectomy|0|||
143016491|NCT00678379|515602674|FG002|Overall Study|Injection performed after tonsillectomy|1|||
143016492|NCT00678379|515602672|FG000|Overall Study|Incomplete Data|4|||
143016493|NCT00678379|515602673|FG001|Overall Study|Incomplete Data|3|||
143016494|NCT00678379|515602674|FG002|Overall Study|Incomplete Data|3|||
143016495|NCT01272193|515602675|FG000|Overall Study|Adverse Event|1|||
143016496|NCT01272193|515602676|FG001|Overall Study|Adverse Event|1|||
143016497|NCT01272193|515602675|FG000|Overall Study|Lack of Efficacy|0|||
143016498|NCT01272193|515602676|FG001|Overall Study|Lack of Efficacy|3|||
143016499|NCT01272193|515602675|FG000|Overall Study|Withdrawal Criteria|1|||
143016500|NCT01272193|515602676|FG001|Overall Study|Withdrawal Criteria|1|||
143016501|NCT01272193|515602675|FG000|Overall Study|Unclassified|8|||
143016502|NCT01272193|515602676|FG001|Overall Study|Unclassified|7|||
143016503|NCT01440647|515602679|FG000|Overall Study|Death|2|||
143016504|NCT01440647|515602680|FG001|Overall Study|Death|3|||
143016505|NCT01637961|515602687|FG000|Overall Study|Ineligible: wrong primary|1|||
143016506|NCT01637961|515602687|FG000|Overall Study|Ineligible: inadequate pathology|1|||
143016507|NCT03101293|515602688|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
143016508|NCT03101293|515602689|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
143016509|NCT03451331|515602696|FG000|Overall Study|Withdrawal by Subject|1|||
143016510|NCT03451331|515602697|FG001|Overall Study|Withdrawal by Subject|0|||
143016511|NCT03451331|515602696|FG000|Overall Study|Unable to start treatment.|1|||
143016512|NCT03451331|515602697|FG001|Overall Study|Unable to start treatment.|1|||
143016513|NCT02773446|515602698|FG000|First Admission|Withdrawal by Subject|0|||
143016514|NCT02773446|515602699|FG001|First Admission|Withdrawal by Subject|0|||
143016515|NCT02773446|515602700|FG002|First Admission|Withdrawal by Subject|0|||
143016516|NCT02773446|515602701|FG003|First Admission|Withdrawal by Subject|1|||
143016517|NCT02773446|515602702|FG004|First Admission|Withdrawal by Subject|0|||
143016518|NCT02773446|515602703|FG005|First Admission|Withdrawal by Subject|0|||
143016519|NCT02773446|515602698|FG000|First Admission|Lost to Follow-up|1|||
143016520|NCT02773446|515602699|FG001|First Admission|Lost to Follow-up|0|||
143016521|NCT02773446|515602700|FG002|First Admission|Lost to Follow-up|0|||
143016522|NCT02773446|515602701|FG003|First Admission|Lost to Follow-up|0|||
143016523|NCT02773446|515602702|FG004|First Admission|Lost to Follow-up|0|||
143016524|NCT02773446|515602703|FG005|First Admission|Lost to Follow-up|0|||
143016525|NCT00289731|515602704|FG000|Overall Study|Adverse Event|1|||
143016526|NCT00289731|515602705|FG001|Overall Study|Adverse Event|2|||
143016527|NCT00289731|515602706|FG002|Overall Study|Adverse Event|2|||
143016528|NCT00289731|515602704|FG000|Overall Study|Other|1|||
143016529|NCT00289731|515602705|FG001|Overall Study|Other|0|||
143016530|NCT00289731|515602706|FG002|Overall Study|Other|0|||
143016531|NCT04023994|515602707|FG000|Overall Study|Lost to Follow-up|0|||
143016532|NCT04023994|515602708|FG001|Overall Study|Lost to Follow-up|1|||
143016533|NCT04023994|515602709|FG002|Overall Study|Lost to Follow-up|2|||
143016534|NCT04023994|515602710|FG003|Overall Study|Lost to Follow-up|0|||
143016535|NCT04023994|515602711|FG004|Overall Study|Lost to Follow-up|0|||
143016536|NCT04023994|515602712|FG005|Overall Study|Lost to Follow-up|0|||
143016537|NCT04023994|515602707|FG000|Overall Study|Withdrawal by Subject|0|||
143016538|NCT04023994|515602708|FG001|Overall Study|Withdrawal by Subject|0|||
143016539|NCT04023994|515602709|FG002|Overall Study|Withdrawal by Subject|0|||
143016540|NCT04023994|515602710|FG003|Overall Study|Withdrawal by Subject|1|||
143016541|NCT04023994|515602711|FG004|Overall Study|Withdrawal by Subject|0|||
143016542|NCT04023994|515602712|FG005|Overall Study|Withdrawal by Subject|0|||
143016543|NCT01613131|515602713|FG000|Overall Study|Withdrawal by Subject|3|||
143016544|NCT01613131|515602714|FG001|Overall Study|Withdrawal by Subject|5|||
143016545|NCT01017029|515602715|FG000|Overall Study|Lost to Follow-up|1|||
143016546|NCT01017029|515602716|FG001|Overall Study|Lost to Follow-up|0|||
143016547|NCT01017029|515602715|FG000|Overall Study|Administrative problem|0|||
143016548|NCT01017029|515602716|FG001|Overall Study|Administrative problem|1|||
143016549|NCT01017029|515602715|FG000|Overall Study|Death|3|||
143016550|NCT01017029|515602716|FG001|Overall Study|Death|1|||
143016551|NCT00736333|515602719|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
143016552|NCT00736333|515602719|FG000|Overall Study|Data Missing|2|||
143016553|NCT00736333|515602719|FG000|Overall Study|Tumor Progression|75|||
143016554|NCT00736333|515602719|FG000|Overall Study|Toxicity|6|||
143016555|NCT00736333|515602719|FG000|Overall Study|Withdrawal by Subject|10|||
143016556|NCT00736333|515602719|FG000|Overall Study|Death|7|||
143016557|NCT00736333|515602719|FG000|Overall Study|Other|4|||
143016558|NCT04991311|515602720|FG000|Overall Study|Adverse Event|1|||
143016559|NCT03876873|515602723|FG000|Overall Study|Physician Decision|0|||
143016560|NCT03876873|515602724|FG001|Overall Study|Physician Decision|1|||
143016561|NCT02117479|515602726|FG000|Overall Study|Death|13|||
143016562|NCT02117479|515602727|FG001|Overall Study|Death|8|||
143016563|NCT02117479|515602726|FG000|Overall Study|Adverse Event|8|||
143016564|NCT02117479|515602727|FG001|Overall Study|Adverse Event|16|||
143016565|NCT02117479|515602726|FG000|Overall Study|Subject decision|8|||
143016566|NCT02117479|515602727|FG001|Overall Study|Subject decision|9|||
143016567|NCT02117479|515602726|FG000|Overall Study|Disease progression|104|||
143016568|NCT02117479|515602727|FG001|Overall Study|Disease progression|108|||
143016569|NCT02117479|515602726|FG000|Overall Study|Noncompliance with study treatment|1|||
143016570|NCT02117479|515602727|FG001|Overall Study|Noncompliance with study treatment|0|||
143016571|NCT02117479|515602726|FG000|Overall Study|Study terminated by the sponsor|4|||
143016572|NCT02117479|515602727|FG001|Overall Study|Study terminated by the sponsor|6|||
143016573|NCT02117479|515602726|FG000|Overall Study|Physician Decision|7|||
143016574|NCT02117479|515602727|FG001|Overall Study|Physician Decision|2|||
143016575|NCT02117479|515602726|FG000|Overall Study|Other unspecified|11|||
143016576|NCT02117479|515602727|FG001|Overall Study|Other unspecified|7|||
143016577|NCT01453374|515602730|FG000|Overall Study|Adverse Event|7|||
143016578|NCT01453374|515602730|FG000|Overall Study|Lack of Efficacy|1|||
143016579|NCT01453374|515602730|FG000|Overall Study|Lost to Follow-up|3|||
143016580|NCT01453374|515602730|FG000|Overall Study|Withdrawal by Subject|5|||
143016581|NCT01453374|515602730|FG000|Overall Study|Incarcerated|2|||
143016582|NCT01223196|515602731|FG000|Overall Study|Lost to Follow-up|2|||
143016583|NCT01223196|515602732|FG001|Overall Study|Lost to Follow-up|0|||
143016584|NCT01223196|515602731|FG000|Overall Study|Physician Decision|1|||
143016585|NCT01223196|515602732|FG001|Overall Study|Physician Decision|0|||
143016586|NCT01223196|515602731|FG000|Overall Study|Withdrawal by Subject|1|||
143016587|NCT01223196|515602732|FG001|Overall Study|Withdrawal by Subject|0|||
143016588|NCT01238822|515602735|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
143016589|NCT01462695|515602743|FG000|Overall Study|Adverse Event|1|||
143016590|NCT01462695|515602744|FG001|Overall Study|Adverse Event|1|||
143016591|NCT01462695|515602743|FG000|Overall Study|Death|2|||
143016592|NCT01462695|515602744|FG001|Overall Study|Death|0|||
143016593|NCT01462695|515602743|FG000|Overall Study|Lack of Efficacy|6|||
143016594|NCT01462695|515602744|FG001|Overall Study|Lack of Efficacy|12|||
143016595|NCT01462695|515602743|FG000|Overall Study|Physician Decision|5|||
143016596|NCT01462695|515602744|FG001|Overall Study|Physician Decision|0|||
143016597|NCT01462695|515602743|FG000|Overall Study|Withdrawal by Subject|2|||
143016598|NCT01462695|515602744|FG001|Overall Study|Withdrawal by Subject|0|||
143016599|NCT01462695|515602743|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
143016600|NCT01462695|515602744|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
143016601|NCT00061945|515602746|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
143016602|NCT00061945|515602747|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
143016603|NCT00061945|515602746|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
143016604|NCT00061945|515602747|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
143016605|NCT00061945|515602746|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
143016606|NCT00061945|515602747|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
143016607|NCT00061945|515602746|FG000|Course IV: Alemtuzumab|Early exits|6|||
143016608|NCT00061945|515602747|FG001|Course IV: Alemtuzumab|Early exits|15|||
143016609|NCT01039584|515602748|FG000|Overall Study|Withdrawal by Subject|4|||
143016610|NCT01039584|515602749|FG001|Overall Study|Withdrawal by Subject|2|||
143016611|NCT01039584|515602750|FG002|Overall Study|Withdrawal by Subject|1|||
143016612|NCT01039584|515602748|FG000|Overall Study|Protocol Violation|10|||
143016613|NCT01039584|515602749|FG001|Overall Study|Protocol Violation|4|||
143016614|NCT01039584|515602750|FG002|Overall Study|Protocol Violation|6|||
143016615|NCT01039584|515602748|FG000|Overall Study|Lost to Follow-up|5|||
143016616|NCT01039584|515602749|FG001|Overall Study|Lost to Follow-up|3|||
143016617|NCT01039584|515602750|FG002|Overall Study|Lost to Follow-up|4|||
143016618|NCT01039584|515602748|FG000|Overall Study|Negative Baseline culture for Candida|59|||
143016619|NCT01039584|515602749|FG001|Overall Study|Negative Baseline culture for Candida|59|||
143016620|NCT01039584|515602750|FG002|Overall Study|Negative Baseline culture for Candida|24|||
143016621|NCT01039584|515602748|FG000|Overall Study|Lack of Efficacy|7|||
143016622|NCT01039584|515602749|FG001|Overall Study|Lack of Efficacy|6|||
143016623|NCT01039584|515602750|FG002|Overall Study|Lack of Efficacy|10|||
143016624|NCT01039584|515602748|FG000|Overall Study|other|1|||
143016625|NCT01039584|515602749|FG001|Overall Study|other|3|||
143016626|NCT01039584|515602750|FG002|Overall Study|other|1|||
143016627|NCT01039584|515602748|FG000|Overall Study|Pap smear with significant pathology|10|||
143016628|NCT01039584|515602749|FG001|Overall Study|Pap smear with significant pathology|10|||
143016629|NCT01039584|515602750|FG002|Overall Study|Pap smear with significant pathology|3|||
143016630|NCT01039584|515602748|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
143016631|NCT01039584|515602749|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
143016632|NCT01039584|515602750|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
143016633|NCT03672396|515602753|FG000|Overall Study|Withdrawal by Subject|4|||
143016634|NCT03672396|515602753|FG000|Overall Study|Physician Decision|1|||
143016635|NCT03672396|515602753|FG000|Overall Study|Adverse Event|1|||
143016636|NCT00363129|515602756|FG000|Overall Study|Withdrawal by Subject|11|||
143016637|NCT00363129|515602757|FG001|Overall Study|Withdrawal by Subject|18|||
143016638|NCT00363129|515602756|FG000|Overall Study|Adverse Event|8|||
143016639|NCT00363129|515602757|FG001|Overall Study|Adverse Event|3|||
143016640|NCT00363129|515602756|FG000|Overall Study|Alternate Treatment|2|||
143016641|NCT00363129|515602757|FG001|Overall Study|Alternate Treatment|4|||
143016642|NCT00363129|515602756|FG000|Overall Study|Other Medical Problems|2|||
143016643|NCT00363129|515602757|FG001|Overall Study|Other Medical Problems|4|||
143016644|NCT00363129|515602756|FG000|Overall Study|Death|0|||
143016645|NCT00363129|515602757|FG001|Overall Study|Death|1|||
143016646|NCT00363129|515602756|FG000|Overall Study|Other Reasons|6|||
143016647|NCT00363129|515602757|FG001|Overall Study|Other Reasons|3|||
143016648|NCT03707522|515602758|FG000|Overall Study|Lost to Follow-up|24|||
143016649|NCT03707522|515602759|FG001|Overall Study|Lost to Follow-up|27|||
143016650|NCT03707522|515602760|FG002|Overall Study|Lost to Follow-up|41|||
143016651|NCT03707522|515602761|FG003|Overall Study|Lost to Follow-up|36|||
143016652|NCT03001011|515602762|FG000|Overall Study|Adverse Event|9|||
143016653|NCT03001011|515602763|FG001|Overall Study|Adverse Event|3|||
143016654|NCT03001011|515602762|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
143016655|NCT03001011|515602763|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
143016656|NCT03001011|515602762|FG000|Overall Study|Other than specified above|3|||
143016657|NCT03001011|515602763|FG001|Overall Study|Other than specified above|8|||
143016658|NCT01021137|515602764|FG000|Overall Study|Lost to Follow-up|9|||
143016659|NCT01021137|515602765|FG001|Overall Study|Lost to Follow-up|4|||
143016660|NCT01021137|515602766|FG002|Overall Study|Lost to Follow-up|2|||
143016661|NCT01021137|515602767|FG003|Overall Study|Lost to Follow-up|6|||
143016662|NCT01021137|515602764|FG000|Overall Study|Withdrawal by Subject|1|||
143016663|NCT01021137|515602765|FG001|Overall Study|Withdrawal by Subject|0|||
143016664|NCT01021137|515602766|FG002|Overall Study|Withdrawal by Subject|0|||
143016665|NCT01021137|515602767|FG003|Overall Study|Withdrawal by Subject|3|||
143016666|NCT00659581|515602768|FG000|Overall Study|Adverse Event|1006|||
143363671|NCT00062868|516873783|FG003|Dose Level 3|Lost to Follow-up|0|||
143363672|NCT00062868|516873784|FG004|Dose Level 3|Lost to Follow-up|0|||
143016667|NCT00659581|515602768|FG000|Overall Study|Lack of Efficacy|1183|||
143016668|NCT00659581|515602768|FG000|Overall Study|Other|6393|||
143016669|NCT03125915|515602778|FG000|1 Month Follow up|Lost to Follow-up|3|||
143016670|NCT03125915|515602779|FG001|1 Month Follow up|Lost to Follow-up|3|||
143016671|NCT03125915|515602780|FG002|1 Month Follow up|Lost to Follow-up|2|||
143016672|NCT03125915|515602781|FG003|1 Month Follow up|Lost to Follow-up|3|||
143016673|NCT03125915|515602778|FG000|3 Month Follow-up|Lost to Follow-up|6|||
143016674|NCT03125915|515602779|FG001|3 Month Follow-up|Lost to Follow-up|4|||
143152983|NCT04618471|516104208|FG000|Overall Study|Screen Failure|62|||
143152984|NCT04618471|516104208|FG000|Overall Study|Withdrawal by Subject|6|||
143152985|NCT04618471|516104208|FG000|Overall Study|Physician Decision|2|||
143152986|NCT04618471|516104208|FG000|Overall Study|Lost to Follow-up|1|||
143152987|NCT04618471|516104208|FG000|Overall Study|Various other reasons|2|||
143152988|NCT04618471|516104208|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
143153017|NCT04425018|516104215|FG000|Overall Study|Withdrawal by Subject|1|||
143153018|NCT04425018|516104216|FG001|Overall Study|Withdrawal by Subject|2|||
143235174|NCT04225897|516413519|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
143235175|NCT04225897|516413520|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
143016675|NCT03125915|515602780|FG002|3 Month Follow-up|Lost to Follow-up|4|||
143016676|NCT03125915|515602781|FG003|3 Month Follow-up|Lost to Follow-up|2|||
143016677|NCT03125915|515602778|FG000|6 Month Follow-up|Lost to Follow-up|7|||
143016678|NCT03125915|515602779|FG001|6 Month Follow-up|Lost to Follow-up|3|||
143016679|NCT03125915|515602780|FG002|6 Month Follow-up|Lost to Follow-up|6|||
143016680|NCT03125915|515602781|FG003|6 Month Follow-up|Lost to Follow-up|3|||
143016681|NCT01309828|515602784|FG000|Overall Study|Adverse Event|10|||
143016682|NCT01309828|515602785|FG001|Overall Study|Adverse Event|11|||
143153067|NCT05774977|516104237|FG000|Overall Study|Withdrawal by Subject|2|||
143016683|NCT01309828|515602784|FG000|Overall Study|Voluntary Withdrawal|5|||
143016684|NCT01309828|515602785|FG001|Overall Study|Voluntary Withdrawal|4|||
143016685|NCT01309828|515602784|FG000|Overall Study|Major Protocol Deviation|0|||
143485392|NCT02831673|517322809|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
143016686|NCT01309828|515602785|FG001|Overall Study|Major Protocol Deviation|1|||
143016687|NCT01309828|515602784|FG000|Overall Study|Other|1|||
143016688|NCT01309828|515602785|FG001|Overall Study|Other|0|||
143016689|NCT00217971|515602786|FG000|Overall Study|Adverse Event|1|||
143016690|NCT00217971|515602787|FG001|Overall Study|Adverse Event|1|||
143016691|NCT00217971|515602786|FG000|Overall Study|Lost to Follow-up|15|||
143016692|NCT00217971|515602787|FG001|Overall Study|Lost to Follow-up|19|||
143016693|NCT00217971|515602786|FG000|Overall Study|Physician Decision|0|||
143016694|NCT00217971|515602787|FG001|Overall Study|Physician Decision|1|||
143016695|NCT00217971|515602786|FG000|Overall Study|Withdrawal by Subject|7|||
143016696|NCT00217971|515602787|FG001|Overall Study|Withdrawal by Subject|12|||
143016697|NCT00217971|515602786|FG000|Overall Study|non compliant|1|||
143016698|NCT00217971|515602787|FG001|Overall Study|non compliant|0|||
143016699|NCT02556632|515602788|FG000|Overall Study|Lost to Follow-up|1|||
143016700|NCT02556632|515602789|FG001|Overall Study|Lost to Follow-up|0|||
143016701|NCT02556632|515602790|FG002|Overall Study|Lost to Follow-up|0|||
143016702|NCT02556632|515602788|FG000|Overall Study|Disliked Intervention|1|||
143016703|NCT02556632|515602789|FG001|Overall Study|Disliked Intervention|1|||
143016704|NCT02556632|515602790|FG002|Overall Study|Disliked Intervention|1|||
143016705|NCT02556632|515602788|FG000|Overall Study|No Reason|1|||
143016706|NCT02556632|515602789|FG001|Overall Study|No Reason|0|||
143016707|NCT02556632|515602790|FG002|Overall Study|No Reason|1|||
143016708|NCT02556632|515602788|FG000|Overall Study|Personal Issues|0|||
143016709|NCT02556632|515602789|FG001|Overall Study|Personal Issues|1|||
143016710|NCT02556632|515602790|FG002|Overall Study|Personal Issues|1|||
143016711|NCT02556632|515602788|FG000|Overall Study|Changed Mind|0|||
143016712|NCT02556632|515602789|FG001|Overall Study|Changed Mind|1|||
143016713|NCT02556632|515602790|FG002|Overall Study|Changed Mind|0|||
143016714|NCT02556632|515602788|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
143016715|NCT02556632|515602789|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
143016716|NCT02556632|515602790|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
143016717|NCT02556632|515602788|FG000|Overall Study|Unrelated Adverse Event|1|||
143016718|NCT02556632|515602789|FG001|Overall Study|Unrelated Adverse Event|0|||
143016719|NCT02556632|515602790|FG002|Overall Study|Unrelated Adverse Event|3|||
143016720|NCT02556632|515602788|FG000|Overall Study|Related Adverse Event|0|||
143016721|NCT02556632|515602789|FG001|Overall Study|Related Adverse Event|1|||
143016722|NCT02556632|515602790|FG002|Overall Study|Related Adverse Event|0|||
143016723|NCT02556632|515602788|FG000|Overall Study|Possibly Related Adverse Event|0|||
143016724|NCT02556632|515602789|FG001|Overall Study|Possibly Related Adverse Event|0|||
143016725|NCT02556632|515602790|FG002|Overall Study|Possibly Related Adverse Event|1|||
143016726|NCT02556632|515602788|FG000|Overall Study|Did Not Start RT|0|||
143016727|NCT02556632|515602789|FG001|Overall Study|Did Not Start RT|1|||
143016728|NCT02556632|515602790|FG002|Overall Study|Did Not Start RT|0|||
143016729|NCT02556632|515602788|FG000|Overall Study|Ineligible|0|||
143016730|NCT02556632|515602789|FG001|Overall Study|Ineligible|1|||
143016731|NCT02556632|515602790|FG002|Overall Study|Ineligible|0|||
143016732|NCT02556632|515602788|FG000|Overall Study|Disliked Study Procedures|0|||
143016733|NCT02556632|515602789|FG001|Overall Study|Disliked Study Procedures|0|||
143016734|NCT02556632|515602790|FG002|Overall Study|Disliked Study Procedures|1|||
143016735|NCT02556632|515602788|FG000|Overall Study|Treatment or Change Delay|0|||
143016736|NCT02556632|515602789|FG001|Overall Study|Treatment or Change Delay|0|||
143016737|NCT02556632|515602790|FG002|Overall Study|Treatment or Change Delay|1|||
143016738|NCT00808015|515602791|FG000|Overall Study|Death|1|||
143016739|NCT00808015|515602791|FG000|Overall Study|Lack of Efficacy|58|||
143016740|NCT00808015|515602791|FG000|Overall Study|Lost to Follow-up|76|||
143016741|NCT00808015|515602791|FG000|Overall Study|Participants not willing to participate|158|||
143016742|NCT00808015|515602791|FG000|Overall Study|Adverse Event|22|||
143016743|NCT00808015|515602791|FG000|Overall Study|Other|25|||
143016744|NCT00808015|515602791|FG000|Overall Study|Enrolled but not treated|4|||
143016745|NCT00928135|515602801|FG000|Overall Study|Withdrawal by Subject|1|||
143016746|NCT00928135|515602802|FG001|Overall Study|Withdrawal by Subject|0|||
143235176|NCT04225897|516413521|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
143016747|NCT03338673|515602803|FG000|Overall Study|Lost to Follow-up|1|||
143485393|NCT02831673|517322810|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
143485394|NCT02831673|517322811|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
143016748|NCT03338673|515602804|FG001|Overall Study|Lost to Follow-up|1|||
143016749|NCT04523831|515602806|FG000|Overall Study|Lost to Follow-up|15|||
143016750|NCT04523831|515602807|FG001|Overall Study|Lost to Follow-up|17|||
143016751|NCT04523831|515602806|FG000|Overall Study|Death|0|||
143016752|NCT04523831|515602807|FG001|Overall Study|Death|3|||
143016753|NCT04523831|515602806|FG000|Overall Study|Adverse Event|2|||
143016754|NCT04523831|515602807|FG001|Overall Study|Adverse Event|0|||
143016755|NCT04556838|515602808|FG000|Overall Study|Withdrawal by Subject|3|||
143016756|NCT04556838|515602809|FG001|Overall Study|Withdrawal by Subject|1|||
143016757|NCT04556838|515602810|FG002|Overall Study|Withdrawal by Subject|2|||
143016758|NCT04556838|515602808|FG000|Overall Study|Adverse Event|0|||
143016759|NCT04556838|515602809|FG001|Overall Study|Adverse Event|1|||
143016760|NCT04556838|515602810|FG002|Overall Study|Adverse Event|1|||
143016761|NCT04556838|515602808|FG000|Overall Study|Lost to Follow-up|0|||
143016762|NCT04556838|515602809|FG001|Overall Study|Lost to Follow-up|0|||
143016763|NCT04556838|515602810|FG002|Overall Study|Lost to Follow-up|2|||
143016764|NCT04556838|515602808|FG000|Overall Study|Subject travel|0|||
143016765|NCT04556838|515602809|FG001|Overall Study|Subject travel|1|||
143016766|NCT04556838|515602810|FG002|Overall Study|Subject travel|0|||
143016767|NCT04556838|515602808|FG000|Overall Study|Physician Decision|1|||
143016768|NCT04556838|515602809|FG001|Overall Study|Physician Decision|0|||
143016769|NCT04556838|515602810|FG002|Overall Study|Physician Decision|0|||
143016770|NCT03033069|515602811|FG000|Overall Study|Adverse Event|6|||
143016771|NCT03033069|515602812|FG001|Overall Study|Adverse Event|7|||
143016772|NCT03033069|515602813|FG002|Overall Study|Adverse Event|4|||
143016773|NCT03033069|515602814|FG003|Overall Study|Adverse Event|6|||
143016774|NCT03033069|515602811|FG000|Overall Study|Lack of Efficacy|0|||
143016775|NCT03033069|515602812|FG001|Overall Study|Lack of Efficacy|0|||
143016776|NCT03033069|515602813|FG002|Overall Study|Lack of Efficacy|1|||
143016777|NCT03033069|515602814|FG003|Overall Study|Lack of Efficacy|0|||
143016778|NCT03033069|515602811|FG000|Overall Study|Lost to Follow-up|6|||
143016779|NCT03033069|515602812|FG001|Overall Study|Lost to Follow-up|5|||
143016780|NCT03033069|515602813|FG002|Overall Study|Lost to Follow-up|5|||
143016781|NCT03033069|515602814|FG003|Overall Study|Lost to Follow-up|6|||
143016782|NCT03033069|515602811|FG000|Overall Study|Non-Compliance With Study Drug|1|||
143016783|NCT03033069|515602812|FG001|Overall Study|Non-Compliance With Study Drug|1|||
143016784|NCT03033069|515602813|FG002|Overall Study|Non-Compliance With Study Drug|1|||
143016785|NCT03033069|515602814|FG003|Overall Study|Non-Compliance With Study Drug|0|||
143016786|NCT03033069|515602811|FG000|Overall Study|Protocol Deviation|0|||
143016787|NCT03033069|515602812|FG001|Overall Study|Protocol Deviation|1|||
143016788|NCT03033069|515602813|FG002|Overall Study|Protocol Deviation|0|||
143016789|NCT03033069|515602814|FG003|Overall Study|Protocol Deviation|0|||
143016790|NCT03033069|515602811|FG000|Overall Study|Withdrawal by Subject|10|||
143016791|NCT03033069|515602812|FG001|Overall Study|Withdrawal by Subject|10|||
143016792|NCT03033069|515602813|FG002|Overall Study|Withdrawal by Subject|11|||
143016793|NCT03033069|515602814|FG003|Overall Study|Withdrawal by Subject|6|||
143016794|NCT03033069|515602811|FG000|Overall Study|Withdrawal By Caregiver|1|||
143016795|NCT03033069|515602812|FG001|Overall Study|Withdrawal By Caregiver|0|||
143016796|NCT03033069|515602813|FG002|Overall Study|Withdrawal By Caregiver|0|||
143016797|NCT03033069|515602814|FG003|Overall Study|Withdrawal By Caregiver|0|||
143485395|NCT02831673|517322812|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
143016798|NCT03033069|515602811|FG000|Overall Study|Reason not Specified|0|||
143016799|NCT03033069|515602812|FG001|Overall Study|Reason not Specified|1|||
143016800|NCT03033069|515602813|FG002|Overall Study|Reason not Specified|0|||
143016801|NCT03033069|515602814|FG003|Overall Study|Reason not Specified|1|||
143016802|NCT02623426|515602815|FG000|Overall Study|Lost to Follow-up|0|||
143016803|NCT02623426|515602816|FG001|Overall Study|Lost to Follow-up|0|||
143016804|NCT02623426|515602817|FG002|Overall Study|Lost to Follow-up|1|||
143016805|NCT02623426|515602815|FG000|Overall Study|Withdrawal by Subject|1|||
143016806|NCT02623426|515602816|FG001|Overall Study|Withdrawal by Subject|2|||
143016807|NCT02623426|515602817|FG002|Overall Study|Withdrawal by Subject|2|||
143016808|NCT03751124|515602818|FG000|Overall Study|Adverse Event|4|||
143016809|NCT03751124|515602819|FG001|Overall Study|Adverse Event|3|||
143016810|NCT03751124|515602818|FG000|Overall Study|Protocol Deviation|0|||
143016811|NCT03751124|515602819|FG001|Overall Study|Protocol Deviation|1|||
143016812|NCT03751124|515602818|FG000|Overall Study|Lost to Follow-up|6|||
143016813|NCT03751124|515602819|FG001|Overall Study|Lost to Follow-up|4|||
143016814|NCT03751124|515602818|FG000|Overall Study|Withdrawal by Subject|6|||
143016815|NCT03751124|515602819|FG001|Overall Study|Withdrawal by Subject|8|||
143016816|NCT03751124|515602818|FG000|Overall Study|Lack of Efficacy|1|||
143016817|NCT03751124|515602819|FG001|Overall Study|Lack of Efficacy|1|||
143016818|NCT03751124|515602818|FG000|Overall Study|Pregnancy|0|||
143016819|NCT03751124|515602819|FG001|Overall Study|Pregnancy|1|||
143016820|NCT03751124|515602818|FG000|Overall Study|Other|9|||
143016821|NCT03751124|515602819|FG001|Overall Study|Other|9|||
143016822|NCT03751124|515602818|FG000|Overall Study|Participants who did not receive any study drug|0|||
143016823|NCT03751124|515602819|FG001|Overall Study|Participants who did not receive any study drug|1|||
143016824|NCT00555399|515602830|FG000|Overall Study|Withdrawal by Subject|0|||
143016825|NCT00555399|515602831|FG001|Overall Study|Withdrawal by Subject|0|||
143016826|NCT00555399|515602832|FG002|Overall Study|Withdrawal by Subject|1|||
143016827|NCT00555399|515602833|FG003|Overall Study|Withdrawal by Subject|0|||
143016828|NCT00555399|515602834|FG004|Overall Study|Withdrawal by Subject|0|||
143016829|NCT00555399|515602835|FG005|Overall Study|Withdrawal by Subject|0|||
143016830|NCT00555399|515602836|FG006|Overall Study|Withdrawal by Subject|0|||
143016831|NCT00555399|515602837|FG007|Overall Study|Withdrawal by Subject|0|||
143016832|NCT00555399|515602838|FG008|Overall Study|Withdrawal by Subject|0|||
143016833|NCT00555399|515602839|FG009|Overall Study|Withdrawal by Subject|0|||
143016834|NCT00555399|515602840|FG010|Overall Study|Withdrawal by Subject|0|||
143016835|NCT00555399|515602841|FG011|Overall Study|Withdrawal by Subject|1|||
143016836|NCT00555399|515602830|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
143016837|NCT00555399|515602831|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
143016838|NCT00555399|515602832|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
143016839|NCT00555399|515602833|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
143016840|NCT00555399|515602834|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
143016841|NCT00555399|515602835|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
143016842|NCT00555399|515602836|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
143016843|NCT00555399|515602837|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
143016844|NCT00555399|515602838|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
143016845|NCT00555399|515602839|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
143016846|NCT00555399|515602840|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
143016847|NCT00555399|515602841|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
143016848|NCT05458895|515602842|FG000|Overall Study|Withdrawal by Subject|8|||
143153159|NCT04828486|516105883|FG000|Overall Study|Adverse Event|2|||
143153160|NCT04828486|516105883|FG000|Overall Study|Death|1|||
143363673|NCT00062868|516873785|FG005|Dose Level 3|Lost to Follow-up|0|||
143485396|NCT02831673|517322813|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
143485397|NCT02831673|517322809|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
143485398|NCT02831673|517322810|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
143016849|NCT05458895|515602842|FG000|Overall Study|Lost to Follow-up|17|||
143016850|NCT05458895|515602842|FG000|Overall Study|Pregnancy|2|||
143016851|NCT05458895|515602842|FG000|Overall Study|Withdrawal by Study Team|1|||
143016852|NCT04639310|515602843|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
143016853|NCT04639310|515602844|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
143016854|NCT03053622|515604845|FG000|Overall Study|Lost to Follow-up|0|||
143016855|NCT03053622|515604846|FG001|Overall Study|Lost to Follow-up|0|||
143016856|NCT03053622|515604847|FG002|Overall Study|Lost to Follow-up|0|||
143016857|NCT03053622|515604848|FG003|Overall Study|Lost to Follow-up|1|||
143153161|NCT04828486|516105883|FG000|Overall Study|Disease Progression|8|||
143363674|NCT00062868|516873786|FG006|Dose Level 3|Lost to Follow-up|0|||
143016858|NCT01416142|515604849|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
143016859|NCT01416142|515604850|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
143016860|NCT01416142|515604851|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
143016861|NCT00736099|515604863|FG000|Overall Study|Adverse Event|61|||
143016862|NCT00736099|515604864|FG001|Overall Study|Adverse Event|18|||
143016863|NCT00736099|515604863|FG000|Overall Study|Protocol Violation|10|||
143016864|NCT00736099|515604864|FG001|Overall Study|Protocol Violation|4|||
143016865|NCT00736099|515604863|FG000|Overall Study|Lost to Follow-up|12|||
143016866|NCT00736099|515604864|FG001|Overall Study|Lost to Follow-up|5|||
143016867|NCT00736099|515604863|FG000|Overall Study|Withdrawal by Subject|42|||
143016868|NCT00736099|515604864|FG001|Overall Study|Withdrawal by Subject|13|||
143016869|NCT00736099|515604863|FG000|Overall Study|Lack of Efficacy|15|||
143016870|NCT00736099|515604864|FG001|Overall Study|Lack of Efficacy|8|||
143016871|NCT00736099|515604863|FG000|Overall Study|Other reason|43|||
143016872|NCT00736099|515604864|FG001|Overall Study|Other reason|10|||
143016873|NCT03862625|515604869|FG000|Overall Study|Lost to Follow-up|0|||
143016874|NCT03862625|515604870|FG001|Overall Study|Lost to Follow-up|1|||
143016875|NCT02082912|515604871|FG000|Overall Study|Physician Decision|0|||
143016876|NCT02082912|515604872|FG001|Overall Study|Physician Decision|1|||
143016877|NCT00856778|515604873|FG000|Overall Study|Adverse Event|7|||
143016878|NCT00856778|515604873|FG000|Overall Study|Withdrawal by Subject|10|||
143016879|NCT00856778|515604873|FG000|Overall Study|Study deviation|2|||
143016880|NCT00856778|515604873|FG000|Overall Study|Lost to Follow-up|5|||
143016881|NCT00550420|515604875|FG000|Overall Study|Adverse Event|28|||
143016882|NCT00550420|515604875|FG000|Overall Study|Lost to Follow-up|8|||
143016883|NCT00550420|515604875|FG000|Overall Study|Protocol Violation|11|||
143016884|NCT00550420|515604875|FG000|Overall Study|Withdrawal by Subject|30|||
143016885|NCT00550420|515604875|FG000|Overall Study|Still in study at termination|206|||
143016886|NCT00550420|515604875|FG000|Overall Study|Missing|2|||
143016887|NCT00550420|515604875|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
143016888|NCT00550420|515604875|FG000|Overall Study|Investigators opinion|1|||
143016889|NCT00550420|515604875|FG000|Overall Study|Lack of curative effect|1|||
143016890|NCT00550420|515604875|FG000|Overall Study|Unethical stop of enrollment|2|||
143016891|NCT00550420|515604875|FG000|Overall Study|Caregiver's decision to withdraw|1|||
143016892|NCT00550420|515604875|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
143016893|NCT00550420|515604875|FG000|Overall Study|Exclusion criteria|1|||
143016894|NCT00550420|515604875|FG000|Overall Study|Prohibited medicine|1|||
143016895|NCT00782275|515604876|FG000|Overall Study|Adverse Event|11|||
143016896|NCT00782275|515604876|FG000|Overall Study|Withdrawal by Subject|1|||
143016897|NCT00782275|515604876|FG000|Overall Study|Progressive Disease|21|||
143016898|NCT00782275|515604876|FG000|Overall Study|Physician Decision|4|||
143016899|NCT00782275|515604876|FG000|Overall Study|Not started treatment|1|||
143016900|NCT00782275|515604876|FG000|Overall Study|Other|3|||
143016901|NCT04378010|515604877|FG000|Overall Study|Adverse Event|8|||
143016902|NCT04378010|515604878|FG001|Overall Study|Adverse Event|14|||
143016903|NCT04378010|515604879|FG002|Overall Study|Adverse Event|4|||
143016904|NCT04378010|515604877|FG000|Overall Study|Withdrawal by Subject|0|||
143016905|NCT04378010|515604878|FG001|Overall Study|Withdrawal by Subject|2|||
143016906|NCT04378010|515604879|FG002|Overall Study|Withdrawal by Subject|1|||
143016907|NCT04378010|515604877|FG000|Overall Study|Protocol Violation|2|||
143016908|NCT04378010|515604878|FG001|Overall Study|Protocol Violation|1|||
143016909|NCT04378010|515604879|FG002|Overall Study|Protocol Violation|4|||
143016910|NCT04378010|515604877|FG000|Overall Study|Study terminated by Sponsor|22|||
143016911|NCT04378010|515604878|FG001|Overall Study|Study terminated by Sponsor|16|||
143016912|NCT04378010|515604879|FG002|Overall Study|Study terminated by Sponsor|22|||
143016913|NCT04378010|515604877|FG000|Overall Study|Subject inability to complete study visit|0|||
143016914|NCT04378010|515604878|FG001|Overall Study|Subject inability to complete study visit|0|||
143153162|NCT04828486|516105883|FG000|Overall Study|Other Complicating Disease|1|||
143153163|NCT04828486|516105883|FG000|Overall Study|Withdrawal by Subject|1|||
143016915|NCT04378010|515604879|FG002|Overall Study|Subject inability to complete study visit|1|||
143016916|NCT04378010|515604877|FG000|Overall Study|Subject never dosed|0|||
143016917|NCT04378010|515604878|FG001|Overall Study|Subject never dosed|1|||
143016918|NCT04378010|515604879|FG002|Overall Study|Subject never dosed|0|||
143016919|NCT02019979|515604880|FG000|Overall Study|study terminated|14|||
143016920|NCT02513459|515604881|FG000|Overall Study|Adverse Event|7|||
143016921|NCT02513459|515604881|FG000|Overall Study|Withdrew consent|5|||
143016922|NCT02513459|515604881|FG000|Overall Study|Loss of efficacy|2|||
143016923|NCT02513459|515604881|FG000|Overall Study|Pregnancy|2|||
143016924|NCT02513459|515604881|FG000|Overall Study|Subject decision|2|||
143016925|NCT02513459|515604881|FG000|Overall Study|Lack of response|1|||
143016926|NCT02513459|515604881|FG000|Overall Study|Reproductive plans|1|||
143016927|NCT02513459|515604881|FG000|Overall Study|Surgery planned-- not done|1|||
143016928|NCT03237611|515604882|FG000|Overall Study|Withdrawal by Subject|1|||
143016929|NCT03237611|515604882|FG000|Overall Study|Ineligible|1|||
143016930|NCT00923195|515604883|FG000|Overall Study|Death|0|||
143016931|NCT00923195|515604884|FG001|Overall Study|Death|1|||
143016932|NCT00525031|515604885|FG000|Overall Study|Disease Progression|1|||
143016933|NCT00525031|515604886|FG001|Overall Study|Disease Progression|1|||
143016934|NCT02454972|515604889|FG000|Overall Study|Progressive disease|17|||
143016935|NCT02454972|515604890|FG001|Overall Study|Progressive disease|16|||
143016936|NCT02454972|515604891|FG002|Overall Study|Progressive disease|59|||
143016937|NCT02454972|515604892|FG003|Overall Study|Progressive disease|23|||
143016938|NCT02454972|515604893|FG004|Overall Study|Progressive disease|16|||
143016939|NCT02454972|515604894|FG005|Overall Study|Progressive disease|12|||
143016940|NCT02454972|515604895|FG006|Overall Study|Progressive disease|19|||
143016941|NCT02454972|515604896|FG007|Overall Study|Progressive disease|27|||
143016942|NCT02454972|515604897|FG008|Overall Study|Progressive disease|0|||
143016943|NCT02454972|515604889|FG000|Overall Study|Death|0|||
143016944|NCT02454972|515604890|FG001|Overall Study|Death|0|||
143016945|NCT02454972|515604891|FG002|Overall Study|Death|5|||
143016946|NCT02454972|515604892|FG003|Overall Study|Death|1|||
143016947|NCT02454972|515604893|FG004|Overall Study|Death|0|||
143016948|NCT02454972|515604894|FG005|Overall Study|Death|0|||
143016949|NCT02454972|515604895|FG006|Overall Study|Death|0|||
143016950|NCT02454972|515604896|FG007|Overall Study|Death|0|||
143016951|NCT02454972|515604897|FG008|Overall Study|Death|95|||
143016952|NCT02454972|515604889|FG000|Overall Study|Physician Decision|0|||
143016953|NCT02454972|515604890|FG001|Overall Study|Physician Decision|1|||
143016954|NCT02454972|515604891|FG002|Overall Study|Physician Decision|2|||
143016955|NCT02454972|515604892|FG003|Overall Study|Physician Decision|1|||
143016956|NCT02454972|515604893|FG004|Overall Study|Physician Decision|2|||
143016957|NCT02454972|515604894|FG005|Overall Study|Physician Decision|0|||
143016958|NCT02454972|515604895|FG006|Overall Study|Physician Decision|0|||
143016959|NCT02454972|515604896|FG007|Overall Study|Physician Decision|1|||
143016960|NCT02454972|515604897|FG008|Overall Study|Physician Decision|0|||
143016961|NCT02454972|515604889|FG000|Overall Study|Non treatment-related adverse event|2|||
143016962|NCT02454972|515604890|FG001|Overall Study|Non treatment-related adverse event|0|||
143016963|NCT02454972|515604891|FG002|Overall Study|Non treatment-related adverse event|1|||
143016964|NCT02454972|515604892|FG003|Overall Study|Non treatment-related adverse event|0|||
143016965|NCT02454972|515604893|FG004|Overall Study|Non treatment-related adverse event|0|||
143016966|NCT02454972|515604894|FG005|Overall Study|Non treatment-related adverse event|1|||
143016967|NCT02454972|515604895|FG006|Overall Study|Non treatment-related adverse event|0|||
143016968|NCT02454972|515604896|FG007|Overall Study|Non treatment-related adverse event|1|||
143016969|NCT02454972|515604897|FG008|Overall Study|Non treatment-related adverse event|0|||
143016970|NCT02454972|515604889|FG000|Overall Study|Treatment-related adverse events|0|||
143016971|NCT02454972|515604890|FG001|Overall Study|Treatment-related adverse events|1|||
143016972|NCT02454972|515604891|FG002|Overall Study|Treatment-related adverse events|1|||
143016973|NCT02454972|515604892|FG003|Overall Study|Treatment-related adverse events|0|||
143016974|NCT02454972|515604893|FG004|Overall Study|Treatment-related adverse events|2|||
143016975|NCT02454972|515604894|FG005|Overall Study|Treatment-related adverse events|0|||
143016976|NCT02454972|515604895|FG006|Overall Study|Treatment-related adverse events|0|||
143016977|NCT02454972|515604896|FG007|Overall Study|Treatment-related adverse events|2|||
143016978|NCT02454972|515604897|FG008|Overall Study|Treatment-related adverse events|0|||
143016979|NCT02454972|515604889|FG000|Overall Study|Patient moves to compassionate use|0|||
143016980|NCT02454972|515604890|FG001|Overall Study|Patient moves to compassionate use|0|||
143016981|NCT02454972|515604891|FG002|Overall Study|Patient moves to compassionate use|0|||
143016982|NCT02454972|515604892|FG003|Overall Study|Patient moves to compassionate use|0|||
143016983|NCT02454972|515604893|FG004|Overall Study|Patient moves to compassionate use|0|||
143016984|NCT02454972|515604894|FG005|Overall Study|Patient moves to compassionate use|0|||
143016985|NCT02454972|515604895|FG006|Overall Study|Patient moves to compassionate use|2|||
143016986|NCT02454972|515604896|FG007|Overall Study|Patient moves to compassionate use|0|||
143485399|NCT02831673|517322811|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
143016987|NCT02454972|515604897|FG008|Overall Study|Patient moves to compassionate use|0|||
143016988|NCT02454972|515604889|FG000|Overall Study|Withdrawal by Subject|0|||
143016989|NCT02454972|515604890|FG001|Overall Study|Withdrawal by Subject|1|||
143016990|NCT02454972|515604891|FG002|Overall Study|Withdrawal by Subject|5|||
143016991|NCT02454972|515604892|FG003|Overall Study|Withdrawal by Subject|2|||
143016992|NCT02454972|515604893|FG004|Overall Study|Withdrawal by Subject|3|||
143016993|NCT02454972|515604894|FG005|Overall Study|Withdrawal by Subject|2|||
143016994|NCT02454972|515604895|FG006|Overall Study|Withdrawal by Subject|0|||
143016995|NCT02454972|515604896|FG007|Overall Study|Withdrawal by Subject|1|||
143016996|NCT02454972|515604897|FG008|Overall Study|Withdrawal by Subject|2|||
143016997|NCT02454972|515604889|FG000|Overall Study|Multiple delay/holds on treatment|0|||
143016998|NCT02454972|515604890|FG001|Overall Study|Multiple delay/holds on treatment|0|||
143153173|NCT02063724|516105885|FG000|Overall Study|Disease progression|1|||
143016999|NCT02454972|515604891|FG002|Overall Study|Multiple delay/holds on treatment|0|||
143017000|NCT02454972|515604892|FG003|Overall Study|Multiple delay/holds on treatment|1|||
143017001|NCT02454972|515604893|FG004|Overall Study|Multiple delay/holds on treatment|0|||
143017002|NCT02454972|515604894|FG005|Overall Study|Multiple delay/holds on treatment|0|||
143017003|NCT02454972|515604895|FG006|Overall Study|Multiple delay/holds on treatment|0|||
143017004|NCT02454972|515604896|FG007|Overall Study|Multiple delay/holds on treatment|0|||
143017005|NCT02454972|515604897|FG008|Overall Study|Multiple delay/holds on treatment|0|||
143017006|NCT02454972|515604889|FG000|Overall Study|Never treated|0|||
143017007|NCT02454972|515604890|FG001|Overall Study|Never treated|0|||
143017008|NCT02454972|515604891|FG002|Overall Study|Never treated|3|||
143017009|NCT02454972|515604892|FG003|Overall Study|Never treated|1|||
143017010|NCT02454972|515604893|FG004|Overall Study|Never treated|1|||
143017011|NCT02454972|515604894|FG005|Overall Study|Never treated|0|||
143017012|NCT02454972|515604895|FG006|Overall Study|Never treated|0|||
143017013|NCT02454972|515604896|FG007|Overall Study|Never treated|0|||
143017014|NCT02454972|515604897|FG008|Overall Study|Never treated|5|||
143017015|NCT02454972|515604889|FG000|Overall Study|Lost to Follow-up|0|||
143017016|NCT02454972|515604890|FG001|Overall Study|Lost to Follow-up|0|||
143017017|NCT02454972|515604891|FG002|Overall Study|Lost to Follow-up|0|||
143017018|NCT02454972|515604892|FG003|Overall Study|Lost to Follow-up|0|||
143017019|NCT02454972|515604893|FG004|Overall Study|Lost to Follow-up|0|||
143017020|NCT02454972|515604894|FG005|Overall Study|Lost to Follow-up|0|||
143017021|NCT02454972|515604895|FG006|Overall Study|Lost to Follow-up|0|||
143017022|NCT02454972|515604896|FG007|Overall Study|Lost to Follow-up|0|||
143017023|NCT02454972|515604897|FG008|Overall Study|Lost to Follow-up|2|||
143017024|NCT02454972|515604889|FG000|Overall Study|Study termination|0|||
143017025|NCT02454972|515604890|FG001|Overall Study|Study termination|0|||
143017026|NCT02454972|515604891|FG002|Overall Study|Study termination|0|||
143017027|NCT02454972|515604892|FG003|Overall Study|Study termination|0|||
143017028|NCT02454972|515604893|FG004|Overall Study|Study termination|0|||
143017029|NCT02454972|515604894|FG005|Overall Study|Study termination|0|||
143017030|NCT02454972|515604895|FG006|Overall Study|Study termination|0|||
143017031|NCT02454972|515604896|FG007|Overall Study|Study termination|0|||
143017032|NCT02454972|515604897|FG008|Overall Study|Study termination|6|||
143017033|NCT00686374|515604906|FG000|Overall Study|Lack of Efficacy|10|||
143017034|NCT00686374|515604906|FG000|Overall Study|Adverse Event|8|||
143017035|NCT00686374|515604906|FG000|Overall Study|Withdrew consent|5|||
143017036|NCT00686374|515604906|FG000|Overall Study|Lost to Follow-up|1|||
143017037|NCT00686374|515604906|FG000|Overall Study|Missing reason|33|||
143017038|NCT00686374|515604906|FG000|Overall Study|Other, not specified|4|||
143017039|NCT02770716|515604908|FG000|Overall Study|Death|101|||
143017040|NCT02770716|515604909|FG001|Overall Study|Death|45|||
143017041|NCT02770716|515604908|FG000|Overall Study|Withdrawal by Subject|4|||
143017042|NCT02770716|515604909|FG001|Overall Study|Withdrawal by Subject|2|||
143017043|NCT02770716|515604908|FG000|Overall Study|Lost to Follow-up|1|||
143017044|NCT02770716|515604909|FG001|Overall Study|Lost to Follow-up|0|||
143017045|NCT02770716|515604908|FG000|Overall Study|Various reasons|6|||
143017046|NCT02770716|515604909|FG001|Overall Study|Various reasons|2|||
143153184|NCT05101317|516105895|FG000|Week1-13|Adverse Event|0|||
143153185|NCT05101317|516105896|FG001|Week1-13|Adverse Event|1|||
143153186|NCT05101317|516105897|FG002|Week1-13|Adverse Event|0|||
143153187|NCT05101317|516105898|FG003|Week1-13|Adverse Event|0|||
143485400|NCT02831673|517322812|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
143485401|NCT02831673|517322813|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
143485402|NCT02831673|517322809|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
143017047|NCT03989115|515604911|FG000|Overall Study|Withdrawal by Subject|2|||
143017048|NCT03989115|515604912|FG001|Overall Study|Withdrawal by Subject|1|||
143017049|NCT03989115|515604913|FG002|Overall Study|Withdrawal by Subject|3|||
143017050|NCT03989115|515604914|FG003|Overall Study|Withdrawal by Subject|0|||
143017051|NCT03989115|515604915|FG004|Overall Study|Withdrawal by Subject|17|||
143017052|NCT03989115|515604916|FG005|Overall Study|Withdrawal by Subject|1|||
143017053|NCT03989115|515604917|FG006|Overall Study|Withdrawal by Subject|0|||
143017054|NCT03989115|515604918|FG007|Overall Study|Withdrawal by Subject|0|||
143017055|NCT03989115|515604911|FG000|Overall Study|Sponsor decision to terminate the study|1|||
143017056|NCT03989115|515604912|FG001|Overall Study|Sponsor decision to terminate the study|1|||
143017057|NCT03989115|515604913|FG002|Overall Study|Sponsor decision to terminate the study|0|||
143017058|NCT03989115|515604914|FG003|Overall Study|Sponsor decision to terminate the study|1|||
143153188|NCT05101317|516105895|FG000|Week1-13|Withdrawal by Subject|0|||
143017059|NCT03989115|515604915|FG004|Overall Study|Sponsor decision to terminate the study|11|||
143017060|NCT03989115|515604916|FG005|Overall Study|Sponsor decision to terminate the study|0|||
143017061|NCT03989115|515604917|FG006|Overall Study|Sponsor decision to terminate the study|2|||
143017062|NCT03989115|515604918|FG007|Overall Study|Sponsor decision to terminate the study|1|||
143017063|NCT03989115|515604911|FG000|Overall Study|Lost to Follow-up|2|||
143017064|NCT03989115|515604912|FG001|Overall Study|Lost to Follow-up|0|||
143017065|NCT03989115|515604913|FG002|Overall Study|Lost to Follow-up|0|||
143017066|NCT03989115|515604914|FG003|Overall Study|Lost to Follow-up|0|||
143017067|NCT03989115|515604915|FG004|Overall Study|Lost to Follow-up|1|||
143017068|NCT03989115|515604916|FG005|Overall Study|Lost to Follow-up|0|||
143017069|NCT03989115|515604917|FG006|Overall Study|Lost to Follow-up|0|||
143017070|NCT03989115|515604918|FG007|Overall Study|Lost to Follow-up|0|||
143017071|NCT03989115|515604911|FG000|Overall Study|Death|2|||
143017072|NCT03989115|515604912|FG001|Overall Study|Death|2|||
143017073|NCT03989115|515604913|FG002|Overall Study|Death|9|||
143017074|NCT03989115|515604914|FG003|Overall Study|Death|6|||
143017075|NCT03989115|515604915|FG004|Overall Study|Death|31|||
143017076|NCT03989115|515604916|FG005|Overall Study|Death|6|||
143017077|NCT03989115|515604917|FG006|Overall Study|Death|2|||
143017078|NCT03989115|515604918|FG007|Overall Study|Death|3|||
143017079|NCT03989115|515604911|FG000|Overall Study|Other|1|||
143017080|NCT03989115|515604912|FG001|Overall Study|Other|2|||
143017081|NCT03989115|515604913|FG002|Overall Study|Other|0|||
143017082|NCT03989115|515604914|FG003|Overall Study|Other|0|||
143017083|NCT03989115|515604915|FG004|Overall Study|Other|5|||
143017084|NCT03989115|515604916|FG005|Overall Study|Other|0|||
143017085|NCT03989115|515604917|FG006|Overall Study|Other|0|||
143017086|NCT03989115|515604918|FG007|Overall Study|Other|0|||
143017087|NCT01415921|515604920|FG000|Overall Study|Adverse Event|0|||
143017088|NCT01415921|515604921|FG001|Overall Study|Adverse Event|1|||
143017089|NCT01415921|515604920|FG000|Overall Study|Physician Decision|1|||
143017090|NCT01415921|515604921|FG001|Overall Study|Physician Decision|1|||
143017091|NCT01415921|515604920|FG000|Overall Study|Withdrawal by Subject|0|||
143017092|NCT01415921|515604921|FG001|Overall Study|Withdrawal by Subject|1|||
143017093|NCT01415921|515604920|FG000|Overall Study|Other|2|||
143017094|NCT01415921|515604921|FG001|Overall Study|Other|0|||
143017095|NCT01244815|515604922|FG000|Overall Study|Not Treated|0|||
143017096|NCT01244815|515604923|FG001|Overall Study|Not Treated|1|||
143017097|NCT01244815|515604924|FG002|Overall Study|Not Treated|0|||
143017098|NCT01244815|515604925|FG003|Overall Study|Not Treated|0|||
143017099|NCT01244815|515604922|FG000|Overall Study|Adverse Event|4|||
143017100|NCT01244815|515604923|FG001|Overall Study|Adverse Event|7|||
143017101|NCT01244815|515604924|FG002|Overall Study|Adverse Event|5|||
143017102|NCT01244815|515604925|FG003|Overall Study|Adverse Event|5|||
143017103|NCT01244815|515604922|FG000|Overall Study|Treatment Failure|0|||
143017104|NCT01244815|515604923|FG001|Overall Study|Treatment Failure|0|||
143017105|NCT01244815|515604924|FG002|Overall Study|Treatment Failure|0|||
143017106|NCT01244815|515604925|FG003|Overall Study|Treatment Failure|1|||
143017107|NCT01244815|515604922|FG000|Overall Study|Lost to Follow-up|3|||
143017108|NCT01244815|515604923|FG001|Overall Study|Lost to Follow-up|2|||
143017109|NCT01244815|515604924|FG002|Overall Study|Lost to Follow-up|3|||
143017110|NCT01244815|515604925|FG003|Overall Study|Lost to Follow-up|2|||
143017111|NCT01244815|515604922|FG000|Overall Study|Withdrawal by Subject|0|||
143017112|NCT01244815|515604923|FG001|Overall Study|Withdrawal by Subject|2|||
143017113|NCT01244815|515604924|FG002|Overall Study|Withdrawal by Subject|0|||
143017114|NCT01244815|515604925|FG003|Overall Study|Withdrawal by Subject|3|||
143017115|NCT01244815|515604922|FG000|Overall Study|Protocol Violation|7|||
143017116|NCT01244815|515604923|FG001|Overall Study|Protocol Violation|4|||
143017117|NCT01244815|515604924|FG002|Overall Study|Protocol Violation|3|||
143017118|NCT01244815|515604925|FG003|Overall Study|Protocol Violation|1|||
143017119|NCT01244815|515604922|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
143017120|NCT01244815|515604923|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
143017121|NCT01244815|515604924|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
143017122|NCT01244815|515604925|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
143017123|NCT01808209|515604927|FG000|Overall Study|Lost to Follow-up|0|||
143017124|NCT01808209|515604928|FG001|Overall Study|Lost to Follow-up|1|||
143017125|NCT02983227|515604932|FG000|Overall Study|Adverse Event|21|||
143017126|NCT02983227|515604933|FG001|Overall Study|Adverse Event|3|||
143017127|NCT02983227|515604932|FG000|Overall Study|Death|3|||
143017128|NCT02983227|515604933|FG001|Overall Study|Death|0|||
143017129|NCT02983227|515604932|FG000|Overall Study|Lack of Efficacy|8|||
143017130|NCT02983227|515604933|FG001|Overall Study|Lack of Efficacy|1|||
143017131|NCT02983227|515604932|FG000|Overall Study|Lost to Follow-up|3|||
143017132|NCT02983227|515604933|FG001|Overall Study|Lost to Follow-up|0|||
143017133|NCT02983227|515604932|FG000|Overall Study|Multiple Reasons|2|||
143017134|NCT02983227|515604933|FG001|Overall Study|Multiple Reasons|1|||
143017135|NCT02983227|515604932|FG000|Overall Study|Physician Decision|3|||
143017136|NCT02983227|515604933|FG001|Overall Study|Physician Decision|1|||
143017137|NCT02983227|515604932|FG000|Overall Study|Withdrawal by Subject|19|||
143017138|NCT02983227|515604933|FG001|Overall Study|Withdrawal by Subject|8|||
143017139|NCT01027884|515604934|FG000|Overall Study|Adverse Event|2|||
143485403|NCT02831673|517322810|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
143153189|NCT05101317|516105896|FG001|Week1-13|Withdrawal by Subject|2|||
143153190|NCT05101317|516105897|FG002|Week1-13|Withdrawal by Subject|0|||
143485404|NCT02831673|517322811|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
143485405|NCT02831673|517322812|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
143485406|NCT02831673|517322813|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
143485407|NCT02831673|517322809|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
143485408|NCT02831673|517322810|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
143485409|NCT02831673|517322811|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
143485410|NCT02831673|517322812|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
143485411|NCT02831673|517322813|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
143485412|NCT02831673|517322809|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
143485413|NCT02831673|517322810|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
143153191|NCT05101317|516105898|FG003|Week1-13|Withdrawal by Subject|0|||
143153192|NCT05101317|516105895|FG000|Week1-13|Early Withdrawl|0|||
143153193|NCT05101317|516105896|FG001|Week1-13|Early Withdrawl|0|||
143153194|NCT05101317|516105897|FG002|Week1-13|Early Withdrawl|0|||
143153195|NCT05101317|516105898|FG003|Week1-13|Early Withdrawl|1|||
143153196|NCT05101317|516105895|FG000|Week 13-25|Lost to Follow-up|0|||
143153197|NCT05101317|516105896|FG001|Week 13-25|Lost to Follow-up|0|||
143153198|NCT05101317|516105897|FG002|Week 13-25|Lost to Follow-up|1|||
143153199|NCT05101317|516105898|FG003|Week 13-25|Lost to Follow-up|0|||
143153200|NCT05101317|516105895|FG000|Week 13-25|Withdrawal by Subject|1|||
143153201|NCT05101317|516105896|FG001|Week 13-25|Withdrawal by Subject|1|||
143153202|NCT05101317|516105897|FG002|Week 13-25|Withdrawal by Subject|0|||
143153203|NCT05101317|516105898|FG003|Week 13-25|Withdrawal by Subject|0|||
143153204|NCT05101317|516105895|FG000|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
143153205|NCT05101317|516105896|FG001|Week 13-25|Patient decide to have oral contraception/refuse to come back|2|||
143153206|NCT05101317|516105897|FG002|Week 13-25|Patient decide to have oral contraception/refuse to come back|1|||
143153207|NCT05101317|516105898|FG003|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
143153228|NCT02513563|516105905|FG000|Overall Study|Death|4|||
143153229|NCT02513563|516105905|FG000|Overall Study|Withdrawal by Subject|4|||
143153230|NCT02513563|516105905|FG000|Overall Study|Physician Decision|1|||
143017140|NCT01027884|515604935|FG001|Overall Study|Adverse Event|1|||
143153311|NCT06042855|516105937|FG000|Overall Study|No Receipt of Study Drug|48|||
143153312|NCT06042855|516105938|FG001|Overall Study|No Receipt of Study Drug|57|||
143153313|NCT06042855|516105937|FG000|Overall Study|Administratively Withdrawn|59|||
143153314|NCT06042855|516105938|FG001|Overall Study|Administratively Withdrawn|59|||
143153315|NCT03674411|516105939|FG000|Overall Study|Non-treatment|4|||
143017141|NCT01027884|515604934|FG000|Overall Study|Protocol Violation|1|||
143017142|NCT01027884|515604935|FG001|Overall Study|Protocol Violation|0|||
143017143|NCT01027884|515604934|FG000|Overall Study|Non-compliance|1|||
143017144|NCT01027884|515604935|FG001|Overall Study|Non-compliance|1|||
143017145|NCT01027884|515604934|FG000|Overall Study|Withdrawal by Subject|0|||
143017146|NCT01027884|515604935|FG001|Overall Study|Withdrawal by Subject|1|||
143017147|NCT01027884|515604934|FG000|Overall Study|Lost to Follow-up|0|||
143017148|NCT01027884|515604935|FG001|Overall Study|Lost to Follow-up|1|||
143017149|NCT01027884|515604934|FG000|Overall Study|Spinal fixation surgery|0|||
143017150|NCT01027884|515604935|FG001|Overall Study|Spinal fixation surgery|3|||
143017151|NCT02059187|515604936|FG000|Overall Study|Adverse Event|0|||
143017152|NCT02059187|515604937|FG001|Overall Study|Adverse Event|3|||
143017153|NCT02059187|515604936|FG000|Overall Study|Death|1|||
143017154|NCT02059187|515604937|FG001|Overall Study|Death|1|||
143017155|NCT02059187|515604936|FG000|Overall Study|Lost to Follow-up|9|||
143017156|NCT02059187|515604937|FG001|Overall Study|Lost to Follow-up|8|||
143017157|NCT02059187|515604936|FG000|Overall Study|Non-compliance with study drug|1|||
143017158|NCT02059187|515604937|FG001|Overall Study|Non-compliance with study drug|0|||
143017159|NCT02059187|515604936|FG000|Overall Study|Physician Decision|1|||
143017160|NCT02059187|515604937|FG001|Overall Study|Physician Decision|2|||
143017161|NCT02059187|515604936|FG000|Overall Study|Protocol Violation|1|||
143017162|NCT02059187|515604937|FG001|Overall Study|Protocol Violation|0|||
143017163|NCT02059187|515604936|FG000|Overall Study|Withdrawal by Subject|12|||
143017164|NCT02059187|515604937|FG001|Overall Study|Withdrawal by Subject|8|||
143017165|NCT02729194|515604938|FG000|Overall Study|Withdrawal by Subject|3|||
143017166|NCT00845026|515604939|FG000|Study Period III|Adverse Event|23|||
143017167|NCT00845026|515604940|FG001|Study Period III|Adverse Event|19|||
143017168|NCT00845026|515604939|FG000|Study Period III|Perceived lack of efficacy|27|||
143017169|NCT00845026|515604940|FG001|Study Period III|Perceived lack of efficacy|15|||
143017170|NCT00845026|515604939|FG000|Study Period III|Withdrawal by Subject|19|||
143017171|NCT00845026|515604940|FG001|Study Period III|Withdrawal by Subject|15|||
143017172|NCT00845026|515604939|FG000|Study Period III|Entry Criteria not met|8|||
143017173|NCT00845026|515604940|FG001|Study Period III|Entry Criteria not met|11|||
143017174|NCT00845026|515604939|FG000|Study Period III|Lost to Follow-up|4|||
143017175|NCT00845026|515604940|FG001|Study Period III|Lost to Follow-up|5|||
143017176|NCT00845026|515604939|FG000|Study Period III|Protocol Violation|8|||
143017177|NCT00845026|515604940|FG001|Study Period III|Protocol Violation|1|||
143017178|NCT00845026|515604939|FG000|Study Period III|Scheduled conflict|3|||
143017179|NCT00845026|515604940|FG001|Study Period III|Scheduled conflict|1|||
143017180|NCT00845026|515604939|FG000|Study Period III|Subject is moving or has moved|2|||
143017181|NCT00845026|515604940|FG001|Study Period III|Subject is moving or has moved|4|||
143017182|NCT00845026|515604939|FG000|Study Period III|Transportation issues|1|||
143017183|NCT00845026|515604940|FG001|Study Period III|Transportation issues|1|||
143017184|NCT00845026|515604939|FG000|Study Period IV|Adverse Event|4|||
143017185|NCT00845026|515604940|FG001|Study Period IV|Adverse Event|0|||
143017186|NCT00845026|515604939|FG000|Study Period IV|Perceived lack of efficacy|2|||
143017187|NCT00845026|515604940|FG001|Study Period IV|Perceived lack of efficacy|1|||
143017188|NCT00845026|515604939|FG000|Study Period IV|Protocol Violation|3|||
143017189|NCT00845026|515604940|FG001|Study Period IV|Protocol Violation|1|||
143017190|NCT00845026|515604939|FG000|Study Period IV|Lost to Follow-up|1|||
143017191|NCT00845026|515604940|FG001|Study Period IV|Lost to Follow-up|0|||
143017192|NCT00845026|515604939|FG000|Study Period IV|Withdrawal by Subject|4|||
143017193|NCT00845026|515604940|FG001|Study Period IV|Withdrawal by Subject|1|||
143017194|NCT00845026|515604939|FG000|Study Period IV|Entry Criteria Not Met|1|||
143017195|NCT00845026|515604940|FG001|Study Period IV|Entry Criteria Not Met|0|||
143017196|NCT00845026|515604939|FG000|Study Period IV|Subject is moving or has moved|0|||
143017197|NCT00845026|515604940|FG001|Study Period IV|Subject is moving or has moved|1|||
143017198|NCT00845026|515604939|FG000|Study Period IV|Scheduling conflict|1|||
143017199|NCT00845026|515604940|FG001|Study Period IV|Scheduling conflict|0|||
143017200|NCT03012815|515604941|FG000|Overall Study|Lost to Follow-up|1|||
143017201|NCT03012815|515604942|FG001|Overall Study|Lost to Follow-up|0|||
143017202|NCT03012815|515604941|FG000|Overall Study|Physician Decision|3|||
143017203|NCT03012815|515604942|FG001|Overall Study|Physician Decision|2|||
143017204|NCT03012815|515604941|FG000|Overall Study|Adverse Event|1|||
143017205|NCT03012815|515604942|FG001|Overall Study|Adverse Event|0|||
143017206|NCT00879970|515604943|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
143017207|NCT00879970|515604944|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
143017208|NCT00879970|515604945|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
143017209|NCT00879970|515604946|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
143017210|NCT00879970|515604947|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
143017211|NCT00879970|515604943|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
143017212|NCT00879970|515604944|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
143017213|NCT00879970|515604945|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
143017214|NCT00879970|515604946|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
143017215|NCT00879970|515604947|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
143017216|NCT00879970|515604943|FG000|Period 1 TZD Randomization|Death|2|||
143017217|NCT00879970|515604944|FG001|Period 1 TZD Randomization|Death|1|||
143017218|NCT00879970|515604945|FG002|Period 1 TZD Randomization|Death|0|||
143017219|NCT00879970|515604946|FG003|Period 1 TZD Randomization|Death|0|||
143017220|NCT00879970|515604947|FG004|Period 1 TZD Randomization|Death|0|||
143017221|NCT00879970|515604943|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
143017222|NCT00879970|515604944|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
143017223|NCT00879970|515604945|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
143017224|NCT00879970|515604946|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
143017225|NCT00879970|515604947|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
143017226|NCT00879970|515604943|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
143017227|NCT00879970|515604944|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
143017228|NCT00879970|515604945|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
143017229|NCT00879970|515604946|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
143017230|NCT00879970|515604947|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
143017231|NCT00879970|515604943|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
143017232|NCT00879970|515604944|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
143017233|NCT00879970|515604945|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
143017234|NCT00879970|515604946|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
143017235|NCT00879970|515604947|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
143017236|NCT00879970|515604943|FG000|Period 2 Vitamin D Randomization|Death|0|||
143017237|NCT00879970|515604944|FG001|Period 2 Vitamin D Randomization|Death|0|||
143017238|NCT00879970|515604945|FG002|Period 2 Vitamin D Randomization|Death|0|||
143017239|NCT00879970|515604946|FG003|Period 2 Vitamin D Randomization|Death|2|||
143017240|NCT00879970|515604947|FG004|Period 2 Vitamin D Randomization|Death|0|||
143017241|NCT04380701|515604948|FG000|Overall Study|Pregnancy|0|||
143017242|NCT04380701|515604949|FG001|Overall Study|Pregnancy|0|||
143017243|NCT04380701|515604950|FG002|Overall Study|Pregnancy|0|||
143017244|NCT04380701|515604951|FG003|Overall Study|Pregnancy|0|||
143017245|NCT04380701|515604952|FG004|Overall Study|Pregnancy|0|||
143017246|NCT04380701|515604953|FG005|Overall Study|Pregnancy|0|||
143017247|NCT04380701|515604954|FG006|Overall Study|Pregnancy|0|||
143017248|NCT04380701|515604955|FG007|Overall Study|Pregnancy|0|||
143017249|NCT04380701|515604956|FG008|Overall Study|Pregnancy|0|||
143017250|NCT04380701|515604957|FG009|Overall Study|Pregnancy|0|||
143017251|NCT04380701|515604958|FG010|Overall Study|Pregnancy|0|||
143017252|NCT04380701|515604959|FG011|Overall Study|Pregnancy|0|||
143017253|NCT04380701|515604960|FG012|Overall Study|Pregnancy|0|||
143017254|NCT04380701|515604961|FG013|Overall Study|Pregnancy|0|||
143017255|NCT04380701|515604962|FG014|Overall Study|Pregnancy|0|||
143017256|NCT04380701|515604963|FG015|Overall Study|Pregnancy|0|||
143017257|NCT04380701|515604964|FG016|Overall Study|Pregnancy|0|||
143017258|NCT04380701|515604965|FG017|Overall Study|Pregnancy|0|||
143017259|NCT04380701|515604966|FG018|Overall Study|Pregnancy|0|||
143017260|NCT04380701|515604967|FG019|Overall Study|Pregnancy|0|||
143017261|NCT04380701|515604968|FG020|Overall Study|Pregnancy|0|||
143017262|NCT04380701|515604969|FG021|Overall Study|Pregnancy|0|||
143017263|NCT04380701|515604970|FG022|Overall Study|Pregnancy|0|||
143017264|NCT04380701|515604971|FG023|Overall Study|Pregnancy|0|||
143017265|NCT04380701|515604972|FG024|Overall Study|Pregnancy|0|||
143017266|NCT04380701|515604973|FG025|Overall Study|Pregnancy|0|||
143017267|NCT04380701|515604974|FG026|Overall Study|Pregnancy|0|||
143017268|NCT04380701|515604975|FG027|Overall Study|Pregnancy|0|||
143017269|NCT04380701|515604976|FG028|Overall Study|Pregnancy|0|||
143017270|NCT04380701|515604977|FG029|Overall Study|Pregnancy|0|||
143017271|NCT04380701|515604978|FG030|Overall Study|Pregnancy|0|||
143017272|NCT04380701|515604979|FG031|Overall Study|Pregnancy|0|||
143017273|NCT04380701|515604980|FG032|Overall Study|Pregnancy|1|||
143017274|NCT04380701|515604981|FG033|Overall Study|Pregnancy|0|||
143017275|NCT04380701|515604948|FG000|Overall Study|Lost to Follow-up|0|||
143017276|NCT04380701|515604949|FG001|Overall Study|Lost to Follow-up|0|||
143017277|NCT04380701|515604950|FG002|Overall Study|Lost to Follow-up|0|||
143017278|NCT04380701|515604951|FG003|Overall Study|Lost to Follow-up|0|||
143017279|NCT04380701|515604952|FG004|Overall Study|Lost to Follow-up|0|||
143017280|NCT04380701|515604953|FG005|Overall Study|Lost to Follow-up|0|||
143017281|NCT04380701|515604954|FG006|Overall Study|Lost to Follow-up|0|||
143017282|NCT04380701|515604955|FG007|Overall Study|Lost to Follow-up|0|||
143017283|NCT04380701|515604956|FG008|Overall Study|Lost to Follow-up|0|||
143017284|NCT04380701|515604957|FG009|Overall Study|Lost to Follow-up|0|||
143017285|NCT04380701|515604958|FG010|Overall Study|Lost to Follow-up|0|||
143017286|NCT04380701|515604959|FG011|Overall Study|Lost to Follow-up|0|||
143017287|NCT04380701|515604960|FG012|Overall Study|Lost to Follow-up|0|||
143017288|NCT04380701|515604961|FG013|Overall Study|Lost to Follow-up|0|||
143017289|NCT04380701|515604962|FG014|Overall Study|Lost to Follow-up|0|||
143017290|NCT04380701|515604963|FG015|Overall Study|Lost to Follow-up|0|||
143017291|NCT04380701|515604964|FG016|Overall Study|Lost to Follow-up|0|||
143017292|NCT04380701|515604965|FG017|Overall Study|Lost to Follow-up|0|||
143017293|NCT04380701|515604966|FG018|Overall Study|Lost to Follow-up|0|||
143017294|NCT04380701|515604967|FG019|Overall Study|Lost to Follow-up|0|||
143017295|NCT04380701|515604968|FG020|Overall Study|Lost to Follow-up|1|||
143017296|NCT04380701|515604969|FG021|Overall Study|Lost to Follow-up|0|||
143017297|NCT04380701|515604970|FG022|Overall Study|Lost to Follow-up|0|||
143017298|NCT04380701|515604971|FG023|Overall Study|Lost to Follow-up|1|||
143017299|NCT04380701|515604972|FG024|Overall Study|Lost to Follow-up|0|||
143017300|NCT04380701|515604973|FG025|Overall Study|Lost to Follow-up|0|||
143017301|NCT04380701|515604974|FG026|Overall Study|Lost to Follow-up|0|||
143017302|NCT04380701|515604975|FG027|Overall Study|Lost to Follow-up|0|||
143017303|NCT04380701|515604976|FG028|Overall Study|Lost to Follow-up|0|||
143017304|NCT04380701|515604977|FG029|Overall Study|Lost to Follow-up|1|||
143017305|NCT04380701|515604978|FG030|Overall Study|Lost to Follow-up|0|||
143017306|NCT04380701|515604979|FG031|Overall Study|Lost to Follow-up|0|||
143017307|NCT04380701|515604980|FG032|Overall Study|Lost to Follow-up|0|||
143017308|NCT04380701|515604981|FG033|Overall Study|Lost to Follow-up|1|||
143017309|NCT04380701|515604948|FG000|Overall Study|Private reason(s)|0|||
143017310|NCT04380701|515604949|FG001|Overall Study|Private reason(s)|0|||
143017311|NCT04380701|515604950|FG002|Overall Study|Private reason(s)|0|||
143017312|NCT04380701|515604951|FG003|Overall Study|Private reason(s)|0|||
143017313|NCT04380701|515604952|FG004|Overall Study|Private reason(s)|0|||
143017314|NCT04380701|515604953|FG005|Overall Study|Private reason(s)|0|||
143017315|NCT04380701|515604954|FG006|Overall Study|Private reason(s)|1|||
143017316|NCT04380701|515604955|FG007|Overall Study|Private reason(s)|0|||
143017317|NCT04380701|515604956|FG008|Overall Study|Private reason(s)|1|||
143017318|NCT04380701|515604957|FG009|Overall Study|Private reason(s)|1|||
143017319|NCT04380701|515604958|FG010|Overall Study|Private reason(s)|0|||
143017320|NCT04380701|515604959|FG011|Overall Study|Private reason(s)|0|||
143017321|NCT04380701|515604960|FG012|Overall Study|Private reason(s)|0|||
143017322|NCT04380701|515604961|FG013|Overall Study|Private reason(s)|0|||
143017323|NCT04380701|515604962|FG014|Overall Study|Private reason(s)|0|||
143017324|NCT04380701|515604963|FG015|Overall Study|Private reason(s)|0|||
143017325|NCT04380701|515604964|FG016|Overall Study|Private reason(s)|0|||
143017326|NCT04380701|515604965|FG017|Overall Study|Private reason(s)|0|||
143017327|NCT04380701|515604966|FG018|Overall Study|Private reason(s)|0|||
143017328|NCT04380701|515604967|FG019|Overall Study|Private reason(s)|0|||
143017329|NCT04380701|515604968|FG020|Overall Study|Private reason(s)|0|||
143017330|NCT04380701|515604969|FG021|Overall Study|Private reason(s)|0|||
143017331|NCT04380701|515604970|FG022|Overall Study|Private reason(s)|0|||
143017332|NCT04380701|515604971|FG023|Overall Study|Private reason(s)|1|||
143017333|NCT04380701|515604972|FG024|Overall Study|Private reason(s)|0|||
143017334|NCT04380701|515604973|FG025|Overall Study|Private reason(s)|0|||
143017335|NCT04380701|515604974|FG026|Overall Study|Private reason(s)|0|||
143017336|NCT04380701|515604975|FG027|Overall Study|Private reason(s)|0|||
143017337|NCT04380701|515604976|FG028|Overall Study|Private reason(s)|0|||
143017338|NCT04380701|515604977|FG029|Overall Study|Private reason(s)|1|||
143017339|NCT04380701|515604978|FG030|Overall Study|Private reason(s)|0|||
143017340|NCT04380701|515604979|FG031|Overall Study|Private reason(s)|0|||
143017341|NCT04380701|515604980|FG032|Overall Study|Private reason(s)|0|||
143017342|NCT04380701|515604981|FG033|Overall Study|Private reason(s)|0|||
143017343|NCT04380701|515604948|FG000|Overall Study|Withdrawal by Subject|0|||
143017344|NCT04380701|515604949|FG001|Overall Study|Withdrawal by Subject|0|||
143017345|NCT04380701|515604950|FG002|Overall Study|Withdrawal by Subject|0|||
143017346|NCT04380701|515604951|FG003|Overall Study|Withdrawal by Subject|0|||
143153339|NCT02227199|516105953|FG000|Overall Study|Physician Decision|0|||
143363675|NCT00062868|516873787|FG007|Dose Level 3|Lost to Follow-up|0|||
143017347|NCT04380701|515604952|FG004|Overall Study|Withdrawal by Subject|0|||
143017348|NCT04380701|515604953|FG005|Overall Study|Withdrawal by Subject|0|||
143017349|NCT04380701|515604954|FG006|Overall Study|Withdrawal by Subject|1|||
143153340|NCT02227199|516105954|FG001|Overall Study|Physician Decision|0|||
143017350|NCT04380701|515604955|FG007|Overall Study|Withdrawal by Subject|1|||
143017351|NCT04380701|515604956|FG008|Overall Study|Withdrawal by Subject|0|||
143017352|NCT04380701|515604957|FG009|Overall Study|Withdrawal by Subject|0|||
143017353|NCT04380701|515604958|FG010|Overall Study|Withdrawal by Subject|0|||
143017354|NCT04380701|515604959|FG011|Overall Study|Withdrawal by Subject|1|||
143017355|NCT04380701|515604960|FG012|Overall Study|Withdrawal by Subject|0|||
143017356|NCT04380701|515604961|FG013|Overall Study|Withdrawal by Subject|1|||
143153341|NCT02227199|516105955|FG002|Overall Study|Physician Decision|1|||
143017357|NCT04380701|515604962|FG014|Overall Study|Withdrawal by Subject|0|||
143153342|NCT02227199|516105953|FG000|Overall Study|Adverse Event|0|||
143153343|NCT02227199|516105954|FG001|Overall Study|Adverse Event|0|||
143017358|NCT04380701|515604963|FG015|Overall Study|Withdrawal by Subject|0|||
143017359|NCT04380701|515604964|FG016|Overall Study|Withdrawal by Subject|1|||
143017360|NCT04380701|515604965|FG017|Overall Study|Withdrawal by Subject|0|||
143017361|NCT04380701|515604966|FG018|Overall Study|Withdrawal by Subject|0|||
143017362|NCT04380701|515604967|FG019|Overall Study|Withdrawal by Subject|0|||
143017363|NCT04380701|515604968|FG020|Overall Study|Withdrawal by Subject|0|||
143017364|NCT04380701|515604969|FG021|Overall Study|Withdrawal by Subject|0|||
143017365|NCT04380701|515604970|FG022|Overall Study|Withdrawal by Subject|2|||
143017366|NCT04380701|515604971|FG023|Overall Study|Withdrawal by Subject|2|||
143017367|NCT04380701|515604972|FG024|Overall Study|Withdrawal by Subject|1|||
143017368|NCT04380701|515604973|FG025|Overall Study|Withdrawal by Subject|1|||
143017369|NCT04380701|515604974|FG026|Overall Study|Withdrawal by Subject|0|||
143017370|NCT04380701|515604975|FG027|Overall Study|Withdrawal by Subject|0|||
143017371|NCT04380701|515604976|FG028|Overall Study|Withdrawal by Subject|0|||
143017372|NCT04380701|515604977|FG029|Overall Study|Withdrawal by Subject|0|||
143017373|NCT04380701|515604978|FG030|Overall Study|Withdrawal by Subject|0|||
143017374|NCT04380701|515604979|FG031|Overall Study|Withdrawal by Subject|0|||
143017375|NCT04380701|515604980|FG032|Overall Study|Withdrawal by Subject|0|||
143017376|NCT04380701|515604981|FG033|Overall Study|Withdrawal by Subject|0|||
143017377|NCT04380701|515604948|FG000|Overall Study|Adverse Event|0|||
143017378|NCT04380701|515604949|FG001|Overall Study|Adverse Event|0|||
143017379|NCT04380701|515604950|FG002|Overall Study|Adverse Event|0|||
143017380|NCT04380701|515604951|FG003|Overall Study|Adverse Event|0|||
143017381|NCT04380701|515604952|FG004|Overall Study|Adverse Event|0|||
143017382|NCT04380701|515604953|FG005|Overall Study|Adverse Event|1|||
143017383|NCT04380701|515604954|FG006|Overall Study|Adverse Event|0|||
143017384|NCT04380701|515604955|FG007|Overall Study|Adverse Event|0|||
143017385|NCT04380701|515604956|FG008|Overall Study|Adverse Event|0|||
143017386|NCT04380701|515604957|FG009|Overall Study|Adverse Event|0|||
143017387|NCT04380701|515604958|FG010|Overall Study|Adverse Event|0|||
143017388|NCT04380701|515604959|FG011|Overall Study|Adverse Event|0|||
143017389|NCT04380701|515604960|FG012|Overall Study|Adverse Event|0|||
143017390|NCT04380701|515604961|FG013|Overall Study|Adverse Event|0|||
143017391|NCT04380701|515604962|FG014|Overall Study|Adverse Event|0|||
143017392|NCT04380701|515604963|FG015|Overall Study|Adverse Event|1|||
143017393|NCT04380701|515604964|FG016|Overall Study|Adverse Event|0|||
143017394|NCT04380701|515604965|FG017|Overall Study|Adverse Event|0|||
143017395|NCT04380701|515604966|FG018|Overall Study|Adverse Event|0|||
143017396|NCT04380701|515604967|FG019|Overall Study|Adverse Event|1|||
143017397|NCT04380701|515604968|FG020|Overall Study|Adverse Event|0|||
143017398|NCT04380701|515604969|FG021|Overall Study|Adverse Event|0|||
143017399|NCT04380701|515604970|FG022|Overall Study|Adverse Event|0|||
143017400|NCT04380701|515604971|FG023|Overall Study|Adverse Event|0|||
143017401|NCT04380701|515604972|FG024|Overall Study|Adverse Event|0|||
143017402|NCT04380701|515604973|FG025|Overall Study|Adverse Event|0|||
143017403|NCT04380701|515604974|FG026|Overall Study|Adverse Event|0|||
143017404|NCT04380701|515604975|FG027|Overall Study|Adverse Event|0|||
143017405|NCT04380701|515604976|FG028|Overall Study|Adverse Event|0|||
143017406|NCT04380701|515604977|FG029|Overall Study|Adverse Event|0|||
143017407|NCT04380701|515604978|FG030|Overall Study|Adverse Event|0|||
143017408|NCT04380701|515604979|FG031|Overall Study|Adverse Event|0|||
143017409|NCT04380701|515604980|FG032|Overall Study|Adverse Event|0|||
143017410|NCT04380701|515604981|FG033|Overall Study|Adverse Event|0|||
143017411|NCT04380701|515604948|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
143153344|NCT02227199|516105955|FG002|Overall Study|Adverse Event|3|||
143017412|NCT04380701|515604949|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
143017413|NCT04380701|515604950|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
143017414|NCT04380701|515604951|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
143017415|NCT04380701|515604952|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
143017416|NCT04380701|515604953|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
143017417|NCT04380701|515604954|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
143017418|NCT04380701|515604955|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
143017419|NCT04380701|515604956|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
143017420|NCT04380701|515604957|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
143017421|NCT04380701|515604958|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
143017422|NCT04380701|515604959|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
143017423|NCT04380701|515604960|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
143017424|NCT04380701|515604961|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
143017425|NCT04380701|515604962|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
143017426|NCT04380701|515604963|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
143017427|NCT04380701|515604964|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
143017428|NCT04380701|515604965|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
143017429|NCT04380701|515604966|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
143017430|NCT04380701|515604967|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
143017431|NCT04380701|515604968|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
143017432|NCT04380701|515604969|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
143017433|NCT04380701|515604970|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
143017434|NCT04380701|515604971|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
143017435|NCT04380701|515604972|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
143017436|NCT04380701|515604973|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
143017437|NCT04380701|515604974|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
143017438|NCT04380701|515604975|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
143017439|NCT04380701|515604976|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
143017440|NCT04380701|515604977|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
143017441|NCT04380701|515604978|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
143017442|NCT04380701|515604979|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
143017443|NCT04380701|515604980|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
143017444|NCT04380701|515604981|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
143017445|NCT04380701|515604948|FG000|Overall Study|Physician Decision|0|||
143017446|NCT04380701|515604949|FG001|Overall Study|Physician Decision|0|||
143017447|NCT04380701|515604950|FG002|Overall Study|Physician Decision|0|||
143017448|NCT04380701|515604951|FG003|Overall Study|Physician Decision|0|||
143017449|NCT04380701|515604952|FG004|Overall Study|Physician Decision|0|||
143017450|NCT04380701|515604953|FG005|Overall Study|Physician Decision|0|||
143017451|NCT04380701|515604954|FG006|Overall Study|Physician Decision|0|||
143017452|NCT04380701|515604955|FG007|Overall Study|Physician Decision|0|||
143017453|NCT04380701|515604956|FG008|Overall Study|Physician Decision|0|||
143017454|NCT04380701|515604957|FG009|Overall Study|Physician Decision|0|||
143017455|NCT04380701|515604958|FG010|Overall Study|Physician Decision|0|||
143017456|NCT04380701|515604959|FG011|Overall Study|Physician Decision|0|||
143017457|NCT04380701|515604960|FG012|Overall Study|Physician Decision|0|||
143017458|NCT04380701|515604961|FG013|Overall Study|Physician Decision|0|||
143017459|NCT04380701|515604962|FG014|Overall Study|Physician Decision|0|||
143017460|NCT04380701|515604963|FG015|Overall Study|Physician Decision|0|||
143017461|NCT04380701|515604964|FG016|Overall Study|Physician Decision|0|||
143017462|NCT04380701|515604965|FG017|Overall Study|Physician Decision|0|||
143017463|NCT04380701|515604966|FG018|Overall Study|Physician Decision|0|||
143017464|NCT04380701|515604967|FG019|Overall Study|Physician Decision|0|||
143017465|NCT04380701|515604968|FG020|Overall Study|Physician Decision|0|||
143017466|NCT04380701|515604969|FG021|Overall Study|Physician Decision|0|||
143017467|NCT04380701|515604970|FG022|Overall Study|Physician Decision|0|||
143017468|NCT04380701|515604971|FG023|Overall Study|Physician Decision|0|||
143017469|NCT04380701|515604972|FG024|Overall Study|Physician Decision|2|||
143017470|NCT04380701|515604973|FG025|Overall Study|Physician Decision|0|||
143017471|NCT04380701|515604974|FG026|Overall Study|Physician Decision|0|||
143017472|NCT04380701|515604975|FG027|Overall Study|Physician Decision|0|||
143017473|NCT04380701|515604976|FG028|Overall Study|Physician Decision|0|||
143017474|NCT04380701|515604977|FG029|Overall Study|Physician Decision|0|||
143017475|NCT04380701|515604978|FG030|Overall Study|Physician Decision|0|||
143153351|NCT03998462|516105957|FG000|Overall Study|Withdrawal by Subject|10|||
143153352|NCT03998462|516105958|FG001|Overall Study|Withdrawal by Subject|4|||
143153353|NCT03998462|516105957|FG000|Overall Study|Lost to Follow-up|1|||
143153354|NCT03998462|516105958|FG001|Overall Study|Lost to Follow-up|0|||
143153355|NCT03998462|516105957|FG000|Overall Study|Technical Difficulties|1|||
143153356|NCT03998462|516105958|FG001|Overall Study|Technical Difficulties|2|||
143153357|NCT05710224|516105959|FG000|Overall Study|Death|1|||
143153358|NCT05710224|516105960|FG001|Overall Study|Death|0|||
143153359|NCT05710224|516105959|FG000|Overall Study|Lost to Follow-up|16|||
143153360|NCT05710224|516105960|FG001|Overall Study|Lost to Follow-up|7|||
143153361|NCT05710224|516105959|FG000|Overall Study|Withdrawal by Subject|4|||
143017476|NCT04380701|515604979|FG031|Overall Study|Physician Decision|0|||
143017477|NCT04380701|515604980|FG032|Overall Study|Physician Decision|0|||
143017478|NCT04380701|515604981|FG033|Overall Study|Physician Decision|0|||
143017479|NCT04380701|515604948|FG000|Overall Study|Death|0|||
143017480|NCT04380701|515604949|FG001|Overall Study|Death|0|||
143153362|NCT05710224|516105960|FG001|Overall Study|Withdrawal by Subject|6|||
143153363|NCT05710224|516105959|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
143153364|NCT05710224|516105960|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
143017481|NCT04380701|515604950|FG002|Overall Study|Death|0|||
143017482|NCT04380701|515604951|FG003|Overall Study|Death|0|||
143017483|NCT04380701|515604952|FG004|Overall Study|Death|0|||
143017484|NCT04380701|515604953|FG005|Overall Study|Death|0|||
143017485|NCT04380701|515604954|FG006|Overall Study|Death|0|||
143017486|NCT04380701|515604955|FG007|Overall Study|Death|0|||
143153365|NCT05710224|516105959|FG000|Overall Study|Participants Left The City|0|||
143153366|NCT05710224|516105960|FG001|Overall Study|Participants Left The City|2|||
143017487|NCT04380701|515604956|FG008|Overall Study|Death|0|||
143017488|NCT04380701|515604957|FG009|Overall Study|Death|0|||
143017489|NCT04380701|515604958|FG010|Overall Study|Death|0|||
143017490|NCT04380701|515604959|FG011|Overall Study|Death|0|||
143017491|NCT04380701|515604960|FG012|Overall Study|Death|0|||
143017492|NCT04380701|515604961|FG013|Overall Study|Death|0|||
143017493|NCT04380701|515604962|FG014|Overall Study|Death|0|||
143017494|NCT04380701|515604963|FG015|Overall Study|Death|0|||
143017495|NCT04380701|515604964|FG016|Overall Study|Death|0|||
143017496|NCT04380701|515604965|FG017|Overall Study|Death|0|||
143017497|NCT04380701|515604966|FG018|Overall Study|Death|0|||
143017498|NCT04380701|515604967|FG019|Overall Study|Death|0|||
143017499|NCT04380701|515604968|FG020|Overall Study|Death|0|||
143017500|NCT04380701|515604969|FG021|Overall Study|Death|0|||
143017501|NCT04380701|515604970|FG022|Overall Study|Death|0|||
143017502|NCT04380701|515604971|FG023|Overall Study|Death|0|||
143017503|NCT04380701|515604972|FG024|Overall Study|Death|1|||
143017504|NCT04380701|515604973|FG025|Overall Study|Death|0|||
143017505|NCT04380701|515604974|FG026|Overall Study|Death|0|||
143017506|NCT04380701|515604975|FG027|Overall Study|Death|0|||
143017507|NCT04380701|515604976|FG028|Overall Study|Death|0|||
143017508|NCT04380701|515604977|FG029|Overall Study|Death|0|||
143017509|NCT04380701|515604978|FG030|Overall Study|Death|0|||
143017510|NCT04380701|515604979|FG031|Overall Study|Death|0|||
143017511|NCT04380701|515604980|FG032|Overall Study|Death|0|||
143017512|NCT04380701|515604981|FG033|Overall Study|Death|0|||
143017513|NCT04380701|515604948|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
143017514|NCT04380701|515604949|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
143017515|NCT04380701|515604950|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
143017516|NCT04380701|515604951|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
143017517|NCT04380701|515604952|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
143017518|NCT04380701|515604953|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
143017519|NCT04380701|515604954|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
143017520|NCT04380701|515604955|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
143017521|NCT04380701|515604956|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
143017522|NCT04380701|515604957|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
143017523|NCT04380701|515604958|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
143017524|NCT04380701|515604959|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
143017525|NCT04380701|515604960|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
143017526|NCT04380701|515604961|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
143017527|NCT04380701|515604962|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
143017528|NCT04380701|515604963|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
143017529|NCT04380701|515604964|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
143017530|NCT04380701|515604965|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
143017531|NCT04380701|515604966|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
143017532|NCT04380701|515604967|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
143017533|NCT04380701|515604968|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
143017534|NCT04380701|515604969|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
143017535|NCT04380701|515604970|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
143017536|NCT04380701|515604971|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
143017537|NCT04380701|515604972|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
143017538|NCT04380701|515604973|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
143017539|NCT04380701|515604974|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
143017540|NCT04380701|515604975|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
143017541|NCT04380701|515604976|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
143017542|NCT04380701|515604977|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
143017543|NCT04380701|515604978|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
143017544|NCT04380701|515604979|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
143017545|NCT04380701|515604980|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
143017546|NCT04380701|515604981|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
143017547|NCT00558519|515604982|FG000|Overall Study|Ph+|20|||
143017548|NCT00558519|515604982|FG000|Overall Study|Ineligible|1|||
143017549|NCT00558519|515604982|FG000|Overall Study|Insufficient data|1|||
143017550|NCT00558519|515604982|FG000|Overall Study|Never received treatment|1|||
143017551|NCT00383019|515604983|FG000|Overall Study|Adverse Event|5|||
143017552|NCT00383019|515604984|FG001|Overall Study|Adverse Event|1|||
143017553|NCT00383019|515604983|FG000|Overall Study|Withdrawal by Subject|0|||
143017554|NCT00383019|515604984|FG001|Overall Study|Withdrawal by Subject|1|||
143017555|NCT02278952|515604985|FG000|Overall Study|Insufficient Sample|6|||
143485414|NCT02831673|517322811|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
143485415|NCT02831673|517322812|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
143485416|NCT02831673|517322813|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
143017556|NCT00995930|515604992|FG000|Overall Study|Protocol deviation|2|||
143017557|NCT00995930|515604993|FG001|Overall Study|Protocol deviation|5|||
143017558|NCT00995930|515604992|FG000|Overall Study|Death|0|||
143017559|NCT00995930|515604993|FG001|Overall Study|Death|1|||
143017560|NCT00995930|515604992|FG000|Overall Study|Administrative problems|4|||
143017561|NCT00995930|515604993|FG001|Overall Study|Administrative problems|2|||
143017562|NCT00995930|515604992|FG000|Overall Study|Lost to Follow-up|1|||
143017563|NCT00995930|515604993|FG001|Overall Study|Lost to Follow-up|2|||
143017564|NCT00995930|515604992|FG000|Overall Study|Withdrawal by Subject|3|||
143017565|NCT00995930|515604993|FG001|Overall Study|Withdrawal by Subject|4|||
143017566|NCT00995930|515604992|FG000|Overall Study|Adverse Event|11|||
143017567|NCT00995930|515604993|FG001|Overall Study|Adverse Event|14|||
143017568|NCT01458119|515604994|FG000|Overall Study|Physician Decision|4|||
143017569|NCT01458119|515604994|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
143017570|NCT01458119|515604994|FG000|Overall Study|Pregnancy|1|||
143017571|NCT01458119|515604994|FG000|Overall Study|Death|2|||
143017572|NCT01458119|515604994|FG000|Overall Study|Adverse Event|1|||
143017573|NCT01458119|515604994|FG000|Overall Study|Consent Withdrawn by Participant|8|||
143017574|NCT01458119|515604994|FG000|Overall Study|Non-compliance With Study Drug|3|||
143017575|NCT02094937|515604999|FG000|8 Weeks in Period 1|Adverse Event|9|||
143017576|NCT02094937|515605000|FG001|8 Weeks in Period 1|Adverse Event|0|||
143017577|NCT02094937|515605001|FG002|8 Weeks in Period 1|Adverse Event|0|||
143017578|NCT02094937|515605002|FG003|8 Weeks in Period 1|Adverse Event|0|||
143017579|NCT02094937|515604999|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
143017580|NCT02094937|515605000|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
143017581|NCT02094937|515605001|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
143017582|NCT02094937|515605002|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
143017583|NCT02094937|515604999|FG000|8 Weeks in Period 1|Protocol Violation|2|||
143017584|NCT02094937|515605000|FG001|8 Weeks in Period 1|Protocol Violation|0|||
143017585|NCT02094937|515605001|FG002|8 Weeks in Period 1|Protocol Violation|0|||
143017586|NCT02094937|515605002|FG003|8 Weeks in Period 1|Protocol Violation|0|||
143017587|NCT02094937|515604999|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
143017588|NCT02094937|515605000|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
143017589|NCT02094937|515605001|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
143017590|NCT02094937|515605002|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
143017591|NCT02094937|515604999|FG000|8 Weeks in Period 1|Physician Decision|1|||
143017592|NCT02094937|515605000|FG001|8 Weeks in Period 1|Physician Decision|0|||
143153374|NCT03369223|516105965|FG000|Overall Study|Lost to Follow-up|0|||
143153375|NCT03369223|516105966|FG001|Overall Study|Lost to Follow-up|0|||
143153376|NCT03369223|516105967|FG002|Overall Study|Lost to Follow-up|0|||
143153377|NCT03369223|516105968|FG003|Overall Study|Lost to Follow-up|0|||
143153378|NCT03369223|516105969|FG004|Overall Study|Lost to Follow-up|0|||
143153379|NCT03369223|516105970|FG005|Overall Study|Lost to Follow-up|0|||
143153380|NCT03369223|516105971|FG006|Overall Study|Lost to Follow-up|0|||
143153381|NCT03369223|516105972|FG007|Overall Study|Lost to Follow-up|0|||
143153382|NCT03369223|516105973|FG008|Overall Study|Lost to Follow-up|0|||
143153383|NCT03369223|516105974|FG009|Overall Study|Lost to Follow-up|0|||
143153384|NCT03369223|516105975|FG010|Overall Study|Lost to Follow-up|0|||
143153385|NCT03369223|516105976|FG011|Overall Study|Lost to Follow-up|0|||
143153386|NCT03369223|516105977|FG012|Overall Study|Lost to Follow-up|0|||
143153387|NCT03369223|516105978|FG013|Overall Study|Lost to Follow-up|0|||
143153388|NCT03369223|516105979|FG014|Overall Study|Lost to Follow-up|0|||
143153389|NCT03369223|516105980|FG015|Overall Study|Lost to Follow-up|0|||
143153390|NCT03369223|516105981|FG016|Overall Study|Lost to Follow-up|0|||
143153391|NCT03369223|516105982|FG017|Overall Study|Lost to Follow-up|0|||
143153392|NCT03369223|516105983|FG018|Overall Study|Lost to Follow-up|2|||
143153393|NCT03369223|516105984|FG019|Overall Study|Lost to Follow-up|1|||
143153394|NCT03369223|516105965|FG000|Overall Study|Participant no longer meets study criteria|0|||
143153395|NCT03369223|516105966|FG001|Overall Study|Participant no longer meets study criteria|0|||
143485417|NCT02831673|517322809|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
143153396|NCT03369223|516105967|FG002|Overall Study|Participant no longer meets study criteria|0|||
143153397|NCT03369223|516105968|FG003|Overall Study|Participant no longer meets study criteria|0|||
143153398|NCT03369223|516105969|FG004|Overall Study|Participant no longer meets study criteria|0|||
143153399|NCT03369223|516105970|FG005|Overall Study|Participant no longer meets study criteria|0|||
143017593|NCT02094937|515605001|FG002|8 Weeks in Period 1|Physician Decision|0|||
143017594|NCT02094937|515605002|FG003|8 Weeks in Period 1|Physician Decision|0|||
143017595|NCT02094937|515604999|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
143017596|NCT02094937|515605000|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
143017597|NCT02094937|515605001|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
143017598|NCT02094937|515605002|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
143017599|NCT02094937|515604999|FG000|12 Weeks in Period 2|Adverse Event|0|||
143017600|NCT02094937|515605000|FG001|12 Weeks in Period 2|Adverse Event|2|||
143017601|NCT02094937|515605001|FG002|12 Weeks in Period 2|Adverse Event|4|||
143017602|NCT02094937|515605002|FG003|12 Weeks in Period 2|Adverse Event|1|||
143017603|NCT02094937|515604999|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
143017604|NCT02094937|515605000|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
143017605|NCT02094937|515605001|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
143017606|NCT02094937|515605002|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
143017607|NCT02094937|515604999|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
143017608|NCT02094937|515605000|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
143017609|NCT02094937|515605001|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
143017610|NCT02094937|515605002|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
143017611|NCT02094937|515604999|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
143017612|NCT02094937|515605000|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
143017613|NCT02094937|515605001|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
143017614|NCT02094937|515605002|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
143017615|NCT02094937|515604999|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
143017616|NCT02094937|515605000|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
143017617|NCT02094937|515605001|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
143017618|NCT02094937|515605002|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
143017619|NCT03185949|515605005|FG000|ITT Analysis|Withdrawal by Subject|4|||
143017620|NCT03185949|515605006|FG001|ITT Analysis|Withdrawal by Subject|3|||
143017621|NCT03185949|515605005|FG000|PP Analysis|Protocol Violation|2|||
143017622|NCT03185949|515605006|FG001|PP Analysis|Protocol Violation|2|||
143017623|NCT03185949|515605005|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
143017624|NCT03185949|515605006|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
143017625|NCT05788237|515605012|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
143017626|NCT05788237|515605013|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
143017627|NCT05788237|515605014|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
143017628|NCT05788237|515605015|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
143017629|NCT05788237|515605012|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
143017630|NCT05788237|515605013|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
143017631|NCT05788237|515605014|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
143017632|NCT05788237|515605015|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
143017633|NCT05788237|515605012|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
143017634|NCT05788237|515605013|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
143017635|NCT05788237|515605014|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
143017636|NCT05788237|515605015|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
143017637|NCT05788237|515605012|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
143017638|NCT05788237|515605013|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
143017639|NCT05788237|515605014|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
143017640|NCT05788237|515605015|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
143017641|NCT05788237|515605012|FG000|SSA (Approximately 2 Months)|Death|0|||
143017642|NCT05788237|515605013|FG001|SSA (Approximately 2 Months)|Death|1|||
143017643|NCT05788237|515605014|FG002|SSA (Approximately 2 Months)|Death|0|||
143017644|NCT05788237|515605015|FG003|SSA (Approximately 2 Months)|Death|0|||
143017645|NCT05788237|515605012|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
143017646|NCT05788237|515605013|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
143017647|NCT05788237|515605014|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
143017648|NCT05788237|515605015|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
143017649|NCT05788237|515605012|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
143017650|NCT05788237|515605013|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
143017651|NCT05788237|515605014|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
143017652|NCT05788237|515605015|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
143017653|NCT05788237|515605012|FG000|SSB (Approximately 1 Month)|Other|0|||
143017654|NCT05788237|515605013|FG001|SSB (Approximately 1 Month)|Other|0|||
143017655|NCT05788237|515605014|FG002|SSB (Approximately 1 Month)|Other|0|||
143017656|NCT05788237|515605015|FG003|SSB (Approximately 1 Month)|Other|1|||
143017657|NCT05166421|515605018|FG000|Overall Study|Other|3|||
143017658|NCT05166421|515605019|FG001|Overall Study|Other|1|||
143017659|NCT05166421|515605020|FG002|Overall Study|Other|1|||
143017660|NCT05166421|515605018|FG000|Overall Study|Withdrawal by Subject|5|||
143017661|NCT05166421|515605019|FG001|Overall Study|Withdrawal by Subject|3|||
143153400|NCT03369223|516105971|FG006|Overall Study|Participant no longer meets study criteria|0|||
143153401|NCT03369223|516105972|FG007|Overall Study|Participant no longer meets study criteria|0|||
143017662|NCT05166421|515605020|FG002|Overall Study|Withdrawal by Subject|6|||
143017663|NCT05166421|515605018|FG000|Overall Study|Lost to Follow-up|4|||
143017664|NCT05166421|515605019|FG001|Overall Study|Lost to Follow-up|1|||
143017665|NCT05166421|515605020|FG002|Overall Study|Lost to Follow-up|7|||
143017666|NCT00265083|515606456|FG000|Overall Study|Adverse Event|5|||
143017667|NCT00265083|515606457|FG001|Overall Study|Adverse Event|13|||
143017668|NCT00265083|515606458|FG002|Overall Study|Adverse Event|15|||
143363676|NCT00062868|516873788|FG008|Dose Level 3|Lost to Follow-up|0|||
143017669|NCT00265083|515606456|FG000|Overall Study|Lost to Follow-up|3|||
143017670|NCT00265083|515606457|FG001|Overall Study|Lost to Follow-up|4|||
143017671|NCT00265083|515606458|FG002|Overall Study|Lost to Follow-up|4|||
143017672|NCT00265083|515606456|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
143017673|NCT00265083|515606457|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
143017674|NCT00265083|515606458|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
143017675|NCT00265083|515606456|FG000|Overall Study|Other|1|||
143017676|NCT00265083|515606457|FG001|Overall Study|Other|12|||
143017677|NCT00265083|515606458|FG002|Overall Study|Other|9|||
143017678|NCT00787566|515606465|FG000|Overall Study|AE related to chemotherapy|0|||
143017679|NCT00787566|515606466|FG001|Overall Study|AE related to chemotherapy|1|||
143017680|NCT00787566|515606467|FG002|Overall Study|AE related to chemotherapy|0|||
143017681|NCT02140164|515606468|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
143017682|NCT01814761|515606473|FG000|Overall Study|Other Reasons|1|||
143017683|NCT01814761|515606474|FG001|Overall Study|Other Reasons|10|||
143017684|NCT01814761|515606473|FG000|Overall Study|Ocular Adverse Event|6|||
143017685|NCT01814761|515606474|FG001|Overall Study|Ocular Adverse Event|15|||
143153402|NCT03369223|516105973|FG008|Overall Study|Participant no longer meets study criteria|0|||
143153403|NCT03369223|516105974|FG009|Overall Study|Participant no longer meets study criteria|0|||
143153404|NCT03369223|516105975|FG010|Overall Study|Participant no longer meets study criteria|0|||
143153405|NCT03369223|516105976|FG011|Overall Study|Participant no longer meets study criteria|0|||
143153406|NCT03369223|516105977|FG012|Overall Study|Participant no longer meets study criteria|0|||
143153407|NCT03369223|516105978|FG013|Overall Study|Participant no longer meets study criteria|0|||
143153408|NCT03369223|516105979|FG014|Overall Study|Participant no longer meets study criteria|2|||
143153409|NCT03369223|516105980|FG015|Overall Study|Participant no longer meets study criteria|0|||
143153410|NCT03369223|516105981|FG016|Overall Study|Participant no longer meets study criteria|2|||
143153411|NCT03369223|516105982|FG017|Overall Study|Participant no longer meets study criteria|0|||
143153412|NCT03369223|516105983|FG018|Overall Study|Participant no longer meets study criteria|0|||
143153413|NCT03369223|516105984|FG019|Overall Study|Participant no longer meets study criteria|0|||
143153414|NCT03369223|516105965|FG000|Overall Study|Other reasons|0|||
143153415|NCT03369223|516105966|FG001|Overall Study|Other reasons|0|||
143153416|NCT03369223|516105967|FG002|Overall Study|Other reasons|0|||
143153417|NCT03369223|516105968|FG003|Overall Study|Other reasons|0|||
143153418|NCT03369223|516105969|FG004|Overall Study|Other reasons|0|||
143153419|NCT03369223|516105970|FG005|Overall Study|Other reasons|0|||
143153420|NCT03369223|516105971|FG006|Overall Study|Other reasons|0|||
143153421|NCT03369223|516105972|FG007|Overall Study|Other reasons|0|||
143153422|NCT03369223|516105973|FG008|Overall Study|Other reasons|0|||
143153423|NCT03369223|516105974|FG009|Overall Study|Other reasons|0|||
143153424|NCT03369223|516105975|FG010|Overall Study|Other reasons|0|||
143153425|NCT03369223|516105976|FG011|Overall Study|Other reasons|0|||
143153426|NCT03369223|516105977|FG012|Overall Study|Other reasons|0|||
143153427|NCT03369223|516105978|FG013|Overall Study|Other reasons|1|||
143153428|NCT03369223|516105979|FG014|Overall Study|Other reasons|2|||
143153429|NCT03369223|516105980|FG015|Overall Study|Other reasons|0|||
143153430|NCT03369223|516105981|FG016|Overall Study|Other reasons|1|||
143153431|NCT03369223|516105982|FG017|Overall Study|Other reasons|0|||
143153432|NCT03369223|516105983|FG018|Overall Study|Other reasons|0|||
143153433|NCT03369223|516105984|FG019|Overall Study|Other reasons|2|||
143153434|NCT03369223|516105965|FG000|Overall Study|Death|0|||
143153435|NCT03369223|516105966|FG001|Overall Study|Death|0|||
143153436|NCT03369223|516105967|FG002|Overall Study|Death|0|||
143363677|NCT00062868|516873789|FG009|Dose Level 3|Lost to Follow-up|0|||
143485418|NCT02831673|517322810|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
143017686|NCT01814761|515606473|FG000|Overall Study|Lost to Follow-up|1|||
143017687|NCT01814761|515606474|FG001|Overall Study|Lost to Follow-up|5|||
143017688|NCT01872689|515606486|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
143017689|NCT01872689|515606487|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
143017690|NCT01872689|515606488|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
143017691|NCT01872689|515606489|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
143017692|NCT01872689|515606486|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
143153437|NCT03369223|516105968|FG003|Overall Study|Death|0|||
143153438|NCT03369223|516105969|FG004|Overall Study|Death|0|||
143153439|NCT03369223|516105970|FG005|Overall Study|Death|0|||
143153440|NCT03369223|516105971|FG006|Overall Study|Death|0|||
143485419|NCT02831673|517322811|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
143485420|NCT02831673|517322812|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
143153441|NCT03369223|516105972|FG007|Overall Study|Death|0|||
143153442|NCT03369223|516105973|FG008|Overall Study|Death|0|||
143153443|NCT03369223|516105974|FG009|Overall Study|Death|0|||
143153444|NCT03369223|516105975|FG010|Overall Study|Death|0|||
143153445|NCT03369223|516105976|FG011|Overall Study|Death|0|||
143153446|NCT03369223|516105977|FG012|Overall Study|Death|0|||
143153447|NCT03369223|516105978|FG013|Overall Study|Death|1|||
143153448|NCT03369223|516105979|FG014|Overall Study|Death|0|||
143153449|NCT03369223|516105980|FG015|Overall Study|Death|0|||
143017693|NCT01872689|515606487|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
143017694|NCT01872689|515606488|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
143017695|NCT01872689|515606489|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
143017696|NCT01872689|515606486|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
143017697|NCT01872689|515606487|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
143017698|NCT01872689|515606488|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
143017699|NCT01872689|515606489|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
143017700|NCT01872689|515606486|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
143017701|NCT01872689|515606487|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
143017702|NCT01872689|515606488|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
143017703|NCT01872689|515606489|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
143017704|NCT01872689|515606486|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
143017705|NCT01872689|515606487|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
143017706|NCT01872689|515606488|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
143017707|NCT01872689|515606489|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
143017708|NCT01872689|515606486|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
143017709|NCT01872689|515606487|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
143017710|NCT01872689|515606488|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
143017711|NCT01872689|515606489|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
143017712|NCT01872689|515606486|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
143017713|NCT01872689|515606487|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
143017714|NCT01872689|515606488|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
143017715|NCT01872689|515606489|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
143017716|NCT01872689|515606486|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
143017717|NCT01872689|515606487|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
143017718|NCT01872689|515606488|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
143017719|NCT01872689|515606489|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
143017720|NCT01872689|515606486|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
143017721|NCT01872689|515606487|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
143017722|NCT01872689|515606488|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
143017723|NCT01872689|515606489|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
143017724|NCT01872689|515606486|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
143017725|NCT01872689|515606487|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
143017726|NCT01872689|515606488|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
143017727|NCT01872689|515606489|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
143017728|NCT01872689|515606486|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
143017729|NCT01872689|515606487|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
143017730|NCT01872689|515606488|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
143017731|NCT01872689|515606489|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
143017732|NCT01872689|515606486|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
143017733|NCT01872689|515606487|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
143017734|NCT01872689|515606488|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
143153450|NCT03369223|516105981|FG016|Overall Study|Death|0|||
143153451|NCT03369223|516105982|FG017|Overall Study|Death|0|||
143153452|NCT03369223|516105983|FG018|Overall Study|Death|1|||
143153453|NCT03369223|516105984|FG019|Overall Study|Death|0|||
143153454|NCT03369223|516105965|FG000|Overall Study|Adverse event unrelated to study drug|0|||
143153455|NCT03369223|516105966|FG001|Overall Study|Adverse event unrelated to study drug|0|||
143153456|NCT03369223|516105967|FG002|Overall Study|Adverse event unrelated to study drug|0|||
143153457|NCT03369223|516105968|FG003|Overall Study|Adverse event unrelated to study drug|0|||
143153458|NCT03369223|516105969|FG004|Overall Study|Adverse event unrelated to study drug|0|||
143153459|NCT03369223|516105970|FG005|Overall Study|Adverse event unrelated to study drug|0|||
143153460|NCT03369223|516105971|FG006|Overall Study|Adverse event unrelated to study drug|1|||
143153461|NCT03369223|516105972|FG007|Overall Study|Adverse event unrelated to study drug|0|||
143153462|NCT03369223|516105973|FG008|Overall Study|Adverse event unrelated to study drug|0|||
143153463|NCT03369223|516105974|FG009|Overall Study|Adverse event unrelated to study drug|1|||
143153464|NCT03369223|516105975|FG010|Overall Study|Adverse event unrelated to study drug|0|||
143153465|NCT03369223|516105976|FG011|Overall Study|Adverse event unrelated to study drug|0|||
143153466|NCT03369223|516105977|FG012|Overall Study|Adverse event unrelated to study drug|0|||
143153467|NCT03369223|516105978|FG013|Overall Study|Adverse event unrelated to study drug|4|||
143153468|NCT03369223|516105979|FG014|Overall Study|Adverse event unrelated to study drug|2|||
143153469|NCT03369223|516105980|FG015|Overall Study|Adverse event unrelated to study drug|0|||
143153470|NCT03369223|516105981|FG016|Overall Study|Adverse event unrelated to study drug|2|||
143363678|NCT00062868|516873790|FG010|Dose Level 3|Lost to Follow-up|0|||
143153471|NCT03369223|516105982|FG017|Overall Study|Adverse event unrelated to study drug|1|||
143153472|NCT03369223|516105983|FG018|Overall Study|Adverse event unrelated to study drug|3|||
143363679|NCT00062868|516873791|FG011|Dose Level 3|Lost to Follow-up|0|||
143363680|NCT00062868|516873792|FG012|Dose Level 3|Lost to Follow-up|0|||
143017735|NCT01872689|515606489|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
143017736|NCT01872689|515606486|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
143017737|NCT01872689|515606487|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
143017738|NCT01872689|515606488|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
143017739|NCT01872689|515606489|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
143017740|NCT01872689|515606486|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
143017741|NCT01872689|515606487|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
143017742|NCT01872689|515606488|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
143017743|NCT01872689|515606489|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
143017744|NCT01070966|515606496|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
143017745|NCT01070966|515606496|FG000|Participants for Safety Evaluation|Off-label use|9|||
143017746|NCT01070966|515606496|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
143017747|NCT01070966|515606496|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
143017748|NCT01070966|515606496|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
143017749|NCT01070966|515606496|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
143017750|NCT01070966|515606496|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
143017751|NCT01070966|515606496|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
143017752|NCT01725113|515606497|FG000|Overall Study|Kidney Transplant|1|||
143017753|NCT01725113|515606498|FG001|Overall Study|Kidney Transplant|1|||
143017754|NCT01725113|515606497|FG000|Overall Study|Withdrawal by Subject|0|||
143017755|NCT01725113|515606498|FG001|Overall Study|Withdrawal by Subject|1|||
143017756|NCT02143947|515606499|FG000|Overall Study|Lost to Follow-up|4|||
143017757|NCT02143947|515606500|FG001|Overall Study|Lost to Follow-up|2|||
143017758|NCT00697112|515606503|FG000|Overall Study|Adverse Event|8|||
143017759|NCT00697112|515606503|FG000|Overall Study|Lost to Follow-up|1|||
143017760|NCT00697112|515606503|FG000|Overall Study|Did not meet inclusion criteria|1|||
143017761|NCT01427920|515606508|FG000|Overall Study|Adverse Event|1|||
143017762|NCT01427920|515606509|FG001|Overall Study|Adverse Event|2|||
143017763|NCT01427920|515606508|FG000|Overall Study|Lack of Efficacy|1|||
143017764|NCT01427920|515606509|FG001|Overall Study|Lack of Efficacy|0|||
143017765|NCT01427920|515606508|FG000|Overall Study|Protocol Violation|1|||
143017766|NCT01427920|515606509|FG001|Overall Study|Protocol Violation|3|||
143017767|NCT01427920|515606508|FG000|Overall Study|Withdrawal Criteria|4|||
143017768|NCT01427920|515606509|FG001|Overall Study|Withdrawal Criteria|4|||
143017769|NCT01427920|515606508|FG000|Overall Study|Unclassified|2|||
143017770|NCT01427920|515606509|FG001|Overall Study|Unclassified|8|||
143017771|NCT04228302|515606510|FG000|Overall Study|Adverse Event|0|||
143017772|NCT04228302|515606511|FG001|Overall Study|Adverse Event|0|||
143017773|NCT04228302|515606512|FG002|Overall Study|Adverse Event|0|||
143017774|NCT04228302|515606513|FG003|Overall Study|Adverse Event|0|||
143017775|NCT04228302|515606514|FG004|Overall Study|Adverse Event|1|||
143153473|NCT03369223|516105984|FG019|Overall Study|Adverse event unrelated to study drug|2|||
143153474|NCT03369223|516105965|FG000|Overall Study|Disease progression|6|||
143485421|NCT02831673|517322813|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
143485422|NCT02831673|517322809|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
143485423|NCT02831673|517322810|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
143485424|NCT02831673|517322811|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
143485425|NCT02831673|517322812|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
143485426|NCT02831673|517322813|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
143485427|NCT02831673|517322809|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
143485428|NCT02831673|517322810|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
143485429|NCT02831673|517322811|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
143153475|NCT03369223|516105966|FG001|Overall Study|Disease progression|8|||
143153476|NCT03369223|516105967|FG002|Overall Study|Disease progression|5|||
143153477|NCT03369223|516105968|FG003|Overall Study|Disease progression|1|||
143153478|NCT03369223|516105969|FG004|Overall Study|Disease progression|9|||
143153479|NCT03369223|516105970|FG005|Overall Study|Disease progression|9|||
143485430|NCT02831673|517322812|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
143485431|NCT02831673|517322813|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
143485432|NCT02831673|517322809|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
143485433|NCT02831673|517322810|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
143485434|NCT02831673|517322811|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
143017776|NCT04228302|515606515|FG005|Overall Study|Adverse Event|0|||
143017777|NCT03066440|515606518|FG000|Overall Study|Physician Decision|1|||
143017778|NCT03066440|515606519|FG001|Overall Study|Physician Decision|1|||
143017779|NCT03066440|515606518|FG000|Overall Study|Protocol Violation|0|||
143017780|NCT03066440|515606519|FG001|Overall Study|Protocol Violation|2|||
143153480|NCT03369223|516105971|FG006|Overall Study|Disease progression|4|||
143017781|NCT00054275|515606522|FG000|Overall Study|Withdrawal by Subject|4|||
143017782|NCT00054275|515606522|FG000|Overall Study|Adverse Event|5|||
143153481|NCT03369223|516105972|FG007|Overall Study|Disease progression|6|||
143153482|NCT03369223|516105973|FG008|Overall Study|Disease progression|10|||
143153483|NCT03369223|516105974|FG009|Overall Study|Disease progression|7|||
143153484|NCT03369223|516105975|FG010|Overall Study|Disease progression|4|||
143153485|NCT03369223|516105976|FG011|Overall Study|Disease progression|1|||
143153486|NCT03369223|516105977|FG012|Overall Study|Disease progression|1|||
143153487|NCT03369223|516105978|FG013|Overall Study|Disease progression|25|||
143153488|NCT03369223|516105979|FG014|Overall Study|Disease progression|22|||
143153489|NCT03369223|516105980|FG015|Overall Study|Disease progression|2|||
143153490|NCT03369223|516105981|FG016|Overall Study|Disease progression|10|||
143153491|NCT03369223|516105982|FG017|Overall Study|Disease progression|1|||
143153492|NCT03369223|516105983|FG018|Overall Study|Disease progression|18|||
143153493|NCT03369223|516105984|FG019|Overall Study|Disease progression|28|||
143153494|NCT03369223|516105965|FG000|Overall Study|Study drug toxicity|0|||
143153495|NCT03369223|516105966|FG001|Overall Study|Study drug toxicity|1|||
143153496|NCT03369223|516105967|FG002|Overall Study|Study drug toxicity|4|||
143153497|NCT03369223|516105968|FG003|Overall Study|Study drug toxicity|0|||
143153498|NCT03369223|516105969|FG004|Overall Study|Study drug toxicity|1|||
143153499|NCT03369223|516105970|FG005|Overall Study|Study drug toxicity|2|||
143153500|NCT03369223|516105971|FG006|Overall Study|Study drug toxicity|4|||
143153501|NCT03369223|516105972|FG007|Overall Study|Study drug toxicity|2|||
143153502|NCT03369223|516105973|FG008|Overall Study|Study drug toxicity|2|||
143153503|NCT03369223|516105974|FG009|Overall Study|Study drug toxicity|0|||
143153504|NCT03369223|516105975|FG010|Overall Study|Study drug toxicity|6|||
143153505|NCT03369223|516105976|FG011|Overall Study|Study drug toxicity|1|||
143153506|NCT03369223|516105977|FG012|Overall Study|Study drug toxicity|2|||
143153507|NCT03369223|516105978|FG013|Overall Study|Study drug toxicity|19|||
143153508|NCT03369223|516105979|FG014|Overall Study|Study drug toxicity|19|||
143153509|NCT03369223|516105980|FG015|Overall Study|Study drug toxicity|0|||
143153510|NCT03369223|516105981|FG016|Overall Study|Study drug toxicity|18|||
143153511|NCT03369223|516105982|FG017|Overall Study|Study drug toxicity|3|||
143153512|NCT03369223|516105983|FG018|Overall Study|Study drug toxicity|11|||
143153513|NCT03369223|516105984|FG019|Overall Study|Study drug toxicity|7|||
143153514|NCT03369223|516105965|FG000|Overall Study|Participant request to discontinue study treatment|0|||
143153515|NCT03369223|516105966|FG001|Overall Study|Participant request to discontinue study treatment|1|||
143153516|NCT03369223|516105967|FG002|Overall Study|Participant request to discontinue study treatment|0|||
143153517|NCT03369223|516105968|FG003|Overall Study|Participant request to discontinue study treatment|0|||
143153518|NCT03369223|516105969|FG004|Overall Study|Participant request to discontinue study treatment|1|||
143153519|NCT03369223|516105970|FG005|Overall Study|Participant request to discontinue study treatment|1|||
143153520|NCT03369223|516105971|FG006|Overall Study|Participant request to discontinue study treatment|1|||
143153521|NCT03369223|516105972|FG007|Overall Study|Participant request to discontinue study treatment|0|||
143153522|NCT03369223|516105973|FG008|Overall Study|Participant request to discontinue study treatment|0|||
143153523|NCT03369223|516105974|FG009|Overall Study|Participant request to discontinue study treatment|0|||
143153524|NCT03369223|516105975|FG010|Overall Study|Participant request to discontinue study treatment|0|||
143153525|NCT03369223|516105976|FG011|Overall Study|Participant request to discontinue study treatment|0|||
143153526|NCT03369223|516105977|FG012|Overall Study|Participant request to discontinue study treatment|0|||
143153527|NCT03369223|516105978|FG013|Overall Study|Participant request to discontinue study treatment|1|||
143153528|NCT03369223|516105979|FG014|Overall Study|Participant request to discontinue study treatment|1|||
143153529|NCT03369223|516105980|FG015|Overall Study|Participant request to discontinue study treatment|0|||
143153530|NCT03369223|516105981|FG016|Overall Study|Participant request to discontinue study treatment|0|||
143153531|NCT03369223|516105982|FG017|Overall Study|Participant request to discontinue study treatment|0|||
143153532|NCT03369223|516105983|FG018|Overall Study|Participant request to discontinue study treatment|1|||
143153533|NCT03369223|516105984|FG019|Overall Study|Participant request to discontinue study treatment|0|||
143153534|NCT03369223|516105965|FG000|Overall Study|Participant withdrew consent|0|||
143153535|NCT03369223|516105966|FG001|Overall Study|Participant withdrew consent|1|||
143153536|NCT03369223|516105967|FG002|Overall Study|Participant withdrew consent|1|||
143153537|NCT03369223|516105968|FG003|Overall Study|Participant withdrew consent|0|||
143153538|NCT03369223|516105969|FG004|Overall Study|Participant withdrew consent|0|||
143153539|NCT03369223|516105970|FG005|Overall Study|Participant withdrew consent|0|||
143153540|NCT03369223|516105971|FG006|Overall Study|Participant withdrew consent|1|||
143153541|NCT03369223|516105972|FG007|Overall Study|Participant withdrew consent|1|||
143153542|NCT03369223|516105973|FG008|Overall Study|Participant withdrew consent|1|||
143153543|NCT03369223|516105974|FG009|Overall Study|Participant withdrew consent|0|||
143153544|NCT03369223|516105975|FG010|Overall Study|Participant withdrew consent|0|||
143485435|NCT02831673|517322812|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
143485436|NCT02831673|517322813|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
143485437|NCT02831673|517322809|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
143485438|NCT02831673|517322810|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
143153545|NCT03369223|516105976|FG011|Overall Study|Participant withdrew consent|1|||
143153546|NCT03369223|516105977|FG012|Overall Study|Participant withdrew consent|0|||
143153547|NCT03369223|516105978|FG013|Overall Study|Participant withdrew consent|0|||
143153548|NCT03369223|516105979|FG014|Overall Study|Participant withdrew consent|3|||
143235177|NCT04225897|516413522|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
143235178|NCT04225897|516413523|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
143235179|NCT04225897|516413524|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
143235180|NCT04225897|516413525|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
143235181|NCT04225897|516413526|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
143235182|NCT04225897|516413527|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
143235183|NCT04225897|516413528|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
143235184|NCT04225897|516413529|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
143235185|NCT04225897|516413518|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
143235186|NCT04225897|516413519|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
143235187|NCT04225897|516413520|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
143235188|NCT04225897|516413521|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
143235189|NCT04225897|516413522|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
143235190|NCT04225897|516413523|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
143235191|NCT04225897|516413524|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
143235192|NCT04225897|516413525|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
143235193|NCT04225897|516413526|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
143235194|NCT04225897|516413527|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
143235195|NCT04225897|516413528|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
143235196|NCT04225897|516413529|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
143235197|NCT00074711|516413531|FG000|Overall Study|Withdrawal by Subject|1|||
143235198|NCT00074711|516413532|FG001|Overall Study|Withdrawal by Subject|1|||
143235199|NCT00074711|516413531|FG000|Overall Study|Lost to Follow-up|10|||
143235200|NCT00074711|516413532|FG001|Overall Study|Lost to Follow-up|8|||
143235201|NCT00074711|516413531|FG000|Overall Study|Participant stopped study drug|4|||
143235202|NCT00074711|516413532|FG001|Overall Study|Participant stopped study drug|6|||
143235203|NCT03466658|516413533|FG000|Overall Study|Withdrawal by Subject|3|||
143235204|NCT00360230|516413534|FG000|Overall Study|Withdrawal by Subject|1|||
143235205|NCT00360230|516413535|FG001|Overall Study|Withdrawal by Subject|1|||
143235206|NCT00360230|516413536|FG002|Overall Study|Withdrawal by Subject|0|||
143235207|NCT00360230|516413537|FG003|Overall Study|Withdrawal by Subject|1|||
143235208|NCT00360230|516413538|FG004|Overall Study|Withdrawal by Subject|1|||
143235209|NCT00360230|516413539|FG005|Overall Study|Withdrawal by Subject|1|||
143235210|NCT00360230|516413540|FG006|Overall Study|Withdrawal by Subject|0|||
143235211|NCT00360230|516413534|FG000|Overall Study|Migrated|4|||
143235212|NCT00360230|516413535|FG001|Overall Study|Migrated|1|||
143235213|NCT00360230|516413536|FG002|Overall Study|Migrated|3|||
143235214|NCT00360230|516413537|FG003|Overall Study|Migrated|1|||
143235215|NCT00360230|516413538|FG004|Overall Study|Migrated|4|||
143235216|NCT00360230|516413539|FG005|Overall Study|Migrated|1|||
143235217|NCT00360230|516413540|FG006|Overall Study|Migrated|1|||
143235218|NCT00360230|516413534|FG000|Overall Study|Other|1|||
143235219|NCT00360230|516413535|FG001|Overall Study|Other|0|||
143235220|NCT00360230|516413536|FG002|Overall Study|Other|0|||
143235221|NCT00360230|516413537|FG003|Overall Study|Other|0|||
143235222|NCT00360230|516413538|FG004|Overall Study|Other|0|||
143235223|NCT00360230|516413539|FG005|Overall Study|Other|0|||
143235224|NCT00360230|516413540|FG006|Overall Study|Other|0|||
143235225|NCT00360230|516413534|FG000|Overall Study|Protocol Violation|0|||
143235226|NCT00360230|516413535|FG001|Overall Study|Protocol Violation|0|||
143235227|NCT00360230|516413536|FG002|Overall Study|Protocol Violation|0|||
143235228|NCT00360230|516413537|FG003|Overall Study|Protocol Violation|0|||
143235229|NCT00360230|516413538|FG004|Overall Study|Protocol Violation|0|||
143235230|NCT00360230|516413539|FG005|Overall Study|Protocol Violation|1|||
143235231|NCT00360230|516413540|FG006|Overall Study|Protocol Violation|0|||
143235232|NCT00360230|516413534|FG000|Overall Study|Death|0|||
143235233|NCT00360230|516413535|FG001|Overall Study|Death|1|||
143235234|NCT00360230|516413536|FG002|Overall Study|Death|0|||
143235235|NCT00360230|516413537|FG003|Overall Study|Death|0|||
143235236|NCT00360230|516413538|FG004|Overall Study|Death|0|||
143235237|NCT00360230|516413539|FG005|Overall Study|Death|1|||
143235238|NCT00360230|516413540|FG006|Overall Study|Death|1|||
143235239|NCT00481832|516413541|FG000|Enrollment|Physician Decision|8|||
143235240|NCT00481832|516413541|FG000|Enrollment|Unable to collect enough stem cells|2|||
143235241|NCT00481832|516413541|FG000|Inter-transplant Period|Adverse Event|4|||
143235242|NCT00481832|516413541|FG000|Inter-transplant Period|Death|3|||
143235243|NCT00481832|516413541|FG000|Inter-transplant Period|Physician Decision|4|||
143235244|NCT00481832|516413541|FG000|Inter-transplant Period|Disease relapse|11|||
143235245|NCT00481832|516413541|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
143235246|NCT00456846|516413542|FG000|Overall Study|Adverse Event|2|||
143235247|NCT00456846|516413543|FG001|Overall Study|Adverse Event|15|||
143235248|NCT00456846|516413542|FG000|Overall Study|Physician Decision|11|||
143235249|NCT00456846|516413543|FG001|Overall Study|Physician Decision|6|||
143235250|NCT00456846|516413542|FG000|Overall Study|Protocol Deviation|2|||
143235251|NCT00456846|516413543|FG001|Overall Study|Protocol Deviation|0|||
143153549|NCT03369223|516105980|FG015|Overall Study|Participant withdrew consent|0|||
143153550|NCT03369223|516105981|FG016|Overall Study|Participant withdrew consent|1|||
143153551|NCT03369223|516105982|FG017|Overall Study|Participant withdrew consent|0|||
143153552|NCT03369223|516105983|FG018|Overall Study|Participant withdrew consent|4|||
143153553|NCT03369223|516105984|FG019|Overall Study|Participant withdrew consent|2|||
143153554|NCT03369223|516105965|FG000|Overall Study|Randomized but not treated|0|||
143153555|NCT03369223|516105966|FG001|Overall Study|Randomized but not treated|0|||
143153556|NCT03369223|516105967|FG002|Overall Study|Randomized but not treated|0|||
143153557|NCT03369223|516105968|FG003|Overall Study|Randomized but not treated|0|||
143153558|NCT03369223|516105969|FG004|Overall Study|Randomized but not treated|0|||
143153559|NCT03369223|516105970|FG005|Overall Study|Randomized but not treated|0|||
143153560|NCT03369223|516105971|FG006|Overall Study|Randomized but not treated|0|||
143153561|NCT03369223|516105972|FG007|Overall Study|Randomized but not treated|0|||
143153562|NCT03369223|516105973|FG008|Overall Study|Randomized but not treated|0|||
143153563|NCT03369223|516105974|FG009|Overall Study|Randomized but not treated|0|||
143153564|NCT03369223|516105975|FG010|Overall Study|Randomized but not treated|0|||
143153565|NCT03369223|516105976|FG011|Overall Study|Randomized but not treated|0|||
143153566|NCT03369223|516105977|FG012|Overall Study|Randomized but not treated|0|||
143153567|NCT03369223|516105978|FG013|Overall Study|Randomized but not treated|1|||
143153568|NCT03369223|516105979|FG014|Overall Study|Randomized but not treated|1|||
143153569|NCT03369223|516105980|FG015|Overall Study|Randomized but not treated|0|||
143153570|NCT03369223|516105981|FG016|Overall Study|Randomized but not treated|0|||
143153571|NCT03369223|516105982|FG017|Overall Study|Randomized but not treated|0|||
143153572|NCT03369223|516105983|FG018|Overall Study|Randomized but not treated|0|||
143153573|NCT03369223|516105984|FG019|Overall Study|Randomized but not treated|0|||
143153574|NCT03573882|516105987|FG000|Overall Study|Study Terminated by Sponsor|22|||
143153575|NCT03573882|516105988|FG001|Overall Study|Study Terminated by Sponsor|17|||
143153576|NCT03573882|516105989|FG002|Overall Study|Study Terminated by Sponsor|18|||
143153577|NCT03573882|516105987|FG000|Overall Study|Withdrawal by Subject|6|||
143153578|NCT03573882|516105988|FG001|Overall Study|Withdrawal by Subject|11|||
143153579|NCT03573882|516105989|FG002|Overall Study|Withdrawal by Subject|7|||
143153580|NCT03573882|516105987|FG000|Overall Study|Adverse Event|7|||
143153581|NCT03573882|516105988|FG001|Overall Study|Adverse Event|5|||
143153582|NCT03573882|516105989|FG002|Overall Study|Adverse Event|6|||
143153583|NCT03573882|516105987|FG000|Overall Study|Lost to Follow-up|2|||
143153584|NCT03573882|516105988|FG001|Overall Study|Lost to Follow-up|5|||
143153585|NCT03573882|516105989|FG002|Overall Study|Lost to Follow-up|3|||
143153586|NCT03573882|516105987|FG000|Overall Study|Physician Decision|4|||
143153587|NCT03573882|516105988|FG001|Overall Study|Physician Decision|3|||
143153588|NCT03573882|516105989|FG002|Overall Study|Physician Decision|2|||
143153589|NCT03573882|516105987|FG000|Overall Study|Participant is Noncompliant with Study Drug|1|||
143153590|NCT03573882|516105988|FG001|Overall Study|Participant is Noncompliant with Study Drug|2|||
143153591|NCT03573882|516105989|FG002|Overall Study|Participant is Noncompliant with Study Drug|1|||
143153592|NCT03573882|516105987|FG000|Overall Study|Pregnancy|1|||
143153593|NCT03573882|516105988|FG001|Overall Study|Pregnancy|2|||
143153594|NCT03573882|516105989|FG002|Overall Study|Pregnancy|0|||
143153595|NCT03573882|516105987|FG000|Overall Study|Other|4|||
143153596|NCT03573882|516105988|FG001|Overall Study|Other|2|||
143153597|NCT03573882|516105989|FG002|Overall Study|Other|2|||
143235252|NCT00456846|516413542|FG000|Overall Study|Participant Discretion|1|||
143235253|NCT00456846|516413543|FG001|Overall Study|Participant Discretion|5|||
143235254|NCT00456846|516413542|FG000|Overall Study|Other|0|||
143235255|NCT00456846|516413543|FG001|Overall Study|Other|2|||
143235256|NCT00581308|516413547|FG000|Pre Discharge|Lost to Follow-up|1|||
143235257|NCT00581308|516413547|FG000|Pre Discharge|Device Removed|1|||
143235258|NCT00581308|516413547|FG000|Month 1|Lost to Follow-up|3|||
143235259|NCT00581308|516413547|FG000|Month 1|Withdrawal by Subject|2|||
143235260|NCT00581308|516413547|FG000|Month 1|Device Removed|2|||
143235261|NCT00581308|516413547|FG000|Month 1|Uknown|1|||
143235262|NCT00581308|516413547|FG000|Month 6|Lost to Follow-up|1|||
143235263|NCT00581308|516413547|FG000|Month 6|Withdrawal by Subject|2|||
143235264|NCT00581308|516413547|FG000|Month 12|Death|1|||
143235265|NCT00581308|516413547|FG000|Month 12|Lost to Follow-up|14|||
143235266|NCT00581308|516413547|FG000|Month 12|Withdrawal by Subject|3|||
143235267|NCT00581308|516413547|FG000|Month 12|Device Removed|1|||
143235268|NCT00581308|516413547|FG000|Month 12|Other|1|||
143235269|NCT02006472|516413548|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
143235270|NCT02006472|516413549|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
143235271|NCT02006472|516413550|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
143235272|NCT02006472|516413551|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
143235273|NCT02006472|516413552|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
143235274|NCT02006472|516413548|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
143235275|NCT02006472|516413549|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
143235276|NCT02006472|516413550|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
143235277|NCT02006472|516413551|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
143235278|NCT02006472|516413552|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
143235279|NCT02006472|516413548|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
143235280|NCT02006472|516413549|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
143235281|NCT02006472|516413550|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
143235282|NCT02006472|516413551|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
143235283|NCT02006472|516413552|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
143235284|NCT02006472|516413548|FG000|Period 1 (Through Week 26)|Other|1|||
143235285|NCT02006472|516413549|FG001|Period 1 (Through Week 26)|Other|5|||
143235286|NCT02006472|516413550|FG002|Period 1 (Through Week 26)|Other|0|||
143235287|NCT02006472|516413551|FG003|Period 1 (Through Week 26)|Other|2|||
143235288|NCT02006472|516413552|FG004|Period 1 (Through Week 26)|Other|3|||
143235289|NCT02006472|516413548|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
143235290|NCT02006472|516413549|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
143235291|NCT02006472|516413550|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
143235292|NCT02006472|516413551|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
143235293|NCT02006472|516413552|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
143235294|NCT02006472|516413548|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
143235295|NCT02006472|516413549|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
143235296|NCT02006472|516413550|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
143235297|NCT02006472|516413551|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
143235298|NCT02006472|516413552|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
143235299|NCT02006472|516413548|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
143235300|NCT02006472|516413549|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
143235301|NCT02006472|516413550|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
143235302|NCT02006472|516413551|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
143235303|NCT02006472|516413552|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
143235304|NCT02006472|516413548|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
143235305|NCT02006472|516413549|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
143235306|NCT02006472|516413550|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
143235307|NCT02006472|516413551|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
143235308|NCT02006472|516413552|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
143235309|NCT02006472|516413548|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
143235310|NCT02006472|516413549|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
143235311|NCT02006472|516413550|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
143235312|NCT02006472|516413551|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
143235313|NCT02006472|516413552|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
143235314|NCT02006472|516413548|FG000|Period 2 (Through Week 52)|Other|0|||
143235315|NCT02006472|516413549|FG001|Period 2 (Through Week 52)|Other|1|||
143235316|NCT02006472|516413550|FG002|Period 2 (Through Week 52)|Other|0|||
143235317|NCT02006472|516413551|FG003|Period 2 (Through Week 52)|Other|1|||
143235318|NCT02006472|516413552|FG004|Period 2 (Through Week 52)|Other|0|||
143235319|NCT02006472|516413548|FG000|Period 2 (Through Week 52)|Not treated|0|||
143235320|NCT02006472|516413549|FG001|Period 2 (Through Week 52)|Not treated|0|||
143235321|NCT02006472|516413550|FG002|Period 2 (Through Week 52)|Not treated|2|||
143235322|NCT02006472|516413551|FG003|Period 2 (Through Week 52)|Not treated|0|||
143235323|NCT02006472|516413552|FG004|Period 2 (Through Week 52)|Not treated|0|||
143235324|NCT02006472|516413548|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
143235325|NCT02006472|516413549|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
143235326|NCT02006472|516413550|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
143235327|NCT02006472|516413551|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
143235328|NCT02006472|516413552|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
143235329|NCT02006472|516413548|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
143235330|NCT02006472|516413549|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
143235331|NCT02006472|516413550|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
143235332|NCT02006472|516413551|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
143235333|NCT02006472|516413552|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
143235334|NCT03219723|516413553|FG000|Overall Study|Case Report Forms Uncollected|6|||
143235335|NCT03219723|516413553|FG000|Overall Study|Protocol Deviation|4|||
143235336|NCT03137381|516413554|FG000|Overall Study|Adverse Event|3|||
143235337|NCT03137381|516413555|FG001|Overall Study|Adverse Event|0|||
143235338|NCT03137381|516413556|FG002|Overall Study|Adverse Event|2|||
143235339|NCT03137381|516413557|FG003|Overall Study|Adverse Event|0|||
143235340|NCT03137381|516413554|FG000|Overall Study|Lost to Follow-up|2|||
143235341|NCT03137381|516413555|FG001|Overall Study|Lost to Follow-up|1|||
143235342|NCT03137381|516413556|FG002|Overall Study|Lost to Follow-up|1|||
143235343|NCT03137381|516413557|FG003|Overall Study|Lost to Follow-up|0|||
143235344|NCT03137381|516413554|FG000|Overall Study|Protocol deviation|1|||
143153675|NCT05942040|516106012|FG000|Overall Study|No longer employed at study site.|0|||
143153676|NCT05942040|516106013|FG001|Overall Study|No longer employed at study site.|0|||
143153677|NCT05942040|516106014|FG002|Overall Study|No longer employed at study site.|3|||
143153692|NCT06061952|516106023|FG000|Overall Study|Withdrawal by Subject|1|||
143153693|NCT06061952|516106024|FG001|Overall Study|Withdrawal by Subject|2|||
143153694|NCT06061952|516106023|FG000|Overall Study|Lost to Follow-up|2|||
143153695|NCT06061952|516106024|FG001|Overall Study|Lost to Follow-up|2|||
143153712|NCT03659916|516106033|FG000|Treatment Period (72 Weeks)|Adverse Event|2|||
143153713|NCT03659916|516106034|FG001|Treatment Period (72 Weeks)|Adverse Event|1|||
143153714|NCT03659916|516106035|FG002|Treatment Period (72 Weeks)|Adverse Event|6|||
143153715|NCT03659916|516106033|FG000|Treatment Period (72 Weeks)|Withdrawal by Subject|1|||
143153716|NCT03659916|516106034|FG001|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
143153717|NCT03659916|516106035|FG002|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
143153718|NCT03659916|516106033|FG000|Treatment Period (72 Weeks)|Physician Decision|0|||
143153719|NCT03659916|516106034|FG001|Treatment Period (72 Weeks)|Physician Decision|1|||
143153720|NCT03659916|516106035|FG002|Treatment Period (72 Weeks)|Physician Decision|0|||
143153721|NCT03659916|516106033|FG000|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
143153722|NCT03659916|516106034|FG001|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
143153723|NCT03659916|516106035|FG002|Treatment Period (72 Weeks)|Lost to Follow-up|1|||
143153724|NCT03659916|516106033|FG000|Treatment Period (72 Weeks)|Other|1|||
143153725|NCT03659916|516106034|FG001|Treatment Period (72 Weeks)|Other|3|||
143153726|NCT03659916|516106035|FG002|Treatment Period (72 Weeks)|Other|9|||
143153727|NCT03659916|516106033|FG000|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
143153728|NCT03659916|516106034|FG001|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
143153729|NCT03659916|516106035|FG002|Optional Extension Treatment (176 Weeks)|Adverse Event|1|||
143153730|NCT03659916|516106033|FG000|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
143153731|NCT03659916|516106034|FG001|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|1|||
143153732|NCT03659916|516106035|FG002|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
143153733|NCT03659916|516106033|FG000|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
143153734|NCT03659916|516106034|FG001|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
143153735|NCT03659916|516106035|FG002|Optional Extension Treatment (176 Weeks)|Physician Decision|1|||
143153736|NCT03659916|516106033|FG000|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|5|||
143153737|NCT03659916|516106034|FG001|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|17|||
143153738|NCT03659916|516106035|FG002|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|11|||
143153739|NCT03659916|516106033|FG000|Optional Extension Treatment (176 Weeks)|Other|4|||
143153740|NCT03659916|516106034|FG001|Optional Extension Treatment (176 Weeks)|Other|0|||
143153741|NCT03659916|516106035|FG002|Optional Extension Treatment (176 Weeks)|Other|3|||
143153742|NCT03659916|516106033|FG000|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|5|||
143153743|NCT03659916|516106034|FG001|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|9|||
143153744|NCT03659916|516106035|FG002|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|17|||
143153745|NCT01068249|516106042|FG000|Overall Study|Death|1|||
143153746|NCT01068249|516106042|FG000|Overall Study|Withdrawal by Subject|3|||
143235345|NCT03137381|516413555|FG001|Overall Study|Protocol deviation|1|||
143235346|NCT03137381|516413556|FG002|Overall Study|Protocol deviation|0|||
143153808|NCT04439123|516107118|FG000|Overall Study|Adverse Event|11|||
143153809|NCT04439123|516107118|FG000|Overall Study|Death|1|||
143153810|NCT04439123|516107118|FG000|Overall Study|Disease progression|19|||
143153811|NCT04439123|516107118|FG000|Overall Study|Withdrawal by Subject|2|||
143153812|NCT04439123|516107118|FG000|Overall Study|Still on treatment|2|||
143485439|NCT02831673|517322811|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
143485440|NCT02831673|517322812|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
143485441|NCT02831673|517322813|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
143485442|NCT02831673|517322809|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
143485443|NCT02831673|517322810|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
143485444|NCT02831673|517322811|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
143485445|NCT02831673|517322812|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
143485446|NCT02831673|517322813|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
143485447|NCT02831673|517322809|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
143485448|NCT02831673|517322810|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
143485449|NCT02831673|517322811|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
143485450|NCT02831673|517322812|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
143485451|NCT02831673|517322813|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
143485452|NCT02831673|517322809|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
143485453|NCT02831673|517322810|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
143485454|NCT02831673|517322811|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
143485455|NCT02831673|517322812|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
143485456|NCT02831673|517322813|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
143235347|NCT03137381|516413557|FG003|Overall Study|Protocol deviation|1|||
143235348|NCT03137381|516413554|FG000|Overall Study|Withdrawal by Investigator|0|||
143235349|NCT03137381|516413555|FG001|Overall Study|Withdrawal by Investigator|1|||
143235350|NCT03137381|516413556|FG002|Overall Study|Withdrawal by Investigator|1|||
143235351|NCT03137381|516413557|FG003|Overall Study|Withdrawal by Investigator|0|||
143235352|NCT03137381|516413554|FG000|Overall Study|Withdrawal by Subject|3|||
143235353|NCT03137381|516413555|FG001|Overall Study|Withdrawal by Subject|4|||
143235354|NCT03137381|516413556|FG002|Overall Study|Withdrawal by Subject|3|||
143235355|NCT03137381|516413557|FG003|Overall Study|Withdrawal by Subject|0|||
143235356|NCT03137381|516413554|FG000|Overall Study|Pregnancy|0|||
143235357|NCT03137381|516413555|FG001|Overall Study|Pregnancy|0|||
143235358|NCT03137381|516413556|FG002|Overall Study|Pregnancy|1|||
143235359|NCT03137381|516413557|FG003|Overall Study|Pregnancy|0|||
143235360|NCT00459316|516413562|FG000|Steps 1 & 2|Other eligibility failure|1|||
143235361|NCT00459316|516413563|FG001|Steps 1 & 2|Other eligibility failure|1|||
143235362|NCT00459316|516413564|FG002|Steps 1 & 2|Other eligibility failure|0|||
143235363|NCT00459316|516413562|FG000|Steps 1 & 2|Death|1|||
143235364|NCT00459316|516413563|FG001|Steps 1 & 2|Death|1|||
143235365|NCT00459316|516413564|FG002|Steps 1 & 2|Death|0|||
143235366|NCT00459316|516413562|FG000|Steps 1 & 2|Not able to get to clinic|7|||
143235367|NCT00459316|516413563|FG001|Steps 1 & 2|Not able to get to clinic|4|||
143235368|NCT00459316|516413564|FG002|Steps 1 & 2|Not able to get to clinic|0|||
143235369|NCT00459316|516413562|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
143235370|NCT00459316|516413563|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
143235371|NCT00459316|516413564|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
143235372|NCT00459316|516413562|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
143235373|NCT00459316|516413563|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
143235374|NCT00459316|516413564|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
143235375|NCT00459316|516413562|FG000|Steps 1 & 2|Lost to Follow-up|5|||
143235376|NCT00459316|516413563|FG001|Steps 1 & 2|Lost to Follow-up|0|||
143235377|NCT00459316|516413564|FG002|Steps 1 & 2|Lost to Follow-up|2|||
143235378|NCT00459316|516413562|FG000|Step 3|Withdrawal by Subject|3|||
143235379|NCT00459316|516413563|FG001|Step 3|Withdrawal by Subject|0|||
143235380|NCT00459316|516413564|FG002|Step 3|Withdrawal by Subject|1|||
143235381|NCT01980017|516413565|FG000|Overall Study|Lost to Follow-up|30|||
143235382|NCT01980017|516413566|FG001|Overall Study|Lost to Follow-up|21|||
143235383|NCT01980017|516413565|FG000|Overall Study|Death|0|||
143235384|NCT01980017|516413566|FG001|Overall Study|Death|1|||
143235385|NCT03044106|516413568|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
143235386|NCT03044106|516413569|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
143235387|NCT01207414|516413570|FG000|Overall Study|Adverse Event|25|||
143235388|NCT01207414|516413571|FG001|Overall Study|Adverse Event|39|||
143235389|NCT01207414|516413570|FG000|Overall Study|Abnormal test procedure results|0|||
143235390|NCT01207414|516413571|FG001|Overall Study|Abnormal test procedure results|1|||
143235391|NCT01207414|516413570|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
143235392|NCT01207414|516413571|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
143235393|NCT01207414|516413570|FG000|Overall Study|Patient withdrew consent|14|||
143235394|NCT01207414|516413571|FG001|Overall Study|Patient withdrew consent|11|||
143235395|NCT01207414|516413570|FG000|Overall Study|Lost to Follow-up|15|||
143235396|NCT01207414|516413571|FG001|Overall Study|Lost to Follow-up|17|||
143235397|NCT01207414|516413570|FG000|Overall Study|Administrative problems|1|||
143235398|NCT01207414|516413571|FG001|Overall Study|Administrative problems|1|||
143235399|NCT01207414|516413570|FG000|Overall Study|Protocol deviation|12|||
143235400|NCT01207414|516413571|FG001|Overall Study|Protocol deviation|9|||
143235401|NCT01207414|516413570|FG000|Overall Study|Randomized in error|1|||
143235402|NCT01207414|516413571|FG001|Overall Study|Randomized in error|0|||
143235403|NCT01748292|516413572|FG000|Overall Study|Adverse Event|2|||
143235404|NCT01748292|516413573|FG001|Overall Study|Adverse Event|4|||
143235405|NCT01748292|516413572|FG000|Overall Study|Lost to Follow-up|0|||
143235406|NCT01748292|516413573|FG001|Overall Study|Lost to Follow-up|3|||
143235407|NCT01748292|516413572|FG000|Overall Study|Death|0|||
143363681|NCT00062868|516873793|FG013|Dose Level 3|Lost to Follow-up|0|||
143235408|NCT01748292|516413573|FG001|Overall Study|Death|3|||
143235409|NCT01748292|516413572|FG000|Overall Study|Withdrawal by Subject|0|||
143235410|NCT01748292|516413573|FG001|Overall Study|Withdrawal by Subject|2|||
143235411|NCT02057250|516413574|FG000|AID Assessment Phase|Adverse Event|3|||
143235412|NCT02057250|516413575|FG001|AID Assessment Phase|Adverse Event|2|||
143235413|NCT02057250|516413576|FG002|AID Assessment Phase|Adverse Event|6|||
143235414|NCT02057250|516413577|FG003|AID Assessment Phase|Adverse Event|1|||
143363682|NCT00062868|516873794|FG014|Dose Level 3|Lost to Follow-up|1|||
143235415|NCT02057250|516413578|FG004|AID Assessment Phase|Adverse Event|0|||
143235416|NCT02057250|516413574|FG000|AID Assessment Phase|Other than specified above|1|||
143235417|NCT02057250|516413575|FG001|AID Assessment Phase|Other than specified above|1|||
143235418|NCT02057250|516413576|FG002|AID Assessment Phase|Other than specified above|1|||
143235419|NCT02057250|516413577|FG003|AID Assessment Phase|Other than specified above|1|||
143235420|NCT02057250|516413578|FG004|AID Assessment Phase|Other than specified above|0|||
143485457|NCT02831673|517322809|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
143235421|NCT02057250|516413574|FG000|Extension Phase|Adverse Event|0|||
143017783|NCT00054275|515606522|FG000|Overall Study|Progressive disease in cycle 1|1|||
143017784|NCT00054275|515606522|FG000|Overall Study|Physician Decision|1|||
143017785|NCT00755937|515606523|FG000|Recruitment|Unknown if infliximab received|164|||
143235422|NCT02057250|516413575|FG001|Extension Phase|Adverse Event|0|||
143235423|NCT02057250|516413576|FG002|Extension Phase|Adverse Event|0|||
143235424|NCT02057250|516413577|FG003|Extension Phase|Adverse Event|0|||
143235425|NCT02057250|516413578|FG004|Extension Phase|Adverse Event|15|||
143235426|NCT02057250|516413574|FG000|Extension Phase|Lack of Efficacy|0|||
143235427|NCT02057250|516413575|FG001|Extension Phase|Lack of Efficacy|0|||
143235428|NCT02057250|516413576|FG002|Extension Phase|Lack of Efficacy|0|||
143235429|NCT02057250|516413577|FG003|Extension Phase|Lack of Efficacy|0|||
143235430|NCT02057250|516413578|FG004|Extension Phase|Lack of Efficacy|10|||
143235431|NCT02057250|516413574|FG000|Extension Phase|Entered in this period but not treated|0|||
143235432|NCT02057250|516413575|FG001|Extension Phase|Entered in this period but not treated|0|||
143485458|NCT02831673|517322810|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
143485459|NCT02831673|517322811|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
143485460|NCT02831673|517322812|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
143485461|NCT02831673|517322813|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
143485462|NCT02831673|517322809|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
143485463|NCT02831673|517322810|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
143235433|NCT02057250|516413576|FG002|Extension Phase|Entered in this period but not treated|0|||
143235434|NCT02057250|516413577|FG003|Extension Phase|Entered in this period but not treated|0|||
143235435|NCT02057250|516413578|FG004|Extension Phase|Entered in this period but not treated|4|||
143235436|NCT02057250|516413574|FG000|Extension Phase|Other than specified above|0|||
143235437|NCT02057250|516413575|FG001|Extension Phase|Other than specified above|0|||
143235438|NCT02057250|516413576|FG002|Extension Phase|Other than specified above|0|||
143235439|NCT02057250|516413577|FG003|Extension Phase|Other than specified above|0|||
143235440|NCT02057250|516413578|FG004|Extension Phase|Other than specified above|7|||
143235441|NCT00910650|516413579|FG000|Overall Study|Death|2|||
143235442|NCT00260533|516413580|FG000|Overall Study|Other|3|||
143235443|NCT00260533|516413581|FG001|Overall Study|Other|3|||
143235444|NCT02224560|516413583|FG000|Overall Study|Protocol Deviation|1|||
143235445|NCT02224560|516413584|FG001|Overall Study|Protocol Deviation|0|||
143235446|NCT02224560|516413585|FG002|Overall Study|Protocol Deviation|0|||
143235447|NCT02224560|516413583|FG000|Overall Study|Withdrawal by Subject|2|||
143235448|NCT02224560|516413584|FG001|Overall Study|Withdrawal by Subject|0|||
143235449|NCT02224560|516413585|FG002|Overall Study|Withdrawal by Subject|1|||
143235450|NCT02224560|516413583|FG000|Overall Study|Met Withdrawal Criteria|1|||
143235451|NCT02224560|516413584|FG001|Overall Study|Met Withdrawal Criteria|0|||
143235452|NCT02224560|516413585|FG002|Overall Study|Met Withdrawal Criteria|0|||
143235453|NCT02224560|516413583|FG000|Overall Study|Adverse Event|4|||
143235454|NCT02224560|516413584|FG001|Overall Study|Adverse Event|1|||
143235455|NCT02224560|516413585|FG002|Overall Study|Adverse Event|1|||
143235456|NCT02224560|516413583|FG000|Overall Study|Withdrawn by Investigator|1|||
143235457|NCT02224560|516413584|FG001|Overall Study|Withdrawn by Investigator|1|||
143235458|NCT02224560|516413585|FG002|Overall Study|Withdrawn by Investigator|0|||
143235459|NCT04030143|516413587|FG000|Overall Study|Adverse Event|5|||
143235460|NCT04030143|516413588|FG001|Overall Study|Adverse Event|10|||
143235461|NCT04030143|516413587|FG000|Overall Study|Lost to Follow-up|3|||
143235462|NCT04030143|516413588|FG001|Overall Study|Lost to Follow-up|7|||
143235463|NCT04030143|516413587|FG000|Overall Study|Protocol Deviation|2|||
143235464|NCT04030143|516413588|FG001|Overall Study|Protocol Deviation|2|||
143235465|NCT04030143|516413587|FG000|Overall Study|Withdrawal by Subject|16|||
143235466|NCT04030143|516413588|FG001|Overall Study|Withdrawal by Subject|18|||
143235467|NCT04030143|516413587|FG000|Overall Study|Physician Decision|1|||
143235468|NCT04030143|516413588|FG001|Overall Study|Physician Decision|1|||
143235469|NCT04030143|516413587|FG000|Overall Study|Due to Covid-19|2|||
143235470|NCT04030143|516413588|FG001|Overall Study|Due to Covid-19|3|||
143235471|NCT04030143|516413587|FG000|Overall Study|Not Due to Covid-19|1|||
143235472|NCT04030143|516413588|FG001|Overall Study|Not Due to Covid-19|1|||
143235473|NCT05966142|516413589|FG000|Overall Study|Death|3|||
143235474|NCT05966142|516413590|FG001|Overall Study|Death|3|||
143235475|NCT05966142|516413589|FG000|Overall Study|Lost to Follow-up|55|||
143235476|NCT05966142|516413590|FG001|Overall Study|Lost to Follow-up|52|||
143235477|NCT05966142|516413589|FG000|Overall Study|Physician Decision|1|||
143235478|NCT05966142|516413590|FG001|Overall Study|Physician Decision|0|||
143235479|NCT05966142|516413589|FG000|Overall Study|Withdrawal by Subject|9|||
143485464|NCT02831673|517322811|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
143485465|NCT02831673|517322812|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
143485466|NCT02831673|517322813|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
143235480|NCT05966142|516413590|FG001|Overall Study|Withdrawal by Subject|8|||
143235481|NCT05966142|516413589|FG000|Overall Study|Duplicate Enrollment|1|||
143235482|NCT05966142|516413590|FG001|Overall Study|Duplicate Enrollment|0|||
143235483|NCT05966142|516413589|FG000|Overall Study|Study Logistical Reason|1|||
143235484|NCT05966142|516413590|FG001|Overall Study|Study Logistical Reason|0|||
143235485|NCT05966142|516413589|FG000|Overall Study|Unable to complete follow up due to change in health|1|||
143235486|NCT05966142|516413590|FG001|Overall Study|Unable to complete follow up due to change in health|1|||
143235487|NCT04408989|516413591|FG000|Overall Study|Lost to Follow-up|0|||
143235488|NCT04408989|516413592|FG001|Overall Study|Lost to Follow-up|0|||
143235489|NCT04408989|516413593|FG002|Overall Study|Lost to Follow-up|1|||
143235490|NCT04408989|516413591|FG000|Overall Study|Withdrawal by Subject|0|||
143235491|NCT04408989|516413592|FG001|Overall Study|Withdrawal by Subject|0|||
143235492|NCT04408989|516413593|FG002|Overall Study|Withdrawal by Subject|2|||
143235493|NCT05135767|516413594|FG000|Baseline|Lost to Follow-up|1|||
143235494|NCT05135767|516413595|FG001|Baseline|Lost to Follow-up|1|||
143235495|NCT05135767|516413594|FG000|Baseline|Withdrawal by Subject|0|||
143235496|NCT05135767|516413595|FG001|Baseline|Withdrawal by Subject|2|||
143235497|NCT05135767|516413594|FG000|Active Study Phase|Lost to Follow-up|2|||
143235498|NCT05135767|516413595|FG001|Active Study Phase|Lost to Follow-up|0|||
143235499|NCT02694185|516413596|FG000|Overall Study|Withdrawal by Subject|45|||
143235500|NCT02694185|516413597|FG001|Overall Study|Withdrawal by Subject|0|||
143235501|NCT05082857|516413598|FG000|Overall Study|participants relocated and could not continue|2|||
143235502|NCT05082857|516413599|FG001|Overall Study|participants relocated and could not continue|1|||
143235503|NCT05082857|516413598|FG000|Overall Study|Lost to Follow-up|1|||
143235504|NCT05082857|516413599|FG001|Overall Study|Lost to Follow-up|3|||
143235505|NCT04363320|516413600|FG000|Overall Study|Lost to Follow-up|43|||
143235506|NCT04363320|516413601|FG001|Overall Study|Lost to Follow-up|42|||
143235507|NCT04363320|516413602|FG002|Overall Study|Lost to Follow-up|24|||
143235508|NCT04363320|516413603|FG003|Overall Study|Lost to Follow-up|29|||
143235509|NCT04363320|516413600|FG000|Overall Study|Death|0|||
143235510|NCT04363320|516413601|FG001|Overall Study|Death|0|||
143235511|NCT04363320|516413602|FG002|Overall Study|Death|1|||
143235512|NCT04363320|516413603|FG003|Overall Study|Death|0|||
143235513|NCT02260934|516413613|FG000|Overall Study|Lost to Follow-up|2|||
143235514|NCT02260934|516413614|FG001|Overall Study|Lost to Follow-up|1|||
143235515|NCT02260934|516413613|FG000|Overall Study|Withdrawal by Subject|0|||
143235516|NCT02260934|516413614|FG001|Overall Study|Withdrawal by Subject|2|||
143235517|NCT02260934|516413613|FG000|Overall Study|Participant Relocated|1|||
143235518|NCT02260934|516413614|FG001|Overall Study|Participant Relocated|0|||
143235519|NCT02260934|516413613|FG000|Overall Study|Site error|0|||
143235520|NCT02260934|516413614|FG001|Overall Study|Site error|1|||
143235521|NCT03605667|516413617|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
143235522|NCT03605667|516413618|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
143235523|NCT03605667|516413617|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
143235524|NCT03605667|516413618|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
143235525|NCT03605667|516413617|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
143235526|NCT03605667|516413618|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
143235527|NCT03605667|516413617|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
143235528|NCT03605667|516413618|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
143235529|NCT03605667|516413617|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
143235530|NCT03605667|516413618|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
143235531|NCT03605667|516413617|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
143235532|NCT03605667|516413618|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
143235533|NCT03605667|516413617|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
143235534|NCT03605667|516413618|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
143235535|NCT03605667|516413617|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
143235536|NCT03605667|516413618|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
143235537|NCT03605667|516413617|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
143235538|NCT03605667|516413618|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
143235539|NCT03605667|516413617|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
143235540|NCT03605667|516413618|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
143235541|NCT03605667|516413617|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
143235542|NCT03605667|516413618|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
143235543|NCT03605667|516413617|FG000|OLE Phase (48 Weeks)|Other|6|||
143235544|NCT03605667|516413618|FG001|OLE Phase (48 Weeks)|Other|8|||
143235545|NCT03605667|516413617|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
143235546|NCT03605667|516413618|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
143235547|NCT03605667|516413617|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
143235548|NCT03605667|516413618|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
143235549|NCT03605667|516413617|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
143235550|NCT03605667|516413618|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
143235551|NCT03605667|516413617|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
143235552|NCT03605667|516413618|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
143485467|NCT02831673|517322809|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
143235553|NCT03605667|516413617|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
143235554|NCT03605667|516413618|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
143235555|NCT03605667|516413617|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
143235556|NCT03605667|516413618|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
143485468|NCT02831673|517322810|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
143235557|NCT03605667|516413617|FG000|OLE Phase (48 Weeks)|Death|0|||
143153995|NCT04337021|516107141|FG000|Overall Study|Lost to Follow-up|54|||
143153996|NCT04337021|516107142|FG001|Overall Study|Lost to Follow-up|66|||
143154022|NCT06375655|516107152|FG000|Overall Study|premature delivery (prior to 35 weeks GA)|2|||
143154023|NCT06375655|516107153|FG001|Overall Study|premature delivery (prior to 35 weeks GA)|1|||
143485469|NCT02831673|517322811|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
143017786|NCT00755937|515606523|FG000|Observational Follow-up|Lost to Follow-up|148|||
143485470|NCT02831673|517322812|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
143485471|NCT02831673|517322813|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
143485472|NCT00477165|517322814|FG000|Overall Study|Adverse Event|7|||
143485473|NCT00477165|517322815|FG001|Overall Study|Adverse Event|2|||
143485474|NCT01823679|517322816|FG000|Overall Study|Death|1|||
143485475|NCT01623271|517322823|FG000|Overall Study|Withdrawal by Subject|2|||
143485476|NCT00879229|517322830|FG000|Overall Study|Study terminated by Sponsor|13|||
143485477|NCT00879229|517322831|FG001|Overall Study|Study terminated by Sponsor|12|||
143485478|NCT00879229|517322830|FG000|Overall Study|Death|4|||
143485479|NCT00879229|517322831|FG001|Overall Study|Death|2|||
143485480|NCT00879229|517322830|FG000|Overall Study|Adverse Event|2|||
143485481|NCT00879229|517322831|FG001|Overall Study|Adverse Event|0|||
143485482|NCT00879229|517322830|FG000|Overall Study|Withdrawal by Subject|1|||
143485483|NCT00879229|517322831|FG001|Overall Study|Withdrawal by Subject|0|||
143485484|NCT00879229|517322830|FG000|Overall Study|Clinical status did not improve|1|||
143485485|NCT00879229|517322831|FG001|Overall Study|Clinical status did not improve|0|||
143485486|NCT00879229|517322830|FG000|Overall Study|Other|1|||
143485487|NCT00879229|517322831|FG001|Overall Study|Other|0|||
143017787|NCT01106352|515606524|FG000|Overall Study|Subjects untreated|0|||
143017788|NCT01106352|515606525|FG001|Overall Study|Subjects untreated|0|||
143017789|NCT01106352|515606526|FG002|Overall Study|Subjects untreated|0|||
143017790|NCT01106352|515606527|FG003|Overall Study|Subjects untreated|3|||
143017791|NCT01106352|515606528|FG004|Overall Study|Subjects untreated|4|||
143017792|NCT01106352|515606524|FG000|Overall Study|Sponsor Decision|1|||
143017793|NCT01106352|515606525|FG001|Overall Study|Sponsor Decision|0|||
143017794|NCT01106352|515606526|FG002|Overall Study|Sponsor Decision|0|||
143017795|NCT01106352|515606527|FG003|Overall Study|Sponsor Decision|0|||
143017796|NCT01106352|515606528|FG004|Overall Study|Sponsor Decision|0|||
143017797|NCT01106352|515606524|FG000|Overall Study|Too ill to come in for the visit|0|||
143017798|NCT01106352|515606525|FG001|Overall Study|Too ill to come in for the visit|0|||
143017799|NCT01106352|515606526|FG002|Overall Study|Too ill to come in for the visit|1|||
143017800|NCT01106352|515606527|FG003|Overall Study|Too ill to come in for the visit|0|||
143017801|NCT01106352|515606528|FG004|Overall Study|Too ill to come in for the visit|0|||
143017802|NCT01106352|515606524|FG000|Overall Study|Lost to Follow-up|0|||
143017803|NCT01106352|515606525|FG001|Overall Study|Lost to Follow-up|0|||
143017804|NCT01106352|515606526|FG002|Overall Study|Lost to Follow-up|0|||
143017805|NCT01106352|515606527|FG003|Overall Study|Lost to Follow-up|0|||
143017806|NCT01106352|515606528|FG004|Overall Study|Lost to Follow-up|1|||
143017807|NCT01106352|515606524|FG000|Overall Study|Death|0|||
143017808|NCT01106352|515606525|FG001|Overall Study|Death|0|||
143017809|NCT01106352|515606526|FG002|Overall Study|Death|1|||
143017810|NCT01106352|515606527|FG003|Overall Study|Death|3|||
143017811|NCT01106352|515606528|FG004|Overall Study|Death|1|||
143017812|NCT01106352|515606524|FG000|Overall Study|Disease progression|0|||
143017813|NCT01106352|515606525|FG001|Overall Study|Disease progression|0|||
143017814|NCT01106352|515606526|FG002|Overall Study|Disease progression|0|||
143017815|NCT01106352|515606527|FG003|Overall Study|Disease progression|1|||
143017816|NCT01106352|515606528|FG004|Overall Study|Disease progression|0|||
143017817|NCT01106352|515606524|FG000|Overall Study|Withdrawal by Subject|0|||
143017818|NCT01106352|515606525|FG001|Overall Study|Withdrawal by Subject|0|||
143017819|NCT01106352|515606526|FG002|Overall Study|Withdrawal by Subject|0|||
143017820|NCT01106352|515606527|FG003|Overall Study|Withdrawal by Subject|3|||
143017821|NCT01106352|515606528|FG004|Overall Study|Withdrawal by Subject|2|||
143017822|NCT01106352|515606524|FG000|Overall Study|Went on hospice|0|||
143017823|NCT01106352|515606525|FG001|Overall Study|Went on hospice|0|||
143017824|NCT01106352|515606526|FG002|Overall Study|Went on hospice|0|||
143017825|NCT01106352|515606527|FG003|Overall Study|Went on hospice|1|||
143485488|NCT00631371|517322832|FG000|Overall Study|Lost to Follow-up|24|||
143485489|NCT00631371|517322833|FG001|Overall Study|Lost to Follow-up|19|||
143485490|NCT00631371|517322832|FG000|Overall Study|Other reason|5|||
143485491|NCT00631371|517322833|FG001|Overall Study|Other reason|12|||
143485492|NCT00631371|517322832|FG000|Overall Study|subject request|38|||
143017826|NCT01106352|515606528|FG004|Overall Study|Went on hospice|0|||
143017827|NCT01106352|515606524|FG000|Overall Study|Subject entered hospice|0|||
143017828|NCT01106352|515606525|FG001|Overall Study|Subject entered hospice|0|||
143017829|NCT01106352|515606526|FG002|Overall Study|Subject entered hospice|0|||
143017830|NCT01106352|515606527|FG003|Overall Study|Subject entered hospice|1|||
143017831|NCT01106352|515606528|FG004|Overall Study|Subject entered hospice|0|||
143485493|NCT00631371|517322833|FG001|Overall Study|subject request|45|||
143017832|NCT01106352|515606524|FG000|Overall Study|Home hospice since July 2013|0|||
143017833|NCT01106352|515606525|FG001|Overall Study|Home hospice since July 2013|0|||
143017834|NCT01106352|515606526|FG002|Overall Study|Home hospice since July 2013|0|||
143485494|NCT00631371|517322832|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
143485495|NCT00631371|517322833|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
143017835|NCT01106352|515606527|FG003|Overall Study|Home hospice since July 2013|1|||
143017836|NCT01106352|515606528|FG004|Overall Study|Home hospice since July 2013|0|||
143017837|NCT03547531|515606529|FG000|Overall Study|not coming in data collection : sick|2|||
143017838|NCT03547531|515606530|FG001|Overall Study|not coming in data collection : sick|2|||
143017839|NCT03547531|515606529|FG000|Overall Study|having family occasion|0|||
143017840|NCT03547531|515606530|FG001|Overall Study|having family occasion|2|||
143017841|NCT03944707|515606538|FG000|Overall Study|Adverse Event|0|||
143017842|NCT03944707|515606539|FG001|Overall Study|Adverse Event|2|||
143017843|NCT03944707|515606538|FG000|Overall Study|Study terminated by sponsor|12|||
143154091|NCT03011372|516107193|FG000|Overall Study|Death|16|||
143154092|NCT03011372|516107193|FG000|Overall Study|Lost to Follow-up|2|||
143154093|NCT03011372|516107193|FG000|Overall Study|Sponsor Decision|17|||
143154094|NCT03011372|516107193|FG000|Overall Study|Withdrawal by Subject|7|||
143154095|NCT03011372|516107193|FG000|Overall Study|Moved to Commercial Supply of Investigational Drug|2|||
143154096|NCT03011372|516107193|FG000|Overall Study|Received First Dose of Chemotherapy for Stem Cell Transplant|1|||
143154097|NCT03011372|516107193|FG000|Overall Study|Sponsor's Decision|2|||
143154107|NCT03860584|516107195|FG000|First Intervention (2 Weeks)|Lack of Efficacy|1|||
143154108|NCT03860584|516107196|FG001|First Intervention (2 Weeks)|Lack of Efficacy|0|||
143154109|NCT03860584|516107195|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
143154110|NCT03860584|516107196|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
143154111|NCT03860584|516107195|FG000|Second Intervention (2 Weeks)|Lost to Follow-up|3|||
143154112|NCT03860584|516107196|FG001|Second Intervention (2 Weeks)|Lost to Follow-up|0|||
143154113|NCT03860584|516107195|FG000|Second Intervention (2 Weeks)|Lack of Efficacy|0|||
143154114|NCT03860584|516107196|FG001|Second Intervention (2 Weeks)|Lack of Efficacy|1|||
143154129|NCT05865886|516107199|FG000|Overall Study|Serious adverse event|0|||
143154130|NCT05865886|516107200|FG001|Overall Study|Serious adverse event|1|||
143154131|NCT02369458|516107205|FG000|Overall Study|Determined to be not eligible|1|||
143154132|NCT02369458|516107206|FG001|Overall Study|Determined to be not eligible|0|||
143154133|NCT03853798|516107211|FG000|Overall Study|Death|0|||
143154134|NCT03853798|516107212|FG001|Overall Study|Death|0|||
143154135|NCT03853798|516107213|FG002|Overall Study|Death|0|||
143154136|NCT03853798|516107214|FG003|Overall Study|Death|0|||
143154137|NCT03853798|516107215|FG004|Overall Study|Death|0|||
143154138|NCT03853798|516107216|FG005|Overall Study|Death|1|||
143154139|NCT03853798|516107217|FG006|Overall Study|Death|0|||
143154140|NCT03853798|516107218|FG007|Overall Study|Death|0|||
143154141|NCT03853798|516107219|FG008|Overall Study|Death|0|||
143154142|NCT03853798|516107211|FG000|Overall Study|Adverse Event|0|||
143154143|NCT03853798|516107212|FG001|Overall Study|Adverse Event|0|||
143154144|NCT03853798|516107213|FG002|Overall Study|Adverse Event|2|||
143154145|NCT03853798|516107214|FG003|Overall Study|Adverse Event|0|||
143154146|NCT03853798|516107215|FG004|Overall Study|Adverse Event|0|||
143154147|NCT03853798|516107216|FG005|Overall Study|Adverse Event|0|||
143154148|NCT03853798|516107217|FG006|Overall Study|Adverse Event|0|||
143154149|NCT03853798|516107218|FG007|Overall Study|Adverse Event|0|||
143154150|NCT03853798|516107219|FG008|Overall Study|Adverse Event|0|||
143154151|NCT03853798|516107211|FG000|Overall Study|Withdrawal by Subject|0|||
143154152|NCT03853798|516107212|FG001|Overall Study|Withdrawal by Subject|1|||
143154153|NCT03853798|516107213|FG002|Overall Study|Withdrawal by Subject|4|||
143154154|NCT03853798|516107214|FG003|Overall Study|Withdrawal by Subject|0|||
143154155|NCT03853798|516107215|FG004|Overall Study|Withdrawal by Subject|0|||
143154156|NCT03853798|516107216|FG005|Overall Study|Withdrawal by Subject|5|||
143154157|NCT03853798|516107217|FG006|Overall Study|Withdrawal by Subject|0|||
143154158|NCT03853798|516107218|FG007|Overall Study|Withdrawal by Subject|0|||
143154159|NCT03853798|516107219|FG008|Overall Study|Withdrawal by Subject|4|||
143154160|NCT03853798|516107211|FG000|Overall Study|Physician Decision|1|||
143154161|NCT03853798|516107212|FG001|Overall Study|Physician Decision|0|||
143154162|NCT03853798|516107213|FG002|Overall Study|Physician Decision|0|||
143154163|NCT03853798|516107214|FG003|Overall Study|Physician Decision|0|||
143154164|NCT03853798|516107215|FG004|Overall Study|Physician Decision|0|||
143154165|NCT03853798|516107216|FG005|Overall Study|Physician Decision|0|||
143154166|NCT03853798|516107217|FG006|Overall Study|Physician Decision|0|||
143154167|NCT03853798|516107218|FG007|Overall Study|Physician Decision|0|||
143154168|NCT03853798|516107219|FG008|Overall Study|Physician Decision|1|||
143154169|NCT03853798|516107211|FG000|Overall Study|Lack of Efficacy|0|||
143154170|NCT03853798|516107212|FG001|Overall Study|Lack of Efficacy|0|||
143154171|NCT03853798|516107213|FG002|Overall Study|Lack of Efficacy|2|||
143154172|NCT03853798|516107214|FG003|Overall Study|Lack of Efficacy|0|||
143154173|NCT03853798|516107215|FG004|Overall Study|Lack of Efficacy|0|||
143154174|NCT03853798|516107216|FG005|Overall Study|Lack of Efficacy|0|||
143154175|NCT03853798|516107217|FG006|Overall Study|Lack of Efficacy|0|||
143154176|NCT03853798|516107218|FG007|Overall Study|Lack of Efficacy|0|||
143154177|NCT03853798|516107219|FG008|Overall Study|Lack of Efficacy|1|||
143154178|NCT03853798|516107211|FG000|Overall Study|Approved Drug Available for Indication|0|||
143154179|NCT03853798|516107212|FG001|Overall Study|Approved Drug Available for Indication|0|||
143154180|NCT03853798|516107213|FG002|Overall Study|Approved Drug Available for Indication|1|||
143154181|NCT03853798|516107214|FG003|Overall Study|Approved Drug Available for Indication|0|||
143154182|NCT03853798|516107215|FG004|Overall Study|Approved Drug Available for Indication|0|||
143154183|NCT03853798|516107216|FG005|Overall Study|Approved Drug Available for Indication|1|||
143154184|NCT03853798|516107217|FG006|Overall Study|Approved Drug Available for Indication|0|||
143154185|NCT03853798|516107218|FG007|Overall Study|Approved Drug Available for Indication|0|||
143154186|NCT03853798|516107219|FG008|Overall Study|Approved Drug Available for Indication|0|||
143154187|NCT03853798|516107211|FG000|Overall Study|Other un-specified|0|||
143154188|NCT03853798|516107212|FG001|Overall Study|Other un-specified|0|||
143154189|NCT03853798|516107213|FG002|Overall Study|Other un-specified|2|||
143154190|NCT03853798|516107214|FG003|Overall Study|Other un-specified|0|||
143154191|NCT03853798|516107215|FG004|Overall Study|Other un-specified|0|||
143154192|NCT03853798|516107216|FG005|Overall Study|Other un-specified|1|||
143154193|NCT03853798|516107217|FG006|Overall Study|Other un-specified|0|||
143154194|NCT03853798|516107218|FG007|Overall Study|Other un-specified|0|||
143154195|NCT03853798|516107219|FG008|Overall Study|Other un-specified|0|||
143154206|NCT02743494|516107222|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
143154207|NCT02743494|516107223|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
143154208|NCT02743494|516107222|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
143154209|NCT02743494|516107223|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
143154210|NCT02743494|516107222|FG000|Treatment Period|Disease recurrence|152|||
143154211|NCT02743494|516107223|FG001|Treatment Period|Disease recurrence|115|||
143154212|NCT02743494|516107222|FG000|Treatment Period|Study drug toxicity|56|||
143154213|NCT02743494|516107223|FG001|Treatment Period|Study drug toxicity|8|||
143154214|NCT02743494|516107222|FG000|Treatment Period|Death|1|||
143154215|NCT02743494|516107223|FG001|Treatment Period|Death|1|||
143154216|NCT02743494|516107222|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
143154217|NCT02743494|516107223|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
143154218|NCT02743494|516107222|FG000|Treatment Period|Participant request to discontinue treatment|31|||
143154219|NCT02743494|516107223|FG001|Treatment Period|Participant request to discontinue treatment|5|||
143154220|NCT02743494|516107222|FG000|Treatment Period|Participant withdrew consent|11|||
143485496|NCT00631371|517322832|FG000|Overall Study|Death|263|||
143485497|NCT00631371|517322833|FG001|Overall Study|Death|239|||
143485498|NCT00513409|517322839|FG000|Overall Study|Adverse Event|0|||
143485499|NCT00513409|517322840|FG001|Overall Study|Adverse Event|1|||
143485500|NCT00513409|517322839|FG000|Overall Study|Withdrawal by Subject|0|||
143485501|NCT00513409|517322840|FG001|Overall Study|Withdrawal by Subject|2|||
143485502|NCT00513409|517322839|FG000|Overall Study|Lost to Follow-up|0|||
143485503|NCT00513409|517322840|FG001|Overall Study|Lost to Follow-up|1|||
143485504|NCT00513409|517322839|FG000|Overall Study|Physician Decision|1|||
143485505|NCT00513409|517322840|FG001|Overall Study|Physician Decision|0|||
143485506|NCT00513409|517322839|FG000|Overall Study|Visit 3 not done|1|||
143485507|NCT00513409|517322840|FG001|Overall Study|Visit 3 not done|2|||
143485508|NCT00812214|517322844|FG000|Overall Study|Lost to Follow-up|3|||
143485509|NCT00812214|517322845|FG001|Overall Study|Lost to Follow-up|1|||
143485510|NCT01659320|517322846|FG000|Overall Study|Withdrawal by Subject|2|||
143485511|NCT01659320|517322846|FG000|Overall Study|Physician Decision|1|||
143485512|NCT00590590|517322847|FG000|Overall Study|Lack of Efficacy|1|||
143485513|NCT00590590|517322848|FG001|Overall Study|Lack of Efficacy|2|||
143485514|NCT00590590|517322849|FG002|Overall Study|Lack of Efficacy|0|||
143485515|NCT00590590|517322847|FG000|Overall Study|Adverse Event|1|||
143485516|NCT00590590|517322848|FG001|Overall Study|Adverse Event|0|||
143485517|NCT00590590|517322849|FG002|Overall Study|Adverse Event|0|||
143485518|NCT00590590|517322847|FG000|Overall Study|Protocol Violation|0|||
143485519|NCT00590590|517322848|FG001|Overall Study|Protocol Violation|0|||
143154221|NCT02743494|516107223|FG001|Treatment Period|Participant withdrew consent|4|||
143154222|NCT02743494|516107222|FG000|Treatment Period|Lost to Follow-up|0|||
143154223|NCT02743494|516107223|FG001|Treatment Period|Lost to Follow-up|1|||
143154224|NCT02743494|516107222|FG000|Treatment Period|Poor/Non-compliance|2|||
143485520|NCT00590590|517322849|FG002|Overall Study|Protocol Violation|2|||
143485521|NCT00590590|517322847|FG000|Overall Study|Lost to Follow-up|4|||
143485522|NCT00590590|517322848|FG001|Overall Study|Lost to Follow-up|1|||
143485523|NCT00590590|517322849|FG002|Overall Study|Lost to Follow-up|2|||
143485524|NCT00590590|517322847|FG000|Overall Study|Withdrawal by Subject|0|||
143154225|NCT02743494|516107223|FG001|Treatment Period|Poor/Non-compliance|0|||
143154226|NCT02743494|516107222|FG000|Treatment Period|Other reasons|4|||
143154227|NCT02743494|516107223|FG001|Treatment Period|Other reasons|1|||
143485525|NCT00590590|517322848|FG001|Overall Study|Withdrawal by Subject|1|||
143485526|NCT00590590|517322849|FG002|Overall Study|Withdrawal by Subject|1|||
143485527|NCT00590590|517322847|FG000|Overall Study|Did not complete due to study closure|1|||
143235558|NCT03605667|516413618|FG001|OLE Phase (48 Weeks)|Death|2|||
143363683|NCT00062868|516873795|FG015|Dose Level 3|Lost to Follow-up|0|||
143154344|NCT02564978|516107627|FG000|Overall Study|Adverse Event|8|||
143154345|NCT02564978|516107627|FG000|Overall Study|Death|1|||
143154346|NCT02564978|516107627|FG000|Overall Study|Lost to Follow-up|1|||
143154347|NCT02564978|516107627|FG000|Overall Study|Withdrawal by Subject|15|||
143154348|NCT02564978|516107627|FG000|Overall Study|Early Study Closure|2|||
143154349|NCT02564978|516107627|FG000|Overall Study|Other Reason|5|||
143181433|NCT04538664|516211741|FG001|Overall Study|Withdrawal by Subject|9|||
143181434|NCT04538664|516211740|FG000|Overall Study|Lost to Follow-up|2|||
143181435|NCT04538664|516211741|FG001|Overall Study|Lost to Follow-up|1|||
143181436|NCT04538664|516211740|FG000|Overall Study|Ongoing|106|||
143181437|NCT04538664|516211741|FG001|Overall Study|Ongoing|115|||
143181438|NCT02142803|516211742|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
143181439|NCT02142803|516211743|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
143181440|NCT02142803|516211744|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
143181441|NCT02142803|516211745|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
143181442|NCT03390504|516211747|FG000|Overall Study|Lost to Follow-up|2|||
143181443|NCT03390504|516211748|FG001|Overall Study|Lost to Follow-up|4|||
143181444|NCT03390504|516211749|FG002|Overall Study|Lost to Follow-up|0|||
143181445|NCT03390504|516211750|FG003|Overall Study|Lost to Follow-up|1|||
143181446|NCT03390504|516211747|FG000|Overall Study|Withdrawal by Subject|3|||
143181447|NCT03390504|516211748|FG001|Overall Study|Withdrawal by Subject|15|||
143181448|NCT03390504|516211749|FG002|Overall Study|Withdrawal by Subject|5|||
143181449|NCT03390504|516211750|FG003|Overall Study|Withdrawal by Subject|2|||
143485528|NCT00590590|517322848|FG001|Overall Study|Did not complete due to study closure|1|||
143485529|NCT00590590|517322849|FG002|Overall Study|Did not complete due to study closure|1|||
143485530|NCT00590590|517322847|FG000|Overall Study|Did not complete study|0|||
143181450|NCT03390504|516211747|FG000|Overall Study|Other|1|||
143181451|NCT03390504|516211748|FG001|Overall Study|Other|2|||
143181452|NCT03390504|516211749|FG002|Overall Study|Other|2|||
143181453|NCT03390504|516211750|FG003|Overall Study|Other|6|||
143181454|NCT00980538|516211751|FG000|Overall Study|Lost to Follow-up|20|||
143181455|NCT00980538|516211751|FG000|Overall Study|Sponsor's Decision|4|||
143181456|NCT00980538|516211751|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
143181457|NCT00980538|516211751|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
143181458|NCT00980538|516211751|FG000|Overall Study|Switch to Commercially Available Medication|25|||
143181459|NCT00980538|516211751|FG000|Overall Study|Participant Non-Compliant|9|||
143181460|NCT00980538|516211751|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
143181461|NCT00980538|516211751|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
143181462|NCT00980538|516211751|FG000|Overall Study|Other|60|||
143181463|NCT00980538|516211751|FG000|Overall Study|Other|1|||
143485531|NCT00590590|517322848|FG001|Overall Study|Did not complete study|1|||
143181464|NCT00642707|516211752|FG000|Overall Study|Adverse Event|0|||
143181465|NCT00642707|516211753|FG001|Overall Study|Adverse Event|0|||
143485532|NCT00590590|517322849|FG002|Overall Study|Did not complete study|0|||
143485533|NCT01514682|517322850|FG000|Overall Study|Withdrawal by Subject|2|||
143154350|NCT00835978|516109548|FG000|Overall Study|Death|33|||
143154351|NCT00835978|516109549|FG001|Overall Study|Death|40|||
143154352|NCT00835978|516109550|FG002|Overall Study|Death|49|||
143154353|NCT00835978|516109551|FG003|Overall Study|Death|4|||
143154354|NCT00835978|516109548|FG000|Overall Study|Lost to Follow-up|3|||
143154355|NCT00835978|516109549|FG001|Overall Study|Lost to Follow-up|4|||
143154356|NCT00835978|516109550|FG002|Overall Study|Lost to Follow-up|2|||
143154357|NCT00835978|516109551|FG003|Overall Study|Lost to Follow-up|1|||
143154358|NCT00835978|516109548|FG000|Overall Study|Other|5|||
143154359|NCT00835978|516109549|FG001|Overall Study|Other|1|||
143154360|NCT00835978|516109550|FG002|Overall Study|Other|8|||
143154361|NCT00835978|516109551|FG003|Overall Study|Other|0|||
143154362|NCT00835978|516109548|FG000|Overall Study|Objective progression or relapse|2|||
143154363|NCT00835978|516109549|FG001|Overall Study|Objective progression or relapse|0|||
143154364|NCT00835978|516109550|FG002|Overall Study|Objective progression or relapse|1|||
143154365|NCT00835978|516109551|FG003|Overall Study|Objective progression or relapse|0|||
143154366|NCT00835978|516109548|FG000|Overall Study|Adverse Event|1|||
143154367|NCT00835978|516109549|FG001|Overall Study|Adverse Event|0|||
143154368|NCT00835978|516109550|FG002|Overall Study|Adverse Event|1|||
143154369|NCT00835978|516109551|FG003|Overall Study|Adverse Event|0|||
143154370|NCT00835978|516109548|FG000|Overall Study|Withdrawal by Subject|0|||
143154371|NCT00835978|516109549|FG001|Overall Study|Withdrawal by Subject|3|||
143154372|NCT00835978|516109550|FG002|Overall Study|Withdrawal by Subject|0|||
143154373|NCT00835978|516109551|FG003|Overall Study|Withdrawal by Subject|5|||
143154374|NCT00835978|516109548|FG000|Overall Study|Study terminated by sponsor|12|||
143154375|NCT00835978|516109549|FG001|Overall Study|Study terminated by sponsor|8|||
143154376|NCT00835978|516109550|FG002|Overall Study|Study terminated by sponsor|30|||
143154377|NCT00835978|516109551|FG003|Overall Study|Study terminated by sponsor|0|||
143154378|NCT02400736|516109554|FG000|Overall Study|Lost to Follow-up|6|||
143154379|NCT02400736|516109555|FG001|Overall Study|Lost to Follow-up|6|||
143154380|NCT02400736|516109554|FG000|Overall Study|Withdrawal by Subject|2|||
143154381|NCT02400736|516109555|FG001|Overall Study|Withdrawal by Subject|1|||
143154382|NCT02400736|516109554|FG000|Overall Study|Moved from the area|3|||
143154383|NCT02400736|516109555|FG001|Overall Study|Moved from the area|1|||
143154384|NCT02927145|516109557|FG000|Initial Recruitment|Withdrawal by Subject|0|||
143154385|NCT02927145|516109558|FG001|Initial Recruitment|Withdrawal by Subject|1|||
143154386|NCT02927145|516109559|FG002|Initial Recruitment|Withdrawal by Subject|1|||
143154387|NCT02927145|516109560|FG003|Initial Recruitment|Withdrawal by Subject|4|||
143154388|NCT02927145|516109561|FG004|Initial Recruitment|Withdrawal by Subject|1|||
143154389|NCT02927145|516109562|FG005|Initial Recruitment|Withdrawal by Subject|1|||
143154390|NCT02927145|516109563|FG006|Initial Recruitment|Withdrawal by Subject|0|||
143154391|NCT02927145|516109564|FG007|Initial Recruitment|Withdrawal by Subject|0|||
143154392|NCT02927145|516109565|FG008|Initial Recruitment|Withdrawal by Subject|2|||
143154393|NCT02927145|516109557|FG000|Initial Recruitment|Adverse Event|0|||
143154394|NCT02927145|516109558|FG001|Initial Recruitment|Adverse Event|0|||
143154395|NCT02927145|516109559|FG002|Initial Recruitment|Adverse Event|0|||
143154396|NCT02927145|516109560|FG003|Initial Recruitment|Adverse Event|0|||
143154397|NCT02927145|516109561|FG004|Initial Recruitment|Adverse Event|2|||
143154398|NCT02927145|516109562|FG005|Initial Recruitment|Adverse Event|0|||
143154399|NCT02927145|516109563|FG006|Initial Recruitment|Adverse Event|0|||
143154400|NCT02927145|516109564|FG007|Initial Recruitment|Adverse Event|0|||
143154401|NCT02927145|516109565|FG008|Initial Recruitment|Adverse Event|0|||
143154402|NCT02927145|516109557|FG000|Invitation for Additional Challenge|Pregnancy|0|||
143154403|NCT02927145|516109558|FG001|Invitation for Additional Challenge|Pregnancy|0|||
143154404|NCT02927145|516109559|FG002|Invitation for Additional Challenge|Pregnancy|0|||
143154405|NCT02927145|516109560|FG003|Invitation for Additional Challenge|Pregnancy|0|||
143154406|NCT02927145|516109561|FG004|Invitation for Additional Challenge|Pregnancy|0|||
143154407|NCT02927145|516109562|FG005|Invitation for Additional Challenge|Pregnancy|0|||
143154408|NCT02927145|516109563|FG006|Invitation for Additional Challenge|Pregnancy|1|||
143154409|NCT02927145|516109564|FG007|Invitation for Additional Challenge|Pregnancy|0|||
143154410|NCT02927145|516109565|FG008|Invitation for Additional Challenge|Pregnancy|0|||
143154411|NCT01002105|516109566|FG000|Overall Study|Lost to Follow-up|10|||
143154412|NCT01002105|516109567|FG001|Overall Study|Lost to Follow-up|16|||
143154413|NCT01002105|516109566|FG000|Overall Study|non compliance|5|||
143154414|NCT01002105|516109567|FG001|Overall Study|non compliance|3|||
143154415|NCT01002105|516109566|FG000|Overall Study|condition worsened|4|||
143235559|NCT03605667|516413617|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
143154416|NCT01002105|516109567|FG001|Overall Study|condition worsened|2|||
143154417|NCT01363440|516109568|FG000|Overall Study|Adverse Event|5|||
143154418|NCT01363440|516109569|FG001|Overall Study|Adverse Event|4|||
143154419|NCT01363440|516109570|FG002|Overall Study|Adverse Event|4|||
143154420|NCT01363440|516109568|FG000|Overall Study|Death|3|||
143154421|NCT01363440|516109569|FG001|Overall Study|Death|7|||
143154422|NCT01363440|516109570|FG002|Overall Study|Death|5|||
143154423|NCT01363440|516109568|FG000|Overall Study|Withdrawal by Subject|9|||
143154424|NCT01363440|516109569|FG001|Overall Study|Withdrawal by Subject|11|||
143154425|NCT01363440|516109570|FG002|Overall Study|Withdrawal by Subject|11|||
143154426|NCT01363440|516109568|FG000|Overall Study|Lost to Follow-up|2|||
143017844|NCT03944707|515606539|FG001|Overall Study|Study terminated by sponsor|7|||
143017845|NCT03944707|515606538|FG000|Overall Study|Subject decision|0|||
143017846|NCT03944707|515606539|FG001|Overall Study|Subject decision|1|||
143017847|NCT03402126|515606540|FG000|Overall Study|Lost to Follow-up|6|||
143017848|NCT03402126|515606540|FG000|Overall Study|Protocol Violation|10|||
143017849|NCT03402126|515606540|FG000|Overall Study|Sponsor request/Study termination|29|||
143017850|NCT03402126|515606540|FG000|Overall Study|Study product no longer in use|1|||
143017851|NCT03402126|515606540|FG000|Overall Study|Technical problems|1|||
143017852|NCT03402126|515606540|FG000|Overall Study|Withdrawal by Subject|6|||
143017853|NCT03402126|515606540|FG000|Overall Study|Physician Decision|2|||
143017854|NCT03402126|515606540|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
143017855|NCT03402126|515606540|FG000|Overall Study|Death|4|||
143017856|NCT02444182|515606541|FG000|Overall Study|non-compliance|2|||
143017857|NCT02444182|515606542|FG001|Overall Study|non-compliance|1|||
143017858|NCT02444182|515606541|FG000|Overall Study|Lost to Follow-up|0|||
143017859|NCT02444182|515606542|FG001|Overall Study|Lost to Follow-up|4|||
143017860|NCT01959230|515606545|FG000|Overall Study|Failure to follow study procedures|0|||
143017861|NCT01959230|515606546|FG001|Overall Study|Failure to follow study procedures|1|||
143017862|NCT01959230|515606545|FG000|Overall Study|Administrative reasons|2|||
143017863|NCT01959230|515606546|FG001|Overall Study|Administrative reasons|0|||
143017864|NCT01959230|515606545|FG000|Overall Study|Withdrawal by Subject|2|||
143017865|NCT01959230|515606546|FG001|Overall Study|Withdrawal by Subject|0|||
143017866|NCT00751998|515606547|FG000|Overall Study|Lost to Follow-up|7|||
143017867|NCT00751998|515606547|FG000|Overall Study|Death|11|||
143017868|NCT00751998|515606547|FG000|Overall Study|Withdrawal by Subject|2|||
143017869|NCT04126733|515606548|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
143017870|NCT04126733|515606548|FG000|Treatment Period|Adverse Event|8|||
143017871|NCT04126733|515606548|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
143017872|NCT04126733|515606548|FG000|Treatment Period|Physician Decision|5|||
143017873|NCT04126733|515606548|FG000|Treatment Period|Death|1|||
143017874|NCT04126733|515606548|FG000|Treatment Period|Other Reasons|2|||
143017875|NCT04126733|515606548|FG000|Active Follow-up Period|Death|13|||
143017876|NCT04126733|515606548|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
143017877|NCT04126733|515606548|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
143017878|NCT04126733|515606548|FG000|Active Follow-up Period|Other Reasons|1|||
143017879|NCT04126733|515606548|FG000|Long-term Follow-up Period|Death|22|||
143017880|NCT04126733|515606548|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
143017881|NCT04126733|515606548|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
143017882|NCT02629133|515606549|FG000|Overall Study|Lost to Follow-up|3|||
143017883|NCT02629133|515606550|FG001|Overall Study|Lost to Follow-up|1|||
143017884|NCT02629133|515606549|FG000|Overall Study|Withdrawal by Subject|1|||
143017885|NCT02629133|515606550|FG001|Overall Study|Withdrawal by Subject|1|||
143017886|NCT03216954|515606551|FG000|Overall Study|Adverse Event|0|||
143017887|NCT03216954|515606552|FG001|Overall Study|Adverse Event|0|||
143017888|NCT03216954|515606553|FG002|Overall Study|Adverse Event|1|||
143017889|NCT03216954|515606554|FG003|Overall Study|Adverse Event|0|||
143017890|NCT03216954|515606555|FG004|Overall Study|Adverse Event|1|||
143017891|NCT03216954|515606551|FG000|Overall Study|Withdrawal by Subject|2|||
143017892|NCT03216954|515606552|FG001|Overall Study|Withdrawal by Subject|0|||
143017893|NCT03216954|515606553|FG002|Overall Study|Withdrawal by Subject|0|||
143017894|NCT03216954|515606554|FG003|Overall Study|Withdrawal by Subject|0|||
143017895|NCT03216954|515606555|FG004|Overall Study|Withdrawal by Subject|0|||
143017896|NCT03216954|515606551|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
143017897|NCT03216954|515606552|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
143017898|NCT03216954|515606553|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
143017899|NCT03216954|515606554|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
143017900|NCT03216954|515606555|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
143017901|NCT02598193|515606556|FG000|Overall Study|Adverse Event|13|||
143017902|NCT02598193|515606556|FG000|Overall Study|Withdrawal by Subject|1|||
143017903|NCT02598193|515606556|FG000|Overall Study|Listed in active lung transplant list|1|||
143017904|NCT02598193|515606556|FG000|Overall Study|Does not want to take Nintedanib|1|||
143017905|NCT05180630|515606557|FG000|First Intervention|Physician Decision|0|||
143017906|NCT05180630|515606558|FG001|First Intervention|Physician Decision|0|||
143017907|NCT05180630|515606559|FG002|First Intervention|Physician Decision|3|||
143154427|NCT01363440|516109569|FG001|Overall Study|Lost to Follow-up|4|||
143017908|NCT02487979|515606560|FG000|Overall Study|Physician Decision|2|||
143017909|NCT02487979|515606560|FG000|Overall Study|Withdrawal by Subject|2|||
143017910|NCT02487979|515606560|FG000|Overall Study|Progressive Disease|17|||
143017911|NCT00447694|515606561|FG000|Overall Study|Adverse Event|2|||
143017912|NCT00447694|515606561|FG000|Overall Study|Abnormal laboratory value|1|||
143017913|NCT00447694|515606561|FG000|Overall Study|Abnormal test procedure result|1|||
143017914|NCT00447694|515606561|FG000|Overall Study|Withdrawal by Subject|2|||
143154428|NCT01363440|516109570|FG002|Overall Study|Lost to Follow-up|5|||
143154429|NCT01363440|516109568|FG000|Overall Study|Other|4|||
143017915|NCT00709735|515606562|FG000|Overall Study|Lost to Follow-up|1|||
143017916|NCT00709735|515606563|FG001|Overall Study|Lost to Follow-up|1|||
143017917|NCT00709735|515606562|FG000|Overall Study|Relapse into Opioid Abuse|0|||
143017918|NCT00709735|515606563|FG001|Overall Study|Relapse into Opioid Abuse|1|||
143017919|NCT00709735|515606562|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
143017920|NCT00709735|515606563|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
143017921|NCT01169987|515606564|FG000|Overall Study|Withdrawal by Subject|3|||
143017922|NCT01169987|515606564|FG000|Overall Study|Lost to Follow-up|24|||
143017923|NCT01169987|515606564|FG000|Overall Study|Other|4|||
143017924|NCT00829439|515606565|FG000|Overall Study|Adverse Event|0|||
143017925|NCT00829439|515606566|FG001|Overall Study|Adverse Event|0|||
143017926|NCT00829439|515606567|FG002|Overall Study|Adverse Event|1|||
143017927|NCT00829439|515606568|FG003|Overall Study|Adverse Event|0|||
143017928|NCT00386100|515606569|FG000|Overall Study|Did not receive study medication|6|||
143017929|NCT00386100|515606570|FG001|Overall Study|Did not receive study medication|4|||
143017930|NCT00386100|515606569|FG000|Overall Study|Adverse Event|15|||
143017931|NCT00386100|515606570|FG001|Overall Study|Adverse Event|25|||
143017932|NCT00386100|515606569|FG000|Overall Study|Death|0|||
143017933|NCT00386100|515606570|FG001|Overall Study|Death|1|||
143017934|NCT00386100|515606569|FG000|Overall Study|Insufficient therapeutic effect|30|||
143017935|NCT00386100|515606570|FG001|Overall Study|Insufficient therapeutic effect|6|||
143017936|NCT00386100|515606569|FG000|Overall Study|Lost to Follow-up|29|||
143017937|NCT00386100|515606570|FG001|Overall Study|Lost to Follow-up|29|||
143017938|NCT00386100|515606569|FG000|Overall Study|Non-compliance|18|||
143017939|NCT00386100|515606570|FG001|Overall Study|Non-compliance|19|||
143017940|NCT00386100|515606569|FG000|Overall Study|Protocol Violation|5|||
143017941|NCT00386100|515606570|FG001|Overall Study|Protocol Violation|3|||
143017942|NCT00386100|515606569|FG000|Overall Study|Withdrawal by Subject|32|||
143017943|NCT00386100|515606570|FG001|Overall Study|Withdrawal by Subject|31|||
143017944|NCT00386100|515606569|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
143017945|NCT00386100|515606570|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
143017946|NCT00386100|515606569|FG000|Overall Study|BMD <2.5|1|||
143017947|NCT00386100|515606570|FG001|Overall Study|BMD <2.5|0|||
143017948|NCT00386100|515606569|FG000|Overall Study|Consecutive elevated Hba1C|1|||
143017949|NCT00386100|515606570|FG001|Overall Study|Consecutive elevated Hba1C|0|||
143017950|NCT00386100|515606569|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
143017951|NCT00386100|515606570|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
143017952|NCT00386100|515606569|FG000|Overall Study|Laboratory findings|1|||
143017953|NCT00386100|515606570|FG001|Overall Study|Laboratory findings|0|||
143017954|NCT00386100|515606569|FG000|Overall Study|Participant's concern due to CPK levels|1|||
143017955|NCT00386100|515606570|FG001|Overall Study|Participant's concern due to CPK levels|0|||
143017956|NCT00386100|515606569|FG000|Overall Study|Participant moving out of state|2|||
143017957|NCT00386100|515606570|FG001|Overall Study|Participant moving out of state|0|||
143017958|NCT00386100|515606569|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
143017959|NCT00386100|515606570|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
143017960|NCT00386100|515606569|FG000|Overall Study|Didn't meet entry criteria|1|||
143017961|NCT00386100|515606570|FG001|Overall Study|Didn't meet entry criteria|1|||
143017962|NCT00386100|515606569|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
143017963|NCT00386100|515606570|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
143017964|NCT00386100|515606569|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
143017965|NCT00386100|515606570|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
143017966|NCT00386100|515606569|FG000|Overall Study|Bad metabolic control & patient security|1|||
143017967|NCT00386100|515606570|FG001|Overall Study|Bad metabolic control & patient security|0|||
143017968|NCT00386100|515606569|FG000|Overall Study|Bone loss by DXA bone scan|1|||
143017969|NCT00386100|515606570|FG001|Overall Study|Bone loss by DXA bone scan|0|||
143017970|NCT00386100|515606569|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
143017971|NCT00386100|515606570|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
143017972|NCT00386100|515606569|FG000|Overall Study|7.6% bone loss|1|||
143017973|NCT00386100|515606570|FG001|Overall Study|7.6% bone loss|0|||
143017974|NCT00386100|515606569|FG000|Overall Study|Osteoporosis|0|||
143017975|NCT00386100|515606570|FG001|Overall Study|Osteoporosis|1|||
143017976|NCT00386100|515606569|FG000|Overall Study|Positive pregnancy test|1|||
143017977|NCT00386100|515606570|FG001|Overall Study|Positive pregnancy test|3|||
143017978|NCT00386100|515606569|FG000|Overall Study|Out of country for 5 months|1|||
143017979|NCT00386100|515606570|FG001|Overall Study|Out of country for 5 months|0|||
143017980|NCT00386100|515606569|FG000|Overall Study|Hb1Ac >8%|0|||
143017981|NCT00386100|515606570|FG001|Overall Study|Hb1Ac >8%|1|||
143017982|NCT00386100|515606569|FG000|Overall Study|Participant randomized in error|1|||
143017983|NCT00386100|515606570|FG001|Overall Study|Participant randomized in error|0|||
143017984|NCT00849524|515606578|FG000|Overall Study|Lack of Efficacy|3|||
143017985|NCT01493531|515606583|FG000|Overall Study|Adverse Event|4|||
143017986|NCT01493531|515606584|FG001|Overall Study|Adverse Event|12|||
143017987|NCT01493531|515606585|FG002|Overall Study|Adverse Event|9|||
143017988|NCT01493531|515606583|FG000|Overall Study|Gout flare|3|||
143017989|NCT01493531|515606584|FG001|Overall Study|Gout flare|0|||
143017990|NCT01493531|515606585|FG002|Overall Study|Gout flare|2|||
143017991|NCT01493531|515606583|FG000|Overall Study|Protocol Violation|8|||
143017992|NCT01493531|515606584|FG001|Overall Study|Protocol Violation|15|||
143017993|NCT01493531|515606585|FG002|Overall Study|Protocol Violation|12|||
143017994|NCT01493531|515606583|FG000|Overall Study|Sponsor terminated study|5|||
143017995|NCT01493531|515606584|FG001|Overall Study|Sponsor terminated study|2|||
143017996|NCT01493531|515606585|FG002|Overall Study|Sponsor terminated study|3|||
143017997|NCT01493531|515606583|FG000|Overall Study|Lost to Follow-up|5|||
143017998|NCT01493531|515606584|FG001|Overall Study|Lost to Follow-up|7|||
143017999|NCT01493531|515606585|FG002|Overall Study|Lost to Follow-up|11|||
143018000|NCT01493531|515606583|FG000|Overall Study|Withdrawal by Subject|16|||
143018001|NCT01493531|515606584|FG001|Overall Study|Withdrawal by Subject|13|||
143018002|NCT01493531|515606585|FG002|Overall Study|Withdrawal by Subject|11|||
143018003|NCT01493531|515606583|FG000|Overall Study|Death|0|||
143018004|NCT01493531|515606584|FG001|Overall Study|Death|1|||
143018005|NCT01493531|515606585|FG002|Overall Study|Death|0|||
143018006|NCT01946282|515606586|FG000|Year 1|Did not return FIT kit|4186|||
143018007|NCT01946282|515606587|FG001|Year 1|Did not return FIT kit|608|||
143018008|NCT01946282|515606588|FG002|Year 1|Did not return FIT kit|654|||
143018009|NCT01946282|515606586|FG000|Year 2|Did not return FIT kit|803|||
143018010|NCT01946282|515606587|FG001|Year 2|Did not return FIT kit|131|||
143018011|NCT01946282|515606588|FG002|Year 2|Did not return FIT kit|115|||
143018012|NCT01946282|515606586|FG000|Year 3|Did not return FIT kit|288|||
143018013|NCT01946282|515606587|FG001|Year 3|Did not return FIT kit|43|||
143018014|NCT01946282|515606588|FG002|Year 3|Did not return FIT kit|30|||
143018015|NCT03031431|515606589|FG000|Overall Study|Infant removed by maternal request|1|||
143018016|NCT03670537|515606594|FG000|Overall Study|Protocol Violation|1|||
143154430|NCT01363440|516109569|FG001|Overall Study|Other|5|||
143154431|NCT01363440|516109570|FG002|Overall Study|Other|2|||
143154432|NCT03695094|516109572|FG000|Overall Study|Adverse Event|1|||
143154433|NCT03695094|516109573|FG001|Overall Study|Adverse Event|1|||
143154434|NCT03695094|516109572|FG000|Overall Study|Withdrawal by Subject|1|||
143154435|NCT03695094|516109573|FG001|Overall Study|Withdrawal by Subject|0|||
143154436|NCT00266812|516109574|FG000|Overall Study|Disease Progression|9|||
143154437|NCT00266812|516109575|FG001|Overall Study|Disease Progression|3|||
143154438|NCT00266812|516109574|FG000|Overall Study|Death|5|||
143154439|NCT00266812|516109575|FG001|Overall Study|Death|4|||
143154440|NCT00266812|516109574|FG000|Overall Study|Adverse Event|3|||
143154441|NCT00266812|516109575|FG001|Overall Study|Adverse Event|1|||
143154442|NCT00266812|516109574|FG000|Overall Study|Protocol Violation|0|||
143154443|NCT00266812|516109575|FG001|Overall Study|Protocol Violation|1|||
143154444|NCT00266812|516109574|FG000|Overall Study|Withdrawal by Subject|0|||
143154445|NCT00266812|516109575|FG001|Overall Study|Withdrawal by Subject|2|||
143154446|NCT00266812|516109574|FG000|Overall Study|Discontinued before starting study drug|4|||
143154447|NCT00266812|516109575|FG001|Overall Study|Discontinued before starting study drug|0|||
143154448|NCT00530075|516109576|FG000|Overall Study|Adverse Event|1|||
143154449|NCT00530075|516109576|FG000|Overall Study|Death|1|||
143154450|NCT00530075|516109576|FG000|Overall Study|Lack of Efficacy|3|||
143154451|NCT00530075|516109576|FG000|Overall Study|Protocol Violation|1|||
143154452|NCT00530075|516109576|FG000|Overall Study|Withdrawal by Subject|1|||
143154453|NCT01166945|516109577|FG000|Randomized|diagnosed with Group A strep|4|||
143154454|NCT01166945|516109578|FG001|Randomized|diagnosed with Group A strep|4|||
143485534|NCT01514682|517322851|FG001|Overall Study|Withdrawal by Subject|3|||
143485535|NCT01514682|517322850|FG000|Overall Study|Physician Decision|4|||
143485536|NCT01514682|517322851|FG001|Overall Study|Physician Decision|3|||
143485537|NCT00132132|517322852|FG000|Overall Study|Lost to Follow-up|7|||
143018017|NCT01889862|515606595|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
143154455|NCT01166945|516109577|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
143154456|NCT01166945|516109578|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
143018018|NCT01889862|515606596|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
143018019|NCT01889862|515606597|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
143018020|NCT01889862|515606598|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
143018021|NCT01889862|515606599|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
143154457|NCT01166945|516109577|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
143154458|NCT01166945|516109578|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
143154459|NCT01166945|516109577|FG000|Day 30|Lost to Follow-up|4|||
143154460|NCT01166945|516109578|FG001|Day 30|Lost to Follow-up|3|||
143154461|NCT03520569|516109582|FG000|Overall Study|Withdrawal by Subject|1|||
143154462|NCT05558410|516109586|FG000|Overall Study|Adverse Event|1|||
143018022|NCT01889862|515606595|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
143018023|NCT01889862|515606596|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
143018024|NCT01889862|515606597|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
143018025|NCT01889862|515606598|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
143154463|NCT05558410|516109587|FG001|Overall Study|Adverse Event|2|||
143154464|NCT05558410|516109588|FG002|Overall Study|Adverse Event|0|||
143154465|NCT05558410|516109586|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
143154466|NCT05558410|516109587|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
143154467|NCT05558410|516109588|FG002|Overall Study|Withdrawal of consent (not due to AE)|2|||
143154468|NCT05558410|516109586|FG000|Overall Study|Lost to Follow-up|10|||
143018026|NCT01889862|515606599|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
143018027|NCT01889862|515606595|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
143018028|NCT01889862|515606596|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
143018029|NCT01889862|515606597|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
143018030|NCT01889862|515606598|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
143018031|NCT01889862|515606599|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
143018032|NCT01889862|515606595|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
143018033|NCT01889862|515606596|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
143018034|NCT01889862|515606597|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
143018035|NCT01889862|515606598|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
143018036|NCT01889862|515606599|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
143018037|NCT01889862|515606595|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
143018038|NCT01889862|515606596|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
143018039|NCT01889862|515606597|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
143018040|NCT01889862|515606598|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
143018041|NCT01889862|515606599|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
143018042|NCT01889862|515606595|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
143018043|NCT01889862|515606596|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
143018044|NCT01889862|515606597|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
143018045|NCT01889862|515606598|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
143018046|NCT01889862|515606599|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
143018047|NCT01889862|515606595|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
143018048|NCT01889862|515606596|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
143018049|NCT01889862|515606597|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
143018050|NCT01889862|515606598|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
143018051|NCT01889862|515606599|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
143018052|NCT01889862|515606595|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
143018053|NCT01889862|515606596|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
143018054|NCT01889862|515606597|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
143018055|NCT01889862|515606598|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
143018056|NCT01889862|515606599|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
143018057|NCT01889862|515606595|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
143018058|NCT01889862|515606596|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
143018059|NCT01889862|515606597|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
143018060|NCT01889862|515606598|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
143018061|NCT01889862|515606599|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
143018062|NCT01889862|515606595|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
143018063|NCT01889862|515606596|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
143018064|NCT01889862|515606597|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
143018065|NCT01889862|515606598|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
143018066|NCT01889862|515606599|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
143018067|NCT04133519|515606600|FG000|Overall Study|Withdrawal by Subject|5|||
143018068|NCT04133519|515606601|FG001|Overall Study|Withdrawal by Subject|4|||
143018069|NCT04133519|515606600|FG000|Overall Study|Protocol Violation|0|||
143018070|NCT04133519|515606601|FG001|Overall Study|Protocol Violation|1|||
143018071|NCT04133519|515606600|FG000|Overall Study|Never started treatment|1|||
143018072|NCT04133519|515606601|FG001|Overall Study|Never started treatment|1|||
143018073|NCT02217345|515606602|FG000|Overall Study|Lost to Follow-up|2|||
143018074|NCT02217345|515606603|FG001|Overall Study|Lost to Follow-up|1|||
143018075|NCT02217345|515606602|FG000|Overall Study|Withdrawal by Subject|3|||
143018076|NCT02217345|515606603|FG001|Overall Study|Withdrawal by Subject|2|||
143018077|NCT02217345|515606602|FG000|Overall Study|Adverse Event|2|||
143018078|NCT02217345|515606603|FG001|Overall Study|Adverse Event|1|||
143018079|NCT02217345|515606602|FG000|Overall Study|Physician Decision|0|||
143018080|NCT02217345|515606603|FG001|Overall Study|Physician Decision|1|||
143018081|NCT01325532|515606604|FG000|Overall Study|Withdrawal by Subject|2|||
143018082|NCT01325532|515606605|FG001|Overall Study|Withdrawal by Subject|0|||
143018083|NCT01280981|515606606|FG000|Overall Study|Withdrawal by Subject|11|||
143018084|NCT01280981|515606606|FG000|Overall Study|Protocol Violation|2|||
143018085|NCT01280981|515606606|FG000|Overall Study|Lack of Efficacy|13|||
143018086|NCT01280981|515606606|FG000|Overall Study|Lost to Follow-up|3|||
143018087|NCT01280981|515606606|FG000|Overall Study|Adverse Event|6|||
143018088|NCT01280981|515606606|FG000|Overall Study|Irregular or discontinued menses|3|||
143018089|NCT01280981|515606606|FG000|Overall Study|Failed to return|45|||
143018090|NCT01280981|515606606|FG000|Overall Study|Non-compliance with protocol|3|||
143018091|NCT01280981|515606606|FG000|Overall Study|Withdrawal of consent|3|||
143485538|NCT00132132|517322853|FG001|Overall Study|Lost to Follow-up|2|||
143018092|NCT01280981|515606606|FG000|Overall Study|Elective surgery|2|||
143485539|NCT03605680|517322856|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
143018093|NCT01280981|515606606|FG000|Overall Study|Study site closure|1|||
143018094|NCT01256398|515606608|FG000|Overall Study|Withdrawal by Subject|1|||
143018095|NCT03056001|515606610|FG000|Overall Study|Death|24|||
143018096|NCT01364298|515606613|FG000|Overall Study|Adverse Event|3|||
143018097|NCT01364298|515606614|FG001|Overall Study|Adverse Event|4|||
143154469|NCT05558410|516109587|FG001|Overall Study|Lost to Follow-up|17|||
143154470|NCT05558410|516109588|FG002|Overall Study|Lost to Follow-up|19|||
143154471|NCT05558410|516109586|FG000|Overall Study|Death|1|||
143154472|NCT05558410|516109587|FG001|Overall Study|Death|0|||
143154473|NCT05558410|516109588|FG002|Overall Study|Death|0|||
143154474|NCT05558410|516109586|FG000|Overall Study|Other non-compliance|0|||
143154475|NCT05558410|516109587|FG001|Overall Study|Other non-compliance|1|||
143154476|NCT05558410|516109588|FG002|Overall Study|Other non-compliance|2|||
143154477|NCT05558410|516109586|FG000|Overall Study|Sponsor Decision|1|||
143154478|NCT05558410|516109587|FG001|Overall Study|Sponsor Decision|0|||
143154479|NCT05558410|516109588|FG002|Overall Study|Sponsor Decision|0|||
143154480|NCT05558410|516109586|FG000|Overall Study|Other|1|||
143154481|NCT05558410|516109587|FG001|Overall Study|Other|0|||
143154482|NCT05558410|516109588|FG002|Overall Study|Other|1|||
143154483|NCT02265744|516109591|FG000|Overall Study|Poor/Non-compliance|1|||
143154484|NCT02265744|516109592|FG001|Overall Study|Poor/Non-compliance|1|||
143154485|NCT02265744|516109593|FG002|Overall Study|Poor/Non-compliance|0|||
143154486|NCT02265744|516109594|FG003|Overall Study|Poor/Non-compliance|0|||
143154487|NCT02265744|516109595|FG004|Overall Study|Poor/Non-compliance|2|||
143154488|NCT02265744|516109591|FG000|Overall Study|Lost to Follow-up|0|||
143154489|NCT02265744|516109592|FG001|Overall Study|Lost to Follow-up|0|||
143154490|NCT02265744|516109593|FG002|Overall Study|Lost to Follow-up|0|||
143154491|NCT02265744|516109594|FG003|Overall Study|Lost to Follow-up|1|||
143154492|NCT02265744|516109595|FG004|Overall Study|Lost to Follow-up|0|||
143154493|NCT02265744|516109591|FG000|Overall Study|Death|0|||
143154494|NCT02265744|516109592|FG001|Overall Study|Death|0|||
143154495|NCT02265744|516109593|FG002|Overall Study|Death|0|||
143154496|NCT02265744|516109594|FG003|Overall Study|Death|2|||
143154497|NCT02265744|516109595|FG004|Overall Study|Death|0|||
143154498|NCT02265744|516109591|FG000|Overall Study|Withdrawal by Subject|2|||
143154499|NCT02265744|516109592|FG001|Overall Study|Withdrawal by Subject|0|||
143154500|NCT02265744|516109593|FG002|Overall Study|Withdrawal by Subject|0|||
143154501|NCT02265744|516109594|FG003|Overall Study|Withdrawal by Subject|2|||
143154502|NCT02265744|516109595|FG004|Overall Study|Withdrawal by Subject|0|||
143154503|NCT02265744|516109591|FG000|Overall Study|Participant request to discontinue|2|||
143154504|NCT02265744|516109592|FG001|Overall Study|Participant request to discontinue|2|||
143154505|NCT02265744|516109593|FG002|Overall Study|Participant request to discontinue|2|||
143154506|NCT02265744|516109594|FG003|Overall Study|Participant request to discontinue|0|||
143154507|NCT02265744|516109595|FG004|Overall Study|Participant request to discontinue|0|||
143154508|NCT02265744|516109591|FG000|Overall Study|Adverse Event|8|||
143154509|NCT02265744|516109592|FG001|Overall Study|Adverse Event|4|||
143154510|NCT02265744|516109593|FG002|Overall Study|Adverse Event|9|||
143154511|NCT02265744|516109594|FG003|Overall Study|Adverse Event|8|||
143154512|NCT02265744|516109595|FG004|Overall Study|Adverse Event|2|||
143154513|NCT02265744|516109591|FG000|Overall Study|Lack of Efficacy|2|||
143154514|NCT02265744|516109592|FG001|Overall Study|Lack of Efficacy|4|||
143154515|NCT02265744|516109593|FG002|Overall Study|Lack of Efficacy|3|||
143154516|NCT02265744|516109594|FG003|Overall Study|Lack of Efficacy|4|||
143154517|NCT02265744|516109595|FG004|Overall Study|Lack of Efficacy|5|||
143154518|NCT02265744|516109591|FG000|Overall Study|Reason not provided by Investigator|1|||
143154519|NCT02265744|516109592|FG001|Overall Study|Reason not provided by Investigator|0|||
143154520|NCT02265744|516109593|FG002|Overall Study|Reason not provided by Investigator|0|||
143154521|NCT02265744|516109594|FG003|Overall Study|Reason not provided by Investigator|2|||
143154522|NCT02265744|516109595|FG004|Overall Study|Reason not provided by Investigator|0|||
143154523|NCT02265744|516109591|FG000|Overall Study|Administrative reason by sponsor|3|||
143154524|NCT02265744|516109592|FG001|Overall Study|Administrative reason by sponsor|2|||
143154525|NCT02265744|516109593|FG002|Overall Study|Administrative reason by sponsor|2|||
143154526|NCT02265744|516109594|FG003|Overall Study|Administrative reason by sponsor|3|||
143154527|NCT02265744|516109595|FG004|Overall Study|Administrative reason by sponsor|3|||
143154528|NCT02265744|516109591|FG000|Overall Study|Subject no longer meets study criteria|0|||
143018098|NCT01364298|515606613|FG000|Overall Study|Lack of adherence to treatment|1|||
143018099|NCT01364298|515606614|FG001|Overall Study|Lack of adherence to treatment|3|||
143018100|NCT01364298|515606613|FG000|Overall Study|Lack of Efficacy|1|||
143018101|NCT01364298|515606614|FG001|Overall Study|Lack of Efficacy|0|||
143018102|NCT01364298|515606613|FG000|Overall Study|Lost to Follow-up|5|||
143154529|NCT02265744|516109592|FG001|Overall Study|Subject no longer meets study criteria|0|||
143154530|NCT02265744|516109593|FG002|Overall Study|Subject no longer meets study criteria|0|||
143154531|NCT02265744|516109594|FG003|Overall Study|Subject no longer meets study criteria|0|||
143154532|NCT02265744|516109595|FG004|Overall Study|Subject no longer meets study criteria|1|||
143154533|NCT02265744|516109591|FG000|Overall Study|Pregnancy|1|||
143154534|NCT02265744|516109592|FG001|Overall Study|Pregnancy|2|||
143154535|NCT02265744|516109593|FG002|Overall Study|Pregnancy|1|||
143154536|NCT02265744|516109594|FG003|Overall Study|Pregnancy|1|||
143154537|NCT02265744|516109595|FG004|Overall Study|Pregnancy|0|||
143154538|NCT00574951|516109596|FG000|Overall Study|Ineligible - improper prior treatment|1|||
143154539|NCT00923702|516109597|FG000|Overall Study|Ongoing enrollment|0|||
143154540|NCT00923702|516109598|FG001|Overall Study|Ongoing enrollment|0|||
143154541|NCT00923702|516109599|FG002|Overall Study|Ongoing enrollment|0|||
143018103|NCT01364298|515606614|FG001|Overall Study|Lost to Follow-up|10|||
143018104|NCT01364298|515606613|FG000|Overall Study|Withdrawal by Subject|3|||
143018105|NCT01364298|515606614|FG001|Overall Study|Withdrawal by Subject|3|||
143018106|NCT01364298|515606613|FG000|Overall Study|Other|1|||
143018107|NCT01364298|515606614|FG001|Overall Study|Other|3|||
143018108|NCT01864525|515606615|FG000|Overall Study|Adverse Event|1|||
143018109|NCT01864525|515606616|FG001|Overall Study|Adverse Event|0|||
143018110|NCT03296553|515606617|FG000|Overall Study|Withdrawal by Subject|1|||
143018111|NCT03296553|515606618|FG001|Overall Study|Withdrawal by Subject|1|||
143018112|NCT03296553|515606617|FG000|Overall Study|Death|1|||
143018113|NCT03296553|515606618|FG001|Overall Study|Death|0|||
143018114|NCT02295280|515606620|FG000|Overall Study|Adverse Event|0|||
143018115|NCT02295280|515606621|FG001|Overall Study|Adverse Event|1|||
143018116|NCT02875067|515606622|FG000|Overall Study|Withdrawal by Subject|1|||
143018117|NCT02875067|515606622|FG000|Overall Study|Withdrawal by Termination of Study|5|||
143018118|NCT00065065|515606623|FG000|Overall Study|Adverse Event|3|||
143018119|NCT00065065|515606624|FG001|Overall Study|Adverse Event|2|||
143018120|NCT00065065|515606623|FG000|Overall Study|Withdrawal by Subject|1|||
143018121|NCT00065065|515606624|FG001|Overall Study|Withdrawal by Subject|5|||
143018122|NCT00065065|515606623|FG000|Overall Study|Lack of Efficacy|4|||
143018123|NCT00065065|515606624|FG001|Overall Study|Lack of Efficacy|11|||
143018124|NCT00065065|515606623|FG000|Overall Study|Other|2|||
143018125|NCT00065065|515606624|FG001|Overall Study|Other|2|||
143018126|NCT04363736|515606626|FG000|Overall Study|Withdrawal by Subject|1|||
143018127|NCT04363736|515606627|FG001|Overall Study|Withdrawal by Subject|0|||
143018128|NCT04363736|515606626|FG000|Overall Study|Lost to Follow-up|10|||
143018129|NCT04363736|515606627|FG001|Overall Study|Lost to Follow-up|7|||
143018130|NCT04363736|515606626|FG000|Overall Study|Death|8|||
143018131|NCT04363736|515606627|FG001|Overall Study|Death|6|||
143018132|NCT01050673|515606628|FG000|Overall Study|Physician Decision|4|||
143018133|NCT01050673|515606629|FG001|Overall Study|Physician Decision|5|||
143018134|NCT02971605|515606630|FG000|Overall Study|Withdrawal by Subject|1|||
143018135|NCT03797222|515606631|FG000|Overall Study|Withdrawal by Subject|1|||
143018136|NCT00789828|515606633|FG000|Core Period (48 Weeks)|Administrative problems|0|||
143018137|NCT00789828|515606634|FG001|Core Period (48 Weeks)|Administrative problems|1|||
143018138|NCT00789828|515606633|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
143018139|NCT00789828|515606634|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
143018140|NCT00789828|515606633|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
143018141|NCT00789828|515606634|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
143018142|NCT00789828|515606633|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
143018143|NCT00789828|515606634|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
143018144|NCT00789828|515606633|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
143018145|NCT00789828|515606634|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
143018146|NCT00789828|515606633|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
143018147|NCT00789828|515606634|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
143018148|NCT00789828|515606633|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
143018149|NCT00789828|515606634|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
143018150|NCT00789828|515606633|FG000|Open-label Extension Period (4 Years)|Death|1|||
143018151|NCT00789828|515606634|FG001|Open-label Extension Period (4 Years)|Death|0|||
143018152|NCT00789828|515606633|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
143018153|NCT00789828|515606634|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
143018154|NCT00789828|515606633|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
143018155|NCT00789828|515606634|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
143018156|NCT01133392|515606635|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
143018157|NCT01133392|515606636|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
143018158|NCT01133392|515606635|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
143018159|NCT01133392|515606636|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
143018160|NCT01246973|515608123|FG000|Overall Study|Other|38|||
143018161|NCT01246973|515608124|FG001|Overall Study|Other|25|||
143018162|NCT01246973|515608123|FG000|Overall Study|Adverse Event|16|||
143018163|NCT01246973|515608124|FG001|Overall Study|Adverse Event|9|||
143018164|NCT01246973|515608123|FG000|Overall Study|Withdrawal by Subject|7|||
143018165|NCT01246973|515608124|FG001|Overall Study|Withdrawal by Subject|13|||
143018166|NCT01335399|515608125|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
143018167|NCT01335399|515608126|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
143018168|NCT01335399|515608125|FG000|Pre-treatment Period|Participant request to discontinue|0|||
143018169|NCT01335399|515608126|FG001|Pre-treatment Period|Participant request to discontinue|1|||
143018170|NCT01335399|515608125|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
143018171|NCT01335399|515608126|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
143018172|NCT01335399|515608125|FG000|Pre-treatment Period|Consent withdrawal|3|||
143018173|NCT01335399|515608126|FG001|Pre-treatment Period|Consent withdrawal|0|||
143018174|NCT01335399|515608125|FG000|Treatment Period|Disease progression|117|||
143018175|NCT01335399|515608126|FG001|Treatment Period|Disease progression|145|||
143018176|NCT01335399|515608125|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
143018177|NCT01335399|515608126|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
143018178|NCT01335399|515608125|FG000|Treatment Period|Study drug toxicity|52|||
143018179|NCT01335399|515608126|FG001|Treatment Period|Study drug toxicity|64|||
143018180|NCT01335399|515608125|FG000|Treatment Period|Participant request to discontinue|30|||
143018181|NCT01335399|515608126|FG001|Treatment Period|Participant request to discontinue|22|||
143018182|NCT01335399|515608125|FG000|Treatment Period|Other reasons|30|||
143018183|NCT01335399|515608126|FG001|Treatment Period|Other reasons|30|||
143018184|NCT01335399|515608125|FG000|Treatment Period|Consent withdrawal|10|||
143018185|NCT01335399|515608126|FG001|Treatment Period|Consent withdrawal|7|||
143018186|NCT01335399|515608125|FG000|Treatment Period|Death|7|||
143018187|NCT01335399|515608126|FG001|Treatment Period|Death|6|||
143018188|NCT01335399|515608125|FG000|Treatment Period|Poor/Non-compliance|3|||
143018189|NCT01335399|515608126|FG001|Treatment Period|Poor/Non-compliance|4|||
143018190|NCT01335399|515608125|FG000|Treatment Period|Lost to Follow-up|2|||
143018191|NCT01335399|515608126|FG001|Treatment Period|Lost to Follow-up|2|||
143018192|NCT01335399|515608125|FG000|Treatment Period|Maximum clinical benefit|1|||
143018193|NCT01335399|515608126|FG001|Treatment Period|Maximum clinical benefit|1|||
143018194|NCT01335399|515608125|FG000|Treatment Period|No longer meet study criteria|1|||
143018195|NCT01335399|515608126|FG001|Treatment Period|No longer meet study criteria|1|||
143018196|NCT01335399|515608125|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
143018197|NCT01335399|515608126|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
143018198|NCT01835470|515608131|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
143018199|NCT01835470|515608131|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
143018200|NCT01011907|515608132|FG000|Overall Study|Withdrawal by Subject|13|||
143018201|NCT01011907|515608133|FG001|Overall Study|Withdrawal by Subject|11|||
143018202|NCT01011907|515608132|FG000|Overall Study|Adverse Event|1|||
143018203|NCT01011907|515608133|FG001|Overall Study|Adverse Event|4|||
143018204|NCT00304954|515608134|FG000|Overall Study|Withdrawal by Subject|0|||
143018205|NCT00304954|515608135|FG001|Overall Study|Withdrawal by Subject|0|||
143018206|NCT00304954|515608136|FG002|Overall Study|Withdrawal by Subject|1|||
143018207|NCT00304954|515608137|FG003|Overall Study|Withdrawal by Subject|0|||
143018208|NCT00304954|515608134|FG000|Overall Study|Adverse Event|1|||
143018209|NCT00304954|515608135|FG001|Overall Study|Adverse Event|0|||
143018210|NCT00304954|515608136|FG002|Overall Study|Adverse Event|0|||
143018211|NCT00304954|515608137|FG003|Overall Study|Adverse Event|0|||
143018212|NCT01406873|515608142|FG000|Overall Study|Withdrawal by Subject|1|||
143018213|NCT01406873|515608143|FG001|Overall Study|Withdrawal by Subject|1|||
143018214|NCT00207714|515608144|FG000|Overall Study|Adverse Event|6|||
143018215|NCT00207714|515608145|FG001|Overall Study|Adverse Event|2|||
143018216|NCT00207714|515608146|FG002|Overall Study|Adverse Event|4|||
143018217|NCT00207714|515608147|FG003|Overall Study|Adverse Event|3|||
143018218|NCT00207714|515608148|FG004|Overall Study|Adverse Event|1|||
143018219|NCT00207714|515608144|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
143018220|NCT00207714|515608145|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
143018221|NCT00207714|515608146|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
143018222|NCT00207714|515608147|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
143018223|NCT00207714|515608148|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
143018224|NCT00207714|515608144|FG000|Overall Study|Other|3|||
143018225|NCT00207714|515608145|FG001|Overall Study|Other|2|||
143018226|NCT00207714|515608146|FG002|Overall Study|Other|5|||
143018227|NCT00207714|515608147|FG003|Overall Study|Other|1|||
143018228|NCT00207714|515608148|FG004|Overall Study|Other|0|||
143018229|NCT03627195|515608149|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
143018230|NCT03627195|515608150|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
143018231|NCT03627195|515608151|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
143018232|NCT03627195|515608152|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
143018233|NCT03627195|515608153|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
143018234|NCT03627195|515608154|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
143018235|NCT02290028|515608159|FG000|Overall Study|Death|217|||
143018236|NCT02290028|515608159|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
143018237|NCT02290028|515608159|FG000|Overall Study|No longer under care of study physician|76|||
143018238|NCT02290028|515608159|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
143018239|NCT02290028|515608159|FG000|Overall Study|Withdrawal by Subject|52|||
143018240|NCT02290028|515608159|FG000|Overall Study|Study site closure|44|||
143018241|NCT02290028|515608159|FG000|Overall Study|Lost to Follow-up|34|||
143018242|NCT02290028|515608159|FG000|Overall Study|Miscellaneous|10|||
143018243|NCT02290028|515608159|FG000|Overall Study|Transition to EP PASSION|1295|||
143018244|NCT02290028|515608159|FG000|Overall Study|Planned study completion at 12 months|257|||
143018245|NCT03202511|515608160|FG000|Overall Study|Withdrawal by Subject|1|||
143018246|NCT03202511|515608161|FG001|Overall Study|Withdrawal by Subject|0|||
143018247|NCT00686790|515608162|FG000|Overall Study|Adverse Event|2|||
143018248|NCT00686790|515608162|FG000|Overall Study|Withdrawal by Subject|1|||
143018249|NCT00686790|515608162|FG000|Overall Study|Death|1|||
143018250|NCT00686790|515608162|FG000|Overall Study|Lost to Follow-up|12|||
143018251|NCT00096382|515608163|FG000|Overall Study|Not treated|1|||
143018252|NCT00096382|515608164|FG001|Overall Study|Not treated|0|||
143018253|NCT00096382|515608163|FG000|Overall Study|Death during treatment|1|||
143018254|NCT00096382|515608164|FG001|Overall Study|Death during treatment|0|||
143018255|NCT04006847|515608165|FG000|Overall Study|Product issue|1|||
143018256|NCT01270841|515608173|FG000|Overall Study|Adverse Event|0|||
143018257|NCT01270841|515608174|FG001|Overall Study|Adverse Event|1|||
143018258|NCT01270841|515608175|FG002|Overall Study|Adverse Event|0|||
143018259|NCT01270841|515608176|FG003|Overall Study|Adverse Event|3|||
143018260|NCT01270841|515608173|FG000|Overall Study|Withdrawal by Subject|3|||
143018261|NCT01270841|515608174|FG001|Overall Study|Withdrawal by Subject|2|||
143018262|NCT01270841|515608175|FG002|Overall Study|Withdrawal by Subject|3|||
143018263|NCT01270841|515608176|FG003|Overall Study|Withdrawal by Subject|3|||
143018264|NCT01270841|515608173|FG000|Overall Study|Lost to Follow-up|3|||
143018265|NCT01270841|515608174|FG001|Overall Study|Lost to Follow-up|1|||
143018266|NCT01270841|515608175|FG002|Overall Study|Lost to Follow-up|4|||
143018267|NCT01270841|515608176|FG003|Overall Study|Lost to Follow-up|2|||
143018268|NCT01270841|515608173|FG000|Overall Study|Physician Decision|0|||
143018269|NCT01270841|515608174|FG001|Overall Study|Physician Decision|1|||
143018270|NCT01270841|515608175|FG002|Overall Study|Physician Decision|0|||
143018271|NCT01270841|515608176|FG003|Overall Study|Physician Decision|0|||
143018272|NCT01270841|515608173|FG000|Overall Study|Did not qualify|6|||
143018273|NCT01270841|515608174|FG001|Overall Study|Did not qualify|3|||
143018274|NCT01270841|515608175|FG002|Overall Study|Did not qualify|4|||
143018275|NCT01270841|515608176|FG003|Overall Study|Did not qualify|5|||
143018276|NCT01270841|515608173|FG000|Overall Study|Protocol Violation|1|||
143018277|NCT01270841|515608174|FG001|Overall Study|Protocol Violation|5|||
143018278|NCT01270841|515608175|FG002|Overall Study|Protocol Violation|0|||
143018279|NCT01270841|515608176|FG003|Overall Study|Protocol Violation|0|||
143018280|NCT01270841|515608173|FG000|Overall Study|Enrolled in error|0|||
143018281|NCT01270841|515608174|FG001|Overall Study|Enrolled in error|1|||
143018282|NCT01270841|515608175|FG002|Overall Study|Enrolled in error|0|||
143018283|NCT01270841|515608176|FG003|Overall Study|Enrolled in error|0|||
143018284|NCT01326702|515608177|FG000|Overall Study|Other|1|||
143018285|NCT01326702|515608178|FG001|Overall Study|Other|0|||
143018286|NCT01326702|515608179|FG002|Overall Study|Other|0|||
143018287|NCT01326702|515608180|FG003|Overall Study|Other|0|||
143018288|NCT01326702|515608181|FG004|Overall Study|Other|0|||
143018289|NCT01326702|515608182|FG005|Overall Study|Other|1|||
143018290|NCT01326702|515608183|FG006|Overall Study|Other|0|||
143018291|NCT01326702|515608177|FG000|Overall Study|progressive disease|1|||
143018292|NCT01326702|515608178|FG001|Overall Study|progressive disease|1|||
143018293|NCT01326702|515608179|FG002|Overall Study|progressive disease|3|||
143018294|NCT01326702|515608180|FG003|Overall Study|progressive disease|1|||
143018295|NCT01326702|515608181|FG004|Overall Study|progressive disease|3|||
143018296|NCT01326702|515608182|FG005|Overall Study|progressive disease|2|||
143018297|NCT01326702|515608183|FG006|Overall Study|progressive disease|3|||
143018298|NCT01326702|515608177|FG000|Overall Study|Death|0|||
143018299|NCT01326702|515608178|FG001|Overall Study|Death|1|||
143018300|NCT01326702|515608179|FG002|Overall Study|Death|0|||
143018301|NCT01326702|515608180|FG003|Overall Study|Death|0|||
143018302|NCT01326702|515608181|FG004|Overall Study|Death|0|||
143018303|NCT01326702|515608182|FG005|Overall Study|Death|0|||
143018304|NCT01326702|515608183|FG006|Overall Study|Death|0|||
143018305|NCT01326702|515608177|FG000|Overall Study|Adverse Event|0|||
143018306|NCT01326702|515608178|FG001|Overall Study|Adverse Event|0|||
143018307|NCT01326702|515608179|FG002|Overall Study|Adverse Event|1|||
143018308|NCT01326702|515608180|FG003|Overall Study|Adverse Event|1|||
143018309|NCT01326702|515608181|FG004|Overall Study|Adverse Event|0|||
143018310|NCT01326702|515608182|FG005|Overall Study|Adverse Event|3|||
143018311|NCT01326702|515608183|FG006|Overall Study|Adverse Event|1|||
143018312|NCT01326702|515608177|FG000|Overall Study|Withdrawal by Subject|0|||
143018313|NCT01326702|515608178|FG001|Overall Study|Withdrawal by Subject|0|||
143018314|NCT01326702|515608179|FG002|Overall Study|Withdrawal by Subject|1|||
143018315|NCT01326702|515608180|FG003|Overall Study|Withdrawal by Subject|0|||
143018316|NCT01326702|515608181|FG004|Overall Study|Withdrawal by Subject|1|||
143018317|NCT01326702|515608182|FG005|Overall Study|Withdrawal by Subject|1|||
143018318|NCT01326702|515608183|FG006|Overall Study|Withdrawal by Subject|3|||
143018319|NCT01326702|515608177|FG000|Overall Study|Not Treated|0|||
143018320|NCT01326702|515608178|FG001|Overall Study|Not Treated|0|||
143018321|NCT01326702|515608179|FG002|Overall Study|Not Treated|0|||
143018322|NCT01326702|515608180|FG003|Overall Study|Not Treated|1|||
143018323|NCT01326702|515608181|FG004|Overall Study|Not Treated|0|||
143018324|NCT01326702|515608182|FG005|Overall Study|Not Treated|1|||
143018325|NCT01326702|515608183|FG006|Overall Study|Not Treated|0|||
143154542|NCT00923702|516109600|FG003|Overall Study|Ongoing enrollment|0|||
143018326|NCT01375010|515608184|FG000|Overall Study|Lost to Follow-up|8|||
143018327|NCT01375010|515608185|FG001|Overall Study|Lost to Follow-up|2|||
143018328|NCT01375010|515608184|FG000|Overall Study|Withdrawal by Subject|4|||
143018329|NCT01375010|515608185|FG001|Overall Study|Withdrawal by Subject|2|||
143018330|NCT02614703|515608187|FG000|Overall Study|Withdrawal by Subject|7|||
143018331|NCT02614703|515608188|FG001|Overall Study|Withdrawal by Subject|1|||
143154543|NCT00923702|516109601|FG004|Overall Study|Ongoing enrollment|354|||
143018332|NCT01835132|515608202|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
143018333|NCT01681771|515608203|FG000|Overall Study|Lost to Follow-up|4|||
143018334|NCT01681771|515608204|FG001|Overall Study|Lost to Follow-up|2|||
143018335|NCT03208933|515608205|FG000|Overall Study|Death|3|||
143018336|NCT03208933|515608205|FG000|Overall Study|Withdrawal by Subject|3|||
143018337|NCT03208933|515608205|FG000|Overall Study|Adverse Event|1|||
143018338|NCT03208933|515608205|FG000|Overall Study|Lost to Follow-up|2|||
143018339|NCT03208933|515608205|FG000|Overall Study|Physician Decision|3|||
143018340|NCT03208933|515608205|FG000|Overall Study|Protocol Violation|1|||
143018341|NCT04242186|515608210|FG000|Overall Study|Death|5|||
143018342|NCT03333382|515608211|FG000|Overall Study|Lost to Follow-up|1|||
143018343|NCT03333382|515608212|FG001|Overall Study|Lost to Follow-up|0|||
143018344|NCT00331773|515608213|FG000|Overall Study|Withdrawal by Subject|6|||
143018345|NCT00331773|515608214|FG001|Overall Study|Withdrawal by Subject|4|||
143018346|NCT00331773|515608213|FG000|Overall Study|Protocol Violation|10|||
143018347|NCT00331773|515608214|FG001|Overall Study|Protocol Violation|3|||
143018348|NCT01792284|515608215|FG000|Lead-in Period|Adverse Event|15|||
143018349|NCT01792284|515608216|FG001|Lead-in Period|Adverse Event|0|||
143018350|NCT01792284|515608217|FG002|Lead-in Period|Adverse Event|0|||
143018351|NCT01792284|515608215|FG000|Lead-in Period|Lost to Follow-up|2|||
143018352|NCT01792284|515608216|FG001|Lead-in Period|Lost to Follow-up|0|||
143018353|NCT01792284|515608217|FG002|Lead-in Period|Lost to Follow-up|0|||
143018354|NCT01792284|515608215|FG000|Lead-in Period|Protocol Violation|1|||
143018355|NCT01792284|515608216|FG001|Lead-in Period|Protocol Violation|0|||
143018356|NCT01792284|515608217|FG002|Lead-in Period|Protocol Violation|0|||
143018357|NCT01792284|515608215|FG000|Lead-in Period|Withdrawal by Subject|10|||
143018358|NCT01792284|515608216|FG001|Lead-in Period|Withdrawal by Subject|0|||
143018359|NCT01792284|515608217|FG002|Lead-in Period|Withdrawal by Subject|0|||
143018360|NCT01792284|515608215|FG000|Lead-in Period|Physician Decision|1|||
143018361|NCT01792284|515608216|FG001|Lead-in Period|Physician Decision|0|||
143018362|NCT01792284|515608217|FG002|Lead-in Period|Physician Decision|0|||
143018363|NCT01792284|515608215|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
143018364|NCT01792284|515608216|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
143018365|NCT01792284|515608217|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
143018366|NCT01792284|515608215|FG000|Randomization Period 1|Withdrawal by Subject|0|||
143018367|NCT01792284|515608216|FG001|Randomization Period 1|Withdrawal by Subject|1|||
143018368|NCT01792284|515608217|FG002|Randomization Period 1|Withdrawal by Subject|1|||
143018369|NCT01792284|515608215|FG000|Randomization Period 1|Physician Decision|0|||
143018370|NCT01792284|515608216|FG001|Randomization Period 1|Physician Decision|1|||
143018371|NCT01792284|515608217|FG002|Randomization Period 1|Physician Decision|1|||
143018372|NCT01792284|515608215|FG000|Randomization Period 1|Adverse Event|0|||
143018373|NCT01792284|515608216|FG001|Randomization Period 1|Adverse Event|0|||
143018374|NCT01792284|515608217|FG002|Randomization Period 1|Adverse Event|2|||
143018375|NCT01792284|515608215|FG000|Randomization Period 1|Lost to Follow-up|0|||
143018376|NCT01792284|515608216|FG001|Randomization Period 1|Lost to Follow-up|0|||
143018377|NCT01792284|515608217|FG002|Randomization Period 1|Lost to Follow-up|1|||
143018378|NCT01792284|515608215|FG000|Randomization Period 2|Protocol Violation|0|||
143018379|NCT01792284|515608216|FG001|Randomization Period 2|Protocol Violation|1|||
143018380|NCT01792284|515608217|FG002|Randomization Period 2|Protocol Violation|0|||
143018381|NCT01792284|515608215|FG000|Randomization Period 2|Withdrawal by Subject|0|||
143018382|NCT01792284|515608216|FG001|Randomization Period 2|Withdrawal by Subject|2|||
143018383|NCT01792284|515608217|FG002|Randomization Period 2|Withdrawal by Subject|0|||
143018384|NCT00379587|515608223|FG000|Overall Study|Lost to Follow-up|2|||
143018385|NCT00830063|515608228|FG000|Overall Study|Adverse Event|7|||
143018386|NCT00830063|515608229|FG001|Overall Study|Adverse Event|13|||
143018387|NCT00830063|515608230|FG002|Overall Study|Adverse Event|16|||
143018388|NCT00830063|515608231|FG003|Overall Study|Adverse Event|13|||
143018389|NCT00830063|515608228|FG000|Overall Study|Death|1|||
143018390|NCT00830063|515608229|FG001|Overall Study|Death|0|||
143018391|NCT00830063|515608230|FG002|Overall Study|Death|0|||
143018392|NCT00830063|515608231|FG003|Overall Study|Death|0|||
143018393|NCT00830063|515608228|FG000|Overall Study|Lost to Follow-up|0|||
143018394|NCT00830063|515608229|FG001|Overall Study|Lost to Follow-up|0|||
143018395|NCT00830063|515608230|FG002|Overall Study|Lost to Follow-up|3|||
143018396|NCT00830063|515608231|FG003|Overall Study|Lost to Follow-up|1|||
143018397|NCT00830063|515608228|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
143181466|NCT00642707|516211754|FG002|Overall Study|Adverse Event|0|||
143485540|NCT03605680|517322857|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
143018398|NCT00830063|515608229|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
143018399|NCT00830063|515608230|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
143018400|NCT00830063|515608231|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
143018401|NCT00830063|515608228|FG000|Overall Study|Lack of Efficacy|51|||
143018402|NCT00830063|515608229|FG001|Overall Study|Lack of Efficacy|23|||
143018403|NCT00830063|515608230|FG002|Overall Study|Lack of Efficacy|25|||
143018404|NCT00830063|515608231|FG003|Overall Study|Lack of Efficacy|32|||
143018405|NCT00830063|515608228|FG000|Overall Study|Other|5|||
143018406|NCT00830063|515608229|FG001|Overall Study|Other|5|||
143018407|NCT00830063|515608230|FG002|Overall Study|Other|8|||
143018408|NCT00830063|515608231|FG003|Overall Study|Other|6|||
143018409|NCT00830063|515608228|FG000|Overall Study|Withdrawal by Subject|16|||
143018410|NCT00830063|515608229|FG001|Overall Study|Withdrawal by Subject|10|||
143018411|NCT00830063|515608230|FG002|Overall Study|Withdrawal by Subject|16|||
143018412|NCT00830063|515608231|FG003|Overall Study|Withdrawal by Subject|13|||
143018413|NCT00830063|515608228|FG000|Overall Study|Protocol Violation|1|||
143018414|NCT00830063|515608229|FG001|Overall Study|Protocol Violation|0|||
143018415|NCT00830063|515608230|FG002|Overall Study|Protocol Violation|3|||
143018416|NCT00830063|515608231|FG003|Overall Study|Protocol Violation|2|||
143018417|NCT00830063|515608228|FG000|Overall Study|Randomized But Not Treated|0|||
143018418|NCT00830063|515608229|FG001|Overall Study|Randomized But Not Treated|2|||
143018419|NCT00830063|515608230|FG002|Overall Study|Randomized But Not Treated|0|||
143018420|NCT00830063|515608231|FG003|Overall Study|Randomized But Not Treated|2|||
143018421|NCT00775983|515608232|FG000|Overall Study|Protocol Violation|1|||
143018422|NCT00775983|515608233|FG001|Overall Study|Protocol Violation|2|||
143018423|NCT00660790|515608234|FG000|Baseline to 3 Months|Death|1|||
143018424|NCT00660790|515608234|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
143018425|NCT00660790|515608234|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
143018426|NCT04356573|515608238|FG000|Overall Study|Didn't Qualify|1|||
143018427|NCT04356573|515608239|FG001|Overall Study|Didn't Qualify|0|||
143018428|NCT03650400|515608240|FG000|Overall Study|Study terminated by sponsor|0|||
143018429|NCT03650400|515608241|FG001|Overall Study|Study terminated by sponsor|5|||
143018430|NCT01965535|515608248|FG000|Overall Study|Lack of Efficacy|2|||
143018431|NCT01965535|515608249|FG001|Overall Study|Lack of Efficacy|1|||
143018432|NCT01749033|515608259|FG000|Overall Study|Did not receive allocated intervention|3|||
143018433|NCT01749033|515608260|FG001|Overall Study|Did not receive allocated intervention|3|||
143018434|NCT01749033|515608261|FG002|Overall Study|Did not receive allocated intervention|0|||
143018435|NCT01749033|515608259|FG000|Overall Study|Lost to Follow-up|0|||
143018436|NCT01749033|515608260|FG001|Overall Study|Lost to Follow-up|2|||
143018437|NCT01749033|515608261|FG002|Overall Study|Lost to Follow-up|1|||
143018438|NCT03056352|515608262|FG000|Overall Study|Lost to Follow-up|1|||
143018439|NCT01254045|515608263|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
143018440|NCT01254045|515608264|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
143018441|NCT01254045|515608265|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
143018442|NCT01254045|515608266|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
143018443|NCT01254045|515608267|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
143018444|NCT01254045|515608268|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
143018445|NCT00597207|515608269|FG000|Overall Study|Lost to Follow-up|5|||
143018446|NCT00597207|515608270|FG001|Overall Study|Lost to Follow-up|7|||
143018447|NCT01374906|515608271|FG000|Overall Study|Abnormal laboratory value(s)|0|||
143018448|NCT01374906|515608272|FG001|Overall Study|Abnormal laboratory value(s)|3|||
143018449|NCT01374906|515608271|FG000|Overall Study|Administrative problems|2|||
143018450|NCT01374906|515608272|FG001|Overall Study|Administrative problems|2|||
143018451|NCT01374906|515608271|FG000|Overall Study|Adverse Event|10|||
143018452|NCT01374906|515608272|FG001|Overall Study|Adverse Event|11|||
143018453|NCT01374906|515608271|FG000|Overall Study|Death|0|||
143018454|NCT01374906|515608272|FG001|Overall Study|Death|2|||
143018455|NCT01374906|515608271|FG000|Overall Study|Protocol Violation|2|||
143018456|NCT01374906|515608272|FG001|Overall Study|Protocol Violation|2|||
143018457|NCT01374906|515608271|FG000|Overall Study|Withdrawal by Subject|15|||
143018458|NCT01374906|515608272|FG001|Overall Study|Withdrawal by Subject|9|||
143018459|NCT01374906|515608271|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
143018460|NCT01374906|515608272|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
143018461|NCT00435825|515608277|FG000|Overall Study|Abnormality of Laboratory Test|0|||
143018462|NCT00435825|515608278|FG001|Overall Study|Abnormality of Laboratory Test|1|||
143018463|NCT00435825|515608279|FG002|Overall Study|Abnormality of Laboratory Test|0|||
143018464|NCT00435825|515608280|FG003|Overall Study|Abnormality of Laboratory Test|0|||
143018465|NCT00435825|515608277|FG000|Overall Study|Insufficient Therapeutic Response|3|||
143018466|NCT00435825|515608278|FG001|Overall Study|Insufficient Therapeutic Response|1|||
143485541|NCT03605680|517322858|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
143018467|NCT00435825|515608279|FG002|Overall Study|Insufficient Therapeutic Response|0|||
143018468|NCT00435825|515608280|FG003|Overall Study|Insufficient Therapeutic Response|3|||
143018469|NCT00435825|515608277|FG000|Overall Study|Other Protocol Violation|1|||
143018470|NCT00435825|515608278|FG001|Overall Study|Other Protocol Violation|0|||
143018471|NCT00435825|515608279|FG002|Overall Study|Other Protocol Violation|0|||
143018472|NCT00435825|515608280|FG003|Overall Study|Other Protocol Violation|0|||
143018473|NCT00435825|515608277|FG000|Overall Study|Refused treatment|2|||
143018474|NCT00435825|515608278|FG001|Overall Study|Refused treatment|0|||
143018475|NCT00435825|515608279|FG002|Overall Study|Refused treatment|0|||
143018476|NCT00435825|515608280|FG003|Overall Study|Refused treatment|5|||
143018477|NCT00435825|515608277|FG000|Overall Study|Failure to return|5|||
143018478|NCT00435825|515608278|FG001|Overall Study|Failure to return|0|||
143018479|NCT00435825|515608279|FG002|Overall Study|Failure to return|4|||
143018480|NCT00435825|515608280|FG003|Overall Study|Failure to return|0|||
143018481|NCT00435825|515608277|FG000|Overall Study|Did not receive study drug|1|||
143018482|NCT00435825|515608278|FG001|Overall Study|Did not receive study drug|0|||
143018483|NCT00435825|515608279|FG002|Overall Study|Did not receive study drug|2|||
143018484|NCT00435825|515608280|FG003|Overall Study|Did not receive study drug|0|||
143018485|NCT00435825|515608277|FG000|Overall Study|Did not enter follow-up|0|||
143018486|NCT00435825|515608278|FG001|Overall Study|Did not enter follow-up|4|||
143018487|NCT00435825|515608279|FG002|Overall Study|Did not enter follow-up|1|||
143018488|NCT00435825|515608280|FG003|Overall Study|Did not enter follow-up|3|||
143018489|NCT00435825|515608277|FG000|Overall Study|Did not complete full follow-up period|6|||
143018490|NCT00435825|515608278|FG001|Overall Study|Did not complete full follow-up period|6|||
143018491|NCT00435825|515608279|FG002|Overall Study|Did not complete full follow-up period|4|||
143018492|NCT00435825|515608280|FG003|Overall Study|Did not complete full follow-up period|5|||
143018493|NCT00430638|515608281|FG000|Overall Study|Adverse Event|15|||
143018494|NCT00430638|515608282|FG001|Overall Study|Adverse Event|15|||
143018495|NCT00430638|515608281|FG000|Overall Study|Uncontrolled blood pressure|48|||
143018496|NCT00430638|515608282|FG001|Overall Study|Uncontrolled blood pressure|13|||
143018497|NCT00430638|515608281|FG000|Overall Study|Lost to Follow-up|1|||
143018498|NCT00430638|515608282|FG001|Overall Study|Lost to Follow-up|7|||
143018499|NCT00430638|515608281|FG000|Overall Study|Protocol Violation|6|||
143018500|NCT00430638|515608282|FG001|Overall Study|Protocol Violation|4|||
143018501|NCT00430638|515608281|FG000|Overall Study|Withdrawal by Subject|4|||
143018502|NCT00430638|515608282|FG001|Overall Study|Withdrawal by Subject|6|||
143018503|NCT00430638|515608281|FG000|Overall Study|Non-compliant|2|||
143018504|NCT00430638|515608282|FG001|Overall Study|Non-compliant|1|||
143018505|NCT00430638|515608281|FG000|Overall Study|Other|2|||
143018506|NCT00430638|515608282|FG001|Overall Study|Other|2|||
143018507|NCT02367781|515608283|FG000|Overall Study|Withdrawal by Subject|20|||
143018508|NCT02367781|515608284|FG001|Overall Study|Withdrawal by Subject|13|||
143018509|NCT02367781|515608283|FG000|Overall Study|Protocol Violation|0|||
143018510|NCT02367781|515608284|FG001|Overall Study|Protocol Violation|1|||
143018511|NCT02367781|515608283|FG000|Overall Study|Physician Decision|7|||
143018512|NCT02367781|515608284|FG001|Overall Study|Physician Decision|0|||
143018513|NCT02367781|515608283|FG000|Overall Study|Randomized in Error|5|||
143018514|NCT02367781|515608284|FG001|Overall Study|Randomized in Error|4|||
143018515|NCT02367781|515608283|FG000|Overall Study|Non-Compliance|1|||
143018516|NCT02367781|515608284|FG001|Overall Study|Non-Compliance|0|||
143018517|NCT02367781|515608283|FG000|Overall Study|Lost to Follow-up|1|||
143018518|NCT02367781|515608284|FG001|Overall Study|Lost to Follow-up|2|||
143018519|NCT02367781|515608283|FG000|Overall Study|Death|330|||
143018520|NCT02367781|515608284|FG001|Overall Study|Death|176|||
143018521|NCT02367781|515608283|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
143018522|NCT02367781|515608284|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
143018523|NCT02367781|515608283|FG000|Overall Study|Prolonged Hospitalization|1|||
143018524|NCT02367781|515608284|FG001|Overall Study|Prolonged Hospitalization|0|||
143018525|NCT02367781|515608283|FG000|Overall Study|Death Prior First Dose|1|||
143018526|NCT02367781|515608284|FG001|Overall Study|Death Prior First Dose|0|||
143018527|NCT02367781|515608283|FG000|Overall Study|Administrative-Change Facility|1|||
143018528|NCT02367781|515608284|FG001|Overall Study|Administrative-Change Facility|0|||
143018529|NCT02367781|515608283|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
143018530|NCT02367781|515608284|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
143018531|NCT02367781|515608283|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
143018532|NCT02367781|515608284|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
143018533|NCT02367781|515608283|FG000|Overall Study|Study Terminated by Sponsor|3|||
143018534|NCT02367781|515608284|FG001|Overall Study|Study Terminated by Sponsor|1|||
143018535|NCT02367781|515608283|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
143018536|NCT02367781|515608284|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
143018537|NCT02367781|515608283|FG000|Overall Study|Sponsor Decision|2|||
143018538|NCT02367781|515608284|FG001|Overall Study|Sponsor Decision|0|||
143018539|NCT02367781|515608283|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
143018540|NCT02367781|515608284|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
143018541|NCT01529749|515608285|FG000|Overall Study|Lost to Follow-up|0|||
143018542|NCT01529749|515608286|FG001|Overall Study|Lost to Follow-up|1|||
143018543|NCT01529749|515608287|FG002|Overall Study|Lost to Follow-up|1|||
143018544|NCT01529749|515608288|FG003|Overall Study|Lost to Follow-up|0|||
143018545|NCT01529749|515608285|FG000|Overall Study|Physician Decision|0|||
143018546|NCT01529749|515608286|FG001|Overall Study|Physician Decision|0|||
143018547|NCT01529749|515608287|FG002|Overall Study|Physician Decision|0|||
143018548|NCT01529749|515608288|FG003|Overall Study|Physician Decision|1|||
143018549|NCT01529749|515608285|FG000|Overall Study|Withdrawal by Subject|0|||
143018550|NCT01529749|515608286|FG001|Overall Study|Withdrawal by Subject|1|||
143154544|NCT05161936|516109602|FG000|Overall Study|Study terminated by Sponsor|1|||
143018551|NCT01529749|515608287|FG002|Overall Study|Withdrawal by Subject|1|||
143018552|NCT01529749|515608288|FG003|Overall Study|Withdrawal by Subject|0|||
143018553|NCT01529749|515608285|FG000|Overall Study|Protocol Violation|0|||
143154545|NCT05161936|516109603|FG001|Overall Study|Study terminated by Sponsor|0|||
143154546|NCT05161936|516109604|FG002|Overall Study|Study terminated by Sponsor|0|||
143154547|NCT05161936|516109602|FG000|Overall Study|Withdrawal by Subject|0|||
143154548|NCT05161936|516109603|FG001|Overall Study|Withdrawal by Subject|0|||
143154549|NCT05161936|516109604|FG002|Overall Study|Withdrawal by Subject|1|||
143154550|NCT01158404|516109605|FG000|Overall Study|Withdrawal by Subject|0|||
143154551|NCT01158404|516109606|FG001|Overall Study|Withdrawal by Subject|1|||
143154552|NCT01158404|516109607|FG002|Overall Study|Withdrawal by Subject|0|||
143154553|NCT01158404|516109608|FG003|Overall Study|Withdrawal by Subject|0|||
143154554|NCT01158404|516109609|FG004|Overall Study|Withdrawal by Subject|3|||
143154555|NCT01158404|516109610|FG005|Overall Study|Withdrawal by Subject|1|||
143154556|NCT01158404|516109611|FG006|Overall Study|Withdrawal by Subject|0|||
143154557|NCT01158404|516109612|FG007|Overall Study|Withdrawal by Subject|1|||
143154558|NCT01158404|516109605|FG000|Overall Study|Physician Decision|0|||
143154559|NCT01158404|516109606|FG001|Overall Study|Physician Decision|0|||
143154560|NCT01158404|516109607|FG002|Overall Study|Physician Decision|0|||
143154561|NCT01158404|516109608|FG003|Overall Study|Physician Decision|0|||
143154562|NCT01158404|516109609|FG004|Overall Study|Physician Decision|0|||
143154563|NCT01158404|516109610|FG005|Overall Study|Physician Decision|0|||
143154564|NCT01158404|516109611|FG006|Overall Study|Physician Decision|0|||
143154565|NCT01158404|516109612|FG007|Overall Study|Physician Decision|1|||
143154566|NCT01158404|516109605|FG000|Overall Study|Progressive Disease|0|||
143154567|NCT01158404|516109606|FG001|Overall Study|Progressive Disease|0|||
143154568|NCT01158404|516109607|FG002|Overall Study|Progressive Disease|0|||
143154569|NCT01158404|516109608|FG003|Overall Study|Progressive Disease|0|||
143154570|NCT01158404|516109609|FG004|Overall Study|Progressive Disease|0|||
143154571|NCT01158404|516109610|FG005|Overall Study|Progressive Disease|0|||
143154572|NCT01158404|516109611|FG006|Overall Study|Progressive Disease|1|||
143154573|NCT01158404|516109612|FG007|Overall Study|Progressive Disease|0|||
143154574|NCT02070991|516109613|FG000|Overall Study|Death|2|||
143154575|NCT02070991|516109614|FG001|Overall Study|Death|0|||
143154576|NCT02070991|516109613|FG000|Overall Study|Withdrawal by Subject|1|||
143154577|NCT02070991|516109614|FG001|Overall Study|Withdrawal by Subject|0|||
143154578|NCT02639559|516109615|FG000|Overall Study|Mobilization failure|0|||
143154579|NCT02639559|516109616|FG001|Overall Study|Mobilization failure|3|||
143154580|NCT02639559|516109615|FG000|Overall Study|Issues with vascular acess|1|||
143154581|NCT02639559|516109616|FG001|Overall Study|Issues with vascular acess|0|||
143154582|NCT04999020|516109617|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
143154583|NCT04999020|516109618|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
143154584|NCT04999020|516109619|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
143154585|NCT04999020|516109620|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
143154586|NCT04999020|516109617|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
143154587|NCT04999020|516109618|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
143154588|NCT04999020|516109619|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
143154589|NCT04999020|516109620|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
143154590|NCT04999020|516109617|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
143154591|NCT04999020|516109618|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
143154592|NCT04999020|516109619|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
143154593|NCT04999020|516109620|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
143154594|NCT04999020|516109617|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
143154595|NCT04999020|516109618|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
143154596|NCT04999020|516109619|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
143154597|NCT04999020|516109620|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
143154598|NCT04999020|516109617|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
143154599|NCT04999020|516109618|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
143154600|NCT04999020|516109619|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
143154601|NCT04999020|516109620|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
143154602|NCT04999020|516109617|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
143154603|NCT04999020|516109618|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
143154604|NCT04999020|516109619|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
143154605|NCT04999020|516109620|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
143154606|NCT04999020|516109617|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
143154607|NCT04999020|516109618|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
143154608|NCT04999020|516109619|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
143154609|NCT04999020|516109620|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
143154610|NCT04999020|516109617|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
143154611|NCT04999020|516109618|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
143154612|NCT04999020|516109619|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
143154613|NCT04999020|516109620|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
143154614|NCT03670628|516109621|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
143154615|NCT03670628|516109622|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
143018554|NCT01529749|515608286|FG001|Overall Study|Protocol Violation|0|||
143018555|NCT01529749|515608287|FG002|Overall Study|Protocol Violation|0|||
143018556|NCT01529749|515608288|FG003|Overall Study|Protocol Violation|1|||
143018557|NCT00378482|515608289|FG000|Overall Study|Lost to Follow-up|1|||
143018558|NCT00378482|515608289|FG000|Overall Study|Lack of Efficacy|8|||
143018559|NCT00378482|515608289|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
143018560|NCT00378482|515608289|FG000|Overall Study|Withdrawal by Subject|4|||
143018561|NCT00378482|515608289|FG000|Overall Study|Adverse Event|9|||
143018562|NCT00766506|515610051|FG000|Overall Study|Use rescue medication after 3 hours|3|||
143018563|NCT00766506|515610052|FG001|Overall Study|Use rescue medication after 3 hours|0|||
143018564|NCT00766506|515610051|FG000|Overall Study|Other|2|||
143018565|NCT00766506|515610052|FG001|Overall Study|Other|2|||
143018566|NCT02496221|515610054|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
143018567|NCT02496221|515610055|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
143018568|NCT02496221|515610054|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
143018569|NCT02496221|515610055|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
143018570|NCT02496221|515610054|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
143018571|NCT02496221|515610055|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
143018572|NCT03262233|515610056|FG000|Overall Study|Withdrawal by Subject|12|||
143018573|NCT03262233|515610057|FG001|Overall Study|Withdrawal by Subject|8|||
143018574|NCT03262233|515610058|FG002|Overall Study|Withdrawal by Subject|21|||
143018575|NCT03262233|515610059|FG003|Overall Study|Withdrawal by Subject|13|||
143018576|NCT03262233|515610056|FG000|Overall Study|Declined due to shock|1|||
143018577|NCT03262233|515610057|FG001|Overall Study|Declined due to shock|2|||
143018578|NCT03262233|515610058|FG002|Overall Study|Declined due to shock|2|||
143018579|NCT03262233|515610059|FG003|Overall Study|Declined due to shock|3|||
143018580|NCT03262233|515610056|FG000|Overall Study|Protocol Violation|5|||
143018581|NCT03262233|515610057|FG001|Overall Study|Protocol Violation|10|||
143018582|NCT03262233|515610058|FG002|Overall Study|Protocol Violation|2|||
143018583|NCT03262233|515610059|FG003|Overall Study|Protocol Violation|13|||
143018584|NCT03262233|515610056|FG000|Overall Study|data collection artifact|0|||
143018585|NCT03262233|515610057|FG001|Overall Study|data collection artifact|1|||
143018586|NCT03262233|515610058|FG002|Overall Study|data collection artifact|0|||
143018587|NCT03262233|515610059|FG003|Overall Study|data collection artifact|0|||
143018588|NCT01120600|515610060|FG000|Overall Study|Adverse Event|7|||
143018589|NCT01120600|515610061|FG001|Overall Study|Adverse Event|7|||
143018590|NCT01120600|515610060|FG000|Overall Study|Excessive Bone Loss|0|||
143018591|NCT01120600|515610061|FG001|Overall Study|Excessive Bone Loss|4|||
143018592|NCT01120600|515610060|FG000|Overall Study|Lost to Follow-up|1|||
143018593|NCT01120600|515610061|FG001|Overall Study|Lost to Follow-up|3|||
143018594|NCT01120600|515610060|FG000|Overall Study|Physician Decision|1|||
143018595|NCT01120600|515610061|FG001|Overall Study|Physician Decision|3|||
143018596|NCT01120600|515610060|FG000|Overall Study|Protocol Violation|0|||
143018597|NCT01120600|515610061|FG001|Overall Study|Protocol Violation|4|||
143018598|NCT01120600|515610060|FG000|Overall Study|Withdrawal by Subject|10|||
143018599|NCT01120600|515610061|FG001|Overall Study|Withdrawal by Subject|11|||
143018600|NCT03990389|515610062|FG000|Overall Study|Lost to Follow-up|3|||
143018601|NCT03990389|515610063|FG001|Overall Study|Lost to Follow-up|0|||
143018602|NCT03770000|515610064|FG000|Overall Study|Premature discontinuation due to PD|0|||
143018603|NCT03770000|515610065|FG001|Overall Study|Premature discontinuation due to PD|0|||
143018604|NCT03770000|515610066|FG002|Overall Study|Premature discontinuation due to PD|1|||
143018605|NCT03770000|515610067|FG003|Overall Study|Premature discontinuation due to PD|3|||
143018606|NCT03770000|515610068|FG004|Overall Study|Premature discontinuation due to PD|2|||
143018607|NCT02595528|515610069|FG000|Overall Study|Withdrawal by Subject|1|||
143018608|NCT02595528|515610070|FG001|Overall Study|Withdrawal by Subject|2|||
143018609|NCT02595528|515610071|FG002|Overall Study|Withdrawal by Subject|1|||
143018610|NCT02595528|515610072|FG003|Overall Study|Withdrawal by Subject|3|||
143018611|NCT02595528|515610069|FG000|Overall Study|Lost to Follow-up|1|||
143018612|NCT02595528|515610070|FG001|Overall Study|Lost to Follow-up|1|||
143018613|NCT02595528|515610071|FG002|Overall Study|Lost to Follow-up|0|||
143018614|NCT02595528|515610072|FG003|Overall Study|Lost to Follow-up|1|||
143018615|NCT00833547|515610073|FG000|Overall Study|Withdrawal by Subject|2|||
143235560|NCT03605667|516413618|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
143018616|NCT00833547|515610074|FG001|Overall Study|Withdrawal by Subject|2|||
143018617|NCT01690520|515610077|FG000|Overall Study|Death|25|||
143018618|NCT01690520|515610078|FG001|Overall Study|Death|21|||
143018619|NCT01690520|515610077|FG000|Overall Study|Lost to Follow-up|2|||
143018620|NCT01690520|515610078|FG001|Overall Study|Lost to Follow-up|3|||
143018621|NCT01690520|515610077|FG000|Overall Study|Withdrawal by Subject|2|||
143018622|NCT01690520|515610078|FG001|Overall Study|Withdrawal by Subject|0|||
143018623|NCT01690520|515610077|FG000|Overall Study|Relapse|0|||
143018624|NCT01690520|515610078|FG001|Overall Study|Relapse|1|||
143018625|NCT01690520|515610077|FG000|Overall Study|Other|0|||
143018626|NCT01690520|515610078|FG001|Overall Study|Other|1|||
143018627|NCT01690520|515610077|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
143018628|NCT01690520|515610078|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
143235561|NCT05632211|516413619|FG000|Overall Study|Withdrawal by Subject|2|||
143154616|NCT03670628|516109621|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
143154617|NCT03670628|516109622|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
143154618|NCT00896233|516109625|FG000|Overall Study|Claustrophobia during MRI|1|||
143154619|NCT02965456|516109626|FG000|Overall Study|Lost to Follow-up|40|||
143154620|NCT02965456|516109627|FG001|Overall Study|Lost to Follow-up|18|||
143154621|NCT02965456|516109626|FG000|Overall Study|Subject Request|22|||
143154622|NCT02965456|516109627|FG001|Overall Study|Subject Request|13|||
143154623|NCT02965456|516109626|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
143154624|NCT02965456|516109627|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
143154625|NCT02965456|516109626|FG000|Overall Study|Adverse Event|3|||
143154626|NCT02965456|516109627|FG001|Overall Study|Adverse Event|0|||
143154627|NCT02965456|516109626|FG000|Overall Study|Noncompliance with Study Drug|1|||
143154628|NCT02965456|516109627|FG001|Overall Study|Noncompliance with Study Drug|1|||
143154629|NCT02965456|516109626|FG000|Overall Study|Worsening Condition|0|||
143154630|NCT02965456|516109627|FG001|Overall Study|Worsening Condition|2|||
143154631|NCT02965456|516109626|FG000|Overall Study|Lack of Efficacy|1|||
143154632|NCT02965456|516109627|FG001|Overall Study|Lack of Efficacy|0|||
143154633|NCT02965456|516109626|FG000|Overall Study|Physician Decision|0|||
143154634|NCT02965456|516109627|FG001|Overall Study|Physician Decision|1|||
143154635|NCT02965456|516109626|FG000|Overall Study|Pregnancy|1|||
143154636|NCT02965456|516109627|FG001|Overall Study|Pregnancy|0|||
143154637|NCT02965456|516109626|FG000|Overall Study|Protocol Violation|0|||
143154638|NCT02965456|516109627|FG001|Overall Study|Protocol Violation|1|||
143154639|NCT02965456|516109626|FG000|Overall Study|Participant ran out of study drug|0|||
143154640|NCT02965456|516109627|FG001|Overall Study|Participant ran out of study drug|1|||
143154641|NCT04465955|516109628|FG000|Overall Study|Withdrew consent|6|||
143154642|NCT04465955|516109629|FG001|Overall Study|Withdrew consent|10|||
143154643|NCT04465955|516109630|FG002|Overall Study|Withdrew consent|7|||
143154644|NCT04465955|516109628|FG000|Overall Study|Adverse Event|6|||
143154645|NCT04465955|516109629|FG001|Overall Study|Adverse Event|5|||
143154646|NCT04465955|516109630|FG002|Overall Study|Adverse Event|1|||
143154647|NCT04465955|516109628|FG000|Overall Study|Lost to Follow-up|2|||
143154648|NCT04465955|516109629|FG001|Overall Study|Lost to Follow-up|0|||
143154649|NCT04465955|516109630|FG002|Overall Study|Lost to Follow-up|3|||
143154650|NCT04465955|516109628|FG000|Overall Study|Other|1|||
143154651|NCT04465955|516109629|FG001|Overall Study|Other|1|||
143154652|NCT04465955|516109630|FG002|Overall Study|Other|3|||
143154653|NCT00387127|516109631|FG000|Overall Study|Lost to Follow-up|0|||
143154654|NCT00387127|516109632|FG001|Overall Study|Lost to Follow-up|4|||
143154655|NCT00387127|516109631|FG000|Overall Study|Death|16|||
143154656|NCT00387127|516109632|FG001|Overall Study|Death|16|||
143154657|NCT00387127|516109631|FG000|Overall Study|Physician Decision|0|||
143154658|NCT00387127|516109632|FG001|Overall Study|Physician Decision|1|||
143154659|NCT00387127|516109631|FG000|Overall Study|Withdrawal by Subject|3|||
143154660|NCT00387127|516109632|FG001|Overall Study|Withdrawal by Subject|2|||
143154661|NCT00387127|516109631|FG000|Overall Study|Required by Protocol Amendment #4|12|||
143154662|NCT00387127|516109632|FG001|Overall Study|Required by Protocol Amendment #4|10|||
143154663|NCT00387127|516109631|FG000|Overall Study|Serious Adverse Event|1|||
143154664|NCT00387127|516109632|FG001|Overall Study|Serious Adverse Event|1|||
143154665|NCT00387127|516109631|FG000|Overall Study|Sponsor Unblinded|1|||
143154666|NCT00387127|516109632|FG001|Overall Study|Sponsor Unblinded|0|||
143154667|NCT00317369|516109638|FG000|Overall Study|Adverse Event|2|||
143154668|NCT00317369|516109639|FG001|Overall Study|Adverse Event|1|||
143154669|NCT00317369|516109640|FG002|Overall Study|Adverse Event|0|||
143154670|NCT00317369|516109638|FG000|Overall Study|Lack of Efficacy|0|||
143154671|NCT00317369|516109639|FG001|Overall Study|Lack of Efficacy|1|||
143154672|NCT00317369|516109640|FG002|Overall Study|Lack of Efficacy|1|||
143154673|NCT00317369|516109638|FG000|Overall Study|Withdrawal by Subject|0|||
143154674|NCT00317369|516109639|FG001|Overall Study|Withdrawal by Subject|0|||
143154675|NCT00317369|516109640|FG002|Overall Study|Withdrawal by Subject|1|||
143154676|NCT01263028|516109644|FG000|Overall Study|Withdrawal by Subject|1|||
143485542|NCT03605680|517322859|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
143485543|NCT03605680|517322856|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
143154677|NCT01263028|516109644|FG000|Overall Study|Adverse Event|1|||
143154678|NCT01263028|516109644|FG000|Overall Study|Study terminated due to low enrollment.|4|||
143154679|NCT01947933|516109651|FG000|Overall Study|Withdrawal by Subject|0|||
143154680|NCT01947933|516109652|FG001|Overall Study|Withdrawal by Subject|0|||
143154681|NCT01947933|516109653|FG002|Overall Study|Withdrawal by Subject|1|||
143154682|NCT01947933|516109654|FG003|Overall Study|Withdrawal by Subject|0|||
143154683|NCT01947933|516109655|FG004|Overall Study|Withdrawal by Subject|0|||
143154684|NCT01947933|516109656|FG005|Overall Study|Withdrawal by Subject|0|||
143154685|NCT01947933|516109657|FG006|Overall Study|Withdrawal by Subject|0|||
143154686|NCT01947933|516109658|FG007|Overall Study|Withdrawal by Subject|0|||
143154687|NCT01947933|516109659|FG008|Overall Study|Withdrawal by Subject|0|||
143154688|NCT01947933|516109651|FG000|Overall Study|Lost to Follow-up|0|||
143154689|NCT01947933|516109652|FG001|Overall Study|Lost to Follow-up|0|||
143154690|NCT01947933|516109653|FG002|Overall Study|Lost to Follow-up|0|||
143018629|NCT00382291|515610079|FG000|Overall Study|Adverse Event|1|||
143018630|NCT00382291|515610080|FG001|Overall Study|Adverse Event|2|||
143018631|NCT00382291|515610081|FG002|Overall Study|Adverse Event|2|||
143018632|NCT00382291|515610079|FG000|Overall Study|Protocol Violation|1|||
143018633|NCT00382291|515610080|FG001|Overall Study|Protocol Violation|0|||
143018634|NCT00382291|515610081|FG002|Overall Study|Protocol Violation|0|||
143018635|NCT00382291|515610079|FG000|Overall Study|Temporary study suspension|2|||
143018636|NCT00382291|515610080|FG001|Overall Study|Temporary study suspension|2|||
143018637|NCT00382291|515610081|FG002|Overall Study|Temporary study suspension|5|||
143018638|NCT00382291|515610079|FG000|Overall Study|Withdrawal by Subject|0|||
143154691|NCT01947933|516109654|FG003|Overall Study|Lost to Follow-up|0|||
143154692|NCT01947933|516109655|FG004|Overall Study|Lost to Follow-up|0|||
143154693|NCT01947933|516109656|FG005|Overall Study|Lost to Follow-up|0|||
143154694|NCT01947933|516109657|FG006|Overall Study|Lost to Follow-up|0|||
143154695|NCT01947933|516109658|FG007|Overall Study|Lost to Follow-up|0|||
143154696|NCT01947933|516109659|FG008|Overall Study|Lost to Follow-up|1|||
143154697|NCT00985790|516109661|FG000|Overall Study|Withdrawal by Subject|1|||
143154698|NCT00985790|516109662|FG001|Overall Study|Withdrawal by Subject|1|||
143154699|NCT00985790|516109661|FG000|Overall Study|Lost to Follow-up|6|||
143154700|NCT00985790|516109662|FG001|Overall Study|Lost to Follow-up|7|||
143154701|NCT00250718|516109663|FG000|Overall Study|Death|1|||
143154702|NCT00250718|516109663|FG000|Overall Study|Adverse Event|1|||
143154703|NCT00250718|516109663|FG000|Overall Study|Withdrawal by Subject|1|||
143154704|NCT03407482|516109667|FG000|Overall Study|Adverse Event|12|||
143154705|NCT03407482|516109667|FG000|Overall Study|Disease Relapse|1|||
143154706|NCT03407482|516109667|FG000|Overall Study|Lost to Follow-up|1|||
143154707|NCT03407482|516109667|FG000|Overall Study|Non-Compliance With Study Drug|1|||
143154708|NCT03407482|516109667|FG000|Overall Study|Pregnancy|2|||
143154709|NCT03407482|516109667|FG000|Overall Study|Protocol Violation|1|||
143154710|NCT03407482|516109667|FG000|Overall Study|Study Terminated By Sponsor|106|||
143154711|NCT03407482|516109667|FG000|Overall Study|Withdrawal by Subject|6|||
143154712|NCT03407482|516109667|FG000|Overall Study|Data Entry Error|1|||
143154713|NCT06100250|516109668|FG000|Overall Study|Lost to Follow-up|5|||
143154714|NCT05259033|516109671|FG000|Overall Study|Withdrawal by Subject|10|||
143154715|NCT05259033|516109672|FG001|Overall Study|Withdrawal by Subject|5|||
143154716|NCT05259033|516109671|FG000|Overall Study|Lost to Follow-up|1|||
143154717|NCT05259033|516109672|FG001|Overall Study|Lost to Follow-up|0|||
143154718|NCT05259033|516109671|FG000|Overall Study|Death|2|||
143154719|NCT05259033|516109672|FG001|Overall Study|Death|0|||
143154720|NCT05752487|516109673|FG000|Overall Study|Enrolled, not treated|9|||
143154721|NCT05752487|516109673|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
143154722|NCT05752487|516109673|FG000|Overall Study|Withdrawal by Subject|2|||
143154723|NCT00424008|516109674|FG000|Overall Study|Adverse Event|8|||
143154724|NCT00424008|516109675|FG001|Overall Study|Adverse Event|6|||
143154725|NCT00424008|516109674|FG000|Overall Study|Lack of Efficacy|40|||
143154726|NCT00424008|516109675|FG001|Overall Study|Lack of Efficacy|34|||
143154727|NCT00424008|516109674|FG000|Overall Study|Lost to Follow-up|1|||
143154728|NCT00424008|516109675|FG001|Overall Study|Lost to Follow-up|2|||
143154729|NCT00424008|516109674|FG000|Overall Study|Withdrawal by Subject|5|||
143154730|NCT00424008|516109675|FG001|Overall Study|Withdrawal by Subject|8|||
143154731|NCT00424008|516109674|FG000|Overall Study|Noncompliance with protocol|13|||
143154732|NCT00424008|516109675|FG001|Overall Study|Noncompliance with protocol|7|||
143154733|NCT00424008|516109674|FG000|Overall Study|Did not meet protocol eligibility|16|||
143154734|NCT00424008|516109675|FG001|Overall Study|Did not meet protocol eligibility|21|||
143154735|NCT00424008|516109674|FG000|Overall Study|Administrative|266|||
143154736|NCT00424008|516109675|FG001|Overall Study|Administrative|257|||
143154737|NCT01860989|516109676|FG000|Overall Study|Unsatisfactory therapeutic|5|||
143154738|NCT02593864|516109677|FG000|Overall Study|Withdrawal by Subject|3|||
143154739|NCT02593864|516109677|FG000|Overall Study|Lost to Follow-up|3|||
143154740|NCT01405911|516109678|FG000|Overall Study|Pre-treatment lab AE|0|||
143154741|NCT01405911|516109679|FG001|Overall Study|Pre-treatment lab AE|1|||
143154742|NCT01405911|516109680|FG002|Overall Study|Pre-treatment lab AE|0|||
143154743|NCT01405911|516109678|FG000|Overall Study|Lost to Follow-up|0|||
143018639|NCT00382291|515610080|FG001|Overall Study|Withdrawal by Subject|2|||
143018640|NCT00382291|515610081|FG002|Overall Study|Withdrawal by Subject|0|||
143018641|NCT00382291|515610079|FG000|Overall Study|Physician Decision|0|||
143154744|NCT01405911|516109679|FG001|Overall Study|Lost to Follow-up|1|||
143154745|NCT01405911|516109680|FG002|Overall Study|Lost to Follow-up|0|||
143154746|NCT01405911|516109678|FG000|Overall Study|Protocol Violation|1|||
143154747|NCT01405911|516109679|FG001|Overall Study|Protocol Violation|0|||
143154748|NCT01405911|516109680|FG002|Overall Study|Protocol Violation|0|||
143154749|NCT01405911|516109678|FG000|Overall Study|Withdrawal by Subject|3|||
143154750|NCT01405911|516109679|FG001|Overall Study|Withdrawal by Subject|1|||
143154751|NCT01405911|516109680|FG002|Overall Study|Withdrawal by Subject|1|||
143154752|NCT04124965|516109684|FG000|Overall Study|Adverse event, non-fatal|3|||
143154753|NCT04124965|516109685|FG001|Overall Study|Adverse event, non-fatal|1|||
143154754|NCT04124965|516109684|FG000|Overall Study|Withdrawal by Subject|1|||
143154755|NCT04124965|516109685|FG001|Overall Study|Withdrawal by Subject|1|||
143018642|NCT00382291|515610080|FG001|Overall Study|Physician Decision|1|||
143018643|NCT00382291|515610081|FG002|Overall Study|Physician Decision|0|||
143018644|NCT00382291|515610079|FG000|Overall Study|Lack of Efficacy|0|||
143018645|NCT00382291|515610080|FG001|Overall Study|Lack of Efficacy|0|||
143018646|NCT00382291|515610081|FG002|Overall Study|Lack of Efficacy|1|||
143018647|NCT02402933|515610082|FG000|Overall Study|Withdrawal by Subject|4|||
143018648|NCT02402933|515610082|FG000|Overall Study|Discontinued; Site Termination|10|||
143018649|NCT01169649|515610087|FG000|Overall Study|Patient Not Treated|3|||
143018650|NCT00534092|515610088|FG000|Overall Study|Lost to Follow-up|1|||
143018651|NCT00534092|515610089|FG001|Overall Study|Lost to Follow-up|0|||
143018652|NCT00534092|515610088|FG000|Overall Study|personal reasons/family concerns|1|||
143018653|NCT00534092|515610089|FG001|Overall Study|personal reasons/family concerns|0|||
143018654|NCT02919475|515610090|FG000|Overall Study|Adverse Event|3|||
143018655|NCT02919475|515610091|FG001|Overall Study|Adverse Event|3|||
143018656|NCT02919475|515610092|FG002|Overall Study|Adverse Event|3|||
143018657|NCT02919475|515610093|FG003|Overall Study|Adverse Event|9|||
143154756|NCT04124965|516109684|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
143154757|NCT04124965|516109685|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
143154758|NCT04124965|516109684|FG000|Overall Study|Pregnancy|1|||
143154759|NCT04124965|516109685|FG001|Overall Study|Pregnancy|0|||
143154760|NCT04124965|516109684|FG000|Overall Study|Sponsor and participant decision|0|||
143154761|NCT04124965|516109685|FG001|Overall Study|Sponsor and participant decision|1|||
143154762|NCT04124965|516109684|FG000|Overall Study|Personal surgery|0|||
143154763|NCT04124965|516109685|FG001|Overall Study|Personal surgery|1|||
143154764|NCT04124965|516109684|FG000|Overall Study|Physician Decision|0|||
143154765|NCT04124965|516109685|FG001|Overall Study|Physician Decision|1|||
143154766|NCT00002874|516109686|FG000|Overall Study|Withdrawal by Subject|1|||
143154767|NCT00002874|516109687|FG001|Overall Study|Withdrawal by Subject|1|||
143154768|NCT00002874|516109686|FG000|Overall Study|Protocol Violation|44|||
143154769|NCT00002874|516109687|FG001|Overall Study|Protocol Violation|34|||
143154770|NCT02530242|516109695|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
143154771|NCT02530242|516109696|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
143154772|NCT01214720|516109697|FG000|Overall Study|Alive and still on treatment|34|||
143154773|NCT01214720|516109698|FG001|Overall Study|Alive and still on treatment|18|||
143154774|NCT01214720|516109697|FG000|Overall Study|Alive and in follow-up|45|||
143154775|NCT01214720|516109698|FG001|Overall Study|Alive and in follow-up|48|||
143154776|NCT01214720|516109697|FG000|Overall Study|Lost to Follow-up|6|||
143154777|NCT01214720|516109698|FG001|Overall Study|Lost to Follow-up|2|||
143154778|NCT05591755|516109699|FG000|Overall Study|Screen Failure|1|||
143154779|NCT05591755|516109700|FG001|Overall Study|Screen Failure|0|||
143154780|NCT05591755|516109701|FG002|Overall Study|Screen Failure|0|||
143154781|NCT05591755|516109702|FG003|Overall Study|Screen Failure|0|||
143154782|NCT05591755|516109699|FG000|Overall Study|Protocol Violation|0|||
143154783|NCT05591755|516109700|FG001|Overall Study|Protocol Violation|0|||
143154784|NCT05591755|516109701|FG002|Overall Study|Protocol Violation|2|||
143154785|NCT05591755|516109702|FG003|Overall Study|Protocol Violation|0|||
143154786|NCT05591755|516109699|FG000|Overall Study|Withdrawal by Subject|0|||
143154787|NCT05591755|516109700|FG001|Overall Study|Withdrawal by Subject|1|||
143154788|NCT05591755|516109701|FG002|Overall Study|Withdrawal by Subject|0|||
143154789|NCT05591755|516109702|FG003|Overall Study|Withdrawal by Subject|0|||
143154790|NCT01397747|516109707|FG000|Overall Study|Multitarget DNA test excluded|689|||
143154791|NCT01397747|516109707|FG000|Overall Study|Colonoscopy excluded|304|||
143154792|NCT01397747|516109707|FG000|Overall Study|FIT excluded|34|||
143154793|NCT03345095|516109710|FG000|Overall Study|Lack of Efficacy|184|||
143154794|NCT03345095|516109711|FG001|Overall Study|Lack of Efficacy|156|||
143154795|NCT03345095|516109710|FG000|Overall Study|Adverse Event|36|||
143154796|NCT03345095|516109711|FG001|Overall Study|Adverse Event|118|||
143154797|NCT03345095|516109710|FG000|Overall Study|Withdrawal by Subject|22|||
143154798|NCT03345095|516109711|FG001|Overall Study|Withdrawal by Subject|59|||
143485544|NCT03605680|517322857|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
143018658|NCT02919475|515610094|FG004|Overall Study|Adverse Event|2|||
143018659|NCT02919475|515610090|FG000|Overall Study|Death|0|||
143018660|NCT02919475|515610091|FG001|Overall Study|Death|1|||
143018661|NCT02919475|515610092|FG002|Overall Study|Death|0|||
143018662|NCT02919475|515610093|FG003|Overall Study|Death|0|||
143018663|NCT02919475|515610094|FG004|Overall Study|Death|0|||
143018664|NCT02919475|515610090|FG000|Overall Study|Lost to Follow-up|0|||
143154799|NCT03345095|516109710|FG000|Overall Study|Physician Decision|3|||
143154800|NCT03345095|516109711|FG001|Overall Study|Physician Decision|18|||
143154801|NCT03345095|516109710|FG000|Overall Study|Death|2|||
143154802|NCT03345095|516109711|FG001|Overall Study|Death|4|||
143154803|NCT03345095|516109710|FG000|Overall Study|Other reasons|2|||
143154804|NCT03345095|516109711|FG001|Overall Study|Other reasons|11|||
143154805|NCT03345095|516109710|FG000|Overall Study|Protocol Violation|0|||
143154806|NCT03345095|516109711|FG001|Overall Study|Protocol Violation|1|||
143154807|NCT01121575|516109712|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
143154808|NCT01121575|516109713|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
143181467|NCT00642707|516211755|FG003|Overall Study|Adverse Event|2|||
143154809|NCT01121575|516109714|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
143154810|NCT01121575|516109715|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
143154811|NCT01121575|516109716|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
143154812|NCT01121575|516109717|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
143154813|NCT01121575|516109712|FG000|Overall Study|Unspecified Reasons|8|||
143154814|NCT01121575|516109713|FG001|Overall Study|Unspecified Reasons|6|||
143154815|NCT01121575|516109714|FG002|Overall Study|Unspecified Reasons|7|||
143154816|NCT01121575|516109715|FG003|Overall Study|Unspecified Reasons|5|||
143154817|NCT01121575|516109716|FG004|Overall Study|Unspecified Reasons|13|||
143154818|NCT01121575|516109717|FG005|Overall Study|Unspecified Reasons|10|||
143018665|NCT02919475|515610091|FG001|Overall Study|Lost to Follow-up|0|||
143018666|NCT02919475|515610092|FG002|Overall Study|Lost to Follow-up|0|||
143018667|NCT02919475|515610093|FG003|Overall Study|Lost to Follow-up|1|||
143018668|NCT02919475|515610094|FG004|Overall Study|Lost to Follow-up|0|||
143018669|NCT02919475|515610090|FG000|Overall Study|Withdrawal by Subject|2|||
143018670|NCT02919475|515610091|FG001|Overall Study|Withdrawal by Subject|3|||
143018671|NCT02919475|515610092|FG002|Overall Study|Withdrawal by Subject|1|||
143018672|NCT02919475|515610093|FG003|Overall Study|Withdrawal by Subject|2|||
143018673|NCT02919475|515610094|FG004|Overall Study|Withdrawal by Subject|2|||
143018674|NCT02919475|515610090|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
143018675|NCT02919475|515610091|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
143018676|NCT02919475|515610092|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
143018677|NCT02919475|515610093|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
143018678|NCT02919475|515610094|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
143018679|NCT02323295|515610098|FG000|Overall Study|Adverse Event|0|||
143018680|NCT02323295|515610099|FG001|Overall Study|Adverse Event|1|||
143018681|NCT02323295|515610098|FG000|Overall Study|Withdrawal by Subject|0|||
143018682|NCT02323295|515610099|FG001|Overall Study|Withdrawal by Subject|1|||
143018683|NCT02323295|515610098|FG000|Overall Study|Patient did not have surgery as planned.|0|||
143018684|NCT02323295|515610099|FG001|Overall Study|Patient did not have surgery as planned.|1|||
143018685|NCT02962882|515610101|FG000|Overall Study|Adverse Event|2|||
143018686|NCT02962882|515610101|FG000|Overall Study|Withdrawal by Subject|2|||
143018687|NCT02962882|515610101|FG000|Overall Study|Transfer from ICU|32|||
143018688|NCT01155063|515610102|FG000|Overall Study|Adverse Event|1|||
143018689|NCT01155063|515610102|FG000|Overall Study|Withdrawal by Subject|1|||
143018690|NCT01155063|515610102|FG000|Overall Study|Study terminated by sponsor|87|||
143018691|NCT01314703|515610103|FG000|Overall Study|screen failure and closed enrollment|8|||
143018692|NCT01663714|515610104|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
143018693|NCT01663714|515610104|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
143018694|NCT01663714|515610104|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
143018695|NCT01663714|515610104|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
143018696|NCT01663714|515610104|FG000|Long-Term Follow-Up|Death|4|||
143018697|NCT01663714|515610104|FG000|Long-Term Follow-Up|Non-compliance|1|||
143018698|NCT00597584|515610105|FG000|Overall Study|Adverse Event|4|||
143018699|NCT00597584|515610106|FG001|Overall Study|Adverse Event|2|||
143018700|NCT00597584|515610105|FG000|Overall Study|Death|53|||
143018701|NCT00597584|515610106|FG001|Overall Study|Death|30|||
143018702|NCT00597584|515610105|FG000|Overall Study|Lack of Efficacy|1|||
143018703|NCT00597584|515610106|FG001|Overall Study|Lack of Efficacy|0|||
143018704|NCT00597584|515610105|FG000|Overall Study|Lost to Follow-up|2|||
143018705|NCT00597584|515610106|FG001|Overall Study|Lost to Follow-up|4|||
143018706|NCT00597584|515610105|FG000|Overall Study|Physician Decision|3|||
143018707|NCT00597584|515610106|FG001|Overall Study|Physician Decision|0|||
143018708|NCT00597584|515610105|FG000|Overall Study|Pregnancy|2|||
143485545|NCT03605680|517322858|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
143485546|NCT03605680|517322859|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
143018709|NCT00597584|515610106|FG001|Overall Study|Pregnancy|0|||
143018710|NCT00597584|515610105|FG000|Overall Study|Withdrawal by Subject|44|||
143018711|NCT00597584|515610106|FG001|Overall Study|Withdrawal by Subject|12|||
143018712|NCT00597584|515610105|FG000|Overall Study|Discontinued Dialysis|0|||
143018713|NCT00597584|515610106|FG001|Overall Study|Discontinued Dialysis|1|||
143485547|NCT03605680|517322856|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
143485548|NCT03605680|517322857|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
143485549|NCT03605680|517322858|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
143018714|NCT00597584|515610105|FG000|Overall Study|Lost ability to consent|1|||
143018715|NCT00597584|515610106|FG001|Overall Study|Lost ability to consent|1|||
143018716|NCT00597584|515610105|FG000|Overall Study|Never dosed|1|||
143018717|NCT00597584|515610106|FG001|Overall Study|Never dosed|0|||
143018718|NCT00597584|515610105|FG000|Overall Study|Relocation|8|||
143018719|NCT00597584|515610106|FG001|Overall Study|Relocation|6|||
143018720|NCT00597584|515610105|FG000|Overall Study|Renal transplant|9|||
143018721|NCT00597584|515610106|FG001|Overall Study|Renal transplant|7|||
143018722|NCT00881959|515610113|FG000|Overall Study|Lost to Follow-up|2|||
143154819|NCT01121575|516109712|FG000|Overall Study|Death|6|||
143154820|NCT01121575|516109713|FG001|Overall Study|Death|0|||
143018723|NCT00881959|515610114|FG001|Overall Study|Lost to Follow-up|4|||
143018724|NCT03751020|515610117|FG000|Overall Study|Withdrawal by Subject|2|||
143154821|NCT01121575|516109714|FG002|Overall Study|Death|0|||
143154822|NCT01121575|516109715|FG003|Overall Study|Death|1|||
143154823|NCT01121575|516109716|FG004|Overall Study|Death|7|||
143154824|NCT01121575|516109717|FG005|Overall Study|Death|1|||
143154825|NCT04971837|516111881|FG000|Overall Study|Long Term Illness|1|||
143154826|NCT04971837|516111881|FG000|Overall Study|BMI too low|9|||
143154827|NCT04971837|516111881|FG000|Overall Study|geographic location|1|||
143154828|NCT04971837|516111881|FG000|Overall Study|Discontinued scheduling conflict|1|||
143154829|NCT05638737|516111882|FG000|Overall Study|Withdrawal by Subject|4|||
143154830|NCT05638737|516111883|FG001|Overall Study|Withdrawal by Subject|7|||
143154831|NCT00504231|516111886|FG000|Overall Study|Discrepant chart documentation re route|0|||
143154832|NCT00504231|516111887|FG001|Overall Study|Discrepant chart documentation re route|0|||
143154833|NCT00504231|516111888|FG002|Overall Study|Discrepant chart documentation re route|1|||
143154834|NCT00504231|516111889|FG003|Overall Study|Discrepant chart documentation re route|0|||
143154835|NCT00088881|516111890|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
143154836|NCT00088881|516111890|FG000|Step 1 - R-CHOP|Adverse Event|1|||
143154837|NCT00088881|516111890|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
143154838|NCT00088881|516111890|FG000|Step 1 - R-CHOP|Physician Decision|1|||
143154839|NCT00088881|516111890|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
143154840|NCT00088881|516111890|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
143154841|NCT00088881|516111890|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
143154842|NCT02323334|516111891|FG000|Period 3|Lost to Follow-up|0|||
143154843|NCT02323334|516111892|FG001|Period 3|Lost to Follow-up|0|||
143154844|NCT02323334|516111893|FG002|Period 3|Lost to Follow-up|1|||
143154845|NCT02323334|516111894|FG003|Period 3|Lost to Follow-up|0|||
143154846|NCT02323334|516111895|FG004|Period 3|Lost to Follow-up|0|||
143154847|NCT02323334|516111896|FG005|Period 3|Lost to Follow-up|0|||
143154848|NCT02323334|516111897|FG006|Period 3|Lost to Follow-up|0|||
143154849|NCT02323334|516111898|FG007|Period 3|Lost to Follow-up|0|||
143154850|NCT02323334|516111899|FG008|Period 3|Lost to Follow-up|0|||
143154851|NCT02323334|516111900|FG009|Period 3|Lost to Follow-up|0|||
143154852|NCT02323334|516111901|FG010|Period 3|Lost to Follow-up|0|||
143154853|NCT02323334|516111902|FG011|Period 3|Lost to Follow-up|0|||
143154854|NCT02323334|516111903|FG012|Period 3|Lost to Follow-up|0|||
143154855|NCT02323334|516111904|FG013|Period 3|Lost to Follow-up|0|||
143154856|NCT02323334|516111905|FG014|Period 3|Lost to Follow-up|0|||
143154857|NCT02323334|516111906|FG015|Period 3|Lost to Follow-up|0|||
143154858|NCT02323334|516111907|FG016|Period 3|Lost to Follow-up|0|||
143154859|NCT02323334|516111891|FG000|Period 3|Withdrawal by Subject|1|||
143154860|NCT02323334|516111892|FG001|Period 3|Withdrawal by Subject|0|||
143154861|NCT02323334|516111893|FG002|Period 3|Withdrawal by Subject|0|||
143154862|NCT02323334|516111894|FG003|Period 3|Withdrawal by Subject|0|||
143154863|NCT02323334|516111895|FG004|Period 3|Withdrawal by Subject|0|||
143154864|NCT02323334|516111896|FG005|Period 3|Withdrawal by Subject|0|||
143154865|NCT02323334|516111897|FG006|Period 3|Withdrawal by Subject|0|||
143154866|NCT02323334|516111898|FG007|Period 3|Withdrawal by Subject|0|||
143154867|NCT02323334|516111899|FG008|Period 3|Withdrawal by Subject|0|||
143154868|NCT02323334|516111900|FG009|Period 3|Withdrawal by Subject|0|||
143154869|NCT02323334|516111901|FG010|Period 3|Withdrawal by Subject|0|||
143154870|NCT02323334|516111902|FG011|Period 3|Withdrawal by Subject|0|||
143154871|NCT02323334|516111903|FG012|Period 3|Withdrawal by Subject|0|||
143154872|NCT02323334|516111904|FG013|Period 3|Withdrawal by Subject|0|||
143154873|NCT02323334|516111905|FG014|Period 3|Withdrawal by Subject|0|||
143154874|NCT02323334|516111906|FG015|Period 3|Withdrawal by Subject|0|||
143154875|NCT02323334|516111907|FG016|Period 3|Withdrawal by Subject|0|||
143154876|NCT03422718|516111915|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
143154877|NCT03422718|516111916|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
143154878|NCT03422718|516111917|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
143154879|NCT03422718|516111918|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
143154880|NCT03422718|516111919|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
143018725|NCT03751020|515610118|FG001|Overall Study|Withdrawal by Subject|0|||
143018726|NCT03751020|515610119|FG002|Overall Study|Withdrawal by Subject|0|||
143018727|NCT03751020|515610117|FG000|Overall Study|Lost to Follow-up|7|||
143018728|NCT03751020|515610118|FG001|Overall Study|Lost to Follow-up|4|||
143154881|NCT03422718|516111920|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
143154882|NCT03422718|516111921|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
143154883|NCT03422718|516111922|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
143154884|NCT03422718|516111915|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
143154885|NCT03422718|516111916|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
143154886|NCT03422718|516111917|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
143154887|NCT03422718|516111918|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
143154888|NCT03422718|516111919|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
143154889|NCT03422718|516111920|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
143018729|NCT03751020|515610119|FG002|Overall Study|Lost to Follow-up|10|||
143018730|NCT00528879|515610120|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
143018731|NCT00528879|515610121|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
143018732|NCT00528879|515610122|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
143018733|NCT00528879|515610123|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
143018734|NCT00528879|515610120|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
143018735|NCT00528879|515610121|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
143018736|NCT00528879|515610122|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
143018737|NCT00528879|515610123|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
143018738|NCT00528879|515610120|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
143018739|NCT00528879|515610121|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
143018740|NCT00528879|515610122|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
143018741|NCT00528879|515610123|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
143018742|NCT00528879|515610120|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
143018743|NCT00528879|515610121|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
143018744|NCT00528879|515610122|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
143018745|NCT00528879|515610123|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
143018746|NCT00528879|515610120|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
143018747|NCT00528879|515610121|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
143018748|NCT00528879|515610122|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
143018749|NCT00528879|515610123|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
143018750|NCT00528879|515610120|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
143018751|NCT00528879|515610121|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
143018752|NCT00528879|515610122|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
143018753|NCT00528879|515610123|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
143018754|NCT00528879|515610120|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
143018755|NCT00528879|515610121|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
143018756|NCT00528879|515610122|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
143018757|NCT00528879|515610123|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
143018758|NCT00528879|515610120|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
143018759|NCT00528879|515610121|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
143018760|NCT00528879|515610122|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
143018761|NCT00528879|515610123|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
143018762|NCT00528879|515610120|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
143018763|NCT00528879|515610121|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
143018764|NCT00528879|515610122|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
143018765|NCT00528879|515610123|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
143018766|NCT00528879|515610120|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
143018767|NCT00528879|515610121|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
143018768|NCT00528879|515610122|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
143018769|NCT00528879|515610123|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
143018770|NCT00528879|515610120|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
143018771|NCT00528879|515610121|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
143018772|NCT00528879|515610122|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
143018773|NCT00528879|515610123|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
143018774|NCT00528879|515610120|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
143018775|NCT00528879|515610121|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
143018776|NCT00528879|515610122|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
143018777|NCT00528879|515610123|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
143018778|NCT00528879|515610120|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
143018779|NCT00528879|515610121|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
143018780|NCT00528879|515610122|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
143018781|NCT00528879|515610123|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
143018782|NCT00528879|515610120|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
143018783|NCT00528879|515610121|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
143018784|NCT00528879|515610122|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
143018785|NCT00528879|515610123|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
143018786|NCT00528879|515610120|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
143018787|NCT00528879|515610121|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
143363684|NCT00062868|516873796|FG016|Dose Level 3|Lost to Follow-up|0|||
143485550|NCT03605680|517322859|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
143485551|NCT03605680|517322856|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
143485552|NCT03605680|517322857|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
143485553|NCT03605680|517322858|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
143485554|NCT03605680|517322859|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
143018788|NCT00528879|515610122|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
143018789|NCT00528879|515610123|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
143018790|NCT00528879|515610120|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
143018791|NCT00528879|515610121|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
143018792|NCT00528879|515610122|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
143018793|NCT00528879|515610123|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
143018794|NCT00078819|515610126|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
143018795|NCT00078819|515610127|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
143018796|NCT00078819|515610128|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
143018797|NCT00078819|515610129|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
143018798|NCT00078819|515610126|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
143018799|NCT00078819|515610127|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
143018800|NCT00078819|515610128|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
143018801|NCT00078819|515610129|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
143018802|NCT00078819|515610126|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
143018803|NCT00078819|515610127|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
143018804|NCT00078819|515610128|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
143018805|NCT00078819|515610129|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
143018806|NCT00078819|515610126|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
143018807|NCT00078819|515610127|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
143018808|NCT00078819|515610128|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
143018809|NCT00078819|515610129|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
143018810|NCT00078819|515610126|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
143018811|NCT00078819|515610127|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
143018812|NCT00078819|515610128|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
143018813|NCT00078819|515610129|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
143018814|NCT00078819|515610126|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
143018815|NCT00078819|515610127|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
143018816|NCT00078819|515610128|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
143018817|NCT00078819|515610129|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
143018818|NCT00078819|515610126|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
143018819|NCT00078819|515610127|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
143018820|NCT00078819|515610128|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
143018821|NCT00078819|515610129|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
143018822|NCT00078819|515610126|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
143018823|NCT00078819|515610127|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
143018824|NCT00078819|515610128|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
143018825|NCT00078819|515610129|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
143018826|NCT01252238|515610130|FG000|Overall Study|Sponsor terminated study|4|||
143018827|NCT01252238|515610131|FG001|Overall Study|Sponsor terminated study|4|||
143018828|NCT01252238|515610132|FG002|Overall Study|Sponsor terminated study|4|||
143018829|NCT00272961|515610133|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
143018830|NCT00272961|515610134|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
143018831|NCT00272961|515610135|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
143018832|NCT00272961|515610136|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
143018833|NCT00272961|515610137|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
143018834|NCT00272961|515610133|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
143018835|NCT00272961|515610134|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
143018836|NCT00272961|515610135|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
143018837|NCT00272961|515610136|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
143018838|NCT00272961|515610137|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
143018839|NCT00272961|515610133|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
143018840|NCT00272961|515610134|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
143018841|NCT00272961|515610135|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
143018842|NCT00272961|515610136|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
143018843|NCT00272961|515610137|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
143018844|NCT00272961|515610133|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
143018845|NCT00272961|515610134|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
143018846|NCT00272961|515610135|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
143018847|NCT00272961|515610136|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
143018848|NCT00272961|515610137|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
143018849|NCT00272961|515610133|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
143018850|NCT00272961|515610134|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
143154890|NCT03422718|516111921|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
143018851|NCT00272961|515610135|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
143018852|NCT00272961|515610136|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
143154891|NCT03422718|516111922|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
143154892|NCT03422718|516111915|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
143154893|NCT03422718|516111916|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
143154894|NCT03422718|516111917|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
143154895|NCT03422718|516111918|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
143154896|NCT03422718|516111919|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
143154897|NCT03422718|516111920|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
143154898|NCT03422718|516111921|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
143154899|NCT03422718|516111922|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
143154900|NCT03422718|516111915|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
143154901|NCT03422718|516111916|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
143154902|NCT03422718|516111917|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
143154903|NCT03422718|516111918|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
143154904|NCT03422718|516111919|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
143154905|NCT03422718|516111920|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
143154906|NCT03422718|516111921|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
143154907|NCT03422718|516111922|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
143154908|NCT03422718|516111915|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
143154909|NCT03422718|516111916|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
143154910|NCT03422718|516111917|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
143154911|NCT03422718|516111918|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
143154912|NCT03422718|516111919|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
143154913|NCT03422718|516111920|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
143154914|NCT03422718|516111921|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
143154915|NCT03422718|516111922|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
143154916|NCT03422718|516111915|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
143154917|NCT03422718|516111916|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
143154918|NCT03422718|516111917|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
143363685|NCT00062868|516873797|FG017|Dose Level 3|Lost to Follow-up|0|||
143363686|NCT00062868|516873798|FG018|Dose Level 3|Lost to Follow-up|0|||
143485555|NCT03605680|517322856|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
143485556|NCT03605680|517322857|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
143018853|NCT00272961|515610137|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
143018854|NCT00272961|515610133|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
143018855|NCT00272961|515610134|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
143018856|NCT00272961|515610135|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
143018857|NCT00272961|515610136|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
143018858|NCT00272961|515610137|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
143018859|NCT00272961|515610133|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
143018860|NCT00272961|515610134|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
143018861|NCT00272961|515610135|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
143018862|NCT00272961|515610136|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
143018863|NCT00272961|515610137|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
143018864|NCT00272961|515610133|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
143018865|NCT00272961|515610134|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
143018866|NCT00272961|515610135|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
143018867|NCT00272961|515610136|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
143018868|NCT00272961|515610137|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
143018869|NCT01507831|515610138|FG000|Overall Study|Randomized but not treated|0|||
143018870|NCT01507831|515610139|FG001|Overall Study|Randomized but not treated|3|||
143018871|NCT01507831|515610138|FG000|Overall Study|Adverse Event|48|||
143018872|NCT01507831|515610139|FG001|Overall Study|Adverse Event|113|||
143018873|NCT01507831|515610138|FG000|Overall Study|Death|6|||
143018874|NCT01507831|515610139|FG001|Overall Study|Death|2|||
143018875|NCT01507831|515610138|FG000|Overall Study|Poor compliance to protocol|38|||
143018876|NCT01507831|515610139|FG001|Overall Study|Poor compliance to protocol|60|||
143018877|NCT01507831|515610138|FG000|Overall Study|Physician Decision|0|||
143018878|NCT01507831|515610139|FG001|Overall Study|Physician Decision|4|||
143018879|NCT01507831|515610138|FG000|Overall Study|Participant moved|5|||
143018880|NCT01507831|515610139|FG001|Overall Study|Participant moved|19|||
143018881|NCT01507831|515610138|FG000|Overall Study|Consent withdrawn by participant|34|||
143018882|NCT01507831|515610139|FG001|Overall Study|Consent withdrawn by participant|72|||
143018883|NCT01507831|515610138|FG000|Overall Study|Related to study drug administration|5|||
143018884|NCT01507831|515610139|FG001|Overall Study|Related to study drug administration|14|||
143018885|NCT01507831|515610138|FG000|Overall Study|Last visit outside protocol visit window|51|||
143154919|NCT03422718|516111918|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
143018886|NCT01507831|515610139|FG001|Overall Study|Last visit outside protocol visit window|143|||
143018887|NCT01507831|515610138|FG000|Overall Study|Selection criteria finally not met|0|||
143018888|NCT01507831|515610139|FG001|Overall Study|Selection criteria finally not met|1|||
143018889|NCT01507831|515610138|FG000|Overall Study|Site closure|0|||
143018890|NCT01507831|515610139|FG001|Overall Study|Site closure|3|||
143018891|NCT01507831|515610138|FG000|Overall Study|Potential lost to follow-up|3|||
143018892|NCT01507831|515610139|FG001|Overall Study|Potential lost to follow-up|0|||
143018893|NCT01507831|515610138|FG000|Overall Study|Other|3|||
143018894|NCT01507831|515610139|FG001|Overall Study|Other|6|||
143018895|NCT03196791|515610140|FG000|Overall Study|Protocol Violation|7|||
143018896|NCT03196791|515610141|FG001|Overall Study|Protocol Violation|3|||
143018897|NCT03196791|515610140|FG000|Overall Study|Withdrawal by Subject|3|||
143018898|NCT03196791|515610141|FG001|Overall Study|Withdrawal by Subject|2|||
143018899|NCT00068237|515610142|FG000|Overall Study|Ineligible|3|||
143018900|NCT00068237|515610142|FG000|Overall Study|No protocol treatment received|2|||
143018901|NCT03276962|515610148|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
143018902|NCT03276962|515610149|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
143018903|NCT03276962|515610150|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
143018904|NCT03276962|515610151|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
143018905|NCT03276962|515610152|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
143018906|NCT03276962|515610148|FG000|Overall Study|Protocol Deviation|2|||
143018907|NCT03276962|515610149|FG001|Overall Study|Protocol Deviation|0|||
143018908|NCT03276962|515610150|FG002|Overall Study|Protocol Deviation|1|||
143018909|NCT03276962|515610151|FG003|Overall Study|Protocol Deviation|2|||
143018910|NCT03276962|515610152|FG004|Overall Study|Protocol Deviation|1|||
143018911|NCT03276962|515610148|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
143018912|NCT03276962|515610149|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
143018913|NCT03276962|515610150|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
143018914|NCT03276962|515610151|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
143018915|NCT03276962|515610152|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
143018916|NCT03276962|515610148|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
143018917|NCT03276962|515610149|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
143018918|NCT03276962|515610150|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
143018919|NCT03276962|515610151|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
143018920|NCT03276962|515610152|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
143018921|NCT03276962|515610148|FG000|Overall Study|Lost to Follow-up|10|||
143018922|NCT03276962|515610149|FG001|Overall Study|Lost to Follow-up|10|||
143018923|NCT03276962|515610150|FG002|Overall Study|Lost to Follow-up|4|||
143018924|NCT03276962|515610151|FG003|Overall Study|Lost to Follow-up|6|||
143018925|NCT03276962|515610152|FG004|Overall Study|Lost to Follow-up|10|||
143018926|NCT03276962|515610148|FG000|Overall Study|Other|0|||
143018927|NCT03276962|515610149|FG001|Overall Study|Other|2|||
143018928|NCT03276962|515610150|FG002|Overall Study|Other|0|||
143018929|NCT03276962|515610151|FG003|Overall Study|Other|2|||
143018930|NCT03276962|515610152|FG004|Overall Study|Other|1|||
143018931|NCT01238211|515610153|FG000|Overall Study|Continues active treatment|31|||
143018932|NCT01238211|515610153|FG000|Overall Study|Adverse Event|7|||
143018933|NCT01238211|515610153|FG000|Overall Study|Death|4|||
143018934|NCT01238211|515610153|FG000|Overall Study|Relapse/Progression|2|||
143018935|NCT01238211|515610153|FG000|Overall Study|Withdrawal by Subject|7|||
143018936|NCT01238211|515610153|FG000|Overall Study|Non-protocol treatment|4|||
143363687|NCT00062868|516873799|FG019|Dose Level 3|Lost to Follow-up|0|||
143363688|NCT00062868|516873800|FG020|Dose Level 3|Lost to Follow-up|0|||
143018937|NCT01238211|515610153|FG000|Overall Study|Investigator/Patient Decision|3|||
143018938|NCT01358708|515610154|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
143018939|NCT01358708|515610155|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
143018940|NCT01358708|515610154|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
143018941|NCT01358708|515610155|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
143018942|NCT03550794|515610160|FG000|Overall Study|No longer met inclusion criteria|1|||
143018943|NCT03550794|515610161|FG001|Overall Study|No longer met inclusion criteria|2|||
143018944|NCT03550794|515610160|FG000|Overall Study|Goals of care changed|1|||
143018945|NCT03550794|515610161|FG001|Overall Study|Goals of care changed|0|||
143018946|NCT03550794|515610160|FG000|Overall Study|Withdrawal by Subject|2|||
143018947|NCT03550794|515610161|FG001|Overall Study|Withdrawal by Subject|0|||
143018948|NCT03550794|515610160|FG000|Overall Study|Death|0|||
143018949|NCT03550794|515610161|FG001|Overall Study|Death|1|||
143018950|NCT01890785|515610162|FG000|Third Intervention|Withdrawal by Subject|0|||
143018951|NCT01890785|515610163|FG001|Third Intervention|Withdrawal by Subject|1|||
143018952|NCT01890785|515610164|FG002|Third Intervention|Withdrawal by Subject|0|||
143018953|NCT01890785|515610165|FG003|Third Intervention|Withdrawal by Subject|0|||
143018954|NCT01890785|515610166|FG004|Third Intervention|Withdrawal by Subject|0|||
143018955|NCT01890785|515610167|FG005|Third Intervention|Withdrawal by Subject|0|||
143018956|NCT02713243|515610168|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
143363689|NCT00062868|516873780|FG000|Dose Level 3|Withdrew|0|||
143018957|NCT02713243|515610169|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
143018958|NCT02713243|515610168|FG000|Overall Study|Administrative problems|0|||
143018959|NCT02713243|515610169|FG001|Overall Study|Administrative problems|1|||
143018960|NCT02713243|515610168|FG000|Overall Study|Protocol deviation|0|||
143018961|NCT02713243|515610169|FG001|Overall Study|Protocol deviation|1|||
143018962|NCT00520351|515610170|FG000|First Intervention|Withdrawal by Subject|1|||
143018963|NCT00520351|515610171|FG001|First Intervention|Withdrawal by Subject|1|||
143018964|NCT03439293|515610175|FG000|Overall Study|Death|22|||
143018965|NCT03439293|515610175|FG000|Overall Study|Withdrawal by Subject|8|||
143018966|NCT03439293|515610175|FG000|Overall Study|Lost to Follow-up|2|||
143018967|NCT03439293|515610175|FG000|Overall Study|Reason Not Specified|28|||
143018968|NCT03439293|515610175|FG000|Overall Study|Missing|1|||
143018969|NCT03077828|515610179|FG000|Treatment Cycles|Death|1|||
143018970|NCT03077828|515610179|FG000|Treatment Cycles|Withdrawal by Subject|1|||
143018971|NCT03077828|515610179|FG000|Treatment Cycles|Screen Fail|2|||
143018972|NCT03077828|515610179|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
143018973|NCT03077828|515610179|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
143018974|NCT03077828|515610179|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
143018975|NCT03077828|515610179|FG000|Follow-up|Patients still in follow-up|15|||
143018976|NCT04288115|515610183|FG000|Overall Study|Withdrawal by Subject|0|||
143018977|NCT04288115|515610184|FG001|Overall Study|Withdrawal by Subject|1|||
143018978|NCT04288115|515610183|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
143018979|NCT04288115|515610184|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
143018980|NCT00729365|515610186|FG000|Overall Study|Physician Decision|33|||
143018981|NCT00729365|515610187|FG001|Overall Study|Physician Decision|6|||
143018982|NCT00729365|515610188|FG002|Overall Study|Physician Decision|7|||
143018983|NCT00869089|515610191|FG000|Overall Study|Lost to Follow-up|1|||
143018984|NCT00869089|515610191|FG000|Overall Study|Withdrawal by Subject|1|||
143018985|NCT00869089|515610191|FG000|Overall Study|Screen Fail|1|||
143018986|NCT02766400|515610193|FG000|Overall Study|Death|1|||
143018987|NCT02766400|515610194|FG001|Overall Study|Death|2|||
143018988|NCT02766400|515610193|FG000|Overall Study|Withdrawal by Subject|1|||
143018989|NCT02766400|515610194|FG001|Overall Study|Withdrawal by Subject|0|||
143018990|NCT05037409|515610196|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
143018991|NCT05037409|515610197|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
143018992|NCT05037409|515610198|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
143018993|NCT03499249|515610199|FG000|Overall Study|Physician Decision|1|||
143018994|NCT02475980|515610204|FG000|Overall Study|Lost to Follow-up|4|||
143018995|NCT02475980|515610204|FG000|Overall Study|Withdrawal by Subject|1|||
143018996|NCT00990093|515610205|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
143018997|NCT00990093|515610206|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
143018998|NCT00990093|515610205|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
143018999|NCT00990093|515610206|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
143019000|NCT00990093|515610205|FG000|Test Period 1 (1-14 Days)|Other|1|||
143019001|NCT00990093|515610206|FG001|Test Period 1 (1-14 Days)|Other|0|||
143019002|NCT00990093|515610205|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
143019003|NCT00990093|515610206|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
143019004|NCT00990093|515610205|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
143019005|NCT00990093|515610206|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
143019006|NCT00990093|515610205|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
143019007|NCT00990093|515610206|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
143019008|NCT00990093|515610205|FG000|Test Period 2 (15-28 Days)|Other|0|||
143019009|NCT00990093|515610206|FG001|Test Period 2 (15-28 Days)|Other|1|||
143019010|NCT05003167|515610213|FG000|Overall Study|Withdrawal by Subject|1|||
143019011|NCT01123980|515610214|FG000|Overall Study|Adverse Event|1|||
143019012|NCT01123980|515610215|FG001|Overall Study|Adverse Event|1|||
143019013|NCT01123980|515610214|FG000|Overall Study|Lack of Efficacy|1|||
143019014|NCT01123980|515610215|FG001|Overall Study|Lack of Efficacy|0|||
143019015|NCT01123980|515610214|FG000|Overall Study|Physician Decision|0|||
143363690|NCT00062868|516873781|FG001|Dose Level 3|Withdrew|0|||
143363691|NCT00062868|516873782|FG002|Dose Level 3|Withdrew|2|||
143019016|NCT01123980|515610215|FG001|Overall Study|Physician Decision|1|||
143019017|NCT01123980|515610214|FG000|Overall Study|Lost to Follow-up|0|||
143019018|NCT01123980|515610215|FG001|Overall Study|Lost to Follow-up|6|||
143019019|NCT01123980|515610214|FG000|Overall Study|Protocol Violation|6|||
143019020|NCT01123980|515610215|FG001|Overall Study|Protocol Violation|6|||
143019021|NCT01123980|515610214|FG000|Overall Study|Withdrawal by Subject|5|||
143019022|NCT01123980|515610215|FG001|Overall Study|Withdrawal by Subject|3|||
143019023|NCT01123980|515610214|FG000|Overall Study|Unclassified|6|||
143019024|NCT01123980|515610215|FG001|Overall Study|Unclassified|7|||
143019025|NCT01225991|515610216|FG000|Overall Study|Withdrawal by Subject|6|||
143019026|NCT00343642|515611280|FG000|Overall Study|Lost to Follow-up|0|||
143019027|NCT00343642|515611281|FG001|Overall Study|Lost to Follow-up|1|||
143019028|NCT00343642|515611282|FG002|Overall Study|Lost to Follow-up|0|||
143019029|NCT00343642|515611280|FG000|Overall Study|Pregnancy|1|||
143019030|NCT00343642|515611281|FG001|Overall Study|Pregnancy|0|||
143019031|NCT00343642|515611282|FG002|Overall Study|Pregnancy|2|||
143019032|NCT00343642|515611280|FG000|Overall Study|Withdrawal by Subject|2|||
143019033|NCT00343642|515611281|FG001|Overall Study|Withdrawal by Subject|3|||
143019034|NCT00343642|515611282|FG002|Overall Study|Withdrawal by Subject|4|||
143019035|NCT00343642|515611280|FG000|Overall Study|Adverse Event|0|||
143019036|NCT00343642|515611281|FG001|Overall Study|Adverse Event|0|||
143019037|NCT00343642|515611282|FG002|Overall Study|Adverse Event|1|||
143019038|NCT00343642|515611280|FG000|Overall Study|Flare up|6|||
143019039|NCT00343642|515611281|FG001|Overall Study|Flare up|4|||
143019040|NCT00343642|515611282|FG002|Overall Study|Flare up|0|||
143019041|NCT01963676|515611283|FG000|Overall Study|Withdrawal by Subject|1|||
143019042|NCT01963676|515611284|FG001|Overall Study|Withdrawal by Subject|0|||
143019043|NCT00860574|515611285|FG000|Overall Study|Death|2|||
143019044|NCT00860574|515611285|FG000|Overall Study|Relapse|1|||
143019045|NCT01246986|515611286|FG000|Overall Study|Lost to Follow-up|0|||
143019046|NCT01246986|515611287|FG001|Overall Study|Lost to Follow-up|1|||
143019047|NCT01246986|515611288|FG002|Overall Study|Lost to Follow-up|3|||
143019048|NCT01246986|515611289|FG003|Overall Study|Lost to Follow-up|0|||
143019049|NCT01246986|515611290|FG004|Overall Study|Lost to Follow-up|0|||
143019050|NCT01246986|515611291|FG005|Overall Study|Lost to Follow-up|1|||
143019051|NCT01246986|515611292|FG006|Overall Study|Lost to Follow-up|0|||
143019052|NCT01246986|515611286|FG000|Overall Study|Withdrawal by Subject|3|||
143019053|NCT01246986|515611287|FG001|Overall Study|Withdrawal by Subject|4|||
143019054|NCT01246986|515611288|FG002|Overall Study|Withdrawal by Subject|3|||
143019055|NCT01246986|515611289|FG003|Overall Study|Withdrawal by Subject|0|||
143019056|NCT01246986|515611290|FG004|Overall Study|Withdrawal by Subject|4|||
143019057|NCT01246986|515611291|FG005|Overall Study|Withdrawal by Subject|0|||
143019058|NCT01246986|515611292|FG006|Overall Study|Withdrawal by Subject|0|||
143019059|NCT01456052|515611295|FG000|Overall Study|Adverse Event|1|||
143019060|NCT01456052|515611296|FG001|Overall Study|Adverse Event|1|||
143019061|NCT01456052|515611297|FG002|Overall Study|Adverse Event|2|||
143019062|NCT01456052|515611295|FG000|Overall Study|Consent withdrawn|0|||
143019063|NCT01456052|515611296|FG001|Overall Study|Consent withdrawn|2|||
143019064|NCT01456052|515611297|FG002|Overall Study|Consent withdrawn|1|||
143019065|NCT01456052|515611295|FG000|Overall Study|Protocol Violation|0|||
143019066|NCT01456052|515611296|FG001|Overall Study|Protocol Violation|1|||
143019067|NCT01456052|515611297|FG002|Overall Study|Protocol Violation|0|||
143019068|NCT01456052|515611295|FG000|Overall Study|Physician Decision|1|||
143019069|NCT01456052|515611296|FG001|Overall Study|Physician Decision|0|||
143019070|NCT01456052|515611297|FG002|Overall Study|Physician Decision|1|||
143019071|NCT01456052|515611295|FG000|Overall Study|Treatment Failure|0|||
143019072|NCT01456052|515611296|FG001|Overall Study|Treatment Failure|1|||
143019073|NCT01456052|515611297|FG002|Overall Study|Treatment Failure|1|||
143019074|NCT03840811|515611298|FG000|Overall Study|Lost to Follow-up|0|||
143019075|NCT03840811|515611299|FG001|Overall Study|Lost to Follow-up|0|||
143019076|NCT03840811|515611300|FG002|Overall Study|Lost to Follow-up|1|||
143019077|NCT01904383|515611301|FG000|Overall Study|CRF not collected|117|||
143019078|NCT01904383|515611301|FG000|Overall Study|Reason not listed|147|||
143019079|NCT01904383|515611301|FG000|Overall Study|Lost to Follow-up|674|||
143019080|NCT01904383|515611301|FG000|Overall Study|Lack of Efficacy|370|||
143019081|NCT01904383|515611301|FG000|Overall Study|Improvement|141|||
143019082|NCT01904383|515611301|FG000|Overall Study|Adverse Event|271|||
143019083|NCT01904383|515611301|FG000|Overall Study|No patient visit after entry|54|||
143019084|NCT01703741|515611302|FG000|Overall Study|Withdrawal by Subject|6|||
143019085|NCT01703741|515611302|FG000|Overall Study|Adverse Event|2|||
143019086|NCT01703741|515611302|FG000|Overall Study|Physician Decision|2|||
143019087|NCT01703741|515611302|FG000|Overall Study|Protocol Violation|1|||
143019088|NCT01703741|515611302|FG000|Overall Study|Lost to Follow-up|3|||
143019089|NCT01703741|515611302|FG000|Overall Study|Subject did not want to continue|2|||
143363692|NCT00062868|516873783|FG003|Dose Level 3|Withdrew|0|||
143363693|NCT00062868|516873784|FG004|Dose Level 3|Withdrew|0|||
143363694|NCT00062868|516873785|FG005|Dose Level 3|Withdrew|0|||
143485557|NCT03605680|517322858|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
143019090|NCT01703741|515611302|FG000|Overall Study|Subject cannot comply with study visits|1|||
143019091|NCT01703741|515611302|FG000|Overall Study|Subject started testosterone injections|1|||
143019092|NCT01368276|515611303|FG000|Overall Study|Death|1|||
143019093|NCT01368276|515611304|FG001|Overall Study|Death|10|||
143019094|NCT02041494|515611305|FG000|Overall Study|Death|1|||
143019095|NCT02041494|515611306|FG001|Overall Study|Death|3|||
143019096|NCT02041494|515611305|FG000|Overall Study|Lost to Follow-up|2|||
143019097|NCT02041494|515611306|FG001|Overall Study|Lost to Follow-up|6|||
143019098|NCT02041494|515611305|FG000|Overall Study|study terminated|16|||
143019099|NCT02041494|515611306|FG001|Overall Study|study terminated|11|||
143019100|NCT03341273|515611307|FG000|Overall Study|Lost to Follow-up|7|||
143019101|NCT03341273|515611308|FG001|Overall Study|Lost to Follow-up|7|||
143019102|NCT03341273|515611307|FG000|Overall Study|Withdrawal by Subject|4|||
143019103|NCT03341273|515611308|FG001|Overall Study|Withdrawal by Subject|2|||
143019104|NCT03341273|515611307|FG000|Overall Study|Physician Decision|1|||
143019105|NCT03341273|515611308|FG001|Overall Study|Physician Decision|0|||
143363695|NCT00062868|516873786|FG006|Dose Level 3|Withdrew|0|||
143154920|NCT03422718|516111919|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
143154921|NCT03422718|516111920|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
143154922|NCT03422718|516111921|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
143154923|NCT03422718|516111922|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
143154924|NCT03309605|516111923|FG000|Overall Study|Adverse Event|0|||
143154925|NCT03309605|516111924|FG001|Overall Study|Adverse Event|0|||
143154926|NCT03309605|516111925|FG002|Overall Study|Adverse Event|0|||
143154927|NCT03309605|516111926|FG003|Overall Study|Adverse Event|1|||
143154928|NCT03309605|516111927|FG004|Overall Study|Adverse Event|0|||
143154929|NCT03309605|516111928|FG005|Overall Study|Adverse Event|0|||
143154930|NCT03309605|516111929|FG006|Overall Study|Adverse Event|2|||
143154931|NCT03309605|516111930|FG007|Overall Study|Adverse Event|1|||
143154932|NCT03309605|516111923|FG000|Overall Study|Withdrawal by Subject|0|||
143154933|NCT03309605|516111924|FG001|Overall Study|Withdrawal by Subject|0|||
143154934|NCT03309605|516111925|FG002|Overall Study|Withdrawal by Subject|0|||
143154935|NCT03309605|516111926|FG003|Overall Study|Withdrawal by Subject|0|||
143154936|NCT03309605|516111927|FG004|Overall Study|Withdrawal by Subject|1|||
143154937|NCT03309605|516111928|FG005|Overall Study|Withdrawal by Subject|0|||
143154938|NCT03309605|516111929|FG006|Overall Study|Withdrawal by Subject|1|||
143154939|NCT03309605|516111930|FG007|Overall Study|Withdrawal by Subject|1|||
143154940|NCT01129284|516111931|FG000|Overall Study|Adverse Event|2|||
143154941|NCT01129284|516111932|FG001|Overall Study|Adverse Event|0|||
143154942|NCT01129284|516111933|FG002|Overall Study|Adverse Event|1|||
143154943|NCT05788328|516111934|FG000|Treatment Period 4 (5 Days)|Other|1|||
143154944|NCT05788328|516111934|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
143154945|NCT00784927|516111940|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
143154946|NCT00784927|516111940|FG000|Overall Study|Protocol Violation|1|||
143154947|NCT00784927|516111940|FG000|Overall Study|Ineligible|1|||
143154948|NCT00422461|516111948|FG000|Overall Study|Adverse Event|1|||
143154949|NCT00422461|516111949|FG001|Overall Study|Adverse Event|2|||
143154950|NCT00422461|516111950|FG002|Overall Study|Adverse Event|1|||
143154951|NCT00422461|516111951|FG003|Overall Study|Adverse Event|1|||
143154952|NCT00422461|516111948|FG000|Overall Study|Other|0|||
143154953|NCT00422461|516111949|FG001|Overall Study|Other|0|||
143154954|NCT00422461|516111950|FG002|Overall Study|Other|0|||
143154955|NCT00422461|516111951|FG003|Overall Study|Other|2|||
143154956|NCT00422461|516111948|FG000|Overall Study|Participants no longer willing to participate in study|1|||
143154957|NCT00422461|516111949|FG001|Overall Study|Participants no longer willing to participate in study|0|||
143154958|NCT00422461|516111950|FG002|Overall Study|Participants no longer willing to participate in study|0|||
143154959|NCT00422461|516111951|FG003|Overall Study|Participants no longer willing to participate in study|0|||
143154960|NCT00422461|516111948|FG000|Overall Study|Randomized but not treated|1|||
143154961|NCT00422461|516111949|FG001|Overall Study|Randomized but not treated|1|||
143154962|NCT00422461|516111950|FG002|Overall Study|Randomized but not treated|0|||
143154963|NCT00422461|516111951|FG003|Overall Study|Randomized but not treated|0|||
143154964|NCT00145327|516111952|FG000|Overall Study|Withdrawal by Subject|77|||
143154965|NCT00145327|516111953|FG001|Overall Study|Withdrawal by Subject|72|||
143154966|NCT00145327|516111954|FG002|Overall Study|Withdrawal by Subject|164|||
143154967|NCT00145327|516111952|FG000|Overall Study|Death|26|||
143154968|NCT00145327|516111953|FG001|Overall Study|Death|18|||
143154969|NCT00145327|516111954|FG002|Overall Study|Death|30|||
143154970|NCT00145327|516111952|FG000|Overall Study|Adverse Event|14|||
143154971|NCT00145327|516111953|FG001|Overall Study|Adverse Event|11|||
143154972|NCT00145327|516111954|FG002|Overall Study|Adverse Event|22|||
143154973|NCT00145327|516111952|FG000|Overall Study|Lost to Follow-up|9|||
143154974|NCT00145327|516111953|FG001|Overall Study|Lost to Follow-up|14|||
143154975|NCT00145327|516111954|FG002|Overall Study|Lost to Follow-up|14|||
143154976|NCT00145327|516111952|FG000|Overall Study|Administrative problems|12|||
143154977|NCT00145327|516111953|FG001|Overall Study|Administrative problems|9|||
143154978|NCT00145327|516111954|FG002|Overall Study|Administrative problems|13|||
143154979|NCT00145327|516111952|FG000|Overall Study|Protocol Violation|2|||
143154980|NCT00145327|516111953|FG001|Overall Study|Protocol Violation|0|||
143154981|NCT00145327|516111954|FG002|Overall Study|Protocol Violation|2|||
143154982|NCT00145327|516111952|FG000|Overall Study|Abnormal laboratory value(s)|1|||
143485558|NCT03605680|517322859|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
143154983|NCT00145327|516111953|FG001|Overall Study|Abnormal laboratory value(s)|0|||
143154984|NCT00145327|516111954|FG002|Overall Study|Abnormal laboratory value(s)|2|||
143154985|NCT00145327|516111952|FG000|Overall Study|Missing - not stated|1|||
143154986|NCT00145327|516111953|FG001|Overall Study|Missing - not stated|0|||
143154987|NCT00145327|516111954|FG002|Overall Study|Missing - not stated|1|||
143154988|NCT01795937|516111955|FG000|Overall Study|Withdrawal by Subject|1|||
143154989|NCT01795937|516111956|FG001|Overall Study|Withdrawal by Subject|0|||
143154990|NCT01795937|516111957|FG002|Overall Study|Withdrawal by Subject|0|||
143154991|NCT01795937|516111955|FG000|Overall Study|Physician Decision|0|||
143154992|NCT01795937|516111956|FG001|Overall Study|Physician Decision|1|||
143154993|NCT01795937|516111957|FG002|Overall Study|Physician Decision|0|||
143154994|NCT01028053|516111958|FG000|Overall Study|Screen Failure|113|||
143019106|NCT03341273|515611307|FG000|Overall Study|Protocol Violation|0|||
143019107|NCT03341273|515611308|FG001|Overall Study|Protocol Violation|1|||
143019108|NCT03341273|515611307|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
143019109|NCT03341273|515611308|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
143019110|NCT03341273|515611307|FG000|Overall Study|Became ineligible after enrollment|1|||
143019111|NCT03341273|515611308|FG001|Overall Study|Became ineligible after enrollment|0|||
143019112|NCT03341273|515611307|FG000|Overall Study|Not Eligible at Enrollment|0|||
143019113|NCT03341273|515611308|FG001|Overall Study|Not Eligible at Enrollment|1|||
143019114|NCT03341273|515611307|FG000|Overall Study|Participant incarcerated|1|||
143019115|NCT03341273|515611308|FG001|Overall Study|Participant incarcerated|0|||
143019116|NCT00685919|515611309|FG000|Overall Study|Withdrawal by Subject|0|||
143019117|NCT00685919|515611310|FG001|Overall Study|Withdrawal by Subject|0|||
143019118|NCT00685919|515611311|FG002|Overall Study|Withdrawal by Subject|1|||
143019119|NCT00685919|515611312|FG003|Overall Study|Withdrawal by Subject|0|||
143019120|NCT00685919|515611309|FG000|Overall Study|Physician Decision|1|||
143019121|NCT00685919|515611310|FG001|Overall Study|Physician Decision|0|||
143019122|NCT00685919|515611311|FG002|Overall Study|Physician Decision|0|||
143019123|NCT00685919|515611312|FG003|Overall Study|Physician Decision|0|||
143019124|NCT01717456|515611317|FG000|End of Treatment|Physician Decision|0|||
143019125|NCT01717456|515611318|FG001|End of Treatment|Physician Decision|1|||
143019126|NCT01717456|515611317|FG000|End of Treatment|Lost to Follow-up|0|||
143019127|NCT01717456|515611318|FG001|End of Treatment|Lost to Follow-up|1|||
143019128|NCT01717456|515611317|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
143019129|NCT01717456|515611318|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
143019130|NCT02622074|515611319|FG000|Overall Study|Death|4|||
143019131|NCT02622074|515611320|FG001|Overall Study|Death|0|||
143019132|NCT02622074|515611321|FG002|Overall Study|Death|0|||
143019133|NCT02622074|515611322|FG003|Overall Study|Death|1|||
143019134|NCT02622074|515611323|FG004|Overall Study|Death|1|||
143019135|NCT02622074|515611324|FG005|Overall Study|Death|0|||
143019136|NCT02622074|515611319|FG000|Overall Study|Withdrawal by Subject|0|||
143019137|NCT02622074|515611320|FG001|Overall Study|Withdrawal by Subject|1|||
143019138|NCT02622074|515611321|FG002|Overall Study|Withdrawal by Subject|0|||
143019139|NCT02622074|515611322|FG003|Overall Study|Withdrawal by Subject|0|||
143019140|NCT02622074|515611323|FG004|Overall Study|Withdrawal by Subject|0|||
143019141|NCT02622074|515611324|FG005|Overall Study|Withdrawal by Subject|0|||
143019142|NCT03870997|515611325|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
143019143|NCT03870997|515611326|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
143019144|NCT03870997|515611327|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
143019145|NCT03870997|515611328|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
143019146|NCT03870997|515611329|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
143019147|NCT03870997|515611330|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
143019148|NCT02410837|515611331|FG000|Overall Study|Death|387|||
143019149|NCT02410837|515611331|FG000|Overall Study|Lost to Follow-up|50|||
143019150|NCT02410837|515611331|FG000|Overall Study|Withdrawal by Subject|44|||
143019151|NCT02410837|515611331|FG000|Overall Study|Physician Decision|6|||
143019152|NCT02410837|515611331|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
143019153|NCT00837577|515611332|FG000|Double-blind Period|Clinical Adverse Event|1|||
143019154|NCT00837577|515611333|FG001|Double-blind Period|Clinical Adverse Event|0|||
143019155|NCT00837577|515611332|FG000|Double-blind Period|Withdrawal by Subject|1|||
143019156|NCT00837577|515611333|FG001|Double-blind Period|Withdrawal by Subject|0|||
143019157|NCT00837577|515611332|FG000|Open-label Period|Clinical Adverse Event|2|||
143019158|NCT00837577|515611333|FG001|Open-label Period|Clinical Adverse Event|2|||
143019159|NCT00837577|515611332|FG000|Open-label Period|Laboratory Adverse Event|0|||
143019160|NCT00837577|515611333|FG001|Open-label Period|Laboratory Adverse Event|1|||
143019161|NCT00837577|515611332|FG000|Open-label Period|Lack of Efficacy|4|||
143019162|NCT00837577|515611333|FG001|Open-label Period|Lack of Efficacy|3|||
143019163|NCT00837577|515611332|FG000|Open-label Period|Withdrawal by Subject|1|||
143019164|NCT00837577|515611333|FG001|Open-label Period|Withdrawal by Subject|2|||
143019165|NCT00837577|515611332|FG000|Open-label Period|Other Reason|1|||
143019166|NCT00837577|515611333|FG001|Open-label Period|Other Reason|1|||
143019167|NCT00986154|515611334|FG000|Overall Study|Death|136|||
143019168|NCT00986154|515611335|FG001|Overall Study|Death|127|||
143019169|NCT00986154|515611334|FG000|Overall Study|Lost to Follow-up|7|||
143019170|NCT00986154|515611335|FG001|Overall Study|Lost to Follow-up|4|||
143019171|NCT00986154|515611334|FG000|Overall Study|Withdrawal by Subject|32|||
143019172|NCT00986154|515611335|FG001|Overall Study|Withdrawal by Subject|33|||
143019173|NCT00986154|515611334|FG000|Overall Study|investigator/subject decide not continue|6|||
143019174|NCT00986154|515611335|FG001|Overall Study|investigator/subject decide not continue|3|||
143019175|NCT00986154|515611334|FG000|Overall Study|never received study drug|25|||
143019176|NCT00986154|515611335|FG001|Overall Study|never received study drug|27|||
143019177|NCT03726437|515611336|FG000|Overall Study|Lost to Follow-up|85|||
143019178|NCT03726437|515611337|FG001|Overall Study|Lost to Follow-up|76|||
143019179|NCT00267007|515611339|FG000|Overall Study|Withdrawal by Subject|6|||
143019180|NCT00267007|515611340|FG001|Overall Study|Withdrawal by Subject|0|||
143019181|NCT00267007|515611339|FG000|Overall Study|Lost to Follow-up|1|||
143019182|NCT00267007|515611340|FG001|Overall Study|Lost to Follow-up|0|||
143019183|NCT00267007|515611339|FG000|Overall Study|Non-compliance|0|||
143019184|NCT00267007|515611340|FG001|Overall Study|Non-compliance|1|||
143019185|NCT00267007|515611339|FG000|Overall Study|Adverse Event|1|||
143019186|NCT00267007|515611340|FG001|Overall Study|Adverse Event|0|||
143019187|NCT01825876|515611346|FG000|Period 2|Withdrawal by Subject|0|||
143019188|NCT01825876|515611347|FG001|Period 2|Withdrawal by Subject|1|||
143019189|NCT01205529|515611348|FG000|Overall Study|Procedure Cancelled|4|||
143019190|NCT01205529|515611348|FG000|Overall Study|Withdrawal by Subject|2|||
143019191|NCT01205529|515611348|FG000|Overall Study|Physician Decision|4|||
143019192|NCT01205529|515611348|FG000|Overall Study|Unstable post op|15|||
143019193|NCT01205529|515611348|FG000|Overall Study|No longer met criteria|30|||
143019194|NCT00033631|515611349|FG000|Overall Study|Protocol Violation|14|||
143019195|NCT00033631|515611350|FG001|Overall Study|Protocol Violation|11|||
143019196|NCT00033631|515611349|FG000|Overall Study|Withdrawal by Subject|4|||
143019197|NCT00033631|515611350|FG001|Overall Study|Withdrawal by Subject|4|||
143019198|NCT02555618|515611351|FG000|Overall Study|Sponsor's Circumstances|1|||
143019199|NCT02555618|515611352|FG001|Overall Study|Sponsor's Circumstances|0|||
143019200|NCT00971204|515611353|FG000|Overall Study|Did not meet all criteria-not treated|14|||
143019201|NCT00971204|515611353|FG000|Overall Study|Lost to Follow-up|10|||
143019202|NCT01361607|515611359|FG000|Overall Study|Adverse Event|38|||
143019203|NCT01361607|515611360|FG001|Overall Study|Adverse Event|29|||
143019204|NCT01361607|515611359|FG000|Overall Study|Withdrawal by Subject|19|||
143019205|NCT01361607|515611360|FG001|Overall Study|Withdrawal by Subject|8|||
143019206|NCT01361607|515611359|FG000|Overall Study|Withdrawal by Investigator|5|||
143019207|NCT01361607|515611360|FG001|Overall Study|Withdrawal by Investigator|3|||
143019208|NCT01361607|515611359|FG000|Overall Study|Lost to Follow-up|1|||
143019209|NCT01361607|515611360|FG001|Overall Study|Lost to Follow-up|0|||
143019210|NCT01361607|515611359|FG000|Overall Study|Met Withdrawal Criteria|1|||
143019211|NCT01361607|515611360|FG001|Overall Study|Met Withdrawal Criteria|1|||
143019212|NCT00373685|515611363|FG000|Overall Study|Death|2|||
143019213|NCT00373685|515611364|FG001|Overall Study|Death|1|||
143019214|NCT00373685|515611363|FG000|Overall Study|Adverse Event|278|||
143019215|NCT00373685|515611364|FG001|Overall Study|Adverse Event|253|||
143019216|NCT00373685|515611363|FG000|Overall Study|Insufficient clinical response|169|||
143019217|NCT00373685|515611364|FG001|Overall Study|Insufficient clinical response|119|||
143019218|NCT00373685|515611363|FG000|Overall Study|Did not meet entrance criteria|167|||
143019219|NCT00373685|515611364|FG001|Overall Study|Did not meet entrance criteria|184|||
143019220|NCT00373685|515611363|FG000|Overall Study|Lost to follow up|83|||
143019221|NCT00373685|515611364|FG001|Overall Study|Lost to follow up|103|||
143019222|NCT00373685|515611363|FG000|Overall Study|No longer willing to participate|337|||
143019223|NCT00373685|515611364|FG001|Overall Study|No longer willing to participate|352|||
143019224|NCT00373685|515611363|FG000|Overall Study|Other|149|||
143019225|NCT00373685|515611364|FG001|Overall Study|Other|146|||
143019226|NCT00373685|515611363|FG000|Overall Study|Protocol Violation|191|||
143019227|NCT00373685|515611364|FG001|Overall Study|Protocol Violation|182|||
143019228|NCT00373685|515611363|FG000|Overall Study|Final Status Unknown|12|||
143019229|NCT00373685|515611364|FG001|Overall Study|Final Status Unknown|4|||
143019230|NCT00373685|515611363|FG000|Overall Study|Randomized, not treated|51|||
143019231|NCT00373685|515611364|FG001|Overall Study|Randomized, not treated|77|||
143019232|NCT02570165|515611365|FG000|Overall Study|Adverse Event|1|||
143019233|NCT02570165|515611366|FG001|Overall Study|Adverse Event|0|||
143019234|NCT02570165|515611367|FG002|Overall Study|Adverse Event|2|||
143019235|NCT02570165|515611368|FG003|Overall Study|Adverse Event|0|||
143019236|NCT02570165|515611369|FG004|Overall Study|Adverse Event|0|||
143019237|NCT02570165|515611370|FG005|Overall Study|Adverse Event|0|||
143019238|NCT02570165|515611371|FG006|Overall Study|Adverse Event|0|||
143019239|NCT02570165|515611365|FG000|Overall Study|Lack of Efficacy|0|||
143485559|NCT03605680|517322856|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
143019240|NCT02570165|515611366|FG001|Overall Study|Lack of Efficacy|1|||
143019241|NCT02570165|515611367|FG002|Overall Study|Lack of Efficacy|0|||
143019242|NCT02570165|515611368|FG003|Overall Study|Lack of Efficacy|0|||
143019243|NCT02570165|515611369|FG004|Overall Study|Lack of Efficacy|4|||
143019244|NCT02570165|515611370|FG005|Overall Study|Lack of Efficacy|0|||
143019245|NCT02570165|515611371|FG006|Overall Study|Lack of Efficacy|0|||
143019246|NCT02570165|515611365|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
143019247|NCT02570165|515611366|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
143019248|NCT02570165|515611367|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
143019249|NCT02570165|515611368|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
143019250|NCT02570165|515611369|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
143019251|NCT02570165|515611370|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
143019252|NCT02570165|515611371|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
143019253|NCT02570165|515611365|FG000|Overall Study|Lost to Follow-up|0|||
143019254|NCT02570165|515611366|FG001|Overall Study|Lost to Follow-up|0|||
143019255|NCT02570165|515611367|FG002|Overall Study|Lost to Follow-up|1|||
143019256|NCT02570165|515611368|FG003|Overall Study|Lost to Follow-up|1|||
143019257|NCT02570165|515611369|FG004|Overall Study|Lost to Follow-up|0|||
143019258|NCT02570165|515611370|FG005|Overall Study|Lost to Follow-up|0|||
143019259|NCT02570165|515611371|FG006|Overall Study|Lost to Follow-up|0|||
143019260|NCT02570165|515611365|FG000|Overall Study|Physician Decision|0|||
143019261|NCT02570165|515611366|FG001|Overall Study|Physician Decision|1|||
143019262|NCT02570165|515611367|FG002|Overall Study|Physician Decision|0|||
143019263|NCT02570165|515611368|FG003|Overall Study|Physician Decision|0|||
143019264|NCT02570165|515611369|FG004|Overall Study|Physician Decision|0|||
143019265|NCT02570165|515611370|FG005|Overall Study|Physician Decision|0|||
143019266|NCT02570165|515611371|FG006|Overall Study|Physician Decision|0|||
143019267|NCT02570165|515611365|FG000|Overall Study|Withdrawal by Subject|0|||
143019268|NCT02570165|515611366|FG001|Overall Study|Withdrawal by Subject|0|||
143019269|NCT02570165|515611367|FG002|Overall Study|Withdrawal by Subject|0|||
143019270|NCT02570165|515611368|FG003|Overall Study|Withdrawal by Subject|2|||
143019271|NCT02570165|515611369|FG004|Overall Study|Withdrawal by Subject|1|||
143019272|NCT02570165|515611370|FG005|Overall Study|Withdrawal by Subject|0|||
143019273|NCT02570165|515611371|FG006|Overall Study|Withdrawal by Subject|0|||
143019274|NCT02570165|515611365|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
143019275|NCT02570165|515611366|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
143019276|NCT02570165|515611367|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
143019277|NCT02570165|515611368|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
143019278|NCT02570165|515611369|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
143019279|NCT02570165|515611370|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
143019280|NCT02570165|515611371|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
143019281|NCT02570165|515611365|FG000|Overall Study|Withdrawal Request by GSK|0|||
143019282|NCT02570165|515611366|FG001|Overall Study|Withdrawal Request by GSK|0|||
143019283|NCT02570165|515611367|FG002|Overall Study|Withdrawal Request by GSK|2|||
143019284|NCT02570165|515611368|FG003|Overall Study|Withdrawal Request by GSK|0|||
143019285|NCT02570165|515611369|FG004|Overall Study|Withdrawal Request by GSK|0|||
143019286|NCT02570165|515611370|FG005|Overall Study|Withdrawal Request by GSK|0|||
143019287|NCT02570165|515611371|FG006|Overall Study|Withdrawal Request by GSK|0|||
143019288|NCT00811070|515611377|FG000|Overall Study|Death|0|||
143019289|NCT00811070|515611378|FG001|Overall Study|Death|0|||
143019290|NCT00811070|515611379|FG002|Overall Study|Death|0|||
143019291|NCT00811070|515611380|FG003|Overall Study|Death|2|||
143019292|NCT00811070|515611381|FG004|Overall Study|Death|5|||
143019293|NCT00811070|515611382|FG005|Overall Study|Death|0|||
143019294|NCT00811070|515611377|FG000|Overall Study|Other|1|||
143019295|NCT00811070|515611378|FG001|Overall Study|Other|0|||
143019296|NCT00811070|515611379|FG002|Overall Study|Other|0|||
143019297|NCT00811070|515611380|FG003|Overall Study|Other|0|||
143019298|NCT00811070|515611381|FG004|Overall Study|Other|0|||
143019299|NCT00811070|515611382|FG005|Overall Study|Other|0|||
143019300|NCT00811070|515611377|FG000|Overall Study|Withdrawal by Subject|0|||
143019301|NCT00811070|515611378|FG001|Overall Study|Withdrawal by Subject|1|||
143019302|NCT00811070|515611379|FG002|Overall Study|Withdrawal by Subject|0|||
143019303|NCT00811070|515611380|FG003|Overall Study|Withdrawal by Subject|0|||
143019304|NCT00811070|515611381|FG004|Overall Study|Withdrawal by Subject|0|||
143019305|NCT00811070|515611382|FG005|Overall Study|Withdrawal by Subject|0|||
143019306|NCT00811070|515611377|FG000|Overall Study|Physician Decision|0|||
143019307|NCT00811070|515611378|FG001|Overall Study|Physician Decision|0|||
143019308|NCT00811070|515611379|FG002|Overall Study|Physician Decision|0|||
143019309|NCT00811070|515611380|FG003|Overall Study|Physician Decision|0|||
143019310|NCT00811070|515611381|FG004|Overall Study|Physician Decision|0|||
143019311|NCT00811070|515611382|FG005|Overall Study|Physician Decision|1|||
143019312|NCT00585039|515611384|FG000|Overall Study|medication spilled|2|||
143019313|NCT00585039|515611385|FG001|Overall Study|medication spilled|0|||
143019314|NCT04147611|515611386|FG000|Overall Study|Physician Decision|0|||
143485560|NCT03605680|517322857|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
143485561|NCT03605680|517322858|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
143485562|NCT03605680|517322859|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
143485563|NCT03605680|517322856|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
143019315|NCT04147611|515611387|FG001|Overall Study|Physician Decision|1|||
143019316|NCT01010230|515611388|FG000|Overall Study|Withdrawal by Subject|6|||
143019317|NCT01010230|515611389|FG001|Overall Study|Withdrawal by Subject|5|||
143019318|NCT01010230|515611388|FG000|Overall Study|Lost to Follow-up|4|||
143019319|NCT01010230|515611389|FG001|Overall Study|Lost to Follow-up|2|||
143019320|NCT01585831|515611396|FG000|Overall Study|Physician Decision|0|||
143019321|NCT01585831|515611397|FG001|Overall Study|Physician Decision|1|||
143019322|NCT01585831|515611396|FG000|Overall Study|Withdrawal by Subject|2|||
143019323|NCT01585831|515611397|FG001|Overall Study|Withdrawal by Subject|1|||
143019324|NCT04444752|515611398|FG000|Overall Study|Adverse Event|1|||
143019325|NCT04444752|515611399|FG001|Overall Study|Adverse Event|0|||
143019326|NCT04444752|515611400|FG002|Overall Study|Adverse Event|0|||
143019327|NCT04444752|515611401|FG003|Overall Study|Adverse Event|2|||
143019328|NCT04444752|515611398|FG000|Overall Study|Lost to Follow-up|2|||
143019329|NCT04444752|515611399|FG001|Overall Study|Lost to Follow-up|6|||
143019330|NCT04444752|515611400|FG002|Overall Study|Lost to Follow-up|2|||
143019331|NCT04444752|515611401|FG003|Overall Study|Lost to Follow-up|5|||
143019332|NCT04444752|515611398|FG000|Overall Study|Physician Decision|0|||
143019333|NCT04444752|515611399|FG001|Overall Study|Physician Decision|0|||
143019334|NCT04444752|515611400|FG002|Overall Study|Physician Decision|0|||
143019335|NCT04444752|515611401|FG003|Overall Study|Physician Decision|2|||
143019336|NCT04444752|515611398|FG000|Overall Study|Pregnancy|0|||
143019337|NCT04444752|515611399|FG001|Overall Study|Pregnancy|0|||
143019338|NCT04444752|515611400|FG002|Overall Study|Pregnancy|0|||
143019339|NCT04444752|515611401|FG003|Overall Study|Pregnancy|1|||
143019340|NCT04444752|515611398|FG000|Overall Study|Withdrawal by Subject|6|||
143019341|NCT04444752|515611399|FG001|Overall Study|Withdrawal by Subject|5|||
143154995|NCT01028053|516111958|FG000|Overall Study|Patient Request|11|||
143154996|NCT01028053|516111958|FG000|Overall Study|Protocol Violation|1|||
143154997|NCT01028053|516111958|FG000|Overall Study|Physician Decision|2|||
143154998|NCT01028053|516111958|FG000|Overall Study|Technical Problem|1|||
143154999|NCT01028053|516111958|FG000|Overall Study|Terminated by Sponsor|1|||
143155000|NCT01028053|516111958|FG000|Overall Study|Various reasons|4|||
143155001|NCT04027946|516111959|FG000|Overall Study|Screen failures|3|||
143155002|NCT03315689|516111964|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
143155003|NCT03315689|516111965|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
143155004|NCT03315689|516111964|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
143155005|NCT03315689|516111965|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
143155006|NCT03315689|516111964|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
143155007|NCT03315689|516111965|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
143155008|NCT00864513|516111967|FG000|Overall Study|Withdrawal by Subject|3|||
143155009|NCT01297244|516111968|FG000|Overall Study|Progressive disease|22|||
143155010|NCT01297244|516111969|FG001|Overall Study|Progressive disease|3|||
143155011|NCT01297244|516111968|FG000|Overall Study|Adverse Event|9|||
143155012|NCT01297244|516111969|FG001|Overall Study|Adverse Event|1|||
143155013|NCT01297244|516111968|FG000|Overall Study|Death|1|||
143155014|NCT01297244|516111969|FG001|Overall Study|Death|1|||
143155015|NCT01297244|516111968|FG000|Overall Study|Clinical progression|1|||
143155016|NCT01297244|516111969|FG001|Overall Study|Clinical progression|1|||
143155017|NCT01297244|516111968|FG000|Overall Study|Withdrawal by Subject|2|||
143155018|NCT01297244|516111969|FG001|Overall Study|Withdrawal by Subject|0|||
143155019|NCT00875667|516111972|FG000|Overall Study|Adverse Event|29|||
143155020|NCT00875667|516111973|FG001|Overall Study|Adverse Event|10|||
143155021|NCT00875667|516111972|FG000|Overall Study|Withdrawal by Subject|17|||
143155022|NCT00875667|516111973|FG001|Overall Study|Withdrawal by Subject|5|||
143155023|NCT00875667|516111972|FG000|Overall Study|Death|7|||
143155024|NCT00875667|516111973|FG001|Overall Study|Death|2|||
143155025|NCT00875667|516111972|FG000|Overall Study|Protocol Violation|2|||
143155026|NCT00875667|516111973|FG001|Overall Study|Protocol Violation|0|||
143155027|NCT00875667|516111972|FG000|Overall Study|Disease Progression|100|||
143155028|NCT00875667|516111973|FG001|Overall Study|Disease Progression|49|||
143155029|NCT00875667|516111972|FG000|Overall Study|Miscellaneous|12|||
143155030|NCT00875667|516111973|FG001|Overall Study|Miscellaneous|6|||
143155031|NCT00875667|516111972|FG000|Overall Study|Randomized but no Study Drug Given|3|||
143155032|NCT00875667|516111973|FG001|Overall Study|Randomized but no Study Drug Given|1|||
143155033|NCT01913470|516111977|FG000|Overall Study|Lost to Follow-up|0|||
143155034|NCT01913470|516111978|FG001|Overall Study|Lost to Follow-up|1|||
143155035|NCT01913470|516111977|FG000|Overall Study|Physician Decision|0|||
143155036|NCT01913470|516111978|FG001|Overall Study|Physician Decision|1|||
143155037|NCT01913470|516111977|FG000|Overall Study|Withdrawal by Subject|0|||
143155038|NCT01913470|516111978|FG001|Overall Study|Withdrawal by Subject|1|||
143155039|NCT02400580|516111990|FG000|Overall Study|Withdrawal by Subject|1|||
143155040|NCT02400580|516111991|FG001|Overall Study|Withdrawal by Subject|1|||
143155041|NCT02400580|516111990|FG000|Overall Study|Adverse Event|1|||
143155042|NCT02400580|516111991|FG001|Overall Study|Adverse Event|0|||
143155043|NCT02384460|516111992|FG000|Overall Study|Protocol Violation|0|||
143155044|NCT02384460|516111993|FG001|Overall Study|Protocol Violation|1|||
143155045|NCT02384460|516111992|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
143019342|NCT04444752|515611400|FG002|Overall Study|Withdrawal by Subject|3|||
143019343|NCT04444752|515611401|FG003|Overall Study|Withdrawal by Subject|4|||
143019344|NCT04444752|515611398|FG000|Overall Study|Protocol Violation|1|||
143019345|NCT04444752|515611399|FG001|Overall Study|Protocol Violation|1|||
143019346|NCT04444752|515611400|FG002|Overall Study|Protocol Violation|0|||
143155046|NCT02384460|516111993|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
143155047|NCT02384460|516111992|FG000|Overall Study|Adverse Event|5|||
143155048|NCT02384460|516111993|FG001|Overall Study|Adverse Event|2|||
143155049|NCT02384460|516111992|FG000|Overall Study|Withdrawal by Subject|0|||
143155050|NCT02384460|516111993|FG001|Overall Study|Withdrawal by Subject|3|||
143155051|NCT02384460|516111992|FG000|Overall Study|Elective medical treatment|1|||
143155052|NCT02384460|516111993|FG001|Overall Study|Elective medical treatment|0|||
143155053|NCT02384460|516111992|FG000|Overall Study|Non-compliance|1|||
143155054|NCT02384460|516111993|FG001|Overall Study|Non-compliance|0|||
143155055|NCT00965094|516111994|FG000|Overall Study|Adverse Event|5|||
143155056|NCT00965094|516111995|FG001|Overall Study|Adverse Event|0|||
143155057|NCT00965094|516111994|FG000|Overall Study|Lost to Follow-up|0|||
143155058|NCT00965094|516111995|FG001|Overall Study|Lost to Follow-up|1|||
143155059|NCT01060111|516111996|FG000|Overall Study|Adverse Event|9|||
143155060|NCT01060111|516111997|FG001|Overall Study|Adverse Event|5|||
143155061|NCT01060111|516111998|FG002|Overall Study|Adverse Event|18|||
143155062|NCT01060111|516111996|FG000|Overall Study|Lack of Efficacy|2|||
143155063|NCT01060111|516111997|FG001|Overall Study|Lack of Efficacy|1|||
143155064|NCT01060111|516111998|FG002|Overall Study|Lack of Efficacy|0|||
143155065|NCT01060111|516111996|FG000|Overall Study|Inappropriate participant|5|||
143155066|NCT01060111|516111997|FG001|Overall Study|Inappropriate participant|4|||
143155067|NCT01060111|516111998|FG002|Overall Study|Inappropriate participant|5|||
143155068|NCT01060111|516111996|FG000|Overall Study|Participants' evasion for hospital visit|0|||
143155069|NCT01060111|516111997|FG001|Overall Study|Participants' evasion for hospital visit|3|||
143155070|NCT01060111|516111998|FG002|Overall Study|Participants' evasion for hospital visit|2|||
143155071|NCT01060111|516111996|FG000|Overall Study|Participants' non-cooperation|8|||
143155072|NCT01060111|516111997|FG001|Overall Study|Participants' non-cooperation|6|||
143155073|NCT01060111|516111998|FG002|Overall Study|Participants' non-cooperation|6|||
143155074|NCT01060111|516111996|FG000|Overall Study|Adverse event and insufficient effect|0|||
143155075|NCT01060111|516111997|FG001|Overall Study|Adverse event and insufficient effect|1|||
143155076|NCT01060111|516111998|FG002|Overall Study|Adverse event and insufficient effect|0|||
143155077|NCT01060111|516111996|FG000|Overall Study|Participants' non-cooperation|1|||
143155078|NCT01060111|516111997|FG001|Overall Study|Participants' non-cooperation|0|||
143155079|NCT01060111|516111998|FG002|Overall Study|Participants' non-cooperation|0|||
143155080|NCT01060111|516111996|FG000|Overall Study|Other|2|||
143155081|NCT01060111|516111997|FG001|Overall Study|Other|3|||
143155082|NCT01060111|516111998|FG002|Overall Study|Other|4|||
143155083|NCT01336972|516112004|FG000|Overall Study|Adverse Event|1|||
143155084|NCT01336972|516112005|FG001|Overall Study|Adverse Event|1|||
143155085|NCT01336972|516112006|FG002|Overall Study|Adverse Event|0|||
143155086|NCT02441114|516112007|FG000|Washout2|Withdrawal by Subject|4|||
143155087|NCT03446573|516112009|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
143155088|NCT03446573|516112010|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
143155089|NCT03446573|516112009|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
143155090|NCT03446573|516112010|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
143155091|NCT03446573|516112009|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
143155092|NCT03446573|516112010|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
143155093|NCT03446573|516112009|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
143155094|NCT03446573|516112010|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
143155095|NCT03446573|516112009|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
143155096|NCT03446573|516112010|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
143155097|NCT03446573|516112009|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
143155098|NCT03446573|516112010|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
143155099|NCT03446573|516112009|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
143155100|NCT03446573|516112010|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
143155101|NCT03446573|516112009|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
143155102|NCT03446573|516112010|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
143155103|NCT03446573|516112009|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
143155104|NCT03446573|516112010|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
143155105|NCT03446573|516112009|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
143155106|NCT03446573|516112010|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
143155107|NCT03446573|516112009|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
143155108|NCT03446573|516112010|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
143155109|NCT03446573|516112009|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
143155110|NCT03446573|516112010|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
143155111|NCT03446573|516112009|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
143155112|NCT03446573|516112010|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
143155113|NCT00625378|516112015|FG000|Overall Study|Adverse Event|22|||
143155114|NCT00625378|516112016|FG001|Overall Study|Adverse Event|0|||
143155115|NCT00625378|516112015|FG000|Overall Study|Withdrawal by Subject|16|||
143155116|NCT00625378|516112016|FG001|Overall Study|Withdrawal by Subject|0|||
143155117|NCT00625378|516112015|FG000|Overall Study|Death|38|||
143155118|NCT00625378|516112016|FG001|Overall Study|Death|0|||
143155119|NCT00625378|516112015|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
143155120|NCT00625378|516112016|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
143155121|NCT00625378|516112015|FG000|Overall Study|Lost to Follow-up|17|||
143155122|NCT00625378|516112016|FG001|Overall Study|Lost to Follow-up|0|||
143155123|NCT00625378|516112015|FG000|Overall Study|Non-compliant with study medication|3|||
143155124|NCT00625378|516112016|FG001|Overall Study|Non-compliant with study medication|0|||
143155125|NCT00625378|516112015|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
143019347|NCT04444752|515611401|FG003|Overall Study|Protocol Violation|0|||
143019348|NCT04444752|515611398|FG000|Overall Study|Patient moving out of town|1|||
143019349|NCT04444752|515611399|FG001|Overall Study|Patient moving out of town|0|||
143019350|NCT04444752|515611400|FG002|Overall Study|Patient moving out of town|0|||
143019351|NCT04444752|515611401|FG003|Overall Study|Patient moving out of town|1|||
143019352|NCT04444752|515611398|FG000|Overall Study|Lack of Efficacy|0|||
143019353|NCT04444752|515611399|FG001|Overall Study|Lack of Efficacy|0|||
143019354|NCT04444752|515611400|FG002|Overall Study|Lack of Efficacy|0|||
143019355|NCT04444752|515611401|FG003|Overall Study|Lack of Efficacy|1|||
143019356|NCT04444752|515611398|FG000|Overall Study|Death|0|||
143019357|NCT04444752|515611399|FG001|Overall Study|Death|0|||
143019358|NCT04444752|515611400|FG002|Overall Study|Death|1|||
143019359|NCT04444752|515611401|FG003|Overall Study|Death|0|||
143019360|NCT00579254|515611402|FG000|Overall Study|Lost to Follow-up|39|||
143019361|NCT00579254|515611402|FG000|Overall Study|Discontinued when study terminated|73|||
143019362|NCT02557672|515611403|FG000|Overall Study|Withdrawal by Subject|4|||
143019363|NCT02557672|515611404|FG001|Overall Study|Withdrawal by Subject|2|||
143019364|NCT01165242|515613219|FG000|Overall Study|Unreachable Subjects|1|||
143019365|NCT01165242|515613220|FG001|Overall Study|Unreachable Subjects|0|||
143019366|NCT01165242|515613221|FG002|Overall Study|Unreachable Subjects|0|||
143019367|NCT01165242|515613219|FG000|Overall Study|Incarcerated Subjects|0|||
143019368|NCT01165242|515613220|FG001|Overall Study|Incarcerated Subjects|1|||
143019369|NCT01165242|515613221|FG002|Overall Study|Incarcerated Subjects|0|||
143019370|NCT01165242|515613219|FG000|Overall Study|Visit 2 Declined by Subject|0|||
143019371|NCT01165242|515613220|FG001|Overall Study|Visit 2 Declined by Subject|0|||
143019372|NCT01165242|515613221|FG002|Overall Study|Visit 2 Declined by Subject|1|||
143019373|NCT01165242|515613219|FG000|Overall Study|Withdrawal by Subject|0|||
143019374|NCT01165242|515613220|FG001|Overall Study|Withdrawal by Subject|2|||
143019375|NCT01165242|515613221|FG002|Overall Study|Withdrawal by Subject|2|||
143019376|NCT01165242|515613219|FG000|Overall Study|Extended Holiday|0|||
143019377|NCT01165242|515613220|FG001|Overall Study|Extended Holiday|0|||
143019378|NCT01165242|515613221|FG002|Overall Study|Extended Holiday|1|||
143019379|NCT01165242|515613219|FG000|Overall Study|Lost to Follow-up|9|||
143019380|NCT01165242|515613220|FG001|Overall Study|Lost to Follow-up|7|||
143019381|NCT01165242|515613221|FG002|Overall Study|Lost to Follow-up|10|||
143019382|NCT03877237|515613222|FG000|Overall Study|Adverse Event|1|||
143019383|NCT03877237|515613223|FG001|Overall Study|Adverse Event|2|||
143019384|NCT03877237|515613222|FG000|Overall Study|Death|3|||
143019385|NCT03877237|515613223|FG001|Overall Study|Death|2|||
143019386|NCT03877237|515613222|FG000|Overall Study|Physician Decision|1|||
143019387|NCT03877237|515613223|FG001|Overall Study|Physician Decision|0|||
143019388|NCT03877237|515613222|FG000|Overall Study|Withdrawal by Subject|0|||
143019389|NCT03877237|515613223|FG001|Overall Study|Withdrawal by Subject|2|||
143019390|NCT03372083|515613225|FG000|Overall Study|Adverse Event|3|||
143019391|NCT03372083|515613225|FG000|Overall Study|Physician Decision|1|||
143019392|NCT03372083|515613225|FG000|Overall Study|Withdrawal by Subject|1|||
143019393|NCT00566098|515613227|FG000|Collection of MILs|Withdrawal by Subject|1|||
143019394|NCT00566098|515613227|FG000|Collection of MILs|Relapsed|1|||
143019395|NCT00566098|515613227|FG000|Generation of MILs Product|Relapsed|1|||
143019396|NCT00566098|515613227|FG000|Administration of ASCT+MILs|Death|10|||
143019397|NCT00566098|515613227|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
143019398|NCT02236754|515613228|FG000|Overall Study|Withdrawal by Subject|1|||
143019399|NCT02236754|515613229|FG001|Overall Study|Withdrawal by Subject|0|||
143019400|NCT02266706|515613230|FG000|Overall Study|Withdrawal by Subject|0|||
143019401|NCT02266706|515613231|FG001|Overall Study|Withdrawal by Subject|1|||
143019402|NCT02266706|515613232|FG002|Overall Study|Withdrawal by Subject|1|||
143019403|NCT02266706|515613233|FG003|Overall Study|Withdrawal by Subject|0|||
143019404|NCT02266706|515613234|FG004|Overall Study|Withdrawal by Subject|0|||
143155126|NCT00625378|516112016|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
143363696|NCT00062868|516873787|FG007|Dose Level 3|Withdrew|0|||
143363697|NCT00062868|516873788|FG008|Dose Level 3|Withdrew|0|||
143363698|NCT00062868|516873789|FG009|Dose Level 3|Withdrew|0|||
143019405|NCT02266706|515613235|FG005|Overall Study|Withdrawal by Subject|1|||
143019406|NCT02266706|515613236|FG006|Overall Study|Withdrawal by Subject|0|||
143019407|NCT02266706|515613237|FG007|Overall Study|Withdrawal by Subject|0|||
143019408|NCT02266706|515613238|FG008|Overall Study|Withdrawal by Subject|0|||
143019409|NCT02266706|515613230|FG000|Overall Study|Screen failure|0|||
143019410|NCT02266706|515613231|FG001|Overall Study|Screen failure|0|||
143019411|NCT02266706|515613232|FG002|Overall Study|Screen failure|0|||
143019412|NCT02266706|515613233|FG003|Overall Study|Screen failure|0|||
143019413|NCT02266706|515613234|FG004|Overall Study|Screen failure|0|||
143019414|NCT02266706|515613235|FG005|Overall Study|Screen failure|1|||
143019415|NCT02266706|515613236|FG006|Overall Study|Screen failure|1|||
143019416|NCT02266706|515613237|FG007|Overall Study|Screen failure|0|||
143019417|NCT02266706|515613238|FG008|Overall Study|Screen failure|0|||
143019418|NCT02266706|515613230|FG000|Overall Study|Enrollment in another study|0|||
143019419|NCT02266706|515613231|FG001|Overall Study|Enrollment in another study|0|||
143363699|NCT00062868|516873790|FG010|Dose Level 3|Withdrew|0|||
143485564|NCT03605680|517322857|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
143485565|NCT03605680|517322858|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
143485566|NCT03605680|517322859|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
143485567|NCT03605680|517322856|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
143485568|NCT03605680|517322857|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
143485569|NCT03605680|517322858|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
143485570|NCT03605680|517322859|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
143485571|NCT03605680|517322856|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
143485572|NCT03605680|517322857|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
143485573|NCT03605680|517322858|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
143155127|NCT00625378|516112015|FG000|Overall Study|Medical decision|1|||
143155128|NCT00625378|516112016|FG001|Overall Study|Medical decision|0|||
143155129|NCT00625378|516112015|FG000|Overall Study|Multiple toxicities|1|||
143155130|NCT00625378|516112016|FG001|Overall Study|Multiple toxicities|0|||
143155131|NCT00625378|516112015|FG000|Overall Study|New cancer|1|||
143155132|NCT00625378|516112016|FG001|Overall Study|New cancer|0|||
143155133|NCT00625378|516112015|FG000|Overall Study|PTA program|2|||
143155134|NCT00625378|516112016|FG001|Overall Study|PTA program|0|||
143155135|NCT00625378|516112015|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
143155136|NCT00625378|516112016|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
143155137|NCT00625378|516112015|FG000|Overall Study|Sponsor decision|1|||
143155138|NCT00625378|516112016|FG001|Overall Study|Sponsor decision|0|||
143155139|NCT00625378|516112015|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
143155140|NCT00625378|516112016|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
143155141|NCT00625378|516112015|FG000|Overall Study|Switch to commercial drug|6|||
143155142|NCT00625378|516112016|FG001|Overall Study|Switch to commercial drug|1|||
143155143|NCT00625378|516112015|FG000|Overall Study|Missing|2|||
143155144|NCT00625378|516112016|FG001|Overall Study|Missing|0|||
143155145|NCT00625378|516112015|FG000|Overall Study|End of treatment not available|2|||
143155146|NCT00625378|516112016|FG001|Overall Study|End of treatment not available|0|||
143155147|NCT00625378|516112015|FG000|Overall Study|Never treated|2|||
143155148|NCT00625378|516112016|FG001|Overall Study|Never treated|0|||
143155149|NCT04270760|516112017|FG000|Overall Study|Withdrawal by Subject|0|||
143155150|NCT04270760|516112018|FG001|Overall Study|Withdrawal by Subject|1|||
143155151|NCT04270760|516112019|FG002|Overall Study|Withdrawal by Subject|3|||
143155152|NCT04270760|516112020|FG003|Overall Study|Withdrawal by Subject|0|||
143155153|NCT04270760|516112021|FG004|Overall Study|Withdrawal by Subject|0|||
143155154|NCT04270760|516112017|FG000|Overall Study|Lost to Follow-up|1|||
143155155|NCT04270760|516112018|FG001|Overall Study|Lost to Follow-up|2|||
143155156|NCT04270760|516112019|FG002|Overall Study|Lost to Follow-up|1|||
143155157|NCT04270760|516112020|FG003|Overall Study|Lost to Follow-up|0|||
143155158|NCT04270760|516112021|FG004|Overall Study|Lost to Follow-up|0|||
143155159|NCT04270760|516112017|FG000|Overall Study|Death|0|||
143155160|NCT04270760|516112018|FG001|Overall Study|Death|0|||
143155161|NCT04270760|516112019|FG002|Overall Study|Death|0|||
143155162|NCT04270760|516112020|FG003|Overall Study|Death|0|||
143155163|NCT04270760|516112021|FG004|Overall Study|Death|1|||
143155164|NCT02448043|516112024|FG000|Overall Study|Withdrawal by Subject|2|||
143155165|NCT02448043|516112025|FG001|Overall Study|Withdrawal by Subject|2|||
143155166|NCT02448043|516112024|FG000|Overall Study|Protocol Violation|1|||
143155167|NCT02448043|516112025|FG001|Overall Study|Protocol Violation|2|||
143155168|NCT00827242|516112027|FG000|Overall Study|Withdrawal by Subject|2|||
143155169|NCT00827242|516112028|FG001|Overall Study|Withdrawal by Subject|4|||
143155170|NCT00827242|516112027|FG000|Overall Study|Protocol Violation|1|||
143155171|NCT00827242|516112028|FG001|Overall Study|Protocol Violation|3|||
143155172|NCT00827242|516112027|FG000|Overall Study|Lost to Follow-up|0|||
143155173|NCT00827242|516112028|FG001|Overall Study|Lost to Follow-up|3|||
143155174|NCT00827242|516112027|FG000|Overall Study|Adverse Event Excluding Death|2|||
143155175|NCT00827242|516112028|FG001|Overall Study|Adverse Event Excluding Death|1|||
143155176|NCT00827242|516112027|FG000|Overall Study|Entry Criteria Not Met|4|||
143485574|NCT03605680|517322859|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
143485575|NCT03605680|517322856|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
143155177|NCT00827242|516112028|FG001|Overall Study|Entry Criteria Not Met|1|||
143155178|NCT00827242|516112027|FG000|Overall Study|Physician Decision|2|||
143155179|NCT00827242|516112028|FG001|Overall Study|Physician Decision|0|||
143155180|NCT00827242|516112027|FG000|Overall Study|Death|1|||
143155181|NCT00827242|516112028|FG001|Overall Study|Death|0|||
143155182|NCT00827242|516112027|FG000|Overall Study|Lack of Efficacy|1|||
143155183|NCT00827242|516112028|FG001|Overall Study|Lack of Efficacy|0|||
143155184|NCT04790201|516112033|FG000|Overall Study|Lost to Follow-up|0|||
143155185|NCT04790201|516112034|FG001|Overall Study|Lost to Follow-up|0|||
143155186|NCT04790201|516112035|FG002|Overall Study|Lost to Follow-up|2|||
143155187|NCT04790201|516112033|FG000|Overall Study|Death|0|||
143155188|NCT04790201|516112034|FG001|Overall Study|Death|1|||
143155189|NCT04790201|516112035|FG002|Overall Study|Death|0|||
143155190|NCT04790201|516112033|FG000|Overall Study|Protocol Violation|1|||
143019420|NCT02266706|515613232|FG002|Overall Study|Enrollment in another study|0|||
143019421|NCT02266706|515613233|FG003|Overall Study|Enrollment in another study|1|||
143019422|NCT02266706|515613234|FG004|Overall Study|Enrollment in another study|0|||
143019423|NCT02266706|515613235|FG005|Overall Study|Enrollment in another study|0|||
143019424|NCT02266706|515613236|FG006|Overall Study|Enrollment in another study|0|||
143019425|NCT02266706|515613237|FG007|Overall Study|Enrollment in another study|0|||
143019426|NCT02266706|515613238|FG008|Overall Study|Enrollment in another study|0|||
143019427|NCT02544633|515613239|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
143019428|NCT02544633|515613240|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
143019429|NCT02544633|515613241|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
143019430|NCT02544633|515613242|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
143019431|NCT02544633|515613239|FG000|Treatment Period|Adverse Event|7|||
143019432|NCT02544633|515613240|FG001|Treatment Period|Adverse Event|4|||
143019433|NCT02544633|515613241|FG002|Treatment Period|Adverse Event|0|||
143019434|NCT02544633|515613242|FG003|Treatment Period|Adverse Event|5|||
143019435|NCT02544633|515613239|FG000|Treatment Period|Lack of Efficacy|17|||
143019436|NCT02544633|515613240|FG001|Treatment Period|Lack of Efficacy|11|||
143019437|NCT02544633|515613241|FG002|Treatment Period|Lack of Efficacy|5|||
143019438|NCT02544633|515613242|FG003|Treatment Period|Lack of Efficacy|5|||
143019439|NCT02544633|515613239|FG000|Treatment Period|Global Deterioration of Health|3|||
143019440|NCT02544633|515613240|FG001|Treatment Period|Global Deterioration of Health|3|||
143019441|NCT02544633|515613241|FG002|Treatment Period|Global Deterioration of Health|0|||
143019442|NCT02544633|515613242|FG003|Treatment Period|Global Deterioration of Health|1|||
143019443|NCT02544633|515613239|FG000|Treatment Period|Withdrawal by Subject|1|||
143019444|NCT02544633|515613240|FG001|Treatment Period|Withdrawal by Subject|0|||
143019445|NCT02544633|515613241|FG002|Treatment Period|Withdrawal by Subject|0|||
143019446|NCT02544633|515613242|FG003|Treatment Period|Withdrawal by Subject|0|||
143019447|NCT02544633|515613239|FG000|Treatment Period|Lost to Follow-up|0|||
143019448|NCT02544633|515613240|FG001|Treatment Period|Lost to Follow-up|1|||
143155191|NCT04790201|516112034|FG001|Overall Study|Protocol Violation|0|||
143155192|NCT04790201|516112035|FG002|Overall Study|Protocol Violation|1|||
143155193|NCT02609633|516112036|FG000|Overall Study|Consent Withdrawn|0|||
143155194|NCT02609633|516112037|FG001|Overall Study|Consent Withdrawn|1|||
143155195|NCT02609633|516112036|FG000|Overall Study|Protocol Deviation|1|||
143155196|NCT02609633|516112037|FG001|Overall Study|Protocol Deviation|0|||
143155197|NCT02609633|516112036|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
143155198|NCT02609633|516112037|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
143155199|NCT02609633|516112036|FG000|Overall Study|Reason not Specified|2|||
143155200|NCT02609633|516112037|FG001|Overall Study|Reason not Specified|1|||
143155201|NCT05762679|516112040|FG000|Overall Study|Withdrawal by Subject|1|||
143155202|NCT05762679|516112040|FG000|Overall Study|No analyzable imaging data|1|||
143155203|NCT00997126|516112041|FG000|Overall Study|Physician Decision|7|||
143019449|NCT02544633|515613241|FG002|Treatment Period|Lost to Follow-up|0|||
143019450|NCT02544633|515613242|FG003|Treatment Period|Lost to Follow-up|0|||
143019451|NCT02544633|515613239|FG000|Treatment Period|Death|0|||
143019452|NCT02544633|515613240|FG001|Treatment Period|Death|0|||
143019453|NCT02544633|515613241|FG002|Treatment Period|Death|1|||
143019454|NCT02544633|515613242|FG003|Treatment Period|Death|0|||
143019455|NCT02544633|515613239|FG000|Treatment Period|Non-compliance|0|||
143019456|NCT02544633|515613240|FG001|Treatment Period|Non-compliance|0|||
143019457|NCT02544633|515613241|FG002|Treatment Period|Non-compliance|1|||
143019458|NCT02544633|515613242|FG003|Treatment Period|Non-compliance|0|||
143019459|NCT02544633|515613239|FG000|Treatment Period|Clinical Disease Progression|0|||
143019460|NCT02544633|515613240|FG001|Treatment Period|Clinical Disease Progression|0|||
143019461|NCT02544633|515613241|FG002|Treatment Period|Clinical Disease Progression|0|||
143019462|NCT02544633|515613242|FG003|Treatment Period|Clinical Disease Progression|1|||
143019463|NCT02544633|515613239|FG000|Survival Follow-up Period|Death|12|||
143019464|NCT02544633|515613240|FG001|Survival Follow-up Period|Death|14|||
143019465|NCT02544633|515613241|FG002|Survival Follow-up Period|Death|3|||
143019466|NCT02544633|515613242|FG003|Survival Follow-up Period|Death|9|||
143155204|NCT00997126|516112042|FG001|Overall Study|Physician Decision|11|||
143155205|NCT00471107|516112043|FG000|Overall Study|Technical problems/data loss|3|||
143155206|NCT00471107|516112044|FG001|Overall Study|Technical problems/data loss|1|||
143019467|NCT02544633|515613239|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
143019468|NCT02544633|515613240|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
143019469|NCT02544633|515613241|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
143019470|NCT02544633|515613242|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
143019471|NCT02544633|515613239|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
143019472|NCT02544633|515613240|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
143019473|NCT02544633|515613241|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
143019474|NCT02544633|515613242|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
143019475|NCT02544633|515613239|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
143019476|NCT02544633|515613240|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
143155207|NCT00471107|516112045|FG002|Overall Study|Technical problems/data loss|3|||
143155208|NCT01769443|516112046|FG000|Overall Study|Study closure|1|||
143155209|NCT01769443|516112047|FG001|Overall Study|Study closure|0|||
143485576|NCT03605680|517322857|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
143485577|NCT03605680|517322858|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
143019477|NCT02544633|515613241|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
143019478|NCT02544633|515613242|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
143019479|NCT01977352|515613243|FG000|Overall Study|Lost to Follow-up|1|||
143019480|NCT01977352|515613244|FG001|Overall Study|Lost to Follow-up|2|||
143019481|NCT00409188|515613245|FG000|Overall Study|Ongoing at data cut-off|383|||
143019482|NCT00409188|515613246|FG001|Overall Study|Ongoing at data cut-off|175|||
143019483|NCT02092961|515613247|FG000|Overall Study|Not reported|1|||
143019484|NCT02092961|515613248|FG001|Overall Study|Not reported|0|||
143485578|NCT03605680|517322859|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
143485579|NCT03605680|517322856|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
143485580|NCT03605680|517322857|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
143485581|NCT03605680|517322858|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
143485582|NCT03605680|517322859|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
143485583|NCT03605680|517322856|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
143019485|NCT02092961|515613249|FG002|Overall Study|Not reported|1|||
143019486|NCT02092961|515613247|FG000|Overall Study|Study stopped|13|||
143019487|NCT02092961|515613248|FG001|Overall Study|Study stopped|9|||
143019488|NCT02092961|515613249|FG002|Overall Study|Study stopped|12|||
143019489|NCT02092961|515613247|FG000|Overall Study|Lack of therapeutic response|2|||
143019490|NCT02092961|515613248|FG001|Overall Study|Lack of therapeutic response|1|||
143019491|NCT02092961|515613249|FG002|Overall Study|Lack of therapeutic response|3|||
143019492|NCT02092961|515613247|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
143019493|NCT02092961|515613248|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
143019494|NCT02092961|515613249|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
143019495|NCT02092961|515613247|FG000|Overall Study|Adverse Event|2|||
143019496|NCT02092961|515613248|FG001|Overall Study|Adverse Event|4|||
143019497|NCT02092961|515613249|FG002|Overall Study|Adverse Event|0|||
143019498|NCT02270983|515613250|FG000|Overall Study|Adverse Event|3|||
143019499|NCT02270983|515613251|FG001|Overall Study|Adverse Event|2|||
143155210|NCT01871727|516112048|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
143155211|NCT01871727|516112049|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
143155212|NCT01871727|516112050|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
143155213|NCT01871727|516112051|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
143155214|NCT01871727|516112052|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
143155215|NCT01871727|516112048|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
143155216|NCT01871727|516112049|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
143155217|NCT01871727|516112050|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
143155218|NCT01871727|516112051|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
143155219|NCT01871727|516112052|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
143155220|NCT01871727|516112048|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
143155221|NCT01871727|516112049|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
143155222|NCT01871727|516112050|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
143155223|NCT01871727|516112051|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
143155224|NCT01871727|516112052|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
143155225|NCT01871727|516112048|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
143155226|NCT01871727|516112049|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
143155227|NCT01871727|516112050|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
143155228|NCT01871727|516112051|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
143155229|NCT01871727|516112052|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
143155230|NCT01871727|516112048|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
143155231|NCT01871727|516112049|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
143155232|NCT01871727|516112050|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
143155233|NCT01871727|516112051|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
143155234|NCT01871727|516112052|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
143155235|NCT01871727|516112048|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
143155236|NCT01871727|516112049|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
143155237|NCT01871727|516112050|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
143155238|NCT01871727|516112051|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
143155239|NCT01871727|516112052|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
143155240|NCT01871727|516112048|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
143155241|NCT01871727|516112049|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
143019500|NCT02270983|515613252|FG002|Overall Study|Adverse Event|6|||
143019501|NCT02270983|515613250|FG000|Overall Study|Lack of Efficacy|2|||
143155242|NCT01871727|516112050|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
143019502|NCT02270983|515613251|FG001|Overall Study|Lack of Efficacy|1|||
143019503|NCT02270983|515613252|FG002|Overall Study|Lack of Efficacy|1|||
143019504|NCT02270983|515613250|FG000|Overall Study|Withdrawal by Subject|1|||
143155243|NCT01871727|516112051|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
143155244|NCT01871727|516112052|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
143155245|NCT02691572|516112053|FG000|Overall Study|Withdrawal by Subject|1|||
143155246|NCT02691572|516112054|FG001|Overall Study|Withdrawal by Subject|0|||
143155247|NCT02691572|516112053|FG000|Overall Study|Protocol Violation|0|||
143155248|NCT02691572|516112054|FG001|Overall Study|Protocol Violation|1|||
143155249|NCT00699751|516112055|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
143155250|NCT00699751|516112056|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
143155251|NCT00699751|516112055|FG000|Period 1: Without/Before Drug Switch|Death|28|||
143155252|NCT00699751|516112056|FG001|Period 1: Without/Before Drug Switch|Death|29|||
143155253|NCT00699751|516112055|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
143155254|NCT00699751|516112056|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
143155255|NCT00699751|516112055|FG000|Period 1: Without/Before Drug Switch|Other|30|||
143155256|NCT00699751|516112056|FG001|Period 1: Without/Before Drug Switch|Other|20|||
143155257|NCT00699751|516112055|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
143155258|NCT00699751|516112056|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
143155259|NCT00699751|516112055|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
143155260|NCT00699751|516112056|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
143155261|NCT00699751|516112055|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
143155262|NCT00699751|516112056|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
143155263|NCT00699751|516112055|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
143155264|NCT00699751|516112056|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
143155265|NCT00294398|516112057|FG000|Overall Study|Lost to Follow-up|21|||
143155266|NCT00294398|516112058|FG001|Overall Study|Lost to Follow-up|26|||
143155267|NCT01428128|516112059|FG000|Overall Study|Withdrawal by Subject|4|||
143155268|NCT01428128|516112059|FG000|Overall Study|Screen failure by p53|10|||
143155269|NCT01428128|516112059|FG000|Overall Study|Received Neulasta in one cycle|2|||
143155270|NCT01428128|516112059|FG000|Overall Study|Adverse Event|1|||
143155271|NCT05089357|516112064|FG000|Overall Study|Withdrawal by Subject|23|||
143155272|NCT05089357|516112064|FG000|Overall Study|Lost to Follow-up|6|||
143155273|NCT05089357|516112064|FG000|Overall Study|Medical reason|1|||
143155274|NCT05089357|516112064|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
143155275|NCT05089357|516112064|FG000|Overall Study|Pregnancy|2|||
143155276|NCT05537571|516112065|FG000|Overall Study|Withdrawal by Subject|1|||
143155277|NCT05537571|516112066|FG001|Overall Study|Withdrawal by Subject|1|||
143155278|NCT05537571|516112067|FG002|Overall Study|Withdrawal by Subject|0|||
143155279|NCT05537571|516112068|FG003|Overall Study|Withdrawal by Subject|0|||
143155280|NCT05537571|516112069|FG004|Overall Study|Withdrawal by Subject|0|||
143155281|NCT05537571|516112065|FG000|Overall Study|Adverse Event|2|||
143155282|NCT05537571|516112066|FG001|Overall Study|Adverse Event|0|||
143155283|NCT05537571|516112067|FG002|Overall Study|Adverse Event|0|||
143155284|NCT05537571|516112068|FG003|Overall Study|Adverse Event|0|||
143155285|NCT05537571|516112069|FG004|Overall Study|Adverse Event|0|||
143155286|NCT05537571|516112065|FG000|Overall Study|Hepatitis A screening result|2|||
143155287|NCT05537571|516112066|FG001|Overall Study|Hepatitis A screening result|0|||
143155288|NCT05537571|516112067|FG002|Overall Study|Hepatitis A screening result|0|||
143155289|NCT05537571|516112068|FG003|Overall Study|Hepatitis A screening result|0|||
143155290|NCT05537571|516112069|FG004|Overall Study|Hepatitis A screening result|0|||
143155291|NCT05537571|516112065|FG000|Overall Study|Lost to Follow-up|0|||
143155292|NCT05537571|516112066|FG001|Overall Study|Lost to Follow-up|0|||
143155293|NCT05537571|516112067|FG002|Overall Study|Lost to Follow-up|1|||
143155294|NCT05537571|516112068|FG003|Overall Study|Lost to Follow-up|0|||
143155295|NCT05537571|516112069|FG004|Overall Study|Lost to Follow-up|1|||
143155296|NCT04210375|516112070|FG000|Overall Study|Death|0|||
143155297|NCT04210375|516112071|FG001|Overall Study|Death|1|||
143155298|NCT04210375|516112072|FG002|Overall Study|Death|0|||
143155299|NCT04210375|516112073|FG003|Overall Study|Death|0|||
143155300|NCT02184156|516112074|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
143155301|NCT02184156|516112075|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
143155302|NCT02184156|516112074|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
143155303|NCT02184156|516112075|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
143485584|NCT03605680|517322857|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
143019505|NCT02270983|515613251|FG001|Overall Study|Withdrawal by Subject|0|||
143019506|NCT02270983|515613252|FG002|Overall Study|Withdrawal by Subject|2|||
143019507|NCT02270983|515613250|FG000|Overall Study|Lost to Follow-up|1|||
143155304|NCT02114684|516112082|FG000|Overall Study|Death|6|||
143155305|NCT02114684|516112083|FG001|Overall Study|Death|4|||
143155306|NCT02114684|516112082|FG000|Overall Study|Lost to Follow-up|1|||
143019508|NCT02270983|515613251|FG001|Overall Study|Lost to Follow-up|1|||
143019509|NCT02270983|515613252|FG002|Overall Study|Lost to Follow-up|2|||
143155307|NCT02114684|516112083|FG001|Overall Study|Lost to Follow-up|2|||
143155308|NCT02114684|516112082|FG000|Overall Study|Withdrawal by Subject|1|||
143155309|NCT02114684|516112083|FG001|Overall Study|Withdrawal by Subject|2|||
143155310|NCT02114684|516112082|FG000|Overall Study|Relocation|3|||
143019510|NCT02270983|515613250|FG000|Overall Study|Protocol Violation|1|||
143019511|NCT02270983|515613251|FG001|Overall Study|Protocol Violation|1|||
143019512|NCT02270983|515613252|FG002|Overall Study|Protocol Violation|1|||
143019513|NCT02270983|515613250|FG000|Overall Study|family emergency|0|||
143019514|NCT02270983|515613251|FG001|Overall Study|family emergency|1|||
143019515|NCT02270983|515613252|FG002|Overall Study|family emergency|0|||
143019516|NCT02270983|515613250|FG000|Overall Study|study procedure non-compliance|1|||
143019517|NCT02270983|515613251|FG001|Overall Study|study procedure non-compliance|0|||
143019518|NCT02270983|515613252|FG002|Overall Study|study procedure non-compliance|0|||
143019519|NCT02270983|515613250|FG000|Overall Study|moved away from study site|0|||
143019520|NCT02270983|515613251|FG001|Overall Study|moved away from study site|1|||
143019521|NCT02270983|515613252|FG002|Overall Study|moved away from study site|0|||
143019522|NCT00854620|515613261|FG000|Overall Study|Adverse Event|1|||
143019523|NCT02370784|515613263|FG000|Overall Study|Patient started prohibited medication|0|||
143019524|NCT02370784|515613264|FG001|Overall Study|Patient started prohibited medication|1|||
143019525|NCT00598559|515613265|FG000|Overall Study|Adverse Event|11|||
143019526|NCT00598559|515613266|FG001|Overall Study|Adverse Event|7|||
143019527|NCT00598559|515613267|FG002|Overall Study|Adverse Event|0|||
143019528|NCT00598559|515613265|FG000|Overall Study|Withdrawal by Subject|2|||
143019529|NCT00598559|515613266|FG001|Overall Study|Withdrawal by Subject|2|||
143019530|NCT00598559|515613267|FG002|Overall Study|Withdrawal by Subject|0|||
143019531|NCT00598559|515613265|FG000|Overall Study|Protocol Non-compliance|1|||
143019532|NCT00598559|515613266|FG001|Overall Study|Protocol Non-compliance|0|||
143019533|NCT00598559|515613267|FG002|Overall Study|Protocol Non-compliance|0|||
143019534|NCT00598559|515613265|FG000|Overall Study|Early discharge from hospital|9|||
143019535|NCT00598559|515613266|FG001|Overall Study|Early discharge from hospital|12|||
143019536|NCT00598559|515613267|FG002|Overall Study|Early discharge from hospital|3|||
143019537|NCT00598559|515613265|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
143019538|NCT00598559|515613266|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
143019539|NCT00598559|515613267|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
143019540|NCT01059071|515613268|FG000|Overall Study|Lack of Efficacy|1|||
143019541|NCT01059071|515613269|FG001|Overall Study|Lack of Efficacy|4|||
143019542|NCT01059071|515613270|FG002|Overall Study|Lack of Efficacy|2|||
143019543|NCT01059071|515613271|FG003|Overall Study|Lack of Efficacy|3|||
143019544|NCT01059071|515613268|FG000|Overall Study|Withdrawal by Subject|1|||
143019545|NCT01059071|515613269|FG001|Overall Study|Withdrawal by Subject|0|||
143019546|NCT01059071|515613270|FG002|Overall Study|Withdrawal by Subject|0|||
143019547|NCT01059071|515613271|FG003|Overall Study|Withdrawal by Subject|2|||
143019548|NCT01059071|515613268|FG000|Overall Study|Physician Decision|0|||
143019549|NCT01059071|515613269|FG001|Overall Study|Physician Decision|0|||
143019550|NCT01059071|515613270|FG002|Overall Study|Physician Decision|0|||
143019551|NCT01059071|515613271|FG003|Overall Study|Physician Decision|1|||
143019552|NCT03763331|515613276|FG000|Overall Study|Lost to Follow-up|1|||
143019553|NCT03763331|515613277|FG001|Overall Study|Lost to Follow-up|0|||
143019554|NCT03763331|515613276|FG000|Overall Study|Withdrawal by Subject|1|||
143019555|NCT03763331|515613277|FG001|Overall Study|Withdrawal by Subject|0|||
143019556|NCT03763331|515613276|FG000|Overall Study|Non-compliance|0|||
143019557|NCT03763331|515613277|FG001|Overall Study|Non-compliance|3|||
143019558|NCT04741503|515613278|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
143019559|NCT04741503|515613279|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
143019560|NCT04741503|515613280|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
143019561|NCT04741503|515613278|FG000|Initial Enrollment|Overquotas removed|0|||
143019562|NCT04741503|515613279|FG001|Initial Enrollment|Overquotas removed|0|||
143019563|NCT04741503|515613280|FG002|Initial Enrollment|Overquotas removed|186|||
143019564|NCT04741503|515613278|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
143019565|NCT04741503|515613279|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
143019566|NCT04741503|515613280|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
143019567|NCT02280421|515613281|FG000|Washout (2 Weeks)|Adverse Event|0|||
143019568|NCT02280421|515613282|FG001|Washout (2 Weeks)|Adverse Event|1|||
143019569|NCT02280421|515613281|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
143019570|NCT02280421|515613282|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
143019571|NCT00515073|515613283|FG000|Overall Study|Withdrawal by Subject|1|||
143019572|NCT00515073|515613283|FG000|Overall Study|Physician Decision|1|||
143019573|NCT02791659|515613284|FG000|Overall Study|Protocol Violation|0|||
143019574|NCT02791659|515613285|FG001|Overall Study|Protocol Violation|1|||
143019575|NCT01625845|515613286|FG000|Overall Study|Adverse Event|1|||
143019576|NCT01625845|515613287|FG001|Overall Study|Adverse Event|2|||
143019577|NCT01625845|515613286|FG000|Overall Study|Lost to Follow-up|2|||
143019578|NCT01625845|515613287|FG001|Overall Study|Lost to Follow-up|1|||
143019579|NCT01625845|515613286|FG000|Overall Study|Withdrawal by Subject|2|||
143019580|NCT01625845|515613287|FG001|Overall Study|Withdrawal by Subject|0|||
143019581|NCT02762565|515613288|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
143019582|NCT00623623|515613289|FG000|Overall Study|Previous enrolment into this study|1|||
143155311|NCT02114684|516112083|FG001|Overall Study|Relocation|1|||
143155312|NCT02114684|516112082|FG000|Overall Study|Rifampicin resistant on culture|0|||
143155313|NCT02114684|516112083|FG001|Overall Study|Rifampicin resistant on culture|1|||
143155314|NCT02114684|516112082|FG000|Overall Study|Patient Incarcerated|1|||
143155315|NCT02114684|516112083|FG001|Overall Study|Patient Incarcerated|0|||
143155316|NCT00283959|516112084|FG000|Extension Period|Low Compliance|1|||
143155317|NCT03828383|516112089|FG000|Overall Study|Lost to Follow-up|3|||
143155318|NCT03828383|516112090|FG001|Overall Study|Lost to Follow-up|2|||
143155319|NCT03828383|516112089|FG000|Overall Study|Withdrawal by Subject|4|||
143155320|NCT03828383|516112090|FG001|Overall Study|Withdrawal by Subject|5|||
143155321|NCT00504309|516112091|FG000|Overall Study|Death|0|||
143155322|NCT00504309|516112092|FG001|Overall Study|Death|0|||
143155323|NCT00504309|516112093|FG002|Overall Study|Death|0|||
143155324|NCT00504309|516112094|FG003|Overall Study|Death|0|||
143155325|NCT00504309|516112095|FG004|Overall Study|Death|1|||
143155326|NCT00504309|516112096|FG005|Overall Study|Death|0|||
143155327|NCT00504309|516112091|FG000|Overall Study|Withdrawal by Subject|0|||
143155328|NCT00504309|516112092|FG001|Overall Study|Withdrawal by Subject|0|||
143155329|NCT00504309|516112093|FG002|Overall Study|Withdrawal by Subject|1|||
143155330|NCT00504309|516112094|FG003|Overall Study|Withdrawal by Subject|0|||
143155331|NCT00504309|516112095|FG004|Overall Study|Withdrawal by Subject|0|||
143155332|NCT00504309|516112096|FG005|Overall Study|Withdrawal by Subject|0|||
143155333|NCT03158311|516112098|FG000|Overall Study|Subject/Guardian Decision|10|||
143155334|NCT03158311|516112099|FG001|Overall Study|Subject/Guardian Decision|6|||
143155335|NCT03158311|516112100|FG002|Overall Study|Subject/Guardian Decision|11|||
143155336|NCT03158311|516112098|FG000|Overall Study|Adverse Event|5|||
143155337|NCT03158311|516112099|FG001|Overall Study|Adverse Event|3|||
143155338|NCT03158311|516112100|FG002|Overall Study|Adverse Event|3|||
143155339|NCT03158311|516112098|FG000|Overall Study|Techinical Problems|3|||
143155340|NCT03158311|516112099|FG001|Overall Study|Techinical Problems|1|||
143155341|NCT03158311|516112100|FG002|Overall Study|Techinical Problems|5|||
143155342|NCT03158311|516112098|FG000|Overall Study|Physician Decision|2|||
143155343|NCT03158311|516112099|FG001|Overall Study|Physician Decision|3|||
143155344|NCT03158311|516112100|FG002|Overall Study|Physician Decision|7|||
143155345|NCT03158311|516112098|FG000|Overall Study|Lost to Follow-up|1|||
143155346|NCT03158311|516112099|FG001|Overall Study|Lost to Follow-up|1|||
143155347|NCT03158311|516112100|FG002|Overall Study|Lost to Follow-up|1|||
143155348|NCT03158311|516112098|FG000|Overall Study|Sponsor decision|1|||
143155349|NCT03158311|516112099|FG001|Overall Study|Sponsor decision|0|||
143155350|NCT03158311|516112100|FG002|Overall Study|Sponsor decision|0|||
143155351|NCT03158311|516112098|FG000|Overall Study|Pregnancy|0|||
143155352|NCT03158311|516112099|FG001|Overall Study|Pregnancy|2|||
143155353|NCT03158311|516112100|FG002|Overall Study|Pregnancy|0|||
143155354|NCT03158311|516112098|FG000|Overall Study|Randomized in error|0|||
143155355|NCT03158311|516112099|FG001|Overall Study|Randomized in error|0|||
143155356|NCT03158311|516112100|FG002|Overall Study|Randomized in error|1|||
143155357|NCT02665455|516112101|FG000|Overall Study|Withdrawal by Subject|6|||
143155358|NCT02665455|516112101|FG000|Overall Study|Lost to Follow-up|1|||
143155359|NCT02665455|516112101|FG000|Overall Study|Adverse Event|1|||
143155360|NCT02665455|516112101|FG000|Overall Study|Protocol Violation|1|||
143155361|NCT01186419|516112102|FG000|Overall Study|Withdrawal by Subject|5|||
143155362|NCT01186419|516112103|FG001|Overall Study|Withdrawal by Subject|3|||
143155363|NCT01186419|516112102|FG000|Overall Study|Adverse Event|1|||
143155364|NCT01186419|516112103|FG001|Overall Study|Adverse Event|2|||
143155365|NCT01186419|516112102|FG000|Overall Study|Physician Decision|0|||
143155366|NCT01186419|516112103|FG001|Overall Study|Physician Decision|3|||
143155367|NCT01186419|516112102|FG000|Overall Study|Other|1|||
143155368|NCT01186419|516112103|FG001|Overall Study|Other|1|||
143155369|NCT00567580|516113950|FG000|Overall Study|Protocol Violation|28|||
143155370|NCT00567580|516113951|FG001|Overall Study|Protocol Violation|24|||
143155371|NCT00567580|516113952|FG002|Overall Study|Protocol Violation|24|||
143155372|NCT00884949|516113954|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
143155373|NCT00884949|516113954|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
143155374|NCT03022630|516113955|FG000|Overall Study|Death|9|||
143155375|NCT03022630|516113956|FG001|Overall Study|Death|7|||
143155376|NCT03022630|516113955|FG000|Overall Study|Withdrawal by Subject|0|||
143155377|NCT03022630|516113956|FG001|Overall Study|Withdrawal by Subject|5|||
143155378|NCT01734928|516113957|FG000|Randomization|Physician Decision|0|||
143155379|NCT01734928|516113958|FG001|Randomization|Physician Decision|1|||
143155380|NCT01734928|516113957|FG000|Randomization|clinical progression|0|||
143155381|NCT01734928|516113958|FG001|Randomization|clinical progression|1|||
143155382|NCT01734928|516113957|FG000|Randomization|progressive disease|0|||
143155383|NCT01734928|516113958|FG001|Randomization|progressive disease|2|||
143155384|NCT01734928|516113957|FG000|Randomization|Withdrew informed consent|0|||
143155385|NCT01734928|516113958|FG001|Randomization|Withdrew informed consent|4|||
143155386|NCT01734928|516113957|FG000|Randomization|Death|1|||
143155387|NCT01734928|516113958|FG001|Randomization|Death|0|||
143155388|NCT01734928|516113957|FG000|Randomization|Randomization error|1|||
143155389|NCT01734928|516113958|FG001|Randomization|Randomization error|0|||
143155390|NCT01734928|516113957|FG000|Randomization|Lost to Follow-up|1|||
143019583|NCT00623623|515613290|FG001|Overall Study|Previous enrolment into this study|1|||
143019584|NCT01078623|515613291|FG000|Treatment Period 1|Adverse Event|1|||
143019585|NCT01078623|515613292|FG001|Treatment Period 1|Adverse Event|1|||
143019586|NCT01078623|515613293|FG002|Treatment Period 1|Adverse Event|1|||
143019587|NCT01078623|515613294|FG003|Treatment Period 1|Adverse Event|0|||
143019588|NCT01078623|515613295|FG004|Treatment Period 1|Adverse Event|0|||
143019589|NCT01078623|515613296|FG005|Treatment Period 1|Adverse Event|0|||
143019590|NCT01078623|515613297|FG006|Treatment Period 1|Adverse Event|1|||
143019591|NCT01078623|515613298|FG007|Treatment Period 1|Adverse Event|0|||
143019592|NCT01078623|515613299|FG008|Treatment Period 1|Adverse Event|1|||
143019593|NCT01078623|515613300|FG009|Treatment Period 1|Adverse Event|1|||
143019594|NCT01078623|515613301|FG010|Treatment Period 1|Adverse Event|0|||
143019595|NCT01078623|515613302|FG011|Treatment Period 1|Adverse Event|0|||
143019596|NCT01078623|515613303|FG012|Treatment Period 1|Adverse Event|0|||
143019597|NCT01078623|515613304|FG013|Treatment Period 1|Adverse Event|0|||
143019598|NCT01078623|515613305|FG014|Treatment Period 1|Adverse Event|0|||
143019599|NCT01078623|515613306|FG015|Treatment Period 1|Adverse Event|0|||
143019600|NCT01078623|515613307|FG016|Treatment Period 1|Adverse Event|0|||
143019601|NCT01078623|515613308|FG017|Treatment Period 1|Adverse Event|0|||
143019602|NCT01078623|515613309|FG018|Treatment Period 1|Adverse Event|0|||
143019603|NCT01078623|515613310|FG019|Treatment Period 1|Adverse Event|0|||
143019604|NCT01078623|515613291|FG000|Treatment Period 1|Withdrawal by Subject|0|||
143019605|NCT01078623|515613292|FG001|Treatment Period 1|Withdrawal by Subject|0|||
143019606|NCT01078623|515613293|FG002|Treatment Period 1|Withdrawal by Subject|0|||
143019607|NCT01078623|515613294|FG003|Treatment Period 1|Withdrawal by Subject|0|||
143019608|NCT01078623|515613295|FG004|Treatment Period 1|Withdrawal by Subject|0|||
143019609|NCT01078623|515613296|FG005|Treatment Period 1|Withdrawal by Subject|0|||
143019610|NCT01078623|515613297|FG006|Treatment Period 1|Withdrawal by Subject|0|||
143019611|NCT01078623|515613298|FG007|Treatment Period 1|Withdrawal by Subject|1|||
143019612|NCT01078623|515613299|FG008|Treatment Period 1|Withdrawal by Subject|0|||
143019613|NCT01078623|515613300|FG009|Treatment Period 1|Withdrawal by Subject|0|||
143019614|NCT01078623|515613301|FG010|Treatment Period 1|Withdrawal by Subject|1|||
143019615|NCT01078623|515613302|FG011|Treatment Period 1|Withdrawal by Subject|0|||
143019616|NCT01078623|515613303|FG012|Treatment Period 1|Withdrawal by Subject|0|||
143019617|NCT01078623|515613304|FG013|Treatment Period 1|Withdrawal by Subject|0|||
143019618|NCT01078623|515613305|FG014|Treatment Period 1|Withdrawal by Subject|0|||
143019619|NCT01078623|515613306|FG015|Treatment Period 1|Withdrawal by Subject|0|||
143019620|NCT01078623|515613307|FG016|Treatment Period 1|Withdrawal by Subject|0|||
143019621|NCT01078623|515613308|FG017|Treatment Period 1|Withdrawal by Subject|0|||
143019622|NCT01078623|515613309|FG018|Treatment Period 1|Withdrawal by Subject|0|||
143019623|NCT01078623|515613310|FG019|Treatment Period 1|Withdrawal by Subject|0|||
143019624|NCT01078623|515613291|FG000|Treatment Period 1|Protocol Violation|0|||
143019625|NCT01078623|515613292|FG001|Treatment Period 1|Protocol Violation|0|||
143019626|NCT01078623|515613293|FG002|Treatment Period 1|Protocol Violation|0|||
143019627|NCT01078623|515613294|FG003|Treatment Period 1|Protocol Violation|0|||
143019628|NCT01078623|515613295|FG004|Treatment Period 1|Protocol Violation|0|||
143019629|NCT01078623|515613296|FG005|Treatment Period 1|Protocol Violation|1|||
143019630|NCT01078623|515613297|FG006|Treatment Period 1|Protocol Violation|0|||
143019631|NCT01078623|515613298|FG007|Treatment Period 1|Protocol Violation|0|||
143019632|NCT01078623|515613299|FG008|Treatment Period 1|Protocol Violation|0|||
143019633|NCT01078623|515613300|FG009|Treatment Period 1|Protocol Violation|0|||
143019634|NCT01078623|515613301|FG010|Treatment Period 1|Protocol Violation|0|||
143019635|NCT01078623|515613302|FG011|Treatment Period 1|Protocol Violation|0|||
143019636|NCT01078623|515613303|FG012|Treatment Period 1|Protocol Violation|0|||
143019637|NCT01078623|515613304|FG013|Treatment Period 1|Protocol Violation|0|||
143019638|NCT01078623|515613305|FG014|Treatment Period 1|Protocol Violation|0|||
143019639|NCT01078623|515613306|FG015|Treatment Period 1|Protocol Violation|0|||
143019640|NCT01078623|515613307|FG016|Treatment Period 1|Protocol Violation|0|||
143019641|NCT01078623|515613308|FG017|Treatment Period 1|Protocol Violation|0|||
143019642|NCT01078623|515613309|FG018|Treatment Period 1|Protocol Violation|0|||
143019643|NCT01078623|515613310|FG019|Treatment Period 1|Protocol Violation|0|||
143019644|NCT01078623|515613291|FG000|Treatment Period 2|Adverse Event|0|||
143019645|NCT01078623|515613292|FG001|Treatment Period 2|Adverse Event|0|||
143019646|NCT01078623|515613293|FG002|Treatment Period 2|Adverse Event|0|||
143019647|NCT01078623|515613294|FG003|Treatment Period 2|Adverse Event|0|||
143019648|NCT01078623|515613295|FG004|Treatment Period 2|Adverse Event|0|||
143019649|NCT01078623|515613296|FG005|Treatment Period 2|Adverse Event|0|||
143019650|NCT01078623|515613297|FG006|Treatment Period 2|Adverse Event|1|||
143019651|NCT01078623|515613298|FG007|Treatment Period 2|Adverse Event|0|||
143019652|NCT01078623|515613299|FG008|Treatment Period 2|Adverse Event|0|||
143019653|NCT01078623|515613300|FG009|Treatment Period 2|Adverse Event|0|||
143019654|NCT01078623|515613301|FG010|Treatment Period 2|Adverse Event|0|||
143019655|NCT01078623|515613302|FG011|Treatment Period 2|Adverse Event|0|||
143019656|NCT01078623|515613303|FG012|Treatment Period 2|Adverse Event|0|||
143019657|NCT01078623|515613304|FG013|Treatment Period 2|Adverse Event|0|||
143019658|NCT01078623|515613305|FG014|Treatment Period 2|Adverse Event|0|||
143019659|NCT01078623|515613306|FG015|Treatment Period 2|Adverse Event|0|||
143019660|NCT01078623|515613307|FG016|Treatment Period 2|Adverse Event|0|||
143019661|NCT01078623|515613308|FG017|Treatment Period 2|Adverse Event|0|||
143019662|NCT01078623|515613309|FG018|Treatment Period 2|Adverse Event|1|||
143019663|NCT01078623|515613310|FG019|Treatment Period 2|Adverse Event|0|||
143019664|NCT01078623|515613291|FG000|Treatment Period 2|Withdrawal by Subject|0|||
143019665|NCT01078623|515613292|FG001|Treatment Period 2|Withdrawal by Subject|0|||
143019666|NCT01078623|515613293|FG002|Treatment Period 2|Withdrawal by Subject|0|||
143019667|NCT01078623|515613294|FG003|Treatment Period 2|Withdrawal by Subject|0|||
143019668|NCT01078623|515613295|FG004|Treatment Period 2|Withdrawal by Subject|0|||
143019669|NCT01078623|515613296|FG005|Treatment Period 2|Withdrawal by Subject|1|||
143019670|NCT01078623|515613297|FG006|Treatment Period 2|Withdrawal by Subject|0|||
143019671|NCT01078623|515613298|FG007|Treatment Period 2|Withdrawal by Subject|0|||
143019672|NCT01078623|515613299|FG008|Treatment Period 2|Withdrawal by Subject|0|||
143019673|NCT01078623|515613300|FG009|Treatment Period 2|Withdrawal by Subject|0|||
143019674|NCT01078623|515613301|FG010|Treatment Period 2|Withdrawal by Subject|0|||
143019675|NCT01078623|515613302|FG011|Treatment Period 2|Withdrawal by Subject|0|||
143019676|NCT01078623|515613303|FG012|Treatment Period 2|Withdrawal by Subject|0|||
143019677|NCT01078623|515613304|FG013|Treatment Period 2|Withdrawal by Subject|0|||
143019678|NCT01078623|515613305|FG014|Treatment Period 2|Withdrawal by Subject|0|||
143019679|NCT01078623|515613306|FG015|Treatment Period 2|Withdrawal by Subject|0|||
143019680|NCT01078623|515613307|FG016|Treatment Period 2|Withdrawal by Subject|0|||
143019681|NCT01078623|515613308|FG017|Treatment Period 2|Withdrawal by Subject|0|||
143019682|NCT01078623|515613309|FG018|Treatment Period 2|Withdrawal by Subject|0|||
143019683|NCT01078623|515613310|FG019|Treatment Period 2|Withdrawal by Subject|0|||
143019684|NCT01078623|515613291|FG000|Treatment Period 3|Adverse Event|0|||
143019685|NCT01078623|515613292|FG001|Treatment Period 3|Adverse Event|0|||
143019686|NCT01078623|515613293|FG002|Treatment Period 3|Adverse Event|0|||
143019687|NCT01078623|515613294|FG003|Treatment Period 3|Adverse Event|0|||
143019688|NCT01078623|515613295|FG004|Treatment Period 3|Adverse Event|1|||
143019689|NCT01078623|515613296|FG005|Treatment Period 3|Adverse Event|0|||
143019690|NCT01078623|515613297|FG006|Treatment Period 3|Adverse Event|0|||
143019691|NCT01078623|515613298|FG007|Treatment Period 3|Adverse Event|0|||
143019692|NCT01078623|515613299|FG008|Treatment Period 3|Adverse Event|0|||
143019693|NCT01078623|515613300|FG009|Treatment Period 3|Adverse Event|0|||
143019694|NCT01078623|515613301|FG010|Treatment Period 3|Adverse Event|0|||
143019695|NCT01078623|515613302|FG011|Treatment Period 3|Adverse Event|0|||
143019696|NCT01078623|515613303|FG012|Treatment Period 3|Adverse Event|0|||
143019697|NCT01078623|515613304|FG013|Treatment Period 3|Adverse Event|1|||
143019698|NCT01078623|515613305|FG014|Treatment Period 3|Adverse Event|0|||
143019699|NCT01078623|515613306|FG015|Treatment Period 3|Adverse Event|0|||
143019700|NCT01078623|515613307|FG016|Treatment Period 3|Adverse Event|0|||
143155391|NCT01734928|516113958|FG001|Randomization|Lost to Follow-up|0|||
143155392|NCT01734928|516113957|FG000|Treatment Period|Lost to Follow-up|0|||
143155393|NCT01734928|516113958|FG001|Treatment Period|Lost to Follow-up|2|||
143155394|NCT01734928|516113957|FG000|Treatment Period|Progressive Disease|167|||
143155395|NCT01734928|516113958|FG001|Treatment Period|Progressive Disease|165|||
143155396|NCT01734928|516113957|FG000|Treatment Period|Adverse Event|39|||
143155397|NCT01734928|516113958|FG001|Treatment Period|Adverse Event|52|||
143155398|NCT01734928|516113957|FG000|Treatment Period|Withdrawal of Consent|25|||
143155399|NCT01734928|516113958|FG001|Treatment Period|Withdrawal of Consent|22|||
143155400|NCT01734928|516113957|FG000|Treatment Period|Death|20|||
143155401|NCT01734928|516113958|FG001|Treatment Period|Death|9|||
143155402|NCT01734928|516113957|FG000|Treatment Period|Other Reasons|27|||
143155403|NCT01734928|516113958|FG001|Treatment Period|Other Reasons|19|||
143155404|NCT01734928|516113957|FG000|Treatment Period|Pregnancy|0|||
143155405|NCT01734928|516113958|FG001|Treatment Period|Pregnancy|1|||
143155406|NCT00620035|516113959|FG000|Overall Study|Adverse Event|106|||
143155407|NCT00620035|516113959|FG000|Overall Study|Withdrawal of Informed Consent|1|||
143155408|NCT00620035|516113959|FG000|Overall Study|Other Reason|38|||
143155409|NCT01778985|516113962|FG000|Overall Study|Lost to Follow-up|1|||
143155410|NCT01778985|516113963|FG001|Overall Study|Lost to Follow-up|0|||
143155411|NCT01778985|516113962|FG000|Overall Study|Physician Decision|2|||
143155412|NCT01778985|516113963|FG001|Overall Study|Physician Decision|2|||
143155413|NCT01778985|516113962|FG000|Overall Study|Protocol Violation|4|||
143155414|NCT01778985|516113963|FG001|Overall Study|Protocol Violation|1|||
143155415|NCT01105130|516113964|FG000|Overall Study|Withdrawal by Subject|4|||
143019701|NCT01078623|515613308|FG017|Treatment Period 3|Adverse Event|0|||
143019702|NCT01078623|515613309|FG018|Treatment Period 3|Adverse Event|0|||
143019703|NCT01078623|515613310|FG019|Treatment Period 3|Adverse Event|0|||
143019704|NCT01078623|515613291|FG000|Treatment Period 4|Adverse Event|0|||
143155416|NCT01105130|516113965|FG001|Overall Study|Withdrawal by Subject|6|||
143155417|NCT01105130|516113966|FG002|Overall Study|Withdrawal by Subject|2|||
143019705|NCT01078623|515613292|FG001|Treatment Period 4|Adverse Event|0|||
143019706|NCT01078623|515613293|FG002|Treatment Period 4|Adverse Event|1|||
143019707|NCT01078623|515613294|FG003|Treatment Period 4|Adverse Event|0|||
143019708|NCT01078623|515613295|FG004|Treatment Period 4|Adverse Event|0|||
143019709|NCT01078623|515613296|FG005|Treatment Period 4|Adverse Event|0|||
143155418|NCT01105130|516113964|FG000|Overall Study|Never Started|2|||
143155419|NCT01105130|516113965|FG001|Overall Study|Never Started|2|||
143155420|NCT01105130|516113966|FG002|Overall Study|Never Started|4|||
143019710|NCT01078623|515613297|FG006|Treatment Period 4|Adverse Event|0|||
143019711|NCT01078623|515613298|FG007|Treatment Period 4|Adverse Event|0|||
143019712|NCT01078623|515613299|FG008|Treatment Period 4|Adverse Event|0|||
143019713|NCT01078623|515613300|FG009|Treatment Period 4|Adverse Event|0|||
143019714|NCT01078623|515613301|FG010|Treatment Period 4|Adverse Event|0|||
143019715|NCT01078623|515613302|FG011|Treatment Period 4|Adverse Event|0|||
143019716|NCT01078623|515613303|FG012|Treatment Period 4|Adverse Event|0|||
143019717|NCT01078623|515613304|FG013|Treatment Period 4|Adverse Event|0|||
143019718|NCT01078623|515613305|FG014|Treatment Period 4|Adverse Event|0|||
143019719|NCT01078623|515613306|FG015|Treatment Period 4|Adverse Event|0|||
143019720|NCT01078623|515613307|FG016|Treatment Period 4|Adverse Event|0|||
143019721|NCT01078623|515613308|FG017|Treatment Period 4|Adverse Event|0|||
143019722|NCT01078623|515613309|FG018|Treatment Period 4|Adverse Event|0|||
143019723|NCT01078623|515613310|FG019|Treatment Period 4|Adverse Event|0|||
143019724|NCT01078623|515613291|FG000|Treatment Period 4|Withdrawal by Subject|0|||
143019725|NCT01078623|515613292|FG001|Treatment Period 4|Withdrawal by Subject|0|||
143019726|NCT01078623|515613293|FG002|Treatment Period 4|Withdrawal by Subject|0|||
143019727|NCT01078623|515613294|FG003|Treatment Period 4|Withdrawal by Subject|0|||
143019728|NCT01078623|515613295|FG004|Treatment Period 4|Withdrawal by Subject|0|||
143019729|NCT01078623|515613296|FG005|Treatment Period 4|Withdrawal by Subject|0|||
143019730|NCT01078623|515613297|FG006|Treatment Period 4|Withdrawal by Subject|0|||
143019731|NCT01078623|515613298|FG007|Treatment Period 4|Withdrawal by Subject|0|||
143019732|NCT01078623|515613299|FG008|Treatment Period 4|Withdrawal by Subject|0|||
143019733|NCT01078623|515613300|FG009|Treatment Period 4|Withdrawal by Subject|0|||
143019734|NCT01078623|515613301|FG010|Treatment Period 4|Withdrawal by Subject|0|||
143019735|NCT01078623|515613302|FG011|Treatment Period 4|Withdrawal by Subject|0|||
143019736|NCT01078623|515613303|FG012|Treatment Period 4|Withdrawal by Subject|0|||
143019737|NCT01078623|515613304|FG013|Treatment Period 4|Withdrawal by Subject|0|||
143019738|NCT01078623|515613305|FG014|Treatment Period 4|Withdrawal by Subject|0|||
143019739|NCT01078623|515613306|FG015|Treatment Period 4|Withdrawal by Subject|1|||
143019740|NCT01078623|515613307|FG016|Treatment Period 4|Withdrawal by Subject|0|||
143019741|NCT01078623|515613308|FG017|Treatment Period 4|Withdrawal by Subject|0|||
143019742|NCT01078623|515613309|FG018|Treatment Period 4|Withdrawal by Subject|0|||
143019743|NCT01078623|515613310|FG019|Treatment Period 4|Withdrawal by Subject|0|||
143019744|NCT00463866|515613311|FG000|Overall Study|Adverse Event|70|||
143019745|NCT00463866|515613312|FG001|Overall Study|Adverse Event|93|||
143019746|NCT00463866|515613311|FG000|Overall Study|Withdrawal by Subject|81|||
143019747|NCT00463866|515613312|FG001|Overall Study|Withdrawal by Subject|79|||
143019748|NCT00463866|515613311|FG000|Overall Study|Lost to Follow-up|46|||
143019749|NCT00463866|515613312|FG001|Overall Study|Lost to Follow-up|55|||
143019750|NCT00463866|515613311|FG000|Overall Study|Incorrect Enrolment|64|||
143019751|NCT00463866|515613312|FG001|Overall Study|Incorrect Enrolment|66|||
143019752|NCT00463866|515613311|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
143019753|NCT00463866|515613312|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
143019754|NCT00463866|515613311|FG000|Overall Study|Safety Reason|1|||
143019755|NCT00463866|515613312|FG001|Overall Study|Safety Reason|3|||
143019756|NCT00463866|515613311|FG000|Overall Study|Mis-Randomization of subject|0|||
143019757|NCT00463866|515613312|FG001|Overall Study|Mis-Randomization of subject|1|||
143019758|NCT00463866|515613311|FG000|Overall Study|Other|22|||
143019759|NCT00463866|515613312|FG001|Overall Study|Other|22|||
143019760|NCT00693784|515613313|FG000|Overall Study|Lost to Follow-up|2|||
143019761|NCT00693784|515613313|FG000|Overall Study|Withdrawal by Subject|2|||
143019762|NCT01042977|515613316|FG000|Overall Study|Adverse Event|4|||
143019763|NCT01042977|515613317|FG001|Overall Study|Adverse Event|12|||
143019764|NCT01042977|515613316|FG000|Overall Study|Death|2|||
143019765|NCT01042977|515613317|FG001|Overall Study|Death|1|||
143019766|NCT01042977|515613316|FG000|Overall Study|Withdrawal by Subject|8|||
143019767|NCT01042977|515613317|FG001|Overall Study|Withdrawal by Subject|16|||
143019768|NCT01042977|515613316|FG000|Overall Study|Lost to Follow-up|0|||
143019769|NCT01042977|515613317|FG001|Overall Study|Lost to Follow-up|2|||
143019770|NCT01042977|515613316|FG000|Overall Study|Poor/non-compliance|3|||
143019771|NCT01042977|515613317|FG001|Overall Study|Poor/non-compliance|4|||
143019772|NCT01042977|515613316|FG000|Overall Study|Subject no longer meets study criteria|15|||
143155421|NCT01105130|516113964|FG000|Overall Study|Toxicity|1|||
143019773|NCT01042977|515613317|FG001|Overall Study|Subject no longer meets study criteria|13|||
143019774|NCT01042977|515613316|FG000|Overall Study|Incorrect enrollment|6|||
143019775|NCT01042977|515613317|FG001|Overall Study|Incorrect enrollment|4|||
143155422|NCT01105130|516113965|FG001|Overall Study|Toxicity|3|||
143019776|NCT01042977|515613316|FG000|Overall Study|Safety|0|||
143019777|NCT01042977|515613317|FG001|Overall Study|Safety|2|||
143019778|NCT01042977|515613316|FG000|Overall Study|Administrative reason by sponsor|0|||
143019779|NCT01042977|515613317|FG001|Overall Study|Administrative reason by sponsor|1|||
143019780|NCT01042977|515613316|FG000|Overall Study|Various|3|||
143019781|NCT01042977|515613317|FG001|Overall Study|Various|0|||
143019782|NCT02424565|515613318|FG000|Period 1 (D0)|Protocol Violation|0|||
143019783|NCT02424565|515613319|FG001|Period 1 (D0)|Protocol Violation|1|||
143019784|NCT03568500|515613320|FG000|Overall Study|Lost to Follow-up|1|||
143019785|NCT03568500|515613321|FG001|Overall Study|Lost to Follow-up|1|||
143019786|NCT03568500|515613322|FG002|Overall Study|Lost to Follow-up|2|||
143019787|NCT03568500|515613320|FG000|Overall Study|Adverse Event|1|||
143019788|NCT03568500|515613321|FG001|Overall Study|Adverse Event|1|||
143019789|NCT03568500|515613322|FG002|Overall Study|Adverse Event|2|||
143019790|NCT03568500|515613320|FG000|Overall Study|Physician Decision|1|||
143019791|NCT03568500|515613321|FG001|Overall Study|Physician Decision|0|||
143019792|NCT03568500|515613322|FG002|Overall Study|Physician Decision|0|||
143019793|NCT03568500|515613320|FG000|Overall Study|Withdrawal by Subject|4|||
143019794|NCT03568500|515613321|FG001|Overall Study|Withdrawal by Subject|2|||
143019795|NCT03568500|515613322|FG002|Overall Study|Withdrawal by Subject|0|||
143019796|NCT03568500|515613320|FG000|Overall Study|Technical Problems|2|||
143019797|NCT03568500|515613321|FG001|Overall Study|Technical Problems|1|||
143019798|NCT03568500|515613322|FG002|Overall Study|Technical Problems|0|||
143019799|NCT03568500|515613320|FG000|Overall Study|Participant Noncompliance|1|||
143019800|NCT03568500|515613321|FG001|Overall Study|Participant Noncompliance|1|||
143019801|NCT03568500|515613322|FG002|Overall Study|Participant Noncompliance|0|||
143019802|NCT02732561|515613345|FG000|Overall Study|Lost to Follow-up|1|||
143019803|NCT02732561|515613346|FG001|Overall Study|Lost to Follow-up|1|||
143019804|NCT02732561|515613345|FG000|Overall Study|Withdrawal by Subject|1|||
143019805|NCT02732561|515613346|FG001|Overall Study|Withdrawal by Subject|0|||
143019806|NCT00106028|515613361|FG000|Overall Study|Adverse Event|3|||
143019807|NCT00106028|515613362|FG001|Overall Study|Adverse Event|2|||
143019808|NCT00106028|515613361|FG000|Overall Study|Protocol Violation|1|||
143019809|NCT00106028|515613362|FG001|Overall Study|Protocol Violation|1|||
143019810|NCT00106028|515613361|FG000|Overall Study|Withdrawal by Subject|2|||
143019811|NCT00106028|515613362|FG001|Overall Study|Withdrawal by Subject|8|||
143019812|NCT00106028|515613361|FG000|Overall Study|Lost to Follow-up|0|||
143019813|NCT00106028|515613362|FG001|Overall Study|Lost to Follow-up|1|||
143019814|NCT01610167|515613363|FG000|Overall Study|Scheduling conflict.|0|||
143019815|NCT01610167|515613364|FG001|Overall Study|Scheduling conflict.|0|||
143019816|NCT01610167|515613365|FG002|Overall Study|Scheduling conflict.|2|||
143019817|NCT06371079|515613367|FG000|Overall Study|Missing data|88|||
143019818|NCT06371079|515613368|FG001|Overall Study|Missing data|247|||
143019819|NCT00411762|515613369|FG000|Overall Study|Withdrawal by Subject|5|||
143019820|NCT04428502|515613370|FG000|Overall Study|Did not meet entrance criteria|14|||
143019821|NCT03712228|515613374|FG000|Treatment Period 1|Lack of Efficacy|0|||
143019822|NCT03712228|515613375|FG001|Treatment Period 1|Lack of Efficacy|0|||
143019823|NCT03712228|515613376|FG002|Treatment Period 1|Lack of Efficacy|0|||
143019824|NCT03712228|515613377|FG003|Treatment Period 1|Lack of Efficacy|0|||
143019825|NCT03712228|515613378|FG004|Treatment Period 1|Lack of Efficacy|0|||
143019826|NCT03712228|515613379|FG005|Treatment Period 1|Lack of Efficacy|1|||
143019827|NCT03712228|515613374|FG000|Treatment Period 2|Pregnancy|0|||
143019828|NCT03712228|515613375|FG001|Treatment Period 2|Pregnancy|0|||
143019829|NCT03712228|515613376|FG002|Treatment Period 2|Pregnancy|0|||
143019830|NCT03712228|515613377|FG003|Treatment Period 2|Pregnancy|1|||
143019831|NCT03712228|515613378|FG004|Treatment Period 2|Pregnancy|0|||
143019832|NCT03712228|515613379|FG005|Treatment Period 2|Pregnancy|0|||
143019833|NCT03712228|515613374|FG000|Treatment Period 2|Withdrawal by Subject|0|||
143019834|NCT03712228|515613375|FG001|Treatment Period 2|Withdrawal by Subject|0|||
143019835|NCT03712228|515613376|FG002|Treatment Period 2|Withdrawal by Subject|0|||
143019836|NCT03712228|515613377|FG003|Treatment Period 2|Withdrawal by Subject|1|||
143019837|NCT03712228|515613378|FG004|Treatment Period 2|Withdrawal by Subject|0|||
143019838|NCT03712228|515613379|FG005|Treatment Period 2|Withdrawal by Subject|0|||
143019839|NCT05288673|515613380|FG000|Overall Study|Consent withdrawn by subject|0|||
143019840|NCT05288673|515613381|FG001|Overall Study|Consent withdrawn by subject|0|||
143019841|NCT05288673|515613382|FG002|Overall Study|Consent withdrawn by subject|1|||
143019842|NCT00124449|515613387|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
143019843|NCT00124449|515613388|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
143019844|NCT00124449|515613387|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
143485585|NCT03605680|517322858|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
143019845|NCT00124449|515613388|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
143019846|NCT00124449|515613387|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
143019847|NCT00124449|515613388|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
143019848|NCT00124449|515613387|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
143019849|NCT00124449|515613388|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
143019850|NCT00124449|515613387|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
143019851|NCT00124449|515613388|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
143019852|NCT00124449|515613387|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
143019853|NCT00124449|515613388|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
143019854|NCT00124449|515613387|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
143019855|NCT00124449|515613388|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
143019856|NCT00124449|515613387|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
143155423|NCT01105130|516113966|FG002|Overall Study|Toxicity|2|||
143155424|NCT01105130|516113964|FG000|Overall Study|Multiple Reasons|3|||
143019857|NCT00124449|515613388|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
143019858|NCT00124449|515613387|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
143019859|NCT00124449|515613388|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
143019860|NCT00124449|515613387|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
143019861|NCT00124449|515613388|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
143019862|NCT00124449|515613387|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
143019863|NCT00124449|515613388|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
143019864|NCT00124449|515613387|FG000|18-Month Untreated Observation Period|Relocated|1|||
143019865|NCT00124449|515613388|FG001|18-Month Untreated Observation Period|Relocated|0|||
143019866|NCT03940586|515613394|FG000|Overall Study|Death|3|||
143019867|NCT03940586|515613395|FG001|Overall Study|Death|2|||
143019868|NCT03940586|515613396|FG002|Overall Study|Death|0|||
143019869|NCT03940586|515613394|FG000|Overall Study|Physician Decision|1|||
143019870|NCT03940586|515613395|FG001|Overall Study|Physician Decision|0|||
143019871|NCT03940586|515613396|FG002|Overall Study|Physician Decision|1|||
143019872|NCT03940586|515613394|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
143019873|NCT03940586|515613395|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
143019874|NCT03940586|515613396|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
143019875|NCT03940586|515613394|FG000|Overall Study|Not Treated|0|||
143019876|NCT03940586|515613395|FG001|Overall Study|Not Treated|2|||
143019877|NCT03940586|515613396|FG002|Overall Study|Not Treated|0|||
143485586|NCT03605680|517322859|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
143485587|NCT03605680|517322856|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
143485588|NCT03605680|517322857|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
143485589|NCT03605680|517322858|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
143485590|NCT03605680|517322859|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
143485591|NCT03605680|517322856|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
143485592|NCT03605680|517322857|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
143485593|NCT03605680|517322858|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
143485594|NCT03605680|517322859|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
143485595|NCT03605680|517322856|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
143485596|NCT03605680|517322857|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
143019878|NCT00964223|515613397|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
143019879|NCT01559818|515613398|FG000|Overall Study|Physician Decision|1|||
143019880|NCT01559818|515613398|FG000|Overall Study|Pregnancy|1|||
143019881|NCT01559818|515613398|FG000|Overall Study|Study terminated by Sponsor|4|||
143019882|NCT01559818|515613398|FG000|Overall Study|Withdrawal by Subject|1|||
143019883|NCT01629693|515613403|FG000|Overall Study|Lost to Follow-up|2|||
143019884|NCT01629693|515613404|FG001|Overall Study|Lost to Follow-up|4|||
143019885|NCT01629693|515613403|FG000|Overall Study|Withdrawal by Subject|2|||
143019886|NCT01629693|515613404|FG001|Overall Study|Withdrawal by Subject|2|||
143019887|NCT01629693|515613403|FG000|Overall Study|Adverse Event|1|||
143019888|NCT01629693|515613404|FG001|Overall Study|Adverse Event|0|||
143485597|NCT03605680|517322858|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
143485598|NCT03605680|517322859|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
143485599|NCT03605680|517322856|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
143485600|NCT03605680|517322857|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
143485601|NCT03605680|517322858|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
143485602|NCT03605680|517322859|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
143485603|NCT03605680|517322856|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
143485604|NCT03605680|517322857|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
143485605|NCT03605680|517322858|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
143485606|NCT03605680|517322859|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
143485607|NCT03605680|517322856|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
143485608|NCT03605680|517322857|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
143485609|NCT03605680|517322858|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
143485610|NCT03605680|517322859|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
143485611|NCT03605680|517322856|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
143485612|NCT03605680|517322857|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
143019889|NCT01629693|515613403|FG000|Overall Study|Investigator decision|0|||
143019890|NCT01629693|515613404|FG001|Overall Study|Investigator decision|1|||
143019891|NCT01629693|515613403|FG000|Overall Study|Poor comfort of study lenses|0|||
143019892|NCT01629693|515613404|FG001|Overall Study|Poor comfort of study lenses|2|||
143019893|NCT01629693|515613403|FG000|Overall Study|Subject decision unrelated to AE|0|||
143155425|NCT01105130|516113965|FG001|Overall Study|Multiple Reasons|0|||
143019894|NCT01629693|515613404|FG001|Overall Study|Subject decision unrelated to AE|1|||
143019895|NCT01025193|515613406|FG000|Overall Study|Protocol Violation|1|||
143019896|NCT01025193|515613406|FG000|Overall Study|Adverse Event|3|||
143155426|NCT01105130|516113966|FG002|Overall Study|Multiple Reasons|2|||
143019897|NCT02133352|515613407|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
143019898|NCT00928252|515614793|FG000|Overall Study|Physician Decision|3|||
143019899|NCT01605461|515614794|FG000|Overall Study|Lost to Follow-up|3|||
143019900|NCT01605461|515614794|FG000|Overall Study|Withdrawal by Subject|1|||
143019901|NCT01847313|515614797|FG000|Overall Study|Death|0|||
143019902|NCT01847313|515614798|FG001|Overall Study|Death|1|||
143019903|NCT01847313|515614797|FG000|Overall Study|Withdrawal by Subject|0|||
143019904|NCT01847313|515614798|FG001|Overall Study|Withdrawal by Subject|1|||
143019905|NCT00936884|515614800|FG000|Double-blind|Withdrawal by Subject|6|||
143019906|NCT00936884|515614801|FG001|Double-blind|Withdrawal by Subject|4|||
143019907|NCT00936884|515614802|FG002|Double-blind|Withdrawal by Subject|0|||
143019908|NCT00936884|515614800|FG000|Double-blind|Death|2|||
143019909|NCT00936884|515614801|FG001|Double-blind|Death|1|||
143019910|NCT00936884|515614802|FG002|Double-blind|Death|0|||
143019911|NCT00936884|515614800|FG000|Double-blind|Lack of Efficacy|1|||
143019912|NCT00936884|515614801|FG001|Double-blind|Lack of Efficacy|1|||
143019913|NCT00936884|515614802|FG002|Double-blind|Lack of Efficacy|0|||
143019914|NCT00936884|515614800|FG000|Double-blind|Adverse Event|1|||
143019915|NCT00936884|515614801|FG001|Double-blind|Adverse Event|0|||
143019916|NCT00936884|515614802|FG002|Double-blind|Adverse Event|0|||
143019917|NCT00936884|515614800|FG000|Double-blind|Physician Decision|1|||
143019918|NCT00936884|515614801|FG001|Double-blind|Physician Decision|0|||
143019919|NCT00936884|515614802|FG002|Double-blind|Physician Decision|0|||
143019920|NCT00936884|515614800|FG000|Double-blind|No post baseline diary entry|1|||
143019921|NCT00936884|515614801|FG001|Double-blind|No post baseline diary entry|0|||
143019922|NCT00936884|515614802|FG002|Double-blind|No post baseline diary entry|0|||
143019923|NCT00936884|515614800|FG000|Double-blind|Did not receive study drug|0|||
143019924|NCT00936884|515614801|FG001|Double-blind|Did not receive study drug|1|||
143019925|NCT00936884|515614802|FG002|Double-blind|Did not receive study drug|0|||
143019926|NCT01294592|515614805|FG000|Overall Study|Adverse Event|28|||
143019927|NCT01294592|515614806|FG001|Overall Study|Adverse Event|13|||
143019928|NCT01294592|515614805|FG000|Overall Study|Lack of Efficacy|7|||
143019929|NCT01294592|515614806|FG001|Overall Study|Lack of Efficacy|5|||
143019930|NCT01294592|515614805|FG000|Overall Study|Protocol Violation|1|||
143019931|NCT01294592|515614806|FG001|Overall Study|Protocol Violation|7|||
143019932|NCT01294592|515614805|FG000|Overall Study|Lost to Follow-up|7|||
143019933|NCT01294592|515614806|FG001|Overall Study|Lost to Follow-up|9|||
143019934|NCT01294592|515614805|FG000|Overall Study|Physician Decision|6|||
143019935|NCT01294592|515614806|FG001|Overall Study|Physician Decision|11|||
143019936|NCT01294592|515614805|FG000|Overall Study|Withdrawal by Subject|28|||
143019937|NCT01294592|515614806|FG001|Overall Study|Withdrawal by Subject|28|||
143019938|NCT02853929|515614807|FG000|Overall Study|Lost to Follow-up|3|||
143019939|NCT02853929|515614808|FG001|Overall Study|Lost to Follow-up|0|||
143019940|NCT02853929|515614807|FG000|Overall Study|Withdrawal by Subject|1|||
143019941|NCT02853929|515614808|FG001|Overall Study|Withdrawal by Subject|0|||
143019942|NCT02853929|515614807|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
143019943|NCT02853929|515614808|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
143019944|NCT03549130|515614809|FG000|Overall Study|Adverse Event|0|||
143019945|NCT03549130|515614810|FG001|Overall Study|Adverse Event|1|||
143019946|NCT03549130|515614809|FG000|Overall Study|Lost to Follow-up|0|||
143019947|NCT03549130|515614810|FG001|Overall Study|Lost to Follow-up|1|||
143019948|NCT01113710|515614811|FG000|Overall Study|Adverse Event|64|||
143019949|NCT01113710|515614811|FG000|Overall Study|Lack of Efficacy|41|||
143019950|NCT01113710|515614811|FG000|Overall Study|No Information Available|40|||
143019951|NCT01113710|515614811|FG000|Overall Study|Withdrawal by Subject|28|||
143019952|NCT01113710|515614811|FG000|Overall Study|Lost to Follow-up|20|||
143019953|NCT01113710|515614811|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
143019954|NCT01113710|515614811|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
143019955|NCT01113710|515614811|FG000|Overall Study|Lack of Patient's Compliance|8|||
143019956|NCT01113710|515614811|FG000|Overall Study|Other|7|||
143019957|NCT01113710|515614811|FG000|Overall Study|Adverse Event/Other|5|||
143019958|NCT01113710|515614811|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
143019959|NCT01113710|515614811|FG000|Overall Study|Lack of Efficacy/Other|4|||
143019960|NCT01113710|515614811|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
143019961|NCT01113710|515614811|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
143019962|NCT01113710|515614811|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
143019963|NCT01113710|515614811|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
143019964|NCT01113710|515614811|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
143019965|NCT01113710|515614811|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
143019966|NCT01113710|515614811|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
143019967|NCT01113710|515614811|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
143019968|NCT01113710|515614811|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
143019969|NCT01113710|515614811|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
143019970|NCT01113710|515614811|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
143019971|NCT01113710|515614811|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
143019972|NCT01113710|515614811|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
143019973|NCT02265952|515614812|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
143019974|NCT02265952|515614813|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
143019975|NCT02265952|515614812|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
143019976|NCT02265952|515614813|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
143019977|NCT00326885|515614815|FG000|Overall Study|Adverse Event|1|||
143019978|NCT00326885|515614815|FG000|Overall Study|Withdrawal by Subject|3|||
143019979|NCT00326885|515614815|FG000|Overall Study|Physician Decision|1|||
143019980|NCT00326885|515614815|FG000|Overall Study|Hospice withdrew consent|2|||
143019981|NCT02499354|515614817|FG000|Overall Study|Withdrawal by Subject|1|||
143019982|NCT02499354|515614818|FG001|Overall Study|Withdrawal by Subject|0|||
143019983|NCT01677910|515614821|FG000|Double-Blind Treatment Period|Adverse Event|6|||
143019984|NCT01677910|515614822|FG001|Double-Blind Treatment Period|Adverse Event|2|||
143019985|NCT01677910|515614823|FG002|Double-Blind Treatment Period|Adverse Event|3|||
143019986|NCT01677910|515614824|FG003|Double-Blind Treatment Period|Adverse Event|0|||
143019987|NCT01677910|515614821|FG000|Double-Blind Treatment Period|Physician Decision|0|||
143019988|NCT01677910|515614822|FG001|Double-Blind Treatment Period|Physician Decision|0|||
143019989|NCT01677910|515614823|FG002|Double-Blind Treatment Period|Physician Decision|1|||
143019990|NCT01677910|515614824|FG003|Double-Blind Treatment Period|Physician Decision|0|||
143019991|NCT01677910|515614821|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
143019992|NCT01677910|515614822|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
143019993|NCT01677910|515614823|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
143019994|NCT01677910|515614824|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
143019995|NCT01677910|515614821|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
143019996|NCT01677910|515614822|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
143019997|NCT01677910|515614823|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
143019998|NCT01677910|515614824|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
143019999|NCT01677910|515614821|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
143020000|NCT01677910|515614822|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
143020001|NCT01677910|515614823|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
143020002|NCT01677910|515614824|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
143020003|NCT01677910|515614821|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
143020004|NCT01677910|515614822|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
143020005|NCT01677910|515614823|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
143020006|NCT01677910|515614824|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
143020007|NCT01677910|515614821|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
143020008|NCT01677910|515614822|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
143020009|NCT01677910|515614823|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
143020010|NCT01677910|515614824|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
143020011|NCT01677910|515614821|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
143020012|NCT01677910|515614822|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
143020013|NCT01677910|515614823|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
143020014|NCT01677910|515614824|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
143020015|NCT01677910|515614821|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
143020016|NCT01677910|515614822|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
143020017|NCT01677910|515614823|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
143020018|NCT01677910|515614824|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
143020019|NCT01677910|515614821|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
143020020|NCT01677910|515614822|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
143020021|NCT01677910|515614823|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
143020022|NCT01677910|515614824|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
143020023|NCT01170364|515614835|FG000|Overall Study|Protocol Violation|4|||
143020024|NCT01170364|515614836|FG001|Overall Study|Protocol Violation|1|||
143020025|NCT04132232|515614837|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
143020026|NCT04132232|515614838|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
143020027|NCT04132232|515614837|FG000|Overall Study|Lost to Follow-up|6|||
143020028|NCT04132232|515614838|FG001|Overall Study|Lost to Follow-up|7|||
143020029|NCT00368537|515614840|FG000|Randomization|No study drug dosed|13|||
143020030|NCT00368537|515614841|FG001|Randomization|No study drug dosed|6|||
143020031|NCT00368537|515614840|FG000|Baseline Participants|Lost to Follow-up|16|||
143020032|NCT00368537|515614841|FG001|Baseline Participants|Lost to Follow-up|17|||
143020033|NCT00368537|515614840|FG000|Baseline Participants|Withdrawal by Subject|6|||
143020034|NCT00368537|515614841|FG001|Baseline Participants|Withdrawal by Subject|4|||
143020035|NCT00368537|515614840|FG000|Baseline Participants|Death|1|||
143020036|NCT00368537|515614841|FG001|Baseline Participants|Death|2|||
143020037|NCT00368537|515614840|FG000|Baseline Participants|No susceptibility|1|||
143020038|NCT00368537|515614841|FG001|Baseline Participants|No susceptibility|0|||
143020039|NCT00368537|515614840|FG000|Baseline Participants|Patient uncompliant|0|||
143020040|NCT00368537|515614841|FG001|Baseline Participants|Patient uncompliant|1|||
143020041|NCT01886300|515614842|FG000|Overall Study|Trial terminated by sponsor|16|||
143020042|NCT01797120|515614847|FG000|Overall Study|Disesae progression|37|||
143020043|NCT01797120|515614848|FG001|Overall Study|Disesae progression|49|||
143020044|NCT01797120|515614847|FG000|Overall Study|Adverse Event|13|||
143020045|NCT01797120|515614848|FG001|Overall Study|Adverse Event|5|||
143020046|NCT01797120|515614847|FG000|Overall Study|Withdrawal by Subject|6|||
143020047|NCT01797120|515614848|FG001|Overall Study|Withdrawal by Subject|6|||
143020048|NCT01797120|515614847|FG000|Overall Study|Symptomatic progression|2|||
143020049|NCT01797120|515614848|FG001|Overall Study|Symptomatic progression|1|||
143020050|NCT01797120|515614847|FG000|Overall Study|Non-compliance|1|||
143020051|NCT01797120|515614848|FG001|Overall Study|Non-compliance|0|||
143020052|NCT01797120|515614847|FG000|Overall Study|Physician Decision|3|||
143020053|NCT01797120|515614848|FG001|Overall Study|Physician Decision|0|||
143020054|NCT01797120|515614847|FG000|Overall Study|still on treatment|2|||
143020055|NCT01797120|515614848|FG001|Overall Study|still on treatment|4|||
143020056|NCT01797120|515614847|FG000|Overall Study|never start protocol therapy|2|||
143020057|NCT01797120|515614848|FG001|Overall Study|never start protocol therapy|0|||
143485613|NCT03605680|517322858|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
143485614|NCT03605680|517322859|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
143485615|NCT03189446|517322860|FG000|Overall Study|Adverse Event|2|||
143485616|NCT03189446|517322860|FG000|Overall Study|Withdrawal by Subject|2|||
143485617|NCT03189446|517322860|FG000|Overall Study|Physician Decision|1|||
143485618|NCT05594173|517322861|FG000|Overall Study|Adverse Event|1|||
143485619|NCT05594173|517322861|FG000|Overall Study|COVID-19 Pandemic|2|||
143485620|NCT00647556|517322862|FG000|Overall Study|Adverse Event|0|||
143020058|NCT04120194|515614850|FG000|Overall Study|Lost to Follow-up|11|||
143020059|NCT04120194|515614851|FG001|Overall Study|Lost to Follow-up|8|||
143020060|NCT04120194|515614850|FG000|Overall Study|Adverse Event|4|||
143020061|NCT04120194|515614851|FG001|Overall Study|Adverse Event|5|||
143020062|NCT04120194|515614850|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
143020063|NCT04120194|515614851|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
143020064|NCT04120194|515614850|FG000|Overall Study|Miscellaneous|4|||
143020065|NCT04120194|515614851|FG001|Overall Study|Miscellaneous|5|||
143020066|NCT00553540|515614852|FG000|Overall Study|discharged after first visit|2|||
143020067|NCT00553540|515614853|FG001|Overall Study|discharged after first visit|5|||
143020068|NCT02114931|515614857|FG000|Overall Study|Withdrawal by Subject|15|||
143020069|NCT02114931|515614858|FG001|Overall Study|Withdrawal by Subject|18|||
143020070|NCT02114931|515614857|FG000|Overall Study|Adverse Event|4|||
143020071|NCT02114931|515614858|FG001|Overall Study|Adverse Event|6|||
143020072|NCT02114931|515614857|FG000|Overall Study|Lost to Follow-up|3|||
143020073|NCT02114931|515614858|FG001|Overall Study|Lost to Follow-up|3|||
143020074|NCT02114931|515614857|FG000|Overall Study|Physician Decision|1|||
143020075|NCT02114931|515614858|FG001|Overall Study|Physician Decision|2|||
143020076|NCT02114931|515614857|FG000|Overall Study|Other|2|||
143020077|NCT02114931|515614858|FG001|Overall Study|Other|1|||
143020078|NCT03565211|515614862|FG000|Overall Study|Withdrawal by Subject|2|||
143020079|NCT03565211|515614862|FG000|Overall Study|Lost to Follow-up|1|||
143020080|NCT03565211|515614862|FG000|Overall Study|Adverse Event|44|||
143020081|NCT03565211|515614862|FG000|Overall Study|Personal issues|1|||
143020082|NCT00667719|515614866|FG000|Overall Study|Adverse Event|39|||
143020083|NCT00667719|515614866|FG000|Overall Study|Abnormal Test Procedure|1|||
143020084|NCT00667719|515614866|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
143155427|NCT00327171|516113967|FG000|Overall Study|Did not receive study medication|3|||
143155428|NCT00327171|516113968|FG001|Overall Study|Did not receive study medication|0|||
143155429|NCT00327171|516113967|FG000|Overall Study|Adverse Event|23|||
143155430|NCT00327171|516113968|FG001|Overall Study|Adverse Event|23|||
143155431|NCT00327171|516113967|FG000|Overall Study|Disease progression/lack of efficacy|68|||
143155432|NCT00327171|516113968|FG001|Overall Study|Disease progression/lack of efficacy|69|||
143155433|NCT00327171|516113967|FG000|Overall Study|Investigator/participant request|1|||
143155434|NCT00327171|516113968|FG001|Overall Study|Investigator/participant request|8|||
143155435|NCT00327171|516113967|FG000|Overall Study|Clinical progression|12|||
143155436|NCT00327171|516113968|FG001|Overall Study|Clinical progression|8|||
143020085|NCT00667719|515614866|FG000|Overall Study|Protocol Violation|3|||
143020086|NCT00667719|515614866|FG000|Overall Study|Withdrawal by Subject|17|||
143020087|NCT00667719|515614866|FG000|Overall Study|Lost to Follow-up|8|||
143020088|NCT01159769|515614867|FG000|Overall Study|Adverse Event|1|||
143155437|NCT00327171|516113967|FG000|Overall Study|Undisclosed history of ischemia|0|||
143155438|NCT00327171|516113968|FG001|Overall Study|Undisclosed history of ischemia|1|||
143155439|NCT00327171|516113967|FG000|Overall Study|Other|1|||
143155440|NCT00327171|516113968|FG001|Overall Study|Other|0|||
143155441|NCT00456612|516113969|FG000|Overall Study|Withdrawal by Subject|3|||
143155442|NCT00758043|516113970|FG000|Overall Study|Adverse Event|1|||
143020089|NCT03063632|515614868|FG000|Overall Study|Death|4|||
143020090|NCT03063632|515614869|FG001|Overall Study|Death|6|||
143020091|NCT03063632|515614868|FG000|Overall Study|Lost to Follow-up|0|||
143020092|NCT03063632|515614869|FG001|Overall Study|Lost to Follow-up|1|||
143020093|NCT03063632|515614868|FG000|Overall Study|Withdrawal by Subject|0|||
143155443|NCT00758043|516113971|FG001|Overall Study|Adverse Event|20|||
143155444|NCT00758043|516113972|FG002|Overall Study|Adverse Event|12|||
143020094|NCT03063632|515614869|FG001|Overall Study|Withdrawal by Subject|2|||
143020095|NCT03063632|515614868|FG000|Overall Study|Physician Decision|2|||
143020096|NCT03063632|515614869|FG001|Overall Study|Physician Decision|0|||
143020097|NCT03063632|515614868|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
143020098|NCT03063632|515614869|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
143020099|NCT03652961|515614872|FG000|Overall Study|Lost to Follow-up|3|||
143020100|NCT03652961|515614872|FG000|Overall Study|Screen Failure|1|||
143020101|NCT02741271|515614873|FG000|Overall Study|Lost to Follow-up|2|||
143020102|NCT02741271|515614874|FG001|Overall Study|Lost to Follow-up|0|||
143020103|NCT02741271|515614873|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
143020104|NCT02741271|515614874|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
143020105|NCT00410410|515614875|FG000|Induction Period (IP)|Death|1|||
143020106|NCT00410410|515614876|FG001|Induction Period (IP)|Death|0|||
143020107|NCT00410410|515614877|FG002|Induction Period (IP)|Death|0|||
143485621|NCT00647556|517322863|FG001|Overall Study|Adverse Event|1|||
143485622|NCT00647556|517322862|FG000|Overall Study|Lost to Follow-up|1|||
143485623|NCT00647556|517322863|FG001|Overall Study|Lost to Follow-up|0|||
143485624|NCT00647556|517322862|FG000|Overall Study|Protocol Violation|0|||
143485625|NCT00647556|517322863|FG001|Overall Study|Protocol Violation|1|||
143485626|NCT00647556|517322862|FG000|Overall Study|Withdrawal by Subject|1|||
143485627|NCT00647556|517322863|FG001|Overall Study|Withdrawal by Subject|0|||
143485628|NCT00647556|517322862|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
143485629|NCT00647556|517322863|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
143485630|NCT01192022|517322864|FG000|Overall Study|Withdrawal of Consent|3|||
143485631|NCT01192022|517322865|FG001|Overall Study|Withdrawal of Consent|1|||
143485632|NCT01192022|517322866|FG002|Overall Study|Withdrawal of Consent|0|||
143485633|NCT01192022|517322867|FG003|Overall Study|Withdrawal of Consent|0|||
143485634|NCT01192022|517322868|FG004|Overall Study|Withdrawal of Consent|0|||
143485635|NCT01192022|517322864|FG000|Overall Study|Lost to Follow-up|4|||
143485636|NCT01192022|517322865|FG001|Overall Study|Lost to Follow-up|2|||
143485637|NCT01192022|517322866|FG002|Overall Study|Lost to Follow-up|1|||
143485638|NCT01192022|517322867|FG003|Overall Study|Lost to Follow-up|1|||
143485639|NCT01192022|517322868|FG004|Overall Study|Lost to Follow-up|0|||
143485640|NCT01192022|517322864|FG000|Overall Study|Adverse Event|1|||
143485641|NCT01192022|517322865|FG001|Overall Study|Adverse Event|0|||
143485642|NCT01192022|517322866|FG002|Overall Study|Adverse Event|0|||
143485643|NCT01192022|517322867|FG003|Overall Study|Adverse Event|0|||
143485644|NCT01192022|517322868|FG004|Overall Study|Adverse Event|0|||
143485645|NCT01192022|517322864|FG000|Overall Study|Fatal Adverse Event|4|||
143485646|NCT01192022|517322865|FG001|Overall Study|Fatal Adverse Event|6|||
143485647|NCT01192022|517322866|FG002|Overall Study|Fatal Adverse Event|0|||
143485648|NCT01192022|517322867|FG003|Overall Study|Fatal Adverse Event|0|||
143485649|NCT01192022|517322868|FG004|Overall Study|Fatal Adverse Event|1|||
143485650|NCT01192022|517322864|FG000|Overall Study|Physician withdrew-patient hardship|1|||
143485651|NCT01192022|517322865|FG001|Overall Study|Physician withdrew-patient hardship|0|||
143485652|NCT01192022|517322866|FG002|Overall Study|Physician withdrew-patient hardship|0|||
143485653|NCT01192022|517322867|FG003|Overall Study|Physician withdrew-patient hardship|0|||
143485654|NCT01192022|517322868|FG004|Overall Study|Physician withdrew-patient hardship|0|||
143020108|NCT00410410|515614878|FG003|Induction Period (IP)|Death|0|||
143020109|NCT00410410|515614879|FG004|Induction Period (IP)|Death|0|||
143020110|NCT00410410|515614880|FG005|Induction Period (IP)|Death|0|||
143020111|NCT00410410|515614881|FG006|Induction Period (IP)|Death|0|||
143020112|NCT00410410|515614882|FG007|Induction Period (IP)|Death|0|||
143020113|NCT00410410|515614883|FG008|Induction Period (IP)|Death|0|||
143020114|NCT00410410|515614875|FG000|Induction Period (IP)|Adverse Event|3|||
143020115|NCT00410410|515614876|FG001|Induction Period (IP)|Adverse Event|4|||
143485655|NCT01192022|517322864|FG000|Overall Study|Patient too sick from chemotherapy|0|||
143485656|NCT01192022|517322865|FG001|Overall Study|Patient too sick from chemotherapy|1|||
143485657|NCT01192022|517322866|FG002|Overall Study|Patient too sick from chemotherapy|0|||
143485658|NCT01192022|517322867|FG003|Overall Study|Patient too sick from chemotherapy|0|||
143020116|NCT00410410|515614877|FG002|Induction Period (IP)|Adverse Event|2|||
143020117|NCT00410410|515614878|FG003|Induction Period (IP)|Adverse Event|4|||
143020118|NCT00410410|515614879|FG004|Induction Period (IP)|Adverse Event|1|||
143020119|NCT00410410|515614880|FG005|Induction Period (IP)|Adverse Event|0|||
143020120|NCT00410410|515614881|FG006|Induction Period (IP)|Adverse Event|0|||
143020121|NCT00410410|515614882|FG007|Induction Period (IP)|Adverse Event|0|||
143020122|NCT00410410|515614883|FG008|Induction Period (IP)|Adverse Event|0|||
143020123|NCT00410410|515614875|FG000|Induction Period (IP)|Lack of Efficacy|26|||
143485659|NCT01192022|517322868|FG004|Overall Study|Patient too sick from chemotherapy|0|||
143485660|NCT01192022|517322864|FG000|Overall Study|Patient needed surgery|0|||
143485661|NCT01192022|517322865|FG001|Overall Study|Patient needed surgery|1|||
143485662|NCT01192022|517322866|FG002|Overall Study|Patient needed surgery|0|||
143485663|NCT01192022|517322867|FG003|Overall Study|Patient needed surgery|0|||
143485664|NCT01192022|517322868|FG004|Overall Study|Patient needed surgery|0|||
143485665|NCT01192022|517322864|FG000|Overall Study|Parents did not allow all follow up|0|||
143485666|NCT01192022|517322865|FG001|Overall Study|Parents did not allow all follow up|0|||
143020124|NCT00410410|515614876|FG001|Induction Period (IP)|Lack of Efficacy|24|||
143020125|NCT00410410|515614877|FG002|Induction Period (IP)|Lack of Efficacy|8|||
143020126|NCT00410410|515614878|FG003|Induction Period (IP)|Lack of Efficacy|8|||
143020127|NCT00410410|515614879|FG004|Induction Period (IP)|Lack of Efficacy|7|||
143020128|NCT00410410|515614880|FG005|Induction Period (IP)|Lack of Efficacy|7|||
143020129|NCT00410410|515614881|FG006|Induction Period (IP)|Lack of Efficacy|0|||
143020130|NCT00410410|515614882|FG007|Induction Period (IP)|Lack of Efficacy|0|||
143020131|NCT00410410|515614883|FG008|Induction Period (IP)|Lack of Efficacy|0|||
143020132|NCT00410410|515614875|FG000|Induction Period (IP)|Lost to Follow-up|2|||
143020133|NCT00410410|515614876|FG001|Induction Period (IP)|Lost to Follow-up|2|||
143020134|NCT00410410|515614877|FG002|Induction Period (IP)|Lost to Follow-up|2|||
143020135|NCT00410410|515614878|FG003|Induction Period (IP)|Lost to Follow-up|3|||
143020136|NCT00410410|515614879|FG004|Induction Period (IP)|Lost to Follow-up|0|||
143020137|NCT00410410|515614880|FG005|Induction Period (IP)|Lost to Follow-up|1|||
143020138|NCT00410410|515614881|FG006|Induction Period (IP)|Lost to Follow-up|0|||
143020139|NCT00410410|515614882|FG007|Induction Period (IP)|Lost to Follow-up|0|||
143020140|NCT00410410|515614883|FG008|Induction Period (IP)|Lost to Follow-up|0|||
143020141|NCT00410410|515614875|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
143155445|NCT00758043|516113973|FG003|Overall Study|Adverse Event|62|||
143155446|NCT00758043|516113970|FG000|Overall Study|Lack of Efficacy|0|||
143020142|NCT00410410|515614876|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
143020143|NCT00410410|515614877|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
143020144|NCT00410410|515614878|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
143020145|NCT00410410|515614879|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
143020146|NCT00410410|515614880|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
143020147|NCT00410410|515614881|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
143020148|NCT00410410|515614882|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
143020149|NCT00410410|515614883|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
143020150|NCT00410410|515614875|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
143020151|NCT00410410|515614876|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
143020152|NCT00410410|515614877|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
143020153|NCT00410410|515614878|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
143020154|NCT00410410|515614879|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
143020155|NCT00410410|515614880|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
143020156|NCT00410410|515614881|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
143020157|NCT00410410|515614882|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
143020158|NCT00410410|515614883|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
143020159|NCT00410410|515614875|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
143020160|NCT00410410|515614876|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
143020161|NCT00410410|515614877|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
143020162|NCT00410410|515614878|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
143020163|NCT00410410|515614879|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
143020164|NCT00410410|515614880|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
143020165|NCT00410410|515614881|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
143020166|NCT00410410|515614882|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
143020167|NCT00410410|515614883|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
143020168|NCT00410410|515614875|FG000|Induction Period (IP)|Other|0|||
143020169|NCT00410410|515614876|FG001|Induction Period (IP)|Other|0|||
143020170|NCT00410410|515614877|FG002|Induction Period (IP)|Other|1|||
143020171|NCT00410410|515614878|FG003|Induction Period (IP)|Other|0|||
143020172|NCT00410410|515614879|FG004|Induction Period (IP)|Other|0|||
143020173|NCT00410410|515614880|FG005|Induction Period (IP)|Other|0|||
143155447|NCT00758043|516113971|FG001|Overall Study|Lack of Efficacy|6|||
143155448|NCT00758043|516113972|FG002|Overall Study|Lack of Efficacy|18|||
143155449|NCT00758043|516113973|FG003|Overall Study|Lack of Efficacy|12|||
143155450|NCT00758043|516113970|FG000|Overall Study|Refused Further Treatment|0|||
143155451|NCT00758043|516113971|FG001|Overall Study|Refused Further Treatment|11|||
143155452|NCT00758043|516113972|FG002|Overall Study|Refused Further Treatment|5|||
143020174|NCT00410410|515614881|FG006|Induction Period (IP)|Other|0|||
143020175|NCT00410410|515614882|FG007|Induction Period (IP)|Other|0|||
143020176|NCT00410410|515614883|FG008|Induction Period (IP)|Other|0|||
143020177|NCT00410410|515614875|FG000|Maintenance Period (MP)|Death|0|||
143020178|NCT00410410|515614876|FG001|Maintenance Period (MP)|Death|0|||
143020179|NCT00410410|515614877|FG002|Maintenance Period (MP)|Death|0|||
143020180|NCT00410410|515614878|FG003|Maintenance Period (MP)|Death|0|||
143020181|NCT00410410|515614879|FG004|Maintenance Period (MP)|Death|0|||
143020182|NCT00410410|515614880|FG005|Maintenance Period (MP)|Death|0|||
143020183|NCT00410410|515614881|FG006|Maintenance Period (MP)|Death|1|||
143020184|NCT00410410|515614882|FG007|Maintenance Period (MP)|Death|0|||
143020185|NCT00410410|515614883|FG008|Maintenance Period (MP)|Death|0|||
143020186|NCT00410410|515614875|FG000|Maintenance Period (MP)|Adverse Event|0|||
143155453|NCT00758043|516113973|FG003|Overall Study|Refused Further Treatment|8|||
143155454|NCT00758043|516113970|FG000|Overall Study|Lost to Follow-up|0|||
143020187|NCT00410410|515614876|FG001|Maintenance Period (MP)|Adverse Event|0|||
143020188|NCT00410410|515614877|FG002|Maintenance Period (MP)|Adverse Event|0|||
143020189|NCT00410410|515614878|FG003|Maintenance Period (MP)|Adverse Event|0|||
143020190|NCT00410410|515614879|FG004|Maintenance Period (MP)|Adverse Event|0|||
143020191|NCT00410410|515614880|FG005|Maintenance Period (MP)|Adverse Event|0|||
143020192|NCT00410410|515614881|FG006|Maintenance Period (MP)|Adverse Event|1|||
143020193|NCT00410410|515614882|FG007|Maintenance Period (MP)|Adverse Event|3|||
143020194|NCT00410410|515614883|FG008|Maintenance Period (MP)|Adverse Event|0|||
143020195|NCT00410410|515614875|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
143020196|NCT00410410|515614876|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
143020197|NCT00410410|515614877|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
143020198|NCT00410410|515614878|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
143020199|NCT00410410|515614879|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
143020200|NCT00410410|515614880|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
143020201|NCT00410410|515614881|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
143020202|NCT00410410|515614882|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
143020203|NCT00410410|515614883|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
143020204|NCT00410410|515614875|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
143020205|NCT00410410|515614876|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
143020206|NCT00410410|515614877|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
143020207|NCT00410410|515614878|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
143020208|NCT00410410|515614879|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
143020209|NCT00410410|515614880|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
143020210|NCT00410410|515614881|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
143020211|NCT00410410|515614882|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
143020212|NCT00410410|515614883|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
143020213|NCT00410410|515614875|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
143020214|NCT00410410|515614876|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
143020215|NCT00410410|515614877|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
143020216|NCT00410410|515614878|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
143020217|NCT00410410|515614879|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
143020218|NCT00410410|515614880|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
143020219|NCT00410410|515614881|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
143020220|NCT00410410|515614882|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
143020221|NCT00410410|515614883|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
143020222|NCT00410410|515614875|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
143020223|NCT00410410|515614876|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
143020224|NCT00410410|515614877|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
143020225|NCT00410410|515614878|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
143020226|NCT00410410|515614879|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
143020227|NCT00410410|515614880|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
143020228|NCT00410410|515614881|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
143020229|NCT00410410|515614882|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
143020230|NCT00410410|515614883|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
143020231|NCT00410410|515614875|FG000|Open-Label Period (OL)|Death|0|||
143020232|NCT00410410|515614876|FG001|Open-Label Period (OL)|Death|0|||
143020233|NCT00410410|515614877|FG002|Open-Label Period (OL)|Death|0|||
143020234|NCT00410410|515614878|FG003|Open-Label Period (OL)|Death|0|||
143020235|NCT00410410|515614879|FG004|Open-Label Period (OL)|Death|0|||
143020236|NCT00410410|515614880|FG005|Open-Label Period (OL)|Death|0|||
143020237|NCT00410410|515614881|FG006|Open-Label Period (OL)|Death|0|||
143020238|NCT00410410|515614882|FG007|Open-Label Period (OL)|Death|0|||
143020239|NCT00410410|515614883|FG008|Open-Label Period (OL)|Death|1|||
143020240|NCT00410410|515614875|FG000|Open-Label Period (OL)|Adverse Event|0|||
143020241|NCT00410410|515614876|FG001|Open-Label Period (OL)|Adverse Event|0|||
143020242|NCT00410410|515614877|FG002|Open-Label Period (OL)|Adverse Event|0|||
143020243|NCT00410410|515614878|FG003|Open-Label Period (OL)|Adverse Event|0|||
143020244|NCT00410410|515614879|FG004|Open-Label Period (OL)|Adverse Event|0|||
143020245|NCT00410410|515614880|FG005|Open-Label Period (OL)|Adverse Event|0|||
143155455|NCT00758043|516113971|FG001|Overall Study|Lost to Follow-up|2|||
143155456|NCT00758043|516113972|FG002|Overall Study|Lost to Follow-up|2|||
143155457|NCT00758043|516113973|FG003|Overall Study|Lost to Follow-up|5|||
143155458|NCT00758043|516113970|FG000|Overall Study|Withdrawal by Subject|0|||
143155459|NCT00758043|516113971|FG001|Overall Study|Withdrawal by Subject|1|||
143155460|NCT00758043|516113972|FG002|Overall Study|Withdrawal by Subject|1|||
143020246|NCT00410410|515614881|FG006|Open-Label Period (OL)|Adverse Event|0|||
143020247|NCT00410410|515614882|FG007|Open-Label Period (OL)|Adverse Event|0|||
143155461|NCT00758043|516113973|FG003|Overall Study|Withdrawal by Subject|4|||
143363700|NCT00062868|516873791|FG011|Dose Level 3|Withdrew|0|||
143020248|NCT00410410|515614883|FG008|Open-Label Period (OL)|Adverse Event|10|||
143020249|NCT00410410|515614875|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
143020250|NCT00410410|515614876|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
143020251|NCT00410410|515614877|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
143155462|NCT00758043|516113970|FG000|Overall Study|Required Prohibited Medication|0|||
143020252|NCT00410410|515614878|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
143020253|NCT00410410|515614879|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
143020254|NCT00410410|515614880|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
143020255|NCT00410410|515614881|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
143020256|NCT00410410|515614882|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
143020257|NCT00410410|515614883|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
143020258|NCT00410410|515614875|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
143020259|NCT00410410|515614876|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
143020260|NCT00410410|515614877|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
143020261|NCT00410410|515614878|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
143020262|NCT00410410|515614879|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
143020263|NCT00410410|515614880|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
143020264|NCT00410410|515614881|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
143020265|NCT00410410|515614882|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
143020266|NCT00410410|515614883|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
143020267|NCT00410410|515614875|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
143020268|NCT00410410|515614876|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
143020269|NCT00410410|515614877|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
143020270|NCT00410410|515614878|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
143020271|NCT00410410|515614879|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
143020272|NCT00410410|515614880|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
143020273|NCT00410410|515614881|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
143020274|NCT00410410|515614882|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
143020275|NCT00410410|515614883|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
143020276|NCT00410410|515614875|FG000|Open-Label Period (OL)|Pregnancy|0|||
143020277|NCT00410410|515614876|FG001|Open-Label Period (OL)|Pregnancy|0|||
143020278|NCT00410410|515614877|FG002|Open-Label Period (OL)|Pregnancy|0|||
143020279|NCT00410410|515614878|FG003|Open-Label Period (OL)|Pregnancy|0|||
143155463|NCT00758043|516113971|FG001|Overall Study|Required Prohibited Medication|0|||
143155464|NCT00758043|516113972|FG002|Overall Study|Required Prohibited Medication|1|||
143155465|NCT00758043|516113973|FG003|Overall Study|Required Prohibited Medication|3|||
143155466|NCT00758043|516113970|FG000|Overall Study|Non-Compliant With study Drug|0|||
143155467|NCT00758043|516113971|FG001|Overall Study|Non-Compliant With study Drug|0|||
143155468|NCT00758043|516113972|FG002|Overall Study|Non-Compliant With study Drug|0|||
143155469|NCT00758043|516113973|FG003|Overall Study|Non-Compliant With study Drug|1|||
143155470|NCT00758043|516113970|FG000|Overall Study|Other Reasons|0|||
143155471|NCT00758043|516113971|FG001|Overall Study|Other Reasons|1|||
143155472|NCT00758043|516113972|FG002|Overall Study|Other Reasons|0|||
143155473|NCT00758043|516113973|FG003|Overall Study|Other Reasons|5|||
143155474|NCT03073109|516113974|FG000|Overall Study|Adverse Event|0|||
143155475|NCT03073109|516113975|FG001|Overall Study|Adverse Event|1|||
143155476|NCT03073109|516113974|FG000|Overall Study|Other|2|||
143155477|NCT03073109|516113975|FG001|Overall Study|Other|0|||
143155478|NCT03073109|516113974|FG000|Overall Study|Lost to Follow-up|8|||
143155479|NCT03073109|516113975|FG001|Overall Study|Lost to Follow-up|1|||
143155480|NCT01875237|516113976|FG000|Overall Study|GVDH before DLI|1|||
143155481|NCT01875237|516113977|FG001|Overall Study|GVDH before DLI|0|||
143155482|NCT01875237|516113976|FG000|Overall Study|DLI cells could not be produced|1|||
143155483|NCT01875237|516113977|FG001|Overall Study|DLI cells could not be produced|0|||
143155484|NCT00245570|516113980|FG000|Washout Between Periods III and IV|Adverse Event|0|||
143155485|NCT00245570|516113981|FG001|Washout Between Periods III and IV|Adverse Event|1|||
143155486|NCT00245570|516113982|FG002|Washout Between Periods III and IV|Adverse Event|0|||
143155487|NCT00245570|516113983|FG003|Washout Between Periods III and IV|Adverse Event|0|||
143155488|NCT00245570|516113984|FG004|Washout Between Periods III and IV|Adverse Event|0|||
143155489|NCT00245570|516113985|FG005|Washout Between Periods III and IV|Adverse Event|0|||
143155490|NCT01028560|516113992|FG000|Overall Study|Lack of Efficacy|3|||
143155491|NCT01028560|516113993|FG001|Overall Study|Lack of Efficacy|6|||
143155492|NCT01028560|516113992|FG000|Overall Study|Withdrawal by Subject|7|||
143155493|NCT01028560|516113993|FG001|Overall Study|Withdrawal by Subject|12|||
143155494|NCT01960842|516113998|FG000|Overall Study|Adverse Event|1|||
143155495|NCT01960842|516113998|FG000|Overall Study|Withdrawal by Subject|2|||
143155496|NCT02391584|516113999|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
143155497|NCT02391584|516114000|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
143155498|NCT02391584|516113999|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
143155499|NCT02391584|516114000|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
143155500|NCT02391584|516113999|FG000|3 Month|Lost to Follow-up|1|||
143155501|NCT02391584|516114000|FG001|3 Month|Lost to Follow-up|0|||
143155502|NCT02391584|516113999|FG000|6 Month|Withdrawal by Subject|1|||
143155503|NCT02391584|516114000|FG001|6 Month|Withdrawal by Subject|0|||
143155504|NCT02391584|516113999|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
143020280|NCT00410410|515614879|FG004|Open-Label Period (OL)|Pregnancy|0|||
143020281|NCT00410410|515614880|FG005|Open-Label Period (OL)|Pregnancy|0|||
143020282|NCT00410410|515614881|FG006|Open-Label Period (OL)|Pregnancy|0|||
143020283|NCT00410410|515614882|FG007|Open-Label Period (OL)|Pregnancy|0|||
143020284|NCT00410410|515614883|FG008|Open-Label Period (OL)|Pregnancy|1|||
143020285|NCT00410410|515614875|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
143020286|NCT00410410|515614876|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
143020287|NCT00410410|515614877|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
143020288|NCT00410410|515614878|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
143020289|NCT00410410|515614879|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
143020290|NCT00410410|515614880|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
143020291|NCT00410410|515614881|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
143020292|NCT00410410|515614882|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
143020293|NCT00410410|515614883|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
143020294|NCT00410410|515614875|FG000|Open-Label Period (OL)|Other|0|||
143020295|NCT00410410|515614876|FG001|Open-Label Period (OL)|Other|0|||
143020296|NCT00410410|515614877|FG002|Open-Label Period (OL)|Other|0|||
143020297|NCT00410410|515614878|FG003|Open-Label Period (OL)|Other|0|||
143020298|NCT00410410|515614879|FG004|Open-Label Period (OL)|Other|0|||
143020299|NCT00410410|515614880|FG005|Open-Label Period (OL)|Other|0|||
143020300|NCT00410410|515614881|FG006|Open-Label Period (OL)|Other|0|||
143020301|NCT00410410|515614882|FG007|Open-Label Period (OL)|Other|0|||
143020302|NCT00410410|515614883|FG008|Open-Label Period (OL)|Other|7|||
143020303|NCT01783496|515614884|FG000|Overall Study|Lost to Follow-up|0|||
143020304|NCT01783496|515614885|FG001|Overall Study|Lost to Follow-up|0|||
143020305|NCT01783496|515614886|FG002|Overall Study|Lost to Follow-up|0|||
143020306|NCT01783496|515614887|FG003|Overall Study|Lost to Follow-up|2|||
143020307|NCT01783496|515614888|FG004|Overall Study|Lost to Follow-up|0|||
143020308|NCT01783496|515614889|FG005|Overall Study|Lost to Follow-up|1|||
143020309|NCT01783496|515614884|FG000|Overall Study|Withdrawal by Subject|1|||
143020310|NCT01783496|515614885|FG001|Overall Study|Withdrawal by Subject|0|||
143020311|NCT01783496|515614886|FG002|Overall Study|Withdrawal by Subject|0|||
143020312|NCT01783496|515614887|FG003|Overall Study|Withdrawal by Subject|0|||
143020313|NCT01783496|515614888|FG004|Overall Study|Withdrawal by Subject|0|||
143020314|NCT01783496|515614889|FG005|Overall Study|Withdrawal by Subject|0|||
143020315|NCT01789281|515614892|FG000|Overall Study|Disease progression|15|||
143020316|NCT01789281|515614893|FG001|Overall Study|Disease progression|4|||
143020317|NCT01789281|515614892|FG000|Overall Study|Adverse Event|5|||
143020318|NCT01789281|515614893|FG001|Overall Study|Adverse Event|5|||
143020319|NCT01789281|515614892|FG000|Overall Study|Withdrawal by Subject|1|||
143020320|NCT01789281|515614893|FG001|Overall Study|Withdrawal by Subject|0|||
143020321|NCT01789281|515614892|FG000|Overall Study|Lost to Follow-up|1|||
143020322|NCT01789281|515614893|FG001|Overall Study|Lost to Follow-up|0|||
143020323|NCT01789281|515614892|FG000|Overall Study|Administrative problems|0|||
143020324|NCT01789281|515614893|FG001|Overall Study|Administrative problems|1|||
143020325|NCT00686920|515614894|FG000|Overall Study|Death|45|||
143020326|NCT00686920|515614895|FG001|Overall Study|Death|14|||
143020327|NCT00686920|515614894|FG000|Overall Study|Liver Transplant|23|||
143020328|NCT00686920|515614895|FG001|Overall Study|Liver Transplant|8|||
143020329|NCT00686920|515614894|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
143020330|NCT00686920|515614895|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
143020331|NCT00686920|515614894|FG000|Overall Study|Withdrawal by Subject|23|||
143020332|NCT00686920|515614895|FG001|Overall Study|Withdrawal by Subject|5|||
143020333|NCT00686920|515614894|FG000|Overall Study|Protocol Violation|2|||
143155505|NCT02391584|516114000|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
143155506|NCT01371565|516114022|FG000|Overall Study|Withdrawal by Subject|1|||
143155507|NCT01371565|516114022|FG000|Overall Study|Death|1|||
143155508|NCT01371565|516114022|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
143155509|NCT04996264|516114023|FG000|Overall Study|Lost to Follow-up|0|||
143155510|NCT04996264|516114024|FG001|Overall Study|Lost to Follow-up|1|||
143155511|NCT04996264|516114023|FG000|Overall Study|Withdrawal by Subject|4|||
143155512|NCT04996264|516114024|FG001|Overall Study|Withdrawal by Subject|3|||
143155513|NCT04996264|516114023|FG000|Overall Study|1 left AMA|0|||
143155514|NCT04996264|516114024|FG001|Overall Study|1 left AMA|1|||
143020334|NCT00686920|515614895|FG001|Overall Study|Protocol Violation|1|||
143020335|NCT00686920|515614894|FG000|Overall Study|Adverse Event|10|||
143020336|NCT00686920|515614895|FG001|Overall Study|Adverse Event|2|||
143020337|NCT00686920|515614894|FG000|Overall Study|Personal Reason|0|||
143155515|NCT04996264|516114023|FG000|Overall Study|Subject changed hospitals|0|||
143155516|NCT04996264|516114024|FG001|Overall Study|Subject changed hospitals|1|||
143155517|NCT04996264|516114023|FG000|Overall Study|unable to complete due to work|0|||
143155518|NCT04996264|516114024|FG001|Overall Study|unable to complete due to work|1|||
143155519|NCT04392635|516114025|FG000|Overall Study|Lost to Follow-up|0|||
143155520|NCT04392635|516114026|FG001|Overall Study|Lost to Follow-up|1|||
143020338|NCT00686920|515614895|FG001|Overall Study|Personal Reason|1|||
143020339|NCT00686920|515614894|FG000|Overall Study|Lost to Follow-up|15|||
143020340|NCT00686920|515614895|FG001|Overall Study|Lost to Follow-up|3|||
143020341|NCT00686920|515614894|FG000|Overall Study|Moved to Another State|1|||
143020342|NCT00686920|515614895|FG001|Overall Study|Moved to Another State|0|||
143020343|NCT00686920|515614894|FG000|Overall Study|Transferred to Nursing Home|1|||
143020344|NCT00686920|515614895|FG001|Overall Study|Transferred to Nursing Home|0|||
143020345|NCT00686920|515614894|FG000|Overall Study|Noncompliance|9|||
143020346|NCT00686920|515614895|FG001|Overall Study|Noncompliance|0|||
143020347|NCT00686920|515614894|FG000|Overall Study|Principal Investigator Decision|2|||
143020348|NCT00686920|515614895|FG001|Overall Study|Principal Investigator Decision|0|||
143020349|NCT00947011|515614897|FG000|Overall Study|Study was terminated,PI left institution|12|||
143020350|NCT00449930|515614898|FG000|Overall Study|Adverse Event|9|||
143020351|NCT00449930|515614899|FG001|Overall Study|Adverse Event|19|||
143020352|NCT00449930|515614898|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
143020353|NCT00449930|515614899|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
143020354|NCT00449930|515614898|FG000|Overall Study|Lack of Efficacy|10|||
143020355|NCT00449930|515614899|FG001|Overall Study|Lack of Efficacy|1|||
143020356|NCT00449930|515614898|FG000|Overall Study|Lost to Follow-up|9|||
143020357|NCT00449930|515614899|FG001|Overall Study|Lost to Follow-up|14|||
143020358|NCT00449930|515614898|FG000|Overall Study|Physician Decision|1|||
143020359|NCT00449930|515614899|FG001|Overall Study|Physician Decision|2|||
143020360|NCT00449930|515614898|FG000|Overall Study|Protocol Violation|14|||
143020361|NCT00449930|515614899|FG001|Overall Study|Protocol Violation|15|||
143020362|NCT00449930|515614898|FG000|Overall Study|Withdrawal by Subject|16|||
143020363|NCT00449930|515614899|FG001|Overall Study|Withdrawal by Subject|23|||
143020364|NCT00449930|515614898|FG000|Overall Study|Glycemic discontinuation criteria|1|||
143020365|NCT00449930|515614899|FG001|Overall Study|Glycemic discontinuation criteria|1|||
143020366|NCT01964105|515614900|FG000|Overall Study|Lost to Follow-up|2|||
143020367|NCT01964105|515614901|FG001|Overall Study|Lost to Follow-up|13|||
143020368|NCT01964105|515614902|FG002|Overall Study|Lost to Follow-up|0|||
143020369|NCT02746705|515614903|FG000|Overall Study|Physician Decision|1|||
143020370|NCT02746705|515614904|FG001|Overall Study|Physician Decision|1|||
143020371|NCT02746705|515614903|FG000|Overall Study|Lost to Follow-up|1|||
143020372|NCT02746705|515614904|FG001|Overall Study|Lost to Follow-up|0|||
143020373|NCT02746705|515614903|FG000|Overall Study|outlier scores deemed not valid|0|||
143020374|NCT02746705|515614904|FG001|Overall Study|outlier scores deemed not valid|1|||
143155521|NCT02030418|516114028|FG000|Overall Study|Death|78|||
143155522|NCT02030418|516114028|FG000|Overall Study|Missed 12-Month Visit|9|||
143155523|NCT02030418|516114028|FG000|Overall Study|Withdrawn|57|||
143155524|NCT05061706|516114029|FG000|Overall Study|Adverse Event|29|||
143020375|NCT00575328|515614905|FG000|Overall Study|Adverse Event|1|||
143020376|NCT00575328|515614906|FG001|Overall Study|Adverse Event|1|||
143020377|NCT00575328|515614905|FG000|Overall Study|Lost to Follow-up|2|||
143155525|NCT05061706|516114030|FG001|Overall Study|Adverse Event|1|||
143155526|NCT05061706|516114029|FG000|Overall Study|Lack of Efficacy|0|||
143155527|NCT05061706|516114030|FG001|Overall Study|Lack of Efficacy|1|||
143155528|NCT05061706|516114029|FG000|Overall Study|Lost to Follow-up|2|||
143155529|NCT05061706|516114030|FG001|Overall Study|Lost to Follow-up|2|||
143155530|NCT05061706|516114029|FG000|Overall Study|Protocol Violation|3|||
143155531|NCT05061706|516114030|FG001|Overall Study|Protocol Violation|1|||
143155532|NCT05061706|516114029|FG000|Overall Study|Withdrawal by Subject|3|||
143155533|NCT05061706|516114030|FG001|Overall Study|Withdrawal by Subject|9|||
143155534|NCT01179516|516114035|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
143155535|NCT01179516|516114036|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
143155536|NCT01179516|516114037|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
143155537|NCT01179516|516114035|FG000|Overall Study|Lack of Efficacy|4|||
143155538|NCT01179516|516114036|FG001|Overall Study|Lack of Efficacy|2|||
143155539|NCT01179516|516114037|FG002|Overall Study|Lack of Efficacy|0|||
143155540|NCT01179516|516114035|FG000|Overall Study|Noncompliance with Study Drug|2|||
143155541|NCT01179516|516114036|FG001|Overall Study|Noncompliance with Study Drug|0|||
143155542|NCT01179516|516114037|FG002|Overall Study|Noncompliance with Study Drug|1|||
143155543|NCT01179516|516114035|FG000|Overall Study|Protocol Deviations|4|||
143155544|NCT01179516|516114036|FG001|Overall Study|Protocol Deviations|3|||
143155545|NCT01179516|516114037|FG002|Overall Study|Protocol Deviations|3|||
143155546|NCT01179516|516114035|FG000|Overall Study|Withdrawal of Consent|2|||
143155547|NCT01179516|516114036|FG001|Overall Study|Withdrawal of Consent|6|||
143155548|NCT01179516|516114037|FG002|Overall Study|Withdrawal of Consent|10|||
143155549|NCT01179516|516114035|FG000|Overall Study|Lost to Follow-up|7|||
143020378|NCT00575328|515614906|FG001|Overall Study|Lost to Follow-up|1|||
143020379|NCT01430104|515614907|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
143155550|NCT01179516|516114036|FG001|Overall Study|Lost to Follow-up|7|||
143155551|NCT01179516|516114037|FG002|Overall Study|Lost to Follow-up|3|||
143155552|NCT01179516|516114035|FG000|Overall Study|Other|2|||
143155553|NCT01179516|516114036|FG001|Overall Study|Other|0|||
143155554|NCT01179516|516114037|FG002|Overall Study|Other|2|||
143020380|NCT02124746|515614908|FG000|Overall Study|Adverse Event|2|||
143020381|NCT02124746|515614909|FG001|Overall Study|Adverse Event|1|||
143020382|NCT02124746|515614910|FG002|Overall Study|Adverse Event|2|||
143020383|NCT02124746|515614908|FG000|Overall Study|Death|2|||
143020384|NCT02124746|515614909|FG001|Overall Study|Death|1|||
143020385|NCT02124746|515614910|FG002|Overall Study|Death|3|||
143020386|NCT02124746|515614908|FG000|Overall Study|Lack of Efficacy|3|||
143020387|NCT02124746|515614909|FG001|Overall Study|Lack of Efficacy|2|||
143155555|NCT02697422|516114051|FG000|Overall Study|Declined exit survey|9|||
143155556|NCT02697422|516114052|FG001|Overall Study|Declined exit survey|2|||
143155557|NCT02697422|516114051|FG000|Overall Study|Lost to Follow-up|13|||
143155558|NCT02697422|516114052|FG001|Overall Study|Lost to Follow-up|8|||
143155559|NCT02697422|516114051|FG000|Overall Study|Death|2|||
143155560|NCT02697422|516114052|FG001|Overall Study|Death|1|||
143155561|NCT02697422|516114051|FG000|Overall Study|Withdrawal by Subject|0|||
143155562|NCT02697422|516114052|FG001|Overall Study|Withdrawal by Subject|1|||
143155563|NCT02697422|516114051|FG000|Overall Study|Physician Decision|1|||
143155564|NCT02697422|516114052|FG001|Overall Study|Physician Decision|1|||
143155565|NCT02697422|516114051|FG000|Overall Study|Exit survey data lost|1|||
143155566|NCT02697422|516114052|FG001|Overall Study|Exit survey data lost|0|||
143155567|NCT03501277|516114053|FG000|Intervention Period 1 (4 Days)|Other|0|||
143155568|NCT03501277|516114054|FG001|Intervention Period 1 (4 Days)|Other|0|||
143155569|NCT03501277|516114055|FG002|Intervention Period 1 (4 Days)|Other|1|||
143155570|NCT03501277|516114056|FG003|Intervention Period 1 (4 Days)|Other|0|||
143155571|NCT03501277|516114053|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
143155572|NCT03501277|516114054|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
143155573|NCT03501277|516114055|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
143155574|NCT03501277|516114056|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
143155575|NCT03501277|516114053|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
143155576|NCT03501277|516114054|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
143155577|NCT03501277|516114055|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
143155578|NCT03501277|516114056|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
143155579|NCT03501277|516114053|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
143155580|NCT03501277|516114054|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
143155581|NCT03501277|516114055|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
143155582|NCT03501277|516114056|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
143155583|NCT03983109|516114057|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
143155584|NCT03983109|516114058|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
143155585|NCT04149353|516114062|FG000|Overall Study|Study terminated|1|||
143155586|NCT02068599|516114063|FG000|Overall Study|Adverse Event|4|||
143155587|NCT02068599|516114064|FG001|Overall Study|Adverse Event|1|||
143155588|NCT02068599|516114065|FG002|Overall Study|Adverse Event|1|||
143155589|NCT02068599|516114063|FG000|Overall Study|Withdrawal by Subject|2|||
143155590|NCT02068599|516114064|FG001|Overall Study|Withdrawal by Subject|7|||
143155591|NCT02068599|516114065|FG002|Overall Study|Withdrawal by Subject|5|||
143155592|NCT02068599|516114063|FG000|Overall Study|Protocol Violation|4|||
143155593|NCT02068599|516114064|FG001|Overall Study|Protocol Violation|2|||
143155594|NCT02068599|516114065|FG002|Overall Study|Protocol Violation|3|||
143155595|NCT02068599|516114063|FG000|Overall Study|Lost to Follow-up|1|||
143155596|NCT02068599|516114064|FG001|Overall Study|Lost to Follow-up|0|||
143155597|NCT02068599|516114065|FG002|Overall Study|Lost to Follow-up|0|||
143155598|NCT02068599|516114063|FG000|Overall Study|Lack of Efficacy|0|||
143155599|NCT02068599|516114064|FG001|Overall Study|Lack of Efficacy|0|||
143155600|NCT02068599|516114065|FG002|Overall Study|Lack of Efficacy|3|||
143155601|NCT02068599|516114063|FG000|Overall Study|Noncompliance|0|||
143155602|NCT02068599|516114064|FG001|Overall Study|Noncompliance|0|||
143155603|NCT02068599|516114065|FG002|Overall Study|Noncompliance|1|||
143155604|NCT03019588|516114066|FG000|Overall Study|Death|44|||
143155605|NCT03019588|516114067|FG001|Overall Study|Death|46|||
143155606|NCT03019588|516114066|FG000|Overall Study|Study terminated by Sponsor|3|||
143155607|NCT03019588|516114067|FG001|Overall Study|Study terminated by Sponsor|1|||
143155608|NCT00887588|516114068|FG000|Core Period|Death|1|||
143155609|NCT00887588|516114069|FG001|Core Period|Death|1|||
143155610|NCT00887588|516114068|FG000|Core Period|Lost to Follow-up|3|||
143155611|NCT00887588|516114069|FG001|Core Period|Lost to Follow-up|1|||
143155612|NCT00887588|516114068|FG000|Core Period|Withdrawal by Subject|6|||
143155613|NCT00887588|516114069|FG001|Core Period|Withdrawal by Subject|8|||
143155614|NCT00887588|516114068|FG000|Core Period|Adverse Event|9|||
143155615|NCT00887588|516114069|FG001|Core Period|Adverse Event|11|||
143155616|NCT00887588|516114068|FG000|Extension Period|Adverse Event|4|||
143155617|NCT00887588|516114069|FG001|Extension Period|Adverse Event|4|||
143155618|NCT00887588|516114068|FG000|Extension Period|Death|0|||
143155619|NCT00887588|516114069|FG001|Extension Period|Death|1|||
143155620|NCT00887588|516114068|FG000|Extension Period|Protocol deviation|1|||
143155621|NCT00887588|516114069|FG001|Extension Period|Protocol deviation|0|||
143155622|NCT00887588|516114068|FG000|Extension Period|Lost to Follow-up|1|||
143155623|NCT00887588|516114069|FG001|Extension Period|Lost to Follow-up|0|||
143155624|NCT00366535|516114070|FG000|First Phase: 12 Weeks|Adverse Event|1|||
143155625|NCT00366535|516114071|FG001|First Phase: 12 Weeks|Adverse Event|3|||
143155626|NCT00366535|516114070|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
143155627|NCT00366535|516114071|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
143155628|NCT00366535|516114070|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
143155629|NCT00366535|516114071|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
143155630|NCT00366535|516114070|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
143155631|NCT00366535|516114071|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
143155632|NCT02958527|516114072|FG000|Overall Study|Not collected CRFs|12|||
143155633|NCT03753542|516114073|FG000|Overall Study|Lost to Follow-up|9|||
143020388|NCT02124746|515614910|FG002|Overall Study|Lack of Efficacy|2|||
143020389|NCT02124746|515614908|FG000|Overall Study|Physician Decision|6|||
143020390|NCT02124746|515614909|FG001|Overall Study|Physician Decision|4|||
143020391|NCT02124746|515614910|FG002|Overall Study|Physician Decision|5|||
143020392|NCT02124746|515614908|FG000|Overall Study|Non-Compliance with Study Drug|0|||
143020393|NCT02124746|515614909|FG001|Overall Study|Non-Compliance with Study Drug|1|||
143020394|NCT02124746|515614910|FG002|Overall Study|Non-Compliance with Study Drug|0|||
143020395|NCT02124746|515614908|FG000|Overall Study|Withdrawal by Subject|3|||
143020396|NCT02124746|515614909|FG001|Overall Study|Withdrawal by Subject|3|||
143020397|NCT02124746|515614910|FG002|Overall Study|Withdrawal by Subject|0|||
143020398|NCT02124746|515614908|FG000|Overall Study|Study Terminated by Sponsor|0|||
143485667|NCT01192022|517322866|FG002|Overall Study|Parents did not allow all follow up|0|||
143485668|NCT01192022|517322867|FG003|Overall Study|Parents did not allow all follow up|1|||
143485669|NCT01192022|517322868|FG004|Overall Study|Parents did not allow all follow up|0|||
143485670|NCT03865706|517322870|FG000|Overall Study|Death|0|||
143020399|NCT02124746|515614909|FG001|Overall Study|Study Terminated by Sponsor|0|||
143020400|NCT02124746|515614910|FG002|Overall Study|Study Terminated by Sponsor|6|||
143020401|NCT02124746|515614908|FG000|Overall Study|Disease Progression|3|||
143020402|NCT02124746|515614909|FG001|Overall Study|Disease Progression|6|||
143020403|NCT02124746|515614910|FG002|Overall Study|Disease Progression|4|||
143020404|NCT03124381|515614913|FG000|Overall Study|Lost to Follow-up|1|||
143020405|NCT03124381|515614914|FG001|Overall Study|Lost to Follow-up|1|||
143020406|NCT03124381|515614913|FG000|Overall Study|Withdrawal by Subject|6|||
143020407|NCT03124381|515614914|FG001|Overall Study|Withdrawal by Subject|3|||
143020408|NCT03124381|515614913|FG000|Overall Study|Protocol Violation|0|||
143020409|NCT03124381|515614914|FG001|Overall Study|Protocol Violation|1|||
143020410|NCT03124381|515614913|FG000|Overall Study|Adverse Event|1|||
143020411|NCT03124381|515614914|FG001|Overall Study|Adverse Event|1|||
143020412|NCT03124381|515614913|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
143020413|NCT03124381|515614914|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
143020414|NCT05017493|515614925|FG000|Overall Study|Withdrawal by Subject|26|||
143020415|NCT05017493|515614926|FG001|Overall Study|Withdrawal by Subject|0|||
143020416|NCT05017493|515614925|FG000|Overall Study|Physician Decision|15|||
143485671|NCT03865706|517322871|FG001|Overall Study|Death|3|||
143485672|NCT03865706|517322872|FG002|Overall Study|Death|1|||
143485673|NCT02095535|517322873|FG000|Recruitment|Protocol Violation|2|||
143485674|NCT00623480|517322874|FG000|Overall Study|Lost to Follow-up|0|||
143485675|NCT00623480|517322875|FG001|Overall Study|Lost to Follow-up|1|||
143485676|NCT00623480|517322874|FG000|Overall Study|Withdrawal by Subject|2|||
143485677|NCT00623480|517322875|FG001|Overall Study|Withdrawal by Subject|4|||
143485678|NCT00623480|517322874|FG000|Overall Study|Lack of Efficacy|1|||
143485679|NCT00623480|517322875|FG001|Overall Study|Lack of Efficacy|0|||
143485680|NCT00623480|517322874|FG000|Overall Study|Non-compliant with study medication|4|||
143485681|NCT00623480|517322875|FG001|Overall Study|Non-compliant with study medication|0|||
143485682|NCT00623480|517322874|FG000|Overall Study|Protocol Violation|0|||
143485683|NCT00623480|517322875|FG001|Overall Study|Protocol Violation|1|||
143485684|NCT00623480|517322874|FG000|Overall Study|Site closed by sponsor|0|||
143485685|NCT00623480|517322875|FG001|Overall Study|Site closed by sponsor|1|||
143485686|NCT00781456|517322876|FG000|Overall Study|Adverse Event|3|||
143485687|NCT00781456|517322877|FG001|Overall Study|Adverse Event|3|||
143485688|NCT00781456|517322876|FG000|Overall Study|Withdrawal by Subject|3|||
143485689|NCT00781456|517322877|FG001|Overall Study|Withdrawal by Subject|5|||
143485690|NCT00781456|517322876|FG000|Overall Study|Protocol Violation|4|||
143485691|NCT00781456|517322877|FG001|Overall Study|Protocol Violation|1|||
143485692|NCT00781456|517322876|FG000|Overall Study|Noncompliance With Protocol|1|||
143485693|NCT00781456|517322877|FG001|Overall Study|Noncompliance With Protocol|1|||
143485694|NCT00781456|517322876|FG000|Overall Study|Lost to Follow-up|10|||
143020417|NCT05017493|515614926|FG001|Overall Study|Physician Decision|0|||
143020418|NCT05017493|515614925|FG000|Overall Study|Protocol Violation|81|||
143020419|NCT05017493|515614926|FG001|Overall Study|Protocol Violation|0|||
143020420|NCT04071626|515614928|FG000|Overall Study|Withdrawal by Subject|1|||
143485695|NCT00781456|517322877|FG001|Overall Study|Lost to Follow-up|5|||
143020421|NCT04071626|515614929|FG001|Overall Study|Withdrawal by Subject|1|||
143155634|NCT03753542|516114074|FG001|Overall Study|Lost to Follow-up|14|||
143155635|NCT04180696|516114077|FG000|Overall Study|Death|5|||
143155636|NCT04180696|516114078|FG001|Overall Study|Death|6|||
143155637|NCT04180696|516114077|FG000|Overall Study|Lost to Follow-up|1|||
143485696|NCT00781456|517322876|FG000|Overall Study|Other Reason, Unknown|0|||
143020422|NCT04071626|515614928|FG000|Overall Study|Protocol Violation|0|||
143020423|NCT04071626|515614929|FG001|Overall Study|Protocol Violation|1|||
143020424|NCT00529568|515614930|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
143020425|NCT00529568|515614931|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
143155638|NCT04180696|516114078|FG001|Overall Study|Lost to Follow-up|0|||
143485697|NCT00781456|517322877|FG001|Overall Study|Other Reason, Unknown|1|||
143485698|NCT01594853|517322878|FG000|Overall Study|Withdrawal by Subject|1|||
143485699|NCT01594853|517322879|FG001|Overall Study|Withdrawal by Subject|1|||
143485700|NCT01594853|517322878|FG000|Overall Study|Lost to Follow-up|1|||
143485701|NCT01594853|517322879|FG001|Overall Study|Lost to Follow-up|1|||
143020426|NCT00529568|515614932|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
143020427|NCT00529568|515614930|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
143020428|NCT00529568|515614931|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
143020429|NCT00529568|515614932|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
143020430|NCT00529568|515614930|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
143020431|NCT00529568|515614931|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
143020432|NCT00529568|515614932|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
143020433|NCT00529568|515614930|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
143020434|NCT00529568|515614931|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
143020435|NCT00529568|515614932|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
143020436|NCT00529568|515614930|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
143020437|NCT00529568|515614931|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
143020438|NCT00529568|515614932|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
143020439|NCT00529568|515614930|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
143020440|NCT00529568|515614931|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
143020441|NCT00529568|515614932|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
143020442|NCT00529568|515614930|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
143020443|NCT00529568|515614931|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
143020444|NCT00529568|515614932|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
143020445|NCT00529568|515614930|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
143020446|NCT00529568|515614931|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
143020447|NCT00529568|515614932|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
143020448|NCT00529568|515614930|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
143020449|NCT00529568|515614931|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
143020450|NCT00529568|515614932|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
143020451|NCT00529568|515614930|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
143020452|NCT00529568|515614931|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
143020453|NCT00529568|515614932|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
143020454|NCT00529568|515614930|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
143020455|NCT00529568|515614931|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
143020456|NCT00529568|515614932|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
143020457|NCT00931385|515614933|FG000|Overall Study|Adverse Event|2|||
143020458|NCT00931385|515614934|FG001|Overall Study|Adverse Event|1|||
143020459|NCT00931385|515614935|FG002|Overall Study|Adverse Event|0|||
143020460|NCT00931385|515614936|FG003|Overall Study|Adverse Event|3|||
143020461|NCT00931385|515614933|FG000|Overall Study|Protocol Violation|0|||
143020462|NCT00931385|515614934|FG001|Overall Study|Protocol Violation|0|||
143020463|NCT00931385|515614935|FG002|Overall Study|Protocol Violation|1|||
143020464|NCT00931385|515614936|FG003|Overall Study|Protocol Violation|0|||
143020465|NCT00931385|515614933|FG000|Overall Study|Withdrawal by Subject|0|||
143020466|NCT00931385|515614934|FG001|Overall Study|Withdrawal by Subject|1|||
143020467|NCT00931385|515614935|FG002|Overall Study|Withdrawal by Subject|0|||
143020468|NCT00931385|515614936|FG003|Overall Study|Withdrawal by Subject|1|||
143020469|NCT00931385|515614933|FG000|Overall Study|Lost to Follow-up|0|||
143020470|NCT00931385|515614934|FG001|Overall Study|Lost to Follow-up|0|||
143020471|NCT00931385|515614935|FG002|Overall Study|Lost to Follow-up|0|||
143020472|NCT00931385|515614936|FG003|Overall Study|Lost to Follow-up|1|||
143020473|NCT01201356|515614937|FG000|Overall Study|Adverse Event|170|||
143020474|NCT01201356|515614937|FG000|Overall Study|Abnormal laboratory value(s)|51|||
143020475|NCT01201356|515614937|FG000|Overall Study|Abnormal test procedure result(s)|3|||
143020476|NCT01201356|515614937|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
143020477|NCT01201356|515614937|FG000|Overall Study|Condition no longer requires study drug|12|||
143020478|NCT01201356|515614937|FG000|Overall Study|Withdrawal by Subject|144|||
143020479|NCT01201356|515614937|FG000|Overall Study|Lost to Follow-up|50|||
143020480|NCT01201356|515614937|FG000|Overall Study|administrative problems|74|||
143020481|NCT01201356|515614937|FG000|Overall Study|Death|16|||
143020482|NCT01201356|515614937|FG000|Overall Study|Protocol Violation|12|||
143020483|NCT00665626|515614938|FG000|Overall Study|Lack of Efficacy|8|||
143020484|NCT00665626|515614939|FG001|Overall Study|Lack of Efficacy|5|||
143020485|NCT00665626|515614938|FG000|Overall Study|Lost to Follow-up|0|||
143020486|NCT00665626|515614939|FG001|Overall Study|Lost to Follow-up|2|||
143020487|NCT00665626|515614938|FG000|Overall Study|Withdrawal by Subject|0|||
143020488|NCT00665626|515614939|FG001|Overall Study|Withdrawal by Subject|1|||
143020489|NCT00665626|515614938|FG000|Overall Study|Protocol Violation|0|||
143020490|NCT00665626|515614939|FG001|Overall Study|Protocol Violation|2|||
143020491|NCT00665626|515614938|FG000|Overall Study|Adverse Event|1|||
143020492|NCT00665626|515614939|FG001|Overall Study|Adverse Event|9|||
143020493|NCT00665626|515614938|FG000|Overall Study|Due to exclusion criteria|0|||
143020494|NCT00665626|515614939|FG001|Overall Study|Due to exclusion criteria|1|||
143020495|NCT00665626|515614938|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
143020496|NCT00665626|515614939|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
143020497|NCT00665626|515614938|FG000|Overall Study|Unably to comply with dosing regimen|0|||
143020498|NCT00665626|515614939|FG001|Overall Study|Unably to comply with dosing regimen|1|||
143020499|NCT00665626|515614938|FG000|Overall Study|Death|1|||
143020500|NCT00665626|515614939|FG001|Overall Study|Death|0|||
143020501|NCT04079842|515614940|FG000|Overall Study|Request of subject|2|||
143020502|NCT04079842|515614940|FG000|Overall Study|Unable to draw Arterial samples|1|||
143020503|NCT02904200|515614941|FG000|Overall Study|Withdrawal by Subject|1|||
143020504|NCT02904200|515614942|FG001|Overall Study|Withdrawal by Subject|0|||
143020505|NCT00420290|515614943|FG000|Overall Study|Adverse Event|3|||
143020506|NCT00420290|515614944|FG001|Overall Study|Adverse Event|1|||
143020507|NCT00420290|515614943|FG000|Overall Study|Withdrawal by Subject|0|||
143020508|NCT00420290|515614944|FG001|Overall Study|Withdrawal by Subject|2|||
143020509|NCT00420290|515614943|FG000|Overall Study|did not meet inclusion/exclusion|1|||
143020510|NCT00420290|515614944|FG001|Overall Study|did not meet inclusion/exclusion|1|||
143020511|NCT01623830|515616760|FG000|Overall Study|Withdrawal by Subject|6|||
143020512|NCT01623830|515616761|FG001|Overall Study|Withdrawal by Subject|7|||
143020513|NCT01623830|515616760|FG000|Overall Study|Exclusion from Study|1|||
143020514|NCT01623830|515616761|FG001|Overall Study|Exclusion from Study|2|||
143020515|NCT02024698|515616762|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
143020516|NCT02024698|515616763|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
143020517|NCT00275028|515616764|FG000|Overall Study|Withdrew consent before treatment began|1|||
143020518|NCT00275028|515616764|FG000|Overall Study|Withdrawal by Subject|5|||
143020519|NCT00275028|515616764|FG000|Overall Study|Adverse Event|9|||
143020520|NCT00275028|515616764|FG000|Overall Study|Progressive Disease|30|||
143020521|NCT00275028|515616764|FG000|Overall Study|Physician Decision|2|||
143020522|NCT01859390|515616767|FG000|Overall Study|Insufficient Sputum Collected|1|||
143020523|NCT01859390|515616768|FG001|Overall Study|Insufficient Sputum Collected|3|||
143020524|NCT01859390|515616767|FG000|Overall Study|Sample Missing Collection Date|0|||
143020525|NCT01859390|515616768|FG001|Overall Study|Sample Missing Collection Date|1|||
143020526|NCT01859390|515616767|FG000|Overall Study|Tube Cracked|0|||
143020527|NCT01859390|515616768|FG001|Overall Study|Tube Cracked|2|||
143020528|NCT01859390|515616767|FG000|Overall Study|Shipment Error|0|||
143020529|NCT01859390|515616768|FG001|Overall Study|Shipment Error|1|||
143020530|NCT02764489|515616770|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
143020531|NCT02764489|515616771|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
143020532|NCT02764489|515616770|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
143020533|NCT02764489|515616771|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
143020534|NCT02764489|515616770|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
143020535|NCT02764489|515616771|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
143020536|NCT02764489|515616770|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
143020537|NCT02764489|515616771|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
143020538|NCT01706198|515616773|FG000|Overall Study|Adverse Event|12|||
143020539|NCT01706198|515616774|FG001|Overall Study|Adverse Event|15|||
143020540|NCT01706198|515616773|FG000|Overall Study|Protocol Violation|7|||
143020541|NCT01706198|515616774|FG001|Overall Study|Protocol Violation|5|||
143020542|NCT01706198|515616773|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
143020543|NCT01706198|515616774|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
143020544|NCT01706198|515616773|FG000|Overall Study|Lost to Follow-up|97|||
143020545|NCT01706198|515616774|FG001|Overall Study|Lost to Follow-up|93|||
143020546|NCT01706198|515616773|FG000|Overall Study|Physician Decision|23|||
143020547|NCT01706198|515616774|FG001|Overall Study|Physician Decision|37|||
143020548|NCT01706198|515616773|FG000|Overall Study|Withdrawal by Subject|23|||
143020549|NCT01706198|515616774|FG001|Overall Study|Withdrawal by Subject|31|||
143020550|NCT04313283|515616775|FG000|Overall Study|did not complete intervention|4|||
143020551|NCT01084005|515616776|FG000|Overall Study|Adverse Event|1|||
143020552|NCT01084005|515616777|FG001|Overall Study|Adverse Event|8|||
143020553|NCT01084005|515616776|FG000|Overall Study|Protocol Violation|3|||
143020554|NCT01084005|515616777|FG001|Overall Study|Protocol Violation|7|||
143020555|NCT01084005|515616776|FG000|Overall Study|Withdrawal by Subject|1|||
143020556|NCT01084005|515616777|FG001|Overall Study|Withdrawal by Subject|1|||
143020557|NCT02736227|515616782|FG000|Overall Study|Withdrawal by Subject|0|||
143020558|NCT02736227|515616783|FG001|Overall Study|Withdrawal by Subject|0|||
143020559|NCT02736227|515616784|FG002|Overall Study|Withdrawal by Subject|1|||
143020560|NCT02736227|515616782|FG000|Overall Study|Physician Decision|0|||
143020561|NCT02736227|515616783|FG001|Overall Study|Physician Decision|0|||
143020562|NCT02736227|515616784|FG002|Overall Study|Physician Decision|5|||
143020563|NCT02736227|515616782|FG000|Overall Study|Non Compliant|0|||
143020564|NCT02736227|515616783|FG001|Overall Study|Non Compliant|0|||
143155639|NCT04180696|516114077|FG000|Overall Study|Withdrawal by Subject|0|||
143155640|NCT04180696|516114078|FG001|Overall Study|Withdrawal by Subject|1|||
143155641|NCT04739709|516114084|FG000|Overall Study|Physician Decision|1|||
143155642|NCT04739709|516114085|FG001|Overall Study|Physician Decision|0|||
143020565|NCT02736227|515616784|FG002|Overall Study|Non Compliant|2|||
143020566|NCT01967888|515616785|FG000|Overall Study|Lost to Follow-up|6|||
143020567|NCT01967888|515616786|FG001|Overall Study|Lost to Follow-up|4|||
143020568|NCT01967888|515616785|FG000|Overall Study|Withdrawal by Subject|1|||
143020569|NCT01967888|515616786|FG001|Overall Study|Withdrawal by Subject|1|||
143020570|NCT01967888|515616785|FG000|Overall Study|Did Not Have Transplant|1|||
143020571|NCT01967888|515616786|FG001|Overall Study|Did Not Have Transplant|0|||
143020572|NCT01967888|515616785|FG000|Overall Study|Research visit not done, data recorded|1|||
143020573|NCT01967888|515616786|FG001|Overall Study|Research visit not done, data recorded|0|||
143020574|NCT01967888|515616785|FG000|Overall Study|Subject excluded after randomization|1|||
143155643|NCT00433290|516114088|FG000|Overall Study|Adverse Event|24|||
143155644|NCT00433290|516114089|FG001|Overall Study|Adverse Event|7|||
143155645|NCT00433290|516114088|FG000|Overall Study|Lack of Efficacy|1|||
143155646|NCT00433290|516114089|FG001|Overall Study|Lack of Efficacy|5|||
143155647|NCT00433290|516114088|FG000|Overall Study|Withdrawal by Subject|4|||
143155648|NCT00433290|516114089|FG001|Overall Study|Withdrawal by Subject|2|||
143155649|NCT00433290|516114088|FG000|Overall Study|Protocol Violation|3|||
143155650|NCT00433290|516114089|FG001|Overall Study|Protocol Violation|2|||
143155651|NCT00433290|516114088|FG000|Overall Study|Physician Decision|2|||
143155652|NCT00433290|516114089|FG001|Overall Study|Physician Decision|0|||
143155653|NCT00433290|516114088|FG000|Overall Study|Entry Criteria Not Met|0|||
143155654|NCT00433290|516114089|FG001|Overall Study|Entry Criteria Not Met|1|||
143155655|NCT00433290|516114088|FG000|Overall Study|Lost to Follow-up|1|||
143155656|NCT00433290|516114089|FG001|Overall Study|Lost to Follow-up|0|||
143155657|NCT01018953|516114094|FG000|Overall Study|Adverse Event|2|||
143155658|NCT01018953|516114094|FG000|Overall Study|Withdrawal by Subject|1|||
143155659|NCT01018953|516114094|FG000|Overall Study|Study termination by sponsor|5|||
143155660|NCT00724503|516114095|FG000|Overall Study|Lost to Follow-up|4|||
143155661|NCT00724503|516114096|FG001|Overall Study|Lost to Follow-up|8|||
143155662|NCT00724503|516114095|FG000|Overall Study|Withdrawal by Subject|11|||
143155663|NCT00724503|516114096|FG001|Overall Study|Withdrawal by Subject|23|||
143155664|NCT00724503|516114095|FG000|Overall Study|Death|190|||
143155665|NCT00724503|516114096|FG001|Overall Study|Death|182|||
143155666|NCT00724503|516114095|FG000|Overall Study|Adverse Event|1|||
143155667|NCT00724503|516114096|FG001|Overall Study|Adverse Event|0|||
143155668|NCT00724503|516114095|FG000|Overall Study|Not otherwise specified|4|||
143155669|NCT00724503|516114096|FG001|Overall Study|Not otherwise specified|7|||
143155670|NCT01928771|516114099|FG000|Overall Study|Adverse Event|6|||
143155671|NCT01928771|516114100|FG001|Overall Study|Adverse Event|5|||
143155672|NCT01928771|516114101|FG002|Overall Study|Adverse Event|1|||
143155673|NCT01928771|516114099|FG000|Overall Study|Death|2|||
143155674|NCT01928771|516114100|FG001|Overall Study|Death|2|||
143155675|NCT01928771|516114101|FG002|Overall Study|Death|2|||
143155676|NCT01928771|516114099|FG000|Overall Study|Lost to Follow-up|5|||
143155677|NCT01928771|516114100|FG001|Overall Study|Lost to Follow-up|6|||
143155678|NCT01928771|516114101|FG002|Overall Study|Lost to Follow-up|3|||
143155679|NCT01928771|516114099|FG000|Overall Study|Withdrawal by Subject|20|||
143155680|NCT01928771|516114100|FG001|Overall Study|Withdrawal by Subject|15|||
143155681|NCT01928771|516114101|FG002|Overall Study|Withdrawal by Subject|17|||
143155682|NCT01928771|516114099|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
143155683|NCT01928771|516114100|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
143155684|NCT01928771|516114101|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
143155685|NCT01928771|516114099|FG000|Overall Study|Other Reasons|9|||
143155686|NCT01928771|516114100|FG001|Overall Study|Other Reasons|9|||
143155687|NCT01928771|516114101|FG002|Overall Study|Other Reasons|14|||
143155688|NCT01928771|516114099|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
143155689|NCT01928771|516114100|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
143155690|NCT01928771|516114101|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
143155691|NCT01937117|516114102|FG000|Overall Study|Disease Progression|7|||
143155692|NCT01937117|516114102|FG000|Overall Study|Physician Decision|4|||
143155693|NCT01937117|516114102|FG000|Overall Study|Adverse Event|2|||
143155694|NCT01407367|516114105|FG000|Overall Study|Death|24|||
143155695|NCT01407367|516114106|FG001|Overall Study|Death|32|||
143155696|NCT01407367|516114105|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
143155697|NCT01407367|516114106|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
143155698|NCT01407367|516114105|FG000|Overall Study|Withdrawal by Subject|4|||
143155699|NCT01407367|516114106|FG001|Overall Study|Withdrawal by Subject|15|||
143020575|NCT01967888|515616786|FG001|Overall Study|Subject excluded after randomization|0|||
143155700|NCT01407367|516114105|FG000|Overall Study|Lost to Follow-up|0|||
143155701|NCT01407367|516114106|FG001|Overall Study|Lost to Follow-up|2|||
143155702|NCT01245062|516114107|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
143155703|NCT01245062|516114108|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
143155704|NCT01245062|516114109|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
143155705|NCT01245062|516114107|FG000|Randomization and Crossover Phase|Physician Decision|2|||
143020576|NCT01967888|515616785|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
143155706|NCT01245062|516114108|FG001|Randomization and Crossover Phase|Physician Decision|4|||
143155707|NCT01245062|516114109|FG002|Randomization and Crossover Phase|Physician Decision|0|||
143155708|NCT01245062|516114107|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
143155709|NCT01245062|516114108|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
143020577|NCT01967888|515616786|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
143020578|NCT01967888|515616785|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
143020579|NCT01967888|515616786|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
143020580|NCT00827359|515616787|FG000|Overall Study|Progressive Diseas|19|||
143020581|NCT00827359|515616787|FG000|Overall Study|Unacceptable Toxicity|5|||
143020582|NCT00827359|515616787|FG000|Overall Study|Ineligible|1|||
143020583|NCT03840135|515616788|FG000|Overall Study|Protocol Violation|6|||
143020584|NCT03840135|515616789|FG001|Overall Study|Protocol Violation|1|||
143020585|NCT03840135|515616788|FG000|Overall Study|Withdrawal by Subject|1|||
143020586|NCT03840135|515616789|FG001|Overall Study|Withdrawal by Subject|0|||
143020587|NCT00323609|515616790|FG000|Overall Study|Death|16|||
143020588|NCT00323609|515616791|FG001|Overall Study|Death|21|||
143020589|NCT00323609|515616792|FG002|Overall Study|Death|0|||
143020590|NCT00323609|515616793|FG003|Overall Study|Death|0|||
143020591|NCT00323609|515616790|FG000|Overall Study|Lost to Follow-up|9|||
143020592|NCT00323609|515616791|FG001|Overall Study|Lost to Follow-up|10|||
143020593|NCT00323609|515616792|FG002|Overall Study|Lost to Follow-up|0|||
143020594|NCT00323609|515616793|FG003|Overall Study|Lost to Follow-up|0|||
143020595|NCT00323609|515616790|FG000|Overall Study|Physician Decision|2|||
143020596|NCT00323609|515616791|FG001|Overall Study|Physician Decision|0|||
143020597|NCT00323609|515616792|FG002|Overall Study|Physician Decision|0|||
143020598|NCT00323609|515616793|FG003|Overall Study|Physician Decision|1|||
143020599|NCT00323609|515616790|FG000|Overall Study|Withdrawal by Subject|11|||
143020600|NCT00323609|515616791|FG001|Overall Study|Withdrawal by Subject|23|||
143020601|NCT00323609|515616792|FG002|Overall Study|Withdrawal by Subject|4|||
143020602|NCT00323609|515616793|FG003|Overall Study|Withdrawal by Subject|4|||
143020603|NCT00323609|515616790|FG000|Overall Study|Other non-VCF-related medical condition|3|||
143020604|NCT00323609|515616791|FG001|Overall Study|Other non-VCF-related medical condition|2|||
143020605|NCT00323609|515616792|FG002|Overall Study|Other non-VCF-related medical condition|0|||
143020606|NCT00323609|515616793|FG003|Overall Study|Other non-VCF-related medical condition|0|||
143020607|NCT00323609|515616790|FG000|Overall Study|Sponsor discontinued trial|29|||
143020608|NCT00323609|515616791|FG001|Overall Study|Sponsor discontinued trial|29|||
143020609|NCT00323609|515616792|FG002|Overall Study|Sponsor discontinued trial|0|||
143020610|NCT00323609|515616793|FG003|Overall Study|Sponsor discontinued trial|0|||
143020611|NCT00323609|515616790|FG000|Overall Study|Unrelenting or severe back pain|1|||
143020612|NCT00323609|515616791|FG001|Overall Study|Unrelenting or severe back pain|1|||
143020613|NCT00323609|515616792|FG002|Overall Study|Unrelenting or severe back pain|0|||
143020614|NCT00323609|515616793|FG003|Overall Study|Unrelenting or severe back pain|0|||
143020615|NCT00323609|515616790|FG000|Overall Study|Logistical withdrawal|9|||
143020616|NCT00323609|515616791|FG001|Overall Study|Logistical withdrawal|5|||
143020617|NCT00323609|515616792|FG002|Overall Study|Logistical withdrawal|0|||
143020618|NCT00323609|515616793|FG003|Overall Study|Logistical withdrawal|1|||
143020619|NCT00323609|515616790|FG000|Overall Study|Other reason|11|||
143020620|NCT00323609|515616791|FG001|Overall Study|Other reason|8|||
143020621|NCT00323609|515616792|FG002|Overall Study|Other reason|4|||
143020622|NCT00323609|515616793|FG003|Overall Study|Other reason|9|||
143020623|NCT01827371|515616794|FG000|Overall Study|Adverse Event|0|||
143020624|NCT01827371|515616795|FG001|Overall Study|Adverse Event|0|||
143020625|NCT01827371|515616796|FG002|Overall Study|Adverse Event|4|||
143020626|NCT01827371|515616797|FG003|Overall Study|Adverse Event|2|||
143020627|NCT01827371|515616794|FG000|Overall Study|Lost to Follow-up|0|||
143020628|NCT01827371|515616795|FG001|Overall Study|Lost to Follow-up|2|||
143020629|NCT01827371|515616796|FG002|Overall Study|Lost to Follow-up|0|||
143020630|NCT01827371|515616797|FG003|Overall Study|Lost to Follow-up|4|||
143020631|NCT01827371|515616794|FG000|Overall Study|Protocol Violation|1|||
143020632|NCT01827371|515616795|FG001|Overall Study|Protocol Violation|0|||
143020633|NCT01827371|515616796|FG002|Overall Study|Protocol Violation|0|||
143020634|NCT01827371|515616797|FG003|Overall Study|Protocol Violation|0|||
143020635|NCT01827371|515616794|FG000|Overall Study|Withdrawal by Subject|1|||
143020636|NCT01827371|515616795|FG001|Overall Study|Withdrawal by Subject|2|||
143020637|NCT01827371|515616796|FG002|Overall Study|Withdrawal by Subject|2|||
143020638|NCT01827371|515616797|FG003|Overall Study|Withdrawal by Subject|3|||
143020639|NCT01827371|515616794|FG000|Overall Study|Physician Decision|0|||
143020640|NCT01827371|515616795|FG001|Overall Study|Physician Decision|1|||
143020641|NCT01827371|515616796|FG002|Overall Study|Physician Decision|0|||
143020642|NCT01827371|515616797|FG003|Overall Study|Physician Decision|1|||
143155710|NCT01245062|516114109|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
143020643|NCT01827371|515616794|FG000|Overall Study|Temporary study halt to vaccinations|11|||
143020644|NCT01827371|515616795|FG001|Overall Study|Temporary study halt to vaccinations|2|||
143020645|NCT01827371|515616796|FG002|Overall Study|Temporary study halt to vaccinations|5|||
143020646|NCT01827371|515616797|FG003|Overall Study|Temporary study halt to vaccinations|13|||
143020647|NCT00950599|515616804|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
143020648|NCT00950599|515616805|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
143020649|NCT00950599|515616806|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
143020650|NCT00950599|515616807|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
143020651|NCT00950599|515616808|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
143020652|NCT00950599|515616809|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
143020653|NCT00950599|515616810|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
143020654|NCT00950599|515616811|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
143020655|NCT00950599|515616812|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
143020656|NCT00950599|515616813|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
143020657|NCT00950599|515616804|FG000|Double-Blind Treatment Period|Adverse Event|0|||
143020658|NCT00950599|515616805|FG001|Double-Blind Treatment Period|Adverse Event|1|||
143020659|NCT00950599|515616806|FG002|Double-Blind Treatment Period|Adverse Event|1|||
143020660|NCT00950599|515616807|FG003|Double-Blind Treatment Period|Adverse Event|1|||
143020661|NCT00950599|515616808|FG004|Double-Blind Treatment Period|Adverse Event|1|||
143020662|NCT00950599|515616809|FG005|Double-Blind Treatment Period|Adverse Event|1|||
143020663|NCT00950599|515616810|FG006|Double-Blind Treatment Period|Adverse Event|0|||
143020664|NCT00950599|515616811|FG007|Double-Blind Treatment Period|Adverse Event|0|||
143020665|NCT00950599|515616812|FG008|Double-Blind Treatment Period|Adverse Event|0|||
143020666|NCT00950599|515616813|FG009|Double-Blind Treatment Period|Adverse Event|0|||
143020667|NCT00950599|515616804|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
143020668|NCT00950599|515616805|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
143020669|NCT00950599|515616806|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
143020670|NCT00950599|515616807|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
143020671|NCT00950599|515616808|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
143020672|NCT00950599|515616809|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
143020673|NCT00950599|515616810|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
143020674|NCT00950599|515616811|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
143020675|NCT00950599|515616812|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
143020676|NCT00950599|515616813|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
143020677|NCT00950599|515616804|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
143020678|NCT00950599|515616805|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
143020679|NCT00950599|515616806|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
143020680|NCT00950599|515616807|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
143020681|NCT00950599|515616808|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
143020682|NCT00950599|515616809|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
143020683|NCT00950599|515616810|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
143020684|NCT00950599|515616811|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
143020685|NCT00950599|515616812|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
143020686|NCT00950599|515616813|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
143020687|NCT00950599|515616804|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
143020688|NCT00950599|515616805|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
143020689|NCT00950599|515616806|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
143020690|NCT00950599|515616807|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
143020691|NCT00950599|515616808|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
143020692|NCT00950599|515616809|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
143020693|NCT00950599|515616810|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
143020694|NCT00950599|515616811|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
143020695|NCT00950599|515616812|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
143020696|NCT00950599|515616813|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
143020697|NCT00950599|515616804|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
143020698|NCT00950599|515616805|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
143020699|NCT00950599|515616806|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
143020700|NCT00950599|515616807|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
143114860|NCT02345889|515962443|FG002|Overall Study|Polyposis identified during procedure|0|||
143114861|NCT02345889|515962444|FG003|Overall Study|Polyposis identified during procedure|1|||
143114862|NCT02345889|515962441|FG000|Overall Study|Recognized ineligible post-randomization|1|||
143114863|NCT02345889|515962442|FG001|Overall Study|Recognized ineligible post-randomization|0|||
143114864|NCT02345889|515962443|FG002|Overall Study|Recognized ineligible post-randomization|2|||
143114865|NCT02345889|515962444|FG003|Overall Study|Recognized ineligible post-randomization|1|||
143114866|NCT02345889|515962441|FG000|Overall Study|Ulcerative Colitis identified|1|||
143114867|NCT02345889|515962442|FG001|Overall Study|Ulcerative Colitis identified|0|||
143114868|NCT02345889|515962443|FG002|Overall Study|Ulcerative Colitis identified|0|||
143114869|NCT02345889|515962444|FG003|Overall Study|Ulcerative Colitis identified|0|||
143114870|NCT02345889|515962441|FG000|Overall Study|Cecum not intubated|1|||
143114871|NCT02345889|515962442|FG001|Overall Study|Cecum not intubated|0|||
143114872|NCT02345889|515962443|FG002|Overall Study|Cecum not intubated|0|||
143114873|NCT02345889|515962444|FG003|Overall Study|Cecum not intubated|0|||
143114874|NCT04325698|515962445|FG000|Overall Study|Study Terminated By Sponsor|1|||
143114875|NCT04325698|515962446|FG001|Overall Study|Study Terminated By Sponsor|1|||
143114876|NCT04325698|515962445|FG000|Overall Study|Withdrawal by Subject|0|||
143114877|NCT04325698|515962446|FG001|Overall Study|Withdrawal by Subject|2|||
143020701|NCT00950599|515616808|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
143020702|NCT00950599|515616809|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
143020703|NCT00950599|515616810|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
143020704|NCT00950599|515616811|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
143020705|NCT00950599|515616812|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
143020706|NCT00950599|515616813|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
143020707|NCT00950599|515616804|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
143020708|NCT00950599|515616805|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
143020709|NCT00950599|515616806|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
143020710|NCT00950599|515616807|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
143020711|NCT00950599|515616808|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
143020712|NCT00950599|515616809|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
143020713|NCT00950599|515616810|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
143020714|NCT00950599|515616811|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
143020715|NCT00950599|515616812|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
143020716|NCT00950599|515616813|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
143020717|NCT00950599|515616804|FG000|Follow-Up Period|Adverse Event|0|||
143020718|NCT00950599|515616805|FG001|Follow-Up Period|Adverse Event|0|||
143020719|NCT00950599|515616806|FG002|Follow-Up Period|Adverse Event|0|||
143020720|NCT00950599|515616807|FG003|Follow-Up Period|Adverse Event|0|||
143020721|NCT00950599|515616808|FG004|Follow-Up Period|Adverse Event|0|||
143020722|NCT00950599|515616809|FG005|Follow-Up Period|Adverse Event|0|||
143020723|NCT00950599|515616810|FG006|Follow-Up Period|Adverse Event|0|||
143020724|NCT00950599|515616811|FG007|Follow-Up Period|Adverse Event|0|||
143020725|NCT00950599|515616812|FG008|Follow-Up Period|Adverse Event|1|||
143020726|NCT00950599|515616813|FG009|Follow-Up Period|Adverse Event|0|||
143020727|NCT00950599|515616804|FG000|Follow-Up Period|Lack of Efficacy|0|||
143020728|NCT00950599|515616805|FG001|Follow-Up Period|Lack of Efficacy|0|||
143020729|NCT00950599|515616806|FG002|Follow-Up Period|Lack of Efficacy|0|||
143020730|NCT00950599|515616807|FG003|Follow-Up Period|Lack of Efficacy|0|||
143020731|NCT00950599|515616808|FG004|Follow-Up Period|Lack of Efficacy|0|||
143020732|NCT00950599|515616809|FG005|Follow-Up Period|Lack of Efficacy|0|||
143020733|NCT00950599|515616810|FG006|Follow-Up Period|Lack of Efficacy|0|||
143020734|NCT00950599|515616811|FG007|Follow-Up Period|Lack of Efficacy|0|||
143020735|NCT00950599|515616812|FG008|Follow-Up Period|Lack of Efficacy|3|||
143020736|NCT00950599|515616813|FG009|Follow-Up Period|Lack of Efficacy|0|||
143020737|NCT00950599|515616804|FG000|Follow-Up Period|Lost to Follow-up|0|||
143020738|NCT00950599|515616805|FG001|Follow-Up Period|Lost to Follow-up|0|||
143020739|NCT00950599|515616806|FG002|Follow-Up Period|Lost to Follow-up|0|||
143020740|NCT00950599|515616807|FG003|Follow-Up Period|Lost to Follow-up|0|||
143155711|NCT01245062|516114107|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
143155712|NCT01245062|516114108|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
143155713|NCT01245062|516114109|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
143020741|NCT00950599|515616808|FG004|Follow-Up Period|Lost to Follow-up|0|||
143020742|NCT00950599|515616809|FG005|Follow-Up Period|Lost to Follow-up|0|||
143020743|NCT00950599|515616810|FG006|Follow-Up Period|Lost to Follow-up|0|||
143020744|NCT00950599|515616811|FG007|Follow-Up Period|Lost to Follow-up|0|||
143155714|NCT01245062|516114107|FG000|Cross-over Phase|Lost to Follow-up|0|||
143155715|NCT01245062|516114108|FG001|Cross-over Phase|Lost to Follow-up|0|||
143155716|NCT01245062|516114109|FG002|Cross-over Phase|Lost to Follow-up|1|||
143155717|NCT01245062|516114107|FG000|Cross-over Phase|Physician Decision|0|||
143155718|NCT01245062|516114108|FG001|Cross-over Phase|Physician Decision|0|||
143155719|NCT01245062|516114109|FG002|Cross-over Phase|Physician Decision|1|||
143155720|NCT01245062|516114107|FG000|Cross-over Phase|Withdrew Consent|0|||
143155721|NCT01245062|516114108|FG001|Cross-over Phase|Withdrew Consent|0|||
143155722|NCT01245062|516114109|FG002|Cross-over Phase|Withdrew Consent|4|||
143155723|NCT01245062|516114107|FG000|Cross-over Phase|Study closed/ terminated|0|||
143155724|NCT01245062|516114108|FG001|Cross-over Phase|Study closed/ terminated|0|||
143155725|NCT01245062|516114109|FG002|Cross-over Phase|Study closed/ terminated|11|||
143155726|NCT01452347|516114110|FG000|Overall Study|Adverse Event|2|||
143155727|NCT01452347|516114111|FG001|Overall Study|Adverse Event|1|||
143020745|NCT00950599|515616812|FG008|Follow-Up Period|Lost to Follow-up|5|||
143020746|NCT00950599|515616813|FG009|Follow-Up Period|Lost to Follow-up|1|||
143155728|NCT01452347|516114110|FG000|Overall Study|Non compliance protocol|2|||
143155729|NCT01452347|516114111|FG001|Overall Study|Non compliance protocol|0|||
143155730|NCT01452347|516114110|FG000|Overall Study|Lost to Follow-up|2|||
143155731|NCT01452347|516114111|FG001|Overall Study|Lost to Follow-up|0|||
143020747|NCT00950599|515616804|FG000|Follow-Up Period|Physician Decision|0|||
143020748|NCT00950599|515616805|FG001|Follow-Up Period|Physician Decision|0|||
143020749|NCT00950599|515616806|FG002|Follow-Up Period|Physician Decision|0|||
143020750|NCT00950599|515616807|FG003|Follow-Up Period|Physician Decision|0|||
143020751|NCT00950599|515616808|FG004|Follow-Up Period|Physician Decision|0|||
143020752|NCT00950599|515616809|FG005|Follow-Up Period|Physician Decision|0|||
143020753|NCT00950599|515616810|FG006|Follow-Up Period|Physician Decision|0|||
143020754|NCT00950599|515616811|FG007|Follow-Up Period|Physician Decision|0|||
143020755|NCT00950599|515616812|FG008|Follow-Up Period|Physician Decision|1|||
143020756|NCT00950599|515616813|FG009|Follow-Up Period|Physician Decision|0|||
143020757|NCT00950599|515616804|FG000|Follow-Up Period|Poor/Noncompliance|0|||
143155732|NCT01452347|516114110|FG000|Overall Study|Withdrawal by Subject|3|||
143155733|NCT01452347|516114111|FG001|Overall Study|Withdrawal by Subject|3|||
143155734|NCT01452347|516114110|FG000|Overall Study|Not treated|6|||
143155735|NCT01452347|516114111|FG001|Overall Study|Not treated|3|||
143485702|NCT01594853|517322878|FG000|Overall Study|noncompliance with exercise|0|||
143485703|NCT01594853|517322879|FG001|Overall Study|noncompliance with exercise|1|||
143485704|NCT03776175|517322882|FG000|Treatment Period (42 Days)|Adverse Event|0|||
143485705|NCT03776175|517322883|FG001|Treatment Period (42 Days)|Adverse Event|1|||
143485706|NCT03776175|517322884|FG002|Treatment Period (42 Days)|Adverse Event|1|||
143485707|NCT03776175|517322885|FG003|Treatment Period (42 Days)|Adverse Event|0|||
143485708|NCT03776175|517322882|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
143485709|NCT03776175|517322883|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
143485710|NCT03776175|517322884|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
143485711|NCT03776175|517322885|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
143485712|NCT03776175|517322882|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
143485713|NCT03776175|517322883|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
143485714|NCT03776175|517322884|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
143485715|NCT03776175|517322885|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
143485716|NCT03776175|517322882|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
143485717|NCT03776175|517322883|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
143485718|NCT03776175|517322884|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
143485719|NCT03776175|517322885|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
143485720|NCT03776175|517322882|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
143485721|NCT03776175|517322883|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
143485722|NCT03776175|517322884|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
143485723|NCT03776175|517322885|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
143485724|NCT03776175|517322882|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
143485725|NCT03776175|517322883|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
143485726|NCT03776175|517322884|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
143485727|NCT03776175|517322885|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
143485728|NCT04091087|517322886|FG000|Overall Study|Not treated|1|||
143485729|NCT04091087|517322887|FG001|Overall Study|Not treated|0|||
143485730|NCT04091087|517322886|FG000|Overall Study|Adverse Event|4|||
143485731|NCT04091087|517322887|FG001|Overall Study|Adverse Event|4|||
143485732|NCT04091087|517322886|FG000|Overall Study|Protocol Violation|0|||
143020758|NCT00950599|515616805|FG001|Follow-Up Period|Poor/Noncompliance|0|||
143155736|NCT01452347|516114110|FG000|Overall Study|Other reason not defined above|2|||
143155737|NCT01452347|516114111|FG001|Overall Study|Other reason not defined above|0|||
143155738|NCT05762744|516114112|FG000|1st iv Glucose Tolerance Test|Withdrawal by Subject|0|||
143155739|NCT05762744|516114113|FG001|1st iv Glucose Tolerance Test|Withdrawal by Subject|1|||
143155740|NCT05762744|516114112|FG000|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
143155741|NCT05762744|516114113|FG001|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
143155742|NCT01671059|516114114|FG000|Overall Study|Adverse Event|4|||
143155743|NCT01671059|516114114|FG000|Overall Study|Lack of Efficacy|1|||
143155744|NCT00853047|516114118|FG000|Core Phase|Participant Request|0|||
143155745|NCT00853047|516114119|FG001|Core Phase|Participant Request|0|||
143155746|NCT00853047|516114120|FG002|Core Phase|Participant Request|0|||
143155747|NCT00853047|516114121|FG003|Core Phase|Participant Request|1|||
143155748|NCT00853047|516114122|FG004|Core Phase|Participant Request|0|||
143155749|NCT00853047|516114123|FG005|Core Phase|Participant Request|0|||
143155750|NCT00853047|516114118|FG000|Open-Label Extension Phase|Participant Request|0|||
143155751|NCT00853047|516114119|FG001|Open-Label Extension Phase|Participant Request|0|||
143155752|NCT00853047|516114120|FG002|Open-Label Extension Phase|Participant Request|0|||
143155753|NCT00853047|516114121|FG003|Open-Label Extension Phase|Participant Request|0|||
143155754|NCT00853047|516114122|FG004|Open-Label Extension Phase|Participant Request|0|||
143155755|NCT00853047|516114123|FG005|Open-Label Extension Phase|Participant Request|7|||
143155756|NCT00853047|516114118|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
143155757|NCT00853047|516114119|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
143485733|NCT04091087|517322887|FG001|Overall Study|Protocol Violation|1|||
143155758|NCT00853047|516114120|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
143155759|NCT00853047|516114121|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
143155760|NCT00853047|516114122|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
143155761|NCT00853047|516114123|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
143485734|NCT04091087|517322886|FG000|Overall Study|Withdrawal by Subject|5|||
143485735|NCT04091087|517322887|FG001|Overall Study|Withdrawal by Subject|2|||
143485736|NCT03273166|517322888|FG000|Overall Study|Withdrawn prior to Completion|31|||
143485737|NCT02083380|517322891|FG000|Overall Study|Lack of Efficacy|68|||
143020759|NCT00950599|515616806|FG002|Follow-Up Period|Poor/Noncompliance|0|||
143020760|NCT00950599|515616807|FG003|Follow-Up Period|Poor/Noncompliance|0|||
143020761|NCT00950599|515616808|FG004|Follow-Up Period|Poor/Noncompliance|0|||
143020762|NCT00950599|515616809|FG005|Follow-Up Period|Poor/Noncompliance|0|||
143020763|NCT00950599|515616810|FG006|Follow-Up Period|Poor/Noncompliance|0|||
143020764|NCT00950599|515616811|FG007|Follow-Up Period|Poor/Noncompliance|0|||
143020765|NCT00950599|515616812|FG008|Follow-Up Period|Poor/Noncompliance|1|||
143020766|NCT00950599|515616813|FG009|Follow-Up Period|Poor/Noncompliance|0|||
143020767|NCT00950599|515616804|FG000|Follow-Up Period|Subject withdrew Consent|0|||
143020768|NCT00950599|515616805|FG001|Follow-Up Period|Subject withdrew Consent|0|||
143020769|NCT00950599|515616806|FG002|Follow-Up Period|Subject withdrew Consent|0|||
143020770|NCT00950599|515616807|FG003|Follow-Up Period|Subject withdrew Consent|0|||
143020771|NCT00950599|515616808|FG004|Follow-Up Period|Subject withdrew Consent|0|||
143020772|NCT00950599|515616809|FG005|Follow-Up Period|Subject withdrew Consent|0|||
143020773|NCT00950599|515616810|FG006|Follow-Up Period|Subject withdrew Consent|0|||
143020774|NCT00950599|515616811|FG007|Follow-Up Period|Subject withdrew Consent|0|||
143020775|NCT00950599|515616812|FG008|Follow-Up Period|Subject withdrew Consent|2|||
143020776|NCT00950599|515616813|FG009|Follow-Up Period|Subject withdrew Consent|1|||
143020777|NCT02436135|515616814|FG000|Overall Study|Progressive Disease|3|||
143020778|NCT02436135|515616815|FG001|Overall Study|Progressive Disease|1|||
143485738|NCT02083380|517322892|FG001|Overall Study|Lack of Efficacy|79|||
143485739|NCT02083380|517322893|FG002|Overall Study|Lack of Efficacy|64|||
143485740|NCT02083380|517322891|FG000|Overall Study|Withdrawal by Subject|9|||
143485741|NCT02083380|517322892|FG001|Overall Study|Withdrawal by Subject|3|||
143485742|NCT02083380|517322893|FG002|Overall Study|Withdrawal by Subject|7|||
143485743|NCT02083380|517322891|FG000|Overall Study|Physician Decision|1|||
143485744|NCT02083380|517322892|FG001|Overall Study|Physician Decision|6|||
143485745|NCT02083380|517322893|FG002|Overall Study|Physician Decision|3|||
143485746|NCT02083380|517322891|FG000|Overall Study|Adverse Event|0|||
143485747|NCT02083380|517322892|FG001|Overall Study|Adverse Event|0|||
143485748|NCT02083380|517322893|FG002|Overall Study|Adverse Event|1|||
143485749|NCT02083380|517322891|FG000|Overall Study|Lost to Follow-up|5|||
143485750|NCT02083380|517322892|FG001|Overall Study|Lost to Follow-up|3|||
143485751|NCT02083380|517322893|FG002|Overall Study|Lost to Follow-up|3|||
143485752|NCT02083380|517322891|FG000|Overall Study|Other|8|||
143485753|NCT02083380|517322892|FG001|Overall Study|Other|4|||
143485754|NCT02083380|517322893|FG002|Overall Study|Other|6|||
143485755|NCT02412787|517322894|FG000|Overall Study|Withdrawal by Subject|9|||
143485756|NCT02412787|517322894|FG000|Overall Study|Participation Terminated by Investigator|1|||
143485757|NCT02412787|517322894|FG000|Overall Study|Site Terminated by Sponsor|21|||
143485758|NCT02412787|517322894|FG000|Overall Study|Technical Problems|1|||
143485759|NCT02412787|517322894|FG000|Overall Study|Reason Not Specified|1|||
143485760|NCT03246958|517322895|FG000|Overall Study|Withdrawal by Subject|0|||
143485761|NCT03246958|517322896|FG001|Overall Study|Withdrawal by Subject|1|||
143485762|NCT03246958|517322897|FG002|Overall Study|Withdrawal by Subject|0|||
143485763|NCT03246958|517322898|FG003|Overall Study|Withdrawal by Subject|0|||
143485764|NCT03246958|517322899|FG004|Overall Study|Withdrawal by Subject|0|||
143485765|NCT03246958|517322900|FG005|Overall Study|Withdrawal by Subject|1|||
143485766|NCT03246958|517322901|FG006|Overall Study|Withdrawal by Subject|0|||
143485767|NCT03246958|517322895|FG000|Overall Study|Progression|13|||
143485768|NCT03246958|517322896|FG001|Overall Study|Progression|9|||
143485769|NCT03246958|517322897|FG002|Overall Study|Progression|3|||
143485770|NCT03246958|517322898|FG003|Overall Study|Progression|2|||
143485771|NCT03246958|517322899|FG004|Overall Study|Progression|1|||
143485772|NCT03246958|517322900|FG005|Overall Study|Progression|2|||
143485773|NCT03246958|517322901|FG006|Overall Study|Progression|1|||
143485774|NCT03246958|517322895|FG000|Overall Study|Adverse Event|2|||
143485775|NCT03246958|517322896|FG001|Overall Study|Adverse Event|2|||
143485776|NCT03246958|517322897|FG002|Overall Study|Adverse Event|0|||
143020779|NCT02436135|515616814|FG000|Overall Study|Investigator Discretion|1|||
143020780|NCT02436135|515616815|FG001|Overall Study|Investigator Discretion|2|||
143020781|NCT02436135|515616814|FG000|Overall Study|Adverse Event|1|||
143020782|NCT02436135|515616815|FG001|Overall Study|Adverse Event|0|||
143020783|NCT02436135|515616814|FG000|Overall Study|Withdrawal by Participant|1|||
143020784|NCT02436135|515616815|FG001|Overall Study|Withdrawal by Participant|0|||
143485777|NCT03246958|517322898|FG003|Overall Study|Adverse Event|1|||
143485778|NCT03246958|517322899|FG004|Overall Study|Adverse Event|1|||
143485779|NCT03246958|517322900|FG005|Overall Study|Adverse Event|0|||
143485780|NCT03246958|517322901|FG006|Overall Study|Adverse Event|2|||
143485781|NCT03246958|517322895|FG000|Overall Study|Death|0|||
143485782|NCT03246958|517322896|FG001|Overall Study|Death|1|||
143485783|NCT03246958|517322897|FG002|Overall Study|Death|0|||
143485784|NCT03246958|517322898|FG003|Overall Study|Death|0|||
143020785|NCT02436135|515616814|FG000|Overall Study|Study Terminated By Sponsor|0|||
143020786|NCT02436135|515616815|FG001|Overall Study|Study Terminated By Sponsor|1|||
143020787|NCT00475852|515616816|FG000|Overall Study|Death|444|||
143020788|NCT00475852|515616817|FG001|Overall Study|Death|456|||
143020789|NCT00475852|515616816|FG000|Overall Study|Withdrawal by Subject|19|||
143485785|NCT03246958|517322899|FG004|Overall Study|Death|0|||
143020790|NCT00475852|515616817|FG001|Overall Study|Withdrawal by Subject|24|||
143020791|NCT00475852|515616816|FG000|Overall Study|Lost to Follow-up|54|||
143020792|NCT00475852|515616817|FG001|Overall Study|Lost to Follow-up|68|||
143020793|NCT02063698|515616818|FG000|Overall Study|did not complete booklet for days 2-8|1|||
143020794|NCT02063698|515616819|FG001|Overall Study|did not complete booklet for days 2-8|2|||
143020795|NCT00297479|515616820|FG000|Overall Study|Lost to Follow-up|37|||
143020796|NCT00297479|515616821|FG001|Overall Study|Lost to Follow-up|54|||
143020797|NCT00297479|515616822|FG002|Overall Study|Lost to Follow-up|51|||
143020798|NCT01684722|515616823|FG000|Overall Study|Lost to Follow-up|78|||
143020799|NCT01684722|515616824|FG001|Overall Study|Lost to Follow-up|56|||
143020800|NCT01684722|515616825|FG002|Overall Study|Lost to Follow-up|75|||
143020801|NCT01684722|515616826|FG003|Overall Study|Lost to Follow-up|89|||
143020802|NCT01684722|515616823|FG000|Overall Study|Death|19|||
143020803|NCT01684722|515616824|FG001|Overall Study|Death|21|||
143020804|NCT01684722|515616825|FG002|Overall Study|Death|19|||
143020805|NCT01684722|515616826|FG003|Overall Study|Death|21|||
143020806|NCT01664494|515616827|FG000|Overall Study|Withdrawal by Subject|27|||
143020807|NCT01664494|515616827|FG000|Overall Study|Death|18|||
143020808|NCT01664494|515616827|FG000|Overall Study|Other|49|||
143155762|NCT00853047|516114118|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
143485786|NCT03246958|517322900|FG005|Overall Study|Death|0|||
143485787|NCT03246958|517322901|FG006|Overall Study|Death|0|||
143485788|NCT03246958|517322895|FG000|Overall Study|Physician Decision|0|||
143485789|NCT03246958|517322896|FG001|Overall Study|Physician Decision|0|||
143485790|NCT03246958|517322897|FG002|Overall Study|Physician Decision|0|||
143485791|NCT03246958|517322898|FG003|Overall Study|Physician Decision|1|||
143485792|NCT03246958|517322899|FG004|Overall Study|Physician Decision|0|||
143485793|NCT03246958|517322900|FG005|Overall Study|Physician Decision|0|||
143485794|NCT03246958|517322901|FG006|Overall Study|Physician Decision|0|||
143485795|NCT03246958|517322895|FG000|Overall Study|Never start treatment|1|||
143485796|NCT03246958|517322896|FG001|Overall Study|Never start treatment|0|||
143485797|NCT03246958|517322897|FG002|Overall Study|Never start treatment|0|||
143485798|NCT03246958|517322898|FG003|Overall Study|Never start treatment|0|||
143485799|NCT03246958|517322899|FG004|Overall Study|Never start treatment|0|||
143485800|NCT03246958|517322900|FG005|Overall Study|Never start treatment|0|||
143485801|NCT03246958|517322901|FG006|Overall Study|Never start treatment|0|||
143485802|NCT03246958|517322895|FG000|Overall Study|Over enrollment|0|||
143485803|NCT03246958|517322896|FG001|Overall Study|Over enrollment|2|||
143485804|NCT03246958|517322897|FG002|Overall Study|Over enrollment|0|||
143485805|NCT03246958|517322898|FG003|Overall Study|Over enrollment|0|||
143485806|NCT03246958|517322899|FG004|Overall Study|Over enrollment|0|||
143485807|NCT03246958|517322900|FG005|Overall Study|Over enrollment|0|||
143485808|NCT03246958|517322901|FG006|Overall Study|Over enrollment|0|||
143020809|NCT01664494|515616827|FG000|Overall Study|Lost to Follow-up|99|||
143155763|NCT00853047|516114119|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
143155764|NCT00853047|516114120|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
143155765|NCT00853047|516114121|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
143155766|NCT00853047|516114122|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
143155767|NCT00853047|516114123|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
143155768|NCT00853047|516114118|FG000|Open-Label Extension Phase|Investigator Decision|0|||
143155769|NCT00853047|516114119|FG001|Open-Label Extension Phase|Investigator Decision|0|||
143155770|NCT00853047|516114120|FG002|Open-Label Extension Phase|Investigator Decision|0|||
143155771|NCT00853047|516114121|FG003|Open-Label Extension Phase|Investigator Decision|0|||
143155772|NCT00853047|516114122|FG004|Open-Label Extension Phase|Investigator Decision|0|||
143155773|NCT00853047|516114123|FG005|Open-Label Extension Phase|Investigator Decision|1|||
143155774|NCT00853047|516114118|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
143155775|NCT00853047|516114119|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
143155776|NCT00853047|516114120|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
143155777|NCT00853047|516114121|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
143155778|NCT00853047|516114122|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
143155779|NCT00853047|516114123|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
143155780|NCT01033071|516114124|FG000|Overall Study|Adverse Event|28|||
143155781|NCT01033071|516114125|FG001|Overall Study|Adverse Event|51|||
143155782|NCT01033071|516114126|FG002|Overall Study|Adverse Event|26|||
143155783|NCT01033071|516114124|FG000|Overall Study|Protocol Violation|0|||
143155784|NCT01033071|516114125|FG001|Overall Study|Protocol Violation|2|||
143485809|NCT03363321|517322902|FG000|Overall Study|Withdrawal by Subject|0|||
143485810|NCT03363321|517322903|FG001|Overall Study|Withdrawal by Subject|1|||
143020810|NCT00219557|515616828|FG000|Phase 1|Lack of Efficacy|3|||
143155785|NCT01033071|516114126|FG002|Overall Study|Protocol Violation|1|||
143155786|NCT01033071|516114124|FG000|Overall Study|Lost to Follow-up|4|||
143020811|NCT00219557|515616829|FG001|Phase 1|Lack of Efficacy|0|||
143020812|NCT00219557|515616830|FG002|Phase 1|Lack of Efficacy|0|||
143020813|NCT00219557|515616828|FG000|Phase 1|Adverse Event|2|||
143020814|NCT00219557|515616829|FG001|Phase 1|Adverse Event|0|||
143155787|NCT01033071|516114125|FG001|Overall Study|Lost to Follow-up|5|||
143485811|NCT03363321|517322904|FG002|Overall Study|Withdrawal by Subject|0|||
143485812|NCT03363321|517322905|FG003|Overall Study|Withdrawal by Subject|1|||
143020815|NCT00219557|515616830|FG002|Phase 1|Adverse Event|0|||
143020816|NCT00219557|515616828|FG000|Phase 1|Withdrawal by Subject|1|||
143020817|NCT00219557|515616829|FG001|Phase 1|Withdrawal by Subject|0|||
143020818|NCT00219557|515616830|FG002|Phase 1|Withdrawal by Subject|0|||
143020819|NCT00219557|515616828|FG000|Phase 1|Started chemotherapy at other institute|1|||
143020820|NCT00219557|515616829|FG001|Phase 1|Started chemotherapy at other institute|0|||
143020821|NCT00219557|515616830|FG002|Phase 1|Started chemotherapy at other institute|0|||
143020822|NCT00219557|515616828|FG000|Phase 2|Lack of Efficacy|0|||
143020823|NCT00219557|515616829|FG001|Phase 2|Lack of Efficacy|21|||
143020824|NCT00219557|515616830|FG002|Phase 2|Lack of Efficacy|15|||
143020825|NCT00219557|515616828|FG000|Phase 2|Adverse Event|0|||
143020826|NCT00219557|515616829|FG001|Phase 2|Adverse Event|22|||
143020827|NCT00219557|515616830|FG002|Phase 2|Adverse Event|2|||
143020828|NCT00219557|515616828|FG000|Phase 2|Death|0|||
143020829|NCT00219557|515616829|FG001|Phase 2|Death|8|||
143485813|NCT03363321|517322906|FG004|Overall Study|Withdrawal by Subject|0|||
143485814|NCT02915523|517322908|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
143485815|NCT02915523|517322909|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
143485816|NCT02915523|517322910|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
143485817|NCT02915523|517322911|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
143485818|NCT02915523|517322908|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
143485819|NCT02915523|517322909|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
143485820|NCT02915523|517322910|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
143485821|NCT02915523|517322911|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
143485822|NCT02915523|517322908|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
143485823|NCT02915523|517322909|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
143485824|NCT02915523|517322910|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
143485825|NCT02915523|517322911|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
143485826|NCT02915523|517322908|FG000|Expansion Phase (Phase 2)|Death|0|||
143485827|NCT02915523|517322909|FG001|Expansion Phase (Phase 2)|Death|0|||
143485828|NCT02915523|517322910|FG002|Expansion Phase (Phase 2)|Death|26|||
143485829|NCT02915523|517322911|FG003|Expansion Phase (Phase 2)|Death|53|||
143485830|NCT02915523|517322908|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
143485831|NCT02915523|517322909|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
143485832|NCT02915523|517322910|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
143485833|NCT02915523|517322911|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
143485834|NCT02915523|517322908|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
143485835|NCT02915523|517322909|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
143485836|NCT02915523|517322910|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
143485837|NCT02915523|517322911|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
143485838|NCT02915523|517322908|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
143485839|NCT02915523|517322909|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
143485840|NCT02915523|517322910|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
143485841|NCT02915523|517322911|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
143485842|NCT00915681|517322912|FG000|Overall Study|Screening failures|46|||
143485843|NCT03221751|517322914|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
143485844|NCT03221751|517322915|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
143485845|NCT00414453|517322920|FG000|Overall Study|Abnormal lab work|16|||
143485846|NCT01780831|517322921|FG000|Overall Study|Withdrawal by Subject|0|||
143485847|NCT01780831|517322922|FG001|Overall Study|Withdrawal by Subject|0|||
143485848|NCT01780831|517322923|FG002|Overall Study|Withdrawal by Subject|4|||
143485849|NCT01780831|517322924|FG003|Overall Study|Withdrawal by Subject|0|||
143485850|NCT01780831|517322921|FG000|Overall Study|Lost to Follow-up|0|||
143485851|NCT01780831|517322922|FG001|Overall Study|Lost to Follow-up|0|||
143485852|NCT01780831|517322923|FG002|Overall Study|Lost to Follow-up|0|||
143485853|NCT01780831|517322924|FG003|Overall Study|Lost to Follow-up|1|||
143485854|NCT02706873|517322928|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
143485855|NCT02706873|517322929|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
143485856|NCT02706873|517322930|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
143485857|NCT02706873|517322931|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
143485858|NCT02706873|517322928|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
143020830|NCT00219557|515616830|FG002|Phase 2|Death|2|||
143485859|NCT02706873|517322929|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
143485860|NCT02706873|517322930|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
143485861|NCT02706873|517322931|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
143485862|NCT02706873|517322928|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
143485863|NCT02706873|517322929|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
143485864|NCT02706873|517322930|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
143485865|NCT02706873|517322931|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
143020831|NCT00219557|515616828|FG000|Phase 2|Other|0|||
143020832|NCT00219557|515616829|FG001|Phase 2|Other|8|||
143020833|NCT00219557|515616830|FG002|Phase 2|Other|6|||
143020834|NCT00219557|515616828|FG000|Phase 2|Withdrawal by Subject|0|||
143020835|NCT00219557|515616829|FG001|Phase 2|Withdrawal by Subject|9|||
143020836|NCT00219557|515616830|FG002|Phase 2|Withdrawal by Subject|5|||
143020837|NCT00219557|515616828|FG000|Phase 2|Treatment not received|0|||
143020838|NCT00219557|515616829|FG001|Phase 2|Treatment not received|1|||
143020839|NCT00219557|515616830|FG002|Phase 2|Treatment not received|3|||
143020840|NCT01427803|515616835|FG000|Overall Study|Lost to Follow-up|32|||
143020841|NCT01427803|515616836|FG001|Overall Study|Lost to Follow-up|26|||
143020842|NCT01427803|515616835|FG000|Overall Study|Withdrawal by Subject|20|||
143020843|NCT01427803|515616836|FG001|Overall Study|Withdrawal by Subject|0|||
143020844|NCT01427803|515616835|FG000|Overall Study|Unable to complete full treatment period|6|||
143020845|NCT01427803|515616836|FG001|Overall Study|Unable to complete full treatment period|0|||
143020846|NCT01427803|515616835|FG000|Overall Study|Protocol Violation|1|||
143020847|NCT01427803|515616836|FG001|Overall Study|Protocol Violation|0|||
143020848|NCT01427803|515616835|FG000|Overall Study|Physician Decision|3|||
143020849|NCT01427803|515616836|FG001|Overall Study|Physician Decision|0|||
143020850|NCT01427803|515616835|FG000|Overall Study|did not take product|1|||
143020851|NCT01427803|515616836|FG001|Overall Study|did not take product|0|||
143020852|NCT03412019|515616839|FG000|Overall Study|Withdrawal by Subject|1|||
143020853|NCT03412019|515616840|FG001|Overall Study|Withdrawal by Subject|1|||
143020854|NCT01612156|515616846|FG000|Overall Study|Protocol Violation|2|||
143020855|NCT01612156|515616847|FG001|Overall Study|Protocol Violation|0|||
143020856|NCT01953783|515616848|FG000|Overall Study|Progressive disease|2|||
143020857|NCT00814658|515616854|FG000|Overall Study|Lost to Follow-up|0|||
143020858|NCT00814658|515616855|FG001|Overall Study|Lost to Follow-up|1|||
143020859|NCT00814658|515616854|FG000|Overall Study|Physician Decision|1|||
143020860|NCT00814658|515616855|FG001|Overall Study|Physician Decision|0|||
143020861|NCT00814658|515616854|FG000|Overall Study|Adverse Event|3|||
143020862|NCT00814658|515616855|FG001|Overall Study|Adverse Event|3|||
143020863|NCT05266456|515616856|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
143020864|NCT05266456|515616857|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
143020865|NCT05266456|515616858|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
143020866|NCT05266456|515616859|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
143020867|NCT05266456|515616856|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
143020868|NCT05266456|515616857|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
143020869|NCT05266456|515616858|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
143020870|NCT05266456|515616859|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
143485866|NCT02706873|517322928|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
143485867|NCT02706873|517322929|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
143485868|NCT02706873|517322930|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
143485869|NCT02706873|517322931|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
143485870|NCT02706873|517322928|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
143485871|NCT02706873|517322929|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
143485872|NCT02706873|517322930|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
143485873|NCT02706873|517322931|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
143485874|NCT02706873|517322928|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
143485875|NCT02706873|517322929|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
143485876|NCT02706873|517322930|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
143485877|NCT02706873|517322931|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
143485878|NCT02706873|517322928|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
143485879|NCT02706873|517322929|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
143485880|NCT02706873|517322930|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
143485881|NCT02706873|517322931|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
143485882|NCT02706873|517322928|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
143485883|NCT02706873|517322929|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
143485884|NCT02706873|517322930|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
143020871|NCT05266456|515616856|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
143020872|NCT05266456|515616857|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
143020873|NCT05266456|515616858|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
143020874|NCT05266456|515616859|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
143020875|NCT05266456|515616856|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
143155788|NCT01033071|516114126|FG002|Overall Study|Lost to Follow-up|5|||
143155789|NCT01033071|516114124|FG000|Overall Study|Withdrawal by Subject|17|||
143155790|NCT01033071|516114125|FG001|Overall Study|Withdrawal by Subject|14|||
143155791|NCT01033071|516114126|FG002|Overall Study|Withdrawal by Subject|11|||
143020876|NCT05266456|515616857|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
143020877|NCT05266456|515616858|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
143155792|NCT01033071|516114124|FG000|Overall Study|Lack of Efficacy|0|||
143020878|NCT05266456|515616859|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
143020879|NCT05266456|515616856|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
143155793|NCT01033071|516114125|FG001|Overall Study|Lack of Efficacy|1|||
143155794|NCT01033071|516114126|FG002|Overall Study|Lack of Efficacy|1|||
143155795|NCT01033071|516114124|FG000|Overall Study|Other|6|||
143485885|NCT02706873|517322931|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
143485886|NCT02706873|517322928|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
143485887|NCT02706873|517322929|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
143485888|NCT02706873|517322930|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
143020880|NCT05266456|515616857|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
143020881|NCT05266456|515616858|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
143020882|NCT05266456|515616859|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
143020883|NCT01141283|515616861|FG000|Overall Study|Adverse Event|56|||
143020884|NCT01141283|515616861|FG000|Overall Study|Lost to Follow-up|4|||
143020885|NCT01141283|515616861|FG000|Overall Study|Withdrawal by Subject|14|||
143020886|NCT01141283|515616861|FG000|Overall Study|Administrative|4|||
143020887|NCT01141283|515616861|FG000|Overall Study|Lack of Efficacy|10|||
143020888|NCT03811249|515616868|FG000|Overall Study|Withdrawal by Subject|44|||
143020889|NCT03811249|515616868|FG000|Overall Study|Missed Visit|24|||
143020890|NCT00571922|515616869|FG000|Overall Study|Completion unknown|36|||
143020891|NCT00571922|515616870|FG001|Overall Study|Completion unknown|36|||
143020892|NCT04304950|515616880|FG000|Overall Study|Lost to Follow-up|1|||
143020893|NCT04304950|515616881|FG001|Overall Study|Lost to Follow-up|1|||
143020894|NCT00345683|515616888|FG000|Overall Study|Lost to Follow-up|19|||
143020895|NCT00345683|515616889|FG001|Overall Study|Lost to Follow-up|7|||
143020896|NCT00345683|515616888|FG000|Overall Study|Other|6|||
143020897|NCT00345683|515616889|FG001|Overall Study|Other|2|||
143020898|NCT03634488|515616890|FG000|Overall Study|Death|1|||
143020899|NCT03634488|515616891|FG001|Overall Study|Death|0|||
143020900|NCT03634488|515616892|FG002|Overall Study|Death|0|||
143020901|NCT03634488|515616890|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
143020902|NCT03634488|515616891|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
143020903|NCT03634488|515616892|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
143020904|NCT01697449|515616899|FG000|Overall Study|Disease progression|47|||
143020905|NCT01697449|515616899|FG000|Overall Study|Adverse Event|7|||
143020906|NCT01697449|515616899|FG000|Overall Study|Lost to Follow-up|5|||
143020907|NCT01697449|515616899|FG000|Overall Study|Withdrawal by Subject|2|||
143020908|NCT01697449|515616899|FG000|Overall Study|Physician Decision|1|||
143020909|NCT01697449|515616899|FG000|Overall Study|Death|2|||
143020910|NCT01697449|515616899|FG000|Overall Study|Other|1|||
143020911|NCT01697449|515616899|FG000|Overall Study|Missing|25|||
143020912|NCT00530439|515616900|FG000|Overall Study|GDM|9|||
143020913|NCT00530439|515616901|FG001|Overall Study|GDM|3|||
143020914|NCT00530439|515616900|FG000|Overall Study|Withdraw|18|||
143020915|NCT00530439|515616901|FG001|Overall Study|Withdraw|14|||
143020916|NCT00530439|515616900|FG000|Overall Study|Missed abortion|1|||
143020917|NCT00530439|515616901|FG001|Overall Study|Missed abortion|4|||
143020918|NCT00530439|515616900|FG000|Overall Study|Misclassification|2|||
143020919|NCT00530439|515616901|FG001|Overall Study|Misclassification|0|||
143020920|NCT00530439|515616900|FG000|Overall Study|Twin pregnancy|0|||
143020921|NCT00530439|515616901|FG001|Overall Study|Twin pregnancy|2|||
143020922|NCT00530439|515616900|FG000|Overall Study|Severe malformation/abortion|0|||
143020923|NCT00530439|515616901|FG001|Overall Study|Severe malformation/abortion|3|||
143155796|NCT01033071|516114125|FG001|Overall Study|Other|4|||
143155797|NCT01033071|516114126|FG002|Overall Study|Other|3|||
143155798|NCT03554473|516115685|FG000|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|2|||
143155799|NCT03554473|516115686|FG001|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
143020924|NCT02046369|515616902|FG000|Overall Study|Adverse Event|3|||
143020925|NCT02046369|515616903|FG001|Overall Study|Adverse Event|3|||
143020926|NCT02046369|515616902|FG000|Overall Study|Lack of Efficacy|3|||
143020927|NCT02046369|515616903|FG001|Overall Study|Lack of Efficacy|3|||
143020928|NCT02046369|515616902|FG000|Overall Study|Lost to Follow-up|3|||
143020929|NCT02046369|515616903|FG001|Overall Study|Lost to Follow-up|3|||
143020930|NCT02046369|515616902|FG000|Overall Study|Protocol Violation|1|||
143020931|NCT02046369|515616903|FG001|Overall Study|Protocol Violation|2|||
143020932|NCT02046369|515616902|FG000|Overall Study|Withdrawal by Subject|3|||
143155800|NCT03554473|516115687|FG002|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
143155801|NCT03554473|516115685|FG000|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|1|||
143155802|NCT03554473|516115686|FG001|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
143155803|NCT03554473|516115687|FG002|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
143155804|NCT03554473|516115685|FG000|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
143181468|NCT00642707|516211752|FG000|Overall Study|Withdrawal by Subject|1|||
143020933|NCT02046369|515616903|FG001|Overall Study|Withdrawal by Subject|6|||
143020934|NCT02046369|515616902|FG000|Overall Study|never received study drug|0|||
143020935|NCT02046369|515616903|FG001|Overall Study|never received study drug|1|||
143020936|NCT02046369|515616902|FG000|Overall Study|non compliance|1|||
143020937|NCT02046369|515616903|FG001|Overall Study|non compliance|0|||
143020938|NCT04385199|515616904|FG000|Overall Study|Withdrawal by Subject|1|||
143020939|NCT04385199|515616905|FG001|Overall Study|Withdrawal by Subject|0|||
143020940|NCT01473758|515618973|FG000|Cycle 1|Adverse Event|10|||
143020941|NCT01473758|515618974|FG001|Cycle 1|Adverse Event|2|||
143020942|NCT01473758|515618975|FG002|Cycle 1|Adverse Event|0|||
143020943|NCT01473758|515618976|FG003|Cycle 1|Adverse Event|0|||
143020944|NCT01473758|515618973|FG000|Cycle 1|Withdrawal by Subject|1|||
143020945|NCT01473758|515618974|FG001|Cycle 1|Withdrawal by Subject|1|||
143020946|NCT01473758|515618975|FG002|Cycle 1|Withdrawal by Subject|0|||
143020947|NCT01473758|515618976|FG003|Cycle 1|Withdrawal by Subject|0|||
143020948|NCT01473758|515618973|FG000|Cycle 2|Adverse Event|0|||
143020949|NCT01473758|515618974|FG001|Cycle 2|Adverse Event|0|||
143020950|NCT01473758|515618975|FG002|Cycle 2|Adverse Event|5|||
143020951|NCT01473758|515618976|FG003|Cycle 2|Adverse Event|0|||
143020952|NCT02763579|515618986|FG000|Global Period|Death|167|||
143020953|NCT02763579|515618987|FG001|Global Period|Death|151|||
143020954|NCT02763579|515618988|FG002|Global Period|Death|0|||
143020955|NCT02763579|515618989|FG003|Global Period|Death|0|||
143020956|NCT02763579|515618986|FG000|Global Period|Lost to Follow-up|2|||
143020957|NCT02763579|515618987|FG001|Global Period|Lost to Follow-up|4|||
143020958|NCT02763579|515618988|FG002|Global Period|Lost to Follow-up|0|||
143020959|NCT02763579|515618989|FG003|Global Period|Lost to Follow-up|0|||
143020960|NCT02763579|515618986|FG000|Global Period|Physician Decision|0|||
143020961|NCT02763579|515618987|FG001|Global Period|Physician Decision|2|||
143020962|NCT02763579|515618988|FG002|Global Period|Physician Decision|0|||
143020963|NCT02763579|515618989|FG003|Global Period|Physician Decision|0|||
143020964|NCT02763579|515618986|FG000|Global Period|Study Terminated By Sponsor|21|||
143020965|NCT02763579|515618987|FG001|Global Period|Study Terminated By Sponsor|26|||
143020966|NCT02763579|515618988|FG002|Global Period|Study Terminated By Sponsor|0|||
143020967|NCT02763579|515618989|FG003|Global Period|Study Terminated By Sponsor|0|||
143020968|NCT02763579|515618986|FG000|Global Period|Withdrawal by Subject|12|||
143020969|NCT02763579|515618987|FG001|Global Period|Withdrawal by Subject|18|||
143020970|NCT02763579|515618988|FG002|Global Period|Withdrawal by Subject|0|||
143020971|NCT02763579|515618989|FG003|Global Period|Withdrawal by Subject|0|||
143020972|NCT02763579|515618986|FG000|China Period|Death|0|||
143020973|NCT02763579|515618987|FG001|China Period|Death|0|||
143020974|NCT02763579|515618988|FG002|China Period|Death|46|||
143020975|NCT02763579|515618989|FG003|China Period|Death|48|||
143020976|NCT02763579|515618986|FG000|China Period|Lost to Follow-up|0|||
143020977|NCT02763579|515618987|FG001|China Period|Lost to Follow-up|0|||
143020978|NCT02763579|515618988|FG002|China Period|Lost to Follow-up|1|||
143020979|NCT02763579|515618989|FG003|China Period|Lost to Follow-up|1|||
143020980|NCT02763579|515618986|FG000|China Period|Physician Decision|0|||
143020981|NCT02763579|515618987|FG001|China Period|Physician Decision|0|||
143020982|NCT02763579|515618988|FG002|China Period|Physician Decision|0|||
143020983|NCT02763579|515618989|FG003|China Period|Physician Decision|1|||
143020984|NCT02763579|515618986|FG000|China Period|Study Terminated By Sponsor|0|||
143020985|NCT02763579|515618987|FG001|China Period|Study Terminated By Sponsor|0|||
143020986|NCT02763579|515618988|FG002|China Period|Study Terminated By Sponsor|3|||
143020987|NCT02763579|515618989|FG003|China Period|Study Terminated By Sponsor|4|||
143020988|NCT02763579|515618986|FG000|China Period|Withdrawal by Subject|0|||
143020989|NCT02763579|515618987|FG001|China Period|Withdrawal by Subject|0|||
143020990|NCT02763579|515618988|FG002|China Period|Withdrawal by Subject|3|||
143020991|NCT02763579|515618989|FG003|China Period|Withdrawal by Subject|3|||
143020992|NCT00606684|515618990|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
143020993|NCT00606684|515618991|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
143020994|NCT00606684|515618992|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
143020995|NCT00606684|515618993|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
143020996|NCT00606684|515618994|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
143020997|NCT00606684|515618995|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
143020998|NCT00606684|515618996|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
143020999|NCT00606684|515618990|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
143021000|NCT00606684|515618991|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
143021001|NCT00606684|515618992|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
143021002|NCT00606684|515618993|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
143021003|NCT00606684|515618994|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
143021004|NCT00606684|515618995|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
143021005|NCT00606684|515618996|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
143021006|NCT00606684|515618990|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
143021007|NCT00606684|515618991|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
143021008|NCT00606684|515618992|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
143155805|NCT03554473|516115686|FG001|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
143021009|NCT00606684|515618993|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
143155806|NCT03554473|516115687|FG002|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|4|||
143155807|NCT05206604|516115691|FG000|Overall Study|Non-compliance with study drug|0|||
143155808|NCT05206604|516115692|FG001|Overall Study|Non-compliance with study drug|0|||
143021010|NCT00606684|515618994|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
143021011|NCT00606684|515618995|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
143021012|NCT00606684|515618996|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
143363701|NCT00062868|516873792|FG012|Dose Level 3|Withdrew|0|||
143363702|NCT00062868|516873793|FG013|Dose Level 3|Withdrew|0|||
143363703|NCT00062868|516873794|FG014|Dose Level 3|Withdrew|0|||
143363704|NCT00062868|516873795|FG015|Dose Level 3|Withdrew|0|||
143363705|NCT00062868|516873796|FG016|Dose Level 3|Withdrew|0|||
143485889|NCT02706873|517322931|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
143485890|NCT02706873|517322928|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
143485891|NCT02706873|517322929|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
143485892|NCT02706873|517322930|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
143485893|NCT02706873|517322931|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
143485894|NCT02706873|517322928|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
143485895|NCT02706873|517322929|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
143485896|NCT02706873|517322930|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
143485897|NCT02706873|517322931|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
143485898|NCT02706873|517322928|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
143485899|NCT02706873|517322929|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
143485900|NCT02706873|517322930|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
143485901|NCT02706873|517322931|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
143485902|NCT02706873|517322928|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
143485903|NCT02706873|517322929|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
143485904|NCT02706873|517322930|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
143485905|NCT02706873|517322931|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
143485906|NCT00464334|517322936|FG000|Overall Study|Adverse Event|0|||
143485907|NCT00464334|517322937|FG001|Overall Study|Adverse Event|0|||
143485908|NCT00464334|517322938|FG002|Overall Study|Adverse Event|0|||
143485909|NCT00464334|517322939|FG003|Overall Study|Adverse Event|1|||
143485910|NCT00464334|517322940|FG004|Overall Study|Adverse Event|1|||
143485911|NCT00464334|517322941|FG005|Overall Study|Adverse Event|1|||
143485912|NCT00464334|517322942|FG006|Overall Study|Adverse Event|0|||
143485913|NCT00464334|517322943|FG007|Overall Study|Adverse Event|0|||
143485914|NCT00464334|517322944|FG008|Overall Study|Adverse Event|2|||
143485915|NCT00464334|517322945|FG009|Overall Study|Adverse Event|1|||
143485916|NCT00464334|517322946|FG010|Overall Study|Adverse Event|2|||
143485917|NCT00464334|517322936|FG000|Overall Study|Lack of Efficacy|0|||
143485918|NCT00464334|517322937|FG001|Overall Study|Lack of Efficacy|1|||
143485919|NCT00464334|517322938|FG002|Overall Study|Lack of Efficacy|0|||
143485920|NCT00464334|517322939|FG003|Overall Study|Lack of Efficacy|0|||
143485921|NCT00464334|517322940|FG004|Overall Study|Lack of Efficacy|0|||
143485922|NCT00464334|517322941|FG005|Overall Study|Lack of Efficacy|0|||
143485923|NCT00464334|517322942|FG006|Overall Study|Lack of Efficacy|0|||
143485924|NCT00464334|517322943|FG007|Overall Study|Lack of Efficacy|0|||
143485925|NCT00464334|517322944|FG008|Overall Study|Lack of Efficacy|0|||
143485926|NCT00464334|517322945|FG009|Overall Study|Lack of Efficacy|0|||
143485927|NCT00464334|517322946|FG010|Overall Study|Lack of Efficacy|0|||
143485928|NCT00464334|517322936|FG000|Overall Study|Lost to Follow-up|0|||
143485929|NCT00464334|517322937|FG001|Overall Study|Lost to Follow-up|0|||
143485930|NCT00464334|517322938|FG002|Overall Study|Lost to Follow-up|1|||
143485931|NCT00464334|517322939|FG003|Overall Study|Lost to Follow-up|0|||
143485932|NCT00464334|517322940|FG004|Overall Study|Lost to Follow-up|1|||
143363706|NCT00062868|516873797|FG017|Dose Level 3|Withdrew|0|||
143363707|NCT00062868|516873798|FG018|Dose Level 3|Withdrew|0|||
143363708|NCT00062868|516873799|FG019|Dose Level 3|Withdrew|0|||
143363709|NCT00062868|516873800|FG020|Dose Level 3|Withdrew|0|||
143363710|NCT04949399|516873801|FG000|Overall Study|Lost to Follow-up|11|||
143363711|NCT04949399|516873802|FG001|Overall Study|Lost to Follow-up|6|||
143485933|NCT00464334|517322941|FG005|Overall Study|Lost to Follow-up|0|||
143485934|NCT00464334|517322942|FG006|Overall Study|Lost to Follow-up|1|||
143485935|NCT00464334|517322943|FG007|Overall Study|Lost to Follow-up|0|||
143485936|NCT00464334|517322944|FG008|Overall Study|Lost to Follow-up|0|||
143485937|NCT00464334|517322945|FG009|Overall Study|Lost to Follow-up|0|||
143485938|NCT00464334|517322946|FG010|Overall Study|Lost to Follow-up|2|||
143485939|NCT00464334|517322936|FG000|Overall Study|Progressive Disease|0|||
143485940|NCT00464334|517322937|FG001|Overall Study|Progressive Disease|0|||
143485941|NCT00464334|517322938|FG002|Overall Study|Progressive Disease|0|||
143485942|NCT00464334|517322939|FG003|Overall Study|Progressive Disease|0|||
143485943|NCT00464334|517322940|FG004|Overall Study|Progressive Disease|0|||
143485944|NCT00464334|517322941|FG005|Overall Study|Progressive Disease|1|||
143485945|NCT00464334|517322942|FG006|Overall Study|Progressive Disease|0|||
143485946|NCT00464334|517322943|FG007|Overall Study|Progressive Disease|0|||
143485947|NCT00464334|517322944|FG008|Overall Study|Progressive Disease|1|||
143485948|NCT00464334|517322945|FG009|Overall Study|Progressive Disease|0|||
143485949|NCT00464334|517322946|FG010|Overall Study|Progressive Disease|0|||
143485950|NCT00464334|517322936|FG000|Overall Study|Study Terminated by Sponsor|0|||
143485951|NCT00464334|517322937|FG001|Overall Study|Study Terminated by Sponsor|0|||
143363712|NCT04949399|516873801|FG000|Overall Study|Withdrawal by Subject|2|||
143363713|NCT04949399|516873802|FG001|Overall Study|Withdrawal by Subject|3|||
143363714|NCT00670540|516873803|FG000|Overall Study|ineligible|17|||
143485952|NCT00464334|517322938|FG002|Overall Study|Study Terminated by Sponsor|0|||
143485953|NCT00464334|517322939|FG003|Overall Study|Study Terminated by Sponsor|1|||
143485954|NCT00464334|517322940|FG004|Overall Study|Study Terminated by Sponsor|0|||
143485955|NCT00464334|517322941|FG005|Overall Study|Study Terminated by Sponsor|0|||
143485956|NCT00464334|517322942|FG006|Overall Study|Study Terminated by Sponsor|0|||
143485957|NCT00464334|517322943|FG007|Overall Study|Study Terminated by Sponsor|0|||
143485958|NCT00464334|517322944|FG008|Overall Study|Study Terminated by Sponsor|0|||
143485959|NCT00464334|517322945|FG009|Overall Study|Study Terminated by Sponsor|0|||
143485960|NCT00464334|517322946|FG010|Overall Study|Study Terminated by Sponsor|0|||
143485961|NCT00464334|517322936|FG000|Overall Study|Withdrawal by Subject|1|||
143485962|NCT00464334|517322937|FG001|Overall Study|Withdrawal by Subject|7|||
143485963|NCT00464334|517322938|FG002|Overall Study|Withdrawal by Subject|4|||
143485964|NCT00464334|517322939|FG003|Overall Study|Withdrawal by Subject|2|||
143021013|NCT00606684|515618990|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
143021014|NCT00606684|515618991|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
143021015|NCT00606684|515618992|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
143021016|NCT00606684|515618993|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
143021017|NCT00606684|515618994|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
143021018|NCT00606684|515618995|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
143021019|NCT00606684|515618996|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
143021020|NCT00606684|515618990|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
143021021|NCT00606684|515618991|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
143021022|NCT00606684|515618992|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
143021023|NCT00606684|515618993|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
143021024|NCT00606684|515618994|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
143021025|NCT00606684|515618995|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
143021026|NCT00606684|515618996|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
143021027|NCT00606684|515618990|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
143021028|NCT00606684|515618991|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
143021029|NCT00606684|515618992|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
143021030|NCT00606684|515618993|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
143021031|NCT00606684|515618994|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
143021032|NCT00606684|515618995|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
143021033|NCT00606684|515618996|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
143021034|NCT00606684|515618990|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
143021035|NCT00606684|515618991|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
143021036|NCT00606684|515618992|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
143021037|NCT00606684|515618993|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
143021038|NCT00606684|515618994|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
143021039|NCT00606684|515618995|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
143021040|NCT00606684|515618996|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
143021041|NCT00606684|515618990|FG000|Double-Blind Treatment Period|Adverse Event|0|||
143021042|NCT00606684|515618991|FG001|Double-Blind Treatment Period|Adverse Event|3|||
143021043|NCT00606684|515618992|FG002|Double-Blind Treatment Period|Adverse Event|2|||
143021044|NCT00606684|515618993|FG003|Double-Blind Treatment Period|Adverse Event|4|||
143021045|NCT00606684|515618994|FG004|Double-Blind Treatment Period|Adverse Event|2|||
143021046|NCT00606684|515618995|FG005|Double-Blind Treatment Period|Adverse Event|0|||
143021047|NCT00606684|515618996|FG006|Double-Blind Treatment Period|Adverse Event|1|||
143021048|NCT00606684|515618990|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
143021049|NCT00606684|515618991|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
143021050|NCT00606684|515618992|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
143021051|NCT00606684|515618993|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
143021052|NCT00606684|515618994|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
143021053|NCT00606684|515618995|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
143021054|NCT00606684|515618996|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
143021055|NCT00606684|515618990|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
143021056|NCT00606684|515618991|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
143021057|NCT00606684|515618992|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
143021058|NCT00606684|515618993|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
143021059|NCT00606684|515618994|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
143021060|NCT00606684|515618995|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
143021061|NCT00606684|515618996|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
143021062|NCT00606684|515618990|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
143235562|NCT05632211|516413620|FG001|Overall Study|Withdrawal by Subject|0|||
143485965|NCT00464334|517322940|FG004|Overall Study|Withdrawal by Subject|2|||
143485966|NCT00464334|517322941|FG005|Overall Study|Withdrawal by Subject|2|||
143485967|NCT00464334|517322942|FG006|Overall Study|Withdrawal by Subject|2|||
143485968|NCT00464334|517322943|FG007|Overall Study|Withdrawal by Subject|1|||
143485969|NCT00464334|517322944|FG008|Overall Study|Withdrawal by Subject|3|||
143485970|NCT00464334|517322945|FG009|Overall Study|Withdrawal by Subject|0|||
143363715|NCT00670540|516873803|FG000|Overall Study|not living in France|348|||
143363716|NCT00670540|516873803|FG000|Overall Study|refused to participate|189|||
143363717|NCT00670540|516873803|FG000|Overall Study|controls randomised for no follow up|2770|||
143363718|NCT00670540|516873803|FG000|Overall Study|missing information inclusion criteria|1|||
143363719|NCT05296629|516875424|FG000|Overall Study|Withdrawal by Subject|3|||
143363720|NCT05296629|516875425|FG001|Overall Study|Withdrawal by Subject|10|||
143363721|NCT05296629|516875426|FG002|Overall Study|Withdrawal by Subject|4|||
143363722|NCT05296629|516875424|FG000|Overall Study|Lost to Follow-up|2|||
143485971|NCT00464334|517322946|FG010|Overall Study|Withdrawal by Subject|0|||
143021063|NCT00606684|515618991|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
143021064|NCT00606684|515618992|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
143021065|NCT00606684|515618993|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
143021066|NCT00606684|515618994|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
143021067|NCT00606684|515618995|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
143021068|NCT00606684|515618996|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
143021069|NCT00606684|515618990|FG000|Double-Blind Treatment Period|Physician Decision|0|||
143021070|NCT00606684|515618991|FG001|Double-Blind Treatment Period|Physician Decision|5|||
143021071|NCT00606684|515618992|FG002|Double-Blind Treatment Period|Physician Decision|1|||
143021072|NCT00606684|515618993|FG003|Double-Blind Treatment Period|Physician Decision|0|||
143021073|NCT00606684|515618994|FG004|Double-Blind Treatment Period|Physician Decision|3|||
143485972|NCT03948178|517322947|FG000|Overall Study|Protocol Violation|1|||
143485973|NCT03948178|517322947|FG000|Overall Study|Lost to Follow-up|2|||
143485974|NCT03948178|517322947|FG000|Overall Study|Withdrawal by Subject|2|||
143485975|NCT03948178|517322947|FG000|Overall Study|Reason not known|2|||
143485976|NCT03948178|517322947|FG000|Overall Study|Personal reason|14|||
143485977|NCT03948178|517322947|FG000|Overall Study|Disease progression|30|||
143485978|NCT03948178|517322947|FG000|Overall Study|Adverse Event|12|||
143485979|NCT03948178|517322947|FG000|Overall Study|Sponsor terminated study|164|||
143485980|NCT01297270|517322948|FG000|Overall Study|Adverse Event|19|||
143485981|NCT01297270|517322949|FG001|Overall Study|Adverse Event|32|||
143485982|NCT01297270|517322950|FG002|Overall Study|Adverse Event|5|||
143485983|NCT01297270|517322948|FG000|Overall Study|Lack of Efficacy|15|||
143485984|NCT01297270|517322949|FG001|Overall Study|Lack of Efficacy|17|||
143485985|NCT01297270|517322950|FG002|Overall Study|Lack of Efficacy|15|||
143485986|NCT01297270|517322948|FG000|Overall Study|Lost to Follow-up|1|||
143485987|NCT01297270|517322949|FG001|Overall Study|Lost to Follow-up|2|||
143485988|NCT01297270|517322950|FG002|Overall Study|Lost to Follow-up|1|||
143485989|NCT01297270|517322948|FG000|Overall Study|Protocol Violation|0|||
143485990|NCT01297270|517322949|FG001|Overall Study|Protocol Violation|2|||
143485991|NCT01297270|517322950|FG002|Overall Study|Protocol Violation|0|||
143485992|NCT01297270|517322948|FG000|Overall Study|Withdrawal by Subject|7|||
143485993|NCT01297270|517322949|FG001|Overall Study|Withdrawal by Subject|15|||
143021074|NCT00606684|515618995|FG005|Double-Blind Treatment Period|Physician Decision|1|||
143155809|NCT05206604|516115693|FG002|Overall Study|Non-compliance with study drug|0|||
143155810|NCT05206604|516115694|FG003|Overall Study|Non-compliance with study drug|0|||
143155811|NCT05206604|516115695|FG004|Overall Study|Non-compliance with study drug|0|||
143155812|NCT05206604|516115696|FG005|Overall Study|Non-compliance with study drug|1|||
143155813|NCT05206604|516115697|FG006|Overall Study|Non-compliance with study drug|0|||
143155814|NCT05206604|516115698|FG007|Overall Study|Non-compliance with study drug|0|||
143155815|NCT03735498|516115699|FG000|Overall Study|Withdrawal by Subject|3|||
143155816|NCT03735498|516115699|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
143155817|NCT00160615|516115700|FG000|Overall Study|Adverse Event|5|||
143155818|NCT00160615|516115701|FG001|Overall Study|Adverse Event|12|||
143155819|NCT00160615|516115700|FG000|Overall Study|Withdrawal by Subject|0|||
143155820|NCT00160615|516115701|FG001|Overall Study|Withdrawal by Subject|2|||
143155821|NCT00160615|516115700|FG000|Overall Study|Lack of Efficacy|11|||
143155822|NCT00160615|516115701|FG001|Overall Study|Lack of Efficacy|23|||
143155823|NCT00160615|516115700|FG000|Overall Study|Patient decision|1|||
143155824|NCT00160615|516115701|FG001|Overall Study|Patient decision|2|||
143155825|NCT00160615|516115700|FG000|Overall Study|Investigator decision|1|||
143155826|NCT00160615|516115701|FG001|Overall Study|Investigator decision|1|||
143155827|NCT00160615|516115700|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
143155828|NCT00160615|516115701|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
143155829|NCT00160615|516115700|FG000|Overall Study|Switch to surgical treatment|0|||
143021075|NCT00606684|515618996|FG006|Double-Blind Treatment Period|Physician Decision|2|||
143155830|NCT00160615|516115701|FG001|Overall Study|Switch to surgical treatment|2|||
143363723|NCT05296629|516875425|FG001|Overall Study|Lost to Follow-up|7|||
143363724|NCT05296629|516875426|FG002|Overall Study|Lost to Follow-up|1|||
143485994|NCT01297270|517322950|FG002|Overall Study|Withdrawal by Subject|7|||
143485995|NCT01297270|517322948|FG000|Overall Study|Other reason not defined above|3|||
143485996|NCT01297270|517322949|FG001|Overall Study|Other reason not defined above|3|||
143485997|NCT01297270|517322950|FG002|Overall Study|Other reason not defined above|1|||
143485998|NCT01297270|517322948|FG000|Overall Study|Not treated|0|||
143485999|NCT01297270|517322949|FG001|Overall Study|Not treated|1|||
143021076|NCT00606684|515618990|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
143021077|NCT00606684|515618991|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
143021078|NCT00606684|515618992|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
143021079|NCT00606684|515618993|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
143021080|NCT00606684|515618994|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
143021081|NCT00606684|515618995|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
143021082|NCT00606684|515618996|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
143021083|NCT01764854|515618999|FG000|Overall Study|Adverse Event|0|||
143021084|NCT01764854|515619000|FG001|Overall Study|Adverse Event|0|||
143021085|NCT01764854|515619001|FG002|Overall Study|Adverse Event|2|||
143021086|NCT01764854|515619002|FG003|Overall Study|Adverse Event|0|||
143021087|NCT01764854|515618999|FG000|Overall Study|Withdrawal by Subject|0|||
143021088|NCT01764854|515619000|FG001|Overall Study|Withdrawal by Subject|0|||
143021089|NCT01764854|515619001|FG002|Overall Study|Withdrawal by Subject|1|||
143021090|NCT01764854|515619002|FG003|Overall Study|Withdrawal by Subject|0|||
143021091|NCT01764854|515618999|FG000|Overall Study|relocation|0|||
143021092|NCT01764854|515619000|FG001|Overall Study|relocation|0|||
143021093|NCT01764854|515619001|FG002|Overall Study|relocation|2|||
143021094|NCT01764854|515619002|FG003|Overall Study|relocation|0|||
143021095|NCT01764854|515618999|FG000|Overall Study|Protocol Violation|0|||
143021096|NCT01764854|515619000|FG001|Overall Study|Protocol Violation|0|||
143021097|NCT01764854|515619001|FG002|Overall Study|Protocol Violation|1|||
143021098|NCT01764854|515619002|FG003|Overall Study|Protocol Violation|2|||
143021099|NCT01759381|515619012|FG000|Overall Study|Death|1|||
143021100|NCT01759381|515619013|FG001|Overall Study|Death|0|||
143021101|NCT00910858|515619014|FG000|Pharmacokinetic Phase|Adverse Event|1|||
143021102|NCT00910858|515619015|FG001|Pharmacokinetic Phase|Adverse Event|0|||
143021103|NCT00910858|515619016|FG002|Pharmacokinetic Phase|Adverse Event|0|||
143021104|NCT00910858|515619014|FG000|Monotherapy Phase|Adverse Event|3|||
143021105|NCT00910858|515619015|FG001|Monotherapy Phase|Adverse Event|2|||
143021106|NCT00910858|515619016|FG002|Monotherapy Phase|Adverse Event|0|||
143021107|NCT00910858|515619014|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
143021108|NCT00910858|515619015|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
143021109|NCT00910858|515619016|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
143021110|NCT00910858|515619014|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
143021111|NCT00910858|515619015|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
143021112|NCT00910858|515619016|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
143021113|NCT00910858|515619014|FG000|Monotherapy Phase|Protocol Violation|1|||
143021114|NCT00910858|515619015|FG001|Monotherapy Phase|Protocol Violation|0|||
143021115|NCT00910858|515619016|FG002|Monotherapy Phase|Protocol Violation|0|||
143021116|NCT00910858|515619014|FG000|Monotherapy Phase|Other|3|||
143021117|NCT00910858|515619015|FG001|Monotherapy Phase|Other|4|||
143021118|NCT00910858|515619016|FG002|Monotherapy Phase|Other|2|||
143021119|NCT00910858|515619014|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
143021120|NCT00910858|515619015|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
143155831|NCT00160615|516115700|FG000|Overall Study|Non-compliance was suspected|0|||
143155832|NCT00160615|516115701|FG001|Overall Study|Non-compliance was suspected|1|||
143155833|NCT00160615|516115700|FG000|Overall Study|Poor compliance|0|||
143155834|NCT00160615|516115701|FG001|Overall Study|Poor compliance|1|||
143155835|NCT03166631|516115702|FG000|Overall Study|Progressive disease|2|||
143155836|NCT03166631|516115703|FG001|Overall Study|Progressive disease|1|||
143155837|NCT03166631|516115704|FG002|Overall Study|Progressive disease|3|||
143155838|NCT03166631|516115705|FG003|Overall Study|Progressive disease|4|||
143155839|NCT03166631|516115706|FG004|Overall Study|Progressive disease|2|||
143155840|NCT03166631|516115707|FG005|Overall Study|Progressive disease|2|||
143155841|NCT03166631|516115708|FG006|Overall Study|Progressive disease|5|||
143155842|NCT03166631|516115709|FG007|Overall Study|Progressive disease|6|||
143155843|NCT03166631|516115710|FG008|Overall Study|Progressive disease|11|||
143155844|NCT03166631|516115711|FG009|Overall Study|Progressive disease|5|||
143155845|NCT03166631|516115712|FG010|Overall Study|Progressive disease|7|||
143155846|NCT03166631|516115702|FG000|Overall Study|Physician Decision|0|||
143021121|NCT00910858|515619016|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
143021122|NCT00910858|515619014|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
143021123|NCT00910858|515619015|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
143021124|NCT00910858|515619016|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
143021125|NCT00910858|515619014|FG000|Combined Treatment Phase|Protocol Violation|1|||
143021126|NCT00910858|515619015|FG001|Combined Treatment Phase|Protocol Violation|0|||
143155847|NCT03166631|516115703|FG001|Overall Study|Physician Decision|0|||
143155848|NCT03166631|516115704|FG002|Overall Study|Physician Decision|0|||
143155849|NCT03166631|516115705|FG003|Overall Study|Physician Decision|0|||
143021127|NCT00910858|515619016|FG002|Combined Treatment Phase|Protocol Violation|0|||
143021128|NCT00910858|515619014|FG000|Combined Treatment Phase|Other|0|||
143021129|NCT00910858|515619015|FG001|Combined Treatment Phase|Other|2|||
143021130|NCT00910858|515619016|FG002|Combined Treatment Phase|Other|1|||
143155850|NCT03166631|516115706|FG004|Overall Study|Physician Decision|0|||
143021131|NCT00447603|515619023|FG000|Screening|Withdrawal by Subject|1|||
143155851|NCT03166631|516115707|FG005|Overall Study|Physician Decision|0|||
143021132|NCT00447603|515619024|FG001|Screening|Withdrawal by Subject|0|||
143021133|NCT00447603|515619025|FG002|Screening|Withdrawal by Subject|0|||
143021134|NCT00447603|515619023|FG000|Screening|Protocol Violation|1|||
143021135|NCT00447603|515619024|FG001|Screening|Protocol Violation|0|||
143021136|NCT00447603|515619025|FG002|Screening|Protocol Violation|0|||
143021137|NCT00447603|515619023|FG000|Screening|Screen Failure|4|||
143021138|NCT00447603|515619024|FG001|Screening|Screen Failure|0|||
143021139|NCT00447603|515619025|FG002|Screening|Screen Failure|0|||
143021140|NCT00447603|515619023|FG000|Screening|Study Terminated by Sponsor|15|||
143021141|NCT00447603|515619024|FG001|Screening|Study Terminated by Sponsor|0|||
143021142|NCT00447603|515619025|FG002|Screening|Study Terminated by Sponsor|0|||
143021143|NCT00447603|515619023|FG000|Filter Period|Adverse Event|0|||
143021144|NCT00447603|515619024|FG001|Filter Period|Adverse Event|0|||
143021145|NCT00447603|515619025|FG002|Filter Period|Adverse Event|1|||
143021146|NCT00447603|515619023|FG000|Filter Period|Screen Failure|0|||
143021147|NCT00447603|515619024|FG001|Filter Period|Screen Failure|3|||
143021148|NCT00447603|515619025|FG002|Filter Period|Screen Failure|4|||
143021149|NCT00447603|515619023|FG000|Filter Period|Study terminated by Sponsor|0|||
143021150|NCT00447603|515619024|FG001|Filter Period|Study terminated by Sponsor|1|||
143021151|NCT00447603|515619025|FG002|Filter Period|Study terminated by Sponsor|10|||
143021152|NCT01165684|515619028|FG000|Overall Study|Adverse Event|1|||
143021153|NCT01165684|515619029|FG001|Overall Study|Adverse Event|1|||
143021154|NCT01165684|515619028|FG000|Overall Study|Lack of Efficacy|2|||
143021155|NCT01165684|515619029|FG001|Overall Study|Lack of Efficacy|1|||
143021156|NCT01165684|515619028|FG000|Overall Study|Protocol Violation|7|||
143021157|NCT01165684|515619029|FG001|Overall Study|Protocol Violation|15|||
143021158|NCT01165684|515619028|FG000|Overall Study|Withdrawal Criteria|2|||
143021159|NCT01165684|515619029|FG001|Overall Study|Withdrawal Criteria|13|||
143021160|NCT01165684|515619028|FG000|Overall Study|Unclassified|16|||
143021161|NCT01165684|515619029|FG001|Overall Study|Unclassified|22|||
143021162|NCT02008721|515619036|FG000|Overall Study|Withdrawal by Subject|5|||
143021163|NCT02008721|515619037|FG001|Overall Study|Withdrawal by Subject|1|||
143021164|NCT02008721|515619036|FG000|Overall Study|Death|4|||
143021165|NCT02008721|515619037|FG001|Overall Study|Death|2|||
143021166|NCT02008721|515619036|FG000|Overall Study|Adverse Event|3|||
143021167|NCT02008721|515619037|FG001|Overall Study|Adverse Event|5|||
143021168|NCT02008721|515619036|FG000|Overall Study|Protocol Violation|3|||
143021169|NCT02008721|515619037|FG001|Overall Study|Protocol Violation|2|||
143021170|NCT00909727|515619039|FG000|Overall Study|Adverse Event|1|||
143021171|NCT00909727|515619040|FG001|Overall Study|Adverse Event|0|||
143021172|NCT00909727|515619039|FG000|Overall Study|Wrong Genotype|1|||
143021173|NCT00909727|515619040|FG001|Overall Study|Wrong Genotype|0|||
143021174|NCT00909727|515619039|FG000|Overall Study|Withdrawal of Consent|1|||
143021175|NCT00909727|515619040|FG001|Overall Study|Withdrawal of Consent|0|||
143021176|NCT00909727|515619039|FG000|Overall Study|Prohibited Medication|1|||
143021177|NCT00909727|515619040|FG001|Overall Study|Prohibited Medication|0|||
143021178|NCT01339910|515619042|FG000|Overall Study|Withdrawal by Subject|1|||
143021179|NCT01339910|515619043|FG001|Overall Study|Withdrawal by Subject|0|||
143021180|NCT01339910|515619042|FG000|Overall Study|Physician Decision|1|||
143021181|NCT01339910|515619043|FG001|Overall Study|Physician Decision|0|||
143021182|NCT01339910|515619042|FG000|Overall Study|Disease relapse|1|||
143021183|NCT01339910|515619043|FG001|Overall Study|Disease relapse|4|||
143021184|NCT00672620|515619044|FG000|Overall Study|Adverse Event|7|||
143021185|NCT00672620|515619045|FG001|Overall Study|Adverse Event|7|||
143021186|NCT00672620|515619046|FG002|Overall Study|Adverse Event|12|||
143021187|NCT00672620|515619047|FG003|Overall Study|Adverse Event|17|||
143021188|NCT00672620|515619044|FG000|Overall Study|Lack of Efficacy|1|||
143021189|NCT00672620|515619045|FG001|Overall Study|Lack of Efficacy|2|||
143021190|NCT00672620|515619046|FG002|Overall Study|Lack of Efficacy|2|||
143021191|NCT00672620|515619047|FG003|Overall Study|Lack of Efficacy|0|||
143021192|NCT00672620|515619044|FG000|Overall Study|Noncompliance with Study Drug|3|||
143021193|NCT00672620|515619045|FG001|Overall Study|Noncompliance with Study Drug|4|||
143021194|NCT00672620|515619046|FG002|Overall Study|Noncompliance with Study Drug|0|||
143021195|NCT00672620|515619047|FG003|Overall Study|Noncompliance with Study Drug|2|||
143021196|NCT00672620|515619044|FG000|Overall Study|Protocol Deviations|5|||
143021197|NCT00672620|515619045|FG001|Overall Study|Protocol Deviations|7|||
143021198|NCT00672620|515619046|FG002|Overall Study|Protocol Deviations|2|||
143021199|NCT00672620|515619047|FG003|Overall Study|Protocol Deviations|5|||
143155852|NCT03166631|516115708|FG006|Overall Study|Physician Decision|1|||
143155853|NCT03166631|516115709|FG007|Overall Study|Physician Decision|0|||
143155854|NCT03166631|516115710|FG008|Overall Study|Physician Decision|1|||
143021200|NCT00672620|515619044|FG000|Overall Study|Withdrawal of Consent|6|||
143155855|NCT03166631|516115711|FG009|Overall Study|Physician Decision|0|||
143155856|NCT03166631|516115712|FG010|Overall Study|Physician Decision|1|||
143021201|NCT00672620|515619045|FG001|Overall Study|Withdrawal of Consent|12|||
143021202|NCT00672620|515619046|FG002|Overall Study|Withdrawal of Consent|5|||
143021203|NCT00672620|515619047|FG003|Overall Study|Withdrawal of Consent|6|||
143021204|NCT00672620|515619044|FG000|Overall Study|Lost to Follow-up|8|||
143021205|NCT00672620|515619045|FG001|Overall Study|Lost to Follow-up|19|||
143155857|NCT03166631|516115702|FG000|Overall Study|Death|0|||
143021206|NCT00672620|515619046|FG002|Overall Study|Lost to Follow-up|8|||
143021207|NCT00672620|515619047|FG003|Overall Study|Lost to Follow-up|11|||
143021208|NCT00672620|515619044|FG000|Overall Study|Reason not Specified|3|||
143021209|NCT00672620|515619045|FG001|Overall Study|Reason not Specified|3|||
143021210|NCT00672620|515619046|FG002|Overall Study|Reason not Specified|2|||
143021211|NCT00672620|515619047|FG003|Overall Study|Reason not Specified|1|||
143021212|NCT01567306|515619049|FG000|Overall Study|Protocol Violation|2|||
143021213|NCT01567306|515619050|FG001|Overall Study|Protocol Violation|2|||
143021214|NCT01567306|515619051|FG002|Overall Study|Protocol Violation|0|||
143021215|NCT01567306|515619052|FG003|Overall Study|Protocol Violation|3|||
143021216|NCT01567306|515619053|FG004|Overall Study|Protocol Violation|1|||
143021217|NCT01567306|515619054|FG005|Overall Study|Protocol Violation|1|||
143021218|NCT01567306|515619049|FG000|Overall Study|Change site living|1|||
143021219|NCT01567306|515619050|FG001|Overall Study|Change site living|0|||
143021220|NCT01567306|515619051|FG002|Overall Study|Change site living|0|||
143021221|NCT01567306|515619052|FG003|Overall Study|Change site living|0|||
143021222|NCT01567306|515619053|FG004|Overall Study|Change site living|0|||
143021223|NCT01567306|515619054|FG005|Overall Study|Change site living|0|||
143021224|NCT01567306|515619049|FG000|Overall Study|Adverse Event|0|||
143021225|NCT01567306|515619050|FG001|Overall Study|Adverse Event|0|||
143021226|NCT01567306|515619051|FG002|Overall Study|Adverse Event|0|||
143021227|NCT01567306|515619052|FG003|Overall Study|Adverse Event|2|||
143021228|NCT01567306|515619053|FG004|Overall Study|Adverse Event|4|||
143021229|NCT01567306|515619054|FG005|Overall Study|Adverse Event|1|||
143486000|NCT01297270|517322950|FG002|Overall Study|Not treated|0|||
143486001|NCT01627860|517322953|FG000|Overall Study|Adverse Event|9|||
143486002|NCT01627860|517322954|FG001|Overall Study|Adverse Event|4|||
143486003|NCT01627860|517322953|FG000|Overall Study|Withdrawal by Subject|2|||
143486004|NCT01627860|517322954|FG001|Overall Study|Withdrawal by Subject|1|||
143486005|NCT01627860|517322953|FG000|Overall Study|Seizure frequency doubled|0|||
143486006|NCT01627860|517322954|FG001|Overall Study|Seizure frequency doubled|1|||
143486007|NCT01627860|517322953|FG000|Overall Study|Protocol Violation|1|||
143486008|NCT01627860|517322954|FG001|Overall Study|Protocol Violation|0|||
143486009|NCT01326546|517322955|FG000|Overall Study|Lost to Follow-up|8|||
143486010|NCT01326546|517322956|FG001|Overall Study|Lost to Follow-up|7|||
143486011|NCT01326546|517322955|FG000|Overall Study|Protocol Violation|3|||
143486012|NCT01326546|517322956|FG001|Overall Study|Protocol Violation|4|||
143486013|NCT01326546|517322955|FG000|Overall Study|Pregnancy|0|||
143486014|NCT01326546|517322956|FG001|Overall Study|Pregnancy|1|||
143486015|NCT01326546|517322955|FG000|Overall Study|Adverse Event|1|||
143021230|NCT01567306|515619049|FG000|Overall Study|Lost to Follow-up|0|||
143021231|NCT01567306|515619050|FG001|Overall Study|Lost to Follow-up|0|||
143021232|NCT01567306|515619051|FG002|Overall Study|Lost to Follow-up|0|||
143021233|NCT01567306|515619052|FG003|Overall Study|Lost to Follow-up|0|||
143021234|NCT01567306|515619053|FG004|Overall Study|Lost to Follow-up|2|||
143021235|NCT01567306|515619054|FG005|Overall Study|Lost to Follow-up|0|||
143021236|NCT01567306|515619049|FG000|Overall Study|Withdrawal by Subject|0|||
143021237|NCT01567306|515619050|FG001|Overall Study|Withdrawal by Subject|0|||
143021238|NCT01567306|515619051|FG002|Overall Study|Withdrawal by Subject|0|||
143021239|NCT01567306|515619052|FG003|Overall Study|Withdrawal by Subject|0|||
143021240|NCT01567306|515619053|FG004|Overall Study|Withdrawal by Subject|0|||
143021241|NCT01567306|515619054|FG005|Overall Study|Withdrawal by Subject|1|||
143021242|NCT00891774|515619059|FG000|Overall Study|Lost to Follow-up|5|||
143021243|NCT00891774|515619059|FG000|Overall Study|Illness (Self/Mother)|3|||
143021244|NCT00891774|515619059|FG000|Overall Study|Withdrawal by Subject|2|||
143021245|NCT00891774|515619059|FG000|Overall Study|Protocol Violation|4|||
143021246|NCT01894984|515619060|FG000|Overall Study|Other|314|||
143021247|NCT01894984|515619061|FG001|Overall Study|Other|175|||
143021248|NCT02974114|515619062|FG000|Overall Study|Other (Not specified)|0|||
143021249|NCT02974114|515619063|FG001|Overall Study|Other (Not specified)|1|||
143486016|NCT01326546|517322956|FG001|Overall Study|Adverse Event|0|||
143021250|NCT02974114|515619064|FG002|Overall Study|Other (Not specified)|2|||
143021251|NCT01271933|515619067|FG000|Single-Blind Phase|Lack of Efficacy|37|||
143021252|NCT01271933|515619068|FG001|Single-Blind Phase|Lack of Efficacy|0|||
143021253|NCT01271933|515619069|FG002|Single-Blind Phase|Lack of Efficacy|0|||
143021254|NCT01271933|515619067|FG000|Single-Blind Phase|Lost to Follow-up|10|||
143021255|NCT01271933|515619068|FG001|Single-Blind Phase|Lost to Follow-up|0|||
143021256|NCT01271933|515619069|FG002|Single-Blind Phase|Lost to Follow-up|0|||
143021257|NCT01271933|515619067|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
143021258|NCT01271933|515619068|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
143021259|NCT01271933|515619069|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
143021260|NCT01271933|515619067|FG000|Single-Blind Phase|Protocol Violation|3|||
143021261|NCT01271933|515619068|FG001|Single-Blind Phase|Protocol Violation|0|||
143021262|NCT01271933|515619069|FG002|Single-Blind Phase|Protocol Violation|0|||
143486017|NCT01326546|517322955|FG000|Overall Study|Withdrawal by Subject|5|||
143486018|NCT01326546|517322956|FG001|Overall Study|Withdrawal by Subject|1|||
143486019|NCT03152019|517322957|FG000|Overall Study|Adverse Event|0|||
143486020|NCT03152019|517322958|FG001|Overall Study|Adverse Event|1|||
143486021|NCT00923130|517322961|FG000|Overall Study|Stopped treatment due to progression|17|||
143486022|NCT00923130|517322961|FG000|Overall Study|Death|1|||
143486023|NCT00923130|517322961|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
143486024|NCT00923130|517322961|FG000|Overall Study|Switched to alternative treatment|2|||
143021263|NCT01271933|515619067|FG000|Single-Blind Phase|Adverse Event|52|||
143021264|NCT01271933|515619068|FG001|Single-Blind Phase|Adverse Event|0|||
143021265|NCT01271933|515619069|FG002|Single-Blind Phase|Adverse Event|0|||
143021266|NCT01271933|515619067|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
143021267|NCT01271933|515619068|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
143021268|NCT01271933|515619069|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
143021269|NCT01271933|515619067|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
143021270|NCT01271933|515619068|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
143021271|NCT01271933|515619069|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
143021272|NCT01271933|515619067|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
143021273|NCT01271933|515619068|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
143021274|NCT01271933|515619069|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
143021275|NCT01271933|515619067|FG000|Double-Blind Phase|Randomized but not treated|0|||
143021276|NCT01271933|515619068|FG001|Double-Blind Phase|Randomized but not treated|0|||
143021277|NCT01271933|515619069|FG002|Double-Blind Phase|Randomized but not treated|1|||
143021278|NCT01271933|515619067|FG000|Double-Blind Phase|Lack of Efficacy|0|||
143021279|NCT01271933|515619068|FG001|Double-Blind Phase|Lack of Efficacy|6|||
143021280|NCT01271933|515619069|FG002|Double-Blind Phase|Lack of Efficacy|9|||
143021281|NCT01271933|515619067|FG000|Double-Blind Phase|Lost to Follow-up|0|||
143486025|NCT00923130|517322961|FG000|Overall Study|Refused further treatment|2|||
143486026|NCT05098041|517324522|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
143486027|NCT00401752|517324525|FG000|Overall Study|Adverse Event|2|||
143486028|NCT00401752|517324526|FG001|Overall Study|Adverse Event|5|||
143486029|NCT00401752|517324525|FG000|Overall Study|Withdrawal by Subject|2|||
143486030|NCT00401752|517324526|FG001|Overall Study|Withdrawal by Subject|6|||
143486031|NCT00401752|517324525|FG000|Overall Study|Lost to Follow-up|1|||
143486032|NCT00401752|517324526|FG001|Overall Study|Lost to Follow-up|4|||
143486033|NCT00401752|517324525|FG000|Overall Study|Development of any exclusion criteria|4|||
143486034|NCT00401752|517324526|FG001|Overall Study|Development of any exclusion criteria|2|||
143486035|NCT00401752|517324525|FG000|Overall Study|Physician Decision|1|||
143486036|NCT00401752|517324526|FG001|Overall Study|Physician Decision|1|||
143486037|NCT02432235|517324527|FG000|Overall Study|Death|1|||
143486038|NCT02432235|517324528|FG001|Overall Study|Death|1|||
143486039|NCT02432235|517324529|FG002|Overall Study|Death|2|||
143486040|NCT02432235|517324530|FG003|Overall Study|Death|2|||
143486041|NCT02432235|517324531|FG004|Overall Study|Death|1|||
143486042|NCT02432235|517324532|FG005|Overall Study|Death|3|||
143486043|NCT02432235|517324533|FG006|Overall Study|Death|11|||
143486044|NCT02432235|517324534|FG007|Overall Study|Death|15|||
143486045|NCT02432235|517324535|FG008|Overall Study|Death|15|||
143486046|NCT02432235|517324536|FG009|Overall Study|Death|3|||
143486047|NCT02432235|517324537|FG010|Overall Study|Death|1|||
143486048|NCT02432235|517324538|FG011|Overall Study|Death|0|||
143486049|NCT02432235|517324527|FG000|Overall Study|Withdrawal by Subject|0|||
143486050|NCT02432235|517324528|FG001|Overall Study|Withdrawal by Subject|1|||
143486051|NCT02432235|517324529|FG002|Overall Study|Withdrawal by Subject|0|||
143486052|NCT02432235|517324530|FG003|Overall Study|Withdrawal by Subject|0|||
143486053|NCT02432235|517324531|FG004|Overall Study|Withdrawal by Subject|0|||
143486054|NCT02432235|517324532|FG005|Overall Study|Withdrawal by Subject|2|||
143486055|NCT02432235|517324533|FG006|Overall Study|Withdrawal by Subject|5|||
143486056|NCT02432235|517324534|FG007|Overall Study|Withdrawal by Subject|3|||
143486057|NCT02432235|517324535|FG008|Overall Study|Withdrawal by Subject|1|||
143486058|NCT02432235|517324536|FG009|Overall Study|Withdrawal by Subject|0|||
143021282|NCT01271933|515619068|FG001|Double-Blind Phase|Lost to Follow-up|1|||
143021283|NCT01271933|515619069|FG002|Double-Blind Phase|Lost to Follow-up|1|||
143486059|NCT02432235|517324537|FG010|Overall Study|Withdrawal by Subject|0|||
143486060|NCT02432235|517324538|FG011|Overall Study|Withdrawal by Subject|0|||
143486061|NCT02432235|517324527|FG000|Overall Study|Lost to Follow-up|0|||
143486062|NCT02432235|517324528|FG001|Overall Study|Lost to Follow-up|0|||
143486063|NCT02432235|517324529|FG002|Overall Study|Lost to Follow-up|0|||
143486064|NCT02432235|517324530|FG003|Overall Study|Lost to Follow-up|0|||
143486065|NCT02432235|517324531|FG004|Overall Study|Lost to Follow-up|0|||
143486066|NCT02432235|517324532|FG005|Overall Study|Lost to Follow-up|1|||
143021284|NCT01271933|515619067|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
143021285|NCT01271933|515619068|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
143486067|NCT02432235|517324533|FG006|Overall Study|Lost to Follow-up|0|||
143486068|NCT02432235|517324534|FG007|Overall Study|Lost to Follow-up|0|||
143486069|NCT02432235|517324535|FG008|Overall Study|Lost to Follow-up|1|||
143486070|NCT02432235|517324536|FG009|Overall Study|Lost to Follow-up|0|||
143486071|NCT02432235|517324537|FG010|Overall Study|Lost to Follow-up|0|||
143486072|NCT02432235|517324538|FG011|Overall Study|Lost to Follow-up|0|||
143486073|NCT02432235|517324527|FG000|Overall Study|Miscellaneous|0|||
143486074|NCT02432235|517324528|FG001|Overall Study|Miscellaneous|0|||
143486075|NCT02432235|517324529|FG002|Overall Study|Miscellaneous|0|||
143486076|NCT02432235|517324530|FG003|Overall Study|Miscellaneous|0|||
143486077|NCT02432235|517324531|FG004|Overall Study|Miscellaneous|1|||
143486078|NCT02432235|517324532|FG005|Overall Study|Miscellaneous|6|||
143486079|NCT02432235|517324533|FG006|Overall Study|Miscellaneous|2|||
143486080|NCT02432235|517324534|FG007|Overall Study|Miscellaneous|2|||
143486081|NCT02432235|517324535|FG008|Overall Study|Miscellaneous|4|||
143486082|NCT02432235|517324536|FG009|Overall Study|Miscellaneous|0|||
143486083|NCT02432235|517324537|FG010|Overall Study|Miscellaneous|0|||
143021286|NCT01271933|515619069|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
143021287|NCT01271933|515619067|FG000|Double-Blind Phase|Adverse Event|0|||
143021288|NCT01271933|515619068|FG001|Double-Blind Phase|Adverse Event|3|||
143021289|NCT01271933|515619069|FG002|Double-Blind Phase|Adverse Event|0|||
143021290|NCT01271933|515619067|FG000|Double-Blind Phase|Participant request-personal reason|0|||
143021291|NCT01271933|515619068|FG001|Double-Blind Phase|Participant request-personal reason|1|||
143021292|NCT01271933|515619069|FG002|Double-Blind Phase|Participant request-personal reason|0|||
143021293|NCT01138150|515619070|FG000|Overall Study|blood unable to be processed|0|||
143021294|NCT01138150|515619071|FG001|Overall Study|blood unable to be processed|1|||
143021295|NCT01138150|515619070|FG000|Overall Study|Physician Decision|1|||
143021296|NCT01138150|515619071|FG001|Overall Study|Physician Decision|0|||
143021297|NCT01620983|515619072|FG000|Overall Study|Lost to Follow-up|8|||
143021298|NCT01620983|515619073|FG001|Overall Study|Lost to Follow-up|4|||
143021299|NCT01620983|515619074|FG002|Overall Study|Lost to Follow-up|9|||
143021300|NCT01620983|515619072|FG000|Overall Study|Withdrawal by Subject|6|||
143021301|NCT01620983|515619073|FG001|Overall Study|Withdrawal by Subject|8|||
143021302|NCT01620983|515619074|FG002|Overall Study|Withdrawal by Subject|1|||
143021303|NCT01620983|515619072|FG000|Overall Study|Death|2|||
143021304|NCT01620983|515619073|FG001|Overall Study|Death|0|||
143021305|NCT01620983|515619074|FG002|Overall Study|Death|0|||
143021306|NCT01620983|515619072|FG000|Overall Study|Physician Decision|3|||
143021307|NCT01620983|515619073|FG001|Overall Study|Physician Decision|10|||
143021308|NCT01620983|515619074|FG002|Overall Study|Physician Decision|5|||
143021309|NCT00545233|515619075|FG000|Overall Study|Adverse Event|10|||
143021310|NCT00545233|515619076|FG001|Overall Study|Adverse Event|5|||
143021311|NCT00545233|515619075|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
143021312|NCT00545233|515619076|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
143021313|NCT00545233|515619075|FG000|Overall Study|Protocol Violation|2|||
143021314|NCT00545233|515619076|FG001|Overall Study|Protocol Violation|0|||
143021315|NCT00545233|515619075|FG000|Overall Study|Refused Treatment|9|||
143021316|NCT00545233|515619076|FG001|Overall Study|Refused Treatment|7|||
143021317|NCT00545233|515619075|FG000|Overall Study|Failure to Return|4|||
143021318|NCT00545233|515619076|FG001|Overall Study|Failure to Return|6|||
143021319|NCT00545233|515619075|FG000|Overall Study|Insufficient response|14|||
143021320|NCT00545233|515619076|FG001|Overall Study|Insufficient response|15|||
143021321|NCT00545233|515619075|FG000|Overall Study|Physician Decision|2|||
143021322|NCT00545233|515619076|FG001|Overall Study|Physician Decision|1|||
143021323|NCT00479401|515619080|FG000|Overall Study|Adverse Event|24|||
143021324|NCT00479401|515619081|FG001|Overall Study|Adverse Event|20|||
143021325|NCT00479401|515619082|FG002|Overall Study|Adverse Event|4|||
143021326|NCT00479401|515619080|FG000|Overall Study|Lack of Efficacy|2|||
143021327|NCT00479401|515619081|FG001|Overall Study|Lack of Efficacy|2|||
143021328|NCT00479401|515619082|FG002|Overall Study|Lack of Efficacy|4|||
143021329|NCT00479401|515619080|FG000|Overall Study|Protocol Violation|2|||
143021330|NCT00479401|515619081|FG001|Overall Study|Protocol Violation|1|||
143021331|NCT00479401|515619082|FG002|Overall Study|Protocol Violation|1|||
143021332|NCT00479401|515619080|FG000|Overall Study|Lost to Follow-up|1|||
143021333|NCT00479401|515619081|FG001|Overall Study|Lost to Follow-up|1|||
143021334|NCT00479401|515619082|FG002|Overall Study|Lost to Follow-up|1|||
143021335|NCT00479401|515619080|FG000|Overall Study|Withdrawal by Subject|16|||
143021336|NCT00479401|515619081|FG001|Overall Study|Withdrawal by Subject|10|||
143021337|NCT00479401|515619082|FG002|Overall Study|Withdrawal by Subject|2|||
143021338|NCT00479401|515619080|FG000|Overall Study|Exclusion criteria, relocation|4|||
143021339|NCT00479401|515619081|FG001|Overall Study|Exclusion criteria, relocation|3|||
143021340|NCT00479401|515619082|FG002|Overall Study|Exclusion criteria, relocation|0|||
143021341|NCT01571635|515619085|FG000|Overall Study|Adverse Event|3|||
143021342|NCT01571635|515619086|FG001|Overall Study|Adverse Event|0|||
143021343|NCT01571635|515619087|FG002|Overall Study|Adverse Event|2|||
143021344|NCT01571635|515619088|FG003|Overall Study|Adverse Event|3|||
143021345|NCT01571635|515619089|FG004|Overall Study|Adverse Event|5|||
143021346|NCT01571635|515619085|FG000|Overall Study|Other reasons|2|||
143021347|NCT01571635|515619086|FG001|Overall Study|Other reasons|1|||
143021348|NCT01571635|515619087|FG002|Overall Study|Other reasons|2|||
143021349|NCT01571635|515619088|FG003|Overall Study|Other reasons|2|||
143021350|NCT01571635|515619089|FG004|Overall Study|Other reasons|1|||
143021351|NCT01571635|515619085|FG000|Overall Study|Study terminated by sponsor|0|||
143021352|NCT01571635|515619086|FG001|Overall Study|Study terminated by sponsor|4|||
143155858|NCT03166631|516115703|FG001|Overall Study|Death|0|||
143486084|NCT02432235|517324538|FG011|Overall Study|Miscellaneous|1|||
143486085|NCT00382993|517324539|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
143021353|NCT01571635|515619087|FG002|Overall Study|Study terminated by sponsor|1|||
143021354|NCT01571635|515619088|FG003|Overall Study|Study terminated by sponsor|3|||
143021355|NCT01571635|515619089|FG004|Overall Study|Study terminated by sponsor|1|||
143021356|NCT01571635|515619085|FG000|Overall Study|Withdrew consent|1|||
143021357|NCT01571635|515619086|FG001|Overall Study|Withdrew consent|1|||
143021358|NCT01571635|515619087|FG002|Overall Study|Withdrew consent|2|||
143021359|NCT01571635|515619088|FG003|Overall Study|Withdrew consent|3|||
143021360|NCT01571635|515619089|FG004|Overall Study|Withdrew consent|0|||
143021361|NCT01571635|515619085|FG000|Overall Study|Lack of Efficacy|0|||
143021362|NCT01571635|515619086|FG001|Overall Study|Lack of Efficacy|2|||
143021363|NCT01571635|515619087|FG002|Overall Study|Lack of Efficacy|0|||
143021364|NCT01571635|515619088|FG003|Overall Study|Lack of Efficacy|1|||
143021365|NCT01571635|515619089|FG004|Overall Study|Lack of Efficacy|2|||
143021366|NCT02868281|515619090|FG000|Overall Study|Adverse Event|2|||
143021367|NCT02868281|515619091|FG001|Overall Study|Adverse Event|2|||
143021368|NCT02868281|515619090|FG000|Overall Study|Protocol Violation|13|||
143021369|NCT02868281|515619091|FG001|Overall Study|Protocol Violation|10|||
143021370|NCT02868281|515619090|FG000|Overall Study|Lost to Follow-up|3|||
143021371|NCT02868281|515619091|FG001|Overall Study|Lost to Follow-up|6|||
143021372|NCT02868281|515619090|FG000|Overall Study|Withdrawal by Subject|11|||
143021373|NCT02868281|515619091|FG001|Overall Study|Withdrawal by Subject|15|||
143021374|NCT02868281|515619090|FG000|Overall Study|Physician Decision|2|||
143021375|NCT02868281|515619091|FG001|Overall Study|Physician Decision|0|||
143021376|NCT02868281|515619090|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
143021377|NCT02868281|515619091|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
143021378|NCT02868281|515619090|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
143021379|NCT02868281|515619091|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
143021380|NCT02868281|515619090|FG000|Overall Study|Long journey/moving away|1|||
143021381|NCT02868281|515619091|FG001|Overall Study|Long journey/moving away|1|||
143021382|NCT01335464|515619092|FG000|Overall Study|Adverse Event|15|||
143021383|NCT01335464|515619093|FG001|Overall Study|Adverse Event|25|||
143021384|NCT01335464|515619092|FG000|Overall Study|Non compliant with protocol|2|||
143021385|NCT01335464|515619093|FG001|Overall Study|Non compliant with protocol|0|||
143021386|NCT01335464|515619092|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
143021387|NCT01335464|515619093|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
143021388|NCT01335464|515619092|FG000|Overall Study|Not treated|2|||
143021389|NCT01335464|515619093|FG001|Overall Study|Not treated|0|||
143021390|NCT01335464|515619092|FG000|Overall Study|Reason other than those stated above|1|||
143021391|NCT01335464|515619093|FG001|Overall Study|Reason other than those stated above|1|||
143021392|NCT01722266|515619094|FG000|Overall Study|Withdrawal by Subject|1|||
143021393|NCT01722266|515619095|FG001|Overall Study|Withdrawal by Subject|2|||
143021394|NCT01722266|515619096|FG002|Overall Study|Withdrawal by Subject|0|||
143021395|NCT01722266|515619097|FG003|Overall Study|Withdrawal by Subject|0|||
143021396|NCT01722266|515619094|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
143021397|NCT01722266|515619095|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
143021398|NCT01722266|515619096|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
143021399|NCT01722266|515619097|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
143021400|NCT01722266|515619094|FG000|Overall Study|Dropped out due to Nausea|0|||
143021401|NCT01722266|515619095|FG001|Overall Study|Dropped out due to Nausea|0|||
143021402|NCT01722266|515619096|FG002|Overall Study|Dropped out due to Nausea|2|||
143021403|NCT01722266|515619097|FG003|Overall Study|Dropped out due to Nausea|0|||
143021404|NCT02533999|515619101|FG000|Overall Study|Lost to Follow-up|3|||
143021405|NCT02533999|515619102|FG001|Overall Study|Lost to Follow-up|5|||
143021406|NCT02533999|515619101|FG000|Overall Study|Protocol Violation|3|||
143021407|NCT02533999|515619102|FG001|Overall Study|Protocol Violation|0|||
143021408|NCT02533999|515619101|FG000|Overall Study|Adverse Event|0|||
143021409|NCT02533999|515619102|FG001|Overall Study|Adverse Event|1|||
143021410|NCT02533999|515619101|FG000|Overall Study|Randomized but intervention not received|0|||
143155859|NCT03166631|516115704|FG002|Overall Study|Death|0|||
143155860|NCT03166631|516115705|FG003|Overall Study|Death|0|||
143155861|NCT03166631|516115706|FG004|Overall Study|Death|1|||
143155862|NCT03166631|516115707|FG005|Overall Study|Death|0|||
143155863|NCT03166631|516115708|FG006|Overall Study|Death|1|||
143155864|NCT03166631|516115709|FG007|Overall Study|Death|0|||
143155865|NCT03166631|516115710|FG008|Overall Study|Death|0|||
143155866|NCT03166631|516115711|FG009|Overall Study|Death|0|||
143155867|NCT03166631|516115712|FG010|Overall Study|Death|0|||
143155868|NCT03166631|516115702|FG000|Overall Study|Adverse Event|1|||
143155869|NCT03166631|516115703|FG001|Overall Study|Adverse Event|0|||
143363725|NCT05296629|516875424|FG000|Overall Study|Adverse Event|0|||
143021411|NCT02533999|515619102|FG001|Overall Study|Randomized but intervention not received|1|||
143021412|NCT02473510|515619103|FG000|Overall Study|Lost to Follow-up|1|||
143021413|NCT02473510|515619104|FG001|Overall Study|Lost to Follow-up|2|||
143021414|NCT02191579|515619105|FG000|Treatment 1|Multiple Reasons Specified|27|||
143155870|NCT03166631|516115704|FG002|Overall Study|Adverse Event|0|||
143155871|NCT03166631|516115705|FG003|Overall Study|Adverse Event|0|||
143155872|NCT03166631|516115706|FG004|Overall Study|Adverse Event|0|||
143155873|NCT03166631|516115707|FG005|Overall Study|Adverse Event|1|||
143021415|NCT02191579|515619106|FG001|Treatment 1|Multiple Reasons Specified|58|||
143021416|NCT02191579|515619105|FG000|Treatment 2|Multiple Reasons Specified|0|||
143021417|NCT02191579|515619106|FG001|Treatment 2|Multiple Reasons Specified|25|||
143021418|NCT02006147|515619107|FG000|Overall Study|Protocol Violation|1|||
143021419|NCT02006147|515619108|FG001|Overall Study|Protocol Violation|1|||
143021420|NCT02006147|515619109|FG002|Overall Study|Protocol Violation|0|||
143021421|NCT02006147|515619110|FG003|Overall Study|Protocol Violation|0|||
143021422|NCT02006147|515619107|FG000|Overall Study|Withdrawal by Subject|0|||
143021423|NCT02006147|515619108|FG001|Overall Study|Withdrawal by Subject|1|||
143021424|NCT02006147|515619109|FG002|Overall Study|Withdrawal by Subject|0|||
143021425|NCT02006147|515619110|FG003|Overall Study|Withdrawal by Subject|0|||
143021426|NCT02006147|515619107|FG000|Overall Study|Withdrawal by Sponsor|1|||
143021427|NCT02006147|515619108|FG001|Overall Study|Withdrawal by Sponsor|0|||
143021428|NCT02006147|515619109|FG002|Overall Study|Withdrawal by Sponsor|0|||
143021429|NCT02006147|515619110|FG003|Overall Study|Withdrawal by Sponsor|0|||
143021430|NCT00408876|515619111|FG000|Overall Study|Adverse Event|9|||
143021431|NCT00408876|515619112|FG001|Overall Study|Adverse Event|17|||
143021432|NCT00408876|515619113|FG002|Overall Study|Adverse Event|27|||
143021433|NCT00408876|515619114|FG003|Overall Study|Adverse Event|10|||
143021434|NCT00408876|515619111|FG000|Overall Study|Withdrawal by Subject|3|||
143021435|NCT00408876|515619112|FG001|Overall Study|Withdrawal by Subject|6|||
143021436|NCT00408876|515619113|FG002|Overall Study|Withdrawal by Subject|6|||
143021437|NCT00408876|515619114|FG003|Overall Study|Withdrawal by Subject|14|||
143021438|NCT00408876|515619111|FG000|Overall Study|Lack of Efficacy|2|||
143021439|NCT00408876|515619112|FG001|Overall Study|Lack of Efficacy|4|||
143021440|NCT00408876|515619113|FG002|Overall Study|Lack of Efficacy|5|||
143021441|NCT00408876|515619114|FG003|Overall Study|Lack of Efficacy|6|||
143021442|NCT00408876|515619111|FG000|Overall Study|Lost to Follow-up|1|||
143021443|NCT00408876|515619112|FG001|Overall Study|Lost to Follow-up|6|||
143021444|NCT00408876|515619113|FG002|Overall Study|Lost to Follow-up|5|||
143021445|NCT00408876|515619114|FG003|Overall Study|Lost to Follow-up|2|||
143021446|NCT00408876|515619111|FG000|Overall Study|Protocol Violation|0|||
143021447|NCT00408876|515619112|FG001|Overall Study|Protocol Violation|3|||
143021448|NCT00408876|515619113|FG002|Overall Study|Protocol Violation|4|||
143021449|NCT00408876|515619114|FG003|Overall Study|Protocol Violation|3|||
143021450|NCT00408876|515619111|FG000|Overall Study|Physician Decision|1|||
143021451|NCT00408876|515619112|FG001|Overall Study|Physician Decision|0|||
143021452|NCT00408876|515619113|FG002|Overall Study|Physician Decision|3|||
143021453|NCT00408876|515619114|FG003|Overall Study|Physician Decision|0|||
143021454|NCT03404206|515619115|FG000|Overall Study|Withdrawal by Subject|1|||
143021455|NCT03404206|515619116|FG001|Overall Study|Withdrawal by Subject|1|||
143021456|NCT03404206|515619117|FG002|Overall Study|Withdrawal by Subject|0|||
143021457|NCT03404206|515619115|FG000|Overall Study|Lost to Follow-up|3|||
143021458|NCT03404206|515619116|FG001|Overall Study|Lost to Follow-up|1|||
143021459|NCT03404206|515619117|FG002|Overall Study|Lost to Follow-up|0|||
143021460|NCT05478603|515619118|FG000|Overall Study|Withdrawal by Subject|0|||
143021461|NCT05478603|515619119|FG001|Overall Study|Withdrawal by Subject|1|||
143021462|NCT05478603|515619120|FG002|Overall Study|Withdrawal by Subject|0|||
143021463|NCT05478603|515619121|FG003|Overall Study|Withdrawal by Subject|0|||
143021464|NCT03182686|515619124|FG000|Overall Study|Lost to Follow-up|2|||
143021465|NCT03182686|515619125|FG001|Overall Study|Lost to Follow-up|0|||
143021466|NCT03182686|515619124|FG000|Overall Study|Adverse Event|2|||
143021467|NCT03182686|515619125|FG001|Overall Study|Adverse Event|0|||
143021468|NCT03182686|515619124|FG000|Overall Study|Withdrawal by Subject|3|||
143021469|NCT03182686|515619125|FG001|Overall Study|Withdrawal by Subject|0|||
143021470|NCT01154127|515619126|FG000|Period 1 (21 Days)|Adverse Event|3|||
143021471|NCT01154127|515619127|FG001|Period 1 (21 Days)|Adverse Event|4|||
143021472|NCT01154127|515619126|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
143021473|NCT01154127|515619127|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
143021474|NCT01154127|515619126|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
143021475|NCT01154127|515619127|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
143021476|NCT01154127|515619126|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
143021477|NCT01154127|515619127|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
143021478|NCT01154127|515619126|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
143021479|NCT01154127|515619127|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
143021480|NCT01169844|515619128|FG000|Overall Study|Adverse Event|0|||
143021481|NCT01169844|515619129|FG001|Overall Study|Adverse Event|1|||
143021482|NCT01169844|515619128|FG000|Overall Study|Patient withdrew consent|4|||
143021483|NCT01169844|515619129|FG001|Overall Study|Patient withdrew consent|0|||
143021484|NCT01169844|515619128|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
143021485|NCT01169844|515619129|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
143021486|NCT01337050|515619133|FG000|Overall Study|Death|0|||
143021487|NCT01337050|515619134|FG001|Overall Study|Death|0|||
143021488|NCT01337050|515619135|FG002|Overall Study|Death|4|||
143021489|NCT01337050|515619133|FG000|Overall Study|Other|4|||
143021490|NCT01337050|515619134|FG001|Overall Study|Other|6|||
143021491|NCT01337050|515619135|FG002|Overall Study|Other|8|||
143021492|NCT01337050|515619133|FG000|Overall Study|Participants refused further follow-up|0|||
143021493|NCT01337050|515619134|FG001|Overall Study|Participants refused further follow-up|7|||
143021494|NCT01337050|515619135|FG002|Overall Study|Participants refused further follow-up|7|||
143021495|NCT00003102|515619136|FG000|Overall Study|Physician Decision|1|||
143021496|NCT00003102|515619137|FG001|Overall Study|Physician Decision|1|||
143021497|NCT00003102|515619138|FG002|Overall Study|Physician Decision|0|||
143021498|NCT00003102|515619136|FG000|Overall Study|Progressive Disease|0|||
143021499|NCT00003102|515619137|FG001|Overall Study|Progressive Disease|1|||
143021500|NCT00003102|515619138|FG002|Overall Study|Progressive Disease|0|||
143021501|NCT00003102|515619136|FG000|Overall Study|Adverse Event|0|||
143021502|NCT00003102|515619137|FG001|Overall Study|Adverse Event|1|||
143021503|NCT00003102|515619138|FG002|Overall Study|Adverse Event|1|||
143021504|NCT00003102|515619136|FG000|Overall Study|Death|0|||
143021505|NCT00003102|515619137|FG001|Overall Study|Death|0|||
143021506|NCT00003102|515619138|FG002|Overall Study|Death|1|||
143021507|NCT00096486|515619139|FG000|Overall Study|Withdrawal by Subject|0|||
143021508|NCT00096486|515619140|FG001|Overall Study|Withdrawal by Subject|0|||
143021509|NCT00096486|515619141|FG002|Overall Study|Withdrawal by Subject|1|||
143021510|NCT00096486|515619142|FG003|Overall Study|Withdrawal by Subject|1|||
143021511|NCT00096486|515619139|FG000|Overall Study|Not Treated|0|||
143021512|NCT00096486|515619140|FG001|Overall Study|Not Treated|0|||
143021513|NCT00096486|515619141|FG002|Overall Study|Not Treated|1|||
143021514|NCT00096486|515619142|FG003|Overall Study|Not Treated|1|||
143155874|NCT03166631|516115708|FG006|Overall Study|Adverse Event|1|||
143155875|NCT03166631|516115709|FG007|Overall Study|Adverse Event|0|||
143155876|NCT03166631|516115710|FG008|Overall Study|Adverse Event|1|||
143155877|NCT03166631|516115711|FG009|Overall Study|Adverse Event|2|||
143155878|NCT03166631|516115712|FG010|Overall Study|Adverse Event|1|||
143155879|NCT03166631|516115702|FG000|Overall Study|Withdrawal by Subject|0|||
143155880|NCT03166631|516115703|FG001|Overall Study|Withdrawal by Subject|0|||
143155881|NCT03166631|516115704|FG002|Overall Study|Withdrawal by Subject|0|||
143155882|NCT03166631|516115705|FG003|Overall Study|Withdrawal by Subject|0|||
143155883|NCT03166631|516115706|FG004|Overall Study|Withdrawal by Subject|0|||
143155884|NCT03166631|516115707|FG005|Overall Study|Withdrawal by Subject|0|||
143155885|NCT03166631|516115708|FG006|Overall Study|Withdrawal by Subject|0|||
143155886|NCT03166631|516115709|FG007|Overall Study|Withdrawal by Subject|0|||
143155887|NCT03166631|516115710|FG008|Overall Study|Withdrawal by Subject|1|||
143155888|NCT03166631|516115711|FG009|Overall Study|Withdrawal by Subject|1|||
143155889|NCT03166631|516115712|FG010|Overall Study|Withdrawal by Subject|0|||
143155890|NCT03787212|516115716|FG000|Period 1|Study Termination|2|||
143155891|NCT03787212|516115717|FG001|Period 1|Study Termination|2|||
143155892|NCT02014103|516115718|FG000|Overall Study|Protocol Violation|7|||
143155893|NCT02014103|516115719|FG001|Overall Study|Protocol Violation|7|||
143155894|NCT02014103|516115718|FG000|Overall Study|Adverse Event|1|||
143155895|NCT02014103|516115719|FG001|Overall Study|Adverse Event|0|||
143155896|NCT02014103|516115718|FG000|Overall Study|Lost venous access|1|||
143155897|NCT02014103|516115719|FG001|Overall Study|Lost venous access|0|||
143155898|NCT02014103|516115718|FG000|Overall Study|Withdrawal by Subject|0|||
143155899|NCT02014103|516115719|FG001|Overall Study|Withdrawal by Subject|2|||
143155900|NCT00382070|516115720|FG000|Overall Study|No follow up data mapped to Other|17|||
143155901|NCT00382070|516115721|FG001|Overall Study|No follow up data mapped to Other|19|||
143155902|NCT00382070|516115720|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
143155903|NCT00382070|516115721|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
143155904|NCT00382070|516115720|FG000|Overall Study|No clinical assessment|9|||
143021515|NCT01512979|515619143|FG000|Overall Study|Adverse Event|2|||
143021516|NCT01512979|515619144|FG001|Overall Study|Adverse Event|2|||
143021517|NCT01512979|515619143|FG000|Overall Study|Protocol Violation|1|||
143021518|NCT01512979|515619144|FG001|Overall Study|Protocol Violation|4|||
143021519|NCT01512979|515619143|FG000|Overall Study|Lost to Follow-up|2|||
143021520|NCT01512979|515619144|FG001|Overall Study|Lost to Follow-up|5|||
143021521|NCT01512979|515619143|FG000|Overall Study|Withdrawal by Subject|1|||
143021522|NCT01512979|515619144|FG001|Overall Study|Withdrawal by Subject|2|||
143021523|NCT01512979|515619143|FG000|Overall Study|Reason other than stated above|13|||
143021524|NCT01512979|515619144|FG001|Overall Study|Reason other than stated above|9|||
143021525|NCT04049552|515619145|FG000|Overall Study|Lost to Follow-up|1|||
143021526|NCT00738920|515619148|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
143021527|NCT00738920|515619149|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
143155905|NCT00382070|516115721|FG001|Overall Study|No clinical assessment|11|||
143155906|NCT04289298|516115722|FG000|Overall Study|Lost to Follow-up|5|||
143155907|NCT04289298|516115723|FG001|Overall Study|Lost to Follow-up|0|||
143155908|NCT04289298|516115722|FG000|Overall Study|Withdrawal by Subject|2|||
143155909|NCT04289298|516115723|FG001|Overall Study|Withdrawal by Subject|0|||
143021528|NCT00738920|515619150|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
143021529|NCT00738920|515619148|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
143021530|NCT00738920|515619149|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
143021531|NCT00738920|515619150|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
143155910|NCT01629563|516115725|FG000|Overall Study|Adverse Event|16|||
143155911|NCT01629563|516115726|FG001|Overall Study|Adverse Event|16|||
143021532|NCT00738920|515619148|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
143021533|NCT00738920|515619149|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
143021534|NCT00738920|515619150|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
143021535|NCT00738920|515619148|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
143021536|NCT00738920|515619149|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
143021537|NCT00738920|515619150|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
143021538|NCT00738920|515619148|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
143021539|NCT00738920|515619149|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
143021540|NCT00738920|515619150|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
143021541|NCT00738920|515619148|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
143021542|NCT00738920|515619149|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
143021543|NCT00738920|515619150|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
143021544|NCT00738920|515619148|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
143021545|NCT00738920|515619149|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
143021546|NCT00738920|515619150|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
143021547|NCT00738920|515619148|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
143021548|NCT00738920|515619149|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
143021549|NCT00738920|515619150|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
143021550|NCT00738920|515619148|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
143021551|NCT00738920|515619149|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
143021552|NCT00738920|515619150|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
143021553|NCT00738920|515619148|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
143021554|NCT00738920|515619149|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
143021555|NCT00738920|515619150|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
143021556|NCT03705169|515619155|FG000|Overall Study|Lost to Follow-up|0|||
143021557|NCT03705169|515619156|FG001|Overall Study|Lost to Follow-up|0|||
143021558|NCT03705169|515619157|FG002|Overall Study|Lost to Follow-up|0|||
143021559|NCT03705169|515619158|FG003|Overall Study|Lost to Follow-up|2|||
143021560|NCT03705169|515619159|FG004|Overall Study|Lost to Follow-up|0|||
143021561|NCT03705169|515619160|FG005|Overall Study|Lost to Follow-up|2|||
143021562|NCT03705169|515619161|FG006|Overall Study|Lost to Follow-up|1|||
143021563|NCT03705169|515619162|FG007|Overall Study|Lost to Follow-up|0|||
143021564|NCT03705169|515619163|FG008|Overall Study|Lost to Follow-up|0|||
143021565|NCT03705169|515619164|FG009|Overall Study|Lost to Follow-up|1|||
143021566|NCT03705169|515619155|FG000|Overall Study|Adverse Event|0|||
143021567|NCT03705169|515619156|FG001|Overall Study|Adverse Event|0|||
143021568|NCT03705169|515619157|FG002|Overall Study|Adverse Event|0|||
143021569|NCT03705169|515619158|FG003|Overall Study|Adverse Event|1|||
143021570|NCT03705169|515619159|FG004|Overall Study|Adverse Event|0|||
143021571|NCT03705169|515619160|FG005|Overall Study|Adverse Event|0|||
143021572|NCT03705169|515619161|FG006|Overall Study|Adverse Event|0|||
143021573|NCT03705169|515619162|FG007|Overall Study|Adverse Event|0|||
143021574|NCT03705169|515619163|FG008|Overall Study|Adverse Event|0|||
143021575|NCT03705169|515619164|FG009|Overall Study|Adverse Event|0|||
143021576|NCT03705169|515619155|FG000|Overall Study|Site Closure|0|||
143021577|NCT03705169|515619156|FG001|Overall Study|Site Closure|0|||
143021578|NCT03705169|515619157|FG002|Overall Study|Site Closure|0|||
143021579|NCT03705169|515619158|FG003|Overall Study|Site Closure|1|||
143021580|NCT03705169|515619159|FG004|Overall Study|Site Closure|0|||
143021581|NCT03705169|515619160|FG005|Overall Study|Site Closure|0|||
143021582|NCT03705169|515619161|FG006|Overall Study|Site Closure|0|||
143021583|NCT03705169|515619162|FG007|Overall Study|Site Closure|0|||
143021584|NCT03705169|515619163|FG008|Overall Study|Site Closure|0|||
143486086|NCT00382993|517324540|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
143486087|NCT00382993|517324539|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
143486088|NCT00382993|517324540|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
143486089|NCT00382993|517324539|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
143486090|NCT00382993|517324540|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
143486091|NCT00382993|517324539|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
143021585|NCT03705169|515619164|FG009|Overall Study|Site Closure|0|||
143021586|NCT03705169|515619155|FG000|Overall Study|Did not receive study treatment|0|||
143021587|NCT03705169|515619156|FG001|Overall Study|Did not receive study treatment|0|||
143021588|NCT03705169|515619157|FG002|Overall Study|Did not receive study treatment|0|||
143021589|NCT03705169|515619158|FG003|Overall Study|Did not receive study treatment|1|||
143021590|NCT03705169|515619159|FG004|Overall Study|Did not receive study treatment|0|||
143021591|NCT03705169|515619160|FG005|Overall Study|Did not receive study treatment|0|||
143021592|NCT03705169|515619161|FG006|Overall Study|Did not receive study treatment|0|||
143021593|NCT03705169|515619162|FG007|Overall Study|Did not receive study treatment|0|||
143021594|NCT03705169|515619163|FG008|Overall Study|Did not receive study treatment|0|||
143021595|NCT03705169|515619164|FG009|Overall Study|Did not receive study treatment|0|||
143021596|NCT03705169|515619155|FG000|Overall Study|Concerns about study visit compliance|0|||
143486092|NCT00382993|517324540|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
143486093|NCT00382993|517324539|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
143486094|NCT00382993|517324540|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
143486095|NCT00382993|517324539|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
143486096|NCT00382993|517324540|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
143486097|NCT00382993|517324539|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
143486098|NCT00382993|517324540|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
143486099|NCT00382993|517324539|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
143486100|NCT00382993|517324540|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
143486101|NCT00382993|517324539|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
143486102|NCT00382993|517324540|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
143486103|NCT00382993|517324539|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
143486104|NCT00382993|517324540|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
143486105|NCT01965262|517324547|FG000|Second Intervention (7 Days)|Discontinued|0|||
143155912|NCT01629563|516115725|FG000|Overall Study|Death|2|||
143155913|NCT01629563|516115726|FG001|Overall Study|Death|0|||
143155914|NCT01629563|516115725|FG000|Overall Study|Lack of Efficacy|2|||
143155915|NCT01629563|516115726|FG001|Overall Study|Lack of Efficacy|3|||
143155916|NCT01629563|516115725|FG000|Overall Study|Lost to Follow-up|1|||
143155917|NCT01629563|516115726|FG001|Overall Study|Lost to Follow-up|0|||
143155918|NCT01629563|516115725|FG000|Overall Study|Pregnancy|1|||
143155919|NCT01629563|516115726|FG001|Overall Study|Pregnancy|2|||
143155920|NCT01629563|516115725|FG000|Overall Study|Protocol Violation|0|||
143155921|NCT01629563|516115726|FG001|Overall Study|Protocol Violation|1|||
143155922|NCT01629563|516115725|FG000|Overall Study|Withdrawal by Subject|27|||
143155923|NCT01629563|516115726|FG001|Overall Study|Withdrawal by Subject|20|||
143155924|NCT01629563|516115725|FG000|Overall Study|surgery|0|||
143155925|NCT01629563|516115726|FG001|Overall Study|surgery|3|||
143155926|NCT01629563|516115725|FG000|Overall Study|Lack of return of menses|12|||
143155927|NCT01629563|516115726|FG001|Overall Study|Lack of return of menses|7|||
143155928|NCT01629563|516115725|FG000|Overall Study|Protocol Violation|0|||
143155929|NCT01629563|516115726|FG001|Overall Study|Protocol Violation|1|||
143155930|NCT02370394|516115736|FG000|Overall Study|Lost to Follow-up|2|||
143155931|NCT02370394|516115737|FG001|Overall Study|Lost to Follow-up|1|||
143155932|NCT02370394|516115736|FG000|Overall Study|Withdrawal by Subject|0|||
143155933|NCT02370394|516115737|FG001|Overall Study|Withdrawal by Subject|1|||
143155934|NCT03684057|516115738|FG000|Overall Study|Withdrawal by Subject|4|||
143155935|NCT03684057|516115739|FG001|Overall Study|Withdrawal by Subject|5|||
143155936|NCT02316613|516115740|FG000|Overall Study|Death|63|||
143155937|NCT02316613|516115740|FG000|Overall Study|Lost to Follow-up|9|||
143155938|NCT02316613|516115740|FG000|Overall Study|Lymphoma transformation|2|||
143155939|NCT02316613|516115740|FG000|Overall Study|Participant moved/changed medical team|11|||
143155940|NCT02316613|516115740|FG000|Overall Study|No data and duplicate cases|5|||
143155941|NCT02316613|516115740|FG000|Overall Study|Did not met selection criteria|14|||
143155942|NCT03197935|516115741|FG000|Overall Study|Death due to any cause|26|||
143155943|NCT03197935|516115742|FG001|Overall Study|Death due to any cause|15|||
143155944|NCT03197935|516115741|FG000|Overall Study|Lost to Follow-up|3|||
143155945|NCT03197935|516115742|FG001|Overall Study|Lost to Follow-up|5|||
143155946|NCT03197935|516115741|FG000|Overall Study|Physician Decision|2|||
143155947|NCT03197935|516115742|FG001|Overall Study|Physician Decision|1|||
143155948|NCT03197935|516115741|FG000|Overall Study|Withdrawal by Subject|16|||
143155949|NCT03197935|516115742|FG001|Overall Study|Withdrawal by Subject|8|||
143155950|NCT05938010|516115743|FG000|Overall Study|Lost to Follow-up|2|||
143155951|NCT01348698|516115744|FG000|Overall Study|Does not meet lesion size criteria|1|||
143155952|NCT01348698|516115744|FG000|Overall Study|Death|3|||
143155953|NCT01348698|516115744|FG000|Overall Study|PI decision to close study|68|||
143155954|NCT03558672|516115745|FG000|Overall Study|Study Early Termination|10|||
143155955|NCT00983957|516115746|FG000|Overall Study|Adverse Event|1|||
143155956|NCT00983957|516115746|FG000|Overall Study|Personal Reasons|1|||
143155957|NCT00790933|516115747|FG000|Overall Study|Adverse Event|94|||
143155958|NCT00790933|516115748|FG001|Overall Study|Adverse Event|119|||
143155959|NCT00790933|516115749|FG002|Overall Study|Adverse Event|65|||
143155960|NCT00790933|516115750|FG003|Overall Study|Adverse Event|5|||
143155961|NCT00790933|516115751|FG004|Overall Study|Adverse Event|69|||
143155962|NCT00790933|516115747|FG000|Overall Study|Protocol Violation(s)|8|||
143155963|NCT00790933|516115748|FG001|Overall Study|Protocol Violation(s)|18|||
143155964|NCT00790933|516115749|FG002|Overall Study|Protocol Violation(s)|7|||
143155965|NCT00790933|516115750|FG003|Overall Study|Protocol Violation(s)|0|||
143155966|NCT00790933|516115751|FG004|Overall Study|Protocol Violation(s)|12|||
143155967|NCT00790933|516115747|FG000|Overall Study|Lack of Efficacy|192|||
143155968|NCT00790933|516115748|FG001|Overall Study|Lack of Efficacy|176|||
143155969|NCT00790933|516115749|FG002|Overall Study|Lack of Efficacy|130|||
143486106|NCT01965262|517324548|FG001|Second Intervention (7 Days)|Discontinued|1|||
143155970|NCT00790933|516115750|FG003|Overall Study|Lack of Efficacy|1|||
143155971|NCT00790933|516115751|FG004|Overall Study|Lack of Efficacy|121|||
143155972|NCT00790933|516115747|FG000|Overall Study|Study Terminated by Sponsor|0|||
143021597|NCT03705169|515619156|FG001|Overall Study|Concerns about study visit compliance|0|||
143021598|NCT03705169|515619157|FG002|Overall Study|Concerns about study visit compliance|0|||
143021599|NCT03705169|515619158|FG003|Overall Study|Concerns about study visit compliance|1|||
143021600|NCT03705169|515619159|FG004|Overall Study|Concerns about study visit compliance|0|||
143021601|NCT03705169|515619160|FG005|Overall Study|Concerns about study visit compliance|0|||
143021602|NCT03705169|515619161|FG006|Overall Study|Concerns about study visit compliance|0|||
143021603|NCT03705169|515619162|FG007|Overall Study|Concerns about study visit compliance|0|||
143021604|NCT03705169|515619163|FG008|Overall Study|Concerns about study visit compliance|0|||
143021605|NCT03705169|515619164|FG009|Overall Study|Concerns about study visit compliance|0|||
143021606|NCT00185211|515619165|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
143021607|NCT00185211|515619166|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
143021608|NCT00185211|515619165|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
143021609|NCT00185211|515619166|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
143021610|NCT00185211|515619165|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
143021611|NCT00185211|515619166|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
143021612|NCT00185211|515619165|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
143021613|NCT00185211|515619166|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
143021614|NCT00185211|515619165|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
143021615|NCT00185211|515619166|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
143021616|NCT00185211|515619165|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
143021617|NCT00185211|515619166|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
143021618|NCT00185211|515619165|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
143021619|NCT00185211|515619166|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
143021620|NCT00185211|515619165|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
143021621|NCT00185211|515619166|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
143021622|NCT00185211|515619165|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
143021623|NCT00185211|515619166|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
143021624|NCT00185211|515619165|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
143021625|NCT00185211|515619166|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
143021626|NCT00185211|515619165|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
143021627|NCT00185211|515619166|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
143021628|NCT00185211|515619165|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
143021629|NCT00185211|515619166|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
143021630|NCT01759537|515619167|FG000|Overall Study|Death|1|||
143021631|NCT01759537|515619168|FG001|Overall Study|Death|1|||
143021632|NCT01759537|515619167|FG000|Overall Study|Pregnancy|1|||
143021633|NCT01759537|515619168|FG001|Overall Study|Pregnancy|1|||
143021634|NCT01759537|515619167|FG000|Overall Study|Lost to Follow-up|9|||
143021635|NCT01759537|515619168|FG001|Overall Study|Lost to Follow-up|9|||
143021636|NCT01759537|515619167|FG000|Overall Study|Accident involving jaw fracture|1|||
143021637|NCT01759537|515619168|FG001|Overall Study|Accident involving jaw fracture|1|||
143021638|NCT01759537|515619167|FG000|Overall Study|Subcrestal implant too coronal|1|||
143021639|NCT01759537|515619168|FG001|Overall Study|Subcrestal implant too coronal|1|||
143021640|NCT02257632|515621474|FG000|Overall Study|Withdrawal by Subject|0|||
143021641|NCT02257632|515621475|FG001|Overall Study|Withdrawal by Subject|1|||
143021642|NCT02257632|515621474|FG000|Overall Study|Adverse Event|1|||
143021643|NCT02257632|515621475|FG001|Overall Study|Adverse Event|2|||
143021644|NCT01393990|515621476|FG000|Overall Study|Adverse Event|0|||
143021645|NCT01393990|515621477|FG001|Overall Study|Adverse Event|0|||
143021646|NCT01393990|515621478|FG002|Overall Study|Adverse Event|0|||
143021647|NCT01393990|515621479|FG003|Overall Study|Adverse Event|0|||
143021648|NCT01393990|515621480|FG004|Overall Study|Adverse Event|0|||
143021649|NCT01393990|515621481|FG005|Overall Study|Adverse Event|0|||
143021650|NCT01393990|515621482|FG006|Overall Study|Adverse Event|0|||
143021651|NCT01393990|515621483|FG007|Overall Study|Adverse Event|0|||
143021652|NCT01393990|515621484|FG008|Overall Study|Adverse Event|0|||
143021653|NCT01393990|515621485|FG009|Overall Study|Adverse Event|0|||
143021654|NCT01393990|515621486|FG010|Overall Study|Adverse Event|0|||
143021655|NCT01393990|515621487|FG011|Overall Study|Adverse Event|0|||
143021656|NCT01393990|515621488|FG012|Overall Study|Adverse Event|0|||
143021657|NCT01393990|515621489|FG013|Overall Study|Adverse Event|0|||
143021658|NCT01393990|515621490|FG014|Overall Study|Adverse Event|1|||
143021659|NCT01393990|515621491|FG015|Overall Study|Adverse Event|1|||
143021660|NCT01393990|515621492|FG016|Overall Study|Adverse Event|0|||
143021661|NCT01393990|515621493|FG017|Overall Study|Adverse Event|0|||
143021662|NCT01393990|515621476|FG000|Overall Study|Progressive Disease|1|||
143021663|NCT01393990|515621477|FG001|Overall Study|Progressive Disease|0|||
143021664|NCT01393990|515621478|FG002|Overall Study|Progressive Disease|0|||
143021665|NCT01393990|515621479|FG003|Overall Study|Progressive Disease|1|||
143021666|NCT01393990|515621480|FG004|Overall Study|Progressive Disease|1|||
143021667|NCT01393990|515621481|FG005|Overall Study|Progressive Disease|1|||
143155973|NCT00790933|516115748|FG001|Overall Study|Study Terminated by Sponsor|0|||
143021668|NCT01393990|515621482|FG006|Overall Study|Progressive Disease|1|||
143021669|NCT01393990|515621483|FG007|Overall Study|Progressive Disease|1|||
143021670|NCT01393990|515621484|FG008|Overall Study|Progressive Disease|3|||
143021671|NCT01393990|515621485|FG009|Overall Study|Progressive Disease|1|||
143021672|NCT01393990|515621486|FG010|Overall Study|Progressive Disease|0|||
143021673|NCT01393990|515621487|FG011|Overall Study|Progressive Disease|0|||
143021674|NCT01393990|515621488|FG012|Overall Study|Progressive Disease|0|||
143021675|NCT01393990|515621489|FG013|Overall Study|Progressive Disease|1|||
143021676|NCT01393990|515621490|FG014|Overall Study|Progressive Disease|6|||
143021677|NCT01393990|515621491|FG015|Overall Study|Progressive Disease|1|||
143021678|NCT01393990|515621492|FG016|Overall Study|Progressive Disease|0|||
143021679|NCT01393990|515621493|FG017|Overall Study|Progressive Disease|0|||
143021680|NCT01393990|515621476|FG000|Overall Study|Death|0|||
143021681|NCT01393990|515621477|FG001|Overall Study|Death|0|||
143021682|NCT01393990|515621478|FG002|Overall Study|Death|0|||
143021683|NCT01393990|515621479|FG003|Overall Study|Death|0|||
143021684|NCT01393990|515621480|FG004|Overall Study|Death|1|||
143021685|NCT01393990|515621481|FG005|Overall Study|Death|0|||
143021686|NCT01393990|515621482|FG006|Overall Study|Death|0|||
143021687|NCT01393990|515621483|FG007|Overall Study|Death|0|||
143021688|NCT01393990|515621484|FG008|Overall Study|Death|0|||
143021689|NCT01393990|515621485|FG009|Overall Study|Death|0|||
143021690|NCT01393990|515621486|FG010|Overall Study|Death|0|||
143021691|NCT01393990|515621487|FG011|Overall Study|Death|0|||
143021692|NCT01393990|515621488|FG012|Overall Study|Death|0|||
143021693|NCT01393990|515621489|FG013|Overall Study|Death|1|||
143021694|NCT01393990|515621490|FG014|Overall Study|Death|1|||
143021695|NCT01393990|515621491|FG015|Overall Study|Death|0|||
143021696|NCT01393990|515621492|FG016|Overall Study|Death|0|||
143021697|NCT01393990|515621493|FG017|Overall Study|Death|0|||
143021698|NCT01393990|515621476|FG000|Overall Study|Withdrawal by Subject|0|||
143021699|NCT01393990|515621477|FG001|Overall Study|Withdrawal by Subject|0|||
143021700|NCT01393990|515621478|FG002|Overall Study|Withdrawal by Subject|0|||
143021701|NCT01393990|515621479|FG003|Overall Study|Withdrawal by Subject|0|||
143021702|NCT01393990|515621480|FG004|Overall Study|Withdrawal by Subject|0|||
143021703|NCT01393990|515621481|FG005|Overall Study|Withdrawal by Subject|0|||
143021704|NCT01393990|515621482|FG006|Overall Study|Withdrawal by Subject|0|||
143021705|NCT01393990|515621483|FG007|Overall Study|Withdrawal by Subject|0|||
143021706|NCT01393990|515621484|FG008|Overall Study|Withdrawal by Subject|0|||
143021707|NCT01393990|515621485|FG009|Overall Study|Withdrawal by Subject|0|||
143021708|NCT01393990|515621486|FG010|Overall Study|Withdrawal by Subject|0|||
143021709|NCT01393990|515621487|FG011|Overall Study|Withdrawal by Subject|0|||
143021710|NCT01393990|515621488|FG012|Overall Study|Withdrawal by Subject|0|||
143021711|NCT01393990|515621489|FG013|Overall Study|Withdrawal by Subject|0|||
143021712|NCT01393990|515621490|FG014|Overall Study|Withdrawal by Subject|1|||
143021713|NCT01393990|515621491|FG015|Overall Study|Withdrawal by Subject|1|||
143021714|NCT01393990|515621492|FG016|Overall Study|Withdrawal by Subject|0|||
143021715|NCT01393990|515621493|FG017|Overall Study|Withdrawal by Subject|0|||
143021716|NCT00331630|515621495|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
143021717|NCT00331630|515621495|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
143021718|NCT00331630|515621495|FG000|Follow up for 5 Years|Death|5|||
143021719|NCT00331630|515621495|FG000|Follow up for 5 Years|Data collection was stopped|24|||
143021720|NCT01312779|515621496|FG000|Overall Study|Withdrawal by Subject|2|||
143021721|NCT01312779|515621496|FG000|Overall Study|Death|3|||
143021722|NCT01312779|515621496|FG000|Overall Study|Not Implanted with Device|27|||
143021723|NCT00549198|515621500|FG000|Overall Study|Adverse Event|28|||
143021724|NCT00549198|515621501|FG001|Overall Study|Adverse Event|26|||
143021725|NCT00549198|515621500|FG000|Overall Study|Insufficient Viral Load Response|4|||
143021726|NCT00549198|515621501|FG001|Overall Study|Insufficient Viral Load Response|2|||
143021727|NCT00549198|515621500|FG000|Overall Study|Protocol-defined Virological Failure|7|||
143021728|NCT00549198|515621501|FG001|Overall Study|Protocol-defined Virological Failure|0|||
143021729|NCT00549198|515621500|FG000|Overall Study|Non-compliance|2|||
143021730|NCT00549198|515621501|FG001|Overall Study|Non-compliance|4|||
143021731|NCT00549198|515621500|FG000|Overall Study|Lost to Follow-up|7|||
143021732|NCT00549198|515621501|FG001|Overall Study|Lost to Follow-up|8|||
143021733|NCT00549198|515621500|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
143021734|NCT00549198|515621501|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
143021735|NCT00549198|515621500|FG000|Overall Study|Protocol Violation|7|||
143021736|NCT00549198|515621501|FG001|Overall Study|Protocol Violation|2|||
143021737|NCT00549198|515621500|FG000|Overall Study|Investigator Decision|4|||
143021738|NCT00549198|515621501|FG001|Overall Study|Investigator Decision|3|||
143021739|NCT00549198|515621500|FG000|Overall Study|Withdrawal by Subject|7|||
143021740|NCT00549198|515621501|FG001|Overall Study|Withdrawal by Subject|7|||
143021741|NCT00549198|515621500|FG000|Overall Study|Disease Progression|1|||
143155974|NCT00790933|516115749|FG002|Overall Study|Study Terminated by Sponsor|1|||
143155975|NCT00790933|516115750|FG003|Overall Study|Study Terminated by Sponsor|0|||
143021742|NCT00549198|515621501|FG001|Overall Study|Disease Progression|0|||
143021743|NCT00549198|515621500|FG000|Overall Study|Participant Moved|2|||
143021744|NCT00549198|515621501|FG001|Overall Study|Participant Moved|0|||
143486107|NCT01965262|517324547|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
143486108|NCT01965262|517324548|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
143486109|NCT01965262|517324547|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
143486110|NCT01965262|517324548|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
143486111|NCT00906087|517324554|FG000|Initial Washout|Withdrawal by Subject|1|||
143486112|NCT00906087|517324554|FG000|Initial Washout|Physician Decision|1|||
143021745|NCT00549198|515621500|FG000|Overall Study|Participant not able to perform Week 96|1|||
143155976|NCT00790933|516115751|FG004|Overall Study|Study Terminated by Sponsor|0|||
143155977|NCT00790933|516115747|FG000|Overall Study|Withdrawal by Subject|123|||
143155978|NCT00790933|516115748|FG001|Overall Study|Withdrawal by Subject|120|||
143155979|NCT00790933|516115749|FG002|Overall Study|Withdrawal by Subject|52|||
143155980|NCT00790933|516115750|FG003|Overall Study|Withdrawal by Subject|6|||
143155981|NCT00790933|516115751|FG004|Overall Study|Withdrawal by Subject|50|||
143155982|NCT00790933|516115747|FG000|Overall Study|Lost to Follow-up|13|||
143155983|NCT00790933|516115748|FG001|Overall Study|Lost to Follow-up|31|||
143155984|NCT00790933|516115749|FG002|Overall Study|Lost to Follow-up|10|||
143155985|NCT00790933|516115750|FG003|Overall Study|Lost to Follow-up|1|||
143155986|NCT00790933|516115751|FG004|Overall Study|Lost to Follow-up|15|||
143155987|NCT00790933|516115747|FG000|Overall Study|Reason Not Specified|8|||
143155988|NCT00790933|516115748|FG001|Overall Study|Reason Not Specified|16|||
143155989|NCT00790933|516115749|FG002|Overall Study|Reason Not Specified|4|||
143155990|NCT00790933|516115750|FG003|Overall Study|Reason Not Specified|1|||
143155991|NCT00790933|516115751|FG004|Overall Study|Reason Not Specified|9|||
143155992|NCT00894647|516115754|FG000|Overall Study|Adverse Event|5|||
143155993|NCT00894647|516115755|FG001|Overall Study|Adverse Event|4|||
143155994|NCT00894647|516115754|FG000|Overall Study|Withdrawal by Subject|4|||
143155995|NCT00894647|516115755|FG001|Overall Study|Withdrawal by Subject|4|||
143155996|NCT00894647|516115754|FG000|Overall Study|Lost to Follow-up|0|||
143155997|NCT00894647|516115755|FG001|Overall Study|Lost to Follow-up|2|||
143155998|NCT00894647|516115754|FG000|Overall Study|Non-compliance with study procedures|0|||
143155999|NCT00894647|516115755|FG001|Overall Study|Non-compliance with study procedures|2|||
143156000|NCT00894647|516115754|FG000|Overall Study|Other, not due to AE|1|||
143156001|NCT00894647|516115755|FG001|Overall Study|Other, not due to AE|2|||
143156002|NCT01967277|516115756|FG000|Overall Study|Lost to Follow-up|1|||
143156003|NCT01967277|516115757|FG001|Overall Study|Lost to Follow-up|2|||
143156004|NCT01967277|516115756|FG000|Overall Study|Unrelated illness|0|||
143156005|NCT01967277|516115757|FG001|Overall Study|Unrelated illness|1|||
143156006|NCT01829165|516115758|FG000|Overall Study|Did not complete intervention|2|||
143156007|NCT01829165|516115759|FG001|Overall Study|Did not complete intervention|0|||
143156008|NCT02573467|516115760|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
143156009|NCT02573467|516115761|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
143156010|NCT02573467|516115762|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
143156011|NCT02573467|516115763|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
143156012|NCT02573467|516115760|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
143156013|NCT02573467|516115761|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
143156014|NCT02573467|516115762|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
143156015|NCT02573467|516115763|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
143156016|NCT02573467|516115760|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
143156017|NCT02573467|516115761|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
143156018|NCT02573467|516115762|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
143156019|NCT02573467|516115763|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
143156020|NCT02573467|516115760|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
143156021|NCT02573467|516115761|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
143156022|NCT02573467|516115762|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
143156023|NCT02573467|516115763|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
143156024|NCT02573467|516115760|FG000|Post-treatment Follow up Epoch|Death|1|||
143156025|NCT02573467|516115761|FG001|Post-treatment Follow up Epoch|Death|1|||
143156026|NCT02573467|516115762|FG002|Post-treatment Follow up Epoch|Death|0|||
143021746|NCT00549198|515621501|FG001|Overall Study|Participant not able to perform Week 96|0|||
143156027|NCT02573467|516115763|FG003|Post-treatment Follow up Epoch|Death|1|||
143156028|NCT02573467|516115760|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
143156029|NCT02573467|516115761|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
143156030|NCT02573467|516115762|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
143156031|NCT02573467|516115763|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
143156032|NCT02573467|516115760|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
143156033|NCT02573467|516115761|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
143156034|NCT02573467|516115762|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
143156035|NCT02573467|516115763|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
143156036|NCT00710970|516115766|FG000|Overall Study|Never took drug|3|||
143156037|NCT02153827|516115767|FG000|Overall Study|Lost to Follow-up|3|||
143156038|NCT02153827|516115768|FG001|Overall Study|Lost to Follow-up|9|||
143486113|NCT01046877|517324564|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
143156039|NCT00397930|516115769|FG000|Overall Study|Personal reasons|14|||
143156040|NCT00397930|516115770|FG001|Overall Study|Personal reasons|8|||
143156041|NCT00397930|516115769|FG000|Overall Study|Other medical|9|||
143156042|NCT00397930|516115770|FG001|Overall Study|Other medical|4|||
143156043|NCT00397930|516115769|FG000|Overall Study|Unknown reasons|9|||
143156044|NCT00397930|516115770|FG001|Overall Study|Unknown reasons|14|||
143156045|NCT00397930|516115769|FG000|Overall Study|Noncompliant|3|||
143156046|NCT00397930|516115770|FG001|Overall Study|Noncompliant|2|||
143156047|NCT00397930|516115769|FG000|Overall Study|Too time-consuming|2|||
143156048|NCT00397930|516115770|FG001|Overall Study|Too time-consuming|9|||
143156049|NCT00397930|516115769|FG000|Overall Study|Started own yoga program|1|||
143156050|NCT00397930|516115770|FG001|Overall Study|Started own yoga program|1|||
143156051|NCT00397930|516115769|FG000|Overall Study|Did not want to be in control group|0|||
143156052|NCT00397930|516115770|FG001|Overall Study|Did not want to be in control group|1|||
143156053|NCT00397930|516115769|FG000|Overall Study|Withdrawal by Subject|0|||
143156054|NCT00397930|516115770|FG001|Overall Study|Withdrawal by Subject|8|||
143156055|NCT00397930|516115769|FG000|Overall Study|Missing data|0|||
143156056|NCT00397930|516115770|FG001|Overall Study|Missing data|4|||
143156057|NCT04233580|516115772|FG000|Overall Study|Adverse Event|3|||
143156058|NCT04233580|516115773|FG001|Overall Study|Adverse Event|3|||
143156059|NCT04233580|516115772|FG000|Overall Study|Withdrawal by Subject|2|||
143156060|NCT04233580|516115773|FG001|Overall Study|Withdrawal by Subject|1|||
143156061|NCT04676646|516115774|FG000|Open-label Run-in Phase|Adverse Event|3|||
143156062|NCT04676646|516115775|FG001|Open-label Run-in Phase|Adverse Event|0|||
143156063|NCT04676646|516115776|FG002|Open-label Run-in Phase|Adverse Event|0|||
143156064|NCT04676646|516115774|FG000|Open-label Run-in Phase|Death|3|||
143156065|NCT04676646|516115775|FG001|Open-label Run-in Phase|Death|0|||
143156066|NCT04676646|516115776|FG002|Open-label Run-in Phase|Death|0|||
143156067|NCT04676646|516115774|FG000|Open-label Run-in Phase|Study-specific Withdrawal Criteria|2|||
143156068|NCT04676646|516115775|FG001|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
143156069|NCT04676646|516115776|FG002|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
143156070|NCT04676646|516115774|FG000|Open-label Run-in Phase|Failure to Meet Randomization Criteria|144|||
143156071|NCT04676646|516115775|FG001|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
143156072|NCT04676646|516115776|FG002|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
143156073|NCT04676646|516115774|FG000|Open-label Run-in Phase|Lost to Follow-up|1|||
143156074|NCT04676646|516115775|FG001|Open-label Run-in Phase|Lost to Follow-up|0|||
143156075|NCT04676646|516115776|FG002|Open-label Run-in Phase|Lost to Follow-up|0|||
143156076|NCT04676646|516115774|FG000|Open-label Run-in Phase|Withdrawal by Subject|8|||
143156077|NCT04676646|516115775|FG001|Open-label Run-in Phase|Withdrawal by Subject|0|||
143156078|NCT04676646|516115776|FG002|Open-label Run-in Phase|Withdrawal by Subject|0|||
143156079|NCT04676646|516115774|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|1|||
143156080|NCT04676646|516115775|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
143156081|NCT04676646|516115776|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
143156082|NCT04676646|516115774|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|1|||
143156083|NCT04676646|516115775|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
143156084|NCT04676646|516115776|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
143156085|NCT04676646|516115774|FG000|Randomised-withdrawal Phase|Adverse Event|0|||
143156086|NCT04676646|516115775|FG001|Randomised-withdrawal Phase|Adverse Event|5|||
143156087|NCT04676646|516115776|FG002|Randomised-withdrawal Phase|Adverse Event|5|||
143156088|NCT04676646|516115774|FG000|Randomised-withdrawal Phase|Death|0|||
143156089|NCT04676646|516115775|FG001|Randomised-withdrawal Phase|Death|1|||
143156090|NCT04676646|516115776|FG002|Randomised-withdrawal Phase|Death|2|||
143156091|NCT04676646|516115774|FG000|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|0|||
143156092|NCT04676646|516115775|FG001|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|2|||
143156093|NCT04676646|516115776|FG002|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|4|||
143156094|NCT04676646|516115774|FG000|Randomised-withdrawal Phase|Lost to Follow-up|0|||
143156095|NCT04676646|516115775|FG001|Randomised-withdrawal Phase|Lost to Follow-up|1|||
143156096|NCT04676646|516115776|FG002|Randomised-withdrawal Phase|Lost to Follow-up|0|||
143156097|NCT04676646|516115774|FG000|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
143156098|NCT04676646|516115775|FG001|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|1|||
143156099|NCT04676646|516115776|FG002|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
143156100|NCT04676646|516115774|FG000|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
143156101|NCT04676646|516115775|FG001|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|1|||
143156102|NCT04676646|516115776|FG002|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
143156103|NCT04676646|516115774|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
143156104|NCT04676646|516115775|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
143021747|NCT00549198|515621500|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
143021748|NCT00549198|515621501|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
143021749|NCT00549198|515621500|FG000|Overall Study|Prohibited Medication|1|||
143021750|NCT00549198|515621501|FG001|Overall Study|Prohibited Medication|2|||
143021751|NCT00549198|515621500|FG000|Overall Study|Participant planning pregnancy|1|||
143021752|NCT00549198|515621501|FG001|Overall Study|Participant planning pregnancy|0|||
143021753|NCT00549198|515621500|FG000|Overall Study|Participant overweight, no scan possible|1|||
143021754|NCT00549198|515621501|FG001|Overall Study|Participant overweight, no scan possible|0|||
143021755|NCT00549198|515621500|FG000|Overall Study|No scan facilities|0|||
143021756|NCT00549198|515621501|FG001|Overall Study|No scan facilities|2|||
143021757|NCT00549198|515621500|FG000|Overall Study|Pregnancy|0|||
143021758|NCT00549198|515621501|FG001|Overall Study|Pregnancy|3|||
143021759|NCT00549198|515621500|FG000|Overall Study|Not Exposed to Study Drug|3|||
143021760|NCT00549198|515621501|FG001|Overall Study|Not Exposed to Study Drug|4|||
143021761|NCT02480010|515621502|FG000|Overall Study|Adverse Event|3|||
143021762|NCT02480010|515621503|FG001|Overall Study|Adverse Event|1|||
143021763|NCT02480010|515621502|FG000|Overall Study|Death|1|||
143021764|NCT02480010|515621503|FG001|Overall Study|Death|0|||
143021765|NCT02480010|515621502|FG000|Overall Study|Insufficient therapeutic response|31|||
143021766|NCT02480010|515621503|FG001|Overall Study|Insufficient therapeutic response|29|||
143021767|NCT02480010|515621502|FG000|Overall Study|Refused Treatment|0|||
143021768|NCT02480010|515621503|FG001|Overall Study|Refused Treatment|3|||
143021769|NCT03377556|515621506|FG000|Overall Study|Adverse Event|5|||
143021770|NCT03377556|515621506|FG000|Overall Study|Refusal unrelated to adverse events|1|||
143021771|NCT03377556|515621506|FG000|Overall Study|Progression/relapse|38|||
143021772|NCT03377556|515621506|FG000|Overall Study|Death|3|||
143021773|NCT00472446|515621507|FG000|Overall Study|Protocol Violation|0|||
143021774|NCT00472446|515621508|FG001|Overall Study|Protocol Violation|0|||
143021775|NCT00472446|515621509|FG002|Overall Study|Protocol Violation|0|||
143021776|NCT00472446|515621510|FG003|Overall Study|Protocol Violation|1|||
143021777|NCT00472446|515621507|FG000|Overall Study|Reintervention|0|||
143021778|NCT00472446|515621508|FG001|Overall Study|Reintervention|0|||
143021779|NCT00472446|515621509|FG002|Overall Study|Reintervention|1|||
143021780|NCT00472446|515621510|FG003|Overall Study|Reintervention|1|||
143021781|NCT00472446|515621507|FG000|Overall Study|Questionnaires not returned|5|||
143021782|NCT00472446|515621508|FG001|Overall Study|Questionnaires not returned|6|||
143021783|NCT00472446|515621509|FG002|Overall Study|Questionnaires not returned|6|||
143021784|NCT00472446|515621510|FG003|Overall Study|Questionnaires not returned|4|||
143021785|NCT00827827|515621511|FG000|Overall Study|Lost to Follow-up|3|||
143021786|NCT00827827|515621512|FG001|Overall Study|Lost to Follow-up|0|||
143021787|NCT00827827|515621511|FG000|Overall Study|Fall at home- hospitalization|1|||
143021788|NCT00827827|515621512|FG001|Overall Study|Fall at home- hospitalization|0|||
143021789|NCT00827827|515621511|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
143021790|NCT00827827|515621512|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
143021791|NCT00827827|515621511|FG000|Overall Study|Gout|1|||
143021792|NCT00827827|515621512|FG001|Overall Study|Gout|0|||
143021793|NCT00827827|515621511|FG000|Overall Study|Transportation issues|1|||
143021794|NCT00827827|515621512|FG001|Overall Study|Transportation issues|0|||
143021795|NCT00827827|515621511|FG000|Overall Study|Burned with water at home|1|||
143021796|NCT00827827|515621512|FG001|Overall Study|Burned with water at home|0|||
143021797|NCT01907737|515621521|FG000|Overall Study|Withdrawal by Subject|1|||
143021798|NCT00901628|515621538|FG000|Overall Study|disconnection of catheter|4|||
143021799|NCT00901628|515621539|FG001|Overall Study|disconnection of catheter|8|||
143021800|NCT00901628|515621538|FG000|Overall Study|disconnection of drain|0|||
143021801|NCT00901628|515621539|FG001|Overall Study|disconnection of drain|1|||
143021802|NCT00901628|515621538|FG000|Overall Study|peroneal nerve palsy|0|||
143021803|NCT00901628|515621539|FG001|Overall Study|peroneal nerve palsy|1|||
143021804|NCT00608205|515621540|FG000|Overall Study|Adverse Event|3|||
143486114|NCT01046877|517324564|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
143486115|NCT01834274|517324565|FG000|Overall Study|Study Termination|41|||
143021805|NCT00608205|515621541|FG001|Overall Study|Adverse Event|2|||
143021806|NCT00608205|515621540|FG000|Overall Study|Patient non-compliant|0|||
143021807|NCT00608205|515621541|FG001|Overall Study|Patient non-compliant|1|||
143021808|NCT01909466|515621546|FG000|Overall Study|Lost to Follow-up|5|||
143486116|NCT01834274|517324566|FG001|Overall Study|Study Termination|38|||
143021809|NCT01909466|515621547|FG001|Overall Study|Lost to Follow-up|7|||
143021810|NCT01909466|515621546|FG000|Overall Study|Adverse Event|3|||
143021811|NCT01909466|515621547|FG001|Overall Study|Adverse Event|4|||
143021812|NCT01909466|515621546|FG000|Overall Study|Met Withdrawal Criteria|0|||
143021813|NCT01909466|515621547|FG001|Overall Study|Met Withdrawal Criteria|3|||
143021814|NCT01909466|515621546|FG000|Overall Study|Physician Decision|2|||
143021815|NCT01909466|515621547|FG001|Overall Study|Physician Decision|0|||
143021816|NCT01909466|515621546|FG000|Overall Study|Withdrawal by Subject|11|||
143021817|NCT01909466|515621547|FG001|Overall Study|Withdrawal by Subject|9|||
143021818|NCT01909466|515621546|FG000|Overall Study|Lack of Efficacy|1|||
143021819|NCT01909466|515621547|FG001|Overall Study|Lack of Efficacy|0|||
143021820|NCT00295854|515621551|FG000|Overall Study|Adverse Event|7|||
143021821|NCT00295854|515621552|FG001|Overall Study|Adverse Event|7|||
143021822|NCT00295854|515621553|FG002|Overall Study|Adverse Event|6|||
143021823|NCT00295854|515621551|FG000|Overall Study|Protocol Violation|1|||
143021824|NCT00295854|515621552|FG001|Overall Study|Protocol Violation|1|||
143021825|NCT00295854|515621553|FG002|Overall Study|Protocol Violation|1|||
143021826|NCT00295854|515621551|FG000|Overall Study|Lost to Follow-up|2|||
143021827|NCT00295854|515621552|FG001|Overall Study|Lost to Follow-up|0|||
143021828|NCT00295854|515621553|FG002|Overall Study|Lost to Follow-up|1|||
143021829|NCT00295854|515621551|FG000|Overall Study|Withdrawal by Subject|3|||
143021830|NCT00295854|515621552|FG001|Overall Study|Withdrawal by Subject|7|||
143021831|NCT00295854|515621553|FG002|Overall Study|Withdrawal by Subject|4|||
143021832|NCT00295854|515621551|FG000|Overall Study|did not continue to meet criteria|1|||
143021833|NCT00295854|515621552|FG001|Overall Study|did not continue to meet criteria|1|||
143021834|NCT00295854|515621553|FG002|Overall Study|did not continue to meet criteria|2|||
143021835|NCT00295854|515621551|FG000|Overall Study|required a prohibited medication|1|||
143021836|NCT00295854|515621552|FG001|Overall Study|required a prohibited medication|0|||
143021837|NCT00295854|515621553|FG002|Overall Study|required a prohibited medication|0|||
143021838|NCT00295854|515621551|FG000|Overall Study|Other|3|||
143021839|NCT00295854|515621552|FG001|Overall Study|Other|5|||
143021840|NCT00295854|515621553|FG002|Overall Study|Other|1|||
143021841|NCT00772577|515621554|FG000|Overall Study|Adverse Event|6|||
143021842|NCT00772577|515621555|FG001|Overall Study|Adverse Event|3|||
143021843|NCT00772577|515621554|FG000|Overall Study|Abnormal laboratory values|0|||
143021844|NCT00772577|515621555|FG001|Overall Study|Abnormal laboratory values|1|||
143021845|NCT00772577|515621554|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
143021846|NCT00772577|515621555|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
143021847|NCT00772577|515621554|FG000|Overall Study|Patient withdrew consent|8|||
143021848|NCT00772577|515621555|FG001|Overall Study|Patient withdrew consent|5|||
143021849|NCT00772577|515621554|FG000|Overall Study|Lost to Follow-up|4|||
143021850|NCT00772577|515621555|FG001|Overall Study|Lost to Follow-up|3|||
143021851|NCT00772577|515621554|FG000|Overall Study|Administrative problems|2|||
143021852|NCT00772577|515621555|FG001|Overall Study|Administrative problems|1|||
143021853|NCT00772577|515621554|FG000|Overall Study|Protocol Deviation|3|||
143156105|NCT04676646|516115776|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|1|||
143156106|NCT04676646|516115774|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
143156107|NCT04676646|516115775|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|1|||
143156108|NCT04676646|516115776|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
143156109|NCT04676646|516115774|FG000|Randomised-withdrawal Phase|Withdrawal by Subject|0|||
143156110|NCT04676646|516115775|FG001|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
143156111|NCT04676646|516115776|FG002|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
143156112|NCT04433975|516115777|FG000|1-month Follow Up|Withdrawal by Subject|1|||
143156113|NCT04433975|516115778|FG001|1-month Follow Up|Withdrawal by Subject|1|||
143156114|NCT04433975|516115777|FG000|1-month Follow Up|Lost to Follow-up|21|||
143156115|NCT04433975|516115778|FG001|1-month Follow Up|Lost to Follow-up|25|||
143156116|NCT04433975|516115777|FG000|3-month Follow Up|Lost to Follow-up|20|||
143156117|NCT04433975|516115778|FG001|3-month Follow Up|Lost to Follow-up|24|||
143156118|NCT04433975|516115777|FG000|3-month Follow Up|Death|1|||
143156119|NCT04433975|516115778|FG001|3-month Follow Up|Death|0|||
143156120|NCT04433975|516115777|FG000|3-month Follow Up|Withdrawal by Subject|2|||
143156121|NCT04433975|516115778|FG001|3-month Follow Up|Withdrawal by Subject|0|||
143156122|NCT04433975|516115777|FG000|6-month Follow Up|Lost to Follow-up|23|||
143156123|NCT04433975|516115778|FG001|6-month Follow Up|Lost to Follow-up|28|||
143156124|NCT04433975|516115777|FG000|6-month Follow Up|Withdrawal by Subject|1|||
143156125|NCT04433975|516115778|FG001|6-month Follow Up|Withdrawal by Subject|1|||
143156126|NCT04433975|516115777|FG000|9-month Follow Up|Lost to Follow-up|27|||
143156127|NCT04433975|516115778|FG001|9-month Follow Up|Lost to Follow-up|36|||
143156128|NCT04433975|516115777|FG000|9-month Follow Up|Death|0|||
143156129|NCT04433975|516115778|FG001|9-month Follow Up|Death|1|||
143156130|NCT04433975|516115777|FG000|12-month Follow Up|Lost to Follow-up|27|||
143156131|NCT04433975|516115778|FG001|12-month Follow Up|Lost to Follow-up|31|||
143156132|NCT01873833|516115782|FG000|Overall Study|Withdrawal by Subject|1|||
143021854|NCT00772577|515621555|FG001|Overall Study|Protocol Deviation|2|||
143021855|NCT03211156|515621556|FG000|Overall Study|Withdrawal by Subject|0|||
143021856|NCT03211156|515621557|FG001|Overall Study|Withdrawal by Subject|2|||
143021857|NCT03211156|515621556|FG000|Overall Study|Lost to Follow-up|1|||
143156133|NCT01301092|516115788|FG000|Overall Study|Lost to Follow-up|0|||
143156134|NCT01301092|516115789|FG001|Overall Study|Lost to Follow-up|0|||
143021858|NCT03211156|515621557|FG001|Overall Study|Lost to Follow-up|1|||
143021859|NCT03211156|515621556|FG000|Overall Study|Adverse Event|1|||
143021860|NCT03211156|515621557|FG001|Overall Study|Adverse Event|0|||
143021861|NCT02965820|515621558|FG000|Period 2, Second 30 Days|Adverse Event|1|||
143156135|NCT01301092|516115790|FG002|Overall Study|Lost to Follow-up|1|||
143021862|NCT02965820|515621559|FG001|Period 2, Second 30 Days|Adverse Event|1|||
143021863|NCT00829413|515621564|FG000|Overall Study|No study drug admimnistered|13|||
143021864|NCT00829413|515621564|FG000|Overall Study|Training Patients|67|||
143021865|NCT00829413|515621564|FG000|Overall Study|No truth standard procedure available|9|||
143021866|NCT00829413|515621564|FG000|Overall Study|Technically inadequate truth standard|2|||
143021867|NCT00829413|515621564|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
143021868|NCT04272775|515621566|FG000|Overall Study|Study Terminated by Sponsor|1|||
143021869|NCT04272775|515621567|FG001|Overall Study|Study Terminated by Sponsor|0|||
143021870|NCT04272775|515621566|FG000|Overall Study|Protocol Violation|0|||
143021871|NCT04272775|515621567|FG001|Overall Study|Protocol Violation|1|||
143021872|NCT04272775|515621566|FG000|Overall Study|Symptomatic Deterioration|1|||
143021873|NCT04272775|515621567|FG001|Overall Study|Symptomatic Deterioration|1|||
143021874|NCT04272775|515621566|FG000|Overall Study|Withdrawal by Subject|1|||
143021875|NCT04272775|515621567|FG001|Overall Study|Withdrawal by Subject|2|||
143021876|NCT04272775|515621566|FG000|Overall Study|Adverse Event|1|||
143021877|NCT04272775|515621567|FG001|Overall Study|Adverse Event|2|||
143021878|NCT04272775|515621566|FG000|Overall Study|Progressive Disease|3|||
143021879|NCT04272775|515621567|FG001|Overall Study|Progressive Disease|1|||
143021880|NCT00738673|515621568|FG000|Overall Study|Adverse Event|1|||
143021881|NCT00738673|515621569|FG001|Overall Study|Adverse Event|0|||
143021882|NCT00738673|515621568|FG000|Overall Study|Lack of Efficacy|19|||
143486117|NCT01834274|517324565|FG000|Overall Study|Withdrawal by Subject|1|||
143486118|NCT01834274|517324566|FG001|Overall Study|Withdrawal by Subject|1|||
143486119|NCT01834274|517324565|FG000|Overall Study|Lost to Follow-up|3|||
143486120|NCT01834274|517324566|FG001|Overall Study|Lost to Follow-up|1|||
143486121|NCT01834274|517324565|FG000|Overall Study|Other|2|||
143486122|NCT01834274|517324566|FG001|Overall Study|Other|1|||
143486123|NCT03681119|517324567|FG000|Overall Study|No specific reason|4|||
143486124|NCT03681119|517324568|FG001|Overall Study|No specific reason|0|||
143486125|NCT03681119|517324567|FG000|Overall Study|Sickness|2|||
143486126|NCT03681119|517324568|FG001|Overall Study|Sickness|0|||
143486127|NCT00606320|517324573|FG000|Overall Study|Adverse Event|3|||
143486128|NCT00606320|517324573|FG000|Overall Study|Lack of Efficacy|5|||
143486129|NCT00606320|517324573|FG000|Overall Study|Physician Decision|7|||
143486130|NCT00606320|517324573|FG000|Overall Study|Protocol Violation|8|||
143486131|NCT00606320|517324573|FG000|Overall Study|Withdrawal by Subject|10|||
143486132|NCT00606320|517324573|FG000|Overall Study|Progression to depressive phase|4|||
143486133|NCT01152021|517324574|FG000|Overall Study|Adverse Event|4|||
143486134|NCT01152021|517324575|FG001|Overall Study|Adverse Event|4|||
143486135|NCT01152021|517324574|FG000|Overall Study|Study drug had expired|1|||
143486136|NCT01152021|517324575|FG001|Overall Study|Study drug had expired|0|||
143486137|NCT01152021|517324574|FG000|Overall Study|Physician Decision|1|||
143486138|NCT01152021|517324575|FG001|Overall Study|Physician Decision|1|||
143486139|NCT01152021|517324574|FG000|Overall Study|No access to study drug in Pharmacy|0|||
143486140|NCT01152021|517324575|FG001|Overall Study|No access to study drug in Pharmacy|1|||
143486141|NCT00563186|517324576|FG000|Overall Study|LOS<48 hours|97|||
143486142|NCT00563186|517324577|FG001|Overall Study|LOS<48 hours|74|||
143486143|NCT00563186|517324576|FG000|Overall Study|Incomplete data|1|||
143486144|NCT00563186|517324577|FG001|Overall Study|Incomplete data|1|||
143486145|NCT02595723|517324578|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
143486146|NCT02595723|517324579|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
143486147|NCT02595723|517324580|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
143486148|NCT02595723|517324578|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
143486149|NCT02595723|517324579|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
143021883|NCT00738673|515621569|FG001|Overall Study|Lack of Efficacy|8|||
143021884|NCT00738673|515621568|FG000|Overall Study|Protocol Violation|1|||
143021885|NCT00738673|515621569|FG001|Overall Study|Protocol Violation|2|||
143021886|NCT00738673|515621568|FG000|Overall Study|Withdrawal by Subject|3|||
143021887|NCT00738673|515621569|FG001|Overall Study|Withdrawal by Subject|1|||
143021888|NCT03175120|515621571|FG000|Overall Study|Adverse Event|2|||
143021889|NCT03175120|515621572|FG001|Overall Study|Adverse Event|2|||
143021890|NCT03175120|515621571|FG000|Overall Study|Protocol Violation|5|||
143021891|NCT03175120|515621572|FG001|Overall Study|Protocol Violation|2|||
143021892|NCT03175120|515621571|FG000|Overall Study|Lost to Follow-up|1|||
143486150|NCT02595723|517324580|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
143486151|NCT04839380|517324581|FG000|Overall Study|Withdrawal by Subject|2|||
143486152|NCT04839380|517324581|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
143486153|NCT01347554|517324582|FG000|Overall Study|Lack of Efficacy|7|||
143486154|NCT01347554|517324583|FG001|Overall Study|Lack of Efficacy|11|||
143486155|NCT00513500|517324584|FG000|Overall Study|Lost to Follow-up|35|||
143021893|NCT03175120|515621572|FG001|Overall Study|Lost to Follow-up|0|||
143021894|NCT03175120|515621571|FG000|Overall Study|Withdrawal by Subject|2|||
143021895|NCT03175120|515621572|FG001|Overall Study|Withdrawal by Subject|5|||
143021896|NCT03175120|515621571|FG000|Overall Study|Other|2|||
143363726|NCT05296629|516875425|FG001|Overall Study|Adverse Event|4|||
143486156|NCT00513500|517324585|FG001|Overall Study|Lost to Follow-up|39|||
143486157|NCT00513500|517324584|FG000|Overall Study|Death|2|||
143486158|NCT00513500|517324585|FG001|Overall Study|Death|1|||
143486159|NCT00513500|517324584|FG000|Overall Study|Hospitalized|4|||
143486160|NCT00513500|517324585|FG001|Overall Study|Hospitalized|14|||
143021897|NCT03175120|515621572|FG001|Overall Study|Other|3|||
143021898|NCT03263819|515621576|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
143021899|NCT03263819|515621577|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
143021900|NCT00863057|515621579|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
143021901|NCT00863057|515621580|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
143021902|NCT00863057|515621581|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
143021903|NCT00863057|515621582|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
143021904|NCT00863057|515621579|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
143021905|NCT00863057|515621580|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
143021906|NCT00863057|515621581|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
143021907|NCT00863057|515621582|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
143021908|NCT00863057|515621579|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
143021909|NCT00863057|515621580|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
143021910|NCT00863057|515621581|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
143021911|NCT00863057|515621582|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
143021912|NCT00863057|515621579|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
143021913|NCT00863057|515621580|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
143021914|NCT00863057|515621581|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
143021915|NCT00863057|515621582|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
143021916|NCT01698320|515621588|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
143021917|NCT01698320|515621589|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
143021918|NCT01698320|515621590|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
143021919|NCT01698320|515621588|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
143021920|NCT01698320|515621589|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
143021921|NCT01698320|515621590|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
143021922|NCT01698320|515621588|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
143021923|NCT01698320|515621589|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
143021924|NCT01698320|515621590|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
143021925|NCT01698320|515621588|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
143021926|NCT01698320|515621589|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
143021927|NCT01698320|515621590|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
143021928|NCT01698320|515621588|FG000|12-Week Double-Blind Period|Adverse Event|0|||
143021929|NCT01698320|515621589|FG001|12-Week Double-Blind Period|Adverse Event|1|||
143156136|NCT03334175|516115791|FG000|Overall Study|Lost to Follow-up|0|||
143156137|NCT03334175|516115792|FG001|Overall Study|Lost to Follow-up|1|||
143156138|NCT01350973|516115793|FG000|Overall Study|Adverse Event|4|||
143156139|NCT01350973|516115794|FG001|Overall Study|Adverse Event|7|||
143156140|NCT01350973|516115795|FG002|Overall Study|Adverse Event|7|||
143156141|NCT01350973|516115793|FG000|Overall Study|Voluntary Withdrawal|2|||
143156142|NCT01350973|516115794|FG001|Overall Study|Voluntary Withdrawal|1|||
143156143|NCT01350973|516115795|FG002|Overall Study|Voluntary Withdrawal|1|||
143156144|NCT03738215|516115796|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
143156145|NCT03738215|516115797|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
143156146|NCT03738215|516115798|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
143156147|NCT03738215|516115796|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
143156148|NCT03738215|516115797|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
143156149|NCT03738215|516115798|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
143156150|NCT03738215|516115796|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
143156151|NCT03738215|516115797|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
143156152|NCT03738215|516115798|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
143156153|NCT03738215|516115796|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
143156154|NCT03738215|516115797|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
143156155|NCT03738215|516115798|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
143156156|NCT03738215|516115796|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
143156157|NCT03738215|516115797|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
143156158|NCT03738215|516115798|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
143156159|NCT03738215|516115796|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
143156160|NCT03738215|516115797|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
143156161|NCT03738215|516115798|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
143156162|NCT03738215|516115796|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
143156163|NCT03738215|516115797|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
143156164|NCT03738215|516115798|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
143156165|NCT03738215|516115796|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
143021930|NCT01698320|515621590|FG002|12-Week Double-Blind Period|Adverse Event|1|||
143486161|NCT00749996|517324588|FG000|Overall Study|Lost to Follow-up|7|||
143021931|NCT01698320|515621588|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
143021932|NCT01698320|515621589|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
143235563|NCT05632211|516413621|FG002|Overall Study|Withdrawal by Subject|2|||
143021933|NCT01698320|515621590|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
143021934|NCT01698320|515621588|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
143021935|NCT01698320|515621589|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
143021936|NCT01698320|515621590|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
143021937|NCT01698320|515621588|FG000|12-Week Double-Blind Period|Pregnancy|0|||
143021938|NCT01698320|515621589|FG001|12-Week Double-Blind Period|Pregnancy|1|||
143021939|NCT01698320|515621590|FG002|12-Week Double-Blind Period|Pregnancy|1|||
143021940|NCT01698320|515621588|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
143021941|NCT01698320|515621589|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
143021942|NCT01698320|515621590|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
143021943|NCT01698320|515621588|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
143021944|NCT01698320|515621589|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
143021945|NCT01698320|515621590|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
143021946|NCT01698320|515621588|FG000|40-Week Open-Label Period|Adverse Event|0|||
143021947|NCT01698320|515621589|FG001|40-Week Open-Label Period|Adverse Event|3|||
143021948|NCT01698320|515621590|FG002|40-Week Open-Label Period|Adverse Event|2|||
143021949|NCT01698320|515621588|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
143021950|NCT01698320|515621589|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
143021951|NCT01698320|515621590|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
143021952|NCT01698320|515621588|FG000|40-Week Open-Label Period|Pregnancy|0|||
143021953|NCT01698320|515621589|FG001|40-Week Open-Label Period|Pregnancy|2|||
143021954|NCT01698320|515621590|FG002|40-Week Open-Label Period|Pregnancy|1|||
143021955|NCT01698320|515621588|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
143021956|NCT01698320|515621589|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
143021957|NCT01698320|515621590|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
143486162|NCT00749996|517324589|FG001|Overall Study|Lost to Follow-up|4|||
143486163|NCT00749996|517324588|FG000|Overall Study|Withdrawal by Subject|5|||
143021958|NCT01698320|515621588|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
143021959|NCT01698320|515621589|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
143021960|NCT01698320|515621590|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
143021961|NCT01023269|515621591|FG000|Overall Study|early termination of the study|2|||
143021962|NCT01023269|515621592|FG001|Overall Study|early termination of the study|0|||
143021963|NCT02040766|515621596|FG000|Overall Study|Adverse Event|1|||
143021964|NCT02040766|515621597|FG001|Overall Study|Adverse Event|1|||
143021965|NCT02040766|515621598|FG002|Overall Study|Adverse Event|1|||
143021966|NCT02040766|515621599|FG003|Overall Study|Adverse Event|0|||
143021967|NCT02040766|515621600|FG004|Overall Study|Adverse Event|2|||
143021968|NCT02040766|515621596|FG000|Overall Study|Withdrawal by Subject|4|||
143021969|NCT02040766|515621597|FG001|Overall Study|Withdrawal by Subject|3|||
143021970|NCT02040766|515621598|FG002|Overall Study|Withdrawal by Subject|2|||
143021971|NCT02040766|515621599|FG003|Overall Study|Withdrawal by Subject|3|||
143021972|NCT02040766|515621600|FG004|Overall Study|Withdrawal by Subject|2|||
143021973|NCT02040766|515621596|FG000|Overall Study|Non-compliance|0|||
143021974|NCT02040766|515621597|FG001|Overall Study|Non-compliance|1|||
143021975|NCT02040766|515621598|FG002|Overall Study|Non-compliance|0|||
143021976|NCT02040766|515621599|FG003|Overall Study|Non-compliance|0|||
143021977|NCT02040766|515621600|FG004|Overall Study|Non-compliance|0|||
143021978|NCT02040766|515621596|FG000|Overall Study|Protocol Violation|2|||
143021979|NCT02040766|515621597|FG001|Overall Study|Protocol Violation|1|||
143021980|NCT02040766|515621598|FG002|Overall Study|Protocol Violation|2|||
143021981|NCT02040766|515621599|FG003|Overall Study|Protocol Violation|3|||
143021982|NCT02040766|515621600|FG004|Overall Study|Protocol Violation|0|||
143021983|NCT02040766|515621596|FG000|Overall Study|Lost to Follow-up|4|||
143021984|NCT02040766|515621597|FG001|Overall Study|Lost to Follow-up|1|||
143021985|NCT02040766|515621598|FG002|Overall Study|Lost to Follow-up|3|||
143021986|NCT02040766|515621599|FG003|Overall Study|Lost to Follow-up|1|||
143021987|NCT02040766|515621600|FG004|Overall Study|Lost to Follow-up|4|||
143021988|NCT02040766|515621596|FG000|Overall Study|Not reported|1|||
143021989|NCT02040766|515621597|FG001|Overall Study|Not reported|0|||
143021990|NCT02040766|515621598|FG002|Overall Study|Not reported|0|||
143021991|NCT02040766|515621599|FG003|Overall Study|Not reported|0|||
143021992|NCT02040766|515621600|FG004|Overall Study|Not reported|0|||
143021993|NCT02040766|515621596|FG000|Overall Study|Lack of Efficacy|6|||
143021994|NCT02040766|515621597|FG001|Overall Study|Lack of Efficacy|3|||
143021995|NCT02040766|515621598|FG002|Overall Study|Lack of Efficacy|4|||
143021996|NCT02040766|515621599|FG003|Overall Study|Lack of Efficacy|6|||
143021997|NCT02040766|515621600|FG004|Overall Study|Lack of Efficacy|5|||
143021998|NCT00591253|515621601|FG000|Overall Study|Adverse Event|3|||
143021999|NCT00591253|515621602|FG001|Overall Study|Adverse Event|3|||
143022000|NCT00591253|515621603|FG002|Overall Study|Adverse Event|1|||
143022001|NCT00591253|515621601|FG000|Overall Study|Protocol Violation|2|||
143022002|NCT00591253|515621602|FG001|Overall Study|Protocol Violation|2|||
143022003|NCT00591253|515621603|FG002|Overall Study|Protocol Violation|2|||
143022004|NCT00591253|515621601|FG000|Overall Study|Lost to Follow-up|2|||
143022005|NCT00591253|515621602|FG001|Overall Study|Lost to Follow-up|4|||
143486164|NCT00749996|517324589|FG001|Overall Study|Withdrawal by Subject|4|||
143022006|NCT00591253|515621603|FG002|Overall Study|Lost to Follow-up|0|||
143022007|NCT00591253|515621601|FG000|Overall Study|Withdrawal by Subject|1|||
143022008|NCT00591253|515621602|FG001|Overall Study|Withdrawal by Subject|7|||
143022009|NCT00591253|515621603|FG002|Overall Study|Withdrawal by Subject|6|||
143022010|NCT00591253|515621601|FG000|Overall Study|Lack of Efficacy|1|||
143022011|NCT00591253|515621602|FG001|Overall Study|Lack of Efficacy|0|||
143022012|NCT00591253|515621603|FG002|Overall Study|Lack of Efficacy|3|||
143022013|NCT00591253|515621601|FG000|Overall Study|Other|5|||
143022014|NCT00591253|515621602|FG001|Overall Study|Other|5|||
143022015|NCT00591253|515621603|FG002|Overall Study|Other|3|||
143022016|NCT01504867|515621607|FG000|Overall Study|Inclusion criteria not met|2|||
143022017|NCT01504867|515621608|FG001|Overall Study|Inclusion criteria not met|2|||
143022018|NCT01504867|515621607|FG000|Overall Study|Consent revoked|5|||
143022019|NCT01504867|515621608|FG001|Overall Study|Consent revoked|1|||
143022020|NCT01783730|515621609|FG000|Overall Study|Failed to meet inclusion criteria|6|||
143022021|NCT01841359|515621610|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
143022022|NCT01841359|515621610|FG000|Overall Study|Concommitant medical issues|2|||
143022023|NCT01841359|515621610|FG000|Overall Study|Adverse Event|3|||
143022024|NCT01841359|515621610|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
143022025|NCT02151461|515621611|FG000|Overall Study|Adverse Event|5|||
143022026|NCT02151461|515621612|FG001|Overall Study|Adverse Event|1|||
143022027|NCT02151461|515621613|FG002|Overall Study|Adverse Event|0|||
143022028|NCT02151461|515621614|FG003|Overall Study|Adverse Event|2|||
143022029|NCT02151461|515621611|FG000|Overall Study|Lost to Follow-up|0|||
143022030|NCT02151461|515621612|FG001|Overall Study|Lost to Follow-up|0|||
143022031|NCT02151461|515621613|FG002|Overall Study|Lost to Follow-up|1|||
143022032|NCT02151461|515621614|FG003|Overall Study|Lost to Follow-up|1|||
143022033|NCT02151461|515621611|FG000|Overall Study|Withdrawal by Subject|1|||
143486165|NCT00749996|517324588|FG000|Overall Study|Protocol Violation|2|||
143486166|NCT00749996|517324589|FG001|Overall Study|Protocol Violation|3|||
143486167|NCT00749996|517324588|FG000|Overall Study|Physician Decision|2|||
143486168|NCT00749996|517324589|FG001|Overall Study|Physician Decision|0|||
143486169|NCT00749996|517324588|FG000|Overall Study|Pregnancy|0|||
143486170|NCT00749996|517324589|FG001|Overall Study|Pregnancy|2|||
143486171|NCT00749996|517324588|FG000|Overall Study|Adverse Event|1|||
143486172|NCT00749996|517324589|FG001|Overall Study|Adverse Event|0|||
143486173|NCT00749996|517324588|FG000|Overall Study|Death|1|||
143486174|NCT00749996|517324589|FG001|Overall Study|Death|0|||
143486175|NCT00004259|517324590|FG000|Overall Study|Protocol Violation|1|||
143486176|NCT00004259|517324591|FG001|Overall Study|Protocol Violation|2|||
143486177|NCT00004259|517324592|FG002|Overall Study|Protocol Violation|0|||
143486178|NCT00004259|517324593|FG003|Overall Study|Protocol Violation|0|||
143486179|NCT00004259|517324590|FG000|Overall Study|Withdrawal by Subject|0|||
143486180|NCT00004259|517324591|FG001|Overall Study|Withdrawal by Subject|2|||
143486181|NCT00004259|517324592|FG002|Overall Study|Withdrawal by Subject|0|||
143486182|NCT00004259|517324593|FG003|Overall Study|Withdrawal by Subject|0|||
143486183|NCT01902290|517324598|FG000|Overall Study|Withdrawal by Subject|19|||
143486184|NCT01902290|517324599|FG001|Overall Study|Withdrawal by Subject|27|||
143486185|NCT01902290|517324598|FG000|Overall Study|Lost to Follow-up|2|||
143022034|NCT02151461|515621612|FG001|Overall Study|Withdrawal by Subject|0|||
143022035|NCT02151461|515621613|FG002|Overall Study|Withdrawal by Subject|1|||
143022036|NCT02151461|515621614|FG003|Overall Study|Withdrawal by Subject|1|||
143486186|NCT01902290|517324599|FG001|Overall Study|Lost to Follow-up|2|||
143486187|NCT01902290|517324598|FG000|Overall Study|Death|1|||
143486188|NCT01902290|517324599|FG001|Overall Study|Death|0|||
143486189|NCT01902290|517324598|FG000|Overall Study|Sponsor Decision|26|||
143486190|NCT01902290|517324599|FG001|Overall Study|Sponsor Decision|24|||
143486191|NCT00517829|517324600|FG000|Overall Study|Adverse Event|22|||
143486192|NCT00517829|517324601|FG001|Overall Study|Adverse Event|34|||
143486193|NCT00517829|517324600|FG000|Overall Study|Disease Progression|39|||
143022037|NCT02151461|515621611|FG000|Overall Study|Treatment discontinuation|0|||
143022038|NCT02151461|515621612|FG001|Overall Study|Treatment discontinuation|0|||
143022039|NCT02151461|515621613|FG002|Overall Study|Treatment discontinuation|1|||
143022040|NCT02151461|515621614|FG003|Overall Study|Treatment discontinuation|0|||
143022041|NCT00871169|515621615|FG000|Overall Study|Protocol Violation|1|||
143022042|NCT00871169|515621615|FG000|Overall Study|Patient did not receive study treatment|2|||
143022043|NCT03210259|515621616|FG000|12-Week Run-in Period|Adverse Event|1|||
143022044|NCT03210259|515621617|FG001|12-Week Run-in Period|Adverse Event|0|||
143022045|NCT03210259|515621618|FG002|12-Week Run-in Period|Adverse Event|0|||
143022046|NCT03210259|515621616|FG000|12-Week Run-in Period|Death|1|||
143022047|NCT03210259|515621617|FG001|12-Week Run-in Period|Death|0|||
143022048|NCT03210259|515621618|FG002|12-Week Run-in Period|Death|0|||
143486194|NCT00517829|517324601|FG001|Overall Study|Disease Progression|32|||
143486195|NCT00517829|517324600|FG000|Overall Study|Patient Request|6|||
143486196|NCT00517829|517324601|FG001|Overall Study|Patient Request|5|||
143486197|NCT00517829|517324600|FG000|Overall Study|Investigator Request|5|||
143486198|NCT00517829|517324601|FG001|Overall Study|Investigator Request|3|||
143486199|NCT00517829|517324600|FG000|Overall Study|Other|3|||
143486200|NCT00517829|517324601|FG001|Overall Study|Other|1|||
143022049|NCT03210259|515621616|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
143022050|NCT03210259|515621617|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
143022051|NCT03210259|515621618|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
143022052|NCT03210259|515621616|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
143022053|NCT03210259|515621617|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
143022054|NCT03210259|515621618|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
143022055|NCT03210259|515621616|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
143022056|NCT03210259|515621617|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
143022057|NCT03210259|515621618|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
143022058|NCT03210259|515621616|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
143022059|NCT03210259|515621617|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
143022060|NCT03210259|515621618|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
143022061|NCT03210259|515621616|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
143022062|NCT03210259|515621617|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
143022063|NCT03210259|515621618|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
143022064|NCT03210259|515621616|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
143022065|NCT03210259|515621617|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
143022066|NCT03210259|515621618|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
143022067|NCT03210259|515621616|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
143022068|NCT03210259|515621617|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
143022069|NCT03210259|515621618|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
143156166|NCT03738215|516115797|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
143156167|NCT03738215|516115798|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
143156168|NCT03738215|516115796|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
143156169|NCT03738215|516115797|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
143156170|NCT03738215|516115798|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
143486201|NCT00109707|517324607|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
143486202|NCT00109707|517324608|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
143486203|NCT00109707|517324609|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
143486204|NCT00109707|517324607|FG000|Overall Study|Abnormal laboratory values|1|||
143486205|NCT00109707|517324608|FG001|Overall Study|Abnormal laboratory values|0|||
143486206|NCT00109707|517324609|FG002|Overall Study|Abnormal laboratory values|0|||
143486207|NCT00109707|517324607|FG000|Overall Study|Administrative problems|2|||
143486208|NCT00109707|517324608|FG001|Overall Study|Administrative problems|0|||
143486209|NCT00109707|517324609|FG002|Overall Study|Administrative problems|1|||
143486210|NCT00109707|517324607|FG000|Overall Study|Adverse Event|10|||
143486211|NCT00109707|517324608|FG001|Overall Study|Adverse Event|2|||
143486212|NCT00109707|517324609|FG002|Overall Study|Adverse Event|3|||
143486213|NCT00109707|517324607|FG000|Overall Study|Death|4|||
143486214|NCT00109707|517324608|FG001|Overall Study|Death|0|||
143486215|NCT00109707|517324609|FG002|Overall Study|Death|0|||
143486216|NCT00109707|517324607|FG000|Overall Study|Disease progression|12|||
143486217|NCT00109707|517324608|FG001|Overall Study|Disease progression|4|||
143486218|NCT00109707|517324609|FG002|Overall Study|Disease progression|3|||
143486219|NCT00109707|517324607|FG000|Overall Study|Lost to Follow-up|3|||
143486220|NCT00109707|517324608|FG001|Overall Study|Lost to Follow-up|0|||
143486221|NCT00109707|517324609|FG002|Overall Study|Lost to Follow-up|0|||
143486222|NCT00109707|517324607|FG000|Overall Study|Protocol Violation|1|||
143486223|NCT00109707|517324608|FG001|Overall Study|Protocol Violation|0|||
143486224|NCT00109707|517324609|FG002|Overall Study|Protocol Violation|0|||
143486225|NCT00109707|517324607|FG000|Overall Study|Patient withdrew consent|6|||
143486226|NCT00109707|517324608|FG001|Overall Study|Patient withdrew consent|1|||
143486227|NCT00109707|517324609|FG002|Overall Study|Patient withdrew consent|0|||
143486228|NCT02443883|517324613|FG000|Overall Study|Adverse Event|0|||
143156171|NCT03738215|516115796|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
143156172|NCT03738215|516115797|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
143156173|NCT03738215|516115798|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
143156174|NCT02638493|516115799|FG000|Overall Study|Inability to provide semen samples|2|||
143486229|NCT02443883|517324614|FG001|Overall Study|Adverse Event|1|||
143486230|NCT02443883|517324615|FG002|Overall Study|Adverse Event|0|||
143486231|NCT02443883|517324616|FG003|Overall Study|Adverse Event|0|||
143486232|NCT02443883|517324613|FG000|Overall Study|Lost to Follow-up|3|||
143486233|NCT02443883|517324614|FG001|Overall Study|Lost to Follow-up|2|||
143486234|NCT02443883|517324615|FG002|Overall Study|Lost to Follow-up|1|||
143486235|NCT02443883|517324616|FG003|Overall Study|Lost to Follow-up|0|||
143486236|NCT02443883|517324613|FG000|Overall Study|Physician Decision|1|||
143486237|NCT02443883|517324614|FG001|Overall Study|Physician Decision|1|||
143022070|NCT03210259|515621616|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
143022071|NCT03210259|515621617|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
143486238|NCT02443883|517324615|FG002|Overall Study|Physician Decision|0|||
143486239|NCT02443883|517324616|FG003|Overall Study|Physician Decision|3|||
143486240|NCT02443883|517324613|FG000|Overall Study|Withdrawal by Subject|1|||
143486241|NCT02443883|517324614|FG001|Overall Study|Withdrawal by Subject|0|||
143486242|NCT02443883|517324615|FG002|Overall Study|Withdrawal by Subject|0|||
143486243|NCT02443883|517324616|FG003|Overall Study|Withdrawal by Subject|2|||
143486244|NCT02443883|517324613|FG000|Overall Study|Randomized, but never treated|1|||
143486245|NCT02443883|517324614|FG001|Overall Study|Randomized, but never treated|0|||
143486246|NCT02443883|517324615|FG002|Overall Study|Randomized, but never treated|0|||
143486247|NCT02443883|517324616|FG003|Overall Study|Randomized, but never treated|0|||
143486248|NCT02199080|517324617|FG000|Overall Study|Protocol Violation|12|||
143486249|NCT02250274|517324618|FG000|Overall Study|Insufficient blood draw amount|7|||
143486250|NCT02250274|517324619|FG001|Overall Study|Insufficient blood draw amount|6|||
143486251|NCT00446511|517324622|FG000|Overall Study|Adverse Event|7|||
143486252|NCT00446511|517324623|FG001|Overall Study|Adverse Event|2|||
143486253|NCT00446511|517324624|FG002|Overall Study|Adverse Event|3|||
143486254|NCT00446511|517324625|FG003|Overall Study|Adverse Event|1|||
143486255|NCT00446511|517324622|FG000|Overall Study|Protocol Violation|0|||
143486256|NCT00446511|517324623|FG001|Overall Study|Protocol Violation|0|||
143486257|NCT00446511|517324624|FG002|Overall Study|Protocol Violation|0|||
143486258|NCT00446511|517324625|FG003|Overall Study|Protocol Violation|1|||
143486259|NCT00446511|517324622|FG000|Overall Study|Withdrawal by Subject|0|||
143486260|NCT00446511|517324623|FG001|Overall Study|Withdrawal by Subject|0|||
143486261|NCT00446511|517324624|FG002|Overall Study|Withdrawal by Subject|0|||
143486262|NCT00446511|517324625|FG003|Overall Study|Withdrawal by Subject|3|||
143486263|NCT00446511|517324622|FG000|Overall Study|Administrative Problems|3|||
143486264|NCT00446511|517324623|FG001|Overall Study|Administrative Problems|0|||
143486265|NCT00446511|517324624|FG002|Overall Study|Administrative Problems|4|||
143486266|NCT00446511|517324625|FG003|Overall Study|Administrative Problems|1|||
143486267|NCT00835237|517324628|FG000|Overall Study|Lost to Follow-up|4|||
143486268|NCT00835237|517324629|FG001|Overall Study|Lost to Follow-up|0|||
143486269|NCT00835237|517324628|FG000|Overall Study|Withdrawal by Subject|2|||
143486270|NCT00835237|517324629|FG001|Overall Study|Withdrawal by Subject|0|||
143486271|NCT01265550|517324632|FG000|Pre Randomization|Withdrawal by Subject|0|||
143486272|NCT01265550|517324633|FG001|Pre Randomization|Withdrawal by Subject|0|||
143486273|NCT01265550|517324634|FG002|Pre Randomization|Withdrawal by Subject|0|||
143486274|NCT01265550|517324635|FG003|Pre Randomization|Withdrawal by Subject|70|||
143486275|NCT01265550|517324632|FG000|Pre Randomization|Technical Exclusions|0|||
143486276|NCT01265550|517324633|FG001|Pre Randomization|Technical Exclusions|0|||
143486277|NCT01265550|517324634|FG002|Pre Randomization|Technical Exclusions|0|||
143486278|NCT01265550|517324635|FG003|Pre Randomization|Technical Exclusions|54|||
143486279|NCT01265550|517324632|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
143486280|NCT01265550|517324633|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
143486281|NCT01265550|517324634|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
143486282|NCT01265550|517324635|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
143486283|NCT01265550|517324632|FG000|Pre Randomization|Non-GERD organic disorders|0|||
143486284|NCT01265550|517324633|FG001|Pre Randomization|Non-GERD organic disorders|0|||
143486285|NCT01265550|517324634|FG002|Pre Randomization|Non-GERD organic disorders|0|||
143486286|NCT01265550|517324635|FG003|Pre Randomization|Non-GERD organic disorders|23|||
143486287|NCT01265550|517324632|FG000|Pre Randomization|Functional heartburn|0|||
143486288|NCT01265550|517324633|FG001|Pre Randomization|Functional heartburn|0|||
143486289|NCT01265550|517324634|FG002|Pre Randomization|Functional heartburn|0|||
143486290|NCT01265550|517324635|FG003|Pre Randomization|Functional heartburn|99|||
143486291|NCT03436862|517324637|FG000|Overall Study|Adverse Event|4|||
143486292|NCT03436862|517324637|FG000|Overall Study|Progressive Disease|2|||
143486293|NCT02937818|517324638|FG000|Overall Study|Participants decision|2|||
143486294|NCT02937818|517324639|FG001|Overall Study|Participants decision|1|||
143486295|NCT02937818|517324640|FG002|Overall Study|Participants decision|1|||
143486296|NCT02937818|517324641|FG003|Overall Study|Participants decision|1|||
143486297|NCT02937818|517324638|FG000|Overall Study|Adverse Event|2|||
143486298|NCT02937818|517324639|FG001|Overall Study|Adverse Event|4|||
143486299|NCT02937818|517324640|FG002|Overall Study|Adverse Event|1|||
143486300|NCT02937818|517324641|FG003|Overall Study|Adverse Event|1|||
143486301|NCT02937818|517324638|FG000|Overall Study|Disease progression|17|||
143486302|NCT02937818|517324639|FG001|Overall Study|Disease progression|15|||
143486303|NCT02937818|517324640|FG002|Overall Study|Disease progression|7|||
143486304|NCT02937818|517324641|FG003|Overall Study|Disease progression|19|||
143486305|NCT02937818|517324638|FG000|Overall Study|Condition under investigation worsened|0|||
143486306|NCT02937818|517324639|FG001|Overall Study|Condition under investigation worsened|0|||
143486307|NCT02937818|517324640|FG002|Overall Study|Condition under investigation worsened|1|||
143486308|NCT02937818|517324641|FG003|Overall Study|Condition under investigation worsened|0|||
143486309|NCT00689871|517324644|FG000|Overall Study|Lost to Follow-up|123|||
143486310|NCT00689871|517324645|FG001|Overall Study|Lost to Follow-up|13|||
143486311|NCT00689871|517324646|FG002|Overall Study|Lost to Follow-up|37|||
143486312|NCT00689871|517324647|FG003|Overall Study|Lost to Follow-up|1|||
143486313|NCT00689871|517324644|FG000|Overall Study|Explanted of All Study Devices|36|||
143486314|NCT00689871|517324645|FG001|Overall Study|Explanted of All Study Devices|25|||
143486315|NCT00689871|517324646|FG002|Overall Study|Explanted of All Study Devices|29|||
143486316|NCT00689871|517324647|FG003|Overall Study|Explanted of All Study Devices|3|||
143486317|NCT00689871|517324644|FG000|Overall Study|Withdrawal by Subject|13|||
143486318|NCT00689871|517324645|FG001|Overall Study|Withdrawal by Subject|3|||
143486319|NCT00689871|517324646|FG002|Overall Study|Withdrawal by Subject|4|||
143022072|NCT03210259|515621618|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
143022073|NCT03210259|515621616|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
143022074|NCT03210259|515621617|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
143022075|NCT03210259|515621618|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
143022076|NCT00252187|515621619|FG000|Overall Study|Adverse Event|3|||
143022077|NCT00252187|515621620|FG001|Overall Study|Adverse Event|1|||
143022078|NCT00252187|515621619|FG000|Overall Study|Withdrawal by Subject|1|||
143022079|NCT00252187|515621620|FG001|Overall Study|Withdrawal by Subject|0|||
143022080|NCT01875445|515621623|FG000|Overall Study|Lost to Follow-up|5|||
143022081|NCT01875445|515621624|FG001|Overall Study|Lost to Follow-up|0|||
143022082|NCT01875445|515621623|FG000|Overall Study|Withdrawal by Subject|2|||
143022083|NCT01875445|515621624|FG001|Overall Study|Withdrawal by Subject|0|||
143022084|NCT01102777|515621625|FG000|Overall Study|Death|2|||
143022085|NCT01102777|515621626|FG001|Overall Study|Death|6|||
143022086|NCT01102777|515621625|FG000|Overall Study|Lost to Follow-up|7|||
143022087|NCT01102777|515621626|FG001|Overall Study|Lost to Follow-up|10|||
143022088|NCT00706706|515621627|FG000|Overall Study|Death|53|||
143022089|NCT00706706|515621627|FG000|Overall Study|Lost to Follow-up|7|||
143022090|NCT00706706|515621627|FG000|Overall Study|Study endpoint had reached|45|||
143022091|NCT01154153|515621634|FG000|Overall Study|Poor compliance to protocol|2|||
143022092|NCT01154153|515621635|FG001|Overall Study|Poor compliance to protocol|0|||
143022093|NCT01154153|515621634|FG000|Overall Study|Unable to use labs|2|||
143022094|NCT01154153|515621635|FG001|Overall Study|Unable to use labs|3|||
143022095|NCT01154153|515621634|FG000|Overall Study|Withdrew consent|1|||
143022096|NCT01154153|515621635|FG001|Overall Study|Withdrew consent|0|||
143022097|NCT03493698|515621642|FG000|Treatment Period C|Adverse Event|1|||
143022098|NCT03493698|515621642|FG000|Treatment Period C|Withdrawal by Subject|1|||
143022099|NCT03361956|515621643|FG000|Overall Study|Adverse Event|1|||
143022100|NCT03361956|515621644|FG001|Overall Study|Adverse Event|0|||
143022101|NCT03361956|515621645|FG002|Overall Study|Adverse Event|1|||
143486320|NCT00689871|517324647|FG003|Overall Study|Withdrawal by Subject|1|||
143022102|NCT03361956|515621646|FG003|Overall Study|Adverse Event|1|||
143022103|NCT03361956|515621647|FG004|Overall Study|Adverse Event|0|||
143022104|NCT03361956|515621643|FG000|Overall Study|Other|0|||
143022105|NCT03361956|515621644|FG001|Overall Study|Other|0|||
143022106|NCT03361956|515621645|FG002|Overall Study|Other|0|||
143022107|NCT03361956|515621646|FG003|Overall Study|Other|1|||
143022108|NCT03361956|515621647|FG004|Overall Study|Other|0|||
143022109|NCT03361956|515621643|FG000|Overall Study|Withdrawal by Subject|2|||
143022110|NCT03361956|515621644|FG001|Overall Study|Withdrawal by Subject|2|||
143156175|NCT02638493|516115800|FG001|Overall Study|Inability to provide semen samples|0|||
143156176|NCT02638493|516115801|FG002|Overall Study|Inability to provide semen samples|0|||
143156177|NCT01695772|516115805|FG000|Overall Study|Withdrawal by Subject|18|||
143156178|NCT01695772|516115805|FG000|Overall Study|Progressive Disease|8|||
143156179|NCT01695772|516115805|FG000|Overall Study|Investigator Decision|5|||
143156180|NCT01695772|516115805|FG000|Overall Study|Lost to Follow-up|4|||
143156181|NCT01695772|516115805|FG000|Overall Study|Protocol Violation|2|||
143156182|NCT01695772|516115805|FG000|Overall Study|Unspecified Reason|1|||
143156183|NCT02724644|516117421|FG000|Overall Study|Adverse Event|7|||
143156184|NCT02724644|516117422|FG001|Overall Study|Adverse Event|1|||
143156185|NCT02724644|516117421|FG000|Overall Study|Lost to Follow-up|6|||
143156186|NCT02724644|516117422|FG001|Overall Study|Lost to Follow-up|2|||
143156187|NCT02724644|516117421|FG000|Overall Study|Withdrawal by Subject|7|||
143156188|NCT02724644|516117422|FG001|Overall Study|Withdrawal by Subject|1|||
143156189|NCT02724644|516117421|FG000|Overall Study|Administrative|1|||
143156190|NCT02724644|516117422|FG001|Overall Study|Administrative|0|||
143156191|NCT01108796|516117425|FG000|Overall Study|Adverse Event|0|||
143156192|NCT01108796|516117426|FG001|Overall Study|Adverse Event|1|||
143156193|NCT01108796|516117425|FG000|Overall Study|Lost to Follow-up|7|||
143156194|NCT01108796|516117426|FG001|Overall Study|Lost to Follow-up|6|||
143156195|NCT00960856|516117428|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
143022111|NCT03361956|515621645|FG002|Overall Study|Withdrawal by Subject|2|||
143022112|NCT03361956|515621646|FG003|Overall Study|Withdrawal by Subject|0|||
143156196|NCT00960856|516117429|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
143156197|NCT00960856|516117430|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
143156198|NCT00960856|516117431|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
143156199|NCT00960856|516117428|FG000|Washout Period of 7 Days|Adverse Event|0|||
143156200|NCT00960856|516117429|FG001|Washout Period of 7 Days|Adverse Event|0|||
143156201|NCT00960856|516117430|FG002|Washout Period of 7 Days|Adverse Event|1|||
143156202|NCT00960856|516117431|FG003|Washout Period of 7 Days|Adverse Event|0|||
143156203|NCT02595749|516117435|FG000|Overall Study|Withdrawal by Subject|12|||
143022113|NCT03361956|515621647|FG004|Overall Study|Withdrawal by Subject|3|||
143022114|NCT03361956|515621643|FG000|Overall Study|Disease Relapse|0|||
143022115|NCT03361956|515621644|FG001|Overall Study|Disease Relapse|0|||
143022116|NCT03361956|515621645|FG002|Overall Study|Disease Relapse|1|||
143022117|NCT03361956|515621646|FG003|Overall Study|Disease Relapse|0|||
143022118|NCT03361956|515621647|FG004|Overall Study|Disease Relapse|0|||
143022119|NCT03361956|515621643|FG000|Overall Study|Physician Decision|0|||
143022120|NCT03361956|515621644|FG001|Overall Study|Physician Decision|2|||
143022121|NCT03361956|515621645|FG002|Overall Study|Physician Decision|0|||
143022122|NCT03361956|515621646|FG003|Overall Study|Physician Decision|1|||
143022123|NCT03361956|515621647|FG004|Overall Study|Physician Decision|0|||
143022124|NCT03361956|515621643|FG000|Overall Study|Lost to Follow-up|0|||
143022125|NCT03361956|515621644|FG001|Overall Study|Lost to Follow-up|0|||
143022126|NCT03361956|515621645|FG002|Overall Study|Lost to Follow-up|1|||
143022127|NCT03361956|515621646|FG003|Overall Study|Lost to Follow-up|1|||
143022128|NCT03361956|515621647|FG004|Overall Study|Lost to Follow-up|2|||
143022129|NCT04147715|515621649|FG000|Overall Study|Adverse Event|0|||
143022130|NCT04147715|515621650|FG001|Overall Study|Adverse Event|0|||
143022131|NCT04147715|515621651|FG002|Overall Study|Adverse Event|0|||
143022132|NCT04147715|515621652|FG003|Overall Study|Adverse Event|0|||
143022133|NCT04147715|515621653|FG004|Overall Study|Adverse Event|0|||
143022134|NCT04147715|515621654|FG005|Overall Study|Adverse Event|0|||
143022135|NCT04147715|515621655|FG006|Overall Study|Adverse Event|0|||
143022136|NCT04147715|515621656|FG007|Overall Study|Adverse Event|2|||
143022137|NCT04147715|515621657|FG008|Overall Study|Adverse Event|1|||
143022138|NCT04147715|515621658|FG009|Overall Study|Adverse Event|0|||
143022139|NCT04147715|515621659|FG010|Overall Study|Adverse Event|0|||
143022140|NCT04147715|515621660|FG011|Overall Study|Adverse Event|0|||
143022141|NCT00291330|515621665|FG000|Overall Study|Adverse Event|47|||
143022142|NCT00291330|515621666|FG001|Overall Study|Adverse Event|40|||
143022143|NCT00291330|515621665|FG000|Overall Study|Protocol Violation|13|||
143022144|NCT00291330|515621666|FG001|Overall Study|Protocol Violation|20|||
143022145|NCT00291330|515621665|FG000|Overall Study|Lost to Follow-up|16|||
143022146|NCT00291330|515621666|FG001|Overall Study|Lost to Follow-up|11|||
143022147|NCT00291330|515621665|FG000|Overall Study|Withdrawal by Subject|22|||
143022148|NCT00291330|515621666|FG001|Overall Study|Withdrawal by Subject|25|||
143022149|NCT00291330|515621665|FG000|Overall Study|Other|3|||
143022150|NCT00291330|515621666|FG001|Overall Study|Other|1|||
143022151|NCT00566709|515621669|FG000|Overall Study|Protocol Violation|5|||
143022152|NCT00566709|515621670|FG001|Overall Study|Protocol Violation|0|||
143022153|NCT01829295|515621671|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
143022154|NCT01829295|515621672|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
143022155|NCT01829295|515621673|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
143022156|NCT01829295|515621674|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
143022157|NCT01829295|515621671|FG000|6-12 Months|Adverse Event|0|||
143022158|NCT01829295|515621672|FG001|6-12 Months|Adverse Event|0|||
143022159|NCT01829295|515621673|FG002|6-12 Months|Adverse Event|3|||
143022160|NCT01829295|515621674|FG003|6-12 Months|Adverse Event|2|||
143022161|NCT01829295|515621671|FG000|6-12 Months|Lost to Follow-up|2|||
143022162|NCT01829295|515621672|FG001|6-12 Months|Lost to Follow-up|0|||
143022163|NCT01829295|515621673|FG002|6-12 Months|Lost to Follow-up|0|||
143022164|NCT01829295|515621674|FG003|6-12 Months|Lost to Follow-up|0|||
143022165|NCT01829295|515621671|FG000|6-12 Months|Withdrawal by Subject|2|||
143022166|NCT01829295|515621672|FG001|6-12 Months|Withdrawal by Subject|2|||
143022167|NCT01829295|515621673|FG002|6-12 Months|Withdrawal by Subject|0|||
143022168|NCT01829295|515621674|FG003|6-12 Months|Withdrawal by Subject|0|||
143022169|NCT00299728|515621675|FG000|Overall Study|Lost to Follow-up|0|||
143022170|NCT00299728|515621676|FG001|Overall Study|Lost to Follow-up|1|||
143022171|NCT00299728|515621675|FG000|Overall Study|Withdrawal by Subject|0|||
143022172|NCT00299728|515621676|FG001|Overall Study|Withdrawal by Subject|1|||
143022173|NCT00299728|515621675|FG000|Overall Study|Progressive disease|0|||
143022174|NCT00299728|515621676|FG001|Overall Study|Progressive disease|1|||
143022175|NCT02468557|515623294|FG000|Overall Study|Adverse Event|1|||
143022176|NCT02468557|515623294|FG000|Overall Study|Death|1|||
143156204|NCT02595749|516117436|FG001|Overall Study|Withdrawal by Subject|7|||
143156205|NCT01562444|516117439|FG000|Overall Study|Did not meet entry criteria|2|||
143156206|NCT01562444|516117440|FG001|Overall Study|Did not meet entry criteria|0|||
143022177|NCT02468557|515623294|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
143022178|NCT02468557|515623294|FG000|Overall Study|All Enrolled but Never Dosed|4|||
143022179|NCT03322462|515623298|FG000|Overall Study|Technical difficulties|2|||
143022180|NCT03322462|515623298|FG000|Overall Study|Other|1|||
143022181|NCT01003886|515623304|FG000|Overall Study|Lack of Efficacy|5|||
143022182|NCT01003886|515623304|FG000|Overall Study|Lost to Follow-up|169|||
143022183|NCT01003886|515623304|FG000|Overall Study|Withdrawal by Subject|39|||
143022184|NCT01003886|515623304|FG000|Overall Study|Other|14|||
143022185|NCT01003886|515623304|FG000|Overall Study|Adverse Event|3|||
143022186|NCT04467697|515623321|FG000|Overall Study|Adverse Event|2|||
143022187|NCT04467697|515623321|FG000|Overall Study|Lost to Follow-up|6|||
143022188|NCT04467697|515623321|FG000|Overall Study|Withdrawal by Subject|9|||
143022189|NCT04467697|515623321|FG000|Overall Study|Protocol Violation|3|||
143022190|NCT05751629|515623322|FG000|Overall Study|Withdrawal by Subject|6|||
143022191|NCT05751629|515623322|FG000|Overall Study|Death|25|||
143022192|NCT05751629|515623322|FG000|Overall Study|Study Site Closed|9|||
143022193|NCT05751629|515623322|FG000|Overall Study|Physician Decision|1|||
143022194|NCT00673361|515623328|FG000|Overall Study|Screen Failure|2|||
143022195|NCT03038113|515623333|FG000|Overall Study|Withdrawal by Subject|0|||
143022196|NCT03038113|515623334|FG001|Overall Study|Withdrawal by Subject|0|||
143022197|NCT03038113|515623335|FG002|Overall Study|Withdrawal by Subject|1|||
143022198|NCT03038113|515623336|FG003|Overall Study|Withdrawal by Subject|0|||
143022199|NCT03038113|515623337|FG004|Overall Study|Withdrawal by Subject|0|||
143022200|NCT03038113|515623338|FG005|Overall Study|Withdrawal by Subject|0|||
143022201|NCT03038113|515623339|FG006|Overall Study|Withdrawal by Subject|0|||
143022202|NCT03038113|515623340|FG007|Overall Study|Withdrawal by Subject|0|||
143022203|NCT03038113|515623341|FG008|Overall Study|Withdrawal by Subject|0|||
143022204|NCT03038113|515623342|FG009|Overall Study|Withdrawal by Subject|0|||
143022205|NCT03038113|515623343|FG010|Overall Study|Withdrawal by Subject|0|||
143022206|NCT03038113|515623344|FG011|Overall Study|Withdrawal by Subject|0|||
143022207|NCT03038113|515623345|FG012|Overall Study|Withdrawal by Subject|0|||
143022208|NCT03038113|515623346|FG013|Overall Study|Withdrawal by Subject|1|||
143022209|NCT03038113|515623333|FG000|Overall Study|Lost to Follow-up|0|||
143022210|NCT03038113|515623334|FG001|Overall Study|Lost to Follow-up|0|||
143022211|NCT03038113|515623335|FG002|Overall Study|Lost to Follow-up|0|||
143022212|NCT03038113|515623336|FG003|Overall Study|Lost to Follow-up|0|||
143022213|NCT03038113|515623337|FG004|Overall Study|Lost to Follow-up|0|||
143022214|NCT03038113|515623338|FG005|Overall Study|Lost to Follow-up|0|||
143022215|NCT03038113|515623339|FG006|Overall Study|Lost to Follow-up|1|||
143022216|NCT03038113|515623340|FG007|Overall Study|Lost to Follow-up|0|||
143022217|NCT03038113|515623341|FG008|Overall Study|Lost to Follow-up|0|||
143022218|NCT03038113|515623342|FG009|Overall Study|Lost to Follow-up|0|||
143022219|NCT03038113|515623343|FG010|Overall Study|Lost to Follow-up|0|||
143022220|NCT03038113|515623344|FG011|Overall Study|Lost to Follow-up|0|||
143022221|NCT03038113|515623345|FG012|Overall Study|Lost to Follow-up|0|||
143022222|NCT03038113|515623346|FG013|Overall Study|Lost to Follow-up|0|||
143022223|NCT03882047|515623348|FG000|Overall Study|Adverse Event|0|||
143022224|NCT03882047|515623349|FG001|Overall Study|Adverse Event|2|||
143022225|NCT03882047|515623350|FG002|Overall Study|Adverse Event|2|||
143022226|NCT03882047|515623348|FG000|Overall Study|Treatment Failure|3|||
143022227|NCT03882047|515623349|FG001|Overall Study|Treatment Failure|3|||
143022228|NCT03882047|515623350|FG002|Overall Study|Treatment Failure|12|||
143022229|NCT03882047|515623348|FG000|Overall Study|Lost to Follow-up|0|||
143022230|NCT03882047|515623349|FG001|Overall Study|Lost to Follow-up|1|||
143022231|NCT03882047|515623350|FG002|Overall Study|Lost to Follow-up|0|||
143022232|NCT03882047|515623348|FG000|Overall Study|Did Not Wish to Continue|1|||
143022233|NCT03882047|515623349|FG001|Overall Study|Did Not Wish to Continue|4|||
143022234|NCT03882047|515623350|FG002|Overall Study|Did Not Wish to Continue|1|||
143022235|NCT03882047|515623348|FG000|Overall Study|Noncompliance With Protocol|2|||
143022236|NCT03882047|515623349|FG001|Overall Study|Noncompliance With Protocol|0|||
143022237|NCT03882047|515623350|FG002|Overall Study|Noncompliance With Protocol|0|||
143022238|NCT03882047|515623348|FG000|Overall Study|Did Not Meet Eligibility|0|||
143022239|NCT03882047|515623349|FG001|Overall Study|Did Not Meet Eligibility|0|||
143022240|NCT03882047|515623350|FG002|Overall Study|Did Not Meet Eligibility|1|||
143022241|NCT00723554|515623351|FG000|Overall Study|Adverse Event|12|||
143022242|NCT00723554|515623351|FG000|Overall Study|Investigator's judgement|5|||
143022243|NCT00723554|515623351|FG000|Overall Study|Inhaled medication other than iloprost|4|||
143022244|NCT00723554|515623351|FG000|Overall Study|Withdrawal of consent|3|||
143022245|NCT00723554|515623351|FG000|Overall Study|Other|3|||
143022246|NCT00723554|515623351|FG000|Overall Study|Lost to Follow-up|1|||
143022247|NCT00723554|515623351|FG000|Overall Study|Non-compliance|1|||
143022248|NCT01418352|515623356|FG000|Overall Study|Lost to Follow-up|2|||
143022249|NCT01418352|515623357|FG001|Overall Study|Lost to Follow-up|0|||
143022250|NCT01418352|515623358|FG002|Overall Study|Lost to Follow-up|0|||
143022251|NCT01418352|515623359|FG003|Overall Study|Lost to Follow-up|0|||
143022252|NCT01418352|515623356|FG000|Overall Study|Adverse Event|0|||
143022253|NCT01418352|515623357|FG001|Overall Study|Adverse Event|1|||
143022254|NCT01418352|515623358|FG002|Overall Study|Adverse Event|0|||
143022255|NCT01418352|515623359|FG003|Overall Study|Adverse Event|0|||
143022256|NCT01418352|515623356|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
143022257|NCT01418352|515623357|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
143022258|NCT01418352|515623358|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
143022259|NCT01418352|515623359|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
143022260|NCT01418352|515623356|FG000|Overall Study|Subject Withdrew Consent|0|||
143022261|NCT01418352|515623357|FG001|Overall Study|Subject Withdrew Consent|1|||
143022262|NCT01418352|515623358|FG002|Overall Study|Subject Withdrew Consent|2|||
143022263|NCT01418352|515623359|FG003|Overall Study|Subject Withdrew Consent|1|||
143022264|NCT01418352|515623356|FG000|Overall Study|Protocol Deviation|0|||
143022265|NCT01418352|515623357|FG001|Overall Study|Protocol Deviation|0|||
143022266|NCT01418352|515623358|FG002|Overall Study|Protocol Deviation|1|||
143022267|NCT01418352|515623359|FG003|Overall Study|Protocol Deviation|0|||
143022268|NCT01418352|515623356|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
143022269|NCT01418352|515623357|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
143486321|NCT00689871|517324644|FG000|Overall Study|Death|1|||
143486322|NCT00689871|517324645|FG001|Overall Study|Death|10|||
143486323|NCT00689871|517324646|FG002|Overall Study|Death|2|||
143022270|NCT01418352|515623358|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
143022271|NCT01418352|515623359|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
143022272|NCT01401478|515623361|FG000|Overall Study|Study drug not available|6|||
143022273|NCT01401478|515623361|FG000|Overall Study|Adverse Event|5|||
143022274|NCT01401478|515623361|FG000|Overall Study|Hyperphosphatemia|5|||
143022275|NCT01401478|515623361|FG000|Overall Study|Lost to Follow-up|5|||
143022276|NCT01401478|515623361|FG000|Overall Study|Kidney transplantation|3|||
143022277|NCT01401478|515623361|FG000|Overall Study|Withdrawal by Subject|3|||
143022278|NCT01401478|515623361|FG000|Overall Study|Blood samples not available|1|||
143022279|NCT01401478|515623361|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
143022280|NCT01401478|515623361|FG000|Overall Study|Low intact parathyroid hormone|1|||
143022281|NCT01401478|515623361|FG000|Overall Study|Serious adverse event|1|||
143022282|NCT03255031|515623362|FG000|Overall Study|Adverse Event|5|||
143022283|NCT03255031|515623363|FG001|Overall Study|Adverse Event|3|||
143022284|NCT03255031|515623362|FG000|Overall Study|Physician Decision|2|||
143022285|NCT03255031|515623363|FG001|Overall Study|Physician Decision|1|||
143022286|NCT03255031|515623362|FG000|Overall Study|Withdrawal by Subject|9|||
143022287|NCT03255031|515623363|FG001|Overall Study|Withdrawal by Subject|3|||
143022288|NCT01809314|515623364|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
143022289|NCT01809314|515623364|FG000|Overall Study|Adverse Event|6|||
143022290|NCT01809314|515623364|FG000|Overall Study|Insufficient Therapeutic Response|14|||
143022291|NCT01809314|515623364|FG000|Overall Study|Lost to Follow-up|724|||
143022292|NCT01092702|515623365|FG000|Overall Study|Withdrawal by Subject|7|||
143022293|NCT01092702|515623365|FG000|Overall Study|Lost to Follow-up|2|||
143022294|NCT03567057|515623367|FG000|Overall Study|Adverse Event|56|||
143022295|NCT03567057|515623368|FG001|Overall Study|Adverse Event|53|||
143022296|NCT03567057|515623369|FG002|Overall Study|Adverse Event|28|||
143022297|NCT03567057|515623367|FG000|Overall Study|Withdrawal by Subject|22|||
143022298|NCT03567057|515623368|FG001|Overall Study|Withdrawal by Subject|24|||
143022299|NCT03567057|515623369|FG002|Overall Study|Withdrawal by Subject|13|||
143022300|NCT03567057|515623367|FG000|Overall Study|Lost to Follow-up|3|||
143022301|NCT03567057|515623368|FG001|Overall Study|Lost to Follow-up|5|||
143022302|NCT03567057|515623369|FG002|Overall Study|Lost to Follow-up|2|||
143022303|NCT03567057|515623367|FG000|Overall Study|COVID-19 pandemic|4|||
143022304|NCT03567057|515623368|FG001|Overall Study|COVID-19 pandemic|3|||
143022305|NCT03567057|515623369|FG002|Overall Study|COVID-19 pandemic|0|||
143022306|NCT03567057|515623367|FG000|Overall Study|Non-compliance with study drug|4|||
143022307|NCT03567057|515623368|FG001|Overall Study|Non-compliance with study drug|2|||
143022308|NCT03567057|515623369|FG002|Overall Study|Non-compliance with study drug|0|||
143022309|NCT03567057|515623367|FG000|Overall Study|Lack of Efficacy|3|||
143022310|NCT03567057|515623368|FG001|Overall Study|Lack of Efficacy|0|||
143022311|NCT03567057|515623369|FG002|Overall Study|Lack of Efficacy|1|||
143022312|NCT03567057|515623367|FG000|Overall Study|Death|1|||
143022313|NCT03567057|515623368|FG001|Overall Study|Death|0|||
143022314|NCT03567057|515623369|FG002|Overall Study|Death|0|||
143022315|NCT03567057|515623367|FG000|Overall Study|Physician Decision|1|||
143022316|NCT03567057|515623368|FG001|Overall Study|Physician Decision|0|||
143022317|NCT03567057|515623369|FG002|Overall Study|Physician Decision|0|||
143022318|NCT03567057|515623367|FG000|Overall Study|Unstable medical condition|1|||
143022319|NCT03567057|515623368|FG001|Overall Study|Unstable medical condition|0|||
143022320|NCT03567057|515623369|FG002|Overall Study|Unstable medical condition|0|||
143022321|NCT03567057|515623367|FG000|Overall Study|Medical history event|0|||
143022322|NCT03567057|515623368|FG001|Overall Study|Medical history event|0|||
143022323|NCT03567057|515623369|FG002|Overall Study|Medical history event|1|||
143022324|NCT03567057|515623367|FG000|Overall Study|Other|0|||
143022325|NCT03567057|515623368|FG001|Overall Study|Other|0|||
143022326|NCT03567057|515623369|FG002|Overall Study|Other|1|||
143486324|NCT00689871|517324647|FG003|Overall Study|Death|2|||
143022327|NCT00490061|515623370|FG000|Overall Study|Physician Decision|1|||
143022328|NCT00886483|515623375|FG000|Overall Study|Lost to Follow-up|0|||
143022329|NCT00886483|515623376|FG001|Overall Study|Lost to Follow-up|1|||
143022330|NCT00886483|515623375|FG000|Overall Study|Pursue medications|1|||
143022331|NCT00886483|515623376|FG001|Overall Study|Pursue medications|2|||
143022332|NCT00886483|515623375|FG000|Overall Study|Distance to center, poor grades|1|||
143022333|NCT00886483|515623376|FG001|Overall Study|Distance to center, poor grades|0|||
143022334|NCT01580020|515623377|FG000|Overall Study|Lack of Efficacy|0|||
143022335|NCT01580020|515623378|FG001|Overall Study|Lack of Efficacy|5|||
143022336|NCT01580020|515623379|FG002|Overall Study|Lack of Efficacy|0|||
143022337|NCT01580020|515623380|FG003|Overall Study|Lack of Efficacy|1|||
143235564|NCT05632211|516413619|FG000|Overall Study|Other reasons|1|||
143022338|NCT01580020|515623377|FG000|Overall Study|Withdrawal by Subject|0|||
143022339|NCT01580020|515623378|FG001|Overall Study|Withdrawal by Subject|1|||
143022340|NCT01580020|515623379|FG002|Overall Study|Withdrawal by Subject|1|||
143022341|NCT01580020|515623380|FG003|Overall Study|Withdrawal by Subject|0|||
143486325|NCT00689871|517324644|FG000|Overall Study|Physician Decision|2|||
143022342|NCT01580020|515623377|FG000|Overall Study|Adverse Event|1|||
143022343|NCT01580020|515623378|FG001|Overall Study|Adverse Event|1|||
143022344|NCT01580020|515623379|FG002|Overall Study|Adverse Event|1|||
143022345|NCT01580020|515623380|FG003|Overall Study|Adverse Event|1|||
143022346|NCT01580020|515623377|FG000|Overall Study|Administrative Problems|0|||
143022347|NCT01580020|515623378|FG001|Overall Study|Administrative Problems|0|||
143022348|NCT01580020|515623379|FG002|Overall Study|Administrative Problems|1|||
143022349|NCT01580020|515623380|FG003|Overall Study|Administrative Problems|0|||
143022350|NCT01580020|515623377|FG000|Overall Study|Lost to Follow-up|0|||
143022351|NCT01580020|515623378|FG001|Overall Study|Lost to Follow-up|0|||
143022352|NCT01580020|515623379|FG002|Overall Study|Lost to Follow-up|1|||
143022353|NCT01580020|515623380|FG003|Overall Study|Lost to Follow-up|0|||
143022354|NCT01724359|515623382|FG000|Overall Study|Adverse Event|10|||
143022355|NCT01724359|515623382|FG000|Overall Study|Death|1|||
143022356|NCT01724359|515623382|FG000|Overall Study|Other|20|||
143022357|NCT01208402|515623384|FG000|Overall Study|Withdrawal by Subject|1|||
143022358|NCT01208402|515623385|FG001|Overall Study|Withdrawal by Subject|0|||
143022359|NCT02168270|515623388|FG000|Overall Study|Lack of Efficacy|4|||
143022360|NCT02175966|515623389|FG000|Follow-up Period|Lack of Efficacy|10|||
143022361|NCT02175966|515623390|FG001|Follow-up Period|Lack of Efficacy|6|||
143022362|NCT01752920|515623391|FG000|Overall Study|Adverse Event|1|||
143022363|NCT01752920|515623392|FG001|Overall Study|Adverse Event|0|||
143022364|NCT01752920|515623393|FG002|Overall Study|Adverse Event|5|||
143022365|NCT01752920|515623394|FG003|Overall Study|Adverse Event|10|||
143022366|NCT01752920|515623391|FG000|Overall Study|Clinical Disease Progression|6|||
143022367|NCT01752920|515623392|FG001|Overall Study|Clinical Disease Progression|4|||
143022368|NCT01752920|515623393|FG002|Overall Study|Clinical Disease Progression|1|||
143022369|NCT01752920|515623394|FG003|Overall Study|Clinical Disease Progression|13|||
143022370|NCT01752920|515623391|FG000|Overall Study|Physician Decision|1|||
143022371|NCT01752920|515623392|FG001|Overall Study|Physician Decision|0|||
143022372|NCT01752920|515623393|FG002|Overall Study|Physician Decision|0|||
143022373|NCT01752920|515623394|FG003|Overall Study|Physician Decision|3|||
143022374|NCT01752920|515623391|FG000|Overall Study|Radiographic Disease Progression|20|||
143022375|NCT01752920|515623392|FG001|Overall Study|Radiographic Disease Progression|7|||
143022376|NCT01752920|515623393|FG002|Overall Study|Radiographic Disease Progression|12|||
143022377|NCT01752920|515623394|FG003|Overall Study|Radiographic Disease Progression|29|||
143022378|NCT01752920|515623391|FG000|Overall Study|Study Terminated by Sponsor|0|||
143022379|NCT01752920|515623392|FG001|Overall Study|Study Terminated by Sponsor|0|||
143022380|NCT01752920|515623393|FG002|Overall Study|Study Terminated by Sponsor|0|||
143022381|NCT01752920|515623394|FG003|Overall Study|Study Terminated by Sponsor|1|||
143022382|NCT01752920|515623391|FG000|Overall Study|Withdrawal by Subject|0|||
143022383|NCT01752920|515623392|FG001|Overall Study|Withdrawal by Subject|1|||
143022384|NCT01752920|515623393|FG002|Overall Study|Withdrawal by Subject|0|||
143022385|NCT01752920|515623394|FG003|Overall Study|Withdrawal by Subject|1|||
143022386|NCT01752920|515623391|FG000|Overall Study|Lack of clinical benefit|1|||
143022387|NCT01752920|515623392|FG001|Overall Study|Lack of clinical benefit|1|||
143022388|NCT01752920|515623393|FG002|Overall Study|Lack of clinical benefit|1|||
143022389|NCT01752920|515623394|FG003|Overall Study|Lack of clinical benefit|1|||
143022390|NCT01738581|515623395|FG000|Overall Study|Lost to Follow-up|1|||
143022391|NCT01738581|515623396|FG001|Overall Study|Lost to Follow-up|0|||
143022392|NCT00210626|515623397|FG000|Overall Study|Adverse Event|1|||
143156207|NCT01562444|516117441|FG002|Overall Study|Did not meet entry criteria|3|||
143486326|NCT00689871|517324645|FG001|Overall Study|Physician Decision|1|||
143156208|NCT01562444|516117439|FG000|Overall Study|Did not comply with blood draw schedule|1|||
143156209|NCT01562444|516117440|FG001|Overall Study|Did not comply with blood draw schedule|0|||
143156210|NCT01562444|516117441|FG002|Overall Study|Did not comply with blood draw schedule|1|||
143156211|NCT01562444|516117439|FG000|Overall Study|Unavailable serological results|0|||
143156212|NCT01562444|516117440|FG001|Overall Study|Unavailable serological results|2|||
143156213|NCT01562444|516117441|FG002|Overall Study|Unavailable serological results|2|||
143156214|NCT01562444|516117439|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
143156215|NCT01562444|516117440|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
143486327|NCT00689871|517324646|FG002|Overall Study|Physician Decision|1|||
143022393|NCT00210626|515623398|FG001|Overall Study|Adverse Event|2|||
143022394|NCT00210626|515623397|FG000|Overall Study|Protocol Violation|1|||
143156216|NCT01562444|516117441|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
143156217|NCT01562444|516117439|FG000|Overall Study|Protocol forbidden medication|1|||
143156218|NCT01562444|516117440|FG001|Overall Study|Protocol forbidden medication|0|||
143156219|NCT01562444|516117441|FG002|Overall Study|Protocol forbidden medication|0|||
143156220|NCT03387046|516117448|FG000|Overall Study|Adverse Event|1|||
143156221|NCT03387046|516117449|FG001|Overall Study|Adverse Event|1|||
143486328|NCT00689871|517324647|FG003|Overall Study|Physician Decision|0|||
143486329|NCT02054897|517324648|FG000|Overall Study|Withdrawal by Subject|2|||
143022395|NCT00210626|515623398|FG001|Overall Study|Protocol Violation|5|||
143022396|NCT00210626|515623397|FG000|Overall Study|Lost to Follow-up|11|||
143022397|NCT00210626|515623398|FG001|Overall Study|Lost to Follow-up|11|||
143022398|NCT00210626|515623397|FG000|Overall Study|Death|1|||
143022399|NCT00210626|515623398|FG001|Overall Study|Death|0|||
143022400|NCT00210626|515623397|FG000|Overall Study|Withdrawal by Subject|29|||
143022401|NCT00210626|515623398|FG001|Overall Study|Withdrawal by Subject|20|||
143022402|NCT00210626|515623397|FG000|Overall Study|Physician Decision|0|||
143022403|NCT00210626|515623398|FG001|Overall Study|Physician Decision|2|||
143022404|NCT00210626|515623397|FG000|Overall Study|Sponser Request|1|||
143022405|NCT00210626|515623398|FG001|Overall Study|Sponser Request|0|||
143022406|NCT00210626|515623397|FG000|Overall Study|Other|4|||
143022407|NCT00210626|515623398|FG001|Overall Study|Other|5|||
143022408|NCT00771901|515623399|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
143022409|NCT00771901|515623400|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
143022410|NCT00771901|515623401|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
143022411|NCT02862535|515623402|FG000|Overall Study|Death|7|||
143022412|NCT02862535|515623403|FG001|Overall Study|Death|3|||
143022413|NCT02862535|515623404|FG002|Overall Study|Death|2|||
143022414|NCT02862535|515623405|FG003|Overall Study|Death|5|||
143022415|NCT02862535|515623402|FG000|Overall Study|Study Terminated by Sponsor|1|||
143022416|NCT02862535|515623403|FG001|Overall Study|Study Terminated by Sponsor|3|||
143022417|NCT02862535|515623404|FG002|Overall Study|Study Terminated by Sponsor|8|||
143022418|NCT02862535|515623405|FG003|Overall Study|Study Terminated by Sponsor|5|||
143022419|NCT02862535|515623402|FG000|Overall Study|Enrolled, not Treated|1|||
143022420|NCT02862535|515623403|FG001|Overall Study|Enrolled, not Treated|0|||
143022421|NCT02862535|515623404|FG002|Overall Study|Enrolled, not Treated|0|||
143022422|NCT02862535|515623405|FG003|Overall Study|Enrolled, not Treated|1|||
143022423|NCT02280356|515623411|FG000|Overall Study|Not Treated|2|||
143022424|NCT02280356|515623411|FG000|Overall Study|Withdrawal by Subject|1|||
143022425|NCT02280356|515623411|FG000|Overall Study|Not evaluable|2|||
143022426|NCT01086215|515623414|FG000|Overall Study|Death|14|||
143022427|NCT01086215|515623415|FG001|Overall Study|Death|8|||
143022428|NCT01086215|515623416|FG002|Overall Study|Death|8|||
143022429|NCT01086215|515623417|FG003|Overall Study|Death|1|||
143022430|NCT01086215|515623414|FG000|Overall Study|Lost to Follow-up|22|||
143022431|NCT01086215|515623415|FG001|Overall Study|Lost to Follow-up|39|||
143022432|NCT01086215|515623416|FG002|Overall Study|Lost to Follow-up|18|||
143022433|NCT01086215|515623417|FG003|Overall Study|Lost to Follow-up|2|||
143022434|NCT01965652|515623418|FG000|Overall Study|Adverse Event|40|||
143156222|NCT03055195|516117450|FG000|Overall Study|Lack of Efficacy|1|||
143486330|NCT02054897|517324649|FG001|Overall Study|Withdrawal by Subject|0|||
143486331|NCT02054897|517324650|FG002|Overall Study|Withdrawal by Subject|2|||
143022435|NCT01965652|515623419|FG001|Overall Study|Adverse Event|37|||
143156223|NCT03055195|516117451|FG001|Overall Study|Lack of Efficacy|0|||
143156224|NCT03055195|516117450|FG000|Overall Study|Withdrawal by Subject|6|||
143156225|NCT03055195|516117451|FG001|Overall Study|Withdrawal by Subject|7|||
143486332|NCT02054897|517324648|FG000|Overall Study|Missing follow-up information|3|||
143486333|NCT02054897|517324649|FG001|Overall Study|Missing follow-up information|5|||
143486334|NCT02054897|517324650|FG002|Overall Study|Missing follow-up information|3|||
143486335|NCT02054897|517324648|FG000|Overall Study|Lost to Follow-up|4|||
143486336|NCT02054897|517324649|FG001|Overall Study|Lost to Follow-up|2|||
143486337|NCT02054897|517324650|FG002|Overall Study|Lost to Follow-up|7|||
143486338|NCT02054897|517324648|FG000|Overall Study|Randomized but not exposed|1|||
143486339|NCT02054897|517324649|FG001|Overall Study|Randomized but not exposed|0|||
143486340|NCT02054897|517324650|FG002|Overall Study|Randomized but not exposed|0|||
143486341|NCT00550680|517324653|FG000|Overall Study|Administrative Reasons|1|||
143486342|NCT00550680|517324653|FG000|Overall Study|Adverse Event|5|||
143486343|NCT00550680|517324653|FG000|Overall Study|Death|3|||
143486344|NCT00550680|517324653|FG000|Overall Study|Early Improvement|1|||
143486345|NCT00550680|517324653|FG000|Overall Study|Lost to Follow-up|3|||
143486346|NCT00550680|517324653|FG000|Overall Study|Lack of Efficacy|1|||
143486347|NCT00550680|517324653|FG000|Overall Study|Other|10|||
143486348|NCT00550680|517324653|FG000|Overall Study|Protocol Violation|7|||
143486349|NCT00550680|517324653|FG000|Overall Study|Refused Treatment|19|||
143486350|NCT00550680|517324653|FG000|Overall Study|Screen Failure|6|||
143486351|NCT00250835|517324654|FG000|Overall Study|Withdrawal by Subject|1|||
143486352|NCT01100437|517324655|FG000|Titration/Stabilization|Adverse Event|0|||
143022436|NCT01965652|515623418|FG000|Overall Study|Withdrawal by Subject|62|||
143486353|NCT01100437|517324656|FG001|Titration/Stabilization|Adverse Event|0|||
143022437|NCT01965652|515623419|FG001|Overall Study|Withdrawal by Subject|69|||
143022438|NCT01965652|515623418|FG000|Overall Study|Lost to Follow-up|53|||
143022439|NCT01965652|515623419|FG001|Overall Study|Lost to Follow-up|40|||
143156226|NCT03055195|516117450|FG000|Overall Study|Study Terminated by Sponsor|2|||
143156227|NCT03055195|516117451|FG001|Overall Study|Study Terminated by Sponsor|6|||
143156228|NCT03055195|516117450|FG000|Overall Study|Protocol Violation|2|||
143022440|NCT01965652|515623418|FG000|Overall Study|Protocol Violation|34|||
143156229|NCT03055195|516117451|FG001|Overall Study|Protocol Violation|1|||
143022441|NCT01965652|515623419|FG001|Overall Study|Protocol Violation|38|||
143486354|NCT01100437|517324657|FG002|Titration/Stabilization|Adverse Event|4|||
143022442|NCT01965652|515623418|FG000|Overall Study|Death|3|||
143022443|NCT01965652|515623419|FG001|Overall Study|Death|4|||
143486355|NCT01100437|517324655|FG000|Titration/Stabilization|Non-compliance|0|||
143022444|NCT01965652|515623418|FG000|Overall Study|Other - Miscellaneous|18|||
143022445|NCT01965652|515623419|FG001|Overall Study|Other - Miscellaneous|21|||
143022446|NCT01965652|515623418|FG000|Overall Study|Pregnancy|0|||
143022447|NCT01965652|515623419|FG001|Overall Study|Pregnancy|1|||
143022448|NCT01121900|515623422|FG000|First Intervention Period|Adverse Event|1|||
143022449|NCT01121900|515623423|FG001|First Intervention Period|Adverse Event|1|||
143022450|NCT01121900|515623422|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
143022451|NCT01121900|515623423|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
143022452|NCT03469271|515623424|FG000|Overall Study|Withdrawal by Subject|2|||
143022453|NCT03469271|515623425|FG001|Overall Study|Withdrawal by Subject|0|||
143022454|NCT03469271|515623426|FG002|Overall Study|Withdrawal by Subject|0|||
143022455|NCT03469271|515623427|FG003|Overall Study|Withdrawal by Subject|1|||
143022456|NCT01328054|515623430|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
143022457|NCT01328054|515623431|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
143022458|NCT01328054|515623430|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
143022459|NCT01328054|515623431|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
143022460|NCT01328054|515623430|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
143022461|NCT01328054|515623431|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
143022462|NCT03760510|515623432|FG000|Overall Study|Not ventilated for 24 hours|105|||
143022463|NCT03760510|515623433|FG001|Overall Study|Not ventilated for 24 hours|97|||
143022464|NCT00871728|515623434|FG000|Overall Study|Adverse Event|1|||
143022465|NCT00871728|515623434|FG000|Overall Study|Protocol Violation|7|||
143022466|NCT00871728|515623434|FG000|Overall Study|Lost to Follow-up|2|||
143022467|NCT00871728|515623434|FG000|Overall Study|Failed to Visit Hospital|4|||
143022468|NCT00871728|515623434|FG000|Overall Study|Participant Non-compliance|1|||
143022469|NCT00871728|515623434|FG000|Overall Study|Withdrawal of Informed Consent|5|||
143022470|NCT02418910|515623437|FG000|Overall Study|Lost to Follow-up|3|||
143022471|NCT02418910|515623437|FG000|Overall Study|Withdrawal by Subject|4|||
143022472|NCT02472977|515623441|FG000|Overall Study|Disease progression|4|||
143022473|NCT02472977|515623442|FG001|Overall Study|Disease progression|25|||
143022474|NCT02472977|515623443|FG002|Overall Study|Disease progression|6|||
143022475|NCT02472977|515623441|FG000|Overall Study|Withdrawal by Subject|0|||
143022476|NCT02472977|515623442|FG001|Overall Study|Withdrawal by Subject|1|||
143022477|NCT02472977|515623443|FG002|Overall Study|Withdrawal by Subject|0|||
143022478|NCT02472977|515623441|FG000|Overall Study|Study drug toxicity|2|||
143022479|NCT02472977|515623442|FG001|Overall Study|Study drug toxicity|0|||
143022480|NCT02472977|515623443|FG002|Overall Study|Study drug toxicity|2|||
143022481|NCT02472977|515623441|FG000|Overall Study|Subject request to discontinue treatment|0|||
143022482|NCT02472977|515623442|FG001|Overall Study|Subject request to discontinue treatment|1|||
143022483|NCT02472977|515623443|FG002|Overall Study|Subject request to discontinue treatment|0|||
143022484|NCT02629965|515623446|FG000|Period 1|Adverse Event|1|||
143022485|NCT02629965|515623447|FG001|Period 1|Adverse Event|0|||
143022486|NCT02629965|515623446|FG000|Period 1|Unexpected worsening of disease|2|||
143022487|NCT02629965|515623447|FG001|Period 1|Unexpected worsening of disease|0|||
143022488|NCT02629965|515623446|FG000|Period 1|Other than listed above|1|||
143022489|NCT02629965|515623447|FG001|Period 1|Other than listed above|2|||
143022490|NCT02629965|515623446|FG000|Period 2|Adverse Event|1|||
143022491|NCT02629965|515623447|FG001|Period 2|Adverse Event|0|||
143022492|NCT03443869|515623448|FG000|Overall Study|Death|3|||
143022493|NCT03443869|515623449|FG001|Overall Study|Death|3|||
143022494|NCT03443869|515623448|FG000|Overall Study|Withdrawal by Subject|34|||
143022495|NCT03443869|515623449|FG001|Overall Study|Withdrawal by Subject|22|||
143022496|NCT03443869|515623448|FG000|Overall Study|Lost to Follow-up|1|||
143022497|NCT03443869|515623449|FG001|Overall Study|Lost to Follow-up|2|||
143022498|NCT03443869|515623448|FG000|Overall Study|Physician Decision|3|||
143022499|NCT03443869|515623449|FG001|Overall Study|Physician Decision|3|||
143022500|NCT03443869|515623448|FG000|Overall Study|Other|4|||
143022501|NCT03443869|515623449|FG001|Overall Study|Other|4|||
143156230|NCT03055195|516117450|FG000|Overall Study|Physician Decision|1|||
143156231|NCT03055195|516117451|FG001|Overall Study|Physician Decision|0|||
143156232|NCT00986232|516117452|FG000|Overall Study|Adverse Event|1|||
143156233|NCT00986232|516117453|FG001|Overall Study|Adverse Event|2|||
143156234|NCT00986232|516117454|FG002|Overall Study|Adverse Event|3|||
143156235|NCT00986232|516117455|FG003|Overall Study|Adverse Event|0|||
143022502|NCT02390219|515623450|FG000|Overall Study|Death|1|||
143156236|NCT00986232|516117452|FG000|Overall Study|Lost to Follow-up|19|||
143156237|NCT00986232|516117453|FG001|Overall Study|Lost to Follow-up|12|||
143156238|NCT00986232|516117454|FG002|Overall Study|Lost to Follow-up|12|||
143022503|NCT02390219|515623450|FG000|Overall Study|Physician Decision|1|||
143022504|NCT02390219|515623450|FG000|Overall Study|Adverse Event|6|||
143022505|NCT02390219|515623450|FG000|Overall Study|Withdrawal by Subject|1|||
143156239|NCT00986232|516117455|FG003|Overall Study|Lost to Follow-up|7|||
143156240|NCT00986232|516117452|FG000|Overall Study|Protocol Violation|2|||
143022506|NCT02390219|515623450|FG000|Overall Study|Lost to Follow-up|2|||
143022507|NCT02390219|515623450|FG000|Overall Study|Other|2|||
143022508|NCT02230085|515623451|FG000|Overall Study|Physician Decision|1|||
143156241|NCT00986232|516117453|FG001|Overall Study|Protocol Violation|3|||
143363727|NCT05296629|516875426|FG002|Overall Study|Adverse Event|2|||
143022509|NCT02230085|515623451|FG000|Overall Study|Withdrawal by Subject|3|||
143022510|NCT01298596|515623452|FG000|Overall Study|Withdrawal by Subject|1|||
143022511|NCT01298596|515623453|FG001|Overall Study|Withdrawal by Subject|1|||
143022512|NCT01298596|515623452|FG000|Overall Study|Death|5|||
143022513|NCT01298596|515623453|FG001|Overall Study|Death|3|||
143022514|NCT01298596|515623452|FG000|Overall Study|Lost to Follow-up|6|||
143022515|NCT01298596|515623453|FG001|Overall Study|Lost to Follow-up|14|||
143022516|NCT01298596|515623452|FG000|Overall Study|Referred for further management|16|||
143022517|NCT01298596|515623453|FG001|Overall Study|Referred for further management|15|||
143022518|NCT04128696|515623454|FG000|Overall Study|Lost to Follow-up|3|||
143022519|NCT04128696|515623455|FG001|Overall Study|Lost to Follow-up|7|||
143022520|NCT04128696|515623454|FG000|Overall Study|Withdrawal by Subject|12|||
143022521|NCT04128696|515623455|FG001|Overall Study|Withdrawal by Subject|11|||
143022522|NCT04128696|515623454|FG000|Overall Study|Study Closed/Terminated|26|||
143022523|NCT04128696|515623455|FG001|Overall Study|Study Closed/Terminated|38|||
143022524|NCT04128696|515623454|FG000|Overall Study|Physician Decision|2|||
143022525|NCT04128696|515623455|FG001|Overall Study|Physician Decision|3|||
143022526|NCT02173301|515623456|FG000|Overall Study|Adverse Event|7|||
143022527|NCT02173301|515623457|FG001|Overall Study|Adverse Event|8|||
143022528|NCT02173301|515623458|FG002|Overall Study|Adverse Event|13|||
143022529|NCT02173301|515623459|FG003|Overall Study|Adverse Event|5|||
143022530|NCT02173301|515623456|FG000|Overall Study|Withdrawal by Subject|8|||
143022531|NCT02173301|515623457|FG001|Overall Study|Withdrawal by Subject|10|||
143022532|NCT02173301|515623458|FG002|Overall Study|Withdrawal by Subject|4|||
143022533|NCT02173301|515623459|FG003|Overall Study|Withdrawal by Subject|8|||
143022534|NCT02173301|515623456|FG000|Overall Study|Lost to Follow-up|4|||
143022535|NCT02173301|515623457|FG001|Overall Study|Lost to Follow-up|4|||
143022536|NCT02173301|515623458|FG002|Overall Study|Lost to Follow-up|2|||
143022537|NCT02173301|515623459|FG003|Overall Study|Lost to Follow-up|2|||
143022538|NCT02173301|515623456|FG000|Overall Study|Protocol Violation|0|||
143022539|NCT02173301|515623457|FG001|Overall Study|Protocol Violation|1|||
143022540|NCT02173301|515623458|FG002|Overall Study|Protocol Violation|0|||
143022541|NCT02173301|515623459|FG003|Overall Study|Protocol Violation|0|||
143022542|NCT02173301|515623456|FG000|Overall Study|Physician Decision|0|||
143022543|NCT02173301|515623457|FG001|Overall Study|Physician Decision|0|||
143022544|NCT02173301|515623458|FG002|Overall Study|Physician Decision|1|||
143022545|NCT02173301|515623459|FG003|Overall Study|Physician Decision|0|||
143486356|NCT01100437|517324656|FG001|Titration/Stabilization|Non-compliance|0|||
143486357|NCT01100437|517324657|FG002|Titration/Stabilization|Non-compliance|1|||
143486358|NCT01100437|517324655|FG000|Titration/Stabilization|Sponsor canceled study|0|||
143486359|NCT01100437|517324656|FG001|Titration/Stabilization|Sponsor canceled study|0|||
143486360|NCT01100437|517324657|FG002|Titration/Stabilization|Sponsor canceled study|1|||
143022546|NCT02173301|515623456|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
143022547|NCT02173301|515623457|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
143022548|NCT02173301|515623458|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
143022549|NCT02173301|515623459|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
143022550|NCT03120520|515623460|FG000|Overall Study|Lost to Follow-up|1|||
143022551|NCT03120520|515623461|FG001|Overall Study|Lost to Follow-up|1|||
143022552|NCT03120520|515623462|FG002|Overall Study|Lost to Follow-up|1|||
143363728|NCT05296629|516875424|FG000|Overall Study|Protocol Violation|0|||
143363729|NCT05296629|516875425|FG001|Overall Study|Protocol Violation|2|||
143022553|NCT03120520|515623463|FG003|Overall Study|Lost to Follow-up|1|||
143022554|NCT03120520|515623460|FG000|Overall Study|Withdrawal by Subject|3|||
143022555|NCT03120520|515623461|FG001|Overall Study|Withdrawal by Subject|2|||
143022556|NCT03120520|515623462|FG002|Overall Study|Withdrawal by Subject|3|||
143022557|NCT03120520|515623463|FG003|Overall Study|Withdrawal by Subject|2|||
143022558|NCT03120520|515623460|FG000|Overall Study|Other|0|||
143022559|NCT03120520|515623461|FG001|Overall Study|Other|1|||
143022560|NCT03120520|515623462|FG002|Overall Study|Other|0|||
143022561|NCT03120520|515623463|FG003|Overall Study|Other|0|||
143486361|NCT01100437|517324655|FG000|Maintenance|Withdrawal by Subject|0|||
143022562|NCT02196506|515623464|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
143022563|NCT02196506|515623465|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
143022564|NCT02196506|515623466|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
143022565|NCT02196506|515623467|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
143022566|NCT02196506|515623464|FG000|Phase A|Withdrawal by Subject|34|||
143022567|NCT02196506|515623465|FG001|Phase A|Withdrawal by Subject|0|||
143022568|NCT02196506|515623466|FG002|Phase A|Withdrawal by Subject|0|||
143156242|NCT00986232|516117454|FG002|Overall Study|Protocol Violation|0|||
143022569|NCT02196506|515623467|FG003|Phase A|Withdrawal by Subject|0|||
143022570|NCT02196506|515623464|FG000|Phase A|Adverse Event|22|||
143022571|NCT02196506|515623465|FG001|Phase A|Adverse Event|0|||
143022572|NCT02196506|515623466|FG002|Phase A|Adverse Event|0|||
143486362|NCT01100437|517324656|FG001|Maintenance|Withdrawal by Subject|0|||
143486363|NCT01100437|517324657|FG002|Maintenance|Withdrawal by Subject|1|||
143486364|NCT01100437|517324655|FG000|Maintenance|Sponsor termination of study|0|||
143022573|NCT02196506|515623467|FG003|Phase A|Adverse Event|0|||
143486365|NCT01100437|517324656|FG001|Maintenance|Sponsor termination of study|0|||
143486366|NCT01100437|517324657|FG002|Maintenance|Sponsor termination of study|1|||
143486367|NCT00894556|517324660|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
143486368|NCT00894556|517324661|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
143486369|NCT00894556|517324662|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
143486370|NCT00894556|517324663|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
143486371|NCT00894556|517324660|FG000|Treatment Phase|Lost to Follow-up|2|||
143486372|NCT00894556|517324661|FG001|Treatment Phase|Lost to Follow-up|3|||
143486373|NCT00894556|517324662|FG002|Treatment Phase|Lost to Follow-up|1|||
143486374|NCT00894556|517324663|FG003|Treatment Phase|Lost to Follow-up|0|||
143486375|NCT00894556|517324660|FG000|Treatment Phase|Lack of Qualifying Event|2|||
143486376|NCT00894556|517324661|FG001|Treatment Phase|Lack of Qualifying Event|1|||
143486377|NCT00894556|517324662|FG002|Treatment Phase|Lack of Qualifying Event|0|||
143486378|NCT00894556|517324663|FG003|Treatment Phase|Lack of Qualifying Event|0|||
143486379|NCT01014689|517324666|FG000|Overall Study|Lack of Efficacy|0|||
143486380|NCT01014689|517324667|FG001|Overall Study|Lack of Efficacy|1|||
143486381|NCT01014689|517324666|FG000|Overall Study|Adverse Event|3|||
143486382|NCT01014689|517324667|FG001|Overall Study|Adverse Event|0|||
143486383|NCT01014689|517324666|FG000|Overall Study|Withdrawal by Subject|5|||
143486384|NCT01014689|517324667|FG001|Overall Study|Withdrawal by Subject|4|||
143486385|NCT01014689|517324666|FG000|Overall Study|Protocol Violation|1|||
143486386|NCT01014689|517324667|FG001|Overall Study|Protocol Violation|1|||
143486387|NCT01014689|517324666|FG000|Overall Study|Lost to Follow-up|3|||
143486388|NCT01014689|517324667|FG001|Overall Study|Lost to Follow-up|7|||
143486389|NCT01014689|517324666|FG000|Overall Study|Pregnancy|1|||
143486390|NCT01014689|517324667|FG001|Overall Study|Pregnancy|0|||
143486391|NCT00333359|517324674|FG000|Overall Study|Adverse Event|29|||
143486392|NCT00333359|517324675|FG001|Overall Study|Adverse Event|35|||
143486393|NCT00333359|517324674|FG000|Overall Study|Withdrawal by Subject|19|||
143486394|NCT00333359|517324675|FG001|Overall Study|Withdrawal by Subject|37|||
143486395|NCT00333359|517324674|FG000|Overall Study|Physician Decision|2|||
143486396|NCT00333359|517324675|FG001|Overall Study|Physician Decision|2|||
143486397|NCT00333359|517324674|FG000|Overall Study|Protocol Non-compliance|2|||
143486398|NCT00333359|517324675|FG001|Overall Study|Protocol Non-compliance|8|||
143486399|NCT00333359|517324674|FG000|Overall Study|Lost to Follow-up|15|||
143486400|NCT00333359|517324675|FG001|Overall Study|Lost to Follow-up|25|||
143486401|NCT00333359|517324674|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
143486402|NCT00333359|517324675|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
143486403|NCT00333359|517324674|FG000|Overall Study|Treatment Failure|3|||
143486404|NCT00333359|517324675|FG001|Overall Study|Treatment Failure|8|||
143486405|NCT00333359|517324674|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
143486406|NCT00333359|517324675|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
143486407|NCT00805480|517324678|FG000|Overall Study|Withdrawal by Subject|13|||
143486408|NCT00805480|517324679|FG001|Overall Study|Withdrawal by Subject|5|||
143486409|NCT00805480|517324680|FG002|Overall Study|Withdrawal by Subject|11|||
143486410|NCT00805480|517324681|FG003|Overall Study|Withdrawal by Subject|5|||
143486411|NCT00805480|517324678|FG000|Overall Study|Lost to Follow-up|1|||
143486412|NCT00805480|517324679|FG001|Overall Study|Lost to Follow-up|2|||
143486413|NCT00805480|517324680|FG002|Overall Study|Lost to Follow-up|0|||
143486414|NCT00805480|517324681|FG003|Overall Study|Lost to Follow-up|0|||
143486415|NCT00805480|517324678|FG000|Overall Study|Adverse Event|0|||
143486416|NCT00805480|517324679|FG001|Overall Study|Adverse Event|0|||
143022574|NCT02196506|515623464|FG000|Phase A|Lost to Follow-up|9|||
143022575|NCT02196506|515623465|FG001|Phase A|Lost to Follow-up|0|||
143022576|NCT02196506|515623466|FG002|Phase A|Lost to Follow-up|0|||
143022577|NCT02196506|515623467|FG003|Phase A|Lost to Follow-up|0|||
143022578|NCT02196506|515623464|FG000|Phase A|Protocol deviation|12|||
143022579|NCT02196506|515623465|FG001|Phase A|Protocol deviation|0|||
143022580|NCT02196506|515623466|FG002|Phase A|Protocol deviation|0|||
143022581|NCT02196506|515623467|FG003|Phase A|Protocol deviation|0|||
143022582|NCT02196506|515623464|FG000|Phase A|Participant withdrawn by investigator|10|||
143022583|NCT02196506|515623465|FG001|Phase A|Participant withdrawn by investigator|0|||
143022584|NCT02196506|515623466|FG002|Phase A|Participant withdrawn by investigator|0|||
143022585|NCT02196506|515623467|FG003|Phase A|Participant withdrawn by investigator|0|||
143486417|NCT00805480|517324680|FG002|Overall Study|Adverse Event|1|||
143486418|NCT00805480|517324681|FG003|Overall Study|Adverse Event|0|||
143486419|NCT01534533|517324682|FG000|Overall Study|Lost to Follow-up|3|||
143022586|NCT02196506|515623464|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
143022587|NCT02196506|515623465|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
143022588|NCT02196506|515623466|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
143235565|NCT05632211|516413620|FG001|Overall Study|Other reasons|1|||
143235566|NCT05632211|516413621|FG002|Overall Study|Other reasons|1|||
143363730|NCT05296629|516875426|FG002|Overall Study|Protocol Violation|0|||
143486420|NCT01534533|517324683|FG001|Overall Study|Lost to Follow-up|0|||
143486421|NCT01534533|517324684|FG002|Overall Study|Lost to Follow-up|4|||
143486422|NCT01534533|517324685|FG003|Overall Study|Lost to Follow-up|3|||
143486423|NCT01534533|517324682|FG000|Overall Study|Withdrawal by Subject|5|||
143022589|NCT02196506|515623467|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
143022590|NCT02196506|515623464|FG000|Phase B|Lack of Efficacy|0|||
143022591|NCT02196506|515623465|FG001|Phase B|Lack of Efficacy|1|||
143022592|NCT02196506|515623466|FG002|Phase B|Lack of Efficacy|2|||
143022593|NCT02196506|515623467|FG003|Phase B|Lack of Efficacy|0|||
143022594|NCT02196506|515623464|FG000|Phase B|Withdrawal by Participant|0|||
143022595|NCT02196506|515623465|FG001|Phase B|Withdrawal by Participant|8|||
143022596|NCT02196506|515623466|FG002|Phase B|Withdrawal by Participant|1|||
143022597|NCT02196506|515623467|FG003|Phase B|Withdrawal by Participant|0|||
143022598|NCT02196506|515623464|FG000|Phase B|Adverse Event|0|||
143022599|NCT02196506|515623465|FG001|Phase B|Adverse Event|4|||
143022600|NCT02196506|515623466|FG002|Phase B|Adverse Event|1|||
143022601|NCT02196506|515623467|FG003|Phase B|Adverse Event|0|||
143022602|NCT02196506|515623464|FG000|Phase B|Lost to Follow-up|0|||
143022603|NCT02196506|515623465|FG001|Phase B|Lost to Follow-up|2|||
143022604|NCT02196506|515623466|FG002|Phase B|Lost to Follow-up|1|||
143022605|NCT02196506|515623467|FG003|Phase B|Lost to Follow-up|0|||
143022606|NCT02196506|515623464|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
143022607|NCT02196506|515623465|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
143022608|NCT02196506|515623466|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
143022609|NCT02196506|515623467|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
143022610|NCT02196506|515623464|FG000|Phase A+|Withdrawal by Participant|0|||
143022611|NCT02196506|515623465|FG001|Phase A+|Withdrawal by Participant|0|||
143022612|NCT02196506|515623466|FG002|Phase A+|Withdrawal by Participant|0|||
143022613|NCT02196506|515623467|FG003|Phase A+|Withdrawal by Participant|5|||
143022614|NCT02196506|515623464|FG000|Phase A+|Adverse Event|0|||
143022615|NCT02196506|515623465|FG001|Phase A+|Adverse Event|0|||
143022616|NCT02196506|515623466|FG002|Phase A+|Adverse Event|0|||
143022617|NCT02196506|515623467|FG003|Phase A+|Adverse Event|1|||
143022618|NCT02196506|515623464|FG000|Phase A+|Lost to Follow-up|0|||
143022619|NCT02196506|515623465|FG001|Phase A+|Lost to Follow-up|0|||
143022620|NCT02196506|515623466|FG002|Phase A+|Lost to Follow-up|0|||
143022621|NCT02196506|515623467|FG003|Phase A+|Lost to Follow-up|6|||
143022622|NCT02196506|515623464|FG000|Phase A+|Participant withdrawn by investigator|0|||
143022623|NCT02196506|515623465|FG001|Phase A+|Participant withdrawn by investigator|0|||
143022624|NCT02196506|515623466|FG002|Phase A+|Participant withdrawn by investigator|0|||
143022625|NCT02196506|515623467|FG003|Phase A+|Participant withdrawn by investigator|1|||
143022626|NCT01606137|515623468|FG000|Overall Study|Adverse Event|85|||
143022627|NCT01606137|515623468|FG000|Overall Study|Withdrawal by Subject|74|||
143022628|NCT01606137|515623468|FG000|Overall Study|Lack of Efficacy|56|||
143022629|NCT01606137|515623468|FG000|Overall Study|Lost to Follow-up|15|||
143022630|NCT01606137|515623468|FG000|Overall Study|Protocol Violation|1|||
143022631|NCT01606137|515623468|FG000|Overall Study|Patient non-compliance|9|||
143022632|NCT01606137|515623468|FG000|Overall Study|Death|1|||
143022633|NCT01606137|515623468|FG000|Overall Study|Decreased/no pain|4|||
143022634|NCT01606137|515623468|FG000|Overall Study|Issues with driving|4|||
143022635|NCT01606137|515623468|FG000|Overall Study|multiple sclerosis less stable|1|||
143022636|NCT01606137|515623468|FG000|Overall Study|Increased bilirubin|1|||
143022637|NCT01606137|515623468|FG000|Overall Study|Spray causes nausea|1|||
143022638|NCT01606137|515623468|FG000|Overall Study|Not enough improvement|4|||
143022639|NCT01606137|515623468|FG000|Overall Study|Wanted to try another treatment|1|||
143022640|NCT01606137|515623468|FG000|Overall Study|Patient leaving country|1|||
143022641|NCT01606137|515623468|FG000|Overall Study|Personal reasons|1|||
143156243|NCT00986232|516117455|FG003|Overall Study|Protocol Violation|1|||
143156244|NCT00986232|516117452|FG000|Overall Study|Withdrawal by Subject|13|||
143156245|NCT00986232|516117453|FG001|Overall Study|Withdrawal by Subject|16|||
143156246|NCT00986232|516117454|FG002|Overall Study|Withdrawal by Subject|12|||
143156247|NCT00986232|516117455|FG003|Overall Study|Withdrawal by Subject|3|||
143156248|NCT00986232|516117452|FG000|Overall Study|Missed one or more bleeds|13|||
143156249|NCT00986232|516117453|FG001|Overall Study|Missed one or more bleeds|10|||
143156250|NCT00986232|516117454|FG002|Overall Study|Missed one or more bleeds|6|||
143156251|NCT00986232|516117455|FG003|Overall Study|Missed one or more bleeds|7|||
143022642|NCT01606137|515623468|FG000|Overall Study|Unable to tolerate study med. taste|1|||
143022643|NCT01606137|515623468|FG000|Overall Study|Patient moving|1|||
143022644|NCT01606137|515623468|FG000|Overall Study|Unable to collect consistent data|1|||
143022645|NCT00720798|515625596|FG000|Overall Study|Adverse Event|304|||
143156252|NCT00986232|516117452|FG000|Overall Study|Incomplete safety follow-up|3|||
143156253|NCT00986232|516117453|FG001|Overall Study|Incomplete safety follow-up|7|||
143156254|NCT00986232|516117454|FG002|Overall Study|Incomplete safety follow-up|2|||
143022646|NCT00720798|515625596|FG000|Overall Study|Death|39|||
143156255|NCT00986232|516117455|FG003|Overall Study|Incomplete safety follow-up|2|||
143156256|NCT01433978|516117461|FG000|Core Study|Adverse Event, Non-Fatal|0|||
143156257|NCT01433978|516117462|FG001|Core Study|Adverse Event, Non-Fatal|1|||
143022647|NCT00720798|515625596|FG000|Overall Study|Insufficient Therapeutic Response|129|||
143022648|NCT00720798|515625596|FG000|Overall Study|Protocol Violation|4|||
143022649|NCT00720798|515625596|FG000|Overall Study|Refused Treatment|151|||
143022650|NCT00720798|515625596|FG000|Overall Study|Failure to Return|46|||
143022651|NCT00720798|515625596|FG000|Overall Study|Reason not Specified|83|||
143486424|NCT01534533|517324683|FG001|Overall Study|Withdrawal by Subject|3|||
143486425|NCT01534533|517324684|FG002|Overall Study|Withdrawal by Subject|4|||
143486426|NCT01534533|517324685|FG003|Overall Study|Withdrawal by Subject|1|||
143486427|NCT04311502|517326458|FG000|Overall Study|Death|1|||
143486428|NCT04311502|517326459|FG001|Overall Study|Death|1|||
143486429|NCT04311502|517326460|FG002|Overall Study|Death|1|||
143486430|NCT04311502|517326458|FG000|Overall Study|Lost to Follow-up|2|||
143486431|NCT04311502|517326459|FG001|Overall Study|Lost to Follow-up|3|||
143486432|NCT04311502|517326460|FG002|Overall Study|Lost to Follow-up|0|||
143486433|NCT04311502|517326458|FG000|Overall Study|Participant is in prison|1|||
143486434|NCT04311502|517326459|FG001|Overall Study|Participant is in prison|0|||
143486435|NCT04311502|517326460|FG002|Overall Study|Participant is in prison|0|||
143486436|NCT04311502|517326458|FG000|Overall Study|Participant moved out of country|1|||
143486437|NCT04311502|517326459|FG001|Overall Study|Participant moved out of country|0|||
143486438|NCT04311502|517326460|FG002|Overall Study|Participant moved out of country|0|||
143486439|NCT04311502|517326458|FG000|Overall Study|Withdrawal by Subject|2|||
143486440|NCT04311502|517326459|FG001|Overall Study|Withdrawal by Subject|0|||
143486441|NCT04311502|517326460|FG002|Overall Study|Withdrawal by Subject|0|||
143486442|NCT04311502|517326458|FG000|Overall Study|DSMB Mandated Extension of follow-up|29|||
143486443|NCT04311502|517326459|FG001|Overall Study|DSMB Mandated Extension of follow-up|0|||
143486444|NCT04311502|517326460|FG002|Overall Study|DSMB Mandated Extension of follow-up|0|||
143486445|NCT03040999|517326461|FG000|Overall Study|Lost to Follow-up|2|||
143486446|NCT03040999|517326462|FG001|Overall Study|Lost to Follow-up|2|||
143486447|NCT03040999|517326461|FG000|Overall Study|Withdrawal by Subject|12|||
143486448|NCT03040999|517326462|FG001|Overall Study|Withdrawal by Subject|13|||
143486449|NCT03040999|517326461|FG000|Overall Study|Death|155|||
143486450|NCT03040999|517326462|FG001|Overall Study|Death|171|||
143156258|NCT01433978|516117463|FG002|Core Study|Adverse Event, Non-Fatal|0|||
143156259|NCT01433978|516117461|FG000|Core Study|Lack of Efficacy|5|||
143486451|NCT03040999|517326461|FG000|Overall Study|Physician Decision|0|||
143486452|NCT03040999|517326462|FG001|Overall Study|Physician Decision|3|||
143486453|NCT00880893|517326465|FG000|Overall Study|Protocol Violation|13|||
143486454|NCT00880893|517326466|FG001|Overall Study|Protocol Violation|1|||
143486455|NCT00880893|517326465|FG000|Overall Study|Withdrawal by Subject|15|||
143486456|NCT00880893|517326466|FG001|Overall Study|Withdrawal by Subject|11|||
143486457|NCT00880893|517326465|FG000|Overall Study|Lost to Follow-up|76|||
143486458|NCT00880893|517326466|FG001|Overall Study|Lost to Follow-up|33|||
143486459|NCT00880893|517326465|FG000|Overall Study|Serious adverse event|3|||
143486460|NCT00880893|517326466|FG001|Overall Study|Serious adverse event|0|||
143486461|NCT01783678|517326467|FG000|Overall Study|Randomized but Not Treated|0|||
143486462|NCT01783678|517326468|FG001|Overall Study|Randomized but Not Treated|0|||
143486463|NCT01783678|517326469|FG002|Overall Study|Randomized but Not Treated|0|||
143486464|NCT01783678|517326470|FG003|Overall Study|Randomized but Not Treated|1|||
143486465|NCT01783678|517326471|FG004|Overall Study|Randomized but Not Treated|0|||
143486466|NCT01783678|517326472|FG005|Overall Study|Randomized but Not Treated|0|||
143486467|NCT01783678|517326467|FG000|Overall Study|Lack of Efficacy|1|||
143486468|NCT01783678|517326468|FG001|Overall Study|Lack of Efficacy|13|||
143486469|NCT01783678|517326469|FG002|Overall Study|Lack of Efficacy|1|||
143486470|NCT01783678|517326470|FG003|Overall Study|Lack of Efficacy|3|||
143486471|NCT01783678|517326471|FG004|Overall Study|Lack of Efficacy|6|||
143486472|NCT01783678|517326472|FG005|Overall Study|Lack of Efficacy|5|||
143486473|NCT01783678|517326467|FG000|Overall Study|Lost to Follow-up|0|||
143486474|NCT01783678|517326468|FG001|Overall Study|Lost to Follow-up|4|||
143486475|NCT01783678|517326469|FG002|Overall Study|Lost to Follow-up|0|||
143486476|NCT01783678|517326470|FG003|Overall Study|Lost to Follow-up|2|||
143156260|NCT01433978|516117462|FG001|Core Study|Lack of Efficacy|1|||
143156261|NCT01433978|516117463|FG002|Core Study|Lack of Efficacy|0|||
143156262|NCT01433978|516117461|FG000|Core Study|Study Terminated by Sponsor|6|||
143156263|NCT01433978|516117462|FG001|Core Study|Study Terminated by Sponsor|9|||
143156264|NCT01433978|516117463|FG002|Core Study|Study Terminated by Sponsor|0|||
143235567|NCT05417438|516413622|FG000|Overall Study|Withdrawal by Subject|3|||
143486477|NCT01783678|517326471|FG004|Overall Study|Lost to Follow-up|1|||
143486478|NCT01783678|517326472|FG005|Overall Study|Lost to Follow-up|0|||
143156265|NCT01433978|516117461|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
143156266|NCT01433978|516117462|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
143486479|NCT01783678|517326467|FG000|Overall Study|Withdrew Consent|1|||
143486480|NCT01783678|517326468|FG001|Overall Study|Withdrew Consent|1|||
143486481|NCT01783678|517326469|FG002|Overall Study|Withdrew Consent|0|||
143486482|NCT01783678|517326470|FG003|Overall Study|Withdrew Consent|2|||
143486483|NCT01783678|517326471|FG004|Overall Study|Withdrew Consent|0|||
143486484|NCT01783678|517326472|FG005|Overall Study|Withdrew Consent|0|||
143486485|NCT00112905|517326473|FG000|Overall Study|Adverse Event|4|||
143486486|NCT00112905|517326473|FG000|Overall Study|Death|1|||
143486487|NCT00112905|517326473|FG000|Overall Study|Ineligibility|5|||
143486488|NCT00112905|517326473|FG000|Overall Study|Alternative treatment|1|||
143486489|NCT00112905|517326473|FG000|Overall Study|performance status was deteiorating|1|||
143156267|NCT01433978|516117463|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
143486490|NCT02600507|517326474|FG000|Overall Study|Adverse Event|3|||
143022652|NCT00433381|515625597|FG000|Overall Study|Ineligible / no protocol treatment|3|||
143022653|NCT00433381|515625598|FG001|Overall Study|Ineligible / no protocol treatment|3|||
143022654|NCT02806232|515625599|FG000|Overall Study|Lost to Follow-up|1|||
143022655|NCT02806232|515625600|FG001|Overall Study|Lost to Follow-up|2|||
143022656|NCT02806232|515625601|FG002|Overall Study|Lost to Follow-up|1|||
143022657|NCT02806232|515625602|FG003|Overall Study|Lost to Follow-up|0|||
143022658|NCT02806232|515625603|FG004|Overall Study|Lost to Follow-up|0|||
143022659|NCT02806232|515625604|FG005|Overall Study|Lost to Follow-up|1|||
143022660|NCT02806232|515625605|FG006|Overall Study|Lost to Follow-up|0|||
143022661|NCT02806232|515625606|FG007|Overall Study|Lost to Follow-up|0|||
143022662|NCT02806232|515625607|FG008|Overall Study|Lost to Follow-up|0|||
143022663|NCT02806232|515625599|FG000|Overall Study|Withdrawal by Subject|0|||
143022664|NCT02806232|515625600|FG001|Overall Study|Withdrawal by Subject|2|||
143022665|NCT02806232|515625601|FG002|Overall Study|Withdrawal by Subject|0|||
143022666|NCT02806232|515625602|FG003|Overall Study|Withdrawal by Subject|0|||
143022667|NCT02806232|515625603|FG004|Overall Study|Withdrawal by Subject|2|||
143022668|NCT02806232|515625604|FG005|Overall Study|Withdrawal by Subject|1|||
143022669|NCT02806232|515625605|FG006|Overall Study|Withdrawal by Subject|0|||
143022670|NCT02806232|515625606|FG007|Overall Study|Withdrawal by Subject|0|||
143022671|NCT02806232|515625607|FG008|Overall Study|Withdrawal by Subject|0|||
143022672|NCT01133821|515625608|FG000|Overall Study|Lost to Follow-up|8|||
143156268|NCT01433978|516117461|FG000|Extension Phase|Lack of Efficacy|0|||
143156269|NCT01433978|516117462|FG001|Extension Phase|Lack of Efficacy|0|||
143156270|NCT01433978|516117463|FG002|Extension Phase|Lack of Efficacy|1|||
143156271|NCT01433978|516117461|FG000|Extension Phase|Study Terminated by Sponsor|0|||
143156272|NCT01433978|516117462|FG001|Extension Phase|Study Terminated by Sponsor|0|||
143156273|NCT01433978|516117463|FG002|Extension Phase|Study Terminated by Sponsor|4|||
143156274|NCT00976391|516117464|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
143156275|NCT00976391|516117465|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
143156276|NCT00976391|516117464|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
143156277|NCT00976391|516117465|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
143156278|NCT00976391|516117464|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
143156279|NCT00976391|516117465|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
143156280|NCT00976391|516117464|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
143156281|NCT00976391|516117465|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
143156282|NCT00976391|516117464|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
143156283|NCT00976391|516117465|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
143156284|NCT00976391|516117464|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
143156285|NCT00976391|516117465|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
143156286|NCT00976391|516117464|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
143156287|NCT00976391|516117465|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
143156288|NCT00976391|516117464|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
143156289|NCT00976391|516117465|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
143156290|NCT00976391|516117464|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
143156291|NCT00976391|516117465|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
143156292|NCT00976391|516117464|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
143156293|NCT00976391|516117465|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
143156294|NCT00976391|516117464|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
143156295|NCT00976391|516117465|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
143156296|NCT00976391|516117464|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
143156297|NCT00976391|516117465|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
143156298|NCT00976391|516117464|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
143156299|NCT00976391|516117465|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
143156300|NCT00976391|516117464|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
143156301|NCT00976391|516117465|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
143156302|NCT02565186|516117466|FG000|Overall Study|Adverse Event|113|||
143156303|NCT02565186|516117467|FG001|Overall Study|Adverse Event|148|||
143156304|NCT02565186|516117466|FG000|Overall Study|Lost to Follow-up|102|||
143156305|NCT02565186|516117467|FG001|Overall Study|Lost to Follow-up|93|||
143022673|NCT01133821|515625609|FG001|Overall Study|Lost to Follow-up|11|||
143022674|NCT01133821|515625608|FG000|Overall Study|Withdrawal by Subject|8|||
143156306|NCT02565186|516117466|FG000|Overall Study|Non-Compliance|57|||
143156307|NCT02565186|516117467|FG001|Overall Study|Non-Compliance|55|||
143156308|NCT02565186|516117466|FG000|Overall Study|Withdrawal by Subject|229|||
143156309|NCT02565186|516117467|FG001|Overall Study|Withdrawal by Subject|214|||
143156310|NCT02565186|516117466|FG000|Overall Study|Physician Decision|18|||
143022675|NCT01133821|515625609|FG001|Overall Study|Withdrawal by Subject|3|||
143022676|NCT01133821|515625608|FG000|Overall Study|preferred other treatment|1|||
143022677|NCT01133821|515625609|FG001|Overall Study|preferred other treatment|1|||
143156311|NCT02565186|516117467|FG001|Overall Study|Physician Decision|16|||
143156312|NCT02565186|516117466|FG000|Overall Study|Sponsor Request|5|||
143156313|NCT02565186|516117467|FG001|Overall Study|Sponsor Request|9|||
143156314|NCT02565186|516117466|FG000|Overall Study|Missing|1|||
143156315|NCT02565186|516117467|FG001|Overall Study|Missing|0|||
143156316|NCT02565186|516117466|FG000|Overall Study|Did Not Receive Study Drug|55|||
143022678|NCT01133821|515625608|FG000|Overall Study|Protocol Violation|0|||
143022679|NCT01133821|515625609|FG001|Overall Study|Protocol Violation|1|||
143022680|NCT01133821|515625608|FG000|Overall Study|Refused participation|1|||
143022681|NCT01133821|515625609|FG001|Overall Study|Refused participation|3|||
143022682|NCT00434161|515625612|FG000|Overall Study|Adverse Event|5|||
143022683|NCT00434161|515625613|FG001|Overall Study|Adverse Event|1|||
143022684|NCT00434161|515625614|FG002|Overall Study|Adverse Event|4|||
143022685|NCT00434161|515625612|FG000|Overall Study|Lost to Follow-up|0|||
143022686|NCT00434161|515625613|FG001|Overall Study|Lost to Follow-up|1|||
143022687|NCT00434161|515625614|FG002|Overall Study|Lost to Follow-up|0|||
143022688|NCT00434161|515625612|FG000|Overall Study|Death|1|||
143022689|NCT00434161|515625613|FG001|Overall Study|Death|0|||
143022690|NCT00434161|515625614|FG002|Overall Study|Death|1|||
143022691|NCT00434161|515625612|FG000|Overall Study|Non-Compliance|1|||
143022692|NCT00434161|515625613|FG001|Overall Study|Non-Compliance|1|||
143022693|NCT00434161|515625614|FG002|Overall Study|Non-Compliance|0|||
143022694|NCT00434161|515625612|FG000|Overall Study|Withdrawal by Subject|2|||
143022695|NCT00434161|515625613|FG001|Overall Study|Withdrawal by Subject|0|||
143022696|NCT00434161|515625614|FG002|Overall Study|Withdrawal by Subject|3|||
143022697|NCT00434161|515625612|FG000|Overall Study|Logistical error study assessments|1|||
143022698|NCT00434161|515625613|FG001|Overall Study|Logistical error study assessments|0|||
143022699|NCT00434161|515625614|FG002|Overall Study|Logistical error study assessments|3|||
143022700|NCT03342898|515625615|FG000|Overall Study|Adverse Event|3|||
143022701|NCT03342898|515625616|FG001|Overall Study|Adverse Event|1|||
143022702|NCT03342898|515625617|FG002|Overall Study|Adverse Event|0|||
143022703|NCT03342898|515625615|FG000|Overall Study|Lost to Follow-up|44|||
143022704|NCT03342898|515625616|FG001|Overall Study|Lost to Follow-up|40|||
143022705|NCT03342898|515625617|FG002|Overall Study|Lost to Follow-up|42|||
143022706|NCT03342898|515625615|FG000|Overall Study|Withdrawal of Consent|5|||
143022707|NCT03342898|515625616|FG001|Overall Study|Withdrawal of Consent|9|||
143022708|NCT03342898|515625617|FG002|Overall Study|Withdrawal of Consent|11|||
143022709|NCT03342898|515625615|FG000|Overall Study|Death|0|||
143022710|NCT03342898|515625616|FG001|Overall Study|Death|1|||
143022711|NCT03342898|515625617|FG002|Overall Study|Death|1|||
143022712|NCT03342898|515625615|FG000|Overall Study|Reason not Specified|2|||
143022713|NCT03342898|515625616|FG001|Overall Study|Reason not Specified|2|||
143022714|NCT03342898|515625617|FG002|Overall Study|Reason not Specified|0|||
143022715|NCT01387282|515625618|FG000|Overall Study|Death|47|||
143022716|NCT01387282|515625619|FG001|Overall Study|Death|16|||
143022717|NCT01387282|515625618|FG000|Overall Study|Other|5|||
143022718|NCT01387282|515625619|FG001|Overall Study|Other|1|||
143022719|NCT01387282|515625618|FG000|Overall Study|Unrelated AE|6|||
143022720|NCT01387282|515625619|FG001|Overall Study|Unrelated AE|4|||
143022721|NCT01387282|515625618|FG000|Overall Study|Withdrawal by patient|33|||
143022722|NCT01387282|515625619|FG001|Overall Study|Withdrawal by patient|23|||
143022723|NCT01387282|515625618|FG000|Overall Study|Study drug-related AE|2|||
143022724|NCT01387282|515625619|FG001|Overall Study|Study drug-related AE|2|||
143022725|NCT01387282|515625618|FG000|Overall Study|Lost to Follow-up|4|||
143022726|NCT01387282|515625619|FG001|Overall Study|Lost to Follow-up|1|||
143022727|NCT03997448|515625622|FG000|Study Treatment|Disease Progression|1|||
143022728|NCT03997448|515625622|FG000|Study Treatment|Symptomatic Deterioration|1|||
143022729|NCT03997448|515625622|FG000|Follow up|Death|2|||
143022730|NCT03997448|515625622|FG000|Follow up|study terminated|1|||
143022731|NCT01621490|515625623|FG000|Overall Study|Subject no longer meets study criteria|0|||
143022732|NCT01621490|515625624|FG001|Overall Study|Subject no longer meets study criteria|0|||
143022733|NCT01621490|515625625|FG002|Overall Study|Subject no longer meets study criteria|0|||
143022734|NCT01621490|515625626|FG003|Overall Study|Subject no longer meets study criteria|0|||
143022735|NCT01621490|515625627|FG004|Overall Study|Subject no longer meets study criteria|1|||
143022736|NCT01621490|515625628|FG005|Overall Study|Subject no longer meets study criteria|0|||
143022737|NCT01621490|515625629|FG006|Overall Study|Subject no longer meets study criteria|0|||
143022738|NCT01621490|515625630|FG007|Overall Study|Subject no longer meets study criteria|0|||
143022739|NCT01621490|515625631|FG008|Overall Study|Subject no longer meets study criteria|0|||
143022740|NCT01621490|515625632|FG009|Overall Study|Subject no longer meets study criteria|0|||
143022741|NCT01621490|515625633|FG010|Overall Study|Subject no longer meets study criteria|0|||
143022742|NCT01621490|515625623|FG000|Overall Study|Maximum clinical benefit|3|||
143022743|NCT01621490|515625624|FG001|Overall Study|Maximum clinical benefit|2|||
143022744|NCT01621490|515625625|FG002|Overall Study|Maximum clinical benefit|0|||
143022745|NCT01621490|515625626|FG003|Overall Study|Maximum clinical benefit|0|||
143022746|NCT01621490|515625627|FG004|Overall Study|Maximum clinical benefit|0|||
143022747|NCT01621490|515625628|FG005|Overall Study|Maximum clinical benefit|0|||
143235568|NCT00321620|516415055|FG000|Overall Study|Death|269|||
143022748|NCT01621490|515625629|FG006|Overall Study|Maximum clinical benefit|1|||
143022749|NCT01621490|515625630|FG007|Overall Study|Maximum clinical benefit|2|||
143022750|NCT01621490|515625631|FG008|Overall Study|Maximum clinical benefit|2|||
143022751|NCT01621490|515625632|FG009|Overall Study|Maximum clinical benefit|0|||
143022752|NCT01621490|515625633|FG010|Overall Study|Maximum clinical benefit|0|||
143022753|NCT01621490|515625623|FG000|Overall Study|Withdrawal by Subject|1|||
143022754|NCT01621490|515625624|FG001|Overall Study|Withdrawal by Subject|0|||
143022755|NCT01621490|515625625|FG002|Overall Study|Withdrawal by Subject|0|||
143022756|NCT01621490|515625626|FG003|Overall Study|Withdrawal by Subject|0|||
143022757|NCT01621490|515625627|FG004|Overall Study|Withdrawal by Subject|0|||
143022758|NCT01621490|515625628|FG005|Overall Study|Withdrawal by Subject|1|||
143022759|NCT01621490|515625629|FG006|Overall Study|Withdrawal by Subject|0|||
143022760|NCT01621490|515625630|FG007|Overall Study|Withdrawal by Subject|0|||
143022761|NCT01621490|515625631|FG008|Overall Study|Withdrawal by Subject|0|||
143022762|NCT01621490|515625632|FG009|Overall Study|Withdrawal by Subject|0|||
143022763|NCT01621490|515625633|FG010|Overall Study|Withdrawal by Subject|0|||
143022764|NCT01621490|515625623|FG000|Overall Study|Subject request to discontinue study|1|||
143022765|NCT01621490|515625624|FG001|Overall Study|Subject request to discontinue study|3|||
143022766|NCT01621490|515625625|FG002|Overall Study|Subject request to discontinue study|1|||
143022767|NCT01621490|515625626|FG003|Overall Study|Subject request to discontinue study|1|||
143022768|NCT01621490|515625627|FG004|Overall Study|Subject request to discontinue study|0|||
143022769|NCT01621490|515625628|FG005|Overall Study|Subject request to discontinue study|2|||
143022770|NCT01621490|515625629|FG006|Overall Study|Subject request to discontinue study|1|||
143022771|NCT01621490|515625630|FG007|Overall Study|Subject request to discontinue study|0|||
143022772|NCT01621490|515625631|FG008|Overall Study|Subject request to discontinue study|1|||
143022773|NCT01621490|515625632|FG009|Overall Study|Subject request to discontinue study|0|||
143022774|NCT01621490|515625633|FG010|Overall Study|Subject request to discontinue study|0|||
143022775|NCT01621490|515625623|FG000|Overall Study|Adverse event unrelated to study drug|1|||
143022776|NCT01621490|515625624|FG001|Overall Study|Adverse event unrelated to study drug|1|||
143022777|NCT01621490|515625625|FG002|Overall Study|Adverse event unrelated to study drug|0|||
143022778|NCT01621490|515625626|FG003|Overall Study|Adverse event unrelated to study drug|0|||
143022779|NCT01621490|515625627|FG004|Overall Study|Adverse event unrelated to study drug|0|||
143022780|NCT01621490|515625628|FG005|Overall Study|Adverse event unrelated to study drug|0|||
143022781|NCT01621490|515625629|FG006|Overall Study|Adverse event unrelated to study drug|0|||
143022782|NCT01621490|515625630|FG007|Overall Study|Adverse event unrelated to study drug|2|||
143022783|NCT01621490|515625631|FG008|Overall Study|Adverse event unrelated to study drug|0|||
143022784|NCT01621490|515625632|FG009|Overall Study|Adverse event unrelated to study drug|0|||
143022785|NCT01621490|515625633|FG010|Overall Study|Adverse event unrelated to study drug|0|||
143022786|NCT01621490|515625623|FG000|Overall Study|Disease progression|27|||
143022787|NCT01621490|515625624|FG001|Overall Study|Disease progression|28|||
143235569|NCT00321620|516415056|FG001|Overall Study|Death|294|||
143235570|NCT00321620|516415055|FG000|Overall Study|Withdrawal by Subject|164|||
143235571|NCT00321620|516415056|FG001|Overall Study|Withdrawal by Subject|147|||
143235572|NCT00321620|516415055|FG000|Overall Study|Disease progression|113|||
143235573|NCT00321620|516415056|FG001|Overall Study|Disease progression|117|||
143235574|NCT00321620|516415055|FG000|Overall Study|Adverse Event|43|||
143235575|NCT00321620|516415056|FG001|Overall Study|Adverse Event|56|||
143235576|NCT00321620|516415055|FG000|Overall Study|Lost to Follow-up|13|||
143235577|NCT00321620|516415056|FG001|Overall Study|Lost to Follow-up|9|||
143235578|NCT00321620|516415055|FG000|Overall Study|Physician Decision|4|||
143235579|NCT00321620|516415056|FG001|Overall Study|Physician Decision|1|||
143235580|NCT00321620|516415055|FG000|Overall Study|Noncompliance|14|||
143235581|NCT00321620|516415056|FG001|Overall Study|Noncompliance|7|||
143235582|NCT00321620|516415055|FG000|Overall Study|Protocol deviation|4|||
143235583|NCT00321620|516415056|FG001|Overall Study|Protocol deviation|3|||
143235584|NCT00321620|516415055|FG000|Overall Study|Ineligibility determined|2|||
143235585|NCT00321620|516415056|FG001|Overall Study|Ineligibility determined|3|||
143235586|NCT00321620|516415055|FG000|Overall Study|Participant request|75|||
143235587|NCT00321620|516415056|FG001|Overall Study|Participant request|52|||
143235588|NCT00321620|516415055|FG000|Overall Study|Other|42|||
143486491|NCT02600507|517326475|FG001|Overall Study|Adverse Event|15|||
143486492|NCT02600507|517326476|FG002|Overall Study|Adverse Event|5|||
143235589|NCT00321620|516415056|FG001|Overall Study|Other|33|||
143235590|NCT03181932|516415057|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
143235591|NCT03181932|516415058|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
143235592|NCT03181932|516415057|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
143235593|NCT03181932|516415058|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
143235594|NCT03181932|516415057|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
143022788|NCT01621490|515625625|FG002|Overall Study|Disease progression|1|||
143022789|NCT01621490|515625626|FG003|Overall Study|Disease progression|5|||
143022790|NCT01621490|515625627|FG004|Overall Study|Disease progression|3|||
143022791|NCT01621490|515625628|FG005|Overall Study|Disease progression|8|||
143022792|NCT01621490|515625629|FG006|Overall Study|Disease progression|7|||
143022793|NCT01621490|515625630|FG007|Overall Study|Disease progression|1|||
143022794|NCT01621490|515625631|FG008|Overall Study|Disease progression|4|||
143022795|NCT01621490|515625632|FG009|Overall Study|Disease progression|1|||
143022796|NCT01621490|515625633|FG010|Overall Study|Disease progression|1|||
143235595|NCT03181932|516415058|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
143235596|NCT03181932|516415057|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
143486493|NCT02600507|517326474|FG000|Overall Study|Lack of Efficacy|3|||
143022797|NCT01621490|515625623|FG000|Overall Study|Study drug toxicity|1|||
143022798|NCT01621490|515625624|FG001|Overall Study|Study drug toxicity|4|||
143022799|NCT01621490|515625625|FG002|Overall Study|Study drug toxicity|5|||
143022800|NCT01621490|515625626|FG003|Overall Study|Study drug toxicity|3|||
143022801|NCT01621490|515625627|FG004|Overall Study|Study drug toxicity|1|||
143022802|NCT01621490|515625628|FG005|Overall Study|Study drug toxicity|10|||
143022803|NCT01621490|515625629|FG006|Overall Study|Study drug toxicity|1|||
143022804|NCT01621490|515625630|FG007|Overall Study|Study drug toxicity|4|||
143022805|NCT01621490|515625631|FG008|Overall Study|Study drug toxicity|1|||
143022806|NCT01621490|515625632|FG009|Overall Study|Study drug toxicity|0|||
143022807|NCT01621490|515625633|FG010|Overall Study|Study drug toxicity|0|||
143022808|NCT01621490|515625623|FG000|Overall Study|Death|0|||
143022809|NCT01621490|515625624|FG001|Overall Study|Death|0|||
143022810|NCT01621490|515625625|FG002|Overall Study|Death|0|||
143022811|NCT01621490|515625626|FG003|Overall Study|Death|0|||
143022812|NCT01621490|515625627|FG004|Overall Study|Death|0|||
143022813|NCT01621490|515625628|FG005|Overall Study|Death|0|||
143022814|NCT01621490|515625629|FG006|Overall Study|Death|0|||
143022815|NCT01621490|515625630|FG007|Overall Study|Death|0|||
143022816|NCT01621490|515625631|FG008|Overall Study|Death|1|||
143022817|NCT01621490|515625632|FG009|Overall Study|Death|0|||
143022818|NCT01621490|515625633|FG010|Overall Study|Death|0|||
143022819|NCT01621490|515625623|FG000|Overall Study|Other reasons|7|||
143022820|NCT01621490|515625624|FG001|Overall Study|Other reasons|6|||
143022821|NCT01621490|515625625|FG002|Overall Study|Other reasons|4|||
143022822|NCT01621490|515625626|FG003|Overall Study|Other reasons|1|||
143022823|NCT01621490|515625627|FG004|Overall Study|Other reasons|1|||
143022824|NCT01621490|515625628|FG005|Overall Study|Other reasons|3|||
143022825|NCT01621490|515625629|FG006|Overall Study|Other reasons|1|||
143022826|NCT01621490|515625630|FG007|Overall Study|Other reasons|1|||
143022827|NCT01621490|515625631|FG008|Overall Study|Other reasons|1|||
143022828|NCT01621490|515625632|FG009|Overall Study|Other reasons|0|||
143022829|NCT01621490|515625633|FG010|Overall Study|Other reasons|0|||
143022830|NCT00506753|515625634|FG000|Overall Study|Lost to Follow-up|21|||
143022831|NCT00506753|515625635|FG001|Overall Study|Lost to Follow-up|15|||
143022832|NCT00125359|515625636|FG000|Overall Study|Death|4|||
143156317|NCT02565186|516117467|FG001|Overall Study|Did Not Receive Study Drug|86|||
143156318|NCT02217982|516117468|FG000|Overall Study|Trial discontinued|1|||
143156319|NCT02217982|516117469|FG001|Overall Study|Trial discontinued|0|||
143156320|NCT02217982|516117468|FG000|Overall Study|Adverse Event|0|||
143156321|NCT02217982|516117469|FG001|Overall Study|Adverse Event|1|||
143156322|NCT02421510|516117470|FG000|Overall Study|Other|4|||
143156323|NCT02421510|516117471|FG001|Overall Study|Other|2|||
143156324|NCT02421510|516117472|FG002|Overall Study|Other|3|||
143156325|NCT02421510|516117470|FG000|Overall Study|Protocol Violation|1|||
143156326|NCT02421510|516117471|FG001|Overall Study|Protocol Violation|2|||
143156327|NCT02421510|516117472|FG002|Overall Study|Protocol Violation|0|||
143156328|NCT02421510|516117470|FG000|Overall Study|Death|1|||
143156329|NCT02421510|516117471|FG001|Overall Study|Death|0|||
143156330|NCT02421510|516117472|FG002|Overall Study|Death|0|||
143156331|NCT02421510|516117470|FG000|Overall Study|Noncompliance with study drug|1|||
143156332|NCT02421510|516117471|FG001|Overall Study|Noncompliance with study drug|0|||
143156333|NCT02421510|516117472|FG002|Overall Study|Noncompliance with study drug|0|||
143156334|NCT02421510|516117470|FG000|Overall Study|Physician Decision|1|||
143156335|NCT02421510|516117471|FG001|Overall Study|Physician Decision|1|||
143156336|NCT02421510|516117472|FG002|Overall Study|Physician Decision|3|||
143156337|NCT02421510|516117470|FG000|Overall Study|Adverse Event|9|||
143156338|NCT02421510|516117471|FG001|Overall Study|Adverse Event|10|||
143156339|NCT02421510|516117472|FG002|Overall Study|Adverse Event|18|||
143156340|NCT02421510|516117470|FG000|Overall Study|Pregnancy|1|||
143022833|NCT00125359|515625636|FG000|Overall Study|Adverse Event|5|||
143156341|NCT02421510|516117471|FG001|Overall Study|Pregnancy|1|||
143156342|NCT02421510|516117472|FG002|Overall Study|Pregnancy|0|||
143022834|NCT00125359|515625636|FG000|Overall Study|Physician Decision|14|||
143022835|NCT02451670|515625637|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
143022836|NCT02451670|515625638|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
143022837|NCT00461500|515625639|FG000|Overall Study|Adverse Event|1|||
143022838|NCT00461500|515625640|FG001|Overall Study|Adverse Event|0|||
143022839|NCT00461500|515625639|FG000|Overall Study|Lack of Efficacy|0|||
143022840|NCT00461500|515625640|FG001|Overall Study|Lack of Efficacy|1|||
143022841|NCT00461500|515625639|FG000|Overall Study|Expired Drug Treatment|1|||
143022842|NCT00461500|515625640|FG001|Overall Study|Expired Drug Treatment|1|||
143022843|NCT00461500|515625639|FG000|Overall Study|Study Stopped|1|||
143022844|NCT00461500|515625640|FG001|Overall Study|Study Stopped|2|||
143022845|NCT00461500|515625639|FG000|Overall Study|Drug Treatment Misuse|1|||
143156343|NCT02421510|516117470|FG000|Overall Study|Withdrawal by Subject|14|||
143156344|NCT02421510|516117471|FG001|Overall Study|Withdrawal by Subject|18|||
143156345|NCT02421510|516117472|FG002|Overall Study|Withdrawal by Subject|12|||
143156346|NCT02421510|516117470|FG000|Overall Study|Lost to Follow-up|1|||
143156347|NCT02421510|516117471|FG001|Overall Study|Lost to Follow-up|1|||
143156348|NCT02421510|516117472|FG002|Overall Study|Lost to Follow-up|0|||
143486494|NCT02600507|517326475|FG001|Overall Study|Lack of Efficacy|8|||
143486495|NCT02600507|517326476|FG002|Overall Study|Lack of Efficacy|5|||
143486496|NCT02600507|517326474|FG000|Overall Study|Lost to Follow-up|3|||
143486497|NCT02600507|517326475|FG001|Overall Study|Lost to Follow-up|5|||
143486498|NCT02600507|517326476|FG002|Overall Study|Lost to Follow-up|2|||
143486499|NCT02600507|517326474|FG000|Overall Study|Protocol Violation|12|||
143486500|NCT02600507|517326475|FG001|Overall Study|Protocol Violation|4|||
143486501|NCT02600507|517326476|FG002|Overall Study|Protocol Violation|4|||
143486502|NCT02600507|517326474|FG000|Overall Study|Physician Decision|1|||
143486503|NCT02600507|517326475|FG001|Overall Study|Physician Decision|0|||
143486504|NCT02600507|517326476|FG002|Overall Study|Physician Decision|1|||
143486505|NCT02600507|517326474|FG000|Overall Study|Withdrawal by Subject|7|||
143486506|NCT02600507|517326475|FG001|Overall Study|Withdrawal by Subject|11|||
143486507|NCT02600507|517326476|FG002|Overall Study|Withdrawal by Subject|7|||
143486508|NCT02600507|517326474|FG000|Overall Study|Other|0|||
143486509|NCT02600507|517326475|FG001|Overall Study|Other|1|||
143486510|NCT02600507|517326476|FG002|Overall Study|Other|1|||
143022846|NCT00461500|515625640|FG001|Overall Study|Drug Treatment Misuse|0|||
143022847|NCT00461500|515625639|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
143022848|NCT00461500|515625640|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
143022849|NCT00461500|515625639|FG000|Overall Study|Lost to Follow-up|2|||
143022850|NCT00461500|515625640|FG001|Overall Study|Lost to Follow-up|2|||
143156349|NCT02852434|516117473|FG000|Overall Study|Withdrawal by Subject|0|||
143156350|NCT02852434|516117474|FG001|Overall Study|Withdrawal by Subject|1|||
143156351|NCT02852434|516117473|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
143156352|NCT02852434|516117474|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
143486511|NCT04541004|517326481|FG000|Overall Study|Adverse Event|2|||
143022851|NCT02038634|515625645|FG000|Overall Study|Lost to Follow-up|0|||
143022852|NCT02038634|515625646|FG001|Overall Study|Lost to Follow-up|1|||
143022853|NCT01664052|515625647|FG000|Phase 1|No device placement|6|||
143022854|NCT01664052|515625648|FG001|Phase 1|No device placement|0|||
143022855|NCT01664052|515625647|FG000|Phase 1|No HSG 1 hr post placement|1|||
143022856|NCT01664052|515625648|FG001|Phase 1|No HSG 1 hr post placement|0|||
143022857|NCT01664052|515625647|FG000|Phase 2|No device placement|0|||
143022858|NCT01664052|515625648|FG001|Phase 2|No device placement|4|||
143022859|NCT01034137|515625656|FG000|Overall Study|Adverse Event|9|||
143022860|NCT01034137|515625657|FG001|Overall Study|Adverse Event|10|||
143022861|NCT01034137|515625658|FG002|Overall Study|Adverse Event|8|||
143022862|NCT01034137|515625656|FG000|Overall Study|Withdrawal by Subject|4|||
143022863|NCT01034137|515625657|FG001|Overall Study|Withdrawal by Subject|3|||
143022864|NCT01034137|515625658|FG002|Overall Study|Withdrawal by Subject|3|||
143022865|NCT01034137|515625656|FG000|Overall Study|Lack of Efficacy|9|||
143022866|NCT01034137|515625657|FG001|Overall Study|Lack of Efficacy|4|||
143022867|NCT01034137|515625658|FG002|Overall Study|Lack of Efficacy|13|||
143022868|NCT01034137|515625656|FG000|Overall Study|Protocol Violation|2|||
143022869|NCT01034137|515625657|FG001|Overall Study|Protocol Violation|2|||
143022870|NCT01034137|515625658|FG002|Overall Study|Protocol Violation|1|||
143022871|NCT01034137|515625656|FG000|Overall Study|Refused treatment or did not cooperate|2|||
143022872|NCT01034137|515625657|FG001|Overall Study|Refused treatment or did not cooperate|0|||
143022873|NCT01034137|515625658|FG002|Overall Study|Refused treatment or did not cooperate|1|||
143022874|NCT01034137|515625656|FG000|Overall Study|Administrative or other|2|||
143022875|NCT01034137|515625657|FG001|Overall Study|Administrative or other|3|||
143022876|NCT01034137|515625658|FG002|Overall Study|Administrative or other|4|||
143022877|NCT03572933|515625659|FG000|Overall Study|Adverse Event|4|||
143022878|NCT03572933|515625660|FG001|Overall Study|Adverse Event|1|||
143022879|NCT03572933|515625659|FG000|Overall Study|Withdrawal by Subject|0|||
143022880|NCT03572933|515625660|FG001|Overall Study|Withdrawal by Subject|1|||
143022881|NCT00387712|515625664|FG000|Overall Study|Physician Decision|6|||
143022882|NCT00387712|515625665|FG001|Overall Study|Physician Decision|4|||
143022883|NCT00387712|515625664|FG000|Overall Study|Lost to Follow-up|17|||
143022884|NCT00387712|515625665|FG001|Overall Study|Lost to Follow-up|20|||
143156353|NCT05987540|516117476|FG000|Overall Study|Withdrawal by Subject|2|||
143156354|NCT05987540|516117476|FG000|Overall Study|Death|1|||
143486512|NCT00605085|517326482|FG000|Overall Study|Withdrawal by Subject|8|||
143022885|NCT00387712|515625664|FG000|Overall Study|Withdrawal by Subject|6|||
143022886|NCT00387712|515625665|FG001|Overall Study|Withdrawal by Subject|12|||
143022887|NCT02040428|515625666|FG000|Overall Study|Death|4|||
143022888|NCT02040428|515625667|FG001|Overall Study|Death|3|||
143022889|NCT02040428|515625666|FG000|Overall Study|Withdrawal by Subject|1|||
143022890|NCT02040428|515625667|FG001|Overall Study|Withdrawal by Subject|1|||
143022891|NCT01772368|515625669|FG000|Overall Study|Adverse Event|1|||
143022892|NCT01772368|515625669|FG000|Overall Study|Withdrawal by Subject|3|||
143022893|NCT01772368|515625669|FG000|Overall Study|Protocol Violation|2|||
143156355|NCT05987540|516117476|FG000|Overall Study|Study Termination|1|||
143022894|NCT01772368|515625669|FG000|Overall Study|Other|1|||
143486513|NCT00605085|517326483|FG001|Overall Study|Withdrawal by Subject|5|||
143486514|NCT00605085|517326482|FG000|Overall Study|Adverse Event|9|||
143486515|NCT00605085|517326483|FG001|Overall Study|Adverse Event|5|||
143022895|NCT03347695|515625676|FG000|Overall Study|Death|0|||
143022896|NCT03347695|515625677|FG001|Overall Study|Death|4|||
143022897|NCT03347695|515625676|FG000|Overall Study|Lost to Follow-up|0|||
143022898|NCT03347695|515625677|FG001|Overall Study|Lost to Follow-up|1|||
143022899|NCT04633837|515625680|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
143022900|NCT04633837|515625681|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
143022901|NCT02668783|515625682|FG000|Overall Study|Pregnancy|0|||
143022902|NCT02668783|515625683|FG001|Overall Study|Pregnancy|1|||
143022903|NCT02668783|515625682|FG000|Overall Study|Protocol Violation|2|||
143022904|NCT02668783|515625683|FG001|Overall Study|Protocol Violation|1|||
143156356|NCT05987540|516117476|FG000|Overall Study|Adverse Event|2|||
143486516|NCT00605085|517326482|FG000|Overall Study|Pregnancy|2|||
143486517|NCT00605085|517326483|FG001|Overall Study|Pregnancy|0|||
143486518|NCT00605085|517326482|FG000|Overall Study|Protocol Violation|3|||
143486519|NCT00605085|517326483|FG001|Overall Study|Protocol Violation|2|||
143486520|NCT00605085|517326482|FG000|Overall Study|Lost to Follow-up|10|||
143486521|NCT00605085|517326483|FG001|Overall Study|Lost to Follow-up|5|||
143486522|NCT00605085|517326482|FG000|Overall Study|administrative reasons|18|||
143486523|NCT00605085|517326483|FG001|Overall Study|administrative reasons|8|||
143486524|NCT00621504|517326484|FG000|Overall Study|Adverse Event|1|||
143156357|NCT02061592|516117477|FG000|Period 1|Withdrawal by Subject|1|||
143156358|NCT02061592|516117478|FG001|Period 1|Withdrawal by Subject|0|||
143156359|NCT02061592|516117477|FG000|Period 1|Protocol Violation|1|||
143156360|NCT02061592|516117478|FG001|Period 1|Protocol Violation|0|||
143156361|NCT02061592|516117477|FG000|Period 2|Lost to Follow-up|0|||
143156362|NCT02061592|516117478|FG001|Period 2|Lost to Follow-up|1|||
143156363|NCT03338023|516117479|FG000|Overall Study|Withdrawal by Subject|3|||
143156364|NCT03338023|516117480|FG001|Overall Study|Withdrawal by Subject|4|||
143156365|NCT03338023|516117479|FG000|Overall Study|Protocol Violation|3|||
143156366|NCT03338023|516117480|FG001|Overall Study|Protocol Violation|3|||
143156367|NCT03338023|516117479|FG000|Overall Study|Lost to Follow-up|2|||
143156368|NCT03338023|516117480|FG001|Overall Study|Lost to Follow-up|1|||
143156369|NCT03338023|516117479|FG000|Overall Study|Physician Decision|1|||
143156370|NCT03338023|516117480|FG001|Overall Study|Physician Decision|2|||
143156371|NCT00685698|516117483|FG000|Overall Study|Withdrawal by Subject|1|||
143156372|NCT00685698|516117483|FG000|Overall Study|Protocol Violation|6|||
143156373|NCT00685698|516117483|FG000|Overall Study|Adverse Event|3|||
143156374|NCT00685698|516117483|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
143156375|NCT00685698|516117483|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
143156376|NCT00685698|516117483|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
143156377|NCT01149538|516117496|FG000|Overall Study|Lost to Follow-up|0|||
143156378|NCT01149538|516117497|FG001|Overall Study|Lost to Follow-up|1|||
143156379|NCT01149538|516117496|FG000|Overall Study|Withdrawal by Subject|5|||
143156380|NCT01149538|516117497|FG001|Overall Study|Withdrawal by Subject|3|||
143156381|NCT00888849|516117500|FG000|Overall Study|Death|4|||
143156382|NCT00888849|516117501|FG001|Overall Study|Death|7|||
143156383|NCT00888849|516117500|FG000|Overall Study|Lost to Follow-up|1|||
143156384|NCT00888849|516117501|FG001|Overall Study|Lost to Follow-up|2|||
143156385|NCT04576949|516117502|FG000|Overall Study|Adverse Event|1|||
143156386|NCT04576949|516117503|FG001|Overall Study|Adverse Event|3|||
143156387|NCT04576949|516117504|FG002|Overall Study|Adverse Event|2|||
143156388|NCT04576949|516117502|FG000|Overall Study|Withdrawal by Subject|41|||
143156389|NCT04576949|516117503|FG001|Overall Study|Withdrawal by Subject|26|||
143156390|NCT04576949|516117504|FG002|Overall Study|Withdrawal by Subject|18|||
143156391|NCT04576949|516117502|FG000|Overall Study|Physician Decision|3|||
143156392|NCT04576949|516117503|FG001|Overall Study|Physician Decision|0|||
143156393|NCT04576949|516117504|FG002|Overall Study|Physician Decision|0|||
143156394|NCT04576949|516117502|FG000|Overall Study|Death|0|||
143156395|NCT04576949|516117503|FG001|Overall Study|Death|1|||
143486525|NCT00621504|517326485|FG001|Overall Study|Adverse Event|3|||
143486526|NCT00621504|517326484|FG000|Overall Study|At the request of sponsor/investigator|1|||
143486527|NCT00621504|517326485|FG001|Overall Study|At the request of sponsor/investigator|0|||
143486528|NCT00621504|517326484|FG000|Overall Study|Withdrew consent|9|||
143486529|NCT00621504|517326485|FG001|Overall Study|Withdrew consent|6|||
143022905|NCT02668783|515625682|FG000|Overall Study|Study terminated by sponsor|9|||
143022906|NCT02668783|515625683|FG001|Overall Study|Study terminated by sponsor|10|||
143156396|NCT04576949|516117504|FG002|Overall Study|Death|0|||
143156397|NCT04576949|516117502|FG000|Overall Study|Lost to Follow-up|29|||
143156398|NCT04576949|516117503|FG001|Overall Study|Lost to Follow-up|37|||
143156399|NCT04576949|516117504|FG002|Overall Study|Lost to Follow-up|24|||
143156400|NCT04576949|516117502|FG000|Overall Study|Other, Not Specified|2|||
143156401|NCT04576949|516117503|FG001|Overall Study|Other, Not Specified|3|||
143235597|NCT03181932|516415058|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
143022907|NCT02668783|515625682|FG000|Overall Study|Subject moved|1|||
143156402|NCT04576949|516117504|FG002|Overall Study|Other, Not Specified|1|||
143156403|NCT04576949|516117502|FG000|Overall Study|Other|1|||
143156404|NCT04576949|516117503|FG001|Overall Study|Other|0|||
143486530|NCT00621504|517326484|FG000|Overall Study|Lost to Follow-up|8|||
143486531|NCT00621504|517326485|FG001|Overall Study|Lost to Follow-up|10|||
143022908|NCT02668783|515625683|FG001|Overall Study|Subject moved|0|||
143022909|NCT02668783|515625682|FG000|Overall Study|Withdrawal by Subject|1|||
143022910|NCT02668783|515625683|FG001|Overall Study|Withdrawal by Subject|0|||
143022911|NCT00112489|515625684|FG000|Overall Study|Refused further treatment|8|||
143022912|NCT00112489|515625684|FG000|Overall Study|Adverse Event|12|||
143022913|NCT00112489|515625684|FG000|Overall Study|Death|2|||
143022914|NCT00112489|515625684|FG000|Overall Study|Other, Not Specified|9|||
143022915|NCT00112489|515625684|FG000|Overall Study|Patient never treated|2|||
143022916|NCT00112489|515625684|FG000|Overall Study|Ineligible|7|||
143022917|NCT00268346|515625685|FG000|Overall Study|Adverse Event|0|||
143022918|NCT00268346|515625686|FG001|Overall Study|Adverse Event|1|||
143022919|NCT00268346|515625685|FG000|Overall Study|Death|0|||
143022920|NCT00268346|515625686|FG001|Overall Study|Death|1|||
143022921|NCT00268346|515625685|FG000|Overall Study|Withdrawal by Subject|0|||
143022922|NCT00268346|515625686|FG001|Overall Study|Withdrawal by Subject|1|||
143022923|NCT01799590|515625687|FG000|Overall Study|Adverse Event|13|||
143022924|NCT01799590|515625688|FG001|Overall Study|Adverse Event|7|||
143022925|NCT01799590|515625689|FG002|Overall Study|Adverse Event|5|||
143022926|NCT01799590|515625687|FG000|Overall Study|Pregnancy|2|||
143022927|NCT01799590|515625688|FG001|Overall Study|Pregnancy|0|||
143022928|NCT01799590|515625689|FG002|Overall Study|Pregnancy|0|||
143022929|NCT01799590|515625687|FG000|Overall Study|Lack of Efficacy|3|||
143022930|NCT01799590|515625688|FG001|Overall Study|Lack of Efficacy|1|||
143022931|NCT01799590|515625689|FG002|Overall Study|Lack of Efficacy|3|||
143022932|NCT01799590|515625687|FG000|Overall Study|Participants convenience|4|||
143022933|NCT01799590|515625688|FG001|Overall Study|Participants convenience|4|||
143022934|NCT01799590|515625689|FG002|Overall Study|Participants convenience|2|||
143022935|NCT01799590|515625687|FG000|Overall Study|Aggravation of complications|0|||
143022936|NCT01799590|515625688|FG001|Overall Study|Aggravation of complications|1|||
143022937|NCT01799590|515625689|FG002|Overall Study|Aggravation of complications|1|||
143022938|NCT01799590|515625687|FG000|Overall Study|Using drugs with restricted days of use|0|||
143022939|NCT01799590|515625688|FG001|Overall Study|Using drugs with restricted days of use|3|||
143022940|NCT01799590|515625689|FG002|Overall Study|Using drugs with restricted days of use|2|||
143022941|NCT01799590|515625687|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
143022942|NCT01799590|515625688|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
143022943|NCT01799590|515625689|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
143022944|NCT01799590|515625687|FG000|Overall Study|Other|3|||
143022945|NCT01799590|515625688|FG001|Overall Study|Other|0|||
143022946|NCT01799590|515625689|FG002|Overall Study|Other|1|||
143022947|NCT02043366|515625694|FG000|Overall Study|Lost to Follow-up|2|||
143022948|NCT02043366|515625695|FG001|Overall Study|Lost to Follow-up|2|||
143022949|NCT02043366|515625696|FG002|Overall Study|Lost to Follow-up|2|||
143022950|NCT02043366|515625697|FG003|Overall Study|Lost to Follow-up|2|||
143022951|NCT02043366|515625698|FG004|Overall Study|Lost to Follow-up|2|||
143022952|NCT02043366|515625699|FG005|Overall Study|Lost to Follow-up|2|||
143022953|NCT00294723|515625700|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
143022954|NCT00294723|515625701|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
143022955|NCT00294723|515625702|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
143022956|NCT00294723|515625700|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
143022957|NCT00294723|515625701|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
143022958|NCT00294723|515625702|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
143022959|NCT00294723|515625700|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
143022960|NCT00294723|515625701|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
143156405|NCT04576949|516117504|FG002|Overall Study|Other|0|||
143156406|NCT04584554|516117505|FG000|Overall Study|Withdrawal by Subject|2|||
143156407|NCT04584554|516117506|FG001|Overall Study|Withdrawal by Subject|2|||
143156408|NCT02583477|516117507|FG000|Overall Study|Adverse Event|0|||
143156409|NCT02583477|516117508|FG001|Overall Study|Adverse Event|2|||
143156410|NCT02583477|516117507|FG000|Overall Study|Death|1|||
143156411|NCT02583477|516117508|FG001|Overall Study|Death|16|||
143022961|NCT00294723|515625702|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
143156412|NCT02583477|516117507|FG000|Overall Study|Study terminated|2|||
143156413|NCT02583477|516117508|FG001|Overall Study|Study terminated|2|||
143156414|NCT00514917|516117509|FG000|Overall Study|Death|4|||
143156415|NCT00514917|516117510|FG001|Overall Study|Death|10|||
143022962|NCT00294723|515625700|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
143022963|NCT00294723|515625701|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
143022964|NCT00294723|515625702|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
143022965|NCT00294723|515625700|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
143022966|NCT00294723|515625701|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
143022967|NCT00294723|515625702|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
143022968|NCT00294723|515625700|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
143022969|NCT00294723|515625701|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
143022970|NCT00294723|515625702|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
143156416|NCT00514917|516117509|FG000|Overall Study|Protocol Violation|1|||
143156417|NCT00514917|516117510|FG001|Overall Study|Protocol Violation|0|||
143022971|NCT00294723|515625700|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
143022972|NCT00294723|515625701|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
143022973|NCT00294723|515625702|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
143022974|NCT00294723|515625700|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
143022975|NCT00294723|515625701|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
143022976|NCT00294723|515625702|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
143022977|NCT00294723|515625700|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
143022978|NCT00294723|515625701|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
143022979|NCT00294723|515625702|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
143022980|NCT00294723|515625700|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
143022981|NCT00294723|515625701|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
143022982|NCT00294723|515625702|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
143022983|NCT00294723|515625700|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
143022984|NCT00294723|515625701|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
143022985|NCT00294723|515625702|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
143022986|NCT00294723|515625700|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
143022987|NCT00294723|515625701|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
143022988|NCT00294723|515625702|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
143022989|NCT00752791|515625703|FG000|Overall Study|Adverse Event|7|||
143022990|NCT00752791|515625703|FG000|Overall Study|Withdrawal by Subject|1|||
143022991|NCT00752791|515625703|FG000|Overall Study|Physician Decision|1|||
143022992|NCT00752791|515625703|FG000|Overall Study|Death|1|||
143022993|NCT00752791|515625703|FG000|Overall Study|Renal transplant|3|||
143022994|NCT00752791|515625703|FG000|Overall Study|Switched to hemodialysis|2|||
143022995|NCT00752791|515625703|FG000|Overall Study|Protocol deviation|1|||
143022996|NCT01977092|515625704|FG000|Overall Study|Death|3|||
143022997|NCT01977092|515625705|FG001|Overall Study|Death|4|||
143022998|NCT01977092|515625704|FG000|Overall Study|Lost to Follow-up|23|||
143022999|NCT01977092|515625705|FG001|Overall Study|Lost to Follow-up|14|||
143023000|NCT01977092|515625704|FG000|Overall Study|Withdrawal by Subject|2|||
143023001|NCT01977092|515625705|FG001|Overall Study|Withdrawal by Subject|1|||
143023002|NCT01977092|515625704|FG000|Overall Study|In prison|3|||
143023003|NCT01977092|515625705|FG001|Overall Study|In prison|11|||
143023004|NCT00678392|515625706|FG000|Overall Study|Adverse Event|0|||
143486532|NCT00621504|517326484|FG000|Overall Study|Other|1|||
143486533|NCT00621504|517326485|FG001|Overall Study|Other|0|||
143486534|NCT00621504|517326484|FG000|Overall Study|Death|6|||
143023005|NCT00678392|515625707|FG001|Overall Study|Adverse Event|6|||
143023006|NCT00678392|515625706|FG000|Overall Study|Death|280|||
143023007|NCT00678392|515625707|FG001|Overall Study|Death|269|||
143023008|NCT00678392|515625706|FG000|Overall Study|Lost to Follow-up|15|||
143023009|NCT00678392|515625707|FG001|Overall Study|Lost to Follow-up|13|||
143023010|NCT00678392|515625706|FG000|Overall Study|Objective Progression or Relapse|3|||
143023011|NCT00678392|515625707|FG001|Overall Study|Objective Progression or Relapse|8|||
143023012|NCT00678392|515625706|FG000|Overall Study|Sponsor's Decision|1|||
143023013|NCT00678392|515625707|FG001|Overall Study|Sponsor's Decision|2|||
143023014|NCT00678392|515625706|FG000|Overall Study|Withdrawal by Subject|4|||
143023015|NCT00678392|515625707|FG001|Overall Study|Withdrawal by Subject|4|||
143023016|NCT00678392|515625706|FG000|Overall Study|Randomized But Not Treated|2|||
143023017|NCT00678392|515625707|FG001|Overall Study|Randomized But Not Treated|7|||
143023018|NCT00678392|515625706|FG000|Overall Study|Other|56|||
143023019|NCT00678392|515625707|FG001|Overall Study|Other|53|||
143023020|NCT01958281|515625708|FG000|Overall Study|Lack of Efficacy|5|||
143023021|NCT01958281|515625709|FG001|Overall Study|Lack of Efficacy|2|||
143023022|NCT01958281|515625710|FG002|Overall Study|Lack of Efficacy|0|||
143023023|NCT01958281|515625708|FG000|Overall Study|Adverse Event|0|||
143023024|NCT01958281|515625709|FG001|Overall Study|Adverse Event|2|||
143023025|NCT01958281|515625710|FG002|Overall Study|Adverse Event|0|||
143023026|NCT01958281|515625708|FG000|Overall Study|Withdrew Consent|1|||
143023027|NCT01958281|515625709|FG001|Overall Study|Withdrew Consent|0|||
143023028|NCT01958281|515625710|FG002|Overall Study|Withdrew Consent|0|||
143156418|NCT00514917|516117509|FG000|Overall Study|Lost to Follow-up|4|||
143023029|NCT03341507|515625713|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
143156419|NCT00514917|516117510|FG001|Overall Study|Lost to Follow-up|3|||
143156420|NCT00514917|516117509|FG000|Overall Study|Withdrawal by Subject|18|||
143023030|NCT02927847|515625714|FG000|Overall Study|Lost to Follow-up|1|||
143156421|NCT00514917|516117510|FG001|Overall Study|Withdrawal by Subject|16|||
143156422|NCT00514917|516117509|FG000|Overall Study|Discontinued due to study closure|88|||
143156423|NCT00514917|516117510|FG001|Overall Study|Discontinued due to study closure|81|||
143023031|NCT02927847|515625715|FG001|Overall Study|Lost to Follow-up|0|||
143023032|NCT02927847|515625714|FG000|Overall Study|Withdrawal by Subject|4|||
143023033|NCT02927847|515625715|FG001|Overall Study|Withdrawal by Subject|2|||
143156424|NCT00514917|516117509|FG000|Overall Study|Undefined|11|||
143486535|NCT00621504|517326485|FG001|Overall Study|Death|6|||
143023034|NCT02927847|515625714|FG000|Overall Study|PI withdrawn due to missed visits|1|||
143156425|NCT00514917|516117510|FG001|Overall Study|Undefined|5|||
143156426|NCT03767894|516117511|FG000|Overall Study|Withdrawal by Subject|1|||
143156427|NCT00977561|516117514|FG000|Overall Study|Death|3|||
143156428|NCT00977561|516117515|FG001|Overall Study|Death|2|||
143156429|NCT00977561|516117514|FG000|Overall Study|Study terminated|0|||
143156430|NCT00977561|516117515|FG001|Overall Study|Study terminated|2|||
143156431|NCT00977561|516117514|FG000|Overall Study|Other|2|||
143156432|NCT00977561|516117515|FG001|Overall Study|Other|0|||
143156433|NCT01860404|516117518|FG000|Overall Study|Lost to Follow-up|3|||
143156434|NCT01860404|516117519|FG001|Overall Study|Lost to Follow-up|4|||
143156435|NCT01860404|516117520|FG002|Overall Study|Lost to Follow-up|1|||
143156436|NCT01860404|516117521|FG003|Overall Study|Lost to Follow-up|6|||
143156437|NCT01860404|516117522|FG004|Overall Study|Lost to Follow-up|4|||
143156438|NCT01860404|516117518|FG000|Overall Study|Withdrawal by Subject|0|||
143156439|NCT01860404|516117519|FG001|Overall Study|Withdrawal by Subject|0|||
143156440|NCT01860404|516117520|FG002|Overall Study|Withdrawal by Subject|4|||
143156441|NCT01860404|516117521|FG003|Overall Study|Withdrawal by Subject|0|||
143156442|NCT01860404|516117522|FG004|Overall Study|Withdrawal by Subject|0|||
143156443|NCT00309244|516117523|FG000|Overall Study|Adverse Event|29|||
143156444|NCT00309244|516117524|FG001|Overall Study|Adverse Event|12|||
143156445|NCT00309244|516117523|FG000|Overall Study|Lost to Follow-up|6|||
143156446|NCT00309244|516117524|FG001|Overall Study|Lost to Follow-up|22|||
143156447|NCT00309244|516117523|FG000|Overall Study|Physician Decision|5|||
143156448|NCT00309244|516117524|FG001|Overall Study|Physician Decision|8|||
143156449|NCT00309244|516117523|FG000|Overall Study|Protocol Violation|6|||
143156450|NCT00309244|516117524|FG001|Overall Study|Protocol Violation|3|||
143156451|NCT00309244|516117523|FG000|Overall Study|Withdrawal by Subject|50|||
143156452|NCT00309244|516117524|FG001|Overall Study|Withdrawal by Subject|32|||
143156453|NCT00309244|516117523|FG000|Overall Study|Various|7|||
143156454|NCT00309244|516117524|FG001|Overall Study|Various|7|||
143156455|NCT00309244|516117523|FG000|Overall Study|Randomized but not dosed|11|||
143156456|NCT00309244|516117524|FG001|Overall Study|Randomized but not dosed|12|||
143156457|NCT00309244|516117523|FG000|Overall Study|Death|4|||
143156458|NCT00309244|516117524|FG001|Overall Study|Death|1|||
143156459|NCT02187055|516117525|FG000|Overall Study|Lack of Efficacy|10|||
143156460|NCT02187055|516117526|FG001|Overall Study|Lack of Efficacy|3|||
143156461|NCT02187055|516117527|FG002|Overall Study|Lack of Efficacy|7|||
143156462|NCT02187055|516117525|FG000|Overall Study|Lost to Follow-up|2|||
143156463|NCT02187055|516117526|FG001|Overall Study|Lost to Follow-up|7|||
143156464|NCT02187055|516117527|FG002|Overall Study|Lost to Follow-up|3|||
143156465|NCT02187055|516117525|FG000|Overall Study|No longer meets eligibility criteria|0|||
143156466|NCT02187055|516117526|FG001|Overall Study|No longer meets eligibility criteria|2|||
143156467|NCT02187055|516117527|FG002|Overall Study|No longer meets eligibility criteria|0|||
143156468|NCT02187055|516117525|FG000|Overall Study|No longer willing to participate|6|||
143156469|NCT02187055|516117526|FG001|Overall Study|No longer willing to participate|8|||
143156470|NCT02187055|516117527|FG002|Overall Study|No longer willing to participate|10|||
143156471|NCT02187055|516117525|FG000|Overall Study|Other|5|||
143156472|NCT02187055|516117526|FG001|Overall Study|Other|6|||
143156473|NCT02187055|516117527|FG002|Overall Study|Other|3|||
143156474|NCT02187055|516117525|FG000|Overall Study|Protocol Violation|9|||
143156475|NCT02187055|516117526|FG001|Overall Study|Protocol Violation|9|||
143156476|NCT02187055|516117527|FG002|Overall Study|Protocol Violation|4|||
143156477|NCT02187055|516117525|FG000|Overall Study|Pregnancy|3|||
143156478|NCT02187055|516117526|FG001|Overall Study|Pregnancy|1|||
143156479|NCT02187055|516117527|FG002|Overall Study|Pregnancy|0|||
143156480|NCT02187055|516117525|FG000|Overall Study|Withdrawal by Subject|11|||
143156481|NCT02187055|516117526|FG001|Overall Study|Withdrawal by Subject|11|||
143156482|NCT02187055|516117527|FG002|Overall Study|Withdrawal by Subject|11|||
143156483|NCT02187055|516117525|FG000|Overall Study|Adverse Event|21|||
143156484|NCT02187055|516117526|FG001|Overall Study|Adverse Event|26|||
143156485|NCT02187055|516117527|FG002|Overall Study|Adverse Event|36|||
143156486|NCT02187055|516117525|FG000|Overall Study|Death|2|||
143156487|NCT02187055|516117526|FG001|Overall Study|Death|0|||
143156488|NCT02187055|516117527|FG002|Overall Study|Death|0|||
143156489|NCT02939781|516117528|FG000|Overall Study|Protocol Violation|8|||
143156490|NCT02939781|516117528|FG000|Overall Study|Withdrawal by Subject|1|||
143156491|NCT01740427|516117529|FG000|Overall Study|Objective Progression or Relapse|286|||
143156492|NCT01740427|516117530|FG001|Overall Study|Objective Progression or Relapse|172|||
143156493|NCT01740427|516117529|FG000|Overall Study|Adverse Event|32|||
143156494|NCT01740427|516117530|FG001|Overall Study|Adverse Event|9|||
143156495|NCT01740427|516117529|FG000|Overall Study|Global Deterioration of Health Status|28|||
143156496|NCT01740427|516117530|FG001|Overall Study|Global Deterioration of Health Status|12|||
143156497|NCT01740427|516117529|FG000|Overall Study|Participant Refused Continued Treatment|27|||
143156498|NCT01740427|516117530|FG001|Overall Study|Participant Refused Continued Treatment|15|||
143156499|NCT01740427|516117529|FG000|Overall Study|Unspecified reasons|52|||
143156500|NCT01740427|516117530|FG001|Overall Study|Unspecified reasons|8|||
143156501|NCT01740427|516117529|FG000|Overall Study|Death|10|||
143156502|NCT01740427|516117530|FG001|Overall Study|Death|3|||
143156503|NCT01740427|516117529|FG000|Overall Study|Protocol Violation|5|||
143023035|NCT02927847|515625715|FG001|Overall Study|PI withdrawn due to missed visits|1|||
143156504|NCT01740427|516117530|FG001|Overall Study|Protocol Violation|3|||
143156505|NCT01740427|516117529|FG000|Overall Study|Lost to Follow-up|3|||
143156506|NCT01740427|516117530|FG001|Overall Study|Lost to Follow-up|0|||
143156507|NCT01740427|516117529|FG000|Overall Study|Site Terminated by Sponsor|1|||
143156508|NCT01740427|516117530|FG001|Overall Study|Site Terminated by Sponsor|0|||
143156509|NCT01980888|516117531|FG000|Overall Study|Study Terminated by Sponsor|116|||
143156510|NCT01980888|516117532|FG001|Overall Study|Study Terminated by Sponsor|122|||
143156511|NCT01980888|516117531|FG000|Overall Study|Withdrew Consent|17|||
143156512|NCT01980888|516117532|FG001|Overall Study|Withdrew Consent|6|||
143156513|NCT01980888|516117531|FG000|Overall Study|Investigator's Discretion|8|||
143156514|NCT01980888|516117532|FG001|Overall Study|Investigator's Discretion|3|||
143156515|NCT01980888|516117531|FG000|Overall Study|Non-Compliance with Study Drug|3|||
143156516|NCT01980888|516117532|FG001|Overall Study|Non-Compliance with Study Drug|2|||
143156517|NCT04625972|516117534|FG000|Overall Study|Death|3|||
143156518|NCT04625972|516117535|FG001|Overall Study|Death|2|||
143156519|NCT04625972|516117534|FG000|Overall Study|Lost to Follow-up|82|||
143156520|NCT04625972|516117535|FG001|Overall Study|Lost to Follow-up|38|||
143156521|NCT04625972|516117534|FG000|Overall Study|Physician Decision|2|||
143156522|NCT04625972|516117535|FG001|Overall Study|Physician Decision|0|||
143156523|NCT04625972|516117534|FG000|Overall Study|Protocol Violation|0|||
143156524|NCT04625972|516117535|FG001|Overall Study|Protocol Violation|1|||
143156525|NCT04625972|516117534|FG000|Overall Study|Withdrawal by Subject|37|||
143156526|NCT04625972|516117535|FG001|Overall Study|Withdrawal by Subject|24|||
143156527|NCT04625972|516117534|FG000|Overall Study|Not specified elsewhere|8|||
143156528|NCT04625972|516117535|FG001|Overall Study|Not specified elsewhere|6|||
143156529|NCT01483651|516117536|FG000|Overall Study|Withdrawal by Subject|0|||
143156530|NCT01483651|516117537|FG001|Overall Study|Withdrawal by Subject|1|||
143156531|NCT01483651|516117538|FG002|Overall Study|Withdrawal by Subject|1|||
143156532|NCT01483651|516117539|FG003|Overall Study|Withdrawal by Subject|0|||
143156533|NCT01483651|516117540|FG004|Overall Study|Withdrawal by Subject|0|||
143156534|NCT01483651|516117541|FG005|Overall Study|Withdrawal by Subject|1|||
143156535|NCT02015104|516117542|FG000|Overall Study|Withdrew consent after first dose drug|1|||
143156536|NCT02015104|516117543|FG001|Overall Study|Withdrew consent after first dose drug|0|||
143156537|NCT02015104|516117542|FG000|Overall Study|Withdrew consent prior to treatment|0|||
143156538|NCT02015104|516117543|FG001|Overall Study|Withdrew consent prior to treatment|1|||
143156539|NCT06025695|516117544|FG000|Overall Study|Adverse Event|5|||
143156540|NCT06025695|516117545|FG001|Overall Study|Adverse Event|6|||
143156541|NCT06025695|516117544|FG000|Overall Study|Migrated / Moved from the Study Area|13|||
143156542|NCT06025695|516117545|FG001|Overall Study|Migrated / Moved from the Study Area|10|||
143156543|NCT06025695|516117544|FG000|Overall Study|Other|23|||
143156544|NCT06025695|516117545|FG001|Overall Study|Other|19|||
143156545|NCT06025695|516117544|FG000|Overall Study|Adverse Event Requiring Expedited Report|1|||
143156546|NCT06025695|516117545|FG001|Overall Study|Adverse Event Requiring Expedited Report|0|||
143156547|NCT01560416|516117546|FG000|Randomized Phase|Crossover Participants|7|||
143156548|NCT01560416|516117547|FG001|Randomized Phase|Crossover Participants|0|||
143156549|NCT01030900|516117548|FG000|Overall Study|Not treated due to congestive heart failure|1|||
143156550|NCT01030900|516117548|FG000|Overall Study|Not treated due to rapid disease|1|||
143156551|NCT01179399|516117549|FG000|Overall Study|Adverse Event|1|||
143156552|NCT01179399|516117549|FG000|Overall Study|Lack of Efficacy|30|||
143156553|NCT01179399|516117549|FG000|Overall Study|Withdrawal by Subject|1|||
143156554|NCT00441896|516117550|FG000|Overall Study|Withdrawal by Subject|0|||
143156555|NCT00441896|516117551|FG001|Overall Study|Withdrawal by Subject|0|||
143156556|NCT00441896|516117552|FG002|Overall Study|Withdrawal by Subject|0|||
143156557|NCT00441896|516117553|FG003|Overall Study|Withdrawal by Subject|1|||
143156558|NCT00441896|516117554|FG004|Overall Study|Withdrawal by Subject|0|||
143156559|NCT00441896|516117555|FG005|Overall Study|Withdrawal by Subject|0|||
143156560|NCT00441896|516117556|FG006|Overall Study|Withdrawal by Subject|0|||
143156561|NCT00441896|516117557|FG007|Overall Study|Withdrawal by Subject|0|||
143156562|NCT00441896|516117558|FG008|Overall Study|Withdrawal by Subject|0|||
143156563|NCT00441896|516117559|FG009|Overall Study|Withdrawal by Subject|0|||
143156564|NCT00441896|516117550|FG000|Overall Study|Other|0|||
143023036|NCT01405820|515625716|FG000|Randomized Treatment Period|Adverse Event|3|||
143156565|NCT00441896|516117551|FG001|Overall Study|Other|0|||
143156566|NCT00441896|516117552|FG002|Overall Study|Other|0|||
143156567|NCT00441896|516117553|FG003|Overall Study|Other|0|||
143156568|NCT00441896|516117554|FG004|Overall Study|Other|1|||
143156569|NCT00441896|516117555|FG005|Overall Study|Other|0|||
143156570|NCT00441896|516117556|FG006|Overall Study|Other|0|||
143156571|NCT00441896|516117557|FG007|Overall Study|Other|0|||
143156572|NCT00441896|516117558|FG008|Overall Study|Other|0|||
143156573|NCT00441896|516117559|FG009|Overall Study|Other|0|||
143156574|NCT00004859|516117563|FG000|Overall Study|Lack of Efficacy|43|||
143156575|NCT00004859|516117564|FG001|Overall Study|Lack of Efficacy|113|||
143156576|NCT00004859|516117563|FG000|Overall Study|Adverse Event|31|||
143156577|NCT00004859|516117564|FG001|Overall Study|Adverse Event|93|||
143156578|NCT00004859|516117563|FG000|Overall Study|Death|5|||
143023037|NCT01405820|515625717|FG001|Randomized Treatment Period|Adverse Event|3|||
143023038|NCT01405820|515625718|FG002|Randomized Treatment Period|Adverse Event|3|||
143023039|NCT01405820|515625719|FG003|Randomized Treatment Period|Adverse Event|0|||
143023040|NCT01405820|515625720|FG004|Randomized Treatment Period|Adverse Event|2|||
143023041|NCT01405820|515625721|FG005|Randomized Treatment Period|Adverse Event|1|||
143023042|NCT01405820|515625716|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
143023043|NCT01405820|515625717|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
143023044|NCT01405820|515625718|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
143023045|NCT01405820|515625719|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
143023046|NCT01405820|515625720|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
143023047|NCT01405820|515625721|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
143023048|NCT01405820|515625716|FG000|Randomized Treatment Period|Other|2|||
143023049|NCT01405820|515625717|FG001|Randomized Treatment Period|Other|2|||
143023050|NCT01405820|515625718|FG002|Randomized Treatment Period|Other|1|||
143023051|NCT01405820|515625719|FG003|Randomized Treatment Period|Other|1|||
143023052|NCT01405820|515625720|FG004|Randomized Treatment Period|Other|0|||
143023053|NCT01405820|515625721|FG005|Randomized Treatment Period|Other|0|||
143023054|NCT01405820|515625716|FG000|Randomized Treatment Period|Physician Decision|0|||
143023055|NCT01405820|515625717|FG001|Randomized Treatment Period|Physician Decision|2|||
143023056|NCT01405820|515625718|FG002|Randomized Treatment Period|Physician Decision|1|||
143023057|NCT01405820|515625719|FG003|Randomized Treatment Period|Physician Decision|0|||
143023058|NCT01405820|515625720|FG004|Randomized Treatment Period|Physician Decision|0|||
143023059|NCT01405820|515625721|FG005|Randomized Treatment Period|Physician Decision|0|||
143023060|NCT01405820|515625716|FG000|Randomized Treatment Period|Rescue|0|||
143023061|NCT01405820|515625717|FG001|Randomized Treatment Period|Rescue|1|||
143023062|NCT01405820|515625718|FG002|Randomized Treatment Period|Rescue|13|||
143023063|NCT01405820|515625719|FG003|Randomized Treatment Period|Rescue|10|||
143023064|NCT01405820|515625720|FG004|Randomized Treatment Period|Rescue|8|||
143023065|NCT01405820|515625721|FG005|Randomized Treatment Period|Rescue|8|||
143023066|NCT01405820|515625716|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
143023067|NCT01405820|515625717|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
143023068|NCT01405820|515625718|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
143023069|NCT01405820|515625719|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
143156579|NCT00004859|516117564|FG001|Overall Study|Death|5|||
143156580|NCT00004859|516117563|FG000|Overall Study|Withdrawal by Subject|7|||
143156581|NCT00004859|516117564|FG001|Overall Study|Withdrawal by Subject|33|||
143156582|NCT00004859|516117563|FG000|Overall Study|Protocol Violation|2|||
143156583|NCT00004859|516117564|FG001|Overall Study|Protocol Violation|2|||
143156584|NCT00004859|516117563|FG000|Overall Study|other disease|0|||
143156585|NCT00004859|516117564|FG001|Overall Study|other disease|3|||
143156586|NCT00004859|516117563|FG000|Overall Study|error|3|||
143156587|NCT00004859|516117564|FG001|Overall Study|error|1|||
143156588|NCT00004859|516117563|FG000|Overall Study|missing data|14|||
143156589|NCT00004859|516117564|FG001|Overall Study|missing data|11|||
143156590|NCT00004859|516117563|FG000|Overall Study|Other|13|||
143156591|NCT00004859|516117564|FG001|Overall Study|Other|21|||
143156592|NCT04073407|516117565|FG000|Part 1|Withdrawal by Subject|1|||
143156593|NCT04073407|516117566|FG001|Part 1|Withdrawal by Subject|0|||
143156594|NCT04073407|516117565|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
143156595|NCT04073407|516117566|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
143156596|NCT04073407|516117565|FG000|Part 2|Withdrawal by Subject|0|||
143156597|NCT04073407|516117566|FG001|Part 2|Withdrawal by Subject|1|||
143156598|NCT02545127|516119350|FG000|Overall Study|Lost to Follow-up|1|||
143156599|NCT02545127|516119351|FG001|Overall Study|Lost to Follow-up|0|||
143156600|NCT02082483|516119352|FG000|Overall Study|Lost to Follow-up|1|||
143156601|NCT02082483|516119353|FG001|Overall Study|Lost to Follow-up|1|||
143156602|NCT02082483|516119352|FG000|Overall Study|Withdrawal by Subject|2|||
143156603|NCT02082483|516119353|FG001|Overall Study|Withdrawal by Subject|1|||
143156604|NCT02082483|516119352|FG000|Overall Study|Physician Decision|1|||
143156605|NCT02082483|516119353|FG001|Overall Study|Physician Decision|1|||
143156606|NCT02082483|516119352|FG000|Overall Study|Death|2|||
143156607|NCT02082483|516119353|FG001|Overall Study|Death|3|||
143156608|NCT00762788|516119354|FG000|Overall Study|Lost to Follow-up|26|||
143156609|NCT00762788|516119355|FG001|Overall Study|Lost to Follow-up|37|||
143156610|NCT00762788|516119356|FG002|Overall Study|Lost to Follow-up|21|||
143156611|NCT00762788|516119357|FG003|Overall Study|Lost to Follow-up|26|||
143156612|NCT00762788|516119358|FG004|Overall Study|Lost to Follow-up|13|||
143156613|NCT00762788|516119359|FG005|Overall Study|Lost to Follow-up|21|||
143156614|NCT00669331|516119360|FG000|Randomisation to First Dose|Adverse Event|1|||
143156615|NCT00669331|516119361|FG001|Randomisation to First Dose|Adverse Event|0|||
143156616|NCT00669331|516119360|FG000|Randomisation to First Dose|Protocol Violation|1|||
143486536|NCT01979523|517326490|FG000|Overall Study|Withdrawal by Subject|1|||
143023070|NCT01405820|515625720|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
143023071|NCT01405820|515625721|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
143023072|NCT01405820|515625716|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
143363731|NCT04978363|516875433|FG000|Overall Study|Other medical issues unrelated to the study|0|||
143363732|NCT04978363|516875434|FG001|Overall Study|Other medical issues unrelated to the study|0|||
143363733|NCT04978363|516875435|FG002|Overall Study|Other medical issues unrelated to the study|0|||
143363734|NCT04978363|516875436|FG003|Overall Study|Other medical issues unrelated to the study|0|||
143363735|NCT04978363|516875437|FG004|Overall Study|Other medical issues unrelated to the study|1|||
143363736|NCT04978363|516875438|FG005|Overall Study|Other medical issues unrelated to the study|0|||
143363737|NCT04978363|516875439|FG006|Overall Study|Other medical issues unrelated to the study|0|||
143363738|NCT04978363|516875440|FG007|Overall Study|Other medical issues unrelated to the study|0|||
143363739|NCT04978363|516875441|FG008|Overall Study|Other medical issues unrelated to the study|0|||
143363740|NCT04978363|516875442|FG009|Overall Study|Other medical issues unrelated to the study|0|||
143363741|NCT04978363|516875443|FG010|Overall Study|Other medical issues unrelated to the study|0|||
143363742|NCT04978363|516875433|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
143363743|NCT04978363|516875434|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
143486537|NCT01979523|517326491|FG001|Overall Study|Withdrawal by Subject|0|||
143486538|NCT03311711|517326492|FG000|Overall Study|Death|1|||
143486539|NCT03311711|517326493|FG001|Overall Study|Death|0|||
143486540|NCT03311711|517326494|FG002|Overall Study|Death|0|||
143486541|NCT03311711|517326495|FG003|Overall Study|Death|0|||
143486542|NCT03311711|517326496|FG004|Overall Study|Death|0|||
143486543|NCT03311711|517326497|FG005|Overall Study|Death|0|||
143486544|NCT03311711|517326498|FG006|Overall Study|Death|1|||
143486545|NCT03311711|517326499|FG007|Overall Study|Death|0|||
143486546|NCT03311711|517326500|FG008|Overall Study|Death|1|||
143486547|NCT03311711|517326501|FG009|Overall Study|Death|0|||
143486548|NCT03311711|517326492|FG000|Overall Study|Death of dyad partner|0|||
143486549|NCT03311711|517326493|FG001|Overall Study|Death of dyad partner|1|||
143486550|NCT03311711|517326494|FG002|Overall Study|Death of dyad partner|0|||
143486551|NCT03311711|517326495|FG003|Overall Study|Death of dyad partner|0|||
143486552|NCT03311711|517326496|FG004|Overall Study|Death of dyad partner|0|||
143486553|NCT03311711|517326497|FG005|Overall Study|Death of dyad partner|0|||
143486554|NCT03311711|517326498|FG006|Overall Study|Death of dyad partner|0|||
143486555|NCT03311711|517326499|FG007|Overall Study|Death of dyad partner|1|||
143486556|NCT03311711|517326500|FG008|Overall Study|Death of dyad partner|0|||
143486557|NCT03311711|517326501|FG009|Overall Study|Death of dyad partner|1|||
143486558|NCT03311711|517326492|FG000|Overall Study|Lost to Follow-up|2|||
143486559|NCT03311711|517326493|FG001|Overall Study|Lost to Follow-up|2|||
143486560|NCT03311711|517326494|FG002|Overall Study|Lost to Follow-up|0|||
143486561|NCT03311711|517326495|FG003|Overall Study|Lost to Follow-up|0|||
143486562|NCT03311711|517326496|FG004|Overall Study|Lost to Follow-up|0|||
143486563|NCT03311711|517326497|FG005|Overall Study|Lost to Follow-up|0|||
143486564|NCT03311711|517326498|FG006|Overall Study|Lost to Follow-up|1|||
143486565|NCT03311711|517326499|FG007|Overall Study|Lost to Follow-up|1|||
143486566|NCT03311711|517326500|FG008|Overall Study|Lost to Follow-up|0|||
143486567|NCT03311711|517326501|FG009|Overall Study|Lost to Follow-up|0|||
143486568|NCT03311711|517326492|FG000|Overall Study|Withdrawal by Subject|1|||
143486569|NCT03311711|517326493|FG001|Overall Study|Withdrawal by Subject|1|||
143486570|NCT03311711|517326494|FG002|Overall Study|Withdrawal by Subject|0|||
143486571|NCT03311711|517326495|FG003|Overall Study|Withdrawal by Subject|0|||
143486572|NCT03311711|517326496|FG004|Overall Study|Withdrawal by Subject|0|||
143486573|NCT03311711|517326497|FG005|Overall Study|Withdrawal by Subject|0|||
143486574|NCT03311711|517326498|FG006|Overall Study|Withdrawal by Subject|3|||
143486575|NCT03311711|517326499|FG007|Overall Study|Withdrawal by Subject|3|||
143486576|NCT03311711|517326500|FG008|Overall Study|Withdrawal by Subject|0|||
143486577|NCT03311711|517326501|FG009|Overall Study|Withdrawal by Subject|0|||
143486578|NCT01339559|517326508|FG000|Overall Study|Adverse Event|92|||
143486579|NCT01339559|517326508|FG000|Overall Study|Death|5|||
143486580|NCT01339559|517326508|FG000|Overall Study|Lack of Efficacy|164|||
143486581|NCT01339559|517326508|FG000|Overall Study|Lost to Follow-up|22|||
143486582|NCT01339559|517326508|FG000|Overall Study|Subject choice|89|||
143486583|NCT01339559|517326508|FG000|Overall Study|Protocol Violation|15|||
143486584|NCT01339559|517326508|FG000|Overall Study|Study closure at site|1|||
143486585|NCT01339559|517326508|FG000|Overall Study|Incarcerated|2|||
143486586|NCT01339559|517326508|FG000|Overall Study|Epilepsy surgery|1|||
143486587|NCT01339559|517326508|FG000|Overall Study|Pregnancy planned|2|||
143486588|NCT01339559|517326508|FG000|Overall Study|Left the country|1|||
143486589|NCT01339559|517326508|FG000|Overall Study|Investigator decision|2|||
143486590|NCT01339559|517326508|FG000|Overall Study|Patient didn't wish to continue|1|||
143486591|NCT01339559|517326508|FG000|Overall Study|PI decision|1|||
143486592|NCT01661140|517326509|FG000|Open-Label Period|Adverse Event|44|||
143486593|NCT01661140|517326510|FG001|Open-Label Period|Adverse Event|0|||
143486594|NCT01661140|517326511|FG002|Open-Label Period|Adverse Event|0|||
143486595|NCT01661140|517326509|FG000|Open-Label Period|Protocol Violation|3|||
143486596|NCT01661140|517326510|FG001|Open-Label Period|Protocol Violation|0|||
143486597|NCT01661140|517326511|FG002|Open-Label Period|Protocol Violation|0|||
143486598|NCT01661140|517326509|FG000|Open-Label Period|Withdrawal by Subject|5|||
143486599|NCT01661140|517326510|FG001|Open-Label Period|Withdrawal by Subject|0|||
143023073|NCT01405820|515625717|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
143023074|NCT01405820|515625718|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
143023075|NCT01405820|515625719|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
143023076|NCT01405820|515625720|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
143023077|NCT01405820|515625721|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
143023078|NCT01405820|515625716|FG000|Randomized Treatment Period|Death|0|||
143023079|NCT01405820|515625717|FG001|Randomized Treatment Period|Death|0|||
143023080|NCT01405820|515625718|FG002|Randomized Treatment Period|Death|0|||
143023081|NCT01405820|515625719|FG003|Randomized Treatment Period|Death|1|||
143023082|NCT01405820|515625720|FG004|Randomized Treatment Period|Death|0|||
143023083|NCT01405820|515625721|FG005|Randomized Treatment Period|Death|0|||
143023084|NCT01405820|515625716|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
143023085|NCT01405820|515625717|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
143023086|NCT01405820|515625718|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
143023087|NCT01405820|515625719|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
143023088|NCT01405820|515625720|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
143023089|NCT01405820|515625721|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
143023090|NCT01405820|515625716|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
143023091|NCT01405820|515625717|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
143023092|NCT01405820|515625718|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
143023093|NCT01405820|515625719|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
143023094|NCT01405820|515625720|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
143023095|NCT01405820|515625721|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
143023096|NCT01405820|515625716|FG000|Open-Label Treatment Period|Other|1|||
143023097|NCT01405820|515625717|FG001|Open-Label Treatment Period|Other|1|||
143023098|NCT01405820|515625718|FG002|Open-Label Treatment Period|Other|1|||
143023099|NCT01405820|515625719|FG003|Open-Label Treatment Period|Other|1|||
143023100|NCT01405820|515625720|FG004|Open-Label Treatment Period|Other|1|||
143023101|NCT01405820|515625721|FG005|Open-Label Treatment Period|Other|1|||
143023102|NCT01405820|515625716|FG000|Open-Label Treatment Period|Physician Decision|0|||
143023103|NCT01405820|515625717|FG001|Open-Label Treatment Period|Physician Decision|0|||
143023104|NCT01405820|515625718|FG002|Open-Label Treatment Period|Physician Decision|1|||
143023105|NCT01405820|515625719|FG003|Open-Label Treatment Period|Physician Decision|2|||
143023106|NCT01405820|515625720|FG004|Open-Label Treatment Period|Physician Decision|1|||
143023107|NCT01405820|515625721|FG005|Open-Label Treatment Period|Physician Decision|0|||
143023108|NCT01405820|515625716|FG000|Open-Label Treatment Period|Adverse Event|0|||
143023109|NCT01405820|515625717|FG001|Open-Label Treatment Period|Adverse Event|0|||
143023110|NCT01405820|515625718|FG002|Open-Label Treatment Period|Adverse Event|0|||
143023111|NCT01405820|515625719|FG003|Open-Label Treatment Period|Adverse Event|1|||
143023112|NCT01405820|515625720|FG004|Open-Label Treatment Period|Adverse Event|0|||
143023113|NCT01405820|515625721|FG005|Open-Label Treatment Period|Adverse Event|0|||
143023114|NCT00441584|515625724|FG000|Overall Study|Lack of Efficacy|79|||
143023115|NCT00441584|515625724|FG000|Overall Study|Withdrawal by Subject|8|||
143023116|NCT00441584|515625724|FG000|Overall Study|Adverse Event|6|||
143023117|NCT00441584|515625724|FG000|Overall Study|Protocol Violation|5|||
143023118|NCT00441584|515625724|FG000|Overall Study|Lost to Follow-up|4|||
143023119|NCT00441584|515625724|FG000|Overall Study|Failure to meet eligibility criteria|3|||
143023120|NCT00619619|515625727|FG000|Overall Study|Physician Decision|0|||
143023121|NCT00619619|515625728|FG001|Overall Study|Physician Decision|0|||
143023122|NCT00619619|515625729|FG002|Overall Study|Physician Decision|1|||
143023123|NCT00619619|515625730|FG003|Overall Study|Physician Decision|0|||
143023124|NCT00619619|515625731|FG004|Overall Study|Physician Decision|0|||
143023125|NCT00619619|515625732|FG005|Overall Study|Physician Decision|0|||
143023126|NCT00619619|515625733|FG006|Overall Study|Physician Decision|0|||
143023127|NCT00619619|515625734|FG007|Overall Study|Physician Decision|0|||
143023128|NCT00619619|515625727|FG000|Overall Study|Protocol Violation|0|||
143023129|NCT00619619|515625728|FG001|Overall Study|Protocol Violation|0|||
143023130|NCT00619619|515625729|FG002|Overall Study|Protocol Violation|0|||
143023131|NCT00619619|515625730|FG003|Overall Study|Protocol Violation|1|||
143023132|NCT00619619|515625731|FG004|Overall Study|Protocol Violation|0|||
143023133|NCT00619619|515625732|FG005|Overall Study|Protocol Violation|0|||
143023134|NCT00619619|515625733|FG006|Overall Study|Protocol Violation|1|||
143023135|NCT00619619|515625734|FG007|Overall Study|Protocol Violation|1|||
143023136|NCT00619619|515625727|FG000|Overall Study|Adverse Event|0|||
143023137|NCT00619619|515625728|FG001|Overall Study|Adverse Event|0|||
143023138|NCT00619619|515625729|FG002|Overall Study|Adverse Event|0|||
143023139|NCT00619619|515625730|FG003|Overall Study|Adverse Event|0|||
143023140|NCT00619619|515625731|FG004|Overall Study|Adverse Event|2|||
143023141|NCT00619619|515625732|FG005|Overall Study|Adverse Event|0|||
143023142|NCT00619619|515625733|FG006|Overall Study|Adverse Event|0|||
143023143|NCT00619619|515625734|FG007|Overall Study|Adverse Event|2|||
143023144|NCT01814137|515625736|FG000|Overall Study|Adverse Event|0|||
143023145|NCT01814137|515625737|FG001|Overall Study|Adverse Event|1|||
143023146|NCT01814137|515625736|FG000|Overall Study|Withdrawal by Subject|2|||
143023147|NCT01814137|515625737|FG001|Overall Study|Withdrawal by Subject|2|||
143023148|NCT01814137|515625736|FG000|Overall Study|Physician Decision|1|||
143486600|NCT01661140|517326511|FG002|Open-Label Period|Withdrawal by Subject|0|||
143486601|NCT01661140|517326509|FG000|Open-Label Period|Investigator Decision|3|||
143486602|NCT01661140|517326510|FG001|Open-Label Period|Investigator Decision|0|||
143486603|NCT01661140|517326511|FG002|Open-Label Period|Investigator Decision|0|||
143486604|NCT01661140|517326509|FG000|Open-Label Period|Death|1|||
143023149|NCT01814137|515625737|FG001|Overall Study|Physician Decision|1|||
143023150|NCT01814137|515625736|FG000|Overall Study|Unclassified|2|||
143023151|NCT01814137|515625737|FG001|Overall Study|Unclassified|1|||
143023152|NCT01952574|515625738|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
143023153|NCT01952574|515625739|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
143023154|NCT01952574|515625740|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
143023155|NCT01952574|515625741|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
143023156|NCT01952574|515625742|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
143023157|NCT01952574|515625743|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
143023158|NCT01952574|515625744|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
143023159|NCT01952574|515625738|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
143023160|NCT01952574|515625739|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
143023161|NCT01952574|515625740|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
143023162|NCT01952574|515625741|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
143023163|NCT01952574|515625742|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
143023164|NCT01952574|515625743|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
143023165|NCT01952574|515625744|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
143023166|NCT01952574|515625738|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
143023167|NCT01952574|515625739|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
143023168|NCT01952574|515625740|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
143023169|NCT01952574|515625741|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
143023170|NCT01952574|515625742|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
143023171|NCT01952574|515625743|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
143023172|NCT01952574|515625744|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
143156617|NCT00669331|516119361|FG001|Randomisation to First Dose|Protocol Violation|0|||
143156618|NCT00669331|516119360|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
143156619|NCT00669331|516119361|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
143156620|NCT00669331|516119360|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
143156621|NCT00669331|516119361|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
143156622|NCT00669331|516119360|FG000|Randomisation to First Dose|Death|1|||
143156623|NCT00669331|516119361|FG001|Randomisation to First Dose|Death|0|||
143156624|NCT00669331|516119360|FG000|Randomisation to First Dose|Sponsor decision|0|||
143156625|NCT00669331|516119361|FG001|Randomisation to First Dose|Sponsor decision|1|||
143156626|NCT00669331|516119360|FG000|Randomisation to First Dose|Randomised in error|3|||
143156627|NCT00669331|516119361|FG001|Randomisation to First Dose|Randomised in error|10|||
143156628|NCT00669331|516119360|FG000|Blinded Treatment Period|Adverse Event|16|||
143156629|NCT00669331|516119361|FG001|Blinded Treatment Period|Adverse Event|10|||
143156630|NCT00669331|516119360|FG000|Blinded Treatment Period|Protocol Violation|1|||
143156631|NCT00669331|516119361|FG001|Blinded Treatment Period|Protocol Violation|1|||
143156632|NCT00669331|516119360|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
143156633|NCT00669331|516119361|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
143156634|NCT00669331|516119360|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
143156635|NCT00669331|516119361|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
143156636|NCT00669331|516119360|FG000|Blinded Treatment Period|Death|0|||
143156637|NCT00669331|516119361|FG001|Blinded Treatment Period|Death|2|||
143156638|NCT00669331|516119360|FG000|Blinded Treatment Period|Physician Decision|3|||
143156639|NCT00669331|516119361|FG001|Blinded Treatment Period|Physician Decision|3|||
143156640|NCT00669331|516119360|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
143156641|NCT00669331|516119361|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
143156642|NCT01454063|516119362|FG000|Randomized|Adverse Event|1|||
143156643|NCT01454063|516119363|FG001|Randomized|Adverse Event|1|||
143156644|NCT01454063|516119362|FG000|Randomized|Protocol Violation|0|||
143156645|NCT01454063|516119363|FG001|Randomized|Protocol Violation|1|||
143156646|NCT00509600|516119367|FG000|Overall Study|Adverse Event|1|||
143156647|NCT02568423|516119368|FG000|Overall Study|Lost to Follow-up|0|||
143156648|NCT02568423|516119369|FG001|Overall Study|Lost to Follow-up|2|||
143156649|NCT02568423|516119370|FG002|Overall Study|Lost to Follow-up|0|||
143156650|NCT02568423|516119371|FG003|Overall Study|Lost to Follow-up|0|||
143023173|NCT01952574|515625738|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
143156651|NCT02568423|516119372|FG004|Overall Study|Lost to Follow-up|0|||
143156652|NCT02568423|516119373|FG005|Overall Study|Lost to Follow-up|0|||
143156653|NCT02568423|516119374|FG006|Overall Study|Lost to Follow-up|0|||
143156654|NCT02568423|516119375|FG007|Overall Study|Lost to Follow-up|0|||
143156655|NCT02568423|516119368|FG000|Overall Study|Physician Decision|0|||
143156656|NCT02568423|516119369|FG001|Overall Study|Physician Decision|0|||
143156657|NCT02568423|516119370|FG002|Overall Study|Physician Decision|0|||
143156658|NCT02568423|516119371|FG003|Overall Study|Physician Decision|0|||
143156659|NCT02568423|516119372|FG004|Overall Study|Physician Decision|0|||
143486605|NCT01661140|517326510|FG001|Open-Label Period|Death|0|||
143235598|NCT03181932|516415057|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
143235599|NCT03181932|516415058|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
143235600|NCT03181932|516415057|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
143235601|NCT03181932|516415058|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
143235602|NCT03181932|516415057|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
143235603|NCT03181932|516415058|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
143235604|NCT03181932|516415057|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
143235605|NCT03181932|516415058|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
143235606|NCT03181932|516415057|FG000|Period 2 (Open-label Period)|Reason missing|2|||
143235607|NCT03181932|516415058|FG001|Period 2 (Open-label Period)|Reason missing|0|||
143235608|NCT03304626|516415059|FG000|Overall Study|Adverse Event|1|||
143235609|NCT03304626|516415060|FG001|Overall Study|Adverse Event|0|||
143235610|NCT03304626|516415059|FG000|Overall Study|Lack of Efficacy|1|||
143235611|NCT03304626|516415060|FG001|Overall Study|Lack of Efficacy|1|||
143235612|NCT00744497|516415061|FG000|Overall Study|Withdrawal by Subject|21|||
143235613|NCT00744497|516415062|FG001|Overall Study|Withdrawal by Subject|18|||
143235614|NCT00744497|516415061|FG000|Overall Study|Death|11|||
143235615|NCT00744497|516415062|FG001|Overall Study|Death|9|||
143235616|NCT00744497|516415061|FG000|Overall Study|Lost to Follow-up|4|||
143235617|NCT00744497|516415062|FG001|Overall Study|Lost to Follow-up|2|||
143235618|NCT00744497|516415061|FG000|Overall Study|Poor compliance/noncompliance|9|||
143235619|NCT00744497|516415062|FG001|Overall Study|Poor compliance/noncompliance|5|||
143235620|NCT00744497|516415061|FG000|Overall Study|No longer meets study criteria|7|||
143235621|NCT00744497|516415062|FG001|Overall Study|No longer meets study criteria|3|||
143235622|NCT00744497|516415061|FG000|Overall Study|Administrative Reason By Sponsor|25|||
143235623|NCT00744497|516415062|FG001|Overall Study|Administrative Reason By Sponsor|8|||
143235624|NCT00744497|516415061|FG000|Overall Study|Disease progression|312|||
143235625|NCT00744497|516415062|FG001|Overall Study|Disease progression|219|||
143235626|NCT00744497|516415061|FG000|Overall Study|Study drug toxicity|68|||
143235627|NCT00744497|516415062|FG001|Overall Study|Study drug toxicity|141|||
143235628|NCT00744497|516415061|FG000|Overall Study|Adverse event unrelated to study drug|78|||
143235629|NCT00744497|516415062|FG001|Overall Study|Adverse event unrelated to study drug|122|||
143235630|NCT00744497|516415061|FG000|Overall Study|Patient requested to stop study drug|65|||
143235631|NCT00744497|516415062|FG001|Overall Study|Patient requested to stop study drug|80|||
143235632|NCT00744497|516415061|FG000|Overall Study|Maximum clinical benefit|141|||
143235633|NCT00744497|516415062|FG001|Overall Study|Maximum clinical benefit|142|||
143235634|NCT00744497|516415061|FG000|Overall Study|Not defined|19|||
143235635|NCT00744497|516415062|FG001|Overall Study|Not defined|13|||
143235636|NCT03182374|516415070|FG000|Overall Study|Lost to Follow-up|3|||
143235637|NCT03182374|516415071|FG001|Overall Study|Lost to Follow-up|2|||
143235638|NCT03182374|516415070|FG000|Overall Study|Lack of Efficacy|8|||
143235639|NCT03182374|516415071|FG001|Overall Study|Lack of Efficacy|14|||
143235640|NCT03182374|516415070|FG000|Overall Study|Withdrawal by Subject|1|||
143235641|NCT03182374|516415071|FG001|Overall Study|Withdrawal by Subject|1|||
143235642|NCT03182374|516415070|FG000|Overall Study|exit for non-compliance|1|||
143235643|NCT03182374|516415071|FG001|Overall Study|exit for non-compliance|1|||
143235644|NCT03182374|516415070|FG000|Overall Study|one subject was randomized but not treated|1|||
143235645|NCT03182374|516415071|FG001|Overall Study|one subject was randomized but not treated|0|||
143235646|NCT03182374|516415070|FG000|Overall Study|Other reasons|0|||
143235647|NCT03182374|516415071|FG001|Overall Study|Other reasons|3|||
143235648|NCT01462370|516415073|FG000|Overall Study|Lack of Qualifying Event|1|||
143235649|NCT01462370|516415074|FG001|Overall Study|Lack of Qualifying Event|1|||
143235650|NCT01462370|516415073|FG000|Overall Study|Physician Decision|0|||
143235651|NCT01462370|516415074|FG001|Overall Study|Physician Decision|1|||
143235652|NCT01462370|516415073|FG000|Overall Study|Withdrawal by Subject|0|||
143235653|NCT01462370|516415074|FG001|Overall Study|Withdrawal by Subject|3|||
143235654|NCT01747876|516415075|FG000|Overall Study|Adverse Event|1|||
143235655|NCT01747876|516415076|FG001|Overall Study|Adverse Event|0|||
143235656|NCT01747876|516415077|FG002|Overall Study|Adverse Event|2|||
143235657|NCT01747876|516415075|FG000|Overall Study|Withdrawal by Subject|0|||
143235658|NCT01747876|516415076|FG001|Overall Study|Withdrawal by Subject|1|||
143235659|NCT01747876|516415077|FG002|Overall Study|Withdrawal by Subject|1|||
143235660|NCT01747876|516415075|FG000|Overall Study|Disease progression|4|||
143235661|NCT01747876|516415076|FG001|Overall Study|Disease progression|13|||
143235662|NCT01747876|516415077|FG002|Overall Study|Disease progression|8|||
143235663|NCT01747876|516415075|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
143235664|NCT01747876|516415076|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
143235665|NCT01747876|516415077|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
143235666|NCT03198715|516415080|FG000|Overall Study|Death|0|||
143235667|NCT03198715|516415081|FG001|Overall Study|Death|0|||
143235668|NCT03198715|516415082|FG002|Overall Study|Death|1|||
143023174|NCT01952574|515625739|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
143235669|NCT03198715|516415083|FG003|Overall Study|Death|0|||
143235670|NCT03198715|516415084|FG004|Overall Study|Death|2|||
143235671|NCT03198715|516415080|FG000|Overall Study|Other|0|||
143235672|NCT03198715|516415081|FG001|Overall Study|Other|1|||
143235673|NCT03198715|516415082|FG002|Overall Study|Other|1|||
143023175|NCT01952574|515625740|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
143023176|NCT01952574|515625741|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
143023177|NCT01952574|515625742|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
143235674|NCT03198715|516415083|FG003|Overall Study|Other|0|||
143235675|NCT03198715|516415084|FG004|Overall Study|Other|0|||
143235676|NCT00853307|516415087|FG000|Overall Study|Adverse Event|1|||
143235677|NCT00853307|516415088|FG001|Overall Study|Adverse Event|2|||
143235678|NCT00853307|516415087|FG000|Overall Study|Withdrawal by Subject|1|||
143235679|NCT00853307|516415088|FG001|Overall Study|Withdrawal by Subject|2|||
143235680|NCT00853307|516415087|FG000|Overall Study|Reason Not Specified|0|||
143235681|NCT00853307|516415088|FG001|Overall Study|Reason Not Specified|1|||
143235682|NCT00914316|516415091|FG000|Phase 1|Physician Decision|4|||
143235683|NCT00914316|516415092|FG001|Phase 1|Physician Decision|0|||
143235684|NCT00914316|516415093|FG002|Phase 1|Physician Decision|1|||
143235685|NCT00914316|516415094|FG003|Phase 1|Physician Decision|2|||
143235686|NCT00914316|516415091|FG000|Phase 1|Withdrawal by Subject|0|||
143235687|NCT00914316|516415092|FG001|Phase 1|Withdrawal by Subject|2|||
143235688|NCT00914316|516415093|FG002|Phase 1|Withdrawal by Subject|4|||
143235689|NCT00914316|516415094|FG003|Phase 1|Withdrawal by Subject|0|||
143235690|NCT00914316|516415091|FG000|Phase 1|Adverse Event|1|||
143235691|NCT00914316|516415092|FG001|Phase 1|Adverse Event|0|||
143235692|NCT00914316|516415093|FG002|Phase 1|Adverse Event|0|||
143235693|NCT00914316|516415094|FG003|Phase 1|Adverse Event|0|||
143486606|NCT01661140|517326511|FG002|Open-Label Period|Death|0|||
143486607|NCT01661140|517326509|FG000|Open-Label Period|Administrative/Other|1|||
143486608|NCT01661140|517326510|FG001|Open-Label Period|Administrative/Other|0|||
143486609|NCT01661140|517326511|FG002|Open-Label Period|Administrative/Other|0|||
143486610|NCT01661140|517326509|FG000|Open-Label Period|Sponsor termination|16|||
143235694|NCT00914316|516415091|FG000|Phase 2|Withdrawal by Subject|1|||
143235695|NCT00914316|516415092|FG001|Phase 2|Withdrawal by Subject|0|||
143235696|NCT00914316|516415093|FG002|Phase 2|Withdrawal by Subject|1|||
143235697|NCT00914316|516415094|FG003|Phase 2|Withdrawal by Subject|0|||
143235698|NCT02399163|516415099|FG000|Overall Study|Adverse Event|2|||
143235699|NCT02399163|516415099|FG000|Overall Study|Protocol Deviation|2|||
143235700|NCT02399163|516415099|FG000|Overall Study|Withdrawal by Participant|5|||
143235701|NCT00837434|516415103|FG000|Overall Study|Physician Decision|3|||
143235702|NCT00837434|516415104|FG001|Overall Study|Physician Decision|0|||
143235703|NCT00837434|516415103|FG000|Overall Study|Lost to Follow-up|1|||
143235704|NCT00837434|516415104|FG001|Overall Study|Lost to Follow-up|1|||
143235705|NCT00837434|516415103|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
143235706|NCT00837434|516415104|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
143235707|NCT00837434|516415103|FG000|Overall Study|Noncompliant|2|||
143235708|NCT00837434|516415104|FG001|Overall Study|Noncompliant|0|||
143235709|NCT00837434|516415103|FG000|Overall Study|Baseline assessments not done in time|1|||
143235710|NCT00837434|516415104|FG001|Overall Study|Baseline assessments not done in time|0|||
143235711|NCT00837434|516415103|FG000|Overall Study|Unable to obtain study drug|1|||
143235712|NCT00837434|516415104|FG001|Overall Study|Unable to obtain study drug|0|||
143235713|NCT01921205|516415105|FG000|Overall Study|Adverse Event|12|||
143235714|NCT01921205|516415106|FG001|Overall Study|Adverse Event|7|||
143235715|NCT01921205|516415105|FG000|Overall Study|Lack of Efficacy|1|||
143235716|NCT01921205|516415106|FG001|Overall Study|Lack of Efficacy|0|||
143235717|NCT01921205|516415105|FG000|Overall Study|Protocol Violation|1|||
143235718|NCT01921205|516415106|FG001|Overall Study|Protocol Violation|3|||
143235719|NCT01921205|516415105|FG000|Overall Study|Lost to Follow-up|1|||
143235720|NCT01921205|516415106|FG001|Overall Study|Lost to Follow-up|1|||
143235721|NCT01921205|516415105|FG000|Overall Study|Withdrawal by Subject|6|||
143235722|NCT01921205|516415106|FG001|Overall Study|Withdrawal by Subject|5|||
143235723|NCT01921205|516415105|FG000|Overall Study|Use Of Prohibited Medication|0|||
143235724|NCT01921205|516415106|FG001|Overall Study|Use Of Prohibited Medication|1|||
143486611|NCT01661140|517326510|FG001|Open-Label Period|Sponsor termination|0|||
143486612|NCT01661140|517326511|FG002|Open-Label Period|Sponsor termination|0|||
143235725|NCT01921205|516415105|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
143235726|NCT01921205|516415106|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
143235727|NCT01921205|516415105|FG000|Overall Study|Non Compliance Of The Parent|0|||
143235728|NCT01921205|516415106|FG001|Overall Study|Non Compliance Of The Parent|1|||
143235729|NCT01921205|516415105|FG000|Overall Study|Non Compliance Of Child|0|||
143235730|NCT01921205|516415106|FG001|Overall Study|Non Compliance Of Child|1|||
143235731|NCT00886379|516415107|FG000|Overall Study|Transferred Schools|0|||
143235732|NCT00886379|516415108|FG001|Overall Study|Transferred Schools|0|||
143486613|NCT01661140|517326509|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
143486614|NCT01661140|517326510|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
143235733|NCT00886379|516415109|FG002|Overall Study|Transferred Schools|2|||
143235734|NCT00886379|516415110|FG003|Overall Study|Transferred Schools|1|||
143235735|NCT00886379|516415111|FG004|Overall Study|Transferred Schools|1|||
143235736|NCT00886379|516415107|FG000|Overall Study|Final blood draw not obtained|3|||
143486615|NCT01661140|517326511|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
143156660|NCT02568423|516119373|FG005|Overall Study|Physician Decision|1|||
143156661|NCT02568423|516119374|FG006|Overall Study|Physician Decision|0|||
143156662|NCT02568423|516119375|FG007|Overall Study|Physician Decision|0|||
143156663|NCT03794544|516119378|FG000|Overall Study|Withdrawal by Subject|1|||
143156664|NCT03794544|516119379|FG001|Overall Study|Withdrawal by Subject|1|||
143156665|NCT03794544|516119380|FG002|Overall Study|Withdrawal by Subject|0|||
143156666|NCT03794544|516119381|FG003|Overall Study|Withdrawal by Subject|0|||
143156667|NCT03794544|516119378|FG000|Overall Study|Death|0|||
143156668|NCT03794544|516119379|FG001|Overall Study|Death|0|||
143156669|NCT03794544|516119380|FG002|Overall Study|Death|0|||
143156670|NCT03794544|516119381|FG003|Overall Study|Death|1|||
143156671|NCT03794544|516119378|FG000|Overall Study|Lost to Follow-up|0|||
143156672|NCT03794544|516119379|FG001|Overall Study|Lost to Follow-up|1|||
143156673|NCT03794544|516119380|FG002|Overall Study|Lost to Follow-up|1|||
143156674|NCT03794544|516119381|FG003|Overall Study|Lost to Follow-up|0|||
143156675|NCT03794544|516119378|FG000|Overall Study|Other|0|||
143156676|NCT03794544|516119379|FG001|Overall Study|Other|1|||
143156677|NCT03794544|516119380|FG002|Overall Study|Other|0|||
143156678|NCT03794544|516119381|FG003|Overall Study|Other|0|||
143156679|NCT01027416|516119382|FG000|Overall Study|Withdrawal by Subject|0|||
143156680|NCT01027416|516119383|FG001|Overall Study|Withdrawal by Subject|1|||
143156681|NCT01027416|516119382|FG000|Overall Study|Physician Decision|1|||
143156682|NCT01027416|516119383|FG001|Overall Study|Physician Decision|4|||
143156683|NCT00421733|516119384|FG000|Overall Study|Adverse Event|4|||
143156684|NCT00421733|516119385|FG001|Overall Study|Adverse Event|9|||
143156685|NCT00421733|516119386|FG002|Overall Study|Adverse Event|2|||
143156686|NCT00421733|516119384|FG000|Overall Study|Lost to Follow-up|1|||
143156687|NCT00421733|516119385|FG001|Overall Study|Lost to Follow-up|2|||
143156688|NCT00421733|516119386|FG002|Overall Study|Lost to Follow-up|4|||
143156689|NCT00421733|516119384|FG000|Overall Study|Withdrawal by Subject|1|||
143156690|NCT00421733|516119385|FG001|Overall Study|Withdrawal by Subject|2|||
143156691|NCT00421733|516119386|FG002|Overall Study|Withdrawal by Subject|7|||
143156692|NCT00421733|516119384|FG000|Overall Study|Death|0|||
143156693|NCT00421733|516119385|FG001|Overall Study|Death|3|||
143156694|NCT00421733|516119386|FG002|Overall Study|Death|0|||
143156695|NCT00421733|516119384|FG000|Overall Study|Required dialysis|1|||
143156696|NCT00421733|516119385|FG001|Overall Study|Required dialysis|0|||
143156697|NCT00421733|516119386|FG002|Overall Study|Required dialysis|0|||
143156698|NCT00421733|516119384|FG000|Overall Study|Administrative|2|||
143156699|NCT00421733|516119385|FG001|Overall Study|Administrative|0|||
143156700|NCT00421733|516119386|FG002|Overall Study|Administrative|0|||
143156701|NCT00421733|516119384|FG000|Overall Study|Did not satisfy entry criteria|1|||
143156702|NCT00421733|516119385|FG001|Overall Study|Did not satisfy entry criteria|3|||
143156703|NCT00421733|516119386|FG002|Overall Study|Did not satisfy entry criteria|2|||
143156704|NCT00421733|516119384|FG000|Overall Study|Sponsor request|1|||
143156705|NCT00421733|516119385|FG001|Overall Study|Sponsor request|0|||
143156706|NCT00421733|516119386|FG002|Overall Study|Sponsor request|3|||
143156707|NCT00421733|516119384|FG000|Overall Study|Protocol deviation|4|||
143156708|NCT00421733|516119385|FG001|Overall Study|Protocol deviation|7|||
143156709|NCT00421733|516119386|FG002|Overall Study|Protocol deviation|2|||
143156710|NCT00120250|516119387|FG000|Overall Study|Lost to Follow-up|1|||
143156711|NCT00120250|516119388|FG001|Overall Study|Lost to Follow-up|1|||
143156712|NCT00120250|516119387|FG000|Overall Study|Protocol Violation|0|||
143156713|NCT00120250|516119388|FG001|Overall Study|Protocol Violation|1|||
143156714|NCT00720083|516119389|FG000|Overall Study|Ineligible|1|||
143156715|NCT00720083|516119390|FG001|Overall Study|Ineligible|2|||
143156716|NCT00103506|516119393|FG000|Overall Study|Study closed by sponsor|34|||
143156717|NCT00103506|516119394|FG001|Overall Study|Study closed by sponsor|37|||
143156718|NCT00103506|516119393|FG000|Overall Study|Death|257|||
143156719|NCT00103506|516119394|FG001|Overall Study|Death|253|||
143156720|NCT00103506|516119393|FG000|Overall Study|Lost to Follow-up|13|||
143156721|NCT00103506|516119394|FG001|Overall Study|Lost to Follow-up|13|||
143156722|NCT00103506|516119393|FG000|Overall Study|Withdrawal by Subject|18|||
143156723|NCT00103506|516119394|FG001|Overall Study|Withdrawal by Subject|21|||
143156724|NCT00585585|516119395|FG000|Overall Study|Adverse Event|1|||
143156725|NCT02056288|516119396|FG000|In-Hospital Data|Surgery cancelled|1|||
143156726|NCT02056288|516119397|FG001|In-Hospital Data|Surgery cancelled|0|||
143156727|NCT02056288|516119396|FG000|In-Hospital Data|Protocol Violation|3|||
143156728|NCT02056288|516119397|FG001|In-Hospital Data|Protocol Violation|0|||
143156729|NCT02056288|516119396|FG000|In-Hospital Data|Physician Decision|1|||
143156730|NCT02056288|516119397|FG001|In-Hospital Data|Physician Decision|0|||
143156731|NCT02056288|516119396|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
143156732|NCT02056288|516119397|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
143156733|NCT01441414|516119398|FG000|Overall Study|Participant died|9|||
143156734|NCT01441414|516119398|FG000|Overall Study|Other reasons|3|||
143156735|NCT01441414|516119398|FG000|Overall Study|Study terminated by sponsor|2|||
143156736|NCT01441414|516119398|FG000|Overall Study|Subject refused further follow-up|1|||
143156737|NCT01773889|516119399|FG000|Overall Study|lack of funding|2|||
143156738|NCT03954938|516119400|FG000|Overall Study|Withdrawal by Subject|2|||
143023178|NCT01952574|515625743|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
143023179|NCT01952574|515625744|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
143023180|NCT01952574|515625738|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
143023181|NCT01952574|515625739|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
143023182|NCT01952574|515625740|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
143023183|NCT01952574|515625741|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
143023184|NCT01952574|515625742|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
143023185|NCT01952574|515625743|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
143023186|NCT01952574|515625744|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
143023187|NCT01952574|515625738|FG000|Open-label Treatment Phase|Missing|0|||
143023188|NCT01952574|515625739|FG001|Open-label Treatment Phase|Missing|0|||
143023189|NCT01952574|515625740|FG002|Open-label Treatment Phase|Missing|0|||
143023190|NCT01952574|515625741|FG003|Open-label Treatment Phase|Missing|0|||
143023191|NCT01952574|515625742|FG004|Open-label Treatment Phase|Missing|4|||
143023192|NCT01952574|515625743|FG005|Open-label Treatment Phase|Missing|0|||
143023193|NCT01952574|515625744|FG006|Open-label Treatment Phase|Missing|0|||
143023194|NCT01952574|515625738|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
143023195|NCT01952574|515625739|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
143023196|NCT01952574|515625740|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
143023197|NCT01952574|515625741|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
143023198|NCT01952574|515625742|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
143023199|NCT01952574|515625743|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
143023200|NCT01952574|515625744|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
143023201|NCT01952574|515625738|FG000|Open-label Treatment Phase|Death|0|||
143023202|NCT01952574|515625739|FG001|Open-label Treatment Phase|Death|0|||
143023203|NCT01952574|515625740|FG002|Open-label Treatment Phase|Death|0|||
143023204|NCT01952574|515625741|FG003|Open-label Treatment Phase|Death|0|||
143023205|NCT01952574|515625742|FG004|Open-label Treatment Phase|Death|1|||
143023206|NCT01952574|515625743|FG005|Open-label Treatment Phase|Death|0|||
143023207|NCT01952574|515625744|FG006|Open-label Treatment Phase|Death|0|||
143023208|NCT01952574|515625738|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
143023209|NCT01952574|515625739|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
143023210|NCT01952574|515625740|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
143023211|NCT01952574|515625741|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
143023212|NCT01952574|515625742|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
143023213|NCT01952574|515625743|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
143023214|NCT01952574|515625744|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
143023215|NCT01952574|515625738|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
143023216|NCT01952574|515625739|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
143023217|NCT01952574|515625740|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
143023218|NCT01952574|515625741|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
143023219|NCT01952574|515625742|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
143023220|NCT01952574|515625743|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
143023221|NCT01952574|515625744|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
143023222|NCT01107535|515625745|FG000|Overall Study|Death|5|||
143023223|NCT01360632|515625746|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
143023224|NCT01360632|515625747|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
143023225|NCT01360632|515625748|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
143023226|NCT01360632|515625749|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
143023227|NCT01360632|515625750|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
143023228|NCT01360632|515625746|FG000|Phase A (8 Weeks)|Adverse Event|60|||
143023229|NCT01360632|515625747|FG001|Phase A (8 Weeks)|Adverse Event|0|||
143156739|NCT03954938|516119400|FG000|Overall Study|Adverse Event|1|||
143156740|NCT00617903|516119406|FG000|Overall Study|Withdrawal by Subject|2|||
143156741|NCT00617903|516119407|FG001|Overall Study|Withdrawal by Subject|3|||
143156742|NCT00617903|516119406|FG000|Overall Study|Lost to Follow-up|1|||
143156743|NCT00617903|516119407|FG001|Overall Study|Lost to Follow-up|1|||
143156744|NCT00617903|516119406|FG000|Overall Study|Lack of Efficacy|0|||
143156745|NCT00617903|516119407|FG001|Overall Study|Lack of Efficacy|1|||
143156746|NCT00617903|516119406|FG000|Overall Study|Adverse Event|0|||
143156747|NCT00617903|516119407|FG001|Overall Study|Adverse Event|1|||
143156748|NCT00617903|516119406|FG000|Overall Study|noncompliance|0|||
143156749|NCT00617903|516119407|FG001|Overall Study|noncompliance|1|||
143156750|NCT01814332|516119415|FG000|Overall Study|Adverse Event|8|||
143156751|NCT01814332|516119416|FG001|Overall Study|Adverse Event|3|||
143156752|NCT01814332|516119415|FG000|Overall Study|Withdrawal by Subject|3|||
143023230|NCT01360632|515625748|FG002|Phase A (8 Weeks)|Adverse Event|0|||
143486616|NCT01661140|517326509|FG000|Open-Label Period|Lost to Follow-up|2|||
143156753|NCT01814332|516119416|FG001|Overall Study|Withdrawal by Subject|8|||
143023231|NCT01360632|515625749|FG003|Phase A (8 Weeks)|Adverse Event|0|||
143156754|NCT01814332|516119415|FG000|Overall Study|Protocol Violation|0|||
143156755|NCT01814332|516119416|FG001|Overall Study|Protocol Violation|4|||
143156756|NCT01814332|516119415|FG000|Overall Study|Lost to Follow-up|5|||
143156757|NCT01814332|516119416|FG001|Overall Study|Lost to Follow-up|1|||
143156758|NCT01755637|516119417|FG000|Period 1|Adverse Event|0|||
143486617|NCT01661140|517326510|FG001|Open-Label Period|Lost to Follow-up|0|||
143486618|NCT01661140|517326511|FG002|Open-Label Period|Lost to Follow-up|0|||
143486619|NCT01661140|517326509|FG000|Double-Blind Period|Refused Treatment|0|||
143486620|NCT01661140|517326510|FG001|Double-Blind Period|Refused Treatment|0|||
143486621|NCT01661140|517326511|FG002|Double-Blind Period|Refused Treatment|1|||
143486622|NCT01661140|517326509|FG000|Double-Blind Period|Adverse Event|0|||
143486623|NCT01661140|517326510|FG001|Double-Blind Period|Adverse Event|16|||
143486624|NCT01661140|517326511|FG002|Double-Blind Period|Adverse Event|18|||
143486625|NCT01661140|517326509|FG000|Double-Blind Period|Protocol Violation|0|||
143156759|NCT01755637|516119418|FG001|Period 1|Adverse Event|1|||
143156760|NCT04882215|516119419|FG000|Overall Study|Withdrawal by Subject|5|||
143156761|NCT04882215|516119420|FG001|Overall Study|Withdrawal by Subject|0|||
143156762|NCT04098302|516119421|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|3|||
143156763|NCT04098302|516119422|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|11|||
143156764|NCT04098302|516119423|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
143156765|NCT04098302|516119424|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
143156766|NCT04098302|516119421|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|5|||
143156767|NCT04098302|516119422|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
143156768|NCT04098302|516119423|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
143156769|NCT04098302|516119424|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
143156770|NCT04098302|516119421|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|2|||
143156771|NCT04098302|516119422|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|3|||
143156772|NCT04098302|516119423|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
143156773|NCT04098302|516119424|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
143156774|NCT04098302|516119421|FG000|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
143156775|NCT04098302|516119422|FG001|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
143156776|NCT04098302|516119423|FG002|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
143156777|NCT04098302|516119424|FG003|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
143156778|NCT04098302|516119421|FG000|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
143156779|NCT04098302|516119422|FG001|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
143156780|NCT04098302|516119423|FG002|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
143156781|NCT04098302|516119424|FG003|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
143156782|NCT04098302|516119421|FG000|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
143156783|NCT04098302|516119422|FG001|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
143156784|NCT04098302|516119423|FG002|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
143156785|NCT04098302|516119424|FG003|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|1|||
143156786|NCT04098302|516119421|FG000|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
143156787|NCT04098302|516119422|FG001|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
143156788|NCT04098302|516119423|FG002|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|1|||
143156789|NCT04098302|516119424|FG003|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
143156790|NCT04098302|516119421|FG000|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
143156791|NCT04098302|516119422|FG001|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
143156792|NCT04098302|516119423|FG002|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
143156793|NCT04098302|516119424|FG003|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|1|||
143156794|NCT00724893|516119425|FG000|Overall Study|Adverse Event|76|||
143156795|NCT00724893|516119426|FG001|Overall Study|Adverse Event|142|||
143156796|NCT00724893|516119425|FG000|Overall Study|Withdrawal by Subject|0|||
143156797|NCT00724893|516119426|FG001|Overall Study|Withdrawal by Subject|1|||
143156798|NCT00724893|516119425|FG000|Overall Study|Lack of virologic response|94|||
143156799|NCT00724893|516119426|FG001|Overall Study|Lack of virologic response|202|||
143156800|NCT00724893|516119425|FG000|Overall Study|Reason not specified|193|||
143156801|NCT00724893|516119426|FG001|Overall Study|Reason not specified|7|||
143156802|NCT00724893|516119425|FG000|Overall Study|Patient choice|0|||
143156803|NCT00724893|516119426|FG001|Overall Study|Patient choice|26|||
143156804|NCT00724893|516119425|FG000|Overall Study|Geographic reasons|0|||
143156805|NCT00724893|516119426|FG001|Overall Study|Geographic reasons|11|||
143156806|NCT00724893|516119425|FG000|Overall Study|Incarceration|0|||
143156807|NCT00724893|516119426|FG001|Overall Study|Incarceration|9|||
143156808|NCT00724893|516119425|FG000|Overall Study|Substance abuse|0|||
143156809|NCT00724893|516119426|FG001|Overall Study|Substance abuse|3|||
143156810|NCT00724893|516119425|FG000|Overall Study|Financial reasons|0|||
143486626|NCT01661140|517326510|FG001|Double-Blind Period|Protocol Violation|2|||
143486627|NCT01661140|517326511|FG002|Double-Blind Period|Protocol Violation|3|||
143486628|NCT01661140|517326509|FG000|Double-Blind Period|Withdrawal by Subject|0|||
143486629|NCT01661140|517326510|FG001|Double-Blind Period|Withdrawal by Subject|1|||
143486630|NCT01661140|517326511|FG002|Double-Blind Period|Withdrawal by Subject|3|||
143156811|NCT00724893|516119426|FG001|Overall Study|Financial reasons|2|||
143156812|NCT00724893|516119425|FG000|Overall Study|Assigned shorter treatment|0|||
143156813|NCT00724893|516119426|FG001|Overall Study|Assigned shorter treatment|2|||
143486631|NCT01661140|517326509|FG000|Double-Blind Period|Investigator's Decision|0|||
143486632|NCT01661140|517326510|FG001|Double-Blind Period|Investigator's Decision|1|||
143023232|NCT01360632|515625750|FG004|Phase A (8 Weeks)|Adverse Event|0|||
143023233|NCT01360632|515625746|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
143023234|NCT01360632|515625747|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
143023235|NCT01360632|515625748|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
143023236|NCT01360632|515625749|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
143023237|NCT01360632|515625750|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
143023238|NCT01360632|515625746|FG000|Phase A (8 Weeks)|Physician Decision|10|||
143023239|NCT01360632|515625747|FG001|Phase A (8 Weeks)|Physician Decision|0|||
143023240|NCT01360632|515625748|FG002|Phase A (8 Weeks)|Physician Decision|0|||
143023241|NCT01360632|515625749|FG003|Phase A (8 Weeks)|Physician Decision|0|||
143023242|NCT01360632|515625750|FG004|Phase A (8 Weeks)|Physician Decision|0|||
143023243|NCT01360632|515625746|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
143023244|NCT01360632|515625747|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
143023245|NCT01360632|515625748|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
143023246|NCT01360632|515625749|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
143023247|NCT01360632|515625750|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
143023248|NCT01360632|515625746|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
143023249|NCT01360632|515625747|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
143023250|NCT01360632|515625748|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
143023251|NCT01360632|515625749|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
143023252|NCT01360632|515625750|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
143023253|NCT01360632|515625746|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
143023254|NCT01360632|515625747|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
143023255|NCT01360632|515625748|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
143023256|NCT01360632|515625749|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
143023257|NCT01360632|515625750|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
143023258|NCT01360632|515625746|FG000|Phase B (6 Weeks)|Adverse Event|0|||
143023259|NCT01360632|515625747|FG001|Phase B (6 Weeks)|Adverse Event|3|||
143023260|NCT01360632|515625748|FG002|Phase B (6 Weeks)|Adverse Event|9|||
143023261|NCT01360632|515625749|FG003|Phase B (6 Weeks)|Adverse Event|3|||
143023262|NCT01360632|515625750|FG004|Phase B (6 Weeks)|Adverse Event|0|||
143023263|NCT01360632|515625746|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
143023264|NCT01360632|515625747|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
143023265|NCT01360632|515625748|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
143023266|NCT01360632|515625749|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
143023267|NCT01360632|515625750|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
143023268|NCT01360632|515625746|FG000|Phase B (6 Weeks)|Physician Decision|0|||
143023269|NCT01360632|515625747|FG001|Phase B (6 Weeks)|Physician Decision|0|||
143023270|NCT01360632|515625748|FG002|Phase B (6 Weeks)|Physician Decision|0|||
143023271|NCT01360632|515625749|FG003|Phase B (6 Weeks)|Physician Decision|1|||
143023272|NCT01360632|515625750|FG004|Phase B (6 Weeks)|Physician Decision|0|||
143023273|NCT01360632|515625746|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
143023274|NCT01360632|515625747|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
143023275|NCT01360632|515625748|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
143023276|NCT01360632|515625749|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
143023277|NCT01360632|515625750|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
143023278|NCT01360632|515625746|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
143023279|NCT01360632|515625747|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
143023280|NCT01360632|515625748|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
143023281|NCT01360632|515625749|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
143023282|NCT01360632|515625750|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
143023283|NCT01360632|515625746|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
143023284|NCT01360632|515625747|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
143023285|NCT01360632|515625748|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
143023286|NCT01360632|515625749|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
143023287|NCT01360632|515625750|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
143023288|NCT01360632|515625746|FG000|Phase A+|Lost to Follow-up|0|||
143023289|NCT01360632|515625747|FG001|Phase A+|Lost to Follow-up|0|||
143023290|NCT01360632|515625748|FG002|Phase A+|Lost to Follow-up|0|||
143023291|NCT01360632|515625749|FG003|Phase A+|Lost to Follow-up|0|||
143023292|NCT01360632|515625750|FG004|Phase A+|Lost to Follow-up|2|||
143023293|NCT01360632|515625746|FG000|Phase A+|Adverse Event|0|||
143023294|NCT01360632|515625747|FG001|Phase A+|Adverse Event|0|||
143156814|NCT00724893|516119425|FG000|Overall Study|Lost to Follow-up|0|||
143156815|NCT00724893|516119426|FG001|Overall Study|Lost to Follow-up|52|||
143486633|NCT01661140|517326511|FG002|Double-Blind Period|Investigator's Decision|2|||
143023295|NCT01360632|515625748|FG002|Phase A+|Adverse Event|0|||
143023296|NCT01360632|515625749|FG003|Phase A+|Adverse Event|0|||
143023297|NCT01360632|515625750|FG004|Phase A+|Adverse Event|2|||
143023298|NCT01360632|515625746|FG000|Phase A+|Met Withdrawal Criteria|0|||
143023299|NCT01360632|515625747|FG001|Phase A+|Met Withdrawal Criteria|0|||
143023300|NCT01360632|515625748|FG002|Phase A+|Met Withdrawal Criteria|0|||
143023301|NCT01360632|515625749|FG003|Phase A+|Met Withdrawal Criteria|0|||
143023302|NCT01360632|515625750|FG004|Phase A+|Met Withdrawal Criteria|7|||
143023303|NCT01360632|515625746|FG000|Phase A+|Physician Decision|0|||
143023304|NCT01360632|515625747|FG001|Phase A+|Physician Decision|0|||
143023305|NCT01360632|515625748|FG002|Phase A+|Physician Decision|0|||
143486634|NCT01661140|517326509|FG000|Double-Blind Period|Sponsor Termination|0|||
143486635|NCT01661140|517326510|FG001|Double-Blind Period|Sponsor Termination|14|||
143486636|NCT01661140|517326511|FG002|Double-Blind Period|Sponsor Termination|17|||
143486637|NCT01661140|517326509|FG000|Double-Blind Period|Administrative/Other|0|||
143486638|NCT01661140|517326510|FG001|Double-Blind Period|Administrative/Other|7|||
143486639|NCT01661140|517326511|FG002|Double-Blind Period|Administrative/Other|6|||
143486640|NCT01137773|517326512|FG000|Overall Study|Death|3|||
143486641|NCT01137773|517326513|FG001|Overall Study|Death|3|||
143486642|NCT01137773|517326512|FG000|Overall Study|Lost to Follow-up|6|||
143486643|NCT01137773|517326513|FG001|Overall Study|Lost to Follow-up|0|||
143486644|NCT03548051|517326514|FG000|Overall Study|Death|1|||
143486645|NCT03548051|517326515|FG001|Overall Study|Death|1|||
143486646|NCT03548051|517326514|FG000|Overall Study|Withdrawal by Subject|1|||
143486647|NCT03548051|517326515|FG001|Overall Study|Withdrawal by Subject|0|||
143486648|NCT00817531|517326517|FG000|Overall Study|Adverse Event|1|||
143486649|NCT00817531|517326517|FG000|Overall Study|Lack of Efficacy|1|||
143486650|NCT02239939|517326518|FG000|Overall Study|Adverse Event|1|||
143486651|NCT02239939|517326519|FG001|Overall Study|Adverse Event|0|||
143486652|NCT02239939|517326518|FG000|Overall Study|Withdrawal by Subject|1|||
143486653|NCT02239939|517326519|FG001|Overall Study|Withdrawal by Subject|1|||
143486654|NCT02239939|517326518|FG000|Overall Study|Lost to Follow-up|0|||
143486655|NCT02239939|517326519|FG001|Overall Study|Lost to Follow-up|1|||
143486656|NCT03325673|517326521|FG000|Overall Study|Adverse Event|4|||
143486657|NCT03325673|517326522|FG001|Overall Study|Adverse Event|0|||
143486658|NCT01870401|517326523|FG000|Overall Study|Death|48|||
143486659|NCT01870401|517326524|FG001|Overall Study|Death|24|||
143486660|NCT01870401|517326523|FG000|Overall Study|Withdrawal by Subject|39|||
143486661|NCT01870401|517326524|FG001|Overall Study|Withdrawal by Subject|26|||
143486662|NCT01870401|517326523|FG000|Overall Study|Lost to Follow-up|19|||
143486663|NCT01870401|517326524|FG001|Overall Study|Lost to Follow-up|14|||
143486664|NCT01870401|517326523|FG000|Overall Study|Other|9|||
143486665|NCT01870401|517326524|FG001|Overall Study|Other|7|||
143486666|NCT01870401|517326523|FG000|Overall Study|On-going in the Study|35|||
143486667|NCT01870401|517326524|FG001|Overall Study|On-going in the Study|25|||
143486668|NCT03509350|517326527|FG000|Overall Study|Withdrawal by Subject|0|||
143486669|NCT03509350|517326528|FG001|Overall Study|Withdrawal by Subject|2|||
143486670|NCT00535132|517326529|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
143486671|NCT00535132|517326530|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
143486672|NCT00535132|517326529|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
143486673|NCT00535132|517326530|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
143486674|NCT02590588|517326531|FG000|Overall Study|Adverse Event|1|||
143486675|NCT02559687|517326539|FG000|Overall Study|Death|112|||
143486676|NCT02559687|517326539|FG000|Overall Study|Sponsor Decision|5|||
143486677|NCT02559687|517326539|FG000|Overall Study|Withdrawal by Subject|4|||
143486678|NCT04951037|517326540|FG000|Overall Study|Lost to Follow-up|16|||
143156816|NCT00724893|516119425|FG000|Overall Study|Unknown, missing data|1|||
143156817|NCT00724893|516119426|FG001|Overall Study|Unknown, missing data|1|||
143156818|NCT01290731|516119427|FG000|Overall Study|Withdrawal by Subject|1|||
143156819|NCT01279200|516119428|FG000|Overall Study|Withdrawal by Subject|1|||
143156820|NCT01279200|516119429|FG001|Overall Study|Withdrawal by Subject|3|||
143156821|NCT01279200|516119428|FG000|Overall Study|Patient withdrawal due to high cost|0|||
143156822|NCT01279200|516119429|FG001|Overall Study|Patient withdrawal due to high cost|1|||
143156823|NCT01279200|516119428|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
143156824|NCT01279200|516119429|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
143156825|NCT01279200|516119428|FG000|Overall Study|ultrasound screening failure|0|||
143156826|NCT01279200|516119429|FG001|Overall Study|ultrasound screening failure|1|||
143156827|NCT01279200|516119428|FG000|Overall Study|Lost to Follow-up|0|||
143156828|NCT01279200|516119429|FG001|Overall Study|Lost to Follow-up|1|||
143156829|NCT01279200|516119428|FG000|Overall Study|Adverse Event|1|||
143156830|NCT01279200|516119429|FG001|Overall Study|Adverse Event|0|||
143156831|NCT01399099|516119430|FG000|Overall Study|Lost to Follow-up|14|||
143156832|NCT01399099|516119430|FG000|Overall Study|Physician Decision|1|||
143156833|NCT01399099|516119430|FG000|Overall Study|Protocol Violation|1|||
143156834|NCT01399099|516119430|FG000|Overall Study|Skin Irritation|13|||
143486679|NCT04951037|517326540|FG000|Overall Study|Withdrawal by Subject|5|||
143486680|NCT04951037|517326540|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
143486681|NCT05630937|517326543|FG000|Overall Study|Study terminated by sponsor|1|||
143156835|NCT01399099|516119430|FG000|Overall Study|Infection|1|||
143023306|NCT01360632|515625749|FG003|Phase A+|Physician Decision|0|||
143023307|NCT01360632|515625750|FG004|Phase A+|Physician Decision|3|||
143156836|NCT01399099|516119430|FG000|Overall Study|Miscellaneous|4|||
143156837|NCT01668537|516119432|FG000|Overall Study|Request to Discontinue Prematurely|1|||
143156838|NCT01668537|516119433|FG001|Overall Study|Request to Discontinue Prematurely|1|||
143156839|NCT01668537|516119432|FG000|Overall Study|Subject unwilling/unable to comply|5|||
143486682|NCT05630937|517326544|FG001|Overall Study|Study terminated by sponsor|1|||
143486683|NCT05630937|517326545|FG002|Overall Study|Study terminated by sponsor|8|||
143486684|NCT05630937|517326546|FG003|Overall Study|Study terminated by sponsor|0|||
143023308|NCT01360632|515625746|FG000|Phase A+|Withdrawal by Subject|0|||
143023309|NCT01360632|515625747|FG001|Phase A+|Withdrawal by Subject|0|||
143023310|NCT01360632|515625748|FG002|Phase A+|Withdrawal by Subject|0|||
143023311|NCT01360632|515625749|FG003|Phase A+|Withdrawal by Subject|0|||
143023312|NCT01360632|515625750|FG004|Phase A+|Withdrawal by Subject|8|||
143023313|NCT01360632|515625746|FG000|Phase A+|Protocol Deviation|0|||
143023314|NCT01360632|515625747|FG001|Phase A+|Protocol Deviation|0|||
143023315|NCT01360632|515625748|FG002|Phase A+|Protocol Deviation|0|||
143023316|NCT01360632|515625749|FG003|Phase A+|Protocol Deviation|0|||
143023317|NCT01360632|515625750|FG004|Phase A+|Protocol Deviation|3|||
143023318|NCT02123459|515625754|FG000|Washout Period (1 Day)|Adverse Event|1|||
143023319|NCT02123459|515625755|FG001|Washout Period (1 Day)|Adverse Event|0|||
143023320|NCT00254397|515625760|FG000|Overall Study|Disease Progression|4|||
143023321|NCT00254397|515625761|FG001|Overall Study|Disease Progression|1|||
143023322|NCT00254397|515625762|FG002|Overall Study|Disease Progression|16|||
143023323|NCT00254397|515625763|FG003|Overall Study|Disease Progression|23|||
143023324|NCT00254397|515625760|FG000|Overall Study|Non-Compliant|0|||
143023325|NCT00254397|515625761|FG001|Overall Study|Non-Compliant|0|||
143023326|NCT00254397|515625762|FG002|Overall Study|Non-Compliant|0|||
143023327|NCT00254397|515625763|FG003|Overall Study|Non-Compliant|1|||
143023328|NCT00254397|515625760|FG000|Overall Study|Adverse Event|2|||
143023329|NCT00254397|515625761|FG001|Overall Study|Adverse Event|0|||
143023330|NCT00254397|515625762|FG002|Overall Study|Adverse Event|3|||
143023331|NCT00254397|515625763|FG003|Overall Study|Adverse Event|1|||
143023332|NCT01070394|515625764|FG000|Overall Study|Adverse Event|6|||
143023333|NCT01070394|515625764|FG000|Overall Study|Withdrawal by Subject|1|||
143023334|NCT01715415|515625776|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
143023335|NCT01715415|515625777|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
143023336|NCT01715415|515625776|FG000|Double-blind Treatment|Adverse Event|3|||
143023337|NCT01715415|515625777|FG001|Double-blind Treatment|Adverse Event|0|||
143023338|NCT01715415|515625776|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
143023339|NCT01715415|515625777|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
143023340|NCT01715415|515625776|FG000|Double-blind Treatment|Other|1|||
143023341|NCT01715415|515625777|FG001|Double-blind Treatment|Other|0|||
143023342|NCT01715415|515625776|FG000|Open-label Treatment|Adverse Event|0|||
143023343|NCT01715415|515625777|FG001|Open-label Treatment|Adverse Event|1|||
143023344|NCT01715415|515625776|FG000|Open-label Treatment|Subject Noncompliant|0|||
143023345|NCT01715415|515625777|FG001|Open-label Treatment|Subject Noncompliant|1|||
143023346|NCT01015612|515625778|FG000|Overall Study|Death|113|||
143023347|NCT01015612|515625778|FG000|Overall Study|Withdrawal by Subject|40|||
143023348|NCT00066807|515625779|FG000|Overall Study|Study was terminated early|14|||
143023349|NCT00066807|515625780|FG001|Overall Study|Study was terminated early|15|||
143023350|NCT05028751|515625781|FG000|Overall Study|Study Terminated by Sponsor|3|||
143023351|NCT05028751|515625782|FG001|Overall Study|Study Terminated by Sponsor|0|||
143023352|NCT05028751|515625783|FG002|Overall Study|Study Terminated by Sponsor|0|||
143023353|NCT05028751|515625784|FG003|Overall Study|Study Terminated by Sponsor|0|||
143023354|NCT05028751|515625781|FG000|Overall Study|Death|9|||
143023355|NCT05028751|515625782|FG001|Overall Study|Death|3|||
143023356|NCT05028751|515625783|FG002|Overall Study|Death|2|||
143023357|NCT05028751|515625784|FG003|Overall Study|Death|4|||
143156840|NCT01668537|516119433|FG001|Overall Study|Subject unwilling/unable to comply|0|||
143156841|NCT01668537|516119432|FG000|Overall Study|Reason Precludes Participation|1|||
143156842|NCT01668537|516119433|FG001|Overall Study|Reason Precludes Participation|0|||
143156843|NCT01668537|516119432|FG000|Overall Study|Lost to Follow-up|13|||
143156844|NCT01668537|516119433|FG001|Overall Study|Lost to Follow-up|6|||
143156845|NCT01668537|516119432|FG000|Overall Study|Other|2|||
143156846|NCT01668537|516119433|FG001|Overall Study|Other|3|||
143156847|NCT01181128|516119437|FG000|Overall Study|Withdrawal by Subject|2|||
143156848|NCT01181128|516119438|FG001|Overall Study|Withdrawal by Subject|2|||
143156849|NCT01181128|516119439|FG002|Overall Study|Withdrawal by Subject|0|||
143156850|NCT01181128|516119437|FG000|Overall Study|Death|1|||
143023358|NCT05028751|515625781|FG000|Overall Study|Withdrawal by Subject|0|||
143023359|NCT05028751|515625782|FG001|Overall Study|Withdrawal by Subject|0|||
143023360|NCT05028751|515625783|FG002|Overall Study|Withdrawal by Subject|1|||
143023361|NCT05028751|515625784|FG003|Overall Study|Withdrawal by Subject|0|||
143023362|NCT05028751|515625781|FG000|Overall Study|Miscellaneous|2|||
143023363|NCT05028751|515625782|FG001|Overall Study|Miscellaneous|0|||
143156851|NCT01181128|516119438|FG001|Overall Study|Death|0|||
143156852|NCT01181128|516119439|FG002|Overall Study|Death|0|||
143156853|NCT01181128|516119437|FG000|Overall Study|Physician Decision|2|||
143156854|NCT01181128|516119438|FG001|Overall Study|Physician Decision|0|||
143156855|NCT01181128|516119439|FG002|Overall Study|Physician Decision|0|||
143023364|NCT05028751|515625783|FG002|Overall Study|Miscellaneous|0|||
143023365|NCT05028751|515625784|FG003|Overall Study|Miscellaneous|0|||
143023366|NCT03586830|515625786|FG000|Overall Study|Site terminated by Sponsor|1|||
143023367|NCT03586830|515625787|FG001|Overall Study|Site terminated by Sponsor|4|||
143023368|NCT03586830|515625788|FG002|Overall Study|Site terminated by Sponsor|3|||
143023369|NCT03586830|515625789|FG003|Overall Study|Site terminated by Sponsor|3|||
143023370|NCT03586830|515625786|FG000|Overall Study|Lost to Follow-up|0|||
143023371|NCT03586830|515625787|FG001|Overall Study|Lost to Follow-up|2|||
143023372|NCT03586830|515625788|FG002|Overall Study|Lost to Follow-up|2|||
143023373|NCT03586830|515625789|FG003|Overall Study|Lost to Follow-up|1|||
143023374|NCT03586830|515625786|FG000|Overall Study|Withdrawal by Subject|1|||
143023375|NCT03586830|515625787|FG001|Overall Study|Withdrawal by Subject|0|||
143023376|NCT03586830|515625788|FG002|Overall Study|Withdrawal by Subject|3|||
143023377|NCT03586830|515625789|FG003|Overall Study|Withdrawal by Subject|1|||
143023378|NCT04578548|515625790|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
143023379|NCT04578548|515625791|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
143023380|NCT04578548|515625790|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
143023381|NCT04578548|515625791|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
143023382|NCT04578548|515625790|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
143023383|NCT04578548|515625791|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
143023384|NCT04578548|515625790|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
143023385|NCT04578548|515625791|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
143023386|NCT04578548|515625790|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
143023387|NCT04578548|515625791|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
143023388|NCT04578548|515625790|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
143023389|NCT04578548|515625791|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
143023390|NCT00395083|515625794|FG000|Overall Study|Withdrawal by Subject|6|||
143023391|NCT00395083|515625795|FG001|Overall Study|Withdrawal by Subject|5|||
143023392|NCT00395083|515625794|FG000|Overall Study|Developed another disease|4|||
143023393|NCT00395083|515625795|FG001|Overall Study|Developed another disease|3|||
143023394|NCT00972153|515625796|FG000|Overall Study|Equipment malfunction during case|0|||
143023395|NCT00972153|515625797|FG001|Overall Study|Equipment malfunction during case|1|||
143023396|NCT00972153|515625798|FG002|Overall Study|Equipment malfunction during case|0|||
143023397|NCT01077713|515625799|FG000|Overall Study|Withdrawal by Subject|1|||
143023398|NCT01077713|515625800|FG001|Overall Study|Withdrawal by Subject|2|||
143023399|NCT01077713|515625799|FG000|Overall Study|Progressive Disease (PD)|0|||
143023400|NCT01077713|515625800|FG001|Overall Study|Progressive Disease (PD)|1|||
143023401|NCT01077713|515625799|FG000|Overall Study|Death|28|||
143023402|NCT01077713|515625800|FG001|Overall Study|Death|29|||
143023403|NCT01077713|515625799|FG000|Overall Study|Lost to Follow-up|1|||
143023404|NCT01077713|515625800|FG001|Overall Study|Lost to Follow-up|1|||
143023405|NCT01077713|515625799|FG000|Overall Study|Adverse Event|2|||
143023406|NCT01077713|515625800|FG001|Overall Study|Adverse Event|1|||
143023407|NCT01077713|515625799|FG000|Overall Study|Other|4|||
143023408|NCT01077713|515625800|FG001|Overall Study|Other|2|||
143023409|NCT04136626|515625801|FG000|Treatment Phase|Withdrawal by Subject|1|||
143023410|NCT04136626|515625802|FG001|Treatment Phase|Withdrawal by Subject|9|||
143023411|NCT04136626|515625801|FG000|Treatment Phase|Adverse Event|1|||
143023412|NCT04136626|515625802|FG001|Treatment Phase|Adverse Event|0|||
143023413|NCT04136626|515625801|FG000|Treatment Phase|Lost to Follow-up|1|||
143023414|NCT04136626|515625802|FG001|Treatment Phase|Lost to Follow-up|5|||
143023415|NCT04136626|515625801|FG000|12-month Follow-up|Lost to Follow-up|8|||
143023416|NCT04136626|515625802|FG001|12-month Follow-up|Lost to Follow-up|7|||
143023417|NCT00628745|515625803|FG000|Overall Study|Withdrawal by Subject|63|||
143023418|NCT00628745|515625804|FG001|Overall Study|Withdrawal by Subject|3|||
143023419|NCT00628745|515625805|FG002|Overall Study|Withdrawal by Subject|9|||
143023420|NCT00628745|515625806|FG003|Overall Study|Withdrawal by Subject|2|||
143023421|NCT00628745|515625807|FG004|Overall Study|Withdrawal by Subject|69|||
143023422|NCT00628745|515625803|FG000|Overall Study|Does not meet inclusion criteria|0|||
143156856|NCT01181128|516119437|FG000|Overall Study|Adverse Event|0|||
143156857|NCT01181128|516119438|FG001|Overall Study|Adverse Event|2|||
143156858|NCT01181128|516119439|FG002|Overall Study|Adverse Event|0|||
143156859|NCT01181128|516119437|FG000|Overall Study|Other|1|||
143156860|NCT01181128|516119438|FG001|Overall Study|Other|1|||
143156861|NCT01181128|516119439|FG002|Overall Study|Other|1|||
143156862|NCT00629239|516119440|FG000|Overall Study|Adverse Event|7|||
143156863|NCT00629239|516119441|FG001|Overall Study|Adverse Event|4|||
143156864|NCT00629239|516119440|FG000|Overall Study|Physician Decision|1|||
143156865|NCT00629239|516119441|FG001|Overall Study|Physician Decision|0|||
143156866|NCT00183391|516119444|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
143156867|NCT00183391|516119445|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
143156868|NCT00183391|516119444|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
143156869|NCT00183391|516119445|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
143023423|NCT00628745|515625804|FG001|Overall Study|Does not meet inclusion criteria|12|||
143023424|NCT00628745|515625805|FG002|Overall Study|Does not meet inclusion criteria|0|||
143156870|NCT02336503|516119447|FG000|Overall Study|Lost to Follow-up|0|||
143156871|NCT02336503|516119448|FG001|Overall Study|Lost to Follow-up|3|||
143156872|NCT02336503|516119449|FG002|Overall Study|Lost to Follow-up|0|||
143156873|NCT02336503|516119450|FG003|Overall Study|Lost to Follow-up|2|||
143023425|NCT00628745|515625806|FG003|Overall Study|Does not meet inclusion criteria|0|||
143156874|NCT02336503|516119447|FG000|Overall Study|Withdrawal by Subject|2|||
143486685|NCT05630937|517326543|FG000|Overall Study|Lost to Follow-up|0|||
143156875|NCT02336503|516119448|FG001|Overall Study|Withdrawal by Subject|0|||
143156876|NCT02336503|516119449|FG002|Overall Study|Withdrawal by Subject|0|||
143023426|NCT00628745|515625807|FG004|Overall Study|Does not meet inclusion criteria|18|||
143023427|NCT00628745|515625803|FG000|Overall Study|Participation in an interventional clinical trial|81|||
143023428|NCT00628745|515625804|FG001|Overall Study|Participation in an interventional clinical trial|4|||
143023429|NCT00628745|515625805|FG002|Overall Study|Participation in an interventional clinical trial|7|||
143023430|NCT00628745|515625806|FG003|Overall Study|Participation in an interventional clinical trial|0|||
143023431|NCT00628745|515625807|FG004|Overall Study|Participation in an interventional clinical trial|63|||
143023432|NCT00628745|515625803|FG000|Overall Study|Physician Decision|8|||
143023433|NCT00628745|515625804|FG001|Overall Study|Physician Decision|4|||
143023434|NCT00628745|515625805|FG002|Overall Study|Physician Decision|3|||
143023435|NCT00628745|515625806|FG003|Overall Study|Physician Decision|0|||
143023436|NCT00628745|515625807|FG004|Overall Study|Physician Decision|30|||
143023437|NCT00628745|515625803|FG000|Overall Study|Lost to Follow-up|109|||
143023438|NCT00628745|515625804|FG001|Overall Study|Lost to Follow-up|7|||
143023439|NCT00628745|515625805|FG002|Overall Study|Lost to Follow-up|7|||
143023440|NCT00628745|515625806|FG003|Overall Study|Lost to Follow-up|0|||
143023441|NCT00628745|515625807|FG004|Overall Study|Lost to Follow-up|498|||
143023442|NCT00628745|515625803|FG000|Overall Study|Death|197|||
143023443|NCT00628745|515625804|FG001|Overall Study|Death|81|||
143023444|NCT00628745|515625805|FG002|Overall Study|Death|12|||
143023445|NCT00628745|515625806|FG003|Overall Study|Death|4|||
143023446|NCT00628745|515625807|FG004|Overall Study|Death|939|||
143023447|NCT00628745|515625803|FG000|Overall Study|Participant transferred to another THAOS site|6|||
143023448|NCT00628745|515625804|FG001|Overall Study|Participant transferred to another THAOS site|0|||
143023449|NCT00628745|515625805|FG002|Overall Study|Participant transferred to another THAOS site|0|||
143023450|NCT00628745|515625806|FG003|Overall Study|Participant transferred to another THAOS site|0|||
143023451|NCT00628745|515625807|FG004|Overall Study|Participant transferred to another THAOS site|7|||
143023452|NCT00628745|515625803|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
143023453|NCT00628745|515625804|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
143023454|NCT00628745|515625805|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
143023455|NCT00628745|515625806|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
143023456|NCT00628745|515625807|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
143023457|NCT00628745|515625803|FG000|Overall Study|Site closure|152|||
143023458|NCT00628745|515625804|FG001|Overall Study|Site closure|146|||
143023459|NCT00628745|515625805|FG002|Overall Study|Site closure|6|||
143023460|NCT00628745|515625806|FG003|Overall Study|Site closure|8|||
143023461|NCT00628745|515625807|FG004|Overall Study|Site closure|691|||
143023462|NCT00628745|515625803|FG000|Overall Study|Duplicate participant|0|||
143023463|NCT00628745|515625804|FG001|Overall Study|Duplicate participant|0|||
143023464|NCT00628745|515625805|FG002|Overall Study|Duplicate participant|0|||
143023465|NCT00628745|515625806|FG003|Overall Study|Duplicate participant|0|||
143023466|NCT00628745|515625807|FG004|Overall Study|Duplicate participant|1|||
143023467|NCT00628745|515625803|FG000|Overall Study|Missing|4|||
143023468|NCT00628745|515625804|FG001|Overall Study|Missing|3|||
143023469|NCT00628745|515625805|FG002|Overall Study|Missing|0|||
143156877|NCT02336503|516119450|FG003|Overall Study|Withdrawal by Subject|4|||
143156878|NCT02336503|516119447|FG000|Overall Study|Adverse Event|0|||
143156879|NCT02336503|516119448|FG001|Overall Study|Adverse Event|0|||
143156880|NCT02336503|516119449|FG002|Overall Study|Adverse Event|1|||
143023470|NCT00628745|515625806|FG003|Overall Study|Missing|0|||
143156881|NCT02336503|516119450|FG003|Overall Study|Adverse Event|0|||
143156882|NCT02460380|516119451|FG000|Overall Study|Withdrawal by Subject|10|||
143156883|NCT02460380|516119452|FG001|Overall Study|Withdrawal by Subject|5|||
143156884|NCT00052715|516119456|FG000|Overall Study|wrong histology|1|||
143156885|NCT01936974|516119457|FG000|Overall Study|Physician Decision|2|||
143156886|NCT01936974|516119458|FG001|Overall Study|Physician Decision|5|||
143156887|NCT02807181|516119459|FG000|Overall Study|Death|28|||
143156888|NCT02807181|516119460|FG001|Overall Study|Death|24|||
143156889|NCT02807181|516119459|FG000|Overall Study|Withdrawal by Subject|1|||
143235737|NCT00886379|516415108|FG001|Overall Study|Final blood draw not obtained|3|||
143486686|NCT05630937|517326544|FG001|Overall Study|Lost to Follow-up|0|||
143023471|NCT00628745|515625807|FG004|Overall Study|Missing|10|||
143023472|NCT00628745|515625803|FG000|Overall Study|Othe reasons|987|||
143023473|NCT00628745|515625804|FG001|Overall Study|Othe reasons|373|||
143023474|NCT00628745|515625805|FG002|Overall Study|Othe reasons|105|||
143023475|NCT00628745|515625806|FG003|Overall Study|Othe reasons|1|||
143023476|NCT00628745|515625807|FG004|Overall Study|Othe reasons|1772|||
143023477|NCT01513551|515627252|FG000|Overall Study|Death|0|||
143023478|NCT01513551|515627253|FG001|Overall Study|Death|1|||
143156890|NCT02807181|516119460|FG001|Overall Study|Withdrawal by Subject|1|||
143156891|NCT02807181|516119459|FG000|Overall Study|Lost to Follow-up|0|||
143156892|NCT02807181|516119460|FG001|Overall Study|Lost to Follow-up|2|||
143156893|NCT02807181|516119459|FG000|Overall Study|Subject decision|1|||
143156894|NCT02807181|516119460|FG001|Overall Study|Subject decision|0|||
143023479|NCT01513551|515627254|FG002|Overall Study|Death|0|||
143023480|NCT01513551|515627252|FG000|Overall Study|Lost to Follow-up|3|||
143023481|NCT01513551|515627253|FG001|Overall Study|Lost to Follow-up|5|||
143023482|NCT01513551|515627254|FG002|Overall Study|Lost to Follow-up|2|||
143023483|NCT01513551|515627252|FG000|Overall Study|Withdrawal by Subject|1|||
143023484|NCT01513551|515627253|FG001|Overall Study|Withdrawal by Subject|0|||
143023485|NCT01513551|515627254|FG002|Overall Study|Withdrawal by Subject|2|||
143023486|NCT01513551|515627252|FG000|Overall Study|Randomized but not vaccinated|0|||
143023487|NCT01513551|515627253|FG001|Overall Study|Randomized but not vaccinated|0|||
143023488|NCT01513551|515627254|FG002|Overall Study|Randomized but not vaccinated|1|||
143023489|NCT01335477|515627255|FG000|Overall Study|Adverse Event|30|||
143023490|NCT01335477|515627256|FG001|Overall Study|Adverse Event|42|||
143023491|NCT01335477|515627255|FG000|Overall Study|Non compliant with protocol|0|||
143023492|NCT01335477|515627256|FG001|Overall Study|Non compliant with protocol|2|||
143023493|NCT01335477|515627255|FG000|Overall Study|Lost to Follow-up|1|||
143023494|NCT01335477|515627256|FG001|Overall Study|Lost to Follow-up|2|||
143023495|NCT01335477|515627255|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
143023496|NCT01335477|515627256|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
143023497|NCT01335477|515627255|FG000|Overall Study|Not treated|1|||
143023498|NCT01335477|515627256|FG001|Overall Study|Not treated|2|||
143023499|NCT01335477|515627255|FG000|Overall Study|Reason other than those stated above|2|||
143023500|NCT01335477|515627256|FG001|Overall Study|Reason other than those stated above|2|||
143023501|NCT02497391|515627258|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
143023502|NCT02497391|515627259|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
143023503|NCT02497391|515627260|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
143023504|NCT02497391|515627261|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
143023505|NCT02497391|515627262|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
143023506|NCT02497391|515627263|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
143023507|NCT02497391|515627258|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
143023508|NCT02497391|515627259|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
143023509|NCT02497391|515627260|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
143023510|NCT02497391|515627261|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
143023511|NCT02497391|515627262|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
143023512|NCT02497391|515627263|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
143023513|NCT02497391|515627258|FG000|Period 3 (14 Days)|Adverse Event|0|||
143023514|NCT02497391|515627259|FG001|Period 3 (14 Days)|Adverse Event|1|||
143023515|NCT02497391|515627260|FG002|Period 3 (14 Days)|Adverse Event|0|||
143023516|NCT02497391|515627261|FG003|Period 3 (14 Days)|Adverse Event|0|||
143023517|NCT02497391|515627262|FG004|Period 3 (14 Days)|Adverse Event|0|||
143023518|NCT02497391|515627263|FG005|Period 3 (14 Days)|Adverse Event|0|||
143023519|NCT02497391|515627258|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
143023520|NCT02497391|515627259|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
143023521|NCT02497391|515627260|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
143023522|NCT02497391|515627261|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
143023523|NCT02497391|515627262|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
143023524|NCT02497391|515627263|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
143023525|NCT02497391|515627258|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
143156895|NCT02807181|516119459|FG000|Overall Study|Biopsy of tumor removed from resection|1|||
143156896|NCT02807181|516119460|FG001|Overall Study|Biopsy of tumor removed from resection|0|||
143156897|NCT02807181|516119459|FG000|Overall Study|In Study|3|||
143156898|NCT02807181|516119460|FG001|Overall Study|In Study|3|||
143156899|NCT02807181|516119459|FG000|Overall Study|Post Progression|3|||
143156900|NCT02807181|516119460|FG001|Overall Study|Post Progression|2|||
143156901|NCT05507450|516119462|FG000|Overall Study|Death|0|||
143156902|NCT05507450|516119463|FG001|Overall Study|Death|0|||
143156903|NCT05507450|516119464|FG002|Overall Study|Death|1|||
143156904|NCT05507450|516119465|FG003|Overall Study|Death|0|||
143156905|NCT05507450|516119462|FG000|Overall Study|Lost to Follow-up|22|||
143156906|NCT05507450|516119463|FG001|Overall Study|Lost to Follow-up|20|||
143156907|NCT05507450|516119464|FG002|Overall Study|Lost to Follow-up|20|||
143156908|NCT05507450|516119465|FG003|Overall Study|Lost to Follow-up|7|||
143156909|NCT05507450|516119462|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
143156910|NCT05507450|516119463|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
143156911|NCT05507450|516119464|FG002|Overall Study|Randomized By Mistake Without Study Treatment|1|||
143156912|NCT05507450|516119465|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
143156913|NCT05507450|516119462|FG000|Overall Study|Withdrawal by Subject|4|||
143156914|NCT05507450|516119463|FG001|Overall Study|Withdrawal by Subject|11|||
143156915|NCT05507450|516119464|FG002|Overall Study|Withdrawal by Subject|7|||
143156916|NCT05507450|516119465|FG003|Overall Study|Withdrawal by Subject|3|||
143156917|NCT05507450|516119462|FG000|Overall Study|Participant left the country|0|||
143156918|NCT05507450|516119463|FG001|Overall Study|Participant left the country|0|||
143156919|NCT05507450|516119464|FG002|Overall Study|Participant left the country|1|||
143156920|NCT05507450|516119465|FG003|Overall Study|Participant left the country|0|||
143156921|NCT01078545|516119466|FG000|Overall Study|Lost to Follow-up|13|||
143156922|NCT01078545|516119466|FG000|Overall Study|Physician Decision|6|||
143156923|NCT01078545|516119466|FG000|Overall Study|Withdrawal by Subject|3|||
143023526|NCT02497391|515627259|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
143023527|NCT02497391|515627260|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
143023528|NCT02497391|515627261|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
143023529|NCT02497391|515627262|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
143023530|NCT02497391|515627263|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
143023531|NCT03740698|515627265|FG000|Overall Study|Physician Decision|0|||
143023532|NCT03740698|515627266|FG001|Overall Study|Physician Decision|1|||
143023533|NCT03740698|515627267|FG002|Overall Study|Physician Decision|1|||
143023534|NCT01466686|515627273|FG000|Overall Study|Withdrawal by Subject|1|||
143023535|NCT00633152|515627283|FG000|Overall Study|Adverse Event|1|||
143023536|NCT00633152|515627284|FG001|Overall Study|Adverse Event|0|||
143023537|NCT00633152|515627283|FG000|Overall Study|Randomized, did not receive study drug|5|||
143023538|NCT00633152|515627284|FG001|Overall Study|Randomized, did not receive study drug|2|||
143023539|NCT00633152|515627283|FG000|Overall Study|Withdrawal by Subject|1|||
143023540|NCT00633152|515627284|FG001|Overall Study|Withdrawal by Subject|1|||
143023541|NCT00633152|515627283|FG000|Overall Study|Lost to Follow-up|4|||
143023542|NCT00633152|515627284|FG001|Overall Study|Lost to Follow-up|1|||
143023543|NCT00633152|515627283|FG000|Overall Study|Miscellaneous Other|3|||
143023544|NCT00633152|515627284|FG001|Overall Study|Miscellaneous Other|2|||
143023545|NCT02049359|515627285|FG000|Overall Study|Lost to Follow-up|26|||
143023546|NCT02049359|515627286|FG001|Overall Study|Lost to Follow-up|19|||
143023547|NCT03273387|515627287|FG000|Overall Study|Death|2|||
143023548|NCT03273387|515627288|FG001|Overall Study|Death|2|||
143023549|NCT03273387|515627287|FG000|Overall Study|Withdrawal by Subject|1|||
143023550|NCT03273387|515627288|FG001|Overall Study|Withdrawal by Subject|1|||
143023551|NCT05216978|515627289|FG000|Overall Study|Withdrawal by Subject|3|||
143023552|NCT05216978|515627289|FG000|Overall Study|Lost to Follow-up|5|||
143023553|NCT00658320|515627291|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
143023554|NCT00658320|515627292|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
143023555|NCT00658320|515627291|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
143023556|NCT00658320|515627292|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
143023557|NCT00658320|515627291|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
143023558|NCT00658320|515627292|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
143023559|NCT00658320|515627291|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
143023560|NCT00658320|515627292|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
143023561|NCT01405950|515627293|FG000|Overall Study|Withdrawal by Subject|1|||
143023562|NCT01405950|515627294|FG001|Overall Study|Withdrawal by Subject|0|||
143023563|NCT01405950|515627295|FG002|Overall Study|Withdrawal by Subject|0|||
143023564|NCT01405950|515627296|FG003|Overall Study|Withdrawal by Subject|0|||
143023565|NCT01381900|515627306|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
143023566|NCT01381900|515627307|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
143023567|NCT01381900|515627308|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
143023568|NCT01381900|515627306|FG000|Overall Study|Adverse Event|4|||
143023569|NCT01381900|515627307|FG001|Overall Study|Adverse Event|6|||
143023570|NCT01381900|515627308|FG002|Overall Study|Adverse Event|7|||
143023571|NCT01381900|515627306|FG000|Overall Study|Noncompliance with study drug|0|||
143023572|NCT01381900|515627307|FG001|Overall Study|Noncompliance with study drug|0|||
143023573|NCT01381900|515627308|FG002|Overall Study|Noncompliance with study drug|1|||
143023574|NCT01381900|515627306|FG000|Overall Study|Physician Decision|0|||
143023575|NCT01381900|515627307|FG001|Overall Study|Physician Decision|1|||
143156924|NCT01078545|516119466|FG000|Overall Study|Death|3|||
143156925|NCT01078545|516119466|FG000|Overall Study|Participant moved to another physician|1|||
143156926|NCT02497755|516119467|FG000|Overall Study|Protocol Violation|1|||
143486687|NCT05630937|517326545|FG002|Overall Study|Lost to Follow-up|1|||
143156927|NCT02497755|516119468|FG001|Overall Study|Protocol Violation|0|||
143156928|NCT01774370|516119469|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
143156929|NCT01774370|516119469|FG000|Overall Study|Administered prior to the contract date|4|||
143486688|NCT05630937|517326546|FG003|Overall Study|Lost to Follow-up|0|||
143023576|NCT01381900|515627308|FG002|Overall Study|Physician Decision|1|||
143023577|NCT01381900|515627306|FG000|Overall Study|Protocol Violation|0|||
143486689|NCT05630937|517326543|FG000|Overall Study|Enrolled but not treated|0|||
143486690|NCT05630937|517326544|FG001|Overall Study|Enrolled but not treated|0|||
143486691|NCT05630937|517326545|FG002|Overall Study|Enrolled but not treated|0|||
143023578|NCT01381900|515627307|FG001|Overall Study|Protocol Violation|1|||
143023579|NCT01381900|515627308|FG002|Overall Study|Protocol Violation|1|||
143486692|NCT05630937|517326546|FG003|Overall Study|Enrolled but not treated|1|||
143023580|NCT01381900|515627306|FG000|Overall Study|Withdrawal by Subject|0|||
143023581|NCT01381900|515627307|FG001|Overall Study|Withdrawal by Subject|0|||
143023582|NCT01381900|515627308|FG002|Overall Study|Withdrawal by Subject|1|||
143023583|NCT01381900|515627306|FG000|Overall Study|Early withdraw|3|||
143023584|NCT01381900|515627307|FG001|Overall Study|Early withdraw|1|||
143156930|NCT01774370|516119469|FG000|Overall Study|Subjects of contraindications|34|||
143486693|NCT00267748|517326551|FG000|Non-randomized Period|Progressive disease|10|||
143486694|NCT00267748|517326552|FG001|Non-randomized Period|Progressive disease|0|||
143023585|NCT01381900|515627308|FG002|Overall Study|Early withdraw|1|||
143023586|NCT02410252|515627309|FG000|Overall Study|Withdrawal by Subject|4|||
143023587|NCT02410252|515627309|FG000|Overall Study|Physician Decision|2|||
143023588|NCT01452529|515627321|FG000|Run-in Period|Adverse Event|96|||
143023589|NCT01452529|515627322|FG001|Run-in Period|Adverse Event|0|||
143023590|NCT01452529|515627323|FG002|Run-in Period|Adverse Event|0|||
143023591|NCT01452529|515627321|FG000|Run-in Period|Withdrawal by Subject|49|||
143023592|NCT01452529|515627322|FG001|Run-in Period|Withdrawal by Subject|0|||
143023593|NCT01452529|515627323|FG002|Run-in Period|Withdrawal by Subject|0|||
143023594|NCT01452529|515627321|FG000|Run-in Period|Lost to Follow-up|19|||
143023595|NCT01452529|515627322|FG001|Run-in Period|Lost to Follow-up|0|||
143023596|NCT01452529|515627323|FG002|Run-in Period|Lost to Follow-up|0|||
143023597|NCT01452529|515627321|FG000|Run-in Period|Lack of Efficacy|46|||
143023598|NCT01452529|515627322|FG001|Run-in Period|Lack of Efficacy|0|||
143023599|NCT01452529|515627323|FG002|Run-in Period|Lack of Efficacy|0|||
143023600|NCT01452529|515627321|FG000|Run-in Period|Confirmed or suspected diversion|23|||
143023601|NCT01452529|515627322|FG001|Run-in Period|Confirmed or suspected diversion|0|||
143023602|NCT01452529|515627323|FG002|Run-in Period|Confirmed or suspected diversion|0|||
143023603|NCT01452529|515627321|FG000|Run-in Period|Administrative|21|||
143023604|NCT01452529|515627322|FG001|Run-in Period|Administrative|0|||
143023605|NCT01452529|515627323|FG002|Run-in Period|Administrative|0|||
143023606|NCT01452529|515627321|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
143023607|NCT01452529|515627322|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
143023608|NCT01452529|515627323|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
143023609|NCT01452529|515627321|FG000|Double-blind (DB) Period|Adverse Event|0|||
143023610|NCT01452529|515627322|FG001|Double-blind (DB) Period|Adverse Event|18|||
143023611|NCT01452529|515627323|FG002|Double-blind (DB) Period|Adverse Event|11|||
143023612|NCT01452529|515627321|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
143023613|NCT01452529|515627322|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
143023614|NCT01452529|515627323|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
143023615|NCT01452529|515627321|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
143023616|NCT01452529|515627322|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
143023617|NCT01452529|515627323|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
143023618|NCT01452529|515627321|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
143023619|NCT01452529|515627322|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
143023620|NCT01452529|515627323|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
143023621|NCT01452529|515627321|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
143023622|NCT01452529|515627322|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
143023623|NCT01452529|515627323|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
143023624|NCT01452529|515627321|FG000|Double-blind (DB) Period|Administrative|0|||
143023625|NCT01452529|515627322|FG001|Double-blind (DB) Period|Administrative|11|||
143023626|NCT01452529|515627323|FG002|Double-blind (DB) Period|Administrative|7|||
143023627|NCT03551730|515627324|FG000|Overall Study|Adverse Event|1|||
143023628|NCT03551730|515627325|FG001|Overall Study|Adverse Event|0|||
143023629|NCT03551730|515627326|FG002|Overall Study|Adverse Event|0|||
143023630|NCT03551730|515627327|FG003|Overall Study|Adverse Event|0|||
143023631|NCT00671879|515627341|FG000|Overall Study|Withdrawal by Subject|0|||
143023632|NCT00671879|515627342|FG001|Overall Study|Withdrawal by Subject|4|||
143156931|NCT01774370|516119469|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
143156932|NCT01774370|516119469|FG000|Overall Study|Follow-up failure|34|||
143156933|NCT05436288|516119470|FG000|Overall Study|Lost to Follow-up|1|||
143156934|NCT05436288|516119470|FG000|Overall Study|Adverse Event|1|||
143156935|NCT02280499|516119476|FG000|Overall Study|Death|14|||
143156936|NCT02280499|516119476|FG000|Overall Study|Lost to Follow-up|42|||
143156937|NCT02280499|516119476|FG000|Overall Study|Adverse Event|5|||
143156938|NCT01436500|516119477|FG000|Overall Study|Death|1|||
143156939|NCT01436500|516119478|FG001|Overall Study|Death|0|||
143156940|NCT01436500|516119479|FG002|Overall Study|Death|0|||
143156941|NCT01436500|516119480|FG003|Overall Study|Death|0|||
143156942|NCT01436500|516119481|FG004|Overall Study|Death|0|||
143156943|NCT01436500|516119477|FG000|Overall Study|Adverse Event|0|||
143156944|NCT01436500|516119478|FG001|Overall Study|Adverse Event|2|||
143156945|NCT01436500|516119479|FG002|Overall Study|Adverse Event|2|||
143156946|NCT01436500|516119480|FG003|Overall Study|Adverse Event|0|||
143156947|NCT01436500|516119481|FG004|Overall Study|Adverse Event|1|||
143156948|NCT01436500|516119477|FG000|Overall Study|Withdrawal by Subject|0|||
143023633|NCT00671879|515627343|FG002|Overall Study|Withdrawal by Subject|6|||
143023634|NCT02884206|515627344|FG000|Valsartan Run-in Period|Death|1|||
143023635|NCT02884206|515627345|FG001|Valsartan Run-in Period|Death|0|||
143156949|NCT01436500|516119478|FG001|Overall Study|Withdrawal by Subject|0|||
143156950|NCT01436500|516119479|FG002|Overall Study|Withdrawal by Subject|2|||
143156951|NCT01436500|516119480|FG003|Overall Study|Withdrawal by Subject|0|||
143156952|NCT01436500|516119481|FG004|Overall Study|Withdrawal by Subject|2|||
143156953|NCT01436500|516119477|FG000|Overall Study|Physician Decision|0|||
143235738|NCT00886379|516415109|FG002|Overall Study|Final blood draw not obtained|4|||
143156954|NCT01436500|516119478|FG001|Overall Study|Physician Decision|0|||
143023636|NCT02884206|515627346|FG002|Valsartan Run-in Period|Death|0|||
143486695|NCT00267748|517326553|FG002|Non-randomized Period|Progressive disease|0|||
143486696|NCT00267748|517326551|FG000|Non-randomized Period|Adverse Event|8|||
143486697|NCT00267748|517326552|FG001|Non-randomized Period|Adverse Event|0|||
143486698|NCT00267748|517326553|FG002|Non-randomized Period|Adverse Event|0|||
143486699|NCT00267748|517326551|FG000|Non-randomized Period|Death|1|||
143486700|NCT00267748|517326552|FG001|Non-randomized Period|Death|0|||
143486701|NCT00267748|517326553|FG002|Non-randomized Period|Death|0|||
143486702|NCT00267748|517326551|FG000|Non-randomized Period|Participant not willing to participate|1|||
143486703|NCT00267748|517326552|FG001|Non-randomized Period|Participant not willing to participate|0|||
143486704|NCT00267748|517326553|FG002|Non-randomized Period|Participant not willing to participate|0|||
143486705|NCT00267748|517326551|FG000|Non-randomized Period|Other|3|||
143486706|NCT00267748|517326552|FG001|Non-randomized Period|Other|0|||
143486707|NCT00267748|517326553|FG002|Non-randomized Period|Other|0|||
143486708|NCT00267748|517326551|FG000|Randomized Period|Death|0|||
143486709|NCT00267748|517326552|FG001|Randomized Period|Death|2|||
143486710|NCT00267748|517326553|FG002|Randomized Period|Death|3|||
143486711|NCT00267748|517326551|FG000|Randomized Period|Adverse Event|0|||
143486712|NCT00267748|517326552|FG001|Randomized Period|Adverse Event|23|||
143486713|NCT00267748|517326553|FG002|Randomized Period|Adverse Event|25|||
143486714|NCT00267748|517326551|FG000|Randomized Period|Global deterioration of health status|0|||
143486715|NCT00267748|517326552|FG001|Randomized Period|Global deterioration of health status|6|||
143486716|NCT00267748|517326553|FG002|Randomized Period|Global deterioration of health status|7|||
143023637|NCT02884206|515627344|FG000|Valsartan Run-in Period|Adverse Event|31|||
143023638|NCT02884206|515627345|FG001|Valsartan Run-in Period|Adverse Event|0|||
143023639|NCT02884206|515627346|FG002|Valsartan Run-in Period|Adverse Event|0|||
143023640|NCT02884206|515627344|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
143023641|NCT02884206|515627345|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
143023642|NCT02884206|515627346|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
143363744|NCT04978363|516875435|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
143486717|NCT00267748|517326551|FG000|Randomized Period|Lost to Follow-up|0|||
143486718|NCT00267748|517326552|FG001|Randomized Period|Lost to Follow-up|1|||
143486719|NCT00267748|517326553|FG002|Randomized Period|Lost to Follow-up|0|||
143486720|NCT00267748|517326551|FG000|Randomized Period|Objective progression or relapse|0|||
143486721|NCT00267748|517326552|FG001|Randomized Period|Objective progression or relapse|77|||
143486722|NCT00267748|517326553|FG002|Randomized Period|Objective progression or relapse|86|||
143486723|NCT00267748|517326551|FG000|Randomized Period|Withdrawal by Subject|0|||
143023643|NCT02884206|515627344|FG000|Valsartan Run-in Period|Protocol deviation|4|||
143023644|NCT02884206|515627345|FG001|Valsartan Run-in Period|Protocol deviation|0|||
143023645|NCT02884206|515627346|FG002|Valsartan Run-in Period|Protocol deviation|0|||
143023646|NCT02884206|515627344|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
143023647|NCT02884206|515627345|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
143023648|NCT02884206|515627346|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
143023649|NCT02884206|515627344|FG000|Valsartan Run-in Period|Physician Decision|1|||
143023650|NCT02884206|515627345|FG001|Valsartan Run-in Period|Physician Decision|0|||
143023651|NCT02884206|515627346|FG002|Valsartan Run-in Period|Physician Decision|0|||
143023652|NCT02884206|515627344|FG000|LCZ696 Run-in Period|Adverse Event|38|||
143023653|NCT02884206|515627345|FG001|LCZ696 Run-in Period|Adverse Event|0|||
143023654|NCT02884206|515627346|FG002|LCZ696 Run-in Period|Adverse Event|0|||
143023655|NCT02884206|515627344|FG000|LCZ696 Run-in Period|Death|2|||
143023656|NCT02884206|515627345|FG001|LCZ696 Run-in Period|Death|0|||
143023657|NCT02884206|515627346|FG002|LCZ696 Run-in Period|Death|0|||
143023658|NCT02884206|515627344|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
143023659|NCT02884206|515627345|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
143023660|NCT02884206|515627346|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
143023661|NCT02884206|515627344|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
143023662|NCT02884206|515627345|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
143023663|NCT02884206|515627346|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
143023664|NCT02884206|515627344|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
143023665|NCT02884206|515627345|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
143023666|NCT02884206|515627346|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
143023667|NCT02884206|515627344|FG000|LCZ696 Run-in Period|Physician Decision|1|||
143023668|NCT02884206|515627345|FG001|LCZ696 Run-in Period|Physician Decision|0|||
143023669|NCT02884206|515627346|FG002|LCZ696 Run-in Period|Physician Decision|0|||
143023670|NCT02884206|515627344|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
143023671|NCT02884206|515627345|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
143023672|NCT02884206|515627346|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
143023673|NCT02884206|515627344|FG000|Double-Blind Period|Death|0|||
143023674|NCT02884206|515627345|FG001|Double-Blind Period|Death|28|||
143023675|NCT02884206|515627346|FG002|Double-Blind Period|Death|39|||
143023676|NCT02884206|515627344|FG000|Double-Blind Period|Patient/guardian decision|0|||
143023677|NCT02884206|515627345|FG001|Double-Blind Period|Patient/guardian decision|10|||
143023678|NCT02884206|515627346|FG002|Double-Blind Period|Patient/guardian decision|13|||
143023679|NCT02884206|515627344|FG000|Double-Blind Period|Lost to Follow-up|0|||
143023680|NCT02884206|515627345|FG001|Double-Blind Period|Lost to Follow-up|4|||
143023681|NCT02884206|515627346|FG002|Double-Blind Period|Lost to Follow-up|4|||
143023682|NCT02884206|515627344|FG000|Double-Blind Period|Physician Decision|0|||
143023683|NCT02884206|515627345|FG001|Double-Blind Period|Physician Decision|2|||
143023684|NCT02884206|515627346|FG002|Double-Blind Period|Physician Decision|0|||
143023685|NCT02884206|515627344|FG000|Double-Blind Period|Adverse Event|0|||
143023686|NCT02884206|515627345|FG001|Double-Blind Period|Adverse Event|0|||
143023687|NCT02884206|515627346|FG002|Double-Blind Period|Adverse Event|3|||
143023688|NCT02884206|515627344|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
143023689|NCT02884206|515627345|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
143023690|NCT02884206|515627346|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
143023691|NCT03907280|515627351|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
143023692|NCT03907280|515627352|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
143023693|NCT03907280|515627353|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
143023694|NCT02231710|515627354|FG000|Overall Study|Physician Decision|1|||
143023695|NCT01399723|515627355|FG000|Overall Study|Lost to Follow-up|0|||
143023696|NCT01399723|515627356|FG001|Overall Study|Lost to Follow-up|1|||
143023697|NCT04081337|515627357|FG000|Overall Study|Adverse Event|0|||
143023698|NCT04081337|515627358|FG001|Overall Study|Adverse Event|1|||
143023699|NCT04081337|515627357|FG000|Overall Study|Withdrawal by Subject|2|||
143023700|NCT04081337|515627358|FG001|Overall Study|Withdrawal by Subject|0|||
143023701|NCT04081337|515627357|FG000|Overall Study|Physician Decision|1|||
143023702|NCT04081337|515627358|FG001|Overall Study|Physician Decision|2|||
143023703|NCT04081337|515627357|FG000|Overall Study|Lost to Follow-up|1|||
143023704|NCT04081337|515627358|FG001|Overall Study|Lost to Follow-up|0|||
143023705|NCT01464827|515627359|FG000|Overall Study|Adverse Event|0|||
143023706|NCT01464827|515627360|FG001|Overall Study|Adverse Event|0|||
143023707|NCT01464827|515627361|FG002|Overall Study|Adverse Event|0|||
143023708|NCT01464827|515627362|FG003|Overall Study|Adverse Event|0|||
143023709|NCT01464827|515627363|FG004|Overall Study|Adverse Event|0|||
143023710|NCT01464827|515627364|FG005|Overall Study|Adverse Event|0|||
143023711|NCT01464827|515627365|FG006|Overall Study|Adverse Event|0|||
143023712|NCT01464827|515627366|FG007|Overall Study|Adverse Event|0|||
143023713|NCT01464827|515627367|FG008|Overall Study|Adverse Event|0|||
143023714|NCT01464827|515627368|FG009|Overall Study|Adverse Event|0|||
143023715|NCT01464827|515627369|FG010|Overall Study|Adverse Event|0|||
143023716|NCT01464827|515627370|FG011|Overall Study|Adverse Event|0|||
143023717|NCT01464827|515627371|FG012|Overall Study|Adverse Event|1|||
143023718|NCT01464827|515627372|FG013|Overall Study|Adverse Event|0|||
143023719|NCT01464827|515627359|FG000|Overall Study|Withdrawal by Subject|1|||
143023720|NCT01464827|515627360|FG001|Overall Study|Withdrawal by Subject|0|||
143023721|NCT01464827|515627361|FG002|Overall Study|Withdrawal by Subject|0|||
143023722|NCT01464827|515627362|FG003|Overall Study|Withdrawal by Subject|0|||
143023723|NCT01464827|515627363|FG004|Overall Study|Withdrawal by Subject|1|||
143023724|NCT01464827|515627364|FG005|Overall Study|Withdrawal by Subject|0|||
143023725|NCT01464827|515627365|FG006|Overall Study|Withdrawal by Subject|0|||
143023726|NCT01464827|515627366|FG007|Overall Study|Withdrawal by Subject|1|||
143023727|NCT01464827|515627367|FG008|Overall Study|Withdrawal by Subject|0|||
143023728|NCT01464827|515627368|FG009|Overall Study|Withdrawal by Subject|0|||
143023729|NCT01464827|515627369|FG010|Overall Study|Withdrawal by Subject|0|||
143023730|NCT01464827|515627370|FG011|Overall Study|Withdrawal by Subject|0|||
143023731|NCT01464827|515627371|FG012|Overall Study|Withdrawal by Subject|0|||
143023732|NCT01464827|515627372|FG013|Overall Study|Withdrawal by Subject|0|||
143023733|NCT01464827|515627359|FG000|Overall Study|Lost to Follow-up|0|||
143023734|NCT01464827|515627360|FG001|Overall Study|Lost to Follow-up|2|||
143023735|NCT01464827|515627361|FG002|Overall Study|Lost to Follow-up|0|||
143023736|NCT01464827|515627362|FG003|Overall Study|Lost to Follow-up|2|||
143023737|NCT01464827|515627363|FG004|Overall Study|Lost to Follow-up|3|||
143023738|NCT01464827|515627364|FG005|Overall Study|Lost to Follow-up|1|||
143023739|NCT01464827|515627365|FG006|Overall Study|Lost to Follow-up|2|||
143023740|NCT01464827|515627366|FG007|Overall Study|Lost to Follow-up|2|||
143156955|NCT01436500|516119479|FG002|Overall Study|Physician Decision|1|||
143156956|NCT01436500|516119480|FG003|Overall Study|Physician Decision|0|||
143156957|NCT01436500|516119481|FG004|Overall Study|Physician Decision|0|||
143156958|NCT01436500|516119477|FG000|Overall Study|liver transplant|1|||
143156959|NCT01436500|516119478|FG001|Overall Study|liver transplant|0|||
143156960|NCT01436500|516119479|FG002|Overall Study|liver transplant|0|||
143156961|NCT01436500|516119480|FG003|Overall Study|liver transplant|0|||
143023741|NCT01464827|515627367|FG008|Overall Study|Lost to Follow-up|0|||
143023742|NCT01464827|515627368|FG009|Overall Study|Lost to Follow-up|0|||
143023743|NCT01464827|515627369|FG010|Overall Study|Lost to Follow-up|0|||
143023744|NCT01464827|515627370|FG011|Overall Study|Lost to Follow-up|1|||
143156962|NCT01436500|516119481|FG004|Overall Study|liver transplant|0|||
143023745|NCT01464827|515627371|FG012|Overall Study|Lost to Follow-up|0|||
143023746|NCT01464827|515627372|FG013|Overall Study|Lost to Follow-up|1|||
143023747|NCT01464827|515627359|FG000|Overall Study|Other|2|||
143023748|NCT01464827|515627360|FG001|Overall Study|Other|3|||
143023749|NCT01464827|515627361|FG002|Overall Study|Other|0|||
143023750|NCT01464827|515627362|FG003|Overall Study|Other|2|||
143023751|NCT01464827|515627363|FG004|Overall Study|Other|3|||
143023752|NCT01464827|515627364|FG005|Overall Study|Other|0|||
143023753|NCT01464827|515627365|FG006|Overall Study|Other|1|||
143023754|NCT01464827|515627366|FG007|Overall Study|Other|0|||
143023755|NCT01464827|515627367|FG008|Overall Study|Other|3|||
143023756|NCT01464827|515627368|FG009|Overall Study|Other|1|||
143023757|NCT01464827|515627369|FG010|Overall Study|Other|2|||
143023758|NCT01464827|515627370|FG011|Overall Study|Other|0|||
143023759|NCT01464827|515627371|FG012|Overall Study|Other|1|||
143023760|NCT01464827|515627372|FG013|Overall Study|Other|0|||
143023761|NCT01464827|515627359|FG000|Overall Study|Not Treated|0|||
143023762|NCT01464827|515627360|FG001|Overall Study|Not Treated|2|||
143023763|NCT01464827|515627361|FG002|Overall Study|Not Treated|0|||
143023764|NCT01464827|515627362|FG003|Overall Study|Not Treated|0|||
143023765|NCT01464827|515627363|FG004|Overall Study|Not Treated|1|||
143023766|NCT01464827|515627364|FG005|Overall Study|Not Treated|0|||
143023767|NCT01464827|515627365|FG006|Overall Study|Not Treated|1|||
143023768|NCT01464827|515627366|FG007|Overall Study|Not Treated|0|||
143023769|NCT01464827|515627367|FG008|Overall Study|Not Treated|0|||
143023770|NCT01464827|515627368|FG009|Overall Study|Not Treated|2|||
143023771|NCT01464827|515627369|FG010|Overall Study|Not Treated|0|||
143023772|NCT01464827|515627370|FG011|Overall Study|Not Treated|1|||
143023773|NCT01464827|515627371|FG012|Overall Study|Not Treated|0|||
143023774|NCT01464827|515627372|FG013|Overall Study|Not Treated|2|||
143023775|NCT03487796|515627373|FG000|Overall Study|Lost to Follow-up|18|||
143023776|NCT03487796|515627374|FG001|Overall Study|Lost to Follow-up|6|||
143023777|NCT00124020|515627375|FG000|Overall Study|Death|67|||
143023778|NCT00124020|515627376|FG001|Overall Study|Death|71|||
143023779|NCT00124020|515627375|FG000|Overall Study|Withdrawal by Subject|13|||
143023780|NCT00124020|515627376|FG001|Overall Study|Withdrawal by Subject|11|||
143023781|NCT00124020|515627375|FG000|Overall Study|Lost to Follow-up|5|||
143023782|NCT00124020|515627376|FG001|Overall Study|Lost to Follow-up|8|||
143023783|NCT00124020|515627375|FG000|Overall Study|Other|1|||
143023784|NCT00124020|515627376|FG001|Overall Study|Other|1|||
143023785|NCT00124020|515627375|FG000|Overall Study|Transfer to another hospital|2|||
143023786|NCT00124020|515627376|FG001|Overall Study|Transfer to another hospital|0|||
143023787|NCT05487456|515627380|FG000|Overall Study|Withdrawal by Subject|0|||
143023788|NCT05487456|515627381|FG001|Overall Study|Withdrawal by Subject|0|||
143023789|NCT05487456|515627382|FG002|Overall Study|Withdrawal by Subject|1|||
143023790|NCT05487456|515627383|FG003|Overall Study|Withdrawal by Subject|0|||
143023791|NCT01625377|515627384|FG000|Overall Study|Death|1|||
143023792|NCT01625377|515627385|FG001|Overall Study|Death|1|||
143023793|NCT01625377|515627384|FG000|Overall Study|Administrative Problem|1|||
143023794|NCT01625377|515627385|FG001|Overall Study|Administrative Problem|1|||
143023795|NCT01625377|515627384|FG000|Overall Study|Protocol Violation|0|||
143023796|NCT01625377|515627385|FG001|Overall Study|Protocol Violation|3|||
143023797|NCT01625377|515627384|FG000|Overall Study|Adverse Event|3|||
143023798|NCT01625377|515627385|FG001|Overall Study|Adverse Event|16|||
143023799|NCT01625377|515627384|FG000|Overall Study|Graft loss|1|||
143023800|NCT01625377|515627385|FG001|Overall Study|Graft loss|0|||
143023801|NCT01625377|515627384|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
143023802|NCT01625377|515627385|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
143023803|NCT01625377|515627384|FG000|Overall Study|Abnormal laboratory values|1|||
143023804|NCT01625377|515627385|FG001|Overall Study|Abnormal laboratory values|0|||
143023805|NCT01489956|515627386|FG000|Overall Study|Lost to Follow-up|1|||
143023806|NCT01489956|515627387|FG001|Overall Study|Lost to Follow-up|0|||
143023807|NCT01489956|515627388|FG002|Overall Study|Lost to Follow-up|0|||
143023808|NCT01489956|515627386|FG000|Overall Study|Withdrawal by Subject|0|||
143023809|NCT01489956|515627387|FG001|Overall Study|Withdrawal by Subject|0|||
143023810|NCT01489956|515627388|FG002|Overall Study|Withdrawal by Subject|1|||
143023811|NCT02784106|515627389|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
143023812|NCT02784106|515627390|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
143023813|NCT02784106|515627391|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
143023814|NCT02784106|515627392|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
143023815|NCT02784106|515627389|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
143023816|NCT02784106|515627390|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
143023817|NCT02784106|515627391|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
143023818|NCT02784106|515627392|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
143023819|NCT02784106|515627389|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
143023820|NCT02784106|515627390|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
143023821|NCT02784106|515627391|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
143023822|NCT02784106|515627392|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
143023823|NCT02784106|515627389|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
143023824|NCT02784106|515627390|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
143023825|NCT02784106|515627391|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
143023826|NCT02784106|515627392|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
143023827|NCT02784106|515627389|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
143023828|NCT02784106|515627390|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
143023829|NCT02784106|515627391|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
143023830|NCT02784106|515627392|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
143023831|NCT02784106|515627389|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
143023832|NCT02784106|515627390|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
143023833|NCT02784106|515627391|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
143023834|NCT02784106|515627392|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
143023835|NCT00718159|515627393|FG000|Overall Study|Progressive Disease|3|||
143023836|NCT00718159|515627394|FG001|Overall Study|Progressive Disease|3|||
143023837|NCT00718159|515627395|FG002|Overall Study|Progressive Disease|2|||
143023838|NCT00718159|515627396|FG003|Overall Study|Progressive Disease|0|||
143023839|NCT00718159|515627397|FG004|Overall Study|Progressive Disease|6|||
143486724|NCT00267748|517326552|FG001|Randomized Period|Withdrawal by Subject|9|||
143486725|NCT00267748|517326553|FG002|Randomized Period|Withdrawal by Subject|2|||
143023840|NCT00718159|515627398|FG005|Overall Study|Progressive Disease|0|||
143156963|NCT01436500|516119477|FG000|Overall Study|initiation of dialysis|0|||
143156964|NCT01436500|516119478|FG001|Overall Study|initiation of dialysis|0|||
143156965|NCT01436500|516119479|FG002|Overall Study|initiation of dialysis|0|||
143156966|NCT01436500|516119480|FG003|Overall Study|initiation of dialysis|0|||
143156967|NCT01436500|516119481|FG004|Overall Study|initiation of dialysis|1|||
143156968|NCT01436500|516119477|FG000|Overall Study|discontinued study drug|1|||
143156969|NCT01436500|516119478|FG001|Overall Study|discontinued study drug|0|||
143156970|NCT01436500|516119479|FG002|Overall Study|discontinued study drug|0|||
143156971|NCT01436500|516119480|FG003|Overall Study|discontinued study drug|0|||
143156972|NCT01436500|516119481|FG004|Overall Study|discontinued study drug|0|||
143156973|NCT01436500|516119477|FG000|Overall Study|Other|0|||
143156974|NCT01436500|516119478|FG001|Overall Study|Other|1|||
143156975|NCT01436500|516119479|FG002|Overall Study|Other|0|||
143156976|NCT01436500|516119480|FG003|Overall Study|Other|1|||
143156977|NCT01436500|516119481|FG004|Overall Study|Other|0|||
143156978|NCT00356421|516119489|FG000|Overall Study|Lack of Efficacy|3|||
143156979|NCT00356421|516119490|FG001|Overall Study|Lack of Efficacy|0|||
143156980|NCT00356421|516119489|FG000|Overall Study|Withdrawal by Subject|9|||
143156981|NCT00356421|516119490|FG001|Overall Study|Withdrawal by Subject|2|||
143156982|NCT00356421|516119489|FG000|Overall Study|Related to study drug|15|||
143156983|NCT00356421|516119490|FG001|Overall Study|Related to study drug|12|||
143156984|NCT00356421|516119489|FG000|Overall Study|Not related to study drug|5|||
143156985|NCT00356421|516119490|FG001|Overall Study|Not related to study drug|3|||
143156986|NCT00545948|516119494|FG000|Overall Study|Not Treated|1|||
143156987|NCT00545948|516119495|FG001|Overall Study|Not Treated|1|||
143156988|NCT00545948|516119496|FG002|Overall Study|Not Treated|7|||
143156989|NCT03336866|516119511|FG000|Overall Study|Lost to Follow-up|2|||
143156990|NCT03336866|516119512|FG001|Overall Study|Lost to Follow-up|0|||
143156991|NCT03336866|516119513|FG002|Overall Study|Lost to Follow-up|3|||
143156992|NCT03336866|516119511|FG000|Overall Study|Withdrawal by Subject|1|||
143156993|NCT03336866|516119512|FG001|Overall Study|Withdrawal by Subject|1|||
143156994|NCT03336866|516119513|FG002|Overall Study|Withdrawal by Subject|0|||
143156995|NCT03336866|516119511|FG000|Overall Study|Noncompliance with clinic house rules|0|||
143156996|NCT03336866|516119512|FG001|Overall Study|Noncompliance with clinic house rules|0|||
143156997|NCT03336866|516119513|FG002|Overall Study|Noncompliance with clinic house rules|1|||
143156998|NCT00541775|516119514|FG000|Overall Study|Adverse Event|3|||
143156999|NCT00541775|516119515|FG001|Overall Study|Adverse Event|2|||
143157000|NCT00541775|516119516|FG002|Overall Study|Adverse Event|1|||
143157001|NCT00541775|516119514|FG000|Overall Study|Lack of Efficacy|0|||
143157002|NCT00541775|516119515|FG001|Overall Study|Lack of Efficacy|0|||
143157003|NCT00541775|516119516|FG002|Overall Study|Lack of Efficacy|3|||
143157004|NCT00541775|516119514|FG000|Overall Study|Lost to Follow-up|0|||
143157005|NCT00541775|516119515|FG001|Overall Study|Lost to Follow-up|0|||
143157006|NCT00541775|516119516|FG002|Overall Study|Lost to Follow-up|2|||
143157007|NCT00541775|516119514|FG000|Overall Study|Protocol Violation|1|||
143023841|NCT00718159|515627399|FG006|Overall Study|Progressive Disease|0|||
143023842|NCT00718159|515627393|FG000|Overall Study|Death due to Adverse Event|0|||
143023843|NCT00718159|515627394|FG001|Overall Study|Death due to Adverse Event|0|||
143363745|NCT04978363|516875436|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
143486726|NCT00267748|517326551|FG000|Randomized Period|Other|0|||
143486727|NCT00267748|517326552|FG001|Randomized Period|Other|9|||
143023844|NCT00718159|515627395|FG002|Overall Study|Death due to Adverse Event|0|||
143157008|NCT00541775|516119515|FG001|Overall Study|Protocol Violation|0|||
143157009|NCT00541775|516119516|FG002|Overall Study|Protocol Violation|0|||
143157010|NCT00541775|516119514|FG000|Overall Study|Withdrawal by Subject and Other|5|||
143157011|NCT00541775|516119515|FG001|Overall Study|Withdrawal by Subject and Other|0|||
143157012|NCT00541775|516119516|FG002|Overall Study|Withdrawal by Subject and Other|2|||
143157013|NCT00421993|516119517|FG000|Overall Study|Withdrawal by Subject|22|||
143157014|NCT00421993|516119518|FG001|Overall Study|Withdrawal by Subject|23|||
143235739|NCT00886379|516415110|FG003|Overall Study|Final blood draw not obtained|2|||
143235740|NCT00886379|516415111|FG004|Overall Study|Final blood draw not obtained|2|||
143235741|NCT03367793|516415112|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
143235742|NCT03367793|516415113|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
143235743|NCT03367793|516415114|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
143235744|NCT03367793|516415115|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
143235745|NCT03367793|516415116|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
143235746|NCT03367793|516415117|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
143486728|NCT00267748|517326553|FG002|Randomized Period|Other|6|||
143486729|NCT00267748|517326551|FG000|Randomized Period|randomized but not treated|0|||
143235747|NCT00003475|516415118|FG000|Overall Study|Not evaluable|13|||
143235748|NCT04682366|516415119|FG000|Overall Study|Lost to Follow-up|1|||
143235749|NCT04682366|516415120|FG001|Overall Study|Lost to Follow-up|1|||
143235750|NCT04543279|516415124|FG000|Overall Study|Withdrawal by Subject|1|||
143235751|NCT04543279|516415125|FG001|Overall Study|Withdrawal by Subject|0|||
143235752|NCT04543279|516415124|FG000|Overall Study|Adverse Event|1|||
143235753|NCT04543279|516415125|FG001|Overall Study|Adverse Event|0|||
143235754|NCT04543279|516415124|FG000|Overall Study|Physician Decision|1|||
143235755|NCT04543279|516415125|FG001|Overall Study|Physician Decision|0|||
143235756|NCT00929695|516415126|FG000|Overall Study|Death|2|||
143235757|NCT00929695|516415127|FG001|Overall Study|Death|1|||
143235758|NCT00929695|516415126|FG000|Overall Study|Withdrawal by Subject|0|||
143235759|NCT00929695|516415127|FG001|Overall Study|Withdrawal by Subject|2|||
143235760|NCT00929695|516415126|FG000|Overall Study|discharge home|4|||
143235761|NCT00929695|516415127|FG001|Overall Study|discharge home|3|||
143235762|NCT00929695|516415126|FG000|Overall Study|incorrect stratification|2|||
143235763|NCT00929695|516415127|FG001|Overall Study|incorrect stratification|0|||
143235764|NCT02651675|516415132|FG000|Overall Study|Death|0|||
143235765|NCT02651675|516415133|FG001|Overall Study|Death|0|||
143235766|NCT02651675|516415134|FG002|Overall Study|Death|1|||
143235767|NCT03597347|516415138|FG000|Overall Study|Withdrawal by Subject|1|||
143235768|NCT03597347|516415139|FG001|Overall Study|Withdrawal by Subject|1|||
143235769|NCT03597347|516415140|FG002|Overall Study|Withdrawal by Subject|0|||
143235770|NCT03597347|516415138|FG000|Overall Study|Withdrawal due to Covid-19|3|||
143235771|NCT03597347|516415139|FG001|Overall Study|Withdrawal due to Covid-19|0|||
143235772|NCT03597347|516415140|FG002|Overall Study|Withdrawal due to Covid-19|0|||
143235773|NCT03597347|516415138|FG000|Overall Study|Sponsor decision to terminate study|3|||
143235774|NCT03597347|516415139|FG001|Overall Study|Sponsor decision to terminate study|2|||
143235775|NCT03597347|516415140|FG002|Overall Study|Sponsor decision to terminate study|4|||
143235776|NCT04606134|516415141|FG000|Overall Study|Adverse Event|0|||
143235777|NCT04606134|516415142|FG001|Overall Study|Adverse Event|1|||
143235778|NCT00107653|516415143|FG000|Overall Study|Adverse Event|24|||
143235779|NCT00107653|516415144|FG001|Overall Study|Adverse Event|43|||
143235780|NCT00107653|516415143|FG000|Overall Study|Insufficient Therapeutic Response|25|||
143235781|NCT00107653|516415144|FG001|Overall Study|Insufficient Therapeutic Response|11|||
143235782|NCT00107653|516415143|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
143235783|NCT00107653|516415144|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
143235784|NCT00107653|516415143|FG000|Overall Study|Protocol Violation|1|||
143235785|NCT00107653|516415144|FG001|Overall Study|Protocol Violation|0|||
143235786|NCT00107653|516415143|FG000|Overall Study|Withdrawal by Subject|12|||
143235787|NCT00107653|516415144|FG001|Overall Study|Withdrawal by Subject|13|||
143235788|NCT00107653|516415143|FG000|Overall Study|Lost to Follow-up|13|||
143235789|NCT00107653|516415144|FG001|Overall Study|Lost to Follow-up|5|||
143235790|NCT00107653|516415143|FG000|Overall Study|Administrative Reasons|3|||
143235791|NCT00107653|516415144|FG001|Overall Study|Administrative Reasons|3|||
143235792|NCT02018562|516415148|FG000|Overall Study|Withdrawal by Subject|2|||
143235793|NCT02018562|516415149|FG001|Overall Study|Withdrawal by Subject|0|||
143235794|NCT02018562|516415148|FG000|Overall Study|Discharged prior to study completion|1|||
143235795|NCT02018562|516415149|FG001|Overall Study|Discharged prior to study completion|0|||
143235796|NCT05194124|516415151|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
143235797|NCT05194124|516415152|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
143235798|NCT05194124|516415153|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
143235799|NCT05194124|516415154|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
143235800|NCT05194124|516415155|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
143486730|NCT00267748|517326552|FG001|Randomized Period|randomized but not treated|0|||
143486731|NCT00267748|517326553|FG002|Randomized Period|randomized but not treated|3|||
143235801|NCT05194124|516415156|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
143235802|NCT05194124|516415157|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
143235803|NCT05194124|516415158|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
143235804|NCT05194124|516415159|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
143235805|NCT05194124|516415160|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
143235806|NCT05194124|516415151|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
143235807|NCT05194124|516415152|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
143023845|NCT00718159|515627396|FG003|Overall Study|Death due to Adverse Event|2|||
143023846|NCT00718159|515627397|FG004|Overall Study|Death due to Adverse Event|2|||
143023847|NCT00718159|515627398|FG005|Overall Study|Death due to Adverse Event|0|||
143023848|NCT00718159|515627399|FG006|Overall Study|Death due to Adverse Event|0|||
143023849|NCT00718159|515627393|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
143023850|NCT00718159|515627394|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
143023851|NCT00718159|515627395|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
143023852|NCT00718159|515627396|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
143023853|NCT00718159|515627397|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
143023854|NCT00718159|515627398|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
143023855|NCT00718159|515627399|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
143023856|NCT00718159|515627393|FG000|Overall Study|Investigator Decision|0|||
143023857|NCT00718159|515627394|FG001|Overall Study|Investigator Decision|0|||
143023858|NCT00718159|515627395|FG002|Overall Study|Investigator Decision|0|||
143023859|NCT00718159|515627396|FG003|Overall Study|Investigator Decision|0|||
143023860|NCT00718159|515627397|FG004|Overall Study|Investigator Decision|0|||
143023861|NCT00718159|515627398|FG005|Overall Study|Investigator Decision|1|||
143023862|NCT00718159|515627399|FG006|Overall Study|Investigator Decision|1|||
143023863|NCT03222141|515627400|FG000|Overall Study|Death|15|||
143023864|NCT03222141|515627400|FG000|Overall Study|Lost to Follow-up|3|||
143023865|NCT00415532|515627401|FG000|Treatment Period|Adverse Event|2|||
143023866|NCT00415532|515627402|FG001|Treatment Period|Adverse Event|3|||
143023867|NCT00415532|515627401|FG000|Treatment Period|Death|2|||
143023868|NCT00415532|515627402|FG001|Treatment Period|Death|1|||
143023869|NCT00415532|515627401|FG000|Treatment Period|Lost to Follow-up|1|||
143023870|NCT00415532|515627402|FG001|Treatment Period|Lost to Follow-up|1|||
143023871|NCT00415532|515627401|FG000|Treatment Period|Protocol Violation|1|||
143023872|NCT00415532|515627402|FG001|Treatment Period|Protocol Violation|0|||
143023873|NCT00415532|515627401|FG000|Treatment Period|Withdrawal by Subject|6|||
143023874|NCT00415532|515627402|FG001|Treatment Period|Withdrawal by Subject|6|||
143023875|NCT00415532|515627401|FG000|Treatment Period|Other|2|||
143023876|NCT00415532|515627402|FG001|Treatment Period|Other|2|||
143023877|NCT00415532|515627401|FG000|Treatment Period|Ineligibility determined|1|||
143023878|NCT00415532|515627402|FG001|Treatment Period|Ineligibility determined|1|||
143023879|NCT00415532|515627401|FG000|Treatment Period|Noncompliance|1|||
143023880|NCT00415532|515627402|FG001|Treatment Period|Noncompliance|1|||
143023881|NCT00415532|515627401|FG000|Treatment Period|Requirement for alternative therapy|1|||
143023882|NCT00415532|515627402|FG001|Treatment Period|Requirement for alternative therapy|0|||
143023883|NCT00415532|515627401|FG000|Safety Follow Up Period|Adverse Event|1|||
143023884|NCT00415532|515627402|FG001|Safety Follow Up Period|Adverse Event|3|||
143023885|NCT00415532|515627401|FG000|Safety Follow Up Period|Death|3|||
143023886|NCT00415532|515627402|FG001|Safety Follow Up Period|Death|0|||
143023887|NCT00415532|515627401|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
143023888|NCT00415532|515627402|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
143023889|NCT00415532|515627401|FG000|Safety Follow Up Period|Other|1|||
143023890|NCT00415532|515627402|FG001|Safety Follow Up Period|Other|4|||
143023891|NCT00415532|515627401|FG000|Safety Follow Up Period|Ineligibility determined|1|||
143023892|NCT00415532|515627402|FG001|Safety Follow Up Period|Ineligibility determined|1|||
143023893|NCT00415532|515627401|FG000|Safety Follow Up Period|Noncompliance|1|||
143023894|NCT00415532|515627402|FG001|Safety Follow Up Period|Noncompliance|0|||
143023895|NCT00415532|515627401|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
143023896|NCT00415532|515627402|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
143023897|NCT05085964|515627403|FG000|Overall Study|Premature termination of study|21|||
143023898|NCT05085964|515627404|FG001|Overall Study|Premature termination of study|0|||
143023899|NCT03156270|515627405|FG000|Overall Study|Failed pre-treatment screening|1|||
143023900|NCT03156270|515627405|FG000|Overall Study|Lost to Follow-up|1|||
143023901|NCT00446654|515627406|FG000|Overall Study|Withdrawal by Subject|1|||
143023902|NCT00446654|515627407|FG001|Overall Study|Withdrawal by Subject|0|||
143023903|NCT00446654|515627406|FG000|Overall Study|Adverse Event|1|||
143023904|NCT00446654|515627407|FG001|Overall Study|Adverse Event|0|||
143023905|NCT02087059|515627409|FG000|Overall Study|Disease Progression|1|||
143023906|NCT02087059|515627409|FG000|Overall Study|Adverse Event|5|||
143023907|NCT02087059|515627409|FG000|Overall Study|Lost to Follow-up|1|||
143023908|NCT00593333|515627410|FG000|Overall Study|Lost to Follow-up|10|||
143023909|NCT00593333|515627411|FG001|Overall Study|Lost to Follow-up|11|||
143023910|NCT01261325|515627412|FG000|Overall Study|Lack of Efficacy|1|||
143023911|NCT01261325|515627413|FG001|Overall Study|Lack of Efficacy|1|||
143023912|NCT01261325|515627414|FG002|Overall Study|Lack of Efficacy|0|||
143023913|NCT01261325|515627412|FG000|Overall Study|Withdrawal by Subject|2|||
143023914|NCT01261325|515627413|FG001|Overall Study|Withdrawal by Subject|2|||
143023915|NCT01261325|515627414|FG002|Overall Study|Withdrawal by Subject|4|||
143023916|NCT01261325|515627412|FG000|Overall Study|SAE, non-fatal|1|||
143023917|NCT01261325|515627413|FG001|Overall Study|SAE, non-fatal|5|||
143023918|NCT01261325|515627414|FG002|Overall Study|SAE, non-fatal|1|||
143023919|NCT01261325|515627412|FG000|Overall Study|AE, non-serious non-fatal|9|||
143023920|NCT01261325|515627413|FG001|Overall Study|AE, non-serious non-fatal|15|||
143023921|NCT01261325|515627414|FG002|Overall Study|AE, non-serious non-fatal|13|||
143023922|NCT01261325|515627412|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
143023923|NCT01261325|515627413|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
143023924|NCT01261325|515627414|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
143023925|NCT01261325|515627412|FG000|Overall Study|Non Compliance|2|||
143023926|NCT01261325|515627413|FG001|Overall Study|Non Compliance|0|||
143023927|NCT01261325|515627414|FG002|Overall Study|Non Compliance|0|||
143486732|NCT03245450|517326554|FG000|Overall Study|Radiological disease progression|3|||
143023928|NCT01261325|515627412|FG000|Overall Study|Patient Randomized by Mistake|0|||
143023929|NCT01261325|515627413|FG001|Overall Study|Patient Randomized by Mistake|1|||
143023930|NCT01261325|515627414|FG002|Overall Study|Patient Randomized by Mistake|0|||
143023931|NCT01261325|515627412|FG000|Overall Study|Erroneously Randomized|1|||
143023932|NCT01261325|515627413|FG001|Overall Study|Erroneously Randomized|0|||
143023933|NCT01261325|515627414|FG002|Overall Study|Erroneously Randomized|0|||
143023934|NCT01261325|515627412|FG000|Overall Study|Screen Failure|1|||
143023935|NCT01261325|515627413|FG001|Overall Study|Screen Failure|0|||
143023936|NCT01261325|515627414|FG002|Overall Study|Screen Failure|0|||
143023937|NCT01261325|515627412|FG000|Overall Study|Randomized in Error|0|||
143023938|NCT01261325|515627413|FG001|Overall Study|Randomized in Error|0|||
143023939|NCT01261325|515627414|FG002|Overall Study|Randomized in Error|1|||
143023940|NCT01261325|515627412|FG000|Overall Study|Protocol Violation|0|||
143023941|NCT01261325|515627413|FG001|Overall Study|Protocol Violation|3|||
143023942|NCT01261325|515627414|FG002|Overall Study|Protocol Violation|1|||
143023943|NCT01261325|515627412|FG000|Overall Study|Lost to Follow-up|0|||
143023944|NCT01261325|515627413|FG001|Overall Study|Lost to Follow-up|1|||
143023945|NCT01261325|515627414|FG002|Overall Study|Lost to Follow-up|3|||
143023946|NCT01261325|515627412|FG000|Overall Study|AE, serious fatal|0|||
143023947|NCT01261325|515627413|FG001|Overall Study|AE, serious fatal|0|||
143023948|NCT01261325|515627414|FG002|Overall Study|AE, serious fatal|2|||
143023949|NCT02330081|515627423|FG000|Overall Study|Adverse Event|1|||
143023950|NCT02330081|515627423|FG000|Overall Study|Donation did not meet criteria|1|||
143023951|NCT02330081|515627423|FG000|Overall Study|Protocol Violation|6|||
143023952|NCT00895583|515627426|FG000|Overall Study|Adverse Event|28|||
143023953|NCT00895583|515627427|FG001|Overall Study|Adverse Event|4|||
143023954|NCT00895583|515627426|FG000|Overall Study|Death|2|||
143023955|NCT00895583|515627427|FG001|Overall Study|Death|1|||
143023956|NCT00895583|515627426|FG000|Overall Study|Physician Decision|3|||
143023957|NCT00895583|515627427|FG001|Overall Study|Physician Decision|1|||
143023958|NCT00895583|515627426|FG000|Overall Study|Lost to Follow-up|1|||
143023959|NCT00895583|515627427|FG001|Overall Study|Lost to Follow-up|3|||
143023960|NCT00895583|515627426|FG000|Overall Study|Protocol Violation|1|||
143023961|NCT00895583|515627427|FG001|Overall Study|Protocol Violation|0|||
143157015|NCT00421993|516119519|FG002|Overall Study|Withdrawal by Subject|23|||
143157016|NCT00421993|516119520|FG003|Overall Study|Withdrawal by Subject|24|||
143157017|NCT00421993|516119517|FG000|Overall Study|Lost to Follow-up|18|||
143157018|NCT00421993|516119518|FG001|Overall Study|Lost to Follow-up|19|||
143157019|NCT00421993|516119519|FG002|Overall Study|Lost to Follow-up|22|||
143157020|NCT00421993|516119520|FG003|Overall Study|Lost to Follow-up|20|||
143157021|NCT00421993|516119517|FG000|Overall Study|Adverse Event|11|||
143157022|NCT00421993|516119518|FG001|Overall Study|Adverse Event|1|||
143157023|NCT00421993|516119519|FG002|Overall Study|Adverse Event|6|||
143157024|NCT00421993|516119520|FG003|Overall Study|Adverse Event|4|||
143157025|NCT00421993|516119517|FG000|Overall Study|Protocol Violation|2|||
143157026|NCT00421993|516119518|FG001|Overall Study|Protocol Violation|2|||
143157027|NCT00421993|516119519|FG002|Overall Study|Protocol Violation|0|||
143157028|NCT00421993|516119520|FG003|Overall Study|Protocol Violation|1|||
143157029|NCT00421993|516119517|FG000|Overall Study|Lack of Efficacy|0|||
143157030|NCT00421993|516119518|FG001|Overall Study|Lack of Efficacy|3|||
143157031|NCT00421993|516119519|FG002|Overall Study|Lack of Efficacy|0|||
143157032|NCT00421993|516119520|FG003|Overall Study|Lack of Efficacy|5|||
143157033|NCT00421993|516119517|FG000|Overall Study|Pregnancy|0|||
143157034|NCT00421993|516119518|FG001|Overall Study|Pregnancy|1|||
143157035|NCT00421993|516119519|FG002|Overall Study|Pregnancy|1|||
143157036|NCT00421993|516119520|FG003|Overall Study|Pregnancy|2|||
143157037|NCT00421993|516119517|FG000|Overall Study|Subject transportation issues|0|||
143157038|NCT00421993|516119518|FG001|Overall Study|Subject transportation issues|0|||
143157039|NCT00421993|516119519|FG002|Overall Study|Subject transportation issues|0|||
143157040|NCT00421993|516119520|FG003|Overall Study|Subject transportation issues|1|||
143486733|NCT03245450|517326555|FG001|Overall Study|Radiological disease progression|3|||
143023962|NCT00895583|515627426|FG000|Overall Study|Withdrawal by Subject|4|||
143023963|NCT00895583|515627427|FG001|Overall Study|Withdrawal by Subject|2|||
143023964|NCT00895583|515627426|FG000|Overall Study|Lack of Efficacy|5|||
143157041|NCT04193176|516121493|FG000|Overall Study|Withdrawal by Subject|6|||
143157042|NCT04193176|516121494|FG001|Overall Study|Withdrawal by Subject|10|||
143157043|NCT03928704|516121498|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
143157044|NCT03928704|516121499|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
143157045|NCT03928704|516121500|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
143023965|NCT00895583|515627427|FG001|Overall Study|Lack of Efficacy|0|||
143023966|NCT00895583|515627426|FG000|Overall Study|Other|0|||
143023967|NCT00895583|515627427|FG001|Overall Study|Other|1|||
143023968|NCT00580983|515627431|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
143023969|NCT03740100|515627434|FG000|Overall Study|Adverse Event|1|||
143023970|NCT03740100|515627434|FG000|Overall Study|Death|1|||
143023971|NCT03016078|515627435|FG000|Overall Study|Protocol Violation|1|||
143023972|NCT03016078|515627435|FG000|Overall Study|Protocol Violation|1|||
143023973|NCT02378506|515627436|FG000|Overall Study|Lack of Efficacy|3|||
143023974|NCT02378506|515627436|FG000|Overall Study|Withdrawal by Subject|4|||
143023975|NCT02378506|515627436|FG000|Overall Study|Protocol Violation|2|||
143023976|NCT02378506|515627436|FG000|Overall Study|Death|1|||
143023977|NCT02378506|515627436|FG000|Overall Study|Adverse Event|14|||
143023978|NCT02378506|515627436|FG000|Overall Study|Randomized But Not Treated|1|||
143023979|NCT03387059|515627438|FG000|Overall Study|Study termination|5|||
143023980|NCT03387059|515627439|FG001|Overall Study|Study termination|4|||
143023981|NCT02482805|515629103|FG000|Overall Study|Lost to Follow-up|4|||
143023982|NCT02482805|515629104|FG001|Overall Study|Lost to Follow-up|4|||
143363746|NCT04978363|516875437|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
143363747|NCT04978363|516875438|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
143486734|NCT03245450|517326556|FG002|Overall Study|Radiological disease progression|2|||
143486735|NCT03245450|517326557|FG003|Overall Study|Radiological disease progression|2|||
143486736|NCT03245450|517326558|FG004|Overall Study|Radiological disease progression|7|||
143023983|NCT02482805|515629105|FG002|Overall Study|Lost to Follow-up|0|||
143023984|NCT01806597|515629106|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
143023985|NCT01806597|515629107|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
143023986|NCT01806597|515629108|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
143023987|NCT01806597|515629109|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
143023988|NCT01806597|515629110|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
143023989|NCT01806597|515629111|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
143023990|NCT01806597|515629106|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
143023991|NCT01806597|515629107|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
143023992|NCT01806597|515629108|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
143023993|NCT01806597|515629109|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
143023994|NCT01806597|515629110|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
143023995|NCT01806597|515629111|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
143023996|NCT01806597|515629106|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
143023997|NCT01806597|515629107|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
143023998|NCT01806597|515629108|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
143023999|NCT01806597|515629109|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
143024000|NCT01806597|515629110|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
143024001|NCT01806597|515629111|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
143024002|NCT01806597|515629106|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
143024003|NCT01806597|515629107|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
143024004|NCT01806597|515629108|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
143024005|NCT01806597|515629109|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
143157046|NCT03928704|516121501|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
143157047|NCT03928704|516121502|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
143157048|NCT03928704|516121503|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
143157049|NCT03928704|516121498|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
143157050|NCT03928704|516121499|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
143157051|NCT03928704|516121500|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
143157052|NCT03928704|516121501|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
143157053|NCT03928704|516121502|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
143157054|NCT03928704|516121503|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
143157055|NCT03928704|516121498|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
143157056|NCT03928704|516121499|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
143157057|NCT03928704|516121500|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
143157058|NCT03928704|516121501|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
143157059|NCT03928704|516121502|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
143157060|NCT03928704|516121503|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
143157061|NCT03928704|516121498|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
143157062|NCT03928704|516121499|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
143157063|NCT03928704|516121500|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
143024006|NCT01806597|515629110|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
143024007|NCT01806597|515629111|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
143024008|NCT01806597|515629106|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
143024009|NCT01806597|515629107|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
143024010|NCT01806597|515629108|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
143235808|NCT05194124|516415153|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
143235809|NCT05194124|516415154|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
143235810|NCT05194124|516415155|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
143235811|NCT05194124|516415156|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
143235812|NCT05194124|516415157|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
143235813|NCT05194124|516415158|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
143235814|NCT05194124|516415159|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
143235815|NCT05194124|516415160|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
143235816|NCT03642873|516415161|FG000|Third Intervention (1 Day)|Screen failure|0|||
143235817|NCT03642873|516415162|FG001|Third Intervention (1 Day)|Screen failure|0|||
143235818|NCT03642873|516415163|FG002|Third Intervention (1 Day)|Screen failure|0|||
143235819|NCT03642873|516415164|FG003|Third Intervention (1 Day)|Screen failure|0|||
143235820|NCT03642873|516415165|FG004|Third Intervention (1 Day)|Screen failure|1|||
143235821|NCT03642873|516415166|FG005|Third Intervention (1 Day)|Screen failure|0|||
143235822|NCT01253291|516415167|FG000|Overall Study|Withdrawal by Subject|1|||
143235823|NCT01253291|516415168|FG001|Overall Study|Withdrawal by Subject|1|||
143235824|NCT01253291|516415169|FG002|Overall Study|Withdrawal by Subject|0|||
143235825|NCT01253291|516415170|FG003|Overall Study|Withdrawal by Subject|0|||
143235826|NCT01253291|516415171|FG004|Overall Study|Withdrawal by Subject|0|||
143235827|NCT01253291|516415167|FG000|Overall Study|Adverse Event|0|||
143024011|NCT01806597|515629109|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
143024012|NCT01806597|515629110|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
143024013|NCT01806597|515629111|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
143024014|NCT01806597|515629106|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
143024015|NCT01806597|515629107|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
143024016|NCT01806597|515629108|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
143024017|NCT01806597|515629109|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
143024018|NCT01806597|515629110|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
143024019|NCT01806597|515629111|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
143024020|NCT01806597|515629106|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
143024021|NCT01806597|515629107|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
143235828|NCT01253291|516415168|FG001|Overall Study|Adverse Event|1|||
143235829|NCT01253291|516415169|FG002|Overall Study|Adverse Event|0|||
143235830|NCT01253291|516415170|FG003|Overall Study|Adverse Event|0|||
143235831|NCT01253291|516415171|FG004|Overall Study|Adverse Event|0|||
143235832|NCT01253291|516415167|FG000|Overall Study|Lack of Efficacy|1|||
143235833|NCT01253291|516415168|FG001|Overall Study|Lack of Efficacy|0|||
143235834|NCT01253291|516415169|FG002|Overall Study|Lack of Efficacy|0|||
143235835|NCT01253291|516415170|FG003|Overall Study|Lack of Efficacy|0|||
143235836|NCT01253291|516415171|FG004|Overall Study|Lack of Efficacy|0|||
143235837|NCT01253291|516415167|FG000|Overall Study|Physician Decision|2|||
143235838|NCT01253291|516415168|FG001|Overall Study|Physician Decision|0|||
143235839|NCT01253291|516415169|FG002|Overall Study|Physician Decision|0|||
143235840|NCT01253291|516415170|FG003|Overall Study|Physician Decision|0|||
143235841|NCT01253291|516415171|FG004|Overall Study|Physician Decision|2|||
143235842|NCT03157830|516415173|FG000|Overall Study|Lost to Follow-up|1|||
143235843|NCT03157830|516415173|FG000|Overall Study|Withdrawal by Subject|1|||
143235844|NCT03694353|516415175|FG000|Overall Study|Withdrawal by Subject|1|||
143235845|NCT03694353|516415175|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
143235846|NCT05720897|516415176|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
143235847|NCT05720897|516415177|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
143024022|NCT01806597|515629108|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
143024023|NCT01806597|515629109|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
143157064|NCT03928704|516121501|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
143157065|NCT03928704|516121502|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
143157066|NCT03928704|516121503|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
143157067|NCT03928704|516121498|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
143157068|NCT03928704|516121499|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
143157069|NCT03928704|516121500|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
143157070|NCT03928704|516121501|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
143157071|NCT03928704|516121502|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
143157072|NCT03928704|516121503|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
143157073|NCT03928704|516121498|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
143157074|NCT03928704|516121499|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
143235848|NCT00400179|516415178|FG000|Overall Study|Adverse Event|2|||
143235849|NCT00400179|516415179|FG001|Overall Study|Adverse Event|2|||
143235850|NCT00400179|516415178|FG000|Overall Study|Death|1|||
143235851|NCT00400179|516415179|FG001|Overall Study|Death|2|||
143235852|NCT00400179|516415178|FG000|Overall Study|Withdrew Consent|1|||
143235853|NCT00400179|516415179|FG001|Overall Study|Withdrew Consent|5|||
143235854|NCT00400179|516415178|FG000|Overall Study|Disease progression|1|||
143235855|NCT00400179|516415179|FG001|Overall Study|Disease progression|1|||
143235856|NCT00400179|516415178|FG000|Overall Study|Intercurrent illness|0|||
143235857|NCT00400179|516415179|FG001|Overall Study|Intercurrent illness|1|||
143235858|NCT00400179|516415178|FG000|Overall Study|Investigator judgment|0|||
143235859|NCT00400179|516415179|FG001|Overall Study|Investigator judgment|1|||
143235860|NCT00400179|516415178|FG000|Overall Study|Randomization error/patient ineligible|1|||
143235861|NCT00400179|516415179|FG001|Overall Study|Randomization error/patient ineligible|6|||
143235862|NCT04780061|516415180|FG000|Overall Study|Withdrawal by Subject|5|||
143235863|NCT04780061|516415181|FG001|Overall Study|Withdrawal by Subject|8|||
143235864|NCT04780061|516415180|FG000|Overall Study|Adverse Event|2|||
143235865|NCT04780061|516415181|FG001|Overall Study|Adverse Event|2|||
143235866|NCT04780061|516415180|FG000|Overall Study|Lost to Follow-up|1|||
143024024|NCT01806597|515629110|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
143024025|NCT01806597|515629111|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
143024026|NCT01806597|515629106|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
143024027|NCT01806597|515629107|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
143024028|NCT01806597|515629108|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
143024029|NCT01806597|515629109|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
143024030|NCT01806597|515629110|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
143024031|NCT01806597|515629111|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
143024032|NCT01806597|515629106|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
143157075|NCT03928704|516121500|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
143235867|NCT04780061|516415181|FG001|Overall Study|Lost to Follow-up|5|||
143235868|NCT04050553|516415182|FG000|Period 1|Physician Decision|2|||
143235869|NCT04050553|516415183|FG001|Period 1|Physician Decision|2|||
143235870|NCT04050553|516415182|FG000|Period 1|Adverse Event|1|||
143235871|NCT04050553|516415183|FG001|Period 1|Adverse Event|1|||
143235872|NCT04050553|516415182|FG000|Period 1|Withdrawal by Subject|0|||
143235873|NCT04050553|516415183|FG001|Period 1|Withdrawal by Subject|1|||
143235874|NCT04050553|516415182|FG000|Wash-out|Adverse Event|0|||
143235875|NCT04050553|516415183|FG001|Wash-out|Adverse Event|1|||
143235876|NCT04050553|516415182|FG000|Wash-out|Withdrawal by Subject|0|||
143235877|NCT04050553|516415183|FG001|Wash-out|Withdrawal by Subject|1|||
143235878|NCT00734149|516415184|FG000|Overall Study|Withdrawal by Subject|1|||
143235879|NCT04314284|516415185|FG000|Overall Study|Withdrawal by Subject|4|||
143235880|NCT04314284|516415186|FG001|Overall Study|Withdrawal by Subject|7|||
143235881|NCT04314284|516415185|FG000|Overall Study|Consented but did not complete survey|0|||
143235882|NCT04314284|516415186|FG001|Overall Study|Consented but did not complete survey|6|||
143235883|NCT01652235|516415187|FG000|Overall Study|Death|9|||
143235884|NCT01652235|516415187|FG000|Overall Study|Lost to Follow-up|5|||
143235885|NCT01652235|516415187|FG000|Overall Study|Withdrawal by Subject|2|||
143235886|NCT02023086|516415188|FG000|Overall Study|Withdrawal by Subject|2|||
143235887|NCT02023086|516415189|FG001|Overall Study|Withdrawal by Subject|0|||
143235888|NCT03589859|516415192|FG000|Overall Study|Withdrawal by Subject|0|||
143235889|NCT03589859|516415193|FG001|Overall Study|Withdrawal by Subject|6|||
143235890|NCT05565742|516415195|FG000|Overall Study|Withdrawal by Subject|0|||
143235891|NCT05565742|516415196|FG001|Overall Study|Withdrawal by Subject|0|||
143235892|NCT05565742|516415197|FG002|Overall Study|Withdrawal by Subject|2|||
143235893|NCT05565742|516415198|FG003|Overall Study|Withdrawal by Subject|2|||
143235894|NCT05565742|516415199|FG004|Overall Study|Withdrawal by Subject|2|||
143235895|NCT05565742|516415195|FG000|Overall Study|Death|1|||
143235896|NCT05565742|516415196|FG001|Overall Study|Death|0|||
143157076|NCT03928704|516121501|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
143157077|NCT03928704|516121502|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
143157078|NCT03928704|516121503|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
143157079|NCT03928704|516121498|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
143157080|NCT03928704|516121499|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
143157081|NCT03928704|516121500|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
143157082|NCT03928704|516121501|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
143157083|NCT03928704|516121502|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
143157084|NCT03928704|516121503|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
143157085|NCT03928704|516121498|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
143235897|NCT05565742|516415197|FG002|Overall Study|Death|0|||
143235898|NCT05565742|516415198|FG003|Overall Study|Death|0|||
143235899|NCT05565742|516415199|FG004|Overall Study|Death|0|||
143235900|NCT05565742|516415195|FG000|Overall Study|Participant Travelled Abroad|0|||
143235901|NCT05565742|516415196|FG001|Overall Study|Participant Travelled Abroad|0|||
143157086|NCT03928704|516121499|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
143157087|NCT03928704|516121500|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
143235902|NCT05565742|516415197|FG002|Overall Study|Participant Travelled Abroad|0|||
143235903|NCT05565742|516415198|FG003|Overall Study|Participant Travelled Abroad|0|||
143235904|NCT05565742|516415199|FG004|Overall Study|Participant Travelled Abroad|1|||
143235905|NCT04163341|516415200|FG000|Overall Study|Withdrawal by Subject|2|||
143235906|NCT04163341|516415201|FG001|Overall Study|Withdrawal by Subject|0|||
143235907|NCT04163341|516415200|FG000|Overall Study|Lost to Follow-up|3|||
143235908|NCT04163341|516415201|FG001|Overall Study|Lost to Follow-up|4|||
143235909|NCT04272242|516415202|FG000|Overall Study|Withdrawal by Subject|3|||
143235910|NCT04272242|516415202|FG000|Overall Study|Lost to Follow-up|1|||
143235911|NCT04272242|516415202|FG000|Overall Study|Adverse Event|1|||
143235912|NCT02681523|516415203|FG000|Overall Study|Adverse Event|1|||
143235913|NCT02681523|516415203|FG000|Overall Study|Patient Non-compliance|1|||
143235914|NCT02638220|516415204|FG000|Overall Study|Lost to Follow-up|6|||
143235915|NCT02638220|516415204|FG000|Overall Study|Withdrawal by Subject|3|||
143235916|NCT02638220|516415204|FG000|Overall Study|Physician Decision|1|||
143235917|NCT02638220|516415204|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
143235918|NCT04639245|516417318|FG000|Overall Study|Death|1|||
143235919|NCT00129402|516417341|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
143235920|NCT00129402|516417342|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
143235921|NCT00129402|516417343|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
143235922|NCT00129402|516417344|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
143235923|NCT00129402|516417345|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
143235924|NCT00129402|516417346|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
143235925|NCT00129402|516417347|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
143235926|NCT00129402|516417341|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
143235927|NCT00129402|516417342|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
143235928|NCT00129402|516417343|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
143235929|NCT00129402|516417344|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
143235930|NCT00129402|516417345|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
143235931|NCT00129402|516417346|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
143235932|NCT00129402|516417347|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
143235933|NCT00129402|516417341|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
143235934|NCT00129402|516417342|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
143235935|NCT00129402|516417343|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
143235936|NCT00129402|516417344|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
143235937|NCT00129402|516417345|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
143235938|NCT00129402|516417346|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
143235939|NCT00129402|516417347|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
143235940|NCT00129402|516417341|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
143235941|NCT00129402|516417342|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
143235942|NCT00129402|516417343|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
143235943|NCT00129402|516417344|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
143235944|NCT00129402|516417345|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
143235945|NCT00129402|516417346|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
143235946|NCT00129402|516417347|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
143235947|NCT00129402|516417341|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
143235948|NCT00129402|516417342|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
143235949|NCT00129402|516417343|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
143235950|NCT00129402|516417344|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
143235951|NCT00129402|516417345|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
143235952|NCT00129402|516417346|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
143235953|NCT00129402|516417347|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
143235954|NCT00129402|516417341|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
143024033|NCT01806597|515629107|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
143024034|NCT01806597|515629108|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
143024035|NCT01806597|515629109|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
143235955|NCT00129402|516417342|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
143235956|NCT00129402|516417343|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
143235957|NCT00129402|516417344|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
143235958|NCT00129402|516417345|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
143235959|NCT00129402|516417346|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
143235960|NCT00129402|516417347|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
143235961|NCT00129402|516417341|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
143235962|NCT00129402|516417342|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
143024036|NCT01806597|515629110|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
143235963|NCT00129402|516417343|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
143235964|NCT00129402|516417344|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
143235965|NCT00129402|516417345|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
143235966|NCT00129402|516417346|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
143363748|NCT04978363|516875439|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
143486737|NCT03245450|517326559|FG005|Overall Study|Radiological disease progression|6|||
143486738|NCT03245450|517326560|FG006|Overall Study|Radiological disease progression|6|||
143486739|NCT03245450|517326554|FG000|Overall Study|Clinical disease progression|0|||
143486740|NCT03245450|517326555|FG001|Overall Study|Clinical disease progression|0|||
143486741|NCT03245450|517326556|FG002|Overall Study|Clinical disease progression|1|||
143486742|NCT03245450|517326557|FG003|Overall Study|Clinical disease progression|0|||
143486743|NCT03245450|517326558|FG004|Overall Study|Clinical disease progression|0|||
143486744|NCT03245450|517326559|FG005|Overall Study|Clinical disease progression|2|||
143486745|NCT03245450|517326560|FG006|Overall Study|Clinical disease progression|0|||
143486746|NCT03245450|517326554|FG000|Overall Study|Other|0|||
143486747|NCT03245450|517326555|FG001|Overall Study|Other|0|||
143486748|NCT03245450|517326556|FG002|Overall Study|Other|0|||
143486749|NCT03245450|517326557|FG003|Overall Study|Other|1|||
143486750|NCT03245450|517326558|FG004|Overall Study|Other|1|||
143486751|NCT03245450|517326559|FG005|Overall Study|Other|1|||
143486752|NCT03245450|517326560|FG006|Overall Study|Other|1|||
143486753|NCT03245450|517326554|FG000|Overall Study|Withdrawal by Subject|0|||
143486754|NCT03245450|517326555|FG001|Overall Study|Withdrawal by Subject|1|||
143486755|NCT03245450|517326556|FG002|Overall Study|Withdrawal by Subject|0|||
143486756|NCT03245450|517326557|FG003|Overall Study|Withdrawal by Subject|0|||
143486757|NCT03245450|517326558|FG004|Overall Study|Withdrawal by Subject|0|||
143486758|NCT03245450|517326559|FG005|Overall Study|Withdrawal by Subject|0|||
143486759|NCT03245450|517326560|FG006|Overall Study|Withdrawal by Subject|0|||
143486760|NCT03245450|517326554|FG000|Overall Study|Adverse Event|0|||
143486761|NCT03245450|517326555|FG001|Overall Study|Adverse Event|0|||
143486762|NCT03245450|517326556|FG002|Overall Study|Adverse Event|0|||
143486763|NCT03245450|517326557|FG003|Overall Study|Adverse Event|0|||
143486764|NCT03245450|517326558|FG004|Overall Study|Adverse Event|1|||
143486765|NCT03245450|517326559|FG005|Overall Study|Adverse Event|0|||
143486766|NCT03245450|517326560|FG006|Overall Study|Adverse Event|2|||
143486767|NCT02429414|517326561|FG000|Overall Study|Physician Decision|0|||
143486768|NCT02429414|517326562|FG001|Overall Study|Physician Decision|1|||
143486769|NCT01784861|517326568|FG000|Overall Study|Adverse Event|0|||
143157088|NCT03928704|516121501|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
143157089|NCT03928704|516121502|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
143157090|NCT03928704|516121503|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
143157091|NCT03928704|516121498|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
143157092|NCT03928704|516121499|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
143157093|NCT03928704|516121500|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
143157094|NCT03928704|516121501|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
143157095|NCT03928704|516121502|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
143157096|NCT03928704|516121503|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
143157097|NCT03928704|516121498|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
143157098|NCT03928704|516121499|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
143157099|NCT03928704|516121500|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
143157100|NCT03928704|516121501|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
143157101|NCT03928704|516121502|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
143157102|NCT03928704|516121503|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
143157103|NCT02181621|516121509|FG000|Overall Study|Adverse Event|1|||
143157104|NCT02181621|516121510|FG001|Overall Study|Adverse Event|0|||
143157105|NCT02181621|516121509|FG000|Overall Study|Previously Enrolled|0|||
143157106|NCT02181621|516121510|FG001|Overall Study|Previously Enrolled|1|||
143157107|NCT02181621|516121509|FG000|Overall Study|Enrollment Hold|1|||
143157108|NCT02181621|516121510|FG001|Overall Study|Enrollment Hold|1|||
143157109|NCT01783015|516121511|FG000|Blinded Treatment|Adverse Event|0|||
143157110|NCT01783015|516121512|FG001|Blinded Treatment|Adverse Event|1|||
143157111|NCT01783015|516121513|FG002|Blinded Treatment|Adverse Event|0|||
143157112|NCT01783015|516121511|FG000|Blinded Treatment|Protocol Violation|0|||
143157113|NCT01783015|516121512|FG001|Blinded Treatment|Protocol Violation|1|||
143486770|NCT01784861|517326569|FG001|Overall Study|Adverse Event|0|||
143486771|NCT01784861|517326570|FG002|Overall Study|Adverse Event|1|||
143486772|NCT01784861|517326571|FG003|Overall Study|Adverse Event|2|||
143486773|NCT01784861|517326572|FG004|Overall Study|Adverse Event|1|||
143486774|NCT01784861|517326573|FG005|Overall Study|Adverse Event|0|||
143486775|NCT01784861|517326568|FG000|Overall Study|Withdrawal by Subject|0|||
143157114|NCT01783015|516121513|FG002|Blinded Treatment|Protocol Violation|0|||
143157115|NCT01783015|516121511|FG000|Blinded Treatment|Withdrawal by Subject|0|||
143157116|NCT01783015|516121512|FG001|Blinded Treatment|Withdrawal by Subject|1|||
143157117|NCT01783015|516121513|FG002|Blinded Treatment|Withdrawal by Subject|0|||
143486776|NCT01784861|517326569|FG001|Overall Study|Withdrawal by Subject|0|||
143486777|NCT01784861|517326570|FG002|Overall Study|Withdrawal by Subject|0|||
143486778|NCT01784861|517326571|FG003|Overall Study|Withdrawal by Subject|1|||
143486779|NCT01784861|517326572|FG004|Overall Study|Withdrawal by Subject|0|||
143486780|NCT01784861|517326573|FG005|Overall Study|Withdrawal by Subject|0|||
143024037|NCT01806597|515629111|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
143024038|NCT01806597|515629106|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
143024039|NCT01806597|515629107|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
143024040|NCT01806597|515629108|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
143024041|NCT01806597|515629109|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
143024042|NCT01806597|515629110|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
143024043|NCT01806597|515629111|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
143024044|NCT01806597|515629106|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
143024045|NCT01806597|515629107|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
143024046|NCT01806597|515629108|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
143024047|NCT01806597|515629109|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
143024048|NCT01806597|515629110|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
143024049|NCT01806597|515629111|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
143157118|NCT01783015|516121511|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
143157119|NCT01783015|516121512|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
143157120|NCT01783015|516121513|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
143157121|NCT01783015|516121511|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
143157122|NCT01783015|516121512|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
143157123|NCT01783015|516121513|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
143157124|NCT00985192|516121514|FG000|Overall Study|Withdrawal by Subject|1|||
143157125|NCT00985192|516121514|FG000|Overall Study|Disease Progression|1|||
143157126|NCT00985192|516121514|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
143157127|NCT03607695|516121516|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
143157128|NCT03607695|516121516|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
143157129|NCT00289978|516121522|FG000|Overall Study|Withdrawal by Subject|31|||
143157130|NCT00289978|516121523|FG001|Overall Study|Withdrawal by Subject|17|||
143157131|NCT00289978|516121524|FG002|Overall Study|Withdrawal by Subject|28|||
143157132|NCT00289978|516121522|FG000|Overall Study|Adverse Event|22|||
143157133|NCT00289978|516121523|FG001|Overall Study|Adverse Event|13|||
143157134|NCT00289978|516121524|FG002|Overall Study|Adverse Event|18|||
143157135|NCT00289978|516121522|FG000|Overall Study|Lack of Efficacy|13|||
143157136|NCT00289978|516121523|FG001|Overall Study|Lack of Efficacy|6|||
143157137|NCT00289978|516121524|FG002|Overall Study|Lack of Efficacy|25|||
143157138|NCT00289978|516121522|FG000|Overall Study|Abnormal laboratory value(s)|20|||
143157139|NCT00289978|516121523|FG001|Overall Study|Abnormal laboratory value(s)|9|||
143157140|NCT00289978|516121524|FG002|Overall Study|Abnormal laboratory value(s)|1|||
143157141|NCT00289978|516121522|FG000|Overall Study|Lost to Follow-up|3|||
143157142|NCT00289978|516121523|FG001|Overall Study|Lost to Follow-up|5|||
143157143|NCT00289978|516121524|FG002|Overall Study|Lost to Follow-up|7|||
143157144|NCT00289978|516121522|FG000|Overall Study|Protocol Violation|5|||
143157145|NCT00289978|516121523|FG001|Overall Study|Protocol Violation|5|||
143157146|NCT00289978|516121524|FG002|Overall Study|Protocol Violation|4|||
143157147|NCT00289978|516121522|FG000|Overall Study|Abnormal test procedure result(s)|2|||
143157148|NCT00289978|516121523|FG001|Overall Study|Abnormal test procedure result(s)|1|||
143157149|NCT00289978|516121524|FG002|Overall Study|Abnormal test procedure result(s)|1|||
143157150|NCT00289978|516121522|FG000|Overall Study|Death|1|||
143157151|NCT00289978|516121523|FG001|Overall Study|Death|0|||
143157152|NCT00289978|516121524|FG002|Overall Study|Death|2|||
143157153|NCT01524705|516121525|FG000|Overall Study|Adverse Event|2|||
143157154|NCT01524705|516121526|FG001|Overall Study|Adverse Event|0|||
143157155|NCT01524705|516121525|FG000|Overall Study|Death|1|||
143157156|NCT01524705|516121526|FG001|Overall Study|Death|0|||
143157157|NCT01524705|516121525|FG000|Overall Study|Lost to Follow-up|0|||
143157158|NCT01524705|516121526|FG001|Overall Study|Lost to Follow-up|1|||
143157159|NCT01524705|516121525|FG000|Overall Study|Withdrawal by Subject|0|||
143157160|NCT01524705|516121526|FG001|Overall Study|Withdrawal by Subject|1|||
143157161|NCT01524705|516121525|FG000|Overall Study|Pancreatic Cancer|0|||
143157162|NCT01524705|516121526|FG001|Overall Study|Pancreatic Cancer|1|||
143157163|NCT00585169|516121527|FG000|Overall Study|Withdrawal by Subject|1|||
143157164|NCT03055221|516121528|FG000|Overall Study|Adverse Event|2|||
143157165|NCT03055221|516121528|FG000|Overall Study|Withdrawal by Subject|4|||
143363749|NCT04978363|516875440|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
143363750|NCT04978363|516875441|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
143157166|NCT03055221|516121528|FG000|Overall Study|Death|6|||
143157167|NCT03055221|516121528|FG000|Overall Study|Physician Decision|1|||
143157168|NCT03055221|516121528|FG000|Overall Study|Study terminated by Sponsor|3|||
143157169|NCT03055221|516121528|FG000|Overall Study|Lost to Follow-up|4|||
143157170|NCT01243424|516121529|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
143157171|NCT01243424|516121530|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
143157172|NCT01243424|516121529|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
143157173|NCT01243424|516121530|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
143235967|NCT00129402|516417347|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
143235968|NCT00129402|516417341|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
143235969|NCT00129402|516417342|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
143235970|NCT00129402|516417343|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
143235971|NCT00129402|516417344|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
143235972|NCT00129402|516417345|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
143235973|NCT00129402|516417346|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
143235974|NCT00129402|516417347|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
143235975|NCT00129402|516417341|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
143235976|NCT00129402|516417342|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
143235977|NCT00129402|516417343|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
143235978|NCT00129402|516417344|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
143235979|NCT00129402|516417345|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
143235980|NCT00129402|516417346|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
143235981|NCT00129402|516417347|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
143235982|NCT00129402|516417341|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
143235983|NCT00129402|516417342|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
143235984|NCT00129402|516417343|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
143235985|NCT00129402|516417344|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
143235986|NCT00129402|516417345|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
143235987|NCT00129402|516417346|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
143235988|NCT00129402|516417347|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
143235989|NCT00129402|516417341|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
143235990|NCT00129402|516417342|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
143235991|NCT00129402|516417343|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
143235992|NCT00129402|516417344|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
143235993|NCT00129402|516417345|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
143235994|NCT00129402|516417346|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
143235995|NCT00129402|516417347|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
143235996|NCT00129402|516417341|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
143235997|NCT00129402|516417342|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
143235998|NCT00129402|516417343|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
143235999|NCT00129402|516417344|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
143236000|NCT00129402|516417345|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
143236001|NCT00129402|516417346|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
143236002|NCT00129402|516417347|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
143236003|NCT00129402|516417341|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
143236004|NCT00129402|516417342|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
143236005|NCT00129402|516417343|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
143236006|NCT00129402|516417344|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
143236007|NCT00129402|516417345|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
143236008|NCT00129402|516417346|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
143236009|NCT00129402|516417347|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
143236010|NCT03041038|516417348|FG000|Overall Study|Withdrawal by Subject|4|||
143236011|NCT03041038|516417349|FG001|Overall Study|Withdrawal by Subject|0|||
143486781|NCT01784861|517326568|FG000|Overall Study|Physician Decision|0|||
143486782|NCT01784861|517326569|FG001|Overall Study|Physician Decision|0|||
143486783|NCT01784861|517326570|FG002|Overall Study|Physician Decision|0|||
143486784|NCT01784861|517326571|FG003|Overall Study|Physician Decision|2|||
143486785|NCT01784861|517326572|FG004|Overall Study|Physician Decision|0|||
143486786|NCT01784861|517326573|FG005|Overall Study|Physician Decision|1|||
143486787|NCT01604265|517326574|FG000|Overall Study|Adverse Event|1|||
143486788|NCT01604265|517326575|FG001|Overall Study|Adverse Event|0|||
143486789|NCT01604265|517326574|FG000|Overall Study|Withdrawal by Subject|1|||
143486790|NCT01604265|517326575|FG001|Overall Study|Withdrawal by Subject|0|||
143236012|NCT03041038|516417348|FG000|Overall Study|Lost to Follow-up|1|||
143486791|NCT01895322|517326576|FG000|Overall Study|Adverse Event|1|||
143486792|NCT01895322|517326576|FG000|Overall Study|Withdrawal by Subject|2|||
143486793|NCT01895322|517326576|FG000|Overall Study|Protocol Violation|10|||
143486794|NCT00143312|517326579|FG000|Overall Study|Death|11|||
143024050|NCT01806597|515629106|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
143486795|NCT00143312|517326579|FG000|Overall Study|Adverse Event|2|||
143486796|NCT00143312|517326579|FG000|Overall Study|Lost to Follow-up|1|||
143486797|NCT00143312|517326579|FG000|Overall Study|Other|1|||
143486798|NCT00143312|517326579|FG000|Overall Study|Withdrawal by Subject|1|||
143486799|NCT01029366|517326580|FG000|Overall Study|Withdrawal by Subject|1|||
143024051|NCT01806597|515629107|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
143024052|NCT01806597|515629108|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
143024053|NCT01806597|515629109|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
143157174|NCT01243424|516121529|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
143157175|NCT01243424|516121530|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
143157176|NCT01243424|516121529|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
143157177|NCT01243424|516121530|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
143157178|NCT01243424|516121529|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
143157179|NCT01243424|516121530|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
143157180|NCT01243424|516121529|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
143157181|NCT01243424|516121530|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
143157182|NCT01243424|516121529|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
143157183|NCT01243424|516121530|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
143157184|NCT01243424|516121529|FG000|Discontinuation From Treatment|Not treated|5|||
143157185|NCT01243424|516121530|FG001|Discontinuation From Treatment|Not treated|4|||
143157186|NCT01243424|516121529|FG000|Discontinuation From Treatment|Adverse Event|457|||
143157187|NCT01243424|516121530|FG001|Discontinuation From Treatment|Adverse Event|523|||
143157188|NCT01243424|516121529|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
143157189|NCT01243424|516121530|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
143157190|NCT01243424|516121529|FG000|Discontinuation From Treatment|Protocol Violation|46|||
143157191|NCT01243424|516121530|FG001|Discontinuation From Treatment|Protocol Violation|47|||
143157192|NCT01243424|516121529|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
143157193|NCT01243424|516121530|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
143157194|NCT01243424|516121529|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
143157195|NCT01243424|516121530|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
143157196|NCT01243424|516121529|FG000|Discontinuation From Treatment|Other than listed above|230|||
143157197|NCT01243424|516121530|FG001|Discontinuation From Treatment|Other than listed above|211|||
143157198|NCT01964560|516121535|FG000|Overall Study|Adverse Event|23|||
143157199|NCT01964560|516121535|FG000|Overall Study|Lack of Efficacy|46|||
143024054|NCT01806597|515629110|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
143024055|NCT01806597|515629111|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
143024056|NCT01806597|515629106|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
143024057|NCT01806597|515629107|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
143024058|NCT01806597|515629108|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
143157200|NCT01964560|516121535|FG000|Overall Study|Protocol deviation|2|||
143157201|NCT01964560|516121535|FG000|Overall Study|Lost to Follow-up|4|||
143157202|NCT01964560|516121535|FG000|Overall Study|Withdrawal by Subject|64|||
143157203|NCT01964560|516121535|FG000|Overall Study|Surgery-hemispherotomy|1|||
143157204|NCT01964560|516121535|FG000|Overall Study|Surgery|1|||
143157205|NCT01964560|516121535|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
143157206|NCT01964560|516121535|FG000|Overall Study|Patient and Investigator choice|1|||
143157207|NCT01964560|516121535|FG000|Overall Study|Patient was prescribed CBD|1|||
143157208|NCT01964560|516121535|FG000|Overall Study|Participant moved to another country|1|||
143157209|NCT01301001|516121545|FG000|First Intervention|Lost to Follow-up|4|||
143157210|NCT01301001|516121546|FG001|First Intervention|Lost to Follow-up|4|||
143157211|NCT01301001|516121545|FG000|First Intervention|Withdrawal by Subject|1|||
143157212|NCT01301001|516121546|FG001|First Intervention|Withdrawal by Subject|4|||
143157213|NCT01301001|516121545|FG000|First Intervention|Adverse Event|5|||
143157214|NCT01301001|516121546|FG001|First Intervention|Adverse Event|0|||
143157215|NCT01301001|516121545|FG000|First Intervention|Protocol Violation|0|||
143157216|NCT01301001|516121546|FG001|First Intervention|Protocol Violation|1|||
143157217|NCT01301001|516121545|FG000|Second Intervention|Adverse Event|2|||
143157218|NCT01301001|516121546|FG001|Second Intervention|Adverse Event|0|||
143157219|NCT01301001|516121545|FG000|Second Intervention|Withdrawal by Subject|2|||
143157220|NCT01301001|516121546|FG001|Second Intervention|Withdrawal by Subject|0|||
143157221|NCT01160744|516121547|FG000|Overall Study|Withdrawal by Subject|11|||
143157222|NCT01160744|516121548|FG001|Overall Study|Withdrawal by Subject|5|||
143157223|NCT01160744|516121549|FG002|Overall Study|Withdrawal by Subject|6|||
143157224|NCT01160744|516121550|FG003|Overall Study|Withdrawal by Subject|4|||
143157225|NCT01160744|516121547|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
143236013|NCT03041038|516417349|FG001|Overall Study|Lost to Follow-up|1|||
143236014|NCT03041038|516417348|FG000|Overall Study|Protocol Violation|1|||
143236015|NCT03041038|516417349|FG001|Overall Study|Protocol Violation|1|||
143486800|NCT01029366|517326581|FG001|Overall Study|Withdrawal by Subject|0|||
143157226|NCT01160744|516121548|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
143157227|NCT01160744|516121549|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
143157228|NCT01160744|516121550|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
143157229|NCT02301429|516121559|FG000|Overall Study|not acceptable vascular anatomy|3|||
143236016|NCT02703597|516417352|FG000|Assignment to Baseline|Lost to Follow-up|17|||
143486801|NCT01029366|517326580|FG000|Overall Study|Death|1|||
143024059|NCT01806597|515629109|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
143024060|NCT01806597|515629110|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
143024061|NCT01806597|515629111|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
143024062|NCT01806597|515629106|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
143024063|NCT01806597|515629107|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
143024064|NCT01806597|515629108|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
143024065|NCT01806597|515629109|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
143024066|NCT01806597|515629110|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
143024067|NCT01806597|515629111|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
143024068|NCT01806597|515629106|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
143024069|NCT01806597|515629107|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
143024070|NCT01806597|515629108|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
143024071|NCT01806597|515629109|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
143024072|NCT01806597|515629110|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
143024073|NCT01806597|515629111|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
143024074|NCT01806597|515629106|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
143024075|NCT01806597|515629107|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
143024076|NCT01806597|515629108|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
143024077|NCT01806597|515629109|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
143024078|NCT01806597|515629110|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
143024079|NCT01806597|515629111|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
143024080|NCT01806597|515629106|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
143024081|NCT01806597|515629107|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
143024082|NCT01806597|515629108|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
143024083|NCT01806597|515629109|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
143024084|NCT01806597|515629110|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
143236017|NCT02703597|516417353|FG001|Assignment to Baseline|Lost to Follow-up|16|||
143024085|NCT01806597|515629111|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
143157230|NCT00500110|516121560|FG000|Overall Study|Withdrawal by Subject|3|||
143157231|NCT01502072|516121561|FG000|Overall Study|Withdrawal by Subject|1|||
143157232|NCT01502072|516121562|FG001|Overall Study|Withdrawal by Subject|0|||
143157233|NCT01502072|516121563|FG002|Overall Study|Withdrawal by Subject|0|||
143157234|NCT01502072|516121561|FG000|Overall Study|Death|0|||
143157235|NCT01502072|516121562|FG001|Overall Study|Death|1|||
143157236|NCT01502072|516121563|FG002|Overall Study|Death|0|||
143157237|NCT05156125|516121564|FG000|Overall Study|Lack of Efficacy|1|||
143157238|NCT05156125|516121565|FG001|Overall Study|Lack of Efficacy|1|||
143157239|NCT05156125|516121566|FG002|Overall Study|Lack of Efficacy|1|||
143157240|NCT05156125|516121564|FG000|Overall Study|Physician Decision|0|||
143157241|NCT05156125|516121565|FG001|Overall Study|Physician Decision|0|||
143157242|NCT05156125|516121566|FG002|Overall Study|Physician Decision|1|||
143157243|NCT05156125|516121564|FG000|Overall Study|Non-compliance|0|||
143157244|NCT05156125|516121565|FG001|Overall Study|Non-compliance|1|||
143157245|NCT05156125|516121566|FG002|Overall Study|Non-compliance|1|||
143157246|NCT05156125|516121564|FG000|Overall Study|Withdrawal by Subject|0|||
143157247|NCT05156125|516121565|FG001|Overall Study|Withdrawal by Subject|0|||
143157248|NCT05156125|516121566|FG002|Overall Study|Withdrawal by Subject|1|||
143157249|NCT05156125|516121564|FG000|Overall Study|Adverse Event|2|||
143157250|NCT05156125|516121565|FG001|Overall Study|Adverse Event|1|||
143157251|NCT05156125|516121566|FG002|Overall Study|Adverse Event|0|||
143157252|NCT03123588|516121569|FG000|Overall Study|Study Terminated by Sponsor|2|||
143157253|NCT03123588|516121570|FG001|Overall Study|Study Terminated by Sponsor|5|||
143157254|NCT03123588|516121569|FG000|Overall Study|Withdrawal by Subject|1|||
143157255|NCT03123588|516121570|FG001|Overall Study|Withdrawal by Subject|0|||
143157256|NCT03123588|516121569|FG000|Overall Study|Adverse Event|1|||
143157257|NCT03123588|516121570|FG001|Overall Study|Adverse Event|0|||
143157258|NCT03123588|516121569|FG000|Overall Study|Physician Decision|2|||
143157259|NCT03123588|516121570|FG001|Overall Study|Physician Decision|1|||
143157260|NCT01717859|516121574|FG000|Overall Study|Adverse Event|5|||
143157261|NCT01717859|516121574|FG000|Overall Study|Moved out of state|1|||
143157262|NCT01717859|516121574|FG000|Overall Study|Patient concerned about mental health|1|||
143157263|NCT01717859|516121574|FG000|Overall Study|Lost to Follow-up|1|||
143157264|NCT01717859|516121574|FG000|Overall Study|Withdrawal by Subject|2|||
143157265|NCT01623752|516121575|FG000|Phase 1 (78 Weeks)|No Data|249|||
143157266|NCT01623752|516121576|FG001|Phase 1 (78 Weeks)|No Data|66|||
143157267|NCT01623752|516121577|FG002|Phase 1 (78 Weeks)|No Data|2|||
143157268|NCT01623752|516121575|FG000|Phase 1 (78 Weeks)|Other|33|||
143157269|NCT01623752|516121576|FG001|Phase 1 (78 Weeks)|Other|20|||
143157270|NCT01623752|516121577|FG002|Phase 1 (78 Weeks)|Other|0|||
143157271|NCT01623752|516121575|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
143157272|NCT01623752|516121576|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
143157273|NCT01623752|516121577|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
143157274|NCT01623752|516121575|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
143486802|NCT01029366|517326581|FG001|Overall Study|Death|1|||
143486803|NCT01029366|517326580|FG000|Overall Study|disease progression|2|||
143486804|NCT01029366|517326581|FG001|Overall Study|disease progression|0|||
143486805|NCT01029366|517326580|FG000|Overall Study|manufacturing failure|0|||
143486806|NCT01029366|517326581|FG001|Overall Study|manufacturing failure|1|||
143486807|NCT00440947|517326582|FG000|36-Week Induction Phase|Adverse Event|16|||
143024086|NCT01806597|515629106|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
143024087|NCT01806597|515629107|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
143024088|NCT01806597|515629108|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
143486808|NCT00440947|517326583|FG001|36-Week Induction Phase|Adverse Event|0|||
143024089|NCT01806597|515629109|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
143024090|NCT01806597|515629110|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
143024091|NCT01806597|515629111|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
143024092|NCT01806597|515629106|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
143024093|NCT01806597|515629107|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
143024094|NCT01806597|515629108|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
143024095|NCT01806597|515629109|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
143024096|NCT01806597|515629110|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
143024097|NCT01806597|515629111|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
143024098|NCT01144663|515629112|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
143024099|NCT01144663|515629113|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
143024100|NCT01144663|515629114|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
143024101|NCT01144663|515629115|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
143024102|NCT01144663|515629112|FG000|Primary Vaccination Phase|Adverse Event|1|||
143024103|NCT01144663|515629113|FG001|Primary Vaccination Phase|Adverse Event|0|||
143024104|NCT01144663|515629114|FG002|Primary Vaccination Phase|Adverse Event|0|||
143024105|NCT01144663|515629115|FG003|Primary Vaccination Phase|Adverse Event|1|||
143024106|NCT01144663|515629112|FG000|Primary Vaccination Phase|Protocol Violation|2|||
143024107|NCT01144663|515629113|FG001|Primary Vaccination Phase|Protocol Violation|0|||
143024108|NCT01144663|515629114|FG002|Primary Vaccination Phase|Protocol Violation|1|||
143024109|NCT01144663|515629115|FG003|Primary Vaccination Phase|Protocol Violation|0|||
143024110|NCT01144663|515629112|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
143024111|NCT01144663|515629113|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
143024112|NCT01144663|515629114|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
143024113|NCT01144663|515629115|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
143024114|NCT01144663|515629112|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
143024115|NCT01144663|515629113|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
143024116|NCT01144663|515629114|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
143024117|NCT01144663|515629115|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
143024118|NCT01144663|515629112|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
143024119|NCT01144663|515629113|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
143024120|NCT01144663|515629114|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
143024121|NCT01144663|515629115|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
143024122|NCT01144663|515629112|FG000|Primary Vaccination Phase|Other|0|||
143024123|NCT01144663|515629113|FG001|Primary Vaccination Phase|Other|1|||
143024124|NCT01144663|515629114|FG002|Primary Vaccination Phase|Other|0|||
143024125|NCT01144663|515629115|FG003|Primary Vaccination Phase|Other|2|||
143024126|NCT01144663|515629112|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
143024127|NCT01144663|515629113|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
143024128|NCT01144663|515629114|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
143024129|NCT01144663|515629115|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
143024130|NCT01144663|515629112|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
143024131|NCT01144663|515629113|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
143024132|NCT01144663|515629114|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
143024133|NCT01144663|515629115|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
143024134|NCT01144663|515629112|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
143024135|NCT01144663|515629113|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
143024136|NCT01144663|515629114|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
143024137|NCT01144663|515629115|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
143024138|NCT01144663|515629112|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
143024139|NCT01144663|515629113|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
143024140|NCT01144663|515629114|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
143024141|NCT01144663|515629115|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
143024142|NCT01144663|515629112|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
143024143|NCT01144663|515629113|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
143024144|NCT01144663|515629114|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
143024145|NCT01144663|515629115|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
143024146|NCT01144663|515629112|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
143486809|NCT00440947|517326584|FG002|36-Week Induction Phase|Adverse Event|0|||
143236018|NCT02703597|516417352|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
143236019|NCT02703597|516417353|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
143236020|NCT02703597|516417352|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
143236021|NCT02703597|516417353|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
143236022|NCT02703597|516417352|FG000|First Post-test to First Follow-up|Site drop out|0|||
143236023|NCT02703597|516417353|FG001|First Post-test to First Follow-up|Site drop out|58|||
143236024|NCT02703597|516417352|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
143236025|NCT02703597|516417353|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
143236026|NCT02703597|516417352|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
143236027|NCT02703597|516417353|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
143236028|NCT02703597|516417352|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
143236029|NCT02703597|516417353|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
143236030|NCT02461758|516417354|FG000|Overall Study|Lost to Follow-up|0|||
143236031|NCT02461758|516417355|FG001|Overall Study|Lost to Follow-up|1|||
143236032|NCT02461758|516417356|FG002|Overall Study|Lost to Follow-up|1|||
143236033|NCT02461758|516417357|FG003|Overall Study|Lost to Follow-up|0|||
143236034|NCT03216226|516417358|FG000|Overall Study|Adverse Event|3|||
143236035|NCT03216226|516417359|FG001|Overall Study|Adverse Event|0|||
143236036|NCT03216226|516417358|FG000|Overall Study|Protocol Violation|1|||
143236037|NCT03216226|516417359|FG001|Overall Study|Protocol Violation|3|||
143236038|NCT03216226|516417358|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
143236039|NCT03216226|516417359|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
143236040|NCT03216226|516417358|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
143236041|NCT03216226|516417359|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
143236042|NCT03216226|516417358|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
143236043|NCT03216226|516417359|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
143236044|NCT01352715|516417361|FG000|Overall Study|Death|3|||
143236045|NCT01352715|516417362|FG001|Overall Study|Death|3|||
143236046|NCT01352715|516417361|FG000|Overall Study|Lost to Follow-up|5|||
143236047|NCT01352715|516417362|FG001|Overall Study|Lost to Follow-up|7|||
143236048|NCT01352715|516417361|FG000|Overall Study|Withdrawal by Subject|4|||
143236049|NCT01352715|516417362|FG001|Overall Study|Withdrawal by Subject|8|||
143236050|NCT01352715|516417361|FG000|Overall Study|site closure|16|||
143236051|NCT01352715|516417362|FG001|Overall Study|site closure|15|||
143236052|NCT01352715|516417361|FG000|Overall Study|no final visit in closeout period|15|||
143236053|NCT01352715|516417362|FG001|Overall Study|no final visit in closeout period|12|||
143236054|NCT01352715|516417361|FG000|Overall Study|major ineligibility|2|||
143236055|NCT01352715|516417362|FG001|Overall Study|major ineligibility|1|||
143236056|NCT04596267|516417363|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
143236057|NCT04596267|516417364|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
143236058|NCT04596267|516417363|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
143236059|NCT04596267|516417364|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
143236060|NCT04109547|516417365|FG000|Overall Study|Withdrawal by Subject|3|||
143236061|NCT04109547|516417366|FG001|Overall Study|Withdrawal by Subject|2|||
143236062|NCT04109547|516417367|FG002|Overall Study|Withdrawal by Subject|6|||
143024147|NCT01144663|515629113|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
143024148|NCT01144663|515629114|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
143024149|NCT01144663|515629115|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
143024150|NCT01267266|515629118|FG000|Enrollment Phase|Withdrawal by Subject|2|||
143024151|NCT01267266|515629119|FG001|Enrollment Phase|Withdrawal by Subject|0|||
143024152|NCT01267266|515629118|FG000|Lead-in Phase|Lack of Efficacy|20|||
143024153|NCT01267266|515629119|FG001|Lead-in Phase|Lack of Efficacy|0|||
143236063|NCT04109547|516417368|FG003|Overall Study|Withdrawal by Subject|6|||
143236064|NCT04109547|516417365|FG000|Overall Study|Lost to Follow-up|0|||
143236065|NCT04109547|516417366|FG001|Overall Study|Lost to Follow-up|0|||
143236066|NCT04109547|516417367|FG002|Overall Study|Lost to Follow-up|0|||
143236067|NCT04109547|516417368|FG003|Overall Study|Lost to Follow-up|1|||
143236068|NCT04109547|516417365|FG000|Overall Study|Physician Decision|1|||
143236069|NCT04109547|516417366|FG001|Overall Study|Physician Decision|2|||
143236070|NCT04109547|516417367|FG002|Overall Study|Physician Decision|0|||
143236071|NCT04109547|516417368|FG003|Overall Study|Physician Decision|0|||
143236072|NCT05249582|516417369|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
143236073|NCT05249582|516417370|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
143024154|NCT01267266|515629118|FG000|Lead-in Phase|Adverse Event|2|||
143024155|NCT01267266|515629119|FG001|Lead-in Phase|Adverse Event|0|||
143236074|NCT05249582|516417369|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
143363751|NCT04978363|516875442|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
143024156|NCT01267266|515629118|FG000|Lead-in Phase|Withdrawal by Subject|1|||
143024157|NCT01267266|515629119|FG001|Lead-in Phase|Withdrawal by Subject|0|||
143024158|NCT03433001|515629121|FG000|Overall Study|Lack of Efficacy|109|||
143024159|NCT03433001|515629121|FG000|Overall Study|Adverse Event|69|||
143024160|NCT03433001|515629121|FG000|Overall Study|Withdrawal by Subject|10|||
143024161|NCT03433001|515629121|FG000|Overall Study|Death|12|||
143024162|NCT03433001|515629121|FG000|Overall Study|Lost to Follow-up|4|||
143024163|NCT03433001|515629121|FG000|Overall Study|Other|25|||
143024164|NCT01007916|515629124|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
143024165|NCT01007916|515629125|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
143024166|NCT01007916|515629124|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
143024167|NCT01007916|515629125|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
143024168|NCT01927757|515629129|FG000|Overall Study|Withdrawal by Subject|14|||
143024169|NCT01927757|515629129|FG000|Overall Study|Lost to Follow-up|2|||
143024170|NCT01927757|515629129|FG000|Overall Study|Decision by Sponsor|2|||
143024171|NCT01927757|515629129|FG000|Overall Study|Other|1|||
143024172|NCT01927757|515629129|FG000|Overall Study|Ethical Reasons|4|||
143024173|NCT00613574|515629130|FG000|Overall Study|Adverse Event|3|||
143157275|NCT01623752|516121576|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
143157276|NCT01623752|516121577|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
143157277|NCT01623752|516121575|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
143157278|NCT01623752|516121576|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
143236075|NCT05249582|516417370|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
143236076|NCT05249582|516417369|FG000|Overall Study|Declined to use virtual reality headset|1|||
143236077|NCT05249582|516417370|FG001|Overall Study|Declined to use virtual reality headset|0|||
143236078|NCT01710345|516417373|FG000|Overall Study|Adverse Event|0|||
143157279|NCT01623752|516121577|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
143157280|NCT01623752|516121575|FG000|Phase 2 (78 Weeks)|Other|5|||
143157281|NCT01623752|516121576|FG001|Phase 2 (78 Weeks)|Other|1|||
143157282|NCT01623752|516121577|FG002|Phase 2 (78 Weeks)|Other|0|||
143157283|NCT01623752|516121575|FG000|Phase 2 (78 Weeks)|No Data|43|||
143157284|NCT01623752|516121576|FG001|Phase 2 (78 Weeks)|No Data|11|||
143157285|NCT01623752|516121577|FG002|Phase 2 (78 Weeks)|No Data|0|||
143157286|NCT01623752|516121575|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
143157287|NCT01623752|516121576|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
143157288|NCT01623752|516121577|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
143157289|NCT04389671|516121580|FG000|Overall Study|Death|7|||
143157290|NCT02287025|516121581|FG000|Overall Study|Not treated|2|||
143157291|NCT02287025|516121582|FG001|Overall Study|Not treated|0|||
143157292|NCT02287025|516121581|FG000|Overall Study|Progression of disease|3|||
143157293|NCT02287025|516121582|FG001|Overall Study|Progression of disease|2|||
143157294|NCT02287025|516121581|FG000|Overall Study|Adverse Event|2|||
143157295|NCT02287025|516121582|FG001|Overall Study|Adverse Event|4|||
143157296|NCT02287025|516121581|FG000|Overall Study|Withdrawal by Subject|2|||
143157297|NCT02287025|516121582|FG001|Overall Study|Withdrawal by Subject|2|||
143157298|NCT02287025|516121581|FG000|Overall Study|Screening failed|1|||
143157299|NCT02287025|516121582|FG001|Overall Study|Screening failed|1|||
143157300|NCT00899847|516121583|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
143157301|NCT01096186|516121584|FG000|Overall Study|Adverse Event|16|||
143157302|NCT01096186|516121584|FG000|Overall Study|Death|4|||
143157303|NCT01096186|516121584|FG000|Overall Study|Lack of Efficacy|4|||
143157304|NCT01096186|516121584|FG000|Overall Study|Lost to Follow-up|2|||
143157305|NCT01096186|516121584|FG000|Overall Study|Withdrawal by Subject|22|||
143157306|NCT01096186|516121584|FG000|Overall Study|Physician Decision|1|||
143157307|NCT01096186|516121584|FG000|Overall Study|Noncompliance with study drug|1|||
143157308|NCT04053452|516121585|FG000|Overall Study|Withdrawal by Subject|1|||
143157309|NCT04053452|516121586|FG001|Overall Study|Withdrawal by Subject|0|||
143157310|NCT04053452|516121585|FG000|Overall Study|Time restraint due to inpatient needs|1|||
143157311|NCT04053452|516121586|FG001|Overall Study|Time restraint due to inpatient needs|2|||
143157312|NCT01421134|516121591|FG000|Overall Study|Adverse Event|3|||
143157313|NCT01421134|516121592|FG001|Overall Study|Adverse Event|5|||
143157314|NCT01421134|516121591|FG000|Overall Study|Lack of Efficacy|2|||
143157315|NCT01421134|516121592|FG001|Overall Study|Lack of Efficacy|4|||
143157316|NCT01421134|516121591|FG000|Overall Study|Protocol Violation|0|||
143157317|NCT01421134|516121592|FG001|Overall Study|Protocol Violation|3|||
143236079|NCT01710345|516417374|FG001|Overall Study|Adverse Event|2|||
143236080|NCT01710345|516417375|FG002|Overall Study|Adverse Event|0|||
143024174|NCT00613574|515629130|FG000|Overall Study|Lost to Follow-up|2|||
143157318|NCT01421134|516121591|FG000|Overall Study|Withdrawal by Subject|1|||
143157319|NCT01421134|516121592|FG001|Overall Study|Withdrawal by Subject|1|||
143157320|NCT01421134|516121591|FG000|Overall Study|Administrative|0|||
143157321|NCT01421134|516121592|FG001|Overall Study|Administrative|1|||
143157322|NCT01421134|516121591|FG000|Overall Study|Lost to Follow-up|1|||
143157323|NCT01421134|516121592|FG001|Overall Study|Lost to Follow-up|1|||
143157324|NCT02959892|516121593|FG000|Overall Study|PET tracer synthesis failure|1|||
143024175|NCT00613574|515629130|FG000|Overall Study|Other|1|||
143024176|NCT04604184|515629132|FG000|Overall Study|Adverse Event|5|||
143157325|NCT02959892|516121594|FG001|Overall Study|PET tracer synthesis failure|0|||
143024177|NCT04604184|515629133|FG001|Overall Study|Adverse Event|5|||
143157326|NCT02959892|516121593|FG000|Overall Study|Study termination|0|||
143236081|NCT01710345|516417373|FG000|Overall Study|Lack of Efficacy|2|||
143236082|NCT01710345|516417374|FG001|Overall Study|Lack of Efficacy|3|||
143236083|NCT01710345|516417375|FG002|Overall Study|Lack of Efficacy|1|||
143236084|NCT01710345|516417373|FG000|Overall Study|Drug Dosing Error|1|||
143236085|NCT01710345|516417374|FG001|Overall Study|Drug Dosing Error|0|||
143236086|NCT01710345|516417375|FG002|Overall Study|Drug Dosing Error|0|||
143236087|NCT00449696|516417377|FG000|Overall Study|Other Treatment Required|6|||
143236088|NCT00449696|516417378|FG001|Overall Study|Other Treatment Required|1|||
143236089|NCT00449696|516417377|FG000|Overall Study|Withdrawal by Subject|5|||
143236090|NCT00449696|516417378|FG001|Overall Study|Withdrawal by Subject|5|||
143236091|NCT00449696|516417377|FG000|Overall Study|Lost to Follow-up|2|||
143236092|NCT00449696|516417378|FG001|Overall Study|Lost to Follow-up|3|||
143236093|NCT00449696|516417377|FG000|Overall Study|Others|7|||
143236094|NCT00449696|516417378|FG001|Overall Study|Others|0|||
143236095|NCT01353898|516417384|FG000|Overall Study|Study site terminated|0|||
143236096|NCT01353898|516417385|FG001|Overall Study|Study site terminated|0|||
143236097|NCT01353898|516417386|FG002|Overall Study|Study site terminated|0|||
143236098|NCT01353898|516417387|FG003|Overall Study|Study site terminated|0|||
143236099|NCT01353898|516417388|FG004|Overall Study|Study site terminated|0|||
143236100|NCT01353898|516417389|FG005|Overall Study|Study site terminated|1|||
143236101|NCT03558737|516417392|FG000|Overall Study|Death|1|||
143236102|NCT03558737|516417393|FG001|Overall Study|Death|1|||
143236103|NCT02158442|516417394|FG000|Overall Study|Withdrawal by Subject|1|||
143236104|NCT02158442|516417395|FG001|Overall Study|Withdrawal by Subject|0|||
143236105|NCT02158442|516417394|FG000|Overall Study|Perfusion staff not available|1|||
143236106|NCT02158442|516417395|FG001|Overall Study|Perfusion staff not available|0|||
143236107|NCT01409707|516417396|FG000|Overall Study|Withdrawal by Subject|5|||
143236108|NCT01409707|516417397|FG001|Overall Study|Withdrawal by Subject|17|||
143236109|NCT01409707|516417398|FG002|Overall Study|Withdrawal by Subject|16|||
143236110|NCT01217229|516417399|FG000|Overall Study|Adverse Event|1|||
143236111|NCT01217229|516417399|FG000|Overall Study|Disease progression, deterioration|2|||
143236112|NCT01217229|516417399|FG000|Overall Study|Disease progression, Cheson criteria|14|||
143236113|NCT01217229|516417399|FG000|Overall Study|Protocol Violation|1|||
143236114|NCT01217229|516417399|FG000|Overall Study|Disease progression not confirmed|2|||
143236115|NCT05386329|516417401|FG000|Overall Study|Lost to Follow-up|3|||
143236116|NCT03041181|516417403|FG000|Overall Study|Disease Progression|1|||
143236117|NCT03041181|516417404|FG001|Overall Study|Disease Progression|2|||
143236118|NCT03224819|516417405|FG000|Overall Study|Withdrawal by Subject|0|||
143236119|NCT03224819|516417406|FG001|Overall Study|Withdrawal by Subject|0|||
143236120|NCT03224819|516417407|FG002|Overall Study|Withdrawal by Subject|0|||
143236121|NCT03224819|516417408|FG003|Overall Study|Withdrawal by Subject|0|||
143236122|NCT03224819|516417409|FG004|Overall Study|Withdrawal by Subject|0|||
143236123|NCT03224819|516417410|FG005|Overall Study|Withdrawal by Subject|0|||
143236124|NCT03224819|516417411|FG006|Overall Study|Withdrawal by Subject|0|||
143236125|NCT03224819|516417412|FG007|Overall Study|Withdrawal by Subject|0|||
143236126|NCT03224819|516417413|FG008|Overall Study|Withdrawal by Subject|0|||
143236127|NCT03224819|516417414|FG009|Overall Study|Withdrawal by Subject|0|||
143236128|NCT03224819|516417415|FG010|Overall Study|Withdrawal by Subject|0|||
143236129|NCT03224819|516417416|FG011|Overall Study|Withdrawal by Subject|0|||
143236130|NCT03224819|516417417|FG012|Overall Study|Withdrawal by Subject|1|||
143236131|NCT03224819|516417418|FG013|Overall Study|Withdrawal by Subject|0|||
143236132|NCT03224819|516417405|FG000|Overall Study|Sponsor Decision|0|||
143236133|NCT03224819|516417406|FG001|Overall Study|Sponsor Decision|0|||
143236134|NCT03224819|516417407|FG002|Overall Study|Sponsor Decision|0|||
143236135|NCT03224819|516417408|FG003|Overall Study|Sponsor Decision|1|||
143236136|NCT03224819|516417409|FG004|Overall Study|Sponsor Decision|1|||
143236137|NCT03224819|516417410|FG005|Overall Study|Sponsor Decision|2|||
143236138|NCT03224819|516417411|FG006|Overall Study|Sponsor Decision|1|||
143236139|NCT03224819|516417412|FG007|Overall Study|Sponsor Decision|1|||
143236140|NCT03224819|516417413|FG008|Overall Study|Sponsor Decision|1|||
143236141|NCT03224819|516417414|FG009|Overall Study|Sponsor Decision|2|||
143236142|NCT03224819|516417415|FG010|Overall Study|Sponsor Decision|1|||
143236143|NCT03224819|516417416|FG011|Overall Study|Sponsor Decision|1|||
143236144|NCT03224819|516417417|FG012|Overall Study|Sponsor Decision|1|||
143236145|NCT03224819|516417418|FG013|Overall Study|Sponsor Decision|0|||
143236146|NCT03224819|516417405|FG000|Overall Study|Lost to Follow-up|0|||
143236147|NCT03224819|516417406|FG001|Overall Study|Lost to Follow-up|0|||
143236148|NCT03224819|516417407|FG002|Overall Study|Lost to Follow-up|0|||
143236149|NCT03224819|516417408|FG003|Overall Study|Lost to Follow-up|0|||
143236150|NCT03224819|516417409|FG004|Overall Study|Lost to Follow-up|0|||
143236151|NCT03224819|516417410|FG005|Overall Study|Lost to Follow-up|0|||
143236152|NCT03224819|516417411|FG006|Overall Study|Lost to Follow-up|0|||
143236153|NCT03224819|516417412|FG007|Overall Study|Lost to Follow-up|0|||
143236154|NCT03224819|516417413|FG008|Overall Study|Lost to Follow-up|1|||
143236155|NCT03224819|516417414|FG009|Overall Study|Lost to Follow-up|0|||
143236156|NCT03224819|516417415|FG010|Overall Study|Lost to Follow-up|0|||
143236157|NCT03224819|516417416|FG011|Overall Study|Lost to Follow-up|0|||
143236158|NCT03224819|516417417|FG012|Overall Study|Lost to Follow-up|0|||
143236159|NCT03224819|516417418|FG013|Overall Study|Lost to Follow-up|0|||
143236160|NCT03224819|516417405|FG000|Overall Study|Death|0|||
143236161|NCT03224819|516417406|FG001|Overall Study|Death|1|||
143236162|NCT03224819|516417407|FG002|Overall Study|Death|0|||
143236163|NCT03224819|516417408|FG003|Overall Study|Death|0|||
143236164|NCT03224819|516417409|FG004|Overall Study|Death|0|||
143236165|NCT03224819|516417410|FG005|Overall Study|Death|0|||
143236166|NCT03224819|516417411|FG006|Overall Study|Death|0|||
143236167|NCT03224819|516417412|FG007|Overall Study|Death|1|||
143236168|NCT03224819|516417413|FG008|Overall Study|Death|0|||
143236169|NCT03224819|516417414|FG009|Overall Study|Death|0|||
143236170|NCT03224819|516417415|FG010|Overall Study|Death|0|||
143236171|NCT03224819|516417416|FG011|Overall Study|Death|1|||
143236172|NCT03224819|516417417|FG012|Overall Study|Death|0|||
143236173|NCT03224819|516417418|FG013|Overall Study|Death|0|||
143236174|NCT01903460|516417421|FG000|Overall Study|Adverse Event|0|||
143236175|NCT01903460|516417422|FG001|Overall Study|Adverse Event|0|||
143236176|NCT01903460|516417423|FG002|Overall Study|Adverse Event|0|||
143236177|NCT01903460|516417424|FG003|Overall Study|Adverse Event|1|||
143236178|NCT03104868|516417425|FG000|6 Week Follow up|Lost to Follow-up|5|||
143236179|NCT03104868|516417426|FG001|6 Week Follow up|Lost to Follow-up|8|||
143236180|NCT03104868|516417425|FG000|6 Week Follow up|Death|1|||
143236181|NCT03104868|516417426|FG001|6 Week Follow up|Death|1|||
143236182|NCT03104868|516417425|FG000|6 Week Follow up|Withdrawal by Subject|7|||
143236183|NCT03104868|516417426|FG001|6 Week Follow up|Withdrawal by Subject|6|||
143236184|NCT03104868|516417425|FG000|6 Week Follow up|Completed Later Timepoint|24|||
143236185|NCT03104868|516417426|FG001|6 Week Follow up|Completed Later Timepoint|22|||
143236186|NCT03104868|516417425|FG000|6 Month Follow up|Lost to Follow-up|2|||
143236187|NCT03104868|516417426|FG001|6 Month Follow up|Lost to Follow-up|2|||
143024178|NCT04604184|515629132|FG000|Overall Study|Death|2|||
143024179|NCT04604184|515629133|FG001|Overall Study|Death|1|||
143024180|NCT04604184|515629132|FG000|Overall Study|Withdrawal by Subject|1|||
143024181|NCT04604184|515629133|FG001|Overall Study|Withdrawal by Subject|3|||
143236188|NCT03104868|516417425|FG000|6 Month Follow up|Death|0|||
143236189|NCT03104868|516417426|FG001|6 Month Follow up|Death|1|||
143236190|NCT03104868|516417425|FG000|6 Month Follow up|Completed Later Timepoint|22|||
143236191|NCT03104868|516417426|FG001|6 Month Follow up|Completed Later Timepoint|32|||
143236192|NCT03104868|516417425|FG000|12 Month Follow up|Lost to Follow-up|1|||
143486810|NCT00440947|517326585|FG003|36-Week Induction Phase|Adverse Event|0|||
143486811|NCT00440947|517326586|FG004|36-Week Induction Phase|Adverse Event|0|||
143486812|NCT00440947|517326582|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
143486813|NCT00440947|517326583|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
143486814|NCT00440947|517326584|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
143486815|NCT00440947|517326585|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
143486816|NCT00440947|517326586|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
143486817|NCT00440947|517326582|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
143486818|NCT00440947|517326583|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
143486819|NCT00440947|517326584|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
143486820|NCT00440947|517326585|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
143486821|NCT00440947|517326586|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
143486822|NCT00440947|517326582|FG000|36-Week Induction Phase|Non-compliance|10|||
143486823|NCT00440947|517326583|FG001|36-Week Induction Phase|Non-compliance|0|||
143486824|NCT00440947|517326584|FG002|36-Week Induction Phase|Non-compliance|0|||
143486825|NCT00440947|517326585|FG003|36-Week Induction Phase|Non-compliance|0|||
143486826|NCT00440947|517326586|FG004|36-Week Induction Phase|Non-compliance|0|||
143486827|NCT00440947|517326582|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
143024182|NCT04604184|515629132|FG000|Overall Study|Not treated|2|||
143024183|NCT04604184|515629133|FG001|Overall Study|Not treated|2|||
143024184|NCT04604184|515629132|FG000|Overall Study|Due to sponsor decision|9|||
143024185|NCT04604184|515629133|FG001|Overall Study|Due to sponsor decision|7|||
143024186|NCT04604184|515629132|FG000|Overall Study|Physician Decision|0|||
143024187|NCT04604184|515629133|FG001|Overall Study|Physician Decision|1|||
143024188|NCT04604184|515629132|FG000|Overall Study|Transfer to healthcare|1|||
143236193|NCT03104868|516417426|FG001|12 Month Follow up|Lost to Follow-up|2|||
143236194|NCT03104868|516417425|FG000|12 Month Follow up|Death|0|||
143236195|NCT03104868|516417426|FG001|12 Month Follow up|Death|1|||
143024189|NCT04604184|515629133|FG001|Overall Study|Transfer to healthcare|0|||
143236196|NCT03104868|516417425|FG000|12 Month Follow up|Withdrawal by Subject|0|||
143236197|NCT03104868|516417426|FG001|12 Month Follow up|Withdrawal by Subject|3|||
143236198|NCT03104868|516417425|FG000|12 Month Follow up|Completed Later Timepoint|32|||
143236199|NCT03104868|516417426|FG001|12 Month Follow up|Completed Later Timepoint|29|||
143236200|NCT03104868|516417425|FG000|18 Month Follow up|Lost to Follow-up|7|||
143236201|NCT03104868|516417426|FG001|18 Month Follow up|Lost to Follow-up|11|||
143024190|NCT01798485|515629134|FG000|Overall Study|Adverse Event|32|||
143024191|NCT01798485|515629135|FG001|Overall Study|Adverse Event|40|||
143236202|NCT03104868|516417425|FG000|18 Month Follow up|Death|2|||
143236203|NCT03104868|516417426|FG001|18 Month Follow up|Death|1|||
143236204|NCT03104868|516417425|FG000|18 Month Follow up|Withdrawal by Subject|1|||
143236205|NCT03104868|516417426|FG001|18 Month Follow up|Withdrawal by Subject|2|||
143236206|NCT03104868|516417425|FG000|18 Month Follow up|Graft Loss|1|||
143236207|NCT03104868|516417426|FG001|18 Month Follow up|Graft Loss|1|||
143236208|NCT03104868|516417425|FG000|18 Month Follow up|Completed Later Timepoint|19|||
143236209|NCT03104868|516417426|FG001|18 Month Follow up|Completed Later Timepoint|20|||
143236210|NCT03104868|516417425|FG000|24 Month Follow up|Lost to Follow-up|15|||
143236211|NCT03104868|516417426|FG001|24 Month Follow up|Lost to Follow-up|16|||
143236212|NCT03104868|516417425|FG000|24 Month Follow up|Death|3|||
143236213|NCT03104868|516417426|FG001|24 Month Follow up|Death|2|||
143236214|NCT03104868|516417425|FG000|24 Month Follow up|Withdrawal by Subject|1|||
143236215|NCT03104868|516417426|FG001|24 Month Follow up|Withdrawal by Subject|0|||
143236216|NCT03104868|516417425|FG000|24 Month Follow up|Graft Loss|2|||
143236217|NCT03104868|516417426|FG001|24 Month Follow up|Graft Loss|0|||
143236218|NCT00005780|516417427|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
143236219|NCT04973449|516417428|FG000|Overall Study|Withdrawal by Subject|3|||
143236220|NCT04973449|516417429|FG001|Overall Study|Withdrawal by Subject|3|||
143236221|NCT04973449|516417430|FG002|Overall Study|Withdrawal by Subject|2|||
143236222|NCT04973449|516417431|FG003|Overall Study|Withdrawal by Subject|5|||
143236223|NCT04973449|516417432|FG004|Overall Study|Withdrawal by Subject|5|||
143236224|NCT04973449|516417433|FG005|Overall Study|Withdrawal by Subject|4|||
143236225|NCT04973449|516417434|FG006|Overall Study|Withdrawal by Subject|7|||
143236226|NCT04973449|516417435|FG007|Overall Study|Withdrawal by Subject|5|||
143236227|NCT04973449|516417428|FG000|Overall Study|Lost to Follow-up|15|||
143236228|NCT04973449|516417429|FG001|Overall Study|Lost to Follow-up|16|||
143236229|NCT04973449|516417430|FG002|Overall Study|Lost to Follow-up|16|||
143236230|NCT04973449|516417431|FG003|Overall Study|Lost to Follow-up|13|||
143236231|NCT04973449|516417432|FG004|Overall Study|Lost to Follow-up|5|||
143236232|NCT04973449|516417433|FG005|Overall Study|Lost to Follow-up|6|||
143236233|NCT04973449|516417434|FG006|Overall Study|Lost to Follow-up|10|||
143236234|NCT04973449|516417435|FG007|Overall Study|Lost to Follow-up|6|||
143236235|NCT04973449|516417428|FG000|Overall Study|Death|1|||
143236236|NCT04973449|516417429|FG001|Overall Study|Death|0|||
143236237|NCT04973449|516417430|FG002|Overall Study|Death|0|||
143236238|NCT04973449|516417431|FG003|Overall Study|Death|0|||
143236239|NCT04973449|516417432|FG004|Overall Study|Death|0|||
143236240|NCT04973449|516417433|FG005|Overall Study|Death|1|||
143236241|NCT04973449|516417434|FG006|Overall Study|Death|0|||
143236242|NCT04973449|516417435|FG007|Overall Study|Death|0|||
143236243|NCT04973449|516417428|FG000|Overall Study|Other|1|||
143236244|NCT04973449|516417429|FG001|Overall Study|Other|1|||
143236245|NCT04973449|516417430|FG002|Overall Study|Other|2|||
143236246|NCT04973449|516417431|FG003|Overall Study|Other|1|||
143236247|NCT04973449|516417432|FG004|Overall Study|Other|4|||
143236248|NCT04973449|516417433|FG005|Overall Study|Other|0|||
143236249|NCT04973449|516417434|FG006|Overall Study|Other|2|||
143236250|NCT04973449|516417435|FG007|Overall Study|Other|2|||
143236251|NCT00888173|516417437|FG000|Overall Study|Wrong Primary|1|||
143236252|NCT00888173|516417437|FG000|Overall Study|Ineligible: required test not done|1|||
143236253|NCT00829426|516417443|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
143236254|NCT00829426|516417444|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
143236255|NCT04672239|516417447|FG000|Week 2 Survey|Failed survey check items|1|||
143236256|NCT04672239|516417448|FG001|Week 2 Survey|Failed survey check items|2|||
143236257|NCT04672239|516417449|FG002|Week 2 Survey|Failed survey check items|3|||
143236258|NCT04672239|516417447|FG000|Week 2 Survey|Partially completed survey|7|||
143236259|NCT04672239|516417448|FG001|Week 2 Survey|Partially completed survey|1|||
143236260|NCT04672239|516417449|FG002|Week 2 Survey|Partially completed survey|4|||
143236261|NCT04672239|516417447|FG000|Week 2 Survey|Withdrawal by Subject|0|||
143486828|NCT00440947|517326583|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
143486829|NCT00440947|517326584|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
143486830|NCT00440947|517326585|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
143486831|NCT00440947|517326586|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
143486832|NCT00440947|517326582|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
143236262|NCT04672239|516417448|FG001|Week 2 Survey|Withdrawal by Subject|1|||
143236263|NCT04672239|516417449|FG002|Week 2 Survey|Withdrawal by Subject|0|||
143236264|NCT04672239|516417447|FG000|Week 2 Survey|Lost to Follow-up|3|||
143236265|NCT04672239|516417448|FG001|Week 2 Survey|Lost to Follow-up|2|||
143236266|NCT04672239|516417449|FG002|Week 2 Survey|Lost to Follow-up|5|||
143236267|NCT04672239|516417447|FG000|Week 6 Survey|Failed survey check items|2|||
143236268|NCT04672239|516417448|FG001|Week 6 Survey|Failed survey check items|2|||
143236269|NCT04672239|516417449|FG002|Week 6 Survey|Failed survey check items|2|||
143236270|NCT04672239|516417447|FG000|Week 6 Survey|Partially completed survey|3|||
143236271|NCT04672239|516417448|FG001|Week 6 Survey|Partially completed survey|3|||
143236272|NCT04672239|516417449|FG002|Week 6 Survey|Partially completed survey|2|||
143236273|NCT04672239|516417447|FG000|Week 6 Survey|Withdrawal by Subject|1|||
143236274|NCT04672239|516417448|FG001|Week 6 Survey|Withdrawal by Subject|1|||
143236275|NCT04672239|516417449|FG002|Week 6 Survey|Withdrawal by Subject|1|||
143236276|NCT04672239|516417447|FG000|Week 6 Survey|Withdrawn by PI|0|||
143486833|NCT00440947|517326583|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
143486834|NCT00440947|517326584|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
143486835|NCT00440947|517326585|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
143486836|NCT00440947|517326586|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
143486837|NCT00440947|517326582|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
143486838|NCT00440947|517326583|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
143486839|NCT00440947|517326584|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
143486840|NCT00440947|517326585|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
143486841|NCT00440947|517326586|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
143486842|NCT00440947|517326582|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
143486843|NCT00440947|517326583|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
143486844|NCT00440947|517326584|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
143486845|NCT00440947|517326585|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
143486846|NCT00440947|517326586|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
143486847|NCT00440947|517326582|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
143486848|NCT00440947|517326583|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
143486849|NCT00440947|517326584|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
143486850|NCT00440947|517326585|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
143486851|NCT00440947|517326586|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
143486852|NCT00440947|517326582|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
143486853|NCT00440947|517326583|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
143486854|NCT00440947|517326584|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
143486855|NCT00440947|517326585|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
143486856|NCT00440947|517326586|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
143486857|NCT00440947|517326582|FG000|36-Week Induction Phase|Incarceration|3|||
143486858|NCT00440947|517326583|FG001|36-Week Induction Phase|Incarceration|0|||
143486859|NCT00440947|517326584|FG002|36-Week Induction Phase|Incarceration|0|||
143486860|NCT00440947|517326585|FG003|36-Week Induction Phase|Incarceration|0|||
143486861|NCT00440947|517326586|FG004|36-Week Induction Phase|Incarceration|0|||
143486862|NCT00440947|517326582|FG000|36-Week Induction Phase|Pregnancy|1|||
143486863|NCT00440947|517326583|FG001|36-Week Induction Phase|Pregnancy|0|||
143486864|NCT00440947|517326584|FG002|36-Week Induction Phase|Pregnancy|0|||
143486865|NCT00440947|517326585|FG003|36-Week Induction Phase|Pregnancy|0|||
143486866|NCT00440947|517326586|FG004|36-Week Induction Phase|Pregnancy|0|||
143486867|NCT00440947|517326582|FG000|48-Week Randomization Phase|Adverse Event|0|||
143486868|NCT00440947|517326583|FG001|48-Week Randomization Phase|Adverse Event|2|||
143157327|NCT02959892|516121594|FG001|Overall Study|Study termination|1|||
143157328|NCT00122187|516121595|FG000|Overall Study|Withdrew because of resource limitations|2|||
143157329|NCT00122187|516121596|FG001|Overall Study|Withdrew because of resource limitations|2|||
143157330|NCT00799864|516121600|FG000|Overall Study|Participant reached a virologic endpoint|9|||
143157331|NCT00799864|516121601|FG001|Overall Study|Participant reached a virologic endpoint|2|||
143157332|NCT00799864|516121602|FG002|Overall Study|Participant reached a virologic endpoint|2|||
143157333|NCT00799864|516121603|FG003|Overall Study|Participant reached a virologic endpoint|0|||
143157334|NCT00799864|516121604|FG004|Overall Study|Participant reached a virologic endpoint|0|||
143157335|NCT00799864|516121600|FG000|Overall Study|Other|2|||
143157336|NCT00799864|516121601|FG001|Overall Study|Other|1|||
143157337|NCT00799864|516121602|FG002|Overall Study|Other|0|||
143157338|NCT00799864|516121603|FG003|Overall Study|Other|0|||
143157339|NCT00799864|516121604|FG004|Overall Study|Other|0|||
143157340|NCT03528577|516121605|FG000|Sequence 1|Failed Spirometry|1|||
143157341|NCT03528577|516121605|FG000|Sequence 1|Restricted medication|1|||
143157342|NCT03528577|516121605|FG000|Sequence 2|Adverse Event|1|||
143157343|NCT03528577|516121605|FG000|Sequence 2|Withdrawal by Subject|1|||
143157344|NCT03528577|516121605|FG000|Sequence 2|Failed Spirometry|1|||
143157345|NCT03528577|516121605|FG000|Sequence 3|Failed Spirometry|1|||
143157346|NCT03528577|516121605|FG000|Sequence 4|Failed Spirometry|2|||
143157347|NCT03528577|516121605|FG000|Sequence 4|Adverse Event|1|||
143157348|NCT04263532|516121606|FG000|Overall Study|Withdrawal by Subject|2|||
143157349|NCT04263532|516121607|FG001|Overall Study|Withdrawal by Subject|0|||
143157350|NCT05064800|516121608|FG000|Period 3|Withdrawal by Subject|0|||
143157351|NCT05064800|516121609|FG001|Period 3|Withdrawal by Subject|0|||
143486869|NCT00440947|517326584|FG002|48-Week Randomization Phase|Adverse Event|5|||
143486870|NCT00440947|517326585|FG003|48-Week Randomization Phase|Adverse Event|0|||
143486871|NCT00440947|517326586|FG004|48-Week Randomization Phase|Adverse Event|0|||
143486872|NCT00440947|517326582|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
143486873|NCT00440947|517326583|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
143157352|NCT05064800|516121610|FG002|Period 3|Withdrawal by Subject|0|||
143157353|NCT05064800|516121611|FG003|Period 3|Withdrawal by Subject|0|||
143157354|NCT05064800|516121612|FG004|Period 3|Withdrawal by Subject|1|||
143157355|NCT05064800|516121613|FG005|Period 3|Withdrawal by Subject|0|||
143157356|NCT01543503|516121614|FG000|Overall Study|Lost to Follow-up|32|||
143024192|NCT01798485|515629134|FG000|Overall Study|Withdrawal by Subject|27|||
143024193|NCT01798485|515629135|FG001|Overall Study|Withdrawal by Subject|31|||
143024194|NCT01798485|515629134|FG000|Overall Study|Lost to Follow-up|0|||
143024195|NCT01798485|515629135|FG001|Overall Study|Lost to Follow-up|3|||
143024196|NCT01798485|515629134|FG000|Overall Study|Physician Decision|14|||
143024197|NCT01798485|515629135|FG001|Overall Study|Physician Decision|10|||
143024198|NCT01798485|515629134|FG000|Overall Study|Objective Disease Progression|152|||
143024199|NCT01798485|515629135|FG001|Overall Study|Objective Disease Progression|106|||
143024200|NCT01798485|515629134|FG000|Overall Study|Death|25|||
143024201|NCT01798485|515629135|FG001|Overall Study|Death|22|||
143024202|NCT01798485|515629134|FG000|Overall Study|Sponsor Decision|61|||
143024203|NCT01798485|515629135|FG001|Overall Study|Sponsor Decision|54|||
143024204|NCT01798485|515629134|FG000|Overall Study|Clinical Progression|35|||
143024205|NCT01798485|515629135|FG001|Overall Study|Clinical Progression|24|||
143024206|NCT00770991|515629139|FG000|Overall Study|Physician Decision|2|||
143024207|NCT00770991|515629140|FG001|Overall Study|Physician Decision|0|||
143024208|NCT00770991|515629139|FG000|Overall Study|Withdrawal by Subject|1|||
143024209|NCT00770991|515629140|FG001|Overall Study|Withdrawal by Subject|0|||
143024210|NCT00770991|515629139|FG000|Overall Study|Adverse Event|1|||
143024211|NCT00770991|515629140|FG001|Overall Study|Adverse Event|5|||
143024212|NCT00770991|515629139|FG000|Overall Study|Pregnancy|1|||
143024213|NCT00770991|515629140|FG001|Overall Study|Pregnancy|0|||
143024214|NCT01992107|515629141|FG000|Overall Study|Administrative reasons|2|||
143024215|NCT01992107|515629142|FG001|Overall Study|Administrative reasons|0|||
143024216|NCT01992107|515629143|FG002|Overall Study|Administrative reasons|0|||
143157357|NCT01543503|516121615|FG001|Overall Study|Lost to Follow-up|36|||
143157358|NCT01543503|516121614|FG000|Overall Study|Adverse Event|9|||
143157359|NCT01543503|516121615|FG001|Overall Study|Adverse Event|13|||
143157360|NCT01543503|516121614|FG000|Overall Study|Lack of Efficacy|4|||
143157361|NCT01543503|516121615|FG001|Overall Study|Lack of Efficacy|16|||
143157362|NCT01543503|516121614|FG000|Overall Study|Participant withdrew informed consent|8|||
143157363|NCT01543503|516121615|FG001|Overall Study|Participant withdrew informed consent|10|||
143157364|NCT01543503|516121614|FG000|Overall Study|Change of jobs|0|||
143157365|NCT01543503|516121615|FG001|Overall Study|Change of jobs|1|||
143157366|NCT01543503|516121614|FG000|Overall Study|Intolerance to the biologic treatment|0|||
143157367|NCT01543503|516121615|FG001|Overall Study|Intolerance to the biologic treatment|1|||
143157368|NCT01543503|516121614|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
143157369|NCT01543503|516121615|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
143157370|NCT01543503|516121614|FG000|Overall Study|Participant did not complete last visit|0|||
143157371|NCT01543503|516121615|FG001|Overall Study|Participant did not complete last visit|2|||
143157372|NCT01543503|516121614|FG000|Overall Study|Refused to continue treatment|7|||
143157373|NCT01543503|516121615|FG001|Overall Study|Refused to continue treatment|0|||
143157374|NCT01543503|516121614|FG000|Overall Study|Incorrect medication received|1|||
143157375|NCT01543503|516121615|FG001|Overall Study|Incorrect medication received|0|||
143157376|NCT01543503|516121614|FG000|Overall Study|Participant moved to another city|2|||
143157377|NCT01543503|516121615|FG001|Overall Study|Participant moved to another city|0|||
143157378|NCT01543503|516121614|FG000|Overall Study|Participant will not return for visits|0|||
143157379|NCT01543503|516121615|FG001|Overall Study|Participant will not return for visits|2|||
143157380|NCT01543503|516121614|FG000|Overall Study|Participant transferred to another city|1|||
143157381|NCT01543503|516121615|FG001|Overall Study|Participant transferred to another city|0|||
143157382|NCT01543503|516121614|FG000|Overall Study|Participant moved to Scotland|1|||
143157383|NCT01543503|516121615|FG001|Overall Study|Participant moved to Scotland|0|||
143157384|NCT01543503|516121614|FG000|Overall Study|Participant decision to stop treatment|1|||
143157385|NCT01543503|516121615|FG001|Overall Study|Participant decision to stop treatment|0|||
143157386|NCT01543503|516121614|FG000|Overall Study|Investigator did not wish to participate|1|||
143157387|NCT01543503|516121615|FG001|Overall Study|Investigator did not wish to participate|1|||
143157388|NCT01543503|516121614|FG000|Overall Study|Participant recruited after closing date|0|||
143157389|NCT01543503|516121615|FG001|Overall Study|Participant recruited after closing date|1|||
143157390|NCT01543503|516121614|FG000|Overall Study|Site stopped participation|5|||
143157391|NCT01543503|516121615|FG001|Overall Study|Site stopped participation|1|||
143157392|NCT01543503|516121614|FG000|Overall Study|Participant did not attend a visit|1|||
143157393|NCT01543503|516121615|FG001|Overall Study|Participant did not attend a visit|0|||
143157394|NCT01543503|516121614|FG000|Overall Study|Moved to other rheumatologic site|0|||
143024217|NCT01992107|515629141|FG000|Overall Study|Adverse Event|0|||
143024218|NCT01992107|515629142|FG001|Overall Study|Adverse Event|1|||
143157395|NCT01543503|516121615|FG001|Overall Study|Moved to other rheumatologic site|1|||
143024219|NCT01992107|515629143|FG002|Overall Study|Adverse Event|0|||
143024220|NCT01992107|515629141|FG000|Overall Study|Lost to Follow-up|46|||
143024221|NCT01992107|515629142|FG001|Overall Study|Lost to Follow-up|22|||
143024222|NCT01992107|515629143|FG002|Overall Study|Lost to Follow-up|26|||
143157396|NCT01543503|516121614|FG000|Overall Study|Participant consented to another study|0|||
143024223|NCT01992107|515629141|FG000|Overall Study|noncompliance and were unavailable|7|||
143024224|NCT01992107|515629142|FG001|Overall Study|noncompliance and were unavailable|3|||
143024225|NCT01992107|515629143|FG002|Overall Study|noncompliance and were unavailable|2|||
143024226|NCT01992107|515629141|FG000|Overall Study|Withdrawal by Subject|13|||
143024227|NCT01992107|515629142|FG001|Overall Study|Withdrawal by Subject|7|||
143024228|NCT01992107|515629143|FG002|Overall Study|Withdrawal by Subject|8|||
143024229|NCT02087046|515629144|FG000|Overall Study|Adverse Event|4|||
143024230|NCT02087046|515629144|FG000|Overall Study|Death|1|||
143024231|NCT02087046|515629144|FG000|Overall Study|Lost to Follow-up|3|||
143024232|NCT02087046|515629144|FG000|Overall Study|Withdrawal by Subject|2|||
143024233|NCT02087046|515629144|FG000|Overall Study|Physician Decision|1|||
143024234|NCT01214603|515629145|FG000|Overall Study|Adverse Event|0|||
143024235|NCT01214603|515629146|FG001|Overall Study|Adverse Event|0|||
143024236|NCT01214603|515629147|FG002|Overall Study|Adverse Event|1|||
143024237|NCT01214603|515629145|FG000|Overall Study|Death|1|||
143024238|NCT01214603|515629146|FG001|Overall Study|Death|0|||
143024239|NCT01214603|515629147|FG002|Overall Study|Death|0|||
143024240|NCT01214603|515629145|FG000|Overall Study|Progressive Disease|4|||
143024241|NCT01214603|515629146|FG001|Overall Study|Progressive Disease|1|||
143024242|NCT01214603|515629147|FG002|Overall Study|Progressive Disease|3|||
143024243|NCT02444533|515629148|FG000|Overall Study|Not able to complete forms|0|||
143486874|NCT00440947|517326584|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
143486875|NCT00440947|517326585|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
143486876|NCT00440947|517326586|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
143486877|NCT00440947|517326582|FG000|48-Week Randomization Phase|Non-compliance|0|||
143486878|NCT00440947|517326583|FG001|48-Week Randomization Phase|Non-compliance|3|||
143486879|NCT00440947|517326584|FG002|48-Week Randomization Phase|Non-compliance|4|||
143486880|NCT00440947|517326585|FG003|48-Week Randomization Phase|Non-compliance|0|||
143486881|NCT00440947|517326586|FG004|48-Week Randomization Phase|Non-compliance|0|||
143486882|NCT00440947|517326582|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
143486883|NCT00440947|517326583|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
143486884|NCT00440947|517326584|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
143486885|NCT00440947|517326585|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
143024244|NCT02444533|515629149|FG001|Overall Study|Not able to complete forms|2|||
143024245|NCT02444533|515629148|FG000|Overall Study|Only gave post-procedure complications|2|||
143024246|NCT02444533|515629149|FG001|Overall Study|Only gave post-procedure complications|2|||
143024247|NCT01155583|515629150|FG000|Phase I|Screen failure - did not start treatment|0|||
143024248|NCT01155583|515629151|FG001|Phase I|Screen failure - did not start treatment|0|||
143024249|NCT01155583|515629152|FG002|Phase I|Screen failure - did not start treatment|0|||
143024250|NCT01155583|515629153|FG003|Phase I|Screen failure - did not start treatment|0|||
143024251|NCT01155583|515629154|FG004|Phase I|Screen failure - did not start treatment|1|||
143024252|NCT01155583|515629155|FG005|Phase I|Screen failure - did not start treatment|0|||
143486886|NCT00440947|517326586|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
143486887|NCT00440947|517326582|FG000|48-Week Randomization Phase|Protocol Violation|0|||
143486888|NCT00440947|517326583|FG001|48-Week Randomization Phase|Protocol Violation|0|||
143486889|NCT00440947|517326584|FG002|48-Week Randomization Phase|Protocol Violation|1|||
143486890|NCT00440947|517326585|FG003|48-Week Randomization Phase|Protocol Violation|0|||
143486891|NCT00440947|517326586|FG004|48-Week Randomization Phase|Protocol Violation|0|||
143486892|NCT00440947|517326582|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
143486893|NCT00440947|517326583|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
143486894|NCT00440947|517326584|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
143486895|NCT00440947|517326585|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
143486896|NCT00440947|517326586|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
143486897|NCT00440947|517326582|FG000|48-Week Randomization Phase|Pregnancy|0|||
143486898|NCT00440947|517326583|FG001|48-Week Randomization Phase|Pregnancy|0|||
143486899|NCT00440947|517326584|FG002|48-Week Randomization Phase|Pregnancy|1|||
143486900|NCT00440947|517326585|FG003|48-Week Randomization Phase|Pregnancy|0|||
143486901|NCT00440947|517326586|FG004|48-Week Randomization Phase|Pregnancy|0|||
143486902|NCT00440947|517326582|FG000|48-Week Randomization Phase|Incarceration|0|||
143024253|NCT01155583|515629156|FG006|Phase I|Screen failure - did not start treatment|0|||
143024254|NCT01155583|515629157|FG007|Phase I|Screen failure - did not start treatment|2|||
143024255|NCT01155583|515629158|FG008|Phase I|Screen failure - did not start treatment|0|||
143486903|NCT00440947|517326583|FG001|48-Week Randomization Phase|Incarceration|3|||
143486904|NCT00440947|517326584|FG002|48-Week Randomization Phase|Incarceration|0|||
143486905|NCT00440947|517326585|FG003|48-Week Randomization Phase|Incarceration|0|||
143024256|NCT01155583|515629150|FG000|Phase I|Withdrawal by Subject|0|||
143024257|NCT01155583|515629151|FG001|Phase I|Withdrawal by Subject|0|||
143024258|NCT01155583|515629152|FG002|Phase I|Withdrawal by Subject|0|||
143024259|NCT01155583|515629153|FG003|Phase I|Withdrawal by Subject|0|||
143024260|NCT01155583|515629154|FG004|Phase I|Withdrawal by Subject|0|||
143024261|NCT01155583|515629155|FG005|Phase I|Withdrawal by Subject|0|||
143024262|NCT01155583|515629156|FG006|Phase I|Withdrawal by Subject|0|||
143024263|NCT01155583|515629157|FG007|Phase I|Withdrawal by Subject|1|||
143486906|NCT00440947|517326586|FG004|48-Week Randomization Phase|Incarceration|0|||
143486907|NCT00440947|517326582|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
143486908|NCT00440947|517326583|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
143486909|NCT00440947|517326584|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
143486910|NCT00440947|517326585|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
143486911|NCT00440947|517326586|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
143486912|NCT00440947|517326582|FG000|48-Week Randomization Phase|Physician Decision|0|||
143486913|NCT00440947|517326583|FG001|48-Week Randomization Phase|Physician Decision|2|||
143486914|NCT00440947|517326584|FG002|48-Week Randomization Phase|Physician Decision|0|||
143486915|NCT00440947|517326585|FG003|48-Week Randomization Phase|Physician Decision|0|||
143486916|NCT00440947|517326586|FG004|48-Week Randomization Phase|Physician Decision|0|||
143486917|NCT00440947|517326582|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
143486918|NCT00440947|517326583|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
143486919|NCT00440947|517326584|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
143486920|NCT00440947|517326585|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
143486921|NCT00440947|517326586|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
143486922|NCT00440947|517326582|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
143486923|NCT00440947|517326583|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
143486924|NCT00440947|517326584|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
143486925|NCT00440947|517326585|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
143486926|NCT00440947|517326586|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
143486927|NCT00440947|517326582|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
143157397|NCT01543503|516121615|FG001|Overall Study|Participant consented to another study|2|||
143157398|NCT01543503|516121614|FG000|Overall Study|Participant went to United States|1|||
143157399|NCT01543503|516121615|FG001|Overall Study|Participant went to United States|0|||
143157400|NCT01543503|516121614|FG000|Overall Study|Screen failure|1|||
143157401|NCT01543503|516121615|FG001|Overall Study|Screen failure|0|||
143157402|NCT01663987|516121620|FG000|Overall Study|Adverse Event|7|||
143157403|NCT01663987|516121621|FG001|Overall Study|Adverse Event|2|||
143157404|NCT01663987|516121620|FG000|Overall Study|Lost to Follow-up|1|||
143157405|NCT01663987|516121621|FG001|Overall Study|Lost to Follow-up|1|||
143157406|NCT01663987|516121620|FG000|Overall Study|Withdrawal by Subject|2|||
143157407|NCT01663987|516121621|FG001|Overall Study|Withdrawal by Subject|3|||
143157408|NCT01663987|516121620|FG000|Overall Study|Other reason not defined above|3|||
143157409|NCT01663987|516121621|FG001|Overall Study|Other reason not defined above|0|||
143157410|NCT03808909|516121626|FG000|Overall Study|Lost to Follow-up|3|||
143157411|NCT03808909|516121627|FG001|Overall Study|Lost to Follow-up|0|||
143157412|NCT00501085|516121628|FG000|Overall Study|Lost to Follow-up|195|||
143157413|NCT00501085|516121628|FG000|Overall Study|Withdrawal by Subject|34|||
143157414|NCT00501085|516121628|FG000|Overall Study|Subject Decision|1|||
143157415|NCT00501085|516121628|FG000|Overall Study|Revision Surgery|7|||
143157416|NCT00501085|516121628|FG000|Overall Study|Explantation Surgery|26|||
143157417|NCT00501085|516121628|FG000|Overall Study|Adverse Event|4|||
143157418|NCT00501085|516121628|FG000|Overall Study|Non-Compliance|24|||
143157419|NCT00501085|516121628|FG000|Overall Study|Study closed by sponsor|109|||
143157420|NCT00501085|516121628|FG000|Overall Study|Other loss to follow-up|32|||
143157421|NCT01487161|516121629|FG000|Overall Study|Adverse Event|1|||
143157422|NCT01487161|516121630|FG001|Overall Study|Adverse Event|0|||
143157423|NCT01487161|516121631|FG002|Overall Study|Adverse Event|0|||
143157424|NCT01487161|516121632|FG003|Overall Study|Adverse Event|0|||
143157425|NCT01487161|516121629|FG000|Overall Study|Withdrawal by Subject|1|||
143157426|NCT01487161|516121630|FG001|Overall Study|Withdrawal by Subject|1|||
143157427|NCT01487161|516121631|FG002|Overall Study|Withdrawal by Subject|1|||
143157428|NCT01487161|516121632|FG003|Overall Study|Withdrawal by Subject|2|||
143157429|NCT01487161|516121629|FG000|Overall Study|missing data|0|||
143157430|NCT01487161|516121630|FG001|Overall Study|missing data|1|||
143157431|NCT01487161|516121631|FG002|Overall Study|missing data|0|||
143157432|NCT01487161|516121632|FG003|Overall Study|missing data|0|||
143157433|NCT02945046|516121633|FG000|Overall Study|Adverse Event|1|||
143157434|NCT02945046|516121634|FG001|Overall Study|Adverse Event|0|||
143157435|NCT02945046|516121635|FG002|Overall Study|Adverse Event|2|||
143236277|NCT04672239|516417448|FG001|Week 6 Survey|Withdrawn by PI|1|||
143157436|NCT02945046|516121633|FG000|Overall Study|Withdrawal by Subject|3|||
143157437|NCT02945046|516121634|FG001|Overall Study|Withdrawal by Subject|3|||
143157438|NCT02945046|516121635|FG002|Overall Study|Withdrawal by Subject|3|||
143157439|NCT02945046|516121633|FG000|Overall Study|Protocol Violation|2|||
143157440|NCT02945046|516121634|FG001|Overall Study|Protocol Violation|3|||
143157441|NCT02945046|516121635|FG002|Overall Study|Protocol Violation|2|||
143157442|NCT02945046|516121633|FG000|Overall Study|Lost to Follow-up|1|||
143157443|NCT02945046|516121634|FG001|Overall Study|Lost to Follow-up|1|||
143157444|NCT02945046|516121635|FG002|Overall Study|Lost to Follow-up|0|||
143157445|NCT02945046|516121633|FG000|Overall Study|Lack of Efficacy|1|||
143157446|NCT02945046|516121634|FG001|Overall Study|Lack of Efficacy|2|||
143157447|NCT02945046|516121635|FG002|Overall Study|Lack of Efficacy|1|||
143157448|NCT02945046|516121633|FG000|Overall Study|Other than specified|5|||
143157449|NCT02945046|516121634|FG001|Overall Study|Other than specified|4|||
143157450|NCT02945046|516121635|FG002|Overall Study|Other than specified|7|||
143486928|NCT00440947|517326583|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
143486929|NCT00440947|517326584|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
143486930|NCT00440947|517326585|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
143486931|NCT00440947|517326586|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
143486932|NCT00440947|517326582|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
143486933|NCT00440947|517326583|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
143486934|NCT00440947|517326584|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
143486935|NCT00440947|517326585|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
143486936|NCT00440947|517326586|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
143024264|NCT01155583|515629158|FG008|Phase I|Withdrawal by Subject|0|||
143024265|NCT00585351|515629159|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
143024266|NCT00585351|515629160|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
143024267|NCT00585351|515629161|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
143024268|NCT00585351|515629162|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
143024269|NCT00585351|515629163|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
143024270|NCT00585351|515629164|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
143024271|NCT00585351|515629165|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
143024272|NCT00585351|515629166|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
143024273|NCT00585351|515629159|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
143024274|NCT00585351|515629160|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
143024275|NCT00585351|515629161|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
143024276|NCT00585351|515629162|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
143024277|NCT00585351|515629163|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
143024278|NCT00585351|515629164|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
143024279|NCT00585351|515629165|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
143024280|NCT00585351|515629166|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
143024281|NCT00585351|515629159|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
143024282|NCT00585351|515629160|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
143024283|NCT00585351|515629161|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
143024284|NCT00585351|515629162|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
143024285|NCT00585351|515629163|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
143024286|NCT00585351|515629164|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
143024287|NCT00585351|515629165|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
143024288|NCT00585351|515629166|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
143024289|NCT00585351|515629159|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
143024290|NCT00585351|515629160|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
143024291|NCT00585351|515629161|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
143024292|NCT00585351|515629162|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
143024293|NCT00585351|515629163|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
143024294|NCT00585351|515629164|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
143024295|NCT00585351|515629165|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
143024296|NCT00585351|515629166|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
143024297|NCT00585351|515629159|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
143024298|NCT00585351|515629160|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
143024299|NCT00585351|515629161|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
143024300|NCT00585351|515629162|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
143024301|NCT00585351|515629163|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
143024302|NCT00585351|515629164|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
143024303|NCT00585351|515629165|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
143024304|NCT00585351|515629166|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
143024305|NCT00585351|515629159|FG000|Enrollment Period (Intervention)|Death|0|||
143024306|NCT00585351|515629160|FG001|Enrollment Period (Intervention)|Death|0|||
143024307|NCT00585351|515629161|FG002|Enrollment Period (Intervention)|Death|0|||
143024308|NCT00585351|515629162|FG003|Enrollment Period (Intervention)|Death|0|||
143024309|NCT00585351|515629163|FG004|Enrollment Period (Intervention)|Death|1|||
143024310|NCT00585351|515629164|FG005|Enrollment Period (Intervention)|Death|0|||
143024311|NCT00585351|515629165|FG006|Enrollment Period (Intervention)|Death|1|||
143024312|NCT00585351|515629166|FG007|Enrollment Period (Intervention)|Death|0|||
143236278|NCT04672239|516417449|FG002|Week 6 Survey|Withdrawn by PI|0|||
143236279|NCT04672239|516417447|FG000|Week 6 Survey|Lost to Follow-up|12|||
143236280|NCT04672239|516417448|FG001|Week 6 Survey|Lost to Follow-up|2|||
143236281|NCT04672239|516417449|FG002|Week 6 Survey|Lost to Follow-up|5|||
143486937|NCT00440947|517326582|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
143486938|NCT00440947|517326583|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
143486939|NCT00440947|517326584|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
143024313|NCT00585351|515629159|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
143024314|NCT00585351|515629160|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
143024315|NCT00585351|515629161|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
143024316|NCT00585351|515629162|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
143024317|NCT00585351|515629163|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
143024318|NCT00585351|515629164|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
143024319|NCT00585351|515629165|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
143024320|NCT00585351|515629166|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
143024321|NCT01001169|515629167|FG000|Overall Study|Withdrawal by Subject|2|||
143024322|NCT01001169|515629168|FG001|Overall Study|Withdrawal by Subject|1|||
143024323|NCT02536378|515629173|FG000|Overall Study|Physician Decision|0|||
143024324|NCT02536378|515629174|FG001|Overall Study|Physician Decision|2|||
143024325|NCT02536378|515629173|FG000|Overall Study|Withdrawal by Subject|0|||
143024326|NCT02536378|515629174|FG001|Overall Study|Withdrawal by Subject|1|||
143024327|NCT02536378|515629173|FG000|Overall Study|Death|1|||
143024328|NCT02536378|515629174|FG001|Overall Study|Death|2|||
143024329|NCT02536378|515629173|FG000|Overall Study|Patient refused further follow up|6|||
143024330|NCT02536378|515629174|FG001|Overall Study|Patient refused further follow up|2|||
143024331|NCT00602030|515629175|FG000|Lead-in Phase|Disease Progression|2|||
143024332|NCT00602030|515629176|FG001|Lead-in Phase|Disease Progression|3|||
143024333|NCT00602030|515629177|FG002|Lead-in Phase|Disease Progression|0|||
143024334|NCT00602030|515629178|FG003|Lead-in Phase|Disease Progression|0|||
143024335|NCT00602030|515629179|FG004|Lead-in Phase|Disease Progression|0|||
143024336|NCT00602030|515629175|FG000|Lead-in Phase|Adverse Event|0|||
143024337|NCT00602030|515629176|FG001|Lead-in Phase|Adverse Event|2|||
143024338|NCT00602030|515629177|FG002|Lead-in Phase|Adverse Event|0|||
143024339|NCT00602030|515629178|FG003|Lead-in Phase|Adverse Event|0|||
143024340|NCT00602030|515629179|FG004|Lead-in Phase|Adverse Event|0|||
143024341|NCT00602030|515629175|FG000|Double-blind Phase|Disease progression|0|||
143024342|NCT00602030|515629176|FG001|Double-blind Phase|Disease progression|0|||
143024343|NCT00602030|515629177|FG002|Double-blind Phase|Disease progression|33|||
143024344|NCT00602030|515629178|FG003|Double-blind Phase|Disease progression|30|||
143024345|NCT00602030|515629179|FG004|Double-blind Phase|Disease progression|0|||
143024346|NCT00602030|515629175|FG000|Double-blind Phase|Adverse Event|0|||
143024347|NCT00602030|515629176|FG001|Double-blind Phase|Adverse Event|0|||
143024348|NCT00602030|515629177|FG002|Double-blind Phase|Adverse Event|9|||
143024349|NCT00602030|515629178|FG003|Double-blind Phase|Adverse Event|18|||
143024350|NCT00602030|515629179|FG004|Double-blind Phase|Adverse Event|0|||
143024351|NCT00602030|515629175|FG000|Double-blind Phase|Consent withdrawal|0|||
143024352|NCT00602030|515629176|FG001|Double-blind Phase|Consent withdrawal|0|||
143024353|NCT00602030|515629177|FG002|Double-blind Phase|Consent withdrawal|4|||
143024354|NCT00602030|515629178|FG003|Double-blind Phase|Consent withdrawal|3|||
143024355|NCT00602030|515629179|FG004|Double-blind Phase|Consent withdrawal|0|||
143024356|NCT00602030|515629175|FG000|Double-blind Phase|Death|0|||
143024357|NCT00602030|515629176|FG001|Double-blind Phase|Death|0|||
143024358|NCT00602030|515629177|FG002|Double-blind Phase|Death|3|||
143024359|NCT00602030|515629178|FG003|Double-blind Phase|Death|3|||
143024360|NCT00602030|515629179|FG004|Double-blind Phase|Death|0|||
143024361|NCT00602030|515629175|FG000|Double-blind Phase|Administrative decision|0|||
143024362|NCT00602030|515629176|FG001|Double-blind Phase|Administrative decision|0|||
143024363|NCT00602030|515629177|FG002|Double-blind Phase|Administrative decision|0|||
143024364|NCT00602030|515629178|FG003|Double-blind Phase|Administrative decision|2|||
143024365|NCT00602030|515629179|FG004|Double-blind Phase|Administrative decision|0|||
143024366|NCT00602030|515629175|FG000|Double-blind Phase|Ineligibility|0|||
143024367|NCT00602030|515629176|FG001|Double-blind Phase|Ineligibility|0|||
143024368|NCT00602030|515629177|FG002|Double-blind Phase|Ineligibility|0|||
143024369|NCT00602030|515629178|FG003|Double-blind Phase|Ineligibility|1|||
143486940|NCT00440947|517326585|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
143486941|NCT00440947|517326586|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
143486942|NCT00440947|517326582|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
143486943|NCT00440947|517326583|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
143486944|NCT00440947|517326584|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
143486945|NCT00440947|517326585|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
143486946|NCT00440947|517326586|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
143024370|NCT00602030|515629179|FG004|Double-blind Phase|Ineligibility|0|||
143024371|NCT00602030|515629175|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
143024372|NCT00602030|515629176|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
143024373|NCT00602030|515629177|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
143024374|NCT00602030|515629178|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
143024375|NCT00602030|515629179|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
143024376|NCT00602030|515629175|FG000|Double-blind Phase|Reason not specified|0|||
143024377|NCT00602030|515629176|FG001|Double-blind Phase|Reason not specified|0|||
143024378|NCT00602030|515629177|FG002|Double-blind Phase|Reason not specified|4|||
143024379|NCT00602030|515629178|FG003|Double-blind Phase|Reason not specified|2|||
143024380|NCT00602030|515629179|FG004|Double-blind Phase|Reason not specified|0|||
143024381|NCT00602030|515629175|FG000|Crossover Phase|Disease Progression|0|||
143024382|NCT00602030|515629176|FG001|Crossover Phase|Disease Progression|0|||
143024383|NCT00602030|515629177|FG002|Crossover Phase|Disease Progression|0|||
143024384|NCT00602030|515629178|FG003|Crossover Phase|Disease Progression|0|||
143024385|NCT00602030|515629179|FG004|Crossover Phase|Disease Progression|11|||
143024386|NCT00602030|515629175|FG000|Crossover Phase|Adverse Event|0|||
143024387|NCT00602030|515629176|FG001|Crossover Phase|Adverse Event|0|||
143024388|NCT00602030|515629177|FG002|Crossover Phase|Adverse Event|0|||
143024389|NCT00602030|515629178|FG003|Crossover Phase|Adverse Event|0|||
143024390|NCT00602030|515629179|FG004|Crossover Phase|Adverse Event|3|||
143024391|NCT00602030|515629175|FG000|Crossover Phase|Consent withdrawal|0|||
143024392|NCT00602030|515629176|FG001|Crossover Phase|Consent withdrawal|0|||
143024393|NCT00602030|515629177|FG002|Crossover Phase|Consent withdrawal|0|||
143024394|NCT00602030|515629178|FG003|Crossover Phase|Consent withdrawal|0|||
143024395|NCT00602030|515629179|FG004|Crossover Phase|Consent withdrawal|2|||
143024396|NCT00798889|515629180|FG000|Overall Study|Adverse Event|53|||
143024397|NCT00798889|515629180|FG000|Overall Study|Protocol Violation|2|||
143024398|NCT00798889|515629180|FG000|Overall Study|Withdrawal by Subject|31|||
143024399|NCT00798889|515629180|FG000|Overall Study|Lost to Follow-up|1|||
143024400|NCT00798889|515629180|FG000|Overall Study|Lack of Efficacy|213|||
143024401|NCT00798889|515629180|FG000|Overall Study|Decision of Sponsor|11|||
143024402|NCT00798889|515629180|FG000|Overall Study|Enrolled, Not treated|3|||
143024403|NCT00457665|515629187|FG000|12 Months|Drug allergy|1|||
143024404|NCT00457665|515629188|FG001|12 Months|Drug allergy|1|||
143024405|NCT00457665|515629187|FG000|12 Months|High HIV viral load|5|||
143024406|NCT00457665|515629188|FG001|12 Months|High HIV viral load|1|||
143024407|NCT00457665|515629187|FG000|12 Months|Lipodystrophy|2|||
143024408|NCT00457665|515629188|FG001|12 Months|Lipodystrophy|0|||
143024409|NCT00457665|515629187|FG000|12 Months|Withdrawal by Subject|0|||
143024410|NCT00457665|515629188|FG001|12 Months|Withdrawal by Subject|2|||
143024411|NCT00457665|515629187|FG000|12 Months|Abnormal Liver function tests|0|||
143024412|NCT00457665|515629188|FG001|12 Months|Abnormal Liver function tests|5|||
143024413|NCT00457665|515629187|FG000|24 Months|Withdrawal by Subject|3|||
143024414|NCT00457665|515629188|FG001|24 Months|Withdrawal by Subject|2|||
143024415|NCT00457665|515629187|FG000|24 Months|Lipodystrophy|1|||
143024416|NCT00457665|515629188|FG001|24 Months|Lipodystrophy|1|||
143024417|NCT00457665|515629187|FG000|24 Months|Abnormal liver function tests|1|||
143024418|NCT00457665|515629188|FG001|24 Months|Abnormal liver function tests|5|||
143024419|NCT01620489|515629195|FG000|Overall Study|Adverse Event|17|||
143024420|NCT01620489|515629196|FG001|Overall Study|Adverse Event|4|||
143024421|NCT01620489|515629195|FG000|Overall Study|Protocol Violation|0|||
143024422|NCT01620489|515629196|FG001|Overall Study|Protocol Violation|3|||
143024423|NCT01620489|515629195|FG000|Overall Study|Withdrawal Criteria|17|||
143024424|NCT01620489|515629196|FG001|Overall Study|Withdrawal Criteria|25|||
143024425|NCT01620489|515629195|FG000|Overall Study|Unclassified|1|||
143024426|NCT01620489|515629196|FG001|Overall Study|Unclassified|2|||
143024427|NCT00696709|515629198|FG000|Overall Study|Withdrawal by Subject|1|||
143024428|NCT00696709|515629199|FG001|Overall Study|Withdrawal by Subject|2|||
143024429|NCT00696709|515629200|FG002|Overall Study|Withdrawal by Subject|1|||
143024430|NCT00696709|515629201|FG003|Overall Study|Withdrawal by Subject|4|||
143024431|NCT00696709|515629202|FG004|Overall Study|Withdrawal by Subject|3|||
143024432|NCT00696709|515629198|FG000|Overall Study|Protocol Violation|1|||
143024433|NCT00696709|515629199|FG001|Overall Study|Protocol Violation|0|||
143024434|NCT00696709|515629200|FG002|Overall Study|Protocol Violation|0|||
143024435|NCT00696709|515629201|FG003|Overall Study|Protocol Violation|0|||
143024436|NCT00696709|515629202|FG004|Overall Study|Protocol Violation|0|||
143024437|NCT00696709|515629198|FG000|Overall Study|Lost to Follow-up|1|||
143024438|NCT00696709|515629199|FG001|Overall Study|Lost to Follow-up|1|||
143024439|NCT00696709|515629200|FG002|Overall Study|Lost to Follow-up|0|||
143024440|NCT00696709|515629201|FG003|Overall Study|Lost to Follow-up|0|||
143157451|NCT03113136|516121636|FG000|Overall Study|Lost to Follow-up|22|||
143486947|NCT00440947|517326582|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
143486948|NCT00440947|517326583|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
143024441|NCT00696709|515629202|FG004|Overall Study|Lost to Follow-up|0|||
143024442|NCT00696709|515629198|FG000|Overall Study|Adverse Event|0|||
143024443|NCT00696709|515629199|FG001|Overall Study|Adverse Event|0|||
143024444|NCT00696709|515629200|FG002|Overall Study|Adverse Event|0|||
143024445|NCT00696709|515629201|FG003|Overall Study|Adverse Event|1|||
143024446|NCT00696709|515629202|FG004|Overall Study|Adverse Event|0|||
143024447|NCT01227668|515629203|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
143024448|NCT01227668|515629204|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
143024449|NCT01227668|515629203|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
143024450|NCT01227668|515629204|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
143024451|NCT01227668|515629203|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
143024452|NCT01227668|515629204|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
143363752|NCT04978363|516875443|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
143024453|NCT01227668|515629203|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
143024454|NCT01227668|515629204|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
143024455|NCT01227668|515629203|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
143024456|NCT01227668|515629204|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
143024457|NCT01227668|515629203|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
143024458|NCT01227668|515629204|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
143024459|NCT01227668|515629203|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
143024460|NCT01227668|515629204|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
143024461|NCT01227668|515629203|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
143024462|NCT01227668|515629204|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
143024463|NCT01227668|515629203|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
143024464|NCT01227668|515629204|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
143024465|NCT01227668|515629203|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
143024466|NCT01227668|515629204|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
143024467|NCT01227668|515629203|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
143024468|NCT01227668|515629204|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
143024469|NCT01227668|515629203|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
143024470|NCT01227668|515629204|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
143024471|NCT01306253|515629208|FG000|Overall Study|Lost to Follow-up|1|||
143024472|NCT01306253|515629209|FG001|Overall Study|Lost to Follow-up|1|||
143024473|NCT01709383|515629216|FG000|Overall Study|Lost to Follow-up|1|||
143024474|NCT01709383|515629217|FG001|Overall Study|Lost to Follow-up|0|||
143024475|NCT03264066|515629218|FG000|Overall Study|Adverse Event|1|||
143024476|NCT03264066|515629219|FG001|Overall Study|Adverse Event|1|||
143024477|NCT03264066|515629220|FG002|Overall Study|Adverse Event|0|||
143024478|NCT03264066|515629221|FG003|Overall Study|Adverse Event|0|||
143024479|NCT03264066|515629222|FG004|Overall Study|Adverse Event|0|||
143024480|NCT03264066|515629223|FG005|Overall Study|Adverse Event|0|||
143024481|NCT03264066|515629218|FG000|Overall Study|Death|12|||
143024482|NCT03264066|515629219|FG001|Overall Study|Death|12|||
143024483|NCT03264066|515629220|FG002|Overall Study|Death|8|||
143024484|NCT03264066|515629221|FG003|Overall Study|Death|10|||
143024485|NCT03264066|515629222|FG004|Overall Study|Death|6|||
143024486|NCT03264066|515629223|FG005|Overall Study|Death|1|||
143024487|NCT03264066|515629218|FG000|Overall Study|Lost to Follow-up|1|||
143024488|NCT03264066|515629219|FG001|Overall Study|Lost to Follow-up|0|||
143024489|NCT03264066|515629220|FG002|Overall Study|Lost to Follow-up|0|||
143024490|NCT03264066|515629221|FG003|Overall Study|Lost to Follow-up|0|||
143024491|NCT03264066|515629222|FG004|Overall Study|Lost to Follow-up|0|||
143024492|NCT03264066|515629223|FG005|Overall Study|Lost to Follow-up|0|||
143024493|NCT03264066|515629218|FG000|Overall Study|Progressive Disease|0|||
143024494|NCT03264066|515629219|FG001|Overall Study|Progressive Disease|2|||
143024495|NCT03264066|515629220|FG002|Overall Study|Progressive Disease|1|||
143024496|NCT03264066|515629221|FG003|Overall Study|Progressive Disease|0|||
143024497|NCT03264066|515629222|FG004|Overall Study|Progressive Disease|0|||
143024498|NCT03264066|515629223|FG005|Overall Study|Progressive Disease|0|||
143024499|NCT03264066|515629218|FG000|Overall Study|Study Terminated by Sponsor|5|||
143024500|NCT03264066|515629219|FG001|Overall Study|Study Terminated by Sponsor|5|||
143024501|NCT03264066|515629220|FG002|Overall Study|Study Terminated by Sponsor|8|||
143024502|NCT03264066|515629221|FG003|Overall Study|Study Terminated by Sponsor|5|||
143024503|NCT03264066|515629222|FG004|Overall Study|Study Terminated by Sponsor|1|||
143024504|NCT03264066|515629223|FG005|Overall Study|Study Terminated by Sponsor|2|||
143024505|NCT03264066|515629218|FG000|Overall Study|Withdrawal by Subject|1|||
143024506|NCT03264066|515629219|FG001|Overall Study|Withdrawal by Subject|0|||
143024507|NCT03264066|515629220|FG002|Overall Study|Withdrawal by Subject|0|||
143024508|NCT03264066|515629221|FG003|Overall Study|Withdrawal by Subject|5|||
143024509|NCT03264066|515629222|FG004|Overall Study|Withdrawal by Subject|0|||
143024510|NCT03264066|515629223|FG005|Overall Study|Withdrawal by Subject|0|||
143024511|NCT01484028|515629224|FG000|Period 1|Lost to Follow-up|0|||
143024512|NCT01484028|515629225|FG001|Period 1|Lost to Follow-up|1|||
143024513|NCT01484028|515629226|FG002|Period 1|Lost to Follow-up|0|||
143024514|NCT01484028|515629227|FG003|Period 1|Lost to Follow-up|0|||
143024515|NCT01484028|515629224|FG000|Period 1|Non-Compliance to Protocol|0|||
143024516|NCT01484028|515629225|FG001|Period 1|Non-Compliance to Protocol|1|||
143024517|NCT01484028|515629226|FG002|Period 1|Non-Compliance to Protocol|0|||
143024518|NCT01484028|515629227|FG003|Period 1|Non-Compliance to Protocol|1|||
143024519|NCT01484028|515629224|FG000|Period 1|Lens Discomfort|0|||
143024520|NCT01484028|515629225|FG001|Period 1|Lens Discomfort|1|||
143024521|NCT01484028|515629226|FG002|Period 1|Lens Discomfort|0|||
143024522|NCT01484028|515629227|FG003|Period 1|Lens Discomfort|0|||
143024523|NCT01193517|515629228|FG000|Overall Study|Early Progression|1|||
143024524|NCT01193517|515629229|FG001|Overall Study|Early Progression|0|||
143024525|NCT01193517|515629230|FG002|Overall Study|Early Progression|0|||
143024526|NCT00146770|515629231|FG000|Overall Study|Adverse Event|2|||
143024527|NCT00146770|515629232|FG001|Overall Study|Adverse Event|0|||
143024528|NCT00146770|515629231|FG000|Overall Study|Pregnancy|1|||
143024529|NCT00146770|515629232|FG001|Overall Study|Pregnancy|0|||
143024530|NCT00146770|515629231|FG000|Overall Study|Withdrawal by Subject|2|||
143024531|NCT00146770|515629232|FG001|Overall Study|Withdrawal by Subject|0|||
143024532|NCT01626859|515629235|FG000|Overall Study|Adverse Event|1|||
143024533|NCT01626859|515629236|FG001|Overall Study|Adverse Event|3|||
143024534|NCT01626859|515629237|FG002|Overall Study|Adverse Event|2|||
143024535|NCT01626859|515629235|FG000|Overall Study|Physician Decision|0|||
143024536|NCT01626859|515629236|FG001|Overall Study|Physician Decision|1|||
143024537|NCT01626859|515629237|FG002|Overall Study|Physician Decision|0|||
143024538|NCT01626859|515629235|FG000|Overall Study|Withdrawal by Subject|1|||
143024539|NCT01626859|515629236|FG001|Overall Study|Withdrawal by Subject|4|||
143024540|NCT01626859|515629237|FG002|Overall Study|Withdrawal by Subject|2|||
143024541|NCT02826603|515629240|FG000|Overall Study|Adverse Event|17|||
143024542|NCT02826603|515629241|FG001|Overall Study|Adverse Event|9|||
143024543|NCT02826603|515629240|FG000|Overall Study|Lack of Efficacy|4|||
143024544|NCT02826603|515629241|FG001|Overall Study|Lack of Efficacy|9|||
143024545|NCT02826603|515629240|FG000|Overall Study|Lost to Follow-up|13|||
143024546|NCT02826603|515629241|FG001|Overall Study|Lost to Follow-up|12|||
143024547|NCT02826603|515629240|FG000|Overall Study|Noncompliance with treatment|0|||
143024548|NCT02826603|515629241|FG001|Overall Study|Noncompliance with treatment|2|||
143024549|NCT02826603|515629240|FG000|Overall Study|Physician Decision|1|||
143024550|NCT02826603|515629241|FG001|Overall Study|Physician Decision|7|||
143024551|NCT02826603|515629240|FG000|Overall Study|Pregnancy|1|||
143024552|NCT02826603|515629241|FG001|Overall Study|Pregnancy|2|||
143024553|NCT02826603|515629240|FG000|Overall Study|Protocol Violation|3|||
143024554|NCT02826603|515629241|FG001|Overall Study|Protocol Violation|3|||
143024555|NCT02826603|515629240|FG000|Overall Study|Withdrawal by Subject|20|||
143024556|NCT02826603|515629241|FG001|Overall Study|Withdrawal by Subject|19|||
143024557|NCT02826603|515629240|FG000|Overall Study|Death|2|||
143024558|NCT02826603|515629241|FG001|Overall Study|Death|0|||
143024559|NCT02826603|515629240|FG000|Overall Study|New therapy for study indication|0|||
143024560|NCT02826603|515629241|FG001|Overall Study|New therapy for study indication|1|||
143024561|NCT00905489|515629242|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
143024562|NCT00905489|515629242|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
143024563|NCT00905489|515629242|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
143024564|NCT00583596|515629243|FG000|Overall Study|Lost to Follow-up|110|||
143024565|NCT00583596|515629243|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
143024566|NCT00583596|515629243|FG000|Overall Study|Death|2|||
143024567|NCT00583596|515629243|FG000|Overall Study|Withdrawal by Subject|6|||
143024568|NCT00583596|515629243|FG000|Overall Study|Lost to Follow-up|94|||
143024569|NCT00583596|515629243|FG000|Overall Study|Data not complete|1|||
143024570|NCT00583596|515629243|FG000|Overall Study|Not consented|15|||
143024571|NCT00583596|515629243|FG000|Overall Study|Outside f-up window|26|||
143024572|NCT02668302|515629247|FG000|Overall Study|Withdrawal by Subject|1|||
143024573|NCT02668302|515629248|FG001|Overall Study|Withdrawal by Subject|0|||
143024574|NCT03775681|515629249|FG000|Overall Study|Physician Decision|3|||
143024575|NCT01855126|515629250|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
143024576|NCT01855126|515629251|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
143236282|NCT04672239|516417447|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
143236283|NCT04672239|516417448|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
143236284|NCT04672239|516417449|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
143236285|NCT04672239|516417447|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
143024577|NCT01855126|515629250|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
143024578|NCT01855126|515629251|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
143024579|NCT00616928|515629252|FG000|Overall Study|Adverse Event|6|||
143024580|NCT00616928|515629253|FG001|Overall Study|Adverse Event|3|||
143024581|NCT00616928|515629254|FG002|Overall Study|Adverse Event|2|||
143024582|NCT00616928|515629255|FG003|Overall Study|Adverse Event|2|||
143024583|NCT00616928|515629252|FG000|Overall Study|Other|51|||
143024584|NCT00616928|515629253|FG001|Overall Study|Other|8|||
143024585|NCT00616928|515629254|FG002|Overall Study|Other|15|||
143024586|NCT00616928|515629255|FG003|Overall Study|Other|5|||
143024587|NCT00616928|515629252|FG000|Overall Study|Lost to Follow-up|5|||
143024588|NCT00616928|515629253|FG001|Overall Study|Lost to Follow-up|7|||
143024589|NCT00616928|515629254|FG002|Overall Study|Lost to Follow-up|0|||
143024590|NCT00616928|515629255|FG003|Overall Study|Lost to Follow-up|0|||
143236286|NCT04672239|516417448|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
143236287|NCT04672239|516417449|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
143236288|NCT04672239|516417447|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
143024591|NCT03558997|515629256|FG000|Overall Study|Adverse Event|0|||
143024592|NCT03558997|515629257|FG001|Overall Study|Adverse Event|2|||
143024593|NCT03558997|515629258|FG002|Overall Study|Adverse Event|5|||
143236289|NCT04672239|516417448|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
143024594|NCT03558997|515629259|FG003|Overall Study|Adverse Event|1|||
143236290|NCT04672239|516417449|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
143236291|NCT04672239|516417447|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
143024595|NCT03558997|515629256|FG000|Overall Study|Physician Decision|0|||
143024596|NCT03558997|515629257|FG001|Overall Study|Physician Decision|0|||
143024597|NCT03558997|515629258|FG002|Overall Study|Physician Decision|1|||
143024598|NCT03558997|515629259|FG003|Overall Study|Physician Decision|0|||
143024599|NCT03558997|515629256|FG000|Overall Study|Withdrawal by Subject|1|||
143024600|NCT03558997|515629257|FG001|Overall Study|Withdrawal by Subject|0|||
143024601|NCT03558997|515629258|FG002|Overall Study|Withdrawal by Subject|1|||
143024602|NCT03558997|515629259|FG003|Overall Study|Withdrawal by Subject|1|||
143024603|NCT03558997|515629256|FG000|Overall Study|Lost to Follow-up|0|||
143024604|NCT03558997|515629257|FG001|Overall Study|Lost to Follow-up|0|||
143024605|NCT03558997|515629258|FG002|Overall Study|Lost to Follow-up|1|||
143024606|NCT03558997|515629259|FG003|Overall Study|Lost to Follow-up|0|||
143024607|NCT03529955|515629262|FG000|Overall Study|Adverse Event|1|||
143024608|NCT03529955|515629262|FG000|Overall Study|Lack of Efficacy|1|||
143024609|NCT01098240|515629263|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
143024610|NCT01098240|515629264|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
143024611|NCT01098240|515629265|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
143024612|NCT01098240|515629263|FG000|Open-Label Phase|Protocol Violation|4|||
143024613|NCT01098240|515629264|FG001|Open-Label Phase|Protocol Violation|0|||
143024614|NCT01098240|515629265|FG002|Open-Label Phase|Protocol Violation|0|||
143024615|NCT01098240|515629263|FG000|Open-Label Phase|Lost to Follow-up|13|||
143024616|NCT01098240|515629264|FG001|Open-Label Phase|Lost to Follow-up|0|||
143024617|NCT01098240|515629265|FG002|Open-Label Phase|Lost to Follow-up|0|||
143024618|NCT01098240|515629263|FG000|Open-Label Phase|Other|19|||
143024619|NCT01098240|515629264|FG001|Open-Label Phase|Other|0|||
143024620|NCT01098240|515629265|FG002|Open-Label Phase|Other|0|||
143024621|NCT01098240|515629263|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
143024622|NCT01098240|515629264|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
143024623|NCT01098240|515629265|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
143024624|NCT01098240|515629263|FG000|Open-Label Phase|Pregnancy|1|||
143024625|NCT01098240|515629264|FG001|Open-Label Phase|Pregnancy|0|||
143024626|NCT01098240|515629265|FG002|Open-Label Phase|Pregnancy|0|||
143024627|NCT01098240|515629263|FG000|Open-Label Phase|Withdrawal by Subject|9|||
143024628|NCT01098240|515629264|FG001|Open-Label Phase|Withdrawal by Subject|0|||
143024629|NCT01098240|515629265|FG002|Open-Label Phase|Withdrawal by Subject|0|||
143024630|NCT01098240|515629263|FG000|Open-Label Phase|Adverse Event|12|||
143024631|NCT01098240|515629264|FG001|Open-Label Phase|Adverse Event|0|||
143024632|NCT01098240|515629265|FG002|Open-Label Phase|Adverse Event|0|||
143024633|NCT01098240|515629263|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
143024634|NCT01098240|515629264|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
143024635|NCT01098240|515629265|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
143024636|NCT01098240|515629263|FG000|Double-Blind Phase|Protocol Violation|0|||
143024637|NCT01098240|515629264|FG001|Double-Blind Phase|Protocol Violation|2|||
143024638|NCT01098240|515629265|FG002|Double-Blind Phase|Protocol Violation|4|||
143024639|NCT01098240|515629263|FG000|Double-Blind Phase|Lost to Follow-up|0|||
143024640|NCT01098240|515629264|FG001|Double-Blind Phase|Lost to Follow-up|2|||
143024641|NCT01098240|515629265|FG002|Double-Blind Phase|Lost to Follow-up|0|||
143024642|NCT01098240|515629263|FG000|Double-Blind Phase|Other|0|||
143024643|NCT01098240|515629264|FG001|Double-Blind Phase|Other|2|||
143024644|NCT01098240|515629265|FG002|Double-Blind Phase|Other|2|||
143024645|NCT01098240|515629263|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
143024646|NCT01098240|515629264|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
143024647|NCT01098240|515629265|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
143024648|NCT01098240|515629263|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
143024649|NCT01098240|515629264|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
143024650|NCT01098240|515629265|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
143024651|NCT01098240|515629263|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
143024652|NCT01098240|515629264|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
143236292|NCT04672239|516417448|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
143236293|NCT04672239|516417449|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
143236294|NCT04672239|516417447|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
143236295|NCT04672239|516417448|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
143236296|NCT04672239|516417449|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
143236297|NCT04672239|516417447|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
143236298|NCT04672239|516417448|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
143236299|NCT04672239|516417449|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
143024653|NCT01098240|515629265|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
143024654|NCT01098240|515629263|FG000|Double-Blind Phase|Adverse Event|0|||
143024655|NCT01098240|515629264|FG001|Double-Blind Phase|Adverse Event|3|||
143236300|NCT04672239|516417447|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
143024656|NCT01098240|515629265|FG002|Double-Blind Phase|Adverse Event|3|||
143024657|NCT03280537|515629266|FG000|Overall Study|Withdrawal by Subject|2|||
143024658|NCT03280537|515629267|FG001|Overall Study|Withdrawal by Subject|4|||
143024659|NCT01588106|515629268|FG000|Overall Study|Withdrawal by Subject|5|||
143024660|NCT01588106|515629269|FG001|Overall Study|Withdrawal by Subject|4|||
143024661|NCT04274192|515629274|FG000|Overall Study|Protocol Violation|1|||
143236301|NCT04672239|516417448|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
143024662|NCT04274192|515629275|FG001|Overall Study|Protocol Violation|0|||
143486949|NCT00440947|517326584|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
143486950|NCT00440947|517326585|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
143486951|NCT00440947|517326586|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
143486952|NCT00440947|517326582|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
143486953|NCT00440947|517326583|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
143486954|NCT00440947|517326584|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
143486955|NCT00440947|517326585|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
143486956|NCT00440947|517326586|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
143486957|NCT00440947|517326582|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
143486958|NCT00440947|517326583|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
143486959|NCT00440947|517326584|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
143486960|NCT00440947|517326585|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
143486961|NCT00440947|517326586|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
143486962|NCT00440947|517326582|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
143486963|NCT00440947|517326583|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
143486964|NCT00440947|517326584|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
143486965|NCT00440947|517326585|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
143486966|NCT00440947|517326586|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
143486967|NCT00440947|517326582|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
143486968|NCT00440947|517326583|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
143486969|NCT00440947|517326584|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
143486970|NCT00440947|517326585|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
143486971|NCT00440947|517326586|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
143486972|NCT00440947|517326582|FG000|Optional 60-Week Extension Phase|Other|0|||
143486973|NCT00440947|517326583|FG001|Optional 60-Week Extension Phase|Other|0|||
143486974|NCT00440947|517326584|FG002|Optional 60-Week Extension Phase|Other|0|||
143486975|NCT00440947|517326585|FG003|Optional 60-Week Extension Phase|Other|1|||
143486976|NCT00440947|517326586|FG004|Optional 60-Week Extension Phase|Other|0|||
143486977|NCT00440947|517326582|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
143486978|NCT00440947|517326583|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
143486979|NCT00440947|517326584|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
143486980|NCT00440947|517326585|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
143486981|NCT00440947|517326586|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
143486982|NCT00440947|517326582|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
143486983|NCT00440947|517326583|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
143486984|NCT00440947|517326584|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
143486985|NCT00440947|517326585|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
143486986|NCT00440947|517326586|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
143486987|NCT02898259|517326587|FG000|Overall Study|Adverse Event|0|||
143486988|NCT02898259|517326588|FG001|Overall Study|Adverse Event|0|||
143486989|NCT02898259|517326589|FG002|Overall Study|Adverse Event|1|||
143486990|NCT02898259|517326590|FG003|Overall Study|Adverse Event|0|||
143486991|NCT02898259|517326591|FG004|Overall Study|Adverse Event|0|||
143486992|NCT02898259|517326587|FG000|Overall Study|Lack of Efficacy|1|||
143486993|NCT02898259|517326588|FG001|Overall Study|Lack of Efficacy|1|||
143486994|NCT02898259|517326589|FG002|Overall Study|Lack of Efficacy|3|||
143486995|NCT02898259|517326590|FG003|Overall Study|Lack of Efficacy|0|||
143486996|NCT02898259|517326591|FG004|Overall Study|Lack of Efficacy|0|||
143486997|NCT02898259|517326587|FG000|Overall Study|Lost to Follow-up|0|||
143486998|NCT02898259|517326588|FG001|Overall Study|Lost to Follow-up|0|||
143486999|NCT02898259|517326589|FG002|Overall Study|Lost to Follow-up|1|||
143487000|NCT02898259|517326590|FG003|Overall Study|Lost to Follow-up|0|||
143487001|NCT02898259|517326591|FG004|Overall Study|Lost to Follow-up|0|||
143487002|NCT02898259|517326587|FG000|Overall Study|Transformation before study began|0|||
143487003|NCT02898259|517326588|FG001|Overall Study|Transformation before study began|0|||
143487004|NCT02898259|517326589|FG002|Overall Study|Transformation before study began|0|||
143487005|NCT02898259|517326590|FG003|Overall Study|Transformation before study began|1|||
143487006|NCT02898259|517326591|FG004|Overall Study|Transformation before study began|0|||
143487007|NCT01827670|517326596|FG000|Overall Study|Withdrawal of Consent|3|||
143487008|NCT01827670|517326597|FG001|Overall Study|Withdrawal of Consent|2|||
143487009|NCT01827670|517326596|FG000|Overall Study|Lost to Follow-up|0|||
143487010|NCT01827670|517326597|FG001|Overall Study|Lost to Follow-up|1|||
143487011|NCT03016325|517326602|FG000|Treatment Period|Participant withdrew consent|0|||
143487012|NCT03016325|517326603|FG001|Treatment Period|Participant withdrew consent|1|||
143487013|NCT03016325|517326604|FG002|Treatment Period|Participant withdrew consent|0|||
143487014|NCT03016325|517326605|FG003|Treatment Period|Participant withdrew consent|0|||
143487015|NCT03016325|517326606|FG004|Treatment Period|Participant withdrew consent|0|||
143487016|NCT03016325|517326607|FG005|Treatment Period|Participant withdrew consent|0|||
143487017|NCT03016325|517326608|FG006|Treatment Period|Participant withdrew consent|0|||
143487018|NCT03016325|517326609|FG007|Treatment Period|Participant withdrew consent|0|||
143487019|NCT03016325|517326602|FG000|Treatment Period|Death|0|||
143024663|NCT00874757|515629276|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
143024664|NCT02034799|515631113|FG000|Overall Study|Withdrawal by Subject|0|||
143024665|NCT02034799|515631114|FG001|Overall Study|Withdrawal by Subject|2|||
143024666|NCT02034799|515631113|FG000|Overall Study|Lost to Follow-up|0|||
143024667|NCT02034799|515631114|FG001|Overall Study|Lost to Follow-up|1|||
143024668|NCT02034799|515631113|FG000|Overall Study|Death|2|||
143024669|NCT02034799|515631114|FG001|Overall Study|Death|1|||
143024670|NCT02961920|515631125|FG000|Overall Study|did not achive stydy protocol schedule|1|||
143024671|NCT02961920|515631126|FG001|Overall Study|did not achive stydy protocol schedule|1|||
143024672|NCT04527471|515631127|FG000|Overall Study|Adverse Event|1|||
143024673|NCT04527471|515631128|FG001|Overall Study|Adverse Event|0|||
143024674|NCT04527471|515631127|FG000|Overall Study|Lost to Follow-up|1|||
143024675|NCT04527471|515631128|FG001|Overall Study|Lost to Follow-up|0|||
143024676|NCT02891200|515631134|FG000|Overall Study|Lost to Follow-up|31|||
143024677|NCT02891200|515631135|FG001|Overall Study|Lost to Follow-up|36|||
143024678|NCT02891200|515631134|FG000|Overall Study|Death|10|||
143024679|NCT02891200|515631135|FG001|Overall Study|Death|9|||
143024680|NCT02891200|515631134|FG000|Overall Study|Withdrawal by Subject|1|||
143024681|NCT02891200|515631135|FG001|Overall Study|Withdrawal by Subject|4|||
143024682|NCT04480463|515631138|FG000|Overall Study|Death|0|||
143024683|NCT04480463|515631139|FG001|Overall Study|Death|1|||
143024684|NCT04480463|515631138|FG000|Overall Study|Adverse Event|6|||
143024685|NCT04480463|515631139|FG001|Overall Study|Adverse Event|8|||
143024686|NCT04480463|515631138|FG000|Overall Study|Lost to Follow-up|3|||
143024687|NCT04480463|515631139|FG001|Overall Study|Lost to Follow-up|2|||
143024688|NCT04480463|515631138|FG000|Overall Study|Physician Decision|2|||
143024689|NCT04480463|515631139|FG001|Overall Study|Physician Decision|5|||
143024690|NCT04480463|515631138|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
143024691|NCT04480463|515631139|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
143024692|NCT04480463|515631138|FG000|Overall Study|Protocol Violation|2|||
143024693|NCT04480463|515631139|FG001|Overall Study|Protocol Violation|1|||
143024694|NCT04480463|515631138|FG000|Overall Study|Withdrawal by Subject|6|||
143024695|NCT04480463|515631139|FG001|Overall Study|Withdrawal by Subject|7|||
143024696|NCT04480463|515631138|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
143024697|NCT04480463|515631139|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
143024698|NCT04480463|515631138|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
143024699|NCT04480463|515631139|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
143024700|NCT04480463|515631138|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
143024701|NCT04480463|515631139|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
143024702|NCT04480463|515631138|FG000|Overall Study|Other|6|||
143024703|NCT04480463|515631139|FG001|Overall Study|Other|4|||
143024704|NCT00444795|515631140|FG000|Overall Study|Not Treated|1|||
143024705|NCT00444795|515631140|FG000|Overall Study|Treated Prior to the Contract Date|2|||
143024706|NCT00988169|515631141|FG000|Overall Study|Withdrawal by Subject|1|||
143024707|NCT02322879|515631142|FG000|First Intervention|Physician Decision|1|||
143024708|NCT02322879|515631143|FG001|First Intervention|Physician Decision|0|||
143024709|NCT02637076|515631144|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
143024710|NCT02637076|515631145|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
143024711|NCT02637076|515631144|FG000|Overall Study|Withdrawal by Subject|0|||
143024712|NCT02637076|515631145|FG001|Overall Study|Withdrawal by Subject|4|||
143024713|NCT02711956|515631153|FG000|Overall Study|Adverse Event|0|||
143024714|NCT02711956|515631154|FG001|Overall Study|Adverse Event|0|||
143024715|NCT02711956|515631155|FG002|Overall Study|Adverse Event|0|||
143024716|NCT02711956|515631156|FG003|Overall Study|Adverse Event|1|||
143024717|NCT02711956|515631157|FG004|Overall Study|Adverse Event|2|||
143024718|NCT02711956|515631158|FG005|Overall Study|Adverse Event|0|||
143024719|NCT02711956|515631159|FG006|Overall Study|Adverse Event|0|||
143024720|NCT02711956|515631160|FG007|Overall Study|Adverse Event|1|||
143024721|NCT02711956|515631161|FG008|Overall Study|Adverse Event|1|||
143024722|NCT02711956|515631162|FG009|Overall Study|Adverse Event|1|||
143157452|NCT03113136|516121637|FG001|Overall Study|Lost to Follow-up|47|||
143157453|NCT03113136|516121638|FG002|Overall Study|Lost to Follow-up|54|||
143157454|NCT03113136|516121636|FG000|Overall Study|Withdrawal by Subject|4|||
143157455|NCT03113136|516121637|FG001|Overall Study|Withdrawal by Subject|13|||
143157456|NCT03113136|516121638|FG002|Overall Study|Withdrawal by Subject|14|||
143157457|NCT03113136|516121636|FG000|Overall Study|Ineligible|0|||
143024723|NCT02711956|515631163|FG010|Overall Study|Adverse Event|1|||
143024724|NCT02711956|515631164|FG011|Overall Study|Adverse Event|0|||
143157458|NCT03113136|516121637|FG001|Overall Study|Ineligible|2|||
143157459|NCT03113136|516121638|FG002|Overall Study|Ineligible|1|||
143157460|NCT03113136|516121636|FG000|Overall Study|Study Team Decision|1|||
143157461|NCT03113136|516121637|FG001|Overall Study|Study Team Decision|4|||
143024725|NCT02711956|515631165|FG012|Overall Study|Adverse Event|0|||
143024726|NCT02711956|515631166|FG013|Overall Study|Adverse Event|0|||
143024727|NCT02711956|515631167|FG014|Overall Study|Adverse Event|2|||
143024728|NCT02711956|515631153|FG000|Overall Study|Physician Decision|0|||
143024729|NCT02711956|515631154|FG001|Overall Study|Physician Decision|0|||
143024730|NCT02711956|515631155|FG002|Overall Study|Physician Decision|0|||
143024731|NCT02711956|515631156|FG003|Overall Study|Physician Decision|2|||
143024732|NCT02711956|515631157|FG004|Overall Study|Physician Decision|0|||
143024733|NCT02711956|515631158|FG005|Overall Study|Physician Decision|0|||
143024734|NCT02711956|515631159|FG006|Overall Study|Physician Decision|0|||
143024735|NCT02711956|515631160|FG007|Overall Study|Physician Decision|0|||
143024736|NCT02711956|515631161|FG008|Overall Study|Physician Decision|0|||
143024737|NCT02711956|515631162|FG009|Overall Study|Physician Decision|0|||
143024738|NCT02711956|515631163|FG010|Overall Study|Physician Decision|0|||
143024739|NCT02711956|515631164|FG011|Overall Study|Physician Decision|0|||
143024740|NCT02711956|515631165|FG012|Overall Study|Physician Decision|0|||
143024741|NCT02711956|515631166|FG013|Overall Study|Physician Decision|0|||
143024742|NCT02711956|515631167|FG014|Overall Study|Physician Decision|0|||
143024743|NCT02711956|515631153|FG000|Overall Study|Withdrawal by Subject|0|||
143024744|NCT02711956|515631154|FG001|Overall Study|Withdrawal by Subject|0|||
143024745|NCT02711956|515631155|FG002|Overall Study|Withdrawal by Subject|0|||
143024746|NCT02711956|515631156|FG003|Overall Study|Withdrawal by Subject|0|||
143024747|NCT02711956|515631157|FG004|Overall Study|Withdrawal by Subject|0|||
143024748|NCT02711956|515631158|FG005|Overall Study|Withdrawal by Subject|0|||
143024749|NCT02711956|515631159|FG006|Overall Study|Withdrawal by Subject|1|||
143024750|NCT02711956|515631160|FG007|Overall Study|Withdrawal by Subject|0|||
143024751|NCT02711956|515631161|FG008|Overall Study|Withdrawal by Subject|0|||
143024752|NCT02711956|515631162|FG009|Overall Study|Withdrawal by Subject|0|||
143024753|NCT02711956|515631163|FG010|Overall Study|Withdrawal by Subject|0|||
143024754|NCT02711956|515631164|FG011|Overall Study|Withdrawal by Subject|1|||
143024755|NCT02711956|515631165|FG012|Overall Study|Withdrawal by Subject|6|||
143024756|NCT02711956|515631166|FG013|Overall Study|Withdrawal by Subject|0|||
143024757|NCT02711956|515631167|FG014|Overall Study|Withdrawal by Subject|1|||
143024758|NCT02711956|515631153|FG000|Overall Study|Clinical progression|1|||
143024759|NCT02711956|515631154|FG001|Overall Study|Clinical progression|0|||
143024760|NCT02711956|515631155|FG002|Overall Study|Clinical progression|0|||
143024761|NCT02711956|515631156|FG003|Overall Study|Clinical progression|0|||
143024762|NCT02711956|515631157|FG004|Overall Study|Clinical progression|0|||
143024763|NCT02711956|515631158|FG005|Overall Study|Clinical progression|0|||
143024764|NCT02711956|515631159|FG006|Overall Study|Clinical progression|1|||
143024765|NCT02711956|515631160|FG007|Overall Study|Clinical progression|0|||
143024766|NCT02711956|515631161|FG008|Overall Study|Clinical progression|1|||
143024767|NCT02711956|515631162|FG009|Overall Study|Clinical progression|0|||
143024768|NCT02711956|515631163|FG010|Overall Study|Clinical progression|0|||
143024769|NCT02711956|515631164|FG011|Overall Study|Clinical progression|2|||
143024770|NCT02711956|515631165|FG012|Overall Study|Clinical progression|4|||
143024771|NCT02711956|515631166|FG013|Overall Study|Clinical progression|1|||
143024772|NCT02711956|515631167|FG014|Overall Study|Clinical progression|1|||
143024773|NCT02711956|515631153|FG000|Overall Study|Radiographic progression|1|||
143024774|NCT02711956|515631154|FG001|Overall Study|Radiographic progression|1|||
143024775|NCT02711956|515631155|FG002|Overall Study|Radiographic progression|2|||
143024776|NCT02711956|515631156|FG003|Overall Study|Radiographic progression|0|||
143024777|NCT02711956|515631157|FG004|Overall Study|Radiographic progression|1|||
143024778|NCT02711956|515631158|FG005|Overall Study|Radiographic progression|0|||
143024779|NCT02711956|515631159|FG006|Overall Study|Radiographic progression|0|||
143024780|NCT02711956|515631160|FG007|Overall Study|Radiographic progression|0|||
143024781|NCT02711956|515631161|FG008|Overall Study|Radiographic progression|2|||
143024782|NCT02711956|515631162|FG009|Overall Study|Radiographic progression|1|||
143487020|NCT03016325|517326603|FG001|Treatment Period|Death|0|||
143487021|NCT03016325|517326604|FG002|Treatment Period|Death|0|||
143487022|NCT03016325|517326605|FG003|Treatment Period|Death|0|||
143024783|NCT02711956|515631163|FG010|Overall Study|Radiographic progression|0|||
143024784|NCT02711956|515631164|FG011|Overall Study|Radiographic progression|5|||
143024785|NCT02711956|515631165|FG012|Overall Study|Radiographic progression|3|||
143024786|NCT02711956|515631166|FG013|Overall Study|Radiographic progression|0|||
143024787|NCT02711956|515631167|FG014|Overall Study|Radiographic progression|1|||
143024788|NCT02711956|515631153|FG000|Overall Study|PSA progression with clinical progression|0|||
143024789|NCT02711956|515631154|FG001|Overall Study|PSA progression with clinical progression|0|||
143024790|NCT02711956|515631155|FG002|Overall Study|PSA progression with clinical progression|0|||
143157462|NCT03113136|516121638|FG002|Overall Study|Study Team Decision|0|||
143487023|NCT03016325|517326606|FG004|Treatment Period|Death|2|||
143024791|NCT02711956|515631156|FG003|Overall Study|PSA progression with clinical progression|0|||
143024792|NCT02711956|515631157|FG004|Overall Study|PSA progression with clinical progression|1|||
143157463|NCT04689009|516121640|FG000|Overall Study|Adverse Event|1|||
143024793|NCT02711956|515631158|FG005|Overall Study|PSA progression with clinical progression|0|||
143487024|NCT03016325|517326607|FG005|Treatment Period|Death|0|||
143487025|NCT03016325|517326608|FG006|Treatment Period|Death|0|||
143024794|NCT02711956|515631159|FG006|Overall Study|PSA progression with clinical progression|0|||
143024795|NCT02711956|515631160|FG007|Overall Study|PSA progression with clinical progression|0|||
143024796|NCT02711956|515631161|FG008|Overall Study|PSA progression with clinical progression|0|||
143024797|NCT02711956|515631162|FG009|Overall Study|PSA progression with clinical progression|0|||
143024798|NCT02711956|515631163|FG010|Overall Study|PSA progression with clinical progression|0|||
143024799|NCT02711956|515631164|FG011|Overall Study|PSA progression with clinical progression|0|||
143024800|NCT02711956|515631165|FG012|Overall Study|PSA progression with clinical progression|1|||
143024801|NCT02711956|515631166|FG013|Overall Study|PSA progression with clinical progression|1|||
143024802|NCT02711956|515631167|FG014|Overall Study|PSA progression with clinical progression|0|||
143024803|NCT02711956|515631153|FG000|Overall Study|PSA progression with radiographic progression|0|||
143024804|NCT02711956|515631154|FG001|Overall Study|PSA progression with radiographic progression|1|||
143024805|NCT02711956|515631155|FG002|Overall Study|PSA progression with radiographic progression|0|||
143024806|NCT02711956|515631156|FG003|Overall Study|PSA progression with radiographic progression|0|||
143024807|NCT02711956|515631157|FG004|Overall Study|PSA progression with radiographic progression|0|||
143024808|NCT02711956|515631158|FG005|Overall Study|PSA progression with radiographic progression|2|||
143024809|NCT02711956|515631159|FG006|Overall Study|PSA progression with radiographic progression|2|||
143024810|NCT02711956|515631160|FG007|Overall Study|PSA progression with radiographic progression|1|||
143024811|NCT02711956|515631161|FG008|Overall Study|PSA progression with radiographic progression|0|||
143024812|NCT02711956|515631162|FG009|Overall Study|PSA progression with radiographic progression|1|||
143024813|NCT02711956|515631163|FG010|Overall Study|PSA progression with radiographic progression|0|||
143024814|NCT02711956|515631164|FG011|Overall Study|PSA progression with radiographic progression|1|||
143024815|NCT02711956|515631165|FG012|Overall Study|PSA progression with radiographic progression|2|||
143024816|NCT02711956|515631166|FG013|Overall Study|PSA progression with radiographic progression|3|||
143024817|NCT02711956|515631167|FG014|Overall Study|PSA progression with radiographic progression|3|||
143024818|NCT03734237|515631168|FG000|Overall Study|Lost to Follow-up|1|||
143024819|NCT03734237|515631169|FG001|Overall Study|Lost to Follow-up|3|||
143024820|NCT03734237|515631170|FG002|Overall Study|Lost to Follow-up|0|||
143024821|NCT03734237|515631168|FG000|Overall Study|Withdrawal by Subject|7|||
143024822|NCT03734237|515631169|FG001|Overall Study|Withdrawal by Subject|9|||
143024823|NCT03734237|515631170|FG002|Overall Study|Withdrawal by Subject|10|||
143024824|NCT03294538|515631175|FG000|Overall Study|Adverse Event|0|||
143024825|NCT03294538|515631176|FG001|Overall Study|Adverse Event|1|||
143024826|NCT03294538|515631177|FG002|Overall Study|Adverse Event|1|||
143024827|NCT03294538|515631175|FG000|Overall Study|Lost to Follow-up|1|||
143024828|NCT03294538|515631176|FG001|Overall Study|Lost to Follow-up|0|||
143024829|NCT03294538|515631177|FG002|Overall Study|Lost to Follow-up|0|||
143024830|NCT03294538|515631175|FG000|Overall Study|Outside of Visit Window|4|||
143024831|NCT03294538|515631176|FG001|Overall Study|Outside of Visit Window|4|||
143024832|NCT03294538|515631177|FG002|Overall Study|Outside of Visit Window|1|||
143024833|NCT01238848|515631182|FG000|Overall Study|Physician Decision|13|||
143024834|NCT01238848|515631183|FG001|Overall Study|Physician Decision|5|||
143024835|NCT00576901|515631185|FG000|Overall Study|Withdrawal by Subject|1|||
143024836|NCT00576901|515631185|FG000|Overall Study|Disease course|1|||
143024837|NCT00576901|515631185|FG000|Overall Study|Protocol Violation|1|||
143024838|NCT00782509|515631188|FG000|Overall Study|Adverse Event|20|||
143024839|NCT00782509|515631189|FG001|Overall Study|Adverse Event|10|||
143024840|NCT00782509|515631190|FG002|Overall Study|Adverse Event|20|||
143024841|NCT00782509|515631188|FG000|Overall Study|Lost to Follow-up|1|||
143024842|NCT00782509|515631189|FG001|Overall Study|Lost to Follow-up|2|||
143024843|NCT00782509|515631190|FG002|Overall Study|Lost to Follow-up|3|||
143024844|NCT00782509|515631188|FG000|Overall Study|Withdrawal by Subject|3|||
143024845|NCT00782509|515631189|FG001|Overall Study|Withdrawal by Subject|5|||
143024846|NCT00782509|515631190|FG002|Overall Study|Withdrawal by Subject|8|||
143024847|NCT00782509|515631188|FG000|Overall Study|Non compliance with protocol|2|||
143024848|NCT00782509|515631189|FG001|Overall Study|Non compliance with protocol|0|||
143024849|NCT00782509|515631190|FG002|Overall Study|Non compliance with protocol|0|||
143157464|NCT04689009|516121641|FG001|Overall Study|Adverse Event|0|||
143157465|NCT04689009|516121640|FG000|Overall Study|Lost to Follow-up|1|||
143157466|NCT04689009|516121641|FG001|Overall Study|Lost to Follow-up|2|||
143157467|NCT04689009|516121640|FG000|Overall Study|Withdrawal by Subject|4|||
143157468|NCT04689009|516121641|FG001|Overall Study|Withdrawal by Subject|3|||
143487026|NCT03016325|517326609|FG007|Treatment Period|Death|0|||
143024850|NCT00782509|515631188|FG000|Overall Study|Other reasons not stated above|5|||
143024851|NCT00782509|515631189|FG001|Overall Study|Other reasons not stated above|2|||
143024852|NCT00782509|515631190|FG002|Overall Study|Other reasons not stated above|3|||
143024853|NCT00782509|515631188|FG000|Overall Study|Lack of Efficacy|10|||
143024854|NCT00782509|515631189|FG001|Overall Study|Lack of Efficacy|5|||
143024855|NCT00782509|515631190|FG002|Overall Study|Lack of Efficacy|2|||
143487027|NCT03016325|517326602|FG000|Treatment Period|Participant refuses assessments|0|||
143157469|NCT04689009|516121640|FG000|Overall Study|Protocol Violation|1|||
143157470|NCT04689009|516121641|FG001|Overall Study|Protocol Violation|0|||
143157471|NCT02675452|516121643|FG000|Overall Study|Sponsor decision|0|||
143487028|NCT03016325|517326603|FG001|Treatment Period|Participant refuses assessments|0|||
143487029|NCT03016325|517326604|FG002|Treatment Period|Participant refuses assessments|1|||
143487030|NCT03016325|517326605|FG003|Treatment Period|Participant refuses assessments|0|||
143487031|NCT03016325|517326606|FG004|Treatment Period|Participant refuses assessments|0|||
143487032|NCT03016325|517326607|FG005|Treatment Period|Participant refuses assessments|0|||
143487033|NCT03016325|517326608|FG006|Treatment Period|Participant refuses assessments|0|||
143487034|NCT03016325|517326609|FG007|Treatment Period|Participant refuses assessments|0|||
143487035|NCT03016325|517326602|FG000|32-Day Follow-Up Period|Death|2|||
143487036|NCT03016325|517326603|FG001|32-Day Follow-Up Period|Death|0|||
143487037|NCT03016325|517326604|FG002|32-Day Follow-Up Period|Death|5|||
143487038|NCT03016325|517326605|FG003|32-Day Follow-Up Period|Death|6|||
143487039|NCT03016325|517326606|FG004|32-Day Follow-Up Period|Death|3|||
143487040|NCT03016325|517326607|FG005|32-Day Follow-Up Period|Death|0|||
143487041|NCT03016325|517326608|FG006|32-Day Follow-Up Period|Death|0|||
143487042|NCT03016325|517326609|FG007|32-Day Follow-Up Period|Death|0|||
143024856|NCT00368966|515631198|FG000|Infant Series|Withdrawal by Subject|11|||
143157472|NCT02675452|516121644|FG001|Overall Study|Sponsor decision|0|||
143157473|NCT02675452|516121645|FG002|Overall Study|Sponsor decision|0|||
143487043|NCT03016325|517326602|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
143487044|NCT03016325|517326603|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
143487045|NCT03016325|517326604|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
143487046|NCT03016325|517326605|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
143487047|NCT03016325|517326606|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
143487048|NCT03016325|517326607|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
143487049|NCT03016325|517326608|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
143487050|NCT03016325|517326609|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
143487051|NCT03016325|517326602|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
143487052|NCT03016325|517326603|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
143487053|NCT03016325|517326604|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
143487054|NCT03016325|517326605|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
143487055|NCT03016325|517326606|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
143487056|NCT03016325|517326607|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
143487057|NCT03016325|517326608|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
143487058|NCT03016325|517326609|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
143487059|NCT03016325|517326602|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
143487060|NCT03016325|517326603|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
143487061|NCT03016325|517326604|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
143487062|NCT03016325|517326605|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
143487063|NCT03016325|517326606|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
143487064|NCT03016325|517326607|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
143487065|NCT03016325|517326608|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
143487066|NCT03016325|517326609|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
143487067|NCT03016325|517326602|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
143487068|NCT03016325|517326603|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
143487069|NCT03016325|517326604|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
143487070|NCT03016325|517326605|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
143487071|NCT03016325|517326606|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
143487072|NCT03016325|517326607|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
143487073|NCT03016325|517326608|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
143487074|NCT03016325|517326609|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
143487075|NCT03016325|517326602|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
143487076|NCT03016325|517326603|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
143487077|NCT03016325|517326604|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
143487078|NCT03016325|517326605|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
143487079|NCT03016325|517326606|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
143487080|NCT03016325|517326607|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
143487081|NCT03016325|517326608|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
143157474|NCT02675452|516121646|FG003|Overall Study|Sponsor decision|0|||
143157475|NCT02675452|516121647|FG004|Overall Study|Sponsor decision|0|||
143157476|NCT02675452|516121648|FG005|Overall Study|Sponsor decision|0|||
143157477|NCT02675452|516121649|FG006|Overall Study|Sponsor decision|0|||
143157478|NCT02675452|516121650|FG007|Overall Study|Sponsor decision|0|||
143157479|NCT02675452|516121651|FG008|Overall Study|Sponsor decision|0|||
143487082|NCT03016325|517326609|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
143024857|NCT00368966|515631199|FG001|Infant Series|Withdrawal by Subject|6|||
143157480|NCT02675452|516121652|FG009|Overall Study|Sponsor decision|1|||
143157481|NCT02675452|516121653|FG010|Overall Study|Sponsor decision|0|||
143157482|NCT02675452|516121654|FG011|Overall Study|Sponsor decision|0|||
143157483|NCT02675452|516121655|FG012|Overall Study|Sponsor decision|0|||
143157484|NCT02675452|516121656|FG013|Overall Study|Sponsor decision|2|||
143157485|NCT02675452|516121657|FG014|Overall Study|Sponsor decision|1|||
143487083|NCT03016325|517326602|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
143487084|NCT03016325|517326603|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
143487085|NCT03016325|517326604|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
143487086|NCT03016325|517326605|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
143487087|NCT03016325|517326606|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
143487088|NCT03016325|517326607|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
143487089|NCT03016325|517326608|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
143487090|NCT03016325|517326609|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
143487091|NCT03016325|517326602|FG000|182-Day Follow-Up Period|Death|3|||
143487092|NCT03016325|517326603|FG001|182-Day Follow-Up Period|Death|3|||
143487093|NCT03016325|517326604|FG002|182-Day Follow-Up Period|Death|11|||
143487094|NCT03016325|517326605|FG003|182-Day Follow-Up Period|Death|12|||
143487095|NCT03016325|517326606|FG004|182-Day Follow-Up Period|Death|9|||
143487096|NCT03016325|517326607|FG005|182-Day Follow-Up Period|Death|0|||
143487097|NCT03016325|517326608|FG006|182-Day Follow-Up Period|Death|0|||
143487098|NCT03016325|517326609|FG007|182-Day Follow-Up Period|Death|1|||
143487099|NCT03016325|517326602|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
143487100|NCT03016325|517326603|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
143487101|NCT03016325|517326604|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
143487102|NCT03016325|517326605|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
143487103|NCT03016325|517326606|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
143487104|NCT03016325|517326607|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
143487105|NCT03016325|517326608|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
143487106|NCT03016325|517326609|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
143487107|NCT03016325|517326602|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
143487108|NCT03016325|517326603|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
143487109|NCT03016325|517326604|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
143487110|NCT03016325|517326605|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
143487111|NCT03016325|517326606|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
143487112|NCT03016325|517326607|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
143487113|NCT03016325|517326608|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
143487114|NCT03016325|517326609|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
143487115|NCT03016325|517326602|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
143487116|NCT03016325|517326603|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
143487117|NCT03016325|517326604|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
143487118|NCT03016325|517326605|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
143487119|NCT03016325|517326606|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
143487120|NCT03016325|517326607|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
143487121|NCT03016325|517326608|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
143487122|NCT03016325|517326609|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
143487123|NCT03016325|517326602|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
143487124|NCT03016325|517326603|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
143487125|NCT03016325|517326604|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
143487126|NCT03016325|517326605|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
143487127|NCT03016325|517326606|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
143487128|NCT03016325|517326607|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
143487129|NCT03016325|517326608|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
143487130|NCT03016325|517326609|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
143487131|NCT03016325|517326602|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
143487132|NCT03016325|517326603|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
143487133|NCT03016325|517326604|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
143487134|NCT03016325|517326605|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
143487135|NCT03016325|517326606|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
143487136|NCT03016325|517326607|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
143487137|NCT03016325|517326608|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
143487138|NCT03016325|517326609|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
143487139|NCT03016325|517326602|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
143487140|NCT03016325|517326603|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
143487141|NCT03016325|517326604|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
143487142|NCT03016325|517326605|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
143487143|NCT03016325|517326606|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
143487144|NCT03016325|517326607|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
143487145|NCT03016325|517326608|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
143487146|NCT03016325|517326609|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
143487147|NCT03016325|517326602|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
143487148|NCT03016325|517326603|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
143487149|NCT03016325|517326604|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
143487150|NCT03016325|517326605|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
143487151|NCT03016325|517326606|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
143487152|NCT03016325|517326607|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
143487153|NCT03016325|517326608|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
143487154|NCT03016325|517326609|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
143487155|NCT02970292|517326610|FG000|Overall Study|Physician Decision|1|||
143487156|NCT02970292|517326611|FG001|Overall Study|Physician Decision|1|||
143487157|NCT02970292|517326610|FG000|Overall Study|Withdrawal by Subject|11|||
143487158|NCT02970292|517326611|FG001|Overall Study|Withdrawal by Subject|5|||
143487159|NCT02970292|517326610|FG000|Overall Study|Noncompliance with study drug|2|||
143487160|NCT02970292|517326611|FG001|Overall Study|Noncompliance with study drug|2|||
143487161|NCT02970292|517326610|FG000|Overall Study|Adverse Event|5|||
143487162|NCT02970292|517326611|FG001|Overall Study|Adverse Event|0|||
143487163|NCT02970292|517326610|FG000|Overall Study|Lack of Efficacy|1|||
143487164|NCT02970292|517326611|FG001|Overall Study|Lack of Efficacy|0|||
143487165|NCT02970292|517326610|FG000|Overall Study|Lost to Follow-up|1|||
143487166|NCT02970292|517326611|FG001|Overall Study|Lost to Follow-up|0|||
143487167|NCT02970292|517326610|FG000|Overall Study|Protocol Violation|2|||
143487168|NCT02970292|517326611|FG001|Overall Study|Protocol Violation|0|||
143487169|NCT02970292|517326610|FG000|Overall Study|Other|1|||
143487170|NCT02970292|517326611|FG001|Overall Study|Other|0|||
143487171|NCT02813694|517326612|FG000|Overall Study|Physician Decision|0|||
143487172|NCT02813694|517326613|FG001|Overall Study|Physician Decision|1|||
143487173|NCT02813694|517326612|FG000|Overall Study|Withdrawal by Subject|10|||
143487174|NCT02813694|517326613|FG001|Overall Study|Withdrawal by Subject|9|||
143487175|NCT02813694|517326612|FG000|Overall Study|Lost to Follow-up|1|||
143487176|NCT02813694|517326613|FG001|Overall Study|Lost to Follow-up|1|||
143487177|NCT02813694|517326612|FG000|Overall Study|Death|3|||
143487178|NCT02813694|517326613|FG001|Overall Study|Death|3|||
143487179|NCT02813694|517326612|FG000|Overall Study|Randomized- did not receive study drug|2|||
143487180|NCT02813694|517326613|FG001|Overall Study|Randomized- did not receive study drug|0|||
143487181|NCT02813694|517326612|FG000|Overall Study|Patient hospitalized|1|||
143487182|NCT02813694|517326613|FG001|Overall Study|Patient hospitalized|0|||
143487183|NCT02941627|517326621|FG000|Overall Study|Death|1|||
143487184|NCT02941627|517326621|FG000|Overall Study|Surgical failure|1|||
143487185|NCT02941627|517326621|FG000|Overall Study|cholesteatoma prevented implantation|1|||
143487186|NCT01087905|517326622|FG000|Overall Study|Lost to Follow-up|24|||
143487187|NCT01087905|517326623|FG001|Overall Study|Lost to Follow-up|28|||
143487188|NCT01087905|517326624|FG002|Overall Study|Lost to Follow-up|18|||
143487189|NCT01087905|517326625|FG003|Overall Study|Lost to Follow-up|31|||
143487190|NCT01087905|517326626|FG004|Overall Study|Lost to Follow-up|27|||
143487191|NCT01087905|517326627|FG005|Overall Study|Lost to Follow-up|25|||
143487192|NCT01087905|517326628|FG006|Overall Study|Lost to Follow-up|20|||
143487193|NCT01087905|517326629|FG007|Overall Study|Lost to Follow-up|24|||
143487194|NCT01087905|517326622|FG000|Overall Study|Withdrawal by Subject|5|||
143487195|NCT01087905|517326623|FG001|Overall Study|Withdrawal by Subject|4|||
143487196|NCT01087905|517326624|FG002|Overall Study|Withdrawal by Subject|4|||
143487197|NCT01087905|517326625|FG003|Overall Study|Withdrawal by Subject|5|||
143487198|NCT01087905|517326626|FG004|Overall Study|Withdrawal by Subject|4|||
143024858|NCT00368966|515631198|FG000|Infant Series|Protocol Violation|2|||
143157486|NCT02675452|516121658|FG015|Overall Study|Sponsor decision|0|||
143157487|NCT02675452|516121659|FG016|Overall Study|Sponsor decision|1|||
143157488|NCT02675452|516121660|FG017|Overall Study|Sponsor decision|0|||
143157489|NCT02675452|516121661|FG018|Overall Study|Sponsor decision|0|||
143157490|NCT02675452|516121662|FG019|Overall Study|Sponsor decision|0|||
143157491|NCT02675452|516121663|FG020|Overall Study|Sponsor decision|0|||
143157492|NCT02675452|516121664|FG021|Overall Study|Sponsor decision|0|||
143157493|NCT02675452|516121665|FG022|Overall Study|Sponsor decision|0|||
143157494|NCT02675452|516121666|FG023|Overall Study|Sponsor decision|0|||
143157495|NCT02675452|516121667|FG024|Overall Study|Sponsor decision|0|||
143236302|NCT04672239|516417449|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
143487199|NCT01087905|517326627|FG005|Overall Study|Withdrawal by Subject|3|||
143487200|NCT01087905|517326628|FG006|Overall Study|Withdrawal by Subject|3|||
143487201|NCT01087905|517326629|FG007|Overall Study|Withdrawal by Subject|5|||
143487202|NCT01618214|517326630|FG000|Overall Study|Adverse Event|3|||
143487203|NCT01618214|517326631|FG001|Overall Study|Adverse Event|1|||
143487204|NCT01618214|517326630|FG000|Overall Study|Lack of Efficacy|1|||
143487205|NCT01618214|517326631|FG001|Overall Study|Lack of Efficacy|1|||
143487206|NCT01618214|517326630|FG000|Overall Study|Protocol Violation|1|||
143487207|NCT01618214|517326631|FG001|Overall Study|Protocol Violation|4|||
143487208|NCT01618214|517326630|FG000|Overall Study|Withdrawal Criteria|1|||
143487209|NCT01618214|517326631|FG001|Overall Study|Withdrawal Criteria|2|||
143157496|NCT02675452|516121668|FG025|Overall Study|Sponsor decision|0|||
143157497|NCT02675452|516121669|FG026|Overall Study|Sponsor decision|2|||
143157498|NCT02675452|516121670|FG027|Overall Study|Sponsor decision|0|||
143157499|NCT02675452|516121671|FG028|Overall Study|Sponsor decision|0|||
143024859|NCT00368966|515631199|FG001|Infant Series|Protocol Violation|1|||
143024860|NCT00368966|515631198|FG000|Infant Series|Lost to Follow-up|2|||
143024861|NCT00368966|515631199|FG001|Infant Series|Lost to Follow-up|0|||
143487210|NCT01618214|517326630|FG000|Overall Study|Unclassified|4|||
143487211|NCT01618214|517326631|FG001|Overall Study|Unclassified|5|||
143487212|NCT00606086|517326632|FG000|Overall Study|Adverse Event|1|||
143487213|NCT00606086|517326633|FG001|Overall Study|Adverse Event|1|||
143487214|NCT00606086|517326632|FG000|Overall Study|Lost to Follow-up|4|||
143487215|NCT00606086|517326633|FG001|Overall Study|Lost to Follow-up|8|||
143487216|NCT00606086|517326632|FG000|Overall Study|Protocol Violation|1|||
143487217|NCT00606086|517326633|FG001|Overall Study|Protocol Violation|0|||
143487218|NCT00606086|517326632|FG000|Overall Study|Withdrawal by Subject|5|||
143487219|NCT00606086|517326633|FG001|Overall Study|Withdrawal by Subject|3|||
143487220|NCT00606086|517326632|FG000|Overall Study|Non-compliance|0|||
143487221|NCT00606086|517326633|FG001|Overall Study|Non-compliance|1|||
143487222|NCT00606086|517326632|FG000|Overall Study|Randomized, not treated|1|||
143487223|NCT00606086|517326633|FG001|Overall Study|Randomized, not treated|2|||
143487224|NCT01929408|517326639|FG000|Overall Study|received HCT as initial treatment|8|||
143487225|NCT02068547|517327824|FG000|Overall Study|Lost to Follow-up|3|||
143487226|NCT02068547|517327825|FG001|Overall Study|Lost to Follow-up|3|||
143487227|NCT02068547|517327824|FG000|Overall Study|Physician Decision|1|||
143487228|NCT02068547|517327825|FG001|Overall Study|Physician Decision|0|||
143487229|NCT01289015|517327828|FG000|Overall Study|Protocol Violation|12|||
143487230|NCT01289015|517327829|FG001|Overall Study|Protocol Violation|9|||
143487231|NCT01289015|517327828|FG000|Overall Study|Adverse Event|3|||
143487232|NCT01289015|517327829|FG001|Overall Study|Adverse Event|0|||
143487233|NCT01289015|517327828|FG000|Overall Study|Lost to Follow-up|33|||
143487234|NCT01289015|517327829|FG001|Overall Study|Lost to Follow-up|17|||
143487235|NCT01289015|517327828|FG000|Overall Study|Withdrawal by Subject|17|||
143487236|NCT01289015|517327829|FG001|Overall Study|Withdrawal by Subject|8|||
143487237|NCT01289015|517327828|FG000|Overall Study|Disease progression|1|||
143487238|NCT01289015|517327829|FG001|Overall Study|Disease progression|0|||
143487239|NCT01289015|517327828|FG000|Overall Study|Negative baseline culture and others|33|||
143487240|NCT01289015|517327829|FG001|Overall Study|Negative baseline culture and others|20|||
143487241|NCT03031301|517327837|FG000|Overall Study|Protocol Violation|4|||
143487242|NCT03031301|517327838|FG001|Overall Study|Protocol Violation|8|||
143487243|NCT03031301|517327837|FG000|Overall Study|Withdrawal by Subject|7|||
143487244|NCT03031301|517327838|FG001|Overall Study|Withdrawal by Subject|4|||
143487245|NCT03031301|517327837|FG000|Overall Study|Lost to Follow-up|4|||
143487246|NCT03031301|517327838|FG001|Overall Study|Lost to Follow-up|12|||
143487247|NCT03031301|517327837|FG000|Overall Study|Noncompliance|1|||
143487248|NCT03031301|517327838|FG001|Overall Study|Noncompliance|3|||
143487249|NCT03031301|517327837|FG000|Overall Study|Technical issue|1|||
143487250|NCT03031301|517327838|FG001|Overall Study|Technical issue|1|||
143487251|NCT03031301|517327837|FG000|Overall Study|Adverse Event|1|||
143487252|NCT03031301|517327838|FG001|Overall Study|Adverse Event|0|||
143487253|NCT02599961|517327840|FG000|Overall Study|Withdrawal by Subject|1|||
143487254|NCT02599961|517327840|FG000|Overall Study|Subject Non-Compliance|2|||
143487255|NCT02599961|517327840|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
143487256|NCT02599961|517327840|FG000|Overall Study|Other, Not Specified|3|||
143487257|NCT00391222|517327848|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
143487258|NCT00391222|517327849|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
143487259|NCT00391222|517327850|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
143487260|NCT00391222|517327851|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
143487261|NCT00391222|517327848|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
143363753|NCT04978363|516875433|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
143363754|NCT04978363|516875434|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
143363755|NCT04978363|516875435|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
143363756|NCT04978363|516875436|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
143363757|NCT04978363|516875437|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
143487262|NCT00391222|517327849|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
143487263|NCT00391222|517327850|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
143487264|NCT00391222|517327851|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
143487265|NCT00391222|517327848|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
143487266|NCT00391222|517327849|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
143487267|NCT00391222|517327850|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
143487268|NCT00391222|517327851|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
143487269|NCT00391222|517327848|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
143487270|NCT00391222|517327849|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
143487271|NCT00391222|517327850|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
143487272|NCT00391222|517327851|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
143024862|NCT00368966|515631198|FG000|Infant Series|Randomization error|0|||
143024863|NCT00368966|515631199|FG001|Infant Series|Randomization error|1|||
143236303|NCT01099267|516417450|FG000|MDS-003 Study|Adverse Event|37|||
143363758|NCT04978363|516875438|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
143363759|NCT04978363|516875439|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
143363760|NCT04978363|516875440|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
143363761|NCT04978363|516875441|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
143363762|NCT04978363|516875442|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
143363763|NCT04978363|516875443|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
143363764|NCT04672460|516875444|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
143363765|NCT04672460|516875445|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
143363766|NCT04672460|516875444|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
143363767|NCT04672460|516875445|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
143363768|NCT04672460|516875444|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
143363769|NCT04672460|516875445|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
143363770|NCT04672460|516875444|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
143363771|NCT04672460|516875445|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
143363772|NCT04672460|516875444|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
143363773|NCT04672460|516875445|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
143363774|NCT04672460|516875444|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
143363775|NCT04672460|516875445|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
143363776|NCT04672460|516875444|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
143363777|NCT04672460|516875445|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
143363778|NCT04672460|516875444|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
143363779|NCT04672460|516875445|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
143363780|NCT04672460|516875444|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
143363781|NCT04672460|516875445|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
143363782|NCT04672460|516875444|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
143363783|NCT04672460|516875445|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
143363784|NCT04672460|516875444|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
143363785|NCT04672460|516875445|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
143363786|NCT04672460|516875444|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
143363787|NCT04672460|516875445|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
143363788|NCT04672460|516875444|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
143363789|NCT04672460|516875445|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
143363790|NCT04672460|516875444|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
143363791|NCT04672460|516875445|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
143363792|NCT04672460|516875444|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
143363793|NCT04672460|516875445|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
143363794|NCT04672460|516875444|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
143363795|NCT04672460|516875445|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
143363796|NCT04672460|516875444|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
143363797|NCT04672460|516875445|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
143363798|NCT01876043|516875449|FG000|Overall Study|Death|1|||
143363799|NCT01876043|516875449|FG000|Overall Study|Withdrawal by Subject|1|||
143363800|NCT00049517|516875450|FG000|Induction|Disease progression|0|||
143363801|NCT00049517|516875451|FG001|Induction|Disease progression|0|||
143363802|NCT00049517|516875452|FG002|Induction|Disease progression|0|||
143363803|NCT00049517|516875453|FG003|Induction|Disease progression|0|||
143363804|NCT00049517|516875454|FG004|Induction|Disease progression|18|||
143363805|NCT00049517|516875455|FG005|Induction|Disease progression|11|||
143363806|NCT00049517|516875450|FG000|Induction|Adverse Event|0|||
143363807|NCT00049517|516875451|FG001|Induction|Adverse Event|0|||
143363808|NCT00049517|516875452|FG002|Induction|Adverse Event|0|||
143363809|NCT00049517|516875453|FG003|Induction|Adverse Event|0|||
143363810|NCT00049517|516875454|FG004|Induction|Adverse Event|5|||
143363811|NCT00049517|516875455|FG005|Induction|Adverse Event|7|||
143363812|NCT00049517|516875450|FG000|Induction|Death|0|||
143363813|NCT00049517|516875451|FG001|Induction|Death|0|||
143363814|NCT00049517|516875452|FG002|Induction|Death|0|||
143487273|NCT00391222|517327848|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
143487274|NCT00391222|517327849|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
143487275|NCT00391222|517327850|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
143487276|NCT00391222|517327851|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
143363815|NCT00049517|516875453|FG003|Induction|Death|0|||
143363816|NCT00049517|516875454|FG004|Induction|Death|9|||
143363817|NCT00049517|516875455|FG005|Induction|Death|6|||
143363818|NCT00049517|516875450|FG000|Induction|Withdrawal by Subject|0|||
143363819|NCT00049517|516875451|FG001|Induction|Withdrawal by Subject|0|||
143363820|NCT00049517|516875452|FG002|Induction|Withdrawal by Subject|0|||
143363821|NCT00049517|516875453|FG003|Induction|Withdrawal by Subject|0|||
143363822|NCT00049517|516875454|FG004|Induction|Withdrawal by Subject|1|||
143487277|NCT00391222|517327848|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
143487278|NCT00391222|517327849|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
143487279|NCT00391222|517327850|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
143487280|NCT00391222|517327851|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
143487281|NCT00391222|517327848|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
143487282|NCT00391222|517327849|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
143487283|NCT00391222|517327850|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
143487284|NCT00391222|517327851|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
143487285|NCT00391222|517327848|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
143487286|NCT00391222|517327849|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
143487287|NCT00391222|517327850|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
143487288|NCT00391222|517327851|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
143487289|NCT00391222|517327848|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
143487290|NCT00391222|517327849|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
143487291|NCT00391222|517327850|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
143487292|NCT00391222|517327851|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
143487293|NCT00391222|517327848|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
143487294|NCT00391222|517327849|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
143487295|NCT00391222|517327850|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
143487296|NCT00391222|517327851|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
143487297|NCT00391222|517327848|FG000|Period III (Double-Blind Treatment)|Other|6|||
143487298|NCT00391222|517327849|FG001|Period III (Double-Blind Treatment)|Other|1|||
143487299|NCT00391222|517327850|FG002|Period III (Double-Blind Treatment)|Other|6|||
143487300|NCT00391222|517327851|FG003|Period III (Double-Blind Treatment)|Other|0|||
143487301|NCT02111993|517327852|FG000|Overall Study|Physician Decision|5|||
143487302|NCT02111993|517327853|FG001|Overall Study|Physician Decision|4|||
143487303|NCT00796315|517327854|FG000|Overall Study|Protocol Violation|0|||
143487304|NCT00796315|517327855|FG001|Overall Study|Protocol Violation|1|||
143487305|NCT00796315|517327856|FG002|Overall Study|Protocol Violation|0|||
143487306|NCT00889265|517327858|FG000|Overall Study|Adverse Event|1|||
143487307|NCT00889265|517327858|FG000|Overall Study|Lost to Follow-up|5|||
143487308|NCT00889265|517327858|FG000|Overall Study|Protocol Violation|1|||
143487309|NCT03028870|517327859|FG000|Overall Study|Adverse Event|7|||
143487310|NCT03028870|517327860|FG001|Overall Study|Adverse Event|4|||
143487311|NCT03028870|517327861|FG002|Overall Study|Adverse Event|3|||
143487312|NCT03028870|517327862|FG003|Overall Study|Adverse Event|3|||
143487313|NCT03028870|517327859|FG000|Overall Study|Withdrawal by Subject|1|||
143487314|NCT03028870|517327860|FG001|Overall Study|Withdrawal by Subject|1|||
143487315|NCT03028870|517327861|FG002|Overall Study|Withdrawal by Subject|1|||
143487316|NCT03028870|517327862|FG003|Overall Study|Withdrawal by Subject|2|||
143487317|NCT03028870|517327859|FG000|Overall Study|Lost to Follow-up|1|||
143487318|NCT03028870|517327860|FG001|Overall Study|Lost to Follow-up|0|||
143487319|NCT03028870|517327861|FG002|Overall Study|Lost to Follow-up|0|||
143487320|NCT03028870|517327862|FG003|Overall Study|Lost to Follow-up|0|||
143487321|NCT03028870|517327859|FG000|Overall Study|Lack of Efficacy|3|||
143487322|NCT03028870|517327860|FG001|Overall Study|Lack of Efficacy|0|||
143487323|NCT03028870|517327861|FG002|Overall Study|Lack of Efficacy|0|||
143487324|NCT03028870|517327862|FG003|Overall Study|Lack of Efficacy|0|||
143487325|NCT03028870|517327859|FG000|Overall Study|Administrative|5|||
143487326|NCT03028870|517327860|FG001|Overall Study|Administrative|5|||
143487327|NCT03028870|517327861|FG002|Overall Study|Administrative|12|||
143487328|NCT03028870|517327862|FG003|Overall Study|Administrative|4|||
143487329|NCT02069899|517327865|FG000|Overall Study|Adverse Event|6|||
143487330|NCT02069899|517327866|FG001|Overall Study|Adverse Event|0|||
143487331|NCT02069899|517327867|FG002|Overall Study|Adverse Event|1|||
143487332|NCT02069899|517327865|FG000|Overall Study|Withdrawal by Participant|2|||
143487333|NCT02069899|517327866|FG001|Overall Study|Withdrawal by Participant|0|||
143487334|NCT02069899|517327867|FG002|Overall Study|Withdrawal by Participant|0|||
143157500|NCT02675452|516121643|FG000|Overall Study|Withdrawal by Subject|0|||
143157501|NCT02675452|516121644|FG001|Overall Study|Withdrawal by Subject|0|||
143157502|NCT02675452|516121645|FG002|Overall Study|Withdrawal by Subject|0|||
143157503|NCT02675452|516121646|FG003|Overall Study|Withdrawal by Subject|0|||
143157504|NCT02675452|516121647|FG004|Overall Study|Withdrawal by Subject|0|||
143157505|NCT02675452|516121648|FG005|Overall Study|Withdrawal by Subject|0|||
143157506|NCT02675452|516121649|FG006|Overall Study|Withdrawal by Subject|0|||
143157507|NCT02675452|516121650|FG007|Overall Study|Withdrawal by Subject|0|||
143157508|NCT02675452|516121651|FG008|Overall Study|Withdrawal by Subject|0|||
143157509|NCT02675452|516121652|FG009|Overall Study|Withdrawal by Subject|1|||
143157510|NCT02675452|516121653|FG010|Overall Study|Withdrawal by Subject|0|||
143157511|NCT02675452|516121654|FG011|Overall Study|Withdrawal by Subject|1|||
143157512|NCT02675452|516121655|FG012|Overall Study|Withdrawal by Subject|0|||
143487335|NCT02069899|517327865|FG000|Overall Study|Lost to Follow-up|1|||
143487336|NCT02069899|517327866|FG001|Overall Study|Lost to Follow-up|0|||
143487337|NCT02069899|517327867|FG002|Overall Study|Lost to Follow-up|1|||
143487338|NCT02069899|517327865|FG000|Overall Study|Other|4|||
143487339|NCT02069899|517327866|FG001|Overall Study|Other|0|||
143487340|NCT02069899|517327867|FG002|Overall Study|Other|0|||
143487341|NCT02069899|517327865|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
143487342|NCT02069899|517327866|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
143487343|NCT02069899|517327867|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
143487344|NCT02069899|517327865|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
143487345|NCT02069899|517327866|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
143487346|NCT02069899|517327867|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
143487347|NCT00531752|517327870|FG000|First Double-blind Intervention Period|Adverse Event|2|||
143487348|NCT00531752|517327871|FG001|First Double-blind Intervention Period|Adverse Event|0|||
143487349|NCT00531752|517327872|FG002|First Double-blind Intervention Period|Adverse Event|1|||
143487350|NCT00531752|517327873|FG003|First Double-blind Intervention Period|Adverse Event|1|||
143487351|NCT00531752|517327870|FG000|First Double-blind Intervention Period|Other|1|||
143487352|NCT00531752|517327871|FG001|First Double-blind Intervention Period|Other|4|||
143487353|NCT00531752|517327872|FG002|First Double-blind Intervention Period|Other|4|||
143487354|NCT00531752|517327873|FG003|First Double-blind Intervention Period|Other|0|||
143487355|NCT00531752|517327870|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
143487356|NCT00531752|517327871|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
143487357|NCT00531752|517327872|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
143487358|NCT00531752|517327873|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
143487359|NCT00531752|517327870|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
143487360|NCT00531752|517327871|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
143487361|NCT00531752|517327872|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
143487362|NCT00531752|517327873|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
143487363|NCT00531752|517327870|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
143487364|NCT00531752|517327871|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
143487365|NCT00531752|517327872|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
143487366|NCT00531752|517327873|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
143487367|NCT00531752|517327870|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
143487368|NCT00531752|517327871|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
143487369|NCT00531752|517327872|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
143487370|NCT00531752|517327873|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
143487371|NCT00531752|517327870|FG000|Second Double-blind Intervention Period|Other|1|||
143487372|NCT00531752|517327871|FG001|Second Double-blind Intervention Period|Other|1|||
143487373|NCT00531752|517327872|FG002|Second Double-blind Intervention Period|Other|0|||
143487374|NCT00531752|517327873|FG003|Second Double-blind Intervention Period|Other|0|||
143487375|NCT00531752|517327870|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
143487376|NCT00531752|517327871|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
143487377|NCT00531752|517327872|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
143487378|NCT00531752|517327873|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
143487379|NCT00531752|517327870|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
143487380|NCT00531752|517327871|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
143487381|NCT00531752|517327872|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
143487382|NCT00531752|517327873|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
143487383|NCT00490451|517327874|FG000|Overall Study|Adverse Event|3|||
143487384|NCT00490451|517327875|FG001|Overall Study|Adverse Event|3|||
143487385|NCT00490451|517327874|FG000|Overall Study|Death|3|||
143487386|NCT00490451|517327875|FG001|Overall Study|Death|1|||
143487387|NCT00490451|517327874|FG000|Overall Study|Withdrawal by Subject|2|||
143487388|NCT00490451|517327875|FG001|Overall Study|Withdrawal by Subject|0|||
143487389|NCT00490451|517327874|FG000|Overall Study|Investigator Decision|1|||
143487390|NCT00490451|517327875|FG001|Overall Study|Investigator Decision|0|||
143487391|NCT00490451|517327874|FG000|Overall Study|Protocol Violation|1|||
143487392|NCT00490451|517327875|FG001|Overall Study|Protocol Violation|0|||
143487393|NCT00490451|517327874|FG000|Overall Study|Progressive Disease|53|||
143487394|NCT00490451|517327875|FG001|Overall Study|Progressive Disease|34|||
143487395|NCT01181011|517327876|FG000|Overall Study|Adverse Event|2|||
143487396|NCT01181011|517327876|FG000|Overall Study|Lost to Follow-up|1|||
143487397|NCT04703075|517327877|FG000|Overall Study|Adverse Event|11|||
143487398|NCT04703075|517327878|FG001|Overall Study|Adverse Event|7|||
143024864|NCT00368966|515631198|FG000|Infant Series|Failed to meet eligibility criteria|0|||
143024865|NCT00368966|515631199|FG001|Infant Series|Failed to meet eligibility criteria|1|||
143157513|NCT02675452|516121656|FG013|Overall Study|Withdrawal by Subject|1|||
143157514|NCT02675452|516121657|FG014|Overall Study|Withdrawal by Subject|1|||
143487399|NCT04703075|517327877|FG000|Overall Study|Lost to Follow-up|6|||
143157515|NCT02675452|516121658|FG015|Overall Study|Withdrawal by Subject|0|||
143487400|NCT04703075|517327878|FG001|Overall Study|Lost to Follow-up|12|||
143024866|NCT00368966|515631198|FG000|Infant Series|Adverse Event|0|||
143487401|NCT04703075|517327877|FG000|Overall Study|Physician Decision|3|||
143487402|NCT04703075|517327878|FG001|Overall Study|Physician Decision|0|||
143487403|NCT04703075|517327877|FG000|Overall Study|Moved|0|||
143487404|NCT04703075|517327878|FG001|Overall Study|Moved|2|||
143487405|NCT04703075|517327877|FG000|Overall Study|Index INH Resistant|0|||
143487406|NCT04703075|517327878|FG001|Overall Study|Index INH Resistant|1|||
143487407|NCT04703075|517327877|FG000|Overall Study|Lack of Efficacy|6|||
143487408|NCT04703075|517327878|FG001|Overall Study|Lack of Efficacy|18|||
143487409|NCT02788747|517327881|FG000|Overall Study|Adverse Event|1|||
143487410|NCT02788747|517327882|FG001|Overall Study|Adverse Event|0|||
143487411|NCT02788747|517327883|FG002|Overall Study|Adverse Event|0|||
143487412|NCT00254501|517327884|FG000|Overall Study|Lost to Follow-up|1|||
143487413|NCT00254501|517327885|FG001|Overall Study|Lost to Follow-up|1|||
143487414|NCT01119248|517327886|FG000|Overall Study|Physician Decision|5|||
143487415|NCT01967550|517327887|FG000|Overall Study|Withdrawal by Subject|1|||
143487416|NCT01967550|517327888|FG001|Overall Study|Withdrawal by Subject|0|||
143487417|NCT01967550|517327887|FG000|Overall Study|Adverse Event|2|||
143487418|NCT01967550|517327888|FG001|Overall Study|Adverse Event|0|||
143487419|NCT01967550|517327887|FG000|Overall Study|Protocol Violation|2|||
143487420|NCT01967550|517327888|FG001|Overall Study|Protocol Violation|1|||
143487421|NCT01967550|517327887|FG000|Overall Study|Non Compliance|0|||
143487422|NCT01967550|517327888|FG001|Overall Study|Non Compliance|1|||
143487423|NCT01836783|517327894|FG000|Overall Study|Withdrawal by Subject|0|||
143487424|NCT01836783|517327895|FG001|Overall Study|Withdrawal by Subject|2|||
143487425|NCT01035905|517327899|FG000|Overall Study|Lack of Efficacy|1|||
143487426|NCT01035905|517327900|FG001|Overall Study|Lack of Efficacy|1|||
143487427|NCT04942925|517327901|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
143487428|NCT04942925|517327902|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
143487429|NCT04942925|517327901|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
143487430|NCT04942925|517327902|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
143487431|NCT01273883|517327903|FG000|First Intervention|Adverse Event|2|||
143487432|NCT01273883|517327904|FG001|First Intervention|Adverse Event|1|||
143487433|NCT01273883|517327903|FG000|Second Intervention|Lost to Follow-up|1|||
143487434|NCT01273883|517327904|FG001|Second Intervention|Lost to Follow-up|1|||
143487435|NCT01273883|517327903|FG000|Second Intervention|Lack of Efficacy|1|||
143487436|NCT01273883|517327904|FG001|Second Intervention|Lack of Efficacy|0|||
143487437|NCT04489888|517327910|FG000|Overall Study|Death|75|||
143487438|NCT04489888|517327910|FG000|Overall Study|Sponsor Decision|26|||
143487439|NCT01430455|517327914|FG000|Overall Study|Withdrawal by Subject|1|||
143487440|NCT01430455|517327914|FG000|Overall Study|Switched to follow-up phase|1|||
143487441|NCT03829657|517327918|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
143487442|NCT03829657|517327919|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
143487443|NCT03829657|517327920|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
143487444|NCT03829657|517327921|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
143487445|NCT03829657|517327922|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
143487446|NCT03829657|517327918|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
143487447|NCT03829657|517327919|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
143487448|NCT03829657|517327920|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
143487449|NCT03829657|517327921|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
143487450|NCT03829657|517327922|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
143487451|NCT03829657|517327918|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
143487452|NCT03829657|517327919|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
143487453|NCT03829657|517327920|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
143487454|NCT03829657|517327921|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
143487455|NCT03829657|517327922|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
143487456|NCT03829657|517327918|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
143487457|NCT03829657|517327919|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
143487458|NCT03829657|517327920|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
143487459|NCT03829657|517327921|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
143487460|NCT03829657|517327922|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
143024867|NCT00368966|515631199|FG001|Infant Series|Adverse Event|1|||
143024868|NCT00368966|515631198|FG000|Infant Series|Failed to return|1|||
143236304|NCT01099267|516417450|FG000|MDS-003 Study|Lack of Efficacy|52|||
143487461|NCT03829657|517327918|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
143487462|NCT03829657|517327919|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
143487463|NCT03829657|517327920|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
143487464|NCT03829657|517327921|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
143487465|NCT03829657|517327922|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
143487466|NCT03829657|517327918|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
143487467|NCT03829657|517327919|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
143487468|NCT03829657|517327920|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
143487469|NCT03829657|517327921|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
143487470|NCT03829657|517327922|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
143487471|NCT03829657|517327918|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
143487472|NCT03829657|517327919|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
143487473|NCT03829657|517327920|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
143487474|NCT03829657|517327921|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
143487475|NCT03829657|517327922|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
143487476|NCT03829657|517327918|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
143487477|NCT03829657|517327919|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
143487478|NCT03829657|517327920|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
143487479|NCT03829657|517327921|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
143487480|NCT03829657|517327922|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
143487481|NCT03829657|517327918|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
143487482|NCT03829657|517327919|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
143487483|NCT03829657|517327920|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
143487484|NCT03829657|517327921|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
143487485|NCT03829657|517327922|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
143487486|NCT03829657|517327918|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
143487487|NCT03829657|517327919|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
143487488|NCT03829657|517327920|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
143487489|NCT03829657|517327921|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
143487490|NCT03829657|517327922|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
143487491|NCT01425008|517327924|FG000|Dose Escalation Phase|Progressive Disease|2|||
143487492|NCT01425008|517327925|FG001|Dose Escalation Phase|Progressive Disease|3|||
143487493|NCT01425008|517327926|FG002|Dose Escalation Phase|Progressive Disease|2|||
143487494|NCT01425008|517327927|FG003|Dose Escalation Phase|Progressive Disease|3|||
143487495|NCT01425008|517327928|FG004|Dose Escalation Phase|Progressive Disease|5|||
143487496|NCT01425008|517327929|FG005|Dose Escalation Phase|Progressive Disease|4|||
143487497|NCT01425008|517327930|FG006|Dose Escalation Phase|Progressive Disease|0|||
143024869|NCT00368966|515631199|FG001|Infant Series|Failed to return|0|||
143024870|NCT00368966|515631198|FG000|After Infant|Failed to return|3|||
143024871|NCT00368966|515631199|FG001|After Infant|Failed to return|1|||
143024872|NCT00368966|515631198|FG000|After Infant|Adverse Event|1|||
143024873|NCT00368966|515631199|FG001|After Infant|Adverse Event|2|||
143024874|NCT00368966|515631198|FG000|After Infant|Withdrawal by Subject|1|||
143024875|NCT00368966|515631199|FG001|After Infant|Withdrawal by Subject|1|||
143024876|NCT00368966|515631198|FG000|After Infant|Death|1|||
143363823|NCT00049517|516875455|FG005|Induction|Withdrawal by Subject|3|||
143363824|NCT00049517|516875450|FG000|Induction|Alternative therapy|0|||
143363825|NCT00049517|516875451|FG001|Induction|Alternative therapy|0|||
143363826|NCT00049517|516875452|FG002|Induction|Alternative therapy|0|||
143363827|NCT00049517|516875453|FG003|Induction|Alternative therapy|0|||
143487498|NCT01425008|517327931|FG007|Dose Escalation Phase|Progressive Disease|2|||
143487499|NCT01425008|517327932|FG008|Dose Escalation Phase|Progressive Disease|6|||
143487500|NCT01425008|517327933|FG009|Dose Escalation Phase|Progressive Disease|2|||
143487501|NCT01425008|517327934|FG010|Dose Escalation Phase|Progressive Disease|0|||
143487502|NCT01425008|517327935|FG011|Dose Escalation Phase|Progressive Disease|0|||
143487503|NCT01425008|517327936|FG012|Dose Escalation Phase|Progressive Disease|0|||
143487504|NCT01425008|517327937|FG013|Dose Escalation Phase|Progressive Disease|0|||
143487505|NCT01425008|517327938|FG014|Dose Escalation Phase|Progressive Disease|0|||
143487506|NCT01425008|517327939|FG015|Dose Escalation Phase|Progressive Disease|0|||
143487507|NCT01425008|517327940|FG016|Dose Escalation Phase|Progressive Disease|0|||
143487508|NCT01425008|517327941|FG017|Dose Escalation Phase|Progressive Disease|0|||
143487509|NCT01425008|517327942|FG018|Dose Escalation Phase|Progressive Disease|0|||
143487510|NCT01425008|517327924|FG000|Dose Escalation Phase|Adverse Event|2|||
143487511|NCT01425008|517327925|FG001|Dose Escalation Phase|Adverse Event|0|||
143487512|NCT01425008|517327926|FG002|Dose Escalation Phase|Adverse Event|0|||
143487513|NCT01425008|517327927|FG003|Dose Escalation Phase|Adverse Event|0|||
143487514|NCT01425008|517327928|FG004|Dose Escalation Phase|Adverse Event|0|||
143487515|NCT01425008|517327929|FG005|Dose Escalation Phase|Adverse Event|2|||
143487516|NCT01425008|517327930|FG006|Dose Escalation Phase|Adverse Event|0|||
143487517|NCT01425008|517327931|FG007|Dose Escalation Phase|Adverse Event|0|||
143487518|NCT01425008|517327932|FG008|Dose Escalation Phase|Adverse Event|2|||
143487519|NCT01425008|517327933|FG009|Dose Escalation Phase|Adverse Event|0|||
143487520|NCT01425008|517327934|FG010|Dose Escalation Phase|Adverse Event|0|||
143487521|NCT01425008|517327935|FG011|Dose Escalation Phase|Adverse Event|0|||
143487522|NCT01425008|517327936|FG012|Dose Escalation Phase|Adverse Event|0|||
143024877|NCT00368966|515631199|FG001|After Infant|Death|0|||
143024878|NCT00368966|515631198|FG000|After Infant|Lost to Follow-up|0|||
143363828|NCT00049517|516875454|FG004|Induction|Alternative therapy|2|||
143024879|NCT00368966|515631199|FG001|After Infant|Lost to Follow-up|1|||
143236305|NCT01099267|516417450|FG000|MDS-003 Study|Withdrawal by Subject|8|||
143236306|NCT01099267|516417450|FG000|MDS-003 Study|Lost to Follow-up|1|||
143236307|NCT01099267|516417450|FG000|MDS-003 Study|Death|11|||
143236308|NCT01099267|516417450|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
143236309|NCT01099267|516417450|FG000|MDS-003 Study|Disease Progression|7|||
143236310|NCT01099267|516417450|FG000|MDS-003 Study|Investigator Decision|2|||
143236311|NCT01099267|516417450|FG000|MDS-003 Study|Non-Compliance|2|||
143236312|NCT01099267|516417450|FG000|MDS-003 Study|Loss of Response|1|||
143236313|NCT01099267|516417450|FG000|MDS-003 Study|Secondary Malign Disease|1|||
143236314|NCT04986904|516417451|FG000|Overall Study|Lost to Follow-up|11|||
143236315|NCT04986904|516417451|FG000|Overall Study|Withdrawal by Subject|1|||
143236316|NCT01838395|516417460|FG000|Overall Study|Withdrawal by Subject|0|||
143236317|NCT01838395|516417461|FG001|Overall Study|Withdrawal by Subject|0|||
143236318|NCT01838395|516417462|FG002|Overall Study|Withdrawal by Subject|0|||
143236319|NCT01838395|516417463|FG003|Overall Study|Withdrawal by Subject|0|||
143236320|NCT01838395|516417464|FG004|Overall Study|Withdrawal by Subject|1|||
143236321|NCT01838395|516417465|FG005|Overall Study|Withdrawal by Subject|0|||
143236322|NCT01838395|516417460|FG000|Overall Study|Death|0|||
143236323|NCT01838395|516417461|FG001|Overall Study|Death|0|||
143236324|NCT01838395|516417462|FG002|Overall Study|Death|1|||
143236325|NCT01838395|516417463|FG003|Overall Study|Death|0|||
143236326|NCT01838395|516417464|FG004|Overall Study|Death|0|||
143236327|NCT01838395|516417465|FG005|Overall Study|Death|0|||
143236328|NCT01838395|516417460|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
143236329|NCT01838395|516417461|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
143236330|NCT01838395|516417462|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
143236331|NCT01838395|516417463|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
143236332|NCT01838395|516417464|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
143236333|NCT01838395|516417465|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
143236334|NCT02532517|516417470|FG000|Overall Study|Did not complete 24-Month visit|4|||
143236335|NCT02532517|516417470|FG000|Overall Study|Failed Angiographic eligibility|1|||
143236336|NCT02532517|516417470|FG000|Overall Study|Lost to Follow-up|4|||
143236337|NCT02532517|516417470|FG000|Overall Study|Withdrawal by Subject|4|||
143236338|NCT02532517|516417470|FG000|Overall Study|Death|4|||
143236339|NCT03312231|516417471|FG000|Overall Study|Lost to Follow-up|2|||
143236340|NCT03312231|516417472|FG001|Overall Study|Lost to Follow-up|6|||
143236341|NCT03312231|516417473|FG002|Overall Study|Lost to Follow-up|1|||
143236342|NCT03312231|516417474|FG003|Overall Study|Lost to Follow-up|3|||
143487523|NCT01425008|517327937|FG013|Dose Escalation Phase|Adverse Event|0|||
143024880|NCT00368966|515631198|FG000|Toddler Dose|Withdrawal by Subject|1|||
143024881|NCT00368966|515631199|FG001|Toddler Dose|Withdrawal by Subject|1|||
143024882|NCT00368966|515631198|FG000|Toddler Dose|Lost to Follow-up|0|||
143024883|NCT00368966|515631199|FG001|Toddler Dose|Lost to Follow-up|2|||
143236343|NCT03312231|516417475|FG004|Overall Study|Lost to Follow-up|1|||
143236344|NCT03312231|516417471|FG000|Overall Study|Withdrawal by Subject|0|||
143236345|NCT03312231|516417472|FG001|Overall Study|Withdrawal by Subject|3|||
143236346|NCT03312231|516417473|FG002|Overall Study|Withdrawal by Subject|1|||
143487524|NCT01425008|517327938|FG014|Dose Escalation Phase|Adverse Event|0|||
143487525|NCT01425008|517327939|FG015|Dose Escalation Phase|Adverse Event|0|||
143487526|NCT01425008|517327940|FG016|Dose Escalation Phase|Adverse Event|0|||
143487527|NCT01425008|517327941|FG017|Dose Escalation Phase|Adverse Event|0|||
143487528|NCT01425008|517327942|FG018|Dose Escalation Phase|Adverse Event|0|||
143487529|NCT01425008|517327924|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
143487530|NCT01425008|517327925|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
143487531|NCT01425008|517327926|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
143487532|NCT01425008|517327927|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
143487533|NCT01425008|517327928|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
143487534|NCT01425008|517327929|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
143487535|NCT01425008|517327930|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
143487536|NCT01425008|517327931|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
143487537|NCT01425008|517327932|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
143487538|NCT01425008|517327933|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
143487539|NCT01425008|517327934|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
143487540|NCT01425008|517327935|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
143487541|NCT01425008|517327936|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
143487542|NCT01425008|517327937|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
143487543|NCT01425008|517327938|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
143236347|NCT03312231|516417474|FG003|Overall Study|Withdrawal by Subject|0|||
143236348|NCT03312231|516417475|FG004|Overall Study|Withdrawal by Subject|0|||
143236349|NCT03312231|516417471|FG000|Overall Study|Death|0|||
143236350|NCT03312231|516417472|FG001|Overall Study|Death|1|||
143236351|NCT03312231|516417473|FG002|Overall Study|Death|1|||
143487544|NCT01425008|517327939|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
143487545|NCT01425008|517327940|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
143487546|NCT01425008|517327941|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
143487547|NCT01425008|517327942|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
143487548|NCT01425008|517327924|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
143487549|NCT01425008|517327925|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
143487550|NCT01425008|517327926|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
143487551|NCT01425008|517327927|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
143487552|NCT01425008|517327928|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
143487553|NCT01425008|517327929|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
143487554|NCT01425008|517327930|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
143487555|NCT01425008|517327931|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
143487556|NCT01425008|517327932|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
143487557|NCT01425008|517327933|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
143487558|NCT01425008|517327934|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
143487559|NCT01425008|517327935|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
143487560|NCT01425008|517327936|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
143487561|NCT01425008|517327937|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
143487562|NCT01425008|517327938|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
143487563|NCT01425008|517327939|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
143487564|NCT01425008|517327940|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
143487565|NCT01425008|517327941|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
143487566|NCT01425008|517327942|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
143487567|NCT01425008|517327924|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
143487568|NCT01425008|517327925|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
143487569|NCT01425008|517327926|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
143487570|NCT01425008|517327927|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
143487571|NCT01425008|517327928|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
143487572|NCT01425008|517327929|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
143487573|NCT01425008|517327930|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
143487574|NCT01425008|517327931|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
143487575|NCT01425008|517327932|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
143487576|NCT01425008|517327933|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
143487577|NCT01425008|517327934|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
143487578|NCT01425008|517327935|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
143487579|NCT01425008|517327936|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
143487580|NCT01425008|517327937|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
143487581|NCT01425008|517327938|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
143487582|NCT01425008|517327939|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
143487583|NCT01425008|517327940|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
143487584|NCT01425008|517327941|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
143487585|NCT01425008|517327942|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
143487586|NCT01425008|517327924|FG000|Dose Escalation Phase|Other|0|||
143487587|NCT01425008|517327925|FG001|Dose Escalation Phase|Other|0|||
143487588|NCT01425008|517327926|FG002|Dose Escalation Phase|Other|0|||
143487589|NCT01425008|517327927|FG003|Dose Escalation Phase|Other|0|||
143487590|NCT01425008|517327928|FG004|Dose Escalation Phase|Other|0|||
143487591|NCT01425008|517327929|FG005|Dose Escalation Phase|Other|0|||
143487592|NCT01425008|517327930|FG006|Dose Escalation Phase|Other|0|||
143487593|NCT01425008|517327931|FG007|Dose Escalation Phase|Other|0|||
143236352|NCT03312231|516417474|FG003|Overall Study|Death|0|||
143236353|NCT03312231|516417475|FG004|Overall Study|Death|0|||
143236354|NCT03312231|516417471|FG000|Overall Study|Study Vaccination not Received|1|||
143236355|NCT03312231|516417472|FG001|Overall Study|Study Vaccination not Received|1|||
143236356|NCT03312231|516417473|FG002|Overall Study|Study Vaccination not Received|1|||
143236357|NCT03312231|516417474|FG003|Overall Study|Study Vaccination not Received|0|||
143236358|NCT03312231|516417475|FG004|Overall Study|Study Vaccination not Received|0|||
143236359|NCT05430854|516417483|FG000|Overall Study|Trial terminated by Sponsor|39|||
143236360|NCT05430854|516417484|FG001|Overall Study|Trial terminated by Sponsor|50|||
143363829|NCT00049517|516875455|FG005|Induction|Alternative therapy|2|||
143487594|NCT01425008|517327932|FG008|Dose Escalation Phase|Other|1|||
143487595|NCT01425008|517327933|FG009|Dose Escalation Phase|Other|0|||
143487596|NCT01425008|517327934|FG010|Dose Escalation Phase|Other|0|||
143487597|NCT01425008|517327935|FG011|Dose Escalation Phase|Other|0|||
143487598|NCT01425008|517327936|FG012|Dose Escalation Phase|Other|0|||
143487599|NCT01425008|517327937|FG013|Dose Escalation Phase|Other|0|||
143487600|NCT01425008|517327938|FG014|Dose Escalation Phase|Other|0|||
143487601|NCT01425008|517327939|FG015|Dose Escalation Phase|Other|0|||
143363830|NCT00049517|516875450|FG000|Induction|Other complicating disease|0|||
143487602|NCT01425008|517327940|FG016|Dose Escalation Phase|Other|0|||
143487603|NCT01425008|517327941|FG017|Dose Escalation Phase|Other|0|||
143487604|NCT01425008|517327942|FG018|Dose Escalation Phase|Other|0|||
143487605|NCT01425008|517327924|FG000|Dose Expansion Phase|Progressive Disease|0|||
143363831|NCT00049517|516875451|FG001|Induction|Other complicating disease|0|||
143487606|NCT01425008|517327925|FG001|Dose Expansion Phase|Progressive Disease|0|||
143487607|NCT01425008|517327926|FG002|Dose Expansion Phase|Progressive Disease|0|||
143487608|NCT01425008|517327927|FG003|Dose Expansion Phase|Progressive Disease|0|||
143487609|NCT01425008|517327928|FG004|Dose Expansion Phase|Progressive Disease|0|||
143487610|NCT01425008|517327929|FG005|Dose Expansion Phase|Progressive Disease|0|||
143487611|NCT01425008|517327930|FG006|Dose Expansion Phase|Progressive Disease|0|||
143487612|NCT01425008|517327931|FG007|Dose Expansion Phase|Progressive Disease|0|||
143487613|NCT01425008|517327932|FG008|Dose Expansion Phase|Progressive Disease|0|||
143487614|NCT01425008|517327933|FG009|Dose Expansion Phase|Progressive Disease|0|||
143487615|NCT01425008|517327934|FG010|Dose Expansion Phase|Progressive Disease|10|||
143487616|NCT01425008|517327935|FG011|Dose Expansion Phase|Progressive Disease|4|||
143487617|NCT01425008|517327936|FG012|Dose Expansion Phase|Progressive Disease|12|||
143487618|NCT01425008|517327937|FG013|Dose Expansion Phase|Progressive Disease|1|||
143487619|NCT01425008|517327938|FG014|Dose Expansion Phase|Progressive Disease|5|||
143487620|NCT01425008|517327939|FG015|Dose Expansion Phase|Progressive Disease|8|||
143487621|NCT01425008|517327940|FG016|Dose Expansion Phase|Progressive Disease|9|||
143487622|NCT01425008|517327941|FG017|Dose Expansion Phase|Progressive Disease|2|||
143487623|NCT01425008|517327942|FG018|Dose Expansion Phase|Progressive Disease|10|||
143487624|NCT01425008|517327924|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
143487625|NCT01425008|517327925|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
143487626|NCT01425008|517327926|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
143487627|NCT01425008|517327927|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
143487628|NCT01425008|517327928|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
143487629|NCT01425008|517327929|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
143487630|NCT01425008|517327930|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
143024884|NCT01689974|515631200|FG000|Overall Study|Termination of Study|5|||
143024885|NCT01689974|515631201|FG001|Overall Study|Termination of Study|5|||
143024886|NCT01333033|515631205|FG000|Overall Study|Ineligible|0|||
143024887|NCT01333033|515631206|FG001|Overall Study|Ineligible|0|||
143157516|NCT02675452|516121659|FG016|Overall Study|Withdrawal by Subject|2|||
143157517|NCT02675452|516121660|FG017|Overall Study|Withdrawal by Subject|0|||
143157518|NCT02675452|516121661|FG018|Overall Study|Withdrawal by Subject|0|||
143157519|NCT02675452|516121662|FG019|Overall Study|Withdrawal by Subject|0|||
143157520|NCT02675452|516121663|FG020|Overall Study|Withdrawal by Subject|0|||
143157521|NCT02675452|516121664|FG021|Overall Study|Withdrawal by Subject|0|||
143157522|NCT02675452|516121665|FG022|Overall Study|Withdrawal by Subject|3|||
143157523|NCT02675452|516121666|FG023|Overall Study|Withdrawal by Subject|0|||
143157524|NCT02675452|516121667|FG024|Overall Study|Withdrawal by Subject|1|||
143157525|NCT02675452|516121668|FG025|Overall Study|Withdrawal by Subject|0|||
143157526|NCT02675452|516121669|FG026|Overall Study|Withdrawal by Subject|1|||
143157527|NCT02675452|516121670|FG027|Overall Study|Withdrawal by Subject|3|||
143157528|NCT02675452|516121671|FG028|Overall Study|Withdrawal by Subject|4|||
143157529|NCT02675452|516121643|FG000|Overall Study|Death|0|||
143157530|NCT02675452|516121644|FG001|Overall Study|Death|0|||
143157531|NCT02675452|516121645|FG002|Overall Study|Death|1|||
143157532|NCT02675452|516121646|FG003|Overall Study|Death|0|||
143157533|NCT02675452|516121647|FG004|Overall Study|Death|0|||
143157534|NCT02675452|516121648|FG005|Overall Study|Death|1|||
143157535|NCT02675452|516121649|FG006|Overall Study|Death|0|||
143157536|NCT02675452|516121650|FG007|Overall Study|Death|0|||
143157537|NCT02675452|516121651|FG008|Overall Study|Death|1|||
143157538|NCT02675452|516121652|FG009|Overall Study|Death|0|||
143157539|NCT02675452|516121653|FG010|Overall Study|Death|0|||
143157540|NCT02675452|516121654|FG011|Overall Study|Death|0|||
143363832|NCT00049517|516875452|FG002|Induction|Other complicating disease|0|||
143363833|NCT00049517|516875453|FG003|Induction|Other complicating disease|0|||
143363834|NCT00049517|516875454|FG004|Induction|Other complicating disease|3|||
143363835|NCT00049517|516875455|FG005|Induction|Other complicating disease|0|||
143363836|NCT00049517|516875450|FG000|Induction|Reasons not reported|0|||
143363837|NCT00049517|516875451|FG001|Induction|Reasons not reported|0|||
143487631|NCT01425008|517327931|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
143487632|NCT01425008|517327932|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
143487633|NCT01425008|517327933|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
143024888|NCT01333033|515631207|FG002|Overall Study|Ineligible|0|||
143024889|NCT01333033|515631208|FG003|Overall Study|Ineligible|0|||
143024890|NCT01333033|515631209|FG004|Overall Study|Ineligible|6|||
143157541|NCT02675452|516121655|FG012|Overall Study|Death|1|||
143157542|NCT02675452|516121656|FG013|Overall Study|Death|0|||
143363838|NCT00049517|516875452|FG002|Induction|Reasons not reported|0|||
143157543|NCT02675452|516121657|FG014|Overall Study|Death|0|||
143157544|NCT02675452|516121658|FG015|Overall Study|Death|2|||
143157545|NCT02675452|516121659|FG016|Overall Study|Death|0|||
143363839|NCT00049517|516875453|FG003|Induction|Reasons not reported|0|||
143363840|NCT00049517|516875454|FG004|Induction|Reasons not reported|22|||
143363841|NCT00049517|516875455|FG005|Induction|Reasons not reported|25|||
143157546|NCT02675452|516121660|FG017|Overall Study|Death|0|||
143157547|NCT02675452|516121661|FG018|Overall Study|Death|4|||
143157548|NCT02675452|516121662|FG019|Overall Study|Death|3|||
143157549|NCT02675452|516121663|FG020|Overall Study|Death|3|||
143487634|NCT01425008|517327934|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
143487635|NCT01425008|517327935|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
143487636|NCT01425008|517327936|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
143487637|NCT01425008|517327937|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
143487638|NCT01425008|517327938|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
143487639|NCT01425008|517327939|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
143487640|NCT01425008|517327940|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
143487641|NCT01425008|517327941|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
143487642|NCT01425008|517327942|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
143487643|NCT01425008|517327924|FG000|Dose Expansion Phase|Other|0|||
143487644|NCT01425008|517327925|FG001|Dose Expansion Phase|Other|0|||
143487645|NCT01425008|517327926|FG002|Dose Expansion Phase|Other|0|||
143487646|NCT01425008|517327927|FG003|Dose Expansion Phase|Other|0|||
143487647|NCT01425008|517327928|FG004|Dose Expansion Phase|Other|0|||
143487648|NCT01425008|517327929|FG005|Dose Expansion Phase|Other|0|||
143487649|NCT01425008|517327930|FG006|Dose Expansion Phase|Other|0|||
143487650|NCT01425008|517327931|FG007|Dose Expansion Phase|Other|0|||
143487651|NCT01425008|517327932|FG008|Dose Expansion Phase|Other|0|||
143487652|NCT01425008|517327933|FG009|Dose Expansion Phase|Other|0|||
143487653|NCT01425008|517327934|FG010|Dose Expansion Phase|Other|0|||
143487654|NCT01425008|517327935|FG011|Dose Expansion Phase|Other|0|||
143487655|NCT01425008|517327936|FG012|Dose Expansion Phase|Other|1|||
143487656|NCT01425008|517327937|FG013|Dose Expansion Phase|Other|0|||
143487657|NCT01425008|517327938|FG014|Dose Expansion Phase|Other|0|||
143487658|NCT01425008|517327939|FG015|Dose Expansion Phase|Other|0|||
143487659|NCT01425008|517327940|FG016|Dose Expansion Phase|Other|2|||
143487660|NCT01425008|517327941|FG017|Dose Expansion Phase|Other|0|||
143487661|NCT01425008|517327942|FG018|Dose Expansion Phase|Other|4|||
143487662|NCT01425008|517327924|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
143487663|NCT01425008|517327925|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
143487664|NCT01425008|517327926|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
143487665|NCT01425008|517327927|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
143487666|NCT01425008|517327928|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
143487667|NCT01425008|517327929|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
143487668|NCT01425008|517327930|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
143487669|NCT01425008|517327931|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
143487670|NCT01425008|517327932|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
143487671|NCT01425008|517327933|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
143487672|NCT01425008|517327934|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
143487673|NCT01425008|517327935|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
143236361|NCT05430854|516417485|FG002|Overall Study|Trial terminated by Sponsor|46|||
143236362|NCT05430854|516417483|FG000|Overall Study|Withdrawal by Subject|0|||
143236363|NCT05430854|516417484|FG001|Overall Study|Withdrawal by Subject|3|||
143236364|NCT05430854|516417485|FG002|Overall Study|Withdrawal by Subject|0|||
143487674|NCT01425008|517327936|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
143487675|NCT01425008|517327937|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
143487676|NCT01425008|517327938|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
143487677|NCT01425008|517327939|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
143236365|NCT03472885|516417493|FG000|24-Week Treatment Period|Adverse Event|1|||
143236366|NCT02201953|516417494|FG000|Overall Study|Randomized but Never Treated|1|||
143236367|NCT02201953|516417495|FG001|Overall Study|Randomized but Never Treated|5|||
143236368|NCT02201953|516417494|FG000|Overall Study|Lack of Efficacy|9|||
143236369|NCT02201953|516417495|FG001|Overall Study|Lack of Efficacy|30|||
143236370|NCT02201953|516417494|FG000|Overall Study|Lost to Follow-up|8|||
143236371|NCT02201953|516417495|FG001|Overall Study|Lost to Follow-up|8|||
143236372|NCT02201953|516417494|FG000|Overall Study|Withdrew Consent|2|||
143236373|NCT02201953|516417495|FG001|Overall Study|Withdrew Consent|5|||
143236374|NCT02201953|516417494|FG000|Overall Study|Adverse Event|0|||
143236375|NCT02201953|516417495|FG001|Overall Study|Adverse Event|5|||
143487678|NCT01425008|517327940|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
143487679|NCT01425008|517327941|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
143487680|NCT01425008|517327942|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
143487681|NCT01425008|517327924|FG000|Dose Expansion Phase|Adverse Event|0|||
143487682|NCT01425008|517327925|FG001|Dose Expansion Phase|Adverse Event|0|||
143487683|NCT01425008|517327926|FG002|Dose Expansion Phase|Adverse Event|0|||
143487684|NCT01425008|517327927|FG003|Dose Expansion Phase|Adverse Event|0|||
143487685|NCT01425008|517327928|FG004|Dose Expansion Phase|Adverse Event|0|||
143487686|NCT01425008|517327929|FG005|Dose Expansion Phase|Adverse Event|0|||
143236376|NCT02201953|516417494|FG000|Overall Study|Death|0|||
143236377|NCT02201953|516417495|FG001|Overall Study|Death|3|||
143236378|NCT01586364|516419414|FG000|Overall Study|Withdrawal by Subject|40|||
143236379|NCT01586364|516419414|FG000|Overall Study|Adverse Event|37|||
143236380|NCT01586364|516419414|FG000|Overall Study|Lost to Follow-up|17|||
143487687|NCT01425008|517327930|FG006|Dose Expansion Phase|Adverse Event|0|||
143487688|NCT01425008|517327931|FG007|Dose Expansion Phase|Adverse Event|0|||
143487689|NCT01425008|517327932|FG008|Dose Expansion Phase|Adverse Event|0|||
143487690|NCT01425008|517327933|FG009|Dose Expansion Phase|Adverse Event|0|||
143487691|NCT01425008|517327934|FG010|Dose Expansion Phase|Adverse Event|2|||
143487692|NCT01425008|517327935|FG011|Dose Expansion Phase|Adverse Event|3|||
143487693|NCT01425008|517327936|FG012|Dose Expansion Phase|Adverse Event|3|||
143487694|NCT01425008|517327937|FG013|Dose Expansion Phase|Adverse Event|0|||
143487695|NCT01425008|517327938|FG014|Dose Expansion Phase|Adverse Event|1|||
143487696|NCT01425008|517327939|FG015|Dose Expansion Phase|Adverse Event|1|||
143487697|NCT01425008|517327940|FG016|Dose Expansion Phase|Adverse Event|5|||
143487698|NCT01425008|517327941|FG017|Dose Expansion Phase|Adverse Event|0|||
143487699|NCT01425008|517327942|FG018|Dose Expansion Phase|Adverse Event|3|||
143487700|NCT01425008|517327924|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
143487701|NCT01425008|517327925|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
143487702|NCT01425008|517327926|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
143487703|NCT01425008|517327927|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
143487704|NCT01425008|517327928|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
143487705|NCT01425008|517327929|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
143487706|NCT01425008|517327930|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
143487707|NCT01425008|517327931|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
143487708|NCT01425008|517327932|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
143487709|NCT01425008|517327933|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
143487710|NCT01425008|517327934|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
143487711|NCT01425008|517327935|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
143487712|NCT01425008|517327936|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
143487713|NCT01425008|517327937|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
143487714|NCT01425008|517327938|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
143487715|NCT01425008|517327939|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
143487716|NCT01425008|517327940|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
143487717|NCT01425008|517327941|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
143487718|NCT01425008|517327942|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
143487719|NCT01425008|517327924|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
143487720|NCT01425008|517327925|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
143487721|NCT01425008|517327926|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
143487722|NCT01425008|517327927|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
143487723|NCT01425008|517327928|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
143487724|NCT01425008|517327929|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
143487725|NCT01425008|517327930|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
143487726|NCT01425008|517327931|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
143487727|NCT01425008|517327932|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
143487728|NCT01425008|517327933|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
143487729|NCT01425008|517327934|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
143487730|NCT01425008|517327935|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
143487731|NCT01425008|517327936|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
143487732|NCT01425008|517327937|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
143236381|NCT01586364|516419414|FG000|Overall Study|Protocol Violation|16|||
143236382|NCT01586364|516419414|FG000|Overall Study|Lack of Efficacy|1|||
143236383|NCT01586364|516419414|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
143487733|NCT01425008|517327938|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
143487734|NCT01425008|517327939|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
143487735|NCT01425008|517327940|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
143487736|NCT01425008|517327941|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
143487737|NCT01425008|517327942|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
143487738|NCT00562588|517327943|FG000|Overall Study|Adverse Event|40|||
143487739|NCT00562588|517327944|FG001|Overall Study|Adverse Event|58|||
143487740|NCT00562588|517327943|FG000|Overall Study|Protocol Violation|30|||
143487741|NCT00562588|517327944|FG001|Overall Study|Protocol Violation|26|||
143487742|NCT00562588|517327943|FG000|Overall Study|Lost to Follow-up|12|||
143487743|NCT00562588|517327944|FG001|Overall Study|Lost to Follow-up|4|||
143487744|NCT00562588|517327943|FG000|Overall Study|Withdrawal by Subject|10|||
143157550|NCT02675452|516121664|FG021|Overall Study|Death|3|||
143157551|NCT02675452|516121665|FG022|Overall Study|Death|7|||
143157552|NCT02675452|516121666|FG023|Overall Study|Death|5|||
143157553|NCT02675452|516121667|FG024|Overall Study|Death|3|||
143157554|NCT02675452|516121668|FG025|Overall Study|Death|4|||
143157555|NCT02675452|516121669|FG026|Overall Study|Death|7|||
143157556|NCT02675452|516121670|FG027|Overall Study|Death|6|||
143157557|NCT02675452|516121671|FG028|Overall Study|Death|9|||
143157558|NCT02675452|516121643|FG000|Overall Study|Lost to Follow-up|0|||
143157559|NCT02675452|516121644|FG001|Overall Study|Lost to Follow-up|1|||
143157560|NCT02675452|516121645|FG002|Overall Study|Lost to Follow-up|0|||
143157561|NCT02675452|516121646|FG003|Overall Study|Lost to Follow-up|0|||
143157562|NCT02675452|516121647|FG004|Overall Study|Lost to Follow-up|0|||
143157563|NCT02675452|516121648|FG005|Overall Study|Lost to Follow-up|0|||
143157564|NCT02675452|516121649|FG006|Overall Study|Lost to Follow-up|0|||
143236384|NCT01586364|516419414|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
143236385|NCT01586364|516419414|FG000|Overall Study|Other-Site closure due to PI illness|1|||
143236386|NCT01586364|516419414|FG000|Overall Study|Other-PI discretion, site closing|2|||
143236387|NCT01586364|516419414|FG000|Overall Study|Other-Not specified|1|||
143236388|NCT00091949|516419415|FG000|Overall Study|Withdrawal by Subject|117|||
143236389|NCT00091949|516419416|FG001|Overall Study|Withdrawal by Subject|110|||
143236390|NCT00091949|516419415|FG000|Overall Study|Lost to Follow-up|58|||
143236391|NCT00091949|516419416|FG001|Overall Study|Lost to Follow-up|41|||
143236392|NCT05366738|516419417|FG000|Overall Study|Adverse Event|0|||
143236393|NCT05366738|516419418|FG001|Overall Study|Adverse Event|1|||
143236394|NCT05366738|516419419|FG002|Overall Study|Adverse Event|0|||
143236395|NCT05291520|516419420|FG000|Overall Study|Lost to Follow-up|0|||
143236396|NCT05291520|516419421|FG001|Overall Study|Lost to Follow-up|0|||
143236397|NCT05291520|516419422|FG002|Overall Study|Lost to Follow-up|1|||
143236398|NCT01347112|516419423|FG000|Overall Study|Withdrawal by Subject|1|||
143236399|NCT01347112|516419424|FG001|Overall Study|Withdrawal by Subject|7|||
143236400|NCT01347112|516419423|FG000|Overall Study|Lost to Follow-up|3|||
143236401|NCT01347112|516419424|FG001|Overall Study|Lost to Follow-up|5|||
143236402|NCT00696072|516419425|FG000|Overall Study|continuing active treatment|10|||
143236403|NCT00696072|516419426|FG001|Overall Study|continuing active treatment|13|||
143236404|NCT00696072|516419425|FG000|Overall Study|Adverse Event|10|||
143236405|NCT00696072|516419426|FG001|Overall Study|Adverse Event|6|||
143236406|NCT00696072|516419425|FG000|Overall Study|Patient Request|3|||
143236407|NCT00696072|516419426|FG001|Overall Study|Patient Request|7|||
143236408|NCT00696072|516419425|FG000|Overall Study|Investigator Request|1|||
143236409|NCT00696072|516419426|FG001|Overall Study|Investigator Request|4|||
143236410|NCT00696072|516419425|FG000|Overall Study|Sponsor Request|0|||
143236411|NCT00696072|516419426|FG001|Overall Study|Sponsor Request|1|||
143487745|NCT00562588|517327944|FG001|Overall Study|Withdrawal by Subject|9|||
143487746|NCT00562588|517327943|FG000|Overall Study|Other|0|||
143236412|NCT00696072|516419425|FG000|Overall Study|Disease Progression|32|||
143236413|NCT00696072|516419426|FG001|Overall Study|Disease Progression|30|||
143236414|NCT00696072|516419425|FG000|Overall Study|Non-specified|1|||
143236415|NCT00696072|516419426|FG001|Overall Study|Non-specified|2|||
143236416|NCT01597596|516419427|FG000|Overall Study|Study terminated by sponsor|1|||
143236417|NCT01597596|516419428|FG001|Overall Study|Study terminated by sponsor|0|||
143236418|NCT01597596|516419427|FG000|Overall Study|Physician Decision|0|||
143236419|NCT01597596|516419428|FG001|Overall Study|Physician Decision|1|||
143236420|NCT03591406|516419431|FG000|Overall Study|Adverse Event|5|||
143236421|NCT03591406|516419432|FG001|Overall Study|Adverse Event|3|||
143236422|NCT03591406|516419431|FG000|Overall Study|Protocol Violation|2|||
143236423|NCT03591406|516419432|FG001|Overall Study|Protocol Violation|1|||
143236424|NCT03591406|516419431|FG000|Overall Study|Withdrawal by Subject|0|||
143236425|NCT03591406|516419432|FG001|Overall Study|Withdrawal by Subject|5|||
143487747|NCT00562588|517327944|FG001|Overall Study|Other|2|||
143487748|NCT02867995|517327946|FG000|Overall Study|Withdrawal by Subject|0|||
143487749|NCT02867995|517327947|FG001|Overall Study|Withdrawal by Subject|1|||
143487750|NCT02867995|517327946|FG000|Overall Study|Lost to Follow-up|0|||
143487751|NCT02867995|517327947|FG001|Overall Study|Lost to Follow-up|2|||
143487752|NCT03315871|517327948|FG000|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
143487753|NCT03315871|517327949|FG001|PROSTVAC + CV301 + M7824|Withdrawal by Subject|2|||
143487754|NCT03315871|517327950|FG002|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
143487755|NCT03315871|517327948|FG000|PROSTVAC + CV301 + M7824|Adverse Event|0|||
143487756|NCT03315871|517327949|FG001|PROSTVAC + CV301 + M7824|Adverse Event|2|||
143487757|NCT03315871|517327950|FG002|PROSTVAC + CV301 + M7824|Adverse Event|0|||
143487758|NCT03315871|517327948|FG000|PROSTVAC + CV301 + M7824|Physician Decision|0|||
143487759|NCT03315871|517327949|FG001|PROSTVAC + CV301 + M7824|Physician Decision|1|||
143487760|NCT03315871|517327950|FG002|PROSTVAC + CV301 + M7824|Physician Decision|0|||
143487761|NCT03315871|517327948|FG000|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
143487762|NCT03315871|517327949|FG001|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|1|||
143236426|NCT01198795|516419442|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
143236427|NCT01198795|516419442|FG000|Overall Study|Withdrawal by Subject|17|||
143236428|NCT01198795|516419442|FG000|Overall Study|Lost to Follow-up|15|||
143236429|NCT01198795|516419442|FG000|Overall Study|Adverse Event|9|||
143236430|NCT01198795|516419442|FG000|Overall Study|Lack of Efficacy|5|||
143236431|NCT01198795|516419442|FG000|Overall Study|Protocol Violation|2|||
143487763|NCT03315871|517327950|FG002|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
143236432|NCT01198795|516419442|FG000|Overall Study|Other Reason|4|||
143236433|NCT01614886|516419444|FG000|Overall Study|Adverse Event|15|||
143236434|NCT01614886|516419445|FG001|Overall Study|Adverse Event|20|||
143236435|NCT01614886|516419444|FG000|Overall Study|Withdrawal by Subject|4|||
143236436|NCT01614886|516419445|FG001|Overall Study|Withdrawal by Subject|4|||
143236437|NCT01614886|516419444|FG000|Overall Study|Death|1|||
143236438|NCT01614886|516419445|FG001|Overall Study|Death|0|||
143487764|NCT03315871|517327948|FG000|PROSTVAC + CV301|Progressive disease|0|||
143236439|NCT01614886|516419444|FG000|Overall Study|Protocol deviation|0|||
143487765|NCT03315871|517327949|FG001|PROSTVAC + CV301|Progressive disease|0|||
143487766|NCT03315871|517327950|FG002|PROSTVAC + CV301|Progressive disease|1|||
143487767|NCT03315871|517327948|FG000|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
143487768|NCT03315871|517327949|FG001|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
143487769|NCT03315871|517327950|FG002|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|1|||
143487770|NCT04099251|517329448|FG000|Pre-Treatment|Other reasons|1|||
143487771|NCT04099251|517329449|FG001|Pre-Treatment|Other reasons|0|||
143487772|NCT04099251|517329448|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
143487773|NCT04099251|517329449|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
143487774|NCT04099251|517329448|FG000|Blinded Treatment Phase|Other reasons|16|||
143487775|NCT04099251|517329449|FG001|Blinded Treatment Phase|Other reasons|7|||
143487776|NCT04099251|517329448|FG000|Blinded Treatment Phase|Disease recurrence|26|||
143487777|NCT04099251|517329449|FG001|Blinded Treatment Phase|Disease recurrence|41|||
143487778|NCT04099251|517329448|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
143487779|NCT04099251|517329449|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
143487780|NCT04099251|517329448|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
143487781|NCT04099251|517329449|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
143487782|NCT04099251|517329448|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
143487783|NCT04099251|517329449|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
143487784|NCT04099251|517329448|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
143487785|NCT04099251|517329449|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
143487786|NCT04099251|517329448|FG000|Blinded Treatment Phase|Death|6|||
143487787|NCT04099251|517329449|FG001|Blinded Treatment Phase|Death|2|||
143487788|NCT04099251|517329448|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
143487789|NCT04099251|517329449|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
143487790|NCT04099251|517329448|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
143487791|NCT04099251|517329449|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
143487792|NCT04099251|517329448|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
143487793|NCT04099251|517329449|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
143487794|NCT04099251|517329448|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
143487795|NCT04099251|517329449|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
143487796|NCT04099251|517329448|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
143487797|NCT04099251|517329449|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
143487798|NCT04099251|517329448|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
143487799|NCT04099251|517329449|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
143487800|NCT04099251|517329448|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
143487801|NCT04099251|517329449|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
143487802|NCT04099251|517329448|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
143487803|NCT04099251|517329449|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
143487804|NCT04099251|517329448|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
143487805|NCT04099251|517329449|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
143487806|NCT05032157|517329450|FG000|Overall Study|Adverse Event|12|||
143487807|NCT05032157|517329451|FG001|Overall Study|Adverse Event|7|||
143487808|NCT05032157|517329450|FG000|Overall Study|Pregnancy|0|||
143487809|NCT05032157|517329451|FG001|Overall Study|Pregnancy|2|||
143487810|NCT05032157|517329450|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
143487811|NCT05032157|517329451|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
143236440|NCT01614886|516419445|FG001|Overall Study|Protocol deviation|2|||
143236441|NCT01527370|516419446|FG000|Overall Study|Withdrawal by Subject|4|||
143487812|NCT05032157|517329450|FG000|Overall Study|Protocol Deviation|8|||
143487813|NCT05032157|517329451|FG001|Overall Study|Protocol Deviation|4|||
143487814|NCT05032157|517329450|FG000|Overall Study|Lost to Follow-up|1|||
143487815|NCT05032157|517329451|FG001|Overall Study|Lost to Follow-up|3|||
143487816|NCT05032157|517329450|FG000|Overall Study|Physician Decision|7|||
143487817|NCT05032157|517329451|FG001|Overall Study|Physician Decision|2|||
143487818|NCT05032157|517329450|FG000|Overall Study|Patient Decision|38|||
143487819|NCT05032157|517329451|FG001|Overall Study|Patient Decision|19|||
143487820|NCT03657043|517329452|FG000|Overall Study|Withdrawal by Subject|1|||
143487821|NCT03657043|517329453|FG001|Overall Study|Withdrawal by Subject|1|||
143487822|NCT03657043|517329454|FG002|Overall Study|Withdrawal by Subject|0|||
143487823|NCT03657043|517329455|FG003|Overall Study|Withdrawal by Subject|0|||
143487824|NCT03657043|517329456|FG004|Overall Study|Withdrawal by Subject|4|||
143487825|NCT03657043|517329452|FG000|Overall Study|Study closure by Sponsor|0|||
143487826|NCT03657043|517329453|FG001|Overall Study|Study closure by Sponsor|2|||
143487827|NCT03657043|517329454|FG002|Overall Study|Study closure by Sponsor|0|||
143487828|NCT03657043|517329455|FG003|Overall Study|Study closure by Sponsor|0|||
143487829|NCT03657043|517329456|FG004|Overall Study|Study closure by Sponsor|17|||
143487830|NCT03657043|517329452|FG000|Overall Study|Lost to Follow-up|0|||
143487831|NCT03657043|517329453|FG001|Overall Study|Lost to Follow-up|0|||
143487832|NCT03657043|517329454|FG002|Overall Study|Lost to Follow-up|0|||
143487833|NCT03657043|517329455|FG003|Overall Study|Lost to Follow-up|0|||
143487834|NCT03657043|517329456|FG004|Overall Study|Lost to Follow-up|4|||
143487835|NCT03657043|517329452|FG000|Overall Study|Death|6|||
143487836|NCT03657043|517329453|FG001|Overall Study|Death|5|||
143487837|NCT03657043|517329454|FG002|Overall Study|Death|0|||
143487838|NCT03657043|517329455|FG003|Overall Study|Death|0|||
143487839|NCT03657043|517329456|FG004|Overall Study|Death|53|||
143487840|NCT03657043|517329452|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
143487841|NCT03657043|517329453|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
143487842|NCT03657043|517329454|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
143487843|NCT03657043|517329455|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
143487844|NCT03657043|517329456|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
143487845|NCT03657043|517329452|FG000|Overall Study|Adverse Event|0|||
143487846|NCT03657043|517329453|FG001|Overall Study|Adverse Event|0|||
143487847|NCT03657043|517329454|FG002|Overall Study|Adverse Event|0|||
143487848|NCT03657043|517329455|FG003|Overall Study|Adverse Event|0|||
143487849|NCT03657043|517329456|FG004|Overall Study|Adverse Event|2|||
143487850|NCT03657043|517329452|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
143487851|NCT03657043|517329453|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
143487852|NCT03657043|517329454|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
143487853|NCT03657043|517329455|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
143487854|NCT03657043|517329456|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
143487855|NCT03657043|517329452|FG000|Overall Study|Withdrawal - declined follow-up|0|||
143487856|NCT03657043|517329453|FG001|Overall Study|Withdrawal - declined follow-up|0|||
143487857|NCT03657043|517329454|FG002|Overall Study|Withdrawal - declined follow-up|0|||
143487858|NCT03657043|517329455|FG003|Overall Study|Withdrawal - declined follow-up|0|||
143487859|NCT03657043|517329456|FG004|Overall Study|Withdrawal - declined follow-up|1|||
143487860|NCT03047980|517329457|FG000|Overall Study|Adverse Event|1|||
143487861|NCT02627495|517329458|FG000|Overall Study|Withdrawal by Subject|4|||
143487862|NCT02164981|517329459|FG000|Started|Withdrawal by Subject|2|||
143487863|NCT02164981|517329460|FG001|Started|Withdrawal by Subject|1|||
143487864|NCT02164981|517329461|FG002|Started|Withdrawal by Subject|0|||
143487865|NCT02164981|517329459|FG000|Started|Protocol Violation|2|||
143487866|NCT02164981|517329460|FG001|Started|Protocol Violation|0|||
143487867|NCT02164981|517329461|FG002|Started|Protocol Violation|0|||
143487868|NCT02164981|517329459|FG000|Started|Adverse Event|1|||
143487869|NCT02164981|517329460|FG001|Started|Adverse Event|2|||
143487870|NCT02164981|517329461|FG002|Started|Adverse Event|0|||
143487871|NCT02164981|517329459|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
143487872|NCT02164981|517329460|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
143487873|NCT02164981|517329461|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
143487874|NCT02164981|517329459|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
143487875|NCT02164981|517329460|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
143487876|NCT02164981|517329461|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
143487877|NCT02164981|517329459|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
143487878|NCT02164981|517329460|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
143487879|NCT02164981|517329461|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
143487880|NCT01736579|517329462|FG000|Overall Study|Termination of Study by Sponsor|2|||
143487881|NCT01736579|517329463|FG001|Overall Study|Termination of Study by Sponsor|2|||
143487882|NCT02404103|517329466|FG000|Overall Study|Adverse Event|1|||
143487883|NCT02404103|517329467|FG001|Overall Study|Adverse Event|0|||
143487884|NCT02404103|517329466|FG000|Overall Study|Lost to Follow-up|3|||
143487885|NCT02404103|517329467|FG001|Overall Study|Lost to Follow-up|3|||
143487886|NCT01995071|517329468|FG000|Overall Study|Adverse Event|0|||
143487887|NCT01995071|517329469|FG001|Overall Study|Adverse Event|0|||
143487888|NCT01995071|517329470|FG002|Overall Study|Adverse Event|0|||
143487889|NCT01995071|517329471|FG003|Overall Study|Adverse Event|0|||
143487890|NCT01995071|517329472|FG004|Overall Study|Adverse Event|0|||
143487891|NCT01995071|517329473|FG005|Overall Study|Adverse Event|0|||
143487892|NCT01995071|517329474|FG006|Overall Study|Adverse Event|1|||
143487893|NCT01995071|517329475|FG007|Overall Study|Adverse Event|0|||
143487894|NCT01995071|517329476|FG008|Overall Study|Adverse Event|0|||
143487895|NCT01995071|517329477|FG009|Overall Study|Adverse Event|0|||
143157565|NCT02675452|516121650|FG007|Overall Study|Lost to Follow-up|0|||
143487896|NCT01995071|517329478|FG010|Overall Study|Adverse Event|0|||
143487897|NCT01995071|517329479|FG011|Overall Study|Adverse Event|0|||
143487898|NCT01995071|517329468|FG000|Overall Study|Moved|0|||
143487899|NCT01995071|517329469|FG001|Overall Study|Moved|0|||
143487900|NCT01995071|517329470|FG002|Overall Study|Moved|1|||
143487901|NCT01995071|517329471|FG003|Overall Study|Moved|0|||
143487902|NCT01995071|517329472|FG004|Overall Study|Moved|1|||
143487903|NCT01995071|517329473|FG005|Overall Study|Moved|0|||
143487904|NCT01995071|517329474|FG006|Overall Study|Moved|0|||
143157566|NCT02675452|516121651|FG008|Overall Study|Lost to Follow-up|0|||
143157567|NCT02675452|516121652|FG009|Overall Study|Lost to Follow-up|0|||
143157568|NCT02675452|516121653|FG010|Overall Study|Lost to Follow-up|0|||
143157569|NCT02675452|516121654|FG011|Overall Study|Lost to Follow-up|0|||
143157570|NCT02675452|516121655|FG012|Overall Study|Lost to Follow-up|1|||
143487905|NCT01995071|517329475|FG007|Overall Study|Moved|0|||
143487906|NCT01995071|517329476|FG008|Overall Study|Moved|0|||
143487907|NCT01995071|517329477|FG009|Overall Study|Moved|0|||
143487908|NCT01995071|517329478|FG010|Overall Study|Moved|1|||
143487909|NCT01995071|517329479|FG011|Overall Study|Moved|0|||
143487910|NCT01995071|517329468|FG000|Overall Study|Lost to Follow-up|1|||
143487911|NCT01995071|517329469|FG001|Overall Study|Lost to Follow-up|0|||
143487912|NCT01995071|517329470|FG002|Overall Study|Lost to Follow-up|0|||
143157571|NCT02675452|516121656|FG013|Overall Study|Lost to Follow-up|0|||
143157572|NCT02675452|516121657|FG014|Overall Study|Lost to Follow-up|0|||
143157573|NCT02675452|516121658|FG015|Overall Study|Lost to Follow-up|0|||
143157574|NCT02675452|516121659|FG016|Overall Study|Lost to Follow-up|0|||
143157575|NCT02675452|516121660|FG017|Overall Study|Lost to Follow-up|0|||
143157576|NCT02675452|516121661|FG018|Overall Study|Lost to Follow-up|0|||
143157577|NCT02675452|516121662|FG019|Overall Study|Lost to Follow-up|0|||
143157578|NCT02675452|516121663|FG020|Overall Study|Lost to Follow-up|0|||
143157579|NCT02675452|516121664|FG021|Overall Study|Lost to Follow-up|0|||
143157580|NCT02675452|516121665|FG022|Overall Study|Lost to Follow-up|0|||
143157581|NCT02675452|516121666|FG023|Overall Study|Lost to Follow-up|0|||
143157582|NCT02675452|516121667|FG024|Overall Study|Lost to Follow-up|0|||
143157583|NCT02675452|516121668|FG025|Overall Study|Lost to Follow-up|0|||
143157584|NCT02675452|516121669|FG026|Overall Study|Lost to Follow-up|1|||
143157585|NCT02675452|516121670|FG027|Overall Study|Lost to Follow-up|0|||
143157586|NCT02675452|516121671|FG028|Overall Study|Lost to Follow-up|0|||
143157587|NCT02675452|516121643|FG000|Overall Study|Other|0|||
143157588|NCT02675452|516121644|FG001|Overall Study|Other|0|||
143157589|NCT02675452|516121645|FG002|Overall Study|Other|0|||
143157590|NCT02675452|516121646|FG003|Overall Study|Other|0|||
143157591|NCT02675452|516121647|FG004|Overall Study|Other|0|||
143157592|NCT02675452|516121648|FG005|Overall Study|Other|0|||
143157593|NCT02675452|516121649|FG006|Overall Study|Other|0|||
143157594|NCT02675452|516121650|FG007|Overall Study|Other|0|||
143157595|NCT02675452|516121651|FG008|Overall Study|Other|0|||
143157596|NCT02675452|516121652|FG009|Overall Study|Other|0|||
143157597|NCT02675452|516121653|FG010|Overall Study|Other|0|||
143157598|NCT02675452|516121654|FG011|Overall Study|Other|0|||
143157599|NCT02675452|516121655|FG012|Overall Study|Other|0|||
143157600|NCT02675452|516121656|FG013|Overall Study|Other|0|||
143157601|NCT02675452|516121657|FG014|Overall Study|Other|0|||
143157602|NCT02675452|516121658|FG015|Overall Study|Other|0|||
143157603|NCT02675452|516121659|FG016|Overall Study|Other|0|||
143157604|NCT02675452|516121660|FG017|Overall Study|Other|0|||
143157605|NCT02675452|516121661|FG018|Overall Study|Other|0|||
143157606|NCT02675452|516121662|FG019|Overall Study|Other|0|||
143157607|NCT02675452|516121663|FG020|Overall Study|Other|0|||
143157608|NCT02675452|516121664|FG021|Overall Study|Other|0|||
143157609|NCT02675452|516121665|FG022|Overall Study|Other|0|||
143157610|NCT02675452|516121666|FG023|Overall Study|Other|0|||
143157611|NCT02675452|516121667|FG024|Overall Study|Other|0|||
143157612|NCT02675452|516121668|FG025|Overall Study|Other|0|||
143157613|NCT02675452|516121669|FG026|Overall Study|Other|1|||
143157614|NCT02675452|516121670|FG027|Overall Study|Other|0|||
143157615|NCT02675452|516121671|FG028|Overall Study|Other|0|||
143157616|NCT02975700|516121673|FG000|Overall Study|Adverse Event|1|||
143157617|NCT02975700|516121673|FG000|Overall Study|Progressive disease|3|||
143157618|NCT02975700|516121673|FG000|Overall Study|Failed screening criteria|2|||
143157619|NCT01541254|516121675|FG000|Overall Study|Withdrawal by Subject|1|||
143157620|NCT01541254|516121675|FG000|Overall Study|excluded - metal allergy|1|||
143157621|NCT01541254|516121675|FG000|Overall Study|enrolled after study closed|1|||
143157622|NCT01541254|516121675|FG000|Overall Study|GI bleed prior to procedure|1|||
143157623|NCT01541254|516121675|FG000|Overall Study|stent not required|1|||
143157624|NCT01541254|516121675|FG000|Overall Study|alternate stent used|1|||
143157625|NCT05737745|516121679|FG000|Overall Study|Withdrawal by Subject|0|||
143157626|NCT05737745|516121680|FG001|Overall Study|Withdrawal by Subject|6|||
143157627|NCT05737745|516121681|FG002|Overall Study|Withdrawal by Subject|1|||
143157628|NCT02021318|516121682|FG000|Overall Study|Adverse Event|2|||
143157629|NCT02021318|516121683|FG001|Overall Study|Adverse Event|1|||
143157630|NCT02021318|516121682|FG000|Overall Study|Death|33|||
143157631|NCT02021318|516121683|FG001|Overall Study|Death|34|||
143157632|NCT02021318|516121682|FG000|Overall Study|Lost to Follow-up|3|||
143157633|NCT02021318|516121683|FG001|Overall Study|Lost to Follow-up|3|||
143157634|NCT02021318|516121682|FG000|Overall Study|Progressive Disease|0|||
143157635|NCT02021318|516121683|FG001|Overall Study|Progressive Disease|1|||
143157636|NCT02021318|516121682|FG000|Overall Study|Withdrawal by Subject|30|||
143157637|NCT02021318|516121683|FG001|Overall Study|Withdrawal by Subject|18|||
143157638|NCT02021318|516121682|FG000|Overall Study|Physician Decision|3|||
143157639|NCT02021318|516121683|FG001|Overall Study|Physician Decision|3|||
143157640|NCT02021318|516121682|FG000|Overall Study|Miscellaneous|2|||
143157641|NCT02021318|516121683|FG001|Overall Study|Miscellaneous|3|||
143157642|NCT00689052|516121684|FG000|Overall Study|Adverse Event|4|||
143157643|NCT00689052|516121685|FG001|Overall Study|Adverse Event|6|||
143157644|NCT00689052|516121684|FG000|Overall Study|Protocol Violation|1|||
143487913|NCT01995071|517329471|FG003|Overall Study|Lost to Follow-up|0|||
143236442|NCT01527370|516419446|FG000|Overall Study|Physician Decision|1|||
143236443|NCT01527370|516419446|FG000|Overall Study|Death|1|||
143236444|NCT01472289|516419450|FG000|Overall Study|Death|2|||
143236445|NCT02435992|516419451|FG000|Overall Study|non compliance with protocol|2|||
143236446|NCT02435992|516419452|FG001|Overall Study|non compliance with protocol|0|||
143236447|NCT02435992|516419453|FG002|Overall Study|non compliance with protocol|1|||
143236448|NCT02435992|516419454|FG003|Overall Study|non compliance with protocol|0|||
143236449|NCT02435992|516419455|FG004|Overall Study|non compliance with protocol|0|||
143236450|NCT02435992|516419451|FG000|Overall Study|Adverse Event|11|||
143236451|NCT02435992|516419452|FG001|Overall Study|Adverse Event|6|||
143236452|NCT02435992|516419453|FG002|Overall Study|Adverse Event|12|||
143236453|NCT02435992|516419454|FG003|Overall Study|Adverse Event|0|||
143236454|NCT02435992|516419455|FG004|Overall Study|Adverse Event|0|||
143236455|NCT02435992|516419451|FG000|Overall Study|Lack of Efficacy|4|||
143236456|NCT02435992|516419452|FG001|Overall Study|Lack of Efficacy|10|||
143236457|NCT02435992|516419453|FG002|Overall Study|Lack of Efficacy|9|||
143236458|NCT02435992|516419454|FG003|Overall Study|Lack of Efficacy|0|||
143236459|NCT02435992|516419455|FG004|Overall Study|Lack of Efficacy|0|||
143236460|NCT02435992|516419451|FG000|Overall Study|Withdrawal by Subject|10|||
143236461|NCT02435992|516419452|FG001|Overall Study|Withdrawal by Subject|8|||
143236462|NCT02435992|516419453|FG002|Overall Study|Withdrawal by Subject|20|||
143236463|NCT02435992|516419454|FG003|Overall Study|Withdrawal by Subject|0|||
143236464|NCT02435992|516419455|FG004|Overall Study|Withdrawal by Subject|0|||
143236465|NCT02435992|516419451|FG000|Overall Study|Other Reason|1|||
143236466|NCT02435992|516419452|FG001|Overall Study|Other Reason|0|||
143236467|NCT02435992|516419453|FG002|Overall Study|Other Reason|0|||
143236468|NCT02435992|516419454|FG003|Overall Study|Other Reason|0|||
143236469|NCT02435992|516419455|FG004|Overall Study|Other Reason|0|||
143236470|NCT02435992|516419451|FG000|Overall Study|Physician Decision|0|||
143236471|NCT02435992|516419452|FG001|Overall Study|Physician Decision|0|||
143236472|NCT02435992|516419453|FG002|Overall Study|Physician Decision|1|||
143236473|NCT02435992|516419454|FG003|Overall Study|Physician Decision|0|||
143236474|NCT02435992|516419455|FG004|Overall Study|Physician Decision|0|||
143236475|NCT03873116|516419456|FG000|Part 1|Study drug discontinuation due to rash|0|||
143236476|NCT03873116|516419457|FG001|Part 1|Study drug discontinuation due to rash|0|||
143236477|NCT03873116|516419458|FG002|Part 1|Study drug discontinuation due to rash|0|||
143236478|NCT03873116|516419459|FG003|Part 1|Study drug discontinuation due to rash|0|||
143236479|NCT03873116|516419460|FG004|Part 1|Study drug discontinuation due to rash|0|||
143236480|NCT03873116|516419461|FG005|Part 1|Study drug discontinuation due to rash|1|||
143236481|NCT03873116|516419456|FG000|Part 2|Withdrawal by Subject|0|||
143236482|NCT03873116|516419457|FG001|Part 2|Withdrawal by Subject|0|||
143236483|NCT03873116|516419458|FG002|Part 2|Withdrawal by Subject|1|||
143236484|NCT03873116|516419459|FG003|Part 2|Withdrawal by Subject|0|||
143236485|NCT03873116|516419460|FG004|Part 2|Withdrawal by Subject|0|||
143236486|NCT03873116|516419461|FG005|Part 2|Withdrawal by Subject|0|||
143236487|NCT03873116|516419456|FG000|Part 2|Lab abnormality or AE|0|||
143236488|NCT03873116|516419457|FG001|Part 2|Lab abnormality or AE|0|||
143236489|NCT03873116|516419458|FG002|Part 2|Lab abnormality or AE|0|||
143236490|NCT03873116|516419459|FG003|Part 2|Lab abnormality or AE|0|||
143236491|NCT03873116|516419460|FG004|Part 2|Lab abnormality or AE|1|||
143236492|NCT03873116|516419461|FG005|Part 2|Lab abnormality or AE|0|||
143236493|NCT03873116|516419456|FG000|Part 3|Withdrawal by Subject|0|||
143236494|NCT03873116|516419457|FG001|Part 3|Withdrawal by Subject|0|||
143236495|NCT03873116|516419458|FG002|Part 3|Withdrawal by Subject|0|||
143236496|NCT03873116|516419459|FG003|Part 3|Withdrawal by Subject|0|||
143236497|NCT03873116|516419460|FG004|Part 3|Withdrawal by Subject|1|||
143236498|NCT03873116|516419461|FG005|Part 3|Withdrawal by Subject|0|||
143236499|NCT02531802|516419462|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
143236500|NCT02531802|516419463|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
143236501|NCT02531802|516419464|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
143236502|NCT02531802|516419465|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
143236503|NCT02531802|516419466|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
143236504|NCT02531802|516419467|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
143236505|NCT02531802|516419468|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
143236506|NCT02531802|516419469|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
143236507|NCT02531802|516419470|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
143236508|NCT02531802|516419471|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
143236509|NCT02531802|516419472|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
143236510|NCT02531802|516419473|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
143236511|NCT02531802|516419474|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
143236512|NCT02531802|516419475|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
143236513|NCT02531802|516419476|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
143236514|NCT02531802|516419477|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
143236515|NCT02531802|516419478|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
143487914|NCT01995071|517329472|FG004|Overall Study|Lost to Follow-up|0|||
143487915|NCT01995071|517329473|FG005|Overall Study|Lost to Follow-up|0|||
143487916|NCT01995071|517329474|FG006|Overall Study|Lost to Follow-up|0|||
143487917|NCT01995071|517329475|FG007|Overall Study|Lost to Follow-up|1|||
143487918|NCT01995071|517329476|FG008|Overall Study|Lost to Follow-up|1|||
143487919|NCT01995071|517329477|FG009|Overall Study|Lost to Follow-up|0|||
143487920|NCT01995071|517329478|FG010|Overall Study|Lost to Follow-up|0|||
143487921|NCT01995071|517329479|FG011|Overall Study|Lost to Follow-up|0|||
143487922|NCT01995071|517329468|FG000|Overall Study|Incarcerated|0|||
143487923|NCT01995071|517329469|FG001|Overall Study|Incarcerated|0|||
143487924|NCT01995071|517329470|FG002|Overall Study|Incarcerated|0|||
143487925|NCT01995071|517329471|FG003|Overall Study|Incarcerated|0|||
143487926|NCT01995071|517329472|FG004|Overall Study|Incarcerated|0|||
143487927|NCT01995071|517329473|FG005|Overall Study|Incarcerated|0|||
143487928|NCT01995071|517329474|FG006|Overall Study|Incarcerated|0|||
143487929|NCT01995071|517329475|FG007|Overall Study|Incarcerated|1|||
143487930|NCT01995071|517329476|FG008|Overall Study|Incarcerated|0|||
143487931|NCT01995071|517329477|FG009|Overall Study|Incarcerated|0|||
143487932|NCT01995071|517329478|FG010|Overall Study|Incarcerated|0|||
143487933|NCT01995071|517329479|FG011|Overall Study|Incarcerated|0|||
143487934|NCT02543528|517329485|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
143487935|NCT02543528|517329486|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
143487936|NCT02543528|517329487|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
143487937|NCT02543528|517329488|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
143487938|NCT02543528|517329489|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
143487939|NCT02543528|517329485|FG000|Adaptation Period|Lens Handling Difficultes|0|||
143487940|NCT02543528|517329486|FG001|Adaptation Period|Lens Handling Difficultes|0|||
143487941|NCT02543528|517329487|FG002|Adaptation Period|Lens Handling Difficultes|0|||
143487942|NCT02543528|517329488|FG003|Adaptation Period|Lens Handling Difficultes|0|||
143487943|NCT02543528|517329489|FG004|Adaptation Period|Lens Handling Difficultes|8|||
143487944|NCT02543528|517329485|FG000|Adaptation Period|Lost to Follow-up|0|||
143487945|NCT02543528|517329486|FG001|Adaptation Period|Lost to Follow-up|0|||
143487946|NCT02543528|517329487|FG002|Adaptation Period|Lost to Follow-up|0|||
143487947|NCT02543528|517329488|FG003|Adaptation Period|Lost to Follow-up|0|||
143487948|NCT02543528|517329489|FG004|Adaptation Period|Lost to Follow-up|14|||
143236516|NCT02531802|516419479|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
143236517|NCT02531802|516419480|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
143236518|NCT02531802|516419481|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
143236519|NCT02531802|516419482|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
143236520|NCT02531802|516419462|FG000|Received Vaccination 2|Physician Decision|0|||
143236521|NCT02531802|516419463|FG001|Received Vaccination 2|Physician Decision|0|||
143236522|NCT02531802|516419464|FG002|Received Vaccination 2|Physician Decision|0|||
143236523|NCT02531802|516419465|FG003|Received Vaccination 2|Physician Decision|0|||
143236524|NCT02531802|516419466|FG004|Received Vaccination 2|Physician Decision|0|||
143236525|NCT02531802|516419467|FG005|Received Vaccination 2|Physician Decision|1|||
143236526|NCT02531802|516419468|FG006|Received Vaccination 2|Physician Decision|0|||
143236527|NCT02531802|516419469|FG007|Received Vaccination 2|Physician Decision|0|||
143236528|NCT02531802|516419470|FG008|Received Vaccination 2|Physician Decision|0|||
143236529|NCT02531802|516419471|FG009|Received Vaccination 2|Physician Decision|2|||
143236530|NCT02531802|516419472|FG010|Received Vaccination 2|Physician Decision|0|||
143236531|NCT02531802|516419473|FG011|Received Vaccination 2|Physician Decision|0|||
143236532|NCT02531802|516419474|FG012|Received Vaccination 2|Physician Decision|0|||
143236533|NCT02531802|516419475|FG013|Received Vaccination 2|Physician Decision|1|||
143236534|NCT02531802|516419476|FG014|Received Vaccination 2|Physician Decision|0|||
143236535|NCT02531802|516419477|FG015|Received Vaccination 2|Physician Decision|0|||
143236536|NCT02531802|516419478|FG016|Received Vaccination 2|Physician Decision|0|||
143236537|NCT02531802|516419479|FG017|Received Vaccination 2|Physician Decision|1|||
143236538|NCT02531802|516419480|FG018|Received Vaccination 2|Physician Decision|0|||
143363842|NCT00049517|516875450|FG000|Conditioning/Transplant|Disease progression|14|||
143363843|NCT00049517|516875451|FG001|Conditioning/Transplant|Disease progression|6|||
143487949|NCT02543528|517329485|FG000|Adaptation Period|Adverse Event|0|||
143487950|NCT02543528|517329486|FG001|Adaptation Period|Adverse Event|0|||
143487951|NCT02543528|517329487|FG002|Adaptation Period|Adverse Event|0|||
143487952|NCT02543528|517329488|FG003|Adaptation Period|Adverse Event|0|||
143487953|NCT02543528|517329489|FG004|Adaptation Period|Adverse Event|2|||
143487954|NCT02543528|517329485|FG000|Extended Wear Period|Adverse Event|17|||
143487955|NCT02543528|517329486|FG001|Extended Wear Period|Adverse Event|11|||
143487956|NCT02543528|517329487|FG002|Extended Wear Period|Adverse Event|16|||
143487957|NCT02543528|517329488|FG003|Extended Wear Period|Adverse Event|3|||
143487958|NCT02543528|517329489|FG004|Extended Wear Period|Adverse Event|0|||
143487959|NCT02543528|517329485|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
143487960|NCT02543528|517329486|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
143487961|NCT02543528|517329487|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
143487962|NCT02543528|517329488|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
143487963|NCT02543528|517329489|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
143487964|NCT02543528|517329485|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
143487965|NCT02543528|517329486|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
143487966|NCT02543528|517329487|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
143487967|NCT02543528|517329488|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
143487968|NCT02543528|517329489|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
143487969|NCT02543528|517329485|FG000|Extended Wear Period|Lost to Follow-up|0|||
143487970|NCT02543528|517329486|FG001|Extended Wear Period|Lost to Follow-up|1|||
143487971|NCT02543528|517329487|FG002|Extended Wear Period|Lost to Follow-up|2|||
143487972|NCT02543528|517329488|FG003|Extended Wear Period|Lost to Follow-up|1|||
143487973|NCT02543528|517329489|FG004|Extended Wear Period|Lost to Follow-up|0|||
143487974|NCT02543528|517329485|FG000|Extended Wear Period|Withdrawal by Subject|10|||
143487975|NCT02543528|517329486|FG001|Extended Wear Period|Withdrawal by Subject|9|||
143487976|NCT02543528|517329487|FG002|Extended Wear Period|Withdrawal by Subject|4|||
143487977|NCT02543528|517329488|FG003|Extended Wear Period|Withdrawal by Subject|5|||
143487978|NCT02543528|517329489|FG004|Extended Wear Period|Withdrawal by Subject|0|||
143487979|NCT01408147|517329490|FG000|Overall Study|Withdrawal by Subject|0|||
143487980|NCT01408147|517329491|FG001|Overall Study|Withdrawal by Subject|1|||
143487981|NCT01042600|517329492|FG000|Overall Study|Ineligible|1|||
143487982|NCT01042600|517329493|FG001|Overall Study|Ineligible|0|||
143487983|NCT05048719|517329494|FG000|Overall Study|Withdrawal by Subject|2|||
143487984|NCT05048719|517329495|FG001|Overall Study|Withdrawal by Subject|1|||
143487985|NCT05048719|517329496|FG002|Overall Study|Withdrawal by Subject|3|||
143487986|NCT05048719|517329497|FG003|Overall Study|Withdrawal by Subject|1|||
143487987|NCT05048719|517329498|FG004|Overall Study|Withdrawal by Subject|0|||
143487988|NCT05048719|517329499|FG005|Overall Study|Withdrawal by Subject|2|||
143487989|NCT05048719|517329500|FG006|Overall Study|Withdrawal by Subject|1|||
143487990|NCT05048719|517329501|FG007|Overall Study|Withdrawal by Subject|1|||
143487991|NCT05048719|517329502|FG008|Overall Study|Withdrawal by Subject|0|||
143487992|NCT05048719|517329494|FG000|Overall Study|Death|1|||
143487993|NCT05048719|517329495|FG001|Overall Study|Death|0|||
143487994|NCT05048719|517329496|FG002|Overall Study|Death|0|||
143487995|NCT05048719|517329497|FG003|Overall Study|Death|0|||
143487996|NCT05048719|517329498|FG004|Overall Study|Death|0|||
143487997|NCT05048719|517329499|FG005|Overall Study|Death|0|||
143487998|NCT05048719|517329500|FG006|Overall Study|Death|0|||
143487999|NCT05048719|517329501|FG007|Overall Study|Death|0|||
143488000|NCT05048719|517329502|FG008|Overall Study|Death|0|||
143488001|NCT05048719|517329494|FG000|Overall Study|Adverse Event|0|||
143488002|NCT05048719|517329495|FG001|Overall Study|Adverse Event|1|||
143488003|NCT05048719|517329496|FG002|Overall Study|Adverse Event|2|||
143488004|NCT05048719|517329497|FG003|Overall Study|Adverse Event|0|||
143488005|NCT05048719|517329498|FG004|Overall Study|Adverse Event|1|||
143488006|NCT05048719|517329499|FG005|Overall Study|Adverse Event|0|||
143488007|NCT05048719|517329500|FG006|Overall Study|Adverse Event|0|||
143488008|NCT05048719|517329501|FG007|Overall Study|Adverse Event|0|||
143488009|NCT05048719|517329502|FG008|Overall Study|Adverse Event|0|||
143488010|NCT05048719|517329494|FG000|Overall Study|Lost to Follow-up|0|||
143488011|NCT05048719|517329495|FG001|Overall Study|Lost to Follow-up|0|||
143488012|NCT05048719|517329496|FG002|Overall Study|Lost to Follow-up|1|||
143488013|NCT05048719|517329497|FG003|Overall Study|Lost to Follow-up|3|||
143488014|NCT05048719|517329498|FG004|Overall Study|Lost to Follow-up|1|||
143488015|NCT05048719|517329499|FG005|Overall Study|Lost to Follow-up|1|||
143488016|NCT05048719|517329500|FG006|Overall Study|Lost to Follow-up|1|||
143488017|NCT05048719|517329501|FG007|Overall Study|Lost to Follow-up|1|||
143488018|NCT05048719|517329502|FG008|Overall Study|Lost to Follow-up|0|||
143488019|NCT05048719|517329494|FG000|Overall Study|Physician Decision|0|||
143488020|NCT05048719|517329495|FG001|Overall Study|Physician Decision|0|||
143488021|NCT05048719|517329496|FG002|Overall Study|Physician Decision|0|||
143488022|NCT05048719|517329497|FG003|Overall Study|Physician Decision|0|||
143488023|NCT05048719|517329498|FG004|Overall Study|Physician Decision|0|||
143488024|NCT05048719|517329499|FG005|Overall Study|Physician Decision|0|||
143024891|NCT01333033|515631210|FG005|Overall Study|Ineligible|8|||
143488025|NCT05048719|517329500|FG006|Overall Study|Physician Decision|0|||
143488026|NCT05048719|517329501|FG007|Overall Study|Physician Decision|1|||
143488027|NCT05048719|517329502|FG008|Overall Study|Physician Decision|1|||
143488028|NCT05048719|517329494|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
143488029|NCT05048719|517329495|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
143488030|NCT05048719|517329496|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
143488031|NCT05048719|517329497|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
143488032|NCT05048719|517329498|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
143488033|NCT05048719|517329499|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
143488034|NCT05048719|517329500|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
143488035|NCT05048719|517329501|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
143488036|NCT05048719|517329502|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
143488037|NCT05048719|517329494|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
143488038|NCT05048719|517329495|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
143488039|NCT05048719|517329496|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
143488040|NCT05048719|517329497|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
143488041|NCT05048719|517329498|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
143488042|NCT05048719|517329499|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
143488043|NCT05048719|517329500|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
143488044|NCT05048719|517329501|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
143488045|NCT05048719|517329502|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
143488046|NCT05048719|517329494|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
143488047|NCT05048719|517329495|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
143488048|NCT05048719|517329496|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
143488049|NCT05048719|517329497|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
143488050|NCT05048719|517329498|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
143488051|NCT05048719|517329499|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
143488052|NCT05048719|517329500|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
143488053|NCT05048719|517329501|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
143488054|NCT05048719|517329502|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
143488055|NCT05048719|517329494|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
143488056|NCT05048719|517329495|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
143488057|NCT05048719|517329496|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
143488058|NCT05048719|517329497|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
143488059|NCT05048719|517329498|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
143488060|NCT05048719|517329499|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
143488061|NCT05048719|517329500|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
143488062|NCT05048719|517329501|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
143488063|NCT05048719|517329502|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
143488064|NCT05048719|517329494|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
143488065|NCT05048719|517329495|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
143488066|NCT05048719|517329496|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
143488067|NCT05048719|517329497|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
143488068|NCT05048719|517329498|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
143488069|NCT05048719|517329499|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
143488070|NCT05048719|517329500|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
143488071|NCT05048719|517329501|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
143488072|NCT05048719|517329502|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
143488073|NCT03257267|517329503|FG000|Overall Study|Adverse Event|17|||
143488074|NCT03257267|517329504|FG001|Overall Study|Adverse Event|7|||
143488075|NCT03257267|517329503|FG000|Overall Study|Death|96|||
143488076|NCT03257267|517329504|FG001|Overall Study|Death|98|||
143488077|NCT03257267|517329503|FG000|Overall Study|Lost to Follow-up|2|||
143488078|NCT03257267|517329504|FG001|Overall Study|Lost to Follow-up|2|||
143488079|NCT03257267|517329503|FG000|Overall Study|Non-compliance with Study Drug|0|||
143488080|NCT03257267|517329504|FG001|Overall Study|Non-compliance with Study Drug|2|||
143488081|NCT03257267|517329503|FG000|Overall Study|Participant Decision|35|||
143488082|NCT03257267|517329504|FG001|Overall Study|Participant Decision|43|||
143488083|NCT03257267|517329503|FG000|Overall Study|Sponsor Decision|1|||
143488084|NCT03257267|517329504|FG001|Overall Study|Sponsor Decision|0|||
143488085|NCT03257267|517329503|FG000|Overall Study|Physician Decision|1|||
143488086|NCT03257267|517329504|FG001|Overall Study|Physician Decision|3|||
143488087|NCT03257267|517329503|FG000|Overall Study|Disease Progression|109|||
143488088|NCT03257267|517329504|FG001|Overall Study|Disease Progression|121|||
143488089|NCT03257267|517329503|FG000|Overall Study|Withdrawal by Subject|8|||
143488090|NCT03257267|517329504|FG001|Overall Study|Withdrawal by Subject|26|||
143488091|NCT03257267|517329503|FG000|Overall Study|Other|0|||
143488092|NCT03257267|517329504|FG001|Overall Study|Other|2|||
143488093|NCT02229552|517329505|FG000|Baseline|Withdrawal by Subject|6|||
143488094|NCT02229552|517329505|FG000|1-year Follow up|Withdrawal by Subject|7|||
143488095|NCT02229552|517329505|FG000|1-year Follow up|Lost to Follow-up|18|||
143488096|NCT02229552|517329505|FG000|2-Year Follow up|Withdrawal by Subject|9|||
143488097|NCT02229552|517329505|FG000|2-Year Follow up|Lost to Follow-up|17|||
143488098|NCT01982292|517329506|FG000|Overall Study|Adverse Event|2|||
143488099|NCT01982292|517329507|FG001|Overall Study|Adverse Event|0|||
143488100|NCT01982292|517329506|FG000|Overall Study|Death|1|||
143488101|NCT01982292|517329507|FG001|Overall Study|Death|0|||
143488102|NCT01982292|517329506|FG000|Overall Study|Lost to Follow-up|2|||
143488103|NCT01982292|517329507|FG001|Overall Study|Lost to Follow-up|0|||
143488104|NCT01982292|517329506|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
143488105|NCT01982292|517329507|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
143488106|NCT01982292|517329506|FG000|Overall Study|Protocol Deviation|1|||
143488107|NCT01982292|517329507|FG001|Overall Study|Protocol Deviation|0|||
143488108|NCT01982292|517329506|FG000|Overall Study|Patient/Guardian Decision|3|||
143488109|NCT01982292|517329507|FG001|Overall Study|Patient/Guardian Decision|1|||
143488110|NCT01982292|517329506|FG000|Overall Study|Technical Problems|2|||
143488111|NCT01982292|517329507|FG001|Overall Study|Technical Problems|0|||
143488112|NCT00971945|517329509|FG000|Overall Study|Progressive Disease|3|||
143488113|NCT00971945|517329509|FG000|Overall Study|Change in treatment policy|1|||
143488114|NCT00971945|517329509|FG000|Overall Study|Other reasons|2|||
143488115|NCT03354663|517329510|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
143488116|NCT03354663|517329510|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
143488117|NCT03354663|517329510|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
143488118|NCT03354663|517329510|FG000|Completed 30-day Visit|Missed Visit|1|||
143488119|NCT00746252|517329513|FG000|Overall Study|weight gain >7.5 %|1|||
143488120|NCT00746252|517329514|FG001|Overall Study|weight gain >7.5 %|2|||
143488121|NCT01391000|517329515|FG000|Overall Study|Lost to Follow-up|2|||
143488122|NCT01391000|517329516|FG001|Overall Study|Lost to Follow-up|0|||
143488123|NCT00082888|517329517|FG000|Overall Study|Ineligible|1|||
143488124|NCT00082888|517329518|FG001|Overall Study|Ineligible|0|||
143488125|NCT00082888|517329519|FG002|Overall Study|Ineligible|0|||
143488126|NCT02684981|517329520|FG000|Overall Study|Permanently discontinued the treatment|157|||
143488127|NCT02684981|517329521|FG001|Overall Study|Permanently discontinued the treatment|161|||
143488128|NCT02684981|517329522|FG002|Overall Study|Permanently discontinued the treatment|110|||
143488129|NCT02684981|517329520|FG000|Overall Study|Other|83|||
143488130|NCT02684981|517329521|FG001|Overall Study|Other|49|||
143488131|NCT02684981|517329522|FG002|Overall Study|Other|17|||
143488132|NCT00820898|517329525|FG000|Overall Study|Inelgible - wrong primary site|1|||
143488133|NCT00356278|517329528|FG000|Overall Study|Withdrawal by Subject|25|||
143488134|NCT00356278|517329529|FG001|Overall Study|Withdrawal by Subject|15|||
143488135|NCT00356278|517329530|FG002|Overall Study|Withdrawal by Subject|19|||
143488136|NCT00527605|517329531|FG000|Overall Study|Adverse Event|3|||
143488137|NCT00527605|517329532|FG001|Overall Study|Adverse Event|0|||
143488138|NCT00527605|517329531|FG000|Overall Study|Withdrawal by Subject|3|||
143488139|NCT00527605|517329532|FG001|Overall Study|Withdrawal by Subject|7|||
143488140|NCT00527605|517329531|FG000|Overall Study|Lost to Follow-up|6|||
143488141|NCT00527605|517329532|FG001|Overall Study|Lost to Follow-up|2|||
143488142|NCT00527605|517329531|FG000|Overall Study|Protocol Violation|1|||
143488143|NCT00527605|517329532|FG001|Overall Study|Protocol Violation|2|||
143488144|NCT03468309|517329533|FG000|Overall Study|Lost to Follow-up|4|||
143488145|NCT03468309|517329533|FG000|Overall Study|Withdrawal by Subject|2|||
143488146|NCT00179309|517329534|FG000|Treatment|Toxicity|2|||
143488147|NCT00179309|517329535|FG001|Treatment|Toxicity|3|||
143488148|NCT00179309|517329534|FG000|Treatment|Withdrawal by Subject|1|||
143488149|NCT00179309|517329535|FG001|Treatment|Withdrawal by Subject|2|||
143488150|NCT00179309|517329534|FG000|Treatment|Allergy|1|||
143488151|NCT00179309|517329535|FG001|Treatment|Allergy|0|||
143488152|NCT00488982|517329536|FG000|Course 1|Physician Decision|0|||
143488153|NCT00488982|517329537|FG001|Course 1|Physician Decision|2|||
143488154|NCT00488982|517329538|FG002|Course 1|Physician Decision|4|||
143488155|NCT00488982|517329536|FG000|Course 1|Withdrawal by Subject|0|||
143488156|NCT00488982|517329537|FG001|Course 1|Withdrawal by Subject|8|||
143488157|NCT00488982|517329538|FG002|Course 1|Withdrawal by Subject|2|||
143488158|NCT00488982|517329536|FG000|Course 1|nonprotocol therapy|0|||
143024892|NCT01333033|515631205|FG000|Overall Study|Withdrawal by Subject|0|||
143024893|NCT01333033|515631206|FG001|Overall Study|Withdrawal by Subject|0|||
143024894|NCT01333033|515631207|FG002|Overall Study|Withdrawal by Subject|0|||
143024895|NCT01333033|515631208|FG003|Overall Study|Withdrawal by Subject|0|||
143488159|NCT00488982|517329537|FG001|Course 1|nonprotocol therapy|2|||
143488160|NCT00488982|517329538|FG002|Course 1|nonprotocol therapy|2|||
143488161|NCT00488982|517329536|FG000|Course 1|Adverse Event|0|||
143488162|NCT00488982|517329537|FG001|Course 1|Adverse Event|0|||
143488163|NCT00488982|517329538|FG002|Course 1|Adverse Event|6|||
143157645|NCT00689052|516121685|FG001|Overall Study|Protocol Violation|0|||
143488164|NCT02669017|517329539|FG000|Overall Study|Death|1|||
143488165|NCT02669017|517329540|FG001|Overall Study|Death|2|||
143488166|NCT02669017|517329541|FG002|Overall Study|Death|2|||
143488167|NCT02669017|517329542|FG003|Overall Study|Death|3|||
143488168|NCT02669017|517329543|FG004|Overall Study|Death|8|||
143488169|NCT02669017|517329544|FG005|Overall Study|Death|18|||
143488170|NCT02669017|517329545|FG006|Overall Study|Death|10|||
143488171|NCT02669017|517329546|FG007|Overall Study|Death|47|||
143488172|NCT02669017|517329547|FG008|Overall Study|Death|20|||
143488173|NCT02669017|517329539|FG000|Overall Study|Withdrawal by Subject|0|||
143488174|NCT02669017|517329540|FG001|Overall Study|Withdrawal by Subject|0|||
143488175|NCT02669017|517329541|FG002|Overall Study|Withdrawal by Subject|0|||
143157646|NCT00689052|516121684|FG000|Overall Study|Lost to Follow-up|2|||
143488176|NCT02669017|517329542|FG003|Overall Study|Withdrawal by Subject|1|||
143488177|NCT02669017|517329543|FG004|Overall Study|Withdrawal by Subject|2|||
143488178|NCT02669017|517329544|FG005|Overall Study|Withdrawal by Subject|0|||
143488179|NCT02669017|517329545|FG006|Overall Study|Withdrawal by Subject|0|||
143488180|NCT02669017|517329546|FG007|Overall Study|Withdrawal by Subject|2|||
143488181|NCT02669017|517329547|FG008|Overall Study|Withdrawal by Subject|2|||
143236539|NCT02531802|516419481|FG019|Received Vaccination 2|Physician Decision|0|||
143236540|NCT02531802|516419482|FG020|Received Vaccination 2|Physician Decision|0|||
143236541|NCT02531802|516419462|FG000|Received Vaccination 2|Adverse Event|0|||
143236542|NCT02531802|516419463|FG001|Received Vaccination 2|Adverse Event|0|||
143236543|NCT02531802|516419464|FG002|Received Vaccination 2|Adverse Event|0|||
143236544|NCT02531802|516419465|FG003|Received Vaccination 2|Adverse Event|0|||
143488182|NCT02669017|517329539|FG000|Overall Study|Lost to Follow-up|0|||
143488183|NCT02669017|517329540|FG001|Overall Study|Lost to Follow-up|0|||
143488184|NCT02669017|517329541|FG002|Overall Study|Lost to Follow-up|0|||
143488185|NCT02669017|517329542|FG003|Overall Study|Lost to Follow-up|0|||
143488186|NCT02669017|517329543|FG004|Overall Study|Lost to Follow-up|0|||
143488187|NCT02669017|517329544|FG005|Overall Study|Lost to Follow-up|0|||
143488188|NCT02669017|517329545|FG006|Overall Study|Lost to Follow-up|0|||
143488189|NCT02669017|517329546|FG007|Overall Study|Lost to Follow-up|0|||
143488190|NCT02669017|517329547|FG008|Overall Study|Lost to Follow-up|1|||
143488191|NCT02669017|517329539|FG000|Overall Study|Miscellaneous|0|||
143488192|NCT02669017|517329540|FG001|Overall Study|Miscellaneous|0|||
143488193|NCT02669017|517329541|FG002|Overall Study|Miscellaneous|0|||
143488194|NCT02669017|517329542|FG003|Overall Study|Miscellaneous|0|||
143488195|NCT02669017|517329543|FG004|Overall Study|Miscellaneous|2|||
143488196|NCT02669017|517329544|FG005|Overall Study|Miscellaneous|1|||
143488197|NCT02669017|517329545|FG006|Overall Study|Miscellaneous|1|||
143488198|NCT02669017|517329546|FG007|Overall Study|Miscellaneous|13|||
143488199|NCT02669017|517329547|FG008|Overall Study|Miscellaneous|2|||
143488200|NCT01709149|517329550|FG000|Open-label Lead-in Phase|Adverse Event|109|||
143488201|NCT01709149|517329551|FG001|Open-label Lead-in Phase|Adverse Event|0|||
143488202|NCT01709149|517329552|FG002|Open-label Lead-in Phase|Adverse Event|0|||
143236545|NCT02531802|516419466|FG004|Received Vaccination 2|Adverse Event|0|||
143236546|NCT02531802|516419467|FG005|Received Vaccination 2|Adverse Event|2|||
143236547|NCT02531802|516419468|FG006|Received Vaccination 2|Adverse Event|0|||
143236548|NCT02531802|516419469|FG007|Received Vaccination 2|Adverse Event|0|||
143236549|NCT02531802|516419470|FG008|Received Vaccination 2|Adverse Event|0|||
143236550|NCT02531802|516419471|FG009|Received Vaccination 2|Adverse Event|0|||
143236551|NCT02531802|516419472|FG010|Received Vaccination 2|Adverse Event|0|||
143236552|NCT02531802|516419473|FG011|Received Vaccination 2|Adverse Event|0|||
143236553|NCT02531802|516419474|FG012|Received Vaccination 2|Adverse Event|0|||
143236554|NCT02531802|516419475|FG013|Received Vaccination 2|Adverse Event|0|||
143236555|NCT02531802|516419476|FG014|Received Vaccination 2|Adverse Event|0|||
143236556|NCT02531802|516419477|FG015|Received Vaccination 2|Adverse Event|0|||
143236557|NCT02531802|516419478|FG016|Received Vaccination 2|Adverse Event|0|||
143236558|NCT02531802|516419479|FG017|Received Vaccination 2|Adverse Event|2|||
143236559|NCT02531802|516419480|FG018|Received Vaccination 2|Adverse Event|1|||
143236560|NCT02531802|516419481|FG019|Received Vaccination 2|Adverse Event|0|||
143236561|NCT02531802|516419482|FG020|Received Vaccination 2|Adverse Event|1|||
143236562|NCT02531802|516419462|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
143236563|NCT02531802|516419463|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
143236564|NCT02531802|516419464|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
143236565|NCT02531802|516419465|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
143236566|NCT02531802|516419466|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
143236567|NCT02531802|516419467|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
143488203|NCT01709149|517329550|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
143488204|NCT01709149|517329551|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
143488205|NCT01709149|517329552|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
143488206|NCT01709149|517329550|FG000|Open-label Lead-in Phase|Death|1|||
143236568|NCT02531802|516419468|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
143236569|NCT02531802|516419469|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
143236570|NCT02531802|516419470|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
143236571|NCT02531802|516419471|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
143236572|NCT02531802|516419472|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
143236573|NCT02531802|516419473|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
143236574|NCT02531802|516419474|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
143236575|NCT02531802|516419475|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
143236576|NCT02531802|516419476|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
143488207|NCT01709149|517329551|FG001|Open-label Lead-in Phase|Death|0|||
143488208|NCT01709149|517329552|FG002|Open-label Lead-in Phase|Death|0|||
143488209|NCT01709149|517329550|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
143488210|NCT01709149|517329551|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
143488211|NCT01709149|517329552|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
143488212|NCT01709149|517329550|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
143024896|NCT01333033|515631209|FG004|Overall Study|Withdrawal by Subject|4|||
143236577|NCT02531802|516419477|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
143236578|NCT02531802|516419478|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
143236579|NCT02531802|516419479|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
143236580|NCT02531802|516419480|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
143236581|NCT02531802|516419481|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
143236582|NCT02531802|516419482|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
143236583|NCT01523366|516419483|FG000|Treatment Period 1|Withdrawal by Subject|1|||
143236584|NCT01523366|516419484|FG001|Treatment Period 1|Withdrawal by Subject|0|||
143236585|NCT01523366|516419483|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
143236586|NCT01523366|516419484|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
143236587|NCT00071058|516419491|FG000|Overall Study|brain tumor-removed from study|1|||
143236588|NCT01210313|516419497|FG000|Overall Study|Withdrawal by Subject|3|||
143236589|NCT01210313|516419497|FG000|Overall Study|Adverse Event|2|||
143236590|NCT01210313|516419497|FG000|Overall Study|Distant recurrence|4|||
143236591|NCT01210313|516419497|FG000|Overall Study|Non-compliance|7|||
143236592|NCT04189952|516419500|FG000|Follow-up Period|Death|1|||
143236593|NCT04189952|516419500|FG000|Follow-up Period|Withdrawal by Subject|1|||
143236594|NCT00870740|516419501|FG000|Overall Study|Adverse Event|2|||
143236595|NCT00870740|516419502|FG001|Overall Study|Adverse Event|1|||
143236596|NCT00870740|516419503|FG002|Overall Study|Adverse Event|3|||
143236597|NCT00870740|516419504|FG003|Overall Study|Adverse Event|2|||
143236598|NCT00870740|516419505|FG004|Overall Study|Adverse Event|1|||
143236599|NCT00870740|516419506|FG005|Overall Study|Adverse Event|6|||
143236600|NCT00870740|516419501|FG000|Overall Study|Consent Withdrawn|6|||
143236601|NCT00870740|516419502|FG001|Overall Study|Consent Withdrawn|3|||
143236602|NCT00870740|516419503|FG002|Overall Study|Consent Withdrawn|4|||
143236603|NCT00870740|516419504|FG003|Overall Study|Consent Withdrawn|6|||
143236604|NCT00870740|516419505|FG004|Overall Study|Consent Withdrawn|6|||
143236605|NCT00870740|516419506|FG005|Overall Study|Consent Withdrawn|5|||
143236606|NCT00870740|516419501|FG000|Overall Study|Investigator Decision|2|||
143236607|NCT00870740|516419502|FG001|Overall Study|Investigator Decision|0|||
143236608|NCT00870740|516419503|FG002|Overall Study|Investigator Decision|1|||
143236609|NCT00870740|516419504|FG003|Overall Study|Investigator Decision|0|||
143236610|NCT00870740|516419505|FG004|Overall Study|Investigator Decision|0|||
143236611|NCT00870740|516419506|FG005|Overall Study|Investigator Decision|0|||
143236612|NCT00870740|516419501|FG000|Overall Study|Subject Non-compliance|0|||
143236613|NCT00870740|516419502|FG001|Overall Study|Subject Non-compliance|0|||
143236614|NCT00870740|516419503|FG002|Overall Study|Subject Non-compliance|0|||
143488213|NCT01709149|517329551|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
143488214|NCT01709149|517329552|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
143488215|NCT01709149|517329550|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
143488216|NCT01709149|517329551|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
143488217|NCT01709149|517329552|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
143488218|NCT01709149|517329550|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
143024897|NCT01333033|515631210|FG005|Overall Study|Withdrawal by Subject|2|||
143024898|NCT01333033|515631205|FG000|Overall Study|PET inevaluable|0|||
143236615|NCT00870740|516419504|FG003|Overall Study|Subject Non-compliance|0|||
143236616|NCT00870740|516419505|FG004|Overall Study|Subject Non-compliance|0|||
143236617|NCT00870740|516419506|FG005|Overall Study|Subject Non-compliance|1|||
143236618|NCT00870740|516419501|FG000|Overall Study|Death|0|||
143236619|NCT00870740|516419502|FG001|Overall Study|Death|0|||
143236620|NCT00870740|516419503|FG002|Overall Study|Death|0|||
143236621|NCT00870740|516419504|FG003|Overall Study|Death|0|||
143236622|NCT00870740|516419505|FG004|Overall Study|Death|1|||
143236623|NCT00870740|516419506|FG005|Overall Study|Death|0|||
143236624|NCT00870740|516419501|FG000|Overall Study|Other|2|||
143488219|NCT01709149|517329551|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
143488220|NCT01709149|517329552|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
143488221|NCT01709149|517329550|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
143488222|NCT01709149|517329551|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
143236625|NCT00870740|516419502|FG001|Overall Study|Other|5|||
143236626|NCT00870740|516419503|FG002|Overall Study|Other|2|||
143236627|NCT00870740|516419504|FG003|Overall Study|Other|4|||
143236628|NCT00870740|516419505|FG004|Overall Study|Other|3|||
143236629|NCT00870740|516419506|FG005|Overall Study|Other|5|||
143236630|NCT04298697|516419513|FG000|Overall Study|Lost to Follow-up|5|||
143236631|NCT04298697|516419514|FG001|Overall Study|Lost to Follow-up|5|||
143024899|NCT01333033|515631206|FG001|Overall Study|PET inevaluable|0|||
143236632|NCT04298697|516419515|FG002|Overall Study|Lost to Follow-up|1|||
143236633|NCT04298697|516419516|FG003|Overall Study|Lost to Follow-up|0|||
143236634|NCT04298697|516419513|FG000|Overall Study|Withdrawal by Subject|0|||
143236635|NCT04298697|516419514|FG001|Overall Study|Withdrawal by Subject|3|||
143024900|NCT01333033|515631207|FG002|Overall Study|PET inevaluable|0|||
143236636|NCT04298697|516419515|FG002|Overall Study|Withdrawal by Subject|2|||
143236637|NCT04298697|516419516|FG003|Overall Study|Withdrawal by Subject|3|||
143488223|NCT01709149|517329552|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
143488224|NCT01709149|517329550|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
143488225|NCT01709149|517329551|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
143488226|NCT01709149|517329552|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
143488227|NCT01709149|517329550|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
143488228|NCT01709149|517329551|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
143488229|NCT01709149|517329552|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
143488230|NCT01425203|517329553|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
143488231|NCT01425203|517329554|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
143488232|NCT01425203|517329555|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
143488233|NCT01425203|517329553|FG000|Treatment Phase|Failure at futility timepoint|8|||
143488234|NCT01425203|517329554|FG001|Treatment Phase|Failure at futility timepoint|27|||
143488235|NCT01425203|517329555|FG002|Treatment Phase|Failure at futility timepoint|0|||
143488236|NCT01425203|517329553|FG000|Treatment Phase|Other virologic failure criteria|5|||
143024901|NCT01333033|515631208|FG003|Overall Study|PET inevaluable|0|||
143024902|NCT01333033|515631209|FG004|Overall Study|PET inevaluable|2|||
143024903|NCT01333033|515631210|FG005|Overall Study|PET inevaluable|4|||
143024904|NCT01333033|515631205|FG000|Overall Study|Adverse Event|0|||
143488237|NCT01425203|517329554|FG001|Treatment Phase|Other virologic failure criteria|3|||
143488238|NCT01425203|517329555|FG002|Treatment Phase|Other virologic failure criteria|0|||
143488239|NCT01425203|517329553|FG000|Treatment Phase|Unidentified reasons|11|||
143488240|NCT01425203|517329554|FG001|Treatment Phase|Unidentified reasons|5|||
143488241|NCT01425203|517329555|FG002|Treatment Phase|Unidentified reasons|0|||
143488242|NCT01425203|517329553|FG000|Treatment Phase|Did not receive treatment|0|||
143488243|NCT01425203|517329554|FG001|Treatment Phase|Did not receive treatment|1|||
143488244|NCT01425203|517329555|FG002|Treatment Phase|Did not receive treatment|0|||
143488245|NCT01425203|517329553|FG000|Crossover Phase|Failure at futility timepoint|0|||
143488246|NCT01425203|517329554|FG001|Crossover Phase|Failure at futility timepoint|0|||
143488247|NCT01425203|517329555|FG002|Crossover Phase|Failure at futility timepoint|3|||
143488248|NCT01425203|517329553|FG000|Crossover Phase|Other virologic failure criteria|0|||
143488249|NCT01425203|517329554|FG001|Crossover Phase|Other virologic failure criteria|0|||
143488250|NCT01425203|517329555|FG002|Crossover Phase|Other virologic failure criteria|3|||
143488251|NCT03603496|517329559|FG000|Overall Study|Death|19|||
143488252|NCT03603496|517329560|FG001|Overall Study|Death|24|||
143488253|NCT03603496|517329559|FG000|Overall Study|Lost to Follow-up|141|||
143488254|NCT03603496|517329560|FG001|Overall Study|Lost to Follow-up|141|||
143488255|NCT03603496|517329559|FG000|Overall Study|Withdrawal by Subject|26|||
143488256|NCT03603496|517329560|FG001|Overall Study|Withdrawal by Subject|20|||
143488257|NCT00075504|517329561|FG000|Overall Study|Withdrawal by Subject|9|||
143488258|NCT00075504|517329562|FG001|Overall Study|Withdrawal by Subject|7|||
143488259|NCT02228590|517329563|FG000|Overall Study|Withdrawal by Subject|1|||
143488260|NCT00960843|517329573|FG000|Overall Study|Lost to Follow-up|2|||
143488261|NCT00960843|517329574|FG001|Overall Study|Lost to Follow-up|0|||
143488262|NCT00960843|517329573|FG000|Overall Study|Protocol Violation|0|||
143488263|NCT00960843|517329574|FG001|Overall Study|Protocol Violation|4|||
143488264|NCT00960843|517329573|FG000|Overall Study|Repeated needle dislodgment|0|||
143488265|NCT00960843|517329574|FG001|Overall Study|Repeated needle dislodgment|1|||
143488266|NCT00652366|517329575|FG000|Overall Study|Adverse Event|8|||
143488267|NCT00652366|517329576|FG001|Overall Study|Adverse Event|4|||
143488268|NCT00652366|517329577|FG002|Overall Study|Adverse Event|7|||
143488269|NCT00652366|517329578|FG003|Overall Study|Adverse Event|17|||
143488270|NCT00652366|517329579|FG004|Overall Study|Adverse Event|13|||
143488271|NCT00652366|517329575|FG000|Overall Study|Death|5|||
143488272|NCT00652366|517329576|FG001|Overall Study|Death|4|||
143488273|NCT00652366|517329577|FG002|Overall Study|Death|1|||
143488274|NCT00652366|517329578|FG003|Overall Study|Death|8|||
143488275|NCT00652366|517329579|FG004|Overall Study|Death|5|||
143488276|NCT00652366|517329575|FG000|Overall Study|Lack of Efficacy|84|||
143488277|NCT00652366|517329576|FG001|Overall Study|Lack of Efficacy|58|||
143488278|NCT00652366|517329577|FG002|Overall Study|Lack of Efficacy|53|||
143488279|NCT00652366|517329578|FG003|Overall Study|Lack of Efficacy|133|||
143488280|NCT00652366|517329579|FG004|Overall Study|Lack of Efficacy|13|||
143024905|NCT01333033|515631206|FG001|Overall Study|Adverse Event|0|||
143024906|NCT01333033|515631207|FG002|Overall Study|Adverse Event|0|||
143024907|NCT01333033|515631208|FG003|Overall Study|Adverse Event|0|||
143488281|NCT00652366|517329575|FG000|Overall Study|Violation of Selection Criteria|0|||
143488282|NCT00652366|517329576|FG001|Overall Study|Violation of Selection Criteria|0|||
143488283|NCT00652366|517329577|FG002|Overall Study|Violation of Selection Criteria|1|||
143488284|NCT00652366|517329578|FG003|Overall Study|Violation of Selection Criteria|0|||
143488285|NCT00652366|517329579|FG004|Overall Study|Violation of Selection Criteria|0|||
143488286|NCT00652366|517329575|FG000|Overall Study|Protocol Violation|1|||
143488287|NCT00652366|517329576|FG001|Overall Study|Protocol Violation|0|||
143488288|NCT00652366|517329577|FG002|Overall Study|Protocol Violation|0|||
143488289|NCT00652366|517329578|FG003|Overall Study|Protocol Violation|0|||
143488290|NCT00652366|517329579|FG004|Overall Study|Protocol Violation|0|||
143488291|NCT00652366|517329575|FG000|Overall Study|Refused treatment|3|||
143488292|NCT00652366|517329576|FG001|Overall Study|Refused treatment|7|||
143488293|NCT00652366|517329577|FG002|Overall Study|Refused treatment|6|||
143488294|NCT00652366|517329578|FG003|Overall Study|Refused treatment|17|||
143488295|NCT00652366|517329579|FG004|Overall Study|Refused treatment|5|||
143488296|NCT00652366|517329575|FG000|Overall Study|Other|5|||
143488297|NCT00652366|517329576|FG001|Overall Study|Other|2|||
143488298|NCT00652366|517329577|FG002|Overall Study|Other|3|||
143488299|NCT00652366|517329578|FG003|Overall Study|Other|4|||
143488300|NCT00652366|517329579|FG004|Overall Study|Other|0|||
143488301|NCT03861559|517329590|FG000|Overall Study|Adverse Event|0|||
143488302|NCT03861559|517329591|FG001|Overall Study|Adverse Event|2|||
143488303|NCT03861559|517329590|FG000|Overall Study|Treatment failure|0|||
143488304|NCT03861559|517329591|FG001|Overall Study|Treatment failure|2|||
143488305|NCT03861559|517329590|FG000|Overall Study|Noncompliance|1|||
143488306|NCT03861559|517329591|FG001|Overall Study|Noncompliance|1|||
143488307|NCT03861559|517329590|FG000|Overall Study|Did not meet eligibility requirements|1|||
143488308|NCT03861559|517329591|FG001|Overall Study|Did not meet eligibility requirements|0|||
143488309|NCT00879697|517329595|FG000|Overall Study|Physician Decision|2|||
143488310|NCT00879697|517329596|FG001|Overall Study|Physician Decision|2|||
143488311|NCT02500121|517329597|FG000|Overall Study|Lost to Follow-up|0|||
143488312|NCT02500121|517329598|FG001|Overall Study|Lost to Follow-up|1|||
143488313|NCT02500121|517329597|FG000|Overall Study|Withdrawal by Subject|1|||
143488314|NCT02500121|517329598|FG001|Overall Study|Withdrawal by Subject|1|||
143488315|NCT02500121|517329597|FG000|Overall Study|Death|26|||
143488316|NCT02500121|517329598|FG001|Overall Study|Death|24|||
143488317|NCT01437397|517329600|FG000|Overall Study|Lost to Follow-up|9|||
143488318|NCT01437397|517329601|FG001|Overall Study|Lost to Follow-up|4|||
143488319|NCT01437397|517329602|FG002|Overall Study|Lost to Follow-up|2|||
143488320|NCT01437397|517329603|FG003|Overall Study|Lost to Follow-up|4|||
143488321|NCT01437397|517329604|FG004|Overall Study|Lost to Follow-up|5|||
143488322|NCT01437397|517329600|FG000|Overall Study|Withdrawal by Subject|11|||
143488323|NCT01437397|517329601|FG001|Overall Study|Withdrawal by Subject|12|||
143488324|NCT01437397|517329602|FG002|Overall Study|Withdrawal by Subject|24|||
143488325|NCT01437397|517329603|FG003|Overall Study|Withdrawal by Subject|11|||
143488326|NCT01437397|517329604|FG004|Overall Study|Withdrawal by Subject|22|||
143488327|NCT01437397|517329600|FG000|Overall Study|Protocol Violation|10|||
143488328|NCT01437397|517329601|FG001|Overall Study|Protocol Violation|12|||
143488329|NCT01437397|517329602|FG002|Overall Study|Protocol Violation|13|||
143488330|NCT01437397|517329603|FG003|Overall Study|Protocol Violation|21|||
143488331|NCT01437397|517329604|FG004|Overall Study|Protocol Violation|19|||
143488332|NCT01437397|517329600|FG000|Overall Study|Lack of Efficacy|5|||
143488333|NCT01437397|517329601|FG001|Overall Study|Lack of Efficacy|4|||
143488334|NCT01437397|517329602|FG002|Overall Study|Lack of Efficacy|8|||
143488335|NCT01437397|517329603|FG003|Overall Study|Lack of Efficacy|10|||
143488336|NCT01437397|517329604|FG004|Overall Study|Lack of Efficacy|20|||
143488337|NCT01437397|517329600|FG000|Overall Study|Adverse Event|21|||
143488338|NCT01437397|517329601|FG001|Overall Study|Adverse Event|22|||
143488339|NCT01437397|517329602|FG002|Overall Study|Adverse Event|16|||
143488340|NCT01437397|517329603|FG003|Overall Study|Adverse Event|14|||
143488341|NCT01437397|517329604|FG004|Overall Study|Adverse Event|21|||
143488342|NCT01437397|517329600|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
143488343|NCT01437397|517329601|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
143488344|NCT01437397|517329602|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
143488345|NCT01437397|517329603|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
143488346|NCT01437397|517329604|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
143488347|NCT00903175|517329605|FG000|Period 1 - First Line|Adverse Event|36|||
143488348|NCT00903175|517329606|FG001|Period 1 - First Line|Adverse Event|50|||
143488349|NCT00903175|517329605|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
143488350|NCT00903175|517329606|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
143488351|NCT00903175|517329605|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
143488352|NCT00903175|517329606|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
143488353|NCT00903175|517329605|FG000|Period 1 - First Line|Protocol Violation|3|||
143488354|NCT00903175|517329606|FG001|Period 1 - First Line|Protocol Violation|3|||
143488355|NCT00903175|517329605|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
143488356|NCT00903175|517329606|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
143488357|NCT00903175|517329605|FG000|Period 1 - First Line|Administrative problems|12|||
143488358|NCT00903175|517329606|FG001|Period 1 - First Line|Administrative problems|13|||
143488359|NCT00903175|517329605|FG000|Period 1 - First Line|Death|17|||
143488360|NCT00903175|517329606|FG001|Period 1 - First Line|Death|10|||
143488361|NCT00903175|517329605|FG000|Period 2 - Second Line|Missing|1|||
143488362|NCT00903175|517329606|FG001|Period 2 - Second Line|Missing|0|||
143488363|NCT00903175|517329605|FG000|Period 2 - Second Line|Adverse Event|16|||
143488364|NCT00903175|517329606|FG001|Period 2 - Second Line|Adverse Event|20|||
143488365|NCT00903175|517329605|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
143488366|NCT00903175|517329606|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
143488367|NCT00903175|517329605|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
143488368|NCT00903175|517329606|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
143488369|NCT00903175|517329605|FG000|Period 2 - Second Line|Administrative problems|19|||
143488370|NCT00903175|517329606|FG001|Period 2 - Second Line|Administrative problems|9|||
143488371|NCT00903175|517329605|FG000|Period 2 - Second Line|Death|5|||
143488372|NCT00903175|517329606|FG001|Period 2 - Second Line|Death|2|||
143488373|NCT03074474|517329609|FG000|Overall Study|Lost to Follow-up|10|||
143488374|NCT03074474|517329609|FG000|Overall Study|Withdrawal by Subject|10|||
143488375|NCT03074474|517329609|FG000|Overall Study|Death|4|||
143488376|NCT03074474|517329609|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
143488377|NCT02124564|517329615|FG000|Treatment Period|Adverse Event|2|||
143488378|NCT02124564|517329615|FG000|Treatment Period|Lack of Efficacy|3|||
143488379|NCT02124564|517329615|FG000|Treatment Period|Withdrawal by Subject|2|||
143488380|NCT02043548|517329616|FG000|Overall Study|Lack of Efficacy|1|||
143488381|NCT02043548|517329617|FG001|Overall Study|Lack of Efficacy|0|||
143488382|NCT02043548|517329616|FG000|Overall Study|Adverse Event|0|||
143488383|NCT02043548|517329617|FG001|Overall Study|Adverse Event|1|||
143488384|NCT04418076|517329623|FG000|Overall Study|Death|1|||
143488385|NCT04418076|517329624|FG001|Overall Study|Death|0|||
143488386|NCT04418076|517329625|FG002|Overall Study|Death|0|||
143488387|NCT04418076|517329626|FG003|Overall Study|Death|0|||
143488388|NCT04418076|517329623|FG000|Overall Study|Lost to Follow-up|2|||
143488389|NCT04418076|517329624|FG001|Overall Study|Lost to Follow-up|5|||
143488390|NCT04418076|517329625|FG002|Overall Study|Lost to Follow-up|1|||
143488391|NCT04418076|517329626|FG003|Overall Study|Lost to Follow-up|2|||
143488392|NCT04418076|517329623|FG000|Overall Study|Withdrawal by Subject|1|||
143488393|NCT04418076|517329624|FG001|Overall Study|Withdrawal by Subject|0|||
143488394|NCT04418076|517329625|FG002|Overall Study|Withdrawal by Subject|1|||
143488395|NCT04418076|517329626|FG003|Overall Study|Withdrawal by Subject|1|||
143488396|NCT04418076|517329623|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
143488397|NCT04418076|517329624|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
143488398|NCT04418076|517329625|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
143488399|NCT04418076|517329626|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
143488400|NCT00264238|517329627|FG000|Overall Study|Protocol Violation|1|||
143488401|NCT01452152|517329630|FG000|Overall Study|Study termination by sponsor|5|||
143157647|NCT00689052|516121685|FG001|Overall Study|Lost to Follow-up|0|||
143157648|NCT00689052|516121684|FG000|Overall Study|Withdrawal by Subject|2|||
143157649|NCT00689052|516121685|FG001|Overall Study|Withdrawal by Subject|0|||
143157650|NCT00689052|516121684|FG000|Overall Study|Early termination of the trial|22|||
143157651|NCT00689052|516121685|FG001|Overall Study|Early termination of the trial|24|||
143157652|NCT02569242|516121686|FG000|Overall Study|Death|1|||
143157653|NCT02569242|516121687|FG001|Overall Study|Death|0|||
143157654|NCT02569242|516121686|FG000|Overall Study|Withdrawal by Subject|0|||
143157655|NCT02569242|516121687|FG001|Overall Study|Withdrawal by Subject|1|||
143157656|NCT02405962|516121690|FG000|Overall Study|Lost to Follow-up|1|||
143157657|NCT02405962|516121691|FG001|Overall Study|Lost to Follow-up|4|||
143157658|NCT02405962|516121690|FG000|Overall Study|A participant has moved to another place|0|||
143157659|NCT02405962|516121691|FG001|Overall Study|A participant has moved to another place|1|||
143157660|NCT00165698|516121692|FG000|Overall Study|Adverse Event|2|||
143157661|NCT00165698|516121693|FG001|Overall Study|Adverse Event|10|||
143157662|NCT00165698|516121692|FG000|Overall Study|Lost to Follow-up|2|||
143157663|NCT00165698|516121693|FG001|Overall Study|Lost to Follow-up|2|||
143157664|NCT00165698|516121692|FG000|Overall Study|Withdrawal by Subject|2|||
143157665|NCT00165698|516121693|FG001|Overall Study|Withdrawal by Subject|1|||
143157666|NCT00165698|516121692|FG000|Overall Study|Protocol Violation|1|||
143157667|NCT00165698|516121693|FG001|Overall Study|Protocol Violation|0|||
143157668|NCT00165698|516121692|FG000|Overall Study|Not Taken/Lost the medicine|1|||
143157669|NCT00165698|516121693|FG001|Overall Study|Not Taken/Lost the medicine|2|||
143157670|NCT03882801|516124249|FG000|Period 1|Adverse Event|0|||
143157671|NCT03882801|516124250|FG001|Period 1|Adverse Event|1|||
143157672|NCT03882801|516124249|FG000|Period 1|Non-compliance with study drug|1|||
143157673|NCT03882801|516124250|FG001|Period 1|Non-compliance with study drug|1|||
143157674|NCT03882801|516124249|FG000|Period 1|Never treated with study drug|1|||
143157675|NCT03882801|516124250|FG001|Period 1|Never treated with study drug|0|||
143157676|NCT03882801|516124249|FG000|Washout Period|Physician Decision|0|||
143157677|NCT03882801|516124250|FG001|Washout Period|Physician Decision|1|||
143157678|NCT03882801|516124249|FG000|Period 2|Non-compliance with study drug|0|||
143488402|NCT01452152|517329631|FG001|Overall Study|Study termination by sponsor|0|||
143488403|NCT01452152|517329632|FG002|Overall Study|Study termination by sponsor|4|||
143488404|NCT00272038|517331221|FG000|Overall Study|withdrew before they received 2 cycles|7|||
143488405|NCT04986202|517331228|FG000|Overall Study|Death|10|||
143363844|NCT00049517|516875452|FG002|Conditioning/Transplant|Disease progression|10|||
143488406|NCT04986202|517331229|FG001|Overall Study|Death|3|||
143488407|NCT04986202|517331230|FG002|Overall Study|Death|10|||
143488408|NCT04986202|517331228|FG000|Overall Study|Physician Decision|3|||
143488409|NCT04986202|517331229|FG001|Overall Study|Physician Decision|1|||
143488410|NCT04986202|517331230|FG002|Overall Study|Physician Decision|2|||
143157679|NCT03882801|516124250|FG001|Period 2|Non-compliance with study drug|1|||
143157680|NCT01567085|516124251|FG000|Overall Study|Death|6|||
143024908|NCT01333033|515631209|FG004|Overall Study|Adverse Event|2|||
143024909|NCT01333033|515631210|FG005|Overall Study|Adverse Event|1|||
143488411|NCT04986202|517331228|FG000|Overall Study|Withdrawal by Subject|4|||
143488412|NCT04986202|517331229|FG001|Overall Study|Withdrawal by Subject|2|||
143488413|NCT04986202|517331230|FG002|Overall Study|Withdrawal by Subject|4|||
143488414|NCT02118792|517331231|FG000|Overall Study|Withdrawal by Subject|6|||
143488415|NCT02118792|517331232|FG001|Overall Study|Withdrawal by Subject|3|||
143488416|NCT02118792|517331231|FG000|Overall Study|Lost to Follow-up|4|||
143488417|NCT02118792|517331232|FG001|Overall Study|Lost to Follow-up|4|||
143488418|NCT02118792|517331231|FG000|Overall Study|Adverse Event|5|||
143488419|NCT02118792|517331232|FG001|Overall Study|Adverse Event|4|||
143488420|NCT02118792|517331231|FG000|Overall Study|Withdrawal by parent/guardian|14|||
143488421|NCT02118792|517331232|FG001|Overall Study|Withdrawal by parent/guardian|20|||
143488422|NCT02118792|517331231|FG000|Overall Study|Other|1|||
143488423|NCT02118792|517331232|FG001|Overall Study|Other|6|||
143488424|NCT02118792|517331231|FG000|Overall Study|Randomised but not treated|1|||
143488425|NCT02118792|517331232|FG001|Overall Study|Randomised but not treated|0|||
143488426|NCT01777152|517331236|FG000|Overall Study|Withdrawal by Subject|22|||
143488427|NCT01777152|517331237|FG001|Overall Study|Withdrawal by Subject|16|||
143488428|NCT01777152|517331236|FG000|Overall Study|Lost to Follow-up|3|||
143488429|NCT01777152|517331237|FG001|Overall Study|Lost to Follow-up|5|||
143488430|NCT01777152|517331236|FG000|Overall Study|Death|68|||
143488431|NCT01777152|517331237|FG001|Overall Study|Death|89|||
143488432|NCT01777152|517331236|FG000|Overall Study|Not eligible, no study drug received|1|||
143488433|NCT01777152|517331237|FG001|Overall Study|Not eligible, no study drug received|0|||
143488434|NCT01777152|517331236|FG000|Overall Study|Change of diagnosis|1|||
143488435|NCT01777152|517331237|FG001|Overall Study|Change of diagnosis|0|||
143488436|NCT03548558|517331238|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
143488437|NCT03548558|517331239|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
143488438|NCT03548558|517331240|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
143488439|NCT03548558|517331241|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
143488440|NCT03548558|517331242|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
143488441|NCT03548558|517331243|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
143488442|NCT03548558|517331244|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
143488443|NCT03548558|517331238|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
143488444|NCT03548558|517331239|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
143488445|NCT03548558|517331240|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
143488446|NCT03548558|517331241|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
143488447|NCT03548558|517331242|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
143488448|NCT03548558|517331243|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
143488449|NCT03548558|517331244|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
143488450|NCT03548558|517331238|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
143488451|NCT03548558|517331239|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
143488452|NCT03548558|517331240|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
143488453|NCT03548558|517331241|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
143488454|NCT03548558|517331242|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
143488455|NCT03548558|517331243|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
143488456|NCT03548558|517331244|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
143488457|NCT03548558|517331238|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
143488458|NCT03548558|517331239|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
143488459|NCT03548558|517331240|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
143488460|NCT03548558|517331241|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
143488461|NCT03548558|517331242|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
143488462|NCT03548558|517331243|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
143488463|NCT03548558|517331244|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
143488464|NCT03548558|517331238|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
143488465|NCT03548558|517331239|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
143488466|NCT03548558|517331240|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
143488467|NCT03548558|517331241|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
143488468|NCT03548558|517331242|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
143488469|NCT03548558|517331243|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
143488470|NCT03548558|517331244|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
143488471|NCT03548558|517331238|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
143024910|NCT01333033|515631205|FG000|Overall Study|Progression|0|||
143157681|NCT01567085|516124251|FG000|Overall Study|Adverse Event|6|||
143157682|NCT01567085|516124251|FG000|Overall Study|Lost to Follow-up|3|||
143157683|NCT01567085|516124251|FG000|Overall Study|Graft loss|2|||
143157684|NCT01567085|516124251|FG000|Overall Study|Renal transplantectomy|1|||
143157685|NCT01567085|516124251|FG000|Overall Study|Returned to chronic dialysis|1|||
143024911|NCT01333033|515631206|FG001|Overall Study|Progression|0|||
143157686|NCT01567085|516124251|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
143157687|NCT03312114|516124257|FG000|Overall Study|All the five enrolled dropped out of the|5|||
143157688|NCT00944645|516124258|FG000|Period 2|Adverse Event|1|||
143157689|NCT00944645|516124259|FG001|Period 2|Adverse Event|0|||
143157690|NCT00944645|516124258|FG000|Period 2|Lost to Follow-up|0|||
143157691|NCT00944645|516124259|FG001|Period 2|Lost to Follow-up|3|||
143157692|NCT00944645|516124258|FG000|Period 2|Withdrawal by Subject|7|||
143157693|NCT00944645|516124259|FG001|Period 2|Withdrawal by Subject|6|||
143157694|NCT03537729|516124260|FG000|Overall Study|Death|2|||
143157695|NCT03537729|516124261|FG001|Overall Study|Death|2|||
143157696|NCT03537729|516124262|FG002|Overall Study|Death|7|||
143157697|NCT03537729|516124260|FG000|Overall Study|Withdrawal by Subject|3|||
143157698|NCT03537729|516124261|FG001|Overall Study|Withdrawal by Subject|3|||
143157699|NCT03537729|516124262|FG002|Overall Study|Withdrawal by Subject|0|||
143157700|NCT03537729|516124260|FG000|Overall Study|Subject Moved|8|||
143157701|NCT03537729|516124261|FG001|Overall Study|Subject Moved|5|||
143157702|NCT03537729|516124262|FG002|Overall Study|Subject Moved|4|||
143157703|NCT03537729|516124260|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
143157704|NCT03537729|516124261|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
143157705|NCT03537729|516124262|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
143157706|NCT03537729|516124260|FG000|Overall Study|COVID-19 Site Restrictions|11|||
143157707|NCT03537729|516124261|FG001|Overall Study|COVID-19 Site Restrictions|15|||
143157708|NCT03537729|516124262|FG002|Overall Study|COVID-19 Site Restrictions|18|||
143157709|NCT03537729|516124260|FG000|Overall Study|Decline in Health|5|||
143157710|NCT03537729|516124261|FG001|Overall Study|Decline in Health|9|||
143157711|NCT03537729|516124262|FG002|Overall Study|Decline in Health|4|||
143157712|NCT03537729|516124260|FG000|Overall Study|Determined Ineligible|0|||
143157713|NCT03537729|516124261|FG001|Overall Study|Determined Ineligible|0|||
143157714|NCT03537729|516124262|FG002|Overall Study|Determined Ineligible|1|||
143157715|NCT00284934|516124263|FG000|Overall Study|Adverse Event|1|||
143157716|NCT00284934|516124264|FG001|Overall Study|Adverse Event|2|||
143157717|NCT00284934|516124263|FG000|Overall Study|Other reasons|3|||
143157718|NCT00284934|516124264|FG001|Overall Study|Other reasons|1|||
143157719|NCT00454142|516124265|FG000|Overall Study|Withdrawal by Subject|1|||
143157720|NCT01245751|516124272|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
143157721|NCT01245751|516124273|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
143157722|NCT01245751|516124274|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
143157723|NCT01245751|516124275|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
143157724|NCT01245751|516124272|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
143157725|NCT01245751|516124273|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
143157726|NCT01245751|516124274|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
143157727|NCT01245751|516124275|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
143157728|NCT01245751|516124272|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
143157729|NCT01245751|516124273|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
143157730|NCT01245751|516124274|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
143157731|NCT01245751|516124275|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
143157732|NCT02802865|516124276|FG000|Overall Study|Pregnancy|1|||
143157733|NCT02802865|516124277|FG001|Overall Study|Pregnancy|1|||
143157734|NCT02802865|516124276|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
143157735|NCT02802865|516124277|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
143157736|NCT02018887|516124280|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
143157737|NCT02018887|516124281|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
143157738|NCT02018887|516124282|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
143157739|NCT02018887|516124283|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
143157740|NCT02018887|516124284|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
143157741|NCT02018887|516124285|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
143157742|NCT02018887|516124286|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
143157743|NCT02018887|516124287|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
143157744|NCT02018887|516124288|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
143157745|NCT02018887|516124289|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
143157746|NCT02018887|516124290|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
143157747|NCT02018887|516124280|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
143157748|NCT02018887|516124281|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
143157749|NCT02018887|516124282|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
143157750|NCT02018887|516124283|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
143157751|NCT02018887|516124284|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
143157752|NCT02018887|516124285|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
143157753|NCT02018887|516124286|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
143157754|NCT02018887|516124287|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
143157755|NCT02018887|516124288|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
143157756|NCT02018887|516124289|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
143157757|NCT02018887|516124290|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
143157758|NCT02018887|516124280|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
143157759|NCT02018887|516124281|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
143236638|NCT01033019|516419517|FG000|Overall Study|Withdrawal by Subject|1|||
143236639|NCT01033019|516419518|FG001|Overall Study|Withdrawal by Subject|0|||
143236640|NCT01498068|516419523|FG000|Overall Study|Withdrawal by Subject|1|||
143236641|NCT01498068|516419524|FG001|Overall Study|Withdrawal by Subject|1|||
143236642|NCT00551642|516419526|FG000|Treatment Period|Protocol Deviation|6|||
143236643|NCT00551642|516419527|FG001|Treatment Period|Protocol Deviation|11|||
143236644|NCT00551642|516419526|FG000|Treatment Period|Delivery device failure|1|||
143236645|NCT00551642|516419527|FG001|Treatment Period|Delivery device failure|3|||
143236646|NCT00551642|516419526|FG000|Treatment Period|Physician Decision|0|||
143236647|NCT00551642|516419527|FG001|Treatment Period|Physician Decision|1|||
143236648|NCT00551642|516419526|FG000|Treatment Period|Death|33|||
143236649|NCT00551642|516419527|FG001|Treatment Period|Death|31|||
143488472|NCT03548558|517331239|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
143488473|NCT03548558|517331240|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
143488474|NCT03548558|517331241|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
143488475|NCT03548558|517331242|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
143488476|NCT03548558|517331243|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
143488477|NCT03548558|517331244|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
143488478|NCT01496885|517331249|FG000|Overall Study|Lost to Follow-up|13|||
143488479|NCT01496885|517331249|FG000|Overall Study|Withdrawal by Subject|7|||
143488480|NCT01496885|517331249|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
143488481|NCT01496885|517331249|FG000|Overall Study|Death|1|||
143488482|NCT01485627|517331252|FG000|Overall Study|Patient withdrew|6|||
143488483|NCT01485627|517331253|FG001|Overall Study|Patient withdrew|5|||
143488484|NCT01485627|517331252|FG000|Overall Study|Patient died|3|||
143488485|NCT01485627|517331253|FG001|Overall Study|Patient died|1|||
143488486|NCT01485627|517331252|FG000|Overall Study|Patient lost to followup|0|||
143488487|NCT01485627|517331253|FG001|Overall Study|Patient lost to followup|1|||
143488488|NCT01485627|517331252|FG000|Overall Study|Caregiver withdrew|3|||
143488489|NCT01485627|517331253|FG001|Overall Study|Caregiver withdrew|3|||
143488490|NCT01485627|517331252|FG000|Overall Study|Caregiver lost to follow up|11|||
143488491|NCT01485627|517331253|FG001|Overall Study|Caregiver lost to follow up|12|||
143488492|NCT01485627|517331252|FG000|Overall Study|Caregiver died|1|||
143488493|NCT01485627|517331253|FG001|Overall Study|Caregiver died|0|||
143488494|NCT01485627|517331252|FG000|Overall Study|caregiver was not bereaved|42|||
143488495|NCT01485627|517331253|FG001|Overall Study|caregiver was not bereaved|35|||
143488496|NCT00290433|517331265|FG000|Overall Study|Disease Progression|13|||
143488497|NCT00290433|517331265|FG000|Overall Study|Adverse Event|14|||
143488498|NCT00290433|517331265|FG000|Overall Study|Withdrawal by Subject|1|||
143488499|NCT00290433|517331265|FG000|Overall Study|Non-Compliance|1|||
143488500|NCT00290433|517331265|FG000|Overall Study|Congestive Heart Failure|1|||
143488501|NCT00290433|517331265|FG000|Overall Study|Transplant in CR|5|||
143488502|NCT00290433|517331265|FG000|Overall Study|Unrelated Infection/Death|1|||
143488503|NCT00252057|517331268|FG000|Overall Study|Withdrawal by Subject|2|||
143488504|NCT00252057|517331269|FG001|Overall Study|Withdrawal by Subject|5|||
143488505|NCT00252057|517331268|FG000|Overall Study|Death|1|||
143488506|NCT00252057|517331269|FG001|Overall Study|Death|2|||
143488507|NCT00252057|517331268|FG000|Overall Study|Participant previously enrolled|0|||
143488508|NCT00252057|517331269|FG001|Overall Study|Participant previously enrolled|1|||
143488509|NCT01098071|517331272|FG000|Overall Study|Surgery (adenoidectomy)|2|||
143488510|NCT01098071|517331272|FG000|Overall Study|Lost to Follow-up|13|||
143488511|NCT01903837|517331274|FG000|Part A|Withdrawal by Subject|4|||
143488512|NCT01903837|517331275|FG001|Part A|Withdrawal by Subject|9|||
143488513|NCT01903837|517331276|FG002|Part A|Withdrawal by Subject|8|||
143488514|NCT01903837|517331277|FG003|Part A|Withdrawal by Subject|5|||
143488515|NCT01903837|517331274|FG000|Part A|Adverse Event|3|||
143488516|NCT01903837|517331275|FG001|Part A|Adverse Event|6|||
143024912|NCT01333033|515631207|FG002|Overall Study|Progression|0|||
143024913|NCT01333033|515631208|FG003|Overall Study|Progression|0|||
143024914|NCT01333033|515631209|FG004|Overall Study|Progression|0|||
143236650|NCT00551642|516419526|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
143236651|NCT00551642|516419527|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
143363845|NCT00049517|516875453|FG003|Conditioning/Transplant|Disease progression|6|||
143488517|NCT01903837|517331276|FG002|Part A|Adverse Event|9|||
143488518|NCT01903837|517331277|FG003|Part A|Adverse Event|6|||
143488519|NCT01903837|517331274|FG000|Part A|Lost to Follow-up|9|||
143488520|NCT01903837|517331275|FG001|Part A|Lost to Follow-up|7|||
143488521|NCT01903837|517331276|FG002|Part A|Lost to Follow-up|7|||
143488522|NCT01903837|517331277|FG003|Part A|Lost to Follow-up|2|||
143488523|NCT01903837|517331274|FG000|Part A|Non-compliance with study drug|1|||
143024915|NCT01333033|515631210|FG005|Overall Study|Progression|1|||
143236652|NCT00551642|516419526|FG000|Treatment Period|Adverse Event|15|||
143236653|NCT00551642|516419527|FG001|Treatment Period|Adverse Event|12|||
143488524|NCT01903837|517331275|FG001|Part A|Non-compliance with study drug|4|||
143236654|NCT00551642|516419526|FG000|Treatment Period|Withdrawal by Subject|2|||
143363846|NCT00049517|516875454|FG004|Conditioning/Transplant|Disease progression|0|||
143024916|NCT01333033|515631205|FG000|Overall Study|MD Decision|0|||
143488525|NCT01903837|517331276|FG002|Part A|Non-compliance with study drug|4|||
143488526|NCT01903837|517331277|FG003|Part A|Non-compliance with study drug|0|||
143488527|NCT01903837|517331274|FG000|Part A|Physician Decision|1|||
143488528|NCT01903837|517331275|FG001|Part A|Physician Decision|1|||
143488529|NCT01903837|517331276|FG002|Part A|Physician Decision|0|||
143488530|NCT01903837|517331277|FG003|Part A|Physician Decision|0|||
143488531|NCT01903837|517331274|FG000|Part A|Protocol Violation|1|||
143488532|NCT01903837|517331275|FG001|Part A|Protocol Violation|1|||
143488533|NCT01903837|517331276|FG002|Part A|Protocol Violation|0|||
143024917|NCT01333033|515631206|FG001|Overall Study|MD Decision|0|||
143024918|NCT01333033|515631207|FG002|Overall Study|MD Decision|0|||
143024919|NCT01333033|515631208|FG003|Overall Study|MD Decision|0|||
143024920|NCT01333033|515631209|FG004|Overall Study|MD Decision|0|||
143024921|NCT01333033|515631210|FG005|Overall Study|MD Decision|2|||
143024922|NCT03687125|515631211|FG000|Overall Study|Progressive Disease|2|||
143024923|NCT03687125|515631212|FG001|Overall Study|Progressive Disease|1|||
143024924|NCT03687125|515631211|FG000|Overall Study|Protocol Violation|1|||
143488534|NCT01903837|517331277|FG003|Part A|Protocol Violation|0|||
143488535|NCT01903837|517331274|FG000|Part B|Lost to Follow-up|0|||
143488536|NCT01903837|517331275|FG001|Part B|Lost to Follow-up|3|||
143488537|NCT01903837|517331276|FG002|Part B|Lost to Follow-up|3|||
143488538|NCT01903837|517331277|FG003|Part B|Lost to Follow-up|4|||
143488539|NCT01903837|517331274|FG000|Part B|Withdrawal by Subject|1|||
143488540|NCT01903837|517331275|FG001|Part B|Withdrawal by Subject|2|||
143488541|NCT01903837|517331276|FG002|Part B|Withdrawal by Subject|0|||
143488542|NCT01903837|517331277|FG003|Part B|Withdrawal by Subject|3|||
143488543|NCT01903837|517331274|FG000|Part B|Adverse Event|3|||
143488544|NCT01903837|517331275|FG001|Part B|Adverse Event|0|||
143488545|NCT01903837|517331276|FG002|Part B|Adverse Event|2|||
143488546|NCT01903837|517331277|FG003|Part B|Adverse Event|0|||
143488547|NCT01903837|517331274|FG000|Part B|Non-compliance with study drug|2|||
143488548|NCT01903837|517331275|FG001|Part B|Non-compliance with study drug|0|||
143488549|NCT01903837|517331276|FG002|Part B|Non-compliance with study drug|0|||
143488550|NCT01903837|517331277|FG003|Part B|Non-compliance with study drug|1|||
143488551|NCT01903837|517331274|FG000|Part B|Incarceration|2|||
143488552|NCT01903837|517331275|FG001|Part B|Incarceration|0|||
143488553|NCT01903837|517331276|FG002|Part B|Incarceration|0|||
143488554|NCT01903837|517331277|FG003|Part B|Incarceration|1|||
143488555|NCT01903837|517331274|FG000|Part B|Physician Decision|1|||
143488556|NCT01903837|517331275|FG001|Part B|Physician Decision|0|||
143488557|NCT01903837|517331276|FG002|Part B|Physician Decision|0|||
143488558|NCT01903837|517331277|FG003|Part B|Physician Decision|2|||
143488559|NCT01903837|517331274|FG000|Part B|Lack of Efficacy|0|||
143488560|NCT01903837|517331275|FG001|Part B|Lack of Efficacy|1|||
143488561|NCT01903837|517331276|FG002|Part B|Lack of Efficacy|0|||
143488562|NCT01903837|517331277|FG003|Part B|Lack of Efficacy|0|||
143488563|NCT05048342|517331278|FG000|Overall Study|Adverse Event|1|||
143488564|NCT05048342|517331278|FG000|Overall Study|Subject decision|2|||
143488565|NCT00797732|517331279|FG000|Overall Study|Withdrawal by Subject|3|||
143488566|NCT00797732|517331280|FG001|Overall Study|Withdrawal by Subject|3|||
143488567|NCT00797732|517331281|FG002|Overall Study|Withdrawal by Subject|0|||
143488568|NCT00797732|517331279|FG000|Overall Study|Lost to Follow-up|1|||
143488569|NCT00797732|517331280|FG001|Overall Study|Lost to Follow-up|0|||
143488570|NCT00797732|517331281|FG002|Overall Study|Lost to Follow-up|0|||
143488571|NCT00797732|517331279|FG000|Overall Study|Death|1|||
143488572|NCT00797732|517331280|FG001|Overall Study|Death|0|||
143488573|NCT00797732|517331281|FG002|Overall Study|Death|0|||
143488574|NCT00797732|517331279|FG000|Overall Study|Not meet inclusion criteria|0|||
143488575|NCT00797732|517331280|FG001|Overall Study|Not meet inclusion criteria|0|||
143488576|NCT00797732|517331281|FG002|Overall Study|Not meet inclusion criteria|7|||
143488577|NCT00797732|517331279|FG000|Overall Study|Excluded due to time constraints|0|||
143024925|NCT03687125|515631212|FG001|Overall Study|Protocol Violation|0|||
143024926|NCT02022007|515631215|FG000|Overall Study|Withdrawal by Subject|1|||
143488578|NCT00797732|517331280|FG001|Overall Study|Excluded due to time constraints|0|||
143488579|NCT00797732|517331281|FG002|Overall Study|Excluded due to time constraints|24|||
143157760|NCT02018887|516124282|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
143488580|NCT00797732|517331279|FG000|Overall Study|Refused to Participate|0|||
143024927|NCT02022007|515631216|FG001|Overall Study|Withdrawal by Subject|1|||
143024928|NCT02022007|515631217|FG002|Overall Study|Withdrawal by Subject|1|||
143488581|NCT00797732|517331280|FG001|Overall Study|Refused to Participate|0|||
143488582|NCT00797732|517331281|FG002|Overall Study|Refused to Participate|123|||
143024929|NCT02022007|515631215|FG000|Overall Study|Noncompliant|0|||
143488583|NCT02275338|517331287|FG000|Overall Study|Adverse Event|15|||
143488584|NCT02275338|517331287|FG000|Overall Study|Lack of Efficacy|3|||
143488585|NCT02275338|517331287|FG000|Overall Study|Withdrawal by Subject|4|||
143488586|NCT02275338|517331287|FG000|Overall Study|Disease progression (death)|1|||
143024930|NCT02022007|515631216|FG001|Overall Study|Noncompliant|0|||
143488587|NCT02275338|517331287|FG000|Overall Study|Ineligible to start Phase 2|4|||
143488588|NCT02275338|517331287|FG000|Overall Study|Reason not specified|5|||
143488589|NCT02275338|517331287|FG000|Overall Study|Does not meet entry criteria|1|||
143488590|NCT01857869|517331292|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
143236655|NCT00551642|516419527|FG001|Treatment Period|Withdrawal by Subject|1|||
143236656|NCT00198822|516419528|FG000|Overall Study|Lost to Follow-up|14|||
143236657|NCT00198822|516419529|FG001|Overall Study|Lost to Follow-up|20|||
143236658|NCT00198822|516419530|FG002|Overall Study|Lost to Follow-up|21|||
143236659|NCT03011099|516419531|FG000|Overall Study|Withdrawal by Subject|0|||
143236660|NCT03011099|516419532|FG001|Overall Study|Withdrawal by Subject|2|||
143236661|NCT00283296|516419538|FG000|Overall Study|in-home trial not completed|5|||
143236662|NCT02668653|516419539|FG000|Overall Study|Refractory disease|41|||
143236663|NCT02668653|516419540|FG001|Overall Study|Refractory disease|70|||
143236664|NCT02668653|516419539|FG000|Overall Study|Relapse|44|||
143236665|NCT02668653|516419540|FG001|Overall Study|Relapse|65|||
143236666|NCT02668653|516419539|FG000|Overall Study|Adverse Event|58|||
143236667|NCT02668653|516419540|FG001|Overall Study|Adverse Event|23|||
143488591|NCT01857869|517331293|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
143488592|NCT01857869|517331294|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
143488593|NCT01857869|517331295|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
143488594|NCT01857869|517331296|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
143488595|NCT01857869|517331297|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
143488596|NCT01857869|517331298|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
143236668|NCT02668653|516419539|FG000|Overall Study|Subject decision to stop study drug|25|||
143236669|NCT02668653|516419540|FG001|Overall Study|Subject decision to stop study drug|23|||
143236670|NCT02668653|516419539|FG000|Overall Study|Other reasons not specified|16|||
143236671|NCT02668653|516419540|FG001|Overall Study|Other reasons not specified|11|||
143236672|NCT02668653|516419539|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
143236673|NCT02668653|516419540|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
143236674|NCT02668653|516419539|FG000|Overall Study|Investigator decision|10|||
143236675|NCT02668653|516419540|FG001|Overall Study|Investigator decision|7|||
143236676|NCT02668653|516419539|FG000|Overall Study|Failure to meet continuation criteria|5|||
143236677|NCT02668653|516419540|FG001|Overall Study|Failure to meet continuation criteria|12|||
143236678|NCT02668653|516419539|FG000|Overall Study|Lost to Follow-up|1|||
143236679|NCT02668653|516419540|FG001|Overall Study|Lost to Follow-up|0|||
143236680|NCT02668653|516419539|FG000|Overall Study|Pregnancy|0|||
143236681|NCT02668653|516419540|FG001|Overall Study|Pregnancy|1|||
143236682|NCT02668653|516419539|FG000|Overall Study|Death|0|||
143236683|NCT02668653|516419540|FG001|Overall Study|Death|1|||
143236684|NCT01294553|516419541|FG000|Overall Study|Duplicated Participants|1|||
143236685|NCT01294553|516419541|FG000|Overall Study|Protocol Violation|268|||
143236686|NCT00453206|516419542|FG000|Overall Study|Death|1|||
143236687|NCT00577889|516419549|FG000|Overall Study|Withdrawal by Subject|1|||
143236688|NCT00577889|516419550|FG001|Overall Study|Withdrawal by Subject|0|||
143236689|NCT00577889|516419551|FG002|Overall Study|Withdrawal by Subject|0|||
143236690|NCT00993967|516419555|FG000|Overall Study|Adverse Event|8|||
143236691|NCT00993967|516419555|FG000|Overall Study|Death|1|||
143236692|NCT00993967|516419555|FG000|Overall Study|Lost to Follow-up|14|||
143236693|NCT00993967|516419555|FG000|Overall Study|Withdrawal by Subject|36|||
143236694|NCT00993967|516419555|FG000|Overall Study|Protocol Violation|2|||
143236695|NCT00541658|516419560|FG000|Overall Study|Adverse Event|28|||
143236696|NCT00541658|516419561|FG001|Overall Study|Adverse Event|37|||
143236697|NCT00541658|516419562|FG002|Overall Study|Adverse Event|25|||
143236698|NCT00541658|516419560|FG000|Overall Study|Physician Decision|0|||
143236699|NCT00541658|516419561|FG001|Overall Study|Physician Decision|0|||
143236700|NCT00541658|516419562|FG002|Overall Study|Physician Decision|4|||
143236701|NCT00541658|516419560|FG000|Overall Study|Lost to Follow-up|3|||
143236702|NCT00541658|516419561|FG001|Overall Study|Lost to Follow-up|3|||
143236703|NCT00541658|516419562|FG002|Overall Study|Lost to Follow-up|6|||
143236704|NCT00541658|516419560|FG000|Overall Study|Protocol Violation|0|||
143236705|NCT00541658|516419561|FG001|Overall Study|Protocol Violation|1|||
143236706|NCT00541658|516419562|FG002|Overall Study|Protocol Violation|1|||
143236707|NCT00541658|516419560|FG000|Overall Study|Withdrawal by Subject|28|||
143236708|NCT00541658|516419561|FG001|Overall Study|Withdrawal by Subject|32|||
143236709|NCT00541658|516419562|FG002|Overall Study|Withdrawal by Subject|32|||
143236710|NCT00541658|516419560|FG000|Overall Study|Took No Study Drug|1|||
143236711|NCT00541658|516419561|FG001|Overall Study|Took No Study Drug|0|||
143236712|NCT00541658|516419562|FG002|Overall Study|Took No Study Drug|0|||
143236713|NCT03866577|516419563|FG000|Overall Study|Protocol Violation|0|||
143236714|NCT03866577|516419564|FG001|Overall Study|Protocol Violation|0|||
143236715|NCT03866577|516419565|FG002|Overall Study|Protocol Violation|0|||
143236716|NCT03866577|516419566|FG003|Overall Study|Protocol Violation|0|||
143488597|NCT01857869|517331299|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
143488598|NCT01857869|517331300|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
143488599|NCT01857869|517331301|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
143236717|NCT03866577|516419567|FG004|Overall Study|Protocol Violation|0|||
143236718|NCT03866577|516419568|FG005|Overall Study|Protocol Violation|0|||
143236719|NCT03866577|516419569|FG006|Overall Study|Protocol Violation|0|||
143236720|NCT03866577|516419570|FG007|Overall Study|Protocol Violation|0|||
143236721|NCT03866577|516419571|FG008|Overall Study|Protocol Violation|0|||
143236722|NCT03866577|516419572|FG009|Overall Study|Protocol Violation|0|||
143236723|NCT03866577|516419573|FG010|Overall Study|Protocol Violation|0|||
143488600|NCT01857869|517331292|FG000|Primary/Challenge Phase|Pregnancy|1|||
143157761|NCT02018887|516124283|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
143488601|NCT01857869|517331293|FG001|Primary/Challenge Phase|Pregnancy|0|||
143488602|NCT01857869|517331294|FG002|Primary/Challenge Phase|Pregnancy|0|||
143488603|NCT01857869|517331295|FG003|Primary/Challenge Phase|Pregnancy|0|||
143488604|NCT01857869|517331296|FG004|Primary/Challenge Phase|Pregnancy|0|||
143488605|NCT01857869|517331297|FG005|Primary/Challenge Phase|Pregnancy|0|||
143488606|NCT01857869|517331298|FG006|Primary/Challenge Phase|Pregnancy|0|||
143488607|NCT01857869|517331299|FG007|Primary/Challenge Phase|Pregnancy|0|||
143488608|NCT01857869|517331300|FG008|Primary/Challenge Phase|Pregnancy|0|||
143488609|NCT01857869|517331301|FG009|Primary/Challenge Phase|Pregnancy|0|||
143488610|NCT01857869|517331292|FG000|Primary/Challenge Phase|Protocol Violation|1|||
143488611|NCT01857869|517331293|FG001|Primary/Challenge Phase|Protocol Violation|0|||
143488612|NCT01857869|517331294|FG002|Primary/Challenge Phase|Protocol Violation|0|||
143488613|NCT01857869|517331295|FG003|Primary/Challenge Phase|Protocol Violation|0|||
143488614|NCT01857869|517331296|FG004|Primary/Challenge Phase|Protocol Violation|0|||
143488615|NCT01857869|517331297|FG005|Primary/Challenge Phase|Protocol Violation|0|||
143488616|NCT01857869|517331298|FG006|Primary/Challenge Phase|Protocol Violation|0|||
143488617|NCT01857869|517331299|FG007|Primary/Challenge Phase|Protocol Violation|0|||
143488618|NCT01857869|517331300|FG008|Primary/Challenge Phase|Protocol Violation|0|||
143488619|NCT01857869|517331301|FG009|Primary/Challenge Phase|Protocol Violation|0|||
143488620|NCT01857869|517331292|FG000|Primary/Challenge Phase|Other|1|||
143488621|NCT01857869|517331293|FG001|Primary/Challenge Phase|Other|1|||
143488622|NCT01857869|517331294|FG002|Primary/Challenge Phase|Other|0|||
143488623|NCT01857869|517331295|FG003|Primary/Challenge Phase|Other|0|||
143488624|NCT01857869|517331296|FG004|Primary/Challenge Phase|Other|0|||
143488625|NCT01857869|517331297|FG005|Primary/Challenge Phase|Other|0|||
143488626|NCT01857869|517331298|FG006|Primary/Challenge Phase|Other|0|||
143488627|NCT01857869|517331299|FG007|Primary/Challenge Phase|Other|0|||
143488628|NCT01857869|517331300|FG008|Primary/Challenge Phase|Other|0|||
143488629|NCT01857869|517331301|FG009|Primary/Challenge Phase|Other|0|||
143488630|NCT01857869|517331292|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
143488631|NCT01857869|517331293|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
143488632|NCT01857869|517331294|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
143488633|NCT01857869|517331295|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
143488634|NCT01857869|517331296|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
143488635|NCT01857869|517331297|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
143488636|NCT01857869|517331298|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
143488637|NCT01857869|517331299|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
143488638|NCT01857869|517331300|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
143488639|NCT01857869|517331301|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
143157762|NCT02018887|516124284|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
143157763|NCT02018887|516124285|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
143157764|NCT02018887|516124286|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
143157765|NCT02018887|516124287|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
143157766|NCT02018887|516124288|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
143157767|NCT02018887|516124289|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
143157768|NCT02018887|516124290|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
143157769|NCT02018887|516124280|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
143157770|NCT02018887|516124281|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
143157771|NCT02018887|516124282|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
143157772|NCT02018887|516124283|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
143157773|NCT02018887|516124284|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
143157774|NCT02018887|516124285|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
143157775|NCT02018887|516124286|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
143157776|NCT02018887|516124287|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
143157777|NCT02018887|516124288|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
143157778|NCT02018887|516124289|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
143157779|NCT02018887|516124290|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
143157780|NCT01058005|516124291|FG000|Overall Study|Adverse Event|0|||
143157781|NCT01058005|516124292|FG001|Overall Study|Adverse Event|2|||
143157782|NCT01058005|516124293|FG002|Overall Study|Adverse Event|1|||
143157783|NCT01058005|516124291|FG000|Overall Study|Physician Decision|2|||
143157784|NCT01058005|516124292|FG001|Overall Study|Physician Decision|2|||
143157785|NCT01058005|516124293|FG002|Overall Study|Physician Decision|0|||
143157786|NCT01058005|516124291|FG000|Overall Study|Withdrawal by Subject|4|||
143157787|NCT01058005|516124292|FG001|Overall Study|Withdrawal by Subject|5|||
143488640|NCT01857869|517331292|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
143488641|NCT01857869|517331293|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
143157788|NCT01058005|516124293|FG002|Overall Study|Withdrawal by Subject|11|||
143157789|NCT01058005|516124291|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
143157790|NCT01058005|516124292|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
143157791|NCT01058005|516124293|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
143157792|NCT01058005|516124291|FG000|Overall Study|Reason Missing|5|||
143157793|NCT01058005|516124292|FG001|Overall Study|Reason Missing|3|||
143488642|NCT01857869|517331294|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
143488643|NCT01857869|517331295|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
143488644|NCT01857869|517331296|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
143488645|NCT01857869|517331297|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
143488646|NCT01857869|517331298|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
143488647|NCT01857869|517331299|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
143488648|NCT01857869|517331300|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
143488649|NCT01857869|517331301|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
143488650|NCT04607733|517331312|FG000|Overall Study|Lost to Follow-up|1|||
143488651|NCT04607733|517331313|FG001|Overall Study|Lost to Follow-up|0|||
143488652|NCT04607733|517331314|FG002|Overall Study|Lost to Follow-up|0|||
143488653|NCT04607733|517331315|FG003|Overall Study|Lost to Follow-up|1|||
143488654|NCT04607733|517331316|FG004|Overall Study|Lost to Follow-up|1|||
143488655|NCT04607733|517331317|FG005|Overall Study|Lost to Follow-up|0|||
143488656|NCT04607733|517331312|FG000|Overall Study|Withdrawal by Subject|0|||
143488657|NCT04607733|517331313|FG001|Overall Study|Withdrawal by Subject|0|||
143488658|NCT04607733|517331314|FG002|Overall Study|Withdrawal by Subject|0|||
143157794|NCT01058005|516124293|FG002|Overall Study|Reason Missing|1|||
143488659|NCT04607733|517331315|FG003|Overall Study|Withdrawal by Subject|0|||
143488660|NCT04607733|517331316|FG004|Overall Study|Withdrawal by Subject|1|||
143488661|NCT04607733|517331317|FG005|Overall Study|Withdrawal by Subject|0|||
143488662|NCT01665807|517331318|FG000|Overall Study|Withdrawal by Subject|2|||
143488663|NCT01665807|517331319|FG001|Overall Study|Withdrawal by Subject|0|||
143488664|NCT01665807|517331320|FG002|Overall Study|Withdrawal by Subject|1|||
143488665|NCT03594227|517331322|FG000|Overall Study|Adverse Event|2|||
143488666|NCT03594227|517331323|FG001|Overall Study|Adverse Event|1|||
143488667|NCT03594227|517331324|FG002|Overall Study|Adverse Event|0|||
143488668|NCT03594227|517331325|FG003|Overall Study|Adverse Event|2|||
143488669|NCT03594227|517331322|FG000|Overall Study|Lost to Follow-up|1|||
143488670|NCT03594227|517331323|FG001|Overall Study|Lost to Follow-up|1|||
143488671|NCT03594227|517331324|FG002|Overall Study|Lost to Follow-up|1|||
143488672|NCT03594227|517331325|FG003|Overall Study|Lost to Follow-up|0|||
143488673|NCT03594227|517331322|FG000|Overall Study|Withdrawal by Subject|1|||
143488674|NCT03594227|517331323|FG001|Overall Study|Withdrawal by Subject|1|||
143488675|NCT03594227|517331324|FG002|Overall Study|Withdrawal by Subject|1|||
143488676|NCT03594227|517331325|FG003|Overall Study|Withdrawal by Subject|1|||
143157795|NCT01145222|516124294|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
143157796|NCT01145222|516124295|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
143157797|NCT01145222|516124296|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
143157798|NCT01145222|516124297|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
143157799|NCT01145222|516124294|FG000|Overall Study|Poor bowel preparation|0|||
143157800|NCT01145222|516124295|FG001|Overall Study|Poor bowel preparation|0|||
143157801|NCT01145222|516124296|FG002|Overall Study|Poor bowel preparation|0|||
143157802|NCT01145222|516124297|FG003|Overall Study|Poor bowel preparation|1|||
143157803|NCT01698008|516124298|FG000|Overall Study|Withdrawal by Subject|1|||
143157804|NCT01698008|516124299|FG001|Overall Study|Withdrawal by Subject|2|||
143157805|NCT01011283|516124301|FG000|Overall Study|Adverse Event|4|||
143157806|NCT01011283|516124302|FG001|Overall Study|Adverse Event|2|||
143157807|NCT01011283|516124301|FG000|Overall Study|Progressive Disease|0|||
143157808|NCT01011283|516124302|FG001|Overall Study|Progressive Disease|2|||
143157809|NCT01011283|516124301|FG000|Overall Study|Terminated by Sponsor|5|||
143157810|NCT01011283|516124302|FG001|Overall Study|Terminated by Sponsor|5|||
143157811|NCT01011283|516124301|FG000|Overall Study|Other|2|||
143157812|NCT01011283|516124302|FG001|Overall Study|Other|2|||
143157813|NCT04865978|516124303|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
143157814|NCT04865978|516124304|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
143157815|NCT02181738|516124305|FG000|Overall Study|Participant Withdrew Consent|2|||
143157816|NCT02181738|516124306|FG001|Overall Study|Participant Withdrew Consent|1|||
143157817|NCT02181738|516124307|FG002|Overall Study|Participant Withdrew Consent|1|||
143236724|NCT03866577|516419574|FG011|Overall Study|Protocol Violation|1|||
143488677|NCT03594227|517331322|FG000|Overall Study|Pregnancy|0|||
143157818|NCT02181738|516124308|FG003|Overall Study|Participant Withdrew Consent|1|||
143157819|NCT02181738|516124305|FG000|Overall Study|Lost to Follow-up|1|||
143157820|NCT02181738|516124306|FG001|Overall Study|Lost to Follow-up|2|||
143157821|NCT02181738|516124307|FG002|Overall Study|Lost to Follow-up|1|||
143488678|NCT03594227|517331323|FG001|Overall Study|Pregnancy|1|||
143488679|NCT03594227|517331324|FG002|Overall Study|Pregnancy|0|||
143488680|NCT03594227|517331325|FG003|Overall Study|Pregnancy|0|||
143488681|NCT03594227|517331322|FG000|Overall Study|Sponsor Decision|0|||
143157822|NCT02181738|516124308|FG003|Overall Study|Lost to Follow-up|1|||
143157823|NCT02181738|516124305|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
143157824|NCT02181738|516124306|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
143157825|NCT02181738|516124307|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
143157826|NCT02181738|516124308|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
143157827|NCT02181738|516124305|FG000|Overall Study|Poor/Non-Compliance|1|||
143488682|NCT03594227|517331323|FG001|Overall Study|Sponsor Decision|0|||
143488683|NCT03594227|517331324|FG002|Overall Study|Sponsor Decision|0|||
143488684|NCT03594227|517331325|FG003|Overall Study|Sponsor Decision|1|||
143488685|NCT03594227|517331322|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
143488686|NCT03594227|517331323|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
143488687|NCT03594227|517331324|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
143488688|NCT03594227|517331325|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
143488689|NCT00790907|517331326|FG000|Overall Study|Adverse Event|9|||
143488690|NCT00790907|517331327|FG001|Overall Study|Adverse Event|7|||
143488691|NCT00790907|517331328|FG002|Overall Study|Adverse Event|6|||
143488692|NCT00790907|517331326|FG000|Overall Study|Physician Decision|304|||
143488693|NCT00790907|517331327|FG001|Overall Study|Physician Decision|271|||
143488694|NCT00790907|517331328|FG002|Overall Study|Physician Decision|255|||
143488695|NCT00790907|517331326|FG000|Overall Study|Withdrawal by Subject|1|||
143488696|NCT00790907|517331327|FG001|Overall Study|Withdrawal by Subject|7|||
143488697|NCT00790907|517331328|FG002|Overall Study|Withdrawal by Subject|5|||
143488698|NCT00790907|517331326|FG000|Overall Study|Bleeding Event|11|||
143488699|NCT00790907|517331327|FG001|Overall Study|Bleeding Event|16|||
143488700|NCT00790907|517331328|FG002|Overall Study|Bleeding Event|21|||
143488701|NCT00790907|517331326|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
143488702|NCT00790907|517331327|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
143488703|NCT00790907|517331328|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
143488704|NCT00790907|517331326|FG000|Overall Study|Qualifying Condition Not Present|29|||
143488705|NCT00790907|517331327|FG001|Overall Study|Qualifying Condition Not Present|14|||
143488706|NCT00790907|517331328|FG002|Overall Study|Qualifying Condition Not Present|16|||
143488707|NCT00790907|517331326|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
143488708|NCT00790907|517331327|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
143488709|NCT00790907|517331328|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
143488710|NCT00790907|517331326|FG000|Overall Study|Did Not Receive Study Drug|10|||
143488711|NCT00790907|517331327|FG001|Overall Study|Did Not Receive Study Drug|0|||
143488712|NCT00790907|517331328|FG002|Overall Study|Did Not Receive Study Drug|0|||
143488713|NCT01888640|517331329|FG000|Overall Study|Lost to Follow-up|1|||
143488714|NCT01888640|517331330|FG001|Overall Study|Lost to Follow-up|2|||
143488715|NCT01888640|517331331|FG002|Overall Study|Lost to Follow-up|0|||
143488716|NCT01888640|517331329|FG000|Overall Study|Withdrawal by Subject|15|||
143488717|NCT01888640|517331330|FG001|Overall Study|Withdrawal by Subject|11|||
143488718|NCT01888640|517331331|FG002|Overall Study|Withdrawal by Subject|4|||
143488719|NCT01888640|517331329|FG000|Overall Study|Minimum dose not met|10|||
143488720|NCT01888640|517331330|FG001|Overall Study|Minimum dose not met|16|||
143488721|NCT01888640|517331331|FG002|Overall Study|Minimum dose not met|0|||
143488722|NCT01888640|517331329|FG000|Overall Study|Given wrong unit (placebo)|1|||
143488723|NCT01888640|517331330|FG001|Overall Study|Given wrong unit (placebo)|0|||
143488724|NCT01888640|517331331|FG002|Overall Study|Given wrong unit (placebo)|0|||
143488725|NCT01888640|517331329|FG000|Overall Study|Excluded for prior TENS|0|||
143488726|NCT01888640|517331330|FG001|Overall Study|Excluded for prior TENS|1|||
143488727|NCT01888640|517331331|FG002|Overall Study|Excluded for prior TENS|0|||
143488728|NCT01888640|517331329|FG000|Overall Study|Researcher Termination of Participant|0|||
143488729|NCT01888640|517331330|FG001|Overall Study|Researcher Termination of Participant|1|||
143488730|NCT01888640|517331331|FG002|Overall Study|Researcher Termination of Participant|1|||
143488731|NCT00774345|517331332|FG000|Pre-treatment|Other reasons|2|||
143488732|NCT00774345|517331333|FG001|Pre-treatment|Other reasons|0|||
143488733|NCT00774345|517331332|FG000|Treatment|Adverse Event|61|||
143488734|NCT00774345|517331333|FG001|Treatment|Adverse Event|15|||
143488735|NCT00774345|517331332|FG000|Treatment|Progressive Disease without histologic transformation|51|||
143488736|NCT00774345|517331333|FG001|Treatment|Progressive Disease without histologic transformation|111|||
143488737|NCT00774345|517331332|FG000|Treatment|Progressive Disease with histologic transformation|4|||
143488738|NCT00774345|517331333|FG001|Treatment|Progressive Disease with histologic transformation|2|||
143488739|NCT00774345|517331332|FG000|Treatment|Withdrawal by Subject|5|||
143488740|NCT00774345|517331333|FG001|Treatment|Withdrawal by Subject|2|||
143488741|NCT00774345|517331332|FG000|Treatment|Lost to Follow-up|1|||
143488742|NCT00774345|517331333|FG001|Treatment|Lost to Follow-up|1|||
143488743|NCT00774345|517331332|FG000|Treatment|Death|4|||
143488744|NCT00774345|517331333|FG001|Treatment|Death|0|||
143488745|NCT00774345|517331332|FG000|Treatment|Other Reasons|32|||
143488746|NCT00774345|517331333|FG001|Treatment|Other Reasons|26|||
143488747|NCT01277549|517331334|FG000|Overall Study|Failed to meet eligibility criteria|13|||
143488748|NCT01277549|517331335|FG001|Overall Study|Failed to meet eligibility criteria|9|||
143488749|NCT01277549|517331334|FG000|Overall Study|Withdrawal by Subject|1|||
143488750|NCT01277549|517331335|FG001|Overall Study|Withdrawal by Subject|3|||
143488751|NCT01277549|517331334|FG000|Overall Study|Protocol Violation|10|||
143157828|NCT02181738|516124306|FG001|Overall Study|Poor/Non-Compliance|0|||
143488752|NCT01277549|517331335|FG001|Overall Study|Protocol Violation|1|||
143488753|NCT01277549|517331334|FG000|Overall Study|Physician Decision|2|||
143024931|NCT02022007|515631217|FG002|Overall Study|Noncompliant|1|||
143488754|NCT01277549|517331335|FG001|Overall Study|Physician Decision|1|||
143488755|NCT00623428|517331336|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
143488756|NCT00623428|517331337|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
143488757|NCT00623428|517331336|FG000|Treatment Period|Death|0|||
143488758|NCT00623428|517331337|FG001|Treatment Period|Death|1|||
143488759|NCT00623428|517331336|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
143488760|NCT00623428|517331337|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
143488761|NCT00623428|517331336|FG000|Treatment Period|Insufficient therapeutic response|0|||
143488762|NCT00623428|517331337|FG001|Treatment Period|Insufficient therapeutic response|2|||
143488763|NCT00623428|517331336|FG000|Treatment Period|Other|0|||
143488764|NCT00623428|517331337|FG001|Treatment Period|Other|1|||
143488765|NCT00623428|517331336|FG000|Treatment Period|Withdrawal by Subject|0|||
143488766|NCT00623428|517331337|FG001|Treatment Period|Withdrawal by Subject|1|||
143488767|NCT00623428|517331336|FG000|Follow-up Period|Relapse post-treatment|11|||
143488768|NCT00623428|517331337|FG001|Follow-up Period|Relapse post-treatment|3|||
143488769|NCT00623428|517331336|FG000|Follow-up Period|Failure to return|10|||
143488770|NCT00623428|517331337|FG001|Follow-up Period|Failure to return|2|||
143488771|NCT00623428|517331336|FG000|Follow-up Period|Patient withdrew consent|5|||
143488772|NCT00623428|517331337|FG001|Follow-up Period|Patient withdrew consent|4|||
143488773|NCT00623428|517331336|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
143488774|NCT00623428|517331337|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
143488775|NCT00623428|517331336|FG000|Follow-up Period|Did not cooperate|0|||
143488776|NCT00623428|517331337|FG001|Follow-up Period|Did not cooperate|3|||
143488777|NCT00623428|517331336|FG000|Follow-up Period|Reason not specified|1|||
143488778|NCT00623428|517331337|FG001|Follow-up Period|Reason not specified|1|||
143488779|NCT00623428|517331336|FG000|Follow-up Period|Death|0|||
143488780|NCT00623428|517331337|FG001|Follow-up Period|Death|1|||
143488781|NCT02109484|517331339|FG000|Overall Study|Lost to Follow-up|0|||
143488782|NCT02109484|517331340|FG001|Overall Study|Lost to Follow-up|0|||
143488783|NCT02109484|517331341|FG002|Overall Study|Lost to Follow-up|0|||
143488784|NCT02109484|517331342|FG003|Overall Study|Lost to Follow-up|1|||
143488785|NCT02109484|517331343|FG004|Overall Study|Lost to Follow-up|1|||
143488786|NCT02109484|517331344|FG005|Overall Study|Lost to Follow-up|0|||
143488787|NCT02109484|517331345|FG006|Overall Study|Lost to Follow-up|1|||
143488788|NCT02109484|517331346|FG007|Overall Study|Lost to Follow-up|0|||
143488789|NCT02109484|517331339|FG000|Overall Study|Withdrawal by Subject|0|||
143488790|NCT02109484|517331340|FG001|Overall Study|Withdrawal by Subject|0|||
143488791|NCT02109484|517331341|FG002|Overall Study|Withdrawal by Subject|0|||
143488792|NCT02109484|517331342|FG003|Overall Study|Withdrawal by Subject|0|||
143488793|NCT02109484|517331343|FG004|Overall Study|Withdrawal by Subject|1|||
143488794|NCT02109484|517331344|FG005|Overall Study|Withdrawal by Subject|1|||
143488795|NCT02109484|517331345|FG006|Overall Study|Withdrawal by Subject|1|||
143488796|NCT02109484|517331346|FG007|Overall Study|Withdrawal by Subject|0|||
143488797|NCT02109484|517331339|FG000|Overall Study|Physician Decision|0|||
143488798|NCT02109484|517331340|FG001|Overall Study|Physician Decision|0|||
143488799|NCT02109484|517331341|FG002|Overall Study|Physician Decision|0|||
143488800|NCT02109484|517331342|FG003|Overall Study|Physician Decision|0|||
143488801|NCT02109484|517331343|FG004|Overall Study|Physician Decision|2|||
143488802|NCT02109484|517331344|FG005|Overall Study|Physician Decision|0|||
143488803|NCT02109484|517331345|FG006|Overall Study|Physician Decision|0|||
143488804|NCT02109484|517331346|FG007|Overall Study|Physician Decision|0|||
143488805|NCT02109484|517331339|FG000|Overall Study|Death|0|||
143488806|NCT02109484|517331340|FG001|Overall Study|Death|0|||
143488807|NCT02109484|517331341|FG002|Overall Study|Death|0|||
143157829|NCT02181738|516124307|FG002|Overall Study|Poor/Non-Compliance|2|||
143157830|NCT02181738|516124308|FG003|Overall Study|Poor/Non-Compliance|1|||
143157831|NCT02181738|516124305|FG000|Overall Study|Disease Progression|28|||
143157832|NCT02181738|516124306|FG001|Overall Study|Disease Progression|35|||
143157833|NCT02181738|516124307|FG002|Overall Study|Disease Progression|40|||
143157834|NCT02181738|516124308|FG003|Overall Study|Disease Progression|0|||
143157835|NCT02181738|516124305|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
143157836|NCT02181738|516124306|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
143157837|NCT02181738|516124307|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
143157838|NCT02181738|516124308|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
143157839|NCT02181738|516124305|FG000|Overall Study|Study Drug Toxicity|6|||
143157840|NCT02181738|516124306|FG001|Overall Study|Study Drug Toxicity|11|||
143157841|NCT02181738|516124307|FG002|Overall Study|Study Drug Toxicity|8|||
143157842|NCT02181738|516124308|FG003|Overall Study|Study Drug Toxicity|1|||
143157843|NCT02181738|516124305|FG000|Overall Study|Other Reasons|14|||
143488808|NCT02109484|517331342|FG003|Overall Study|Death|0|||
143488809|NCT02109484|517331343|FG004|Overall Study|Death|0|||
143488810|NCT02109484|517331344|FG005|Overall Study|Death|0|||
143488811|NCT02109484|517331345|FG006|Overall Study|Death|0|||
143157844|NCT02181738|516124306|FG001|Overall Study|Other Reasons|16|||
143157845|NCT02181738|516124307|FG002|Overall Study|Other Reasons|28|||
143488812|NCT02109484|517331346|FG007|Overall Study|Death|2|||
143488813|NCT02109484|517331339|FG000|Overall Study|Moved away from study area|0|||
143488814|NCT02109484|517331340|FG001|Overall Study|Moved away from study area|0|||
143488815|NCT02109484|517331341|FG002|Overall Study|Moved away from study area|0|||
143488816|NCT02109484|517331342|FG003|Overall Study|Moved away from study area|0|||
143488817|NCT02109484|517331343|FG004|Overall Study|Moved away from study area|0|||
143488818|NCT02109484|517331344|FG005|Overall Study|Moved away from study area|0|||
143488819|NCT02109484|517331345|FG006|Overall Study|Moved away from study area|1|||
143488820|NCT02109484|517331346|FG007|Overall Study|Moved away from study area|1|||
143488821|NCT01097863|517331347|FG000|Overall Study|Discomfort|1|||
143488822|NCT01097863|517331348|FG001|Overall Study|Discomfort|0|||
143488823|NCT01097863|517331349|FG002|Overall Study|Discomfort|1|||
143488824|NCT01097863|517331347|FG000|Overall Study|Did not return for final visit|0|||
143488825|NCT01097863|517331348|FG001|Overall Study|Did not return for final visit|0|||
143488826|NCT01097863|517331349|FG002|Overall Study|Did not return for final visit|1|||
143488827|NCT00419380|517331350|FG000|Overall Study|Lack of Efficacy|1|||
143488828|NCT00419380|517331351|FG001|Overall Study|Lack of Efficacy|7|||
143488829|NCT00419380|517331350|FG000|Overall Study|Physician Decision|0|||
143488830|NCT00419380|517331351|FG001|Overall Study|Physician Decision|1|||
143488831|NCT00419380|517331350|FG000|Overall Study|Lost to Follow-up|0|||
143488832|NCT00419380|517331351|FG001|Overall Study|Lost to Follow-up|1|||
143488833|NCT00419380|517331350|FG000|Overall Study|Withdrawal by Subject|0|||
143488834|NCT00419380|517331351|FG001|Overall Study|Withdrawal by Subject|1|||
143488835|NCT03099707|517331352|FG000|Overall Study|Withdrawal by Subject|0|||
143488836|NCT03099707|517331353|FG001|Overall Study|Withdrawal by Subject|3|||
143488837|NCT03099707|517331352|FG000|Overall Study|Lost to Follow-up|0|||
143488838|NCT03099707|517331353|FG001|Overall Study|Lost to Follow-up|1|||
143488839|NCT01400451|517331360|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
143488840|NCT01400451|517331361|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
143488841|NCT01400451|517331362|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
143488842|NCT01400451|517331360|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
143488843|NCT01400451|517331361|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
143488844|NCT01400451|517331362|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
143488845|NCT01400451|517331360|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
143488846|NCT01400451|517331361|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
143488847|NCT01400451|517331362|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
143488848|NCT01400451|517331360|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
143488849|NCT01400451|517331361|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
143488850|NCT01400451|517331362|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
143488851|NCT01400451|517331360|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
143488852|NCT01400451|517331361|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
143488853|NCT01400451|517331362|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
143488854|NCT03215771|517331365|FG000|Overall Study|Withdrawal by Subject|2|||
143488855|NCT03215771|517331365|FG000|Overall Study|Physician Decision|1|||
143488856|NCT00574275|517331370|FG000|Overall Study|Randomized but not treated|2|||
143488857|NCT00574275|517331371|FG001|Overall Study|Randomized but not treated|3|||
143488858|NCT00574275|517331370|FG000|Overall Study|Adverse Event|32|||
143488859|NCT00574275|517331371|FG001|Overall Study|Adverse Event|76|||
143488860|NCT00574275|517331370|FG000|Overall Study|Disease progression|160|||
143488861|NCT00574275|517331371|FG001|Overall Study|Disease progression|146|||
143488862|NCT00574275|517331370|FG000|Overall Study|Lost to Follow-up|2|||
143488863|NCT00574275|517331371|FG001|Overall Study|Lost to Follow-up|1|||
143488864|NCT00574275|517331370|FG000|Overall Study|Study stopped based on DMC decision|62|||
143488865|NCT00574275|517331371|FG001|Overall Study|Study stopped based on DMC decision|23|||
143488866|NCT00574275|517331370|FG000|Overall Study|Withdrawal by Subject|15|||
143488867|NCT00574275|517331371|FG001|Overall Study|Withdrawal by Subject|17|||
143488868|NCT00574275|517331370|FG000|Overall Study|Error calculating tumor measurement|1|||
143488869|NCT00574275|517331371|FG001|Overall Study|Error calculating tumor measurement|0|||
143488870|NCT00574275|517331370|FG000|Overall Study|Physician Decision|1|||
143488871|NCT00574275|517331371|FG001|Overall Study|Physician Decision|1|||
143488872|NCT00574275|517331370|FG000|Overall Study|Protocol Violation|0|||
143488873|NCT00574275|517331371|FG001|Overall Study|Protocol Violation|1|||
143488874|NCT00574275|517331370|FG000|Overall Study|Patient and Investigator decision|0|||
143157846|NCT02181738|516124308|FG003|Overall Study|Other Reasons|0|||
143157847|NCT02181738|516124305|FG000|Overall Study|Maximum Clinical Benefit|3|||
143488875|NCT00574275|517331371|FG001|Overall Study|Patient and Investigator decision|1|||
143488876|NCT00574275|517331370|FG000|Overall Study|Insurance change|0|||
143488877|NCT00574275|517331371|FG001|Overall Study|Insurance change|1|||
143488878|NCT00574275|517331370|FG000|Overall Study|Operation for curative intent|0|||
143488879|NCT00574275|517331371|FG001|Overall Study|Operation for curative intent|1|||
143488880|NCT02703311|517331372|FG000|Overall Study|Death|5|||
143488881|NCT02703311|517331372|FG000|Overall Study|Withdrawal by Subject|3|||
143488882|NCT01967537|517331373|FG000|Overall Study|Withdrawal by Subject|52|||
143488883|NCT01967537|517331373|FG000|Overall Study|Refuse treatment|2|||
143488884|NCT01967537|517331373|FG000|Overall Study|Lost to Follow-up|6|||
143488885|NCT00137111|517331374|FG000|Total Therapy|Death|35|||
143488886|NCT00137111|517331375|FG001|Total Therapy|Death|0|||
143488887|NCT00137111|517331376|FG002|Total Therapy|Death|0|||
143488888|NCT00137111|517331377|FG003|Total Therapy|Death|0|||
143488889|NCT00137111|517331374|FG000|Total Therapy|Non Compliance|5|||
143488890|NCT00137111|517331375|FG001|Total Therapy|Non Compliance|0|||
143488891|NCT00137111|517331376|FG002|Total Therapy|Non Compliance|0|||
143488892|NCT00137111|517331377|FG003|Total Therapy|Non Compliance|0|||
143488893|NCT00562354|517331378|FG000|Overall Study|Physician Decision|0|||
143488894|NCT00562354|517331379|FG001|Overall Study|Physician Decision|1|||
143488895|NCT00562354|517331378|FG000|Overall Study|Lost to Follow-up|0|||
143488896|NCT00562354|517331379|FG001|Overall Study|Lost to Follow-up|1|||
143488897|NCT00784654|517331380|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
143488898|NCT00784654|517331381|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
143488899|NCT00784654|517331382|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
143488900|NCT00784654|517331380|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
143488901|NCT00784654|517331381|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
143488902|NCT00784654|517331382|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
143488903|NCT00784654|517331380|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
143488904|NCT00784654|517331381|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
143488905|NCT00784654|517331382|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
143488906|NCT00784654|517331380|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
143488907|NCT00784654|517331381|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
143488908|NCT00784654|517331382|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
143488909|NCT00784654|517331380|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
143488910|NCT00784654|517331381|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
143488911|NCT00784654|517331382|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
143488912|NCT00784654|517331380|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
143488913|NCT00784654|517331381|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
143488914|NCT00784654|517331382|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
143488915|NCT00784654|517331380|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
143488916|NCT00784654|517331381|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
143488917|NCT00784654|517331382|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
143488918|NCT00784654|517331380|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
143488919|NCT00784654|517331381|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
143488920|NCT00784654|517331382|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
143488921|NCT00784654|517331380|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
143488922|NCT00784654|517331381|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
143488923|NCT00784654|517331382|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
143488924|NCT00784654|517331380|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
143488925|NCT00784654|517331381|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
143488926|NCT00784654|517331382|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
143488927|NCT00784654|517331380|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
143488928|NCT00784654|517331381|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
143488929|NCT00784654|517331382|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
143488930|NCT00784654|517331380|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
143488931|NCT00784654|517331381|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
143488932|NCT00784654|517331382|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
143488933|NCT00784654|517331380|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
143488934|NCT00784654|517331381|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
143488935|NCT00784654|517331382|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
143488936|NCT00784654|517331380|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
143488937|NCT00784654|517331381|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
143488938|NCT00784654|517331382|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
143488939|NCT00784654|517331380|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
143488940|NCT00784654|517331381|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
143488941|NCT00784654|517331382|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
143488942|NCT00784654|517331380|FG000|Randomized Withdrawal Period|Adverse Event|0|||
143488943|NCT00784654|517331381|FG001|Randomized Withdrawal Period|Adverse Event|1|||
143488944|NCT00784654|517331382|FG002|Randomized Withdrawal Period|Adverse Event|1|||
143488945|NCT00784654|517331380|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
143488946|NCT00784654|517331381|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
143488947|NCT00784654|517331382|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
143488948|NCT00784654|517331380|FG000|Randomized Withdrawal Period|Family reasons|0|||
143488949|NCT00784654|517331381|FG001|Randomized Withdrawal Period|Family reasons|0|||
143488950|NCT00784654|517331382|FG002|Randomized Withdrawal Period|Family reasons|1|||
143488951|NCT00317109|517331383|FG000|Overall Study|Withdrawal by Subject|2|||
143488952|NCT00317109|517331384|FG001|Overall Study|Withdrawal by Subject|0|||
143488953|NCT00317109|517331383|FG000|Overall Study|Migated/moved from study area|1|||
143488954|NCT00317109|517331384|FG001|Overall Study|Migated/moved from study area|0|||
143488955|NCT01079182|517331385|FG000|Overall Study|Lost to Follow-up|1634|||
143488956|NCT01079182|517331385|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
143488957|NCT01079182|517331385|FG000|Overall Study|Lack of Efficacy|514|||
143488958|NCT01079182|517331385|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
143488959|NCT01079182|517331385|FG000|Overall Study|Reasons not Evaluated|271|||
143488960|NCT01026831|517331386|FG000|Overall Study|Adverse Event|4|||
143488961|NCT01026831|517331387|FG001|Overall Study|Adverse Event|3|||
143488962|NCT01026831|517331386|FG000|Overall Study|Lost to Follow-up|2|||
143488963|NCT01026831|517331387|FG001|Overall Study|Lost to Follow-up|0|||
143488964|NCT01026831|517331386|FG000|Overall Study|Physician Decision|1|||
143488965|NCT01026831|517331387|FG001|Overall Study|Physician Decision|1|||
143488966|NCT01026831|517331386|FG000|Overall Study|Protocol Violation|0|||
143488967|NCT01026831|517331387|FG001|Overall Study|Protocol Violation|2|||
143488968|NCT01026831|517331386|FG000|Overall Study|Withdrawal by Subject|7|||
143488969|NCT01026831|517331387|FG001|Overall Study|Withdrawal by Subject|5|||
143488970|NCT04417894|517331389|FG000|Overall Study|Lost to Follow-up|3|||
143488971|NCT04417894|517331390|FG001|Overall Study|Lost to Follow-up|0|||
143488972|NCT04417894|517331389|FG000|Overall Study|Withdrawal by Subject|7|||
143488973|NCT04417894|517331390|FG001|Overall Study|Withdrawal by Subject|6|||
143488974|NCT04417894|517331389|FG000|Overall Study|Lack of Efficacy|3|||
143488975|NCT04417894|517331390|FG001|Overall Study|Lack of Efficacy|1|||
143488976|NCT01508702|517331391|FG000|Overall Study|Adverse Event|7|||
143488977|NCT01508702|517331392|FG001|Overall Study|Adverse Event|3|||
143488978|NCT01508702|517331391|FG000|Overall Study|Gout flare|2|||
143488979|NCT01508702|517331392|FG001|Overall Study|Gout flare|0|||
143488980|NCT01508702|517331391|FG000|Overall Study|Protocol Violation|2|||
143488981|NCT01508702|517331392|FG001|Overall Study|Protocol Violation|1|||
143488982|NCT01508702|517331391|FG000|Overall Study|Lost to Follow-up|1|||
143488983|NCT01508702|517331392|FG001|Overall Study|Lost to Follow-up|2|||
143488984|NCT01508702|517331391|FG000|Overall Study|Withdrawal by Subject|11|||
143488985|NCT01508702|517331392|FG001|Overall Study|Withdrawal by Subject|7|||
143488986|NCT03461757|517331393|FG000|Overall Study|Adverse Event|1|||
143488987|NCT03461757|517331394|FG001|Overall Study|Adverse Event|0|||
143488988|NCT03461757|517331393|FG000|Overall Study|Lost to Follow-up|13|||
143488989|NCT03461757|517331394|FG001|Overall Study|Lost to Follow-up|7|||
143488990|NCT03461757|517331393|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
143488991|NCT03461757|517331394|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
143488992|NCT03461757|517331393|FG000|Overall Study|Non-compliance with study treatment|0|||
143488993|NCT03461757|517331394|FG001|Overall Study|Non-compliance with study treatment|1|||
143488994|NCT03461757|517331393|FG000|Overall Study|Pregnancy|2|||
143488995|NCT03461757|517331394|FG001|Overall Study|Pregnancy|0|||
143488996|NCT03461757|517331393|FG000|Overall Study|Protocol Violation|1|||
143488997|NCT03461757|517331394|FG001|Overall Study|Protocol Violation|1|||
143488998|NCT03461757|517331393|FG000|Overall Study|Withdrawal by Subject|7|||
143488999|NCT03461757|517331394|FG001|Overall Study|Withdrawal by Subject|7|||
143489000|NCT03461757|517331393|FG000|Overall Study|Other Reasons|1|||
143489001|NCT03461757|517331394|FG001|Overall Study|Other Reasons|4|||
143489002|NCT02425826|517331395|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
143489003|NCT02425826|517331396|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
143489004|NCT02425826|517331397|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
143489005|NCT02425826|517331395|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
143489006|NCT02425826|517331396|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
143489007|NCT02425826|517331397|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
143489008|NCT02425826|517331395|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
143489009|NCT02425826|517331396|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
143489010|NCT02425826|517331397|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
143489011|NCT02425826|517331395|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
143489012|NCT02425826|517331396|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
143157848|NCT02181738|516124306|FG001|Overall Study|Maximum Clinical Benefit|0|||
143157849|NCT02181738|516124307|FG002|Overall Study|Maximum Clinical Benefit|1|||
143157850|NCT02181738|516124308|FG003|Overall Study|Maximum Clinical Benefit|0|||
143489013|NCT02425826|517331397|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
143489014|NCT02425826|517331395|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
143489015|NCT02425826|517331396|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
143489016|NCT02425826|517331397|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
143489017|NCT02425826|517331395|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
143489018|NCT02425826|517331396|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
143489019|NCT02425826|517331397|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
143489020|NCT02425826|517331395|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
143489021|NCT02425826|517331396|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
143489022|NCT02425826|517331397|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
143489023|NCT02425826|517331395|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
143236725|NCT03866577|516419575|FG012|Overall Study|Protocol Violation|0|||
143236726|NCT03866577|516419563|FG000|Overall Study|Withdrawal by Subject|0|||
143236727|NCT03866577|516419564|FG001|Overall Study|Withdrawal by Subject|0|||
143236728|NCT03866577|516419565|FG002|Overall Study|Withdrawal by Subject|0|||
143236729|NCT03866577|516419566|FG003|Overall Study|Withdrawal by Subject|0|||
143236730|NCT03866577|516419567|FG004|Overall Study|Withdrawal by Subject|0|||
143236731|NCT03866577|516419568|FG005|Overall Study|Withdrawal by Subject|0|||
143363847|NCT00049517|516875455|FG005|Conditioning/Transplant|Disease progression|0|||
143363848|NCT00049517|516875450|FG000|Conditioning/Transplant|Adverse Event|2|||
143363849|NCT00049517|516875451|FG001|Conditioning/Transplant|Adverse Event|1|||
143489024|NCT02425826|517331396|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
143489025|NCT02425826|517331397|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
143489026|NCT02425826|517331395|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
143489027|NCT02425826|517331396|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
143489028|NCT02425826|517331397|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
143489029|NCT02425826|517331395|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
143489030|NCT02425826|517331396|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
143489031|NCT02425826|517331397|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
143489032|NCT03368170|517334354|FG000|Overall Study|Adverse Event|2|||
143489033|NCT03368170|517334355|FG001|Overall Study|Adverse Event|1|||
143489034|NCT00328627|517334363|FG000|Overall Study|Hyperglycemic Rescue|41|||
143489035|NCT00328627|517334364|FG001|Overall Study|Hyperglycemic Rescue|18|||
143489036|NCT00328627|517334365|FG002|Overall Study|Hyperglycemic Rescue|16|||
143489037|NCT00328627|517334366|FG003|Overall Study|Hyperglycemic Rescue|13|||
143489038|NCT00328627|517334367|FG004|Overall Study|Hyperglycemic Rescue|6|||
143489039|NCT00328627|517334368|FG005|Overall Study|Hyperglycemic Rescue|5|||
143489040|NCT00328627|517334369|FG006|Overall Study|Hyperglycemic Rescue|19|||
143489041|NCT00328627|517334370|FG007|Overall Study|Hyperglycemic Rescue|6|||
143489042|NCT00328627|517334371|FG008|Overall Study|Hyperglycemic Rescue|6|||
143489043|NCT00328627|517334372|FG009|Overall Study|Hyperglycemic Rescue|11|||
143489044|NCT00328627|517334373|FG010|Overall Study|Hyperglycemic Rescue|3|||
143489045|NCT00328627|517334374|FG011|Overall Study|Hyperglycemic Rescue|2|||
143489046|NCT00328627|517334363|FG000|Overall Study|Adverse Event|3|||
143489047|NCT00328627|517334364|FG001|Overall Study|Adverse Event|1|||
143489048|NCT00328627|517334365|FG002|Overall Study|Adverse Event|2|||
143489049|NCT00328627|517334366|FG003|Overall Study|Adverse Event|3|||
143489050|NCT00328627|517334367|FG004|Overall Study|Adverse Event|1|||
143489051|NCT00328627|517334368|FG005|Overall Study|Adverse Event|2|||
143489052|NCT00328627|517334369|FG006|Overall Study|Adverse Event|1|||
143489053|NCT00328627|517334370|FG007|Overall Study|Adverse Event|2|||
143489054|NCT00328627|517334371|FG008|Overall Study|Adverse Event|0|||
143489055|NCT00328627|517334372|FG009|Overall Study|Adverse Event|7|||
143489056|NCT00328627|517334373|FG010|Overall Study|Adverse Event|5|||
143489057|NCT00328627|517334374|FG011|Overall Study|Adverse Event|4|||
143489058|NCT00328627|517334363|FG000|Overall Study|Protocol Violation|2|||
143489059|NCT00328627|517334364|FG001|Overall Study|Protocol Violation|2|||
143489060|NCT00328627|517334365|FG002|Overall Study|Protocol Violation|2|||
143489061|NCT00328627|517334366|FG003|Overall Study|Protocol Violation|8|||
143489062|NCT00328627|517334367|FG004|Overall Study|Protocol Violation|5|||
143489063|NCT00328627|517334368|FG005|Overall Study|Protocol Violation|5|||
143489064|NCT00328627|517334369|FG006|Overall Study|Protocol Violation|6|||
143489065|NCT00328627|517334370|FG007|Overall Study|Protocol Violation|2|||
143489066|NCT00328627|517334371|FG008|Overall Study|Protocol Violation|1|||
143489067|NCT00328627|517334372|FG009|Overall Study|Protocol Violation|4|||
143489068|NCT00328627|517334373|FG010|Overall Study|Protocol Violation|6|||
143489069|NCT00328627|517334374|FG011|Overall Study|Protocol Violation|2|||
143489070|NCT00328627|517334363|FG000|Overall Study|Lost to Follow-up|4|||
143489071|NCT00328627|517334364|FG001|Overall Study|Lost to Follow-up|2|||
143489072|NCT00328627|517334365|FG002|Overall Study|Lost to Follow-up|2|||
143489073|NCT00328627|517334366|FG003|Overall Study|Lost to Follow-up|4|||
143489074|NCT00328627|517334367|FG004|Overall Study|Lost to Follow-up|0|||
143489075|NCT00328627|517334368|FG005|Overall Study|Lost to Follow-up|2|||
143489076|NCT00328627|517334369|FG006|Overall Study|Lost to Follow-up|3|||
143489077|NCT00328627|517334370|FG007|Overall Study|Lost to Follow-up|0|||
143489078|NCT00328627|517334371|FG008|Overall Study|Lost to Follow-up|3|||
143489079|NCT00328627|517334372|FG009|Overall Study|Lost to Follow-up|2|||
143489080|NCT00328627|517334373|FG010|Overall Study|Lost to Follow-up|0|||
143489081|NCT00328627|517334374|FG011|Overall Study|Lost to Follow-up|1|||
143489082|NCT00328627|517334363|FG000|Overall Study|Withdrawal by Subject|5|||
143489083|NCT00328627|517334364|FG001|Overall Study|Withdrawal by Subject|4|||
143489084|NCT00328627|517334365|FG002|Overall Study|Withdrawal by Subject|5|||
143489085|NCT00328627|517334366|FG003|Overall Study|Withdrawal by Subject|6|||
143489086|NCT00328627|517334367|FG004|Overall Study|Withdrawal by Subject|2|||
143489087|NCT00328627|517334368|FG005|Overall Study|Withdrawal by Subject|5|||
143489088|NCT00328627|517334369|FG006|Overall Study|Withdrawal by Subject|4|||
143363850|NCT00049517|516875452|FG002|Conditioning/Transplant|Adverse Event|4|||
143363851|NCT00049517|516875453|FG003|Conditioning/Transplant|Adverse Event|8|||
143489089|NCT00328627|517334370|FG007|Overall Study|Withdrawal by Subject|4|||
143489090|NCT00328627|517334371|FG008|Overall Study|Withdrawal by Subject|4|||
143489091|NCT00328627|517334372|FG009|Overall Study|Withdrawal by Subject|5|||
143489092|NCT00328627|517334373|FG010|Overall Study|Withdrawal by Subject|2|||
143489093|NCT00328627|517334374|FG011|Overall Study|Withdrawal by Subject|7|||
143489094|NCT00328627|517334363|FG000|Overall Study|Pregnancy|0|||
143489095|NCT00328627|517334364|FG001|Overall Study|Pregnancy|1|||
143489096|NCT00328627|517334365|FG002|Overall Study|Pregnancy|0|||
143489097|NCT00328627|517334366|FG003|Overall Study|Pregnancy|0|||
143489098|NCT00328627|517334367|FG004|Overall Study|Pregnancy|0|||
143489099|NCT00328627|517334368|FG005|Overall Study|Pregnancy|0|||
143489100|NCT00328627|517334369|FG006|Overall Study|Pregnancy|0|||
143489101|NCT00328627|517334370|FG007|Overall Study|Pregnancy|0|||
143489102|NCT00328627|517334371|FG008|Overall Study|Pregnancy|0|||
143489103|NCT00328627|517334372|FG009|Overall Study|Pregnancy|0|||
143489104|NCT00328627|517334373|FG010|Overall Study|Pregnancy|0|||
143489105|NCT00328627|517334374|FG011|Overall Study|Pregnancy|0|||
143489106|NCT00328627|517334363|FG000|Overall Study|Physician Decision|4|||
143489107|NCT00328627|517334364|FG001|Overall Study|Physician Decision|3|||
143489108|NCT00328627|517334365|FG002|Overall Study|Physician Decision|1|||
143489109|NCT00328627|517334366|FG003|Overall Study|Physician Decision|2|||
143489110|NCT00328627|517334367|FG004|Overall Study|Physician Decision|1|||
143489111|NCT00328627|517334368|FG005|Overall Study|Physician Decision|1|||
143489112|NCT00328627|517334369|FG006|Overall Study|Physician Decision|1|||
143489113|NCT00328627|517334370|FG007|Overall Study|Physician Decision|0|||
143489114|NCT00328627|517334371|FG008|Overall Study|Physician Decision|3|||
143489115|NCT00328627|517334372|FG009|Overall Study|Physician Decision|2|||
143489116|NCT00328627|517334373|FG010|Overall Study|Physician Decision|1|||
143489117|NCT00328627|517334374|FG011|Overall Study|Physician Decision|0|||
143489118|NCT00328627|517334363|FG000|Overall Study|Other|0|||
143489119|NCT00328627|517334364|FG001|Overall Study|Other|0|||
143489120|NCT00328627|517334365|FG002|Overall Study|Other|0|||
143489121|NCT00328627|517334366|FG003|Overall Study|Other|1|||
143489122|NCT00328627|517334367|FG004|Overall Study|Other|0|||
143489123|NCT00328627|517334368|FG005|Overall Study|Other|0|||
143489124|NCT00328627|517334369|FG006|Overall Study|Other|1|||
143489125|NCT00328627|517334370|FG007|Overall Study|Other|0|||
143489126|NCT00328627|517334371|FG008|Overall Study|Other|0|||
143489127|NCT00328627|517334372|FG009|Overall Study|Other|1|||
143489128|NCT00328627|517334373|FG010|Overall Study|Other|1|||
143489129|NCT00328627|517334374|FG011|Overall Study|Other|0|||
143489130|NCT02049944|517334375|FG000|Overall Study|Protocol Violation|2|||
143489131|NCT01765673|517334376|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
143489132|NCT01284114|517334377|FG000|Overall Study|viral infection|1|||
143489133|NCT01284114|517334377|FG000|Overall Study|From the results of ALLTITUDE study|1|||
143489134|NCT01284114|517334377|FG000|Overall Study|Symptomatic hypotension|1|||
143489135|NCT01284114|517334377|FG000|Overall Study|dizziness|1|||
143489136|NCT03445000|517334380|FG000|Overall Study|Disease progression|8|||
143489137|NCT03445000|517334380|FG000|Overall Study|Adverse Event|3|||
143489138|NCT03445000|517334380|FG000|Overall Study|Death|2|||
143489139|NCT03445000|517334380|FG000|Overall Study|Physician Decision|1|||
143489140|NCT00706134|517334381|FG000|Overall Study|Adverse Event|8|||
143489141|NCT00706134|517334382|FG001|Overall Study|Adverse Event|7|||
143489142|NCT00706134|517334383|FG002|Overall Study|Adverse Event|2|||
143489143|NCT00706134|517334384|FG003|Overall Study|Adverse Event|3|||
143489144|NCT00706134|517334381|FG000|Overall Study|Lost to Follow-up|0|||
143489145|NCT00706134|517334382|FG001|Overall Study|Lost to Follow-up|1|||
143489146|NCT00706134|517334383|FG002|Overall Study|Lost to Follow-up|0|||
143489147|NCT00706134|517334384|FG003|Overall Study|Lost to Follow-up|0|||
143489148|NCT00706134|517334381|FG000|Overall Study|Protocol Violation|0|||
143489149|NCT00706134|517334382|FG001|Overall Study|Protocol Violation|6|||
143489150|NCT00706134|517334383|FG002|Overall Study|Protocol Violation|0|||
143489151|NCT00706134|517334384|FG003|Overall Study|Protocol Violation|3|||
143489152|NCT00706134|517334381|FG000|Overall Study|Withdrawal by Subject|1|||
143489153|NCT00706134|517334382|FG001|Overall Study|Withdrawal by Subject|2|||
143489154|NCT00706134|517334383|FG002|Overall Study|Withdrawal by Subject|1|||
143489155|NCT00706134|517334384|FG003|Overall Study|Withdrawal by Subject|0|||
143489156|NCT00706134|517334381|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
143489157|NCT00706134|517334382|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
143489158|NCT00706134|517334383|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
143489159|NCT00706134|517334384|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
143489160|NCT00706134|517334381|FG000|Overall Study|Did not meet study criteria|2|||
143489161|NCT00706134|517334382|FG001|Overall Study|Did not meet study criteria|0|||
143489162|NCT00706134|517334383|FG002|Overall Study|Did not meet study criteria|0|||
143489163|NCT00706134|517334384|FG003|Overall Study|Did not meet study criteria|0|||
143489164|NCT03409744|517334385|FG000|Overall Study|Death|2|||
143489165|NCT03409744|517334385|FG000|Overall Study|Physician Decision|5|||
143489166|NCT03409744|517334385|FG000|Overall Study|Pregnancy|1|||
143489167|NCT03409744|517334385|FG000|Overall Study|Lost to Follow-up|1|||
143489168|NCT03409744|517334385|FG000|Overall Study|Protocol Violation|1|||
143489169|NCT04872101|517334387|FG000|Overall Study|Withdrawal by Subject|10|||
143489170|NCT04872101|517334388|FG001|Overall Study|Withdrawal by Subject|16|||
143489171|NCT04872101|517334387|FG000|Overall Study|Lack of Efficacy|6|||
143489172|NCT04872101|517334388|FG001|Overall Study|Lack of Efficacy|14|||
143489173|NCT04872101|517334387|FG000|Overall Study|Adverse Event|1|||
143489174|NCT04872101|517334388|FG001|Overall Study|Adverse Event|6|||
143489175|NCT04872101|517334387|FG000|Overall Study|Lost to Follow-up|2|||
143489176|NCT04872101|517334388|FG001|Overall Study|Lost to Follow-up|1|||
143489177|NCT04872101|517334387|FG000|Overall Study|Pregnancy|2|||
143489178|NCT04872101|517334388|FG001|Overall Study|Pregnancy|0|||
143489179|NCT04872101|517334387|FG000|Overall Study|Prohibited Medication|1|||
143489180|NCT04872101|517334388|FG001|Overall Study|Prohibited Medication|0|||
143489181|NCT04872101|517334387|FG000|Overall Study|Not dosed|1|||
143489182|NCT04872101|517334388|FG001|Overall Study|Not dosed|0|||
143489183|NCT03691974|517334389|FG000|Overall Study|Physician Decision|1|||
143489184|NCT03691974|517334390|FG001|Overall Study|Physician Decision|0|||
143489185|NCT03691974|517334389|FG000|Overall Study|Adverse Event|1|||
143489186|NCT03691974|517334390|FG001|Overall Study|Adverse Event|0|||
143489187|NCT03691974|517334389|FG000|Overall Study|Withdrawal by Subject|11|||
143489188|NCT03691974|517334390|FG001|Overall Study|Withdrawal by Subject|9|||
143489189|NCT03691974|517334389|FG000|Overall Study|Protocol Violation|1|||
143489190|NCT03691974|517334390|FG001|Overall Study|Protocol Violation|0|||
143489191|NCT03691974|517334389|FG000|Overall Study|Lost to Follow-up|8|||
143489192|NCT03691974|517334390|FG001|Overall Study|Lost to Follow-up|7|||
143489193|NCT00691483|517334391|FG000|Overall Study|Adverse Event|14|||
143489194|NCT00691483|517334392|FG001|Overall Study|Adverse Event|6|||
143489195|NCT00691483|517334391|FG000|Overall Study|Lost to Follow-up|17|||
143489196|NCT00691483|517334392|FG001|Overall Study|Lost to Follow-up|10|||
143489197|NCT00691483|517334391|FG000|Overall Study|Withdrawal by Subject|24|||
143489198|NCT00691483|517334392|FG001|Overall Study|Withdrawal by Subject|7|||
143489199|NCT00691483|517334391|FG000|Overall Study|Other known cause|6|||
143489200|NCT00691483|517334392|FG001|Overall Study|Other known cause|1|||
143489201|NCT00691483|517334391|FG000|Overall Study|Randomized by not treated|7|||
143489202|NCT00691483|517334392|FG001|Overall Study|Randomized by not treated|1|||
143489203|NCT02921971|517334399|FG000|Overall Study|Adverse Event|1|||
143489204|NCT02921971|517334400|FG001|Overall Study|Adverse Event|2|||
143489205|NCT02921971|517334399|FG000|Overall Study|Lack of Efficacy|3|||
143489206|NCT02921971|517334400|FG001|Overall Study|Lack of Efficacy|1|||
143489207|NCT02921971|517334399|FG000|Overall Study|Other than specified above|2|||
143489208|NCT02921971|517334400|FG001|Overall Study|Other than specified above|1|||
143489209|NCT00452699|517334401|FG000|Overall Study|Adverse Event|10|||
143489210|NCT00452699|517334402|FG001|Overall Study|Adverse Event|3|||
143489211|NCT00452699|517334401|FG000|Overall Study|Lack of Efficacy|6|||
143489212|NCT00452699|517334402|FG001|Overall Study|Lack of Efficacy|4|||
143489213|NCT00452699|517334401|FG000|Overall Study|Lost to Follow-up|6|||
143489214|NCT00452699|517334402|FG001|Overall Study|Lost to Follow-up|9|||
143489215|NCT00452699|517334401|FG000|Overall Study|Protocol Violation|21|||
143489216|NCT00452699|517334402|FG001|Overall Study|Protocol Violation|25|||
143489217|NCT00452699|517334401|FG000|Overall Study|Withdrawal by Subject|26|||
143489218|NCT00452699|517334402|FG001|Overall Study|Withdrawal by Subject|25|||
143489219|NCT00452699|517334401|FG000|Overall Study|Other|12|||
143489220|NCT00452699|517334402|FG001|Overall Study|Other|7|||
143489221|NCT02105454|517334403|FG000|Overall Study|Withdrawal by Subject|1|||
143489222|NCT00493870|517334404|FG000|Overall Study|Lost to Follow-up|12|||
143489223|NCT00493870|517334405|FG001|Overall Study|Lost to Follow-up|15|||
143489224|NCT02721355|517334406|FG000|Overall Study|Lost to Follow-up|6|||
143489225|NCT02721355|517334407|FG001|Overall Study|Lost to Follow-up|1|||
143489226|NCT00883337|517334410|FG000|Core Treatment Period|Adverse Event|9|||
143489227|NCT00883337|517334411|FG001|Core Treatment Period|Adverse Event|12|||
143489228|NCT00883337|517334412|FG002|Core Treatment Period|Adverse Event|22|||
143489229|NCT00883337|517334410|FG000|Core Treatment Period|Lack of Efficacy|7|||
143489230|NCT00883337|517334411|FG001|Core Treatment Period|Lack of Efficacy|4|||
143489231|NCT00883337|517334412|FG002|Core Treatment Period|Lack of Efficacy|2|||
143489232|NCT00883337|517334410|FG000|Core Treatment Period|Lost to Follow-up|1|||
143489233|NCT00883337|517334411|FG001|Core Treatment Period|Lost to Follow-up|1|||
143489234|NCT00883337|517334412|FG002|Core Treatment Period|Lost to Follow-up|0|||
143489235|NCT00883337|517334410|FG000|Core Treatment Period|Withdrawal by Subject|2|||
143489236|NCT00883337|517334411|FG001|Core Treatment Period|Withdrawal by Subject|2|||
143489237|NCT00883337|517334412|FG002|Core Treatment Period|Withdrawal by Subject|6|||
143489238|NCT00883337|517334410|FG000|Core Treatment Period|Wish to be pregnant|1|||
143489239|NCT00883337|517334411|FG001|Core Treatment Period|Wish to be pregnant|2|||
143489240|NCT00883337|517334412|FG002|Core Treatment Period|Wish to be pregnant|1|||
143489241|NCT00883337|517334410|FG000|Core Treatment Period|Poor compliance to protocol|0|||
143489242|NCT00883337|517334411|FG001|Core Treatment Period|Poor compliance to protocol|0|||
143489243|NCT00883337|517334412|FG002|Core Treatment Period|Poor compliance to protocol|1|||
143489244|NCT00883337|517334410|FG000|Core Treatment Period|Other than above|0|||
143489245|NCT00883337|517334411|FG001|Core Treatment Period|Other than above|1|||
143489246|NCT00883337|517334412|FG002|Core Treatment Period|Other than above|1|||
143489247|NCT00883337|517334410|FG000|Extension Treatment Period|Adverse Event|8|||
143489248|NCT00883337|517334411|FG001|Extension Treatment Period|Adverse Event|5|||
143489249|NCT00883337|517334412|FG002|Extension Treatment Period|Adverse Event|5|||
143489250|NCT00883337|517334410|FG000|Extension Treatment Period|Lack of Efficacy|8|||
143489251|NCT00883337|517334411|FG001|Extension Treatment Period|Lack of Efficacy|8|||
143489252|NCT00883337|517334412|FG002|Extension Treatment Period|Lack of Efficacy|8|||
143024932|NCT01388647|515631218|FG000|Overall Study|Adverse Event|1|||
143024933|NCT01388647|515631219|FG001|Overall Study|Adverse Event|2|||
143489253|NCT00883337|517334410|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
143489254|NCT00883337|517334411|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
143489255|NCT00883337|517334412|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
143489256|NCT00883337|517334410|FG000|Extension Treatment Period|Lost to Follow-up|1|||
143489257|NCT00883337|517334411|FG001|Extension Treatment Period|Lost to Follow-up|0|||
143489258|NCT00883337|517334412|FG002|Extension Treatment Period|Lost to Follow-up|0|||
143489259|NCT00883337|517334410|FG000|Extension Treatment Period|Other than above|10|||
143489260|NCT00883337|517334411|FG001|Extension Treatment Period|Other than above|9|||
143489261|NCT00883337|517334412|FG002|Extension Treatment Period|Other than above|5|||
143489262|NCT01652287|517334414|FG000|Overall Study|Withdrawal by Subject|2|||
143489263|NCT01652287|517334415|FG001|Overall Study|Withdrawal by Subject|0|||
143489264|NCT00763139|517334421|FG000|Overall Study|Adverse Event|4|||
143489265|NCT00763139|517334422|FG001|Overall Study|Adverse Event|2|||
143489266|NCT00763139|517334421|FG000|Overall Study|Withdrawal by Subject|0|||
143489267|NCT00763139|517334422|FG001|Overall Study|Withdrawal by Subject|1|||
143489268|NCT00763139|517334421|FG000|Overall Study|med change not allowed by protocol|1|||
143489269|NCT00763139|517334422|FG001|Overall Study|med change not allowed by protocol|0|||
143489270|NCT01592760|517334423|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
143489271|NCT01592760|517334424|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
143489272|NCT01592760|517334425|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
143489273|NCT04312009|517334426|FG000|Overall Study|Withdrawal by Subject|2|||
143489274|NCT04312009|517334427|FG001|Overall Study|Withdrawal by Subject|1|||
143489275|NCT01363986|517334430|FG000|Overall Study|Disease progression|1|||
143489276|NCT01637142|517334431|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
143489277|NCT02354703|517334432|FG000|Overall Study|Withdrawal by Subject|1|||
143489278|NCT02354703|517334433|FG001|Overall Study|Withdrawal by Subject|1|||
143489279|NCT02354703|517334434|FG002|Overall Study|Withdrawal by Subject|1|||
143489280|NCT02354703|517334435|FG003|Overall Study|Withdrawal by Subject|1|||
143489281|NCT02354703|517334432|FG000|Overall Study|Lost to Follow-up|2|||
143489282|NCT02354703|517334433|FG001|Overall Study|Lost to Follow-up|7|||
143489283|NCT02354703|517334434|FG002|Overall Study|Lost to Follow-up|9|||
143489284|NCT02354703|517334435|FG003|Overall Study|Lost to Follow-up|2|||
143489285|NCT02354703|517334432|FG000|Overall Study|Adverse Event|0|||
143489286|NCT02354703|517334433|FG001|Overall Study|Adverse Event|0|||
143489287|NCT02354703|517334434|FG002|Overall Study|Adverse Event|1|||
143489288|NCT02354703|517334435|FG003|Overall Study|Adverse Event|0|||
143489289|NCT04681170|517334440|FG000|Stratified Enrolment & run-in|Death|1|||
143489290|NCT04681170|517334441|FG001|Stratified Enrolment & run-in|Death|0|||
143489291|NCT04681170|517334440|FG000|Stratified Enrolment & run-in|Withdrawal by Subject|0|||
143489292|NCT04681170|517334441|FG001|Stratified Enrolment & run-in|Withdrawal by Subject|1|||
143489293|NCT04681170|517334440|FG000|Stratified Enrolment & run-in|Protocol Violation|0|||
143489294|NCT04681170|517334441|FG001|Stratified Enrolment & run-in|Protocol Violation|1|||
143489295|NCT04681170|517334440|FG000|Open Label Efficacy Phase|Adverse Event|0|||
143489296|NCT04681170|517334441|FG001|Open Label Efficacy Phase|Adverse Event|2|||
143489297|NCT04681170|517334440|FG000|Open Label Safety Phase|Withdrawal by Subject|0|||
143489298|NCT04681170|517334441|FG001|Open Label Safety Phase|Withdrawal by Subject|1|||
143489299|NCT04681170|517334440|FG000|Open Label Safety Phase|AEs and none compliance|0|||
143489300|NCT04681170|517334441|FG001|Open Label Safety Phase|AEs and none compliance|1|||
143489301|NCT02468648|517334442|FG000|Overall Study|Death|1|||
143489302|NCT05131204|517334443|FG000|Overall Study|Sponsor request|2|||
143489303|NCT05131204|517334444|FG001|Overall Study|Sponsor request|1|||
143489304|NCT04232696|517334445|FG000|Overall Study|Implant attempted but not completed|5|||
143024934|NCT01507896|515631220|FG000|Overall Study|Withdrawal by Subject|1|||
143024935|NCT01507896|515631220|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
143024936|NCT00818623|515631223|FG000|Overall Study|Adverse Event|1|||
143489305|NCT04232696|517334446|FG001|Overall Study|Implant attempted but not completed|2|||
143489306|NCT04232696|517334445|FG000|Overall Study|Not satisfied with therapy outcome|0|||
143489307|NCT04232696|517334446|FG001|Overall Study|Not satisfied with therapy outcome|8|||
143489308|NCT04232696|517334445|FG000|Overall Study|Adverse Event|0|||
143489309|NCT04232696|517334446|FG001|Overall Study|Adverse Event|3|||
143489310|NCT04232696|517334445|FG000|Overall Study|Withdrawal by Subject|0|||
143489311|NCT04232696|517334446|FG001|Overall Study|Withdrawal by Subject|3|||
143489312|NCT04232696|517334445|FG000|Overall Study|Missed Visit|0|||
143489313|NCT04232696|517334446|FG001|Overall Study|Missed Visit|2|||
143489314|NCT04232696|517334445|FG000|Overall Study|Other reason|0|||
143489315|NCT04232696|517334446|FG001|Overall Study|Other reason|1|||
143489316|NCT02787863|517334447|FG000|Overall Study|Death|1|||
143489317|NCT02787863|517334448|FG001|Overall Study|Death|0|||
143157851|NCT02181738|516124305|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
143236732|NCT03866577|516419569|FG006|Overall Study|Withdrawal by Subject|0|||
143236733|NCT03866577|516419570|FG007|Overall Study|Withdrawal by Subject|0|||
143236734|NCT03866577|516419571|FG008|Overall Study|Withdrawal by Subject|1|||
143236735|NCT03866577|516419572|FG009|Overall Study|Withdrawal by Subject|1|||
143236736|NCT03866577|516419573|FG010|Overall Study|Withdrawal by Subject|0|||
143236737|NCT03866577|516419574|FG011|Overall Study|Withdrawal by Subject|0|||
143236738|NCT03866577|516419575|FG012|Overall Study|Withdrawal by Subject|0|||
143236739|NCT03866577|516419563|FG000|Overall Study|Not qualified for IVIg infusion|0|||
143236740|NCT03866577|516419564|FG001|Overall Study|Not qualified for IVIg infusion|0|||
143236741|NCT03866577|516419565|FG002|Overall Study|Not qualified for IVIg infusion|0|||
143489318|NCT02787863|517334449|FG002|Overall Study|Death|1|||
143489319|NCT02787863|517334450|FG003|Overall Study|Death|0|||
143489320|NCT02787863|517334451|FG004|Overall Study|Death|0|||
143489321|NCT02787863|517334452|FG005|Overall Study|Death|0|||
143489322|NCT02787863|517334453|FG006|Overall Study|Death|0|||
143489323|NCT02787863|517334454|FG007|Overall Study|Death|0|||
143489324|NCT02787863|517334447|FG000|Overall Study|Withdrawal by Subject|0|||
143489325|NCT02787863|517334448|FG001|Overall Study|Withdrawal by Subject|1|||
143489326|NCT02787863|517334449|FG002|Overall Study|Withdrawal by Subject|1|||
143489327|NCT02787863|517334450|FG003|Overall Study|Withdrawal by Subject|0|||
143489328|NCT02787863|517334451|FG004|Overall Study|Withdrawal by Subject|0|||
143489329|NCT02787863|517334452|FG005|Overall Study|Withdrawal by Subject|0|||
143489330|NCT02787863|517334453|FG006|Overall Study|Withdrawal by Subject|0|||
143157852|NCT02181738|516124306|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
143157853|NCT02181738|516124307|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
143157854|NCT02181738|516124308|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
143157855|NCT00114777|516124309|FG000|Randomization to Month 36|Death|10|||
143157856|NCT00114777|516124310|FG001|Randomization to Month 36|Death|4|||
143157857|NCT00114777|516124311|FG002|Randomization to Month 36|Death|3|||
143157858|NCT00114777|516124309|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
143157859|NCT00114777|516124310|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
143157860|NCT00114777|516124311|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
143157861|NCT00114777|516124309|FG000|Randomization to Month 36|Lack of Efficacy|19|||
143157862|NCT00114777|516124310|FG001|Randomization to Month 36|Lack of Efficacy|15|||
143157863|NCT00114777|516124311|FG002|Randomization to Month 36|Lack of Efficacy|17|||
143157864|NCT00114777|516124309|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
143157865|NCT00114777|516124310|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
143157866|NCT00114777|516124311|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
143157867|NCT00114777|516124309|FG000|Randomization to Month 36|Adverse Event|34|||
143157868|NCT00114777|516124310|FG001|Randomization to Month 36|Adverse Event|35|||
143157869|NCT00114777|516124311|FG002|Randomization to Month 36|Adverse Event|44|||
143157870|NCT00114777|516124309|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
143157871|NCT00114777|516124310|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
143157872|NCT00114777|516124311|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
143157873|NCT00114777|516124309|FG000|Randomization to Month 36|Other|9|||
143157874|NCT00114777|516124310|FG001|Randomization to Month 36|Other|3|||
143157875|NCT00114777|516124311|FG002|Randomization to Month 36|Other|12|||
143157876|NCT00114777|516124309|FG000|Long-Term Extension to Month 84|Death|8|||
143157877|NCT00114777|516124310|FG001|Long-Term Extension to Month 84|Death|13|||
143157878|NCT00114777|516124311|FG002|Long-Term Extension to Month 84|Death|7|||
143157879|NCT00114777|516124309|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
143157880|NCT00114777|516124310|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
143157881|NCT00114777|516124311|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
143157882|NCT00114777|516124309|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
143157883|NCT00114777|516124310|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
143157884|NCT00114777|516124311|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
143157885|NCT00114777|516124309|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
143157886|NCT00114777|516124310|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
143157887|NCT00114777|516124311|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
143157888|NCT00114777|516124309|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
143157889|NCT00114777|516124310|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
143157890|NCT00114777|516124311|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
143157891|NCT00114777|516124309|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
143157892|NCT00114777|516124310|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
143157893|NCT00114777|516124311|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
143363852|NCT00049517|516875454|FG004|Conditioning/Transplant|Adverse Event|0|||
143024937|NCT00818623|515631224|FG001|Overall Study|Adverse Event|0|||
143236742|NCT03866577|516419566|FG003|Overall Study|Not qualified for IVIg infusion|0|||
143489331|NCT02787863|517334454|FG007|Overall Study|Withdrawal by Subject|0|||
143489332|NCT01368835|517334455|FG000|Overall Study|Inclusion criteria/photography quality|22|||
143489333|NCT01368835|517334455|FG000|Overall Study|Lost to Follow-up|11|||
143489334|NCT01678144|517334456|FG000|Stage 1: MAR Classic|Adverse Event|1|||
143489335|NCT03118297|517334457|FG000|Overall Study|Lost to Follow-up|0|||
143489336|NCT03118297|517334458|FG001|Overall Study|Lost to Follow-up|2|||
143489337|NCT02754726|517334459|FG000|Overall Study|Progressive Disease by RECIST|13|||
143489338|NCT02754726|517334459|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
143489339|NCT02754726|517334459|FG000|Overall Study|Clinical Disease Progression|5|||
143489340|NCT02754726|517334459|FG000|Overall Study|Adverse Event|3|||
143489341|NCT02754726|517334459|FG000|Overall Study|Withdrawal by Subject|1|||
143489342|NCT02754726|517334459|FG000|Overall Study|Tolerability|1|||
143489343|NCT01885000|517334460|FG000|Overall Study|Adverse Event|1|||
143489344|NCT01885000|517334461|FG001|Overall Study|Adverse Event|0|||
143489345|NCT01885000|517334460|FG000|Overall Study|Withdrawal by Subject|1|||
143489346|NCT01885000|517334461|FG001|Overall Study|Withdrawal by Subject|1|||
143489347|NCT01885000|517334460|FG000|Overall Study|Protocol Violation|0|||
143489348|NCT01885000|517334461|FG001|Overall Study|Protocol Violation|1|||
143489349|NCT02162732|517334462|FG000|Overall Study|Biopsy not performed.|18|||
143489350|NCT02363686|517334463|FG000|Overall Study|Withdrawal by Subject|22|||
143489351|NCT02363686|517334463|FG000|Overall Study|incomplete FEES examinations|13|||
143489352|NCT03446885|517334472|FG000|Overall Study|Lost to Follow-up|1|||
143489353|NCT03446885|517334473|FG001|Overall Study|Lost to Follow-up|0|||
143489354|NCT03446885|517334472|FG000|Overall Study|Did not complete entire visit|1|||
143489355|NCT03446885|517334473|FG001|Overall Study|Did not complete entire visit|0|||
143489356|NCT05882318|517334476|FG000|Overall Study|Withdrawal by Subject|1|||
143489357|NCT05882318|517334477|FG001|Overall Study|Withdrawal by Subject|0|||
143489358|NCT05882318|517334476|FG000|Overall Study|Protocol Violation|0|||
143489359|NCT05882318|517334477|FG001|Overall Study|Protocol Violation|1|||
143489360|NCT04735653|517334478|FG000|Overall Study|Lost to Follow-up|17|||
143489361|NCT04735653|517334479|FG001|Overall Study|Lost to Follow-up|7|||
143489362|NCT04735653|517334478|FG000|Overall Study|Withdrawal by Subject|8|||
143489363|NCT04735653|517334479|FG001|Overall Study|Withdrawal by Subject|2|||
143489364|NCT04735653|517334478|FG000|Overall Study|Death|0|||
143489365|NCT04735653|517334479|FG001|Overall Study|Death|2|||
143489366|NCT04735653|517334478|FG000|Overall Study|Removed due to determination of participant noncompliance|2|||
143489367|NCT04735653|517334479|FG001|Overall Study|Removed due to determination of participant noncompliance|0|||
143489368|NCT03557359|517334480|FG000|Dose 1: 240 mg|Adverse Event|1|||
143489369|NCT03557359|517334481|FG001|Dose 1: 240 mg|Adverse Event|0|||
143489370|NCT02264990|517334482|FG000|Overall Study|Death|255|||
143489371|NCT02264990|517334483|FG001|Overall Study|Death|250|||
143489372|NCT02264990|517334482|FG000|Overall Study|Withdrawal by Subject|4|||
143489373|NCT02264990|517334483|FG001|Overall Study|Withdrawal by Subject|5|||
143489374|NCT02264990|517334482|FG000|Overall Study|Lost to Follow-up|1|||
143489375|NCT02264990|517334483|FG001|Overall Study|Lost to Follow-up|3|||
143489376|NCT02264990|517334482|FG000|Overall Study|Other|0|||
143489377|NCT02264990|517334483|FG001|Overall Study|Other|1|||
143489378|NCT01294800|517334485|FG000|Overall Study|Adverse Event|7|||
143489379|NCT01294800|517334486|FG001|Overall Study|Adverse Event|6|||
143489380|NCT01294800|517334487|FG002|Overall Study|Adverse Event|12|||
143489381|NCT01294800|517334488|FG003|Overall Study|Adverse Event|5|||
143489382|NCT01294800|517334485|FG000|Overall Study|Subject Withdrew Consent|2|||
143489383|NCT01294800|517334486|FG001|Overall Study|Subject Withdrew Consent|2|||
143489384|NCT01294800|517334487|FG002|Overall Study|Subject Withdrew Consent|2|||
143489385|NCT01294800|517334488|FG003|Overall Study|Subject Withdrew Consent|11|||
143489386|NCT01294800|517334485|FG000|Overall Study|Lost to Follow-up|0|||
143489387|NCT01294800|517334486|FG001|Overall Study|Lost to Follow-up|0|||
143489388|NCT01294800|517334487|FG002|Overall Study|Lost to Follow-up|1|||
143489389|NCT01294800|517334488|FG003|Overall Study|Lost to Follow-up|0|||
143489390|NCT01294800|517334485|FG000|Overall Study|Non-compliance With Protocol|0|||
143489391|NCT01294800|517334486|FG001|Overall Study|Non-compliance With Protocol|1|||
143489392|NCT01294800|517334487|FG002|Overall Study|Non-compliance With Protocol|1|||
143489393|NCT01294800|517334488|FG003|Overall Study|Non-compliance With Protocol|0|||
143489394|NCT01294800|517334485|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
143489395|NCT01294800|517334486|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
143489396|NCT01294800|517334487|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
143157894|NCT00114777|516124309|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
143157895|NCT00114777|516124310|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
143157896|NCT00114777|516124311|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
143489397|NCT01294800|517334488|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
143489398|NCT01662895|517334495|FG000|Overall Study|Lost to Follow-up|0|||
143489399|NCT01662895|517334496|FG001|Overall Study|Lost to Follow-up|1|||
143489400|NCT00705939|517334497|FG000|Overall Study|Protocol Violation|0|||
143489401|NCT00705939|517334498|FG001|Overall Study|Protocol Violation|0|||
143489402|NCT00705939|517334499|FG002|Overall Study|Protocol Violation|1|||
143489403|NCT00705939|517334497|FG000|Overall Study|Withdrawal by Subject|0|||
143489404|NCT00705939|517334498|FG001|Overall Study|Withdrawal by Subject|1|||
143489405|NCT00705939|517334499|FG002|Overall Study|Withdrawal by Subject|3|||
143489406|NCT00705939|517334497|FG000|Overall Study|Physician Decision|0|||
143489407|NCT00705939|517334498|FG001|Overall Study|Physician Decision|1|||
143489408|NCT00705939|517334499|FG002|Overall Study|Physician Decision|0|||
143489409|NCT01441063|517334500|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
143489410|NCT01441063|517334500|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
143489411|NCT01761266|517336174|FG000|Overall Study|Death|415|||
143489412|NCT01761266|517336175|FG001|Overall Study|Death|402|||
143489413|NCT01761266|517336174|FG000|Overall Study|Lost to Follow-up|8|||
143489414|NCT01761266|517336175|FG001|Overall Study|Lost to Follow-up|12|||
143489415|NCT01761266|517336174|FG000|Overall Study|Withdrawal by Subject|14|||
143489416|NCT01761266|517336175|FG001|Overall Study|Withdrawal by Subject|10|||
143489417|NCT01761266|517336174|FG000|Overall Study|Sponsor Decision|41|||
143489418|NCT01761266|517336175|FG001|Overall Study|Sponsor Decision|52|||
143489419|NCT01662440|517336176|FG000|Overall Study|Adverse Event|1|||
143489420|NCT01662440|517336177|FG001|Overall Study|Adverse Event|0|||
143489421|NCT01662440|517336178|FG002|Overall Study|Adverse Event|0|||
143489422|NCT01662440|517336179|FG003|Overall Study|Adverse Event|1|||
143489423|NCT01662440|517336176|FG000|Overall Study|Death|0|||
143489424|NCT01662440|517336177|FG001|Overall Study|Death|1|||
143489425|NCT01662440|517336178|FG002|Overall Study|Death|0|||
143489426|NCT01662440|517336179|FG003|Overall Study|Death|0|||
143489427|NCT01662440|517336176|FG000|Overall Study|Lost to Follow-up|2|||
143489428|NCT01662440|517336177|FG001|Overall Study|Lost to Follow-up|2|||
143489429|NCT01662440|517336178|FG002|Overall Study|Lost to Follow-up|4|||
143489430|NCT01662440|517336179|FG003|Overall Study|Lost to Follow-up|1|||
143489431|NCT01662440|517336176|FG000|Overall Study|Subject moved to another country.|0|||
143489432|NCT01662440|517336177|FG001|Overall Study|Subject moved to another country.|1|||
143489433|NCT01662440|517336178|FG002|Overall Study|Subject moved to another country.|0|||
143489434|NCT01662440|517336179|FG003|Overall Study|Subject moved to another country.|0|||
143489435|NCT01662440|517336176|FG000|Overall Study|Protocol Violation|1|||
143489436|NCT01662440|517336177|FG001|Overall Study|Protocol Violation|0|||
143489437|NCT01662440|517336178|FG002|Overall Study|Protocol Violation|0|||
143489438|NCT01662440|517336179|FG003|Overall Study|Protocol Violation|0|||
143489439|NCT01662440|517336176|FG000|Overall Study|Withdrawal by Subject|5|||
143489440|NCT01662440|517336177|FG001|Overall Study|Withdrawal by Subject|2|||
143489441|NCT01662440|517336178|FG002|Overall Study|Withdrawal by Subject|2|||
143489442|NCT01662440|517336179|FG003|Overall Study|Withdrawal by Subject|2|||
143489443|NCT00264004|517336180|FG000|Overall Study|Adverse Event|2|||
143489444|NCT00264004|517336181|FG001|Overall Study|Adverse Event|3|||
143489445|NCT00264004|517336182|FG002|Overall Study|Adverse Event|6|||
143489446|NCT00264004|517336183|FG003|Overall Study|Adverse Event|4|||
143489447|NCT00264004|517336180|FG000|Overall Study|Withdrawal by Subject|0|||
143489448|NCT00264004|517336181|FG001|Overall Study|Withdrawal by Subject|1|||
143489449|NCT00264004|517336182|FG002|Overall Study|Withdrawal by Subject|2|||
143489450|NCT00264004|517336183|FG003|Overall Study|Withdrawal by Subject|2|||
143489451|NCT00264004|517336180|FG000|Overall Study|Other|2|||
143489452|NCT00264004|517336181|FG001|Overall Study|Other|2|||
143489453|NCT00264004|517336182|FG002|Overall Study|Other|0|||
143489454|NCT00264004|517336183|FG003|Overall Study|Other|3|||
143489455|NCT00264004|517336180|FG000|Overall Study|Development study specific disc. crit.|1|||
143489456|NCT00264004|517336181|FG001|Overall Study|Development study specific disc. crit.|0|||
143489457|NCT00264004|517336182|FG002|Overall Study|Development study specific disc. crit.|1|||
143489458|NCT00264004|517336183|FG003|Overall Study|Development study specific disc. crit.|0|||
143489459|NCT00264004|517336180|FG000|Overall Study|Cond. under inv. worsened|9|||
143489460|NCT00264004|517336181|FG001|Overall Study|Cond. under inv. worsened|5|||
143489461|NCT00264004|517336182|FG002|Overall Study|Cond. under inv. worsened|3|||
143489462|NCT00264004|517336183|FG003|Overall Study|Cond. under inv. worsened|4|||
143489463|NCT00264004|517336180|FG000|Overall Study|Not treated|3|||
143489464|NCT00264004|517336181|FG001|Overall Study|Not treated|0|||
143489465|NCT00264004|517336182|FG002|Overall Study|Not treated|2|||
143489466|NCT00264004|517336183|FG003|Overall Study|Not treated|2|||
143489467|NCT03860961|517336185|FG000|Overall Study|Withdrawal by Subject|6|||
143489468|NCT03860961|517336186|FG001|Overall Study|Withdrawal by Subject|11|||
143157897|NCT00114777|516124309|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
143489469|NCT03860961|517336185|FG000|Overall Study|Death|10|||
143489470|NCT03860961|517336186|FG001|Overall Study|Death|6|||
143489471|NCT03860961|517336185|FG000|Overall Study|Incomplete two-year data|4|||
143489472|NCT03860961|517336186|FG001|Overall Study|Incomplete two-year data|0|||
143489473|NCT02475681|517336187|FG000|Overall Study|Death|16|||
143157898|NCT00114777|516124310|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
143489474|NCT02475681|517336188|FG001|Overall Study|Death|6|||
143489475|NCT02475681|517336189|FG002|Overall Study|Death|9|||
143489476|NCT02475681|517336187|FG000|Overall Study|Physician Decision|0|||
143489477|NCT02475681|517336188|FG001|Overall Study|Physician Decision|3|||
143363853|NCT00049517|516875455|FG005|Conditioning/Transplant|Adverse Event|0|||
143024938|NCT00818623|515631225|FG002|Overall Study|Adverse Event|1|||
143489478|NCT02475681|517336189|FG002|Overall Study|Physician Decision|1|||
143489479|NCT02475681|517336187|FG000|Overall Study|Withdrawal by Subject|12|||
143489480|NCT02475681|517336188|FG001|Overall Study|Withdrawal by Subject|6|||
143489481|NCT02475681|517336189|FG002|Overall Study|Withdrawal by Subject|9|||
143489482|NCT02475681|517336187|FG000|Overall Study|Lost to Follow-up|2|||
143489483|NCT02475681|517336188|FG001|Overall Study|Lost to Follow-up|1|||
143489484|NCT02475681|517336189|FG002|Overall Study|Lost to Follow-up|3|||
143489485|NCT02475681|517336187|FG000|Overall Study|Ongoing in Study|0|||
143489486|NCT02475681|517336188|FG001|Overall Study|Ongoing in Study|163|||
143489487|NCT02475681|517336189|FG002|Overall Study|Ongoing in Study|157|||
143489488|NCT02475681|517336187|FG000|Overall Study|Reasons other than above listed|2|||
143489489|NCT02475681|517336188|FG001|Overall Study|Reasons other than above listed|0|||
143489490|NCT02475681|517336189|FG002|Overall Study|Reasons other than above listed|0|||
143489491|NCT01745146|517336198|FG000|Overall Study|Withdrawal by Subject|1|||
143489492|NCT01745146|517336199|FG001|Overall Study|Withdrawal by Subject|3|||
143489493|NCT01745146|517336198|FG000|Overall Study|Lost to Follow-up|2|||
143489494|NCT01745146|517336199|FG001|Overall Study|Lost to Follow-up|0|||
143489495|NCT04623242|517336200|FG000|Overall Study|Withdrawal by Subject|7|||
143489496|NCT04623242|517336201|FG001|Overall Study|Withdrawal by Subject|12|||
143489497|NCT04623242|517336202|FG002|Overall Study|Withdrawal by Subject|5|||
143489498|NCT04623242|517336203|FG003|Overall Study|Withdrawal by Subject|7|||
143489499|NCT04623242|517336204|FG004|Overall Study|Withdrawal by Subject|0|||
143489500|NCT04623242|517336200|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
143489501|NCT04623242|517336201|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
143489502|NCT04623242|517336202|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
143489503|NCT04623242|517336203|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
143489504|NCT04623242|517336204|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
143489505|NCT04623242|517336200|FG000|Overall Study|Subject unblinded to mutation status|0|||
143489506|NCT04623242|517336201|FG001|Overall Study|Subject unblinded to mutation status|0|||
143489507|NCT04623242|517336202|FG002|Overall Study|Subject unblinded to mutation status|0|||
143489508|NCT04623242|517336203|FG003|Overall Study|Subject unblinded to mutation status|13|||
143489509|NCT04623242|517336204|FG004|Overall Study|Subject unblinded to mutation status|0|||
143489510|NCT00326898|517336205|FG000|Overall Study|Disease progression|52|||
143489511|NCT00326898|517336206|FG001|Overall Study|Disease progression|54|||
143489512|NCT00326898|517336207|FG002|Overall Study|Disease progression|102|||
143489513|NCT00326898|517336205|FG000|Overall Study|Adverse Event|124|||
143489514|NCT00326898|517336206|FG001|Overall Study|Adverse Event|128|||
143489515|NCT00326898|517336207|FG002|Overall Study|Adverse Event|33|||
143489516|NCT00326898|517336205|FG000|Overall Study|Death|2|||
143489517|NCT00326898|517336206|FG001|Overall Study|Death|0|||
143489518|NCT00326898|517336207|FG002|Overall Study|Death|0|||
143489519|NCT00326898|517336205|FG000|Overall Study|Withdrawal by Subject|134|||
143489520|NCT00326898|517336206|FG001|Overall Study|Withdrawal by Subject|128|||
143489521|NCT00326898|517336207|FG002|Overall Study|Withdrawal by Subject|32|||
143489522|NCT00326898|517336205|FG000|Overall Study|Alternative therapy|1|||
143489523|NCT00326898|517336206|FG001|Overall Study|Alternative therapy|0|||
143489524|NCT00326898|517336207|FG002|Overall Study|Alternative therapy|0|||
143489525|NCT00326898|517336205|FG000|Overall Study|Other complicating disease|5|||
143489526|NCT00326898|517336206|FG001|Overall Study|Other complicating disease|5|||
143157899|NCT00114777|516124311|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
143157900|NCT00114777|516124309|FG000|Long-Term Extension to Month 84|Other|2|||
143157901|NCT00114777|516124310|FG001|Long-Term Extension to Month 84|Other|0|||
143157902|NCT00114777|516124311|FG002|Long-Term Extension to Month 84|Other|2|||
143157903|NCT04477486|516124312|FG000|Overall Study|Death|2|||
143157904|NCT04477486|516124312|FG000|Overall Study|Ongoing at Time of Analysis|11|||
143157905|NCT01851369|516124313|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
143157906|NCT01851369|516124314|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
143157907|NCT01851369|516124315|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
143157908|NCT01851369|516124316|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
143157909|NCT01851369|516124317|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
143157910|NCT01851369|516124318|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
143157911|NCT01851369|516124319|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
143157912|NCT01851369|516124320|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
143157913|NCT01851369|516124321|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
143236743|NCT03866577|516419567|FG004|Overall Study|Not qualified for IVIg infusion|0|||
143363854|NCT00049517|516875450|FG000|Conditioning/Transplant|Death|1|||
143489527|NCT00326898|517336207|FG002|Overall Study|Other complicating disease|4|||
143489528|NCT00326898|517336205|FG000|Overall Study|Other/Missing/Unknown|33|||
143489529|NCT00326898|517336206|FG001|Overall Study|Other/Missing/Unknown|28|||
143489530|NCT00326898|517336207|FG002|Overall Study|Other/Missing/Unknown|32|||
143489531|NCT03847987|517336208|FG000|Overall Study|Lost to Follow-up|1|||
143489532|NCT03847987|517336209|FG001|Overall Study|Lost to Follow-up|0|||
143489533|NCT03847987|517336208|FG000|Overall Study|Adverse Event|2|||
143489534|NCT03847987|517336209|FG001|Overall Study|Adverse Event|0|||
143489535|NCT02111564|517336210|FG000|Overall Study|Death|109|||
143489536|NCT02111564|517336211|FG001|Overall Study|Death|120|||
143489537|NCT02111564|517336210|FG000|Overall Study|Lost to Follow-up|2|||
143489538|NCT02111564|517336211|FG001|Overall Study|Lost to Follow-up|3|||
143489539|NCT02111564|517336210|FG000|Overall Study|Withdrawal by Subject|20|||
143489540|NCT02111564|517336211|FG001|Overall Study|Withdrawal by Subject|20|||
143489541|NCT00687362|517336212|FG000|Overall Study|Protocol Violation|2|||
143489542|NCT00687362|517336212|FG000|Overall Study|Withdrawal by Subject|1|||
143489543|NCT03823391|517336218|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
143489544|NCT03823391|517336219|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
143489545|NCT03823391|517336218|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
143489546|NCT03823391|517336219|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
143489547|NCT03042468|517336226|FG000|Overall Study|Death|0|||
143489548|NCT03042468|517336227|FG001|Overall Study|Death|1|||
143489549|NCT03042468|517336228|FG002|Overall Study|Death|1|||
143489550|NCT03042468|517336229|FG003|Overall Study|Death|0|||
143489551|NCT03042468|517336230|FG004|Overall Study|Death|0|||
143489552|NCT03042468|517336231|FG005|Overall Study|Death|0|||
143489553|NCT03042468|517336226|FG000|Overall Study|Withdrawal by Subject|0|||
143489554|NCT03042468|517336227|FG001|Overall Study|Withdrawal by Subject|0|||
143489555|NCT03042468|517336228|FG002|Overall Study|Withdrawal by Subject|0|||
143489556|NCT03042468|517336229|FG003|Overall Study|Withdrawal by Subject|0|||
143489557|NCT03042468|517336230|FG004|Overall Study|Withdrawal by Subject|0|||
143489558|NCT03042468|517336231|FG005|Overall Study|Withdrawal by Subject|1|||
143489559|NCT03042468|517336226|FG000|Overall Study|Lost to Follow-up|0|||
143489560|NCT03042468|517336227|FG001|Overall Study|Lost to Follow-up|0|||
143489561|NCT03042468|517336228|FG002|Overall Study|Lost to Follow-up|0|||
143489562|NCT03042468|517336229|FG003|Overall Study|Lost to Follow-up|0|||
143489563|NCT03042468|517336230|FG004|Overall Study|Lost to Follow-up|1|||
143489564|NCT03042468|517336231|FG005|Overall Study|Lost to Follow-up|1|||
143489565|NCT03092726|517336234|FG000|Overall Study|Adverse Event|3|||
143489566|NCT03092726|517336235|FG001|Overall Study|Adverse Event|10|||
143489567|NCT03092726|517336234|FG000|Overall Study|Lack of Efficacy|0|||
143489568|NCT03092726|517336235|FG001|Overall Study|Lack of Efficacy|1|||
143489569|NCT03092726|517336234|FG000|Overall Study|Lost to Follow-up|1|||
143489570|NCT03092726|517336235|FG001|Overall Study|Lost to Follow-up|0|||
143489571|NCT03092726|517336234|FG000|Overall Study|Withdrawal by Subject|5|||
143489572|NCT03092726|517336235|FG001|Overall Study|Withdrawal by Subject|3|||
143489573|NCT05980299|517336236|FG000|Overall Study|Death|28|||
143489574|NCT05980299|517336237|FG001|Overall Study|Death|0|||
143489575|NCT05980299|517336236|FG000|Overall Study|Discharged from Nursing Home|9|||
143489576|NCT05980299|517336237|FG001|Overall Study|Discharged from Nursing Home|0|||
143489577|NCT05980299|517336236|FG000|Overall Study|Lost to Follow-up|0|||
143489578|NCT05980299|517336237|FG001|Overall Study|Lost to Follow-up|10|||
143489579|NCT02728830|517336268|FG000|Overall Study|Exclusionary Surgery|9|||
143489580|NCT02728830|517336268|FG000|Overall Study|Exclusionary Pathology|6|||
143489581|NCT02728830|517336268|FG000|Overall Study|Physician Decision|3|||
143489582|NCT02728830|517336268|FG000|Overall Study|Withdrawal by Subject|2|||
143489583|NCT02728830|517336268|FG000|Overall Study|Lost to Follow-up|1|||
143489584|NCT02728830|517336268|FG000|Overall Study|Exclusionary Lab Values|1|||
143489585|NCT02728830|517336268|FG000|Overall Study|Contraindicated Illness|1|||
143489586|NCT02728830|517336268|FG000|Overall Study|Language Barrier|1|||
143489587|NCT03504397|517336269|FG000|Overall Study|Progressive Disease|151|||
143489588|NCT03504397|517336270|FG001|Overall Study|Progressive Disease|199|||
143489589|NCT03504397|517336269|FG000|Overall Study|Withdrawal by Subject|29|||
143489590|NCT03504397|517336270|FG001|Overall Study|Withdrawal by Subject|17|||
143489591|NCT03504397|517336269|FG000|Overall Study|Lost to Follow-up|1|||
143489592|NCT03504397|517336270|FG001|Overall Study|Lost to Follow-up|0|||
143489593|NCT03504397|517336269|FG000|Overall Study|Death|14|||
143489594|NCT03504397|517336270|FG001|Overall Study|Death|16|||
143489595|NCT03504397|517336269|FG000|Overall Study|Adverse Event|40|||
143489596|NCT03504397|517336270|FG001|Overall Study|Adverse Event|14|||
143489597|NCT03504397|517336269|FG000|Overall Study|miscellaneous|17|||
143489598|NCT03504397|517336270|FG001|Overall Study|miscellaneous|15|||
143489599|NCT03504397|517336269|FG000|Overall Study|Protocol deviation|1|||
143489600|NCT03504397|517336270|FG001|Overall Study|Protocol deviation|0|||
143489601|NCT03504397|517336269|FG000|Overall Study|Participants who did not take the study drug|4|||
143489602|NCT03504397|517336270|FG001|Overall Study|Participants who did not take the study drug|4|||
143489603|NCT01692301|517336273|FG000|Overall Study|Adverse Event|15|||
143489604|NCT01692301|517336274|FG001|Overall Study|Adverse Event|12|||
143489605|NCT01692301|517336273|FG000|Overall Study|Death|1|||
143489606|NCT01692301|517336274|FG001|Overall Study|Death|2|||
143489607|NCT01692301|517336273|FG000|Overall Study|Lack of Efficacy|0|||
143489608|NCT01692301|517336274|FG001|Overall Study|Lack of Efficacy|5|||
143489609|NCT01692301|517336273|FG000|Overall Study|Non-compliance with study treatment|1|||
143489610|NCT01692301|517336274|FG001|Overall Study|Non-compliance with study treatment|2|||
143489611|NCT01692301|517336273|FG000|Overall Study|Protocol deviation|9|||
143489612|NCT01692301|517336274|FG001|Overall Study|Protocol deviation|2|||
143489613|NCT01692301|517336273|FG000|Overall Study|Patient/guardian decision|16|||
143489614|NCT01692301|517336274|FG001|Overall Study|Patient/guardian decision|15|||
143489615|NCT01692301|517336273|FG000|Overall Study|Technical problems|0|||
143489616|NCT01692301|517336274|FG001|Overall Study|Technical problems|1|||
143489617|NCT01692301|517336273|FG000|Overall Study|Physician Decision|2|||
143489618|NCT01692301|517336274|FG001|Overall Study|Physician Decision|2|||
143489619|NCT01692301|517336273|FG000|Overall Study|Lost to Follow-up|1|||
143489620|NCT01692301|517336274|FG001|Overall Study|Lost to Follow-up|1|||
143489621|NCT01142726|517336275|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
143489622|NCT01142726|517336276|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
143489623|NCT01142726|517336277|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
143489624|NCT01142726|517336275|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
143489625|NCT01142726|517336276|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
143489626|NCT01142726|517336277|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
143489627|NCT01142726|517336275|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
143489628|NCT01142726|517336276|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
143489629|NCT01142726|517336277|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
143489630|NCT01142726|517336275|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
143489631|NCT01142726|517336276|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
143489632|NCT01142726|517336277|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
143489633|NCT01142726|517336275|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
143489634|NCT01142726|517336276|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
143489635|NCT01142726|517336277|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
143489636|NCT01142726|517336275|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
143489637|NCT01142726|517336276|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
143489638|NCT01142726|517336277|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
143489639|NCT01142726|517336275|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
143489640|NCT01142726|517336276|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
143489641|NCT01142726|517336277|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
143489642|NCT01142726|517336275|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
143489643|NCT01142726|517336276|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
143489644|NCT01142726|517336277|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
143489645|NCT01142726|517336275|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
143489646|NCT01142726|517336276|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
143489647|NCT01142726|517336277|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
143489648|NCT01142726|517336275|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
143489649|NCT01142726|517336276|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
143489650|NCT01142726|517336277|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
143489651|NCT01142726|517336275|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
143489652|NCT01142726|517336276|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
143489653|NCT01142726|517336277|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
143489654|NCT01142726|517336275|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
143489655|NCT01142726|517336276|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
143489656|NCT01142726|517336277|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
143489657|NCT01142726|517336275|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
143489658|NCT01142726|517336276|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
143489659|NCT01142726|517336277|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
143489660|NCT01142726|517336275|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
143489661|NCT01142726|517336276|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
143489662|NCT01142726|517336277|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
143489663|NCT01142726|517336275|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
143489664|NCT01142726|517336276|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
143489665|NCT01142726|517336277|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
143489666|NCT01142726|517336275|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
143489667|NCT01142726|517336276|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
143489668|NCT01142726|517336277|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
143489669|NCT01568593|517336278|FG000|Overall Study|Lack of Efficacy|4|||
143489670|NCT01568593|517336279|FG001|Overall Study|Lack of Efficacy|1|||
143489671|NCT01568593|517336278|FG000|Overall Study|Adverse Event|3|||
143489672|NCT01568593|517336279|FG001|Overall Study|Adverse Event|2|||
143489673|NCT02780648|517336281|FG000|Overall Study|Disease Progression|1|||
143489674|NCT02780648|517336282|FG001|Overall Study|Disease Progression|0|||
143489675|NCT00293579|517336289|FG000|Overall Study|Withdrawal by Subject|1|||
143489676|NCT03167073|517336290|FG000|Overall Study|Stillbirth|1|||
143489677|NCT03167073|517336291|FG001|Overall Study|Stillbirth|0|||
143489678|NCT01276236|517336292|FG000|Overall Study|Lack of Efficacy|2|||
143489679|NCT01276236|517336292|FG000|Overall Study|Withdrawal by Subject|4|||
143489680|NCT03127384|517336294|FG000|Overall Study|Lost to Follow-up|4|||
143489681|NCT03127384|517336294|FG000|Overall Study|Subject request|2|||
143489682|NCT01294579|517336295|FG000|Overall Study|Disease progression|12|||
143489683|NCT01294579|517336295|FG000|Overall Study|Adverse Event|11|||
143489684|NCT01294579|517336295|FG000|Overall Study|Study closed/terminated|3|||
143489685|NCT01294579|517336295|FG000|Overall Study|Lost to Follow-up|1|||
143489686|NCT01294579|517336295|FG000|Overall Study|Physician Decision|3|||
143489687|NCT01294579|517336295|FG000|Overall Study|Withdrawal by Subject|5|||
143489688|NCT01180660|517336298|FG000|Overall Study|Changed to open surgery|1|||
143489689|NCT01180660|517336299|FG001|Overall Study|Changed to open surgery|0|||
143489690|NCT00262873|517336300|FG000|Overall Study|Adverse Event|3|||
143489691|NCT00262873|517336300|FG000|Overall Study|Withdrawal by Subject|5|||
143489692|NCT00844753|517336301|FG000|Overall Study|Lack of Efficacy|1|||
143489693|NCT00844753|517336302|FG001|Overall Study|Lack of Efficacy|0|||
143489694|NCT00844753|517336303|FG002|Overall Study|Lack of Efficacy|2|||
143489695|NCT00844753|517336304|FG003|Overall Study|Lack of Efficacy|2|||
143489696|NCT00844753|517336301|FG000|Overall Study|Adverse Event|3|||
143489697|NCT00844753|517336302|FG001|Overall Study|Adverse Event|2|||
143489698|NCT00844753|517336303|FG002|Overall Study|Adverse Event|5|||
143489699|NCT00844753|517336304|FG003|Overall Study|Adverse Event|5|||
143489700|NCT00844753|517336301|FG000|Overall Study|Lost to Follow-up|1|||
143489701|NCT00844753|517336302|FG001|Overall Study|Lost to Follow-up|1|||
143489702|NCT00844753|517336303|FG002|Overall Study|Lost to Follow-up|0|||
143489703|NCT00844753|517336304|FG003|Overall Study|Lost to Follow-up|1|||
143489704|NCT00844753|517336301|FG000|Overall Study|could not swallow medication|2|||
143489705|NCT00844753|517336302|FG001|Overall Study|could not swallow medication|0|||
143489706|NCT00844753|517336303|FG002|Overall Study|could not swallow medication|0|||
143489707|NCT00844753|517336304|FG003|Overall Study|could not swallow medication|0|||
143489708|NCT00844753|517336301|FG000|Overall Study|Withdrawal by Subject|1|||
143489709|NCT00844753|517336302|FG001|Overall Study|Withdrawal by Subject|0|||
143489710|NCT00844753|517336303|FG002|Overall Study|Withdrawal by Subject|0|||
143489711|NCT00844753|517336304|FG003|Overall Study|Withdrawal by Subject|3|||
143489712|NCT03440814|517336307|FG000|Overall Study|Adverse Event|2|||
143489713|NCT03440814|517336308|FG001|Overall Study|Adverse Event|1|||
143489714|NCT03440814|517336307|FG000|Overall Study|Lost to Follow-up|2|||
143489715|NCT03440814|517336308|FG001|Overall Study|Lost to Follow-up|0|||
143489716|NCT03440814|517336307|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
143489717|NCT03440814|517336308|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
143489718|NCT00088374|517336309|FG000|Overall Study|patient did not receive any 17AAG|1|||
143489719|NCT00088374|517336309|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
143489720|NCT00852995|517336310|FG000|Overall Study|Adverse Event|1|||
143489721|NCT00852995|517336311|FG001|Overall Study|Adverse Event|0|||
143489722|NCT00852995|517336312|FG002|Overall Study|Adverse Event|4|||
143489723|NCT00852995|517336313|FG003|Overall Study|Adverse Event|0|||
143489724|NCT00852995|517336314|FG004|Overall Study|Adverse Event|0|||
143489725|NCT00852995|517336310|FG000|Overall Study|Lost to Follow-up|0|||
143489726|NCT00852995|517336311|FG001|Overall Study|Lost to Follow-up|1|||
143489727|NCT00852995|517336312|FG002|Overall Study|Lost to Follow-up|1|||
143489728|NCT00852995|517336313|FG003|Overall Study|Lost to Follow-up|0|||
143489729|NCT00852995|517336314|FG004|Overall Study|Lost to Follow-up|0|||
143489730|NCT00852995|517336310|FG000|Overall Study|Withdrawal by Subject|4|||
143489731|NCT00852995|517336311|FG001|Overall Study|Withdrawal by Subject|0|||
143489732|NCT00852995|517336312|FG002|Overall Study|Withdrawal by Subject|0|||
143489733|NCT00852995|517336313|FG003|Overall Study|Withdrawal by Subject|1|||
143489734|NCT00852995|517336314|FG004|Overall Study|Withdrawal by Subject|2|||
143489735|NCT00852995|517336310|FG000|Overall Study|Non-Compliance|0|||
143489736|NCT00852995|517336311|FG001|Overall Study|Non-Compliance|0|||
143489737|NCT00852995|517336312|FG002|Overall Study|Non-Compliance|0|||
143489738|NCT00852995|517336313|FG003|Overall Study|Non-Compliance|2|||
143489739|NCT00852995|517336314|FG004|Overall Study|Non-Compliance|0|||
143489740|NCT00852995|517336310|FG000|Overall Study|Progressive Disease|1|||
143489741|NCT00852995|517336311|FG001|Overall Study|Progressive Disease|0|||
143489742|NCT00852995|517336312|FG002|Overall Study|Progressive Disease|0|||
143489743|NCT00852995|517336313|FG003|Overall Study|Progressive Disease|2|||
143489744|NCT00852995|517336314|FG004|Overall Study|Progressive Disease|1|||
143489745|NCT00852995|517336310|FG000|Overall Study|Physician Decision|1|||
143489746|NCT00852995|517336311|FG001|Overall Study|Physician Decision|0|||
143489747|NCT00852995|517336312|FG002|Overall Study|Physician Decision|0|||
143489748|NCT00852995|517336313|FG003|Overall Study|Physician Decision|0|||
143489749|NCT00852995|517336314|FG004|Overall Study|Physician Decision|0|||
143489750|NCT00852995|517336310|FG000|Overall Study|Protocol Violation|0|||
143489751|NCT00852995|517336311|FG001|Overall Study|Protocol Violation|0|||
143489752|NCT00852995|517336312|FG002|Overall Study|Protocol Violation|0|||
143489753|NCT00852995|517336313|FG003|Overall Study|Protocol Violation|0|||
143489754|NCT00852995|517336314|FG004|Overall Study|Protocol Violation|1|||
143024939|NCT00818623|515631226|FG003|Overall Study|Adverse Event|0|||
143489755|NCT00852995|517336310|FG000|Overall Study|Moved Out of Area|1|||
143489756|NCT00852995|517336311|FG001|Overall Study|Moved Out of Area|0|||
143489757|NCT00852995|517336312|FG002|Overall Study|Moved Out of Area|0|||
143489758|NCT00852995|517336313|FG003|Overall Study|Moved Out of Area|0|||
143489759|NCT00852995|517336314|FG004|Overall Study|Moved Out of Area|0|||
143236744|NCT03866577|516419568|FG005|Overall Study|Not qualified for IVIg infusion|0|||
143236745|NCT03866577|516419569|FG006|Overall Study|Not qualified for IVIg infusion|0|||
143236746|NCT03866577|516419570|FG007|Overall Study|Not qualified for IVIg infusion|0|||
143236747|NCT03866577|516419571|FG008|Overall Study|Not qualified for IVIg infusion|0|||
143236748|NCT03866577|516419572|FG009|Overall Study|Not qualified for IVIg infusion|1|||
143236749|NCT03866577|516419573|FG010|Overall Study|Not qualified for IVIg infusion|0|||
143236750|NCT03866577|516419574|FG011|Overall Study|Not qualified for IVIg infusion|0|||
143236751|NCT03866577|516419575|FG012|Overall Study|Not qualified for IVIg infusion|0|||
143236752|NCT05523089|516419576|FG000|Overall Study|Withdrawal by Subject|1|||
143236753|NCT05523089|516419577|FG001|Overall Study|Withdrawal by Subject|0|||
143236754|NCT05523089|516419578|FG002|Overall Study|Withdrawal by Subject|0|||
143236755|NCT05523089|516419576|FG000|Overall Study|Lost to Follow-up|1|||
143236756|NCT05523089|516419577|FG001|Overall Study|Lost to Follow-up|0|||
143236757|NCT05523089|516419578|FG002|Overall Study|Lost to Follow-up|0|||
143236758|NCT02083354|516421429|FG000|Overall Study|Withdrawal by Subject|9|||
143236759|NCT02083354|516421429|FG000|Overall Study|Lost to Follow-up|1|||
143236760|NCT02083354|516421429|FG000|Overall Study|Adverse Event|3|||
143236761|NCT02083354|516421429|FG000|Overall Study|Disease progression|46|||
143236762|NCT02083354|516421429|FG000|Overall Study|Study closed/terminated|5|||
143236763|NCT02419001|516421450|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
143236764|NCT02419001|516421451|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
143489760|NCT03595553|517336315|FG000|Overall Study|Withdrawal by Subject|20|||
143489761|NCT03595553|517336316|FG001|Overall Study|Withdrawal by Subject|8|||
143489762|NCT03595553|517336315|FG000|Overall Study|Physician Decision|3|||
143489763|NCT03595553|517336316|FG001|Overall Study|Physician Decision|2|||
143489764|NCT03595553|517336315|FG000|Overall Study|Adverse Event|2|||
143489765|NCT03595553|517336316|FG001|Overall Study|Adverse Event|5|||
143489766|NCT03595553|517336315|FG000|Overall Study|Death|24|||
143489767|NCT03595553|517336316|FG001|Overall Study|Death|22|||
143489768|NCT03595553|517336315|FG000|Overall Study|Lost to Follow-up|6|||
143489769|NCT03595553|517336316|FG001|Overall Study|Lost to Follow-up|7|||
143489770|NCT03595553|517336315|FG000|Overall Study|Other as indicated in CSR|3|||
143489771|NCT03595553|517336316|FG001|Overall Study|Other as indicated in CSR|3|||
143489772|NCT03595553|517336315|FG000|Overall Study|Sponsor Decision|0|||
143489773|NCT03595553|517336316|FG001|Overall Study|Sponsor Decision|1|||
143489774|NCT00371865|517336321|FG000|Overall Study|Lack of Efficacy|0|||
143489775|NCT00371865|517336322|FG001|Overall Study|Lack of Efficacy|2|||
143489776|NCT00371865|517336321|FG000|Overall Study|Protocol Violation|3|||
143489777|NCT00371865|517336322|FG001|Overall Study|Protocol Violation|2|||
143489778|NCT00371865|517336321|FG000|Overall Study|Withdrawal by Subject|12|||
143489779|NCT00371865|517336322|FG001|Overall Study|Withdrawal by Subject|10|||
143489780|NCT01632566|517336326|FG000|Overall Study|Withdrawal by Subject|0|||
143489781|NCT01632566|517336327|FG001|Overall Study|Withdrawal by Subject|1|||
143489782|NCT01632566|517336328|FG002|Overall Study|Withdrawal by Subject|0|||
143489783|NCT01632566|517336329|FG003|Overall Study|Withdrawal by Subject|0|||
143489784|NCT01632566|517336330|FG004|Overall Study|Withdrawal by Subject|0|||
143489785|NCT01632566|517336326|FG000|Overall Study|Sponsor Decision|0|||
143489786|NCT01632566|517336327|FG001|Overall Study|Sponsor Decision|2|||
143489787|NCT01632566|517336328|FG002|Overall Study|Sponsor Decision|9|||
143489788|NCT01632566|517336329|FG003|Overall Study|Sponsor Decision|2|||
143489789|NCT01632566|517336330|FG004|Overall Study|Sponsor Decision|2|||
143489790|NCT01358864|517336338|FG000|Overall Study|Adverse Event|0|||
143489791|NCT01358864|517336339|FG001|Overall Study|Adverse Event|6|||
143489792|NCT01358864|517336340|FG002|Overall Study|Adverse Event|9|||
143489793|NCT01358864|517336341|FG003|Overall Study|Adverse Event|0|||
143489794|NCT01358864|517336342|FG004|Overall Study|Adverse Event|4|||
143489795|NCT01358864|517336343|FG005|Overall Study|Adverse Event|8|||
143489796|NCT01358864|517336344|FG006|Overall Study|Adverse Event|12|||
143489797|NCT01358864|517336345|FG007|Overall Study|Adverse Event|7|||
143489798|NCT01358864|517336338|FG000|Overall Study|Lack of Efficacy|26|||
143236765|NCT02066181|516421452|FG000|Overall Study|Withdrawal by Subject|1|||
143236766|NCT02066181|516421453|FG001|Overall Study|Withdrawal by Subject|1|||
143236767|NCT02141295|516421459|FG000|Overall Study|Adverse Event|1|||
143236768|NCT02141295|516421460|FG001|Overall Study|Adverse Event|18|||
143363855|NCT00049517|516875451|FG001|Conditioning/Transplant|Death|0|||
143489799|NCT01358864|517336339|FG001|Overall Study|Lack of Efficacy|3|||
143489800|NCT01358864|517336340|FG002|Overall Study|Lack of Efficacy|4|||
143489801|NCT01358864|517336341|FG003|Overall Study|Lack of Efficacy|19|||
143489802|NCT01358864|517336342|FG004|Overall Study|Lack of Efficacy|7|||
143489803|NCT01358864|517336343|FG005|Overall Study|Lack of Efficacy|4|||
143489804|NCT01358864|517336344|FG006|Overall Study|Lack of Efficacy|49|||
143489805|NCT01358864|517336345|FG007|Overall Study|Lack of Efficacy|44|||
143489806|NCT01358864|517336338|FG000|Overall Study|Lost to Follow-up|0|||
143489807|NCT01358864|517336339|FG001|Overall Study|Lost to Follow-up|0|||
143489808|NCT01358864|517336340|FG002|Overall Study|Lost to Follow-up|1|||
143489809|NCT01358864|517336341|FG003|Overall Study|Lost to Follow-up|0|||
143489810|NCT01358864|517336342|FG004|Overall Study|Lost to Follow-up|0|||
143489811|NCT01358864|517336343|FG005|Overall Study|Lost to Follow-up|0|||
143489812|NCT01358864|517336344|FG006|Overall Study|Lost to Follow-up|0|||
143489813|NCT01358864|517336345|FG007|Overall Study|Lost to Follow-up|1|||
143489814|NCT01358864|517336338|FG000|Overall Study|Withdrawal by Subject|3|||
143489815|NCT01358864|517336339|FG001|Overall Study|Withdrawal by Subject|4|||
143489816|NCT01358864|517336340|FG002|Overall Study|Withdrawal by Subject|2|||
143489817|NCT01358864|517336341|FG003|Overall Study|Withdrawal by Subject|0|||
143489818|NCT01358864|517336342|FG004|Overall Study|Withdrawal by Subject|0|||
143489819|NCT01358864|517336343|FG005|Overall Study|Withdrawal by Subject|1|||
143489820|NCT01358864|517336344|FG006|Overall Study|Withdrawal by Subject|1|||
143489821|NCT01358864|517336345|FG007|Overall Study|Withdrawal by Subject|3|||
143489822|NCT01358864|517336338|FG000|Overall Study|Other reason not defined above|2|||
143489823|NCT01358864|517336339|FG001|Overall Study|Other reason not defined above|0|||
143489824|NCT01358864|517336340|FG002|Overall Study|Other reason not defined above|0|||
143489825|NCT01358864|517336341|FG003|Overall Study|Other reason not defined above|0|||
143489826|NCT01358864|517336342|FG004|Overall Study|Other reason not defined above|0|||
143489827|NCT01358864|517336343|FG005|Overall Study|Other reason not defined above|0|||
143489828|NCT01358864|517336344|FG006|Overall Study|Other reason not defined above|2|||
143489829|NCT01358864|517336345|FG007|Overall Study|Other reason not defined above|0|||
143489830|NCT01358864|517336338|FG000|Overall Study|Not treated|0|||
143489831|NCT01358864|517336339|FG001|Overall Study|Not treated|0|||
143489832|NCT01358864|517336340|FG002|Overall Study|Not treated|0|||
143489833|NCT01358864|517336341|FG003|Overall Study|Not treated|0|||
143489834|NCT01358864|517336342|FG004|Overall Study|Not treated|0|||
143489835|NCT01358864|517336343|FG005|Overall Study|Not treated|0|||
143489836|NCT01358864|517336344|FG006|Overall Study|Not treated|1|||
143489837|NCT01358864|517336345|FG007|Overall Study|Not treated|0|||
143489838|NCT01003210|517336346|FG000|Overall Study|Lost to Follow-up|1|||
143489839|NCT01003210|517336347|FG001|Overall Study|Lost to Follow-up|3|||
143489840|NCT00271817|517336348|FG000|Part 1|Adverse Event|68|||
143489841|NCT00271817|517336349|FG001|Part 1|Adverse Event|25|||
143489842|NCT00271817|517336350|FG002|Part 1|Adverse Event|156|||
143489843|NCT00271817|517336348|FG000|Part 1|Lost to Follow-up|6|||
143489844|NCT00271817|517336349|FG001|Part 1|Lost to Follow-up|8|||
143489845|NCT00271817|517336350|FG002|Part 1|Lost to Follow-up|24|||
143489846|NCT00271817|517336348|FG000|Part 1|Protocol Violation|5|||
143489847|NCT00271817|517336349|FG001|Part 1|Protocol Violation|4|||
143489848|NCT00271817|517336350|FG002|Part 1|Protocol Violation|7|||
143489849|NCT00271817|517336348|FG000|Part 1|Patient Moved|3|||
143489850|NCT00271817|517336349|FG001|Part 1|Patient Moved|1|||
143489851|NCT00271817|517336350|FG002|Part 1|Patient Moved|5|||
143489852|NCT00271817|517336348|FG000|Part 1|Withdrawal by Subject|23|||
143489853|NCT00271817|517336349|FG001|Part 1|Withdrawal by Subject|17|||
143489854|NCT00271817|517336350|FG002|Part 1|Withdrawal by Subject|45|||
143489855|NCT00271817|517336348|FG000|Part 1|LDL < 50 mg/dL|1|||
143489856|NCT00271817|517336349|FG001|Part 1|LDL < 50 mg/dL|4|||
143489857|NCT00271817|517336350|FG002|Part 1|LDL < 50 mg/dL|48|||
143489858|NCT00271817|517336348|FG000|Part 2|Adverse Event|0|||
143489859|NCT00271817|517336349|FG001|Part 2|Adverse Event|17|||
143489860|NCT00271817|517336350|FG002|Part 2|Adverse Event|33|||
143489861|NCT00271817|517336348|FG000|Part 2|Lack of Efficacy|0|||
143489862|NCT00271817|517336349|FG001|Part 2|Lack of Efficacy|1|||
143489863|NCT00271817|517336350|FG002|Part 2|Lack of Efficacy|6|||
143489864|NCT00271817|517336348|FG000|Part 2|Lost to Follow-up|0|||
143489865|NCT00271817|517336349|FG001|Part 2|Lost to Follow-up|6|||
143489866|NCT00271817|517336350|FG002|Part 2|Lost to Follow-up|18|||
143489867|NCT00271817|517336348|FG000|Part 2|Protocol Violation|0|||
143489868|NCT00271817|517336349|FG001|Part 2|Protocol Violation|3|||
143489869|NCT00271817|517336350|FG002|Part 2|Protocol Violation|5|||
143489870|NCT00271817|517336348|FG000|Part 2|Patient Moved|0|||
143489871|NCT00271817|517336349|FG001|Part 2|Patient Moved|0|||
143489872|NCT00271817|517336350|FG002|Part 2|Patient Moved|5|||
143489873|NCT00271817|517336348|FG000|Part 2|Withdrawal by Subject|0|||
143489874|NCT00271817|517336349|FG001|Part 2|Withdrawal by Subject|2|||
143489875|NCT00271817|517336350|FG002|Part 2|Withdrawal by Subject|13|||
143489876|NCT00271817|517336348|FG000|Part 2|LDL < 50 mg/dL|0|||
143489877|NCT00271817|517336349|FG001|Part 2|LDL < 50 mg/dL|3|||
143489878|NCT00271817|517336350|FG002|Part 2|LDL < 50 mg/dL|4|||
143489879|NCT01471782|517336352|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
143489880|NCT01471782|517336353|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
143489881|NCT01471782|517336354|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
143489882|NCT01471782|517336355|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
143489883|NCT01471782|517336356|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
143489884|NCT01471782|517336357|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
143489885|NCT01471782|517336352|FG000|Overall Study|Lack of Efficacy|1|||
143489886|NCT01471782|517336353|FG001|Overall Study|Lack of Efficacy|2|||
143489887|NCT01471782|517336354|FG002|Overall Study|Lack of Efficacy|1|||
143489888|NCT01471782|517336355|FG003|Overall Study|Lack of Efficacy|1|||
143489889|NCT01471782|517336356|FG004|Overall Study|Lack of Efficacy|5|||
143489890|NCT01471782|517336357|FG005|Overall Study|Lack of Efficacy|18|||
143489891|NCT01471782|517336352|FG000|Overall Study|Adverse Event|1|||
143489892|NCT01471782|517336353|FG001|Overall Study|Adverse Event|1|||
143236769|NCT02141295|516421461|FG002|Overall Study|Adverse Event|11|||
143236770|NCT02141295|516421459|FG000|Overall Study|Physician Decision|2|||
143236771|NCT02141295|516421460|FG001|Overall Study|Physician Decision|19|||
143236772|NCT02141295|516421461|FG002|Overall Study|Physician Decision|14|||
143236773|NCT02141295|516421459|FG000|Overall Study|Study terminated by sponsor|0|||
143236774|NCT02141295|516421460|FG001|Overall Study|Study terminated by sponsor|6|||
143236775|NCT02141295|516421461|FG002|Overall Study|Study terminated by sponsor|6|||
143236776|NCT02141295|516421459|FG000|Overall Study|Non-compliance|0|||
143236777|NCT02141295|516421460|FG001|Overall Study|Non-compliance|1|||
143236778|NCT02141295|516421461|FG002|Overall Study|Non-compliance|0|||
143236779|NCT02141295|516421459|FG000|Overall Study|Progressive disease|3|||
143236780|NCT02141295|516421460|FG001|Overall Study|Progressive disease|32|||
143236781|NCT02141295|516421461|FG002|Overall Study|Progressive disease|50|||
143236782|NCT02141295|516421459|FG000|Overall Study|Reason not specified|0|||
143236783|NCT02141295|516421460|FG001|Overall Study|Reason not specified|9|||
143236784|NCT02141295|516421461|FG002|Overall Study|Reason not specified|10|||
143236785|NCT02141295|516421459|FG000|Overall Study|Withdrawal by Subject|0|||
143236786|NCT02141295|516421460|FG001|Overall Study|Withdrawal by Subject|9|||
143236787|NCT02141295|516421461|FG002|Overall Study|Withdrawal by Subject|4|||
143236788|NCT01710501|516421462|FG000|Overall Study|Lost to Follow-up|2|||
143236789|NCT01710501|516421463|FG001|Overall Study|Lost to Follow-up|0|||
143236790|NCT01710501|516421464|FG002|Overall Study|Lost to Follow-up|0|||
143236791|NCT02536976|516421465|FG000|Overall Study|Physician Decision|0|||
143236792|NCT02536976|516421466|FG001|Overall Study|Physician Decision|1|||
143236793|NCT02144610|516421469|FG000|Overall Study|Physician Decision|1|||
143236794|NCT02144610|516421470|FG001|Overall Study|Physician Decision|0|||
143236795|NCT02144610|516421469|FG000|Overall Study|Withdrawal by Subject|1|||
143236796|NCT02144610|516421470|FG001|Overall Study|Withdrawal by Subject|5|||
143236797|NCT02144610|516421469|FG000|Overall Study|Death|2|||
143236798|NCT02144610|516421470|FG001|Overall Study|Death|2|||
143236799|NCT02144610|516421469|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
143236800|NCT02144610|516421470|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
143236801|NCT02144610|516421469|FG000|Overall Study|Other|0|||
143236802|NCT02144610|516421470|FG001|Overall Study|Other|1|||
143236803|NCT00214201|516421472|FG000|Overall Study|Withdrawal by Subject|2|||
143236804|NCT00214201|516421473|FG001|Overall Study|Withdrawal by Subject|0|||
143236805|NCT00214201|516421472|FG000|Overall Study|Death|0|||
143236806|NCT00214201|516421473|FG001|Overall Study|Death|2|||
143236807|NCT03250273|516421485|FG000|Overall Study|Disease Progression|2|||
143236808|NCT03250273|516421486|FG001|Overall Study|Disease Progression|11|||
143236809|NCT03250273|516421485|FG000|Overall Study|Death|0|||
143236810|NCT03250273|516421486|FG001|Overall Study|Death|1|||
143236811|NCT01744977|516421487|FG000|Overall Study|Withdrawal by Subject|1|||
143236812|NCT01744977|516421488|FG001|Overall Study|Withdrawal by Subject|2|||
143236813|NCT01744977|516421487|FG000|Overall Study|Death|2|||
143236814|NCT01744977|516421488|FG001|Overall Study|Death|3|||
143236815|NCT01744977|516421487|FG000|Overall Study|Lost to Follow-up|2|||
143236816|NCT01744977|516421488|FG001|Overall Study|Lost to Follow-up|0|||
143236817|NCT01744977|516421487|FG000|Overall Study|No longer meets inclusion|6|||
143236818|NCT01744977|516421488|FG001|Overall Study|No longer meets inclusion|0|||
143236819|NCT02131259|516421489|FG000|Overall Study|Progressive disease|751|||
143489893|NCT01471782|517336354|FG002|Overall Study|Adverse Event|2|||
143489894|NCT01471782|517336355|FG003|Overall Study|Adverse Event|2|||
143489895|NCT01471782|517336356|FG004|Overall Study|Adverse Event|3|||
143489896|NCT01471782|517336357|FG005|Overall Study|Adverse Event|1|||
143489897|NCT01471782|517336352|FG000|Overall Study|Other|0|||
143489898|NCT01471782|517336353|FG001|Overall Study|Other|0|||
143489899|NCT01471782|517336354|FG002|Overall Study|Other|1|||
143489900|NCT01471782|517336355|FG003|Overall Study|Other|1|||
143236820|NCT02131259|516421489|FG000|Overall Study|Adverse Event|341|||
143236821|NCT02131259|516421489|FG000|Overall Study|Lost to Follow-up|7|||
143236822|NCT02131259|516421489|FG000|Overall Study|Relocation|32|||
143236823|NCT02131259|516421489|FG000|Overall Study|Other|63|||
143236824|NCT02131259|516421489|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
143236825|NCT02131259|516421489|FG000|Overall Study|Progressive disease/relocation|1|||
143236826|NCT02131259|516421489|FG000|Overall Study|Progressive disease/other|2|||
143236827|NCT02131259|516421489|FG000|Overall Study|AE/lost to follow-up|1|||
143236828|NCT02131259|516421489|FG000|Overall Study|AE/other|1|||
143236829|NCT02131259|516421489|FG000|Overall Study|Progressive disease/AE/other|1|||
143236830|NCT02131259|516421489|FG000|Overall Study|Missing|3|||
143236831|NCT04004988|516421492|FG000|Period 1|Physician Decision|2|||
143236832|NCT04004988|516421493|FG001|Period 1|Physician Decision|0|||
143236833|NCT04004988|516421492|FG000|Period 1|Withdrawal by Subject|0|||
143236834|NCT04004988|516421493|FG001|Period 1|Withdrawal by Subject|1|||
143236835|NCT04004988|516421492|FG000|Period 1|Adverse Event|1|||
143236836|NCT04004988|516421493|FG001|Period 1|Adverse Event|2|||
143236837|NCT01055197|516421496|FG000|Overall Study|Protocol Violation|7|||
143236838|NCT01055197|516421497|FG001|Overall Study|Protocol Violation|2|||
143236839|NCT01055197|516421496|FG000|Overall Study|Withdrawal by Subject|2|||
143236840|NCT01055197|516421497|FG001|Overall Study|Withdrawal by Subject|0|||
143489901|NCT01471782|517336356|FG004|Overall Study|Other|6|||
143489902|NCT01471782|517336357|FG005|Overall Study|Other|5|||
143489903|NCT01471782|517336352|FG000|Overall Study|Change of Chemotherapy|1|||
143489904|NCT01471782|517336353|FG001|Overall Study|Change of Chemotherapy|1|||
143489905|NCT01471782|517336354|FG002|Overall Study|Change of Chemotherapy|0|||
143489906|NCT01471782|517336355|FG003|Overall Study|Change of Chemotherapy|0|||
143489907|NCT01471782|517336356|FG004|Overall Study|Change of Chemotherapy|1|||
143489908|NCT01471782|517336357|FG005|Overall Study|Change of Chemotherapy|4|||
143489909|NCT01471782|517336352|FG000|Overall Study|Disease Relapse|0|||
143489910|NCT01471782|517336353|FG001|Overall Study|Disease Relapse|0|||
143489911|NCT01471782|517336354|FG002|Overall Study|Disease Relapse|0|||
143489912|NCT01471782|517336355|FG003|Overall Study|Disease Relapse|1|||
143489913|NCT01471782|517336356|FG004|Overall Study|Disease Relapse|2|||
143489914|NCT01471782|517336357|FG005|Overall Study|Disease Relapse|1|||
143489915|NCT01471782|517336352|FG000|Overall Study|Physician Decision|0|||
143489916|NCT01471782|517336353|FG001|Overall Study|Physician Decision|0|||
143489917|NCT01471782|517336354|FG002|Overall Study|Physician Decision|0|||
143489918|NCT01471782|517336355|FG003|Overall Study|Physician Decision|0|||
143489919|NCT01471782|517336356|FG004|Overall Study|Physician Decision|3|||
143489920|NCT01471782|517336357|FG005|Overall Study|Physician Decision|8|||
143489921|NCT01471782|517336352|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
143489922|NCT01471782|517336353|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
143489923|NCT01471782|517336354|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
143489924|NCT01471782|517336355|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
143489925|NCT01471782|517336356|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
143489926|NCT01471782|517336357|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
143489927|NCT01471782|517336352|FG000|Overall Study|Death|0|||
143489928|NCT01471782|517336353|FG001|Overall Study|Death|0|||
143489929|NCT01471782|517336354|FG002|Overall Study|Death|0|||
143489930|NCT01471782|517336355|FG003|Overall Study|Death|0|||
143489931|NCT01471782|517336356|FG004|Overall Study|Death|0|||
143489932|NCT01471782|517336357|FG005|Overall Study|Death|1|||
143489933|NCT00861744|517336358|FG000|Overall Study|Adverse Event|0|||
143489934|NCT00861744|517336359|FG001|Overall Study|Adverse Event|0|||
143489935|NCT00861744|517336360|FG002|Overall Study|Adverse Event|0|||
143489936|NCT00861744|517336361|FG003|Overall Study|Adverse Event|1|||
143489937|NCT00861744|517336358|FG000|Overall Study|Lost to Follow-up|7|||
143489938|NCT00861744|517336359|FG001|Overall Study|Lost to Follow-up|19|||
143489939|NCT00861744|517336360|FG002|Overall Study|Lost to Follow-up|17|||
143489940|NCT00861744|517336361|FG003|Overall Study|Lost to Follow-up|12|||
143489941|NCT00861744|517336358|FG000|Overall Study|Withdrawal by Subject|10|||
143489942|NCT00861744|517336359|FG001|Overall Study|Withdrawal by Subject|6|||
143489943|NCT00861744|517336360|FG002|Overall Study|Withdrawal by Subject|6|||
143489944|NCT00861744|517336361|FG003|Overall Study|Withdrawal by Subject|19|||
143489945|NCT00861744|517336358|FG000|Overall Study|Protocol Violation|0|||
143489946|NCT00861744|517336359|FG001|Overall Study|Protocol Violation|1|||
143489947|NCT00861744|517336360|FG002|Overall Study|Protocol Violation|0|||
143489948|NCT00861744|517336361|FG003|Overall Study|Protocol Violation|0|||
143489949|NCT00861744|517336358|FG000|Overall Study|Migration from study area|0|||
143489950|NCT00861744|517336359|FG001|Overall Study|Migration from study area|3|||
143489951|NCT00861744|517336360|FG002|Overall Study|Migration from study area|1|||
143489952|NCT00861744|517336361|FG003|Overall Study|Migration from study area|0|||
143489953|NCT00861744|517336358|FG000|Overall Study|Blood draws|0|||
143489954|NCT00861744|517336359|FG001|Overall Study|Blood draws|0|||
143489955|NCT00861744|517336360|FG002|Overall Study|Blood draws|0|||
143489956|NCT00861744|517336361|FG003|Overall Study|Blood draws|1|||
143489957|NCT01344876|517336362|FG000|Overall Study|Adverse Event|0|||
143489958|NCT01344876|517336363|FG001|Overall Study|Adverse Event|0|||
143489959|NCT01344876|517336364|FG002|Overall Study|Adverse Event|0|||
143489960|NCT01344876|517336365|FG003|Overall Study|Adverse Event|0|||
143489961|NCT01344876|517336366|FG004|Overall Study|Adverse Event|1|||
143489962|NCT01344876|517336362|FG000|Overall Study|Withdrawal by Subject|0|||
143489963|NCT01344876|517336363|FG001|Overall Study|Withdrawal by Subject|0|||
143489964|NCT01344876|517336364|FG002|Overall Study|Withdrawal by Subject|1|||
143489965|NCT01344876|517336365|FG003|Overall Study|Withdrawal by Subject|0|||
143489966|NCT01344876|517336366|FG004|Overall Study|Withdrawal by Subject|0|||
143489967|NCT01344876|517336362|FG000|Overall Study|Definite progression of primary disease|1|||
143489968|NCT01344876|517336363|FG001|Overall Study|Definite progression of primary disease|0|||
143489969|NCT01344876|517336364|FG002|Overall Study|Definite progression of primary disease|0|||
143489970|NCT01344876|517336365|FG003|Overall Study|Definite progression of primary disease|3|||
143489971|NCT01344876|517336366|FG004|Overall Study|Definite progression of primary disease|0|||
143489972|NCT04428424|517336367|FG000|Overall Study|Does not meet entrance criteria|132|||
143489973|NCT04428424|517336367|FG000|Overall Study|Lost to Follow-up|115|||
143489974|NCT03124563|517336370|FG000|Overall Study|Lost to Follow-up|1|||
143489975|NCT03124563|517336371|FG001|Overall Study|Lost to Follow-up|1|||
143489976|NCT03124563|517336370|FG000|Overall Study|Withdrawal by Subject|1|||
143489977|NCT03124563|517336371|FG001|Overall Study|Withdrawal by Subject|1|||
143489978|NCT00925015|517338219|FG000|Overall Study|Adverse Event|1|||
143024940|NCT00818623|515631227|FG004|Overall Study|Adverse Event|0|||
143024941|NCT00818623|515631228|FG005|Overall Study|Adverse Event|1|||
143489979|NCT00925015|517338220|FG001|Overall Study|Adverse Event|2|||
143489980|NCT00925015|517338221|FG002|Overall Study|Adverse Event|1|||
143489981|NCT00925015|517338219|FG000|Overall Study|Physician Decision|0|||
143489982|NCT00925015|517338220|FG001|Overall Study|Physician Decision|1|||
143489983|NCT00925015|517338221|FG002|Overall Study|Physician Decision|0|||
143489984|NCT00925015|517338219|FG000|Overall Study|Progressive Disease|7|||
143489985|NCT00925015|517338220|FG001|Overall Study|Progressive Disease|3|||
143489986|NCT00925015|517338221|FG002|Overall Study|Progressive Disease|4|||
143489987|NCT00925015|517338219|FG000|Overall Study|Withdrawal by Subject|0|||
143489988|NCT00925015|517338220|FG001|Overall Study|Withdrawal by Subject|0|||
143489989|NCT00925015|517338221|FG002|Overall Study|Withdrawal by Subject|1|||
143489990|NCT02469090|517338222|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
143489991|NCT02469090|517338223|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
143489992|NCT02469090|517338224|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
143489993|NCT02469090|517338222|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
143489994|NCT02469090|517338223|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
143489995|NCT02469090|517338224|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
143489996|NCT02469090|517338222|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
143489997|NCT02469090|517338223|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
143489998|NCT02469090|517338224|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
143489999|NCT02469090|517338222|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
143490000|NCT02469090|517338223|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
143490001|NCT02469090|517338224|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
143490002|NCT02469090|517338222|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
143490003|NCT02469090|517338223|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
143490004|NCT02469090|517338224|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
143490005|NCT02469090|517338222|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
143490006|NCT02469090|517338223|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
143490007|NCT02469090|517338224|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
143490008|NCT02469090|517338222|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
143490009|NCT02469090|517338223|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
143490010|NCT02469090|517338224|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
143490011|NCT02469090|517338222|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
143490012|NCT02469090|517338223|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
143490013|NCT02469090|517338224|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
143490014|NCT05030311|517338231|FG000|Overall Study|Technical problems|0|||
143490015|NCT05030311|517338232|FG001|Overall Study|Technical problems|1|||
143490016|NCT05030311|517338231|FG000|Overall Study|Withdrawal by Subject|31|||
143490017|NCT05030311|517338232|FG001|Overall Study|Withdrawal by Subject|17|||
143490018|NCT05030311|517338231|FG000|Overall Study|Adverse Event|13|||
143490019|NCT05030311|517338232|FG001|Overall Study|Adverse Event|5|||
143490020|NCT05030311|517338231|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
143490021|NCT05030311|517338232|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
143490022|NCT05030311|517338231|FG000|Overall Study|Physician Decision|5|||
143490023|NCT05030311|517338232|FG001|Overall Study|Physician Decision|2|||
143490024|NCT05030311|517338231|FG000|Overall Study|Lost to Follow-up|5|||
143490025|NCT05030311|517338232|FG001|Overall Study|Lost to Follow-up|1|||
143490026|NCT05030311|517338231|FG000|Overall Study|Protocol Violation|4|||
143490027|NCT05030311|517338232|FG001|Overall Study|Protocol Violation|4|||
143490028|NCT00493038|517338233|FG000|Treatment|Adverse Event|8|||
143490029|NCT00493038|517338234|FG001|Treatment|Adverse Event|4|||
143490030|NCT00493038|517338233|FG000|Treatment|Lost to Follow-up|5|||
143490031|NCT00493038|517338234|FG001|Treatment|Lost to Follow-up|3|||
143490032|NCT00493038|517338233|FG000|Treatment|Withdrawal by Subject|11|||
143490033|NCT00493038|517338234|FG001|Treatment|Withdrawal by Subject|12|||
143490034|NCT00493038|517338233|FG000|Treatment|Other|0|||
143490035|NCT00493038|517338234|FG001|Treatment|Other|1|||
143490036|NCT00493038|517338233|FG000|Follow-up|Lost to Follow-up|1|||
143490037|NCT00493038|517338234|FG001|Follow-up|Lost to Follow-up|0|||
143490038|NCT03345472|517338236|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
143157914|NCT01851369|516124322|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
143236841|NCT00389610|516421498|FG000|Overall Study|Disease Progression|0|||
143490039|NCT03345472|517338236|FG000|Implant to 3 Months|Physician Decision|1|||
143490040|NCT03345472|517338236|FG000|Implant to 3 Months|Adverse Event|1|||
143490041|NCT03345472|517338236|FG000|3 Months to 12 Months|Physician Decision|3|||
143490042|NCT03345472|517338236|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
143490043|NCT03345472|517338236|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
143490044|NCT03345472|517338236|FG000|3 Months to 12 Months|Adverse Event|1|||
143490045|NCT03345472|517338236|FG000|3 Months to 12 Months|Death|1|||
143490046|NCT01926782|517338237|FG000|Overall Study|Participant moved|2|||
143490047|NCT01926782|517338238|FG001|Overall Study|Participant moved|0|||
143490048|NCT01926782|517338239|FG002|Overall Study|Participant moved|1|||
143024942|NCT00818623|515631229|FG006|Overall Study|Adverse Event|0|||
143024943|NCT00818623|515631230|FG007|Overall Study|Adverse Event|0|||
143024944|NCT00818623|515631223|FG000|Overall Study|Bad prostate specific antigen response|0|||
143024945|NCT00818623|515631224|FG001|Overall Study|Bad prostate specific antigen response|3|||
143024946|NCT00818623|515631225|FG002|Overall Study|Bad prostate specific antigen response|2|||
143024947|NCT00818623|515631226|FG003|Overall Study|Bad prostate specific antigen response|5|||
143024948|NCT00818623|515631227|FG004|Overall Study|Bad prostate specific antigen response|0|||
143024949|NCT00818623|515631228|FG005|Overall Study|Bad prostate specific antigen response|1|||
143024950|NCT00818623|515631229|FG006|Overall Study|Bad prostate specific antigen response|0|||
143024951|NCT00818623|515631230|FG007|Overall Study|Bad prostate specific antigen response|0|||
143024952|NCT00818623|515631223|FG000|Overall Study|Withdrawal by Subject|0|||
143024953|NCT00818623|515631224|FG001|Overall Study|Withdrawal by Subject|1|||
143024954|NCT00818623|515631225|FG002|Overall Study|Withdrawal by Subject|1|||
143024955|NCT00818623|515631226|FG003|Overall Study|Withdrawal by Subject|0|||
143024956|NCT00818623|515631227|FG004|Overall Study|Withdrawal by Subject|0|||
143024957|NCT00818623|515631228|FG005|Overall Study|Withdrawal by Subject|1|||
143024958|NCT00818623|515631229|FG006|Overall Study|Withdrawal by Subject|1|||
143024959|NCT00818623|515631230|FG007|Overall Study|Withdrawal by Subject|1|||
143024960|NCT00818623|515631223|FG000|Overall Study|Protocol Violation|1|||
143024961|NCT00818623|515631224|FG001|Overall Study|Protocol Violation|0|||
143024962|NCT00818623|515631225|FG002|Overall Study|Protocol Violation|0|||
143024963|NCT00818623|515631226|FG003|Overall Study|Protocol Violation|0|||
143024964|NCT00818623|515631227|FG004|Overall Study|Protocol Violation|1|||
143024965|NCT00818623|515631228|FG005|Overall Study|Protocol Violation|0|||
143024966|NCT00818623|515631229|FG006|Overall Study|Protocol Violation|1|||
143024967|NCT00818623|515631230|FG007|Overall Study|Protocol Violation|0|||
143024968|NCT00818623|515631223|FG000|Overall Study|Need of additional treatment|0|||
143490049|NCT01926782|517338240|FG003|Overall Study|Participant moved|1|||
143490050|NCT01926782|517338241|FG004|Overall Study|Participant moved|0|||
143490051|NCT01926782|517338242|FG005|Overall Study|Participant moved|3|||
143490052|NCT01926782|517338237|FG000|Overall Study|Physician Decision|0|||
143490053|NCT01926782|517338238|FG001|Overall Study|Physician Decision|2|||
143024969|NCT00818623|515631224|FG001|Overall Study|Need of additional treatment|0|||
143024970|NCT00818623|515631225|FG002|Overall Study|Need of additional treatment|0|||
143024971|NCT00818623|515631226|FG003|Overall Study|Need of additional treatment|0|||
143024972|NCT00818623|515631227|FG004|Overall Study|Need of additional treatment|1|||
143024973|NCT00818623|515631228|FG005|Overall Study|Need of additional treatment|0|||
143024974|NCT00818623|515631229|FG006|Overall Study|Need of additional treatment|0|||
143024975|NCT00818623|515631230|FG007|Overall Study|Need of additional treatment|0|||
143024976|NCT00818623|515631223|FG000|Overall Study|Lack of trial drug at site|0|||
143024977|NCT00818623|515631224|FG001|Overall Study|Lack of trial drug at site|0|||
143024978|NCT00818623|515631225|FG002|Overall Study|Lack of trial drug at site|0|||
143024979|NCT00818623|515631226|FG003|Overall Study|Lack of trial drug at site|0|||
143490054|NCT01926782|517338239|FG002|Overall Study|Physician Decision|1|||
143490055|NCT01926782|517338240|FG003|Overall Study|Physician Decision|1|||
143490056|NCT01926782|517338241|FG004|Overall Study|Physician Decision|0|||
143490057|NCT01926782|517338242|FG005|Overall Study|Physician Decision|0|||
143490058|NCT01926782|517338237|FG000|Overall Study|Other than specified|2|||
143490059|NCT01926782|517338238|FG001|Overall Study|Other than specified|3|||
143490060|NCT01926782|517338239|FG002|Overall Study|Other than specified|5|||
143490061|NCT01926782|517338240|FG003|Overall Study|Other than specified|12|||
143490062|NCT01926782|517338241|FG004|Overall Study|Other than specified|4|||
143490063|NCT01926782|517338242|FG005|Overall Study|Other than specified|11|||
143490064|NCT01926782|517338237|FG000|Overall Study|Adverse Event|13|||
143490065|NCT01926782|517338238|FG001|Overall Study|Adverse Event|4|||
143490066|NCT01926782|517338239|FG002|Overall Study|Adverse Event|17|||
143490067|NCT01926782|517338240|FG003|Overall Study|Adverse Event|4|||
143490068|NCT01926782|517338241|FG004|Overall Study|Adverse Event|3|||
143490069|NCT01926782|517338242|FG005|Overall Study|Adverse Event|14|||
143490070|NCT01926782|517338237|FG000|Overall Study|Poor compliance to protocol|5|||
143490071|NCT01926782|517338238|FG001|Overall Study|Poor compliance to protocol|3|||
143490072|NCT01926782|517338239|FG002|Overall Study|Poor compliance to protocol|8|||
143490073|NCT01926782|517338240|FG003|Overall Study|Poor compliance to protocol|0|||
143024980|NCT00818623|515631227|FG004|Overall Study|Lack of trial drug at site|2|||
143024981|NCT00818623|515631228|FG005|Overall Study|Lack of trial drug at site|0|||
143024982|NCT00818623|515631229|FG006|Overall Study|Lack of trial drug at site|1|||
143024983|NCT00818623|515631230|FG007|Overall Study|Lack of trial drug at site|0|||
143024984|NCT00818623|515631223|FG000|Overall Study|Disease progression|0|||
143024985|NCT00818623|515631224|FG001|Overall Study|Disease progression|0|||
143363856|NCT00049517|516875452|FG002|Conditioning/Transplant|Death|0|||
143024986|NCT00818623|515631225|FG002|Overall Study|Disease progression|0|||
143024987|NCT00818623|515631226|FG003|Overall Study|Disease progression|0|||
143490074|NCT01926782|517338241|FG004|Overall Study|Poor compliance to protocol|1|||
143490075|NCT01926782|517338242|FG005|Overall Study|Poor compliance to protocol|6|||
143490076|NCT01926782|517338237|FG000|Overall Study|Randomized and not treated|0|||
143490077|NCT01926782|517338238|FG001|Overall Study|Randomized and not treated|0|||
143490078|NCT01926782|517338239|FG002|Overall Study|Randomized and not treated|0|||
143024988|NCT00818623|515631227|FG004|Overall Study|Disease progression|0|||
143024989|NCT00818623|515631228|FG005|Overall Study|Disease progression|0|||
143024990|NCT00818623|515631229|FG006|Overall Study|Disease progression|1|||
143024991|NCT00818623|515631230|FG007|Overall Study|Disease progression|0|||
143024992|NCT01821625|515631232|FG000|Overall Study|Withdrawal by Subject|2|||
143024993|NCT01821625|515631232|FG000|Overall Study|Lack of Efficacy|2|||
143024994|NCT01821625|515631232|FG000|Overall Study|Adverse Event|1|||
143024995|NCT01821625|515631232|FG000|Overall Study|Medical contraindication|1|||
143024996|NCT02535000|515631235|FG000|Overall Study|Cancellation of surgery.|1|||
143024997|NCT02535000|515631236|FG001|Overall Study|Cancellation of surgery.|2|||
143024998|NCT01851590|515631237|FG000|Overall Study|Withdrawal by Subject|0|||
143024999|NCT01851590|515631238|FG001|Overall Study|Withdrawal by Subject|0|||
143025000|NCT01851590|515631239|FG002|Overall Study|Withdrawal by Subject|1|||
143025001|NCT01851590|515631237|FG000|Overall Study|Adverse Event|0|||
143025002|NCT01851590|515631238|FG001|Overall Study|Adverse Event|0|||
143025003|NCT01851590|515631239|FG002|Overall Study|Adverse Event|2|||
143025004|NCT01851590|515631237|FG000|Overall Study|Lack of Efficacy|0|||
143025005|NCT01851590|515631238|FG001|Overall Study|Lack of Efficacy|1|||
143025006|NCT01851590|515631239|FG002|Overall Study|Lack of Efficacy|0|||
143025007|NCT01186978|515631241|FG000|Overall Study|Withdrawal by Subject|1|||
143025008|NCT00947856|515631242|FG000|Treatment Period|Progressive Disease|33|||
143025009|NCT00947856|515631243|FG001|Treatment Period|Progressive Disease|12|||
143025010|NCT00947856|515631242|FG000|Treatment Period|Adverse Event|15|||
143025011|NCT00947856|515631243|FG001|Treatment Period|Adverse Event|9|||
143025012|NCT00947856|515631242|FG000|Treatment Period|Physician Decision|14|||
143025013|NCT00947856|515631243|FG001|Treatment Period|Physician Decision|6|||
143025014|NCT00947856|515631242|FG000|Treatment Period|Study Stopped by Sponsor|4|||
143025015|NCT00947856|515631243|FG001|Treatment Period|Study Stopped by Sponsor|4|||
143025016|NCT00947856|515631242|FG000|Treatment Period|Withdrawal by Subject|12|||
143025017|NCT00947856|515631243|FG001|Treatment Period|Withdrawal by Subject|1|||
143025018|NCT00947856|515631242|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
143025019|NCT00947856|515631243|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
143025020|NCT00947856|515631242|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
143025021|NCT00947856|515631243|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
143025022|NCT00947856|515631242|FG000|Follow-up Period|Lost to Follow-up|7|||
143157915|NCT01851369|516124323|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
143157916|NCT01851369|516124324|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
143490079|NCT01926782|517338240|FG003|Overall Study|Randomized and not treated|1|||
143025023|NCT00947856|515631243|FG001|Follow-up Period|Lost to Follow-up|0|||
143025024|NCT00947856|515631242|FG000|Follow-up Period|Patient unavailable for site visits|1|||
143025025|NCT00947856|515631243|FG001|Follow-up Period|Patient unavailable for site visits|0|||
143157917|NCT01851369|516124325|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
143157918|NCT03364686|516124328|FG000|Overall Study|Physician Decision|2|||
143490080|NCT01926782|517338241|FG004|Overall Study|Randomized and not treated|0|||
143490081|NCT01926782|517338242|FG005|Overall Study|Randomized and not treated|0|||
143490082|NCT01926782|517338237|FG000|Overall Study|Withdrawal by Subject|6|||
143490083|NCT01926782|517338238|FG001|Overall Study|Withdrawal by Subject|1|||
143490084|NCT01926782|517338239|FG002|Overall Study|Withdrawal by Subject|8|||
143490085|NCT01926782|517338240|FG003|Overall Study|Withdrawal by Subject|1|||
143490086|NCT01926782|517338241|FG004|Overall Study|Withdrawal by Subject|0|||
143490087|NCT01926782|517338242|FG005|Overall Study|Withdrawal by Subject|5|||
143490088|NCT01926782|517338237|FG000|Overall Study|Related to study drug administration|0|||
143490089|NCT01926782|517338238|FG001|Overall Study|Related to study drug administration|0|||
143490090|NCT01926782|517338239|FG002|Overall Study|Related to study drug administration|0|||
143490091|NCT01926782|517338240|FG003|Overall Study|Related to study drug administration|0|||
143490092|NCT01926782|517338241|FG004|Overall Study|Related to study drug administration|0|||
143490093|NCT01926782|517338242|FG005|Overall Study|Related to study drug administration|2|||
143490094|NCT01100944|517338243|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
143490095|NCT01100944|517338244|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
143490096|NCT01100944|517338245|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
143490097|NCT01100944|517338243|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
143490098|NCT01100944|517338244|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
143490099|NCT01100944|517338245|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
143490100|NCT01100944|517338243|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
143490101|NCT01100944|517338244|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
143025026|NCT00947856|515631242|FG000|Follow-up Period|Withdrawal by Subject|1|||
143025027|NCT00947856|515631243|FG001|Follow-up Period|Withdrawal by Subject|0|||
143157919|NCT00395512|516124330|FG000|Overall Study|Adverse Event|3|||
143157920|NCT00395512|516124331|FG001|Overall Study|Adverse Event|8|||
143025028|NCT00543439|515631244|FG000|Period 1|Adverse Event|0|||
143025029|NCT00543439|515631245|FG001|Period 1|Adverse Event|2|||
143490102|NCT01100944|517338245|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
143025030|NCT00543439|515631246|FG002|Period 1|Adverse Event|1|||
143025031|NCT00543439|515631244|FG000|Period 1|Withdrawal by Subject|1|||
143025032|NCT00543439|515631245|FG001|Period 1|Withdrawal by Subject|1|||
143025033|NCT00543439|515631246|FG002|Period 1|Withdrawal by Subject|0|||
143025034|NCT00543439|515631244|FG000|Period 1|Physician Decision|0|||
143025035|NCT00543439|515631245|FG001|Period 1|Physician Decision|0|||
143025036|NCT00543439|515631246|FG002|Period 1|Physician Decision|1|||
143025037|NCT00543439|515631244|FG000|Period 2|Protocol Violation|1|||
143025038|NCT00543439|515631245|FG001|Period 2|Protocol Violation|0|||
143025039|NCT00543439|515631246|FG002|Period 2|Protocol Violation|1|||
143025040|NCT00543439|515631244|FG000|Period 2|Adverse Event|0|||
143025041|NCT00543439|515631245|FG001|Period 2|Adverse Event|1|||
143025042|NCT00543439|515631246|FG002|Period 2|Adverse Event|1|||
143025043|NCT02115256|515631253|FG000|Overall Study|Withdrawal by Subject|0|||
143025044|NCT02115256|515631254|FG001|Overall Study|Withdrawal by Subject|1|||
143025045|NCT00656019|515631255|FG000|Overall Study|Not Eligible|10|||
143025046|NCT00656019|515631256|FG001|Overall Study|Not Eligible|0|||
143025047|NCT00656019|515631257|FG002|Overall Study|Not Eligible|0|||
143025048|NCT00656019|515631258|FG003|Overall Study|Not Eligible|0|||
143025049|NCT00656019|515631255|FG000|Overall Study|Withdrawal by Subject|2|||
143025050|NCT00656019|515631256|FG001|Overall Study|Withdrawal by Subject|0|||
143025051|NCT00656019|515631257|FG002|Overall Study|Withdrawal by Subject|0|||
143025052|NCT00656019|515631258|FG003|Overall Study|Withdrawal by Subject|0|||
143025053|NCT00656019|515631255|FG000|Overall Study|Lost to Follow-up|2|||
143025054|NCT00656019|515631256|FG001|Overall Study|Lost to Follow-up|1|||
143490103|NCT01100944|517338243|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
143490104|NCT01100944|517338244|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
143490105|NCT01100944|517338245|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
143490106|NCT02217566|517338246|FG000|Overall Study|Lost to Follow-up|2|||
143490107|NCT02217566|517338246|FG000|Overall Study|Death|3|||
143490108|NCT02217566|517338246|FG000|Overall Study|Early study termination|6|||
143490109|NCT02296242|517338247|FG000|Overall Study|Death|1|||
143490110|NCT02296242|517338248|FG001|Overall Study|Death|1|||
143490111|NCT02296242|517338249|FG002|Overall Study|Death|1|||
143490112|NCT02296242|517338250|FG003|Overall Study|Death|1|||
143490113|NCT02296242|517338251|FG004|Overall Study|Death|1|||
143490114|NCT02296242|517338247|FG000|Overall Study|Withdrawal by Subject|0|||
143490115|NCT02296242|517338248|FG001|Overall Study|Withdrawal by Subject|0|||
143025055|NCT00656019|515631257|FG002|Overall Study|Lost to Follow-up|0|||
143025056|NCT00656019|515631258|FG003|Overall Study|Lost to Follow-up|0|||
143025057|NCT01078090|515631270|FG000|Overall Study|Lost to Follow-up|2363|||
143025058|NCT01078090|515631270|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
143025059|NCT01078090|515631270|FG000|Overall Study|Lack of Efficacy|1193|||
143025060|NCT01078090|515631270|FG000|Overall Study|ADR and lack of efficacy|61|||
143025061|NCT01078090|515631270|FG000|Overall Study|Other|523|||
143025062|NCT02669264|515631272|FG000|Overall Study|Death|5|||
143025063|NCT02669264|515631273|FG001|Overall Study|Death|5|||
143025064|NCT02669264|515631274|FG002|Overall Study|Death|3|||
143025065|NCT02669264|515631275|FG003|Overall Study|Death|3|||
143025066|NCT02669264|515631276|FG004|Overall Study|Death|3|||
143025067|NCT02669264|515631277|FG005|Overall Study|Death|6|||
143025068|NCT02669264|515631278|FG006|Overall Study|Death|3|||
143157921|NCT00395512|516124332|FG002|Overall Study|Adverse Event|6|||
143157922|NCT00395512|516124333|FG003|Overall Study|Adverse Event|6|||
143157923|NCT00395512|516124330|FG000|Overall Study|Protocol Violation|2|||
143157924|NCT00395512|516124331|FG001|Overall Study|Protocol Violation|3|||
143157925|NCT00395512|516124332|FG002|Overall Study|Protocol Violation|6|||
143157926|NCT00395512|516124333|FG003|Overall Study|Protocol Violation|7|||
143157927|NCT00395512|516124330|FG000|Overall Study|Lost to Follow-up|2|||
143157928|NCT00395512|516124331|FG001|Overall Study|Lost to Follow-up|6|||
143157929|NCT00395512|516124332|FG002|Overall Study|Lost to Follow-up|5|||
143157930|NCT00395512|516124333|FG003|Overall Study|Lost to Follow-up|5|||
143157931|NCT00395512|516124330|FG000|Overall Study|Withdrawal by Subject|6|||
143157932|NCT00395512|516124331|FG001|Overall Study|Withdrawal by Subject|5|||
143157933|NCT00395512|516124332|FG002|Overall Study|Withdrawal by Subject|5|||
143157934|NCT00395512|516124333|FG003|Overall Study|Withdrawal by Subject|12|||
143157935|NCT00395512|516124330|FG000|Overall Study|Physician Decision|6|||
143157936|NCT00395512|516124331|FG001|Overall Study|Physician Decision|4|||
143157937|NCT00395512|516124332|FG002|Overall Study|Physician Decision|2|||
143157938|NCT00395512|516124333|FG003|Overall Study|Physician Decision|2|||
143157939|NCT00395512|516124330|FG000|Overall Study|Other|1|||
143490116|NCT02296242|517338249|FG002|Overall Study|Withdrawal by Subject|1|||
143490117|NCT02296242|517338250|FG003|Overall Study|Withdrawal by Subject|1|||
143025069|NCT02669264|515631272|FG000|Overall Study|Withdrawal by Subject|0|||
143025070|NCT02669264|515631273|FG001|Overall Study|Withdrawal by Subject|1|||
143157940|NCT00395512|516124331|FG001|Overall Study|Other|1|||
143157941|NCT00395512|516124332|FG002|Overall Study|Other|0|||
143157942|NCT00395512|516124333|FG003|Overall Study|Other|0|||
143157943|NCT00395512|516124330|FG000|Overall Study|Hyperglycemic Rescue|18|||
143157944|NCT00395512|516124331|FG001|Overall Study|Hyperglycemic Rescue|10|||
143025071|NCT02669264|515631274|FG002|Overall Study|Withdrawal by Subject|0|||
143025072|NCT02669264|515631275|FG003|Overall Study|Withdrawal by Subject|0|||
143025073|NCT02669264|515631276|FG004|Overall Study|Withdrawal by Subject|1|||
143025074|NCT02669264|515631277|FG005|Overall Study|Withdrawal by Subject|0|||
143025075|NCT02669264|515631278|FG006|Overall Study|Withdrawal by Subject|0|||
143025076|NCT02669264|515631272|FG000|Overall Study|Lost to Follow-up|0|||
143025077|NCT02669264|515631273|FG001|Overall Study|Lost to Follow-up|0|||
143025078|NCT02669264|515631274|FG002|Overall Study|Lost to Follow-up|0|||
143025079|NCT02669264|515631275|FG003|Overall Study|Lost to Follow-up|0|||
143025080|NCT02669264|515631276|FG004|Overall Study|Lost to Follow-up|1|||
143025081|NCT02669264|515631277|FG005|Overall Study|Lost to Follow-up|0|||
143025082|NCT02669264|515631278|FG006|Overall Study|Lost to Follow-up|0|||
143025083|NCT02669264|515631272|FG000|Overall Study|Miscellaneous|0|||
143025084|NCT02669264|515631273|FG001|Overall Study|Miscellaneous|0|||
143025085|NCT02669264|515631274|FG002|Overall Study|Miscellaneous|0|||
143025086|NCT02669264|515631275|FG003|Overall Study|Miscellaneous|0|||
143025087|NCT02669264|515631276|FG004|Overall Study|Miscellaneous|0|||
143025088|NCT02669264|515631277|FG005|Overall Study|Miscellaneous|0|||
143025089|NCT02669264|515631278|FG006|Overall Study|Miscellaneous|2|||
143025090|NCT01688037|515631279|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
143025091|NCT01688037|515631280|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
143025092|NCT01688037|515631281|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
143025093|NCT01688037|515631279|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
143025094|NCT01688037|515631280|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
143025095|NCT01688037|515631281|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
143025096|NCT01688037|515631279|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
143025097|NCT01688037|515631280|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
143025098|NCT01688037|515631281|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
143025099|NCT01688037|515631279|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
143025100|NCT01688037|515631280|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
143025101|NCT01688037|515631281|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
143025102|NCT01688037|515631279|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
143025103|NCT01688037|515631280|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
143025104|NCT01688037|515631281|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
143025105|NCT01688037|515631279|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
143025106|NCT01688037|515631280|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
143490118|NCT02296242|517338251|FG004|Overall Study|Withdrawal by Subject|3|||
143490119|NCT02296242|517338247|FG000|Overall Study|Disease Progression|1|||
143490120|NCT02296242|517338248|FG001|Overall Study|Disease Progression|3|||
143490121|NCT02296242|517338249|FG002|Overall Study|Disease Progression|2|||
143490122|NCT02296242|517338250|FG003|Overall Study|Disease Progression|8|||
143490123|NCT02296242|517338251|FG004|Overall Study|Disease Progression|11|||
143490124|NCT02296242|517338247|FG000|Overall Study|Unacceptable Toxicity|0|||
143490125|NCT02296242|517338248|FG001|Overall Study|Unacceptable Toxicity|0|||
143490126|NCT02296242|517338249|FG002|Overall Study|Unacceptable Toxicity|0|||
143490127|NCT02296242|517338250|FG003|Overall Study|Unacceptable Toxicity|0|||
143490128|NCT02296242|517338251|FG004|Overall Study|Unacceptable Toxicity|1|||
143490129|NCT02296242|517338247|FG000|Overall Study|Patient Condition Changed|0|||
143490130|NCT02296242|517338248|FG001|Overall Study|Patient Condition Changed|0|||
143490131|NCT02296242|517338249|FG002|Overall Study|Patient Condition Changed|2|||
143490132|NCT02296242|517338250|FG003|Overall Study|Patient Condition Changed|0|||
143490133|NCT02296242|517338251|FG004|Overall Study|Patient Condition Changed|1|||
143490134|NCT02296242|517338247|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
143490135|NCT02296242|517338248|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
143490136|NCT02296242|517338249|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
143490137|NCT02296242|517338250|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
143490138|NCT02296242|517338251|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
143490139|NCT02296242|517338247|FG000|Overall Study|Lost to Follow-up|1|||
143490140|NCT02296242|517338248|FG001|Overall Study|Lost to Follow-up|0|||
143490141|NCT02296242|517338249|FG002|Overall Study|Lost to Follow-up|0|||
143490142|NCT02296242|517338250|FG003|Overall Study|Lost to Follow-up|0|||
143490143|NCT02296242|517338251|FG004|Overall Study|Lost to Follow-up|0|||
143490144|NCT02296242|517338247|FG000|Overall Study|Need for Hydroxyurea|2|||
143025107|NCT01688037|515631281|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
143025108|NCT01688037|515631279|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
143025109|NCT01688037|515631280|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
143025110|NCT01688037|515631281|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
143025111|NCT01688037|515631279|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
143490145|NCT02296242|517338248|FG001|Overall Study|Need for Hydroxyurea|0|||
143490146|NCT02296242|517338249|FG002|Overall Study|Need for Hydroxyurea|0|||
143490147|NCT02296242|517338250|FG003|Overall Study|Need for Hydroxyurea|0|||
143025112|NCT01688037|515631280|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
143490148|NCT02296242|517338251|FG004|Overall Study|Need for Hydroxyurea|0|||
143490149|NCT02296242|517338247|FG000|Overall Study|Screened for Other Protocol|0|||
143490150|NCT02296242|517338248|FG001|Overall Study|Screened for Other Protocol|1|||
143490151|NCT02296242|517338249|FG002|Overall Study|Screened for Other Protocol|0|||
143490152|NCT02296242|517338250|FG003|Overall Study|Screened for Other Protocol|0|||
143490153|NCT02296242|517338251|FG004|Overall Study|Screened for Other Protocol|0|||
143490154|NCT02296242|517338247|FG000|Overall Study|Physician Decision|0|||
143490155|NCT02296242|517338248|FG001|Overall Study|Physician Decision|1|||
143490156|NCT02296242|517338249|FG002|Overall Study|Physician Decision|0|||
143490157|NCT02296242|517338250|FG003|Overall Study|Physician Decision|1|||
143490158|NCT02296242|517338251|FG004|Overall Study|Physician Decision|0|||
143490159|NCT02296242|517338247|FG000|Overall Study|Alternative Treatment|0|||
143490160|NCT02296242|517338248|FG001|Overall Study|Alternative Treatment|0|||
143490161|NCT02296242|517338249|FG002|Overall Study|Alternative Treatment|0|||
143490162|NCT02296242|517338250|FG003|Overall Study|Alternative Treatment|1|||
143490163|NCT02296242|517338251|FG004|Overall Study|Alternative Treatment|0|||
143490164|NCT02296242|517338247|FG000|Overall Study|Adverse Event|0|||
143490165|NCT02296242|517338248|FG001|Overall Study|Adverse Event|0|||
143490166|NCT02296242|517338249|FG002|Overall Study|Adverse Event|0|||
143490167|NCT02296242|517338250|FG003|Overall Study|Adverse Event|1|||
143490168|NCT02296242|517338251|FG004|Overall Study|Adverse Event|0|||
143490169|NCT02296242|517338247|FG000|Overall Study|Lack of Efficacy|0|||
143490170|NCT02296242|517338248|FG001|Overall Study|Lack of Efficacy|0|||
143490171|NCT02296242|517338249|FG002|Overall Study|Lack of Efficacy|0|||
143490172|NCT02296242|517338250|FG003|Overall Study|Lack of Efficacy|0|||
143490173|NCT02296242|517338251|FG004|Overall Study|Lack of Efficacy|3|||
143490174|NCT01639833|517338253|FG000|Overall Study|Death|4|||
143490175|NCT01639833|517338254|FG001|Overall Study|Death|2|||
143490176|NCT01639833|517338253|FG000|Overall Study|Withdrawal by Subject|2|||
143490177|NCT01639833|517338254|FG001|Overall Study|Withdrawal by Subject|2|||
143490178|NCT00070941|517338255|FG000|Overall Study|Adverse Event|10|||
143490179|NCT00070941|517338256|FG001|Overall Study|Adverse Event|8|||
143490180|NCT00070941|517338257|FG002|Overall Study|Adverse Event|4|||
143490181|NCT02064387|517338258|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
143490182|NCT02064387|517338259|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
143490183|NCT02064387|517338260|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
143490184|NCT02064387|517338261|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
143490185|NCT02064387|517338262|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
143490186|NCT02064387|517338263|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
143490187|NCT02064387|517338264|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
143490188|NCT02064387|517338265|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
143490189|NCT02064387|517338266|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
143490190|NCT02064387|517338267|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
143490191|NCT02064387|517338268|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
143490192|NCT02064387|517338269|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
143490193|NCT02064387|517338258|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
143490194|NCT02064387|517338259|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
143490195|NCT02064387|517338260|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
143490196|NCT02064387|517338261|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
143490197|NCT02064387|517338262|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
143490198|NCT02064387|517338263|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
143490199|NCT02064387|517338264|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
143490200|NCT02064387|517338265|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
143490201|NCT02064387|517338266|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
143490202|NCT02064387|517338267|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
143490203|NCT02064387|517338268|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
143490204|NCT02064387|517338269|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
143490205|NCT02064387|517338258|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
143490206|NCT02064387|517338259|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
143157945|NCT00395512|516124332|FG002|Overall Study|Hyperglycemic Rescue|4|||
143157946|NCT00395512|516124333|FG003|Overall Study|Hyperglycemic Rescue|6|||
143157947|NCT01478087|516124334|FG000|Overall Study|due to sponsor closing study|1|||
143157948|NCT01210443|516124336|FG000|Overall Study|Study terminated by sponsor|2|||
143157949|NCT00063999|516124339|FG000|Overall Study|Withdrawal by Subject|1|||
143490207|NCT02064387|517338260|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
143490208|NCT02064387|517338261|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
143490209|NCT02064387|517338262|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
143490210|NCT02064387|517338263|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
143490211|NCT02064387|517338264|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
143490212|NCT02064387|517338265|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
143490213|NCT02064387|517338266|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
143490214|NCT02064387|517338267|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
143157950|NCT00063999|516124340|FG001|Overall Study|Withdrawal by Subject|0|||
143025113|NCT01688037|515631281|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
143025114|NCT01688037|515631279|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
143025115|NCT01688037|515631280|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
143025116|NCT01688037|515631281|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
143025117|NCT01688037|515631279|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
143025118|NCT01688037|515631280|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
143025119|NCT01688037|515631281|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
143025120|NCT02220907|515631282|FG000|Overall Study|Adverse Event|7|||
143025121|NCT02220907|515631282|FG000|Overall Study|Physician Decision|1|||
143025122|NCT02220907|515631282|FG000|Overall Study|Withdrawal by Subject|2|||
143025123|NCT02220907|515631282|FG000|Overall Study|Conflict with the stopping criteria|1|||
143025124|NCT02995837|515631283|FG000|Overall Study|Lost to Follow-up|9|||
143025125|NCT02995837|515631284|FG001|Overall Study|Lost to Follow-up|8|||
143025126|NCT01859702|515631285|FG000|Overall Study|Protocol deviation|3|||
143490215|NCT02064387|517338268|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
143490216|NCT02064387|517338269|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
143490217|NCT02064387|517338258|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
143490218|NCT02064387|517338259|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
143490219|NCT02064387|517338260|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
143490220|NCT02064387|517338261|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
143490221|NCT02064387|517338262|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
143490222|NCT02064387|517338263|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
143490223|NCT02064387|517338264|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
143490224|NCT02064387|517338265|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
143490225|NCT02064387|517338266|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
143490226|NCT02064387|517338267|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
143490227|NCT02064387|517338268|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
143490228|NCT02064387|517338269|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
143490229|NCT02064387|517338258|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
143490230|NCT02064387|517338259|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
143490231|NCT02064387|517338260|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
143490232|NCT02064387|517338261|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
143490233|NCT02064387|517338262|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
143490234|NCT02064387|517338263|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
143490235|NCT02064387|517338264|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
143490236|NCT02064387|517338265|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
143490237|NCT02064387|517338266|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
143490238|NCT02064387|517338267|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
143490239|NCT02064387|517338268|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
143490240|NCT02064387|517338269|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
143490241|NCT02499029|517338270|FG000|Overall Study|Lost to Follow-up|2|||
143490242|NCT02499029|517338271|FG001|Overall Study|Lost to Follow-up|2|||
143490243|NCT02499029|517338270|FG000|Overall Study|Physician Decision|2|||
143490244|NCT02499029|517338271|FG001|Overall Study|Physician Decision|1|||
143490245|NCT02499029|517338270|FG000|Overall Study|Death|1|||
143490246|NCT02499029|517338271|FG001|Overall Study|Death|0|||
143490247|NCT01707693|517338272|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
143490248|NCT01707693|517338273|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
143490249|NCT01707693|517338272|FG000|Overall Study Allocation|Protocol Violation|4|||
143490250|NCT01707693|517338273|FG001|Overall Study Allocation|Protocol Violation|3|||
143490251|NCT01707693|517338272|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
143490252|NCT01707693|517338273|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
143490253|NCT01707693|517338272|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
143490254|NCT01707693|517338273|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
143490255|NCT03847610|517338274|FG000|Overall Study|Withdrawal by Subject|1|||
143490256|NCT03298022|517338275|FG000|Overall Study|Lack of Efficacy|4|||
143490257|NCT03298022|517338275|FG000|Overall Study|Withdrawal by Subject|7|||
143490258|NCT03298022|517338275|FG000|Overall Study|Adverse Event|1|||
143490259|NCT03298022|517338275|FG000|Overall Study|disease relapse|1|||
143490260|NCT01445769|517338276|FG000|Overall Study|Consent Withdrawn|2|||
143490261|NCT01445769|517338276|FG000|Overall Study|Disease Progression|1|||
143490262|NCT01445769|517338276|FG000|Overall Study|Lost to Follow-up|5|||
143490263|NCT04472429|517338277|FG000|Randomized Period|Ongoing|90|||
143025127|NCT01859702|515631285|FG000|Overall Study|Adverse Event|2|||
143025128|NCT03507439|515631289|FG000|Overall Study|Other|2|||
143025129|NCT03507439|515631290|FG001|Overall Study|Other|1|||
143025130|NCT03507439|515631289|FG000|Overall Study|Withdrawal by Subject|1|||
143025131|NCT03507439|515631290|FG001|Overall Study|Withdrawal by Subject|0|||
143025132|NCT03507439|515631289|FG000|Overall Study|Death|1|||
143236842|NCT00389610|516421499|FG001|Overall Study|Disease Progression|19|||
143490264|NCT04472429|517338278|FG001|Randomized Period|Ongoing|40|||
143490265|NCT04472429|517338279|FG002|Randomized Period|Ongoing|0|||
143025133|NCT03507439|515631290|FG001|Overall Study|Death|1|||
143025134|NCT00982410|515632854|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
143025135|NCT00982410|515632855|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
143025136|NCT00982410|515632854|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
143025137|NCT00982410|515632855|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
143025138|NCT00982410|515632854|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
143025139|NCT00982410|515632855|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
143025140|NCT00982410|515632854|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
143025141|NCT00982410|515632855|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
143025142|NCT00982410|515632854|FG000|6-month Follow-up Assessment|participant no transportation|1|||
143025143|NCT00982410|515632855|FG001|6-month Follow-up Assessment|participant no transportation|0|||
143025144|NCT00982410|515632854|FG000|6-month Follow-up Assessment|incarceration|0|||
143025145|NCT00982410|515632855|FG001|6-month Follow-up Assessment|incarceration|2|||
143025146|NCT00982410|515632854|FG000|6-month Follow-up Assessment|patent surgery|0|||
143025147|NCT00982410|515632855|FG001|6-month Follow-up Assessment|patent surgery|1|||
143025148|NCT00982410|515632854|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
143025149|NCT00982410|515632855|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
143025150|NCT00982410|515632854|FG000|12-month Follow-up Assessment|Death|0|||
143025151|NCT00982410|515632855|FG001|12-month Follow-up Assessment|Death|2|||
143025152|NCT00982410|515632854|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
143025153|NCT00982410|515632855|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
143025154|NCT00982410|515632854|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
143025155|NCT00982410|515632855|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
143025156|NCT00982410|515632854|FG000|12-month Follow-up Assessment|incarceration|2|||
143025157|NCT00982410|515632855|FG001|12-month Follow-up Assessment|incarceration|1|||
143025158|NCT00982410|515632854|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
143025159|NCT00982410|515632855|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
143025160|NCT04014959|515632856|FG000|Baseline MRI and Assessments|Physician Decision|2|||
143025161|NCT04014959|515632856|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
143025162|NCT04014959|515632856|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
143025163|NCT02004847|515632857|FG000|Overall Study|Protocol Violation|1|||
143025164|NCT02004847|515632858|FG001|Overall Study|Protocol Violation|1|||
143025165|NCT03381248|515632862|FG000|0-6 Months|Withdrawal by Subject|4|||
143236843|NCT00389610|516421498|FG000|Overall Study|Death|0|||
143236844|NCT00389610|516421499|FG001|Overall Study|Death|1|||
143236845|NCT00389610|516421498|FG000|Overall Study|Physician Decision|0|||
143236846|NCT00389610|516421499|FG001|Overall Study|Physician Decision|1|||
143236847|NCT00389610|516421498|FG000|Overall Study|Withdrawal by Subject|0|||
143236848|NCT00389610|516421499|FG001|Overall Study|Withdrawal by Subject|1|||
143236849|NCT00538902|516421500|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
143236850|NCT00538902|516421501|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
143236851|NCT00538902|516421502|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
143236852|NCT00538902|516421500|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
143236853|NCT00538902|516421501|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
143236854|NCT00538902|516421502|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
143236855|NCT00538902|516421500|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
143236856|NCT00538902|516421501|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
143236857|NCT00538902|516421502|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
143236858|NCT00538902|516421500|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
143236859|NCT00538902|516421501|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
143236860|NCT00538902|516421502|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
143236861|NCT00538902|516421500|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
143236862|NCT00538902|516421501|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
143236863|NCT00538902|516421502|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
143236864|NCT00538902|516421500|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
143236865|NCT00538902|516421501|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
143236866|NCT00538902|516421502|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
143236867|NCT00538902|516421500|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
143236868|NCT00538902|516421501|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
143236869|NCT00538902|516421502|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
143236870|NCT00538902|516421500|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
143025166|NCT03381248|515632863|FG001|0-6 Months|Withdrawal by Subject|1|||
143025167|NCT03381248|515632862|FG000|0-6 Months|Lost to Follow-up|3|||
143025168|NCT03381248|515632863|FG001|0-6 Months|Lost to Follow-up|2|||
143025169|NCT03381248|515632862|FG000|0-6 Months|Lack of Efficacy|1|||
143025170|NCT03381248|515632863|FG001|0-6 Months|Lack of Efficacy|0|||
143025171|NCT03381248|515632862|FG000|0-6 Months|Adverse Event|1|||
143236871|NCT00538902|516421501|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
143236872|NCT00538902|516421502|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
143236873|NCT00887809|516421503|FG000|Overall Study|Patient Not Treated|3|||
143025172|NCT03381248|515632863|FG001|0-6 Months|Adverse Event|0|||
143025173|NCT03381248|515632862|FG000|0-6 Months|Protocol Violation|2|||
143025174|NCT03381248|515632863|FG001|0-6 Months|Protocol Violation|1|||
143025175|NCT03381248|515632862|FG000|0-6 Months|Physician Decision|1|||
143490266|NCT04472429|517338277|FG000|Randomized Period|Death|52|||
143025176|NCT03381248|515632863|FG001|0-6 Months|Physician Decision|0|||
143025177|NCT03381248|515632862|FG000|0-6 Months|Planning another procedure|1|||
143025178|NCT03381248|515632863|FG001|0-6 Months|Planning another procedure|2|||
143025179|NCT03381248|515632862|FG000|6-12 Months|Withdrawal by Subject|1|||
143025180|NCT03381248|515632863|FG001|6-12 Months|Withdrawal by Subject|3|||
143025181|NCT03381248|515632862|FG000|6-12 Months|Lost to Follow-up|0|||
143025182|NCT03381248|515632863|FG001|6-12 Months|Lost to Follow-up|2|||
143025183|NCT03381248|515632862|FG000|6-12 Months|Protocol Violation|3|||
143025184|NCT03381248|515632863|FG001|6-12 Months|Protocol Violation|2|||
143025185|NCT03381248|515632862|FG000|6-12 Months|Planning another procedure|6|||
143025186|NCT03381248|515632863|FG001|6-12 Months|Planning another procedure|2|||
143025187|NCT03381248|515632862|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
143025188|NCT03381248|515632863|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
143025189|NCT03381248|515632862|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
143025190|NCT03381248|515632863|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
143025191|NCT03381248|515632862|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
143025192|NCT03381248|515632863|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
143025193|NCT04582266|515632864|FG000|Overall Study|Lost to Follow-up|7|||
143025194|NCT04582266|515632865|FG001|Overall Study|Lost to Follow-up|5|||
143025195|NCT04582266|515632864|FG000|Overall Study|Withdrawal by Subject|1|||
143025196|NCT04582266|515632865|FG001|Overall Study|Withdrawal by Subject|0|||
143025197|NCT04582266|515632864|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
143025198|NCT04582266|515632865|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
143025199|NCT03031899|515632871|FG000|Overall Study|Protocol Violation|1|||
143025200|NCT03031899|515632871|FG000|Overall Study|lesion disappeared after stopping habit|1|||
143025201|NCT00094302|515632872|FG000|Overall Study|Lost to Follow-up|43|||
143025202|NCT00094302|515632873|FG001|Overall Study|Lost to Follow-up|41|||
143025203|NCT00094302|515632872|FG000|Overall Study|Physician Decision|5|||
143490267|NCT04472429|517338278|FG001|Randomized Period|Death|37|||
143490268|NCT04472429|517338279|FG002|Randomized Period|Death|0|||
143490269|NCT04472429|517338277|FG000|Randomized Period|Lost to Follow-up|4|||
143490270|NCT04472429|517338278|FG001|Randomized Period|Lost to Follow-up|0|||
143490271|NCT04472429|517338279|FG002|Randomized Period|Lost to Follow-up|0|||
143490272|NCT04472429|517338277|FG000|Randomized Period|Physician Decision|1|||
143490273|NCT04472429|517338278|FG001|Randomized Period|Physician Decision|2|||
143490274|NCT04472429|517338279|FG002|Randomized Period|Physician Decision|0|||
143490275|NCT04472429|517338277|FG000|Randomized Period|Withdrawal by Subject|6|||
143490276|NCT04472429|517338278|FG001|Randomized Period|Withdrawal by Subject|5|||
143490277|NCT04472429|517338279|FG002|Randomized Period|Withdrawal by Subject|0|||
143490278|NCT04472429|517338277|FG000|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
143490279|NCT04472429|517338278|FG001|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|1|||
143490280|NCT04472429|517338279|FG002|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
143490281|NCT04472429|517338277|FG000|Randomized Period|New Diagnosis of Lymphoma|1|||
143490282|NCT04472429|517338278|FG001|Randomized Period|New Diagnosis of Lymphoma|0|||
143490283|NCT04472429|517338279|FG002|Randomized Period|New Diagnosis of Lymphoma|0|||
143490284|NCT04472429|517338277|FG000|Open-label Monotherapy Period|Ongoing|0|||
143490285|NCT04472429|517338278|FG001|Open-label Monotherapy Period|Ongoing|0|||
143490286|NCT04472429|517338279|FG002|Open-label Monotherapy Period|Ongoing|32|||
143490287|NCT04472429|517338277|FG000|Open-label Monotherapy Period|Death|0|||
143490288|NCT04472429|517338278|FG001|Open-label Monotherapy Period|Death|0|||
143490289|NCT04472429|517338279|FG002|Open-label Monotherapy Period|Death|35|||
143490290|NCT04472429|517338277|FG000|Open-label Monotherapy Period|Lost to Follow-up|0|||
143490291|NCT04472429|517338278|FG001|Open-label Monotherapy Period|Lost to Follow-up|0|||
143490292|NCT04472429|517338279|FG002|Open-label Monotherapy Period|Lost to Follow-up|2|||
143490293|NCT05130463|517338280|FG000|Overall Study|Unspecified reasons|2|||
143490294|NCT05130463|517338280|FG000|Overall Study|off-label indication dose|435|||
143025204|NCT00094302|515632873|FG001|Overall Study|Physician Decision|8|||
143157951|NCT00063999|516124339|FG000|Overall Study|Ineligible|44|||
143363857|NCT00049517|516875453|FG003|Conditioning/Transplant|Death|2|||
143363858|NCT00049517|516875454|FG004|Conditioning/Transplant|Death|0|||
143490295|NCT02695628|517338281|FG000|Overall Study|Withdrawal by Subject|1|||
143490296|NCT02678390|517338282|FG000|AE (1 Day)|Withdrawal by Subject|0|||
143490297|NCT02678390|517338283|FG001|AE (1 Day)|Withdrawal by Subject|1|||
143490298|NCT05073458|517338286|FG000|24-week Double-blind Period|Adverse Event|1|||
143025205|NCT00094302|515632872|FG000|Overall Study|Withdrawal by Subject|103|||
143025206|NCT00094302|515632873|FG001|Overall Study|Withdrawal by Subject|111|||
143025207|NCT00094302|515632872|FG000|Overall Study|Death|266|||
143025208|NCT00094302|515632873|FG001|Overall Study|Death|246|||
143490299|NCT05073458|517338287|FG001|24-week Double-blind Period|Adverse Event|0|||
143490300|NCT05073458|517338286|FG000|24-week Double-blind Period|Physician Decision|1|||
143236874|NCT00887809|516421504|FG001|Overall Study|Patient Not Treated|0|||
143236875|NCT00887809|516421503|FG000|Overall Study|Death|1|||
143236876|NCT00887809|516421504|FG001|Overall Study|Death|0|||
143236877|NCT02000440|516421507|FG000|Overall Study|Adverse Event|3|||
143236878|NCT02000440|516421507|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
143236879|NCT01550003|516421508|FG000|Overall Study|Adverse Event|0|||
143236880|NCT01550003|516421509|FG001|Overall Study|Adverse Event|9|||
143236881|NCT01550003|516421510|FG002|Overall Study|Adverse Event|15|||
143236882|NCT01550003|516421508|FG000|Overall Study|Lack of Efficacy|4|||
143236883|NCT01550003|516421509|FG001|Overall Study|Lack of Efficacy|11|||
143236884|NCT01550003|516421510|FG002|Overall Study|Lack of Efficacy|15|||
143236885|NCT01550003|516421508|FG000|Overall Study|Protocol Violation|0|||
143236886|NCT01550003|516421509|FG001|Overall Study|Protocol Violation|3|||
143236887|NCT01550003|516421510|FG002|Overall Study|Protocol Violation|2|||
143236888|NCT01550003|516421508|FG000|Overall Study|Lost to Follow-up|1|||
143490301|NCT05073458|517338287|FG001|24-week Double-blind Period|Physician Decision|0|||
143490302|NCT05073458|517338286|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
143490303|NCT05073458|517338287|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
143490304|NCT05073458|517338286|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
143490305|NCT05073458|517338287|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
143490306|NCT05073458|517338286|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
143490307|NCT05073458|517338287|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
143490308|NCT05073458|517338286|FG000|24-week Open-label Period|Adverse Event|1|||
143490309|NCT05073458|517338287|FG001|24-week Open-label Period|Adverse Event|2|||
143490310|NCT02158091|517338288|FG000|Overall Study|DLT|2|||
143490311|NCT02158091|517338289|FG001|Overall Study|DLT|1|||
143490312|NCT02158091|517338290|FG002|Overall Study|DLT|0|||
143490313|NCT05913232|517338291|FG000|Overall Study|Adverse Event|0|||
143490314|NCT05913232|517338292|FG001|Overall Study|Adverse Event|2|||
143490315|NCT05913232|517338293|FG002|Overall Study|Adverse Event|1|||
143490316|NCT05913232|517338294|FG003|Overall Study|Adverse Event|1|||
143490317|NCT01318109|517338295|FG000|Overall Study|Adverse Event|0|||
143490318|NCT01318109|517338296|FG001|Overall Study|Adverse Event|2|||
143490319|NCT01318109|517338297|FG002|Overall Study|Adverse Event|0|||
143490320|NCT01318109|517338295|FG000|Overall Study|Withdrawal by Subject|1|||
143490321|NCT01318109|517338296|FG001|Overall Study|Withdrawal by Subject|0|||
143490322|NCT01318109|517338297|FG002|Overall Study|Withdrawal by Subject|0|||
143490323|NCT01318109|517338295|FG000|Overall Study|Schedule Conflict|0|||
143490324|NCT01318109|517338296|FG001|Overall Study|Schedule Conflict|1|||
143490325|NCT01318109|517338297|FG002|Overall Study|Schedule Conflict|0|||
143490326|NCT01328951|517338298|FG000|Overall Study|Disease Progression|17|||
143490327|NCT01328951|517338299|FG001|Overall Study|Disease Progression|14|||
143490328|NCT01328951|517338298|FG000|Overall Study|Adverse Event|2|||
143490329|NCT01328951|517338299|FG001|Overall Study|Adverse Event|0|||
143490330|NCT01328951|517338298|FG000|Overall Study|Death|243|||
143490331|NCT01328951|517338299|FG001|Overall Study|Death|258|||
143490332|NCT01328951|517338298|FG000|Overall Study|Lost to Follow-up|6|||
143490333|NCT01328951|517338299|FG001|Overall Study|Lost to Follow-up|7|||
143490334|NCT01328951|517338298|FG000|Overall Study|Withdrawal by Subject|6|||
143490335|NCT01328951|517338299|FG001|Overall Study|Withdrawal by Subject|6|||
143490336|NCT01328951|517338298|FG000|Overall Study|Study Closed by the Sponsor|36|||
143490337|NCT01328951|517338299|FG001|Overall Study|Study Closed by the Sponsor|31|||
143490338|NCT01328951|517338298|FG000|Overall Study|Other|11|||
143490339|NCT01328951|517338299|FG001|Overall Study|Other|6|||
143490340|NCT01627899|517338307|FG000|Overall Study|Study terminated early by sponsor.|5|||
143490341|NCT05103332|517338308|FG000|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
143490342|NCT05103332|517338309|FG001|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
143490343|NCT05103332|517338310|FG002|DB Period (6 Months=168 Days)|Lost to Follow-up|1|||
143490344|NCT05103332|517338311|FG003|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
143490345|NCT05103332|517338312|FG004|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
143490346|NCT05103332|517338313|FG005|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
143490347|NCT05103332|517338314|FG006|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
143490348|NCT05103332|517338315|FG007|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
143490349|NCT05103332|517338316|FG008|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
143490350|NCT05103332|517338317|FG009|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
143490351|NCT05103332|517338318|FG010|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
143490352|NCT05103332|517338319|FG011|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
143490353|NCT05103332|517338320|FG012|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
143490354|NCT05103332|517338321|FG013|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
143490355|NCT05103332|517338322|FG014|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
143490356|NCT05103332|517338323|FG015|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
143490357|NCT05103332|517338324|FG016|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
143236889|NCT01550003|516421509|FG001|Overall Study|Lost to Follow-up|4|||
143236890|NCT01550003|516421510|FG002|Overall Study|Lost to Follow-up|8|||
143236891|NCT01550003|516421508|FG000|Overall Study|Consent withdrawn|2|||
143236892|NCT01550003|516421509|FG001|Overall Study|Consent withdrawn|11|||
143236893|NCT01550003|516421510|FG002|Overall Study|Consent withdrawn|23|||
143025209|NCT01907087|515632876|FG000|Overall Study|Withdrawal by Subject|1|||
143025210|NCT02180061|515632877|FG000|Overall Study|Adverse Event|4|||
143025211|NCT02180061|515632878|FG001|Overall Study|Adverse Event|2|||
143025212|NCT02180061|515632877|FG000|Overall Study|Clinical Progression|5|||
143025213|NCT02180061|515632878|FG001|Overall Study|Clinical Progression|1|||
143025214|NCT02180061|515632877|FG000|Overall Study|Progressive Disease|15|||
143025215|NCT02180061|515632878|FG001|Overall Study|Progressive Disease|5|||
143025216|NCT02180061|515632877|FG000|Overall Study|Physician Decision|1|||
143025217|NCT02180061|515632878|FG001|Overall Study|Physician Decision|0|||
143025218|NCT01469364|515632881|FG000|Overall Study|Adverse Event|1|||
143025219|NCT01469364|515632881|FG000|Overall Study|Withdrawal by Subject|1|||
143025220|NCT01299038|515632886|FG000|Overall Study|Withdrawal by Subject|1|||
143025221|NCT01299038|515632887|FG001|Overall Study|Withdrawal by Subject|0|||
143490358|NCT05103332|517338325|FG017|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
143025222|NCT00555009|515632892|FG000|Overall Study|Withdrawal by Subject|0|||
143025223|NCT00555009|515632893|FG001|Overall Study|Withdrawal by Subject|1|||
143025224|NCT00555009|515632892|FG000|Overall Study|Terminated by Sponsor|2|||
143025225|NCT00555009|515632893|FG001|Overall Study|Terminated by Sponsor|5|||
143025226|NCT00832078|515632894|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
143490359|NCT05103332|517338308|FG000|DB Period (6 Months=168 Days)|Physician Decision|0|||
143490360|NCT05103332|517338309|FG001|DB Period (6 Months=168 Days)|Physician Decision|1|||
143490361|NCT05103332|517338310|FG002|DB Period (6 Months=168 Days)|Physician Decision|0|||
143490362|NCT05103332|517338311|FG003|DB Period (6 Months=168 Days)|Physician Decision|1|||
143490363|NCT05103332|517338312|FG004|DB Period (6 Months=168 Days)|Physician Decision|0|||
143490364|NCT05103332|517338313|FG005|DB Period (6 Months=168 Days)|Physician Decision|0|||
143490365|NCT05103332|517338314|FG006|DB Period (6 Months=168 Days)|Physician Decision|0|||
143490366|NCT05103332|517338315|FG007|DB Period (6 Months=168 Days)|Physician Decision|0|||
143490367|NCT05103332|517338316|FG008|DB Period (6 Months=168 Days)|Physician Decision|0|||
143490368|NCT05103332|517338317|FG009|DB Period (6 Months=168 Days)|Physician Decision|0|||
143490369|NCT05103332|517338318|FG010|DB Period (6 Months=168 Days)|Physician Decision|0|||
143490370|NCT05103332|517338319|FG011|DB Period (6 Months=168 Days)|Physician Decision|0|||
143490371|NCT05103332|517338320|FG012|DB Period (6 Months=168 Days)|Physician Decision|0|||
143490372|NCT05103332|517338321|FG013|DB Period (6 Months=168 Days)|Physician Decision|0|||
143490373|NCT05103332|517338322|FG014|DB Period (6 Months=168 Days)|Physician Decision|0|||
143490374|NCT05103332|517338323|FG015|DB Period (6 Months=168 Days)|Physician Decision|0|||
143490375|NCT05103332|517338324|FG016|DB Period (6 Months=168 Days)|Physician Decision|0|||
143490376|NCT05103332|517338325|FG017|DB Period (6 Months=168 Days)|Physician Decision|0|||
143490377|NCT05103332|517338308|FG000|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|2|||
143025227|NCT00832078|515632895|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
143025228|NCT00832078|515632894|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
143025229|NCT00832078|515632895|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
143025230|NCT02058628|515632896|FG000|Overall Study|Adverse Event|1|||
143025231|NCT02058628|515632897|FG001|Overall Study|Adverse Event|0|||
143157952|NCT00063999|516124340|FG001|Overall Study|Ineligible|24|||
143157953|NCT04243837|516124344|FG000|Overall Study|Adverse Event|2|||
143157954|NCT04243837|516124345|FG001|Overall Study|Adverse Event|1|||
143157955|NCT04243837|516124344|FG000|Overall Study|Withdrawal by Subject|4|||
143157956|NCT04243837|516124345|FG001|Overall Study|Withdrawal by Subject|2|||
143157957|NCT04243837|516124344|FG000|Overall Study|Covid-19 lock down|1|||
143157958|NCT04243837|516124345|FG001|Overall Study|Covid-19 lock down|0|||
143157959|NCT04243837|516124344|FG000|Overall Study|Study Terminated by Sponsor|11|||
143157960|NCT04243837|516124345|FG001|Overall Study|Study Terminated by Sponsor|12|||
143157961|NCT03511066|516124354|FG000|Overall Study|Withdrawal by Subject|1|||
143157962|NCT03511066|516124355|FG001|Overall Study|Withdrawal by Subject|2|||
143157963|NCT03511066|516124356|FG002|Overall Study|Withdrawal by Subject|3|||
143157964|NCT03511066|516124354|FG000|Overall Study|Lost to Follow-up|2|||
143157965|NCT03511066|516124355|FG001|Overall Study|Lost to Follow-up|3|||
143157966|NCT03511066|516124356|FG002|Overall Study|Lost to Follow-up|0|||
143157967|NCT04560309|516124357|FG000|Overall Study|Meet drop out criteria|1|||
143157968|NCT04560309|516124358|FG001|Overall Study|Meet drop out criteria|1|||
143157969|NCT05085405|516124359|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
143157970|NCT05085405|516124360|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
143157971|NCT05085405|516124361|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
143157972|NCT05085405|516124362|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
143157973|NCT05085405|516124363|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
143157974|NCT05085405|516124364|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
143025232|NCT02058628|515632896|FG000|Overall Study|Withdrawal by Subject|2|||
143157975|NCT05085405|516124359|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
143157976|NCT05085405|516124360|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
143025233|NCT02058628|515632897|FG001|Overall Study|Withdrawal by Subject|2|||
143025234|NCT02058628|515632896|FG000|Overall Study|Lost to Follow-up|2|||
143025235|NCT02058628|515632897|FG001|Overall Study|Lost to Follow-up|4|||
143025236|NCT02058628|515632896|FG000|Overall Study|Not in time schedule|0|||
143025237|NCT02058628|515632897|FG001|Overall Study|Not in time schedule|1|||
143025238|NCT02058628|515632896|FG000|Overall Study|The visit date was not in timeline|0|||
143025239|NCT02058628|515632897|FG001|Overall Study|The visit date was not in timeline|1|||
143025240|NCT02058628|515632896|FG000|Overall Study|A lot of time for study for participant|1|||
143025241|NCT02058628|515632897|FG001|Overall Study|A lot of time for study for participant|0|||
143025242|NCT02058628|515632896|FG000|Overall Study|Non compliance|1|||
143025243|NCT02058628|515632897|FG001|Overall Study|Non compliance|0|||
143025244|NCT01165996|515632904|FG000|Overall Study|Death|1|||
143025245|NCT01165996|515632904|FG000|Overall Study|Physician Decision|1|||
143025246|NCT00096265|515632905|FG000|Overall Study|Ineligible|1|||
143025247|NCT00096265|515632906|FG001|Overall Study|Ineligible|0|||
143025248|NCT00096265|515632907|FG002|Overall Study|Ineligible|0|||
143025249|NCT01506323|515632908|FG000|Overall Study|Lost to Follow-up|5|||
143025250|NCT01506323|515632909|FG001|Overall Study|Lost to Follow-up|4|||
143025251|NCT01506323|515632908|FG000|Overall Study|Withdrawal by Subject|4|||
143025252|NCT01506323|515632909|FG001|Overall Study|Withdrawal by Subject|4|||
143025253|NCT01506323|515632908|FG000|Overall Study|Lack of Efficacy|1|||
143025254|NCT01506323|515632909|FG001|Overall Study|Lack of Efficacy|3|||
143025255|NCT01506323|515632908|FG000|Overall Study|Moved out of area|5|||
143025256|NCT01506323|515632909|FG001|Overall Study|Moved out of area|2|||
143025257|NCT01506323|515632908|FG000|Overall Study|Schedule or Transportation conflict|8|||
143025258|NCT01506323|515632909|FG001|Overall Study|Schedule or Transportation conflict|0|||
143025259|NCT01506323|515632908|FG000|Overall Study|Started another treatment|1|||
143025260|NCT01506323|515632909|FG001|Overall Study|Started another treatment|0|||
143025261|NCT02232074|515632910|FG000|Overall Study|Withdrawal by Subject|5|||
143025262|NCT02232074|515632911|FG001|Overall Study|Withdrawal by Subject|3|||
143025263|NCT02232074|515632910|FG000|Overall Study|No legal concerns at baseline|36|||
143025264|NCT02232074|515632911|FG001|Overall Study|No legal concerns at baseline|41|||
143025265|NCT02232074|515632910|FG000|Overall Study|deemed ineligible|0|||
143025266|NCT02232074|515632911|FG001|Overall Study|deemed ineligible|1|||
143025267|NCT00130520|515632914|FG000|Overall Study|Adverse Event|11|||
143025268|NCT00130520|515632914|FG000|Overall Study|Death|1|||
143025269|NCT00130520|515632914|FG000|Overall Study|Physician Decision|1|||
143025270|NCT00130520|515632914|FG000|Overall Study|Withdrawal by Subject|1|||
143025271|NCT00130520|515632914|FG000|Overall Study|Disease Progression|23|||
143025272|NCT00130520|515632914|FG000|Overall Study|Protocol non-compliance|1|||
143025273|NCT00130520|515632914|FG000|Overall Study|Did not meet re-treatment criteria|1|||
143025274|NCT02295774|515632915|FG000|Overall Study|Physician Decision|1|||
143025275|NCT02295774|515632915|FG000|Overall Study|Withdrawal by Subject|2|||
143025276|NCT01075763|515632916|FG000|Overall Study|Lost to Follow-up|2|||
143025277|NCT01075763|515632917|FG001|Overall Study|Lost to Follow-up|1|||
143025278|NCT01075763|515632916|FG000|Overall Study|Lack of Efficacy|0|||
143236894|NCT01550003|516421508|FG000|Overall Study|Missing|1|||
143236895|NCT01550003|516421509|FG001|Overall Study|Missing|0|||
143236896|NCT01550003|516421510|FG002|Overall Study|Missing|2|||
143236897|NCT01550003|516421508|FG000|Overall Study|Study closure as announced by sponsor|7|||
143236898|NCT01550003|516421509|FG001|Overall Study|Study closure as announced by sponsor|6|||
143363859|NCT00049517|516875455|FG005|Conditioning/Transplant|Death|0|||
143490378|NCT05103332|517338309|FG001|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
143490379|NCT05103332|517338310|FG002|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
143490380|NCT05103332|517338311|FG003|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
143490381|NCT05103332|517338312|FG004|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
143490382|NCT05103332|517338313|FG005|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
143490383|NCT05103332|517338314|FG006|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
143490384|NCT05103332|517338315|FG007|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
143025279|NCT01075763|515632917|FG001|Overall Study|Lack of Efficacy|1|||
143025280|NCT01075763|515632916|FG000|Overall Study|Withdrawal by Subject|2|||
143025281|NCT01075763|515632917|FG001|Overall Study|Withdrawal by Subject|2|||
143025282|NCT03083483|515632919|FG000|Overall Study|Adverse Event|1|||
143025283|NCT03083483|515632920|FG001|Overall Study|Adverse Event|1|||
143025284|NCT03083483|515632921|FG002|Overall Study|Adverse Event|1|||
143025285|NCT03083483|515632919|FG000|Overall Study|Lost to Follow-up|2|||
143025286|NCT03083483|515632920|FG001|Overall Study|Lost to Follow-up|1|||
143025287|NCT03083483|515632921|FG002|Overall Study|Lost to Follow-up|1|||
143025288|NCT03083483|515632919|FG000|Overall Study|technological issues|1|||
143025289|NCT03083483|515632920|FG001|Overall Study|technological issues|0|||
143025290|NCT03083483|515632921|FG002|Overall Study|technological issues|1|||
143025291|NCT02637557|515632926|FG000|Overall Study|Adverse Event|3|||
143025292|NCT02637557|515632927|FG001|Overall Study|Adverse Event|1|||
143025293|NCT02637557|515632928|FG002|Overall Study|Adverse Event|3|||
143363860|NCT00049517|516875450|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
143025294|NCT02637557|515632929|FG003|Overall Study|Adverse Event|3|||
143025295|NCT02637557|515632926|FG000|Overall Study|Lost to Follow-up|1|||
143025296|NCT02637557|515632927|FG001|Overall Study|Lost to Follow-up|1|||
143363861|NCT00049517|516875451|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
143490385|NCT05103332|517338316|FG008|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
143490386|NCT05103332|517338317|FG009|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
143490387|NCT05103332|517338318|FG010|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
143490388|NCT05103332|517338319|FG011|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
143490389|NCT05103332|517338320|FG012|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
143490390|NCT05103332|517338321|FG013|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
143490391|NCT05103332|517338322|FG014|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
143490392|NCT05103332|517338323|FG015|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
143490393|NCT05103332|517338324|FG016|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
143490394|NCT05103332|517338325|FG017|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
143490395|NCT05103332|517338308|FG000|DB Period (6 Months=168 Days)|Other|0|||
143490396|NCT05103332|517338309|FG001|DB Period (6 Months=168 Days)|Other|0|||
143490397|NCT05103332|517338310|FG002|DB Period (6 Months=168 Days)|Other|0|||
143490398|NCT05103332|517338311|FG003|DB Period (6 Months=168 Days)|Other|1|||
143490399|NCT05103332|517338312|FG004|DB Period (6 Months=168 Days)|Other|0|||
143490400|NCT05103332|517338313|FG005|DB Period (6 Months=168 Days)|Other|0|||
143490401|NCT05103332|517338314|FG006|DB Period (6 Months=168 Days)|Other|0|||
143490402|NCT05103332|517338315|FG007|DB Period (6 Months=168 Days)|Other|0|||
143490403|NCT05103332|517338316|FG008|DB Period (6 Months=168 Days)|Other|0|||
143490404|NCT05103332|517338317|FG009|DB Period (6 Months=168 Days)|Other|0|||
143490405|NCT05103332|517338318|FG010|DB Period (6 Months=168 Days)|Other|0|||
143490406|NCT05103332|517338319|FG011|DB Period (6 Months=168 Days)|Other|0|||
143490407|NCT05103332|517338320|FG012|DB Period (6 Months=168 Days)|Other|0|||
143490408|NCT05103332|517338321|FG013|DB Period (6 Months=168 Days)|Other|0|||
143490409|NCT05103332|517338322|FG014|DB Period (6 Months=168 Days)|Other|0|||
143490410|NCT05103332|517338323|FG015|DB Period (6 Months=168 Days)|Other|0|||
143490411|NCT05103332|517338324|FG016|DB Period (6 Months=168 Days)|Other|0|||
143490412|NCT05103332|517338325|FG017|DB Period (6 Months=168 Days)|Other|0|||
143490413|NCT05103332|517338308|FG000|OLE Period (24 Months=672 Days)|Adverse Event|0|||
143490414|NCT05103332|517338309|FG001|OLE Period (24 Months=672 Days)|Adverse Event|0|||
143490415|NCT05103332|517338310|FG002|OLE Period (24 Months=672 Days)|Adverse Event|0|||
143490416|NCT05103332|517338311|FG003|OLE Period (24 Months=672 Days)|Adverse Event|0|||
143490417|NCT05103332|517338312|FG004|OLE Period (24 Months=672 Days)|Adverse Event|0|||
143490418|NCT05103332|517338313|FG005|OLE Period (24 Months=672 Days)|Adverse Event|0|||
143490419|NCT05103332|517338314|FG006|OLE Period (24 Months=672 Days)|Adverse Event|0|||
143490420|NCT05103332|517338315|FG007|OLE Period (24 Months=672 Days)|Adverse Event|0|||
143490421|NCT05103332|517338316|FG008|OLE Period (24 Months=672 Days)|Adverse Event|0|||
143490422|NCT05103332|517338317|FG009|OLE Period (24 Months=672 Days)|Adverse Event|0|||
143490423|NCT05103332|517338318|FG010|OLE Period (24 Months=672 Days)|Adverse Event|1|||
143490424|NCT05103332|517338319|FG011|OLE Period (24 Months=672 Days)|Adverse Event|0|||
143490425|NCT05103332|517338320|FG012|OLE Period (24 Months=672 Days)|Adverse Event|0|||
143490426|NCT05103332|517338321|FG013|OLE Period (24 Months=672 Days)|Adverse Event|0|||
143490427|NCT05103332|517338322|FG014|OLE Period (24 Months=672 Days)|Adverse Event|0|||
143490428|NCT05103332|517338323|FG015|OLE Period (24 Months=672 Days)|Adverse Event|0|||
143490429|NCT05103332|517338324|FG016|OLE Period (24 Months=672 Days)|Adverse Event|0|||
143490430|NCT05103332|517338325|FG017|OLE Period (24 Months=672 Days)|Adverse Event|0|||
143490431|NCT05103332|517338308|FG000|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
143490432|NCT05103332|517338309|FG001|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
143490433|NCT05103332|517338310|FG002|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
143490434|NCT05103332|517338311|FG003|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
143490435|NCT05103332|517338312|FG004|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
143490436|NCT05103332|517338313|FG005|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
143490437|NCT05103332|517338314|FG006|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
143490438|NCT05103332|517338315|FG007|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
143490439|NCT05103332|517338316|FG008|OLE Period (24 Months=672 Days)|Lost to Follow-up|1|||
143157977|NCT05085405|516124361|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
143157978|NCT05085405|516124362|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
143157979|NCT05085405|516124363|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
143157980|NCT05085405|516124364|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
143157981|NCT00455455|516124365|FG000|Washout|Withdrawal by Subject|0|||
143157982|NCT00455455|516124366|FG001|Washout|Withdrawal by Subject|1|||
143157983|NCT00455455|516124365|FG000|Washout|Withdrawal by Subject|1|||
143157984|NCT00455455|516124366|FG001|Washout|Withdrawal by Subject|0|||
143157985|NCT00663351|516124368|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
143157986|NCT00663351|516124369|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
143157987|NCT00663351|516124368|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
143157988|NCT00663351|516124369|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
143025297|NCT02637557|515632928|FG002|Overall Study|Lost to Follow-up|0|||
143025298|NCT02637557|515632929|FG003|Overall Study|Lost to Follow-up|1|||
143025299|NCT02637557|515632926|FG000|Overall Study|Physician Decision|1|||
143025300|NCT02637557|515632927|FG001|Overall Study|Physician Decision|0|||
143025301|NCT02637557|515632928|FG002|Overall Study|Physician Decision|0|||
143025302|NCT02637557|515632929|FG003|Overall Study|Physician Decision|0|||
143025303|NCT02637557|515632926|FG000|Overall Study|Protocol Violation|2|||
143025304|NCT02637557|515632927|FG001|Overall Study|Protocol Violation|0|||
143025305|NCT02637557|515632928|FG002|Overall Study|Protocol Violation|2|||
143025306|NCT02637557|515632929|FG003|Overall Study|Protocol Violation|1|||
143025307|NCT02637557|515632926|FG000|Overall Study|Withdrawal by Subject|1|||
143025308|NCT02637557|515632927|FG001|Overall Study|Withdrawal by Subject|3|||
143025309|NCT02637557|515632928|FG002|Overall Study|Withdrawal by Subject|4|||
143025310|NCT02637557|515632929|FG003|Overall Study|Withdrawal by Subject|2|||
143025311|NCT01751412|515632930|FG000|Overall Study|Disease Progression Before Treatment|1|||
143025312|NCT00582036|515632933|FG000|Overall Study|Withdrawal by Subject|0|||
143025313|NCT00582036|515632934|FG001|Overall Study|Withdrawal by Subject|1|||
143025314|NCT01769378|515632938|FG000|Overall Study|Adverse Event|10|||
143025315|NCT01769378|515632939|FG001|Overall Study|Adverse Event|0|||
143025316|NCT01769378|515632938|FG000|Overall Study|Entry criteria not met|1|||
143025317|NCT01769378|515632939|FG001|Overall Study|Entry criteria not met|0|||
143025318|NCT01769378|515632938|FG000|Overall Study|Protocol Violation|1|||
143025319|NCT01769378|515632939|FG001|Overall Study|Protocol Violation|1|||
143025320|NCT01769378|515632938|FG000|Overall Study|Withdrawal by Subject|10|||
143025321|NCT01769378|515632939|FG001|Overall Study|Withdrawal by Subject|3|||
143025322|NCT01769378|515632938|FG000|Overall Study|Sponsor Decision|1|||
143025323|NCT01769378|515632939|FG001|Overall Study|Sponsor Decision|0|||
143025324|NCT01769378|515632938|FG000|Overall Study|Lost to Follow-up|2|||
143025325|NCT01769378|515632939|FG001|Overall Study|Lost to Follow-up|0|||
143025326|NCT01090765|515632940|FG000|Overall Study|Patient withdrew consent|0|||
143025327|NCT01090765|515632941|FG001|Overall Study|Patient withdrew consent|0|||
143025328|NCT01090765|515632942|FG002|Overall Study|Patient withdrew consent|0|||
143025329|NCT01090765|515632943|FG003|Overall Study|Patient withdrew consent|0|||
143025330|NCT01090765|515632944|FG004|Overall Study|Patient withdrew consent|1|||
143025331|NCT01090765|515632945|FG005|Overall Study|Patient withdrew consent|1|||
143025332|NCT01090765|515632940|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
143025333|NCT01090765|515632941|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
143025334|NCT01090765|515632942|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
143025335|NCT01090765|515632943|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
143025336|NCT01090765|515632944|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
143025337|NCT01090765|515632945|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
143025338|NCT01090765|515632940|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
143025339|NCT01090765|515632941|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
143025340|NCT01090765|515632942|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
143025341|NCT01090765|515632943|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
143025342|NCT01090765|515632944|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
143025343|NCT01090765|515632945|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
143025344|NCT02623959|515632946|FG000|Overall Study|Progression|0|||
143025345|NCT02623959|515632947|FG001|Overall Study|Progression|1|||
143025346|NCT01787825|515632948|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
143025347|NCT01787825|515632949|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
143025348|NCT01787825|515632948|FG000|Overall Study|Data Not Analyzable|5|||
143025349|NCT01787825|515632949|FG001|Overall Study|Data Not Analyzable|1|||
143025350|NCT01755858|515632955|FG000|Overall Study|Adverse Event|1|||
143025351|NCT01755858|515632956|FG001|Overall Study|Adverse Event|1|||
143025352|NCT01259869|515632957|FG000|Overall Study|Duplicated registration|1|||
143025353|NCT00175019|515632958|FG000|Overall Study|Adverse Event|54|||
143025354|NCT00175019|515632959|FG001|Overall Study|Adverse Event|22|||
143025355|NCT00175019|515632960|FG002|Overall Study|Adverse Event|2|||
143025356|NCT00175019|515632958|FG000|Overall Study|Protocol Violation|6|||
143025357|NCT00175019|515632959|FG001|Overall Study|Protocol Violation|3|||
143025358|NCT00175019|515632960|FG002|Overall Study|Protocol Violation|3|||
143025359|NCT00175019|515632958|FG000|Overall Study|Lost to Follow-up|42|||
143236899|NCT01550003|516421510|FG002|Overall Study|Study closure as announced by sponsor|24|||
143025360|NCT00175019|515632959|FG001|Overall Study|Lost to Follow-up|39|||
143025361|NCT00175019|515632960|FG002|Overall Study|Lost to Follow-up|9|||
143025362|NCT00175019|515632958|FG000|Overall Study|Did not continue under Amendment 4|1|||
143025363|NCT00175019|515632959|FG001|Overall Study|Did not continue under Amendment 4|1|||
143025364|NCT00175019|515632960|FG002|Overall Study|Did not continue under Amendment 4|2|||
143025365|NCT00175019|515632958|FG000|Overall Study|Personal Reason(s)|39|||
143025366|NCT00175019|515632959|FG001|Overall Study|Personal Reason(s)|31|||
143025367|NCT00175019|515632960|FG002|Overall Study|Personal Reason(s)|8|||
143025368|NCT00175019|515632958|FG000|Overall Study|Therapeutic Failure|10|||
143025369|NCT00175019|515632959|FG001|Overall Study|Therapeutic Failure|38|||
143025370|NCT00175019|515632960|FG002|Overall Study|Therapeutic Failure|22|||
143025371|NCT00175019|515632958|FG000|Overall Study|Gout Flare|2|||
143490440|NCT05103332|517338317|FG009|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
143490441|NCT05103332|517338318|FG010|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
143490442|NCT05103332|517338319|FG011|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
143490443|NCT05103332|517338320|FG012|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
143490444|NCT05103332|517338321|FG013|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
143490445|NCT05103332|517338322|FG014|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
143490446|NCT05103332|517338323|FG015|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
143490447|NCT05103332|517338324|FG016|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
143490448|NCT05103332|517338325|FG017|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
143490449|NCT05103332|517338308|FG000|OLE Period (24 Months=672 Days)|Physician Decision|0|||
143490450|NCT05103332|517338309|FG001|OLE Period (24 Months=672 Days)|Physician Decision|0|||
143490451|NCT05103332|517338310|FG002|OLE Period (24 Months=672 Days)|Physician Decision|0|||
143490452|NCT05103332|517338311|FG003|OLE Period (24 Months=672 Days)|Physician Decision|0|||
143490453|NCT05103332|517338312|FG004|OLE Period (24 Months=672 Days)|Physician Decision|0|||
143490454|NCT05103332|517338313|FG005|OLE Period (24 Months=672 Days)|Physician Decision|0|||
143490455|NCT05103332|517338314|FG006|OLE Period (24 Months=672 Days)|Physician Decision|0|||
143490456|NCT05103332|517338315|FG007|OLE Period (24 Months=672 Days)|Physician Decision|0|||
143490457|NCT05103332|517338316|FG008|OLE Period (24 Months=672 Days)|Physician Decision|0|||
143490458|NCT05103332|517338317|FG009|OLE Period (24 Months=672 Days)|Physician Decision|0|||
143490459|NCT05103332|517338318|FG010|OLE Period (24 Months=672 Days)|Physician Decision|0|||
143490460|NCT05103332|517338319|FG011|OLE Period (24 Months=672 Days)|Physician Decision|1|||
143490461|NCT05103332|517338320|FG012|OLE Period (24 Months=672 Days)|Physician Decision|0|||
143490462|NCT05103332|517338321|FG013|OLE Period (24 Months=672 Days)|Physician Decision|0|||
143490463|NCT05103332|517338322|FG014|OLE Period (24 Months=672 Days)|Physician Decision|0|||
143490464|NCT05103332|517338323|FG015|OLE Period (24 Months=672 Days)|Physician Decision|0|||
143490465|NCT05103332|517338324|FG016|OLE Period (24 Months=672 Days)|Physician Decision|0|||
143490466|NCT05103332|517338325|FG017|OLE Period (24 Months=672 Days)|Physician Decision|0|||
143490467|NCT05103332|517338308|FG000|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
143490468|NCT05103332|517338309|FG001|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
143490469|NCT05103332|517338310|FG002|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
143490470|NCT05103332|517338311|FG003|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
143490471|NCT05103332|517338312|FG004|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
143490472|NCT05103332|517338313|FG005|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
143490473|NCT05103332|517338314|FG006|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
143490474|NCT05103332|517338315|FG007|OLE Period (24 Months=672 Days)|Reason Not Specified|1|||
143490475|NCT05103332|517338316|FG008|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
143490476|NCT05103332|517338317|FG009|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
143490477|NCT05103332|517338318|FG010|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
143490478|NCT05103332|517338319|FG011|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
143490479|NCT05103332|517338320|FG012|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
143490480|NCT05103332|517338321|FG013|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
143490481|NCT05103332|517338322|FG014|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
143490482|NCT05103332|517338323|FG015|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
143490483|NCT05103332|517338324|FG016|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
143490484|NCT05103332|517338325|FG017|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
143490485|NCT05103332|517338308|FG000|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
143490486|NCT05103332|517338309|FG001|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
143490487|NCT05103332|517338310|FG002|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
143490488|NCT05103332|517338311|FG003|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
143490489|NCT05103332|517338312|FG004|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
143490490|NCT05103332|517338313|FG005|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
143490491|NCT05103332|517338314|FG006|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
143490492|NCT05103332|517338315|FG007|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
143490493|NCT05103332|517338316|FG008|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
143490494|NCT05103332|517338317|FG009|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
143490495|NCT05103332|517338318|FG010|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
143490496|NCT05103332|517338319|FG011|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
143490497|NCT05103332|517338320|FG012|SFU Period (6 Months=168 Days)|Lost to Follow-up|2|||
143490498|NCT05103332|517338321|FG013|SFU Period (6 Months=168 Days)|Lost to Follow-up|1|||
143490499|NCT05103332|517338322|FG014|SFU Period (6 Months=168 Days)|Lost to Follow-up|5|||
143490500|NCT05103332|517338323|FG015|SFU Period (6 Months=168 Days)|Lost to Follow-up|3|||
143490501|NCT05103332|517338324|FG016|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
143490502|NCT05103332|517338325|FG017|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
143490503|NCT05103332|517338308|FG000|SFU Period (6 Months=168 Days)|Physician Decision|0|||
143490504|NCT05103332|517338309|FG001|SFU Period (6 Months=168 Days)|Physician Decision|0|||
143490505|NCT05103332|517338310|FG002|SFU Period (6 Months=168 Days)|Physician Decision|0|||
143490506|NCT05103332|517338311|FG003|SFU Period (6 Months=168 Days)|Physician Decision|0|||
143025372|NCT00175019|515632959|FG001|Overall Study|Gout Flare|3|||
143025373|NCT00175019|515632960|FG002|Overall Study|Gout Flare|0|||
143025374|NCT00175019|515632958|FG000|Overall Study|Reason Not Specified|40|||
143025375|NCT00175019|515632959|FG001|Overall Study|Reason Not Specified|34|||
143025376|NCT00175019|515632960|FG002|Overall Study|Reason Not Specified|11|||
143025377|NCT00755326|515632972|FG000|Overall Study|Lost to Follow-up|2|||
143025378|NCT00755326|515632973|FG001|Overall Study|Lost to Follow-up|3|||
143025379|NCT00617461|515632982|FG000|First Treatment Intervention Period|Adverse Event|2|||
143025380|NCT00617461|515632983|FG001|First Treatment Intervention Period|Adverse Event|0|||
143025381|NCT00617461|515632982|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
143025382|NCT00617461|515632983|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
143025383|NCT00617461|515632982|FG000|First Treatment Intervention Period|Protocol Violation|2|||
143025384|NCT00617461|515632983|FG001|First Treatment Intervention Period|Protocol Violation|1|||
143025385|NCT00617461|515632982|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
143025386|NCT00617461|515632983|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
143025387|NCT00617461|515632982|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
143025388|NCT00617461|515632983|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
143025389|NCT00617461|515632982|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
143025390|NCT00617461|515632983|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
143025391|NCT00617461|515632982|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
143025392|NCT00617461|515632983|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
143025393|NCT00617461|515632982|FG000|Second Treatment Intervention Period|Adverse Event|0|||
143025394|NCT00617461|515632983|FG001|Second Treatment Intervention Period|Adverse Event|1|||
143025395|NCT00617461|515632982|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
143025396|NCT00617461|515632983|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
143025397|NCT00617461|515632982|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
143025398|NCT00617461|515632983|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
143025399|NCT00617461|515632982|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
143025400|NCT00617461|515632983|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
143025401|NCT00358826|515632987|FG000|Core Study|Adverse Event|1|||
143025402|NCT00358826|515632988|FG001|Core Study|Adverse Event|3|||
143025403|NCT00358826|515632989|FG002|Core Study|Adverse Event|1|||
143025404|NCT00358826|515632990|FG003|Core Study|Adverse Event|1|||
143025405|NCT00358826|515632991|FG004|Core Study|Adverse Event|0|||
143025406|NCT00358826|515632992|FG005|Core Study|Adverse Event|0|||
143025407|NCT00358826|515632993|FG006|Core Study|Adverse Event|0|||
143025408|NCT00358826|515632994|FG007|Core Study|Adverse Event|0|||
143025409|NCT00358826|515632987|FG000|Core Study|Withdrawal by Subject|2|||
143025410|NCT00358826|515632988|FG001|Core Study|Withdrawal by Subject|2|||
143025411|NCT00358826|515632989|FG002|Core Study|Withdrawal by Subject|0|||
143025412|NCT00358826|515632990|FG003|Core Study|Withdrawal by Subject|0|||
143025413|NCT00358826|515632991|FG004|Core Study|Withdrawal by Subject|0|||
143025414|NCT00358826|515632992|FG005|Core Study|Withdrawal by Subject|0|||
143025415|NCT00358826|515632993|FG006|Core Study|Withdrawal by Subject|0|||
143025416|NCT00358826|515632994|FG007|Core Study|Withdrawal by Subject|0|||
143025417|NCT00358826|515632987|FG000|Core Study|Lost to Follow-up|0|||
143025418|NCT00358826|515632988|FG001|Core Study|Lost to Follow-up|0|||
143025419|NCT00358826|515632989|FG002|Core Study|Lost to Follow-up|0|||
143025420|NCT00358826|515632990|FG003|Core Study|Lost to Follow-up|1|||
143025421|NCT00358826|515632991|FG004|Core Study|Lost to Follow-up|0|||
143025422|NCT00358826|515632992|FG005|Core Study|Lost to Follow-up|0|||
143025423|NCT00358826|515632993|FG006|Core Study|Lost to Follow-up|0|||
143025424|NCT00358826|515632994|FG007|Core Study|Lost to Follow-up|0|||
143025425|NCT00358826|515632987|FG000|Core Study|Physician Decision|0|||
143025426|NCT00358826|515632988|FG001|Core Study|Physician Decision|0|||
143025427|NCT00358826|515632989|FG002|Core Study|Physician Decision|1|||
143025428|NCT00358826|515632990|FG003|Core Study|Physician Decision|0|||
143025429|NCT00358826|515632991|FG004|Core Study|Physician Decision|0|||
143025430|NCT00358826|515632992|FG005|Core Study|Physician Decision|0|||
143490507|NCT05103332|517338312|FG004|SFU Period (6 Months=168 Days)|Physician Decision|0|||
143490508|NCT05103332|517338313|FG005|SFU Period (6 Months=168 Days)|Physician Decision|0|||
143490509|NCT05103332|517338314|FG006|SFU Period (6 Months=168 Days)|Physician Decision|0|||
143236900|NCT01550003|516421508|FG000|Overall Study|Protocol Noncompliance|1|||
143236901|NCT01550003|516421509|FG001|Overall Study|Protocol Noncompliance|0|||
143490510|NCT05103332|517338315|FG007|SFU Period (6 Months=168 Days)|Physician Decision|0|||
143490511|NCT05103332|517338316|FG008|SFU Period (6 Months=168 Days)|Physician Decision|0|||
143490512|NCT05103332|517338317|FG009|SFU Period (6 Months=168 Days)|Physician Decision|0|||
143025431|NCT00358826|515632993|FG006|Core Study|Physician Decision|0|||
143025432|NCT00358826|515632994|FG007|Core Study|Physician Decision|0|||
143025433|NCT00358826|515632987|FG000|MDCT Substudy|Adverse Event|0|||
143025434|NCT00358826|515632988|FG001|MDCT Substudy|Adverse Event|0|||
143025435|NCT00358826|515632989|FG002|MDCT Substudy|Adverse Event|0|||
143025436|NCT00358826|515632990|FG003|MDCT Substudy|Adverse Event|0|||
143025437|NCT00358826|515632991|FG004|MDCT Substudy|Adverse Event|1|||
143236902|NCT01550003|516421510|FG002|Overall Study|Protocol Noncompliance|0|||
143025438|NCT00358826|515632992|FG005|MDCT Substudy|Adverse Event|0|||
143025439|NCT00358826|515632993|FG006|MDCT Substudy|Adverse Event|0|||
143025440|NCT00358826|515632994|FG007|MDCT Substudy|Adverse Event|0|||
143025441|NCT00358826|515632987|FG000|MDCT Substudy|Lost to Follow-up|0|||
143025442|NCT00358826|515632988|FG001|MDCT Substudy|Lost to Follow-up|0|||
143025443|NCT00358826|515632989|FG002|MDCT Substudy|Lost to Follow-up|0|||
143025444|NCT00358826|515632990|FG003|MDCT Substudy|Lost to Follow-up|0|||
143025445|NCT00358826|515632991|FG004|MDCT Substudy|Lost to Follow-up|0|||
143025446|NCT00358826|515632992|FG005|MDCT Substudy|Lost to Follow-up|1|||
143025447|NCT00358826|515632993|FG006|MDCT Substudy|Lost to Follow-up|0|||
143025448|NCT00358826|515632994|FG007|MDCT Substudy|Lost to Follow-up|0|||
143025449|NCT00358826|515632987|FG000|MDCT Substudy|Withdrawal by Subject|0|||
143025450|NCT00358826|515632988|FG001|MDCT Substudy|Withdrawal by Subject|0|||
143025451|NCT00358826|515632989|FG002|MDCT Substudy|Withdrawal by Subject|0|||
143025452|NCT00358826|515632990|FG003|MDCT Substudy|Withdrawal by Subject|0|||
143025453|NCT00358826|515632991|FG004|MDCT Substudy|Withdrawal by Subject|0|||
143025454|NCT00358826|515632992|FG005|MDCT Substudy|Withdrawal by Subject|1|||
143025455|NCT00358826|515632993|FG006|MDCT Substudy|Withdrawal by Subject|0|||
143025456|NCT00358826|515632994|FG007|MDCT Substudy|Withdrawal by Subject|0|||
143025457|NCT00903383|515632995|FG000|Overall Study|Adverse Event|1|||
143025458|NCT00903383|515632996|FG001|Overall Study|Adverse Event|2|||
143025459|NCT00903383|515632997|FG002|Overall Study|Adverse Event|3|||
143025460|NCT00903383|515632998|FG003|Overall Study|Adverse Event|1|||
143025461|NCT00903383|515632995|FG000|Overall Study|Physician Decision|1|||
143025462|NCT00903383|515632996|FG001|Overall Study|Physician Decision|2|||
143363862|NCT00049517|516875452|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
143490513|NCT05103332|517338318|FG010|SFU Period (6 Months=168 Days)|Physician Decision|0|||
143490514|NCT05103332|517338319|FG011|SFU Period (6 Months=168 Days)|Physician Decision|0|||
143490515|NCT05103332|517338320|FG012|SFU Period (6 Months=168 Days)|Physician Decision|0|||
143490516|NCT05103332|517338321|FG013|SFU Period (6 Months=168 Days)|Physician Decision|0|||
143490517|NCT05103332|517338322|FG014|SFU Period (6 Months=168 Days)|Physician Decision|0|||
143490518|NCT05103332|517338323|FG015|SFU Period (6 Months=168 Days)|Physician Decision|0|||
143490519|NCT05103332|517338324|FG016|SFU Period (6 Months=168 Days)|Physician Decision|0|||
143490520|NCT05103332|517338325|FG017|SFU Period (6 Months=168 Days)|Physician Decision|1|||
143490521|NCT05103332|517338308|FG000|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
143490522|NCT05103332|517338309|FG001|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
143490523|NCT05103332|517338310|FG002|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
143490524|NCT05103332|517338311|FG003|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
143490525|NCT05103332|517338312|FG004|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
143490526|NCT05103332|517338313|FG005|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
143490527|NCT05103332|517338314|FG006|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
143490528|NCT05103332|517338315|FG007|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
143490529|NCT05103332|517338316|FG008|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
143490530|NCT05103332|517338317|FG009|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
143490531|NCT05103332|517338318|FG010|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
143490532|NCT05103332|517338319|FG011|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
143490533|NCT05103332|517338320|FG012|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|4|||
143490534|NCT05103332|517338321|FG013|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
143490535|NCT05103332|517338322|FG014|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|1|||
143490536|NCT05103332|517338323|FG015|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|7|||
143490537|NCT05103332|517338324|FG016|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
143490538|NCT05103332|517338325|FG017|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
143490539|NCT05103332|517338308|FG000|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
143490540|NCT05103332|517338309|FG001|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
143025463|NCT00903383|515632997|FG002|Overall Study|Physician Decision|0|||
143025464|NCT00903383|515632998|FG003|Overall Study|Physician Decision|0|||
143025465|NCT00903383|515632995|FG000|Overall Study|Lost to Follow-up|0|||
143157989|NCT00663351|516124368|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
143157990|NCT00663351|516124369|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
143025466|NCT00903383|515632996|FG001|Overall Study|Lost to Follow-up|0|||
143025467|NCT00903383|515632997|FG002|Overall Study|Lost to Follow-up|0|||
143025468|NCT00903383|515632998|FG003|Overall Study|Lost to Follow-up|1|||
143157991|NCT00663351|516124368|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
143025469|NCT00903383|515632995|FG000|Overall Study|Decision of Sponsor|1|||
143025470|NCT00903383|515632996|FG001|Overall Study|Decision of Sponsor|0|||
143025471|NCT00903383|515632997|FG002|Overall Study|Decision of Sponsor|0|||
143025472|NCT00903383|515632998|FG003|Overall Study|Decision of Sponsor|0|||
143025473|NCT00903383|515632995|FG000|Overall Study|Withdrawal by Subject|4|||
143025474|NCT00903383|515632996|FG001|Overall Study|Withdrawal by Subject|1|||
143025475|NCT00903383|515632997|FG002|Overall Study|Withdrawal by Subject|0|||
143025476|NCT00903383|515632998|FG003|Overall Study|Withdrawal by Subject|2|||
143025477|NCT00903383|515632995|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
143025478|NCT00903383|515632996|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
143025479|NCT00903383|515632997|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
143025480|NCT00903383|515632998|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
143025481|NCT00903383|515632995|FG000|Overall Study|Patient Decision|0|||
143025482|NCT00903383|515632996|FG001|Overall Study|Patient Decision|0|||
143025483|NCT00903383|515632997|FG002|Overall Study|Patient Decision|0|||
143025484|NCT00903383|515632998|FG003|Overall Study|Patient Decision|1|||
143025485|NCT04317781|515633000|FG000|Overall Study|Adverse Event|1|||
143025486|NCT04317781|515633000|FG000|Overall Study|Disease relapse|1|||
143025487|NCT04317781|515633000|FG000|Overall Study|Withdrawal by Subject|1|||
143236903|NCT01550003|516421508|FG000|Overall Study|Study closure|0|||
143490541|NCT05103332|517338310|FG002|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
143490542|NCT05103332|517338311|FG003|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
143490543|NCT05103332|517338312|FG004|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
143490544|NCT05103332|517338313|FG005|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
143490545|NCT05103332|517338314|FG006|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
143490546|NCT05103332|517338315|FG007|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
143490547|NCT05103332|517338316|FG008|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
143490548|NCT05103332|517338317|FG009|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
143490549|NCT05103332|517338318|FG010|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
143490550|NCT05103332|517338319|FG011|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
143490551|NCT05103332|517338320|FG012|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
143490552|NCT05103332|517338321|FG013|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
143490553|NCT05103332|517338322|FG014|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
143490554|NCT05103332|517338323|FG015|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
143490555|NCT05103332|517338324|FG016|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
143490556|NCT05103332|517338325|FG017|SFU Period (6 Months=168 Days)|Reason Not Specified|2|||
143490557|NCT05103332|517338308|FG000|SFU Period (6 Months=168 Days)|Death|0|||
143490558|NCT05103332|517338309|FG001|SFU Period (6 Months=168 Days)|Death|0|||
143490559|NCT05103332|517338310|FG002|SFU Period (6 Months=168 Days)|Death|0|||
143490560|NCT05103332|517338311|FG003|SFU Period (6 Months=168 Days)|Death|0|||
143490561|NCT05103332|517338312|FG004|SFU Period (6 Months=168 Days)|Death|0|||
143490562|NCT05103332|517338313|FG005|SFU Period (6 Months=168 Days)|Death|0|||
143490563|NCT05103332|517338314|FG006|SFU Period (6 Months=168 Days)|Death|0|||
143490564|NCT05103332|517338315|FG007|SFU Period (6 Months=168 Days)|Death|0|||
143490565|NCT05103332|517338316|FG008|SFU Period (6 Months=168 Days)|Death|0|||
143490566|NCT05103332|517338317|FG009|SFU Period (6 Months=168 Days)|Death|0|||
143490567|NCT05103332|517338318|FG010|SFU Period (6 Months=168 Days)|Death|0|||
143490568|NCT05103332|517338319|FG011|SFU Period (6 Months=168 Days)|Death|0|||
143490569|NCT05103332|517338320|FG012|SFU Period (6 Months=168 Days)|Death|0|||
143490570|NCT05103332|517338321|FG013|SFU Period (6 Months=168 Days)|Death|0|||
143490571|NCT05103332|517338322|FG014|SFU Period (6 Months=168 Days)|Death|1|||
143490572|NCT05103332|517338323|FG015|SFU Period (6 Months=168 Days)|Death|0|||
143490573|NCT05103332|517338324|FG016|SFU Period (6 Months=168 Days)|Death|0|||
143490574|NCT05103332|517338325|FG017|SFU Period (6 Months=168 Days)|Death|1|||
143490575|NCT04428476|517338326|FG000|Overall Study|Withdrawal by Subject|1|||
143490576|NCT04428476|517338326|FG000|Overall Study|Still on treatment|12|||
143490577|NCT04982250|517338328|FG000|Overall Study|Lost to Follow-up|0|||
143490578|NCT04982250|517338329|FG001|Overall Study|Lost to Follow-up|26|||
143490579|NCT04982250|517338330|FG002|Overall Study|Lost to Follow-up|0|||
143490580|NCT04982250|517338331|FG003|Overall Study|Lost to Follow-up|0|||
143490581|NCT04982250|517338332|FG004|Overall Study|Lost to Follow-up|72|||
143490582|NCT04982250|517338333|FG005|Overall Study|Lost to Follow-up|69|||
143490583|NCT04982250|517338328|FG000|Overall Study|Not Eligible to Enroll|0|||
143490584|NCT04982250|517338329|FG001|Overall Study|Not Eligible to Enroll|0|||
143490585|NCT04982250|517338330|FG002|Overall Study|Not Eligible to Enroll|0|||
143490586|NCT04982250|517338331|FG003|Overall Study|Not Eligible to Enroll|0|||
143490587|NCT04982250|517338332|FG004|Overall Study|Not Eligible to Enroll|10|||
143490588|NCT04982250|517338333|FG005|Overall Study|Not Eligible to Enroll|7|||
143490589|NCT04042103|517338346|FG000|Overall Study|Lost to Follow-up|1|||
143490590|NCT04042103|517338346|FG000|Overall Study|Withdrawal by Subject|1|||
143490591|NCT04209855|517338348|FG000|Overall Study|Death|161|||
143490592|NCT04209855|517338349|FG001|Overall Study|Death|177|||
143490593|NCT04209855|517338348|FG000|Overall Study|PI Discretion|1|||
143490594|NCT04209855|517338349|FG001|Overall Study|PI Discretion|1|||
143490595|NCT04209855|517338348|FG000|Overall Study|Lost to Follow-up|5|||
143490596|NCT04209855|517338349|FG001|Overall Study|Lost to Follow-up|2|||
143490597|NCT04209855|517338348|FG000|Overall Study|Withdrew consent|10|||
143025488|NCT02110706|515633001|FG000|Overall Study|Adverse Event|2|||
143025489|NCT02110706|515633002|FG001|Overall Study|Adverse Event|3|||
143025490|NCT02110706|515633001|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
143025491|NCT02110706|515633002|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
143025492|NCT00310856|515633003|FG000|Overall Study|Withdrawal by Subject|2|||
143025493|NCT00310856|515633004|FG001|Overall Study|Withdrawal by Subject|2|||
143025494|NCT00310856|515633005|FG002|Overall Study|Withdrawal by Subject|2|||
143025495|NCT00310856|515633003|FG000|Overall Study|Lost to Follow-up|1|||
143025496|NCT00310856|515633004|FG001|Overall Study|Lost to Follow-up|2|||
143025497|NCT00310856|515633005|FG002|Overall Study|Lost to Follow-up|6|||
143025498|NCT00310856|515633003|FG000|Overall Study|Inappropriate enrollment|1|||
143025499|NCT00310856|515633004|FG001|Overall Study|Inappropriate enrollment|1|||
143025500|NCT00310856|515633005|FG002|Overall Study|Inappropriate enrollment|0|||
143025501|NCT00310856|515633003|FG000|Overall Study|Unable to classify|1|||
143025502|NCT00310856|515633004|FG001|Overall Study|Unable to classify|0|||
143025503|NCT00310856|515633005|FG002|Overall Study|Unable to classify|0|||
143025504|NCT00321711|515633007|FG000|Part A|Adverse Event|3|||
143025505|NCT00321711|515633008|FG001|Part A|Adverse Event|3|||
143025506|NCT00321711|515633009|FG002|Part A|Adverse Event|2|||
143025507|NCT00321711|515633010|FG003|Part A|Adverse Event|0|||
143025508|NCT00321711|515633011|FG004|Part A|Adverse Event|0|||
143025509|NCT00321711|515633007|FG000|Part A|Withdrawal by Subject|1|||
143025510|NCT00321711|515633008|FG001|Part A|Withdrawal by Subject|1|||
143025511|NCT00321711|515633009|FG002|Part A|Withdrawal by Subject|1|||
143025512|NCT00321711|515633010|FG003|Part A|Withdrawal by Subject|0|||
143025513|NCT00321711|515633011|FG004|Part A|Withdrawal by Subject|0|||
143025514|NCT00321711|515633007|FG000|Part A|Disease progression|0|||
143025515|NCT00321711|515633008|FG001|Part A|Disease progression|1|||
143025516|NCT00321711|515633009|FG002|Part A|Disease progression|0|||
143025517|NCT00321711|515633010|FG003|Part A|Disease progression|0|||
143025518|NCT00321711|515633011|FG004|Part A|Disease progression|0|||
143025519|NCT00321711|515633007|FG000|Part A|Requirement for alternative therapy|0|||
143025520|NCT00321711|515633008|FG001|Part A|Requirement for alternative therapy|2|||
143025521|NCT00321711|515633009|FG002|Part A|Requirement for alternative therapy|1|||
143025522|NCT00321711|515633010|FG003|Part A|Requirement for alternative therapy|0|||
143025523|NCT00321711|515633011|FG004|Part A|Requirement for alternative therapy|0|||
143025524|NCT00321711|515633007|FG000|Part A|Physician Decision|0|||
143025525|NCT00321711|515633008|FG001|Part A|Physician Decision|1|||
143025526|NCT00321711|515633009|FG002|Part A|Physician Decision|3|||
143025527|NCT00321711|515633010|FG003|Part A|Physician Decision|0|||
143025528|NCT00321711|515633011|FG004|Part A|Physician Decision|0|||
143025529|NCT00321711|515633007|FG000|Part A|Other|1|||
143025530|NCT00321711|515633008|FG001|Part A|Other|2|||
143025531|NCT00321711|515633009|FG002|Part A|Other|3|||
143025532|NCT00321711|515633010|FG003|Part A|Other|0|||
143025533|NCT00321711|515633011|FG004|Part A|Other|0|||
143025534|NCT00321711|515633007|FG000|Part A|Protocol deviation|0|||
143025535|NCT00321711|515633008|FG001|Part A|Protocol deviation|0|||
143236904|NCT01550003|516421509|FG001|Overall Study|Study closure|1|||
143236905|NCT01550003|516421510|FG002|Overall Study|Study closure|1|||
143236906|NCT01550003|516421508|FG000|Overall Study|Patient reached adulthood|0|||
143236907|NCT01550003|516421509|FG001|Overall Study|Patient reached adulthood|1|||
143236908|NCT01550003|516421510|FG002|Overall Study|Patient reached adulthood|0|||
143236909|NCT01550003|516421508|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
143236910|NCT01550003|516421509|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
143236911|NCT01550003|516421510|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
143236912|NCT01550003|516421508|FG000|Overall Study|Sponsor's order|0|||
143236913|NCT01550003|516421509|FG001|Overall Study|Sponsor's order|3|||
143236914|NCT01550003|516421510|FG002|Overall Study|Sponsor's order|3|||
143363863|NCT00049517|516875453|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
143490598|NCT04209855|517338349|FG001|Overall Study|Withdrew consent|24|||
143490599|NCT04209855|517338348|FG000|Overall Study|Sponsor decision|44|||
143490600|NCT04209855|517338349|FG001|Overall Study|Sponsor decision|18|||
143490601|NCT04209855|517338348|FG000|Overall Study|Other than specified|6|||
143236915|NCT01550003|516421508|FG000|Overall Study|Sponsor's decision|1|||
143490602|NCT04209855|517338349|FG001|Overall Study|Other than specified|4|||
143490603|NCT04518462|517338350|FG000|Overall Study|Withdrawal by Subject|0|||
143490604|NCT04518462|517338351|FG001|Overall Study|Withdrawal by Subject|0|||
143236916|NCT01550003|516421509|FG001|Overall Study|Sponsor's decision|5|||
143490605|NCT04518462|517338352|FG002|Overall Study|Withdrawal by Subject|1|||
143490606|NCT04518462|517338350|FG000|Overall Study|Physician Decision|1|||
143025536|NCT00321711|515633009|FG002|Part A|Protocol deviation|1|||
143025537|NCT00321711|515633010|FG003|Part A|Protocol deviation|0|||
143025538|NCT00321711|515633011|FG004|Part A|Protocol deviation|0|||
143025539|NCT00321711|515633007|FG000|Part B|Noncompliance|0|||
143025540|NCT00321711|515633008|FG001|Part B|Noncompliance|0|||
143025541|NCT00321711|515633009|FG002|Part B|Noncompliance|0|||
143025542|NCT00321711|515633010|FG003|Part B|Noncompliance|0|||
143025543|NCT00321711|515633011|FG004|Part B|Noncompliance|1|||
143025544|NCT00321711|515633007|FG000|Part B|Adverse Event|0|||
143025545|NCT00321711|515633008|FG001|Part B|Adverse Event|0|||
143025546|NCT00321711|515633009|FG002|Part B|Adverse Event|0|||
143025547|NCT00321711|515633010|FG003|Part B|Adverse Event|2|||
143025548|NCT00321711|515633011|FG004|Part B|Adverse Event|1|||
143490607|NCT04518462|517338351|FG001|Overall Study|Physician Decision|1|||
143490608|NCT04518462|517338352|FG002|Overall Study|Physician Decision|0|||
143490609|NCT04153188|517338357|FG000|Overall Study|Lost to Follow-up|1|||
143490610|NCT04153188|517338358|FG001|Overall Study|Lost to Follow-up|1|||
143490611|NCT04153188|517338357|FG000|Overall Study|Withdrawal by Subject|2|||
143490612|NCT04153188|517338358|FG001|Overall Study|Withdrawal by Subject|0|||
143490613|NCT04153188|517338357|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
143490614|NCT04153188|517338358|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
143490615|NCT01314716|517338360|FG000|Double-Blind Phase|Randomized but not treated|1|||
143490616|NCT01314716|517338361|FG001|Double-Blind Phase|Randomized but not treated|1|||
143490617|NCT01314716|517338360|FG000|Double-Blind Phase|Adverse Event|10|||
143490618|NCT01314716|517338361|FG001|Double-Blind Phase|Adverse Event|4|||
143490619|NCT01314716|517338360|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
143490620|NCT01314716|517338361|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
143490621|NCT01314716|517338360|FG000|Double-Blind Phase|Lost to Follow-up|0|||
143490622|NCT01314716|517338361|FG001|Double-Blind Phase|Lost to Follow-up|1|||
143490623|NCT01314716|517338360|FG000|Double-Blind Phase|Sponsor request|1|||
143490624|NCT01314716|517338361|FG001|Double-Blind Phase|Sponsor request|2|||
143490625|NCT01314716|517338360|FG000|Double-Blind Phase|Physician Decision|0|||
143490626|NCT01314716|517338361|FG001|Double-Blind Phase|Physician Decision|1|||
143490627|NCT01314716|517338360|FG000|Open-Label Phase|Adverse Event|4|||
143490628|NCT01314716|517338361|FG001|Open-Label Phase|Adverse Event|6|||
143490629|NCT01314716|517338360|FG000|Open-Label Phase|Withdrawal by Subject|1|||
143490630|NCT01314716|517338361|FG001|Open-Label Phase|Withdrawal by Subject|2|||
143490631|NCT01314716|517338360|FG000|Open-Label Phase|Physician Decision|5|||
143490632|NCT01314716|517338361|FG001|Open-Label Phase|Physician Decision|4|||
143490633|NCT00936208|517338362|FG000|Overall Study|Protocol Violation|37|||
143490634|NCT00936208|517338363|FG001|Overall Study|Protocol Violation|22|||
143490635|NCT00700271|517338364|FG000|Overall Study|Adverse Event|4|||
143490636|NCT00700271|517338365|FG001|Overall Study|Adverse Event|6|||
143490637|NCT00700271|517338364|FG000|Overall Study|Protocol Violation|1|||
143490638|NCT00700271|517338365|FG001|Overall Study|Protocol Violation|0|||
143490639|NCT00700271|517338364|FG000|Overall Study|Administrative Reasons|1|||
143490640|NCT00700271|517338365|FG001|Overall Study|Administrative Reasons|0|||
143490641|NCT00700271|517338364|FG000|Overall Study|Withdrawal by Subject|6|||
143490642|NCT00700271|517338365|FG001|Overall Study|Withdrawal by Subject|4|||
143490643|NCT00700271|517338364|FG000|Overall Study|Lost to Follow-up|2|||
143490644|NCT00700271|517338365|FG001|Overall Study|Lost to Follow-up|2|||
143490645|NCT05107765|517338366|FG000|Overall Study|Lost to Follow-up|4|||
143490646|NCT05107765|517338367|FG001|Overall Study|Lost to Follow-up|1|||
143490647|NCT05107765|517338366|FG000|Overall Study|Withdrawn by investigator due to non-compliance|1|||
143490648|NCT05107765|517338367|FG001|Overall Study|Withdrawn by investigator due to non-compliance|0|||
143490649|NCT05107765|517338366|FG000|Overall Study|Withdrawal by Subjects due to scheduling issues|6|||
143490650|NCT05107765|517338367|FG001|Overall Study|Withdrawal by Subjects due to scheduling issues|3|||
143490651|NCT01411085|517338368|FG000|Overall Study|Physician Decision|1|||
143490652|NCT01411085|517338368|FG000|Overall Study|Protocol Violation|1|||
143490653|NCT01411085|517338368|FG000|Overall Study|Adverse Event|1|||
143490654|NCT04818593|517338369|FG000|Overall Study|Low Oocyte Yield|8|||
143490655|NCT04818593|517338370|FG001|Overall Study|Low Oocyte Yield|8|||
143490656|NCT04818593|517338369|FG000|Overall Study|Not ICSI Insemination|7|||
143490657|NCT04818593|517338370|FG001|Overall Study|Not ICSI Insemination|7|||
143490658|NCT04818593|517338369|FG000|Overall Study|Poor Sperm Quality|2|||
143490659|NCT04818593|517338370|FG001|Overall Study|Poor Sperm Quality|2|||
143490660|NCT04818593|517338369|FG000|Overall Study|Withdrawal by Subject|2|||
143490661|NCT04818593|517338370|FG001|Overall Study|Withdrawal by Subject|2|||
143490662|NCT04818593|517338369|FG000|Overall Study|Conversion to IUI due to low response|1|||
143490663|NCT04818593|517338370|FG001|Overall Study|Conversion to IUI due to low response|1|||
143490664|NCT01564862|517338371|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
143490665|NCT01564862|517338372|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
143490666|NCT01564862|517338373|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
143490667|NCT01564862|517338371|FG000|Overall Study|Major Protocol Deviation|3|||
143490668|NCT01564862|517338372|FG001|Overall Study|Major Protocol Deviation|3|||
143490669|NCT01564862|517338373|FG002|Overall Study|Major Protocol Deviation|4|||
143490670|NCT01564862|517338371|FG000|Overall Study|Lost to Follow-up|10|||
143490671|NCT01564862|517338372|FG001|Overall Study|Lost to Follow-up|8|||
143490672|NCT01564862|517338373|FG002|Overall Study|Lost to Follow-up|6|||
143236917|NCT01550003|516421510|FG002|Overall Study|Sponsor's decision|4|||
143490673|NCT01564862|517338371|FG000|Overall Study|Voluntary Withdrawal|9|||
143490674|NCT01564862|517338372|FG001|Overall Study|Voluntary Withdrawal|6|||
143490675|NCT01564862|517338373|FG002|Overall Study|Voluntary Withdrawal|8|||
143490676|NCT01564862|517338371|FG000|Overall Study|Lack of Efficacy|1|||
143490677|NCT01564862|517338372|FG001|Overall Study|Lack of Efficacy|5|||
143490678|NCT01564862|517338373|FG002|Overall Study|Lack of Efficacy|6|||
143490679|NCT01564862|517338371|FG000|Overall Study|Other reason(s)|1|||
143236918|NCT01550003|516421508|FG000|Overall Study|Subject mother passed away|0|||
143490680|NCT01564862|517338372|FG001|Overall Study|Other reason(s)|0|||
143490681|NCT01564862|517338373|FG002|Overall Study|Other reason(s)|0|||
143490682|NCT01371981|517338374|FG000|Overall Study|Adverse Event|12|||
143025549|NCT00321711|515633007|FG000|Part B|Disease progression|0|||
143025550|NCT00321711|515633008|FG001|Part B|Disease progression|0|||
143025551|NCT00321711|515633009|FG002|Part B|Disease progression|0|||
143025552|NCT00321711|515633010|FG003|Part B|Disease progression|1|||
143025553|NCT00321711|515633011|FG004|Part B|Disease progression|0|||
143025554|NCT00321711|515633007|FG000|Part B|Physician Decision|0|||
143025555|NCT00321711|515633008|FG001|Part B|Physician Decision|0|||
143025556|NCT00321711|515633009|FG002|Part B|Physician Decision|0|||
143025557|NCT00321711|515633010|FG003|Part B|Physician Decision|1|||
143025558|NCT00321711|515633011|FG004|Part B|Physician Decision|2|||
143025559|NCT00321711|515633007|FG000|Part B|Death|0|||
143025560|NCT00321711|515633008|FG001|Part B|Death|0|||
143025561|NCT00321711|515633009|FG002|Part B|Death|0|||
143025562|NCT00321711|515633010|FG003|Part B|Death|2|||
143025563|NCT00321711|515633011|FG004|Part B|Death|1|||
143025564|NCT01185288|515633012|FG000|Overall Study|Adverse Event|7|||
143025565|NCT01185288|515633013|FG001|Overall Study|Adverse Event|6|||
143025566|NCT01185288|515633012|FG000|Overall Study|Withdrawal by Subject|6|||
143025567|NCT01185288|515633013|FG001|Overall Study|Withdrawal by Subject|4|||
143025568|NCT01185288|515633012|FG000|Overall Study|Lost to Follow-up|2|||
143025569|NCT01185288|515633013|FG001|Overall Study|Lost to Follow-up|5|||
143025570|NCT01185288|515633012|FG000|Overall Study|Lack of Efficacy|2|||
143025571|NCT01185288|515633013|FG001|Overall Study|Lack of Efficacy|0|||
143025572|NCT01185288|515633012|FG000|Overall Study|Investigator discretion|1|||
143025573|NCT01185288|515633013|FG001|Overall Study|Investigator discretion|0|||
143025574|NCT01185288|515633012|FG000|Overall Study|Did not meet inclusion criteria|1|||
143025575|NCT01185288|515633013|FG001|Overall Study|Did not meet inclusion criteria|0|||
143025576|NCT01185288|515633012|FG000|Overall Study|Noncompliance|0|||
143025577|NCT01185288|515633013|FG001|Overall Study|Noncompliance|1|||
143025578|NCT02100956|515633014|FG000|At Least One Week Between Injections|Adverse Event|0|||
143025579|NCT02100956|515633015|FG001|At Least One Week Between Injections|Adverse Event|1|||
143025580|NCT00289458|515633016|FG000|Overall Study|Death|1|||
143025581|NCT00289458|515633017|FG001|Overall Study|Death|0|||
143025582|NCT00289458|515633018|FG002|Overall Study|Death|0|||
143025583|NCT00289458|515633016|FG000|Overall Study|Physician Decision|3|||
143025584|NCT00289458|515633017|FG001|Overall Study|Physician Decision|4|||
143025585|NCT00289458|515633018|FG002|Overall Study|Physician Decision|2|||
143025586|NCT00289458|515633016|FG000|Overall Study|Withdrawal by Subject|2|||
143025587|NCT00289458|515633017|FG001|Overall Study|Withdrawal by Subject|2|||
143025588|NCT00289458|515633018|FG002|Overall Study|Withdrawal by Subject|4|||
143025589|NCT00759148|515634591|FG000|Overall Study|Adverse Event|1|||
143025590|NCT00759148|515634592|FG001|Overall Study|Adverse Event|6|||
143025591|NCT00759148|515634591|FG000|Overall Study|Withdrawal by Subject|3|||
143025592|NCT00759148|515634592|FG001|Overall Study|Withdrawal by Subject|7|||
143025593|NCT00759148|515634591|FG000|Overall Study|Lost to Follow-up|3|||
143025594|NCT00759148|515634592|FG001|Overall Study|Lost to Follow-up|9|||
143025595|NCT00759148|515634591|FG000|Overall Study|Treatment Failure|6|||
143025596|NCT00759148|515634592|FG001|Overall Study|Treatment Failure|10|||
143025597|NCT00759148|515634591|FG000|Overall Study|Reason not given|1|||
143025598|NCT00759148|515634592|FG001|Overall Study|Reason not given|0|||
143157992|NCT00663351|516124369|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
143157993|NCT00663351|516124368|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
143157994|NCT00663351|516124369|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
143157995|NCT00663351|516124368|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
143157996|NCT00663351|516124369|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
143025599|NCT01341639|515634593|FG000|Infant Series|Protocol Violation|1|||
143025600|NCT01341639|515634594|FG001|Infant Series|Protocol Violation|0|||
143025601|NCT01341639|515634593|FG000|Infant Series|Not Vaccinated|0|||
143025602|NCT01341639|515634594|FG001|Infant Series|Not Vaccinated|1|||
143025603|NCT01341639|515634593|FG000|Infant Series|Adverse Event|0|||
143025604|NCT01341639|515634594|FG001|Infant Series|Adverse Event|5|||
143025605|NCT01341639|515634593|FG000|Infant Series|Withdrawal by Subject|11|||
143025606|NCT01341639|515634594|FG001|Infant Series|Withdrawal by Subject|8|||
143157997|NCT00567112|516124370|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
143490683|NCT01371981|517338375|FG001|Overall Study|Adverse Event|17|||
143025607|NCT01341639|515634593|FG000|Infant Series|Lost to Follow-up|0|||
143025608|NCT01341639|515634594|FG001|Infant Series|Lost to Follow-up|2|||
143025609|NCT01341639|515634593|FG000|Infant Series|Site 0048 Participants|17|||
143025610|NCT01341639|515634594|FG001|Infant Series|Site 0048 Participants|16|||
143025611|NCT01341639|515634593|FG000|Interim Period|Withdrawal by Subject|6|||
143025612|NCT01341639|515634594|FG001|Interim Period|Withdrawal by Subject|7|||
143025613|NCT01341639|515634593|FG000|Interim Period|Lost to Follow-up|2|||
143157998|NCT00567112|516124371|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
143025614|NCT01341639|515634594|FG001|Interim Period|Lost to Follow-up|0|||
143025615|NCT01341639|515634593|FG000|Interim Period|Physician Decision|0|||
143025616|NCT01341639|515634594|FG001|Interim Period|Physician Decision|1|||
143025617|NCT01341639|515634593|FG000|Interim Period|Protocol Violation|0|||
143025618|NCT01341639|515634594|FG001|Interim Period|Protocol Violation|1|||
143025619|NCT01341639|515634593|FG000|Post-Treatment|Withdrawal by Subject|0|||
143025620|NCT01341639|515634594|FG001|Post-Treatment|Withdrawal by Subject|1|||
143025621|NCT01341639|515634593|FG000|Post-Treatment|Adverse Event|0|||
143025622|NCT01341639|515634594|FG001|Post-Treatment|Adverse Event|2|||
143025623|NCT01241461|515634595|FG000|Overall Study|Progressive Disease|3|||
143025624|NCT01241461|515634596|FG001|Overall Study|Progressive Disease|6|||
143025625|NCT02247479|515634597|FG000|Overall Study|Adverse Event|8|||
143025626|NCT02247479|515634598|FG001|Overall Study|Adverse Event|9|||
143025627|NCT02247479|515634599|FG002|Overall Study|Adverse Event|8|||
143025628|NCT02247479|515634597|FG000|Overall Study|Death|5|||
143025629|NCT02247479|515634598|FG001|Overall Study|Death|4|||
143025630|NCT02247479|515634599|FG002|Overall Study|Death|6|||
143025631|NCT02247479|515634597|FG000|Overall Study|Lost to Follow-up|3|||
143025632|NCT02247479|515634598|FG001|Overall Study|Lost to Follow-up|3|||
143025633|NCT02247479|515634599|FG002|Overall Study|Lost to Follow-up|1|||
143025634|NCT02247479|515634597|FG000|Overall Study|Non-compliance|0|||
143025635|NCT02247479|515634598|FG001|Overall Study|Non-compliance|0|||
143025636|NCT02247479|515634599|FG002|Overall Study|Non-compliance|1|||
143025637|NCT02247479|515634597|FG000|Overall Study|Withdrawal by Subject|25|||
143025638|NCT02247479|515634598|FG001|Overall Study|Withdrawal by Subject|29|||
143025639|NCT02247479|515634599|FG002|Overall Study|Withdrawal by Subject|24|||
143025640|NCT02247479|515634597|FG000|Overall Study|Study Terminated by Sponsor|98|||
143025641|NCT02247479|515634598|FG001|Overall Study|Study Terminated by Sponsor|88|||
143025642|NCT02247479|515634599|FG002|Overall Study|Study Terminated by Sponsor|94|||
143025643|NCT02247479|515634597|FG000|Overall Study|Physician Decision|1|||
143025644|NCT02247479|515634598|FG001|Overall Study|Physician Decision|0|||
143025645|NCT02247479|515634599|FG002|Overall Study|Physician Decision|2|||
143025646|NCT02247479|515634597|FG000|Overall Study|Unspecified Reason|2|||
143025647|NCT02247479|515634598|FG001|Overall Study|Unspecified Reason|5|||
143025648|NCT02247479|515634599|FG002|Overall Study|Unspecified Reason|2|||
143025649|NCT01073020|515634600|FG000|Overall Study|Withdrawal by Subject|6|||
143025650|NCT01073020|515634601|FG001|Overall Study|Withdrawal by Subject|4|||
143025651|NCT01073020|515634602|FG002|Overall Study|Withdrawal by Subject|1|||
143025652|NCT01073020|515634603|FG003|Overall Study|Withdrawal by Subject|2|||
143025653|NCT01073020|515634600|FG000|Overall Study|Physician Decision|1|||
143025654|NCT01073020|515634601|FG001|Overall Study|Physician Decision|0|||
143025655|NCT01073020|515634602|FG002|Overall Study|Physician Decision|2|||
143025656|NCT01073020|515634603|FG003|Overall Study|Physician Decision|0|||
143025657|NCT01073020|515634600|FG000|Overall Study|Death|0|||
143025658|NCT01073020|515634601|FG001|Overall Study|Death|1|||
143025659|NCT01073020|515634602|FG002|Overall Study|Death|0|||
143025660|NCT01073020|515634603|FG003|Overall Study|Death|0|||
143025661|NCT01132118|515634604|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
143025662|NCT01132118|515634605|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
143025663|NCT01132118|515634604|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
143025664|NCT01132118|515634605|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
143025665|NCT01132118|515634604|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
143025666|NCT01132118|515634605|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
143025667|NCT02761980|515634612|FG000|Overall Study|Adverse Event|4|||
143025668|NCT02761980|515634613|FG001|Overall Study|Adverse Event|6|||
143025669|NCT02761980|515634614|FG002|Overall Study|Adverse Event|5|||
143236919|NCT01550003|516421509|FG001|Overall Study|Subject mother passed away|1|||
143490684|NCT01371981|517338376|FG002|Overall Study|Adverse Event|0|||
143490685|NCT01371981|517338377|FG003|Overall Study|Adverse Event|4|||
143490686|NCT01371981|517338378|FG004|Overall Study|Adverse Event|1|||
143490687|NCT01371981|517338379|FG005|Overall Study|Adverse Event|0|||
143490688|NCT01371981|517338374|FG000|Overall Study|Death|22|||
143490689|NCT01371981|517338375|FG001|Overall Study|Death|16|||
143490690|NCT01371981|517338376|FG002|Overall Study|Death|0|||
143490691|NCT01371981|517338377|FG003|Overall Study|Death|0|||
143490692|NCT01371981|517338378|FG004|Overall Study|Death|2|||
143025670|NCT02761980|515634615|FG003|Overall Study|Adverse Event|6|||
143490693|NCT01371981|517338379|FG005|Overall Study|Death|2|||
143025671|NCT02761980|515634612|FG000|Overall Study|Withdrawal by Subject|0|||
143025672|NCT02761980|515634613|FG001|Overall Study|Withdrawal by Subject|1|||
143025673|NCT02761980|515634614|FG002|Overall Study|Withdrawal by Subject|0|||
143236920|NCT01550003|516421510|FG002|Overall Study|Subject mother passed away|0|||
143025674|NCT02761980|515634615|FG003|Overall Study|Withdrawal by Subject|0|||
143025675|NCT02761980|515634612|FG000|Overall Study|Other|0|||
143025676|NCT02761980|515634613|FG001|Overall Study|Other|0|||
143025677|NCT02761980|515634614|FG002|Overall Study|Other|1|||
143025678|NCT02761980|515634615|FG003|Overall Study|Other|0|||
143025679|NCT03705351|515634616|FG000|Overall Study|Study termination|3|||
143025680|NCT03705351|515634616|FG000|Overall Study|Death|1|||
143025681|NCT03705351|515634616|FG000|Overall Study|Lack of Efficacy|2|||
143025682|NCT03705351|515634616|FG000|Overall Study|Withdrawal by Subject|1|||
143236921|NCT01550003|516421508|FG000|Overall Study|Discontinuation|0|||
143490694|NCT01371981|517338374|FG000|Overall Study|Lack of Efficacy|69|||
143025683|NCT01162499|515634623|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
143025684|NCT01162499|515634624|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
143025685|NCT01590433|515634625|FG000|Overall Study|Lost to Follow-up|20|||
143025686|NCT01590433|515634626|FG001|Overall Study|Lost to Follow-up|8|||
143025687|NCT01590433|515634625|FG000|Overall Study|Withdrawal by Subject|21|||
143025688|NCT01590433|515634626|FG001|Overall Study|Withdrawal by Subject|11|||
143025689|NCT01590433|515634625|FG000|Overall Study|Adverse Event|11|||
143025690|NCT01590433|515634626|FG001|Overall Study|Adverse Event|3|||
143025691|NCT00322556|515634627|FG000|Overall Study|Adverse Event|1|||
143025692|NCT00322556|515634627|FG000|Overall Study|Withdrawal by Subject|1|||
143025693|NCT00322556|515634627|FG000|Overall Study|Lost to Follow-up|3|||
143025694|NCT00322556|515634627|FG000|Overall Study|Other Reason|7|||
143025695|NCT00586521|515634628|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
143025696|NCT02710071|515634632|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
143025697|NCT02710071|515634633|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
143025698|NCT02710071|515634632|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
143025699|NCT02710071|515634633|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
143025700|NCT01673009|515634638|FG000|Overall Study|Physician Decision|5|||
143025701|NCT01673009|515634638|FG000|Overall Study|Withdrawal by Subject|8|||
143025702|NCT01844583|515634639|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
143025703|NCT01844583|515634640|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
143025704|NCT00989261|515634641|FG000|Overall Study|Still in follow up|12|||
143025705|NCT00989261|515634642|FG001|Overall Study|Still in follow up|21|||
143025706|NCT00989261|515634641|FG000|Overall Study|Withdrawal by Subject|0|||
143025707|NCT00989261|515634642|FG001|Overall Study|Withdrawal by Subject|1|||
143025708|NCT00989261|515634641|FG000|Overall Study|Lost to Follow-up|3|||
143490695|NCT01371981|517338375|FG001|Overall Study|Lack of Efficacy|61|||
143490696|NCT01371981|517338376|FG002|Overall Study|Lack of Efficacy|4|||
143490697|NCT01371981|517338377|FG003|Overall Study|Lack of Efficacy|8|||
143490698|NCT01371981|517338378|FG004|Overall Study|Lack of Efficacy|5|||
143490699|NCT01371981|517338379|FG005|Overall Study|Lack of Efficacy|0|||
143490700|NCT01371981|517338374|FG000|Overall Study|Physician Decision|48|||
143490701|NCT01371981|517338375|FG001|Overall Study|Physician Decision|63|||
143490702|NCT01371981|517338376|FG002|Overall Study|Physician Decision|1|||
143490703|NCT01371981|517338377|FG003|Overall Study|Physician Decision|7|||
143490704|NCT01371981|517338378|FG004|Overall Study|Physician Decision|14|||
143490705|NCT01371981|517338379|FG005|Overall Study|Physician Decision|3|||
143490706|NCT01371981|517338374|FG000|Overall Study|Withdrawal by Subject|12|||
143490707|NCT01371981|517338375|FG001|Overall Study|Withdrawal by Subject|19|||
143490708|NCT01371981|517338376|FG002|Overall Study|Withdrawal by Subject|1|||
143490709|NCT01371981|517338377|FG003|Overall Study|Withdrawal by Subject|2|||
143490710|NCT01371981|517338378|FG004|Overall Study|Withdrawal by Subject|10|||
143490711|NCT01371981|517338379|FG005|Overall Study|Withdrawal by Subject|3|||
143490712|NCT01371981|517338374|FG000|Overall Study|Ineligible|19|||
143490713|NCT01371981|517338375|FG001|Overall Study|Ineligible|13|||
143490714|NCT01371981|517338376|FG002|Overall Study|Ineligible|0|||
143490715|NCT01371981|517338377|FG003|Overall Study|Ineligible|0|||
143490716|NCT01371981|517338378|FG004|Overall Study|Ineligible|0|||
143490717|NCT01371981|517338379|FG005|Overall Study|Ineligible|4|||
143490718|NCT01371981|517338374|FG000|Overall Study|Did not start treatment|2|||
143490719|NCT01371981|517338375|FG001|Overall Study|Did not start treatment|3|||
143025709|NCT00989261|515634642|FG001|Overall Study|Lost to Follow-up|0|||
143025710|NCT02398188|515634643|FG000|Overall Study|Adverse Event|2|||
143025711|NCT02398188|515634644|FG001|Overall Study|Adverse Event|3|||
143025712|NCT02398188|515634643|FG000|Overall Study|Lost to Follow-up|5|||
143025713|NCT02398188|515634644|FG001|Overall Study|Lost to Follow-up|0|||
143025714|NCT02398188|515634643|FG000|Overall Study|Non-compliance|4|||
143025715|NCT02398188|515634644|FG001|Overall Study|Non-compliance|4|||
143025716|NCT02398188|515634643|FG000|Overall Study|Protocol Violation|6|||
143490720|NCT01371981|517338376|FG002|Overall Study|Did not start treatment|0|||
143490721|NCT01371981|517338377|FG003|Overall Study|Did not start treatment|0|||
143490722|NCT01371981|517338378|FG004|Overall Study|Did not start treatment|0|||
143490723|NCT01371981|517338379|FG005|Overall Study|Did not start treatment|2|||
143490724|NCT03809611|517338380|FG000|Overall Study|Withdrawal by Subject|1|||
143490725|NCT03809611|517338381|FG001|Overall Study|Withdrawal by Subject|1|||
143490726|NCT02193074|517338382|FG000|Overall Study|Withdrawal by Subject|1|||
143490727|NCT02193074|517338383|FG001|Overall Study|Withdrawal by Subject|2|||
143490728|NCT02193074|517338382|FG000|Overall Study|Adverse Event|16|||
143490729|NCT02193074|517338383|FG001|Overall Study|Adverse Event|13|||
143490730|NCT02600494|517338384|FG000|Part A (6 Week Double-Blind Treatment)|Adverse Event|13|||
143490731|NCT02600494|517338385|FG001|Part A (6 Week Double-Blind Treatment)|Adverse Event|15|||
143490732|NCT02600494|517338386|FG002|Part A (6 Week Double-Blind Treatment)|Adverse Event|4|||
143490733|NCT02600494|517338384|FG000|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
143490734|NCT02600494|517338385|FG001|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|4|||
143490735|NCT02600494|517338386|FG002|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
143490736|NCT02600494|517338384|FG000|Part A (6 Week Double-Blind Treatment)|Protocol Violation|13|||
143025717|NCT02398188|515634644|FG001|Overall Study|Protocol Violation|10|||
143025718|NCT02398188|515634643|FG000|Overall Study|Sponsor Decision|2|||
143025719|NCT02398188|515634644|FG001|Overall Study|Sponsor Decision|1|||
143025720|NCT02398188|515634643|FG000|Overall Study|Pregnancy|1|||
143025721|NCT02398188|515634644|FG001|Overall Study|Pregnancy|0|||
143025722|NCT02398188|515634643|FG000|Overall Study|Withdrawal by Subject|7|||
143025723|NCT02398188|515634644|FG001|Overall Study|Withdrawal by Subject|16|||
143025724|NCT03209570|515634645|FG000|Overall Study|Death|1|||
143025725|NCT03209570|515634646|FG001|Overall Study|Death|0|||
143025726|NCT03209570|515634645|FG000|Overall Study|Incomplete Data|8|||
143025727|NCT03209570|515634646|FG001|Overall Study|Incomplete Data|10|||
143025728|NCT03209570|515634645|FG000|Overall Study|Protocol Violation|1|||
143025729|NCT03209570|515634646|FG001|Overall Study|Protocol Violation|0|||
143025730|NCT03209570|515634645|FG000|Overall Study|Withdrawal by Subject|0|||
143025731|NCT03209570|515634646|FG001|Overall Study|Withdrawal by Subject|3|||
143025732|NCT00220701|515634647|FG000|Overall Study|Lost to Follow-up|5|||
143025733|NCT00220701|515634648|FG001|Overall Study|Lost to Follow-up|4|||
143025734|NCT00952484|515634654|FG000|Overall Study|Withdrawal by Subject|0|||
143025735|NCT00952484|515634655|FG001|Overall Study|Withdrawal by Subject|1|||
143025736|NCT00952484|515634656|FG002|Overall Study|Withdrawal by Subject|0|||
143025737|NCT02750306|515634657|FG000|Overall Study|Withdrawal by Subject|5|||
143025738|NCT02750306|515634658|FG001|Overall Study|Withdrawal by Subject|2|||
143025739|NCT02750306|515634657|FG000|Overall Study|Protocol Violation|1|||
143025740|NCT02750306|515634658|FG001|Overall Study|Protocol Violation|0|||
143025741|NCT00192296|515634661|FG000|Overall Study|Withdrawal by Subject|0|||
143025742|NCT00192296|515634662|FG001|Overall Study|Withdrawal by Subject|1|||
143025743|NCT00192296|515634663|FG002|Overall Study|Withdrawal by Subject|0|||
143025744|NCT00192296|515634664|FG003|Overall Study|Withdrawal by Subject|0|||
143025745|NCT01829477|515634665|FG000|Overall Study|Study Terminated by Sponsor|15|||
143025746|NCT01829477|515634666|FG001|Overall Study|Study Terminated by Sponsor|15|||
143025747|NCT01829477|515634665|FG000|Overall Study|Withdrawal by Subject|1|||
143025748|NCT01829477|515634666|FG001|Overall Study|Withdrawal by Subject|0|||
143025749|NCT03465891|515634667|FG000|Overall Study|Withdrawal by Subject|0|||
143025750|NCT03465891|515634668|FG001|Overall Study|Withdrawal by Subject|1|||
143025751|NCT03465891|515634667|FG000|Overall Study|Disease progression|1|||
143025752|NCT03465891|515634668|FG001|Overall Study|Disease progression|0|||
143025753|NCT03361423|515634669|FG000|Overall Study|Withdrawal by Subject|4|||
143025754|NCT03361423|515634670|FG001|Overall Study|Withdrawal by Subject|3|||
143025755|NCT03361423|515634669|FG000|Overall Study|Did not treat|19|||
143025756|NCT03361423|515634670|FG001|Overall Study|Did not treat|18|||
143025757|NCT03361423|515634669|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
143025758|NCT03361423|515634670|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
143025759|NCT03361423|515634669|FG000|Overall Study|Missing data|4|||
143025760|NCT03361423|515634670|FG001|Overall Study|Missing data|1|||
143025761|NCT05034731|515634671|FG000|Overall Study|Screen fail|1|||
143025762|NCT05034731|515634672|FG001|Overall Study|Screen fail|1|||
143025763|NCT00299156|515634675|FG000|Period 2 (Randomized)|Screen Failure|0|||
143025764|NCT00299156|515634676|FG001|Period 2 (Randomized)|Screen Failure|1|||
143025765|NCT00299156|515634677|FG002|Period 2 (Randomized)|Screen Failure|0|||
143025766|NCT02015793|515634681|FG000|Overall Study|Adverse Event|3|||
143025767|NCT02015793|515634682|FG001|Overall Study|Adverse Event|3|||
143025768|NCT02015793|515634681|FG000|Overall Study|Withdrawal by Subject|1|||
143025769|NCT02015793|515634682|FG001|Overall Study|Withdrawal by Subject|1|||
143025770|NCT00320593|515634683|FG000|Overall Study|Lost to Follow-up|3|||
143025771|NCT00320593|515634684|FG001|Overall Study|Lost to Follow-up|0|||
143157999|NCT00567112|516124372|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
143158000|NCT00567112|516124370|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
143158001|NCT00567112|516124371|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
143158002|NCT00567112|516124372|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
143158003|NCT00567112|516124370|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
143025772|NCT00320593|515634683|FG000|Overall Study|Moved to another state|1|||
143025773|NCT00320593|515634684|FG001|Overall Study|Moved to another state|0|||
143025774|NCT00320593|515634683|FG000|Overall Study|Withdrawal by Subject|2|||
143025775|NCT00320593|515634684|FG001|Overall Study|Withdrawal by Subject|1|||
143025776|NCT00320593|515634683|FG000|Overall Study|Withdrawal by clinical center|1|||
143025777|NCT00320593|515634684|FG001|Overall Study|Withdrawal by clinical center|0|||
143025778|NCT01716754|515634687|FG000|Overall Study|Death|0|||
143025779|NCT01716754|515634688|FG001|Overall Study|Death|0|||
143025780|NCT01716754|515634689|FG002|Overall Study|Death|0|||
143025781|NCT01716754|515634690|FG003|Overall Study|Death|1|||
143025782|NCT01716754|515634687|FG000|Overall Study|Protocol deviation|0|||
143025783|NCT01716754|515634688|FG001|Overall Study|Protocol deviation|2|||
143025784|NCT01716754|515634689|FG002|Overall Study|Protocol deviation|7|||
143025785|NCT01716754|515634690|FG003|Overall Study|Protocol deviation|2|||
143025786|NCT01716754|515634687|FG000|Overall Study|Non-compliance with study treatment|0|||
143025787|NCT01716754|515634688|FG001|Overall Study|Non-compliance with study treatment|0|||
143158004|NCT00567112|516124371|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
143025788|NCT01716754|515634689|FG002|Overall Study|Non-compliance with study treatment|1|||
143025789|NCT01716754|515634690|FG003|Overall Study|Non-compliance with study treatment|0|||
143025790|NCT01716754|515634687|FG000|Overall Study|Physician Decision|1|||
143025791|NCT01716754|515634688|FG001|Overall Study|Physician Decision|0|||
143025792|NCT01716754|515634689|FG002|Overall Study|Physician Decision|0|||
143025793|NCT01716754|515634690|FG003|Overall Study|Physician Decision|0|||
143025794|NCT01716754|515634687|FG000|Overall Study|Lost to Follow-up|1|||
143025795|NCT01716754|515634688|FG001|Overall Study|Lost to Follow-up|0|||
143025796|NCT01716754|515634689|FG002|Overall Study|Lost to Follow-up|0|||
143025797|NCT01716754|515634690|FG003|Overall Study|Lost to Follow-up|1|||
143025798|NCT01716754|515634687|FG000|Overall Study|Adverse Event|4|||
143025799|NCT01716754|515634688|FG001|Overall Study|Adverse Event|2|||
143025800|NCT01716754|515634689|FG002|Overall Study|Adverse Event|2|||
143025801|NCT01716754|515634690|FG003|Overall Study|Adverse Event|1|||
143025802|NCT01716754|515634687|FG000|Overall Study|Withdrawal by Subject|5|||
143025803|NCT01716754|515634688|FG001|Overall Study|Withdrawal by Subject|0|||
143025804|NCT01716754|515634689|FG002|Overall Study|Withdrawal by Subject|4|||
143025805|NCT01716754|515634690|FG003|Overall Study|Withdrawal by Subject|3|||
143025806|NCT02970669|515634710|FG000|Double-blind Period|Adverse Event|4|||
143025807|NCT02970669|515634711|FG001|Double-blind Period|Adverse Event|0|||
143025808|NCT02970669|515634710|FG000|Double-blind Period|Death|1|||
143025809|NCT02970669|515634711|FG001|Double-blind Period|Death|0|||
143025810|NCT02970669|515634710|FG000|Double-blind Period|Study terminated by sponsor|1|||
143025811|NCT02970669|515634711|FG001|Double-blind Period|Study terminated by sponsor|2|||
143025812|NCT02970669|515634710|FG000|Double-blind Period|Physician Decision|0|||
143025813|NCT02970669|515634711|FG001|Double-blind Period|Physician Decision|2|||
143025814|NCT02970669|515634710|FG000|Double-blind Period|Withdrawal by Subject|2|||
143025815|NCT02970669|515634711|FG001|Double-blind Period|Withdrawal by Subject|2|||
143025816|NCT02970669|515634710|FG000|Open-label Period|Withdrawal by Subject|2|||
143025817|NCT02970669|515634711|FG001|Open-label Period|Withdrawal by Subject|2|||
143025818|NCT02970669|515634710|FG000|Open-label Period|Adverse Event|1|||
143025819|NCT02970669|515634711|FG001|Open-label Period|Adverse Event|0|||
143025820|NCT02970669|515634710|FG000|Open-label Period|Physician Decision|1|||
143025821|NCT02970669|515634711|FG001|Open-label Period|Physician Decision|0|||
143025822|NCT00876733|515634718|FG000|Overall Study|Adverse Event|34|||
143025823|NCT00876733|515634719|FG001|Overall Study|Adverse Event|20|||
143025824|NCT00876733|515634720|FG002|Overall Study|Adverse Event|10|||
143025825|NCT00876733|515634721|FG003|Overall Study|Adverse Event|3|||
143025826|NCT00876733|515634718|FG000|Overall Study|Lack of Efficacy|17|||
143025827|NCT00876733|515634719|FG001|Overall Study|Lack of Efficacy|9|||
143025828|NCT00876733|515634720|FG002|Overall Study|Lack of Efficacy|10|||
143025829|NCT00876733|515634721|FG003|Overall Study|Lack of Efficacy|1|||
143025830|NCT00876733|515634718|FG000|Overall Study|Lost to Follow-up|26|||
143025831|NCT00876733|515634719|FG001|Overall Study|Lost to Follow-up|10|||
143025832|NCT00876733|515634720|FG002|Overall Study|Lost to Follow-up|3|||
143025833|NCT00876733|515634721|FG003|Overall Study|Lost to Follow-up|2|||
143025834|NCT00876733|515634718|FG000|Overall Study|Data not available|14|||
143025835|NCT00876733|515634719|FG001|Overall Study|Data not available|3|||
143025836|NCT00876733|515634720|FG002|Overall Study|Data not available|7|||
143025837|NCT00876733|515634721|FG003|Overall Study|Data not available|1|||
143025838|NCT02611752|515634722|FG000|Overall Study|Adverse Event|0|||
143025839|NCT02611752|515634723|FG001|Overall Study|Adverse Event|1|||
143025840|NCT02843074|515634726|FG000|Overall Study|Withdrawal by Subject|5|||
143025841|NCT02843074|515634726|FG000|Overall Study|Progressive disease|1|||
143025842|NCT02843074|515634726|FG000|Overall Study|Physician Decision|1|||
143025843|NCT02843074|515634726|FG000|Overall Study|Lost to Follow-up|1|||
143025844|NCT02843074|515634726|FG000|Overall Study|Death|9|||
143025845|NCT03521999|515634727|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
143025846|NCT03521999|515634728|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
143025847|NCT03521999|515634727|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
143025848|NCT03521999|515634728|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
143025849|NCT03521999|515634727|FG000|Completed 3 Month Follow up|Death|0|||
143025850|NCT03521999|515634728|FG001|Completed 3 Month Follow up|Death|1|||
143490737|NCT02600494|517338385|FG001|Part A (6 Week Double-Blind Treatment)|Protocol Violation|10|||
143490738|NCT02600494|517338386|FG002|Part A (6 Week Double-Blind Treatment)|Protocol Violation|14|||
143490739|NCT02600494|517338384|FG000|Part A (6 Week Double-Blind Treatment)|Physician Decision|2|||
143490740|NCT02600494|517338385|FG001|Part A (6 Week Double-Blind Treatment)|Physician Decision|3|||
143025851|NCT03521999|515634727|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
143025852|NCT03521999|515634728|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
143025853|NCT01564758|515634729|FG000|Overall Study|Death|8|||
143025854|NCT01564758|515634729|FG000|Overall Study|Adverse Event|3|||
143025855|NCT01564758|515634729|FG000|Overall Study|Other|3|||
143025856|NCT01211769|515634730|FG000|Overall Study|Lost to Follow-up|7|||
143025857|NCT01211769|515634731|FG001|Overall Study|Lost to Follow-up|9|||
143025858|NCT01211769|515634732|FG002|Overall Study|Lost to Follow-up|5|||
143025859|NCT01211769|515634733|FG003|Overall Study|Lost to Follow-up|9|||
143025860|NCT01211769|515634730|FG000|Overall Study|Physician Decision|2|||
143025861|NCT01211769|515634731|FG001|Overall Study|Physician Decision|0|||
143025862|NCT01211769|515634732|FG002|Overall Study|Physician Decision|2|||
143025863|NCT01211769|515634733|FG003|Overall Study|Physician Decision|1|||
143025864|NCT01211769|515634730|FG000|Overall Study|Adverse Event|0|||
143025865|NCT01211769|515634731|FG001|Overall Study|Adverse Event|1|||
143025866|NCT01211769|515634732|FG002|Overall Study|Adverse Event|1|||
143025867|NCT01211769|515634733|FG003|Overall Study|Adverse Event|1|||
143025868|NCT01348542|515634734|FG000|Overall Study|Withdrawal by Subject|3|||
143025869|NCT01348542|515634735|FG001|Overall Study|Withdrawal by Subject|0|||
143025870|NCT00753714|515634739|FG000|Overall Study|Lack of Efficacy|21|||
143025871|NCT00753714|515634740|FG001|Overall Study|Lack of Efficacy|34|||
143025872|NCT00753714|515634739|FG000|Overall Study|Adverse Event|26|||
143025873|NCT00753714|515634740|FG001|Overall Study|Adverse Event|18|||
143025874|NCT00753714|515634739|FG000|Overall Study|Protocol Violation|1|||
143025875|NCT00753714|515634740|FG001|Overall Study|Protocol Violation|0|||
143025876|NCT00753714|515634739|FG000|Overall Study|Lost to Follow-up|0|||
143025877|NCT00753714|515634740|FG001|Overall Study|Lost to Follow-up|1|||
143025878|NCT00753714|515634739|FG000|Overall Study|Withdrawal by Subject|2|||
143025879|NCT00753714|515634740|FG001|Overall Study|Withdrawal by Subject|1|||
143025880|NCT00753714|515634739|FG000|Overall Study|Death|3|||
143025881|NCT00753714|515634740|FG001|Overall Study|Death|3|||
143025882|NCT00753714|515634739|FG000|Overall Study|Other|7|||
143025883|NCT00753714|515634740|FG001|Overall Study|Other|5|||
143025884|NCT02277769|515634742|FG000|Overall Study|Protocol Violation|3|||
143025885|NCT02277769|515634743|FG001|Overall Study|Protocol Violation|3|||
143025886|NCT02277769|515634744|FG002|Overall Study|Protocol Violation|5|||
143025887|NCT02277769|515634742|FG000|Overall Study|Lack of Efficacy|17|||
143025888|NCT02277769|515634743|FG001|Overall Study|Lack of Efficacy|0|||
143025889|NCT02277769|515634744|FG002|Overall Study|Lack of Efficacy|4|||
143025890|NCT02277769|515634742|FG000|Overall Study|Adverse Event|14|||
143025891|NCT02277769|515634743|FG001|Overall Study|Adverse Event|2|||
143025892|NCT02277769|515634744|FG002|Overall Study|Adverse Event|4|||
143025893|NCT02277769|515634742|FG000|Overall Study|Other than specified above|12|||
143025894|NCT02277769|515634743|FG001|Overall Study|Other than specified above|8|||
143025895|NCT02277769|515634744|FG002|Overall Study|Other than specified above|5|||
143025896|NCT01754259|515634747|FG000|Overall Study|Withdrawal by Subject|2|||
143025897|NCT01754259|515634748|FG001|Overall Study|Withdrawal by Subject|4|||
143025898|NCT01754259|515634747|FG000|Overall Study|Adverse Event|3|||
143025899|NCT01754259|515634748|FG001|Overall Study|Adverse Event|1|||
143025900|NCT01754259|515634747|FG000|Overall Study|Lost to Follow-up|0|||
143025901|NCT01754259|515634748|FG001|Overall Study|Lost to Follow-up|1|||
143025902|NCT01626885|515634755|FG000|Overall Study|Adverse Event|8|||
143025903|NCT01626885|515634755|FG000|Overall Study|Withdrawal by Subject|4|||
143025904|NCT01533428|515634758|FG000|Overall Study|Adverse Event|0|||
143025905|NCT01533428|515634759|FG001|Overall Study|Adverse Event|1|||
143025906|NCT01533428|515634758|FG000|Overall Study|Lost to Follow-up|2|||
143025907|NCT01533428|515634759|FG001|Overall Study|Lost to Follow-up|1|||
143025908|NCT01533428|515634758|FG000|Overall Study|Withdrawal by Subject|7|||
143025909|NCT01533428|515634759|FG001|Overall Study|Withdrawal by Subject|6|||
143025910|NCT04535583|515634764|FG000|Overall Study|Lost to Follow-up|1|||
143025911|NCT04535583|515634764|FG000|Overall Study|Physician Decision|1|||
143025912|NCT04535583|515634764|FG000|Overall Study|Withdrawal by Subject|1|||
143025913|NCT01748890|515634765|FG000|Overall Study|Insufficient recruitment for analysis|4|||
143025914|NCT00526890|515634766|FG000|Overall Study|Adverse Event|2|||
143236922|NCT01550003|516421509|FG001|Overall Study|Discontinuation|1|||
143236923|NCT01550003|516421510|FG002|Overall Study|Discontinuation|0|||
143236924|NCT01550003|516421508|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
143236925|NCT01550003|516421509|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
143236926|NCT01550003|516421510|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
143236927|NCT01550003|516421508|FG000|Overall Study|Site closure|0|||
143236928|NCT01550003|516421509|FG001|Overall Study|Site closure|2|||
143236929|NCT01550003|516421510|FG002|Overall Study|Site closure|0|||
143236930|NCT01550003|516421508|FG000|Overall Study|Pregnancy|0|||
143236931|NCT01550003|516421509|FG001|Overall Study|Pregnancy|1|||
143236932|NCT01550003|516421510|FG002|Overall Study|Pregnancy|0|||
143363864|NCT00049517|516875454|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
143490741|NCT02600494|517338386|FG002|Part A (6 Week Double-Blind Treatment)|Physician Decision|4|||
143025915|NCT03035227|515634767|FG000|Overall Study|study stopped due to PI leaving institut|1|||
143025916|NCT03035227|515634768|FG001|Overall Study|study stopped due to PI leaving institut|1|||
143025917|NCT00859469|515634770|FG000|Overall Study|Adverse Event|2|||
143025918|NCT00859469|515634770|FG000|Overall Study|Lack of Efficacy|9|||
143025919|NCT00859469|515634770|FG000|Overall Study|Withdrawal by Subject|1|||
143025920|NCT00859469|515634770|FG000|Overall Study|Death|16|||
143025921|NCT04345471|515634775|FG000|Overall Study|Adverse Event|8|||
143025922|NCT04345471|515634776|FG001|Overall Study|Adverse Event|5|||
143025923|NCT04345471|515634777|FG002|Overall Study|Adverse Event|6|||
143025924|NCT04345471|515634775|FG000|Overall Study|Lack of Efficacy|1|||
143025925|NCT04345471|515634776|FG001|Overall Study|Lack of Efficacy|1|||
143236933|NCT01550003|516421508|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
143025926|NCT04345471|515634777|FG002|Overall Study|Lack of Efficacy|0|||
143025927|NCT04345471|515634775|FG000|Overall Study|Protocol Violation|0|||
143025928|NCT04345471|515634776|FG001|Overall Study|Protocol Violation|1|||
143025929|NCT04345471|515634777|FG002|Overall Study|Protocol Violation|2|||
143025930|NCT04345471|515634775|FG000|Overall Study|Withdrawal by Subject|10|||
143025931|NCT04345471|515634776|FG001|Overall Study|Withdrawal by Subject|5|||
143025932|NCT04345471|515634777|FG002|Overall Study|Withdrawal by Subject|10|||
143025933|NCT03083132|515634780|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
143025934|NCT03083132|515634781|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
143025935|NCT03083132|515634780|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
143025936|NCT03083132|515634781|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
143025937|NCT03083132|515634780|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
143025938|NCT03083132|515634781|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
143025939|NCT03118739|515634782|FG000|Overall Study|Physician Decision|0|||
143025940|NCT03118739|515634783|FG001|Overall Study|Physician Decision|1|||
143025941|NCT03118739|515634782|FG000|Overall Study|Withdrawal by Subject|5|||
143025942|NCT03118739|515634783|FG001|Overall Study|Withdrawal by Subject|3|||
143025943|NCT03118739|515634782|FG000|Overall Study|Lost to Follow-up|2|||
143025944|NCT03118739|515634783|FG001|Overall Study|Lost to Follow-up|0|||
143025945|NCT00669955|515634784|FG000|Overall Study|Adverse Event|3|||
143025946|NCT00669955|515634785|FG001|Overall Study|Adverse Event|5|||
143025947|NCT00669955|515634784|FG000|Overall Study|Death|0|||
143025948|NCT00669955|515634785|FG001|Overall Study|Death|1|||
143025949|NCT00669955|515634784|FG000|Overall Study|Withdrawal by Subject|2|||
143025950|NCT00669955|515634785|FG001|Overall Study|Withdrawal by Subject|3|||
143025951|NCT00669955|515634784|FG000|Overall Study|Lost to Follow-up|5|||
143025952|NCT00669955|515634785|FG001|Overall Study|Lost to Follow-up|7|||
143025953|NCT00669955|515634784|FG000|Overall Study|Protocol Violation|2|||
143025954|NCT00669955|515634785|FG001|Overall Study|Protocol Violation|7|||
143025955|NCT00669955|515634784|FG000|Overall Study|Investigator Sponsor Judgement|0|||
143025956|NCT00669955|515634785|FG001|Overall Study|Investigator Sponsor Judgement|1|||
143025957|NCT00669955|515634784|FG000|Overall Study|not compliant with study drug/visit|2|||
143025958|NCT00669955|515634785|FG001|Overall Study|not compliant with study drug/visit|3|||
143025959|NCT05188521|515636873|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
143025960|NCT05188521|515636874|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
143025961|NCT00458302|515636875|FG000|Overall Study|Adverse Event|4|||
143025962|NCT00458302|515636876|FG001|Overall Study|Adverse Event|14|||
143025963|NCT00458302|515636875|FG000|Overall Study|Pregnancy|2|||
143025964|NCT00458302|515636876|FG001|Overall Study|Pregnancy|1|||
143025965|NCT00458302|515636875|FG000|Overall Study|Protocol Violation|0|||
143025966|NCT00458302|515636876|FG001|Overall Study|Protocol Violation|2|||
143025967|NCT00458302|515636875|FG000|Overall Study|Withdrawal by Subject|6|||
143025968|NCT00458302|515636876|FG001|Overall Study|Withdrawal by Subject|4|||
143025969|NCT00458302|515636875|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
143025970|NCT00458302|515636876|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
143025971|NCT00458302|515636875|FG000|Overall Study|Study Termination By Sponsor|1|||
143025972|NCT00458302|515636876|FG001|Overall Study|Study Termination By Sponsor|0|||
143025973|NCT00458302|515636875|FG000|Overall Study|Lost to Follow-up|2|||
143025974|NCT00458302|515636876|FG001|Overall Study|Lost to Follow-up|0|||
143025975|NCT00458302|515636875|FG000|Overall Study|Other|4|||
143025976|NCT00458302|515636876|FG001|Overall Study|Other|2|||
143025977|NCT01379781|515636880|FG000|Overall Study|Lost to Follow-up|11|||
143025978|NCT01379781|515636881|FG001|Overall Study|Lost to Follow-up|8|||
143025979|NCT01060670|515636882|FG000|Run In|screen failure|0|||
143025980|NCT01060670|515636883|FG001|Run In|screen failure|238|||
143025981|NCT00056160|515636889|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
143025982|NCT00056160|515636890|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
143025983|NCT00056160|515636889|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
143025984|NCT00056160|515636890|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
143025985|NCT00056160|515636889|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
143025986|NCT00056160|515636890|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
143025987|NCT00056160|515636889|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
143025988|NCT00056160|515636890|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
143025989|NCT00056160|515636889|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
143025990|NCT00056160|515636890|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
143025991|NCT00056160|515636889|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
143025992|NCT00056160|515636890|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
143025993|NCT00056160|515636889|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
143025994|NCT00056160|515636890|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
143025995|NCT00056160|515636889|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
143025996|NCT00056160|515636890|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
143025997|NCT00056160|515636889|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
143025998|NCT00056160|515636890|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
143025999|NCT00056160|515636889|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
143026000|NCT00056160|515636890|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
143026001|NCT00056160|515636889|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
143026002|NCT00056160|515636890|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
143026003|NCT00056160|515636889|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
143026004|NCT00056160|515636890|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
143026005|NCT00056160|515636889|FG000|Final Follow-up|Transferred into expanded access study.|3|||
143026006|NCT00056160|515636890|FG001|Final Follow-up|Transferred into expanded access study.|0|||
143026007|NCT00056160|515636889|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
143026008|NCT00056160|515636890|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
143026009|NCT00056160|515636889|FG000|Final Follow-up|Adverse Event|1|||
143026010|NCT00056160|515636890|FG001|Final Follow-up|Adverse Event|0|||
143026011|NCT01628120|515636892|FG000|Overall Study|Withdrawal by Subject|7|||
143026012|NCT01628120|515636892|FG000|Overall Study|Adverse Event|12|||
143026013|NCT01628120|515636892|FG000|Overall Study|Lost to Follow-up|1|||
143026014|NCT01628120|515636892|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
143026015|NCT01628120|515636892|FG000|Overall Study|Non-compliant with Study Procedures|1|||
143026016|NCT01628120|515636892|FG000|Overall Study|Not Treated|3|||
143026017|NCT01628120|515636892|FG000|Overall Study|Sponsor Decision|5|||
143026018|NCT01628120|515636892|FG000|Overall Study|Switched Dialysis Method|2|||
143026019|NCT01628120|515636892|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
143026020|NCT01628120|515636892|FG000|Overall Study|Moved or Relocated|5|||
143026021|NCT01628120|515636892|FG000|Overall Study|Kidney Transplant|2|||
143026022|NCT01628120|515636892|FG000|Overall Study|Use of Standard of Care|1|||
143026023|NCT00704418|515636893|FG000|Overall Study|Withdrawal by Subject|2|||
143026024|NCT00704418|515636894|FG001|Overall Study|Withdrawal by Subject|0|||
143026025|NCT00704418|515636893|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
143026026|NCT00704418|515636894|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
143026027|NCT01579474|515636895|FG000|Overall Study|Adverse Event|1|||
143026028|NCT01579474|515636896|FG001|Overall Study|Adverse Event|13|||
143026029|NCT01579474|515636897|FG002|Overall Study|Adverse Event|2|||
143026030|NCT01579474|515636898|FG003|Overall Study|Adverse Event|0|||
143026031|NCT01579474|515636899|FG004|Overall Study|Adverse Event|0|||
143026032|NCT01579474|515636900|FG005|Overall Study|Adverse Event|1|||
143026033|NCT01579474|515636895|FG000|Overall Study|Lack of Efficacy|1|||
143026034|NCT01579474|515636896|FG001|Overall Study|Lack of Efficacy|0|||
143026035|NCT01579474|515636897|FG002|Overall Study|Lack of Efficacy|0|||
143026036|NCT01579474|515636898|FG003|Overall Study|Lack of Efficacy|0|||
143026037|NCT01579474|515636899|FG004|Overall Study|Lack of Efficacy|1|||
143026038|NCT01579474|515636900|FG005|Overall Study|Lack of Efficacy|0|||
143026039|NCT01579474|515636895|FG000|Overall Study|Withdrawal by Subject|1|||
143026040|NCT01579474|515636896|FG001|Overall Study|Withdrawal by Subject|0|||
143026041|NCT01579474|515636897|FG002|Overall Study|Withdrawal by Subject|0|||
143026042|NCT01579474|515636898|FG003|Overall Study|Withdrawal by Subject|0|||
143026043|NCT01579474|515636899|FG004|Overall Study|Withdrawal by Subject|0|||
143026044|NCT01579474|515636900|FG005|Overall Study|Withdrawal by Subject|0|||
143026045|NCT04161144|515636901|FG000|Overall Study|Withdrawal by Subject|0|||
143026046|NCT04161144|515636902|FG001|Overall Study|Withdrawal by Subject|1|||
143026047|NCT04161144|515636901|FG000|Overall Study|Protocol Violation|1|||
143026048|NCT04161144|515636902|FG001|Overall Study|Protocol Violation|0|||
143026049|NCT00449072|515636904|FG000|Overall Study|Adverse Event|3|||
143026050|NCT00449072|515636905|FG001|Overall Study|Adverse Event|1|||
143026051|NCT00449072|515636904|FG000|Overall Study|Protocol Violation|14|||
143026052|NCT00449072|515636905|FG001|Overall Study|Protocol Violation|12|||
143490742|NCT02600494|517338384|FG000|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|15|||
143490743|NCT02600494|517338385|FG001|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|11|||
143490744|NCT02600494|517338386|FG002|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|14|||
143490745|NCT02600494|517338384|FG000|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|12|||
143490746|NCT02600494|517338385|FG001|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|28|||
143490747|NCT02600494|517338386|FG002|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|10|||
143490748|NCT02600494|517338384|FG000|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
143026053|NCT00449072|515636904|FG000|Overall Study|Lost to Follow-up|5|||
143026054|NCT00449072|515636905|FG001|Overall Study|Lost to Follow-up|7|||
143026055|NCT00449072|515636904|FG000|Overall Study|Withdrawal by Subject|11|||
143026056|NCT00449072|515636905|FG001|Overall Study|Withdrawal by Subject|8|||
143026057|NCT00449072|515636904|FG000|Overall Study|Lack of Efficacy|1|||
143026058|NCT00449072|515636905|FG001|Overall Study|Lack of Efficacy|1|||
143026059|NCT00449072|515636904|FG000|Overall Study|Physician Decision|1|||
143026060|NCT00449072|515636905|FG001|Overall Study|Physician Decision|0|||
143026061|NCT00449072|515636904|FG000|Overall Study|Not treated|0|||
143026062|NCT00449072|515636905|FG001|Overall Study|Not treated|1|||
143026063|NCT00449072|515636904|FG000|Overall Study|Excluded medication|0|||
143026064|NCT00449072|515636905|FG001|Overall Study|Excluded medication|2|||
143026065|NCT00449072|515636904|FG000|Overall Study|Non-compliance|2|||
143026066|NCT00449072|515636905|FG001|Overall Study|Non-compliance|5|||
143026067|NCT00449072|515636904|FG000|Overall Study|Sponsor decision|1|||
143026068|NCT00449072|515636905|FG001|Overall Study|Sponsor decision|3|||
143026069|NCT00449072|515636904|FG000|Overall Study|Relocation|3|||
143026070|NCT00449072|515636905|FG001|Overall Study|Relocation|2|||
143026071|NCT00421174|515636908|FG000|Overall Study|Withdrawal by Subject|0|||
143026072|NCT00421174|515636909|FG001|Overall Study|Withdrawal by Subject|1|||
143026073|NCT00421174|515636908|FG000|Overall Study|Ineligible due to infection|2|||
143026074|NCT00421174|515636909|FG001|Overall Study|Ineligible due to infection|0|||
143026075|NCT02173704|515636910|FG000|Overall Study|Adverse Event|1|||
143026076|NCT02173704|515636911|FG001|Overall Study|Adverse Event|0|||
143026077|NCT02173704|515636910|FG000|Overall Study|Lost to Follow-up|1|||
143026078|NCT02173704|515636911|FG001|Overall Study|Lost to Follow-up|0|||
143026079|NCT02173704|515636910|FG000|Overall Study|Other|1|||
143026080|NCT02173704|515636911|FG001|Overall Study|Other|0|||
143026081|NCT02173704|515636910|FG000|Overall Study|Protocol Violation|1|||
143026082|NCT02173704|515636911|FG001|Overall Study|Protocol Violation|0|||
143026083|NCT02173704|515636910|FG000|Overall Study|Withdrawal by Subject|9|||
143026084|NCT02173704|515636911|FG001|Overall Study|Withdrawal by Subject|4|||
143026085|NCT00419926|515636912|FG000|Overall Study|Withdrawal by Subject|7|||
143026086|NCT00419926|515636913|FG001|Overall Study|Withdrawal by Subject|3|||
143026087|NCT00419926|515636912|FG000|Overall Study|Administrative Problem|4|||
143026088|NCT00419926|515636913|FG001|Overall Study|Administrative Problem|4|||
143026089|NCT00419926|515636912|FG000|Overall Study|Lost to Follow-up|1|||
143026090|NCT00419926|515636913|FG001|Overall Study|Lost to Follow-up|2|||
143026091|NCT00419926|515636912|FG000|Overall Study|Death|2|||
143026092|NCT00419926|515636913|FG001|Overall Study|Death|1|||
143026093|NCT04041570|515636918|FG000|Overall Study|Moved from Area|0|||
143026094|NCT04041570|515636919|FG001|Overall Study|Moved from Area|2|||
143026095|NCT01338636|515636920|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
143026096|NCT03532009|515636923|FG000|Overall Study|Other|1|||
143026097|NCT03532009|515636924|FG001|Overall Study|Other|1|||
143026098|NCT03532009|515636923|FG000|Overall Study|Death|1|||
143026099|NCT03532009|515636924|FG001|Overall Study|Death|1|||
143026100|NCT03532009|515636923|FG000|Overall Study|Withdrawal by Patient|0|||
143026101|NCT03532009|515636924|FG001|Overall Study|Withdrawal by Patient|2|||
143026102|NCT00681863|515636929|FG000|Overall Study|Adverse Event|1|||
143026103|NCT00681863|515636929|FG000|Overall Study|Lost to Follow-up|2|||
143026104|NCT00681863|515636929|FG000|Overall Study|Lack of Efficacy|2|||
143026105|NCT00681863|515636929|FG000|Overall Study|Other|18|||
143026106|NCT00384033|515636939|FG000|Overall Study|Adverse Event|10|||
143026107|NCT00384033|515636940|FG001|Overall Study|Adverse Event|8|||
143026108|NCT00384033|515636941|FG002|Overall Study|Adverse Event|11|||
143026109|NCT00384033|515636942|FG003|Overall Study|Adverse Event|20|||
143026110|NCT00384033|515636939|FG000|Overall Study|Failed to return|1|||
143026111|NCT00384033|515636940|FG001|Overall Study|Failed to return|3|||
143026112|NCT00384033|515636941|FG002|Overall Study|Failed to return|2|||
143026113|NCT00384033|515636942|FG003|Overall Study|Failed to return|2|||
143026114|NCT00384033|515636939|FG000|Overall Study|Physician Decision|1|||
143026115|NCT00384033|515636940|FG001|Overall Study|Physician Decision|0|||
143026116|NCT00384033|515636941|FG002|Overall Study|Physician Decision|0|||
143026117|NCT00384033|515636942|FG003|Overall Study|Physician Decision|0|||
143490749|NCT02600494|517338385|FG001|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|1|||
143490750|NCT02600494|517338386|FG002|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
143490751|NCT02600494|517338384|FG000|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
143490752|NCT02600494|517338385|FG001|Part B (6 Month Open-Label Treatment)|Adverse Event|12|||
143490753|NCT02600494|517338386|FG002|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
143490754|NCT02600494|517338384|FG000|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
143026118|NCT00384033|515636939|FG000|Overall Study|Lost to Follow-up|6|||
143026119|NCT00384033|515636940|FG001|Overall Study|Lost to Follow-up|12|||
143026120|NCT00384033|515636941|FG002|Overall Study|Lost to Follow-up|7|||
143026121|NCT00384033|515636942|FG003|Overall Study|Lost to Follow-up|7|||
143026122|NCT00384033|515636939|FG000|Overall Study|Other|2|||
143026123|NCT00384033|515636940|FG001|Overall Study|Other|0|||
143026124|NCT00384033|515636941|FG002|Overall Study|Other|0|||
143026125|NCT00384033|515636942|FG003|Overall Study|Other|0|||
143026126|NCT00384033|515636939|FG000|Overall Study|Protocol Violation|5|||
143026127|NCT00384033|515636940|FG001|Overall Study|Protocol Violation|0|||
143026128|NCT00384033|515636941|FG002|Overall Study|Protocol Violation|5|||
143490755|NCT02600494|517338385|FG001|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|4|||
143026129|NCT00384033|515636942|FG003|Overall Study|Protocol Violation|6|||
143026130|NCT00384033|515636939|FG000|Overall Study|Withdrawal by Subject|6|||
143026131|NCT00384033|515636940|FG001|Overall Study|Withdrawal by Subject|2|||
143026132|NCT00384033|515636941|FG002|Overall Study|Withdrawal by Subject|5|||
143026133|NCT00384033|515636942|FG003|Overall Study|Withdrawal by Subject|2|||
143026134|NCT00384033|515636939|FG000|Overall Study|Lack of Efficacy|7|||
143026135|NCT00384033|515636940|FG001|Overall Study|Lack of Efficacy|3|||
143026136|NCT00384033|515636941|FG002|Overall Study|Lack of Efficacy|3|||
143026137|NCT00384033|515636942|FG003|Overall Study|Lack of Efficacy|1|||
143026138|NCT00384033|515636939|FG000|Overall Study|Randomized but not treated|3|||
143026139|NCT00384033|515636940|FG001|Overall Study|Randomized but not treated|7|||
143026140|NCT00384033|515636941|FG002|Overall Study|Randomized but not treated|10|||
143026141|NCT00384033|515636942|FG003|Overall Study|Randomized but not treated|2|||
143026142|NCT02737306|515636944|FG000|Overall Study|Adverse Event|3|||
143026143|NCT02737306|515636945|FG001|Overall Study|Adverse Event|0|||
143490756|NCT02600494|517338386|FG002|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
143490757|NCT02600494|517338384|FG000|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
143490758|NCT02600494|517338385|FG001|Part B (6 Month Open-Label Treatment)|Protocol Violation|8|||
143490759|NCT02600494|517338386|FG002|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
143490760|NCT02600494|517338384|FG000|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
143490761|NCT02600494|517338385|FG001|Part B (6 Month Open-Label Treatment)|Physician Decision|1|||
143490762|NCT02600494|517338386|FG002|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
143490763|NCT02600494|517338384|FG000|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
143490764|NCT02600494|517338385|FG001|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|17|||
143490765|NCT02600494|517338386|FG002|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
143490766|NCT02600494|517338384|FG000|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
143026144|NCT02737306|515636944|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
143026145|NCT02737306|515636945|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
143026146|NCT01336894|515636946|FG000|Follow-up|Study terminated prematurely|2|||
143026147|NCT01336894|515636947|FG001|Follow-up|Study terminated prematurely|7|||
143026148|NCT02540356|515636948|FG000|Overall Study|Terminated due to disease progression|1|||
143026149|NCT02540356|515636949|FG001|Overall Study|Terminated due to disease progression|0|||
143026150|NCT03335371|515636950|FG000|Overall Study|Lost to Follow-up|0|||
143026151|NCT03335371|515636951|FG001|Overall Study|Lost to Follow-up|0|||
143026152|NCT03335371|515636952|FG002|Overall Study|Lost to Follow-up|0|||
143026153|NCT03335371|515636953|FG003|Overall Study|Lost to Follow-up|0|||
143026154|NCT03335371|515636954|FG004|Overall Study|Lost to Follow-up|1|||
143026155|NCT03335371|515636950|FG000|Overall Study|Withdrawal by Subject|0|||
143026156|NCT03335371|515636951|FG001|Overall Study|Withdrawal by Subject|0|||
143026157|NCT03335371|515636952|FG002|Overall Study|Withdrawal by Subject|0|||
143026158|NCT03335371|515636953|FG003|Overall Study|Withdrawal by Subject|0|||
143026159|NCT03335371|515636954|FG004|Overall Study|Withdrawal by Subject|1|||
143026160|NCT03335371|515636950|FG000|Overall Study|Randomization Error|0|||
143026161|NCT03335371|515636951|FG001|Overall Study|Randomization Error|0|||
143026162|NCT03335371|515636952|FG002|Overall Study|Randomization Error|1|||
143026163|NCT03335371|515636953|FG003|Overall Study|Randomization Error|0|||
143026164|NCT03335371|515636954|FG004|Overall Study|Randomization Error|0|||
143026165|NCT00684671|515636955|FG000|Overall Study|Adverse Event|1|||
143026166|NCT00684671|515636956|FG001|Overall Study|Adverse Event|0|||
143026167|NCT00684671|515636957|FG002|Overall Study|Adverse Event|0|||
143026168|NCT00684671|515636955|FG000|Overall Study|Lost to Follow-up|1|||
143026169|NCT00684671|515636956|FG001|Overall Study|Lost to Follow-up|0|||
143026170|NCT00684671|515636957|FG002|Overall Study|Lost to Follow-up|0|||
143026171|NCT00684671|515636955|FG000|Overall Study|Alcoholic dependance|1|||
143026172|NCT00684671|515636956|FG001|Overall Study|Alcoholic dependance|0|||
143026173|NCT00684671|515636957|FG002|Overall Study|Alcoholic dependance|0|||
143026174|NCT01725451|515636958|FG000|Period 1|Withdrawal by Subject|1|||
143026175|NCT01725451|515636959|FG001|Period 1|Withdrawal by Subject|0|||
143026176|NCT01725451|515636960|FG002|Period 1|Withdrawal by Subject|0|||
143026177|NCT01725451|515636961|FG003|Period 1|Withdrawal by Subject|0|||
143026178|NCT01725451|515636958|FG000|Washout From Period 3|Protocol Violation|0|||
143026179|NCT01725451|515636959|FG001|Washout From Period 3|Protocol Violation|0|||
143026180|NCT01725451|515636960|FG002|Washout From Period 3|Protocol Violation|1|||
143026181|NCT01725451|515636961|FG003|Washout From Period 3|Protocol Violation|0|||
143026182|NCT01725451|515636958|FG000|Washout From Period 3|Adverse Event|0|||
143026183|NCT01725451|515636959|FG001|Washout From Period 3|Adverse Event|1|||
143026184|NCT01725451|515636960|FG002|Washout From Period 3|Adverse Event|0|||
143158005|NCT00567112|516124372|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
143158006|NCT02362412|516124373|FG000|Treatment Period III|Lost to Follow-up|0|||
143490767|NCT02600494|517338385|FG001|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|11|||
143490768|NCT02600494|517338386|FG002|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
143026185|NCT01725451|515636961|FG003|Washout From Period 3|Adverse Event|0|||
143026186|NCT01725451|515636958|FG000|Period 4|Adverse Event|0|||
143158007|NCT02362412|516124374|FG001|Treatment Period III|Lost to Follow-up|1|||
143158008|NCT03467945|516124375|FG000|Treatment Period 2|Withdrawal by Subject|0|||
143158009|NCT03467945|516124376|FG001|Treatment Period 2|Withdrawal by Subject|1|||
143026187|NCT01725451|515636959|FG001|Period 4|Adverse Event|0|||
143026188|NCT01725451|515636960|FG002|Period 4|Adverse Event|1|||
143026189|NCT01725451|515636961|FG003|Period 4|Adverse Event|0|||
143026190|NCT00283686|515636967|FG000|Overall Study|Death|1|||
143026191|NCT00283686|515636968|FG001|Overall Study|Death|1|||
143026192|NCT00283686|515636969|FG002|Overall Study|Death|1|||
143026193|NCT00283686|515636970|FG003|Overall Study|Death|0|||
143026194|NCT00283686|515636967|FG000|Overall Study|Lost to Follow-up|21|||
143026195|NCT00283686|515636968|FG001|Overall Study|Lost to Follow-up|31|||
143026196|NCT00283686|515636969|FG002|Overall Study|Lost to Follow-up|26|||
143026197|NCT00283686|515636970|FG003|Overall Study|Lost to Follow-up|20|||
143026198|NCT00283686|515636967|FG000|Overall Study|Less than full participation|7|||
143026199|NCT00283686|515636968|FG001|Overall Study|Less than full participation|9|||
143026200|NCT00283686|515636969|FG002|Overall Study|Less than full participation|6|||
143026201|NCT00283686|515636970|FG003|Overall Study|Less than full participation|12|||
143026202|NCT01076166|515636971|FG000|Overall Study|Adverse Event|3|||
143026203|NCT01076166|515636971|FG000|Overall Study|Symptoms improved/resolved|6|||
143026204|NCT00481247|515636972|FG000|Overall Study|Death|0|||
143026205|NCT00481247|515636973|FG001|Overall Study|Death|1|||
143026206|NCT00481247|515636972|FG000|Overall Study|Disease progression|18|||
143026207|NCT00481247|515636973|FG001|Overall Study|Disease progression|22|||
143026208|NCT00481247|515636972|FG000|Overall Study|Intolerance|42|||
143026209|NCT00481247|515636973|FG001|Overall Study|Intolerance|17|||
143026210|NCT00481247|515636972|FG000|Overall Study|Treatment failure|10|||
143026211|NCT00481247|515636973|FG001|Overall Study|Treatment failure|14|||
143026212|NCT00481247|515636972|FG000|Overall Study|AE unrelated to study drug|13|||
143026213|NCT00481247|515636973|FG001|Overall Study|AE unrelated to study drug|4|||
143026214|NCT00481247|515636972|FG000|Overall Study|Withdrawal by Subject|8|||
143026215|NCT00481247|515636973|FG001|Overall Study|Withdrawal by Subject|13|||
143026216|NCT00481247|515636972|FG000|Overall Study|Pregnancy|2|||
143026217|NCT00481247|515636973|FG001|Overall Study|Pregnancy|1|||
143026218|NCT00481247|515636972|FG000|Overall Study|Lost to Follow-up|1|||
143026219|NCT00481247|515636973|FG001|Overall Study|Lost to Follow-up|2|||
143026220|NCT00481247|515636972|FG000|Overall Study|Poor compliance/noncompliance|1|||
143026221|NCT00481247|515636973|FG001|Overall Study|Poor compliance/noncompliance|7|||
143026222|NCT00481247|515636972|FG000|Overall Study|Administrative reason by sponsor|157|||
143026223|NCT00481247|515636973|FG001|Overall Study|Administrative reason by sponsor|162|||
143026224|NCT00481247|515636972|FG000|Overall Study|Varied|6|||
143026225|NCT00481247|515636973|FG001|Overall Study|Varied|15|||
143026226|NCT00481247|515636972|FG000|Overall Study|Did not receive treatment|1|||
143026227|NCT00481247|515636973|FG001|Overall Study|Did not receive treatment|2|||
143026228|NCT00638157|515636976|FG000|Overall Study|Adverse Event|0|||
143026229|NCT00638157|515636977|FG001|Overall Study|Adverse Event|1|||
143026230|NCT00638157|515636976|FG000|Overall Study|Clinical (symptomatic) failure|1|||
143026231|NCT00638157|515636977|FG001|Overall Study|Clinical (symptomatic) failure|1|||
143026232|NCT00638157|515636976|FG000|Overall Study|Microbiological failure|1|||
143026233|NCT00638157|515636977|FG001|Overall Study|Microbiological failure|0|||
143026234|NCT00638157|515636976|FG000|Overall Study|Lost to Follow-up|1|||
143026235|NCT00638157|515636977|FG001|Overall Study|Lost to Follow-up|0|||
143026236|NCT00638157|515636976|FG000|Overall Study|Physician Decision|1|||
143026237|NCT00638157|515636977|FG001|Overall Study|Physician Decision|0|||
143026238|NCT00638157|515636976|FG000|Overall Study|Other|1|||
143026239|NCT00638157|515636977|FG001|Overall Study|Other|2|||
143026240|NCT00638157|515636976|FG000|Overall Study|Randomized, not treated|2|||
143026241|NCT00638157|515636977|FG001|Overall Study|Randomized, not treated|0|||
143026242|NCT02649231|515636978|FG000|Overall Study|Adverse Event|0|||
143026243|NCT02649231|515636979|FG001|Overall Study|Adverse Event|0|||
143026244|NCT02649231|515636980|FG002|Overall Study|Adverse Event|0|||
143026245|NCT02649231|515636981|FG003|Overall Study|Adverse Event|1|||
143026246|NCT02649231|515636978|FG000|Overall Study|Lost to Follow-up|2|||
143026247|NCT02649231|515636979|FG001|Overall Study|Lost to Follow-up|1|||
143026248|NCT02649231|515636980|FG002|Overall Study|Lost to Follow-up|1|||
143026249|NCT02649231|515636981|FG003|Overall Study|Lost to Follow-up|0|||
143026250|NCT02649231|515636978|FG000|Overall Study|Withdrawal by Subject|0|||
143026251|NCT02649231|515636979|FG001|Overall Study|Withdrawal by Subject|1|||
143490769|NCT02028455|517338391|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
143490770|NCT02028455|517338392|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
143490771|NCT02028455|517338393|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
143490772|NCT02028455|517338394|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
143490773|NCT02028455|517338395|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
143490774|NCT02028455|517338396|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
143026252|NCT02649231|515636980|FG002|Overall Study|Withdrawal by Subject|0|||
143026253|NCT02649231|515636981|FG003|Overall Study|Withdrawal by Subject|1|||
143026254|NCT02649231|515636978|FG000|Overall Study|Protocol Violation|2|||
143026255|NCT02649231|515636979|FG001|Overall Study|Protocol Violation|1|||
143026256|NCT02649231|515636980|FG002|Overall Study|Protocol Violation|1|||
143026257|NCT02649231|515636981|FG003|Overall Study|Protocol Violation|0|||
143026258|NCT00437281|515636982|FG000|Overall Study|Adverse Event|0|||
143026259|NCT00437281|515636983|FG001|Overall Study|Adverse Event|0|||
143026260|NCT00437281|515636984|FG002|Overall Study|Adverse Event|0|||
143026261|NCT00437281|515636985|FG003|Overall Study|Adverse Event|1|||
143026262|NCT00437281|515636986|FG004|Overall Study|Adverse Event|0|||
143026263|NCT00437281|515636987|FG005|Overall Study|Adverse Event|1|||
143026264|NCT00437281|515636988|FG006|Overall Study|Adverse Event|0|||
143490775|NCT02028455|517338397|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
143026265|NCT00437281|515636989|FG007|Overall Study|Adverse Event|0|||
143026266|NCT00437281|515636990|FG008|Overall Study|Adverse Event|0|||
143026267|NCT00437281|515636991|FG009|Overall Study|Adverse Event|1|||
143026268|NCT00437281|515636992|FG010|Overall Study|Adverse Event|0|||
143026269|NCT00437281|515636993|FG011|Overall Study|Adverse Event|0|||
143026270|NCT00437281|515636994|FG012|Overall Study|Adverse Event|0|||
143026271|NCT00437281|515636995|FG013|Overall Study|Adverse Event|1|||
143026272|NCT00437281|515636996|FG014|Overall Study|Adverse Event|1|||
143026273|NCT00437281|515636997|FG015|Overall Study|Adverse Event|0|||
143026274|NCT00437281|515636998|FG016|Overall Study|Adverse Event|0|||
143026275|NCT00437281|515636999|FG017|Overall Study|Adverse Event|0|||
143026276|NCT00437281|515637000|FG018|Overall Study|Adverse Event|1|||
143026277|NCT00437281|515637001|FG019|Overall Study|Adverse Event|0|||
143026278|NCT00437281|515636982|FG000|Overall Study|Lost to Follow-up|0|||
143026279|NCT00437281|515636983|FG001|Overall Study|Lost to Follow-up|0|||
143026280|NCT00437281|515636984|FG002|Overall Study|Lost to Follow-up|0|||
143026281|NCT00437281|515636985|FG003|Overall Study|Lost to Follow-up|0|||
143026282|NCT00437281|515636986|FG004|Overall Study|Lost to Follow-up|0|||
143026283|NCT00437281|515636987|FG005|Overall Study|Lost to Follow-up|0|||
143026284|NCT00437281|515636988|FG006|Overall Study|Lost to Follow-up|0|||
143026285|NCT00437281|515636989|FG007|Overall Study|Lost to Follow-up|0|||
143026286|NCT00437281|515636990|FG008|Overall Study|Lost to Follow-up|0|||
143026287|NCT00437281|515636991|FG009|Overall Study|Lost to Follow-up|0|||
143026288|NCT00437281|515636992|FG010|Overall Study|Lost to Follow-up|0|||
143026289|NCT00437281|515636993|FG011|Overall Study|Lost to Follow-up|0|||
143026290|NCT00437281|515636994|FG012|Overall Study|Lost to Follow-up|0|||
143026291|NCT00437281|515636995|FG013|Overall Study|Lost to Follow-up|0|||
143026292|NCT00437281|515636996|FG014|Overall Study|Lost to Follow-up|0|||
143026293|NCT00437281|515636997|FG015|Overall Study|Lost to Follow-up|0|||
143026294|NCT00437281|515636998|FG016|Overall Study|Lost to Follow-up|0|||
143026295|NCT00437281|515636999|FG017|Overall Study|Lost to Follow-up|0|||
143026296|NCT00437281|515637000|FG018|Overall Study|Lost to Follow-up|0|||
143026297|NCT00437281|515637001|FG019|Overall Study|Lost to Follow-up|1|||
143026298|NCT01214330|515637004|FG000|Overall Study|Withdrawal by Subject|2|||
143026299|NCT01214330|515637004|FG000|Overall Study|Withdrawal by Subject|2|||
143026300|NCT03402893|515637005|FG000|Overall Study|Withdrawal by Subject|1|||
143026301|NCT00686036|515637008|FG000|Overall Study|Adverse Event|3|||
143026302|NCT00686036|515637009|FG001|Overall Study|Adverse Event|0|||
143026303|NCT00686036|515637008|FG000|Overall Study|Withdrawal by Subject|3|||
143026304|NCT00686036|515637009|FG001|Overall Study|Withdrawal by Subject|1|||
143026305|NCT00686036|515637008|FG000|Overall Study|Study terminated by AstraZeneca|2|||
143026306|NCT00686036|515637009|FG001|Overall Study|Study terminated by AstraZeneca|1|||
143026307|NCT00686036|515637008|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
143026308|NCT00686036|515637009|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
143026309|NCT00686036|515637008|FG000|Overall Study|Other reasons not identified|0|||
143026310|NCT00686036|515637009|FG001|Overall Study|Other reasons not identified|4|||
143026311|NCT00467584|515637010|FG000|Overall Study|Withdrawal by Subject|4|||
143026312|NCT00467584|515637011|FG001|Overall Study|Withdrawal by Subject|5|||
143026313|NCT00467584|515637012|FG002|Overall Study|Withdrawal by Subject|1|||
143026314|NCT00926289|515637016|FG000|Overall Study|Adverse Event|9|||
143026315|NCT00926289|515637017|FG001|Overall Study|Adverse Event|11|||
143026316|NCT00926289|515637016|FG000|Overall Study|Protocol Violation|8|||
143026317|NCT00926289|515637017|FG001|Overall Study|Protocol Violation|12|||
143026318|NCT00926289|515637016|FG000|Overall Study|Lost to Follow-up|3|||
143026319|NCT00926289|515637017|FG001|Overall Study|Lost to Follow-up|6|||
143026320|NCT00926289|515637016|FG000|Overall Study|Withdrawal by Subject|4|||
143158010|NCT03467945|516124377|FG002|Treatment Period 2|Withdrawal by Subject|0|||
143158011|NCT03467945|516124378|FG003|Treatment Period 2|Withdrawal by Subject|0|||
143158012|NCT03467945|516124375|FG000|Treatment Period 3|Withdrawal by Subject|1|||
143158013|NCT03467945|516124376|FG001|Treatment Period 3|Withdrawal by Subject|0|||
143158014|NCT03467945|516124377|FG002|Treatment Period 3|Withdrawal by Subject|2|||
143158015|NCT03467945|516124378|FG003|Treatment Period 3|Withdrawal by Subject|1|||
143158016|NCT00032487|516124381|FG000|Overall Study|Withdrawal by Subject|67|||
143158017|NCT00032487|516124382|FG001|Overall Study|Withdrawal by Subject|43|||
143158018|NCT00032487|516124381|FG000|Overall Study|Adverse Event|3|||
143026321|NCT00926289|515637017|FG001|Overall Study|Withdrawal by Subject|4|||
143026322|NCT00926289|515637016|FG000|Overall Study|Other|1|||
143026323|NCT00926289|515637017|FG001|Overall Study|Other|3|||
143026324|NCT01202747|515637018|FG000|Overall Study|Withdrawal by Subject|1|||
143026325|NCT01446913|515637019|FG000|Overall Study|Significant illness|1|||
143026326|NCT01446913|515637020|FG001|Overall Study|Significant illness|1|||
143026327|NCT01446913|515637021|FG002|Overall Study|Significant illness|1|||
143026328|NCT01446913|515637019|FG000|Overall Study|Withdrawal by Subject|5|||
143026329|NCT01446913|515637020|FG001|Overall Study|Withdrawal by Subject|3|||
143026330|NCT01446913|515637021|FG002|Overall Study|Withdrawal by Subject|5|||
143158019|NCT00032487|516124382|FG001|Overall Study|Adverse Event|7|||
143158020|NCT00032487|516124381|FG000|Overall Study|Lost to Follow-up|57|||
143026331|NCT01446913|515637019|FG000|Overall Study|Physician Decision|0|||
143026332|NCT01446913|515637020|FG001|Overall Study|Physician Decision|0|||
143026333|NCT01446913|515637021|FG002|Overall Study|Physician Decision|2|||
143026334|NCT01446913|515637019|FG000|Overall Study|Lost to Follow-up|3|||
143026335|NCT01446913|515637020|FG001|Overall Study|Lost to Follow-up|5|||
143026336|NCT01446913|515637021|FG002|Overall Study|Lost to Follow-up|3|||
143026337|NCT02427607|515637022|FG000|Overall Study|Withdrawal by Subject|1|||
143026338|NCT01364870|515637023|FG000|Overall Study|Withdrawal by Subject|13|||
143026339|NCT01364870|515637024|FG001|Overall Study|Withdrawal by Subject|24|||
143026340|NCT01364870|515637025|FG002|Overall Study|Withdrawal by Subject|10|||
143026341|NCT01364870|515637023|FG000|Overall Study|Adverse Event|8|||
143026342|NCT01364870|515637024|FG001|Overall Study|Adverse Event|6|||
143026343|NCT01364870|515637025|FG002|Overall Study|Adverse Event|4|||
143026344|NCT01364870|515637023|FG000|Overall Study|Protocol Violation|1|||
143026345|NCT01364870|515637024|FG001|Overall Study|Protocol Violation|0|||
143026346|NCT01364870|515637025|FG002|Overall Study|Protocol Violation|0|||
143026347|NCT00095199|515637030|FG000|Overall Study|Adverse Event|40|||
143026348|NCT00095199|515637031|FG001|Overall Study|Adverse Event|22|||
143026349|NCT00095199|515637032|FG002|Overall Study|Adverse Event|26|||
143026350|NCT00095199|515637033|FG003|Overall Study|Adverse Event|11|||
143026351|NCT00095199|515637030|FG000|Overall Study|Progressive disease|213|||
143026352|NCT00095199|515637031|FG001|Overall Study|Progressive disease|179|||
143026353|NCT00095199|515637032|FG002|Overall Study|Progressive disease|105|||
143026354|NCT00095199|515637033|FG003|Overall Study|Progressive disease|98|||
143026355|NCT00095199|515637030|FG000|Overall Study|Death|10|||
143026356|NCT00095199|515637031|FG001|Overall Study|Death|6|||
143026357|NCT00095199|515637032|FG002|Overall Study|Death|11|||
143026358|NCT00095199|515637033|FG003|Overall Study|Death|9|||
143026359|NCT00095199|515637030|FG000|Overall Study|Withdrawal by Subject|21|||
143026360|NCT00095199|515637031|FG001|Overall Study|Withdrawal by Subject|16|||
143026361|NCT00095199|515637032|FG002|Overall Study|Withdrawal by Subject|13|||
143026362|NCT00095199|515637033|FG003|Overall Study|Withdrawal by Subject|22|||
143026363|NCT00095199|515637030|FG000|Overall Study|Protocol Violation|4|||
143026364|NCT00095199|515637031|FG001|Overall Study|Protocol Violation|4|||
143026365|NCT00095199|515637032|FG002|Overall Study|Protocol Violation|2|||
143026366|NCT00095199|515637033|FG003|Overall Study|Protocol Violation|0|||
143026367|NCT00095199|515637030|FG000|Overall Study|Liver function test results elevated|0|||
143026368|NCT00095199|515637031|FG001|Overall Study|Liver function test results elevated|0|||
143026369|NCT00095199|515637032|FG002|Overall Study|Liver function test results elevated|1|||
143026370|NCT00095199|515637033|FG003|Overall Study|Liver function test results elevated|1|||
143026371|NCT00095199|515637030|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
143026372|NCT00095199|515637031|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
143026373|NCT00095199|515637032|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
143026374|NCT00095199|515637033|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
143026375|NCT00095199|515637030|FG000|Overall Study|Physician Decision|5|||
143026376|NCT00095199|515637031|FG001|Overall Study|Physician Decision|6|||
143026377|NCT00095199|515637032|FG002|Overall Study|Physician Decision|1|||
143026378|NCT00095199|515637033|FG003|Overall Study|Physician Decision|1|||
143026379|NCT00095199|515637030|FG000|Overall Study|Not eligible|1|||
143490776|NCT02028455|517338398|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
143490777|NCT02028455|517338391|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
143490778|NCT02028455|517338392|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
143490779|NCT02028455|517338393|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
143490780|NCT02028455|517338394|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
143490781|NCT02028455|517338395|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
143490782|NCT02028455|517338396|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
143490783|NCT02028455|517338397|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
143490784|NCT02028455|517338398|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
143490785|NCT02028455|517338391|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
143490786|NCT02028455|517338392|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
143490787|NCT02028455|517338393|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
143490788|NCT02028455|517338394|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
143490789|NCT02028455|517338395|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
143490790|NCT02028455|517338396|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
143490791|NCT02028455|517338397|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
143490792|NCT02028455|517338398|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
143490793|NCT02028455|517338391|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
143026380|NCT00095199|515637031|FG001|Overall Study|Not eligible|7|||
143026381|NCT00095199|515637032|FG002|Overall Study|Not eligible|0|||
143026382|NCT00095199|515637033|FG003|Overall Study|Not eligible|1|||
143026383|NCT00095199|515637030|FG000|Overall Study|Started Palliative Radiotherapy|1|||
143026384|NCT00095199|515637031|FG001|Overall Study|Started Palliative Radiotherapy|0|||
143026385|NCT00095199|515637032|FG002|Overall Study|Started Palliative Radiotherapy|0|||
143026386|NCT00095199|515637033|FG003|Overall Study|Started Palliative Radiotherapy|0|||
143026387|NCT00095199|515637030|FG000|Overall Study|Started radiotherapy regimen|0|||
143026388|NCT00095199|515637031|FG001|Overall Study|Started radiotherapy regimen|1|||
143026389|NCT00095199|515637032|FG002|Overall Study|Started radiotherapy regimen|0|||
143026390|NCT00095199|515637033|FG003|Overall Study|Started radiotherapy regimen|0|||
143026391|NCT00095199|515637030|FG000|Overall Study|Primary tumor removed in other surgery|0|||
143026392|NCT00095199|515637031|FG001|Overall Study|Primary tumor removed in other surgery|1|||
143026393|NCT00095199|515637032|FG002|Overall Study|Primary tumor removed in other surgery|0|||
143026394|NCT00095199|515637033|FG003|Overall Study|Primary tumor removed in other surgery|0|||
143026395|NCT00095199|515637030|FG000|Overall Study|Data inadvertently lost by site|1|||
143026396|NCT00095199|515637031|FG001|Overall Study|Data inadvertently lost by site|0|||
143026397|NCT00095199|515637032|FG002|Overall Study|Data inadvertently lost by site|0|||
143026398|NCT00095199|515637033|FG003|Overall Study|Data inadvertently lost by site|0|||
143026399|NCT03896490|515637068|FG000|Overall Study|Withdrawal by Subject|1|||
143026400|NCT03896490|515637069|FG001|Overall Study|Withdrawal by Subject|1|||
143026401|NCT01736553|515637074|FG000|Overall Study|Death|12|||
143026402|NCT01736553|515637075|FG001|Overall Study|Death|0|||
143026403|NCT01736553|515637074|FG000|Overall Study|Withdrawal by Subject|5|||
143026404|NCT01736553|515637075|FG001|Overall Study|Withdrawal by Subject|2|||
143026405|NCT01736553|515637074|FG000|Overall Study|Lost to Follow-up|2|||
143026406|NCT01736553|515637075|FG001|Overall Study|Lost to Follow-up|2|||
143026407|NCT01896297|515637076|FG000|Overall Study|Died in post treatment phase|1|||
143026408|NCT00003782|515637077|FG000|Overall Study|No follow up data|30|||
143026409|NCT00003782|515637078|FG001|Overall Study|No follow up data|31|||
143026410|NCT00003782|515637079|FG002|Overall Study|No follow up data|26|||
143236934|NCT01550003|516421509|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
143236935|NCT01550003|516421510|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
143236936|NCT01550003|516421508|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
143236937|NCT01550003|516421509|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
143236938|NCT01550003|516421510|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
143236939|NCT01550003|516421508|FG000|Overall Study|Switching to adult rheumatologist|0|||
143236940|NCT01550003|516421509|FG001|Overall Study|Switching to adult rheumatologist|0|||
143236941|NCT01550003|516421510|FG002|Overall Study|Switching to adult rheumatologist|1|||
143236942|NCT01550003|516421508|FG000|Overall Study|Patient transition to adult care|0|||
143236943|NCT01550003|516421509|FG001|Overall Study|Patient transition to adult care|0|||
143236944|NCT01550003|516421510|FG002|Overall Study|Patient transition to adult care|1|||
143236945|NCT01550003|516421508|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
143236946|NCT01550003|516421509|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
143236947|NCT01550003|516421510|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
143236948|NCT01550003|516421508|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
143236949|NCT01550003|516421509|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
143236950|NCT01550003|516421510|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
143236951|NCT01550003|516421508|FG000|Overall Study|Per Sponsor request|1|||
143236952|NCT01550003|516421509|FG001|Overall Study|Per Sponsor request|0|||
143236953|NCT01550003|516421510|FG002|Overall Study|Per Sponsor request|1|||
143236954|NCT01550003|516421508|FG000|Overall Study|Patient not compliance|0|||
143236955|NCT01550003|516421509|FG001|Overall Study|Patient not compliance|0|||
143236956|NCT01550003|516421510|FG002|Overall Study|Patient not compliance|1|||
143236957|NCT01550003|516421508|FG000|Overall Study|Non-compliance|0|||
143236958|NCT01550003|516421509|FG001|Overall Study|Non-compliance|0|||
143236959|NCT01550003|516421510|FG002|Overall Study|Non-compliance|1|||
143236960|NCT01550003|516421508|FG000|Overall Study|Study closed|0|||
143236961|NCT01550003|516421509|FG001|Overall Study|Study closed|1|||
143236962|NCT01550003|516421510|FG002|Overall Study|Study closed|0|||
143236963|NCT01550003|516421508|FG000|Overall Study|Transitioned to adult rheumatology|0|||
143236964|NCT01550003|516421509|FG001|Overall Study|Transitioned to adult rheumatology|0|||
143236965|NCT01550003|516421510|FG002|Overall Study|Transitioned to adult rheumatology|1|||
143026411|NCT01890707|515637080|FG000|Overall Study|Lost to Follow-up|1|||
143026412|NCT01890707|515637081|FG001|Overall Study|Lost to Follow-up|1|||
143026413|NCT00929708|515637084|FG000|Overall Study|Protocol Violation|2|||
143026414|NCT00929708|515637085|FG001|Overall Study|Protocol Violation|1|||
143026415|NCT00929708|515637086|FG002|Overall Study|Protocol Violation|1|||
143026416|NCT00929708|515637087|FG003|Overall Study|Protocol Violation|1|||
143026417|NCT00929708|515637088|FG004|Overall Study|Protocol Violation|1|||
143236966|NCT03675126|516421511|FG000|Overall Study|Study Terminated by Sponsor|9|||
143236967|NCT03675126|516421511|FG000|Overall Study|Death|2|||
143236968|NCT03675126|516421511|FG000|Overall Study|Withdrawal by Subject|4|||
143236969|NCT01690143|516421512|FG000|Overall Study|Withdrawal by Subject|1|||
143236970|NCT03773978|516421513|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
143026418|NCT00929708|515637084|FG000|Overall Study|Withdrawal by Subject|2|||
143236971|NCT03773978|516421514|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
143236972|NCT03773978|516421513|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
143026419|NCT00929708|515637085|FG001|Overall Study|Withdrawal by Subject|0|||
143026420|NCT00929708|515637086|FG002|Overall Study|Withdrawal by Subject|0|||
143026421|NCT00929708|515637087|FG003|Overall Study|Withdrawal by Subject|2|||
143026422|NCT00929708|515637088|FG004|Overall Study|Withdrawal by Subject|1|||
143026423|NCT00929708|515637084|FG000|Overall Study|Adverse Event|0|||
143026424|NCT00929708|515637085|FG001|Overall Study|Adverse Event|0|||
143026425|NCT00929708|515637086|FG002|Overall Study|Adverse Event|0|||
143026426|NCT00929708|515637087|FG003|Overall Study|Adverse Event|0|||
143026427|NCT00929708|515637088|FG004|Overall Study|Adverse Event|3|||
143026428|NCT00929708|515637084|FG000|Overall Study|Physician Decision|0|||
143026429|NCT00929708|515637085|FG001|Overall Study|Physician Decision|2|||
143026430|NCT00929708|515637086|FG002|Overall Study|Physician Decision|2|||
143026431|NCT00929708|515637087|FG003|Overall Study|Physician Decision|2|||
143026432|NCT00929708|515637088|FG004|Overall Study|Physician Decision|1|||
143026433|NCT00929708|515637084|FG000|Overall Study|Lost to Follow-up|0|||
143026434|NCT00929708|515637085|FG001|Overall Study|Lost to Follow-up|0|||
143026435|NCT00929708|515637086|FG002|Overall Study|Lost to Follow-up|0|||
143026436|NCT00929708|515637087|FG003|Overall Study|Lost to Follow-up|1|||
143026437|NCT00929708|515637088|FG004|Overall Study|Lost to Follow-up|0|||
143026438|NCT01893138|515637089|FG000|Double-Blind Period|Withdrawal by Subject|1|||
143026439|NCT01893138|515637090|FG001|Double-Blind Period|Withdrawal by Subject|1|||
143026440|NCT01893138|515637089|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
143490794|NCT02028455|517338392|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
143490795|NCT02028455|517338393|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
143490796|NCT02028455|517338394|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
143490797|NCT02028455|517338395|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
143490798|NCT02028455|517338396|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
143490799|NCT02028455|517338397|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
143490800|NCT02028455|517338398|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
143490801|NCT04179175|517340214|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
143490802|NCT04179175|517340215|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
143490803|NCT04179175|517340216|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
143490804|NCT04179175|517340217|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
143490805|NCT04179175|517340218|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
143490806|NCT04179175|517340219|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
143490807|NCT04179175|517340214|FG000|Overall Study|Adverse Event|5|||
143490808|NCT04179175|517340215|FG001|Overall Study|Adverse Event|3|||
143490809|NCT04179175|517340216|FG002|Overall Study|Adverse Event|3|||
143490810|NCT04179175|517340217|FG003|Overall Study|Adverse Event|4|||
143490811|NCT04179175|517340218|FG004|Overall Study|Adverse Event|6|||
143490812|NCT04179175|517340219|FG005|Overall Study|Adverse Event|6|||
143490813|NCT04179175|517340214|FG000|Overall Study|Lack of Efficacy|5|||
143490814|NCT04179175|517340215|FG001|Overall Study|Lack of Efficacy|1|||
143490815|NCT04179175|517340216|FG002|Overall Study|Lack of Efficacy|3|||
143490816|NCT04179175|517340217|FG003|Overall Study|Lack of Efficacy|2|||
143490817|NCT04179175|517340218|FG004|Overall Study|Lack of Efficacy|18|||
143490818|NCT04179175|517340219|FG005|Overall Study|Lack of Efficacy|7|||
143490819|NCT04179175|517340214|FG000|Overall Study|Lost to Follow-up|5|||
143490820|NCT04179175|517340215|FG001|Overall Study|Lost to Follow-up|3|||
143490821|NCT04179175|517340216|FG002|Overall Study|Lost to Follow-up|2|||
143490822|NCT04179175|517340217|FG003|Overall Study|Lost to Follow-up|2|||
143490823|NCT04179175|517340218|FG004|Overall Study|Lost to Follow-up|4|||
143490824|NCT04179175|517340219|FG005|Overall Study|Lost to Follow-up|5|||
143490825|NCT04179175|517340214|FG000|Overall Study|Physician Decision|2|||
143490826|NCT04179175|517340215|FG001|Overall Study|Physician Decision|0|||
143490827|NCT04179175|517340216|FG002|Overall Study|Physician Decision|2|||
143490828|NCT04179175|517340217|FG003|Overall Study|Physician Decision|3|||
143490829|NCT04179175|517340218|FG004|Overall Study|Physician Decision|1|||
143490830|NCT04179175|517340219|FG005|Overall Study|Physician Decision|1|||
143490831|NCT04179175|517340214|FG000|Overall Study|Pregnancy|3|||
143490832|NCT04179175|517340215|FG001|Overall Study|Pregnancy|0|||
143490833|NCT04179175|517340216|FG002|Overall Study|Pregnancy|3|||
143490834|NCT04179175|517340217|FG003|Overall Study|Pregnancy|0|||
143490835|NCT04179175|517340218|FG004|Overall Study|Pregnancy|1|||
143490836|NCT04179175|517340219|FG005|Overall Study|Pregnancy|2|||
143026441|NCT01893138|515637090|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
143026442|NCT01893138|515637089|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
143026443|NCT01893138|515637090|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
143026444|NCT01893138|515637089|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
143490837|NCT04179175|517340214|FG000|Overall Study|Withdrawal by Subject|22|||
143490838|NCT04179175|517340215|FG001|Overall Study|Withdrawal by Subject|10|||
143026445|NCT01893138|515637090|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
143490839|NCT04179175|517340216|FG002|Overall Study|Withdrawal by Subject|12|||
143490840|NCT04179175|517340217|FG003|Overall Study|Withdrawal by Subject|8|||
143490841|NCT04179175|517340218|FG004|Overall Study|Withdrawal by Subject|23|||
143490842|NCT04179175|517340219|FG005|Overall Study|Withdrawal by Subject|31|||
143490843|NCT04179175|517340214|FG000|Overall Study|Technical problems|0|||
143490844|NCT04179175|517340215|FG001|Overall Study|Technical problems|0|||
143490845|NCT04179175|517340216|FG002|Overall Study|Technical problems|1|||
143490846|NCT04179175|517340217|FG003|Overall Study|Technical problems|1|||
143490847|NCT04179175|517340218|FG004|Overall Study|Technical problems|0|||
143490848|NCT04179175|517340219|FG005|Overall Study|Technical problems|0|||
143490849|NCT05593016|517340220|FG000|Overall Study|Death|1|||
143490850|NCT05593016|517340221|FG001|Overall Study|Death|1|||
143490851|NCT05593016|517340222|FG002|Overall Study|Death|1|||
143490852|NCT05593016|517340223|FG003|Overall Study|Death|0|||
143490853|NCT05593016|517340224|FG004|Overall Study|Death|0|||
143490854|NCT05593016|517340220|FG000|Overall Study|Lost to Follow-up|1|||
143490855|NCT05593016|517340221|FG001|Overall Study|Lost to Follow-up|1|||
143490856|NCT05593016|517340222|FG002|Overall Study|Lost to Follow-up|1|||
143490857|NCT05593016|517340223|FG003|Overall Study|Lost to Follow-up|2|||
143490858|NCT05593016|517340224|FG004|Overall Study|Lost to Follow-up|0|||
143490859|NCT04705051|517340225|FG000|Overall Study|Enrolled but not treated|1|||
143490860|NCT04705051|517340225|FG000|Overall Study|Study terminated by sponsor|23|||
143490861|NCT02968810|517340226|FG000|Overall Study|Lost to Follow-up|1|||
143490862|NCT02968810|517340227|FG001|Overall Study|Lost to Follow-up|0|||
143490863|NCT02968810|517340226|FG000|Overall Study|Physician Decision|1|||
143490864|NCT02968810|517340227|FG001|Overall Study|Physician Decision|0|||
143490865|NCT02968810|517340226|FG000|Overall Study|Withdrawal by Subject|1|||
143490866|NCT02968810|517340227|FG001|Overall Study|Withdrawal by Subject|3|||
143490867|NCT02968810|517340226|FG000|Overall Study|Disease Progression|0|||
143490868|NCT02968810|517340227|FG001|Overall Study|Disease Progression|1|||
143490869|NCT01790503|517340230|FG000|Overall Study|Adverse Event|1|||
143490870|NCT01790503|517340231|FG001|Overall Study|Adverse Event|0|||
143490871|NCT01790503|517340232|FG002|Overall Study|Adverse Event|0|||
143490872|NCT01790503|517340233|FG003|Overall Study|Adverse Event|0|||
143490873|NCT01790503|517340234|FG004|Overall Study|Adverse Event|0|||
143490874|NCT01790503|517340235|FG005|Overall Study|Adverse Event|2|||
143490875|NCT01790503|517340236|FG006|Overall Study|Adverse Event|0|||
143490876|NCT01790503|517340237|FG007|Overall Study|Adverse Event|0|||
143490877|NCT01790503|517340238|FG008|Overall Study|Adverse Event|2|||
143490878|NCT01790503|517340239|FG009|Overall Study|Adverse Event|4|||
143490879|NCT01790503|517340240|FG010|Overall Study|Adverse Event|7|||
143490880|NCT01790503|517340230|FG000|Overall Study|Withdrawal by Subject|0|||
143490881|NCT01790503|517340231|FG001|Overall Study|Withdrawal by Subject|0|||
143490882|NCT01790503|517340232|FG002|Overall Study|Withdrawal by Subject|1|||
143490883|NCT01790503|517340233|FG003|Overall Study|Withdrawal by Subject|1|||
143490884|NCT01790503|517340234|FG004|Overall Study|Withdrawal by Subject|1|||
143490885|NCT01790503|517340235|FG005|Overall Study|Withdrawal by Subject|2|||
143490886|NCT01790503|517340236|FG006|Overall Study|Withdrawal by Subject|1|||
143490887|NCT01790503|517340237|FG007|Overall Study|Withdrawal by Subject|0|||
143490888|NCT01790503|517340238|FG008|Overall Study|Withdrawal by Subject|0|||
143490889|NCT01790503|517340239|FG009|Overall Study|Withdrawal by Subject|0|||
143490890|NCT01790503|517340240|FG010|Overall Study|Withdrawal by Subject|1|||
143490891|NCT01790503|517340230|FG000|Overall Study|Disease progression|2|||
143490892|NCT01790503|517340231|FG001|Overall Study|Disease progression|1|||
143490893|NCT01790503|517340232|FG002|Overall Study|Disease progression|0|||
143490894|NCT01790503|517340233|FG003|Overall Study|Disease progression|1|||
143490895|NCT01790503|517340234|FG004|Overall Study|Disease progression|2|||
143490896|NCT01790503|517340235|FG005|Overall Study|Disease progression|1|||
143490897|NCT01790503|517340236|FG006|Overall Study|Disease progression|0|||
143490898|NCT01790503|517340237|FG007|Overall Study|Disease progression|1|||
143490899|NCT01790503|517340238|FG008|Overall Study|Disease progression|0|||
143490900|NCT01790503|517340239|FG009|Overall Study|Disease progression|17|||
143490901|NCT01790503|517340240|FG010|Overall Study|Disease progression|7|||
143490902|NCT01790503|517340230|FG000|Overall Study|Protocol Violation|0|||
143490903|NCT01790503|517340231|FG001|Overall Study|Protocol Violation|0|||
143490904|NCT01790503|517340232|FG002|Overall Study|Protocol Violation|0|||
143490905|NCT01790503|517340233|FG003|Overall Study|Protocol Violation|0|||
143490906|NCT01790503|517340234|FG004|Overall Study|Protocol Violation|0|||
143490907|NCT01790503|517340235|FG005|Overall Study|Protocol Violation|0|||
143490908|NCT01790503|517340236|FG006|Overall Study|Protocol Violation|0|||
143490909|NCT01790503|517340237|FG007|Overall Study|Protocol Violation|0|||
143490910|NCT01790503|517340238|FG008|Overall Study|Protocol Violation|0|||
143490911|NCT01790503|517340239|FG009|Overall Study|Protocol Violation|1|||
143490912|NCT01790503|517340240|FG010|Overall Study|Protocol Violation|0|||
143490913|NCT01790503|517340230|FG000|Overall Study|Physician Decision|0|||
143490914|NCT01790503|517340231|FG001|Overall Study|Physician Decision|0|||
143490915|NCT01790503|517340232|FG002|Overall Study|Physician Decision|0|||
143363865|NCT00049517|516875455|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
143490916|NCT01790503|517340233|FG003|Overall Study|Physician Decision|0|||
143490917|NCT01790503|517340234|FG004|Overall Study|Physician Decision|0|||
143490918|NCT01790503|517340235|FG005|Overall Study|Physician Decision|0|||
143490919|NCT01790503|517340236|FG006|Overall Study|Physician Decision|0|||
143490920|NCT01790503|517340237|FG007|Overall Study|Physician Decision|0|||
143490921|NCT01790503|517340238|FG008|Overall Study|Physician Decision|0|||
143490922|NCT01790503|517340239|FG009|Overall Study|Physician Decision|1|||
143490923|NCT01790503|517340240|FG010|Overall Study|Physician Decision|1|||
143490924|NCT01790503|517340230|FG000|Overall Study|Death|0|||
143490925|NCT01790503|517340231|FG001|Overall Study|Death|0|||
143490926|NCT01790503|517340232|FG002|Overall Study|Death|0|||
143490927|NCT01790503|517340233|FG003|Overall Study|Death|0|||
143490928|NCT01790503|517340234|FG004|Overall Study|Death|0|||
143490929|NCT01790503|517340235|FG005|Overall Study|Death|0|||
143490930|NCT01790503|517340236|FG006|Overall Study|Death|0|||
143490931|NCT01790503|517340237|FG007|Overall Study|Death|0|||
143490932|NCT01790503|517340238|FG008|Overall Study|Death|0|||
143490933|NCT01790503|517340239|FG009|Overall Study|Death|1|||
143490934|NCT01790503|517340240|FG010|Overall Study|Death|0|||
143490935|NCT01790503|517340230|FG000|Overall Study|Non Compliance|0|||
143490936|NCT01790503|517340231|FG001|Overall Study|Non Compliance|0|||
143490937|NCT01790503|517340232|FG002|Overall Study|Non Compliance|0|||
143490938|NCT01790503|517340233|FG003|Overall Study|Non Compliance|0|||
143490939|NCT01790503|517340234|FG004|Overall Study|Non Compliance|1|||
143490940|NCT01790503|517340235|FG005|Overall Study|Non Compliance|0|||
143490941|NCT01790503|517340236|FG006|Overall Study|Non Compliance|0|||
143490942|NCT01790503|517340237|FG007|Overall Study|Non Compliance|0|||
143490943|NCT01790503|517340238|FG008|Overall Study|Non Compliance|0|||
143490944|NCT01790503|517340239|FG009|Overall Study|Non Compliance|0|||
143490945|NCT01790503|517340240|FG010|Overall Study|Non Compliance|0|||
143490946|NCT01790503|517340230|FG000|Overall Study|Other|0|||
143490947|NCT01790503|517340231|FG001|Overall Study|Other|0|||
143490948|NCT01790503|517340232|FG002|Overall Study|Other|0|||
143490949|NCT01790503|517340233|FG003|Overall Study|Other|0|||
143490950|NCT01790503|517340234|FG004|Overall Study|Other|1|||
143490951|NCT01790503|517340235|FG005|Overall Study|Other|0|||
143490952|NCT01790503|517340236|FG006|Overall Study|Other|0|||
143490953|NCT01790503|517340237|FG007|Overall Study|Other|0|||
143490954|NCT01790503|517340238|FG008|Overall Study|Other|1|||
143490955|NCT01790503|517340239|FG009|Overall Study|Other|2|||
143490956|NCT01790503|517340240|FG010|Overall Study|Other|0|||
143490957|NCT00049673|517340241|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
143490958|NCT00049673|517340242|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
143490959|NCT01535729|517340243|FG000|Overall Study|Withdrawal by Subject|2|||
143490960|NCT01535729|517340243|FG000|Overall Study|Disease progression|230|||
143490961|NCT01535729|517340243|FG000|Overall Study|Discontinued treatment|25|||
143490962|NCT01535729|517340243|FG000|Overall Study|Lost to Follow-up|8|||
143490963|NCT01535729|517340243|FG000|Overall Study|Death|52|||
143490964|NCT01535729|517340243|FG000|Overall Study|Other|19|||
143490965|NCT01535729|517340243|FG000|Overall Study|Did not sign informed consent|1|||
143490966|NCT01535729|517340243|FG000|Overall Study|No previous chemotherapy|33|||
143490967|NCT01535729|517340243|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
143490968|NCT01535729|517340243|FG000|Overall Study|Protocol Violation|11|||
143490969|NCT01535729|517340243|FG000|Overall Study|Screening failure|1|||
143490970|NCT01535729|517340243|FG000|Overall Study|Not treated|9|||
143490971|NCT01535729|517340243|FG000|Overall Study|No participant record available|5|||
143490972|NCT01262365|517340246|FG000|Overall Study|Lack of Efficacy|35|||
143490973|NCT01262365|517340247|FG001|Overall Study|Lack of Efficacy|30|||
143490974|NCT01262365|517340248|FG002|Overall Study|Lack of Efficacy|47|||
143490975|NCT01262365|517340246|FG000|Overall Study|Protocol Violation|3|||
143490976|NCT01262365|517340247|FG001|Overall Study|Protocol Violation|1|||
143026446|NCT01893138|515637089|FG000|Open Label - Unblinded Period|Adverse Event|1|||
143158021|NCT00032487|516124382|FG001|Overall Study|Lost to Follow-up|58|||
143490977|NCT01262365|517340248|FG002|Overall Study|Protocol Violation|1|||
143490978|NCT01262365|517340246|FG000|Overall Study|Lost to Follow-up|3|||
143490979|NCT01262365|517340247|FG001|Overall Study|Lost to Follow-up|7|||
143490980|NCT01262365|517340248|FG002|Overall Study|Lost to Follow-up|6|||
143026447|NCT01893138|515637090|FG001|Open Label - Unblinded Period|Adverse Event|0|||
143026448|NCT01326026|515637091|FG000|Overall Study|Adverse Event|4|||
143490981|NCT01262365|517340246|FG000|Overall Study|Withdrawal by Subject|17|||
143490982|NCT01262365|517340247|FG001|Overall Study|Withdrawal by Subject|22|||
143490983|NCT01262365|517340248|FG002|Overall Study|Withdrawal by Subject|22|||
143490984|NCT01262365|517340246|FG000|Overall Study|Death|1|||
143490985|NCT01262365|517340247|FG001|Overall Study|Death|2|||
143490986|NCT01262365|517340248|FG002|Overall Study|Death|1|||
143490987|NCT01262365|517340246|FG000|Overall Study|Adverse Event|26|||
143490988|NCT01262365|517340247|FG001|Overall Study|Adverse Event|16|||
143490989|NCT01262365|517340248|FG002|Overall Study|Adverse Event|11|||
143490990|NCT01262365|517340246|FG000|Overall Study|sponsor decision|1|||
143490991|NCT01262365|517340247|FG001|Overall Study|sponsor decision|1|||
143490992|NCT01262365|517340248|FG002|Overall Study|sponsor decision|0|||
143490993|NCT01262365|517340246|FG000|Overall Study|Randomization error|1|||
143490994|NCT01262365|517340247|FG001|Overall Study|Randomization error|0|||
143490995|NCT01262365|517340248|FG002|Overall Study|Randomization error|2|||
143490996|NCT01262365|517340246|FG000|Overall Study|Non-compliance|1|||
143490997|NCT01262365|517340247|FG001|Overall Study|Non-compliance|0|||
143490998|NCT01262365|517340248|FG002|Overall Study|Non-compliance|2|||
143490999|NCT01262365|517340246|FG000|Overall Study|Suspected pregnancy|1|||
143491000|NCT01262365|517340247|FG001|Overall Study|Suspected pregnancy|0|||
143491001|NCT01262365|517340248|FG002|Overall Study|Suspected pregnancy|0|||
143491002|NCT01262365|517340246|FG000|Overall Study|Patient pregnant|1|||
143491003|NCT01262365|517340247|FG001|Overall Study|Patient pregnant|0|||
143491004|NCT01262365|517340248|FG002|Overall Study|Patient pregnant|1|||
143491005|NCT01262365|517340246|FG000|Overall Study|Toxicity related to study drug|0|||
143491006|NCT01262365|517340247|FG001|Overall Study|Toxicity related to study drug|1|||
143491007|NCT01262365|517340248|FG002|Overall Study|Toxicity related to study drug|0|||
143491008|NCT01262365|517340246|FG000|Overall Study|Cannot tolerate the protocol|0|||
143491009|NCT01262365|517340247|FG001|Overall Study|Cannot tolerate the protocol|1|||
143491010|NCT01262365|517340248|FG002|Overall Study|Cannot tolerate the protocol|0|||
143491011|NCT01262365|517340246|FG000|Overall Study|Patient unavailable|0|||
143491012|NCT01262365|517340247|FG001|Overall Study|Patient unavailable|0|||
143491013|NCT01262365|517340248|FG002|Overall Study|Patient unavailable|1|||
143491014|NCT02787850|517340249|FG000|Overall Study|Withdrawal by Subject|0|||
143491015|NCT02787850|517340250|FG001|Overall Study|Withdrawal by Subject|1|||
143491016|NCT00494091|517340251|FG000|Overall Study|Death|5|||
143491017|NCT00494091|517340252|FG001|Overall Study|Death|54|||
143491018|NCT00494091|517340251|FG000|Overall Study|Lost to Follow-up|0|||
143491019|NCT00494091|517340252|FG001|Overall Study|Lost to Follow-up|4|||
143491020|NCT00494091|517340251|FG000|Overall Study|Other|1|||
143491021|NCT00494091|517340252|FG001|Overall Study|Other|11|||
143491022|NCT00494091|517340251|FG000|Overall Study|Withdrawal by Subject|0|||
143491023|NCT00494091|517340252|FG001|Overall Study|Withdrawal by Subject|7|||
143491024|NCT02322710|517340255|FG000|Overall Study|No efficacy assessment post-baseline|0|||
143491025|NCT02322710|517340256|FG001|Overall Study|No efficacy assessment post-baseline|1|||
143491026|NCT02322710|517340255|FG000|Overall Study|Protocol Violation|20|||
143491027|NCT02322710|517340256|FG001|Overall Study|Protocol Violation|25|||
143491028|NCT04161131|517340257|FG000|Overall Study|Ineligible|2|||
143491029|NCT04161131|517340257|FG000|Overall Study|Lost to Follow-up|4|||
143491030|NCT03733392|517340261|FG000|Overall Study|Withdrawal by Subject|11|||
143491031|NCT03733392|517340262|FG001|Overall Study|Withdrawal by Subject|1|||
143491032|NCT03733392|517340261|FG000|Overall Study|Death|1|||
143491033|NCT03733392|517340262|FG001|Overall Study|Death|0|||
143026449|NCT01326026|515637092|FG001|Overall Study|Adverse Event|3|||
143026450|NCT01326026|515637091|FG000|Overall Study|Withdrawal Criteria|5|||
143026451|NCT01326026|515637092|FG001|Overall Study|Withdrawal Criteria|7|||
143026452|NCT01326026|515637091|FG000|Overall Study|Other|3|||
143026453|NCT01326026|515637092|FG001|Overall Study|Other|3|||
143026454|NCT04317053|515637099|FG000|Overall Study|Withdrawn (screen failure)|4|||
143026455|NCT04317053|515637100|FG001|Overall Study|Withdrawn (screen failure)|2|||
143026456|NCT02224456|515638476|FG000|Overall Study|Lack of Efficacy|1|||
143026457|NCT02224456|515638476|FG000|Overall Study|Lost to Follow-up|15|||
143026458|NCT02224456|515638476|FG000|Overall Study|Withdrawal by Subject|9|||
143026459|NCT02224456|515638476|FG000|Overall Study|Physician Decision|3|||
143026460|NCT02224456|515638476|FG000|Overall Study|Death|2|||
143026461|NCT02224456|515638476|FG000|Overall Study|Pregnancy|4|||
143026462|NCT02224456|515638476|FG000|Overall Study|Protocol Violation|1|||
143026463|NCT02224456|515638476|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
143026464|NCT01644890|515638477|FG000|Overall Study|Adverse Event|7|||
143026465|NCT01644890|515638478|FG001|Overall Study|Adverse Event|20|||
143026466|NCT01644890|515638477|FG000|Overall Study|Death|1|||
143026467|NCT01644890|515638478|FG001|Overall Study|Death|3|||
143026468|NCT01644890|515638477|FG000|Overall Study|Physician Decision|3|||
143026469|NCT01644890|515638478|FG001|Overall Study|Physician Decision|9|||
143026470|NCT01644890|515638477|FG000|Overall Study|Protocol Violation|6|||
143026471|NCT01644890|515638478|FG001|Overall Study|Protocol Violation|7|||
143026472|NCT01644890|515638477|FG000|Overall Study|Withdrawal by Subject|19|||
143026473|NCT01644890|515638478|FG001|Overall Study|Withdrawal by Subject|27|||
143026474|NCT01644890|515638477|FG000|Overall Study|Progression Disease|160|||
143026475|NCT01644890|515638478|FG001|Overall Study|Progression Disease|131|||
143026476|NCT01644890|515638477|FG000|Overall Study|Clinical Progression|6|||
143026477|NCT01644890|515638478|FG001|Overall Study|Clinical Progression|6|||
143026478|NCT01644890|515638477|FG000|Overall Study|> 28 days since last dose of study drug|6|||
143491034|NCT03733392|517340261|FG000|Overall Study|Lost to Follow-up|5|||
143491035|NCT03733392|517340262|FG001|Overall Study|Lost to Follow-up|0|||
143491036|NCT03733392|517340261|FG000|Overall Study|Protocol Violation|0|||
143491037|NCT03733392|517340262|FG001|Overall Study|Protocol Violation|1|||
143491038|NCT03733392|517340261|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
143026479|NCT01644890|515638478|FG001|Overall Study|> 28 days since last dose of study drug|3|||
143026480|NCT01644890|515638477|FG000|Overall Study|Other|8|||
143026481|NCT01644890|515638478|FG001|Overall Study|Other|9|||
143026482|NCT02742090|515638479|FG000|Overall Study|Adverse Event|10|||
143026483|NCT02742090|515638479|FG000|Overall Study|Death|3|||
143026484|NCT02742090|515638479|FG000|Overall Study|Disease Progression|25|||
143026485|NCT02742090|515638479|FG000|Overall Study|Investigator's Decision|1|||
143026486|NCT02742090|515638479|FG000|Overall Study|Lost to Follow-up|1|||
143026487|NCT02742090|515638479|FG000|Overall Study|Non-compliance with Study|1|||
143026488|NCT02742090|515638479|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
143026489|NCT02742090|515638479|FG000|Overall Study|Withdrawal by Subject|4|||
143026490|NCT02742090|515638479|FG000|Overall Study|Reason Not Specified|1|||
143026491|NCT01767597|515638480|FG000|Overall Study|Incomplete intervention|3|||
143026492|NCT01767597|515638481|FG001|Overall Study|Incomplete intervention|1|||
143026493|NCT01767597|515638480|FG000|Overall Study|Withdrawal by Subject|1|||
143026494|NCT01767597|515638481|FG001|Overall Study|Withdrawal by Subject|0|||
143026495|NCT03355742|515638482|FG000|Overall Study|Lost to Follow-up|4|||
143026496|NCT03355742|515638482|FG000|Overall Study|Withdrawal by Subject|29|||
143026497|NCT03355742|515638482|FG000|Overall Study|Physician Decision|6|||
143026498|NCT03355742|515638482|FG000|Overall Study|Death|55|||
143026499|NCT03355742|515638482|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
143026500|NCT00836927|515638483|FG000|Overall Study|Progressive disease|2|||
143026501|NCT00836927|515638484|FG001|Overall Study|Progressive disease|0|||
143026502|NCT00836927|515638485|FG002|Overall Study|Progressive disease|0|||
143026503|NCT00836927|515638486|FG003|Overall Study|Progressive disease|1|||
143026504|NCT00836927|515638487|FG004|Overall Study|Progressive disease|1|||
143026505|NCT00836927|515638483|FG000|Overall Study|Withdrawal by Subject|1|||
143026506|NCT00836927|515638484|FG001|Overall Study|Withdrawal by Subject|0|||
143026507|NCT00836927|515638485|FG002|Overall Study|Withdrawal by Subject|0|||
143026508|NCT00836927|515638486|FG003|Overall Study|Withdrawal by Subject|0|||
143026509|NCT00836927|515638487|FG004|Overall Study|Withdrawal by Subject|0|||
143026510|NCT00614055|515638493|FG000|Overall Study|Adverse Event|1|||
143026511|NCT00614055|515638494|FG001|Overall Study|Adverse Event|0|||
143026512|NCT00614055|515638495|FG002|Overall Study|Adverse Event|0|||
143026513|NCT00614055|515638493|FG000|Overall Study|Protocol Violation|2|||
143026514|NCT00614055|515638494|FG001|Overall Study|Protocol Violation|2|||
143026515|NCT00614055|515638495|FG002|Overall Study|Protocol Violation|1|||
143026516|NCT00614055|515638493|FG000|Overall Study|Lack of Efficacy|0|||
143026517|NCT00614055|515638494|FG001|Overall Study|Lack of Efficacy|0|||
143026518|NCT00614055|515638495|FG002|Overall Study|Lack of Efficacy|2|||
143026519|NCT00614055|515638493|FG000|Overall Study|Unclassified|1|||
143026520|NCT00614055|515638494|FG001|Overall Study|Unclassified|4|||
143026521|NCT00614055|515638495|FG002|Overall Study|Unclassified|2|||
143026522|NCT04820842|515638500|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
143026523|NCT04820842|515638501|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
143026524|NCT04820842|515638502|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
143026525|NCT04820842|515638503|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
143026526|NCT04820842|515638504|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
143026527|NCT04820842|515638505|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
143026528|NCT04820842|515638506|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
143026529|NCT04820842|515638500|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
143026530|NCT04820842|515638501|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
143026531|NCT04820842|515638502|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
143026532|NCT04820842|515638503|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
143026533|NCT04820842|515638504|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
143026534|NCT04820842|515638505|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
143026535|NCT04820842|515638506|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
143026536|NCT04820842|515638500|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
143026537|NCT04820842|515638501|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
143026538|NCT04820842|515638502|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
143026539|NCT04820842|515638503|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
143026540|NCT04820842|515638504|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
143026541|NCT04820842|515638505|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
143026542|NCT04820842|515638506|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
143026543|NCT04820842|515638500|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
143026544|NCT04820842|515638501|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
143026545|NCT04820842|515638502|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
143026546|NCT04820842|515638503|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
143026547|NCT04820842|515638504|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
143026548|NCT04820842|515638505|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
143158022|NCT00032487|516124381|FG000|Overall Study|Had other reason|12|||
143026549|NCT04820842|515638506|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
143026550|NCT01296932|515638507|FG000|Overall Study|Dose limiting toxicity|0|||
143491039|NCT03733392|517340262|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
143491040|NCT03733392|517340261|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
143491041|NCT03733392|517340262|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
143491042|NCT03733392|517340261|FG000|Overall Study|Patient Non-Compliance|2|||
143026551|NCT01296932|515638508|FG001|Overall Study|Dose limiting toxicity|0|||
143026552|NCT01296932|515638509|FG002|Overall Study|Dose limiting toxicity|0|||
143026553|NCT01296932|515638510|FG003|Overall Study|Dose limiting toxicity|0|||
143026554|NCT01296932|515638511|FG004|Overall Study|Dose limiting toxicity|0|||
143026555|NCT01296932|515638512|FG005|Overall Study|Dose limiting toxicity|0|||
143026556|NCT01296932|515638513|FG006|Overall Study|Dose limiting toxicity|1|||
143026557|NCT01296932|515638514|FG007|Overall Study|Dose limiting toxicity|0|||
143026558|NCT01296932|515638515|FG008|Overall Study|Dose limiting toxicity|1|||
143026559|NCT01296932|515638507|FG000|Overall Study|Progressive disease|2|||
143026560|NCT01296932|515638508|FG001|Overall Study|Progressive disease|0|||
143026561|NCT01296932|515638509|FG002|Overall Study|Progressive disease|1|||
143026562|NCT01296932|515638510|FG003|Overall Study|Progressive disease|1|||
143026563|NCT01296932|515638511|FG004|Overall Study|Progressive disease|2|||
143026564|NCT01296932|515638512|FG005|Overall Study|Progressive disease|3|||
143026565|NCT01296932|515638513|FG006|Overall Study|Progressive disease|1|||
143026566|NCT01296932|515638514|FG007|Overall Study|Progressive disease|0|||
143026567|NCT01296932|515638515|FG008|Overall Study|Progressive disease|0|||
143026568|NCT01296932|515638507|FG000|Overall Study|Withdrawal by Subject|0|||
143026569|NCT01296932|515638508|FG001|Overall Study|Withdrawal by Subject|0|||
143026570|NCT01296932|515638509|FG002|Overall Study|Withdrawal by Subject|1|||
143026571|NCT01296932|515638510|FG003|Overall Study|Withdrawal by Subject|1|||
143026572|NCT01296932|515638511|FG004|Overall Study|Withdrawal by Subject|0|||
143026573|NCT01296932|515638512|FG005|Overall Study|Withdrawal by Subject|0|||
143026574|NCT01296932|515638513|FG006|Overall Study|Withdrawal by Subject|3|||
143026575|NCT01296932|515638514|FG007|Overall Study|Withdrawal by Subject|0|||
143026576|NCT01296932|515638515|FG008|Overall Study|Withdrawal by Subject|0|||
143026577|NCT01296932|515638507|FG000|Overall Study|Adverse Event|1|||
143026578|NCT01296932|515638508|FG001|Overall Study|Adverse Event|1|||
143026579|NCT01296932|515638509|FG002|Overall Study|Adverse Event|1|||
143026580|NCT01296932|515638510|FG003|Overall Study|Adverse Event|2|||
143026581|NCT01296932|515638511|FG004|Overall Study|Adverse Event|1|||
143026582|NCT01296932|515638512|FG005|Overall Study|Adverse Event|0|||
143026583|NCT01296932|515638513|FG006|Overall Study|Adverse Event|0|||
143026584|NCT01296932|515638514|FG007|Overall Study|Adverse Event|0|||
143026585|NCT01296932|515638515|FG008|Overall Study|Adverse Event|1|||
143026586|NCT01296932|515638507|FG000|Overall Study|Investigator decision|0|||
143026587|NCT01296932|515638508|FG001|Overall Study|Investigator decision|1|||
143026588|NCT01296932|515638509|FG002|Overall Study|Investigator decision|0|||
143026589|NCT01296932|515638510|FG003|Overall Study|Investigator decision|1|||
143026590|NCT01296932|515638511|FG004|Overall Study|Investigator decision|0|||
143026591|NCT01296932|515638512|FG005|Overall Study|Investigator decision|0|||
143026592|NCT01296932|515638513|FG006|Overall Study|Investigator decision|1|||
143026593|NCT01296932|515638514|FG007|Overall Study|Investigator decision|0|||
143026594|NCT01296932|515638515|FG008|Overall Study|Investigator decision|1|||
143026595|NCT01296932|515638507|FG000|Overall Study|No clinical benefit anymore|0|||
143026596|NCT01296932|515638508|FG001|Overall Study|No clinical benefit anymore|1|||
143026597|NCT01296932|515638509|FG002|Overall Study|No clinical benefit anymore|0|||
143026598|NCT01296932|515638510|FG003|Overall Study|No clinical benefit anymore|0|||
143158023|NCT00032487|516124382|FG001|Overall Study|Had other reason|12|||
143158024|NCT04913675|516124383|FG000|Main Study (Up to Week 36)|Death|0|||
143158025|NCT04913675|516124384|FG001|Main Study (Up to Week 36)|Death|2|||
143158026|NCT04913675|516124385|FG002|Main Study (Up to Week 36)|Death|2|||
143158027|NCT04913675|516124386|FG003|Main Study (Up to Week 36)|Death|0|||
143158028|NCT04913675|516124383|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
143158029|NCT04913675|516124384|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
143158030|NCT04913675|516124385|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
143158031|NCT04913675|516124386|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
143158032|NCT04913675|516124383|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
143158033|NCT04913675|516124384|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
143026599|NCT01296932|515638511|FG004|Overall Study|No clinical benefit anymore|0|||
143026600|NCT01296932|515638512|FG005|Overall Study|No clinical benefit anymore|0|||
143026601|NCT01296932|515638513|FG006|Overall Study|No clinical benefit anymore|0|||
143026602|NCT01296932|515638514|FG007|Overall Study|No clinical benefit anymore|0|||
143026603|NCT01296932|515638515|FG008|Overall Study|No clinical benefit anymore|0|||
143026604|NCT01296932|515638507|FG000|Overall Study|Physician Decision|0|||
143026605|NCT01296932|515638508|FG001|Overall Study|Physician Decision|0|||
143026606|NCT01296932|515638509|FG002|Overall Study|Physician Decision|1|||
143158034|NCT04913675|516124385|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
143158035|NCT04913675|516124386|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
143491043|NCT03733392|517340262|FG001|Overall Study|Patient Non-Compliance|1|||
143491044|NCT03733392|517340261|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
143491045|NCT03733392|517340262|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
143491046|NCT03733392|517340261|FG000|Overall Study|Withdrawal prior to procedure|5|||
143491047|NCT03733392|517340262|FG001|Overall Study|Withdrawal prior to procedure|2|||
143491048|NCT00130832|517340263|FG000|Overall Study|Adverse Event|1|||
143491049|NCT00130832|517340264|FG001|Overall Study|Adverse Event|1|||
143491050|NCT00130832|517340263|FG000|Overall Study|Lost to Follow-up|1|||
143491051|NCT00130832|517340264|FG001|Overall Study|Lost to Follow-up|2|||
143491052|NCT00130832|517340263|FG000|Overall Study|Protocol Violation|6|||
143491053|NCT00130832|517340264|FG001|Overall Study|Protocol Violation|8|||
143491054|NCT00130832|517340263|FG000|Overall Study|Withdrawal by Subject|6|||
143491055|NCT00130832|517340264|FG001|Overall Study|Withdrawal by Subject|1|||
143491056|NCT00130832|517340263|FG000|Overall Study|Moved|2|||
143491057|NCT00130832|517340264|FG001|Overall Study|Moved|2|||
143491058|NCT00130832|517340263|FG000|Overall Study|Other|0|||
143491059|NCT00130832|517340264|FG001|Overall Study|Other|3|||
143491060|NCT03905863|517340265|FG000|Overall Study|Adverse Event|2|||
143491061|NCT03905863|517340266|FG001|Overall Study|Adverse Event|4|||
143491062|NCT03905863|517340265|FG000|Overall Study|Withdrawal by Subject|2|||
143491063|NCT03905863|517340266|FG001|Overall Study|Withdrawal by Subject|2|||
143491064|NCT03905863|517340265|FG000|Overall Study|Physician Decision|0|||
143491065|NCT03905863|517340266|FG001|Overall Study|Physician Decision|3|||
143491066|NCT03905863|517340265|FG000|Overall Study|Lost to Follow-up|1|||
143491067|NCT03905863|517340266|FG001|Overall Study|Lost to Follow-up|0|||
143491068|NCT03905863|517340265|FG000|Overall Study|Protocol Violation|0|||
143491069|NCT03905863|517340266|FG001|Overall Study|Protocol Violation|2|||
143491070|NCT03905863|517340265|FG000|Overall Study|Death|0|||
143491071|NCT03905863|517340266|FG001|Overall Study|Death|1|||
143491072|NCT02605642|517340271|FG000|Overall Study|Other|11|||
143491073|NCT02605642|517340272|FG001|Overall Study|Other|1|||
143491074|NCT02605642|517340271|FG000|Overall Study|Participant non-compliance|2|||
143491075|NCT02605642|517340272|FG001|Overall Study|Participant non-compliance|4|||
143491076|NCT02605642|517340271|FG000|Overall Study|Physician Decision|10|||
143491077|NCT02605642|517340272|FG001|Overall Study|Physician Decision|0|||
143491078|NCT02605642|517340271|FG000|Overall Study|Lost to Follow-up|12|||
143491079|NCT02605642|517340272|FG001|Overall Study|Lost to Follow-up|1|||
143491080|NCT02605642|517340271|FG000|Overall Study|Adverse Event|14|||
143491081|NCT02605642|517340272|FG001|Overall Study|Adverse Event|2|||
143491082|NCT02605642|517340271|FG000|Overall Study|Withdrawal by Subject|23|||
143491083|NCT02605642|517340272|FG001|Overall Study|Withdrawal by Subject|2|||
143491084|NCT02605642|517340271|FG000|Overall Study|Lack of response|24|||
143491085|NCT02605642|517340272|FG001|Overall Study|Lack of response|11|||
143491086|NCT00984204|517340282|FG000|Overall Study|Death|1|||
143491087|NCT00984204|517340282|FG000|Overall Study|Lost to Follow-up|4|||
143491088|NCT00984204|517340282|FG000|Overall Study|Lack of Efficacy|10|||
143491089|NCT00699348|517340289|FG000|Overall Study|Death|6|||
143491090|NCT00699348|517340289|FG000|Overall Study|Adverse Event|15|||
143491091|NCT00699348|517340289|FG000|Overall Study|Withdrawal by Subject|11|||
143491092|NCT00699348|517340289|FG000|Overall Study|Protocol Violation|10|||
143491093|NCT00699348|517340289|FG000|Overall Study|Lack of Efficacy|8|||
143491094|NCT00699348|517340289|FG000|Overall Study|Failure to return|1|||
143491095|NCT00699348|517340289|FG000|Overall Study|Blood transfusion|24|||
143491096|NCT00699348|517340289|FG000|Overall Study|Renal transplantation|10|||
143491097|NCT00699348|517340289|FG000|Overall Study|Other|5|||
143491098|NCT04401267|517340290|FG000|Overall Study|Death|0|||
143491099|NCT04401267|517340291|FG001|Overall Study|Death|1|||
143491100|NCT04401267|517340290|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
143491101|NCT04401267|517340291|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
143491102|NCT04401267|517340290|FG000|Overall Study|Found to be Ineligible|1|||
143491103|NCT04401267|517340291|FG001|Overall Study|Found to be Ineligible|0|||
143491104|NCT01407926|517340304|FG000|Overall Study|Lost to Follow-up|55|||
143491105|NCT02814565|517340305|FG000|Overall Study|Lack of Efficacy|0|||
143491106|NCT02814565|517340306|FG001|Overall Study|Lack of Efficacy|1|||
143491107|NCT02814565|517340305|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
143491108|NCT02814565|517340306|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
143491109|NCT01191697|517340307|FG000|Overall Study|Death|1|||
143491110|NCT01191697|517340307|FG000|Overall Study|Physician Decision|2|||
143491111|NCT01191697|517340307|FG000|Overall Study|Pursue chemoradiation|2|||
143491112|NCT01191697|517340307|FG000|Overall Study|Break from chemotherapy|2|||
143491113|NCT01191697|517340307|FG000|Overall Study|Withdrawal by Subject|1|||
143491114|NCT01191697|517340307|FG000|Overall Study|Surveillance|1|||
143491115|NCT01191697|517340307|FG000|Overall Study|Adverse Event|2|||
143491116|NCT01191697|517340307|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
143491117|NCT01191697|517340307|FG000|Overall Study|Not completed but analyzed|25|||
143491118|NCT04227899|517340310|FG000|Overall Study|Withdrawal by Subject|6|||
143491119|NCT04227899|517340311|FG001|Overall Study|Withdrawal by Subject|3|||
143491120|NCT04227899|517340310|FG000|Overall Study|Death|12|||
143026607|NCT01296932|515638510|FG003|Overall Study|Physician Decision|0|||
143026608|NCT01296932|515638511|FG004|Overall Study|Physician Decision|0|||
143026609|NCT01296932|515638512|FG005|Overall Study|Physician Decision|0|||
143026610|NCT01296932|515638513|FG006|Overall Study|Physician Decision|0|||
143026611|NCT01296932|515638514|FG007|Overall Study|Physician Decision|0|||
143026612|NCT01296932|515638515|FG008|Overall Study|Physician Decision|0|||
143026613|NCT01296932|515638507|FG000|Overall Study|IV problems, administration not possible|0|||
143026614|NCT01296932|515638508|FG001|Overall Study|IV problems, administration not possible|0|||
143026615|NCT01296932|515638509|FG002|Overall Study|IV problems, administration not possible|1|||
143026616|NCT01296932|515638510|FG003|Overall Study|IV problems, administration not possible|0|||
143026617|NCT01296932|515638511|FG004|Overall Study|IV problems, administration not possible|0|||
143026618|NCT01296932|515638512|FG005|Overall Study|IV problems, administration not possible|0|||
143026619|NCT01296932|515638513|FG006|Overall Study|IV problems, administration not possible|0|||
143026620|NCT01296932|515638514|FG007|Overall Study|IV problems, administration not possible|0|||
143026621|NCT01296932|515638515|FG008|Overall Study|IV problems, administration not possible|0|||
143026622|NCT01296932|515638507|FG000|Overall Study|per protocol|0|||
143026623|NCT01296932|515638508|FG001|Overall Study|per protocol|0|||
143026624|NCT01296932|515638509|FG002|Overall Study|per protocol|1|||
143026625|NCT01296932|515638510|FG003|Overall Study|per protocol|1|||
143026626|NCT01296932|515638511|FG004|Overall Study|per protocol|0|||
143026627|NCT01296932|515638512|FG005|Overall Study|per protocol|0|||
143026628|NCT01296932|515638513|FG006|Overall Study|per protocol|0|||
143026629|NCT01296932|515638514|FG007|Overall Study|per protocol|0|||
143026630|NCT01296932|515638515|FG008|Overall Study|per protocol|0|||
143026631|NCT01296932|515638507|FG000|Overall Study|Low benefit and too many side effects|0|||
143026632|NCT01296932|515638508|FG001|Overall Study|Low benefit and too many side effects|0|||
143026633|NCT01296932|515638509|FG002|Overall Study|Low benefit and too many side effects|0|||
143026634|NCT01296932|515638510|FG003|Overall Study|Low benefit and too many side effects|0|||
143026635|NCT01296932|515638511|FG004|Overall Study|Low benefit and too many side effects|0|||
143026636|NCT01296932|515638512|FG005|Overall Study|Low benefit and too many side effects|0|||
143026637|NCT01296932|515638513|FG006|Overall Study|Low benefit and too many side effects|0|||
143026638|NCT01296932|515638514|FG007|Overall Study|Low benefit and too many side effects|1|||
143026639|NCT01296932|515638515|FG008|Overall Study|Low benefit and too many side effects|0|||
143026640|NCT01296932|515638507|FG000|Overall Study|No adequate treatment response|0|||
143026641|NCT01296932|515638508|FG001|Overall Study|No adequate treatment response|0|||
143026642|NCT01296932|515638509|FG002|Overall Study|No adequate treatment response|0|||
143026643|NCT01296932|515638510|FG003|Overall Study|No adequate treatment response|0|||
143026644|NCT01296932|515638511|FG004|Overall Study|No adequate treatment response|0|||
143026645|NCT01296932|515638512|FG005|Overall Study|No adequate treatment response|0|||
143026646|NCT01296932|515638513|FG006|Overall Study|No adequate treatment response|0|||
143236973|NCT03773978|516421514|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
143026647|NCT01296932|515638514|FG007|Overall Study|No adequate treatment response|1|||
143026648|NCT01296932|515638515|FG008|Overall Study|No adequate treatment response|0|||
143026649|NCT01296932|515638507|FG000|Overall Study|Dosage already reduced, AE still present|0|||
143026650|NCT01296932|515638508|FG001|Overall Study|Dosage already reduced, AE still present|0|||
143026651|NCT01296932|515638509|FG002|Overall Study|Dosage already reduced, AE still present|0|||
143026652|NCT01296932|515638510|FG003|Overall Study|Dosage already reduced, AE still present|0|||
143026653|NCT01296932|515638511|FG004|Overall Study|Dosage already reduced, AE still present|0|||
143026654|NCT01296932|515638512|FG005|Overall Study|Dosage already reduced, AE still present|0|||
143026655|NCT01296932|515638513|FG006|Overall Study|Dosage already reduced, AE still present|0|||
143026656|NCT01296932|515638514|FG007|Overall Study|Dosage already reduced, AE still present|0|||
143026657|NCT01296932|515638515|FG008|Overall Study|Dosage already reduced, AE still present|1|||
143026658|NCT02207621|515638517|FG000|Overall Study|Adverse Event|71|||
143026659|NCT02207621|515638518|FG001|Overall Study|Adverse Event|15|||
143236974|NCT03773978|516421513|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
143236975|NCT03773978|516421514|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
143236976|NCT03773978|516421513|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
143236977|NCT03773978|516421514|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
143236978|NCT03773978|516421513|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
143026660|NCT02207621|515638519|FG002|Overall Study|Adverse Event|132|||
143026661|NCT02207621|515638517|FG000|Overall Study|Withdrawal by Subject|9|||
143026662|NCT02207621|515638518|FG001|Overall Study|Withdrawal by Subject|9|||
143026663|NCT02207621|515638519|FG002|Overall Study|Withdrawal by Subject|13|||
143026664|NCT02207621|515638517|FG000|Overall Study|Non-Compliant|3|||
143026665|NCT02207621|515638518|FG001|Overall Study|Non-Compliant|3|||
143026666|NCT02207621|515638519|FG002|Overall Study|Non-Compliant|1|||
143236979|NCT03773978|516421514|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
143236980|NCT03773978|516421513|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
143491121|NCT04227899|517340311|FG001|Overall Study|Death|6|||
143491122|NCT04227899|517340310|FG000|Overall Study|Lost to Follow-up|2|||
143491123|NCT04227899|517340311|FG001|Overall Study|Lost to Follow-up|1|||
143026667|NCT02207621|515638517|FG000|Overall Study|Lost to Follow-up|1|||
143026668|NCT02207621|515638518|FG001|Overall Study|Lost to Follow-up|0|||
143026669|NCT02207621|515638519|FG002|Overall Study|Lost to Follow-up|3|||
143026670|NCT02207621|515638517|FG000|Overall Study|Lack of Efficacy|10|||
143026671|NCT02207621|515638518|FG001|Overall Study|Lack of Efficacy|2|||
143026672|NCT02207621|515638519|FG002|Overall Study|Lack of Efficacy|4|||
143026673|NCT02207621|515638517|FG000|Overall Study|Disallowed Concurrent Medication|2|||
143026674|NCT02207621|515638518|FG001|Overall Study|Disallowed Concurrent Medication|5|||
143236981|NCT03773978|516421514|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
143236982|NCT03773978|516421513|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
143236983|NCT03773978|516421514|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
143236984|NCT03773978|516421513|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
143236985|NCT03773978|516421514|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
143236986|NCT03773978|516421513|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
143236987|NCT03773978|516421514|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
143236988|NCT03773978|516421513|FG000|DBW Period|Adverse Event|2|||
143236989|NCT03773978|516421514|FG001|DBW Period|Adverse Event|2|||
143236990|NCT03773978|516421513|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
143236991|NCT03773978|516421514|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
143236992|NCT03773978|516421513|FG000|DBW Period|Withdrawal by Subject|2|||
143236993|NCT03773978|516421514|FG001|DBW Period|Withdrawal by Subject|1|||
143236994|NCT03773978|516421513|FG000|DBW Period|Due to epidemic or pandemic|5|||
143236995|NCT03773978|516421514|FG001|DBW Period|Due to epidemic or pandemic|6|||
143236996|NCT03773978|516421513|FG000|DBW Period|Study team decision|1|||
143236997|NCT03773978|516421514|FG001|DBW Period|Study team decision|0|||
143236998|NCT03755934|516421517|FG000|Overall Study|Adverse Event|4|||
143236999|NCT03755934|516421518|FG001|Overall Study|Adverse Event|1|||
143237000|NCT03755934|516421519|FG002|Overall Study|Adverse Event|1|||
143237001|NCT03755934|516421520|FG003|Overall Study|Adverse Event|3|||
143237002|NCT03755934|516421517|FG000|Overall Study|Physician Decision|2|||
143237003|NCT03755934|516421518|FG001|Overall Study|Physician Decision|0|||
143237004|NCT03755934|516421519|FG002|Overall Study|Physician Decision|0|||
143237005|NCT03755934|516421520|FG003|Overall Study|Physician Decision|1|||
143237006|NCT03755934|516421517|FG000|Overall Study|Withdrawal by Subject|5|||
143237007|NCT03755934|516421518|FG001|Overall Study|Withdrawal by Subject|0|||
143237008|NCT03755934|516421519|FG002|Overall Study|Withdrawal by Subject|0|||
143237009|NCT03755934|516421520|FG003|Overall Study|Withdrawal by Subject|1|||
143237010|NCT03755934|516421517|FG000|Overall Study|Other|3|||
143237011|NCT03755934|516421518|FG001|Overall Study|Other|1|||
143237012|NCT03755934|516421519|FG002|Overall Study|Other|3|||
143237013|NCT03755934|516421520|FG003|Overall Study|Other|1|||
143237014|NCT03058146|516421521|FG000|Overall Study|Withdrawal by Subject|4|||
143237015|NCT03058146|516421522|FG001|Overall Study|Withdrawal by Subject|1|||
143237016|NCT03058146|516421521|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
143237017|NCT03058146|516421522|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
143237018|NCT00632229|516421523|FG000|Overall Study|Adverse Event|6|||
143237019|NCT00632229|516421524|FG001|Overall Study|Adverse Event|0|||
143237020|NCT00632229|516421523|FG000|Overall Study|Lost to Follow-up|0|||
143026675|NCT02207621|515638519|FG002|Overall Study|Disallowed Concurrent Medication|2|||
143026676|NCT02207621|515638517|FG000|Overall Study|Physician Decision|1|||
143026677|NCT02207621|515638518|FG001|Overall Study|Physician Decision|2|||
143026678|NCT02207621|515638519|FG002|Overall Study|Physician Decision|2|||
143158036|NCT04913675|516124383|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
143158037|NCT04913675|516124384|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
143158038|NCT04913675|516124385|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
143158039|NCT04913675|516124386|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
143158040|NCT04913675|516124383|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
143158041|NCT04913675|516124384|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
143158042|NCT04913675|516124385|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
143158043|NCT04913675|516124386|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
143158044|NCT04518410|516124387|FG000|Overall Study|Lost to Follow-up|1|||
143158045|NCT04518410|516124388|FG001|Overall Study|Lost to Follow-up|1|||
143158046|NCT04518410|516124389|FG002|Overall Study|Lost to Follow-up|8|||
143158047|NCT04518410|516124390|FG003|Overall Study|Lost to Follow-up|5|||
143158048|NCT04518410|516124391|FG004|Overall Study|Lost to Follow-up|92|||
143363866|NCT00049517|516875450|FG000|Conditioning/Transplant|Alternative therapy|4|||
143158049|NCT04518410|516124392|FG005|Overall Study|Lost to Follow-up|25|||
143158050|NCT04518410|516124393|FG006|Overall Study|Lost to Follow-up|25|||
143158051|NCT04518410|516124394|FG007|Overall Study|Lost to Follow-up|3|||
143237021|NCT00632229|516421524|FG001|Overall Study|Lost to Follow-up|3|||
143237022|NCT00632229|516421523|FG000|Overall Study|Lack of Efficacy|0|||
143237023|NCT00632229|516421524|FG001|Overall Study|Lack of Efficacy|2|||
143237024|NCT00632229|516421523|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
143237025|NCT00632229|516421524|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
143237026|NCT01467960|516421525|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
143026679|NCT02207621|515638517|FG000|Overall Study|Protocol Violation|4|||
143026680|NCT02207621|515638518|FG001|Overall Study|Protocol Violation|10|||
143026681|NCT02207621|515638519|FG002|Overall Study|Protocol Violation|6|||
143026682|NCT02207621|515638517|FG000|Overall Study|Death|2|||
143026683|NCT02207621|515638518|FG001|Overall Study|Death|0|||
143026684|NCT02207621|515638519|FG002|Overall Study|Death|0|||
143026685|NCT02207621|515638517|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
143026686|NCT02207621|515638518|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
143026687|NCT02207621|515638519|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
143026688|NCT00992407|515638526|FG000|Overall Study|Protocol Violation|2|||
143026689|NCT00992407|515638527|FG001|Overall Study|Protocol Violation|1|||
143026690|NCT00992407|515638526|FG000|Overall Study|Lost to Follow-up|3|||
143026691|NCT00992407|515638527|FG001|Overall Study|Lost to Follow-up|3|||
143026692|NCT00992407|515638526|FG000|Overall Study|Adverse Event|3|||
143026693|NCT00992407|515638527|FG001|Overall Study|Adverse Event|2|||
143026694|NCT00992407|515638526|FG000|Overall Study|protocol Violation & Adverse events|2|||
143026695|NCT00992407|515638527|FG001|Overall Study|protocol Violation & Adverse events|4|||
143026696|NCT00992407|515638526|FG000|Overall Study|Other|2|||
143026697|NCT00992407|515638527|FG001|Overall Study|Other|0|||
143026698|NCT00992407|515638526|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
143026699|NCT00992407|515638527|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
143026700|NCT00992407|515638526|FG000|Overall Study|Study medication not administered|17|||
143026701|NCT00992407|515638527|FG001|Overall Study|Study medication not administered|13|||
143026702|NCT04700449|515638530|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
143026703|NCT04700449|515638531|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
143026704|NCT04700449|515638532|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
143026705|NCT04700449|515638533|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
143026706|NCT04700449|515638530|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
143026707|NCT04700449|515638531|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
143026708|NCT04700449|515638532|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
143026709|NCT04700449|515638533|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
143026710|NCT04700449|515638530|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
143026711|NCT04700449|515638531|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
143026712|NCT04700449|515638532|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
143026713|NCT04700449|515638533|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
143026714|NCT04700449|515638530|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
143026715|NCT04700449|515638531|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
143026716|NCT04700449|515638532|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
143026717|NCT04700449|515638533|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
143026718|NCT04700449|515638530|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
143026719|NCT04700449|515638531|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
143026720|NCT04700449|515638532|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
143026721|NCT04700449|515638533|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
143026722|NCT04700449|515638530|FG000|Stage 1: Double-Blind Period|Other|0|||
143026723|NCT04700449|515638531|FG001|Stage 1: Double-Blind Period|Other|0|||
143026724|NCT04700449|515638532|FG002|Stage 1: Double-Blind Period|Other|1|||
143026725|NCT04700449|515638533|FG003|Stage 1: Double-Blind Period|Other|0|||
143026726|NCT04700449|515638530|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
143026727|NCT04700449|515638531|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
143026728|NCT04700449|515638532|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
143026729|NCT04700449|515638533|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
143026730|NCT04700449|515638530|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
143026731|NCT04700449|515638531|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
143026732|NCT04700449|515638532|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
143026733|NCT04700449|515638533|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
143026734|NCT04700449|515638530|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
143026735|NCT04700449|515638531|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
143026736|NCT04700449|515638532|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
143026737|NCT04700449|515638533|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
143026738|NCT04700449|515638530|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
143026739|NCT04700449|515638531|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
143026740|NCT04700449|515638532|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
143026741|NCT04700449|515638533|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
143026742|NCT04700449|515638530|FG000|Stage 2 Sub-study 1|Other|1|||
143026743|NCT04700449|515638531|FG001|Stage 2 Sub-study 1|Other|2|||
143026744|NCT04700449|515638532|FG002|Stage 2 Sub-study 1|Other|0|||
143026745|NCT04700449|515638533|FG003|Stage 2 Sub-study 1|Other|0|||
143026746|NCT04700449|515638530|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
143026747|NCT04700449|515638531|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
143026748|NCT04700449|515638532|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
143026749|NCT04700449|515638533|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
143026750|NCT04700449|515638530|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
143491124|NCT02479802|517340312|FG000|Overall Study|Lost to Follow-up|1|||
143026751|NCT04700449|515638531|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
143026752|NCT04700449|515638532|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
143026753|NCT04700449|515638533|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
143026754|NCT04700449|515638530|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
143026755|NCT04700449|515638531|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
143026756|NCT04700449|515638532|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
143026757|NCT04700449|515638533|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
143026758|NCT04700449|515638530|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
143026759|NCT04700449|515638531|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
143026760|NCT04700449|515638532|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
143026761|NCT04700449|515638533|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
143026762|NCT04700449|515638530|FG000|Stage 2 Sub-study 2|Other|0|||
143026763|NCT04700449|515638531|FG001|Stage 2 Sub-study 2|Other|0|||
143026764|NCT04700449|515638532|FG002|Stage 2 Sub-study 2|Other|0|||
143026765|NCT04700449|515638533|FG003|Stage 2 Sub-study 2|Other|5|||
143026766|NCT02396381|515638534|FG000|Overall Study|Adverse Event|3|||
143026767|NCT02396381|515638535|FG001|Overall Study|Adverse Event|2|||
143026768|NCT02396381|515638534|FG000|Overall Study|Withdrawal by Subject|33|||
143026769|NCT02396381|515638535|FG001|Overall Study|Withdrawal by Subject|24|||
143026770|NCT02396381|515638534|FG000|Overall Study|Lost to Follow-up|49|||
143026771|NCT02396381|515638535|FG001|Overall Study|Lost to Follow-up|31|||
143026772|NCT02396381|515638534|FG000|Overall Study|Protocol Violation|1|||
143026773|NCT02396381|515638535|FG001|Overall Study|Protocol Violation|0|||
143026774|NCT02396381|515638534|FG000|Overall Study|Site terminated by sponsor|7|||
143026775|NCT02396381|515638535|FG001|Overall Study|Site terminated by sponsor|8|||
143026776|NCT02396381|515638534|FG000|Overall Study|Physician Decision|5|||
143026777|NCT02396381|515638535|FG001|Overall Study|Physician Decision|5|||
143026778|NCT02396381|515638534|FG000|Overall Study|Pregnancy|2|||
143026779|NCT02396381|515638535|FG001|Overall Study|Pregnancy|0|||
143026780|NCT02396381|515638534|FG000|Overall Study|Non-compliance with study procedures|1|||
143026781|NCT02396381|515638535|FG001|Overall Study|Non-compliance with study procedures|0|||
143026782|NCT02396381|515638534|FG000|Overall Study|Moved out of town/state|1|||
143026783|NCT02396381|515638535|FG001|Overall Study|Moved out of town/state|3|||
143026784|NCT02396381|515638534|FG000|Overall Study|Could not complete visit|1|||
143026785|NCT02396381|515638535|FG001|Overall Study|Could not complete visit|0|||
143026786|NCT02396381|515638534|FG000|Overall Study|Possible conflict of interest|1|||
143026787|NCT02396381|515638535|FG001|Overall Study|Possible conflict of interest|0|||
143026788|NCT02396381|515638534|FG000|Overall Study|Randomization/Screening Error|3|||
143026789|NCT02396381|515638535|FG001|Overall Study|Randomization/Screening Error|1|||
143026790|NCT01000337|515638537|FG000|Overall Study|Lost to Follow-up|4|||
143026791|NCT01000337|515638538|FG001|Overall Study|Lost to Follow-up|3|||
143026792|NCT02385526|515638539|FG000|Overall Study|Withdrawal by Subject|0|||
143026793|NCT02385526|515638540|FG001|Overall Study|Withdrawal by Subject|2|||
143026794|NCT02385526|515638541|FG002|Overall Study|Withdrawal by Subject|0|||
143026795|NCT02385526|515638539|FG000|Overall Study|Lost to Follow-up|0|||
143026796|NCT02385526|515638540|FG001|Overall Study|Lost to Follow-up|1|||
143026797|NCT02385526|515638541|FG002|Overall Study|Lost to Follow-up|0|||
143026798|NCT02385526|515638539|FG000|Overall Study|Physician Decision|1|||
143026799|NCT02385526|515638540|FG001|Overall Study|Physician Decision|0|||
143026800|NCT02385526|515638541|FG002|Overall Study|Physician Decision|0|||
143026801|NCT02385526|515638539|FG000|Overall Study|Protocol Violation|1|||
143026802|NCT02385526|515638540|FG001|Overall Study|Protocol Violation|0|||
143158052|NCT04518410|516124395|FG008|Overall Study|Lost to Follow-up|2|||
143158053|NCT04518410|516124396|FG009|Overall Study|Lost to Follow-up|13|||
143491125|NCT02479802|517340312|FG000|Overall Study|Adverse Event|1|||
143491126|NCT05702515|517340313|FG000|Overall Study|7 patients were excluded due to the inability to complete a chest radiograph.|7|||
143158054|NCT04518410|516124397|FG010|Overall Study|Lost to Follow-up|9|||
143158055|NCT04518410|516124398|FG011|Overall Study|Lost to Follow-up|13|||
143491127|NCT02792842|517340318|FG000|Overall Study|Adverse Event|4|||
143491128|NCT02792842|517340319|FG001|Overall Study|Adverse Event|2|||
143491129|NCT02792842|517340320|FG002|Overall Study|Adverse Event|3|||
143491130|NCT02792842|517340318|FG000|Overall Study|Withdrawal by Subject|0|||
143491131|NCT02792842|517340319|FG001|Overall Study|Withdrawal by Subject|1|||
143491132|NCT02792842|517340320|FG002|Overall Study|Withdrawal by Subject|2|||
143491133|NCT02792842|517340318|FG000|Overall Study|Lost to Follow-up|0|||
143491134|NCT02792842|517340319|FG001|Overall Study|Lost to Follow-up|0|||
143491135|NCT02792842|517340320|FG002|Overall Study|Lost to Follow-up|1|||
143491136|NCT02792842|517340318|FG000|Overall Study|Schedule delay|0|||
143491137|NCT02792842|517340319|FG001|Overall Study|Schedule delay|1|||
143026803|NCT02385526|515638541|FG002|Overall Study|Protocol Violation|0|||
143026804|NCT01006707|515638543|FG000|Study Session 1|Lost to Follow-up|2|||
143026805|NCT01006707|515638544|FG001|Study Session 1|Lost to Follow-up|0|||
143026806|NCT01006707|515638545|FG002|Study Session 1|Lost to Follow-up|0|||
143026807|NCT01006707|515638543|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
143026808|NCT01006707|515638544|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
143026809|NCT01006707|515638545|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
143026810|NCT01842958|515638546|FG000|Overall Study|Lost to Follow-up|1|||
143026811|NCT01842958|515638547|FG001|Overall Study|Lost to Follow-up|1|||
143158056|NCT04518410|516124399|FG012|Overall Study|Lost to Follow-up|9|||
143026812|NCT00622908|515638548|FG000|Overall Study|Protocol Violation|1|||
143026813|NCT00622908|515638549|FG001|Overall Study|Protocol Violation|0|||
143026814|NCT00622908|515638548|FG000|Overall Study|Adverse Event|0|||
143026815|NCT00622908|515638549|FG001|Overall Study|Adverse Event|1|||
143026816|NCT00622908|515638548|FG000|Overall Study|Lack of Efficacy|1|||
143026817|NCT00622908|515638549|FG001|Overall Study|Lack of Efficacy|7|||
143026818|NCT00622908|515638548|FG000|Overall Study|Lost to Follow-up|1|||
143026819|NCT00622908|515638549|FG001|Overall Study|Lost to Follow-up|0|||
143026820|NCT00622908|515638548|FG000|Overall Study|Refusal|0|||
143026821|NCT00622908|515638549|FG001|Overall Study|Refusal|1|||
143026822|NCT00622908|515638548|FG000|Overall Study|Termination by study sponser|0|||
143026823|NCT00622908|515638549|FG001|Overall Study|Termination by study sponser|1|||
143026824|NCT03937466|515638550|FG000|Overall Study|not eligbile after the 2-week diary|9|||
143026825|NCT03937466|515638550|FG000|Overall Study|never returned their diary|6|||
143026826|NCT03937466|515638550|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
143026827|NCT03937466|515638550|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
143026828|NCT03213210|515638551|FG000|Overall Study|Lost to Follow-up|2|||
143026829|NCT03213210|515638551|FG000|Overall Study|Study termination|3|||
143026830|NCT01166568|515638557|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
143026831|NCT01166568|515638558|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
143026832|NCT01166568|515638559|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
143026833|NCT01166568|515638557|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
143026834|NCT01166568|515638558|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
143026835|NCT01166568|515638559|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
143026836|NCT01166568|515638557|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
143026837|NCT01166568|515638558|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
143026838|NCT01166568|515638559|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
143026839|NCT00947427|515638560|FG000|Overall Study|Withdrawal by Subject|1|||
143026840|NCT00947427|515638561|FG001|Overall Study|Withdrawal by Subject|3|||
143026841|NCT00947427|515638560|FG000|Overall Study|Protocol Violation|0|||
143491138|NCT02792842|517340320|FG002|Overall Study|Schedule delay|1|||
143491139|NCT01847885|517340321|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
143491140|NCT01847885|517340322|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
143491141|NCT01847885|517340323|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
143491142|NCT01847885|517340321|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
143491143|NCT01847885|517340322|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
143491144|NCT01847885|517340323|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
143491145|NCT01847885|517340321|FG000|Initial Enrollment (Consented)|Screen failure|39|||
143491146|NCT01847885|517340322|FG001|Initial Enrollment (Consented)|Screen failure|0|||
143491147|NCT01847885|517340323|FG002|Initial Enrollment (Consented)|Screen failure|0|||
143491148|NCT01847885|517340321|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
143491149|NCT01847885|517340322|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
143491150|NCT01847885|517340323|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
143491151|NCT01847885|517340321|FG000|Randomization|Protocol Violation|0|||
143491152|NCT01847885|517340322|FG001|Randomization|Protocol Violation|1|||
143491153|NCT01847885|517340323|FG002|Randomization|Protocol Violation|0|||
143491154|NCT01847885|517340321|FG000|Randomization|Withdrawal by Subject|0|||
143491155|NCT01847885|517340322|FG001|Randomization|Withdrawal by Subject|0|||
143491156|NCT01847885|517340323|FG002|Randomization|Withdrawal by Subject|2|||
143491157|NCT01847885|517340321|FG000|Randomization|Screen Failure|0|||
143491158|NCT01847885|517340322|FG001|Randomization|Screen Failure|3|||
143491159|NCT01847885|517340323|FG002|Randomization|Screen Failure|0|||
143491160|NCT05779072|517340324|FG000|Overall Study|Lost to Follow-up|0|||
143491161|NCT05779072|517340325|FG001|Overall Study|Lost to Follow-up|1|||
143491162|NCT05779072|517340324|FG000|Overall Study|Withdrawal by Subject|1|||
143491163|NCT05779072|517340325|FG001|Overall Study|Withdrawal by Subject|5|||
143491164|NCT03694925|517340326|FG000|Overall Study|Inadequate laboratory testing|0|||
143491165|NCT03694925|517340327|FG001|Overall Study|Inadequate laboratory testing|3|||
143491166|NCT03694925|517340328|FG002|Overall Study|Inadequate laboratory testing|0|||
143491167|NCT00343889|517340338|FG000|Overall Study|Lost to Follow-up|2|||
143491168|NCT00343889|517340339|FG001|Overall Study|Lost to Follow-up|0|||
143491169|NCT00343889|517340338|FG000|Overall Study|Withdrawal by Subject|0|||
143491170|NCT00343889|517340339|FG001|Overall Study|Withdrawal by Subject|1|||
143026842|NCT00947427|515638561|FG001|Overall Study|Protocol Violation|1|||
143026843|NCT00249821|515638562|FG000|Overall Study|Technical problem|0|||
143026844|NCT00249821|515638563|FG001|Overall Study|Technical problem|1|||
143026845|NCT01411995|515638565|FG000|Overall Study|Failed IUD insertion|0|||
143026846|NCT01411995|515638566|FG001|Overall Study|Failed IUD insertion|1|||
143026847|NCT00319956|515638569|FG000|Overall Study|Death|20|||
143026848|NCT00319956|515638570|FG001|Overall Study|Death|24|||
143026849|NCT04000009|515638571|FG000|Overall Study|Adverse Event|13|||
143026850|NCT04000009|515638571|FG000|Overall Study|Lack of Efficacy|7|||
143026851|NCT04000009|515638571|FG000|Overall Study|Lost to Follow-up|8|||
143491171|NCT00343889|517340338|FG000|Overall Study|Protocol Violation|1|||
143026852|NCT04000009|515638571|FG000|Overall Study|Noncompliance with study drug|4|||
143026853|NCT04000009|515638571|FG000|Overall Study|Physician Decision|1|||
143026854|NCT04000009|515638571|FG000|Overall Study|Use of prohibited medication|3|||
143026855|NCT04000009|515638571|FG000|Overall Study|Pregnancy|1|||
143026856|NCT04000009|515638571|FG000|Overall Study|Withdrawal by Subject|22|||
143026857|NCT04000009|515638571|FG000|Overall Study|Study terminated by sponsor|98|||
143026858|NCT04000009|515638571|FG000|Overall Study|Not further specified|8|||
143026859|NCT02292238|515638572|FG000|Overall Study|Protocol Violation|1|||
143026860|NCT02292238|515638573|FG001|Overall Study|Protocol Violation|2|||
143026861|NCT02292238|515638572|FG000|Overall Study|Withdrawal by Subject|2|||
143026862|NCT02292238|515638573|FG001|Overall Study|Withdrawal by Subject|1|||
143026863|NCT02292238|515638572|FG000|Overall Study|Lost to Follow-up|1|||
143026864|NCT02292238|515638573|FG001|Overall Study|Lost to Follow-up|0|||
143026865|NCT02292238|515638572|FG000|Overall Study|Physician Decision|0|||
143026866|NCT02292238|515638573|FG001|Overall Study|Physician Decision|1|||
143026867|NCT00619385|515638576|FG000|Overall Study|Adverse Event|0|||
143026868|NCT00619385|515638577|FG001|Overall Study|Adverse Event|0|||
143026869|NCT00619385|515638578|FG002|Overall Study|Adverse Event|3|||
143026870|NCT00619385|515638576|FG000|Overall Study|Other|1|||
143026871|NCT00619385|515638577|FG001|Overall Study|Other|2|||
143026872|NCT00619385|515638578|FG002|Overall Study|Other|1|||
143026873|NCT02041702|515638579|FG000|Overall Study|Lost to Follow-up|1|||
143026874|NCT02041702|515638580|FG001|Overall Study|Lost to Follow-up|6|||
143026875|NCT02041702|515638579|FG000|Overall Study|Death|4|||
143026876|NCT02041702|515638580|FG001|Overall Study|Death|0|||
143491172|NCT00343889|517340339|FG001|Overall Study|Protocol Violation|0|||
143491173|NCT03652662|517340342|FG000|Overall Study|Withdrawal by Subject|2|||
143026877|NCT02041702|515638579|FG000|Overall Study|Withdrawal by Subject|4|||
143491174|NCT03652662|517340343|FG001|Overall Study|Withdrawal by Subject|1|||
143026878|NCT02041702|515638580|FG001|Overall Study|Withdrawal by Subject|3|||
143026879|NCT02041702|515638579|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
143026880|NCT02041702|515638580|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
143026881|NCT02041702|515638579|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
143026882|NCT02041702|515638580|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
143026883|NCT03271528|515638581|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
143026884|NCT03271528|515638582|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
143026885|NCT03271528|515638581|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
143491175|NCT03652662|517340342|FG000|Overall Study|Lost to Follow-up|1|||
143491176|NCT03652662|517340343|FG001|Overall Study|Lost to Follow-up|0|||
143491177|NCT00487539|517340344|FG000|Overall Study|Adverse Event|3|||
143491178|NCT00487539|517340345|FG001|Overall Study|Adverse Event|2|||
143491179|NCT00487539|517340346|FG002|Overall Study|Adverse Event|1|||
143491180|NCT00487539|517340347|FG003|Overall Study|Adverse Event|1|||
143491181|NCT00487539|517340344|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
143491182|NCT00487539|517340345|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
143491183|NCT00487539|517340346|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
143491184|NCT00487539|517340347|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
143026886|NCT03271528|515638582|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
143026887|NCT03271528|515638581|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
143026888|NCT03271528|515638582|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
143026889|NCT03271528|515638581|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
143026890|NCT03271528|515638582|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
143026891|NCT03271528|515638581|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
143026892|NCT03271528|515638582|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
143026893|NCT03271528|515638581|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
143026894|NCT03271528|515638582|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
143026895|NCT03271528|515638581|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
143026896|NCT03271528|515638582|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
143026897|NCT00745251|515638583|FG000|Overall Study|Adverse Event|1|||
143026898|NCT00745251|515638584|FG001|Overall Study|Adverse Event|2|||
143026899|NCT00745251|515638583|FG000|Overall Study|Withdrawal by Subject|1|||
143491185|NCT00487539|517340344|FG000|Overall Study|Other|3|||
143491186|NCT00487539|517340345|FG001|Overall Study|Other|1|||
143491187|NCT00487539|517340346|FG002|Overall Study|Other|2|||
143491188|NCT00487539|517340347|FG003|Overall Study|Other|2|||
143026900|NCT00745251|515638584|FG001|Overall Study|Withdrawal by Subject|1|||
143026901|NCT02928848|515638585|FG000|Arm 2|Withdrawal by Subject|1|||
143491189|NCT02751502|517340348|FG000|Overall Study|Lack of funding|4|||
143491190|NCT03499028|517340349|FG000|Overall Study|Lost to Follow-up|12|||
143026902|NCT02928848|515638586|FG001|Arm 2|Withdrawal by Subject|0|||
143026903|NCT03850509|515638587|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
143158057|NCT04518410|516124400|FG013|Overall Study|Lost to Follow-up|13|||
143491191|NCT03499028|517340350|FG001|Overall Study|Lost to Follow-up|9|||
143491192|NCT03499028|517340349|FG000|Overall Study|Withdrawal by Subject|5|||
143026904|NCT03850509|515638588|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
143026905|NCT00969332|515638589|FG000|Overall Study|Physician Decision|8|||
143026906|NCT00969332|515638589|FG000|Overall Study|Withdrawal by Subject|3|||
143026907|NCT02666430|515638590|FG000|Period 1|Lost to Follow-up|1|||
143026908|NCT02666430|515638591|FG001|Period 1|Lost to Follow-up|0|||
143026909|NCT02666430|515638590|FG000|Period 1|Adverse Event|0|||
143026910|NCT02666430|515638591|FG001|Period 1|Adverse Event|1|||
143026911|NCT02666430|515638590|FG000|Period 2|Withdrawal by Subject|1|||
143026912|NCT02666430|515638591|FG001|Period 2|Withdrawal by Subject|4|||
143026913|NCT02666430|515638590|FG000|Period 3|Lost to Follow-up|1|||
143026914|NCT02666430|515638591|FG001|Period 3|Lost to Follow-up|0|||
143026915|NCT03828461|515638592|FG000|Overall Study|Lost to Follow-up|1|||
143026916|NCT03828461|515638592|FG000|Overall Study|Withdrawal by Subject|3|||
143026917|NCT00576199|515638593|FG000|Overall Study|Adverse Event|12|||
143026918|NCT00576199|515638593|FG000|Overall Study|Insufficient Therapeutic Response|14|||
143026919|NCT00576199|515638593|FG000|Overall Study|Refused Treatment|2|||
143026920|NCT00576199|515638593|FG000|Overall Study|Reason Unspecified|2|||
143026921|NCT01463683|515638595|FG000|Overall Study|Adverse Event|2|||
143491193|NCT03499028|517340350|FG001|Overall Study|Withdrawal by Subject|8|||
143491194|NCT03499028|517340349|FG000|Overall Study|Unplanned SNF discharge|5|||
143026922|NCT01463683|515638596|FG001|Overall Study|Adverse Event|0|||
143026923|NCT01463683|515638597|FG002|Overall Study|Adverse Event|0|||
143026924|NCT01463683|515638595|FG000|Overall Study|Lost to Follow-up|10|||
143026925|NCT01463683|515638596|FG001|Overall Study|Lost to Follow-up|9|||
143026926|NCT01463683|515638597|FG002|Overall Study|Lost to Follow-up|7|||
143026927|NCT01463683|515638595|FG000|Overall Study|Physician Decision|0|||
143026928|NCT01463683|515638596|FG001|Overall Study|Physician Decision|3|||
143026929|NCT01463683|515638597|FG002|Overall Study|Physician Decision|1|||
143026930|NCT01463683|515638595|FG000|Overall Study|Pregnancy|2|||
143026931|NCT01463683|515638596|FG001|Overall Study|Pregnancy|2|||
143026932|NCT01463683|515638597|FG002|Overall Study|Pregnancy|1|||
143026933|NCT01463683|515638595|FG000|Overall Study|Withdrawal by Subject|5|||
143026934|NCT01463683|515638596|FG001|Overall Study|Withdrawal by Subject|17|||
143026935|NCT01463683|515638597|FG002|Overall Study|Withdrawal by Subject|2|||
143026936|NCT03111147|515638598|FG000|Overall Study|Lost to Follow-up|2|||
143026937|NCT03111147|515638599|FG001|Overall Study|Lost to Follow-up|5|||
143026938|NCT03111147|515638598|FG000|Overall Study|Withdrawal by Subject|4|||
143026939|NCT03111147|515638599|FG001|Overall Study|Withdrawal by Subject|3|||
143026940|NCT03111147|515638598|FG000|Overall Study|Protocol Violation|2|||
143026941|NCT03111147|515638599|FG001|Overall Study|Protocol Violation|1|||
143026942|NCT03111147|515638598|FG000|Overall Study|Death|1|||
143026943|NCT03111147|515638599|FG001|Overall Study|Death|1|||
143026944|NCT01618305|515638600|FG000|Overall Study|Death|0|||
143158058|NCT04518410|516124401|FG014|Overall Study|Lost to Follow-up|8|||
143491195|NCT03499028|517340350|FG001|Overall Study|Unplanned SNF discharge|8|||
143491196|NCT00720109|517340351|FG000|Induction Period|Did not meet eligibility criteria|3|||
143491197|NCT00720109|517340352|FG001|Induction Period|Did not meet eligibility criteria|0|||
143491198|NCT00720109|517340353|FG002|Induction Period|Did not meet eligibility criteria|0|||
143491199|NCT00720109|517340351|FG000|Induction Period|Bone Marrow Transplant|2|||
143491200|NCT00720109|517340352|FG001|Induction Period|Bone Marrow Transplant|0|||
143491201|NCT00720109|517340353|FG002|Induction Period|Bone Marrow Transplant|0|||
143491202|NCT00720109|517340351|FG000|Induction Period|Physician Decision|1|||
143491203|NCT00720109|517340352|FG001|Induction Period|Physician Decision|0|||
143491204|NCT00720109|517340353|FG002|Induction Period|Physician Decision|0|||
143491205|NCT00720109|517340351|FG000|Risk Stratification Period|Adverse Event|0|||
143491206|NCT00720109|517340352|FG001|Risk Stratification Period|Adverse Event|1|||
143491207|NCT00720109|517340353|FG002|Risk Stratification Period|Adverse Event|0|||
143491208|NCT00720109|517340351|FG000|Risk Stratification Period|Physician Decision|0|||
143491209|NCT00720109|517340352|FG001|Risk Stratification Period|Physician Decision|2|||
143491210|NCT00720109|517340353|FG002|Risk Stratification Period|Physician Decision|1|||
143491211|NCT00720109|517340351|FG000|Risk Stratification Period|Bone marrow transplant|0|||
143491212|NCT00720109|517340352|FG001|Risk Stratification Period|Bone marrow transplant|9|||
143491213|NCT00720109|517340353|FG002|Risk Stratification Period|Bone marrow transplant|7|||
143491214|NCT00720109|517340351|FG000|Risk Stratification Period|Disease progression or relapse|0|||
143491215|NCT00720109|517340352|FG001|Risk Stratification Period|Disease progression or relapse|2|||
143491216|NCT00720109|517340353|FG002|Risk Stratification Period|Disease progression or relapse|0|||
143026945|NCT01618305|515638601|FG001|Overall Study|Death|1|||
143158059|NCT04518410|516124402|FG015|Overall Study|Lost to Follow-up|10|||
143026946|NCT01618305|515638600|FG000|Overall Study|Lost to Follow-up|11|||
143026947|NCT01618305|515638601|FG001|Overall Study|Lost to Follow-up|7|||
143026948|NCT01618305|515638600|FG000|Overall Study|Protocol Violation|1|||
143026949|NCT01618305|515638601|FG001|Overall Study|Protocol Violation|0|||
143026950|NCT01618305|515638600|FG000|Overall Study|Withdrawal by Subject|3|||
143026951|NCT01618305|515638601|FG001|Overall Study|Withdrawal by Subject|2|||
143026952|NCT02102490|515638603|FG000|Overall Study|Death|6|||
143026953|NCT02102490|515638603|FG000|Overall Study|Lost to Follow-up|1|||
143158060|NCT04518410|516124403|FG016|Overall Study|Lost to Follow-up|6|||
143026954|NCT00385541|515638604|FG000|Overall Study|severe pain, clinician requested unblind|0|||
143026955|NCT00385541|515638605|FG001|Overall Study|severe pain, clinician requested unblind|1|||
143026956|NCT02154529|515638606|FG000|Overall Study|Death|1|||
143026957|NCT02154529|515638607|FG001|Overall Study|Death|1|||
143026958|NCT02154529|515638608|FG002|Overall Study|Death|5|||
143026959|NCT02154529|515638609|FG003|Overall Study|Death|1|||
143026960|NCT02154529|515638606|FG000|Overall Study|Termination of study by sponsor|2|||
143026961|NCT02154529|515638607|FG001|Overall Study|Termination of study by sponsor|2|||
143026962|NCT02154529|515638608|FG002|Overall Study|Termination of study by sponsor|3|||
143026963|NCT02154529|515638609|FG003|Overall Study|Termination of study by sponsor|1|||
143026964|NCT02154529|515638606|FG000|Overall Study|Lost to Follow-up|1|||
143026965|NCT02154529|515638607|FG001|Overall Study|Lost to Follow-up|0|||
143026966|NCT02154529|515638608|FG002|Overall Study|Lost to Follow-up|0|||
143026967|NCT02154529|515638609|FG003|Overall Study|Lost to Follow-up|0|||
143026968|NCT02192905|515640091|FG000|Overall Study|Lost to Follow-up|1|||
143026969|NCT03093454|515640101|FG000|Overall Study|Withdrawal by Subject|1|||
143026970|NCT03093454|515640102|FG001|Overall Study|Withdrawal by Subject|1|||
143026971|NCT03093454|515640101|FG000|Overall Study|Scheduling conflict|3|||
143026972|NCT03093454|515640102|FG001|Overall Study|Scheduling conflict|1|||
143026973|NCT03093454|515640101|FG000|Overall Study|Physician Decision|2|||
143026974|NCT03093454|515640102|FG001|Overall Study|Physician Decision|1|||
143026975|NCT00356200|515640103|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
143026976|NCT00356200|515640104|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
143026977|NCT00356200|515640103|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
143026978|NCT00356200|515640104|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
143026979|NCT00635778|515640105|FG000|Overall Study|Adverse Event|1|||
143026980|NCT00635778|515640106|FG001|Overall Study|Adverse Event|0|||
143026981|NCT00635778|515640107|FG002|Overall Study|Adverse Event|0|||
143026982|NCT00635778|515640108|FG003|Overall Study|Adverse Event|3|||
143026983|NCT00635778|515640109|FG004|Overall Study|Adverse Event|3|||
143026984|NCT00635778|515640110|FG005|Overall Study|Adverse Event|6|||
143026985|NCT00635778|515640111|FG006|Overall Study|Adverse Event|1|||
143026986|NCT00635778|515640105|FG000|Overall Study|Withdrawal by Subject|0|||
143026987|NCT00635778|515640106|FG001|Overall Study|Withdrawal by Subject|0|||
143026988|NCT00635778|515640107|FG002|Overall Study|Withdrawal by Subject|0|||
143026989|NCT00635778|515640108|FG003|Overall Study|Withdrawal by Subject|1|||
143026990|NCT00635778|515640109|FG004|Overall Study|Withdrawal by Subject|0|||
143026991|NCT00635778|515640110|FG005|Overall Study|Withdrawal by Subject|1|||
143026992|NCT00635778|515640111|FG006|Overall Study|Withdrawal by Subject|1|||
143026993|NCT00635778|515640105|FG000|Overall Study|Progressive disease|0|||
143026994|NCT00635778|515640106|FG001|Overall Study|Progressive disease|3|||
143026995|NCT00635778|515640107|FG002|Overall Study|Progressive disease|3|||
143026996|NCT00635778|515640108|FG003|Overall Study|Progressive disease|4|||
143026997|NCT00635778|515640109|FG004|Overall Study|Progressive disease|5|||
143026998|NCT00635778|515640110|FG005|Overall Study|Progressive disease|14|||
143026999|NCT00635778|515640111|FG006|Overall Study|Progressive disease|4|||
143027000|NCT02750761|515640120|FG000|Overall Study|Lost to Follow-up|0|||
143027001|NCT02750761|515640121|FG001|Overall Study|Lost to Follow-up|0|||
143027002|NCT02750761|515640122|FG002|Overall Study|Lost to Follow-up|1|||
143027003|NCT02750761|515640123|FG003|Overall Study|Lost to Follow-up|0|||
143027004|NCT02750761|515640124|FG004|Overall Study|Lost to Follow-up|0|||
143027005|NCT02750761|515640125|FG005|Overall Study|Lost to Follow-up|0|||
143027006|NCT01612000|515640126|FG000|Overall Study|Lost to Follow-up|6|||
143027007|NCT01612000|515640127|FG001|Overall Study|Lost to Follow-up|4|||
143027008|NCT01612000|515640128|FG002|Overall Study|Lost to Follow-up|4|||
143027009|NCT01612000|515640129|FG003|Overall Study|Lost to Follow-up|8|||
143027010|NCT01612000|515640126|FG000|Overall Study|Physician Decision|0|||
143027011|NCT01612000|515640127|FG001|Overall Study|Physician Decision|0|||
143027012|NCT01612000|515640128|FG002|Overall Study|Physician Decision|1|||
143491217|NCT00720109|517340351|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
143491218|NCT00720109|517340352|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
143491219|NCT00720109|517340353|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
143491220|NCT01110200|517340354|FG000|Overall Study|Adverse Event|28|||
143491221|NCT01110200|517340355|FG001|Overall Study|Adverse Event|28|||
143491222|NCT01110200|517340354|FG000|Overall Study|Withdrawal by Subject|25|||
143027013|NCT01612000|515640129|FG003|Overall Study|Physician Decision|0|||
143027014|NCT01612000|515640126|FG000|Overall Study|Withdrawal by Subject|3|||
143027015|NCT01612000|515640127|FG001|Overall Study|Withdrawal by Subject|1|||
143027016|NCT01612000|515640128|FG002|Overall Study|Withdrawal by Subject|2|||
143027017|NCT01612000|515640129|FG003|Overall Study|Withdrawal by Subject|2|||
143027018|NCT01180244|515640132|FG000|Overall Study|Lack of Efficacy|0|||
143027019|NCT01180244|515640133|FG001|Overall Study|Lack of Efficacy|7|||
143027020|NCT01180244|515640132|FG000|Overall Study|Physician Decision|3|||
143027021|NCT01180244|515640133|FG001|Overall Study|Physician Decision|0|||
143027022|NCT01180244|515640132|FG000|Overall Study|Adverse Event|1|||
143027023|NCT01180244|515640133|FG001|Overall Study|Adverse Event|0|||
143027024|NCT01180244|515640132|FG000|Overall Study|Withdrawal by Subject|0|||
143027025|NCT01180244|515640133|FG001|Overall Study|Withdrawal by Subject|1|||
143027026|NCT01180244|515640132|FG000|Overall Study|Protocol Violation|1|||
143027027|NCT01180244|515640133|FG001|Overall Study|Protocol Violation|0|||
143027028|NCT01180244|515640132|FG000|Overall Study|Lost to Follow-up|1|||
143027029|NCT01180244|515640133|FG001|Overall Study|Lost to Follow-up|0|||
143027030|NCT02866175|515640136|FG000|Overall Study|Adverse Event|56|||
143027031|NCT02866175|515640137|FG001|Overall Study|Adverse Event|54|||
143027032|NCT02866175|515640136|FG000|Overall Study|Withdrawal by Subject|31|||
143027033|NCT02866175|515640137|FG001|Overall Study|Withdrawal by Subject|52|||
143027034|NCT02866175|515640136|FG000|Overall Study|Death|30|||
143027035|NCT02866175|515640137|FG001|Overall Study|Death|23|||
143027036|NCT02866175|515640136|FG000|Overall Study|Other|7|||
143027037|NCT02866175|515640137|FG001|Overall Study|Other|14|||
143027038|NCT02866175|515640136|FG000|Overall Study|Progressive disease|1|||
143027039|NCT02866175|515640137|FG001|Overall Study|Progressive disease|1|||
143027040|NCT02866175|515640136|FG000|Overall Study|Lost to Follow-up|2|||
143027041|NCT02866175|515640137|FG001|Overall Study|Lost to Follow-up|0|||
143027042|NCT02866175|515640136|FG000|Overall Study|Lack of Efficacy|0|||
143027043|NCT02866175|515640137|FG001|Overall Study|Lack of Efficacy|1|||
143027044|NCT02866175|515640136|FG000|Overall Study|Physician Decision|3|||
143027045|NCT02866175|515640137|FG001|Overall Study|Physician Decision|15|||
143027046|NCT02866175|515640136|FG000|Overall Study|Did not receive treatment|5|||
143027047|NCT02866175|515640137|FG001|Overall Study|Did not receive treatment|15|||
143027048|NCT01694485|515640138|FG000|Overall Study|Withdrawal by Subject|20|||
143027049|NCT01694485|515640139|FG001|Overall Study|Withdrawal by Subject|6|||
143027050|NCT01694485|515640140|FG002|Overall Study|Withdrawal by Subject|7|||
143027051|NCT01694485|515640141|FG003|Overall Study|Withdrawal by Subject|25|||
143027052|NCT01694485|515640142|FG004|Overall Study|Withdrawal by Subject|18|||
143027053|NCT01694485|515640138|FG000|Overall Study|Sponsor Decision|3|||
143027054|NCT01694485|515640139|FG001|Overall Study|Sponsor Decision|0|||
143027055|NCT01694485|515640140|FG002|Overall Study|Sponsor Decision|0|||
143027056|NCT01694485|515640141|FG003|Overall Study|Sponsor Decision|2|||
143027057|NCT01694485|515640142|FG004|Overall Study|Sponsor Decision|0|||
143027058|NCT01694485|515640138|FG000|Overall Study|Lost to Follow-up|9|||
143027059|NCT01694485|515640139|FG001|Overall Study|Lost to Follow-up|1|||
143027060|NCT01694485|515640140|FG002|Overall Study|Lost to Follow-up|6|||
143027061|NCT01694485|515640141|FG003|Overall Study|Lost to Follow-up|10|||
143027062|NCT01694485|515640142|FG004|Overall Study|Lost to Follow-up|7|||
143027063|NCT01694485|515640138|FG000|Overall Study|Death|1|||
143027064|NCT01694485|515640139|FG001|Overall Study|Death|0|||
143027065|NCT01694485|515640140|FG002|Overall Study|Death|0|||
143027066|NCT01694485|515640141|FG003|Overall Study|Death|1|||
143027067|NCT01694485|515640142|FG004|Overall Study|Death|0|||
143027068|NCT01595009|515640143|FG000|Core|Patients completed per protocol|85|||
143027069|NCT01595009|515640144|FG001|Core|Patients completed per protocol|44|||
143027070|NCT01595009|515640145|FG002|Core|Patients completed per protocol|0|||
143027071|NCT01595009|515640146|FG003|Core|Patients completed per protocol|0|||
143027072|NCT01595009|515640143|FG000|Core|Adverse Event|19|||
143027073|NCT01595009|515640144|FG001|Core|Adverse Event|23|||
143027074|NCT01595009|515640145|FG002|Core|Adverse Event|0|||
143027075|NCT01595009|515640146|FG003|Core|Adverse Event|0|||
143027076|NCT01595009|515640143|FG000|Core|Disease progression|14|||
143027077|NCT01595009|515640144|FG001|Core|Disease progression|26|||
143027078|NCT01595009|515640145|FG002|Core|Disease progression|0|||
143027079|NCT01595009|515640146|FG003|Core|Disease progression|0|||
143027080|NCT01595009|515640143|FG000|Core|Withdrawal by Subject|4|||
143027081|NCT01595009|515640144|FG001|Core|Withdrawal by Subject|17|||
143027082|NCT01595009|515640145|FG002|Core|Withdrawal by Subject|0|||
143027083|NCT01595009|515640146|FG003|Core|Withdrawal by Subject|0|||
143027084|NCT01595009|515640143|FG000|Core|Death|3|||
143027085|NCT01595009|515640144|FG001|Core|Death|6|||
143027086|NCT01595009|515640145|FG002|Core|Death|0|||
143027087|NCT01595009|515640146|FG003|Core|Death|0|||
143027088|NCT01595009|515640143|FG000|Core|Lost to Follow-up|1|||
143027089|NCT01595009|515640144|FG001|Core|Lost to Follow-up|2|||
143027090|NCT01595009|515640145|FG002|Core|Lost to Follow-up|0|||
143027091|NCT01595009|515640146|FG003|Core|Lost to Follow-up|0|||
143491223|NCT01110200|517340355|FG001|Overall Study|Withdrawal by Subject|32|||
143491224|NCT01110200|517340354|FG000|Overall Study|Lack of Efficacy|16|||
143027092|NCT01595009|515640143|FG000|Core|Protocol deviation|0|||
143027093|NCT01595009|515640144|FG001|Core|Protocol deviation|1|||
143027094|NCT01595009|515640145|FG002|Core|Protocol deviation|0|||
143027095|NCT01595009|515640146|FG003|Core|Protocol deviation|0|||
143027096|NCT01595009|515640143|FG000|Core|Administrative problems|0|||
143027097|NCT01595009|515640144|FG001|Core|Administrative problems|1|||
143027098|NCT01595009|515640145|FG002|Core|Administrative problems|0|||
143027099|NCT01595009|515640146|FG003|Core|Administrative problems|0|||
143027100|NCT01595009|515640143|FG000|Extension|Administrative problems|0|||
143027101|NCT01595009|515640144|FG001|Extension|Administrative problems|0|||
143027102|NCT01595009|515640145|FG002|Extension|Administrative problems|0|||
143027103|NCT01595009|515640146|FG003|Extension|Administrative problems|1|||
143027104|NCT01595009|515640143|FG000|Extension|Patients completed per protocol|0|||
143491225|NCT01110200|517340355|FG001|Overall Study|Lack of Efficacy|25|||
143363867|NCT00049517|516875451|FG001|Conditioning/Transplant|Alternative therapy|4|||
143363868|NCT00049517|516875452|FG002|Conditioning/Transplant|Alternative therapy|2|||
143491226|NCT01110200|517340354|FG000|Overall Study|Protocol Violation|14|||
143491227|NCT01110200|517340355|FG001|Overall Study|Protocol Violation|12|||
143491228|NCT01110200|517340354|FG000|Overall Study|Physician Decision|13|||
143491229|NCT01110200|517340355|FG001|Overall Study|Physician Decision|17|||
143491230|NCT01110200|517340354|FG000|Overall Study|Lost to Follow-up|10|||
143491231|NCT01110200|517340355|FG001|Overall Study|Lost to Follow-up|7|||
143491232|NCT03467958|517340356|FG000|Overall Study|Adverse Event|20|||
143491233|NCT03467958|517340357|FG001|Overall Study|Adverse Event|32|||
143491234|NCT03467958|517340358|FG002|Overall Study|Adverse Event|5|||
143491235|NCT03467958|517340359|FG003|Overall Study|Adverse Event|3|||
143491236|NCT03467958|517340360|FG004|Overall Study|Adverse Event|3|||
143491237|NCT03467958|517340361|FG005|Overall Study|Adverse Event|3|||
143491238|NCT03467958|517340362|FG006|Overall Study|Adverse Event|6|||
143491239|NCT03467958|517340363|FG007|Overall Study|Adverse Event|5|||
143491240|NCT03467958|517340364|FG008|Overall Study|Adverse Event|0|||
143491241|NCT03467958|517340356|FG000|Overall Study|Lack of Efficacy|59|||
143491242|NCT03467958|517340357|FG001|Overall Study|Lack of Efficacy|120|||
143491243|NCT03467958|517340358|FG002|Overall Study|Lack of Efficacy|6|||
143491244|NCT03467958|517340359|FG003|Overall Study|Lack of Efficacy|9|||
143491245|NCT03467958|517340360|FG004|Overall Study|Lack of Efficacy|8|||
143491246|NCT03467958|517340361|FG005|Overall Study|Lack of Efficacy|9|||
143491247|NCT03467958|517340362|FG006|Overall Study|Lack of Efficacy|11|||
143491248|NCT03467958|517340363|FG007|Overall Study|Lack of Efficacy|9|||
143491249|NCT03467958|517340364|FG008|Overall Study|Lack of Efficacy|3|||
143491250|NCT03467958|517340356|FG000|Overall Study|Lost to Follow-up|1|||
143491251|NCT03467958|517340357|FG001|Overall Study|Lost to Follow-up|2|||
143491252|NCT03467958|517340358|FG002|Overall Study|Lost to Follow-up|1|||
143491253|NCT03467958|517340359|FG003|Overall Study|Lost to Follow-up|0|||
143491254|NCT03467958|517340360|FG004|Overall Study|Lost to Follow-up|4|||
143491255|NCT03467958|517340361|FG005|Overall Study|Lost to Follow-up|0|||
143491256|NCT03467958|517340362|FG006|Overall Study|Lost to Follow-up|0|||
143491257|NCT03467958|517340363|FG007|Overall Study|Lost to Follow-up|0|||
143491258|NCT03467958|517340364|FG008|Overall Study|Lost to Follow-up|0|||
143491259|NCT03467958|517340356|FG000|Overall Study|Other reasons|8|||
143491260|NCT03467958|517340357|FG001|Overall Study|Other reasons|14|||
143491261|NCT03467958|517340358|FG002|Overall Study|Other reasons|2|||
143491262|NCT03467958|517340359|FG003|Overall Study|Other reasons|1|||
143491263|NCT03467958|517340360|FG004|Overall Study|Other reasons|4|||
143491264|NCT03467958|517340361|FG005|Overall Study|Other reasons|0|||
143491265|NCT03467958|517340362|FG006|Overall Study|Other reasons|1|||
143491266|NCT03467958|517340363|FG007|Overall Study|Other reasons|0|||
143491267|NCT03467958|517340364|FG008|Overall Study|Other reasons|1|||
143491268|NCT03467958|517340356|FG000|Overall Study|Pregnancy|1|||
143491269|NCT03467958|517340357|FG001|Overall Study|Pregnancy|0|||
143491270|NCT03467958|517340358|FG002|Overall Study|Pregnancy|0|||
143491271|NCT03467958|517340359|FG003|Overall Study|Pregnancy|0|||
143491272|NCT03467958|517340360|FG004|Overall Study|Pregnancy|0|||
143491273|NCT03467958|517340361|FG005|Overall Study|Pregnancy|1|||
143491274|NCT03467958|517340362|FG006|Overall Study|Pregnancy|0|||
143491275|NCT03467958|517340363|FG007|Overall Study|Pregnancy|0|||
143491276|NCT03467958|517340364|FG008|Overall Study|Pregnancy|0|||
143491277|NCT03467958|517340356|FG000|Overall Study|Study terminated by sponsor|65|||
143491278|NCT03467958|517340357|FG001|Overall Study|Study terminated by sponsor|117|||
143491279|NCT03467958|517340358|FG002|Overall Study|Study terminated by sponsor|45|||
143491280|NCT03467958|517340359|FG003|Overall Study|Study terminated by sponsor|64|||
143491281|NCT03467958|517340360|FG004|Overall Study|Study terminated by sponsor|66|||
143491282|NCT03467958|517340361|FG005|Overall Study|Study terminated by sponsor|17|||
143491283|NCT03467958|517340362|FG006|Overall Study|Study terminated by sponsor|11|||
143491284|NCT03467958|517340363|FG007|Overall Study|Study terminated by sponsor|5|||
143491285|NCT03467958|517340364|FG008|Overall Study|Study terminated by sponsor|5|||
143491286|NCT03467958|517340356|FG000|Overall Study|Withdrawal by Subject|25|||
143491287|NCT03467958|517340357|FG001|Overall Study|Withdrawal by Subject|44|||
143491288|NCT03467958|517340358|FG002|Overall Study|Withdrawal by Subject|7|||
143491289|NCT03467958|517340359|FG003|Overall Study|Withdrawal by Subject|8|||
143491290|NCT03467958|517340360|FG004|Overall Study|Withdrawal by Subject|6|||
143491291|NCT03467958|517340361|FG005|Overall Study|Withdrawal by Subject|8|||
143491292|NCT03467958|517340362|FG006|Overall Study|Withdrawal by Subject|4|||
143491293|NCT03467958|517340363|FG007|Overall Study|Withdrawal by Subject|1|||
143491294|NCT03467958|517340364|FG008|Overall Study|Withdrawal by Subject|4|||
143158061|NCT04518410|516124404|FG017|Overall Study|Lost to Follow-up|13|||
143158062|NCT04518410|516124405|FG018|Overall Study|Lost to Follow-up|21|||
143158063|NCT04518410|516124406|FG019|Overall Study|Lost to Follow-up|6|||
143158064|NCT04518410|516124407|FG020|Overall Study|Lost to Follow-up|7|||
143158065|NCT04518410|516124408|FG021|Overall Study|Lost to Follow-up|21|||
143158066|NCT04518410|516124409|FG022|Overall Study|Lost to Follow-up|1|||
143158067|NCT04518410|516124410|FG023|Overall Study|Lost to Follow-up|7|||
143158068|NCT04518410|516124411|FG024|Overall Study|Lost to Follow-up|6|||
143158069|NCT04518410|516124387|FG000|Overall Study|Withdrawal by Subject|1|||
143027105|NCT01595009|515640144|FG001|Extension|Patients completed per protocol|0|||
143027106|NCT01595009|515640145|FG002|Extension|Patients completed per protocol|0|||
143027107|NCT01595009|515640146|FG003|Extension|Patients completed per protocol|2|||
143027108|NCT01595009|515640143|FG000|Extension|Disease progression|0|||
143027109|NCT01595009|515640144|FG001|Extension|Disease progression|0|||
143027110|NCT01595009|515640145|FG002|Extension|Disease progression|4|||
143027111|NCT01595009|515640146|FG003|Extension|Disease progression|7|||
143027112|NCT01595009|515640143|FG000|Extension|Adverse Event|0|||
143027113|NCT01595009|515640144|FG001|Extension|Adverse Event|0|||
143027114|NCT01595009|515640145|FG002|Extension|Adverse Event|0|||
143027115|NCT01595009|515640146|FG003|Extension|Adverse Event|1|||
143027116|NCT02907203|515640148|FG000|Overall Study|Death|1|||
143027117|NCT02907203|515640148|FG000|Overall Study|Lost to Follow-up|3|||
143027118|NCT02907203|515640148|FG000|Overall Study|Withdrawal by Subject|3|||
143027119|NCT02907203|515640148|FG000|Overall Study|Surgical bypass|1|||
143027120|NCT04956666|515640149|FG000|Overall Study|Adverse Event|18|||
143027121|NCT04956666|515640149|FG000|Overall Study|Physician Decision|5|||
143027122|NCT02035137|515640154|FG000|Overall Study|Physician Decision|0|||
143027123|NCT02035137|515640155|FG001|Overall Study|Physician Decision|0|||
143027124|NCT02035137|515640156|FG002|Overall Study|Physician Decision|1|||
143027125|NCT02035137|515640154|FG000|Overall Study|Withdrawal by Subject|0|||
143027126|NCT02035137|515640155|FG001|Overall Study|Withdrawal by Subject|1|||
143027127|NCT02035137|515640156|FG002|Overall Study|Withdrawal by Subject|2|||
143027128|NCT02035137|515640154|FG000|Overall Study|Ineligible|0|||
143027129|NCT02035137|515640155|FG001|Overall Study|Ineligible|1|||
143027130|NCT02035137|515640156|FG002|Overall Study|Ineligible|2|||
143027131|NCT02035137|515640154|FG000|Overall Study|Disease progression prior to treatment start|2|||
143027132|NCT02035137|515640155|FG001|Overall Study|Disease progression prior to treatment start|0|||
143027133|NCT02035137|515640156|FG002|Overall Study|Disease progression prior to treatment start|0|||
143027134|NCT00290745|515640163|FG000|Overall Study|Withdrawal by Subject|4|||
143027135|NCT00290745|515640163|FG000|Overall Study|Physician Decision|2|||
143027136|NCT00290745|515640163|FG000|Overall Study|Surgery after 3 months for progression|3|||
143027137|NCT00290745|515640163|FG000|Overall Study|Baseline MRI not available|3|||
143027138|NCT00760383|515640164|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
143027139|NCT00760383|515640165|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
143027140|NCT00783796|515640166|FG000|Overall Study|Did not receive any stent|4|||
143027141|NCT00783796|515640166|FG000|Overall Study|Received non-XIENCE V stent|1|||
143027142|NCT00783796|515640166|FG000|Overall Study|Received commercial XIENCE V stent|1|||
143027143|NCT00626925|515640171|FG000|Overall Study|Lost to Follow-up|1|||
143027144|NCT00626925|515640172|FG001|Overall Study|Lost to Follow-up|2|||
143027145|NCT00626925|515640171|FG000|Overall Study|relapse|1|||
143027146|NCT00626925|515640172|FG001|Overall Study|relapse|0|||
143027147|NCT00626925|515640171|FG000|Overall Study|Adverse effect|6|||
143027148|NCT00626925|515640172|FG001|Overall Study|Adverse effect|2|||
143027149|NCT00626925|515640171|FG000|Overall Study|Lack of Efficacy|1|||
143027150|NCT00626925|515640172|FG001|Overall Study|Lack of Efficacy|4|||
143027151|NCT00626925|515640171|FG000|Overall Study|Time constraints|3|||
143027152|NCT00626925|515640172|FG001|Overall Study|Time constraints|1|||
143027153|NCT01215942|515640176|FG000|Treatment Period|Adverse Event|15|||
143027154|NCT01215942|515640177|FG001|Treatment Period|Adverse Event|26|||
143027155|NCT01215942|515640176|FG000|Treatment Period|Death|2|||
143027156|NCT01215942|515640177|FG001|Treatment Period|Death|4|||
143027157|NCT01215942|515640176|FG000|Treatment Period|Lack of Efficacy|23|||
143027158|NCT01215942|515640177|FG001|Treatment Period|Lack of Efficacy|62|||
143027159|NCT01215942|515640176|FG000|Treatment Period|Lost to Follow-up|3|||
143027160|NCT01215942|515640177|FG001|Treatment Period|Lost to Follow-up|4|||
143237027|NCT01467960|516421526|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
143237028|NCT01467960|516421527|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
143237029|NCT01467960|516421528|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
143237030|NCT01467960|516421529|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
143237031|NCT01467960|516421530|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
143237032|NCT00737672|516421537|FG000|Overall Study|Graft Abandonment|48|||
143491295|NCT00866307|517340365|FG000|Induction|Adverse Event|5|||
143491296|NCT00866307|517340366|FG001|Induction|Adverse Event|0|||
143027161|NCT01215942|515640176|FG000|Treatment Period|Withdrawal by Subject|17|||
143027162|NCT01215942|515640177|FG001|Treatment Period|Withdrawal by Subject|40|||
143027163|NCT01215942|515640176|FG000|Treatment Period|Physician Decision|5|||
143027164|NCT01215942|515640177|FG001|Treatment Period|Physician Decision|5|||
143027165|NCT01215942|515640176|FG000|Treatment Period|Protocol Violation|0|||
143027166|NCT01215942|515640177|FG001|Treatment Period|Protocol Violation|1|||
143027167|NCT01215942|515640176|FG000|Treatment Period|Sponsor Decision|349|||
143237033|NCT00737672|516421538|FG001|Overall Study|Graft Abandonment|56|||
143363869|NCT00049517|516875453|FG003|Conditioning/Transplant|Alternative therapy|1|||
143491297|NCT00866307|517340367|FG002|Induction|Adverse Event|0|||
143027168|NCT01215942|515640177|FG001|Treatment Period|Sponsor Decision|530|||
143027169|NCT01215942|515640176|FG000|Post-Treatment Follow-Up Period|Death|0|||
143237034|NCT00737672|516421537|FG000|Overall Study|Death|23|||
143491298|NCT00866307|517340365|FG000|Induction|Death|2|||
143027170|NCT01215942|515640177|FG001|Post-Treatment Follow-Up Period|Death|1|||
143027171|NCT01215942|515640176|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
143027172|NCT01215942|515640177|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
143027173|NCT01215942|515640176|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
143027174|NCT01215942|515640177|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
143027175|NCT01215942|515640176|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
143027176|NCT01215942|515640177|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
143027177|NCT01215942|515640176|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
143027178|NCT01215942|515640177|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
143027179|NCT03305055|515640178|FG000|Overall Study|Withdrawal by Subject|0|||
143027180|NCT03305055|515640179|FG001|Overall Study|Withdrawal by Subject|1|||
143027181|NCT03305055|515640178|FG000|Overall Study|Adverse Event|1|||
143027182|NCT03305055|515640179|FG001|Overall Study|Adverse Event|1|||
143027183|NCT00113490|515640180|FG000|Overall Study|Withdrawal by Subject|1|||
143027184|NCT00113490|515640181|FG001|Overall Study|Withdrawal by Subject|3|||
143027185|NCT00113490|515640180|FG000|Overall Study|Lost to Follow-up|1|||
143027186|NCT00113490|515640181|FG001|Overall Study|Lost to Follow-up|0|||
143027187|NCT00819247|515640182|FG000|Overall Study|Adverse Event|0|||
143027188|NCT00819247|515640183|FG001|Overall Study|Adverse Event|5|||
143027189|NCT00819247|515640184|FG002|Overall Study|Adverse Event|3|||
143027190|NCT00819247|515640182|FG000|Overall Study|Insufficient testosterone response|5|||
143027191|NCT00819247|515640183|FG001|Overall Study|Insufficient testosterone response|8|||
143027192|NCT00819247|515640184|FG002|Overall Study|Insufficient testosterone response|10|||
143027193|NCT00819247|515640182|FG000|Overall Study|Withdrawal by Subject|1|||
143027194|NCT00819247|515640183|FG001|Overall Study|Withdrawal by Subject|0|||
143027195|NCT00819247|515640184|FG002|Overall Study|Withdrawal by Subject|0|||
143027196|NCT00819247|515640182|FG000|Overall Study|Protocol Violation|1|||
143027197|NCT00819247|515640183|FG001|Overall Study|Protocol Violation|0|||
143027198|NCT00819247|515640184|FG002|Overall Study|Protocol Violation|1|||
143027199|NCT00819247|515640182|FG000|Overall Study|Mistakenly withdrawn|0|||
143158070|NCT04518410|516124388|FG001|Overall Study|Withdrawal by Subject|2|||
143158071|NCT04518410|516124389|FG002|Overall Study|Withdrawal by Subject|2|||
143158072|NCT04518410|516124390|FG003|Overall Study|Withdrawal by Subject|3|||
143158073|NCT04518410|516124391|FG004|Overall Study|Withdrawal by Subject|20|||
143158074|NCT04518410|516124392|FG005|Overall Study|Withdrawal by Subject|20|||
143158075|NCT04518410|516124393|FG006|Overall Study|Withdrawal by Subject|25|||
143158076|NCT04518410|516124394|FG007|Overall Study|Withdrawal by Subject|6|||
143158077|NCT04518410|516124395|FG008|Overall Study|Withdrawal by Subject|1|||
143158078|NCT04518410|516124396|FG009|Overall Study|Withdrawal by Subject|12|||
143158079|NCT04518410|516124397|FG010|Overall Study|Withdrawal by Subject|5|||
143158080|NCT04518410|516124398|FG011|Overall Study|Withdrawal by Subject|7|||
143158081|NCT04518410|516124399|FG012|Overall Study|Withdrawal by Subject|2|||
143158082|NCT04518410|516124400|FG013|Overall Study|Withdrawal by Subject|13|||
143158083|NCT04518410|516124401|FG014|Overall Study|Withdrawal by Subject|4|||
143158084|NCT04518410|516124402|FG015|Overall Study|Withdrawal by Subject|9|||
143158085|NCT04518410|516124403|FG016|Overall Study|Withdrawal by Subject|0|||
143158086|NCT04518410|516124404|FG017|Overall Study|Withdrawal by Subject|15|||
143158087|NCT04518410|516124405|FG018|Overall Study|Withdrawal by Subject|12|||
143158088|NCT04518410|516124406|FG019|Overall Study|Withdrawal by Subject|9|||
143158089|NCT04518410|516124407|FG020|Overall Study|Withdrawal by Subject|14|||
143158090|NCT04518410|516124408|FG021|Overall Study|Withdrawal by Subject|3|||
143158091|NCT04518410|516124409|FG022|Overall Study|Withdrawal by Subject|2|||
143158092|NCT04518410|516124410|FG023|Overall Study|Withdrawal by Subject|9|||
143158093|NCT04518410|516124411|FG024|Overall Study|Withdrawal by Subject|8|||
143158094|NCT04518410|516124387|FG000|Overall Study|Other|1|||
143158095|NCT04518410|516124388|FG001|Overall Study|Other|0|||
143158096|NCT04518410|516124389|FG002|Overall Study|Other|0|||
143158097|NCT04518410|516124390|FG003|Overall Study|Other|1|||
143158098|NCT04518410|516124391|FG004|Overall Study|Other|6|||
143158099|NCT04518410|516124392|FG005|Overall Study|Other|6|||
143158100|NCT04518410|516124393|FG006|Overall Study|Other|5|||
143158101|NCT04518410|516124394|FG007|Overall Study|Other|2|||
143158102|NCT04518410|516124395|FG008|Overall Study|Other|0|||
143158103|NCT04518410|516124396|FG009|Overall Study|Other|1|||
143158104|NCT04518410|516124397|FG010|Overall Study|Other|0|||
143158105|NCT04518410|516124398|FG011|Overall Study|Other|2|||
143158106|NCT04518410|516124399|FG012|Overall Study|Other|0|||
143158107|NCT04518410|516124400|FG013|Overall Study|Other|0|||
143158108|NCT04518410|516124401|FG014|Overall Study|Other|0|||
143158109|NCT04518410|516124402|FG015|Overall Study|Other|3|||
143158110|NCT04518410|516124403|FG016|Overall Study|Other|1|||
143158111|NCT04518410|516124404|FG017|Overall Study|Other|1|||
143363870|NCT00049517|516875454|FG004|Conditioning/Transplant|Alternative therapy|1|||
143027200|NCT00819247|515640183|FG001|Overall Study|Mistakenly withdrawn|1|||
143158112|NCT04518410|516124405|FG018|Overall Study|Other|1|||
143158113|NCT04518410|516124406|FG019|Overall Study|Other|0|||
143158114|NCT04518410|516124407|FG020|Overall Study|Other|1|||
143158115|NCT04518410|516124408|FG021|Overall Study|Other|0|||
143027201|NCT00819247|515640184|FG002|Overall Study|Mistakenly withdrawn|0|||
143027202|NCT00819247|515640182|FG000|Overall Study|Bad prostate-specific antigen response|3|||
143027203|NCT00819247|515640183|FG001|Overall Study|Bad prostate-specific antigen response|2|||
143027204|NCT00819247|515640184|FG002|Overall Study|Bad prostate-specific antigen response|0|||
143027205|NCT00819247|515640182|FG000|Overall Study|Other|1|||
143027206|NCT00819247|515640183|FG001|Overall Study|Other|0|||
143027207|NCT00819247|515640184|FG002|Overall Study|Other|0|||
143027208|NCT02162758|515640185|FG000|Overall Study|Study termination|0|||
143027209|NCT02162758|515640186|FG001|Overall Study|Study termination|1|||
143027210|NCT04471935|515640187|FG000|Overall Study|Withdrawal by Subject|1|||
143027211|NCT04471935|515640187|FG000|Overall Study|Deemed ineligible to participate|1|||
143027212|NCT01766921|515640190|FG000|Overall Study|Administrative Reason|5|||
143027213|NCT01766921|515640191|FG001|Overall Study|Administrative Reason|5|||
143027214|NCT01766921|515640190|FG000|Overall Study|Death|1|||
143027215|NCT01766921|515640191|FG001|Overall Study|Death|1|||
143027216|NCT01766921|515640190|FG000|Overall Study|Lost to Follow-up|1|||
143027217|NCT01766921|515640191|FG001|Overall Study|Lost to Follow-up|3|||
143027218|NCT01766921|515640190|FG000|Overall Study|Unclassified|2|||
143027219|NCT01766921|515640191|FG001|Overall Study|Unclassified|2|||
143027220|NCT01766921|515640190|FG000|Overall Study|Protocol Violation|1|||
143027221|NCT01766921|515640191|FG001|Overall Study|Protocol Violation|1|||
143027222|NCT01766921|515640190|FG000|Overall Study|Withdrawal by Subject|14|||
143027223|NCT01766921|515640191|FG001|Overall Study|Withdrawal by Subject|5|||
143027224|NCT01659567|515640196|FG000|Overall Study|Lack of Efficacy|22|||
143027225|NCT01659567|515640196|FG000|Overall Study|Switched to Pegferon|6|||
143027226|NCT01659567|515640196|FG000|Overall Study|Adverse Event|12|||
143027227|NCT01659567|515640196|FG000|Overall Study|Good result at early stage of treatment|5|||
143027228|NCT01659567|515640196|FG000|Overall Study|Withdrawal by Subject|64|||
143027229|NCT01659567|515640196|FG000|Overall Study|Progression of the main disease|1|||
143027230|NCT01659567|515640196|FG000|Overall Study|Other|13|||
143027231|NCT00708422|515640204|FG000|Overall Study|Adverse Event|3|||
143027232|NCT00708422|515640205|FG001|Overall Study|Adverse Event|1|||
143027233|NCT00708422|515640204|FG000|Overall Study|Withdrawal by Subject|1|||
143027234|NCT00708422|515640205|FG001|Overall Study|Withdrawal by Subject|0|||
143027235|NCT01254409|515640206|FG000|Overall Study|Adverse Event|0|||
143027236|NCT01254409|515640207|FG001|Overall Study|Adverse Event|1|||
143027237|NCT01254409|515640208|FG002|Overall Study|Adverse Event|0|||
143027238|NCT01254409|515640209|FG003|Overall Study|Adverse Event|0|||
143027239|NCT05476679|515640215|FG000|Overall Study|Withdrawal by Subject|0|||
143027240|NCT05476679|515640216|FG001|Overall Study|Withdrawal by Subject|0|||
143027241|NCT05476679|515640217|FG002|Overall Study|Withdrawal by Subject|0|||
143027242|NCT05476679|515640218|FG003|Overall Study|Withdrawal by Subject|1|||
143027243|NCT05476679|515640219|FG004|Overall Study|Withdrawal by Subject|0|||
143027244|NCT05476679|515640215|FG000|Overall Study|Lost to Follow-up|0|||
143027245|NCT05476679|515640216|FG001|Overall Study|Lost to Follow-up|0|||
143027246|NCT05476679|515640217|FG002|Overall Study|Lost to Follow-up|0|||
143027247|NCT05476679|515640218|FG003|Overall Study|Lost to Follow-up|1|||
143027248|NCT05476679|515640219|FG004|Overall Study|Lost to Follow-up|0|||
143027249|NCT00601354|515640222|FG000|Overall Study|Lost to Follow-up|4|||
143027250|NCT00601354|515640223|FG001|Overall Study|Lost to Follow-up|5|||
143027251|NCT01862328|515640226|FG000|Overall Study|Progressive Disease|3|||
143027252|NCT01862328|515640227|FG001|Overall Study|Progressive Disease|11|||
143027253|NCT01862328|515640228|FG002|Overall Study|Progressive Disease|5|||
143027254|NCT01862328|515640229|FG003|Overall Study|Progressive Disease|6|||
143491299|NCT00866307|517340366|FG001|Induction|Death|0|||
143491300|NCT00866307|517340367|FG002|Induction|Death|0|||
143491301|NCT00866307|517340365|FG000|Induction|Physician Decision|5|||
143491302|NCT00866307|517340366|FG001|Induction|Physician Decision|0|||
143491303|NCT00866307|517340367|FG002|Induction|Physician Decision|0|||
143491304|NCT00866307|517340365|FG000|Induction|Progressive Disease|1|||
143491305|NCT00866307|517340366|FG001|Induction|Progressive Disease|0|||
143491306|NCT00866307|517340367|FG002|Induction|Progressive Disease|0|||
143491307|NCT00866307|517340365|FG000|Induction|Identification of Patients with Day 29 M|3|||
143491308|NCT00866307|517340366|FG001|Induction|Identification of Patients with Day 29 M|0|||
143027255|NCT01862328|515640230|FG004|Overall Study|Progressive Disease|7|||
143027256|NCT01862328|515640231|FG005|Overall Study|Progressive Disease|4|||
143027257|NCT01862328|515640232|FG006|Overall Study|Progressive Disease|3|||
143491309|NCT00866307|517340367|FG002|Induction|Identification of Patients with Day 29 M|0|||
143491310|NCT00866307|517340365|FG000|Induction|Inadequate cytognetic samples th|1|||
143027258|NCT01862328|515640226|FG000|Overall Study|Adverse Event|0|||
143027259|NCT01862328|515640227|FG001|Overall Study|Adverse Event|4|||
143027260|NCT01862328|515640228|FG002|Overall Study|Adverse Event|0|||
143027261|NCT01862328|515640229|FG003|Overall Study|Adverse Event|1|||
143027262|NCT01862328|515640230|FG004|Overall Study|Adverse Event|0|||
143027263|NCT01862328|515640231|FG005|Overall Study|Adverse Event|2|||
143027264|NCT01862328|515640232|FG006|Overall Study|Adverse Event|4|||
143027265|NCT01862328|515640226|FG000|Overall Study|Other|0|||
143027266|NCT01862328|515640227|FG001|Overall Study|Other|2|||
143491311|NCT00866307|517340366|FG001|Induction|Inadequate cytognetic samples th|0|||
143027267|NCT01862328|515640228|FG002|Overall Study|Other|1|||
143027268|NCT01862328|515640229|FG003|Overall Study|Other|0|||
143027269|NCT01862328|515640230|FG004|Overall Study|Other|4|||
143027270|NCT01862328|515640231|FG005|Overall Study|Other|0|||
143027271|NCT01862328|515640232|FG006|Overall Study|Other|1|||
143027272|NCT01862328|515640226|FG000|Overall Study|Withdrawal by Subject|1|||
143027273|NCT01862328|515640227|FG001|Overall Study|Withdrawal by Subject|1|||
143027274|NCT01862328|515640228|FG002|Overall Study|Withdrawal by Subject|0|||
143027275|NCT01862328|515640229|FG003|Overall Study|Withdrawal by Subject|0|||
143027276|NCT01862328|515640230|FG004|Overall Study|Withdrawal by Subject|1|||
143027277|NCT01862328|515640231|FG005|Overall Study|Withdrawal by Subject|1|||
143027278|NCT01862328|515640232|FG006|Overall Study|Withdrawal by Subject|1|||
143027279|NCT01862328|515640226|FG000|Overall Study|Symptomatic Deterioration|0|||
143027280|NCT01862328|515640227|FG001|Overall Study|Symptomatic Deterioration|0|||
143027281|NCT01862328|515640228|FG002|Overall Study|Symptomatic Deterioration|0|||
143027282|NCT01862328|515640229|FG003|Overall Study|Symptomatic Deterioration|0|||
143027283|NCT01862328|515640230|FG004|Overall Study|Symptomatic Deterioration|0|||
143027284|NCT01862328|515640231|FG005|Overall Study|Symptomatic Deterioration|0|||
143027285|NCT01862328|515640232|FG006|Overall Study|Symptomatic Deterioration|1|||
143027286|NCT00936975|515640233|FG000|Overall Study|Withdrawal by Subject|1|||
143027287|NCT00936975|515640233|FG000|Overall Study|Disease progression|3|||
143027288|NCT00936975|515640233|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
143027289|NCT02482571|515640234|FG000|Overall Study|Adverse Event|1|||
143027290|NCT02482571|515640234|FG000|Overall Study|Scanner or Respiract failure|3|||
143027291|NCT02482571|515640234|FG000|Overall Study|Withdrawal by Subject|4|||
143027292|NCT01498484|515640235|FG000|Overall Study|Death|6|||
143027293|NCT01498484|515640236|FG001|Overall Study|Death|3|||
143027294|NCT01498484|515640237|FG002|Overall Study|Death|1|||
143027295|NCT01498484|515640238|FG003|Overall Study|Death|1|||
143027296|NCT01498484|515640239|FG004|Overall Study|Death|0|||
143027297|NCT01498484|515640240|FG005|Overall Study|Death|0|||
143027298|NCT01498484|515640241|FG006|Overall Study|Death|10|||
143027299|NCT01498484|515640242|FG007|Overall Study|Death|1|||
143027300|NCT01498484|515640243|FG008|Overall Study|Death|0|||
143027301|NCT01498484|515640235|FG000|Overall Study|Physician Decision|3|||
143027302|NCT01498484|515640236|FG001|Overall Study|Physician Decision|2|||
143027303|NCT01498484|515640237|FG002|Overall Study|Physician Decision|1|||
143027304|NCT01498484|515640238|FG003|Overall Study|Physician Decision|1|||
143027305|NCT01498484|515640239|FG004|Overall Study|Physician Decision|0|||
143027306|NCT01498484|515640240|FG005|Overall Study|Physician Decision|0|||
143027307|NCT01498484|515640241|FG006|Overall Study|Physician Decision|8|||
143027308|NCT01498484|515640242|FG007|Overall Study|Physician Decision|13|||
143027309|NCT01498484|515640243|FG008|Overall Study|Physician Decision|1|||
143027310|NCT01498484|515640235|FG000|Overall Study|Adverse Event|0|||
143027311|NCT01498484|515640236|FG001|Overall Study|Adverse Event|0|||
143027312|NCT01498484|515640237|FG002|Overall Study|Adverse Event|0|||
143027313|NCT01498484|515640238|FG003|Overall Study|Adverse Event|0|||
143027314|NCT01498484|515640239|FG004|Overall Study|Adverse Event|0|||
143027315|NCT01498484|515640240|FG005|Overall Study|Adverse Event|1|||
143027316|NCT01498484|515640241|FG006|Overall Study|Adverse Event|0|||
143027317|NCT01498484|515640242|FG007|Overall Study|Adverse Event|0|||
143027318|NCT01498484|515640243|FG008|Overall Study|Adverse Event|0|||
143027319|NCT01498484|515640235|FG000|Overall Study|Withdrawal by Subject|0|||
143027320|NCT01498484|515640236|FG001|Overall Study|Withdrawal by Subject|0|||
143027321|NCT01498484|515640237|FG002|Overall Study|Withdrawal by Subject|0|||
143027322|NCT01498484|515640238|FG003|Overall Study|Withdrawal by Subject|1|||
143027323|NCT01498484|515640239|FG004|Overall Study|Withdrawal by Subject|0|||
143027324|NCT01498484|515640240|FG005|Overall Study|Withdrawal by Subject|0|||
143491312|NCT00866307|517340367|FG002|Induction|Inadequate cytognetic samples th|0|||
143491313|NCT00866307|517340365|FG000|Induction|Improper post-induction consent|2|||
143491314|NCT00866307|517340366|FG001|Induction|Improper post-induction consent|0|||
143491315|NCT00866307|517340367|FG002|Induction|Improper post-induction consent|0|||
143491316|NCT00866307|517340365|FG000|Induction|Study was closed at the time|1|||
143027325|NCT01498484|515640241|FG006|Overall Study|Withdrawal by Subject|1|||
143027326|NCT01498484|515640242|FG007|Overall Study|Withdrawal by Subject|0|||
143027327|NCT01498484|515640243|FG008|Overall Study|Withdrawal by Subject|0|||
143027328|NCT01498484|515640235|FG000|Overall Study|Other|5|||
143027329|NCT01498484|515640236|FG001|Overall Study|Other|2|||
143027330|NCT01498484|515640237|FG002|Overall Study|Other|0|||
143027331|NCT01498484|515640238|FG003|Overall Study|Other|0|||
143027332|NCT01498484|515640239|FG004|Overall Study|Other|1|||
143027333|NCT01498484|515640240|FG005|Overall Study|Other|0|||
143027334|NCT01498484|515640241|FG006|Overall Study|Other|3|||
143027335|NCT01498484|515640242|FG007|Overall Study|Other|0|||
143027336|NCT01498484|515640243|FG008|Overall Study|Other|1|||
143158116|NCT04518410|516124409|FG022|Overall Study|Other|1|||
143491317|NCT00866307|517340366|FG001|Induction|Study was closed at the time|0|||
143027337|NCT01199601|515640244|FG000|Overall Study|Lost to Follow-up|47|||
143027338|NCT01199601|515640245|FG001|Overall Study|Lost to Follow-up|66|||
143027339|NCT01199601|515640244|FG000|Overall Study|Withdrawal by Subject|15|||
143027340|NCT01199601|515640245|FG001|Overall Study|Withdrawal by Subject|3|||
143027341|NCT01199601|515640244|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
143027342|NCT01199601|515640245|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
143027343|NCT00278512|515640247|FG000|Overall Study|Death|1|||
143027344|NCT00278512|515640248|FG001|Overall Study|Death|0|||
143027345|NCT01620177|515640249|FG000|Overall Study|Failure at Screening Visit|43|||
143027346|NCT01620177|515640249|FG000|Overall Study|Withdrawal by Subject|26|||
143027347|NCT01620177|515640249|FG000|Overall Study|Lost to Follow-up|7|||
143027348|NCT01620177|515640249|FG000|Overall Study|Physician Decision|2|||
143027349|NCT01620177|515640249|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
143027350|NCT01789320|515640253|FG000|Overall Study|Re-enrolled into study|1|||
143027351|NCT01789320|515640253|FG000|Overall Study|Lost to Follow-up|1|||
143027352|NCT00203307|515640260|FG000|First Intervention|Adverse Event|2|||
143027353|NCT00203307|515640261|FG001|First Intervention|Adverse Event|0|||
143027354|NCT02789111|515640262|FG000|Overall Study|Withdrawal by Subject|1|||
143027355|NCT02789111|515640263|FG001|Overall Study|Withdrawal by Subject|4|||
143027356|NCT02178709|515642200|FG000|Overall Study|Adverse Event|5|||
143027357|NCT02178709|515642200|FG000|Overall Study|Death|2|||
143027358|NCT02178709|515642200|FG000|Overall Study|Withdrawal by Subject|2|||
143027359|NCT02178709|515642200|FG000|Overall Study|Physician Decision|2|||
143027360|NCT02178709|515642200|FG000|Overall Study|Disease Progression|5|||
143027361|NCT02946385|515642201|FG000|Overall Study|Lost to Follow-up|0|||
143027362|NCT02946385|515642202|FG001|Overall Study|Lost to Follow-up|0|||
143027363|NCT02946385|515642203|FG002|Overall Study|Lost to Follow-up|3|||
143027364|NCT02946385|515642204|FG003|Overall Study|Lost to Follow-up|0|||
143027365|NCT02946385|515642205|FG004|Overall Study|Lost to Follow-up|2|||
143027366|NCT02946385|515642206|FG005|Overall Study|Lost to Follow-up|1|||
143027367|NCT00313703|515642207|FG000|Overall Study|Lost to Follow-up|11|||
143027368|NCT00313703|515642208|FG001|Overall Study|Lost to Follow-up|2|||
143027369|NCT00313703|515642209|FG002|Overall Study|Lost to Follow-up|5|||
143027370|NCT00313703|515642210|FG003|Overall Study|Lost to Follow-up|12|||
143027371|NCT03329027|515642213|FG000|Overall Study|Lost to Follow-up|1|||
143027372|NCT03329027|515642214|FG001|Overall Study|Lost to Follow-up|0|||
143027373|NCT03329027|515642215|FG002|Overall Study|Lost to Follow-up|1|||
143027374|NCT03329027|515642213|FG000|Overall Study|Protocol Violation|9|||
143027375|NCT03329027|515642214|FG001|Overall Study|Protocol Violation|5|||
143027376|NCT03329027|515642215|FG002|Overall Study|Protocol Violation|7|||
143027377|NCT04849988|515642218|FG000|Overall Study|Lack of Efficacy|3|||
143027378|NCT04849988|515642219|FG001|Overall Study|Lack of Efficacy|4|||
143027379|NCT04849988|515642220|FG002|Overall Study|Lack of Efficacy|1|||
143027380|NCT04849988|515642221|FG003|Overall Study|Lack of Efficacy|4|||
143027381|NCT04849988|515642218|FG000|Overall Study|Other reasons|1|||
143027382|NCT04849988|515642219|FG001|Overall Study|Other reasons|2|||
143027383|NCT04849988|515642220|FG002|Overall Study|Other reasons|2|||
143027384|NCT04849988|515642221|FG003|Overall Study|Other reasons|1|||
143027385|NCT00101582|515642228|FG000|Overall Study|Ineligibility determined|0|||
143027386|NCT00101582|515642229|FG001|Overall Study|Ineligibility determined|1|||
143027387|NCT00101582|515642228|FG000|Overall Study|Adverse Event|1|||
143027388|NCT00101582|515642229|FG001|Overall Study|Adverse Event|4|||
143027389|NCT00101582|515642228|FG000|Overall Study|Withdrawal by Subject|6|||
143027390|NCT00101582|515642229|FG001|Overall Study|Withdrawal by Subject|4|||
143027391|NCT00101582|515642228|FG000|Overall Study|Physician Decision|1|||
143027392|NCT00101582|515642229|FG001|Overall Study|Physician Decision|0|||
143027393|NCT00101582|515642228|FG000|Overall Study|Death|3|||
143027394|NCT00101582|515642229|FG001|Overall Study|Death|5|||
143027395|NCT00101582|515642228|FG000|Overall Study|Other|0|||
143027396|NCT00101582|515642229|FG001|Overall Study|Other|1|||
143027397|NCT01919190|515642230|FG000|Overall Study|Intra-op findings, etc.|3|||
143027398|NCT01919190|515642231|FG001|Overall Study|Intra-op findings, etc.|0|||
143027399|NCT02146430|515642232|FG000|Overall Study|Protocol Violation|5|||
143027400|NCT02146430|515642233|FG001|Overall Study|Protocol Violation|4|||
143027401|NCT02146430|515642234|FG002|Overall Study|Protocol Violation|8|||
143027402|NCT02146430|515642235|FG003|Overall Study|Protocol Violation|6|||
143027403|NCT02146430|515642232|FG000|Overall Study|Lack of Efficacy|13|||
143491318|NCT00866307|517340367|FG002|Induction|Study was closed at the time|0|||
143491319|NCT00866307|517340365|FG000|Consolidation/Maintenance|Adverse Event|0|||
143027404|NCT02146430|515642233|FG001|Overall Study|Lack of Efficacy|11|||
143027405|NCT02146430|515642234|FG002|Overall Study|Lack of Efficacy|8|||
143027406|NCT02146430|515642235|FG003|Overall Study|Lack of Efficacy|5|||
143027407|NCT02146430|515642232|FG000|Overall Study|Adverse Event|20|||
143027408|NCT02146430|515642233|FG001|Overall Study|Adverse Event|40|||
143027409|NCT02146430|515642234|FG002|Overall Study|Adverse Event|32|||
143027410|NCT02146430|515642235|FG003|Overall Study|Adverse Event|49|||
143027411|NCT02146430|515642232|FG000|Overall Study|Reason missing or not reported|2|||
143027412|NCT02146430|515642233|FG001|Overall Study|Reason missing or not reported|3|||
143027413|NCT02146430|515642234|FG002|Overall Study|Reason missing or not reported|4|||
143027414|NCT02146430|515642235|FG003|Overall Study|Reason missing or not reported|5|||
143027415|NCT02146430|515642232|FG000|Overall Study|Withdrawal by Subject|27|||
143027416|NCT02146430|515642233|FG001|Overall Study|Withdrawal by Subject|29|||
143027417|NCT02146430|515642234|FG002|Overall Study|Withdrawal by Subject|30|||
143027418|NCT02146430|515642235|FG003|Overall Study|Withdrawal by Subject|34|||
143027419|NCT01893905|515642236|FG000|Overall Study|Withdrawal by Subject|1|||
143027420|NCT01893905|515642237|FG001|Overall Study|Withdrawal by Subject|0|||
143027421|NCT01893905|515642236|FG000|Overall Study|Adverse Event|9|||
143027422|NCT01893905|515642237|FG001|Overall Study|Adverse Event|3|||
143027423|NCT01893905|515642236|FG000|Overall Study|Lack of Efficacy|5|||
143027424|NCT01893905|515642237|FG001|Overall Study|Lack of Efficacy|7|||
143027425|NCT01893905|515642236|FG000|Overall Study|Lost to Follow-up|1|||
143027426|NCT01893905|515642237|FG001|Overall Study|Lost to Follow-up|0|||
143027427|NCT01893905|515642236|FG000|Overall Study|Protocol Violation|6|||
143027428|NCT01893905|515642237|FG001|Overall Study|Protocol Violation|1|||
143027429|NCT01893905|515642236|FG000|Overall Study|Lack of adherence to treatment|2|||
143027430|NCT01893905|515642237|FG001|Overall Study|Lack of adherence to treatment|0|||
143027431|NCT01893905|515642236|FG000|Overall Study|Other reason|1|||
143027432|NCT01893905|515642237|FG001|Overall Study|Other reason|3|||
143027433|NCT03312530|515642238|FG000|Overall Study|Death|5|||
143027434|NCT03312530|515642239|FG001|Overall Study|Death|5|||
143027435|NCT03312530|515642240|FG002|Overall Study|Death|4|||
143027436|NCT03312530|515642241|FG003|Overall Study|Death|10|||
143027437|NCT03312530|515642242|FG004|Overall Study|Death|8|||
143027438|NCT03312530|515642238|FG000|Overall Study|Lost to Follow-up|0|||
143027439|NCT03312530|515642239|FG001|Overall Study|Lost to Follow-up|0|||
143027440|NCT03312530|515642240|FG002|Overall Study|Lost to Follow-up|0|||
143027441|NCT03312530|515642241|FG003|Overall Study|Lost to Follow-up|1|||
143027442|NCT03312530|515642242|FG004|Overall Study|Lost to Follow-up|0|||
143027443|NCT03312530|515642238|FG000|Overall Study|Participant in another sponsor study.|0|||
143237035|NCT00737672|516421538|FG001|Overall Study|Death|22|||
143237036|NCT00737672|516421537|FG000|Overall Study|Withdrawal by Subject|1|||
143237037|NCT00737672|516421538|FG001|Overall Study|Withdrawal by Subject|2|||
143237038|NCT00737672|516421537|FG000|Overall Study|Lost to Follow-up|1|||
143237039|NCT00737672|516421538|FG001|Overall Study|Lost to Follow-up|0|||
143237040|NCT00737672|516421537|FG000|Overall Study|Miscellaneous|7|||
143237041|NCT00737672|516421538|FG001|Overall Study|Miscellaneous|1|||
143237042|NCT00737672|516421537|FG000|Overall Study|Physician Decision|0|||
143237043|NCT00737672|516421538|FG001|Overall Study|Physician Decision|2|||
143237044|NCT03955146|516421539|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
143237045|NCT03955146|516421540|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
143237046|NCT03955146|516421541|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
143237047|NCT03955146|516421542|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
143237048|NCT03955146|516421539|FG000|DB Period (48 Weeks)|Adverse Event|2|||
143237049|NCT03955146|516421540|FG001|DB Period (48 Weeks)|Adverse Event|5|||
143237050|NCT03955146|516421541|FG002|DB Period (48 Weeks)|Adverse Event|1|||
143237051|NCT03955146|516421542|FG003|DB Period (48 Weeks)|Adverse Event|2|||
143237052|NCT03955146|516421539|FG000|DB Period (48 Weeks)|Death|13|||
143237053|NCT03955146|516421540|FG001|DB Period (48 Weeks)|Death|17|||
143237054|NCT03955146|516421541|FG002|DB Period (48 Weeks)|Death|1|||
143237055|NCT03955146|516421542|FG003|DB Period (48 Weeks)|Death|0|||
143237056|NCT03955146|516421539|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
143237057|NCT03955146|516421540|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
143237058|NCT03955146|516421541|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
143237059|NCT03955146|516421542|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
143237060|NCT03955146|516421539|FG000|DB Period (48 Weeks)|Disease Progression|2|||
143237061|NCT03955146|516421540|FG001|DB Period (48 Weeks)|Disease Progression|0|||
143237062|NCT03955146|516421541|FG002|DB Period (48 Weeks)|Disease Progression|0|||
143237063|NCT03955146|516421542|FG003|DB Period (48 Weeks)|Disease Progression|0|||
143237064|NCT03955146|516421539|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
143491320|NCT00866307|517340366|FG001|Consolidation/Maintenance|Adverse Event|0|||
143027444|NCT03312530|515642239|FG001|Overall Study|Participant in another sponsor study.|0|||
143237065|NCT03955146|516421540|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
143237066|NCT03955146|516421541|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
143237067|NCT03955146|516421542|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
143237068|NCT03955146|516421539|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
143237069|NCT03955146|516421540|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
143237070|NCT03955146|516421541|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
143491321|NCT00866307|517340367|FG002|Consolidation/Maintenance|Adverse Event|8|||
143491322|NCT00866307|517340365|FG000|Consolidation/Maintenance|Death|0|||
143027445|NCT03312530|515642240|FG002|Overall Study|Participant in another sponsor study.|0|||
143491323|NCT00866307|517340366|FG001|Consolidation/Maintenance|Death|0|||
143027446|NCT03312530|515642241|FG003|Overall Study|Participant in another sponsor study.|1|||
143237071|NCT03955146|516421542|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
143237072|NCT03955146|516421539|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
143027447|NCT03312530|515642242|FG004|Overall Study|Participant in another sponsor study.|0|||
143027448|NCT03312530|515642238|FG000|Overall Study|Study terminated by sponsor|1|||
143237073|NCT03955146|516421540|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
143491324|NCT00866307|517340367|FG002|Consolidation/Maintenance|Death|1|||
143158117|NCT04518410|516124410|FG023|Overall Study|Other|2|||
143158118|NCT04518410|516124411|FG024|Overall Study|Other|2|||
143158119|NCT04518410|516124387|FG000|Overall Study|Protocol Violation|0|||
143158120|NCT04518410|516124388|FG001|Overall Study|Protocol Violation|0|||
143158121|NCT04518410|516124389|FG002|Overall Study|Protocol Violation|0|||
143158122|NCT04518410|516124390|FG003|Overall Study|Protocol Violation|2|||
143158123|NCT04518410|516124391|FG004|Overall Study|Protocol Violation|17|||
143158124|NCT04518410|516124392|FG005|Overall Study|Protocol Violation|1|||
143158125|NCT04518410|516124393|FG006|Overall Study|Protocol Violation|2|||
143158126|NCT04518410|516124394|FG007|Overall Study|Protocol Violation|1|||
143158127|NCT04518410|516124395|FG008|Overall Study|Protocol Violation|0|||
143158128|NCT04518410|516124396|FG009|Overall Study|Protocol Violation|0|||
143158129|NCT04518410|516124397|FG010|Overall Study|Protocol Violation|0|||
143158130|NCT04518410|516124398|FG011|Overall Study|Protocol Violation|0|||
143158131|NCT04518410|516124399|FG012|Overall Study|Protocol Violation|0|||
143158132|NCT04518410|516124400|FG013|Overall Study|Protocol Violation|0|||
143158133|NCT04518410|516124401|FG014|Overall Study|Protocol Violation|0|||
143158134|NCT04518410|516124402|FG015|Overall Study|Protocol Violation|0|||
143158135|NCT04518410|516124403|FG016|Overall Study|Protocol Violation|1|||
143158136|NCT04518410|516124404|FG017|Overall Study|Protocol Violation|1|||
143158137|NCT04518410|516124405|FG018|Overall Study|Protocol Violation|0|||
143158138|NCT04518410|516124406|FG019|Overall Study|Protocol Violation|0|||
143158139|NCT04518410|516124407|FG020|Overall Study|Protocol Violation|1|||
143158140|NCT04518410|516124408|FG021|Overall Study|Protocol Violation|2|||
143158141|NCT04518410|516124409|FG022|Overall Study|Protocol Violation|0|||
143158142|NCT04518410|516124410|FG023|Overall Study|Protocol Violation|3|||
143158143|NCT04518410|516124411|FG024|Overall Study|Protocol Violation|0|||
143158144|NCT04518410|516124387|FG000|Overall Study|Death|0|||
143158145|NCT04518410|516124388|FG001|Overall Study|Death|0|||
143158146|NCT04518410|516124389|FG002|Overall Study|Death|0|||
143158147|NCT04518410|516124390|FG003|Overall Study|Death|0|||
143158148|NCT04518410|516124391|FG004|Overall Study|Death|12|||
143158149|NCT04518410|516124392|FG005|Overall Study|Death|2|||
143158150|NCT04518410|516124393|FG006|Overall Study|Death|11|||
143158151|NCT04518410|516124394|FG007|Overall Study|Death|0|||
143158152|NCT04518410|516124395|FG008|Overall Study|Death|1|||
143158153|NCT04518410|516124396|FG009|Overall Study|Death|0|||
143158154|NCT04518410|516124397|FG010|Overall Study|Death|0|||
143158155|NCT04518410|516124398|FG011|Overall Study|Death|0|||
143158156|NCT04518410|516124399|FG012|Overall Study|Death|0|||
143158157|NCT04518410|516124400|FG013|Overall Study|Death|1|||
143158158|NCT04518410|516124401|FG014|Overall Study|Death|1|||
143158159|NCT04518410|516124402|FG015|Overall Study|Death|0|||
143158160|NCT04518410|516124403|FG016|Overall Study|Death|0|||
143158161|NCT04518410|516124404|FG017|Overall Study|Death|1|||
143158162|NCT04518410|516124405|FG018|Overall Study|Death|4|||
143158163|NCT04518410|516124406|FG019|Overall Study|Death|4|||
143158164|NCT04518410|516124407|FG020|Overall Study|Death|1|||
143158165|NCT04518410|516124408|FG021|Overall Study|Death|0|||
143158166|NCT04518410|516124409|FG022|Overall Study|Death|0|||
143158167|NCT04518410|516124410|FG023|Overall Study|Death|0|||
143158168|NCT04518410|516124411|FG024|Overall Study|Death|0|||
143158169|NCT04518410|516124387|FG000|Overall Study|Requirement to start alternative therapy|0|||
143158170|NCT04518410|516124388|FG001|Overall Study|Requirement to start alternative therapy|0|||
143158171|NCT04518410|516124389|FG002|Overall Study|Requirement to start alternative therapy|1|||
143158172|NCT04518410|516124390|FG003|Overall Study|Requirement to start alternative therapy|0|||
143158173|NCT04518410|516124391|FG004|Overall Study|Requirement to start alternative therapy|0|||
143158174|NCT04518410|516124392|FG005|Overall Study|Requirement to start alternative therapy|0|||
143158175|NCT04518410|516124393|FG006|Overall Study|Requirement to start alternative therapy|0|||
143158176|NCT04518410|516124394|FG007|Overall Study|Requirement to start alternative therapy|0|||
143158177|NCT04518410|516124395|FG008|Overall Study|Requirement to start alternative therapy|0|||
143158178|NCT04518410|516124396|FG009|Overall Study|Requirement to start alternative therapy|0|||
143158179|NCT04518410|516124397|FG010|Overall Study|Requirement to start alternative therapy|0|||
143158180|NCT04518410|516124398|FG011|Overall Study|Requirement to start alternative therapy|0|||
143158181|NCT04518410|516124399|FG012|Overall Study|Requirement to start alternative therapy|0|||
143158182|NCT04518410|516124400|FG013|Overall Study|Requirement to start alternative therapy|0|||
143158183|NCT04518410|516124401|FG014|Overall Study|Requirement to start alternative therapy|0|||
143158184|NCT04518410|516124402|FG015|Overall Study|Requirement to start alternative therapy|0|||
143491325|NCT00866307|517340365|FG000|Consolidation/Maintenance|Physician Decision|0|||
143158185|NCT04518410|516124403|FG016|Overall Study|Requirement to start alternative therapy|0|||
143158186|NCT04518410|516124404|FG017|Overall Study|Requirement to start alternative therapy|0|||
143158187|NCT04518410|516124405|FG018|Overall Study|Requirement to start alternative therapy|0|||
143158188|NCT04518410|516124406|FG019|Overall Study|Requirement to start alternative therapy|0|||
143158189|NCT04518410|516124407|FG020|Overall Study|Requirement to start alternative therapy|0|||
143158190|NCT04518410|516124408|FG021|Overall Study|Requirement to start alternative therapy|0|||
143158191|NCT04518410|516124409|FG022|Overall Study|Requirement to start alternative therapy|0|||
143158192|NCT04518410|516124410|FG023|Overall Study|Requirement to start alternative therapy|0|||
143491326|NCT00866307|517340366|FG001|Consolidation/Maintenance|Physician Decision|3|||
143491327|NCT00866307|517340367|FG002|Consolidation/Maintenance|Physician Decision|2|||
143491328|NCT00866307|517340365|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
143491329|NCT00866307|517340366|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
143491330|NCT00866307|517340367|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
143491331|NCT00866307|517340365|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
143491332|NCT00866307|517340366|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
143491333|NCT00866307|517340367|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
143491334|NCT00866307|517340365|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
143491335|NCT00866307|517340366|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
143491336|NCT00866307|517340367|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
143491337|NCT00866307|517340365|FG000|Consolidation/Maintenance|Therapy error|0|||
143491338|NCT00866307|517340366|FG001|Consolidation/Maintenance|Therapy error|1|||
143491339|NCT00866307|517340367|FG002|Consolidation/Maintenance|Therapy error|0|||
143491340|NCT00866307|517340365|FG000|Consolidation/Maintenance|Non-compliance|0|||
143491341|NCT00866307|517340366|FG001|Consolidation/Maintenance|Non-compliance|0|||
143491342|NCT00866307|517340367|FG002|Consolidation/Maintenance|Non-compliance|1|||
143491343|NCT00866307|517340365|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
143491344|NCT00866307|517340366|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
143491345|NCT00866307|517340367|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
143491346|NCT01687712|517340368|FG000|Cycle 1|Not Biochemically Pregnant|386|||
143491347|NCT01687712|517340369|FG001|Cycle 1|Not Biochemically Pregnant|348|||
143491348|NCT01687712|517340368|FG000|Cycle 1|Early Pregnancy Loss|43|||
143491349|NCT01687712|517340369|FG001|Cycle 1|Early Pregnancy Loss|60|||
143491350|NCT01687712|517340368|FG000|Cycle 1|Ectopic Pregnancy|5|||
143491351|NCT01687712|517340369|FG001|Cycle 1|Ectopic Pregnancy|5|||
143491352|NCT01687712|517340368|FG000|Cycle 1|Heterotropic Pregnancy|1|||
143491353|NCT01687712|517340369|FG001|Cycle 1|Heterotropic Pregnancy|0|||
143491354|NCT01687712|517340368|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
143491355|NCT01687712|517340369|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
143491356|NCT01687712|517340368|FG000|Cycle 1|Abortion|3|||
143491357|NCT01687712|517340369|FG001|Cycle 1|Abortion|0|||
143491358|NCT01687712|517340368|FG000|Cycle 1|Intrauterine Fetal Death|0|||
143491359|NCT01687712|517340369|FG001|Cycle 1|Intrauterine Fetal Death|1|||
143491360|NCT01687712|517340368|FG000|Cycle 1|Lost to Follow-up|1|||
143491361|NCT01687712|517340369|FG001|Cycle 1|Lost to Follow-up|1|||
143491362|NCT01687712|517340368|FG000|Cycle 2|Not Biochemically Pregnant|74|||
143491363|NCT01687712|517340369|FG001|Cycle 2|Not Biochemically Pregnant|77|||
143491364|NCT01687712|517340368|FG000|Cycle 2|Early Pregnancy Loss|18|||
143491365|NCT01687712|517340369|FG001|Cycle 2|Early Pregnancy Loss|16|||
143491366|NCT01687712|517340368|FG000|Cycle 2|Ectopic Pregnancy|0|||
143491367|NCT01687712|517340369|FG001|Cycle 2|Ectopic Pregnancy|1|||
143491368|NCT01687712|517340368|FG000|Cycle 2|Still Birth|1|||
143491369|NCT01687712|517340369|FG001|Cycle 2|Still Birth|0|||
143491370|NCT01687712|517340368|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
143491371|NCT01687712|517340369|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
143491372|NCT01687712|517340368|FG000|Cycle 3|Not Biochemically Pregnant|21|||
143491373|NCT01687712|517340369|FG001|Cycle 3|Not Biochemically Pregnant|22|||
143491374|NCT01687712|517340368|FG000|Cycle 3|Early Pregnancy Loss|1|||
143491375|NCT01687712|517340369|FG001|Cycle 3|Early Pregnancy Loss|2|||
143491376|NCT01687712|517340368|FG000|Cycle 3|Ectopic Pregnancy|1|||
143491377|NCT01687712|517340369|FG001|Cycle 3|Ectopic Pregnancy|0|||
143027449|NCT03312530|515642239|FG001|Overall Study|Study terminated by sponsor|0|||
143027450|NCT03312530|515642240|FG002|Overall Study|Study terminated by sponsor|2|||
143491378|NCT01687712|517340368|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
143491379|NCT01687712|517340369|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
143491380|NCT02573155|517340370|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
143491381|NCT02573155|517340371|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
143491382|NCT02573155|517340370|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
143491383|NCT02573155|517340371|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
143491384|NCT02573155|517340370|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
143491385|NCT02573155|517340371|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
143491386|NCT02573155|517340370|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
143491387|NCT02573155|517340371|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
143491388|NCT02573155|517340370|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
143491389|NCT02573155|517340371|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
143491390|NCT02573155|517340370|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
143491391|NCT02573155|517340371|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
143491392|NCT02573155|517340370|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
143491393|NCT02573155|517340371|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
143491394|NCT02573155|517340370|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
143491395|NCT02573155|517340371|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
143027451|NCT03312530|515642241|FG003|Overall Study|Study terminated by sponsor|3|||
143027452|NCT03312530|515642242|FG004|Overall Study|Study terminated by sponsor|7|||
143027453|NCT03312530|515642238|FG000|Overall Study|Withdrawal by Subject|0|||
143027454|NCT03312530|515642239|FG001|Overall Study|Withdrawal by Subject|1|||
143027455|NCT03312530|515642240|FG002|Overall Study|Withdrawal by Subject|0|||
143027456|NCT03312530|515642241|FG003|Overall Study|Withdrawal by Subject|0|||
143027457|NCT03312530|515642242|FG004|Overall Study|Withdrawal by Subject|0|||
143027458|NCT03312530|515642238|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
143027459|NCT03312530|515642239|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
143027460|NCT03312530|515642240|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
143027461|NCT03312530|515642241|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
143027462|NCT03312530|515642242|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
143027463|NCT04583579|515642248|FG000|Overall Study|Lost to Follow-up|4|||
143027464|NCT01691508|515642249|FG000|Overall Study|Adverse Event|3|||
143027465|NCT01691508|515642250|FG001|Overall Study|Adverse Event|3|||
143027466|NCT01691508|515642249|FG000|Overall Study|Withdrawal by Subject|1|||
143027467|NCT01691508|515642250|FG001|Overall Study|Withdrawal by Subject|0|||
143027468|NCT02688400|515642257|FG000|Overall Study|Protocol Violation|2|||
143027469|NCT02688400|515642258|FG001|Overall Study|Protocol Violation|5|||
143027470|NCT02688400|515642257|FG000|Overall Study|Lack of Efficacy|7|||
143027471|NCT02688400|515642258|FG001|Overall Study|Lack of Efficacy|7|||
143027472|NCT02688400|515642257|FG000|Overall Study|Adverse Event|21|||
143027473|NCT02688400|515642258|FG001|Overall Study|Adverse Event|12|||
143027474|NCT02688400|515642257|FG000|Overall Study|Withdrawal by Subject|15|||
143027475|NCT02688400|515642258|FG001|Overall Study|Withdrawal by Subject|13|||
143027476|NCT02688400|515642257|FG000|Overall Study|No study medication intake|1|||
143027477|NCT02688400|515642258|FG001|Overall Study|No study medication intake|4|||
143027478|NCT02688400|515642257|FG000|Overall Study|Lost to Follow-up|0|||
143027479|NCT02688400|515642258|FG001|Overall Study|Lost to Follow-up|3|||
143027480|NCT03731182|515642267|FG000|Overall Study|Lost to Follow-up|2|||
143027481|NCT03731182|515642268|FG001|Overall Study|Lost to Follow-up|0|||
143027482|NCT03731182|515642267|FG000|Overall Study|Physician Decision|1|||
143027483|NCT03731182|515642268|FG001|Overall Study|Physician Decision|0|||
143027484|NCT03731182|515642267|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
143027485|NCT03731182|515642268|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
143027486|NCT02006706|515642269|FG000|Overall Study|Lost to Follow-up|1|||
143027487|NCT00958256|515642270|FG000|Overall Study|Adverse Event|3|||
143027488|NCT03036579|515642272|FG000|2 Years|Lost to Follow-up|1|||
143027489|NCT03036579|515642273|FG001|2 Years|Lost to Follow-up|0|||
143027490|NCT03036579|515642272|FG000|3 Years|Lost to Follow-up|0|||
143027491|NCT03036579|515642273|FG001|3 Years|Lost to Follow-up|1|||
143027492|NCT02848599|515642274|FG000|Overall Study|Protocol Violation|7|||
143027493|NCT02848599|515642275|FG001|Overall Study|Protocol Violation|9|||
143027494|NCT04828161|515642276|FG000|Overall Study|Withdrawal by Subject|0|||
143027495|NCT04828161|515642277|FG001|Overall Study|Withdrawal by Subject|3|||
143027496|NCT04828161|515642278|FG002|Overall Study|Withdrawal by Subject|3|||
143027497|NCT04828161|515642279|FG003|Overall Study|Withdrawal by Subject|4|||
143027498|NCT04828161|515642276|FG000|Overall Study|Lost to Follow-up|1|||
143027499|NCT04828161|515642277|FG001|Overall Study|Lost to Follow-up|4|||
143027500|NCT04828161|515642278|FG002|Overall Study|Lost to Follow-up|2|||
143027501|NCT04828161|515642279|FG003|Overall Study|Lost to Follow-up|2|||
143027502|NCT04828161|515642276|FG000|Overall Study|Other|2|||
143027503|NCT04828161|515642277|FG001|Overall Study|Other|0|||
143027504|NCT04828161|515642278|FG002|Overall Study|Other|2|||
143027505|NCT04828161|515642279|FG003|Overall Study|Other|0|||
143027506|NCT04828161|515642276|FG000|Overall Study|Death|0|||
143027507|NCT04828161|515642277|FG001|Overall Study|Death|0|||
143027508|NCT04828161|515642278|FG002|Overall Study|Death|0|||
143158193|NCT04518410|516124411|FG024|Overall Study|Requirement to start alternative therapy|0|||
143158194|NCT04518410|516124387|FG000|Overall Study|Randomized but not treated|0|||
143491396|NCT01681433|517340372|FG000|Overall Study|Lack of Efficacy|23|||
143491397|NCT01681433|517340373|FG001|Overall Study|Lack of Efficacy|23|||
143491398|NCT01681433|517340372|FG000|Overall Study|Withdrawal by Subject|5|||
143491399|NCT01681433|517340373|FG001|Overall Study|Withdrawal by Subject|5|||
143491400|NCT01681433|517340372|FG000|Overall Study|Protocol Violation|2|||
143491401|NCT01681433|517340373|FG001|Overall Study|Protocol Violation|0|||
143491402|NCT01681433|517340372|FG000|Overall Study|Adverse Event|2|||
143027509|NCT04828161|515642279|FG003|Overall Study|Death|2|||
143158195|NCT04518410|516124388|FG001|Overall Study|Randomized but not treated|0|||
143027510|NCT05431153|515642280|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
143027511|NCT05431153|515642281|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
143027512|NCT05431153|515642282|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
143158196|NCT04518410|516124389|FG002|Overall Study|Randomized but not treated|0|||
143363871|NCT00049517|516875455|FG005|Conditioning/Transplant|Alternative therapy|0|||
143491403|NCT01681433|517340373|FG001|Overall Study|Adverse Event|4|||
143027513|NCT05431153|515642283|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
143027514|NCT05431153|515642284|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
143027515|NCT05431153|515642285|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
143027516|NCT02352337|515642286|FG000|Overall Study|Patients never treated|4|||
143027517|NCT02352337|515642287|FG001|Overall Study|Patients never treated|1|||
143027518|NCT02352337|515642288|FG002|Overall Study|Patients never treated|2|||
143027519|NCT02458638|515642289|FG000|Overall Study|Death|309|||
143027520|NCT02458638|515642289|FG000|Overall Study|End of Cohort/End of Study|67|||
143027521|NCT02458638|515642289|FG000|Overall Study|Lost to Follow-up|31|||
143027522|NCT02458638|515642289|FG000|Overall Study|Other Reasons|4|||
143027523|NCT02458638|515642289|FG000|Overall Study|Physician Decision|1|||
143027524|NCT02458638|515642289|FG000|Overall Study|Withdrawal by Subject|47|||
143027525|NCT04540497|515642294|FG000|Overall Study|Adverse Event|0|||
143027526|NCT04540497|515642295|FG001|Overall Study|Adverse Event|2|||
143027527|NCT04540497|515642294|FG000|Overall Study|Lost to Follow-up|1|||
143027528|NCT04540497|515642295|FG001|Overall Study|Lost to Follow-up|0|||
143027529|NCT04540497|515642294|FG000|Overall Study|Withdrawal by Subject|1|||
143027530|NCT04540497|515642295|FG001|Overall Study|Withdrawal by Subject|1|||
143027531|NCT04540497|515642294|FG000|Overall Study|Miscellaneous|2|||
143027532|NCT04540497|515642295|FG001|Overall Study|Miscellaneous|1|||
143027533|NCT01829464|515642299|FG000|Overall Study|Adverse Event|1|||
143027534|NCT01829464|515642300|FG001|Overall Study|Adverse Event|0|||
143027535|NCT01829464|515642301|FG002|Overall Study|Adverse Event|0|||
143027536|NCT01829464|515642299|FG000|Overall Study|Lost to Follow-up|0|||
143027537|NCT01829464|515642300|FG001|Overall Study|Lost to Follow-up|0|||
143027538|NCT01829464|515642301|FG002|Overall Study|Lost to Follow-up|1|||
143027539|NCT01829464|515642299|FG000|Overall Study|Withdrawal by Subject|2|||
143027540|NCT01829464|515642300|FG001|Overall Study|Withdrawal by Subject|0|||
143027541|NCT01829464|515642301|FG002|Overall Study|Withdrawal by Subject|0|||
143027542|NCT01829464|515642299|FG000|Overall Study|Study terminated by sponsor|25|||
143027543|NCT01829464|515642300|FG001|Overall Study|Study terminated by sponsor|28|||
143027544|NCT01829464|515642301|FG002|Overall Study|Study terminated by sponsor|25|||
143027545|NCT01829464|515642299|FG000|Overall Study|Lack of Efficacy|0|||
143027546|NCT01829464|515642300|FG001|Overall Study|Lack of Efficacy|1|||
143027547|NCT01829464|515642301|FG002|Overall Study|Lack of Efficacy|0|||
143027548|NCT03738332|515642306|FG000|Overall Study|Withdrawal by Subject|1|||
143027549|NCT02336737|515642307|FG000|Overall Study|Withdrawal by Subject|5|||
143027550|NCT02336737|515642307|FG000|Overall Study|Physician Decision|8|||
143027551|NCT00812253|515642308|FG000|Overall Study|Withdrawal by Subject|3|||
143027552|NCT00812253|515642309|FG001|Overall Study|Withdrawal by Subject|2|||
143027553|NCT00812253|515642308|FG000|Overall Study|Protocol Violation|1|||
143027554|NCT00812253|515642309|FG001|Overall Study|Protocol Violation|1|||
143027555|NCT00812253|515642308|FG000|Overall Study|Lost to Follow-up|2|||
143027556|NCT00812253|515642309|FG001|Overall Study|Lost to Follow-up|0|||
143027557|NCT01884025|515642310|FG000|Overall Study|Lost to Follow-up|3|||
143027558|NCT01884025|515642311|FG001|Overall Study|Lost to Follow-up|4|||
143027559|NCT00620763|515642317|FG000|Period: First Intervention|Withdrawal by Subject|0|||
143027560|NCT00620763|515642318|FG001|Period: First Intervention|Withdrawal by Subject|2|||
143027561|NCT00620763|515642317|FG000|Period: First Intervention|Protocol Violation|0|||
143027562|NCT00620763|515642318|FG001|Period: First Intervention|Protocol Violation|3|||
143027563|NCT00620763|515642317|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
143027564|NCT00620763|515642318|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
143027565|NCT00729859|515642319|FG000|Overall Study|Adverse Event|0|||
143027566|NCT00729859|515642320|FG001|Overall Study|Adverse Event|1|||
143027567|NCT00729859|515642321|FG002|Overall Study|Adverse Event|0|||
143027568|NCT00729859|515642319|FG000|Overall Study|Withdrawal by Subject|0|||
143027569|NCT00729859|515642320|FG001|Overall Study|Withdrawal by Subject|1|||
143237074|NCT03955146|516421541|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
143237075|NCT03955146|516421542|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
143237076|NCT03955146|516421539|FG000|DB Period (48 Weeks)|Participant Decision|9|||
143491404|NCT01681433|517340372|FG000|Overall Study|Lost to Follow-up|0|||
143491405|NCT01681433|517340373|FG001|Overall Study|Lost to Follow-up|1|||
143491406|NCT00903929|517340374|FG000|Overall Study|Withdrawal by Subject|0|||
143027570|NCT00729859|515642321|FG002|Overall Study|Withdrawal by Subject|0|||
143027571|NCT02623829|515642324|FG000|Overall Study|Lost to Follow-up|1|||
143027572|NCT02623829|515642325|FG001|Overall Study|Lost to Follow-up|1|||
143027573|NCT02985151|515642326|FG000|Original Randomization|Withdrawal by Subject|0|||
143027574|NCT02985151|515642327|FG001|Original Randomization|Withdrawal by Subject|1|||
143027575|NCT04104646|515642334|FG000|Overall Study|Withdrawal by Subject|1|||
143027576|NCT04104646|515642335|FG001|Overall Study|Withdrawal by Subject|1|||
143027577|NCT04104646|515642334|FG000|Overall Study|Lost to Follow-up|1|||
143027578|NCT04104646|515642335|FG001|Overall Study|Lost to Follow-up|0|||
143027579|NCT04104646|515642334|FG000|Overall Study|Physician Decision|2|||
143237077|NCT03955146|516421540|FG001|DB Period (48 Weeks)|Participant Decision|12|||
143237078|NCT03955146|516421541|FG002|DB Period (48 Weeks)|Participant Decision|1|||
143027580|NCT04104646|515642335|FG001|Overall Study|Physician Decision|0|||
143491407|NCT00903929|517340375|FG001|Overall Study|Withdrawal by Subject|0|||
143027581|NCT02607800|515642336|FG000|Overall Study|Lost to Follow-up|7|||
143027582|NCT02607800|515642337|FG001|Overall Study|Lost to Follow-up|10|||
143027583|NCT02607800|515642336|FG000|Overall Study|Withdrew Consent|2|||
143027584|NCT02607800|515642337|FG001|Overall Study|Withdrew Consent|0|||
143027585|NCT02607800|515642336|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
143027586|NCT02607800|515642337|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
143027587|NCT02486796|515642338|FG000|Overall Study|Withdrawal by Subject|1|||
143027588|NCT02486796|515642339|FG001|Overall Study|Withdrawal by Subject|1|||
143027589|NCT02486796|515642338|FG000|Overall Study|Physician Decision|1|||
143027590|NCT02486796|515642339|FG001|Overall Study|Physician Decision|0|||
143027591|NCT02974153|515642340|FG000|Overall Study|Adverse Event|6|||
143027592|NCT02974153|515642341|FG001|Overall Study|Adverse Event|0|||
143027593|NCT02974153|515642342|FG002|Overall Study|Adverse Event|1|||
143027594|NCT02974153|515642340|FG000|Overall Study|Lack of Efficacy|6|||
143027595|NCT02974153|515642341|FG001|Overall Study|Lack of Efficacy|5|||
143027596|NCT02974153|515642342|FG002|Overall Study|Lack of Efficacy|10|||
143027597|NCT02974153|515642340|FG000|Overall Study|Lost to Follow-up|9|||
143027598|NCT02974153|515642341|FG001|Overall Study|Lost to Follow-up|10|||
143027599|NCT02974153|515642342|FG002|Overall Study|Lost to Follow-up|17|||
143027600|NCT02974153|515642340|FG000|Overall Study|Physician Decision|0|||
143027601|NCT02974153|515642341|FG001|Overall Study|Physician Decision|2|||
143027602|NCT02974153|515642342|FG002|Overall Study|Physician Decision|1|||
143027603|NCT02974153|515642340|FG000|Overall Study|Withdrawal by Subject|9|||
143027604|NCT02974153|515642341|FG001|Overall Study|Withdrawal by Subject|16|||
143491408|NCT00903929|517340376|FG002|Overall Study|Withdrawal by Subject|1|||
143491409|NCT00903929|517340377|FG003|Overall Study|Withdrawal by Subject|2|||
143491410|NCT00903929|517340374|FG000|Overall Study|Adverse Event|0|||
143491411|NCT00903929|517340375|FG001|Overall Study|Adverse Event|0|||
143491412|NCT00903929|517340376|FG002|Overall Study|Adverse Event|0|||
143491413|NCT00903929|517340377|FG003|Overall Study|Adverse Event|1|||
143027605|NCT02974153|515642342|FG002|Overall Study|Withdrawal by Subject|11|||
143027606|NCT02974153|515642340|FG000|Overall Study|Study Burden|8|||
143027607|NCT02974153|515642341|FG001|Overall Study|Study Burden|7|||
143027608|NCT02974153|515642342|FG002|Overall Study|Study Burden|3|||
143027609|NCT02974153|515642340|FG000|Overall Study|Other|14|||
143027610|NCT02974153|515642341|FG001|Overall Study|Other|8|||
143027611|NCT02974153|515642342|FG002|Overall Study|Other|7|||
143027612|NCT00423800|515642343|FG000|Overall Study|Protocol Violation|0|||
143027613|NCT00423800|515642344|FG001|Overall Study|Protocol Violation|1|||
143027614|NCT00679783|515642346|FG000|Overall Study|Adverse Event|0|||
143027615|NCT00679783|515642347|FG001|Overall Study|Adverse Event|0|||
143027616|NCT00679783|515642348|FG002|Overall Study|Adverse Event|0|||
143027617|NCT00679783|515642349|FG003|Overall Study|Adverse Event|3|||
143027618|NCT00679783|515642350|FG004|Overall Study|Adverse Event|0|||
143027619|NCT00679783|515642351|FG005|Overall Study|Adverse Event|0|||
143027620|NCT00679783|515642352|FG006|Overall Study|Adverse Event|1|||
143027621|NCT00679783|515642346|FG000|Overall Study|Lack of Efficacy|0|||
143027622|NCT00679783|515642347|FG001|Overall Study|Lack of Efficacy|1|||
143027623|NCT00679783|515642348|FG002|Overall Study|Lack of Efficacy|0|||
143027624|NCT00679783|515642349|FG003|Overall Study|Lack of Efficacy|2|||
143027625|NCT00679783|515642350|FG004|Overall Study|Lack of Efficacy|0|||
143027626|NCT00679783|515642351|FG005|Overall Study|Lack of Efficacy|0|||
143027627|NCT00679783|515642352|FG006|Overall Study|Lack of Efficacy|0|||
143027628|NCT00679783|515642346|FG000|Overall Study|Withdrawal by Subject|0|||
143491414|NCT02289950|517340381|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
143491415|NCT02289950|517340382|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
143491416|NCT02289950|517340381|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
143027629|NCT00679783|515642347|FG001|Overall Study|Withdrawal by Subject|0|||
143027630|NCT00679783|515642348|FG002|Overall Study|Withdrawal by Subject|1|||
143027631|NCT00679783|515642349|FG003|Overall Study|Withdrawal by Subject|1|||
143027632|NCT00679783|515642350|FG004|Overall Study|Withdrawal by Subject|0|||
143027633|NCT00679783|515642351|FG005|Overall Study|Withdrawal by Subject|0|||
143491417|NCT02289950|517340382|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
143491418|NCT02289950|517340381|FG000|Overall Study|Lost to Follow-up|1|||
143027634|NCT00679783|515642352|FG006|Overall Study|Withdrawal by Subject|0|||
143158197|NCT04518410|516124390|FG003|Overall Study|Randomized but not treated|2|||
143158198|NCT04518410|516124391|FG004|Overall Study|Randomized but not treated|6|||
143158199|NCT04518410|516124392|FG005|Overall Study|Randomized but not treated|4|||
143027635|NCT00679783|515642346|FG000|Overall Study|Not Captured|0|||
143027636|NCT00679783|515642347|FG001|Overall Study|Not Captured|0|||
143027637|NCT00679783|515642348|FG002|Overall Study|Not Captured|0|||
143491419|NCT02289950|517340382|FG001|Overall Study|Lost to Follow-up|0|||
143027638|NCT00679783|515642349|FG003|Overall Study|Not Captured|5|||
143027639|NCT00679783|515642350|FG004|Overall Study|Not Captured|0|||
143027640|NCT00679783|515642351|FG005|Overall Study|Not Captured|0|||
143027641|NCT00679783|515642352|FG006|Overall Study|Not Captured|0|||
143027642|NCT00679783|515642346|FG000|Overall Study|Ongoing at data cut-off|2|||
143027643|NCT00679783|515642347|FG001|Overall Study|Ongoing at data cut-off|2|||
143491420|NCT02289950|517340381|FG000|Overall Study|Physician Decision|9|||
143027644|NCT00679783|515642348|FG002|Overall Study|Ongoing at data cut-off|0|||
143027645|NCT00679783|515642349|FG003|Overall Study|Ongoing at data cut-off|9|||
143027646|NCT00679783|515642350|FG004|Overall Study|Ongoing at data cut-off|1|||
143027647|NCT00679783|515642351|FG005|Overall Study|Ongoing at data cut-off|0|||
143027648|NCT00679783|515642352|FG006|Overall Study|Ongoing at data cut-off|0|||
143027649|NCT00491504|515642353|FG000|Overall Study|Adverse Event|0|||
143027650|NCT00491504|515642354|FG001|Overall Study|Adverse Event|1|||
143027651|NCT00491504|515642355|FG002|Overall Study|Adverse Event|0|||
143027652|NCT00491504|515642356|FG003|Overall Study|Adverse Event|0|||
143027653|NCT00491504|515642353|FG000|Overall Study|Withdrawal by Subject|0|||
143027654|NCT00491504|515642354|FG001|Overall Study|Withdrawal by Subject|0|||
143027655|NCT00491504|515642355|FG002|Overall Study|Withdrawal by Subject|1|||
143027656|NCT00491504|515642356|FG003|Overall Study|Withdrawal by Subject|2|||
143027657|NCT00491504|515642353|FG000|Overall Study|Protocol Violation|0|||
143027658|NCT00491504|515642354|FG001|Overall Study|Protocol Violation|0|||
143027659|NCT00491504|515642355|FG002|Overall Study|Protocol Violation|3|||
143027660|NCT00491504|515642356|FG003|Overall Study|Protocol Violation|2|||
143027661|NCT02568384|515642359|FG000|Overall Study|Mobile devices incompatible with App|2|||
143027662|NCT01488578|515642360|FG000|Overall Study|Protocol Violation|1836|||
143027663|NCT00717756|515642361|FG000|Overall Study|Withdrawal by Subject|1|||
143027664|NCT00306384|515642362|FG000|Overall Study|Adverse Event|103|||
143027665|NCT00306384|515642363|FG001|Overall Study|Adverse Event|87|||
143027666|NCT00306384|515642364|FG002|Overall Study|Adverse Event|40|||
143027667|NCT00306384|515642362|FG000|Overall Study|Major protocol deviation|43|||
143027668|NCT00306384|515642363|FG001|Overall Study|Major protocol deviation|51|||
143027669|NCT00306384|515642364|FG002|Overall Study|Major protocol deviation|18|||
143027670|NCT00306384|515642362|FG000|Overall Study|Lost to Follow-up|57|||
143027671|NCT00306384|515642363|FG001|Overall Study|Lost to Follow-up|41|||
143027672|NCT00306384|515642364|FG002|Overall Study|Lost to Follow-up|35|||
143027673|NCT00306384|515642362|FG000|Overall Study|Voluntary withdrawal|199|||
143027674|NCT00306384|515642363|FG001|Overall Study|Voluntary withdrawal|187|||
143027675|NCT00306384|515642364|FG002|Overall Study|Voluntary withdrawal|91|||
143027676|NCT00306384|515642362|FG000|Overall Study|Study termination|1|||
143027677|NCT00306384|515642363|FG001|Overall Study|Study termination|0|||
143027678|NCT00306384|515642364|FG002|Overall Study|Study termination|1|||
143027679|NCT00306384|515642362|FG000|Overall Study|Pregnancy|3|||
143027680|NCT00306384|515642363|FG001|Overall Study|Pregnancy|1|||
143027681|NCT00306384|515642364|FG002|Overall Study|Pregnancy|1|||
143027682|NCT00306384|515642362|FG000|Overall Study|Lack of Efficacy|26|||
143027683|NCT00306384|515642363|FG001|Overall Study|Lack of Efficacy|40|||
143027684|NCT00306384|515642364|FG002|Overall Study|Lack of Efficacy|38|||
143027685|NCT00306384|515642362|FG000|Overall Study|Investigator discretion|28|||
143027686|NCT00306384|515642363|FG001|Overall Study|Investigator discretion|31|||
143027687|NCT00306384|515642364|FG002|Overall Study|Investigator discretion|21|||
143027688|NCT00306384|515642362|FG000|Overall Study|Other|80|||
143027689|NCT00306384|515642363|FG001|Overall Study|Other|70|||
143027690|NCT00306384|515642364|FG002|Overall Study|Other|32|||
143027691|NCT00306384|515642362|FG000|Overall Study|Site closure|2|||
143027692|NCT00306384|515642363|FG001|Overall Study|Site closure|0|||
143027693|NCT00306384|515642364|FG002|Overall Study|Site closure|0|||
143027694|NCT00673790|515642365|FG000|Overall Study|Adverse Event|23|||
143027695|NCT00673790|515642366|FG001|Overall Study|Adverse Event|14|||
143027696|NCT00673790|515642367|FG002|Overall Study|Adverse Event|2|||
143027697|NCT00673790|515642365|FG000|Overall Study|Lack of Efficacy|2|||
143027698|NCT00673790|515642366|FG001|Overall Study|Lack of Efficacy|2|||
143158200|NCT04518410|516124393|FG006|Overall Study|Randomized but not treated|3|||
143491421|NCT02289950|517340382|FG001|Overall Study|Physician Decision|3|||
143491422|NCT02289950|517340381|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
143491423|NCT02289950|517340382|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
143491424|NCT02289950|517340381|FG000|Overall Study|Withdrawal by Subject|1|||
143491425|NCT02289950|517340382|FG001|Overall Study|Withdrawal by Subject|3|||
143491426|NCT02289950|517340381|FG000|Overall Study|Test article held for greater than 28 days|0|||
143491427|NCT02289950|517340382|FG001|Overall Study|Test article held for greater than 28 days|1|||
143491428|NCT02289950|517340381|FG000|Overall Study|Adverse Event|11|||
143027699|NCT00673790|515642367|FG002|Overall Study|Lack of Efficacy|2|||
143027700|NCT00673790|515642365|FG000|Overall Study|Protocol Violation|6|||
143027701|NCT00673790|515642366|FG001|Overall Study|Protocol Violation|9|||
143158201|NCT04518410|516124394|FG007|Overall Study|Randomized but not treated|3|||
143027702|NCT00673790|515642367|FG002|Overall Study|Protocol Violation|1|||
143158202|NCT04518410|516124395|FG008|Overall Study|Randomized but not treated|0|||
143363872|NCT00049517|516875450|FG000|Conditioning/Transplant|Other complicating disease|2|||
143491429|NCT02289950|517340382|FG001|Overall Study|Adverse Event|3|||
143027703|NCT00673790|515642365|FG000|Overall Study|Withdrawal by Subject|7|||
143027704|NCT00673790|515642366|FG001|Overall Study|Withdrawal by Subject|4|||
143027705|NCT00673790|515642367|FG002|Overall Study|Withdrawal by Subject|1|||
143027706|NCT00673790|515642365|FG000|Overall Study|Lost to Follow-up|6|||
143027707|NCT00673790|515642366|FG001|Overall Study|Lost to Follow-up|6|||
143027708|NCT00673790|515642367|FG002|Overall Study|Lost to Follow-up|5|||
143027709|NCT00673790|515642365|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
143027710|NCT00673790|515642366|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
143027711|NCT00673790|515642367|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
143027712|NCT00673790|515642365|FG000|Overall Study|Poor compliance|1|||
143027713|NCT00673790|515642366|FG001|Overall Study|Poor compliance|0|||
143027714|NCT00673790|515642367|FG002|Overall Study|Poor compliance|0|||
143027715|NCT00673790|515642365|FG000|Overall Study|Participated in two Nebivolol studies|0|||
143027716|NCT00673790|515642366|FG001|Overall Study|Participated in two Nebivolol studies|0|||
143027717|NCT00673790|515642367|FG002|Overall Study|Participated in two Nebivolol studies|1|||
143027718|NCT00673790|515642365|FG000|Overall Study|Unconfirmed pregnancy|0|||
143027719|NCT00673790|515642366|FG001|Overall Study|Unconfirmed pregnancy|1|||
143027720|NCT00673790|515642367|FG002|Overall Study|Unconfirmed pregnancy|0|||
143027721|NCT00673790|515642365|FG000|Overall Study|Randomization criteria not met|0|||
143027722|NCT00673790|515642366|FG001|Overall Study|Randomization criteria not met|1|||
143027723|NCT00673790|515642367|FG002|Overall Study|Randomization criteria not met|0|||
143027724|NCT00601484|515642373|FG000|Overall Study|Adverse Event|0|||
143027725|NCT00601484|515642374|FG001|Overall Study|Adverse Event|1|||
143027726|NCT00601484|515642373|FG000|Overall Study|Lost to Follow-up|4|||
143027727|NCT00601484|515642374|FG001|Overall Study|Lost to Follow-up|3|||
143027728|NCT00601484|515642373|FG000|Overall Study|Lack of Efficacy|0|||
143027729|NCT00601484|515642374|FG001|Overall Study|Lack of Efficacy|2|||
143027730|NCT00601484|515642373|FG000|Overall Study|Withdrawal by Subject|1|||
143027731|NCT00601484|515642374|FG001|Overall Study|Withdrawal by Subject|1|||
143027732|NCT00601484|515642373|FG000|Overall Study|Randomized, but not treated|0|||
143027733|NCT00601484|515642374|FG001|Overall Study|Randomized, but not treated|1|||
143027734|NCT03977584|515642375|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
143027735|NCT03977584|515642376|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
143027736|NCT03977584|515642377|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
143027737|NCT02729896|515642383|FG000|Overall Study|Death|0|||
143027738|NCT02729896|515642384|FG001|Overall Study|Death|2|||
143027739|NCT02729896|515642385|FG002|Overall Study|Death|13|||
143027740|NCT02729896|515642383|FG000|Overall Study|Lost to Follow-up|0|||
143027741|NCT02729896|515642384|FG001|Overall Study|Lost to Follow-up|2|||
143027742|NCT02729896|515642385|FG002|Overall Study|Lost to Follow-up|3|||
143027743|NCT02729896|515642383|FG000|Overall Study|Other|0|||
143027744|NCT02729896|515642384|FG001|Overall Study|Other|2|||
143027745|NCT02729896|515642385|FG002|Overall Study|Other|0|||
143027746|NCT02729896|515642383|FG000|Overall Study|Physician Decision|1|||
143027747|NCT02729896|515642384|FG001|Overall Study|Physician Decision|2|||
143491430|NCT02289950|517340381|FG000|Overall Study|Death|1|||
143491431|NCT02289950|517340382|FG001|Overall Study|Death|1|||
143491432|NCT02289950|517340381|FG000|Overall Study|Other|5|||
143491433|NCT02289950|517340382|FG001|Overall Study|Other|2|||
143491434|NCT02289950|517340381|FG000|Overall Study|Not Treated|2|||
143491435|NCT02289950|517340382|FG001|Overall Study|Not Treated|1|||
143491436|NCT04440592|517340390|FG000|Overall Study|Adverse Event|8|||
143491437|NCT04440592|517340391|FG001|Overall Study|Adverse Event|0|||
143491438|NCT04440592|517340390|FG000|Overall Study|Lost to Follow-up|1|||
143491439|NCT04440592|517340391|FG001|Overall Study|Lost to Follow-up|0|||
143158203|NCT04518410|516124396|FG009|Overall Study|Randomized but not treated|4|||
143363873|NCT00049517|516875451|FG001|Conditioning/Transplant|Other complicating disease|0|||
143491440|NCT04440592|517340390|FG000|Overall Study|Withdrawal by Subject|1|||
143491441|NCT04440592|517340391|FG001|Overall Study|Withdrawal by Subject|1|||
143491442|NCT04440592|517340390|FG000|Overall Study|Other therapy needed|0|||
143491443|NCT04440592|517340391|FG001|Overall Study|Other therapy needed|1|||
143491444|NCT02396589|517340397|FG000|Intervention|Lost to Follow-up|1|||
143491445|NCT02396589|517340398|FG001|Intervention|Lost to Follow-up|0|||
143491446|NCT02396589|517340397|FG000|6 Month Follow-up|change in health status|0|||
143491447|NCT02396589|517340398|FG001|6 Month Follow-up|change in health status|1|||
143491448|NCT02396589|517340397|FG000|9 Month Follow-up|Death|0|||
143491449|NCT02396589|517340398|FG001|9 Month Follow-up|Death|1|||
143491450|NCT02396589|517340397|FG000|12 Month Follow up|Lost to Follow-up|0|||
143491451|NCT02396589|517340398|FG001|12 Month Follow up|Lost to Follow-up|2|||
143491452|NCT00598975|517342529|FG000|Overall Study|Adverse Event|1|||
143491453|NCT00598975|517342530|FG001|Overall Study|Adverse Event|1|||
143491454|NCT00598975|517342529|FG000|Overall Study|Brain metastases|1|||
143027748|NCT02729896|515642385|FG002|Overall Study|Physician Decision|3|||
143027749|NCT02729896|515642383|FG000|Overall Study|Progressive Disease|0|||
143027750|NCT02729896|515642384|FG001|Overall Study|Progressive Disease|1|||
143491455|NCT00598975|517342530|FG001|Overall Study|Brain metastases|0|||
143027751|NCT02729896|515642385|FG002|Overall Study|Progressive Disease|0|||
143027752|NCT02729896|515642383|FG000|Overall Study|Withdrawal by Subject|1|||
143027753|NCT02729896|515642384|FG001|Overall Study|Withdrawal by Subject|0|||
143158204|NCT04518410|516124397|FG010|Overall Study|Randomized but not treated|0|||
143491456|NCT00598975|517342529|FG000|Overall Study|Withdrawal by Subject|1|||
143491457|NCT00598975|517342530|FG001|Overall Study|Withdrawal by Subject|1|||
143027754|NCT02729896|515642385|FG002|Overall Study|Withdrawal by Subject|3|||
143027755|NCT00582309|515642386|FG000|Overall Study|Protocol Violation|0|||
143027756|NCT00582309|515642387|FG001|Overall Study|Protocol Violation|0|||
143027757|NCT00582309|515642388|FG002|Overall Study|Protocol Violation|2|||
143027758|NCT01565083|515642393|FG000|Overall Study|Withdrawal by Subject|6|||
143027759|NCT01565083|515642394|FG001|Overall Study|Withdrawal by Subject|4|||
143027760|NCT01565083|515642393|FG000|Overall Study|Lost to Follow-up|2|||
143027761|NCT01565083|515642394|FG001|Overall Study|Lost to Follow-up|7|||
143027762|NCT01565083|515642393|FG000|Overall Study|Death|22|||
143027763|NCT01565083|515642394|FG001|Overall Study|Death|23|||
143027764|NCT01565083|515642393|FG000|Overall Study|Other|3|||
143027765|NCT01565083|515642394|FG001|Overall Study|Other|5|||
143027766|NCT02708277|515642395|FG000|Overall Study|Lost to Follow-up|7|||
143027767|NCT02708277|515642396|FG001|Overall Study|Lost to Follow-up|4|||
143027768|NCT01058421|515642397|FG000|1 Month Outcomes|Death|10|||
143027769|NCT01058421|515642398|FG001|1 Month Outcomes|Death|6|||
143027770|NCT01058421|515642397|FG000|1 Month Outcomes|Lost to Follow-up|8|||
143027771|NCT01058421|515642398|FG001|1 Month Outcomes|Lost to Follow-up|7|||
143027772|NCT01058421|515642397|FG000|1 Month Outcomes|Remained in Hospital|5|||
143027773|NCT01058421|515642398|FG001|1 Month Outcomes|Remained in Hospital|12|||
143027774|NCT01058421|515642397|FG000|1 Month Outcomes|Remained in Other Facility|16|||
143027775|NCT01058421|515642398|FG001|1 Month Outcomes|Remained in Other Facility|17|||
143027776|NCT01058421|515642397|FG000|3 Month Outcomes|Death|3|||
143027777|NCT01058421|515642398|FG001|3 Month Outcomes|Death|5|||
143027778|NCT01058421|515642397|FG000|3 Month Outcomes|Lost to Follow-up|12|||
143027779|NCT01058421|515642398|FG001|3 Month Outcomes|Lost to Follow-up|11|||
143027780|NCT01058421|515642397|FG000|3 Month Outcomes|Remained in Hospital|0|||
143027781|NCT01058421|515642398|FG001|3 Month Outcomes|Remained in Hospital|2|||
143027782|NCT01058421|515642397|FG000|3 Month Outcomes|Remained in Other Facility|5|||
143027783|NCT01058421|515642398|FG001|3 Month Outcomes|Remained in Other Facility|8|||
143027784|NCT01058421|515642397|FG000|6 Month Outcomes|Death|2|||
143027785|NCT01058421|515642398|FG001|6 Month Outcomes|Death|2|||
143027786|NCT01058421|515642397|FG000|6 Month Outcomes|Lost to Follow-up|16|||
143027787|NCT01058421|515642398|FG001|6 Month Outcomes|Lost to Follow-up|21|||
143027788|NCT01058421|515642397|FG000|6 Month Outcomes|Remained in Other Facility|1|||
143027789|NCT01058421|515642398|FG001|6 Month Outcomes|Remained in Other Facility|3|||
143027790|NCT01960816|515642399|FG000|Overall Study|Lost to Follow-up|1|||
143027791|NCT01118728|515642400|FG000|Overall Study|Adverse Event|17|||
143027792|NCT01118728|515642400|FG000|Overall Study|Lack of Efficacy|27|||
143027793|NCT01118728|515642400|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
143027794|NCT01118728|515642400|FG000|Overall Study|Withdrawal by Subject|3|||
143027795|NCT01118728|515642400|FG000|Overall Study|Lost to Follow-up|4|||
143027796|NCT01309919|515642415|FG000|Overall Study|Did not receive a postpartum IUD|17|||
143027797|NCT01309919|515642416|FG001|Overall Study|Did not receive a postpartum IUD|48|||
143027798|NCT01052116|515644159|FG000|Overall Study|Lost to Follow-up|11|||
143027799|NCT01052116|515644160|FG001|Overall Study|Lost to Follow-up|17|||
143027800|NCT01052116|515644159|FG000|Overall Study|Withdrawal by Subject|3|||
143027801|NCT01052116|515644160|FG001|Overall Study|Withdrawal by Subject|6|||
143027802|NCT01052116|515644159|FG000|Overall Study|Spirometry not performed|0|||
143027803|NCT01052116|515644160|FG001|Overall Study|Spirometry not performed|4|||
143027804|NCT01768858|515644161|FG000|Overall Study|Lost to Follow-up|9|||
143027805|NCT01768858|515644161|FG000|Overall Study|Lack of Efficacy|8|||
143491458|NCT00598975|517342529|FG000|Overall Study|Withdrawal of consent|0|||
143491459|NCT00598975|517342530|FG001|Overall Study|Withdrawal of consent|1|||
143027806|NCT01768858|515644161|FG000|Overall Study|Serious Adverse Event|1|||
143027807|NCT01768858|515644161|FG000|Overall Study|Participant moved to Germany|1|||
143027808|NCT01768858|515644161|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
143027809|NCT01768858|515644161|FG000|Overall Study|Exanthema|1|||
143027810|NCT01768858|515644161|FG000|Overall Study|Withdrawal by Subject|1|||
143027811|NCT03093324|515644163|FG000|Overall Study|Adverse Event|4|||
143027812|NCT03093324|515644164|FG001|Overall Study|Adverse Event|15|||
143027813|NCT03093324|515644163|FG000|Overall Study|Lost to Follow-up|1|||
143027814|NCT03093324|515644164|FG001|Overall Study|Lost to Follow-up|0|||
143027815|NCT03093324|515644163|FG000|Overall Study|Protocol Deviation|2|||
143027816|NCT03093324|515644164|FG001|Overall Study|Protocol Deviation|2|||
143027817|NCT03093324|515644163|FG000|Overall Study|Withdrawal by Subject|2|||
143158205|NCT04518410|516124398|FG011|Overall Study|Randomized but not treated|0|||
143158206|NCT04518410|516124399|FG012|Overall Study|Randomized but not treated|1|||
143158207|NCT04518410|516124400|FG013|Overall Study|Randomized but not treated|3|||
143158208|NCT04518410|516124401|FG014|Overall Study|Randomized but not treated|3|||
143027818|NCT03093324|515644164|FG001|Overall Study|Withdrawal by Subject|2|||
143027819|NCT01691859|515644165|FG000|Overall Study|Adverse Event|19|||
143027820|NCT01691859|515644165|FG000|Overall Study|Lack of Efficacy|11|||
143027821|NCT01691859|515644165|FG000|Overall Study|Protocol Violation|4|||
143158209|NCT04518410|516124402|FG015|Overall Study|Randomized but not treated|3|||
143158210|NCT04518410|516124403|FG016|Overall Study|Randomized but not treated|4|||
143491460|NCT00598975|517342529|FG000|Overall Study|Disease progression|8|||
143158211|NCT04518410|516124404|FG017|Overall Study|Randomized but not treated|5|||
143027822|NCT01691859|515644165|FG000|Overall Study|Product commercially available|221|||
143027823|NCT01691859|515644165|FG000|Overall Study|Study closed/terminated|50|||
143027824|NCT01691859|515644165|FG000|Overall Study|Lost to Follow-up|5|||
143027825|NCT01691859|515644165|FG000|Overall Study|Physician Decision|6|||
143027826|NCT01691859|515644165|FG000|Overall Study|Withdrawal by Subject|31|||
143027827|NCT00278200|515644166|FG000|Overall Study|Death|1|||
143027828|NCT00278200|515644167|FG001|Overall Study|Death|3|||
143027829|NCT00278200|515644166|FG000|Overall Study|Physician Decision|0|||
143027830|NCT00278200|515644167|FG001|Overall Study|Physician Decision|1|||
143027831|NCT03519256|515644168|FG000|Overall Study|Disease recurrence|4|||
143027832|NCT03519256|515644169|FG001|Overall Study|Disease recurrence|4|||
143027833|NCT03519256|515644170|FG002|Overall Study|Disease recurrence|5|||
143027834|NCT03519256|515644171|FG003|Overall Study|Disease recurrence|2|||
143027835|NCT03519256|515644168|FG000|Overall Study|Study drug toxicity|0|||
143027836|NCT03519256|515644169|FG001|Overall Study|Study drug toxicity|2|||
143027837|NCT03519256|515644170|FG002|Overall Study|Study drug toxicity|5|||
143027838|NCT03519256|515644171|FG003|Overall Study|Study drug toxicity|2|||
143027839|NCT03519256|515644168|FG000|Overall Study|Adverse event unrelated to study drug|0|||
143027840|NCT03519256|515644169|FG001|Overall Study|Adverse event unrelated to study drug|1|||
143027841|NCT03519256|515644170|FG002|Overall Study|Adverse event unrelated to study drug|1|||
143027842|NCT03519256|515644171|FG003|Overall Study|Adverse event unrelated to study drug|0|||
143027843|NCT03519256|515644168|FG000|Overall Study|Participant request to discontinue study treatment|0|||
143027844|NCT03519256|515644169|FG001|Overall Study|Participant request to discontinue study treatment|0|||
143027845|NCT03519256|515644170|FG002|Overall Study|Participant request to discontinue study treatment|0|||
143027846|NCT03519256|515644171|FG003|Overall Study|Participant request to discontinue study treatment|2|||
143027847|NCT03519256|515644168|FG000|Overall Study|Other reasons|0|||
143027848|NCT03519256|515644169|FG001|Overall Study|Other reasons|0|||
143027849|NCT03519256|515644170|FG002|Overall Study|Other reasons|2|||
143027850|NCT03519256|515644171|FG003|Overall Study|Other reasons|0|||
143027851|NCT03519256|515644168|FG000|Overall Study|Disease progression|6|||
143027852|NCT03519256|515644169|FG001|Overall Study|Disease progression|3|||
143027853|NCT03519256|515644170|FG002|Overall Study|Disease progression|2|||
143027854|NCT03519256|515644171|FG003|Overall Study|Disease progression|1|||
143027855|NCT03519256|515644168|FG000|Overall Study|Lost to Follow-up|0|||
143027856|NCT03519256|515644169|FG001|Overall Study|Lost to Follow-up|1|||
143491461|NCT00598975|517342530|FG001|Overall Study|Disease progression|3|||
143491462|NCT00598975|517342529|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
143491463|NCT00598975|517342530|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
143491464|NCT01178138|517342531|FG000|Overall Study|Lost to Follow-up|8|||
143491465|NCT01178138|517342531|FG000|Overall Study|Withdrawal by Subject|7|||
143491466|NCT01178138|517342531|FG000|Overall Study|Physician Decision|8|||
143491467|NCT01241708|517342532|FG000|Overall Study|Withdrawal by Subject|6|||
143491468|NCT01241708|517342532|FG000|Overall Study|Screen Failure|6|||
143491469|NCT01241708|517342532|FG000|Overall Study|Did not move forward with 2nd Transplant|39|||
143491470|NCT01241708|517342532|FG000|Overall Study|Lost to Follow-up|5|||
143491471|NCT04183335|517342535|FG000|Overall Study|Adverse Event|1|||
143491472|NCT04183335|517342536|FG001|Overall Study|Adverse Event|0|||
143491473|NCT04183335|517342535|FG000|Overall Study|Withdrawal by Subject|12|||
143491474|NCT04183335|517342536|FG001|Overall Study|Withdrawal by Subject|3|||
143491475|NCT02944448|517342537|FG000|Overall Study|Adverse Event|37|||
143491476|NCT02944448|517342538|FG001|Overall Study|Adverse Event|6|||
143491477|NCT02944448|517342537|FG000|Overall Study|Lack of Efficacy|8|||
143491478|NCT02944448|517342538|FG001|Overall Study|Lack of Efficacy|5|||
143491479|NCT02944448|517342537|FG000|Overall Study|Lost to Follow-up|3|||
143491480|NCT02944448|517342538|FG001|Overall Study|Lost to Follow-up|1|||
143491481|NCT02944448|517342537|FG000|Overall Study|Protocol Violation|25|||
143491482|NCT02944448|517342538|FG001|Overall Study|Protocol Violation|7|||
143491483|NCT02944448|517342537|FG000|Overall Study|Withdrawal by Subject|14|||
143491484|NCT02944448|517342538|FG001|Overall Study|Withdrawal by Subject|4|||
143027857|NCT03519256|515644170|FG002|Overall Study|Lost to Follow-up|0|||
143027858|NCT03519256|515644171|FG003|Overall Study|Lost to Follow-up|0|||
143027859|NCT00135707|515644176|FG000|Overall Study|Lost to Follow-up|94|||
143027860|NCT00135707|515644177|FG001|Overall Study|Lost to Follow-up|89|||
143027861|NCT00135707|515644176|FG000|Overall Study|Withdrawal by Subject|0|||
143027862|NCT00135707|515644177|FG001|Overall Study|Withdrawal by Subject|1|||
143027863|NCT00135707|515644176|FG000|Overall Study|Institutional review board request|1|||
143027864|NCT00135707|515644177|FG001|Overall Study|Institutional review board request|0|||
143491485|NCT02944448|517342537|FG000|Overall Study|Sponsor did not supply drug in time|0|||
143491486|NCT02944448|517342538|FG001|Overall Study|Sponsor did not supply drug in time|1|||
143491487|NCT02944448|517342537|FG000|Overall Study|Noncompliant with dosing|1|||
143491488|NCT02944448|517342538|FG001|Overall Study|Noncompliant with dosing|0|||
143491489|NCT02944448|517342537|FG000|Overall Study|Abnormal laboratory values|1|||
143491490|NCT02944448|517342538|FG001|Overall Study|Abnormal laboratory values|0|||
143027865|NCT02524379|515644182|FG000|Overall Study|Death|1|||
143027866|NCT03679741|515644183|FG000|Period 1|No longer meet eligibility criteria|1|||
143027867|NCT03679741|515644184|FG001|Period 1|No longer meet eligibility criteria|0|||
143027868|NCT03679741|515644183|FG000|Period 1|Lost to Follow-up|0|||
143027869|NCT03679741|515644184|FG001|Period 1|Lost to Follow-up|1|||
143027870|NCT03679741|515644183|FG000|Period 1|Adverse Event|1|||
143027871|NCT03679741|515644184|FG001|Period 1|Adverse Event|1|||
143027872|NCT03679741|515644183|FG000|Period 1|Withdrawal by Subject|0|||
143027873|NCT03679741|515644184|FG001|Period 1|Withdrawal by Subject|1|||
143027874|NCT03679741|515644183|FG000|Period 2|Adverse Event|2|||
143027875|NCT03679741|515644184|FG001|Period 2|Adverse Event|1|||
143027876|NCT03679741|515644183|FG000|Period 2|Withdrawal by Subject|1|||
143027877|NCT03679741|515644184|FG001|Period 2|Withdrawal by Subject|1|||
143027878|NCT02227862|515644186|FG000|Overall Study|Protocol Violation|7|||
143027879|NCT02227862|515644187|FG001|Overall Study|Protocol Violation|9|||
143027880|NCT02227862|515644186|FG000|Overall Study|Other|0|||
143027881|NCT02227862|515644187|FG001|Overall Study|Other|2|||
143027882|NCT02227862|515644186|FG000|Overall Study|Adverse Event|4|||
143027883|NCT02227862|515644187|FG001|Overall Study|Adverse Event|3|||
143027884|NCT02227862|515644186|FG000|Overall Study|Withdrawal by Subject|7|||
143027885|NCT02227862|515644187|FG001|Overall Study|Withdrawal by Subject|6|||
143027886|NCT02227862|515644186|FG000|Overall Study|Lost to Follow-up|1|||
143027887|NCT02227862|515644187|FG001|Overall Study|Lost to Follow-up|2|||
143027888|NCT00662025|515644192|FG000|Overall Study|Objective progression or relapse|51|||
143027889|NCT00662025|515644192|FG000|Overall Study|Adverse Event|7|||
143027890|NCT00662025|515644192|FG000|Overall Study|Withdrawal by Subject|1|||
143027891|NCT00662025|515644192|FG000|Overall Study|Results of other clinical study|2|||
143027892|NCT00662025|515644192|FG000|Overall Study|Target lesion cannot be evaluated|1|||
143027893|NCT00662025|515644192|FG000|Overall Study|Domestic circumstances|1|||
143027894|NCT01700621|515644193|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
143027895|NCT01700621|515644194|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
143027896|NCT01700621|515644193|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
143237079|NCT03955146|516421542|FG003|DB Period (48 Weeks)|Participant Decision|1|||
143237080|NCT03955146|516421539|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
143237081|NCT03955146|516421540|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
143237082|NCT03955146|516421541|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
143237083|NCT03955146|516421542|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
143237084|NCT03955146|516421539|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
143237085|NCT03955146|516421540|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
143237086|NCT03955146|516421541|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
143237087|NCT03955146|516421542|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
143237088|NCT03955146|516421539|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
143237089|NCT03955146|516421540|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
143237090|NCT03955146|516421541|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
143237091|NCT03955146|516421542|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
143237092|NCT03955146|516421539|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
143237093|NCT03955146|516421540|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
143237094|NCT03955146|516421541|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
143237095|NCT03955146|516421542|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
143237096|NCT03955146|516421539|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
143237097|NCT03955146|516421540|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
143237098|NCT03955146|516421541|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
143237099|NCT03955146|516421542|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
143237100|NCT03955146|516421539|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
143237101|NCT03955146|516421540|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
143237102|NCT03955146|516421541|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
143237103|NCT03955146|516421542|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
143491491|NCT01268293|517342539|FG000|Overall Study|Disease progression|7|||
143491492|NCT01268293|517342539|FG000|Overall Study|Adverse Event|1|||
143237104|NCT03955146|516421539|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
143237105|NCT03955146|516421540|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
143237106|NCT03955146|516421541|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
143237107|NCT03955146|516421542|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
143237108|NCT03955146|516421539|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
143237109|NCT03955146|516421540|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
143237110|NCT03955146|516421541|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
143237111|NCT03955146|516421542|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
143237112|NCT03955146|516421539|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
143237113|NCT03955146|516421540|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
143237114|NCT03955146|516421541|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
143237115|NCT03955146|516421542|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
143237116|NCT03955146|516421539|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
143027897|NCT01700621|515644194|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
143027898|NCT01700621|515644193|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
143237117|NCT03955146|516421540|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
143237118|NCT03955146|516421541|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
143237119|NCT03955146|516421542|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
143237120|NCT03955146|516421539|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
143237121|NCT03955146|516421540|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
143237122|NCT03955146|516421541|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
143237123|NCT03955146|516421542|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
143237124|NCT02002598|516421543|FG000|Dose Level 1|Withdrawal by Subject|1|||
143237125|NCT02002598|516421544|FG001|Dose Level 1|Withdrawal by Subject|0|||
143237126|NCT02002598|516421545|FG002|Dose Level 1|Withdrawal by Subject|0|||
143237127|NCT02002598|516421546|FG003|Dose Level 1|Withdrawal by Subject|0|||
143237128|NCT02002598|516421547|FG004|Dose Level 1|Withdrawal by Subject|0|||
143237129|NCT02628873|516421548|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
143237130|NCT02628873|516421549|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
143237131|NCT02628873|516421548|FG000|Second Test (1 Hour)|Physician Decision|1|||
143237132|NCT02628873|516421549|FG001|Second Test (1 Hour)|Physician Decision|0|||
143237133|NCT04123470|516421552|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
143237134|NCT04123470|516421553|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
143027899|NCT01700621|515644194|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
143027900|NCT03349333|515644197|FG000|Overall Study|Progression of Disease|36|||
143027901|NCT03349333|515644197|FG000|Overall Study|Adverse Event|11|||
143027902|NCT03349333|515644197|FG000|Overall Study|Other|6|||
143027903|NCT03349333|515644197|FG000|Overall Study|Withdrawal by Subject|5|||
143027904|NCT03349333|515644197|FG000|Overall Study|Conditions interfere with participation|2|||
143027905|NCT03349333|515644197|FG000|Overall Study|Physician Decision|2|||
143027906|NCT03349333|515644197|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
143027907|NCT03349333|515644197|FG000|Overall Study|Patients in treatment less than 24 month|8|||
143027908|NCT03019965|515644198|FG000|Overall Study|Withdrawal by Subject|1|||
143027909|NCT03019965|515644199|FG001|Overall Study|Withdrawal by Subject|0|||
143027910|NCT03019965|515644198|FG000|Overall Study|Protocol Violation|1|||
143027911|NCT03019965|515644199|FG001|Overall Study|Protocol Violation|3|||
143027912|NCT03019965|515644198|FG000|Overall Study|viral or fungal infection|3|||
143027913|NCT03019965|515644199|FG001|Overall Study|viral or fungal infection|4|||
143027914|NCT03019965|515644198|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
143027915|NCT03019965|515644199|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
143237135|NCT04123470|516421552|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
143237136|NCT04123470|516421553|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
143237137|NCT04123470|516421552|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
143237138|NCT04123470|516421553|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
143237139|NCT04123470|516421552|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
143237140|NCT04123470|516421553|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
143237141|NCT05972993|516421567|FG000|Overall Study|Lost to Follow-up|2|||
143237142|NCT05972993|516421568|FG001|Overall Study|Lost to Follow-up|0|||
143237143|NCT05972993|516421569|FG002|Overall Study|Lost to Follow-up|1|||
143237144|NCT05972993|516421570|FG003|Overall Study|Lost to Follow-up|0|||
143237145|NCT05972993|516421571|FG004|Overall Study|Lost to Follow-up|0|||
143237146|NCT05972993|516421572|FG005|Overall Study|Lost to Follow-up|0|||
143237147|NCT05972993|516421573|FG006|Overall Study|Lost to Follow-up|0|||
143237148|NCT05972993|516421574|FG007|Overall Study|Lost to Follow-up|2|||
143237149|NCT05972993|516421575|FG008|Overall Study|Lost to Follow-up|0|||
143237150|NCT04825678|516421578|FG000|Overall Study|Decision by Sponsor|2|||
143237151|NCT04825678|516421579|FG001|Overall Study|Decision by Sponsor|3|||
143237152|NCT04825678|516421578|FG000|Overall Study|Withdrawal of Consent From Study|7|||
143237153|NCT04825678|516421579|FG001|Overall Study|Withdrawal of Consent From Study|9|||
143237154|NCT04825678|516421578|FG000|Overall Study|Lost to Follow-up|3|||
143237155|NCT04825678|516421579|FG001|Overall Study|Lost to Follow-up|4|||
143237156|NCT04825678|516421578|FG000|Overall Study|Never Received Investigational Product|1|||
143237157|NCT04825678|516421579|FG001|Overall Study|Never Received Investigational Product|1|||
143237158|NCT00911170|516421583|FG000|Treatment Period|Randomized in error|1|||
143491493|NCT01268293|517342539|FG000|Overall Study|Subject choice|1|||
143491494|NCT00618748|517342540|FG000|Overall Study|Adverse Event|4|||
143237159|NCT00911170|516421584|FG001|Treatment Period|Randomized in error|1|||
143237160|NCT00911170|516421583|FG000|Treatment Period|Ineligibility determined|1|||
143491495|NCT00618748|517342541|FG001|Overall Study|Adverse Event|3|||
143237161|NCT00911170|516421584|FG001|Treatment Period|Ineligibility determined|3|||
143491496|NCT00618748|517342542|FG002|Overall Study|Adverse Event|8|||
143491497|NCT00618748|517342540|FG000|Overall Study|Physician Decision|3|||
143491498|NCT00618748|517342541|FG001|Overall Study|Physician Decision|1|||
143027916|NCT03019965|515644198|FG000|Overall Study|Physician Decision|1|||
143027917|NCT03019965|515644199|FG001|Overall Study|Physician Decision|1|||
143027918|NCT01915732|515644200|FG000|Overall Study|Withdrawal by Subject|18|||
143027919|NCT01915732|515644201|FG001|Overall Study|Withdrawal by Subject|18|||
143027920|NCT01915732|515644200|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
143027921|NCT01915732|515644201|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
143027922|NCT01915732|515644200|FG000|Overall Study|Adverse Event|12|||
143027923|NCT01915732|515644201|FG001|Overall Study|Adverse Event|4|||
143027924|NCT01915732|515644200|FG000|Overall Study|Protocol Violation|5|||
143027925|NCT01915732|515644201|FG001|Overall Study|Protocol Violation|5|||
143027926|NCT01915732|515644200|FG000|Overall Study|Lack of Efficacy|6|||
143027927|NCT01915732|515644201|FG001|Overall Study|Lack of Efficacy|11|||
143027928|NCT01915732|515644200|FG000|Overall Study|Lost to Follow-up|22|||
143027929|NCT01915732|515644201|FG001|Overall Study|Lost to Follow-up|26|||
143027930|NCT01915732|515644200|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
143027931|NCT01915732|515644201|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
143027932|NCT01915732|515644200|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
143027933|NCT01915732|515644201|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
143027934|NCT01915732|515644200|FG000|Overall Study|Drug Release Error|1|||
143027935|NCT01915732|515644201|FG001|Overall Study|Drug Release Error|0|||
143027936|NCT01915732|515644200|FG000|Overall Study|Recovered|1|||
143027937|NCT01915732|515644201|FG001|Overall Study|Recovered|0|||
143027938|NCT01915732|515644200|FG000|Overall Study|Pregnancy|1|||
143027939|NCT01915732|515644201|FG001|Overall Study|Pregnancy|0|||
143027940|NCT01915732|515644200|FG000|Overall Study|Poor Perceived Efficacy|1|||
143027941|NCT01915732|515644201|FG001|Overall Study|Poor Perceived Efficacy|0|||
143027942|NCT01915732|515644200|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
143027943|NCT01915732|515644201|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
143027944|NCT01915732|515644200|FG000|Overall Study|Got Well|0|||
143027945|NCT01915732|515644201|FG001|Overall Study|Got Well|1|||
143027946|NCT01915732|515644200|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
143027947|NCT01915732|515644201|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
143027948|NCT01915732|515644200|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
143027949|NCT01915732|515644201|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
143027950|NCT01915732|515644200|FG000|Overall Study|Job Transfer|0|||
143027951|NCT01915732|515644201|FG001|Overall Study|Job Transfer|1|||
143027952|NCT01915732|515644200|FG000|Overall Study|Improper Facial Procedure|0|||
143027953|NCT01915732|515644201|FG001|Overall Study|Improper Facial Procedure|1|||
143027954|NCT01915732|515644200|FG000|Overall Study|Poor Conscious Effect|0|||
143027955|NCT01915732|515644201|FG001|Overall Study|Poor Conscious Effect|1|||
143027956|NCT01325207|515644202|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
143027957|NCT01325207|515644203|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
143027958|NCT01325207|515644204|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
143027959|NCT01325207|515644205|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
143027960|NCT01325207|515644206|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
143027961|NCT01325207|515644207|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
143027962|NCT01325207|515644202|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
143027963|NCT01325207|515644203|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
143027964|NCT01325207|515644204|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
143027965|NCT01325207|515644205|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
143027966|NCT01325207|515644206|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
143027967|NCT01325207|515644207|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
143027968|NCT01325207|515644202|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
143027969|NCT01325207|515644203|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
143027970|NCT01325207|515644204|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
143027971|NCT01325207|515644205|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
143027972|NCT01325207|515644206|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
143027973|NCT01325207|515644207|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
143027974|NCT01325207|515644202|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
143027975|NCT01325207|515644203|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
143027976|NCT01325207|515644204|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
143027977|NCT01325207|515644205|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
143027978|NCT01325207|515644206|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
143491499|NCT00618748|517342542|FG002|Overall Study|Physician Decision|1|||
143491500|NCT00618748|517342540|FG000|Overall Study|Withdrawal by Subject|4|||
143491501|NCT00618748|517342541|FG001|Overall Study|Withdrawal by Subject|1|||
143027979|NCT01325207|515644207|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
143027980|NCT01325207|515644202|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
143027981|NCT01325207|515644203|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
143027982|NCT01325207|515644204|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
143027983|NCT01325207|515644205|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
143027984|NCT01325207|515644206|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
143027985|NCT01325207|515644207|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
143027986|NCT01325207|515644202|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
143027987|NCT01325207|515644203|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
143491502|NCT00618748|517342542|FG002|Overall Study|Withdrawal by Subject|5|||
143491503|NCT02597855|517342545|FG000|Overall Study|Lost to Follow-up|2|||
143491504|NCT02597855|517342546|FG001|Overall Study|Lost to Follow-up|1|||
143491505|NCT03704194|517342551|FG000|Overall Study|Withdrawal by Subject|0|||
143491506|NCT03704194|517342552|FG001|Overall Study|Withdrawal by Subject|1|||
143491507|NCT00559507|517342555|FG000|Overall Study|Not treated, patient ineligible|3|||
143491508|NCT03757988|517342558|FG000|Overall Study|Withdrawal by Subject|1|||
143491509|NCT02450487|517342559|FG000|Overall Study|Lost to Follow-up|3|||
143491510|NCT03132636|517342560|FG000|Overall Study|Adverse Event|1|||
143491511|NCT03132636|517342561|FG001|Overall Study|Adverse Event|2|||
143491512|NCT03132636|517342560|FG000|Overall Study|Death|4|||
143491513|NCT03132636|517342561|FG001|Overall Study|Death|7|||
143491514|NCT03132636|517342560|FG000|Overall Study|Lost to Follow-up|3|||
143491515|NCT03132636|517342561|FG001|Overall Study|Lost to Follow-up|2|||
143491516|NCT03132636|517342560|FG000|Overall Study|Non compliance with protocol by participant|1|||
143491517|NCT03132636|517342561|FG001|Overall Study|Non compliance with protocol by participant|1|||
143491518|NCT03132636|517342560|FG000|Overall Study|Subject decision|1|||
143491519|NCT03132636|517342561|FG001|Overall Study|Subject decision|9|||
143491520|NCT03132636|517342560|FG000|Overall Study|Sponsor decision|0|||
143491521|NCT03132636|517342561|FG001|Overall Study|Sponsor decision|1|||
143491522|NCT03132636|517342560|FG000|Overall Study|Physician Decision|1|||
143491523|NCT03132636|517342561|FG001|Overall Study|Physician Decision|0|||
143491524|NCT03132636|517342560|FG000|Overall Study|Progressive disease|33|||
143491525|NCT03132636|517342561|FG001|Overall Study|Progressive disease|36|||
143491526|NCT03132636|517342560|FG000|Overall Study|Withdrawal of consent|2|||
143237162|NCT00911170|516421583|FG000|Treatment Period|Protocol deviation|1|||
143491527|NCT03132636|517342561|FG001|Overall Study|Withdrawal of consent|5|||
143491528|NCT03132636|517342560|FG000|Overall Study|Did not re-consent|1|||
143491529|NCT03132636|517342561|FG001|Overall Study|Did not re-consent|0|||
143491530|NCT03132636|517342560|FG000|Overall Study|Lost insurance coverage|1|||
143491531|NCT03132636|517342561|FG001|Overall Study|Lost insurance coverage|0|||
143491532|NCT03132636|517342560|FG000|Overall Study|Related to radiological outcomes|0|||
143491533|NCT03132636|517342561|FG001|Overall Study|Related to radiological outcomes|1|||
143491534|NCT03132636|517342560|FG000|Overall Study|Unable to come to site for continued visits|0|||
143491535|NCT03132636|517342561|FG001|Overall Study|Unable to come to site for continued visits|1|||
143491536|NCT03286842|517342562|FG000|Overall Study|Patients rolled over to another study|80|||
143491537|NCT01562548|517342568|FG000|Overall Study|Lost to Follow-up|0|||
143237163|NCT00911170|516421584|FG001|Treatment Period|Protocol deviation|2|||
143491538|NCT01562548|517342569|FG001|Overall Study|Lost to Follow-up|0|||
143491539|NCT01562548|517342570|FG002|Overall Study|Lost to Follow-up|1|||
143491540|NCT01562548|517342571|FG003|Overall Study|Lost to Follow-up|0|||
143491541|NCT02926209|517342573|FG000|Study Cohort|Poor Bowel Preparation|1|||
143491542|NCT02926209|517342574|FG001|Study Cohort|Poor Bowel Preparation|0|||
143491543|NCT01239160|517342575|FG000|Overall Study|Lost to Follow-up|3|||
143491544|NCT01239160|517342576|FG001|Overall Study|Lost to Follow-up|5|||
143491545|NCT01239160|517342577|FG002|Overall Study|Lost to Follow-up|0|||
143491546|NCT01239160|517342575|FG000|Overall Study|Withdrawal by Subject|17|||
143491547|NCT01239160|517342576|FG001|Overall Study|Withdrawal by Subject|6|||
143491548|NCT01239160|517342577|FG002|Overall Study|Withdrawal by Subject|2|||
143491549|NCT01239160|517342575|FG000|Overall Study|Physician Decision|5|||
143491550|NCT01239160|517342576|FG001|Overall Study|Physician Decision|7|||
143491551|NCT01239160|517342577|FG002|Overall Study|Physician Decision|2|||
143491552|NCT01239160|517342575|FG000|Overall Study|Early Termination Due to Study Closure|0|||
143491553|NCT01239160|517342576|FG001|Overall Study|Early Termination Due to Study Closure|1|||
143491554|NCT01239160|517342577|FG002|Overall Study|Early Termination Due to Study Closure|6|||
143491555|NCT01764633|517342578|FG000|Overall Study|Withdrawal by Subject|105|||
143491556|NCT01764633|517342579|FG001|Overall Study|Withdrawal by Subject|88|||
143491557|NCT01764633|517342578|FG000|Overall Study|Lost to Follow-up|13|||
143491558|NCT01764633|517342579|FG001|Overall Study|Lost to Follow-up|5|||
143491559|NCT04418765|517342581|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
143491560|NCT04418765|517342582|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
143491561|NCT04418765|517342583|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
143491562|NCT04418765|517342581|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
143491563|NCT04418765|517342582|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
143491564|NCT04418765|517342583|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
143237164|NCT00911170|516421583|FG000|Treatment Period|Adverse Event|9|||
143237165|NCT00911170|516421584|FG001|Treatment Period|Adverse Event|10|||
143237166|NCT00911170|516421583|FG000|Treatment Period|Withdrawal by Subject|4|||
143237167|NCT00911170|516421584|FG001|Treatment Period|Withdrawal by Subject|4|||
143491565|NCT04418765|517342581|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
143491566|NCT04418765|517342582|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
143491567|NCT04418765|517342583|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
143491568|NCT04418765|517342581|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
143237168|NCT00911170|516421583|FG000|Treatment Period|Disease progression|0|||
143027988|NCT01325207|515644204|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
143027989|NCT01325207|515644205|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
143027990|NCT01325207|515644206|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
143027991|NCT01325207|515644207|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
143027992|NCT01325207|515644202|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
143027993|NCT01325207|515644203|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
143027994|NCT01325207|515644204|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
143027995|NCT01325207|515644205|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
143027996|NCT01325207|515644206|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
143027997|NCT01325207|515644207|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
143027998|NCT01974895|515644208|FG000|Overall Study|Protocol Violation|1|||
143027999|NCT01974895|515644209|FG001|Overall Study|Protocol Violation|0|||
143028000|NCT01974895|515644208|FG000|Overall Study|Lost to Follow-up|4|||
143028001|NCT01974895|515644209|FG001|Overall Study|Lost to Follow-up|6|||
143028002|NCT01974895|515644208|FG000|Overall Study|Withdrawal by Subject|0|||
143028003|NCT01974895|515644209|FG001|Overall Study|Withdrawal by Subject|1|||
143028004|NCT01974895|515644208|FG000|Overall Study|Other (Missed Visit)|1|||
143028005|NCT01974895|515644209|FG001|Overall Study|Other (Missed Visit)|0|||
143028006|NCT01974895|515644208|FG000|Overall Study|Other (Reason unknown)|9|||
143028007|NCT01974895|515644209|FG001|Overall Study|Other (Reason unknown)|8|||
143028008|NCT00635154|515644210|FG000|Overall Study|Alternative Treatment|8|||
143028009|NCT00635154|515644210|FG000|Overall Study|Other|4|||
143028010|NCT00635154|515644210|FG000|Overall Study|Still on treatment|21|||
143028011|NCT01513148|515644211|FG000|Overall Study|Protocol Violation|2|||
143028012|NCT01513148|515644212|FG001|Overall Study|Protocol Violation|2|||
143028013|NCT03500484|515644213|FG000|Overall Study|Adverse Event|2|||
143028014|NCT03500484|515644214|FG001|Overall Study|Adverse Event|0|||
143028015|NCT03500484|515644213|FG000|Overall Study|Physician Decision|1|||
143028016|NCT03500484|515644214|FG001|Overall Study|Physician Decision|0|||
143028017|NCT03500484|515644213|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
143028018|NCT03500484|515644214|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
143028019|NCT02795104|515644215|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
143028020|NCT02795104|515644216|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
143028021|NCT02795104|515644217|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
143028022|NCT02795104|515644215|FG000|Overall Study|Withdrawal by Subject|0|||
143028023|NCT02795104|515644216|FG001|Overall Study|Withdrawal by Subject|2|||
143028024|NCT02795104|515644217|FG002|Overall Study|Withdrawal by Subject|0|||
143028025|NCT02795104|515644215|FG000|Overall Study|Lost to Follow-up|0|||
143028026|NCT02795104|515644216|FG001|Overall Study|Lost to Follow-up|0|||
143028027|NCT02795104|515644217|FG002|Overall Study|Lost to Follow-up|1|||
143028028|NCT01654380|515644218|FG000|Part B, Period 1|Physician Decision|0|||
143028029|NCT01654380|515644219|FG001|Part B, Period 1|Physician Decision|0|||
143028030|NCT01654380|515644220|FG002|Part B, Period 1|Physician Decision|1|||
143028031|NCT01654380|515644221|FG003|Part B, Period 1|Physician Decision|0|||
143028032|NCT04652453|515644224|FG000|Overall Study|Death|8|||
143028033|NCT04652453|515644225|FG001|Overall Study|Death|2|||
143028034|NCT04652453|515644226|FG002|Overall Study|Death|0|||
143028035|NCT04652453|515644224|FG000|Overall Study|Hospice|5|||
143028036|NCT04652453|515644225|FG001|Overall Study|Hospice|5|||
143028037|NCT04652453|515644226|FG002|Overall Study|Hospice|0|||
143028038|NCT04652453|515644224|FG000|Overall Study|Withdrawal by Subject|2|||
143028039|NCT04652453|515644225|FG001|Overall Study|Withdrawal by Subject|0|||
143028040|NCT04652453|515644226|FG002|Overall Study|Withdrawal by Subject|0|||
143028041|NCT04543136|515644227|FG000|Overall Study|Withdrawal by Subject|0|||
143028042|NCT04543136|515644228|FG001|Overall Study|Withdrawal by Subject|1|||
143028043|NCT04543136|515644229|FG002|Overall Study|Withdrawal by Subject|0|||
143028044|NCT04543136|515644230|FG003|Overall Study|Withdrawal by Subject|1|||
143028045|NCT04543136|515644231|FG004|Overall Study|Withdrawal by Subject|0|||
143028046|NCT04543136|515644232|FG005|Overall Study|Withdrawal by Subject|0|||
143028047|NCT02192099|515644233|FG000|Overall Study|Adverse Event|1|||
143028048|NCT02192099|515644233|FG000|Overall Study|Lost to Follow-up|2|||
143237169|NCT00911170|516421584|FG001|Treatment Period|Disease progression|2|||
143028049|NCT02192099|515644233|FG000|Overall Study|Physician Decision|1|||
143028050|NCT02192099|515644233|FG000|Overall Study|Pregnancy|1|||
143028051|NCT02192099|515644233|FG000|Overall Study|Protocol Violation|8|||
143028052|NCT02192099|515644233|FG000|Overall Study|Study Terminated by Sponsor|32|||
143028053|NCT02192099|515644233|FG000|Overall Study|Withdrawal by Subject|11|||
143028054|NCT02192099|515644233|FG000|Overall Study|Miscellaneous Reasons|5|||
143028055|NCT04128007|515644242|FG000|Overall Study|Withdrawal by Subject|9|||
143028056|NCT04128007|515644243|FG001|Overall Study|Withdrawal by Subject|6|||
143028057|NCT04128007|515644242|FG000|Overall Study|Protocol Violation|1|||
143028058|NCT04128007|515644243|FG001|Overall Study|Protocol Violation|0|||
143028059|NCT04128007|515644242|FG000|Overall Study|Lost to Follow-up|8|||
143028060|NCT04128007|515644243|FG001|Overall Study|Lost to Follow-up|7|||
143028061|NCT04128007|515644242|FG000|Overall Study|Adverse Event|5|||
143028062|NCT04128007|515644243|FG001|Overall Study|Adverse Event|2|||
143028063|NCT04128007|515644242|FG000|Overall Study|Not reported|0|||
143028064|NCT04128007|515644243|FG001|Overall Study|Not reported|2|||
143028065|NCT02978326|515644248|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
143028066|NCT02978326|515644249|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
143028067|NCT02978326|515644250|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
143028068|NCT02978326|515644248|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
143028069|NCT02978326|515644249|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
143028070|NCT02978326|515644250|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
143028071|NCT02978326|515644248|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
143028072|NCT02978326|515644249|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
143028073|NCT02978326|515644250|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
143028074|NCT02978326|515644248|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
143028075|NCT02978326|515644249|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
143028076|NCT02978326|515644250|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
143028077|NCT00865709|515644253|FG000|Treatment|Adverse Event|9|||
143028078|NCT00865709|515644254|FG001|Treatment|Adverse Event|6|||
143028079|NCT00865709|515644253|FG000|Treatment|Withdrawal by Subject|10|||
143028080|NCT00865709|515644254|FG001|Treatment|Withdrawal by Subject|7|||
143028081|NCT00865709|515644253|FG000|Treatment|Physician Decision|3|||
143028082|NCT00865709|515644254|FG001|Treatment|Physician Decision|2|||
143028083|NCT00865709|515644253|FG000|Treatment|Surgery|8|||
143028084|NCT00865709|515644254|FG001|Treatment|Surgery|3|||
143028085|NCT00429923|515644255|FG000|Overall Study|Adverse Event|0|||
143028086|NCT00429923|515644256|FG001|Overall Study|Adverse Event|2|||
143491569|NCT04418765|517342582|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
143491570|NCT04418765|517342583|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
143028087|NCT00429923|515644257|FG002|Overall Study|Adverse Event|3|||
143028088|NCT00429923|515644255|FG000|Overall Study|Lack of Efficacy|4|||
143028089|NCT00429923|515644256|FG001|Overall Study|Lack of Efficacy|1|||
143028090|NCT00429923|515644257|FG002|Overall Study|Lack of Efficacy|33|||
143028091|NCT00429923|515644255|FG000|Overall Study|Lost to Follow-up|0|||
143028092|NCT00429923|515644256|FG001|Overall Study|Lost to Follow-up|0|||
143028093|NCT00429923|515644257|FG002|Overall Study|Lost to Follow-up|2|||
143028094|NCT00429923|515644255|FG000|Overall Study|Withdrew Consent|1|||
143028095|NCT00429923|515644256|FG001|Overall Study|Withdrew Consent|0|||
143028096|NCT00429923|515644257|FG002|Overall Study|Withdrew Consent|1|||
143028097|NCT00429923|515644255|FG000|Overall Study|Early Termination|0|||
143028098|NCT00429923|515644256|FG001|Overall Study|Early Termination|1|||
143028099|NCT00429923|515644257|FG002|Overall Study|Early Termination|0|||
143028100|NCT01265784|515644258|FG000|Overall Study|Lost to Follow-up|5|||
143028101|NCT01265784|515644259|FG001|Overall Study|Lost to Follow-up|3|||
143028102|NCT01265784|515644260|FG002|Overall Study|Lost to Follow-up|2|||
143028103|NCT01265784|515644258|FG000|Overall Study|Withdrawal by Subject|0|||
143028104|NCT01265784|515644259|FG001|Overall Study|Withdrawal by Subject|5|||
143028105|NCT01265784|515644260|FG002|Overall Study|Withdrawal by Subject|0|||
143028106|NCT01265784|515644258|FG000|Overall Study|Physician Decision|1|||
143028107|NCT01265784|515644259|FG001|Overall Study|Physician Decision|0|||
143028108|NCT01265784|515644260|FG002|Overall Study|Physician Decision|1|||
143028109|NCT01265784|515644258|FG000|Overall Study|Adverse Event|1|||
143028110|NCT01265784|515644259|FG001|Overall Study|Adverse Event|0|||
143028111|NCT01265784|515644260|FG002|Overall Study|Adverse Event|0|||
143028112|NCT01265784|515644258|FG000|Overall Study|Death|3|||
143028113|NCT01265784|515644259|FG001|Overall Study|Death|0|||
143028114|NCT01265784|515644260|FG002|Overall Study|Death|0|||
143028115|NCT01265784|515644258|FG000|Overall Study|Protocol Violation|2|||
143028116|NCT01265784|515644259|FG001|Overall Study|Protocol Violation|0|||
143028117|NCT01265784|515644260|FG002|Overall Study|Protocol Violation|0|||
143028118|NCT01265784|515644258|FG000|Overall Study|Incorrectly Randomized|0|||
143028119|NCT01265784|515644259|FG001|Overall Study|Incorrectly Randomized|0|||
143028120|NCT01265784|515644260|FG002|Overall Study|Incorrectly Randomized|1|||
143028121|NCT01937364|515644261|FG000|Overall Study|Adverse Event|2|||
143491571|NCT04418765|517342581|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
143028122|NCT01937364|515644262|FG001|Overall Study|Adverse Event|1|||
143028123|NCT03922477|515644265|FG000|Overall Study|Death|9|||
143491572|NCT04418765|517342582|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
143491573|NCT04418765|517342583|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
143491574|NCT04418765|517342581|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
143028124|NCT03922477|515644265|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
143028125|NCT03922477|515644265|FG000|Overall Study|Physician Decision|1|||
143028126|NCT03922477|515644265|FG000|Overall Study|Withdrawal by Subject|2|||
143028127|NCT01656889|515644266|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
143028128|NCT01656889|515644267|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
143028129|NCT01656889|515644266|FG000|Treatment Period, 12 Weeks|Death|0|||
143028130|NCT01656889|515644267|FG001|Treatment Period, 12 Weeks|Death|1|||
143028131|NCT01656889|515644266|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
143028132|NCT01656889|515644267|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
143028133|NCT01656889|515644266|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
143028134|NCT01656889|515644267|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
143028135|NCT01656889|515644266|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
143028136|NCT01656889|515644267|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
143028137|NCT01656889|515644266|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
143028138|NCT01656889|515644267|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
143028139|NCT01656889|515644266|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
143028140|NCT01656889|515644267|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
143028141|NCT01656889|515644266|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
143028142|NCT01656889|515644267|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
143028143|NCT01656889|515644266|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
143028144|NCT01656889|515644267|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
143028145|NCT01656889|515644266|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
143028146|NCT01656889|515644267|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
143028147|NCT02521948|515644268|FG000|Overall Study|Adverse Event|2|||
143028148|NCT02521948|515644268|FG000|Overall Study|Death|4|||
143028149|NCT02521948|515644268|FG000|Overall Study|Lost to Follow-up|1|||
143028150|NCT02521948|515644268|FG000|Overall Study|Did not attend one or both follow-ups|6|||
143028151|NCT00814320|515644269|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
143028152|NCT00814320|515644270|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
143028153|NCT00814320|515644269|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
143028154|NCT00814320|515644270|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
143028155|NCT00814320|515644269|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
143028156|NCT00814320|515644270|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
143028157|NCT00814320|515644269|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
143028158|NCT00814320|515644270|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
143028159|NCT00814320|515644269|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
143028160|NCT00814320|515644270|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
143028161|NCT00814320|515644269|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
143028162|NCT00814320|515644270|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
143028163|NCT00814320|515644269|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
143028164|NCT00814320|515644270|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
143028165|NCT00814320|515644269|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
143028166|NCT00814320|515644270|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
143028167|NCT00814320|515644269|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
143028168|NCT00814320|515644270|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
143028169|NCT00814320|515644269|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
143028170|NCT00814320|515644270|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
143028171|NCT02799602|515644271|FG000|Overall Study|Protocol Violation|1|||
143028172|NCT02799602|515644272|FG001|Overall Study|Protocol Violation|0|||
143028173|NCT02799602|515644271|FG000|Overall Study|Physician Decision|5|||
143028174|NCT02799602|515644272|FG001|Overall Study|Physician Decision|6|||
143028175|NCT02799602|515644271|FG000|Overall Study|Lost to Follow-up|4|||
143028176|NCT02799602|515644272|FG001|Overall Study|Lost to Follow-up|2|||
143028177|NCT02799602|515644271|FG000|Overall Study|Additional primary malignancy|11|||
143028178|NCT02799602|515644272|FG001|Overall Study|Additional primary malignancy|6|||
143028179|NCT02799602|515644271|FG000|Overall Study|Non-compliance with study drug|14|||
143028180|NCT02799602|515644272|FG001|Overall Study|Non-compliance with study drug|12|||
143028181|NCT02799602|515644271|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
143028182|NCT02799602|515644272|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
143028183|NCT02799602|515644271|FG000|Overall Study|Withdrawal by Subject|26|||
143028184|NCT02799602|515644272|FG001|Overall Study|Withdrawal by Subject|40|||
143028185|NCT02799602|515644271|FG000|Overall Study|Progressive disease - clinical progression|131|||
143237170|NCT00911170|516421583|FG000|Treatment Period|Physician Decision|5|||
143491575|NCT04418765|517342582|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
143491576|NCT04418765|517342583|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
143491577|NCT04418765|517342581|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
143491578|NCT04418765|517342582|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
143491579|NCT04418765|517342583|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
143491580|NCT04418765|517342581|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
143491581|NCT04418765|517342582|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
143491582|NCT04418765|517342583|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
143491583|NCT04418765|517342581|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
143237171|NCT00911170|516421584|FG001|Treatment Period|Physician Decision|5|||
143028186|NCT02799602|515644272|FG001|Overall Study|Progressive disease - clinical progression|276|||
143028187|NCT02799602|515644271|FG000|Overall Study|Progressive disease - radiological progression|90|||
143028188|NCT02799602|515644272|FG001|Overall Study|Progressive disease - radiological progression|133|||
143028189|NCT02799602|515644271|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
143237172|NCT00911170|516421583|FG000|Treatment Period|Lost to Follow-up|0|||
143237173|NCT00911170|516421584|FG001|Treatment Period|Lost to Follow-up|1|||
143237174|NCT00911170|516421583|FG000|Treatment Period|Death|6|||
143237175|NCT00911170|516421584|FG001|Treatment Period|Death|9|||
143237176|NCT00911170|516421583|FG000|Long Term Follow-Up|Continuing in study|274|||
143237177|NCT00911170|516421584|FG001|Long Term Follow-Up|Continuing in study|269|||
143237178|NCT00911170|516421583|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
143237179|NCT00911170|516421584|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
143237180|NCT00911170|516421583|FG000|Long Term Follow-Up|Physician Decision|5|||
143237181|NCT00911170|516421584|FG001|Long Term Follow-Up|Physician Decision|4|||
143237182|NCT00911170|516421583|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
143237183|NCT00911170|516421584|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
143237184|NCT00911170|516421583|FG000|Long Term Follow-Up|Death|116|||
143237185|NCT00911170|516421584|FG001|Long Term Follow-Up|Death|121|||
143237186|NCT02594124|516421585|FG000|Overall Study|Adverse Event|0|||
143237187|NCT02594124|516421586|FG001|Overall Study|Adverse Event|5|||
143237188|NCT02594124|516421587|FG002|Overall Study|Adverse Event|8|||
143237189|NCT02594124|516421588|FG003|Overall Study|Adverse Event|1|||
143237190|NCT02594124|516421589|FG004|Overall Study|Adverse Event|0|||
143237191|NCT02594124|516421590|FG005|Overall Study|Adverse Event|0|||
143237192|NCT02594124|516421591|FG006|Overall Study|Adverse Event|2|||
143237193|NCT02594124|516421592|FG007|Overall Study|Adverse Event|2|||
143237194|NCT02594124|516421593|FG008|Overall Study|Adverse Event|0|||
143237195|NCT02594124|516421585|FG000|Overall Study|Withdrawal by Subject|2|||
143237196|NCT02594124|516421586|FG001|Overall Study|Withdrawal by Subject|3|||
143237197|NCT02594124|516421587|FG002|Overall Study|Withdrawal by Subject|5|||
143237198|NCT02594124|516421588|FG003|Overall Study|Withdrawal by Subject|1|||
143237199|NCT02594124|516421589|FG004|Overall Study|Withdrawal by Subject|8|||
143237200|NCT02594124|516421590|FG005|Overall Study|Withdrawal by Subject|4|||
143237201|NCT02594124|516421591|FG006|Overall Study|Withdrawal by Subject|13|||
143237202|NCT02594124|516421592|FG007|Overall Study|Withdrawal by Subject|19|||
143237203|NCT02594124|516421593|FG008|Overall Study|Withdrawal by Subject|0|||
143237204|NCT02594124|516421585|FG000|Overall Study|Physician Decision|0|||
143237205|NCT02594124|516421586|FG001|Overall Study|Physician Decision|2|||
143237206|NCT02594124|516421587|FG002|Overall Study|Physician Decision|0|||
143237207|NCT02594124|516421588|FG003|Overall Study|Physician Decision|0|||
143237208|NCT02594124|516421589|FG004|Overall Study|Physician Decision|0|||
143237209|NCT02594124|516421590|FG005|Overall Study|Physician Decision|0|||
143237210|NCT02594124|516421591|FG006|Overall Study|Physician Decision|0|||
143237211|NCT02594124|516421592|FG007|Overall Study|Physician Decision|1|||
143237212|NCT02594124|516421593|FG008|Overall Study|Physician Decision|0|||
143237213|NCT02594124|516421585|FG000|Overall Study|Commercial drug|0|||
143237214|NCT02594124|516421586|FG001|Overall Study|Commercial drug|1|||
143237215|NCT02594124|516421587|FG002|Overall Study|Commercial drug|6|||
143237216|NCT02594124|516421588|FG003|Overall Study|Commercial drug|3|||
143237217|NCT02594124|516421589|FG004|Overall Study|Commercial drug|0|||
143237218|NCT02594124|516421590|FG005|Overall Study|Commercial drug|0|||
143237219|NCT02594124|516421591|FG006|Overall Study|Commercial drug|7|||
143237220|NCT02594124|516421592|FG007|Overall Study|Commercial drug|11|||
143237221|NCT02594124|516421593|FG008|Overall Study|Commercial drug|2|||
143237222|NCT02594124|516421585|FG000|Overall Study|Reason Not Specified|1|||
143237223|NCT02594124|516421586|FG001|Overall Study|Reason Not Specified|3|||
143237224|NCT02594124|516421587|FG002|Overall Study|Reason Not Specified|4|||
143237225|NCT02594124|516421588|FG003|Overall Study|Reason Not Specified|0|||
143237226|NCT02594124|516421589|FG004|Overall Study|Reason Not Specified|0|||
143237227|NCT02594124|516421590|FG005|Overall Study|Reason Not Specified|1|||
143237228|NCT02594124|516421591|FG006|Overall Study|Reason Not Specified|1|||
143237229|NCT02594124|516421592|FG007|Overall Study|Reason Not Specified|6|||
143237230|NCT02594124|516421593|FG008|Overall Study|Reason Not Specified|1|||
143237231|NCT01824836|516421594|FG000|Overall Study|Adverse Event|48|||
143237232|NCT01824836|516421594|FG000|Overall Study|Withdrawal by Subject|63|||
143237233|NCT01824836|516421594|FG000|Overall Study|Other complicating disease|116|||
143237234|NCT01824836|516421594|FG000|Overall Study|Disease progression|5|||
143237235|NCT01824836|516421594|FG000|Overall Study|Alternative therapy|2|||
143237236|NCT01824836|516421594|FG000|Overall Study|Depression|1|||
143237237|NCT01824836|516421594|FG000|Overall Study|Non-compliance|3|||
143237238|NCT01824836|516421594|FG000|Overall Study|Patient regained ovarian function|3|||
143237239|NCT01824836|516421594|FG000|Overall Study|Lost to Follow-up|8|||
143237240|NCT01824836|516421594|FG000|Overall Study|Physician Decision|2|||
143237241|NCT01824836|516421594|FG000|Overall Study|Research office was closed|3|||
143237242|NCT01824836|516421594|FG000|Overall Study|Relocation|3|||
143237243|NCT01824836|516421594|FG000|Overall Study|Insurance-related issue|1|||
143237244|NCT01824836|516421594|FG000|Overall Study|Transportation issue|1|||
143237245|NCT01824836|516421594|FG000|Overall Study|Patient transferred care|1|||
143237246|NCT01824836|516421594|FG000|Overall Study|Unknown reasons|4|||
143237247|NCT01824836|516421594|FG000|Overall Study|Never started treatment|16|||
143237248|NCT02514083|516421596|FG000|Overall Study|Adverse Event|1|||
143237249|NCT01899040|516421597|FG000|Overall Study|Randomized in error|0|||
143237250|NCT01899040|516421598|FG001|Overall Study|Randomized in error|1|||
143028190|NCT02799602|515644272|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
143028191|NCT02799602|515644271|FG000|Overall Study|Death|9|||
143028192|NCT02799602|515644272|FG001|Overall Study|Death|5|||
143028193|NCT02799602|515644271|FG000|Overall Study|Other|287|||
143028194|NCT02799602|515644272|FG001|Overall Study|Other|118|||
143028195|NCT02799602|515644271|FG000|Overall Study|Study drug never administered|0|||
143028196|NCT02799602|515644272|FG001|Overall Study|Study drug never administered|3|||
143028197|NCT03730103|515644273|FG000|Overall Study|Did not meet inclusion criteria|0|||
143028198|NCT03730103|515644274|FG001|Overall Study|Did not meet inclusion criteria|5|||
143028199|NCT02308111|515644275|FG000|Overall Study|Adverse Event|31|||
143028200|NCT02308111|515644276|FG001|Overall Study|Adverse Event|19|||
143028201|NCT02308111|515644275|FG000|Overall Study|Death|9|||
143028202|NCT02308111|515644276|FG001|Overall Study|Death|6|||
143028203|NCT02308111|515644275|FG000|Overall Study|Lost to Follow-up|2|||
143028204|NCT02308111|515644276|FG001|Overall Study|Lost to Follow-up|7|||
143028205|NCT02308111|515644275|FG000|Overall Study|Physician Decision|6|||
143028206|NCT02308111|515644276|FG001|Overall Study|Physician Decision|17|||
143028207|NCT02308111|515644275|FG000|Overall Study|Protocol Violation|0|||
143028208|NCT02308111|515644276|FG001|Overall Study|Protocol Violation|1|||
143028209|NCT02308111|515644275|FG000|Overall Study|Withdrawal by Subject|28|||
143028210|NCT02308111|515644276|FG001|Overall Study|Withdrawal by Subject|38|||
143028211|NCT02308111|515644275|FG000|Overall Study|Study Terminated by Sponsor|72|||
143028212|NCT02308111|515644276|FG001|Overall Study|Study Terminated by Sponsor|61|||
143028213|NCT02308111|515644275|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
143028214|NCT02308111|515644276|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
143028215|NCT02308111|515644275|FG000|Overall Study|Site Closure|3|||
143028216|NCT02308111|515644276|FG001|Overall Study|Site Closure|3|||
143028217|NCT02308111|515644275|FG000|Overall Study|Non-compliance with Study Drug|3|||
143028218|NCT02308111|515644276|FG001|Overall Study|Non-compliance with Study Drug|1|||
143028219|NCT02308111|515644275|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
143028220|NCT02308111|515644276|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
143028221|NCT02308111|515644275|FG000|Overall Study|Liver Transplant|3|||
143028222|NCT02308111|515644276|FG001|Overall Study|Liver Transplant|3|||
143028223|NCT02308111|515644275|FG000|Overall Study|Liver Transplant Waitlist|2|||
143028224|NCT02308111|515644276|FG001|Overall Study|Liver Transplant Waitlist|2|||
143028225|NCT02308111|515644275|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
143028226|NCT02308111|515644276|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
143028227|NCT01873859|515644279|FG000|Overall Study|Withdrawal by Subject|0|||
143028228|NCT01873859|515644280|FG001|Overall Study|Withdrawal by Subject|4|||
143028229|NCT03072459|515644281|FG000|Overall Study|Device revised/removed|1|||
143028230|NCT03072459|515644281|FG000|Overall Study|Subject not able to return|1|||
143028231|NCT02275364|515644282|FG000|Period 1|Withdrawal by Subject|1|||
143028232|NCT02275364|515644283|FG001|Period 1|Withdrawal by Subject|0|||
143028233|NCT02275364|515644282|FG000|Period 1|Other reason|1|||
143028234|NCT02275364|515644283|FG001|Period 1|Other reason|0|||
143028235|NCT03504852|515644284|FG000|Overall Study|Withdrawal of informed consent|2|||
143028236|NCT03504852|515644285|FG001|Overall Study|Withdrawal of informed consent|1|||
143028237|NCT03504852|515644286|FG002|Overall Study|Withdrawal of informed consent|0|||
143028238|NCT03504852|515644284|FG000|Overall Study|Withdrawal by Subject|5|||
143028239|NCT03504852|515644285|FG001|Overall Study|Withdrawal by Subject|5|||
143028240|NCT03504852|515644286|FG002|Overall Study|Withdrawal by Subject|1|||
143028241|NCT03504852|515644284|FG000|Overall Study|Lost to Follow-up|4|||
143028242|NCT03504852|515644285|FG001|Overall Study|Lost to Follow-up|1|||
143028243|NCT03504852|515644286|FG002|Overall Study|Lost to Follow-up|0|||
143028244|NCT03504852|515644284|FG000|Overall Study|New therapy for study indication|1|||
143158212|NCT04518410|516124405|FG018|Overall Study|Randomized but not treated|4|||
143158213|NCT04518410|516124406|FG019|Overall Study|Randomized but not treated|0|||
143158214|NCT04518410|516124407|FG020|Overall Study|Randomized but not treated|0|||
143158215|NCT04518410|516124408|FG021|Overall Study|Randomized but not treated|5|||
143028245|NCT03504852|515644285|FG001|Overall Study|New therapy for study indication|0|||
143028246|NCT03504852|515644286|FG002|Overall Study|New therapy for study indication|0|||
143028247|NCT03504852|515644284|FG000|Overall Study|Lack of Efficacy|1|||
143028248|NCT03504852|515644285|FG001|Overall Study|Lack of Efficacy|2|||
143028249|NCT03504852|515644286|FG002|Overall Study|Lack of Efficacy|0|||
143028250|NCT03504852|515644284|FG000|Overall Study|Death|0|||
143028251|NCT03504852|515644285|FG001|Overall Study|Death|1|||
143028252|NCT03504852|515644286|FG002|Overall Study|Death|0|||
143028253|NCT03504852|515644284|FG000|Overall Study|Adverse Event|4|||
143028254|NCT03504852|515644285|FG001|Overall Study|Adverse Event|8|||
143028255|NCT03504852|515644286|FG002|Overall Study|Adverse Event|2|||
143028256|NCT01066052|515644287|FG000|Overall Study|Enrolled But Not Treated|3|||
143028257|NCT01066052|515644288|FG001|Overall Study|Enrolled But Not Treated|0|||
143028258|NCT01200394|515644289|FG000|Overall Study|Adverse Event|0|||
143028259|NCT01200394|515644290|FG001|Overall Study|Adverse Event|14|||
143028260|NCT01200394|515644289|FG000|Overall Study|Death|1|||
143158216|NCT04518410|516124409|FG022|Overall Study|Randomized but not treated|0|||
143028261|NCT01200394|515644290|FG001|Overall Study|Death|0|||
143491584|NCT04418765|517342582|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
143491585|NCT04418765|517342583|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
143491586|NCT04418765|517342581|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
143028262|NCT01200394|515644289|FG000|Overall Study|Lost to Follow-up|0|||
143028263|NCT01200394|515644290|FG001|Overall Study|Lost to Follow-up|1|||
143028264|NCT01200394|515644289|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
143491587|NCT04418765|517342582|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
143491588|NCT04418765|517342583|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
143491589|NCT04418765|517342581|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
143491590|NCT04418765|517342582|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
143491591|NCT04418765|517342583|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
143491592|NCT04418765|517342581|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
143491593|NCT04418765|517342582|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
143491594|NCT04418765|517342583|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
143491595|NCT04418765|517342581|FG000|Extension Period (48 Weeks)|Other than specified|0|||
143491596|NCT04418765|517342582|FG001|Extension Period (48 Weeks)|Other than specified|5|||
143491597|NCT04418765|517342583|FG002|Extension Period (48 Weeks)|Other than specified|2|||
143491598|NCT04372927|517342586|FG000|Overall Study|Death|1|||
143491599|NCT00577993|517342589|FG000|Overall Study|Adverse Event|1|||
143491600|NCT00577993|517342590|FG001|Overall Study|Adverse Event|0|||
143491601|NCT00577993|517342591|FG002|Overall Study|Adverse Event|0|||
143491602|NCT00577993|517342589|FG000|Overall Study|Death|0|||
143491603|NCT00577993|517342590|FG001|Overall Study|Death|1|||
143491604|NCT00577993|517342591|FG002|Overall Study|Death|1|||
143491605|NCT00577993|517342589|FG000|Overall Study|Lack of Efficacy|0|||
143491606|NCT00577993|517342590|FG001|Overall Study|Lack of Efficacy|1|||
143491607|NCT00577993|517342591|FG002|Overall Study|Lack of Efficacy|0|||
143491608|NCT00577993|517342589|FG000|Overall Study|Protocol Violation|2|||
143491609|NCT00577993|517342590|FG001|Overall Study|Protocol Violation|3|||
143491610|NCT00577993|517342591|FG002|Overall Study|Protocol Violation|0|||
143491611|NCT00577993|517342589|FG000|Overall Study|Withdrawal by Subject|1|||
143491612|NCT00577993|517342590|FG001|Overall Study|Withdrawal by Subject|0|||
143491613|NCT00577993|517342591|FG002|Overall Study|Withdrawal by Subject|2|||
143491614|NCT00577993|517342589|FG000|Overall Study|Conversion|2|||
143491615|NCT00577993|517342590|FG001|Overall Study|Conversion|5|||
143491616|NCT00577993|517342591|FG002|Overall Study|Conversion|0|||
143491617|NCT00577993|517342589|FG000|Overall Study|Uninsured|1|||
143491618|NCT00577993|517342590|FG001|Overall Study|Uninsured|0|||
143491619|NCT00577993|517342591|FG002|Overall Study|Uninsured|0|||
143491620|NCT02574637|517342598|FG000|Double-blind Period|Adverse Event|1|||
143491621|NCT02574637|517342599|FG001|Double-blind Period|Adverse Event|0|||
143491622|NCT02574637|517342600|FG002|Double-blind Period|Adverse Event|0|||
143491623|NCT02574637|517342601|FG003|Double-blind Period|Adverse Event|0|||
143491624|NCT02574637|517342602|FG004|Double-blind Period|Adverse Event|0|||
143491625|NCT02574637|517342603|FG005|Double-blind Period|Adverse Event|0|||
143491626|NCT02574637|517342604|FG006|Double-blind Period|Adverse Event|0|||
143491627|NCT02574637|517342605|FG007|Double-blind Period|Adverse Event|0|||
143491628|NCT02574637|517342606|FG008|Double-blind Period|Adverse Event|0|||
143491629|NCT02574637|517342607|FG009|Double-blind Period|Adverse Event|0|||
143491630|NCT02574637|517342598|FG000|Double-blind Period|Lack of Efficacy|0|||
143491631|NCT02574637|517342599|FG001|Double-blind Period|Lack of Efficacy|0|||
143491632|NCT02574637|517342600|FG002|Double-blind Period|Lack of Efficacy|2|||
143491633|NCT02574637|517342601|FG003|Double-blind Period|Lack of Efficacy|0|||
143491634|NCT02574637|517342602|FG004|Double-blind Period|Lack of Efficacy|0|||
143491635|NCT02574637|517342603|FG005|Double-blind Period|Lack of Efficacy|0|||
143491636|NCT02574637|517342604|FG006|Double-blind Period|Lack of Efficacy|0|||
143491637|NCT02574637|517342605|FG007|Double-blind Period|Lack of Efficacy|0|||
143491638|NCT02574637|517342606|FG008|Double-blind Period|Lack of Efficacy|0|||
143491639|NCT02574637|517342607|FG009|Double-blind Period|Lack of Efficacy|0|||
143491640|NCT02574637|517342598|FG000|Double-blind Period|Protocol Deviation|1|||
143491641|NCT02574637|517342599|FG001|Double-blind Period|Protocol Deviation|0|||
143491642|NCT02574637|517342600|FG002|Double-blind Period|Protocol Deviation|0|||
143028265|NCT01200394|515644290|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
143028266|NCT01200394|515644289|FG000|Overall Study|Protocol Violation|0|||
143028267|NCT01200394|515644290|FG001|Overall Study|Protocol Violation|3|||
143491643|NCT02574637|517342601|FG003|Double-blind Period|Protocol Deviation|0|||
143491644|NCT02574637|517342602|FG004|Double-blind Period|Protocol Deviation|0|||
143028268|NCT01200394|515644289|FG000|Overall Study|Withdrawal by Subject|0|||
143491645|NCT02574637|517342603|FG005|Double-blind Period|Protocol Deviation|0|||
143491646|NCT02574637|517342604|FG006|Double-blind Period|Protocol Deviation|0|||
143491647|NCT02574637|517342605|FG007|Double-blind Period|Protocol Deviation|0|||
143491648|NCT02574637|517342606|FG008|Double-blind Period|Protocol Deviation|0|||
143491649|NCT02574637|517342607|FG009|Double-blind Period|Protocol Deviation|0|||
143491650|NCT02574637|517342598|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
143491651|NCT02574637|517342599|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
143028269|NCT01200394|515644290|FG001|Overall Study|Withdrawal by Subject|5|||
143028270|NCT01200394|515644289|FG000|Overall Study|Other|0|||
143028271|NCT01200394|515644290|FG001|Overall Study|Other|1|||
143028272|NCT01835145|515644291|FG000|Overall Study|Ineligible prior to treatment|1|||
143028273|NCT01835145|515644292|FG001|Overall Study|Ineligible prior to treatment|0|||
143028274|NCT02984683|515644295|FG000|Overall Study|Adverse Event|3|||
143028275|NCT02984683|515644296|FG001|Overall Study|Adverse Event|3|||
143028276|NCT02984683|515644295|FG000|Overall Study|Withdrawal by Subject|1|||
143028277|NCT02984683|515644296|FG001|Overall Study|Withdrawal by Subject|0|||
143028278|NCT02984683|515644295|FG000|Overall Study|Disease progression|7|||
143028279|NCT02984683|515644296|FG001|Overall Study|Disease progression|9|||
143028280|NCT02415959|515644301|FG000|Overall Study|Adverse Event|0|||
143028281|NCT02415959|515644302|FG001|Overall Study|Adverse Event|1|||
143028282|NCT02415959|515644303|FG002|Overall Study|Adverse Event|0|||
143028283|NCT02415959|515644304|FG003|Overall Study|Adverse Event|0|||
143028284|NCT02415959|515644305|FG004|Overall Study|Adverse Event|0|||
143028285|NCT02415959|515644301|FG000|Overall Study|Protocol Violation|0|||
143028286|NCT02415959|515644302|FG001|Overall Study|Protocol Violation|0|||
143028287|NCT02415959|515644303|FG002|Overall Study|Protocol Violation|0|||
143028288|NCT02415959|515644304|FG003|Overall Study|Protocol Violation|1|||
143028289|NCT02415959|515644305|FG004|Overall Study|Protocol Violation|0|||
143028290|NCT02260492|515644306|FG000|Overall Study|Adverse Event|6|||
143028291|NCT02260492|515644307|FG001|Overall Study|Adverse Event|1|||
143028292|NCT02260492|515644308|FG002|Overall Study|Adverse Event|2|||
143028293|NCT02260492|515644306|FG000|Overall Study|Death|0|||
143028294|NCT02260492|515644307|FG001|Overall Study|Death|1|||
143028295|NCT02260492|515644308|FG002|Overall Study|Death|0|||
143028296|NCT02260492|515644306|FG000|Overall Study|Lost to Follow-up|12|||
143028297|NCT02260492|515644307|FG001|Overall Study|Lost to Follow-up|9|||
143028298|NCT02260492|515644308|FG002|Overall Study|Lost to Follow-up|0|||
143028299|NCT02260492|515644306|FG000|Overall Study|Physician Decision|2|||
143028300|NCT02260492|515644307|FG001|Overall Study|Physician Decision|0|||
143028301|NCT02260492|515644308|FG002|Overall Study|Physician Decision|1|||
143028302|NCT02260492|515644306|FG000|Overall Study|Withdrawal by Subject|3|||
143028303|NCT02260492|515644307|FG001|Overall Study|Withdrawal by Subject|2|||
143028304|NCT02260492|515644308|FG002|Overall Study|Withdrawal by Subject|2|||
143028305|NCT01290263|515645518|FG000|Overall Study|Adverse Event|0|||
143028306|NCT01290263|515645519|FG001|Overall Study|Adverse Event|0|||
143028307|NCT01290263|515645520|FG002|Overall Study|Adverse Event|0|||
143028308|NCT01290263|515645521|FG003|Overall Study|Adverse Event|1|||
143028309|NCT01290263|515645522|FG004|Overall Study|Adverse Event|1|||
143028310|NCT01290263|515645518|FG000|Overall Study|Lack of Efficacy|8|||
143028311|NCT01290263|515645519|FG001|Overall Study|Lack of Efficacy|2|||
143028312|NCT01290263|515645520|FG002|Overall Study|Lack of Efficacy|7|||
143491652|NCT02574637|517342600|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
143491653|NCT02574637|517342601|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
143491654|NCT02574637|517342602|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
143491655|NCT02574637|517342603|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
143491656|NCT02574637|517342604|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
143491657|NCT02574637|517342605|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
143491658|NCT02574637|517342606|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
143491659|NCT02574637|517342607|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
143491660|NCT02574637|517342598|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
143491661|NCT02574637|517342599|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
143491662|NCT02574637|517342600|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
143491663|NCT02574637|517342601|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
143491664|NCT02574637|517342602|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
143491665|NCT02574637|517342603|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
143491666|NCT02574637|517342604|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
143491667|NCT02574637|517342605|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
143491668|NCT02574637|517342606|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
143491669|NCT02574637|517342607|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
143491670|NCT02574637|517342598|FG000|Double-blind Period|Reason Not Specified|0|||
143028313|NCT01290263|515645521|FG003|Overall Study|Lack of Efficacy|24|||
143028314|NCT01290263|515645522|FG004|Overall Study|Lack of Efficacy|33|||
143028315|NCT01290263|515645518|FG000|Overall Study|Withdrawal by Subject|3|||
143028316|NCT01290263|515645519|FG001|Overall Study|Withdrawal by Subject|1|||
143028317|NCT01290263|515645520|FG002|Overall Study|Withdrawal by Subject|0|||
143028318|NCT01290263|515645521|FG003|Overall Study|Withdrawal by Subject|1|||
143028319|NCT01290263|515645522|FG004|Overall Study|Withdrawal by Subject|2|||
143028320|NCT01290263|515645518|FG000|Overall Study|Participant Non-Compliance|0|||
143028321|NCT01290263|515645519|FG001|Overall Study|Participant Non-Compliance|0|||
143028322|NCT01290263|515645520|FG002|Overall Study|Participant Non-Compliance|0|||
143028323|NCT01290263|515645521|FG003|Overall Study|Participant Non-Compliance|1|||
143028324|NCT01290263|515645522|FG004|Overall Study|Participant Non-Compliance|1|||
143028325|NCT01521559|515645523|FG000|Overall Study|Adverse Event|0|||
143028326|NCT01521559|515645524|FG001|Overall Study|Adverse Event|4|||
143491671|NCT02574637|517342599|FG001|Double-blind Period|Reason Not Specified|0|||
143491672|NCT02574637|517342600|FG002|Double-blind Period|Reason Not Specified|0|||
143491673|NCT02574637|517342601|FG003|Double-blind Period|Reason Not Specified|1|||
143491674|NCT02574637|517342602|FG004|Double-blind Period|Reason Not Specified|0|||
143491675|NCT02574637|517342603|FG005|Double-blind Period|Reason Not Specified|0|||
143491676|NCT02574637|517342604|FG006|Double-blind Period|Reason Not Specified|0|||
143491677|NCT02574637|517342605|FG007|Double-blind Period|Reason Not Specified|0|||
143491678|NCT02574637|517342606|FG008|Double-blind Period|Reason Not Specified|0|||
143491679|NCT02574637|517342607|FG009|Double-blind Period|Reason Not Specified|0|||
143491680|NCT02574637|517342598|FG000|Open-label (OL) Period|Adverse Event|0|||
143491681|NCT02574637|517342599|FG001|Open-label (OL) Period|Adverse Event|0|||
143491682|NCT02574637|517342600|FG002|Open-label (OL) Period|Adverse Event|0|||
143158217|NCT04518410|516124410|FG023|Overall Study|Randomized but not treated|3|||
143158218|NCT04518410|516124411|FG024|Overall Study|Randomized but not treated|1|||
143158219|NCT04518410|516124387|FG000|Overall Study|Screen Fail but Randomized|0|||
143158220|NCT04518410|516124388|FG001|Overall Study|Screen Fail but Randomized|0|||
143158221|NCT04518410|516124389|FG002|Overall Study|Screen Fail but Randomized|0|||
143158222|NCT04518410|516124390|FG003|Overall Study|Screen Fail but Randomized|0|||
143158223|NCT04518410|516124391|FG004|Overall Study|Screen Fail but Randomized|2|||
143158224|NCT04518410|516124392|FG005|Overall Study|Screen Fail but Randomized|0|||
143158225|NCT04518410|516124393|FG006|Overall Study|Screen Fail but Randomized|0|||
143158226|NCT04518410|516124394|FG007|Overall Study|Screen Fail but Randomized|0|||
143158227|NCT04518410|516124395|FG008|Overall Study|Screen Fail but Randomized|0|||
143158228|NCT04518410|516124396|FG009|Overall Study|Screen Fail but Randomized|0|||
143158229|NCT04518410|516124397|FG010|Overall Study|Screen Fail but Randomized|0|||
143158230|NCT04518410|516124398|FG011|Overall Study|Screen Fail but Randomized|0|||
143158231|NCT04518410|516124399|FG012|Overall Study|Screen Fail but Randomized|0|||
143158232|NCT04518410|516124400|FG013|Overall Study|Screen Fail but Randomized|0|||
143158233|NCT04518410|516124401|FG014|Overall Study|Screen Fail but Randomized|0|||
143158234|NCT04518410|516124402|FG015|Overall Study|Screen Fail but Randomized|0|||
143158235|NCT04518410|516124403|FG016|Overall Study|Screen Fail but Randomized|0|||
143158236|NCT04518410|516124404|FG017|Overall Study|Screen Fail but Randomized|0|||
143158237|NCT04518410|516124405|FG018|Overall Study|Screen Fail but Randomized|0|||
143158238|NCT04518410|516124406|FG019|Overall Study|Screen Fail but Randomized|0|||
143158239|NCT04518410|516124407|FG020|Overall Study|Screen Fail but Randomized|0|||
143158240|NCT04518410|516124408|FG021|Overall Study|Screen Fail but Randomized|0|||
143158241|NCT04518410|516124409|FG022|Overall Study|Screen Fail but Randomized|0|||
143158242|NCT04518410|516124410|FG023|Overall Study|Screen Fail but Randomized|0|||
143158243|NCT04518410|516124411|FG024|Overall Study|Screen Fail but Randomized|0|||
143158244|NCT04518410|516124387|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
143158245|NCT04518410|516124388|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
143158246|NCT04518410|516124389|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
143158247|NCT04518410|516124390|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
143158248|NCT04518410|516124391|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
143158249|NCT04518410|516124392|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
143158250|NCT04518410|516124393|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
143158251|NCT04518410|516124394|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
143158252|NCT04518410|516124395|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
143158253|NCT04518410|516124396|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
143158254|NCT04518410|516124397|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
143158255|NCT04518410|516124398|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
143158256|NCT04518410|516124399|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
143158257|NCT04518410|516124400|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
143158258|NCT04518410|516124401|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
143158259|NCT04518410|516124402|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
143158260|NCT04518410|516124403|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
143158261|NCT04518410|516124404|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
143158262|NCT04518410|516124405|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
143181469|NCT00642707|516211753|FG001|Overall Study|Withdrawal by Subject|0|||
143491683|NCT02574637|517342601|FG003|Open-label (OL) Period|Adverse Event|0|||
143491684|NCT02574637|517342602|FG004|Open-label (OL) Period|Adverse Event|0|||
143491685|NCT02574637|517342603|FG005|Open-label (OL) Period|Adverse Event|0|||
143491686|NCT02574637|517342604|FG006|Open-label (OL) Period|Adverse Event|0|||
143491687|NCT02574637|517342605|FG007|Open-label (OL) Period|Adverse Event|0|||
143491688|NCT02574637|517342606|FG008|Open-label (OL) Period|Adverse Event|1|||
143491689|NCT02574637|517342607|FG009|Open-label (OL) Period|Adverse Event|0|||
143491690|NCT02574637|517342598|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
143491691|NCT02574637|517342599|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
143491692|NCT02574637|517342600|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
143491693|NCT02574637|517342601|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
143491694|NCT02574637|517342602|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
143491695|NCT02574637|517342603|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
143237251|NCT01899040|516421599|FG002|Overall Study|Randomized in error|1|||
143237252|NCT01899040|516421597|FG000|Overall Study|Adverse Event|3|||
143237253|NCT01899040|516421598|FG001|Overall Study|Adverse Event|1|||
143237254|NCT01899040|516421599|FG002|Overall Study|Adverse Event|2|||
143237255|NCT01899040|516421597|FG000|Overall Study|Unspecified reasons|4|||
143237256|NCT01899040|516421598|FG001|Overall Study|Unspecified reasons|4|||
143237257|NCT01899040|516421599|FG002|Overall Study|Unspecified reasons|0|||
143237258|NCT01899040|516421597|FG000|Overall Study|Compliance issues|1|||
143237259|NCT01899040|516421598|FG001|Overall Study|Compliance issues|2|||
143237260|NCT01899040|516421599|FG002|Overall Study|Compliance issues|0|||
143237261|NCT01671319|516423259|FG000|Overall Study|Withdrawal by Subject|1|||
143237262|NCT00463567|516423260|FG000|Overall Study|Adverse Event|29|||
143237263|NCT00463567|516423261|FG001|Overall Study|Adverse Event|26|||
143237264|NCT00463567|516423262|FG002|Overall Study|Adverse Event|17|||
143491696|NCT02574637|517342604|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
143491697|NCT02574637|517342605|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
143491698|NCT02574637|517342606|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
143491699|NCT02574637|517342607|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
143491700|NCT02574637|517342598|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
143491701|NCT02574637|517342599|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
143491702|NCT02574637|517342600|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
143491703|NCT02574637|517342601|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
143491704|NCT02574637|517342602|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
143491705|NCT02574637|517342603|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
143491706|NCT02574637|517342604|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
143491707|NCT02574637|517342605|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
143491708|NCT02574637|517342606|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
143491709|NCT02574637|517342607|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
143491710|NCT04016311|517342608|FG000|Overall Study|Withdrawal by Subject|1|||
143491711|NCT04016311|517342609|FG001|Overall Study|Withdrawal by Subject|0|||
143491712|NCT04029519|517342613|FG000|Overall Study|Protocol Violation|1|||
143491713|NCT04029519|517342613|FG000|Overall Study|Withdrawal by Subject|3|||
143491714|NCT04029519|517342613|FG000|Overall Study|Lost to Follow-up|1|||
143491715|NCT00094055|517342614|FG000|Overall Study|Adverse Event|11|||
143491716|NCT00094055|517342614|FG000|Overall Study|Death|4|||
143491717|NCT00094055|517342614|FG000|Overall Study|Lack of Efficacy|17|||
143491718|NCT00094055|517342614|FG000|Overall Study|Lost to Follow-up|2|||
143491719|NCT00094055|517342614|FG000|Overall Study|progressive disease|2|||
143491720|NCT00094055|517342614|FG000|Overall Study|clinical progression|1|||
143491721|NCT00094055|517342614|FG000|Overall Study|roll-over to another study|14|||
143491722|NCT00094055|517342614|FG000|Overall Study|Withdrawal by Subject|9|||
143491723|NCT01081795|517342617|FG000|Overall Study|Adverse Event|18|||
143491724|NCT01081795|517342618|FG001|Overall Study|Adverse Event|23|||
143491725|NCT01081795|517342619|FG002|Overall Study|Adverse Event|6|||
143491726|NCT01081795|517342617|FG000|Overall Study|Lack of Efficacy|7|||
143491727|NCT01081795|517342618|FG001|Overall Study|Lack of Efficacy|5|||
143491728|NCT01081795|517342619|FG002|Overall Study|Lack of Efficacy|19|||
143491729|NCT01081795|517342617|FG000|Overall Study|Subject's schedule|1|||
143491730|NCT01081795|517342618|FG001|Overall Study|Subject's schedule|1|||
143491731|NCT01081795|517342619|FG002|Overall Study|Subject's schedule|2|||
143491732|NCT01081795|517342617|FG000|Overall Study|Revocation of informed consent|2|||
143491733|NCT01081795|517342618|FG001|Overall Study|Revocation of informed consent|0|||
143491734|NCT01081795|517342619|FG002|Overall Study|Revocation of informed consent|0|||
143491735|NCT01081795|517342617|FG000|Overall Study|Ineligible for participation|1|||
143491736|NCT01081795|517342618|FG001|Overall Study|Ineligible for participation|0|||
143491737|NCT01081795|517342619|FG002|Overall Study|Ineligible for participation|0|||
143028327|NCT01521559|515645523|FG000|Overall Study|Death|1|||
143491738|NCT01081795|517342617|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
143491739|NCT01081795|517342618|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
143491740|NCT01081795|517342619|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
143491741|NCT01081795|517342617|FG000|Overall Study|Using drug with restricted days of use|2|||
143491742|NCT01081795|517342618|FG001|Overall Study|Using drug with restricted days of use|3|||
143491743|NCT01081795|517342619|FG002|Overall Study|Using drug with restricted days of use|2|||
143491744|NCT01081795|517342617|FG000|Overall Study|Other|1|||
143028328|NCT01521559|515645524|FG001|Overall Study|Death|0|||
143028329|NCT01521559|515645523|FG000|Overall Study|Withdrawal by Subject|9|||
143028330|NCT01521559|515645524|FG001|Overall Study|Withdrawal by Subject|11|||
143028331|NCT01521559|515645523|FG000|Overall Study|Lost to Follow-up|3|||
143028332|NCT01521559|515645524|FG001|Overall Study|Lost to Follow-up|1|||
143028333|NCT01521559|515645523|FG000|Overall Study|Protocol Violation|1|||
143028334|NCT01521559|515645524|FG001|Overall Study|Protocol Violation|0|||
143028335|NCT01521559|515645523|FG000|Overall Study|Other|1|||
143028336|NCT01521559|515645524|FG001|Overall Study|Other|2|||
143028337|NCT00275002|515645526|FG000|Overall Study|Death|1|||
143028338|NCT00275002|515645527|FG001|Overall Study|Death|0|||
143028339|NCT00275002|515645526|FG000|Overall Study|Disease progression|21|||
143028340|NCT00275002|515645527|FG001|Overall Study|Disease progression|15|||
143028341|NCT00275002|515645526|FG000|Overall Study|Adverse Event|0|||
143028342|NCT00275002|515645527|FG001|Overall Study|Adverse Event|1|||
143028343|NCT02918162|515645528|FG000|Overall Study|Withdrawal by Subject|1|||
143028344|NCT02918162|515645528|FG000|Overall Study|Omental Disease|1|||
143028345|NCT05456529|515645529|FG000|8-week Continuous Treatment (CT) Period|Lost to Follow-up|5|||
143028346|NCT05456529|515645529|FG000|8-week Continuous Treatment (CT) Period|Lack of Efficacy|2|||
143028347|NCT05456529|515645529|FG000|8-week Continuous Treatment (CT) Period|Protocol-specified Withdrawal Criterion Met|1|||
143028348|NCT05456529|515645529|FG000|8-week Continuous Treatment (CT) Period|Withdrawal by Subject|3|||
143028349|NCT05456529|515645529|FG000|44-week Long-term Safety Period|Lost to Follow-up|12|||
143028350|NCT05456529|515645529|FG000|44-week Long-term Safety Period|Lack of Efficacy|1|||
143028351|NCT05456529|515645529|FG000|44-week Long-term Safety Period|Physician Decision|2|||
143028352|NCT05456529|515645529|FG000|44-week Long-term Safety Period|Protocol-specified Withdrawal Criterion Met|1|||
143028353|NCT05456529|515645529|FG000|44-week Long-term Safety Period|Withdrawal by Subject|12|||
143158263|NCT04518410|516124406|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
143491745|NCT01081795|517342618|FG001|Overall Study|Other|2|||
143491746|NCT01081795|517342619|FG002|Overall Study|Other|0|||
143491747|NCT02462473|517342620|FG000|Overall Study|Death|1|||
143491748|NCT02462473|517342620|FG000|Overall Study|Other|3|||
143491749|NCT00661271|517342621|FG000|Overall Study|Lost to Follow-up|28|||
143491750|NCT00661271|517342622|FG001|Overall Study|Lost to Follow-up|25|||
143491751|NCT03728309|517342627|FG000|Overall Study|Randomized but not Treated|0|||
143491752|NCT03728309|517342628|FG001|Overall Study|Randomized but not Treated|1|||
143491753|NCT03728309|517342627|FG000|Overall Study|Adverse Event|0|||
143491754|NCT03728309|517342628|FG001|Overall Study|Adverse Event|1|||
143491755|NCT03728309|517342627|FG000|Overall Study|Withdrawal by Subject|2|||
143491756|NCT03728309|517342628|FG001|Overall Study|Withdrawal by Subject|8|||
143491757|NCT03728309|517342627|FG000|Overall Study|Lost to Follow-up|9|||
143491758|NCT03728309|517342628|FG001|Overall Study|Lost to Follow-up|10|||
143491759|NCT03728309|517342627|FG000|Overall Study|Protocol Deviation|0|||
143491760|NCT03728309|517342628|FG001|Overall Study|Protocol Deviation|1|||
143491761|NCT03728309|517342627|FG000|Overall Study|Due to COVID|1|||
143491762|NCT03728309|517342628|FG001|Overall Study|Due to COVID|3|||
143491763|NCT02436876|517342631|FG000|Overall Study|Lost to Follow-up|0|||
143491764|NCT02436876|517342632|FG001|Overall Study|Lost to Follow-up|1|||
143491765|NCT02436876|517342633|FG002|Overall Study|Lost to Follow-up|1|||
143491766|NCT02436876|517342634|FG003|Overall Study|Lost to Follow-up|1|||
143491767|NCT02436876|517342631|FG000|Overall Study|Withdrawal by Subject|1|||
143491768|NCT02436876|517342632|FG001|Overall Study|Withdrawal by Subject|0|||
143491769|NCT02436876|517342633|FG002|Overall Study|Withdrawal by Subject|0|||
143491770|NCT02436876|517342634|FG003|Overall Study|Withdrawal by Subject|1|||
143491771|NCT02436876|517342631|FG000|Overall Study|Physician Decision|0|||
143491772|NCT02436876|517342632|FG001|Overall Study|Physician Decision|2|||
143491773|NCT02436876|517342633|FG002|Overall Study|Physician Decision|1|||
143491774|NCT02436876|517342634|FG003|Overall Study|Physician Decision|0|||
143491775|NCT02436876|517342631|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
143491776|NCT02436876|517342632|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
143491777|NCT02436876|517342633|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
143491778|NCT02436876|517342634|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
143158264|NCT04518410|516124407|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
143158265|NCT04518410|516124408|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
143237265|NCT00463567|516423263|FG003|Overall Study|Adverse Event|46|||
143491779|NCT00953758|517342635|FG000|Overall Study|Death|2|||
143028354|NCT05456529|515645529|FG000|44-week Long-term Safety Period|Withdrawal by Sponsor|2|||
143028355|NCT05456529|515645529|FG000|44-week Long-term Safety Period|Unable to Attend the Follow-up Visit|1|||
143028356|NCT00395226|515645530|FG000|Overall Study|Adverse Event|4|||
143028357|NCT00395226|515645531|FG001|Overall Study|Adverse Event|3|||
143028358|NCT00395226|515645530|FG000|Overall Study|Withdrawal by Subject|0|||
143028359|NCT00395226|515645531|FG001|Overall Study|Withdrawal by Subject|1|||
143491780|NCT00953758|517342636|FG001|Overall Study|Death|0|||
143491781|NCT00953758|517342637|FG002|Overall Study|Death|1|||
143491782|NCT00953758|517342638|FG003|Overall Study|Death|1|||
143237266|NCT00463567|516423264|FG004|Overall Study|Adverse Event|10|||
143237267|NCT00463567|516423265|FG005|Overall Study|Adverse Event|10|||
143237268|NCT00463567|516423266|FG006|Overall Study|Adverse Event|4|||
143237269|NCT00463567|516423260|FG000|Overall Study|Withdrawal by Subject|29|||
143237270|NCT00463567|516423261|FG001|Overall Study|Withdrawal by Subject|22|||
143237271|NCT00463567|516423262|FG002|Overall Study|Withdrawal by Subject|20|||
143237272|NCT00463567|516423263|FG003|Overall Study|Withdrawal by Subject|37|||
143237273|NCT00463567|516423264|FG004|Overall Study|Withdrawal by Subject|6|||
143237274|NCT00463567|516423265|FG005|Overall Study|Withdrawal by Subject|5|||
143237275|NCT00463567|516423266|FG006|Overall Study|Withdrawal by Subject|1|||
143237276|NCT00463567|516423260|FG000|Overall Study|Protocol Deviation|13|||
143237277|NCT00463567|516423261|FG001|Overall Study|Protocol Deviation|9|||
143237278|NCT00463567|516423262|FG002|Overall Study|Protocol Deviation|14|||
143237279|NCT00463567|516423263|FG003|Overall Study|Protocol Deviation|11|||
143237280|NCT00463567|516423264|FG004|Overall Study|Protocol Deviation|1|||
143237281|NCT00463567|516423265|FG005|Overall Study|Protocol Deviation|1|||
143237282|NCT00463567|516423266|FG006|Overall Study|Protocol Deviation|2|||
143237283|NCT00463567|516423260|FG000|Overall Study|Lost to Follow-up|12|||
143237284|NCT00463567|516423261|FG001|Overall Study|Lost to Follow-up|6|||
143237285|NCT00463567|516423262|FG002|Overall Study|Lost to Follow-up|13|||
143237286|NCT00463567|516423263|FG003|Overall Study|Lost to Follow-up|8|||
143237287|NCT00463567|516423264|FG004|Overall Study|Lost to Follow-up|1|||
143237288|NCT00463567|516423265|FG005|Overall Study|Lost to Follow-up|1|||
143237289|NCT00463567|516423266|FG006|Overall Study|Lost to Follow-up|1|||
143237290|NCT00463567|516423260|FG000|Overall Study|Administrative problems|5|||
143237291|NCT00463567|516423261|FG001|Overall Study|Administrative problems|3|||
143237292|NCT00463567|516423262|FG002|Overall Study|Administrative problems|6|||
143237293|NCT00463567|516423263|FG003|Overall Study|Administrative problems|9|||
143237294|NCT00463567|516423264|FG004|Overall Study|Administrative problems|3|||
143237295|NCT00463567|516423265|FG005|Overall Study|Administrative problems|2|||
143237296|NCT00463567|516423266|FG006|Overall Study|Administrative problems|2|||
143237297|NCT00463567|516423260|FG000|Overall Study|Lack of Efficacy|4|||
143237298|NCT00463567|516423261|FG001|Overall Study|Lack of Efficacy|9|||
143237299|NCT00463567|516423262|FG002|Overall Study|Lack of Efficacy|9|||
143237300|NCT00463567|516423263|FG003|Overall Study|Lack of Efficacy|17|||
143237301|NCT00463567|516423264|FG004|Overall Study|Lack of Efficacy|1|||
143237302|NCT00463567|516423265|FG005|Overall Study|Lack of Efficacy|0|||
143237303|NCT00463567|516423266|FG006|Overall Study|Lack of Efficacy|1|||
143237304|NCT00463567|516423260|FG000|Overall Study|Abnormal lab value(s)|1|||
143237305|NCT00463567|516423261|FG001|Overall Study|Abnormal lab value(s)|1|||
143237306|NCT00463567|516423262|FG002|Overall Study|Abnormal lab value(s)|2|||
143237307|NCT00463567|516423263|FG003|Overall Study|Abnormal lab value(s)|1|||
143237308|NCT00463567|516423264|FG004|Overall Study|Abnormal lab value(s)|1|||
143237309|NCT00463567|516423265|FG005|Overall Study|Abnormal lab value(s)|0|||
143237310|NCT00463567|516423266|FG006|Overall Study|Abnormal lab value(s)|0|||
143237311|NCT00463567|516423260|FG000|Overall Study|Abnormal test procedure result(s)|1|||
143237312|NCT00463567|516423261|FG001|Overall Study|Abnormal test procedure result(s)|1|||
143237313|NCT00463567|516423262|FG002|Overall Study|Abnormal test procedure result(s)|6|||
143237314|NCT00463567|516423263|FG003|Overall Study|Abnormal test procedure result(s)|2|||
143237315|NCT00463567|516423264|FG004|Overall Study|Abnormal test procedure result(s)|0|||
143237316|NCT00463567|516423265|FG005|Overall Study|Abnormal test procedure result(s)|2|||
143237317|NCT00463567|516423266|FG006|Overall Study|Abnormal test procedure result(s)|0|||
143491783|NCT00953758|517342639|FG004|Overall Study|Death|1|||
143491784|NCT00953758|517342640|FG005|Overall Study|Death|1|||
143491785|NCT00953758|517342641|FG006|Overall Study|Death|1|||
143491786|NCT00953758|517342642|FG007|Overall Study|Death|3|||
143491787|NCT00953758|517342643|FG008|Overall Study|Death|1|||
143491788|NCT00953758|517342644|FG009|Overall Study|Death|0|||
143237318|NCT00463567|516423260|FG000|Overall Study|Death|1|||
143237319|NCT00463567|516423261|FG001|Overall Study|Death|0|||
143237320|NCT00463567|516423262|FG002|Overall Study|Death|2|||
143237321|NCT00463567|516423263|FG003|Overall Study|Death|0|||
143237322|NCT00463567|516423264|FG004|Overall Study|Death|0|||
143237323|NCT00463567|516423265|FG005|Overall Study|Death|0|||
143237324|NCT00463567|516423266|FG006|Overall Study|Death|0|||
143237325|NCT01124006|516423267|FG000|Overall Study|Withdrawal by Subject|2|||
143491789|NCT00953758|517342635|FG000|Overall Study|Participant refused further follow-up|0|||
143237326|NCT01124006|516423268|FG001|Overall Study|Withdrawal by Subject|2|||
143237327|NCT01124006|516423269|FG002|Overall Study|Withdrawal by Subject|0|||
143237328|NCT01124006|516423267|FG000|Overall Study|Lost to Follow-up|1|||
143237329|NCT01124006|516423268|FG001|Overall Study|Lost to Follow-up|0|||
143237330|NCT01124006|516423269|FG002|Overall Study|Lost to Follow-up|1|||
143237331|NCT01124006|516423267|FG000|Overall Study|Other|0|||
143237332|NCT01124006|516423268|FG001|Overall Study|Other|0|||
143237333|NCT01124006|516423269|FG002|Overall Study|Other|1|||
143237334|NCT03038100|516423270|FG000|Overall Study|Death|289|||
143237335|NCT03038100|516423271|FG001|Overall Study|Death|272|||
143237336|NCT03038100|516423270|FG000|Overall Study|Lost to Follow-up|9|||
143491790|NCT00953758|517342636|FG001|Overall Study|Participant refused further follow-up|0|||
143237337|NCT03038100|516423271|FG001|Overall Study|Lost to Follow-up|10|||
143237338|NCT03038100|516423270|FG000|Overall Study|Protocol Deviation|1|||
143237339|NCT03038100|516423271|FG001|Overall Study|Protocol Deviation|4|||
143237340|NCT03038100|516423270|FG000|Overall Study|Withdrawal by Subject|45|||
143237341|NCT03038100|516423271|FG001|Overall Study|Withdrawal by Subject|51|||
143237342|NCT03038100|516423270|FG000|Overall Study|Study Terminated By Sponsor|305|||
143237343|NCT03038100|516423271|FG001|Overall Study|Study Terminated By Sponsor|311|||
143237344|NCT03038100|516423270|FG000|Overall Study|Physician Decision|1|||
143237345|NCT03038100|516423271|FG001|Overall Study|Physician Decision|3|||
143237346|NCT04154904|516423272|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
143237347|NCT04154904|516423273|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
143237348|NCT04154904|516423274|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
143237349|NCT02392624|516423275|FG000|Overall Study|Withdrawal by Subject|15|||
143237350|NCT02392624|516423276|FG001|Overall Study|Withdrawal by Subject|12|||
143237351|NCT02392624|516423277|FG002|Overall Study|Withdrawal by Subject|9|||
143237352|NCT02392624|516423275|FG000|Overall Study|Adverse Event|4|||
143237353|NCT02392624|516423276|FG001|Overall Study|Adverse Event|1|||
143237354|NCT02392624|516423277|FG002|Overall Study|Adverse Event|2|||
143237355|NCT02392624|516423275|FG000|Overall Study|Pregnancy|1|||
143237356|NCT02392624|516423276|FG001|Overall Study|Pregnancy|0|||
143237357|NCT02392624|516423277|FG002|Overall Study|Pregnancy|0|||
143237358|NCT02392624|516423275|FG000|Overall Study|Protocol Violation|0|||
143237359|NCT02392624|516423276|FG001|Overall Study|Protocol Violation|0|||
143237360|NCT02392624|516423277|FG002|Overall Study|Protocol Violation|1|||
143237361|NCT02392624|516423275|FG000|Overall Study|Sponsor/Investigator Decision|2|||
143237362|NCT02392624|516423276|FG001|Overall Study|Sponsor/Investigator Decision|1|||
143237363|NCT02392624|516423277|FG002|Overall Study|Sponsor/Investigator Decision|0|||
143237364|NCT02392624|516423275|FG000|Overall Study|Other|49|||
143237365|NCT02392624|516423276|FG001|Overall Study|Other|1|||
143028360|NCT00395226|515645530|FG000|Overall Study|Lost to Follow-up|0|||
143237366|NCT02392624|516423277|FG002|Overall Study|Other|1|||
143237367|NCT00706238|516423278|FG000|Overall Study|Disease progression|4|||
143237368|NCT00706238|516423278|FG000|Overall Study|Other|1|||
143237369|NCT00936715|516423279|FG000|Overall Study|Investigators Discretion|1|||
143237370|NCT00936715|516423279|FG000|Overall Study|Protocol Violation|1|||
143237371|NCT00936715|516423279|FG000|Overall Study|Safety or Tolerability Reasons|4|||
143237372|NCT02492763|516423280|FG000|Overall Study|Withdrawal by Subject|0|||
143237373|NCT02492763|516423281|FG001|Overall Study|Withdrawal by Subject|2|||
143237374|NCT02492763|516423282|FG002|Overall Study|Withdrawal by Subject|1|||
143237375|NCT02492763|516423283|FG003|Overall Study|Withdrawal by Subject|0|||
143491791|NCT00953758|517342637|FG002|Overall Study|Participant refused further follow-up|1|||
143491792|NCT00953758|517342638|FG003|Overall Study|Participant refused further follow-up|0|||
143028361|NCT00395226|515645531|FG001|Overall Study|Lost to Follow-up|1|||
143028362|NCT00576381|515645535|FG000|Overall Study|Reoperation|3|||
143028363|NCT00576381|515645535|FG000|Overall Study|Adverse Event|4|||
143028364|NCT01031537|515645539|FG000|Overall Study|medical reasons not related to study|3|||
143028365|NCT01031537|515645539|FG000|Overall Study|Lack of Efficacy|1|||
143491793|NCT00953758|517342639|FG004|Overall Study|Participant refused further follow-up|3|||
143491794|NCT00953758|517342640|FG005|Overall Study|Participant refused further follow-up|0|||
143028366|NCT01031537|515645539|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
143028367|NCT01031537|515645539|FG000|Overall Study|moved, met exclusion criteria|10|||
143028368|NCT01031537|515645539|FG000|Overall Study|Withdrawal by Subject|5|||
143028369|NCT01031537|515645539|FG000|Overall Study|PI removal, no longer met eligibility|12|||
143028370|NCT02655237|515645540|FG000|Overall Study|Adverse Event|10|||
143237376|NCT02492763|516423280|FG000|Overall Study|Adverse Event|3|||
143237377|NCT02492763|516423281|FG001|Overall Study|Adverse Event|1|||
143237378|NCT02492763|516423282|FG002|Overall Study|Adverse Event|1|||
143237379|NCT02492763|516423283|FG003|Overall Study|Adverse Event|2|||
143491795|NCT00953758|517342641|FG006|Overall Study|Participant refused further follow-up|0|||
143491796|NCT00953758|517342642|FG007|Overall Study|Participant refused further follow-up|0|||
143491797|NCT00953758|517342643|FG008|Overall Study|Participant refused further follow-up|1|||
143491798|NCT00953758|517342644|FG009|Overall Study|Participant refused further follow-up|0|||
143237380|NCT02492763|516423280|FG000|Overall Study|Death|0|||
143237381|NCT02492763|516423281|FG001|Overall Study|Death|0|||
143237382|NCT02492763|516423282|FG002|Overall Study|Death|1|||
143237383|NCT02492763|516423283|FG003|Overall Study|Death|0|||
143237384|NCT02492763|516423280|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
143237385|NCT02492763|516423281|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
143237386|NCT02492763|516423282|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
143028371|NCT02655237|515645541|FG001|Overall Study|Adverse Event|7|||
143028372|NCT02655237|515645540|FG000|Overall Study|Protocol Deviation|2|||
143028373|NCT02655237|515645541|FG001|Overall Study|Protocol Deviation|0|||
143237387|NCT02492763|516423283|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
143237388|NCT02492763|516423280|FG000|Overall Study|Lost to Follow-up|0|||
143237389|NCT02492763|516423281|FG001|Overall Study|Lost to Follow-up|0|||
143237390|NCT02492763|516423282|FG002|Overall Study|Lost to Follow-up|1|||
143491799|NCT00953758|517342635|FG000|Overall Study|Lost to Follow-up|0|||
143491800|NCT00953758|517342636|FG001|Overall Study|Lost to Follow-up|0|||
143491801|NCT00953758|517342637|FG002|Overall Study|Lost to Follow-up|0|||
143491802|NCT00953758|517342638|FG003|Overall Study|Lost to Follow-up|1|||
143491803|NCT00953758|517342639|FG004|Overall Study|Lost to Follow-up|0|||
143491804|NCT00953758|517342640|FG005|Overall Study|Lost to Follow-up|0|||
143491805|NCT00953758|517342641|FG006|Overall Study|Lost to Follow-up|0|||
143491806|NCT00953758|517342642|FG007|Overall Study|Lost to Follow-up|1|||
143491807|NCT00953758|517342643|FG008|Overall Study|Lost to Follow-up|0|||
143491808|NCT00953758|517342644|FG009|Overall Study|Lost to Follow-up|1|||
143491809|NCT00953758|517342635|FG000|Overall Study|Physician Decision|0|||
143491810|NCT00953758|517342636|FG001|Overall Study|Physician Decision|0|||
143491811|NCT00953758|517342637|FG002|Overall Study|Physician Decision|0|||
143491812|NCT00953758|517342638|FG003|Overall Study|Physician Decision|0|||
143491813|NCT00953758|517342639|FG004|Overall Study|Physician Decision|1|||
143491814|NCT00953758|517342640|FG005|Overall Study|Physician Decision|0|||
143491815|NCT00953758|517342641|FG006|Overall Study|Physician Decision|0|||
143491816|NCT00953758|517342642|FG007|Overall Study|Physician Decision|0|||
143491817|NCT00953758|517342643|FG008|Overall Study|Physician Decision|0|||
143491818|NCT00953758|517342644|FG009|Overall Study|Physician Decision|0|||
143491819|NCT00953758|517342635|FG000|Overall Study|Disease progression|0|||
143491820|NCT00953758|517342636|FG001|Overall Study|Disease progression|0|||
143491821|NCT00953758|517342637|FG002|Overall Study|Disease progression|0|||
143491822|NCT00953758|517342638|FG003|Overall Study|Disease progression|0|||
143491823|NCT00953758|517342639|FG004|Overall Study|Disease progression|1|||
143158266|NCT04518410|516124409|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
143491824|NCT00953758|517342640|FG005|Overall Study|Disease progression|0|||
143491825|NCT00953758|517342641|FG006|Overall Study|Disease progression|0|||
143491826|NCT00953758|517342642|FG007|Overall Study|Disease progression|0|||
143491827|NCT00953758|517342643|FG008|Overall Study|Disease progression|0|||
143491828|NCT00953758|517342644|FG009|Overall Study|Disease progression|0|||
143491829|NCT00953758|517342635|FG000|Overall Study|Participant went for transplant|0|||
143491830|NCT00953758|517342636|FG001|Overall Study|Participant went for transplant|0|||
143491831|NCT00953758|517342637|FG002|Overall Study|Participant went for transplant|0|||
143491832|NCT00953758|517342638|FG003|Overall Study|Participant went for transplant|0|||
143491833|NCT00953758|517342639|FG004|Overall Study|Participant went for transplant|0|||
143491834|NCT00953758|517342640|FG005|Overall Study|Participant went for transplant|0|||
143491835|NCT00953758|517342641|FG006|Overall Study|Participant went for transplant|0|||
143491836|NCT00953758|517342642|FG007|Overall Study|Participant went for transplant|0|||
143491837|NCT00953758|517342643|FG008|Overall Study|Participant went for transplant|1|||
143491838|NCT00953758|517342644|FG009|Overall Study|Participant went for transplant|0|||
143491839|NCT01536860|517342645|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
143491840|NCT01536860|517342646|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
143491841|NCT01536860|517342647|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
143491842|NCT01164722|517342648|FG000|Overall Study|Adverse Event|0|||
143491843|NCT01164722|517342649|FG001|Overall Study|Adverse Event|1|||
143491844|NCT01164722|517342648|FG000|Overall Study|Withdrawal by Subject|3|||
143491845|NCT01164722|517342649|FG001|Overall Study|Withdrawal by Subject|4|||
143491846|NCT01164722|517342648|FG000|Overall Study|Lost to Follow-up|3|||
143491847|NCT01164722|517342649|FG001|Overall Study|Lost to Follow-up|6|||
143491848|NCT01164722|517342648|FG000|Overall Study|met protocol criteria for non-treatment|11|||
143491849|NCT01164722|517342649|FG001|Overall Study|met protocol criteria for non-treatment|1|||
143491850|NCT01164722|517342648|FG000|Overall Study|enrolled on other study, concomitant med|1|||
143491851|NCT01164722|517342649|FG001|Overall Study|enrolled on other study, concomitant med|3|||
143491852|NCT00999908|517342650|FG000|Treatment Period 1|Subject withdrew consent|2|||
143491853|NCT00999908|517342651|FG001|Treatment Period 1|Subject withdrew consent|0|||
143491854|NCT00999908|517342652|FG002|Treatment Period 1|Subject withdrew consent|0|||
143491855|NCT00999908|517342650|FG000|Treatment Period 2|Protocol Violation|1|||
143491856|NCT00999908|517342651|FG001|Treatment Period 2|Protocol Violation|0|||
143491857|NCT00999908|517342652|FG002|Treatment Period 2|Protocol Violation|0|||
143158267|NCT04518410|516124410|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
143491858|NCT00927095|517342654|FG000|Overall Study|Adverse Event|3|||
143491859|NCT00927095|517342655|FG001|Overall Study|Adverse Event|1|||
143491860|NCT00927095|517342656|FG002|Overall Study|Adverse Event|0|||
143158268|NCT04518410|516124411|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
143158269|NCT04518410|516124387|FG000|Overall Study|Dual Enrolled Subject|0|||
143491861|NCT00927095|517342654|FG000|Overall Study|Withdrawal by Subject|2|||
143491862|NCT00927095|517342655|FG001|Overall Study|Withdrawal by Subject|1|||
143491863|NCT00927095|517342656|FG002|Overall Study|Withdrawal by Subject|1|||
143491864|NCT00927095|517342654|FG000|Overall Study|Physician Decision|1|||
143491865|NCT00927095|517342655|FG001|Overall Study|Physician Decision|2|||
143491866|NCT00927095|517342656|FG002|Overall Study|Physician Decision|1|||
143491867|NCT01290692|517342661|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
143491868|NCT03115151|517342665|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
143491869|NCT03115151|517342666|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
143491870|NCT03115151|517342665|FG000|Overall Study|Epidural catheter removal|1|||
143491871|NCT03115151|517342666|FG001|Overall Study|Epidural catheter removal|0|||
143491872|NCT03115151|517342665|FG000|Overall Study|Withdrawal by Subject|0|||
143491873|NCT03115151|517342666|FG001|Overall Study|Withdrawal by Subject|1|||
143491874|NCT03115151|517342665|FG000|Overall Study|Intervention not received according to the protocol.|1|||
143491875|NCT03115151|517342666|FG001|Overall Study|Intervention not received according to the protocol.|1|||
143491876|NCT03115151|517342665|FG000|Overall Study|Physician Decision|1|||
143491877|NCT03115151|517342666|FG001|Overall Study|Physician Decision|0|||
143491878|NCT03115151|517342665|FG000|Overall Study|Randomization not applied|1|||
143491879|NCT03115151|517342666|FG001|Overall Study|Randomization not applied|1|||
143491880|NCT03403205|517342667|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
143491881|NCT03403205|517342668|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
143491882|NCT03403205|517342669|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
143491883|NCT03403205|517342670|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
143491884|NCT03403205|517342671|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
143491885|NCT03403205|517342672|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
143491886|NCT03403205|517342667|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
143491887|NCT03403205|517342668|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
143491888|NCT03403205|517342669|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
143491889|NCT03403205|517342670|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
143491890|NCT03403205|517342671|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
143491891|NCT03403205|517342672|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
143491892|NCT03403205|517342667|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
143491893|NCT03403205|517342668|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
143158270|NCT04518410|516124388|FG001|Overall Study|Dual Enrolled Subject|0|||
143491894|NCT03403205|517342669|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
143491895|NCT03403205|517342670|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
143491896|NCT03403205|517342671|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
143491897|NCT03403205|517342672|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
143491898|NCT03403205|517342667|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
143491899|NCT03403205|517342668|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
143491900|NCT03403205|517342669|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
143491901|NCT03403205|517342670|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
143491902|NCT03403205|517342671|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
143491903|NCT03403205|517342672|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
143491904|NCT03403205|517342667|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
143491905|NCT03403205|517342668|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
143491906|NCT03403205|517342669|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
143491907|NCT03403205|517342670|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
143158271|NCT04518410|516124389|FG002|Overall Study|Dual Enrolled Subject|0|||
143158272|NCT04518410|516124390|FG003|Overall Study|Dual Enrolled Subject|0|||
143158273|NCT04518410|516124391|FG004|Overall Study|Dual Enrolled Subject|0|||
143158274|NCT04518410|516124392|FG005|Overall Study|Dual Enrolled Subject|0|||
143158275|NCT04518410|516124393|FG006|Overall Study|Dual Enrolled Subject|0|||
143491908|NCT03403205|517342671|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
143491909|NCT03403205|517342672|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
143491910|NCT03403205|517342667|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
143491911|NCT03403205|517342668|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
143491912|NCT03403205|517342669|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
143491913|NCT03403205|517342670|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
143491914|NCT03403205|517342671|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
143491915|NCT03403205|517342672|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
143491916|NCT03403205|517342667|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
143491917|NCT03403205|517342668|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
143491918|NCT03403205|517342669|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
143491919|NCT03403205|517342670|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
143491920|NCT03403205|517342671|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
143491921|NCT03403205|517342672|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
143491922|NCT03403205|517342667|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
143491923|NCT03403205|517342668|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
143491924|NCT03403205|517342669|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
143491925|NCT03403205|517342670|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
143491926|NCT03403205|517342671|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
143491927|NCT03403205|517342672|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
143158276|NCT04518410|516124394|FG007|Overall Study|Dual Enrolled Subject|0|||
143158277|NCT04518410|516124395|FG008|Overall Study|Dual Enrolled Subject|0|||
143028374|NCT02655237|515645540|FG000|Overall Study|Withdrawal by Participant|1|||
143028375|NCT02655237|515645541|FG001|Overall Study|Withdrawal by Participant|2|||
143028376|NCT02655237|515645540|FG000|Overall Study|Lack of Efficacy|0|||
143028377|NCT02655237|515645541|FG001|Overall Study|Lack of Efficacy|1|||
143028378|NCT02655237|515645540|FG000|Overall Study|Recovery Leading to Surgery|2|||
143028379|NCT02655237|515645541|FG001|Overall Study|Recovery Leading to Surgery|1|||
143028380|NCT02655237|515645540|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
143028381|NCT02655237|515645541|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
143028382|NCT02655237|515645540|FG000|Overall Study|Randomized but Not Treated|1|||
143028383|NCT02655237|515645541|FG001|Overall Study|Randomized but Not Treated|0|||
143028384|NCT02132247|515645542|FG000|Overall Study|Protocol Violation|1|||
143028385|NCT02132247|515645543|FG001|Overall Study|Protocol Violation|0|||
143028386|NCT00520741|515645550|FG000|Overall Study|Adverse Event|16|||
143028387|NCT00520741|515645551|FG001|Overall Study|Adverse Event|56|||
143028388|NCT00520741|515645550|FG000|Overall Study|Lack of Efficacy|11|||
143028389|NCT00520741|515645551|FG001|Overall Study|Lack of Efficacy|30|||
143028390|NCT00520741|515645550|FG000|Overall Study|Withdrawal by Subject|0|||
143028391|NCT00520741|515645551|FG001|Overall Study|Withdrawal by Subject|11|||
143028392|NCT00520741|515645550|FG000|Overall Study|Protocol Violation|2|||
143028393|NCT00520741|515645551|FG001|Overall Study|Protocol Violation|15|||
143028394|NCT00520741|515645550|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
143028395|NCT00520741|515645551|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
143028396|NCT00520741|515645550|FG000|Overall Study|Lost to Follow-up|4|||
143028397|NCT00520741|515645551|FG001|Overall Study|Lost to Follow-up|4|||
143028398|NCT00520741|515645550|FG000|Overall Study|Other reasons for premature termination|0|||
143028399|NCT00520741|515645551|FG001|Overall Study|Other reasons for premature termination|6|||
143028400|NCT03702621|515645552|FG000|Overall Study|Physician Decision|6|||
143028401|NCT03702621|515645553|FG001|Overall Study|Physician Decision|6|||
143028402|NCT00634907|515645557|FG000|Overall Study|Withdrawal by Subject|3|||
143028403|NCT00634907|515645558|FG001|Overall Study|Withdrawal by Subject|0|||
143028404|NCT00634907|515645557|FG000|Overall Study|Physician Decision|3|||
143028405|NCT00634907|515645558|FG001|Overall Study|Physician Decision|9|||
143028406|NCT00634907|515645557|FG000|Overall Study|Withdrawal by Subject|11|||
143028407|NCT00634907|515645558|FG001|Overall Study|Withdrawal by Subject|8|||
143028408|NCT02374918|515645559|FG000|Overall Study|Protocol Violation|2|||
143028409|NCT02374918|515645560|FG001|Overall Study|Protocol Violation|0|||
143028410|NCT02374918|515645561|FG002|Overall Study|Protocol Violation|2|||
143028411|NCT02374918|515645562|FG003|Overall Study|Protocol Violation|1|||
143028412|NCT02374918|515645559|FG000|Overall Study|Withdrawal by Subject|1|||
143028413|NCT02374918|515645560|FG001|Overall Study|Withdrawal by Subject|1|||
143028414|NCT02374918|515645561|FG002|Overall Study|Withdrawal by Subject|1|||
143028415|NCT02374918|515645562|FG003|Overall Study|Withdrawal by Subject|0|||
143028416|NCT02374918|515645559|FG000|Overall Study|Lack of Efficacy|0|||
143028417|NCT02374918|515645560|FG001|Overall Study|Lack of Efficacy|0|||
143028418|NCT02374918|515645561|FG002|Overall Study|Lack of Efficacy|1|||
143028419|NCT02374918|515645562|FG003|Overall Study|Lack of Efficacy|1|||
143028420|NCT02204371|515645564|FG000|Overall Study|Adverse Event|1|||
143028421|NCT01506947|515645568|FG000|Overall Study|Lost to Follow-up|7|||
143028422|NCT01506947|515645568|FG000|Overall Study|Adverse Event|5|||
143028423|NCT01506947|515645568|FG000|Overall Study|Death|1|||
143028424|NCT01506947|515645568|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
143028425|NCT02720510|515645571|FG000|Overall Study|Study Terminated by the sponsor|2|||
143028426|NCT02720510|515645572|FG001|Overall Study|Study Terminated by the sponsor|0|||
143028427|NCT02720510|515645571|FG000|Overall Study|Adverse Event|0|||
143028428|NCT02720510|515645572|FG001|Overall Study|Adverse Event|1|||
143028429|NCT02720510|515645571|FG000|Overall Study|Physician Decision|1|||
143028430|NCT02720510|515645572|FG001|Overall Study|Physician Decision|2|||
143028431|NCT03267264|515645575|FG000|Overall Study|Withdrawal by Subject|1|||
143028432|NCT03267264|515645576|FG001|Overall Study|Withdrawal by Subject|0|||
143028433|NCT03267264|515645577|FG002|Overall Study|Withdrawal by Subject|2|||
143028434|NCT03267264|515645578|FG003|Overall Study|Withdrawal by Subject|4|||
143028435|NCT02752776|515645579|FG000|Overall Study|Adverse Event|15|||
143028436|NCT02752776|515645580|FG001|Overall Study|Adverse Event|23|||
143158278|NCT04518410|516124396|FG009|Overall Study|Dual Enrolled Subject|0|||
143158279|NCT04518410|516124397|FG010|Overall Study|Dual Enrolled Subject|0|||
143158280|NCT04518410|516124398|FG011|Overall Study|Dual Enrolled Subject|0|||
143158281|NCT04518410|516124399|FG012|Overall Study|Dual Enrolled Subject|0|||
143028437|NCT02752776|515645581|FG002|Overall Study|Adverse Event|11|||
143028438|NCT02752776|515645579|FG000|Overall Study|Lack of Efficacy|2|||
143028439|NCT02752776|515645580|FG001|Overall Study|Lack of Efficacy|6|||
143028440|NCT02752776|515645581|FG002|Overall Study|Lack of Efficacy|14|||
143028441|NCT02752776|515645579|FG000|Overall Study|Lost to Follow-up|11|||
143028442|NCT02752776|515645580|FG001|Overall Study|Lost to Follow-up|12|||
143028443|NCT02752776|515645581|FG002|Overall Study|Lost to Follow-up|4|||
143028444|NCT02752776|515645579|FG000|Overall Study|Non-compliance with study treatment|0|||
143028445|NCT02752776|515645580|FG001|Overall Study|Non-compliance with study treatment|0|||
143028446|NCT02752776|515645581|FG002|Overall Study|Non-compliance with study treatment|1|||
143028447|NCT02752776|515645579|FG000|Overall Study|Physician Decision|2|||
143028448|NCT02752776|515645580|FG001|Overall Study|Physician Decision|6|||
143028449|NCT02752776|515645581|FG002|Overall Study|Physician Decision|2|||
143028450|NCT02752776|515645579|FG000|Overall Study|Pregnancy|1|||
143028451|NCT02752776|515645580|FG001|Overall Study|Pregnancy|6|||
143028452|NCT02752776|515645581|FG002|Overall Study|Pregnancy|3|||
143028453|NCT02752776|515645579|FG000|Overall Study|Protocol Violation|10|||
143028454|NCT02752776|515645580|FG001|Overall Study|Protocol Violation|13|||
143028455|NCT02752776|515645581|FG002|Overall Study|Protocol Violation|6|||
143028456|NCT02752776|515645579|FG000|Overall Study|Subject/guardian decision|8|||
143028457|NCT02752776|515645580|FG001|Overall Study|Subject/guardian decision|6|||
143028458|NCT02752776|515645581|FG002|Overall Study|Subject/guardian decision|4|||
143028459|NCT02752776|515645579|FG000|Overall Study|Death|0|||
143028460|NCT02752776|515645580|FG001|Overall Study|Death|0|||
143028461|NCT02752776|515645581|FG002|Overall Study|Death|1|||
143028462|NCT02752776|515645579|FG000|Overall Study|Withdrawal by Subject|3|||
143028463|NCT02752776|515645580|FG001|Overall Study|Withdrawal by Subject|4|||
143028464|NCT02752776|515645581|FG002|Overall Study|Withdrawal by Subject|2|||
143028465|NCT03522948|515645582|FG000|Overall Study|Lost to Follow-up|1|||
143028466|NCT00084084|515645583|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
143028467|NCT00084084|515645583|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
143028468|NCT01047345|515645588|FG000|Base Study|Adverse Event|3|||
143028469|NCT01047345|515645589|FG001|Base Study|Adverse Event|0|||
143028470|NCT01047345|515645590|FG002|Base Study|Adverse Event|0|||
143028471|NCT01047345|515645588|FG000|Base Study|Lost to Follow-up|4|||
143028472|NCT01047345|515645589|FG001|Base Study|Lost to Follow-up|1|||
143028473|NCT01047345|515645590|FG002|Base Study|Lost to Follow-up|0|||
143028474|NCT01047345|515645588|FG000|Base Study|Protocol Violation|3|||
143028475|NCT01047345|515645589|FG001|Base Study|Protocol Violation|1|||
143028476|NCT01047345|515645590|FG002|Base Study|Protocol Violation|0|||
143028477|NCT01047345|515645588|FG000|Base Study|Withdrawal by Subject|12|||
143028478|NCT01047345|515645589|FG001|Base Study|Withdrawal by Subject|4|||
143028479|NCT01047345|515645590|FG002|Base Study|Withdrawal by Subject|0|||
143028480|NCT01047345|515645588|FG000|Extension|Withdrawal by Subject|0|||
143028481|NCT01047345|515645589|FG001|Extension|Withdrawal by Subject|0|||
143028482|NCT01047345|515645590|FG002|Extension|Withdrawal by Subject|1|||
143028483|NCT01047345|515645588|FG000|Extension|Lost to Follow-up|0|||
143028484|NCT01047345|515645589|FG001|Extension|Lost to Follow-up|0|||
143028485|NCT01047345|515645590|FG002|Extension|Lost to Follow-up|5|||
143028486|NCT01816477|515645591|FG000|Overall Study|Withdrawal by Subject|13|||
143028487|NCT01816477|515645592|FG001|Overall Study|Withdrawal by Subject|1|||
143028488|NCT01816477|515645591|FG000|Overall Study|Unable to tolerate catheter placement|3|||
143028489|NCT01816477|515645592|FG001|Overall Study|Unable to tolerate catheter placement|0|||
143028490|NCT00108732|515645593|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
143028491|NCT00108732|515645593|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
143028492|NCT00108732|515645593|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
143028493|NCT00108732|515645593|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
143028494|NCT00108732|515645593|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
143028495|NCT00108732|515645593|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
143028496|NCT00108732|515645593|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
143028497|NCT02116803|515645595|FG000|Overall Study|Adverse Event|2|||
143028498|NCT02116803|515645596|FG001|Overall Study|Adverse Event|1|||
143028499|NCT02116803|515645595|FG000|Overall Study|Physician Decision|1|||
143028500|NCT02116803|515645596|FG001|Overall Study|Physician Decision|0|||
143028501|NCT02116803|515645595|FG000|Overall Study|Progressive disease|4|||
143028502|NCT02116803|515645596|FG001|Overall Study|Progressive disease|0|||
143028503|NCT02116803|515645595|FG000|Overall Study|Study terminated by sponsor|2|||
143028504|NCT02116803|515645596|FG001|Overall Study|Study terminated by sponsor|1|||
143028505|NCT02116803|515645595|FG000|Overall Study|Death|1|||
143028506|NCT02116803|515645596|FG001|Overall Study|Death|0|||
143028507|NCT01946165|515645597|FG000|Overall Study|Physician Decision|2|||
143028508|NCT01946165|515645598|FG001|Overall Study|Physician Decision|0|||
143028509|NCT01946165|515645597|FG000|Overall Study|Withdrawal by Subject|0|||
143028510|NCT01946165|515645598|FG001|Overall Study|Withdrawal by Subject|2|||
143028511|NCT01901055|515645599|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
143028512|NCT01901055|515645600|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
143158282|NCT04518410|516124400|FG013|Overall Study|Dual Enrolled Subject|0|||
143158283|NCT04518410|516124401|FG014|Overall Study|Dual Enrolled Subject|0|||
143158284|NCT04518410|516124402|FG015|Overall Study|Dual Enrolled Subject|0|||
143028513|NCT01901055|515645599|FG000|Randomization But Not Titrated|Physician Decision|0|||
143028514|NCT01901055|515645600|FG001|Randomization But Not Titrated|Physician Decision|1|||
143028515|NCT01901055|515645599|FG000|Started Protocol to Week 6|Physician Decision|2|||
143028516|NCT01901055|515645600|FG001|Started Protocol to Week 6|Physician Decision|1|||
143028517|NCT01901055|515645599|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
143028518|NCT01901055|515645600|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
143158285|NCT04518410|516124403|FG016|Overall Study|Dual Enrolled Subject|0|||
143028519|NCT01901055|515645599|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
143028520|NCT01901055|515645600|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
143028521|NCT01901055|515645599|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
143028522|NCT01901055|515645600|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
143028523|NCT01901055|515645599|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
143028524|NCT01901055|515645600|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
143028525|NCT01901055|515645599|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
143028526|NCT01901055|515645600|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
143028527|NCT01901055|515645599|FG000|Week 24|Withdrawal by Subject|13|||
143028528|NCT01901055|515645600|FG001|Week 24|Withdrawal by Subject|19|||
143028529|NCT01901055|515645599|FG000|Week 24|Physician Decision|1|||
143028530|NCT01901055|515645600|FG001|Week 24|Physician Decision|0|||
143028531|NCT01901055|515645599|FG000|Week 36|Withdrawal by Subject|0|||
143028532|NCT01901055|515645600|FG001|Week 36|Withdrawal by Subject|5|||
143028533|NCT01179919|515645601|FG000|Overall Study|Protocol Violation|1|||
143028534|NCT01179919|515645601|FG000|Overall Study|Adverse Event|1|||
143028535|NCT00698685|515645605|FG000|Overall Study|Sister withdrew as donor|1|||
143028536|NCT00698685|515645605|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
143028537|NCT01399736|515645612|FG000|Overall Study|Withdrawal by Subject|4|||
143028538|NCT01399736|515645613|FG001|Overall Study|Withdrawal by Subject|2|||
143028539|NCT01399736|515645612|FG000|Overall Study|Lost to Follow-up|0|||
143028540|NCT01399736|515645613|FG001|Overall Study|Lost to Follow-up|2|||
143028541|NCT00386009|515645617|FG000|Overall Study|Adverse Event|0|||
143028542|NCT00386009|515645618|FG001|Overall Study|Adverse Event|2|||
143028543|NCT00386009|515645617|FG000|Overall Study|Death|1|||
143028544|NCT00386009|515645618|FG001|Overall Study|Death|0|||
143028545|NCT00386009|515645617|FG000|Overall Study|Entry Criteria Not Met|0|||
143028546|NCT00386009|515645618|FG001|Overall Study|Entry Criteria Not Met|2|||
143028547|NCT00386009|515645617|FG000|Overall Study|Lost to Follow-up|1|||
143028548|NCT00386009|515645618|FG001|Overall Study|Lost to Follow-up|1|||
143028549|NCT00386009|515645617|FG000|Overall Study|Protocol Violation|1|||
143028550|NCT00386009|515645618|FG001|Overall Study|Protocol Violation|0|||
143028551|NCT00386009|515645617|FG000|Overall Study|Sponsor Decision|1|||
143028552|NCT00386009|515645618|FG001|Overall Study|Sponsor Decision|1|||
143028553|NCT00386009|515645617|FG000|Overall Study|Withdrawal by Subject|5|||
143028554|NCT00386009|515645618|FG001|Overall Study|Withdrawal by Subject|4|||
143028555|NCT04799158|515645623|FG000|Run-In Period|Adverse Event|6|||
143028556|NCT04799158|515645624|FG001|Run-In Period|Adverse Event|0|||
143028557|NCT04799158|515645625|FG002|Run-In Period|Adverse Event|0|||
143028558|NCT04799158|515645626|FG003|Run-In Period|Adverse Event|0|||
143028559|NCT04799158|515645627|FG004|Run-In Period|Adverse Event|0|||
143028560|NCT04799158|515645623|FG000|Run-In Period|Lost to Follow-up|4|||
143028561|NCT04799158|515645624|FG001|Run-In Period|Lost to Follow-up|0|||
143028562|NCT04799158|515645625|FG002|Run-In Period|Lost to Follow-up|0|||
143028563|NCT04799158|515645626|FG003|Run-In Period|Lost to Follow-up|0|||
143028564|NCT04799158|515645627|FG004|Run-In Period|Lost to Follow-up|0|||
143158286|NCT04518410|516124404|FG017|Overall Study|Dual Enrolled Subject|1|||
143158287|NCT04518410|516124405|FG018|Overall Study|Dual Enrolled Subject|0|||
143491928|NCT03403205|517342667|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
143491929|NCT03403205|517342668|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
143491930|NCT03403205|517342669|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
143491931|NCT03403205|517342670|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
143491932|NCT03403205|517342671|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
143491933|NCT03403205|517342672|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
143028565|NCT04799158|515645623|FG000|Run-In Period|Significant Protocol Deviation|1|||
143158288|NCT04518410|516124406|FG019|Overall Study|Dual Enrolled Subject|0|||
143158289|NCT04518410|516124407|FG020|Overall Study|Dual Enrolled Subject|0|||
143158290|NCT04518410|516124408|FG021|Overall Study|Dual Enrolled Subject|0|||
143158291|NCT04518410|516124409|FG022|Overall Study|Dual Enrolled Subject|0|||
143158292|NCT04518410|516124410|FG023|Overall Study|Dual Enrolled Subject|0|||
143158293|NCT04518410|516124411|FG024|Overall Study|Dual Enrolled Subject|0|||
143158294|NCT03462563|516124412|FG000|Overall Study|Death|1|||
143158295|NCT03462563|516124413|FG001|Overall Study|Death|1|||
143158296|NCT03462563|516124412|FG000|Overall Study|Termination of study|2|||
143158297|NCT03462563|516124413|FG001|Overall Study|Termination of study|1|||
143028566|NCT04799158|515645624|FG001|Run-In Period|Significant Protocol Deviation|0|||
143028567|NCT04799158|515645625|FG002|Run-In Period|Significant Protocol Deviation|0|||
143028568|NCT04799158|515645626|FG003|Run-In Period|Significant Protocol Deviation|0|||
143028569|NCT04799158|515645627|FG004|Run-In Period|Significant Protocol Deviation|0|||
143028570|NCT04799158|515645623|FG000|Run-In Period|Withdrawal by Subject|11|||
143158298|NCT03462563|516124412|FG000|Overall Study|Adverse Event|1|||
143028571|NCT04799158|515645624|FG001|Run-In Period|Withdrawal by Subject|0|||
143158299|NCT03462563|516124413|FG001|Overall Study|Adverse Event|3|||
143237391|NCT02492763|516423283|FG003|Overall Study|Lost to Follow-up|0|||
143363874|NCT00049517|516875452|FG002|Conditioning/Transplant|Other complicating disease|0|||
143028572|NCT04799158|515645625|FG002|Run-In Period|Withdrawal by Subject|0|||
143028573|NCT04799158|515645626|FG003|Run-In Period|Withdrawal by Subject|0|||
143028574|NCT04799158|515645627|FG004|Run-In Period|Withdrawal by Subject|0|||
143028575|NCT04799158|515645623|FG000|Run-In Period|Miscellaneous|3|||
143028576|NCT04799158|515645624|FG001|Run-In Period|Miscellaneous|0|||
143028577|NCT04799158|515645625|FG002|Run-In Period|Miscellaneous|0|||
143028578|NCT04799158|515645626|FG003|Run-In Period|Miscellaneous|0|||
143028579|NCT04799158|515645627|FG004|Run-In Period|Miscellaneous|0|||
143028580|NCT04799158|515645623|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
143028581|NCT04799158|515645624|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
143028582|NCT04799158|515645625|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
143028583|NCT04799158|515645626|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
143028584|NCT04799158|515645627|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
143028585|NCT04799158|515645623|FG000|On-Demand Treatment Period|Adverse Event|0|||
143028586|NCT04799158|515645624|FG001|On-Demand Treatment Period|Adverse Event|1|||
143028587|NCT04799158|515645625|FG002|On-Demand Treatment Period|Adverse Event|0|||
143028588|NCT04799158|515645626|FG003|On-Demand Treatment Period|Adverse Event|0|||
143028589|NCT04799158|515645627|FG004|On-Demand Treatment Period|Adverse Event|1|||
143028590|NCT04799158|515645623|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
143028591|NCT04799158|515645624|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
143028592|NCT04799158|515645625|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
143028593|NCT04799158|515645626|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
143028594|NCT04799158|515645627|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
143028595|NCT04799158|515645623|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
143028596|NCT04799158|515645624|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
143028597|NCT04799158|515645625|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
143028598|NCT04799158|515645626|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
143028599|NCT04799158|515645627|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
143028600|NCT04799158|515645623|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
143028601|NCT04799158|515645624|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
143028602|NCT04799158|515645625|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
143028603|NCT04799158|515645626|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
143028604|NCT04799158|515645627|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
143028605|NCT04799158|515645623|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
143028606|NCT04799158|515645624|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
143028607|NCT04799158|515645625|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
143028608|NCT04799158|515645626|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
143028609|NCT04799158|515645627|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
143028610|NCT04799158|515645623|FG000|On-Demand Treatment Period|Miscellaneous|0|||
143028611|NCT04799158|515645624|FG001|On-Demand Treatment Period|Miscellaneous|0|||
143028612|NCT04799158|515645625|FG002|On-Demand Treatment Period|Miscellaneous|0|||
143028613|NCT04799158|515645626|FG003|On-Demand Treatment Period|Miscellaneous|0|||
143028614|NCT04799158|515645627|FG004|On-Demand Treatment Period|Miscellaneous|1|||
143028615|NCT03387098|515645628|FG000|Overall Study|progressive disease|1|||
143028616|NCT03387098|515645628|FG000|Overall Study|Withdrawal by Subject|2|||
143028617|NCT03387098|515645628|FG000|Overall Study|study terminated by sponsor|1|||
143028618|NCT01485536|515645632|FG000|Overall Study|Withdrawal by Subject|3|||
143491934|NCT03403205|517342667|FG000|Extension Period (Up to 60 Months)|Death|1|||
143491935|NCT03403205|517342668|FG001|Extension Period (Up to 60 Months)|Death|0|||
143491936|NCT03403205|517342669|FG002|Extension Period (Up to 60 Months)|Death|0|||
143491937|NCT03403205|517342670|FG003|Extension Period (Up to 60 Months)|Death|0|||
143491938|NCT03403205|517342671|FG004|Extension Period (Up to 60 Months)|Death|0|||
143491939|NCT03403205|517342672|FG005|Extension Period (Up to 60 Months)|Death|0|||
143491940|NCT03403205|517342667|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
143491941|NCT03403205|517342668|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
143491942|NCT03403205|517342669|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
143491943|NCT03403205|517342670|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
143028619|NCT01485536|515645632|FG000|Overall Study|Adverse Event|1|||
143028620|NCT01734772|515645633|FG000|Overall Study|Adverse Event|1|||
143028621|NCT01734772|515645634|FG001|Overall Study|Adverse Event|2|||
143028622|NCT01734772|515645633|FG000|Overall Study|Withdrawal by Subject|0|||
143491944|NCT03403205|517342671|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
143491945|NCT03403205|517342672|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
143491946|NCT03403205|517342667|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
143028623|NCT01734772|515645634|FG001|Overall Study|Withdrawal by Subject|1|||
143028624|NCT02626949|515645635|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
143028625|NCT02626949|515645636|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
143028626|NCT02626949|515645635|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
143114878|NCT00962091|515962447|FG000|Overall Study|Withdrawal by Subject|1|||
143114879|NCT00962091|515962448|FG001|Overall Study|Withdrawal by Subject|2|||
143114880|NCT00962091|515962449|FG002|Overall Study|Withdrawal by Subject|1|||
143028627|NCT02626949|515645636|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
143028628|NCT02626949|515645635|FG000|Enrolled|Lost to Follow-up|7|||
143028629|NCT02626949|515645636|FG001|Enrolled|Lost to Follow-up|6|||
143028630|NCT02626949|515645635|FG000|Enrolled|Withdrawal by Subject|3|||
143028631|NCT02626949|515645636|FG001|Enrolled|Withdrawal by Subject|2|||
143028632|NCT00329602|515645638|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
143028633|NCT00329602|515645639|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
143028634|NCT00329602|515645640|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
143028635|NCT00329602|515645638|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
143028636|NCT00329602|515645639|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
143028637|NCT00329602|515645640|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
143028638|NCT00329602|515645638|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
143028639|NCT00329602|515645639|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
143028640|NCT00329602|515645640|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
143028641|NCT00329602|515645638|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
143028642|NCT00329602|515645639|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
143028643|NCT00329602|515645640|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
143028644|NCT00329602|515645638|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
143028645|NCT00329602|515645639|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
143028646|NCT00329602|515645640|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
143028647|NCT00329602|515645638|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
143028648|NCT00329602|515645639|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
143028649|NCT00329602|515645640|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
143028650|NCT03595657|515645641|FG000|Overall Study|Adverse Event|14|||
143028651|NCT03595657|515645641|FG000|Overall Study|Death|1|||
143028652|NCT03595657|515645641|FG000|Overall Study|Lack of Efficacy|40|||
143028653|NCT03595657|515645641|FG000|Overall Study|Withdrawal by Subject|10|||
143028654|NCT03595657|515645641|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
143028655|NCT03595657|515645641|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
143028656|NCT00663871|515645642|FG000|Overall Study|Lost to Follow-up|5|||
143028657|NCT00663871|515645643|FG001|Overall Study|Lost to Follow-up|5|||
143028658|NCT00663871|515645642|FG000|Overall Study|Withdrawal by Subject|5|||
143028659|NCT00663871|515645643|FG001|Overall Study|Withdrawal by Subject|2|||
143028660|NCT03131999|515645646|FG000|Overall Study|Withdrawal by Subject|0|||
143028661|NCT03131999|515645647|FG001|Overall Study|Withdrawal by Subject|1|||
143028662|NCT02683187|515645648|FG000|Overall Study|Failed IV access|3|||
143028663|NCT02683187|515645648|FG000|Overall Study|Withdrawal by Subject|5|||
143028664|NCT05328375|515647733|FG000|Overall Study|Withdrawal by Subject|0|||
143028665|NCT05328375|515647734|FG001|Overall Study|Withdrawal by Subject|1|||
143028666|NCT04736199|515647735|FG000|Overall Study|Adverse Event|28|||
143028667|NCT04736199|515647736|FG001|Overall Study|Adverse Event|22|||
143028668|NCT04736199|515647735|FG000|Overall Study|Death|9|||
143028669|NCT04736199|515647736|FG001|Overall Study|Death|3|||
143028670|NCT04736199|515647735|FG000|Overall Study|Lost to Follow-up|4|||
143028671|NCT04736199|515647736|FG001|Overall Study|Lost to Follow-up|1|||
143028672|NCT04736199|515647735|FG000|Overall Study|Physician Decision|5|||
143028673|NCT04736199|515647736|FG001|Overall Study|Physician Decision|9|||
143028674|NCT04736199|515647735|FG000|Overall Study|Withdrawal by Subject|21|||
143028675|NCT04736199|515647736|FG001|Overall Study|Withdrawal by Subject|9|||
143028676|NCT04736199|515647735|FG000|Overall Study|Progressive disease|120|||
143028677|NCT04736199|515647736|FG001|Overall Study|Progressive disease|101|||
143028678|NCT04736199|515647735|FG000|Overall Study|Subject decision|13|||
143028679|NCT04736199|515647736|FG001|Overall Study|Subject decision|13|||
143028680|NCT04736199|515647735|FG000|Overall Study|Required study drug interruption longer than allowed per protocol|2|||
143028681|NCT04736199|515647736|FG001|Overall Study|Required study drug interruption longer than allowed per protocol|0|||
143028682|NCT04736199|515647735|FG000|Overall Study|Additional primary malignancy|1|||
143028683|NCT04736199|515647736|FG001|Overall Study|Additional primary malignancy|0|||
143028684|NCT04736199|515647735|FG000|Overall Study|Non-compliance with study drug|0|||
143491947|NCT03403205|517342668|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
143491948|NCT03403205|517342669|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
143491949|NCT03403205|517342670|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
143491950|NCT03403205|517342671|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
143491951|NCT03403205|517342672|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
143491952|NCT03403205|517342667|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
143028685|NCT04736199|515647736|FG001|Overall Study|Non-compliance with study drug|1|||
143028686|NCT04736199|515647735|FG000|Overall Study|Other reason|0|||
143028687|NCT04736199|515647736|FG001|Overall Study|Other reason|1|||
143028688|NCT04736199|515647735|FG000|Overall Study|Ongoing with study drug|240|||
143028689|NCT04736199|515647736|FG001|Overall Study|Ongoing with study drug|63|||
143028690|NCT04736199|515647735|FG000|Overall Study|Study drug never administered|3|||
143491953|NCT03403205|517342668|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
143491954|NCT03403205|517342669|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
143028691|NCT04736199|515647736|FG001|Overall Study|Study drug never administered|0|||
143028692|NCT05514119|515647740|FG000|Overall Study|Ineligible due to disease progression|1|||
143028693|NCT05568225|515647741|FG000|Primary Treatment Period|Termination of the study by the Sponsor|0|||
143028694|NCT05568225|515647742|FG001|Primary Treatment Period|Termination of the study by the Sponsor|0|||
143028695|NCT05568225|515647743|FG002|Primary Treatment Period|Termination of the study by the Sponsor|1|||
143028696|NCT05568225|515647741|FG000|Primary Treatment Period|Physician Decision|0|||
143028697|NCT05568225|515647742|FG001|Primary Treatment Period|Physician Decision|1|||
143028698|NCT05568225|515647743|FG002|Primary Treatment Period|Physician Decision|0|||
143028699|NCT05568225|515647741|FG000|Primary Treatment Period|Disease progression|0|||
143028700|NCT05568225|515647742|FG001|Primary Treatment Period|Disease progression|1|||
143028701|NCT05568225|515647743|FG002|Primary Treatment Period|Disease progression|0|||
143028702|NCT05568225|515647741|FG000|Primary Treatment Period|Lack of Efficacy|0|||
143028703|NCT05568225|515647742|FG001|Primary Treatment Period|Lack of Efficacy|1|||
143028704|NCT05568225|515647743|FG002|Primary Treatment Period|Lack of Efficacy|0|||
143028705|NCT05568225|515647741|FG000|Primary Treatment Period|Withdrawal of conset|1|||
143028706|NCT05568225|515647742|FG001|Primary Treatment Period|Withdrawal of conset|0|||
143028707|NCT05568225|515647743|FG002|Primary Treatment Period|Withdrawal of conset|4|||
143028708|NCT05568225|515647741|FG000|Primary Treatment Period|Adverse Event|1|||
143028709|NCT05568225|515647742|FG001|Primary Treatment Period|Adverse Event|0|||
143028710|NCT05568225|515647743|FG002|Primary Treatment Period|Adverse Event|0|||
143028711|NCT05568225|515647741|FG000|Extension Treatment Period|Termination of the study by the Sponsor|0|||
143028712|NCT05568225|515647742|FG001|Extension Treatment Period|Termination of the study by the Sponsor|0|||
143028713|NCT05568225|515647743|FG002|Extension Treatment Period|Termination of the study by the Sponsor|1|||
143028714|NCT05568225|515647741|FG000|Extension Treatment Period|Protocol Violation|0|||
143028715|NCT05568225|515647742|FG001|Extension Treatment Period|Protocol Violation|0|||
143028716|NCT05568225|515647743|FG002|Extension Treatment Period|Protocol Violation|1|||
143028717|NCT05568225|515647741|FG000|Extension Treatment Period|Lack of Efficacy|0|||
143028718|NCT05568225|515647742|FG001|Extension Treatment Period|Lack of Efficacy|0|||
143028719|NCT05568225|515647743|FG002|Extension Treatment Period|Lack of Efficacy|1|||
143028720|NCT02228382|515647744|FG000|Overall Study|Death|5|||
143028721|NCT02228382|515647745|FG001|Overall Study|Death|7|||
143028722|NCT02228382|515647746|FG002|Overall Study|Death|5|||
143028723|NCT02228382|515647747|FG003|Overall Study|Death|0|||
143028724|NCT02228382|515647748|FG004|Overall Study|Death|2|||
143028725|NCT02228382|515647744|FG000|Overall Study|Participant refused further follow-up|0|||
143028726|NCT02228382|515647745|FG001|Overall Study|Participant refused further follow-up|0|||
143028727|NCT02228382|515647746|FG002|Overall Study|Participant refused further follow-up|1|||
143028728|NCT02228382|515647747|FG003|Overall Study|Participant refused further follow-up|0|||
143028729|NCT02228382|515647748|FG004|Overall Study|Participant refused further follow-up|0|||
143028730|NCT02228382|515647744|FG000|Overall Study|Study terminated by sponsor|3|||
143028731|NCT02228382|515647745|FG001|Overall Study|Study terminated by sponsor|5|||
143028732|NCT02228382|515647746|FG002|Overall Study|Study terminated by sponsor|7|||
143028733|NCT02228382|515647747|FG003|Overall Study|Study terminated by sponsor|0|||
143028734|NCT02228382|515647748|FG004|Overall Study|Study terminated by sponsor|0|||
143028735|NCT02228382|515647744|FG000|Overall Study|Lost to Follow-up|0|||
143028736|NCT02228382|515647745|FG001|Overall Study|Lost to Follow-up|0|||
143028737|NCT02228382|515647746|FG002|Overall Study|Lost to Follow-up|3|||
143028738|NCT02228382|515647747|FG003|Overall Study|Lost to Follow-up|1|||
143028739|NCT02228382|515647748|FG004|Overall Study|Lost to Follow-up|0|||
143028740|NCT02228382|515647744|FG000|Overall Study|Withdrawal by Subject|0|||
143028741|NCT02228382|515647745|FG001|Overall Study|Withdrawal by Subject|3|||
143028742|NCT02228382|515647746|FG002|Overall Study|Withdrawal by Subject|2|||
143028743|NCT02228382|515647747|FG003|Overall Study|Withdrawal by Subject|1|||
143028744|NCT02228382|515647748|FG004|Overall Study|Withdrawal by Subject|0|||
143028745|NCT02228382|515647744|FG000|Overall Study|Other|2|||
143028746|NCT02228382|515647745|FG001|Overall Study|Other|3|||
143028747|NCT02228382|515647746|FG002|Overall Study|Other|3|||
143028748|NCT02228382|515647747|FG003|Overall Study|Other|0|||
143028749|NCT02228382|515647748|FG004|Overall Study|Other|0|||
143028750|NCT02324465|515647749|FG000|Overall Study|device failure|0|||
143028751|NCT02324465|515647750|FG001|Overall Study|device failure|1|||
143028752|NCT01618266|515647764|FG000|Overall Study|Lost to Follow-up|9|||
143028753|NCT01618266|515647764|FG000|Overall Study|Treatment satisfaction|10|||
143028754|NCT01618266|515647764|FG000|Overall Study|Other reasons|11|||
143028755|NCT01618266|515647764|FG000|Overall Study|Lack of Efficacy|23|||
143028756|NCT01618266|515647764|FG000|Overall Study|Protocol Violation|43|||
143028757|NCT00625807|515647765|FG000|Overall Study|schedule conflict|2|||
143028758|NCT00625807|515647766|FG001|Overall Study|schedule conflict|8|||
143028759|NCT02224391|515647767|FG000|Overall Study|Lost to Follow-up|26|||
143028760|NCT02224391|515647768|FG001|Overall Study|Lost to Follow-up|19|||
143028761|NCT02224391|515647767|FG000|Overall Study|Withdrawal by Subject|6|||
143028762|NCT02224391|515647768|FG001|Overall Study|Withdrawal by Subject|5|||
143028763|NCT01802879|515647769|FG000|Overall Study|Administrative problems|2|||
143028764|NCT01802879|515647769|FG000|Overall Study|Disease progression|6|||
143028765|NCT00266409|515647770|FG000|Overall Study|Lack of Efficacy|2|||
143028766|NCT00266409|515647771|FG001|Overall Study|Lack of Efficacy|6|||
143028767|NCT00266409|515647772|FG002|Overall Study|Lack of Efficacy|1|||
143028768|NCT00266409|515647773|FG003|Overall Study|Lack of Efficacy|2|||
143028769|NCT00266409|515647770|FG000|Overall Study|Adverse Event|7|||
143028770|NCT00266409|515647771|FG001|Overall Study|Adverse Event|2|||
143028771|NCT00266409|515647772|FG002|Overall Study|Adverse Event|1|||
143028772|NCT00266409|515647773|FG003|Overall Study|Adverse Event|1|||
143028773|NCT00266409|515647770|FG000|Overall Study|Lost to Follow-up|18|||
143028774|NCT00266409|515647771|FG001|Overall Study|Lost to Follow-up|21|||
143028775|NCT00266409|515647772|FG002|Overall Study|Lost to Follow-up|6|||
143028776|NCT00266409|515647773|FG003|Overall Study|Lost to Follow-up|8|||
143028777|NCT00266409|515647770|FG000|Overall Study|Withdrawal by Subject|6|||
143237392|NCT02492763|516423280|FG000|Overall Study|Non-Compliance With Study Drug|0|||
143237393|NCT02492763|516423281|FG001|Overall Study|Non-Compliance With Study Drug|1|||
143237394|NCT02492763|516423282|FG002|Overall Study|Non-Compliance With Study Drug|0|||
143237395|NCT02492763|516423283|FG003|Overall Study|Non-Compliance With Study Drug|0|||
143237396|NCT02492763|516423280|FG000|Overall Study|Screen Failure|0|||
143237397|NCT02492763|516423281|FG001|Overall Study|Screen Failure|0|||
143237398|NCT02492763|516423282|FG002|Overall Study|Screen Failure|0|||
143237399|NCT02492763|516423283|FG003|Overall Study|Screen Failure|1|||
143237400|NCT02492763|516423280|FG000|Overall Study|Study Terminated by Sponsor|13|||
143237401|NCT02492763|516423281|FG001|Overall Study|Study Terminated by Sponsor|10|||
143237402|NCT02492763|516423282|FG002|Overall Study|Study Terminated by Sponsor|6|||
143237403|NCT02492763|516423283|FG003|Overall Study|Study Terminated by Sponsor|10|||
143237404|NCT03877510|516423284|FG000|Overall Study|Death|6|||
143237405|NCT03877510|516423284|FG000|Overall Study|Lost to Follow-up|2|||
143237406|NCT03877510|516423284|FG000|Overall Study|Non-compliance with study drug|2|||
143237407|NCT03877510|516423284|FG000|Overall Study|Lack of Efficacy|14|||
143237408|NCT03877510|516423284|FG000|Overall Study|Adverse Event|20|||
143237409|NCT03877510|516423284|FG000|Overall Study|Withdrawal by Subject|22|||
143491955|NCT03403205|517342670|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
143491956|NCT03403205|517342671|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
143491957|NCT03403205|517342672|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
143491958|NCT03403205|517342667|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
143491959|NCT03403205|517342668|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
143491960|NCT03403205|517342669|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
143491961|NCT03403205|517342670|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
143491962|NCT03403205|517342671|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
143491963|NCT03403205|517342672|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
143491964|NCT03403205|517342667|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
143491965|NCT03403205|517342668|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
143491966|NCT03403205|517342669|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
143491967|NCT03403205|517342670|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
143491968|NCT03403205|517342671|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
143491969|NCT03403205|517342672|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
143491970|NCT03403205|517342667|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
143491971|NCT03403205|517342668|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
143491972|NCT03403205|517342669|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
143491973|NCT03403205|517342670|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
143491974|NCT03403205|517342671|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
143491975|NCT03403205|517342672|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
143491976|NCT00706030|517342673|FG000|Overall Study|Disease Progression|4|||
143491977|NCT00706030|517342674|FG001|Overall Study|Disease Progression|6|||
143491978|NCT00706030|517342675|FG002|Overall Study|Disease Progression|46|||
143491979|NCT00706030|517342676|FG003|Overall Study|Disease Progression|12|||
143491980|NCT00706030|517342673|FG000|Overall Study|Adverse Event|1|||
143491981|NCT00706030|517342674|FG001|Overall Study|Adverse Event|0|||
143491982|NCT00706030|517342675|FG002|Overall Study|Adverse Event|4|||
143491983|NCT00706030|517342676|FG003|Overall Study|Adverse Event|2|||
143491984|NCT00706030|517342673|FG000|Overall Study|Withdrawal by Subject|1|||
143491985|NCT00706030|517342674|FG001|Overall Study|Withdrawal by Subject|0|||
143491986|NCT00706030|517342675|FG002|Overall Study|Withdrawal by Subject|2|||
143491987|NCT00706030|517342676|FG003|Overall Study|Withdrawal by Subject|0|||
143237410|NCT03877510|516423284|FG000|Overall Study|Miscellaneous|1|||
143491988|NCT00706030|517342673|FG000|Overall Study|Physician Decision|0|||
143237411|NCT01337960|516423285|FG000|Overall Study|Lost to Follow-up|1|||
143237412|NCT01337960|516423286|FG001|Overall Study|Lost to Follow-up|0|||
143028778|NCT00266409|515647771|FG001|Overall Study|Withdrawal by Subject|10|||
143028779|NCT00266409|515647772|FG002|Overall Study|Withdrawal by Subject|3|||
143028780|NCT00266409|515647773|FG003|Overall Study|Withdrawal by Subject|9|||
143028781|NCT00266409|515647770|FG000|Overall Study|Protocol Violation|5|||
143028782|NCT00266409|515647771|FG001|Overall Study|Protocol Violation|3|||
143028783|NCT00266409|515647772|FG002|Overall Study|Protocol Violation|4|||
143028784|NCT00266409|515647773|FG003|Overall Study|Protocol Violation|2|||
143028785|NCT00266409|515647770|FG000|Overall Study|Other|7|||
143028786|NCT00266409|515647771|FG001|Overall Study|Other|4|||
143028787|NCT00266409|515647772|FG002|Overall Study|Other|2|||
143028788|NCT00266409|515647773|FG003|Overall Study|Other|0|||
143028789|NCT00712010|515647776|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
143028790|NCT02187042|515647777|FG000|Overall Study|Death|1|||
143028791|NCT02187042|515647778|FG001|Overall Study|Death|1|||
143028792|NCT02187042|515647777|FG000|Overall Study|Toxicity|6|||
143028793|NCT02187042|515647778|FG001|Overall Study|Toxicity|5|||
143028794|NCT02187042|515647777|FG000|Overall Study|Participant choice|1|||
143028795|NCT02187042|515647778|FG001|Overall Study|Participant choice|0|||
143028796|NCT02187042|515647777|FG000|Overall Study|Doctor choice|1|||
143028797|NCT02187042|515647778|FG001|Overall Study|Doctor choice|0|||
143028798|NCT02187042|515647777|FG000|Overall Study|Progressive disease|4|||
143028799|NCT02187042|515647778|FG001|Overall Study|Progressive disease|8|||
143028800|NCT00282256|515647781|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
143028801|NCT00282256|515647781|FG000|Extension Treatment Period|Adverse Event|2|||
143028802|NCT00948675|515647782|FG000|Overall Study|Lost to Follow-up|1|||
143028803|NCT00948675|515647783|FG001|Overall Study|Lost to Follow-up|0|||
143028804|NCT01984242|515647784|FG000|Overall Study|Death|52|||
143028805|NCT01984242|515647785|FG001|Overall Study|Death|50|||
143028806|NCT01984242|515647786|FG002|Overall Study|Death|52|||
143028807|NCT01984242|515647784|FG000|Overall Study|Withdrawal by Subject|5|||
143028808|NCT01984242|515647785|FG001|Overall Study|Withdrawal by Subject|3|||
143028809|NCT01984242|515647786|FG002|Overall Study|Withdrawal by Subject|10|||
143028810|NCT01984242|515647784|FG000|Overall Study|Physician Decision|0|||
143028811|NCT01984242|515647785|FG001|Overall Study|Physician Decision|0|||
143028812|NCT01984242|515647786|FG002|Overall Study|Physician Decision|1|||
143158300|NCT03462563|516124412|FG000|Overall Study|Unspecified reason|10|||
143158301|NCT03462563|516124413|FG001|Overall Study|Unspecified reason|12|||
143158302|NCT03462563|516124412|FG000|Overall Study|Physician Decision|1|||
143158303|NCT03462563|516124413|FG001|Overall Study|Physician Decision|0|||
143158304|NCT04796207|516124414|FG000|Overall Study|Lost to Follow-up|7|||
143158305|NCT04796207|516124415|FG001|Overall Study|Lost to Follow-up|2|||
143158306|NCT03003468|516124416|FG000|Overall Study|Withdrawal by Subject|0|||
143158307|NCT03003468|516124417|FG001|Overall Study|Withdrawal by Subject|0|||
143158308|NCT03003468|516124418|FG002|Overall Study|Withdrawal by Subject|1|||
143158309|NCT03003468|516124416|FG000|Overall Study|No measurable lesions|0|||
143158310|NCT03003468|516124417|FG001|Overall Study|No measurable lesions|0|||
143158311|NCT03003468|516124418|FG002|Overall Study|No measurable lesions|1|||
143158312|NCT01107457|516124421|FG000|Part A|Adverse Event|1|||
143158313|NCT01107457|516124422|FG001|Part A|Adverse Event|2|||
143158314|NCT01107457|516124423|FG002|Part A|Adverse Event|1|||
143158315|NCT01107457|516124424|FG003|Part A|Adverse Event|0|||
143158316|NCT01107457|516124425|FG004|Part A|Adverse Event|0|||
143158317|NCT01107457|516124426|FG005|Part A|Adverse Event|0|||
143158318|NCT01107457|516124421|FG000|Part A|Withdrawal by Subject|3|||
143158319|NCT01107457|516124422|FG001|Part A|Withdrawal by Subject|3|||
143158320|NCT01107457|516124423|FG002|Part A|Withdrawal by Subject|0|||
143158321|NCT01107457|516124424|FG003|Part A|Withdrawal by Subject|3|||
143158322|NCT01107457|516124425|FG004|Part A|Withdrawal by Subject|1|||
143158323|NCT01107457|516124426|FG005|Part A|Withdrawal by Subject|0|||
143158324|NCT01107457|516124421|FG000|Part A|Lost to Follow-up|0|||
143158325|NCT01107457|516124422|FG001|Part A|Lost to Follow-up|1|||
143158326|NCT01107457|516124423|FG002|Part A|Lost to Follow-up|0|||
143158327|NCT01107457|516124424|FG003|Part A|Lost to Follow-up|0|||
143158328|NCT01107457|516124425|FG004|Part A|Lost to Follow-up|0|||
143158329|NCT01107457|516124426|FG005|Part A|Lost to Follow-up|0|||
143158330|NCT01107457|516124421|FG000|Part A|Lack of Efficacy|1|||
143158331|NCT01107457|516124422|FG001|Part A|Lack of Efficacy|0|||
143158332|NCT01107457|516124423|FG002|Part A|Lack of Efficacy|0|||
143158333|NCT01107457|516124424|FG003|Part A|Lack of Efficacy|0|||
143158334|NCT01107457|516124425|FG004|Part A|Lack of Efficacy|0|||
143158335|NCT01107457|516124426|FG005|Part A|Lack of Efficacy|0|||
143158336|NCT01107457|516124421|FG000|Part A|Protocol Violation|0|||
143158337|NCT01107457|516124422|FG001|Part A|Protocol Violation|1|||
143158338|NCT01107457|516124423|FG002|Part A|Protocol Violation|0|||
143158339|NCT01107457|516124424|FG003|Part A|Protocol Violation|0|||
143158340|NCT01107457|516124425|FG004|Part A|Protocol Violation|0|||
143158341|NCT01107457|516124426|FG005|Part A|Protocol Violation|0|||
143028813|NCT01984242|515647784|FG000|Overall Study|Lost to Follow-up|4|||
143028814|NCT01984242|515647785|FG001|Overall Study|Lost to Follow-up|0|||
143028815|NCT01984242|515647786|FG002|Overall Study|Lost to Follow-up|3|||
143028816|NCT01984242|515647784|FG000|Overall Study|Sponsor Decision|1|||
143028817|NCT01984242|515647785|FG001|Overall Study|Sponsor Decision|0|||
143028818|NCT01984242|515647786|FG002|Overall Study|Sponsor Decision|0|||
143028819|NCT01984242|515647784|FG000|Overall Study|Non-Compliance|1|||
143028820|NCT01984242|515647785|FG001|Overall Study|Non-Compliance|0|||
143028821|NCT01984242|515647786|FG002|Overall Study|Non-Compliance|0|||
143158342|NCT01107457|516124421|FG000|Part B and C|Adverse Event|0|||
143158343|NCT01107457|516124422|FG001|Part B and C|Adverse Event|0|||
143158344|NCT01107457|516124423|FG002|Part B and C|Adverse Event|0|||
143028822|NCT01984242|515647784|FG000|Overall Study|Study terminated by Sponsor|38|||
143028823|NCT01984242|515647785|FG001|Overall Study|Study terminated by Sponsor|50|||
143028824|NCT01984242|515647786|FG002|Overall Study|Study terminated by Sponsor|34|||
143028825|NCT01984242|515647784|FG000|Overall Study|Disease Progression|0|||
143028826|NCT01984242|515647785|FG001|Overall Study|Disease Progression|0|||
143028827|NCT01984242|515647786|FG002|Overall Study|Disease Progression|1|||
143028828|NCT00770510|515647788|FG000|Overall Study|Lost to Follow-up|2|||
143028829|NCT00770510|515647788|FG000|Overall Study|Pregnancy|1|||
143028830|NCT00770510|515647788|FG000|Overall Study|Withdrawal by Subject|2|||
143028831|NCT04094870|515647789|FG000|Overall Study|Lost to Follow-up|1|||
143028832|NCT04094870|515647790|FG001|Overall Study|Lost to Follow-up|1|||
143028833|NCT03384745|515647793|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
143028834|NCT03384745|515647794|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
143028835|NCT03384745|515647795|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
143028836|NCT03384745|515647796|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
143028837|NCT03384745|515647797|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
143028838|NCT03384745|515647798|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
143028839|NCT03384745|515647793|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
143028840|NCT03384745|515647794|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
143028841|NCT03384745|515647795|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
143028842|NCT03384745|515647796|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
143028843|NCT03384745|515647797|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
143028844|NCT03384745|515647798|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
143028845|NCT03384745|515647793|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
143028846|NCT03384745|515647794|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
143028847|NCT03384745|515647795|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
143028848|NCT03384745|515647796|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
143028849|NCT03384745|515647797|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
143028850|NCT03384745|515647798|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
143028851|NCT03384745|515647793|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
143028852|NCT03384745|515647794|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
143028853|NCT03384745|515647795|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
143028854|NCT03384745|515647796|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
143028855|NCT03384745|515647797|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
143028856|NCT03384745|515647798|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
143028857|NCT03384745|515647793|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
143028858|NCT03384745|515647794|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
143028859|NCT03384745|515647795|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
143028860|NCT03384745|515647796|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
143028861|NCT03384745|515647797|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
143028862|NCT03384745|515647798|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
143028863|NCT03384745|515647793|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
143028864|NCT03384745|515647794|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
143028865|NCT03384745|515647795|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
143028866|NCT03384745|515647796|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
143028867|NCT03384745|515647797|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
143028868|NCT03384745|515647798|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
143028869|NCT03384745|515647793|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
143028870|NCT03384745|515647794|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
143028871|NCT03384745|515647795|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
143028872|NCT03384745|515647796|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
143028873|NCT03384745|515647797|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
143028874|NCT03384745|515647798|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
143028875|NCT03384745|515647793|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
143028876|NCT03384745|515647794|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
143028877|NCT03384745|515647795|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
143028878|NCT03384745|515647796|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
143028879|NCT03384745|515647797|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
143028880|NCT03384745|515647798|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
143028881|NCT03384745|515647793|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
143028882|NCT03384745|515647794|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
143028883|NCT03384745|515647795|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
143028884|NCT03384745|515647796|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
143028885|NCT03384745|515647797|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
143028886|NCT03384745|515647798|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
143028887|NCT03384745|515647793|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
143028888|NCT03384745|515647794|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
143028889|NCT03384745|515647795|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
143028890|NCT03384745|515647796|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
143028891|NCT03384745|515647797|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
143028892|NCT03384745|515647798|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
143028893|NCT03384745|515647793|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
143028894|NCT03384745|515647794|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
143028895|NCT03384745|515647795|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
143028896|NCT03384745|515647796|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
143028897|NCT03384745|515647797|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
143028898|NCT03384745|515647798|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
143028899|NCT01592370|515647799|FG000|Overall Study|Disease Progression|62|||
143028900|NCT01592370|515647800|FG001|Overall Study|Disease Progression|16|||
143028901|NCT01592370|515647801|FG002|Overall Study|Disease Progression|52|||
143028902|NCT01592370|515647802|FG003|Overall Study|Disease Progression|3|||
143028903|NCT01592370|515647803|FG004|Overall Study|Disease Progression|3|||
143028904|NCT01592370|515647804|FG005|Overall Study|Disease Progression|31|||
143028905|NCT01592370|515647805|FG006|Overall Study|Disease Progression|14|||
143028906|NCT01592370|515647799|FG000|Overall Study|Study Drug Toxicity|14|||
143028907|NCT01592370|515647800|FG001|Overall Study|Study Drug Toxicity|3|||
143028908|NCT01592370|515647801|FG002|Overall Study|Study Drug Toxicity|0|||
143028909|NCT01592370|515647802|FG003|Overall Study|Study Drug Toxicity|0|||
143028910|NCT01592370|515647803|FG004|Overall Study|Study Drug Toxicity|0|||
143028911|NCT01592370|515647804|FG005|Overall Study|Study Drug Toxicity|0|||
143028912|NCT01592370|515647805|FG006|Overall Study|Study Drug Toxicity|1|||
143028913|NCT01592370|515647799|FG000|Overall Study|AE unrelated to study drug|4|||
143028914|NCT01592370|515647800|FG001|Overall Study|AE unrelated to study drug|3|||
143028915|NCT01592370|515647801|FG002|Overall Study|AE unrelated to study drug|0|||
143028916|NCT01592370|515647802|FG003|Overall Study|AE unrelated to study drug|0|||
143028917|NCT01592370|515647803|FG004|Overall Study|AE unrelated to study drug|0|||
143028918|NCT01592370|515647804|FG005|Overall Study|AE unrelated to study drug|0|||
143028919|NCT01592370|515647805|FG006|Overall Study|AE unrelated to study drug|1|||
143028920|NCT01592370|515647799|FG000|Overall Study|Request to discontinue study treatment|5|||
143028921|NCT01592370|515647800|FG001|Overall Study|Request to discontinue study treatment|0|||
143028922|NCT01592370|515647801|FG002|Overall Study|Request to discontinue study treatment|2|||
143028923|NCT01592370|515647802|FG003|Overall Study|Request to discontinue study treatment|0|||
143028924|NCT01592370|515647803|FG004|Overall Study|Request to discontinue study treatment|1|||
143028925|NCT01592370|515647804|FG005|Overall Study|Request to discontinue study treatment|2|||
143028926|NCT01592370|515647805|FG006|Overall Study|Request to discontinue study treatment|0|||
143028927|NCT01592370|515647799|FG000|Overall Study|Withdrew consent|1|||
143028928|NCT01592370|515647800|FG001|Overall Study|Withdrew consent|2|||
143028929|NCT01592370|515647801|FG002|Overall Study|Withdrew consent|1|||
143028930|NCT01592370|515647802|FG003|Overall Study|Withdrew consent|1|||
143028931|NCT01592370|515647803|FG004|Overall Study|Withdrew consent|0|||
143028932|NCT01592370|515647804|FG005|Overall Study|Withdrew consent|0|||
143028933|NCT01592370|515647805|FG006|Overall Study|Withdrew consent|0|||
143028934|NCT01592370|515647799|FG000|Overall Study|Maximum clinical benefit|11|||
143028935|NCT01592370|515647800|FG001|Overall Study|Maximum clinical benefit|1|||
143028936|NCT01592370|515647801|FG002|Overall Study|Maximum clinical benefit|7|||
143028937|NCT01592370|515647802|FG003|Overall Study|Maximum clinical benefit|1|||
143028938|NCT01592370|515647803|FG004|Overall Study|Maximum clinical benefit|0|||
143028939|NCT01592370|515647804|FG005|Overall Study|Maximum clinical benefit|0|||
143028940|NCT01592370|515647805|FG006|Overall Study|Maximum clinical benefit|0|||
143028941|NCT01592370|515647799|FG000|Overall Study|No longer meets study criteria|1|||
143028942|NCT01592370|515647800|FG001|Overall Study|No longer meets study criteria|0|||
143028943|NCT01592370|515647801|FG002|Overall Study|No longer meets study criteria|0|||
143158345|NCT01107457|516124424|FG003|Part B and C|Adverse Event|0|||
143158346|NCT01107457|516124425|FG004|Part B and C|Adverse Event|0|||
143158347|NCT01107457|516124426|FG005|Part B and C|Adverse Event|12|||
143158348|NCT01107457|516124421|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
143491989|NCT00706030|517342674|FG001|Overall Study|Physician Decision|0|||
143028944|NCT01592370|515647802|FG003|Overall Study|No longer meets study criteria|0|||
143028945|NCT01592370|515647803|FG004|Overall Study|No longer meets study criteria|0|||
143028946|NCT01592370|515647804|FG005|Overall Study|No longer meets study criteria|0|||
143028947|NCT01592370|515647805|FG006|Overall Study|No longer meets study criteria|0|||
143028948|NCT01592370|515647799|FG000|Overall Study|Other Reasons|6|||
143028949|NCT01592370|515647800|FG001|Overall Study|Other Reasons|0|||
143158349|NCT01107457|516124422|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
143491990|NCT00706030|517342675|FG002|Overall Study|Physician Decision|2|||
143028950|NCT01592370|515647801|FG002|Overall Study|Other Reasons|10|||
143028951|NCT01592370|515647802|FG003|Overall Study|Other Reasons|0|||
143028952|NCT01592370|515647803|FG004|Overall Study|Other Reasons|0|||
143028953|NCT01592370|515647804|FG005|Overall Study|Other Reasons|1|||
143028954|NCT01592370|515647805|FG006|Overall Study|Other Reasons|0|||
143028955|NCT01592370|515647799|FG000|Overall Study|Not Treated|0|||
143028956|NCT01592370|515647800|FG001|Overall Study|Not Treated|0|||
143158350|NCT01107457|516124423|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
143158351|NCT01107457|516124424|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
143028957|NCT01592370|515647801|FG002|Overall Study|Not Treated|0|||
143028958|NCT01592370|515647802|FG003|Overall Study|Not Treated|0|||
143028959|NCT01592370|515647803|FG004|Overall Study|Not Treated|2|||
143028960|NCT01592370|515647804|FG005|Overall Study|Not Treated|2|||
143028961|NCT01592370|515647805|FG006|Overall Study|Not Treated|0|||
143028962|NCT02742181|515647806|FG000|Overall Study|Physician Decision|1|||
143028963|NCT02742181|515647807|FG001|Overall Study|Physician Decision|0|||
143028964|NCT00319449|515647810|FG000|Overall Study|Subject did not wish to continue|1|||
143028965|NCT00319449|515647811|FG001|Overall Study|Subject did not wish to continue|0|||
143028966|NCT00319449|515647810|FG000|Overall Study|Noncompliance with the protocol|1|||
143028967|NCT00319449|515647811|FG001|Overall Study|Noncompliance with the protocol|0|||
143028968|NCT00455533|515647812|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
143028969|NCT00455533|515647813|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
143028970|NCT00455533|515647814|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
143028971|NCT00455533|515647812|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
143028972|NCT00455533|515647813|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
143028973|NCT00455533|515647814|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
143028974|NCT00455533|515647812|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
143028975|NCT00455533|515647813|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
143028976|NCT00455533|515647814|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
143028977|NCT00455533|515647812|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
143028978|NCT00455533|515647813|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
143028979|NCT00455533|515647814|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
143028980|NCT00455533|515647812|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
143028981|NCT00455533|515647813|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
143028982|NCT00455533|515647814|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
143028983|NCT00455533|515647812|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
143028984|NCT00455533|515647813|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
143028985|NCT00455533|515647814|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
143028986|NCT00455533|515647812|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
143028987|NCT00455533|515647813|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
143028988|NCT00455533|515647814|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
143028989|NCT00455533|515647812|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
143028990|NCT00455533|515647813|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
143028991|NCT00455533|515647814|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
143028992|NCT00455533|515647812|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
143028993|NCT00455533|515647813|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
143158352|NCT01107457|516124425|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
143158353|NCT01107457|516124426|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
143158354|NCT01107457|516124421|FG000|Part B and C|Physician Decision|0|||
143491991|NCT00706030|517342676|FG003|Overall Study|Physician Decision|0|||
143158355|NCT01107457|516124422|FG001|Part B and C|Physician Decision|0|||
143158356|NCT01107457|516124423|FG002|Part B and C|Physician Decision|0|||
143158357|NCT01107457|516124424|FG003|Part B and C|Physician Decision|0|||
143158358|NCT01107457|516124425|FG004|Part B and C|Physician Decision|0|||
143158359|NCT01107457|516124426|FG005|Part B and C|Physician Decision|3|||
143158360|NCT01107457|516124421|FG000|Part B and C|Lack of Efficacy|0|||
143158361|NCT01107457|516124422|FG001|Part B and C|Lack of Efficacy|0|||
143158362|NCT01107457|516124423|FG002|Part B and C|Lack of Efficacy|0|||
143158363|NCT01107457|516124424|FG003|Part B and C|Lack of Efficacy|0|||
143158364|NCT01107457|516124425|FG004|Part B and C|Lack of Efficacy|0|||
143158365|NCT01107457|516124426|FG005|Part B and C|Lack of Efficacy|7|||
143158366|NCT01107457|516124421|FG000|Part B and C|Lost to Follow-up|0|||
143158367|NCT01107457|516124422|FG001|Part B and C|Lost to Follow-up|0|||
143158368|NCT01107457|516124423|FG002|Part B and C|Lost to Follow-up|0|||
143158369|NCT01107457|516124424|FG003|Part B and C|Lost to Follow-up|0|||
143158370|NCT01107457|516124425|FG004|Part B and C|Lost to Follow-up|0|||
143158371|NCT01107457|516124426|FG005|Part B and C|Lost to Follow-up|10|||
143158372|NCT01107457|516124421|FG000|Part B and C|Protocol Violation|0|||
143491992|NCT00706030|517342673|FG000|Overall Study|Not recorded|0|||
143491993|NCT00706030|517342674|FG001|Overall Study|Not recorded|0|||
143491994|NCT00706030|517342675|FG002|Overall Study|Not recorded|2|||
143491995|NCT00706030|517342676|FG003|Overall Study|Not recorded|0|||
143491996|NCT00706030|517342673|FG000|Overall Study|Protocol Violation|0|||
143491997|NCT00706030|517342674|FG001|Overall Study|Protocol Violation|0|||
143028994|NCT00455533|515647814|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
143158373|NCT01107457|516124422|FG001|Part B and C|Protocol Violation|0|||
143158374|NCT01107457|516124423|FG002|Part B and C|Protocol Violation|0|||
143158375|NCT01107457|516124424|FG003|Part B and C|Protocol Violation|0|||
143158376|NCT01107457|516124425|FG004|Part B and C|Protocol Violation|0|||
143158377|NCT01107457|516124426|FG005|Part B and C|Protocol Violation|1|||
143158378|NCT01107457|516124421|FG000|Part B and C|Sponsor Decision|0|||
143491998|NCT00706030|517342675|FG002|Overall Study|Protocol Violation|1|||
143491999|NCT00706030|517342676|FG003|Overall Study|Protocol Violation|1|||
143492000|NCT00706030|517342673|FG000|Overall Study|Failed to return|0|||
143492001|NCT00706030|517342674|FG001|Overall Study|Failed to return|0|||
143492002|NCT00706030|517342675|FG002|Overall Study|Failed to return|1|||
143492003|NCT00706030|517342676|FG003|Overall Study|Failed to return|0|||
143492004|NCT00706030|517342673|FG000|Overall Study|Symptomatic Deterioration|0|||
143492005|NCT00706030|517342674|FG001|Overall Study|Symptomatic Deterioration|0|||
143492006|NCT00706030|517342675|FG002|Overall Study|Symptomatic Deterioration|1|||
143492007|NCT00706030|517342676|FG003|Overall Study|Symptomatic Deterioration|0|||
143492008|NCT00706030|517342673|FG000|Overall Study|No treatment received|0|||
143492009|NCT00706030|517342674|FG001|Overall Study|No treatment received|0|||
143492010|NCT00706030|517342675|FG002|Overall Study|No treatment received|0|||
143492011|NCT00706030|517342676|FG003|Overall Study|No treatment received|1|||
143492012|NCT00706030|517342673|FG000|Overall Study|Death|0|||
143492013|NCT00706030|517342674|FG001|Overall Study|Death|0|||
143492014|NCT00706030|517342675|FG002|Overall Study|Death|1|||
143492015|NCT00706030|517342676|FG003|Overall Study|Death|0|||
143492016|NCT04673786|517342677|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
143492017|NCT04673786|517342678|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
143492018|NCT04673786|517342679|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
143492019|NCT04673786|517342677|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
143492020|NCT04673786|517342678|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
143492021|NCT04673786|517342679|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
143363875|NCT00049517|516875453|FG003|Conditioning/Transplant|Other complicating disease|4|||
143363876|NCT00049517|516875454|FG004|Conditioning/Transplant|Other complicating disease|0|||
143363877|NCT00049517|516875455|FG005|Conditioning/Transplant|Other complicating disease|1|||
143363878|NCT00049517|516875450|FG000|Conditioning/Transplant|Reasons not reported|25|||
143363879|NCT00049517|516875451|FG001|Conditioning/Transplant|Reasons not reported|31|||
143492022|NCT04673786|517342677|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
143492023|NCT04673786|517342678|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
143492024|NCT04673786|517342679|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
143492025|NCT04673786|517342677|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
143492026|NCT04673786|517342678|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
143492027|NCT04673786|517342679|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
143492028|NCT04673786|517342677|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
143492029|NCT04673786|517342678|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
143492030|NCT04673786|517342679|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
143492031|NCT04673786|517342677|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
143492032|NCT04673786|517342678|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
143492033|NCT04673786|517342679|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
143492034|NCT02682901|517342680|FG000|Overall Study|Adverse Event|10|||
143492035|NCT02682901|517342681|FG001|Overall Study|Adverse Event|3|||
143492036|NCT02682901|517342680|FG000|Overall Study|Lack of Efficacy|0|||
143492037|NCT02682901|517342681|FG001|Overall Study|Lack of Efficacy|1|||
143492038|NCT03713944|517342682|FG000|Study Treatment|Patient non-compliance|1|||
143492039|NCT03713944|517342682|FG000|Study Treatment|Alternative Cancer Therapy|3|||
143492040|NCT03713944|517342682|FG000|Study Treatment|Disease Progression|18|||
143492041|NCT03713944|517342682|FG000|Study Treatment|AE/Side Effects/Complications|2|||
143492042|NCT03713944|517342682|FG000|Study Treatment|Death|2|||
143492043|NCT03713944|517342682|FG000|Study Treatment|Withdrawal by Subject|1|||
143492044|NCT03713944|517342682|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
143492045|NCT03713944|517342682|FG000|Study Treatment|Symptomatic Deterioration|2|||
143492046|NCT03713944|517342682|FG000|Follow up|Withdrawal by Subject|2|||
143492047|NCT03713944|517342682|FG000|Follow up|Death|11|||
143492048|NCT03713944|517342682|FG000|Follow up|Study Terminated|3|||
143492049|NCT00044512|517342688|FG000|Follow Up|Lost to Follow-up|2|||
143492050|NCT02799069|517342689|FG000|Overall Study|Adverse Event|0|||
143492051|NCT02799069|517342690|FG001|Overall Study|Adverse Event|2|||
143492052|NCT02799069|517342691|FG002|Overall Study|Adverse Event|2|||
143492053|NCT02799069|517342689|FG000|Overall Study|Lack of Efficacy|2|||
143492054|NCT02799069|517342690|FG001|Overall Study|Lack of Efficacy|0|||
143492055|NCT02799069|517342691|FG002|Overall Study|Lack of Efficacy|0|||
143028995|NCT00455533|515647812|FG000|Period Two: Randomized Period|Death|0|||
143028996|NCT00455533|515647813|FG001|Period Two: Randomized Period|Death|0|||
143028997|NCT00455533|515647814|FG002|Period Two: Randomized Period|Death|3|||
143028998|NCT00455533|515647812|FG000|Period Two: Randomized Period|Disease Progression|0|||
143158379|NCT01107457|516124422|FG001|Part B and C|Sponsor Decision|0|||
143158380|NCT01107457|516124423|FG002|Part B and C|Sponsor Decision|0|||
143158381|NCT01107457|516124424|FG003|Part B and C|Sponsor Decision|0|||
143492056|NCT02799069|517342689|FG000|Overall Study|Lost to Follow-up|1|||
143492057|NCT02799069|517342690|FG001|Overall Study|Lost to Follow-up|1|||
143492058|NCT02799069|517342691|FG002|Overall Study|Lost to Follow-up|0|||
143158382|NCT01107457|516124425|FG004|Part B and C|Sponsor Decision|0|||
143363880|NCT00049517|516875452|FG002|Conditioning/Transplant|Reasons not reported|18|||
143158383|NCT01107457|516124426|FG005|Part B and C|Sponsor Decision|66|||
143158384|NCT01107457|516124421|FG000|Part B and C|Withdrawal by Subject|0|||
143492059|NCT02799069|517342689|FG000|Overall Study|Withdrawal by Subject|4|||
143492060|NCT02799069|517342690|FG001|Overall Study|Withdrawal by Subject|4|||
143492061|NCT02799069|517342691|FG002|Overall Study|Withdrawal by Subject|3|||
143492062|NCT02799069|517342689|FG000|Overall Study|Protocol Violation|1|||
143492063|NCT02799069|517342690|FG001|Overall Study|Protocol Violation|0|||
143492064|NCT02799069|517342691|FG002|Overall Study|Protocol Violation|2|||
143492065|NCT00454805|517342695|FG000|Overall Study|Withdrawal by Subject|9|||
143492066|NCT00454805|517342696|FG001|Overall Study|Withdrawal by Subject|2|||
143492067|NCT00454805|517342695|FG000|Overall Study|Death|0|||
143492068|NCT00454805|517342696|FG001|Overall Study|Death|2|||
143492069|NCT00454805|517342695|FG000|Overall Study|Disease progression|16|||
143492070|NCT00454805|517342696|FG001|Overall Study|Disease progression|19|||
143492071|NCT00454805|517342695|FG000|Overall Study|In order to begin radiotherapy|1|||
143492072|NCT00454805|517342696|FG001|Overall Study|In order to begin radiotherapy|0|||
143492073|NCT04947800|517342704|FG000|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|8|||
143492074|NCT04947800|517342705|FG001|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
143158385|NCT01107457|516124422|FG001|Part B and C|Withdrawal by Subject|0|||
143158386|NCT01107457|516124423|FG002|Part B and C|Withdrawal by Subject|0|||
143158387|NCT01107457|516124424|FG003|Part B and C|Withdrawal by Subject|0|||
143158388|NCT01107457|516124425|FG004|Part B and C|Withdrawal by Subject|0|||
143158389|NCT01107457|516124426|FG005|Part B and C|Withdrawal by Subject|16|||
143363881|NCT00049517|516875453|FG003|Conditioning/Transplant|Reasons not reported|15|||
143363882|NCT00049517|516875454|FG004|Conditioning/Transplant|Reasons not reported|5|||
143363883|NCT00049517|516875455|FG005|Conditioning/Transplant|Reasons not reported|5|||
143363884|NCT00940017|516875456|FG000|Overall Study|did not meet entrance criteria|3|||
143363885|NCT00940017|516875456|FG000|Overall Study|Adverse Event|1|||
143363886|NCT01684046|516875459|FG000|Period 1, First 30 Days|Adverse Event|0|||
143363887|NCT01684046|516875460|FG001|Period 1, First 30 Days|Adverse Event|2|||
143363888|NCT00926393|516875466|FG000|Overall Study|Withdrawal by Subject|1|||
143363889|NCT00926393|516875467|FG001|Overall Study|Withdrawal by Subject|2|||
143363890|NCT00926393|516875466|FG000|Overall Study|Adverse Event|1|||
143363891|NCT00926393|516875467|FG001|Overall Study|Adverse Event|1|||
143363892|NCT01575860|516875468|FG000|Overall Study|Withdrawal by Subject|1|||
143363893|NCT01575860|516875468|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
143363894|NCT00278564|516875471|FG000|Overall Study|Lack of Efficacy|4|||
143363895|NCT00003377|516875472|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
143363896|NCT00003377|516875473|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
143363897|NCT00003377|516875474|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
143363898|NCT00003377|516875475|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
143363899|NCT00003377|516875476|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
143363900|NCT00003377|516875472|FG000|Period II|Ureteral stent complications|0|||
143363901|NCT00003377|516875473|FG001|Period II|Ureteral stent complications|0|||
143363902|NCT00003377|516875474|FG002|Period II|Ureteral stent complications|0|||
143363903|NCT00003377|516875475|FG003|Period II|Ureteral stent complications|0|||
143363904|NCT00003377|516875476|FG004|Period II|Ureteral stent complications|1|||
143363905|NCT04541186|516875480|FG000|Main Study|Adverse Event|0|||
143363906|NCT04541186|516875481|FG001|Main Study|Adverse Event|0|||
143363907|NCT04541186|516875482|FG002|Main Study|Adverse Event|4|||
143363908|NCT04541186|516875483|FG003|Main Study|Adverse Event|0|||
143363909|NCT04541186|516875484|FG004|Main Study|Adverse Event|0|||
143363910|NCT04541186|516875480|FG000|Main Study|Investigator Decision|0|||
143363911|NCT04541186|516875481|FG001|Main Study|Investigator Decision|0|||
143363912|NCT04541186|516875482|FG002|Main Study|Investigator Decision|1|||
143363913|NCT04541186|516875483|FG003|Main Study|Investigator Decision|1|||
143363914|NCT04541186|516875484|FG004|Main Study|Investigator Decision|0|||
143363915|NCT04541186|516875480|FG000|Main Study|Withdrawal by Subject|1|||
143363916|NCT04541186|516875481|FG001|Main Study|Withdrawal by Subject|1|||
143363917|NCT04541186|516875482|FG002|Main Study|Withdrawal by Subject|0|||
143363918|NCT04541186|516875483|FG003|Main Study|Withdrawal by Subject|0|||
143363919|NCT04541186|516875484|FG004|Main Study|Withdrawal by Subject|0|||
143363920|NCT04541186|516875480|FG000|Main Study|COVID-19-related Dose Interruption|0|||
143492075|NCT04947800|517342706|FG002|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
143492076|NCT03977467|517342707|FG000|Overall Study|Disease Progression|1|||
143492077|NCT03977467|517342708|FG001|Overall Study|Disease Progression|1|||
143492078|NCT03977467|517342709|FG002|Overall Study|Disease Progression|30|||
143492079|NCT03977467|517342710|FG003|Overall Study|Disease Progression|0|||
143363921|NCT04541186|516875481|FG001|Main Study|COVID-19-related Dose Interruption|0|||
143363922|NCT04541186|516875482|FG002|Main Study|COVID-19-related Dose Interruption|0|||
143492080|NCT03977467|517342707|FG000|Overall Study|Adverse Event|0|||
143492081|NCT03977467|517342708|FG001|Overall Study|Adverse Event|1|||
143492082|NCT03977467|517342709|FG002|Overall Study|Adverse Event|0|||
143492083|NCT03977467|517342710|FG003|Overall Study|Adverse Event|0|||
143158390|NCT01107457|516124421|FG000|Part B and C|Clinical Relapse|0|||
143363923|NCT04541186|516875483|FG003|Main Study|COVID-19-related Dose Interruption|0|||
143028999|NCT00455533|515647813|FG001|Period Two: Randomized Period|Disease Progression|1|||
143029000|NCT00455533|515647814|FG002|Period Two: Randomized Period|Disease Progression|1|||
143029001|NCT00455533|515647812|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
143029002|NCT00455533|515647813|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
143029003|NCT00455533|515647814|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
143029004|NCT00455533|515647812|FG000|Period Two: Randomized Period|Other - need reasons|0|||
143029005|NCT00455533|515647813|FG001|Period Two: Randomized Period|Other - need reasons|1|||
143029006|NCT00455533|515647814|FG002|Period Two: Randomized Period|Other - need reasons|0|||
143029007|NCT00455533|515647812|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
143029008|NCT00455533|515647813|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
143029009|NCT00455533|515647814|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
143029010|NCT00455533|515647812|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
143029011|NCT00455533|515647813|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
143029012|NCT00455533|515647814|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
143029013|NCT02739984|515647815|FG000|Overall Study|Sponsor Decision|1|||
143029014|NCT02739984|515647816|FG001|Overall Study|Sponsor Decision|0|||
143029015|NCT02739984|515647815|FG000|Overall Study|Withdrawal by Subject|1|||
143029016|NCT02739984|515647816|FG001|Overall Study|Withdrawal by Subject|1|||
143029017|NCT02739984|515647815|FG000|Overall Study|Death|0|||
143029018|NCT02739984|515647816|FG001|Overall Study|Death|1|||
143029019|NCT02739984|515647815|FG000|Overall Study|Lost to Follow-up|3|||
143029020|NCT02739984|515647816|FG001|Overall Study|Lost to Follow-up|0|||
143029021|NCT01346410|515647817|FG000|Overall Study|Death|1|||
143029022|NCT02576990|515647818|FG000|Overall Study|Death|29|||
143029023|NCT02576990|515647819|FG001|Overall Study|Death|18|||
143363924|NCT04541186|516875484|FG004|Main Study|COVID-19-related Dose Interruption|1|||
143363925|NCT04541186|516875480|FG000|Main Study|Randomized in Error Not Treated|0|||
143029024|NCT02576990|515647818|FG000|Overall Study|Physician Decision|1|||
143029025|NCT02576990|515647819|FG001|Overall Study|Physician Decision|0|||
143029026|NCT02576990|515647818|FG000|Overall Study|Screen failure|2|||
143029027|NCT02576990|515647819|FG001|Overall Study|Screen failure|0|||
143029028|NCT02576990|515647818|FG000|Overall Study|Sponsor's decision|24|||
143029029|NCT02576990|515647819|FG001|Overall Study|Sponsor's decision|4|||
143029030|NCT02576990|515647818|FG000|Overall Study|Withdrawal by Subject|0|||
143029031|NCT02576990|515647819|FG001|Overall Study|Withdrawal by Subject|2|||
143029032|NCT00979628|515647820|FG000|Overall Study|received regimen < 24 hours|7|||
143029033|NCT00979628|515647821|FG001|Overall Study|received regimen < 24 hours|6|||
143029034|NCT00979628|515647822|FG002|Overall Study|received regimen < 24 hours|5|||
143029035|NCT00979628|515647820|FG000|Overall Study|received steroids|1|||
143029036|NCT00979628|515647821|FG001|Overall Study|received steroids|1|||
143029037|NCT00979628|515647822|FG002|Overall Study|received steroids|0|||
143029038|NCT00979628|515647820|FG000|Overall Study|transferred to ICU|1|||
143029039|NCT00979628|515647821|FG001|Overall Study|transferred to ICU|2|||
143029040|NCT00979628|515647822|FG002|Overall Study|transferred to ICU|1|||
143029041|NCT01048333|515647823|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
143029042|NCT01048333|515647824|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
143029043|NCT01048333|515647825|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
143029044|NCT01048333|515647826|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
143029045|NCT01048333|515647827|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
143029046|NCT01048333|515647828|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
143029047|NCT03008460|515647834|FG000|Overall Study|Protocol deviation|0|||
143029048|NCT03008460|515647835|FG001|Overall Study|Protocol deviation|2|||
143029049|NCT03008460|515647834|FG000|Overall Study|Study drug not dispensed|0|||
143029050|NCT03008460|515647835|FG001|Overall Study|Study drug not dispensed|1|||
143029051|NCT03008460|515647834|FG000|Overall Study|Adverse Event|0|||
143029052|NCT03008460|515647835|FG001|Overall Study|Adverse Event|1|||
143029053|NCT03008460|515647834|FG000|Overall Study|Withdrawal by Subject|5|||
143029054|NCT03008460|515647835|FG001|Overall Study|Withdrawal by Subject|6|||
143029055|NCT03008460|515647834|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
143029056|NCT03008460|515647835|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
143029057|NCT03008460|515647834|FG000|Overall Study|End of study visit outside permitted time window|0|||
143029058|NCT03008460|515647835|FG001|Overall Study|End of study visit outside permitted time window|1|||
143363926|NCT04541186|516875481|FG001|Main Study|Randomized in Error Not Treated|0|||
143363927|NCT04541186|516875482|FG002|Main Study|Randomized in Error Not Treated|1|||
143363928|NCT04541186|516875483|FG003|Main Study|Randomized in Error Not Treated|0|||
143029059|NCT03008460|515647834|FG000|Overall Study|Lost to Follow-up|1|||
143029060|NCT03008460|515647835|FG001|Overall Study|Lost to Follow-up|3|||
143029061|NCT00767325|515647840|FG000|Overall Study|Lack of Efficacy|2|||
143029062|NCT00767325|515647840|FG000|Overall Study|Adverse Event|7|||
143158391|NCT01107457|516124422|FG001|Part B and C|Clinical Relapse|0|||
143363929|NCT04541186|516875484|FG004|Main Study|Randomized in Error Not Treated|0|||
143029063|NCT00767325|515647840|FG000|Overall Study|Lost to Follow-up|3|||
143029064|NCT00767325|515647840|FG000|Overall Study|No longer met study criteria|2|||
143029065|NCT00767325|515647840|FG000|Overall Study|Missed visit due to family reasons|1|||
143492084|NCT03977467|517342707|FG000|Overall Study|Death|0|||
143363930|NCT04541186|516875480|FG000|Fibrate Expansion Study|Other than Specified|0|||
143363931|NCT04541186|516875481|FG001|Fibrate Expansion Study|Other than Specified|0|||
143363932|NCT04541186|516875482|FG002|Fibrate Expansion Study|Other than Specified|0|||
143363933|NCT04541186|516875483|FG003|Fibrate Expansion Study|Other than Specified|0|||
143363934|NCT04541186|516875484|FG004|Fibrate Expansion Study|Other than Specified|1|||
143363935|NCT00058058|516875489|FG000|Overall Study|Withdrawal by Subject|4|||
143363936|NCT00058058|516875489|FG000|Overall Study|Ineligible|20|||
143363937|NCT00058058|516875489|FG000|Overall Study|Claustrophobic|5|||
143363938|NCT00058058|516875489|FG000|Overall Study|technical issues|6|||
143363939|NCT00058058|516875489|FG000|Overall Study|Poor positioning, illness,pain|3|||
143363940|NCT00582790|516875492|FG000|Overall Study|Rapid progression of disease|1|||
143363941|NCT03681691|516875496|FG000|Overall Study|COVID|1|||
143363942|NCT03681691|516875497|FG001|Overall Study|COVID|0|||
143363943|NCT03681691|516875496|FG000|Overall Study|prolonged bleeding|1|||
143363944|NCT03681691|516875497|FG001|Overall Study|prolonged bleeding|0|||
143363945|NCT03681691|516875496|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
143363946|NCT03681691|516875497|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
143363947|NCT00748969|516875498|FG000|Overall Study|Withdrawal by Subject|1|||
143363948|NCT00748969|516875499|FG001|Overall Study|Withdrawal by Subject|0|||
143363949|NCT00748969|516875498|FG000|Overall Study|Withdrawal by Subject|0|||
143363950|NCT00748969|516875499|FG001|Overall Study|Withdrawal by Subject|1|||
143363951|NCT02334306|516875500|FG000|Double-blind Period|Adverse Event|0|||
143363952|NCT02334306|516875501|FG001|Double-blind Period|Adverse Event|1|||
143363953|NCT02334306|516875500|FG000|Double-blind Period|Withdrawal by Subject|1|||
143363954|NCT02334306|516875501|FG001|Double-blind Period|Withdrawal by Subject|1|||
143363955|NCT00465985|516875502|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
143363956|NCT00465985|516875503|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
143363957|NCT00465985|516875502|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
143363958|NCT00465985|516875503|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
143363959|NCT00465985|516875502|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
143363960|NCT00465985|516875503|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
143363961|NCT00465985|516875502|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
143363962|NCT00465985|516875503|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
143363963|NCT01687270|516875504|FG000|Overall Study|Lack of Efficacy|11|||
143363964|NCT01687270|516875504|FG000|Overall Study|Lost to Follow-up|1|||
143363965|NCT03532178|516875505|FG000|First Period|Withdrawal by Subject|1|||
143363966|NCT03532178|516875506|FG001|First Period|Withdrawal by Subject|3|||
143363967|NCT03532178|516875505|FG000|First Period|technical issues in data collection Technical issues|0|||
143363968|NCT03532178|516875506|FG001|First Period|technical issues in data collection Technical issues|1|||
143363969|NCT03532178|516875505|FG000|Second Period|Withdrawal by Subject|1|||
143363970|NCT03532178|516875506|FG001|Second Period|Withdrawal by Subject|1|||
143363971|NCT03532178|516875505|FG000|Second Period|Technical issues|0|||
143363972|NCT03532178|516875506|FG001|Second Period|Technical issues|1|||
143363973|NCT03302156|516875507|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
143363974|NCT03302156|516875508|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
143363975|NCT03302156|516875509|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
143363976|NCT02390557|516875510|FG000|Wave 2|Survey non-respondent|72|||
143363977|NCT02390557|516875511|FG001|Wave 2|Survey non-respondent|41|||
143363978|NCT02390557|516875512|FG002|Wave 2|Survey non-respondent|23|||
143363979|NCT03278028|516875515|FG000|Overall Study|Lost to Follow-up|1|||
143363980|NCT03278028|516875516|FG001|Overall Study|Lost to Follow-up|0|||
143029066|NCT03538756|515647841|FG000|Long-Term Follow-up|Adverse Event|0|||
143029067|NCT03538756|515647842|FG001|Long-Term Follow-up|Adverse Event|0|||
143029068|NCT03538756|515647843|FG002|Long-Term Follow-up|Adverse Event|6|||
143029069|NCT03538756|515647841|FG000|Long-Term Follow-up|Death|0|||
143029070|NCT03538756|515647842|FG001|Long-Term Follow-up|Death|0|||
143029071|NCT03538756|515647843|FG002|Long-Term Follow-up|Death|1|||
143029072|NCT03538756|515647841|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
143029073|NCT03538756|515647842|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
143029074|NCT03538756|515647843|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
143029075|NCT03538756|515647841|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
143029076|NCT03538756|515647842|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
143029077|NCT03538756|515647843|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
143029078|NCT03538756|515647841|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
143158392|NCT01107457|516124423|FG002|Part B and C|Clinical Relapse|0|||
143363981|NCT03278028|516875515|FG000|Overall Study|Withdrawal by Subject|3|||
143363982|NCT03278028|516875516|FG001|Overall Study|Withdrawal by Subject|1|||
143363983|NCT03278028|516875515|FG000|Overall Study|Pregnancy|0|||
143363984|NCT03278028|516875516|FG001|Overall Study|Pregnancy|1|||
143363985|NCT03635112|516875517|FG000|Overall Study|Adverse Event|5|||
143363986|NCT03635112|516875518|FG001|Overall Study|Adverse Event|9|||
143363987|NCT03635112|516875519|FG002|Overall Study|Adverse Event|14|||
143363988|NCT03635112|516875517|FG000|Overall Study|Lost to Follow-up|1|||
143363989|NCT03635112|516875518|FG001|Overall Study|Lost to Follow-up|0|||
143029079|NCT03538756|515647842|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
143029080|NCT03538756|515647843|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
143029081|NCT00752856|515647844|FG000|Overall Study|randomized but did not do viral kinetics|0|||
143029082|NCT00752856|515647845|FG001|Overall Study|randomized but did not do viral kinetics|1|||
143029083|NCT00996736|515647846|FG000|Overall Study|Death|1|||
143029084|NCT00996736|515647847|FG001|Overall Study|Death|1|||
143029085|NCT00996736|515647846|FG000|Overall Study|Lost to Follow-up|15|||
143029086|NCT00996736|515647847|FG001|Overall Study|Lost to Follow-up|14|||
143029087|NCT00996736|515647846|FG000|Overall Study|Visit not within 3-month window|5|||
143029088|NCT00996736|515647847|FG001|Overall Study|Visit not within 3-month window|3|||
143029089|NCT02688608|515647848|FG000|Overall Study|Lost to Follow-up|1|||
143029090|NCT03495869|515647851|FG000|Overall Study|Lost to Follow-up|4|||
143029091|NCT03495869|515647852|FG001|Overall Study|Lost to Follow-up|17|||
143029092|NCT03495869|515647853|FG002|Overall Study|Lost to Follow-up|8|||
143029093|NCT03495869|515647854|FG003|Overall Study|Lost to Follow-up|14|||
143029094|NCT03495869|515647851|FG000|Overall Study|Withdrawal by Subject|0|||
143029095|NCT03495869|515647852|FG001|Overall Study|Withdrawal by Subject|3|||
143029096|NCT03495869|515647853|FG002|Overall Study|Withdrawal by Subject|0|||
143029097|NCT03495869|515647854|FG003|Overall Study|Withdrawal by Subject|3|||
143029098|NCT03495869|515647851|FG000|Overall Study|Dropped from study|0|||
143029099|NCT03495869|515647852|FG001|Overall Study|Dropped from study|7|||
143029100|NCT03495869|515647853|FG002|Overall Study|Dropped from study|2|||
143029101|NCT03495869|515647854|FG003|Overall Study|Dropped from study|4|||
143029102|NCT04634409|515647855|FG000|Overall Study|Death|0|||
143029103|NCT04634409|515647856|FG001|Overall Study|Death|0|||
143029104|NCT04634409|515647857|FG002|Overall Study|Death|0|||
143029105|NCT04634409|515647858|FG003|Overall Study|Death|0|||
143029106|NCT04634409|515647859|FG004|Overall Study|Death|0|||
143029107|NCT04634409|515647860|FG005|Overall Study|Death|0|||
143029108|NCT04634409|515647861|FG006|Overall Study|Death|0|||
143029109|NCT04634409|515647862|FG007|Overall Study|Death|0|||
143029110|NCT04634409|515647863|FG008|Overall Study|Death|0|||
143029111|NCT04634409|515647864|FG009|Overall Study|Death|0|||
143029112|NCT04634409|515647865|FG010|Overall Study|Death|1|||
143029113|NCT04634409|515647866|FG011|Overall Study|Death|0|||
143029114|NCT04634409|515647867|FG012|Overall Study|Death|1|||
143029115|NCT04634409|515647868|FG013|Overall Study|Death|0|||
143029116|NCT04634409|515647869|FG014|Overall Study|Death|0|||
143029117|NCT04634409|515647870|FG015|Overall Study|Death|0|||
143029118|NCT04634409|515647871|FG016|Overall Study|Death|0|||
143029119|NCT04634409|515647872|FG017|Overall Study|Death|0|||
143029120|NCT04634409|515647873|FG018|Overall Study|Death|0|||
143029121|NCT04634409|515647874|FG019|Overall Study|Death|0|||
143029122|NCT04634409|515647875|FG020|Overall Study|Death|0|||
143158393|NCT01107457|516124424|FG003|Part B and C|Clinical Relapse|0|||
143158394|NCT01107457|516124425|FG004|Part B and C|Clinical Relapse|0|||
143158395|NCT01107457|516124426|FG005|Part B and C|Clinical Relapse|4|||
143158396|NCT01227395|516124427|FG000|Overall Study|Protocol Violation|0|||
143158397|NCT01227395|516124428|FG001|Overall Study|Protocol Violation|1|||
143158398|NCT02547935|516124439|FG000|Overall Study|Other|0|||
143158399|NCT02547935|516124440|FG001|Overall Study|Other|1|||
143158400|NCT02547935|516124441|FG002|Overall Study|Other|0|||
143158401|NCT02547935|516124439|FG000|Overall Study|Withdrawal by Subject|2|||
143158402|NCT02547935|516124440|FG001|Overall Study|Withdrawal by Subject|3|||
143158403|NCT02547935|516124441|FG002|Overall Study|Withdrawal by Subject|4|||
143158404|NCT02547935|516124439|FG000|Overall Study|Screen Failure|2|||
143158405|NCT02547935|516124440|FG001|Overall Study|Screen Failure|0|||
143158406|NCT02547935|516124441|FG002|Overall Study|Screen Failure|0|||
143237413|NCT01337960|516423287|FG002|Overall Study|Lost to Follow-up|0|||
143237414|NCT01337960|516423285|FG000|Overall Study|Withdrawal by Subject|1|||
143029123|NCT04634409|515647876|FG021|Overall Study|Death|0|||
143029124|NCT04634409|515647877|FG022|Overall Study|Death|0|||
143029125|NCT04634409|515647878|FG023|Overall Study|Death|0|||
143029126|NCT04634409|515647879|FG024|Overall Study|Death|0|||
143029127|NCT04634409|515647880|FG025|Overall Study|Death|0|||
143029128|NCT04634409|515647881|FG026|Overall Study|Death|0|||
143158407|NCT02547935|516124439|FG000|Overall Study|Physician Decision|0|||
143158408|NCT02547935|516124440|FG001|Overall Study|Physician Decision|1|||
143158409|NCT02547935|516124441|FG002|Overall Study|Physician Decision|0|||
143029129|NCT04634409|515647855|FG000|Overall Study|Adverse Event|0|||
143029130|NCT04634409|515647856|FG001|Overall Study|Adverse Event|0|||
143029131|NCT04634409|515647857|FG002|Overall Study|Adverse Event|1|||
143029132|NCT04634409|515647858|FG003|Overall Study|Adverse Event|0|||
143029133|NCT04634409|515647859|FG004|Overall Study|Adverse Event|0|||
143029134|NCT04634409|515647860|FG005|Overall Study|Adverse Event|1|||
143029135|NCT04634409|515647861|FG006|Overall Study|Adverse Event|0|||
143158410|NCT02547935|516124439|FG000|Overall Study|Lost to Follow-up|0|||
143158411|NCT02547935|516124440|FG001|Overall Study|Lost to Follow-up|2|||
143029136|NCT04634409|515647862|FG007|Overall Study|Adverse Event|0|||
143029137|NCT04634409|515647863|FG008|Overall Study|Adverse Event|0|||
143029138|NCT04634409|515647864|FG009|Overall Study|Adverse Event|0|||
143158412|NCT02547935|516124441|FG002|Overall Study|Lost to Follow-up|1|||
143029139|NCT04634409|515647865|FG010|Overall Study|Adverse Event|0|||
143029140|NCT04634409|515647866|FG011|Overall Study|Adverse Event|0|||
143029141|NCT04634409|515647867|FG012|Overall Study|Adverse Event|0|||
143029142|NCT04634409|515647868|FG013|Overall Study|Adverse Event|0|||
143029143|NCT04634409|515647869|FG014|Overall Study|Adverse Event|0|||
143029144|NCT04634409|515647870|FG015|Overall Study|Adverse Event|0|||
143029145|NCT04634409|515647871|FG016|Overall Study|Adverse Event|0|||
143029146|NCT04634409|515647872|FG017|Overall Study|Adverse Event|0|||
143029147|NCT04634409|515647873|FG018|Overall Study|Adverse Event|0|||
143029148|NCT04634409|515647874|FG019|Overall Study|Adverse Event|0|||
143029149|NCT04634409|515647875|FG020|Overall Study|Adverse Event|0|||
143029150|NCT04634409|515647876|FG021|Overall Study|Adverse Event|0|||
143029151|NCT04634409|515647877|FG022|Overall Study|Adverse Event|0|||
143029152|NCT04634409|515647878|FG023|Overall Study|Adverse Event|0|||
143029153|NCT04634409|515647879|FG024|Overall Study|Adverse Event|0|||
143029154|NCT04634409|515647880|FG025|Overall Study|Adverse Event|0|||
143029155|NCT04634409|515647881|FG026|Overall Study|Adverse Event|0|||
143029156|NCT04634409|515647855|FG000|Overall Study|Lost to Follow-up|3|||
143029157|NCT04634409|515647856|FG001|Overall Study|Lost to Follow-up|1|||
143029158|NCT04634409|515647857|FG002|Overall Study|Lost to Follow-up|1|||
143029159|NCT04634409|515647858|FG003|Overall Study|Lost to Follow-up|3|||
143029160|NCT04634409|515647859|FG004|Overall Study|Lost to Follow-up|1|||
143029161|NCT04634409|515647860|FG005|Overall Study|Lost to Follow-up|1|||
143029162|NCT04634409|515647861|FG006|Overall Study|Lost to Follow-up|1|||
143029163|NCT04634409|515647862|FG007|Overall Study|Lost to Follow-up|3|||
143029164|NCT04634409|515647863|FG008|Overall Study|Lost to Follow-up|3|||
143029165|NCT04634409|515647864|FG009|Overall Study|Lost to Follow-up|11|||
143029166|NCT04634409|515647865|FG010|Overall Study|Lost to Follow-up|8|||
143029167|NCT04634409|515647866|FG011|Overall Study|Lost to Follow-up|15|||
143029168|NCT04634409|515647867|FG012|Overall Study|Lost to Follow-up|3|||
143029169|NCT04634409|515647868|FG013|Overall Study|Lost to Follow-up|2|||
143029170|NCT04634409|515647869|FG014|Overall Study|Lost to Follow-up|7|||
143029171|NCT04634409|515647870|FG015|Overall Study|Lost to Follow-up|0|||
143029172|NCT04634409|515647871|FG016|Overall Study|Lost to Follow-up|0|||
143029173|NCT04634409|515647872|FG017|Overall Study|Lost to Follow-up|0|||
143029174|NCT04634409|515647873|FG018|Overall Study|Lost to Follow-up|0|||
143029175|NCT04634409|515647874|FG019|Overall Study|Lost to Follow-up|0|||
143029176|NCT04634409|515647875|FG020|Overall Study|Lost to Follow-up|0|||
143029177|NCT04634409|515647876|FG021|Overall Study|Lost to Follow-up|0|||
143029178|NCT04634409|515647877|FG022|Overall Study|Lost to Follow-up|0|||
143029179|NCT04634409|515647878|FG023|Overall Study|Lost to Follow-up|0|||
143029180|NCT04634409|515647879|FG024|Overall Study|Lost to Follow-up|0|||
143029181|NCT04634409|515647880|FG025|Overall Study|Lost to Follow-up|0|||
143029182|NCT04634409|515647881|FG026|Overall Study|Lost to Follow-up|0|||
143029183|NCT04634409|515647855|FG000|Overall Study|Withdrawal by Subject|3|||
143029184|NCT04634409|515647856|FG001|Overall Study|Withdrawal by Subject|1|||
143029185|NCT04634409|515647857|FG002|Overall Study|Withdrawal by Subject|6|||
143029186|NCT04634409|515647858|FG003|Overall Study|Withdrawal by Subject|4|||
143158413|NCT02547935|516124439|FG000|Overall Study|Death|1|||
143158414|NCT02547935|516124440|FG001|Overall Study|Death|1|||
143158415|NCT02547935|516124441|FG002|Overall Study|Death|0|||
143158416|NCT03259308|516124446|FG000|Overall Study|Adverse Event|5|||
143158417|NCT03259308|516124447|FG001|Overall Study|Adverse Event|4|||
143158418|NCT03259308|516124448|FG002|Overall Study|Adverse Event|1|||
143158419|NCT03259308|516124446|FG000|Overall Study|Withdrawal by Subject|2|||
143158420|NCT03259308|516124447|FG001|Overall Study|Withdrawal by Subject|1|||
143158421|NCT03259308|516124448|FG002|Overall Study|Withdrawal by Subject|3|||
143158422|NCT03259308|516124446|FG000|Overall Study|Lost to Follow-up|0|||
143158423|NCT03259308|516124447|FG001|Overall Study|Lost to Follow-up|0|||
143158424|NCT03259308|516124448|FG002|Overall Study|Lost to Follow-up|1|||
143158425|NCT03259308|516124446|FG000|Overall Study|Pregnancy|0|||
143158426|NCT03259308|516124447|FG001|Overall Study|Pregnancy|0|||
143158427|NCT03259308|516124448|FG002|Overall Study|Pregnancy|1|||
143158428|NCT03259308|516124446|FG000|Overall Study|Protocol Deviation|0|||
143158429|NCT03259308|516124447|FG001|Overall Study|Protocol Deviation|3|||
143363990|NCT03635112|516875519|FG002|Overall Study|Lost to Follow-up|1|||
143029187|NCT04634409|515647859|FG004|Overall Study|Withdrawal by Subject|2|||
143029188|NCT04634409|515647860|FG005|Overall Study|Withdrawal by Subject|0|||
143029189|NCT04634409|515647861|FG006|Overall Study|Withdrawal by Subject|0|||
143029190|NCT04634409|515647862|FG007|Overall Study|Withdrawal by Subject|2|||
143029191|NCT04634409|515647863|FG008|Overall Study|Withdrawal by Subject|3|||
143029192|NCT04634409|515647864|FG009|Overall Study|Withdrawal by Subject|2|||
143029193|NCT04634409|515647865|FG010|Overall Study|Withdrawal by Subject|3|||
143029194|NCT04634409|515647866|FG011|Overall Study|Withdrawal by Subject|2|||
143029195|NCT04634409|515647867|FG012|Overall Study|Withdrawal by Subject|2|||
143029196|NCT04634409|515647868|FG013|Overall Study|Withdrawal by Subject|1|||
143029197|NCT04634409|515647869|FG014|Overall Study|Withdrawal by Subject|5|||
143158430|NCT03259308|516124448|FG002|Overall Study|Protocol Deviation|0|||
143158431|NCT03259308|516124446|FG000|Overall Study|Lack of Efficacy|0|||
143158432|NCT03259308|516124447|FG001|Overall Study|Lack of Efficacy|0|||
143029198|NCT04634409|515647870|FG015|Overall Study|Withdrawal by Subject|0|||
143029199|NCT04634409|515647871|FG016|Overall Study|Withdrawal by Subject|0|||
143029200|NCT04634409|515647872|FG017|Overall Study|Withdrawal by Subject|1|||
143029201|NCT04634409|515647873|FG018|Overall Study|Withdrawal by Subject|0|||
143029202|NCT04634409|515647874|FG019|Overall Study|Withdrawal by Subject|0|||
143029203|NCT04634409|515647875|FG020|Overall Study|Withdrawal by Subject|0|||
143029204|NCT04634409|515647876|FG021|Overall Study|Withdrawal by Subject|0|||
143029205|NCT04634409|515647877|FG022|Overall Study|Withdrawal by Subject|0|||
143029206|NCT04634409|515647878|FG023|Overall Study|Withdrawal by Subject|1|||
143029207|NCT04634409|515647879|FG024|Overall Study|Withdrawal by Subject|0|||
143029208|NCT04634409|515647880|FG025|Overall Study|Withdrawal by Subject|0|||
143029209|NCT04634409|515647881|FG026|Overall Study|Withdrawal by Subject|0|||
143029210|NCT04634409|515647855|FG000|Overall Study|Other - As reported by Investigator|1|||
143029211|NCT04634409|515647856|FG001|Overall Study|Other - As reported by Investigator|0|||
143029212|NCT04634409|515647857|FG002|Overall Study|Other - As reported by Investigator|0|||
143029213|NCT04634409|515647858|FG003|Overall Study|Other - As reported by Investigator|0|||
143029214|NCT04634409|515647859|FG004|Overall Study|Other - As reported by Investigator|0|||
143029215|NCT04634409|515647860|FG005|Overall Study|Other - As reported by Investigator|0|||
143029216|NCT04634409|515647861|FG006|Overall Study|Other - As reported by Investigator|0|||
143029217|NCT04634409|515647862|FG007|Overall Study|Other - As reported by Investigator|6|||
143029218|NCT04634409|515647863|FG008|Overall Study|Other - As reported by Investigator|4|||
143029219|NCT04634409|515647864|FG009|Overall Study|Other - As reported by Investigator|0|||
143029220|NCT04634409|515647865|FG010|Overall Study|Other - As reported by Investigator|1|||
143029221|NCT04634409|515647866|FG011|Overall Study|Other - As reported by Investigator|2|||
143029222|NCT04634409|515647867|FG012|Overall Study|Other - As reported by Investigator|2|||
143029223|NCT04634409|515647868|FG013|Overall Study|Other - As reported by Investigator|1|||
143029224|NCT04634409|515647869|FG014|Overall Study|Other - As reported by Investigator|0|||
143029225|NCT04634409|515647870|FG015|Overall Study|Other - As reported by Investigator|0|||
143029226|NCT04634409|515647871|FG016|Overall Study|Other - As reported by Investigator|0|||
143029227|NCT04634409|515647872|FG017|Overall Study|Other - As reported by Investigator|0|||
143029228|NCT04634409|515647873|FG018|Overall Study|Other - As reported by Investigator|0|||
143029229|NCT04634409|515647874|FG019|Overall Study|Other - As reported by Investigator|0|||
143029230|NCT04634409|515647875|FG020|Overall Study|Other - As reported by Investigator|0|||
143029231|NCT04634409|515647876|FG021|Overall Study|Other - As reported by Investigator|0|||
143029232|NCT04634409|515647877|FG022|Overall Study|Other - As reported by Investigator|0|||
143029233|NCT04634409|515647878|FG023|Overall Study|Other - As reported by Investigator|0|||
143029234|NCT04634409|515647879|FG024|Overall Study|Other - As reported by Investigator|0|||
143029235|NCT04634409|515647880|FG025|Overall Study|Other - As reported by Investigator|0|||
143029236|NCT04634409|515647881|FG026|Overall Study|Other - As reported by Investigator|0|||
143029237|NCT01497938|515647882|FG000|Overall Study|Adverse Event|0|||
143029238|NCT01497938|515647883|FG001|Overall Study|Adverse Event|1|||
143029239|NCT01497938|515647882|FG000|Overall Study|Physician Decision|0|||
143029240|NCT01497938|515647883|FG001|Overall Study|Physician Decision|1|||
143029241|NCT01497938|515647882|FG000|Overall Study|Withdrawal by Subject|4|||
143029242|NCT01497938|515647883|FG001|Overall Study|Withdrawal by Subject|0|||
143029243|NCT01497938|515647882|FG000|Overall Study|Device Violation|1|||
143029244|NCT01497938|515647883|FG001|Overall Study|Device Violation|0|||
143029245|NCT03708211|515647884|FG000|Overall Study|Progressive Disease|10|||
143029246|NCT03708211|515647885|FG001|Overall Study|Progressive Disease|7|||
143029247|NCT03708211|515647884|FG000|Overall Study|Withdrawal by Subject|0|||
143029248|NCT03708211|515647885|FG001|Overall Study|Withdrawal by Subject|1|||
143029249|NCT03708211|515647884|FG000|Overall Study|Other|2|||
143029250|NCT03708211|515647885|FG001|Overall Study|Other|0|||
143029251|NCT00365352|515647886|FG000|Overall Study|Adverse Event|6|||
143029252|NCT00365352|515647887|FG001|Overall Study|Adverse Event|7|||
143029253|NCT00365352|515647888|FG002|Overall Study|Adverse Event|8|||
143029254|NCT00365352|515647886|FG000|Overall Study|Participant Withdrew Consent|8|||
143029255|NCT00365352|515647887|FG001|Overall Study|Participant Withdrew Consent|3|||
143029256|NCT00365352|515647888|FG002|Overall Study|Participant Withdrew Consent|4|||
143029257|NCT00365352|515647886|FG000|Overall Study|Lack of Efficacy|3|||
143029258|NCT00365352|515647887|FG001|Overall Study|Lack of Efficacy|0|||
143029259|NCT00365352|515647888|FG002|Overall Study|Lack of Efficacy|0|||
143029260|NCT00365352|515647886|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
143029261|NCT00365352|515647887|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
143029262|NCT00365352|515647888|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
143029263|NCT00365352|515647886|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
143029264|NCT00365352|515647887|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
143029265|NCT00365352|515647888|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
143029266|NCT00365352|515647886|FG000|Overall Study|Lost to Follow-up|1|||
143029267|NCT00365352|515647887|FG001|Overall Study|Lost to Follow-up|1|||
143029268|NCT00365352|515647888|FG002|Overall Study|Lost to Follow-up|0|||
143029269|NCT00365352|515647886|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
143029270|NCT00365352|515647887|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
143029271|NCT00365352|515647888|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
143029272|NCT00462982|515647893|FG000|Overall Study|Adverse Event|1|||
143029273|NCT00462982|515647893|FG000|Overall Study|Patient Not Treated|2|||
143029274|NCT02109133|515647896|FG000|Overall Study|Lost to Follow-up|1|||
143029275|NCT02109133|515647897|FG001|Overall Study|Lost to Follow-up|0|||
143029276|NCT05200858|515647898|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
143029277|NCT05200858|515647899|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
143029278|NCT05200858|515647900|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
143029279|NCT05200858|515647901|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
143029280|NCT00409578|515647902|FG000|Overall Study|Adverse Event|27|||
143029281|NCT00409578|515647903|FG001|Overall Study|Adverse Event|37|||
143029282|NCT00409578|515647904|FG002|Overall Study|Adverse Event|25|||
143029283|NCT00409578|515647905|FG003|Overall Study|Adverse Event|33|||
143029284|NCT00409578|515647902|FG000|Overall Study|Abnormal laboratory value(s)|2|||
143029285|NCT00409578|515647903|FG001|Overall Study|Abnormal laboratory value(s)|2|||
143029286|NCT00409578|515647904|FG002|Overall Study|Abnormal laboratory value(s)|2|||
143029287|NCT00409578|515647905|FG003|Overall Study|Abnormal laboratory value(s)|4|||
143029288|NCT00409578|515647902|FG000|Overall Study|Lack of Efficacy|0|||
143029289|NCT00409578|515647903|FG001|Overall Study|Lack of Efficacy|0|||
143029290|NCT00409578|515647904|FG002|Overall Study|Lack of Efficacy|0|||
143029291|NCT00409578|515647905|FG003|Overall Study|Lack of Efficacy|2|||
143029292|NCT00409578|515647902|FG000|Overall Study|Subject no longer requires study drug|0|||
143029293|NCT00409578|515647903|FG001|Overall Study|Subject no longer requires study drug|0|||
143029294|NCT00409578|515647904|FG002|Overall Study|Subject no longer requires study drug|0|||
143029295|NCT00409578|515647905|FG003|Overall Study|Subject no longer requires study drug|1|||
143029296|NCT00409578|515647902|FG000|Overall Study|Withdrawal by Subject|8|||
143029297|NCT00409578|515647903|FG001|Overall Study|Withdrawal by Subject|15|||
143029298|NCT00409578|515647904|FG002|Overall Study|Withdrawal by Subject|16|||
143029299|NCT00409578|515647905|FG003|Overall Study|Withdrawal by Subject|17|||
143029300|NCT00409578|515647902|FG000|Overall Study|Lost to Follow-up|2|||
143029301|NCT00409578|515647903|FG001|Overall Study|Lost to Follow-up|0|||
143029302|NCT00409578|515647904|FG002|Overall Study|Lost to Follow-up|2|||
143029303|NCT00409578|515647905|FG003|Overall Study|Lost to Follow-up|2|||
143029304|NCT00409578|515647902|FG000|Overall Study|Administrative problems|8|||
143029305|NCT00409578|515647903|FG001|Overall Study|Administrative problems|9|||
143029306|NCT00409578|515647904|FG002|Overall Study|Administrative problems|2|||
143029307|NCT00409578|515647905|FG003|Overall Study|Administrative problems|4|||
143029308|NCT00409578|515647902|FG000|Overall Study|Death|2|||
143029309|NCT00409578|515647903|FG001|Overall Study|Death|4|||
143029310|NCT00409578|515647904|FG002|Overall Study|Death|4|||
143029311|NCT00409578|515647905|FG003|Overall Study|Death|2|||
143029312|NCT00409578|515647902|FG000|Overall Study|Protocol Violation|3|||
143029313|NCT00409578|515647903|FG001|Overall Study|Protocol Violation|2|||
143029314|NCT00409578|515647904|FG002|Overall Study|Protocol Violation|3|||
143029315|NCT00409578|515647905|FG003|Overall Study|Protocol Violation|1|||
143029316|NCT00409578|515647902|FG000|Overall Study|Missing|0|||
143029317|NCT00409578|515647903|FG001|Overall Study|Missing|1|||
143029318|NCT00409578|515647904|FG002|Overall Study|Missing|0|||
143029319|NCT00409578|515647905|FG003|Overall Study|Missing|1|||
143029320|NCT02448771|515647908|FG000|Overall Study|Disease Progression|30|||
143158433|NCT03259308|516124448|FG002|Overall Study|Lack of Efficacy|1|||
143158434|NCT00003474|516124452|FG000|Overall Study|Not Evaluable|14|||
143158435|NCT03020888|516124455|FG000|Overall Study|Physician Decision|4|||
143158436|NCT03020888|516124455|FG000|Overall Study|Withdrawal by Subject|6|||
143158437|NCT03020888|516124455|FG000|Overall Study|Insurance coverage|2|||
143158438|NCT03020888|516124455|FG000|Overall Study|Lost to Follow-up|1|||
143158439|NCT00300495|516124458|FG000|Overall Study|Protocol Violation|4|||
143158440|NCT00300495|516124459|FG001|Overall Study|Protocol Violation|1|||
143158441|NCT02186171|516124472|FG000|Overall Study|Withdrawal by Subject|1|||
143158442|NCT02186171|516124473|FG001|Overall Study|Withdrawal by Subject|9|||
143158443|NCT02186171|516124472|FG000|Overall Study|Lost to Follow-up|2|||
143158444|NCT02186171|516124473|FG001|Overall Study|Lost to Follow-up|2|||
143158445|NCT02186171|516124472|FG000|Overall Study|Death|1|||
143158446|NCT02186171|516124473|FG001|Overall Study|Death|2|||
143158447|NCT02186171|516124472|FG000|Overall Study|Protocol-specified Criteria|0|||
143158448|NCT02186171|516124473|FG001|Overall Study|Protocol-specified Criteria|2|||
143158449|NCT03834883|516124475|FG000|Second Treatment|Withdrawal by Subject|1|||
143158450|NCT03834883|516124476|FG001|Second Treatment|Withdrawal by Subject|0|||
143029321|NCT02448771|515647908|FG000|Overall Study|Unacceptable Toxicity|1|||
143029322|NCT02448771|515647908|FG000|Overall Study|Physician Decision|3|||
143029323|NCT02448771|515647908|FG000|Overall Study|Started new therapy|2|||
143029324|NCT00770315|515647910|FG000|Overall Study|Adverse Event|11|||
143029325|NCT00770315|515647911|FG001|Overall Study|Adverse Event|17|||
143029326|NCT00770315|515647912|FG002|Overall Study|Adverse Event|16|||
143029327|NCT00770315|515647913|FG003|Overall Study|Adverse Event|6|||
143029328|NCT00770315|515647910|FG000|Overall Study|Lost to Follow-up|9|||
143029329|NCT00770315|515647911|FG001|Overall Study|Lost to Follow-up|5|||
143158451|NCT03834883|516124477|FG002|Second Treatment|Withdrawal by Subject|0|||
143029330|NCT00770315|515647912|FG002|Overall Study|Lost to Follow-up|10|||
143029331|NCT00770315|515647913|FG003|Overall Study|Lost to Follow-up|3|||
143029332|NCT00770315|515647910|FG000|Overall Study|Withdrawal by Subject|13|||
143029333|NCT00770315|515647911|FG001|Overall Study|Withdrawal by Subject|17|||
143029334|NCT00770315|515647912|FG002|Overall Study|Withdrawal by Subject|24|||
143029335|NCT00770315|515647913|FG003|Overall Study|Withdrawal by Subject|20|||
143029336|NCT00770315|515647910|FG000|Overall Study|Noncompliance with Protocol|7|||
143029337|NCT00770315|515647911|FG001|Overall Study|Noncompliance with Protocol|4|||
143029338|NCT00770315|515647912|FG002|Overall Study|Noncompliance with Protocol|7|||
143029339|NCT00770315|515647913|FG003|Overall Study|Noncompliance with Protocol|9|||
143029340|NCT04256421|515647914|FG000|Overall Study|Death|171|||
143029341|NCT04256421|515647915|FG001|Overall Study|Death|180|||
143029342|NCT04256421|515647914|FG000|Overall Study|Lost to Follow-up|1|||
143029343|NCT04256421|515647915|FG001|Overall Study|Lost to Follow-up|1|||
143029344|NCT04256421|515647914|FG000|Overall Study|Withdrawal by Subject|9|||
143029345|NCT04256421|515647915|FG001|Overall Study|Withdrawal by Subject|10|||
143029346|NCT04256421|515647914|FG000|Overall Study|Ongoing in Study|66|||
143029347|NCT04256421|515647915|FG001|Overall Study|Ongoing in Study|52|||
143029348|NCT02354586|515650359|FG000|Overall Study|Death|230|||
143029349|NCT02354586|515650359|FG000|Overall Study|Withdrawal by Subject|59|||
143029350|NCT02354586|515650359|FG000|Overall Study|Lost to Follow-up|11|||
143029351|NCT02354586|515650359|FG000|Overall Study|Sponsor decision|51|||
143029352|NCT02354586|515650359|FG000|Overall Study|Site closure|2|||
143029353|NCT02354586|515650359|FG000|Overall Study|Intercurrent illness|1|||
143029354|NCT02354586|515650359|FG000|Overall Study|Protocol Violation|3|||
143029355|NCT02354586|515650359|FG000|Overall Study|Physician Decision|13|||
143029356|NCT02354586|515650359|FG000|Overall Study|Lack of Efficacy|86|||
143029357|NCT02354586|515650359|FG000|Overall Study|Adverse Event|7|||
143029358|NCT02402166|515650360|FG000|Overall Study|Adverse Event|2|||
143029359|NCT02402166|515650360|FG000|Overall Study|Withdrawal by Subject|2|||
143029360|NCT02402166|515650360|FG000|Overall Study|Lost to Follow-up|1|||
143029361|NCT00995410|515650363|FG000|Overall Study|Adverse Event|51|||
143029362|NCT00995410|515650363|FG000|Overall Study|Withdrawal by Subject|7|||
143029363|NCT00995410|515650363|FG000|Overall Study|Lost to Follow-up|2|||
143029364|NCT00995410|515650363|FG000|Overall Study|Misc|28|||
143029365|NCT02492958|515650365|FG000|Overall Study|Withdrawal by Subject|0|||
143029366|NCT02492958|515650366|FG001|Overall Study|Withdrawal by Subject|0|||
143029367|NCT02492958|515650367|FG002|Overall Study|Withdrawal by Subject|1|||
143029368|NCT02492958|515650368|FG003|Overall Study|Withdrawal by Subject|0|||
143029369|NCT02492958|515650365|FG000|Overall Study|Adverse Event|1|||
143029370|NCT02492958|515650366|FG001|Overall Study|Adverse Event|0|||
143029371|NCT02492958|515650367|FG002|Overall Study|Adverse Event|1|||
143029372|NCT02492958|515650368|FG003|Overall Study|Adverse Event|0|||
143029373|NCT00454636|515650369|FG000|Overall Study|Adverse Event|10|||
143029374|NCT00454636|515650370|FG001|Overall Study|Adverse Event|6|||
143029375|NCT00454636|515650371|FG002|Overall Study|Adverse Event|9|||
143029376|NCT00454636|515650372|FG003|Overall Study|Adverse Event|15|||
143029377|NCT00454636|515650369|FG000|Overall Study|Disease Progression|11|||
143029378|NCT00454636|515650370|FG001|Overall Study|Disease Progression|12|||
143029379|NCT00454636|515650371|FG002|Overall Study|Disease Progression|4|||
143029380|NCT00454636|515650372|FG003|Overall Study|Disease Progression|11|||
143029381|NCT00454636|515650369|FG000|Overall Study|Protocol Violation|3|||
143029382|NCT00454636|515650370|FG001|Overall Study|Protocol Violation|2|||
143158452|NCT03834883|516124478|FG003|Second Treatment|Withdrawal by Subject|0|||
143158453|NCT03834883|516124475|FG000|Second Treatment|COVID-19 pandemic|1|||
143158454|NCT03834883|516124476|FG001|Second Treatment|COVID-19 pandemic|0|||
143158455|NCT03834883|516124477|FG002|Second Treatment|COVID-19 pandemic|1|||
143158456|NCT03834883|516124478|FG003|Second Treatment|COVID-19 pandemic|1|||
143158457|NCT03572218|516124479|FG000|Overall Study|Lost to Follow-up|3|||
143158458|NCT03572218|516124480|FG001|Overall Study|Lost to Follow-up|2|||
143158459|NCT03572218|516124479|FG000|Overall Study|No longer available for study visits|2|||
143158460|NCT03572218|516124480|FG001|Overall Study|No longer available for study visits|1|||
143029383|NCT00454636|515650371|FG002|Overall Study|Protocol Violation|3|||
143029384|NCT00454636|515650372|FG003|Overall Study|Protocol Violation|3|||
143029385|NCT00454636|515650369|FG000|Overall Study|Death|6|||
143029386|NCT00454636|515650370|FG001|Overall Study|Death|1|||
143158461|NCT03572218|516124479|FG000|Overall Study|No longer interested|1|||
143158462|NCT03572218|516124480|FG001|Overall Study|No longer interested|2|||
143029387|NCT00454636|515650371|FG002|Overall Study|Death|1|||
143029388|NCT00454636|515650372|FG003|Overall Study|Death|1|||
143029389|NCT00454636|515650369|FG000|Overall Study|Patient refusal|1|||
143029390|NCT00454636|515650370|FG001|Overall Study|Patient refusal|1|||
143029391|NCT00454636|515650371|FG002|Overall Study|Patient refusal|3|||
143029392|NCT00454636|515650372|FG003|Overall Study|Patient refusal|2|||
143029393|NCT00454636|515650369|FG000|Overall Study|Lost to Follow-up|0|||
143029394|NCT00454636|515650370|FG001|Overall Study|Lost to Follow-up|1|||
143029395|NCT00454636|515650371|FG002|Overall Study|Lost to Follow-up|0|||
143029396|NCT00454636|515650372|FG003|Overall Study|Lost to Follow-up|0|||
143158463|NCT02487199|516124481|FG000|Overall Study|Withdrew Consent|0|||
143029397|NCT03552757|515650375|FG000|Overall Study|Withdrawal by Subject|10|||
143029398|NCT03552757|515650376|FG001|Overall Study|Withdrawal by Subject|5|||
143029399|NCT03552757|515650377|FG002|Overall Study|Withdrawal by Subject|12|||
143029400|NCT03552757|515650375|FG000|Overall Study|Lost to Follow-up|2|||
143029401|NCT03552757|515650376|FG001|Overall Study|Lost to Follow-up|7|||
143029402|NCT03552757|515650377|FG002|Overall Study|Lost to Follow-up|7|||
143029403|NCT03552757|515650375|FG000|Overall Study|Death|1|||
143029404|NCT03552757|515650376|FG001|Overall Study|Death|1|||
143029405|NCT03552757|515650377|FG002|Overall Study|Death|1|||
143029406|NCT00449150|515650378|FG000|Overall Study|Adverse Event|11|||
143029407|NCT00449150|515650379|FG001|Overall Study|Adverse Event|18|||
143029408|NCT00449150|515650380|FG002|Overall Study|Adverse Event|9|||
143029409|NCT00449150|515650378|FG000|Overall Study|Lack of Efficacy|1|||
143029410|NCT00449150|515650379|FG001|Overall Study|Lack of Efficacy|2|||
143029411|NCT00449150|515650380|FG002|Overall Study|Lack of Efficacy|2|||
143029412|NCT00449150|515650378|FG000|Overall Study|Other|16|||
143029413|NCT00449150|515650379|FG001|Overall Study|Other|13|||
143029414|NCT00449150|515650380|FG002|Overall Study|Other|14|||
143029415|NCT00449150|515650378|FG000|Overall Study|Withdrawal by Subject|17|||
143029416|NCT00449150|515650379|FG001|Overall Study|Withdrawal by Subject|18|||
143029417|NCT00449150|515650380|FG002|Overall Study|Withdrawal by Subject|21|||
143029418|NCT00449150|515650378|FG000|Overall Study|Protocol Violation|1|||
143029419|NCT00449150|515650379|FG001|Overall Study|Protocol Violation|2|||
143029420|NCT00449150|515650380|FG002|Overall Study|Protocol Violation|1|||
143029421|NCT02660242|515650386|FG000|Glucose Tabs|Lost to Follow-up|1|||
143029422|NCT02660242|515650386|FG000|Glucagon Injection|Lost to Follow-up|1|||
143029423|NCT02796664|515650392|FG000|Overall Study|Withdrawal by Subject|0|||
143029424|NCT02796664|515650393|FG001|Overall Study|Withdrawal by Subject|3|||
143029425|NCT02796664|515650392|FG000|Overall Study|Noncompliance|1|||
143029426|NCT02796664|515650393|FG001|Overall Study|Noncompliance|1|||
143029427|NCT02796664|515650392|FG000|Overall Study|Death|0|||
143029428|NCT02796664|515650393|FG001|Overall Study|Death|1|||
143029429|NCT02246478|515650394|FG000|Multiple-dose Phase|Protocol Violation|1|||
143029430|NCT02246478|515650395|FG001|Multiple-dose Phase|Protocol Violation|0|||
143029431|NCT02246478|515650396|FG002|Multiple-dose Phase|Protocol Violation|0|||
143029432|NCT02246478|515650397|FG003|Multiple-dose Phase|Protocol Violation|1|||
143029433|NCT00536575|515650400|FG000|Overall Study|Withdrawal by Subject|1|||
143029434|NCT00536575|515650400|FG000|Overall Study|Death|1|||
143029435|NCT01089647|515650402|FG000|Overall Study|Lost to Follow-up|2|||
143029436|NCT01089647|515650403|FG001|Overall Study|Lost to Follow-up|2|||
143029437|NCT01089647|515650402|FG000|Overall Study|Withdrawal by Subject|2|||
143029438|NCT01089647|515650403|FG001|Overall Study|Withdrawal by Subject|1|||
143029439|NCT01089647|515650402|FG000|Overall Study|Adverse Event|0|||
143029440|NCT01089647|515650403|FG001|Overall Study|Adverse Event|1|||
143029441|NCT01531205|515650404|FG000|Overall Study|Did not proceed to surgery|1|||
143029442|NCT00927810|515650405|FG000|Overall Study|Withdrawal by Subject|0|||
143029443|NCT00927810|515650406|FG001|Overall Study|Withdrawal by Subject|3|||
143029444|NCT00927810|515650407|FG002|Overall Study|Withdrawal by Subject|0|||
143029445|NCT00927810|515650408|FG003|Overall Study|Withdrawal by Subject|1|||
143029446|NCT00927810|515650405|FG000|Overall Study|Lost to Follow-up|0|||
143029447|NCT00927810|515650406|FG001|Overall Study|Lost to Follow-up|2|||
143029448|NCT00927810|515650407|FG002|Overall Study|Lost to Follow-up|1|||
143029449|NCT00927810|515650408|FG003|Overall Study|Lost to Follow-up|1|||
143029450|NCT00927810|515650405|FG000|Overall Study|Death|0|||
143029451|NCT00927810|515650406|FG001|Overall Study|Death|2|||
143029452|NCT00927810|515650407|FG002|Overall Study|Death|0|||
143029453|NCT00927810|515650408|FG003|Overall Study|Death|0|||
143029454|NCT00927810|515650405|FG000|Overall Study|Abnormal laboratory value(s)|0|||
143029455|NCT00927810|515650406|FG001|Overall Study|Abnormal laboratory value(s)|1|||
143029456|NCT00927810|515650407|FG002|Overall Study|Abnormal laboratory value(s)|0|||
143029457|NCT00927810|515650408|FG003|Overall Study|Abnormal laboratory value(s)|0|||
143029458|NCT00198029|515650412|FG000|Overall Study|Withdrawal by Subject|4|||
143029459|NCT02465567|515650413|FG000|Overall Study|Adverse Event|118|||
143029460|NCT02465567|515650414|FG001|Overall Study|Adverse Event|113|||
143029461|NCT02465567|515650415|FG002|Overall Study|Adverse Event|147|||
143029462|NCT02465567|515650416|FG003|Overall Study|Adverse Event|138|||
143029463|NCT02465567|515650413|FG000|Overall Study|Lack of Efficacy|103|||
143029464|NCT02465567|515650414|FG001|Overall Study|Lack of Efficacy|102|||
143029465|NCT02465567|515650415|FG002|Overall Study|Lack of Efficacy|171|||
143029466|NCT02465567|515650416|FG003|Overall Study|Lack of Efficacy|135|||
143237415|NCT01337960|516423286|FG001|Overall Study|Withdrawal by Subject|0|||
143029467|NCT02465567|515650413|FG000|Overall Study|Withdrawal by Subject|104|||
143029468|NCT02465567|515650414|FG001|Overall Study|Withdrawal by Subject|94|||
143029469|NCT02465567|515650415|FG002|Overall Study|Withdrawal by Subject|123|||
143029470|NCT02465567|515650416|FG003|Overall Study|Withdrawal by Subject|130|||
143029471|NCT02465567|515650413|FG000|Overall Study|Physician Decision|23|||
143029472|NCT02465567|515650414|FG001|Overall Study|Physician Decision|33|||
143029473|NCT02465567|515650415|FG002|Overall Study|Physician Decision|38|||
143029474|NCT02465567|515650416|FG003|Overall Study|Physician Decision|28|||
143029475|NCT02465567|515650413|FG000|Overall Study|Major Protocol Deviation|24|||
143029476|NCT02465567|515650414|FG001|Overall Study|Major Protocol Deviation|26|||
143029477|NCT02465567|515650415|FG002|Overall Study|Major Protocol Deviation|22|||
143029478|NCT02465567|515650416|FG003|Overall Study|Major Protocol Deviation|25|||
143029479|NCT02465567|515650413|FG000|Overall Study|Lost to Follow-up|25|||
143029480|NCT02465567|515650414|FG001|Overall Study|Lost to Follow-up|21|||
143029481|NCT02465567|515650415|FG002|Overall Study|Lost to Follow-up|19|||
143029482|NCT02465567|515650416|FG003|Overall Study|Lost to Follow-up|15|||
143029483|NCT02465567|515650413|FG000|Overall Study|Protocol Specified Criteria|20|||
143029484|NCT02465567|515650414|FG001|Overall Study|Protocol Specified Criteria|10|||
143029485|NCT02465567|515650415|FG002|Overall Study|Protocol Specified Criteria|9|||
143029486|NCT02465567|515650416|FG003|Overall Study|Protocol Specified Criteria|12|||
143029487|NCT02465567|515650413|FG000|Overall Study|Administrative Reasons|12|||
143029488|NCT02465567|515650414|FG001|Overall Study|Administrative Reasons|9|||
143029489|NCT02465567|515650415|FG002|Overall Study|Administrative Reasons|11|||
143029490|NCT02465567|515650416|FG003|Overall Study|Administrative Reasons|5|||
143029491|NCT02465567|515650413|FG000|Overall Study|Randomized but not treated|1|||
143029492|NCT02465567|515650414|FG001|Overall Study|Randomized but not treated|5|||
143029493|NCT02465567|515650415|FG002|Overall Study|Randomized but not treated|4|||
143029494|NCT02465567|515650416|FG003|Overall Study|Randomized but not treated|5|||
143029495|NCT02465567|515650413|FG000|Overall Study|enrolled in >1 studies|18|||
143029496|NCT02465567|515650414|FG001|Overall Study|enrolled in >1 studies|11|||
143029497|NCT02465567|515650415|FG002|Overall Study|enrolled in >1 studies|19|||
143029498|NCT02465567|515650416|FG003|Overall Study|enrolled in >1 studies|15|||
143029499|NCT02465567|515650413|FG000|Overall Study|missing PI Signature|1|||
143029500|NCT02465567|515650414|FG001|Overall Study|missing PI Signature|0|||
143029501|NCT02465567|515650415|FG002|Overall Study|missing PI Signature|0|||
143029502|NCT02465567|515650416|FG003|Overall Study|missing PI Signature|0|||
143029503|NCT02001558|515650417|FG000|Overall Study|Lost to Follow-up|8|||
143029504|NCT02001558|515650418|FG001|Overall Study|Lost to Follow-up|14|||
143029505|NCT06331156|515650419|FG000|Overall Study|Adverse Event|1|||
143029506|NCT06331156|515650420|FG001|Overall Study|Adverse Event|0|||
143029507|NCT06331156|515650419|FG000|Overall Study|Lost to Follow-up|1|||
143029508|NCT06331156|515650420|FG001|Overall Study|Lost to Follow-up|0|||
143029509|NCT06331156|515650419|FG000|Overall Study|Migrated / Moved from the study area|4|||
143029510|NCT06331156|515650420|FG001|Overall Study|Migrated / Moved from the study area|3|||
143029511|NCT06331156|515650419|FG000|Overall Study|Other|7|||
143029512|NCT06331156|515650420|FG001|Overall Study|Other|0|||
143029513|NCT06331156|515650419|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
143029514|NCT06331156|515650420|FG001|Overall Study|Adverse event requiring expedited reporting|1|||
143029515|NCT04117607|515650421|FG000|Overall Study|Early Termination|0|||
143029516|NCT04117607|515650422|FG001|Overall Study|Early Termination|1|||
143029517|NCT04117607|515650423|FG002|Overall Study|Early Termination|0|||
143029518|NCT04117607|515650424|FG003|Overall Study|Early Termination|0|||
143029519|NCT04117607|515650425|FG004|Overall Study|Early Termination|0|||
143029520|NCT04117607|515650426|FG005|Overall Study|Early Termination|0|||
143029521|NCT04117607|515650427|FG006|Overall Study|Early Termination|1|||
143029522|NCT04117607|515650428|FG007|Overall Study|Early Termination|0|||
143029523|NCT04117607|515650429|FG008|Overall Study|Early Termination|0|||
143029524|NCT04117607|515650430|FG009|Overall Study|Early Termination|0|||
143029525|NCT04117607|515650431|FG010|Overall Study|Early Termination|0|||
143029526|NCT04117607|515650432|FG011|Overall Study|Early Termination|0|||
143029527|NCT04117607|515650433|FG012|Overall Study|Early Termination|0|||
143029528|NCT04117607|515650434|FG013|Overall Study|Early Termination|0|||
143029529|NCT01626079|515650436|FG000|Overall Study|Death|167|||
143029530|NCT01626079|515650437|FG001|Overall Study|Death|192|||
143029531|NCT01626079|515650438|FG002|Overall Study|Death|39|||
143029532|NCT01626079|515650436|FG000|Overall Study|Withdrawal by Subject|23|||
143029533|NCT01626079|515650437|FG001|Overall Study|Withdrawal by Subject|37|||
143029534|NCT01626079|515650438|FG002|Overall Study|Withdrawal by Subject|5|||
143029535|NCT01626079|515650436|FG000|Overall Study|Lost to Follow-up|7|||
143029536|NCT01626079|515650437|FG001|Overall Study|Lost to Follow-up|4|||
143029537|NCT01626079|515650438|FG002|Overall Study|Lost to Follow-up|2|||
143029538|NCT01626079|515650436|FG000|Overall Study|Missed Visits|1|||
143029539|NCT01626079|515650437|FG001|Overall Study|Missed Visits|4|||
143029540|NCT01626079|515650438|FG002|Overall Study|Missed Visits|6|||
143029541|NCT01457053|515650445|FG000|Overall Study|Unable to undergo selected treatment|1|||
143029542|NCT01457053|515650446|FG001|Overall Study|Unable to undergo selected treatment|1|||
143029543|NCT00814463|515650448|FG000|Overall Study|Lost to Follow-up|1|||
143029544|NCT02430870|515650450|FG000|Part 2|Voluntary Withdrawal|0|||
143029545|NCT02430870|515650451|FG001|Part 2|Voluntary Withdrawal|0|||
143029546|NCT02430870|515650452|FG002|Part 2|Voluntary Withdrawal|0|||
143029547|NCT02430870|515650453|FG003|Part 2|Voluntary Withdrawal|0|||
143029548|NCT02430870|515650454|FG004|Part 2|Voluntary Withdrawal|0|||
143029549|NCT02430870|515650455|FG005|Part 2|Voluntary Withdrawal|0|||
143029550|NCT02430870|515650456|FG006|Part 2|Voluntary Withdrawal|1|||
143029551|NCT02430870|515650457|FG007|Part 2|Voluntary Withdrawal|0|||
143029552|NCT02430870|515650450|FG000|Part 2|Other Reason Not Specified|0|||
143029553|NCT02430870|515650451|FG001|Part 2|Other Reason Not Specified|0|||
143029554|NCT02430870|515650452|FG002|Part 2|Other Reason Not Specified|0|||
143029555|NCT02430870|515650453|FG003|Part 2|Other Reason Not Specified|0|||
143029556|NCT02430870|515650454|FG004|Part 2|Other Reason Not Specified|0|||
143029557|NCT02430870|515650455|FG005|Part 2|Other Reason Not Specified|0|||
143029558|NCT02430870|515650456|FG006|Part 2|Other Reason Not Specified|0|||
143029559|NCT02430870|515650457|FG007|Part 2|Other Reason Not Specified|1|||
143029560|NCT02780687|515650458|FG000|Overall Study|Adverse Event|1|||
143029561|NCT02780687|515650459|FG001|Overall Study|Adverse Event|1|||
143029562|NCT02780687|515650458|FG000|Overall Study|Withdrawal by Subject|2|||
143029563|NCT02780687|515650459|FG001|Overall Study|Withdrawal by Subject|1|||
143029564|NCT02780687|515650458|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
143029565|NCT02780687|515650459|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
143029566|NCT02780687|515650458|FG000|Overall Study|progressive disease|29|||
143029567|NCT02780687|515650459|FG001|Overall Study|progressive disease|6|||
143029568|NCT03982433|515650460|FG000|Overall Study|Lost to Follow-up|1|||
143029569|NCT00984295|515650465|FG000|Overall Study|Lost to Follow-up|31|||
143029570|NCT00984295|515650466|FG001|Overall Study|Lost to Follow-up|12|||
143029571|NCT00984295|515650467|FG002|Overall Study|Lost to Follow-up|13|||
143029572|NCT00984295|515650465|FG000|Overall Study|Protocol Violation|2|||
143029573|NCT00984295|515650466|FG001|Overall Study|Protocol Violation|1|||
143029574|NCT00984295|515650467|FG002|Overall Study|Protocol Violation|4|||
143029575|NCT00984295|515650465|FG000|Overall Study|Withdrawal by Subject|18|||
143029576|NCT00984295|515650466|FG001|Overall Study|Withdrawal by Subject|9|||
143029577|NCT00984295|515650467|FG002|Overall Study|Withdrawal by Subject|12|||
143029578|NCT00984295|515650465|FG000|Overall Study|CAE - discontinued test vaccine|0|||
143029579|NCT00984295|515650466|FG001|Overall Study|CAE - discontinued test vaccine|1|||
143029580|NCT00984295|515650467|FG002|Overall Study|CAE - discontinued test vaccine|3|||
143029581|NCT00984295|515650465|FG000|Overall Study|Missed one or more blood samplings|3|||
143029582|NCT00984295|515650466|FG001|Overall Study|Missed one or more blood samplings|7|||
143029583|NCT00984295|515650467|FG002|Overall Study|Missed one or more blood samplings|2|||
143029584|NCT00984295|515650465|FG000|Overall Study|Incomplete safety follow-up|11|||
143029585|NCT00984295|515650466|FG001|Overall Study|Incomplete safety follow-up|2|||
143029586|NCT00984295|515650467|FG002|Overall Study|Incomplete safety follow-up|3|||
143029587|NCT04582539|515650468|FG000|Overall Study|Death|1|||
143029588|NCT04582539|515650469|FG001|Overall Study|Death|1|||
143029589|NCT04582539|515650470|FG002|Overall Study|Death|0|||
143029590|NCT04582539|515650471|FG003|Overall Study|Death|1|||
143029591|NCT04582539|515650472|FG004|Overall Study|Death|0|||
143029592|NCT04582539|515650468|FG000|Overall Study|Lost to Follow-up|1|||
143029593|NCT04582539|515650469|FG001|Overall Study|Lost to Follow-up|0|||
143029594|NCT04582539|515650470|FG002|Overall Study|Lost to Follow-up|0|||
143029595|NCT04582539|515650471|FG003|Overall Study|Lost to Follow-up|0|||
143029596|NCT04582539|515650472|FG004|Overall Study|Lost to Follow-up|0|||
143029597|NCT04582539|515650468|FG000|Overall Study|Study Terminated by Sponsor|1|||
143029598|NCT04582539|515650469|FG001|Overall Study|Study Terminated by Sponsor|3|||
143029599|NCT04582539|515650470|FG002|Overall Study|Study Terminated by Sponsor|2|||
143029600|NCT04582539|515650471|FG003|Overall Study|Study Terminated by Sponsor|2|||
143029601|NCT04582539|515650472|FG004|Overall Study|Study Terminated by Sponsor|3|||
143029602|NCT04582539|515650468|FG000|Overall Study|Physician Decision|0|||
143029603|NCT04582539|515650469|FG001|Overall Study|Physician Decision|1|||
143029604|NCT04582539|515650470|FG002|Overall Study|Physician Decision|0|||
143029605|NCT04582539|515650471|FG003|Overall Study|Physician Decision|0|||
143029606|NCT04582539|515650472|FG004|Overall Study|Physician Decision|0|||
143029607|NCT04582539|515650468|FG000|Overall Study|Withdrawal by Subject|1|||
143029608|NCT04582539|515650469|FG001|Overall Study|Withdrawal by Subject|0|||
143029609|NCT04582539|515650470|FG002|Overall Study|Withdrawal by Subject|2|||
143363991|NCT03635112|516875517|FG000|Overall Study|Physician Decision|5|||
143363992|NCT03635112|516875518|FG001|Overall Study|Physician Decision|7|||
143363993|NCT03635112|516875519|FG002|Overall Study|Physician Decision|5|||
143363994|NCT03635112|516875517|FG000|Overall Study|Protocol Violation|0|||
143029610|NCT04582539|515650471|FG003|Overall Study|Withdrawal by Subject|1|||
143029611|NCT04582539|515650472|FG004|Overall Study|Withdrawal by Subject|0|||
143029612|NCT04582539|515650468|FG000|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
143029613|NCT04582539|515650469|FG001|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
143029614|NCT04582539|515650470|FG002|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
143363995|NCT03635112|516875518|FG001|Overall Study|Protocol Violation|0|||
143029615|NCT04582539|515650471|FG003|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|1|||
143029616|NCT04582539|515650472|FG004|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
143029617|NCT00788957|515650481|FG000|Part 1|Death|8|||
143029618|NCT00788957|515650482|FG001|Part 1|Death|0|||
143029619|NCT00788957|515650483|FG002|Part 1|Death|0|||
143363996|NCT03635112|516875519|FG002|Overall Study|Protocol Violation|1|||
143029620|NCT00788957|515650484|FG003|Part 1|Death|0|||
143029621|NCT00788957|515650485|FG004|Part 1|Death|0|||
143029622|NCT00788957|515650486|FG005|Part 1|Death|0|||
143029623|NCT00788957|515650481|FG000|Part 1|Lost to Follow-up|1|||
143029624|NCT00788957|515650482|FG001|Part 1|Lost to Follow-up|0|||
143029625|NCT00788957|515650483|FG002|Part 1|Lost to Follow-up|0|||
143029626|NCT00788957|515650484|FG003|Part 1|Lost to Follow-up|0|||
143029627|NCT00788957|515650485|FG004|Part 1|Lost to Follow-up|0|||
143029628|NCT00788957|515650486|FG005|Part 1|Lost to Follow-up|0|||
143029629|NCT00788957|515650481|FG000|Part 2|Withdrawal by Subject|0|||
143029630|NCT00788957|515650482|FG001|Part 2|Withdrawal by Subject|9|||
143029631|NCT00788957|515650483|FG002|Part 2|Withdrawal by Subject|5|||
143029632|NCT00788957|515650484|FG003|Part 2|Withdrawal by Subject|3|||
143029633|NCT00788957|515650485|FG004|Part 2|Withdrawal by Subject|0|||
143029634|NCT00788957|515650486|FG005|Part 2|Withdrawal by Subject|0|||
143029635|NCT00788957|515650481|FG000|Part 2|Death|0|||
143029636|NCT00788957|515650482|FG001|Part 2|Death|32|||
143029637|NCT00788957|515650483|FG002|Part 2|Death|35|||
143029638|NCT00788957|515650484|FG003|Part 2|Death|37|||
143029639|NCT00788957|515650485|FG004|Part 2|Death|0|||
143029640|NCT00788957|515650486|FG005|Part 2|Death|0|||
143029641|NCT00788957|515650481|FG000|Part 2|Lost to Follow-up|0|||
143029642|NCT00788957|515650482|FG001|Part 2|Lost to Follow-up|0|||
143029643|NCT00788957|515650483|FG002|Part 2|Lost to Follow-up|3|||
143029644|NCT00788957|515650484|FG003|Part 2|Lost to Follow-up|0|||
143029645|NCT00788957|515650485|FG004|Part 2|Lost to Follow-up|0|||
143029646|NCT00788957|515650486|FG005|Part 2|Lost to Follow-up|0|||
143029647|NCT00788957|515650481|FG000|Part 2|On-study at time of data cut-off|0|||
143029648|NCT00788957|515650482|FG001|Part 2|On-study at time of data cut-off|1|||
143029649|NCT00788957|515650483|FG002|Part 2|On-study at time of data cut-off|1|||
143029650|NCT00788957|515650484|FG003|Part 2|On-study at time of data cut-off|1|||
143029651|NCT00788957|515650485|FG004|Part 2|On-study at time of data cut-off|0|||
143029652|NCT00788957|515650486|FG005|Part 2|On-study at time of data cut-off|0|||
143029653|NCT00788957|515650481|FG000|Part 3|Withdrawal by Subject|0|||
143029654|NCT00788957|515650482|FG001|Part 3|Withdrawal by Subject|0|||
143029655|NCT00788957|515650483|FG002|Part 3|Withdrawal by Subject|0|||
143029656|NCT00788957|515650484|FG003|Part 3|Withdrawal by Subject|0|||
143029657|NCT00788957|515650485|FG004|Part 3|Withdrawal by Subject|0|||
143029658|NCT00788957|515650486|FG005|Part 3|Withdrawal by Subject|2|||
143029659|NCT00788957|515650481|FG000|Part 3|Death|0|||
143029660|NCT00788957|515650482|FG001|Part 3|Death|0|||
143029661|NCT00788957|515650483|FG002|Part 3|Death|0|||
143029662|NCT00788957|515650484|FG003|Part 3|Death|0|||
143029663|NCT00788957|515650485|FG004|Part 3|Death|8|||
143029664|NCT00788957|515650486|FG005|Part 3|Death|8|||
143029665|NCT00788957|515650481|FG000|Part 3|On-study at time of data cut-off|0|||
143029666|NCT00788957|515650482|FG001|Part 3|On-study at time of data cut-off|0|||
143029667|NCT00788957|515650483|FG002|Part 3|On-study at time of data cut-off|0|||
143029668|NCT00788957|515650484|FG003|Part 3|On-study at time of data cut-off|0|||
143029669|NCT00788957|515650485|FG004|Part 3|On-study at time of data cut-off|1|||
143029670|NCT00788957|515650486|FG005|Part 3|On-study at time of data cut-off|0|||
143029671|NCT00662129|515650487|FG000|Overall Study|Protocol Violation|1|||
143029672|NCT00662129|515650487|FG000|Overall Study|Cancel prior to beginning treatment|1|||
143029673|NCT00662129|515650487|FG000|Overall Study|Ineligible|1|||
143029674|NCT03276975|515650488|FG000|Overall Study|Withdrawal by Subject|1|||
143029675|NCT03276975|515650489|FG001|Overall Study|Withdrawal by Subject|0|||
143029676|NCT02153736|515650496|FG000|Overall Study|Lost to Follow-up|1|||
143029677|NCT02153736|515650497|FG001|Overall Study|Lost to Follow-up|0|||
143029678|NCT02153736|515650496|FG000|Overall Study|Medical status change made ineligible|1|||
143029679|NCT02153736|515650497|FG001|Overall Study|Medical status change made ineligible|0|||
143029680|NCT02153736|515650496|FG000|Overall Study|Death|0|||
143029681|NCT02153736|515650497|FG001|Overall Study|Death|1|||
143158464|NCT02487199|516124482|FG001|Overall Study|Withdrew Consent|1|||
143158465|NCT00520572|516125982|FG000|Overall Study|Adverse Event|9|||
143158466|NCT00520572|516125983|FG001|Overall Study|Adverse Event|3|||
143158467|NCT00520572|516125984|FG002|Overall Study|Adverse Event|6|||
143158468|NCT00520572|516125985|FG003|Overall Study|Adverse Event|9|||
143158469|NCT00520572|516125986|FG004|Overall Study|Adverse Event|7|||
143029682|NCT02153736|515650496|FG000|Overall Study|Withdrawal by Subject|0|||
143492085|NCT03977467|517342708|FG001|Overall Study|Death|0|||
143029683|NCT02153736|515650497|FG001|Overall Study|Withdrawal by Subject|1|||
143029684|NCT00796510|515650506|FG000|Overall Study|Death|1|||
143029685|NCT00796510|515650507|FG001|Overall Study|Death|0|||
143029686|NCT00796510|515650506|FG000|Overall Study|Study Terminated|2|||
143029687|NCT00796510|515650507|FG001|Overall Study|Study Terminated|0|||
143492086|NCT03977467|517342709|FG002|Overall Study|Death|3|||
143029688|NCT05030753|515650508|FG000|9-week|Lost to Follow-up|10|||
143029689|NCT05030753|515650509|FG001|9-week|Lost to Follow-up|7|||
143158470|NCT00520572|516125987|FG005|Overall Study|Adverse Event|2|||
143029690|NCT05030753|515650508|FG000|9-week|Withdrawal by Subject|1|||
143029691|NCT05030753|515650509|FG001|9-week|Withdrawal by Subject|0|||
143029692|NCT05030753|515650508|FG000|9-week|Excluded from analysis due to missing covariates|2|||
143029693|NCT05030753|515650509|FG001|9-week|Excluded from analysis due to missing covariates|1|||
143029694|NCT05030753|515650508|FG000|6-month post intervention|Lost to Follow-up|5|||
143029695|NCT05030753|515650509|FG001|6-month post intervention|Lost to Follow-up|4|||
143029696|NCT05030753|515650508|FG000|6-month post intervention|Withdrawal by Subject|4|||
143158471|NCT00520572|516125982|FG000|Overall Study|Withdrawal by Subject|0|||
143029697|NCT05030753|515650509|FG001|6-month post intervention|Withdrawal by Subject|0|||
143029698|NCT05030753|515650508|FG000|18-month post intervention|Lost to Follow-up|3|||
143029699|NCT05030753|515650509|FG001|18-month post intervention|Lost to Follow-up|1|||
143029700|NCT00720122|515650515|FG000|Overall Study|Lost to Follow-up|1|||
143029701|NCT00720122|515650515|FG000|Overall Study|Physician Decision|1|||
143029702|NCT00720122|515650515|FG000|Overall Study|Withdrawal by Subject|7|||
143029703|NCT00510510|515650516|FG000|Overall Study|Adverse Event|4|||
143029704|NCT00510510|515650517|FG001|Overall Study|Adverse Event|3|||
143029705|NCT00510510|515650518|FG002|Overall Study|Adverse Event|6|||
143029706|NCT00510510|515650516|FG000|Overall Study|Lack of Efficacy|0|||
143029707|NCT00510510|515650517|FG001|Overall Study|Lack of Efficacy|1|||
143029708|NCT00510510|515650518|FG002|Overall Study|Lack of Efficacy|1|||
143029709|NCT00510510|515650516|FG000|Overall Study|Subjects no longer requires study drug|0|||
143029710|NCT00510510|515650517|FG001|Overall Study|Subjects no longer requires study drug|0|||
143029711|NCT00510510|515650518|FG002|Overall Study|Subjects no longer requires study drug|2|||
143029712|NCT00510510|515650516|FG000|Overall Study|Withdrawal by Subject|1|||
143029713|NCT00510510|515650517|FG001|Overall Study|Withdrawal by Subject|2|||
143029714|NCT00510510|515650518|FG002|Overall Study|Withdrawal by Subject|3|||
143029715|NCT00510510|515650516|FG000|Overall Study|Lost to Follow-up|0|||
143029716|NCT00510510|515650517|FG001|Overall Study|Lost to Follow-up|0|||
143029717|NCT00510510|515650518|FG002|Overall Study|Lost to Follow-up|1|||
143029718|NCT00510510|515650516|FG000|Overall Study|Protocol Violation|0|||
143029719|NCT00510510|515650517|FG001|Overall Study|Protocol Violation|3|||
143029720|NCT00510510|515650518|FG002|Overall Study|Protocol Violation|4|||
143029721|NCT01361126|515650519|FG000|Overall Study|Sponsor decision|0|||
143029722|NCT01361126|515650520|FG001|Overall Study|Sponsor decision|2|||
143029723|NCT00911859|515650521|FG000|Treatment Period|Adverse Event|3|||
143029724|NCT00911859|515650522|FG001|Treatment Period|Adverse Event|3|||
143029725|NCT00911859|515650523|FG002|Treatment Period|Adverse Event|7|||
143029726|NCT00911859|515650521|FG000|Treatment Period|Death|1|||
143029727|NCT00911859|515650522|FG001|Treatment Period|Death|3|||
143029728|NCT00911859|515650523|FG002|Treatment Period|Death|5|||
143029729|NCT00911859|515650521|FG000|Treatment Period|Lack of Efficacy|1|||
143029730|NCT00911859|515650522|FG001|Treatment Period|Lack of Efficacy|7|||
143029731|NCT00911859|515650523|FG002|Treatment Period|Lack of Efficacy|5|||
143029732|NCT00911859|515650521|FG000|Treatment Period|Physician Decision|3|||
143029733|NCT00911859|515650522|FG001|Treatment Period|Physician Decision|3|||
143029734|NCT00911859|515650523|FG002|Treatment Period|Physician Decision|3|||
143029735|NCT00911859|515650521|FG000|Treatment Period|Withdrawal by Subject|0|||
143029736|NCT00911859|515650522|FG001|Treatment Period|Withdrawal by Subject|4|||
143029737|NCT00911859|515650523|FG002|Treatment Period|Withdrawal by Subject|5|||
143029738|NCT00911859|515650521|FG000|Treatment Period|Did not receive study treatment|0|||
143029739|NCT00911859|515650522|FG001|Treatment Period|Did not receive study treatment|1|||
143029740|NCT00911859|515650523|FG002|Treatment Period|Did not receive study treatment|0|||
143029741|NCT00911859|515650521|FG000|Maintainance Period|Lack of Efficacy|0|||
143029742|NCT00911859|515650522|FG001|Maintainance Period|Lack of Efficacy|0|||
143029743|NCT00911859|515650523|FG002|Maintainance Period|Lack of Efficacy|9|||
143029744|NCT00911859|515650521|FG000|Maintainance Period|Physician Decision|0|||
143029745|NCT00911859|515650522|FG001|Maintainance Period|Physician Decision|0|||
143029746|NCT00911859|515650523|FG002|Maintainance Period|Physician Decision|9|||
143029747|NCT00911859|515650521|FG000|Maintainance Period|Withdrawal by Subject|0|||
143029748|NCT00911859|515650522|FG001|Maintainance Period|Withdrawal by Subject|0|||
143029749|NCT00911859|515650523|FG002|Maintainance Period|Withdrawal by Subject|3|||
143029750|NCT00911859|515650521|FG000|Follow-up Period|Death|5|||
143029751|NCT00911859|515650522|FG001|Follow-up Period|Death|8|||
143029752|NCT00911859|515650523|FG002|Follow-up Period|Death|10|||
143029753|NCT00911859|515650521|FG000|Follow-up Period|Lost to Follow-up|1|||
143029754|NCT00911859|515650522|FG001|Follow-up Period|Lost to Follow-up|1|||
143029755|NCT00911859|515650523|FG002|Follow-up Period|Lost to Follow-up|0|||
143029756|NCT00911859|515650521|FG000|Follow-up Period|Withdrawal by Subject|0|||
143029757|NCT00911859|515650522|FG001|Follow-up Period|Withdrawal by Subject|4|||
143029758|NCT00911859|515650523|FG002|Follow-up Period|Withdrawal by Subject|4|||
143029759|NCT00911859|515650521|FG000|Follow-up Period|Study terminated by sponsor|5|||
143029760|NCT00911859|515650522|FG001|Follow-up Period|Study terminated by sponsor|33|||
143029761|NCT00911859|515650523|FG002|Follow-up Period|Study terminated by sponsor|27|||
143029762|NCT02346201|515650530|FG000|Overall Study|Adverse Event|3|||
143029763|NCT02346201|515650531|FG001|Overall Study|Adverse Event|2|||
143029764|NCT02346201|515650530|FG000|Overall Study|Lost to Follow-up|1|||
143029765|NCT02346201|515650531|FG001|Overall Study|Lost to Follow-up|0|||
143029766|NCT02346201|515650530|FG000|Overall Study|Withdrawal by Subject|6|||
143029767|NCT02346201|515650531|FG001|Overall Study|Withdrawal by Subject|3|||
143029768|NCT02346201|515650530|FG000|Overall Study|Unavailable for future follow-up|0|||
143029769|NCT02346201|515650531|FG001|Overall Study|Unavailable for future follow-up|1|||
143029770|NCT02346201|515650530|FG000|Overall Study|Physician Decision|0|||
143029771|NCT02346201|515650531|FG001|Overall Study|Physician Decision|1|||
143029772|NCT02346201|515650530|FG000|Overall Study|Missed final visit|0|||
143029773|NCT02346201|515650531|FG001|Overall Study|Missed final visit|2|||
143029774|NCT01508936|515650534|FG000|Overall Study|Adverse Event|11|||
143029775|NCT01508936|515650535|FG001|Overall Study|Adverse Event|32|||
143029776|NCT01508936|515650534|FG000|Overall Study|Lack of Efficacy|0|||
143029777|NCT01508936|515650535|FG001|Overall Study|Lack of Efficacy|1|||
143029778|NCT01508936|515650534|FG000|Overall Study|Withdrawal by Subject|4|||
143029779|NCT01508936|515650535|FG001|Overall Study|Withdrawal by Subject|18|||
143029780|NCT01508936|515650534|FG000|Overall Study|Protocol Violation|2|||
143029781|NCT01508936|515650535|FG001|Overall Study|Protocol Violation|3|||
143029782|NCT01508936|515650534|FG000|Overall Study|Lost to Follow-up|2|||
143029783|NCT01508936|515650535|FG001|Overall Study|Lost to Follow-up|9|||
143029784|NCT01508936|515650534|FG000|Overall Study|Other|0|||
143029785|NCT01508936|515650535|FG001|Overall Study|Other|5|||
143029786|NCT01508936|515650534|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
143029787|NCT01508936|515650535|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
143029788|NCT00679367|515650536|FG000|Overall Study|Adverse Event|7|||
143029789|NCT00679367|515650536|FG000|Overall Study|inability to swallow oral drugs|1|||
143029790|NCT00679367|515650536|FG000|Overall Study|Lack of Efficacy|3|||
143029791|NCT00679367|515650536|FG000|Overall Study|Withdrawal by Subject|1|||
143029792|NCT03365947|515650537|FG000|Overall Study|Lost to Follow-up|0|||
143029793|NCT03365947|515650538|FG001|Overall Study|Lost to Follow-up|0|||
143029794|NCT03365947|515650539|FG002|Overall Study|Lost to Follow-up|0|||
143029795|NCT03365947|515650540|FG003|Overall Study|Lost to Follow-up|0|||
143029796|NCT03365947|515650541|FG004|Overall Study|Lost to Follow-up|0|||
143029797|NCT03365947|515650542|FG005|Overall Study|Lost to Follow-up|1|||
143029798|NCT03365947|515650543|FG006|Overall Study|Lost to Follow-up|0|||
143029799|NCT03365947|515650544|FG007|Overall Study|Lost to Follow-up|0|||
143029800|NCT03365947|515650545|FG008|Overall Study|Lost to Follow-up|0|||
143029801|NCT03365947|515650546|FG009|Overall Study|Lost to Follow-up|0|||
143029802|NCT03365947|515650547|FG010|Overall Study|Lost to Follow-up|0|||
143029803|NCT03365947|515650548|FG011|Overall Study|Lost to Follow-up|0|||
143029804|NCT03365947|515650549|FG012|Overall Study|Lost to Follow-up|0|||
143029805|NCT03365947|515650550|FG013|Overall Study|Lost to Follow-up|0|||
143029806|NCT03365947|515650551|FG014|Overall Study|Lost to Follow-up|0|||
143029807|NCT03365947|515650552|FG015|Overall Study|Lost to Follow-up|0|||
143029808|NCT03365947|515650553|FG016|Overall Study|Lost to Follow-up|0|||
143029809|NCT03365947|515650554|FG017|Overall Study|Lost to Follow-up|0|||
143029810|NCT03365947|515650555|FG018|Overall Study|Lost to Follow-up|0|||
143029811|NCT02518685|515650556|FG000|Overall Study|Adverse Event|29|||
143029812|NCT02518685|515650557|FG001|Overall Study|Adverse Event|1|||
143029813|NCT02518685|515650556|FG000|Overall Study|Withdrawal by Subject|10|||
143029814|NCT02518685|515650557|FG001|Overall Study|Withdrawal by Subject|3|||
143029815|NCT02518685|515650556|FG000|Overall Study|relocation, study fatigue|7|||
143029816|NCT02518685|515650557|FG001|Overall Study|relocation, study fatigue|2|||
143029817|NCT02518685|515650556|FG000|Overall Study|Pregnancy|1|||
143029818|NCT02518685|515650557|FG001|Overall Study|Pregnancy|0|||
143029819|NCT02518685|515650556|FG000|Overall Study|Physician Decision|1|||
143029820|NCT02518685|515650557|FG001|Overall Study|Physician Decision|0|||
143029821|NCT02518685|515650556|FG000|Overall Study|Lost to Follow-up|1|||
143029822|NCT02518685|515650557|FG001|Overall Study|Lost to Follow-up|4|||
143029823|NCT02785913|515652782|FG000|Overall Study|Adverse Event|5|||
143158472|NCT00520572|516125983|FG001|Overall Study|Withdrawal by Subject|9|||
143158473|NCT00520572|516125984|FG002|Overall Study|Withdrawal by Subject|5|||
143158474|NCT00520572|516125985|FG003|Overall Study|Withdrawal by Subject|2|||
143158475|NCT00520572|516125986|FG004|Overall Study|Withdrawal by Subject|2|||
143158476|NCT00520572|516125987|FG005|Overall Study|Withdrawal by Subject|0|||
143158477|NCT00520572|516125982|FG000|Overall Study|Protocol Violation|0|||
143158478|NCT00520572|516125983|FG001|Overall Study|Protocol Violation|0|||
143158479|NCT00520572|516125984|FG002|Overall Study|Protocol Violation|1|||
143158480|NCT00520572|516125985|FG003|Overall Study|Protocol Violation|0|||
143158481|NCT00520572|516125986|FG004|Overall Study|Protocol Violation|0|||
143029824|NCT02785913|515652782|FG000|Overall Study|Death|2|||
143029825|NCT02785913|515652782|FG000|Overall Study|Progression|18|||
143029826|NCT02785913|515652782|FG000|Overall Study|Not protocol specified|1|||
143029827|NCT02841709|515652783|FG000|5th Intervention|Adverse Event|2|||
143029828|NCT02841709|515652784|FG001|5th Intervention|Adverse Event|0|||
143029829|NCT02841709|515652785|FG002|5th Intervention|Adverse Event|0|||
143029830|NCT02841709|515652786|FG003|5th Intervention|Adverse Event|0|||
143029831|NCT02841709|515652787|FG004|5th Intervention|Adverse Event|2|||
143029832|NCT01929109|515652788|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
143029833|NCT01929109|515652789|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
143158482|NCT00520572|516125987|FG005|Overall Study|Protocol Violation|0|||
143158483|NCT00520572|516125982|FG000|Overall Study|Lack of Efficacy|1|||
143158484|NCT00520572|516125983|FG001|Overall Study|Lack of Efficacy|1|||
143158485|NCT00520572|516125984|FG002|Overall Study|Lack of Efficacy|1|||
143029834|NCT01929109|515652790|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
143029835|NCT01929109|515652791|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
143029836|NCT01929109|515652792|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
143029837|NCT02309099|515652802|FG000|Overall Study|Adverse Event|2|||
143029838|NCT02309099|515652803|FG001|Overall Study|Adverse Event|0|||
143029839|NCT02016300|515652804|FG000|Overall Study|Lost to Follow-up|0|||
143029840|NCT02016300|515652805|FG001|Overall Study|Lost to Follow-up|3|||
143029841|NCT06165744|515652807|FG000|Overall Study|Non device-related adverse event|1|||
143029842|NCT01546987|515652808|FG000|Overall Study|Protocol Violation|3|||
143029843|NCT01546987|515652809|FG001|Overall Study|Protocol Violation|4|||
143029844|NCT02518113|515652810|FG000|Overall Study|Adverse Event|1|||
143363997|NCT03635112|516875517|FG000|Overall Study|Study Terminated by Sponsor|11|||
143363998|NCT03635112|516875518|FG001|Overall Study|Study Terminated by Sponsor|17|||
143363999|NCT03635112|516875519|FG002|Overall Study|Study Terminated by Sponsor|21|||
143364000|NCT03635112|516875517|FG000|Overall Study|Withdrawal by Subject|4|||
143364001|NCT03635112|516875518|FG001|Overall Study|Withdrawal by Subject|9|||
143364002|NCT03635112|516875519|FG002|Overall Study|Withdrawal by Subject|7|||
143364003|NCT03635112|516875517|FG000|Overall Study|Miscellaneous|0|||
143364004|NCT03635112|516875518|FG001|Overall Study|Miscellaneous|0|||
143364005|NCT03635112|516875519|FG002|Overall Study|Miscellaneous|1|||
143364006|NCT00463151|516875520|FG000|Overall Study|Adverse Event|0|||
143364007|NCT00463151|516875521|FG001|Overall Study|Adverse Event|0|||
143364008|NCT00463151|516875522|FG002|Overall Study|Adverse Event|1|||
143364009|NCT00463151|516875523|FG003|Overall Study|Adverse Event|0|||
143364010|NCT00463151|516875520|FG000|Overall Study|Lack of Efficacy|2|||
143364011|NCT00463151|516875521|FG001|Overall Study|Lack of Efficacy|5|||
143364012|NCT00463151|516875522|FG002|Overall Study|Lack of Efficacy|2|||
143029845|NCT02518113|515652811|FG001|Overall Study|Adverse Event|0|||
143029846|NCT02518113|515652812|FG002|Overall Study|Adverse Event|1|||
143364013|NCT00463151|516875523|FG003|Overall Study|Lack of Efficacy|5|||
143364014|NCT00463151|516875520|FG000|Overall Study|Protocol Violation|0|||
143364015|NCT00463151|516875521|FG001|Overall Study|Protocol Violation|0|||
143364016|NCT00463151|516875522|FG002|Overall Study|Protocol Violation|0|||
143364017|NCT00463151|516875523|FG003|Overall Study|Protocol Violation|1|||
143492087|NCT03977467|517342710|FG003|Overall Study|Death|0|||
143492088|NCT03977467|517342707|FG000|Overall Study|Lack of Efficacy|0|||
143492089|NCT03977467|517342708|FG001|Overall Study|Lack of Efficacy|0|||
143492090|NCT03977467|517342709|FG002|Overall Study|Lack of Efficacy|1|||
143492091|NCT03977467|517342710|FG003|Overall Study|Lack of Efficacy|0|||
143029847|NCT02518113|515652813|FG003|Overall Study|Adverse Event|0|||
143029848|NCT02518113|515652810|FG000|Overall Study|Death|1|||
143029849|NCT02518113|515652811|FG001|Overall Study|Death|2|||
143029850|NCT02518113|515652812|FG002|Overall Study|Death|0|||
143029851|NCT02518113|515652813|FG003|Overall Study|Death|0|||
143029852|NCT02518113|515652810|FG000|Overall Study|Physician Decision|0|||
143492092|NCT03977467|517342707|FG000|Overall Study|Withdrawal by Subject|2|||
143492093|NCT03977467|517342708|FG001|Overall Study|Withdrawal by Subject|1|||
143029853|NCT02518113|515652811|FG001|Overall Study|Physician Decision|1|||
143029854|NCT02518113|515652812|FG002|Overall Study|Physician Decision|0|||
143029855|NCT02518113|515652813|FG003|Overall Study|Physician Decision|0|||
143029856|NCT02518113|515652810|FG000|Overall Study|Progressive Disease|1|||
143029857|NCT02518113|515652811|FG001|Overall Study|Progressive Disease|2|||
143029858|NCT02518113|515652812|FG002|Overall Study|Progressive Disease|3|||
143492094|NCT03977467|517342709|FG002|Overall Study|Withdrawal by Subject|4|||
143029859|NCT02518113|515652813|FG003|Overall Study|Progressive Disease|0|||
143029860|NCT00797108|515652814|FG000|Overall Study|Adverse Event|1|||
143492095|NCT03977467|517342710|FG003|Overall Study|Withdrawal by Subject|0|||
143492096|NCT03977467|517342707|FG000|Overall Study|Study Terminated|1|||
143492097|NCT03977467|517342708|FG001|Overall Study|Study Terminated|0|||
143029861|NCT00797108|515652815|FG001|Overall Study|Adverse Event|0|||
143029862|NCT00797108|515652816|FG002|Overall Study|Adverse Event|3|||
143029863|NCT00797108|515652814|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
143029864|NCT00797108|515652815|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
143029865|NCT00797108|515652816|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
143029866|NCT00797108|515652814|FG000|Overall Study|Global Deterioration of Health Status|0|||
143029867|NCT00797108|515652815|FG001|Overall Study|Global Deterioration of Health Status|1|||
143029868|NCT00797108|515652816|FG002|Overall Study|Global Deterioration of Health Status|0|||
143492098|NCT03977467|517342709|FG002|Overall Study|Study Terminated|0|||
143492099|NCT03977467|517342710|FG003|Overall Study|Study Terminated|1|||
143492100|NCT01250379|517342713|FG000|Overall Study|Death|141|||
143029869|NCT00797108|515652814|FG000|Overall Study|Lack of Efficacy|1|||
143029870|NCT00797108|515652815|FG001|Overall Study|Lack of Efficacy|0|||
143029871|NCT00797108|515652816|FG002|Overall Study|Lack of Efficacy|1|||
143029872|NCT00797108|515652814|FG000|Overall Study|Other|0|||
143029873|NCT00797108|515652815|FG001|Overall Study|Other|0|||
143364018|NCT00463151|516875520|FG000|Overall Study|Withdrawal by Subject|0|||
143029874|NCT00797108|515652816|FG002|Overall Study|Other|2|||
143029875|NCT00797108|515652814|FG000|Overall Study|Randomized but not Treated|2|||
143364019|NCT00463151|516875521|FG001|Overall Study|Withdrawal by Subject|0|||
143364020|NCT00463151|516875522|FG002|Overall Study|Withdrawal by Subject|0|||
143492101|NCT01250379|517342714|FG001|Overall Study|Death|148|||
143492102|NCT01250379|517342713|FG000|Overall Study|Withdrawal by Subject|32|||
143492103|NCT01250379|517342714|FG001|Overall Study|Withdrawal by Subject|20|||
143029876|NCT00797108|515652815|FG001|Overall Study|Randomized but not Treated|0|||
143029877|NCT00797108|515652816|FG002|Overall Study|Randomized but not Treated|0|||
143029878|NCT00287118|515652817|FG000|Overall Study|Adverse Event|30|||
143029879|NCT00287118|515652817|FG000|Overall Study|Death|1|||
143029880|NCT00287118|515652817|FG000|Overall Study|Lack of Efficacy|11|||
143029881|NCT00287118|515652817|FG000|Overall Study|Lost to Follow-up|1|||
143029882|NCT00287118|515652817|FG000|Overall Study|Protocol Violation|2|||
143029883|NCT00287118|515652817|FG000|Overall Study|Other|7|||
143029884|NCT02270736|515652818|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
143029885|NCT02270736|515652819|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
143029886|NCT02270736|515652820|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
143029887|NCT02270736|515652821|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
143029888|NCT02270736|515652822|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
143029889|NCT02270736|515652818|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
143029890|NCT02270736|515652819|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
143029891|NCT02270736|515652820|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
143029892|NCT02270736|515652821|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
143029893|NCT02270736|515652822|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
143029894|NCT02270736|515652818|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
143029895|NCT02270736|515652819|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
143029896|NCT02270736|515652820|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
143029897|NCT02270736|515652821|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
143029898|NCT02270736|515652822|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
143029899|NCT02270736|515652818|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
143029900|NCT02270736|515652819|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
143029901|NCT02270736|515652820|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
143029902|NCT02270736|515652821|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
143029903|NCT02270736|515652822|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
143029904|NCT02270736|515652818|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
143029905|NCT02270736|515652819|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
143029906|NCT02270736|515652820|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
143029907|NCT02270736|515652821|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
143029908|NCT02270736|515652822|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
143029909|NCT02270736|515652818|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
143029910|NCT02270736|515652819|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
143029911|NCT02270736|515652820|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
143029912|NCT02270736|515652821|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
143029913|NCT02270736|515652822|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
143029914|NCT02270736|515652818|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
143029915|NCT02270736|515652819|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
143029916|NCT02270736|515652820|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
143029917|NCT02270736|515652821|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
143029918|NCT02270736|515652822|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
143029919|NCT02270736|515652818|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
143029920|NCT02270736|515652819|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
143029921|NCT02270736|515652820|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
143029922|NCT02270736|515652821|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
143029923|NCT02270736|515652822|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
143029924|NCT02270736|515652818|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
143029925|NCT02270736|515652819|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
143029926|NCT02270736|515652820|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
143029927|NCT02270736|515652821|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
143029928|NCT02270736|515652822|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
143029929|NCT01631864|515652823|FG000|Overall Study|Withdrawal by Subject|0|||
143029930|NCT01631864|515652824|FG001|Overall Study|Withdrawal by Subject|1|||
143158486|NCT00520572|516125985|FG003|Overall Study|Lack of Efficacy|2|||
143158487|NCT00520572|516125986|FG004|Overall Study|Lack of Efficacy|1|||
143158488|NCT00520572|516125987|FG005|Overall Study|Lack of Efficacy|0|||
143158489|NCT00520572|516125982|FG000|Overall Study|Lost to Follow-up|0|||
143158490|NCT00520572|516125983|FG001|Overall Study|Lost to Follow-up|0|||
143158491|NCT00520572|516125984|FG002|Overall Study|Lost to Follow-up|0|||
143158492|NCT00520572|516125985|FG003|Overall Study|Lost to Follow-up|0|||
143158493|NCT00520572|516125986|FG004|Overall Study|Lost to Follow-up|1|||
143158494|NCT00520572|516125987|FG005|Overall Study|Lost to Follow-up|0|||
143158495|NCT00520572|516125982|FG000|Overall Study|Incorrect enrollment|1|||
143158496|NCT00520572|516125983|FG001|Overall Study|Incorrect enrollment|0|||
143029931|NCT01631864|515652823|FG000|Overall Study|Adverse Event|2|||
143029932|NCT01631864|515652824|FG001|Overall Study|Adverse Event|3|||
143029933|NCT00262600|515652825|FG000|Overall Study|Lost to Follow-up|17|||
143029934|NCT00262600|515652826|FG001|Overall Study|Lost to Follow-up|31|||
143158497|NCT00520572|516125984|FG002|Overall Study|Incorrect enrollment|1|||
143158498|NCT00520572|516125985|FG003|Overall Study|Incorrect enrollment|0|||
143158499|NCT00520572|516125986|FG004|Overall Study|Incorrect enrollment|1|||
143029935|NCT00262600|515652827|FG002|Overall Study|Lost to Follow-up|41|||
143029936|NCT00262600|515652825|FG000|Overall Study|Withdrawal by Subject|128|||
143029937|NCT00262600|515652826|FG001|Overall Study|Withdrawal by Subject|145|||
143029938|NCT00262600|515652827|FG002|Overall Study|Withdrawal by Subject|139|||
143029939|NCT00262600|515652825|FG000|Overall Study|Not Treated|32|||
143029940|NCT00262600|515652826|FG001|Overall Study|Not Treated|17|||
143029941|NCT00262600|515652827|FG002|Overall Study|Not Treated|24|||
143029942|NCT00262600|515652825|FG000|Overall Study|Other|58|||
143029943|NCT00262600|515652826|FG001|Overall Study|Other|59|||
143029944|NCT00262600|515652827|FG002|Overall Study|Other|62|||
143029945|NCT02710123|515652830|FG000|Overall Study|Lost to Follow-up|3|||
143029946|NCT02710123|515652831|FG001|Overall Study|Lost to Follow-up|4|||
143029947|NCT02710123|515652830|FG000|Overall Study|Withdrawal by Subject|1|||
143029948|NCT02710123|515652831|FG001|Overall Study|Withdrawal by Subject|1|||
143029949|NCT02710123|515652830|FG000|Overall Study|Illness unrelated to study intervention|1|||
143029950|NCT02710123|515652831|FG001|Overall Study|Illness unrelated to study intervention|0|||
143029951|NCT00561730|515652836|FG000|Overall Study|Adverse Event|2|||
143029952|NCT00561730|515652836|FG000|Overall Study|Handling of the drug|1|||
143029953|NCT00561730|515652836|FG000|Overall Study|Lost to Follow-up|5|||
143029954|NCT00561730|515652836|FG000|Overall Study|Not specified reasons|1|||
143029955|NCT04373434|515652853|FG000|Overall Study|Lost to Follow-up|37|||
143029956|NCT04373434|515652854|FG001|Overall Study|Lost to Follow-up|32|||
143029957|NCT04373434|515652853|FG000|Overall Study|Refused at 9 months|1|||
143029958|NCT04373434|515652854|FG001|Overall Study|Refused at 9 months|2|||
143029959|NCT04373434|515652853|FG000|Overall Study|Refused at 4 months|7|||
143029960|NCT04373434|515652854|FG001|Overall Study|Refused at 4 months|3|||
143029961|NCT04373434|515652853|FG000|Overall Study|Excluded|2|||
143029962|NCT04373434|515652854|FG001|Overall Study|Excluded|0|||
143029963|NCT00527423|515652855|FG000|Overall Study|Protocol Violation|1|||
143029964|NCT00527423|515652855|FG000|Overall Study|Adverse Event|5|||
143029965|NCT00527423|515652855|FG000|Overall Study|Physician Decision|4|||
143029966|NCT00527423|515652855|FG000|Overall Study|Withdrawal by Subject|10|||
143029967|NCT00527423|515652855|FG000|Overall Study|Lost to Follow-up|4|||
143029968|NCT00527423|515652855|FG000|Overall Study|OTHER|4|||
143029969|NCT00527423|515652855|FG000|Overall Study|Death|9|||
143029970|NCT03194464|515652859|FG000|Overall Study|data not usable|2|||
143029971|NCT01860976|515652866|FG000|Blinded Treatment|Adverse Event|1|||
143029972|NCT01860976|515652867|FG001|Blinded Treatment|Adverse Event|3|||
143029973|NCT01860976|515652866|FG000|Blinded Treatment|Lack of Efficacy|5|||
143029974|NCT01860976|515652867|FG001|Blinded Treatment|Lack of Efficacy|12|||
143029975|NCT01860976|515652866|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
143029976|NCT01860976|515652867|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
143029977|NCT01860976|515652866|FG000|Blinded Treatment|Withdrawal by Subject|3|||
143029978|NCT01860976|515652867|FG001|Blinded Treatment|Withdrawal by Subject|5|||
143029979|NCT01860976|515652866|FG000|Blinded Treatment|Subject no longer met criteria|1|||
143029980|NCT01860976|515652867|FG001|Blinded Treatment|Subject no longer met criteria|0|||
143029981|NCT01860976|515652866|FG000|Blinded Treatment|Entered Open-Label in error|0|||
143029982|NCT01860976|515652867|FG001|Blinded Treatment|Entered Open-Label in error|1|||
143029983|NCT01860976|515652866|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
143029984|NCT01860976|515652867|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
143029985|NCT01860976|515652866|FG000|Open-Label|Adverse Event|2|||
143029986|NCT01860976|515652867|FG001|Open-Label|Adverse Event|4|||
143029987|NCT01860976|515652866|FG000|Open-Label|Lack of Efficacy|16|||
143029988|NCT01860976|515652867|FG001|Open-Label|Lack of Efficacy|8|||
143029989|NCT01860976|515652866|FG000|Open-Label|Lost to Follow-up|1|||
143158500|NCT00520572|516125987|FG005|Overall Study|Incorrect enrollment|0|||
143158501|NCT00520572|516125982|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
143158502|NCT00520572|516125983|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
143158503|NCT00520572|516125984|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
143158504|NCT00520572|516125985|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
143158505|NCT00520572|516125986|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
143158506|NCT00520572|516125987|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
143158507|NCT00520572|516125982|FG000|Overall Study|Long break in taking Medication|0|||
143158508|NCT00520572|516125983|FG001|Overall Study|Long break in taking Medication|0|||
143158509|NCT00520572|516125984|FG002|Overall Study|Long break in taking Medication|0|||
143492104|NCT01250379|517342713|FG000|Overall Study|Physician Decision|11|||
143029990|NCT01860976|515652867|FG001|Open-Label|Lost to Follow-up|2|||
143029991|NCT01860976|515652866|FG000|Open-Label|Subject request discontinue treatment|4|||
143029992|NCT01860976|515652867|FG001|Open-Label|Subject request discontinue treatment|3|||
143029993|NCT01860976|515652866|FG000|Open-Label|Withdrawal by Subject|4|||
143029994|NCT01860976|515652867|FG001|Open-Label|Withdrawal by Subject|1|||
143029995|NCT01860976|515652866|FG000|Open-Label|Other Reasons|1|||
143029996|NCT01860976|515652867|FG001|Open-Label|Other Reasons|1|||
143029997|NCT01860976|515652866|FG000|Long Term Extension|Adverse Event|4|||
143029998|NCT01860976|515652867|FG001|Long Term Extension|Adverse Event|0|||
143029999|NCT01860976|515652866|FG000|Long Term Extension|Lack of Efficacy|2|||
143030000|NCT01860976|515652867|FG001|Long Term Extension|Lack of Efficacy|0|||
143030001|NCT01860976|515652866|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
143030002|NCT01860976|515652867|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
143030003|NCT01860976|515652866|FG000|Long Term Extension|Lost to Follow-up|2|||
143030004|NCT01860976|515652867|FG001|Long Term Extension|Lost to Follow-up|0|||
143030005|NCT01860976|515652866|FG000|Long Term Extension|subject withdrew consent|7|||
143030006|NCT01860976|515652867|FG001|Long Term Extension|subject withdrew consent|0|||
143030007|NCT02153398|515652868|FG000|Overall Study|Withdrawal by Subject|1|||
143030008|NCT02153398|515652869|FG001|Overall Study|Withdrawal by Subject|0|||
143030009|NCT02153398|515652870|FG002|Overall Study|Withdrawal by Subject|0|||
143030010|NCT02153398|515652871|FG003|Overall Study|Withdrawal by Subject|0|||
143030011|NCT02153398|515652872|FG004|Overall Study|Withdrawal by Subject|0|||
143030012|NCT02153398|515652868|FG000|Overall Study|Adverse Event|0|||
143030013|NCT02153398|515652869|FG001|Overall Study|Adverse Event|0|||
143030014|NCT02153398|515652870|FG002|Overall Study|Adverse Event|1|||
143030015|NCT02153398|515652871|FG003|Overall Study|Adverse Event|1|||
143030016|NCT02153398|515652872|FG004|Overall Study|Adverse Event|0|||
143030017|NCT00721409|515652874|FG000|Overall Study|Global deterioration of health status|2|||
143030018|NCT00721409|515652875|FG001|Overall Study|Global deterioration of health status|6|||
143030019|NCT00721409|515652876|FG002|Overall Study|Global deterioration of health status|3|||
143030020|NCT00721409|515652874|FG000|Overall Study|Death|0|||
143030021|NCT00721409|515652875|FG001|Overall Study|Death|1|||
143030022|NCT00721409|515652876|FG002|Overall Study|Death|0|||
143030023|NCT00721409|515652874|FG000|Overall Study|Randomized not Treated|0|||
143030024|NCT00721409|515652875|FG001|Overall Study|Randomized not Treated|1|||
143030025|NCT00721409|515652876|FG002|Overall Study|Randomized not Treated|4|||
143030026|NCT00721409|515652874|FG000|Overall Study|Reason not specified|1|||
143030027|NCT00721409|515652875|FG001|Overall Study|Reason not specified|0|||
143030028|NCT00721409|515652876|FG002|Overall Study|Reason not specified|2|||
143030029|NCT00721409|515652874|FG000|Overall Study|Adverse Event|0|||
143030030|NCT00721409|515652875|FG001|Overall Study|Adverse Event|13|||
143030031|NCT00721409|515652876|FG002|Overall Study|Adverse Event|2|||
143030032|NCT00721409|515652874|FG000|Overall Study|Lost to Follow-up|0|||
143030033|NCT00721409|515652875|FG001|Overall Study|Lost to Follow-up|0|||
143030034|NCT00721409|515652876|FG002|Overall Study|Lost to Follow-up|1|||
143030035|NCT00721409|515652874|FG000|Overall Study|Withdrawal by Subject|1|||
143030036|NCT00721409|515652875|FG001|Overall Study|Withdrawal by Subject|6|||
143030037|NCT00721409|515652876|FG002|Overall Study|Withdrawal by Subject|5|||
143030038|NCT00721409|515652874|FG000|Overall Study|Objective progression or relapse|8|||
143030039|NCT00721409|515652875|FG001|Overall Study|Objective progression or relapse|55|||
143030040|NCT00721409|515652876|FG002|Overall Study|Objective progression or relapse|62|||
143030041|NCT02433678|515652877|FG000|Overall Study|Lost to Follow-up|1|||
143030042|NCT02433678|515652878|FG001|Overall Study|Lost to Follow-up|2|||
143030043|NCT04424407|515652882|FG000|Overall Study|Withdrawal by Subject|2|||
143030044|NCT04424407|515652882|FG000|Overall Study|Lost to Follow-up|1|||
143030045|NCT03803943|515652885|FG000|Overall Study|Withdrawal by Subject|2|||
143030046|NCT03803943|515652886|FG001|Overall Study|Withdrawal by Subject|2|||
143030047|NCT03803943|515652887|FG002|Overall Study|Withdrawal by Subject|2|||
143030048|NCT03803943|515652888|FG003|Overall Study|Withdrawal by Subject|2|||
143158510|NCT00520572|516125985|FG003|Overall Study|Long break in taking Medication|1|||
143158511|NCT00520572|516125986|FG004|Overall Study|Long break in taking Medication|0|||
143158512|NCT00520572|516125987|FG005|Overall Study|Long break in taking Medication|0|||
143158513|NCT00520572|516125982|FG000|Overall Study|Did not receive Treatment|1|||
143158514|NCT00520572|516125983|FG001|Overall Study|Did not receive Treatment|0|||
143158515|NCT00520572|516125984|FG002|Overall Study|Did not receive Treatment|1|||
143158516|NCT00520572|516125985|FG003|Overall Study|Did not receive Treatment|0|||
143158517|NCT00520572|516125986|FG004|Overall Study|Did not receive Treatment|0|||
143158518|NCT00520572|516125987|FG005|Overall Study|Did not receive Treatment|0|||
143158519|NCT03548415|516125990|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
143158520|NCT03548415|516125991|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
143158521|NCT03548415|516125992|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
143158522|NCT03548415|516125993|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
143158523|NCT03548415|516125994|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
143158524|NCT04605588|516125998|FG000|Overall Study|Withdrawal by Subject|1|||
143158525|NCT04605588|516125999|FG001|Overall Study|Withdrawal by Subject|0|||
143158526|NCT01230814|516126000|FG000|Overall Study|Lost to Follow-up|11|||
143158527|NCT01230814|516126001|FG001|Overall Study|Lost to Follow-up|3|||
143030049|NCT01574248|515652891|FG000|Overall Study|Withdrawal by Subject|2|||
143030050|NCT01574248|515652892|FG001|Overall Study|Withdrawal by Subject|0|||
143030051|NCT01574248|515652891|FG000|Overall Study|Missing primary endpoint data|1|||
143030052|NCT01574248|515652892|FG001|Overall Study|Missing primary endpoint data|0|||
143030053|NCT01424722|515652893|FG000|Overall Study|Sponsor terminated investigation|2258|||
143158528|NCT01230814|516126000|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
143158529|NCT01230814|516126001|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
143158530|NCT01803737|516126004|FG000|Overall Study|Lack of Time|1|||
143030054|NCT01781286|515652894|FG000|Overall Study|Lost to Follow-up|0|||
143030055|NCT01781286|515652895|FG001|Overall Study|Lost to Follow-up|0|||
143030056|NCT01781286|515652896|FG002|Overall Study|Lost to Follow-up|0|||
143030057|NCT01781286|515652897|FG003|Overall Study|Lost to Follow-up|0|||
143030058|NCT01781286|515652898|FG004|Overall Study|Lost to Follow-up|0|||
143030059|NCT01781286|515652899|FG005|Overall Study|Lost to Follow-up|1|||
143030060|NCT01781286|515652894|FG000|Overall Study|Time Constraints|2|||
143030061|NCT01781286|515652895|FG001|Overall Study|Time Constraints|0|||
143030062|NCT01781286|515652896|FG002|Overall Study|Time Constraints|2|||
143030063|NCT01781286|515652897|FG003|Overall Study|Time Constraints|0|||
143030064|NCT01781286|515652898|FG004|Overall Study|Time Constraints|0|||
143030065|NCT01781286|515652899|FG005|Overall Study|Time Constraints|0|||
143030066|NCT01781286|515652894|FG000|Overall Study|Noncompliance|0|||
143030067|NCT01781286|515652895|FG001|Overall Study|Noncompliance|0|||
143030068|NCT01781286|515652896|FG002|Overall Study|Noncompliance|0|||
143030069|NCT01781286|515652897|FG003|Overall Study|Noncompliance|1|||
143030070|NCT01781286|515652898|FG004|Overall Study|Noncompliance|0|||
143030071|NCT01781286|515652899|FG005|Overall Study|Noncompliance|0|||
143030072|NCT03594123|515652900|FG000|Overall Study|Lost to Follow-up|0|||
143030073|NCT03594123|515652901|FG001|Overall Study|Lost to Follow-up|1|||
143030074|NCT03594123|515652900|FG000|Overall Study|Adverse Event|8|||
143030075|NCT03594123|515652901|FG001|Overall Study|Adverse Event|5|||
143030076|NCT03594123|515652900|FG000|Overall Study|Site Terminated by Sponsor|4|||
143030077|NCT03594123|515652901|FG001|Overall Study|Site Terminated by Sponsor|1|||
143030078|NCT03594123|515652900|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
143030079|NCT03594123|515652901|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
143030080|NCT03594123|515652900|FG000|Overall Study|Lack of Efficacy|1|||
143030081|NCT03594123|515652901|FG001|Overall Study|Lack of Efficacy|0|||
143030082|NCT03594123|515652900|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
143030083|NCT03594123|515652901|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
143030084|NCT03365375|515652902|FG000|Overall Study|Withdrawal by Subject|0|||
143030085|NCT03365375|515652903|FG001|Overall Study|Withdrawal by Subject|1|||
143030086|NCT03365375|515652902|FG000|Overall Study|Lost to Follow-up|0|||
143030087|NCT03365375|515652903|FG001|Overall Study|Lost to Follow-up|4|||
143030088|NCT02483975|515652904|FG000|Overall Study|Adverse Event|0|||
143030089|NCT02483975|515652905|FG001|Overall Study|Adverse Event|1|||
143030090|NCT02483975|515652904|FG000|Overall Study|Lost to Follow-up|0|||
143030091|NCT02483975|515652905|FG001|Overall Study|Lost to Follow-up|1|||
143030092|NCT02483975|515652904|FG000|Overall Study|Physician Decision|2|||
143030093|NCT02483975|515652905|FG001|Overall Study|Physician Decision|0|||
143030094|NCT00818883|515652906|FG000|Overall Study|Adverse Event|28|||
143030095|NCT00818883|515652907|FG001|Overall Study|Adverse Event|19|||
143030096|NCT00818883|515652906|FG000|Overall Study|Protocol Violation|2|||
143030097|NCT00818883|515652907|FG001|Overall Study|Protocol Violation|2|||
143030098|NCT00818883|515652906|FG000|Overall Study|Lost to Follow-up|3|||
143030099|NCT00818883|515652907|FG001|Overall Study|Lost to Follow-up|2|||
143030100|NCT00818883|515652906|FG000|Overall Study|Withdrawal by Subject|16|||
143030101|NCT00818883|515652907|FG001|Overall Study|Withdrawal by Subject|14|||
143030102|NCT00818883|515652906|FG000|Overall Study|Lack of Efficacy|0|||
143030103|NCT00818883|515652907|FG001|Overall Study|Lack of Efficacy|2|||
143030104|NCT00818883|515652906|FG000|Overall Study|Other|2|||
143030105|NCT00818883|515652907|FG001|Overall Study|Other|7|||
143030106|NCT02166697|515652908|FG000|Overall Study|Protocol Violation|347|||
143030107|NCT01505530|515652911|FG000|Overall Study|Progressive Disease|19|||
143030108|NCT01505530|515652912|FG001|Overall Study|Progressive Disease|17|||
143030109|NCT01505530|515652913|FG002|Overall Study|Progressive Disease|18|||
143030110|NCT01505530|515652911|FG000|Overall Study|Adverse Event|1|||
143030111|NCT01505530|515652912|FG001|Overall Study|Adverse Event|1|||
143030112|NCT01505530|515652913|FG002|Overall Study|Adverse Event|0|||
143030113|NCT01505530|515652911|FG000|Overall Study|Withdrawal by Subject|7|||
143030114|NCT01505530|515652912|FG001|Overall Study|Withdrawal by Subject|8|||
143030115|NCT01505530|515652913|FG002|Overall Study|Withdrawal by Subject|6|||
143030116|NCT01505530|515652911|FG000|Overall Study|Physician Decision|6|||
143030117|NCT01505530|515652912|FG001|Overall Study|Physician Decision|2|||
143030118|NCT01505530|515652913|FG002|Overall Study|Physician Decision|5|||
143030119|NCT01505530|515652911|FG000|Overall Study|Sponsor Decision|1|||
143030120|NCT01505530|515652912|FG001|Overall Study|Sponsor Decision|8|||
143030121|NCT01505530|515652913|FG002|Overall Study|Sponsor Decision|7|||
143030122|NCT01505530|515652911|FG000|Overall Study|Death|7|||
143030123|NCT01505530|515652912|FG001|Overall Study|Death|6|||
143030124|NCT01505530|515652913|FG002|Overall Study|Death|5|||
143030125|NCT01505530|515652911|FG000|Overall Study|entry criteria not met|0|||
143030126|NCT01505530|515652912|FG001|Overall Study|entry criteria not met|1|||
143030127|NCT01505530|515652913|FG002|Overall Study|entry criteria not met|0|||
143030128|NCT00973700|515652917|FG000|Overall Study|Withdrawal by Subject|2|||
143030129|NCT00973700|515652918|FG001|Overall Study|Withdrawal by Subject|2|||
143030130|NCT00973700|515652919|FG002|Overall Study|Withdrawal by Subject|8|||
143030131|NCT00973700|515652920|FG003|Overall Study|Withdrawal by Subject|4|||
143158531|NCT01803737|516126005|FG001|Overall Study|Lack of Time|0|||
143030132|NCT00973700|515652921|FG004|Overall Study|Withdrawal by Subject|4|||
143030133|NCT00973700|515652917|FG000|Overall Study|Lost to Follow-up|5|||
143030134|NCT00973700|515652918|FG001|Overall Study|Lost to Follow-up|0|||
143030135|NCT00973700|515652919|FG002|Overall Study|Lost to Follow-up|1|||
143030136|NCT00973700|515652920|FG003|Overall Study|Lost to Follow-up|8|||
143030137|NCT00973700|515652921|FG004|Overall Study|Lost to Follow-up|5|||
143030138|NCT00973700|515652917|FG000|Overall Study|Inappropriate enrolment|0|||
143030139|NCT00973700|515652918|FG001|Overall Study|Inappropriate enrolment|0|||
143030140|NCT00973700|515652919|FG002|Overall Study|Inappropriate enrolment|0|||
143030141|NCT00973700|515652920|FG003|Overall Study|Inappropriate enrolment|4|||
143030142|NCT00973700|515652921|FG004|Overall Study|Inappropriate enrolment|0|||
143030143|NCT00973700|515652917|FG000|Overall Study|Unable to Classify|0|||
143030144|NCT00973700|515652918|FG001|Overall Study|Unable to Classify|0|||
143030145|NCT00973700|515652919|FG002|Overall Study|Unable to Classify|1|||
143030146|NCT00973700|515652920|FG003|Overall Study|Unable to Classify|2|||
143030147|NCT00973700|515652921|FG004|Overall Study|Unable to Classify|1|||
143030148|NCT03499964|515652924|FG000|Overall Study|Lack of Efficacy|6|||
143030149|NCT03499964|515652925|FG001|Overall Study|Lack of Efficacy|26|||
143030150|NCT03499964|515652924|FG000|Overall Study|Adverse Event|1|||
143030151|NCT03499964|515652925|FG001|Overall Study|Adverse Event|0|||
143030152|NCT03499964|515652924|FG000|Overall Study|Death|1|||
143030153|NCT03499964|515652925|FG001|Overall Study|Death|0|||
143030154|NCT03499964|515652924|FG000|Overall Study|Withdrawal by Subject|2|||
143030155|NCT03499964|515652925|FG001|Overall Study|Withdrawal by Subject|1|||
143030156|NCT03499964|515652924|FG000|Overall Study|Lost to Follow-up|1|||
143030157|NCT03499964|515652925|FG001|Overall Study|Lost to Follow-up|0|||
143030158|NCT01966042|515652926|FG000|Overall Study|Death|2|||
143030159|NCT01193608|515652928|FG000|Overall Study|Other|0|||
143030160|NCT01193608|515652929|FG001|Overall Study|Other|1|||
143030161|NCT01193608|515652930|FG002|Overall Study|Other|0|||
143030162|NCT01193608|515652931|FG003|Overall Study|Other|0|||
143030163|NCT01193608|515652932|FG004|Overall Study|Other|0|||
143030164|NCT01193608|515652933|FG005|Overall Study|Other|0|||
143030165|NCT01193608|515652928|FG000|Overall Study|Withdrawal by Subject|0|||
143030166|NCT01193608|515652929|FG001|Overall Study|Withdrawal by Subject|1|||
143030167|NCT01193608|515652930|FG002|Overall Study|Withdrawal by Subject|2|||
143030168|NCT01193608|515652931|FG003|Overall Study|Withdrawal by Subject|3|||
143030169|NCT01193608|515652932|FG004|Overall Study|Withdrawal by Subject|3|||
143030170|NCT01193608|515652933|FG005|Overall Study|Withdrawal by Subject|0|||
143030171|NCT01193608|515652928|FG000|Overall Study|Lost to Follow-up|0|||
143030172|NCT01193608|515652929|FG001|Overall Study|Lost to Follow-up|0|||
143030173|NCT01193608|515652930|FG002|Overall Study|Lost to Follow-up|0|||
143030174|NCT01193608|515652931|FG003|Overall Study|Lost to Follow-up|0|||
143030175|NCT01193608|515652932|FG004|Overall Study|Lost to Follow-up|1|||
143030176|NCT01193608|515652933|FG005|Overall Study|Lost to Follow-up|2|||
143030177|NCT01193608|515652928|FG000|Overall Study|Adverse Event|0|||
143030178|NCT01193608|515652929|FG001|Overall Study|Adverse Event|0|||
143158532|NCT01803737|516126004|FG000|Overall Study|Medical Reason|0|||
143158533|NCT01803737|516126005|FG001|Overall Study|Medical Reason|1|||
143158534|NCT01803737|516126004|FG000|Overall Study|Lost to Follow-up|0|||
143158535|NCT01803737|516126005|FG001|Overall Study|Lost to Follow-up|2|||
143158536|NCT01748552|516126008|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
143158537|NCT01748552|516126009|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
143158538|NCT01748552|516126010|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
143158539|NCT01748552|516126011|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
143158540|NCT01748552|516126012|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
143158541|NCT01748552|516126013|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
143158542|NCT01748552|516126014|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
143158543|NCT01748552|516126015|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
143030179|NCT01193608|515652930|FG002|Overall Study|Adverse Event|0|||
143030180|NCT01193608|515652931|FG003|Overall Study|Adverse Event|0|||
143030181|NCT01193608|515652932|FG004|Overall Study|Adverse Event|1|||
143030182|NCT01193608|515652933|FG005|Overall Study|Adverse Event|0|||
143030183|NCT01400113|515652937|FG000|Overall Study|Withdrawal by Subject|1|||
143492105|NCT01250379|517342714|FG001|Overall Study|Physician Decision|3|||
143030184|NCT01400113|515652938|FG001|Overall Study|Withdrawal by Subject|1|||
143030185|NCT00337571|515652940|FG000|Overall Study|Lack of Efficacy|3|||
143030186|NCT00337571|515652941|FG001|Overall Study|Lack of Efficacy|0|||
143030187|NCT00337571|515652942|FG002|Overall Study|Lack of Efficacy|0|||
143030188|NCT00337571|515652943|FG003|Overall Study|Lack of Efficacy|0|||
143030189|NCT00337571|515652940|FG000|Overall Study|Adverse Event|4|||
143030190|NCT00337571|515652941|FG001|Overall Study|Adverse Event|5|||
143030191|NCT00337571|515652942|FG002|Overall Study|Adverse Event|8|||
143030192|NCT00337571|515652943|FG003|Overall Study|Adverse Event|4|||
143030193|NCT00337571|515652940|FG000|Overall Study|Withdrawal by Subject|2|||
143030194|NCT00337571|515652941|FG001|Overall Study|Withdrawal by Subject|2|||
143030195|NCT00337571|515652942|FG002|Overall Study|Withdrawal by Subject|1|||
143030196|NCT00337571|515652943|FG003|Overall Study|Withdrawal by Subject|0|||
143030197|NCT00337571|515652940|FG000|Overall Study|Lost to Follow-up|3|||
143030198|NCT00337571|515652941|FG001|Overall Study|Lost to Follow-up|1|||
143030199|NCT00337571|515652942|FG002|Overall Study|Lost to Follow-up|0|||
143030200|NCT00337571|515652943|FG003|Overall Study|Lost to Follow-up|1|||
143030201|NCT00337571|515652940|FG000|Overall Study|Poor/noncompliance|1|||
143030202|NCT00337571|515652941|FG001|Overall Study|Poor/noncompliance|1|||
143030203|NCT00337571|515652942|FG002|Overall Study|Poor/noncompliance|1|||
143030204|NCT00337571|515652943|FG003|Overall Study|Poor/noncompliance|1|||
143030205|NCT00337571|515652940|FG000|Overall Study|No longer met study criteria|1|||
143030206|NCT00337571|515652941|FG001|Overall Study|No longer met study criteria|0|||
143030207|NCT00337571|515652942|FG002|Overall Study|No longer met study criteria|0|||
143030208|NCT00337571|515652943|FG003|Overall Study|No longer met study criteria|0|||
143030209|NCT00337571|515652940|FG000|Overall Study|High Potassium level|0|||
143030210|NCT00337571|515652941|FG001|Overall Study|High Potassium level|0|||
143030211|NCT00337571|515652942|FG002|Overall Study|High Potassium level|0|||
143030212|NCT00337571|515652943|FG003|Overall Study|High Potassium level|1|||
143030213|NCT00424489|515652944|FG000|Overall Study|Death|3|||
143030214|NCT04257929|515652945|FG000|Overall Study|Adverse Event|1|||
143030215|NCT04257929|515652946|FG001|Overall Study|Adverse Event|0|||
143030216|NCT04257929|515652947|FG002|Overall Study|Adverse Event|1|||
143030217|NCT04257929|515652945|FG000|Overall Study|Withdrawal by Subject|1|||
143030218|NCT04257929|515652946|FG001|Overall Study|Withdrawal by Subject|0|||
143030219|NCT04257929|515652947|FG002|Overall Study|Withdrawal by Subject|0|||
143030220|NCT04257929|515652945|FG000|Overall Study|COVID-19|0|||
143158544|NCT01748552|516126016|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
143158545|NCT01748552|516126017|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
143158546|NCT01748552|516126018|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
143158547|NCT01748552|516126019|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
143158548|NCT01748552|516126008|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
143158549|NCT01748552|516126009|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
143158550|NCT01748552|516126010|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
143158551|NCT01748552|516126011|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
143158552|NCT01748552|516126012|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
143158553|NCT01748552|516126013|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
143158554|NCT01748552|516126014|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
143158555|NCT01748552|516126015|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
143158556|NCT01748552|516126016|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
143158557|NCT01748552|516126017|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
143158558|NCT01748552|516126018|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
143158559|NCT01748552|516126019|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
143158560|NCT00504556|516126020|FG000|Overall Study|Adverse Event|11|||
143158561|NCT00504556|516126021|FG001|Overall Study|Adverse Event|11|||
143158562|NCT00504556|516126022|FG002|Overall Study|Adverse Event|14|||
143158563|NCT00504556|516126023|FG003|Overall Study|Adverse Event|13|||
143158564|NCT00504556|516126024|FG004|Overall Study|Adverse Event|5|||
143158565|NCT00504556|516126020|FG000|Overall Study|Death|3|||
143158566|NCT00504556|516126021|FG001|Overall Study|Death|3|||
143158567|NCT00504556|516126022|FG002|Overall Study|Death|1|||
143158568|NCT00504556|516126023|FG003|Overall Study|Death|0|||
143158569|NCT00504556|516126024|FG004|Overall Study|Death|2|||
143158570|NCT00504556|516126020|FG000|Overall Study|Protocol Violation|1|||
143158571|NCT00504556|516126021|FG001|Overall Study|Protocol Violation|3|||
143158572|NCT00504556|516126022|FG002|Overall Study|Protocol Violation|2|||
143158573|NCT00504556|516126023|FG003|Overall Study|Protocol Violation|1|||
143158574|NCT00504556|516126024|FG004|Overall Study|Protocol Violation|2|||
143158575|NCT00504556|516126020|FG000|Overall Study|Lost to Follow-up|0|||
143158576|NCT00504556|516126021|FG001|Overall Study|Lost to Follow-up|0|||
143158577|NCT00504556|516126022|FG002|Overall Study|Lost to Follow-up|1|||
143158578|NCT00504556|516126023|FG003|Overall Study|Lost to Follow-up|1|||
143158579|NCT00504556|516126024|FG004|Overall Study|Lost to Follow-up|1|||
143158580|NCT00504556|516126020|FG000|Overall Study|Withdrawal by Subject|16|||
143158581|NCT00504556|516126021|FG001|Overall Study|Withdrawal by Subject|16|||
143030221|NCT04257929|515652946|FG001|Overall Study|COVID-19|1|||
143030222|NCT04257929|515652947|FG002|Overall Study|COVID-19|1|||
143158582|NCT00504556|516126022|FG002|Overall Study|Withdrawal by Subject|7|||
143158583|NCT00504556|516126023|FG003|Overall Study|Withdrawal by Subject|8|||
143158584|NCT00504556|516126024|FG004|Overall Study|Withdrawal by Subject|12|||
143158585|NCT00504556|516126020|FG000|Overall Study|administrative reasons|0|||
143158586|NCT00504556|516126021|FG001|Overall Study|administrative reasons|2|||
143158587|NCT00504556|516126022|FG002|Overall Study|administrative reasons|2|||
143158588|NCT00504556|516126023|FG003|Overall Study|administrative reasons|1|||
143030223|NCT04257929|515652945|FG000|Overall Study|Lost to Follow-up|0|||
143030224|NCT04257929|515652946|FG001|Overall Study|Lost to Follow-up|0|||
143030225|NCT04257929|515652947|FG002|Overall Study|Lost to Follow-up|1|||
143030226|NCT02579096|515652948|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
143030227|NCT02579096|515652949|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
143030228|NCT02579096|515652948|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
143030229|NCT02579096|515652949|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
143030230|NCT02579096|515652948|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
143030231|NCT02579096|515652949|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
143030232|NCT02579096|515652948|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
143030233|NCT02579096|515652949|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
143030234|NCT02579096|515652948|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
143030235|NCT02579096|515652949|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
143030236|NCT02579096|515652948|FG000|Phase 2, Weeks 25 - 48|Death|2|||
143030237|NCT02579096|515652949|FG001|Phase 2, Weeks 25 - 48|Death|4|||
143030238|NCT02579096|515652948|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
143030239|NCT02579096|515652949|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
143030240|NCT02579096|515652948|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
143030241|NCT02579096|515652949|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
143030242|NCT02579096|515652948|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
143030243|NCT02579096|515652949|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
143030244|NCT02579096|515652948|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
143030245|NCT02579096|515652949|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
143030246|NCT02579096|515652948|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
143030247|NCT02579096|515652949|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
143030248|NCT02579096|515652948|FG000|Phase 3, Weeks 49 - 72|Death|3|||
143030249|NCT02579096|515652949|FG001|Phase 3, Weeks 49 - 72|Death|2|||
143030250|NCT02579096|515652948|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
143030251|NCT02579096|515652949|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
143030252|NCT02579096|515652948|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
143030253|NCT02579096|515652949|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
143030254|NCT02579096|515652948|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
143030255|NCT02579096|515652949|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
143030256|NCT02579096|515652948|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
143030257|NCT02579096|515652949|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
143030258|NCT02579096|515652948|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
143030259|NCT02579096|515652949|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
143030260|NCT02579096|515652948|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
143030261|NCT02579096|515652949|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
143030262|NCT02097121|515652954|FG000|Overall Study|Other, not specified|4|||
143030263|NCT02097121|515652955|FG001|Overall Study|Other, not specified|2|||
143030264|NCT02097121|515652956|FG002|Overall Study|Other, not specified|3|||
143030265|NCT02097121|515652954|FG000|Overall Study|Lack of Efficacy|2|||
143030266|NCT02097121|515652955|FG001|Overall Study|Lack of Efficacy|1|||
143030267|NCT02097121|515652956|FG002|Overall Study|Lack of Efficacy|3|||
143030268|NCT02097121|515652954|FG000|Overall Study|Withdrawal by Subject|0|||
143030269|NCT02097121|515652955|FG001|Overall Study|Withdrawal by Subject|1|||
143030270|NCT02097121|515652956|FG002|Overall Study|Withdrawal by Subject|2|||
143030271|NCT02097121|515652954|FG000|Overall Study|Adverse Event|0|||
143030272|NCT02097121|515652955|FG001|Overall Study|Adverse Event|1|||
143030273|NCT02097121|515652956|FG002|Overall Study|Adverse Event|0|||
143030274|NCT02097121|515652954|FG000|Overall Study|Lost to Follow-up|1|||
143030275|NCT02097121|515652955|FG001|Overall Study|Lost to Follow-up|1|||
143030276|NCT02097121|515652956|FG002|Overall Study|Lost to Follow-up|2|||
143030277|NCT03066999|515652957|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
143030278|NCT03066999|515652958|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
143030279|NCT00661999|515652959|FG000|Overall Study|Adverse Event|11|||
143030280|NCT00661999|515652960|FG001|Overall Study|Adverse Event|5|||
143030281|NCT00661999|515652961|FG002|Overall Study|Adverse Event|8|||
143030282|NCT00661999|515652959|FG000|Overall Study|Death|8|||
143030283|NCT00661999|515652960|FG001|Overall Study|Death|6|||
143030284|NCT00661999|515652961|FG002|Overall Study|Death|3|||
143030285|NCT00661999|515652959|FG000|Overall Study|Other Reasons|5|||
143030286|NCT00661999|515652960|FG001|Overall Study|Other Reasons|12|||
143030287|NCT00661999|515652961|FG002|Overall Study|Other Reasons|23|||
143030288|NCT00661999|515652959|FG000|Overall Study|Withdrawal by Subject|30|||
143030289|NCT00661999|515652960|FG001|Overall Study|Withdrawal by Subject|23|||
143492106|NCT01250379|517342713|FG000|Overall Study|Protocol Violation|2|||
143030290|NCT00661999|515652961|FG002|Overall Study|Withdrawal by Subject|14|||
143030291|NCT00661999|515652959|FG000|Overall Study|Alternative Treatment|1|||
143030292|NCT00661999|515652960|FG001|Overall Study|Alternative Treatment|0|||
143030293|NCT00661999|515652961|FG002|Overall Study|Alternative Treatment|0|||
143030294|NCT00661999|515652959|FG000|Overall Study|Other Medical Problems|4|||
143030295|NCT00661999|515652960|FG001|Overall Study|Other Medical Problems|4|||
143030296|NCT00661999|515652961|FG002|Overall Study|Other Medical Problems|9|||
143030297|NCT01790568|515652962|FG000|Overall Study|Progression prior to transplant|0|||
143030298|NCT01790568|515652963|FG001|Overall Study|Progression prior to transplant|1|||
143030299|NCT02994056|515652965|FG000|Overall Study|Death|8|||
143492107|NCT01250379|517342714|FG001|Overall Study|Protocol Violation|8|||
143492108|NCT01250379|517342713|FG000|Overall Study|Lost to Follow-up|9|||
143492109|NCT01250379|517342714|FG001|Overall Study|Lost to Follow-up|6|||
143492110|NCT01250379|517342713|FG000|Overall Study|Adverse Event|5|||
143492111|NCT01250379|517342714|FG001|Overall Study|Adverse Event|4|||
143492112|NCT01250379|517342713|FG000|Overall Study|Other|0|||
143492113|NCT01250379|517342714|FG001|Overall Study|Other|4|||
143492114|NCT01250379|517342713|FG000|Overall Study|Participant noncompliance|2|||
143492115|NCT01250379|517342714|FG001|Overall Study|Participant noncompliance|0|||
143492116|NCT01489527|517342715|FG000|Overall Study|Pregnancy|9|||
143492117|NCT01489527|517342716|FG001|Overall Study|Pregnancy|14|||
143492118|NCT01489527|517342715|FG000|Overall Study|Participant moved|6|||
143492119|NCT01489527|517342716|FG001|Overall Study|Participant moved|7|||
143492120|NCT01489527|517342715|FG000|Overall Study|Withdrawal by Subject|0|||
143492121|NCT01489527|517342716|FG001|Overall Study|Withdrawal by Subject|4|||
143492122|NCT01489527|517342715|FG000|Overall Study|Lost to Follow-up|5|||
143492123|NCT01489527|517342716|FG001|Overall Study|Lost to Follow-up|1|||
143492124|NCT01489527|517342715|FG000|Overall Study|Procedures|1|||
143492125|NCT01489527|517342716|FG001|Overall Study|Procedures|0|||
143492126|NCT01489527|517342715|FG000|Overall Study|Not compliant|1|||
143492127|NCT01489527|517342716|FG001|Overall Study|Not compliant|0|||
143492128|NCT01984268|517342717|FG000|Overall Study|Study Terminated|15|||
143492129|NCT04899232|517342718|FG000|Screening Period|Physician Decision|1|||
143492130|NCT04899232|517342719|FG001|Screening Period|Physician Decision|0|||
143492131|NCT04899232|517342720|FG002|Screening Period|Physician Decision|0|||
143492132|NCT04899232|517342718|FG000|Screening Period|Withdrawal by Subject|1|||
143492133|NCT04899232|517342719|FG001|Screening Period|Withdrawal by Subject|0|||
143492134|NCT04899232|517342720|FG002|Screening Period|Withdrawal by Subject|0|||
143492135|NCT04899232|517342718|FG000|Screening Period|Participant discharged before receiving intervention|3|||
143492136|NCT04899232|517342719|FG001|Screening Period|Participant discharged before receiving intervention|0|||
143492137|NCT04899232|517342720|FG002|Screening Period|Participant discharged before receiving intervention|0|||
143492138|NCT05061719|517342724|FG000|Overall Study|Adverse Event|60|||
143492139|NCT05061719|517342724|FG000|Overall Study|Death|1|||
143492140|NCT05061719|517342724|FG000|Overall Study|Lack of Efficacy|7|||
143492141|NCT05061719|517342724|FG000|Overall Study|Lost to Follow-up|5|||
143492142|NCT05061719|517342724|FG000|Overall Study|Pregnancy|1|||
143492143|NCT05061719|517342724|FG000|Overall Study|Protocol Violation|8|||
143492144|NCT05061719|517342724|FG000|Overall Study|Withdrawal by Subject|41|||
143492145|NCT05061719|517342724|FG000|Overall Study|Site Closure|2|||
143492146|NCT02392429|517344764|FG000|Screening|Screen failure|15|||
143492147|NCT02392429|517344764|FG000|Enrolled Participants|Ineligible due to disease|3|||
143492148|NCT02392429|517344764|FG000|Enrolled Participants|Withdrawal by Subject|4|||
143492149|NCT02392429|517344764|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
143492150|NCT02392429|517344764|FG000|Evaluable|Death|5|||
143492151|NCT02392429|517344764|FG000|Evaluable|Withdrawal by Subject|1|||
143492152|NCT02392429|517344764|FG000|Evaluable|Adverse Event|1|||
143492153|NCT02392429|517344764|FG000|Evaluable|remission bone marrow biopsy|3|||
143492154|NCT04137887|517344768|FG000|Overall Study|Death|102|||
143492155|NCT04137887|517344769|FG001|Overall Study|Death|92|||
143492156|NCT04137887|517344768|FG000|Overall Study|Withdrawal by Subject|2|||
143492157|NCT04137887|517344769|FG001|Overall Study|Withdrawal by Subject|3|||
143492158|NCT04137887|517344768|FG000|Overall Study|Randomized but not treated|0|||
143492159|NCT04137887|517344769|FG001|Overall Study|Randomized but not treated|1|||
143492160|NCT02740478|517344771|FG000|Overall Study|Withdrawal by Subject|1|||
143492161|NCT01934140|517344773|FG000|Persistence Phase (Year 6-10)|Other|24|||
143492162|NCT01934140|517344774|FG001|Persistence Phase (Year 6-10)|Other|6|||
143492163|NCT01934140|517344773|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
143492164|NCT01934140|517344774|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
143492165|NCT01934140|517344773|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
143492166|NCT01934140|517344774|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
143492167|NCT01934140|517344773|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
143492168|NCT01934140|517344774|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
143492169|NCT01934140|517344773|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
143492170|NCT01934140|517344774|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
143492171|NCT01934140|517344773|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
143492172|NCT01934140|517344774|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
143492173|NCT01934140|517344773|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
143492174|NCT01934140|517344774|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
143492175|NCT01934140|517344773|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
143492176|NCT01934140|517344774|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
143492177|NCT05499559|517344775|FG000|Overall Study|Lost to Follow-up|467|||
143492178|NCT02770326|517344778|FG000|Overall Study|Death|3|||
143492179|NCT02770326|517344778|FG000|Overall Study|Lost to Follow-up|1|||
143492180|NCT02889796|517344779|FG000|Overall Study|Withdrew Consent|18|||
143492181|NCT02889796|517344780|FG001|Overall Study|Withdrew Consent|29|||
143030300|NCT02994056|515652965|FG000|Overall Study|Withdrew Consent|1|||
143030301|NCT02879643|515652966|FG000|Overall Study|Adverse Event|0|||
143030302|NCT02879643|515652967|FG001|Overall Study|Adverse Event|0|||
143030303|NCT02879643|515652968|FG002|Overall Study|Adverse Event|1|||
143030304|NCT02879643|515652969|FG003|Overall Study|Adverse Event|1|||
143030305|NCT02879643|515652970|FG004|Overall Study|Adverse Event|0|||
143030306|NCT04947579|515652975|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
143030307|NCT04947579|515652976|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
143030308|NCT04947579|515652977|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
143030309|NCT04947579|515652978|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
143030310|NCT04947579|515652979|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
143030311|NCT04947579|515652980|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
143030312|NCT04947579|515652975|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
143030313|NCT04947579|515652976|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
143030314|NCT04947579|515652977|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
143030315|NCT04947579|515652978|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
143030316|NCT04947579|515652979|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
143030317|NCT04947579|515652980|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
143030318|NCT04947579|515652975|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
143030319|NCT04947579|515652976|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
143030320|NCT04947579|515652977|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
143030321|NCT04947579|515652978|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
143030322|NCT04947579|515652979|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
143030323|NCT04947579|515652980|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
143030324|NCT04947579|515652975|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
143030325|NCT04947579|515652976|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
143030326|NCT04947579|515652977|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
143030327|NCT04947579|515652978|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
143030328|NCT04947579|515652979|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
143030329|NCT04947579|515652980|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
143030330|NCT04947579|515652975|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
143030331|NCT04947579|515652976|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
143030332|NCT04947579|515652977|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
143030333|NCT04947579|515652978|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
143030334|NCT04947579|515652979|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
143030335|NCT04947579|515652980|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
143030336|NCT04947579|515652975|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
143030337|NCT04947579|515652976|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
143030338|NCT04947579|515652977|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
143030339|NCT04947579|515652978|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
143030340|NCT04947579|515652979|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
143030341|NCT04947579|515652980|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
143030342|NCT04947579|515652975|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
143030343|NCT04947579|515652976|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
143030344|NCT04947579|515652977|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
143030345|NCT04947579|515652978|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
143030346|NCT04947579|515652979|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
143030347|NCT04947579|515652980|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
143030348|NCT04947579|515652975|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
143030349|NCT04947579|515652976|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
143030350|NCT04947579|515652977|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
143030351|NCT04947579|515652978|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
143030352|NCT04947579|515652979|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
143030353|NCT04947579|515652980|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
143030354|NCT04947579|515652975|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
143030355|NCT04947579|515652976|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
143158589|NCT00504556|516126024|FG004|Overall Study|administrative reasons|2|||
143158590|NCT00504556|516126020|FG000|Overall Study|did not meet entry criteria|2|||
143158591|NCT00504556|516126021|FG001|Overall Study|did not meet entry criteria|0|||
143158592|NCT00504556|516126022|FG002|Overall Study|did not meet entry criteria|1|||
143492182|NCT02889796|517344781|FG002|Overall Study|Withdrew Consent|20|||
143492183|NCT02889796|517344782|FG003|Overall Study|Withdrew Consent|1|||
143158593|NCT00504556|516126023|FG003|Overall Study|did not meet entry criteria|1|||
143158594|NCT00504556|516126024|FG004|Overall Study|did not meet entry criteria|0|||
143158595|NCT00504556|516126020|FG000|Overall Study|data monitor committee decision|0|||
143492184|NCT02889796|517344783|FG004|Overall Study|Withdrew Consent|2|||
143158596|NCT00504556|516126021|FG001|Overall Study|data monitor committee decision|0|||
143492185|NCT02889796|517344784|FG005|Overall Study|Withdrew Consent|35|||
143030356|NCT04947579|515652977|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
143030357|NCT04947579|515652978|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
143030358|NCT04947579|515652979|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
143030359|NCT04947579|515652980|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
143030360|NCT04947579|515652975|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
143030361|NCT04947579|515652976|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
143030362|NCT04947579|515652977|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
143030363|NCT04947579|515652978|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
143030364|NCT04947579|515652979|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
143030365|NCT04947579|515652980|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
143030366|NCT04947579|515652975|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
143030367|NCT04947579|515652976|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
143030368|NCT04947579|515652977|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
143030369|NCT04947579|515652978|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
143030370|NCT04947579|515652979|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
143030371|NCT04947579|515652980|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
143030372|NCT00634179|515652983|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
143030373|NCT04272801|515652984|FG000|Overall Study|Withdrawal by Subject|4|||
143030374|NCT04272801|515652984|FG000|Overall Study|Lost to Follow-up|4|||
143030375|NCT04272801|515652984|FG000|Overall Study|Ineligible|1|||
143030376|NCT02456909|515652985|FG000|Overall Study|Did not receive allocated intervention|24|||
143030377|NCT02456909|515652986|FG001|Overall Study|Did not receive allocated intervention|26|||
143030378|NCT02456909|515652985|FG000|Overall Study|Did not complete the primary outcome|0|||
143030379|NCT02456909|515652986|FG001|Overall Study|Did not complete the primary outcome|1|||
143030380|NCT01575054|515652987|FG000|Overall Study|Other Reasons|5|||
143030381|NCT01575054|515652988|FG001|Overall Study|Other Reasons|3|||
143030382|NCT01575054|515652987|FG000|Overall Study|Protocol Violation|2|||
143030383|NCT01575054|515652988|FG001|Overall Study|Protocol Violation|1|||
143030384|NCT01575054|515652987|FG000|Overall Study|Personal Reasons|10|||
143030385|NCT01575054|515652988|FG001|Overall Study|Personal Reasons|11|||
143030386|NCT01575054|515652987|FG000|Overall Study|Lost to Follow-up|3|||
143030387|NCT01575054|515652988|FG001|Overall Study|Lost to Follow-up|3|||
143030388|NCT01575054|515652987|FG000|Overall Study|Adverse Event|9|||
143030389|NCT01575054|515652988|FG001|Overall Study|Adverse Event|8|||
143030390|NCT05109234|515652991|FG000|Overall Study|Adverse Event|2|||
143030391|NCT05109234|515652992|FG001|Overall Study|Adverse Event|2|||
143030392|NCT05109234|515652991|FG000|Overall Study|Lack of Efficacy|5|||
143030393|NCT05109234|515652992|FG001|Overall Study|Lack of Efficacy|0|||
143030394|NCT05109234|515652991|FG000|Overall Study|Consent withdrawn by Participant (not due to AE)|1|||
143030395|NCT05109234|515652992|FG001|Overall Study|Consent withdrawn by Participant (not due to AE)|0|||
143030396|NCT05109234|515652991|FG000|Overall Study|Consent withdrawn by parent/guardian (not AE)|3|||
143030397|NCT05109234|515652992|FG001|Overall Study|Consent withdrawn by parent/guardian (not AE)|4|||
143030398|NCT05109234|515652991|FG000|Overall Study|Evacuated from Ukraine due to the war|2|||
143030399|NCT05109234|515652992|FG001|Overall Study|Evacuated from Ukraine due to the war|0|||
143030400|NCT05109234|515652991|FG000|Overall Study|Missed safety visit; study incomplete per protocol|1|||
143030401|NCT05109234|515652992|FG001|Overall Study|Missed safety visit; study incomplete per protocol|0|||
143030402|NCT03968224|515652993|FG000|Overall Study|Lost to Follow-up|11|||
143030403|NCT03968224|515652994|FG001|Overall Study|Lost to Follow-up|18|||
143030404|NCT02585258|515652995|FG000|Overall Study|Adverse Event|28|||
143030405|NCT02585258|515652996|FG001|Overall Study|Adverse Event|29|||
143030406|NCT02585258|515652995|FG000|Overall Study|Death|3|||
143030407|NCT02585258|515652996|FG001|Overall Study|Death|2|||
143030408|NCT02585258|515652995|FG000|Overall Study|Lack of Efficacy|7|||
143030409|NCT02585258|515652996|FG001|Overall Study|Lack of Efficacy|9|||
143030410|NCT02585258|515652995|FG000|Overall Study|includes covid-related access problems|42|||
143030411|NCT02585258|515652996|FG001|Overall Study|includes covid-related access problems|46|||
143030412|NCT02585258|515652995|FG000|Overall Study|Lost to Follow-up|5|||
143030413|NCT02585258|515652996|FG001|Overall Study|Lost to Follow-up|2|||
143158597|NCT00504556|516126022|FG002|Overall Study|data monitor committee decision|0|||
143492186|NCT02889796|517344779|FG000|Overall Study|Investigator's Discretion|10|||
143158598|NCT00504556|516126023|FG003|Overall Study|data monitor committee decision|100|||
143158599|NCT00504556|516126024|FG004|Overall Study|data monitor committee decision|0|||
143158600|NCT00504556|516126020|FG000|Overall Study|Other|2|||
143158601|NCT00504556|516126021|FG001|Overall Study|Other|2|||
143030414|NCT01027143|515654549|FG000|Overall Study|Lost to Follow-up|9|||
143030415|NCT01027143|515654550|FG001|Overall Study|Lost to Follow-up|4|||
143030416|NCT00502775|515654557|FG000|Overall Study|Adverse Event|1|||
143030417|NCT00502775|515654558|FG001|Overall Study|Adverse Event|2|||
143158602|NCT00504556|516126022|FG002|Overall Study|Other|2|||
143158603|NCT00504556|516126023|FG003|Overall Study|Other|3|||
143158604|NCT00504556|516126024|FG004|Overall Study|Other|0|||
143158605|NCT00504556|516126020|FG000|Overall Study|not in safety analysis set|0|||
143237416|NCT01337960|516423287|FG002|Overall Study|Withdrawal by Subject|0|||
143237417|NCT01936870|516423292|FG000|Overall Study|No Visit After Treatment|176|||
143237418|NCT01936870|516423292|FG000|Overall Study|Protocol Violation|12|||
143237419|NCT01936870|516423292|FG000|Overall Study|No Drug Administration|1|||
143237420|NCT00763035|516423299|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
143237421|NCT00763035|516423300|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
143237422|NCT00763035|516423299|FG000|First Intervention|Adverse Event|0|||
143237423|NCT00763035|516423300|FG001|First Intervention|Adverse Event|1|||
143237424|NCT00763035|516423299|FG000|Second Intervention|Adverse Event|1|||
143237425|NCT00763035|516423300|FG001|Second Intervention|Adverse Event|0|||
143237426|NCT00763035|516423299|FG000|Second Intervention|Physician Decision|2|||
143237427|NCT00763035|516423300|FG001|Second Intervention|Physician Decision|0|||
143237428|NCT02796170|516423301|FG000|Overall Study|Lost to Follow-up|3|||
143364021|NCT00463151|516875523|FG003|Overall Study|Withdrawal by Subject|1|||
143492187|NCT02889796|517344780|FG001|Overall Study|Investigator's Discretion|9|||
143492188|NCT02889796|517344781|FG002|Overall Study|Investigator's Discretion|10|||
143492189|NCT02889796|517344782|FG003|Overall Study|Investigator's Discretion|3|||
143492190|NCT02889796|517344783|FG004|Overall Study|Investigator's Discretion|0|||
143492191|NCT02889796|517344784|FG005|Overall Study|Investigator's Discretion|15|||
143492192|NCT02889796|517344779|FG000|Overall Study|Adverse Event|17|||
143492193|NCT02889796|517344780|FG001|Overall Study|Adverse Event|8|||
143492194|NCT02889796|517344781|FG002|Overall Study|Adverse Event|8|||
143492195|NCT02889796|517344782|FG003|Overall Study|Adverse Event|4|||
143492196|NCT02889796|517344783|FG004|Overall Study|Adverse Event|1|||
143492197|NCT02889796|517344784|FG005|Overall Study|Adverse Event|7|||
143492198|NCT02889796|517344779|FG000|Overall Study|Lost to Follow-up|5|||
143492199|NCT02889796|517344780|FG001|Overall Study|Lost to Follow-up|7|||
143492200|NCT02889796|517344781|FG002|Overall Study|Lost to Follow-up|2|||
143492201|NCT02889796|517344782|FG003|Overall Study|Lost to Follow-up|0|||
143492202|NCT02889796|517344783|FG004|Overall Study|Lost to Follow-up|2|||
143492203|NCT02889796|517344784|FG005|Overall Study|Lost to Follow-up|6|||
143492204|NCT02889796|517344779|FG000|Overall Study|Protocol Violation|0|||
143492205|NCT02889796|517344780|FG001|Overall Study|Protocol Violation|1|||
143492206|NCT02889796|517344781|FG002|Overall Study|Protocol Violation|3|||
143492207|NCT02889796|517344782|FG003|Overall Study|Protocol Violation|0|||
143492208|NCT02889796|517344783|FG004|Overall Study|Protocol Violation|0|||
143492209|NCT02889796|517344784|FG005|Overall Study|Protocol Violation|4|||
143492210|NCT02889796|517344779|FG000|Overall Study|Non-compliance With Study Drug|0|||
143492211|NCT02889796|517344780|FG001|Overall Study|Non-compliance With Study Drug|2|||
143492212|NCT02889796|517344781|FG002|Overall Study|Non-compliance With Study Drug|0|||
143492213|NCT02889796|517344782|FG003|Overall Study|Non-compliance With Study Drug|0|||
143492214|NCT02889796|517344783|FG004|Overall Study|Non-compliance With Study Drug|1|||
143492215|NCT02889796|517344784|FG005|Overall Study|Non-compliance With Study Drug|2|||
143492216|NCT02889796|517344779|FG000|Overall Study|Death|1|||
143492217|NCT02889796|517344780|FG001|Overall Study|Death|1|||
143492218|NCT02889796|517344781|FG002|Overall Study|Death|0|||
143492219|NCT02889796|517344782|FG003|Overall Study|Death|1|||
143492220|NCT02889796|517344783|FG004|Overall Study|Death|0|||
143492221|NCT02889796|517344784|FG005|Overall Study|Death|1|||
143492222|NCT02889796|517344779|FG000|Overall Study|Pregnancy|0|||
143492223|NCT02889796|517344780|FG001|Overall Study|Pregnancy|1|||
143492224|NCT02889796|517344781|FG002|Overall Study|Pregnancy|1|||
143492225|NCT02889796|517344782|FG003|Overall Study|Pregnancy|0|||
143492226|NCT02889796|517344783|FG004|Overall Study|Pregnancy|0|||
143492227|NCT02889796|517344784|FG005|Overall Study|Pregnancy|0|||
143492228|NCT02889796|517344779|FG000|Overall Study|Randomized but not Dosed|2|||
143492229|NCT02889796|517344780|FG001|Overall Study|Randomized but not Dosed|0|||
143492230|NCT02889796|517344781|FG002|Overall Study|Randomized but not Dosed|0|||
143492231|NCT02889796|517344782|FG003|Overall Study|Randomized but not Dosed|0|||
143492232|NCT02889796|517344783|FG004|Overall Study|Randomized but not Dosed|0|||
143492233|NCT02889796|517344784|FG005|Overall Study|Randomized but not Dosed|2|||
143492234|NCT04294459|517344786|FG000|Overall Study|Adverse Event|0|||
143492235|NCT04294459|517344787|FG001|Overall Study|Adverse Event|1|||
143492236|NCT04033367|517344788|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
143492237|NCT04033367|517344789|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
143492238|NCT04033367|517344788|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
143492239|NCT04033367|517344789|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
143492240|NCT04033367|517344788|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
143492241|NCT04033367|517344789|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
143492242|NCT04033367|517344788|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
143237429|NCT02796170|516423302|FG001|Overall Study|Lost to Follow-up|0|||
143237430|NCT03879772|516423305|FG000|Overall Study|Adverse Event|2|||
143237431|NCT03879772|516423306|FG001|Overall Study|Adverse Event|2|||
143237432|NCT03879772|516423307|FG002|Overall Study|Adverse Event|3|||
143492243|NCT04033367|517344789|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
143492244|NCT02421887|517344790|FG000|Overall Study|Lost to Follow-up|5|||
143492245|NCT02421887|517344791|FG001|Overall Study|Lost to Follow-up|0|||
143492246|NCT02421887|517344790|FG000|Overall Study|Withdrawal by Subject|8|||
143030418|NCT00502775|515654559|FG002|Overall Study|Adverse Event|1|||
143030419|NCT00502775|515654557|FG000|Overall Study|Protocol Violation|1|||
143030420|NCT00502775|515654558|FG001|Overall Study|Protocol Violation|5|||
143030421|NCT00502775|515654559|FG002|Overall Study|Protocol Violation|2|||
143030422|NCT00502775|515654557|FG000|Overall Study|Withdrawal by Subject|1|||
143030423|NCT00502775|515654558|FG001|Overall Study|Withdrawal by Subject|1|||
143030424|NCT00502775|515654559|FG002|Overall Study|Withdrawal by Subject|2|||
143030425|NCT00502775|515654557|FG000|Overall Study|Sponsor Terminated Study|1|||
143030426|NCT00502775|515654558|FG001|Overall Study|Sponsor Terminated Study|0|||
143030427|NCT00502775|515654559|FG002|Overall Study|Sponsor Terminated Study|1|||
143030428|NCT00502775|515654557|FG000|Overall Study|Non-compliance with eDiary|4|||
143030429|NCT00502775|515654558|FG001|Overall Study|Non-compliance with eDiary|1|||
143030430|NCT00502775|515654559|FG002|Overall Study|Non-compliance with eDiary|1|||
143030431|NCT00502775|515654557|FG000|Overall Study|Subject unable to swallow capsule|1|||
143030432|NCT00502775|515654558|FG001|Overall Study|Subject unable to swallow capsule|0|||
143030433|NCT00502775|515654559|FG002|Overall Study|Subject unable to swallow capsule|1|||
143030434|NCT00502775|515654557|FG000|Overall Study|Logpad compliance <80%|1|||
143030435|NCT00502775|515654558|FG001|Overall Study|Logpad compliance <80%|0|||
143030436|NCT00502775|515654559|FG002|Overall Study|Logpad compliance <80%|0|||
143030437|NCT00502775|515654557|FG000|Overall Study|Randomized in error|0|||
143030438|NCT00502775|515654558|FG001|Overall Study|Randomized in error|1|||
143030439|NCT00502775|515654559|FG002|Overall Study|Randomized in error|1|||
143030440|NCT00502775|515654557|FG000|Overall Study|Non-compliance|0|||
143030441|NCT00502775|515654558|FG001|Overall Study|Non-compliance|2|||
143030442|NCT00502775|515654559|FG002|Overall Study|Non-compliance|2|||
143030443|NCT00502775|515654557|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
143030444|NCT00502775|515654558|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
143030445|NCT00502775|515654559|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
143030446|NCT00502775|515654557|FG000|Overall Study|Declining pollen counts|0|||
143030447|NCT00502775|515654558|FG001|Overall Study|Declining pollen counts|1|||
143030448|NCT00502775|515654559|FG002|Overall Study|Declining pollen counts|1|||
143030449|NCT00502775|515654557|FG000|Overall Study|Subject in jail|0|||
143030450|NCT00502775|515654558|FG001|Overall Study|Subject in jail|1|||
143030451|NCT00502775|515654559|FG002|Overall Study|Subject in jail|0|||
143030452|NCT00502775|515654557|FG000|Overall Study|Subject took disallowed drug|0|||
143030453|NCT00502775|515654558|FG001|Overall Study|Subject took disallowed drug|0|||
143030454|NCT00502775|515654559|FG002|Overall Study|Subject took disallowed drug|1|||
143030455|NCT02819362|515654565|FG000|Overall Study|On-site MRI could not be performed|70|||
143030456|NCT05301751|515654566|FG000|Overall Study|Withdrawal by Subject|0|||
143030457|NCT05301751|515654567|FG001|Overall Study|Withdrawal by Subject|0|||
143030458|NCT05301751|515654568|FG002|Overall Study|Withdrawal by Subject|1|||
143030459|NCT05301751|515654569|FG003|Overall Study|Withdrawal by Subject|0|||
143030460|NCT01545076|515654572|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
143158606|NCT00504556|516126021|FG001|Overall Study|not in safety analysis set|1|||
143158607|NCT00504556|516126022|FG002|Overall Study|not in safety analysis set|1|||
143158608|NCT00504556|516126023|FG003|Overall Study|not in safety analysis set|0|||
143158609|NCT00504556|516126024|FG004|Overall Study|not in safety analysis set|1|||
143158610|NCT01529112|516126027|FG000|Overall Study|Adverse Event|2|||
143158611|NCT01529112|516126028|FG001|Overall Study|Adverse Event|0|||
143158612|NCT01529112|516126027|FG000|Overall Study|Death|59|||
143158613|NCT01529112|516126028|FG001|Overall Study|Death|38|||
143158614|NCT01529112|516126027|FG000|Overall Study|Protocol Violation|1|||
143158615|NCT01529112|516126028|FG001|Overall Study|Protocol Violation|0|||
143158616|NCT01529112|516126027|FG000|Overall Study|Withdrawal by Subject|7|||
143158617|NCT01529112|516126028|FG001|Overall Study|Withdrawal by Subject|3|||
143158618|NCT02741193|516126029|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
143158619|NCT02741193|516126029|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
143158620|NCT02502383|516126030|FG000|Overall Study|Lost to Follow-up|130|||
143158621|NCT02502383|516126031|FG001|Overall Study|Lost to Follow-up|131|||
143158622|NCT02502383|516126030|FG000|Overall Study|Withdrawal by Subject|31|||
143158623|NCT02502383|516126031|FG001|Overall Study|Withdrawal by Subject|24|||
143158624|NCT00676052|516126032|FG000|Overall Study|Adverse Event|0|||
143492247|NCT02421887|517344791|FG001|Overall Study|Withdrawal by Subject|5|||
143158625|NCT00676052|516126033|FG001|Overall Study|Adverse Event|1|||
143158626|NCT00676052|516126034|FG002|Overall Study|Adverse Event|1|||
143030461|NCT01545076|515654573|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
143030462|NCT01545076|515654574|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
143158627|NCT00676052|516126035|FG003|Overall Study|Adverse Event|2|||
143030463|NCT01545076|515654575|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
143030464|NCT01545076|515654576|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
143030465|NCT01545076|515654572|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
143158628|NCT00676052|516126036|FG004|Overall Study|Adverse Event|2|||
143158629|NCT00676052|516126037|FG005|Overall Study|Adverse Event|2|||
143158630|NCT00676052|516126032|FG000|Overall Study|Lack of Efficacy|2|||
143158631|NCT00676052|516126033|FG001|Overall Study|Lack of Efficacy|2|||
143030466|NCT01545076|515654573|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
143030467|NCT01545076|515654574|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
143030468|NCT01545076|515654575|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
143030469|NCT01545076|515654576|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
143030470|NCT01545076|515654572|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
143030471|NCT01545076|515654573|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
143030472|NCT01545076|515654574|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
143030473|NCT01545076|515654575|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
143030474|NCT01545076|515654576|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
143030475|NCT01545076|515654572|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
143030476|NCT01545076|515654573|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
143030477|NCT01545076|515654574|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
143030478|NCT01545076|515654575|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
143030479|NCT01545076|515654576|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
143030480|NCT01545076|515654572|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
143030481|NCT01545076|515654573|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
143030482|NCT01545076|515654574|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
143030483|NCT01545076|515654575|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
143030484|NCT01545076|515654576|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
143030485|NCT01545076|515654572|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
143030486|NCT01545076|515654573|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
143030487|NCT01545076|515654574|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
143030488|NCT01545076|515654575|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
143030489|NCT01545076|515654576|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
143030490|NCT01545076|515654572|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
143030491|NCT01545076|515654573|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
143030492|NCT01545076|515654574|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
143030493|NCT01545076|515654575|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
143030494|NCT01545076|515654576|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
143030495|NCT01545076|515654572|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
143030496|NCT01545076|515654573|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
143030497|NCT01545076|515654574|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
143030498|NCT01545076|515654575|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
143030499|NCT01545076|515654576|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
143030500|NCT01545076|515654572|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
143030501|NCT01545076|515654573|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
143030502|NCT01545076|515654574|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
143030503|NCT01545076|515654575|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
143030504|NCT01545076|515654576|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
143030505|NCT05381948|515654577|FG000|Overall Study|Adverse Event: Ocular - Study Eye|0|||
143030506|NCT05381948|515654578|FG001|Overall Study|Adverse Event: Ocular - Study Eye|1|||
143030507|NCT05381948|515654579|FG002|Overall Study|Adverse Event: Ocular - Study Eye|0|||
143030508|NCT05381948|515654577|FG000|Overall Study|Adverse Event: Non-ocular|0|||
143030509|NCT05381948|515654578|FG001|Overall Study|Adverse Event: Non-ocular|1|||
143030510|NCT05381948|515654579|FG002|Overall Study|Adverse Event: Non-ocular|0|||
143030511|NCT05381948|515654577|FG000|Overall Study|Lost to Follow-up|1|||
143030512|NCT05381948|515654578|FG001|Overall Study|Lost to Follow-up|0|||
143030513|NCT05381948|515654579|FG002|Overall Study|Lost to Follow-up|0|||
143030514|NCT05381948|515654577|FG000|Overall Study|Protocol Deviation|0|||
143030515|NCT05381948|515654578|FG001|Overall Study|Protocol Deviation|2|||
143030516|NCT05381948|515654579|FG002|Overall Study|Protocol Deviation|0|||
143030517|NCT05381948|515654577|FG000|Overall Study|Withdrawal by Subject|1|||
143030518|NCT05381948|515654578|FG001|Overall Study|Withdrawal by Subject|0|||
143030519|NCT05381948|515654579|FG002|Overall Study|Withdrawal by Subject|1|||
143030520|NCT05381948|515654577|FG000|Overall Study|Death|0|||
143030521|NCT05381948|515654578|FG001|Overall Study|Death|2|||
143030522|NCT05381948|515654579|FG002|Overall Study|Death|0|||
143030523|NCT05381948|515654577|FG000|Overall Study|Discontinued study without receiving study drug|0|||
143030524|NCT05381948|515654578|FG001|Overall Study|Discontinued study without receiving study drug|0|||
143030525|NCT05381948|515654579|FG002|Overall Study|Discontinued study without receiving study drug|1|||
143030526|NCT04471207|515654580|FG000|Overall Study|Lost to Follow-up|4|||
143030527|NCT04471207|515654581|FG001|Overall Study|Lost to Follow-up|1|||
143237433|NCT03879772|516423308|FG003|Overall Study|Adverse Event|4|||
143237434|NCT03879772|516423309|FG004|Overall Study|Adverse Event|3|||
143237435|NCT03879772|516423305|FG000|Overall Study|Treatment Failure|1|||
143237436|NCT03879772|516423306|FG001|Overall Study|Treatment Failure|0|||
143030528|NCT04471207|515654580|FG000|Overall Study|Medication Contraindication|0|||
143030529|NCT04471207|515654581|FG001|Overall Study|Medication Contraindication|1|||
143030530|NCT04471207|515654580|FG000|Overall Study|Loss of Interest|2|||
143237437|NCT03879772|516423307|FG002|Overall Study|Treatment Failure|0|||
143030531|NCT04471207|515654581|FG001|Overall Study|Loss of Interest|1|||
143030532|NCT04471207|515654580|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
143030533|NCT04471207|515654581|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
143030534|NCT04471207|515654580|FG000|Overall Study|Scheduling Conflicts|3|||
143030535|NCT04471207|515654581|FG001|Overall Study|Scheduling Conflicts|1|||
143030536|NCT04471207|515654580|FG000|Overall Study|Physician Decision|1|||
143030537|NCT04471207|515654581|FG001|Overall Study|Physician Decision|0|||
143030538|NCT04471207|515654580|FG000|Overall Study|Unwilling to Use System|0|||
143030539|NCT04471207|515654581|FG001|Overall Study|Unwilling to Use System|1|||
143030540|NCT02446132|515654584|FG000|Overall Study|Adverse Event|10|||
143030541|NCT02446132|515654585|FG001|Overall Study|Adverse Event|27|||
143030542|NCT02446132|515654586|FG002|Overall Study|Adverse Event|27|||
143030543|NCT02446132|515654584|FG000|Overall Study|Death|2|||
143030544|NCT02446132|515654585|FG001|Overall Study|Death|13|||
143030545|NCT02446132|515654586|FG002|Overall Study|Death|10|||
143030546|NCT02446132|515654584|FG000|Overall Study|Lack of Efficacy|1|||
143030547|NCT02446132|515654585|FG001|Overall Study|Lack of Efficacy|10|||
143030548|NCT02446132|515654586|FG002|Overall Study|Lack of Efficacy|6|||
143030549|NCT02446132|515654584|FG000|Overall Study|Lost to Follow-up|2|||
143030550|NCT02446132|515654585|FG001|Overall Study|Lost to Follow-up|4|||
143030551|NCT02446132|515654586|FG002|Overall Study|Lost to Follow-up|5|||
143030552|NCT02446132|515654584|FG000|Overall Study|Non-compliance With Study Drug|2|||
143030553|NCT02446132|515654585|FG001|Overall Study|Non-compliance With Study Drug|2|||
143030554|NCT02446132|515654586|FG002|Overall Study|Non-compliance With Study Drug|3|||
143030555|NCT02446132|515654584|FG000|Overall Study|Physician Decision|1|||
143030556|NCT02446132|515654585|FG001|Overall Study|Physician Decision|8|||
143030557|NCT02446132|515654586|FG002|Overall Study|Physician Decision|13|||
143030558|NCT02446132|515654584|FG000|Overall Study|Protocol Deviation|0|||
143030559|NCT02446132|515654585|FG001|Overall Study|Protocol Deviation|0|||
143030560|NCT02446132|515654586|FG002|Overall Study|Protocol Deviation|1|||
143030561|NCT02446132|515654584|FG000|Overall Study|Study Subject Withdrawal by Parent or Guardian|14|||
143030562|NCT02446132|515654585|FG001|Overall Study|Study Subject Withdrawal by Parent or Guardian|36|||
143030563|NCT02446132|515654586|FG002|Overall Study|Study Subject Withdrawal by Parent or Guardian|22|||
143030564|NCT02446132|515654584|FG000|Overall Study|Study Terminated by Sponsor|4|||
143030565|NCT02446132|515654585|FG001|Overall Study|Study Terminated by Sponsor|35|||
143030566|NCT02446132|515654586|FG002|Overall Study|Study Terminated by Sponsor|58|||
143030567|NCT02446132|515654584|FG000|Overall Study|Trial Site Terminated by Sponsor|6|||
143030568|NCT02446132|515654585|FG001|Overall Study|Trial Site Terminated by Sponsor|4|||
143030569|NCT02446132|515654586|FG002|Overall Study|Trial Site Terminated by Sponsor|5|||
143030570|NCT02446132|515654584|FG000|Overall Study|Withdrawal by Subject|11|||
143030571|NCT02446132|515654585|FG001|Overall Study|Withdrawal by Subject|29|||
143492248|NCT02421887|517344790|FG000|Overall Study|Physician Decision|2|||
143492249|NCT02421887|517344791|FG001|Overall Study|Physician Decision|4|||
143492250|NCT02421887|517344790|FG000|Overall Study|Adverse Event|2|||
143492251|NCT02421887|517344791|FG001|Overall Study|Adverse Event|0|||
143492252|NCT01978093|517344792|FG000|Overall Study|Death|1|||
143492253|NCT01978093|517344793|FG001|Overall Study|Death|0|||
143492254|NCT01978093|517344792|FG000|Overall Study|Adverse Event|0|||
143492255|NCT01978093|517344793|FG001|Overall Study|Adverse Event|5|||
143492256|NCT01978093|517344792|FG000|Overall Study|Protocol Violation|8|||
143492257|NCT01978093|517344793|FG001|Overall Study|Protocol Violation|2|||
143492258|NCT01978093|517344792|FG000|Overall Study|Withdrawal by Subject|29|||
143030572|NCT02446132|515654586|FG002|Overall Study|Withdrawal by Subject|25|||
143030573|NCT02446132|515654584|FG000|Overall Study|Reason not Specified|4|||
143030574|NCT02446132|515654585|FG001|Overall Study|Reason not Specified|16|||
143030575|NCT02446132|515654586|FG002|Overall Study|Reason not Specified|10|||
143030576|NCT02446132|515654584|FG000|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|0|||
143030577|NCT02446132|515654585|FG001|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|1|||
143030578|NCT02446132|515654586|FG002|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|5|||
143030579|NCT05526248|515654587|FG000|Overall Study|Lost to Follow-up|1|||
143030580|NCT05526248|515654587|FG000|Overall Study|Adverse Event|2|||
143030581|NCT05526248|515654587|FG000|Overall Study|Withdrawal by Subject|1|||
143030582|NCT03444038|515654588|FG000|Overall Study|Adverse Event|12|||
143030583|NCT03444038|515654588|FG000|Overall Study|Withdrawal by Subject|7|||
143030584|NCT03444038|515654588|FG000|Overall Study|Lost to Follow-up|1|||
143030585|NCT03444038|515654588|FG000|Overall Study|Physician Decision|2|||
143492259|NCT01978093|517344793|FG001|Overall Study|Withdrawal by Subject|25|||
143492260|NCT01978093|517344792|FG000|Overall Study|Lost to Follow-up|11|||
143030586|NCT03444038|515654588|FG000|Overall Study|Lack of Efficacy|7|||
143030587|NCT00977106|515654589|FG000|Overall Study|Adverse Event|5|||
143030588|NCT00977106|515654590|FG001|Overall Study|Adverse Event|6|||
143030589|NCT00977106|515654589|FG000|Overall Study|Withdrawal by Subject|2|||
143030590|NCT00977106|515654590|FG001|Overall Study|Withdrawal by Subject|2|||
143030591|NCT00977106|515654589|FG000|Overall Study|Lack of Efficacy|2|||
143030592|NCT00977106|515654590|FG001|Overall Study|Lack of Efficacy|2|||
143492261|NCT01978093|517344793|FG001|Overall Study|Lost to Follow-up|15|||
143492262|NCT01978093|517344792|FG000|Overall Study|Migrated/moved from study area|11|||
143030593|NCT00977106|515654589|FG000|Overall Study|Protocol Violation|0|||
143030594|NCT00977106|515654590|FG001|Overall Study|Protocol Violation|1|||
143030595|NCT00977106|515654589|FG000|Overall Study|Other|1|||
143030596|NCT00977106|515654590|FG001|Overall Study|Other|0|||
143030597|NCT00436007|515654593|FG000|Overall Study|Withdrawal by Subject|5|||
143030598|NCT00436007|515654594|FG001|Overall Study|Withdrawal by Subject|3|||
143030599|NCT00436007|515654595|FG002|Overall Study|Withdrawal by Subject|4|||
143030600|NCT00436007|515654593|FG000|Overall Study|Lost to Follow-up|14|||
143030601|NCT00436007|515654594|FG001|Overall Study|Lost to Follow-up|10|||
143030602|NCT00436007|515654595|FG002|Overall Study|Lost to Follow-up|13|||
143030603|NCT00436007|515654593|FG000|Overall Study|Physician Decision|0|||
143030604|NCT00436007|515654594|FG001|Overall Study|Physician Decision|0|||
143030605|NCT00436007|515654595|FG002|Overall Study|Physician Decision|2|||
143030606|NCT00436007|515654593|FG000|Overall Study|Death|0|||
143030607|NCT00436007|515654594|FG001|Overall Study|Death|1|||
143030608|NCT00436007|515654595|FG002|Overall Study|Death|3|||
143030609|NCT00436007|515654593|FG000|Overall Study|Other|0|||
143030610|NCT00436007|515654594|FG001|Overall Study|Other|0|||
143030611|NCT00436007|515654595|FG002|Overall Study|Other|1|||
143030612|NCT01957488|515654596|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
143030613|NCT01957488|515654597|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
143030614|NCT01957488|515654598|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
143030615|NCT01957488|515654599|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
143030616|NCT01957488|515654600|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
143030617|NCT01957488|515654601|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
143030618|NCT01957488|515654596|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
143030619|NCT01957488|515654597|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
143030620|NCT01957488|515654598|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
143030621|NCT01957488|515654599|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
143030622|NCT01957488|515654600|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
143030623|NCT01957488|515654601|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
143030624|NCT01957488|515654596|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
143030625|NCT01957488|515654597|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
143030626|NCT01957488|515654598|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
143030627|NCT01957488|515654599|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
143030628|NCT01957488|515654600|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
143030629|NCT01957488|515654601|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
143030630|NCT01957488|515654596|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
143030631|NCT01957488|515654597|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
143030632|NCT01957488|515654598|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
143030633|NCT01957488|515654599|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
143030634|NCT01957488|515654600|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
143030635|NCT01957488|515654601|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
143030636|NCT01957488|515654596|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
143030637|NCT01957488|515654597|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
143030638|NCT01957488|515654598|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
143030639|NCT01957488|515654599|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
143030640|NCT01957488|515654600|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
143030641|NCT01957488|515654601|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
143030642|NCT01957488|515654596|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
143030643|NCT01957488|515654597|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
143030644|NCT01957488|515654598|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
143030645|NCT01957488|515654599|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
143030646|NCT01957488|515654600|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
143237438|NCT03879772|516423308|FG003|Overall Study|Treatment Failure|2|||
143237439|NCT03879772|516423309|FG004|Overall Study|Treatment Failure|1|||
143237440|NCT03879772|516423305|FG000|Overall Study|Lost to Follow-up|0|||
143237441|NCT03879772|516423306|FG001|Overall Study|Lost to Follow-up|0|||
143237442|NCT03879772|516423307|FG002|Overall Study|Lost to Follow-up|0|||
143237443|NCT03879772|516423308|FG003|Overall Study|Lost to Follow-up|0|||
143030647|NCT01957488|515654601|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
143237444|NCT03879772|516423309|FG004|Overall Study|Lost to Follow-up|1|||
143237445|NCT03879772|516423305|FG000|Overall Study|Withdrawal by Subject|0|||
143030648|NCT01957488|515654596|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
143030649|NCT01957488|515654597|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
143237446|NCT03879772|516423306|FG001|Overall Study|Withdrawal by Subject|1|||
143030650|NCT01957488|515654598|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
143030651|NCT01957488|515654599|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
143030652|NCT01957488|515654600|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
143030653|NCT01957488|515654601|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
143030654|NCT01957488|515654596|FG000|Test Period 2 (2 Weeks)|Other|1|||
143030655|NCT01957488|515654597|FG001|Test Period 2 (2 Weeks)|Other|0|||
143030656|NCT01957488|515654598|FG002|Test Period 2 (2 Weeks)|Other|0|||
143030657|NCT01957488|515654599|FG003|Test Period 2 (2 Weeks)|Other|0|||
143030658|NCT01957488|515654600|FG004|Test Period 2 (2 Weeks)|Other|0|||
143030659|NCT01957488|515654601|FG005|Test Period 2 (2 Weeks)|Other|0|||
143030660|NCT01957488|515654596|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
143030661|NCT01957488|515654597|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
143030662|NCT01957488|515654598|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
143030663|NCT01957488|515654599|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
143030664|NCT01957488|515654600|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
143030665|NCT01957488|515654601|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
143030666|NCT01957488|515654596|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
143030667|NCT01957488|515654597|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
143030668|NCT01957488|515654598|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
143030669|NCT01957488|515654599|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
143030670|NCT01957488|515654600|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
143030671|NCT01957488|515654601|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
143030672|NCT01957488|515654596|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
143030673|NCT01957488|515654597|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
143030674|NCT01957488|515654598|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
143030675|NCT01957488|515654599|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
143030676|NCT01957488|515654600|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
143030677|NCT01957488|515654601|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
143030678|NCT01957488|515654596|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
143030679|NCT01957488|515654597|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
143030680|NCT01957488|515654598|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
143030681|NCT01957488|515654599|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
143030682|NCT01957488|515654600|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
143030683|NCT01957488|515654601|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
143030684|NCT01957488|515654596|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
143030685|NCT01957488|515654597|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
143030686|NCT01957488|515654598|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
143030687|NCT01957488|515654599|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
143030688|NCT01957488|515654600|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
143030689|NCT01957488|515654601|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
143030690|NCT02419313|515654602|FG000|First Intervention|Lost to Follow-up|2|||
143030691|NCT02419313|515654603|FG001|First Intervention|Lost to Follow-up|0|||
143030692|NCT02419313|515654602|FG000|Second Intervention|Lost to Follow-up|1|||
143030693|NCT02419313|515654603|FG001|Second Intervention|Lost to Follow-up|0|||
143030694|NCT00810368|515654604|FG000|Overall Study|Lost to Follow-up|4|||
143030695|NCT00810368|515654605|FG001|Overall Study|Lost to Follow-up|2|||
143030696|NCT00810368|515654604|FG000|Overall Study|Lack of Efficacy|2|||
143030697|NCT00810368|515654605|FG001|Overall Study|Lack of Efficacy|0|||
143030698|NCT00623103|515654606|FG000|Overall Study|Adverse Event|70|||
143030699|NCT00623103|515654607|FG001|Overall Study|Adverse Event|60|||
143030700|NCT00623103|515654606|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
143030701|NCT00623103|515654607|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
143492263|NCT01978093|517344793|FG001|Overall Study|Migrated/moved from study area|13|||
143492264|NCT01978093|517344792|FG000|Overall Study|Loss of kaiser coverage|4|||
143492265|NCT01978093|517344793|FG001|Overall Study|Loss of kaiser coverage|10|||
143492266|NCT01978093|517344792|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
143492267|NCT01978093|517344793|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
143492268|NCT01978093|517344792|FG000|Overall Study|Mother lost custody of child|0|||
143492269|NCT01978093|517344793|FG001|Overall Study|Mother lost custody of child|1|||
143492270|NCT01978093|517344792|FG000|Overall Study|Child was in care of grandmother|0|||
143492271|NCT01978093|517344793|FG001|Overall Study|Child was in care of grandmother|1|||
143492272|NCT01978093|517344792|FG000|Overall Study|N/A for vaccine administration|0|||
143492273|NCT01978093|517344793|FG001|Overall Study|N/A for vaccine administration|1|||
143030702|NCT00623103|515654606|FG000|Overall Study|Withdrawal by Subject|18|||
143492274|NCT03124784|517344794|FG000|Overall Study|Adverse Event|1|||
143030703|NCT00623103|515654607|FG001|Overall Study|Withdrawal by Subject|24|||
143030704|NCT00623103|515654606|FG000|Overall Study|Lost to Follow-up|4|||
143158632|NCT00676052|516126034|FG002|Overall Study|Lack of Efficacy|1|||
143158633|NCT00676052|516126035|FG003|Overall Study|Lack of Efficacy|1|||
143158634|NCT00676052|516126036|FG004|Overall Study|Lack of Efficacy|2|||
143158635|NCT00676052|516126037|FG005|Overall Study|Lack of Efficacy|1|||
143158636|NCT00676052|516126032|FG000|Overall Study|Protocol Violation|5|||
143364022|NCT05349084|516875524|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
143364023|NCT00293462|516875525|FG000|Overall Study|Withdrawal by Subject|4|||
143364024|NCT00293462|516875526|FG001|Overall Study|Withdrawal by Subject|3|||
143492275|NCT03124784|517344794|FG000|Overall Study|Computer/Equip Malfunction|1|||
143030705|NCT00623103|515654607|FG001|Overall Study|Lost to Follow-up|1|||
143030706|NCT00623103|515654606|FG000|Overall Study|Administrative problems|2|||
143030707|NCT00623103|515654607|FG001|Overall Study|Administrative problems|4|||
143030708|NCT00623103|515654606|FG000|Overall Study|Death|11|||
143030709|NCT00623103|515654607|FG001|Overall Study|Death|11|||
143158637|NCT00676052|516126033|FG001|Overall Study|Protocol Violation|3|||
143492276|NCT01784965|517344795|FG000|Overall Study|Withdrawal by Subject|6|||
143492277|NCT01784965|517344796|FG001|Overall Study|Withdrawal by Subject|3|||
143492278|NCT01784965|517344795|FG000|Overall Study|Adverse Event|0|||
143492279|NCT01784965|517344796|FG001|Overall Study|Adverse Event|8|||
143492280|NCT03806127|517344797|FG000|Overall Study|Withdrawal by Subject|4|||
143492281|NCT03806127|517344798|FG001|Overall Study|Withdrawal by Subject|5|||
143492282|NCT03806127|517344797|FG000|Overall Study|Protocol Violation|3|||
143492283|NCT03806127|517344798|FG001|Overall Study|Protocol Violation|1|||
143492284|NCT03806127|517344797|FG000|Overall Study|Adverse Event|3|||
143492285|NCT03806127|517344798|FG001|Overall Study|Adverse Event|0|||
143492286|NCT03806127|517344797|FG000|Overall Study|Unable to Complete Procedures|0|||
143492287|NCT03806127|517344798|FG001|Overall Study|Unable to Complete Procedures|1|||
143492288|NCT03806127|517344797|FG000|Overall Study|Pregnancy|0|||
143492289|NCT03806127|517344798|FG001|Overall Study|Pregnancy|1|||
143492290|NCT03806127|517344797|FG000|Overall Study|Lost to Follow-up|5|||
143030710|NCT00623103|515654606|FG000|Overall Study|Protocol deviation|2|||
143030711|NCT00623103|515654607|FG001|Overall Study|Protocol deviation|1|||
143030712|NCT01400425|515654608|FG000|Overall Study|Withdrawal by Subject|10|||
143030713|NCT00442936|515654612|FG000|Overall Study|Protocol Violation|1|||
143030714|NCT00442936|515654613|FG001|Overall Study|Protocol Violation|0|||
143030715|NCT00442936|515654614|FG002|Overall Study|Protocol Violation|1|||
143492291|NCT03806127|517344798|FG001|Overall Study|Lost to Follow-up|1|||
143492292|NCT03806127|517344797|FG000|Overall Study|Physician Decision|1|||
143492293|NCT03806127|517344798|FG001|Overall Study|Physician Decision|1|||
143492294|NCT03806127|517344797|FG000|Overall Study|Could Not Come Due to Covid|1|||
143492295|NCT03806127|517344798|FG001|Overall Study|Could Not Come Due to Covid|0|||
143492296|NCT03806127|517344797|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
143492297|NCT03806127|517344798|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
143492298|NCT03806127|517344797|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
143492299|NCT03806127|517344798|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
143030716|NCT00442936|515654615|FG003|Overall Study|Protocol Violation|1|||
143030717|NCT00524459|515654617|FG000|Overall Study|Withdrawal by Subject|1|||
143158638|NCT00676052|516126034|FG002|Overall Study|Protocol Violation|2|||
143158639|NCT00676052|516126035|FG003|Overall Study|Protocol Violation|2|||
143492300|NCT03806127|517344797|FG000|Overall Study|Covid 19 Restrictions|2|||
143492301|NCT03806127|517344798|FG001|Overall Study|Covid 19 Restrictions|0|||
143492302|NCT03806127|517344797|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
143492303|NCT03806127|517344798|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
143492304|NCT03806127|517344797|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
143492305|NCT03806127|517344798|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
143492306|NCT01467492|517344799|FG000|Overall Study|Withdrawal by Subject|6|||
143492307|NCT01467492|517344800|FG001|Overall Study|Withdrawal by Subject|4|||
143492308|NCT01467492|517344799|FG000|Overall Study|Study Terminated by Sponsor|6|||
143492309|NCT01467492|517344800|FG001|Overall Study|Study Terminated by Sponsor|4|||
143492310|NCT01467492|517344799|FG000|Overall Study|Adverse Event|4|||
143492311|NCT01467492|517344800|FG001|Overall Study|Adverse Event|3|||
143492312|NCT01467492|517344799|FG000|Overall Study|Lost to Follow-up|3|||
143492313|NCT01467492|517344800|FG001|Overall Study|Lost to Follow-up|2|||
143492314|NCT01467492|517344799|FG000|Overall Study|Undefined|2|||
143492315|NCT01467492|517344800|FG001|Overall Study|Undefined|0|||
143492316|NCT01467492|517344799|FG000|Overall Study|Enrolled But Not Treated|1|||
143492317|NCT01467492|517344800|FG001|Overall Study|Enrolled But Not Treated|0|||
143492318|NCT01491178|517344801|FG000|Overall Study|Adverse Event|1016|||
143492319|NCT01491178|517344801|FG000|Overall Study|Improvement of NVAF|210|||
143492320|NCT01491178|517344801|FG000|Overall Study|To conduct invasive treatment|59|||
143492321|NCT01491178|517344801|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
143492322|NCT01491178|517344801|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
143158640|NCT00676052|516126036|FG004|Overall Study|Protocol Violation|1|||
143158641|NCT00676052|516126037|FG005|Overall Study|Protocol Violation|2|||
143158642|NCT00676052|516126032|FG000|Overall Study|Lost to Follow-up|0|||
143492323|NCT01491178|517344801|FG000|Overall Study|To take a contraindication|20|||
143492324|NCT01491178|517344801|FG000|Overall Study|Other than specified above|657|||
143492325|NCT01604512|517344802|FG000|Overall Study|Withdrawal by Subject|3|||
143030718|NCT00524459|515654617|FG000|Overall Study|Other|1|||
143030719|NCT02428699|515654618|FG000|Washout Period 1|Screen Failure|1|||
143030720|NCT02428699|515654619|FG001|Washout Period 1|Screen Failure|2|||
143030721|NCT02684578|515654620|FG000|Overall Study|Withdrawal by Subject|10|||
143030722|NCT02684578|515654621|FG001|Overall Study|Withdrawal by Subject|7|||
143158643|NCT00676052|516126033|FG001|Overall Study|Lost to Follow-up|0|||
143158644|NCT00676052|516126034|FG002|Overall Study|Lost to Follow-up|0|||
143158645|NCT00676052|516126035|FG003|Overall Study|Lost to Follow-up|0|||
143158646|NCT00676052|516126036|FG004|Overall Study|Lost to Follow-up|1|||
143492326|NCT01604512|517344802|FG000|Overall Study|Not treated|4|||
143492327|NCT01415752|517344803|FG000|Induction (Step 1)|Ineligible|4|||
143492328|NCT01415752|517344804|FG001|Induction (Step 1)|Ineligible|3|||
143492329|NCT01415752|517344805|FG002|Induction (Step 1)|Ineligible|4|||
143492330|NCT01415752|517344806|FG003|Induction (Step 1)|Ineligible|4|||
143492331|NCT01415752|517344803|FG000|Maintenance (Step 2)|Lack of Efficacy|12|||
143492332|NCT01415752|517344804|FG001|Maintenance (Step 2)|Lack of Efficacy|10|||
143492333|NCT01415752|517344805|FG002|Maintenance (Step 2)|Lack of Efficacy|8|||
143492334|NCT01415752|517344806|FG003|Maintenance (Step 2)|Lack of Efficacy|3|||
143492335|NCT01415752|517344803|FG000|Maintenance (Step 2)|Adverse Event|3|||
143492336|NCT01415752|517344804|FG001|Maintenance (Step 2)|Adverse Event|4|||
143492337|NCT01415752|517344805|FG002|Maintenance (Step 2)|Adverse Event|9|||
143492338|NCT01415752|517344806|FG003|Maintenance (Step 2)|Adverse Event|6|||
143492339|NCT01415752|517344803|FG000|Maintenance (Step 2)|Death|1|||
143492340|NCT01415752|517344804|FG001|Maintenance (Step 2)|Death|1|||
143492341|NCT01415752|517344805|FG002|Maintenance (Step 2)|Death|2|||
143492342|NCT01415752|517344806|FG003|Maintenance (Step 2)|Death|0|||
143492343|NCT01415752|517344803|FG000|Maintenance (Step 2)|Withdrawal by Subject|2|||
143492344|NCT01415752|517344804|FG001|Maintenance (Step 2)|Withdrawal by Subject|1|||
143492345|NCT01415752|517344805|FG002|Maintenance (Step 2)|Withdrawal by Subject|3|||
143492346|NCT01415752|517344806|FG003|Maintenance (Step 2)|Withdrawal by Subject|3|||
143492347|NCT01415752|517344803|FG000|Maintenance (Step 2)|Alternative therapy|0|||
143492348|NCT01415752|517344804|FG001|Maintenance (Step 2)|Alternative therapy|1|||
143492349|NCT01415752|517344805|FG002|Maintenance (Step 2)|Alternative therapy|0|||
143492350|NCT01415752|517344806|FG003|Maintenance (Step 2)|Alternative therapy|0|||
143492351|NCT01415752|517344803|FG000|Maintenance (Step 2)|Other reasons|3|||
143492352|NCT01415752|517344804|FG001|Maintenance (Step 2)|Other reasons|6|||
143492353|NCT01415752|517344805|FG002|Maintenance (Step 2)|Other reasons|4|||
143492354|NCT01415752|517344806|FG003|Maintenance (Step 2)|Other reasons|6|||
143492355|NCT01415752|517344803|FG000|Maintenance (Step 2)|Did not receive treatment|1|||
143030723|NCT02684578|515654620|FG000|Overall Study|Lost to Follow-up|0|||
143030724|NCT02684578|515654621|FG001|Overall Study|Lost to Follow-up|3|||
143237447|NCT03879772|516423307|FG002|Overall Study|Withdrawal by Subject|3|||
143237448|NCT03879772|516423308|FG003|Overall Study|Withdrawal by Subject|1|||
143237449|NCT03879772|516423309|FG004|Overall Study|Withdrawal by Subject|1|||
143237450|NCT03879772|516423305|FG000|Overall Study|Protocol Violation|0|||
143237451|NCT03879772|516423306|FG001|Overall Study|Protocol Violation|0|||
143237452|NCT03879772|516423307|FG002|Overall Study|Protocol Violation|3|||
143237453|NCT03879772|516423308|FG003|Overall Study|Protocol Violation|1|||
143237454|NCT03879772|516423309|FG004|Overall Study|Protocol Violation|2|||
143237455|NCT03879772|516423305|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
143237456|NCT03879772|516423306|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
143237457|NCT03879772|516423307|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
143030725|NCT02684578|515654620|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
143030726|NCT02684578|515654621|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
143030727|NCT02684578|515654620|FG000|Overall Study|Missing follow-up data|0|||
143030728|NCT02684578|515654621|FG001|Overall Study|Missing follow-up data|1|||
143158647|NCT00676052|516126037|FG005|Overall Study|Lost to Follow-up|0|||
143158648|NCT00676052|516126032|FG000|Overall Study|Physician Decision|1|||
143158649|NCT00676052|516126033|FG001|Overall Study|Physician Decision|1|||
143158650|NCT00676052|516126034|FG002|Overall Study|Physician Decision|1|||
143158651|NCT00676052|516126035|FG003|Overall Study|Physician Decision|0|||
143158652|NCT00676052|516126036|FG004|Overall Study|Physician Decision|0|||
143158653|NCT00676052|516126037|FG005|Overall Study|Physician Decision|1|||
143158654|NCT00676052|516126032|FG000|Overall Study|Withdrawal by Subject|1|||
143158655|NCT00676052|516126033|FG001|Overall Study|Withdrawal by Subject|0|||
143158656|NCT00676052|516126034|FG002|Overall Study|Withdrawal by Subject|1|||
143158657|NCT00676052|516126035|FG003|Overall Study|Withdrawal by Subject|0|||
143158658|NCT00676052|516126036|FG004|Overall Study|Withdrawal by Subject|0|||
143158659|NCT00676052|516126037|FG005|Overall Study|Withdrawal by Subject|0|||
143158660|NCT01428713|516126038|FG000|Overall Study|Non-compliance|2|||
143158661|NCT01428713|516126039|FG001|Overall Study|Non-compliance|2|||
143158662|NCT01428713|516126038|FG000|Overall Study|Withdrawal by Subject|1|||
143158663|NCT01428713|516126039|FG001|Overall Study|Withdrawal by Subject|1|||
143237458|NCT03879772|516423308|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
143030729|NCT01153984|515654622|FG000|Overall Study|Withdrawal by Subject|1|||
143030730|NCT01153984|515654622|FG000|Overall Study|Adverse Event|1|||
143030731|NCT02460159|515654623|FG000|Overall Study|Adverse Event|4|||
143158664|NCT01428713|516126038|FG000|Overall Study|Adverse Event|0|||
143158665|NCT01428713|516126039|FG001|Overall Study|Adverse Event|2|||
143158666|NCT02930941|516126040|FG000|Overall Study|Lost to Follow-up|1|||
143158667|NCT02930941|516126041|FG001|Overall Study|Lost to Follow-up|2|||
143158668|NCT00527748|516126053|FG000|Overall Study|Other|3|||
143158669|NCT00710554|516126056|FG000|Overall Study|Adverse Event|24|||
143158670|NCT00710554|516126057|FG001|Overall Study|Adverse Event|7|||
143158671|NCT00710554|516126056|FG000|Overall Study|Withdrawal by Subject|7|||
143237459|NCT03879772|516423309|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
143492356|NCT01415752|517344804|FG001|Maintenance (Step 2)|Did not receive treatment|0|||
143492357|NCT01415752|517344805|FG002|Maintenance (Step 2)|Did not receive treatment|2|||
143492358|NCT01415752|517344806|FG003|Maintenance (Step 2)|Did not receive treatment|1|||
143492359|NCT01415752|517344803|FG000|Maintenance (Step 2)|ineligible|1|||
143030732|NCT02460159|515654624|FG001|Overall Study|Adverse Event|1|||
143030733|NCT02460159|515654623|FG000|Overall Study|Withdrawal by Subject|2|||
143030734|NCT02460159|515654624|FG001|Overall Study|Withdrawal by Subject|0|||
143030735|NCT00806156|515654625|FG000|Overall Study|Death|35|||
143030736|NCT00806156|515654626|FG001|Overall Study|Death|95|||
143030737|NCT00806156|515654625|FG000|Overall Study|Did not meet eligibility criteria|1|||
143030738|NCT00806156|515654626|FG001|Overall Study|Did not meet eligibility criteria|0|||
143030739|NCT00806156|515654625|FG000|Overall Study|Study terminated by Sponsor|2|||
143030740|NCT00806156|515654626|FG001|Overall Study|Study terminated by Sponsor|40|||
143030741|NCT00806156|515654625|FG000|Overall Study|Consent withdrawn by subject|1|||
143030742|NCT00806156|515654626|FG001|Overall Study|Consent withdrawn by subject|3|||
143030743|NCT00806156|515654625|FG000|Overall Study|Lost to Follow-up|0|||
143030744|NCT00806156|515654626|FG001|Overall Study|Lost to Follow-up|1|||
143030745|NCT01025037|515654634|FG000|Overall Study|Adverse Event|3|||
143030746|NCT01025037|515654634|FG000|Overall Study|Lost to Follow-up|7|||
143030747|NCT01025037|515654634|FG000|Overall Study|Withdrawal by Subject|1|||
143030748|NCT01890915|515654635|FG000|Overall Study|Adverse Event|1|||
143030749|NCT01890915|515654636|FG001|Overall Study|Adverse Event|0|||
143030750|NCT01890915|515654635|FG000|Overall Study|Protocol Violation|2|||
143030751|NCT01890915|515654636|FG001|Overall Study|Protocol Violation|0|||
143030752|NCT01890915|515654635|FG000|Overall Study|Equipment Malfunction|0|||
143030753|NCT01890915|515654636|FG001|Overall Study|Equipment Malfunction|1|||
143030754|NCT02114697|515654637|FG000|Overall Study|Study terminated|5|||
143030755|NCT02114697|515654638|FG001|Overall Study|Study terminated|4|||
143030756|NCT02674334|515654639|FG000|Overall Study|Lost to Follow-up|5|||
143158672|NCT00710554|516126057|FG001|Overall Study|Withdrawal by Subject|3|||
143158673|NCT00710554|516126056|FG000|Overall Study|Lost to Follow-up|7|||
143158674|NCT00710554|516126057|FG001|Overall Study|Lost to Follow-up|1|||
143158675|NCT00710554|516126056|FG000|Overall Study|Lack of Efficacy|11|||
143158676|NCT00710554|516126057|FG001|Overall Study|Lack of Efficacy|12|||
143158677|NCT00710554|516126056|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
143158678|NCT00710554|516126057|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
143158679|NCT01093885|516126058|FG000|Overall Study|Adverse Event|4|||
143158680|NCT01093885|516126058|FG000|Overall Study|Lost to Follow-up|1|||
143158681|NCT01560988|516126059|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
143158682|NCT01560988|516126060|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
143158683|NCT01560988|516126059|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
143158684|NCT01560988|516126060|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
143158685|NCT01560988|516126059|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
143158686|NCT01560988|516126060|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
143158687|NCT01346709|516126061|FG000|Overall Study|Protocol Violation|35|||
143158688|NCT01346709|516126061|FG000|Overall Study|Lost to Follow-up|31|||
143158689|NCT01346709|516126061|FG000|Overall Study|Missing data in candidate risk factor|285|||
143158690|NCT03835117|516126067|FG000|Phase II - Week 13- Week 24|Lost to Follow-up|2|||
143158691|NCT03835117|516126068|FG001|Phase II - Week 13- Week 24|Lost to Follow-up|3|||
143158692|NCT03892915|516126078|FG000|Overall Study|Lost to Follow-up|6|||
143158693|NCT03892915|516126079|FG001|Overall Study|Lost to Follow-up|12|||
143158694|NCT03892915|516126078|FG000|Overall Study|Death|0|||
143158695|NCT03892915|516126079|FG001|Overall Study|Death|2|||
143158696|NCT03892915|516126078|FG000|Overall Study|Withdrawal by Subject|1|||
143158697|NCT03892915|516126079|FG001|Overall Study|Withdrawal by Subject|1|||
143158698|NCT03892915|516126078|FG000|Overall Study|unsuccessful delivery|13|||
143158699|NCT03892915|516126079|FG001|Overall Study|unsuccessful delivery|18|||
143158700|NCT00191152|516126080|FG000|Initial Treatment|Adverse Event|43|||
143158701|NCT00191152|516126081|FG001|Initial Treatment|Adverse Event|67|||
143158702|NCT00191152|516126080|FG000|Initial Treatment|Physician Decision|40|||
143158703|NCT00191152|516126081|FG001|Initial Treatment|Physician Decision|31|||
143158704|NCT00191152|516126080|FG000|Initial Treatment|Withdrawal by Subject|40|||
143158705|NCT00191152|516126081|FG001|Initial Treatment|Withdrawal by Subject|28|||
143158706|NCT00191152|516126080|FG000|Initial Treatment|Lost to Follow-up|0|||
143158707|NCT00191152|516126081|FG001|Initial Treatment|Lost to Follow-up|6|||
143158708|NCT00191152|516126080|FG000|Initial Treatment|Other|18|||
143158709|NCT00191152|516126081|FG001|Initial Treatment|Other|21|||
143158710|NCT00191152|516126080|FG000|Crossover Treatment|Adverse Event|8|||
143158711|NCT00191152|516126081|FG001|Crossover Treatment|Adverse Event|8|||
143492360|NCT01415752|517344804|FG001|Maintenance (Step 2)|ineligible|1|||
143030757|NCT02674334|515654640|FG001|Overall Study|Lost to Follow-up|3|||
143158712|NCT00191152|516126080|FG000|Crossover Treatment|Physician Decision|7|||
143158713|NCT00191152|516126081|FG001|Crossover Treatment|Physician Decision|7|||
143158714|NCT00191152|516126080|FG000|Crossover Treatment|Withdrawal by Subject|6|||
143030758|NCT02674334|515654639|FG000|Overall Study|participant difficulty breathing|1|||
143158715|NCT00191152|516126081|FG001|Crossover Treatment|Withdrawal by Subject|9|||
143030759|NCT02674334|515654640|FG001|Overall Study|participant difficulty breathing|0|||
143030760|NCT02674334|515654639|FG000|Overall Study|NIRS not recording|1|||
143030761|NCT02674334|515654640|FG001|Overall Study|NIRS not recording|0|||
143030762|NCT01345019|515654645|FG000|Blinded Treatment Phase|Death|147|||
143492361|NCT01415752|517344805|FG002|Maintenance (Step 2)|ineligible|1|||
143492362|NCT01415752|517344806|FG003|Maintenance (Step 2)|ineligible|0|||
143492363|NCT01415752|517344803|FG000|Maintenance (Step 2)|Missing|4|||
143492364|NCT01415752|517344804|FG001|Maintenance (Step 2)|Missing|1|||
143492365|NCT01415752|517344805|FG002|Maintenance (Step 2)|Missing|4|||
143492366|NCT01415752|517344806|FG003|Maintenance (Step 2)|Missing|3|||
143492367|NCT01391507|517344807|FG000|Overall Study|Death|0|||
143492368|NCT01391507|517344808|FG001|Overall Study|Death|0|||
143492369|NCT01391507|517344809|FG002|Overall Study|Death|0|||
143237460|NCT00930046|516423310|FG000|Overall Study|Wound catheter malfunctioned|1|||
143237461|NCT00930046|516423311|FG001|Overall Study|Wound catheter malfunctioned|2|||
143492370|NCT01391507|517344810|FG003|Overall Study|Death|1|||
143492371|NCT01391507|517344807|FG000|Overall Study|Adverse Event|1|||
143492372|NCT01391507|517344808|FG001|Overall Study|Adverse Event|1|||
143492373|NCT01391507|517344809|FG002|Overall Study|Adverse Event|2|||
143492374|NCT01391507|517344810|FG003|Overall Study|Adverse Event|2|||
143492375|NCT01391507|517344807|FG000|Overall Study|Withdrawal by Subject|1|||
143492376|NCT01391507|517344808|FG001|Overall Study|Withdrawal by Subject|2|||
143492377|NCT01391507|517344809|FG002|Overall Study|Withdrawal by Subject|1|||
143492378|NCT01391507|517344810|FG003|Overall Study|Withdrawal by Subject|1|||
143492379|NCT01391507|517344807|FG000|Overall Study|Lack of Efficacy|0|||
143030763|NCT01345019|515654646|FG001|Blinded Treatment Phase|Death|137|||
143030764|NCT01345019|515654645|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
143030765|NCT01345019|515654646|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
143030766|NCT01345019|515654645|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
143030767|NCT01345019|515654646|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
143030768|NCT01345019|515654645|FG000|Blinded Treatment Phase|Disease Progression|12|||
143030769|NCT01345019|515654646|FG001|Blinded Treatment Phase|Disease Progression|10|||
143030770|NCT01345019|515654645|FG000|Blinded Treatment Phase|Adverse Event|6|||
143030771|NCT01345019|515654646|FG001|Blinded Treatment Phase|Adverse Event|13|||
143030772|NCT01345019|515654645|FG000|Blinded Treatment Phase|Administrative Decision|10|||
143237462|NCT01598532|516423312|FG000|Overall Study|Lost to Follow-up|3|||
143237463|NCT01598532|516423312|FG000|Overall Study|Did not meet inclusion criteria|8|||
143237464|NCT00912808|516423313|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
143237465|NCT00912808|516423314|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
143237466|NCT00912808|516423313|FG000|Washout|Withdrawal by Subject|0|||
143237467|NCT00912808|516423314|FG001|Washout|Withdrawal by Subject|1|||
143492380|NCT01391507|517344808|FG001|Overall Study|Lack of Efficacy|0|||
143492381|NCT01391507|517344809|FG002|Overall Study|Lack of Efficacy|0|||
143492382|NCT01391507|517344810|FG003|Overall Study|Lack of Efficacy|1|||
143492383|NCT01391507|517344807|FG000|Overall Study|Protocol Violation|2|||
143492384|NCT01391507|517344808|FG001|Overall Study|Protocol Violation|1|||
143492385|NCT01391507|517344809|FG002|Overall Study|Protocol Violation|1|||
143492386|NCT01391507|517344810|FG003|Overall Study|Protocol Violation|2|||
143492387|NCT01453855|517344811|FG000|Overall Study|Adverse Event|3|||
143492388|NCT01453855|517344812|FG001|Overall Study|Adverse Event|4|||
143492389|NCT01453855|517344811|FG000|Overall Study|Lost to Follow-up|2|||
143492390|NCT01453855|517344812|FG001|Overall Study|Lost to Follow-up|1|||
143492391|NCT01453855|517344811|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
143492392|NCT01453855|517344812|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
143492393|NCT01453855|517344811|FG000|Overall Study|Noncompliance|1|||
143492394|NCT01453855|517344812|FG001|Overall Study|Noncompliance|0|||
143492395|NCT01453855|517344811|FG000|Overall Study|Inadequate Control of IOP|1|||
143492396|NCT01453855|517344812|FG001|Overall Study|Inadequate Control of IOP|5|||
143492397|NCT01453855|517344811|FG000|Overall Study|Other|0|||
143492398|NCT01453855|517344812|FG001|Overall Study|Other|1|||
143237468|NCT00912808|516423313|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
143237469|NCT00912808|516423314|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
143237470|NCT00912808|516423313|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
143237471|NCT00912808|516423314|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
143492399|NCT04781816|517344817|FG000|Overall Study|Adverse Event|0|||
143030773|NCT01345019|515654646|FG001|Blinded Treatment Phase|Administrative Decision|8|||
143030774|NCT01345019|515654645|FG000|Blinded Treatment Phase|Noncompliance|5|||
143030775|NCT01345019|515654646|FG001|Blinded Treatment Phase|Noncompliance|3|||
143030776|NCT01345019|515654645|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
143237472|NCT00702221|516423315|FG000|Overall Study|Adverse Event|4|||
143237473|NCT00702221|516423316|FG001|Overall Study|Adverse Event|3|||
143237474|NCT03345784|516423323|FG000|Overall Study|Withdrawal by Subject|2|||
143237475|NCT03345784|516423324|FG001|Overall Study|Withdrawal by Subject|1|||
143492400|NCT04781816|517344818|FG001|Overall Study|Adverse Event|1|||
143492401|NCT04781816|517344817|FG000|Overall Study|Withdrawal by Subject|1|||
143492402|NCT04781816|517344818|FG001|Overall Study|Withdrawal by Subject|1|||
143492403|NCT04781816|517344817|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
143492404|NCT04781816|517344818|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
143492405|NCT02062658|517344819|FG000|Overall Study|Withdrawal by Subject|1|||
143492406|NCT02062658|517344819|FG000|Overall Study|Lack of Efficacy|1|||
143237476|NCT04798196|516423326|FG000|Overall Study|Lost to Follow-up|3|||
143030777|NCT01345019|515654646|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
143030778|NCT01345019|515654645|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
143030779|NCT01345019|515654646|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
143030780|NCT01345019|515654645|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
143030781|NCT01345019|515654646|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
143030782|NCT01345019|515654645|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
143030783|NCT01345019|515654646|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
143030784|NCT01345019|515654645|FG000|Open Label Treatment Phase|Death|49|||
143030785|NCT01345019|515654646|FG001|Open Label Treatment Phase|Death|48|||
143030786|NCT01345019|515654645|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
143030787|NCT01345019|515654646|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
143030788|NCT01345019|515654645|FG000|Open Label Treatment Phase|Adverse Event|30|||
143030789|NCT01345019|515654646|FG001|Open Label Treatment Phase|Adverse Event|51|||
143030790|NCT01345019|515654645|FG000|Open Label Treatment Phase|Administrative Decision|30|||
143030791|NCT01345019|515654646|FG001|Open Label Treatment Phase|Administrative Decision|15|||
143030792|NCT01345019|515654645|FG000|Open Label Treatment Phase|Disease Progression|17|||
143030793|NCT01345019|515654646|FG001|Open Label Treatment Phase|Disease Progression|18|||
143030794|NCT01345019|515654645|FG000|Open Label Treatment Phase|Noncompliance|5|||
143030795|NCT01345019|515654646|FG001|Open Label Treatment Phase|Noncompliance|4|||
143492407|NCT01121393|517344820|FG000|Overall Study|Progressive disease|201|||
143492408|NCT01121393|517344821|FG001|Overall Study|Progressive disease|20|||
143492409|NCT01121393|517344820|FG000|Overall Study|Other Adverse events|24|||
143492410|NCT01121393|517344821|FG001|Overall Study|Other Adverse events|45|||
143492411|NCT01121393|517344820|FG000|Overall Study|Non-compliant with protocol|0|||
143030796|NCT01345019|515654645|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
143030797|NCT01345019|515654646|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
143030798|NCT01345019|515654645|FG000|Open Label Treatment Phase|Pregnancy|1|||
143030799|NCT01345019|515654646|FG001|Open Label Treatment Phase|Pregnancy|0|||
143030800|NCT01345019|515654645|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
143030801|NCT01345019|515654646|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
143030802|NCT01345019|515654645|FG000|Open Label Treatment Phase|Protocol Violation|0|||
143030803|NCT01345019|515654646|FG001|Open Label Treatment Phase|Protocol Violation|1|||
143030804|NCT03830164|515654648|FG000|Overall Study|Adverse Event|0|||
143158716|NCT00191152|516126080|FG000|Crossover Treatment|Lost to Follow-up|2|||
143158717|NCT00191152|516126081|FG001|Crossover Treatment|Lost to Follow-up|1|||
143158718|NCT00191152|516126080|FG000|Crossover Treatment|Other|4|||
143158719|NCT00191152|516126081|FG001|Crossover Treatment|Other|3|||
143158720|NCT02829957|516126089|FG000|Overall Study|Lost to Follow-up|2|||
143158721|NCT02829957|516126090|FG001|Overall Study|Lost to Follow-up|1|||
143158722|NCT04146909|516126093|FG000|Overall Study|Withdrawal by Subject|3|||
143158723|NCT04146909|516126093|FG000|Overall Study|Did not qualify after consented|1|||
143158724|NCT00754559|516126094|FG000|Overall Study|Adverse Event|15|||
143158725|NCT00754559|516126094|FG000|Overall Study|Protocol Violation|11|||
143158726|NCT00754559|516126094|FG000|Overall Study|Lack of Efficacy|10|||
143158727|NCT00754559|516126094|FG000|Overall Study|Lost to Follow-up|2|||
143158728|NCT00754559|516126094|FG000|Overall Study|Administrative reason|1|||
143158729|NCT00754559|516126094|FG000|Overall Study|Other|5|||
143158730|NCT00754559|516126094|FG000|Overall Study|Withdrawal by Subject|3|||
143158731|NCT04000724|516126099|FG000|Overall Study|Withdrawal by Subject|5|||
143158732|NCT04000724|516126100|FG001|Overall Study|Withdrawal by Subject|3|||
143158733|NCT04000724|516126101|FG002|Overall Study|Withdrawal by Subject|4|||
143158734|NCT04000724|516126099|FG000|Overall Study|Lost to Follow-up|11|||
143158735|NCT04000724|516126100|FG001|Overall Study|Lost to Follow-up|7|||
143158736|NCT04000724|516126101|FG002|Overall Study|Lost to Follow-up|13|||
143158737|NCT01370538|516126102|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
143158738|NCT01370538|516126103|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
143158739|NCT01370538|516126102|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
143158740|NCT01370538|516126103|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
143158741|NCT01370538|516126102|FG000|Overall Study|Adverse Event|1|||
143158742|NCT01370538|516126103|FG001|Overall Study|Adverse Event|0|||
143158743|NCT01370538|516126102|FG000|Overall Study|Protocol Violation|8|||
143158744|NCT01370538|516126103|FG001|Overall Study|Protocol Violation|5|||
143158745|NCT01370538|516126102|FG000|Overall Study|Development of study specific withdrawal|1|||
143158746|NCT01370538|516126103|FG001|Overall Study|Development of study specific withdrawal|1|||
143158747|NCT01370538|516126102|FG000|Overall Study|Lost to follow up|6|||
143158748|NCT01370538|516126103|FG001|Overall Study|Lost to follow up|10|||
143158749|NCT04193527|516126104|FG000|Overall Study|Other|1|||
143158750|NCT04193527|516126105|FG001|Overall Study|Other|1|||
143158751|NCT04193527|516126106|FG002|Overall Study|Other|0|||
143158752|NCT00676689|516126107|FG000|Overall Study|Screen Failure|2|||
143158753|NCT00676689|516126107|FG000|Overall Study|Death|2|||
143158754|NCT00676689|516126107|FG000|Overall Study|Lost to Follow-up|4|||
143158755|NCT00676689|516126107|FG000|Overall Study|Physician Decision|1|||
143158756|NCT00676689|516126107|FG000|Overall Study|Withdrawal by Subject|3|||
143492412|NCT01121393|517344821|FG001|Overall Study|Non-compliant with protocol|3|||
143492413|NCT01121393|517344820|FG000|Overall Study|Lost to Follow-up|1|||
143030805|NCT03830164|515654649|FG001|Overall Study|Adverse Event|2|||
143030806|NCT03830164|515654650|FG002|Overall Study|Adverse Event|0|||
143030807|NCT03830164|515654648|FG000|Overall Study|Lack of Efficacy|1|||
143030808|NCT03830164|515654649|FG001|Overall Study|Lack of Efficacy|5|||
143030809|NCT03830164|515654650|FG002|Overall Study|Lack of Efficacy|0|||
143030810|NCT03830164|515654648|FG000|Overall Study|Lost to Follow-up|0|||
143492414|NCT01121393|517344821|FG001|Overall Study|Lost to Follow-up|0|||
143492415|NCT01121393|517344820|FG000|Overall Study|Refused cont. medication|7|||
143492416|NCT01121393|517344821|FG001|Overall Study|Refused cont. medication|7|||
143492417|NCT01121393|517344820|FG000|Overall Study|Not treated|3|||
143492418|NCT01121393|517344821|FG001|Overall Study|Not treated|9|||
143492419|NCT01121393|517344820|FG000|Overall Study|Other than listed|6|||
143492420|NCT01121393|517344821|FG001|Overall Study|Other than listed|0|||
143492421|NCT03033745|517344822|FG000|Overall Study|Protocol Violation|0|||
143492422|NCT03033745|517344823|FG001|Overall Study|Protocol Violation|0|||
143030811|NCT03830164|515654649|FG001|Overall Study|Lost to Follow-up|1|||
143030812|NCT03830164|515654650|FG002|Overall Study|Lost to Follow-up|0|||
143030813|NCT03830164|515654648|FG000|Overall Study|Withdrawal by Subject|1|||
143030814|NCT03830164|515654649|FG001|Overall Study|Withdrawal by Subject|0|||
143237477|NCT04798196|516423327|FG001|Overall Study|Lost to Follow-up|1|||
143237478|NCT04798196|516423328|FG002|Overall Study|Lost to Follow-up|3|||
143237479|NCT01249261|516423331|FG000|Overall Study|Withdrawal by Subject|1|||
143237480|NCT01249261|516423332|FG001|Overall Study|Withdrawal by Subject|0|||
143237481|NCT00482053|516423335|FG000|Inter-treatment Period|Disease progression|1|||
143237482|NCT00728689|516423339|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
143237483|NCT00728689|516423340|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
143237484|NCT03131570|516423344|FG000|Overall Study|Adverse Event|1|||
143237485|NCT03131570|516423345|FG001|Overall Study|Adverse Event|0|||
143237486|NCT00871975|516423347|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
143237487|NCT00871975|516423347|FG000|Overall Study|Catheters could not be inserted|1|||
143237488|NCT00871975|516423347|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
143237489|NCT00871975|516423347|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
143237490|NCT05567783|516423348|FG000|Overall Study|Death|2|||
143237491|NCT05567783|516423349|FG001|Overall Study|Death|3|||
143237492|NCT05567783|516423350|FG002|Overall Study|Death|0|||
143237493|NCT05567783|516423348|FG000|Overall Study|Lost to Follow-up|25|||
143237494|NCT05567783|516423349|FG001|Overall Study|Lost to Follow-up|19|||
143237495|NCT05567783|516423350|FG002|Overall Study|Lost to Follow-up|17|||
143237496|NCT05567783|516423348|FG000|Overall Study|Physician Decision|10|||
143237497|NCT05567783|516423349|FG001|Overall Study|Physician Decision|7|||
143237498|NCT05567783|516423350|FG002|Overall Study|Physician Decision|9|||
143237499|NCT05567783|516423348|FG000|Overall Study|Study Terminated by Sponsor|924|||
143237500|NCT05567783|516423349|FG001|Overall Study|Study Terminated by Sponsor|937|||
143237501|NCT05567783|516423350|FG002|Overall Study|Study Terminated by Sponsor|941|||
143237502|NCT05567783|516423348|FG000|Overall Study|Withdrawal by Subject|23|||
143237503|NCT05567783|516423349|FG001|Overall Study|Withdrawal by Subject|27|||
143237504|NCT05567783|516423350|FG002|Overall Study|Withdrawal by Subject|24|||
143237505|NCT05567783|516423348|FG000|Overall Study|Incarcerated|1|||
143237506|NCT05567783|516423349|FG001|Overall Study|Incarcerated|0|||
143237507|NCT05567783|516423350|FG002|Overall Study|Incarcerated|0|||
143237508|NCT05567783|516423348|FG000|Overall Study|Participant randomized in error|4|||
143237509|NCT05567783|516423349|FG001|Overall Study|Participant randomized in error|2|||
143237510|NCT05567783|516423350|FG002|Overall Study|Participant randomized in error|2|||
143237511|NCT00001959|516423353|FG000|Overall Study|newly diagnosed colon cancer|1|||
143237512|NCT00001959|516423353|FG000|Overall Study|disabling sedation|1|||
143237513|NCT00001959|516423353|FG000|Overall Study|non-compliance|1|||
143237514|NCT03113487|516423358|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
143237515|NCT03777982|516423359|FG000|Overall Study|Physician Decision|0|||
143237516|NCT03777982|516423360|FG001|Overall Study|Physician Decision|1|||
143030815|NCT03830164|515654650|FG002|Overall Study|Withdrawal by Subject|0|||
143030816|NCT00995553|515654653|FG000|Overall Study|Withdrawal by Subject|2|||
143030817|NCT00995553|515654654|FG001|Overall Study|Withdrawal by Subject|6|||
143030818|NCT00950807|515654659|FG000|Treatment Period 1|Lack of Efficacy|1|||
143237517|NCT03995368|516423361|FG000|Overall Study|Lost to Follow-up|1|||
143030819|NCT00950807|515654660|FG001|Treatment Period 1|Lack of Efficacy|0|||
143492423|NCT03033745|517344824|FG002|Overall Study|Protocol Violation|1|||
143492424|NCT03033745|517344822|FG000|Overall Study|Adverse Event|1|||
143492425|NCT03033745|517344823|FG001|Overall Study|Adverse Event|0|||
143492426|NCT03033745|517344824|FG002|Overall Study|Adverse Event|1|||
143492427|NCT03033745|517344822|FG000|Overall Study|Withdrawal by Subject|0|||
143237518|NCT03995368|516423362|FG001|Overall Study|Lost to Follow-up|4|||
143237519|NCT03995368|516423363|FG002|Overall Study|Lost to Follow-up|1|||
143237520|NCT03995368|516423361|FG000|Overall Study|Did not meet inclusion criteria|1|||
143237521|NCT03995368|516423362|FG001|Overall Study|Did not meet inclusion criteria|6|||
143237522|NCT03995368|516423363|FG002|Overall Study|Did not meet inclusion criteria|3|||
143237523|NCT03995368|516423361|FG000|Overall Study|Withdrawal by Subject|0|||
143237524|NCT03995368|516423362|FG001|Overall Study|Withdrawal by Subject|1|||
143492428|NCT03033745|517344823|FG001|Overall Study|Withdrawal by Subject|1|||
143492429|NCT03033745|517344824|FG002|Overall Study|Withdrawal by Subject|0|||
143492430|NCT00608985|517344825|FG000|Overall Study|Adverse Event|2|||
143492431|NCT00608985|517344826|FG001|Overall Study|Adverse Event|7|||
143492432|NCT00608985|517344827|FG002|Overall Study|Adverse Event|4|||
143492433|NCT00608985|517344828|FG003|Overall Study|Adverse Event|6|||
143492434|NCT00608985|517344825|FG000|Overall Study|Administrative/Other|7|||
143492435|NCT00608985|517344826|FG001|Overall Study|Administrative/Other|4|||
143492436|NCT00608985|517344827|FG002|Overall Study|Administrative/Other|1|||
143492437|NCT00608985|517344828|FG003|Overall Study|Administrative/Other|2|||
143492438|NCT00608985|517344825|FG000|Overall Study|Withdrawal of Consent|5|||
143492439|NCT00608985|517344826|FG001|Overall Study|Withdrawal of Consent|1|||
143492440|NCT00608985|517344827|FG002|Overall Study|Withdrawal of Consent|1|||
143492441|NCT00608985|517344828|FG003|Overall Study|Withdrawal of Consent|1|||
143492442|NCT00608985|517344825|FG000|Overall Study|Lost to Follow-up|2|||
143492443|NCT00608985|517344826|FG001|Overall Study|Lost to Follow-up|1|||
143492444|NCT00608985|517344827|FG002|Overall Study|Lost to Follow-up|0|||
143492445|NCT00608985|517344828|FG003|Overall Study|Lost to Follow-up|0|||
143492446|NCT02706730|517344831|FG000|Overall Study|Adverse Event|3|||
143492447|NCT02706730|517344831|FG000|Overall Study|Lack of Efficacy|5|||
143492448|NCT02706730|517344831|FG000|Overall Study|Withdrawal by Subject|11|||
143492449|NCT02706730|517344831|FG000|Overall Study|Study Terminated by Sponsor|11|||
143492450|NCT02706730|517344831|FG000|Overall Study|Subject chose not to receive injection|3|||
143492451|NCT01999582|517344838|FG000|Overall Study|Withdrawal by Subject|0|||
143492452|NCT01999582|517344839|FG001|Overall Study|Withdrawal by Subject|0|||
143492453|NCT01999582|517344840|FG002|Overall Study|Withdrawal by Subject|0|||
143492454|NCT01999582|517344841|FG003|Overall Study|Withdrawal by Subject|1|||
143492455|NCT01999582|517344842|FG004|Overall Study|Withdrawal by Subject|0|||
143492456|NCT01999582|517344843|FG005|Overall Study|Withdrawal by Subject|0|||
143492457|NCT01999582|517344838|FG000|Overall Study|Adverse Event|0|||
143492458|NCT01999582|517344839|FG001|Overall Study|Adverse Event|0|||
143492459|NCT01999582|517344840|FG002|Overall Study|Adverse Event|3|||
143492460|NCT01999582|517344841|FG003|Overall Study|Adverse Event|0|||
143492461|NCT01999582|517344842|FG004|Overall Study|Adverse Event|1|||
143492462|NCT01999582|517344843|FG005|Overall Study|Adverse Event|0|||
143492463|NCT01999582|517344838|FG000|Overall Study|Other Reasons|1|||
143492464|NCT01999582|517344839|FG001|Overall Study|Other Reasons|0|||
143492465|NCT01999582|517344840|FG002|Overall Study|Other Reasons|3|||
143492466|NCT01999582|517344841|FG003|Overall Study|Other Reasons|1|||
143492467|NCT01999582|517344842|FG004|Overall Study|Other Reasons|1|||
143492468|NCT01999582|517344843|FG005|Overall Study|Other Reasons|2|||
143492469|NCT01999582|517344838|FG000|Overall Study|Protocol Violation|1|||
143492470|NCT01999582|517344839|FG001|Overall Study|Protocol Violation|0|||
143030820|NCT00950807|515654661|FG002|Treatment Period 1|Lack of Efficacy|0|||
143030821|NCT00950807|515654662|FG003|Treatment Period 1|Lack of Efficacy|0|||
143030822|NCT00950807|515654663|FG004|Treatment Period 1|Lack of Efficacy|0|||
143030823|NCT00950807|515654664|FG005|Treatment Period 1|Lack of Efficacy|1|||
143030824|NCT00950807|515654665|FG006|Treatment Period 1|Lack of Efficacy|0|||
143030825|NCT00950807|515654666|FG007|Treatment Period 1|Lack of Efficacy|0|||
143030826|NCT00950807|515654667|FG008|Treatment Period 1|Lack of Efficacy|0|||
143030827|NCT00950807|515654668|FG009|Treatment Period 1|Lack of Efficacy|0|||
143030828|NCT00950807|515654659|FG000|Treatment Period 1|Protocol Violation|1|||
143030829|NCT00950807|515654660|FG001|Treatment Period 1|Protocol Violation|0|||
143030830|NCT00950807|515654661|FG002|Treatment Period 1|Protocol Violation|0|||
143030831|NCT00950807|515654662|FG003|Treatment Period 1|Protocol Violation|0|||
143030832|NCT00950807|515654663|FG004|Treatment Period 1|Protocol Violation|0|||
143030833|NCT00950807|515654664|FG005|Treatment Period 1|Protocol Violation|0|||
143030834|NCT00950807|515654665|FG006|Treatment Period 1|Protocol Violation|0|||
143030835|NCT00950807|515654666|FG007|Treatment Period 1|Protocol Violation|0|||
143030836|NCT00950807|515654667|FG008|Treatment Period 1|Protocol Violation|0|||
143030837|NCT00950807|515654668|FG009|Treatment Period 1|Protocol Violation|0|||
143492471|NCT01999582|517344840|FG002|Overall Study|Protocol Violation|0|||
143492472|NCT01999582|517344841|FG003|Overall Study|Protocol Violation|0|||
143492473|NCT01999582|517344842|FG004|Overall Study|Protocol Violation|0|||
143030838|NCT00950807|515654659|FG000|Treatment Period 1|Lost to Follow-up|0|||
143030839|NCT00950807|515654660|FG001|Treatment Period 1|Lost to Follow-up|0|||
143492474|NCT01999582|517344843|FG005|Overall Study|Protocol Violation|1|||
143492475|NCT01999582|517344838|FG000|Overall Study|Lack of Efficacy|1|||
143030840|NCT00950807|515654661|FG002|Treatment Period 1|Lost to Follow-up|1|||
143030841|NCT00950807|515654662|FG003|Treatment Period 1|Lost to Follow-up|0|||
143030842|NCT00950807|515654663|FG004|Treatment Period 1|Lost to Follow-up|0|||
143030843|NCT00950807|515654664|FG005|Treatment Period 1|Lost to Follow-up|0|||
143030844|NCT00950807|515654665|FG006|Treatment Period 1|Lost to Follow-up|0|||
143492476|NCT01999582|517344839|FG001|Overall Study|Lack of Efficacy|3|||
143492477|NCT01999582|517344840|FG002|Overall Study|Lack of Efficacy|0|||
143492478|NCT01999582|517344841|FG003|Overall Study|Lack of Efficacy|1|||
143492479|NCT01999582|517344842|FG004|Overall Study|Lack of Efficacy|0|||
143492480|NCT01999582|517344843|FG005|Overall Study|Lack of Efficacy|0|||
143030845|NCT00950807|515654666|FG007|Treatment Period 1|Lost to Follow-up|0|||
143492481|NCT02347176|517344844|FG000|Overall Study|Lost to Follow-up|2|||
143492482|NCT02347176|517344845|FG001|Overall Study|Lost to Follow-up|3|||
143492483|NCT02347176|517344846|FG002|Overall Study|Lost to Follow-up|1|||
143492484|NCT02347176|517344847|FG003|Overall Study|Lost to Follow-up|1|||
143492485|NCT02347176|517344844|FG000|Overall Study|Withdrawal by Subject|9|||
143492486|NCT02347176|517344845|FG001|Overall Study|Withdrawal by Subject|5|||
143492487|NCT02347176|517344846|FG002|Overall Study|Withdrawal by Subject|5|||
143492488|NCT02347176|517344847|FG003|Overall Study|Withdrawal by Subject|3|||
143492489|NCT02347176|517344844|FG000|Overall Study|Other|1|||
143492490|NCT02347176|517344845|FG001|Overall Study|Other|2|||
143492491|NCT02347176|517344846|FG002|Overall Study|Other|2|||
143492492|NCT02347176|517344847|FG003|Overall Study|Other|0|||
143492493|NCT02161211|517344848|FG000|Overall Study|Lost to Follow-up|21|||
143492494|NCT02161211|517344849|FG001|Overall Study|Lost to Follow-up|27|||
143492495|NCT02161211|517344850|FG002|Overall Study|Lost to Follow-up|21|||
143492496|NCT02161211|517344848|FG000|Overall Study|Dropped|12|||
143492497|NCT02161211|517344849|FG001|Overall Study|Dropped|5|||
143492498|NCT02161211|517344850|FG002|Overall Study|Dropped|9|||
143492499|NCT01703858|517344852|FG000|Overall Study|Withdrawal by Subject|0|||
143492500|NCT01703858|517344853|FG001|Overall Study|Withdrawal by Subject|1|||
143492501|NCT01703858|517344854|FG002|Overall Study|Withdrawal by Subject|0|||
143492502|NCT01543087|517344856|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
143492503|NCT01543087|517344857|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
143492504|NCT01543087|517344858|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
143030846|NCT00950807|515654667|FG008|Treatment Period 1|Lost to Follow-up|0|||
143030847|NCT00950807|515654668|FG009|Treatment Period 1|Lost to Follow-up|0|||
143030848|NCT00950807|515654659|FG000|Treatment Period 1|Withdrawal by Subject|1|||
143030849|NCT00950807|515654660|FG001|Treatment Period 1|Withdrawal by Subject|0|||
143030850|NCT00950807|515654661|FG002|Treatment Period 1|Withdrawal by Subject|0|||
143030851|NCT00950807|515654662|FG003|Treatment Period 1|Withdrawal by Subject|0|||
143030852|NCT00950807|515654663|FG004|Treatment Period 1|Withdrawal by Subject|1|||
143030853|NCT00950807|515654664|FG005|Treatment Period 1|Withdrawal by Subject|0|||
143030854|NCT00950807|515654665|FG006|Treatment Period 1|Withdrawal by Subject|0|||
143030855|NCT00950807|515654666|FG007|Treatment Period 1|Withdrawal by Subject|0|||
143492505|NCT01543087|517344859|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
143492506|NCT01543087|517344860|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
143492507|NCT01543087|517344861|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
143492508|NCT01543087|517344856|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
143492509|NCT01543087|517344857|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
143492510|NCT01543087|517344858|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
143492511|NCT01543087|517344859|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
143030856|NCT00950807|515654667|FG008|Treatment Period 1|Withdrawal by Subject|1|||
143030857|NCT00950807|515654668|FG009|Treatment Period 1|Withdrawal by Subject|0|||
143030858|NCT00950807|515654659|FG000|Treatment Period 1|Adverse Event|0|||
143030859|NCT00950807|515654660|FG001|Treatment Period 1|Adverse Event|0|||
143030860|NCT00950807|515654661|FG002|Treatment Period 1|Adverse Event|0|||
143237525|NCT03995368|516423363|FG002|Overall Study|Withdrawal by Subject|1|||
143237526|NCT03592186|516423364|FG000|Overall Study|Withdrawal by Subject|1|||
143237527|NCT03592186|516423365|FG001|Overall Study|Withdrawal by Subject|0|||
143237528|NCT03592186|516423364|FG000|Overall Study|Lost to Follow-up|16|||
143237529|NCT03592186|516423365|FG001|Overall Study|Lost to Follow-up|11|||
143237530|NCT01052493|516423366|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
143492512|NCT01543087|517344860|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
143492513|NCT01543087|517344861|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
143492514|NCT01543087|517344856|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
143492515|NCT01543087|517344857|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
143492516|NCT01543087|517344858|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
143492517|NCT01543087|517344859|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
143492518|NCT01543087|517344860|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
143492519|NCT01543087|517344861|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
143492520|NCT01543087|517344856|FG000|Stage 1 (48 Months)|Other than specified|5|||
143492521|NCT01543087|517344857|FG001|Stage 1 (48 Months)|Other than specified|0|||
143492522|NCT01543087|517344858|FG002|Stage 1 (48 Months)|Other than specified|9|||
143492523|NCT01543087|517344859|FG003|Stage 1 (48 Months)|Other than specified|0|||
143492524|NCT01543087|517344860|FG004|Stage 1 (48 Months)|Other than specified|0|||
143492525|NCT01543087|517344861|FG005|Stage 1 (48 Months)|Other than specified|0|||
143492526|NCT01543087|517344856|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
143492527|NCT01543087|517344857|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
143492528|NCT01543087|517344858|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
143492529|NCT01543087|517344859|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
143030861|NCT00950807|515654662|FG003|Treatment Period 1|Adverse Event|0|||
143030862|NCT00950807|515654663|FG004|Treatment Period 1|Adverse Event|0|||
143030863|NCT00950807|515654664|FG005|Treatment Period 1|Adverse Event|1|||
143237531|NCT01052493|516423367|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
143492530|NCT01543087|517344860|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
143492531|NCT01543087|517344861|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
143492532|NCT01543087|517344856|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
143492533|NCT01543087|517344857|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
143492534|NCT01543087|517344858|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
143492535|NCT01543087|517344859|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
143492536|NCT01543087|517344860|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
143492537|NCT01543087|517344861|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
143492538|NCT01543087|517344856|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
143492539|NCT01543087|517344857|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
143492540|NCT01543087|517344858|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
143492541|NCT01543087|517344859|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
143492542|NCT01543087|517344860|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
143492543|NCT01543087|517344861|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
143492544|NCT01325428|517344863|FG000|Part A|Progressive disease according to RECIST|9|||
143492545|NCT01325428|517344863|FG000|Part A|Clinical signs, symptoms of progression|2|||
143492546|NCT01325428|517344863|FG000|Part A|Other adverse event|1|||
143492547|NCT01325428|517344863|FG000|Part A|Refused continue taking trial medication|2|||
143492548|NCT01325428|517344863|FG000|Part A|Other reason not defined above|2|||
143492549|NCT01325428|517344863|FG000|Part B|Refused continue taking trial medication|2|||
143492550|NCT01325428|517344863|FG000|Part B|Other reason not defined above|1|||
143492551|NCT01422239|517344864|FG000|Overall Study|Lost to Follow-up|4|||
143492552|NCT01422239|517344865|FG001|Overall Study|Lost to Follow-up|3|||
143492553|NCT00730639|517344874|FG000|Overall Study|Adverse Event|3|||
143492554|NCT00730639|517344875|FG001|Overall Study|Adverse Event|0|||
143492555|NCT00730639|517344876|FG002|Overall Study|Adverse Event|9|||
143492556|NCT00730639|517344877|FG003|Overall Study|Adverse Event|8|||
143492557|NCT00730639|517344878|FG004|Overall Study|Adverse Event|23|||
143492558|NCT00730639|517344874|FG000|Overall Study|Complete Response|0|||
143492559|NCT00730639|517344875|FG001|Overall Study|Complete Response|0|||
143492560|NCT00730639|517344876|FG002|Overall Study|Complete Response|2|||
143492561|NCT00730639|517344877|FG003|Overall Study|Complete Response|2|||
143492562|NCT00730639|517344878|FG004|Overall Study|Complete Response|1|||
143492563|NCT00730639|517344874|FG000|Overall Study|Completed Maximum Cycles|0|||
143492564|NCT00730639|517344875|FG001|Overall Study|Completed Maximum Cycles|0|||
143492565|NCT00730639|517344876|FG002|Overall Study|Completed Maximum Cycles|11|||
143492566|NCT00730639|517344877|FG003|Overall Study|Completed Maximum Cycles|3|||
143492567|NCT00730639|517344878|FG004|Overall Study|Completed Maximum Cycles|6|||
143492568|NCT00730639|517344874|FG000|Overall Study|Death|0|||
143492569|NCT00730639|517344875|FG001|Overall Study|Death|0|||
143492570|NCT00730639|517344876|FG002|Overall Study|Death|0|||
143492571|NCT00730639|517344877|FG003|Overall Study|Death|0|||
143492572|NCT00730639|517344878|FG004|Overall Study|Death|2|||
143492573|NCT00730639|517344874|FG000|Overall Study|Disease Progression|12|||
143492574|NCT00730639|517344875|FG001|Overall Study|Disease Progression|13|||
143492575|NCT00730639|517344876|FG002|Overall Study|Disease Progression|48|||
143492576|NCT00730639|517344877|FG003|Overall Study|Disease Progression|32|||
143492577|NCT00730639|517344878|FG004|Overall Study|Disease Progression|88|||
143492578|NCT00730639|517344874|FG000|Overall Study|non-specified|0|||
143492579|NCT00730639|517344875|FG001|Overall Study|non-specified|0|||
143492580|NCT00730639|517344876|FG002|Overall Study|non-specified|4|||
143492581|NCT00730639|517344877|FG003|Overall Study|non-specified|2|||
143492582|NCT00730639|517344878|FG004|Overall Study|non-specified|3|||
143492583|NCT00730639|517344874|FG000|Overall Study|Protocol Violation|0|||
143492584|NCT00730639|517344875|FG001|Overall Study|Protocol Violation|0|||
143492585|NCT00730639|517344876|FG002|Overall Study|Protocol Violation|1|||
143492586|NCT00730639|517344877|FG003|Overall Study|Protocol Violation|0|||
143492587|NCT00730639|517344878|FG004|Overall Study|Protocol Violation|0|||
143492588|NCT00730639|517344874|FG000|Overall Study|Withdrawal by Subject|0|||
143492589|NCT00730639|517344875|FG001|Overall Study|Withdrawal by Subject|0|||
143492590|NCT00730639|517344876|FG002|Overall Study|Withdrawal by Subject|6|||
143492591|NCT00730639|517344877|FG003|Overall Study|Withdrawal by Subject|3|||
143492592|NCT00730639|517344878|FG004|Overall Study|Withdrawal by Subject|4|||
143492593|NCT00730639|517344874|FG000|Overall Study|Treatment on-going|2|||
143492594|NCT00730639|517344875|FG001|Overall Study|Treatment on-going|5|||
143492595|NCT00730639|517344876|FG002|Overall Study|Treatment on-going|5|||
143492596|NCT00730639|517344877|FG003|Overall Study|Treatment on-going|4|||
143492597|NCT00730639|517344878|FG004|Overall Study|Treatment on-going|4|||
143492598|NCT01844895|517344880|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
143492599|NCT01844895|517344880|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
143492600|NCT01844895|517344880|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
143492601|NCT01844895|517344880|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
143492602|NCT01844895|517344880|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
143492603|NCT01844895|517344880|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
143492604|NCT01844895|517344880|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
143492605|NCT02508194|517344883|FG000|Overall Study|Death|5|||
143492606|NCT02508194|517344884|FG001|Overall Study|Death|3|||
143492607|NCT02508194|517344883|FG000|Overall Study|Lost to Follow-up|25|||
143492608|NCT02508194|517344884|FG001|Overall Study|Lost to Follow-up|18|||
143492609|NCT02508194|517344883|FG000|Overall Study|Withdrawal by Subject|20|||
143492610|NCT02508194|517344884|FG001|Overall Study|Withdrawal by Subject|18|||
143492611|NCT02508194|517344883|FG000|Overall Study|Error in Randomization|1|||
143492612|NCT02508194|517344884|FG001|Overall Study|Error in Randomization|3|||
143492613|NCT02508194|517344883|FG000|Overall Study|Principal Investigator Decision|1|||
143492614|NCT02508194|517344884|FG001|Overall Study|Principal Investigator Decision|2|||
143492615|NCT00511355|517344888|FG000|Overall Study|Adverse Event|4|||
143492616|NCT00511355|517344889|FG001|Overall Study|Adverse Event|4|||
143492617|NCT00511355|517344888|FG000|Overall Study|Pregnancy Wish|1|||
143492618|NCT00511355|517344889|FG001|Overall Study|Pregnancy Wish|0|||
143492619|NCT00511355|517344888|FG000|Overall Study|Lost to Follow-up|2|||
143492620|NCT00511355|517344889|FG001|Overall Study|Lost to Follow-up|1|||
143492621|NCT00511355|517344888|FG000|Overall Study|Other Reason|0|||
143492622|NCT00511355|517344889|FG001|Overall Study|Other Reason|1|||
143492623|NCT00511355|517344888|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
143492624|NCT00511355|517344889|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
143492625|NCT00511355|517344888|FG000|Overall Study|Withdrawal of informed consent|0|||
143492626|NCT00511355|517344889|FG001|Overall Study|Withdrawal of informed consent|1|||
143492627|NCT00511355|517344888|FG000|Overall Study|Other reason pre-treatment|0|||
143492628|NCT00511355|517344889|FG001|Overall Study|Other reason pre-treatment|1|||
143492629|NCT00217087|517344890|FG000|Overall Study|decided to have esophagectomy|1|||
143492630|NCT00217087|517344891|FG001|Overall Study|decided to have esophagectomy|2|||
143492631|NCT00217087|517344890|FG000|Overall Study|completed less than 12 months return|10|||
143492632|NCT00217087|517344891|FG001|Overall Study|completed less than 12 months return|18|||
143492633|NCT04158648|517344898|FG000|Overall Study|Ongoing in the Study|69|||
143492634|NCT04158648|517344898|FG000|Overall Study|Withdrawal by Subject|4|||
143492635|NCT02926950|517344899|FG000|Overall Study|Adverse Event|4|||
143492636|NCT02926950|517344900|FG001|Overall Study|Adverse Event|6|||
143492637|NCT02926950|517344899|FG000|Overall Study|At the participant's own request|21|||
143492638|NCT02926950|517344900|FG001|Overall Study|At the participant's own request|25|||
143492639|NCT02926950|517344899|FG000|Overall Study|Reason not Specified|17|||
143492640|NCT02926950|517344900|FG001|Overall Study|Reason not Specified|9|||
143492641|NCT02926950|517344899|FG000|Overall Study|Lost to Follow-up|7|||
143492642|NCT02926950|517344900|FG001|Overall Study|Lost to Follow-up|8|||
143492643|NCT05036083|517344901|FG000|Overall Study|Physician Decision|1|||
143492644|NCT05036083|517344901|FG000|Overall Study|Withdrawal by Subject|1|||
143492645|NCT05036083|517344901|FG000|Overall Study|Labs outside instition parameter, eGFR|3|||
143492646|NCT05036083|517344901|FG000|Overall Study|IV not sustainable|1|||
143492647|NCT04622046|517344902|FG000|Intervention Period|Adverse Event|1|||
143492648|NCT04622046|517344902|FG000|Intervention Period|Withdrawal by Subject|2|||
143492649|NCT04622046|517344902|FG000|Extension Period|Ongoing in the Extension Period|21|||
143492650|NCT04341948|517344903|FG000|Overall Study|Adverse Event|0|||
143492651|NCT04341948|517344904|FG001|Overall Study|Adverse Event|1|||
143492652|NCT04341948|517344903|FG000|Overall Study|Lost to Follow-up|6|||
143492653|NCT04341948|517344904|FG001|Overall Study|Lost to Follow-up|1|||
143492654|NCT04341948|517344903|FG000|Overall Study|Physician Decision|1|||
143492655|NCT04341948|517344904|FG001|Overall Study|Physician Decision|2|||
143492656|NCT04341948|517344903|FG000|Overall Study|Withdrawal by Participant|6|||
143492657|NCT04341948|517344904|FG001|Overall Study|Withdrawal by Participant|3|||
143492658|NCT04341948|517344903|FG000|Overall Study|Lack of compliance by Participant|1|||
143492659|NCT04341948|517344904|FG001|Overall Study|Lack of compliance by Participant|0|||
143492660|NCT03087955|517346925|FG000|Overall Study|Death|4|||
143492661|NCT03087955|517346926|FG001|Overall Study|Death|0|||
143492662|NCT03087955|517346925|FG000|Overall Study|Lack of Efficacy|2|||
143492663|NCT03087955|517346926|FG001|Overall Study|Lack of Efficacy|0|||
143492664|NCT03087955|517346925|FG000|Overall Study|Lost to Follow-up|1|||
143492665|NCT03087955|517346926|FG001|Overall Study|Lost to Follow-up|0|||
143492666|NCT04441905|517346927|FG000|Overall Study|Lost to Follow-up|1|||
143492667|NCT04441905|517346928|FG001|Overall Study|Lost to Follow-up|0|||
143492668|NCT04441905|517346929|FG002|Overall Study|Lost to Follow-up|0|||
143492669|NCT04441905|517346930|FG003|Overall Study|Lost to Follow-up|0|||
143492670|NCT04441905|517346931|FG004|Overall Study|Lost to Follow-up|0|||
143492671|NCT04441905|517346932|FG005|Overall Study|Lost to Follow-up|0|||
143237532|NCT01052493|516423368|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
143237533|NCT00307801|516423369|FG000|Overall Study|Adverse Event|12|||
143492672|NCT04441905|517346927|FG000|Overall Study|Enrolled but treatment not administered|0|||
143492673|NCT04441905|517346928|FG001|Overall Study|Enrolled but treatment not administered|1|||
143492674|NCT04441905|517346929|FG002|Overall Study|Enrolled but treatment not administered|0|||
143492675|NCT04441905|517346930|FG003|Overall Study|Enrolled but treatment not administered|0|||
143492676|NCT04441905|517346931|FG004|Overall Study|Enrolled but treatment not administered|0|||
143492677|NCT04441905|517346932|FG005|Overall Study|Enrolled but treatment not administered|0|||
143492678|NCT04441905|517346927|FG000|Overall Study|Became ineligible after enrollment|0|||
143492679|NCT04441905|517346928|FG001|Overall Study|Became ineligible after enrollment|0|||
143492680|NCT04441905|517346929|FG002|Overall Study|Became ineligible after enrollment|0|||
143492681|NCT04441905|517346930|FG003|Overall Study|Became ineligible after enrollment|0|||
143492682|NCT04441905|517346931|FG004|Overall Study|Became ineligible after enrollment|1|||
143492683|NCT04441905|517346932|FG005|Overall Study|Became ineligible after enrollment|0|||
143492684|NCT03266016|517346936|FG000|Acute Phase (0 to 28 Days)|Withdrawal by Subject|1|||
143492685|NCT03266016|517346937|FG001|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
143492686|NCT03266016|517346938|FG002|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
143492687|NCT03266016|517346939|FG003|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
143492688|NCT03266016|517346936|FG000|Acute Phase (0 to 28 Days)|Completed study at acute phase.|75|||
143492689|NCT03266016|517346937|FG001|Acute Phase (0 to 28 Days)|Completed study at acute phase.|56|||
143492690|NCT03266016|517346938|FG002|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
143492691|NCT03266016|517346939|FG003|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
143492692|NCT00482014|517346940|FG000|Overall Study|Withdrawal by Subject|1|||
143492693|NCT00482014|517346941|FG001|Overall Study|Withdrawal by Subject|2|||
143492694|NCT00482014|517346942|FG002|Overall Study|Withdrawal by Subject|3|||
143492695|NCT00482014|517346943|FG003|Overall Study|Withdrawal by Subject|4|||
143492696|NCT00482014|517346940|FG000|Overall Study|Adverse Event|3|||
143492697|NCT00482014|517346941|FG001|Overall Study|Adverse Event|0|||
143492698|NCT00482014|517346942|FG002|Overall Study|Adverse Event|2|||
143492699|NCT00482014|517346943|FG003|Overall Study|Adverse Event|8|||
143492700|NCT00482014|517346940|FG000|Overall Study|Death|1|||
143158757|NCT00676689|516126107|FG000|Overall Study|Continuing FU|49|||
143158758|NCT01827943|516126108|FG000|Overall Study|Protocol Violation|8|||
143158759|NCT01827943|516126108|FG000|Overall Study|Never treated because of an rapid progression|1|||
143158760|NCT01666314|516126109|FG000|Overall Study|Adverse Event|3|||
143158761|NCT01666314|516126110|FG001|Overall Study|Adverse Event|13|||
143158762|NCT01666314|516126111|FG002|Overall Study|Adverse Event|7|||
143158763|NCT01666314|516126112|FG003|Overall Study|Adverse Event|7|||
143158764|NCT01666314|516126109|FG000|Overall Study|Progressive Disease|11|||
143158765|NCT01666314|516126110|FG001|Overall Study|Progressive Disease|9|||
143158766|NCT01666314|516126111|FG002|Overall Study|Progressive Disease|19|||
143158767|NCT01666314|516126112|FG003|Overall Study|Progressive Disease|20|||
143158768|NCT01666314|516126109|FG000|Overall Study|Symptomatic Deterioration|1|||
143158769|NCT01666314|516126110|FG001|Overall Study|Symptomatic Deterioration|0|||
143158770|NCT01666314|516126111|FG002|Overall Study|Symptomatic Deterioration|2|||
143158771|NCT01666314|516126112|FG003|Overall Study|Symptomatic Deterioration|0|||
143158772|NCT01666314|516126109|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
143158773|NCT01666314|516126110|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
143158774|NCT01666314|516126111|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
143158775|NCT01666314|516126112|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
143158776|NCT01666314|516126109|FG000|Overall Study|Withdrawal by Subject|1|||
143158777|NCT01666314|516126110|FG001|Overall Study|Withdrawal by Subject|1|||
143158778|NCT01666314|516126111|FG002|Overall Study|Withdrawal by Subject|2|||
143158779|NCT01666314|516126112|FG003|Overall Study|Withdrawal by Subject|3|||
143158780|NCT01666314|516126109|FG000|Overall Study|Reason not Specified|10|||
143158781|NCT01666314|516126110|FG001|Overall Study|Reason not Specified|7|||
143158782|NCT01666314|516126111|FG002|Overall Study|Reason not Specified|5|||
143158783|NCT01666314|516126112|FG003|Overall Study|Reason not Specified|5|||
143158784|NCT05660538|516126113|FG000|Overall Study|Adverse Event|0|||
143158785|NCT05660538|516126114|FG001|Overall Study|Adverse Event|0|||
143158786|NCT05660538|516126115|FG002|Overall Study|Adverse Event|1|||
143158787|NCT05660538|516126116|FG003|Overall Study|Adverse Event|0|||
143158788|NCT05660538|516126113|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
143158789|NCT05660538|516126114|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
143158790|NCT05660538|516126115|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
143158791|NCT05660538|516126116|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
143158792|NCT05660538|516126113|FG000|Overall Study|Lost to Follow-up|0|||
143158793|NCT05660538|516126114|FG001|Overall Study|Lost to Follow-up|0|||
143158794|NCT05660538|516126115|FG002|Overall Study|Lost to Follow-up|1|||
143158795|NCT05660538|516126116|FG003|Overall Study|Lost to Follow-up|1|||
143158796|NCT05660538|516126113|FG000|Overall Study|Death|0|||
143158797|NCT05660538|516126114|FG001|Overall Study|Death|0|||
143158798|NCT05660538|516126115|FG002|Overall Study|Death|1|||
143158799|NCT05660538|516126116|FG003|Overall Study|Death|0|||
143158800|NCT05660538|516126113|FG000|Overall Study|Physician Decision|0|||
143158801|NCT05660538|516126114|FG001|Overall Study|Physician Decision|0|||
143158802|NCT05660538|516126115|FG002|Overall Study|Physician Decision|0|||
143158803|NCT05660538|516126116|FG003|Overall Study|Physician Decision|1|||
143158804|NCT05660538|516126113|FG000|Overall Study|Sponsor Decision|1|||
143158805|NCT05660538|516126114|FG001|Overall Study|Sponsor Decision|0|||
143158806|NCT05660538|516126115|FG002|Overall Study|Sponsor Decision|0|||
143158807|NCT05660538|516126116|FG003|Overall Study|Sponsor Decision|0|||
143158808|NCT05660538|516126113|FG000|Overall Study|Other|1|||
143158809|NCT05660538|516126114|FG001|Overall Study|Other|0|||
143158810|NCT05660538|516126115|FG002|Overall Study|Other|0|||
143492701|NCT00482014|517346941|FG001|Overall Study|Death|2|||
143492702|NCT00482014|517346942|FG002|Overall Study|Death|1|||
143492703|NCT00482014|517346943|FG003|Overall Study|Death|4|||
143492704|NCT00482014|517346940|FG000|Overall Study|Lack of Efficacy|1|||
143492705|NCT00482014|517346941|FG001|Overall Study|Lack of Efficacy|0|||
143492706|NCT00482014|517346942|FG002|Overall Study|Lack of Efficacy|4|||
143492707|NCT00482014|517346943|FG003|Overall Study|Lack of Efficacy|6|||
143492708|NCT00482014|517346940|FG000|Overall Study|Sponsor Decision|1|||
143492709|NCT00482014|517346941|FG001|Overall Study|Sponsor Decision|2|||
143492710|NCT00482014|517346942|FG002|Overall Study|Sponsor Decision|1|||
143492711|NCT00482014|517346943|FG003|Overall Study|Sponsor Decision|1|||
143492712|NCT03686397|517346944|FG000|Overall Study|Lack of Efficacy|3|||
143492713|NCT03686397|517346945|FG001|Overall Study|Lack of Efficacy|5|||
143492714|NCT03686397|517346944|FG000|Overall Study|Adverse Event|0|||
143492715|NCT03686397|517346945|FG001|Overall Study|Adverse Event|1|||
143492716|NCT03686397|517346944|FG000|Overall Study|Protocol Violation|0|||
143492717|NCT03686397|517346945|FG001|Overall Study|Protocol Violation|1|||
143492718|NCT03686397|517346944|FG000|Overall Study|Withdrawal by Subject|0|||
143492719|NCT03686397|517346945|FG001|Overall Study|Withdrawal by Subject|1|||
143492720|NCT03686397|517346944|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
143492721|NCT03686397|517346945|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
143492722|NCT00122135|517346948|FG000|Overall Study|Withdrawal by Subject|3|||
143492723|NCT00122135|517346949|FG001|Overall Study|Withdrawal by Subject|0|||
143492724|NCT03269344|517346950|FG000|Overall Study|Protocol Violation|4|||
143492725|NCT03269344|517346951|FG001|Overall Study|Protocol Violation|3|||
143492726|NCT00805740|517346952|FG000|Overall Study|Death|7|||
143492727|NCT00805740|517346953|FG001|Overall Study|Death|4|||
143492728|NCT00805740|517346952|FG000|Overall Study|Withdrawal by Subject|1|||
143492729|NCT00805740|517346953|FG001|Overall Study|Withdrawal by Subject|0|||
143492730|NCT00805740|517346952|FG000|Overall Study|Lost to Follow-up|1|||
143492731|NCT00805740|517346953|FG001|Overall Study|Lost to Follow-up|0|||
143492732|NCT00805740|517346952|FG000|Overall Study|Randomized, but not treated|2|||
143492733|NCT00805740|517346953|FG001|Overall Study|Randomized, but not treated|0|||
143492734|NCT00200850|517346963|FG000|Overall Study|relocation|1|||
143492735|NCT00200850|517346964|FG001|Overall Study|relocation|0|||
143492736|NCT00200850|517346965|FG002|Overall Study|relocation|1|||
143492737|NCT00200850|517346963|FG000|Overall Study|too busy|1|||
143492738|NCT00200850|517346964|FG001|Overall Study|too busy|0|||
143492739|NCT00200850|517346965|FG002|Overall Study|too busy|0|||
143492740|NCT00200850|517346963|FG000|Overall Study|Pregnancy|0|||
143492741|NCT00200850|517346964|FG001|Overall Study|Pregnancy|0|||
143492742|NCT00200850|517346965|FG002|Overall Study|Pregnancy|1|||
143492743|NCT00200850|517346963|FG000|Overall Study|Poor adherence|0|||
143492744|NCT00200850|517346964|FG001|Overall Study|Poor adherence|0|||
143492745|NCT00200850|517346965|FG002|Overall Study|Poor adherence|1|||
143492746|NCT00200850|517346963|FG000|Overall Study|optic neuritis|0|||
143492747|NCT00200850|517346964|FG001|Overall Study|optic neuritis|0|||
143492748|NCT00200850|517346965|FG002|Overall Study|optic neuritis|1|||
143492749|NCT00200850|517346963|FG000|Overall Study|Adverse Event|1|||
143492750|NCT00200850|517346964|FG001|Overall Study|Adverse Event|1|||
143492751|NCT00200850|517346965|FG002|Overall Study|Adverse Event|2|||
143492752|NCT01449708|517346966|FG000|Overall Study|Protocol Violation|0|||
143492753|NCT01449708|517346967|FG001|Overall Study|Protocol Violation|1|||
143492754|NCT01449708|517346966|FG000|Overall Study|surgical complication|1|||
143492755|NCT01449708|517346967|FG001|Overall Study|surgical complication|2|||
143492756|NCT01449708|517346966|FG000|Overall Study|respiratory failure|1|||
143492757|NCT01449708|517346967|FG001|Overall Study|respiratory failure|0|||
143492758|NCT02908880|517346970|FG000|Overall Study|Lost to Follow-up|4|||
143492759|NCT02908880|517346970|FG000|Overall Study|Explantation of the device|1|||
143237534|NCT00307801|516423370|FG001|Overall Study|Adverse Event|4|||
143237535|NCT00307801|516423369|FG000|Overall Study|Withdrawal by Subject|9|||
143237536|NCT00307801|516423370|FG001|Overall Study|Withdrawal by Subject|4|||
143237537|NCT00307801|516423369|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
143237538|NCT00307801|516423370|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
143237539|NCT00307801|516423369|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
143237540|NCT00307801|516423370|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
143237541|NCT00307801|516423369|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
143492760|NCT02908880|517346970|FG000|Overall Study|Withdrawal by Subject|17|||
143492761|NCT02908880|517346970|FG000|Overall Study|Death|5|||
143492762|NCT01882907|517346971|FG000|Overall Study|Adverse Event|3|||
143030864|NCT00950807|515654665|FG006|Treatment Period 1|Adverse Event|0|||
143492763|NCT01882907|517346972|FG001|Overall Study|Adverse Event|1|||
143492764|NCT01882907|517346971|FG000|Overall Study|Lack of Efficacy|0|||
143492765|NCT01882907|517346972|FG001|Overall Study|Lack of Efficacy|3|||
143492766|NCT01882907|517346971|FG000|Overall Study|Lost to Follow-up|1|||
143492767|NCT01882907|517346972|FG001|Overall Study|Lost to Follow-up|4|||
143492768|NCT01882907|517346971|FG000|Overall Study|Protocol Violation|10|||
143030865|NCT00950807|515654666|FG007|Treatment Period 1|Adverse Event|0|||
143492769|NCT01882907|517346972|FG001|Overall Study|Protocol Violation|14|||
143492770|NCT01882907|517346971|FG000|Overall Study|Withdrawal by Subject|0|||
143030866|NCT00950807|515654667|FG008|Treatment Period 1|Adverse Event|0|||
143492771|NCT01882907|517346972|FG001|Overall Study|Withdrawal by Subject|6|||
143492772|NCT01396005|517346977|FG000|Overall Study|Withdrawal by Subject|0|||
143492773|NCT01396005|517346978|FG001|Overall Study|Withdrawal by Subject|1|||
143492774|NCT01396005|517346977|FG000|Overall Study|Non-compliance with protocol|0|||
143492775|NCT01396005|517346978|FG001|Overall Study|Non-compliance with protocol|1|||
143492776|NCT00424827|517346981|FG000|Overall Study|Adverse Event|1|||
143492777|NCT00491179|517346984|FG000|Overall Study|Adverse Event|5|||
143492778|NCT00491179|517346985|FG001|Overall Study|Adverse Event|1|||
143492779|NCT00491179|517346984|FG000|Overall Study|Withdrawal by Subject|2|||
143492780|NCT00491179|517346985|FG001|Overall Study|Withdrawal by Subject|1|||
143492781|NCT04269395|517346986|FG000|Overall Study|Lost to Follow-up|1|||
143492782|NCT04269395|517346987|FG001|Overall Study|Lost to Follow-up|0|||
143492783|NCT04269395|517346986|FG000|Overall Study|Study terminated by Sponsor|13|||
143492784|NCT04269395|517346987|FG001|Overall Study|Study terminated by Sponsor|10|||
143492785|NCT00584233|517346988|FG000|Overall Study|Withdrawal by Subject|5|||
143492786|NCT00584233|517346988|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
143492787|NCT00159432|517346989|FG000|Overall Study|Adverse Event|1|||
143492788|NCT00159432|517346989|FG000|Overall Study|Death|1|||
143492789|NCT00159432|517346989|FG000|Overall Study|Lack of Efficacy|8|||
143492790|NCT05689047|517346992|FG000|Overall Study|Lost to Follow-up|0|||
143492791|NCT05689047|517346993|FG001|Overall Study|Lost to Follow-up|1|||
143492792|NCT05689047|517346992|FG000|Overall Study|Protocol Deviation|1|||
143492793|NCT05689047|517346993|FG001|Overall Study|Protocol Deviation|0|||
143492794|NCT03946670|517346994|FG000|Overall Study|Progressive Disease|26|||
143492795|NCT03946670|517346995|FG001|Overall Study|Progressive Disease|23|||
143492796|NCT03946670|517346994|FG000|Overall Study|Adverse Event|7|||
143492797|NCT03946670|517346995|FG001|Overall Study|Adverse Event|9|||
143492798|NCT03946670|517346994|FG000|Overall Study|Death|5|||
143492799|NCT03946670|517346995|FG001|Overall Study|Death|6|||
143492800|NCT03946670|517346994|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
143492801|NCT03946670|517346995|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
143492802|NCT03946670|517346994|FG000|Overall Study|Subject Decision|4|||
143492803|NCT03946670|517346995|FG001|Overall Study|Subject Decision|4|||
143492804|NCT03946670|517346994|FG000|Overall Study|Physician Decision|3|||
143492805|NCT03946670|517346995|FG001|Overall Study|Physician Decision|3|||
143492806|NCT03946670|517346994|FG000|Overall Study|New Therapy for Study Indication|1|||
143492807|NCT03946670|517346995|FG001|Overall Study|New Therapy for Study Indication|0|||
143492808|NCT03946670|517346994|FG000|Overall Study|Not treated|1|||
143492809|NCT03946670|517346995|FG001|Overall Study|Not treated|1|||
143492810|NCT03083886|517346996|FG000|Overall Study|Withdrawal by Subject|51|||
143492811|NCT03083886|517346997|FG001|Overall Study|Withdrawal by Subject|73|||
143492812|NCT03083886|517346998|FG002|Overall Study|Withdrawal by Subject|104|||
143492813|NCT03083886|517346996|FG000|Overall Study|Missing Baseline data|43|||
143492814|NCT03083886|517346997|FG001|Overall Study|Missing Baseline data|42|||
143492815|NCT03083886|517346998|FG002|Overall Study|Missing Baseline data|31|||
143492816|NCT03083886|517346996|FG000|Overall Study|Investigator terminated|1|||
143492817|NCT03083886|517346997|FG001|Overall Study|Investigator terminated|6|||
143492818|NCT03083886|517346998|FG002|Overall Study|Investigator terminated|3|||
143492819|NCT01285908|517347003|FG000|Baseline Measurement|unable to insert catheter|1|||
143492820|NCT01285908|517347004|FG001|Baseline Measurement|unable to insert catheter|0|||
143492821|NCT01285908|517347005|FG002|Baseline Measurement|unable to insert catheter|0|||
143492822|NCT01285908|517347003|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
143492823|NCT01285908|517347004|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
143492824|NCT01285908|517347005|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
143492825|NCT01285908|517347003|FG000|Baseline Measurement|unable to tolerate procedure|1|||
143492826|NCT01285908|517347004|FG001|Baseline Measurement|unable to tolerate procedure|0|||
143492827|NCT01285908|517347005|FG002|Baseline Measurement|unable to tolerate procedure|0|||
143492828|NCT03529773|517347006|FG000|Overall Study|Adverse Event|0|||
143492829|NCT03529773|517347007|FG001|Overall Study|Adverse Event|0|||
143492830|NCT03529773|517347008|FG002|Overall Study|Adverse Event|0|||
143492831|NCT03529773|517347009|FG003|Overall Study|Adverse Event|0|||
143492832|NCT03529773|517347010|FG004|Overall Study|Adverse Event|0|||
143492833|NCT03529773|517347011|FG005|Overall Study|Adverse Event|0|||
143492834|NCT03529773|517347012|FG006|Overall Study|Adverse Event|0|||
143492835|NCT03529773|517347013|FG007|Overall Study|Adverse Event|0|||
143492836|NCT03529773|517347014|FG008|Overall Study|Adverse Event|0|||
143492837|NCT03529773|517347015|FG009|Overall Study|Adverse Event|0|||
143492838|NCT03529773|517347016|FG010|Overall Study|Adverse Event|0|||
143492839|NCT03529773|517347017|FG011|Overall Study|Adverse Event|0|||
143492840|NCT03529773|517347018|FG012|Overall Study|Adverse Event|0|||
143492841|NCT03529773|517347019|FG013|Overall Study|Adverse Event|0|||
143492842|NCT03529773|517347020|FG014|Overall Study|Adverse Event|0|||
143492843|NCT03529773|517347021|FG015|Overall Study|Adverse Event|0|||
143492844|NCT03529773|517347022|FG016|Overall Study|Adverse Event|0|||
143492845|NCT03529773|517347023|FG017|Overall Study|Adverse Event|0|||
143492846|NCT03529773|517347024|FG018|Overall Study|Adverse Event|0|||
143492847|NCT03529773|517347025|FG019|Overall Study|Adverse Event|0|||
143492848|NCT03529773|517347026|FG020|Overall Study|Adverse Event|0|||
143492849|NCT03529773|517347027|FG021|Overall Study|Adverse Event|0|||
143492850|NCT03529773|517347028|FG022|Overall Study|Adverse Event|0|||
143492851|NCT03529773|517347029|FG023|Overall Study|Adverse Event|0|||
143492852|NCT03529773|517347030|FG024|Overall Study|Adverse Event|0|||
143492853|NCT03529773|517347031|FG025|Overall Study|Adverse Event|0|||
143492854|NCT03529773|517347032|FG026|Overall Study|Adverse Event|0|||
143492855|NCT03529773|517347033|FG027|Overall Study|Adverse Event|0|||
143492856|NCT03529773|517347034|FG028|Overall Study|Adverse Event|0|||
143492857|NCT03529773|517347035|FG029|Overall Study|Adverse Event|0|||
143492858|NCT03529773|517347036|FG030|Overall Study|Adverse Event|1|||
143492859|NCT03529773|517347037|FG031|Overall Study|Adverse Event|0|||
143492860|NCT03529773|517347038|FG032|Overall Study|Adverse Event|0|||
143492861|NCT03529773|517347039|FG033|Overall Study|Adverse Event|0|||
143492862|NCT03529773|517347040|FG034|Overall Study|Adverse Event|0|||
143492863|NCT03529773|517347041|FG035|Overall Study|Adverse Event|1|||
143492864|NCT03529773|517347042|FG036|Overall Study|Adverse Event|0|||
143492865|NCT03529773|517347043|FG037|Overall Study|Adverse Event|0|||
143492866|NCT03529773|517347044|FG038|Overall Study|Adverse Event|1|||
143492867|NCT03529773|517347045|FG039|Overall Study|Adverse Event|1|||
143492868|NCT03529773|517347006|FG000|Overall Study|Death|0|||
143492869|NCT03529773|517347007|FG001|Overall Study|Death|0|||
143492870|NCT03529773|517347008|FG002|Overall Study|Death|0|||
143492871|NCT03529773|517347009|FG003|Overall Study|Death|0|||
143492872|NCT03529773|517347010|FG004|Overall Study|Death|0|||
143492873|NCT03529773|517347011|FG005|Overall Study|Death|0|||
143492874|NCT03529773|517347012|FG006|Overall Study|Death|0|||
143492875|NCT03529773|517347013|FG007|Overall Study|Death|0|||
143492876|NCT03529773|517347014|FG008|Overall Study|Death|0|||
143492877|NCT03529773|517347015|FG009|Overall Study|Death|0|||
143492878|NCT03529773|517347016|FG010|Overall Study|Death|0|||
143492879|NCT03529773|517347017|FG011|Overall Study|Death|0|||
143492880|NCT03529773|517347018|FG012|Overall Study|Death|1|||
143492881|NCT03529773|517347019|FG013|Overall Study|Death|0|||
143492882|NCT03529773|517347020|FG014|Overall Study|Death|0|||
143492883|NCT03529773|517347021|FG015|Overall Study|Death|0|||
143492884|NCT03529773|517347022|FG016|Overall Study|Death|0|||
143492885|NCT03529773|517347023|FG017|Overall Study|Death|0|||
143492886|NCT03529773|517347024|FG018|Overall Study|Death|0|||
143492887|NCT03529773|517347025|FG019|Overall Study|Death|1|||
143492888|NCT03529773|517347026|FG020|Overall Study|Death|0|||
143492889|NCT03529773|517347027|FG021|Overall Study|Death|0|||
143492890|NCT03529773|517347028|FG022|Overall Study|Death|1|||
143492891|NCT03529773|517347029|FG023|Overall Study|Death|0|||
143492892|NCT03529773|517347030|FG024|Overall Study|Death|0|||
143492893|NCT03529773|517347031|FG025|Overall Study|Death|0|||
143492894|NCT03529773|517347032|FG026|Overall Study|Death|0|||
143492895|NCT03529773|517347033|FG027|Overall Study|Death|0|||
143492896|NCT03529773|517347034|FG028|Overall Study|Death|0|||
143492897|NCT03529773|517347035|FG029|Overall Study|Death|0|||
143492898|NCT03529773|517347036|FG030|Overall Study|Death|0|||
143492899|NCT03529773|517347037|FG031|Overall Study|Death|0|||
143492900|NCT03529773|517347038|FG032|Overall Study|Death|0|||
143492901|NCT03529773|517347039|FG033|Overall Study|Death|1|||
143492902|NCT03529773|517347040|FG034|Overall Study|Death|1|||
143492903|NCT03529773|517347041|FG035|Overall Study|Death|0|||
143158811|NCT05660538|516126116|FG003|Overall Study|Other|1|||
143158812|NCT05660538|516126113|FG000|Overall Study|Randomized but did not receive study drug|1|||
143158813|NCT05660538|516126114|FG001|Overall Study|Randomized but did not receive study drug|0|||
143158814|NCT05660538|516126115|FG002|Overall Study|Randomized but did not receive study drug|0|||
143158815|NCT05660538|516126116|FG003|Overall Study|Randomized but did not receive study drug|1|||
143492904|NCT03529773|517347042|FG036|Overall Study|Death|1|||
143492905|NCT03529773|517347043|FG037|Overall Study|Death|0|||
143181470|NCT00642707|516211754|FG002|Overall Study|Withdrawal by Subject|0|||
143492906|NCT03529773|517347044|FG038|Overall Study|Death|0|||
143492907|NCT03529773|517347045|FG039|Overall Study|Death|0|||
143492908|NCT03529773|517347006|FG000|Overall Study|Lost to Follow-up|0|||
143492909|NCT03529773|517347007|FG001|Overall Study|Lost to Follow-up|0|||
143492910|NCT03529773|517347008|FG002|Overall Study|Lost to Follow-up|1|||
143492911|NCT03529773|517347009|FG003|Overall Study|Lost to Follow-up|0|||
143492912|NCT03529773|517347010|FG004|Overall Study|Lost to Follow-up|1|||
143492913|NCT03529773|517347011|FG005|Overall Study|Lost to Follow-up|1|||
143492914|NCT03529773|517347012|FG006|Overall Study|Lost to Follow-up|0|||
143492915|NCT03529773|517347013|FG007|Overall Study|Lost to Follow-up|0|||
143492916|NCT03529773|517347014|FG008|Overall Study|Lost to Follow-up|0|||
143492917|NCT03529773|517347015|FG009|Overall Study|Lost to Follow-up|0|||
143492918|NCT03529773|517347016|FG010|Overall Study|Lost to Follow-up|0|||
143492919|NCT03529773|517347017|FG011|Overall Study|Lost to Follow-up|0|||
143492920|NCT03529773|517347018|FG012|Overall Study|Lost to Follow-up|0|||
143492921|NCT03529773|517347019|FG013|Overall Study|Lost to Follow-up|1|||
143492922|NCT03529773|517347020|FG014|Overall Study|Lost to Follow-up|4|||
143492923|NCT03529773|517347021|FG015|Overall Study|Lost to Follow-up|1|||
143492924|NCT03529773|517347022|FG016|Overall Study|Lost to Follow-up|1|||
143492925|NCT03529773|517347023|FG017|Overall Study|Lost to Follow-up|0|||
143492926|NCT03529773|517347024|FG018|Overall Study|Lost to Follow-up|1|||
143492927|NCT03529773|517347025|FG019|Overall Study|Lost to Follow-up|1|||
143492928|NCT03529773|517347026|FG020|Overall Study|Lost to Follow-up|2|||
143492929|NCT03529773|517347027|FG021|Overall Study|Lost to Follow-up|4|||
143492930|NCT03529773|517347028|FG022|Overall Study|Lost to Follow-up|3|||
143492931|NCT03529773|517347029|FG023|Overall Study|Lost to Follow-up|4|||
143492932|NCT03529773|517347030|FG024|Overall Study|Lost to Follow-up|3|||
143492933|NCT03529773|517347031|FG025|Overall Study|Lost to Follow-up|5|||
143492934|NCT03529773|517347032|FG026|Overall Study|Lost to Follow-up|5|||
143492935|NCT03529773|517347033|FG027|Overall Study|Lost to Follow-up|0|||
143492936|NCT03529773|517347034|FG028|Overall Study|Lost to Follow-up|0|||
143492937|NCT03529773|517347035|FG029|Overall Study|Lost to Follow-up|0|||
143492938|NCT03529773|517347036|FG030|Overall Study|Lost to Follow-up|1|||
143492939|NCT03529773|517347037|FG031|Overall Study|Lost to Follow-up|0|||
143492940|NCT03529773|517347038|FG032|Overall Study|Lost to Follow-up|0|||
143492941|NCT03529773|517347039|FG033|Overall Study|Lost to Follow-up|1|||
143492942|NCT03529773|517347040|FG034|Overall Study|Lost to Follow-up|1|||
143492943|NCT03529773|517347041|FG035|Overall Study|Lost to Follow-up|0|||
143492944|NCT03529773|517347042|FG036|Overall Study|Lost to Follow-up|0|||
143030867|NCT00950807|515654668|FG009|Treatment Period 1|Adverse Event|0|||
143030868|NCT00950807|515654659|FG000|Washout Period 1|Lack of Efficacy|0|||
143030869|NCT00950807|515654660|FG001|Washout Period 1|Lack of Efficacy|0|||
143030870|NCT00950807|515654661|FG002|Washout Period 1|Lack of Efficacy|0|||
143030871|NCT00950807|515654662|FG003|Washout Period 1|Lack of Efficacy|0|||
143030872|NCT00950807|515654663|FG004|Washout Period 1|Lack of Efficacy|0|||
143030873|NCT00950807|515654664|FG005|Washout Period 1|Lack of Efficacy|0|||
143030874|NCT00950807|515654665|FG006|Washout Period 1|Lack of Efficacy|1|||
143158816|NCT05660538|516126113|FG000|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
143158817|NCT05660538|516126114|FG001|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|4|||
143158818|NCT05660538|516126115|FG002|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
143158819|NCT05660538|516126116|FG003|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
143158820|NCT01125748|516126117|FG000|Overall Study|Adverse Event|0|||
143158821|NCT01125748|516126118|FG001|Overall Study|Adverse Event|2|||
143158822|NCT01125748|516126117|FG000|Overall Study|Lost to Follow-up|0|||
143158823|NCT01125748|516126118|FG001|Overall Study|Lost to Follow-up|1|||
143158824|NCT01125748|516126117|FG000|Overall Study|Physician Decision|8|||
143158825|NCT01125748|516126118|FG001|Overall Study|Physician Decision|7|||
143158826|NCT01125748|516126117|FG000|Overall Study|Patient Decision to Withdraw|2|||
143158827|NCT01125748|516126118|FG001|Overall Study|Patient Decision to Withdraw|4|||
143158828|NCT01751685|516126119|FG000|6-mo Followup|Missed study visit|1|||
143158829|NCT01751685|516126120|FG001|6-mo Followup|Missed study visit|0|||
143158830|NCT01751685|516126119|FG000|6-mo Followup|Withdrawal by Subject|2|||
143158831|NCT01751685|516126120|FG001|6-mo Followup|Withdrawal by Subject|2|||
143158832|NCT01751685|516126119|FG000|6-mo Followup|Lost to Follow-up|0|||
143158833|NCT01751685|516126120|FG001|6-mo Followup|Lost to Follow-up|1|||
143158834|NCT01751685|516126119|FG000|12-mo Followup|Lost to Follow-up|5|||
143158835|NCT01751685|516126120|FG001|12-mo Followup|Lost to Follow-up|0|||
143158836|NCT01028391|516126121|FG000|Overall Study|Adverse Event|4|||
143158837|NCT01028391|516126122|FG001|Overall Study|Adverse Event|0|||
143158838|NCT01028391|516126121|FG000|Overall Study|Lack of Efficacy|0|||
143158839|NCT01028391|516126122|FG001|Overall Study|Lack of Efficacy|2|||
143158840|NCT01028391|516126121|FG000|Overall Study|Lost to Follow-up|3|||
143158841|NCT01028391|516126122|FG001|Overall Study|Lost to Follow-up|4|||
143158842|NCT01028391|516126121|FG000|Overall Study|Physician Decision|0|||
143158843|NCT01028391|516126122|FG001|Overall Study|Physician Decision|1|||
143492945|NCT03529773|517347043|FG037|Overall Study|Lost to Follow-up|3|||
143492946|NCT03529773|517347044|FG038|Overall Study|Lost to Follow-up|1|||
143492947|NCT03529773|517347045|FG039|Overall Study|Lost to Follow-up|1|||
143492948|NCT03529773|517347006|FG000|Overall Study|No longer meets eligibility criteria|0|||
143492949|NCT03529773|517347007|FG001|Overall Study|No longer meets eligibility criteria|0|||
143492950|NCT03529773|517347008|FG002|Overall Study|No longer meets eligibility criteria|0|||
143492951|NCT03529773|517347009|FG003|Overall Study|No longer meets eligibility criteria|0|||
143492952|NCT03529773|517347010|FG004|Overall Study|No longer meets eligibility criteria|0|||
143492953|NCT03529773|517347011|FG005|Overall Study|No longer meets eligibility criteria|0|||
143492954|NCT03529773|517347012|FG006|Overall Study|No longer meets eligibility criteria|0|||
143492955|NCT03529773|517347013|FG007|Overall Study|No longer meets eligibility criteria|0|||
143030875|NCT00950807|515654666|FG007|Washout Period 1|Lack of Efficacy|0|||
143030876|NCT00950807|515654667|FG008|Washout Period 1|Lack of Efficacy|0|||
143030877|NCT00950807|515654668|FG009|Washout Period 1|Lack of Efficacy|0|||
143158844|NCT01028391|516126121|FG000|Overall Study|Withdrawal by Subject|6|||
143158845|NCT01028391|516126122|FG001|Overall Study|Withdrawal by Subject|3|||
143158846|NCT01028391|516126121|FG000|Overall Study|Needed excluded medication|1|||
143492956|NCT03529773|517347014|FG008|Overall Study|No longer meets eligibility criteria|0|||
143492957|NCT03529773|517347015|FG009|Overall Study|No longer meets eligibility criteria|0|||
143492958|NCT03529773|517347016|FG010|Overall Study|No longer meets eligibility criteria|0|||
143492959|NCT03529773|517347017|FG011|Overall Study|No longer meets eligibility criteria|0|||
143492960|NCT03529773|517347018|FG012|Overall Study|No longer meets eligibility criteria|0|||
143492961|NCT03529773|517347019|FG013|Overall Study|No longer meets eligibility criteria|0|||
143492962|NCT03529773|517347020|FG014|Overall Study|No longer meets eligibility criteria|0|||
143492963|NCT03529773|517347021|FG015|Overall Study|No longer meets eligibility criteria|0|||
143492964|NCT03529773|517347022|FG016|Overall Study|No longer meets eligibility criteria|0|||
143492965|NCT03529773|517347023|FG017|Overall Study|No longer meets eligibility criteria|0|||
143492966|NCT03529773|517347024|FG018|Overall Study|No longer meets eligibility criteria|0|||
143492967|NCT03529773|517347025|FG019|Overall Study|No longer meets eligibility criteria|0|||
143492968|NCT03529773|517347026|FG020|Overall Study|No longer meets eligibility criteria|0|||
143492969|NCT03529773|517347027|FG021|Overall Study|No longer meets eligibility criteria|0|||
143492970|NCT03529773|517347028|FG022|Overall Study|No longer meets eligibility criteria|1|||
143492971|NCT03529773|517347029|FG023|Overall Study|No longer meets eligibility criteria|0|||
143492972|NCT03529773|517347030|FG024|Overall Study|No longer meets eligibility criteria|0|||
143492973|NCT03529773|517347031|FG025|Overall Study|No longer meets eligibility criteria|0|||
143030878|NCT00950807|515654659|FG000|Washout Period 1|Withdrawal by Subject|0|||
143030879|NCT00950807|515654660|FG001|Washout Period 1|Withdrawal by Subject|0|||
143030880|NCT00950807|515654661|FG002|Washout Period 1|Withdrawal by Subject|0|||
143030881|NCT00950807|515654662|FG003|Washout Period 1|Withdrawal by Subject|0|||
143030882|NCT00950807|515654663|FG004|Washout Period 1|Withdrawal by Subject|0|||
143030883|NCT00950807|515654664|FG005|Washout Period 1|Withdrawal by Subject|0|||
143030884|NCT00950807|515654665|FG006|Washout Period 1|Withdrawal by Subject|0|||
143030885|NCT00950807|515654666|FG007|Washout Period 1|Withdrawal by Subject|0|||
143030886|NCT00950807|515654667|FG008|Washout Period 1|Withdrawal by Subject|1|||
143030887|NCT00950807|515654668|FG009|Washout Period 1|Withdrawal by Subject|0|||
143030888|NCT00950807|515654659|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
143030889|NCT00950807|515654660|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
143030890|NCT00950807|515654661|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
143030891|NCT00950807|515654662|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
143030892|NCT00950807|515654663|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
143030893|NCT00950807|515654664|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
143030894|NCT00950807|515654665|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
143492974|NCT03529773|517347032|FG026|Overall Study|No longer meets eligibility criteria|0|||
143492975|NCT03529773|517347033|FG027|Overall Study|No longer meets eligibility criteria|0|||
143492976|NCT03529773|517347034|FG028|Overall Study|No longer meets eligibility criteria|0|||
143492977|NCT03529773|517347035|FG029|Overall Study|No longer meets eligibility criteria|0|||
143492978|NCT03529773|517347036|FG030|Overall Study|No longer meets eligibility criteria|0|||
143492979|NCT03529773|517347037|FG031|Overall Study|No longer meets eligibility criteria|0|||
143492980|NCT03529773|517347038|FG032|Overall Study|No longer meets eligibility criteria|0|||
143492981|NCT03529773|517347039|FG033|Overall Study|No longer meets eligibility criteria|0|||
143492982|NCT03529773|517347040|FG034|Overall Study|No longer meets eligibility criteria|0|||
143492983|NCT03529773|517347041|FG035|Overall Study|No longer meets eligibility criteria|0|||
143492984|NCT03529773|517347042|FG036|Overall Study|No longer meets eligibility criteria|0|||
143492985|NCT03529773|517347043|FG037|Overall Study|No longer meets eligibility criteria|0|||
143492986|NCT03529773|517347044|FG038|Overall Study|No longer meets eligibility criteria|1|||
143492987|NCT03529773|517347045|FG039|Overall Study|No longer meets eligibility criteria|0|||
143492988|NCT03529773|517347006|FG000|Overall Study|Other|0|||
143492989|NCT03529773|517347007|FG001|Overall Study|Other|0|||
143492990|NCT03529773|517347008|FG002|Overall Study|Other|0|||
143492991|NCT03529773|517347009|FG003|Overall Study|Other|0|||
143492992|NCT03529773|517347010|FG004|Overall Study|Other|0|||
143492993|NCT03529773|517347011|FG005|Overall Study|Other|0|||
143492994|NCT03529773|517347012|FG006|Overall Study|Other|0|||
143492995|NCT03529773|517347013|FG007|Overall Study|Other|0|||
143492996|NCT03529773|517347014|FG008|Overall Study|Other|0|||
143492997|NCT03529773|517347015|FG009|Overall Study|Other|0|||
143492998|NCT03529773|517347016|FG010|Overall Study|Other|0|||
143492999|NCT03529773|517347017|FG011|Overall Study|Other|0|||
143493000|NCT03529773|517347018|FG012|Overall Study|Other|1|||
143030895|NCT00950807|515654666|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
143493001|NCT03529773|517347019|FG013|Overall Study|Other|0|||
143493002|NCT03529773|517347020|FG014|Overall Study|Other|2|||
143030896|NCT00950807|515654667|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
143493003|NCT03529773|517347021|FG015|Overall Study|Other|0|||
143493004|NCT03529773|517347022|FG016|Overall Study|Other|0|||
143493005|NCT03529773|517347023|FG017|Overall Study|Other|3|||
143493006|NCT03529773|517347024|FG018|Overall Study|Other|0|||
143030897|NCT00950807|515654668|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
143030898|NCT00950807|515654659|FG000|Washout Period 1|Adverse Event|2|||
143493007|NCT03529773|517347025|FG019|Overall Study|Other|0|||
143493008|NCT03529773|517347026|FG020|Overall Study|Other|1|||
143493009|NCT03529773|517347027|FG021|Overall Study|Other|0|||
143493010|NCT03529773|517347028|FG022|Overall Study|Other|1|||
143493011|NCT03529773|517347029|FG023|Overall Study|Other|0|||
143493012|NCT03529773|517347030|FG024|Overall Study|Other|3|||
143493013|NCT03529773|517347031|FG025|Overall Study|Other|2|||
143493014|NCT03529773|517347032|FG026|Overall Study|Other|2|||
143493015|NCT03529773|517347033|FG027|Overall Study|Other|0|||
143493016|NCT03529773|517347034|FG028|Overall Study|Other|0|||
143493017|NCT03529773|517347035|FG029|Overall Study|Other|0|||
143493018|NCT03529773|517347036|FG030|Overall Study|Other|0|||
143493019|NCT03529773|517347037|FG031|Overall Study|Other|0|||
143493020|NCT03529773|517347038|FG032|Overall Study|Other|0|||
143493021|NCT03529773|517347039|FG033|Overall Study|Other|0|||
143493022|NCT03529773|517347040|FG034|Overall Study|Other|1|||
143493023|NCT03529773|517347041|FG035|Overall Study|Other|1|||
143493024|NCT03529773|517347042|FG036|Overall Study|Other|0|||
143493025|NCT03529773|517347043|FG037|Overall Study|Other|0|||
143493026|NCT03529773|517347044|FG038|Overall Study|Other|0|||
143493027|NCT03529773|517347045|FG039|Overall Study|Other|0|||
143493028|NCT03529773|517347006|FG000|Overall Study|Physician Decision|0|||
143493029|NCT03529773|517347007|FG001|Overall Study|Physician Decision|0|||
143493030|NCT03529773|517347008|FG002|Overall Study|Physician Decision|0|||
143493031|NCT03529773|517347009|FG003|Overall Study|Physician Decision|0|||
143493032|NCT03529773|517347010|FG004|Overall Study|Physician Decision|0|||
143493033|NCT03529773|517347011|FG005|Overall Study|Physician Decision|0|||
143493034|NCT03529773|517347012|FG006|Overall Study|Physician Decision|0|||
143493035|NCT03529773|517347013|FG007|Overall Study|Physician Decision|0|||
143493036|NCT03529773|517347014|FG008|Overall Study|Physician Decision|0|||
143493037|NCT03529773|517347015|FG009|Overall Study|Physician Decision|0|||
143493038|NCT03529773|517347016|FG010|Overall Study|Physician Decision|0|||
143493039|NCT03529773|517347017|FG011|Overall Study|Physician Decision|0|||
143493040|NCT03529773|517347018|FG012|Overall Study|Physician Decision|0|||
143493041|NCT03529773|517347019|FG013|Overall Study|Physician Decision|0|||
143493042|NCT03529773|517347020|FG014|Overall Study|Physician Decision|0|||
143493043|NCT03529773|517347021|FG015|Overall Study|Physician Decision|0|||
143493044|NCT03529773|517347022|FG016|Overall Study|Physician Decision|0|||
143493045|NCT03529773|517347023|FG017|Overall Study|Physician Decision|0|||
143493046|NCT03529773|517347024|FG018|Overall Study|Physician Decision|0|||
143493047|NCT03529773|517347025|FG019|Overall Study|Physician Decision|1|||
143493048|NCT03529773|517347026|FG020|Overall Study|Physician Decision|1|||
143493049|NCT03529773|517347027|FG021|Overall Study|Physician Decision|0|||
143493050|NCT03529773|517347028|FG022|Overall Study|Physician Decision|0|||
143493051|NCT03529773|517347029|FG023|Overall Study|Physician Decision|0|||
143493052|NCT03529773|517347030|FG024|Overall Study|Physician Decision|0|||
143493053|NCT03529773|517347031|FG025|Overall Study|Physician Decision|0|||
143493054|NCT03529773|517347032|FG026|Overall Study|Physician Decision|0|||
143493055|NCT03529773|517347033|FG027|Overall Study|Physician Decision|0|||
143493056|NCT03529773|517347034|FG028|Overall Study|Physician Decision|0|||
143493057|NCT03529773|517347035|FG029|Overall Study|Physician Decision|0|||
143493058|NCT03529773|517347036|FG030|Overall Study|Physician Decision|0|||
143493059|NCT03529773|517347037|FG031|Overall Study|Physician Decision|0|||
143493060|NCT03529773|517347038|FG032|Overall Study|Physician Decision|0|||
143493061|NCT03529773|517347039|FG033|Overall Study|Physician Decision|0|||
143493062|NCT03529773|517347040|FG034|Overall Study|Physician Decision|0|||
143493063|NCT03529773|517347041|FG035|Overall Study|Physician Decision|0|||
143493064|NCT03529773|517347042|FG036|Overall Study|Physician Decision|0|||
143493065|NCT03529773|517347043|FG037|Overall Study|Physician Decision|0|||
143493066|NCT03529773|517347044|FG038|Overall Study|Physician Decision|0|||
143493067|NCT03529773|517347045|FG039|Overall Study|Physician Decision|0|||
143493068|NCT03529773|517347006|FG000|Overall Study|Protocol Violation|0|||
143493069|NCT03529773|517347007|FG001|Overall Study|Protocol Violation|0|||
143493070|NCT03529773|517347008|FG002|Overall Study|Protocol Violation|0|||
143493071|NCT03529773|517347009|FG003|Overall Study|Protocol Violation|0|||
143493072|NCT03529773|517347010|FG004|Overall Study|Protocol Violation|0|||
143493073|NCT03529773|517347011|FG005|Overall Study|Protocol Violation|0|||
143493074|NCT03529773|517347012|FG006|Overall Study|Protocol Violation|0|||
143493075|NCT03529773|517347013|FG007|Overall Study|Protocol Violation|0|||
143493076|NCT03529773|517347014|FG008|Overall Study|Protocol Violation|0|||
143493077|NCT03529773|517347015|FG009|Overall Study|Protocol Violation|0|||
143493078|NCT03529773|517347016|FG010|Overall Study|Protocol Violation|0|||
143493079|NCT03529773|517347017|FG011|Overall Study|Protocol Violation|0|||
143493080|NCT03529773|517347018|FG012|Overall Study|Protocol Violation|0|||
143493081|NCT03529773|517347019|FG013|Overall Study|Protocol Violation|0|||
143493082|NCT03529773|517347020|FG014|Overall Study|Protocol Violation|0|||
143493083|NCT03529773|517347021|FG015|Overall Study|Protocol Violation|0|||
143493084|NCT03529773|517347022|FG016|Overall Study|Protocol Violation|0|||
143493085|NCT03529773|517347023|FG017|Overall Study|Protocol Violation|0|||
143493086|NCT03529773|517347024|FG018|Overall Study|Protocol Violation|0|||
143493087|NCT03529773|517347025|FG019|Overall Study|Protocol Violation|0|||
143493088|NCT03529773|517347026|FG020|Overall Study|Protocol Violation|0|||
143493089|NCT03529773|517347027|FG021|Overall Study|Protocol Violation|0|||
143493090|NCT03529773|517347028|FG022|Overall Study|Protocol Violation|0|||
143493091|NCT03529773|517347029|FG023|Overall Study|Protocol Violation|0|||
143493092|NCT03529773|517347030|FG024|Overall Study|Protocol Violation|0|||
143493093|NCT03529773|517347031|FG025|Overall Study|Protocol Violation|0|||
143493094|NCT03529773|517347032|FG026|Overall Study|Protocol Violation|0|||
143493095|NCT03529773|517347033|FG027|Overall Study|Protocol Violation|0|||
143493096|NCT03529773|517347034|FG028|Overall Study|Protocol Violation|0|||
143493097|NCT03529773|517347035|FG029|Overall Study|Protocol Violation|0|||
143493098|NCT03529773|517347036|FG030|Overall Study|Protocol Violation|1|||
143493099|NCT03529773|517347037|FG031|Overall Study|Protocol Violation|0|||
143493100|NCT03529773|517347038|FG032|Overall Study|Protocol Violation|0|||
143493101|NCT03529773|517347039|FG033|Overall Study|Protocol Violation|0|||
143493102|NCT03529773|517347040|FG034|Overall Study|Protocol Violation|0|||
143493103|NCT03529773|517347041|FG035|Overall Study|Protocol Violation|0|||
143493104|NCT03529773|517347042|FG036|Overall Study|Protocol Violation|0|||
143493105|NCT03529773|517347043|FG037|Overall Study|Protocol Violation|0|||
143493106|NCT03529773|517347044|FG038|Overall Study|Protocol Violation|0|||
143493107|NCT03529773|517347045|FG039|Overall Study|Protocol Violation|0|||
143493108|NCT03529773|517347006|FG000|Overall Study|Withdrawal by Subject|0|||
143493109|NCT03529773|517347007|FG001|Overall Study|Withdrawal by Subject|0|||
143493110|NCT03529773|517347008|FG002|Overall Study|Withdrawal by Subject|0|||
143493111|NCT03529773|517347009|FG003|Overall Study|Withdrawal by Subject|0|||
143493112|NCT03529773|517347010|FG004|Overall Study|Withdrawal by Subject|0|||
143493113|NCT03529773|517347011|FG005|Overall Study|Withdrawal by Subject|0|||
143030899|NCT00950807|515654660|FG001|Washout Period 1|Adverse Event|0|||
143030900|NCT00950807|515654661|FG002|Washout Period 1|Adverse Event|0|||
143030901|NCT00950807|515654662|FG003|Washout Period 1|Adverse Event|1|||
143030902|NCT00950807|515654663|FG004|Washout Period 1|Adverse Event|1|||
143030903|NCT00950807|515654664|FG005|Washout Period 1|Adverse Event|0|||
143030904|NCT00950807|515654665|FG006|Washout Period 1|Adverse Event|0|||
143030905|NCT00950807|515654666|FG007|Washout Period 1|Adverse Event|0|||
143030906|NCT00950807|515654667|FG008|Washout Period 1|Adverse Event|0|||
143030907|NCT00950807|515654668|FG009|Washout Period 1|Adverse Event|0|||
143030908|NCT00950807|515654659|FG000|Treatment Period 2|Lack of Efficacy|1|||
143030909|NCT00950807|515654660|FG001|Treatment Period 2|Lack of Efficacy|0|||
143030910|NCT00950807|515654661|FG002|Treatment Period 2|Lack of Efficacy|0|||
143030911|NCT00950807|515654662|FG003|Treatment Period 2|Lack of Efficacy|0|||
143030912|NCT00950807|515654663|FG004|Treatment Period 2|Lack of Efficacy|0|||
143030913|NCT00950807|515654664|FG005|Treatment Period 2|Lack of Efficacy|0|||
143030914|NCT00950807|515654665|FG006|Treatment Period 2|Lack of Efficacy|0|||
143030915|NCT00950807|515654666|FG007|Treatment Period 2|Lack of Efficacy|0|||
143030916|NCT00950807|515654667|FG008|Treatment Period 2|Lack of Efficacy|0|||
143030917|NCT00950807|515654668|FG009|Treatment Period 2|Lack of Efficacy|0|||
143030918|NCT00950807|515654659|FG000|Treatment Period 2|Withdrawal by Subject|0|||
143030919|NCT00950807|515654660|FG001|Treatment Period 2|Withdrawal by Subject|0|||
143030920|NCT00950807|515654661|FG002|Treatment Period 2|Withdrawal by Subject|0|||
143030921|NCT00950807|515654662|FG003|Treatment Period 2|Withdrawal by Subject|0|||
143030922|NCT00950807|515654663|FG004|Treatment Period 2|Withdrawal by Subject|0|||
143030923|NCT00950807|515654664|FG005|Treatment Period 2|Withdrawal by Subject|0|||
143030924|NCT00950807|515654665|FG006|Treatment Period 2|Withdrawal by Subject|1|||
143030925|NCT00950807|515654666|FG007|Treatment Period 2|Withdrawal by Subject|2|||
143030926|NCT00950807|515654667|FG008|Treatment Period 2|Withdrawal by Subject|0|||
143030927|NCT00950807|515654668|FG009|Treatment Period 2|Withdrawal by Subject|0|||
143158847|NCT01028391|516126122|FG001|Overall Study|Needed excluded medication|1|||
143158848|NCT00694161|516126123|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
143493114|NCT03529773|517347012|FG006|Overall Study|Withdrawal by Subject|0|||
143493115|NCT03529773|517347013|FG007|Overall Study|Withdrawal by Subject|1|||
143493116|NCT03529773|517347014|FG008|Overall Study|Withdrawal by Subject|0|||
143493117|NCT03529773|517347015|FG009|Overall Study|Withdrawal by Subject|1|||
143493118|NCT03529773|517347016|FG010|Overall Study|Withdrawal by Subject|1|||
143493119|NCT03529773|517347017|FG011|Overall Study|Withdrawal by Subject|0|||
143493120|NCT03529773|517347018|FG012|Overall Study|Withdrawal by Subject|0|||
143030928|NCT00950807|515654659|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
143030929|NCT00950807|515654660|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
143030930|NCT00950807|515654661|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
143158849|NCT00694161|516126123|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
143158850|NCT00694161|516126123|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
143158851|NCT03601052|516126124|FG000|Overall Study|Lost to Follow-up|2|||
143493121|NCT03529773|517347019|FG013|Overall Study|Withdrawal by Subject|0|||
143493122|NCT03529773|517347020|FG014|Overall Study|Withdrawal by Subject|0|||
143493123|NCT03529773|517347021|FG015|Overall Study|Withdrawal by Subject|3|||
143030931|NCT00950807|515654662|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
143030932|NCT00950807|515654663|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
143493124|NCT03529773|517347022|FG016|Overall Study|Withdrawal by Subject|0|||
143493125|NCT03529773|517347023|FG017|Overall Study|Withdrawal by Subject|2|||
143493126|NCT03529773|517347024|FG018|Overall Study|Withdrawal by Subject|3|||
143493127|NCT03529773|517347025|FG019|Overall Study|Withdrawal by Subject|1|||
143493128|NCT03529773|517347026|FG020|Overall Study|Withdrawal by Subject|3|||
143493129|NCT03529773|517347027|FG021|Overall Study|Withdrawal by Subject|1|||
143493130|NCT03529773|517347028|FG022|Overall Study|Withdrawal by Subject|1|||
143493131|NCT03529773|517347029|FG023|Overall Study|Withdrawal by Subject|2|||
143493132|NCT03529773|517347030|FG024|Overall Study|Withdrawal by Subject|2|||
143493133|NCT03529773|517347031|FG025|Overall Study|Withdrawal by Subject|4|||
143493134|NCT03529773|517347032|FG026|Overall Study|Withdrawal by Subject|2|||
143493135|NCT03529773|517347033|FG027|Overall Study|Withdrawal by Subject|1|||
143493136|NCT03529773|517347034|FG028|Overall Study|Withdrawal by Subject|1|||
143493137|NCT03529773|517347035|FG029|Overall Study|Withdrawal by Subject|0|||
143493138|NCT03529773|517347036|FG030|Overall Study|Withdrawal by Subject|0|||
143493139|NCT03529773|517347037|FG031|Overall Study|Withdrawal by Subject|0|||
143493140|NCT03529773|517347038|FG032|Overall Study|Withdrawal by Subject|0|||
143493141|NCT03529773|517347039|FG033|Overall Study|Withdrawal by Subject|0|||
143493142|NCT03529773|517347040|FG034|Overall Study|Withdrawal by Subject|1|||
143493143|NCT03529773|517347041|FG035|Overall Study|Withdrawal by Subject|2|||
143493144|NCT03529773|517347042|FG036|Overall Study|Withdrawal by Subject|0|||
143493145|NCT03529773|517347043|FG037|Overall Study|Withdrawal by Subject|2|||
143493146|NCT03529773|517347044|FG038|Overall Study|Withdrawal by Subject|1|||
143493147|NCT03529773|517347045|FG039|Overall Study|Withdrawal by Subject|1|||
143493148|NCT03529773|517347006|FG000|Overall Study|Screen Failure|0|||
143493149|NCT03529773|517347007|FG001|Overall Study|Screen Failure|0|||
143493150|NCT03529773|517347008|FG002|Overall Study|Screen Failure|0|||
143493151|NCT03529773|517347009|FG003|Overall Study|Screen Failure|0|||
143493152|NCT03529773|517347010|FG004|Overall Study|Screen Failure|0|||
143493153|NCT03529773|517347011|FG005|Overall Study|Screen Failure|0|||
143493154|NCT03529773|517347012|FG006|Overall Study|Screen Failure|0|||
143493155|NCT03529773|517347013|FG007|Overall Study|Screen Failure|0|||
143493156|NCT03529773|517347014|FG008|Overall Study|Screen Failure|0|||
143493157|NCT03529773|517347015|FG009|Overall Study|Screen Failure|0|||
143493158|NCT03529773|517347016|FG010|Overall Study|Screen Failure|0|||
143493159|NCT03529773|517347017|FG011|Overall Study|Screen Failure|0|||
143493160|NCT03529773|517347018|FG012|Overall Study|Screen Failure|0|||
143493161|NCT03529773|517347019|FG013|Overall Study|Screen Failure|0|||
143493162|NCT03529773|517347020|FG014|Overall Study|Screen Failure|0|||
143493163|NCT03529773|517347021|FG015|Overall Study|Screen Failure|0|||
143493164|NCT03529773|517347022|FG016|Overall Study|Screen Failure|0|||
143493165|NCT03529773|517347023|FG017|Overall Study|Screen Failure|0|||
143493166|NCT03529773|517347024|FG018|Overall Study|Screen Failure|0|||
143493167|NCT03529773|517347025|FG019|Overall Study|Screen Failure|0|||
143493168|NCT03529773|517347026|FG020|Overall Study|Screen Failure|0|||
143493169|NCT03529773|517347027|FG021|Overall Study|Screen Failure|0|||
143493170|NCT03529773|517347028|FG022|Overall Study|Screen Failure|0|||
143493171|NCT03529773|517347029|FG023|Overall Study|Screen Failure|0|||
143493172|NCT03529773|517347030|FG024|Overall Study|Screen Failure|0|||
143493173|NCT03529773|517347031|FG025|Overall Study|Screen Failure|0|||
143493174|NCT03529773|517347032|FG026|Overall Study|Screen Failure|0|||
143493175|NCT03529773|517347033|FG027|Overall Study|Screen Failure|0|||
143493176|NCT03529773|517347034|FG028|Overall Study|Screen Failure|0|||
143493177|NCT03529773|517347035|FG029|Overall Study|Screen Failure|0|||
143493178|NCT03529773|517347036|FG030|Overall Study|Screen Failure|0|||
143493179|NCT03529773|517347037|FG031|Overall Study|Screen Failure|0|||
143493180|NCT03529773|517347038|FG032|Overall Study|Screen Failure|0|||
143493181|NCT03529773|517347039|FG033|Overall Study|Screen Failure|0|||
143493182|NCT03529773|517347040|FG034|Overall Study|Screen Failure|0|||
143493183|NCT03529773|517347041|FG035|Overall Study|Screen Failure|0|||
143493184|NCT03529773|517347042|FG036|Overall Study|Screen Failure|1|||
143237542|NCT00307801|516423370|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
143237543|NCT00307801|516423369|FG000|Overall Study|Wrong Randomization|1|||
143493185|NCT03529773|517347043|FG037|Overall Study|Screen Failure|1|||
143493186|NCT03529773|517347044|FG038|Overall Study|Screen Failure|0|||
143493187|NCT03529773|517347045|FG039|Overall Study|Screen Failure|1|||
143493188|NCT03529773|517347006|FG000|Overall Study|Randomized but not vaccinated|0|||
143493189|NCT03529773|517347007|FG001|Overall Study|Randomized but not vaccinated|0|||
143493190|NCT03529773|517347008|FG002|Overall Study|Randomized but not vaccinated|0|||
143493191|NCT03529773|517347009|FG003|Overall Study|Randomized but not vaccinated|0|||
143493192|NCT03529773|517347010|FG004|Overall Study|Randomized but not vaccinated|0|||
143493193|NCT03529773|517347011|FG005|Overall Study|Randomized but not vaccinated|0|||
143493194|NCT03529773|517347012|FG006|Overall Study|Randomized but not vaccinated|0|||
143493195|NCT03529773|517347013|FG007|Overall Study|Randomized but not vaccinated|0|||
143493196|NCT03529773|517347014|FG008|Overall Study|Randomized but not vaccinated|0|||
143493197|NCT03529773|517347015|FG009|Overall Study|Randomized but not vaccinated|0|||
143493198|NCT03529773|517347016|FG010|Overall Study|Randomized but not vaccinated|0|||
143493199|NCT03529773|517347017|FG011|Overall Study|Randomized but not vaccinated|0|||
143493200|NCT03529773|517347018|FG012|Overall Study|Randomized but not vaccinated|0|||
143493201|NCT03529773|517347019|FG013|Overall Study|Randomized but not vaccinated|0|||
143030933|NCT00950807|515654664|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
143030934|NCT00950807|515654665|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
143493202|NCT03529773|517347020|FG014|Overall Study|Randomized but not vaccinated|0|||
143493203|NCT03529773|517347021|FG015|Overall Study|Randomized but not vaccinated|0|||
143030935|NCT00950807|515654666|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
143030936|NCT00950807|515654667|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
143030937|NCT00950807|515654668|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
143493204|NCT03529773|517347022|FG016|Overall Study|Randomized but not vaccinated|0|||
143493205|NCT03529773|517347023|FG017|Overall Study|Randomized but not vaccinated|1|||
143493206|NCT03529773|517347024|FG018|Overall Study|Randomized but not vaccinated|0|||
143493207|NCT03529773|517347025|FG019|Overall Study|Randomized but not vaccinated|0|||
143493208|NCT03529773|517347026|FG020|Overall Study|Randomized but not vaccinated|0|||
143493209|NCT03529773|517347027|FG021|Overall Study|Randomized but not vaccinated|0|||
143493210|NCT03529773|517347028|FG022|Overall Study|Randomized but not vaccinated|0|||
143493211|NCT03529773|517347029|FG023|Overall Study|Randomized but not vaccinated|0|||
143493212|NCT03529773|517347030|FG024|Overall Study|Randomized but not vaccinated|0|||
143493213|NCT03529773|517347031|FG025|Overall Study|Randomized but not vaccinated|0|||
143493214|NCT03529773|517347032|FG026|Overall Study|Randomized but not vaccinated|0|||
143493215|NCT03529773|517347033|FG027|Overall Study|Randomized but not vaccinated|1|||
143493216|NCT03529773|517347034|FG028|Overall Study|Randomized but not vaccinated|0|||
143493217|NCT03529773|517347035|FG029|Overall Study|Randomized but not vaccinated|0|||
143493218|NCT03529773|517347036|FG030|Overall Study|Randomized but not vaccinated|0|||
143493219|NCT03529773|517347037|FG031|Overall Study|Randomized but not vaccinated|0|||
143493220|NCT03529773|517347038|FG032|Overall Study|Randomized but not vaccinated|0|||
143493221|NCT03529773|517347039|FG033|Overall Study|Randomized but not vaccinated|0|||
143493222|NCT03529773|517347040|FG034|Overall Study|Randomized but not vaccinated|0|||
143493223|NCT03529773|517347041|FG035|Overall Study|Randomized but not vaccinated|0|||
143493224|NCT03529773|517347042|FG036|Overall Study|Randomized but not vaccinated|0|||
143493225|NCT03529773|517347043|FG037|Overall Study|Randomized but not vaccinated|0|||
143493226|NCT03529773|517347044|FG038|Overall Study|Randomized but not vaccinated|0|||
143493227|NCT03529773|517347045|FG039|Overall Study|Randomized but not vaccinated|0|||
143493228|NCT01496066|517347046|FG000|Overall Study|Lost to Follow-up|8|||
143493229|NCT01496066|517347047|FG001|Overall Study|Lost to Follow-up|5|||
143493230|NCT01496066|517347046|FG000|Overall Study|Explant|3|||
143493231|NCT01496066|517347047|FG001|Overall Study|Explant|0|||
143493232|NCT01496066|517347046|FG000|Overall Study|Death|1|||
143493233|NCT01496066|517347047|FG001|Overall Study|Death|4|||
143493234|NCT00209339|517347048|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
143493235|NCT00209339|517347048|FG000|At 12 Months Follow-up|Death|1|||
143493236|NCT00209339|517347048|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
143493237|NCT00209339|517347048|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
143493238|NCT00209339|517347048|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
143493239|NCT00209339|517347048|FG000|At 24 Months Follow-up|Death|1|||
143493240|NCT00209339|517347048|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
143493241|NCT00209339|517347048|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
143030938|NCT00950807|515654659|FG000|Treatment Period 2|Adverse Event|0|||
143030939|NCT00950807|515654660|FG001|Treatment Period 2|Adverse Event|1|||
143030940|NCT00950807|515654661|FG002|Treatment Period 2|Adverse Event|0|||
143030941|NCT00950807|515654662|FG003|Treatment Period 2|Adverse Event|1|||
143030942|NCT00950807|515654663|FG004|Treatment Period 2|Adverse Event|0|||
143030943|NCT00950807|515654664|FG005|Treatment Period 2|Adverse Event|1|||
143030944|NCT00950807|515654665|FG006|Treatment Period 2|Adverse Event|0|||
143493242|NCT00209339|517347048|FG000|At 4 Years Follow-up|Death|1|||
143493243|NCT00209339|517347048|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
143030945|NCT00950807|515654666|FG007|Treatment Period 2|Adverse Event|1|||
143030946|NCT00950807|515654667|FG008|Treatment Period 2|Adverse Event|0|||
143030947|NCT00950807|515654668|FG009|Treatment Period 2|Adverse Event|0|||
143030948|NCT00950807|515654659|FG000|Washout Period 2|Lack of Efficacy|1|||
143030949|NCT00950807|515654660|FG001|Washout Period 2|Lack of Efficacy|0|||
143030950|NCT00950807|515654661|FG002|Washout Period 2|Lack of Efficacy|0|||
143030951|NCT00950807|515654662|FG003|Washout Period 2|Lack of Efficacy|0|||
143030952|NCT00950807|515654663|FG004|Washout Period 2|Lack of Efficacy|0|||
143493244|NCT00209339|517347048|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
143030953|NCT00950807|515654664|FG005|Washout Period 2|Lack of Efficacy|0|||
143030954|NCT00950807|515654665|FG006|Washout Period 2|Lack of Efficacy|0|||
143030955|NCT00950807|515654666|FG007|Washout Period 2|Lack of Efficacy|0|||
143493245|NCT00209339|517347048|FG000|At 5 Years Follow-up|Death|1|||
143493246|NCT00429858|517347049|FG000|Overall Study|Withdrawal by Subject|1|||
143493247|NCT00429858|517347049|FG000|Overall Study|Study Termination|1|||
143030956|NCT00950807|515654667|FG008|Washout Period 2|Lack of Efficacy|0|||
143030957|NCT00950807|515654668|FG009|Washout Period 2|Lack of Efficacy|0|||
143158852|NCT00837330|516126125|FG000|Overall Study|Lost to Follow-up|1|||
143158853|NCT00837330|516126126|FG001|Overall Study|Lost to Follow-up|3|||
143158854|NCT00694122|516126127|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
143493248|NCT01587079|517347050|FG000|Overall Study|Protocol-specified criteria|9|||
143493249|NCT01587079|517347050|FG000|Overall Study|Protocol Violation|5|||
143493250|NCT01587079|517347050|FG000|Overall Study|Lost to Follow-up|2|||
143493251|NCT01587079|517347050|FG000|Overall Study|Physician Decision|2|||
143493252|NCT01587079|517347050|FG000|Overall Study|Withdrawal by Subject|7|||
143493253|NCT01587079|517347050|FG000|Overall Study|Adverse Event|14|||
143493254|NCT02268058|517347052|FG000|Overall Study|Protocol Violation|1|||
143493255|NCT02268058|517347053|FG001|Overall Study|Protocol Violation|0|||
143493256|NCT02268058|517347054|FG002|Overall Study|Protocol Violation|0|||
143493257|NCT02268058|517347055|FG003|Overall Study|Protocol Violation|0|||
143493258|NCT04142983|517347056|FG000|Overall Study|Lost to Follow-up|73|||
143493259|NCT04142983|517347056|FG000|Overall Study|Withdrawal by Subject|10|||
143493260|NCT04142983|517347056|FG000|Overall Study|Physician Decision|1|||
143493261|NCT04142983|517347056|FG000|Overall Study|Adverse Event|1|||
143493262|NCT04142983|517347056|FG000|Overall Study|No longer eligible|4|||
143493263|NCT04142983|517347056|FG000|Overall Study|Screen Failure|10|||
143493264|NCT01789970|517347058|FG000|Open-label Titration Period|Adverse Event|68|||
143493265|NCT01789970|517347059|FG001|Open-label Titration Period|Adverse Event|0|||
143493266|NCT01789970|517347060|FG002|Open-label Titration Period|Adverse Event|0|||
143493267|NCT01789970|517347058|FG000|Open-label Titration Period|Lack of Efficacy|31|||
143493268|NCT01789970|517347059|FG001|Open-label Titration Period|Lack of Efficacy|0|||
143493269|NCT01789970|517347060|FG002|Open-label Titration Period|Lack of Efficacy|0|||
143493270|NCT01789970|517347058|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
143493271|NCT01789970|517347059|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
143493272|NCT01789970|517347060|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
143493273|NCT01789970|517347058|FG000|Open-label Titration Period|Protocol Violation|18|||
143493274|NCT01789970|517347059|FG001|Open-label Titration Period|Protocol Violation|0|||
143493275|NCT01789970|517347060|FG002|Open-label Titration Period|Protocol Violation|0|||
143493276|NCT01789970|517347058|FG000|Open-label Titration Period|Lost to Follow-up|5|||
143493277|NCT01789970|517347059|FG001|Open-label Titration Period|Lost to Follow-up|0|||
143493278|NCT01789970|517347060|FG002|Open-label Titration Period|Lost to Follow-up|0|||
143030958|NCT00950807|515654659|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
143030959|NCT00950807|515654660|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
143030960|NCT00950807|515654661|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
143030961|NCT00950807|515654662|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
143030962|NCT00950807|515654663|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
143030963|NCT00950807|515654664|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
143030964|NCT00950807|515654665|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
143030965|NCT00950807|515654666|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
143030966|NCT00950807|515654667|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
143030967|NCT00950807|515654668|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
143030968|NCT00950807|515654659|FG000|Washout Period 2|Adverse Event|3|||
143030969|NCT00950807|515654660|FG001|Washout Period 2|Adverse Event|0|||
143030970|NCT00950807|515654661|FG002|Washout Period 2|Adverse Event|0|||
143030971|NCT00950807|515654662|FG003|Washout Period 2|Adverse Event|1|||
143030972|NCT00950807|515654663|FG004|Washout Period 2|Adverse Event|0|||
143030973|NCT00950807|515654664|FG005|Washout Period 2|Adverse Event|0|||
143030974|NCT00950807|515654665|FG006|Washout Period 2|Adverse Event|0|||
143030975|NCT00950807|515654666|FG007|Washout Period 2|Adverse Event|0|||
143030976|NCT00950807|515654667|FG008|Washout Period 2|Adverse Event|0|||
143030977|NCT00950807|515654668|FG009|Washout Period 2|Adverse Event|0|||
143030978|NCT00950807|515654659|FG000|Treatment Period 3|Withdrawal by Subject|0|||
143030979|NCT00950807|515654660|FG001|Treatment Period 3|Withdrawal by Subject|0|||
143030980|NCT00950807|515654661|FG002|Treatment Period 3|Withdrawal by Subject|0|||
143030981|NCT00950807|515654662|FG003|Treatment Period 3|Withdrawal by Subject|0|||
143030982|NCT00950807|515654663|FG004|Treatment Period 3|Withdrawal by Subject|0|||
143030983|NCT00950807|515654664|FG005|Treatment Period 3|Withdrawal by Subject|0|||
143030984|NCT00950807|515654665|FG006|Treatment Period 3|Withdrawal by Subject|0|||
143030985|NCT00950807|515654666|FG007|Treatment Period 3|Withdrawal by Subject|0|||
143493279|NCT01789970|517347058|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
143493280|NCT01789970|517347059|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
143493281|NCT01789970|517347060|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
143493282|NCT01789970|517347058|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
143364025|NCT00293462|516875527|FG002|Overall Study|Withdrawal by Subject|8|||
143493283|NCT01789970|517347059|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
143493284|NCT01789970|517347060|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
143493285|NCT01789970|517347058|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
143493286|NCT01789970|517347059|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
143030986|NCT00950807|515654667|FG008|Treatment Period 3|Withdrawal by Subject|0|||
143030987|NCT00950807|515654668|FG009|Treatment Period 3|Withdrawal by Subject|1|||
143030988|NCT00950807|515654659|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
143237544|NCT00307801|516423370|FG001|Overall Study|Wrong Randomization|0|||
143364026|NCT00293462|516875525|FG000|Overall Study|Death|1|||
143030989|NCT00950807|515654660|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
143030990|NCT00950807|515654661|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
143030991|NCT00950807|515654662|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
143030992|NCT00950807|515654663|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
143030993|NCT00950807|515654664|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
143030994|NCT00950807|515654665|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
143030995|NCT00950807|515654666|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
143030996|NCT00950807|515654667|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
143030997|NCT00950807|515654668|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
143030998|NCT00950807|515654659|FG000|Treatment Period 3|Adverse Event|0|||
143030999|NCT00950807|515654660|FG001|Treatment Period 3|Adverse Event|0|||
143237545|NCT00307801|516423369|FG000|Overall Study|Lack of Efficacy|0|||
143237546|NCT00307801|516423370|FG001|Overall Study|Lack of Efficacy|2|||
143237547|NCT00307801|516423369|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
143237548|NCT00307801|516423370|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
143493287|NCT01789970|517347060|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
143493288|NCT01789970|517347058|FG000|Open-label Titration Period|Pregnancy|2|||
143493289|NCT01789970|517347059|FG001|Open-label Titration Period|Pregnancy|0|||
143493290|NCT01789970|517347060|FG002|Open-label Titration Period|Pregnancy|0|||
143493291|NCT01789970|517347058|FG000|Open-label Titration Period|Other|76|||
143493292|NCT01789970|517347059|FG001|Open-label Titration Period|Other|0|||
143493293|NCT01789970|517347060|FG002|Open-label Titration Period|Other|0|||
143493294|NCT01789970|517347058|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
143493295|NCT01789970|517347059|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
143493296|NCT01789970|517347060|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
143493297|NCT01789970|517347058|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
143493298|NCT01789970|517347059|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
143493299|NCT01789970|517347060|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
143237549|NCT00307801|516423369|FG000|Overall Study|Frustration with e-diary|1|||
143364027|NCT00293462|516875526|FG001|Overall Study|Death|0|||
143493300|NCT01789970|517347058|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
143493301|NCT01789970|517347059|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
143493302|NCT01789970|517347060|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
143493303|NCT01789970|517347058|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
143493304|NCT01789970|517347059|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
143493305|NCT01789970|517347060|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
143493306|NCT01789970|517347058|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
143493307|NCT01789970|517347059|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
143493308|NCT01789970|517347060|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
143493309|NCT01789970|517347058|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
143493310|NCT01789970|517347059|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
143493311|NCT01789970|517347060|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
143493312|NCT01789970|517347058|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
143493313|NCT01789970|517347059|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
143493314|NCT01789970|517347060|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
143158855|NCT00694122|516126128|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
143158856|NCT00694122|516126127|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
143158857|NCT00694122|516126128|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
143158858|NCT00694122|516126127|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
143158859|NCT00694122|516126128|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
143158860|NCT00086307|516126129|FG000|Overall Study|Lack of Efficacy|1|||
143158861|NCT00086307|516126130|FG001|Overall Study|Lack of Efficacy|1|||
143158862|NCT00086307|516126131|FG002|Overall Study|Lack of Efficacy|2|||
143158863|NCT00086307|516126129|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
143158864|NCT00086307|516126130|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
143158865|NCT00086307|516126131|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
143158866|NCT00086307|516126129|FG000|Overall Study|Nausea and headaches|0|||
143158867|NCT00086307|516126130|FG001|Overall Study|Nausea and headaches|0|||
143158868|NCT00086307|516126131|FG002|Overall Study|Nausea and headaches|1|||
143158869|NCT00086307|516126129|FG000|Overall Study|Constipation and sleepiness|0|||
143158870|NCT00086307|516126130|FG001|Overall Study|Constipation and sleepiness|0|||
143158871|NCT00086307|516126131|FG002|Overall Study|Constipation and sleepiness|1|||
143158872|NCT00086307|516126129|FG000|Overall Study|Suicidal ideation|0|||
143158873|NCT00086307|516126130|FG001|Overall Study|Suicidal ideation|0|||
143158874|NCT00086307|516126131|FG002|Overall Study|Suicidal ideation|1|||
143237550|NCT00307801|516423370|FG001|Overall Study|Frustration with e-diary|0|||
143237551|NCT00307801|516423369|FG000|Overall Study|Protocol Violation|3|||
143237552|NCT00307801|516423370|FG001|Overall Study|Protocol Violation|2|||
143493315|NCT01789970|517347058|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
143493316|NCT01789970|517347059|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
143493317|NCT01789970|517347060|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
143493318|NCT01789970|517347058|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
143493319|NCT01789970|517347059|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
143493320|NCT01789970|517347060|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
143493321|NCT01789970|517347058|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
143493322|NCT01789970|517347059|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
143493323|NCT01789970|517347060|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
143493324|NCT01789970|517347058|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
143493325|NCT01789970|517347059|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
143493326|NCT01789970|517347060|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
143493327|NCT02475655|517347061|FG000|Overall Study|Lost to Follow-up|0|||
143493328|NCT02475655|517347062|FG001|Overall Study|Lost to Follow-up|1|||
143493329|NCT00643994|517347064|FG000|Overall Study|Death|24|||
143493330|NCT00643994|517347064|FG000|Overall Study|Lost to Follow-up|72|||
143493331|NCT00411554|517347073|FG000|Overall Study|Adverse Event|2|||
143493332|NCT00411554|517347074|FG001|Overall Study|Adverse Event|4|||
143493333|NCT00411554|517347073|FG000|Overall Study|Lack of Efficacy|2|||
143493334|NCT00411554|517347074|FG001|Overall Study|Lack of Efficacy|5|||
143493335|NCT00411554|517347073|FG000|Overall Study|Withdrawal by Subject|3|||
143493336|NCT00411554|517347074|FG001|Overall Study|Withdrawal by Subject|0|||
143493337|NCT00411554|517347073|FG000|Overall Study|Patient Moved|1|||
143493338|NCT00411554|517347074|FG001|Overall Study|Patient Moved|0|||
143493339|NCT00699907|517347079|FG000|Overall Study|Withdrawal by Subject|2|||
143493340|NCT00699907|517347080|FG001|Overall Study|Withdrawal by Subject|1|||
143493341|NCT00699907|517347081|FG002|Overall Study|Withdrawal by Subject|0|||
143493342|NCT00699907|517347079|FG000|Overall Study|No usable sample|0|||
143493343|NCT00699907|517347080|FG001|Overall Study|No usable sample|9|||
143493344|NCT00699907|517347081|FG002|Overall Study|No usable sample|8|||
143493345|NCT00430508|517347083|FG000|Overall Study|Adverse Event|2|||
143493346|NCT00430508|517347084|FG001|Overall Study|Adverse Event|3|||
143493347|NCT00430508|517347085|FG002|Overall Study|Adverse Event|5|||
143493348|NCT00430508|517347086|FG003|Overall Study|Adverse Event|3|||
143493349|NCT00430508|517347083|FG000|Overall Study|Withdrawal by Subject|0|||
143493350|NCT00430508|517347084|FG001|Overall Study|Withdrawal by Subject|1|||
143493351|NCT00430508|517347085|FG002|Overall Study|Withdrawal by Subject|1|||
143493352|NCT00430508|517347086|FG003|Overall Study|Withdrawal by Subject|1|||
143493353|NCT00430508|517347083|FG000|Overall Study|responder at visit 4|0|||
143493354|NCT00430508|517347084|FG001|Overall Study|responder at visit 4|0|||
143493355|NCT00430508|517347085|FG002|Overall Study|responder at visit 4|2|||
143493356|NCT00430508|517347086|FG003|Overall Study|responder at visit 4|0|||
143493357|NCT00430508|517347083|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
143493358|NCT00430508|517347084|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
143493359|NCT00430508|517347085|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
143493360|NCT00430508|517347086|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
143493361|NCT00430508|517347083|FG000|Overall Study|Other|1|||
143493362|NCT00430508|517347084|FG001|Overall Study|Other|1|||
143493363|NCT00430508|517347085|FG002|Overall Study|Other|3|||
143493364|NCT00430508|517347086|FG003|Overall Study|Other|0|||
143493365|NCT00993031|517347089|FG000|Overall Study|Death|0|||
143493366|NCT00993031|517347090|FG001|Overall Study|Death|1|||
143493367|NCT00993031|517347089|FG000|Overall Study|Physician Decision|0|||
143493368|NCT00993031|517347090|FG001|Overall Study|Physician Decision|2|||
143493369|NCT00993031|517347089|FG000|Overall Study|Withdrawal by Subject|3|||
143493370|NCT00993031|517347090|FG001|Overall Study|Withdrawal by Subject|3|||
143493371|NCT00993031|517347089|FG000|Overall Study|Lost to Follow-up|19|||
143493372|NCT00993031|517347090|FG001|Overall Study|Lost to Follow-up|13|||
143493373|NCT03870555|517347095|FG000|Period 3 (2 Days)|Adverse Event|1|||
143493374|NCT03870555|517347096|FG001|Period 3 (2 Days)|Adverse Event|0|||
143493375|NCT03870555|517347097|FG002|Period 3 (2 Days)|Adverse Event|0|||
143493376|NCT02925156|517347117|FG000|Overall Study|Lost to Follow-up|27|||
143493377|NCT02925156|517347118|FG001|Overall Study|Lost to Follow-up|53|||
143493378|NCT02925156|517347119|FG002|Overall Study|Lost to Follow-up|51|||
143493379|NCT02925156|517347120|FG003|Overall Study|Lost to Follow-up|59|||
143493380|NCT02925156|517347121|FG004|Overall Study|Lost to Follow-up|89|||
143493381|NCT02925156|517347122|FG005|Overall Study|Lost to Follow-up|107|||
143493382|NCT02925156|517347123|FG006|Overall Study|Lost to Follow-up|34|||
143493383|NCT02925156|517347124|FG007|Overall Study|Lost to Follow-up|36|||
143493384|NCT02925156|517347125|FG008|Overall Study|Lost to Follow-up|73|||
143493385|NCT02925156|517347126|FG009|Overall Study|Lost to Follow-up|34|||
143493386|NCT02665286|517347127|FG000|Overall Study|Lost to Follow-up|3|||
143493387|NCT02665286|517347128|FG001|Overall Study|Lost to Follow-up|2|||
143493388|NCT02665286|517347129|FG002|Overall Study|Lost to Follow-up|1|||
143493389|NCT00516737|517347131|FG000|Overall Study|Lost to Follow-up|2|||
143493390|NCT00516737|517347132|FG001|Overall Study|Lost to Follow-up|0|||
143493391|NCT00516737|517347131|FG000|Overall Study|Physician Decision|0|||
143493392|NCT00516737|517347132|FG001|Overall Study|Physician Decision|1|||
143493393|NCT00516737|517347131|FG000|Overall Study|Withdrawal by Subject|0|||
143493394|NCT00516737|517347132|FG001|Overall Study|Withdrawal by Subject|1|||
143493395|NCT00516737|517347131|FG000|Overall Study|Lack of Qualifying Event|9|||
143493396|NCT00516737|517347132|FG001|Overall Study|Lack of Qualifying Event|6|||
143493397|NCT00512798|517347133|FG000|Overall Study|Death|0|||
143493398|NCT00512798|517347134|FG001|Overall Study|Death|3|||
143493399|NCT00512798|517347133|FG000|Overall Study|Adverse Event|2|||
143493400|NCT00512798|517347134|FG001|Overall Study|Adverse Event|4|||
143493401|NCT00512798|517347133|FG000|Overall Study|Progression of disease|14|||
143493402|NCT00512798|517347134|FG001|Overall Study|Progression of disease|20|||
143493403|NCT00512798|517347133|FG000|Overall Study|Withdrawal by Subject|3|||
143493404|NCT00512798|517347134|FG001|Overall Study|Withdrawal by Subject|0|||
143493405|NCT03208231|517347138|FG000|Overall Study|Death|1|||
143493406|NCT03208231|517347139|FG001|Overall Study|Death|2|||
143493407|NCT03208231|517347138|FG000|Overall Study|Moved and unable to get to clinic|1|||
143493408|NCT03208231|517347139|FG001|Overall Study|Moved and unable to get to clinic|0|||
143493409|NCT03208231|517347138|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
143493410|NCT03208231|517347139|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
143493411|NCT05600309|517347150|FG000|Overall Study|Death|41|||
143493412|NCT05600309|517347151|FG001|Overall Study|Death|38|||
143493413|NCT05600309|517347150|FG000|Overall Study|Sponsor Decision|9|||
143493414|NCT05600309|517347151|FG001|Overall Study|Sponsor Decision|6|||
143493415|NCT03505021|517347152|FG000|Overall Study|Protocol Violation|1|||
143493416|NCT03505021|517347153|FG001|Overall Study|Protocol Violation|0|||
143493417|NCT03505021|517347152|FG000|Overall Study|Death|9|||
143493418|NCT03505021|517347153|FG001|Overall Study|Death|8|||
143493419|NCT03505021|517347152|FG000|Overall Study|Consent withdrawn by subject|6|||
143493420|NCT03505021|517347153|FG001|Overall Study|Consent withdrawn by subject|1|||
143493421|NCT03505021|517347152|FG000|Overall Study|Lost to Follow-up|5|||
143493422|NCT03505021|517347153|FG001|Overall Study|Lost to Follow-up|3|||
143493423|NCT03505021|517347152|FG000|Overall Study|Adverse Event|26|||
143493424|NCT03505021|517347153|FG001|Overall Study|Adverse Event|9|||
143493425|NCT03505021|517347152|FG000|Overall Study|Disease progression|33|||
143493426|NCT03505021|517347153|FG001|Overall Study|Disease progression|17|||
143493427|NCT03505021|517347152|FG000|Overall Study|Other|11|||
143493428|NCT03505021|517347153|FG001|Overall Study|Other|5|||
143493429|NCT03505021|517347152|FG000|Overall Study|Personal reason|21|||
143493430|NCT03505021|517347153|FG001|Overall Study|Personal reason|12|||
143493431|NCT03718143|517348409|FG000|Overall Study|Death|1|||
143493432|NCT03718143|517348410|FG001|Overall Study|Death|0|||
143493433|NCT03718143|517348411|FG002|Overall Study|Death|0|||
143493434|NCT03718143|517348409|FG000|Overall Study|Progression of Disease|1|||
143493435|NCT03718143|517348410|FG001|Overall Study|Progression of Disease|0|||
143493436|NCT03718143|517348411|FG002|Overall Study|Progression of Disease|0|||
143493437|NCT03718143|517348409|FG000|Overall Study|Withdrawal of Informed Consent|1|||
143493438|NCT03718143|517348410|FG001|Overall Study|Withdrawal of Informed Consent|2|||
143493439|NCT03718143|517348411|FG002|Overall Study|Withdrawal of Informed Consent|1|||
143493440|NCT05064059|517348412|FG000|Overall Study|Death|199|||
143493441|NCT05064059|517348413|FG001|Overall Study|Death|196|||
143493442|NCT05064059|517348412|FG000|Overall Study|Physician Decision|4|||
143493443|NCT05064059|517348413|FG001|Overall Study|Physician Decision|2|||
143493444|NCT05064059|517348412|FG000|Overall Study|Sponsor Decision|14|||
143493445|NCT05064059|517348413|FG001|Overall Study|Sponsor Decision|11|||
143493446|NCT05064059|517348412|FG000|Overall Study|Withdrawal by Subject|4|||
143493447|NCT05064059|517348413|FG001|Overall Study|Withdrawal by Subject|11|||
143493448|NCT04316585|517348414|FG000|Overall Study|Adverse Event|2|||
143493449|NCT04316585|517348415|FG001|Overall Study|Adverse Event|1|||
143493450|NCT04316585|517348414|FG000|Overall Study|Lost to Follow-up|1|||
143493451|NCT04316585|517348415|FG001|Overall Study|Lost to Follow-up|0|||
143493452|NCT04316585|517348414|FG000|Overall Study|Withdrawal by Subject|2|||
143493453|NCT04316585|517348415|FG001|Overall Study|Withdrawal by Subject|3|||
143493454|NCT04316585|517348414|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
143493455|NCT04316585|517348415|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
143493456|NCT04316585|517348414|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
143493457|NCT04316585|517348415|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
143493458|NCT01072344|517348417|FG000|Overall Study|Relasped-reached end point|7|||
143493459|NCT01072344|517348418|FG001|Overall Study|Relasped-reached end point|12|||
143493460|NCT01072344|517348417|FG000|Overall Study|Protocol Violation|1|||
143493461|NCT01072344|517348418|FG001|Overall Study|Protocol Violation|2|||
143493462|NCT01072344|517348417|FG000|Overall Study|Lost to Follow-up|3|||
143493463|NCT01072344|517348418|FG001|Overall Study|Lost to Follow-up|4|||
143493464|NCT00808444|517348427|FG000|Overall Study|Withdrawal by Subject|1|||
143493465|NCT00808444|517348428|FG001|Overall Study|Withdrawal by Subject|0|||
143493466|NCT00808444|517348427|FG000|Overall Study|Lost to Follow-up|0|||
143493467|NCT00808444|517348428|FG001|Overall Study|Lost to Follow-up|1|||
143493468|NCT01461044|517348429|FG000|Overall Study|Death|58|||
143493469|NCT01461044|517348430|FG001|Overall Study|Death|35|||
143493470|NCT01461044|517348429|FG000|Overall Study|Lost to Follow-up|12|||
143493471|NCT01461044|517348430|FG001|Overall Study|Lost to Follow-up|5|||
143493472|NCT05227690|517348439|FG000|Overall Study|Adverse Event|5|||
143493473|NCT05227690|517348440|FG001|Overall Study|Adverse Event|6|||
143493474|NCT05227690|517348441|FG002|Overall Study|Adverse Event|10|||
143493475|NCT05227690|517348439|FG000|Overall Study|Lack of Efficacy|2|||
143493476|NCT05227690|517348440|FG001|Overall Study|Lack of Efficacy|4|||
143493477|NCT05227690|517348441|FG002|Overall Study|Lack of Efficacy|1|||
143493478|NCT05227690|517348439|FG000|Overall Study|Physician Decision|6|||
143493479|NCT05227690|517348440|FG001|Overall Study|Physician Decision|0|||
143493480|NCT05227690|517348441|FG002|Overall Study|Physician Decision|4|||
143493481|NCT05227690|517348439|FG000|Overall Study|Withdrawal of consent|28|||
143493482|NCT05227690|517348440|FG001|Overall Study|Withdrawal of consent|27|||
143493483|NCT05227690|517348441|FG002|Overall Study|Withdrawal of consent|21|||
143493484|NCT05227690|517348439|FG000|Overall Study|Other, not specified|2|||
143493485|NCT05227690|517348440|FG001|Overall Study|Other, not specified|2|||
143493486|NCT05227690|517348441|FG002|Overall Study|Other, not specified|1|||
143493487|NCT00223496|517348442|FG000|Overall Study|screen failure|9|||
143493488|NCT00223496|517348442|FG000|Overall Study|Lost to Follow-up|4|||
143493489|NCT00223496|517348442|FG000|Overall Study|Lack of Efficacy|6|||
143493490|NCT00223496|517348442|FG000|Overall Study|Withdrawal by Subject|1|||
143493491|NCT00223496|517348442|FG000|Overall Study|Physician Decision|2|||
143493492|NCT02723201|517348443|FG000|Second Intervention Period|Protocol Violation|1|||
143493493|NCT02723201|517348444|FG001|Second Intervention Period|Protocol Violation|0|||
143493494|NCT02723201|517348445|FG002|Second Intervention Period|Protocol Violation|0|||
143493495|NCT02723201|517348443|FG000|Second Intervention Period|Adverse Event|1|||
143493496|NCT02723201|517348444|FG001|Second Intervention Period|Adverse Event|0|||
143493497|NCT02723201|517348445|FG002|Second Intervention Period|Adverse Event|0|||
143493498|NCT04656652|517348446|FG000|Overall Study|Lost to Follow-up|2|||
143493499|NCT04656652|517348447|FG001|Overall Study|Lost to Follow-up|2|||
143493500|NCT04656652|517348446|FG000|Overall Study|Death|213|||
143493501|NCT04656652|517348447|FG001|Overall Study|Death|212|||
143493502|NCT04656652|517348446|FG000|Overall Study|Other|1|||
143493503|NCT04656652|517348447|FG001|Overall Study|Other|0|||
143493504|NCT04656652|517348446|FG000|Overall Study|Withdrawal by Subject|15|||
143493505|NCT04656652|517348447|FG001|Overall Study|Withdrawal by Subject|29|||
143493506|NCT01414257|517348448|FG000|Overall Study|No Visit After First Day of Treatment|12|||
143493507|NCT01414257|517348448|FG000|Overall Study|Protocol Violation|10|||
143493508|NCT02634580|517348449|FG000|Double-blind Treatment Period|Subject Request|1|||
143493509|NCT02634580|517348450|FG001|Double-blind Treatment Period|Subject Request|0|||
143493510|NCT02634580|517348451|FG002|Double-blind Treatment Period|Subject Request|1|||
143493511|NCT02634580|517348452|FG003|Double-blind Treatment Period|Subject Request|1|||
143493512|NCT02634580|517348449|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
143493513|NCT02634580|517348450|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
143493514|NCT02634580|517348451|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
143493515|NCT02634580|517348452|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
143493516|NCT01790048|517348455|FG000|Overall Study|Incorrect Age|9|||
143493517|NCT01790048|517348456|FG001|Overall Study|Incorrect Age|14|||
143493518|NCT01790048|517348455|FG000|Overall Study|data entry error|0|||
143493519|NCT01790048|517348456|FG001|Overall Study|data entry error|1|||
143493520|NCT01790048|517348455|FG000|Overall Study|Other|0|||
143493521|NCT01790048|517348456|FG001|Overall Study|Other|2|||
143493522|NCT01790048|517348455|FG000|Overall Study|SAM at Enrollment|2|||
143493523|NCT01790048|517348456|FG001|Overall Study|SAM at Enrollment|0|||
143493524|NCT01790048|517348455|FG000|Overall Study|Measurement error|1|||
143493525|NCT01790048|517348456|FG001|Overall Study|Measurement error|0|||
143031000|NCT00950807|515654661|FG002|Treatment Period 3|Adverse Event|0|||
143158875|NCT00086307|516126129|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
143158876|NCT00086307|516126130|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
143158877|NCT00086307|516126131|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
143493526|NCT03178487|517348457|FG000|Period 1|Adverse Event|1|||
143031001|NCT00950807|515654662|FG003|Treatment Period 3|Adverse Event|0|||
143031002|NCT00950807|515654663|FG004|Treatment Period 3|Adverse Event|0|||
143158878|NCT00086307|516126129|FG000|Overall Study|Withdrawal by Subject|0|||
143493527|NCT03178487|517348458|FG001|Period 1|Adverse Event|2|||
143493528|NCT03178487|517348457|FG000|Period 1|Withdrawal by Subject|2|||
143493529|NCT03178487|517348458|FG001|Period 1|Withdrawal by Subject|1|||
143493530|NCT03178487|517348457|FG000|Period 1|Lost to Follow-up|1|||
143493531|NCT03178487|517348458|FG001|Period 1|Lost to Follow-up|0|||
143493532|NCT03178487|517348457|FG000|Period 1|Other|0|||
143493533|NCT03178487|517348458|FG001|Period 1|Other|1|||
143493534|NCT03178487|517348457|FG000|Period 2|Adverse Event|4|||
143493535|NCT03178487|517348458|FG001|Period 2|Adverse Event|4|||
143493536|NCT03178487|517348457|FG000|Period 2|Withdrawal by Subject|6|||
143493537|NCT03178487|517348458|FG001|Period 2|Withdrawal by Subject|6|||
143493538|NCT03178487|517348457|FG000|Period 2|Lost to Follow-up|2|||
143493539|NCT03178487|517348458|FG001|Period 2|Lost to Follow-up|2|||
143493540|NCT03178487|517348457|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
143493541|NCT03178487|517348458|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
143493542|NCT03178487|517348457|FG000|Period 2|Other|8|||
143493543|NCT03178487|517348458|FG001|Period 2|Other|7|||
143493544|NCT02161562|517348461|FG000|Overall Study|Withdrawal by Subject|5|||
143493545|NCT02161562|517348462|FG001|Overall Study|Withdrawal by Subject|8|||
143493546|NCT02161562|517348461|FG000|Overall Study|Protocol Violation|9|||
143493547|NCT02161562|517348462|FG001|Overall Study|Protocol Violation|4|||
143493548|NCT02161562|517348461|FG000|Overall Study|Pregnancy|1|||
143493549|NCT02161562|517348462|FG001|Overall Study|Pregnancy|2|||
143237553|NCT00307801|516423369|FG000|Overall Study|No reason specified|2|||
143237554|NCT00307801|516423370|FG001|Overall Study|No reason specified|0|||
143364028|NCT00293462|516875527|FG002|Overall Study|Death|0|||
143493550|NCT02161562|517348461|FG000|Overall Study|Lost to Follow-up|3|||
143493551|NCT02161562|517348462|FG001|Overall Study|Lost to Follow-up|1|||
143493552|NCT02161562|517348461|FG000|Overall Study|Lack of Efficacy|4|||
143493553|NCT02161562|517348462|FG001|Overall Study|Lack of Efficacy|1|||
143493554|NCT02161562|517348461|FG000|Overall Study|Adverse Event|1|||
143493555|NCT02161562|517348462|FG001|Overall Study|Adverse Event|1|||
143493556|NCT02161562|517348461|FG000|Overall Study|Participant moved back to home country|1|||
143493557|NCT02161562|517348462|FG001|Overall Study|Participant moved back to home country|0|||
143493558|NCT02161562|517348461|FG000|Overall Study|Withdrew due to being out of the country|1|||
143493559|NCT02161562|517348462|FG001|Overall Study|Withdrew due to being out of the country|0|||
143493560|NCT02161562|517348461|FG000|Overall Study|Participant moved out of province|1|||
143493561|NCT02161562|517348462|FG001|Overall Study|Participant moved out of province|0|||
143493562|NCT00756938|517348475|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
143493563|NCT00756938|517348476|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
143493564|NCT00756938|517348477|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
143493565|NCT00756938|517348478|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
143493566|NCT00756938|517348475|FG000|12-week Base Study|Protocol Violation|0|||
143493567|NCT00756938|517348476|FG001|12-week Base Study|Protocol Violation|0|||
143493568|NCT00756938|517348477|FG002|12-week Base Study|Protocol Violation|1|||
143493569|NCT00756938|517348478|FG003|12-week Base Study|Protocol Violation|0|||
143493570|NCT00756938|517348475|FG000|12-week Base Study|Lost to Follow-up|1|||
143493571|NCT00756938|517348476|FG001|12-week Base Study|Lost to Follow-up|0|||
143493572|NCT00756938|517348477|FG002|12-week Base Study|Lost to Follow-up|0|||
143493573|NCT00756938|517348478|FG003|12-week Base Study|Lost to Follow-up|0|||
143493574|NCT00756938|517348475|FG000|Optional Extension|Lack of Efficacy|0|||
143493575|NCT00756938|517348476|FG001|Optional Extension|Lack of Efficacy|0|||
143493576|NCT00756938|517348477|FG002|Optional Extension|Lack of Efficacy|0|||
143493577|NCT00756938|517348478|FG003|Optional Extension|Lack of Efficacy|1|||
143493578|NCT00756938|517348475|FG000|Optional Extension|End of Study|0|||
143493579|NCT00756938|517348476|FG001|Optional Extension|End of Study|0|||
143493580|NCT00756938|517348477|FG002|Optional Extension|End of Study|0|||
143493581|NCT00756938|517348478|FG003|Optional Extension|End of Study|11|||
143493582|NCT00756938|517348475|FG000|Optional Extension|Protocol-specific criteria met|0|||
143493583|NCT00756938|517348476|FG001|Optional Extension|Protocol-specific criteria met|0|||
143493584|NCT00756938|517348477|FG002|Optional Extension|Protocol-specific criteria met|0|||
143493585|NCT00756938|517348478|FG003|Optional Extension|Protocol-specific criteria met|9|||
143493586|NCT00756938|517348475|FG000|Optional Extension|Physician Decision|0|||
143158879|NCT00086307|516126130|FG001|Overall Study|Withdrawal by Subject|0|||
143158880|NCT00086307|516126131|FG002|Overall Study|Withdrawal by Subject|2|||
143158881|NCT00105508|516126132|FG000|Overall Study|Prephase Dropout|1|||
143158882|NCT00105508|516126133|FG001|Overall Study|Prephase Dropout|0|||
143158883|NCT00105508|516126132|FG000|Overall Study|Adverse Event|16|||
143158884|NCT00105508|516126133|FG001|Overall Study|Adverse Event|19|||
143158885|NCT00105508|516126132|FG000|Overall Study|Insufficient Efficacy|1|||
143158886|NCT00105508|516126133|FG001|Overall Study|Insufficient Efficacy|0|||
143158887|NCT00105508|516126132|FG000|Overall Study|Withdrawal by Subject|10|||
143158888|NCT00105508|516126133|FG001|Overall Study|Withdrawal by Subject|6|||
143158889|NCT00105508|516126132|FG000|Overall Study|Lost to Follow-up|3|||
143158890|NCT00105508|516126133|FG001|Overall Study|Lost to Follow-up|0|||
143158891|NCT00105508|516126132|FG000|Overall Study|Protocol Violation|1|||
143158892|NCT00105508|516126133|FG001|Overall Study|Protocol Violation|2|||
143158893|NCT00105508|516126132|FG000|Overall Study|Other|8|||
143364029|NCT00293462|516875525|FG000|Overall Study|Lost to Follow-up|0|||
143493587|NCT00756938|517348476|FG001|Optional Extension|Physician Decision|0|||
143493588|NCT00756938|517348477|FG002|Optional Extension|Physician Decision|0|||
143493589|NCT00756938|517348478|FG003|Optional Extension|Physician Decision|3|||
143493590|NCT00756938|517348475|FG000|Optional Extension|Lost to Follow-up|0|||
143493591|NCT00756938|517348476|FG001|Optional Extension|Lost to Follow-up|0|||
143493592|NCT00756938|517348477|FG002|Optional Extension|Lost to Follow-up|0|||
143493593|NCT00756938|517348478|FG003|Optional Extension|Lost to Follow-up|1|||
143493594|NCT00756938|517348475|FG000|Optional Extension|Protocol Violation|0|||
143493595|NCT00756938|517348476|FG001|Optional Extension|Protocol Violation|0|||
143493596|NCT00756938|517348477|FG002|Optional Extension|Protocol Violation|0|||
143237555|NCT00307801|516423369|FG000|Overall Study|Pregnancy|0|||
143493597|NCT00756938|517348478|FG003|Optional Extension|Protocol Violation|1|||
143493598|NCT00756938|517348475|FG000|Optional Extension|Withdrawal by Subject|0|||
143493599|NCT00756938|517348476|FG001|Optional Extension|Withdrawal by Subject|0|||
143493600|NCT00756938|517348477|FG002|Optional Extension|Withdrawal by Subject|0|||
143493601|NCT00756938|517348478|FG003|Optional Extension|Withdrawal by Subject|10|||
143493602|NCT00756938|517348475|FG000|Optional Extension|Adverse Event|0|||
143493603|NCT00756938|517348476|FG001|Optional Extension|Adverse Event|0|||
143493604|NCT00756938|517348477|FG002|Optional Extension|Adverse Event|0|||
143493605|NCT00756938|517348478|FG003|Optional Extension|Adverse Event|1|||
143493606|NCT00797823|517348479|FG000|First Period (Initial Randomization)|Physician Decision|1|||
143493607|NCT00797823|517348480|FG001|First Period (Initial Randomization)|Physician Decision|0|||
143493608|NCT00797823|517348481|FG002|First Period (Initial Randomization)|Physician Decision|0|||
143493609|NCT03889639|517348482|FG000|Overall Study|Withdrawal by Subject|0|||
143493610|NCT03889639|517348483|FG001|Overall Study|Withdrawal by Subject|0|||
143493611|NCT03889639|517348484|FG002|Overall Study|Withdrawal by Subject|0|||
143493612|NCT03889639|517348485|FG003|Overall Study|Withdrawal by Subject|0|||
143493613|NCT03889639|517348486|FG004|Overall Study|Withdrawal by Subject|0|||
143493614|NCT03889639|517348487|FG005|Overall Study|Withdrawal by Subject|0|||
143493615|NCT03889639|517348488|FG006|Overall Study|Withdrawal by Subject|0|||
143493616|NCT03889639|517348489|FG007|Overall Study|Withdrawal by Subject|1|||
143493617|NCT02556255|517348490|FG000|Overall Study|Lost to Follow-up|4|||
143493618|NCT01834729|517348492|FG000|Overall Study|Did not return bowel diaries|0|||
143493619|NCT01834729|517348493|FG001|Overall Study|Did not return bowel diaries|0|||
143493620|NCT01834729|517348494|FG002|Overall Study|Did not return bowel diaries|3|||
143493621|NCT01834729|517348495|FG003|Overall Study|Did not return bowel diaries|0|||
143493622|NCT01834729|517348492|FG000|Overall Study|Withdrawal by Subject|1|||
143493623|NCT01834729|517348493|FG001|Overall Study|Withdrawal by Subject|1|||
143493624|NCT01834729|517348494|FG002|Overall Study|Withdrawal by Subject|0|||
143493625|NCT01834729|517348495|FG003|Overall Study|Withdrawal by Subject|0|||
143493626|NCT01834729|517348492|FG000|Overall Study|Adverse Event|0|||
143493627|NCT01834729|517348493|FG001|Overall Study|Adverse Event|0|||
143493628|NCT01834729|517348494|FG002|Overall Study|Adverse Event|0|||
143493629|NCT01834729|517348495|FG003|Overall Study|Adverse Event|2|||
143493630|NCT00288080|517348496|FG000|Overall Study|Withdrawal by Subject|1|||
143493631|NCT00288080|517348497|FG001|Overall Study|Withdrawal by Subject|3|||
143493632|NCT00288080|517348496|FG000|Overall Study|Protocol Violation|25|||
143493633|NCT00288080|517348497|FG001|Overall Study|Protocol Violation|20|||
143493634|NCT03403192|517348498|FG000|Overall Study|Lost to Follow-up|1|||
143493635|NCT03403192|517348499|FG001|Overall Study|Lost to Follow-up|2|||
143493636|NCT03403192|517348500|FG002|Overall Study|Lost to Follow-up|0|||
143493637|NCT03403192|517348501|FG003|Overall Study|Lost to Follow-up|0|||
143493638|NCT03403192|517348498|FG000|Overall Study|Unable to respond|0|||
143493639|NCT03403192|517348499|FG001|Overall Study|Unable to respond|1|||
143493640|NCT03403192|517348500|FG002|Overall Study|Unable to respond|0|||
143493641|NCT03403192|517348501|FG003|Overall Study|Unable to respond|0|||
143493642|NCT03403192|517348498|FG000|Overall Study|Incomplete|3|||
143493643|NCT03403192|517348499|FG001|Overall Study|Incomplete|1|||
143493644|NCT03403192|517348500|FG002|Overall Study|Incomplete|3|||
143493645|NCT03403192|517348501|FG003|Overall Study|Incomplete|6|||
143493646|NCT00143455|517348505|FG000|Cohort 1|Adverse Event|8|||
143493647|NCT00143455|517348506|FG001|Cohort 1|Adverse Event|4|||
143493648|NCT00143455|517348507|FG002|Cohort 1|Adverse Event|0|||
143493649|NCT00143455|517348508|FG003|Cohort 1|Adverse Event|0|||
143493650|NCT00143455|517348505|FG000|Cohort 1|Death|5|||
143493651|NCT00143455|517348506|FG001|Cohort 1|Death|2|||
143493652|NCT00143455|517348507|FG002|Cohort 1|Death|0|||
143493653|NCT00143455|517348508|FG003|Cohort 1|Death|0|||
143493654|NCT00143455|517348505|FG000|Cohort 1|Progressive Disease|0|||
143493655|NCT00143455|517348506|FG001|Cohort 1|Progressive Disease|6|||
143493656|NCT00143455|517348507|FG002|Cohort 1|Progressive Disease|0|||
143493657|NCT00143455|517348508|FG003|Cohort 1|Progressive Disease|0|||
143493658|NCT00143455|517348505|FG000|Cohort 1|Withdrawal by Subject|1|||
143493659|NCT00143455|517348506|FG001|Cohort 1|Withdrawal by Subject|4|||
143493660|NCT00143455|517348507|FG002|Cohort 1|Withdrawal by Subject|0|||
143364030|NCT00293462|516875526|FG001|Overall Study|Lost to Follow-up|1|||
143493661|NCT00143455|517348508|FG003|Cohort 1|Withdrawal by Subject|0|||
143493662|NCT00143455|517348505|FG000|Cohort 1|Randomized But Not Treated|0|||
143493663|NCT00143455|517348506|FG001|Cohort 1|Randomized But Not Treated|1|||
143493664|NCT00143455|517348507|FG002|Cohort 1|Randomized But Not Treated|0|||
143493665|NCT00143455|517348508|FG003|Cohort 1|Randomized But Not Treated|0|||
143493666|NCT00143455|517348505|FG000|Cohort 2|Adverse Event|0|||
143493667|NCT00143455|517348506|FG001|Cohort 2|Adverse Event|0|||
143493668|NCT00143455|517348507|FG002|Cohort 2|Adverse Event|42|||
143493669|NCT00143455|517348508|FG003|Cohort 2|Adverse Event|30|||
143493670|NCT00143455|517348505|FG000|Cohort 2|No Longer Required Study Treatment|0|||
143493671|NCT00143455|517348506|FG001|Cohort 2|No Longer Required Study Treatment|0|||
143493672|NCT00143455|517348507|FG002|Cohort 2|No Longer Required Study Treatment|1|||
143493673|NCT00143455|517348508|FG003|Cohort 2|No Longer Required Study Treatment|0|||
143493674|NCT00143455|517348505|FG000|Cohort 2|Protocol Violation|0|||
143493675|NCT00143455|517348506|FG001|Cohort 2|Protocol Violation|0|||
143493676|NCT00143455|517348507|FG002|Cohort 2|Protocol Violation|1|||
143493677|NCT00143455|517348508|FG003|Cohort 2|Protocol Violation|1|||
143493678|NCT00143455|517348505|FG000|Cohort 2|Lost to Follow-up|0|||
143493679|NCT00143455|517348506|FG001|Cohort 2|Lost to Follow-up|0|||
143493680|NCT00143455|517348507|FG002|Cohort 2|Lost to Follow-up|1|||
143493681|NCT00143455|517348508|FG003|Cohort 2|Lost to Follow-up|4|||
143493682|NCT00143455|517348505|FG000|Cohort 2|Death|0|||
143493683|NCT00143455|517348506|FG001|Cohort 2|Death|0|||
143493684|NCT00143455|517348507|FG002|Cohort 2|Death|20|||
143493685|NCT00143455|517348508|FG003|Cohort 2|Death|12|||
143493686|NCT00143455|517348505|FG000|Cohort 2|Progressive Disease|0|||
143493687|NCT00143455|517348506|FG001|Cohort 2|Progressive Disease|0|||
143493688|NCT00143455|517348507|FG002|Cohort 2|Progressive Disease|20|||
143493689|NCT00143455|517348508|FG003|Cohort 2|Progressive Disease|27|||
143493690|NCT00143455|517348505|FG000|Cohort 2|Withdrawal by Subject|0|||
143493691|NCT00143455|517348506|FG001|Cohort 2|Withdrawal by Subject|0|||
143493692|NCT00143455|517348507|FG002|Cohort 2|Withdrawal by Subject|13|||
143493693|NCT00143455|517348508|FG003|Cohort 2|Withdrawal by Subject|12|||
143493694|NCT00143455|517348505|FG000|Cohort 2|Other|0|||
143493695|NCT00143455|517348506|FG001|Cohort 2|Other|0|||
143493696|NCT00143455|517348507|FG002|Cohort 2|Other|7|||
143493697|NCT00143455|517348508|FG003|Cohort 2|Other|6|||
143493698|NCT00143455|517348505|FG000|Cohort 2|Randomized But Not Treated|0|||
143493699|NCT00143455|517348506|FG001|Cohort 2|Randomized But Not Treated|0|||
143493700|NCT00143455|517348507|FG002|Cohort 2|Randomized But Not Treated|1|||
143493701|NCT00143455|517348508|FG003|Cohort 2|Randomized But Not Treated|1|||
143493702|NCT02387580|517348509|FG000|Overall Study|Withdrawal by Subject|0|||
143493703|NCT02387580|517348510|FG001|Overall Study|Withdrawal by Subject|0|||
143493704|NCT02387580|517348511|FG002|Overall Study|Withdrawal by Subject|0|||
143493705|NCT02387580|517348512|FG003|Overall Study|Withdrawal by Subject|1|||
143493706|NCT02387580|517348513|FG004|Overall Study|Withdrawal by Subject|0|||
143493707|NCT02387580|517348514|FG005|Overall Study|Withdrawal by Subject|0|||
143493708|NCT01298492|517348515|FG000|Overall Study|Death|2|||
143493709|NCT01298492|517348515|FG000|Overall Study|Insufficient Clinical Response|22|||
143493710|NCT01298492|517348515|FG000|Overall Study|Lost to Follow-up|12|||
143493711|NCT01298492|517348515|FG000|Overall Study|Withdrawal by Subject|47|||
143493712|NCT01298492|517348515|FG000|Overall Study|Other (Unspecified)|7|||
143493713|NCT01298492|517348515|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
143031003|NCT00950807|515654664|FG005|Treatment Period 3|Adverse Event|0|||
143493714|NCT01298492|517348515|FG000|Overall Study|Protocol Violation|2|||
143493715|NCT01298492|517348515|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
143493716|NCT01298492|517348515|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
143493717|NCT00087646|517348516|FG000|Overall Study|Adverse Event|37|||
143493718|NCT00087646|517348517|FG001|Overall Study|Adverse Event|6|||
143493719|NCT00087646|517348518|FG002|Overall Study|Adverse Event|18|||
143493720|NCT00087646|517348519|FG003|Overall Study|Adverse Event|20|||
143493721|NCT00087646|517348516|FG000|Overall Study|Death|0|||
143493722|NCT00087646|517348517|FG001|Overall Study|Death|1|||
143493723|NCT00087646|517348518|FG002|Overall Study|Death|0|||
143493724|NCT00087646|517348519|FG003|Overall Study|Death|0|||
143493725|NCT00087646|517348516|FG000|Overall Study|Withdrawal by Subject|6|||
143493726|NCT00087646|517348517|FG001|Overall Study|Withdrawal by Subject|1|||
143031004|NCT00950807|515654665|FG006|Treatment Period 3|Adverse Event|1|||
143031005|NCT00950807|515654666|FG007|Treatment Period 3|Adverse Event|0|||
143031006|NCT00950807|515654667|FG008|Treatment Period 3|Adverse Event|0|||
143031007|NCT00950807|515654668|FG009|Treatment Period 3|Adverse Event|0|||
143031008|NCT00337077|515654669|FG000|Overall Study|Progressive disease|25|||
143493727|NCT00087646|517348518|FG002|Overall Study|Withdrawal by Subject|2|||
143493728|NCT00087646|517348519|FG003|Overall Study|Withdrawal by Subject|2|||
143031009|NCT00337077|515654670|FG001|Overall Study|Progressive disease|37|||
143031010|NCT00337077|515654671|FG002|Overall Study|Progressive disease|19|||
143031011|NCT00337077|515654669|FG000|Overall Study|Adverse Event|7|||
143031012|NCT00337077|515654670|FG001|Overall Study|Adverse Event|7|||
143493729|NCT00087646|517348516|FG000|Overall Study|Insufficient therapeutic response|64|||
143493730|NCT00087646|517348517|FG001|Overall Study|Insufficient therapeutic response|24|||
143031013|NCT00337077|515654671|FG002|Overall Study|Adverse Event|1|||
143493731|NCT00087646|517348518|FG002|Overall Study|Insufficient therapeutic response|38|||
143493732|NCT00087646|517348519|FG003|Overall Study|Insufficient therapeutic response|51|||
143493733|NCT00087646|517348516|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
143493734|NCT00087646|517348517|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
143493735|NCT00087646|517348518|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
143493736|NCT00087646|517348519|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
143493737|NCT00087646|517348516|FG000|Overall Study|Failure to Return|5|||
143493738|NCT00087646|517348517|FG001|Overall Study|Failure to Return|2|||
143031014|NCT00337077|515654669|FG000|Overall Study|Death|0|||
143031015|NCT00337077|515654670|FG001|Overall Study|Death|1|||
143031016|NCT00337077|515654671|FG002|Overall Study|Death|0|||
143493739|NCT00087646|517348518|FG002|Overall Study|Failure to Return|2|||
143493740|NCT00087646|517348519|FG003|Overall Study|Failure to Return|3|||
143493741|NCT00087646|517348516|FG000|Overall Study|Administrative/Other|6|||
143493742|NCT00087646|517348517|FG001|Overall Study|Administrative/Other|1|||
143493743|NCT00087646|517348518|FG002|Overall Study|Administrative/Other|1|||
143493744|NCT00087646|517348519|FG003|Overall Study|Administrative/Other|2|||
143493745|NCT00087646|517348516|FG000|Overall Study|Other Protocol Violation|3|||
143493746|NCT00087646|517348517|FG001|Overall Study|Other Protocol Violation|1|||
143493747|NCT00087646|517348518|FG002|Overall Study|Other Protocol Violation|0|||
143493748|NCT00087646|517348519|FG003|Overall Study|Other Protocol Violation|0|||
143493749|NCT00087646|517348516|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
143493750|NCT00087646|517348517|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
143493751|NCT00087646|517348518|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
143493752|NCT00087646|517348519|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
143493753|NCT02902120|517348520|FG000|Overall Study|Lack of Efficacy|1|||
143493754|NCT02004873|517348522|FG000|Overall Study|Implant unsuccessful|6|||
143493755|NCT02004873|517348522|FG000|Overall Study|Awaiting 6-month visit|390|||
143493756|NCT02004873|517348522|FG000|Overall Study|Missed 6-month visit|4|||
143493757|NCT02004873|517348522|FG000|Overall Study|Death|23|||
143493758|NCT02004873|517348522|FG000|Overall Study|Withdrawal by Subject|1|||
143493759|NCT03434977|517348530|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
143493760|NCT03434977|517348531|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
143493761|NCT01724528|517348540|FG000|Overall Study|Death|3|||
143493762|NCT01724528|517348541|FG001|Overall Study|Death|0|||
143493763|NCT01724528|517348540|FG000|Overall Study|Withdrawal by Subject|0|||
143493764|NCT01724528|517348541|FG001|Overall Study|Withdrawal by Subject|2|||
143493765|NCT01724528|517348540|FG000|Overall Study|Protocol Violation|0|||
143493766|NCT01724528|517348541|FG001|Overall Study|Protocol Violation|1|||
143493767|NCT01724528|517348540|FG000|Overall Study|Patient refused to attend last visit|1|||
143493768|NCT01724528|517348541|FG001|Overall Study|Patient refused to attend last visit|0|||
143493769|NCT05574062|517348545|FG000|Pre Run-In|Screening failure|3|||
143493770|NCT05574062|517348546|FG001|Pre Run-In|Screening failure|0|||
143493771|NCT05574062|517348547|FG002|Pre Run-In|Screening failure|0|||
143493772|NCT05574062|517348548|FG003|Pre Run-In|Screening failure|0|||
143493773|NCT05574062|517348549|FG004|Pre Run-In|Screening failure|0|||
143493774|NCT05574062|517348545|FG000|Study Phase Period 1|Withdrawal by Subject|0|||
143493775|NCT05574062|517348546|FG001|Study Phase Period 1|Withdrawal by Subject|1|||
143493776|NCT05574062|517348547|FG002|Study Phase Period 1|Withdrawal by Subject|0|||
143493777|NCT05574062|517348548|FG003|Study Phase Period 1|Withdrawal by Subject|0|||
143493778|NCT05574062|517348549|FG004|Study Phase Period 1|Withdrawal by Subject|0|||
143493779|NCT05574062|517348545|FG000|Study Phase Period 2|Withdrawal by Subject|0|||
143493780|NCT05574062|517348546|FG001|Study Phase Period 2|Withdrawal by Subject|1|||
143493781|NCT05574062|517348547|FG002|Study Phase Period 2|Withdrawal by Subject|0|||
143493782|NCT05574062|517348548|FG003|Study Phase Period 2|Withdrawal by Subject|0|||
143493783|NCT05574062|517348549|FG004|Study Phase Period 2|Withdrawal by Subject|0|||
143493784|NCT05574062|517348545|FG000|Continuation Phase Period 1|Physician Decision|1|||
143493785|NCT05574062|517348546|FG001|Continuation Phase Period 1|Physician Decision|0|||
143493786|NCT05574062|517348547|FG002|Continuation Phase Period 1|Physician Decision|0|||
143493787|NCT05574062|517348548|FG003|Continuation Phase Period 1|Physician Decision|0|||
143158894|NCT00105508|516126133|FG001|Overall Study|Other|9|||
143158895|NCT00683384|516126134|FG000|Overall Study|Death|1|||
143158896|NCT00683384|516126134|FG000|Overall Study|Adverse Event|1|||
143158897|NCT00120874|516126135|FG000|Overall Study|Death|0|||
143158898|NCT00120874|516126136|FG001|Overall Study|Death|1|||
143493788|NCT05574062|517348549|FG004|Continuation Phase Period 1|Physician Decision|0|||
143493789|NCT05574062|517348545|FG000|Continuation Phase Period 1|Withdrawal by Subject|1|||
143493790|NCT05574062|517348546|FG001|Continuation Phase Period 1|Withdrawal by Subject|0|||
143493791|NCT05574062|517348547|FG002|Continuation Phase Period 1|Withdrawal by Subject|0|||
143493792|NCT05574062|517348548|FG003|Continuation Phase Period 1|Withdrawal by Subject|0|||
143493793|NCT05574062|517348549|FG004|Continuation Phase Period 1|Withdrawal by Subject|0|||
143493794|NCT05574062|517348545|FG000|Continuation Phase Period 1|Adverse Event|1|||
143493795|NCT05574062|517348546|FG001|Continuation Phase Period 1|Adverse Event|0|||
143493796|NCT05574062|517348547|FG002|Continuation Phase Period 1|Adverse Event|0|||
143493797|NCT05574062|517348548|FG003|Continuation Phase Period 1|Adverse Event|0|||
143493798|NCT05574062|517348549|FG004|Continuation Phase Period 1|Adverse Event|0|||
143493799|NCT05574062|517348545|FG000|Continuation Phase Period 1|Death|1|||
143493800|NCT05574062|517348546|FG001|Continuation Phase Period 1|Death|0|||
143493801|NCT05574062|517348547|FG002|Continuation Phase Period 1|Death|0|||
143158899|NCT01727154|516126137|FG000|Overall Study|Death|17|||
143158900|NCT01727154|516126137|FG000|Overall Study|Withdrawal by Subject|14|||
143493802|NCT05574062|517348548|FG003|Continuation Phase Period 1|Death|0|||
143493803|NCT05574062|517348549|FG004|Continuation Phase Period 1|Death|0|||
143493804|NCT05574062|517348545|FG000|Continuation Phase Period 2|Withdrawal by Subject|0|||
143493805|NCT05574062|517348546|FG001|Continuation Phase Period 2|Withdrawal by Subject|0|||
143493806|NCT05574062|517348547|FG002|Continuation Phase Period 2|Withdrawal by Subject|0|||
143158901|NCT01727154|516126137|FG000|Overall Study|Subject Withdrew Consent|18|||
143158902|NCT01727154|516126137|FG000|Overall Study|Study Terminated|6|||
143493807|NCT05574062|517348548|FG003|Continuation Phase Period 2|Withdrawal by Subject|1|||
143493808|NCT05574062|517348549|FG004|Continuation Phase Period 2|Withdrawal by Subject|0|||
143493809|NCT05902364|517348550|FG000|Overall Study|Adverse Event|1|||
143493810|NCT05902364|517348551|FG001|Overall Study|Adverse Event|0|||
143493811|NCT02270242|517348552|FG000|Overall Study|Withdrawal by Subject|18|||
143493812|NCT02270242|517348553|FG001|Overall Study|Withdrawal by Subject|25|||
143493813|NCT02270242|517348552|FG000|Overall Study|Lost to Follow-up|41|||
143493814|NCT02270242|517348553|FG001|Overall Study|Lost to Follow-up|27|||
143493815|NCT02270242|517348552|FG000|Overall Study|Physician Decision|0|||
143493816|NCT02270242|517348553|FG001|Overall Study|Physician Decision|1|||
143493817|NCT03864653|517348554|FG000|Overall Study|Withdrawal by Subject|1|||
143031017|NCT00337077|515654669|FG000|Overall Study|Withdrawal by Subject|7|||
143031018|NCT00337077|515654670|FG001|Overall Study|Withdrawal by Subject|2|||
143031019|NCT00337077|515654671|FG002|Overall Study|Withdrawal by Subject|2|||
143031020|NCT00337077|515654669|FG000|Overall Study|Alternative therapy|1|||
143031021|NCT00337077|515654670|FG001|Overall Study|Alternative therapy|0|||
143031022|NCT00337077|515654671|FG002|Overall Study|Alternative therapy|0|||
143031023|NCT00337077|515654669|FG000|Overall Study|Physician Decision|1|||
143031024|NCT00337077|515654670|FG001|Overall Study|Physician Decision|4|||
143031025|NCT00337077|515654671|FG002|Overall Study|Physician Decision|2|||
143031026|NCT00337077|515654669|FG000|Overall Study|Never started treatment|1|||
143031027|NCT00337077|515654670|FG001|Overall Study|Never started treatment|1|||
143031028|NCT00337077|515654671|FG002|Overall Study|Never started treatment|0|||
143031029|NCT00337077|515654669|FG000|Overall Study|Ineligible|1|||
143031030|NCT00337077|515654670|FG001|Overall Study|Ineligible|1|||
143031031|NCT00337077|515654671|FG002|Overall Study|Ineligible|1|||
143031032|NCT06179108|515654676|FG000|Overall Study|Withdrawal by Subject|16|||
143031033|NCT06179108|515654677|FG001|Overall Study|Withdrawal by Subject|19|||
143031034|NCT06179108|515654678|FG002|Overall Study|Withdrawal by Subject|10|||
143031035|NCT06179108|515654679|FG003|Overall Study|Withdrawal by Subject|11|||
143031036|NCT06179108|515654676|FG000|Overall Study|Lost to Follow-up|12|||
143031037|NCT06179108|515654677|FG001|Overall Study|Lost to Follow-up|4|||
143031038|NCT06179108|515654678|FG002|Overall Study|Lost to Follow-up|1|||
143031039|NCT06179108|515654679|FG003|Overall Study|Lost to Follow-up|9|||
143031040|NCT06179108|515654676|FG000|Overall Study|Adverse Event|2|||
143493818|NCT02775851|517350149|FG000|Overall Study|Adverse Event|1|||
143493819|NCT02775851|517350150|FG001|Overall Study|Adverse Event|10|||
143493820|NCT02775851|517350149|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
143493821|NCT02775851|517350150|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
143493822|NCT02775851|517350149|FG000|Overall Study|Progression/Relapse|0|||
143493823|NCT02775851|517350150|FG001|Overall Study|Progression/Relapse|4|||
143493824|NCT02775851|517350149|FG000|Overall Study|Other - Not Protocol Specified|0|||
143493825|NCT02775851|517350150|FG001|Overall Study|Other - Not Protocol Specified|7|||
143493826|NCT02775851|517350149|FG000|Overall Study|Withdrawal by Subject|1|||
143493827|NCT02775851|517350150|FG001|Overall Study|Withdrawal by Subject|0|||
143493828|NCT02615990|517350158|FG000|Overall Study|study terminated|1|||
143493829|NCT02615990|517350159|FG001|Overall Study|study terminated|1|||
143493830|NCT00716976|517350160|FG000|Overall Study|Adverse Event|2|||
143493831|NCT00716976|517350161|FG001|Overall Study|Adverse Event|0|||
143493832|NCT00716976|517350160|FG000|Overall Study|Death|1|||
143493833|NCT00716976|517350161|FG001|Overall Study|Death|0|||
143493834|NCT00716976|517350160|FG000|Overall Study|Physician Decision|2|||
143493835|NCT00716976|517350161|FG001|Overall Study|Physician Decision|2|||
143493836|NCT00716976|517350160|FG000|Overall Study|Withdrawal by Subject|5|||
143493837|NCT00716976|517350161|FG001|Overall Study|Withdrawal by Subject|1|||
143493838|NCT00716976|517350160|FG000|Overall Study|Premature discontinuation cisplatin|5|||
143493839|NCT00716976|517350161|FG001|Overall Study|Premature discontinuation cisplatin|4|||
143493840|NCT00716976|517350160|FG000|Overall Study|Radiation during protocol|1|||
143031041|NCT06179108|515654677|FG001|Overall Study|Adverse Event|3|||
143031042|NCT06179108|515654678|FG002|Overall Study|Adverse Event|3|||
143031043|NCT06179108|515654679|FG003|Overall Study|Adverse Event|2|||
143031044|NCT06179108|515654676|FG000|Overall Study|Protocol Violation|0|||
143031045|NCT06179108|515654677|FG001|Overall Study|Protocol Violation|1|||
143493841|NCT00716976|517350161|FG001|Overall Study|Radiation during protocol|0|||
143493842|NCT00716976|517350160|FG000|Overall Study|Ineligibles|4|||
143493843|NCT00716976|517350161|FG001|Overall Study|Ineligibles|2|||
143493844|NCT02971202|517350162|FG000|Overall Study|Pregnancy|1|||
143493845|NCT02971202|517350163|FG001|Overall Study|Pregnancy|0|||
143493846|NCT02971202|517350164|FG002|Overall Study|Pregnancy|0|||
143493847|NCT02971202|517350162|FG000|Overall Study|screen fail after consent|1|||
143493848|NCT02971202|517350163|FG001|Overall Study|screen fail after consent|0|||
143493849|NCT02971202|517350164|FG002|Overall Study|screen fail after consent|1|||
143493850|NCT03472560|517350165|FG000|Overall Study|Subject transfer to continuation protocol|0|||
143031046|NCT06179108|515654678|FG002|Overall Study|Protocol Violation|0|||
143031047|NCT06179108|515654679|FG003|Overall Study|Protocol Violation|1|||
143031048|NCT06179108|515654676|FG000|Overall Study|Physician Decision|1|||
143031049|NCT06179108|515654677|FG001|Overall Study|Physician Decision|1|||
143031050|NCT06179108|515654678|FG002|Overall Study|Physician Decision|0|||
143031051|NCT06179108|515654679|FG003|Overall Study|Physician Decision|0|||
143031052|NCT06179108|515654676|FG000|Overall Study|Lack of Efficacy|0|||
143031053|NCT06179108|515654677|FG001|Overall Study|Lack of Efficacy|0|||
143031054|NCT06179108|515654678|FG002|Overall Study|Lack of Efficacy|0|||
143031055|NCT06179108|515654679|FG003|Overall Study|Lack of Efficacy|1|||
143031056|NCT06179108|515654676|FG000|Overall Study|Death|0|||
143031057|NCT06179108|515654677|FG001|Overall Study|Death|0|||
143031058|NCT06179108|515654678|FG002|Overall Study|Death|0|||
143031059|NCT06179108|515654679|FG003|Overall Study|Death|1|||
143031060|NCT02468778|515654680|FG000|Overall Study|Death|2|||
143031061|NCT02468778|515654681|FG001|Overall Study|Death|1|||
143031062|NCT02468778|515654682|FG002|Overall Study|Death|0|||
143031063|NCT02468778|515654680|FG000|Overall Study|Lost to Follow-up|1|||
143031064|NCT02468778|515654681|FG001|Overall Study|Lost to Follow-up|2|||
143031065|NCT02468778|515654682|FG002|Overall Study|Lost to Follow-up|2|||
143031066|NCT02468778|515654680|FG000|Overall Study|Withdrawal by Subject|0|||
143031067|NCT02468778|515654681|FG001|Overall Study|Withdrawal by Subject|1|||
143031068|NCT02468778|515654682|FG002|Overall Study|Withdrawal by Subject|1|||
143031069|NCT05295953|515654684|FG000|Overall Study|Withdrawal by Subject|0|||
143031070|NCT05295953|515654685|FG001|Overall Study|Withdrawal by Subject|1|||
143031071|NCT05694013|515654686|FG000|Overall Study|Death|6|||
143031072|NCT05694013|515654687|FG001|Overall Study|Death|2|||
143031073|NCT05694013|515654686|FG000|Overall Study|Participant Decision|0|||
143031074|NCT05694013|515654687|FG001|Overall Study|Participant Decision|1|||
143031075|NCT05694013|515654686|FG000|Overall Study|Physician Decision|1|||
143031076|NCT05694013|515654687|FG001|Overall Study|Physician Decision|0|||
143031077|NCT05694013|515654686|FG000|Overall Study|Progressive Disease|0|||
143031078|NCT05694013|515654687|FG001|Overall Study|Progressive Disease|1|||
143031079|NCT05694013|515654686|FG000|Overall Study|Study Terminated by Sponsor|12|||
143031080|NCT05694013|515654687|FG001|Overall Study|Study Terminated by Sponsor|17|||
143031081|NCT05694013|515654686|FG000|Overall Study|Withdrawal by Subject|3|||
143031082|NCT05694013|515654687|FG001|Overall Study|Withdrawal by Subject|0|||
143031083|NCT04333095|515654692|FG000|Overall Study|Protocol Violation|4|||
143031084|NCT04333095|515654693|FG001|Overall Study|Protocol Violation|0|||
143031085|NCT04333095|515654692|FG000|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|1|||
143031086|NCT04333095|515654693|FG001|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|4|||
143031087|NCT04333095|515654692|FG000|Overall Study|Mini Sternotomy|4|||
143031088|NCT04333095|515654693|FG001|Overall Study|Mini Sternotomy|5|||
143031089|NCT03257462|515654694|FG000|Cohort A|Lost to Follow-up|1|||
143031090|NCT03257462|515654695|FG001|Cohort A|Lost to Follow-up|0|||
143031091|NCT03257462|515654696|FG002|Cohort A|Lost to Follow-up|0|||
143031092|NCT03257462|515654697|FG003|Cohort A|Lost to Follow-up|0|||
143031093|NCT03257462|515654694|FG000|Cohort B|Discontinued due to Sponsor decision|0|||
143158903|NCT01727154|516126137|FG000|Overall Study|No Discontinuation Documentation|4|||
143158904|NCT01348490|516126144|FG000|Overall Study|Death|1|||
143237556|NCT00307801|516423370|FG001|Overall Study|Pregnancy|1|||
143237557|NCT03944577|516423373|FG000|Overall Study|Adverse Event|3|||
143237558|NCT00361296|516423375|FG000|Overall Study|Physician Decision|1|||
143237559|NCT00361296|516423375|FG000|Overall Study|Lack of Efficacy|2|||
143237560|NCT00391586|516423378|FG000|Overall Study|Progressive disease|13|||
143237561|NCT00391586|516423378|FG000|Overall Study|Adverse Event|5|||
143237562|NCT00391586|516423378|FG000|Overall Study|Physician Decision|2|||
143493851|NCT03472560|517350166|FG001|Overall Study|Subject transfer to continuation protocol|1|||
143493852|NCT03472560|517350165|FG000|Overall Study|Withdrawal by Subject|4|||
143493853|NCT03472560|517350166|FG001|Overall Study|Withdrawal by Subject|0|||
143158905|NCT01348490|516126144|FG000|Overall Study|Adverse Event|3|||
143158906|NCT01348490|516126144|FG000|Overall Study|Consent withdrawn|7|||
143158907|NCT01348490|516126144|FG000|Overall Study|Disease progression|3|||
143158908|NCT01348490|516126144|FG000|Overall Study|Lost to Follow-up|1|||
143158909|NCT01348490|516126144|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
143158910|NCT01348490|516126144|FG000|Overall Study|Other Unspecified|8|||
143158911|NCT01184118|516126145|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
143158912|NCT01184118|516126145|FG000|Overall Study|No physiologic confirmation of asthma|8|||
143237563|NCT00391586|516423378|FG000|Overall Study|Death|4|||
143237564|NCT00904982|516423379|FG000|Overall Study|Withdrawal by Subject|2|||
143493854|NCT03472560|517350165|FG000|Overall Study|Progressive disease|24|||
143493855|NCT03472560|517350166|FG001|Overall Study|Progressive disease|8|||
143031094|NCT03257462|515654695|FG001|Cohort B|Discontinued due to Sponsor decision|1|||
143031095|NCT03257462|515654696|FG002|Cohort B|Discontinued due to Sponsor decision|0|||
143031096|NCT03257462|515654697|FG003|Cohort B|Discontinued due to Sponsor decision|0|||
143031097|NCT00368277|515654698|FG000|Overall Study|Adverse Event|33|||
143031098|NCT00368277|515654699|FG001|Overall Study|Adverse Event|49|||
143031099|NCT00368277|515654698|FG000|Overall Study|Death|2|||
143493856|NCT03472560|517350165|FG000|Overall Study|Physician Decision|1|||
143031100|NCT00368277|515654699|FG001|Overall Study|Death|1|||
143031101|NCT00368277|515654698|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
143237565|NCT00904982|516423380|FG001|Overall Study|Withdrawal by Subject|0|||
143237566|NCT00904982|516423381|FG002|Overall Study|Withdrawal by Subject|0|||
143031102|NCT00368277|515654699|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
143031103|NCT00368277|515654698|FG000|Overall Study|Protocol deviation|7|||
143031104|NCT00368277|515654699|FG001|Overall Study|Protocol deviation|0|||
143031105|NCT00368277|515654698|FG000|Overall Study|Patient withdrew consent|32|||
143031106|NCT00368277|515654699|FG001|Overall Study|Patient withdrew consent|28|||
143031107|NCT00368277|515654698|FG000|Overall Study|Lost to Follow-up|8|||
143031108|NCT00368277|515654699|FG001|Overall Study|Lost to Follow-up|6|||
143031109|NCT03740165|515654700|FG000|Overall Study|Death|232|||
143031110|NCT03740165|515654701|FG001|Overall Study|Death|242|||
143031111|NCT03740165|515654702|FG002|Overall Study|Death|229|||
143031112|NCT03740165|515654700|FG000|Overall Study|Lost to Follow-up|0|||
143031113|NCT03740165|515654701|FG001|Overall Study|Lost to Follow-up|0|||
143031114|NCT03740165|515654702|FG002|Overall Study|Lost to Follow-up|1|||
143031115|NCT03740165|515654700|FG000|Overall Study|Withdrawal by Subject|7|||
143031116|NCT03740165|515654701|FG001|Overall Study|Withdrawal by Subject|4|||
143031117|NCT03740165|515654702|FG002|Overall Study|Withdrawal by Subject|3|||
143031118|NCT03740165|515654700|FG000|Overall Study|Ongoing in Study|216|||
143031119|NCT03740165|515654701|FG001|Overall Study|Ongoing in Study|212|||
143031120|NCT03740165|515654702|FG002|Overall Study|Ongoing in Study|221|||
143031121|NCT04347239|515654703|FG000|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|6|||
143031122|NCT04347239|515654704|FG001|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|0|||
143031123|NCT04347239|515654705|FG002|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|4|||
143031124|NCT04347239|515654703|FG000|Open Label|Pt enrolled but withdrew consent prior to dosing|1|||
143031125|NCT04347239|515654704|FG001|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
143031126|NCT04347239|515654705|FG002|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
143031127|NCT03049618|515654706|FG000|Overall Study|Death|1|||
143031128|NCT03049618|515654707|FG001|Overall Study|Death|0|||
143031129|NCT03049618|515654706|FG000|Overall Study|Lack of Efficacy|1|||
143031130|NCT03049618|515654707|FG001|Overall Study|Lack of Efficacy|2|||
143158913|NCT01184118|516126145|FG000|Overall Study|FEV1 <60% predicted|2|||
143158914|NCT01184118|516126145|FG000|Overall Study|Exclusionary medical condition|2|||
143493857|NCT03472560|517350166|FG001|Overall Study|Physician Decision|0|||
143493858|NCT03472560|517350165|FG000|Overall Study|Death|7|||
143493859|NCT03472560|517350166|FG001|Overall Study|Death|4|||
143493860|NCT03472560|517350165|FG000|Overall Study|Adverse Event|5|||
143493861|NCT03472560|517350166|FG001|Overall Study|Adverse Event|3|||
143493862|NCT03472560|517350165|FG000|Overall Study|Global deterioration of health status|0|||
143493863|NCT03472560|517350166|FG001|Overall Study|Global deterioration of health status|4|||
143493864|NCT01946178|517350167|FG000|Overall Study|Pregnancy|1|||
143493865|NCT01946178|517350167|FG000|Overall Study|Lost to Follow-up|1|||
143493866|NCT01534676|517350168|FG000|Overall Study|Study closed due to poor enrollment|2|||
143493867|NCT01534676|517350169|FG001|Overall Study|Study closed due to poor enrollment|1|||
143493868|NCT05425563|517350170|FG000|Overall Study|Withdrawal by Subject|17|||
143493869|NCT02222714|517350172|FG000|Overall Study|Death|0|||
143493870|NCT02222714|517350173|FG001|Overall Study|Death|2|||
143493871|NCT02222714|517350174|FG002|Overall Study|Death|3|||
143493872|NCT02222714|517350175|FG003|Overall Study|Death|4|||
143493873|NCT02222714|517350176|FG004|Overall Study|Death|6|||
143493874|NCT02222714|517350172|FG000|Overall Study|Withdrawal by Subject|0|||
143493875|NCT02222714|517350173|FG001|Overall Study|Withdrawal by Subject|0|||
143493876|NCT02222714|517350174|FG002|Overall Study|Withdrawal by Subject|1|||
143493877|NCT02222714|517350175|FG003|Overall Study|Withdrawal by Subject|0|||
143493878|NCT02222714|517350176|FG004|Overall Study|Withdrawal by Subject|1|||
143493879|NCT04161495|517350177|FG000|Overall Study|Withdrawal by Subject|3|||
143493880|NCT04161495|517350178|FG001|Overall Study|Withdrawal by Subject|0|||
143493881|NCT04161495|517350177|FG000|Overall Study|Protocol Violation|1|||
143493882|NCT04161495|517350178|FG001|Overall Study|Protocol Violation|0|||
143493883|NCT04161495|517350177|FG000|Overall Study|Prohibited concomitant medication|3|||
143158915|NCT01184118|516126145|FG000|Overall Study|Withdrawal by Subject|5|||
143158916|NCT01198548|516126146|FG000|Overall Study|Disease Progression|9|||
143158917|NCT01198548|516126146|FG000|Overall Study|Administrative Decision|1|||
143158918|NCT01793129|516128026|FG000|Overall Study|Lost to Follow-up|3|||
143158919|NCT01793129|516128027|FG001|Overall Study|Lost to Follow-up|7|||
143158920|NCT01793129|516128026|FG000|Overall Study|Withdrawal by Subject|0|||
143493884|NCT04161495|517350178|FG001|Overall Study|Prohibited concomitant medication|0|||
143493885|NCT04161495|517350177|FG000|Overall Study|Adverse Event|1|||
143493886|NCT04161495|517350178|FG001|Overall Study|Adverse Event|0|||
143493887|NCT04161495|517350177|FG000|Overall Study|Other - Unspecified|1|||
143031131|NCT00182091|515654708|FG000|Overall Study|Withdrawal by Subject|1|||
143031132|NCT00182091|515654709|FG001|Overall Study|Withdrawal by Subject|0|||
143158921|NCT01793129|516128027|FG001|Overall Study|Withdrawal by Subject|2|||
143158922|NCT01557244|516128030|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
143493888|NCT04161495|517350178|FG001|Overall Study|Other - Unspecified|0|||
143493889|NCT04161495|517350177|FG000|Overall Study|Death|0|||
143158923|NCT01557244|516128031|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
143493890|NCT04161495|517350178|FG001|Overall Study|Death|1|||
143031133|NCT00182091|515654710|FG002|Overall Study|Withdrawal by Subject|0|||
143031134|NCT00182091|515654711|FG003|Overall Study|Withdrawal by Subject|0|||
143031135|NCT01298570|515656152|FG000|Overall Study|Disease progression, relapse during acti|64|||
143031136|NCT01298570|515656153|FG001|Overall Study|Disease progression, relapse during acti|40|||
143031137|NCT01298570|515656152|FG000|Overall Study|Adverse Event|20|||
143031138|NCT01298570|515656153|FG001|Overall Study|Adverse Event|2|||
143031139|NCT01298570|515656152|FG000|Overall Study|Withdrawal by Subject|21|||
143031140|NCT01298570|515656153|FG001|Overall Study|Withdrawal by Subject|6|||
143031141|NCT01298570|515656152|FG000|Overall Study|Treatment delay > 4 weeks|4|||
143031142|NCT01298570|515656153|FG001|Overall Study|Treatment delay > 4 weeks|5|||
143031143|NCT01298570|515656152|FG000|Overall Study|Physician Decision|4|||
143031144|NCT01298570|515656153|FG001|Overall Study|Physician Decision|2|||
143031145|NCT01298570|515656152|FG000|Overall Study|Other complicating disease|2|||
143031146|NCT01298570|515656153|FG001|Overall Study|Other complicating disease|1|||
143031147|NCT01298570|515656152|FG000|Overall Study|Surgery|2|||
143031148|NCT01298570|515656153|FG001|Overall Study|Surgery|1|||
143031149|NCT01298570|515656152|FG000|Overall Study|Symptomatic progression/deterioration|3|||
143031150|NCT01298570|515656153|FG001|Overall Study|Symptomatic progression/deterioration|2|||
143031151|NCT01298570|515656152|FG000|Overall Study|Death|0|||
143031152|NCT01298570|515656153|FG001|Overall Study|Death|1|||
143031153|NCT01298570|515656152|FG000|Overall Study|Ineligibility|0|||
143031154|NCT01298570|515656153|FG001|Overall Study|Ineligibility|1|||
143031155|NCT01210001|515656154|FG000|Overall Study|Not treated|1|||
143031156|NCT01210001|515656155|FG001|Overall Study|Not treated|0|||
143031157|NCT01210001|515656156|FG002|Overall Study|Not treated|0|||
143031158|NCT01210001|515656154|FG000|Overall Study|Adverse Event|4|||
143031159|NCT01210001|515656155|FG001|Overall Study|Adverse Event|2|||
143031160|NCT01210001|515656156|FG002|Overall Study|Adverse Event|5|||
143031161|NCT01210001|515656154|FG000|Overall Study|Non compliant with protocol|2|||
143031162|NCT01210001|515656155|FG001|Overall Study|Non compliant with protocol|2|||
143031163|NCT01210001|515656156|FG002|Overall Study|Non compliant with protocol|3|||
143031164|NCT01210001|515656154|FG000|Overall Study|Lost to Follow-up|4|||
143031165|NCT01210001|515656155|FG001|Overall Study|Lost to Follow-up|3|||
143031166|NCT01210001|515656156|FG002|Overall Study|Lost to Follow-up|2|||
143031167|NCT01210001|515656154|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
143031168|NCT01210001|515656155|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
143031169|NCT01210001|515656156|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
143031170|NCT01210001|515656154|FG000|Overall Study|Other reason not defined above|2|||
143031171|NCT01210001|515656155|FG001|Overall Study|Other reason not defined above|2|||
143031172|NCT01210001|515656156|FG002|Overall Study|Other reason not defined above|1|||
143031173|NCT01402908|515656158|FG000|Overall Study|Withdrawal by Subject|30|||
143031174|NCT01402908|515656159|FG001|Overall Study|Withdrawal by Subject|17|||
143031175|NCT01402908|515656158|FG000|Overall Study|Lost to Follow-up|3|||
143031176|NCT01402908|515656159|FG001|Overall Study|Lost to Follow-up|1|||
143031177|NCT01402908|515656158|FG000|Overall Study|Physician Decision|1|||
143031178|NCT01402908|515656159|FG001|Overall Study|Physician Decision|0|||
143031179|NCT03103100|515656165|FG000|Overall Study|Adverse Event|1|||
143031180|NCT03103100|515656166|FG001|Overall Study|Adverse Event|0|||
143031181|NCT03103100|515656167|FG002|Overall Study|Adverse Event|0|||
143031182|NCT03103100|515656165|FG000|Overall Study|Physician Decision|1|||
143031183|NCT03103100|515656166|FG001|Overall Study|Physician Decision|0|||
143031184|NCT03103100|515656167|FG002|Overall Study|Physician Decision|2|||
143031185|NCT02906709|515656168|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
143031186|NCT02906709|515656169|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
143031187|NCT02906709|515656168|FG000|Phase A (Week 0 to Week 16)|Death|0|||
143031188|NCT02906709|515656169|FG001|Phase A (Week 0 to Week 16)|Death|1|||
143031189|NCT02906709|515656168|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
143031190|NCT02906709|515656169|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
143031191|NCT02906709|515656168|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
143031192|NCT02906709|515656169|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
143031193|NCT01124149|515656170|FG000|Acute Phase|Withdrawal by Subject|22|||
143031194|NCT01124149|515656170|FG000|Acute Phase|Adverse Event|21|||
143031195|NCT01124149|515656170|FG000|Acute Phase|Lack of Efficacy|17|||
143031196|NCT01124149|515656170|FG000|Acute Phase|Protocol Violation|14|||
143031197|NCT01124149|515656170|FG000|Acute Phase|Lost to Follow-up|2|||
143031198|NCT01124149|515656170|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
143031199|NCT01124149|515656170|FG000|Acute Phase|Sponsor request|1|||
143031200|NCT01124149|515656170|FG000|Acute Phase|UC symptoms not ameliorated|1|||
143031201|NCT01124149|515656170|FG000|Acute Phase|Non-compliance|1|||
143031202|NCT01124149|515656170|FG000|Acute Phase|Low hemoglobin|1|||
143031203|NCT01124149|515656170|FG000|Acute Phase|Travelling to another country|1|||
143031204|NCT01124149|515656170|FG000|Acute Phase|Sponsor decision|1|||
143237567|NCT00904982|516423382|FG003|Overall Study|Withdrawal by Subject|0|||
143031205|NCT01124149|515656170|FG000|Maintenance Phase|Lack of Efficacy|40|||
143031206|NCT01124149|515656170|FG000|Maintenance Phase|Adverse Event|24|||
143031207|NCT01124149|515656170|FG000|Maintenance Phase|Lost to Follow-up|15|||
143031208|NCT01124149|515656170|FG000|Maintenance Phase|Withdrawal by Subject|10|||
143031209|NCT01124149|515656170|FG000|Maintenance Phase|Protocol Violation|5|||
143031210|NCT01124149|515656170|FG000|Maintenance Phase|Coordinator error|1|||
143031211|NCT01124149|515656170|FG000|Maintenance Phase|Non-compliance|1|||
143031212|NCT01644500|515656171|FG000|Overall Study|Adverse Event|6|||
143031213|NCT01644500|515656172|FG001|Overall Study|Adverse Event|1|||
143031214|NCT01644500|515656173|FG002|Overall Study|Adverse Event|2|||
143031215|NCT01644500|515656171|FG000|Overall Study|Death|0|||
143031216|NCT01644500|515656172|FG001|Overall Study|Death|1|||
143031217|NCT01644500|515656173|FG002|Overall Study|Death|0|||
143031218|NCT01644500|515656171|FG000|Overall Study|Lost to Follow-up|3|||
143031219|NCT01644500|515656172|FG001|Overall Study|Lost to Follow-up|8|||
143031220|NCT01644500|515656173|FG002|Overall Study|Lost to Follow-up|0|||
143031221|NCT01644500|515656171|FG000|Overall Study|Protocol Violation|1|||
143031222|NCT01644500|515656172|FG001|Overall Study|Protocol Violation|1|||
143031223|NCT01644500|515656173|FG002|Overall Study|Protocol Violation|0|||
143031224|NCT01644500|515656171|FG000|Overall Study|Withdrawal by Subject|11|||
143031225|NCT01644500|515656172|FG001|Overall Study|Withdrawal by Subject|12|||
143031226|NCT01644500|515656173|FG002|Overall Study|Withdrawal by Subject|12|||
143031227|NCT01644500|515656171|FG000|Overall Study|Physician Decision|1|||
143031228|NCT01644500|515656172|FG001|Overall Study|Physician Decision|1|||
143031229|NCT01644500|515656173|FG002|Overall Study|Physician Decision|1|||
143031230|NCT01439165|515656180|FG000|Overall Study|Protocol Violation|3|||
143031231|NCT01439165|515656181|FG001|Overall Study|Protocol Violation|0|||
143031232|NCT01439165|515656180|FG000|Overall Study|Lost to Follow-up|11|||
143031233|NCT01439165|515656181|FG001|Overall Study|Lost to Follow-up|1|||
143031234|NCT01439165|515656180|FG000|Overall Study|Withdrawal by Subject|7|||
143031235|NCT01439165|515656181|FG001|Overall Study|Withdrawal by Subject|1|||
143031236|NCT03331042|515656185|FG000|Overall Study|Protocol Violation|1|||
143031237|NCT03331042|515656186|FG001|Overall Study|Protocol Violation|0|||
143031238|NCT03331042|515656187|FG002|Overall Study|Protocol Violation|0|||
143031239|NCT03331042|515656188|FG003|Overall Study|Protocol Violation|0|||
143031240|NCT03331042|515656185|FG000|Overall Study|Physician Decision|0|||
143031241|NCT03331042|515656186|FG001|Overall Study|Physician Decision|0|||
143031242|NCT03331042|515656187|FG002|Overall Study|Physician Decision|1|||
143031243|NCT03331042|515656188|FG003|Overall Study|Physician Decision|0|||
143031244|NCT03331042|515656185|FG000|Overall Study|Lost to Follow-up|0|||
143031245|NCT03331042|515656186|FG001|Overall Study|Lost to Follow-up|0|||
143031246|NCT03331042|515656187|FG002|Overall Study|Lost to Follow-up|0|||
143031247|NCT03331042|515656188|FG003|Overall Study|Lost to Follow-up|1|||
143031248|NCT00322491|515656192|FG000|Overall Study|Adverse Event|1|||
143031249|NCT00322491|515656193|FG001|Overall Study|Adverse Event|0|||
143031250|NCT00322491|515656192|FG000|Overall Study|Death|1|||
143031251|NCT00322491|515656193|FG001|Overall Study|Death|2|||
143031252|NCT00688064|515656195|FG000|Overall Study|Protocol Violation|0|||
143031253|NCT00688064|515656196|FG001|Overall Study|Protocol Violation|1|||
143031254|NCT00688064|515656195|FG000|Overall Study|Adverse Event|2|||
143031255|NCT00688064|515656196|FG001|Overall Study|Adverse Event|4|||
143031256|NCT00688064|515656195|FG000|Overall Study|Withdrawal by Subject|7|||
143031257|NCT00688064|515656196|FG001|Overall Study|Withdrawal by Subject|7|||
143031258|NCT00688064|515656195|FG000|Overall Study|Lost to Follow-up|10|||
143031259|NCT00688064|515656196|FG001|Overall Study|Lost to Follow-up|10|||
143031260|NCT00688064|515656195|FG000|Overall Study|Lack of Efficacy|0|||
143031261|NCT00688064|515656196|FG001|Overall Study|Lack of Efficacy|1|||
143031262|NCT00688064|515656195|FG000|Overall Study|Pregnancy|1|||
143031263|NCT00688064|515656196|FG001|Overall Study|Pregnancy|0|||
143031264|NCT00688064|515656195|FG000|Overall Study|Any other reasons|1|||
143031265|NCT00688064|515656196|FG001|Overall Study|Any other reasons|3|||
143158924|NCT01557244|516128032|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
143158925|NCT01557244|516128033|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
143158926|NCT01557244|516128034|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
143493891|NCT03655756|517350179|FG000|Overall Study|Death|1|||
143493892|NCT01340209|517350180|FG000|Overall Study|Adverse Event|1|||
143158927|NCT01557244|516128035|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
143158928|NCT01557244|516128036|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
143158929|NCT01557244|516128030|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
143493893|NCT01340209|517350181|FG001|Overall Study|Adverse Event|1|||
143031266|NCT02194998|515656197|FG000|On-HCV Treatment|Did not pick up study medication|0|||
143031267|NCT02194998|515656198|FG001|On-HCV Treatment|Did not pick up study medication|1|||
143031268|NCT02194998|515656199|FG002|On-HCV Treatment|Did not pick up study medication|0|||
143031269|NCT02194998|515656200|FG003|On-HCV Treatment|Did not pick up study medication|0|||
143031270|NCT02194998|515656197|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
143158930|NCT01557244|516128031|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
143237568|NCT01352793|516423387|FG000|Overall Study|Lost to Follow-up|289|||
143031271|NCT02194998|515656198|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
143031272|NCT02194998|515656199|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
143031273|NCT02194998|515656200|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
143031274|NCT02236130|515656201|FG000|Overall Study|Lost to Follow-up|7|||
143031275|NCT02236130|515656202|FG001|Overall Study|Lost to Follow-up|12|||
143031276|NCT00414765|515656212|FG000|Overall Study|Adverse Event|5|||
143031277|NCT00414765|515656213|FG001|Overall Study|Adverse Event|9|||
143031278|NCT00414765|515656212|FG000|Overall Study|Withdrawal by Subject|1|||
143031279|NCT00414765|515656213|FG001|Overall Study|Withdrawal by Subject|1|||
143031280|NCT00414765|515656212|FG000|Overall Study|Disease Progression|0|||
143031281|NCT00414765|515656213|FG001|Overall Study|Disease Progression|1|||
143031282|NCT01199861|515656214|FG000|Overall Study|Administrative problems|1|||
143031283|NCT01199861|515656215|FG001|Overall Study|Administrative problems|0|||
143031284|NCT01199861|515656214|FG000|Overall Study|Adverse Event|1|||
143031285|NCT01199861|515656215|FG001|Overall Study|Adverse Event|0|||
143031286|NCT04817891|515656216|FG000|Overall Study|Did not pass screening after consenting to participate|1|||
143031287|NCT04817891|515656216|FG000|Overall Study|Adverse Event|1|||
143031288|NCT04817891|515656216|FG000|Overall Study|Withdrawal by Subject|1|||
143031289|NCT05630547|515656217|FG000|Part A (Double-blind Period: 48 Weeks)|Other|0|||
143031290|NCT05630547|515656218|FG001|Part A (Double-blind Period: 48 Weeks)|Other|2|||
143031291|NCT05630547|515656219|FG002|Part A (Double-blind Period: 48 Weeks)|Other|0|||
143031292|NCT05630547|515656220|FG003|Part A (Double-blind Period: 48 Weeks)|Other|0|||
143031293|NCT05630547|515656217|FG000|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|8|||
143031294|NCT05630547|515656218|FG001|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|3|||
143031295|NCT05630547|515656219|FG002|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
143031296|NCT05630547|515656220|FG003|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
143031297|NCT05630547|515656217|FG000|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
143031298|NCT05630547|515656218|FG001|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|1|||
143031299|NCT05630547|515656219|FG002|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
143031300|NCT05630547|515656220|FG003|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
143031301|NCT05630547|515656217|FG000|Part A (Double-blind Period: 48 Weeks)|Adverse Event|1|||
143031302|NCT05630547|515656218|FG001|Part A (Double-blind Period: 48 Weeks)|Adverse Event|13|||
143031303|NCT05630547|515656219|FG002|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
143031304|NCT05630547|515656220|FG003|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
143031305|NCT05630547|515656217|FG000|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
143031306|NCT05630547|515656218|FG001|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|1|||
143031307|NCT05630547|515656219|FG002|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
143031308|NCT05630547|515656220|FG003|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
143031309|NCT05630547|515656217|FG000|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
143031310|NCT05630547|515656218|FG001|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
143031311|NCT05630547|515656219|FG002|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|72|||
143031312|NCT05630547|515656220|FG003|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|62|||
143031313|NCT05630547|515656217|FG000|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
143031314|NCT05630547|515656218|FG001|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
143031315|NCT05630547|515656219|FG002|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
143031316|NCT05630547|515656220|FG003|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|1|||
143031317|NCT05630547|515656217|FG000|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
143031318|NCT05630547|515656218|FG001|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
143031319|NCT05630547|515656219|FG002|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|1|||
143031320|NCT05630547|515656220|FG003|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|3|||
143031321|NCT05630547|515656217|FG000|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
143031322|NCT05630547|515656218|FG001|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
143031323|NCT05630547|515656219|FG002|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
143237569|NCT01352793|516423388|FG001|Overall Study|Lost to Follow-up|125|||
143237570|NCT01352793|516423387|FG000|Overall Study|Withdrawal by Subject|120|||
143237571|NCT01352793|516423388|FG001|Overall Study|Withdrawal by Subject|55|||
143237572|NCT01352793|516423387|FG000|Overall Study|Protocol Violation|44|||
143031324|NCT05630547|515656220|FG003|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
143237573|NCT01352793|516423388|FG001|Overall Study|Protocol Violation|23|||
143237574|NCT01352793|516423387|FG000|Overall Study|Adverse Event|44|||
143237575|NCT01352793|516423388|FG001|Overall Study|Adverse Event|10|||
143237576|NCT01352793|516423387|FG000|Overall Study|Physician Decision|1|||
143237577|NCT01352793|516423388|FG001|Overall Study|Physician Decision|0|||
143237578|NCT01352793|516423387|FG000|Overall Study|Pregnancy|26|||
143237579|NCT01352793|516423388|FG001|Overall Study|Pregnancy|8|||
143237580|NCT01352793|516423387|FG000|Overall Study|Other|25|||
143237581|NCT01352793|516423388|FG001|Overall Study|Other|7|||
143237582|NCT01352793|516423387|FG000|Overall Study|Medication error|2|||
143031325|NCT05630547|515656217|FG000|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
143237583|NCT01352793|516423388|FG001|Overall Study|Medication error|2|||
143031326|NCT05630547|515656218|FG001|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
143237584|NCT01352793|516423387|FG000|Overall Study|Death|1|||
143237585|NCT01352793|516423388|FG001|Overall Study|Death|0|||
143237586|NCT01352793|516423387|FG000|Overall Study|Randomized but not vaccinated|8|||
143237587|NCT01352793|516423388|FG001|Overall Study|Randomized but not vaccinated|0|||
143031327|NCT05630547|515656219|FG002|Part B (Open-label Period: 48 Weeks)|Adverse Event|3|||
143031328|NCT05630547|515656220|FG003|Part B (Open-label Period: 48 Weeks)|Adverse Event|1|||
143031329|NCT05049460|515656221|FG000|Overall Study|Withdrawal by Subject|2|||
143031330|NCT05049460|515656222|FG001|Overall Study|Withdrawal by Subject|2|||
143031331|NCT05049460|515656221|FG000|Overall Study|Lost to Follow-up|2|||
143031332|NCT05049460|515656222|FG001|Overall Study|Lost to Follow-up|2|||
143031333|NCT05097989|515656223|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
143031334|NCT05097989|515656224|FG001|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
143031335|NCT05097989|515656225|FG002|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
143031336|NCT05097989|515656226|FG003|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
143031337|NCT05097989|515656227|FG004|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
143031338|NCT05097989|515656228|FG005|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
143031339|NCT05097989|515656229|FG006|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
143031340|NCT05097989|515656230|FG007|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
143031341|NCT05097989|515656231|FG008|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
143031342|NCT05097989|515656223|FG000|Initial Evaluation Period (26 Weeks)|Death|0|||
143031343|NCT05097989|515656224|FG001|Initial Evaluation Period (26 Weeks)|Death|0|||
143031344|NCT05097989|515656225|FG002|Initial Evaluation Period (26 Weeks)|Death|0|||
143031345|NCT05097989|515656226|FG003|Initial Evaluation Period (26 Weeks)|Death|0|||
143031346|NCT05097989|515656227|FG004|Initial Evaluation Period (26 Weeks)|Death|0|||
143031347|NCT05097989|515656228|FG005|Initial Evaluation Period (26 Weeks)|Death|0|||
143031348|NCT05097989|515656229|FG006|Initial Evaluation Period (26 Weeks)|Death|1|||
143031349|NCT05097989|515656230|FG007|Initial Evaluation Period (26 Weeks)|Death|0|||
143031350|NCT05097989|515656231|FG008|Initial Evaluation Period (26 Weeks)|Death|0|||
143031351|NCT05097989|515656223|FG000|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
143031352|NCT05097989|515656224|FG001|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
143031353|NCT05097989|515656225|FG002|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
143031354|NCT05097989|515656226|FG003|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
143031355|NCT05097989|515656227|FG004|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
143031356|NCT05097989|515656228|FG005|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|2|||
143031357|NCT05097989|515656229|FG006|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
143031358|NCT05097989|515656230|FG007|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
143031359|NCT05097989|515656231|FG008|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
143031360|NCT05097989|515656223|FG000|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
143031361|NCT05097989|515656224|FG001|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
143031362|NCT05097989|515656225|FG002|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
143031363|NCT05097989|515656226|FG003|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
143031364|NCT05097989|515656227|FG004|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
143031365|NCT05097989|515656228|FG005|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
143031366|NCT05097989|515656229|FG006|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
143031367|NCT05097989|515656230|FG007|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|2|||
143031368|NCT05097989|515656231|FG008|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
143031369|NCT05097989|515656223|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
143031370|NCT05097989|515656224|FG001|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
143031371|NCT05097989|515656225|FG002|Initial Evaluation Period (26 Weeks)|Adverse Event|1|||
143031372|NCT05097989|515656226|FG003|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
143031373|NCT05097989|515656227|FG004|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
143031374|NCT05097989|515656228|FG005|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
143031375|NCT05097989|515656229|FG006|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
143031376|NCT05097989|515656230|FG007|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
143031377|NCT05097989|515656231|FG008|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
143031378|NCT05097989|515656223|FG000|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
143031379|NCT05097989|515656224|FG001|Extended Treatment Period (24 Weeks)|Pregnancy|1|||
143031380|NCT05097989|515656225|FG002|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
143031381|NCT05097989|515656226|FG003|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
143031382|NCT05097989|515656227|FG004|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
143237588|NCT01352793|516423387|FG000|Overall Study|No longer meets eligibility criteria|25|||
143237589|NCT01352793|516423388|FG001|Overall Study|No longer meets eligibility criteria|15|||
143237590|NCT01929317|516423391|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
143237591|NCT01929317|516423392|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
143237592|NCT01929317|516423391|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
143237593|NCT01929317|516423392|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
143031383|NCT05097989|515656228|FG005|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
143031384|NCT05097989|515656229|FG006|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
143031385|NCT05097989|515656230|FG007|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
143031386|NCT05097989|515656231|FG008|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
143237594|NCT01929317|516423391|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
143237595|NCT01929317|516423392|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
143237596|NCT01929317|516423391|FG000|Long-term Phase|Adverse Event|5|||
143237597|NCT01929317|516423392|FG001|Long-term Phase|Adverse Event|1|||
143237598|NCT01929317|516423391|FG000|Long-term Phase|Physician Decision|3|||
143237599|NCT01929317|516423392|FG001|Long-term Phase|Physician Decision|0|||
143237600|NCT01929317|516423391|FG000|Long-term Phase|Withdrawal by Subject|4|||
143237601|NCT01929317|516423392|FG001|Long-term Phase|Withdrawal by Subject|0|||
143237602|NCT01929317|516423391|FG000|Long-term Phase|Protocol Violation|1|||
143237603|NCT01929317|516423392|FG001|Long-term Phase|Protocol Violation|0|||
143237604|NCT01929317|516423391|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
143237605|NCT01929317|516423392|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
143237606|NCT01929317|516423391|FG000|Long-term Phase|Study Closed/Terminated|5|||
143237607|NCT01929317|516423392|FG001|Long-term Phase|Study Closed/Terminated|3|||
143237608|NCT02667119|516423393|FG000|Overall Study|Lost to Follow-up|3|||
143237609|NCT02667119|516423394|FG001|Overall Study|Lost to Follow-up|0|||
143031387|NCT05097989|515656223|FG000|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
143237610|NCT01523756|516423395|FG000|Baseline Period|Adverse Event|0|||
143237611|NCT01523756|516423396|FG001|Baseline Period|Adverse Event|1|||
143237612|NCT01523756|516423395|FG000|Test Period 1|Adverse Event|1|||
143237613|NCT01523756|516423396|FG001|Test Period 1|Adverse Event|0|||
143237614|NCT01523756|516423395|FG000|Test Period 2|Withdrawal by Subject|0|||
143237615|NCT01523756|516423396|FG001|Test Period 2|Withdrawal by Subject|1|||
143237616|NCT03783078|516423397|FG000|Overall Study|Death|31|||
143237617|NCT03783078|516423397|FG000|Overall Study|Sponsor Decision|23|||
143237618|NCT03783078|516423397|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
143237619|NCT02059278|516423401|FG000|Overall Study|Adverse Event|1|||
143237620|NCT02059278|516423402|FG001|Overall Study|Adverse Event|1|||
143237621|NCT02059278|516423401|FG000|Overall Study|Lost to Follow-up|1|||
143237622|NCT02059278|516423402|FG001|Overall Study|Lost to Follow-up|0|||
143237623|NCT02059278|516423401|FG000|Overall Study|Withdrawal by Subject|0|||
143237624|NCT02059278|516423402|FG001|Overall Study|Withdrawal by Subject|3|||
143237625|NCT02059278|516423401|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
143237626|NCT02059278|516423402|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
143237627|NCT05530252|516423403|FG000|Overall Study|Lost to Follow-up|1|||
143237628|NCT05530252|516423404|FG001|Overall Study|Lost to Follow-up|1|||
143237629|NCT05530252|516423405|FG002|Overall Study|Lost to Follow-up|1|||
143493894|NCT01340209|517350182|FG002|Overall Study|Adverse Event|2|||
143031388|NCT05097989|515656224|FG001|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
143031389|NCT05097989|515656225|FG002|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
143031390|NCT05097989|515656226|FG003|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
143031391|NCT05097989|515656227|FG004|Extended Treatment Period (24 Weeks)|Lost to Follow-up|1|||
143031392|NCT05097989|515656228|FG005|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
143031393|NCT05097989|515656229|FG006|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
143031394|NCT05097989|515656230|FG007|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
143031395|NCT05097989|515656231|FG008|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
143031396|NCT05097989|515656223|FG000|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
143031397|NCT05097989|515656224|FG001|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
143031398|NCT05097989|515656225|FG002|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
143031399|NCT05097989|515656226|FG003|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
143031400|NCT05097989|515656227|FG004|Extended Treatment Period (24 Weeks)|Adverse Event|1|||
143031401|NCT05097989|515656228|FG005|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
143031402|NCT05097989|515656229|FG006|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
143031403|NCT05097989|515656230|FG007|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
143031404|NCT05097989|515656231|FG008|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
143031405|NCT05097989|515656223|FG000|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
143031406|NCT05097989|515656224|FG001|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
143031407|NCT05097989|515656225|FG002|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
143031408|NCT05097989|515656226|FG003|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
143031409|NCT05097989|515656227|FG004|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
143031410|NCT05097989|515656228|FG005|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
143031411|NCT05097989|515656229|FG006|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
143237630|NCT00651742|516423410|FG000|Overall Study|Objective Disease Progression|22|||
143237631|NCT00651742|516423410|FG000|Overall Study|Toxicity|3|||
143493895|NCT01340209|517350180|FG000|Overall Study|Protocol Violation|1|||
143493896|NCT01340209|517350181|FG001|Overall Study|Protocol Violation|2|||
143493897|NCT01340209|517350182|FG002|Overall Study|Protocol Violation|1|||
143237632|NCT00651742|516423410|FG000|Overall Study|Investigator Judgment|1|||
143237633|NCT00651742|516423410|FG000|Overall Study|Withdrawal of Consent|1|||
143237634|NCT00651742|516423410|FG000|Overall Study|Enrolled but not treated|1|||
143237635|NCT01535040|516423411|FG000|Overall Study|Physician Decision|0|||
143493898|NCT01340209|517350180|FG000|Overall Study|Withdrawal by Subject|0|||
143031412|NCT05097989|515656230|FG007|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
143031413|NCT05097989|515656231|FG008|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
143031414|NCT05097989|515656223|FG000|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|4|||
143031415|NCT05097989|515656224|FG001|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|8|||
143031416|NCT05097989|515656225|FG002|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
143031417|NCT05097989|515656226|FG003|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|1|||
143031418|NCT05097989|515656227|FG004|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
143031419|NCT05097989|515656228|FG005|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
143031420|NCT05097989|515656229|FG006|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|7|||
143031421|NCT05097989|515656230|FG007|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
143031422|NCT05097989|515656231|FG008|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
143031423|NCT05097989|515656223|FG000|Extended Treatment Period (24 Weeks)|Death|0|||
143031424|NCT05097989|515656224|FG001|Extended Treatment Period (24 Weeks)|Death|0|||
143031425|NCT05097989|515656225|FG002|Extended Treatment Period (24 Weeks)|Death|0|||
143031426|NCT05097989|515656226|FG003|Extended Treatment Period (24 Weeks)|Death|0|||
143031427|NCT05097989|515656227|FG004|Extended Treatment Period (24 Weeks)|Death|0|||
143031428|NCT05097989|515656228|FG005|Extended Treatment Period (24 Weeks)|Death|0|||
143031429|NCT05097989|515656229|FG006|Extended Treatment Period (24 Weeks)|Death|0|||
143031430|NCT05097989|515656230|FG007|Extended Treatment Period (24 Weeks)|Death|1|||
143031431|NCT05097989|515656231|FG008|Extended Treatment Period (24 Weeks)|Death|0|||
143031432|NCT05097989|515656223|FG000|Open-label Extension Period (2 Years)|Adverse Event|0|||
143031433|NCT05097989|515656224|FG001|Open-label Extension Period (2 Years)|Adverse Event|0|||
143031434|NCT05097989|515656225|FG002|Open-label Extension Period (2 Years)|Adverse Event|0|||
143031435|NCT05097989|515656226|FG003|Open-label Extension Period (2 Years)|Adverse Event|0|||
143031436|NCT05097989|515656227|FG004|Open-label Extension Period (2 Years)|Adverse Event|1|||
143031437|NCT05097989|515656228|FG005|Open-label Extension Period (2 Years)|Adverse Event|0|||
143031438|NCT05097989|515656229|FG006|Open-label Extension Period (2 Years)|Adverse Event|0|||
143031439|NCT05097989|515656230|FG007|Open-label Extension Period (2 Years)|Adverse Event|0|||
143031440|NCT05097989|515656231|FG008|Open-label Extension Period (2 Years)|Adverse Event|0|||
143031441|NCT05097989|515656223|FG000|Open-label Extension Period (2 Years)|Withdrawal by Subject|1|||
143031442|NCT05097989|515656224|FG001|Open-label Extension Period (2 Years)|Withdrawal by Subject|2|||
143031443|NCT05097989|515656225|FG002|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
143031444|NCT05097989|515656226|FG003|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
143031445|NCT05097989|515656227|FG004|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
143031446|NCT05097989|515656228|FG005|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
143031447|NCT05097989|515656229|FG006|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
143158931|NCT01557244|516128032|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
143158932|NCT01557244|516128033|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
143158933|NCT01557244|516128034|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
143031448|NCT05097989|515656230|FG007|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
143031449|NCT05097989|515656231|FG008|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
143158934|NCT01557244|516128035|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
143158935|NCT01557244|516128036|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
143158936|NCT01557244|516128030|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
143158937|NCT01557244|516128031|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
143158938|NCT01557244|516128032|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
143158939|NCT01557244|516128033|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
143158940|NCT01557244|516128034|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
143158941|NCT01557244|516128035|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
143158942|NCT01557244|516128036|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
143158943|NCT01557244|516128030|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
143158944|NCT01557244|516128031|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
143158945|NCT01557244|516128032|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
143158946|NCT01557244|516128033|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
143158947|NCT01557244|516128034|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
143158948|NCT01557244|516128035|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
143158949|NCT01557244|516128036|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
143158950|NCT01557244|516128030|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
143158951|NCT01557244|516128031|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
143237636|NCT01535040|516423412|FG001|Overall Study|Physician Decision|1|||
143237637|NCT01535040|516423411|FG000|Overall Study|Withdrawal by Subject|13|||
143237638|NCT01535040|516423412|FG001|Overall Study|Withdrawal by Subject|10|||
143364031|NCT00293462|516875527|FG002|Overall Study|Lost to Follow-up|0|||
143493899|NCT01340209|517350181|FG001|Overall Study|Withdrawal by Subject|0|||
143493900|NCT01340209|517350182|FG002|Overall Study|Withdrawal by Subject|1|||
143493901|NCT01340209|517350180|FG000|Overall Study|Other reason not defined above|3|||
143493902|NCT01340209|517350181|FG001|Overall Study|Other reason not defined above|5|||
143493903|NCT01340209|517350182|FG002|Overall Study|Other reason not defined above|4|||
143493904|NCT00253630|517350183|FG000|Overall Study|ineligible|2|||
143493905|NCT03237065|517350186|FG000|Overall Study|Adverse Event|0|||
143493906|NCT03237065|517350187|FG001|Overall Study|Adverse Event|2|||
143493907|NCT03237065|517350186|FG000|Overall Study|Protocol Violation|0|||
143493908|NCT03237065|517350187|FG001|Overall Study|Protocol Violation|1|||
143493909|NCT03237065|517350186|FG000|Overall Study|Withdrawal by Subject|3|||
143493910|NCT03237065|517350187|FG001|Overall Study|Withdrawal by Subject|0|||
143493911|NCT03237065|517350186|FG000|Overall Study|Lost to Follow-up|1|||
143493912|NCT03237065|517350187|FG001|Overall Study|Lost to Follow-up|0|||
143493913|NCT03237065|517350186|FG000|Overall Study|Unable to obtain venous access|0|||
143493914|NCT03237065|517350187|FG001|Overall Study|Unable to obtain venous access|1|||
143493915|NCT00704964|517350189|FG000|Overall Study|Not completed on time|328|||
143493916|NCT00257010|517350190|FG000|Overall Study|Lack of Efficacy|11|||
143493917|NCT00257010|517350190|FG000|Overall Study|Lost to Follow-up|53|||
143493918|NCT00257010|517350190|FG000|Overall Study|Withdrawal by Subject|34|||
143493919|NCT00257010|517350190|FG000|Overall Study|Adverse Event|10|||
143493920|NCT00257010|517350190|FG000|Overall Study|various|11|||
143493921|NCT00257010|517350190|FG000|Overall Study|no headache reported|9|||
143493922|NCT01699087|517350192|FG000|Overall Study|Lost to Follow-up|7|||
143493923|NCT01699087|517350192|FG000|Overall Study|Screen failure (prior to treatment)|15|||
143493924|NCT01699087|517350192|FG000|Overall Study|Unable to make future visits|2|||
143493925|NCT00094757|517350193|FG000|Overall Study|Adverse Event|11|||
143493926|NCT00094757|517350194|FG001|Overall Study|Adverse Event|9|||
143493927|NCT00094757|517350195|FG002|Overall Study|Adverse Event|6|||
143493928|NCT00094757|517350193|FG000|Overall Study|Lack of Efficacy|11|||
143493929|NCT00094757|517350194|FG001|Overall Study|Lack of Efficacy|15|||
143493930|NCT00094757|517350195|FG002|Overall Study|Lack of Efficacy|8|||
143493931|NCT00094757|517350193|FG000|Overall Study|Lost to Follow-up|3|||
143493932|NCT00094757|517350194|FG001|Overall Study|Lost to Follow-up|5|||
143493933|NCT00094757|517350195|FG002|Overall Study|Lost to Follow-up|6|||
143493934|NCT00094757|517350193|FG000|Overall Study|Patient Moved|2|||
143493935|NCT00094757|517350194|FG001|Overall Study|Patient Moved|1|||
143493936|NCT00094757|517350195|FG002|Overall Study|Patient Moved|1|||
143493937|NCT00094757|517350193|FG000|Overall Study|Protocol Violation|8|||
143493938|NCT00094757|517350194|FG001|Overall Study|Protocol Violation|5|||
143493939|NCT00094757|517350195|FG002|Overall Study|Protocol Violation|3|||
143493940|NCT00094757|517350193|FG000|Overall Study|Withdrawal by Subject|14|||
143493941|NCT00094757|517350194|FG001|Overall Study|Withdrawal by Subject|21|||
143493942|NCT00094757|517350195|FG002|Overall Study|Withdrawal by Subject|5|||
143493943|NCT00094757|517350193|FG000|Overall Study|Other|3|||
143493944|NCT00094757|517350194|FG001|Overall Study|Other|3|||
143493945|NCT00094757|517350195|FG002|Overall Study|Other|1|||
143493946|NCT00094757|517350193|FG000|Overall Study|Protocol specified discontinuation|1|||
143493947|NCT00094757|517350194|FG001|Overall Study|Protocol specified discontinuation|3|||
143493948|NCT00094757|517350195|FG002|Overall Study|Protocol specified discontinuation|0|||
143493949|NCT04823949|517350196|FG000|Overall Study|Withdrawal by Subject|0|||
143493950|NCT04823949|517350197|FG001|Overall Study|Withdrawal by Subject|4|||
143493951|NCT04823949|517350196|FG000|Overall Study|Physician Decision|0|||
143493952|NCT04823949|517350197|FG001|Overall Study|Physician Decision|1|||
143493953|NCT00441545|517350199|FG000|First Intervention|Adverse Event|6|||
143493954|NCT00441545|517350200|FG001|First Intervention|Adverse Event|5|||
143493955|NCT00441545|517350199|FG000|First Intervention|Protocol Violation|2|||
143158952|NCT01557244|516128032|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
143158953|NCT01557244|516128033|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
143158954|NCT01557244|516128034|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
143158955|NCT01557244|516128035|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
143493956|NCT00441545|517350200|FG001|First Intervention|Protocol Violation|2|||
143493957|NCT00441545|517350199|FG000|First Intervention|Withdrawal by Subject|3|||
143493958|NCT00441545|517350200|FG001|First Intervention|Withdrawal by Subject|3|||
143493959|NCT00441545|517350199|FG000|First Intervention|Kidney transplant|1|||
143493960|NCT00441545|517350200|FG001|First Intervention|Kidney transplant|1|||
143493961|NCT00441545|517350199|FG000|First Intervention|Lack of Efficacy|2|||
143493962|NCT00441545|517350200|FG001|First Intervention|Lack of Efficacy|0|||
143493963|NCT00441545|517350199|FG000|First Intervention|Subject exceeded safety criteria|0|||
143493964|NCT00441545|517350200|FG001|First Intervention|Subject exceeded safety criteria|1|||
143493965|NCT00441545|517350199|FG000|First Intervention|Subject met an exclusionary criteria|1|||
143493966|NCT00441545|517350200|FG001|First Intervention|Subject met an exclusionary criteria|0|||
143493967|NCT00441545|517350199|FG000|First Intervention|Extended hospitalization|1|||
143493968|NCT00441545|517350200|FG001|First Intervention|Extended hospitalization|0|||
143493969|NCT00441545|517350199|FG000|First Intervention|Site error|1|||
143031450|NCT05097989|515656223|FG000|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|4|||
143031451|NCT05097989|515656224|FG001|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|12|||
143031452|NCT05097989|515656225|FG002|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
143031453|NCT05097989|515656226|FG003|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|8|||
143031454|NCT05097989|515656227|FG004|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
143031455|NCT05097989|515656228|FG005|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|2|||
143031456|NCT05097989|515656229|FG006|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
143031457|NCT05097989|515656230|FG007|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
143031458|NCT05097989|515656231|FG008|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|6|||
143031459|NCT00918567|515656232|FG000|Overall Study|Lack of Efficacy|3|||
143031460|NCT00918567|515656233|FG001|Overall Study|Lack of Efficacy|1|||
143031461|NCT00918567|515656232|FG000|Overall Study|Withdrawal by Subject|1|||
143031462|NCT00918567|515656233|FG001|Overall Study|Withdrawal by Subject|1|||
143031463|NCT00918567|515656232|FG000|Overall Study|Adverse Event|1|||
143031464|NCT00918567|515656233|FG001|Overall Study|Adverse Event|0|||
143031465|NCT03283709|515656243|FG000|Overall Study|trial terminated|0|||
143031466|NCT03283709|515656244|FG001|Overall Study|trial terminated|1|||
143031467|NCT00117949|515656245|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
143031468|NCT00117949|515656246|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
143031469|NCT00117949|515656247|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
143031470|NCT00117949|515656248|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
143031471|NCT00117949|515656245|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
143031472|NCT00117949|515656246|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
143031473|NCT00117949|515656247|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
143031474|NCT00117949|515656248|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
143031475|NCT00117949|515656245|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
143031476|NCT00117949|515656246|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
143031477|NCT00117949|515656247|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
143031478|NCT00117949|515656248|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
143031479|NCT00117949|515656245|FG000|Overall Study|PSA increase >=10ng/mL|0|||
143031480|NCT00117949|515656246|FG001|Overall Study|PSA increase >=10ng/mL|1|||
143031481|NCT00117949|515656247|FG002|Overall Study|PSA increase >=10ng/mL|1|||
143031482|NCT00117949|515656248|FG003|Overall Study|PSA increase >=10ng/mL|0|||
143031483|NCT00117949|515656245|FG000|Overall Study|PSA reduction <=50%|0|||
143031484|NCT00117949|515656246|FG001|Overall Study|PSA reduction <=50%|2|||
143031485|NCT00117949|515656247|FG002|Overall Study|PSA reduction <=50%|2|||
143031486|NCT00117949|515656248|FG003|Overall Study|PSA reduction <=50%|4|||
143031487|NCT00117949|515656245|FG000|Overall Study|Hepatic abnormalities|0|||
143031488|NCT00117949|515656246|FG001|Overall Study|Hepatic abnormalities|1|||
143031489|NCT00117949|515656247|FG002|Overall Study|Hepatic abnormalities|0|||
143031490|NCT00117949|515656248|FG003|Overall Study|Hepatic abnormalities|1|||
143031491|NCT05275998|515656249|FG000|Overall Study|Adverse Event|0|||
143031492|NCT05275998|515656250|FG001|Overall Study|Adverse Event|0|||
143031493|NCT05275998|515656251|FG002|Overall Study|Adverse Event|0|||
143031494|NCT05275998|515656252|FG003|Overall Study|Adverse Event|1|||
143031495|NCT05275998|515656249|FG000|Overall Study|Withdrawal by Subject|0|||
143031496|NCT05275998|515656250|FG001|Overall Study|Withdrawal by Subject|0|||
143031497|NCT05275998|515656251|FG002|Overall Study|Withdrawal by Subject|0|||
143031498|NCT05275998|515656252|FG003|Overall Study|Withdrawal by Subject|1|||
143031499|NCT05275998|515656249|FG000|Overall Study|Physician Decision|0|||
143031500|NCT05275998|515656250|FG001|Overall Study|Physician Decision|0|||
143031501|NCT05275998|515656251|FG002|Overall Study|Physician Decision|0|||
143031502|NCT05275998|515656252|FG003|Overall Study|Physician Decision|1|||
143031503|NCT05275998|515656249|FG000|Overall Study|Protocol Violation|0|||
143031504|NCT05275998|515656250|FG001|Overall Study|Protocol Violation|0|||
143031505|NCT05275998|515656251|FG002|Overall Study|Protocol Violation|1|||
143031506|NCT05275998|515656252|FG003|Overall Study|Protocol Violation|0|||
143031507|NCT01867242|515656257|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
143031508|NCT01867242|515656258|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
143031509|NCT01867242|515656259|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
143031510|NCT00264810|515656262|FG000|Baseline|Withdrawal by Subject|10|||
143158956|NCT01557244|516128036|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
143158957|NCT01557244|516128030|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
143158958|NCT01557244|516128031|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
143158959|NCT01557244|516128032|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
143158960|NCT01557244|516128033|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
143158961|NCT01557244|516128034|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
143158962|NCT01557244|516128035|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
143031511|NCT00264810|515656263|FG001|Baseline|Withdrawal by Subject|10|||
143493970|NCT00441545|517350200|FG001|First Intervention|Site error|0|||
143031512|NCT00264810|515656262|FG000|Baseline|Physician Decision|7|||
143031513|NCT00264810|515656263|FG001|Baseline|Physician Decision|8|||
143031514|NCT00264810|515656262|FG000|Baseline|Subject Compliance Failure|3|||
143031515|NCT00264810|515656263|FG001|Baseline|Subject Compliance Failure|3|||
143031516|NCT00264810|515656262|FG000|Baseline|Insufficient Seizure Frequency|2|||
143493971|NCT00441545|517350199|FG000|First Intervention|Sponsor's request|1|||
143493972|NCT00441545|517350200|FG001|First Intervention|Sponsor's request|0|||
143493973|NCT00441545|517350199|FG000|Second Intervention|Adverse Event|5|||
143493974|NCT00441545|517350200|FG001|Second Intervention|Adverse Event|2|||
143493975|NCT00441545|517350199|FG000|Second Intervention|Protocol Violation|4|||
143493976|NCT00441545|517350200|FG001|Second Intervention|Protocol Violation|1|||
143493977|NCT00441545|517350199|FG000|Second Intervention|Withdrawal by Subject|1|||
143493978|NCT00441545|517350200|FG001|Second Intervention|Withdrawal by Subject|1|||
143493979|NCT00441545|517350199|FG000|Second Intervention|Kidney Transplant|1|||
143493980|NCT00441545|517350200|FG001|Second Intervention|Kidney Transplant|1|||
143493981|NCT00441545|517350199|FG000|Second Intervention|Lack of Efficacy|0|||
143493982|NCT00441545|517350200|FG001|Second Intervention|Lack of Efficacy|1|||
143493983|NCT00441545|517350199|FG000|Second Intervention|Subject exceeded safety criteria|1|||
143493984|NCT00441545|517350200|FG001|Second Intervention|Subject exceeded safety criteria|0|||
143493985|NCT00441545|517350199|FG000|Second Intervention|Subject moved|0|||
143493986|NCT00441545|517350200|FG001|Second Intervention|Subject moved|1|||
143493987|NCT04849780|517350207|FG000|Period 1|Covid-19 Related|1|||
143493988|NCT04849780|517350208|FG001|Period 1|Covid-19 Related|0|||
143493989|NCT04849780|517350207|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
143493990|NCT04849780|517350208|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
143493991|NCT04849780|517350207|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
143493992|NCT04849780|517350208|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
143493993|NCT01353703|517350211|FG000|Overall Study|Migrated/moved from study area|1|||
143493994|NCT01353703|517350212|FG001|Overall Study|Migrated/moved from study area|0|||
143493995|NCT03033875|517350216|FG000|Overall Study|Withdrawal by Subject|5|||
143493996|NCT03033875|517350217|FG001|Overall Study|Withdrawal by Subject|9|||
143493997|NCT03033875|517350218|FG002|Overall Study|Withdrawal by Subject|4|||
143493998|NCT03033875|517350216|FG000|Overall Study|Other|14|||
143493999|NCT03033875|517350217|FG001|Overall Study|Other|15|||
143494000|NCT03033875|517350218|FG002|Overall Study|Other|8|||
143494001|NCT04925752|517350219|FG000|Overall Study|Still on Study|1826|||
143494002|NCT04925752|517350220|FG001|Overall Study|Still on Study|926|||
143494003|NCT04925752|517350219|FG000|Overall Study|Withdrew Consent|128|||
143494004|NCT04925752|517350220|FG001|Overall Study|Withdrew Consent|59|||
143494005|NCT04925752|517350219|FG000|Overall Study|Lost to Follow-up|73|||
143494006|NCT04925752|517350220|FG001|Overall Study|Lost to Follow-up|47|||
143494007|NCT04925752|517350219|FG000|Overall Study|Randomized but Never Treated|12|||
143494008|NCT04925752|517350220|FG001|Overall Study|Randomized but Never Treated|9|||
143494009|NCT04925752|517350219|FG000|Overall Study|Hiv-1 Infection|6|||
143494010|NCT04925752|517350220|FG001|Overall Study|Hiv-1 Infection|7|||
143494011|NCT04925752|517350219|FG000|Overall Study|Investigator's discretion|8|||
143494012|NCT04925752|517350220|FG001|Overall Study|Investigator's discretion|5|||
143494013|NCT04925752|517350219|FG000|Overall Study|Non-compliance with Study Drug|8|||
143494014|NCT04925752|517350220|FG001|Overall Study|Non-compliance with Study Drug|5|||
143494015|NCT04925752|517350219|FG000|Overall Study|Adverse Event|5|||
143494016|NCT04925752|517350220|FG001|Overall Study|Adverse Event|2|||
143494017|NCT04925752|517350219|FG000|Overall Study|Death|4|||
143494018|NCT04925752|517350220|FG001|Overall Study|Death|2|||
143494019|NCT04925752|517350219|FG000|Overall Study|Protocol Violation|1|||
143494020|NCT04925752|517350220|FG001|Overall Study|Protocol Violation|3|||
143494021|NCT04925752|517350219|FG000|Overall Study|Withdrew Assent|1|||
143494022|NCT04925752|517350220|FG001|Overall Study|Withdrew Assent|0|||
143494023|NCT02286947|517350223|FG000|Overall Study|Withdrawal by Subject|2|||
143494024|NCT01614093|517350224|FG000|Overall Study|Withdrawal by Subject|1|||
143494025|NCT00915343|517350227|FG000|Part B - Open Label Period|Treatment switch|0|||
143494026|NCT00915343|517350228|FG001|Part B - Open Label Period|Treatment switch|0|||
143494027|NCT00915343|517350229|FG002|Part B - Open Label Period|Treatment switch|1|||
143031517|NCT00264810|515656263|FG001|Baseline|Insufficient Seizure Frequency|2|||
143031518|NCT00264810|515656262|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
143494028|NCT00915343|517350227|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
143494029|NCT00915343|517350228|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
143494030|NCT00915343|517350229|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
143494031|NCT01972074|517350230|FG000|Overall Study|Adverse Event|4|||
143494032|NCT01972074|517350231|FG001|Overall Study|Adverse Event|1|||
143494033|NCT01972074|517350232|FG002|Overall Study|Adverse Event|0|||
143494034|NCT01972074|517350230|FG000|Overall Study|Lack of Efficacy|1|||
143494035|NCT01972074|517350231|FG001|Overall Study|Lack of Efficacy|1|||
143494036|NCT01972074|517350232|FG002|Overall Study|Lack of Efficacy|0|||
143494037|NCT01972074|517350230|FG000|Overall Study|Lost to Follow-up|0|||
143494038|NCT01972074|517350231|FG001|Overall Study|Lost to Follow-up|1|||
143494039|NCT01972074|517350232|FG002|Overall Study|Lost to Follow-up|1|||
143494040|NCT01972074|517350230|FG000|Overall Study|Withdrawal by Subject|1|||
143237639|NCT01535040|516423411|FG000|Overall Study|Never Started|9|||
143031519|NCT00264810|515656263|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
143031520|NCT00264810|515656262|FG000|Baseline|Other|0|||
143031521|NCT00264810|515656263|FG001|Baseline|Other|1|||
143031522|NCT00264810|515656262|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
143031523|NCT00264810|515656263|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
143031524|NCT00264810|515656262|FG000|Stimulation Optimization Period|Death|0|||
143031525|NCT00264810|515656263|FG001|Stimulation Optimization Period|Death|1|||
143031526|NCT00264810|515656262|FG000|Blinded Evaluation Period|Explant due to infection|1|||
143031527|NCT00264810|515656263|FG001|Blinded Evaluation Period|Explant due to infection|1|||
143031528|NCT00264810|515656262|FG000|Open Label Evaluation Period|Explant due to infection|1|||
143031529|NCT00264810|515656263|FG001|Open Label Evaluation Period|Explant due to infection|1|||
143031530|NCT00264810|515656262|FG000|Open Label Evaluation Period|Death|3|||
143031531|NCT00264810|515656263|FG001|Open Label Evaluation Period|Death|2|||
143031532|NCT00264810|515656262|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
143031533|NCT00264810|515656263|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
143031534|NCT04803357|515656266|FG000|Overall Study|Withdrawal by Subject|31|||
143031535|NCT04803357|515656267|FG001|Overall Study|Withdrawal by Subject|5|||
143031536|NCT02199509|515656268|FG000|Overall Study|Suicidal Ideation|0|||
143031537|NCT02199509|515656269|FG001|Overall Study|Suicidal Ideation|1|||
143031538|NCT02199509|515656268|FG000|Overall Study|Misunderstood titration schedule|1|||
143031539|NCT02199509|515656269|FG001|Overall Study|Misunderstood titration schedule|0|||
143031540|NCT01658943|515656271|FG000|Overall Study|Adverse Event|6|||
143031541|NCT01658943|515656272|FG001|Overall Study|Adverse Event|13|||
143031542|NCT01658943|515656271|FG000|Overall Study|Withdrawal by Subject|9|||
143031543|NCT01658943|515656272|FG001|Overall Study|Withdrawal by Subject|2|||
143031544|NCT01658943|515656271|FG000|Overall Study|Progression/Relapse|39|||
143031545|NCT01658943|515656272|FG001|Overall Study|Progression/Relapse|40|||
143031546|NCT01658943|515656271|FG000|Overall Study|Death|4|||
143031547|NCT01658943|515656272|FG001|Overall Study|Death|2|||
143031548|NCT01658943|515656271|FG000|Overall Study|not protocol specified|4|||
143031549|NCT01658943|515656272|FG001|Overall Study|not protocol specified|1|||
143031550|NCT01658943|515656271|FG000|Overall Study|Not eligible|7|||
143031551|NCT01658943|515656272|FG001|Overall Study|Not eligible|9|||
143031552|NCT01658943|515656271|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
143031553|NCT01658943|515656272|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
143031554|NCT05905783|515656273|FG000|Overall Study|Lost to Follow-up|12|||
143031555|NCT05905783|515656274|FG001|Overall Study|Lost to Follow-up|18|||
143031556|NCT05905783|515656273|FG000|Overall Study|Withdrawal by Subject|29|||
143031557|NCT05905783|515656274|FG001|Overall Study|Withdrawal by Subject|37|||
143031558|NCT05905783|515656273|FG000|Overall Study|Decision by sponsor|69|||
143031559|NCT05905783|515656274|FG001|Overall Study|Decision by sponsor|65|||
143031560|NCT02093689|515656275|FG000|Overall Study|Physician Decision|4|||
143031561|NCT02093689|515656276|FG001|Overall Study|Physician Decision|0|||
143031562|NCT02093689|515656277|FG002|Overall Study|Physician Decision|0|||
143031563|NCT00475020|515656278|FG000|Overall Study|Physician Decision|3|||
143031564|NCT00475020|515656278|FG000|Overall Study|Insurance Denial|1|||
143031565|NCT00475020|515656278|FG000|Overall Study|Donor not able to donate the last minute|1|||
143031566|NCT03481309|515656279|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
143031567|NCT03481309|515656280|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
143031568|NCT03481309|515656281|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
143031569|NCT03481309|515656282|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
143031570|NCT03481309|515656283|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
143031571|NCT03481309|515656284|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
143031572|NCT03309956|515656285|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
143031573|NCT02768298|515656286|FG000|Overall Study|Adverse Event|1|||
143031574|NCT02768298|515656287|FG001|Overall Study|Adverse Event|4|||
143031575|NCT02768298|515656286|FG000|Overall Study|Death|2|||
143031576|NCT02768298|515656287|FG001|Overall Study|Death|1|||
143031577|NCT02768298|515656286|FG000|Overall Study|Non-compliance with study treatment|0|||
143031578|NCT02768298|515656287|FG001|Overall Study|Non-compliance with study treatment|1|||
143031579|NCT02768298|515656286|FG000|Overall Study|Subject/guardian decision|1|||
143031580|NCT02768298|515656287|FG001|Overall Study|Subject/guardian decision|0|||
143031581|NCT02768298|515656286|FG000|Overall Study|Withdrawal of informed consent|0|||
143031582|NCT02768298|515656287|FG001|Overall Study|Withdrawal of informed consent|1|||
143031583|NCT04603937|515656288|FG000|Overall Study|Adverse Event|9|||
143031584|NCT04603937|515656289|FG001|Overall Study|Adverse Event|10|||
143031585|NCT04603937|515656288|FG000|Overall Study|Withdrawal by Subject|7|||
143031586|NCT04603937|515656289|FG001|Overall Study|Withdrawal by Subject|6|||
143031587|NCT04603937|515656288|FG000|Overall Study|Lost to Follow-up|5|||
143031588|NCT04603937|515656289|FG001|Overall Study|Lost to Follow-up|6|||
143031589|NCT04603937|515656288|FG000|Overall Study|Physician Decision|0|||
143031590|NCT04603937|515656289|FG001|Overall Study|Physician Decision|1|||
143031591|NCT04603937|515656288|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
143031592|NCT04603937|515656289|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
143494041|NCT01972074|517350231|FG001|Overall Study|Withdrawal by Subject|1|||
143031593|NCT01611090|515656290|FG000|Randomized Period|Lost to Follow-up|8|||
143031594|NCT01611090|515656291|FG001|Randomized Period|Lost to Follow-up|3|||
143031595|NCT01611090|515656292|FG002|Randomized Period|Lost to Follow-up|0|||
143031596|NCT01611090|515656290|FG000|Randomized Period|Withdrawal by Subject|22|||
143031597|NCT01611090|515656291|FG001|Randomized Period|Withdrawal by Subject|26|||
143031598|NCT01611090|515656292|FG002|Randomized Period|Withdrawal by Subject|0|||
143031599|NCT01611090|515656290|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
143031600|NCT01611090|515656291|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
143031601|NCT01611090|515656292|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
143031602|NCT01611090|515656290|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
143031603|NCT01611090|515656291|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
143031604|NCT01611090|515656292|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
143031605|NCT00336024|515656294|FG000|Overall Study|Death|2|||
143031606|NCT00336024|515656295|FG001|Overall Study|Death|1|||
143031607|NCT00336024|515656294|FG000|Overall Study|Physician Decision|4|||
143031608|NCT00336024|515656295|FG001|Overall Study|Physician Decision|1|||
143031609|NCT00336024|515656294|FG000|Overall Study|Protocol Violation|1|||
143031610|NCT00336024|515656295|FG001|Overall Study|Protocol Violation|0|||
143031611|NCT00336024|515656294|FG000|Overall Study|Withdrawal by Subject|1|||
143031612|NCT00336024|515656295|FG001|Overall Study|Withdrawal by Subject|2|||
143031613|NCT00336024|515656294|FG000|Overall Study|Failure to fulfill consolidation|1|||
143031614|NCT00336024|515656295|FG001|Overall Study|Failure to fulfill consolidation|1|||
143031615|NCT00336024|515656294|FG000|Overall Study|Progressive Disease|4|||
143031616|NCT00336024|515656295|FG001|Overall Study|Progressive Disease|7|||
143031617|NCT00336024|515656294|FG000|Overall Study|Ineligible|7|||
143031618|NCT00336024|515656295|FG001|Overall Study|Ineligible|7|||
143031619|NCT05125952|515656296|FG000|Overall Study|Physician Decision|1|||
143031620|NCT03946449|515656297|FG000|Treatment Extension II|Rolled over to another study|0|||
143031621|NCT03946449|515656298|FG001|Treatment Extension II|Rolled over to another study|0|||
143031622|NCT03946449|515656299|FG002|Treatment Extension II|Rolled over to another study|2|||
143158963|NCT01557244|516128036|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
143158964|NCT01557244|516128030|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
143158965|NCT01557244|516128031|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
143158966|NCT01557244|516128032|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
143158967|NCT01557244|516128033|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
143158968|NCT01557244|516128034|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
143158969|NCT01557244|516128035|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
143237640|NCT01535040|516423412|FG001|Overall Study|Never Started|4|||
143237641|NCT01535040|516423411|FG000|Overall Study|Toxicity|7|||
143494042|NCT01972074|517350232|FG002|Overall Study|Withdrawal by Subject|1|||
143494043|NCT01972074|517350230|FG000|Overall Study|Scanner Unavailable|0|||
143494044|NCT01972074|517350231|FG001|Overall Study|Scanner Unavailable|0|||
143494045|NCT01972074|517350232|FG002|Overall Study|Scanner Unavailable|1|||
143494046|NCT00911989|517350233|FG000|Overall Study|Adverse Event|1|||
143494047|NCT03064841|517350234|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
143494048|NCT03064841|517350234|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
143494049|NCT03064841|517350234|FG000|Overall Study|Screen failure|2|||
143494050|NCT01145066|517350235|FG000|Overall Study|To resume NSAIDs|2|||
143494051|NCT01145066|517350236|FG001|Overall Study|To resume NSAIDs|2|||
143494052|NCT01145066|517350237|FG002|Overall Study|To resume NSAIDs|1|||
143494053|NCT01145066|517350235|FG000|Overall Study|Non-related surgery|0|||
143237642|NCT01535040|516423412|FG001|Overall Study|Toxicity|5|||
143237643|NCT01535040|516423411|FG000|Overall Study|Multiple Reasons|1|||
143237644|NCT01535040|516423412|FG001|Overall Study|Multiple Reasons|1|||
143494054|NCT01145066|517350236|FG001|Overall Study|Non-related surgery|0|||
143494055|NCT01145066|517350237|FG002|Overall Study|Non-related surgery|1|||
143494056|NCT01145066|517350235|FG000|Overall Study|Withdrawal by Subject|0|||
143031623|NCT03946449|515656297|FG000|Treatment Extension II|Withdrawal by Subject|0|||
143031624|NCT03946449|515656298|FG001|Treatment Extension II|Withdrawal by Subject|0|||
143031625|NCT03946449|515656299|FG002|Treatment Extension II|Withdrawal by Subject|1|||
143031626|NCT05067504|515656301|FG000|Period 2 (Day 180)|Lost to Follow-up|0|||
143031627|NCT05067504|515656302|FG001|Period 2 (Day 180)|Lost to Follow-up|1|||
143031628|NCT05067504|515656301|FG000|Period 2 (Day 180)|Withdrawal by Subject|1|||
143237645|NCT01074970|516423413|FG000|Overall Study|Never Treated|0|||
143494057|NCT01145066|517350236|FG001|Overall Study|Withdrawal by Subject|0|||
143494058|NCT01145066|517350237|FG002|Overall Study|Withdrawal by Subject|2|||
143031629|NCT05067504|515656302|FG001|Period 2 (Day 180)|Withdrawal by Subject|0|||
143031630|NCT05067504|515656301|FG000|Period 2 (Day 180)|Not reconsented for Period 2|3|||
143031631|NCT05067504|515656302|FG001|Period 2 (Day 180)|Not reconsented for Period 2|0|||
143494059|NCT01145066|517350235|FG000|Overall Study|To start new med|1|||
143494060|NCT01145066|517350236|FG001|Overall Study|To start new med|0|||
143494061|NCT01145066|517350237|FG002|Overall Study|To start new med|0|||
143031632|NCT05665595|515657999|FG000|Overall Study|Ongoing|692|||
143031633|NCT05665595|515658000|FG001|Overall Study|Ongoing|698|||
143031634|NCT05665595|515657999|FG000|Overall Study|Withdrawal by Subject|2|||
143031635|NCT05665595|515658000|FG001|Overall Study|Withdrawal by Subject|2|||
143031636|NCT05665595|515657999|FG000|Overall Study|Lost to Follow-up|1|||
143031637|NCT05665595|515658000|FG001|Overall Study|Lost to Follow-up|0|||
143031638|NCT05665595|515657999|FG000|Overall Study|Death|6|||
143031639|NCT05665595|515658000|FG001|Overall Study|Death|1|||
143031640|NCT05771428|515658001|FG000|Overall Study|Adverse Event|0|||
143031641|NCT05771428|515658002|FG001|Overall Study|Adverse Event|1|||
143031642|NCT05771428|515658003|FG002|Overall Study|Adverse Event|1|||
143031643|NCT05771428|515658004|FG003|Overall Study|Adverse Event|1|||
143031644|NCT05771428|515658001|FG000|Overall Study|Withdrawal by Subject|3|||
143031645|NCT05771428|515658002|FG001|Overall Study|Withdrawal by Subject|2|||
143031646|NCT05771428|515658003|FG002|Overall Study|Withdrawal by Subject|1|||
143031647|NCT05771428|515658004|FG003|Overall Study|Withdrawal by Subject|4|||
143031648|NCT05771428|515658001|FG000|Overall Study|Other|0|||
143031649|NCT05771428|515658002|FG001|Overall Study|Other|1|||
143031650|NCT05771428|515658003|FG002|Overall Study|Other|2|||
143031651|NCT05771428|515658004|FG003|Overall Study|Other|1|||
143031652|NCT05771428|515658001|FG000|Overall Study|Randomized but Not Treated|0|||
143031653|NCT05771428|515658002|FG001|Overall Study|Randomized but Not Treated|0|||
143031654|NCT05771428|515658003|FG002|Overall Study|Randomized but Not Treated|1|||
143031655|NCT05771428|515658004|FG003|Overall Study|Randomized but Not Treated|0|||
143031656|NCT04025229|515658005|FG000|Overall Study|Adverse Event|1|||
143031657|NCT04025229|515658006|FG001|Overall Study|Adverse Event|0|||
143031658|NCT04025229|515658005|FG000|Overall Study|Withdrawal by Subject|0|||
143031659|NCT04025229|515658006|FG001|Overall Study|Withdrawal by Subject|2|||
143031660|NCT04025229|515658005|FG000|Overall Study|Death|0|||
143031661|NCT04025229|515658006|FG001|Overall Study|Death|1|||
143031662|NCT04025229|515658005|FG000|Overall Study|Physician Decision|0|||
143031663|NCT04025229|515658006|FG001|Overall Study|Physician Decision|1|||
143494062|NCT01145066|517350235|FG000|Overall Study|problems swallowing capsule|1|||
143494063|NCT01145066|517350236|FG001|Overall Study|problems swallowing capsule|0|||
143158970|NCT01557244|516128036|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
143158971|NCT01557244|516128030|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
143158972|NCT01557244|516128031|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
143158973|NCT01557244|516128032|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
143158974|NCT01557244|516128033|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
143158975|NCT01557244|516128034|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
143158976|NCT01557244|516128035|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
143158977|NCT01557244|516128036|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
143158978|NCT01557244|516128030|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
143158979|NCT01557244|516128031|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
143158980|NCT01557244|516128032|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
143158981|NCT01557244|516128033|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
143158982|NCT01557244|516128034|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
143158983|NCT01557244|516128035|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
143158984|NCT01557244|516128036|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
143158985|NCT01557244|516128030|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
143158986|NCT01557244|516128031|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
143158987|NCT01557244|516128032|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
143158988|NCT01557244|516128033|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
143158989|NCT01557244|516128034|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
143158990|NCT01557244|516128035|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
143158991|NCT01557244|516128036|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
143158992|NCT01557244|516128030|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
143158993|NCT01557244|516128031|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
143158994|NCT01557244|516128032|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
143158995|NCT01557244|516128033|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
143158996|NCT01557244|516128034|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
143158997|NCT01557244|516128035|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
143031664|NCT03815942|515658007|FG000|Overall Study|Withdrawal by Subject|0|||
143158998|NCT01557244|516128036|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
143158999|NCT01557244|516128030|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
143494064|NCT01145066|517350237|FG002|Overall Study|problems swallowing capsule|0|||
143031665|NCT03815942|515658008|FG001|Overall Study|Withdrawal by Subject|17|||
143031666|NCT03717064|515658009|FG000|Period 2|Adverse Event|1|||
143031667|NCT00076102|515658010|FG000|Overall Study|Clinical progression|1|||
143031668|NCT00076102|515658010|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
143031669|NCT00076102|515658010|FG000|Overall Study|plexiform neurofibroma surgery|1|||
143031670|NCT00076102|515658010|FG000|Overall Study|refusal of further therapy|2|||
143031671|NCT02180711|515658011|FG000|Overall Study|Death|0|||
143031672|NCT02180711|515658012|FG001|Overall Study|Death|1|||
143031673|NCT02180711|515658013|FG002|Overall Study|Death|0|||
143031674|NCT02180711|515658014|FG003|Overall Study|Death|0|||
143031675|NCT02180711|515658015|FG004|Overall Study|Death|7|||
143031676|NCT02180711|515658016|FG005|Overall Study|Death|0|||
143031677|NCT02180711|515658017|FG006|Overall Study|Death|1|||
143031678|NCT02180711|515658018|FG007|Overall Study|Death|3|||
143031679|NCT02180711|515658011|FG000|Overall Study|Lost to Follow-up|0|||
143031680|NCT02180711|515658012|FG001|Overall Study|Lost to Follow-up|1|||
143031681|NCT02180711|515658013|FG002|Overall Study|Lost to Follow-up|0|||
143031682|NCT02180711|515658014|FG003|Overall Study|Lost to Follow-up|0|||
143031683|NCT02180711|515658015|FG004|Overall Study|Lost to Follow-up|1|||
143031684|NCT02180711|515658016|FG005|Overall Study|Lost to Follow-up|1|||
143031685|NCT02180711|515658017|FG006|Overall Study|Lost to Follow-up|0|||
143031686|NCT02180711|515658018|FG007|Overall Study|Lost to Follow-up|3|||
143031687|NCT02180711|515658011|FG000|Overall Study|Withdrawal by Subject|2|||
143031688|NCT02180711|515658012|FG001|Overall Study|Withdrawal by Subject|1|||
143031689|NCT02180711|515658013|FG002|Overall Study|Withdrawal by Subject|0|||
143031690|NCT02180711|515658014|FG003|Overall Study|Withdrawal by Subject|4|||
143031691|NCT02180711|515658015|FG004|Overall Study|Withdrawal by Subject|3|||
143031692|NCT02180711|515658016|FG005|Overall Study|Withdrawal by Subject|0|||
143031693|NCT02180711|515658017|FG006|Overall Study|Withdrawal by Subject|3|||
143031694|NCT02180711|515658018|FG007|Overall Study|Withdrawal by Subject|2|||
143031695|NCT02180711|515658011|FG000|Overall Study|- Disease Progression|0|||
143031696|NCT02180711|515658012|FG001|Overall Study|- Disease Progression|1|||
143031697|NCT02180711|515658013|FG002|Overall Study|- Disease Progression|0|||
143031698|NCT02180711|515658014|FG003|Overall Study|- Disease Progression|0|||
143031699|NCT02180711|515658015|FG004|Overall Study|- Disease Progression|0|||
143031700|NCT02180711|515658016|FG005|Overall Study|- Disease Progression|0|||
143031701|NCT02180711|515658017|FG006|Overall Study|- Disease Progression|0|||
143031702|NCT02180711|515658018|FG007|Overall Study|- Disease Progression|0|||
143031703|NCT02180711|515658011|FG000|Overall Study|- Subject Started Alternative Cancer Therapy|7|||
143031704|NCT02180711|515658012|FG001|Overall Study|- Subject Started Alternative Cancer Therapy|6|||
143031705|NCT02180711|515658013|FG002|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
143031706|NCT02180711|515658014|FG003|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
143031707|NCT02180711|515658015|FG004|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
143031708|NCT02180711|515658016|FG005|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
143031709|NCT02180711|515658017|FG006|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
143031710|NCT02180711|515658018|FG007|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
143031711|NCT02180711|515658011|FG000|Overall Study|- Study Terminated by Sponsor|2|||
143031712|NCT02180711|515658012|FG001|Overall Study|- Study Terminated by Sponsor|3|||
143031713|NCT02180711|515658013|FG002|Overall Study|- Study Terminated by Sponsor|0|||
143031714|NCT02180711|515658014|FG003|Overall Study|- Study Terminated by Sponsor|5|||
143031715|NCT02180711|515658015|FG004|Overall Study|- Study Terminated by Sponsor|32|||
143031716|NCT02180711|515658016|FG005|Overall Study|- Study Terminated by Sponsor|0|||
143031717|NCT02180711|515658017|FG006|Overall Study|- Study Terminated by Sponsor|4|||
143031718|NCT02180711|515658018|FG007|Overall Study|- Study Terminated by Sponsor|13|||
143031719|NCT02180711|515658011|FG000|Overall Study|- Enrolled into Follow-up Study|0|||
143031720|NCT02180711|515658012|FG001|Overall Study|- Enrolled into Follow-up Study|0|||
143031721|NCT02180711|515658013|FG002|Overall Study|- Enrolled into Follow-up Study|0|||
143031722|NCT02180711|515658014|FG003|Overall Study|- Enrolled into Follow-up Study|1|||
143031723|NCT02180711|515658015|FG004|Overall Study|- Enrolled into Follow-up Study|0|||
143031724|NCT02180711|515658016|FG005|Overall Study|- Enrolled into Follow-up Study|0|||
143031725|NCT02180711|515658017|FG006|Overall Study|- Enrolled into Follow-up Study|0|||
143031726|NCT02180711|515658018|FG007|Overall Study|- Enrolled into Follow-up Study|0|||
143031727|NCT02180711|515658011|FG000|Overall Study|- Other|1|||
143031728|NCT02180711|515658012|FG001|Overall Study|- Other|0|||
143159000|NCT01557244|516128031|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
143159001|NCT01557244|516128032|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
143159002|NCT01557244|516128033|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
143159003|NCT01557244|516128034|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
143159004|NCT01557244|516128035|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
143031729|NCT02180711|515658013|FG002|Overall Study|- Other|0|||
143031730|NCT02180711|515658014|FG003|Overall Study|- Other|1|||
143031731|NCT02180711|515658015|FG004|Overall Study|- Other|0|||
143031732|NCT02180711|515658016|FG005|Overall Study|- Other|0|||
143031733|NCT02180711|515658017|FG006|Overall Study|- Other|0|||
143031734|NCT02180711|515658018|FG007|Overall Study|- Other|0|||
143159005|NCT01557244|516128036|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
143031735|NCT01739790|515658023|FG000|Overall Study|Early Trial Termination|2|||
143031736|NCT01739790|515658024|FG001|Overall Study|Early Trial Termination|4|||
143159006|NCT03931785|516128037|FG000|Overall Study|Lost to Follow-up|4|||
143237646|NCT01074970|516423414|FG001|Overall Study|Never Treated|0|||
143031737|NCT02581345|515658025|FG000|Part 1: up to Week 16|Adverse Event|3|||
143031738|NCT02581345|515658026|FG001|Part 1: up to Week 16|Adverse Event|8|||
143031739|NCT02581345|515658027|FG002|Part 1: up to Week 16|Adverse Event|0|||
143031740|NCT02581345|515658028|FG003|Part 1: up to Week 16|Adverse Event|0|||
143031741|NCT02581345|515658025|FG000|Part 1: up to Week 16|Physician Decision|2|||
143031742|NCT02581345|515658026|FG001|Part 1: up to Week 16|Physician Decision|4|||
143031743|NCT02581345|515658027|FG002|Part 1: up to Week 16|Physician Decision|0|||
143031744|NCT02581345|515658028|FG003|Part 1: up to Week 16|Physician Decision|0|||
143031745|NCT02581345|515658025|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
143031746|NCT02581345|515658026|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
143031747|NCT02581345|515658027|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
143031748|NCT02581345|515658028|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
143031749|NCT02581345|515658025|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
143031750|NCT02581345|515658026|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
143031751|NCT02581345|515658027|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
143031752|NCT02581345|515658028|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
143031753|NCT02581345|515658025|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
143031754|NCT02581345|515658026|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
143031755|NCT02581345|515658027|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
143031756|NCT02581345|515658028|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
143031757|NCT02581345|515658025|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
143031758|NCT02581345|515658026|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
143031759|NCT02581345|515658027|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
143031760|NCT02581345|515658028|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
143031761|NCT02581345|515658025|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
143031762|NCT02581345|515658026|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
143031763|NCT02581345|515658027|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
143031764|NCT02581345|515658028|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
143031765|NCT02581345|515658025|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
143031766|NCT02581345|515658026|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
143031767|NCT02581345|515658027|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
143031768|NCT02581345|515658028|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
143031769|NCT02581345|515658025|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
143031770|NCT02581345|515658026|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
143031771|NCT02581345|515658027|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
143031772|NCT02581345|515658028|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
143031773|NCT02581345|515658025|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
143031774|NCT02581345|515658026|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
143031775|NCT02581345|515658027|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
143031776|NCT02581345|515658028|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
143031777|NCT02581345|515658025|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
143031778|NCT02581345|515658026|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
143031779|NCT02581345|515658027|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
143031780|NCT02581345|515658028|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
143031781|NCT02581345|515658025|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
143031782|NCT02581345|515658026|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
143031783|NCT02581345|515658027|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
143031784|NCT02581345|515658028|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
143031785|NCT01374919|515658031|FG000|Overall Study|Withdrawal by Subject|2|||
143031786|NCT00366899|515658032|FG000|Infant Series|Withdrawal by Subject|4|||
143031787|NCT00366899|515658033|FG001|Infant Series|Withdrawal by Subject|7|||
143031788|NCT00366899|515658032|FG000|Infant Series|Protocol Violation|2|||
143031789|NCT00366899|515658033|FG001|Infant Series|Protocol Violation|1|||
143031790|NCT00366899|515658032|FG000|Infant Series|Failed to return|1|||
143364032|NCT00293462|516875525|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
143494065|NCT01145066|517350235|FG000|Overall Study|Abdominal discomfort|0|||
143494066|NCT01145066|517350236|FG001|Overall Study|Abdominal discomfort|1|||
143494067|NCT01145066|517350237|FG002|Overall Study|Abdominal discomfort|0|||
143494068|NCT01145066|517350235|FG000|Overall Study|Low platelet count|0|||
143494069|NCT01145066|517350236|FG001|Overall Study|Low platelet count|1|||
143031791|NCT00366899|515658033|FG001|Infant Series|Failed to return|1|||
143031792|NCT00366899|515658032|FG000|Infant Series|Lost to Follow-up|0|||
143031793|NCT00366899|515658033|FG001|Infant Series|Lost to Follow-up|2|||
143031794|NCT00366899|515658032|FG000|Infant Series|Adverse Event|0|||
143031795|NCT00366899|515658033|FG001|Infant Series|Adverse Event|1|||
143031796|NCT00366899|515658032|FG000|Infant Series|Physician Decision|1|||
143031797|NCT00366899|515658033|FG001|Infant Series|Physician Decision|0|||
143031798|NCT00366899|515658032|FG000|Infant Series|Randomized but not consented|1|||
143031799|NCT00366899|515658033|FG001|Infant Series|Randomized but not consented|0|||
143031800|NCT00366899|515658032|FG000|After Infant Series|Lost to Follow-up|4|||
143031801|NCT00366899|515658033|FG001|After Infant Series|Lost to Follow-up|3|||
143031802|NCT00366899|515658032|FG000|After Infant Series|Withdrawal by Subject|1|||
143031803|NCT00366899|515658033|FG001|After Infant Series|Withdrawal by Subject|4|||
143494070|NCT01145066|517350237|FG002|Overall Study|Low platelet count|0|||
143494071|NCT03920670|517350238|FG000|Overall Study|Protocol Violation|2|||
143494072|NCT03920670|517350239|FG001|Overall Study|Protocol Violation|2|||
143494073|NCT03920670|517350238|FG000|Overall Study|Adverse Event|1|||
143494074|NCT03920670|517350239|FG001|Overall Study|Adverse Event|0|||
143494075|NCT03687502|517350240|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
143494076|NCT03687502|517350240|FG000|Overall Study|Lumason not available|1|||
143494077|NCT01777581|517350241|FG000|Overall Study|Lost to Follow-up|1|||
143494078|NCT01777581|517350242|FG001|Overall Study|Lost to Follow-up|1|||
143494079|NCT01777581|517350241|FG000|Overall Study|Adverse Event|2|||
143494080|NCT01777581|517350242|FG001|Overall Study|Adverse Event|0|||
143494081|NCT01777581|517350241|FG000|Overall Study|Lack of Efficacy|0|||
143494082|NCT01777581|517350242|FG001|Overall Study|Lack of Efficacy|1|||
143494083|NCT04820309|517350245|FG000|Overall Study|Adverse Event|96|||
143494084|NCT04820309|517350245|FG000|Overall Study|ineligible for further treatment according to inclusion/exclusion criteria|1|||
143494085|NCT04820309|517350245|FG000|Overall Study|Consent Withdrawn|93|||
143494086|NCT04820309|517350245|FG000|Overall Study|failure to adhere to protocol|32|||
143494087|NCT04820309|517350245|FG000|Overall Study|alcohol or drug use|6|||
143494088|NCT04820309|517350245|FG000|Overall Study|Lost to Follow-up|46|||
143494089|NCT04820309|517350245|FG000|Overall Study|Death|2|||
143494090|NCT04820309|517350245|FG000|Overall Study|Pregnancy|1|||
143494091|NCT04820309|517350245|FG000|Overall Study|Other reasons|12|||
143494092|NCT04811716|517350250|FG000|Overall Study|Withdrawal by Subject|2|||
143494093|NCT04811716|517350251|FG001|Overall Study|Withdrawal by Subject|0|||
143494094|NCT04202679|517350252|FG000|Overall Study|Adverse Event|2|||
143494095|NCT04202679|517350253|FG001|Overall Study|Adverse Event|0|||
143494096|NCT04202679|517350252|FG000|Overall Study|Poor compliance to protocol|1|||
143494097|NCT04202679|517350253|FG001|Overall Study|Poor compliance to protocol|0|||
143031804|NCT00366899|515658032|FG000|After Infant Series|Adverse Event|1|||
143031805|NCT00366899|515658033|FG001|After Infant Series|Adverse Event|2|||
143031806|NCT00366899|515658032|FG000|After Infant Series|Protocol Violation|1|||
143031807|NCT00366899|515658033|FG001|After Infant Series|Protocol Violation|0|||
143031808|NCT00366899|515658032|FG000|Toddler Dose|Withdrawal by Subject|1|||
143494098|NCT04202679|517350252|FG000|Overall Study|Withdrawal by Subject|23|||
143494099|NCT04202679|517350253|FG001|Overall Study|Withdrawal by Subject|6|||
143494100|NCT02321436|517350254|FG000|Overall Study|Withdrawal by Subject|1|||
143494101|NCT02321436|517350255|FG001|Overall Study|Withdrawal by Subject|0|||
143494102|NCT02321436|517350254|FG000|Overall Study|Lost to Follow-up|0|||
143494103|NCT02321436|517350255|FG001|Overall Study|Lost to Follow-up|1|||
143494104|NCT03048422|517350258|FG000|Overall Study|Death|1|||
143494105|NCT03048422|517350259|FG001|Overall Study|Death|0|||
143494106|NCT03048422|517350260|FG002|Overall Study|Death|0|||
143494107|NCT03048422|517350258|FG000|Overall Study|Lost to Follow-up|5|||
143494108|NCT03048422|517350259|FG001|Overall Study|Lost to Follow-up|0|||
143494109|NCT03048422|517350260|FG002|Overall Study|Lost to Follow-up|1|||
143494110|NCT03048422|517350258|FG000|Overall Study|Withdrawal by Subject|5|||
143494111|NCT03048422|517350259|FG001|Overall Study|Withdrawal by Subject|7|||
143494112|NCT03048422|517350260|FG002|Overall Study|Withdrawal by Subject|4|||
143494113|NCT03048422|517350258|FG000|Overall Study|Moved|3|||
143494114|NCT03048422|517350259|FG001|Overall Study|Moved|2|||
143494115|NCT03048422|517350260|FG002|Overall Study|Moved|2|||
143494116|NCT03048422|517350258|FG000|Overall Study|Noncompliant with Study Requirements|2|||
143494117|NCT03048422|517350259|FG001|Overall Study|Noncompliant with Study Requirements|1|||
143494118|NCT03048422|517350260|FG002|Overall Study|Noncompliant with Study Requirements|2|||
143494119|NCT03048422|517350258|FG000|Overall Study|Not Able to Get to Clinic|1|||
143494120|NCT03048422|517350259|FG001|Overall Study|Not Able to Get to Clinic|0|||
143494121|NCT03048422|517350260|FG002|Overall Study|Not Able to Get to Clinic|0|||
143494122|NCT02482129|517350261|FG000|Overall Study|Adverse Event-prior to treatment|0|||
143494123|NCT02482129|517350262|FG001|Overall Study|Adverse Event-prior to treatment|1|||
143494124|NCT02482129|517350261|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
143494125|NCT02482129|517350262|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
143031809|NCT00366899|515658033|FG001|Toddler Dose|Withdrawal by Subject|1|||
143031810|NCT00366899|515658032|FG000|Toddler Dose|Protocol Violation|1|||
143031811|NCT00366899|515658033|FG001|Toddler Dose|Protocol Violation|0|||
143494126|NCT02482129|517350261|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
143494127|NCT02482129|517350262|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
143494128|NCT02482129|517350261|FG000|Overall Study|Criteria not met-prior to treatment|1|||
143159007|NCT03931785|516128038|FG001|Overall Study|Lost to Follow-up|1|||
143494129|NCT02482129|517350262|FG001|Overall Study|Criteria not met-prior to treatment|0|||
143494130|NCT02482129|517350261|FG000|Overall Study|Adverse Event|1|||
143494131|NCT02482129|517350262|FG001|Overall Study|Adverse Event|0|||
143494132|NCT02482129|517350261|FG000|Overall Study|Withdrawal by Subject|2|||
143494133|NCT02482129|517350262|FG001|Overall Study|Withdrawal by Subject|0|||
143494134|NCT02482129|517350261|FG000|Overall Study|Criteria not met|1|||
143494135|NCT02482129|517350262|FG001|Overall Study|Criteria not met|0|||
143159008|NCT03931785|516128039|FG002|Overall Study|Lost to Follow-up|4|||
143494136|NCT01928381|517350263|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
143494137|NCT01928381|517350264|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
143494138|NCT01928381|517350265|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
143494139|NCT01928381|517350266|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
143494140|NCT01928381|517350267|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
143494141|NCT01928381|517350268|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
143494142|NCT01928381|517350269|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
143494143|NCT01928381|517350263|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
143494144|NCT01928381|517350264|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
143494145|NCT01928381|517350265|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
143494146|NCT01928381|517350266|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
143494147|NCT01928381|517350267|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
143494148|NCT01928381|517350268|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
143494149|NCT01928381|517350269|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
143494150|NCT01928381|517350263|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
143494151|NCT01928381|517350264|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
143494152|NCT01928381|517350265|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
143494153|NCT01928381|517350266|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
143494154|NCT01928381|517350267|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
143494155|NCT01928381|517350268|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
143494156|NCT01928381|517350269|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
143494157|NCT01928381|517350263|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
143494158|NCT01928381|517350264|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
143494159|NCT01928381|517350265|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
143494160|NCT01928381|517350266|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
143494161|NCT01928381|517350267|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
143494162|NCT01928381|517350268|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
143494163|NCT01928381|517350269|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
143494164|NCT01928381|517350263|FG000|Part 1 - Pain Training|Protocol Violation|1|||
143494165|NCT01928381|517350264|FG001|Part 1 - Pain Training|Protocol Violation|0|||
143494166|NCT01928381|517350265|FG002|Part 1 - Pain Training|Protocol Violation|0|||
143494167|NCT01928381|517350266|FG003|Part 1 - Pain Training|Protocol Violation|0|||
143494168|NCT01928381|517350267|FG004|Part 1 - Pain Training|Protocol Violation|0|||
143494169|NCT01928381|517350268|FG005|Part 1 - Pain Training|Protocol Violation|0|||
143494170|NCT01928381|517350269|FG006|Part 1 - Pain Training|Protocol Violation|0|||
143494171|NCT01928381|517350263|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
143494172|NCT01928381|517350264|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
143494173|NCT01928381|517350265|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
143494174|NCT01928381|517350266|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
143494175|NCT01928381|517350267|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
143494176|NCT01928381|517350268|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
143494177|NCT01928381|517350269|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
143494178|NCT01928381|517350263|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
143494179|NCT01928381|517350264|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
143494180|NCT01928381|517350265|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
143494181|NCT01928381|517350266|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
143494182|NCT01928381|517350267|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
143494183|NCT01928381|517350268|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
143494184|NCT01928381|517350269|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
143494185|NCT01928381|517350263|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
143494186|NCT01928381|517350264|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
143494187|NCT01928381|517350265|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
143494188|NCT01928381|517350266|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
143494189|NCT01928381|517350267|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
143494190|NCT01928381|517350268|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
143494191|NCT01928381|517350269|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
143494192|NCT01928381|517350263|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
143494193|NCT01928381|517350264|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
143494194|NCT01928381|517350265|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
143494195|NCT01928381|517350266|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
143494196|NCT01928381|517350267|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
143494197|NCT01928381|517350268|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
143494198|NCT01928381|517350269|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
143494199|NCT01928381|517350263|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
143494200|NCT01928381|517350264|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
143494201|NCT01928381|517350265|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
143494202|NCT01928381|517350266|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
143031812|NCT03471078|515658035|FG000|Overall Study|Withdrawal by Subject|9|||
143031813|NCT03471078|515658036|FG001|Overall Study|Withdrawal by Subject|1|||
143031814|NCT03471078|515658035|FG000|Overall Study|Adverse Event|4|||
143031815|NCT03471078|515658036|FG001|Overall Study|Adverse Event|1|||
143031816|NCT03471078|515658035|FG000|Overall Study|Physician Decision|3|||
143031817|NCT03471078|515658036|FG001|Overall Study|Physician Decision|2|||
143031818|NCT03471078|515658035|FG000|Overall Study|Death|2|||
143031819|NCT03471078|515658036|FG001|Overall Study|Death|0|||
143031820|NCT03471078|515658035|FG000|Overall Study|Other|3|||
143031821|NCT03471078|515658036|FG001|Overall Study|Other|2|||
143031822|NCT00862979|515658041|FG000|Overall Study|Adverse Event|6|||
143031823|NCT00862979|515658042|FG001|Overall Study|Adverse Event|3|||
143031824|NCT00862979|515658041|FG000|Overall Study|Protocol Violation|0|||
143031825|NCT00862979|515658042|FG001|Overall Study|Protocol Violation|1|||
143031826|NCT00862979|515658041|FG000|Overall Study|Patient withdrew consent|2|||
143031827|NCT00862979|515658042|FG001|Overall Study|Patient withdrew consent|1|||
143031828|NCT00862979|515658041|FG000|Overall Study|Administrative problems|0|||
143031829|NCT00862979|515658042|FG001|Overall Study|Administrative problems|1|||
143031830|NCT00862979|515658041|FG000|Overall Study|Death|0|||
143031831|NCT00862979|515658042|FG001|Overall Study|Death|1|||
143031832|NCT04720664|515658043|FG000|Overall Study|Adverse Event|2|||
143031833|NCT04720664|515658043|FG000|Overall Study|Lack of Efficacy|9|||
143031834|NCT02207231|515658044|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
143031835|NCT02207231|515658045|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
143031836|NCT02207231|515658046|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
143031837|NCT02207231|515658047|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
143031838|NCT02207231|515658044|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
143031839|NCT02207231|515658045|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
143031840|NCT02207231|515658046|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
143031841|NCT02207231|515658047|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
143031842|NCT02207231|515658044|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
143031843|NCT02207231|515658045|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
143031844|NCT02207231|515658046|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
143031845|NCT02207231|515658047|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
143031846|NCT02207231|515658044|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
143031847|NCT02207231|515658045|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
143031848|NCT02207231|515658046|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
143031849|NCT02207231|515658047|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
143031850|NCT02207231|515658044|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
143031851|NCT02207231|515658045|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
143031852|NCT02207231|515658046|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
143031853|NCT02207231|515658047|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
143031854|NCT02207231|515658044|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
143031855|NCT02207231|515658045|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
143031856|NCT02207231|515658046|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
143031857|NCT02207231|515658047|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
143031858|NCT02207231|515658044|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
143031859|NCT02207231|515658045|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
143031860|NCT02207231|515658046|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
143031861|NCT02207231|515658047|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
143031862|NCT02207231|515658044|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
143031863|NCT02207231|515658045|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
143031864|NCT02207231|515658046|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
143031865|NCT02207231|515658047|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
143031866|NCT02207231|515658044|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
143494203|NCT01928381|517350267|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
143494204|NCT01928381|517350268|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
143031867|NCT02207231|515658045|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
143031868|NCT02207231|515658046|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
143031869|NCT02207231|515658047|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
143031870|NCT02207231|515658044|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
143031871|NCT02207231|515658045|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
143031872|NCT02207231|515658046|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
143031873|NCT02207231|515658047|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
143031874|NCT02207231|515658044|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
143031875|NCT02207231|515658045|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
143031876|NCT02207231|515658046|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
143494205|NCT01928381|517350269|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
143494206|NCT01928381|517350263|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
143494207|NCT01928381|517350264|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
143031877|NCT02207231|515658047|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
143031878|NCT02207231|515658044|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
143031879|NCT02207231|515658045|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
143031880|NCT02207231|515658046|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
143031881|NCT02207231|515658047|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
143031882|NCT02207231|515658044|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
143031883|NCT02207231|515658045|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
143031884|NCT02207231|515658046|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
143031885|NCT02207231|515658047|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
143031886|NCT02207231|515658044|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
143031887|NCT02207231|515658045|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
143031888|NCT02207231|515658046|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
143031889|NCT02207231|515658047|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
143031890|NCT02207231|515658044|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
143031891|NCT02207231|515658045|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
143031892|NCT02207231|515658046|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
143031893|NCT02207231|515658047|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
143031894|NCT02207231|515658044|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
143031895|NCT02207231|515658045|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
143031896|NCT02207231|515658046|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
143031897|NCT02207231|515658047|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
143031898|NCT02207231|515658044|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
143031899|NCT02207231|515658045|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
143031900|NCT02207231|515658046|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
143031901|NCT02207231|515658047|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
143031902|NCT02207231|515658044|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
143031903|NCT02207231|515658045|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
143031904|NCT02207231|515658046|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
143031905|NCT02207231|515658047|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
143031906|NCT02207231|515658044|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
143031907|NCT02207231|515658045|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
143031908|NCT02207231|515658046|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
143031909|NCT02207231|515658047|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
143031910|NCT02207231|515658044|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
143031911|NCT02207231|515658045|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
143031912|NCT02207231|515658046|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
143031913|NCT02207231|515658047|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
143031914|NCT02207231|515658044|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
143031915|NCT02207231|515658045|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
143031916|NCT02207231|515658046|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
143031917|NCT02207231|515658047|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
143031918|NCT04557124|515658051|FG000|Allocation (Baseline)|Withdrawal by Subject|0|||
143031919|NCT04557124|515658052|FG001|Allocation (Baseline)|Withdrawal by Subject|1|||
143031920|NCT04557124|515658051|FG000|Mid-point (1 Month)|Missed testing|5|||
143031921|NCT04557124|515658052|FG001|Mid-point (1 Month)|Missed testing|4|||
143031922|NCT04557124|515658051|FG000|Mid-point (1 Month)|Lost to Follow-up|1|||
143031923|NCT04557124|515658052|FG001|Mid-point (1 Month)|Lost to Follow-up|2|||
143031924|NCT04557124|515658051|FG000|Post-testing (2 Months)|Missed testing|1|||
143031925|NCT04557124|515658052|FG001|Post-testing (2 Months)|Missed testing|5|||
143031926|NCT04557124|515658051|FG000|Post-testing (2 Months)|Lost to Follow-up|2|||
143031927|NCT04557124|515658052|FG001|Post-testing (2 Months)|Lost to Follow-up|3|||
143031928|NCT04557124|515658051|FG000|Follow-up (4 Months)|Lost to Follow-up|2|||
143031929|NCT04557124|515658052|FG001|Follow-up (4 Months)|Lost to Follow-up|1|||
143031930|NCT00001849|515658053|FG000|Overall Study|Death|4|||
143031931|NCT00001849|515658053|FG000|Overall Study|Lost to Follow-up|2|||
143031932|NCT00001849|515658053|FG000|Overall Study|Withdrawal by Subject|2|||
143031933|NCT00001849|515658053|FG000|Overall Study|tumor remained occult|6|||
143031934|NCT03127137|515658058|FG000|Overall Study|Requested sedation after consent|1|||
143031935|NCT03127137|515658059|FG001|Overall Study|Requested sedation after consent|0|||
143031936|NCT03127137|515658058|FG000|Overall Study|Malfunction in electronic data collection|1|||
143031937|NCT03127137|515658059|FG001|Overall Study|Malfunction in electronic data collection|0|||
143031938|NCT03127137|515658058|FG000|Overall Study|Post procedure testing could not be obtained|0|||
143031939|NCT03127137|515658059|FG001|Overall Study|Post procedure testing could not be obtained|1|||
143031940|NCT02319148|515658060|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
143031941|NCT02319148|515658061|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
143031942|NCT02319148|515658062|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
143494208|NCT01928381|517350265|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
143494209|NCT01928381|517350266|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
143031943|NCT02319148|515658063|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
143031944|NCT02319148|515658060|FG000|Second Intervention Period|No longer willing to participate|0|||
143031945|NCT02319148|515658061|FG001|Second Intervention Period|No longer willing to participate|1|||
143031946|NCT02319148|515658062|FG002|Second Intervention Period|No longer willing to participate|0|||
143031947|NCT02319148|515658063|FG003|Second Intervention Period|No longer willing to participate|0|||
143031948|NCT02319148|515658060|FG000|Second Intervention Period|Other|0|||
143031949|NCT02319148|515658061|FG001|Second Intervention Period|Other|0|||
143031950|NCT02319148|515658062|FG002|Second Intervention Period|Other|0|||
143031951|NCT02319148|515658063|FG003|Second Intervention Period|Other|1|||
143031952|NCT00264797|515658064|FG000|Overall Study|Withdrawal by Subject|11|||
143031953|NCT00264797|515658065|FG001|Overall Study|Withdrawal by Subject|11|||
143031954|NCT00264797|515658064|FG000|Overall Study|Lost to Follow-up|9|||
143031955|NCT00264797|515658065|FG001|Overall Study|Lost to Follow-up|17|||
143031956|NCT00264797|515658064|FG000|Overall Study|Moved from area|3|||
143031957|NCT00264797|515658065|FG001|Overall Study|Moved from area|1|||
143031958|NCT00264797|515658064|FG000|Overall Study|Practical Problems|2|||
143031959|NCT00264797|515658065|FG001|Overall Study|Practical Problems|3|||
143031960|NCT00264797|515658064|FG000|Overall Study|Incarceration|4|||
143031961|NCT00264797|515658065|FG001|Overall Study|Incarceration|5|||
143031962|NCT00264797|515658064|FG000|Overall Study|Pressure/advice from Outsiders|1|||
143031963|NCT00264797|515658065|FG001|Overall Study|Pressure/advice from Outsiders|1|||
143031964|NCT00264797|515658064|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
143031965|NCT00264797|515658065|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
143031966|NCT00264797|515658064|FG000|Overall Study|Other|3|||
143031967|NCT00264797|515658065|FG001|Overall Study|Other|4|||
143031968|NCT03992196|515658066|FG000|Enrollment|lost to follow-up prior dosing|1|||
143031969|NCT03992196|515658067|FG001|Enrollment|lost to follow-up prior dosing|0|||
143031970|NCT03992196|515658068|FG002|Enrollment|lost to follow-up prior dosing|0|||
143031971|NCT03992196|515658066|FG000|Treatment|Protocol Violation|0|||
143031972|NCT03992196|515658067|FG001|Treatment|Protocol Violation|0|||
143031973|NCT03992196|515658068|FG002|Treatment|Protocol Violation|1|||
143031974|NCT03992196|515658066|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
143031975|NCT03992196|515658067|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
143031976|NCT03992196|515658068|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
143031977|NCT03992196|515658066|FG000|Treatment|Withdrawal due to non-compliance|0|||
143031978|NCT03992196|515658067|FG001|Treatment|Withdrawal due to non-compliance|0|||
143031979|NCT03992196|515658068|FG002|Treatment|Withdrawal due to non-compliance|1|||
143031980|NCT03992196|515658066|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
143031981|NCT03992196|515658067|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
143031982|NCT03992196|515658068|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
143031983|NCT03992196|515658066|FG000|Treatment|Withdrawal by parent/guardian|0|||
143031984|NCT03992196|515658067|FG001|Treatment|Withdrawal by parent/guardian|0|||
143031985|NCT03992196|515658068|FG002|Treatment|Withdrawal by parent/guardian|2|||
143031986|NCT00048048|515658069|FG000|Core Treatment|Withdrawal by Subject|0|||
143031987|NCT00048048|515658070|FG001|Core Treatment|Withdrawal by Subject|0|||
143031988|NCT00048048|515658071|FG002|Core Treatment|Withdrawal by Subject|1|||
143031989|NCT00048048|515658072|FG003|Core Treatment|Withdrawal by Subject|0|||
143031990|NCT00048048|515658073|FG004|Core Treatment|Withdrawal by Subject|0|||
143031991|NCT00048048|515658074|FG005|Core Treatment|Withdrawal by Subject|0|||
143031992|NCT00048048|515658075|FG006|Core Treatment|Withdrawal by Subject|0|||
143031993|NCT00048048|515658076|FG007|Core Treatment|Withdrawal by Subject|0|||
143031994|NCT00048048|515658077|FG008|Core Treatment|Withdrawal by Subject|0|||
143031995|NCT00048048|515658078|FG009|Core Treatment|Withdrawal by Subject|0|||
143031996|NCT00048048|515658079|FG010|Core Treatment|Withdrawal by Subject|0|||
143031997|NCT00048048|515658080|FG011|Core Treatment|Withdrawal by Subject|0|||
143494210|NCT01928381|517350267|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
143494211|NCT01928381|517350268|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
143494212|NCT01928381|517350269|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
143494213|NCT01928381|517350263|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
143494214|NCT01928381|517350264|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
143494215|NCT01928381|517350265|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
143031998|NCT00048048|515658069|FG000|Core Treatment|Adverse Event|0|||
143031999|NCT00048048|515658070|FG001|Core Treatment|Adverse Event|0|||
143032000|NCT00048048|515658071|FG002|Core Treatment|Adverse Event|0|||
143032001|NCT00048048|515658072|FG003|Core Treatment|Adverse Event|0|||
143032002|NCT00048048|515658073|FG004|Core Treatment|Adverse Event|0|||
143032003|NCT00048048|515658074|FG005|Core Treatment|Adverse Event|0|||
143032004|NCT00048048|515658075|FG006|Core Treatment|Adverse Event|0|||
143032005|NCT00048048|515658076|FG007|Core Treatment|Adverse Event|1|||
143032006|NCT00048048|515658077|FG008|Core Treatment|Adverse Event|0|||
143032007|NCT00048048|515658078|FG009|Core Treatment|Adverse Event|0|||
143032008|NCT00048048|515658079|FG010|Core Treatment|Adverse Event|0|||
143032009|NCT00048048|515658080|FG011|Core Treatment|Adverse Event|0|||
143032010|NCT00048048|515658069|FG000|Extension Year 1|Early withdrawals|0|||
143032011|NCT00048048|515658070|FG001|Extension Year 1|Early withdrawals|0|||
143032012|NCT00048048|515658071|FG002|Extension Year 1|Early withdrawals|0|||
143032013|NCT00048048|515658072|FG003|Extension Year 1|Early withdrawals|0|||
143032014|NCT00048048|515658073|FG004|Extension Year 1|Early withdrawals|0|||
143032015|NCT00048048|515658074|FG005|Extension Year 1|Early withdrawals|0|||
143032016|NCT00048048|515658075|FG006|Extension Year 1|Early withdrawals|0|||
143032017|NCT00048048|515658076|FG007|Extension Year 1|Early withdrawals|0|||
143032018|NCT00048048|515658077|FG008|Extension Year 1|Early withdrawals|0|||
143032019|NCT00048048|515658078|FG009|Extension Year 1|Early withdrawals|2|||
143032020|NCT00048048|515658079|FG010|Extension Year 1|Early withdrawals|2|||
143032021|NCT00048048|515658080|FG011|Extension Year 1|Early withdrawals|4|||
143032022|NCT00048048|515658069|FG000|Extension Year 2|Early withdrawals|0|||
143032023|NCT00048048|515658070|FG001|Extension Year 2|Early withdrawals|0|||
143032024|NCT00048048|515658071|FG002|Extension Year 2|Early withdrawals|0|||
143032025|NCT00048048|515658072|FG003|Extension Year 2|Early withdrawals|0|||
143032026|NCT00048048|515658073|FG004|Extension Year 2|Early withdrawals|0|||
143032027|NCT00048048|515658074|FG005|Extension Year 2|Early withdrawals|0|||
143032028|NCT00048048|515658075|FG006|Extension Year 2|Early withdrawals|0|||
143032029|NCT00048048|515658076|FG007|Extension Year 2|Early withdrawals|0|||
143032030|NCT00048048|515658077|FG008|Extension Year 2|Early withdrawals|0|||
143032031|NCT00048048|515658078|FG009|Extension Year 2|Early withdrawals|0|||
143032032|NCT00048048|515658079|FG010|Extension Year 2|Early withdrawals|4|||
143032033|NCT00048048|515658080|FG011|Extension Year 2|Early withdrawals|2|||
143032034|NCT02388763|515658083|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
143032035|NCT02388763|515658084|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
143032036|NCT02388763|515658083|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
143032037|NCT02388763|515658084|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
143032038|NCT05518487|515658085|FG000|Overall Study|Withdrawal by Subject|3|||
143032039|NCT02497781|515658088|FG000|Overall Study|Withdrawal by Subject|2|||
143032040|NCT02497781|515658089|FG001|Overall Study|Withdrawal by Subject|0|||
143032041|NCT02497781|515658088|FG000|Overall Study|Lack of Efficacy|0|||
143032042|NCT02497781|515658089|FG001|Overall Study|Lack of Efficacy|1|||
143032043|NCT02497781|515658088|FG000|Overall Study|Randomised but not treated|1|||
143032044|NCT02497781|515658089|FG001|Overall Study|Randomised but not treated|1|||
143032045|NCT02497781|515658088|FG000|Overall Study|Lost to Follow-up|1|||
143032046|NCT02497781|515658089|FG001|Overall Study|Lost to Follow-up|1|||
143032047|NCT00525590|515658090|FG000|Overall Study|Adverse Event|3|||
143032048|NCT00525590|515658090|FG000|Overall Study|Physician Decision|3|||
143032049|NCT00525590|515658090|FG000|Overall Study|Withdrawal by Subject|16|||
143032050|NCT00525590|515658090|FG000|Overall Study|Lost to Follow-up|1|||
143032051|NCT00525590|515658090|FG000|Overall Study|Death|9|||
143032052|NCT00525590|515658090|FG000|Overall Study|Other|13|||
143032053|NCT00762086|515658091|FG000|Overall Study|Adverse Event|2|||
143032054|NCT00762086|515658092|FG001|Overall Study|Adverse Event|0|||
143032055|NCT00762086|515658091|FG000|Overall Study|Lost to Follow-up|0|||
143032056|NCT00762086|515658092|FG001|Overall Study|Lost to Follow-up|2|||
143032057|NCT00762086|515658091|FG000|Overall Study|Non compliance|1|||
143032058|NCT00762086|515658092|FG001|Overall Study|Non compliance|0|||
143032059|NCT00762086|515658091|FG000|Overall Study|Withdrawal by Subject|2|||
143032060|NCT00762086|515658092|FG001|Overall Study|Withdrawal by Subject|2|||
143032061|NCT00762086|515658091|FG000|Overall Study|Ineligible to participate in the study|1|||
143032062|NCT00762086|515658092|FG001|Overall Study|Ineligible to participate in the study|0|||
143032063|NCT00860405|515658093|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
143032064|NCT00860405|515658094|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
143032065|NCT01492400|515658096|FG000|Overall Study|Miscellaneous Reasons|2|||
143032066|NCT01492400|515658097|FG001|Overall Study|Miscellaneous Reasons|3|||
143032067|NCT01492400|515658096|FG000|Overall Study|Personal Reasons|0|||
143237647|NCT01074970|516423415|FG002|Overall Study|Never Treated|8|||
143237648|NCT01074970|516423416|FG003|Overall Study|Never Treated|1|||
143237649|NCT01074970|516423413|FG000|Overall Study|Adverse Event|1|||
143364033|NCT00293462|516875526|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
143494216|NCT01928381|517350266|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
143494217|NCT01928381|517350267|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
143032068|NCT01492400|515658097|FG001|Overall Study|Personal Reasons|5|||
143032069|NCT01492400|515658096|FG000|Overall Study|Lost to Follow-up|3|||
143032070|NCT01492400|515658097|FG001|Overall Study|Lost to Follow-up|1|||
143032071|NCT01492400|515658096|FG000|Overall Study|Pregnancy|0|||
143032072|NCT01492400|515658097|FG001|Overall Study|Pregnancy|1|||
143032073|NCT01492400|515658096|FG000|Overall Study|Lack of Efficacy|1|||
143032074|NCT01492400|515658097|FG001|Overall Study|Lack of Efficacy|1|||
143032075|NCT01492400|515658096|FG000|Overall Study|Adverse Event|10|||
143032076|NCT01492400|515658097|FG001|Overall Study|Adverse Event|5|||
143032077|NCT02899338|515658098|FG000|Overall Study|Adverse Event|1|||
143032078|NCT02899338|515658099|FG001|Overall Study|Adverse Event|2|||
143032079|NCT02899338|515658098|FG000|Overall Study|Withdrawal by Subject|2|||
143032080|NCT02899338|515658099|FG001|Overall Study|Withdrawal by Subject|0|||
143032081|NCT01370408|515658100|FG000|Overall Study|treatment failure|9|||
143032082|NCT04981912|515658103|FG000|Overall Study|Physician Decision|2|||
143494218|NCT01928381|517350268|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
143494219|NCT01928381|517350269|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
143032083|NCT00661505|515658104|FG000|Overall Study|Adverse Event|3|||
143032084|NCT00661505|515658104|FG000|Overall Study|Protocol Violation|14|||
143494220|NCT01928381|517350263|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
143494221|NCT01928381|517350264|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
143494222|NCT01928381|517350265|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
143494223|NCT01928381|517350266|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
143494224|NCT01928381|517350267|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
143494225|NCT01928381|517350268|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
143494226|NCT01928381|517350269|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
143494227|NCT01928381|517350263|FG000|Washout First Intervention|Protocol Violation|0|||
143494228|NCT01928381|517350264|FG001|Washout First Intervention|Protocol Violation|0|||
143494229|NCT01928381|517350265|FG002|Washout First Intervention|Protocol Violation|0|||
143494230|NCT01928381|517350266|FG003|Washout First Intervention|Protocol Violation|0|||
143494231|NCT01928381|517350267|FG004|Washout First Intervention|Protocol Violation|1|||
143494232|NCT01928381|517350268|FG005|Washout First Intervention|Protocol Violation|0|||
143494233|NCT01928381|517350269|FG006|Washout First Intervention|Protocol Violation|0|||
143494234|NCT01928381|517350263|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
143494235|NCT01928381|517350264|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
143494236|NCT01928381|517350265|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
143494237|NCT01928381|517350266|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
143494238|NCT01928381|517350267|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
143494239|NCT01928381|517350268|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
143494240|NCT01928381|517350269|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
143494241|NCT01928381|517350263|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
143032085|NCT00661505|515658104|FG000|Overall Study|Withdrawal by Subject|8|||
143032086|NCT00661505|515658104|FG000|Overall Study|Lost to Follow-up|3|||
143032087|NCT00661505|515658104|FG000|Overall Study|Other|2|||
143032088|NCT00977470|515658105|FG000|Overall Study|Lack of Efficacy|32|||
143032089|NCT00977470|515658106|FG001|Overall Study|Lack of Efficacy|30|||
143494242|NCT01928381|517350264|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
143494243|NCT01928381|517350265|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
143032090|NCT00977470|515658105|FG000|Overall Study|Physician Decision|2|||
143032091|NCT00977470|515658106|FG001|Overall Study|Physician Decision|0|||
143494244|NCT01928381|517350266|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
143494245|NCT01928381|517350267|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
143494246|NCT01928381|517350268|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
143494247|NCT01928381|517350269|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
143494248|NCT01877083|517350270|FG000|Treatment Phase|Disease Progression|10|||
143032092|NCT00977470|515658105|FG000|Overall Study|Adverse Event|1|||
143032093|NCT00977470|515658106|FG001|Overall Study|Adverse Event|2|||
143032094|NCT00977470|515658105|FG000|Overall Study|Protocol Violation|1|||
143032095|NCT00977470|515658106|FG001|Overall Study|Protocol Violation|0|||
143032096|NCT00977470|515658105|FG000|Overall Study|Withdrawal by Subject|0|||
143032097|NCT00977470|515658106|FG001|Overall Study|Withdrawal by Subject|2|||
143032098|NCT00977470|515658105|FG000|Overall Study|Death|0|||
143032099|NCT00977470|515658106|FG001|Overall Study|Death|2|||
143032100|NCT00977470|515658105|FG000|Overall Study|clinical decline|0|||
143032101|NCT00977470|515658106|FG001|Overall Study|clinical decline|1|||
143032102|NCT00977470|515658105|FG000|Overall Study|prolonged recovery post-surgery|0|||
143032103|NCT00977470|515658106|FG001|Overall Study|prolonged recovery post-surgery|1|||
143032104|NCT00977470|515658105|FG000|Overall Study|Still on-study|2|||
143032105|NCT00977470|515658106|FG001|Overall Study|Still on-study|0|||
143032106|NCT02364557|515658107|FG000|Overall Study|Protocol Violation|3|||
143032107|NCT02364557|515658108|FG001|Overall Study|Protocol Violation|1|||
143032108|NCT01318499|515658109|FG000|Overall Study|Adverse Event|16|||
143494249|NCT01877083|517350270|FG000|Treatment Phase|Clinical Progression|1|||
143494250|NCT01877083|517350270|FG000|Treatment Phase|Adverse Event|6|||
143032109|NCT01318499|515658110|FG001|Overall Study|Adverse Event|11|||
143032110|NCT01318499|515658111|FG002|Overall Study|Adverse Event|6|||
143032111|NCT01318499|515658109|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
143032112|NCT01318499|515658110|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
143032113|NCT01318499|515658111|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
143494251|NCT01877083|517350270|FG000|Treatment Phase|Withdrawal by Subject|2|||
143494252|NCT01877083|517350270|FG000|Treatment Phase|Lost to Follow-up|1|||
143494253|NCT01877083|517350270|FG000|Extension Phase|Disease Progression|3|||
143494254|NCT01877083|517350270|FG000|Extension Phase|Adverse Event|2|||
143494255|NCT00429585|517350273|FG000|Overall Study|Death|1|||
143494256|NCT00429585|517350274|FG001|Overall Study|Death|0|||
143494257|NCT00429585|517350273|FG000|Overall Study|Lost to Follow-up|27|||
143032114|NCT01318499|515658109|FG000|Overall Study|Noncompliance|2|||
143032115|NCT01318499|515658110|FG001|Overall Study|Noncompliance|3|||
143032116|NCT01318499|515658111|FG002|Overall Study|Noncompliance|0|||
143032117|NCT01318499|515658109|FG000|Overall Study|Treatment Failure|19|||
143032118|NCT01318499|515658110|FG001|Overall Study|Treatment Failure|19|||
143032119|NCT01318499|515658111|FG002|Overall Study|Treatment Failure|101|||
143032120|NCT01318499|515658109|FG000|Overall Study|Protocol Violation|2|||
143032121|NCT01318499|515658110|FG001|Overall Study|Protocol Violation|4|||
143032122|NCT01318499|515658111|FG002|Overall Study|Protocol Violation|2|||
143494258|NCT00429585|517350274|FG001|Overall Study|Lost to Follow-up|20|||
143494259|NCT00429585|517350273|FG000|Overall Study|Physician Decision|2|||
143494260|NCT00429585|517350274|FG001|Overall Study|Physician Decision|0|||
143494261|NCT01582308|517350275|FG000|Period 1|Withdrawal by Subject|0|||
143494262|NCT01582308|517350276|FG001|Period 1|Withdrawal by Subject|0|||
143494263|NCT01582308|517350277|FG002|Period 1|Withdrawal by Subject|0|||
143494264|NCT01582308|517350278|FG003|Period 1|Withdrawal by Subject|0|||
143032123|NCT01318499|515658109|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
143032124|NCT01318499|515658110|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
143032125|NCT01318499|515658111|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
143032126|NCT01318499|515658109|FG000|Overall Study|Other|7|||
143032127|NCT01318499|515658110|FG001|Overall Study|Other|10|||
143032128|NCT01318499|515658111|FG002|Overall Study|Other|22|||
143032129|NCT04591626|515658118|FG000|Overall Study|Adverse Event|4|||
143032130|NCT04591626|515658119|FG001|Overall Study|Adverse Event|0|||
143032131|NCT04591626|515658118|FG000|Overall Study|Withdrawal by Subject|5|||
143032132|NCT04591626|515658119|FG001|Overall Study|Withdrawal by Subject|3|||
143032133|NCT04591626|515658118|FG000|Overall Study|Physician Decision|0|||
143032134|NCT04591626|515658119|FG001|Overall Study|Physician Decision|1|||
143032135|NCT04591626|515658118|FG000|Overall Study|Death|0|||
143032136|NCT04591626|515658119|FG001|Overall Study|Death|1|||
143032137|NCT04591626|515658118|FG000|Overall Study|Non-Compliance with Study Drug|1|||
143032138|NCT04591626|515658119|FG001|Overall Study|Non-Compliance with Study Drug|0|||
143032139|NCT01139164|515658123|FG000|Overall Study|Withdrawn prior to study start|0|||
143494265|NCT01582308|517350279|FG004|Period 1|Withdrawal by Subject|0|||
143494266|NCT01582308|517350280|FG005|Period 1|Withdrawal by Subject|0|||
143494267|NCT01582308|517350281|FG006|Period 1|Withdrawal by Subject|1|||
143494268|NCT01582308|517350282|FG007|Period 1|Withdrawal by Subject|0|||
143494269|NCT01582308|517350283|FG008|Period 1|Withdrawal by Subject|0|||
143494270|NCT01582308|517350284|FG009|Period 1|Withdrawal by Subject|0|||
143032140|NCT01139164|515658124|FG001|Overall Study|Withdrawn prior to study start|2|||
143032141|NCT01139164|515658125|FG002|Overall Study|Withdrawn prior to study start|0|||
143032142|NCT00406848|515658126|FG000|Overall Study|Withdrawal by Subject|27|||
143032143|NCT00406848|515658127|FG001|Overall Study|Withdrawal by Subject|22|||
143032144|NCT00406848|515658126|FG000|Overall Study|Adverse Event|38|||
143159009|NCT03931785|516128040|FG003|Overall Study|Lost to Follow-up|3|||
143159010|NCT03931785|516128037|FG000|Overall Study|Adverse Event|1|||
143159011|NCT03931785|516128038|FG001|Overall Study|Adverse Event|0|||
143159012|NCT03931785|516128039|FG002|Overall Study|Adverse Event|3|||
143159013|NCT03931785|516128040|FG003|Overall Study|Adverse Event|4|||
143159014|NCT03931785|516128037|FG000|Overall Study|Protocol Violation|0|||
143159015|NCT03931785|516128038|FG001|Overall Study|Protocol Violation|1|||
143159016|NCT03931785|516128039|FG002|Overall Study|Protocol Violation|0|||
143159017|NCT03931785|516128040|FG003|Overall Study|Protocol Violation|0|||
143159018|NCT03931785|516128037|FG000|Overall Study|Noncompliance With Study drug|0|||
143159019|NCT03931785|516128038|FG001|Overall Study|Noncompliance With Study drug|1|||
143159020|NCT03931785|516128039|FG002|Overall Study|Noncompliance With Study drug|0|||
143159021|NCT03931785|516128040|FG003|Overall Study|Noncompliance With Study drug|0|||
143494271|NCT01582308|517350275|FG000|10-day Washout Following Period 1|Physician Decision|0|||
143494272|NCT01582308|517350276|FG001|10-day Washout Following Period 1|Physician Decision|0|||
143494273|NCT01582308|517350277|FG002|10-day Washout Following Period 1|Physician Decision|0|||
143032145|NCT00406848|515658127|FG001|Overall Study|Adverse Event|7|||
143032146|NCT00406848|515658126|FG000|Overall Study|Lack of Efficacy|9|||
143032147|NCT00406848|515658127|FG001|Overall Study|Lack of Efficacy|14|||
143032148|NCT00406848|515658126|FG000|Overall Study|Protocol Violation|10|||
143032149|NCT00406848|515658127|FG001|Overall Study|Protocol Violation|6|||
143032150|NCT00406848|515658126|FG000|Overall Study|Lost to Follow-up|6|||
143032151|NCT00406848|515658127|FG001|Overall Study|Lost to Follow-up|2|||
143159022|NCT03931785|516128037|FG000|Overall Study|Other Not specified|0|||
143159023|NCT03931785|516128038|FG001|Overall Study|Other Not specified|2|||
143159024|NCT03931785|516128039|FG002|Overall Study|Other Not specified|2|||
143494274|NCT01582308|517350278|FG003|10-day Washout Following Period 1|Physician Decision|0|||
143494275|NCT01582308|517350279|FG004|10-day Washout Following Period 1|Physician Decision|1|||
143494276|NCT01582308|517350280|FG005|10-day Washout Following Period 1|Physician Decision|0|||
143494277|NCT01582308|517350281|FG006|10-day Washout Following Period 1|Physician Decision|0|||
143494278|NCT01582308|517350282|FG007|10-day Washout Following Period 1|Physician Decision|0|||
143494279|NCT01582308|517350283|FG008|10-day Washout Following Period 1|Physician Decision|0|||
143494280|NCT01582308|517350284|FG009|10-day Washout Following Period 1|Physician Decision|0|||
143032152|NCT00406848|515658126|FG000|Overall Study|Physician Decision|2|||
143032153|NCT00406848|515658127|FG001|Overall Study|Physician Decision|2|||
143032154|NCT00406848|515658126|FG000|Overall Study|Sponsor Decision|1|||
143032155|NCT00406848|515658127|FG001|Overall Study|Sponsor Decision|1|||
143032156|NCT01355081|515658130|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
143032157|NCT01355081|515658131|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
143032158|NCT01355081|515658132|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
143032159|NCT01355081|515658130|FG000|Overall Study|Major Protocol Deviation|0|||
143032160|NCT01355081|515658131|FG001|Overall Study|Major Protocol Deviation|1|||
143032161|NCT01355081|515658132|FG002|Overall Study|Major Protocol Deviation|0|||
143032162|NCT01355081|515658130|FG000|Overall Study|Lost to Follow-up|0|||
143032163|NCT01355081|515658131|FG001|Overall Study|Lost to Follow-up|0|||
143032164|NCT01355081|515658132|FG002|Overall Study|Lost to Follow-up|1|||
143032165|NCT01355081|515658130|FG000|Overall Study|Withdrawal of Consent|2|||
143032166|NCT01355081|515658131|FG001|Overall Study|Withdrawal of Consent|3|||
143032167|NCT01355081|515658132|FG002|Overall Study|Withdrawal of Consent|3|||
143032168|NCT01355081|515658130|FG000|Overall Study|Lack of Efficacy|2|||
143032169|NCT01355081|515658131|FG001|Overall Study|Lack of Efficacy|1|||
143032170|NCT01355081|515658132|FG002|Overall Study|Lack of Efficacy|1|||
143032171|NCT01355081|515658130|FG000|Overall Study|Non Compliance with Study Medication|0|||
143032172|NCT01355081|515658131|FG001|Overall Study|Non Compliance with Study Medication|1|||
143032173|NCT01355081|515658132|FG002|Overall Study|Non Compliance with Study Medication|0|||
143032174|NCT02480764|515658133|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
143032175|NCT02480764|515658134|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
143032176|NCT02480764|515658135|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
143032177|NCT02480764|515658133|FG000|Overall Study|Major Protocol Deviation|1|||
143032178|NCT02480764|515658134|FG001|Overall Study|Major Protocol Deviation|4|||
143032179|NCT02480764|515658135|FG002|Overall Study|Major Protocol Deviation|3|||
143032180|NCT02480764|515658133|FG000|Overall Study|Lost to Follow-up|0|||
143032181|NCT02480764|515658134|FG001|Overall Study|Lost to Follow-up|1|||
143032182|NCT02480764|515658135|FG002|Overall Study|Lost to Follow-up|2|||
143032183|NCT02480764|515658133|FG000|Overall Study|Voluntary Withdrawal|6|||
143032184|NCT02480764|515658134|FG001|Overall Study|Voluntary Withdrawal|5|||
143032185|NCT02480764|515658135|FG002|Overall Study|Voluntary Withdrawal|10|||
143032186|NCT02480764|515658133|FG000|Overall Study|Lack of Efficacy|0|||
143032187|NCT02480764|515658134|FG001|Overall Study|Lack of Efficacy|3|||
143032188|NCT02480764|515658135|FG002|Overall Study|Lack of Efficacy|3|||
143032189|NCT02480764|515658133|FG000|Overall Study|Reason not Specified|0|||
143032190|NCT02480764|515658134|FG001|Overall Study|Reason not Specified|1|||
143032191|NCT02480764|515658135|FG002|Overall Study|Reason not Specified|0|||
143032192|NCT02719522|515658136|FG000|Overall Study|Implant Failure|4|||
143032193|NCT02719522|515658136|FG000|Overall Study|Death|2|||
143494281|NCT01582308|517350275|FG000|Period 4|Physician Decision|1|||
143494282|NCT01582308|517350276|FG001|Period 4|Physician Decision|0|||
143494283|NCT01582308|517350277|FG002|Period 4|Physician Decision|0|||
143494284|NCT01582308|517350278|FG003|Period 4|Physician Decision|0|||
143494285|NCT01582308|517350279|FG004|Period 4|Physician Decision|0|||
143494286|NCT01582308|517350280|FG005|Period 4|Physician Decision|1|||
143494287|NCT01582308|517350281|FG006|Period 4|Physician Decision|0|||
143494288|NCT01582308|517350282|FG007|Period 4|Physician Decision|0|||
143032194|NCT02719522|515658136|FG000|Overall Study|Lost to Follow-up|5|||
143032195|NCT02457832|515658137|FG000|Training|Lost to Follow-up|10|||
143032196|NCT02457832|515658138|FG001|Training|Lost to Follow-up|6|||
143032197|NCT02457832|515658139|FG002|Training|Lost to Follow-up|3|||
143032198|NCT02457832|515658137|FG000|One Month Washout|Lost to Follow-up|0|||
143032199|NCT02457832|515658138|FG001|One Month Washout|Lost to Follow-up|1|||
143032200|NCT02457832|515658139|FG002|One Month Washout|Lost to Follow-up|1|||
143032201|NCT03184441|515658140|FG000|Overall Study|Withdrawal by Subject|1|||
143032202|NCT01868009|515658143|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
143032203|NCT01868009|515658144|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
143032204|NCT01868009|515658143|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
143032205|NCT01868009|515658144|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
143032206|NCT01868009|515658143|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
143032207|NCT01868009|515658144|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
143032208|NCT03589326|515658145|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
143032209|NCT03589326|515658146|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
143032210|NCT03589326|515658145|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
143032211|NCT03589326|515658146|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
143032212|NCT03589326|515658145|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
143494289|NCT01582308|517350283|FG008|Period 4|Physician Decision|0|||
143494290|NCT01582308|517350284|FG009|Period 4|Physician Decision|1|||
143494291|NCT01844986|517350287|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
143494292|NCT01844986|517350288|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
143494293|NCT01844986|517350287|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
143494294|NCT01844986|517350288|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
143032213|NCT03589326|515658146|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
143032214|NCT03589326|515658145|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
143032215|NCT03589326|515658146|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
143032216|NCT03589326|515658145|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
143032217|NCT03589326|515658146|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
143032218|NCT02101853|515658149|FG000|Block 1 Induction|Adverse Event|11|||
143032219|NCT02101853|515658150|FG001|Block 1 Induction|Adverse Event|0|||
143032220|NCT02101853|515658151|FG002|Block 1 Induction|Adverse Event|0|||
143032221|NCT02101853|515658152|FG003|Block 1 Induction|Adverse Event|0|||
143032222|NCT02101853|515658153|FG004|Block 1 Induction|Adverse Event|0|||
143032223|NCT02101853|515658154|FG005|Block 1 Induction|Adverse Event|0|||
143032224|NCT02101853|515658149|FG000|Block 1 Induction|Death|20|||
143032225|NCT02101853|515658150|FG001|Block 1 Induction|Death|0|||
143032226|NCT02101853|515658151|FG002|Block 1 Induction|Death|0|||
143032227|NCT02101853|515658152|FG003|Block 1 Induction|Death|0|||
143032228|NCT02101853|515658153|FG004|Block 1 Induction|Death|0|||
143032229|NCT02101853|515658154|FG005|Block 1 Induction|Death|0|||
143032230|NCT02101853|515658149|FG000|Block 1 Induction|Lack of Efficacy|6|||
143032231|NCT02101853|515658150|FG001|Block 1 Induction|Lack of Efficacy|0|||
143032232|NCT02101853|515658151|FG002|Block 1 Induction|Lack of Efficacy|0|||
143032233|NCT02101853|515658152|FG003|Block 1 Induction|Lack of Efficacy|0|||
143032234|NCT02101853|515658153|FG004|Block 1 Induction|Lack of Efficacy|0|||
143032235|NCT02101853|515658154|FG005|Block 1 Induction|Lack of Efficacy|0|||
143032236|NCT02101853|515658149|FG000|Block 1 Induction|Physician Decision|61|||
143032237|NCT02101853|515658150|FG001|Block 1 Induction|Physician Decision|0|||
143032238|NCT02101853|515658151|FG002|Block 1 Induction|Physician Decision|0|||
143032239|NCT02101853|515658152|FG003|Block 1 Induction|Physician Decision|0|||
143032240|NCT02101853|515658153|FG004|Block 1 Induction|Physician Decision|0|||
143032241|NCT02101853|515658154|FG005|Block 1 Induction|Physician Decision|0|||
143032242|NCT02101853|515658149|FG000|Block 1 Induction|Protocol Violation|2|||
143032243|NCT02101853|515658150|FG001|Block 1 Induction|Protocol Violation|0|||
143032244|NCT02101853|515658151|FG002|Block 1 Induction|Protocol Violation|0|||
143032245|NCT02101853|515658152|FG003|Block 1 Induction|Protocol Violation|0|||
143032246|NCT02101853|515658153|FG004|Block 1 Induction|Protocol Violation|0|||
143032247|NCT02101853|515658154|FG005|Block 1 Induction|Protocol Violation|0|||
143032248|NCT02101853|515658149|FG000|Block 1 Induction|Withdrawal by Subject|65|||
143032249|NCT02101853|515658150|FG001|Block 1 Induction|Withdrawal by Subject|0|||
143032250|NCT02101853|515658151|FG002|Block 1 Induction|Withdrawal by Subject|0|||
143032251|NCT02101853|515658152|FG003|Block 1 Induction|Withdrawal by Subject|0|||
143032252|NCT02101853|515658153|FG004|Block 1 Induction|Withdrawal by Subject|0|||
143032253|NCT02101853|515658154|FG005|Block 1 Induction|Withdrawal by Subject|0|||
143032254|NCT02101853|515658149|FG000|Block 1 Induction|Ineligible|8|||
143032255|NCT02101853|515658150|FG001|Block 1 Induction|Ineligible|0|||
143032256|NCT02101853|515658151|FG002|Block 1 Induction|Ineligible|0|||
143032257|NCT02101853|515658152|FG003|Block 1 Induction|Ineligible|0|||
143032258|NCT02101853|515658153|FG004|Block 1 Induction|Ineligible|0|||
143032259|NCT02101853|515658154|FG005|Block 1 Induction|Ineligible|0|||
143032260|NCT02101853|515658149|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
143032261|NCT02101853|515658150|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
143032262|NCT02101853|515658151|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
143159025|NCT03931785|516128040|FG003|Overall Study|Other Not specified|2|||
143159026|NCT03931785|516128037|FG000|Overall Study|Withdrawal by Subject|0|||
143159027|NCT03931785|516128038|FG001|Overall Study|Withdrawal by Subject|2|||
143159028|NCT03931785|516128039|FG002|Overall Study|Withdrawal by Subject|4|||
143032263|NCT02101853|515658152|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
143159029|NCT03931785|516128040|FG003|Overall Study|Withdrawal by Subject|1|||
143159030|NCT03931785|516128037|FG000|Overall Study|Pregnancy|0|||
143159031|NCT03931785|516128038|FG001|Overall Study|Pregnancy|0|||
143159032|NCT03931785|516128039|FG002|Overall Study|Pregnancy|0|||
143494295|NCT01844986|517350287|FG000|Overall Study (Global Cohort)|Death|55|||
143494296|NCT01844986|517350288|FG001|Overall Study (Global Cohort)|Death|26|||
143494297|NCT01844986|517350287|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
143494298|NCT01844986|517350288|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
143494299|NCT01844986|517350287|FG000|Overall Study (China Cohort)|Death|10|||
143494300|NCT01844986|517350288|FG001|Overall Study (China Cohort)|Death|6|||
143032264|NCT02101853|515658153|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
143032265|NCT02101853|515658154|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
143032266|NCT02101853|515658149|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
143159033|NCT03931785|516128040|FG003|Overall Study|Pregnancy|1|||
143159034|NCT00903344|516128041|FG000|Overall Study|Pregnancy|2|||
143159035|NCT00903344|516128042|FG001|Overall Study|Pregnancy|3|||
143159036|NCT00903344|516128041|FG000|Overall Study|Lost to Follow-up|3|||
143494301|NCT03406897|517350289|FG000|Overall Study|Lost to Follow-up|1|||
143032267|NCT02101853|515658150|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
143032268|NCT02101853|515658151|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
143032269|NCT02101853|515658152|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
143032270|NCT02101853|515658153|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
143032271|NCT02101853|515658154|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
143032272|NCT02101853|515658149|FG000|Post Induction Randomization|Adverse Event|0|||
143032273|NCT02101853|515658150|FG001|Post Induction Randomization|Adverse Event|3|||
143032274|NCT02101853|515658151|FG002|Post Induction Randomization|Adverse Event|8|||
143032275|NCT02101853|515658152|FG003|Post Induction Randomization|Adverse Event|4|||
143032276|NCT02101853|515658153|FG004|Post Induction Randomization|Adverse Event|4|||
143032277|NCT02101853|515658154|FG005|Post Induction Randomization|Adverse Event|0|||
143032278|NCT02101853|515658149|FG000|Post Induction Randomization|Death|0|||
143032279|NCT02101853|515658150|FG001|Post Induction Randomization|Death|9|||
143032280|NCT02101853|515658151|FG002|Post Induction Randomization|Death|2|||
143032281|NCT02101853|515658152|FG003|Post Induction Randomization|Death|2|||
143032282|NCT02101853|515658153|FG004|Post Induction Randomization|Death|0|||
143032283|NCT02101853|515658154|FG005|Post Induction Randomization|Death|0|||
143032284|NCT02101853|515658149|FG000|Post Induction Randomization|Lack of Efficacy|0|||
143032285|NCT02101853|515658150|FG001|Post Induction Randomization|Lack of Efficacy|14|||
143032286|NCT02101853|515658151|FG002|Post Induction Randomization|Lack of Efficacy|23|||
143032287|NCT02101853|515658152|FG003|Post Induction Randomization|Lack of Efficacy|18|||
143032288|NCT02101853|515658153|FG004|Post Induction Randomization|Lack of Efficacy|21|||
143032289|NCT02101853|515658154|FG005|Post Induction Randomization|Lack of Efficacy|0|||
143032290|NCT02101853|515658149|FG000|Post Induction Randomization|Physician Decision|0|||
143032291|NCT02101853|515658150|FG001|Post Induction Randomization|Physician Decision|43|||
143032292|NCT02101853|515658151|FG002|Post Induction Randomization|Physician Decision|23|||
143032293|NCT02101853|515658152|FG003|Post Induction Randomization|Physician Decision|14|||
143032294|NCT02101853|515658153|FG004|Post Induction Randomization|Physician Decision|14|||
143032295|NCT02101853|515658154|FG005|Post Induction Randomization|Physician Decision|0|||
143032296|NCT02101853|515658149|FG000|Post Induction Randomization|Protocol Violation|0|||
143032297|NCT02101853|515658150|FG001|Post Induction Randomization|Protocol Violation|3|||
143032298|NCT02101853|515658151|FG002|Post Induction Randomization|Protocol Violation|0|||
143032299|NCT02101853|515658152|FG003|Post Induction Randomization|Protocol Violation|0|||
143032300|NCT02101853|515658153|FG004|Post Induction Randomization|Protocol Violation|0|||
143032301|NCT02101853|515658154|FG005|Post Induction Randomization|Protocol Violation|0|||
143032302|NCT02101853|515658149|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
143032303|NCT02101853|515658150|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
143032304|NCT02101853|515658151|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
143032305|NCT02101853|515658152|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
143032306|NCT02101853|515658153|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
143032307|NCT02101853|515658154|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
143032308|NCT02101853|515658149|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
143032309|NCT02101853|515658150|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
143032310|NCT02101853|515658151|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
143032311|NCT02101853|515658152|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
143032312|NCT02101853|515658153|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
143032313|NCT02101853|515658154|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
143032314|NCT02101853|515658149|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
143032315|NCT02101853|515658150|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
143032316|NCT02101853|515658151|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
143032317|NCT02101853|515658152|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
143032318|NCT02101853|515658153|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
143032319|NCT02101853|515658154|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
143032320|NCT02101853|515658149|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
143032321|NCT02101853|515658150|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
143032322|NCT02101853|515658151|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
143032323|NCT02101853|515658152|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
143032324|NCT02101853|515658153|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
143032325|NCT02101853|515658154|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
143032326|NCT02101853|515658149|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
143032327|NCT02101853|515658150|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
143032328|NCT02101853|515658151|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
143032329|NCT02101853|515658152|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
143032330|NCT02101853|515658153|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
143032331|NCT02101853|515658154|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
143032332|NCT02101853|515658149|FG000|Blinatumomab Salvage Therapy|Death|0|||
143032333|NCT02101853|515658150|FG001|Blinatumomab Salvage Therapy|Death|0|||
143032334|NCT02101853|515658151|FG002|Blinatumomab Salvage Therapy|Death|0|||
143032335|NCT02101853|515658152|FG003|Blinatumomab Salvage Therapy|Death|0|||
143032336|NCT02101853|515658153|FG004|Blinatumomab Salvage Therapy|Death|0|||
143032337|NCT02101853|515658154|FG005|Blinatumomab Salvage Therapy|Death|2|||
143032338|NCT02101853|515658149|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
143032339|NCT02101853|515658150|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
143032340|NCT02101853|515658151|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
143032341|NCT02101853|515658152|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
143032342|NCT02101853|515658153|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
143032343|NCT02101853|515658154|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
143032344|NCT02101853|515658149|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
143032345|NCT02101853|515658150|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
143032346|NCT02101853|515658151|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
143032347|NCT02101853|515658152|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
143032348|NCT02101853|515658153|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
143032349|NCT02101853|515658154|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
143032350|NCT02101853|515658149|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
143032351|NCT02101853|515658150|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
143032352|NCT02101853|515658151|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
143032353|NCT02101853|515658152|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
143032354|NCT02101853|515658153|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
143032355|NCT02101853|515658154|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
143032356|NCT00860028|515658155|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
143032357|NCT00860028|515658156|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
143032358|NCT00936390|515658157|FG000|Overall Study|Protocol Violation|21|||
143032359|NCT00936390|515658158|FG001|Overall Study|Protocol Violation|25|||
143032360|NCT02514174|515658162|FG000|Overall Study|Patient refused to continue medication|1|||
143032361|NCT02514174|515658162|FG000|Overall Study|Adverse Event|2|||
143032362|NCT02514174|515658162|FG000|Overall Study|Study closed by sponsor|9|||
143032363|NCT02514174|515658162|FG000|Overall Study|Progressive disease|11|||
143032364|NCT02514174|515658162|FG000|Overall Study|Treatment change|1|||
143032365|NCT02514174|515658162|FG000|Overall Study|Treated off study with Afatinib.|1|||
143032366|NCT00922779|515658163|FG000|Overall Study|Adverse Event|67|||
143032367|NCT00922779|515658163|FG000|Overall Study|Pregnancy|7|||
143032368|NCT00922779|515658163|FG000|Overall Study|Withdrawal by Subject|308|||
143032369|NCT00922779|515658163|FG000|Overall Study|Lost to Follow-up|44|||
143032370|NCT00922779|515658163|FG000|Overall Study|Other|27|||
143032371|NCT00922779|515658163|FG000|Overall Study|Missing|1874|||
143032372|NCT01922349|515658164|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
143032373|NCT01922349|515658165|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
143032374|NCT01922349|515658166|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
143032375|NCT01922349|515658167|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
143032376|NCT00993616|515658173|FG000|Overall Study|No tumor at entry|1|||
143032377|NCT00993616|515658173|FG000|Overall Study|Never treated|1|||
143032378|NCT01619800|515659753|FG000|Overall Study|study terminated|2|||
143032379|NCT01619800|515659754|FG001|Overall Study|study terminated|0|||
143032380|NCT02684344|515659756|FG000|Overall Study|Withdrawal by Subject|0|||
143032381|NCT02684344|515659757|FG001|Overall Study|Withdrawal by Subject|1|||
143032382|NCT01451762|515659760|FG000|Overall Study|Lost to Follow-up|3|||
143032383|NCT01451762|515659761|FG001|Overall Study|Lost to Follow-up|6|||
143159037|NCT00903344|516128042|FG001|Overall Study|Lost to Follow-up|0|||
143159038|NCT02365064|516128046|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
143159039|NCT02365064|516128047|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
143159040|NCT02365064|516128046|FG000|Overall Study|Withdrawal by Subject|6|||
143159041|NCT02365064|516128047|FG001|Overall Study|Withdrawal by Subject|9|||
143159042|NCT02365064|516128046|FG000|Overall Study|Treatment intolerance|2|||
143159043|NCT02365064|516128047|FG001|Overall Study|Treatment intolerance|4|||
143159044|NCT00605657|516128048|FG000|Overall Study|Adverse Event|1|||
143237650|NCT01074970|516423414|FG001|Overall Study|Adverse Event|0|||
143032384|NCT01451762|515659762|FG002|Overall Study|Lost to Follow-up|6|||
143032385|NCT00863746|515659766|FG000|Treatment|Not treated|4|||
143237651|NCT01074970|516423415|FG002|Overall Study|Adverse Event|4|||
143494302|NCT03406897|517350290|FG001|Overall Study|Lost to Follow-up|2|||
143032386|NCT00863746|515659767|FG001|Treatment|Not treated|2|||
143032387|NCT00863746|515659766|FG000|Treatment|Adverse Event|41|||
143032388|NCT00863746|515659767|FG001|Treatment|Adverse Event|16|||
143032389|NCT00863746|515659766|FG000|Treatment|non-compliant with study medication|4|||
143032390|NCT00863746|515659767|FG001|Treatment|non-compliant with study medication|0|||
143494303|NCT03406897|517350289|FG000|Overall Study|Withdrawal by Subject|4|||
143494304|NCT03406897|517350290|FG001|Overall Study|Withdrawal by Subject|4|||
143032391|NCT00863746|515659766|FG000|Treatment|Consent withdrawn|15|||
143032392|NCT00863746|515659767|FG001|Treatment|Consent withdrawn|14|||
143032393|NCT00863746|515659766|FG000|Treatment|Lost to Follow-up|1|||
143032394|NCT00863746|515659767|FG001|Treatment|Lost to Follow-up|0|||
143032395|NCT00863746|515659766|FG000|Treatment|Protocol Violation|5|||
143032396|NCT00863746|515659767|FG001|Treatment|Protocol Violation|3|||
143032397|NCT00863746|515659766|FG000|Treatment|Other|1|||
143032398|NCT00863746|515659767|FG001|Treatment|Other|0|||
143032399|NCT00863746|515659766|FG000|Survival Follow up|Death|244|||
143032400|NCT00863746|515659767|FG001|Survival Follow up|Death|271|||
143032401|NCT00863746|515659766|FG000|Survival Follow up|Lost to Follow-up|2|||
143032402|NCT00863746|515659767|FG001|Survival Follow up|Lost to Follow-up|1|||
143032403|NCT00863746|515659766|FG000|Survival Follow up|Consent Withdrawn|7|||
143032404|NCT00863746|515659767|FG001|Survival Follow up|Consent Withdrawn|8|||
143032405|NCT03292653|515659768|FG000|Overall Study|Adverse Event|0|||
143032406|NCT03292653|515659769|FG001|Overall Study|Adverse Event|0|||
143032407|NCT03292653|515659770|FG002|Overall Study|Adverse Event|1|||
143032408|NCT03292653|515659768|FG000|Overall Study|Did not Receive Treatment|1|||
143032409|NCT03292653|515659769|FG001|Overall Study|Did not Receive Treatment|0|||
143032410|NCT03292653|515659770|FG002|Overall Study|Did not Receive Treatment|0|||
143032411|NCT04510857|515659771|FG000|Overall Study|Withdrawal by Subject|1|||
143032412|NCT04510857|515659772|FG001|Overall Study|Withdrawal by Subject|2|||
143032413|NCT05346055|515659773|FG000|Overall Study|Withdrawal by Subject|1|||
143032414|NCT05346055|515659773|FG000|Overall Study|Protocol Violation|1|||
143032415|NCT05346055|515659773|FG000|Overall Study|Therapist decision|1|||
143159045|NCT00605657|516128048|FG000|Overall Study|Protocol Violation|1|||
143159046|NCT02123511|516128049|FG000|Overall Study|Cancelled treatment|1|||
143237652|NCT01074970|516423416|FG003|Overall Study|Adverse Event|3|||
143237653|NCT01074970|516423413|FG000|Overall Study|Disease progression during treatment|3|||
143494305|NCT03406897|517350289|FG000|Overall Study|Physician Decision|0|||
143159047|NCT02123511|516128050|FG001|Overall Study|Cancelled treatment|0|||
143159048|NCT02123511|516128049|FG000|Overall Study|Incomplete data|1|||
143159049|NCT02123511|516128050|FG001|Overall Study|Incomplete data|3|||
143159050|NCT02123511|516128049|FG000|Overall Study|Ineligible|0|||
143159051|NCT02123511|516128050|FG001|Overall Study|Ineligible|1|||
143159052|NCT00458705|516128051|FG000|Overall Study|Adverse Event|4|||
143159053|NCT00458705|516128051|FG000|Overall Study|Not Treated|1|||
143159054|NCT00378560|516128054|FG000|Overall Study|Adverse Event|1|||
143159055|NCT00378560|516128055|FG001|Overall Study|Adverse Event|0|||
143159056|NCT00378560|516128054|FG000|Overall Study|Lost to Follow-up|24|||
143159057|NCT00378560|516128055|FG001|Overall Study|Lost to Follow-up|29|||
143159058|NCT00378560|516128054|FG000|Overall Study|Protocol Violation|2|||
143159059|NCT00378560|516128055|FG001|Overall Study|Protocol Violation|0|||
143159060|NCT00378560|516128054|FG000|Overall Study|Withdrawal by Subject|17|||
143159061|NCT00378560|516128055|FG001|Overall Study|Withdrawal by Subject|21|||
143159062|NCT00378560|516128054|FG000|Overall Study|Moved|4|||
143159063|NCT00378560|516128055|FG001|Overall Study|Moved|3|||
143159064|NCT00378560|516128054|FG000|Overall Study|Pregnancy|7|||
143159065|NCT00378560|516128055|FG001|Overall Study|Pregnancy|5|||
143159066|NCT00378560|516128054|FG000|Overall Study|Laboratory test values abnormal|1|||
143159067|NCT00378560|516128055|FG001|Overall Study|Laboratory test values abnormal|0|||
143159068|NCT02773537|516128056|FG000|Overall Study|Lost to Follow-up|0|||
143159069|NCT02773537|516128057|FG001|Overall Study|Lost to Follow-up|1|||
143159070|NCT02773537|516128058|FG002|Overall Study|Lost to Follow-up|4|||
143159071|NCT00927186|516128063|FG000|12 Months Primary Study|Adverse Event|5|||
143159072|NCT00927186|516128064|FG001|12 Months Primary Study|Adverse Event|2|||
143159073|NCT00927186|516128063|FG000|12 Months Primary Study|Lost to Follow-up|1|||
143159074|NCT00927186|516128064|FG001|12 Months Primary Study|Lost to Follow-up|0|||
143159075|NCT00927186|516128063|FG000|12 Months Primary Study|Protocol Violation|0|||
143159076|NCT00927186|516128064|FG001|12 Months Primary Study|Protocol Violation|1|||
143159077|NCT00927186|516128063|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
143159078|NCT00927186|516128064|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
143159079|NCT00604383|516128065|FG000|Overall Study|Withdrawal by Subject|33|||
143159080|NCT00604383|516128066|FG001|Overall Study|Withdrawal by Subject|31|||
143159081|NCT00604383|516128065|FG000|Overall Study|Lost to Follow-up|24|||
143032416|NCT02564263|515659774|FG000|Overall Study|Adverse Event|31|||
143032417|NCT02564263|515659775|FG001|Overall Study|Adverse Event|29|||
143032418|NCT02564263|515659774|FG000|Overall Study|Death|270|||
143032419|NCT02564263|515659775|FG001|Overall Study|Death|262|||
143159082|NCT00604383|516128066|FG001|Overall Study|Lost to Follow-up|19|||
143159083|NCT00604383|516128065|FG000|Overall Study|Death|14|||
143032420|NCT02564263|515659774|FG000|Overall Study|Withdrawal by Subject|4|||
143032421|NCT02564263|515659775|FG001|Overall Study|Withdrawal by Subject|19|||
143159084|NCT00604383|516128066|FG001|Overall Study|Death|22|||
143032422|NCT02564263|515659774|FG000|Overall Study|Sponsor's decision|9|||
143159085|NCT00604383|516128065|FG000|Overall Study|Adverse Event|16|||
143159086|NCT00604383|516128066|FG001|Overall Study|Adverse Event|9|||
143494306|NCT03406897|517350290|FG001|Overall Study|Physician Decision|1|||
143032423|NCT02564263|515659775|FG001|Overall Study|Sponsor's decision|4|||
143032424|NCT00720096|515659776|FG000|Overall Study|Withdrawal by Subject|0|||
143032425|NCT00720096|515659777|FG001|Overall Study|Withdrawal by Subject|2|||
143032426|NCT01074554|515659780|FG000|Overall Study|Adverse Event|3|||
143032427|NCT01074554|515659781|FG001|Overall Study|Adverse Event|3|||
143032428|NCT01074554|515659780|FG000|Overall Study|Lost to Follow-up|0|||
143032429|NCT01074554|515659781|FG001|Overall Study|Lost to Follow-up|1|||
143032430|NCT00497796|515659782|FG000|Overall Study|Adverse event (not related)|9|||
143032431|NCT00497796|515659783|FG001|Overall Study|Adverse event (not related)|9|||
143032432|NCT00497796|515659782|FG000|Overall Study|Adverse event (related)|5|||
143032433|NCT00497796|515659783|FG001|Overall Study|Adverse event (related)|4|||
143032434|NCT00497796|515659782|FG000|Overall Study|CMV infection or disease treatment|30|||
143032435|NCT00497796|515659783|FG001|Overall Study|CMV infection or disease treatment|4|||
143032436|NCT00497796|515659782|FG000|Overall Study|Consent withdrawn|10|||
143032437|NCT00497796|515659783|FG001|Overall Study|Consent withdrawn|3|||
143032438|NCT00497796|515659782|FG000|Overall Study|Investigator/sponsor discretion|31|||
143032439|NCT00497796|515659783|FG001|Overall Study|Investigator/sponsor discretion|34|||
143032440|NCT00497796|515659782|FG000|Overall Study|Lost to Follow-up|0|||
143032441|NCT00497796|515659783|FG001|Overall Study|Lost to Follow-up|1|||
143032442|NCT00497796|515659782|FG000|Overall Study|Not applicable (randomized not treated)|0|||
143032443|NCT00497796|515659783|FG001|Overall Study|Not applicable (randomized not treated)|4|||
143032444|NCT04276883|515659787|FG000|Overall Study|Withdrawal by Subject|2|||
143032445|NCT04276883|515659788|FG001|Overall Study|Withdrawal by Subject|3|||
143032446|NCT04276883|515659789|FG002|Overall Study|Withdrawal by Subject|6|||
143032447|NCT04276883|515659787|FG000|Overall Study|Lost to Follow-up|1|||
143032448|NCT04276883|515659788|FG001|Overall Study|Lost to Follow-up|3|||
143032449|NCT04276883|515659789|FG002|Overall Study|Lost to Follow-up|0|||
143032450|NCT04276883|515659787|FG000|Overall Study|Adverse Event|0|||
143032451|NCT04276883|515659788|FG001|Overall Study|Adverse Event|1|||
143032452|NCT04276883|515659789|FG002|Overall Study|Adverse Event|0|||
143032453|NCT04276883|515659787|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
143032454|NCT04276883|515659788|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
143032455|NCT04276883|515659789|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
143032456|NCT00659607|515659790|FG000|Overall Study|No blood pressure recorded|147|||
143032457|NCT00659607|515659790|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
143032458|NCT00659607|515659790|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
143032459|NCT00659607|515659790|FG000|Overall Study|No recorded efficacy data|15|||
143032460|NCT00659607|515659790|FG000|Overall Study|Inconsistent BP measuring date|2|||
143032461|NCT00320112|515659791|FG000|Overall Study|Lost to Follow-up|3|||
143032462|NCT00320112|515659792|FG001|Overall Study|Lost to Follow-up|4|||
143032463|NCT00320112|515659791|FG000|Overall Study|Withdrawal by Subject|3|||
143032464|NCT00320112|515659792|FG001|Overall Study|Withdrawal by Subject|0|||
143032465|NCT00320112|515659791|FG000|Overall Study|Death|2|||
143032466|NCT00320112|515659792|FG001|Overall Study|Death|1|||
143494307|NCT01299766|517352221|FG000|Overall Study|Death|5|||
143494308|NCT01299766|517352222|FG001|Overall Study|Death|4|||
143032467|NCT02073643|515659797|FG000|Overall Study|Lost to Follow-up|24|||
143032468|NCT05014412|515659801|FG000|Overall Study|Death|11|||
143032469|NCT05014412|515659802|FG001|Overall Study|Death|7|||
143032470|NCT05014412|515659803|FG002|Overall Study|Death|4|||
143032471|NCT05014412|515659804|FG003|Overall Study|Death|7|||
143032472|NCT05014412|515659801|FG000|Overall Study|Withdrawal by Subject|1|||
143032473|NCT05014412|515659802|FG001|Overall Study|Withdrawal by Subject|1|||
143032474|NCT05014412|515659803|FG002|Overall Study|Withdrawal by Subject|1|||
143032475|NCT05014412|515659804|FG003|Overall Study|Withdrawal by Subject|2|||
143032476|NCT05014412|515659801|FG000|Overall Study|Ongoing|21|||
143032477|NCT05014412|515659802|FG001|Overall Study|Ongoing|4|||
143032478|NCT05014412|515659803|FG002|Overall Study|Ongoing|6|||
143032479|NCT05014412|515659804|FG003|Overall Study|Ongoing|20|||
143032480|NCT02353169|515659805|FG000|Overall Study|QTc > 450 msec|1|||
143494309|NCT01299766|517352221|FG000|Overall Study|Withdrawal by Subject|29|||
143494310|NCT01299766|517352222|FG001|Overall Study|Withdrawal by Subject|19|||
143494311|NCT00403260|517352225|FG000|Overall Study|Adverse Event|5|||
143494312|NCT00403260|517352226|FG001|Overall Study|Adverse Event|4|||
143032481|NCT02353169|515659806|FG001|Overall Study|QTc > 450 msec|1|||
143032482|NCT02353169|515659807|FG002|Overall Study|QTc > 450 msec|1|||
143032483|NCT02353169|515659808|FG003|Overall Study|QTc > 450 msec|1|||
143032484|NCT02353169|515659805|FG000|Overall Study|OR team declined|2|||
143032485|NCT02353169|515659806|FG001|Overall Study|OR team declined|0|||
143032486|NCT02353169|515659807|FG002|Overall Study|OR team declined|0|||
143032487|NCT02353169|515659808|FG003|Overall Study|OR team declined|0|||
143032488|NCT02353169|515659805|FG000|Overall Study|Inhalational induction|0|||
143032489|NCT02353169|515659806|FG001|Overall Study|Inhalational induction|2|||
143159087|NCT00604383|516128065|FG000|Overall Study|Physician Decision|0|||
143159088|NCT00604383|516128066|FG001|Overall Study|Physician Decision|3|||
143159089|NCT00290758|516128073|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
143494313|NCT00403260|517352225|FG000|Overall Study|Withdrawal by Subject|5|||
143494314|NCT00403260|517352226|FG001|Overall Study|Withdrawal by Subject|6|||
143494315|NCT00403260|517352225|FG000|Overall Study|Lost to Follow-up|49|||
143494316|NCT00403260|517352226|FG001|Overall Study|Lost to Follow-up|25|||
143494317|NCT00403260|517352225|FG000|Overall Study|Re-appearance of P. falciparum|34|||
143494318|NCT00403260|517352226|FG001|Overall Study|Re-appearance of P. falciparum|25|||
143494319|NCT00403260|517352225|FG000|Overall Study|P. vivax infection|26|||
143494320|NCT00403260|517352226|FG001|Overall Study|P. vivax infection|4|||
143032490|NCT02353169|515659807|FG002|Overall Study|Inhalational induction|0|||
143032491|NCT02353169|515659808|FG003|Overall Study|Inhalational induction|0|||
143032492|NCT02353169|515659805|FG000|Overall Study|ECG data error|0|||
143032493|NCT02353169|515659806|FG001|Overall Study|ECG data error|3|||
143032494|NCT02353169|515659807|FG002|Overall Study|ECG data error|2|||
143032495|NCT02353169|515659808|FG003|Overall Study|ECG data error|2|||
143032496|NCT02353169|515659805|FG000|Overall Study|Pre-op medication|0|||
143032497|NCT02353169|515659806|FG001|Overall Study|Pre-op medication|0|||
143032498|NCT02353169|515659807|FG002|Overall Study|Pre-op medication|1|||
143032499|NCT02353169|515659808|FG003|Overall Study|Pre-op medication|0|||
143032500|NCT03883906|515659812|FG000|Overall Study|Withdrawal by Subject|2|||
143032501|NCT03883906|515659812|FG000|Overall Study|Physician Decision|5|||
143032502|NCT00486837|515659814|FG000|Overall Study|Withdrawal by Subject|1|||
143032503|NCT00486837|515659815|FG001|Overall Study|Withdrawal by Subject|0|||
143032504|NCT00486837|515659814|FG000|Overall Study|Adverse Event|1|||
143032505|NCT00486837|515659815|FG001|Overall Study|Adverse Event|1|||
143032506|NCT00486837|515659814|FG000|Overall Study|Protocol Violation|4|||
143032507|NCT00486837|515659815|FG001|Overall Study|Protocol Violation|2|||
143032508|NCT00486837|515659814|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
143032509|NCT00486837|515659815|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
143032510|NCT04534283|515659820|FG000|Overall Study|Physician Decision|2|||
143032511|NCT04534283|515659820|FG000|Overall Study|Withdrawal by Subject|1|||
143032512|NCT04534283|515659820|FG000|Overall Study|Disease Progression|12|||
143032513|NCT04534283|515659820|FG000|Overall Study|Adverse Event|1|||
143032514|NCT05956665|515659821|FG000|Overall Study|Death|1|||
143032515|NCT05956665|515659821|FG000|Overall Study|Withdrawal by Subject|1|||
143032516|NCT00796822|515659822|FG000|Overall Study|Lost to Follow-up|2|||
143032517|NCT00796822|515659823|FG001|Overall Study|Lost to Follow-up|0|||
143032518|NCT00796822|515659822|FG000|Overall Study|Adverse Event|1|||
143032519|NCT00796822|515659823|FG001|Overall Study|Adverse Event|0|||
143032520|NCT03978624|515659824|FG000|Overall Study|Protocol Violation|1|||
143032521|NCT03978624|515659825|FG001|Overall Study|Protocol Violation|0|||
143032522|NCT01939197|515659830|FG000|Overall Study|Withdrawal by Subject|1|||
143032523|NCT01939197|515659831|FG001|Overall Study|Withdrawal by Subject|0|||
143032524|NCT01939197|515659832|FG002|Overall Study|Withdrawal by Subject|0|||
143032525|NCT01939197|515659833|FG003|Overall Study|Withdrawal by Subject|0|||
143032526|NCT01939197|515659834|FG004|Overall Study|Withdrawal by Subject|1|||
143032527|NCT01939197|515659835|FG005|Overall Study|Withdrawal by Subject|0|||
143032528|NCT01939197|515659836|FG006|Overall Study|Withdrawal by Subject|0|||
143032529|NCT01939197|515659830|FG000|Overall Study|Lost to Follow-up|0|||
143032530|NCT01939197|515659831|FG001|Overall Study|Lost to Follow-up|1|||
143032531|NCT01939197|515659832|FG002|Overall Study|Lost to Follow-up|0|||
143032532|NCT01939197|515659833|FG003|Overall Study|Lost to Follow-up|1|||
143032533|NCT01939197|515659834|FG004|Overall Study|Lost to Follow-up|3|||
143032534|NCT01939197|515659835|FG005|Overall Study|Lost to Follow-up|1|||
143032535|NCT01939197|515659836|FG006|Overall Study|Lost to Follow-up|2|||
143032536|NCT02545998|515659839|FG000|Overall Study|Lost to Follow-up|12|||
143032537|NCT02545998|515659840|FG001|Overall Study|Lost to Follow-up|3|||
143032538|NCT02545998|515659839|FG000|Overall Study|Withdrawal by Subject|3|||
143032539|NCT02545998|515659840|FG001|Overall Study|Withdrawal by Subject|2|||
143032540|NCT02603952|515659849|FG000|Overall Study|Withdrawal by Subject|1|||
143032541|NCT02603952|515659850|FG001|Overall Study|Withdrawal by Subject|0|||
143032542|NCT02603952|515659851|FG002|Overall Study|Withdrawal by Subject|0|||
143494321|NCT00403260|517352225|FG000|Overall Study|Mixed infection with P. vivax|2|||
143494322|NCT00403260|517352226|FG001|Overall Study|Mixed infection with P. vivax|0|||
143494323|NCT00403260|517352225|FG000|Overall Study|Mixed infection with P. falciparum|1|||
143494324|NCT00403260|517352226|FG001|Overall Study|Mixed infection with P. falciparum|0|||
143032543|NCT02603952|515659852|FG003|Overall Study|Withdrawal by Subject|0|||
143032544|NCT02603952|515659849|FG000|Overall Study|Received oseltamivir by error|0|||
143032545|NCT02603952|515659850|FG001|Overall Study|Received oseltamivir by error|0|||
143032546|NCT02603952|515659851|FG002|Overall Study|Received oseltamivir by error|0|||
143032547|NCT02603952|515659852|FG003|Overall Study|Received oseltamivir by error|1|||
143032548|NCT00958243|515659865|FG000|Overall Study|Withdrawal by Subject|0|||
143159090|NCT00290758|516128074|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
143159091|NCT00290758|516128073|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
143159092|NCT00290758|516128074|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
143159093|NCT00290758|516128073|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
143494325|NCT00403260|517352225|FG000|Overall Study|P. vivax infection at screening|1|||
143494326|NCT00403260|517352226|FG001|Overall Study|P. vivax infection at screening|0|||
143032549|NCT00958243|515659866|FG001|Overall Study|Withdrawal by Subject|1|||
143032550|NCT00958243|515659867|FG002|Overall Study|Withdrawal by Subject|3|||
143494327|NCT00403260|517352225|FG000|Overall Study|P. ovale infection|1|||
143494328|NCT00403260|517352226|FG001|Overall Study|P. ovale infection|0|||
143494329|NCT00403260|517352225|FG000|Overall Study|Gametocyte re-appearance|1|||
143494330|NCT00403260|517352226|FG001|Overall Study|Gametocyte re-appearance|1|||
143494331|NCT00403260|517352225|FG000|Overall Study|Withdrawn from study accidentally|0|||
143494332|NCT00403260|517352226|FG001|Overall Study|Withdrawn from study accidentally|1|||
143032551|NCT00958243|515659868|FG003|Overall Study|Withdrawal by Subject|1|||
143032552|NCT00958243|515659869|FG004|Overall Study|Withdrawal by Subject|1|||
143032553|NCT00958243|515659870|FG005|Overall Study|Withdrawal by Subject|5|||
143032554|NCT00958243|515659865|FG000|Overall Study|Lost to Follow-up|2|||
143032555|NCT00958243|515659866|FG001|Overall Study|Lost to Follow-up|5|||
143032556|NCT00958243|515659867|FG002|Overall Study|Lost to Follow-up|11|||
143032557|NCT00958243|515659868|FG003|Overall Study|Lost to Follow-up|2|||
143032558|NCT00958243|515659869|FG004|Overall Study|Lost to Follow-up|8|||
143032559|NCT00958243|515659870|FG005|Overall Study|Lost to Follow-up|5|||
143032560|NCT04646109|515659871|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
143032561|NCT04646109|515659872|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
143032562|NCT06176768|515659873|FG000|Overall Study|Adverse Event|1|||
143032563|NCT06176768|515659874|FG001|Overall Study|Adverse Event|0|||
143032564|NCT06176768|515659873|FG000|Overall Study|Assigned treatment by mistake|1|||
143032565|NCT06176768|515659874|FG001|Overall Study|Assigned treatment by mistake|0|||
143032566|NCT06176768|515659873|FG000|Overall Study|Lost to Follow-up|0|||
143032567|NCT06176768|515659874|FG001|Overall Study|Lost to Follow-up|3|||
143032568|NCT06176768|515659873|FG000|Overall Study|Physician Decision|1|||
143032569|NCT06176768|515659874|FG001|Overall Study|Physician Decision|0|||
143494333|NCT01337973|517352231|FG000|Overall Study|Lost to Follow-up|2|||
143494334|NCT01337973|517352232|FG001|Overall Study|Lost to Follow-up|4|||
143494335|NCT01337973|517352233|FG002|Overall Study|Lost to Follow-up|3|||
143494336|NCT01337973|517352231|FG000|Overall Study|Death|1|||
143494337|NCT01337973|517352232|FG001|Overall Study|Death|2|||
143494338|NCT01337973|517352233|FG002|Overall Study|Death|1|||
143494339|NCT01337973|517352231|FG000|Overall Study|Withdrawal by Subject|10|||
143494340|NCT01337973|517352232|FG001|Overall Study|Withdrawal by Subject|8|||
143494341|NCT01337973|517352233|FG002|Overall Study|Withdrawal by Subject|4|||
143494342|NCT01337973|517352231|FG000|Overall Study|missing data on primary outcome|3|||
143032570|NCT06176768|515659873|FG000|Overall Study|Protocol deviation|3|||
143494343|NCT01337973|517352232|FG001|Overall Study|missing data on primary outcome|1|||
143032571|NCT06176768|515659874|FG001|Overall Study|Protocol deviation|1|||
143032572|NCT06176768|515659873|FG000|Overall Study|Other|1|||
143032573|NCT06176768|515659874|FG001|Overall Study|Other|0|||
143032574|NCT06176768|515659873|FG000|Overall Study|Withdrawal by Subject|6|||
143032575|NCT06176768|515659874|FG001|Overall Study|Withdrawal by Subject|9|||
143159094|NCT00290758|516128074|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
143159095|NCT00290758|516128073|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
143159096|NCT00290758|516128074|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
143159097|NCT00290758|516128073|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
143159098|NCT00290758|516128074|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
143494344|NCT01337973|517352233|FG002|Overall Study|missing data on primary outcome|3|||
143494345|NCT04537208|517352236|FG000|Overall Study|Adverse Event|0|||
143494346|NCT04537208|517352237|FG001|Overall Study|Adverse Event|0|||
143494347|NCT04537208|517352238|FG002|Overall Study|Adverse Event|0|||
143494348|NCT04537208|517352239|FG003|Overall Study|Adverse Event|0|||
143494349|NCT04537208|517352240|FG004|Overall Study|Adverse Event|0|||
143494350|NCT04537208|517352241|FG005|Overall Study|Adverse Event|0|||
143494351|NCT04537208|517352242|FG006|Overall Study|Adverse Event|0|||
143494352|NCT04537208|517352243|FG007|Overall Study|Adverse Event|0|||
143032576|NCT01226797|515659877|FG000|Overall Study|Adverse Event|1|||
143032577|NCT01226797|515659878|FG001|Overall Study|Adverse Event|0|||
143032578|NCT01226797|515659877|FG000|Overall Study|No longer willing to participate|1|||
143159099|NCT00290758|516128073|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
143159100|NCT00290758|516128074|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
143159101|NCT00290758|516128073|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
143494353|NCT04537208|517352244|FG008|Overall Study|Adverse Event|1|||
143494354|NCT04537208|517352245|FG009|Overall Study|Adverse Event|0|||
143032579|NCT01226797|515659878|FG001|Overall Study|No longer willing to participate|0|||
143032580|NCT01226797|515659877|FG000|Overall Study|Protocol Violation|0|||
143494355|NCT04537208|517352246|FG010|Overall Study|Adverse Event|0|||
143032581|NCT01226797|515659878|FG001|Overall Study|Protocol Violation|1|||
143032582|NCT00577460|515659879|FG000|Overall Study|Adverse Event|11|||
143032583|NCT00577460|515659880|FG001|Overall Study|Adverse Event|7|||
143494356|NCT04537208|517352236|FG000|Overall Study|Protocol deviation|0|||
143494357|NCT04537208|517352237|FG001|Overall Study|Protocol deviation|0|||
143494358|NCT04537208|517352238|FG002|Overall Study|Protocol deviation|2|||
143494359|NCT04537208|517352239|FG003|Overall Study|Protocol deviation|0|||
143032584|NCT00577460|515659881|FG002|Overall Study|Adverse Event|14|||
143032585|NCT00577460|515659879|FG000|Overall Study|Protocol Violation|0|||
143032586|NCT00577460|515659880|FG001|Overall Study|Protocol Violation|1|||
143032587|NCT00577460|515659881|FG002|Overall Study|Protocol Violation|1|||
143032588|NCT00577460|515659879|FG000|Overall Study|Lost to Follow-up|0|||
143032589|NCT00577460|515659880|FG001|Overall Study|Lost to Follow-up|3|||
143032590|NCT00577460|515659881|FG002|Overall Study|Lost to Follow-up|4|||
143032591|NCT00577460|515659879|FG000|Overall Study|Withdrawal by Subject|5|||
143032592|NCT00577460|515659880|FG001|Overall Study|Withdrawal by Subject|5|||
143032593|NCT00577460|515659881|FG002|Overall Study|Withdrawal by Subject|6|||
143032594|NCT00577460|515659879|FG000|Overall Study|Other|0|||
143032595|NCT00577460|515659880|FG001|Overall Study|Other|3|||
143032596|NCT00577460|515659881|FG002|Overall Study|Other|2|||
143032597|NCT01974141|515659886|FG000|Overall Study|Other Reasons|28|||
143494360|NCT04537208|517352240|FG004|Overall Study|Protocol deviation|0|||
143494361|NCT04537208|517352241|FG005|Overall Study|Protocol deviation|2|||
143032598|NCT01974141|515659887|FG001|Overall Study|Other Reasons|18|||
143032599|NCT01974141|515659886|FG000|Overall Study|Protocol Violation|2|||
143032600|NCT01974141|515659887|FG001|Overall Study|Protocol Violation|6|||
143032601|NCT01974141|515659886|FG000|Overall Study|Personal Reasons|21|||
143159102|NCT00290758|516128074|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
143159103|NCT00290758|516128073|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
143159104|NCT00290758|516128074|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
143159105|NCT03994120|516128075|FG000|Overall Study|Lost to Follow-up|3|||
143159106|NCT03994120|516128076|FG001|Overall Study|Lost to Follow-up|1|||
143159107|NCT01111292|516128077|FG000|Treatment|Physician Decision|1|||
143159108|NCT01111292|516128078|FG001|Treatment|Physician Decision|1|||
143159109|NCT02619812|516128079|FG000|Overall Study|Withdrawal by Subject|0|||
143159110|NCT02619812|516128080|FG001|Overall Study|Withdrawal by Subject|0|||
143159111|NCT02619812|516128081|FG002|Overall Study|Withdrawal by Subject|1|||
143159112|NCT02619812|516128082|FG003|Overall Study|Withdrawal by Subject|2|||
143159113|NCT03156621|516128088|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
143159114|NCT03156621|516128089|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
143159115|NCT03156621|516128088|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
143159116|NCT03156621|516128089|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
143159117|NCT01362270|516128090|FG000|Overall Study|Withdrawal by Subject|1|||
143159118|NCT01362270|516128091|FG001|Overall Study|Withdrawal by Subject|0|||
143159119|NCT01362270|516128090|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
143159120|NCT01362270|516128091|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
143159121|NCT01362270|516128090|FG000|Overall Study|Met excl. criteria before 1st session|1|||
143159122|NCT01362270|516128091|FG001|Overall Study|Met excl. criteria before 1st session|1|||
143159123|NCT02318277|516128092|FG000|Overall Study|Physician Decision|0|||
143159124|NCT02318277|516128093|FG001|Overall Study|Physician Decision|0|||
143159125|NCT02318277|516128094|FG002|Overall Study|Physician Decision|0|||
143159126|NCT02318277|516128095|FG003|Overall Study|Physician Decision|0|||
143159127|NCT02318277|516128096|FG004|Overall Study|Physician Decision|0|||
143159128|NCT02318277|516128097|FG005|Overall Study|Physician Decision|0|||
143159129|NCT02318277|516128098|FG006|Overall Study|Physician Decision|0|||
143159130|NCT02318277|516128099|FG007|Overall Study|Physician Decision|1|||
143159131|NCT02318277|516128092|FG000|Overall Study|Other|0|||
143159132|NCT02318277|516128093|FG001|Overall Study|Other|0|||
143159133|NCT02318277|516128094|FG002|Overall Study|Other|0|||
143159134|NCT02318277|516128095|FG003|Overall Study|Other|0|||
143159135|NCT02318277|516128096|FG004|Overall Study|Other|0|||
143159136|NCT02318277|516128097|FG005|Overall Study|Other|0|||
143159137|NCT02318277|516128098|FG006|Overall Study|Other|1|||
143159138|NCT02318277|516128099|FG007|Overall Study|Other|0|||
143159139|NCT02318277|516128092|FG000|Overall Study|Withdrawal by Subject|0|||
143159140|NCT02318277|516128093|FG001|Overall Study|Withdrawal by Subject|0|||
143159141|NCT02318277|516128094|FG002|Overall Study|Withdrawal by Subject|1|||
143159142|NCT02318277|516128095|FG003|Overall Study|Withdrawal by Subject|0|||
143494362|NCT04537208|517352242|FG006|Overall Study|Protocol deviation|4|||
143494363|NCT04537208|517352243|FG007|Overall Study|Protocol deviation|0|||
143494364|NCT04537208|517352244|FG008|Overall Study|Protocol deviation|1|||
143494365|NCT04537208|517352245|FG009|Overall Study|Protocol deviation|0|||
143032602|NCT01974141|515659887|FG001|Overall Study|Personal Reasons|20|||
143032603|NCT01974141|515659886|FG000|Overall Study|Lost to Follow-up|38|||
143032604|NCT01974141|515659887|FG001|Overall Study|Lost to Follow-up|29|||
143032605|NCT01974141|515659886|FG000|Overall Study|Pregnancy|3|||
143159143|NCT02318277|516128096|FG004|Overall Study|Withdrawal by Subject|1|||
143159144|NCT02318277|516128097|FG005|Overall Study|Withdrawal by Subject|1|||
143159145|NCT02318277|516128098|FG006|Overall Study|Withdrawal by Subject|6|||
143159146|NCT02318277|516128099|FG007|Overall Study|Withdrawal by Subject|14|||
143159147|NCT02318277|516128092|FG000|Overall Study|Participant trial terminated by sponsor|0|||
143159148|NCT02318277|516128093|FG001|Overall Study|Participant trial terminated by sponsor|0|||
143494366|NCT04537208|517352246|FG010|Overall Study|Protocol deviation|2|||
143032606|NCT01974141|515659887|FG001|Overall Study|Pregnancy|3|||
143032607|NCT01974141|515659886|FG000|Overall Study|Lack of Efficacy|0|||
143032608|NCT01974141|515659887|FG001|Overall Study|Lack of Efficacy|1|||
143032609|NCT01974141|515659886|FG000|Overall Study|Adverse Event|4|||
143032610|NCT01974141|515659887|FG001|Overall Study|Adverse Event|5|||
143032611|NCT04028843|515659888|FG000|Overall Study|Lost to Follow-up|32|||
143032612|NCT04028843|515659889|FG001|Overall Study|Lost to Follow-up|39|||
143032613|NCT04028843|515659888|FG000|Overall Study|Adverse Event|1|||
143032614|NCT04028843|515659889|FG001|Overall Study|Adverse Event|0|||
143032615|NCT04028843|515659888|FG000|Overall Study|Non-viable Pregnancy|0|||
143032616|NCT04028843|515659889|FG001|Overall Study|Non-viable Pregnancy|1|||
143032617|NCT04028843|515659888|FG000|Overall Study|Withdrawal by Subject|4|||
143032618|NCT04028843|515659889|FG001|Overall Study|Withdrawal by Subject|2|||
143032619|NCT04977336|515659890|FG000|Overall Study|Withdrawal of Consent (not due to AE)|1|||
143494367|NCT04537208|517352236|FG000|Overall Study|Withdrawal by Subject|4|||
143494368|NCT04537208|517352237|FG001|Overall Study|Withdrawal by Subject|2|||
143494369|NCT04537208|517352238|FG002|Overall Study|Withdrawal by Subject|1|||
143494370|NCT04537208|517352239|FG003|Overall Study|Withdrawal by Subject|3|||
143494371|NCT04537208|517352240|FG004|Overall Study|Withdrawal by Subject|5|||
143494372|NCT04537208|517352241|FG005|Overall Study|Withdrawal by Subject|1|||
143494373|NCT04537208|517352242|FG006|Overall Study|Withdrawal by Subject|6|||
143494374|NCT04537208|517352243|FG007|Overall Study|Withdrawal by Subject|1|||
143494375|NCT04537208|517352244|FG008|Overall Study|Withdrawal by Subject|7|||
143494376|NCT04537208|517352245|FG009|Overall Study|Withdrawal by Subject|2|||
143494377|NCT04537208|517352246|FG010|Overall Study|Withdrawal by Subject|4|||
143494378|NCT04537208|517352236|FG000|Overall Study|Lost to Follow-up|4|||
143494379|NCT04537208|517352237|FG001|Overall Study|Lost to Follow-up|1|||
143494380|NCT04537208|517352238|FG002|Overall Study|Lost to Follow-up|3|||
143494381|NCT04537208|517352239|FG003|Overall Study|Lost to Follow-up|4|||
143494382|NCT04537208|517352240|FG004|Overall Study|Lost to Follow-up|3|||
143494383|NCT04537208|517352241|FG005|Overall Study|Lost to Follow-up|2|||
143494384|NCT04537208|517352242|FG006|Overall Study|Lost to Follow-up|3|||
143494385|NCT04537208|517352243|FG007|Overall Study|Lost to Follow-up|2|||
143494386|NCT04537208|517352244|FG008|Overall Study|Lost to Follow-up|7|||
143494387|NCT04537208|517352245|FG009|Overall Study|Lost to Follow-up|2|||
143494388|NCT04537208|517352246|FG010|Overall Study|Lost to Follow-up|2|||
143494389|NCT01537211|517352247|FG000|Overall Study|Lost to Follow-up|0|||
143494390|NCT01537211|517352248|FG001|Overall Study|Lost to Follow-up|1|||
143494391|NCT00343512|517352252|FG000|Overall Study|Withdrawal by Subject|2|||
143494392|NCT00197054|517352253|FG000|Overall Study|Withdrawal by Subject|9|||
143494393|NCT00197054|517352254|FG001|Overall Study|Withdrawal by Subject|3|||
143494394|NCT00197054|517352255|FG002|Overall Study|Withdrawal by Subject|3|||
143494395|NCT00197054|517352253|FG000|Overall Study|Moved from area|7|||
143494396|NCT00197054|517352254|FG001|Overall Study|Moved from area|14|||
143494397|NCT00197054|517352255|FG002|Overall Study|Moved from area|9|||
143494398|NCT00197054|517352253|FG000|Overall Study|Lost to Follow-up|1|||
143494399|NCT00197054|517352254|FG001|Overall Study|Lost to Follow-up|4|||
143494400|NCT00197054|517352255|FG002|Overall Study|Lost to Follow-up|0|||
143494401|NCT00323557|517352256|FG000|Overall Study|Physician Decision|1|||
143032620|NCT04977336|515659891|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
143032621|NCT04977336|515659892|FG002|Overall Study|Withdrawal of Consent (not due to AE)|0|||
143032622|NCT04977336|515659893|FG003|Overall Study|Withdrawal of Consent (not due to AE)|1|||
143032623|NCT04977336|515659894|FG004|Overall Study|Withdrawal of Consent (not due to AE)|2|||
143032624|NCT04977336|515659890|FG000|Overall Study|Lost to Follow-up|0|||
143032625|NCT04977336|515659891|FG001|Overall Study|Lost to Follow-up|0|||
143032626|NCT04977336|515659892|FG002|Overall Study|Lost to Follow-up|1|||
143032627|NCT04977336|515659893|FG003|Overall Study|Lost to Follow-up|0|||
143032628|NCT04977336|515659894|FG004|Overall Study|Lost to Follow-up|0|||
143032629|NCT03298451|515659895|FG000|Overall Study|Death|275|||
143032630|NCT03298451|515659896|FG001|Overall Study|Death|260|||
143032631|NCT03298451|515659897|FG002|Overall Study|Death|122|||
143032632|NCT03298451|515659898|FG003|Overall Study|Death|280|||
143032633|NCT03298451|515659895|FG000|Overall Study|Lost to Follow-up|1|||
143032634|NCT03298451|515659896|FG001|Overall Study|Lost to Follow-up|1|||
143032635|NCT03298451|515659897|FG002|Overall Study|Lost to Follow-up|0|||
143032636|NCT03298451|515659898|FG003|Overall Study|Lost to Follow-up|7|||
143032637|NCT03298451|515659895|FG000|Overall Study|Withdrawal by Subject|9|||
143032638|NCT03298451|515659896|FG001|Overall Study|Withdrawal by Subject|7|||
143494402|NCT00323557|517352257|FG001|Overall Study|Physician Decision|0|||
143494403|NCT00684515|517352258|FG000|Overall Study|Adverse Event|3|||
143494404|NCT00684515|517352259|FG001|Overall Study|Adverse Event|3|||
143494405|NCT00684515|517352260|FG002|Overall Study|Adverse Event|1|||
143032639|NCT03298451|515659897|FG002|Overall Study|Withdrawal by Subject|1|||
143032640|NCT03298451|515659898|FG003|Overall Study|Withdrawal by Subject|20|||
143032641|NCT01347710|515659899|FG000|Overall Study|Withdrawal by Subject|2|||
143032642|NCT01347710|515659899|FG000|Overall Study|Adverse Event|4|||
143032643|NCT01347710|515659899|FG000|Overall Study|Angio or SPECT not completed|18|||
143032644|NCT01347710|515659899|FG000|Overall Study|issue with vitals prior to dosing|1|||
143494406|NCT00684515|517352258|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
143032645|NCT01347710|515659899|FG000|Overall Study|Lost to Follow-up|1|||
143032646|NCT01347710|515659899|FG000|Overall Study|Physician Decision|2|||
143032647|NCT01347710|515659899|FG000|Overall Study|Other|3|||
143032648|NCT00878995|515659900|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
143032649|NCT00878995|515659901|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
143032650|NCT02130466|515659902|FG000|Overall Study|Death|4|||
143032651|NCT02130466|515659903|FG001|Overall Study|Death|1|||
143032652|NCT02130466|515659904|FG002|Overall Study|Death|1|||
143032653|NCT02130466|515659905|FG003|Overall Study|Death|3|||
143032654|NCT02130466|515659906|FG004|Overall Study|Death|2|||
143032655|NCT02130466|515659907|FG005|Overall Study|Death|30|||
143494407|NCT00684515|517352259|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
143494408|NCT00684515|517352260|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
143494409|NCT02450578|517352263|FG000|Overall Study|ECG abnormality so not treated|1|||
143494410|NCT02450578|517352264|FG001|Overall Study|ECG abnormality so not treated|0|||
143494411|NCT02450578|517352265|FG002|Overall Study|ECG abnormality so not treated|0|||
143494412|NCT02450578|517352266|FG003|Overall Study|ECG abnormality so not treated|0|||
143494413|NCT00662792|517352267|FG000|Period 1|Personal Reasons|0|||
143494414|NCT00662792|517352268|FG001|Period 1|Personal Reasons|0|||
143494415|NCT00662792|517352269|FG002|Period 1|Personal Reasons|1|||
143494416|NCT00662792|517352270|FG003|Period 1|Personal Reasons|0|||
143494417|NCT00662792|517352267|FG000|Period 1|Refused continuing medication|0|||
143032656|NCT02130466|515659908|FG006|Overall Study|Death|45|||
143032657|NCT02130466|515659909|FG007|Overall Study|Death|2|||
143032658|NCT02130466|515659910|FG008|Overall Study|Death|3|||
143032659|NCT02130466|515659911|FG009|Overall Study|Death|4|||
143159149|NCT02318277|516128094|FG002|Overall Study|Participant trial terminated by sponsor|1|||
143159150|NCT02318277|516128095|FG003|Overall Study|Participant trial terminated by sponsor|0|||
143159151|NCT02318277|516128096|FG004|Overall Study|Participant trial terminated by sponsor|1|||
143159152|NCT02318277|516128097|FG005|Overall Study|Participant trial terminated by sponsor|2|||
143159153|NCT02318277|516128098|FG006|Overall Study|Participant trial terminated by sponsor|5|||
143159154|NCT02318277|516128099|FG007|Overall Study|Participant trial terminated by sponsor|16|||
143159155|NCT02318277|516128092|FG000|Overall Study|Lost to Follow-up|1|||
143159156|NCT02318277|516128093|FG001|Overall Study|Lost to Follow-up|0|||
143159157|NCT02318277|516128094|FG002|Overall Study|Lost to Follow-up|1|||
143159158|NCT02318277|516128095|FG003|Overall Study|Lost to Follow-up|0|||
143159159|NCT02318277|516128096|FG004|Overall Study|Lost to Follow-up|0|||
143159160|NCT02318277|516128097|FG005|Overall Study|Lost to Follow-up|0|||
143159161|NCT02318277|516128098|FG006|Overall Study|Lost to Follow-up|3|||
143159162|NCT02318277|516128099|FG007|Overall Study|Lost to Follow-up|4|||
143159163|NCT02318277|516128092|FG000|Overall Study|Death|5|||
143159164|NCT02318277|516128093|FG001|Overall Study|Death|3|||
143159165|NCT02318277|516128094|FG002|Overall Study|Death|1|||
143159166|NCT02318277|516128095|FG003|Overall Study|Death|4|||
143159167|NCT02318277|516128096|FG004|Overall Study|Death|6|||
143159168|NCT02318277|516128097|FG005|Overall Study|Death|5|||
143159169|NCT02318277|516128098|FG006|Overall Study|Death|34|||
143159170|NCT02318277|516128099|FG007|Overall Study|Death|58|||
143159171|NCT02318277|516128092|FG000|Overall Study|Transitioned to Hospice|0|||
143159172|NCT02318277|516128093|FG001|Overall Study|Transitioned to Hospice|0|||
143159173|NCT02318277|516128094|FG002|Overall Study|Transitioned to Hospice|0|||
143159174|NCT02318277|516128095|FG003|Overall Study|Transitioned to Hospice|0|||
143159175|NCT02318277|516128096|FG004|Overall Study|Transitioned to Hospice|0|||
143159176|NCT02318277|516128097|FG005|Overall Study|Transitioned to Hospice|1|||
143159177|NCT02318277|516128098|FG006|Overall Study|Transitioned to Hospice|0|||
143159178|NCT02318277|516128099|FG007|Overall Study|Transitioned to Hospice|0|||
143159179|NCT01986751|516128106|FG000|Overall Study|improperly consented|10|||
143159180|NCT01986751|516128107|FG001|Overall Study|improperly consented|2|||
143159181|NCT03566550|516128108|FG000|Overall Study|Withdrawal by Subject|0|||
143159182|NCT03566550|516128109|FG001|Overall Study|Withdrawal by Subject|1|||
143159183|NCT01489358|516128111|FG000|Overall Study|Lost to Follow-up|0|||
143159184|NCT01489358|516128112|FG001|Overall Study|Lost to Follow-up|0|||
143159185|NCT01489358|516128113|FG002|Overall Study|Lost to Follow-up|2|||
143364034|NCT00293462|516875527|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
143494418|NCT00662792|517352268|FG001|Period 1|Refused continuing medication|1|||
143494419|NCT00662792|517352269|FG002|Period 1|Refused continuing medication|1|||
143494420|NCT00662792|517352270|FG003|Period 1|Refused continuing medication|0|||
143494421|NCT00662792|517352267|FG000|Period 1|Lost to Follow-up|1|||
143032660|NCT02130466|515659912|FG010|Overall Study|Death|5|||
143032661|NCT02130466|515659913|FG011|Overall Study|Death|3|||
143032662|NCT02130466|515659914|FG012|Overall Study|Death|11|||
143032663|NCT02130466|515659915|FG013|Overall Study|Death|7|||
143032664|NCT02130466|515659902|FG000|Overall Study|Lost to Follow-up|1|||
143159186|NCT00736476|516128114|FG000|Overall Study|Adverse Event|1|||
143159187|NCT00736476|516128115|FG001|Overall Study|Adverse Event|0|||
143159188|NCT01968785|516128116|FG000|Overall Study|Withdrawal by Subject|1|||
143159189|NCT01968785|516128117|FG001|Overall Study|Withdrawal by Subject|0|||
143159190|NCT00098293|516128118|FG000|Double-blind (DB) Phase|Adverse Event|14|||
143159191|NCT00098293|516128119|FG001|Double-blind (DB) Phase|Adverse Event|27|||
143032665|NCT02130466|515659903|FG001|Overall Study|Lost to Follow-up|0|||
143494422|NCT00662792|517352268|FG001|Period 1|Lost to Follow-up|0|||
143494423|NCT00662792|517352269|FG002|Period 1|Lost to Follow-up|0|||
143494424|NCT00662792|517352270|FG003|Period 1|Lost to Follow-up|0|||
143494425|NCT00662792|517352267|FG000|Period 1|Other adverse event (AE)|0|||
143494426|NCT00662792|517352268|FG001|Period 1|Other adverse event (AE)|2|||
143494427|NCT00662792|517352269|FG002|Period 1|Other adverse event (AE)|0|||
143494428|NCT00662792|517352270|FG003|Period 1|Other adverse event (AE)|0|||
143494429|NCT00662792|517352267|FG000|Period 1|Worsening of disease under study (AE)|1|||
143494430|NCT00662792|517352268|FG001|Period 1|Worsening of disease under study (AE)|3|||
143494431|NCT00662792|517352269|FG002|Period 1|Worsening of disease under study (AE)|2|||
143494432|NCT00662792|517352270|FG003|Period 1|Worsening of disease under study (AE)|0|||
143494433|NCT00662792|517352267|FG000|Period 1|Not treated|0|||
143494434|NCT00662792|517352268|FG001|Period 1|Not treated|1|||
143494435|NCT00662792|517352269|FG002|Period 1|Not treated|0|||
143494436|NCT00662792|517352270|FG003|Period 1|Not treated|0|||
143494437|NCT00662792|517352267|FG000|Period 2|Worsening of disease under study|1|||
143494438|NCT00662792|517352268|FG001|Period 2|Worsening of disease under study|0|||
143494439|NCT00662792|517352269|FG002|Period 2|Worsening of disease under study|0|||
143494440|NCT00662792|517352270|FG003|Period 2|Worsening of disease under study|3|||
143494441|NCT00662792|517352267|FG000|Period 3|Refused continuing medication|1|||
143494442|NCT00662792|517352268|FG001|Period 3|Refused continuing medication|0|||
143494443|NCT00662792|517352269|FG002|Period 3|Refused continuing medication|1|||
143494444|NCT00662792|517352270|FG003|Period 3|Refused continuing medication|0|||
143494445|NCT00662792|517352267|FG000|Period 3|Other adverse event (AE)|0|||
143494446|NCT00662792|517352268|FG001|Period 3|Other adverse event (AE)|0|||
143494447|NCT00662792|517352269|FG002|Period 3|Other adverse event (AE)|1|||
143494448|NCT00662792|517352270|FG003|Period 3|Other adverse event (AE)|1|||
143494449|NCT00662792|517352267|FG000|Period 4|Refused continuing medication|0|||
143494450|NCT00662792|517352268|FG001|Period 4|Refused continuing medication|1|||
143494451|NCT00662792|517352269|FG002|Period 4|Refused continuing medication|0|||
143494452|NCT00662792|517352270|FG003|Period 4|Refused continuing medication|0|||
143494453|NCT00662792|517352267|FG000|Period 4|Other adverse event (AE)|1|||
143494454|NCT00662792|517352268|FG001|Period 4|Other adverse event (AE)|0|||
143494455|NCT00662792|517352269|FG002|Period 4|Other adverse event (AE)|0|||
143494456|NCT00662792|517352270|FG003|Period 4|Other adverse event (AE)|0|||
143494457|NCT00662792|517352267|FG000|Period 4|Worsening of disease under study (AE)|0|||
143494458|NCT00662792|517352268|FG001|Period 4|Worsening of disease under study (AE)|0|||
143494459|NCT00662792|517352269|FG002|Period 4|Worsening of disease under study (AE)|0|||
143494460|NCT00662792|517352270|FG003|Period 4|Worsening of disease under study (AE)|1|||
143494461|NCT03021642|517352276|FG000|Washout Period (21 Days)|Adverse Event|1|||
143494462|NCT03021642|517352277|FG001|Washout Period (21 Days)|Adverse Event|1|||
143494463|NCT00090545|517352278|FG000|Overall Study|Disease progression on study|21|||
143494464|NCT00090545|517352279|FG001|Overall Study|Disease progression on study|17|||
143494465|NCT00090545|517352278|FG000|Overall Study|Refused further treatment|1|||
143494466|NCT00090545|517352279|FG001|Overall Study|Refused further treatment|4|||
143494467|NCT00090545|517352278|FG000|Overall Study|Death|0|||
143494468|NCT00090545|517352279|FG001|Overall Study|Death|1|||
143494469|NCT00090545|517352278|FG000|Overall Study|Adverse Event|0|||
143494470|NCT00090545|517352279|FG001|Overall Study|Adverse Event|2|||
143494471|NCT02474082|517352280|FG000|Overall Study|Adverse Event|2|||
143494472|NCT02474082|517352281|FG001|Overall Study|Adverse Event|32|||
143494473|NCT02474082|517352280|FG000|Overall Study|Withdrawal of informed consent|1|||
143032666|NCT02130466|515659904|FG002|Overall Study|Lost to Follow-up|0|||
143032667|NCT02130466|515659905|FG003|Overall Study|Lost to Follow-up|0|||
143032668|NCT02130466|515659906|FG004|Overall Study|Lost to Follow-up|0|||
143032669|NCT02130466|515659907|FG005|Overall Study|Lost to Follow-up|1|||
143032670|NCT02130466|515659908|FG006|Overall Study|Lost to Follow-up|0|||
143032671|NCT02130466|515659909|FG007|Overall Study|Lost to Follow-up|0|||
143032672|NCT02130466|515659910|FG008|Overall Study|Lost to Follow-up|0|||
143159192|NCT00098293|516128120|FG002|Double-blind (DB) Phase|Adverse Event|60|||
143159193|NCT00098293|516128121|FG003|Double-blind (DB) Phase|Adverse Event|0|||
143159194|NCT00098293|516128122|FG004|Double-blind (DB) Phase|Adverse Event|0|||
143159195|NCT00098293|516128118|FG000|Double-blind (DB) Phase|Pregnancy|0|||
143494474|NCT02474082|517352281|FG001|Overall Study|Withdrawal of informed consent|11|||
143494475|NCT02474082|517352280|FG000|Overall Study|Lost to Follow-up|2|||
143494476|NCT02474082|517352281|FG001|Overall Study|Lost to Follow-up|2|||
143032673|NCT02130466|515659911|FG009|Overall Study|Lost to Follow-up|0|||
143159196|NCT00098293|516128119|FG001|Double-blind (DB) Phase|Pregnancy|7|||
143494477|NCT02474082|517352280|FG000|Overall Study|Dose tapering not achieved|0|||
143494478|NCT02474082|517352281|FG001|Overall Study|Dose tapering not achieved|4|||
143494479|NCT02474082|517352280|FG000|Overall Study|Participant/guardian decision|1|||
143494480|NCT02474082|517352281|FG001|Overall Study|Participant/guardian decision|2|||
143494481|NCT02474082|517352280|FG000|Overall Study|Non-compliance with study treatment|0|||
143032674|NCT02130466|515659912|FG010|Overall Study|Lost to Follow-up|0|||
143494482|NCT02474082|517352281|FG001|Overall Study|Non-compliance with study treatment|2|||
143494483|NCT02474082|517352280|FG000|Overall Study|Protocol deviation|0|||
143494484|NCT02474082|517352281|FG001|Overall Study|Protocol deviation|1|||
143032675|NCT02130466|515659913|FG011|Overall Study|Lost to Follow-up|0|||
143032676|NCT02130466|515659914|FG012|Overall Study|Lost to Follow-up|1|||
143032677|NCT02130466|515659915|FG013|Overall Study|Lost to Follow-up|0|||
143032678|NCT02130466|515659902|FG000|Overall Study|Physician Decision|0|||
143032679|NCT02130466|515659903|FG001|Overall Study|Physician Decision|0|||
143032680|NCT02130466|515659904|FG002|Overall Study|Physician Decision|0|||
143032681|NCT02130466|515659905|FG003|Overall Study|Physician Decision|0|||
143032682|NCT02130466|515659906|FG004|Overall Study|Physician Decision|0|||
143032683|NCT02130466|515659907|FG005|Overall Study|Physician Decision|1|||
143032684|NCT02130466|515659908|FG006|Overall Study|Physician Decision|1|||
143032685|NCT02130466|515659909|FG007|Overall Study|Physician Decision|0|||
143032686|NCT02130466|515659910|FG008|Overall Study|Physician Decision|0|||
143159197|NCT00098293|516128120|FG002|Double-blind (DB) Phase|Pregnancy|9|||
143159198|NCT00098293|516128121|FG003|Double-blind (DB) Phase|Pregnancy|0|||
143159199|NCT00098293|516128122|FG004|Double-blind (DB) Phase|Pregnancy|0|||
143159200|NCT00098293|516128118|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
143159201|NCT00098293|516128119|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
143159202|NCT00098293|516128120|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
143159203|NCT00098293|516128121|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
143159204|NCT00098293|516128122|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
143159205|NCT00098293|516128118|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
143159206|NCT00098293|516128119|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
143159207|NCT00098293|516128120|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
143159208|NCT00098293|516128121|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
143159209|NCT00098293|516128122|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
143159210|NCT00098293|516128118|FG000|Double-blind (DB) Phase|Death|1|||
143159211|NCT00098293|516128119|FG001|Double-blind (DB) Phase|Death|2|||
143159212|NCT00098293|516128120|FG002|Double-blind (DB) Phase|Death|2|||
143159213|NCT00098293|516128121|FG003|Double-blind (DB) Phase|Death|0|||
143159214|NCT00098293|516128122|FG004|Double-blind (DB) Phase|Death|0|||
143159215|NCT00098293|516128118|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
143159216|NCT00098293|516128119|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
143159217|NCT00098293|516128120|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
143159218|NCT00098293|516128121|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
143159219|NCT00098293|516128122|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
143159220|NCT00098293|516128118|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
143159221|NCT00098293|516128119|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
143159222|NCT00098293|516128120|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
143159223|NCT00098293|516128121|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
143159224|NCT00098293|516128122|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
143159225|NCT00098293|516128118|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
143159226|NCT00098293|516128119|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
143159227|NCT00098293|516128120|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
143159228|NCT00098293|516128121|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
143159229|NCT00098293|516128122|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
143159230|NCT00098293|516128118|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
143159231|NCT00098293|516128119|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
143159232|NCT00098293|516128120|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
143159233|NCT00098293|516128121|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
143159234|NCT00098293|516128122|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
143159235|NCT00098293|516128118|FG000|Open-label (OL) Phase|Adverse Event|0|||
143159236|NCT00098293|516128119|FG001|Open-label (OL) Phase|Adverse Event|3|||
143159237|NCT00098293|516128120|FG002|Open-label (OL) Phase|Adverse Event|7|||
143159238|NCT00098293|516128121|FG003|Open-label (OL) Phase|Adverse Event|6|||
143159239|NCT00098293|516128122|FG004|Open-label (OL) Phase|Adverse Event|0|||
143159240|NCT00098293|516128118|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
143159241|NCT00098293|516128119|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
143159242|NCT00098293|516128120|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
143159243|NCT00098293|516128121|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
143159244|NCT00098293|516128122|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
143364035|NCT00293462|516875525|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
143364036|NCT00293462|516875526|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
143494485|NCT00939692|517352284|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
143032687|NCT02130466|515659911|FG009|Overall Study|Physician Decision|0|||
143032688|NCT02130466|515659912|FG010|Overall Study|Physician Decision|0|||
143159245|NCT00098293|516128118|FG000|Open-label (OL) Phase|Pregnancy|0|||
143159246|NCT00098293|516128119|FG001|Open-label (OL) Phase|Pregnancy|1|||
143159247|NCT00098293|516128120|FG002|Open-label (OL) Phase|Pregnancy|0|||
143159248|NCT00098293|516128121|FG003|Open-label (OL) Phase|Pregnancy|3|||
143364037|NCT00293462|516875527|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
143032689|NCT02130466|515659913|FG011|Overall Study|Physician Decision|0|||
143032690|NCT02130466|515659914|FG012|Overall Study|Physician Decision|0|||
143032691|NCT02130466|515659915|FG013|Overall Study|Physician Decision|0|||
143032692|NCT02130466|515659902|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
143494486|NCT00939692|517352285|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
143494487|NCT00939692|517352284|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
143494488|NCT00939692|517352285|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
143494489|NCT04317274|517352290|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
143494490|NCT04317274|517352291|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
143494491|NCT04317274|517352292|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
143494492|NCT04317274|517352293|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
143494493|NCT00744874|517352299|FG000|Overall Study|Lost to Follow-up|1|||
143494494|NCT00744874|517352299|FG000|Overall Study|Withdrawal by Subject|1|||
143494495|NCT00744874|517352299|FG000|Overall Study|Study Device not available at procedure|1|||
143494496|NCT00744874|517352299|FG000|Overall Study|Unable to accomodate schedule|1|||
143494497|NCT02971670|517352300|FG000|Overall Study|Withdrawal by Subject|4|||
143494498|NCT02971670|517352301|FG001|Overall Study|Withdrawal by Subject|1|||
143494499|NCT02971670|517352302|FG002|Overall Study|Withdrawal by Subject|1|||
143494500|NCT02971670|517352303|FG003|Overall Study|Withdrawal by Subject|2|||
143494501|NCT02793232|517352304|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
143032693|NCT02130466|515659903|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
143032694|NCT02130466|515659904|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
143032695|NCT02130466|515659905|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
143032696|NCT02130466|515659906|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
143494502|NCT02793232|517352305|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
143494503|NCT02793232|517352306|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
143494504|NCT02793232|517352307|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
143494505|NCT02793232|517352308|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
143494506|NCT02793232|517352309|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
143494507|NCT02793232|517352310|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
143494508|NCT02793232|517352311|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
143494509|NCT02793232|517352312|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
143494510|NCT00725075|517352313|FG000|Overall Study|Use of Excluded Medication|0|||
143494511|NCT00725075|517352314|FG001|Overall Study|Use of Excluded Medication|1|||
143494512|NCT00725075|517352315|FG002|Overall Study|Use of Excluded Medication|0|||
143494513|NCT00725075|517352313|FG000|Overall Study|Protocol Violation|0|||
143494514|NCT00725075|517352314|FG001|Overall Study|Protocol Violation|0|||
143494515|NCT00725075|517352315|FG002|Overall Study|Protocol Violation|1|||
143494516|NCT00725075|517352313|FG000|Overall Study|Lost to Follow-up|1|||
143494517|NCT00725075|517352314|FG001|Overall Study|Lost to Follow-up|0|||
143494518|NCT00725075|517352315|FG002|Overall Study|Lost to Follow-up|0|||
143494519|NCT00725075|517352313|FG000|Overall Study|Withdrawal by Subject|4|||
143494520|NCT00725075|517352314|FG001|Overall Study|Withdrawal by Subject|5|||
143494521|NCT00725075|517352315|FG002|Overall Study|Withdrawal by Subject|4|||
143494522|NCT00725075|517352313|FG000|Overall Study|Adverse Event|2|||
143494523|NCT00725075|517352314|FG001|Overall Study|Adverse Event|1|||
143494524|NCT00725075|517352315|FG002|Overall Study|Adverse Event|1|||
143494525|NCT00725075|517352313|FG000|Overall Study|Worsening of Disease|2|||
143494526|NCT00725075|517352314|FG001|Overall Study|Worsening of Disease|1|||
143494527|NCT00725075|517352315|FG002|Overall Study|Worsening of Disease|2|||
143494528|NCT00725075|517352313|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
143494529|NCT00725075|517352314|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
143494530|NCT00725075|517352315|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
143494531|NCT00725075|517352313|FG000|Overall Study|Other|1|||
143494532|NCT00725075|517352314|FG001|Overall Study|Other|0|||
143494533|NCT00725075|517352315|FG002|Overall Study|Other|0|||
143494534|NCT00352105|517352316|FG000|Overall Study|Death|5|||
143494535|NCT00352105|517352316|FG000|Overall Study|Withdrawal by Subject|5|||
143032697|NCT02130466|515659907|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
143032698|NCT02130466|515659908|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
143032699|NCT02130466|515659909|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
143159249|NCT00098293|516128122|FG004|Open-label (OL) Phase|Pregnancy|0|||
143494536|NCT00352105|517352316|FG000|Overall Study|Lack of Efficacy|9|||
143494537|NCT00352105|517352316|FG000|Overall Study|Adverse Event|19|||
143494538|NCT00352105|517352316|FG000|Overall Study|Protocol Violation|2|||
143494539|NCT02340663|517352317|FG000|Overall Study|Lost to Follow-up|1|||
143494540|NCT02340663|517352318|FG001|Overall Study|Lost to Follow-up|0|||
143494541|NCT02340663|517352317|FG000|Overall Study|Protocol Violation|1|||
143494542|NCT02340663|517352318|FG001|Overall Study|Protocol Violation|0|||
143494543|NCT02340663|517352317|FG000|Overall Study|Withdrawal by Subject|3|||
143494544|NCT02340663|517352318|FG001|Overall Study|Withdrawal by Subject|1|||
143494545|NCT02979431|517352319|FG000|Overall Study|Parent/guardian withdrew consent|2|||
143494546|NCT02979431|517352320|FG001|Overall Study|Parent/guardian withdrew consent|1|||
143494547|NCT02979431|517352321|FG002|Overall Study|Parent/guardian withdrew consent|1|||
143032700|NCT02130466|515659910|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
143032701|NCT02130466|515659911|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
143032702|NCT02130466|515659912|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
143032703|NCT02130466|515659913|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
143032704|NCT02130466|515659914|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
143032705|NCT02130466|515659915|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
143159250|NCT00098293|516128118|FG000|Open-label (OL) Phase|Protocol Violation|0|||
143159251|NCT00098293|516128119|FG001|Open-label (OL) Phase|Protocol Violation|6|||
143494548|NCT02979431|517352322|FG003|Overall Study|Parent/guardian withdrew consent|1|||
143494549|NCT02979431|517352319|FG000|Overall Study|Randomized but received no study drug|1|||
143494550|NCT02979431|517352320|FG001|Overall Study|Randomized but received no study drug|1|||
143494551|NCT02979431|517352321|FG002|Overall Study|Randomized but received no study drug|0|||
143494552|NCT02979431|517352322|FG003|Overall Study|Randomized but received no study drug|0|||
143494553|NCT02979431|517352319|FG000|Overall Study|Adverse Event|0|||
143494554|NCT02979431|517352320|FG001|Overall Study|Adverse Event|0|||
143494555|NCT02979431|517352321|FG002|Overall Study|Adverse Event|1|||
143494556|NCT02979431|517352322|FG003|Overall Study|Adverse Event|0|||
143494557|NCT02979431|517352319|FG000|Overall Study|Subject left country after Day14|1|||
143494558|NCT02979431|517352320|FG001|Overall Study|Subject left country after Day14|0|||
143494559|NCT02979431|517352321|FG002|Overall Study|Subject left country after Day14|0|||
143494560|NCT02979431|517352322|FG003|Overall Study|Subject left country after Day14|0|||
143494561|NCT01580397|517352323|FG000|Overall Study|Lack of Efficacy|14|||
143494562|NCT00357500|517352326|FG000|Overall Study|Adverse Event|3|||
143494563|NCT00357500|517352326|FG000|Overall Study|Withdrawal by Subject|5|||
143494564|NCT00357500|517352326|FG000|Overall Study|Progressive Disease|65|||
143494565|NCT00357500|517352326|FG000|Overall Study|Not Started Protocol Therapy|4|||
143494566|NCT02301403|517352336|FG000|Overall Study|Withdrawal by Subject|28|||
143494567|NCT02301403|517352337|FG001|Overall Study|Withdrawal by Subject|41|||
143494568|NCT01060059|517352338|FG000|Overall Study|Adverse Event|1|||
143494569|NCT01060059|517352339|FG001|Overall Study|Adverse Event|1|||
143494570|NCT01060059|517352338|FG000|Overall Study|Death|2|||
143494571|NCT01060059|517352339|FG001|Overall Study|Death|3|||
143494572|NCT01060059|517352338|FG000|Overall Study|Lost to Follow-up|18|||
143159252|NCT00098293|516128120|FG002|Open-label (OL) Phase|Protocol Violation|13|||
143159253|NCT00098293|516128121|FG003|Open-label (OL) Phase|Protocol Violation|16|||
143159254|NCT00098293|516128122|FG004|Open-label (OL) Phase|Protocol Violation|0|||
143159255|NCT00098293|516128118|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
143159256|NCT00098293|516128119|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
143159257|NCT00098293|516128120|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
143159258|NCT00098293|516128121|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
143159259|NCT00098293|516128122|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
143159260|NCT00098293|516128118|FG000|Open-label (OL) Phase|Death|0|||
143159261|NCT00098293|516128119|FG001|Open-label (OL) Phase|Death|2|||
143159262|NCT00098293|516128120|FG002|Open-label (OL) Phase|Death|3|||
143159263|NCT00098293|516128121|FG003|Open-label (OL) Phase|Death|0|||
143159264|NCT00098293|516128122|FG004|Open-label (OL) Phase|Death|0|||
143159265|NCT00098293|516128118|FG000|Supplemental Phase (SP)|Death|0|||
143159266|NCT00098293|516128119|FG001|Supplemental Phase (SP)|Death|0|||
143159267|NCT00098293|516128120|FG002|Supplemental Phase (SP)|Death|0|||
143159268|NCT00098293|516128121|FG003|Supplemental Phase (SP)|Death|0|||
143159269|NCT00098293|516128122|FG004|Supplemental Phase (SP)|Death|1|||
143159270|NCT00098293|516128118|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
143159271|NCT00098293|516128119|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
143159272|NCT00098293|516128120|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
143159273|NCT00098293|516128121|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
143159274|NCT00098293|516128122|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
143159275|NCT00098293|516128118|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
143159276|NCT00098293|516128119|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
143159277|NCT00098293|516128120|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
143494573|NCT01060059|517352339|FG001|Overall Study|Lost to Follow-up|34|||
143494574|NCT01060059|517352338|FG000|Overall Study|entry criteria not met|4|||
143032706|NCT02130466|515659902|FG000|Overall Study|Withdrawal by Subject|1|||
143032707|NCT02130466|515659903|FG001|Overall Study|Withdrawal by Subject|0|||
143159278|NCT00098293|516128121|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
143159279|NCT00098293|516128122|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
143159280|NCT00098293|516128118|FG000|Supplemental Phase (SP)|Other|0|||
143159281|NCT00098293|516128119|FG001|Supplemental Phase (SP)|Other|0|||
143159282|NCT00098293|516128120|FG002|Supplemental Phase (SP)|Other|0|||
143364038|NCT00293462|516875525|FG000|Overall Study|Refuse Radiation Treatment|1|||
143494575|NCT01060059|517352339|FG001|Overall Study|entry criteria not met|3|||
143494576|NCT01060059|517352338|FG000|Overall Study|Withdrawal by Subject|35|||
143159283|NCT00098293|516128121|FG003|Supplemental Phase (SP)|Other|0|||
143494577|NCT01060059|517352339|FG001|Overall Study|Withdrawal by Subject|23|||
143494578|NCT01060059|517352338|FG000|Overall Study|lack of glycemic control|2|||
143159284|NCT00098293|516128122|FG004|Supplemental Phase (SP)|Other|22|||
143159285|NCT01084135|516128126|FG000|20 Week|Physician Decision|0|||
143159286|NCT01084135|516128127|FG001|20 Week|Physician Decision|1|||
143159287|NCT03335566|516128128|FG000|Overall Study|Adverse Event|0|||
143159288|NCT03335566|516128129|FG001|Overall Study|Adverse Event|1|||
143159289|NCT03335566|516128128|FG000|Overall Study|Lost to Follow-up|1|||
143159290|NCT03335566|516128129|FG001|Overall Study|Lost to Follow-up|0|||
143159291|NCT03335566|516128128|FG000|Overall Study|Technical Problems|1|||
143159292|NCT03335566|516128129|FG001|Overall Study|Technical Problems|0|||
143159293|NCT03335566|516128128|FG000|Overall Study|Protocol Violation|1|||
143159294|NCT03335566|516128129|FG001|Overall Study|Protocol Violation|0|||
143159295|NCT03335566|516128128|FG000|Overall Study|Other than specified above|1|||
143159296|NCT03335566|516128129|FG001|Overall Study|Other than specified above|2|||
143159297|NCT04595370|516128131|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
143159298|NCT04595370|516128132|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
143159299|NCT04595370|516128133|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
143159300|NCT04595370|516128134|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
143159301|NCT04595370|516128135|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
143159302|NCT04595370|516128136|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
143159303|NCT04595370|516128131|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
143159304|NCT04595370|516128132|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
143159305|NCT04595370|516128133|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
143159306|NCT04595370|516128134|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
143159307|NCT04595370|516128135|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
143159308|NCT04595370|516128136|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
143159309|NCT04595370|516128131|FG000|Overall Study|Adverse Event|0|||
143159310|NCT04595370|516128132|FG001|Overall Study|Adverse Event|4|||
143159311|NCT04595370|516128133|FG002|Overall Study|Adverse Event|3|||
143159312|NCT04595370|516128134|FG003|Overall Study|Adverse Event|1|||
143159313|NCT04595370|516128135|FG004|Overall Study|Adverse Event|1|||
143159314|NCT04595370|516128136|FG005|Overall Study|Adverse Event|1|||
143159315|NCT04595370|516128131|FG000|Overall Study|Withdrawal of Consent|1|||
143159316|NCT04595370|516128132|FG001|Overall Study|Withdrawal of Consent|1|||
143159317|NCT04595370|516128133|FG002|Overall Study|Withdrawal of Consent|1|||
143159318|NCT04595370|516128134|FG003|Overall Study|Withdrawal of Consent|0|||
143159319|NCT04595370|516128135|FG004|Overall Study|Withdrawal of Consent|0|||
143159320|NCT04595370|516128136|FG005|Overall Study|Withdrawal of Consent|0|||
143159321|NCT04595370|516128131|FG000|Overall Study|Death|0|||
143159322|NCT04595370|516128132|FG001|Overall Study|Death|1|||
143159323|NCT04595370|516128133|FG002|Overall Study|Death|0|||
143159324|NCT04595370|516128134|FG003|Overall Study|Death|0|||
143159325|NCT04595370|516128135|FG004|Overall Study|Death|1|||
143159326|NCT04595370|516128136|FG005|Overall Study|Death|0|||
143159327|NCT04595370|516128131|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
143159328|NCT04595370|516128132|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
143159329|NCT04595370|516128133|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
143159330|NCT04595370|516128134|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
143159331|NCT04595370|516128135|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
143159332|NCT04595370|516128136|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
143159333|NCT04595370|516128131|FG000|Overall Study|Withdrawal by Subject|0|||
143159334|NCT04595370|516128132|FG001|Overall Study|Withdrawal by Subject|0|||
143159335|NCT04595370|516128133|FG002|Overall Study|Withdrawal by Subject|1|||
143159336|NCT04595370|516128134|FG003|Overall Study|Withdrawal by Subject|0|||
143159337|NCT04595370|516128135|FG004|Overall Study|Withdrawal by Subject|2|||
143159338|NCT04595370|516128136|FG005|Overall Study|Withdrawal by Subject|0|||
143159339|NCT04595370|516128131|FG000|Overall Study|Lost to Follow-up|0|||
143159340|NCT04595370|516128132|FG001|Overall Study|Lost to Follow-up|0|||
143159341|NCT04595370|516128133|FG002|Overall Study|Lost to Follow-up|0|||
143159342|NCT04595370|516128134|FG003|Overall Study|Lost to Follow-up|0|||
143159343|NCT04595370|516128135|FG004|Overall Study|Lost to Follow-up|1|||
143159344|NCT04595370|516128136|FG005|Overall Study|Lost to Follow-up|0|||
143159345|NCT04595370|516128131|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
143159346|NCT04595370|516128132|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
143159347|NCT04595370|516128133|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
143237654|NCT01074970|516423414|FG001|Overall Study|Disease progression during treatment|1|||
143159348|NCT04595370|516128134|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
143159349|NCT04595370|516128135|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
143159350|NCT04595370|516128136|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
143237655|NCT01074970|516423415|FG002|Overall Study|Disease progression during treatment|2|||
143159351|NCT02218268|516128137|FG000|24 Hour Washout|Physician Decision|11|||
143237656|NCT01074970|516423416|FG003|Overall Study|Disease progression during treatment|9|||
143032708|NCT02130466|515659904|FG002|Overall Study|Withdrawal by Subject|0|||
143032709|NCT02130466|515659905|FG003|Overall Study|Withdrawal by Subject|0|||
143032710|NCT02130466|515659906|FG004|Overall Study|Withdrawal by Subject|0|||
143032711|NCT02130466|515659907|FG005|Overall Study|Withdrawal by Subject|1|||
143159352|NCT02218268|516128138|FG001|24 Hour Washout|Physician Decision|9|||
143237657|NCT01074970|516423413|FG000|Overall Study|Lost to Follow-up|0|||
143237658|NCT01074970|516423414|FG001|Overall Study|Lost to Follow-up|0|||
143237659|NCT01074970|516423415|FG002|Overall Study|Lost to Follow-up|1|||
143237660|NCT01074970|516423416|FG003|Overall Study|Lost to Follow-up|0|||
143237661|NCT01074970|516423413|FG000|Overall Study|Withdrawal by Subject|0|||
143237662|NCT01074970|516423414|FG001|Overall Study|Withdrawal by Subject|0|||
143032712|NCT02130466|515659908|FG006|Overall Study|Withdrawal by Subject|0|||
143032713|NCT02130466|515659909|FG007|Overall Study|Withdrawal by Subject|0|||
143159353|NCT03651336|516128139|FG000|Overall Study|Withdrawal by Subject|4|||
143159354|NCT01341990|516128140|FG000|Overall Study|Adverse Event|0|||
143159355|NCT01341990|516128141|FG001|Overall Study|Adverse Event|1|||
143159356|NCT01341990|516128140|FG000|Overall Study|Torn Study Lens|1|||
143159357|NCT01341990|516128141|FG001|Overall Study|Torn Study Lens|0|||
143159358|NCT01341990|516128140|FG000|Overall Study|Withdrawal by Subject|2|||
143159359|NCT01341990|516128141|FG001|Overall Study|Withdrawal by Subject|0|||
143159360|NCT03632720|516128144|FG000|Overall Study|Adverse Event|2|||
143159361|NCT03632720|516128145|FG001|Overall Study|Adverse Event|0|||
143159362|NCT03632720|516128146|FG002|Overall Study|Adverse Event|0|||
143159363|NCT03632720|516128144|FG000|Overall Study|Lost to Follow-up|0|||
143159364|NCT03632720|516128145|FG001|Overall Study|Lost to Follow-up|1|||
143159365|NCT03632720|516128146|FG002|Overall Study|Lost to Follow-up|0|||
143159366|NCT03632720|516128144|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
143159367|NCT03632720|516128145|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
143159368|NCT03632720|516128146|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
143159369|NCT03632720|516128144|FG000|Overall Study|Screen failure|0|||
143159370|NCT03632720|516128145|FG001|Overall Study|Screen failure|1|||
143159371|NCT03632720|516128146|FG002|Overall Study|Screen failure|0|||
143159372|NCT00682435|516128147|FG000|Overall Study|Insufficient data|5|||
143159373|NCT00682435|516128147|FG000|Overall Study|Erroneously enrolled twice|2|||
143159374|NCT01117350|516128148|FG000|Comparative Period|Not Treated|5|||
143159375|NCT01117350|516128149|FG001|Comparative Period|Not Treated|8|||
143159376|NCT01117350|516128148|FG000|Comparative Period|Adverse Event|6|||
143159377|NCT01117350|516128149|FG001|Comparative Period|Adverse Event|33|||
143159378|NCT01117350|516128148|FG000|Comparative Period|Lost to Follow-up|11|||
143159379|NCT01117350|516128149|FG001|Comparative Period|Lost to Follow-up|7|||
143159380|NCT01117350|516128148|FG000|Comparative Period|Withdrawal by Subject|9|||
143159381|NCT01117350|516128149|FG001|Comparative Period|Withdrawal by Subject|13|||
143159382|NCT01117350|516128148|FG000|Comparative Period|Protocol Violation|8|||
143159383|NCT01117350|516128149|FG001|Comparative Period|Protocol Violation|12|||
143159384|NCT01117350|516128148|FG000|Comparative Period|Lack of Efficacy|1|||
143159385|NCT01117350|516128149|FG001|Comparative Period|Lack of Efficacy|0|||
143159386|NCT01117350|516128148|FG000|Comparative Period|Physician Decision|0|||
143159387|NCT01117350|516128149|FG001|Comparative Period|Physician Decision|1|||
143159388|NCT01117350|516128148|FG000|Comparative Period|Move to another city/country|2|||
143159389|NCT01117350|516128149|FG001|Comparative Period|Move to another city/country|1|||
143159390|NCT01117350|516128148|FG000|Extension Period|Not included in extension, not treated|0|||
143159391|NCT01117350|516128149|FG001|Extension Period|Not included in extension, not treated|50|||
143159392|NCT01117350|516128148|FG000|Extension Period|Adverse Event|0|||
143159393|NCT01117350|516128149|FG001|Extension Period|Adverse Event|2|||
143159394|NCT01117350|516128148|FG000|Extension Period|Protocol Violation|0|||
143159395|NCT01117350|516128149|FG001|Extension Period|Protocol Violation|2|||
143159396|NCT01117350|516128148|FG000|Extension Period|Lost to Follow-up|0|||
143159397|NCT01117350|516128149|FG001|Extension Period|Lost to Follow-up|2|||
143159398|NCT01117350|516128148|FG000|Extension Period|Withdrawal by Subject|0|||
143159399|NCT01117350|516128149|FG001|Extension Period|Withdrawal by Subject|3|||
143159400|NCT01117350|516128148|FG000|Extension Period|Lack of Efficacy|0|||
143159401|NCT01117350|516128149|FG001|Extension Period|Lack of Efficacy|2|||
143159402|NCT01117350|516128148|FG000|Extension Period|Inclusion criteria not respected|0|||
143159403|NCT01117350|516128149|FG001|Extension Period|Inclusion criteria not respected|1|||
143237663|NCT01074970|516423415|FG002|Overall Study|Withdrawal by Subject|6|||
143237664|NCT01074970|516423416|FG003|Overall Study|Withdrawal by Subject|4|||
143237665|NCT04323124|516423424|FG000|Overall Study|Adverse Event|0|||
143159404|NCT01117350|516128148|FG000|Extension Period|Prohibited medication|0|||
143159405|NCT01117350|516128149|FG001|Extension Period|Prohibited medication|1|||
143159406|NCT01049828|516128153|FG000|Overall Study|Claustrophibia and Frustration|2|||
143159407|NCT00290238|516128154|FG000|Overall Study|Study terminated|27|||
143159408|NCT00290238|516128155|FG001|Overall Study|Study terminated|27|||
143159409|NCT00290238|516128154|FG000|Overall Study|Lost to Follow-up|0|||
143159410|NCT00290238|516128155|FG001|Overall Study|Lost to Follow-up|1|||
143237666|NCT04323124|516423425|FG001|Overall Study|Adverse Event|0|||
143237667|NCT04323124|516423426|FG002|Overall Study|Adverse Event|0|||
143032714|NCT02130466|515659910|FG008|Overall Study|Withdrawal by Subject|1|||
143159411|NCT00290238|516128154|FG000|Overall Study|Withdrawal by Subject|15|||
143494579|NCT01060059|517352339|FG001|Overall Study|lack of glycemic control|1|||
143494580|NCT01060059|517352338|FG000|Overall Study|lack of compliance|5|||
143494581|NCT01060059|517352339|FG001|Overall Study|lack of compliance|2|||
143494582|NCT00848354|517352344|FG000|Phase 1|Adverse Event|5|||
143494583|NCT00848354|517352345|FG001|Phase 1|Adverse Event|4|||
143159412|NCT00290238|516128155|FG001|Overall Study|Withdrawal by Subject|13|||
143159413|NCT00286455|516128159|FG000|Overall Study|Hyperglycemia rescue|19|||
143159414|NCT00286455|516128160|FG001|Overall Study|Hyperglycemia rescue|13|||
143159415|NCT00286455|516128161|FG002|Overall Study|Hyperglycemia rescue|10|||
143159416|NCT00286455|516128159|FG000|Overall Study|Adverse Event|1|||
143159417|NCT00286455|516128160|FG001|Overall Study|Adverse Event|3|||
143159418|NCT00286455|516128161|FG002|Overall Study|Adverse Event|2|||
143159419|NCT00286455|516128159|FG000|Overall Study|Lost to Follow-up|0|||
143032715|NCT02130466|515659911|FG009|Overall Study|Withdrawal by Subject|0|||
143032716|NCT02130466|515659912|FG010|Overall Study|Withdrawal by Subject|0|||
143032717|NCT02130466|515659913|FG011|Overall Study|Withdrawal by Subject|0|||
143032718|NCT02130466|515659914|FG012|Overall Study|Withdrawal by Subject|0|||
143032719|NCT02130466|515659915|FG013|Overall Study|Withdrawal by Subject|0|||
143032720|NCT04529109|515659916|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
143032721|NCT04529109|515659917|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
143032722|NCT00788125|515661327|FG000|Overall Study|Death|6|||
143032723|NCT00444145|515661335|FG000|Overall Study|Withdrawal by Subject|2|||
143032724|NCT00444145|515661335|FG000|Overall Study|Lost to Follow-up|1|||
143032725|NCT00444145|515661335|FG000|Overall Study|non-compliant|11|||
143159420|NCT00286455|516128160|FG001|Overall Study|Lost to Follow-up|3|||
143159421|NCT00286455|516128161|FG002|Overall Study|Lost to Follow-up|3|||
143159422|NCT00286455|516128159|FG000|Overall Study|Physician Decision|3|||
143159423|NCT00286455|516128160|FG001|Overall Study|Physician Decision|0|||
143159424|NCT00286455|516128161|FG002|Overall Study|Physician Decision|2|||
143159425|NCT00286455|516128159|FG000|Overall Study|Protocol Violation|1|||
143159426|NCT00286455|516128160|FG001|Overall Study|Protocol Violation|1|||
143159427|NCT00286455|516128161|FG002|Overall Study|Protocol Violation|0|||
143159428|NCT00286455|516128159|FG000|Overall Study|Participant Non-compliance|1|||
143159429|NCT00286455|516128160|FG001|Overall Study|Participant Non-compliance|0|||
143159430|NCT00286455|516128161|FG002|Overall Study|Participant Non-compliance|0|||
143159431|NCT00286455|516128159|FG000|Overall Study|Withdrawal by Subject|0|||
143159432|NCT00286455|516128160|FG001|Overall Study|Withdrawal by Subject|8|||
143159433|NCT00286455|516128161|FG002|Overall Study|Withdrawal by Subject|7|||
143159434|NCT01213251|516129920|FG000|Overall Study|Death|2|||
143159435|NCT01213251|516129921|FG001|Overall Study|Death|1|||
143159436|NCT01213251|516129922|FG002|Overall Study|Death|2|||
143159437|NCT01213251|516129920|FG000|Overall Study|Exit|3|||
143159438|NCT01213251|516129921|FG001|Overall Study|Exit|2|||
143159439|NCT01213251|516129922|FG002|Overall Study|Exit|8|||
143159440|NCT01213251|516129920|FG000|Overall Study|Protocol Violation|1|||
143159441|NCT01213251|516129921|FG001|Overall Study|Protocol Violation|1|||
143159442|NCT01213251|516129922|FG002|Overall Study|Protocol Violation|0|||
143159443|NCT01213251|516129920|FG000|Overall Study|Missed 18-Month Follow-up|0|||
143159444|NCT01213251|516129921|FG001|Overall Study|Missed 18-Month Follow-up|0|||
143159445|NCT01213251|516129922|FG002|Overall Study|Missed 18-Month Follow-up|1|||
143159446|NCT01313676|516129927|FG000|Overall Study|Adverse Event|395|||
143159447|NCT01313676|516129928|FG001|Overall Study|Adverse Event|365|||
143159448|NCT01313676|516129929|FG002|Overall Study|Adverse Event|372|||
143159449|NCT01313676|516129930|FG003|Overall Study|Adverse Event|333|||
143159450|NCT01313676|516129927|FG000|Overall Study|Lack of Efficacy|98|||
143159451|NCT01313676|516129928|FG001|Overall Study|Lack of Efficacy|90|||
143159452|NCT01313676|516129929|FG002|Overall Study|Lack of Efficacy|65|||
143159453|NCT01313676|516129930|FG003|Overall Study|Lack of Efficacy|46|||
143159454|NCT01313676|516129927|FG000|Overall Study|Protocol Violation|37|||
143159455|NCT01313676|516129928|FG001|Overall Study|Protocol Violation|44|||
143032726|NCT00444145|515661335|FG000|Overall Study|Screen Failures|5|||
143032727|NCT03805438|515661336|FG000|Overall Study|Lack of Efficacy|1|||
143159456|NCT01313676|516129929|FG002|Overall Study|Protocol Violation|46|||
143159457|NCT01313676|516129930|FG003|Overall Study|Protocol Violation|44|||
143159458|NCT01313676|516129927|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
143159459|NCT01313676|516129928|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
143159460|NCT01313676|516129929|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
143159461|NCT01313676|516129930|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
143159462|NCT01313676|516129927|FG000|Overall Study|Study Closed/terminated|7|||
143159463|NCT01313676|516129928|FG001|Overall Study|Study Closed/terminated|6|||
143159464|NCT01313676|516129929|FG002|Overall Study|Study Closed/terminated|9|||
143159465|NCT01313676|516129930|FG003|Overall Study|Study Closed/terminated|9|||
143159466|NCT01313676|516129927|FG000|Overall Study|Lost to Follow-up|0|||
143159467|NCT01313676|516129928|FG001|Overall Study|Lost to Follow-up|0|||
143159468|NCT01313676|516129929|FG002|Overall Study|Lost to Follow-up|1|||
143494584|NCT00848354|517352344|FG000|Phase 1|Discontinuation of study by sponsor|2|||
143494585|NCT00848354|517352345|FG001|Phase 1|Discontinuation of study by sponsor|1|||
143494586|NCT00848354|517352344|FG000|Phase 1|Failed to return|0|||
143494587|NCT00848354|517352345|FG001|Phase 1|Failed to return|1|||
143494588|NCT00848354|517352344|FG000|Phase 1|Lost to Follow-up|1|||
143494589|NCT00848354|517352345|FG001|Phase 1|Lost to Follow-up|1|||
143494590|NCT00848354|517352344|FG000|Phase 1|Unspecified Reason|1|||
143494591|NCT00848354|517352345|FG001|Phase 1|Unspecified Reason|1|||
143494592|NCT00848354|517352344|FG000|Phase 1|Protocol Violation|1|||
143494593|NCT00848354|517352345|FG001|Phase 1|Protocol Violation|1|||
143494594|NCT00848354|517352344|FG000|Phase 1|Withdrawal by Subject|2|||
143032728|NCT03805438|515661336|FG000|Overall Study|Protocol Violation|1|||
143032729|NCT02848326|515661340|FG000|Treatment Period|Adverse Event|5|||
143032730|NCT02848326|515661341|FG001|Treatment Period|Adverse Event|4|||
143032731|NCT02848326|515661342|FG002|Treatment Period|Adverse Event|11|||
143032732|NCT02848326|515661343|FG003|Treatment Period|Adverse Event|6|||
143032733|NCT02848326|515661344|FG004|Treatment Period|Adverse Event|5|||
143032734|NCT02848326|515661345|FG005|Treatment Period|Adverse Event|7|||
143159469|NCT01313676|516129930|FG003|Overall Study|Lost to Follow-up|0|||
143159470|NCT01313676|516129927|FG000|Overall Study|Physician Decision|53|||
143159471|NCT01313676|516129928|FG001|Overall Study|Physician Decision|64|||
143159472|NCT01313676|516129929|FG002|Overall Study|Physician Decision|62|||
143159473|NCT01313676|516129930|FG003|Overall Study|Physician Decision|48|||
143159474|NCT01313676|516129927|FG000|Overall Study|Decision by Participant or Proxy|643|||
143159475|NCT01313676|516129928|FG001|Overall Study|Decision by Participant or Proxy|527|||
143159476|NCT01313676|516129929|FG002|Overall Study|Decision by Participant or Proxy|515|||
143159477|NCT01313676|516129930|FG003|Overall Study|Decision by Participant or Proxy|492|||
143159478|NCT01313676|516129927|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
143159479|NCT01313676|516129928|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
143159480|NCT01313676|516129929|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
143159481|NCT01313676|516129930|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
143159482|NCT01313676|516129927|FG000|Overall Study|Investigator Site Closed|12|||
143159483|NCT01313676|516129928|FG001|Overall Study|Investigator Site Closed|11|||
143159484|NCT01313676|516129929|FG002|Overall Study|Investigator Site Closed|15|||
143159485|NCT01313676|516129930|FG003|Overall Study|Investigator Site Closed|10|||
143159486|NCT01313676|516129927|FG000|Overall Study|Missing|1|||
143159487|NCT01313676|516129928|FG001|Overall Study|Missing|1|||
143159488|NCT01313676|516129929|FG002|Overall Study|Missing|1|||
143159489|NCT01313676|516129930|FG003|Overall Study|Missing|0|||
143159490|NCT01862029|516129931|FG000|Overall Study|Physician Decision|1|||
143159491|NCT01530256|516129933|FG000|Overall Study|Death|2|||
143159492|NCT02004275|516129940|FG000|Phase 1|Ineligible|0|||
143159493|NCT02004275|516129941|FG001|Phase 1|Ineligible|0|||
143159494|NCT02004275|516129942|FG002|Phase 1|Ineligible|0|||
143159495|NCT02004275|516129943|FG003|Phase 1|Ineligible|1|||
143159496|NCT02004275|516129944|FG004|Phase 1|Ineligible|1|||
143159497|NCT02004275|516129945|FG005|Phase 1|Ineligible|0|||
143159498|NCT02004275|516129940|FG000|Phase 1|Protocol Violation|0|||
143159499|NCT02004275|516129941|FG001|Phase 1|Protocol Violation|0|||
143159500|NCT02004275|516129942|FG002|Phase 1|Protocol Violation|0|||
143159501|NCT02004275|516129943|FG003|Phase 1|Protocol Violation|1|||
143159502|NCT02004275|516129944|FG004|Phase 1|Protocol Violation|0|||
143159503|NCT02004275|516129945|FG005|Phase 1|Protocol Violation|5|||
143159504|NCT02004275|516129940|FG000|Phase 2 Part 1|Ineligible|6|||
143159505|NCT02004275|516129941|FG001|Phase 2 Part 1|Ineligible|9|||
143159506|NCT02004275|516129942|FG002|Phase 2 Part 1|Ineligible|0|||
143159507|NCT02004275|516129943|FG003|Phase 2 Part 1|Ineligible|0|||
143237668|NCT04323124|516423427|FG003|Overall Study|Adverse Event|0|||
143237669|NCT04323124|516423428|FG004|Overall Study|Adverse Event|0|||
143237670|NCT04323124|516423429|FG005|Overall Study|Adverse Event|1|||
143237671|NCT04323124|516423430|FG006|Overall Study|Adverse Event|0|||
143494595|NCT00848354|517352345|FG001|Phase 1|Withdrawal by Subject|4|||
143494596|NCT00848354|517352344|FG000|Phase 1|Lack of Efficacy|0|||
143494597|NCT00848354|517352345|FG001|Phase 1|Lack of Efficacy|1|||
143032735|NCT02848326|515661340|FG000|Treatment Period|Withdrawal of Consent|20|||
143032736|NCT02848326|515661341|FG001|Treatment Period|Withdrawal of Consent|6|||
143159508|NCT02004275|516129944|FG004|Phase 2 Part 1|Ineligible|0|||
143237672|NCT04323124|516423431|FG007|Overall Study|Adverse Event|1|||
143364039|NCT00293462|516875526|FG001|Overall Study|Refuse Radiation Treatment|0|||
143494598|NCT00848354|517352344|FG000|Phase 2 Year 1|Adverse Event|7|||
143494599|NCT00848354|517352345|FG001|Phase 2 Year 1|Adverse Event|2|||
143494600|NCT00848354|517352344|FG000|Phase 2 Year 1|Death|1|||
143494601|NCT00848354|517352345|FG001|Phase 2 Year 1|Death|0|||
143494602|NCT00848354|517352344|FG000|Phase 2 Year 1|Failed to Return|1|||
143159509|NCT02004275|516129945|FG005|Phase 2 Part 1|Ineligible|0|||
143159510|NCT02004275|516129940|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
143159511|NCT02004275|516129941|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
143159512|NCT02004275|516129942|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
143237673|NCT04323124|516423432|FG008|Overall Study|Adverse Event|1|||
143032737|NCT02848326|515661342|FG002|Treatment Period|Withdrawal of Consent|9|||
143032738|NCT02848326|515661343|FG003|Treatment Period|Withdrawal of Consent|6|||
143494603|NCT00848354|517352345|FG001|Phase 2 Year 1|Failed to Return|1|||
143032739|NCT02848326|515661344|FG004|Treatment Period|Withdrawal of Consent|9|||
143032740|NCT02848326|515661345|FG005|Treatment Period|Withdrawal of Consent|6|||
143032741|NCT02848326|515661340|FG000|Treatment Period|Lost to Follow-up|5|||
143032742|NCT02848326|515661341|FG001|Treatment Period|Lost to Follow-up|1|||
143032743|NCT02848326|515661342|FG002|Treatment Period|Lost to Follow-up|11|||
143032744|NCT02848326|515661343|FG003|Treatment Period|Lost to Follow-up|7|||
143032745|NCT02848326|515661344|FG004|Treatment Period|Lost to Follow-up|2|||
143032746|NCT02848326|515661345|FG005|Treatment Period|Lost to Follow-up|3|||
143032747|NCT02848326|515661340|FG000|Treatment Period|Pregnancy|0|||
143032748|NCT02848326|515661341|FG001|Treatment Period|Pregnancy|0|||
143032749|NCT02848326|515661342|FG002|Treatment Period|Pregnancy|1|||
143032750|NCT02848326|515661343|FG003|Treatment Period|Pregnancy|1|||
143032751|NCT02848326|515661344|FG004|Treatment Period|Pregnancy|0|||
143032752|NCT02848326|515661345|FG005|Treatment Period|Pregnancy|1|||
143032753|NCT02848326|515661340|FG000|Treatment Period|Protocol Violation|4|||
143032754|NCT02848326|515661341|FG001|Treatment Period|Protocol Violation|3|||
143032755|NCT02848326|515661342|FG002|Treatment Period|Protocol Violation|4|||
143032756|NCT02848326|515661343|FG003|Treatment Period|Protocol Violation|2|||
143032757|NCT02848326|515661344|FG004|Treatment Period|Protocol Violation|3|||
143032758|NCT02848326|515661345|FG005|Treatment Period|Protocol Violation|3|||
143032759|NCT02848326|515661340|FG000|Treatment Period|Non-compliance with Study Drug|4|||
143032760|NCT02848326|515661341|FG001|Treatment Period|Non-compliance with Study Drug|0|||
143032761|NCT02848326|515661342|FG002|Treatment Period|Non-compliance with Study Drug|0|||
143032762|NCT02848326|515661343|FG003|Treatment Period|Non-compliance with Study Drug|1|||
143032763|NCT02848326|515661344|FG004|Treatment Period|Non-compliance with Study Drug|0|||
143032764|NCT02848326|515661345|FG005|Treatment Period|Non-compliance with Study Drug|0|||
143032765|NCT02848326|515661340|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
143032766|NCT02848326|515661341|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
143032767|NCT02848326|515661342|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
143032768|NCT02848326|515661343|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
143032769|NCT02848326|515661344|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
143032770|NCT02848326|515661345|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
143159513|NCT02004275|516129943|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
143159514|NCT02004275|516129944|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
143159515|NCT02004275|516129945|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
143159516|NCT04621786|516129946|FG000|Overall Study|Lost to Follow-up|9|||
143159517|NCT04621786|516129946|FG000|Overall Study|Protocol Violation|3|||
143159518|NCT00292370|516129947|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
143494604|NCT00848354|517352344|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
143494605|NCT00848354|517352345|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
143494606|NCT00848354|517352344|FG000|Phase 2 Year 1|Unspecified Reason|3|||
143494607|NCT00848354|517352345|FG001|Phase 2 Year 1|Unspecified Reason|0|||
143494608|NCT00848354|517352344|FG000|Phase 2 Year 1|Protocol Violation|4|||
143494609|NCT00848354|517352345|FG001|Phase 2 Year 1|Protocol Violation|1|||
143494610|NCT00848354|517352344|FG000|Phase 2 Year 1|Subject Request|1|||
143494611|NCT00848354|517352345|FG001|Phase 2 Year 1|Subject Request|2|||
143159519|NCT00292370|516129948|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
143159520|NCT00292370|516129949|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
143159521|NCT00292370|516129947|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
143159522|NCT00292370|516129948|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
143159523|NCT00292370|516129949|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
143159524|NCT00292370|516129947|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
143159525|NCT00292370|516129948|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
143159526|NCT00292370|516129949|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
143159527|NCT00292370|516129947|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
143159528|NCT00292370|516129948|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
143159529|NCT00292370|516129949|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
143159530|NCT00292370|516129947|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
143159531|NCT00292370|516129948|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
143494612|NCT00848354|517352344|FG000|Phase 2 Year 2|Adverse Event|12|||
143494613|NCT00848354|517352345|FG001|Phase 2 Year 2|Adverse Event|2|||
143494614|NCT00848354|517352344|FG000|Phase 2 Year 2|Death|2|||
143032771|NCT02848326|515661340|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
143032772|NCT02848326|515661341|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
143032773|NCT02848326|515661342|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
143494615|NCT00848354|517352345|FG001|Phase 2 Year 2|Death|0|||
143494616|NCT00848354|517352344|FG000|Phase 2 Year 2|Failed to return|3|||
143494617|NCT00848354|517352345|FG001|Phase 2 Year 2|Failed to return|0|||
143032774|NCT02848326|515661343|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
143032775|NCT02848326|515661344|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
143032776|NCT02848326|515661345|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
143494618|NCT00848354|517352344|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
143494619|NCT00848354|517352345|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
143032777|NCT00414466|515661346|FG000|Overall Study|Adverse Event|0|||
143032778|NCT00414466|515661347|FG001|Overall Study|Adverse Event|0|||
143032779|NCT00414466|515661348|FG002|Overall Study|Adverse Event|1|||
143032780|NCT00414466|515661349|FG003|Overall Study|Adverse Event|1|||
143032781|NCT00414466|515661346|FG000|Overall Study|Lack of Efficacy|1|||
143032782|NCT00414466|515661347|FG001|Overall Study|Lack of Efficacy|0|||
143494620|NCT00848354|517352344|FG000|Phase 2 Year 2|Unspecified Reason|1|||
143494621|NCT00848354|517352345|FG001|Phase 2 Year 2|Unspecified Reason|0|||
143494622|NCT00848354|517352344|FG000|Phase 2 Year 2|Protocol Violation|1|||
143494623|NCT00848354|517352345|FG001|Phase 2 Year 2|Protocol Violation|1|||
143494624|NCT00848354|517352344|FG000|Phase 2 Year 2|Subject Request|1|||
143494625|NCT00848354|517352345|FG001|Phase 2 Year 2|Subject Request|1|||
143494626|NCT00848354|517352344|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
143494627|NCT00848354|517352345|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
143494628|NCT00644787|517352350|FG000|Period 1: Titration Phase|Adverse Event|11|||
143494629|NCT00644787|517352351|FG001|Period 1: Titration Phase|Adverse Event|0|||
143494630|NCT00644787|517352352|FG002|Period 1: Titration Phase|Adverse Event|0|||
143494631|NCT00644787|517352350|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
143494632|NCT00644787|517352351|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
143494633|NCT00644787|517352352|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
143494634|NCT00644787|517352350|FG000|Period 1: Titration Phase|Physician Decision|1|||
143494635|NCT00644787|517352351|FG001|Period 1: Titration Phase|Physician Decision|0|||
143494636|NCT00644787|517352352|FG002|Period 1: Titration Phase|Physician Decision|0|||
143494637|NCT00644787|517352350|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
143494638|NCT00644787|517352351|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
143494639|NCT00644787|517352352|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
143494640|NCT00644787|517352350|FG000|Period 1: Titration Phase|Worsening of complications|1|||
143494641|NCT00644787|517352351|FG001|Period 1: Titration Phase|Worsening of complications|0|||
143494642|NCT00644787|517352352|FG002|Period 1: Titration Phase|Worsening of complications|0|||
143032783|NCT00414466|515661348|FG002|Overall Study|Lack of Efficacy|0|||
143032784|NCT00414466|515661349|FG003|Overall Study|Lack of Efficacy|0|||
143032785|NCT00414466|515661346|FG000|Overall Study|Withdrawn by Sponsor|1|||
143159532|NCT00292370|516129949|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
143159533|NCT00292370|516129947|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
143159534|NCT00292370|516129948|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
143159535|NCT00292370|516129949|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
143159536|NCT02533674|516129950|FG000|Dose Level I|Progressive disease|1|||
143159537|NCT02533674|516129951|FG001|Dose Level I|Progressive disease|0|||
143159538|NCT02533674|516129952|FG002|Dose Level I|Progressive disease|0|||
143159539|NCT02533674|516129953|FG003|Dose Level I|Progressive disease|0|||
143159540|NCT02533674|516129954|FG004|Dose Level I|Progressive disease|0|||
143159541|NCT02533674|516129955|FG005|Dose Level I|Progressive disease|0|||
143159542|NCT02533674|516129956|FG006|Dose Level I|Progressive disease|0|||
143159543|NCT02533674|516129957|FG007|Dose Level I|Progressive disease|0|||
143159544|NCT02533674|516129950|FG000|Dose Level I|Withdrawal by Subject|1|||
143159545|NCT02533674|516129951|FG001|Dose Level I|Withdrawal by Subject|0|||
143159546|NCT02533674|516129952|FG002|Dose Level I|Withdrawal by Subject|0|||
143159547|NCT02533674|516129953|FG003|Dose Level I|Withdrawal by Subject|0|||
143159548|NCT02533674|516129954|FG004|Dose Level I|Withdrawal by Subject|0|||
143159549|NCT02533674|516129955|FG005|Dose Level I|Withdrawal by Subject|0|||
143159550|NCT02533674|516129956|FG006|Dose Level I|Withdrawal by Subject|0|||
143159551|NCT02533674|516129957|FG007|Dose Level I|Withdrawal by Subject|0|||
143159552|NCT02533674|516129950|FG000|Dose Level I|Physician Decision|1|||
143159553|NCT02533674|516129951|FG001|Dose Level I|Physician Decision|0|||
143159554|NCT02533674|516129952|FG002|Dose Level I|Physician Decision|0|||
143159555|NCT02533674|516129953|FG003|Dose Level I|Physician Decision|0|||
143159556|NCT02533674|516129954|FG004|Dose Level I|Physician Decision|0|||
143159557|NCT02533674|516129955|FG005|Dose Level I|Physician Decision|0|||
143364040|NCT00293462|516875527|FG002|Overall Study|Refuse Radiation Treatment|0|||
143494643|NCT00644787|517352350|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
143494644|NCT00644787|517352351|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
143494645|NCT00644787|517352352|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
143494646|NCT00644787|517352350|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
143494647|NCT00644787|517352351|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
143494648|NCT00644787|517352352|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
143494649|NCT00644787|517352350|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
143494650|NCT00644787|517352351|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
143494651|NCT00644787|517352352|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
143494652|NCT00644787|517352350|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
143494653|NCT00644787|517352351|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
143494654|NCT00644787|517352352|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
143032786|NCT00414466|515661347|FG001|Overall Study|Withdrawn by Sponsor|0|||
143159558|NCT02533674|516129956|FG006|Dose Level I|Physician Decision|0|||
143159559|NCT02533674|516129957|FG007|Dose Level I|Physician Decision|0|||
143237674|NCT04323124|516423433|FG009|Overall Study|Adverse Event|0|||
143237675|NCT04323124|516423434|FG010|Overall Study|Adverse Event|0|||
143237676|NCT04323124|516423435|FG011|Overall Study|Adverse Event|0|||
143237677|NCT04323124|516423436|FG012|Overall Study|Adverse Event|0|||
143237678|NCT04323124|516423437|FG013|Overall Study|Adverse Event|0|||
143237679|NCT04323124|516423438|FG014|Overall Study|Adverse Event|0|||
143237680|NCT04323124|516423424|FG000|Overall Study|Other|0|||
143237681|NCT04323124|516423425|FG001|Overall Study|Other|0|||
143237682|NCT04323124|516423426|FG002|Overall Study|Other|0|||
143237683|NCT04323124|516423427|FG003|Overall Study|Other|0|||
143237684|NCT04323124|516423428|FG004|Overall Study|Other|1|||
143237685|NCT04323124|516423429|FG005|Overall Study|Other|0|||
143237686|NCT04323124|516423430|FG006|Overall Study|Other|0|||
143237687|NCT04323124|516423431|FG007|Overall Study|Other|0|||
143237688|NCT04323124|516423432|FG008|Overall Study|Other|1|||
143237689|NCT04323124|516423433|FG009|Overall Study|Other|0|||
143494655|NCT00644787|517352350|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
143494656|NCT00644787|517352351|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
143494657|NCT00644787|517352352|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
143032787|NCT00414466|515661348|FG002|Overall Study|Withdrawn by Sponsor|0|||
143032788|NCT00414466|515661349|FG003|Overall Study|Withdrawn by Sponsor|0|||
143032789|NCT03480425|515661351|FG000|Overall Study|Force transducer technical failure|1|||
143032790|NCT01244126|515661352|FG000|Overall Study|Protocol Violation|3|||
143032791|NCT01244126|515661353|FG001|Overall Study|Protocol Violation|3|||
143159560|NCT02533674|516129950|FG000|Dose Level I|Death|1|||
143159561|NCT02533674|516129951|FG001|Dose Level I|Death|0|||
143159562|NCT02533674|516129952|FG002|Dose Level I|Death|0|||
143159563|NCT02533674|516129953|FG003|Dose Level I|Death|0|||
143159564|NCT02533674|516129954|FG004|Dose Level I|Death|0|||
143159565|NCT02533674|516129955|FG005|Dose Level I|Death|0|||
143159566|NCT02533674|516129956|FG006|Dose Level I|Death|0|||
143237690|NCT04323124|516423434|FG010|Overall Study|Other|0|||
143237691|NCT04323124|516423435|FG011|Overall Study|Other|0|||
143237692|NCT04323124|516423436|FG012|Overall Study|Other|0|||
143237693|NCT04323124|516423437|FG013|Overall Study|Other|0|||
143237694|NCT04323124|516423438|FG014|Overall Study|Other|0|||
143237695|NCT04323124|516423424|FG000|Overall Study|Coming from a red zone (COVID)|0|||
143237696|NCT04323124|516423425|FG001|Overall Study|Coming from a red zone (COVID)|0|||
143237697|NCT04323124|516423426|FG002|Overall Study|Coming from a red zone (COVID)|0|||
143237698|NCT04323124|516423427|FG003|Overall Study|Coming from a red zone (COVID)|0|||
143237699|NCT04323124|516423428|FG004|Overall Study|Coming from a red zone (COVID)|1|||
143237700|NCT04323124|516423429|FG005|Overall Study|Coming from a red zone (COVID)|1|||
143237701|NCT04323124|516423430|FG006|Overall Study|Coming from a red zone (COVID)|0|||
143237702|NCT04323124|516423431|FG007|Overall Study|Coming from a red zone (COVID)|0|||
143237703|NCT04323124|516423432|FG008|Overall Study|Coming from a red zone (COVID)|0|||
143237704|NCT04323124|516423433|FG009|Overall Study|Coming from a red zone (COVID)|0|||
143237705|NCT04323124|516423434|FG010|Overall Study|Coming from a red zone (COVID)|0|||
143237706|NCT04323124|516423435|FG011|Overall Study|Coming from a red zone (COVID)|0|||
143237707|NCT04323124|516423436|FG012|Overall Study|Coming from a red zone (COVID)|0|||
143237708|NCT04323124|516423437|FG013|Overall Study|Coming from a red zone (COVID)|0|||
143237709|NCT04323124|516423438|FG014|Overall Study|Coming from a red zone (COVID)|0|||
143237710|NCT04323124|516423424|FG000|Overall Study|No longer meets eligibility criteria|0|||
143237711|NCT04323124|516423425|FG001|Overall Study|No longer meets eligibility criteria|0|||
143494658|NCT00644787|517352350|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
143494659|NCT00644787|517352351|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
143494660|NCT00644787|517352352|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
143159567|NCT02533674|516129957|FG007|Dose Level I|Death|0|||
143159568|NCT02533674|516129950|FG000|Dose Level I|Never Treated|1|||
143159569|NCT02533674|516129951|FG001|Dose Level I|Never Treated|0|||
143159570|NCT02533674|516129952|FG002|Dose Level I|Never Treated|0|||
143159571|NCT02533674|516129953|FG003|Dose Level I|Never Treated|0|||
143159572|NCT02533674|516129954|FG004|Dose Level I|Never Treated|0|||
143159573|NCT02533674|516129955|FG005|Dose Level I|Never Treated|0|||
143159574|NCT02533674|516129956|FG006|Dose Level I|Never Treated|0|||
143159575|NCT02533674|516129957|FG007|Dose Level I|Never Treated|0|||
143159576|NCT02533674|516129950|FG000|Dose Level II|Progressive disease|0|||
143159577|NCT02533674|516129951|FG001|Dose Level II|Progressive disease|3|||
143159578|NCT02533674|516129952|FG002|Dose Level II|Progressive disease|0|||
143237712|NCT04323124|516423426|FG002|Overall Study|No longer meets eligibility criteria|0|||
143237713|NCT04323124|516423427|FG003|Overall Study|No longer meets eligibility criteria|0|||
143237714|NCT04323124|516423428|FG004|Overall Study|No longer meets eligibility criteria|0|||
143237715|NCT04323124|516423429|FG005|Overall Study|No longer meets eligibility criteria|0|||
143032792|NCT01244126|515661354|FG002|Overall Study|Protocol Violation|9|||
143237716|NCT04323124|516423430|FG006|Overall Study|No longer meets eligibility criteria|0|||
143159579|NCT02533674|516129953|FG003|Dose Level II|Progressive disease|0|||
143159580|NCT02533674|516129954|FG004|Dose Level II|Progressive disease|0|||
143159581|NCT02533674|516129955|FG005|Dose Level II|Progressive disease|0|||
143494661|NCT00644787|517352350|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
143494662|NCT00644787|517352351|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
143494663|NCT00644787|517352352|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
143494664|NCT00772668|517352358|FG000|Overall Study|Physician Decision|3|||
143494665|NCT01227902|517354336|FG000|Overall Study|Adverse Event|12|||
143494666|NCT01227902|517354337|FG001|Overall Study|Adverse Event|8|||
143494667|NCT01227902|517354338|FG002|Overall Study|Adverse Event|11|||
143494668|NCT01227902|517354339|FG003|Overall Study|Adverse Event|4|||
143494669|NCT01227902|517354336|FG000|Overall Study|Lack of Efficacy|1|||
143494670|NCT01227902|517354337|FG001|Overall Study|Lack of Efficacy|2|||
143494671|NCT01227902|517354338|FG002|Overall Study|Lack of Efficacy|2|||
143494672|NCT01227902|517354339|FG003|Overall Study|Lack of Efficacy|1|||
143494673|NCT01227902|517354336|FG000|Overall Study|Protocol Violation|1|||
143494674|NCT01227902|517354337|FG001|Overall Study|Protocol Violation|0|||
143494675|NCT01227902|517354338|FG002|Overall Study|Protocol Violation|0|||
143494676|NCT01227902|517354339|FG003|Overall Study|Protocol Violation|0|||
143494677|NCT01227902|517354336|FG000|Overall Study|Lost to Follow-up|0|||
143494678|NCT01227902|517354337|FG001|Overall Study|Lost to Follow-up|0|||
143494679|NCT01227902|517354338|FG002|Overall Study|Lost to Follow-up|1|||
143494680|NCT01227902|517354339|FG003|Overall Study|Lost to Follow-up|2|||
143494681|NCT01227902|517354336|FG000|Overall Study|Physician Decision|0|||
143494682|NCT01227902|517354337|FG001|Overall Study|Physician Decision|1|||
143032793|NCT02777528|515661362|FG000|Overall Study|Still in study|24|||
143032794|NCT02777528|515661363|FG001|Overall Study|Still in study|10|||
143159582|NCT02533674|516129956|FG006|Dose Level II|Progressive disease|0|||
143494683|NCT01227902|517354338|FG002|Overall Study|Physician Decision|1|||
143494684|NCT01227902|517354339|FG003|Overall Study|Physician Decision|0|||
143494685|NCT01227902|517354336|FG000|Overall Study|Withdrawal by Subject|4|||
143494686|NCT01227902|517354337|FG001|Overall Study|Withdrawal by Subject|2|||
143494687|NCT01227902|517354338|FG002|Overall Study|Withdrawal by Subject|4|||
143494688|NCT01227902|517354339|FG003|Overall Study|Withdrawal by Subject|3|||
143494689|NCT05280756|517354340|FG000|Overall Study|Lost to Follow-up|1|||
143494690|NCT05280756|517354341|FG001|Overall Study|Lost to Follow-up|1|||
143494691|NCT01354028|517354342|FG000|Overall Study|Physician Decision|0|||
143494692|NCT01354028|517354343|FG001|Overall Study|Physician Decision|2|||
143494693|NCT01354028|517354342|FG000|Overall Study|Discharged before study start|2|||
143494694|NCT01354028|517354343|FG001|Overall Study|Discharged before study start|2|||
143494695|NCT01354028|517354342|FG000|Overall Study|No quiet alert state|0|||
143494696|NCT01354028|517354343|FG001|Overall Study|No quiet alert state|1|||
143494697|NCT00935883|517354346|FG000|Treatment Period|Physician Decision|1|||
143494698|NCT00935883|517354347|FG001|Treatment Period|Physician Decision|0|||
143494699|NCT00935883|517354346|FG000|Treatment Period|Withdrawal by Subject|0|||
143494700|NCT00935883|517354347|FG001|Treatment Period|Withdrawal by Subject|2|||
143494701|NCT01641939|517354348|FG000|Overall Study|Death|90|||
143159583|NCT02533674|516129957|FG007|Dose Level II|Progressive disease|0|||
143159584|NCT02533674|516129950|FG000|Dose Level II|Withdrawal by Subject|0|||
143159585|NCT02533674|516129951|FG001|Dose Level II|Withdrawal by Subject|1|||
143159586|NCT02533674|516129952|FG002|Dose Level II|Withdrawal by Subject|0|||
143159587|NCT02533674|516129953|FG003|Dose Level II|Withdrawal by Subject|0|||
143159588|NCT02533674|516129954|FG004|Dose Level II|Withdrawal by Subject|0|||
143159589|NCT02533674|516129955|FG005|Dose Level II|Withdrawal by Subject|0|||
143159590|NCT02533674|516129956|FG006|Dose Level II|Withdrawal by Subject|0|||
143159591|NCT02533674|516129957|FG007|Dose Level II|Withdrawal by Subject|0|||
143159592|NCT02533674|516129950|FG000|Dose Level II|Treatment-related AE|0|||
143159593|NCT02533674|516129951|FG001|Dose Level II|Treatment-related AE|1|||
143159594|NCT02533674|516129952|FG002|Dose Level II|Treatment-related AE|0|||
143159595|NCT02533674|516129953|FG003|Dose Level II|Treatment-related AE|0|||
143159596|NCT02533674|516129954|FG004|Dose Level II|Treatment-related AE|0|||
143159597|NCT02533674|516129955|FG005|Dose Level II|Treatment-related AE|0|||
143159598|NCT02533674|516129956|FG006|Dose Level II|Treatment-related AE|0|||
143159599|NCT02533674|516129957|FG007|Dose Level II|Treatment-related AE|0|||
143237717|NCT04323124|516423431|FG007|Overall Study|No longer meets eligibility criteria|1|||
143494702|NCT01641939|517354349|FG001|Overall Study|Death|187|||
143494703|NCT01641939|517354350|FG002|Overall Study|Death|61|||
143494704|NCT01641939|517354348|FG000|Overall Study|Lost to Follow-up|3|||
143494705|NCT01641939|517354349|FG001|Overall Study|Lost to Follow-up|2|||
143494706|NCT01641939|517354350|FG002|Overall Study|Lost to Follow-up|1|||
143032795|NCT02777528|515661364|FG002|Overall Study|Still in study|1|||
143032796|NCT02777528|515661362|FG000|Overall Study|Study Device Explanted|1|||
143159600|NCT02533674|516129950|FG000|Dose Level II|Physician Decision|0|||
143159601|NCT02533674|516129951|FG001|Dose Level II|Physician Decision|1|||
143159602|NCT02533674|516129952|FG002|Dose Level II|Physician Decision|0|||
143494707|NCT01641939|517354348|FG000|Overall Study|Withdrawal by Subject|14|||
143494708|NCT01641939|517354349|FG001|Overall Study|Withdrawal by Subject|11|||
143494709|NCT01641939|517354350|FG002|Overall Study|Withdrawal by Subject|5|||
143494710|NCT01641939|517354348|FG000|Overall Study|Study Terminated by Sponsor|10|||
143494711|NCT01641939|517354349|FG001|Overall Study|Study Terminated by Sponsor|28|||
143494712|NCT01641939|517354350|FG002|Overall Study|Study Terminated by Sponsor|3|||
143494713|NCT02894840|517354351|FG000|Overall Study|Lost to Follow-up|1|||
143494714|NCT02894840|517354352|FG001|Overall Study|Lost to Follow-up|0|||
143237718|NCT04323124|516423432|FG008|Overall Study|No longer meets eligibility criteria|0|||
143237719|NCT04323124|516423433|FG009|Overall Study|No longer meets eligibility criteria|0|||
143237720|NCT04323124|516423434|FG010|Overall Study|No longer meets eligibility criteria|0|||
143237721|NCT04323124|516423435|FG011|Overall Study|No longer meets eligibility criteria|0|||
143237722|NCT04323124|516423436|FG012|Overall Study|No longer meets eligibility criteria|0|||
143237723|NCT04323124|516423437|FG013|Overall Study|No longer meets eligibility criteria|1|||
143237724|NCT04323124|516423438|FG014|Overall Study|No longer meets eligibility criteria|1|||
143237725|NCT04323124|516423424|FG000|Overall Study|Study terminated by sponsor|0|||
143237726|NCT04323124|516423425|FG001|Overall Study|Study terminated by sponsor|0|||
143237727|NCT04323124|516423426|FG002|Overall Study|Study terminated by sponsor|0|||
143237728|NCT04323124|516423427|FG003|Overall Study|Study terminated by sponsor|0|||
143237729|NCT04323124|516423428|FG004|Overall Study|Study terminated by sponsor|0|||
143237730|NCT04323124|516423429|FG005|Overall Study|Study terminated by sponsor|0|||
143237731|NCT04323124|516423430|FG006|Overall Study|Study terminated by sponsor|0|||
143237732|NCT04323124|516423431|FG007|Overall Study|Study terminated by sponsor|0|||
143237733|NCT04323124|516423432|FG008|Overall Study|Study terminated by sponsor|0|||
143237734|NCT04323124|516423433|FG009|Overall Study|Study terminated by sponsor|0|||
143237735|NCT04323124|516423434|FG010|Overall Study|Study terminated by sponsor|0|||
143237736|NCT04323124|516423435|FG011|Overall Study|Study terminated by sponsor|2|||
143237737|NCT04323124|516423436|FG012|Overall Study|Study terminated by sponsor|1|||
143237738|NCT04323124|516423437|FG013|Overall Study|Study terminated by sponsor|0|||
143237739|NCT04323124|516423438|FG014|Overall Study|Study terminated by sponsor|0|||
143237740|NCT01432730|516425510|FG000|Period 1|Adverse Event|2|||
143237741|NCT01432730|516425511|FG001|Period 1|Adverse Event|0|||
143237742|NCT01432730|516425510|FG000|Period 2|Adverse Event|0|||
143237743|NCT01432730|516425511|FG001|Period 2|Adverse Event|4|||
143237744|NCT01942837|516425515|FG000|Overall Study|Death|1|||
143237745|NCT01942837|516425515|FG000|Overall Study|Symptomatic or radiographic progression|49|||
143237746|NCT01942837|516425515|FG000|Overall Study|Adverse Event|6|||
143237747|NCT01942837|516425515|FG000|Overall Study|Physician Decision|3|||
143237748|NCT01942837|516425515|FG000|Overall Study|Withdrawal by Subject|2|||
143237749|NCT01942837|516425515|FG000|Overall Study|Intercurrent Illness|1|||
143237750|NCT01942837|516425515|FG000|Overall Study|On treatment|3|||
143237751|NCT01942837|516425515|FG000|Overall Study|Never initiate the treatment|2|||
143237752|NCT01803607|516425517|FG000|Overall Study|Adverse Event|5|||
143494715|NCT02894840|517354353|FG002|Overall Study|Lost to Follow-up|3|||
143494716|NCT02894840|517354354|FG003|Overall Study|Lost to Follow-up|0|||
143494717|NCT00975156|517354360|FG000|Overall Study|Protocol Violation|0|||
143494718|NCT00975156|517354361|FG001|Overall Study|Protocol Violation|1|||
143159603|NCT02533674|516129953|FG003|Dose Level II|Physician Decision|0|||
143159604|NCT02533674|516129954|FG004|Dose Level II|Physician Decision|0|||
143159605|NCT02533674|516129955|FG005|Dose Level II|Physician Decision|0|||
143159606|NCT02533674|516129956|FG006|Dose Level II|Physician Decision|0|||
143159607|NCT02533674|516129957|FG007|Dose Level II|Physician Decision|0|||
143159608|NCT02533674|516129950|FG000|Dose Level II|Non-treatment-related AE|0|||
143159609|NCT02533674|516129951|FG001|Dose Level II|Non-treatment-related AE|1|||
143159610|NCT02533674|516129952|FG002|Dose Level II|Non-treatment-related AE|0|||
143159611|NCT02533674|516129953|FG003|Dose Level II|Non-treatment-related AE|0|||
143159612|NCT02533674|516129954|FG004|Dose Level II|Non-treatment-related AE|0|||
143159613|NCT02533674|516129955|FG005|Dose Level II|Non-treatment-related AE|0|||
143159614|NCT02533674|516129956|FG006|Dose Level II|Non-treatment-related AE|0|||
143159615|NCT02533674|516129957|FG007|Dose Level II|Non-treatment-related AE|0|||
143159616|NCT02533674|516129950|FG000|Dose Level III|Progressive disease|0|||
143159617|NCT02533674|516129951|FG001|Dose Level III|Progressive disease|0|||
143159618|NCT02533674|516129952|FG002|Dose Level III|Progressive disease|2|||
143159619|NCT02533674|516129953|FG003|Dose Level III|Progressive disease|0|||
143159620|NCT02533674|516129954|FG004|Dose Level III|Progressive disease|0|||
143159621|NCT02533674|516129955|FG005|Dose Level III|Progressive disease|0|||
143159622|NCT02533674|516129956|FG006|Dose Level III|Progressive disease|0|||
143237753|NCT01803607|516425518|FG001|Overall Study|Adverse Event|3|||
143237754|NCT01803607|516425517|FG000|Overall Study|Lack of Efficacy|0|||
143237755|NCT01803607|516425518|FG001|Overall Study|Lack of Efficacy|1|||
143159623|NCT02533674|516129957|FG007|Dose Level III|Progressive disease|0|||
143237756|NCT01803607|516425517|FG000|Overall Study|Protocol Violation|3|||
143237757|NCT01803607|516425518|FG001|Overall Study|Protocol Violation|2|||
143237758|NCT01803607|516425517|FG000|Overall Study|Study terminated by sponsor|54|||
143159624|NCT02533674|516129950|FG000|Dose Level III|Withdrawal by Subject|0|||
143159625|NCT02533674|516129951|FG001|Dose Level III|Withdrawal by Subject|0|||
143159626|NCT02533674|516129952|FG002|Dose Level III|Withdrawal by Subject|1|||
143237759|NCT01803607|516425518|FG001|Overall Study|Study terminated by sponsor|56|||
143237760|NCT01803607|516425517|FG000|Overall Study|Withdrawal by Subject|6|||
143237761|NCT01803607|516425518|FG001|Overall Study|Withdrawal by Subject|5|||
143237762|NCT02038933|516425527|FG000|Overall Study|Disease progression|104|||
143494719|NCT02397473|517354364|FG000|Treatment Phase|Adverse Event|1|||
143494720|NCT02397473|517354365|FG001|Treatment Phase|Adverse Event|2|||
143494721|NCT02397473|517354364|FG000|Treatment Phase|Lack of Efficacy|8|||
143494722|NCT02397473|517354365|FG001|Treatment Phase|Lack of Efficacy|1|||
143494723|NCT02397473|517354364|FG000|Treatment Phase|Lost to Follow-up|1|||
143494724|NCT02397473|517354365|FG001|Treatment Phase|Lost to Follow-up|0|||
143494725|NCT02397473|517354364|FG000|Treatment Phase|Withdrawal by Subject|2|||
143494726|NCT02397473|517354365|FG001|Treatment Phase|Withdrawal by Subject|1|||
143494727|NCT02397473|517354364|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
143494728|NCT02397473|517354365|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
143494729|NCT02397473|517354364|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
143494730|NCT02397473|517354365|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
143494731|NCT02397473|517354364|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
143494732|NCT02397473|517354365|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
143494733|NCT02397473|517354364|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
143494734|NCT02397473|517354365|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
143494735|NCT02397473|517354364|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
143032797|NCT02777528|515661363|FG001|Overall Study|Study Device Explanted|0|||
143494736|NCT02397473|517354365|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
143494737|NCT02009878|517354370|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
143032798|NCT02777528|515661364|FG002|Overall Study|Study Device Explanted|0|||
143032799|NCT02777528|515661362|FG000|Overall Study|Death|14|||
143032800|NCT02777528|515661363|FG001|Overall Study|Death|7|||
143032801|NCT02777528|515661364|FG002|Overall Study|Death|1|||
143032802|NCT02777528|515661362|FG000|Overall Study|Withdrawal by Subject|2|||
143032803|NCT02777528|515661363|FG001|Overall Study|Withdrawal by Subject|2|||
143032804|NCT02777528|515661364|FG002|Overall Study|Withdrawal by Subject|1|||
143032805|NCT02777528|515661362|FG000|Overall Study|Physician Decision|2|||
143032806|NCT02777528|515661363|FG001|Overall Study|Physician Decision|1|||
143032807|NCT02777528|515661364|FG002|Overall Study|Physician Decision|0|||
143032808|NCT02777528|515661362|FG000|Overall Study|Lost to Follow-up|2|||
143032809|NCT02777528|515661363|FG001|Overall Study|Lost to Follow-up|0|||
143032810|NCT02777528|515661364|FG002|Overall Study|Lost to Follow-up|0|||
143032811|NCT02777528|515661362|FG000|Overall Study|Discontinued due to Other|1|||
143032812|NCT02777528|515661363|FG001|Overall Study|Discontinued due to Other|0|||
143032813|NCT02777528|515661364|FG002|Overall Study|Discontinued due to Other|0|||
143032814|NCT02127281|515661365|FG000|Overall Study|Lost to Follow-up|1|||
143032815|NCT02127281|515661366|FG001|Overall Study|Lost to Follow-up|0|||
143032816|NCT04885296|515661369|FG000|Period 1|Covid-19 Related|1|||
143159627|NCT02533674|516129953|FG003|Dose Level III|Withdrawal by Subject|0|||
143159628|NCT02533674|516129954|FG004|Dose Level III|Withdrawal by Subject|0|||
143159629|NCT02533674|516129955|FG005|Dose Level III|Withdrawal by Subject|0|||
143159630|NCT02533674|516129956|FG006|Dose Level III|Withdrawal by Subject|0|||
143159631|NCT02533674|516129957|FG007|Dose Level III|Withdrawal by Subject|0|||
143159632|NCT02533674|516129950|FG000|Dose Level III|Treatment-related AE|0|||
143159633|NCT02533674|516129951|FG001|Dose Level III|Treatment-related AE|0|||
143159634|NCT02533674|516129952|FG002|Dose Level III|Treatment-related AE|1|||
143159635|NCT02533674|516129953|FG003|Dose Level III|Treatment-related AE|0|||
143159636|NCT02533674|516129954|FG004|Dose Level III|Treatment-related AE|0|||
143159637|NCT02533674|516129955|FG005|Dose Level III|Treatment-related AE|0|||
143159638|NCT02533674|516129956|FG006|Dose Level III|Treatment-related AE|0|||
143159639|NCT02533674|516129957|FG007|Dose Level III|Treatment-related AE|0|||
143159640|NCT02533674|516129950|FG000|Dose Level IV|Progressive disease|0|||
143159641|NCT02533674|516129951|FG001|Dose Level IV|Progressive disease|0|||
143159642|NCT02533674|516129952|FG002|Dose Level IV|Progressive disease|0|||
143159643|NCT02533674|516129953|FG003|Dose Level IV|Progressive disease|3|||
143159644|NCT02533674|516129954|FG004|Dose Level IV|Progressive disease|0|||
143159645|NCT02533674|516129955|FG005|Dose Level IV|Progressive disease|0|||
143159646|NCT02533674|516129956|FG006|Dose Level IV|Progressive disease|0|||
143159647|NCT02533674|516129957|FG007|Dose Level IV|Progressive disease|0|||
143159648|NCT02533674|516129950|FG000|Dose Level IV|Withdrawal by Subject|0|||
143159649|NCT02533674|516129951|FG001|Dose Level IV|Withdrawal by Subject|0|||
143159650|NCT02533674|516129952|FG002|Dose Level IV|Withdrawal by Subject|0|||
143159651|NCT02533674|516129953|FG003|Dose Level IV|Withdrawal by Subject|1|||
143159652|NCT02533674|516129954|FG004|Dose Level IV|Withdrawal by Subject|0|||
143159653|NCT02533674|516129955|FG005|Dose Level IV|Withdrawal by Subject|0|||
143159654|NCT02533674|516129956|FG006|Dose Level IV|Withdrawal by Subject|0|||
143032817|NCT04885296|515661370|FG001|Period 1|Covid-19 Related|0|||
143159655|NCT02533674|516129957|FG007|Dose Level IV|Withdrawal by Subject|0|||
143159656|NCT02533674|516129950|FG000|Dose Level IV|Physician Decision|0|||
143494738|NCT02009878|517354371|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
143032818|NCT04885296|515661369|FG000|Period 1|Adverse Event|0|||
143159657|NCT02533674|516129951|FG001|Dose Level IV|Physician Decision|0|||
143494739|NCT02009878|517354372|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
143032819|NCT04885296|515661370|FG001|Period 1|Adverse Event|1|||
143494740|NCT01001702|517354373|FG000|Overall Study|Lost to Follow-up|7|||
143494741|NCT01001702|517354373|FG000|Overall Study|Adverse Event|7|||
143032820|NCT04885296|515661369|FG000|Period 1|Withdrawal by Subject|1|||
143159658|NCT02533674|516129952|FG002|Dose Level IV|Physician Decision|0|||
143159659|NCT02533674|516129953|FG003|Dose Level IV|Physician Decision|1|||
143159660|NCT02533674|516129954|FG004|Dose Level IV|Physician Decision|0|||
143159661|NCT02533674|516129955|FG005|Dose Level IV|Physician Decision|0|||
143159662|NCT02533674|516129956|FG006|Dose Level IV|Physician Decision|0|||
143159663|NCT02533674|516129957|FG007|Dose Level IV|Physician Decision|0|||
143237763|NCT02038933|516425527|FG000|Overall Study|Study drug toxicity|6|||
143237764|NCT02038933|516425527|FG000|Overall Study|Adverse event unrelated to study drug|6|||
143237765|NCT02038933|516425527|FG000|Overall Study|Participant request to discontinue treatment|2|||
143237766|NCT02038933|516425527|FG000|Overall Study|Lost to Follow-up|1|||
143237767|NCT02038933|516425527|FG000|Overall Study|Other reasons|2|||
143237768|NCT03819114|516425560|FG000|Overall Study|Protocol Violation|0|||
143237769|NCT03819114|516425561|FG001|Overall Study|Protocol Violation|1|||
143237770|NCT03819114|516425562|FG002|Overall Study|Protocol Violation|1|||
143237771|NCT03819114|516425563|FG003|Overall Study|Protocol Violation|0|||
143237772|NCT03819114|516425560|FG000|Overall Study|Lost to Follow-up|0|||
143237773|NCT03819114|516425561|FG001|Overall Study|Lost to Follow-up|0|||
143237774|NCT03819114|516425562|FG002|Overall Study|Lost to Follow-up|1|||
143237775|NCT03819114|516425563|FG003|Overall Study|Lost to Follow-up|0|||
143237776|NCT04226742|516425564|FG000|Overall Study|Lost to Follow-up|16|||
143237777|NCT04226742|516425565|FG001|Overall Study|Lost to Follow-up|13|||
143237778|NCT04226742|516425564|FG000|Overall Study|Withdrawal by Subject|5|||
143237779|NCT04226742|516425565|FG001|Overall Study|Withdrawal by Subject|3|||
143237780|NCT03841604|516425566|FG000|Overall Study|Withdrawal by Subject|3|||
143237781|NCT03841604|516425567|FG001|Overall Study|Withdrawal by Subject|1|||
143237782|NCT03841604|516425566|FG000|Overall Study|Adverse Event|4|||
143237783|NCT03841604|516425567|FG001|Overall Study|Adverse Event|2|||
143237784|NCT03841604|516425566|FG000|Overall Study|Physician Decision|1|||
143237785|NCT03841604|516425567|FG001|Overall Study|Physician Decision|0|||
143237786|NCT02085161|516425569|FG000|Overall Study|Not Treated|1|||
143237787|NCT02085161|516425570|FG001|Overall Study|Not Treated|0|||
143237788|NCT02085161|516425571|FG002|Overall Study|Not Treated|0|||
143237789|NCT02085161|516425572|FG003|Overall Study|Not Treated|0|||
143237790|NCT02085161|516425569|FG000|Overall Study|Adverse Event|8|||
143237791|NCT02085161|516425570|FG001|Overall Study|Adverse Event|5|||
143237792|NCT02085161|516425571|FG002|Overall Study|Adverse Event|4|||
143237793|NCT02085161|516425572|FG003|Overall Study|Adverse Event|5|||
143237794|NCT02085161|516425569|FG000|Overall Study|Protocol Violation|0|||
143237795|NCT02085161|516425570|FG001|Overall Study|Protocol Violation|1|||
143237796|NCT02085161|516425571|FG002|Overall Study|Protocol Violation|0|||
143237797|NCT02085161|516425572|FG003|Overall Study|Protocol Violation|1|||
143237798|NCT02085161|516425569|FG000|Overall Study|Withdrawal by Subject|2|||
143494742|NCT01001702|517354373|FG000|Overall Study|Sponsor Discontinued Study|4|||
143494743|NCT01001702|517354373|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
143494744|NCT01001702|517354373|FG000|Overall Study|Investigator withdrew Subject|10|||
143494745|NCT01001702|517354373|FG000|Overall Study|Withdrawal by Subject|19|||
143494746|NCT01001702|517354373|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
143494747|NCT04428411|517354380|FG000|Overall Study|Lost to Follow-up|114|||
143494748|NCT01163786|517354381|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
143494749|NCT01163786|517354381|FG000|Treatment With Bortezomib|Adverse Event|2|||
143494750|NCT01163786|517354381|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
143494751|NCT00634569|517354382|FG000|Overall Study|Withdrawal by Subject|0|||
143494752|NCT00634569|517354383|FG001|Overall Study|Withdrawal by Subject|4|||
143494753|NCT00634569|517354382|FG000|Overall Study|Physician Decision|0|||
143494754|NCT00634569|517354383|FG001|Overall Study|Physician Decision|1|||
143494755|NCT02918019|517354384|FG000|Overall Study|Death|0|||
143159664|NCT02533674|516129950|FG000|Dose Level V|Progressive disease|0|||
143159665|NCT02533674|516129951|FG001|Dose Level V|Progressive disease|0|||
143159666|NCT02533674|516129952|FG002|Dose Level V|Progressive disease|0|||
143159667|NCT02533674|516129953|FG003|Dose Level V|Progressive disease|0|||
143159668|NCT02533674|516129954|FG004|Dose Level V|Progressive disease|3|||
143159669|NCT02533674|516129955|FG005|Dose Level V|Progressive disease|0|||
143159670|NCT02533674|516129956|FG006|Dose Level V|Progressive disease|0|||
143159671|NCT02533674|516129957|FG007|Dose Level V|Progressive disease|0|||
143237799|NCT02085161|516425570|FG001|Overall Study|Withdrawal by Subject|4|||
143237800|NCT02085161|516425571|FG002|Overall Study|Withdrawal by Subject|0|||
143237801|NCT02085161|516425572|FG003|Overall Study|Withdrawal by Subject|3|||
143237802|NCT02085161|516425569|FG000|Overall Study|Other Reason|1|||
143159672|NCT02533674|516129950|FG000|Dose Level V|Withdrawal by Subject|0|||
143159673|NCT02533674|516129951|FG001|Dose Level V|Withdrawal by Subject|0|||
143237803|NCT02085161|516425570|FG001|Overall Study|Other Reason|0|||
143237804|NCT02085161|516425571|FG002|Overall Study|Other Reason|1|||
143237805|NCT02085161|516425572|FG003|Overall Study|Other Reason|1|||
143237806|NCT00711191|516425576|FG000|Overall Study|Adverse Event|1|||
143364041|NCT00293462|516875525|FG000|Overall Study|No Show|0|||
143494756|NCT02918019|517354385|FG001|Overall Study|Death|0|||
143494757|NCT02918019|517354386|FG002|Overall Study|Death|1|||
143237807|NCT00711191|516425577|FG001|Overall Study|Adverse Event|1|||
143237808|NCT00711191|516425578|FG002|Overall Study|Adverse Event|2|||
143032821|NCT04885296|515661370|FG001|Period 1|Withdrawal by Subject|1|||
143032822|NCT04885296|515661369|FG000|Period 1|Test Article No Longer Available|1|||
143032823|NCT04885296|515661370|FG001|Period 1|Test Article No Longer Available|0|||
143032824|NCT04885296|515661369|FG000|Period 1|Dispensed Study lens in Error|1|||
143032825|NCT04885296|515661370|FG001|Period 1|Dispensed Study lens in Error|0|||
143032826|NCT04885296|515661369|FG000|Period 1|Lost to Follow-up|1|||
143032827|NCT04885296|515661370|FG001|Period 1|Lost to Follow-up|0|||
143032828|NCT04885296|515661369|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
143032829|NCT04885296|515661370|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
143159674|NCT02533674|516129952|FG002|Dose Level V|Withdrawal by Subject|0|||
143494758|NCT02918019|517354387|FG003|Overall Study|Death|0|||
143494759|NCT02918019|517354384|FG000|Overall Study|Lost to Follow-up|1|||
143494760|NCT02918019|517354385|FG001|Overall Study|Lost to Follow-up|1|||
143494761|NCT02918019|517354386|FG002|Overall Study|Lost to Follow-up|0|||
143494762|NCT02918019|517354387|FG003|Overall Study|Lost to Follow-up|1|||
143494763|NCT02918019|517354384|FG000|Overall Study|Principal investigator request|0|||
143494764|NCT02918019|517354385|FG001|Overall Study|Principal investigator request|0|||
143494765|NCT02918019|517354386|FG002|Overall Study|Principal investigator request|0|||
143494766|NCT02918019|517354387|FG003|Overall Study|Principal investigator request|1|||
143494767|NCT02918019|517354384|FG000|Overall Study|Physician Decision|1|||
143494768|NCT02918019|517354385|FG001|Overall Study|Physician Decision|3|||
143494769|NCT02918019|517354386|FG002|Overall Study|Physician Decision|2|||
143494770|NCT02918019|517354387|FG003|Overall Study|Physician Decision|0|||
143494771|NCT02918019|517354384|FG000|Overall Study|Protocol deviation|1|||
143494772|NCT02918019|517354385|FG001|Overall Study|Protocol deviation|1|||
143494773|NCT02918019|517354386|FG002|Overall Study|Protocol deviation|0|||
143494774|NCT02918019|517354387|FG003|Overall Study|Protocol deviation|2|||
143494775|NCT02918019|517354384|FG000|Overall Study|Withdrawal by Subject|3|||
143494776|NCT02918019|517354385|FG001|Overall Study|Withdrawal by Subject|4|||
143494777|NCT02918019|517354386|FG002|Overall Study|Withdrawal by Subject|6|||
143494778|NCT02918019|517354387|FG003|Overall Study|Withdrawal by Subject|4|||
143494779|NCT02918019|517354384|FG000|Overall Study|Adverse Event|0|||
143494780|NCT02918019|517354385|FG001|Overall Study|Adverse Event|1|||
143494781|NCT02918019|517354386|FG002|Overall Study|Adverse Event|0|||
143032830|NCT05037097|515661371|FG000|Overall Study|Withdrawal by Subject|0|||
143032831|NCT05037097|515661372|FG001|Overall Study|Withdrawal by Subject|1|||
143159675|NCT02533674|516129953|FG003|Dose Level V|Withdrawal by Subject|0|||
143159676|NCT02533674|516129954|FG004|Dose Level V|Withdrawal by Subject|1|||
143159677|NCT02533674|516129955|FG005|Dose Level V|Withdrawal by Subject|0|||
143159678|NCT02533674|516129956|FG006|Dose Level V|Withdrawal by Subject|0|||
143159679|NCT02533674|516129957|FG007|Dose Level V|Withdrawal by Subject|0|||
143159680|NCT02533674|516129950|FG000|Dose Level V|Physician Decision|0|||
143159681|NCT02533674|516129951|FG001|Dose Level V|Physician Decision|0|||
143159682|NCT02533674|516129952|FG002|Dose Level V|Physician Decision|0|||
143159683|NCT02533674|516129953|FG003|Dose Level V|Physician Decision|0|||
143159684|NCT02533674|516129954|FG004|Dose Level V|Physician Decision|1|||
143159685|NCT02533674|516129955|FG005|Dose Level V|Physician Decision|0|||
143159686|NCT02533674|516129956|FG006|Dose Level V|Physician Decision|0|||
143159687|NCT02533674|516129957|FG007|Dose Level V|Physician Decision|0|||
143159688|NCT02533674|516129950|FG000|Dose Level VI|Progressive disease|0|||
143159689|NCT02533674|516129951|FG001|Dose Level VI|Progressive disease|0|||
143159690|NCT02533674|516129952|FG002|Dose Level VI|Progressive disease|0|||
143159691|NCT02533674|516129953|FG003|Dose Level VI|Progressive disease|0|||
143159692|NCT02533674|516129954|FG004|Dose Level VI|Progressive disease|0|||
143159693|NCT02533674|516129955|FG005|Dose Level VI|Progressive disease|7|||
143159694|NCT02533674|516129956|FG006|Dose Level VI|Progressive disease|0|||
143159695|NCT02533674|516129957|FG007|Dose Level VI|Progressive disease|0|||
143159696|NCT02533674|516129950|FG000|Dose Level VI|Withdrawal by Subject|0|||
143159697|NCT02533674|516129951|FG001|Dose Level VI|Withdrawal by Subject|0|||
143159698|NCT02533674|516129952|FG002|Dose Level VI|Withdrawal by Subject|0|||
143159699|NCT02533674|516129953|FG003|Dose Level VI|Withdrawal by Subject|0|||
143159700|NCT02533674|516129954|FG004|Dose Level VI|Withdrawal by Subject|0|||
143159701|NCT02533674|516129955|FG005|Dose Level VI|Withdrawal by Subject|1|||
143159702|NCT02533674|516129956|FG006|Dose Level VI|Withdrawal by Subject|0|||
143237809|NCT00711191|516425576|FG000|Overall Study|Objective progression or relapse|2|||
143237810|NCT00711191|516425577|FG001|Overall Study|Objective progression or relapse|3|||
143159703|NCT02533674|516129957|FG007|Dose Level VI|Withdrawal by Subject|0|||
143237811|NCT00711191|516425578|FG002|Overall Study|Objective progression or relapse|7|||
143494782|NCT02918019|517354387|FG003|Overall Study|Adverse Event|1|||
143494783|NCT01212185|517354388|FG000|Overall Study|Protocol Violation|2|||
143494784|NCT01212185|517354389|FG001|Overall Study|Protocol Violation|1|||
143494785|NCT01463098|517354392|FG000|Part A (11 Days)|Participant Choice|2|||
143494786|NCT01463098|517354393|FG001|Part A (11 Days)|Participant Choice|0|||
143159704|NCT02533674|516129950|FG000|Dose Level VI|Treatment-related AE|0|||
143159705|NCT02533674|516129951|FG001|Dose Level VI|Treatment-related AE|0|||
143494787|NCT01463098|517354394|FG002|Part A (11 Days)|Participant Choice|0|||
143494788|NCT01463098|517354395|FG003|Part A (11 Days)|Participant Choice|0|||
143159706|NCT02533674|516129952|FG002|Dose Level VI|Treatment-related AE|0|||
143159707|NCT02533674|516129953|FG003|Dose Level VI|Treatment-related AE|0|||
143159708|NCT02533674|516129954|FG004|Dose Level VI|Treatment-related AE|0|||
143159709|NCT02533674|516129955|FG005|Dose Level VI|Treatment-related AE|1|||
143159710|NCT02533674|516129956|FG006|Dose Level VI|Treatment-related AE|0|||
143159711|NCT02533674|516129957|FG007|Dose Level VI|Treatment-related AE|0|||
143159712|NCT02533674|516129950|FG000|Dose Level VII|Progressive disease|0|||
143159713|NCT02533674|516129951|FG001|Dose Level VII|Progressive disease|0|||
143159714|NCT02533674|516129952|FG002|Dose Level VII|Progressive disease|0|||
143159715|NCT02533674|516129953|FG003|Dose Level VII|Progressive disease|0|||
143237812|NCT00711191|516425576|FG000|Overall Study|Withdrawal by Subject|0|||
143237813|NCT00711191|516425577|FG001|Overall Study|Withdrawal by Subject|1|||
143237814|NCT00711191|516425578|FG002|Overall Study|Withdrawal by Subject|3|||
143237815|NCT04646044|516425579|FG000|Overall Study|Lost to Follow-up|0|||
143237816|NCT04646044|516425580|FG001|Overall Study|Lost to Follow-up|0|||
143237817|NCT04646044|516425581|FG002|Overall Study|Lost to Follow-up|1|||
143237818|NCT04646044|516425582|FG003|Overall Study|Lost to Follow-up|0|||
143237819|NCT04646044|516425579|FG000|Overall Study|Withdrawal by Subject|0|||
143237820|NCT04646044|516425580|FG001|Overall Study|Withdrawal by Subject|1|||
143237821|NCT04646044|516425581|FG002|Overall Study|Withdrawal by Subject|0|||
143237822|NCT04646044|516425582|FG003|Overall Study|Withdrawal by Subject|0|||
143237823|NCT03038880|516425589|FG000|Overall Study|Death|1|||
143237824|NCT03038880|516425590|FG001|Overall Study|Death|2|||
143237825|NCT03038880|516425591|FG002|Overall Study|Death|0|||
143237826|NCT03038880|516425589|FG000|Overall Study|Physician Decision|2|||
143237827|NCT03038880|516425590|FG001|Overall Study|Physician Decision|1|||
143237828|NCT03038880|516425591|FG002|Overall Study|Physician Decision|0|||
143237829|NCT02803580|516425592|FG000|Overall Study|Death|13|||
143237830|NCT02803580|516425592|FG000|Overall Study|Lost to Follow-up|19|||
143237831|NCT02803580|516425592|FG000|Overall Study|Withdrawal by Subject|3|||
143159716|NCT02533674|516129954|FG004|Dose Level VII|Progressive disease|0|||
143159717|NCT02533674|516129955|FG005|Dose Level VII|Progressive disease|0|||
143159718|NCT02533674|516129956|FG006|Dose Level VII|Progressive disease|10|||
143159719|NCT02533674|516129957|FG007|Dose Level VII|Progressive disease|0|||
143159720|NCT02533674|516129950|FG000|Dose Level VII|Withdrawal by Subject|0|||
143159721|NCT02533674|516129951|FG001|Dose Level VII|Withdrawal by Subject|0|||
143237832|NCT02803580|516425592|FG000|Overall Study|Inclusion in clinical trial|1|||
143237833|NCT02054104|516425593|FG000|Overall Study|Did not want to continue due to college classes|1|||
143237834|NCT02054104|516425594|FG001|Overall Study|Did not want to continue due to college classes|0|||
143237835|NCT02054104|516425593|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
143237836|NCT02054104|516425594|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
143237837|NCT02054104|516425593|FG000|Overall Study|No evidence of immunologic response|2|||
143237838|NCT02054104|516425594|FG001|Overall Study|No evidence of immunologic response|2|||
143237839|NCT02054104|516425593|FG000|Overall Study|Disease Progression On Study|4|||
143237840|NCT02054104|516425594|FG001|Overall Study|Disease Progression On Study|5|||
143494789|NCT01463098|517354396|FG004|Part A (11 Days)|Participant Choice|0|||
143494790|NCT01463098|517354397|FG005|Part A (11 Days)|Participant Choice|0|||
143494791|NCT01463098|517354398|FG006|Part A (11 Days)|Participant Choice|0|||
143494792|NCT01463098|517354399|FG007|Part A (11 Days)|Participant Choice|0|||
143237841|NCT02054104|516425593|FG000|Overall Study|Diagnosis of lymphoma|0|||
143237842|NCT02054104|516425594|FG001|Overall Study|Diagnosis of lymphoma|1|||
143237843|NCT02054104|516425593|FG000|Overall Study|Inconclusive response|0|||
143494793|NCT01463098|517354400|FG008|Part A (11 Days)|Participant Choice|1|||
143494794|NCT01463098|517354401|FG009|Part A (11 Days)|Participant Choice|0|||
143494795|NCT01463098|517354402|FG010|Part A (11 Days)|Participant Choice|0|||
143494796|NCT01463098|517354403|FG011|Part A (11 Days)|Participant Choice|0|||
143494797|NCT01463098|517354404|FG012|Part A (11 Days)|Participant Choice|0|||
143494798|NCT01463098|517354405|FG013|Part A (11 Days)|Participant Choice|0|||
143494799|NCT01463098|517354392|FG000|Part A (11 Days)|Lost to Follow-up|0|||
143494800|NCT01463098|517354393|FG001|Part A (11 Days)|Lost to Follow-up|0|||
143494801|NCT01463098|517354394|FG002|Part A (11 Days)|Lost to Follow-up|0|||
143494802|NCT01463098|517354395|FG003|Part A (11 Days)|Lost to Follow-up|0|||
143494803|NCT01463098|517354396|FG004|Part A (11 Days)|Lost to Follow-up|1|||
143494804|NCT01463098|517354397|FG005|Part A (11 Days)|Lost to Follow-up|0|||
143159722|NCT02533674|516129952|FG002|Dose Level VII|Withdrawal by Subject|0|||
143159723|NCT02533674|516129953|FG003|Dose Level VII|Withdrawal by Subject|0|||
143159724|NCT02533674|516129954|FG004|Dose Level VII|Withdrawal by Subject|0|||
143494805|NCT01463098|517354398|FG006|Part A (11 Days)|Lost to Follow-up|0|||
143494806|NCT01463098|517354399|FG007|Part A (11 Days)|Lost to Follow-up|0|||
143159725|NCT02533674|516129955|FG005|Dose Level VII|Withdrawal by Subject|0|||
143237844|NCT02054104|516425594|FG001|Overall Study|Inconclusive response|1|||
143237845|NCT02404025|516425595|FG000|Overall Study|Adverse Event|1|||
143364042|NCT00293462|516875526|FG001|Overall Study|No Show|0|||
143364043|NCT00293462|516875527|FG002|Overall Study|No Show|1|||
143494807|NCT01463098|517354400|FG008|Part A (11 Days)|Lost to Follow-up|0|||
143237846|NCT02404025|516425595|FG000|Overall Study|Lack of Efficacy|3|||
143237847|NCT02633306|516425599|FG000|Overall Study|Withdrawal by Subject|3|||
143237848|NCT03910244|516425600|FG000|Overall Study|Adverse Event|14|||
143237849|NCT03910244|516425601|FG001|Overall Study|Adverse Event|0|||
143237850|NCT03910244|516425600|FG000|Overall Study|Death|1|||
143237851|NCT03910244|516425601|FG001|Overall Study|Death|0|||
143237852|NCT03910244|516425600|FG000|Overall Study|Lost to Follow-up|0|||
143237853|NCT03910244|516425601|FG001|Overall Study|Lost to Follow-up|2|||
143237854|NCT03910244|516425600|FG000|Overall Study|Joint withdrawal decision|1|||
143237855|NCT03910244|516425601|FG001|Overall Study|Joint withdrawal decision|0|||
143237856|NCT03910244|516425600|FG000|Overall Study|Study Terminated by Sponsor|7|||
143237857|NCT03910244|516425601|FG001|Overall Study|Study Terminated by Sponsor|4|||
143237858|NCT03910244|516425600|FG000|Overall Study|Physician Decision|1|||
143237859|NCT03910244|516425601|FG001|Overall Study|Physician Decision|0|||
143237860|NCT03910244|516425600|FG000|Overall Study|Protocol Violation|1|||
143237861|NCT03910244|516425601|FG001|Overall Study|Protocol Violation|0|||
143237862|NCT03910244|516425600|FG000|Overall Study|Withdrawal by Subject|7|||
143237863|NCT03910244|516425601|FG001|Overall Study|Withdrawal by Subject|2|||
143237864|NCT01213472|516425604|FG000|Overall Study|Recurrence/Progressive disease|25|||
143237865|NCT01213472|516425604|FG000|Overall Study|Withdrawal by Subject|1|||
143237866|NCT01213472|516425604|FG000|Overall Study|Physician Decision|1|||
143237867|NCT03774576|516425605|FG000|Period 2|Adverse Event|1|||
143237868|NCT01746901|516425606|FG000|Naloxone Challenge Phase|Adverse Event|2|||
143237869|NCT01746901|516425607|FG001|Naloxone Challenge Phase|Adverse Event|0|||
143237870|NCT01746901|516425608|FG002|Naloxone Challenge Phase|Adverse Event|0|||
143237871|NCT01746901|516425609|FG003|Naloxone Challenge Phase|Adverse Event|0|||
143237872|NCT01746901|516425610|FG004|Naloxone Challenge Phase|Adverse Event|0|||
143237873|NCT01746901|516425611|FG005|Naloxone Challenge Phase|Adverse Event|0|||
143237874|NCT01746901|516425612|FG006|Naloxone Challenge Phase|Adverse Event|0|||
143237875|NCT01746901|516425613|FG007|Naloxone Challenge Phase|Adverse Event|0|||
143237876|NCT01746901|516425614|FG008|Naloxone Challenge Phase|Adverse Event|0|||
143237877|NCT01746901|516425606|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
143237878|NCT01746901|516425607|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
143237879|NCT01746901|516425608|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
143237880|NCT01746901|516425609|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
143237881|NCT01746901|516425610|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
143237882|NCT01746901|516425611|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
143237883|NCT01746901|516425612|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
143237884|NCT01746901|516425613|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
143237885|NCT01746901|516425614|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
143237886|NCT01746901|516425606|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
143237887|NCT01746901|516425607|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
143237888|NCT01746901|516425608|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
143237889|NCT01746901|516425609|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
143237890|NCT01746901|516425610|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
143237891|NCT01746901|516425611|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
143237892|NCT01746901|516425612|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
143237893|NCT01746901|516425613|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
143237894|NCT01746901|516425614|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
143237895|NCT01746901|516425606|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
143237896|NCT01746901|516425607|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
143237897|NCT01746901|516425608|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
143237898|NCT01746901|516425609|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
143237899|NCT01746901|516425610|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
143237900|NCT01746901|516425611|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
143237901|NCT01746901|516425612|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
143237902|NCT01746901|516425613|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
143237903|NCT01746901|516425614|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
143237904|NCT01746901|516425606|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
143494808|NCT01463098|517354401|FG009|Part A (11 Days)|Lost to Follow-up|0|||
143494809|NCT01463098|517354402|FG010|Part A (11 Days)|Lost to Follow-up|0|||
143237905|NCT01746901|516425607|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
143237906|NCT01746901|516425608|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
143237907|NCT01746901|516425609|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
143494810|NCT01463098|517354403|FG011|Part A (11 Days)|Lost to Follow-up|0|||
143494811|NCT01463098|517354404|FG012|Part A (11 Days)|Lost to Follow-up|0|||
143237908|NCT01746901|516425610|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
143237909|NCT01746901|516425611|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
143237910|NCT01746901|516425612|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
143494812|NCT01463098|517354405|FG013|Part A (11 Days)|Lost to Follow-up|0|||
143494813|NCT01463098|517354392|FG000|Part B (11 Days)|Participant Choice|0|||
143494814|NCT01463098|517354393|FG001|Part B (11 Days)|Participant Choice|0|||
143494815|NCT01463098|517354394|FG002|Part B (11 Days)|Participant Choice|0|||
143494816|NCT01463098|517354395|FG003|Part B (11 Days)|Participant Choice|0|||
143494817|NCT01463098|517354396|FG004|Part B (11 Days)|Participant Choice|0|||
143159726|NCT02533674|516129956|FG006|Dose Level VII|Withdrawal by Subject|3|||
143159727|NCT02533674|516129957|FG007|Dose Level VII|Withdrawal by Subject|0|||
143494818|NCT01463098|517354397|FG005|Part B (11 Days)|Participant Choice|0|||
143494819|NCT01463098|517354398|FG006|Part B (11 Days)|Participant Choice|0|||
143159728|NCT02533674|516129950|FG000|Dose Level VII|Treatment-related AE|0|||
143159729|NCT02533674|516129951|FG001|Dose Level VII|Treatment-related AE|0|||
143159730|NCT02533674|516129952|FG002|Dose Level VII|Treatment-related AE|0|||
143159731|NCT02533674|516129953|FG003|Dose Level VII|Treatment-related AE|0|||
143159732|NCT02533674|516129954|FG004|Dose Level VII|Treatment-related AE|0|||
143159733|NCT02533674|516129955|FG005|Dose Level VII|Treatment-related AE|0|||
143159734|NCT02533674|516129956|FG006|Dose Level VII|Treatment-related AE|1|||
143159735|NCT02533674|516129957|FG007|Dose Level VII|Treatment-related AE|0|||
143159736|NCT02533674|516129950|FG000|Dose Level VII|Death|0|||
143159737|NCT02533674|516129951|FG001|Dose Level VII|Death|0|||
143159738|NCT02533674|516129952|FG002|Dose Level VII|Death|0|||
143159739|NCT02533674|516129953|FG003|Dose Level VII|Death|0|||
143159740|NCT02533674|516129954|FG004|Dose Level VII|Death|0|||
143159741|NCT02533674|516129955|FG005|Dose Level VII|Death|0|||
143159742|NCT02533674|516129956|FG006|Dose Level VII|Death|2|||
143159743|NCT02533674|516129957|FG007|Dose Level VII|Death|0|||
143159744|NCT02533674|516129950|FG000|Dose Level VIII|Progressive disease|0|||
143159745|NCT02533674|516129951|FG001|Dose Level VIII|Progressive disease|0|||
143159746|NCT02533674|516129952|FG002|Dose Level VIII|Progressive disease|0|||
143159747|NCT02533674|516129953|FG003|Dose Level VIII|Progressive disease|0|||
143159748|NCT02533674|516129954|FG004|Dose Level VIII|Progressive disease|0|||
143159749|NCT02533674|516129955|FG005|Dose Level VIII|Progressive disease|0|||
143159750|NCT02533674|516129956|FG006|Dose Level VIII|Progressive disease|0|||
143159751|NCT02533674|516129957|FG007|Dose Level VIII|Progressive disease|3|||
143159752|NCT02533674|516129950|FG000|Dose Level VIII|Withdrawal by Subject|0|||
143159753|NCT02533674|516129951|FG001|Dose Level VIII|Withdrawal by Subject|0|||
143159754|NCT02533674|516129952|FG002|Dose Level VIII|Withdrawal by Subject|0|||
143159755|NCT02533674|516129953|FG003|Dose Level VIII|Withdrawal by Subject|0|||
143159756|NCT02533674|516129954|FG004|Dose Level VIII|Withdrawal by Subject|0|||
143159757|NCT02533674|516129955|FG005|Dose Level VIII|Withdrawal by Subject|0|||
143159758|NCT02533674|516129956|FG006|Dose Level VIII|Withdrawal by Subject|0|||
143159759|NCT02533674|516129957|FG007|Dose Level VIII|Withdrawal by Subject|1|||
143159760|NCT02533674|516129950|FG000|Dose Level VIII|Treatment-related AE|0|||
143159761|NCT02533674|516129951|FG001|Dose Level VIII|Treatment-related AE|0|||
143159762|NCT02533674|516129952|FG002|Dose Level VIII|Treatment-related AE|0|||
143159763|NCT02533674|516129953|FG003|Dose Level VIII|Treatment-related AE|0|||
143159764|NCT02533674|516129954|FG004|Dose Level VIII|Treatment-related AE|0|||
143159765|NCT02533674|516129955|FG005|Dose Level VIII|Treatment-related AE|0|||
143159766|NCT02533674|516129956|FG006|Dose Level VIII|Treatment-related AE|0|||
143159767|NCT02533674|516129957|FG007|Dose Level VIII|Treatment-related AE|1|||
143159768|NCT02533674|516129950|FG000|Dose Level VIII|Never treated|0|||
143159769|NCT02533674|516129951|FG001|Dose Level VIII|Never treated|0|||
143159770|NCT02533674|516129952|FG002|Dose Level VIII|Never treated|0|||
143159771|NCT02533674|516129953|FG003|Dose Level VIII|Never treated|0|||
143159772|NCT02533674|516129954|FG004|Dose Level VIII|Never treated|0|||
143159773|NCT02533674|516129955|FG005|Dose Level VIII|Never treated|0|||
143159774|NCT02533674|516129956|FG006|Dose Level VIII|Never treated|0|||
143159775|NCT02533674|516129957|FG007|Dose Level VIII|Never treated|1|||
143159776|NCT04821245|516129968|FG000|Overall Study|Withdrawal by Subject|3|||
143159777|NCT04821245|516129968|FG000|Overall Study|Physician Decision|1|||
143159778|NCT04821245|516129968|FG000|Overall Study|Protocol Violation|5|||
143159779|NCT03636269|516129971|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
143159780|NCT03636269|516129972|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
143159781|NCT03636269|516129973|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
143159782|NCT03636269|516129971|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
143159783|NCT03636269|516129972|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
143494820|NCT01463098|517354399|FG007|Part B (11 Days)|Participant Choice|0|||
143494821|NCT01463098|517354400|FG008|Part B (11 Days)|Participant Choice|0|||
143494822|NCT01463098|517354401|FG009|Part B (11 Days)|Participant Choice|0|||
143494823|NCT01463098|517354402|FG010|Part B (11 Days)|Participant Choice|0|||
143494824|NCT01463098|517354403|FG011|Part B (11 Days)|Participant Choice|1|||
143494825|NCT01463098|517354404|FG012|Part B (11 Days)|Participant Choice|0|||
143159784|NCT03636269|516129973|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
143159785|NCT03636269|516129971|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
143159786|NCT03636269|516129972|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
143237911|NCT01746901|516425613|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
143494826|NCT01463098|517354405|FG013|Part B (11 Days)|Participant Choice|0|||
143494827|NCT01528787|517354406|FG000|Overall Study|Withdrawal by Subject|0|||
143494828|NCT01528787|517354407|FG001|Overall Study|Withdrawal by Subject|0|||
143494829|NCT01528787|517354408|FG002|Overall Study|Withdrawal by Subject|0|||
143494830|NCT01528787|517354409|FG003|Overall Study|Withdrawal by Subject|1|||
143494831|NCT01528787|517354406|FG000|Overall Study|Family Emergency|0|||
143494832|NCT01528787|517354407|FG001|Overall Study|Family Emergency|0|||
143494833|NCT01528787|517354408|FG002|Overall Study|Family Emergency|1|||
143494834|NCT01528787|517354409|FG003|Overall Study|Family Emergency|0|||
143494835|NCT03433781|517354410|FG000|Overall Study|Progression of Disease|1|||
143494836|NCT03433781|517354411|FG001|Overall Study|Progression of Disease|0|||
143494837|NCT03433781|517354412|FG002|Overall Study|Progression of Disease|0|||
143494838|NCT03433781|517354410|FG000|Overall Study|Physician Decision|0|||
143494839|NCT03433781|517354411|FG001|Overall Study|Physician Decision|1|||
143494840|NCT03433781|517354412|FG002|Overall Study|Physician Decision|0|||
143032832|NCT05037097|515661373|FG002|Overall Study|Withdrawal by Subject|0|||
143237912|NCT01746901|516425614|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
143237913|NCT01746901|516425606|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
143237914|NCT01746901|516425607|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
143237915|NCT01746901|516425608|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
143237916|NCT01746901|516425609|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
143237917|NCT01746901|516425610|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
143237918|NCT01746901|516425611|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
143237919|NCT01746901|516425612|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
143237920|NCT01746901|516425613|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
143237921|NCT01746901|516425614|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
143237922|NCT01746901|516425606|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
143237923|NCT01746901|516425607|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
143237924|NCT01746901|516425608|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
143237925|NCT01746901|516425609|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
143032833|NCT05037097|515661374|FG003|Overall Study|Withdrawal by Subject|1|||
143032834|NCT05037097|515661375|FG004|Overall Study|Withdrawal by Subject|0|||
143237926|NCT01746901|516425610|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
143237927|NCT01746901|516425611|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
143237928|NCT01746901|516425612|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
143237929|NCT01746901|516425613|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
143237930|NCT01746901|516425614|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
143237931|NCT01746901|516425606|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
143237932|NCT01746901|516425607|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
143237933|NCT01746901|516425608|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
143237934|NCT01746901|516425609|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
143237935|NCT01746901|516425610|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
143237936|NCT01746901|516425611|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
143237937|NCT01746901|516425612|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
143237938|NCT01746901|516425613|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
143237939|NCT01746901|516425614|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
143237940|NCT01746901|516425606|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
143237941|NCT01746901|516425607|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
143237942|NCT01746901|516425608|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
143237943|NCT01746901|516425609|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
143237944|NCT01746901|516425610|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
143237945|NCT01746901|516425611|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
143237946|NCT01746901|516425612|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
143237947|NCT01746901|516425613|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
143237948|NCT01746901|516425614|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
143237949|NCT01746901|516425606|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
143237950|NCT01746901|516425607|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
143237951|NCT01746901|516425608|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
143237952|NCT01746901|516425609|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
143237953|NCT01746901|516425610|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
143494841|NCT02568046|517354413|FG000|Overall Study|Adverse Event|0|||
143494842|NCT02568046|517354414|FG001|Overall Study|Adverse Event|1|||
143494843|NCT02568046|517354413|FG000|Overall Study|Death|2|||
143494844|NCT02568046|517354414|FG001|Overall Study|Death|0|||
143494845|NCT02568046|517354413|FG000|Overall Study|Progressive Disease|1|||
143494846|NCT02568046|517354414|FG001|Overall Study|Progressive Disease|0|||
143494847|NCT02568046|517354413|FG000|Overall Study|Withdrawal by Subject|2|||
143032835|NCT05037097|515661376|FG005|Overall Study|Withdrawal by Subject|2|||
143494848|NCT02568046|517354414|FG001|Overall Study|Withdrawal by Subject|1|||
143494849|NCT02568046|517354413|FG000|Overall Study|Other Events|0|||
143494850|NCT02568046|517354414|FG001|Overall Study|Other Events|1|||
143032836|NCT05037097|515661377|FG006|Overall Study|Withdrawal by Subject|0|||
143494851|NCT02809833|517354415|FG000|Overall Study|Death|3|||
143494852|NCT02809833|517354415|FG000|Overall Study|Intolerance|54|||
143237954|NCT01746901|516425611|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
143237955|NCT01746901|516425612|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
143237956|NCT01746901|516425613|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
143237957|NCT01746901|516425614|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
143237958|NCT01746901|516425606|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
143237959|NCT01746901|516425607|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
143237960|NCT01746901|516425608|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
143237961|NCT01746901|516425609|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
143237962|NCT01746901|516425610|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
143237963|NCT01746901|516425611|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
143237964|NCT01746901|516425612|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
143237965|NCT01746901|516425613|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
143237966|NCT01746901|516425614|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
143237967|NCT01746901|516425606|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
143237968|NCT01746901|516425607|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
143237969|NCT01746901|516425608|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
143237970|NCT01746901|516425609|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
143237971|NCT01746901|516425610|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
143237972|NCT01746901|516425611|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
143237973|NCT01746901|516425612|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
143237974|NCT01746901|516425613|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
143237975|NCT01746901|516425614|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
143237976|NCT02085460|516425615|FG000|Overall Study|Adverse Event|2|||
143237977|NCT02085460|516425616|FG001|Overall Study|Adverse Event|2|||
143237978|NCT02085460|516425617|FG002|Overall Study|Adverse Event|1|||
143237979|NCT02085460|516425615|FG000|Overall Study|Physician Decision|1|||
143237980|NCT02085460|516425616|FG001|Overall Study|Physician Decision|1|||
143237981|NCT02085460|516425617|FG002|Overall Study|Physician Decision|2|||
143237982|NCT02085460|516425615|FG000|Overall Study|Withdrawal by Subject|11|||
143237983|NCT02085460|516425616|FG001|Overall Study|Withdrawal by Subject|5|||
143237984|NCT02085460|516425617|FG002|Overall Study|Withdrawal by Subject|7|||
143237985|NCT00907335|516425618|FG000|Overall Study|Withdrawal by Subject|2|||
143237986|NCT00907335|516425619|FG001|Overall Study|Withdrawal by Subject|0|||
143237987|NCT00907335|516425618|FG000|Overall Study|Adverse Event|4|||
143237988|NCT00907335|516425619|FG001|Overall Study|Adverse Event|1|||
143237989|NCT00907335|516425618|FG000|Overall Study|Lost to Follow-up|2|||
143237990|NCT00907335|516425619|FG001|Overall Study|Lost to Follow-up|0|||
143237991|NCT02072668|516425625|FG000|Second Intervention|Lost to Follow-up|1|||
143237992|NCT02072668|516425626|FG001|Second Intervention|Lost to Follow-up|0|||
143237993|NCT02420821|516425631|FG000|Overall Study|Lost to Follow-up|6|||
143237994|NCT02420821|516425632|FG001|Overall Study|Lost to Follow-up|6|||
143237995|NCT02420821|516425631|FG000|Overall Study|Non-compliance|0|||
143237996|NCT02420821|516425632|FG001|Overall Study|Non-compliance|2|||
143237997|NCT02420821|516425631|FG000|Overall Study|Physician Decision|6|||
143237998|NCT02420821|516425632|FG001|Overall Study|Physician Decision|2|||
143237999|NCT02420821|516425631|FG000|Overall Study|Withdrawal by Subject|32|||
143238000|NCT02420821|516425632|FG001|Overall Study|Withdrawal by Subject|25|||
143238001|NCT02420821|516425631|FG000|Overall Study|Death|270|||
143238002|NCT02420821|516425632|FG001|Overall Study|Death|263|||
143238003|NCT02420821|516425631|FG000|Overall Study|Study Terminated By Sponsor|145|||
143238004|NCT02420821|516425632|FG001|Overall Study|Study Terminated By Sponsor|149|||
143238005|NCT02420821|516425631|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
143494853|NCT02809833|517354415|FG000|Overall Study|Lack of Efficacy|89|||
143494854|NCT02809833|517354415|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
143494855|NCT02809833|517354415|FG000|Overall Study|Noncompliance|1|||
143238006|NCT02420821|516425632|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
143238007|NCT02420821|516425631|FG000|Overall Study|Adverse Event|0|||
143238008|NCT02420821|516425632|FG001|Overall Study|Adverse Event|1|||
143238009|NCT02420821|516425631|FG000|Overall Study|Protinuria|0|||
143238010|NCT02420821|516425632|FG001|Overall Study|Protinuria|1|||
143238011|NCT02420821|516425631|FG000|Overall Study|Progressive Disease|1|||
143494856|NCT02809833|517354415|FG000|Overall Study|Withdrawal by Subject|34|||
143238012|NCT02420821|516425632|FG001|Overall Study|Progressive Disease|1|||
143238013|NCT02420821|516425631|FG000|Overall Study|Disease Progression|0|||
143238014|NCT02420821|516425632|FG001|Overall Study|Disease Progression|1|||
143238015|NCT02420821|516425631|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
143238016|NCT02420821|516425632|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
143238017|NCT01658436|516425633|FG000|Overall Study|Adverse Event|6|||
143238018|NCT01658436|516425634|FG001|Overall Study|Adverse Event|5|||
143238019|NCT01658436|516425633|FG000|Overall Study|Physician Decision|1|||
143238020|NCT01658436|516425634|FG001|Overall Study|Physician Decision|0|||
143238021|NCT01658436|516425633|FG000|Overall Study|Progressive disease|12|||
143238022|NCT01658436|516425634|FG001|Overall Study|Progressive disease|4|||
143238023|NCT01658436|516425633|FG000|Overall Study|Study terminated by sponsor|0|||
143238024|NCT01658436|516425634|FG001|Overall Study|Study terminated by sponsor|1|||
143238025|NCT01658436|516425633|FG000|Overall Study|Subject/guardian decision|0|||
143238026|NCT01658436|516425634|FG001|Overall Study|Subject/guardian decision|1|||
143238027|NCT01658436|516425633|FG000|Overall Study|Death|1|||
143238028|NCT01658436|516425634|FG001|Overall Study|Death|0|||
143238029|NCT00686712|516425635|FG000|Overall Study|Protocol Violation|8|||
143238030|NCT00686712|516425636|FG001|Overall Study|Protocol Violation|8|||
143238031|NCT00686712|516425637|FG002|Overall Study|Protocol Violation|10|||
143238032|NCT00686712|516425635|FG000|Overall Study|Lost to Follow-up|1|||
143238033|NCT00686712|516425636|FG001|Overall Study|Lost to Follow-up|2|||
143238034|NCT00686712|516425637|FG002|Overall Study|Lost to Follow-up|3|||
143238035|NCT00686712|516425635|FG000|Overall Study|Adverse Event|1|||
143238036|NCT00686712|516425636|FG001|Overall Study|Adverse Event|1|||
143238037|NCT00686712|516425637|FG002|Overall Study|Adverse Event|0|||
143238038|NCT01318915|516425640|FG000|Overall Study|Lost to Follow-up|1|||
143238039|NCT00926237|516425642|FG000|Overall Study|Withdrawal by Subject|2|||
143238040|NCT00926237|516425643|FG001|Overall Study|Withdrawal by Subject|1|||
143238041|NCT04119414|516425644|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
143238042|NCT04322526|516425650|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
143238043|NCT04322526|516425651|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
143238044|NCT04322526|516425650|FG000|Washout (1 Week)|Lost to Follow-up|1|||
143238045|NCT04322526|516425651|FG001|Washout (1 Week)|Lost to Follow-up|2|||
143238046|NCT01716234|516425652|FG000|Overall Study|Protocol Violation|0|||
143238047|NCT01716234|516425653|FG001|Overall Study|Protocol Violation|0|||
143238048|NCT01716234|516425654|FG002|Overall Study|Protocol Violation|0|||
143238049|NCT01716234|516425655|FG003|Overall Study|Protocol Violation|1|||
143238050|NCT01716234|516425656|FG004|Overall Study|Protocol Violation|1|||
143238051|NCT01716234|516425657|FG005|Overall Study|Protocol Violation|1|||
143238052|NCT01716234|516425658|FG006|Overall Study|Protocol Violation|0|||
143238053|NCT01716234|516425652|FG000|Overall Study|Lack of Efficacy|0|||
143238054|NCT01716234|516425653|FG001|Overall Study|Lack of Efficacy|0|||
143238055|NCT01716234|516425654|FG002|Overall Study|Lack of Efficacy|0|||
143238056|NCT01716234|516425655|FG003|Overall Study|Lack of Efficacy|1|||
143238057|NCT01716234|516425656|FG004|Overall Study|Lack of Efficacy|0|||
143238058|NCT01716234|516425657|FG005|Overall Study|Lack of Efficacy|0|||
143238059|NCT01716234|516425658|FG006|Overall Study|Lack of Efficacy|0|||
143159787|NCT03636269|516129973|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
143159788|NCT03636269|516129971|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
143159789|NCT03636269|516129972|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
143159790|NCT03636269|516129973|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
143159791|NCT03636269|516129971|FG000|Period 1: Double-blind Phase|Other|6|||
143159792|NCT03636269|516129972|FG001|Period 1: Double-blind Phase|Other|3|||
143159793|NCT03636269|516129973|FG002|Period 1: Double-blind Phase|Other|0|||
143159794|NCT03636269|516129971|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
143238060|NCT01716234|516425652|FG000|Overall Study|Did not meet protocol eligibility|0|||
143238061|NCT01716234|516425653|FG001|Overall Study|Did not meet protocol eligibility|0|||
143494857|NCT02809833|517354415|FG000|Overall Study|Lost to Follow-up|35|||
143494858|NCT02809833|517354415|FG000|Overall Study|Adverse Event (AE)|24|||
143494859|NCT02809833|517354415|FG000|Overall Study|Other|5|||
143494860|NCT02809833|517354415|FG000|Overall Study|Missing Information|52|||
143494861|NCT00523991|517354416|FG000|Overall Study|Adverse Event|6|||
143494862|NCT00523991|517354417|FG001|Overall Study|Adverse Event|5|||
143494863|NCT00523991|517354416|FG000|Overall Study|Protocol Violation|1|||
143494864|NCT00523991|517354417|FG001|Overall Study|Protocol Violation|4|||
143494865|NCT00523991|517354416|FG000|Overall Study|Lost to Follow-up|4|||
143494866|NCT00523991|517354417|FG001|Overall Study|Lost to Follow-up|1|||
143494867|NCT00523991|517354416|FG000|Overall Study|Withdrawal by Subject|7|||
143494868|NCT00523991|517354417|FG001|Overall Study|Withdrawal by Subject|17|||
143494869|NCT00523991|517354416|FG000|Overall Study|Other reason (not specified)|3|||
143159795|NCT03636269|516129972|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
143238062|NCT01716234|516425654|FG002|Overall Study|Did not meet protocol eligibility|1|||
143238063|NCT01716234|516425655|FG003|Overall Study|Did not meet protocol eligibility|0|||
143238064|NCT01716234|516425656|FG004|Overall Study|Did not meet protocol eligibility|0|||
143238065|NCT01716234|516425657|FG005|Overall Study|Did not meet protocol eligibility|4|||
143494870|NCT00523991|517354417|FG001|Overall Study|Other reason (not specified)|0|||
143494871|NCT00193063|517354418|FG000|Overall Study|Lack of Efficacy|3|||
143238066|NCT01716234|516425658|FG006|Overall Study|Did not meet protocol eligibility|0|||
143238067|NCT01716234|516425652|FG000|Overall Study|Adverse Event|7|||
143238068|NCT01716234|516425653|FG001|Overall Study|Adverse Event|10|||
143238069|NCT01716234|516425654|FG002|Overall Study|Adverse Event|2|||
143238070|NCT01716234|516425655|FG003|Overall Study|Adverse Event|8|||
143238071|NCT01716234|516425656|FG004|Overall Study|Adverse Event|3|||
143238072|NCT01716234|516425657|FG005|Overall Study|Adverse Event|6|||
143238073|NCT01716234|516425658|FG006|Overall Study|Adverse Event|0|||
143494872|NCT00193063|517354418|FG000|Overall Study|Adverse Event|1|||
143494873|NCT01700192|517354419|FG000|Overall Study|Adverse Event|73|||
143494874|NCT01700192|517354420|FG001|Overall Study|Adverse Event|18|||
143494875|NCT01700192|517354419|FG000|Overall Study|Lack of Efficacy|1|||
143494876|NCT01700192|517354420|FG001|Overall Study|Lack of Efficacy|0|||
143159796|NCT03636269|516129973|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
143159797|NCT03636269|516129971|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
143159798|NCT03636269|516129972|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
143159799|NCT03636269|516129973|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
143159800|NCT03636269|516129971|FG000|Period 2: Open-label Phase|Adverse Event|0|||
143159801|NCT03636269|516129972|FG001|Period 2: Open-label Phase|Adverse Event|0|||
143159802|NCT03636269|516129973|FG002|Period 2: Open-label Phase|Adverse Event|21|||
143159803|NCT03636269|516129971|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
143159804|NCT03636269|516129972|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
143159805|NCT03636269|516129973|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
143159806|NCT03636269|516129971|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
143159807|NCT03636269|516129972|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
143159808|NCT03636269|516129973|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
143159809|NCT03636269|516129971|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
143159810|NCT03636269|516129972|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
143159811|NCT03636269|516129973|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
143159812|NCT03636269|516129971|FG000|Period 2: Open-label Phase|Administrative|0|||
143159813|NCT03636269|516129972|FG001|Period 2: Open-label Phase|Administrative|0|||
143159814|NCT03636269|516129973|FG002|Period 2: Open-label Phase|Administrative|36|||
143159815|NCT03636269|516129971|FG000|Period 2: Open-label Phase|Other|0|||
143159816|NCT03636269|516129972|FG001|Period 2: Open-label Phase|Other|0|||
143159817|NCT03636269|516129973|FG002|Period 2: Open-label Phase|Other|9|||
143159818|NCT03636269|516129971|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
143159819|NCT03636269|516129972|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
143159820|NCT03636269|516129973|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
143159821|NCT00493285|516129987|FG000|Overall Study|Lost to Follow-up|0|||
143159822|NCT00493285|516129988|FG001|Overall Study|Lost to Follow-up|0|||
143159823|NCT00493285|516129989|FG002|Overall Study|Lost to Follow-up|0|||
143159824|NCT00493285|516129990|FG003|Overall Study|Lost to Follow-up|0|||
143159825|NCT00493285|516129991|FG004|Overall Study|Lost to Follow-up|1|||
143159826|NCT00493285|516129992|FG005|Overall Study|Lost to Follow-up|0|||
143159827|NCT03021005|516129993|FG000|Overall Study|Lost to Follow-up|39|||
143159828|NCT03021005|516129994|FG001|Overall Study|Lost to Follow-up|26|||
143159829|NCT01975285|516129995|FG000|Overall Study|Failed Block and follow up|2|||
143159830|NCT01975285|516129996|FG001|Overall Study|Failed Block and follow up|2|||
143159831|NCT04535362|516129997|FG000|Overall Study|Lost to Follow-up|3|||
143159832|NCT04535362|516129998|FG001|Overall Study|Lost to Follow-up|1|||
143159833|NCT03791060|516129999|FG000|Overall Study|Withdrawal by Subject|1|||
143159834|NCT00337194|516130000|FG000|Overall Study|Adverse Event|5|||
143159835|NCT00337194|516130001|FG001|Overall Study|Adverse Event|1|||
143159836|NCT00337194|516130000|FG000|Overall Study|Death|2|||
143159837|NCT00337194|516130001|FG001|Overall Study|Death|0|||
143159838|NCT00337194|516130000|FG000|Overall Study|Withdrawal by Subject|1|||
143159839|NCT00337194|516130001|FG001|Overall Study|Withdrawal by Subject|0|||
143159840|NCT00337194|516130000|FG000|Overall Study|Disease progression|1|||
143159841|NCT00337194|516130001|FG001|Overall Study|Disease progression|2|||
143159842|NCT00337194|516130000|FG000|Overall Study|Subsequent non-protocol therapy|3|||
143159843|NCT00337194|516130001|FG001|Overall Study|Subsequent non-protocol therapy|1|||
143159844|NCT03188705|516130002|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
143159845|NCT03188705|516130002|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
143159846|NCT03774810|516130003|FG000|Phase 1|Lack of Efficacy|21|||
143159847|NCT03774810|516130004|FG001|Phase 1|Lack of Efficacy|0|||
143159848|NCT03774810|516130005|FG002|Phase 1|Lack of Efficacy|0|||
143238074|NCT01716234|516425652|FG000|Overall Study|Withdrawal by Subject|3|||
143238075|NCT01716234|516425653|FG001|Overall Study|Withdrawal by Subject|0|||
143238076|NCT01716234|516425654|FG002|Overall Study|Withdrawal by Subject|2|||
143494877|NCT01700192|517354419|FG000|Overall Study|Lost to Follow-up|42|||
143494878|NCT01700192|517354420|FG001|Overall Study|Lost to Follow-up|29|||
143494879|NCT01700192|517354419|FG000|Overall Study|Noncompliance with study drug|0|||
143159849|NCT03774810|516130006|FG003|Phase 1|Lack of Efficacy|0|||
143159850|NCT03774810|516130007|FG004|Phase 1|Lack of Efficacy|0|||
143159851|NCT03774810|516130003|FG000|Phase 1|Withdrawal by Subject|9|||
143494880|NCT01700192|517354420|FG001|Overall Study|Noncompliance with study drug|5|||
143159852|NCT03774810|516130004|FG001|Phase 1|Withdrawal by Subject|0|||
143159853|NCT03774810|516130005|FG002|Phase 1|Withdrawal by Subject|0|||
143159854|NCT03774810|516130006|FG003|Phase 1|Withdrawal by Subject|0|||
143159855|NCT03774810|516130007|FG004|Phase 1|Withdrawal by Subject|0|||
143159856|NCT03774810|516130003|FG000|Phase 1|Lost to Follow-up|2|||
143159857|NCT03774810|516130004|FG001|Phase 1|Lost to Follow-up|0|||
143159858|NCT03774810|516130005|FG002|Phase 1|Lost to Follow-up|0|||
143159859|NCT03774810|516130006|FG003|Phase 1|Lost to Follow-up|0|||
143238077|NCT01716234|516425655|FG003|Overall Study|Withdrawal by Subject|2|||
143032837|NCT05037097|515661378|FG007|Overall Study|Withdrawal by Subject|0|||
143032838|NCT05037097|515661371|FG000|Overall Study|Lost to Follow-up|0|||
143032839|NCT05037097|515661372|FG001|Overall Study|Lost to Follow-up|1|||
143032840|NCT05037097|515661373|FG002|Overall Study|Lost to Follow-up|0|||
143032841|NCT05037097|515661374|FG003|Overall Study|Lost to Follow-up|0|||
143032842|NCT05037097|515661375|FG004|Overall Study|Lost to Follow-up|1|||
143032843|NCT05037097|515661376|FG005|Overall Study|Lost to Follow-up|1|||
143032844|NCT05037097|515661377|FG006|Overall Study|Lost to Follow-up|0|||
143494881|NCT01700192|517354419|FG000|Overall Study|Physician Decision|2|||
143494882|NCT01700192|517354420|FG001|Overall Study|Physician Decision|3|||
143494883|NCT01700192|517354419|FG000|Overall Study|Pregnancy|1|||
143494884|NCT01700192|517354420|FG001|Overall Study|Pregnancy|4|||
143494885|NCT01700192|517354419|FG000|Overall Study|Progressive disease|1|||
143494886|NCT01700192|517354420|FG001|Overall Study|Progressive disease|0|||
143159860|NCT03774810|516130007|FG004|Phase 1|Lost to Follow-up|0|||
143159861|NCT03774810|516130003|FG000|Phase 2 (3 Months)|Lack of Efficacy|0|||
143159862|NCT03774810|516130004|FG001|Phase 2 (3 Months)|Lack of Efficacy|3|||
143159863|NCT03774810|516130005|FG002|Phase 2 (3 Months)|Lack of Efficacy|2|||
143159864|NCT03774810|516130006|FG003|Phase 2 (3 Months)|Lack of Efficacy|3|||
143159865|NCT03774810|516130007|FG004|Phase 2 (3 Months)|Lack of Efficacy|1|||
143159866|NCT03774810|516130003|FG000|Phase 2 (3 Months)|Withdrawal by Subject|0|||
143159867|NCT03774810|516130004|FG001|Phase 2 (3 Months)|Withdrawal by Subject|5|||
143159868|NCT03774810|516130005|FG002|Phase 2 (3 Months)|Withdrawal by Subject|2|||
143159869|NCT03774810|516130006|FG003|Phase 2 (3 Months)|Withdrawal by Subject|3|||
143159870|NCT03774810|516130007|FG004|Phase 2 (3 Months)|Withdrawal by Subject|1|||
143159871|NCT03774810|516130003|FG000|Phase 2 (3 Months)|Lost to Follow-up|0|||
143159872|NCT03774810|516130004|FG001|Phase 2 (3 Months)|Lost to Follow-up|1|||
143159873|NCT03774810|516130005|FG002|Phase 2 (3 Months)|Lost to Follow-up|0|||
143159874|NCT03774810|516130006|FG003|Phase 2 (3 Months)|Lost to Follow-up|0|||
143159875|NCT03774810|516130007|FG004|Phase 2 (3 Months)|Lost to Follow-up|0|||
143159876|NCT03774810|516130003|FG000|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|0|||
143159877|NCT03774810|516130004|FG001|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|3|||
143159878|NCT03774810|516130005|FG002|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
143159879|NCT03774810|516130006|FG003|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|1|||
143159880|NCT03774810|516130007|FG004|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
143159881|NCT03774810|516130003|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|0|||
143159882|NCT03774810|516130004|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|1|||
143159883|NCT03774810|516130005|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|3|||
143159884|NCT03774810|516130006|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|5|||
143159885|NCT03774810|516130007|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|2|||
143159886|NCT03774810|516130003|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
143159887|NCT03774810|516130004|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
143159888|NCT03774810|516130005|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
143159889|NCT03774810|516130006|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|1|||
143159890|NCT03774810|516130007|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|2|||
143159891|NCT01174459|516130011|FG000|Overall Study|case report form (CRF) not collected|5|||
143159892|NCT03757715|516130015|FG000|Overall Study|Lost to Follow-up|4|||
143159893|NCT03757715|516130016|FG001|Overall Study|Lost to Follow-up|9|||
143159894|NCT03757715|516130015|FG000|Overall Study|Withdrawal by Subject|1|||
143159895|NCT03757715|516130016|FG001|Overall Study|Withdrawal by Subject|1|||
143159896|NCT03302936|516130017|FG000|Overall Study|Protocol Violation|3|||
143159897|NCT03302936|516130018|FG001|Overall Study|Protocol Violation|4|||
143159898|NCT03016403|516130023|FG000|Baseline|Death|5|||
143159899|NCT03016403|516130024|FG001|Baseline|Death|8|||
143159900|NCT03016403|516130025|FG002|Baseline|Death|1|||
143159901|NCT03016403|516130026|FG003|Baseline|Death|0|||
143159902|NCT03016403|516130023|FG000|Baseline|Withdrawal by Subject|2|||
143159903|NCT03016403|516130024|FG001|Baseline|Withdrawal by Subject|8|||
143159904|NCT03016403|516130025|FG002|Baseline|Withdrawal by Subject|4|||
143159905|NCT03016403|516130026|FG003|Baseline|Withdrawal by Subject|10|||
143159906|NCT03016403|516130023|FG000|Baseline|Lost to Follow-up|9|||
143159907|NCT03016403|516130024|FG001|Baseline|Lost to Follow-up|11|||
143032845|NCT05037097|515661378|FG007|Overall Study|Lost to Follow-up|0|||
143159908|NCT03016403|516130025|FG002|Baseline|Lost to Follow-up|6|||
143159909|NCT03016403|516130026|FG003|Baseline|Lost to Follow-up|24|||
143159910|NCT03016403|516130023|FG000|6-week Follow-up|Death|1|||
143494887|NCT01700192|517354419|FG000|Overall Study|Protocol Violation|3|||
143494888|NCT01700192|517354420|FG001|Overall Study|Protocol Violation|4|||
143032846|NCT02322047|515661379|FG000|Overall Study|Physician Decision|1|||
143159911|NCT03016403|516130024|FG001|6-week Follow-up|Death|4|||
143159912|NCT03016403|516130025|FG002|6-week Follow-up|Death|0|||
143159913|NCT03016403|516130026|FG003|6-week Follow-up|Death|0|||
143159914|NCT03016403|516130023|FG000|6-week Follow-up|Lost to Follow-up|2|||
143159915|NCT03016403|516130024|FG001|6-week Follow-up|Lost to Follow-up|7|||
143159916|NCT03016403|516130025|FG002|6-week Follow-up|Lost to Follow-up|4|||
143159917|NCT03016403|516130026|FG003|6-week Follow-up|Lost to Follow-up|8|||
143494889|NCT01700192|517354419|FG000|Overall Study|Technical problems|0|||
143159918|NCT03016403|516130023|FG000|6-week Follow-up|Withdrawal by Subject|0|||
143159919|NCT03016403|516130024|FG001|6-week Follow-up|Withdrawal by Subject|2|||
143159920|NCT03016403|516130025|FG002|6-week Follow-up|Withdrawal by Subject|0|||
143159921|NCT03016403|516130026|FG003|6-week Follow-up|Withdrawal by Subject|1|||
143159922|NCT03016403|516130023|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
143159923|NCT03016403|516130024|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
143159924|NCT03016403|516130025|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
143159925|NCT03016403|516130026|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
143159926|NCT03016403|516130023|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
143159927|NCT03016403|516130024|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
143159928|NCT03016403|516130025|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
143159929|NCT03016403|516130026|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
143159930|NCT03016403|516130023|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
143159931|NCT03016403|516130024|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
143159932|NCT03016403|516130025|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
143159933|NCT03016403|516130026|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
143159934|NCT05463705|516130027|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
143159935|NCT05463705|516130028|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
143159936|NCT05463705|516130029|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
143159937|NCT05463705|516130030|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
143159938|NCT05463705|516130031|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
143159939|NCT05463705|516130032|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
143159940|NCT00576407|516130033|FG000|Overall Study|Death|7|||
143159941|NCT00576407|516130033|FG000|Overall Study|Physician Decision|1|||
143159942|NCT03142334|516130034|FG000|Overall Study|Death|18|||
143159943|NCT03142334|516130035|FG001|Overall Study|Death|33|||
143159944|NCT03142334|516130034|FG000|Overall Study|Withdrawal by Subject|15|||
143159945|NCT03142334|516130035|FG001|Overall Study|Withdrawal by Subject|11|||
143159946|NCT03142334|516130034|FG000|Overall Study|Ongoing on trial follow up|463|||
143159947|NCT03142334|516130035|FG001|Overall Study|Ongoing on trial follow up|454|||
143159948|NCT03071965|516130036|FG000|Overall Study|Adverse Event|0|||
143159949|NCT03071965|516130037|FG001|Overall Study|Adverse Event|0|||
143159950|NCT03071965|516130038|FG002|Overall Study|Adverse Event|1|||
143159951|NCT03071965|516130039|FG003|Overall Study|Adverse Event|0|||
143159952|NCT03071965|516130036|FG000|Overall Study|Death|0|||
143159953|NCT03071965|516130037|FG001|Overall Study|Death|0|||
143159954|NCT03071965|516130038|FG002|Overall Study|Death|1|||
143159955|NCT03071965|516130039|FG003|Overall Study|Death|1|||
143159956|NCT03071965|516130036|FG000|Overall Study|COVID-19|0|||
143364044|NCT00293462|516875525|FG000|Overall Study|Went back to his home country|0|||
143364045|NCT00293462|516875526|FG001|Overall Study|Went back to his home country|0|||
143364046|NCT00293462|516875527|FG002|Overall Study|Went back to his home country|1|||
143364047|NCT00293462|516875525|FG000|Overall Study|Blood clot after chemotherapy|0|||
143364048|NCT00293462|516875526|FG001|Overall Study|Blood clot after chemotherapy|0|||
143364049|NCT00293462|516875527|FG002|Overall Study|Blood clot after chemotherapy|1|||
143364050|NCT00293462|516875525|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
143364051|NCT00293462|516875526|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
143364052|NCT00293462|516875527|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
143364053|NCT00293462|516875525|FG000|Overall Study|Possible Tracheostomy leakage|0|||
143364054|NCT00293462|516875526|FG001|Overall Study|Possible Tracheostomy leakage|1|||
143364055|NCT00293462|516875527|FG002|Overall Study|Possible Tracheostomy leakage|0|||
143364056|NCT00293462|516875525|FG000|Overall Study|Low radiation dose in oral cavity|0|||
143364057|NCT00293462|516875526|FG001|Overall Study|Low radiation dose in oral cavity|1|||
143364058|NCT00293462|516875527|FG002|Overall Study|Low radiation dose in oral cavity|0|||
143364059|NCT00293462|516875525|FG000|Overall Study|Physician Decision|0|||
143364060|NCT00293462|516875526|FG001|Overall Study|Physician Decision|1|||
143364061|NCT00293462|516875527|FG002|Overall Study|Physician Decision|0|||
143364062|NCT03283553|516875528|FG000|Patient Participant Flow|Death|5|||
143364063|NCT03283553|516875529|FG001|Patient Participant Flow|Death|10|||
143364064|NCT03283553|516875528|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
143364065|NCT03283553|516875529|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
143494890|NCT01700192|517354420|FG001|Overall Study|Technical problems|1|||
143032847|NCT02322047|515661380|FG001|Overall Study|Physician Decision|0|||
143494891|NCT01700192|517354419|FG000|Overall Study|Withdrawal by Subject|56|||
143032848|NCT02322047|515661381|FG002|Overall Study|Physician Decision|0|||
143032849|NCT02322047|515661382|FG003|Overall Study|Physician Decision|0|||
143159957|NCT03071965|516130037|FG001|Overall Study|COVID-19|1|||
143159958|NCT03071965|516130038|FG002|Overall Study|COVID-19|0|||
143159959|NCT03071965|516130039|FG003|Overall Study|COVID-19|1|||
143159960|NCT03071965|516130036|FG000|Overall Study|Other Health Reason|0|||
143159961|NCT03071965|516130037|FG001|Overall Study|Other Health Reason|0|||
143159962|NCT03071965|516130038|FG002|Overall Study|Other Health Reason|0|||
143238078|NCT01716234|516425656|FG004|Overall Study|Withdrawal by Subject|1|||
143238079|NCT01716234|516425657|FG005|Overall Study|Withdrawal by Subject|3|||
143238080|NCT01716234|516425658|FG006|Overall Study|Withdrawal by Subject|0|||
143238081|NCT00474812|516425659|FG000|Overall Study|Withdrawal by Subject|5|||
143238082|NCT00474812|516425659|FG000|Overall Study|No Initiation of treatment|2|||
143238083|NCT05408429|516425662|FG000|Overall Study|Lost to Follow-up|1|||
143238084|NCT05408429|516425663|FG001|Overall Study|Lost to Follow-up|1|||
143238085|NCT05408429|516425664|FG002|Overall Study|Lost to Follow-up|0|||
143238086|NCT05408429|516425662|FG000|Overall Study|Withdrawal by Subject|5|||
143238087|NCT05408429|516425663|FG001|Overall Study|Withdrawal by Subject|0|||
143238088|NCT05408429|516425664|FG002|Overall Study|Withdrawal by Subject|1|||
143238089|NCT03435211|516425665|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
143238090|NCT02195518|516425666|FG000|Overall Study|Adverse Event|1|||
143238091|NCT02195518|516425666|FG000|Overall Study|Protocol Violation|4|||
143238092|NCT02195518|516425666|FG000|Overall Study|Pregnancy|2|||
143238093|NCT02195518|516425666|FG000|Overall Study|Withdrawal by Subject|1|||
143238094|NCT02195518|516425666|FG000|Overall Study|Lost to Follow-up|1|||
143494892|NCT01700192|517354420|FG001|Overall Study|Withdrawal by Subject|64|||
143494893|NCT01700192|517354419|FG000|Overall Study|Never received study drug|1|||
143494894|NCT01700192|517354420|FG001|Overall Study|Never received study drug|0|||
143238095|NCT03818256|516425667|FG000|Overall Study|Withdrawal by Subject|2|||
143238096|NCT03818256|516425668|FG001|Overall Study|Withdrawal by Subject|2|||
143238097|NCT03818256|516425667|FG000|Overall Study|Adverse Event|3|||
143494895|NCT00379795|517354427|FG000|Overall Study|Death|31|||
143494896|NCT00379795|517354428|FG001|Overall Study|Death|8|||
143494897|NCT00379795|517354429|FG002|Overall Study|Death|6|||
143494898|NCT00379795|517354430|FG003|Overall Study|Death|4|||
143494899|NCT00379795|517354431|FG004|Overall Study|Death|7|||
143494900|NCT00379795|517354427|FG000|Overall Study|Adverse Event|17|||
143494901|NCT00379795|517354428|FG001|Overall Study|Adverse Event|3|||
143494902|NCT00379795|517354429|FG002|Overall Study|Adverse Event|3|||
143494903|NCT00379795|517354430|FG003|Overall Study|Adverse Event|1|||
143494904|NCT00379795|517354431|FG004|Overall Study|Adverse Event|4|||
143494905|NCT00379795|517354427|FG000|Overall Study|Lost to Follow-up|8|||
143494906|NCT00379795|517354428|FG001|Overall Study|Lost to Follow-up|1|||
143494907|NCT00379795|517354429|FG002|Overall Study|Lost to Follow-up|2|||
143494908|NCT00379795|517354430|FG003|Overall Study|Lost to Follow-up|1|||
143494909|NCT00379795|517354431|FG004|Overall Study|Lost to Follow-up|4|||
143494910|NCT00379795|517354427|FG000|Overall Study|Physician Decision|25|||
143494911|NCT00379795|517354428|FG001|Overall Study|Physician Decision|0|||
143494912|NCT00379795|517354429|FG002|Overall Study|Physician Decision|2|||
143494913|NCT00379795|517354430|FG003|Overall Study|Physician Decision|2|||
143494914|NCT00379795|517354431|FG004|Overall Study|Physician Decision|2|||
143494915|NCT00379795|517354427|FG000|Overall Study|Withdrawal by Subject|94|||
143494916|NCT00379795|517354428|FG001|Overall Study|Withdrawal by Subject|11|||
143494917|NCT00379795|517354429|FG002|Overall Study|Withdrawal by Subject|19|||
143494918|NCT00379795|517354430|FG003|Overall Study|Withdrawal by Subject|7|||
143494919|NCT00379795|517354431|FG004|Overall Study|Withdrawal by Subject|14|||
143494920|NCT00379795|517354427|FG000|Overall Study|Subject non-compliance|7|||
143494921|NCT00379795|517354428|FG001|Overall Study|Subject non-compliance|2|||
143494922|NCT00379795|517354429|FG002|Overall Study|Subject non-compliance|0|||
143494923|NCT00379795|517354430|FG003|Overall Study|Subject non-compliance|0|||
143494924|NCT00379795|517354431|FG004|Overall Study|Subject non-compliance|1|||
143494925|NCT00379795|517354427|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
143494926|NCT00379795|517354428|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
143494927|NCT00379795|517354429|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
143494928|NCT00379795|517354430|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
143494929|NCT00379795|517354431|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
143494930|NCT00379795|517354427|FG000|Overall Study|Subjects condition mandated intervention|34|||
143494931|NCT00379795|517354428|FG001|Overall Study|Subjects condition mandated intervention|9|||
143238098|NCT03818256|516425668|FG001|Overall Study|Adverse Event|1|||
143494932|NCT00379795|517354429|FG002|Overall Study|Subjects condition mandated intervention|7|||
143494933|NCT00379795|517354430|FG003|Overall Study|Subjects condition mandated intervention|5|||
143494934|NCT00379795|517354431|FG004|Overall Study|Subjects condition mandated intervention|7|||
143494935|NCT00379795|517354427|FG000|Overall Study|Sponsor's decision|257|||
143494936|NCT00379795|517354428|FG001|Overall Study|Sponsor's decision|17|||
143494937|NCT00379795|517354429|FG002|Overall Study|Sponsor's decision|54|||
143494938|NCT00379795|517354430|FG003|Overall Study|Sponsor's decision|47|||
143494939|NCT00379795|517354431|FG004|Overall Study|Sponsor's decision|10|||
143238099|NCT03818256|516425667|FG000|Overall Study|Lost to Follow-up|0|||
143494940|NCT01127165|517354432|FG000|Overall Study|Adverse Event|2|||
143494941|NCT01127165|517354433|FG001|Overall Study|Adverse Event|2|||
143238100|NCT03818256|516425668|FG001|Overall Study|Lost to Follow-up|5|||
143238101|NCT03818256|516425667|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
143238102|NCT03818256|516425668|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
143494942|NCT01127165|517354432|FG000|Overall Study|Lack of Efficacy|10|||
143494943|NCT01127165|517354433|FG001|Overall Study|Lack of Efficacy|8|||
143494944|NCT01127165|517354432|FG000|Overall Study|Lost to Follow-up|3|||
143494945|NCT01127165|517354433|FG001|Overall Study|Lost to Follow-up|5|||
143494946|NCT01127165|517354432|FG000|Overall Study|Withdrawal by Subject|1|||
143494947|NCT01127165|517354433|FG001|Overall Study|Withdrawal by Subject|3|||
143494948|NCT01127165|517354432|FG000|Overall Study|Protocol Violation|0|||
143494949|NCT01127165|517354433|FG001|Overall Study|Protocol Violation|1|||
143494950|NCT03175549|517354434|FG000|Overall Study|Lost to Follow-up|2|||
143494951|NCT03175549|517354435|FG001|Overall Study|Lost to Follow-up|2|||
143494952|NCT03175549|517354434|FG000|Overall Study|Medication non-compliance|2|||
143494953|NCT03175549|517354435|FG001|Overall Study|Medication non-compliance|2|||
143494954|NCT02435849|517354436|FG000|Overall Study|Death|23|||
143494955|NCT02435849|517354437|FG001|Overall Study|Death|0|||
143494956|NCT02435849|517354436|FG000|Overall Study|Lack of Efficacy|10|||
143494957|NCT02435849|517354437|FG001|Overall Study|Lack of Efficacy|0|||
143494958|NCT02435849|517354436|FG000|Overall Study|New therapy for study indication|8|||
143494959|NCT02435849|517354437|FG001|Overall Study|New therapy for study indication|0|||
143494960|NCT02435849|517354436|FG000|Overall Study|Subject/guardian decision|5|||
143494961|NCT02435849|517354437|FG001|Overall Study|Subject/guardian decision|1|||
143494962|NCT02435849|517354436|FG000|Overall Study|Lost to Follow-up|1|||
143494963|NCT02435849|517354437|FG001|Overall Study|Lost to Follow-up|0|||
143494964|NCT02435849|517354436|FG000|Overall Study|Physician Decision|1|||
143494965|NCT02435849|517354437|FG001|Overall Study|Physician Decision|0|||
143494966|NCT00763321|517354438|FG000|Open-label Period|Adverse Event|24|||
143494967|NCT00763321|517354439|FG001|Open-label Period|Adverse Event|0|||
143494968|NCT00763321|517354440|FG002|Open-label Period|Adverse Event|0|||
143494969|NCT00763321|517354438|FG000|Open-label Period|Lost to Follow-up|14|||
143494970|NCT00763321|517354439|FG001|Open-label Period|Lost to Follow-up|0|||
143494971|NCT00763321|517354440|FG002|Open-label Period|Lost to Follow-up|0|||
143494972|NCT00763321|517354438|FG000|Open-label Period|Withdrawal by Subject|7|||
143494973|NCT00763321|517354439|FG001|Open-label Period|Withdrawal by Subject|0|||
143494974|NCT00763321|517354440|FG002|Open-label Period|Withdrawal by Subject|0|||
143032850|NCT02322047|515661379|FG000|Overall Study|Withdrawal by Subject|1|||
143032851|NCT02322047|515661380|FG001|Overall Study|Withdrawal by Subject|0|||
143032852|NCT02322047|515661381|FG002|Overall Study|Withdrawal by Subject|0|||
143032853|NCT02322047|515661382|FG003|Overall Study|Withdrawal by Subject|1|||
143032854|NCT02322047|515661379|FG000|Overall Study|Adverse Event|0|||
143032855|NCT02322047|515661380|FG001|Overall Study|Adverse Event|1|||
143032856|NCT02322047|515661381|FG002|Overall Study|Adverse Event|0|||
143032857|NCT02322047|515661382|FG003|Overall Study|Adverse Event|0|||
143032858|NCT02322047|515661379|FG000|Overall Study|Lost to Follow-up|0|||
143032859|NCT02322047|515661380|FG001|Overall Study|Lost to Follow-up|0|||
143032860|NCT02322047|515661381|FG002|Overall Study|Lost to Follow-up|1|||
143032861|NCT02322047|515661382|FG003|Overall Study|Lost to Follow-up|1|||
143032862|NCT00376220|515661387|FG000|Overall Study|Lost to Follow-up|7|||
143032863|NCT00376220|515661388|FG001|Overall Study|Lost to Follow-up|10|||
143032864|NCT00376220|515661387|FG000|Overall Study|Withdrawal by Subject|3|||
143032865|NCT00376220|515661388|FG001|Overall Study|Withdrawal by Subject|2|||
143032866|NCT03311646|515661391|FG000|Overall Study|Physician Decision|1|||
143032867|NCT03311646|515661391|FG000|Overall Study|Withdrawal by Subject|5|||
143032868|NCT03311646|515661391|FG000|Overall Study|Lost to Follow-up|5|||
143032869|NCT03311646|515661391|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
143032870|NCT00531206|515661392|FG000|Overall Study|Adverse Event related|5|||
143032871|NCT00531206|515661392|FG000|Overall Study|Lack of Efficacy|2|||
143032872|NCT00531206|515661392|FG000|Overall Study|Lost to Follow-up|5|||
143032873|NCT00531206|515661392|FG000|Overall Study|including non-related adverse events|8|||
143032874|NCT00920140|515661393|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
143032875|NCT00920140|515661394|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
143032876|NCT00920140|515661395|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
143032877|NCT00920140|515661396|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
143032878|NCT00920140|515661397|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
143494975|NCT00763321|517354438|FG000|Open-label Period|Subject noncompliant|7|||
143494976|NCT00763321|517354439|FG001|Open-label Period|Subject noncompliant|0|||
143032879|NCT00920140|515661393|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
143159963|NCT03071965|516130039|FG003|Overall Study|Other Health Reason|1|||
143494977|NCT00763321|517354440|FG002|Open-label Period|Subject noncompliant|0|||
143494978|NCT00763321|517354438|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
143494979|NCT00763321|517354439|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
143032880|NCT00920140|515661394|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
143032881|NCT00920140|515661395|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
143032882|NCT00920140|515661396|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
143032883|NCT00920140|515661397|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
143032884|NCT00920140|515661393|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
143032885|NCT00920140|515661394|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
143159964|NCT01655069|516130040|FG000|Overall Study|Physician Decision|0|||
143494980|NCT00763321|517354440|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
143032886|NCT00920140|515661395|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
143494981|NCT00763321|517354438|FG000|Open-label Period|Lack of Efficacy|2|||
143032887|NCT00920140|515661396|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
143032888|NCT00920140|515661397|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
143032889|NCT00920140|515661393|FG000|Phase 2|Adverse Event|0|||
143032890|NCT00920140|515661394|FG001|Phase 2|Adverse Event|0|||
143032891|NCT00920140|515661395|FG002|Phase 2|Adverse Event|14|||
143494982|NCT00763321|517354439|FG001|Open-label Period|Lack of Efficacy|0|||
143494983|NCT00763321|517354440|FG002|Open-label Period|Lack of Efficacy|0|||
143494984|NCT00763321|517354438|FG000|Open-label Period|Other|4|||
143494985|NCT00763321|517354439|FG001|Open-label Period|Other|0|||
143494986|NCT00763321|517354440|FG002|Open-label Period|Other|0|||
143494987|NCT00763321|517354438|FG000|Double-blind Period|Lack of Efficacy|0|||
143494988|NCT00763321|517354439|FG001|Double-blind Period|Lack of Efficacy|9|||
143494989|NCT00763321|517354440|FG002|Double-blind Period|Lack of Efficacy|17|||
143494990|NCT00763321|517354438|FG000|Double-blind Period|Adverse Event|0|||
143494991|NCT00763321|517354439|FG001|Double-blind Period|Adverse Event|4|||
143494992|NCT00763321|517354440|FG002|Double-blind Period|Adverse Event|4|||
143494993|NCT00763321|517354438|FG000|Double-blind Period|Lost to Follow-up|0|||
143494994|NCT00763321|517354439|FG001|Double-blind Period|Lost to Follow-up|4|||
143494995|NCT00763321|517354440|FG002|Double-blind Period|Lost to Follow-up|2|||
143032892|NCT00920140|515661396|FG003|Phase 2|Adverse Event|2|||
143032893|NCT00920140|515661397|FG004|Phase 2|Adverse Event|3|||
143032894|NCT00920140|515661393|FG000|Phase 2|Lack of Efficacy|0|||
143032895|NCT00920140|515661394|FG001|Phase 2|Lack of Efficacy|0|||
143032896|NCT00920140|515661395|FG002|Phase 2|Lack of Efficacy|29|||
143032897|NCT00920140|515661396|FG003|Phase 2|Lack of Efficacy|14|||
143032898|NCT00920140|515661397|FG004|Phase 2|Lack of Efficacy|5|||
143032899|NCT00920140|515661393|FG000|Phase 2|Lost to Follow-up|0|||
143032900|NCT00920140|515661394|FG001|Phase 2|Lost to Follow-up|0|||
143032901|NCT00920140|515661395|FG002|Phase 2|Lost to Follow-up|0|||
143032902|NCT00920140|515661396|FG003|Phase 2|Lost to Follow-up|1|||
143032903|NCT00920140|515661397|FG004|Phase 2|Lost to Follow-up|0|||
143032904|NCT00920140|515661393|FG000|Phase 2|Physician Decision|0|||
143032905|NCT00920140|515661394|FG001|Phase 2|Physician Decision|0|||
143032906|NCT00920140|515661395|FG002|Phase 2|Physician Decision|3|||
143032907|NCT00920140|515661396|FG003|Phase 2|Physician Decision|3|||
143032908|NCT00920140|515661397|FG004|Phase 2|Physician Decision|2|||
143032909|NCT00920140|515661393|FG000|Phase 2|Withdrawal by Subject|0|||
143032910|NCT00920140|515661394|FG001|Phase 2|Withdrawal by Subject|0|||
143494996|NCT00763321|517354438|FG000|Double-blind Period|Withdrawal by Subject|0|||
143494997|NCT00763321|517354439|FG001|Double-blind Period|Withdrawal by Subject|2|||
143494998|NCT00763321|517354440|FG002|Double-blind Period|Withdrawal by Subject|3|||
143494999|NCT00763321|517354438|FG000|Double-blind Period|Other|0|||
143495000|NCT00763321|517354439|FG001|Double-blind Period|Other|2|||
143495001|NCT00763321|517354440|FG002|Double-blind Period|Other|3|||
143495002|NCT02486757|517354441|FG000|Overall Study|Lost to Follow-up|1|||
143495003|NCT01017952|517354442|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
143495004|NCT01017952|517354443|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
143495005|NCT01017952|517354444|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
143495006|NCT01017952|517354445|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
143495007|NCT01017952|517354446|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
143495008|NCT01017952|517354442|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
143495009|NCT01017952|517354443|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
143495010|NCT01017952|517354444|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
143495011|NCT01017952|517354445|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
143032911|NCT00920140|515661395|FG002|Phase 2|Withdrawal by Subject|4|||
143159965|NCT01655069|516130041|FG001|Overall Study|Physician Decision|0|||
143159966|NCT01655069|516130042|FG002|Overall Study|Physician Decision|0|||
143159967|NCT01655069|516130043|FG003|Overall Study|Physician Decision|1|||
143159968|NCT01655069|516130040|FG000|Overall Study|Adverse Event|6|||
143159969|NCT01655069|516130041|FG001|Overall Study|Adverse Event|7|||
143159970|NCT01655069|516130042|FG002|Overall Study|Adverse Event|2|||
143159971|NCT01655069|516130043|FG003|Overall Study|Adverse Event|3|||
143159972|NCT01655069|516130040|FG000|Overall Study|Lack of Efficacy|0|||
143495012|NCT01017952|517354446|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
143032912|NCT00920140|515661396|FG003|Phase 2|Withdrawal by Subject|2|||
143032913|NCT00920140|515661397|FG004|Phase 2|Withdrawal by Subject|1|||
143159973|NCT01655069|516130041|FG001|Overall Study|Lack of Efficacy|1|||
143495013|NCT01017952|517354442|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
143495014|NCT01017952|517354443|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
143032914|NCT00728949|515661401|FG000|Overall Study|Adverse Event|8|||
143032915|NCT00728949|515661402|FG001|Overall Study|Adverse Event|0|||
143032916|NCT00728949|515661401|FG000|Overall Study|Withdrawal by Subject|2|||
143032917|NCT00728949|515661402|FG001|Overall Study|Withdrawal by Subject|2|||
143032918|NCT00728949|515661401|FG000|Overall Study|Abnormal Lab Results|0|||
143159974|NCT01655069|516130042|FG002|Overall Study|Lack of Efficacy|0|||
143159975|NCT01655069|516130043|FG003|Overall Study|Lack of Efficacy|0|||
143032919|NCT00728949|515661402|FG001|Overall Study|Abnormal Lab Results|2|||
143032920|NCT00728949|515661401|FG000|Overall Study|On treatment at cutoff date|1|||
143032921|NCT00728949|515661402|FG001|Overall Study|On treatment at cutoff date|0|||
143032922|NCT00755196|515661403|FG000|Overall Study|Lost to Follow-up|1|||
143032923|NCT00755196|515661403|FG000|Overall Study|Lack of Efficiency|1|||
143032924|NCT01604850|515661404|FG000|Overall Study|Enrolled but never treated|0|||
143032925|NCT01604850|515661405|FG001|Overall Study|Enrolled but never treated|1|||
143032926|NCT01604850|515661404|FG000|Overall Study|Efficacy Failure|50|||
143032927|NCT01604850|515661405|FG001|Overall Study|Efficacy Failure|29|||
143032928|NCT01604850|515661404|FG000|Overall Study|Lost to Follow-up|1|||
143032929|NCT01604850|515661405|FG001|Overall Study|Lost to Follow-up|0|||
143032930|NCT01604850|515661404|FG000|Overall Study|Subject withdrew consent|1|||
143032931|NCT01604850|515661405|FG001|Overall Study|Subject withdrew consent|0|||
143032932|NCT01703832|515661406|FG000|Overall Study|Withdrawal by Subject|1|||
143032933|NCT01703832|515661407|FG001|Overall Study|Withdrawal by Subject|0|||
143032934|NCT00243932|515661408|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
143032935|NCT00243932|515661409|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
143032936|NCT00243932|515661410|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
143032937|NCT00543309|515661411|FG000|Overall Study|Physician Decision|0|||
143032938|NCT00543309|515661412|FG001|Overall Study|Physician Decision|1|||
143032939|NCT00543309|515661413|FG002|Overall Study|Physician Decision|0|||
143032940|NCT01458405|515661420|FG000|Phase 1 (up to 12 Months)|Other|0|||
143159976|NCT01655069|516130040|FG000|Overall Study|No Treatment Needed|0|||
143159977|NCT01655069|516130041|FG001|Overall Study|No Treatment Needed|1|||
143159978|NCT01655069|516130042|FG002|Overall Study|No Treatment Needed|0|||
143159979|NCT01655069|516130043|FG003|Overall Study|No Treatment Needed|0|||
143159980|NCT01655069|516130040|FG000|Overall Study|Withdrawal by Subject|2|||
143159981|NCT01655069|516130041|FG001|Overall Study|Withdrawal by Subject|3|||
143159982|NCT01655069|516130042|FG002|Overall Study|Withdrawal by Subject|0|||
143159983|NCT01655069|516130043|FG003|Overall Study|Withdrawal by Subject|0|||
143159984|NCT02346370|516130044|FG000|Overall Study|Not treated|1|||
143159985|NCT02346370|516130045|FG001|Overall Study|Not treated|0|||
143159986|NCT02346370|516130046|FG002|Overall Study|Not treated|0|||
143159987|NCT02346370|516130044|FG000|Overall Study|Withdrawal of consent|1|||
143159988|NCT02346370|516130045|FG001|Overall Study|Withdrawal of consent|0|||
143159989|NCT02346370|516130046|FG002|Overall Study|Withdrawal of consent|0|||
143159990|NCT02346370|516130044|FG000|Overall Study|Death|1|||
143159991|NCT02346370|516130045|FG001|Overall Study|Death|3|||
143159992|NCT02346370|516130046|FG002|Overall Study|Death|1|||
143159993|NCT02346370|516130044|FG000|Overall Study|Sponsor discontinued study|5|||
143159994|NCT02346370|516130045|FG001|Overall Study|Sponsor discontinued study|0|||
143159995|NCT02346370|516130046|FG002|Overall Study|Sponsor discontinued study|2|||
143159996|NCT02346370|516130044|FG000|Overall Study|Radiologic progression|0|||
143159997|NCT02346370|516130045|FG001|Overall Study|Radiologic progression|0|||
143159998|NCT02346370|516130046|FG002|Overall Study|Radiologic progression|1|||
143159999|NCT02346370|516130044|FG000|Overall Study|Physician Decision|0|||
143160000|NCT02346370|516130045|FG001|Overall Study|Physician Decision|1|||
143160001|NCT02346370|516130046|FG002|Overall Study|Physician Decision|0|||
143160002|NCT01217047|516130047|FG000|Overall Study|Lost to Follow-up|0|||
143160003|NCT01217047|516130048|FG001|Overall Study|Lost to Follow-up|1|||
143160004|NCT01217047|516130049|FG002|Overall Study|Lost to Follow-up|0|||
143160005|NCT06399471|516130050|FG000|Overall Study|Withdrawal by Subject|1|||
143160006|NCT05529173|516130051|FG000|Overall Study|Physician Decision|3|||
143160007|NCT05529173|516130052|FG001|Overall Study|Physician Decision|6|||
143160008|NCT05529173|516130051|FG000|Overall Study|Sample shipment delay more than one day|4|||
143160009|NCT05529173|516130052|FG001|Overall Study|Sample shipment delay more than one day|0|||
143160010|NCT05587998|516130053|FG000|Overall Study|Withdrawal by Subject|1|||
143160011|NCT05587998|516130054|FG001|Overall Study|Withdrawal by Subject|1|||
143160012|NCT05587998|516130053|FG000|Overall Study|Not treated|3|||
143160013|NCT05587998|516130054|FG001|Overall Study|Not treated|1|||
143160014|NCT05587998|516130053|FG000|Overall Study|Non-compliance with study procedures|0|||
143160015|NCT05587998|516130054|FG001|Overall Study|Non-compliance with study procedures|1|||
143160016|NCT02453191|516130057|FG000|Overall Study|Withdrawal by Subject|1|||
143160017|NCT01520714|516130058|FG000|Overall Study|Protocol Violation|0|||
143238103|NCT03818256|516425667|FG000|Overall Study|Not reporting for scheduled visits|1|||
143032941|NCT01458405|515661421|FG001|Phase 1 (up to 12 Months)|Other|1|||
143032942|NCT01458405|515661422|FG002|Phase 1 (up to 12 Months)|Other|0|||
143032943|NCT01458405|515661423|FG003|Phase 1 (up to 12 Months)|Other|0|||
143032944|NCT01458405|515661420|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
143160018|NCT01520714|516130059|FG001|Overall Study|Protocol Violation|3|||
143160019|NCT01520714|516130058|FG000|Overall Study|Adverse Event|0|||
143160020|NCT01520714|516130059|FG001|Overall Study|Adverse Event|2|||
143160021|NCT01520714|516130058|FG000|Overall Study|Lack of Efficacy|0|||
143160022|NCT01520714|516130059|FG001|Overall Study|Lack of Efficacy|1|||
143160023|NCT00407030|516130060|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
143160024|NCT00407030|516130061|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
143160025|NCT00407030|516130062|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
143160026|NCT00407030|516130060|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
143238104|NCT03818256|516425668|FG001|Overall Study|Not reporting for scheduled visits|0|||
143238105|NCT03818256|516425667|FG000|Overall Study|Non-compliant with investigational product|1|||
143238106|NCT03818256|516425668|FG001|Overall Study|Non-compliant with investigational product|0|||
143238107|NCT01342211|516425669|FG000|Overall Study|Lost to Follow-up|0|||
143238108|NCT01342211|516425670|FG001|Overall Study|Lost to Follow-up|0|||
143238109|NCT01342211|516425671|FG002|Overall Study|Lost to Follow-up|0|||
143238110|NCT01342211|516425672|FG003|Overall Study|Lost to Follow-up|1|||
143495015|NCT01017952|517354444|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
143495016|NCT01017952|517354445|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
143495017|NCT01017952|517354446|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
143495018|NCT01017952|517354442|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
143495019|NCT01017952|517354443|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
143495020|NCT01017952|517354444|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
143495021|NCT01017952|517354445|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
143160027|NCT00407030|516130061|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
143160028|NCT00407030|516130062|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
143160029|NCT00407030|516130060|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
143160030|NCT00407030|516130061|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
143160031|NCT00407030|516130062|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
143160032|NCT00407030|516130060|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
143160033|NCT00407030|516130061|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
143160034|NCT00407030|516130062|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
143160035|NCT00407030|516130060|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
143160036|NCT00407030|516130061|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
143160037|NCT00407030|516130062|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
143160038|NCT00407030|516130060|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
143160039|NCT00407030|516130061|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
143160040|NCT00407030|516130062|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
143160041|NCT00407030|516130060|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
143160042|NCT00407030|516130061|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
143160043|NCT00407030|516130062|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
143160044|NCT00407030|516130060|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
143160045|NCT00407030|516130061|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
143160046|NCT00407030|516130062|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
143160047|NCT00407030|516130060|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
143160048|NCT00407030|516130061|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
143160049|NCT00407030|516130062|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
143160050|NCT00407030|516130060|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
143160051|NCT00407030|516130061|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
143160052|NCT00407030|516130062|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
143160053|NCT00407030|516130060|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
143160054|NCT00407030|516130061|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
143160055|NCT00407030|516130062|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
143160056|NCT00407030|516130060|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
143160057|NCT00407030|516130061|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
143160058|NCT00407030|516130062|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
143160059|NCT00407030|516130060|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
143160060|NCT00407030|516130061|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
143160061|NCT00407030|516130062|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
143160062|NCT01340170|516130063|FG000|Overall Study|Lost to Follow-up|2|||
143160063|NCT01340170|516130064|FG001|Overall Study|Lost to Follow-up|4|||
143160064|NCT01340170|516130065|FG002|Overall Study|Lost to Follow-up|0|||
143160065|NCT01340170|516130063|FG000|Overall Study|Implant failure|1|||
143160066|NCT01340170|516130064|FG001|Overall Study|Implant failure|3|||
143160067|NCT01340170|516130065|FG002|Overall Study|Implant failure|0|||
143160068|NCT03722030|516130066|FG000|Overall Study|Withdrawal by Subject|1|||
143160069|NCT03722030|516130067|FG001|Overall Study|Withdrawal by Subject|0|||
143160070|NCT03518203|516130070|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
143160071|NCT03518203|516130070|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
143160072|NCT00345592|516130071|FG000|Overall Study|Death|14|||
143160073|NCT00345592|516130072|FG001|Overall Study|Death|16|||
143238111|NCT01342211|516425673|FG004|Overall Study|Lost to Follow-up|0|||
143238112|NCT01342211|516425669|FG000|Overall Study|Adverse Event|0|||
143238113|NCT01342211|516425670|FG001|Overall Study|Adverse Event|0|||
143160074|NCT00345592|516130071|FG000|Overall Study|Withdrawal by Subject|11|||
143160075|NCT00345592|516130072|FG001|Overall Study|Withdrawal by Subject|8|||
143160076|NCT02006654|516130073|FG000|Overall Study|Withdrawal before treatment|4|||
143160077|NCT02006654|516130074|FG001|Overall Study|Withdrawal before treatment|2|||
143160078|NCT02006654|516130073|FG000|Overall Study|Adverse Event|16|||
143160079|NCT02006654|516130074|FG001|Overall Study|Adverse Event|17|||
143160080|NCT02006654|516130073|FG000|Overall Study|Death|1|||
143495022|NCT01017952|517354446|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
143495023|NCT01017952|517354442|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
143495024|NCT01017952|517354443|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
143160081|NCT02006654|516130074|FG001|Overall Study|Death|0|||
143160082|NCT02006654|516130073|FG000|Overall Study|Withdrawal by Subject|14|||
143160083|NCT02006654|516130074|FG001|Overall Study|Withdrawal by Subject|12|||
143160084|NCT02006654|516130073|FG000|Overall Study|Protocol Violation|5|||
143160085|NCT02006654|516130074|FG001|Overall Study|Protocol Violation|8|||
143160086|NCT02006654|516130073|FG000|Overall Study|Lost to Follow-up|1|||
143160087|NCT02006654|516130074|FG001|Overall Study|Lost to Follow-up|0|||
143160088|NCT02006654|516130073|FG000|Overall Study|patient's will|2|||
143160089|NCT02006654|516130074|FG001|Overall Study|patient's will|1|||
143160090|NCT02006654|516130073|FG000|Overall Study|insufficient compliance|1|||
143160091|NCT02006654|516130074|FG001|Overall Study|insufficient compliance|0|||
143160092|NCT02006654|516130073|FG000|Overall Study|worsening cognitive condition|0|||
143160093|NCT02006654|516130074|FG001|Overall Study|worsening cognitive condition|1|||
143160094|NCT02006654|516130073|FG000|Overall Study|faecal incontinence|0|||
143160095|NCT02006654|516130074|FG001|Overall Study|faecal incontinence|1|||
143160096|NCT02006654|516130073|FG000|Overall Study|mood disorder|0|||
143160097|NCT02006654|516130074|FG001|Overall Study|mood disorder|1|||
143160098|NCT02006654|516130073|FG000|Overall Study|disallowed medication|1|||
143160099|NCT02006654|516130074|FG001|Overall Study|disallowed medication|0|||
143160100|NCT02006654|516130073|FG000|Overall Study|moving out of state|0|||
143160101|NCT02006654|516130074|FG001|Overall Study|moving out of state|1|||
143160102|NCT02366130|516130075|FG000|Overall Study|Withdrawal by Subject|3|||
143160103|NCT02366130|516130075|FG000|Overall Study|Ineligible|6|||
143160104|NCT01016015|516130076|FG000|Overall Study|Not Treated|3|||
143160105|NCT01016015|516130076|FG000|Overall Study|Withdrawal by Subject|1|||
143160106|NCT01016015|516130076|FG000|Overall Study|Adverse Event|15|||
143160107|NCT05661734|516130077|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
143160108|NCT05661734|516130077|FG000|Overall Study|Lost to Follow-up|13|||
143160109|NCT05661734|516130077|FG000|Overall Study|Enrolled but not dosed|2|||
143160110|NCT00362609|516130078|FG000|Overall Study|Withdrawal by Subject|0|||
143160111|NCT00362609|516130079|FG001|Overall Study|Withdrawal by Subject|1|||
143160112|NCT00362609|516130078|FG000|Overall Study|Protocol Violation|0|||
143160113|NCT00362609|516130079|FG001|Overall Study|Protocol Violation|1|||
143160114|NCT01800058|516130080|FG000|Overall Study|Lost to Follow-up|1|||
143160115|NCT02946996|516130081|FG000|Overall Study|non-evaluable|3|||
143160116|NCT02946996|516130082|FG001|Overall Study|non-evaluable|6|||
143160117|NCT02946996|516130083|FG002|Overall Study|non-evaluable|5|||
143160118|NCT01245049|516130085|FG000|Overall Study|Migrated/moved from study area|0|||
143160119|NCT01245049|516130086|FG001|Overall Study|Migrated/moved from study area|1|||
143160120|NCT01245049|516130085|FG000|Overall Study|Withdrawal by Subject|0|||
143160121|NCT01245049|516130086|FG001|Overall Study|Withdrawal by Subject|1|||
143160122|NCT01245049|516130085|FG000|Overall Study|Lost to Follow-up|1|||
143160123|NCT01245049|516130086|FG001|Overall Study|Lost to Follow-up|2|||
143160124|NCT00450749|516130087|FG000|Overall Study|Withdrawal by Subject|0|||
143160125|NCT00450749|516130088|FG001|Overall Study|Withdrawal by Subject|0|||
143160126|NCT00450749|516130089|FG002|Overall Study|Withdrawal by Subject|2|||
143160127|NCT00450749|516130087|FG000|Overall Study|Noncompliant|0|||
143160128|NCT00450749|516130088|FG001|Overall Study|Noncompliant|1|||
143160129|NCT00450749|516130089|FG002|Overall Study|Noncompliant|0|||
143160130|NCT04495478|516130090|FG000|Overall Study|Withdrawal by Subject|0|||
143160131|NCT04495478|516130091|FG001|Overall Study|Withdrawal by Subject|0|||
143160132|NCT04495478|516130092|FG002|Overall Study|Withdrawal by Subject|0|||
143160133|NCT04495478|516130093|FG003|Overall Study|Withdrawal by Subject|1|||
143160134|NCT04495478|516130094|FG004|Overall Study|Withdrawal by Subject|0|||
143160135|NCT04495478|516130095|FG005|Overall Study|Withdrawal by Subject|0|||
143160136|NCT04495478|516130096|FG006|Overall Study|Withdrawal by Subject|0|||
143160137|NCT04495478|516130090|FG000|Overall Study|Physician Decision|0|||
143160138|NCT04495478|516130091|FG001|Overall Study|Physician Decision|1|||
143160139|NCT04495478|516130092|FG002|Overall Study|Physician Decision|0|||
143495025|NCT01017952|517354444|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
143495026|NCT01017952|517354445|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
143160140|NCT04495478|516130093|FG003|Overall Study|Physician Decision|0|||
143160141|NCT04495478|516130094|FG004|Overall Study|Physician Decision|1|||
143160142|NCT04495478|516130095|FG005|Overall Study|Physician Decision|0|||
143160143|NCT04495478|516130096|FG006|Overall Study|Physician Decision|0|||
143160144|NCT03178942|516130097|FG000|Overall Study|Withdrawal by Subject|2|||
143160145|NCT03178942|516130098|FG001|Overall Study|Withdrawal by Subject|0|||
143160146|NCT03178942|516130097|FG000|Overall Study|Lost to Follow-up|1|||
143160147|NCT03178942|516130098|FG001|Overall Study|Lost to Follow-up|2|||
143160148|NCT06097273|516130099|FG000|Overall Study|Death|2|||
143160149|NCT06097273|516130100|FG001|Overall Study|Death|1|||
143160150|NCT06097273|516130101|FG002|Overall Study|Death|2|||
143160151|NCT06097273|516130102|FG003|Overall Study|Death|2|||
143160152|NCT06097273|516130099|FG000|Overall Study|Lost to Follow-up|27|||
143160153|NCT06097273|516130100|FG001|Overall Study|Lost to Follow-up|18|||
143160154|NCT06097273|516130101|FG002|Overall Study|Lost to Follow-up|36|||
143160155|NCT06097273|516130102|FG003|Overall Study|Lost to Follow-up|31|||
143160156|NCT06097273|516130099|FG000|Overall Study|Physician Decision|0|||
143160157|NCT06097273|516130100|FG001|Overall Study|Physician Decision|1|||
143160158|NCT06097273|516130101|FG002|Overall Study|Physician Decision|0|||
143160159|NCT06097273|516130102|FG003|Overall Study|Physician Decision|3|||
143160160|NCT06097273|516130099|FG000|Overall Study|Protocol Violation|1|||
143160161|NCT06097273|516130100|FG001|Overall Study|Protocol Violation|1|||
143160162|NCT06097273|516130101|FG002|Overall Study|Protocol Violation|2|||
143160163|NCT06097273|516130102|FG003|Overall Study|Protocol Violation|1|||
143160164|NCT06097273|516130099|FG000|Overall Study|Withdrawal by Subject|14|||
143160165|NCT06097273|516130100|FG001|Overall Study|Withdrawal by Subject|11|||
143160166|NCT06097273|516130101|FG002|Overall Study|Withdrawal by Subject|14|||
143160167|NCT06097273|516130102|FG003|Overall Study|Withdrawal by Subject|15|||
143160168|NCT06097273|516130099|FG000|Overall Study|Other Than Specified|7|||
143160169|NCT06097273|516130100|FG001|Overall Study|Other Than Specified|3|||
143160170|NCT06097273|516130101|FG002|Overall Study|Other Than Specified|11|||
143160171|NCT06097273|516130102|FG003|Overall Study|Other Than Specified|6|||
143160172|NCT01840163|516131509|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
143160173|NCT01840163|516131510|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
143160174|NCT01840163|516131509|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
143160175|NCT01840163|516131510|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
143160176|NCT01840163|516131509|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
143160177|NCT01840163|516131510|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
143160178|NCT00662038|516131511|FG000|Overall Study|Reason not specified|3|||
143160179|NCT00662038|516131511|FG000|Overall Study|Withdrawn consent|22|||
143160180|NCT00662038|516131511|FG000|Overall Study|Withdrawal by Subject|83|||
143160181|NCT00662038|516131511|FG000|Overall Study|Sponsor decision|1|||
143160182|NCT00662038|516131511|FG000|Overall Study|Physician Decision|19|||
143160183|NCT00662038|516131511|FG000|Overall Study|Lung transplantation|44|||
143160184|NCT00662038|516131511|FG000|Overall Study|Lost to Follow-up|1|||
143160185|NCT00662038|516131511|FG000|Overall Study|Death|95|||
143160186|NCT00662038|516131511|FG000|Overall Study|Adverse Event|358|||
143160187|NCT00662038|516131511|FG000|Overall Study|Continued treatment|5|||
143160188|NCT00397046|516131512|FG000|Overall Study|Disease Progression|3|||
143160189|NCT00397046|516131513|FG001|Overall Study|Disease Progression|3|||
143160190|NCT00397046|516131514|FG002|Overall Study|Disease Progression|10|||
143160191|NCT00397046|516131515|FG003|Overall Study|Disease Progression|5|||
143160192|NCT04914000|516131528|FG000|Overall Study|Lost to Follow-up|8|||
143495027|NCT01017952|517354446|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
143495028|NCT01017952|517354442|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
143495029|NCT01017952|517354443|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
143495030|NCT01017952|517354444|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
143495031|NCT01017952|517354445|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
143495032|NCT01017952|517354446|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
143032945|NCT01458405|515661421|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
143032946|NCT01458405|515661422|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
143032947|NCT01458405|515661423|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
143032948|NCT01458405|515661420|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
143032949|NCT01458405|515661421|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
143032950|NCT01458405|515661422|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
143032951|NCT01458405|515661423|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
143032952|NCT01458405|515661420|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
143032953|NCT01458405|515661421|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
143032954|NCT01458405|515661422|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
143032955|NCT01458405|515661423|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
143032956|NCT01249664|515661427|FG000|Overall Study|Withdrawal by Subject|5|||
143032957|NCT01249664|515661428|FG001|Overall Study|Withdrawal by Subject|0|||
143032958|NCT01249664|515661427|FG000|Overall Study|Adverse Event|1|||
143032959|NCT01249664|515661428|FG001|Overall Study|Adverse Event|0|||
143032960|NCT02143102|515661429|FG000|Overall Study|Lost to Follow-up|11|||
143032961|NCT02143102|515661430|FG001|Overall Study|Lost to Follow-up|0|||
143032962|NCT02636907|515661431|FG000|Autoinjector Assessment Period|Adverse Event|2|||
143032963|NCT02636907|515661431|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
143032964|NCT02636907|515661431|FG000|Extension Phase|Adverse Event|2|||
143160193|NCT04914000|516131528|FG000|Overall Study|Withdrawal by Subject|1|||
143032965|NCT02636907|515661431|FG000|Extension Phase|Withdrawal by Subject|4|||
143032966|NCT02636907|515661431|FG000|Extension Phase|Physician Decision|1|||
143032967|NCT02636907|515661431|FG000|Extension Phase|Lost to Follow-up|2|||
143160194|NCT00981175|516131529|FG000|Primary Dose Vaccination|Adverse Event|1|||
143160195|NCT00981175|516131530|FG001|Primary Dose Vaccination|Adverse Event|0|||
143160196|NCT00981175|516131529|FG000|Primary Dose Vaccination|Protocol Violation|0|||
143032968|NCT02636907|515661431|FG000|Extension Phase|Lack of Efficacy|1|||
143032969|NCT01225146|515661437|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
143160197|NCT00981175|516131530|FG001|Primary Dose Vaccination|Protocol Violation|1|||
143160198|NCT00981175|516131529|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
143160199|NCT00981175|516131530|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
143160200|NCT00981175|516131529|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
143160201|NCT00981175|516131530|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
143160202|NCT01750281|516131532|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
143160203|NCT01750281|516131533|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
143160204|NCT01750281|516131534|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
143160205|NCT01750281|516131532|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
143160206|NCT01750281|516131533|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
143160207|NCT01750281|516131534|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
143160208|NCT01750281|516131532|FG000|Overall Study|Did not receive treatment|0|||
143160209|NCT01750281|516131533|FG001|Overall Study|Did not receive treatment|1|||
143160210|NCT01750281|516131534|FG002|Overall Study|Did not receive treatment|0|||
143160211|NCT04189588|516131535|FG000|Overall Study|Death|0|||
143160212|NCT04189588|516131536|FG001|Overall Study|Death|1|||
143160213|NCT04189588|516131535|FG000|Overall Study|Lost to Follow-up|0|||
143160214|NCT04189588|516131536|FG001|Overall Study|Lost to Follow-up|1|||
143160215|NCT01658735|516131540|FG000|Overall Study|Lack of Efficacy|1|||
143160216|NCT01658735|516131541|FG001|Overall Study|Lack of Efficacy|0|||
143160217|NCT01658735|516131542|FG002|Overall Study|Lack of Efficacy|1|||
143160218|NCT01658735|516131540|FG000|Overall Study|Lost to Follow-up|1|||
143160219|NCT01658735|516131541|FG001|Overall Study|Lost to Follow-up|1|||
143160220|NCT01658735|516131542|FG002|Overall Study|Lost to Follow-up|0|||
143160221|NCT01658735|516131540|FG000|Overall Study|Protocol Violation|0|||
143160222|NCT01658735|516131541|FG001|Overall Study|Protocol Violation|1|||
143160223|NCT01658735|516131542|FG002|Overall Study|Protocol Violation|0|||
143160224|NCT01658735|516131540|FG000|Overall Study|Withdrawal by Subject|3|||
143160225|NCT01658735|516131541|FG001|Overall Study|Withdrawal by Subject|5|||
143160226|NCT01658735|516131542|FG002|Overall Study|Withdrawal by Subject|3|||
143160227|NCT01379937|516131543|FG000|Overall Study|Protocol Violation|0|||
143160228|NCT01379937|516131544|FG001|Overall Study|Protocol Violation|0|||
143160229|NCT01379937|516131545|FG002|Overall Study|Protocol Violation|0|||
143160230|NCT01379937|516131546|FG003|Overall Study|Protocol Violation|1|||
143160231|NCT01379937|516131543|FG000|Overall Study|Consent withdrawal|0|||
143160232|NCT01379937|516131544|FG001|Overall Study|Consent withdrawal|1|||
143160233|NCT01379937|516131545|FG002|Overall Study|Consent withdrawal|0|||
143160234|NCT01379937|516131546|FG003|Overall Study|Consent withdrawal|0|||
143160235|NCT01379937|516131543|FG000|Overall Study|Lost to Follow-up|1|||
143160236|NCT01379937|516131544|FG001|Overall Study|Lost to Follow-up|2|||
143160237|NCT01379937|516131545|FG002|Overall Study|Lost to Follow-up|2|||
143160238|NCT01379937|516131546|FG003|Overall Study|Lost to Follow-up|0|||
143160239|NCT01122680|516131547|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
143160240|NCT01122680|516131548|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
143238114|NCT01342211|516425671|FG002|Overall Study|Adverse Event|0|||
143238115|NCT01342211|516425672|FG003|Overall Study|Adverse Event|0|||
143032970|NCT01225146|515661438|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
143032971|NCT01876706|515661441|FG000|Overall Study|BPH Intervention|9|||
143032972|NCT01876706|515661441|FG000|Overall Study|Lost to Follow-up|7|||
143032973|NCT01876706|515661441|FG000|Overall Study|Withdrawals|6|||
143032974|NCT01876706|515661441|FG000|Overall Study|Death|3|||
143032975|NCT00604500|515661442|FG000|Overall Study|Adverse Event|2|||
143032976|NCT00604500|515661442|FG000|Overall Study|Protocol Violation|2|||
143032977|NCT00604500|515661442|FG000|Overall Study|Treatment Failure|1|||
143032978|NCT00604500|515661442|FG000|Overall Study|Withdrawal by Subject|4|||
143032979|NCT00604500|515661442|FG000|Overall Study|Administrative|1|||
143032980|NCT00604500|515661442|FG000|Overall Study|Did not meet protocol eligibility|1|||
143032981|NCT02191891|515661444|FG000|Overall Study|Withdrawal by Subject|0|||
143032982|NCT02191891|515661445|FG001|Overall Study|Withdrawal by Subject|1|||
143032983|NCT02191891|515661446|FG002|Overall Study|Withdrawal by Subject|0|||
143032984|NCT02191891|515661447|FG003|Overall Study|Withdrawal by Subject|0|||
143032985|NCT02191891|515661448|FG004|Overall Study|Withdrawal by Subject|1|||
143032986|NCT02191891|515661444|FG000|Overall Study|Adverse Event|0|||
143032987|NCT02191891|515661445|FG001|Overall Study|Adverse Event|1|||
143032988|NCT02191891|515661446|FG002|Overall Study|Adverse Event|0|||
143032989|NCT02191891|515661447|FG003|Overall Study|Adverse Event|0|||
143032990|NCT02191891|515661448|FG004|Overall Study|Adverse Event|2|||
143032991|NCT02191891|515661444|FG000|Overall Study|Disease Progression|4|||
143032992|NCT02191891|515661445|FG001|Overall Study|Disease Progression|10|||
143160241|NCT01122680|516131549|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
143160242|NCT01122680|516131550|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
143160243|NCT01122680|516131547|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
143160244|NCT01122680|516131548|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
143238116|NCT01342211|516425673|FG004|Overall Study|Adverse Event|1|||
143032993|NCT02191891|515661446|FG002|Overall Study|Disease Progression|4|||
143160245|NCT01122680|516131549|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
143495033|NCT01017952|517354442|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
143495034|NCT01017952|517354443|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
143495035|NCT01017952|517354444|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
143495036|NCT01017952|517354445|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
143495037|NCT01017952|517354446|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
143495038|NCT01017952|517354442|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
143495039|NCT01017952|517354443|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
143495040|NCT01017952|517354444|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
143032994|NCT02191891|515661447|FG003|Overall Study|Disease Progression|2|||
143032995|NCT02191891|515661448|FG004|Overall Study|Disease Progression|7|||
143032996|NCT03561883|515661454|FG000|Overall Study|Adverse Event|10|||
143032997|NCT03561883|515661455|FG001|Overall Study|Adverse Event|13|||
143032998|NCT03561883|515661454|FG000|Overall Study|Non-Compliance With Study Drug|1|||
143032999|NCT03561883|515661455|FG001|Overall Study|Non-Compliance With Study Drug|2|||
143160246|NCT01122680|516131550|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
143160247|NCT01122680|516131547|FG000|Period 1 (4 Weeks)|Other|1|||
143160248|NCT01122680|516131548|FG001|Period 1 (4 Weeks)|Other|1|||
143160249|NCT01122680|516131549|FG002|Period 1 (4 Weeks)|Other|0|||
143160250|NCT01122680|516131550|FG003|Period 1 (4 Weeks)|Other|0|||
143160251|NCT01122680|516131547|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
143160252|NCT01122680|516131548|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
143160253|NCT01122680|516131549|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
143160254|NCT01122680|516131550|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
143160255|NCT01122680|516131547|FG000|Period 2 (4 Weeks)|Other|1|||
143160256|NCT01122680|516131548|FG001|Period 2 (4 Weeks)|Other|0|||
143160257|NCT01122680|516131549|FG002|Period 2 (4 Weeks)|Other|0|||
143160258|NCT01122680|516131550|FG003|Period 2 (4 Weeks)|Other|0|||
143160259|NCT01122680|516131547|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
143160260|NCT01122680|516131548|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
143160261|NCT01122680|516131549|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
143160262|NCT01122680|516131550|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
143160263|NCT01122680|516131547|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
143160264|NCT01122680|516131548|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
143160265|NCT01122680|516131549|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
143160266|NCT01122680|516131550|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
143160267|NCT04985682|516131551|FG000|Overall Study|Withdrawal by Subject|1|||
143160268|NCT00621322|516131554|FG000|Overall Study|Lost to Follow-up|0|||
143160269|NCT00621322|516131555|FG001|Overall Study|Lost to Follow-up|0|||
143160270|NCT00621322|516131556|FG002|Overall Study|Lost to Follow-up|0|||
143160271|NCT00621322|516131557|FG003|Overall Study|Lost to Follow-up|0|||
143160272|NCT00621322|516131558|FG004|Overall Study|Lost to Follow-up|1|||
143160273|NCT00621322|516131559|FG005|Overall Study|Lost to Follow-up|0|||
143160274|NCT00621322|516131554|FG000|Overall Study|Physician Decision|0|||
143160275|NCT00621322|516131555|FG001|Overall Study|Physician Decision|0|||
143160276|NCT00621322|516131556|FG002|Overall Study|Physician Decision|1|||
143160277|NCT00621322|516131557|FG003|Overall Study|Physician Decision|1|||
143160278|NCT00621322|516131558|FG004|Overall Study|Physician Decision|0|||
143160279|NCT00621322|516131559|FG005|Overall Study|Physician Decision|0|||
143160280|NCT00621322|516131554|FG000|Overall Study|Withdrawal by Subject|0|||
143160281|NCT00621322|516131555|FG001|Overall Study|Withdrawal by Subject|0|||
143160282|NCT00621322|516131556|FG002|Overall Study|Withdrawal by Subject|0|||
143160283|NCT00621322|516131557|FG003|Overall Study|Withdrawal by Subject|1|||
143160284|NCT00621322|516131558|FG004|Overall Study|Withdrawal by Subject|0|||
143160285|NCT00621322|516131559|FG005|Overall Study|Withdrawal by Subject|2|||
143160286|NCT00621322|516131554|FG000|Overall Study|Migrated/moved from study area|1|||
143160287|NCT00621322|516131555|FG001|Overall Study|Migrated/moved from study area|0|||
143160288|NCT00621322|516131556|FG002|Overall Study|Migrated/moved from study area|1|||
143160289|NCT00621322|516131557|FG003|Overall Study|Migrated/moved from study area|1|||
143160290|NCT00621322|516131558|FG004|Overall Study|Migrated/moved from study area|0|||
143160291|NCT00621322|516131559|FG005|Overall Study|Migrated/moved from study area|2|||
143160292|NCT00079781|516131560|FG000|Pre-implant Period|Withdrawal by Subject|2|||
143160293|NCT00079781|516131561|FG001|Pre-implant Period|Withdrawal by Subject|0|||
143160294|NCT00079781|516131562|FG002|Pre-implant Period|Withdrawal by Subject|0|||
143160295|NCT00079781|516131560|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
143160296|NCT00079781|516131561|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
143495041|NCT01017952|517354445|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
143495042|NCT01017952|517354446|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
143495043|NCT01017952|517354442|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
143160297|NCT00079781|516131562|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
143160298|NCT00079781|516131560|FG000|Follow-up Period|Withdrawal by Subject|3|||
143160299|NCT00079781|516131561|FG001|Follow-up Period|Withdrawal by Subject|0|||
143160300|NCT00079781|516131562|FG002|Follow-up Period|Withdrawal by Subject|1|||
143033000|NCT03561883|515661454|FG000|Overall Study|Protocol Violation|2|||
143160301|NCT00079781|516131560|FG000|Follow-up Period|Lost to Follow-up|1|||
143160302|NCT00079781|516131561|FG001|Follow-up Period|Lost to Follow-up|0|||
143495044|NCT01017952|517354443|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
143495045|NCT01017952|517354444|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
143495046|NCT01017952|517354445|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
143495047|NCT01017952|517354446|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
143495048|NCT01017952|517354442|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
143495049|NCT01017952|517354443|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
143495050|NCT01017952|517354444|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
143160303|NCT00079781|516131562|FG002|Follow-up Period|Lost to Follow-up|0|||
143160304|NCT00079781|516131560|FG000|Follow-up Period|Death|0|||
143160305|NCT00079781|516131561|FG001|Follow-up Period|Death|0|||
143160306|NCT00079781|516131562|FG002|Follow-up Period|Death|1|||
143160307|NCT00225758|516131563|FG000|Overall Study|Adverse Event|4|||
143160308|NCT04641975|516131564|FG000|Overall Study|Protocol Violation|1|||
143160309|NCT04641975|516131565|FG001|Overall Study|Protocol Violation|2|||
143160310|NCT04641975|516131566|FG002|Overall Study|Protocol Violation|0|||
143160311|NCT04641975|516131567|FG003|Overall Study|Protocol Violation|0|||
143160312|NCT04641975|516131564|FG000|Overall Study|Adverse Event|0|||
143160313|NCT04641975|516131565|FG001|Overall Study|Adverse Event|0|||
143160314|NCT04641975|516131566|FG002|Overall Study|Adverse Event|1|||
143160315|NCT04641975|516131567|FG003|Overall Study|Adverse Event|1|||
143160316|NCT04641975|516131564|FG000|Overall Study|Withdrawal by Subject|1|||
143160317|NCT04641975|516131565|FG001|Overall Study|Withdrawal by Subject|0|||
143160318|NCT04641975|516131566|FG002|Overall Study|Withdrawal by Subject|0|||
143160319|NCT04641975|516131567|FG003|Overall Study|Withdrawal by Subject|0|||
143160320|NCT01259024|516131571|FG000|Overall Study|Physician Decision|1|||
143160321|NCT01657500|516131572|FG000|Overall Study|set impropperly matched|3|||
143160322|NCT01657500|516131573|FG001|Overall Study|set impropperly matched|3|||
143160323|NCT01657500|516131572|FG000|Overall Study|Lost to Follow-up|2|||
143160324|NCT01657500|516131573|FG001|Overall Study|Lost to Follow-up|2|||
143160325|NCT00756444|516131576|FG000|Overall Study|Adverse Event|1|||
143160326|NCT00756444|516131577|FG001|Overall Study|Adverse Event|1|||
143160327|NCT00756444|516131576|FG000|Overall Study|Withdrawal by Subject|6|||
143160328|NCT00756444|516131577|FG001|Overall Study|Withdrawal by Subject|8|||
143160329|NCT00756444|516131576|FG000|Overall Study|Lost to Follow-up|0|||
143160330|NCT00756444|516131577|FG001|Overall Study|Lost to Follow-up|1|||
143160331|NCT00756444|516131576|FG000|Overall Study|Death|5|||
143160332|NCT00756444|516131577|FG001|Overall Study|Death|4|||
143160333|NCT00756444|516131576|FG000|Overall Study|Disease Progression|2|||
143160334|NCT00756444|516131577|FG001|Overall Study|Disease Progression|7|||
143160335|NCT00756444|516131576|FG000|Overall Study|Ineligibility Determined|1|||
143160336|NCT00756444|516131577|FG001|Overall Study|Ineligibility Determined|0|||
143160337|NCT00564070|516131578|FG000|Overall Study|Lost to Follow-up|9|||
143160338|NCT00564070|516131579|FG001|Overall Study|Lost to Follow-up|7|||
143160339|NCT00564070|516131578|FG000|Overall Study|Worsening depression, referred to care|3|||
143160340|NCT00564070|516131579|FG001|Overall Study|Worsening depression, referred to care|0|||
143160341|NCT02264821|516131581|FG000|Overall Study|Protocol Violation|1|||
143160342|NCT02264821|516131582|FG001|Overall Study|Protocol Violation|3|||
143160343|NCT02264821|516131583|FG002|Overall Study|Protocol Violation|6|||
143160344|NCT00552279|516131584|FG000|Overall Study|Adverse Event|0|||
143160345|NCT00552279|516131585|FG001|Overall Study|Adverse Event|1|||
143160346|NCT00552279|516131584|FG000|Overall Study|Withdrawal by Subject|12|||
143160347|NCT00552279|516131585|FG001|Overall Study|Withdrawal by Subject|1|||
143160348|NCT00552279|516131584|FG000|Overall Study|Lost to Follow-up|1|||
143160349|NCT00552279|516131585|FG001|Overall Study|Lost to Follow-up|0|||
143160350|NCT00552279|516131584|FG000|Overall Study|Other|1|||
143160351|NCT00552279|516131585|FG001|Overall Study|Other|1|||
143160352|NCT06083493|516131587|FG000|Overall Study|Technical issues with the interventional device|2|||
143160353|NCT06083493|516131588|FG001|Overall Study|Technical issues with the interventional device|2|||
143160354|NCT06083493|516131587|FG000|Overall Study|Performed incorrect visual task|1|||
143160355|NCT06083493|516131588|FG001|Overall Study|Performed incorrect visual task|0|||
143160356|NCT06083493|516131587|FG000|Overall Study|Insufficient baseline performance|0|||
143160357|NCT06083493|516131588|FG001|Overall Study|Insufficient baseline performance|1|||
143160358|NCT04034056|516131589|FG000|Overall Study|Withdrawal by Subject|2|||
143160359|NCT04034056|516131589|FG000|Overall Study|Reason Not Specified|13|||
143160360|NCT04034056|516131589|FG000|Overall Study|Adverse Event|56|||
143160361|NCT03225989|516131590|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
143160362|NCT03225989|516131591|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
143160363|NCT03225989|516131592|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
143160364|NCT03225989|516131590|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
143160365|NCT03225989|516131591|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
143160366|NCT03225989|516131592|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
143160367|NCT03225989|516131590|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
143495051|NCT01017952|517354445|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
143160368|NCT03225989|516131591|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
143160369|NCT03225989|516131592|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
143160370|NCT03225989|516131590|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
143160371|NCT03225989|516131591|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
143160372|NCT03225989|516131592|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
143160373|NCT03225989|516131590|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
143160374|NCT03225989|516131591|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
143160375|NCT03225989|516131592|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
143160376|NCT03225989|516131590|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
143160377|NCT03225989|516131591|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
143160378|NCT03225989|516131592|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
143160379|NCT03225989|516131590|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
143160380|NCT03225989|516131591|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
143160381|NCT03225989|516131592|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
143160382|NCT03225989|516131590|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
143160383|NCT03225989|516131591|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
143160384|NCT03225989|516131592|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
143160385|NCT03225989|516131590|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
143160386|NCT03225989|516131591|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
143160387|NCT03225989|516131592|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
143160388|NCT03225989|516131590|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
143160389|NCT03225989|516131591|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
143160390|NCT03225989|516131592|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
143160391|NCT03225989|516131590|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
143160392|NCT03225989|516131591|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
143160393|NCT03225989|516131592|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
143160394|NCT03225989|516131590|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
143160395|NCT03225989|516131591|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
143160396|NCT03225989|516131592|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
143160397|NCT03093870|516131593|FG000|Overall Study|Withdrawal by Subject|2|||
143160398|NCT03093870|516131594|FG001|Overall Study|Withdrawal by Subject|6|||
143160399|NCT03093870|516131595|FG002|Overall Study|Withdrawal by Subject|5|||
143160400|NCT03093870|516131593|FG000|Overall Study|Death|1|||
143160401|NCT03093870|516131594|FG001|Overall Study|Death|35|||
143160402|NCT03093870|516131595|FG002|Overall Study|Death|35|||
143160403|NCT03093870|516131593|FG000|Overall Study|Radiographic disease progression|10|||
143160404|NCT03093870|516131594|FG001|Overall Study|Radiographic disease progression|0|||
143160405|NCT03093870|516131595|FG002|Overall Study|Radiographic disease progression|0|||
143160406|NCT03093870|516131593|FG000|Overall Study|Clinical disease progression|1|||
143160407|NCT03093870|516131594|FG001|Overall Study|Clinical disease progression|0|||
143160408|NCT03093870|516131595|FG002|Overall Study|Clinical disease progression|0|||
143160409|NCT03093870|516131593|FG000|Overall Study|Physician Decision|2|||
143160410|NCT03093870|516131594|FG001|Overall Study|Physician Decision|0|||
143160411|NCT03093870|516131595|FG002|Overall Study|Physician Decision|0|||
143160412|NCT03093870|516131593|FG000|Overall Study|Adverse Event|7|||
143160413|NCT03093870|516131594|FG001|Overall Study|Adverse Event|0|||
143160414|NCT03093870|516131595|FG002|Overall Study|Adverse Event|0|||
143160415|NCT03093870|516131593|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
143160416|NCT03093870|516131594|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
143160417|NCT03093870|516131595|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
143160418|NCT03093870|516131593|FG000|Overall Study|Lost to Follow-up|0|||
143160419|NCT03093870|516131594|FG001|Overall Study|Lost to Follow-up|0|||
143160420|NCT03093870|516131595|FG002|Overall Study|Lost to Follow-up|1|||
143160421|NCT00601107|516131596|FG000|Overall Study|Adverse Event|0|||
143160422|NCT00601107|516131597|FG001|Overall Study|Adverse Event|1|||
143160423|NCT00601107|516131598|FG002|Overall Study|Adverse Event|3|||
143160424|NCT00601107|516131599|FG003|Overall Study|Adverse Event|0|||
143160425|NCT00601107|516131596|FG000|Overall Study|Withdrawal by Subject|5|||
143160426|NCT00601107|516131597|FG001|Overall Study|Withdrawal by Subject|4|||
143160427|NCT00601107|516131598|FG002|Overall Study|Withdrawal by Subject|7|||
143160428|NCT00601107|516131599|FG003|Overall Study|Withdrawal by Subject|4|||
143160429|NCT00601107|516131596|FG000|Overall Study|Lost to Follow-up|3|||
143160430|NCT00601107|516131597|FG001|Overall Study|Lost to Follow-up|3|||
143160431|NCT00601107|516131598|FG002|Overall Study|Lost to Follow-up|0|||
143160432|NCT00601107|516131599|FG003|Overall Study|Lost to Follow-up|3|||
143160433|NCT00601107|516131596|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
143238117|NCT01342211|516425669|FG000|Overall Study|Withdrawal by Subject|0|||
143160434|NCT00601107|516131597|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
143160435|NCT00601107|516131598|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
143238118|NCT01342211|516425670|FG001|Overall Study|Withdrawal by Subject|0|||
143160436|NCT00601107|516131599|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
143160437|NCT00601107|516131596|FG000|Overall Study|Worsening of Psoriasis|4|||
143238119|NCT01342211|516425671|FG002|Overall Study|Withdrawal by Subject|0|||
143238120|NCT01342211|516425672|FG003|Overall Study|Withdrawal by Subject|1|||
143238121|NCT01342211|516425673|FG004|Overall Study|Withdrawal by Subject|0|||
143238122|NCT01342211|516425669|FG000|Overall Study|Randomized, but not Treated|0|||
143238123|NCT01342211|516425670|FG001|Overall Study|Randomized, but not Treated|2|||
143238124|NCT01342211|516425671|FG002|Overall Study|Randomized, but not Treated|0|||
143238125|NCT01342211|516425672|FG003|Overall Study|Randomized, but not Treated|0|||
143238126|NCT01342211|516425673|FG004|Overall Study|Randomized, but not Treated|1|||
143238127|NCT01588522|516425678|FG000|Overall Study|Withdrawal by Subject|1|||
143238128|NCT01588522|516425679|FG001|Overall Study|Withdrawal by Subject|5|||
143238129|NCT01588522|516425680|FG002|Overall Study|Withdrawal by Subject|3|||
143238130|NCT01588522|516425681|FG003|Overall Study|Withdrawal by Subject|1|||
143238131|NCT01588522|516425682|FG004|Overall Study|Withdrawal by Subject|2|||
143238132|NCT01588522|516425683|FG005|Overall Study|Withdrawal by Subject|0|||
143238133|NCT01588522|516425678|FG000|Overall Study|Lack of Efficacy|0|||
143238134|NCT01588522|516425679|FG001|Overall Study|Lack of Efficacy|0|||
143238135|NCT01588522|516425680|FG002|Overall Study|Lack of Efficacy|0|||
143238136|NCT01588522|516425681|FG003|Overall Study|Lack of Efficacy|0|||
143238137|NCT01588522|516425682|FG004|Overall Study|Lack of Efficacy|1|||
143238138|NCT01588522|516425683|FG005|Overall Study|Lack of Efficacy|0|||
143238139|NCT01588522|516425678|FG000|Overall Study|Adverse Event|0|||
143238140|NCT01588522|516425679|FG001|Overall Study|Adverse Event|0|||
143238141|NCT01588522|516425680|FG002|Overall Study|Adverse Event|0|||
143238142|NCT01588522|516425681|FG003|Overall Study|Adverse Event|1|||
143238143|NCT01588522|516425682|FG004|Overall Study|Adverse Event|0|||
143238144|NCT01588522|516425683|FG005|Overall Study|Adverse Event|0|||
143238145|NCT01588522|516425678|FG000|Overall Study|Grade 2 alopecia|1|||
143238146|NCT01588522|516425679|FG001|Overall Study|Grade 2 alopecia|0|||
143238147|NCT01588522|516425680|FG002|Overall Study|Grade 2 alopecia|0|||
143238148|NCT01588522|516425681|FG003|Overall Study|Grade 2 alopecia|0|||
143238149|NCT01588522|516425682|FG004|Overall Study|Grade 2 alopecia|0|||
143238150|NCT01588522|516425683|FG005|Overall Study|Grade 2 alopecia|0|||
143238151|NCT01588522|516425678|FG000|Overall Study|Severe toxicity of chemotherapy|0|||
143238152|NCT01588522|516425679|FG001|Overall Study|Severe toxicity of chemotherapy|0|||
143238153|NCT01588522|516425680|FG002|Overall Study|Severe toxicity of chemotherapy|1|||
143238154|NCT01588522|516425681|FG003|Overall Study|Severe toxicity of chemotherapy|0|||
143238155|NCT01588522|516425682|FG004|Overall Study|Severe toxicity of chemotherapy|0|||
143238156|NCT01588522|516425683|FG005|Overall Study|Severe toxicity of chemotherapy|0|||
143238157|NCT01588522|516425678|FG000|Overall Study|Taken off taxane-based regimen|0|||
143238158|NCT01588522|516425679|FG001|Overall Study|Taken off taxane-based regimen|0|||
143238159|NCT01588522|516425680|FG002|Overall Study|Taken off taxane-based regimen|0|||
143238160|NCT01588522|516425681|FG003|Overall Study|Taken off taxane-based regimen|1|||
143238161|NCT01588522|516425682|FG004|Overall Study|Taken off taxane-based regimen|0|||
143238162|NCT01588522|516425683|FG005|Overall Study|Taken off taxane-based regimen|0|||
143238163|NCT01588522|516425678|FG000|Overall Study|Did not initiate chemotherapy|0|||
143238164|NCT01588522|516425679|FG001|Overall Study|Did not initiate chemotherapy|0|||
143238165|NCT01588522|516425680|FG002|Overall Study|Did not initiate chemotherapy|0|||
143238166|NCT01588522|516425681|FG003|Overall Study|Did not initiate chemotherapy|0|||
143238167|NCT01588522|516425682|FG004|Overall Study|Did not initiate chemotherapy|1|||
143238168|NCT01588522|516425683|FG005|Overall Study|Did not initiate chemotherapy|0|||
143238169|NCT03043794|516425684|FG000|Overall Study|Lost to Follow-up|1|||
143238170|NCT03205423|516425689|FG000|Overall Study|Personal|1|||
143238171|NCT03205423|516425690|FG001|Overall Study|Personal|1|||
143238172|NCT03205423|516425689|FG000|Overall Study|Physician Decision|0|||
143238173|NCT03205423|516425690|FG001|Overall Study|Physician Decision|2|||
143238174|NCT02749422|516425693|FG000|Overall Study|Lost to Follow-up|0|||
143238175|NCT02749422|516425694|FG001|Overall Study|Lost to Follow-up|2|||
143238176|NCT02749422|516425693|FG000|Overall Study|Ineligible|0|||
143238177|NCT02749422|516425694|FG001|Overall Study|Ineligible|1|||
143238178|NCT05786651|516425695|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
143238179|NCT02855125|516425696|FG000|Overall Study|Withdrawal by Subject|2|||
143238180|NCT02855125|516425697|FG001|Overall Study|Withdrawal by Subject|2|||
143238181|NCT02855125|516425696|FG000|Overall Study|Clinical Disease Progression|5|||
143238182|NCT02855125|516425697|FG001|Overall Study|Clinical Disease Progression|4|||
143238183|NCT02855125|516425696|FG000|Overall Study|Radiologic Disease Progression|36|||
143238184|NCT02855125|516425697|FG001|Overall Study|Radiologic Disease Progression|39|||
143238185|NCT02855125|516425696|FG000|Overall Study|Adverse Event|11|||
143238186|NCT02855125|516425697|FG001|Overall Study|Adverse Event|7|||
143238187|NCT02855125|516425696|FG000|Overall Study|Physician Decision|1|||
143238188|NCT02855125|516425697|FG001|Overall Study|Physician Decision|0|||
143364066|NCT03283553|516875528|FG000|Patient Participant Flow|Lost to Follow-up|1|||
143364067|NCT03283553|516875529|FG001|Patient Participant Flow|Lost to Follow-up|1|||
143238189|NCT02855125|516425696|FG000|Overall Study|On Treatment|9|||
143238190|NCT02855125|516425697|FG001|Overall Study|On Treatment|11|||
143238191|NCT02855125|516425696|FG000|Overall Study|Randomized but not treated|0|||
143238192|NCT02855125|516425697|FG001|Overall Study|Randomized but not treated|1|||
143238193|NCT04467905|516425698|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
143238194|NCT04467905|516425699|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
143238195|NCT04467905|516425700|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
143238196|NCT04467905|516425698|FG000|Overall Study|Conversion to SR|0|||
143238197|NCT04467905|516425699|FG001|Overall Study|Conversion to SR|0|||
143238198|NCT04467905|516425700|FG002|Overall Study|Conversion to SR|3|||
143238199|NCT04467905|516425698|FG000|Overall Study|Technical issue with Holter ECG|0|||
143238200|NCT04467905|516425699|FG001|Overall Study|Technical issue with Holter ECG|0|||
143238201|NCT04467905|516425700|FG002|Overall Study|Technical issue with Holter ECG|3|||
143238202|NCT04467905|516425698|FG000|Overall Study|Hemodynamic instability|0|||
143238203|NCT04467905|516425699|FG001|Overall Study|Hemodynamic instability|0|||
143238204|NCT04467905|516425700|FG002|Overall Study|Hemodynamic instability|1|||
143238205|NCT04467905|516425698|FG000|Overall Study|Site misinterpretation of protocol|0|||
143238206|NCT04467905|516425699|FG001|Overall Study|Site misinterpretation of protocol|0|||
143238207|NCT04467905|516425700|FG002|Overall Study|Site misinterpretation of protocol|1|||
143238208|NCT04586205|516425705|FG000|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|1|||
143238209|NCT04586205|516425706|FG001|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|2|||
143238210|NCT00905164|516425707|FG000|Period 1|Protocol Violation|0|||
143238211|NCT00905164|516425708|FG001|Period 1|Protocol Violation|1|||
143238212|NCT04145349|516427405|FG000|Overall Study|Withdrawal by Subject|3|||
143238213|NCT04145349|516427406|FG001|Overall Study|Withdrawal by Subject|0|||
143238214|NCT04145349|516427405|FG000|Overall Study|Lost to Follow-up|0|||
143238215|NCT04145349|516427406|FG001|Overall Study|Lost to Follow-up|1|||
143238216|NCT04145349|516427405|FG000|Overall Study|On study treatment (Ongoing)|0|||
143238217|NCT04145349|516427406|FG001|Overall Study|On study treatment (Ongoing)|1|||
143238218|NCT00777153|516427407|FG000|Overall Study|Lost to Follow-up|1|||
143238219|NCT00777153|516427408|FG001|Overall Study|Lost to Follow-up|1|||
143238220|NCT00777153|516427409|FG002|Overall Study|Lost to Follow-up|0|||
143238221|NCT00777153|516427407|FG000|Overall Study|Death|85|||
143238222|NCT00777153|516427408|FG001|Overall Study|Death|73|||
143238223|NCT00777153|516427409|FG002|Overall Study|Death|33|||
143238224|NCT00777153|516427407|FG000|Overall Study|Withdrawal by Subject|3|||
143238225|NCT00777153|516427408|FG001|Overall Study|Withdrawal by Subject|4|||
143238226|NCT00777153|516427409|FG002|Overall Study|Withdrawal by Subject|3|||
143238227|NCT00777153|516427407|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
143238228|NCT00777153|516427408|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
143238229|NCT00777153|516427409|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
143238230|NCT00554216|516427410|FG000|Overall Study|Lost to Follow-up|92|||
143238231|NCT00554216|516427411|FG001|Overall Study|Lost to Follow-up|31|||
143238232|NCT00554216|516427412|FG002|Overall Study|Lost to Follow-up|63|||
143238233|NCT00554216|516427410|FG000|Overall Study|Adverse Event|16|||
143238234|NCT00554216|516427411|FG001|Overall Study|Adverse Event|16|||
143238235|NCT00554216|516427412|FG002|Overall Study|Adverse Event|36|||
143238236|NCT00554216|516427410|FG000|Overall Study|Withdrawal by Subject|92|||
143238237|NCT00554216|516427411|FG001|Overall Study|Withdrawal by Subject|31|||
143238238|NCT00554216|516427412|FG002|Overall Study|Withdrawal by Subject|43|||
143238239|NCT00554216|516427410|FG000|Overall Study|Non compliance|10|||
143238240|NCT00554216|516427411|FG001|Overall Study|Non compliance|4|||
143238241|NCT00554216|516427412|FG002|Overall Study|Non compliance|5|||
143238242|NCT00554216|516427410|FG000|Overall Study|Pregnancy|2|||
143238243|NCT00554216|516427411|FG001|Overall Study|Pregnancy|1|||
143238244|NCT00554216|516427412|FG002|Overall Study|Pregnancy|14|||
143238245|NCT00554216|516427410|FG000|Overall Study|Restricted med|3|||
143238246|NCT00554216|516427411|FG001|Overall Study|Restricted med|1|||
143238247|NCT00554216|516427412|FG002|Overall Study|Restricted med|1|||
143238248|NCT00554216|516427410|FG000|Overall Study|Other|12|||
143238249|NCT00554216|516427411|FG001|Overall Study|Other|7|||
143238250|NCT00554216|516427412|FG002|Overall Study|Other|10|||
143238251|NCT00554216|516427410|FG000|Overall Study|Lack of Efficacy|15|||
143033001|NCT03561883|515661455|FG001|Overall Study|Protocol Violation|3|||
143033002|NCT03561883|515661454|FG000|Overall Study|Withdrawal by Subject|14|||
143033003|NCT03561883|515661455|FG001|Overall Study|Withdrawal by Subject|6|||
143238252|NCT00554216|516427411|FG001|Overall Study|Lack of Efficacy|3|||
143238253|NCT00554216|516427412|FG002|Overall Study|Lack of Efficacy|0|||
143238254|NCT02079246|516427415|FG000|OLEX|Withdrawal before treatment|1|||
143238255|NCT02079246|516427416|FG001|OLEX|Withdrawal before treatment|0|||
143238256|NCT02079246|516427415|FG000|OLEX|Death|11|||
143238257|NCT02079246|516427416|FG001|OLEX|Death|0|||
143238258|NCT02079246|516427415|FG000|OLEX|Adverse Event|66|||
143238259|NCT02079246|516427416|FG001|OLEX|Adverse Event|0|||
143238260|NCT02079246|516427415|FG000|OLEX|Withdrawal by Subject|60|||
143238261|NCT02079246|516427416|FG001|OLEX|Withdrawal by Subject|0|||
143238262|NCT02079246|516427415|FG000|OLEX|Lost to Follow-up|6|||
143238263|NCT02079246|516427416|FG001|OLEX|Lost to Follow-up|0|||
143238264|NCT02079246|516427415|FG000|OLEX|Protocol Violation|6|||
143238265|NCT02079246|516427416|FG001|OLEX|Protocol Violation|0|||
143238266|NCT02079246|516427415|FG000|OLEX|Lack of Efficacy|3|||
143238267|NCT02079246|516427416|FG001|OLEX|Lack of Efficacy|0|||
143238268|NCT02079246|516427415|FG000|OLEX|Results of the lead-in studies|58|||
143238269|NCT02079246|516427416|FG001|OLEX|Results of the lead-in studies|0|||
143238270|NCT02079246|516427415|FG000|OLEX|Other: Disallowed medication|8|||
143238271|NCT02079246|516427416|FG001|OLEX|Other: Disallowed medication|0|||
143238272|NCT02079246|516427415|FG000|OLEX|Other: Insufficient compliance|2|||
143238273|NCT02079246|516427416|FG001|OLEX|Other: Insufficient compliance|0|||
143238274|NCT02079246|516427415|FG000|OLEX|Other: Caregiver unavailable|3|||
143238275|NCT02079246|516427416|FG001|OLEX|Other: Caregiver unavailable|0|||
143238276|NCT02079246|516427415|FG000|OLEX|Other: Coordinator decision|1|||
143238277|NCT02079246|516427416|FG001|OLEX|Other: Coordinator decision|0|||
143238278|NCT02079246|516427415|FG000|OLEX|Other: Worsening of condition|1|||
143238279|NCT02079246|516427416|FG001|OLEX|Other: Worsening of condition|0|||
143238280|NCT02079246|516427415|FG000|OLEX|Other: Moved to nursing home|1|||
143238281|NCT02079246|516427416|FG001|OLEX|Other: Moved to nursing home|0|||
143238282|NCT02079246|516427415|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
143238283|NCT02079246|516427416|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
143238284|NCT02079246|516427415|FG000|OLEX-MEM|Adverse Event|0|||
143238285|NCT02079246|516427416|FG001|OLEX-MEM|Adverse Event|6|||
143238286|NCT02079246|516427415|FG000|OLEX-MEM|Withdrawal by Subject|0|||
143238287|NCT02079246|516427416|FG001|OLEX-MEM|Withdrawal by Subject|7|||
143238288|NCT02079246|516427415|FG000|OLEX-MEM|Protocol Violation|0|||
143238289|NCT02079246|516427416|FG001|OLEX-MEM|Protocol Violation|2|||
143238290|NCT02079246|516427415|FG000|OLEX-MEM|Lost to Follow-up|0|||
143238291|NCT02079246|516427416|FG001|OLEX-MEM|Lost to Follow-up|1|||
143238292|NCT02079246|516427415|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
143238293|NCT02079246|516427416|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
143238294|NCT00775190|516427421|FG000|Overall Study|Lost to Follow-up|2|||
143238295|NCT00775190|516427422|FG001|Overall Study|Lost to Follow-up|3|||
143238296|NCT00775190|516427421|FG000|Overall Study|Withdrawal by Subject|1|||
143238297|NCT00775190|516427422|FG001|Overall Study|Withdrawal by Subject|2|||
143238298|NCT00775190|516427421|FG000|Overall Study|Protocol Violation|1|||
143238299|NCT00775190|516427422|FG001|Overall Study|Protocol Violation|0|||
143238300|NCT01389596|516427423|FG000|Overall Study|Protocol Violation|3|||
143238301|NCT01389596|516427424|FG001|Overall Study|Protocol Violation|4|||
143238302|NCT01389596|516427425|FG002|Overall Study|Protocol Violation|3|||
143238303|NCT01389596|516427423|FG000|Overall Study|Withdrawal by Subject|1|||
143238304|NCT01389596|516427424|FG001|Overall Study|Withdrawal by Subject|2|||
143238305|NCT01389596|516427425|FG002|Overall Study|Withdrawal by Subject|2|||
143238306|NCT01389596|516427423|FG000|Overall Study|Insufficient Clinical Response|3|||
143238307|NCT01389596|516427424|FG001|Overall Study|Insufficient Clinical Response|4|||
143238308|NCT01389596|516427425|FG002|Overall Study|Insufficient Clinical Response|5|||
143238309|NCT01389596|516427423|FG000|Overall Study|Adverse Event|1|||
143238310|NCT01389596|516427424|FG001|Overall Study|Adverse Event|4|||
143238311|NCT01389596|516427425|FG002|Overall Study|Adverse Event|0|||
143238312|NCT01389596|516427423|FG000|Overall Study|Death|0|||
143238313|NCT01389596|516427424|FG001|Overall Study|Death|1|||
143238314|NCT01389596|516427425|FG002|Overall Study|Death|0|||
143238315|NCT01389596|516427423|FG000|Overall Study|Other Unspecified|2|||
143238316|NCT01389596|516427424|FG001|Overall Study|Other Unspecified|1|||
143238317|NCT01389596|516427425|FG002|Overall Study|Other Unspecified|0|||
143238318|NCT01709084|516427426|FG000|Overall Study|Lost to Follow-up|4|||
143238319|NCT01709084|516427427|FG001|Overall Study|Lost to Follow-up|7|||
143238320|NCT01709084|516427426|FG000|Overall Study|Withdrawal by Subject|2|||
143238321|NCT01709084|516427427|FG001|Overall Study|Withdrawal by Subject|2|||
143238322|NCT01709084|516427426|FG000|Overall Study|Adverse Event|5|||
143238323|NCT01709084|516427427|FG001|Overall Study|Adverse Event|0|||
143238324|NCT01709084|516427426|FG000|Overall Study|Other|5|||
143238325|NCT01709084|516427427|FG001|Overall Study|Other|3|||
143238326|NCT01709084|516427426|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
143238327|NCT01709084|516427427|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
143238328|NCT01709084|516427426|FG000|Overall Study|Not Treated|0|||
143238329|NCT01709084|516427427|FG001|Overall Study|Not Treated|2|||
143238330|NCT01354899|516427431|FG000|Overall Study|discharge from the hospital|2|||
143364068|NCT03283553|516875528|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
143238331|NCT01354899|516427431|FG000|Overall Study|Protocol Violation|1|||
143238332|NCT01298648|516427432|FG000|Overall Study|Withdrawal by Subject|2|||
143238333|NCT01298648|516427432|FG000|Overall Study|Lost to Follow-up|21|||
143238334|NCT02351856|516427434|FG000|Overall Study|Adverse Event|2|||
143238335|NCT02351856|516427434|FG000|Overall Study|Physician Decision|5|||
143238336|NCT02351856|516427434|FG000|Overall Study|Study terminated by sponsor|1|||
143238337|NCT01772316|516427435|FG000|Overall Study|Serious adverse event|1|||
143364069|NCT03283553|516875529|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
143238338|NCT01772316|516427435|FG000|Overall Study|Inform consent withdrawn|1|||
143238339|NCT01772316|516427435|FG000|Overall Study|Withdrawn by sponsor decision|5|||
143238340|NCT03763877|516427444|FG000|Overall Study|Withdrawal by Subject|3|||
143238341|NCT03763877|516427445|FG001|Overall Study|Withdrawal by Subject|1|||
143238342|NCT03763877|516427446|FG002|Overall Study|Withdrawal by Subject|3|||
143238343|NCT03763877|516427447|FG003|Overall Study|Withdrawal by Subject|4|||
143238344|NCT03763877|516427444|FG000|Overall Study|Adverse Event|1|||
143160438|NCT00601107|516131597|FG001|Overall Study|Worsening of Psoriasis|1|||
143160439|NCT00601107|516131598|FG002|Overall Study|Worsening of Psoriasis|1|||
143160440|NCT00601107|516131599|FG003|Overall Study|Worsening of Psoriasis|4|||
143160441|NCT00601107|516131596|FG000|Overall Study|Undefined|1|||
143160442|NCT00601107|516131597|FG001|Overall Study|Undefined|0|||
143160443|NCT00601107|516131598|FG002|Overall Study|Undefined|1|||
143160444|NCT00601107|516131599|FG003|Overall Study|Undefined|0|||
143160445|NCT01530997|516131600|FG000|Overall Study|Physician Decision|1|||
143160446|NCT01530997|516131600|FG000|Overall Study|Withdrawal by Subject|1|||
143160447|NCT00609973|516131601|FG000|Overall Study|Adverse Event|2|||
143160448|NCT00609973|516131602|FG001|Overall Study|Adverse Event|1|||
143160449|NCT00609973|516131601|FG000|Overall Study|Protocol Violation|4|||
143160450|NCT00609973|516131602|FG001|Overall Study|Protocol Violation|3|||
143160451|NCT00609973|516131601|FG000|Overall Study|Lost to Follow-up|2|||
143160452|NCT00609973|516131602|FG001|Overall Study|Lost to Follow-up|1|||
143160453|NCT00609973|516131601|FG000|Overall Study|Withdrawal by Subject|0|||
143160454|NCT00609973|516131602|FG001|Overall Study|Withdrawal by Subject|1|||
143160455|NCT01063881|516131603|FG000|Overall Study|Adverse Event|12|||
143160456|NCT01063881|516131604|FG001|Overall Study|Adverse Event|2|||
143160457|NCT01063881|516131605|FG002|Overall Study|Adverse Event|0|||
143160458|NCT01063881|516131603|FG000|Overall Study|Lost to Follow-up|13|||
143160459|NCT01063881|516131604|FG001|Overall Study|Lost to Follow-up|7|||
143160460|NCT01063881|516131605|FG002|Overall Study|Lost to Follow-up|1|||
143160461|NCT01063881|516131603|FG000|Overall Study|Withdrawal by Subject|25|||
143160462|NCT01063881|516131604|FG001|Overall Study|Withdrawal by Subject|1|||
143160463|NCT01063881|516131605|FG002|Overall Study|Withdrawal by Subject|0|||
143160464|NCT01063881|516131603|FG000|Overall Study|Reason for not completed not specified|5|||
143160465|NCT01063881|516131604|FG001|Overall Study|Reason for not completed not specified|1|||
143160466|NCT01063881|516131605|FG002|Overall Study|Reason for not completed not specified|0|||
143160467|NCT01309100|516131606|FG000|Overall Study|Protocol Violation|1|||
143160468|NCT01309100|516131606|FG000|Overall Study|Positive Slit lamp finding|1|||
143160469|NCT01452789|516131609|FG000|Overall Study|Withdrawal by Subject|3|||
143160470|NCT01452789|516131610|FG001|Overall Study|Withdrawal by Subject|2|||
143160471|NCT03520387|516131612|FG000|Pre-Randomization|Withdrawal by Subject|1|||
143160472|NCT03520387|516131613|FG001|Pre-Randomization|Withdrawal by Subject|0|||
143160473|NCT03520387|516131614|FG002|Pre-Randomization|Withdrawal by Subject|0|||
143160474|NCT03520387|516131615|FG003|Pre-Randomization|Withdrawal by Subject|0|||
143160475|NCT03520387|516131616|FG004|Pre-Randomization|Withdrawal by Subject|0|||
143160476|NCT03520387|516131612|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
143160477|NCT03520387|516131613|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
143160478|NCT03520387|516131614|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
143160479|NCT03520387|516131615|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
143160480|NCT03520387|516131616|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
143160481|NCT01945242|516131617|FG000|Overall Study|Physician Decision|3|||
143160482|NCT01945242|516131618|FG001|Overall Study|Physician Decision|3|||
143160483|NCT03163264|516131619|FG000|Overall Study|Withdrawal by Subject|13|||
143160484|NCT03163264|516131620|FG001|Overall Study|Withdrawal by Subject|3|||
143160485|NCT03163264|516131621|FG002|Overall Study|Withdrawal by Subject|4|||
143160486|NCT03163264|516131622|FG003|Overall Study|Withdrawal by Subject|2|||
143160487|NCT03163264|516131619|FG000|Overall Study|Lost to Follow-up|17|||
143160488|NCT03163264|516131620|FG001|Overall Study|Lost to Follow-up|20|||
143160489|NCT03163264|516131621|FG002|Overall Study|Lost to Follow-up|0|||
143160490|NCT03163264|516131622|FG003|Overall Study|Lost to Follow-up|0|||
143160491|NCT03163264|516131619|FG000|Overall Study|Death|0|||
143160492|NCT03163264|516131620|FG001|Overall Study|Death|2|||
143160493|NCT03163264|516131621|FG002|Overall Study|Death|0|||
143160494|NCT03163264|516131622|FG003|Overall Study|Death|0|||
143160495|NCT01026038|516131623|FG000|Overall Study|Lost to Follow-up|1|||
143160496|NCT01026038|516131624|FG001|Overall Study|Lost to Follow-up|1|||
143160497|NCT01026038|516131625|FG002|Overall Study|Lost to Follow-up|0|||
143160498|NCT03679884|516131626|FG000|Overall Study|Other|12|||
143160499|NCT03679884|516131627|FG001|Overall Study|Other|12|||
143160500|NCT03679884|516131628|FG002|Overall Study|Other|12|||
143160501|NCT03679884|516131629|FG003|Overall Study|Other|7|||
143160502|NCT03679884|516131630|FG004|Overall Study|Other|8|||
143160503|NCT03679884|516131626|FG000|Overall Study|Lack of Efficacy|15|||
143160504|NCT03679884|516131627|FG001|Overall Study|Lack of Efficacy|29|||
143160505|NCT03679884|516131628|FG002|Overall Study|Lack of Efficacy|13|||
143160506|NCT03679884|516131629|FG003|Overall Study|Lack of Efficacy|29|||
143160507|NCT03679884|516131630|FG004|Overall Study|Lack of Efficacy|10|||
143160508|NCT03679884|516131626|FG000|Overall Study|Death|1|||
143160509|NCT03679884|516131627|FG001|Overall Study|Death|0|||
143160510|NCT03679884|516131628|FG002|Overall Study|Death|0|||
143160511|NCT03679884|516131629|FG003|Overall Study|Death|0|||
143160512|NCT03679884|516131630|FG004|Overall Study|Death|0|||
143160513|NCT03679884|516131626|FG000|Overall Study|Adverse Event|2|||
143160514|NCT03679884|516131627|FG001|Overall Study|Adverse Event|10|||
143160515|NCT03679884|516131628|FG002|Overall Study|Adverse Event|9|||
143238345|NCT03763877|516427445|FG001|Overall Study|Adverse Event|1|||
143238346|NCT03763877|516427446|FG002|Overall Study|Adverse Event|3|||
143238347|NCT03763877|516427447|FG003|Overall Study|Adverse Event|1|||
143238348|NCT03763877|516427444|FG000|Overall Study|Protocol Violation|1|||
143238349|NCT03763877|516427445|FG001|Overall Study|Protocol Violation|1|||
143238350|NCT03763877|516427446|FG002|Overall Study|Protocol Violation|0|||
143238351|NCT03763877|516427447|FG003|Overall Study|Protocol Violation|0|||
143238352|NCT03763877|516427444|FG000|Overall Study|Lost to Follow-up|0|||
143238353|NCT03763877|516427445|FG001|Overall Study|Lost to Follow-up|1|||
143238354|NCT03763877|516427446|FG002|Overall Study|Lost to Follow-up|1|||
143238355|NCT03763877|516427447|FG003|Overall Study|Lost to Follow-up|0|||
143238356|NCT03040336|516427448|FG000|Overall Study|Death|1|||
143238357|NCT03040336|516427449|FG001|Overall Study|Death|0|||
143238358|NCT03040336|516427448|FG000|Overall Study|Withdrawal by Subject|2|||
143238359|NCT03040336|516427449|FG001|Overall Study|Withdrawal by Subject|3|||
143238360|NCT01774721|516427455|FG000|Overall Study|Death|133|||
143238361|NCT01774721|516427456|FG001|Overall Study|Death|152|||
143238362|NCT01774721|516427455|FG000|Overall Study|Withdrawal by Subject|20|||
143238363|NCT01774721|516427456|FG001|Overall Study|Withdrawal by Subject|14|||
143238364|NCT01774721|516427455|FG000|Overall Study|Lost to Follow-up|6|||
143238365|NCT01774721|516427456|FG001|Overall Study|Lost to Follow-up|7|||
143238366|NCT01774721|516427455|FG000|Overall Study|Did not meet eligibility criteria|0|||
143238367|NCT01774721|516427456|FG001|Overall Study|Did not meet eligibility criteria|3|||
143238368|NCT01774721|516427455|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
143238369|NCT01774721|516427456|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
143238370|NCT01774721|516427455|FG000|Overall Study|Study terminated by sponsor|5|||
143238371|NCT01774721|516427456|FG001|Overall Study|Study terminated by sponsor|0|||
143238372|NCT01774721|516427455|FG000|Overall Study|Disease progression|5|||
143238373|NCT01774721|516427456|FG001|Overall Study|Disease progression|0|||
143238374|NCT00628108|516427460|FG000|Overall Study|Adverse Event|0|||
143238375|NCT00628108|516427461|FG001|Overall Study|Adverse Event|3|||
143238376|NCT00628108|516427460|FG000|Overall Study|Withdrawal by Subject|1|||
143238377|NCT00628108|516427461|FG001|Overall Study|Withdrawal by Subject|0|||
143238378|NCT03848832|516427462|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
143238379|NCT03848832|516427463|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
143238380|NCT03848832|516427464|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
143238381|NCT03848832|516427462|FG000|Overall Study|Withdrawal by Subject|0|||
143238382|NCT03848832|516427463|FG001|Overall Study|Withdrawal by Subject|0|||
143238383|NCT03848832|516427464|FG002|Overall Study|Withdrawal by Subject|1|||
143238384|NCT03848832|516427462|FG000|Overall Study|Withdrawal (Covid-19)|0|||
143238385|NCT03848832|516427463|FG001|Overall Study|Withdrawal (Covid-19)|2|||
143238386|NCT03848832|516427464|FG002|Overall Study|Withdrawal (Covid-19)|0|||
143238387|NCT03848832|516427462|FG000|Overall Study|Physician Decision|2|||
143238388|NCT03848832|516427463|FG001|Overall Study|Physician Decision|1|||
143238389|NCT03848832|516427464|FG002|Overall Study|Physician Decision|3|||
143238390|NCT03848832|516427462|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
143238391|NCT03848832|516427463|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
143238392|NCT03848832|516427464|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
143033004|NCT03561883|515661454|FG000|Overall Study|Lost to Follow-up|2|||
143238393|NCT03848832|516427462|FG000|Overall Study|Adverse Event|1|||
143238394|NCT03848832|516427463|FG001|Overall Study|Adverse Event|0|||
143238395|NCT03848832|516427464|FG002|Overall Study|Adverse Event|0|||
143238396|NCT01759446|516427465|FG000|Overall Study|Protocol Violation|1|||
143238397|NCT01759446|516427466|FG001|Overall Study|Protocol Violation|0|||
143238398|NCT01759446|516427467|FG002|Overall Study|Protocol Violation|1|||
143238399|NCT01759446|516427468|FG003|Overall Study|Protocol Violation|0|||
143238400|NCT01759446|516427469|FG004|Overall Study|Protocol Violation|0|||
143238401|NCT01759446|516427465|FG000|Overall Study|Withdrawal by Subject|0|||
143238402|NCT01759446|516427466|FG001|Overall Study|Withdrawal by Subject|1|||
143238403|NCT01759446|516427467|FG002|Overall Study|Withdrawal by Subject|0|||
143238404|NCT01759446|516427468|FG003|Overall Study|Withdrawal by Subject|1|||
143238405|NCT01759446|516427469|FG004|Overall Study|Withdrawal by Subject|0|||
143238406|NCT01760733|516427471|FG000|Waiting List|Death|18|||
143238407|NCT01760733|516427471|FG000|Waiting List|Removed from waiting list|41|||
143238408|NCT01760733|516427471|FG000|Waiting List|Not received a transplant yet|13|||
143238409|NCT01760733|516427471|FG000|Transplanted|Not reached 10 years post transplant|184|||
143238410|NCT01760733|516427471|FG000|Transplanted|Death|26|||
143238411|NCT01760733|516427471|FG000|Transplanted|Graft loss|7|||
143238412|NCT00815659|516427472|FG000|Overall Study|Adverse Event|9|||
143238413|NCT00815659|516427472|FG000|Overall Study|Withdrawal by Subject|9|||
143238414|NCT00815659|516427472|FG000|Overall Study|Lost to Follow-up|4|||
143238415|NCT00815659|516427472|FG000|Overall Study|Protocol Violation|1|||
143238416|NCT00719472|516427473|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
143238417|NCT00719472|516427473|FG000|Enrolled in Study|Subject decision to withdraw|8|||
143238418|NCT00719472|516427473|FG000|Enrolled in Study|Various Reasons|17|||
143238419|NCT00719472|516427473|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
143238420|NCT00719472|516427473|FG000|Received Cycle 1 Treatment|Death|5|||
143238421|NCT00719472|516427473|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
143238422|NCT00719472|516427473|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
143238423|NCT00719472|516427473|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
143238424|NCT00719472|516427473|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
143238425|NCT00719472|516427473|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
143238426|NCT00719472|516427473|FG000|Received Cycle 2 Treatment|Death|6|||
143238427|NCT00719472|516427473|FG000|Received Cycle 2 Treatment|Disease progression|3|||
143238428|NCT00719472|516427473|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
143238429|NCT00719472|516427473|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
143238430|NCT00719472|516427473|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
143238431|NCT00719472|516427473|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
143238432|NCT03847896|516427474|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
143238433|NCT03847896|516427475|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
143238434|NCT03847896|516427476|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
143238435|NCT03847896|516427477|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
143238436|NCT03847896|516427478|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
143238437|NCT03847896|516427474|FG000|Overall Study|Withdrawal by Subject|2|||
143238438|NCT03847896|516427475|FG001|Overall Study|Withdrawal by Subject|10|||
143238439|NCT03847896|516427476|FG002|Overall Study|Withdrawal by Subject|5|||
143238440|NCT03847896|516427477|FG003|Overall Study|Withdrawal by Subject|9|||
143238441|NCT03847896|516427478|FG004|Overall Study|Withdrawal by Subject|8|||
143238442|NCT03847896|516427474|FG000|Overall Study|Withdrawal by parent/guardian|0|||
143238443|NCT03847896|516427475|FG001|Overall Study|Withdrawal by parent/guardian|0|||
143238444|NCT03847896|516427476|FG002|Overall Study|Withdrawal by parent/guardian|1|||
143238445|NCT03847896|516427477|FG003|Overall Study|Withdrawal by parent/guardian|0|||
143238446|NCT03847896|516427478|FG004|Overall Study|Withdrawal by parent/guardian|0|||
143238447|NCT03847896|516427474|FG000|Overall Study|Adverse Event|2|||
143238448|NCT03847896|516427475|FG001|Overall Study|Adverse Event|1|||
143238449|NCT03847896|516427476|FG002|Overall Study|Adverse Event|3|||
143238450|NCT03847896|516427477|FG003|Overall Study|Adverse Event|2|||
143238451|NCT03847896|516427478|FG004|Overall Study|Adverse Event|4|||
143238452|NCT03847896|516427474|FG000|Overall Study|A severe exacerbation event|0|||
143238453|NCT03847896|516427475|FG001|Overall Study|A severe exacerbation event|0|||
143238454|NCT03847896|516427476|FG002|Overall Study|A severe exacerbation event|0|||
143238455|NCT03847896|516427477|FG003|Overall Study|A severe exacerbation event|0|||
143238456|NCT03847896|516427478|FG004|Overall Study|A severe exacerbation event|3|||
143238457|NCT03847896|516427474|FG000|Overall Study|Protocol Violation|0|||
143238458|NCT03847896|516427475|FG001|Overall Study|Protocol Violation|2|||
143238459|NCT03847896|516427476|FG002|Overall Study|Protocol Violation|1|||
143238460|NCT03847896|516427477|FG003|Overall Study|Protocol Violation|0|||
143238461|NCT03847896|516427478|FG004|Overall Study|Protocol Violation|2|||
143238462|NCT03847896|516427474|FG000|Overall Study|Lost to Follow-up|0|||
143238463|NCT03847896|516427475|FG001|Overall Study|Lost to Follow-up|0|||
143238464|NCT03847896|516427476|FG002|Overall Study|Lost to Follow-up|0|||
143238465|NCT03847896|516427477|FG003|Overall Study|Lost to Follow-up|1|||
143238466|NCT03847896|516427478|FG004|Overall Study|Lost to Follow-up|0|||
143238467|NCT03847896|516427474|FG000|Overall Study|Condition under investigation worsened|0|||
143238468|NCT03847896|516427475|FG001|Overall Study|Condition under investigation worsened|0|||
143238469|NCT03847896|516427476|FG002|Overall Study|Condition under investigation worsened|0|||
143238470|NCT03847896|516427477|FG003|Overall Study|Condition under investigation worsened|1|||
143238471|NCT03847896|516427478|FG004|Overall Study|Condition under investigation worsened|1|||
143238472|NCT03847896|516427474|FG000|Overall Study|Lack of Efficacy|0|||
143238473|NCT03847896|516427475|FG001|Overall Study|Lack of Efficacy|0|||
143238474|NCT03847896|516427476|FG002|Overall Study|Lack of Efficacy|0|||
143238475|NCT03847896|516427477|FG003|Overall Study|Lack of Efficacy|2|||
143238476|NCT03847896|516427478|FG004|Overall Study|Lack of Efficacy|2|||
143238477|NCT03847896|516427474|FG000|Overall Study|Other reasons|3|||
143238478|NCT03847896|516427475|FG001|Overall Study|Other reasons|3|||
143495052|NCT01017952|517354446|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
143495053|NCT01017952|517354442|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
143495054|NCT01017952|517354443|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
143495055|NCT01017952|517354444|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
143495056|NCT01017952|517354445|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
143495057|NCT01017952|517354446|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
143033005|NCT03561883|515661455|FG001|Overall Study|Lost to Follow-up|6|||
143238479|NCT03847896|516427476|FG002|Overall Study|Other reasons|1|||
143238480|NCT03847896|516427477|FG003|Overall Study|Other reasons|2|||
143495058|NCT01017952|517354442|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
143033006|NCT03561883|515661454|FG000|Overall Study|Study Terminated by Sponsor|12|||
143160516|NCT03679884|516131629|FG003|Overall Study|Adverse Event|6|||
143160517|NCT03679884|516131630|FG004|Overall Study|Adverse Event|6|||
143160518|NCT03679884|516131626|FG000|Overall Study|Withdrawal by Subject|12|||
143160519|NCT03679884|516131627|FG001|Overall Study|Withdrawal by Subject|23|||
143160520|NCT03679884|516131628|FG002|Overall Study|Withdrawal by Subject|8|||
143160521|NCT03679884|516131629|FG003|Overall Study|Withdrawal by Subject|8|||
143160522|NCT03679884|516131630|FG004|Overall Study|Withdrawal by Subject|9|||
143160523|NCT03679884|516131626|FG000|Overall Study|Lost to Follow-up|1|||
143160524|NCT03679884|516131627|FG001|Overall Study|Lost to Follow-up|4|||
143160525|NCT03679884|516131628|FG002|Overall Study|Lost to Follow-up|2|||
143160526|NCT03679884|516131629|FG003|Overall Study|Lost to Follow-up|0|||
143160527|NCT03679884|516131630|FG004|Overall Study|Lost to Follow-up|3|||
143160528|NCT01108055|516131634|FG000|Overall Study|Ineligible|11|||
143160529|NCT01108055|516131634|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
143160530|NCT03339453|516131636|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
143160531|NCT03339453|516131637|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
143160532|NCT00236197|516131641|FG000|Overall Study|Withdrawal by Subject|3|||
143160533|NCT00236197|516131642|FG001|Overall Study|Withdrawal by Subject|2|||
143160534|NCT00236197|516131641|FG000|Overall Study|Lost to Follow-up|1|||
143160535|NCT00236197|516131642|FG001|Overall Study|Lost to Follow-up|5|||
143160536|NCT00236197|516131641|FG000|Overall Study|Protocol Violation|0|||
143160537|NCT00236197|516131642|FG001|Overall Study|Protocol Violation|3|||
143160538|NCT00236197|516131641|FG000|Overall Study|Medication non-compliance|1|||
143160539|NCT00236197|516131642|FG001|Overall Study|Medication non-compliance|2|||
143160540|NCT00236197|516131641|FG000|Overall Study|Other|0|||
143160541|NCT00236197|516131642|FG001|Overall Study|Other|2|||
143160542|NCT00800384|516131647|FG000|Overall Study|Withdrawal by Subject|24|||
143160543|NCT00800384|516131648|FG001|Overall Study|Withdrawal by Subject|17|||
143160544|NCT00800384|516131647|FG000|Overall Study|Lost to Follow-up|17|||
143160545|NCT00800384|516131648|FG001|Overall Study|Lost to Follow-up|26|||
143160546|NCT06868667|516131649|FG000|Overall Study|Death|0|||
143160547|NCT06868667|516131650|FG001|Overall Study|Death|4|||
143160548|NCT06868667|516131649|FG000|Overall Study|Lost to Follow-up|0|||
143160549|NCT06868667|516131650|FG001|Overall Study|Lost to Follow-up|1|||
143160550|NCT06868667|516131649|FG000|Overall Study|Withdrawal by Subject|1|||
143160551|NCT06868667|516131650|FG001|Overall Study|Withdrawal by Subject|0|||
143160552|NCT06868667|516131649|FG000|Overall Study|Ongoing|9|||
143160553|NCT06868667|516131650|FG001|Overall Study|Ongoing|9|||
143160554|NCT05330429|516131653|FG000|Overall Study|Study Terminated by Sponsor|4|||
143160555|NCT05330429|516131654|FG001|Overall Study|Study Terminated by Sponsor|33|||
143160556|NCT05330429|516131655|FG002|Overall Study|Study Terminated by Sponsor|12|||
143238481|NCT03847896|516427478|FG004|Overall Study|Other reasons|1|||
143238482|NCT02395471|516427479|FG000|Overall Study|Lost to Follow-up|2|||
143238483|NCT02395471|516427480|FG001|Overall Study|Lost to Follow-up|0|||
143238484|NCT02395471|516427479|FG000|Overall Study|Withdrawal by Subject|2|||
143238485|NCT02395471|516427480|FG001|Overall Study|Withdrawal by Subject|1|||
143238486|NCT02395471|516427479|FG000|Overall Study|Physician Decision|1|||
143238487|NCT02395471|516427480|FG001|Overall Study|Physician Decision|0|||
143238488|NCT02395471|516427479|FG000|Overall Study|Protocol Violation|0|||
143238489|NCT02395471|516427480|FG001|Overall Study|Protocol Violation|1|||
143238490|NCT02395471|516427479|FG000|Overall Study|Failure to swollow sponge twice|1|||
143238491|NCT02395471|516427480|FG001|Overall Study|Failure to swollow sponge twice|0|||
143238492|NCT02395471|516427479|FG000|Overall Study|Patient did not return for procedure|0|||
143238493|NCT02395471|516427480|FG001|Overall Study|Patient did not return for procedure|1|||
143238494|NCT02395471|516427479|FG000|Overall Study|Subject not eligible|1|||
143238495|NCT02395471|516427480|FG001|Overall Study|Subject not eligible|0|||
143495059|NCT01017952|517354443|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
143160557|NCT05330429|516131653|FG000|Overall Study|Death|5|||
143160558|NCT05330429|516131654|FG001|Overall Study|Death|2|||
143160559|NCT05330429|516131655|FG002|Overall Study|Death|4|||
143160560|NCT05330429|516131653|FG000|Overall Study|Withdrew Consent|0|||
143160561|NCT05330429|516131654|FG001|Overall Study|Withdrew Consent|5|||
143160562|NCT05330429|516131655|FG002|Overall Study|Withdrew Consent|4|||
143160563|NCT05330429|516131653|FG000|Overall Study|Investigator's Discretion|0|||
143160564|NCT05330429|516131654|FG001|Overall Study|Investigator's Discretion|1|||
143160565|NCT05330429|516131655|FG002|Overall Study|Investigator's Discretion|3|||
143160566|NCT05330429|516131653|FG000|Overall Study|Subject Decision|1|||
143160567|NCT05330429|516131654|FG001|Overall Study|Subject Decision|2|||
143160568|NCT05330429|516131655|FG002|Overall Study|Subject Decision|0|||
143160569|NCT05330429|516131653|FG000|Overall Study|Lost to Follow-up|0|||
143160570|NCT05330429|516131654|FG001|Overall Study|Lost to Follow-up|1|||
143160571|NCT05330429|516131655|FG002|Overall Study|Lost to Follow-up|0|||
143160572|NCT02151604|516131656|FG000|Overall Study|Lost to Follow-up|3|||
143160573|NCT02151604|516131656|FG000|Overall Study|Withdrawal by Subject|2|||
143238496|NCT02453321|516427481|FG000|Overall Study|Weakness|1|||
143238497|NCT02453321|516427482|FG001|Overall Study|Weakness|1|||
143238498|NCT02453321|516427483|FG002|Overall Study|Weakness|2|||
143160574|NCT02151604|516131656|FG000|Overall Study|Physician Decision|3|||
143238499|NCT02453321|516427481|FG000|Overall Study|Deep Venous Thrombosis|0|||
143033007|NCT03561883|515661455|FG001|Overall Study|Study Terminated by Sponsor|11|||
143033008|NCT03561883|515661454|FG000|Overall Study|Physician Decision|1|||
143033009|NCT03561883|515661455|FG001|Overall Study|Physician Decision|0|||
143033010|NCT03561883|515661454|FG000|Overall Study|Randomized by Mistake|1|||
143033011|NCT03561883|515661455|FG001|Overall Study|Randomized by Mistake|0|||
143033012|NCT03561883|515661454|FG000|Overall Study|Other, Not Specified|3|||
143033013|NCT03561883|515661455|FG001|Overall Study|Other, Not Specified|2|||
143033014|NCT01004172|515661467|FG000|Overall Study|Progressive Disease in CNS Only|16|||
143033015|NCT01004172|515661467|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
143033016|NCT01004172|515661467|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
143033017|NCT01004172|515661467|FG000|Overall Study|Adverse Event|1|||
143160575|NCT02151604|516131656|FG000|Overall Study|Death|1|||
143160576|NCT02931539|516131658|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
143160577|NCT02931539|516131659|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
143160578|NCT02931539|516131660|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
143160579|NCT02931539|516131658|FG000|Period 1: Treatment Phase|Adverse Event|5|||
143495060|NCT01017952|517354444|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
143495061|NCT01017952|517354445|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
143033018|NCT01004172|515661467|FG000|Overall Study|Physician Decision|1|||
143033019|NCT01004172|515661467|FG000|Overall Study|Symptomatic Deterioration|2|||
143160580|NCT02931539|516131659|FG001|Period 1: Treatment Phase|Adverse Event|1|||
143160581|NCT02931539|516131660|FG002|Period 1: Treatment Phase|Adverse Event|0|||
143160582|NCT02931539|516131658|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
143160583|NCT02931539|516131659|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
143495062|NCT01017952|517354446|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
143495063|NCT01017952|517354442|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
143160584|NCT02931539|516131660|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
143160585|NCT02931539|516131658|FG000|Period 1: Treatment Phase|Death|8|||
143160586|NCT02931539|516131659|FG001|Period 1: Treatment Phase|Death|24|||
143160587|NCT02931539|516131660|FG002|Period 1: Treatment Phase|Death|0|||
143160588|NCT02931539|516131658|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
143160589|NCT02931539|516131659|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
143160590|NCT02931539|516131660|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
143160591|NCT02931539|516131658|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
143160592|NCT02931539|516131659|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
143160593|NCT02931539|516131660|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
143160594|NCT02931539|516131658|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
143160595|NCT02931539|516131659|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
143160596|NCT02931539|516131660|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
143160597|NCT02931539|516131658|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
143160598|NCT02931539|516131659|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
143160599|NCT02931539|516131660|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
143160600|NCT00655746|516131661|FG000|Overall Study|Withdrawal by Subject|1|||
143160601|NCT03004183|516133384|FG000|Overall Study|Adverse Event|7|||
143160602|NCT03004183|516133384|FG000|Overall Study|Lost to Follow-up|1|||
143160603|NCT03004183|516133384|FG000|Overall Study|Physician Decision|40|||
143160604|NCT03004183|516133384|FG000|Overall Study|Withdrawal by Subject|1|||
143160605|NCT03004183|516133384|FG000|Overall Study|COVID-19|1|||
143160606|NCT02529488|516133385|FG000|Overall Study|Adverse Event|1|||
143160607|NCT02529488|516133385|FG000|Overall Study|Death|3|||
143160608|NCT02698787|516133386|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
143160609|NCT02698787|516133387|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
143160610|NCT02821000|516133391|FG000|Overall Study|Death|89|||
143160611|NCT02821000|516133391|FG000|Overall Study|Sponsor Decision|12|||
143160612|NCT02821000|516133391|FG000|Overall Study|Withdrawal by Subject|2|||
143160613|NCT00326495|516133392|FG000|Overall Study|Switched to alternative treatment|1|||
143160614|NCT00326495|516133392|FG000|Overall Study|Disease progression before treatment|1|||
143160615|NCT00326495|516133392|FG000|Overall Study|Refused further treatment|2|||
143160616|NCT00326495|516133392|FG000|Overall Study|Subject off study before assessment|1|||
143160617|NCT04359680|516133393|FG000|Overall Study|Withdrawal by Subject|29|||
143160618|NCT04359680|516133394|FG001|Overall Study|Withdrawal by Subject|24|||
143160619|NCT04359680|516133393|FG000|Overall Study|Adverse Event|6|||
143160620|NCT04359680|516133394|FG001|Overall Study|Adverse Event|2|||
143364070|NCT03283553|516875528|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
143364071|NCT03283553|516875529|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
143160621|NCT04359680|516133393|FG000|Overall Study|Lost to Follow-up|56|||
143160622|NCT04359680|516133394|FG001|Overall Study|Lost to Follow-up|59|||
143160623|NCT04359680|516133393|FG000|Overall Study|Protocol Violation|3|||
143495064|NCT01017952|517354443|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
143495065|NCT01017952|517354444|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
143033020|NCT00408902|515661471|FG000|Overall Study|Lack of Efficacy|7|||
143033021|NCT00408902|515661471|FG000|Overall Study|Adverse Event|3|||
143495066|NCT01017952|517354445|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
143495067|NCT01017952|517354446|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
143495068|NCT01017952|517354442|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
143495069|NCT01017952|517354443|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
143495070|NCT01017952|517354444|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
143495071|NCT01017952|517354445|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
143495072|NCT01017952|517354446|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
143495073|NCT01064167|517354447|FG000|Overall Study|Protocol Violation|14|||
143495074|NCT01064167|517354448|FG001|Overall Study|Protocol Violation|15|||
143495075|NCT03984305|517354450|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
143495076|NCT03984305|517354451|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
143495077|NCT03984305|517354450|FG000|Overall Study|Withdrawal by Subject|3|||
143495078|NCT03984305|517354451|FG001|Overall Study|Withdrawal by Subject|3|||
143495079|NCT03984305|517354450|FG000|Overall Study|Lost to Follow-up|1|||
143495080|NCT03984305|517354451|FG001|Overall Study|Lost to Follow-up|0|||
143495081|NCT01656434|517354452|FG000|Overall Study|Adverse Event|199|||
143495082|NCT01656434|517354453|FG001|Overall Study|Adverse Event|63|||
143495083|NCT01656434|517354452|FG000|Overall Study|Enrollment terminated at trial site|2|||
143495084|NCT01656434|517354453|FG001|Overall Study|Enrollment terminated at trial site|0|||
143495085|NCT01656434|517354452|FG000|Overall Study|Lost to Follow-up|309|||
143495086|NCT01656434|517354453|FG001|Overall Study|Lost to Follow-up|76|||
143495087|NCT01656434|517354452|FG000|Overall Study|Site discontinued study participation|24|||
143495088|NCT01656434|517354453|FG001|Overall Study|Site discontinued study participation|9|||
143495089|NCT01656434|517354452|FG000|Overall Study|Screen failure|2|||
143495090|NCT01656434|517354453|FG001|Overall Study|Screen failure|0|||
143495091|NCT01656434|517354452|FG000|Overall Study|Protocol Violation|7|||
143495092|NCT01656434|517354453|FG001|Overall Study|Protocol Violation|0|||
143495093|NCT01656434|517354452|FG000|Overall Study|Pregnancy wish|18|||
143495094|NCT01656434|517354453|FG001|Overall Study|Pregnancy wish|6|||
143495095|NCT01656434|517354452|FG000|Overall Study|Pregnancy|45|||
143495096|NCT01656434|517354453|FG001|Overall Study|Pregnancy|10|||
143495097|NCT01656434|517354452|FG000|Overall Study|Physician Decision|7|||
143495098|NCT01656434|517354453|FG001|Overall Study|Physician Decision|2|||
143495099|NCT01656434|517354452|FG000|Overall Study|Non-compliance with study drug|48|||
143495100|NCT01656434|517354453|FG001|Overall Study|Non-compliance with study drug|9|||
143495101|NCT01656434|517354452|FG000|Overall Study|Study terminated by sponsor|1501|||
143495102|NCT01656434|517354453|FG001|Overall Study|Study terminated by sponsor|348|||
143495103|NCT01656434|517354452|FG000|Overall Study|Participant discontinued; drug related|13|||
143495104|NCT01656434|517354453|FG001|Overall Study|Participant discontinued; drug related|4|||
143495105|NCT01656434|517354452|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
143495106|NCT01656434|517354453|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
143495107|NCT01656434|517354452|FG000|Overall Study|Non-compliance with protocol|39|||
143495108|NCT01656434|517354453|FG001|Overall Study|Non-compliance with protocol|15|||
143495109|NCT01656434|517354452|FG000|Overall Study|Participant moved|40|||
143495110|NCT01656434|517354453|FG001|Overall Study|Participant moved|12|||
143495111|NCT01656434|517354452|FG000|Overall Study|Participant withdrew consent|28|||
143495112|NCT01656434|517354453|FG001|Overall Study|Participant withdrew consent|9|||
143495113|NCT01656434|517354452|FG000|Overall Study|Withdrawal by Subject|64|||
143495114|NCT01656434|517354453|FG001|Overall Study|Withdrawal by Subject|7|||
143495115|NCT01235962|517354454|FG000|Overall Study|Withdrawal by Subject|20|||
143495116|NCT01235962|517354455|FG001|Overall Study|Withdrawal by Subject|19|||
143495117|NCT01235962|517354456|FG002|Overall Study|Withdrawal by Subject|62|||
143495118|NCT01235962|517354457|FG003|Overall Study|Withdrawal by Subject|49|||
143495119|NCT01235962|517354454|FG000|Overall Study|Lost to Follow-up|21|||
143495120|NCT01235962|517354455|FG001|Overall Study|Lost to Follow-up|16|||
143495121|NCT01235962|517354456|FG002|Overall Study|Lost to Follow-up|47|||
143495122|NCT01235962|517354457|FG003|Overall Study|Lost to Follow-up|32|||
143495123|NCT01235962|517354454|FG000|Overall Study|Physician Decision|5|||
143495124|NCT01235962|517354455|FG001|Overall Study|Physician Decision|0|||
143495125|NCT01235962|517354456|FG002|Overall Study|Physician Decision|9|||
143495126|NCT01235962|517354457|FG003|Overall Study|Physician Decision|5|||
143495127|NCT01405053|517354458|FG000|Overall Study|Adverse Event|3|||
143495128|NCT01405053|517354459|FG001|Overall Study|Adverse Event|0|||
143495129|NCT01405053|517354458|FG000|Overall Study|Lost to Follow-up|0|||
143495130|NCT01405053|517354459|FG001|Overall Study|Lost to Follow-up|1|||
143495131|NCT01405053|517354458|FG000|Overall Study|Participant choice|2|||
143495132|NCT01405053|517354459|FG001|Overall Study|Participant choice|1|||
143495133|NCT01405053|517354458|FG000|Overall Study|Inadequate therapeutic effect|2|||
143495134|NCT01405053|517354459|FG001|Overall Study|Inadequate therapeutic effect|1|||
143495135|NCT01405053|517354458|FG000|Overall Study|Withdrawal by Subject|3|||
143495136|NCT01405053|517354459|FG001|Overall Study|Withdrawal by Subject|4|||
143495137|NCT01405053|517354458|FG000|Overall Study|Other|0|||
143495138|NCT01405053|517354459|FG001|Overall Study|Other|1|||
143495139|NCT06098729|517354471|FG000|Overall Study|Withdrawal by Subject|1|||
143495140|NCT00993928|517354472|FG000|Overall Study|Withdrawal by Subject|4|||
143033022|NCT00841100|515661474|FG000|Phase 1 (28 Days)|Adverse Event|1|||
143033023|NCT00841100|515661474|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
143033024|NCT03338972|515661475|FG000|Overall Study|Death|1|||
143033025|NCT03338972|515661476|FG001|Overall Study|Death|1|||
143033026|NCT03338972|515661477|FG002|Overall Study|Death|0|||
143033027|NCT03338972|515661478|FG003|Overall Study|Death|0|||
143033028|NCT03338972|515661475|FG000|Overall Study|Withdrawal by Subject|1|||
143033029|NCT03338972|515661476|FG001|Overall Study|Withdrawal by Subject|0|||
143033030|NCT03338972|515661477|FG002|Overall Study|Withdrawal by Subject|0|||
143033031|NCT03338972|515661478|FG003|Overall Study|Withdrawal by Subject|0|||
143033032|NCT03633721|515661479|FG000|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|2|||
143033033|NCT03633721|515661480|FG001|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
143033034|NCT03633721|515661481|FG002|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|0|||
143033035|NCT03633721|515661482|FG003|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
143033036|NCT03069937|515661483|FG000|Overall Study|Second primary malignancy noted|1|||
143033037|NCT00419770|515663008|FG000|Overall Study|Withdrawal by Subject|5|||
143033038|NCT00419770|515663009|FG001|Overall Study|Withdrawal by Subject|1|||
143033039|NCT04526210|515663015|FG000|Overall Study|Sponsor decision|7|||
143033040|NCT04526210|515663016|FG001|Overall Study|Sponsor decision|5|||
143033041|NCT04526210|515663015|FG000|Overall Study|Withdrawal by Subject|3|||
143238500|NCT02453321|516427482|FG001|Overall Study|Deep Venous Thrombosis|1|||
143238501|NCT02453321|516427483|FG002|Overall Study|Deep Venous Thrombosis|0|||
143238502|NCT01244893|516427484|FG000|Baseline|Protocol Violation|0|||
143238503|NCT01244893|516427485|FG001|Baseline|Protocol Violation|1|||
143238504|NCT01244893|516427484|FG000|1-Week Follow Up|Lost to Follow-up|1|||
143238505|NCT01244893|516427485|FG001|1-Week Follow Up|Lost to Follow-up|0|||
143238506|NCT00357552|516427486|FG000|Screening|Did not meet eligibility criteria|84|||
143238507|NCT00357552|516427486|FG000|Weeks 0 to 24|Death|1|||
143238508|NCT00357552|516427486|FG000|Weeks 24 to 104|Death|3|||
143238509|NCT00357552|516427486|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
143238510|NCT00882557|516427491|FG000|Overall Study|Withdrawal by Subject|1|||
143238511|NCT00882557|516427492|FG001|Overall Study|Withdrawal by Subject|0|||
143238512|NCT00882557|516427491|FG000|Overall Study|Trouble with Vein Access|1|||
143238513|NCT00882557|516427492|FG001|Overall Study|Trouble with Vein Access|0|||
143238514|NCT00882557|516427491|FG000|Overall Study|Randomized Not Treated|0|||
143238515|NCT00882557|516427492|FG001|Overall Study|Randomized Not Treated|1|||
143238516|NCT03938259|516427499|FG000|Overall Study|unable to establish baseline for ventilation|1|||
143238517|NCT03938259|516427500|FG001|Overall Study|unable to establish baseline for ventilation|1|||
143238518|NCT01907854|516427501|FG000|Overall Study|Protocol Violation|1|||
143238519|NCT01907854|516427502|FG001|Overall Study|Protocol Violation|1|||
143238520|NCT01907854|516427501|FG000|Overall Study|Withdrawal by Subject|9|||
143238521|NCT01907854|516427502|FG001|Overall Study|Withdrawal by Subject|7|||
143238522|NCT01907854|516427501|FG000|Overall Study|Lost to Follow-up|2|||
143238523|NCT01907854|516427502|FG001|Overall Study|Lost to Follow-up|2|||
143238524|NCT01907854|516427501|FG000|Overall Study|Unclassified|4|||
143238525|NCT01907854|516427502|FG001|Overall Study|Unclassified|3|||
143238526|NCT01657019|516427503|FG000|Overall Study|Withdrawal by Subject|65|||
143238527|NCT01657019|516427503|FG000|Overall Study|Adverse Event|55|||
143238528|NCT01657019|516427503|FG000|Overall Study|Lost to Follow-up|48|||
143238529|NCT01657019|516427503|FG000|Overall Study|Protocol Violation|6|||
143238530|NCT01657019|516427503|FG000|Overall Study|Lack of Efficacy|3|||
143238531|NCT01657019|516427503|FG000|Overall Study|Other|58|||
143238532|NCT03594110|516427507|FG000|Interventional Part|Participant concerned about study treatment|23|||
143238533|NCT03594110|516427508|FG001|Interventional Part|Participant concerned about study treatment|28|||
143238534|NCT03594110|516427507|FG000|Interventional Part|Doctor advice|38|||
143238535|NCT03594110|516427508|FG001|Interventional Part|Doctor advice|40|||
143238536|NCT03594110|516427507|FG000|Interventional Part|Participants' wish|89|||
143238537|NCT03594110|516427508|FG001|Interventional Part|Participants' wish|68|||
143238538|NCT03594110|516427507|FG000|Interventional Part|Adverse event-non-fatal events|119|||
143495141|NCT00993928|517354473|FG001|Overall Study|Withdrawal by Subject|7|||
143495142|NCT00993928|517354472|FG000|Overall Study|ineligible|1|||
143495143|NCT00993928|517354473|FG001|Overall Study|ineligible|0|||
143495144|NCT02302963|517354474|FG000|Overall Study|Withdrawal by Subject|2|||
143238539|NCT03594110|516427508|FG001|Interventional Part|Adverse event-non-fatal events|116|||
143238540|NCT03594110|516427507|FG000|Interventional Part|Study drug stopped, reason missing|336|||
143238541|NCT03594110|516427508|FG001|Interventional Part|Study drug stopped, reason missing|294|||
143238542|NCT03594110|516427507|FG000|Interventional Part|Cannot attend clinic because of personal problems|8|||
143033042|NCT04526210|515663016|FG001|Overall Study|Withdrawal by Subject|2|||
143238543|NCT03594110|516427508|FG001|Interventional Part|Cannot attend clinic because of personal problems|16|||
143238544|NCT03594110|516427507|FG000|Interventional Part|Cannot attend clinic because moving out of the area|15|||
143495145|NCT02302963|517354475|FG001|Overall Study|Withdrawal by Subject|1|||
143033043|NCT01781637|515663017|FG000|Overall Study|Adverse Event|1|||
143033044|NCT01781637|515663018|FG001|Overall Study|Adverse Event|0|||
143033045|NCT01781637|515663017|FG000|Overall Study|Lack of Efficacy|2|||
143033046|NCT01781637|515663018|FG001|Overall Study|Lack of Efficacy|6|||
143033047|NCT01781637|515663017|FG000|Overall Study|Withdrawal by Subject|1|||
143033048|NCT01781637|515663018|FG001|Overall Study|Withdrawal by Subject|0|||
143033049|NCT00090857|515663019|FG000|Overall Study|Lost to Follow-up|0|||
143033050|NCT00090857|515663020|FG001|Overall Study|Lost to Follow-up|1|||
143033051|NCT00090857|515663019|FG000|Overall Study|Withdrawal by Subject|2|||
143495146|NCT02302963|517354474|FG000|Overall Study|Steroid injection|0|||
143495147|NCT02302963|517354475|FG001|Overall Study|Steroid injection|1|||
143033052|NCT00090857|515663020|FG001|Overall Study|Withdrawal by Subject|0|||
143033053|NCT00090857|515663019|FG000|Overall Study|Adverse Event|2|||
143033054|NCT00090857|515663020|FG001|Overall Study|Adverse Event|2|||
143033055|NCT05097326|515663021|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
143033056|NCT05097326|515663022|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
143033057|NCT00630305|515663027|FG000|Overall Study|Withdrawal by Subject|1|||
143033058|NCT00630305|515663027|FG000|Overall Study|Inability to insert contact lens|1|||
143033059|NCT01085045|515663028|FG000|Part A|Withdrawal by Subject|4|||
143033060|NCT01085045|515663028|FG000|Part A|Adverse Event|6|||
143033061|NCT01085045|515663028|FG000|Part A|Protocol Violation|1|||
143033062|NCT01085045|515663028|FG000|Part A|Protocol Specified Criteria|7|||
143033063|NCT01085045|515663028|FG000|Part B|Withdrawal by Subject|2|||
143495148|NCT02302963|517354474|FG000|Overall Study|Physician Decision|1|||
143495149|NCT02302963|517354475|FG001|Overall Study|Physician Decision|0|||
143495150|NCT01920711|517354478|FG000|Overall Study|Death|347|||
143495151|NCT01920711|517354479|FG001|Overall Study|Death|356|||
143495152|NCT01920711|517354478|FG000|Overall Study|Lost to Follow-up|13|||
143495153|NCT01920711|517354479|FG001|Overall Study|Lost to Follow-up|14|||
143495154|NCT01920711|517354478|FG000|Overall Study|Withdrawal by Subject|4|||
143495155|NCT01920711|517354479|FG001|Overall Study|Withdrawal by Subject|3|||
143495156|NCT03551743|517354483|FG000|Overall Study|Adverse Event|1|||
143495157|NCT03551743|517354484|FG001|Overall Study|Adverse Event|0|||
143495158|NCT03551743|517354485|FG002|Overall Study|Adverse Event|0|||
143495159|NCT03551743|517354486|FG003|Overall Study|Adverse Event|0|||
143495160|NCT03551743|517354483|FG000|Overall Study|Withdrawal by Subject|1|||
143495161|NCT03551743|517354484|FG001|Overall Study|Withdrawal by Subject|0|||
143495162|NCT03551743|517354485|FG002|Overall Study|Withdrawal by Subject|0|||
143495163|NCT03551743|517354486|FG003|Overall Study|Withdrawal by Subject|0|||
143495164|NCT02319044|517354487|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
143495165|NCT02319044|517354488|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
143495166|NCT02319044|517354489|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
143495167|NCT02319044|517354487|FG000|Overall Study|Withdrawal by Subject|3|||
143495168|NCT02319044|517354488|FG001|Overall Study|Withdrawal by Subject|3|||
143495169|NCT02319044|517354489|FG002|Overall Study|Withdrawal by Subject|6|||
143495170|NCT02319044|517354487|FG000|Overall Study|Condition under investigation worsened|100|||
143495171|NCT02319044|517354488|FG001|Overall Study|Condition under investigation worsened|50|||
143495172|NCT02319044|517354489|FG002|Overall Study|Condition under investigation worsened|46|||
143495173|NCT02319044|517354487|FG000|Overall Study|Adverse Event|17|||
143495174|NCT02319044|517354488|FG001|Overall Study|Adverse Event|2|||
143495175|NCT02319044|517354489|FG002|Overall Study|Adverse Event|8|||
143495176|NCT02319044|517354487|FG000|Overall Study|Study specific discontinuation criteria|2|||
143495177|NCT02319044|517354488|FG001|Overall Study|Study specific discontinuation criteria|2|||
143495178|NCT02319044|517354489|FG002|Overall Study|Study specific discontinuation criteria|1|||
143495179|NCT02319044|517354487|FG000|Overall Study|Not treated|0|||
143033064|NCT01085045|515663028|FG000|Part B|Protocol Specified Criteria|6|||
143033065|NCT01085045|515663028|FG000|Part B|Lost to Follow-up|1|||
143033066|NCT01085045|515663028|FG000|Part B|Adverse Event|6|||
143033067|NCT01494506|515663033|FG000|Overall Study|Lack of Efficacy|77|||
143033068|NCT01494506|515663034|FG001|Overall Study|Lack of Efficacy|83|||
143033069|NCT01494506|515663035|FG002|Overall Study|Lack of Efficacy|57|||
143033070|NCT01494506|515663033|FG000|Overall Study|Adverse Event|17|||
143033071|NCT01494506|515663034|FG001|Overall Study|Adverse Event|10|||
143238545|NCT03594110|516427508|FG001|Interventional Part|Cannot attend clinic because moving out of the area|9|||
143495180|NCT02319044|517354488|FG001|Overall Study|Not treated|2|||
143495181|NCT02319044|517354489|FG002|Overall Study|Not treated|2|||
143495182|NCT02317562|517354490|FG000|Overall Study|Physician Decision|1|||
143495183|NCT02317562|517354490|FG000|Overall Study|early termination of the study|8|||
143495184|NCT02317562|517354490|FG000|Overall Study|Lack of Efficacy|4|||
143495185|NCT02317562|517354490|FG000|Overall Study|Withdrawal by Subject|1|||
143495186|NCT00626093|517354491|FG000|Overall Study|Lost to Follow-up|5|||
143495187|NCT00626093|517354491|FG000|Overall Study|Death|1|||
143495188|NCT00626093|517354491|FG000|Overall Study|Physician Decision|4|||
143495189|NCT00626093|517354491|FG000|Overall Study|Withdrawal by Subject|6|||
143033072|NCT01494506|515663035|FG002|Overall Study|Adverse Event|11|||
143033073|NCT01494506|515663033|FG000|Overall Study|Death|9|||
143033074|NCT01494506|515663034|FG001|Overall Study|Death|5|||
143033075|NCT01494506|515663035|FG002|Overall Study|Death|2|||
143033076|NCT01494506|515663033|FG000|Overall Study|Physician Decision|7|||
143033077|NCT01494506|515663034|FG001|Overall Study|Physician Decision|5|||
143033078|NCT01494506|515663035|FG002|Overall Study|Physician Decision|4|||
143495190|NCT00626093|517354491|FG000|Overall Study|Protocol Violation|1|||
143495191|NCT00626093|517354491|FG000|Overall Study|One of the required devices not implante|6|||
143495192|NCT03891901|517354492|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
143033079|NCT01494506|515663033|FG000|Overall Study|Withdrawal by Subject|17|||
143033080|NCT01494506|515663034|FG001|Overall Study|Withdrawal by Subject|20|||
143033081|NCT01494506|515663035|FG002|Overall Study|Withdrawal by Subject|14|||
143033082|NCT01494506|515663033|FG000|Overall Study|Clinical Deterioration|21|||
143033083|NCT01494506|515663034|FG001|Overall Study|Clinical Deterioration|17|||
143495193|NCT03891901|517354493|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
143495194|NCT03891901|517354494|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
143033084|NCT01494506|515663035|FG002|Overall Study|Clinical Deterioration|13|||
143033085|NCT01494506|515663033|FG000|Overall Study|Sponsor Decision|0|||
143033086|NCT01494506|515663034|FG001|Overall Study|Sponsor Decision|0|||
143033087|NCT01494506|515663035|FG002|Overall Study|Sponsor Decision|1|||
143033088|NCT01494506|515663033|FG000|Overall Study|Other|0|||
143033089|NCT01494506|515663034|FG001|Overall Study|Other|3|||
143033090|NCT01494506|515663035|FG002|Overall Study|Other|1|||
143033091|NCT02924038|515663036|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
143033092|NCT02924038|515663037|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
143033093|NCT02395822|515663041|FG000|Overall Study|Withdrawal by Subject|1|||
143033094|NCT02395822|515663041|FG000|Overall Study|Death|1|||
143033095|NCT00453362|515663046|FG000|Overall Study|Adverse Event|5|||
143495195|NCT03891901|517354495|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
143495196|NCT03891901|517354496|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
143495197|NCT03891901|517354497|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
143495198|NCT03891901|517354498|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
143495199|NCT03891901|517354499|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
143495200|NCT03891901|517354500|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
143495201|NCT03891901|517354492|FG000|Overall Study|Adverse Event|2|||
143495202|NCT03891901|517354493|FG001|Overall Study|Adverse Event|2|||
143033096|NCT00453362|515663046|FG000|Overall Study|Death|7|||
143033097|NCT00453362|515663046|FG000|Overall Study|Physician Decision|2|||
143033098|NCT00453362|515663046|FG000|Overall Study|Withdrawal by Subject|3|||
143033099|NCT00453362|515663046|FG000|Overall Study|Progression of disease|56|||
143033100|NCT00453362|515663046|FG000|Overall Study|Screening Failure|14|||
143033101|NCT00433147|515663048|FG000|Overall Study|Adverse Event|0|||
143033102|NCT00433147|515663049|FG001|Overall Study|Adverse Event|1|||
143033103|NCT00433147|515663050|FG002|Overall Study|Adverse Event|0|||
143033104|NCT00433147|515663051|FG003|Overall Study|Adverse Event|0|||
143033105|NCT02937701|515663052|FG000|Day 1 to Week 22|Adverse Event|11|||
143033106|NCT02937701|515663053|FG001|Day 1 to Week 22|Adverse Event|14|||
143033107|NCT02937701|515663054|FG002|Day 1 to Week 22|Adverse Event|0|||
143033108|NCT02937701|515663055|FG003|Day 1 to Week 22|Adverse Event|0|||
143033109|NCT02937701|515663056|FG004|Day 1 to Week 22|Adverse Event|0|||
143033110|NCT02937701|515663052|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
143033111|NCT02937701|515663053|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
143033112|NCT02937701|515663054|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
143033113|NCT02937701|515663055|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
143033114|NCT02937701|515663056|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
143033115|NCT02937701|515663052|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
143033116|NCT02937701|515663053|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
143033117|NCT02937701|515663054|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
143033118|NCT02937701|515663055|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
143033119|NCT02937701|515663056|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
143033120|NCT02937701|515663052|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
143033121|NCT02937701|515663053|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
143033122|NCT02937701|515663054|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
143033123|NCT02937701|515663055|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
143033124|NCT02937701|515663056|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
143033125|NCT02937701|515663052|FG000|Day 1 to Week 22|Death|1|||
143033126|NCT02937701|515663053|FG001|Day 1 to Week 22|Death|1|||
143033127|NCT02937701|515663054|FG002|Day 1 to Week 22|Death|0|||
143033128|NCT02937701|515663055|FG003|Day 1 to Week 22|Death|0|||
143033129|NCT02937701|515663056|FG004|Day 1 to Week 22|Death|0|||
143033130|NCT02937701|515663052|FG000|Day 1 to Week 22|Protocol Violation|1|||
143033131|NCT02937701|515663053|FG001|Day 1 to Week 22|Protocol Violation|1|||
143033132|NCT02937701|515663054|FG002|Day 1 to Week 22|Protocol Violation|0|||
143033133|NCT02937701|515663055|FG003|Day 1 to Week 22|Protocol Violation|0|||
143033134|NCT02937701|515663056|FG004|Day 1 to Week 22|Protocol Violation|0|||
143033135|NCT02937701|515663052|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
143495203|NCT03891901|517354494|FG002|Overall Study|Adverse Event|0|||
143033136|NCT02937701|515663053|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
143160624|NCT04359680|516133394|FG001|Overall Study|Protocol Violation|5|||
143495204|NCT03891901|517354495|FG003|Overall Study|Adverse Event|0|||
143495205|NCT03891901|517354496|FG004|Overall Study|Adverse Event|0|||
143495206|NCT03891901|517354497|FG005|Overall Study|Adverse Event|0|||
143495207|NCT03891901|517354498|FG006|Overall Study|Adverse Event|0|||
143495208|NCT03891901|517354499|FG007|Overall Study|Adverse Event|0|||
143495209|NCT03891901|517354500|FG008|Overall Study|Adverse Event|0|||
143495210|NCT03891901|517354492|FG000|Overall Study|Poor venous access|1|||
143495211|NCT03891901|517354493|FG001|Overall Study|Poor venous access|0|||
143495212|NCT03891901|517354494|FG002|Overall Study|Poor venous access|0|||
143495213|NCT03891901|517354495|FG003|Overall Study|Poor venous access|0|||
143495214|NCT03891901|517354496|FG004|Overall Study|Poor venous access|0|||
143495215|NCT03891901|517354497|FG005|Overall Study|Poor venous access|0|||
143495216|NCT03891901|517354498|FG006|Overall Study|Poor venous access|0|||
143495217|NCT03891901|517354499|FG007|Overall Study|Poor venous access|0|||
143495218|NCT03891901|517354500|FG008|Overall Study|Poor venous access|0|||
143495219|NCT03891901|517354492|FG000|Overall Study|Withdrawal by Subject|0|||
143495220|NCT03891901|517354493|FG001|Overall Study|Withdrawal by Subject|2|||
143495221|NCT03891901|517354494|FG002|Overall Study|Withdrawal by Subject|0|||
143495222|NCT03891901|517354495|FG003|Overall Study|Withdrawal by Subject|0|||
143495223|NCT03891901|517354496|FG004|Overall Study|Withdrawal by Subject|0|||
143495224|NCT03891901|517354497|FG005|Overall Study|Withdrawal by Subject|0|||
143495225|NCT03891901|517354498|FG006|Overall Study|Withdrawal by Subject|0|||
143495226|NCT03891901|517354499|FG007|Overall Study|Withdrawal by Subject|0|||
143495227|NCT03891901|517354500|FG008|Overall Study|Withdrawal by Subject|0|||
143495228|NCT00603915|517354501|FG000|Overall Study|Physician Decision|1|||
143495229|NCT04484285|517355944|FG000|Overall Study|Unable to operate stimulator|3|||
143495230|NCT04484285|517355945|FG001|Overall Study|Unable to operate stimulator|0|||
143495231|NCT00768898|517355946|FG000|Overall Study|Unrelated injury|1|||
143495232|NCT00768898|517355946|FG000|Overall Study|Headache|1|||
143495233|NCT00930059|517355947|FG000|Overall Study|Death|1|||
143495234|NCT00930059|517355948|FG001|Overall Study|Death|0|||
143495235|NCT00930059|517355947|FG000|Overall Study|Did not meet entrance criteria|1|||
143495236|NCT00930059|517355948|FG001|Overall Study|Did not meet entrance criteria|1|||
143495237|NCT00930059|517355947|FG000|Overall Study|Withdrawal by Subject|3|||
143495238|NCT00930059|517355948|FG001|Overall Study|Withdrawal by Subject|4|||
143495239|NCT00930059|517355947|FG000|Overall Study|Other|1|||
143495240|NCT00930059|517355948|FG001|Overall Study|Other|0|||
143495241|NCT00930059|517355947|FG000|Overall Study|1 site terminated by sponsor|1|||
143495242|NCT00930059|517355948|FG001|Overall Study|1 site terminated by sponsor|1|||
143495243|NCT00930059|517355947|FG000|Overall Study|Adverse Event|1|||
143495244|NCT00930059|517355948|FG001|Overall Study|Adverse Event|6|||
143495245|NCT04002310|517355949|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
143495246|NCT04002310|517355950|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
143495247|NCT04002310|517355951|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
143495248|NCT04002310|517355952|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
143495249|NCT04002310|517355953|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
143495250|NCT03064763|517355956|FG000|Overall Study|Lost to Follow-up|1|||
143495251|NCT03064763|517355956|FG000|Overall Study|Death|8|||
143495252|NCT03160560|517355957|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
143495253|NCT03160560|517355958|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
143495254|NCT03160560|517355959|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
143160625|NCT04359680|516133393|FG000|Overall Study|Physician Decision|1|||
143160626|NCT04359680|516133394|FG001|Overall Study|Physician Decision|1|||
143160627|NCT04359680|516133393|FG000|Overall Study|Sponsor Decision|0|||
143160628|NCT04359680|516133394|FG001|Overall Study|Sponsor Decision|1|||
143160629|NCT01654250|516133395|FG000|Overall Study|Lost to Follow-up|1|||
143160630|NCT01654250|516133396|FG001|Overall Study|Lost to Follow-up|0|||
143160631|NCT03280615|516133397|FG000|Overall Study|Lost to Follow-up|1|||
143160632|NCT03280615|516133398|FG001|Overall Study|Lost to Follow-up|2|||
143160633|NCT03280615|516133397|FG000|Overall Study|Adverse Event|1|||
143160634|NCT03280615|516133398|FG001|Overall Study|Adverse Event|1|||
143160635|NCT03280615|516133397|FG000|Overall Study|Withdrawal by Subject|2|||
143160636|NCT03280615|516133398|FG001|Overall Study|Withdrawal by Subject|2|||
143160637|NCT01013870|516133401|FG000|Overall Study|Lost to Follow-up|1|||
143160638|NCT01013870|516133402|FG001|Overall Study|Lost to Follow-up|3|||
143160639|NCT01386645|516133403|FG000|Overall Study|Physician Decision|0|||
143160640|NCT01386645|516133404|FG001|Overall Study|Physician Decision|0|||
143495255|NCT03160560|517355960|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
143495256|NCT03160560|517355957|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
143495257|NCT03160560|517355958|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
143495258|NCT03160560|517355959|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
143495259|NCT03160560|517355960|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
143495260|NCT00619502|517355961|FG000|Overall Study|Lost to Follow-up|8|||
143495261|NCT00619502|517355962|FG001|Overall Study|Lost to Follow-up|10|||
143495262|NCT01777763|517355973|FG000|Overall Study|Adverse Event|2|||
143495263|NCT01777763|517355974|FG001|Overall Study|Adverse Event|32|||
143495264|NCT01777763|517355973|FG000|Overall Study|Protocol Violation|1|||
143495265|NCT01777763|517355974|FG001|Overall Study|Protocol Violation|7|||
143495266|NCT01777763|517355973|FG000|Overall Study|Withdrawal by Subject|0|||
143495267|NCT01777763|517355974|FG001|Overall Study|Withdrawal by Subject|2|||
143495268|NCT01777763|517355973|FG000|Overall Study|Treatment Failure|1|||
143495269|NCT01777763|517355974|FG001|Overall Study|Treatment Failure|6|||
143495270|NCT00804687|517355977|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
143495271|NCT00804687|517355978|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
143495272|NCT00804687|517355979|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
143495273|NCT00804687|517355980|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
143495274|NCT00804687|517355981|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
143495275|NCT00804687|517355982|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
143495276|NCT00804687|517355977|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
143495277|NCT00804687|517355978|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
143495278|NCT00804687|517355979|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
143495279|NCT00804687|517355980|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
143495280|NCT00804687|517355981|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
143495281|NCT00804687|517355982|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
143495282|NCT00804687|517355977|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
143495283|NCT00804687|517355978|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
143495284|NCT00804687|517355979|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
143495285|NCT00804687|517355980|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
143495286|NCT00804687|517355981|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
143495287|NCT00804687|517355982|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
143495288|NCT00804687|517355977|FG000|Period 5: Treatment Period|Positive drug test|1|||
143495289|NCT00804687|517355978|FG001|Period 5: Treatment Period|Positive drug test|0|||
143495290|NCT00804687|517355979|FG002|Period 5: Treatment Period|Positive drug test|0|||
143495291|NCT00804687|517355980|FG003|Period 5: Treatment Period|Positive drug test|0|||
143033137|NCT02937701|515663054|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
143033138|NCT02937701|515663055|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
143033139|NCT02937701|515663056|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
143033140|NCT02937701|515663052|FG000|Day 1 to Week 22|Physician Decision|2|||
143033141|NCT02937701|515663053|FG001|Day 1 to Week 22|Physician Decision|0|||
143033142|NCT02937701|515663054|FG002|Day 1 to Week 22|Physician Decision|0|||
143033143|NCT02937701|515663055|FG003|Day 1 to Week 22|Physician Decision|0|||
143033144|NCT02937701|515663056|FG004|Day 1 to Week 22|Physician Decision|0|||
143033145|NCT02937701|515663052|FG000|Day 1 to Week 22|Other|1|||
143033146|NCT02937701|515663053|FG001|Day 1 to Week 22|Other|0|||
143033147|NCT02937701|515663054|FG002|Day 1 to Week 22|Other|0|||
143033148|NCT02937701|515663055|FG003|Day 1 to Week 22|Other|0|||
143495292|NCT00804687|517355981|FG004|Period 5: Treatment Period|Positive drug test|0|||
143495293|NCT00804687|517355982|FG005|Period 5: Treatment Period|Positive drug test|0|||
143033149|NCT02937701|515663056|FG004|Day 1 to Week 22|Other|0|||
143033150|NCT02937701|515663052|FG000|Week 22 to Week 50|Adverse Event|0|||
143033151|NCT02937701|515663053|FG001|Week 22 to Week 50|Adverse Event|0|||
143033152|NCT02937701|515663054|FG002|Week 22 to Week 50|Adverse Event|10|||
143033153|NCT02937701|515663055|FG003|Week 22 to Week 50|Adverse Event|3|||
143033154|NCT02937701|515663056|FG004|Week 22 to Week 50|Adverse Event|3|||
143033155|NCT02937701|515663052|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
143033156|NCT02937701|515663053|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
143033157|NCT02937701|515663054|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
143033158|NCT02937701|515663055|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
143033159|NCT02937701|515663056|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
143033160|NCT02937701|515663052|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
143160641|NCT01386645|516133405|FG002|Overall Study|Physician Decision|1|||
143160642|NCT01386645|516133403|FG000|Overall Study|Withdrawal by Subject|0|||
143495294|NCT02494596|517355988|FG000|Overall Study|Insufficient Therapeutic Response|3|||
143495295|NCT02494596|517355989|FG001|Overall Study|Insufficient Therapeutic Response|3|||
143495296|NCT02494596|517355990|FG002|Overall Study|Insufficient Therapeutic Response|1|||
143495297|NCT02494596|517355988|FG000|Overall Study|Adverse Event|0|||
143033161|NCT02937701|515663053|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
143160643|NCT01386645|516133404|FG001|Overall Study|Withdrawal by Subject|1|||
143364072|NCT03283553|516875528|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
143364073|NCT03283553|516875529|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
143495298|NCT02494596|517355989|FG001|Overall Study|Adverse Event|1|||
143495299|NCT02494596|517355990|FG002|Overall Study|Adverse Event|0|||
143033162|NCT02937701|515663054|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
143033163|NCT02937701|515663055|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
143033164|NCT02937701|515663056|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
143033165|NCT02937701|515663052|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
143033166|NCT02937701|515663053|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
143495300|NCT02494596|517355988|FG000|Overall Study|Refused Treatment|0|||
143495301|NCT02494596|517355989|FG001|Overall Study|Refused Treatment|1|||
143495302|NCT02494596|517355990|FG002|Overall Study|Refused Treatment|0|||
143495303|NCT02435914|517355995|FG000|Overall Study|Ocular Adverse Event|1|||
143033167|NCT02937701|515663054|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
143033168|NCT02937701|515663055|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
143033169|NCT02937701|515663056|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
143033170|NCT02937701|515663052|FG000|Week 22 to Week 50|Physician Decision|0|||
143033171|NCT02937701|515663053|FG001|Week 22 to Week 50|Physician Decision|0|||
143033172|NCT02937701|515663054|FG002|Week 22 to Week 50|Physician Decision|2|||
143033173|NCT02937701|515663055|FG003|Week 22 to Week 50|Physician Decision|0|||
143033174|NCT02937701|515663056|FG004|Week 22 to Week 50|Physician Decision|1|||
143033175|NCT02937701|515663052|FG000|Week 22 to Week 50|Other|0|||
143033176|NCT02937701|515663053|FG001|Week 22 to Week 50|Other|0|||
143033177|NCT02937701|515663054|FG002|Week 22 to Week 50|Other|0|||
143033178|NCT02937701|515663055|FG003|Week 22 to Week 50|Other|0|||
143033179|NCT02937701|515663056|FG004|Week 22 to Week 50|Other|1|||
143033180|NCT00416520|515663058|FG000|Open-label Period|Adverse Event|28|||
143033181|NCT00416520|515663059|FG001|Open-label Period|Adverse Event|10|||
143033182|NCT00416520|515663060|FG002|Open-label Period|Adverse Event|0|||
143033183|NCT00416520|515663061|FG003|Open-label Period|Adverse Event|0|||
143033184|NCT00416520|515663058|FG000|Open-label Period|Death|2|||
143033185|NCT00416520|515663059|FG001|Open-label Period|Death|1|||
143033186|NCT00416520|515663060|FG002|Open-label Period|Death|0|||
143033187|NCT00416520|515663061|FG003|Open-label Period|Death|0|||
143033188|NCT00416520|515663058|FG000|Open-label Period|Lack of Efficacy|8|||
143033189|NCT00416520|515663059|FG001|Open-label Period|Lack of Efficacy|1|||
143033190|NCT00416520|515663060|FG002|Open-label Period|Lack of Efficacy|0|||
143033191|NCT00416520|515663061|FG003|Open-label Period|Lack of Efficacy|0|||
143033192|NCT00416520|515663058|FG000|Open-label Period|Protocol Violation|3|||
143033193|NCT00416520|515663059|FG001|Open-label Period|Protocol Violation|3|||
143033194|NCT00416520|515663060|FG002|Open-label Period|Protocol Violation|0|||
143033195|NCT00416520|515663061|FG003|Open-label Period|Protocol Violation|0|||
143033196|NCT00416520|515663058|FG000|Open-label Period|Withdrawal by Subject|16|||
143033197|NCT00416520|515663059|FG001|Open-label Period|Withdrawal by Subject|5|||
143033198|NCT00416520|515663060|FG002|Open-label Period|Withdrawal by Subject|0|||
143033199|NCT00416520|515663061|FG003|Open-label Period|Withdrawal by Subject|0|||
143033200|NCT00416520|515663058|FG000|Open-label Period|Other Reasons|3|||
143033201|NCT00416520|515663059|FG001|Open-label Period|Other Reasons|12|||
143033202|NCT00416520|515663060|FG002|Open-label Period|Other Reasons|0|||
143033203|NCT00416520|515663061|FG003|Open-label Period|Other Reasons|0|||
143033204|NCT00416520|515663058|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
143033205|NCT00416520|515663059|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
143033206|NCT00416520|515663060|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
143033207|NCT00416520|515663061|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
143033208|NCT00416520|515663058|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
143238546|NCT03594110|516427507|FG000|Interventional Part|Contraindicated drug started|32|||
143238547|NCT03594110|516427508|FG001|Interventional Part|Contraindicated drug started|18|||
143238548|NCT03594110|516427507|FG000|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|58|||
143238549|NCT03594110|516427508|FG001|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|45|||
143238550|NCT03594110|516427507|FG000|Interventional Part|Adverse event-Serious fatal events|130|||
143238551|NCT03594110|516427508|FG001|Interventional Part|Adverse event-Serious fatal events|121|||
143238552|NCT03594110|516427507|FG000|Non-interventional Part|Withdrawal by Subject|3|||
143495304|NCT02435914|517355996|FG001|Overall Study|Ocular Adverse Event|0|||
143495305|NCT02435914|517355997|FG002|Overall Study|Ocular Adverse Event|0|||
143495306|NCT02435914|517355998|FG003|Overall Study|Ocular Adverse Event|0|||
143495307|NCT02435914|517355995|FG000|Overall Study|Withdrawal by Subject|0|||
143495308|NCT02435914|517355996|FG001|Overall Study|Withdrawal by Subject|1|||
143495309|NCT02435914|517355997|FG002|Overall Study|Withdrawal by Subject|0|||
143495310|NCT02435914|517355998|FG003|Overall Study|Withdrawal by Subject|0|||
143033209|NCT00416520|515663059|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
143033210|NCT00416520|515663060|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
143033211|NCT00416520|515663061|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
143033212|NCT00416520|515663058|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
143033213|NCT00416520|515663059|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
143033214|NCT00416520|515663060|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
143033215|NCT00416520|515663061|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
143033216|NCT01139047|515663062|FG000|Overall Study|Withdrawal by Subject|1|||
143033217|NCT05628675|515663063|FG000|Overall Study|Lost to Follow-up|2|||
143033218|NCT05628675|515663063|FG000|Overall Study|Withdrawal by Subject|1|||
143033219|NCT01941095|515663066|FG000|Overall Study|Insufficient therapeutic response|13|||
143033220|NCT01941095|515663066|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
143033221|NCT01941095|515663066|FG000|Overall Study|Adverse Event|11|||
143033222|NCT01941095|515663066|FG000|Overall Study|Physician Decision|3|||
143033223|NCT01941095|515663066|FG000|Overall Study|Withdrawal by Subject|17|||
143238553|NCT03594110|516427508|FG001|Non-interventional Part|Withdrawal by Subject|4|||
143495311|NCT02435914|517355995|FG000|Overall Study|Other Miscellaneous Reason|0|||
143495312|NCT02435914|517355996|FG001|Overall Study|Other Miscellaneous Reason|0|||
143033224|NCT01941095|515663066|FG000|Overall Study|Lost to Follow-up|10|||
143033225|NCT05818137|515663070|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
143033226|NCT05818137|515663070|FG000|Extension Treatment Period|Ongoing participants|44|||
143033227|NCT01367275|515663071|FG000|Overall Study|Ineligible|1|||
143033228|NCT01367275|515663071|FG000|Overall Study|Disease Progression|2|||
143033229|NCT01087970|515663077|FG000|Overall Study|Protocol Violation|2|||
143033230|NCT04099888|515663085|FG000|Overall Study|Study terminated by sponsor|9|||
143033231|NCT04099888|515663086|FG001|Overall Study|Study terminated by sponsor|11|||
143033232|NCT04099888|515663085|FG000|Overall Study|Lost to Follow-up|1|||
143033233|NCT04099888|515663086|FG001|Overall Study|Lost to Follow-up|1|||
143033234|NCT04099888|515663085|FG000|Overall Study|Withdrawal by Subject|5|||
143033235|NCT04099888|515663086|FG001|Overall Study|Withdrawal by Subject|6|||
143033236|NCT04099888|515663085|FG000|Overall Study|Death|5|||
143033237|NCT04099888|515663086|FG001|Overall Study|Death|2|||
143033238|NCT04099888|515663085|FG000|Overall Study|Other|1|||
143033239|NCT04099888|515663086|FG001|Overall Study|Other|0|||
143033240|NCT04538170|515663089|FG000|Overall Study|Withdrawal by Subject|104|||
143033241|NCT04538170|515663090|FG001|Overall Study|Withdrawal by Subject|210|||
143033242|NCT01682083|515663093|FG000|Overall Study|Lost to Follow-up|11|||
143033243|NCT01682083|515663094|FG001|Overall Study|Lost to Follow-up|18|||
143033244|NCT01682083|515663093|FG000|Overall Study|Withdrawal by Subject|31|||
143033245|NCT01682083|515663094|FG001|Overall Study|Withdrawal by Subject|40|||
143033246|NCT01682083|515663093|FG000|Overall Study|Death|60|||
143033247|NCT01682083|515663094|FG001|Overall Study|Death|93|||
143033248|NCT01682083|515663093|FG000|Overall Study|Physician Decision|5|||
143033249|NCT01682083|515663094|FG001|Overall Study|Physician Decision|4|||
143033250|NCT00437658|515663095|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
143033251|NCT00437658|515663096|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
143033252|NCT00437658|515663097|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
143033253|NCT00437658|515663095|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
143033254|NCT00437658|515663096|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
143033255|NCT00437658|515663097|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
143033256|NCT00437658|515663095|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
143033257|NCT00437658|515663096|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
143033258|NCT00437658|515663097|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
143033259|NCT00437658|515663095|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
143033260|NCT00437658|515663096|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
143033261|NCT00437658|515663097|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
143033262|NCT00437658|515663095|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
143033263|NCT00437658|515663096|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
143033264|NCT00437658|515663097|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
143033265|NCT00437658|515663095|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
143033266|NCT00437658|515663096|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
143033267|NCT00437658|515663097|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
143033268|NCT00437658|515663095|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
143033269|NCT00437658|515663096|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
143033270|NCT00437658|515663097|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
143033271|NCT00437658|515663095|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
143033272|NCT00437658|515663096|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
143033273|NCT00437658|515663097|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
143033274|NCT00437658|515663095|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
143033275|NCT00437658|515663096|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
143033276|NCT00437658|515663097|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
143033277|NCT00437658|515663095|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
143033278|NCT00437658|515663096|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
143033279|NCT00437658|515663097|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
143160644|NCT01386645|516133405|FG002|Overall Study|Withdrawal by Subject|1|||
143160645|NCT01755156|516133415|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
143160646|NCT01755156|516133416|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
143160647|NCT01755156|516133415|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
143160648|NCT01755156|516133416|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
143160649|NCT01755156|516133415|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
143033280|NCT00437658|515663095|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
143033281|NCT00437658|515663096|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
143033282|NCT00437658|515663097|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
143033283|NCT00437658|515663095|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
143033284|NCT00437658|515663096|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
143033285|NCT00437658|515663097|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
143160650|NCT01755156|516133416|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
143160651|NCT01755156|516133415|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
143238554|NCT03594110|516427507|FG000|Non-interventional Part|Lost to Follow-up|45|||
143238555|NCT03594110|516427508|FG001|Non-interventional Part|Lost to Follow-up|41|||
143238556|NCT02900378|516427509|FG000|Randomization (Visit 2)|Adverse Event|14|||
143033286|NCT03952143|515663098|FG000|Lead-In Period|Adverse Event|2|||
143033287|NCT03952143|515663099|FG001|Lead-In Period|Adverse Event|0|||
143033288|NCT03952143|515663100|FG002|Lead-In Period|Adverse Event|0|||
143033289|NCT03952143|515663098|FG000|Lead-In Period|Lack of Efficacy|2|||
143033290|NCT03952143|515663099|FG001|Lead-In Period|Lack of Efficacy|0|||
143033291|NCT03952143|515663100|FG002|Lead-In Period|Lack of Efficacy|0|||
143033292|NCT03952143|515663098|FG000|Lead-In Period|Physician Decision|5|||
143033293|NCT03952143|515663099|FG001|Lead-In Period|Physician Decision|0|||
143033294|NCT03952143|515663100|FG002|Lead-In Period|Physician Decision|0|||
143033295|NCT03952143|515663098|FG000|Lead-In Period|Protocol Violation|5|||
143033296|NCT03952143|515663099|FG001|Lead-In Period|Protocol Violation|0|||
143033297|NCT03952143|515663100|FG002|Lead-In Period|Protocol Violation|0|||
143033298|NCT03952143|515663098|FG000|Lead-In Period|Withdrawal by Subject|19|||
143033299|NCT03952143|515663099|FG001|Lead-In Period|Withdrawal by Subject|0|||
143033300|NCT03952143|515663100|FG002|Lead-In Period|Withdrawal by Subject|0|||
143033301|NCT03952143|515663098|FG000|Treatment Period|Adverse Event|0|||
143033302|NCT03952143|515663099|FG001|Treatment Period|Adverse Event|0|||
143033303|NCT03952143|515663100|FG002|Treatment Period|Adverse Event|1|||
143033304|NCT03952143|515663098|FG000|Treatment Period|Lost to Follow-up|0|||
143033305|NCT03952143|515663099|FG001|Treatment Period|Lost to Follow-up|2|||
143033306|NCT03952143|515663100|FG002|Treatment Period|Lost to Follow-up|0|||
143033307|NCT03952143|515663098|FG000|Treatment Period|Physician Decision|0|||
143033308|NCT03952143|515663099|FG001|Treatment Period|Physician Decision|0|||
143033309|NCT03952143|515663100|FG002|Treatment Period|Physician Decision|2|||
143033310|NCT03952143|515663098|FG000|Treatment Period|Protocol Violation|0|||
143033311|NCT03952143|515663099|FG001|Treatment Period|Protocol Violation|0|||
143033312|NCT03952143|515663100|FG002|Treatment Period|Protocol Violation|1|||
143033313|NCT03952143|515663098|FG000|Treatment Period|Withdrawal by Subject|0|||
143033314|NCT03952143|515663099|FG001|Treatment Period|Withdrawal by Subject|5|||
143033315|NCT03952143|515663100|FG002|Treatment Period|Withdrawal by Subject|26|||
143033316|NCT03952143|515663098|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
143033317|NCT03952143|515663099|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
143238557|NCT02900378|516427510|FG001|Randomization (Visit 2)|Adverse Event|11|||
143238558|NCT02900378|516427509|FG000|Randomization (Visit 2)|Death|1|||
143238559|NCT02900378|516427510|FG001|Randomization (Visit 2)|Death|4|||
143238560|NCT02900378|516427509|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
143238561|NCT02900378|516427510|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
143238562|NCT02900378|516427509|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
143238563|NCT02900378|516427510|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
143238564|NCT02900378|516427509|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
143238565|NCT02900378|516427510|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
143238566|NCT02900378|516427509|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
143238567|NCT02900378|516427510|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
143364074|NCT03686683|516875530|FG000|Overall Study|Withdrawal by Subject|52|||
143364075|NCT03686683|516875531|FG001|Overall Study|Withdrawal by Subject|32|||
143033318|NCT03952143|515663100|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
143033319|NCT03952143|515663098|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
143033320|NCT03952143|515663099|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
143033321|NCT03952143|515663100|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
143033322|NCT01866319|515663101|FG000|Overall Study|Adverse Event|12|||
143033323|NCT01866319|515663102|FG001|Overall Study|Adverse Event|5|||
143033324|NCT01866319|515663103|FG002|Overall Study|Adverse Event|9|||
143033325|NCT01866319|515663101|FG000|Overall Study|Clinical progression|3|||
143033326|NCT01866319|515663102|FG001|Overall Study|Clinical progression|2|||
143033327|NCT01866319|515663103|FG002|Overall Study|Clinical progression|2|||
143033328|NCT01866319|515663101|FG000|Overall Study|Death|153|||
143033329|NCT01866319|515663102|FG001|Overall Study|Death|154|||
143033330|NCT01866319|515663103|FG002|Overall Study|Death|147|||
143033331|NCT01866319|515663101|FG000|Overall Study|Lost to Follow-up|6|||
143033332|NCT01866319|515663102|FG001|Overall Study|Lost to Follow-up|3|||
143160652|NCT01755156|516133416|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
143160653|NCT01755156|516133415|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
143160654|NCT01755156|516133416|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
143160655|NCT01755156|516133415|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
143160656|NCT01755156|516133416|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
143160657|NCT01755156|516133415|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
143160658|NCT01755156|516133416|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
143160659|NCT01755156|516133415|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
143160660|NCT01755156|516133416|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
143160661|NCT01755156|516133415|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
143160662|NCT01755156|516133416|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
143238568|NCT02900378|516427509|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
143238569|NCT02900378|516427510|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
143238570|NCT03818321|516427514|FG000|Overall Study|Withdrawal by Subject|1|||
143033333|NCT01866319|515663103|FG002|Overall Study|Lost to Follow-up|8|||
143033334|NCT01866319|515663101|FG000|Overall Study|Physician Decision|1|||
143033335|NCT01866319|515663102|FG001|Overall Study|Physician Decision|0|||
143033336|NCT01866319|515663103|FG002|Overall Study|Physician Decision|1|||
143033337|NCT01866319|515663101|FG000|Overall Study|Protocol Violation|0|||
143033338|NCT01866319|515663102|FG001|Overall Study|Protocol Violation|0|||
143033339|NCT01866319|515663103|FG002|Overall Study|Protocol Violation|1|||
143033340|NCT01866319|515663101|FG000|Overall Study|Withdrawal by Subject|32|||
143033341|NCT01866319|515663102|FG001|Overall Study|Withdrawal by Subject|14|||
143033342|NCT01866319|515663103|FG002|Overall Study|Withdrawal by Subject|12|||
143033343|NCT00891293|515663104|FG000|Overall Study|Adverse Event|2|||
143033344|NCT00891293|515663104|FG000|Overall Study|Protocol Violation|2|||
143033345|NCT00891293|515663104|FG000|Overall Study|Laboratory abnormality|4|||
143033346|NCT00891293|515663104|FG000|Overall Study|Lost to Follow-up|7|||
143033347|NCT00891293|515663104|FG000|Overall Study|Subject withdrew consent|7|||
143033348|NCT00891293|515663104|FG000|Overall Study|Sponsor termination|62|||
143033349|NCT03912337|515663111|FG000|Overall Study|Withdrawal of Consent From Study|1|||
143033350|NCT03912337|515663112|FG001|Overall Study|Withdrawal of Consent From Study|0|||
143033351|NCT03912337|515663111|FG000|Overall Study|Lost to Follow-up|1|||
143033352|NCT03912337|515663112|FG001|Overall Study|Lost to Follow-up|1|||
143033353|NCT02458469|515663113|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
143033354|NCT02458469|515663114|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
143033355|NCT02458469|515663115|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
143033356|NCT02458469|515663116|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
143033357|NCT02458469|515663117|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
143033358|NCT02458469|515663118|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
143033359|NCT02458469|515663113|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
143033360|NCT02458469|515663114|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
143033361|NCT02458469|515663115|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
143033362|NCT02458469|515663116|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
143033363|NCT02458469|515663117|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
143033364|NCT02458469|515663118|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
143033365|NCT02458469|515663113|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
143033366|NCT02458469|515663114|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
143033367|NCT02458469|515663115|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
143033368|NCT02458469|515663116|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
143033369|NCT02458469|515663117|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
143033370|NCT02458469|515663118|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
143160663|NCT01755156|516133415|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
143160664|NCT01755156|516133416|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
143160665|NCT01755156|516133415|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
143160666|NCT01755156|516133416|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
143160667|NCT02168439|516133417|FG000|Overall Study|Protocol Violation|0|||
143160668|NCT02168439|516133418|FG001|Overall Study|Protocol Violation|2|||
143160669|NCT01292473|516133419|FG000|Overall Study|Adverse Event|1|||
143160670|NCT01292473|516133420|FG001|Overall Study|Adverse Event|0|||
143160671|NCT01292473|516133421|FG002|Overall Study|Adverse Event|1|||
143160672|NCT01292473|516133422|FG003|Overall Study|Adverse Event|1|||
143160673|NCT01292473|516133419|FG000|Overall Study|Lost to Follow-up|1|||
143160674|NCT01292473|516133420|FG001|Overall Study|Lost to Follow-up|1|||
143160675|NCT01292473|516133421|FG002|Overall Study|Lost to Follow-up|2|||
143160676|NCT01292473|516133422|FG003|Overall Study|Lost to Follow-up|2|||
143160677|NCT01292473|516133419|FG000|Overall Study|Withdrawal by Subject|3|||
143160678|NCT01292473|516133420|FG001|Overall Study|Withdrawal by Subject|4|||
143160679|NCT01292473|516133421|FG002|Overall Study|Withdrawal by Subject|3|||
143160680|NCT01292473|516133422|FG003|Overall Study|Withdrawal by Subject|3|||
143160681|NCT01292473|516133419|FG000|Overall Study|Physician Decision|0|||
143160682|NCT01292473|516133420|FG001|Overall Study|Physician Decision|1|||
143033371|NCT03130699|515663119|FG000|Overall Study|Lost to Follow-up|34|||
143033372|NCT03130699|515663120|FG001|Overall Study|Lost to Follow-up|37|||
143160683|NCT01292473|516133421|FG002|Overall Study|Physician Decision|0|||
143160684|NCT01292473|516133422|FG003|Overall Study|Physician Decision|0|||
143160685|NCT01292473|516133419|FG000|Overall Study|Disease Progression|0|||
143160686|NCT01292473|516133420|FG001|Overall Study|Disease Progression|1|||
143033373|NCT03130699|515663121|FG002|Overall Study|Lost to Follow-up|26|||
143033374|NCT03130699|515663119|FG000|Overall Study|Withdrawal by Subject|5|||
143033375|NCT03130699|515663120|FG001|Overall Study|Withdrawal by Subject|1|||
143033376|NCT03130699|515663121|FG002|Overall Study|Withdrawal by Subject|0|||
143033377|NCT03130699|515663119|FG000|Overall Study|Withdrawal by PI|1|||
143033378|NCT03130699|515663120|FG001|Overall Study|Withdrawal by PI|2|||
143033379|NCT03130699|515663121|FG002|Overall Study|Withdrawal by PI|5|||
143033380|NCT03130699|515663119|FG000|Overall Study|Death|0|||
143160687|NCT01292473|516133421|FG002|Overall Study|Disease Progression|3|||
143160688|NCT01292473|516133422|FG003|Overall Study|Disease Progression|6|||
143160689|NCT04432298|516133423|FG000|Overall Study|Other than specified|1|||
143238571|NCT03818321|516427515|FG001|Overall Study|Withdrawal by Subject|2|||
143033381|NCT03130699|515663120|FG001|Overall Study|Death|0|||
143033382|NCT03130699|515663121|FG002|Overall Study|Death|1|||
143033383|NCT00669864|515663124|FG000|Overall Study|Lost to Follow-up|2|||
143033384|NCT00669864|515663124|FG000|Overall Study|Protocol Violation|2|||
143033385|NCT00669864|515663124|FG000|Overall Study|Withdrawal by Subject|3|||
143033386|NCT00669864|515663124|FG000|Overall Study|Other|2|||
143033387|NCT00680121|515663125|FG000|Overall Study|Lost to Follow-up|27|||
143033388|NCT00680121|515663126|FG001|Overall Study|Lost to Follow-up|23|||
143033389|NCT02672553|515663133|FG000|Overall Study|Death|3|||
143033390|NCT02672553|515663134|FG001|Overall Study|Death|5|||
143033391|NCT02672553|515663133|FG000|Overall Study|Valve Explant|1|||
143033392|NCT02672553|515663134|FG001|Overall Study|Valve Explant|0|||
143033393|NCT02672553|515663133|FG000|Overall Study|Conversion to Commercial Valve|3|||
143033394|NCT02672553|515663134|FG001|Overall Study|Conversion to Commercial Valve|0|||
143033395|NCT02672553|515663133|FG000|Overall Study|Withdrawal by Subject|3|||
143033396|NCT02672553|515663134|FG001|Overall Study|Withdrawal by Subject|3|||
143033397|NCT02672553|515663133|FG000|Overall Study|Intraoperative screen failure|2|||
143033398|NCT02672553|515663134|FG001|Overall Study|Intraoperative screen failure|0|||
143033399|NCT01606306|515663135|FG000|Overall Study|Lack of Efficacy|2|||
143033400|NCT01606306|515663136|FG001|Overall Study|Lack of Efficacy|1|||
143033401|NCT01606306|515663137|FG002|Overall Study|Lack of Efficacy|4|||
143033402|NCT01606306|515663138|FG003|Overall Study|Lack of Efficacy|4|||
143033403|NCT01606306|515663139|FG004|Overall Study|Lack of Efficacy|1|||
143033404|NCT01606306|515663140|FG005|Overall Study|Lack of Efficacy|2|||
143033405|NCT01606306|515663135|FG000|Overall Study|Adverse Event|1|||
143033406|NCT01606306|515663136|FG001|Overall Study|Adverse Event|0|||
143033407|NCT01606306|515663137|FG002|Overall Study|Adverse Event|1|||
143033408|NCT01606306|515663138|FG003|Overall Study|Adverse Event|1|||
143033409|NCT01606306|515663139|FG004|Overall Study|Adverse Event|2|||
143033410|NCT01606306|515663140|FG005|Overall Study|Adverse Event|0|||
143033411|NCT01606306|515663135|FG000|Overall Study|Lost to Follow-up|7|||
143033412|NCT01606306|515663136|FG001|Overall Study|Lost to Follow-up|4|||
143033413|NCT01606306|515663137|FG002|Overall Study|Lost to Follow-up|5|||
143033414|NCT01606306|515663138|FG003|Overall Study|Lost to Follow-up|4|||
143033415|NCT01606306|515663139|FG004|Overall Study|Lost to Follow-up|3|||
143033416|NCT01606306|515663140|FG005|Overall Study|Lost to Follow-up|5|||
143033417|NCT01606306|515663135|FG000|Overall Study|Withdrawal by Subject|4|||
143033418|NCT01606306|515663136|FG001|Overall Study|Withdrawal by Subject|3|||
143033419|NCT01606306|515663137|FG002|Overall Study|Withdrawal by Subject|4|||
143033420|NCT01606306|515663138|FG003|Overall Study|Withdrawal by Subject|4|||
143033421|NCT01606306|515663139|FG004|Overall Study|Withdrawal by Subject|5|||
143033422|NCT01606306|515663140|FG005|Overall Study|Withdrawal by Subject|4|||
143033423|NCT01606306|515663135|FG000|Overall Study|Physician Decision|1|||
143033424|NCT01606306|515663136|FG001|Overall Study|Physician Decision|2|||
143033425|NCT01606306|515663137|FG002|Overall Study|Physician Decision|0|||
143160690|NCT04432298|516133424|FG001|Overall Study|Other than specified|0|||
143160691|NCT04432298|516133423|FG000|Overall Study|Lost to Follow-up|0|||
143160692|NCT04432298|516133424|FG001|Overall Study|Lost to Follow-up|1|||
143160693|NCT04432298|516133423|FG000|Overall Study|Death|3|||
143033426|NCT01606306|515663138|FG003|Overall Study|Physician Decision|0|||
143033427|NCT01606306|515663139|FG004|Overall Study|Physician Decision|0|||
143033428|NCT01606306|515663140|FG005|Overall Study|Physician Decision|0|||
143033429|NCT00950872|515663141|FG000|Overall Study|Withdrawal by Subject|1|||
143033430|NCT00950872|515663141|FG000|Overall Study|Did not have surgery|2|||
143033431|NCT02003183|515663142|FG000|Overall Study|Lost to Follow-up|0|||
143033432|NCT02003183|515663143|FG001|Overall Study|Lost to Follow-up|2|||
143033433|NCT01759290|515663144|FG000|Overall Study|Subjects withdrawn consent|5|||
143033434|NCT01759290|515663144|FG000|Overall Study|Physician Decision|2|||
143033435|NCT01759290|515663144|FG000|Overall Study|Death|17|||
143033436|NCT01759290|515663144|FG000|Overall Study|Lost to Follow-up|53|||
143033437|NCT01759290|515663144|FG000|Overall Study|Unknown reason|4|||
143033438|NCT03629249|515663145|FG000|Overall Study|Study terminated by sponsor|197|||
143033439|NCT03629249|515663146|FG001|Overall Study|Study terminated by sponsor|197|||
143033440|NCT03629249|515663147|FG002|Overall Study|Study terminated by sponsor|194|||
143033441|NCT03629249|515663145|FG000|Overall Study|Protocol deviation|0|||
143033442|NCT03629249|515663146|FG001|Overall Study|Protocol deviation|2|||
143033443|NCT03629249|515663147|FG002|Overall Study|Protocol deviation|5|||
143033444|NCT03629249|515663145|FG000|Overall Study|Subject decision|1|||
143033445|NCT03629249|515663146|FG001|Overall Study|Subject decision|1|||
143033446|NCT03629249|515663147|FG002|Overall Study|Subject decision|3|||
143033447|NCT03629249|515663145|FG000|Overall Study|Adverse Event|1|||
143033448|NCT03629249|515663146|FG001|Overall Study|Adverse Event|1|||
143033449|NCT03629249|515663147|FG002|Overall Study|Adverse Event|0|||
143033450|NCT03629249|515663145|FG000|Overall Study|Death|1|||
143160694|NCT04432298|516133424|FG001|Overall Study|Death|2|||
143033451|NCT03629249|515663146|FG001|Overall Study|Death|0|||
143033452|NCT03629249|515663147|FG002|Overall Study|Death|0|||
143033453|NCT03629249|515663145|FG000|Overall Study|Physician Decision|1|||
143033454|NCT03629249|515663146|FG001|Overall Study|Physician Decision|0|||
143033455|NCT03629249|515663147|FG002|Overall Study|Physician Decision|0|||
143033456|NCT01475474|515663153|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
143033457|NCT01475474|515663153|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
143033458|NCT06096168|515663154|FG000|Overall Study|Death|30|||
143033459|NCT06096168|515663154|FG000|Overall Study|Revision|2|||
143033460|NCT01046253|515663155|FG000|Second Intervention|Adverse Event|0|||
143033461|NCT01046253|515663156|FG001|Second Intervention|Adverse Event|1|||
143033462|NCT01046253|515663155|FG000|Second Intervention|Protocol Violation|0|||
143033463|NCT01046253|515663156|FG001|Second Intervention|Protocol Violation|1|||
143033464|NCT02339909|515663157|FG000|Overall Study|Became ineligible after randomisation|89|||
143033465|NCT02339909|515663158|FG001|Overall Study|Became ineligible after randomisation|63|||
143033466|NCT02339909|515663159|FG002|Overall Study|Became ineligible after randomisation|71|||
143033467|NCT01471522|515663160|FG000|Overall Study|Withdrawal by Subject|28|||
143033468|NCT01471522|515663161|FG001|Overall Study|Withdrawal by Subject|22|||
143033469|NCT01471522|515663160|FG000|Overall Study|Lost to Follow-up|36|||
143033470|NCT01471522|515663161|FG001|Overall Study|Lost to Follow-up|26|||
143033471|NCT01691248|515663162|FG000|Overall Study|Protocol Violation|43|||
143033472|NCT01691248|515663163|FG001|Overall Study|Protocol Violation|27|||
143033473|NCT01691248|515663162|FG000|Overall Study|Adverse Event|24|||
143033474|NCT01691248|515663163|FG001|Overall Study|Adverse Event|22|||
143033475|NCT01691248|515663162|FG000|Overall Study|Withdrawal by Subject|20|||
143033476|NCT01691248|515663163|FG001|Overall Study|Withdrawal by Subject|18|||
143033477|NCT01691248|515663162|FG000|Overall Study|Confirmed CDAD|14|||
143033478|NCT01691248|515663163|FG001|Overall Study|Confirmed CDAD|31|||
143033479|NCT01691248|515663162|FG000|Overall Study|Lost to Follow-up|2|||
143033480|NCT01691248|515663163|FG001|Overall Study|Lost to Follow-up|5|||
143033481|NCT01691248|515663162|FG000|Overall Study|Reason not provided|4|||
143033482|NCT01691248|515663163|FG001|Overall Study|Reason not provided|4|||
143033483|NCT01691248|515663162|FG000|Overall Study|Not Treated|4|||
143033484|NCT01691248|515663163|FG001|Overall Study|Not Treated|7|||
143033485|NCT01432171|515663164|FG000|Overall Study|Death|1|||
143033486|NCT01432171|515663165|FG001|Overall Study|Death|2|||
143033487|NCT01432171|515663164|FG000|Overall Study|Lost to Follow-up|6|||
143033488|NCT01432171|515663165|FG001|Overall Study|Lost to Follow-up|5|||
143033489|NCT01432171|515663164|FG000|Overall Study|Withdrawal by Subject|3|||
143033490|NCT01432171|515663165|FG001|Overall Study|Withdrawal by Subject|1|||
143033491|NCT01432171|515663164|FG000|Overall Study|Noncompliance|2|||
143033492|NCT01432171|515663165|FG001|Overall Study|Noncompliance|3|||
143495313|NCT02435914|517355997|FG002|Overall Study|Other Miscellaneous Reason|1|||
143495314|NCT02435914|517355998|FG003|Overall Study|Other Miscellaneous Reason|0|||
143495315|NCT04871711|517356010|FG000|Overall Study|Withdrawal by Subject|11|||
143495316|NCT04871711|517356011|FG001|Overall Study|Withdrawal by Subject|5|||
143495317|NCT04871711|517356010|FG000|Overall Study|Lack of Efficacy|5|||
143495318|NCT04871711|517356011|FG001|Overall Study|Lack of Efficacy|7|||
143495319|NCT04871711|517356010|FG000|Overall Study|Adverse Event|2|||
143033493|NCT01432171|515663164|FG000|Overall Study|Insurance denial trial coverage|1|||
143033494|NCT01432171|515663165|FG001|Overall Study|Insurance denial trial coverage|0|||
143033495|NCT01432171|515663164|FG000|Overall Study|Patient moved to palliative care|1|||
143033496|NCT01432171|515663165|FG001|Overall Study|Patient moved to palliative care|0|||
143033497|NCT02863575|515663166|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
143033498|NCT02863575|515663167|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
143033499|NCT02863575|515663168|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
143033500|NCT02863575|515663166|FG000|Overall Study|Withdrawal by Subject|0|||
143033501|NCT02863575|515663167|FG001|Overall Study|Withdrawal by Subject|1|||
143033502|NCT02863575|515663168|FG002|Overall Study|Withdrawal by Subject|1|||
143033503|NCT02863575|515663166|FG000|Overall Study|Adverse Event|0|||
143033504|NCT02863575|515663167|FG001|Overall Study|Adverse Event|1|||
143033505|NCT02863575|515663168|FG002|Overall Study|Adverse Event|0|||
143114881|NCT00962091|515962450|FG003|Overall Study|Withdrawal by Subject|1|||
143114882|NCT00962091|515962451|FG004|Overall Study|Withdrawal by Subject|0|||
143114883|NCT00962091|515962452|FG005|Overall Study|Withdrawal by Subject|1|||
143114884|NCT00962091|515962453|FG006|Overall Study|Withdrawal by Subject|0|||
143114885|NCT00962091|515962447|FG000|Overall Study|Adverse Event|0|||
143114886|NCT00962091|515962448|FG001|Overall Study|Adverse Event|0|||
143114887|NCT00962091|515962449|FG002|Overall Study|Adverse Event|0|||
143114888|NCT00962091|515962450|FG003|Overall Study|Adverse Event|0|||
143114889|NCT00962091|515962451|FG004|Overall Study|Adverse Event|0|||
143114890|NCT00962091|515962452|FG005|Overall Study|Adverse Event|0|||
143114891|NCT00962091|515962453|FG006|Overall Study|Adverse Event|1|||
143114892|NCT04216589|515962454|FG000|Overall Study|Withdrawal by Subject|2|||
143114893|NCT04216589|515962454|FG000|Overall Study|Protocol Violation|1|||
143114894|NCT04216589|515962454|FG000|Overall Study|Incarceration|1|||
143114895|NCT02326298|515962458|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
143114896|NCT02326298|515962459|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
143114897|NCT02326298|515962460|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
143114898|NCT02326298|515962461|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
143114899|NCT02326298|515962462|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
143495320|NCT04871711|517356011|FG001|Overall Study|Adverse Event|6|||
143495321|NCT04871711|517356010|FG000|Overall Study|Various reasons|2|||
143495322|NCT04871711|517356011|FG001|Overall Study|Various reasons|1|||
143495323|NCT04871711|517356010|FG000|Overall Study|Lost to Follow-up|0|||
143495324|NCT04871711|517356011|FG001|Overall Study|Lost to Follow-up|2|||
143495325|NCT03979274|517356012|FG000|Treatment Period 2|Withdrawal by Subject|0|||
143495326|NCT03979274|517356013|FG001|Treatment Period 2|Withdrawal by Subject|1|||
143495327|NCT01665144|517356014|FG000|Core Part|Withdrawal by Subject|96|||
143495328|NCT01665144|517356015|FG001|Core Part|Withdrawal by Subject|77|||
143495329|NCT01665144|517356016|FG002|Core Part|Withdrawal by Subject|0|||
143495330|NCT01665144|517356014|FG000|Core Part|Adverse Event|45|||
143495331|NCT01665144|517356015|FG001|Core Part|Adverse Event|18|||
143495332|NCT01665144|517356016|FG002|Core Part|Adverse Event|0|||
143495333|NCT01665144|517356014|FG000|Core Part|Lack of Efficacy|16|||
143495334|NCT01665144|517356015|FG001|Core Part|Lack of Efficacy|11|||
143495335|NCT01665144|517356016|FG002|Core Part|Lack of Efficacy|0|||
143495336|NCT01665144|517356014|FG000|Core Part|Lost to Follow-up|9|||
143495337|NCT01665144|517356015|FG001|Core Part|Lost to Follow-up|8|||
143495338|NCT01665144|517356016|FG002|Core Part|Lost to Follow-up|0|||
143495339|NCT01665144|517356014|FG000|Core Part|Physician Decision|13|||
143495340|NCT01665144|517356015|FG001|Core Part|Physician Decision|1|||
143495341|NCT01665144|517356016|FG002|Core Part|Physician Decision|0|||
143495342|NCT01665144|517356014|FG000|Core Part|Progressive disease|8|||
143495343|NCT01665144|517356015|FG001|Core Part|Progressive disease|4|||
143495344|NCT01665144|517356016|FG002|Core Part|Progressive disease|0|||
143495345|NCT01665144|517356014|FG000|Core Part|Non-compliance with study treatment|5|||
143495346|NCT01665144|517356015|FG001|Core Part|Non-compliance with study treatment|0|||
143495347|NCT01665144|517356016|FG002|Core Part|Non-compliance with study treatment|0|||
143495348|NCT01665144|517356014|FG000|Core Part|Death|3|||
143495349|NCT01665144|517356015|FG001|Core Part|Death|1|||
143495350|NCT01665144|517356016|FG002|Core Part|Death|0|||
143495351|NCT01665144|517356014|FG000|Core Part|Protocol deviation|3|||
143495352|NCT01665144|517356015|FG001|Core Part|Protocol deviation|1|||
143495353|NCT01665144|517356016|FG002|Core Part|Protocol deviation|0|||
143495354|NCT01665144|517356014|FG000|Core Part|New therapy for study indication|2|||
143495355|NCT01665144|517356015|FG001|Core Part|New therapy for study indication|1|||
143495356|NCT01665144|517356016|FG002|Core Part|New therapy for study indication|0|||
143495357|NCT01665144|517356014|FG000|Core Part|Technical problems|2|||
143495358|NCT01665144|517356015|FG001|Core Part|Technical problems|0|||
143495359|NCT01665144|517356016|FG002|Core Part|Technical problems|0|||
143495360|NCT01665144|517356014|FG000|Extension Part|Patient/guardian decision|180|||
143495361|NCT01665144|517356015|FG001|Extension Part|Patient/guardian decision|0|||
143495362|NCT01665144|517356016|FG002|Extension Part|Patient/guardian decision|98|||
143495363|NCT01665144|517356014|FG000|Extension Part|Adverse Event|104|||
143495364|NCT01665144|517356015|FG001|Extension Part|Adverse Event|0|||
143495365|NCT01665144|517356016|FG002|Extension Part|Adverse Event|59|||
143495366|NCT01665144|517356014|FG000|Extension Part|Study closed early|42|||
143495367|NCT01665144|517356015|FG001|Extension Part|Study closed early|0|||
143160695|NCT04432298|516133423|FG000|Overall Study|Withdrawal by Subject|2|||
143160696|NCT04432298|516133424|FG001|Overall Study|Withdrawal by Subject|0|||
143160697|NCT01550965|516133437|FG000|Overall Study|Adverse Event|26|||
143160698|NCT01550965|516133437|FG000|Overall Study|Withdrawal by Subject|10|||
143160699|NCT01550965|516133437|FG000|Overall Study|Lost to Follow-up|2|||
143160700|NCT01550965|516133437|FG000|Overall Study|Lack of Efficacy|59|||
143160701|NCT01550965|516133437|FG000|Overall Study|Other|13|||
143160702|NCT02067156|516133448|FG000|Overall Study|Lost to Follow-up|4|||
143160703|NCT00986102|516133449|FG000|Overall Study|Lost to Follow-up|0|||
143160704|NCT00986102|516133450|FG001|Overall Study|Lost to Follow-up|1|||
143160705|NCT00986102|516133451|FG002|Overall Study|Lost to Follow-up|0|||
143160706|NCT00986102|516133452|FG003|Overall Study|Lost to Follow-up|1|||
143160707|NCT00986102|516133449|FG000|Overall Study|Withdrawal by Subject|1|||
143160708|NCT00986102|516133450|FG001|Overall Study|Withdrawal by Subject|1|||
143160709|NCT00986102|516133451|FG002|Overall Study|Withdrawal by Subject|0|||
143160710|NCT00986102|516133452|FG003|Overall Study|Withdrawal by Subject|0|||
143160711|NCT01691482|516133455|FG000|Treatment Period 2|Adverse Event|0|||
143160712|NCT01691482|516133456|FG001|Treatment Period 2|Adverse Event|1|||
143160713|NCT01691482|516133455|FG000|Treatment Period 2|Protocol Violation|1|||
143495368|NCT01665144|517356016|FG002|Extension Part|Study closed early|19|||
143495369|NCT01665144|517356014|FG000|Extension Part|Progressive disease|36|||
143495370|NCT01665144|517356015|FG001|Extension Part|Progressive disease|0|||
143495371|NCT01665144|517356016|FG002|Extension Part|Progressive disease|14|||
143495372|NCT01665144|517356014|FG000|Extension Part|Lack of Efficacy|37|||
143495373|NCT01665144|517356015|FG001|Extension Part|Lack of Efficacy|0|||
143160714|NCT01691482|516133456|FG001|Treatment Period 2|Protocol Violation|1|||
143160715|NCT01392495|516133457|FG000|Overall Study|Death|3|||
143160716|NCT01392495|516133457|FG000|Overall Study|Administrative problems|8|||
143160717|NCT01392495|516133457|FG000|Overall Study|Withdrawal by Subject|2|||
143495374|NCT01665144|517356016|FG002|Extension Part|Lack of Efficacy|12|||
143495375|NCT01665144|517356014|FG000|Extension Part|Physician Decision|29|||
143495376|NCT01665144|517356015|FG001|Extension Part|Physician Decision|0|||
143495377|NCT01665144|517356016|FG002|Extension Part|Physician Decision|13|||
143033506|NCT02637232|515664882|FG000|Overall Study|Lost to Follow-up|42|||
143033507|NCT02637232|515664882|FG000|Overall Study|Adverse Event|11|||
143033508|NCT02637232|515664882|FG000|Overall Study|patient 's decision|2|||
143033509|NCT02999178|515664883|FG000|Overall Study|Adverse Event|85|||
143033510|NCT02999178|515664884|FG001|Overall Study|Adverse Event|62|||
143033511|NCT02999178|515664883|FG000|Overall Study|Protocol Violation|1|||
143033512|NCT02999178|515664884|FG001|Overall Study|Protocol Violation|2|||
143033513|NCT02999178|515664883|FG000|Overall Study|Lost to Follow-up|0|||
143033514|NCT02999178|515664884|FG001|Overall Study|Lost to Follow-up|2|||
143033515|NCT02999178|515664883|FG000|Overall Study|Withdrawal by Subject|21|||
143033516|NCT02999178|515664884|FG001|Overall Study|Withdrawal by Subject|21|||
143033517|NCT02999178|515664883|FG000|Overall Study|Other reason not defined above|7|||
143033518|NCT02999178|515664884|FG001|Overall Study|Other reason not defined above|13|||
143033519|NCT02424188|515664885|FG000|Overall Study|Death|2|||
143033520|NCT02424188|515664886|FG001|Overall Study|Death|2|||
143033521|NCT02424188|515664885|FG000|Overall Study|Lost to Follow-up|1|||
143033522|NCT02424188|515664886|FG001|Overall Study|Lost to Follow-up|3|||
143033523|NCT02424188|515664885|FG000|Overall Study|Incarceration|1|||
143033524|NCT02424188|515664886|FG001|Overall Study|Incarceration|0|||
143033525|NCT02473640|515664887|FG000|Treatment Period 1|Adverse Event|1|||
143033526|NCT01882647|515664888|FG000|Overall Study|Lost to Follow-up|2|||
143033527|NCT01882647|515664889|FG001|Overall Study|Lost to Follow-up|2|||
143033528|NCT01882647|515664888|FG000|Overall Study|Withdrawal by Subject|0|||
143033529|NCT01882647|515664889|FG001|Overall Study|Withdrawal by Subject|4|||
143033530|NCT03601637|515664891|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
143033531|NCT03601637|515664892|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
143033532|NCT03601637|515664891|FG000|Overall Study|Adverse Event|1|||
143033533|NCT03601637|515664892|FG001|Overall Study|Adverse Event|1|||
143033534|NCT03601637|515664891|FG000|Overall Study|Other|0|||
143033535|NCT03601637|515664892|FG001|Overall Study|Other|1|||
143033536|NCT01108094|515664896|FG000|Overall Study|Adverse Event|2|||
143033537|NCT01108094|515664897|FG001|Overall Study|Adverse Event|0|||
143033538|NCT01108094|515664898|FG002|Overall Study|Adverse Event|0|||
143033539|NCT01108094|515664899|FG003|Overall Study|Adverse Event|0|||
143033540|NCT01108094|515664896|FG000|Overall Study|Withdrawal by Subject|1|||
143033541|NCT01108094|515664897|FG001|Overall Study|Withdrawal by Subject|0|||
143033542|NCT01108094|515664898|FG002|Overall Study|Withdrawal by Subject|0|||
143033543|NCT01108094|515664899|FG003|Overall Study|Withdrawal by Subject|0|||
143033544|NCT01101022|515664905|FG000|Overall Study|Adverse Event|6|||
143033545|NCT01101022|515664906|FG001|Overall Study|Adverse Event|2|||
143033546|NCT01101022|515664905|FG000|Overall Study|Protocol Violation|4|||
143033547|NCT01101022|515664906|FG001|Overall Study|Protocol Violation|3|||
143033548|NCT01101022|515664905|FG000|Overall Study|Withdrawal by Subject|3|||
143033549|NCT01101022|515664906|FG001|Overall Study|Withdrawal by Subject|8|||
143033550|NCT01101022|515664905|FG000|Overall Study|Lost to Follow-up|1|||
143033551|NCT01101022|515664906|FG001|Overall Study|Lost to Follow-up|4|||
143033552|NCT01101022|515664905|FG000|Overall Study|Lack of Efficacy|0|||
143033553|NCT01101022|515664906|FG001|Overall Study|Lack of Efficacy|7|||
143033554|NCT01101022|515664905|FG000|Overall Study|Sponsor decision|1|||
143033555|NCT01101022|515664906|FG001|Overall Study|Sponsor decision|1|||
143033556|NCT01101022|515664905|FG000|Overall Study|Non-compliance|1|||
143033557|NCT01101022|515664906|FG001|Overall Study|Non-compliance|0|||
143033558|NCT01101022|515664905|FG000|Overall Study|Work schedule|1|||
143033559|NCT01101022|515664906|FG001|Overall Study|Work schedule|1|||
143033560|NCT01101022|515664905|FG000|Overall Study|Vacation|0|||
143033561|NCT01101022|515664906|FG001|Overall Study|Vacation|1|||
143033562|NCT01519661|515664907|FG000|Overall Study|Protocol deviation|6|||
143033563|NCT01519661|515664907|FG000|Overall Study|Lost to Follow-up|3|||
143033564|NCT01519661|515664907|FG000|Overall Study|Withdrawal by Subject|17|||
143033565|NCT01519661|515664907|FG000|Overall Study|Lack of Efficacy|6|||
143033566|NCT01519661|515664907|FG000|Overall Study|Adverse Event|29|||
143033567|NCT01648166|515664912|FG000|Overall Study|inadequate toenail samples|53|||
143033568|NCT01648166|515664913|FG001|Overall Study|inadequate toenail samples|100|||
143033569|NCT01717976|515664914|FG000|Overall Study|Protocol Violation|0|||
143033570|NCT01717976|515664915|FG001|Overall Study|Protocol Violation|1|||
143033571|NCT01996033|515664917|FG000|Overall Study|Death|1|||
143160718|NCT01392495|516133457|FG000|Overall Study|Adverse Event|3|||
143033572|NCT01996033|515664917|FG000|Overall Study|Physician Decision|1|||
143033573|NCT01996033|515664917|FG000|Overall Study|Withdrawal by Subject|4|||
143033574|NCT01996033|515664917|FG000|Overall Study|Lost to Follow-up|3|||
143033575|NCT03227445|515664918|FG000|Period 1 (28 Days)|Adverse Event|1|||
143033576|NCT03227445|515664919|FG001|Period 1 (28 Days)|Adverse Event|2|||
143033577|NCT03227445|515664920|FG002|Period 1 (28 Days)|Adverse Event|0|||
143033578|NCT03227445|515664921|FG003|Period 1 (28 Days)|Adverse Event|1|||
143033579|NCT03227445|515664918|FG000|Period 1 (28 Days)|Protocol Violation|1|||
143033580|NCT03227445|515664919|FG001|Period 1 (28 Days)|Protocol Violation|0|||
143033581|NCT03227445|515664920|FG002|Period 1 (28 Days)|Protocol Violation|0|||
143033582|NCT03227445|515664921|FG003|Period 1 (28 Days)|Protocol Violation|0|||
143033583|NCT03227445|515664918|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
143160719|NCT01927861|516133459|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
143160720|NCT01927861|516133460|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
143160721|NCT01927861|516133459|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
143160722|NCT01927861|516133460|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
143160723|NCT01248468|516133462|FG000|Overall Study|Administrative problem|1|||
143160724|NCT01248468|516133463|FG001|Overall Study|Administrative problem|0|||
143160725|NCT01248468|516133464|FG002|Overall Study|Administrative problem|0|||
143160726|NCT01248468|516133462|FG000|Overall Study|Lost to Follow-up|9|||
143160727|NCT01248468|516133463|FG001|Overall Study|Lost to Follow-up|12|||
143160728|NCT01248468|516133464|FG002|Overall Study|Lost to Follow-up|4|||
143160729|NCT01248468|516133462|FG000|Overall Study|Pregnancy|1|||
143160730|NCT01248468|516133463|FG001|Overall Study|Pregnancy|0|||
143160731|NCT01248468|516133464|FG002|Overall Study|Pregnancy|0|||
143160732|NCT01248468|516133462|FG000|Overall Study|Withdrawal by Subject|4|||
143160733|NCT01248468|516133463|FG001|Overall Study|Withdrawal by Subject|2|||
143160734|NCT01248468|516133464|FG002|Overall Study|Withdrawal by Subject|0|||
143160735|NCT00468546|516133465|FG000|Week 24 Analysis|Lack of Efficacy|83|||
143160736|NCT00468546|516133466|FG001|Week 24 Analysis|Lack of Efficacy|37|||
143160737|NCT00468546|516133465|FG000|Week 24 Analysis|Refused treatment|5|||
143160738|NCT00468546|516133466|FG001|Week 24 Analysis|Refused treatment|5|||
143160739|NCT00468546|516133465|FG000|Week 24 Analysis|Adverse Event|1|||
143160740|NCT00468546|516133466|FG001|Week 24 Analysis|Adverse Event|8|||
143160741|NCT00468546|516133465|FG000|Week 24 Analysis|Failure to return|3|||
143160742|NCT00468546|516133466|FG001|Week 24 Analysis|Failure to return|4|||
143160743|NCT00468546|516133465|FG000|Week 24 Analysis|Rescue therapy|2|||
143160744|NCT00468546|516133466|FG001|Week 24 Analysis|Rescue therapy|0|||
143160745|NCT00468546|516133465|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
143160746|NCT00468546|516133466|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
143495378|NCT01665144|517356014|FG000|Extension Part|Technical problems|20|||
143495379|NCT01665144|517356015|FG001|Extension Part|Technical problems|0|||
143495380|NCT01665144|517356016|FG002|Extension Part|Technical problems|8|||
143495381|NCT01665144|517356014|FG000|Extension Part|Death|20|||
143495382|NCT01665144|517356015|FG001|Extension Part|Death|0|||
143495383|NCT01665144|517356016|FG002|Extension Part|Death|4|||
143495384|NCT01665144|517356014|FG000|Extension Part|Missing|12|||
143495385|NCT01665144|517356015|FG001|Extension Part|Missing|0|||
143495386|NCT01665144|517356016|FG002|Extension Part|Missing|6|||
143495387|NCT01665144|517356014|FG000|Extension Part|Lost to Follow-up|9|||
143033584|NCT03227445|515664919|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
143033585|NCT03227445|515664920|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
143033586|NCT03227445|515664921|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
143033587|NCT03227445|515664918|FG000|Period 2 (28 Days)|Adverse Event|1|||
143033588|NCT03227445|515664919|FG001|Period 2 (28 Days)|Adverse Event|0|||
143033589|NCT03227445|515664920|FG002|Period 2 (28 Days)|Adverse Event|2|||
143033590|NCT03227445|515664921|FG003|Period 2 (28 Days)|Adverse Event|1|||
143033591|NCT03227445|515664918|FG000|Period 2 (28 Days)|Protocol Violation|0|||
143033592|NCT03227445|515664919|FG001|Period 2 (28 Days)|Protocol Violation|0|||
143033593|NCT03227445|515664920|FG002|Period 2 (28 Days)|Protocol Violation|0|||
143033594|NCT03227445|515664921|FG003|Period 2 (28 Days)|Protocol Violation|1|||
143033595|NCT03227445|515664918|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
143033596|NCT03227445|515664919|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
143033597|NCT03227445|515664920|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
143033598|NCT03227445|515664921|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
143033599|NCT01991470|515664922|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
143033600|NCT01991470|515664922|FG000|Enlite 1 Period|Adverse Event|1|||
143033601|NCT01991470|515664922|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
143033602|NCT01991470|515664922|FG000|Enlite 3 Period|Lost to Follow-up|1|||
143033603|NCT01991470|515664922|FG000|Enlite 3 Period|Physician Decision|2|||
143033604|NCT01991470|515664922|FG000|Enlite 3 Period|Physician Decision|8|||
143033605|NCT01991470|515664922|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
143033606|NCT00864097|515664928|FG000|Overall Study|Death|0|||
143033607|NCT00864097|515664929|FG001|Overall Study|Death|1|||
143160747|NCT00468546|516133465|FG000|Week 24 Analysis|Due to clinical hold|1|||
143160748|NCT00468546|516133466|FG001|Week 24 Analysis|Due to clinical hold|0|||
143160749|NCT00468546|516133465|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
143160750|NCT00468546|516133466|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
143495388|NCT01665144|517356015|FG001|Extension Part|Lost to Follow-up|0|||
143160751|NCT00468546|516133465|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
143495389|NCT01665144|517356016|FG002|Extension Part|Lost to Follow-up|5|||
143495390|NCT01665144|517356014|FG000|Extension Part|New therapy for study indication|3|||
143033608|NCT00864097|515664930|FG002|Overall Study|Death|0|||
143033609|NCT00864097|515664931|FG003|Overall Study|Death|0|||
143160752|NCT00468546|516133466|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
143495391|NCT01665144|517356015|FG001|Extension Part|New therapy for study indication|0|||
143033610|NCT00864097|515664928|FG000|Overall Study|Adverse Event|6|||
143033611|NCT00864097|515664929|FG001|Overall Study|Adverse Event|8|||
143160753|NCT00468546|516133465|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
143160754|NCT00468546|516133466|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
143033612|NCT00864097|515664930|FG002|Overall Study|Adverse Event|11|||
143033613|NCT00864097|515664931|FG003|Overall Study|Adverse Event|9|||
143033614|NCT00864097|515664928|FG000|Overall Study|Lack of Efficacy|9|||
143033615|NCT00864097|515664929|FG001|Overall Study|Lack of Efficacy|3|||
143033616|NCT00864097|515664930|FG002|Overall Study|Lack of Efficacy|7|||
143033617|NCT00864097|515664931|FG003|Overall Study|Lack of Efficacy|2|||
143033618|NCT00864097|515664928|FG000|Overall Study|Lost to Follow-up|0|||
143033619|NCT00864097|515664929|FG001|Overall Study|Lost to Follow-up|1|||
143033620|NCT00864097|515664930|FG002|Overall Study|Lost to Follow-up|0|||
143033621|NCT00864097|515664931|FG003|Overall Study|Lost to Follow-up|1|||
143033622|NCT00864097|515664928|FG000|Overall Study|Withdrawal by Subject|15|||
143033623|NCT00864097|515664929|FG001|Overall Study|Withdrawal by Subject|11|||
143033624|NCT00864097|515664930|FG002|Overall Study|Withdrawal by Subject|11|||
143033625|NCT00864097|515664931|FG003|Overall Study|Withdrawal by Subject|12|||
143033626|NCT00864097|515664928|FG000|Overall Study|Protocol Violation|2|||
143033627|NCT00864097|515664929|FG001|Overall Study|Protocol Violation|1|||
143033628|NCT00864097|515664930|FG002|Overall Study|Protocol Violation|0|||
143033629|NCT00864097|515664931|FG003|Overall Study|Protocol Violation|1|||
143033630|NCT00864097|515664928|FG000|Overall Study|Terminated by sponsor|105|||
143033631|NCT00864097|515664929|FG001|Overall Study|Terminated by sponsor|112|||
143033632|NCT00864097|515664930|FG002|Overall Study|Terminated by sponsor|102|||
143033633|NCT00864097|515664931|FG003|Overall Study|Terminated by sponsor|99|||
143033634|NCT00864097|515664928|FG000|Overall Study|Randomized but not treated|2|||
143033635|NCT00864097|515664929|FG001|Overall Study|Randomized but not treated|0|||
143033636|NCT00864097|515664930|FG002|Overall Study|Randomized but not treated|1|||
143033637|NCT00864097|515664931|FG003|Overall Study|Randomized but not treated|0|||
143033638|NCT00864097|515664928|FG000|Overall Study|Other|0|||
143033639|NCT00864097|515664929|FG001|Overall Study|Other|0|||
143033640|NCT00864097|515664930|FG002|Overall Study|Other|0|||
143033641|NCT00864097|515664931|FG003|Overall Study|Other|1|||
143033642|NCT00262223|515664935|FG000|Treatment Phase|Withdrawal by Subject|3|||
143033643|NCT00262223|515664936|FG001|Treatment Phase|Withdrawal by Subject|6|||
143033644|NCT00262223|515664935|FG000|Treatment Phase|Adverse Event|1|||
143033645|NCT00262223|515664936|FG001|Treatment Phase|Adverse Event|2|||
143033646|NCT00262223|515664935|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
143033647|NCT00262223|515664936|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
143033648|NCT00262223|515664935|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
143033649|NCT00262223|515664936|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
143033650|NCT00262223|515664935|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
143033651|NCT00262223|515664936|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
143033652|NCT02731157|515664939|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
143033653|NCT01239121|515664942|FG000|Overall Study|Withdrawal by Subject|2|||
143033654|NCT01239121|515664943|FG001|Overall Study|Withdrawal by Subject|4|||
143033655|NCT01239121|515664944|FG002|Overall Study|Withdrawal by Subject|0|||
143033656|NCT00623779|515664948|FG000|Overall Study|Adverse Event|1|||
143033657|NCT00623779|515664949|FG001|Overall Study|Adverse Event|3|||
143033658|NCT00623779|515664950|FG002|Overall Study|Adverse Event|0|||
143033659|NCT00623779|515664948|FG000|Overall Study|Criteria from CSR|2|||
143033660|NCT00623779|515664949|FG001|Overall Study|Criteria from CSR|0|||
143033661|NCT00623779|515664950|FG002|Overall Study|Criteria from CSR|1|||
143033662|NCT01856309|515664951|FG000|Overall Study|Death|4|||
143033663|NCT01856309|515664952|FG001|Overall Study|Death|6|||
143033664|NCT01856309|515664953|FG002|Overall Study|Death|11|||
143033665|NCT01856309|515664954|FG003|Overall Study|Death|6|||
143033666|NCT01856309|515664951|FG000|Overall Study|Lost to Follow-up|6|||
143033667|NCT01856309|515664952|FG001|Overall Study|Lost to Follow-up|2|||
143033668|NCT01856309|515664953|FG002|Overall Study|Lost to Follow-up|4|||
143033669|NCT01856309|515664954|FG003|Overall Study|Lost to Follow-up|8|||
143033670|NCT01856309|515664951|FG000|Overall Study|Withdrawal by Subject|11|||
143033671|NCT01856309|515664952|FG001|Overall Study|Withdrawal by Subject|13|||
143033672|NCT01856309|515664953|FG002|Overall Study|Withdrawal by Subject|28|||
143033673|NCT01856309|515664954|FG003|Overall Study|Withdrawal by Subject|26|||
143033674|NCT01856309|515664951|FG000|Overall Study|Other|227|||
143033675|NCT01856309|515664952|FG001|Overall Study|Other|225|||
143033676|NCT01856309|515664953|FG002|Overall Study|Other|447|||
143033677|NCT01856309|515664954|FG003|Overall Study|Other|469|||
143033678|NCT01856309|515664951|FG000|Overall Study|Lack of Efficacy|14|||
143033679|NCT01856309|515664952|FG001|Overall Study|Lack of Efficacy|9|||
143033680|NCT01856309|515664953|FG002|Overall Study|Lack of Efficacy|40|||
143160755|NCT00468546|516133465|FG000|Week 24 to Week 104 Analysis|Death|1|||
143033681|NCT01856309|515664954|FG003|Overall Study|Lack of Efficacy|25|||
143033682|NCT01856309|515664951|FG000|Overall Study|Adverse Event|31|||
143033683|NCT01856309|515664952|FG001|Overall Study|Adverse Event|31|||
143033684|NCT01856309|515664953|FG002|Overall Study|Adverse Event|55|||
143033685|NCT01856309|515664954|FG003|Overall Study|Adverse Event|65|||
143033686|NCT01856309|515664951|FG000|Overall Study|Pregnancy|0|||
143033687|NCT01856309|515664952|FG001|Overall Study|Pregnancy|0|||
143033688|NCT01856309|515664953|FG002|Overall Study|Pregnancy|0|||
143033689|NCT01856309|515664954|FG003|Overall Study|Pregnancy|1|||
143033690|NCT01856309|515664951|FG000|Overall Study|Physician Decision|6|||
143033691|NCT01856309|515664952|FG001|Overall Study|Physician Decision|1|||
143033692|NCT01856309|515664953|FG002|Overall Study|Physician Decision|6|||
143033693|NCT01856309|515664954|FG003|Overall Study|Physician Decision|8|||
143033694|NCT01856309|515664951|FG000|Overall Study|Noncompliance With Study Drug|0|||
143033695|NCT01856309|515664952|FG001|Overall Study|Noncompliance With Study Drug|1|||
143033696|NCT01856309|515664953|FG002|Overall Study|Noncompliance With Study Drug|4|||
143033697|NCT01856309|515664954|FG003|Overall Study|Noncompliance With Study Drug|1|||
143033698|NCT00832377|515664955|FG000|Overall Study|Protocol Violation|1|||
143033699|NCT00220337|515664956|FG000|Overall Study|Adverse Event|70|||
143033700|NCT00220337|515664956|FG000|Overall Study|Lack of Efficacy|17|||
143033701|NCT00220337|515664956|FG000|Overall Study|Withdrawal by Subject|68|||
143033702|NCT00220337|515664956|FG000|Overall Study|Protocol Violation|2|||
143033703|NCT00220337|515664956|FG000|Overall Study|Lost to Follow-up|5|||
143033704|NCT00220337|515664956|FG000|Overall Study|Other|12|||
143033705|NCT00220337|515664956|FG000|Overall Study|Unsatisfactory compliance|5|||
143033706|NCT01273181|515664957|FG000|Phase I, Dose 1|Study termination|1|||
143033707|NCT01273181|515664958|FG001|Phase I, Dose 1|Study termination|0|||
143033708|NCT01273181|515664959|FG002|Phase I, Dose 1|Study termination|0|||
143033709|NCT01273181|515664960|FG003|Phase I, Dose 1|Study termination|0|||
143033710|NCT01273181|515664957|FG000|Phase I, Dose 2|Death during treatment|0|||
143160756|NCT00468546|516133466|FG001|Week 24 to Week 104 Analysis|Death|0|||
143160757|NCT00468546|516133465|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
143160758|NCT00468546|516133466|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
143160759|NCT00468546|516133465|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
143160760|NCT00468546|516133466|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
143160761|NCT00468546|516133465|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
143160762|NCT00468546|516133466|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
143160763|NCT00468546|516133465|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
143160764|NCT00468546|516133466|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
143160765|NCT00468546|516133465|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
143160766|NCT00468546|516133466|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
143160767|NCT00468546|516133465|FG000|Week 24 to Week 104 Analysis|Other|17|||
143160768|NCT00468546|516133466|FG001|Week 24 to Week 104 Analysis|Other|14|||
143160769|NCT00472641|516133467|FG000|Overall Study|Lack of Efficacy|3|||
143160770|NCT00472641|516133467|FG000|Overall Study|Adverse Event|3|||
143160771|NCT00472641|516133467|FG000|Overall Study|Lost to Follow-up|1|||
143160772|NCT03438656|516133468|FG000|Overall Study|Lost to Follow-up|2|||
143160773|NCT01065766|516133471|FG000|Overall Study|Assessed before the contracted date|1|||
143160774|NCT01065766|516133471|FG000|Overall Study|Contraindication to administration|6|||
143160775|NCT01065766|516133471|FG000|Overall Study|Violated dosage/administration|25|||
143160776|NCT04223687|516133475|FG000|Overall Study|Missing primary outcome|1|||
143160777|NCT04223687|516133476|FG001|Overall Study|Missing primary outcome|0|||
143160778|NCT01608308|516133480|FG000|Overall Study|pretreatment medical and billing reasons|0|||
143160779|NCT01608308|516133481|FG001|Overall Study|pretreatment medical and billing reasons|2|||
143160780|NCT04128228|516133482|FG000|Overall Study|Withdrawal by Subject|3|||
143160781|NCT04128228|516133483|FG001|Overall Study|Withdrawal by Subject|3|||
143160782|NCT04128228|516133484|FG002|Overall Study|Withdrawal by Subject|0|||
143160783|NCT04128228|516133485|FG003|Overall Study|Withdrawal by Subject|0|||
143160784|NCT04128228|516133482|FG000|Overall Study|noncompliance|2|||
143160785|NCT04128228|516133483|FG001|Overall Study|noncompliance|2|||
143160786|NCT04128228|516133484|FG002|Overall Study|noncompliance|0|||
143160787|NCT04128228|516133485|FG003|Overall Study|noncompliance|0|||
143160788|NCT05652140|516133486|FG000|Overall Study|Lost to Follow-up|7|||
143160789|NCT05652140|516133487|FG001|Overall Study|Lost to Follow-up|16|||
143160790|NCT05652140|516133488|FG002|Overall Study|Lost to Follow-up|22|||
143160791|NCT05652140|516133489|FG003|Overall Study|Lost to Follow-up|31|||
143160792|NCT04648241|516133493|FG000|Overall Study|Lost to Follow-up|1|||
143160793|NCT04648241|516133494|FG001|Overall Study|Lost to Follow-up|0|||
143160794|NCT02057666|516133495|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
143160795|NCT02057666|516133496|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
143160796|NCT02057666|516133495|FG000|Double Blind Treatment Period|Poor tolerability|7|||
143160797|NCT02057666|516133496|FG001|Double Blind Treatment Period|Poor tolerability|2|||
143160798|NCT02057666|516133495|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
143160799|NCT02057666|516133496|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
143160800|NCT02057666|516133495|FG000|Double Blind Treatment Period|Physician Decision|1|||
143160801|NCT02057666|516133496|FG001|Double Blind Treatment Period|Physician Decision|0|||
143160802|NCT02057666|516133495|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
143160803|NCT02057666|516133496|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
143160804|NCT02057666|516133495|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
143033711|NCT01273181|515664958|FG001|Phase I, Dose 2|Death during treatment|1|||
143033712|NCT01273181|515664959|FG002|Phase I, Dose 2|Death during treatment|0|||
143033713|NCT01273181|515664960|FG003|Phase I, Dose 2|Death during treatment|0|||
143033714|NCT01273181|515664957|FG000|Phase 2, Dose 1|Study termination|0|||
143033715|NCT01273181|515664958|FG001|Phase 2, Dose 1|Study termination|0|||
143033716|NCT01273181|515664959|FG002|Phase 2, Dose 1|Study termination|1|||
143033717|NCT01273181|515664960|FG003|Phase 2, Dose 1|Study termination|0|||
143033718|NCT01273181|515664957|FG000|Phase 2, Dose 2|Death during treatment|0|||
143033719|NCT01273181|515664958|FG001|Phase 2, Dose 2|Death during treatment|0|||
143033720|NCT01273181|515664959|FG002|Phase 2, Dose 2|Death during treatment|0|||
143033721|NCT01273181|515664960|FG003|Phase 2, Dose 2|Death during treatment|1|||
143033722|NCT00944697|515664961|FG000|Overall Study|Withdrawal by Subject|1|||
143033723|NCT00944697|515664962|FG001|Overall Study|Withdrawal by Subject|1|||
143033724|NCT00944697|515664961|FG000|Overall Study|Adverse Event|0|||
143033725|NCT00944697|515664962|FG001|Overall Study|Adverse Event|3|||
143033726|NCT00944697|515664961|FG000|Overall Study|Administrative|1|||
143033727|NCT00944697|515664962|FG001|Overall Study|Administrative|1|||
143033728|NCT03661528|515664963|FG000|Overall Study|Death|1|||
143033729|NCT03661528|515664964|FG001|Overall Study|Death|0|||
143033730|NCT03661528|515664963|FG000|Overall Study|Physician Decision|3|||
143033731|NCT03661528|515664964|FG001|Overall Study|Physician Decision|1|||
143033732|NCT03661528|515664963|FG000|Overall Study|Other than Specified|5|||
143033733|NCT03661528|515664964|FG001|Overall Study|Other than Specified|2|||
143033734|NCT03661528|515664963|FG000|Overall Study|Withdrawal by Subject|5|||
143033735|NCT03661528|515664964|FG001|Overall Study|Withdrawal by Subject|3|||
143033736|NCT03661528|515664963|FG000|Overall Study|Disease Progression|8|||
143033737|NCT03661528|515664964|FG001|Overall Study|Disease Progression|13|||
143033738|NCT03661528|515664963|FG000|Overall Study|Adverse Event|61|||
143033739|NCT03661528|515664964|FG001|Overall Study|Adverse Event|55|||
143033740|NCT02732210|515664965|FG000|Overall Study|Site Closed|0|||
143033741|NCT02732210|515664966|FG001|Overall Study|Site Closed|11|||
143033742|NCT02732210|515664965|FG000|Overall Study|Study Ended|13|||
143033743|NCT02732210|515664966|FG001|Overall Study|Study Ended|13|||
143033744|NCT02732210|515664965|FG000|Overall Study|Withdrawal by Subject|28|||
143033745|NCT02732210|515664966|FG001|Overall Study|Withdrawal by Subject|87|||
143033746|NCT02732210|515664965|FG000|Overall Study|Lost to Follow-up|5|||
143033747|NCT02732210|515664966|FG001|Overall Study|Lost to Follow-up|57|||
143033748|NCT02732210|515664965|FG000|Overall Study|Death|4|||
143033749|NCT02732210|515664966|FG001|Overall Study|Death|15|||
143033750|NCT02732210|515664965|FG000|Overall Study|Other|35|||
143033751|NCT02732210|515664966|FG001|Overall Study|Other|103|||
143033752|NCT02732210|515664965|FG000|Overall Study|Missing|0|||
143033753|NCT02732210|515664966|FG001|Overall Study|Missing|8|||
143033754|NCT01062256|515664968|FG000|Overall Study|Adverse Event|1|||
143033755|NCT01062256|515664969|FG001|Overall Study|Adverse Event|0|||
143033756|NCT01062256|515664970|FG002|Overall Study|Adverse Event|0|||
143033757|NCT01062256|515664968|FG000|Overall Study|Withdrawal by Subject|1|||
143033758|NCT01062256|515664969|FG001|Overall Study|Withdrawal by Subject|1|||
143033759|NCT01062256|515664970|FG002|Overall Study|Withdrawal by Subject|1|||
143033760|NCT01062256|515664968|FG000|Overall Study|Ineligible|1|||
143033761|NCT01062256|515664969|FG001|Overall Study|Ineligible|4|||
143033762|NCT01062256|515664970|FG002|Overall Study|Ineligible|3|||
143033763|NCT01062256|515664968|FG000|Overall Study|Administrative|0|||
143033764|NCT01062256|515664969|FG001|Overall Study|Administrative|2|||
143033765|NCT01062256|515664970|FG002|Overall Study|Administrative|0|||
143033766|NCT03049488|515664971|FG000|Overall Study|Lost to Follow-up|1|||
143033767|NCT03049488|515664972|FG001|Overall Study|Lost to Follow-up|1|||
143033768|NCT03049488|515664973|FG002|Overall Study|Lost to Follow-up|0|||
143033769|NCT03049488|515664974|FG003|Overall Study|Lost to Follow-up|0|||
143033770|NCT03049488|515664975|FG004|Overall Study|Lost to Follow-up|0|||
143033771|NCT03049488|515664976|FG005|Overall Study|Lost to Follow-up|0|||
143033772|NCT03049488|515664971|FG000|Overall Study|Moved from Area|1|||
143033773|NCT03049488|515664972|FG001|Overall Study|Moved from Area|0|||
143033774|NCT03049488|515664973|FG002|Overall Study|Moved from Area|0|||
143033775|NCT03049488|515664974|FG003|Overall Study|Moved from Area|1|||
143033776|NCT03049488|515664975|FG004|Overall Study|Moved from Area|1|||
143033777|NCT03049488|515664976|FG005|Overall Study|Moved from Area|0|||
143033778|NCT03049488|515664971|FG000|Overall Study|Physician Decision|0|||
143033779|NCT03049488|515664972|FG001|Overall Study|Physician Decision|1|||
143033780|NCT03049488|515664973|FG002|Overall Study|Physician Decision|0|||
143033781|NCT03049488|515664974|FG003|Overall Study|Physician Decision|0|||
143033782|NCT03049488|515664975|FG004|Overall Study|Physician Decision|0|||
143033783|NCT03049488|515664976|FG005|Overall Study|Physician Decision|0|||
143033784|NCT03049488|515664971|FG000|Overall Study|Withdrawal by Subject|0|||
143033785|NCT03049488|515664972|FG001|Overall Study|Withdrawal by Subject|0|||
143033786|NCT03049488|515664973|FG002|Overall Study|Withdrawal by Subject|0|||
143033787|NCT03049488|515664974|FG003|Overall Study|Withdrawal by Subject|1|||
143033788|NCT03049488|515664975|FG004|Overall Study|Withdrawal by Subject|1|||
143033789|NCT03049488|515664976|FG005|Overall Study|Withdrawal by Subject|0|||
143033790|NCT01448057|515664977|FG000|Overall Study|Protocol Violation|3|||
143033791|NCT01448057|515664978|FG001|Overall Study|Protocol Violation|2|||
143033792|NCT01448057|515664977|FG000|Overall Study|Lost to Follow-up|3|||
143033793|NCT01448057|515664978|FG001|Overall Study|Lost to Follow-up|0|||
143033794|NCT01448057|515664977|FG000|Overall Study|Adverse Event|0|||
143033795|NCT01448057|515664978|FG001|Overall Study|Adverse Event|2|||
143033796|NCT01448057|515664977|FG000|Overall Study|Withdrawal by Subject|2|||
143033797|NCT01448057|515664978|FG001|Overall Study|Withdrawal by Subject|0|||
143033798|NCT00874237|515664979|FG000|Overall Study|Physician Decision|0|||
143033799|NCT00874237|515664980|FG001|Overall Study|Physician Decision|1|||
143033800|NCT00874237|515664981|FG002|Overall Study|Physician Decision|0|||
143033801|NCT00874237|515664982|FG003|Overall Study|Physician Decision|0|||
143033802|NCT00874237|515664983|FG004|Overall Study|Physician Decision|0|||
143033803|NCT00874237|515664984|FG005|Overall Study|Physician Decision|0|||
143033804|NCT00874237|515664979|FG000|Overall Study|Withdrawal by Subject|0|||
143033805|NCT00874237|515664980|FG001|Overall Study|Withdrawal by Subject|0|||
143033806|NCT00874237|515664981|FG002|Overall Study|Withdrawal by Subject|1|||
143033807|NCT00874237|515664982|FG003|Overall Study|Withdrawal by Subject|0|||
143033808|NCT00874237|515664983|FG004|Overall Study|Withdrawal by Subject|0|||
143033809|NCT00874237|515664984|FG005|Overall Study|Withdrawal by Subject|0|||
143033810|NCT06354270|515665000|FG000|Overall Study|Withdrawal by Subject|1|||
143033811|NCT06354270|515665001|FG001|Overall Study|Withdrawal by Subject|0|||
143033812|NCT02016170|515665002|FG000|Overall Study|Adverse Event|1|||
143033813|NCT02016170|515665003|FG001|Overall Study|Adverse Event|1|||
143033814|NCT02016170|515665004|FG002|Overall Study|Adverse Event|0|||
143033815|NCT02016170|515665002|FG000|Overall Study|Protocol Violation|1|||
143033816|NCT02016170|515665003|FG001|Overall Study|Protocol Violation|0|||
143033817|NCT02016170|515665004|FG002|Overall Study|Protocol Violation|0|||
143033818|NCT00970281|515665007|FG000|Overall Study|Lack of Efficacy|1|||
143033819|NCT00970281|515665008|FG001|Overall Study|Lack of Efficacy|14|||
143033820|NCT00970281|515665007|FG000|Overall Study|Withdrawal by Subject|0|||
143033821|NCT00970281|515665008|FG001|Overall Study|Withdrawal by Subject|1|||
143033822|NCT00970281|515665007|FG000|Overall Study|Physician Decision|1|||
143033823|NCT00970281|515665008|FG001|Overall Study|Physician Decision|1|||
143033824|NCT05277389|515665009|FG000|Overall Study|Lost to Follow-up|1|||
143033825|NCT05277389|515665010|FG001|Overall Study|Lost to Follow-up|4|||
143033826|NCT01766778|515665019|FG000|Overall Study|Adverse Event|4|||
143033827|NCT01766778|515665020|FG001|Overall Study|Adverse Event|4|||
143033828|NCT01766778|515665019|FG000|Overall Study|Withdrawal by Subject|1|||
143033829|NCT01766778|515665020|FG001|Overall Study|Withdrawal by Subject|0|||
143033830|NCT01104662|515665021|FG000|Overall Study|Adverse Event|2|||
143033831|NCT01104662|515665022|FG001|Overall Study|Adverse Event|2|||
143033832|NCT01104662|515665023|FG002|Overall Study|Adverse Event|0|||
143033833|NCT01104662|515665024|FG003|Overall Study|Adverse Event|1|||
143033834|NCT01104662|515665025|FG004|Overall Study|Adverse Event|1|||
143033835|NCT01104662|515665026|FG005|Overall Study|Adverse Event|1|||
143033836|NCT01104662|515665027|FG006|Overall Study|Adverse Event|0|||
143033837|NCT01104662|515665028|FG007|Overall Study|Adverse Event|0|||
143033838|NCT01104662|515665021|FG000|Overall Study|Clinical Failure|1|||
143033839|NCT01104662|515665022|FG001|Overall Study|Clinical Failure|0|||
143033840|NCT01104662|515665023|FG002|Overall Study|Clinical Failure|0|||
143033841|NCT01104662|515665024|FG003|Overall Study|Clinical Failure|0|||
143033842|NCT01104662|515665025|FG004|Overall Study|Clinical Failure|0|||
143033843|NCT01104662|515665026|FG005|Overall Study|Clinical Failure|1|||
143033844|NCT01104662|515665027|FG006|Overall Study|Clinical Failure|0|||
143033845|NCT01104662|515665028|FG007|Overall Study|Clinical Failure|0|||
143033846|NCT01104662|515665021|FG000|Overall Study|Participant left investigator's care|1|||
143033847|NCT01104662|515665022|FG001|Overall Study|Participant left investigator's care|1|||
143033848|NCT01104662|515665023|FG002|Overall Study|Participant left investigator's care|0|||
143033849|NCT01104662|515665024|FG003|Overall Study|Participant left investigator's care|0|||
143033850|NCT01104662|515665025|FG004|Overall Study|Participant left investigator's care|0|||
143033851|NCT01104662|515665026|FG005|Overall Study|Participant left investigator's care|0|||
143033852|NCT01104662|515665027|FG006|Overall Study|Participant left investigator's care|0|||
143033853|NCT01104662|515665028|FG007|Overall Study|Participant left investigator's care|0|||
143033854|NCT01104662|515665021|FG000|Overall Study|Reason not specified|3|||
143033855|NCT01104662|515665022|FG001|Overall Study|Reason not specified|3|||
143033856|NCT01104662|515665023|FG002|Overall Study|Reason not specified|0|||
143033857|NCT01104662|515665024|FG003|Overall Study|Reason not specified|0|||
143033858|NCT01104662|515665025|FG004|Overall Study|Reason not specified|0|||
143033859|NCT01104662|515665026|FG005|Overall Study|Reason not specified|1|||
143033860|NCT01104662|515665027|FG006|Overall Study|Reason not specified|0|||
143033861|NCT01104662|515665028|FG007|Overall Study|Reason not specified|0|||
143033862|NCT01104662|515665021|FG000|Overall Study|Randomized but not treated|3|||
143033863|NCT01104662|515665022|FG001|Overall Study|Randomized but not treated|4|||
143033864|NCT01104662|515665023|FG002|Overall Study|Randomized but not treated|1|||
143033865|NCT01104662|515665024|FG003|Overall Study|Randomized but not treated|0|||
143238572|NCT05038982|516427516|FG000|Overall Study|Withdrawal by Subject|0|||
143033866|NCT01104662|515665025|FG004|Overall Study|Randomized but not treated|0|||
143033867|NCT01104662|515665026|FG005|Overall Study|Randomized but not treated|1|||
143033868|NCT01104662|515665027|FG006|Overall Study|Randomized but not treated|0|||
143033869|NCT01104662|515665028|FG007|Overall Study|Randomized but not treated|0|||
143033870|NCT01411332|515665029|FG000|Enrollment|Protocol Violation|0|||
143033871|NCT01411332|515665030|FG001|Enrollment|Protocol Violation|1|||
143033872|NCT01411332|515665029|FG000|Enrollment|Withdrawal by Subject|0|||
143033873|NCT01411332|515665030|FG001|Enrollment|Withdrawal by Subject|1|||
143033874|NCT01411332|515665029|FG000|Treatment|Lost to Follow-up|1|||
143033875|NCT01411332|515665030|FG001|Treatment|Lost to Follow-up|0|||
143033876|NCT01706926|515665031|FG000|Overall Study|Lost to Follow-up|0|||
143033877|NCT01706926|515665032|FG001|Overall Study|Lost to Follow-up|0|||
143033878|NCT01706926|515665033|FG002|Overall Study|Lost to Follow-up|1|||
143033879|NCT01706926|515665034|FG003|Overall Study|Lost to Follow-up|0|||
143033880|NCT01706926|515665031|FG000|Overall Study|Withdrawal by Subject|2|||
143033881|NCT01706926|515665032|FG001|Overall Study|Withdrawal by Subject|0|||
143033882|NCT01706926|515665033|FG002|Overall Study|Withdrawal by Subject|1|||
143033883|NCT01706926|515665034|FG003|Overall Study|Withdrawal by Subject|2|||
143033884|NCT01706926|515665031|FG000|Overall Study|Other|4|||
143033885|NCT01706926|515665032|FG001|Overall Study|Other|4|||
143033886|NCT01706926|515665033|FG002|Overall Study|Other|4|||
143033887|NCT01706926|515665034|FG003|Overall Study|Other|3|||
143033888|NCT00420303|515666662|FG000|Overall Study|Serious Adverse Event|1|||
143033889|NCT00420303|515666663|FG001|Overall Study|Serious Adverse Event|0|||
143033890|NCT00420303|515666662|FG000|Overall Study|Lack of Efficacy|0|||
143033891|NCT00420303|515666663|FG001|Overall Study|Lack of Efficacy|3|||
143033892|NCT00420303|515666662|FG000|Overall Study|Physician Decision|0|||
143033893|NCT00420303|515666663|FG001|Overall Study|Physician Decision|1|||
143033894|NCT02918877|515666668|FG000|Overall Study|Withdrawal by Subject|2|||
143033895|NCT02918877|515666669|FG001|Overall Study|Withdrawal by Subject|2|||
143033896|NCT02918877|515666668|FG000|Overall Study|Surgery cancelled|1|||
143033897|NCT02918877|515666669|FG001|Overall Study|Surgery cancelled|0|||
143033898|NCT02918877|515666668|FG000|Overall Study|Physician Decision|1|||
143033899|NCT02918877|515666669|FG001|Overall Study|Physician Decision|0|||
143033900|NCT02918877|515666668|FG000|Overall Study|Received intraoperative steroids|1|||
143033901|NCT02918877|515666669|FG001|Overall Study|Received intraoperative steroids|0|||
143033902|NCT02918877|515666668|FG000|Overall Study|Unable to obtain lab samples|1|||
143033903|NCT02918877|515666669|FG001|Overall Study|Unable to obtain lab samples|0|||
143033904|NCT02918877|515666668|FG000|Overall Study|Unsafe to perform BAL|0|||
143033905|NCT02918877|515666669|FG001|Overall Study|Unsafe to perform BAL|1|||
143033906|NCT00088829|515666670|FG000|Overall Study|PI left institution and study was close|22|||
143033907|NCT04455633|515666671|FG000|Double-Blind Period (Up to Week 6)|Adverse Event|4|||
143033908|NCT04455633|515666672|FG001|Double-Blind Period (Up to Week 6)|Adverse Event|17|||
143033909|NCT04455633|515666673|FG002|Double-Blind Period (Up to Week 6)|Adverse Event|28|||
143160805|NCT02057666|516133496|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
143160806|NCT02057666|516133495|FG000|Double Blind Treatment Period|Sponsor's request|70|||
143160807|NCT02057666|516133496|FG001|Double Blind Treatment Period|Sponsor's request|34|||
143160808|NCT02057666|516133495|FG000|Open-Label Treatment Period|Poor tolerability|0|||
143160809|NCT02057666|516133496|FG001|Open-Label Treatment Period|Poor tolerability|1|||
143160810|NCT02057666|516133495|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
143495392|NCT01665144|517356016|FG002|Extension Part|New therapy for study indication|2|||
143495393|NCT01665144|517356014|FG000|Extension Part|Protocol deviation|3|||
143495394|NCT01665144|517356015|FG001|Extension Part|Protocol deviation|0|||
143495395|NCT01665144|517356016|FG002|Extension Part|Protocol deviation|0|||
143495396|NCT01913483|517356017|FG000|Overall Study|Withdrawal by Subject|1|||
143160811|NCT02057666|516133496|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
143160812|NCT02057666|516133495|FG000|Open-Label Treatment Period|Sponsor's request|0|||
143160813|NCT02057666|516133496|FG001|Open-Label Treatment Period|Sponsor's request|4|||
143160814|NCT02489045|516133497|FG000|Overall Study|unable to collect usable data|53|||
143160815|NCT02489045|516133497|FG000|Follow-up|Lost to Follow-up|10|||
143160816|NCT04401293|516133500|FG000|Overall Study|Withdrawal by Subject|1|||
143160817|NCT04401293|516133501|FG001|Overall Study|Withdrawal by Subject|3|||
143160818|NCT00930176|516133508|FG000|Overall Study|Death|1|||
143160819|NCT03760666|516133513|FG000|Overall Study|Adverse Event|2|||
143160820|NCT03760666|516133514|FG001|Overall Study|Adverse Event|4|||
143160821|NCT03760666|516133515|FG002|Overall Study|Adverse Event|1|||
143495397|NCT01913483|517356018|FG001|Overall Study|Withdrawal by Subject|2|||
143033910|NCT04455633|515666671|FG000|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
143033911|NCT04455633|515666672|FG001|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
143033912|NCT04455633|515666673|FG002|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|6|||
143033913|NCT04455633|515666671|FG000|Double-Blind Period (Up to Week 6)|Other, not specified|0|||
143033914|NCT04455633|515666672|FG001|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
143033915|NCT04455633|515666673|FG002|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
143160822|NCT03760666|516133513|FG000|Overall Study|AML Disease Progression|3|||
143238573|NCT05038982|516427517|FG001|Overall Study|Withdrawal by Subject|2|||
143033916|NCT04455633|515666671|FG000|Follow up Period (Weeks 7 to 11)|Other, not specified|1|||
143033917|NCT04455633|515666672|FG001|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
143033918|NCT04455633|515666673|FG002|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
143033919|NCT00883090|515666674|FG000|Overall Study|Sponsor's decision|1|||
143033920|NCT00883090|515666674|FG000|Overall Study|Withdrawal by Subject|1|||
143033921|NCT02532764|515666675|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
143033922|NCT02532764|515666676|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
143033923|NCT02532764|515666677|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
143033924|NCT02532764|515666678|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
143033925|NCT02532764|515666679|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
143033926|NCT02532764|515666680|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
143033927|NCT02532764|515666681|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
143033928|NCT02532764|515666682|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
143495398|NCT01913483|517356017|FG000|Overall Study|Lost to Follow-up|6|||
143495399|NCT01913483|517356018|FG001|Overall Study|Lost to Follow-up|3|||
143033929|NCT02532764|515666683|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
143033930|NCT02532764|515666684|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
143033931|NCT03527745|515666685|FG000|Overall Study|Lost to Follow-up|3|||
143160823|NCT03760666|516133514|FG001|Overall Study|AML Disease Progression|3|||
143160824|NCT03760666|516133515|FG002|Overall Study|AML Disease Progression|0|||
143160825|NCT03760666|516133513|FG000|Overall Study|Physician Decision|0|||
143160826|NCT03760666|516133514|FG001|Overall Study|Physician Decision|3|||
143160827|NCT03760666|516133515|FG002|Overall Study|Physician Decision|0|||
143160828|NCT03760666|516133513|FG000|Overall Study|Withdrawal by Subject|0|||
143160829|NCT03760666|516133514|FG001|Overall Study|Withdrawal by Subject|1|||
143160830|NCT03760666|516133515|FG002|Overall Study|Withdrawal by Subject|0|||
143160831|NCT05486065|516133517|FG000|Overall Study|Withdrawal by Subject|1|||
143160832|NCT05486065|516133518|FG001|Overall Study|Withdrawal by Subject|5|||
143160833|NCT05486065|516133519|FG002|Overall Study|Withdrawal by Subject|4|||
143160834|NCT05486065|516133520|FG003|Overall Study|Withdrawal by Subject|3|||
143160835|NCT05486065|516133517|FG000|Overall Study|Lost to Follow-up|4|||
143160836|NCT05486065|516133518|FG001|Overall Study|Lost to Follow-up|2|||
143160837|NCT05486065|516133519|FG002|Overall Study|Lost to Follow-up|2|||
143160838|NCT05486065|516133520|FG003|Overall Study|Lost to Follow-up|2|||
143160839|NCT05486065|516133517|FG000|Overall Study|Physician Decision|0|||
143160840|NCT05486065|516133518|FG001|Overall Study|Physician Decision|1|||
143160841|NCT05486065|516133519|FG002|Overall Study|Physician Decision|1|||
143160842|NCT05486065|516133520|FG003|Overall Study|Physician Decision|0|||
143160843|NCT05486065|516133517|FG000|Overall Study|Failure to meet randomization criteria|0|||
143160844|NCT05486065|516133518|FG001|Overall Study|Failure to meet randomization criteria|0|||
143160845|NCT05486065|516133519|FG002|Overall Study|Failure to meet randomization criteria|0|||
143160846|NCT05486065|516133520|FG003|Overall Study|Failure to meet randomization criteria|1|||
143160847|NCT01064622|516133521|FG000|Randomized Phase II|Withdrawal by Subject|2|||
143160848|NCT01064622|516133522|FG001|Randomized Phase II|Withdrawal by Subject|2|||
143160849|NCT01064622|516133521|FG000|Randomized Phase II|Protocol Violation|0|||
143160850|NCT01064622|516133522|FG001|Randomized Phase II|Protocol Violation|1|||
143160851|NCT00954538|516133528|FG000|Part III|Withdrawal by Subject|0|||
143160852|NCT00954538|516133529|FG001|Part III|Withdrawal by Subject|0|||
143160853|NCT00954538|516133530|FG002|Part III|Withdrawal by Subject|0|||
143160854|NCT00954538|516133531|FG003|Part III|Withdrawal by Subject|0|||
143160855|NCT00954538|516133532|FG004|Part III|Withdrawal by Subject|1|||
143160856|NCT00954538|516133533|FG005|Part III|Withdrawal by Subject|0|||
143160857|NCT01905683|516133534|FG000|Overall Study|Protocol Violation|1|||
143160858|NCT01905683|516133534|FG000|Overall Study|Re-injection criteria not met; others|13|||
143160859|NCT01905683|516133534|FG000|Overall Study|Physician Decision|1|||
143160860|NCT01905683|516133534|FG000|Overall Study|Lack of Efficacy|8|||
143160861|NCT01905683|516133534|FG000|Overall Study|Withdrawal by Subject|20|||
143160862|NCT01905683|516133534|FG000|Overall Study|Adverse Event|4|||
143160863|NCT01905683|516133534|FG000|Overall Study|Lost to Follow-up|4|||
143160864|NCT00537082|516133539|FG000|Overall Study|Adverse Event|6|||
143160865|NCT00537082|516133540|FG001|Overall Study|Adverse Event|6|||
143160866|NCT00537082|516133541|FG002|Overall Study|Adverse Event|3|||
143160867|NCT00537082|516133539|FG000|Overall Study|Protocol Violation|0|||
143160868|NCT00537082|516133540|FG001|Overall Study|Protocol Violation|2|||
143160869|NCT00537082|516133541|FG002|Overall Study|Protocol Violation|1|||
143160870|NCT00537082|516133539|FG000|Overall Study|Lack of Efficacy|0|||
143160871|NCT00537082|516133540|FG001|Overall Study|Lack of Efficacy|0|||
143160872|NCT00537082|516133541|FG002|Overall Study|Lack of Efficacy|2|||
143160873|NCT00537082|516133539|FG000|Overall Study|Withdrawal by Subject|0|||
143160874|NCT00537082|516133540|FG001|Overall Study|Withdrawal by Subject|1|||
143160875|NCT00537082|516133541|FG002|Overall Study|Withdrawal by Subject|0|||
143160876|NCT00537082|516133539|FG000|Overall Study|Discontinued before initiating treatment|3|||
143160877|NCT00537082|516133540|FG001|Overall Study|Discontinued before initiating treatment|0|||
143160878|NCT00537082|516133541|FG002|Overall Study|Discontinued before initiating treatment|0|||
143160879|NCT02568254|516133542|FG000|Period 2|Adverse Event|0|||
143160880|NCT02568254|516133543|FG001|Period 2|Adverse Event|0|||
143160881|NCT02568254|516133544|FG002|Period 2|Adverse Event|1|||
143495400|NCT01913483|517356017|FG000|Overall Study|Death|14|||
143033932|NCT03527745|515666686|FG001|Overall Study|Lost to Follow-up|6|||
143033933|NCT03527745|515666687|FG002|Overall Study|Lost to Follow-up|7|||
143033934|NCT03527745|515666688|FG003|Overall Study|Lost to Follow-up|9|||
143033935|NCT03527745|515666689|FG004|Overall Study|Lost to Follow-up|0|||
143033936|NCT03527745|515666690|FG005|Overall Study|Lost to Follow-up|2|||
143033937|NCT03527745|515666691|FG006|Overall Study|Lost to Follow-up|3|||
143033938|NCT03527745|515666692|FG007|Overall Study|Lost to Follow-up|2|||
143033939|NCT03527745|515666693|FG008|Overall Study|Lost to Follow-up|3|||
143033940|NCT03527745|515666694|FG009|Overall Study|Lost to Follow-up|2|||
143033941|NCT03527745|515666695|FG010|Overall Study|Lost to Follow-up|1|||
143033942|NCT03527745|515666696|FG011|Overall Study|Lost to Follow-up|1|||
143033943|NCT03527745|515666697|FG012|Overall Study|Lost to Follow-up|0|||
143033944|NCT03527745|515666698|FG013|Overall Study|Lost to Follow-up|0|||
143033945|NCT03527745|515666699|FG014|Overall Study|Lost to Follow-up|0|||
143033946|NCT03527745|515666700|FG015|Overall Study|Lost to Follow-up|0|||
143033947|NCT03527745|515666701|FG016|Overall Study|Lost to Follow-up|1|||
143033948|NCT03527745|515666702|FG017|Overall Study|Lost to Follow-up|0|||
143033949|NCT03527745|515666703|FG018|Overall Study|Lost to Follow-up|0|||
143033950|NCT03527745|515666704|FG019|Overall Study|Lost to Follow-up|1|||
143033951|NCT03527745|515666705|FG020|Overall Study|Lost to Follow-up|1|||
143033952|NCT03527745|515666706|FG021|Overall Study|Lost to Follow-up|5|||
143033953|NCT03527745|515666707|FG022|Overall Study|Lost to Follow-up|6|||
143033954|NCT03527745|515666708|FG023|Overall Study|Lost to Follow-up|8|||
143033955|NCT03527745|515666709|FG024|Overall Study|Lost to Follow-up|1|||
143033956|NCT03527745|515666710|FG025|Overall Study|Lost to Follow-up|3|||
143033957|NCT01475838|515666714|FG000|Randomized Phase|Randomized but Not Treated|0|||
143033958|NCT01475838|515666715|FG001|Randomized Phase|Randomized but Not Treated|5|||
143033959|NCT01475838|515666714|FG000|Randomized Phase|Adverse Event|6|||
143033960|NCT01475838|515666715|FG001|Randomized Phase|Adverse Event|1|||
143033961|NCT01475838|515666714|FG000|Randomized Phase|Pregnancy|0|||
143033962|NCT01475838|515666715|FG001|Randomized Phase|Pregnancy|1|||
143033963|NCT01475838|515666714|FG000|Randomized Phase|Investigators Discretion|1|||
143033964|NCT01475838|515666715|FG001|Randomized Phase|Investigators Discretion|2|||
143033965|NCT01475838|515666714|FG000|Randomized Phase|Withdrew Consent|10|||
143033966|NCT01475838|515666715|FG001|Randomized Phase|Withdrew Consent|14|||
143033967|NCT01475838|515666714|FG000|Randomized Phase|Lost to Follow-up|3|||
143033968|NCT01475838|515666715|FG001|Randomized Phase|Lost to Follow-up|4|||
143033969|NCT01475838|515666714|FG000|Randomized Phase|Participant Noncompliance|1|||
143033970|NCT01475838|515666715|FG001|Randomized Phase|Participant Noncompliance|5|||
143033971|NCT01475838|515666714|FG000|Randomized Phase|Protocol Violation|9|||
143033972|NCT01475838|515666715|FG001|Randomized Phase|Protocol Violation|4|||
143033973|NCT01475838|515666714|FG000|Extension Phase|Participant Noncompliance|1|||
143033974|NCT01475838|515666715|FG001|Extension Phase|Participant Noncompliance|0|||
143033975|NCT00048568|515666721|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
143033976|NCT00048568|515666722|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
143033977|NCT00048568|515666723|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
143033978|NCT00048568|515666721|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
143033979|NCT00048568|515666722|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
143033980|NCT00048568|515666723|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
143033981|NCT00048568|515666721|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
143033982|NCT00048568|515666722|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
143033983|NCT00048568|515666723|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
143033984|NCT00048568|515666721|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
143033985|NCT00048568|515666722|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
143033986|NCT00048568|515666723|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
143033987|NCT00048568|515666721|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
143033988|NCT00048568|515666722|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
143033989|NCT00048568|515666723|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
143033990|NCT00048568|515666721|FG000|Double-Blind Period Days 170 to 365|Death|1|||
143033991|NCT00048568|515666722|FG001|Double-Blind Period Days 170 to 365|Death|1|||
143033992|NCT00048568|515666723|FG002|Double-Blind Period Days 170 to 365|Death|0|||
143033993|NCT00048568|515666721|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
143033994|NCT00048568|515666722|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
143033995|NCT00048568|515666723|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
143495401|NCT01913483|517356018|FG001|Overall Study|Death|17|||
143495402|NCT01816243|517356021|FG000|Overall Study|Adverse Event|6|||
143033996|NCT00048568|515666721|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
143033997|NCT00048568|515666722|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
143033998|NCT00048568|515666723|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
143033999|NCT00048568|515666721|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
143034000|NCT00048568|515666722|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
143034001|NCT00048568|515666723|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
143034002|NCT00048568|515666721|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
143034003|NCT00048568|515666722|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
143034004|NCT00048568|515666723|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
143034005|NCT00048568|515666721|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
143034006|NCT00048568|515666722|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
143034007|NCT00048568|515666723|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
143034008|NCT00048568|515666721|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
143034009|NCT00048568|515666722|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
143034010|NCT00048568|515666723|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
143034011|NCT00048568|515666721|FG000|Open-Label Period|Death|0|||
143034012|NCT00048568|515666722|FG001|Open-Label Period|Death|0|||
143034013|NCT00048568|515666723|FG002|Open-Label Period|Death|13|||
143034014|NCT00048568|515666721|FG000|Open-Label Period|Adverse Event|0|||
143034015|NCT00048568|515666722|FG001|Open-Label Period|Adverse Event|0|||
143034016|NCT00048568|515666723|FG002|Open-Label Period|Adverse Event|49|||
143034017|NCT00048568|515666721|FG000|Open-Label Period|Lack of Efficacy|0|||
143034018|NCT00048568|515666722|FG001|Open-Label Period|Lack of Efficacy|0|||
143034019|NCT00048568|515666723|FG002|Open-Label Period|Lack of Efficacy|32|||
143034020|NCT00048568|515666721|FG000|Open-Label Period|Withdrawal by Subject|0|||
143034021|NCT00048568|515666722|FG001|Open-Label Period|Withdrawal by Subject|0|||
143034022|NCT00048568|515666723|FG002|Open-Label Period|Withdrawal by Subject|26|||
143034023|NCT00048568|515666721|FG000|Open-Label Period|Pregnancy|0|||
143034024|NCT00048568|515666722|FG001|Open-Label Period|Pregnancy|0|||
143034025|NCT00048568|515666723|FG002|Open-Label Period|Pregnancy|5|||
143034026|NCT00048568|515666721|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
143034027|NCT00048568|515666722|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
143034028|NCT00048568|515666723|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
143034029|NCT00048568|515666721|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
143034030|NCT00048568|515666722|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
143034031|NCT00048568|515666723|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
143034032|NCT00048568|515666721|FG000|Open-Label Period|Unknown Reasons|0|||
143034033|NCT00048568|515666722|FG001|Open-Label Period|Unknown Reasons|0|||
143034034|NCT00048568|515666723|FG002|Open-Label Period|Unknown Reasons|25|||
143034035|NCT00048568|515666721|FG000|Open-Label Period|Lost to Follow-up|0|||
143034036|NCT00048568|515666722|FG001|Open-Label Period|Lost to Follow-up|0|||
143034037|NCT00048568|515666723|FG002|Open-Label Period|Lost to Follow-up|7|||
143034038|NCT03831048|515666724|FG000|Overall Study|Protocol Violation|9|||
143160882|NCT02568254|516133545|FG003|Period 2|Adverse Event|0|||
143160883|NCT02568254|516133546|FG004|Period 2|Adverse Event|0|||
143160884|NCT02568254|516133547|FG005|Period 2|Adverse Event|0|||
143160885|NCT02568254|516133542|FG000|Period 3|Unstatisfactory Lens fitting|0|||
143160886|NCT02568254|516133543|FG001|Period 3|Unstatisfactory Lens fitting|0|||
143160887|NCT02568254|516133544|FG002|Period 3|Unstatisfactory Lens fitting|0|||
143160888|NCT02568254|516133545|FG003|Period 3|Unstatisfactory Lens fitting|0|||
143160889|NCT02568254|516133546|FG004|Period 3|Unstatisfactory Lens fitting|1|||
143160890|NCT02568254|516133547|FG005|Period 3|Unstatisfactory Lens fitting|0|||
143160891|NCT03061214|516133552|FG000|Overall Study|Withdrawal by Subject|21|||
143160892|NCT03061214|516133553|FG001|Overall Study|Withdrawal by Subject|26|||
143160893|NCT03061214|516133554|FG002|Overall Study|Withdrawal by Subject|9|||
143160894|NCT03061214|516133552|FG000|Overall Study|Lost to Follow-up|3|||
143160895|NCT03061214|516133553|FG001|Overall Study|Lost to Follow-up|1|||
143160896|NCT03061214|516133554|FG002|Overall Study|Lost to Follow-up|1|||
143160897|NCT03061214|516133552|FG000|Overall Study|Death|1|||
143160898|NCT03061214|516133553|FG001|Overall Study|Death|1|||
143160899|NCT03061214|516133554|FG002|Overall Study|Death|0|||
143160900|NCT01926509|516135417|FG000|Overall Study|vital sign met discontinuation criteria|1|||
143160901|NCT01926509|516135418|FG001|Overall Study|vital sign met discontinuation criteria|0|||
143160902|NCT01926509|516135419|FG002|Overall Study|vital sign met discontinuation criteria|0|||
143160903|NCT01926509|516135420|FG003|Overall Study|vital sign met discontinuation criteria|0|||
143160904|NCT02730169|516135421|FG000|Overall Study|Protocol Violation|1|||
143160905|NCT02730169|516135422|FG001|Overall Study|Protocol Violation|0|||
143160906|NCT02730169|516135423|FG002|Overall Study|Protocol Violation|0|||
143160907|NCT02730169|516135424|FG003|Overall Study|Protocol Violation|1|||
143160908|NCT02730169|516135421|FG000|Overall Study|Adverse Event|2|||
143160909|NCT02730169|516135422|FG001|Overall Study|Adverse Event|3|||
143034039|NCT03831048|515666725|FG001|Overall Study|Protocol Violation|3|||
143034040|NCT03831048|515666724|FG000|Overall Study|Death|4|||
143034041|NCT03831048|515666725|FG001|Overall Study|Death|9|||
143034042|NCT03831048|515666724|FG000|Overall Study|Re-transplant|0|||
143034043|NCT03831048|515666725|FG001|Overall Study|Re-transplant|2|||
143034044|NCT03831048|515666724|FG000|Overall Study|Protocol violation and death|1|||
143034045|NCT03831048|515666725|FG001|Overall Study|Protocol violation and death|1|||
143034046|NCT01328093|515666731|FG000|Double-Blind Phase|Adverse Event|78|||
143034047|NCT01328093|515666732|FG001|Double-Blind Phase|Adverse Event|15|||
143034048|NCT01328093|515666731|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
143034049|NCT01328093|515666732|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
143160910|NCT02730169|516135423|FG002|Overall Study|Adverse Event|3|||
143160911|NCT02730169|516135424|FG003|Overall Study|Adverse Event|0|||
143034050|NCT01328093|515666731|FG000|Double-Blind Phase|Lost to Follow-up|39|||
143034051|NCT01328093|515666732|FG001|Double-Blind Phase|Lost to Follow-up|14|||
143034052|NCT01328093|515666731|FG000|Double-Blind Phase|Protocol Violation|30|||
143034053|NCT01328093|515666732|FG001|Double-Blind Phase|Protocol Violation|10|||
143034054|NCT01328093|515666731|FG000|Double-Blind Phase|Lack of Efficacy|55|||
143034055|NCT01328093|515666732|FG001|Double-Blind Phase|Lack of Efficacy|13|||
143034056|NCT01328093|515666731|FG000|Double-Blind Phase|Sponsor Decision|17|||
143034057|NCT01328093|515666732|FG001|Double-Blind Phase|Sponsor Decision|3|||
143034058|NCT01328093|515666731|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
143034059|NCT01328093|515666732|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
143034060|NCT01328093|515666731|FG000|Double-Blind Phase|Scheduling conflict|8|||
143034061|NCT01328093|515666732|FG001|Double-Blind Phase|Scheduling conflict|3|||
143034062|NCT01328093|515666731|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
143034063|NCT01328093|515666732|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
143034064|NCT01328093|515666731|FG000|Double-Blind Phase|Death|1|||
143034065|NCT01328093|515666732|FG001|Double-Blind Phase|Death|0|||
143034066|NCT01328093|515666731|FG000|Open-Label Phase|Sponsor Decision|98|||
143034067|NCT01328093|515666732|FG001|Open-Label Phase|Sponsor Decision|34|||
143034068|NCT01328093|515666731|FG000|Open-Label Phase|Protocol Violation|8|||
143034069|NCT01328093|515666732|FG001|Open-Label Phase|Protocol Violation|3|||
143034070|NCT01328093|515666731|FG000|Open-Label Phase|Lost to Follow-up|10|||
143034071|NCT01328093|515666732|FG001|Open-Label Phase|Lost to Follow-up|1|||
143034072|NCT01328093|515666731|FG000|Open-Label Phase|Adverse Event|10|||
143034073|NCT01328093|515666732|FG001|Open-Label Phase|Adverse Event|4|||
143034074|NCT01328093|515666731|FG000|Open-Label Phase|Lack of Efficacy|5|||
143034075|NCT01328093|515666732|FG001|Open-Label Phase|Lack of Efficacy|6|||
143034076|NCT01328093|515666731|FG000|Open-Label Phase|Withdrawal by Subject|4|||
143034077|NCT01328093|515666732|FG001|Open-Label Phase|Withdrawal by Subject|1|||
143034078|NCT01328093|515666731|FG000|Open-Label Phase|Scheduling conflict|2|||
143034079|NCT01328093|515666732|FG001|Open-Label Phase|Scheduling conflict|1|||
143034080|NCT01328093|515666731|FG000|Open-Label Phase|Subject is moving or has moved|2|||
143034081|NCT01328093|515666732|FG001|Open-Label Phase|Subject is moving or has moved|0|||
143034082|NCT01328093|515666731|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
143034083|NCT01328093|515666732|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
143034084|NCT00760266|515666733|FG000|Overall Study|Adverse Event|13|||
143034085|NCT00760266|515666734|FG001|Overall Study|Adverse Event|7|||
143034086|NCT00760266|515666733|FG000|Overall Study|Abnormal laboratory value(s)|1|||
143034087|NCT00760266|515666734|FG001|Overall Study|Abnormal laboratory value(s)|0|||
143034088|NCT00760266|515666733|FG000|Overall Study|Abnormal test procedure result(s)|1|||
143034089|NCT00760266|515666734|FG001|Overall Study|Abnormal test procedure result(s)|0|||
143034090|NCT00760266|515666733|FG000|Overall Study|Lack of Efficacy|2|||
143034091|NCT00760266|515666734|FG001|Overall Study|Lack of Efficacy|2|||
143034092|NCT00760266|515666733|FG000|Overall Study|Protocol deviation|2|||
143160912|NCT02730169|516135421|FG000|Overall Study|Adverse Event of Special Interest|0|||
143160913|NCT02730169|516135422|FG001|Overall Study|Adverse Event of Special Interest|1|||
143160914|NCT02730169|516135423|FG002|Overall Study|Adverse Event of Special Interest|2|||
143160915|NCT02730169|516135424|FG003|Overall Study|Adverse Event of Special Interest|0|||
143160916|NCT02730169|516135421|FG000|Overall Study|Withdrawal by Subject|6|||
143160917|NCT02730169|516135422|FG001|Overall Study|Withdrawal by Subject|11|||
143160918|NCT02730169|516135423|FG002|Overall Study|Withdrawal by Subject|6|||
143160919|NCT02730169|516135424|FG003|Overall Study|Withdrawal by Subject|8|||
143160920|NCT02730169|516135421|FG000|Overall Study|Lost to Follow-up|5|||
143160921|NCT02730169|516135422|FG001|Overall Study|Lost to Follow-up|6|||
143160922|NCT02730169|516135423|FG002|Overall Study|Lost to Follow-up|5|||
143160923|NCT02730169|516135424|FG003|Overall Study|Lost to Follow-up|6|||
143160924|NCT02730169|516135421|FG000|Overall Study|Other|0|||
143495403|NCT01816243|517356021|FG000|Overall Study|Lost to Follow-up|1|||
143034093|NCT00760266|515666734|FG001|Overall Study|Protocol deviation|4|||
143034094|NCT00760266|515666733|FG000|Overall Study|Patient withdrew consent|3|||
143034095|NCT00760266|515666734|FG001|Overall Study|Patient withdrew consent|3|||
143034096|NCT00760266|515666733|FG000|Overall Study|Lost to Follow-up|2|||
143034097|NCT00760266|515666734|FG001|Overall Study|Lost to Follow-up|1|||
143034098|NCT00760266|515666733|FG000|Overall Study|Administrative Problems|0|||
143034099|NCT00760266|515666734|FG001|Overall Study|Administrative Problems|1|||
143034100|NCT03657160|515666735|FG000|Overall Study|Adverse Event|5|||
143034101|NCT03657160|515666736|FG001|Overall Study|Adverse Event|6|||
143034102|NCT03657160|515666735|FG000|Overall Study|Protocol Deviation|3|||
143034103|NCT03657160|515666736|FG001|Overall Study|Protocol Deviation|0|||
143034104|NCT03657160|515666735|FG000|Overall Study|Withdrawal by Subject|18|||
143034105|NCT03657160|515666736|FG001|Overall Study|Withdrawal by Subject|16|||
143034106|NCT03657160|515666735|FG000|Overall Study|Site Termination|1|||
143034107|NCT03657160|515666736|FG001|Overall Study|Site Termination|0|||
143034108|NCT03657160|515666735|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
143034109|NCT03657160|515666736|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
143034110|NCT03657160|515666735|FG000|Overall Study|Death|33|||
143034111|NCT03657160|515666736|FG001|Overall Study|Death|26|||
143034112|NCT03657160|515666735|FG000|Overall Study|Death (COVID-19-Related)|1|||
143034113|NCT03657160|515666736|FG001|Overall Study|Death (COVID-19-Related)|0|||
143034114|NCT03657160|515666735|FG000|Overall Study|Reason Not Specified|5|||
143034115|NCT03657160|515666736|FG001|Overall Study|Reason Not Specified|5|||
143034116|NCT03657160|515666735|FG000|Overall Study|Other (COVID-19-Related)|0|||
143034117|NCT03657160|515666736|FG001|Overall Study|Other (COVID-19-Related)|1|||
143034118|NCT00686959|515666737|FG000|Overall Study|Participants censored (no death events)|124|||
143034119|NCT00686959|515666738|FG001|Overall Study|Participants censored (no death events)|117|||
143034120|NCT00537030|515666747|FG000|Overall Study|Physician Decision|2|||
143034121|NCT00537030|515666747|FG000|Overall Study|Withdrawal by Subject|2|||
143034122|NCT00537030|515666747|FG000|Overall Study|≥ Grade 2 allergy|7|||
143034123|NCT00537030|515666747|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
143034124|NCT00537030|515666747|FG000|Overall Study|Ineligible|2|||
143034125|NCT00537030|515666747|FG000|Overall Study|Inevaluable|2|||
143034126|NCT01496183|515666748|FG000|Overall Study|Physician Decision|3|||
143034127|NCT01496183|515666749|FG001|Overall Study|Physician Decision|1|||
143034128|NCT01496183|515666748|FG000|Overall Study|Withdrawal by Subject|0|||
143034129|NCT01496183|515666749|FG001|Overall Study|Withdrawal by Subject|1|||
143034130|NCT00777829|515666752|FG000|Overall Study|Withdrawal by Subject|0|||
143034131|NCT00777829|515666753|FG001|Overall Study|Withdrawal by Subject|2|||
143034132|NCT00745095|515666762|FG000|Overall Study|Declined to participate|1|||
143034133|NCT00745095|515666763|FG001|Overall Study|Declined to participate|0|||
143034134|NCT00745095|515666764|FG002|Overall Study|Declined to participate|0|||
143034135|NCT00745095|515666765|FG003|Overall Study|Declined to participate|0|||
143034136|NCT00745095|515666766|FG004|Overall Study|Declined to participate|92|||
143034137|NCT00745095|515666767|FG005|Overall Study|Declined to participate|95|||
143034138|NCT00745095|515666762|FG000|Overall Study|Ineligible due to GFR criteria|0|||
143034139|NCT00745095|515666763|FG001|Overall Study|Ineligible due to GFR criteria|2|||
143034140|NCT00745095|515666764|FG002|Overall Study|Ineligible due to GFR criteria|3|||
143034141|NCT00745095|515666765|FG003|Overall Study|Ineligible due to GFR criteria|3|||
143034142|NCT00745095|515666766|FG004|Overall Study|Ineligible due to GFR criteria|30|||
143034143|NCT00745095|515666767|FG005|Overall Study|Ineligible due to GFR criteria|28|||
143034144|NCT00162123|515666770|FG000|Overall Study|Disease progression|27|||
143034145|NCT00162123|515666771|FG001|Overall Study|Disease progression|19|||
143034146|NCT00162123|515666772|FG002|Overall Study|Disease progression|10|||
143034147|NCT00162123|515666773|FG003|Overall Study|Disease progression|4|||
143034148|NCT00162123|515666774|FG004|Overall Study|Disease progression|8|||
143034149|NCT00162123|515666775|FG005|Overall Study|Disease progression|3|||
143034150|NCT00162123|515666776|FG006|Overall Study|Disease progression|1|||
143034151|NCT00162123|515666777|FG007|Overall Study|Disease progression|0|||
143034152|NCT00162123|515666770|FG000|Overall Study|Study drug toxicity|6|||
143034153|NCT00162123|515666771|FG001|Overall Study|Study drug toxicity|1|||
143034154|NCT00162123|515666772|FG002|Overall Study|Study drug toxicity|5|||
143034155|NCT00162123|515666773|FG003|Overall Study|Study drug toxicity|0|||
143034156|NCT00162123|515666774|FG004|Overall Study|Study drug toxicity|4|||
143034157|NCT00162123|515666775|FG005|Overall Study|Study drug toxicity|1|||
143034158|NCT00162123|515666776|FG006|Overall Study|Study drug toxicity|1|||
143034159|NCT00162123|515666777|FG007|Overall Study|Study drug toxicity|0|||
143034160|NCT00162123|515666770|FG000|Overall Study|Death|3|||
143034161|NCT00162123|515666771|FG001|Overall Study|Death|3|||
143034162|NCT00162123|515666772|FG002|Overall Study|Death|1|||
143034163|NCT00162123|515666773|FG003|Overall Study|Death|1|||
143034164|NCT00162123|515666774|FG004|Overall Study|Death|1|||
143160925|NCT02730169|516135422|FG001|Overall Study|Other|0|||
143160926|NCT02730169|516135423|FG002|Overall Study|Other|1|||
143160927|NCT02730169|516135424|FG003|Overall Study|Other|1|||
143160928|NCT03681093|516135425|FG000|Overall Study|Subject decision|0|||
143495404|NCT01816243|517356021|FG000|Overall Study|Lack of Efficacy|1|||
143495405|NCT01816243|517356021|FG000|Overall Study|Not eligible for the study|1|||
143495406|NCT01816243|517356021|FG000|Overall Study|Amputation|3|||
143495407|NCT03434379|517356025|FG000|Global Period|Lost to Follow-up|3|||
143495408|NCT03434379|517356026|FG001|Global Period|Lost to Follow-up|6|||
143495409|NCT03434379|517356027|FG002|Global Period|Lost to Follow-up|0|||
143495410|NCT03434379|517356028|FG003|Global Period|Lost to Follow-up|0|||
143034165|NCT00162123|515666775|FG005|Overall Study|Death|1|||
143034166|NCT00162123|515666776|FG006|Overall Study|Death|0|||
143034167|NCT00162123|515666777|FG007|Overall Study|Death|0|||
143034168|NCT00162123|515666770|FG000|Overall Study|Withdrawal by Subject|2|||
143034169|NCT00162123|515666771|FG001|Overall Study|Withdrawal by Subject|0|||
143034170|NCT00162123|515666772|FG002|Overall Study|Withdrawal by Subject|2|||
143034171|NCT00162123|515666773|FG003|Overall Study|Withdrawal by Subject|1|||
143034172|NCT00162123|515666774|FG004|Overall Study|Withdrawal by Subject|1|||
143034173|NCT00162123|515666775|FG005|Overall Study|Withdrawal by Subject|2|||
143160929|NCT03681093|516135426|FG001|Overall Study|Subject decision|2|||
143160930|NCT03681093|516135427|FG002|Overall Study|Subject decision|1|||
143034174|NCT00162123|515666776|FG006|Overall Study|Withdrawal by Subject|1|||
143034175|NCT00162123|515666777|FG007|Overall Study|Withdrawal by Subject|0|||
143160931|NCT01027754|516135428|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
143495411|NCT03434379|517356025|FG000|Global Period|Death|115|||
143495412|NCT03434379|517356026|FG001|Global Period|Death|228|||
143034176|NCT00162123|515666770|FG000|Overall Study|Deterioration without progression|2|||
143034177|NCT00162123|515666771|FG001|Overall Study|Deterioration without progression|2|||
143034178|NCT00162123|515666772|FG002|Overall Study|Deterioration without progression|3|||
143034179|NCT00162123|515666773|FG003|Overall Study|Deterioration without progression|0|||
143034180|NCT00162123|515666774|FG004|Overall Study|Deterioration without progression|1|||
143034181|NCT00162123|515666775|FG005|Overall Study|Deterioration without progression|0|||
143034182|NCT00162123|515666776|FG006|Overall Study|Deterioration without progression|0|||
143034183|NCT00162123|515666777|FG007|Overall Study|Deterioration without progression|0|||
143034184|NCT00162123|515666770|FG000|Overall Study|Adverse Event|1|||
143034185|NCT00162123|515666771|FG001|Overall Study|Adverse Event|2|||
143034186|NCT00162123|515666772|FG002|Overall Study|Adverse Event|0|||
143034187|NCT00162123|515666773|FG003|Overall Study|Adverse Event|2|||
143034188|NCT00162123|515666774|FG004|Overall Study|Adverse Event|1|||
143034189|NCT00162123|515666775|FG005|Overall Study|Adverse Event|0|||
143034190|NCT00162123|515666776|FG006|Overall Study|Adverse Event|0|||
143034191|NCT00162123|515666777|FG007|Overall Study|Adverse Event|0|||
143034192|NCT00162123|515666770|FG000|Overall Study|Not specified (before treatment)|2|||
143034193|NCT00162123|515666771|FG001|Overall Study|Not specified (before treatment)|0|||
143034194|NCT00162123|515666772|FG002|Overall Study|Not specified (before treatment)|0|||
143034195|NCT00162123|515666773|FG003|Overall Study|Not specified (before treatment)|0|||
143034196|NCT00162123|515666774|FG004|Overall Study|Not specified (before treatment)|12|||
143034197|NCT00162123|515666775|FG005|Overall Study|Not specified (before treatment)|1|||
143034198|NCT00162123|515666776|FG006|Overall Study|Not specified (before treatment)|0|||
143034199|NCT00162123|515666777|FG007|Overall Study|Not specified (before treatment)|0|||
143034200|NCT00162123|515666770|FG000|Overall Study|Not specified (after start of treatment)|0|||
143034201|NCT00162123|515666771|FG001|Overall Study|Not specified (after start of treatment)|0|||
143034202|NCT00162123|515666772|FG002|Overall Study|Not specified (after start of treatment)|0|||
143034203|NCT00162123|515666773|FG003|Overall Study|Not specified (after start of treatment)|0|||
143034204|NCT00162123|515666774|FG004|Overall Study|Not specified (after start of treatment)|3|||
143034205|NCT00162123|515666775|FG005|Overall Study|Not specified (after start of treatment)|0|||
143034206|NCT00162123|515666776|FG006|Overall Study|Not specified (after start of treatment)|0|||
143034207|NCT00162123|515666777|FG007|Overall Study|Not specified (after start of treatment)|0|||
143034208|NCT00162123|515666770|FG000|Overall Study|Physician Decision|1|||
143034209|NCT00162123|515666771|FG001|Overall Study|Physician Decision|2|||
143034210|NCT00162123|515666772|FG002|Overall Study|Physician Decision|0|||
143034211|NCT00162123|515666773|FG003|Overall Study|Physician Decision|0|||
143034212|NCT00162123|515666774|FG004|Overall Study|Physician Decision|0|||
143034213|NCT00162123|515666775|FG005|Overall Study|Physician Decision|1|||
143034214|NCT00162123|515666776|FG006|Overall Study|Physician Decision|1|||
143034215|NCT00162123|515666777|FG007|Overall Study|Physician Decision|0|||
143034216|NCT00162123|515666770|FG000|Overall Study|Tumor assessment only (not treated)|0|||
143034217|NCT00162123|515666771|FG001|Overall Study|Tumor assessment only (not treated)|0|||
143034218|NCT00162123|515666772|FG002|Overall Study|Tumor assessment only (not treated)|0|||
143034219|NCT00162123|515666773|FG003|Overall Study|Tumor assessment only (not treated)|0|||
143034220|NCT00162123|515666774|FG004|Overall Study|Tumor assessment only (not treated)|0|||
143034221|NCT00162123|515666775|FG005|Overall Study|Tumor assessment only (not treated)|0|||
143034222|NCT00162123|515666776|FG006|Overall Study|Tumor assessment only (not treated)|0|||
143034223|NCT00162123|515666777|FG007|Overall Study|Tumor assessment only (not treated)|1|||
143160932|NCT01027754|516135429|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
143160933|NCT01027754|516135428|FG000|Overall Study|Withdrawal by Subject|0|||
143160934|NCT01027754|516135429|FG001|Overall Study|Withdrawal by Subject|5|||
143160935|NCT01882829|516135430|FG000|Overall Study|Adverse Event|4|||
143160936|NCT01882829|516135430|FG000|Overall Study|Protocol Violation|1|||
143160937|NCT01882829|516135430|FG000|Overall Study|Withdrawal by Subject|1|||
143160938|NCT02562040|516135431|FG000|Overall Study|Lost to Follow-up|20|||
143160939|NCT02562040|516135432|FG001|Overall Study|Lost to Follow-up|28|||
143160940|NCT02562040|516135431|FG000|Overall Study|Withdrawal by Subject|8|||
143160941|NCT02562040|516135432|FG001|Overall Study|Withdrawal by Subject|7|||
143160942|NCT02562040|516135431|FG000|Overall Study|Adverse Event|1|||
143160943|NCT02562040|516135432|FG001|Overall Study|Adverse Event|0|||
143160944|NCT01902303|516135435|FG000|Overall Study|Adverse Event|0|||
143160945|NCT01902303|516135436|FG001|Overall Study|Adverse Event|1|||
143034224|NCT00162123|515666770|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
143034225|NCT00162123|515666771|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
143034226|NCT00162123|515666772|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
143034227|NCT00162123|515666773|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
143034228|NCT00162123|515666774|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
143034229|NCT00162123|515666775|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
143034230|NCT00162123|515666776|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
143034231|NCT00162123|515666777|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
143034232|NCT01479439|515666781|FG000|Overall Study|Adverse Event|1|||
143160946|NCT01902303|516135435|FG000|Overall Study|Lost to Follow-up|0|||
143160947|NCT01902303|516135436|FG001|Overall Study|Lost to Follow-up|1|||
143034233|NCT01479439|515666782|FG001|Overall Study|Adverse Event|0|||
143034234|NCT01479439|515666783|FG002|Overall Study|Adverse Event|0|||
143034235|NCT01479439|515666781|FG000|Overall Study|Lost to Follow-up|0|||
143034236|NCT01479439|515666782|FG001|Overall Study|Lost to Follow-up|1|||
143034237|NCT01479439|515666783|FG002|Overall Study|Lost to Follow-up|0|||
143034238|NCT01479439|515666781|FG000|Overall Study|Protocol Violation|0|||
143034239|NCT01479439|515666782|FG001|Overall Study|Protocol Violation|0|||
143034240|NCT01479439|515666783|FG002|Overall Study|Protocol Violation|2|||
143034241|NCT01936948|515666784|FG000|Overall Study|no 30-day follow-up data|0|||
143034242|NCT01936948|515666785|FG001|Overall Study|no 30-day follow-up data|3|||
143034243|NCT01936948|515666786|FG002|Overall Study|no 30-day follow-up data|3|||
143034244|NCT01936948|515666787|FG003|Overall Study|no 30-day follow-up data|3|||
143034245|NCT02365207|515666788|FG000|Overall Study|Withdrawal by Subject|1|||
143034246|NCT02365207|515666788|FG000|Overall Study|Physician Decision|1|||
143034247|NCT01395030|515666789|FG000|Overall Study|Did not complete FCH PET/CT|7|||
143034248|NCT02327130|515666790|FG000|Overall Study|Discharged in less than 5 days|5|||
143034249|NCT02327130|515666790|FG000|Overall Study|Physician Decision|2|||
143034250|NCT02327130|515666790|FG000|Overall Study|Unable to provide breath sample|1|||
143034251|NCT02327130|515666790|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
143034252|NCT02327130|515666790|FG000|Overall Study|Met exclusion criteria|3|||
143034253|NCT05214560|515666792|FG000|Overall Study|Screening Failure|1|||
143034254|NCT05214560|515666792|FG000|Overall Study|Physician Decision|4|||
143034255|NCT05214560|515666792|FG000|Overall Study|Withdrawal by Subject|1|||
143034256|NCT05214560|515666792|FG000|Overall Study|Lost to Follow-up|2|||
143034257|NCT05214560|515666792|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
143034258|NCT05214560|515666792|FG000|Overall Study|Study physician not available for the anesthesia|3|||
143034259|NCT05214560|515666792|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
143034260|NCT05214560|515666792|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
143034261|NCT05214560|515666792|FG000|Overall Study|Surgery not performed|3|||
143034262|NCT00352690|515666798|FG000|Overall Study|Determined to be ineligible|2|||
143034263|NCT00352690|515666799|FG001|Overall Study|Determined to be ineligible|0|||
143034264|NCT02343120|515666804|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
143034265|NCT02343120|515666805|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
143034266|NCT02343120|515666806|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
143034267|NCT02343120|515666807|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
143034268|NCT02343120|515666808|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
143034269|NCT02343120|515666804|FG000|Part 1: Dose Escalation|Death|1|||
143034270|NCT02343120|515666805|FG001|Part 1: Dose Escalation|Death|2|||
143034271|NCT02343120|515666806|FG002|Part 1: Dose Escalation|Death|2|||
143034272|NCT02343120|515666807|FG003|Part 1: Dose Escalation|Death|2|||
143034273|NCT02343120|515666808|FG004|Part 1: Dose Escalation|Death|1|||
143034274|NCT02343120|515666804|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
143034275|NCT02343120|515666805|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
143034276|NCT02343120|515666806|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
143160948|NCT01902303|516135435|FG000|Overall Study|Protocol Violation|2|||
143160949|NCT01902303|516135436|FG001|Overall Study|Protocol Violation|2|||
143160950|NCT01902303|516135435|FG000|Overall Study|subject lost investigational product|0|||
143160951|NCT01902303|516135436|FG001|Overall Study|subject lost investigational product|1|||
143160952|NCT01902303|516135435|FG000|Overall Study|Did not develop a cold sore|21|||
143160953|NCT01902303|516135436|FG001|Overall Study|Did not develop a cold sore|19|||
143160954|NCT02933151|516135437|FG000|Overall Study|Lost to Follow-up|19|||
143160955|NCT02933151|516135438|FG001|Overall Study|Lost to Follow-up|18|||
143160956|NCT02933151|516135437|FG000|Overall Study|Death|1732|||
143160957|NCT02933151|516135438|FG001|Overall Study|Death|1827|||
143160958|NCT02933151|516135437|FG000|Overall Study|Transplant|210|||
143034277|NCT02343120|515666807|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
143034278|NCT02343120|515666808|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
143034279|NCT02343120|515666804|FG000|Part 2: Expansion|Sponsor decision|0|||
143034280|NCT02343120|515666805|FG001|Part 2: Expansion|Sponsor decision|0|||
143034281|NCT02343120|515666806|FG002|Part 2: Expansion|Sponsor decision|0|||
143034282|NCT02343120|515666807|FG003|Part 2: Expansion|Sponsor decision|165|||
143034283|NCT02343120|515666808|FG004|Part 2: Expansion|Sponsor decision|67|||
143034284|NCT02343120|515666804|FG000|Part 2: Expansion|Death|0|||
143495413|NCT03434379|517356027|FG002|Global Period|Death|0|||
143495414|NCT03434379|517356028|FG003|Global Period|Death|0|||
143034285|NCT02343120|515666805|FG001|Part 2: Expansion|Death|0|||
143034286|NCT02343120|515666806|FG002|Part 2: Expansion|Death|0|||
143034287|NCT02343120|515666807|FG003|Part 2: Expansion|Death|74|||
143034288|NCT02343120|515666808|FG004|Part 2: Expansion|Death|17|||
143034289|NCT02343120|515666804|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
143160959|NCT02933151|516135438|FG001|Overall Study|Transplant|278|||
143495415|NCT03434379|517356025|FG000|Global Period|Withdrawal by Subject|20|||
143495416|NCT03434379|517356026|FG001|Global Period|Withdrawal by Subject|21|||
143495417|NCT03434379|517356027|FG002|Global Period|Withdrawal by Subject|0|||
143495418|NCT03434379|517356028|FG003|Global Period|Withdrawal by Subject|0|||
143495419|NCT03434379|517356025|FG000|Global Period|Reason Unspecified|0|||
143495420|NCT03434379|517356026|FG001|Global Period|Reason Unspecified|1|||
143238574|NCT03739203|516427518|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
143238575|NCT03739203|516427519|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
143034290|NCT02343120|515666805|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
143034291|NCT02343120|515666806|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
143034292|NCT02343120|515666807|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
143034293|NCT02343120|515666808|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
143034294|NCT02343120|515666804|FG000|Part 2: Expansion|Lost to Follow-up|0|||
143034295|NCT02343120|515666805|FG001|Part 2: Expansion|Lost to Follow-up|0|||
143034296|NCT02343120|515666806|FG002|Part 2: Expansion|Lost to Follow-up|0|||
143034297|NCT02343120|515666807|FG003|Part 2: Expansion|Lost to Follow-up|5|||
143034298|NCT02343120|515666808|FG004|Part 2: Expansion|Lost to Follow-up|2|||
143034299|NCT02343120|515666804|FG000|Part 2: Expansion|Other|0|||
143034300|NCT02343120|515666805|FG001|Part 2: Expansion|Other|0|||
143034301|NCT02343120|515666806|FG002|Part 2: Expansion|Other|0|||
143034302|NCT02343120|515666807|FG003|Part 2: Expansion|Other|1|||
143034303|NCT02343120|515666808|FG004|Part 2: Expansion|Other|5|||
143034304|NCT02343120|515666804|FG000|Part 2: Expansion|Adverse Event|0|||
143034305|NCT02343120|515666805|FG001|Part 2: Expansion|Adverse Event|0|||
143034306|NCT02343120|515666806|FG002|Part 2: Expansion|Adverse Event|0|||
143034307|NCT02343120|515666807|FG003|Part 2: Expansion|Adverse Event|1|||
143034308|NCT02343120|515666808|FG004|Part 2: Expansion|Adverse Event|1|||
143034309|NCT01030965|515666810|FG000|Overall Study|Lack of Efficacy|3|||
143034310|NCT01030965|515666811|FG001|Overall Study|Lack of Efficacy|2|||
143034311|NCT01030965|515666812|FG002|Overall Study|Lack of Efficacy|0|||
143034312|NCT01030965|515666813|FG003|Overall Study|Lack of Efficacy|3|||
143034313|NCT01030965|515666810|FG000|Overall Study|Protocol Violation|1|||
143034314|NCT01030965|515666811|FG001|Overall Study|Protocol Violation|1|||
143160960|NCT02933151|516135437|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
143160961|NCT02933151|516135438|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
143160962|NCT02933151|516135437|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
143160963|NCT02933151|516135438|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
143160964|NCT02933151|516135437|FG000|Overall Study|Recovered Kidney Function|47|||
143160965|NCT02933151|516135438|FG001|Overall Study|Recovered Kidney Function|29|||
143160966|NCT00394472|516135439|FG000|Overall Study|Protocol Violation|1|||
143160967|NCT00394472|516135440|FG001|Overall Study|Protocol Violation|3|||
143160968|NCT00394472|516135439|FG000|Overall Study|incorrect enrolment|4|||
143160969|NCT00394472|516135440|FG001|Overall Study|incorrect enrolment|2|||
143160970|NCT00394472|516135439|FG000|Overall Study|Adverse Event|4|||
143160971|NCT00394472|516135440|FG001|Overall Study|Adverse Event|2|||
143160972|NCT00394472|516135439|FG000|Overall Study|Withdrawal by Subject|0|||
143160973|NCT00394472|516135440|FG001|Overall Study|Withdrawal by Subject|2|||
143160974|NCT00394472|516135439|FG000|Overall Study|Physician Decision|0|||
143160975|NCT00394472|516135440|FG001|Overall Study|Physician Decision|1|||
143160976|NCT00394472|516135439|FG000|Overall Study|Lost to Follow-up|0|||
143160977|NCT00394472|516135440|FG001|Overall Study|Lost to Follow-up|1|||
143160978|NCT02596893|516135441|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
143160979|NCT02596893|516135442|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
143160980|NCT02596893|516135443|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
143160981|NCT02596893|516135444|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
143160982|NCT02596893|516135441|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
143160983|NCT02596893|516135442|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
143160984|NCT02596893|516135443|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
143160985|NCT02596893|516135444|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
143160986|NCT02596893|516135441|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
143160987|NCT02596893|516135442|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
143160988|NCT02596893|516135443|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
143160989|NCT02596893|516135444|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
143160990|NCT02596893|516135441|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
143160991|NCT02596893|516135442|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
143160992|NCT02596893|516135443|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
143160993|NCT02596893|516135444|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
143160994|NCT02596893|516135441|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
143160995|NCT02596893|516135442|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
143238576|NCT03739203|516427520|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
143160996|NCT02596893|516135443|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
143160997|NCT02596893|516135444|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
143034315|NCT01030965|515666812|FG002|Overall Study|Protocol Violation|1|||
143238577|NCT03739203|516427518|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
143034316|NCT01030965|515666813|FG003|Overall Study|Protocol Violation|1|||
143034317|NCT01030965|515666810|FG000|Overall Study|Adverse Event|0|||
143034318|NCT01030965|515666811|FG001|Overall Study|Adverse Event|1|||
143034319|NCT01030965|515666812|FG002|Overall Study|Adverse Event|2|||
143034320|NCT01030965|515666813|FG003|Overall Study|Adverse Event|1|||
143034321|NCT01030965|515666810|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
143034322|NCT01030965|515666811|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
143034323|NCT01030965|515666812|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
143034324|NCT01030965|515666813|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
143034325|NCT01030965|515666810|FG000|Overall Study|Withdrawal by Subject|0|||
143034326|NCT01030965|515666811|FG001|Overall Study|Withdrawal by Subject|1|||
143034327|NCT01030965|515666812|FG002|Overall Study|Withdrawal by Subject|0|||
143034328|NCT01030965|515666813|FG003|Overall Study|Withdrawal by Subject|2|||
143034329|NCT02097290|515666814|FG000|Overall Study|Death|6|||
143034330|NCT02097290|515666814|FG000|Overall Study|Total Withdrawals|3|||
143034331|NCT02097290|515666814|FG000|Overall Study|Attempt|8|||
143034332|NCT02534493|515666815|FG000|Overall Study|Lost to Follow-up|1|||
143034333|NCT02534493|515666815|FG000|Overall Study|Withdrawal by Subject|1|||
143034334|NCT00743197|515666818|FG000|Overall Study|Study terminated due to departure of PI.|1|||
143034335|NCT00743197|515666819|FG001|Overall Study|Study terminated due to departure of PI.|2|||
143034336|NCT01478620|515666820|FG000|Overall Study|Lost to Follow-up|6|||
143034337|NCT02170688|515666823|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
143034338|NCT02170688|515666824|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
143034339|NCT02170688|515666825|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
143034340|NCT02170688|515666826|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
143034341|NCT02170688|515666827|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
143034342|NCT02170688|515666823|FG000|Overall Study|Full dose not received|0|||
143034343|NCT02170688|515666824|FG001|Overall Study|Full dose not received|1|||
143034344|NCT02170688|515666825|FG002|Overall Study|Full dose not received|0|||
143034345|NCT02170688|515666826|FG003|Overall Study|Full dose not received|0|||
143034346|NCT02170688|515666827|FG004|Overall Study|Full dose not received|0|||
143034347|NCT02170688|515666823|FG000|Overall Study|Physician Decision|0|||
143034348|NCT02170688|515666824|FG001|Overall Study|Physician Decision|0|||
143034349|NCT02170688|515666825|FG002|Overall Study|Physician Decision|1|||
143034350|NCT02170688|515666826|FG003|Overall Study|Physician Decision|0|||
143034351|NCT02170688|515666827|FG004|Overall Study|Physician Decision|0|||
143034352|NCT02079532|515666830|FG000|Overall Study|Adverse Event|7|||
143034353|NCT02079532|515666830|FG000|Overall Study|Additional or changed therapy|2|||
143034354|NCT02079532|515666830|FG000|Overall Study|Lack of Efficacy|9|||
143034355|NCT02079532|515666830|FG000|Overall Study|Protocol Violation|3|||
143034356|NCT02079532|515666830|FG000|Overall Study|Withdrawal by Subject|1|||
143034357|NCT02079532|515666830|FG000|Overall Study|Administrative problems|1|||
143034358|NCT02079532|515666830|FG000|Overall Study|Inclusion into ReFIRST|3|||
143034359|NCT02079532|515666830|FG000|Overall Study|Other|3|||
143034360|NCT02158936|515666833|FG000|Overall Study|Study closed/ terminated|57|||
143034361|NCT02158936|515666834|FG001|Overall Study|Study closed/ terminated|77|||
143034362|NCT02158936|515666833|FG000|Overall Study|Azacitidine tx discontinued|53|||
143034363|NCT02158936|515666834|FG001|Overall Study|Azacitidine tx discontinued|46|||
143034364|NCT02158936|515666833|FG000|Overall Study|Adverse Event|39|||
143034365|NCT02158936|515666834|FG001|Overall Study|Adverse Event|24|||
143034366|NCT02158936|515666833|FG000|Overall Study|Withdrawal by Subject|15|||
143034367|NCT02158936|515666834|FG001|Overall Study|Withdrawal by Subject|16|||
143034368|NCT02158936|515666833|FG000|Overall Study|Physician Decision|15|||
143034369|NCT02158936|515666834|FG001|Overall Study|Physician Decision|13|||
143034370|NCT02158936|515666833|FG000|Overall Study|Lost to Follow-up|0|||
143034371|NCT02158936|515666834|FG001|Overall Study|Lost to Follow-up|1|||
143034372|NCT00522457|515666835|FG000|Overall Study|Due to disease progression|16|||
143034373|NCT00522457|515666835|FG000|Overall Study|Adverse Event|2|||
143034374|NCT01507051|515668292|FG000|Overall Study|Withdrawal by Subject|1|||
143034375|NCT01507051|515668293|FG001|Overall Study|Withdrawal by Subject|3|||
143034376|NCT01507051|515668294|FG002|Overall Study|Withdrawal by Subject|1|||
143034377|NCT01507051|515668295|FG003|Overall Study|Withdrawal by Subject|6|||
143034378|NCT01507051|515668292|FG000|Overall Study|Physician Decision|0|||
143034379|NCT01507051|515668293|FG001|Overall Study|Physician Decision|0|||
143034380|NCT01507051|515668294|FG002|Overall Study|Physician Decision|0|||
143034381|NCT01507051|515668295|FG003|Overall Study|Physician Decision|1|||
143034382|NCT01507051|515668292|FG000|Overall Study|Adverse Event|1|||
143034383|NCT01507051|515668293|FG001|Overall Study|Adverse Event|0|||
143034384|NCT01507051|515668294|FG002|Overall Study|Adverse Event|0|||
143034385|NCT01507051|515668295|FG003|Overall Study|Adverse Event|0|||
143034386|NCT00745420|515668297|FG000|Overall Study|Ineligible|1|||
143034387|NCT00485472|515668298|FG000|Overall Study|Adverse Event|8|||
143034388|NCT00485472|515668299|FG001|Overall Study|Adverse Event|5|||
143034389|NCT00485472|515668298|FG000|Overall Study|Lack of Efficacy|5|||
143034390|NCT00485472|515668299|FG001|Overall Study|Lack of Efficacy|4|||
143034391|NCT00485472|515668298|FG000|Overall Study|Withdrawal by Subject|1|||
143034392|NCT00485472|515668299|FG001|Overall Study|Withdrawal by Subject|0|||
143034393|NCT00485472|515668298|FG000|Overall Study|Protocol Violation|0|||
143034394|NCT00485472|515668299|FG001|Overall Study|Protocol Violation|1|||
143034395|NCT00485472|515668298|FG000|Overall Study|Other|2|||
143034396|NCT00485472|515668299|FG001|Overall Study|Other|1|||
143034397|NCT00485472|515668298|FG000|Overall Study|Lost to Follow-up|0|||
143034398|NCT00485472|515668299|FG001|Overall Study|Lost to Follow-up|1|||
143034399|NCT01492361|515668300|FG000|Overall Study|Withdrawal by Subject|281|||
143034400|NCT01492361|515668301|FG001|Overall Study|Withdrawal by Subject|297|||
143034401|NCT01492361|515668300|FG000|Overall Study|Physician Decision|12|||
143034402|NCT01492361|515668301|FG001|Overall Study|Physician Decision|12|||
143034403|NCT01492361|515668300|FG000|Overall Study|Lost to Follow-up|6|||
143034404|NCT01492361|515668301|FG001|Overall Study|Lost to Follow-up|13|||
143034405|NCT01492361|515668300|FG000|Overall Study|Other than specified above|106|||
143034406|NCT01492361|515668301|FG001|Overall Study|Other than specified above|138|||
143034407|NCT00560235|515668305|FG000|Phase 1|Discontinued|8|||
143034408|NCT00560235|515668306|FG001|Phase 1|Discontinued|0|||
143034409|NCT00560235|515668307|FG002|Phase 1|Discontinued|0|||
143034410|NCT00560235|515668305|FG000|Phase 1B|Discontinued|0|||
143034411|NCT00560235|515668306|FG001|Phase 1B|Discontinued|19|||
143034412|NCT00560235|515668307|FG002|Phase 1B|Discontinued|0|||
143034413|NCT00560235|515668305|FG000|Phase 2|Discontinued|0|||
143034414|NCT00560235|515668306|FG001|Phase 2|Discontinued|0|||
143034415|NCT00560235|515668307|FG002|Phase 2|Discontinued|96|||
143034416|NCT00560235|515668305|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
143034417|NCT00560235|515668306|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
143034418|NCT00560235|515668307|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
143034419|NCT04015232|515668308|FG000|Overall Study|Withdrawal by Subject|7|||
143034420|NCT04015232|515668309|FG001|Overall Study|Withdrawal by Subject|4|||
143034421|NCT04015232|515668308|FG000|Overall Study|Protocol Violation|1|||
143034422|NCT04015232|515668309|FG001|Overall Study|Protocol Violation|0|||
143034423|NCT04015232|515668308|FG000|Overall Study|Medical Grounds|3|||
143034424|NCT04015232|515668309|FG001|Overall Study|Medical Grounds|3|||
143034425|NCT01315249|515668310|FG000|Overall Study|Adverse Event|22|||
143034426|NCT01315249|515668311|FG001|Overall Study|Adverse Event|26|||
143034427|NCT01315249|515668310|FG000|Overall Study|Withdrawal by Subject|11|||
143034428|NCT01315249|515668311|FG001|Overall Study|Withdrawal by Subject|10|||
143034429|NCT01315249|515668310|FG000|Overall Study|Protocol Violation|8|||
143034430|NCT01315249|515668311|FG001|Overall Study|Protocol Violation|5|||
143034431|NCT01315249|515668310|FG000|Overall Study|Abnormal test results|1|||
143034432|NCT01315249|515668311|FG001|Overall Study|Abnormal test results|2|||
143034433|NCT01315249|515668310|FG000|Overall Study|Administrative problems|1|||
143034434|NCT01315249|515668311|FG001|Overall Study|Administrative problems|0|||
143034435|NCT01315249|515668310|FG000|Overall Study|inability to use device|1|||
143034436|NCT01315249|515668311|FG001|Overall Study|inability to use device|0|||
143034437|NCT01315249|515668310|FG000|Overall Study|Lack of Efficacy|0|||
143034438|NCT01315249|515668311|FG001|Overall Study|Lack of Efficacy|1|||
143034439|NCT01315249|515668310|FG000|Overall Study|Lost to Follow-up|0|||
143034440|NCT01315249|515668311|FG001|Overall Study|Lost to Follow-up|2|||
143034441|NCT01315249|515668310|FG000|Overall Study|Death|0|||
143034442|NCT01315249|515668311|FG001|Overall Study|Death|1|||
143034443|NCT00365300|515668314|FG000|Open-label Phase|Adverse Event|4|||
143034444|NCT00365300|515668315|FG001|Open-label Phase|Adverse Event|0|||
143034445|NCT00365300|515668314|FG000|Open-label Phase|Failed to Return|1|||
143034446|NCT00365300|515668315|FG001|Open-label Phase|Failed to Return|0|||
143034447|NCT00365300|515668314|FG000|Open-label Phase|Physician Decision|1|||
143034448|NCT00365300|515668315|FG001|Open-label Phase|Physician Decision|0|||
143034449|NCT00365300|515668314|FG000|Open-label Phase|Noncompliance|9|||
143034450|NCT00365300|515668315|FG001|Open-label Phase|Noncompliance|0|||
143034451|NCT00365300|515668314|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
143034452|NCT00365300|515668315|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
143034453|NCT00365300|515668314|FG000|Open-label Phase|Protocol Violation|1|||
143034454|NCT00365300|515668315|FG001|Open-label Phase|Protocol Violation|0|||
143034455|NCT00365300|515668314|FG000|Open-label Phase|Lack of Efficacy|1|||
143034456|NCT00365300|515668315|FG001|Open-label Phase|Lack of Efficacy|0|||
143034457|NCT00365300|515668314|FG000|Open-label Phase|Patient skipped open label phase|1|||
143238578|NCT03739203|516427519|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
143238579|NCT03739203|516427520|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
143238580|NCT03739203|516427518|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
143238581|NCT03739203|516427519|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
143034458|NCT00365300|515668315|FG001|Open-label Phase|Patient skipped open label phase|0|||
143238582|NCT03739203|516427520|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
143034459|NCT00365300|515668314|FG000|Double-blind Phase|Failed to return|1|||
143034460|NCT00365300|515668315|FG001|Double-blind Phase|Failed to return|0|||
143034461|NCT00365300|515668314|FG000|Double-blind Phase|Noncompliance|1|||
143034462|NCT00365300|515668315|FG001|Double-blind Phase|Noncompliance|1|||
143034463|NCT00365300|515668314|FG000|Double-blind Phase|Withdrawal by Subject|0|||
143034464|NCT00365300|515668315|FG001|Double-blind Phase|Withdrawal by Subject|1|||
143034465|NCT00365300|515668314|FG000|Double-blind Phase|Protocol Violation|3|||
143034466|NCT00365300|515668315|FG001|Double-blind Phase|Protocol Violation|1|||
143034467|NCT00365300|515668314|FG000|Double-blind Phase|Lack of Efficacy|6|||
143034468|NCT00365300|515668315|FG001|Double-blind Phase|Lack of Efficacy|6|||
143034469|NCT02896361|515668332|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
143238583|NCT03739203|516427518|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
143034470|NCT02896361|515668333|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
143034471|NCT02896361|515668334|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
143034472|NCT02896361|515668332|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
143034473|NCT02896361|515668333|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
143034474|NCT02896361|515668334|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
143034475|NCT03164772|515668335|FG000|Overall Study|Death|4|||
143034476|NCT03164772|515668336|FG001|Overall Study|Death|2|||
143034477|NCT03164772|515668335|FG000|Overall Study|Adverse Event|1|||
143034478|NCT03164772|515668336|FG001|Overall Study|Adverse Event|4|||
143034479|NCT03164772|515668335|FG000|Overall Study|Progressive Disease|11|||
143034480|NCT03164772|515668336|FG001|Overall Study|Progressive Disease|21|||
143034481|NCT03164772|515668335|FG000|Overall Study|Physician Decision|2|||
143034482|NCT03164772|515668336|FG001|Overall Study|Physician Decision|0|||
143034483|NCT03164772|515668335|FG000|Overall Study|Withdrawal by Subject|0|||
143034484|NCT03164772|515668336|FG001|Overall Study|Withdrawal by Subject|4|||
143034485|NCT01029353|515668339|FG000|Overall Study|Lost to Follow-up|4|||
143034486|NCT01029353|515668340|FG001|Overall Study|Lost to Follow-up|5|||
143034487|NCT01029353|515668341|FG002|Overall Study|Lost to Follow-up|5|||
143034488|NCT01029353|515668342|FG003|Overall Study|Lost to Follow-up|4|||
143034489|NCT01029353|515668339|FG000|Overall Study|Consent Withdrawn|2|||
143160998|NCT02596893|516135441|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
143160999|NCT02596893|516135442|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
143161000|NCT02596893|516135443|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
143161001|NCT02596893|516135444|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
143161002|NCT02596893|516135441|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
143161003|NCT02596893|516135442|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
143034490|NCT01029353|515668340|FG001|Overall Study|Consent Withdrawn|0|||
143034491|NCT01029353|515668341|FG002|Overall Study|Consent Withdrawn|0|||
143034492|NCT01029353|515668342|FG003|Overall Study|Consent Withdrawn|0|||
143034493|NCT01029353|515668339|FG000|Overall Study|Primary Outcome Indeterminate|1|||
143034494|NCT01029353|515668340|FG001|Overall Study|Primary Outcome Indeterminate|3|||
143034495|NCT01029353|515668341|FG002|Overall Study|Primary Outcome Indeterminate|2|||
143034496|NCT01029353|515668342|FG003|Overall Study|Primary Outcome Indeterminate|0|||
143161004|NCT02596893|516135443|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
143161005|NCT02596893|516135444|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
143161006|NCT02596893|516135441|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
143161007|NCT02596893|516135442|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
143161008|NCT02596893|516135443|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
143161009|NCT02596893|516135444|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
143161010|NCT02596893|516135441|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
143161011|NCT02596893|516135442|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
143161012|NCT02596893|516135443|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
143161013|NCT02596893|516135444|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
143161014|NCT02596893|516135441|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
143161015|NCT02596893|516135442|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
143161016|NCT02596893|516135443|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
143161017|NCT02596893|516135444|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
143161018|NCT02596893|516135441|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
143161019|NCT02596893|516135442|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
143161020|NCT02596893|516135443|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
143161021|NCT02596893|516135444|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
143161022|NCT00004228|516135447|FG000|Overall Study|Adverse Event|0|||
143161023|NCT00004228|516135448|FG001|Overall Study|Adverse Event|1|||
143161024|NCT00004228|516135449|FG002|Overall Study|Adverse Event|0|||
143161025|NCT00004228|516135450|FG003|Overall Study|Adverse Event|0|||
143161026|NCT00004228|516135451|FG004|Overall Study|Adverse Event|1|||
143161027|NCT00004228|516135452|FG005|Overall Study|Adverse Event|0|||
143161028|NCT00004228|516135453|FG006|Overall Study|Adverse Event|0|||
143161029|NCT00004228|516135447|FG000|Overall Study|Death|0|||
143495421|NCT03434379|517356027|FG002|Global Period|Reason Unspecified|0|||
143495422|NCT03434379|517356028|FG003|Global Period|Reason Unspecified|0|||
143495423|NCT03434379|517356025|FG000|Global Period|Study Ended by Sponsor|26|||
143495424|NCT03434379|517356026|FG001|Global Period|Study Ended by Sponsor|80|||
143034497|NCT02932878|515668343|FG000|Overall Study|Due to Lab Results|2|||
143034498|NCT02932878|515668344|FG001|Overall Study|Due to Lab Results|1|||
143034499|NCT00849901|515668345|FG000|Acute Treatment Phase|Adverse Event|9|||
143034500|NCT00849901|515668346|FG001|Acute Treatment Phase|Adverse Event|1|||
143034501|NCT00849901|515668347|FG002|Acute Treatment Phase|Adverse Event|3|||
143034502|NCT00849901|515668345|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
143161030|NCT00004228|516135448|FG001|Overall Study|Death|1|||
143161031|NCT00004228|516135449|FG002|Overall Study|Death|2|||
143161032|NCT00004228|516135450|FG003|Overall Study|Death|0|||
143034503|NCT00849901|515668346|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
143034504|NCT00849901|515668347|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
143034505|NCT00849901|515668345|FG000|Acute Treatment Phase|Protocol Violation|0|||
143034506|NCT00849901|515668346|FG001|Acute Treatment Phase|Protocol Violation|2|||
143034507|NCT00849901|515668347|FG002|Acute Treatment Phase|Protocol Violation|1|||
143034508|NCT00849901|515668345|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
143034509|NCT00849901|515668346|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
143034510|NCT00849901|515668347|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
143034511|NCT00849901|515668345|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
143034512|NCT00849901|515668346|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
143034513|NCT00849901|515668347|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
143034514|NCT00849901|515668345|FG000|Acute Treatment Phase|Physician Decision|1|||
143034515|NCT00849901|515668346|FG001|Acute Treatment Phase|Physician Decision|1|||
143034516|NCT00849901|515668347|FG002|Acute Treatment Phase|Physician Decision|1|||
143034517|NCT00849901|515668345|FG000|Acute Treatment Phase|Sponsor Decision|1|||
143034518|NCT00849901|515668346|FG001|Acute Treatment Phase|Sponsor Decision|0|||
143034519|NCT00849901|515668347|FG002|Acute Treatment Phase|Sponsor Decision|0|||
143034520|NCT00849901|515668345|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
143034521|NCT00849901|515668346|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
143034522|NCT00849901|515668347|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
143034523|NCT00849901|515668345|FG000|Extension Phase|Adverse Event|2|||
143034524|NCT00849901|515668346|FG001|Extension Phase|Adverse Event|8|||
143034525|NCT00849901|515668347|FG002|Extension Phase|Adverse Event|4|||
143034526|NCT00849901|515668345|FG000|Extension Phase|Lost to Follow-up|3|||
143034527|NCT00849901|515668346|FG001|Extension Phase|Lost to Follow-up|0|||
143034528|NCT00849901|515668347|FG002|Extension Phase|Lost to Follow-up|1|||
143034529|NCT00849901|515668345|FG000|Extension Phase|Protocol Violation|2|||
143034530|NCT00849901|515668346|FG001|Extension Phase|Protocol Violation|2|||
143034531|NCT00849901|515668347|FG002|Extension Phase|Protocol Violation|4|||
143034532|NCT00849901|515668345|FG000|Extension Phase|Withdrawal by Subject|7|||
143034533|NCT00849901|515668346|FG001|Extension Phase|Withdrawal by Subject|6|||
143034534|NCT00849901|515668347|FG002|Extension Phase|Withdrawal by Subject|3|||
143034535|NCT00849901|515668345|FG000|Extension Phase|Parent or Caregiver Decision|10|||
143034536|NCT00849901|515668346|FG001|Extension Phase|Parent or Caregiver Decision|4|||
143034537|NCT00849901|515668347|FG002|Extension Phase|Parent or Caregiver Decision|4|||
143034538|NCT00849901|515668345|FG000|Extension Phase|Physician Decision|1|||
143034539|NCT00849901|515668346|FG001|Extension Phase|Physician Decision|2|||
143034540|NCT00849901|515668347|FG002|Extension Phase|Physician Decision|0|||
143034541|NCT00849901|515668345|FG000|Extension Phase|Lack of Efficacy|2|||
143034542|NCT00849901|515668346|FG001|Extension Phase|Lack of Efficacy|4|||
143034543|NCT00849901|515668347|FG002|Extension Phase|Lack of Efficacy|1|||
143034544|NCT02152566|515668348|FG000|Overall Study|Lost to Follow-up|1|||
143034545|NCT02152566|515668348|FG000|Overall Study|Withdrawal by Subject|2|||
143034546|NCT02942264|515668350|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
143034547|NCT02942264|515668351|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
143034548|NCT02942264|515668352|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
143034549|NCT02942264|515668353|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
143034550|NCT02942264|515668354|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
143034551|NCT02942264|515668355|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
143034552|NCT02942264|515668356|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
143034553|NCT02942264|515668357|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
143034554|NCT02942264|515668358|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
143034555|NCT02942264|515668350|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
143161033|NCT00004228|516135451|FG004|Overall Study|Death|1|||
143034556|NCT02942264|515668351|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
143034557|NCT02942264|515668352|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
143034558|NCT02942264|515668353|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
143034559|NCT02942264|515668354|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
143034560|NCT02942264|515668355|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
143034561|NCT02942264|515668356|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
143034562|NCT02942264|515668357|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
143034563|NCT02942264|515668358|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
143034564|NCT03980483|515668359|FG000|Overall Study|Adverse Event|13|||
143034565|NCT03980483|515668360|FG001|Overall Study|Adverse Event|29|||
143034566|NCT03980483|515668361|FG002|Overall Study|Adverse Event|11|||
143034567|NCT03980483|515668362|FG003|Overall Study|Adverse Event|2|||
143161034|NCT00004228|516135452|FG005|Overall Study|Death|0|||
143034568|NCT03980483|515668363|FG004|Overall Study|Adverse Event|2|||
143034569|NCT03980483|515668364|FG005|Overall Study|Adverse Event|2|||
143034570|NCT03980483|515668359|FG000|Overall Study|Lack of Efficacy|7|||
143034571|NCT03980483|515668360|FG001|Overall Study|Lack of Efficacy|6|||
143034572|NCT03980483|515668361|FG002|Overall Study|Lack of Efficacy|0|||
143034573|NCT03980483|515668362|FG003|Overall Study|Lack of Efficacy|3|||
143034574|NCT03980483|515668363|FG004|Overall Study|Lack of Efficacy|1|||
143161035|NCT00004228|516135453|FG006|Overall Study|Death|0|||
143034575|NCT03980483|515668364|FG005|Overall Study|Lack of Efficacy|1|||
143034576|NCT03980483|515668359|FG000|Overall Study|Lost to Follow-up|2|||
143034577|NCT03980483|515668360|FG001|Overall Study|Lost to Follow-up|4|||
143034578|NCT03980483|515668361|FG002|Overall Study|Lost to Follow-up|2|||
143034579|NCT03980483|515668362|FG003|Overall Study|Lost to Follow-up|1|||
143034580|NCT03980483|515668363|FG004|Overall Study|Lost to Follow-up|2|||
143034581|NCT03980483|515668364|FG005|Overall Study|Lost to Follow-up|0|||
143034582|NCT03980483|515668359|FG000|Overall Study|Protocol Violation|4|||
143034583|NCT03980483|515668360|FG001|Overall Study|Protocol Violation|2|||
143034584|NCT03980483|515668361|FG002|Overall Study|Protocol Violation|1|||
143034585|NCT03980483|515668362|FG003|Overall Study|Protocol Violation|1|||
143034586|NCT03980483|515668363|FG004|Overall Study|Protocol Violation|0|||
143034587|NCT03980483|515668364|FG005|Overall Study|Protocol Violation|0|||
143034588|NCT03980483|515668359|FG000|Overall Study|Physician Decision|14|||
143034589|NCT03980483|515668360|FG001|Overall Study|Physician Decision|10|||
143034590|NCT03980483|515668361|FG002|Overall Study|Physician Decision|7|||
143034591|NCT03980483|515668362|FG003|Overall Study|Physician Decision|4|||
143034592|NCT03980483|515668363|FG004|Overall Study|Physician Decision|4|||
143034593|NCT03980483|515668364|FG005|Overall Study|Physician Decision|2|||
143034594|NCT03980483|515668359|FG000|Overall Study|Withdrawal by Subject|38|||
143034595|NCT03980483|515668360|FG001|Overall Study|Withdrawal by Subject|21|||
143034596|NCT03980483|515668361|FG002|Overall Study|Withdrawal by Subject|15|||
143034597|NCT03980483|515668362|FG003|Overall Study|Withdrawal by Subject|5|||
143034598|NCT03980483|515668363|FG004|Overall Study|Withdrawal by Subject|3|||
143034599|NCT03980483|515668364|FG005|Overall Study|Withdrawal by Subject|4|||
143034600|NCT03980483|515668359|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
143034601|NCT03980483|515668360|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
143034602|NCT03980483|515668361|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
143034603|NCT03980483|515668362|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
143034604|NCT03980483|515668363|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
143034605|NCT03980483|515668364|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
143034606|NCT03980483|515668359|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
143034607|NCT03980483|515668360|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
143034608|NCT03980483|515668361|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
143034609|NCT03980483|515668362|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
143034610|NCT03980483|515668363|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
143034611|NCT03980483|515668364|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
143034612|NCT03980483|515668359|FG000|Overall Study|Other|0|||
143034613|NCT03980483|515668360|FG001|Overall Study|Other|1|||
143034614|NCT03980483|515668361|FG002|Overall Study|Other|0|||
143034615|NCT03980483|515668362|FG003|Overall Study|Other|0|||
143034616|NCT03980483|515668363|FG004|Overall Study|Other|0|||
143034617|NCT03980483|515668364|FG005|Overall Study|Other|0|||
143034618|NCT01449630|515668367|FG000|Period 1|Physician Decision|1|||
143034619|NCT01449630|515668368|FG001|Period 1|Physician Decision|0|||
143034620|NCT01449630|515668369|FG002|Period 1|Physician Decision|0|||
143034621|NCT01449630|515668370|FG003|Period 1|Physician Decision|1|||
143034622|NCT01449630|515668371|FG004|Period 1|Physician Decision|0|||
143034623|NCT01449630|515668372|FG005|Period 1|Physician Decision|0|||
143034624|NCT01449630|515668373|FG006|Period 1|Physician Decision|0|||
143034625|NCT01449630|515668374|FG007|Period 1|Physician Decision|0|||
143034626|NCT01449630|515668375|FG008|Period 1|Physician Decision|0|||
143034627|NCT01449630|515668367|FG000|Period 1|Sponsor Decision|0|||
143034628|NCT01449630|515668368|FG001|Period 1|Sponsor Decision|0|||
143034629|NCT01449630|515668369|FG002|Period 1|Sponsor Decision|0|||
143034630|NCT01449630|515668370|FG003|Period 1|Sponsor Decision|0|||
143034631|NCT01449630|515668371|FG004|Period 1|Sponsor Decision|0|||
143034632|NCT01449630|515668372|FG005|Period 1|Sponsor Decision|1|||
143034633|NCT01449630|515668373|FG006|Period 1|Sponsor Decision|0|||
143034634|NCT01449630|515668374|FG007|Period 1|Sponsor Decision|0|||
143034635|NCT01449630|515668375|FG008|Period 1|Sponsor Decision|0|||
143034636|NCT01449630|515668367|FG000|Period 2|Sponsor Decision|0|||
143034637|NCT01449630|515668368|FG001|Period 2|Sponsor Decision|0|||
143034638|NCT01449630|515668369|FG002|Period 2|Sponsor Decision|0|||
143034639|NCT01449630|515668370|FG003|Period 2|Sponsor Decision|0|||
143034640|NCT01449630|515668371|FG004|Period 2|Sponsor Decision|0|||
143495425|NCT03434379|517356027|FG002|Global Period|Study Ended by Sponsor|0|||
143034641|NCT01449630|515668372|FG005|Period 2|Sponsor Decision|0|||
143034642|NCT01449630|515668373|FG006|Period 2|Sponsor Decision|1|||
143034643|NCT01449630|515668374|FG007|Period 2|Sponsor Decision|0|||
143034644|NCT01449630|515668375|FG008|Period 2|Sponsor Decision|0|||
143034645|NCT01720264|515668381|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
143034646|NCT01720264|515668381|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
143034647|NCT01720264|515668381|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
143034648|NCT03752528|515668382|FG000|Part A|Lost to Follow-up|1|||
143034649|NCT03752528|515668382|FG000|Part A|Protocol Violation|1|||
143034650|NCT03752528|515668382|FG000|Part B|Protocol Violation|1|||
143034651|NCT03752528|515668382|FG000|Part B|Study terminated by sponsor|3|||
143034652|NCT02549092|515668383|FG000|Treatment Period|Adverse Event|2|||
143034653|NCT02549092|515668384|FG001|Treatment Period|Adverse Event|2|||
143034654|NCT02549092|515668383|FG000|Treatment Period|Withdrawal by Subject|1|||
143034655|NCT02549092|515668384|FG001|Treatment Period|Withdrawal by Subject|3|||
143034656|NCT02549092|515668383|FG000|Treatment Period|Lack of Efficacy|0|||
143034657|NCT02549092|515668384|FG001|Treatment Period|Lack of Efficacy|2|||
143034658|NCT02549092|515668383|FG000|Extension/Transition Period|Adverse Event|1|||
143034659|NCT02549092|515668384|FG001|Extension/Transition Period|Adverse Event|1|||
143034660|NCT02549092|515668383|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
143034661|NCT02549092|515668384|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
143034662|NCT02549092|515668383|FG000|Extension/Transition Period|Other, Not Specified|4|||
143034663|NCT02549092|515668384|FG001|Extension/Transition Period|Other, Not Specified|2|||
143034664|NCT00906347|515668391|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
143034665|NCT00906347|515668392|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
143034666|NCT00906347|515668391|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
143034667|NCT00906347|515668392|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
143034668|NCT00906347|515668391|FG000|Received Study Drug|Refused study drug|1|||
143034669|NCT00906347|515668392|FG001|Received Study Drug|Refused study drug|0|||
143034670|NCT00906347|515668391|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
143034671|NCT00906347|515668392|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
143034672|NCT00472290|515668395|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
143034673|NCT00472290|515668395|FG000|Overall Study|Protocol Specified Criteria|7|||
143034674|NCT00472290|515668395|FG000|Overall Study|Administrative Decision|37|||
143034675|NCT00472290|515668395|FG000|Overall Study|Death|3|||
143034676|NCT00472290|515668395|FG000|Overall Study|Lost to Follow-up|1|||
143034677|NCT00472290|515668395|FG000|Overall Study|Lack of Efficacy|1|||
143034678|NCT00472290|515668395|FG000|Overall Study|Disease Progression|4|||
143034679|NCT00472290|515668395|FG000|Overall Study|Withdrawal by Subject|5|||
143034680|NCT00472290|515668395|FG000|Overall Study|Adverse Event|6|||
143161036|NCT00004228|516135447|FG000|Overall Study|Lack of Efficacy|1|||
143161037|NCT00004228|516135448|FG001|Overall Study|Lack of Efficacy|6|||
143161038|NCT00004228|516135449|FG002|Overall Study|Lack of Efficacy|5|||
143161039|NCT00004228|516135450|FG003|Overall Study|Lack of Efficacy|3|||
143161040|NCT00004228|516135451|FG004|Overall Study|Lack of Efficacy|9|||
143161041|NCT00004228|516135452|FG005|Overall Study|Lack of Efficacy|8|||
143161042|NCT00004228|516135453|FG006|Overall Study|Lack of Efficacy|4|||
143161043|NCT00004228|516135447|FG000|Overall Study|Lost to Follow-up|0|||
143161044|NCT00004228|516135448|FG001|Overall Study|Lost to Follow-up|0|||
143161045|NCT00004228|516135449|FG002|Overall Study|Lost to Follow-up|1|||
143161046|NCT00004228|516135450|FG003|Overall Study|Lost to Follow-up|0|||
143161047|NCT00004228|516135451|FG004|Overall Study|Lost to Follow-up|0|||
143161048|NCT00004228|516135452|FG005|Overall Study|Lost to Follow-up|0|||
143161049|NCT00004228|516135453|FG006|Overall Study|Lost to Follow-up|0|||
143161050|NCT00004228|516135447|FG000|Overall Study|Physician Decision|1|||
143161051|NCT00004228|516135448|FG001|Overall Study|Physician Decision|0|||
143161052|NCT00004228|516135449|FG002|Overall Study|Physician Decision|3|||
143161053|NCT00004228|516135450|FG003|Overall Study|Physician Decision|2|||
143161054|NCT00004228|516135451|FG004|Overall Study|Physician Decision|1|||
143161055|NCT00004228|516135452|FG005|Overall Study|Physician Decision|1|||
143161056|NCT00004228|516135453|FG006|Overall Study|Physician Decision|1|||
143161057|NCT00004228|516135447|FG000|Overall Study|Protocol Violation|0|||
143161058|NCT00004228|516135448|FG001|Overall Study|Protocol Violation|5|||
143161059|NCT00004228|516135449|FG002|Overall Study|Protocol Violation|2|||
143161060|NCT00004228|516135450|FG003|Overall Study|Protocol Violation|1|||
143161061|NCT00004228|516135451|FG004|Overall Study|Protocol Violation|1|||
143161062|NCT00004228|516135452|FG005|Overall Study|Protocol Violation|2|||
143161063|NCT00004228|516135453|FG006|Overall Study|Protocol Violation|0|||
143161064|NCT00004228|516135447|FG000|Overall Study|Withdrawal by Subject|3|||
143161065|NCT00004228|516135448|FG001|Overall Study|Withdrawal by Subject|0|||
143161066|NCT00004228|516135449|FG002|Overall Study|Withdrawal by Subject|1|||
143161067|NCT00004228|516135450|FG003|Overall Study|Withdrawal by Subject|0|||
143161068|NCT00004228|516135451|FG004|Overall Study|Withdrawal by Subject|2|||
143161069|NCT00004228|516135452|FG005|Overall Study|Withdrawal by Subject|1|||
143034681|NCT00472290|515668395|FG000|Overall Study|Requirement for alternative therapy|7|||
143034682|NCT02888171|515668403|FG000|Overall Study|Lost to Follow-up|2|||
143034683|NCT02888171|515668404|FG001|Overall Study|Lost to Follow-up|1|||
143034684|NCT02888171|515668403|FG000|Overall Study|Withdrawal by Subject|3|||
143034685|NCT02888171|515668404|FG001|Overall Study|Withdrawal by Subject|2|||
143161070|NCT00004228|516135453|FG006|Overall Study|Withdrawal by Subject|2|||
143161071|NCT00004228|516135447|FG000|Overall Study|Other|0|||
143161072|NCT00004228|516135448|FG001|Overall Study|Other|0|||
143161073|NCT00004228|516135449|FG002|Overall Study|Other|1|||
143161074|NCT00004228|516135450|FG003|Overall Study|Other|0|||
143034686|NCT02888171|515668403|FG000|Overall Study|Adverse Event|0|||
143034687|NCT02888171|515668404|FG001|Overall Study|Adverse Event|1|||
143161075|NCT00004228|516135451|FG004|Overall Study|Other|0|||
143161076|NCT00004228|516135452|FG005|Overall Study|Other|0|||
143161077|NCT00004228|516135453|FG006|Overall Study|Other|0|||
143161078|NCT00004228|516135447|FG000|Overall Study|ineligible|4|||
143161079|NCT00004228|516135448|FG001|Overall Study|ineligible|2|||
143034688|NCT02920996|515668405|FG000|Overall Study|Adverse Event|8|||
143034689|NCT02920996|515668406|FG001|Overall Study|Adverse Event|0|||
143034690|NCT02920996|515668405|FG000|Overall Study|Physician Decision|1|||
143034691|NCT02920996|515668406|FG001|Overall Study|Physician Decision|0|||
143034692|NCT02920996|515668405|FG000|Overall Study|Death|1|||
143034693|NCT02920996|515668406|FG001|Overall Study|Death|0|||
143034694|NCT02920996|515668405|FG000|Overall Study|Missing|1|||
143034695|NCT02920996|515668406|FG001|Overall Study|Missing|0|||
143034696|NCT02920996|515668405|FG000|Overall Study|Subject Non-Compliance|1|||
143034697|NCT02920996|515668406|FG001|Overall Study|Subject Non-Compliance|0|||
143034698|NCT02507375|515668409|FG000|Overall Study|Progressive Disease|4|||
143034699|NCT02507375|515668410|FG001|Overall Study|Progressive Disease|5|||
143034700|NCT02507375|515668409|FG000|Overall Study|Death|0|||
143034701|NCT02507375|515668410|FG001|Overall Study|Death|1|||
143034702|NCT02507375|515668409|FG000|Overall Study|Refused treatment|0|||
143034703|NCT02507375|515668410|FG001|Overall Study|Refused treatment|1|||
143034704|NCT02507375|515668409|FG000|Overall Study|Adverse Event|0|||
143034705|NCT02507375|515668410|FG001|Overall Study|Adverse Event|1|||
143034706|NCT05150964|515669767|FG000|Overall Study|Lost to Follow-up|2|||
143034707|NCT02017964|515669770|FG000|Overall Study|Patient deemed ineligible|1|||
143034708|NCT00569374|515669774|FG000|Overall Study|Withdrawal by Subject|4|||
143034709|NCT04638153|515669775|FG000|Overall Study|Withdrawal by parent/guardian|0|||
143034710|NCT04638153|515669776|FG001|Overall Study|Withdrawal by parent/guardian|0|||
143034711|NCT04638153|515669777|FG002|Overall Study|Withdrawal by parent/guardian|1|||
143034712|NCT04638153|515669775|FG000|Overall Study|Study terminated by sponsor|4|||
143034713|NCT04638153|515669776|FG001|Overall Study|Study terminated by sponsor|2|||
143034714|NCT04638153|515669777|FG002|Overall Study|Study terminated by sponsor|14|||
143034715|NCT04006171|515669778|FG000|Overall Study|Withdrawal by Subject|8|||
143034716|NCT04006171|515669779|FG001|Overall Study|Withdrawal by Subject|7|||
143034717|NCT04006171|515669778|FG000|Overall Study|missing serum samples|2|||
143034718|NCT04006171|515669779|FG001|Overall Study|missing serum samples|2|||
143034719|NCT04006171|515669778|FG000|Overall Study|insufficient sample volume|2|||
143034720|NCT04006171|515669779|FG001|Overall Study|insufficient sample volume|3|||
143034721|NCT00912288|515669780|FG000|Overall Study|Death|0|||
143034722|NCT00912288|515669781|FG001|Overall Study|Death|1|||
143034723|NCT00912288|515669780|FG000|Overall Study|Adverse Event|1|||
143034724|NCT00912288|515669781|FG001|Overall Study|Adverse Event|1|||
143034725|NCT00912288|515669780|FG000|Overall Study|Lost to Follow-up|1|||
143034726|NCT00912288|515669781|FG001|Overall Study|Lost to Follow-up|0|||
143034727|NCT00912288|515669780|FG000|Overall Study|Protocol Violation|1|||
143034728|NCT00912288|515669781|FG001|Overall Study|Protocol Violation|0|||
143034729|NCT00912288|515669780|FG000|Overall Study|Withdrawal by Subject|3|||
143034730|NCT00912288|515669781|FG001|Overall Study|Withdrawal by Subject|3|||
143034731|NCT00912288|515669780|FG000|Overall Study|Study terminated by sponsor|34|||
143034732|NCT00912288|515669781|FG001|Overall Study|Study terminated by sponsor|35|||
143034733|NCT00912288|515669780|FG000|Overall Study|Other|1|||
143034734|NCT00912288|515669781|FG001|Overall Study|Other|0|||
143034735|NCT01440283|515669784|FG000|Overall Study|Death|3|||
143034736|NCT01440283|515669784|FG000|Overall Study|Withdrawal by Subject|4|||
143034737|NCT01440283|515669784|FG000|Overall Study|Physician Decision|3|||
143034738|NCT01735630|515669785|FG000|Overall Study|Adverse Event|8|||
143034739|NCT01735630|515669786|FG001|Overall Study|Adverse Event|7|||
143034740|NCT01735630|515669785|FG000|Overall Study|Lost to Follow-up|1|||
143034741|NCT01735630|515669786|FG001|Overall Study|Lost to Follow-up|0|||
143034742|NCT01735630|515669785|FG000|Overall Study|Physician Decision|0|||
143034743|NCT01735630|515669786|FG001|Overall Study|Physician Decision|1|||
143034744|NCT01735630|515669785|FG000|Overall Study|Sponsor Decision|2|||
143034745|NCT01735630|515669786|FG001|Overall Study|Sponsor Decision|1|||
143034746|NCT01735630|515669785|FG000|Overall Study|Withdrawal by Subject|7|||
143034747|NCT01735630|515669786|FG001|Overall Study|Withdrawal by Subject|9|||
143034748|NCT03099538|515669787|FG000|Overall Study|Lack of Efficacy|3|||
143034749|NCT01572948|515669788|FG000|Overall Study|Lost to Follow-up|1|||
143034750|NCT01572948|515669789|FG001|Overall Study|Lost to Follow-up|0|||
143034751|NCT01572948|515669788|FG000|Overall Study|unable to contact|0|||
143034752|NCT01572948|515669789|FG001|Overall Study|unable to contact|1|||
143034753|NCT00440557|515669790|FG000|Overall Study|Withdrawal by Subject|10|||
143034754|NCT00440557|515669791|FG001|Overall Study|Withdrawal by Subject|5|||
143495426|NCT03434379|517356028|FG003|Global Period|Study Ended by Sponsor|0|||
143495427|NCT03434379|517356025|FG000|Global Period|Physician Decision|1|||
143034755|NCT00440557|515669792|FG002|Overall Study|Withdrawal by Subject|11|||
143034756|NCT00440557|515669790|FG000|Overall Study|Lost to Follow-up|1|||
143034757|NCT00440557|515669791|FG001|Overall Study|Lost to Follow-up|2|||
143034758|NCT00440557|515669792|FG002|Overall Study|Lost to Follow-up|6|||
143034759|NCT00440557|515669790|FG000|Overall Study|Adverse Event|3|||
143034760|NCT00440557|515669791|FG001|Overall Study|Adverse Event|3|||
143034761|NCT00440557|515669792|FG002|Overall Study|Adverse Event|5|||
143034762|NCT00440557|515669790|FG000|Overall Study|Death|2|||
143034763|NCT00440557|515669791|FG001|Overall Study|Death|6|||
143034764|NCT00440557|515669792|FG002|Overall Study|Death|3|||
143034765|NCT00440557|515669790|FG000|Overall Study|Began Dialysis|4|||
143161080|NCT00004228|516135449|FG002|Overall Study|ineligible|4|||
143495428|NCT03434379|517356026|FG001|Global Period|Physician Decision|0|||
143495429|NCT03434379|517356027|FG002|Global Period|Physician Decision|0|||
143495430|NCT03434379|517356028|FG003|Global Period|Physician Decision|0|||
143161081|NCT00004228|516135450|FG003|Overall Study|ineligible|1|||
143161082|NCT00004228|516135451|FG004|Overall Study|ineligible|1|||
143161083|NCT00004228|516135452|FG005|Overall Study|ineligible|2|||
143495431|NCT03434379|517356025|FG000|China Extension Period|Lost to Follow-up|0|||
143495432|NCT03434379|517356026|FG001|China Extension Period|Lost to Follow-up|0|||
143495433|NCT03434379|517356027|FG002|China Extension Period|Lost to Follow-up|2|||
143495434|NCT03434379|517356028|FG003|China Extension Period|Lost to Follow-up|3|||
143495435|NCT03434379|517356025|FG000|China Extension Period|Death|0|||
143495436|NCT03434379|517356026|FG001|China Extension Period|Death|0|||
143495437|NCT03434379|517356027|FG002|China Extension Period|Death|46|||
143495438|NCT03434379|517356028|FG003|China Extension Period|Death|88|||
143495439|NCT03434379|517356025|FG000|China Extension Period|Withdrawal by Subject|0|||
143495440|NCT03434379|517356026|FG001|China Extension Period|Withdrawal by Subject|0|||
143495441|NCT03434379|517356027|FG002|China Extension Period|Withdrawal by Subject|8|||
143495442|NCT03434379|517356028|FG003|China Extension Period|Withdrawal by Subject|6|||
143495443|NCT03434379|517356025|FG000|China Extension Period|Study Ended by Sponsor|0|||
143495444|NCT03434379|517356026|FG001|China Extension Period|Study Ended by Sponsor|0|||
143495445|NCT03434379|517356027|FG002|China Extension Period|Study Ended by Sponsor|5|||
143495446|NCT03434379|517356028|FG003|China Extension Period|Study Ended by Sponsor|36|||
143495447|NCT00573794|517356032|FG000|Overall Study|Adverse Event|81|||
143495448|NCT00573794|517356032|FG000|Overall Study|Withdrew Consent|90|||
143495449|NCT00573794|517356032|FG000|Overall Study|Lost to Follow-up|13|||
143495450|NCT00573794|517356032|FG000|Overall Study|Protocol Violation|6|||
143495451|NCT00573794|517356032|FG000|Overall Study|Lack of Efficacy|94|||
143495452|NCT00573794|517356032|FG000|Overall Study|Other|46|||
143495453|NCT02026063|517356033|FG000|Overall Study|Physician Decision|0|||
143495454|NCT02026063|517356034|FG001|Overall Study|Physician Decision|10|||
143495455|NCT02026063|517356033|FG000|Overall Study|Noncompliance with Study Drug|1|||
143495456|NCT02026063|517356034|FG001|Overall Study|Noncompliance with Study Drug|1|||
143495457|NCT02026063|517356033|FG000|Overall Study|Withdrawal of Consent|1|||
143495458|NCT02026063|517356034|FG001|Overall Study|Withdrawal of Consent|6|||
143495459|NCT02026063|517356033|FG000|Overall Study|Adverse Event|5|||
143495460|NCT02026063|517356034|FG001|Overall Study|Adverse Event|20|||
143495461|NCT02026063|517356033|FG000|Overall Study|Lack of Efficacy|0|||
143495462|NCT02026063|517356034|FG001|Overall Study|Lack of Efficacy|4|||
143495463|NCT02026063|517356033|FG000|Overall Study|Lost to Follow-up|0|||
143495464|NCT02026063|517356034|FG001|Overall Study|Lost to Follow-up|1|||
143495465|NCT02026063|517356033|FG000|Overall Study|Reason not Specified|2|||
143495466|NCT02026063|517356034|FG001|Overall Study|Reason not Specified|7|||
143495467|NCT02154087|517356036|FG000|Overall Study|Study Termination|1|||
143495468|NCT00486278|517356041|FG000|Overall Study|Adverse Event|5|||
143495469|NCT00486278|517356041|FG000|Overall Study|Withdrawal by Subject|2|||
143495470|NCT00486278|517356041|FG000|Overall Study|Physician Decision|2|||
143495471|NCT04556617|517356047|FG000|Overall Study|progressive disease|0|||
143495472|NCT04556617|517356048|FG001|Overall Study|progressive disease|2|||
143495473|NCT04556617|517356049|FG002|Overall Study|progressive disease|2|||
143495474|NCT04556617|517356050|FG003|Overall Study|progressive disease|1|||
143495475|NCT04556617|517356051|FG004|Overall Study|progressive disease|1|||
143495476|NCT04556617|517356047|FG000|Overall Study|Physician Decision|0|||
143495477|NCT04556617|517356048|FG001|Overall Study|Physician Decision|0|||
143495478|NCT04556617|517356049|FG002|Overall Study|Physician Decision|2|||
143495479|NCT04556617|517356050|FG003|Overall Study|Physician Decision|0|||
143495480|NCT04556617|517356051|FG004|Overall Study|Physician Decision|0|||
143495481|NCT04556617|517356047|FG000|Overall Study|Adverse Event|0|||
143495482|NCT04556617|517356048|FG001|Overall Study|Adverse Event|0|||
143495483|NCT04556617|517356049|FG002|Overall Study|Adverse Event|2|||
143495484|NCT04556617|517356050|FG003|Overall Study|Adverse Event|3|||
143495485|NCT04556617|517356051|FG004|Overall Study|Adverse Event|0|||
143161084|NCT00004228|516135453|FG006|Overall Study|ineligible|5|||
143495486|NCT04556617|517356047|FG000|Overall Study|Withdrawal by Subject|0|||
143495487|NCT04556617|517356048|FG001|Overall Study|Withdrawal by Subject|2|||
143495488|NCT04556617|517356049|FG002|Overall Study|Withdrawal by Subject|1|||
143495489|NCT04556617|517356050|FG003|Overall Study|Withdrawal by Subject|1|||
143495490|NCT04556617|517356051|FG004|Overall Study|Withdrawal by Subject|0|||
143495491|NCT04556617|517356047|FG000|Overall Study|PSA increase|0|||
143495492|NCT04556617|517356048|FG001|Overall Study|PSA increase|1|||
143161085|NCT02255279|516135454|FG000|Overall Study|Lost to Follow-up|2|||
143161086|NCT02255279|516135455|FG001|Overall Study|Lost to Follow-up|2|||
143161087|NCT02255279|516135454|FG000|Overall Study|Protocol Violation|0|||
143161088|NCT02255279|516135455|FG001|Overall Study|Protocol Violation|1|||
143495493|NCT04556617|517356049|FG002|Overall Study|PSA increase|0|||
143495494|NCT04556617|517356050|FG003|Overall Study|PSA increase|0|||
143495495|NCT04556617|517356051|FG004|Overall Study|PSA increase|0|||
143495496|NCT04556617|517356047|FG000|Overall Study|Sponsor study termination|1|||
143495497|NCT04556617|517356048|FG001|Overall Study|Sponsor study termination|0|||
143495498|NCT04556617|517356049|FG002|Overall Study|Sponsor study termination|0|||
143495499|NCT04556617|517356050|FG003|Overall Study|Sponsor study termination|0|||
143495500|NCT04556617|517356051|FG004|Overall Study|Sponsor study termination|0|||
143495501|NCT05702736|517356052|FG000|Overall Study|2 patients didn't participate in the study voluntarily.|2|||
143495502|NCT05702736|517356053|FG001|Overall Study|2 patients didn't participate in the study voluntarily.|0|||
143495503|NCT05702736|517356052|FG000|Overall Study|2 patients didn't complete 6 interviews.|2|||
143495504|NCT05702736|517356053|FG001|Overall Study|2 patients didn't complete 6 interviews.|0|||
143495505|NCT02937350|517356056|FG000|Overall Study|Withdrawal by Subject|0|||
143495506|NCT02937350|517356057|FG001|Overall Study|Withdrawal by Subject|1|||
143495507|NCT02937350|517356058|FG002|Overall Study|Withdrawal by Subject|0|||
143495508|NCT01462266|517356059|FG000|Overall Study|Adverse Event|7|||
143495509|NCT01462266|517356060|FG001|Overall Study|Adverse Event|6|||
143495510|NCT01462266|517356059|FG000|Overall Study|Death|2|||
143034766|NCT00440557|515669791|FG001|Overall Study|Began Dialysis|1|||
143034767|NCT00440557|515669792|FG002|Overall Study|Began Dialysis|4|||
143034768|NCT00440557|515669790|FG000|Overall Study|Principal Investigator decision|0|||
143034769|NCT00440557|515669791|FG001|Overall Study|Principal Investigator decision|3|||
143161089|NCT02255279|516135454|FG000|Overall Study|Withdrawal by Subject|3|||
143161090|NCT02255279|516135455|FG001|Overall Study|Withdrawal by Subject|6|||
143161091|NCT00432991|516135456|FG000|Overall Study|Protocol Violation|7|||
143161092|NCT00432991|516135457|FG001|Overall Study|Protocol Violation|12|||
143161093|NCT00363467|516135458|FG000|Overall Study|Physician Decision|1|||
143161094|NCT03142451|516135459|FG000|Overall Study|Adverse Event|5|||
143161095|NCT03142451|516135460|FG001|Overall Study|Adverse Event|2|||
143161096|NCT03142451|516135459|FG000|Overall Study|Lost to Follow-up|25|||
143161097|NCT03142451|516135460|FG001|Overall Study|Lost to Follow-up|8|||
143034770|NCT00440557|515669792|FG002|Overall Study|Principal Investigator decision|1|||
143034771|NCT00440557|515669790|FG000|Overall Study|Patient moved|1|||
143034772|NCT00440557|515669791|FG001|Overall Study|Patient moved|2|||
143034773|NCT00440557|515669792|FG002|Overall Study|Patient moved|1|||
143034774|NCT00440557|515669790|FG000|Overall Study|Principal Investigator's office closed|3|||
143034775|NCT00440557|515669791|FG001|Overall Study|Principal Investigator's office closed|6|||
143034776|NCT00440557|515669792|FG002|Overall Study|Principal Investigator's office closed|4|||
143034777|NCT00440557|515669790|FG000|Overall Study|Patient transferred to nursing home|0|||
143034778|NCT00440557|515669791|FG001|Overall Study|Patient transferred to nursing home|1|||
143034779|NCT00440557|515669792|FG002|Overall Study|Patient transferred to nursing home|0|||
143034780|NCT00440557|515669790|FG000|Overall Study|Patient had surgery|1|||
143034781|NCT00440557|515669791|FG001|Overall Study|Patient had surgery|0|||
143034782|NCT00440557|515669792|FG002|Overall Study|Patient had surgery|0|||
143034783|NCT01126736|515669793|FG000|Overall Study|Death|2|||
143034784|NCT01126736|515669794|FG001|Overall Study|Death|2|||
143034785|NCT01126736|515669795|FG002|Overall Study|Death|1|||
143034786|NCT01126736|515669796|FG003|Overall Study|Death|19|||
143034787|NCT01126736|515669797|FG004|Overall Study|Death|19|||
143034788|NCT01126736|515669793|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
143034789|NCT01126736|515669794|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
143034790|NCT01126736|515669795|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
143034791|NCT01126736|515669796|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
143034792|NCT01126736|515669797|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
143034793|NCT01126736|515669793|FG000|Overall Study|Lost to Follow-up|0|||
143034794|NCT01126736|515669794|FG001|Overall Study|Lost to Follow-up|0|||
143034795|NCT01126736|515669795|FG002|Overall Study|Lost to Follow-up|0|||
143034796|NCT01126736|515669796|FG003|Overall Study|Lost to Follow-up|1|||
143034797|NCT01126736|515669797|FG004|Overall Study|Lost to Follow-up|1|||
143034798|NCT01126736|515669793|FG000|Overall Study|Administrative reasons|0|||
143034799|NCT01126736|515669794|FG001|Overall Study|Administrative reasons|0|||
143034800|NCT01126736|515669795|FG002|Overall Study|Administrative reasons|0|||
143034801|NCT01126736|515669796|FG003|Overall Study|Administrative reasons|0|||
143034802|NCT01126736|515669797|FG004|Overall Study|Administrative reasons|1|||
143034803|NCT01126736|515669793|FG000|Overall Study|Progressive disease|0|||
143034804|NCT01126736|515669794|FG001|Overall Study|Progressive disease|0|||
143034805|NCT01126736|515669795|FG002|Overall Study|Progressive disease|0|||
143161098|NCT03142451|516135459|FG000|Overall Study|Participant request|24|||
143161099|NCT03142451|516135460|FG001|Overall Study|Participant request|12|||
143161100|NCT03142451|516135459|FG000|Overall Study|Protocol Violation|3|||
143161101|NCT03142451|516135460|FG001|Overall Study|Protocol Violation|1|||
143495511|NCT01462266|517356060|FG001|Overall Study|Death|1|||
143495512|NCT01462266|517356059|FG000|Overall Study|Lack of Efficacy|0|||
143495513|NCT01462266|517356060|FG001|Overall Study|Lack of Efficacy|2|||
143495514|NCT01462266|517356059|FG000|Overall Study|Lost to Follow-up|4|||
143495515|NCT01462266|517356060|FG001|Overall Study|Lost to Follow-up|3|||
143495516|NCT01462266|517356059|FG000|Overall Study|Non-compliance with study drug|3|||
143495517|NCT01462266|517356060|FG001|Overall Study|Non-compliance with study drug|0|||
143034806|NCT01126736|515669796|FG003|Overall Study|Progressive disease|2|||
143034807|NCT01126736|515669797|FG004|Overall Study|Progressive disease|1|||
143161102|NCT03142451|516135459|FG000|Overall Study|Other|1|||
143034808|NCT01126736|515669793|FG000|Overall Study|Withdrawal by Subject|0|||
143034809|NCT01126736|515669794|FG001|Overall Study|Withdrawal by Subject|0|||
143034810|NCT01126736|515669795|FG002|Overall Study|Withdrawal by Subject|0|||
143034811|NCT01126736|515669796|FG003|Overall Study|Withdrawal by Subject|1|||
143034812|NCT01126736|515669797|FG004|Overall Study|Withdrawal by Subject|1|||
143034813|NCT01126736|515669793|FG000|Overall Study|Other|2|||
143034814|NCT01126736|515669794|FG001|Overall Study|Other|4|||
143034815|NCT01126736|515669795|FG002|Overall Study|Other|4|||
143034816|NCT01126736|515669796|FG003|Overall Study|Other|16|||
143034817|NCT01126736|515669797|FG004|Overall Study|Other|15|||
143034818|NCT00877032|515669798|FG000|Overall Study|Did not meet entrance criteria|0|||
143034819|NCT00877032|515669799|FG001|Overall Study|Did not meet entrance criteria|0|||
143034820|NCT00877032|515669800|FG002|Overall Study|Did not meet entrance criteria|0|||
143034821|NCT00877032|515669801|FG003|Overall Study|Did not meet entrance criteria|1|||
143034822|NCT00877032|515669802|FG004|Overall Study|Did not meet entrance criteria|0|||
143034823|NCT00877032|515669803|FG005|Overall Study|Did not meet entrance criteria|0|||
143034824|NCT00877032|515669804|FG006|Overall Study|Did not meet entrance criteria|2|||
143034825|NCT02107092|515669807|FG000|Overall Study|Miscellaneous|3|||
143034826|NCT02107092|515669807|FG000|Overall Study|Subject compliance|3|||
143034827|NCT02107092|515669807|FG000|Overall Study|Hypo-or hyperkalemia|2|||
143034828|NCT02107092|515669807|FG000|Overall Study|Met ECG withdrawal criteria|3|||
143034829|NCT02107092|515669807|FG000|Overall Study|Physician Decision|3|||
143034830|NCT02107092|515669807|FG000|Overall Study|Lost to Follow-up|2|||
143034831|NCT02107092|515669807|FG000|Overall Study|Withdrawal by Subject|9|||
143034832|NCT02107092|515669807|FG000|Overall Study|Adverse Event|7|||
143034833|NCT02107092|515669807|FG000|Overall Study|Expected progression of CKD|12|||
143034834|NCT04213326|515669812|FG000|Overall Study|Consent withdrawn|51|||
143034835|NCT04213326|515669813|FG001|Overall Study|Consent withdrawn|241|||
143034836|NCT04213326|515669812|FG000|Overall Study|Lost to Follow-up|50|||
143034837|NCT04213326|515669813|FG001|Overall Study|Lost to Follow-up|902|||
143034838|NCT04213326|515669812|FG000|Overall Study|Protocol Violation|3|||
143034839|NCT04213326|515669813|FG001|Overall Study|Protocol Violation|25|||
143034840|NCT04213326|515669812|FG000|Overall Study|Participant eligibility changed|106|||
143034841|NCT04213326|515669813|FG001|Overall Study|Participant eligibility changed|19|||
143034842|NCT04213326|515669812|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
143034843|NCT04213326|515669813|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
143034844|NCT04213326|515669812|FG000|Overall Study|Incomplete study visit|0|||
143034845|NCT04213326|515669813|FG001|Overall Study|Incomplete study visit|367|||
143034846|NCT04625114|515669816|FG000|Overall Study|Adverse Event|3|||
143034847|NCT04625114|515669817|FG001|Overall Study|Adverse Event|1|||
143034848|NCT04625114|515669816|FG000|Overall Study|Withdrawal by Subject|2|||
143034849|NCT04625114|515669817|FG001|Overall Study|Withdrawal by Subject|0|||
143034850|NCT01629381|515669818|FG000|Overall Study|Withdrawal by Subject|2|||
143034851|NCT01629381|515669819|FG001|Overall Study|Withdrawal by Subject|5|||
143034852|NCT02849652|515669827|FG000|Overall Study|Lost to Follow-up|104|||
143034853|NCT02849652|515669828|FG001|Overall Study|Lost to Follow-up|35|||
143034854|NCT02849652|515669829|FG002|Overall Study|Lost to Follow-up|116|||
143034855|NCT02849652|515669830|FG003|Overall Study|Lost to Follow-up|22|||
143034856|NCT02849652|515669827|FG000|Overall Study|Withdrawal by Subject|10|||
143034857|NCT02849652|515669828|FG001|Overall Study|Withdrawal by Subject|2|||
143034858|NCT02849652|515669829|FG002|Overall Study|Withdrawal by Subject|8|||
143034859|NCT02849652|515669830|FG003|Overall Study|Withdrawal by Subject|4|||
143034860|NCT02079766|515669831|FG000|Overall Study|Physician Decision|1|||
143034861|NCT02079766|515669832|FG001|Overall Study|Physician Decision|0|||
143034862|NCT02079766|515669831|FG000|Overall Study|Withdrawal by Subject|1|||
143034863|NCT02079766|515669832|FG001|Overall Study|Withdrawal by Subject|0|||
143034864|NCT02781727|515669833|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
143034865|NCT02781727|515669834|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
143034866|NCT02781727|515669833|FG000|Treatment Period|Withdrawal by Subject|1|||
143034867|NCT02781727|515669834|FG001|Treatment Period|Withdrawal by Subject|0|||
143034868|NCT02781727|515669833|FG000|Treatment Period|Lost to Follow-up|0|||
143034869|NCT02781727|515669834|FG001|Treatment Period|Lost to Follow-up|1|||
143034870|NCT03018249|515669838|FG000|Overall Study|Withdrawal by Subject|2|||
143034871|NCT03018249|515669839|FG001|Overall Study|Withdrawal by Subject|2|||
143034872|NCT01044732|515669840|FG000|Overall Study|Lost to Follow-up|2|||
143034873|NCT01044732|515669841|FG001|Overall Study|Lost to Follow-up|1|||
143034874|NCT01044732|515669840|FG000|Overall Study|Physician Decision|5|||
143034875|NCT01044732|515669841|FG001|Overall Study|Physician Decision|3|||
143034876|NCT01044732|515669840|FG000|Overall Study|Protocol Violation|11|||
143034877|NCT01044732|515669841|FG001|Overall Study|Protocol Violation|12|||
143034878|NCT01044732|515669840|FG000|Overall Study|Withdrawal by Subject|0|||
143034879|NCT01044732|515669841|FG001|Overall Study|Withdrawal by Subject|1|||
143034880|NCT01044732|515669840|FG000|Overall Study|Inadequate bowel preparation|11|||
143034881|NCT01044732|515669841|FG001|Overall Study|Inadequate bowel preparation|17|||
143034882|NCT01044732|515669840|FG000|Overall Study|Inability to reach cecum|5|||
143034883|NCT01044732|515669841|FG001|Overall Study|Inability to reach cecum|2|||
143034884|NCT01044732|515669840|FG000|Overall Study|Technical error or malfunction|15|||
143238584|NCT03739203|516427519|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
143034885|NCT01044732|515669841|FG001|Overall Study|Technical error or malfunction|14|||
143034886|NCT01378975|515669842|FG000|Overall Study|Death|77|||
143034887|NCT01378975|515669843|FG001|Overall Study|Death|46|||
143034888|NCT01378975|515669842|FG000|Overall Study|Investigator Request|1|||
143034889|NCT01378975|515669843|FG001|Overall Study|Investigator Request|0|||
143034890|NCT01378975|515669842|FG000|Overall Study|Lost to Follow-up|4|||
143034891|NCT01378975|515669843|FG001|Overall Study|Lost to Follow-up|1|||
143034892|NCT01378975|515669842|FG000|Overall Study|Withdrew Consent|4|||
143034893|NCT01378975|515669843|FG001|Overall Study|Withdrew Consent|3|||
143034894|NCT03125200|515669853|FG000|Overall Study|Study Termination|0|||
143034895|NCT03125200|515669854|FG001|Overall Study|Study Termination|0|||
143034896|NCT03125200|515669855|FG002|Overall Study|Study Termination|0|||
143034897|NCT03125200|515669856|FG003|Overall Study|Study Termination|1|||
143034898|NCT03125200|515669857|FG004|Overall Study|Study Termination|1|||
143034899|NCT03125200|515669858|FG005|Overall Study|Study Termination|2|||
143034900|NCT03125200|515669859|FG006|Overall Study|Study Termination|1|||
143034901|NCT03125200|515669853|FG000|Overall Study|Clinical Progression|0|||
143034902|NCT03125200|515669854|FG001|Overall Study|Clinical Progression|0|||
143034903|NCT03125200|515669855|FG002|Overall Study|Clinical Progression|0|||
143034904|NCT03125200|515669856|FG003|Overall Study|Clinical Progression|1|||
143034905|NCT03125200|515669857|FG004|Overall Study|Clinical Progression|0|||
143034906|NCT03125200|515669858|FG005|Overall Study|Clinical Progression|1|||
143034907|NCT03125200|515669859|FG006|Overall Study|Clinical Progression|0|||
143034908|NCT03125200|515669853|FG000|Overall Study|Progressive Disease|2|||
143034909|NCT03125200|515669854|FG001|Overall Study|Progressive Disease|1|||
143034910|NCT03125200|515669855|FG002|Overall Study|Progressive Disease|2|||
143034911|NCT03125200|515669856|FG003|Overall Study|Progressive Disease|1|||
143034912|NCT03125200|515669857|FG004|Overall Study|Progressive Disease|2|||
143034913|NCT03125200|515669858|FG005|Overall Study|Progressive Disease|0|||
143034914|NCT03125200|515669859|FG006|Overall Study|Progressive Disease|1|||
143034915|NCT03125200|515669853|FG000|Overall Study|Lack of Efficacy|0|||
143034916|NCT03125200|515669854|FG001|Overall Study|Lack of Efficacy|0|||
143034917|NCT03125200|515669855|FG002|Overall Study|Lack of Efficacy|0|||
143034918|NCT03125200|515669856|FG003|Overall Study|Lack of Efficacy|1|||
143034919|NCT03125200|515669857|FG004|Overall Study|Lack of Efficacy|0|||
143034920|NCT03125200|515669858|FG005|Overall Study|Lack of Efficacy|0|||
143034921|NCT03125200|515669859|FG006|Overall Study|Lack of Efficacy|0|||
143034922|NCT03125200|515669853|FG000|Overall Study|Toxicity|0|||
143034923|NCT03125200|515669854|FG001|Overall Study|Toxicity|0|||
143034924|NCT03125200|515669855|FG002|Overall Study|Toxicity|0|||
143034925|NCT03125200|515669856|FG003|Overall Study|Toxicity|1|||
143034926|NCT03125200|515669857|FG004|Overall Study|Toxicity|0|||
143034927|NCT03125200|515669858|FG005|Overall Study|Toxicity|0|||
143034928|NCT03125200|515669859|FG006|Overall Study|Toxicity|0|||
143034929|NCT03125200|515669853|FG000|Overall Study|Consent Withdrawn by Subject|0|||
143034930|NCT03125200|515669854|FG001|Overall Study|Consent Withdrawn by Subject|1|||
143034931|NCT03125200|515669855|FG002|Overall Study|Consent Withdrawn by Subject|0|||
143034932|NCT03125200|515669856|FG003|Overall Study|Consent Withdrawn by Subject|0|||
143034933|NCT03125200|515669857|FG004|Overall Study|Consent Withdrawn by Subject|1|||
143034934|NCT03125200|515669858|FG005|Overall Study|Consent Withdrawn by Subject|0|||
143034935|NCT03125200|515669859|FG006|Overall Study|Consent Withdrawn by Subject|1|||
143034936|NCT00694551|515669860|FG000|Overall Study|Disease Progression|1|||
143034937|NCT00694551|515669861|FG001|Overall Study|Disease Progression|0|||
143034938|NCT00694551|515669862|FG002|Overall Study|Disease Progression|1|||
143034939|NCT01937390|515669866|FG000|Overall Study|Death|2|||
143238585|NCT03739203|516427520|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
143238586|NCT03739203|516427518|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
143238587|NCT03739203|516427519|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
143238588|NCT03739203|516427520|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
143238589|NCT03739203|516427518|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
143034940|NCT01937390|515669866|FG000|Overall Study|Lost to Follow-up|7|||
143034941|NCT01937390|515669866|FG000|Overall Study|Withdrawal by Subject|5|||
143034942|NCT01937390|515669866|FG000|Overall Study|Fail to return|21|||
143034943|NCT03544138|515669869|FG000|Overall Study|Lost to Follow-up|29|||
143034944|NCT03144687|515669876|FG000|Overall Study|Death|0|||
143238590|NCT03739203|516427519|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
143238591|NCT03739203|516427520|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
143034945|NCT03144687|515669877|FG001|Overall Study|Death|2|||
143034946|NCT03144687|515669876|FG000|Overall Study|Lost to Follow-up|0|||
143034947|NCT03144687|515669877|FG001|Overall Study|Lost to Follow-up|1|||
143034948|NCT03144687|515669876|FG000|Overall Study|Physician Decision|0|||
143034949|NCT03144687|515669877|FG001|Overall Study|Physician Decision|1|||
143034950|NCT03144687|515669876|FG000|Overall Study|Withdrawal by Subject|1|||
143034951|NCT03144687|515669877|FG001|Overall Study|Withdrawal by Subject|3|||
143034952|NCT03144687|515669876|FG000|Overall Study|Not Reported|2|||
143034953|NCT03144687|515669877|FG001|Overall Study|Not Reported|0|||
143034954|NCT01054599|515669882|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
143034955|NCT01054599|515669883|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
143034956|NCT01054599|515669882|FG000|Overall Study|Protocol Violation|1|||
143034957|NCT01054599|515669883|FG001|Overall Study|Protocol Violation|0|||
143034958|NCT01054599|515669882|FG000|Overall Study|Spells/seizure-like episodes|1|||
143034959|NCT01054599|515669883|FG001|Overall Study|Spells/seizure-like episodes|1|||
143034960|NCT01054599|515669882|FG000|Overall Study|Timing/scheduling difficulties|1|||
143034961|NCT01054599|515669883|FG001|Overall Study|Timing/scheduling difficulties|1|||
143034962|NCT01054599|515669882|FG000|Overall Study|Visual impairment, WTAR <80|0|||
143034963|NCT01054599|515669883|FG001|Overall Study|Visual impairment, WTAR <80|1|||
143034964|NCT01054599|515669882|FG000|Overall Study|Lost to Follow-up|0|||
143034965|NCT01054599|515669883|FG001|Overall Study|Lost to Follow-up|2|||
143034966|NCT01054599|515669882|FG000|Overall Study|Adverse Event|0|||
143034967|NCT01054599|515669883|FG001|Overall Study|Adverse Event|1|||
143034968|NCT01054599|515669882|FG000|Overall Study|Withdrawal by Subject|0|||
143034969|NCT01054599|515669883|FG001|Overall Study|Withdrawal by Subject|1|||
143034970|NCT00683293|515669884|FG000|Overall Study|Withdrawal by Subject|2|||
143034971|NCT00683293|515669885|FG001|Overall Study|Withdrawal by Subject|3|||
143034972|NCT00824265|515669892|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
143034973|NCT00824265|515669893|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
143034974|NCT00824265|515669892|FG000|Treatment Phase|Protocol Violation|1|||
143034975|NCT00824265|515669893|FG001|Treatment Phase|Protocol Violation|0|||
143034976|NCT00824265|515669892|FG000|Treatment Phase|Lost to Follow-up|1|||
143034977|NCT00824265|515669893|FG001|Treatment Phase|Lost to Follow-up|1|||
143034978|NCT00824265|515669892|FG000|Treatment Phase|Physician Decision|6|||
143034979|NCT00824265|515669893|FG001|Treatment Phase|Physician Decision|12|||
143034980|NCT00824265|515669892|FG000|Treatment Phase|Withdrawal by Subject|6|||
143034981|NCT00824265|515669893|FG001|Treatment Phase|Withdrawal by Subject|15|||
143034982|NCT00824265|515669892|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
143034983|NCT00824265|515669893|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
143034984|NCT00824265|515669892|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
143034985|NCT00824265|515669893|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
143034986|NCT01402947|515669894|FG000|First Intervention|Adverse Event|0|||
143034987|NCT01402947|515669895|FG001|First Intervention|Adverse Event|1|||
143034988|NCT00591630|515669896|FG000|Overall Study|Death|0|||
143034989|NCT00591630|515669897|FG001|Overall Study|Death|0|||
143034990|NCT00591630|515669898|FG002|Overall Study|Death|1|||
143034991|NCT00591630|515669899|FG003|Overall Study|Death|0|||
143034992|NCT01248247|515671465|FG000|Overall Study|Adverse Event|2|||
143034993|NCT01248247|515671466|FG001|Overall Study|Adverse Event|4|||
143034994|NCT01248247|515671467|FG002|Overall Study|Adverse Event|4|||
143034995|NCT01248247|515671468|FG003|Overall Study|Adverse Event|2|||
143034996|NCT01248247|515671465|FG000|Overall Study|Death|0|||
143034997|NCT01248247|515671466|FG001|Overall Study|Death|1|||
143034998|NCT01248247|515671467|FG002|Overall Study|Death|4|||
143034999|NCT01248247|515671468|FG003|Overall Study|Death|7|||
143035000|NCT01248247|515671465|FG000|Overall Study|Lost to Follow-up|0|||
143035001|NCT01248247|515671466|FG001|Overall Study|Lost to Follow-up|1|||
143035002|NCT01248247|515671467|FG002|Overall Study|Lost to Follow-up|1|||
143035003|NCT01248247|515671468|FG003|Overall Study|Lost to Follow-up|0|||
143035004|NCT01248247|515671465|FG000|Overall Study|Alternative treatment|0|||
143035005|NCT01248247|515671466|FG001|Overall Study|Alternative treatment|1|||
143364076|NCT03686683|516875530|FG000|Overall Study|Lost to Follow-up|23|||
143364077|NCT03686683|516875531|FG001|Overall Study|Lost to Follow-up|19|||
143035006|NCT01248247|515671467|FG002|Overall Study|Alternative treatment|0|||
143035007|NCT01248247|515671468|FG003|Overall Study|Alternative treatment|0|||
143035008|NCT01248247|515671465|FG000|Overall Study|Other|2|||
143035009|NCT01248247|515671466|FG001|Overall Study|Other|8|||
143035010|NCT01248247|515671467|FG002|Overall Study|Other|8|||
143035011|NCT01248247|515671468|FG003|Overall Study|Other|5|||
143035012|NCT01248247|515671465|FG000|Overall Study|Progression|18|||
143035013|NCT01248247|515671466|FG001|Overall Study|Progression|27|||
143035014|NCT01248247|515671467|FG002|Overall Study|Progression|56|||
143035015|NCT01248247|515671468|FG003|Overall Study|Progression|44|||
143035016|NCT01248247|515671465|FG000|Overall Study|Refuse further treatment|0|||
143035017|NCT01248247|515671466|FG001|Overall Study|Refuse further treatment|0|||
143035018|NCT01248247|515671467|FG002|Overall Study|Refuse further treatment|1|||
143035019|NCT01248247|515671468|FG003|Overall Study|Refuse further treatment|2|||
143035020|NCT01248247|515671465|FG000|Overall Study|Complicating disease|0|||
143035021|NCT01248247|515671466|FG001|Overall Study|Complicating disease|0|||
143035022|NCT01248247|515671467|FG002|Overall Study|Complicating disease|1|||
143035023|NCT01248247|515671468|FG003|Overall Study|Complicating disease|1|||
143035024|NCT04349917|515671471|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
143035025|NCT04349917|515671472|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
143161103|NCT03142451|516135460|FG001|Overall Study|Other|1|||
143161104|NCT00090402|516135461|FG000|Overall Study|Death|1|||
143161105|NCT00090402|516135462|FG001|Overall Study|Death|1|||
143161106|NCT00090402|516135463|FG002|Overall Study|Death|0|||
143161107|NCT00090402|516135461|FG000|Overall Study|subject moved|0|||
143161108|NCT00090402|516135462|FG001|Overall Study|subject moved|1|||
143161109|NCT00090402|516135463|FG002|Overall Study|subject moved|0|||
143161110|NCT00090402|516135461|FG000|Overall Study|stopped taking study medication|1|||
143161111|NCT00090402|516135462|FG001|Overall Study|stopped taking study medication|0|||
143035026|NCT04349917|515671471|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
143035027|NCT04349917|515671472|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
143035028|NCT04188106|515671473|FG000|Overall Study|Lost to Follow-up|5|||
143035029|NCT04188106|515671473|FG000|Overall Study|Non-Compliance|1|||
143035030|NCT00441467|515671474|FG000|Overall Study|Adverse Event|6|||
143238592|NCT03739203|516427518|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
143238593|NCT03739203|516427519|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
143161112|NCT00090402|516135463|FG002|Overall Study|stopped taking study medication|1|||
143161113|NCT03048019|516135466|FG000|Overall Study|Adverse Event|1|||
143495518|NCT01462266|517356059|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
143495519|NCT01462266|517356060|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
143035031|NCT00441467|515671474|FG000|Overall Study|Withdrawal by Subject|3|||
143035032|NCT00441467|515671474|FG000|Overall Study|Progressive disease|9|||
143035033|NCT02289963|515671475|FG000|Overall Study|Adverse Event|1|||
143035034|NCT02289963|515671476|FG001|Overall Study|Adverse Event|2|||
143035035|NCT02289963|515671475|FG000|Overall Study|Poor compliance to protocol|1|||
143035036|NCT02289963|515671476|FG001|Overall Study|Poor compliance to protocol|0|||
143035037|NCT02289963|515671475|FG000|Overall Study|Withdrawal by Subject|1|||
143035038|NCT02289963|515671476|FG001|Overall Study|Withdrawal by Subject|0|||
143035039|NCT02289963|515671475|FG000|Overall Study|Last injection missed|2|||
143035040|NCT02289963|515671476|FG001|Overall Study|Last injection missed|2|||
143035041|NCT02289963|515671475|FG000|Overall Study|End treatment visit outside visit window|0|||
143035042|NCT02289963|515671476|FG001|Overall Study|End treatment visit outside visit window|4|||
143161114|NCT03048019|516135467|FG001|Overall Study|Adverse Event|0|||
143035043|NCT02289963|515671475|FG000|Overall Study|Other than specified above|0|||
143035044|NCT02289963|515671476|FG001|Overall Study|Other than specified above|2|||
143161115|NCT00862277|516135468|FG000|Overall Study|Protocol Violation|1|||
143161116|NCT00862277|516135469|FG001|Overall Study|Protocol Violation|2|||
143161117|NCT00862277|516135470|FG002|Overall Study|Protocol Violation|5|||
143161118|NCT00382863|516135471|FG000|Overall Study|Death|9|||
143161119|NCT00382863|516135472|FG001|Overall Study|Death|9|||
143161120|NCT00382863|516135471|FG000|Overall Study|Lost to Follow-up|1|||
143161121|NCT00382863|516135472|FG001|Overall Study|Lost to Follow-up|2|||
143161122|NCT00382863|516135471|FG000|Overall Study|Withdrawal by Subject|5|||
143161123|NCT00382863|516135472|FG001|Overall Study|Withdrawal by Subject|25|||
143161124|NCT02451007|516135475|FG000|Overall Study|Withdrawal by Subject|4|||
143161125|NCT02451007|516135475|FG000|Overall Study|Adverse Event|1|||
143161126|NCT02451007|516135475|FG000|Overall Study|Disease Progression|2|||
143161127|NCT01716559|516135476|FG000|Overall Study|Adverse Event|11|||
143161128|NCT01716559|516135476|FG000|Overall Study|Death|21|||
143161129|NCT01716559|516135476|FG000|Overall Study|Withdrawal by Subject|4|||
143161130|NCT01716559|516135476|FG000|Overall Study|Other withdrawal reason|75|||
143161131|NCT00348374|516135477|FG000|Overall Study|Adverse Event|1|||
143161132|NCT00348374|516135478|FG001|Overall Study|Adverse Event|4|||
143161133|NCT00348374|516135477|FG000|Overall Study|Lost to Follow-up|1|||
143161134|NCT00348374|516135478|FG001|Overall Study|Lost to Follow-up|3|||
143161135|NCT00348374|516135477|FG000|Overall Study|Withdrawal by Subject|5|||
143161136|NCT00348374|516135478|FG001|Overall Study|Withdrawal by Subject|5|||
143161137|NCT00348374|516135477|FG000|Overall Study|Other|11|||
143161138|NCT00348374|516135478|FG001|Overall Study|Other|12|||
143161139|NCT00348374|516135477|FG000|Overall Study|ongoing at date of cutoff|1|||
143161140|NCT00348374|516135478|FG001|Overall Study|ongoing at date of cutoff|1|||
143161141|NCT00348374|516135477|FG000|Overall Study|randomized but did not receive treatment|0|||
143495520|NCT01462266|517356059|FG000|Overall Study|Physician Decision|2|||
143495521|NCT01462266|517356060|FG001|Overall Study|Physician Decision|5|||
143495522|NCT01462266|517356059|FG000|Overall Study|Protocol Violation|1|||
143495523|NCT01462266|517356060|FG001|Overall Study|Protocol Violation|3|||
143495524|NCT01462266|517356059|FG000|Overall Study|Withdrawal by Subject|7|||
143495525|NCT01462266|517356060|FG001|Overall Study|Withdrawal by Subject|2|||
143035045|NCT05017480|515671477|FG000|Stage 1 Study|Withdrawal by Subject|8|||
143035046|NCT05017480|515671478|FG001|Stage 1 Study|Withdrawal by Subject|6|||
143161142|NCT00348374|516135478|FG001|Overall Study|randomized but did not receive treatment|7|||
143161143|NCT02180672|516135491|FG000|Overall Study|Lost to Follow-up|5|||
143161144|NCT02180672|516135492|FG001|Overall Study|Lost to Follow-up|7|||
143161145|NCT00661687|516135494|FG000|Overall Study|Study related symptoms and complaints|5|||
143161146|NCT00661687|516135494|FG000|Overall Study|Positive slit lamp findings|4|||
143161147|NCT00661687|516135494|FG000|Overall Study|Inability to maintain wearing schedule|3|||
143161148|NCT00661687|516135494|FG000|Overall Study|Physician Decision|1|||
143364078|NCT03686683|516875530|FG000|Overall Study|Adverse Event|1|||
143495526|NCT01462266|517356059|FG000|Overall Study|Screen failure|1|||
143495527|NCT01462266|517356060|FG001|Overall Study|Screen failure|1|||
143035047|NCT05017480|515671479|FG002|Stage 1 Study|Withdrawal by Subject|0|||
143035048|NCT05017480|515671480|FG003|Stage 1 Study|Withdrawal by Subject|0|||
143035049|NCT05017480|515671481|FG004|Stage 1 Study|Withdrawal by Subject|0|||
143035050|NCT05017480|515671477|FG000|Stage 1 Study|Adverse Event|1|||
143035051|NCT05017480|515671478|FG001|Stage 1 Study|Adverse Event|1|||
143035052|NCT05017480|515671479|FG002|Stage 1 Study|Adverse Event|0|||
143035053|NCT05017480|515671480|FG003|Stage 1 Study|Adverse Event|0|||
143035054|NCT05017480|515671481|FG004|Stage 1 Study|Adverse Event|0|||
143035055|NCT05017480|515671477|FG000|Stage 1 Study|Poor Compliance|1|||
143035056|NCT05017480|515671478|FG001|Stage 1 Study|Poor Compliance|1|||
143035057|NCT05017480|515671479|FG002|Stage 1 Study|Poor Compliance|0|||
143035058|NCT05017480|515671480|FG003|Stage 1 Study|Poor Compliance|0|||
143035059|NCT05017480|515671481|FG004|Stage 1 Study|Poor Compliance|0|||
143035060|NCT05017480|515671477|FG000|Stage 1 Study|Physician Decision|0|||
143035061|NCT05017480|515671478|FG001|Stage 1 Study|Physician Decision|1|||
143035062|NCT05017480|515671479|FG002|Stage 1 Study|Physician Decision|0|||
143035063|NCT05017480|515671480|FG003|Stage 1 Study|Physician Decision|0|||
143035064|NCT05017480|515671481|FG004|Stage 1 Study|Physician Decision|0|||
143035065|NCT05017480|515671477|FG000|Stage 2 Study|Withdrawal by Subject|0|||
143035066|NCT05017480|515671478|FG001|Stage 2 Study|Withdrawal by Subject|0|||
143035067|NCT05017480|515671479|FG002|Stage 2 Study|Withdrawal by Subject|6|||
143035068|NCT05017480|515671480|FG003|Stage 2 Study|Withdrawal by Subject|9|||
143035069|NCT05017480|515671481|FG004|Stage 2 Study|Withdrawal by Subject|11|||
143035070|NCT05017480|515671477|FG000|Stage 2 Study|Lost to Follow-up|0|||
143035071|NCT05017480|515671478|FG001|Stage 2 Study|Lost to Follow-up|0|||
143035072|NCT05017480|515671479|FG002|Stage 2 Study|Lost to Follow-up|0|||
143035073|NCT05017480|515671480|FG003|Stage 2 Study|Lost to Follow-up|2|||
143035074|NCT05017480|515671481|FG004|Stage 2 Study|Lost to Follow-up|1|||
143035075|NCT05017480|515671477|FG000|Stage 2 Study|Adverse Event|0|||
143035076|NCT05017480|515671478|FG001|Stage 2 Study|Adverse Event|0|||
143035077|NCT05017480|515671479|FG002|Stage 2 Study|Adverse Event|0|||
143035078|NCT05017480|515671480|FG003|Stage 2 Study|Adverse Event|1|||
143035079|NCT05017480|515671481|FG004|Stage 2 Study|Adverse Event|0|||
143035080|NCT05017480|515671477|FG000|Stage 2 Study|COVID-19|0|||
143035081|NCT05017480|515671478|FG001|Stage 2 Study|COVID-19|0|||
143035082|NCT05017480|515671479|FG002|Stage 2 Study|COVID-19|0|||
143035083|NCT05017480|515671480|FG003|Stage 2 Study|COVID-19|1|||
143035084|NCT05017480|515671481|FG004|Stage 2 Study|COVID-19|0|||
143035085|NCT05017480|515671477|FG000|Stage 2 Study|Pregnancy|0|||
143035086|NCT05017480|515671478|FG001|Stage 2 Study|Pregnancy|0|||
143035087|NCT05017480|515671479|FG002|Stage 2 Study|Pregnancy|0|||
143035088|NCT05017480|515671480|FG003|Stage 2 Study|Pregnancy|0|||
143035089|NCT05017480|515671481|FG004|Stage 2 Study|Pregnancy|1|||
143035090|NCT02311361|515671482|FG000|Overall Study|Did not receive treatment|0|||
143035091|NCT02311361|515671483|FG001|Overall Study|Did not receive treatment|1|||
143035092|NCT02311361|515671484|FG002|Overall Study|Did not receive treatment|0|||
143035093|NCT02311361|515671485|FG003|Overall Study|Did not receive treatment|1|||
143035094|NCT02653664|515671486|FG000|Post-Treatment|Withdrawal by Subject|6|||
143495528|NCT00803179|517356063|FG000|Overall Study|Lost to Follow-up|3|||
143495529|NCT02419508|517356065|FG000|Overall Study|Adverse Event|9|||
143495530|NCT02419508|517356066|FG001|Overall Study|Adverse Event|3|||
143495531|NCT02419508|517356065|FG000|Overall Study|Withdrawal by Subject|1|||
143495532|NCT02419508|517356066|FG001|Overall Study|Withdrawal by Subject|0|||
143035095|NCT02653664|515671487|FG001|Post-Treatment|Withdrawal by Subject|5|||
143035096|NCT02653664|515671488|FG002|Post-Treatment|Withdrawal by Subject|7|||
143035097|NCT02653664|515671486|FG000|Post-Treatment|Lost to Follow-up|8|||
143035098|NCT02653664|515671487|FG001|Post-Treatment|Lost to Follow-up|1|||
143035099|NCT02653664|515671488|FG002|Post-Treatment|Lost to Follow-up|7|||
143035100|NCT02653664|515671486|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
143495533|NCT02419508|517356065|FG000|Overall Study|Other - Reason not specified|0|||
143495534|NCT02419508|517356066|FG001|Overall Study|Other - Reason not specified|1|||
143495535|NCT03110900|517356067|FG000|Overall Study|Sponsor withdrew|1|||
143495536|NCT03110900|517356068|FG001|Overall Study|Sponsor withdrew|1|||
143495537|NCT03355300|517356069|FG000|Overall Study|Physician Decision|0|||
143495538|NCT03355300|517356070|FG001|Overall Study|Physician Decision|1|||
143035101|NCT02653664|515671487|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
143035102|NCT02653664|515671488|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
143035103|NCT02653664|515671486|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
143035104|NCT02653664|515671487|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
143035105|NCT02653664|515671488|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
143035106|NCT02653664|515671486|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
143035107|NCT02653664|515671487|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
143035108|NCT02653664|515671488|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
143114900|NCT02326298|515962463|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
143238594|NCT03739203|516427520|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
143495539|NCT03355300|517356069|FG000|Overall Study|Lack of Efficacy|2|||
143495540|NCT03355300|517356070|FG001|Overall Study|Lack of Efficacy|1|||
143495541|NCT03355300|517356069|FG000|Overall Study|Other reason|1|||
143035109|NCT02653664|515671486|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
143035110|NCT02653664|515671487|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
143035111|NCT02653664|515671488|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
143035112|NCT02653664|515671486|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
143035113|NCT02653664|515671487|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
143035114|NCT02653664|515671488|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
143035115|NCT02653664|515671486|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
143035116|NCT02653664|515671487|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
143035117|NCT02653664|515671488|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
143035118|NCT02653664|515671486|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
143035119|NCT02653664|515671487|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
143035120|NCT02653664|515671488|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
143035121|NCT02653664|515671486|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
143035122|NCT02653664|515671487|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
143035123|NCT02653664|515671488|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
143035124|NCT01287013|515671489|FG000|Overall Study|Non-evaluable|3|||
143035125|NCT01287013|515671490|FG001|Overall Study|Non-evaluable|5|||
143035126|NCT01287013|515671491|FG002|Overall Study|Non-evaluable|21|||
143035127|NCT03247556|515671494|FG000|Overall Study|Adverse Event|1|||
143035128|NCT03247556|515671495|FG001|Overall Study|Adverse Event|4|||
143035129|NCT03247556|515671496|FG002|Overall Study|Adverse Event|5|||
143035130|NCT03247556|515671494|FG000|Overall Study|Lost to Follow-up|5|||
143035131|NCT03247556|515671495|FG001|Overall Study|Lost to Follow-up|5|||
143035132|NCT03247556|515671496|FG002|Overall Study|Lost to Follow-up|4|||
143035133|NCT03247556|515671494|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
143035134|NCT03247556|515671495|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
143035135|NCT03247556|515671496|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
143035136|NCT03247556|515671494|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
143035137|NCT03247556|515671495|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
143035138|NCT03247556|515671496|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
143035139|NCT03247556|515671494|FG000|Overall Study|Protocol Violation|2|||
143035140|NCT03247556|515671495|FG001|Overall Study|Protocol Violation|0|||
143035141|NCT03247556|515671496|FG002|Overall Study|Protocol Violation|1|||
143035142|NCT03247556|515671494|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
143035143|NCT03247556|515671495|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
143238595|NCT03739203|516427518|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
143238596|NCT03739203|516427519|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
143238597|NCT03739203|516427520|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
143238598|NCT03739203|516427518|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
143035144|NCT03247556|515671496|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
143238599|NCT03739203|516427519|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
143238600|NCT03739203|516427520|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
143495542|NCT03355300|517356070|FG001|Overall Study|Other reason|0|||
143495543|NCT00546052|517356071|FG000|Overall Study|Adverse Event|47|||
143495544|NCT00546052|517356071|FG000|Overall Study|Lost to Follow-up|144|||
143495545|NCT00546052|517356071|FG000|Overall Study|Protocol Violation|9|||
143495546|NCT00546052|517356071|FG000|Overall Study|Withdrawal by Subject|20|||
143238601|NCT03739203|516427518|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
143238602|NCT03739203|516427519|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
143238603|NCT03739203|516427520|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
143238604|NCT03739203|516427518|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
143238605|NCT03739203|516427519|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
143238606|NCT03739203|516427520|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
143238607|NCT01967940|516427523|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
143238608|NCT01967940|516427524|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
143238609|NCT01967940|516427525|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
143238610|NCT01967940|516427526|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
143238611|NCT01967940|516427523|FG000|Part 2|Adverse Event|0|||
143238612|NCT01967940|516427524|FG001|Part 2|Adverse Event|0|||
143495547|NCT00546052|517356071|FG000|Overall Study|Non Compliance|7|||
143495548|NCT01031446|517356082|FG000|Overall Study|Disease Progression|38|||
143495549|NCT01031446|517356082|FG000|Overall Study|Adverse Event|9|||
143495550|NCT01031446|517356082|FG000|Overall Study|Physician Decision|4|||
143035145|NCT01900730|515671500|FG000|Overall Study|Withdrawal by Subject|1|||
143035146|NCT01900730|515671501|FG001|Overall Study|Withdrawal by Subject|0|||
143035147|NCT01900730|515671500|FG000|Overall Study|Screen Failure|1|||
143035148|NCT01900730|515671501|FG001|Overall Study|Screen Failure|0|||
143035149|NCT00051025|515671502|FG000|Overall Study|Progressive Disease|1|||
143035150|NCT00051025|515671503|FG001|Overall Study|Progressive Disease|1|||
143238613|NCT01967940|516427525|FG002|Part 2|Adverse Event|0|||
143238614|NCT01967940|516427526|FG003|Part 2|Adverse Event|1|||
143495551|NCT01031446|517356082|FG000|Overall Study|Withdrawal by Subject|3|||
143495552|NCT01031446|517356082|FG000|Overall Study|Still on treatment|1|||
143035151|NCT00051025|515671502|FG000|Overall Study|Adverse Event|1|||
143035152|NCT00051025|515671503|FG001|Overall Study|Adverse Event|1|||
143035153|NCT00051025|515671502|FG000|Overall Study|Withdrawal by Subject|0|||
143035154|NCT00051025|515671503|FG001|Overall Study|Withdrawal by Subject|1|||
143035155|NCT00051025|515671502|FG000|Overall Study|Death|0|||
143035156|NCT00051025|515671503|FG001|Overall Study|Death|1|||
143035157|NCT01179048|515671504|FG000|Overall Study|Withdrawn - does not allow contact|4|||
143035158|NCT01179048|515671505|FG001|Overall Study|Withdrawn - does not allow contact|8|||
143035159|NCT01179048|515671504|FG000|Overall Study|Lost to Follow-up|8|||
143035160|NCT01179048|515671505|FG001|Overall Study|Lost to Follow-up|9|||
143035161|NCT01179048|515671504|FG000|Overall Study|Alive|127|||
143035162|NCT01179048|515671505|FG001|Overall Study|Alive|142|||
143035163|NCT02109042|515671506|FG000|Overall Study|Sponsor Decision|15|||
143035164|NCT03203447|515671507|FG000|Overall Study|Withdrawal by Subject|2|||
143035165|NCT03203447|515671508|FG001|Overall Study|Withdrawal by Subject|1|||
143035166|NCT03203447|515671507|FG000|Overall Study|Lost to Follow-up|1|||
143035167|NCT03203447|515671508|FG001|Overall Study|Lost to Follow-up|10|||
143035168|NCT03203447|515671507|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
143035169|NCT03203447|515671508|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
143035170|NCT01203878|515671509|FG000|Overall Study|Withdrawal by Subject|0|||
143035171|NCT01203878|515671510|FG001|Overall Study|Withdrawal by Subject|0|||
143035172|NCT01203878|515671511|FG002|Overall Study|Withdrawal by Subject|1|||
143035173|NCT01203878|515671509|FG000|Overall Study|Adverse Event|0|||
143035174|NCT01203878|515671510|FG001|Overall Study|Adverse Event|0|||
143035175|NCT01203878|515671511|FG002|Overall Study|Adverse Event|2|||
143035176|NCT00274937|515671512|FG000|Overall Study|Physician Decision|10|||
143035177|NCT00274937|515671512|FG000|Overall Study|Withdrawal by Subject|6|||
143035178|NCT00274937|515671512|FG000|Overall Study|Progressive Disease|4|||
143035179|NCT00528606|515671513|FG000|Overall Study|Withdrew consent|4|||
143035180|NCT00528606|515671514|FG001|Overall Study|Withdrew consent|3|||
143035181|NCT00528606|515671513|FG000|Overall Study|Lost to Follow-up|4|||
143035182|NCT00528606|515671514|FG001|Overall Study|Lost to Follow-up|1|||
143035183|NCT00528606|515671513|FG000|Overall Study|Adverse Event|3|||
143035184|NCT00528606|515671514|FG001|Overall Study|Adverse Event|0|||
143035185|NCT00528606|515671513|FG000|Overall Study|Other|2|||
143035186|NCT00528606|515671514|FG001|Overall Study|Other|0|||
143035187|NCT01918397|515671516|FG000|Overall Study|Never started treatment|2|||
143035188|NCT01918397|515671517|FG001|Overall Study|Never started treatment|1|||
143035189|NCT01918397|515671518|FG002|Overall Study|Never started treatment|0|||
143035190|NCT01918397|515671519|FG003|Overall Study|Never started treatment|0|||
143035191|NCT01918397|515671516|FG000|Overall Study|Adverse Event|1|||
143035192|NCT01918397|515671517|FG001|Overall Study|Adverse Event|1|||
143035193|NCT01918397|515671518|FG002|Overall Study|Adverse Event|1|||
143035194|NCT01918397|515671519|FG003|Overall Study|Adverse Event|0|||
143035195|NCT01918397|515671516|FG000|Overall Study|Lack of compliance|2|||
143035196|NCT01918397|515671517|FG001|Overall Study|Lack of compliance|2|||
143035197|NCT01918397|515671518|FG002|Overall Study|Lack of compliance|3|||
143035198|NCT01918397|515671519|FG003|Overall Study|Lack of compliance|0|||
143035199|NCT01918397|515671516|FG000|Overall Study|Pregnancy|0|||
143035200|NCT01918397|515671517|FG001|Overall Study|Pregnancy|1|||
143035201|NCT01918397|515671518|FG002|Overall Study|Pregnancy|0|||
143495553|NCT00500682|517356085|FG000|Overall Study|Adverse Event|37|||
143495554|NCT00500682|517356086|FG001|Overall Study|Adverse Event|29|||
143495555|NCT00500682|517356085|FG000|Overall Study|Death|25|||
143495556|NCT00500682|517356086|FG001|Overall Study|Death|16|||
143495557|NCT00500682|517356085|FG000|Overall Study|Lost to Follow-up|11|||
143495558|NCT00500682|517356086|FG001|Overall Study|Lost to Follow-up|11|||
143495559|NCT00500682|517356085|FG000|Overall Study|Physician Decision|6|||
143495560|NCT00500682|517356086|FG001|Overall Study|Physician Decision|10|||
143495561|NCT00500682|517356085|FG000|Overall Study|Pregnancy|2|||
143495562|NCT00500682|517356086|FG001|Overall Study|Pregnancy|0|||
143495563|NCT00500682|517356085|FG000|Overall Study|Protocol Violation|1|||
143495564|NCT00500682|517356086|FG001|Overall Study|Protocol Violation|3|||
143495565|NCT00500682|517356085|FG000|Overall Study|Withdrawal by Subject|80|||
143035202|NCT01918397|515671519|FG003|Overall Study|Pregnancy|0|||
143238615|NCT01967940|516427523|FG000|Part 2|Unknown Reason|0|||
143035203|NCT01918397|515671516|FG000|Overall Study|Rifampin susceptible|0|||
143035204|NCT01918397|515671517|FG001|Overall Study|Rifampin susceptible|0|||
143035205|NCT01918397|515671518|FG002|Overall Study|Rifampin susceptible|0|||
143035206|NCT01918397|515671519|FG003|Overall Study|Rifampin susceptible|2|||
143035207|NCT01918397|515671516|FG000|Overall Study|Treatment failure|0|||
143035208|NCT01918397|515671517|FG001|Overall Study|Treatment failure|0|||
143035209|NCT01918397|515671518|FG002|Overall Study|Treatment failure|0|||
143035210|NCT01918397|515671519|FG003|Overall Study|Treatment failure|1|||
143035211|NCT01918397|515671516|FG000|Overall Study|Withdrawal by Subject|3|||
143035212|NCT01918397|515671517|FG001|Overall Study|Withdrawal by Subject|2|||
143238616|NCT01967940|516427524|FG001|Part 2|Unknown Reason|0|||
143495566|NCT00500682|517356086|FG001|Overall Study|Withdrawal by Subject|74|||
143495567|NCT00500682|517356085|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
143035213|NCT01918397|515671518|FG002|Overall Study|Withdrawal by Subject|1|||
143035214|NCT01918397|515671519|FG003|Overall Study|Withdrawal by Subject|1|||
143035215|NCT01918397|515671516|FG000|Overall Study|XDR at baseline|0|||
143035216|NCT01918397|515671517|FG001|Overall Study|XDR at baseline|0|||
143035217|NCT01918397|515671518|FG002|Overall Study|XDR at baseline|1|||
143035218|NCT01918397|515671519|FG003|Overall Study|XDR at baseline|0|||
143035219|NCT01918397|515671516|FG000|Overall Study|Lost to Follow-up|2|||
143035220|NCT01918397|515671517|FG001|Overall Study|Lost to Follow-up|1|||
143035221|NCT01918397|515671518|FG002|Overall Study|Lost to Follow-up|1|||
143035222|NCT01918397|515671519|FG003|Overall Study|Lost to Follow-up|1|||
143035223|NCT01918397|515671516|FG000|Overall Study|Increased QTc|1|||
143035224|NCT01918397|515671517|FG001|Overall Study|Increased QTc|0|||
143035225|NCT01918397|515671518|FG002|Overall Study|Increased QTc|0|||
143035226|NCT01918397|515671519|FG003|Overall Study|Increased QTc|1|||
143035227|NCT01918397|515671516|FG000|Overall Study|Death|0|||
143035228|NCT01918397|515671517|FG001|Overall Study|Death|0|||
143035229|NCT01918397|515671518|FG002|Overall Study|Death|1|||
143035230|NCT01918397|515671519|FG003|Overall Study|Death|0|||
143035231|NCT01918397|515671516|FG000|Overall Study|Involved in another investigative trial|0|||
143035232|NCT01918397|515671517|FG001|Overall Study|Involved in another investigative trial|0|||
143035233|NCT01918397|515671518|FG002|Overall Study|Involved in another investigative trial|0|||
143035234|NCT01918397|515671519|FG003|Overall Study|Involved in another investigative trial|1|||
143035235|NCT00620022|515671520|FG000|Treatment Period 1|Adverse Event|4|||
143035236|NCT00620022|515671521|FG001|Treatment Period 1|Adverse Event|6|||
143035237|NCT00620022|515671520|FG000|Treatment Period 1|Subject withdrew consent|1|||
143035238|NCT00620022|515671521|FG001|Treatment Period 1|Subject withdrew consent|0|||
143035239|NCT00620022|515671520|FG000|Treatment Period 2|Adverse Event|2|||
143035240|NCT00620022|515671521|FG001|Treatment Period 2|Adverse Event|2|||
143035241|NCT02334722|515671525|FG000|Overall Study|Lost to Follow-up|4|||
143035242|NCT02334722|515671526|FG001|Overall Study|Lost to Follow-up|0|||
143035243|NCT02334722|515671525|FG000|Overall Study|6 week questionnaire not completed|2|||
143035244|NCT02334722|515671526|FG001|Overall Study|6 week questionnaire not completed|0|||
143035245|NCT02334722|515671525|FG000|Overall Study|Unable to obtain medication|1|||
143035246|NCT02334722|515671526|FG001|Overall Study|Unable to obtain medication|1|||
143035247|NCT02334722|515671525|FG000|Overall Study|Withdrawal by Subject|0|||
143035248|NCT02334722|515671526|FG001|Overall Study|Withdrawal by Subject|3|||
143035249|NCT02334722|515671525|FG000|Overall Study|Adverse Event|0|||
143035250|NCT02334722|515671526|FG001|Overall Study|Adverse Event|2|||
143035251|NCT02334722|515671525|FG000|Overall Study|Physician Decision|0|||
143035252|NCT02334722|515671526|FG001|Overall Study|Physician Decision|1|||
143035253|NCT00150462|515671532|FG000|Overall Study|Disease Progression or Relapse|3|||
143035254|NCT00150462|515671533|FG001|Overall Study|Disease Progression or Relapse|1|||
143035255|NCT00150462|515671534|FG002|Overall Study|Disease Progression or Relapse|2|||
143035256|NCT00150462|515671535|FG003|Overall Study|Disease Progression or Relapse|1|||
143035257|NCT00150462|515671536|FG004|Overall Study|Disease Progression or Relapse|2|||
143035258|NCT00150462|515671537|FG005|Overall Study|Disease Progression or Relapse|2|||
143035259|NCT00150462|515671538|FG006|Overall Study|Disease Progression or Relapse|3|||
143035260|NCT00150462|515671539|FG007|Overall Study|Disease Progression or Relapse|5|||
143035261|NCT00150462|515671540|FG008|Overall Study|Disease Progression or Relapse|5|||
143035262|NCT00150462|515671541|FG009|Overall Study|Disease Progression or Relapse|3|||
143035263|NCT00150462|515671542|FG010|Overall Study|Disease Progression or Relapse|2|||
143035264|NCT00150462|515671532|FG000|Overall Study|Withdrawal by Subject|0|||
143035265|NCT00150462|515671533|FG001|Overall Study|Withdrawal by Subject|1|||
143035266|NCT00150462|515671534|FG002|Overall Study|Withdrawal by Subject|1|||
143238617|NCT01967940|516427525|FG002|Part 2|Unknown Reason|0|||
143238618|NCT01967940|516427526|FG003|Part 2|Unknown Reason|1|||
143238619|NCT01663103|516427527|FG000|Overall Study|Withdrawal by Subject|1|||
143238620|NCT01663103|516427528|FG001|Overall Study|Withdrawal by Subject|2|||
143238621|NCT01663103|516427527|FG000|Overall Study|Adverse Event|1|||
143238622|NCT01663103|516427528|FG001|Overall Study|Adverse Event|0|||
143238623|NCT01663103|516427527|FG000|Overall Study|dog bite|1|||
143238624|NCT01663103|516427528|FG001|Overall Study|dog bite|0|||
143238625|NCT01656408|516427529|FG000|Overall Study|Adverse Event|0|||
143035267|NCT00150462|515671535|FG003|Overall Study|Withdrawal by Subject|0|||
143035268|NCT00150462|515671536|FG004|Overall Study|Withdrawal by Subject|1|||
143035269|NCT00150462|515671537|FG005|Overall Study|Withdrawal by Subject|2|||
143035270|NCT00150462|515671538|FG006|Overall Study|Withdrawal by Subject|0|||
143035271|NCT00150462|515671539|FG007|Overall Study|Withdrawal by Subject|1|||
143035272|NCT00150462|515671540|FG008|Overall Study|Withdrawal by Subject|0|||
143035273|NCT00150462|515671541|FG009|Overall Study|Withdrawal by Subject|1|||
143035274|NCT00150462|515671542|FG010|Overall Study|Withdrawal by Subject|0|||
143035275|NCT00150462|515671532|FG000|Overall Study|Death|0|||
143035276|NCT00150462|515671533|FG001|Overall Study|Death|1|||
143035277|NCT00150462|515671534|FG002|Overall Study|Death|0|||
143238626|NCT01656408|516427530|FG001|Overall Study|Adverse Event|0|||
143238627|NCT01656408|516427531|FG002|Overall Study|Adverse Event|1|||
143238628|NCT01656408|516427532|FG003|Overall Study|Adverse Event|0|||
143035278|NCT00150462|515671535|FG003|Overall Study|Death|0|||
143035279|NCT00150462|515671536|FG004|Overall Study|Death|0|||
143035280|NCT00150462|515671537|FG005|Overall Study|Death|0|||
143035281|NCT00150462|515671538|FG006|Overall Study|Death|0|||
143035282|NCT00150462|515671539|FG007|Overall Study|Death|0|||
143035283|NCT00150462|515671540|FG008|Overall Study|Death|1|||
143035284|NCT00150462|515671541|FG009|Overall Study|Death|0|||
143035285|NCT00150462|515671542|FG010|Overall Study|Death|0|||
143035286|NCT00150462|515671532|FG000|Overall Study|Adverse Event|0|||
143035287|NCT00150462|515671533|FG001|Overall Study|Adverse Event|0|||
143035288|NCT00150462|515671534|FG002|Overall Study|Adverse Event|0|||
143035289|NCT00150462|515671535|FG003|Overall Study|Adverse Event|1|||
143035290|NCT00150462|515671536|FG004|Overall Study|Adverse Event|0|||
143035291|NCT00150462|515671537|FG005|Overall Study|Adverse Event|0|||
143035292|NCT00150462|515671538|FG006|Overall Study|Adverse Event|0|||
143035293|NCT00150462|515671539|FG007|Overall Study|Adverse Event|2|||
143035294|NCT00150462|515671540|FG008|Overall Study|Adverse Event|0|||
143035295|NCT00150462|515671541|FG009|Overall Study|Adverse Event|1|||
143035296|NCT00150462|515671542|FG010|Overall Study|Adverse Event|0|||
143035297|NCT00150462|515671532|FG000|Overall Study|Physician Decision|0|||
143035298|NCT00150462|515671533|FG001|Overall Study|Physician Decision|0|||
143035299|NCT00150462|515671534|FG002|Overall Study|Physician Decision|1|||
143035300|NCT00150462|515671535|FG003|Overall Study|Physician Decision|1|||
143035301|NCT00150462|515671536|FG004|Overall Study|Physician Decision|0|||
143035302|NCT00150462|515671537|FG005|Overall Study|Physician Decision|0|||
143035303|NCT00150462|515671538|FG006|Overall Study|Physician Decision|0|||
143035304|NCT00150462|515671539|FG007|Overall Study|Physician Decision|0|||
143035305|NCT00150462|515671540|FG008|Overall Study|Physician Decision|0|||
143035306|NCT00150462|515671541|FG009|Overall Study|Physician Decision|0|||
143035307|NCT00150462|515671542|FG010|Overall Study|Physician Decision|0|||
143035308|NCT00150462|515671532|FG000|Overall Study|Other|0|||
143035309|NCT00150462|515671533|FG001|Overall Study|Other|0|||
143035310|NCT00150462|515671534|FG002|Overall Study|Other|0|||
143035311|NCT00150462|515671535|FG003|Overall Study|Other|0|||
143035312|NCT00150462|515671536|FG004|Overall Study|Other|0|||
143035313|NCT00150462|515671537|FG005|Overall Study|Other|0|||
143035314|NCT00150462|515671538|FG006|Overall Study|Other|0|||
143035315|NCT00150462|515671539|FG007|Overall Study|Other|0|||
143035316|NCT00150462|515671540|FG008|Overall Study|Other|0|||
143035317|NCT00150462|515671541|FG009|Overall Study|Other|1|||
143035318|NCT00150462|515671542|FG010|Overall Study|Other|1|||
143035319|NCT01434693|515671545|FG000|Overall Study|Adverse Event|1|||
143035320|NCT01434693|515671546|FG001|Overall Study|Adverse Event|0|||
143035321|NCT01434693|515671547|FG002|Overall Study|Adverse Event|0|||
143035322|NCT01434693|515671548|FG003|Overall Study|Adverse Event|0|||
143035323|NCT01434693|515671545|FG000|Overall Study|Withdrawal by Subject|1|||
143035324|NCT01434693|515671546|FG001|Overall Study|Withdrawal by Subject|0|||
143035325|NCT01434693|515671547|FG002|Overall Study|Withdrawal by Subject|1|||
143035326|NCT01434693|515671548|FG003|Overall Study|Withdrawal by Subject|1|||
143035327|NCT01434693|515671545|FG000|Overall Study|Lost to Follow-up|1|||
143035328|NCT01434693|515671546|FG001|Overall Study|Lost to Follow-up|0|||
143035329|NCT01434693|515671547|FG002|Overall Study|Lost to Follow-up|0|||
143495568|NCT00500682|517356086|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
143495569|NCT02531646|517356089|FG000|Overall Study|equip. image processing issue|5|||
143495570|NCT02531646|517356090|FG001|Overall Study|equip. image processing issue|1|||
143495571|NCT02531646|517356091|FG002|Overall Study|equip. image processing issue|0|||
143495572|NCT02320487|517356092|FG000|Overall Study|Reason not Specified|1|||
143035330|NCT01434693|515671548|FG003|Overall Study|Lost to Follow-up|0|||
143035331|NCT02087904|515671551|FG000|Overall Study|Did Not Receive Study Drug|0|||
143035332|NCT02087904|515671552|FG001|Overall Study|Did Not Receive Study Drug|0|||
143035333|NCT02087904|515671553|FG002|Overall Study|Did Not Receive Study Drug|2|||
143035334|NCT02087904|515671554|FG003|Overall Study|Did Not Receive Study Drug|1|||
143035335|NCT02087904|515671551|FG000|Overall Study|Adverse Event|8|||
143035336|NCT02087904|515671552|FG001|Overall Study|Adverse Event|4|||
143035337|NCT02087904|515671553|FG002|Overall Study|Adverse Event|4|||
143035338|NCT02087904|515671554|FG003|Overall Study|Adverse Event|12|||
143035339|NCT02087904|515671551|FG000|Overall Study|Lack of Efficacy|3|||
143035340|NCT02087904|515671552|FG001|Overall Study|Lack of Efficacy|6|||
143035341|NCT02087904|515671553|FG002|Overall Study|Lack of Efficacy|3|||
143161149|NCT00661687|516135494|FG000|Overall Study|Adverse Event|2|||
143161150|NCT01362530|516135495|FG000|Base Study (Cycle 1)|Adverse Event|2|||
143161151|NCT01362530|516135496|FG001|Base Study (Cycle 1)|Adverse Event|0|||
143035342|NCT02087904|515671554|FG003|Overall Study|Lack of Efficacy|2|||
143035343|NCT02087904|515671551|FG000|Overall Study|Other|6|||
143035344|NCT02087904|515671552|FG001|Overall Study|Other|2|||
143035345|NCT02087904|515671553|FG002|Overall Study|Other|4|||
143035346|NCT02087904|515671554|FG003|Overall Study|Other|4|||
143035347|NCT02087904|515671551|FG000|Overall Study|Withdrawal by Subject|8|||
143035348|NCT02087904|515671552|FG001|Overall Study|Withdrawal by Subject|3|||
143035349|NCT02087904|515671553|FG002|Overall Study|Withdrawal by Subject|7|||
143495573|NCT02320487|517356092|FG000|Overall Study|Physician Decision|5|||
143035350|NCT02087904|515671554|FG003|Overall Study|Withdrawal by Subject|4|||
143035351|NCT02087904|515671551|FG000|Overall Study|Lost to Follow-up|0|||
143035352|NCT02087904|515671552|FG001|Overall Study|Lost to Follow-up|4|||
143035353|NCT02087904|515671553|FG002|Overall Study|Lost to Follow-up|2|||
143035354|NCT02087904|515671554|FG003|Overall Study|Lost to Follow-up|2|||
143035355|NCT01196052|515671556|FG000|Overall Study|Adverse Event|9|||
143035356|NCT01196052|515671556|FG000|Overall Study|Lost to Follow-up|1|||
143035357|NCT01196052|515671556|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
143035358|NCT01196052|515671556|FG000|Overall Study|Reason not Specified|5|||
143035359|NCT01196052|515671556|FG000|Overall Study|Withdrawal by Subject|6|||
143035360|NCT02178722|515671557|FG000|Overall Study|Withdrawal by Subject|0|||
143035361|NCT02178722|515671558|FG001|Overall Study|Withdrawal by Subject|0|||
143035362|NCT02178722|515671559|FG002|Overall Study|Withdrawal by Subject|0|||
143035363|NCT02178722|515671560|FG003|Overall Study|Withdrawal by Subject|2|||
143035364|NCT02178722|515671561|FG004|Overall Study|Withdrawal by Subject|33|||
143035365|NCT02178722|515671557|FG000|Overall Study|Death|2|||
143035366|NCT02178722|515671558|FG001|Overall Study|Death|13|||
143035367|NCT02178722|515671559|FG002|Overall Study|Death|12|||
143035368|NCT02178722|515671560|FG003|Overall Study|Death|12|||
143035369|NCT02178722|515671561|FG004|Overall Study|Death|205|||
143035370|NCT02178722|515671557|FG000|Overall Study|Lost to Follow-up|0|||
143035371|NCT02178722|515671558|FG001|Overall Study|Lost to Follow-up|0|||
143035372|NCT02178722|515671559|FG002|Overall Study|Lost to Follow-up|0|||
143035373|NCT02178722|515671560|FG003|Overall Study|Lost to Follow-up|2|||
143035374|NCT02178722|515671561|FG004|Overall Study|Lost to Follow-up|11|||
143035375|NCT02178722|515671557|FG000|Overall Study|Study terminated by Sponsor|2|||
143035376|NCT02178722|515671558|FG001|Overall Study|Study terminated by Sponsor|7|||
143035377|NCT02178722|515671559|FG002|Overall Study|Study terminated by Sponsor|6|||
143035378|NCT02178722|515671560|FG003|Overall Study|Study terminated by Sponsor|4|||
143035379|NCT02178722|515671561|FG004|Overall Study|Study terminated by Sponsor|128|||
143035380|NCT02178722|515671557|FG000|Overall Study|Physician Decision|0|||
143035381|NCT02178722|515671558|FG001|Overall Study|Physician Decision|0|||
143035382|NCT02178722|515671559|FG002|Overall Study|Physician Decision|0|||
143035383|NCT02178722|515671560|FG003|Overall Study|Physician Decision|0|||
143035384|NCT02178722|515671561|FG004|Overall Study|Physician Decision|3|||
143035385|NCT02178722|515671557|FG000|Overall Study|Other|0|||
143035386|NCT02178722|515671558|FG001|Overall Study|Other|0|||
143035387|NCT02178722|515671559|FG002|Overall Study|Other|0|||
143035388|NCT02178722|515671560|FG003|Overall Study|Other|0|||
143035389|NCT02178722|515671561|FG004|Overall Study|Other|2|||
143035390|NCT03340727|515671562|FG000|Overall Study|Death|1|||
143035391|NCT03340727|515671563|FG001|Overall Study|Death|0|||
143035392|NCT03340727|515671562|FG000|Overall Study|Lost to Follow-up|31|||
143161152|NCT01362530|516135495|FG000|Base Study (Cycle 1)|Physician Decision|0|||
143161153|NCT01362530|516135496|FG001|Base Study (Cycle 1)|Physician Decision|1|||
143161154|NCT01362530|516135495|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
143035393|NCT03340727|515671563|FG001|Overall Study|Lost to Follow-up|35|||
143035394|NCT03340727|515671562|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
143035395|NCT03340727|515671563|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
143035396|NCT03340727|515671562|FG000|Overall Study|Transferred to another facility|10|||
143035397|NCT03340727|515671563|FG001|Overall Study|Transferred to another facility|7|||
143035398|NCT03340727|515671562|FG000|Overall Study|Withdrawal by Subject|28|||
143035399|NCT03340727|515671563|FG001|Overall Study|Withdrawal by Subject|17|||
143035400|NCT03553823|515671564|FG000|Overall Study|Physician Decision|0|||
143035401|NCT03553823|515671565|FG001|Overall Study|Physician Decision|1|||
143035402|NCT03603314|515671566|FG000|Overall Study|Lost to Follow-up|0|||
143035403|NCT03603314|515671567|FG001|Overall Study|Lost to Follow-up|3|||
143035404|NCT03603314|515671568|FG002|Overall Study|Lost to Follow-up|0|||
143035405|NCT03603314|515671566|FG000|Overall Study|Protocol Violation|0|||
143161155|NCT01362530|516135496|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
143161156|NCT01362530|516135495|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
143495574|NCT02320487|517356092|FG000|Overall Study|Withdrawal by Subject|1|||
143495575|NCT02320487|517356092|FG000|Overall Study|Death|3|||
143495576|NCT02320487|517356092|FG000|Overall Study|Adverse Event|11|||
143035406|NCT03603314|515671567|FG001|Overall Study|Protocol Violation|1|||
143035407|NCT03603314|515671568|FG002|Overall Study|Protocol Violation|0|||
143035408|NCT03603314|515671566|FG000|Overall Study|Adverse Event|2|||
143035409|NCT03603314|515671567|FG001|Overall Study|Adverse Event|0|||
143035410|NCT03603314|515671568|FG002|Overall Study|Adverse Event|0|||
143035411|NCT03603314|515671566|FG000|Overall Study|Physician Decision|1|||
143035412|NCT03603314|515671567|FG001|Overall Study|Physician Decision|1|||
143035413|NCT03603314|515671568|FG002|Overall Study|Physician Decision|0|||
143035414|NCT03603314|515671566|FG000|Overall Study|Withdrawal by Subject|4|||
143035415|NCT03603314|515671567|FG001|Overall Study|Withdrawal by Subject|5|||
143035416|NCT03603314|515671568|FG002|Overall Study|Withdrawal by Subject|3|||
143035417|NCT03603314|515671566|FG000|Overall Study|Other|0|||
143035418|NCT03603314|515671567|FG001|Overall Study|Other|1|||
143035419|NCT03603314|515671568|FG002|Overall Study|Other|0|||
143035420|NCT03450070|515671569|FG000|Overall Study|Withdrawal by Subject|8|||
143035421|NCT00050778|515671570|FG000|Overall Study|Adverse Event|13|||
143035422|NCT00050778|515671571|FG001|Overall Study|Adverse Event|3|||
143035423|NCT00050778|515671572|FG002|Overall Study|Adverse Event|2|||
143035424|NCT00050778|515671570|FG000|Overall Study|Death|0|||
143035425|NCT00050778|515671571|FG001|Overall Study|Death|1|||
143035426|NCT00050778|515671572|FG002|Overall Study|Death|1|||
143035427|NCT00050778|515671570|FG000|Overall Study|Lack of Efficacy|16|||
143035428|NCT00050778|515671571|FG001|Overall Study|Lack of Efficacy|2|||
143035429|NCT00050778|515671572|FG002|Overall Study|Lack of Efficacy|2|||
143035430|NCT00050778|515671570|FG000|Overall Study|Lost to Follow-up|0|||
143035431|NCT00050778|515671571|FG001|Overall Study|Lost to Follow-up|2|||
143035432|NCT00050778|515671572|FG002|Overall Study|Lost to Follow-up|4|||
143035433|NCT00050778|515671570|FG000|Overall Study|Physician Decision|3|||
143035434|NCT00050778|515671571|FG001|Overall Study|Physician Decision|0|||
143035435|NCT00050778|515671572|FG002|Overall Study|Physician Decision|2|||
143035436|NCT00050778|515671570|FG000|Overall Study|Protocol Violation|2|||
143035437|NCT00050778|515671571|FG001|Overall Study|Protocol Violation|0|||
143035438|NCT00050778|515671572|FG002|Overall Study|Protocol Violation|1|||
143035439|NCT00050778|515671570|FG000|Overall Study|Withdrawal by Subject|6|||
143035440|NCT00050778|515671571|FG001|Overall Study|Withdrawal by Subject|8|||
143035441|NCT00050778|515671572|FG002|Overall Study|Withdrawal by Subject|4|||
143035442|NCT00050778|515671570|FG000|Overall Study|Randomized but not treated|4|||
143035443|NCT00050778|515671571|FG001|Overall Study|Randomized but not treated|5|||
143035444|NCT00050778|515671572|FG002|Overall Study|Randomized but not treated|2|||
143035445|NCT00050778|515671570|FG000|Overall Study|Familial and personal reasons|1|||
143035446|NCT00050778|515671571|FG001|Overall Study|Familial and personal reasons|0|||
143035447|NCT00050778|515671572|FG002|Overall Study|Familial and personal reasons|0|||
143035448|NCT02015390|515671575|FG000|Overall Study|Lost to Follow-up|1|||
143035449|NCT02015390|515671576|FG001|Overall Study|Lost to Follow-up|0|||
143035450|NCT02015390|515671575|FG000|Overall Study|Adverse Event|0|||
143035451|NCT02015390|515671576|FG001|Overall Study|Adverse Event|3|||
143035452|NCT02015390|515671575|FG000|Overall Study|Physician Decision|0|||
143035453|NCT02015390|515671576|FG001|Overall Study|Physician Decision|1|||
143035454|NCT00064753|515671579|FG000|Overall Study|Death|251|||
143035455|NCT00064753|515671580|FG001|Overall Study|Death|242|||
143035456|NCT00064753|515671579|FG000|Overall Study|Withdrawal by Subject|198|||
143035457|NCT00064753|515671580|FG001|Overall Study|Withdrawal by Subject|171|||
143035458|NCT00064753|515671579|FG000|Overall Study|Lost to Follow-up|225|||
143035459|NCT00064753|515671580|FG001|Overall Study|Lost to Follow-up|235|||
143035460|NCT02193880|515671581|FG000|Overall Study|patients did not collect enough HPC|3|||
143035461|NCT01661686|515671585|FG000|Overall Study|Lost to Follow-up|2|||
143035462|NCT01661686|515671586|FG001|Overall Study|Lost to Follow-up|1|||
143035463|NCT01661686|515671585|FG000|Overall Study|did not receive allocated intervention|0|||
143035464|NCT01661686|515671586|FG001|Overall Study|did not receive allocated intervention|1|||
143035465|NCT00533273|515671587|FG000|Double-blind|Withdrew consent|0|||
143035466|NCT00533273|515671588|FG001|Double-blind|Withdrew consent|2|||
143035467|NCT00533273|515671587|FG000|Open-label|Withdrawal by Subject|6|||
143035468|NCT00533273|515671588|FG001|Open-label|Withdrawal by Subject|0|||
143035469|NCT00615069|515671590|FG000|Overall Study|Death|10|||
143035470|NCT00615069|515671590|FG000|Overall Study|Physician Decision|2|||
143035471|NCT00615069|515671590|FG000|Overall Study|Withdrawal by Subject|4|||
143035472|NCT00669942|515671591|FG000|Parts 2 and 3|Adverse Event|0|||
143035473|NCT00669942|515671592|FG001|Parts 2 and 3|Adverse Event|0|||
143035474|NCT00669942|515671593|FG002|Parts 2 and 3|Adverse Event|0|||
143035475|NCT00669942|515671594|FG003|Parts 2 and 3|Adverse Event|0|||
143495577|NCT00684957|517356095|FG000|Overall Study|Withdrawal by Subject|1|||
143495578|NCT00684957|517356096|FG001|Overall Study|Withdrawal by Subject|1|||
143495579|NCT00684957|517356095|FG000|Overall Study|Lost to Follow-up|1|||
143495580|NCT00684957|517356096|FG001|Overall Study|Lost to Follow-up|0|||
143495581|NCT01220414|517357666|FG000|Overall Study|Withdrawal by Subject|1|||
143495582|NCT01220414|517357667|FG001|Overall Study|Withdrawal by Subject|0|||
143495583|NCT01220414|517357668|FG002|Overall Study|Withdrawal by Subject|0|||
143035476|NCT00669942|515671595|FG004|Parts 2 and 3|Adverse Event|0|||
143161157|NCT01362530|516135496|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
143161158|NCT01362530|516135495|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
143161159|NCT01362530|516135496|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
143161160|NCT01362530|516135495|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
143161161|NCT01362530|516135496|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
143035477|NCT00669942|515671596|FG005|Parts 2 and 3|Adverse Event|0|||
143161162|NCT01362530|516135495|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
143364079|NCT03686683|516875531|FG001|Overall Study|Adverse Event|0|||
143035478|NCT00669942|515671597|FG006|Parts 2 and 3|Adverse Event|0|||
143035479|NCT00669942|515671598|FG007|Parts 2 and 3|Adverse Event|2|||
143035480|NCT00669942|515671599|FG008|Parts 2 and 3|Adverse Event|1|||
143035481|NCT00669942|515671600|FG009|Parts 2 and 3|Adverse Event|0|||
143035482|NCT00669942|515671601|FG010|Parts 2 and 3|Adverse Event|0|||
143035483|NCT00669942|515671602|FG011|Parts 2 and 3|Adverse Event|0|||
143035484|NCT00669942|515671591|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
143035485|NCT00669942|515671592|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
143035486|NCT00669942|515671593|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
143035487|NCT00669942|515671594|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
143035488|NCT00669942|515671595|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
143035489|NCT00669942|515671596|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
143035490|NCT00669942|515671597|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
143035491|NCT00669942|515671598|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
143035492|NCT00669942|515671599|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
143035493|NCT00669942|515671600|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
143035494|NCT00669942|515671601|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
143035495|NCT00669942|515671602|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
143035496|NCT00669942|515671591|FG000|Parts 2 and 3|Protocol Violation|0|||
143035497|NCT00669942|515671592|FG001|Parts 2 and 3|Protocol Violation|0|||
143035498|NCT00669942|515671593|FG002|Parts 2 and 3|Protocol Violation|0|||
143035499|NCT00669942|515671594|FG003|Parts 2 and 3|Protocol Violation|0|||
143035500|NCT00669942|515671595|FG004|Parts 2 and 3|Protocol Violation|0|||
143035501|NCT00669942|515671596|FG005|Parts 2 and 3|Protocol Violation|1|||
143035502|NCT00669942|515671597|FG006|Parts 2 and 3|Protocol Violation|0|||
143035503|NCT00669942|515671598|FG007|Parts 2 and 3|Protocol Violation|0|||
143035504|NCT00669942|515671599|FG008|Parts 2 and 3|Protocol Violation|0|||
143035505|NCT00669942|515671600|FG009|Parts 2 and 3|Protocol Violation|0|||
143035506|NCT00669942|515671601|FG010|Parts 2 and 3|Protocol Violation|0|||
143035507|NCT00669942|515671602|FG011|Parts 2 and 3|Protocol Violation|0|||
143035508|NCT02996682|515671603|FG000|Overall Study|Death|0|||
143035509|NCT02996682|515671604|FG001|Overall Study|Death|3|||
143035510|NCT00259012|515671606|FG000|Overall Study|Adverse Event|0|||
143035511|NCT00259012|515671607|FG001|Overall Study|Adverse Event|1|||
143035512|NCT00259012|515671606|FG000|Overall Study|Withdrawal by Subject|1|||
143035513|NCT00259012|515671607|FG001|Overall Study|Withdrawal by Subject|0|||
143035514|NCT00259012|515671606|FG000|Overall Study|Physician Decision|0|||
143035515|NCT00259012|515671607|FG001|Overall Study|Physician Decision|1|||
143035516|NCT00259012|515671606|FG000|Overall Study|Lost to Follow-up|0|||
143035517|NCT00259012|515671607|FG001|Overall Study|Lost to Follow-up|1|||
143035518|NCT00259012|515671606|FG000|Overall Study|Protocol Violation|1|||
143035519|NCT00259012|515671607|FG001|Overall Study|Protocol Violation|1|||
143035520|NCT03002077|515671608|FG000|Overall Study|Non-compliance with Study Drug|4|||
143035521|NCT03002077|515671608|FG000|Overall Study|Non-compliance w/Background ADT|1|||
143035522|NCT03002077|515671608|FG000|Overall Study|Study Terminated by Sponsor|257|||
143035523|NCT03002077|515671608|FG000|Overall Study|Site Terminated by Sponsor|5|||
143035524|NCT03002077|515671608|FG000|Overall Study|Miscellaneous Reasons|10|||
143035525|NCT03002077|515671608|FG000|Overall Study|Adverse Event|23|||
143035526|NCT03002077|515671608|FG000|Overall Study|Lack of Efficacy|20|||
143035527|NCT03002077|515671608|FG000|Overall Study|Withdrawal by Subject|72|||
143035528|NCT03002077|515671608|FG000|Overall Study|Lost to Follow-up|21|||
143035529|NCT03002077|515671608|FG000|Overall Study|Pregnancy|4|||
143035530|NCT03002077|515671608|FG000|Overall Study|Protocol Violation|21|||
143035531|NCT00854308|515671615|FG000|Overall Study|Disease progression|42|||
143035532|NCT00854308|515671616|FG001|Overall Study|Disease progression|50|||
143035533|NCT00854308|515671615|FG000|Overall Study|Adverse Event|8|||
143035534|NCT00854308|515671616|FG001|Overall Study|Adverse Event|3|||
143035535|NCT00854308|515671615|FG000|Overall Study|Death|2|||
143161163|NCT01362530|516135496|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
143161164|NCT01362530|516135495|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
143035536|NCT00854308|515671616|FG001|Overall Study|Death|5|||
143035537|NCT00854308|515671615|FG000|Overall Study|Physician Decision|6|||
143035538|NCT00854308|515671616|FG001|Overall Study|Physician Decision|6|||
143035539|NCT00854308|515671615|FG000|Overall Study|Withdrawal by Subject|4|||
143035540|NCT00854308|515671616|FG001|Overall Study|Withdrawal by Subject|2|||
143035541|NCT00854308|515671615|FG000|Overall Study|Sponsor's decision to terminate study|0|||
143035542|NCT00854308|515671616|FG001|Overall Study|Sponsor's decision to terminate study|1|||
143035543|NCT01390844|515671617|FG000|Treatment Phase|Adverse Event|12|||
143035544|NCT01390844|515671618|FG001|Treatment Phase|Adverse Event|2|||
143035545|NCT01390844|515671619|FG002|Treatment Phase|Adverse Event|3|||
143035546|NCT01390844|515671620|FG003|Treatment Phase|Adverse Event|2|||
143035547|NCT01390844|515671617|FG000|Treatment Phase|Treatment Failure|23|||
143035548|NCT01390844|515671618|FG001|Treatment Phase|Treatment Failure|25|||
143035549|NCT01390844|515671619|FG002|Treatment Phase|Treatment Failure|10|||
143035550|NCT01390844|515671620|FG003|Treatment Phase|Treatment Failure|13|||
143035551|NCT01390844|515671617|FG000|Treatment Phase|Non-Medical Reasons|5|||
143035552|NCT01390844|515671618|FG001|Treatment Phase|Non-Medical Reasons|1|||
143035553|NCT01390844|515671619|FG002|Treatment Phase|Non-Medical Reasons|8|||
143035554|NCT01390844|515671620|FG003|Treatment Phase|Non-Medical Reasons|1|||
143035555|NCT01390844|515671617|FG000|Treatment Phase|Non-GCP Compliant|0|||
143035556|NCT01390844|515671618|FG001|Treatment Phase|Non-GCP Compliant|0|||
143035557|NCT01390844|515671619|FG002|Treatment Phase|Non-GCP Compliant|10|||
143035558|NCT01390844|515671620|FG003|Treatment Phase|Non-GCP Compliant|3|||
143035559|NCT01390844|515671617|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
143035560|NCT01390844|515671618|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
143035561|NCT01390844|515671619|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
143035562|NCT01390844|515671620|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
143495584|NCT01220414|517357669|FG003|Overall Study|Withdrawal by Subject|1|||
143495585|NCT03068325|517357674|FG000|Overall Study|Lost to Follow-up|5|||
143495586|NCT00168831|517357675|FG000|Overall Study|Adverse Event|36|||
143495587|NCT00168831|517357676|FG001|Overall Study|Adverse Event|47|||
143495588|NCT00168831|517357677|FG002|Overall Study|Adverse Event|74|||
143495589|NCT00168831|517357675|FG000|Overall Study|Lost to Follow-up|5|||
143035563|NCT03048500|515671623|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
143035564|NCT03048500|515671623|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
143035565|NCT03048500|515671623|FG000|Reached 1st Response/Continued Treatment|Death|1|||
143035566|NCT03048500|515671623|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
143035567|NCT03048500|515671623|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
143035568|NCT03048500|515671623|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
143035569|NCT03048500|515671623|FG000|Follow up for 3 Years|Death|12|||
143035570|NCT01941030|515671626|FG000|Overall Study|Death|3|||
143035571|NCT01941030|515671627|FG001|Overall Study|Death|2|||
143035572|NCT01941030|515671626|FG000|Overall Study|Lost to Follow-up|6|||
143035573|NCT01941030|515671627|FG001|Overall Study|Lost to Follow-up|5|||
143035574|NCT01941030|515671626|FG000|Overall Study|Withdrawal by Subject|4|||
143035575|NCT01941030|515671627|FG001|Overall Study|Withdrawal by Subject|6|||
143035576|NCT00304083|515671631|FG000|Overall Study|Withdrawal by Subject|4|||
143035577|NCT00304083|515671632|FG001|Overall Study|Withdrawal by Subject|2|||
143035578|NCT00304083|515671631|FG000|Overall Study|Physician Decision|8|||
143035579|NCT00304083|515671632|FG001|Overall Study|Physician Decision|3|||
143035580|NCT00304083|515671631|FG000|Overall Study|Disease Progression|5|||
143035581|NCT00304083|515671632|FG001|Overall Study|Disease Progression|1|||
143035582|NCT00304083|515671631|FG000|Overall Study|Other|5|||
143035583|NCT00304083|515671632|FG001|Overall Study|Other|2|||
143035584|NCT03991494|515671633|FG000|Overall Study|Progressive Disease|4|||
143035585|NCT00705536|515673238|FG000|Start Period 1|Withdrawal by Subject|0|||
143035586|NCT00705536|515673239|FG001|Start Period 1|Withdrawal by Subject|0|||
143035587|NCT00705536|515673240|FG002|Start Period 1|Withdrawal by Subject|0|||
143035588|NCT00705536|515673241|FG003|Start Period 1|Withdrawal by Subject|1|||
143035589|NCT01042522|515673242|FG000|Overall Study|Adverse Event|1|||
143035590|NCT01042522|515673243|FG001|Overall Study|Adverse Event|2|||
143035591|NCT01042522|515673242|FG000|Overall Study|Disease Progression|5|||
143035592|NCT01042522|515673243|FG001|Overall Study|Disease Progression|0|||
143035593|NCT01042522|515673242|FG000|Overall Study|Death|1|||
143035594|NCT01042522|515673243|FG001|Overall Study|Death|0|||
143035595|NCT01042522|515673242|FG000|Overall Study|Patient Refused|0|||
143035596|NCT01042522|515673243|FG001|Overall Study|Patient Refused|3|||
143035597|NCT01042522|515673242|FG000|Overall Study|Withdrawal by Subject|1|||
143035598|NCT01042522|515673243|FG001|Overall Study|Withdrawal by Subject|1|||
143035599|NCT00549718|515673246|FG000|Overall Study|Insufficient clinical response|20|||
143035600|NCT00549718|515673247|FG001|Overall Study|Insufficient clinical response|7|||
143035601|NCT00549718|515673248|FG002|Overall Study|Insufficient clinical response|18|||
143035602|NCT00549718|515673249|FG003|Overall Study|Insufficient clinical response|32|||
143035603|NCT00549718|515673246|FG000|Overall Study|Adverse Event|6|||
143035604|NCT00549718|515673247|FG001|Overall Study|Adverse Event|8|||
143035605|NCT00549718|515673248|FG002|Overall Study|Adverse Event|7|||
143035606|NCT00549718|515673249|FG003|Overall Study|Adverse Event|3|||
143035607|NCT00549718|515673246|FG000|Overall Study|Lost to Follow-up|4|||
143035608|NCT00549718|515673247|FG001|Overall Study|Lost to Follow-up|2|||
143035609|NCT00549718|515673248|FG002|Overall Study|Lost to Follow-up|0|||
143035610|NCT00549718|515673249|FG003|Overall Study|Lost to Follow-up|6|||
143035611|NCT00549718|515673246|FG000|Overall Study|Withdrawal by Subject|9|||
143035612|NCT00549718|515673247|FG001|Overall Study|Withdrawal by Subject|18|||
143035613|NCT00549718|515673248|FG002|Overall Study|Withdrawal by Subject|12|||
143035614|NCT00549718|515673249|FG003|Overall Study|Withdrawal by Subject|13|||
143035615|NCT00549718|515673246|FG000|Overall Study|Administrative|2|||
143035616|NCT00549718|515673247|FG001|Overall Study|Administrative|2|||
143035617|NCT00549718|515673248|FG002|Overall Study|Administrative|2|||
143035618|NCT00549718|515673249|FG003|Overall Study|Administrative|1|||
143035619|NCT01746017|515673250|FG000|Period 1|Withdrawal by Subject|0|||
143035620|NCT01746017|515673251|FG001|Period 1|Withdrawal by Subject|0|||
143035621|NCT01746017|515673252|FG002|Period 1|Withdrawal by Subject|0|||
143161165|NCT01362530|516135496|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
143161166|NCT01362530|516135495|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
143161167|NCT01362530|516135496|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
143495590|NCT00168831|517357676|FG001|Overall Study|Lost to Follow-up|6|||
143495591|NCT00168831|517357677|FG002|Overall Study|Lost to Follow-up|4|||
143035622|NCT01746017|515673253|FG003|Period 1|Withdrawal by Subject|0|||
143035623|NCT01746017|515673254|FG004|Period 1|Withdrawal by Subject|0|||
143035624|NCT01746017|515673255|FG005|Period 1|Withdrawal by Subject|0|||
143035625|NCT01746017|515673256|FG006|Period 1|Withdrawal by Subject|1|||
143035626|NCT01746017|515673257|FG007|Period 1|Withdrawal by Subject|0|||
143035627|NCT01746017|515673258|FG008|Period 1|Withdrawal by Subject|0|||
143035628|NCT01746017|515673259|FG009|Period 1|Withdrawal by Subject|0|||
143035629|NCT01746017|515673260|FG010|Period 1|Withdrawal by Subject|0|||
143035630|NCT01746017|515673250|FG000|Period 3|Withdrawal by Subject|0|||
143035631|NCT01746017|515673251|FG001|Period 3|Withdrawal by Subject|0|||
143035632|NCT01746017|515673252|FG002|Period 3|Withdrawal by Subject|0|||
143035633|NCT01746017|515673253|FG003|Period 3|Withdrawal by Subject|0|||
143035634|NCT01746017|515673254|FG004|Period 3|Withdrawal by Subject|0|||
143035635|NCT01746017|515673255|FG005|Period 3|Withdrawal by Subject|1|||
143035636|NCT01746017|515673256|FG006|Period 3|Withdrawal by Subject|0|||
143035637|NCT01746017|515673257|FG007|Period 3|Withdrawal by Subject|0|||
143035638|NCT01746017|515673258|FG008|Period 3|Withdrawal by Subject|0|||
143035639|NCT01746017|515673259|FG009|Period 3|Withdrawal by Subject|0|||
143035640|NCT01746017|515673260|FG010|Period 3|Withdrawal by Subject|0|||
143035641|NCT01675622|515673261|FG000|Overall Study|Withdrawal by Subject|2|||
143035642|NCT01675622|515673262|FG001|Overall Study|Withdrawal by Subject|2|||
143035643|NCT01675622|515673261|FG000|Overall Study|Adverse Event|12|||
143035644|NCT01675622|515673262|FG001|Overall Study|Adverse Event|10|||
143035645|NCT01675622|515673261|FG000|Overall Study|Protocol Violation|4|||
143035646|NCT01675622|515673262|FG001|Overall Study|Protocol Violation|1|||
143035647|NCT01675622|515673261|FG000|Overall Study|Lack of Efficacy|2|||
143035648|NCT01675622|515673262|FG001|Overall Study|Lack of Efficacy|4|||
143035649|NCT01675622|515673261|FG000|Overall Study|Lost to Follow-up|1|||
143035650|NCT01675622|515673262|FG001|Overall Study|Lost to Follow-up|3|||
143035651|NCT01675622|515673261|FG000|Overall Study|Other|5|||
143035652|NCT01675622|515673262|FG001|Overall Study|Other|4|||
143035653|NCT04032977|515673263|FG000|Overall Study|Withdrawal by Subject|6|||
143035654|NCT04032977|515673264|FG001|Overall Study|Withdrawal by Subject|1|||
143035655|NCT04032977|515673263|FG000|Overall Study|Lost to Follow-up|2|||
143035656|NCT04032977|515673264|FG001|Overall Study|Lost to Follow-up|7|||
143035657|NCT04032977|515673263|FG000|Overall Study|Pregnancy|1|||
143035658|NCT04032977|515673264|FG001|Overall Study|Pregnancy|0|||
143035659|NCT02880761|515673266|FG000|Overall Study|Death|6|||
143035660|NCT02880761|515673267|FG001|Overall Study|Death|8|||
143035661|NCT02880761|515673266|FG000|Overall Study|Withdrawal by Subject|3|||
143035662|NCT02880761|515673267|FG001|Overall Study|Withdrawal by Subject|6|||
143035663|NCT02880761|515673266|FG000|Overall Study|Protocol Violation|4|||
143035664|NCT02880761|515673267|FG001|Overall Study|Protocol Violation|3|||
143035665|NCT02880761|515673266|FG000|Overall Study|Lost to Follow-up|3|||
143035666|NCT02880761|515673267|FG001|Overall Study|Lost to Follow-up|4|||
143035667|NCT02106156|515673268|FG000|Overall Study|Patient Died|19|||
143035668|NCT02106156|515673269|FG001|Overall Study|Patient Died|0|||
143035669|NCT02106156|515673270|FG002|Overall Study|Patient Died|0|||
143035670|NCT02106156|515673268|FG000|Overall Study|Lack of Tolerability|305|||
143035671|NCT02106156|515673269|FG001|Overall Study|Lack of Tolerability|3|||
143035672|NCT02106156|515673270|FG002|Overall Study|Lack of Tolerability|0|||
143035673|NCT02106156|515673268|FG000|Overall Study|Lack of Virological Response|1044|||
143035674|NCT02106156|515673269|FG001|Overall Study|Lack of Virological Response|8|||
143035675|NCT02106156|515673270|FG002|Overall Study|Lack of Virological Response|0|||
143035676|NCT02106156|515673268|FG000|Overall Study|Concomitant Disease|74|||
143035677|NCT02106156|515673269|FG001|Overall Study|Concomitant Disease|2|||
143035678|NCT02106156|515673270|FG002|Overall Study|Concomitant Disease|0|||
143035679|NCT02106156|515673268|FG000|Overall Study|Lack of Compliance|211|||
143035680|NCT02106156|515673269|FG001|Overall Study|Lack of Compliance|7|||
143035681|NCT02106156|515673270|FG002|Overall Study|Lack of Compliance|0|||
143035682|NCT02106156|515673268|FG000|Overall Study|Patients Request|307|||
143035683|NCT02106156|515673269|FG001|Overall Study|Patients Request|9|||
143035684|NCT02106156|515673270|FG002|Overall Study|Patients Request|0|||
143035685|NCT02106156|515673268|FG000|Overall Study|Lost to Follow-up|451|||
143495592|NCT00168831|517357675|FG000|Overall Study|Withdrawal by Subject|7|||
143035686|NCT02106156|515673269|FG001|Overall Study|Lost to Follow-up|8|||
143035687|NCT02106156|515673270|FG002|Overall Study|Lost to Follow-up|0|||
143035688|NCT02106156|515673268|FG000|Overall Study|Unplanned Event|82|||
143035689|NCT02106156|515673269|FG001|Overall Study|Unplanned Event|2|||
143035690|NCT02106156|515673270|FG002|Overall Study|Unplanned Event|0|||
143035691|NCT02106156|515673268|FG000|Overall Study|Change of Laboratory Parameter|10|||
143035692|NCT02106156|515673269|FG001|Overall Study|Change of Laboratory Parameter|0|||
143035693|NCT02106156|515673270|FG002|Overall Study|Change of Laboratory Parameter|0|||
143035694|NCT02106156|515673268|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
143035695|NCT02106156|515673269|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
143238629|NCT01656408|516427533|FG004|Overall Study|Adverse Event|0|||
143035696|NCT02106156|515673270|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
143035697|NCT02106156|515673268|FG000|Overall Study|Relocation/Change of Physician|40|||
143035698|NCT02106156|515673269|FG001|Overall Study|Relocation/Change of Physician|1|||
143035699|NCT02106156|515673270|FG002|Overall Study|Relocation/Change of Physician|0|||
143035700|NCT04657770|515673280|FG000|Overall Study|Withdrawal by Subject|3|||
143035701|NCT04657770|515673280|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
143035702|NCT00746798|515673281|FG000|Overall Study|Protocol Violation|0|||
143035703|NCT00746798|515673282|FG001|Overall Study|Protocol Violation|1|||
143035704|NCT00746798|515673283|FG002|Overall Study|Protocol Violation|0|||
143035705|NCT00746798|515673284|FG003|Overall Study|Protocol Violation|0|||
143035706|NCT00746798|515673281|FG000|Overall Study|Withdrawal by Subject|0|||
143035707|NCT00746798|515673282|FG001|Overall Study|Withdrawal by Subject|1|||
143035708|NCT00746798|515673283|FG002|Overall Study|Withdrawal by Subject|1|||
143035709|NCT00746798|515673284|FG003|Overall Study|Withdrawal by Subject|0|||
143035710|NCT00746798|515673281|FG000|Overall Study|Death|0|||
143035711|NCT00746798|515673282|FG001|Overall Study|Death|0|||
143035712|NCT00746798|515673283|FG002|Overall Study|Death|2|||
143035713|NCT00746798|515673284|FG003|Overall Study|Death|0|||
143035714|NCT00746798|515673281|FG000|Overall Study|Participant unable to return for visit|1|||
143035715|NCT00746798|515673282|FG001|Overall Study|Participant unable to return for visit|0|||
143035716|NCT00746798|515673283|FG002|Overall Study|Participant unable to return for visit|0|||
143035717|NCT00746798|515673284|FG003|Overall Study|Participant unable to return for visit|0|||
143035718|NCT00633594|515673287|FG000|Overall Study|Adverse Event|0|||
143035719|NCT00633594|515673288|FG001|Overall Study|Adverse Event|4|||
143035720|NCT00633594|515673289|FG002|Overall Study|Adverse Event|7|||
143035721|NCT00633594|515673287|FG000|Overall Study|Death|0|||
143035722|NCT00633594|515673288|FG001|Overall Study|Death|1|||
143035723|NCT00633594|515673289|FG002|Overall Study|Death|2|||
143035724|NCT00633594|515673287|FG000|Overall Study|Disease Progression|0|||
143035725|NCT00633594|515673288|FG001|Overall Study|Disease Progression|0|||
143035726|NCT00633594|515673289|FG002|Overall Study|Disease Progression|1|||
143035727|NCT00727571|515673291|FG000|Overall Study|Ineligibility determined|1|||
143035728|NCT00727571|515673292|FG001|Overall Study|Ineligibility determined|1|||
143035729|NCT00727571|515673293|FG002|Overall Study|Ineligibility determined|1|||
143035730|NCT00727571|515673294|FG003|Overall Study|Ineligibility determined|0|||
143035731|NCT00727571|515673291|FG000|Overall Study|Death|0|||
143035732|NCT00727571|515673292|FG001|Overall Study|Death|19|||
143035733|NCT00727571|515673293|FG002|Overall Study|Death|5|||
143035734|NCT00727571|515673294|FG003|Overall Study|Death|1|||
143035735|NCT00727571|515673291|FG000|Overall Study|Physician Decision|0|||
143238630|NCT01656408|516427534|FG005|Overall Study|Adverse Event|1|||
143238631|NCT01656408|516427535|FG006|Overall Study|Adverse Event|1|||
143238632|NCT01656408|516427536|FG007|Overall Study|Adverse Event|0|||
143238633|NCT01656408|516427537|FG008|Overall Study|Adverse Event|1|||
143238634|NCT01656408|516427538|FG009|Overall Study|Adverse Event|0|||
143035736|NCT00727571|515673292|FG001|Overall Study|Physician Decision|5|||
143238635|NCT01656408|516427529|FG000|Overall Study|Physician Decision|1|||
143238636|NCT01656408|516427530|FG001|Overall Study|Physician Decision|0|||
143238637|NCT01656408|516427531|FG002|Overall Study|Physician Decision|1|||
143238638|NCT01656408|516427532|FG003|Overall Study|Physician Decision|0|||
143238639|NCT01656408|516427533|FG004|Overall Study|Physician Decision|1|||
143238640|NCT01656408|516427534|FG005|Overall Study|Physician Decision|1|||
143238641|NCT01656408|516427535|FG006|Overall Study|Physician Decision|0|||
143238642|NCT01656408|516427536|FG007|Overall Study|Physician Decision|1|||
143238643|NCT01656408|516427537|FG008|Overall Study|Physician Decision|1|||
143238644|NCT01656408|516427538|FG009|Overall Study|Physician Decision|3|||
143238645|NCT03312634|516429733|FG000|Overall Study|Adverse Event|11|||
143238646|NCT03312634|516429734|FG001|Overall Study|Adverse Event|0|||
143238647|NCT03312634|516429733|FG000|Overall Study|Sponsor request|2|||
143238648|NCT03312634|516429734|FG001|Overall Study|Sponsor request|0|||
143238649|NCT03312634|516429733|FG000|Overall Study|Withdrawal by Subject|31|||
143238650|NCT03312634|516429734|FG001|Overall Study|Withdrawal by Subject|9|||
143238651|NCT03312634|516429733|FG000|Overall Study|Enrolled in an interventional study|0|||
143238652|NCT03312634|516429734|FG001|Overall Study|Enrolled in an interventional study|52|||
143238653|NCT03312634|516429733|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
143495593|NCT00168831|517357676|FG001|Overall Study|Withdrawal by Subject|14|||
143495594|NCT00168831|517357677|FG002|Overall Study|Withdrawal by Subject|19|||
143035737|NCT00727571|515673293|FG002|Overall Study|Physician Decision|0|||
143495595|NCT00168831|517357675|FG000|Overall Study|Protocol Violation|6|||
143035738|NCT00727571|515673294|FG003|Overall Study|Physician Decision|0|||
143035739|NCT00727571|515673291|FG000|Overall Study|Withdrawal by Subject|0|||
143035740|NCT00727571|515673292|FG001|Overall Study|Withdrawal by Subject|10|||
143035741|NCT00727571|515673293|FG002|Overall Study|Withdrawal by Subject|11|||
143035742|NCT00727571|515673294|FG003|Overall Study|Withdrawal by Subject|0|||
143035743|NCT00727571|515673291|FG000|Overall Study|Subject Non Compliance|0|||
143035744|NCT00727571|515673292|FG001|Overall Study|Subject Non Compliance|6|||
143035745|NCT00727571|515673293|FG002|Overall Study|Subject Non Compliance|0|||
143035746|NCT00727571|515673294|FG003|Overall Study|Subject Non Compliance|4|||
143035747|NCT00727571|515673291|FG000|Overall Study|Dismissed from nursing home|0|||
143035748|NCT00727571|515673292|FG001|Overall Study|Dismissed from nursing home|9|||
143238654|NCT03312634|516429734|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
143238655|NCT03312634|516429733|FG000|Overall Study|Death|0|||
143238656|NCT03312634|516429734|FG001|Overall Study|Death|1|||
143238657|NCT03312634|516429733|FG000|Overall Study|Non-compliance|0|||
143238658|NCT03312634|516429734|FG001|Overall Study|Non-compliance|2|||
143035749|NCT00727571|515673293|FG002|Overall Study|Dismissed from nursing home|5|||
143035750|NCT00727571|515673294|FG003|Overall Study|Dismissed from nursing home|0|||
143035751|NCT00727571|515673291|FG000|Overall Study|Hospitalization|0|||
143035752|NCT00727571|515673292|FG001|Overall Study|Hospitalization|1|||
143035753|NCT00727571|515673293|FG002|Overall Study|Hospitalization|0|||
143035754|NCT00727571|515673294|FG003|Overall Study|Hospitalization|1|||
143035755|NCT00727571|515673291|FG000|Overall Study|AE not leading to hospitalization|0|||
143035756|NCT00727571|515673292|FG001|Overall Study|AE not leading to hospitalization|0|||
143035757|NCT00727571|515673293|FG002|Overall Study|AE not leading to hospitalization|2|||
143035758|NCT00727571|515673294|FG003|Overall Study|AE not leading to hospitalization|0|||
143035759|NCT00727571|515673291|FG000|Overall Study|Other|0|||
143035760|NCT00727571|515673292|FG001|Overall Study|Other|4|||
143035761|NCT00727571|515673293|FG002|Overall Study|Other|6|||
143035762|NCT00727571|515673294|FG003|Overall Study|Other|0|||
143035763|NCT02189941|515673295|FG000|Overall Study|Non-compliance|0|||
143035764|NCT02189941|515673296|FG001|Overall Study|Non-compliance|0|||
143035765|NCT02189941|515673297|FG002|Overall Study|Non-compliance|1|||
143035766|NCT00445003|515673298|FG000|Overall Study|Death|1|||
143035767|NCT00445003|515673299|FG001|Overall Study|Death|2|||
143035768|NCT00445003|515673300|FG002|Overall Study|Death|1|||
143035769|NCT00445003|515673298|FG000|Overall Study|Missed Visit|3|||
143035770|NCT00445003|515673299|FG001|Overall Study|Missed Visit|5|||
143035771|NCT00445003|515673300|FG002|Overall Study|Missed Visit|1|||
143035772|NCT00445003|515673298|FG000|Overall Study|Dropped|1|||
143035773|NCT00445003|515673299|FG001|Overall Study|Dropped|3|||
143035774|NCT00445003|515673300|FG002|Overall Study|Dropped|2|||
143035775|NCT01471093|515673301|FG000|Overall Study|Adverse Event|1|||
143035776|NCT01471093|515673302|FG001|Overall Study|Adverse Event|0|||
143035777|NCT01471093|515673303|FG002|Overall Study|Adverse Event|0|||
143035778|NCT01471093|515673304|FG003|Overall Study|Adverse Event|0|||
143035779|NCT02475954|515673305|FG000|Overall Study|Withdrawal by Subject|2|||
143035780|NCT02475954|515673306|FG001|Overall Study|Withdrawal by Subject|2|||
143035781|NCT02475954|515673305|FG000|Overall Study|Lost to Follow-up|11|||
143035782|NCT02475954|515673306|FG001|Overall Study|Lost to Follow-up|9|||
143035783|NCT02475954|515673305|FG000|Overall Study|Death|1|||
143035784|NCT02475954|515673306|FG001|Overall Study|Death|1|||
143035785|NCT00880568|515673308|FG000|Overall Study|Disease progression|3|||
143035786|NCT00880568|515673309|FG001|Overall Study|Disease progression|3|||
143035787|NCT00880568|515673310|FG002|Overall Study|Disease progression|3|||
143035788|NCT00880568|515673311|FG003|Overall Study|Disease progression|1|||
143035789|NCT00880568|515673312|FG004|Overall Study|Disease progression|3|||
143035790|NCT00880568|515673313|FG005|Overall Study|Disease progression|3|||
143035791|NCT00880568|515673314|FG006|Overall Study|Disease progression|5|||
143495596|NCT00168831|517357676|FG001|Overall Study|Protocol Violation|11|||
143495597|NCT00168831|517357677|FG002|Overall Study|Protocol Violation|11|||
143495598|NCT00168831|517357675|FG000|Overall Study|Other|6|||
143495599|NCT00168831|517357676|FG001|Overall Study|Other|3|||
143495600|NCT00168831|517357677|FG002|Overall Study|Other|6|||
143495601|NCT01622569|517357678|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
143495602|NCT01622569|517357679|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
143495603|NCT01622569|517357680|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
143495604|NCT01622569|517357681|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
143495605|NCT01622569|517357678|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
143495606|NCT01622569|517357679|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
143495607|NCT01622569|517357680|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
143495608|NCT01622569|517357681|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
143495609|NCT01622569|517357678|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
143495610|NCT01622569|517357679|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
143495611|NCT01622569|517357680|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
143495612|NCT01622569|517357681|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
143495613|NCT01622569|517357678|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
143495614|NCT01622569|517357679|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
143495615|NCT01622569|517357680|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
143495616|NCT01622569|517357681|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
143495617|NCT01622569|517357678|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
143495618|NCT01622569|517357679|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
143495619|NCT01622569|517357680|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
143495620|NCT01622569|517357681|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
143035792|NCT00880568|515673315|FG007|Overall Study|Disease progression|0|||
143035793|NCT00880568|515673316|FG008|Overall Study|Disease progression|3|||
143035794|NCT00880568|515673308|FG000|Overall Study|Adverse Event|0|||
143035795|NCT00880568|515673309|FG001|Overall Study|Adverse Event|0|||
143035796|NCT00880568|515673310|FG002|Overall Study|Adverse Event|0|||
143035797|NCT00880568|515673311|FG003|Overall Study|Adverse Event|0|||
143035798|NCT00880568|515673312|FG004|Overall Study|Adverse Event|0|||
143035799|NCT00880568|515673313|FG005|Overall Study|Adverse Event|0|||
143035800|NCT00880568|515673314|FG006|Overall Study|Adverse Event|1|||
143035801|NCT00880568|515673315|FG007|Overall Study|Adverse Event|1|||
143035802|NCT00880568|515673316|FG008|Overall Study|Adverse Event|0|||
143035803|NCT00880568|515673308|FG000|Overall Study|Withdrawal by Subject|0|||
143035804|NCT00880568|515673309|FG001|Overall Study|Withdrawal by Subject|0|||
143035805|NCT00880568|515673310|FG002|Overall Study|Withdrawal by Subject|0|||
143035806|NCT00880568|515673311|FG003|Overall Study|Withdrawal by Subject|0|||
143035807|NCT00880568|515673312|FG004|Overall Study|Withdrawal by Subject|0|||
143035808|NCT00880568|515673313|FG005|Overall Study|Withdrawal by Subject|0|||
143035809|NCT00880568|515673314|FG006|Overall Study|Withdrawal by Subject|0|||
143035810|NCT00880568|515673315|FG007|Overall Study|Withdrawal by Subject|1|||
143035811|NCT00880568|515673316|FG008|Overall Study|Withdrawal by Subject|0|||
143035812|NCT00358449|515673319|FG000|Overall Study|Adverse Event|1|||
143035813|NCT00358449|515673320|FG001|Overall Study|Adverse Event|0|||
143035814|NCT00358449|515673321|FG002|Overall Study|Adverse Event|1|||
143035815|NCT00358449|515673319|FG000|Overall Study|Lost to Follow-up|1|||
143035816|NCT00358449|515673320|FG001|Overall Study|Lost to Follow-up|0|||
143035817|NCT00358449|515673321|FG002|Overall Study|Lost to Follow-up|0|||
143035818|NCT00358449|515673319|FG000|Overall Study|Withdrawal by Subject|2|||
143035819|NCT00358449|515673320|FG001|Overall Study|Withdrawal by Subject|0|||
143035820|NCT00358449|515673321|FG002|Overall Study|Withdrawal by Subject|0|||
143035821|NCT00358449|515673319|FG000|Overall Study|Lack of Efficacy|0|||
143035822|NCT00358449|515673320|FG001|Overall Study|Lack of Efficacy|1|||
143035823|NCT00358449|515673321|FG002|Overall Study|Lack of Efficacy|0|||
143035824|NCT00358449|515673319|FG000|Overall Study|Steriod Inhaler was Increased|0|||
143035825|NCT00358449|515673320|FG001|Overall Study|Steriod Inhaler was Increased|0|||
143035826|NCT00358449|515673321|FG002|Overall Study|Steriod Inhaler was Increased|1|||
143035827|NCT01804270|515673322|FG000|Overall Study|Withdrawal by Subject|1|||
143035828|NCT01804270|515673323|FG001|Overall Study|Withdrawal by Subject|1|||
143035829|NCT04407806|515673325|FG000|Overall Study|Withdrawal by Subject|1|||
143035830|NCT04407806|515673326|FG001|Overall Study|Withdrawal by Subject|2|||
143035831|NCT00496964|515673327|FG000|Overall Study|Withdrawal by Subject|0|||
143035832|NCT00496964|515673328|FG001|Overall Study|Withdrawal by Subject|1|||
143035833|NCT03478397|515673329|FG000|Overall Study|Refused to participate|31|||
143035834|NCT03478397|515673330|FG001|Overall Study|Refused to participate|7|||
143035835|NCT02188303|515673331|FG000|Overall Study|Adverse Event|0|||
143035836|NCT02188303|515673332|FG001|Overall Study|Adverse Event|0|||
143035837|NCT02188303|515673333|FG002|Overall Study|Adverse Event|0|||
143035838|NCT02188303|515673334|FG003|Overall Study|Adverse Event|0|||
143035839|NCT02188303|515673335|FG004|Overall Study|Adverse Event|0|||
143035840|NCT02188303|515673336|FG005|Overall Study|Adverse Event|2|||
143035841|NCT02188303|515673337|FG006|Overall Study|Adverse Event|0|||
143035842|NCT02188303|515673338|FG007|Overall Study|Adverse Event|2|||
143035843|NCT02188303|515673331|FG000|Overall Study|Dose Termination Criteria Met|0|||
143035844|NCT02188303|515673332|FG001|Overall Study|Dose Termination Criteria Met|0|||
143035845|NCT02188303|515673333|FG002|Overall Study|Dose Termination Criteria Met|0|||
143035846|NCT02188303|515673334|FG003|Overall Study|Dose Termination Criteria Met|0|||
143035847|NCT02188303|515673335|FG004|Overall Study|Dose Termination Criteria Met|0|||
143035848|NCT02188303|515673336|FG005|Overall Study|Dose Termination Criteria Met|0|||
143035849|NCT02188303|515673337|FG006|Overall Study|Dose Termination Criteria Met|2|||
143035850|NCT02188303|515673338|FG007|Overall Study|Dose Termination Criteria Met|4|||
143035851|NCT04206332|515673339|FG000|Part A|Lost to Follow-up|0|||
143035852|NCT04206332|515673340|FG001|Part A|Lost to Follow-up|1|||
143035853|NCT04206332|515673341|FG002|Part A|Lost to Follow-up|0|||
143035854|NCT04206332|515673342|FG003|Part A|Lost to Follow-up|0|||
143035855|NCT04206332|515673343|FG004|Part A|Lost to Follow-up|0|||
143035856|NCT04206332|515673344|FG005|Part A|Lost to Follow-up|0|||
143035857|NCT04206332|515673345|FG006|Part A|Lost to Follow-up|0|||
143035858|NCT04206332|515673346|FG007|Part A|Lost to Follow-up|0|||
143035859|NCT04206332|515673347|FG008|Part A|Lost to Follow-up|0|||
143035860|NCT04206332|515673348|FG009|Part A|Lost to Follow-up|0|||
143035861|NCT04206332|515673349|FG010|Part A|Lost to Follow-up|0|||
143035862|NCT04206332|515673350|FG011|Part A|Lost to Follow-up|0|||
143035863|NCT04206332|515673351|FG012|Part A|Lost to Follow-up|0|||
143035864|NCT04206332|515673352|FG013|Part A|Lost to Follow-up|0|||
143035865|NCT04206332|515673353|FG014|Part A|Lost to Follow-up|0|||
143238659|NCT03312634|516429733|FG000|Overall Study|Lost to Follow-up|0|||
143495621|NCT01622569|517357678|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
143035866|NCT04206332|515673354|FG015|Part A|Lost to Follow-up|0|||
143035867|NCT04206332|515673355|FG016|Part A|Lost to Follow-up|0|||
143035868|NCT04206332|515673339|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
143035869|NCT04206332|515673340|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
143035870|NCT04206332|515673341|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
143035871|NCT04206332|515673342|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
143035872|NCT04206332|515673343|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
143238660|NCT03312634|516429734|FG001|Overall Study|Lost to Follow-up|1|||
143035873|NCT04206332|515673344|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
143035874|NCT04206332|515673345|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
143035875|NCT04206332|515673346|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
143035876|NCT04206332|515673347|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
143035877|NCT04206332|515673348|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
143035878|NCT04206332|515673349|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
143035879|NCT04206332|515673350|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
143035880|NCT04206332|515673351|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
143035881|NCT04206332|515673352|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
143035882|NCT04206332|515673353|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
143035883|NCT04206332|515673354|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
143035884|NCT04206332|515673355|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
143035885|NCT04206332|515673339|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
143035886|NCT04206332|515673340|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
143035887|NCT04206332|515673341|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
143035888|NCT04206332|515673342|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
143035889|NCT04206332|515673343|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
143035890|NCT04206332|515673344|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
143035891|NCT04206332|515673345|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
143035892|NCT04206332|515673346|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
143035893|NCT04206332|515673347|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
143035894|NCT04206332|515673348|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
143035895|NCT04206332|515673349|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
143035896|NCT04206332|515673350|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
143035897|NCT04206332|515673351|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
143035898|NCT04206332|515673352|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
143035899|NCT04206332|515673353|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
143035900|NCT04206332|515673354|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
143035901|NCT04206332|515673355|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
143035902|NCT04206332|515673339|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
143035903|NCT04206332|515673340|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
143035904|NCT04206332|515673341|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
143161168|NCT01362530|516135495|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
143161169|NCT01362530|516135496|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
143161170|NCT01362530|516135495|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
143161171|NCT01362530|516135496|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
143161172|NCT01362530|516135495|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
143161173|NCT01362530|516135496|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
143161174|NCT01362530|516135495|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
143161175|NCT01362530|516135496|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
143161176|NCT01133977|516135497|FG000|Overall Study|Adverse Event|0|||
143161177|NCT01133977|516135498|FG001|Overall Study|Adverse Event|0|||
143495622|NCT01622569|517357679|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
143495623|NCT01622569|517357680|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
143495624|NCT01622569|517357681|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
143495625|NCT01622569|517357678|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
143495626|NCT01622569|517357679|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
143495627|NCT01622569|517357680|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
143495628|NCT01622569|517357681|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
143495629|NCT01622569|517357678|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
143495630|NCT01622569|517357679|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
143495631|NCT01622569|517357680|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
143495632|NCT01622569|517357681|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
143495633|NCT01505894|517357682|FG000|Overall Study|Adverse Event|1|||
143495634|NCT01505894|517357683|FG001|Overall Study|Adverse Event|0|||
143495635|NCT01505894|517357684|FG002|Overall Study|Adverse Event|0|||
143035905|NCT04206332|515673342|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
143035906|NCT04206332|515673343|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
143035907|NCT04206332|515673344|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
143035908|NCT04206332|515673345|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
143035909|NCT04206332|515673346|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
143035910|NCT04206332|515673347|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
143035911|NCT04206332|515673348|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
143035912|NCT04206332|515673349|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
143035913|NCT04206332|515673350|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
143035914|NCT04206332|515673351|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
143035915|NCT04206332|515673352|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
143035916|NCT04206332|515673353|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
143035917|NCT04206332|515673354|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
143035918|NCT04206332|515673355|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
143035919|NCT04206332|515673339|FG000|Part C|Withdrawal by Subject|0|||
143035920|NCT04206332|515673340|FG001|Part C|Withdrawal by Subject|0|||
143035921|NCT04206332|515673341|FG002|Part C|Withdrawal by Subject|0|||
143035922|NCT04206332|515673342|FG003|Part C|Withdrawal by Subject|0|||
143035923|NCT04206332|515673343|FG004|Part C|Withdrawal by Subject|0|||
143035924|NCT04206332|515673344|FG005|Part C|Withdrawal by Subject|0|||
143035925|NCT04206332|515673345|FG006|Part C|Withdrawal by Subject|0|||
143035926|NCT04206332|515673346|FG007|Part C|Withdrawal by Subject|0|||
143035927|NCT04206332|515673347|FG008|Part C|Withdrawal by Subject|0|||
143035928|NCT04206332|515673348|FG009|Part C|Withdrawal by Subject|0|||
143035929|NCT04206332|515673349|FG010|Part C|Withdrawal by Subject|0|||
143035930|NCT04206332|515673350|FG011|Part C|Withdrawal by Subject|0|||
143035931|NCT04206332|515673351|FG012|Part C|Withdrawal by Subject|0|||
143035932|NCT04206332|515673352|FG013|Part C|Withdrawal by Subject|0|||
143035933|NCT04206332|515673353|FG014|Part C|Withdrawal by Subject|2|||
143035934|NCT04206332|515673354|FG015|Part C|Withdrawal by Subject|0|||
143035935|NCT04206332|515673355|FG016|Part C|Withdrawal by Subject|0|||
143035936|NCT04000815|515673357|FG000|Overall Study|Lost to Follow-up|9|||
143035937|NCT04000815|515673358|FG001|Overall Study|Lost to Follow-up|2|||
143035938|NCT04000815|515673359|FG002|Overall Study|Lost to Follow-up|3|||
143035939|NCT04000815|515673357|FG000|Overall Study|Withdrawal by Subject|4|||
143035940|NCT04000815|515673358|FG001|Overall Study|Withdrawal by Subject|3|||
143035941|NCT04000815|515673359|FG002|Overall Study|Withdrawal by Subject|2|||
143035942|NCT04000815|515673357|FG000|Overall Study|Right ovarian cyst occured|1|||
143035943|NCT04000815|515673358|FG001|Overall Study|Right ovarian cyst occured|0|||
143035944|NCT04000815|515673359|FG002|Overall Study|Right ovarian cyst occured|0|||
143035945|NCT04000815|515673357|FG000|Overall Study|Hypertension occured on follow up|0|||
143035946|NCT04000815|515673358|FG001|Overall Study|Hypertension occured on follow up|0|||
143035947|NCT04000815|515673359|FG002|Overall Study|Hypertension occured on follow up|2|||
143035948|NCT00239577|515673360|FG000|Primary Phase|Adverse Event|0|||
143035949|NCT00239577|515673361|FG001|Primary Phase|Adverse Event|0|||
143035950|NCT00239577|515673362|FG002|Primary Phase|Adverse Event|1|||
143035951|NCT00239577|515673363|FG003|Primary Phase|Adverse Event|0|||
143035952|NCT00239577|515673360|FG000|Primary Phase|Other|5|||
143035953|NCT00239577|515673361|FG001|Primary Phase|Other|3|||
143035954|NCT00239577|515673362|FG002|Primary Phase|Other|2|||
143035955|NCT00239577|515673363|FG003|Primary Phase|Other|0|||
143035956|NCT00856388|515673364|FG000|Overall Study|Other|1|||
143035957|NCT01617668|515673365|FG000|Overall Study|Adverse Event|7|||
143035958|NCT01617668|515673366|FG001|Overall Study|Adverse Event|0|||
143035959|NCT01617668|515673367|FG002|Overall Study|Adverse Event|12|||
143035960|NCT01617668|515673368|FG003|Overall Study|Adverse Event|5|||
143035961|NCT01617668|515673365|FG000|Overall Study|Physician Decision|1|||
143035962|NCT01617668|515673366|FG001|Overall Study|Physician Decision|2|||
143161178|NCT01133977|516135499|FG002|Overall Study|Adverse Event|1|||
143035963|NCT01617668|515673367|FG002|Overall Study|Physician Decision|3|||
143035964|NCT01617668|515673368|FG003|Overall Study|Physician Decision|0|||
143161179|NCT01133977|516135500|FG003|Overall Study|Adverse Event|0|||
143161180|NCT01133977|516135501|FG004|Overall Study|Adverse Event|0|||
143161181|NCT01133977|516135497|FG000|Overall Study|Death|1|||
143161182|NCT01133977|516135498|FG001|Overall Study|Death|1|||
143161183|NCT01133977|516135499|FG002|Overall Study|Death|1|||
143161184|NCT01133977|516135500|FG003|Overall Study|Death|7|||
143035965|NCT01617668|515673365|FG000|Overall Study|Progressive Disease|4|||
143035966|NCT01617668|515673366|FG001|Overall Study|Progressive Disease|4|||
143161185|NCT01133977|516135501|FG004|Overall Study|Death|3|||
143161186|NCT01133977|516135497|FG000|Overall Study|Started a New Line of Therapy|2|||
143161187|NCT01133977|516135498|FG001|Overall Study|Started a New Line of Therapy|6|||
143035967|NCT01617668|515673367|FG002|Overall Study|Progressive Disease|6|||
143035968|NCT01617668|515673368|FG003|Overall Study|Progressive Disease|9|||
143035969|NCT01617668|515673365|FG000|Overall Study|Subject/guardian decision|1|||
143035970|NCT01617668|515673366|FG001|Overall Study|Subject/guardian decision|3|||
143035971|NCT01617668|515673367|FG002|Overall Study|Subject/guardian decision|2|||
143035972|NCT01617668|515673368|FG003|Overall Study|Subject/guardian decision|1|||
143035973|NCT00925769|515673369|FG000|Overall Study|Major toxicity|1|||
143035974|NCT00925769|515673370|FG001|Overall Study|Major toxicity|0|||
143035975|NCT00925769|515673371|FG002|Overall Study|Major toxicity|1|||
143035976|NCT00925769|515673372|FG003|Overall Study|Major toxicity|1|||
143035977|NCT00925769|515673373|FG004|Overall Study|Major toxicity|0|||
143035978|NCT00925769|515673374|FG005|Overall Study|Major toxicity|0|||
143035979|NCT00925769|515673369|FG000|Overall Study|Disease progression|4|||
143035980|NCT00925769|515673370|FG001|Overall Study|Disease progression|5|||
143035981|NCT00925769|515673371|FG002|Overall Study|Disease progression|3|||
143035982|NCT00925769|515673372|FG003|Overall Study|Disease progression|4|||
143035983|NCT00925769|515673373|FG004|Overall Study|Disease progression|2|||
143035984|NCT00925769|515673374|FG005|Overall Study|Disease progression|3|||
143035985|NCT00925769|515673369|FG000|Overall Study|Death|0|||
143035986|NCT00925769|515673370|FG001|Overall Study|Death|0|||
143035987|NCT00925769|515673371|FG002|Overall Study|Death|1|||
143035988|NCT00925769|515673372|FG003|Overall Study|Death|0|||
143035989|NCT00925769|515673373|FG004|Overall Study|Death|0|||
143035990|NCT00925769|515673374|FG005|Overall Study|Death|0|||
143035991|NCT00925769|515673369|FG000|Overall Study|Physician Decision|1|||
143035992|NCT00925769|515673370|FG001|Overall Study|Physician Decision|0|||
143035993|NCT00925769|515673371|FG002|Overall Study|Physician Decision|0|||
143035994|NCT00925769|515673372|FG003|Overall Study|Physician Decision|0|||
143035995|NCT00925769|515673373|FG004|Overall Study|Physician Decision|0|||
143035996|NCT00925769|515673374|FG005|Overall Study|Physician Decision|0|||
143035997|NCT00925769|515673369|FG000|Overall Study|Missing documentation|0|||
143035998|NCT00925769|515673370|FG001|Overall Study|Missing documentation|1|||
143035999|NCT00925769|515673371|FG002|Overall Study|Missing documentation|0|||
143036000|NCT00925769|515673372|FG003|Overall Study|Missing documentation|0|||
143036001|NCT00925769|515673373|FG004|Overall Study|Missing documentation|0|||
143036002|NCT00925769|515673374|FG005|Overall Study|Missing documentation|0|||
143036003|NCT00925769|515673369|FG000|Overall Study|End of study visit not done|0|||
143036004|NCT00925769|515673370|FG001|Overall Study|End of study visit not done|0|||
143036005|NCT00925769|515673371|FG002|Overall Study|End of study visit not done|1|||
143036006|NCT00925769|515673372|FG003|Overall Study|End of study visit not done|0|||
143036007|NCT00925769|515673373|FG004|Overall Study|End of study visit not done|0|||
143036008|NCT00925769|515673374|FG005|Overall Study|End of study visit not done|0|||
143036009|NCT00925769|515673369|FG000|Overall Study|Participant is unable to swallow drug|0|||
143036010|NCT00925769|515673370|FG001|Overall Study|Participant is unable to swallow drug|0|||
143036011|NCT00925769|515673371|FG002|Overall Study|Participant is unable to swallow drug|0|||
143036012|NCT00925769|515673372|FG003|Overall Study|Participant is unable to swallow drug|1|||
143036013|NCT00925769|515673373|FG004|Overall Study|Participant is unable to swallow drug|0|||
143036014|NCT00925769|515673374|FG005|Overall Study|Participant is unable to swallow drug|0|||
143036015|NCT00925769|515673369|FG000|Overall Study|Adverse Event|0|||
143036016|NCT00925769|515673370|FG001|Overall Study|Adverse Event|0|||
143036017|NCT00925769|515673371|FG002|Overall Study|Adverse Event|0|||
143036018|NCT00925769|515673372|FG003|Overall Study|Adverse Event|0|||
143036019|NCT00925769|515673373|FG004|Overall Study|Adverse Event|1|||
143036020|NCT00925769|515673374|FG005|Overall Study|Adverse Event|0|||
143036021|NCT01038856|515673377|FG000|Overall Study|Adverse Event|2|||
143036022|NCT04091971|515673378|FG000|Overall Study|Withdrawal by Subject|1|||
143036023|NCT04091971|515673378|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
143036024|NCT04091971|515673378|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
143036025|NCT01666730|515673379|FG000|Overall Study|Adverse Event|16|||
143036026|NCT01666730|515673379|FG000|Overall Study|Death|2|||
143036027|NCT01666730|515673379|FG000|Overall Study|Physician Decision|5|||
143036028|NCT01666730|515673379|FG000|Overall Study|Withdrawal by Subject|9|||
143036029|NCT01666730|515673379|FG000|Overall Study|Disease progression/relapse|18|||
143036030|NCT00454909|515673380|FG000|Overall Study|Withdrawal by Subject|1|||
143036031|NCT00454909|515673381|FG001|Overall Study|Withdrawal by Subject|0|||
143036032|NCT00454909|515673382|FG002|Overall Study|Withdrawal by Subject|0|||
143036033|NCT00454909|515673380|FG000|Overall Study|Migrated/moved from study area|0|||
143036034|NCT00454909|515673381|FG001|Overall Study|Migrated/moved from study area|0|||
143036035|NCT00454909|515673382|FG002|Overall Study|Migrated/moved from study area|1|||
143036036|NCT00454909|515673380|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
143036037|NCT00454909|515673381|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
143161188|NCT01133977|516135499|FG002|Overall Study|Started a New Line of Therapy|4|||
143036038|NCT00454909|515673382|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
143036039|NCT00454909|515673380|FG000|Overall Study|Others|1|||
143036040|NCT00454909|515673381|FG001|Overall Study|Others|0|||
143036041|NCT00454909|515673382|FG002|Overall Study|Others|0|||
143036042|NCT00870870|515673387|FG000|Overall Study|Withdrawal by Subject|0|||
143036043|NCT00870870|515673388|FG001|Overall Study|Withdrawal by Subject|1|||
143036044|NCT00870870|515673389|FG002|Overall Study|Withdrawal by Subject|1|||
143036045|NCT00870870|515673390|FG003|Overall Study|Withdrawal by Subject|3|||
143036046|NCT00870870|515673387|FG000|Overall Study|Adverse Event|0|||
143036047|NCT00870870|515673388|FG001|Overall Study|Adverse Event|0|||
143036048|NCT00870870|515673389|FG002|Overall Study|Adverse Event|2|||
143036049|NCT00870870|515673390|FG003|Overall Study|Adverse Event|2|||
143036050|NCT03639311|515673393|FG000|Maintenance Phase|Lost to Follow-up|1|||
143036051|NCT03639311|515673394|FG001|Maintenance Phase|Lost to Follow-up|0|||
143036052|NCT03639311|515673395|FG002|Maintenance Phase|Lost to Follow-up|0|||
143036053|NCT03639311|515673393|FG000|Maintenance Phase|Adverse Event|1|||
143036054|NCT03639311|515673394|FG001|Maintenance Phase|Adverse Event|0|||
143036055|NCT03639311|515673395|FG002|Maintenance Phase|Adverse Event|0|||
143036056|NCT03639311|515673393|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
143036057|NCT03639311|515673394|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
143036058|NCT03639311|515673395|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
143036059|NCT03639311|515673393|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
143036060|NCT03639311|515673394|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
143036061|NCT03639311|515673395|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
143036062|NCT03639311|515673393|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
143036063|NCT03639311|515673394|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
143036064|NCT03639311|515673395|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
143036065|NCT03639311|515673393|FG000|Maintenance Phase|Lack of Efficacy|1|||
143036066|NCT03639311|515673394|FG001|Maintenance Phase|Lack of Efficacy|0|||
143036067|NCT03639311|515673395|FG002|Maintenance Phase|Lack of Efficacy|0|||
143036068|NCT00822926|515673396|FG000|Second Injection Visit|Lost to Follow-up|1|||
143036069|NCT00822926|515673397|FG001|Second Injection Visit|Lost to Follow-up|0|||
143036070|NCT00822926|515673396|FG000|Second Injection Visit|Withdrawal by Subject|0|||
143036071|NCT00822926|515673397|FG001|Second Injection Visit|Withdrawal by Subject|1|||
143036072|NCT00119379|515673406|FG000|Overall Study|Adverse Event|4|||
143036073|NCT00119379|515673407|FG001|Overall Study|Adverse Event|1|||
143036074|NCT01569152|515673408|FG000|Phase IIa, Period 1|Early Escape|5|||
143036075|NCT01569152|515673409|FG001|Phase IIa, Period 1|Early Escape|22|||
143036076|NCT01569152|515673410|FG002|Phase IIa, Period 1|Early Escape|0|||
143036077|NCT01569152|515673408|FG000|Phase IIa, Period 1|Adverse Event|4|||
143036078|NCT01569152|515673409|FG001|Phase IIa, Period 1|Adverse Event|0|||
143238661|NCT03312634|516429733|FG000|Overall Study|Enrolled into non-interventional study|0|||
143238662|NCT03312634|516429734|FG001|Overall Study|Enrolled into non-interventional study|5|||
143238663|NCT03312634|516429733|FG000|Overall Study|Worsening clinical condition|0|||
143238664|NCT03312634|516429734|FG001|Overall Study|Worsening clinical condition|1|||
143238665|NCT03312634|516429733|FG000|Overall Study|Participant did not want to travel|0|||
143238666|NCT03312634|516429734|FG001|Overall Study|Participant did not want to travel|1|||
143238667|NCT03312634|516429733|FG000|Overall Study|Physician Decision|1|||
143238668|NCT03312634|516429734|FG001|Overall Study|Physician Decision|0|||
143238669|NCT03312634|516429733|FG000|Overall Study|Other|13|||
143036079|NCT01569152|515673410|FG002|Phase IIa, Period 1|Adverse Event|0|||
143036080|NCT01569152|515673408|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
143036081|NCT01569152|515673409|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
143238670|NCT03312634|516429734|FG001|Overall Study|Other|0|||
143238671|NCT01148979|516429743|FG000|Overall Study|Lost to Follow-up|0|||
143238672|NCT01148979|516429744|FG001|Overall Study|Lost to Follow-up|1|||
143238673|NCT05462756|516429746|FG000|Treatment Period|Adverse Event|3|||
143036082|NCT01569152|515673410|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
143036083|NCT01569152|515673408|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
143036084|NCT01569152|515673409|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
143036085|NCT01569152|515673410|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
143036086|NCT01569152|515673408|FG000|Phase IIa, Period 1|Protocol Violation|0|||
143036087|NCT01569152|515673409|FG001|Phase IIa, Period 1|Protocol Violation|1|||
143238674|NCT05462756|516429747|FG001|Treatment Period|Adverse Event|0|||
143238675|NCT05462756|516429746|FG000|Treatment Period|Assigned Treatment by Mistake|4|||
143238676|NCT05462756|516429747|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
143238677|NCT05462756|516429746|FG000|Treatment Period|Death|0|||
143238678|NCT05462756|516429747|FG001|Treatment Period|Death|1|||
143036088|NCT01569152|515673410|FG002|Phase IIa, Period 1|Protocol Violation|0|||
143036089|NCT01569152|515673408|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
143036090|NCT01569152|515673409|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
143036091|NCT01569152|515673410|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
143238679|NCT05462756|516429746|FG000|Treatment Period|Lost to Follow-up|2|||
143495636|NCT01505894|517357685|FG003|Overall Study|Adverse Event|0|||
143036092|NCT01569152|515673408|FG000|Safety Extension, Period 3|Adverse Event|0|||
143238680|NCT05462756|516429747|FG001|Treatment Period|Lost to Follow-up|1|||
143238681|NCT05462756|516429746|FG000|Treatment Period|Non-Compliance with Study Drug|1|||
143238682|NCT05462756|516429747|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
143238683|NCT05462756|516429746|FG000|Treatment Period|Physician Decision|2|||
143036093|NCT01569152|515673409|FG001|Safety Extension, Period 3|Adverse Event|0|||
143036094|NCT01569152|515673410|FG002|Safety Extension, Period 3|Adverse Event|4|||
143036095|NCT01569152|515673408|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
143036096|NCT01569152|515673409|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
143036097|NCT01569152|515673410|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
143036098|NCT01569152|515673408|FG000|Safety Extension, Period 3|Physician Decision|0|||
143036099|NCT01569152|515673409|FG001|Safety Extension, Period 3|Physician Decision|0|||
143036100|NCT01569152|515673410|FG002|Safety Extension, Period 3|Physician Decision|2|||
143036101|NCT01569152|515673408|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
143036102|NCT01569152|515673409|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
143036103|NCT01569152|515673410|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
143036104|NCT01706536|515673411|FG000|Overall Study|Withdrawal by Subject|1|||
143036105|NCT01706536|515673412|FG001|Overall Study|Withdrawal by Subject|0|||
143036106|NCT01706536|515673413|FG002|Overall Study|Withdrawal by Subject|1|||
143036107|NCT01706536|515673414|FG003|Overall Study|Withdrawal by Subject|0|||
143036108|NCT01706536|515673415|FG004|Overall Study|Withdrawal by Subject|0|||
143036109|NCT01706536|515673411|FG000|Overall Study|Adverse Event|2|||
143036110|NCT01706536|515673412|FG001|Overall Study|Adverse Event|3|||
143036111|NCT01706536|515673413|FG002|Overall Study|Adverse Event|4|||
143036112|NCT01706536|515673414|FG003|Overall Study|Adverse Event|3|||
143036113|NCT01706536|515673415|FG004|Overall Study|Adverse Event|2|||
143036114|NCT01706536|515673411|FG000|Overall Study|Lack of Efficacy|1|||
143036115|NCT01706536|515673412|FG001|Overall Study|Lack of Efficacy|0|||
143036116|NCT01706536|515673413|FG002|Overall Study|Lack of Efficacy|0|||
143036117|NCT01706536|515673414|FG003|Overall Study|Lack of Efficacy|1|||
143036118|NCT01706536|515673415|FG004|Overall Study|Lack of Efficacy|0|||
143036119|NCT01706536|515673411|FG000|Overall Study|non compliance|0|||
143036120|NCT01706536|515673412|FG001|Overall Study|non compliance|1|||
143036121|NCT01706536|515673413|FG002|Overall Study|non compliance|0|||
143036122|NCT01706536|515673414|FG003|Overall Study|non compliance|0|||
143036123|NCT01706536|515673415|FG004|Overall Study|non compliance|0|||
143036124|NCT01469546|515673418|FG000|Received 5 mg Dose|Adverse Event|13|||
143036125|NCT01469546|515673418|FG000|Received 5 mg Dose|Death|2|||
143036126|NCT01469546|515673418|FG000|Received 5 mg Dose|Protocol Violation|2|||
143036127|NCT01469546|515673418|FG000|Received 5 mg Dose|Progressive Disease|3|||
143036128|NCT01469546|515673418|FG000|Received 5 mg Dose|Physician Decision|3|||
143036129|NCT00385684|515673419|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
143036130|NCT00385684|515673420|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
143036131|NCT00385684|515673419|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
143036132|NCT00385684|515673420|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
143036133|NCT00385684|515673419|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
143036134|NCT00385684|515673420|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
143036135|NCT01387737|515674925|FG000|Overall Study|Adverse Event|20|||
143036136|NCT01387737|515674926|FG001|Overall Study|Adverse Event|30|||
143036137|NCT01387737|515674925|FG000|Overall Study|Lack of Efficacy|1|||
143036138|NCT01387737|515674926|FG001|Overall Study|Lack of Efficacy|0|||
143036139|NCT01387737|515674925|FG000|Overall Study|Physician Decision|3|||
143036140|NCT01387737|515674926|FG001|Overall Study|Physician Decision|10|||
143036141|NCT01387737|515674925|FG000|Overall Study|Withdrawal by Subject|27|||
143036142|NCT01387737|515674926|FG001|Overall Study|Withdrawal by Subject|31|||
143036143|NCT01387737|515674925|FG000|Overall Study|Clearly not eligible for the study|1|||
143036144|NCT01387737|515674926|FG001|Overall Study|Clearly not eligible for the study|3|||
143036145|NCT02817841|515674928|FG000|Overall Study|Lost to Follow-up|287|||
143036146|NCT02817841|515674928|FG000|Overall Study|Withdrawal by Subject|183|||
143036147|NCT02817841|515674928|FG000|Overall Study|Adverse event not related to bleeding|131|||
143036148|NCT02817841|515674928|FG000|Overall Study|Adverse event related to bleeding|51|||
143036149|NCT02817841|515674928|FG000|Overall Study|Pregnancy|32|||
143036150|NCT02817841|515674928|FG000|Overall Study|Pregnancy wish|17|||
143036151|NCT02817841|515674928|FG000|Overall Study|Other reasons|53|||
143036152|NCT02817841|515674928|FG000|Overall Study|Protocol Violation|94|||
143036153|NCT00397488|515674929|FG000|Overall Study|Withdrawal by Subject|3|||
143036154|NCT00397488|515674929|FG000|Overall Study|Adverse Event|3|||
143036155|NCT00397488|515674929|FG000|Overall Study|Death|1|||
143036156|NCT02424097|515674932|FG000|Overall Study|Lost to Follow-up|1|||
143036157|NCT02424097|515674933|FG001|Overall Study|Lost to Follow-up|2|||
143036158|NCT01215981|515674936|FG000|Overall Study|Physician Decision|0|||
143036159|NCT01215981|515674937|FG001|Overall Study|Physician Decision|1|||
143036160|NCT01215981|515674936|FG000|Overall Study|Protocol Violation|1|||
143036161|NCT01215981|515674937|FG001|Overall Study|Protocol Violation|0|||
143036162|NCT01215981|515674936|FG000|Overall Study|Withdrawal by Subject|1|||
143036163|NCT01215981|515674937|FG001|Overall Study|Withdrawal by Subject|0|||
143036164|NCT03075761|515674938|FG000|Overall Study|Lost to Follow-up|1|||
143036165|NCT03075761|515674939|FG001|Overall Study|Lost to Follow-up|6|||
143036166|NCT03597256|515674940|FG000|Overall Study|Lost to Follow-up|3|||
143036167|NCT03597256|515674941|FG001|Overall Study|Lost to Follow-up|1|||
143036168|NCT03597256|515674940|FG000|Overall Study|Withdrawal by Subject|0|||
143036169|NCT03597256|515674941|FG001|Overall Study|Withdrawal by Subject|1|||
143036170|NCT03597256|515674940|FG000|Overall Study|Could not return for treatment|0|||
143036171|NCT03597256|515674941|FG001|Overall Study|Could not return for treatment|1|||
143036172|NCT03597256|515674940|FG000|Overall Study|Moved from location|0|||
143036173|NCT03597256|515674941|FG001|Overall Study|Moved from location|1|||
143036174|NCT03597256|515674940|FG000|Overall Study|Not accepted the treatment|0|||
143036175|NCT03597256|515674941|FG001|Overall Study|Not accepted the treatment|1|||
143036176|NCT02943447|515674942|FG000|Blinded Study Phase|Withdrew Consent|1|||
143036177|NCT02943447|515674943|FG001|Blinded Study Phase|Withdrew Consent|2|||
143036178|NCT02943447|515674944|FG002|Blinded Study Phase|Withdrew Consent|1|||
143036179|NCT02943447|515674942|FG000|Blinded Study Phase|Adverse Event|3|||
143036180|NCT02943447|515674943|FG001|Blinded Study Phase|Adverse Event|0|||
143036181|NCT02943447|515674944|FG002|Blinded Study Phase|Adverse Event|0|||
143036182|NCT02943447|515674942|FG000|Blinded Study Phase|Investigator's discretion|1|||
143036183|NCT02943447|515674943|FG001|Blinded Study Phase|Investigator's discretion|0|||
143036184|NCT02943447|515674944|FG002|Blinded Study Phase|Investigator's discretion|0|||
143036185|NCT02943447|515674942|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
143036186|NCT02943447|515674943|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
143036187|NCT02943447|515674944|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
143036188|NCT02943447|515674942|FG000|Open-Label Extension Phase|Adverse Event|4|||
143036189|NCT02943447|515674943|FG001|Open-Label Extension Phase|Adverse Event|7|||
143036190|NCT02943447|515674944|FG002|Open-Label Extension Phase|Adverse Event|3|||
143036191|NCT02943447|515674942|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
143036192|NCT02943447|515674943|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
143036193|NCT02943447|515674944|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
143036194|NCT02943447|515674942|FG000|Open-Label Extension Phase|Withdrew consent|1|||
143036195|NCT02943447|515674943|FG001|Open-Label Extension Phase|Withdrew consent|1|||
143036196|NCT02943447|515674944|FG002|Open-Label Extension Phase|Withdrew consent|1|||
143036197|NCT02943447|515674942|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
143036198|NCT02943447|515674943|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
143036199|NCT02943447|515674944|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
143036200|NCT00840632|515674949|FG000|First Intervention|Withdrawal by Subject|0|||
143036201|NCT00840632|515674950|FG001|First Intervention|Withdrawal by Subject|1|||
143036202|NCT00840632|515674949|FG000|Washout|Withdrawal by Subject|1|||
143036203|NCT00840632|515674950|FG001|Washout|Withdrawal by Subject|1|||
143036204|NCT01136382|515674953|FG000|Overall Study|Other|8|||
143238684|NCT05462756|516429747|FG001|Treatment Period|Physician Decision|0|||
143238685|NCT05462756|516429746|FG000|Treatment Period|Protocol Violation|0|||
143238686|NCT05462756|516429747|FG001|Treatment Period|Protocol Violation|1|||
143238687|NCT05462756|516429746|FG000|Treatment Period|Withdrawal by Subject|5|||
143238688|NCT05462756|516429747|FG001|Treatment Period|Withdrawal by Subject|12|||
143238689|NCT05462756|516429746|FG000|Follow-Up Period|Adverse Event|1|||
143238690|NCT05462756|516429747|FG001|Follow-Up Period|Adverse Event|0|||
143238691|NCT05462756|516429746|FG000|Follow-Up Period|Death|1|||
143238692|NCT05462756|516429747|FG001|Follow-Up Period|Death|0|||
143238693|NCT05462756|516429746|FG000|Follow-Up Period|Lost to Follow-up|3|||
143238694|NCT05462756|516429747|FG001|Follow-Up Period|Lost to Follow-up|1|||
143238695|NCT05462756|516429746|FG000|Follow-Up Period|Withdrawal by Subject|0|||
143238696|NCT05462756|516429747|FG001|Follow-Up Period|Withdrawal by Subject|4|||
143238697|NCT04040933|516429748|FG000|Overall Study|Protocol Violation|1|||
143238698|NCT04040933|516429748|FG000|Overall Study|Withdrawal by Subject|2|||
143238699|NCT00641667|516429751|FG000|Overall Study|Withdrawal by Subject|1|||
143495637|NCT01505894|517357686|FG004|Overall Study|Adverse Event|0|||
143495638|NCT01505894|517357687|FG005|Overall Study|Adverse Event|0|||
143495639|NCT01505894|517357688|FG006|Overall Study|Adverse Event|0|||
143495640|NCT01505894|517357689|FG007|Overall Study|Adverse Event|0|||
143495641|NCT01505894|517357690|FG008|Overall Study|Adverse Event|0|||
143495642|NCT01505894|517357682|FG000|Overall Study|Other than specified|0|||
143495643|NCT01505894|517357683|FG001|Overall Study|Other than specified|0|||
143495644|NCT01505894|517357684|FG002|Overall Study|Other than specified|0|||
143036205|NCT01136382|515674954|FG001|Overall Study|Other|3|||
143036206|NCT01136382|515674953|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
143036207|NCT01136382|515674954|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
143036208|NCT01136382|515674953|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
143036209|NCT01136382|515674954|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
143036210|NCT01136382|515674953|FG000|Overall Study|Withdrawal by Subject|4|||
143036211|NCT01136382|515674954|FG001|Overall Study|Withdrawal by Subject|1|||
143036212|NCT01725529|515674960|FG000|Overall Study|Adverse Event|1|||
143238700|NCT00641667|516429751|FG000|Overall Study|Adverse Event|1|||
143495645|NCT01505894|517357685|FG003|Overall Study|Other than specified|0|||
143495646|NCT01505894|517357686|FG004|Overall Study|Other than specified|1|||
143036213|NCT01725529|515674961|FG001|Overall Study|Adverse Event|0|||
143238701|NCT00641667|516429751|FG000|Overall Study|Physician Decision|1|||
143238702|NCT00641667|516429751|FG000|Overall Study|Worsening of underlying disease|3|||
143495647|NCT01505894|517357687|FG005|Overall Study|Other than specified|0|||
143238703|NCT01235741|516429752|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
143036214|NCT01725529|515674962|FG002|Overall Study|Adverse Event|0|||
143036215|NCT01725529|515674960|FG000|Overall Study|Lost to Follow-up|2|||
143036216|NCT01725529|515674961|FG001|Overall Study|Lost to Follow-up|1|||
143036217|NCT01725529|515674962|FG002|Overall Study|Lost to Follow-up|1|||
143036218|NCT01725529|515674960|FG000|Overall Study|Protocol Violation|0|||
143036219|NCT01725529|515674961|FG001|Overall Study|Protocol Violation|1|||
143036220|NCT01725529|515674962|FG002|Overall Study|Protocol Violation|1|||
143036221|NCT01725529|515674960|FG000|Overall Study|Withdrawal by Subject|12|||
143036222|NCT01725529|515674961|FG001|Overall Study|Withdrawal by Subject|14|||
143036223|NCT01725529|515674962|FG002|Overall Study|Withdrawal by Subject|8|||
143036224|NCT02300103|515674967|FG000|Overall Study|Lack of Efficacy|3|||
143036225|NCT02300103|515674967|FG000|Overall Study|Protocol Violation|1|||
143036226|NCT02300103|515674967|FG000|Overall Study|Withdrew Consent|2|||
143036227|NCT04466111|515674969|FG000|Prior to Trial Phase|Physician Decision|1|||
143036228|NCT04869787|515674975|FG000|Screening|Physician Decision|1|||
143036229|NCT04869787|515674975|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
143036230|NCT00813293|515674976|FG000|Overall Study|Intercurrent illness|1|||
143036231|NCT00813293|515674977|FG001|Overall Study|Intercurrent illness|0|||
143036232|NCT00813293|515674976|FG000|Overall Study|Adverse Event|0|||
143036233|NCT00813293|515674977|FG001|Overall Study|Adverse Event|1|||
143036234|NCT02794974|515674978|FG000|Overall Study|Physician Decision|0|||
143036235|NCT02794974|515674979|FG001|Overall Study|Physician Decision|1|||
143238704|NCT01235741|516429753|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
143238705|NCT01235741|516429754|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
143238706|NCT01235741|516429752|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
143238707|NCT01235741|516429753|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
143238708|NCT01235741|516429754|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
143238709|NCT01235741|516429752|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
143036236|NCT02202850|515674980|FG000|Overall Study|Other|2|||
143036237|NCT02202850|515674981|FG001|Overall Study|Other|2|||
143036238|NCT02202850|515674980|FG000|Overall Study|Enbrel treatment discontinued|15|||
143036239|NCT02202850|515674981|FG001|Overall Study|Enbrel treatment discontinued|3|||
143036240|NCT02202850|515674980|FG000|Overall Study|Lost to Follow-up|7|||
143036241|NCT02202850|515674981|FG001|Overall Study|Lost to Follow-up|1|||
143036242|NCT01873586|515674982|FG000|Overall Study|Lost to Follow-up|3|||
143036243|NCT01981720|515674983|FG000|Overall Study|Adverse Event|1|||
143036244|NCT01981720|515674983|FG000|Overall Study|Withdrawal by Subject|3|||
143036245|NCT01981720|515674983|FG000|Overall Study|Pregnancy|1|||
143036246|NCT00282048|515674984|FG000|Overall Study|Lack of Efficacy|30|||
143036247|NCT00282048|515674984|FG000|Overall Study|Adverse Event|22|||
143036248|NCT00282048|515674984|FG000|Overall Study|Withdrawal by Subject|1|||
143036249|NCT00282048|515674984|FG000|Overall Study|Other|8|||
143036250|NCT00282048|515674984|FG000|Overall Study|Ongoing|1|||
143036251|NCT03522675|515674986|FG000|Overall Study|Screen fail|1|||
143036252|NCT03522675|515674986|FG000|Overall Study|Non-reactive to histamine|1|||
143036253|NCT00707161|515674987|FG000|Overall Study|Physician Decision|6|||
143036254|NCT02674477|515674988|FG000|Overall Study|Protocol Violation|8|||
143036255|NCT02674477|515674989|FG001|Overall Study|Protocol Violation|2|||
143036256|NCT00296647|515674990|FG000|Overall Study|Death|4|||
143036257|NCT00296647|515674991|FG001|Overall Study|Death|1|||
143036258|NCT00296647|515674992|FG002|Overall Study|Death|2|||
143036259|NCT00296647|515674993|FG003|Overall Study|Death|1|||
143036260|NCT00296647|515674994|FG004|Overall Study|Death|1|||
143036261|NCT00296647|515674990|FG000|Overall Study|Withdrawal by Subject|28|||
143036262|NCT00296647|515674991|FG001|Overall Study|Withdrawal by Subject|27|||
143036263|NCT00296647|515674992|FG002|Overall Study|Withdrawal by Subject|32|||
143036264|NCT00296647|515674993|FG003|Overall Study|Withdrawal by Subject|16|||
143036265|NCT00296647|515674994|FG004|Overall Study|Withdrawal by Subject|19|||
143036266|NCT00565448|515674995|FG000|Overall Study|Adverse Event|1|||
143036267|NCT00565448|515674996|FG001|Overall Study|Adverse Event|2|||
143036268|NCT00565448|515674995|FG000|Overall Study|Disease progression|1|||
143036269|NCT00565448|515674996|FG001|Overall Study|Disease progression|0|||
143036270|NCT00565448|515674995|FG000|Overall Study|Withdrawal by Subject|1|||
143036271|NCT00565448|515674996|FG001|Overall Study|Withdrawal by Subject|0|||
143036272|NCT01863745|515674997|FG000|Overall Study|Disease Progression|9|||
143036273|NCT01863745|515674997|FG000|Overall Study|Adverse Event|2|||
143238710|NCT01235741|516429753|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
143238711|NCT01235741|516429754|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
143495648|NCT01505894|517357688|FG006|Overall Study|Other than specified|0|||
143495649|NCT01505894|517357689|FG007|Overall Study|Other than specified|0|||
143036274|NCT01863745|515674997|FG000|Overall Study|Death|1|||
143036275|NCT01863745|515674997|FG000|Overall Study|Withdrawal by Subject|1|||
143036276|NCT00193609|515674998|FG000|Overall Study|Lack of Efficacy|2|||
143036277|NCT00193609|515674998|FG000|Overall Study|Adverse Event|2|||
143036278|NCT00735904|515675000|FG000|Overall Study|Adverse Event|3|||
143036279|NCT00735904|515675000|FG000|Overall Study|Death|20|||
143036280|NCT00735904|515675000|FG000|Overall Study|Protocol Violation|1|||
143036281|NCT00735904|515675000|FG000|Overall Study|Withdrawal by Subject|1|||
143036282|NCT00735904|515675000|FG000|Overall Study|Study Terminated by Sponsor|5|||
143036283|NCT00735904|515675000|FG000|Overall Study|Other|8|||
143036284|NCT01171963|515675004|FG000|Overall Study|Adverse Event|10|||
143036285|NCT01171963|515675005|FG001|Overall Study|Adverse Event|15|||
143036286|NCT01171963|515675004|FG000|Overall Study|Lost to Follow-up|23|||
143036287|NCT01171963|515675005|FG001|Overall Study|Lost to Follow-up|24|||
143036288|NCT01171963|515675004|FG000|Overall Study|Other - diarrhoea|1|||
143036289|NCT01171963|515675005|FG001|Overall Study|Other - diarrhoea|0|||
143036290|NCT01171963|515675004|FG000|Overall Study|Withdrawal by Subject|114|||
143036291|NCT01171963|515675005|FG001|Overall Study|Withdrawal by Subject|129|||
143036292|NCT05093205|515675006|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
143036293|NCT05093205|515675007|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
143036294|NCT05093205|515675008|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
143036295|NCT05093205|515675009|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
143036296|NCT05093205|515675010|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
143036297|NCT05093205|515675011|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
143036298|NCT05093205|515675012|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
143036299|NCT05093205|515675013|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
143036300|NCT05093205|515675014|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
143036301|NCT05093205|515675015|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
143036302|NCT05093205|515675016|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
143036303|NCT05093205|515675017|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
143036304|NCT05093205|515675018|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
143036305|NCT05093205|515675006|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
143036306|NCT05093205|515675007|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
143036307|NCT05093205|515675008|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
143036308|NCT05093205|515675009|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
143036309|NCT05093205|515675010|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
143036310|NCT05093205|515675011|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
143036311|NCT05093205|515675012|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
143036312|NCT05093205|515675013|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
143036313|NCT05093205|515675014|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
143036314|NCT05093205|515675015|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
143036315|NCT05093205|515675016|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
143036316|NCT05093205|515675017|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
143036317|NCT05093205|515675018|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
143036318|NCT05093205|515675006|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
143036319|NCT05093205|515675007|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
143036320|NCT05093205|515675008|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
143036321|NCT05093205|515675009|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
143036322|NCT05093205|515675010|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
143036323|NCT05093205|515675011|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
143036324|NCT05093205|515675012|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
143036325|NCT05093205|515675013|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
143036326|NCT05093205|515675014|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
143036327|NCT05093205|515675015|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
143036328|NCT05093205|515675016|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
143036329|NCT05093205|515675017|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
143036330|NCT05093205|515675018|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
143036331|NCT05093205|515675006|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
143036332|NCT05093205|515675007|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
143036333|NCT05093205|515675008|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
143036334|NCT05093205|515675009|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
143036335|NCT05093205|515675010|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
143036336|NCT05093205|515675011|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
143036337|NCT05093205|515675012|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
143036338|NCT05093205|515675013|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
143036339|NCT05093205|515675014|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
143036340|NCT05093205|515675015|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
143036341|NCT05093205|515675016|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
143036342|NCT05093205|515675017|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
143036343|NCT05093205|515675018|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
143036344|NCT05093205|515675006|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
143036345|NCT05093205|515675007|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
143036346|NCT05093205|515675008|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
143036347|NCT05093205|515675009|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
143036348|NCT05093205|515675010|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
143036349|NCT05093205|515675011|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
143036350|NCT05093205|515675012|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
143036351|NCT05093205|515675013|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
143036352|NCT05093205|515675014|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
143036353|NCT05093205|515675015|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
143036354|NCT05093205|515675016|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
143036355|NCT05093205|515675017|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
143036356|NCT05093205|515675018|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
143036357|NCT05093205|515675006|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
143036358|NCT05093205|515675007|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
143036359|NCT05093205|515675008|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
143036360|NCT05093205|515675009|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
143036361|NCT05093205|515675010|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
143036362|NCT05093205|515675011|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
143036363|NCT05093205|515675012|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
143036364|NCT05093205|515675013|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
143036365|NCT05093205|515675014|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
143036366|NCT05093205|515675015|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
143036367|NCT05093205|515675016|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
143036368|NCT05093205|515675017|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
143036369|NCT05093205|515675018|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
143036370|NCT05093205|515675006|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
143036371|NCT05093205|515675007|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
143036372|NCT05093205|515675008|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
143036373|NCT05093205|515675009|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
143036374|NCT05093205|515675010|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
143036375|NCT05093205|515675011|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
143036376|NCT05093205|515675012|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
143036377|NCT05093205|515675013|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
143036378|NCT05093205|515675014|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
143036379|NCT05093205|515675015|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
143036380|NCT05093205|515675016|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
143036381|NCT05093205|515675017|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
143036382|NCT05093205|515675018|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
143036383|NCT05093205|515675006|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
143036384|NCT05093205|515675007|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
143036385|NCT05093205|515675008|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
143036386|NCT05093205|515675009|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
143036387|NCT05093205|515675010|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
143036388|NCT05093205|515675011|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
143036389|NCT05093205|515675012|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
143036390|NCT05093205|515675013|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
143036391|NCT05093205|515675014|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
143036392|NCT05093205|515675015|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
143036393|NCT05093205|515675016|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
143036394|NCT05093205|515675017|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
143036395|NCT05093205|515675018|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
143036396|NCT05093205|515675006|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
143036397|NCT05093205|515675007|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
143036398|NCT05093205|515675008|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
143036399|NCT05093205|515675009|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
143036400|NCT05093205|515675010|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
143036401|NCT05093205|515675011|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
143036402|NCT05093205|515675012|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
143036403|NCT05093205|515675013|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
143036404|NCT05093205|515675014|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
143036405|NCT05093205|515675015|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
143036406|NCT05093205|515675016|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
143036407|NCT05093205|515675017|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
143036408|NCT05093205|515675018|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
143036409|NCT05093205|515675006|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
143238712|NCT01235741|516429752|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
143238713|NCT01235741|516429753|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
143495650|NCT01505894|517357690|FG008|Overall Study|Other than specified|0|||
143495651|NCT02522767|517357692|FG000|Double-blind|Withdrawal by Subject|8|||
143495652|NCT02522767|517357693|FG001|Double-blind|Withdrawal by Subject|11|||
143036410|NCT05093205|515675007|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
143495653|NCT02522767|517357692|FG000|Double-blind|Lost to Follow-up|1|||
143495654|NCT02522767|517357693|FG001|Double-blind|Lost to Follow-up|0|||
143495655|NCT02522767|517357692|FG000|Double-blind|Adverse Event|1|||
143036411|NCT05093205|515675008|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
143036412|NCT05093205|515675009|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
143036413|NCT05093205|515675010|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
143036414|NCT05093205|515675011|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
143036415|NCT05093205|515675012|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
143036416|NCT05093205|515675013|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
143238714|NCT01235741|516429754|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
143495656|NCT02522767|517357693|FG001|Double-blind|Adverse Event|10|||
143036417|NCT05093205|515675014|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
143036418|NCT05093205|515675015|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
143036419|NCT05093205|515675016|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
143036420|NCT05093205|515675017|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
143036421|NCT05093205|515675018|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
143036422|NCT05093205|515675006|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
143036423|NCT05093205|515675007|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
143036424|NCT05093205|515675008|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
143036425|NCT05093205|515675009|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
143036426|NCT05093205|515675010|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
143036427|NCT05093205|515675011|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
143036428|NCT05093205|515675012|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
143036429|NCT05093205|515675013|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
143036430|NCT05093205|515675014|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
143036431|NCT05093205|515675015|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
143036432|NCT05093205|515675016|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
143036433|NCT05093205|515675017|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
143036434|NCT05093205|515675018|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
143036435|NCT05093205|515675006|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
143036436|NCT05093205|515675007|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
143036437|NCT05093205|515675008|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
143036438|NCT05093205|515675009|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
143036439|NCT05093205|515675010|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
143036440|NCT05093205|515675011|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
143036441|NCT05093205|515675012|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
143036442|NCT05093205|515675013|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
143036443|NCT05093205|515675014|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
143036444|NCT05093205|515675015|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
143036445|NCT05093205|515675016|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
143036446|NCT05093205|515675017|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
143036447|NCT05093205|515675018|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
143036448|NCT05093205|515675006|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
143036449|NCT05093205|515675007|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
143036450|NCT05093205|515675008|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
143036451|NCT05093205|515675009|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
143036452|NCT05093205|515675010|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
143036453|NCT05093205|515675011|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
143036454|NCT05093205|515675012|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
143036455|NCT05093205|515675013|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
143036456|NCT05093205|515675014|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
143036457|NCT05093205|515675015|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
143036458|NCT05093205|515675016|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
143036459|NCT05093205|515675017|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
143036460|NCT05093205|515675018|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
143036461|NCT05093205|515675006|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
143036462|NCT05093205|515675007|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
143036463|NCT05093205|515675008|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
143036464|NCT05093205|515675009|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
143036465|NCT05093205|515675010|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
143036466|NCT05093205|515675011|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
143036467|NCT05093205|515675012|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
143036468|NCT05093205|515675013|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
143036469|NCT05093205|515675014|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
143036470|NCT05093205|515675015|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
143495657|NCT02522767|517357692|FG000|Double-blind|Protocol Violation|0|||
143036471|NCT05093205|515675016|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
143161189|NCT01133977|516135500|FG003|Overall Study|Started a New Line of Therapy|25|||
143161190|NCT01133977|516135501|FG004|Overall Study|Started a New Line of Therapy|33|||
143161191|NCT01133977|516135497|FG000|Overall Study|Lost to Follow-up|0|||
143161192|NCT01133977|516135498|FG001|Overall Study|Lost to Follow-up|0|||
143161193|NCT01133977|516135499|FG002|Overall Study|Lost to Follow-up|0|||
143161194|NCT01133977|516135500|FG003|Overall Study|Lost to Follow-up|2|||
143161195|NCT01133977|516135501|FG004|Overall Study|Lost to Follow-up|1|||
143161196|NCT01133977|516135497|FG000|Overall Study|Withdrawal by Subject|0|||
143161197|NCT01133977|516135498|FG001|Overall Study|Withdrawal by Subject|0|||
143161198|NCT01133977|516135499|FG002|Overall Study|Withdrawal by Subject|0|||
143495658|NCT02522767|517357693|FG001|Double-blind|Protocol Violation|1|||
143495659|NCT02522767|517357692|FG000|Double-blind|Lack of Efficacy|0|||
143495660|NCT02522767|517357693|FG001|Double-blind|Lack of Efficacy|2|||
143036472|NCT05093205|515675017|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
143036473|NCT05093205|515675018|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
143161199|NCT01133977|516135500|FG003|Overall Study|Withdrawal by Subject|5|||
143161200|NCT01133977|516135501|FG004|Overall Study|Withdrawal by Subject|1|||
143495661|NCT02522767|517357692|FG000|Double-blind|Protocol Deviation|1|||
143036474|NCT03361228|515675029|FG000|Overall Study|Other|1|||
143036475|NCT03361228|515675030|FG001|Overall Study|Other|1|||
143036476|NCT03361228|515675029|FG000|Overall Study|Death|3|||
143036477|NCT03361228|515675030|FG001|Overall Study|Death|0|||
143036478|NCT00302952|515675031|FG000|Overall Study|Physician Decision|1|||
143036479|NCT00302952|515675032|FG001|Overall Study|Physician Decision|1|||
143036480|NCT00302952|515675031|FG000|Overall Study|Withdrawal by Subject|2|||
143036481|NCT00302952|515675032|FG001|Overall Study|Withdrawal by Subject|3|||
143036482|NCT00302952|515675031|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
143036483|NCT00302952|515675032|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
143036484|NCT00336479|515675033|FG000|Overall Study|Adverse Event|8|||
143036485|NCT00336479|515675034|FG001|Overall Study|Adverse Event|11|||
143036486|NCT00336479|515675035|FG002|Overall Study|Adverse Event|18|||
143036487|NCT00336479|515675036|FG003|Overall Study|Adverse Event|4|||
143036488|NCT00336479|515675033|FG000|Overall Study|Noncompliant|1|||
143036489|NCT00336479|515675034|FG001|Overall Study|Noncompliant|7|||
143036490|NCT00336479|515675035|FG002|Overall Study|Noncompliant|3|||
143036491|NCT00336479|515675036|FG003|Overall Study|Noncompliant|0|||
143036492|NCT00336479|515675033|FG000|Overall Study|Physician Decision|2|||
143036493|NCT00336479|515675034|FG001|Overall Study|Physician Decision|3|||
143036494|NCT00336479|515675035|FG002|Overall Study|Physician Decision|1|||
143036495|NCT00336479|515675036|FG003|Overall Study|Physician Decision|0|||
143036496|NCT00336479|515675033|FG000|Overall Study|Lost to Follow-up|3|||
143036497|NCT00336479|515675034|FG001|Overall Study|Lost to Follow-up|2|||
143036498|NCT00336479|515675035|FG002|Overall Study|Lost to Follow-up|0|||
143036499|NCT00336479|515675036|FG003|Overall Study|Lost to Follow-up|0|||
143036500|NCT00336479|515675033|FG000|Overall Study|Withdrawal by Subject|3|||
143036501|NCT00336479|515675034|FG001|Overall Study|Withdrawal by Subject|2|||
143036502|NCT00336479|515675035|FG002|Overall Study|Withdrawal by Subject|3|||
143036503|NCT00336479|515675036|FG003|Overall Study|Withdrawal by Subject|0|||
143036504|NCT00336479|515675033|FG000|Overall Study|Other|0|||
143036505|NCT00336479|515675034|FG001|Overall Study|Other|0|||
143036506|NCT00336479|515675035|FG002|Overall Study|Other|1|||
143036507|NCT00336479|515675036|FG003|Overall Study|Other|0|||
143036508|NCT00336479|515675033|FG000|Overall Study|Virologic Stopping Rule|20|||
143036509|NCT00336479|515675034|FG001|Overall Study|Virologic Stopping Rule|0|||
143036510|NCT00336479|515675035|FG002|Overall Study|Virologic Stopping Rule|0|||
143036511|NCT00336479|515675036|FG003|Overall Study|Virologic Stopping Rule|0|||
143036512|NCT02979353|515675048|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
143036513|NCT02979353|515675049|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
143036514|NCT02979353|515675048|FG000|Overall Study|Withdrawal by Subject|16|||
143036515|NCT02979353|515675049|FG001|Overall Study|Withdrawal by Subject|12|||
143036516|NCT02979353|515675048|FG000|Overall Study|Death|10|||
143036517|NCT02979353|515675049|FG001|Overall Study|Death|11|||
143036518|NCT02979353|515675048|FG000|Overall Study|Transfer to Hospice Care|19|||
143036519|NCT02979353|515675049|FG001|Overall Study|Transfer to Hospice Care|14|||
143036520|NCT02979353|515675048|FG000|Overall Study|Lost to Follow-up|1|||
143036521|NCT02979353|515675049|FG001|Overall Study|Lost to Follow-up|5|||
143036522|NCT01722877|515675052|FG000|Overall Study|Death|1|||
143036523|NCT01722877|515675052|FG000|Overall Study|Lost to Follow-up|1|||
143036524|NCT03693430|515675053|FG000|Overall Study|Lost to Follow-up|3|||
143036525|NCT03693430|515675054|FG001|Overall Study|Lost to Follow-up|14|||
143036526|NCT03693430|515675053|FG000|Overall Study|Death|1|||
143036527|NCT03693430|515675054|FG001|Overall Study|Death|0|||
143036528|NCT03693430|515675053|FG000|Overall Study|Withdrawal by Subject|0|||
143036529|NCT03693430|515675054|FG001|Overall Study|Withdrawal by Subject|4|||
143036530|NCT02930005|515675056|FG000|Overall Study|Lost to Follow-up|1|||
143036531|NCT02930005|515675057|FG001|Overall Study|Lost to Follow-up|5|||
143036532|NCT02373098|515675058|FG000|Overall Study|Lost to Follow-up|1|||
143036533|NCT02373098|515675059|FG001|Overall Study|Lost to Follow-up|0|||
143036534|NCT02373098|515675058|FG000|Overall Study|Protocol Violation|3|||
143036535|NCT02373098|515675059|FG001|Overall Study|Protocol Violation|0|||
143036536|NCT02373098|515675058|FG000|Overall Study|Withdrawal by Subject|5|||
143036537|NCT02373098|515675059|FG001|Overall Study|Withdrawal by Subject|0|||
143036538|NCT02373098|515675058|FG000|Overall Study|Adverse Event|3|||
143036539|NCT02373098|515675059|FG001|Overall Study|Adverse Event|0|||
143495662|NCT02522767|517357693|FG001|Double-blind|Protocol Deviation|0|||
143495663|NCT02522767|517357692|FG000|Open-label|Withdrawal by Subject|2|||
143036540|NCT05067647|515675061|FG000|Overall Study|Lost to Follow-up|1|||
143036541|NCT03262012|515675066|FG000|Overall Study|Withdrawal by Subject|15|||
143036542|NCT03262012|515675067|FG001|Overall Study|Withdrawal by Subject|13|||
143036543|NCT03262012|515675068|FG002|Overall Study|Withdrawal by Subject|8|||
143036544|NCT03262012|515675069|FG003|Overall Study|Withdrawal by Subject|7|||
143036545|NCT03262012|515675066|FG000|Overall Study|Adverse Event|10|||
143036546|NCT03262012|515675067|FG001|Overall Study|Adverse Event|12|||
143036547|NCT03262012|515675068|FG002|Overall Study|Adverse Event|4|||
143036548|NCT03262012|515675069|FG003|Overall Study|Adverse Event|6|||
143036549|NCT03262012|515675066|FG000|Overall Study|Physician Decision|2|||
143036550|NCT03262012|515675067|FG001|Overall Study|Physician Decision|5|||
143036551|NCT03262012|515675068|FG002|Overall Study|Physician Decision|1|||
143036552|NCT03262012|515675069|FG003|Overall Study|Physician Decision|0|||
143036553|NCT03262012|515675066|FG000|Overall Study|Lack of Efficacy|0|||
143036554|NCT03262012|515675067|FG001|Overall Study|Lack of Efficacy|5|||
143036555|NCT03262012|515675068|FG002|Overall Study|Lack of Efficacy|1|||
143036556|NCT03262012|515675069|FG003|Overall Study|Lack of Efficacy|2|||
143036557|NCT03262012|515675066|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
143036558|NCT03262012|515675067|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
143036559|NCT03262012|515675068|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
143036560|NCT03262012|515675069|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
143036561|NCT02801877|515675072|FG000|Overall Study|Lost to Follow-up|1|||
143036562|NCT02801877|515675073|FG001|Overall Study|Lost to Follow-up|1|||
143036563|NCT02801877|515675074|FG002|Overall Study|Lost to Follow-up|2|||
143036564|NCT02801877|515675075|FG003|Overall Study|Lost to Follow-up|0|||
143036565|NCT02801877|515675072|FG000|Overall Study|Never Started Treatment|2|||
143036566|NCT02801877|515675073|FG001|Overall Study|Never Started Treatment|0|||
143036567|NCT02801877|515675074|FG002|Overall Study|Never Started Treatment|4|||
143036568|NCT02801877|515675075|FG003|Overall Study|Never Started Treatment|0|||
143036569|NCT00154102|515675076|FG000|Overall Study|investigational study phase ongoing|7|||
143036570|NCT00154102|515675077|FG001|Overall Study|investigational study phase ongoing|2|||
143036571|NCT02682602|515675079|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
143036572|NCT02682602|515675080|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
143036573|NCT02682602|515675079|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
143036574|NCT02682602|515675080|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
143036575|NCT03655106|515677035|FG000|Overall Study|Withdrawal by Subject|3|||
143036576|NCT03655106|515677036|FG001|Overall Study|Withdrawal by Subject|2|||
143036577|NCT03655106|515677035|FG000|Overall Study|Lost to Follow-up|2|||
143036578|NCT03655106|515677036|FG001|Overall Study|Lost to Follow-up|1|||
143036579|NCT03655106|515677035|FG000|Overall Study|Duplicate Enrollment|1|||
143036580|NCT03655106|515677036|FG001|Overall Study|Duplicate Enrollment|1|||
143036581|NCT03655106|515677035|FG000|Overall Study|Protocol Violation|3|||
143036582|NCT03655106|515677036|FG001|Overall Study|Protocol Violation|0|||
143036583|NCT01045096|515677040|FG000|Overall Study|Withdrawal by Subject|2|||
143036584|NCT01045096|515677041|FG001|Overall Study|Withdrawal by Subject|0|||
143036585|NCT01045096|515677042|FG002|Overall Study|Withdrawal by Subject|0|||
143036586|NCT01045096|515677040|FG000|Overall Study|Other|1|||
143036587|NCT01045096|515677041|FG001|Overall Study|Other|0|||
143036588|NCT01045096|515677042|FG002|Overall Study|Other|0|||
143036589|NCT00324168|515677047|FG000|Overall Study|Lost to Follow-up|19|||
143036590|NCT00324168|515677048|FG001|Overall Study|Lost to Follow-up|18|||
143036591|NCT00324168|515677047|FG000|Overall Study|Death|3|||
143036592|NCT00324168|515677048|FG001|Overall Study|Death|3|||
143036593|NCT00324168|515677047|FG000|Overall Study|Patient did not visit in f/u window|6|||
143036594|NCT00324168|515677048|FG001|Overall Study|Patient did not visit in f/u window|9|||
143036595|NCT03497897|515677049|FG000|Overall Study|Adverse Event|1|||
143036596|NCT03497897|515677050|FG001|Overall Study|Adverse Event|1|||
143036597|NCT03497897|515677051|FG002|Overall Study|Adverse Event|1|||
143036598|NCT03497897|515677049|FG000|Overall Study|Lost to Follow-up|2|||
143036599|NCT03497897|515677050|FG001|Overall Study|Lost to Follow-up|0|||
143036600|NCT03497897|515677051|FG002|Overall Study|Lost to Follow-up|2|||
143036601|NCT03497897|515677049|FG000|Overall Study|Physician Decision|1|||
143036602|NCT03497897|515677050|FG001|Overall Study|Physician Decision|0|||
143036603|NCT03497897|515677051|FG002|Overall Study|Physician Decision|0|||
143036604|NCT03497897|515677049|FG000|Overall Study|Subject/Guardian Decision|2|||
143036605|NCT03497897|515677050|FG001|Overall Study|Subject/Guardian Decision|1|||
143036606|NCT03497897|515677051|FG002|Overall Study|Subject/Guardian Decision|3|||
143036607|NCT01993030|515677056|FG000|Overall Study|Adverse Event|0|||
143036608|NCT01993030|515677057|FG001|Overall Study|Adverse Event|4|||
143036609|NCT01710657|515677058|FG000|Overall Study|Lost to Follow-up|2|||
143036610|NCT01710657|515677059|FG001|Overall Study|Lost to Follow-up|0|||
143036611|NCT01710657|515677060|FG002|Overall Study|Lost to Follow-up|1|||
143036612|NCT01710657|515677058|FG000|Overall Study|Protocol Violation|2|||
143036613|NCT01710657|515677059|FG001|Overall Study|Protocol Violation|2|||
143036614|NCT01710657|515677060|FG002|Overall Study|Protocol Violation|0|||
143036615|NCT01710657|515677058|FG000|Overall Study|Adverse Event|14|||
143036616|NCT01710657|515677059|FG001|Overall Study|Adverse Event|8|||
143364080|NCT03686683|516875530|FG000|Overall Study|Death|10|||
143036617|NCT01710657|515677060|FG002|Overall Study|Adverse Event|28|||
143036618|NCT01710657|515677058|FG000|Overall Study|Withdrawal by Subject|0|||
143036619|NCT01710657|515677059|FG001|Overall Study|Withdrawal by Subject|1|||
143036620|NCT01710657|515677060|FG002|Overall Study|Withdrawal by Subject|2|||
143036621|NCT01710657|515677058|FG000|Overall Study|Lack of Efficacy|0|||
143036622|NCT01710657|515677059|FG001|Overall Study|Lack of Efficacy|1|||
143036623|NCT01710657|515677060|FG002|Overall Study|Lack of Efficacy|1|||
143036624|NCT01049334|515677068|FG000|Overall Study|Withdrawal by Subject|5|||
143036625|NCT01049334|515677069|FG001|Overall Study|Withdrawal by Subject|3|||
143036626|NCT01049334|515677068|FG000|Overall Study|Adverse Event|2|||
143036627|NCT01049334|515677069|FG001|Overall Study|Adverse Event|3|||
143036628|NCT01049334|515677068|FG000|Overall Study|Physician Decision|2|||
143036629|NCT01049334|515677069|FG001|Overall Study|Physician Decision|0|||
143036630|NCT01049334|515677068|FG000|Overall Study|Protocol Violation|0|||
143036631|NCT01049334|515677069|FG001|Overall Study|Protocol Violation|1|||
143036632|NCT01367457|515677072|FG000|Overall Study|Death|2|||
143036633|NCT01367457|515677073|FG001|Overall Study|Death|0|||
143036634|NCT01367457|515677074|FG002|Overall Study|Death|0|||
143036635|NCT01367457|515677072|FG000|Overall Study|Investigator's decision|2|||
143036636|NCT01367457|515677073|FG001|Overall Study|Investigator's decision|0|||
143036637|NCT01367457|515677074|FG002|Overall Study|Investigator's decision|0|||
143036638|NCT01367457|515677072|FG000|Overall Study|Clinical decline (CD)|2|||
143036639|NCT01367457|515677073|FG001|Overall Study|Clinical decline (CD)|0|||
143036640|NCT01367457|515677074|FG002|Overall Study|Clinical decline (CD)|0|||
143036641|NCT01367457|515677072|FG000|Overall Study|Progression and death|8|||
143036642|NCT01367457|515677073|FG001|Overall Study|Progression and death|0|||
143036643|NCT01367457|515677074|FG002|Overall Study|Progression and death|0|||
143036644|NCT01367457|515677072|FG000|Overall Study|Toxicity|16|||
143036645|NCT01367457|515677073|FG001|Overall Study|Toxicity|0|||
143036646|NCT01367457|515677074|FG002|Overall Study|Toxicity|0|||
143036647|NCT01367457|515677072|FG000|Overall Study|Progression|137|||
143036648|NCT01367457|515677073|FG001|Overall Study|Progression|0|||
143036649|NCT01367457|515677074|FG002|Overall Study|Progression|0|||
143036650|NCT01367457|515677072|FG000|Overall Study|Patient asks for rest + slow progression|1|||
143036651|NCT01367457|515677073|FG001|Overall Study|Patient asks for rest + slow progression|0|||
143036652|NCT01367457|515677074|FG002|Overall Study|Patient asks for rest + slow progression|0|||
143036653|NCT01367457|515677072|FG000|Overall Study|Investigator's opinion, stable disease|1|||
143036654|NCT01367457|515677073|FG001|Overall Study|Investigator's opinion, stable disease|0|||
143036655|NCT01367457|515677074|FG002|Overall Study|Investigator's opinion, stable disease|0|||
143036656|NCT01367457|515677072|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
143036657|NCT01367457|515677073|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
143036658|NCT01367457|515677074|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
143036659|NCT01367457|515677072|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
143036660|NCT01367457|515677073|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
143036661|NCT01367457|515677074|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
143036662|NCT01367457|515677072|FG000|Overall Study|low grade toxicities + stable disease|1|||
143036663|NCT01367457|515677073|FG001|Overall Study|low grade toxicities + stable disease|0|||
143036664|NCT01367457|515677074|FG002|Overall Study|low grade toxicities + stable disease|0|||
143036665|NCT01367457|515677072|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
143036666|NCT01367457|515677073|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
143036667|NCT01367457|515677074|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
143036668|NCT01367457|515677072|FG000|Overall Study|Withdrawal by Subject|1|||
143036669|NCT01367457|515677073|FG001|Overall Study|Withdrawal by Subject|0|||
143036670|NCT01367457|515677074|FG002|Overall Study|Withdrawal by Subject|0|||
143036671|NCT01367457|515677072|FG000|Overall Study|CD, associated leukaemia|1|||
143036672|NCT01367457|515677073|FG001|Overall Study|CD, associated leukaemia|0|||
143036673|NCT01367457|515677074|FG002|Overall Study|CD, associated leukaemia|0|||
143036674|NCT01367457|515677072|FG000|Overall Study|Uncontrolled pain|1|||
143036675|NCT01367457|515677073|FG001|Overall Study|Uncontrolled pain|0|||
143036676|NCT01367457|515677074|FG002|Overall Study|Uncontrolled pain|0|||
143036677|NCT01367457|515677072|FG000|Overall Study|Overall status worsens to grade 4|1|||
143036678|NCT01367457|515677073|FG001|Overall Study|Overall status worsens to grade 4|0|||
143036679|NCT01367457|515677074|FG002|Overall Study|Overall status worsens to grade 4|0|||
143036680|NCT01367457|515677072|FG000|Overall Study|Stabilisation + frequent infections|1|||
143036681|NCT01367457|515677073|FG001|Overall Study|Stabilisation + frequent infections|0|||
143036682|NCT01367457|515677074|FG002|Overall Study|Stabilisation + frequent infections|0|||
143036683|NCT01367457|515677072|FG000|Overall Study|No clinical benefit|1|||
143036684|NCT01367457|515677073|FG001|Overall Study|No clinical benefit|0|||
143036685|NCT01367457|515677074|FG002|Overall Study|No clinical benefit|0|||
143036686|NCT01367457|515677072|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
143036687|NCT01367457|515677073|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
143036688|NCT01367457|515677074|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
143036689|NCT01367457|515677072|FG000|Overall Study|Overall decline|1|||
143036690|NCT01367457|515677073|FG001|Overall Study|Overall decline|0|||
143161201|NCT02105012|516135506|FG000|Overall Study|Withdrawal by Subject|11|||
143495664|NCT02522767|517357693|FG001|Open-label|Withdrawal by Subject|3|||
143036691|NCT01367457|515677074|FG002|Overall Study|Overall decline|0|||
143036692|NCT01367457|515677072|FG000|Overall Study|Rejection of treatment|1|||
143036693|NCT01367457|515677073|FG001|Overall Study|Rejection of treatment|0|||
143036694|NCT01367457|515677074|FG002|Overall Study|Rejection of treatment|0|||
143036695|NCT01367457|515677072|FG000|Overall Study|Lost to Follow-up|1|||
143161202|NCT02105012|516135506|FG000|Overall Study|Protocol Specified Criteria|9|||
143036696|NCT01367457|515677073|FG001|Overall Study|Lost to Follow-up|0|||
143036697|NCT01367457|515677074|FG002|Overall Study|Lost to Follow-up|0|||
143036698|NCT01367457|515677072|FG000|Overall Study|Death from septic shock|1|||
143161203|NCT02105012|516135506|FG000|Overall Study|Lost to Follow-up|4|||
143036699|NCT01367457|515677073|FG001|Overall Study|Death from septic shock|0|||
143036700|NCT01367457|515677074|FG002|Overall Study|Death from septic shock|0|||
143036701|NCT01367457|515677072|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
143036702|NCT01367457|515677073|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
143036703|NCT01367457|515677074|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
143036704|NCT01367457|515677072|FG000|Overall Study|Patient's Wish|1|||
143036705|NCT01367457|515677073|FG001|Overall Study|Patient's Wish|0|||
143036706|NCT01367457|515677074|FG002|Overall Study|Patient's Wish|0|||
143036707|NCT01367457|515677072|FG000|Overall Study|Palliative. Overall decline|1|||
143036708|NCT01367457|515677073|FG001|Overall Study|Palliative. Overall decline|0|||
143161204|NCT02105012|516135506|FG000|Overall Study|Protocol Violation|4|||
143161205|NCT02105012|516135506|FG000|Overall Study|Physician Decision|3|||
143161206|NCT02105012|516135506|FG000|Overall Study|Adverse Event|1|||
143161207|NCT02105012|516135506|FG000|Overall Study|Lack of Efficacy|1|||
143161208|NCT00474968|516135509|FG000|Overall Study|Withdrawal by Subject|8|||
143036709|NCT01367457|515677074|FG002|Overall Study|Palliative. Overall decline|0|||
143036710|NCT01367457|515677072|FG000|Overall Study|Suspected DP/suspected active infection|1|||
143036711|NCT01367457|515677073|FG001|Overall Study|Suspected DP/suspected active infection|0|||
143036712|NCT01367457|515677074|FG002|Overall Study|Suspected DP/suspected active infection|0|||
143036713|NCT03447262|515677077|FG000|Overall Study|Adverse Event|7|||
143036714|NCT03447262|515677077|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
143036715|NCT03447262|515677077|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
143036716|NCT03447262|515677077|FG000|Overall Study|Death|2|||
143036717|NCT03447262|515677077|FG000|Overall Study|Study Termination by Sponsor|455|||
143036718|NCT03447262|515677077|FG000|Overall Study|Other|4|||
143036719|NCT02058498|515677078|FG000|Overall Study|Withdrawal by Subject|4|||
143036720|NCT05327491|515677079|FG000|Periods 1 & 2|Miscellaneous|0|||
143161209|NCT00474968|516135510|FG001|Overall Study|Withdrawal by Subject|7|||
143036721|NCT05327491|515677080|FG001|Periods 1 & 2|Miscellaneous|1|||
143036722|NCT05327491|515677081|FG002|Periods 1 & 2|Miscellaneous|0|||
143036723|NCT05327491|515677082|FG003|Periods 1 & 2|Miscellaneous|0|||
143036724|NCT05327491|515677079|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
143036725|NCT05327491|515677080|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
143036726|NCT05327491|515677081|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
143036727|NCT05327491|515677082|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
143036728|NCT05612724|515677084|FG000|Overall Study|Lost to Follow-up|4|||
143036729|NCT03988803|515677093|FG000|Period 2|Prematurely discontinued from medication|2|||
143036730|NCT03988803|515677093|FG000|Period 2|Adverse Event|1|||
143036731|NCT02736721|515677094|FG000|Overall Study|Adverse Event|8|||
143036732|NCT02736721|515677094|FG000|Overall Study|Lost to Follow-up|3|||
143036733|NCT02736721|515677094|FG000|Overall Study|Other|5|||
143036734|NCT02422264|515677095|FG000|Overall Study|Serious Adverse Event|1|||
143036735|NCT02422264|515677096|FG001|Overall Study|Serious Adverse Event|0|||
143036736|NCT02422264|515677095|FG000|Overall Study|Withdrawal by Subject|1|||
143036737|NCT02422264|515677096|FG001|Overall Study|Withdrawal by Subject|2|||
143036738|NCT02422264|515677095|FG000|Overall Study|Migrated/moved from study area|3|||
143036739|NCT02422264|515677096|FG001|Overall Study|Migrated/moved from study area|1|||
143036740|NCT02422264|515677095|FG000|Overall Study|Subject vaccinated outside of the study|0|||
143036741|NCT02422264|515677096|FG001|Overall Study|Subject vaccinated outside of the study|1|||
143036742|NCT03021018|515677100|FG000|Overall Study|Adverse Event|1|||
143036743|NCT03021018|515677101|FG001|Overall Study|Adverse Event|0|||
143036744|NCT03021018|515677102|FG002|Overall Study|Adverse Event|0|||
143036745|NCT03021018|515677100|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
143036746|NCT03021018|515677101|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
143036747|NCT03021018|515677102|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
143495665|NCT02522767|517357692|FG000|Open-label|Lost to Follow-up|0|||
143495666|NCT02522767|517357693|FG001|Open-label|Lost to Follow-up|1|||
143495667|NCT02522767|517357692|FG000|Open-label|Adverse Event|2|||
143495668|NCT02522767|517357693|FG001|Open-label|Adverse Event|1|||
143495669|NCT02522767|517357692|FG000|Open-label|Lack of Efficacy|1|||
143495670|NCT02522767|517357693|FG001|Open-label|Lack of Efficacy|1|||
143495671|NCT02522767|517357692|FG000|Open-label|Protocol Violation|0|||
143495672|NCT02522767|517357693|FG001|Open-label|Protocol Violation|1|||
143495673|NCT03634800|517357694|FG000|Overall Study|Adverse Event|1|||
143161210|NCT00474968|516135509|FG000|Overall Study|Protocol Violation|9|||
143161211|NCT00474968|516135510|FG001|Overall Study|Protocol Violation|8|||
143161212|NCT00474968|516135509|FG000|Overall Study|Sample not collected|1|||
143495674|NCT03634800|517357694|FG000|Overall Study|Disease Progression|4|||
143495675|NCT03634800|517357694|FG000|Overall Study|Withdrawal by Subject|1|||
143161213|NCT00474968|516135510|FG001|Overall Study|Sample not collected|1|||
143495676|NCT02624492|517357698|FG000|Overall Study|Adverse Event|2|||
143495677|NCT02624492|517357699|FG001|Overall Study|Adverse Event|2|||
143036748|NCT05038293|515677111|FG000|Overall Study|device was not operating properly for one subject.|1|||
143161214|NCT00215553|516135511|FG000|Overall Study|Adverse Event|0|||
143161215|NCT00215553|516135512|FG001|Overall Study|Adverse Event|1|||
143495678|NCT02624492|517357700|FG002|Overall Study|Adverse Event|2|||
143036749|NCT05038293|515677112|FG001|Overall Study|device was not operating properly for one subject.|0|||
143036750|NCT05038293|515677111|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
143036751|NCT05038293|515677112|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
143036752|NCT01171989|515677113|FG000|Overall Study|Lost to Follow-up|0|||
143036753|NCT01171989|515677114|FG001|Overall Study|Lost to Follow-up|0|||
143036754|NCT01171989|515677115|FG002|Overall Study|Lost to Follow-up|1|||
143036755|NCT01389102|515677116|FG000|Overall Study|Adverse Event|1|||
143036756|NCT01389102|515677117|FG001|Overall Study|Adverse Event|3|||
143036757|NCT01389102|515677118|FG002|Overall Study|Adverse Event|2|||
143036758|NCT01389102|515677119|FG003|Overall Study|Adverse Event|2|||
143036759|NCT01389102|515677120|FG004|Overall Study|Adverse Event|2|||
143036760|NCT01389102|515677121|FG005|Overall Study|Adverse Event|2|||
143036761|NCT01389102|515677116|FG000|Overall Study|Hurricane Katrina|4|||
143036762|NCT01389102|515677117|FG001|Overall Study|Hurricane Katrina|2|||
143036763|NCT01389102|515677118|FG002|Overall Study|Hurricane Katrina|3|||
143036764|NCT01389102|515677119|FG003|Overall Study|Hurricane Katrina|0|||
143036765|NCT01389102|515677120|FG004|Overall Study|Hurricane Katrina|3|||
143036766|NCT01389102|515677121|FG005|Overall Study|Hurricane Katrina|1|||
143036767|NCT01389102|515677116|FG000|Overall Study|Lost to Follow-up|4|||
143036768|NCT01389102|515677117|FG001|Overall Study|Lost to Follow-up|1|||
143036769|NCT01389102|515677118|FG002|Overall Study|Lost to Follow-up|1|||
143036770|NCT01389102|515677119|FG003|Overall Study|Lost to Follow-up|2|||
143036771|NCT01389102|515677120|FG004|Overall Study|Lost to Follow-up|4|||
143036772|NCT01389102|515677121|FG005|Overall Study|Lost to Follow-up|1|||
143036773|NCT01389102|515677116|FG000|Overall Study|Protocol Violation|0|||
143036774|NCT01389102|515677117|FG001|Overall Study|Protocol Violation|0|||
143036775|NCT01389102|515677118|FG002|Overall Study|Protocol Violation|3|||
143036776|NCT01389102|515677119|FG003|Overall Study|Protocol Violation|0|||
143036777|NCT01389102|515677120|FG004|Overall Study|Protocol Violation|1|||
143036778|NCT01389102|515677121|FG005|Overall Study|Protocol Violation|1|||
143036779|NCT01389102|515677116|FG000|Overall Study|Withdrawal by Subject|7|||
143036780|NCT01389102|515677117|FG001|Overall Study|Withdrawal by Subject|4|||
143036781|NCT01389102|515677118|FG002|Overall Study|Withdrawal by Subject|9|||
143036782|NCT01389102|515677119|FG003|Overall Study|Withdrawal by Subject|2|||
143036783|NCT01389102|515677120|FG004|Overall Study|Withdrawal by Subject|3|||
143036784|NCT01389102|515677121|FG005|Overall Study|Withdrawal by Subject|3|||
143036785|NCT01389102|515677116|FG000|Overall Study|Subject Traveling Out of Country|0|||
143036786|NCT01389102|515677117|FG001|Overall Study|Subject Traveling Out of Country|0|||
143036787|NCT01389102|515677118|FG002|Overall Study|Subject Traveling Out of Country|0|||
143036788|NCT01389102|515677119|FG003|Overall Study|Subject Traveling Out of Country|1|||
143036789|NCT01389102|515677120|FG004|Overall Study|Subject Traveling Out of Country|0|||
143036790|NCT01389102|515677121|FG005|Overall Study|Subject Traveling Out of Country|0|||
143036791|NCT01389102|515677116|FG000|Overall Study|Subject Moved|2|||
143036792|NCT01389102|515677117|FG001|Overall Study|Subject Moved|0|||
143036793|NCT01389102|515677118|FG002|Overall Study|Subject Moved|1|||
143036794|NCT01389102|515677119|FG003|Overall Study|Subject Moved|0|||
143036795|NCT01389102|515677120|FG004|Overall Study|Subject Moved|0|||
143036796|NCT01389102|515677121|FG005|Overall Study|Subject Moved|0|||
143036797|NCT01389102|515677116|FG000|Overall Study|Unavailable due to husband's illness|0|||
143036798|NCT01389102|515677117|FG001|Overall Study|Unavailable due to husband's illness|1|||
143036799|NCT01389102|515677118|FG002|Overall Study|Unavailable due to husband's illness|0|||
143036800|NCT01389102|515677119|FG003|Overall Study|Unavailable due to husband's illness|0|||
143036801|NCT01389102|515677120|FG004|Overall Study|Unavailable due to husband's illness|0|||
143036802|NCT01389102|515677121|FG005|Overall Study|Unavailable due to husband's illness|0|||
143036803|NCT01389102|515677116|FG000|Overall Study|Investigator Judgement|0|||
143036804|NCT01389102|515677117|FG001|Overall Study|Investigator Judgement|1|||
143036805|NCT01389102|515677118|FG002|Overall Study|Investigator Judgement|0|||
143036806|NCT01389102|515677119|FG003|Overall Study|Investigator Judgement|0|||
143036807|NCT01389102|515677120|FG004|Overall Study|Investigator Judgement|0|||
143036808|NCT01389102|515677121|FG005|Overall Study|Investigator Judgement|0|||
143036809|NCT00893464|515677122|FG000|Overall Study|Did not complete therapy/experience PD|0|||
143036810|NCT00893464|515677123|FG001|Overall Study|Did not complete therapy/experience PD|0|||
143036811|NCT00893464|515677124|FG002|Overall Study|Did not complete therapy/experience PD|0|||
143036812|NCT00893464|515677125|FG003|Overall Study|Did not complete therapy/experience PD|0|||
143036813|NCT00893464|515677126|FG004|Overall Study|Did not complete therapy/experience PD|0|||
143036814|NCT00893464|515677127|FG005|Overall Study|Did not complete therapy/experience PD|0|||
143495679|NCT02624492|517357698|FG000|Overall Study|Progressive disease|0|||
143036815|NCT00893464|515677128|FG006|Overall Study|Did not complete therapy/experience PD|2|||
143036816|NCT00893464|515677129|FG007|Overall Study|Did not complete therapy/experience PD|2|||
143036817|NCT02910037|515677130|FG000|Overall Study|Withdrawal by Subject|4|||
143036818|NCT02910037|515677130|FG000|Overall Study|Lost to Follow-up|6|||
143036819|NCT00436553|515677131|FG000|Overall Study|Adverse Event|4|||
143036820|NCT00436553|515677132|FG001|Overall Study|Adverse Event|3|||
143036821|NCT00436553|515677133|FG002|Overall Study|Adverse Event|4|||
143036822|NCT00436553|515677131|FG000|Overall Study|Death|3|||
143036823|NCT00436553|515677132|FG001|Overall Study|Death|1|||
143036824|NCT00436553|515677133|FG002|Overall Study|Death|3|||
143036825|NCT00436553|515677131|FG000|Overall Study|Lost to Follow-up|0|||
143036826|NCT00436553|515677132|FG001|Overall Study|Lost to Follow-up|2|||
143036827|NCT00436553|515677133|FG002|Overall Study|Lost to Follow-up|0|||
143036828|NCT00436553|515677131|FG000|Overall Study|Protocol Violation|1|||
143036829|NCT00436553|515677132|FG001|Overall Study|Protocol Violation|0|||
143036830|NCT00436553|515677133|FG002|Overall Study|Protocol Violation|0|||
143036831|NCT00436553|515677131|FG000|Overall Study|Withdrawal by Subject|5|||
143036832|NCT00436553|515677132|FG001|Overall Study|Withdrawal by Subject|6|||
143036833|NCT00436553|515677133|FG002|Overall Study|Withdrawal by Subject|3|||
143036834|NCT01035060|515677138|FG000|Overall Study|Lost to Follow-up|0|||
143036835|NCT01035060|515677139|FG001|Overall Study|Lost to Follow-up|7|||
143036836|NCT01035060|515677138|FG000|Overall Study|Did not quality after 2nd screening|14|||
143036837|NCT01035060|515677139|FG001|Overall Study|Did not quality after 2nd screening|1|||
143036838|NCT01035060|515677138|FG000|Overall Study|Withdrawal by Subject|8|||
143036839|NCT01035060|515677139|FG001|Overall Study|Withdrawal by Subject|6|||
143036840|NCT01035060|515677138|FG000|Overall Study|Physician Decision|2|||
143036841|NCT01035060|515677139|FG001|Overall Study|Physician Decision|0|||
143036842|NCT03136380|515677140|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
143036843|NCT03136380|515677141|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
143036844|NCT03136380|515677142|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
143036845|NCT03136380|515677143|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
143036846|NCT03136380|515677144|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
143036847|NCT01772537|515677145|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
143036848|NCT01772537|515677146|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
143036849|NCT01772537|515677147|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
143036850|NCT02511782|515677148|FG000|Overall Study|Withdrawal by Subject|1|||
143036851|NCT02511782|515677149|FG001|Overall Study|Withdrawal by Subject|0|||
143036852|NCT02511782|515677150|FG002|Overall Study|Withdrawal by Subject|0|||
143036853|NCT03627091|515677151|FG000|Overall Study|Adverse Event|0|||
143036854|NCT03627091|515677152|FG001|Overall Study|Adverse Event|0|||
143036855|NCT03627091|515677153|FG002|Overall Study|Adverse Event|2|||
143036856|NCT03627091|515677151|FG000|Overall Study|Withdrawal by Subject|2|||
143036857|NCT03627091|515677152|FG001|Overall Study|Withdrawal by Subject|0|||
143036858|NCT03627091|515677153|FG002|Overall Study|Withdrawal by Subject|2|||
143036859|NCT03627091|515677151|FG000|Overall Study|Physician Decision|2|||
143036860|NCT03627091|515677152|FG001|Overall Study|Physician Decision|0|||
143036861|NCT03627091|515677153|FG002|Overall Study|Physician Decision|0|||
143036862|NCT03627091|515677151|FG000|Overall Study|Site terminated by sponsor|0|||
143036863|NCT03627091|515677152|FG001|Overall Study|Site terminated by sponsor|1|||
143036864|NCT03627091|515677153|FG002|Overall Study|Site terminated by sponsor|0|||
143036865|NCT03627091|515677151|FG000|Overall Study|Disease relapse|7|||
143036866|NCT03627091|515677152|FG001|Overall Study|Disease relapse|5|||
143036867|NCT03627091|515677153|FG002|Overall Study|Disease relapse|1|||
143036868|NCT03627091|515677151|FG000|Overall Study|Other|1|||
143036869|NCT03627091|515677152|FG001|Overall Study|Other|0|||
143036870|NCT03627091|515677153|FG002|Overall Study|Other|0|||
143036871|NCT00450190|515677154|FG000|Overall Study|Withdrawal by Subject|2|||
143036872|NCT01536574|515677155|FG000|Overall Study|Adverse Event|4|||
143036873|NCT01536574|515677156|FG001|Overall Study|Adverse Event|5|||
143036874|NCT01536574|515677155|FG000|Overall Study|Withdrawal by Subject|1|||
143036875|NCT01536574|515677156|FG001|Overall Study|Withdrawal by Subject|2|||
143036876|NCT01536574|515677155|FG000|Overall Study|Lack of Efficacy|1|||
143036877|NCT01536574|515677156|FG001|Overall Study|Lack of Efficacy|0|||
143036878|NCT01376167|515677157|FG000|Overall Study|Lost to Follow-up|2|||
143036879|NCT01376167|515677158|FG001|Overall Study|Lost to Follow-up|4|||
143036880|NCT01376167|515677159|FG002|Overall Study|Lost to Follow-up|2|||
143036881|NCT01376167|515677157|FG000|Overall Study|Physician Decision|1|||
143036882|NCT01376167|515677158|FG001|Overall Study|Physician Decision|1|||
143036883|NCT01376167|515677159|FG002|Overall Study|Physician Decision|0|||
143036884|NCT01376167|515677157|FG000|Overall Study|Withdrawal by Subject|1|||
143036885|NCT01376167|515677158|FG001|Overall Study|Withdrawal by Subject|5|||
143495680|NCT02624492|517357699|FG001|Overall Study|Progressive disease|2|||
143036886|NCT01376167|515677159|FG002|Overall Study|Withdrawal by Subject|4|||
143036887|NCT00834756|515677160|FG000|First Intervention|Adverse Event|1|||
143036888|NCT00834756|515677161|FG001|First Intervention|Adverse Event|0|||
143036889|NCT00834756|515677160|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
143036890|NCT00834756|515677161|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
143036891|NCT01498120|515677167|FG000|Overall Study|Lost to Follow-up|1|||
143036892|NCT01498120|515677167|FG000|Overall Study|Withdrawal by Subject|5|||
143036893|NCT01498120|515677167|FG000|Overall Study|AE, non-serious non-fatal|3|||
143036894|NCT01498120|515677167|FG000|Overall Study|Other|4|||
143036895|NCT00112463|515677170|FG000|Overall Study|Physician Decision|1|||
143036896|NCT00112463|515677170|FG000|Overall Study|Progression|30|||
143036897|NCT00112463|515677170|FG000|Overall Study|Second Primary|1|||
143036898|NCT00112463|515677170|FG000|Overall Study|Toxicity|3|||
143036899|NCT00112463|515677170|FG000|Overall Study|Withdrawal by Subject|2|||
143036900|NCT00112463|515677170|FG000|Overall Study|Never started treatment|2|||
143036901|NCT01118312|515677171|FG000|Overall Study|Lost to Follow-up|33|||
143036902|NCT01118312|515677172|FG001|Overall Study|Lost to Follow-up|32|||
143036903|NCT01118312|515677171|FG000|Overall Study|Withdrawal by Subject|1|||
143036904|NCT01118312|515677172|FG001|Overall Study|Withdrawal by Subject|3|||
143036905|NCT00678639|515677173|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
143036906|NCT00678639|515677174|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
143036907|NCT00986245|515677175|FG000|First Intervention|Poor compliance|8|||
143036908|NCT00986245|515677176|FG001|First Intervention|Poor compliance|4|||
143036909|NCT00986245|515677175|FG000|First Intervention|Lack of Efficacy|1|||
143036910|NCT00986245|515677176|FG001|First Intervention|Lack of Efficacy|2|||
143036911|NCT00986245|515677175|FG000|First Intervention|Withdrawal by Subject|0|||
143036912|NCT00986245|515677176|FG001|First Intervention|Withdrawal by Subject|1|||
143036913|NCT00986245|515677175|FG000|First Intervention|Protocol Violation|0|||
143036914|NCT00986245|515677176|FG001|First Intervention|Protocol Violation|1|||
143036915|NCT00986245|515677175|FG000|First Intervention|Out of indication|1|||
143036916|NCT00986245|515677176|FG001|First Intervention|Out of indication|0|||
143036917|NCT00986245|515677175|FG000|Second Intervention|Poor compliance|1|||
143036918|NCT00986245|515677176|FG001|Second Intervention|Poor compliance|0|||
143036919|NCT00986245|515677175|FG000|Second Intervention|Lost to Follow-up|1|||
143036920|NCT00986245|515677176|FG001|Second Intervention|Lost to Follow-up|0|||
143036921|NCT00986245|515677175|FG000|Second Intervention|Protocol Violation|0|||
143036922|NCT00986245|515677176|FG001|Second Intervention|Protocol Violation|1|||
143036923|NCT01214850|515677177|FG000|Overall Study|Withdrawal by Subject|38|||
143036924|NCT01214850|515677178|FG001|Overall Study|Withdrawal by Subject|31|||
143036925|NCT01214850|515677179|FG002|Overall Study|Withdrawal by Subject|28|||
143036926|NCT01214850|515677177|FG000|Overall Study|Lost to Follow-up|124|||
143036927|NCT01214850|515677178|FG001|Overall Study|Lost to Follow-up|98|||
143036928|NCT01214850|515677179|FG002|Overall Study|Lost to Follow-up|123|||
143036929|NCT01214850|515677177|FG000|Overall Study|Protocol Violation|5|||
143036930|NCT01214850|515677178|FG001|Overall Study|Protocol Violation|5|||
143036931|NCT01214850|515677179|FG002|Overall Study|Protocol Violation|6|||
143036932|NCT01214850|515677177|FG000|Overall Study|Adverse event or death|11|||
143036933|NCT01214850|515677178|FG001|Overall Study|Adverse event or death|8|||
143036934|NCT01214850|515677179|FG002|Overall Study|Adverse event or death|3|||
143036935|NCT01214850|515677177|FG000|Overall Study|Inappropriate enrollment|2|||
143036936|NCT01214850|515677178|FG001|Overall Study|Inappropriate enrollment|1|||
143036937|NCT01214850|515677179|FG002|Overall Study|Inappropriate enrollment|0|||
143036938|NCT01214850|515677177|FG000|Overall Study|Administrative reason|1|||
143036939|NCT01214850|515677178|FG001|Overall Study|Administrative reason|0|||
143036940|NCT01214850|515677179|FG002|Overall Study|Administrative reason|0|||
143036941|NCT01214850|515677177|FG000|Overall Study|Unable to classify|2|||
143036942|NCT01214850|515677178|FG001|Overall Study|Unable to classify|1|||
143036943|NCT01214850|515677179|FG002|Overall Study|Unable to classify|1|||
143036944|NCT00585689|515677180|FG000|Overall Study|Received different ABI-007 schedule|3|||
143036945|NCT00585689|515677180|FG000|Overall Study|Adverse Event|1|||
143036946|NCT00585689|515677180|FG000|Overall Study|Patient Declined Surgery|1|||
143036947|NCT00585689|515677180|FG000|Overall Study|Patient had unresectable disease|1|||
143036948|NCT00585689|515677180|FG000|Overall Study|Death|1|||
143036949|NCT03897088|515677183|FG000|Overall Study|Withdrawal by Subject|12|||
143036950|NCT03897088|515677184|FG001|Overall Study|Withdrawal by Subject|12|||
143036951|NCT03897088|515677183|FG000|Overall Study|Lost to Follow-up|7|||
143036952|NCT03897088|515677184|FG001|Overall Study|Lost to Follow-up|15|||
143036953|NCT03897088|515677183|FG000|Overall Study|Sponsor Decision|1|||
143036954|NCT03897088|515677184|FG001|Overall Study|Sponsor Decision|2|||
143036955|NCT03897088|515677183|FG000|Overall Study|COVID-19|2|||
143036956|NCT03897088|515677184|FG001|Overall Study|COVID-19|0|||
143036957|NCT03897088|515677183|FG000|Overall Study|Other|3|||
143036958|NCT03897088|515677184|FG001|Overall Study|Other|0|||
143036959|NCT03897088|515677183|FG000|Overall Study|Non-compliance with Study Drug|1|||
143036960|NCT03897088|515677184|FG001|Overall Study|Non-compliance with Study Drug|1|||
143036961|NCT03897088|515677183|FG000|Overall Study|Pregnancy|0|||
143036962|NCT03897088|515677184|FG001|Overall Study|Pregnancy|1|||
143036963|NCT00855738|515677189|FG000|Overall Study|Lost to Follow-up|2|||
143036964|NCT00855738|515677189|FG000|Overall Study|Adverse Event|1|||
143036965|NCT00855738|515677189|FG000|Overall Study|Subject Defaulted|1|||
143036966|NCT00855738|515677189|FG000|Overall Study|Death|1|||
143036967|NCT04320849|515677194|FG000|Overall Study|Withdrawal by Subject|4|||
143036968|NCT04320849|515677194|FG000|Overall Study|Imaging data unavailable|2|||
143036969|NCT04320849|515677194|FG000|Overall Study|Incomplete imaging|2|||
143036970|NCT03929393|515677197|FG000|Overall Study|Death|1|||
143036971|NCT03929393|515677198|FG001|Overall Study|Death|0|||
143036972|NCT03929393|515677197|FG000|Overall Study|Time Commitment|2|||
143036973|NCT03929393|515677198|FG001|Overall Study|Time Commitment|5|||
143036974|NCT03929393|515677197|FG000|Overall Study|Motor Vehicle Accident|0|||
143036975|NCT03929393|515677198|FG001|Overall Study|Motor Vehicle Accident|1|||
143036976|NCT03929393|515677197|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
143161216|NCT00215553|516135513|FG002|Overall Study|Adverse Event|2|||
143036977|NCT03929393|515677198|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
143036978|NCT03929393|515677197|FG000|Overall Study|Other|1|||
143036979|NCT03929393|515677198|FG001|Overall Study|Other|3|||
143036980|NCT00463606|515677204|FG000|Overall Study|Adverse Event|21|||
143036981|NCT00463606|515677205|FG001|Overall Study|Adverse Event|18|||
143036982|NCT00463606|515677206|FG002|Overall Study|Adverse Event|11|||
143036983|NCT00463606|515677204|FG000|Overall Study|Withdrawal by Subject|11|||
143036984|NCT00463606|515677205|FG001|Overall Study|Withdrawal by Subject|11|||
143036985|NCT00463606|515677206|FG002|Overall Study|Withdrawal by Subject|5|||
143036986|NCT00463606|515677204|FG000|Overall Study|Lost to Follow-up|2|||
143238715|NCT01235741|516429752|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
143238716|NCT01235741|516429753|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
143238717|NCT01235741|516429754|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
143238718|NCT01235741|516429752|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
143238719|NCT01235741|516429753|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
143364081|NCT03686683|516875531|FG001|Overall Study|Death|5|||
143495681|NCT02624492|517357700|FG002|Overall Study|Progressive disease|3|||
143495682|NCT00191451|517357702|FG000|Overall Study|Withdrawal by Subject|2|||
143495683|NCT00191451|517357703|FG001|Overall Study|Withdrawal by Subject|3|||
143495684|NCT00191451|517357704|FG002|Overall Study|Withdrawal by Subject|5|||
143036987|NCT00463606|515677205|FG001|Overall Study|Lost to Follow-up|2|||
143036988|NCT00463606|515677206|FG002|Overall Study|Lost to Follow-up|3|||
143036989|NCT00463606|515677204|FG000|Overall Study|Subject noncompliance|1|||
143495685|NCT00191451|517357702|FG000|Overall Study|Physician Decision|2|||
143495686|NCT00191451|517357703|FG001|Overall Study|Physician Decision|9|||
143495687|NCT00191451|517357704|FG002|Overall Study|Physician Decision|6|||
143495688|NCT00191451|517357702|FG000|Overall Study|Sponsor Decision|1|||
143036990|NCT00463606|515677205|FG001|Overall Study|Subject noncompliance|1|||
143036991|NCT00463606|515677206|FG002|Overall Study|Subject noncompliance|0|||
143036992|NCT00463606|515677204|FG000|Overall Study|Subject moved out of town|1|||
143036993|NCT00463606|515677205|FG001|Overall Study|Subject moved out of town|0|||
143036994|NCT00463606|515677206|FG002|Overall Study|Subject moved out of town|0|||
143036995|NCT00463606|515677204|FG000|Overall Study|Physician Decision|0|||
143036996|NCT00463606|515677205|FG001|Overall Study|Physician Decision|1|||
143036997|NCT00463606|515677206|FG002|Overall Study|Physician Decision|0|||
143036998|NCT00463606|515677204|FG000|Overall Study|Sponsor request|0|||
143036999|NCT00463606|515677205|FG001|Overall Study|Sponsor request|1|||
143037000|NCT00463606|515677206|FG002|Overall Study|Sponsor request|0|||
143037001|NCT00463606|515677204|FG000|Overall Study|Exclusion criteria violation|2|||
143037002|NCT00463606|515677205|FG001|Overall Study|Exclusion criteria violation|0|||
143037003|NCT00463606|515677206|FG002|Overall Study|Exclusion criteria violation|0|||
143037004|NCT00463606|515677204|FG000|Overall Study|Coordinator error|1|||
143495689|NCT00191451|517357703|FG001|Overall Study|Sponsor Decision|0|||
143037005|NCT00463606|515677205|FG001|Overall Study|Coordinator error|0|||
143037006|NCT00463606|515677206|FG002|Overall Study|Coordinator error|0|||
143037007|NCT00463606|515677204|FG000|Overall Study|Patient randomized in error|1|||
143037008|NCT00463606|515677205|FG001|Overall Study|Patient randomized in error|0|||
143037009|NCT00463606|515677206|FG002|Overall Study|Patient randomized in error|0|||
143037010|NCT00463606|515677204|FG000|Overall Study|Participation in another ABT-335 trial|1|||
143037011|NCT00463606|515677205|FG001|Overall Study|Participation in another ABT-335 trial|0|||
143037012|NCT00463606|515677206|FG002|Overall Study|Participation in another ABT-335 trial|0|||
143037013|NCT00463606|515677204|FG000|Overall Study|Protocol Violation|0|||
143037014|NCT00463606|515677205|FG001|Overall Study|Protocol Violation|0|||
143037015|NCT00463606|515677206|FG002|Overall Study|Protocol Violation|1|||
143037016|NCT00942968|515678653|FG000|Overall Study|Adverse Event|60|||
143037017|NCT00942968|515678653|FG000|Overall Study|Death|76|||
143037018|NCT00942968|515678653|FG000|Overall Study|Protocol Violation|9|||
143037019|NCT00942968|515678653|FG000|Overall Study|Lost to Follow-up|4|||
143037020|NCT00942968|515678653|FG000|Overall Study|Withdrawal by Subject|44|||
143037021|NCT00942968|515678653|FG000|Overall Study|Sponsor request|5|||
143037022|NCT00942968|515678653|FG000|Overall Study|Physician Decision|11|||
143037023|NCT00942968|515678653|FG000|Overall Study|Progression of disease|12|||
143037024|NCT00942968|515678653|FG000|Overall Study|Inferior vena cava filter placement|4|||
143037025|NCT00942968|515678653|FG000|Overall Study|Pulmonary embolism (PE)|1|||
143037026|NCT00942968|515678653|FG000|Overall Study|Participant required pancreatic biopsy|1|||
143037027|NCT00942968|515678653|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
143037028|NCT01811953|515678654|FG000|Overall Study|Adverse Event|0|||
143037029|NCT01811953|515678655|FG001|Overall Study|Adverse Event|0|||
143037030|NCT01811953|515678656|FG002|Overall Study|Adverse Event|0|||
143037031|NCT01811953|515678657|FG003|Overall Study|Adverse Event|1|||
143037032|NCT01811953|515678658|FG004|Overall Study|Adverse Event|0|||
143037033|NCT01811953|515678659|FG005|Overall Study|Adverse Event|1|||
143037034|NCT01811953|515678654|FG000|Overall Study|Protocol Violation|0|||
143037035|NCT01811953|515678655|FG001|Overall Study|Protocol Violation|0|||
143037036|NCT01811953|515678656|FG002|Overall Study|Protocol Violation|0|||
143037037|NCT01811953|515678657|FG003|Overall Study|Protocol Violation|0|||
143037038|NCT01811953|515678658|FG004|Overall Study|Protocol Violation|1|||
143037039|NCT01811953|515678659|FG005|Overall Study|Protocol Violation|0|||
143037040|NCT01511939|515678663|FG000|Overall Study|Withdrawal by Subject|2|||
143037041|NCT01511939|515678664|FG001|Overall Study|Withdrawal by Subject|1|||
143037042|NCT01511939|515678665|FG002|Overall Study|Withdrawal by Subject|0|||
143037043|NCT00723528|515678668|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
143037044|NCT00723528|515678669|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
143037045|NCT00723528|515678670|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
143037046|NCT00723528|515678671|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
143037047|NCT00723528|515678672|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
143037048|NCT00723528|515678673|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
143037049|NCT00723528|515678674|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
143037050|NCT00723528|515678668|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
143037051|NCT00723528|515678669|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
143037052|NCT00723528|515678670|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
143037053|NCT00723528|515678671|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
143037054|NCT00723528|515678672|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
143037055|NCT00723528|515678673|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
143037056|NCT00723528|515678674|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
143037057|NCT00723528|515678668|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
143037058|NCT00723528|515678669|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
143037059|NCT00723528|515678670|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
143037060|NCT00723528|515678671|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
143037061|NCT00723528|515678672|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
143037062|NCT00723528|515678673|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
143037063|NCT00723528|515678674|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
143037064|NCT00723528|515678668|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
143037065|NCT00723528|515678669|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
143037066|NCT00723528|515678670|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
143037067|NCT00723528|515678671|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
143037068|NCT00723528|515678672|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
143037069|NCT00723528|515678673|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
143037070|NCT00723528|515678674|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
143037071|NCT00723528|515678668|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
143037072|NCT00723528|515678669|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
143037073|NCT00723528|515678670|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
143037074|NCT00723528|515678671|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
143037075|NCT00723528|515678672|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
143037076|NCT00723528|515678673|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
143037077|NCT00723528|515678674|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
143037078|NCT00723528|515678668|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
143037079|NCT00723528|515678669|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
143037080|NCT00723528|515678670|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
143037081|NCT00723528|515678671|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
143037082|NCT00723528|515678672|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
143037083|NCT00723528|515678673|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
143037084|NCT00723528|515678674|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
143037085|NCT00723528|515678668|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
143037086|NCT00723528|515678669|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
143037087|NCT00723528|515678670|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
143037088|NCT00723528|515678671|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
143037089|NCT00723528|515678672|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
143037090|NCT00723528|515678673|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
143037091|NCT00723528|515678674|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
143037092|NCT00723528|515678668|FG000|Period 2: After Controlled Period|Other|0|||
143495690|NCT00191451|517357704|FG002|Overall Study|Sponsor Decision|0|||
143495691|NCT00191451|517357702|FG000|Overall Study|Ineligible|0|||
143495692|NCT00191451|517357703|FG001|Overall Study|Ineligible|1|||
143495693|NCT00191451|517357704|FG002|Overall Study|Ineligible|0|||
143161217|NCT00215553|516135514|FG003|Overall Study|Adverse Event|1|||
143037093|NCT00723528|515678669|FG001|Period 2: After Controlled Period|Other|0|||
143037094|NCT00723528|515678670|FG002|Period 2: After Controlled Period|Other|0|||
143161218|NCT00215553|516135515|FG004|Overall Study|Adverse Event|2|||
143161219|NCT00215553|516135516|FG005|Overall Study|Adverse Event|6|||
143161220|NCT00215553|516135517|FG006|Overall Study|Adverse Event|0|||
143161221|NCT01429623|516135518|FG000|Overall Study|Death|1|||
143495694|NCT00191451|517357702|FG000|Overall Study|Reason Not Specified|2|||
143037095|NCT00723528|515678671|FG003|Period 2: After Controlled Period|Other|0|||
143037096|NCT00723528|515678672|FG004|Period 2: After Controlled Period|Other|1|||
143037097|NCT00723528|515678673|FG005|Period 2: After Controlled Period|Other|4|||
143037098|NCT00723528|515678674|FG006|Period 2: After Controlled Period|Other|0|||
143037099|NCT00723528|515678668|FG000|Period 2: After Controlled Period|Adverse Event|0|||
143037100|NCT00723528|515678669|FG001|Period 2: After Controlled Period|Adverse Event|0|||
143037101|NCT00723528|515678670|FG002|Period 2: After Controlled Period|Adverse Event|0|||
143037102|NCT00723528|515678671|FG003|Period 2: After Controlled Period|Adverse Event|0|||
143037103|NCT00723528|515678672|FG004|Period 2: After Controlled Period|Adverse Event|1|||
143037104|NCT00723528|515678673|FG005|Period 2: After Controlled Period|Adverse Event|0|||
143037105|NCT00723528|515678674|FG006|Period 2: After Controlled Period|Adverse Event|1|||
143037106|NCT00723528|515678668|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
143037107|NCT00723528|515678669|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
143037108|NCT00723528|515678670|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
143037109|NCT00723528|515678671|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
143037110|NCT00723528|515678672|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
143037111|NCT00723528|515678673|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
143037112|NCT00723528|515678674|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
143037113|NCT00723528|515678668|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
143037114|NCT00723528|515678669|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
143037115|NCT00723528|515678670|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
143037116|NCT00723528|515678671|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
143037117|NCT00723528|515678672|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
143037118|NCT00723528|515678673|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
143037119|NCT00723528|515678674|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
143037120|NCT02883452|515678676|FG000|Overall Study|Withdrawal by Subject|1|||
143037121|NCT02883452|515678677|FG001|Overall Study|Withdrawal by Subject|1|||
143037122|NCT02883452|515678678|FG002|Overall Study|Withdrawal by Subject|3|||
143037123|NCT02883452|515678679|FG003|Overall Study|Withdrawal by Subject|0|||
143037124|NCT02883452|515678680|FG004|Overall Study|Withdrawal by Subject|2|||
143037125|NCT02883452|515678681|FG005|Overall Study|Withdrawal by Subject|5|||
143161222|NCT01429623|516135519|FG001|Overall Study|Death|0|||
143161223|NCT01429623|516135518|FG000|Overall Study|Adverse Event|7|||
143161224|NCT01429623|516135519|FG001|Overall Study|Adverse Event|14|||
143161225|NCT01429623|516135518|FG000|Overall Study|Withdrawal by Subject|19|||
143161226|NCT01429623|516135519|FG001|Overall Study|Withdrawal by Subject|13|||
143161227|NCT01429623|516135518|FG000|Overall Study|Physician Decision|2|||
143161228|NCT01429623|516135519|FG001|Overall Study|Physician Decision|3|||
143161229|NCT01429623|516135518|FG000|Overall Study|Protocol Violation|3|||
143161230|NCT01429623|516135519|FG001|Overall Study|Protocol Violation|2|||
143161231|NCT01429623|516135518|FG000|Overall Study|Assorted|1|||
143161232|NCT01429623|516135519|FG001|Overall Study|Assorted|2|||
143161233|NCT01429623|516135518|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
143161234|NCT01429623|516135519|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
143161235|NCT01429623|516135518|FG000|Overall Study|No post baseline data|4|||
143161236|NCT01429623|516135519|FG001|Overall Study|No post baseline data|4|||
143161237|NCT05345405|516135520|FG000|Overall Study|Withdrawal by Subject|2|||
143161238|NCT05345405|516135521|FG001|Overall Study|Withdrawal by Subject|0|||
143161239|NCT05345405|516135522|FG002|Overall Study|Withdrawal by Subject|0|||
143161240|NCT05345405|516135520|FG000|Overall Study|Did not meet eligibility criteria|0|||
143037126|NCT02883452|515678676|FG000|Overall Study|Disease progression|1|||
143037127|NCT02883452|515678677|FG001|Overall Study|Disease progression|0|||
143037128|NCT02883452|515678678|FG002|Overall Study|Disease progression|0|||
143037129|NCT02883452|515678679|FG003|Overall Study|Disease progression|1|||
143037130|NCT02883452|515678680|FG004|Overall Study|Disease progression|4|||
143037131|NCT02883452|515678681|FG005|Overall Study|Disease progression|5|||
143161241|NCT05345405|516135521|FG001|Overall Study|Did not meet eligibility criteria|2|||
143161242|NCT05345405|516135522|FG002|Overall Study|Did not meet eligibility criteria|0|||
143161243|NCT05345405|516135520|FG000|Overall Study|Lost to Follow-up|0|||
143161244|NCT05345405|516135521|FG001|Overall Study|Lost to Follow-up|0|||
143161245|NCT05345405|516135522|FG002|Overall Study|Lost to Follow-up|1|||
143161246|NCT01896986|516135523|FG000|Overall Study|samples lost|14|||
143161247|NCT01896986|516135524|FG001|Overall Study|samples lost|23|||
143161248|NCT01696214|516135527|FG000|Overall Study|Lost to Follow-up|1|||
143161249|NCT01696214|516135528|FG001|Overall Study|Lost to Follow-up|0|||
143161250|NCT01696214|516135529|FG002|Overall Study|Lost to Follow-up|0|||
143161251|NCT01696214|516135530|FG003|Overall Study|Lost to Follow-up|0|||
143161252|NCT00819832|516135533|FG000|Overall Study|Sponsor Termination of Study|3|||
143161253|NCT00819832|516135534|FG001|Overall Study|Sponsor Termination of Study|0|||
143161254|NCT00819832|516135535|FG002|Overall Study|Sponsor Termination of Study|0|||
143161255|NCT00819832|516135536|FG003|Overall Study|Sponsor Termination of Study|0|||
143037132|NCT02883452|515678676|FG000|Overall Study|Adverse Event|2|||
143037133|NCT02883452|515678677|FG001|Overall Study|Adverse Event|1|||
143037134|NCT02883452|515678678|FG002|Overall Study|Adverse Event|1|||
143037135|NCT02883452|515678679|FG003|Overall Study|Adverse Event|1|||
143037136|NCT02883452|515678680|FG004|Overall Study|Adverse Event|1|||
143037137|NCT02883452|515678681|FG005|Overall Study|Adverse Event|3|||
143238720|NCT01235741|516429754|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
143037138|NCT02883452|515678676|FG000|Overall Study|Physician Decision|0|||
143037139|NCT02883452|515678677|FG001|Overall Study|Physician Decision|0|||
143238721|NCT01235741|516429752|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
143238722|NCT01235741|516429753|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
143238723|NCT01235741|516429754|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
143238724|NCT01235741|516429752|FG000|Randomized to Treatment|Adverse Event|0|||
143238725|NCT01235741|516429753|FG001|Randomized to Treatment|Adverse Event|1|||
143238726|NCT01235741|516429754|FG002|Randomized to Treatment|Adverse Event|1|||
143238727|NCT01235741|516429752|FG000|Randomized to Treatment|Sponsor terminated study|0|||
143238728|NCT01235741|516429753|FG001|Randomized to Treatment|Sponsor terminated study|35|||
143238729|NCT01235741|516429754|FG002|Randomized to Treatment|Sponsor terminated study|34|||
143238730|NCT01235741|516429752|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
143238731|NCT01235741|516429753|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
143238732|NCT01235741|516429754|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
143238733|NCT01235741|516429752|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
143238734|NCT01235741|516429753|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
143238735|NCT01235741|516429754|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
143238736|NCT01235741|516429752|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
143238737|NCT01235741|516429753|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
143238738|NCT01235741|516429754|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
143238739|NCT01421719|516429755|FG000|Overall Study|Withdrawal by Subject|4|||
143238740|NCT01712399|516429762|FG000|Overall Study|Lost to Follow-up|1|||
143238741|NCT01712399|516429762|FG000|Overall Study|Withdrawal by Subject|39|||
143238742|NCT01712399|516429762|FG000|Overall Study|Death|1|||
143238743|NCT01712399|516429762|FG000|Overall Study|Adverse Event|11|||
143238744|NCT01712399|516429762|FG000|Overall Study|Study closure|345|||
143238745|NCT01357850|516429767|FG000|Overall Study|Lost to Follow-up|1|||
143238746|NCT01357850|516429768|FG001|Overall Study|Lost to Follow-up|0|||
143238747|NCT01357850|516429769|FG002|Overall Study|Lost to Follow-up|0|||
143238748|NCT01357850|516429770|FG003|Overall Study|Lost to Follow-up|0|||
143238749|NCT04610281|516429771|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
143238750|NCT04610281|516429772|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
143238751|NCT03077412|516429775|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
143238752|NCT03077412|516429776|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
143238753|NCT03077412|516429777|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
143238754|NCT03077412|516429775|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
143238755|NCT03077412|516429776|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
143238756|NCT03077412|516429777|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
143238757|NCT03077412|516429775|FG000|Overall Study|Adverse Event|1|||
143238758|NCT03077412|516429776|FG001|Overall Study|Adverse Event|2|||
143238759|NCT03077412|516429777|FG002|Overall Study|Adverse Event|2|||
143238760|NCT03077412|516429775|FG000|Overall Study|Investigator's Discretion|0|||
143238761|NCT03077412|516429776|FG001|Overall Study|Investigator's Discretion|1|||
143238762|NCT03077412|516429777|FG002|Overall Study|Investigator's Discretion|1|||
143238763|NCT03077412|516429775|FG000|Overall Study|Withdrew Consent|0|||
143238764|NCT03077412|516429776|FG001|Overall Study|Withdrew Consent|2|||
143238765|NCT03077412|516429777|FG002|Overall Study|Withdrew Consent|0|||
143238766|NCT02266888|516429779|FG000|Overall Study|Death|2|||
143238767|NCT02266888|516429780|FG001|Overall Study|Death|2|||
143238768|NCT02266888|516429781|FG002|Overall Study|Death|4|||
143037140|NCT02883452|515678678|FG002|Overall Study|Physician Decision|0|||
143037141|NCT02883452|515678679|FG003|Overall Study|Physician Decision|0|||
143238769|NCT02266888|516429782|FG003|Overall Study|Death|2|||
143238770|NCT02266888|516429779|FG000|Overall Study|Physician Decision|0|||
143238771|NCT02266888|516429780|FG001|Overall Study|Physician Decision|1|||
143037142|NCT02883452|515678680|FG004|Overall Study|Physician Decision|4|||
143037143|NCT02883452|515678681|FG005|Overall Study|Physician Decision|1|||
143037144|NCT02883452|515678676|FG000|Overall Study|Death|1|||
143037145|NCT02883452|515678677|FG001|Overall Study|Death|0|||
143238772|NCT02266888|516429781|FG002|Overall Study|Physician Decision|2|||
143238773|NCT02266888|516429782|FG003|Overall Study|Physician Decision|2|||
143238774|NCT02266888|516429779|FG000|Overall Study|Study Terminated|5|||
143238775|NCT02266888|516429780|FG001|Overall Study|Study Terminated|1|||
143238776|NCT02266888|516429781|FG002|Overall Study|Study Terminated|0|||
143238777|NCT02266888|516429782|FG003|Overall Study|Study Terminated|0|||
143037146|NCT02883452|515678678|FG002|Overall Study|Death|1|||
143037147|NCT02883452|515678679|FG003|Overall Study|Death|0|||
143037148|NCT02883452|515678680|FG004|Overall Study|Death|0|||
143037149|NCT02883452|515678681|FG005|Overall Study|Death|0|||
143037150|NCT02883452|515678676|FG000|Overall Study|Other|0|||
143037151|NCT02883452|515678677|FG001|Overall Study|Other|0|||
143037152|NCT02883452|515678678|FG002|Overall Study|Other|0|||
143037153|NCT02883452|515678679|FG003|Overall Study|Other|0|||
143037154|NCT02883452|515678680|FG004|Overall Study|Other|0|||
143037155|NCT02883452|515678681|FG005|Overall Study|Other|1|||
143037156|NCT00667095|515678691|FG000|Overall Study|Withdrawal by Subject|0|||
143037157|NCT00667095|515678692|FG001|Overall Study|Withdrawal by Subject|1|||
143037158|NCT01520909|515678693|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
143161256|NCT00819832|516135537|FG004|Overall Study|Sponsor Termination of Study|0|||
143161257|NCT00819832|516135538|FG005|Overall Study|Sponsor Termination of Study|0|||
143161258|NCT01796470|516135546|FG000|Overall Study|Adverse Event|4|||
143161259|NCT01796470|516135547|FG001|Overall Study|Adverse Event|2|||
143161260|NCT01796470|516135548|FG002|Overall Study|Adverse Event|2|||
143161261|NCT01796470|516135549|FG003|Overall Study|Adverse Event|1|||
143161262|NCT01796470|516135550|FG004|Overall Study|Adverse Event|3|||
143037159|NCT01520909|515678694|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
143037160|NCT01520909|515678695|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
143037161|NCT01520909|515678693|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
143037162|NCT01520909|515678694|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
143037163|NCT01520909|515678695|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
143037164|NCT01520909|515678693|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
143037165|NCT01520909|515678694|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
143161263|NCT01796470|516135546|FG000|Overall Study|Death|2|||
143161264|NCT01796470|516135547|FG001|Overall Study|Death|0|||
143161265|NCT01796470|516135548|FG002|Overall Study|Death|0|||
143161266|NCT01796470|516135549|FG003|Overall Study|Death|0|||
143161267|NCT01796470|516135550|FG004|Overall Study|Death|1|||
143161268|NCT01796470|516135546|FG000|Overall Study|Initiated New Therapy|9|||
143161269|NCT01796470|516135547|FG001|Overall Study|Initiated New Therapy|0|||
143161270|NCT01796470|516135548|FG002|Overall Study|Initiated New Therapy|0|||
143161271|NCT01796470|516135549|FG003|Overall Study|Initiated New Therapy|0|||
143161272|NCT01796470|516135550|FG004|Overall Study|Initiated New Therapy|2|||
143161273|NCT01796470|516135546|FG000|Overall Study|Lost to Follow-up|0|||
143161274|NCT01796470|516135547|FG001|Overall Study|Lost to Follow-up|1|||
143161275|NCT01796470|516135548|FG002|Overall Study|Lost to Follow-up|0|||
143161276|NCT01796470|516135549|FG003|Overall Study|Lost to Follow-up|0|||
143161277|NCT01796470|516135550|FG004|Overall Study|Lost to Follow-up|0|||
143161278|NCT01796470|516135546|FG000|Overall Study|Physician Decision|5|||
143161279|NCT01796470|516135547|FG001|Overall Study|Physician Decision|4|||
143161280|NCT01796470|516135548|FG002|Overall Study|Physician Decision|1|||
143161281|NCT01796470|516135549|FG003|Overall Study|Physician Decision|0|||
143161282|NCT01796470|516135550|FG004|Overall Study|Physician Decision|1|||
143161283|NCT01796470|516135546|FG000|Overall Study|Progressive Disease|7|||
143161284|NCT01796470|516135547|FG001|Overall Study|Progressive Disease|7|||
143161285|NCT01796470|516135548|FG002|Overall Study|Progressive Disease|3|||
143161286|NCT01796470|516135549|FG003|Overall Study|Progressive Disease|2|||
143161287|NCT01796470|516135550|FG004|Overall Study|Progressive Disease|0|||
143161288|NCT01796470|516135546|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
143161289|NCT01796470|516135547|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
143161290|NCT01796470|516135548|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
143161291|NCT01796470|516135549|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
143037166|NCT01520909|515678695|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
143161292|NCT01796470|516135550|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
143161293|NCT01796470|516135546|FG000|Overall Study|Withdrawal by Subject|7|||
143161294|NCT01796470|516135547|FG001|Overall Study|Withdrawal by Subject|0|||
143161295|NCT01796470|516135548|FG002|Overall Study|Withdrawal by Subject|0|||
143161296|NCT01796470|516135549|FG003|Overall Study|Withdrawal by Subject|0|||
143161297|NCT01796470|516135550|FG004|Overall Study|Withdrawal by Subject|1|||
143161298|NCT00147537|516135551|FG000|Phase 1b|Death|0|||
143161299|NCT00147537|516135552|FG001|Phase 1b|Death|1|||
143161300|NCT00147537|516135553|FG002|Phase 1b|Death|2|||
143037167|NCT01520909|515678693|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
143037168|NCT01520909|515678694|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
143161301|NCT00147537|516135554|FG003|Phase 1b|Death|1|||
143161302|NCT00147537|516135555|FG004|Phase 1b|Death|2|||
143161303|NCT00147537|516135556|FG005|Phase 1b|Death|2|||
143161304|NCT00147537|516135557|FG006|Phase 1b|Death|1|||
143161305|NCT00147537|516135558|FG007|Phase 1b|Death|3|||
143161306|NCT00147537|516135559|FG008|Phase 1b|Death|9|||
143161307|NCT00147537|516135560|FG009|Phase 1b|Death|0|||
143161308|NCT00147537|516135561|FG010|Phase 1b|Death|0|||
143161309|NCT00147537|516135551|FG000|Phase 1b|Lost to Follow-up|2|||
143161310|NCT00147537|516135552|FG001|Phase 1b|Lost to Follow-up|1|||
143161311|NCT00147537|516135553|FG002|Phase 1b|Lost to Follow-up|0|||
143161312|NCT00147537|516135554|FG003|Phase 1b|Lost to Follow-up|0|||
143161313|NCT00147537|516135555|FG004|Phase 1b|Lost to Follow-up|0|||
143495695|NCT00191451|517357703|FG001|Overall Study|Reason Not Specified|1|||
143495696|NCT00191451|517357704|FG002|Overall Study|Reason Not Specified|3|||
143495697|NCT03370770|517357711|FG000|Overall Study|Patient was followed in another hospital center|1|||
143495698|NCT03370770|517357711|FG000|Overall Study|Progressive Disease|98|||
143495699|NCT03370770|517357711|FG000|Overall Study|Adverse Event|2|||
143037169|NCT01520909|515678695|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
143037170|NCT00830206|515678698|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
143037171|NCT00830206|515678699|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
143037172|NCT02419937|515678707|FG000|Overall Study|Lost to Follow-up|1|||
143037173|NCT02419937|515678708|FG001|Overall Study|Lost to Follow-up|0|||
143037174|NCT00553280|515678709|FG000|Overall Study|Adverse Event|19|||
143037175|NCT00553280|515678709|FG000|Overall Study|Lack of Efficacy|3|||
143037176|NCT00553280|515678709|FG000|Overall Study|Withdrawal by Subject|3|||
143037177|NCT00553280|515678709|FG000|Overall Study|Physician Decision|1|||
143037178|NCT02457520|515678710|FG000|Active Treatment Phase|Adverse Event|10|||
143037179|NCT02457520|515678710|FG000|Active Treatment Phase|Lost to Follow-up|8|||
143037180|NCT02457520|515678710|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
143037181|NCT02457520|515678710|FG000|Active Treatment Phase|other|4|||
143037182|NCT02457520|515678710|FG000|Active Treatment Phase|Physician Decision|1|||
143037183|NCT02457520|515678710|FG000|Active Treatment Phase|Protocol Violation|1|||
143037184|NCT02457520|515678710|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
143037185|NCT02457520|515678710|FG000|Post-treatment Period|Other: Retreatment Required|7|||
143037186|NCT02457520|515678710|FG000|Post-treatment Period|Lost to Follow-up|23|||
143037187|NCT02457520|515678710|FG000|Post-treatment Period|Other|3|||
143037188|NCT02457520|515678710|FG000|Post-treatment Period|Physician Decision|1|||
143037189|NCT02457520|515678710|FG000|Post-treatment Period|Withdrawal by Subject|14|||
143037190|NCT00184600|515678711|FG000|Overall Study|Adverse Event|9|||
143037191|NCT00184600|515678712|FG001|Overall Study|Adverse Event|0|||
143037192|NCT00184600|515678713|FG002|Overall Study|Adverse Event|5|||
143037193|NCT00184600|515678711|FG000|Overall Study|Death|3|||
143037194|NCT00184600|515678712|FG001|Overall Study|Death|9|||
143037195|NCT00184600|515678713|FG002|Overall Study|Death|7|||
143037196|NCT00184600|515678711|FG000|Overall Study|Lack of Efficacy|3|||
143037197|NCT00184600|515678712|FG001|Overall Study|Lack of Efficacy|1|||
143037198|NCT00184600|515678713|FG002|Overall Study|Lack of Efficacy|3|||
143037199|NCT00184600|515678711|FG000|Overall Study|Lost to Follow-up|4|||
143037200|NCT00184600|515678712|FG001|Overall Study|Lost to Follow-up|6|||
143037201|NCT00184600|515678713|FG002|Overall Study|Lost to Follow-up|1|||
143037202|NCT00184600|515678711|FG000|Overall Study|Protocol Violation|2|||
143037203|NCT00184600|515678712|FG001|Overall Study|Protocol Violation|2|||
143037204|NCT00184600|515678713|FG002|Overall Study|Protocol Violation|3|||
143037205|NCT00184600|515678711|FG000|Overall Study|Withdrawal by Subject|20|||
143037206|NCT00184600|515678712|FG001|Overall Study|Withdrawal by Subject|28|||
143037207|NCT00184600|515678713|FG002|Overall Study|Withdrawal by Subject|12|||
143037208|NCT00184600|515678711|FG000|Overall Study|Unclassified|4|||
143037209|NCT00184600|515678712|FG001|Overall Study|Unclassified|5|||
143037210|NCT00184600|515678713|FG002|Overall Study|Unclassified|3|||
143037211|NCT00696020|515678716|FG000|Overall Study|Adverse Event|3|||
143037212|NCT00696020|515678717|FG001|Overall Study|Adverse Event|1|||
143037213|NCT00696020|515678718|FG002|Overall Study|Adverse Event|2|||
143037214|NCT00696020|515678719|FG003|Overall Study|Adverse Event|1|||
143037215|NCT00696020|515678716|FG000|Overall Study|Lack of Efficacy|1|||
143037216|NCT00696020|515678717|FG001|Overall Study|Lack of Efficacy|0|||
143037217|NCT00696020|515678718|FG002|Overall Study|Lack of Efficacy|0|||
143037218|NCT00696020|515678719|FG003|Overall Study|Lack of Efficacy|0|||
143037219|NCT00696020|515678716|FG000|Overall Study|Protocol Violation|0|||
143037220|NCT00696020|515678717|FG001|Overall Study|Protocol Violation|0|||
143037221|NCT00696020|515678718|FG002|Overall Study|Protocol Violation|0|||
143037222|NCT00696020|515678719|FG003|Overall Study|Protocol Violation|1|||
143161314|NCT00147537|516135556|FG005|Phase 1b|Lost to Follow-up|0|||
143161315|NCT00147537|516135557|FG006|Phase 1b|Lost to Follow-up|2|||
143161316|NCT00147537|516135558|FG007|Phase 1b|Lost to Follow-up|0|||
143161317|NCT00147537|516135559|FG008|Phase 1b|Lost to Follow-up|1|||
143495700|NCT03370770|517357711|FG000|Overall Study|Death|5|||
143037223|NCT00696020|515678716|FG000|Overall Study|Withdrawal by Subject|0|||
143037224|NCT00696020|515678717|FG001|Overall Study|Withdrawal by Subject|1|||
143495701|NCT02167945|517357712|FG000|Overall Study|Adverse Event|16|||
143495702|NCT02167945|517357712|FG000|Overall Study|Withdrew Consent|42|||
143037225|NCT00696020|515678718|FG002|Overall Study|Withdrawal by Subject|0|||
143037226|NCT00696020|515678719|FG003|Overall Study|Withdrawal by Subject|1|||
143161318|NCT00147537|516135560|FG009|Phase 1b|Lost to Follow-up|0|||
143161319|NCT00147537|516135561|FG010|Phase 1b|Lost to Follow-up|0|||
143037227|NCT00696020|515678716|FG000|Overall Study|Other not stated above|0|||
143037228|NCT00696020|515678717|FG001|Overall Study|Other not stated above|0|||
143037229|NCT00696020|515678718|FG002|Overall Study|Other not stated above|1|||
143037230|NCT00696020|515678719|FG003|Overall Study|Other not stated above|1|||
143037231|NCT00624065|515678720|FG000|Overall Study|Adverse Event|5|||
143037232|NCT00624065|515678721|FG001|Overall Study|Adverse Event|6|||
143037233|NCT00624065|515678720|FG000|Overall Study|Lost to Follow-up|4|||
143037234|NCT00624065|515678721|FG001|Overall Study|Lost to Follow-up|1|||
143037235|NCT00624065|515678720|FG000|Overall Study|Consent withdrawn|6|||
143037236|NCT00624065|515678721|FG001|Overall Study|Consent withdrawn|5|||
143037237|NCT00624065|515678720|FG000|Overall Study|Lack of Efficacy|0|||
143037238|NCT00624065|515678721|FG001|Overall Study|Lack of Efficacy|3|||
143037239|NCT00624065|515678720|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
143037240|NCT00624065|515678721|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
143037241|NCT01387022|515678723|FG000|Overall Study|Death|1|||
143037242|NCT01387022|515678724|FG001|Overall Study|Death|1|||
143037243|NCT01387022|515678723|FG000|Overall Study|Lost to Follow-up|0|||
143037244|NCT01387022|515678724|FG001|Overall Study|Lost to Follow-up|3|||
143037245|NCT02076022|515678725|FG000|Overall Study|Withdrawal by Subject|2|||
143037246|NCT02076022|515678726|FG001|Overall Study|Withdrawal by Subject|0|||
143037247|NCT00312663|515678729|FG000|Immunization Phase|Adverse Event|0|||
143037248|NCT00312663|515678730|FG001|Immunization Phase|Adverse Event|1|||
143037249|NCT00312663|515678731|FG002|Immunization Phase|Adverse Event|0|||
143037250|NCT00286754|515678735|FG000|Overall Study|Adverse Event|2|||
143037251|NCT00286754|515678736|FG001|Overall Study|Adverse Event|2|||
143037252|NCT00286754|515678737|FG002|Overall Study|Adverse Event|3|||
143037253|NCT00286754|515678735|FG000|Overall Study|Withdrawal by Subject|6|||
143037254|NCT00286754|515678736|FG001|Overall Study|Withdrawal by Subject|2|||
143037255|NCT00286754|515678737|FG002|Overall Study|Withdrawal by Subject|0|||
143037256|NCT00286754|515678735|FG000|Overall Study|Lost to Follow-up|12|||
143037257|NCT00286754|515678736|FG001|Overall Study|Lost to Follow-up|14|||
143037258|NCT00286754|515678737|FG002|Overall Study|Lost to Follow-up|6|||
143037259|NCT00286754|515678735|FG000|Overall Study|Moved out of state|0|||
143037260|NCT00286754|515678736|FG001|Overall Study|Moved out of state|0|||
143161320|NCT00147537|516135551|FG000|Phase 1b|Other|0|||
143161321|NCT00147537|516135552|FG001|Phase 1b|Other|0|||
143161322|NCT00147537|516135553|FG002|Phase 1b|Other|2|||
143161323|NCT00147537|516135554|FG003|Phase 1b|Other|1|||
143161324|NCT00147537|516135555|FG004|Phase 1b|Other|1|||
143161325|NCT00147537|516135556|FG005|Phase 1b|Other|1|||
143161326|NCT00147537|516135557|FG006|Phase 1b|Other|14|||
143161327|NCT00147537|516135558|FG007|Phase 1b|Other|4|||
143161328|NCT00147537|516135559|FG008|Phase 1b|Other|4|||
143161329|NCT00147537|516135560|FG009|Phase 1b|Other|0|||
143161330|NCT00147537|516135561|FG010|Phase 1b|Other|0|||
143161331|NCT00147537|516135551|FG000|Phase 1b|Withdrawal by Subject|0|||
143161332|NCT00147537|516135552|FG001|Phase 1b|Withdrawal by Subject|0|||
143161333|NCT00147537|516135553|FG002|Phase 1b|Withdrawal by Subject|0|||
143161334|NCT00147537|516135554|FG003|Phase 1b|Withdrawal by Subject|0|||
143161335|NCT00147537|516135555|FG004|Phase 1b|Withdrawal by Subject|0|||
143161336|NCT00147537|516135556|FG005|Phase 1b|Withdrawal by Subject|0|||
143161337|NCT00147537|516135557|FG006|Phase 1b|Withdrawal by Subject|0|||
143161338|NCT00147537|516135558|FG007|Phase 1b|Withdrawal by Subject|0|||
143161339|NCT00147537|516135559|FG008|Phase 1b|Withdrawal by Subject|2|||
143161340|NCT00147537|516135560|FG009|Phase 1b|Withdrawal by Subject|0|||
143161341|NCT00147537|516135561|FG010|Phase 1b|Withdrawal by Subject|0|||
143161342|NCT00147537|516135551|FG000|Phase 1b|Randomized but not treated|0|||
143161343|NCT00147537|516135552|FG001|Phase 1b|Randomized but not treated|0|||
143161344|NCT00147537|516135553|FG002|Phase 1b|Randomized but not treated|0|||
143161345|NCT00147537|516135554|FG003|Phase 1b|Randomized but not treated|0|||
143161346|NCT00147537|516135555|FG004|Phase 1b|Randomized but not treated|0|||
143161347|NCT00147537|516135556|FG005|Phase 1b|Randomized but not treated|0|||
143161348|NCT00147537|516135557|FG006|Phase 1b|Randomized but not treated|1|||
143161349|NCT00147537|516135558|FG007|Phase 1b|Randomized but not treated|0|||
143161350|NCT00147537|516135559|FG008|Phase 1b|Randomized but not treated|1|||
143161351|NCT00147537|516135560|FG009|Phase 1b|Randomized but not treated|0|||
143161352|NCT00147537|516135561|FG010|Phase 1b|Randomized but not treated|0|||
143161353|NCT00147537|516135551|FG000|Phase 2|Death|0|||
143161354|NCT00147537|516135552|FG001|Phase 2|Death|0|||
143161355|NCT00147537|516135553|FG002|Phase 2|Death|0|||
143161356|NCT00147537|516135554|FG003|Phase 2|Death|0|||
143161357|NCT00147537|516135555|FG004|Phase 2|Death|0|||
143161358|NCT00147537|516135556|FG005|Phase 2|Death|0|||
143161359|NCT00147537|516135557|FG006|Phase 2|Death|0|||
143161360|NCT00147537|516135558|FG007|Phase 2|Death|0|||
143161361|NCT00147537|516135559|FG008|Phase 2|Death|0|||
143161362|NCT00147537|516135560|FG009|Phase 2|Death|85|||
143161363|NCT00147537|516135561|FG010|Phase 2|Death|31|||
143037261|NCT00286754|515678737|FG002|Overall Study|Moved out of state|1|||
143037262|NCT02661295|515678738|FG000|Overall Study|Death|1|||
143161364|NCT00147537|516135551|FG000|Phase 2|Lost to Follow-up|0|||
143161365|NCT00147537|516135552|FG001|Phase 2|Lost to Follow-up|0|||
143037263|NCT02661295|515678738|FG000|Overall Study|Transferred Out|1|||
143037264|NCT02661295|515678738|FG000|Overall Study|Kidney Transplant|1|||
143037265|NCT02661295|515678738|FG000|Overall Study|Withdrawn due to side effects|8|||
143161366|NCT00147537|516135553|FG002|Phase 2|Lost to Follow-up|0|||
143161367|NCT00147537|516135554|FG003|Phase 2|Lost to Follow-up|0|||
143161368|NCT00147537|516135555|FG004|Phase 2|Lost to Follow-up|0|||
143161369|NCT00147537|516135556|FG005|Phase 2|Lost to Follow-up|0|||
143161370|NCT00147537|516135557|FG006|Phase 2|Lost to Follow-up|0|||
143495703|NCT02167945|517357712|FG000|Overall Study|Lost to Follow-up|122|||
143495704|NCT02167945|517357712|FG000|Overall Study|COVID-19 logistical restrictions|6|||
143495705|NCT02167945|517357712|FG000|Overall Study|Other, not specified|63|||
143495706|NCT00132730|517357713|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
143495707|NCT00132730|517357714|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
143495708|NCT00132730|517357715|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
143495709|NCT00132730|517357716|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
143495710|NCT00132730|517357717|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
143495711|NCT00132730|517357718|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
143495712|NCT00132730|517357713|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
143495713|NCT00132730|517357714|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
143495714|NCT00132730|517357715|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
143495715|NCT00132730|517357716|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
143495716|NCT00132730|517357717|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
143495717|NCT00132730|517357718|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
143495718|NCT00132730|517357713|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
143495719|NCT00132730|517357714|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
143495720|NCT00132730|517357715|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
143495721|NCT00132730|517357716|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
143495722|NCT00132730|517357717|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
143495723|NCT00132730|517357718|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
143495724|NCT00132730|517357713|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
143495725|NCT00132730|517357714|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
143495726|NCT00132730|517357715|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
143495727|NCT00132730|517357716|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
143495728|NCT00132730|517357717|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
143495729|NCT00132730|517357718|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
143495730|NCT00132730|517357713|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
143495731|NCT00132730|517357714|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
143495732|NCT00132730|517357715|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
143495733|NCT00132730|517357716|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
143495734|NCT00132730|517357717|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
143495735|NCT00132730|517357718|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
143495736|NCT00132730|517357713|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
143495737|NCT00132730|517357714|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
143495738|NCT00132730|517357715|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
143495739|NCT00132730|517357716|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
143495740|NCT00132730|517357717|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
143495741|NCT00132730|517357718|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
143495742|NCT00132730|517357713|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
143495743|NCT00132730|517357714|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
143495744|NCT00132730|517357715|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
143495745|NCT00132730|517357716|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
143495746|NCT00132730|517357717|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
143495747|NCT00132730|517357718|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
143495748|NCT00132730|517357713|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
143495749|NCT00132730|517357714|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
143495750|NCT00132730|517357715|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
143161371|NCT00147537|516135558|FG007|Phase 2|Lost to Follow-up|0|||
143161372|NCT00147537|516135559|FG008|Phase 2|Lost to Follow-up|0|||
143495751|NCT00132730|517357716|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
143495752|NCT00132730|517357717|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
143495753|NCT00132730|517357718|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
143495754|NCT00132730|517357713|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
143495755|NCT00132730|517357714|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
143495756|NCT00132730|517357715|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
143495757|NCT00132730|517357716|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
143495758|NCT00132730|517357717|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
143161373|NCT00147537|516135560|FG009|Phase 2|Lost to Follow-up|12|||
143161374|NCT00147537|516135561|FG010|Phase 2|Lost to Follow-up|4|||
143161375|NCT00147537|516135551|FG000|Phase 2|Other|0|||
143161376|NCT00147537|516135552|FG001|Phase 2|Other|0|||
143161377|NCT00147537|516135553|FG002|Phase 2|Other|0|||
143161378|NCT00147537|516135554|FG003|Phase 2|Other|0|||
143161379|NCT00147537|516135555|FG004|Phase 2|Other|0|||
143037266|NCT02661295|515678738|FG000|Overall Study|Withdrawn due to access type|1|||
143037267|NCT02661295|515678738|FG000|Overall Study|Withdrawn due to allergies|1|||
143037268|NCT02661295|515678738|FG000|Overall Study|Withdrawn due to non-compliance|1|||
143037269|NCT02661295|515678738|FG000|Overall Study|Withdrawal by Subject|3|||
143238778|NCT02266888|516429779|FG000|Overall Study|No Longer Eligible|0|||
143238779|NCT02266888|516429780|FG001|Overall Study|No Longer Eligible|0|||
143238780|NCT02266888|516429781|FG002|Overall Study|No Longer Eligible|0|||
143238781|NCT02266888|516429782|FG003|Overall Study|No Longer Eligible|2|||
143238782|NCT02266888|516429779|FG000|Overall Study|Randomization Closed|0|||
143238783|NCT02266888|516429780|FG001|Overall Study|Randomization Closed|0|||
143238784|NCT02266888|516429781|FG002|Overall Study|Randomization Closed|4|||
143238785|NCT02266888|516429782|FG003|Overall Study|Randomization Closed|0|||
143238786|NCT02266888|516429779|FG000|Overall Study|Personnel unavailable at transplant|0|||
143238787|NCT02266888|516429780|FG001|Overall Study|Personnel unavailable at transplant|0|||
143238788|NCT02266888|516429781|FG002|Overall Study|Personnel unavailable at transplant|0|||
143238789|NCT02266888|516429782|FG003|Overall Study|Personnel unavailable at transplant|1|||
143238790|NCT02266888|516429779|FG000|Overall Study|Transfer of care|0|||
143238791|NCT02266888|516429780|FG001|Overall Study|Transfer of care|0|||
143238792|NCT02266888|516429781|FG002|Overall Study|Transfer of care|1|||
143238793|NCT02266888|516429782|FG003|Overall Study|Transfer of care|0|||
143238794|NCT01458392|516429783|FG000|Overall Study|Death|2|||
143238795|NCT01458392|516429784|FG001|Overall Study|Death|11|||
143238796|NCT01458392|516429785|FG002|Overall Study|Death|22|||
143238797|NCT01458392|516429783|FG000|Overall Study|At the discretion of the sponsor|0|||
143238798|NCT01458392|516429784|FG001|Overall Study|At the discretion of the sponsor|2|||
143238799|NCT01458392|516429785|FG002|Overall Study|At the discretion of the sponsor|7|||
143238800|NCT01458392|516429783|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
143238801|NCT01458392|516429784|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
143238802|NCT01458392|516429785|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
143238803|NCT01281124|516429788|FG000|Overall Study|Death|1|||
143238804|NCT00753506|516429789|FG000|Overall Study|Withdrawal by Subject|4|||
143238805|NCT00753506|516429790|FG001|Overall Study|Withdrawal by Subject|1|||
143238806|NCT00753506|516429789|FG000|Overall Study|Lost to Follow-up|2|||
143238807|NCT00753506|516429790|FG001|Overall Study|Lost to Follow-up|0|||
143238808|NCT00753506|516429789|FG000|Overall Study|Other reason|1|||
143238809|NCT00753506|516429790|FG001|Overall Study|Other reason|1|||
143238810|NCT01193244|516429795|FG000|Overall Study|Withdrawal by Subject|79|||
143238811|NCT01193244|516429796|FG001|Overall Study|Withdrawal by Subject|97|||
143238812|NCT01193244|516429795|FG000|Overall Study|Other|303|||
143238813|NCT01193244|516429796|FG001|Overall Study|Other|278|||
143238814|NCT01193244|516429795|FG000|Overall Study|Lost to Follow-up|6|||
143238815|NCT01193244|516429796|FG001|Overall Study|Lost to Follow-up|15|||
143238816|NCT01417377|516429797|FG000|Overall Study|Lost to Follow-up|12|||
143238817|NCT01417377|516429797|FG000|Overall Study|Enrolled, but not treated|1|||
143238818|NCT02113982|516429798|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
143238819|NCT02113982|516429799|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
143238820|NCT02113982|516429800|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
143238821|NCT02113982|516429801|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
143238822|NCT02113982|516429802|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
143238823|NCT02113982|516429803|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
143238824|NCT02113982|516429804|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
143238825|NCT02113982|516429805|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
143238826|NCT02113982|516429806|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
143238827|NCT02113982|516429807|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
143238828|NCT02113982|516429808|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
143238829|NCT02113982|516429809|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
143238830|NCT02113982|516429810|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
143238831|NCT02113982|516429811|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
143364082|NCT03686683|516875530|FG000|Overall Study|Progressive Disease|1|||
143364083|NCT03686683|516875531|FG001|Overall Study|Progressive Disease|1|||
143364084|NCT03686683|516875530|FG000|Overall Study|Noncompliance|1|||
143495759|NCT00132730|517357718|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
143495760|NCT00132730|517357713|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
143495761|NCT00132730|517357714|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
143495762|NCT00132730|517357715|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
143037270|NCT02661295|515678738|FG000|Overall Study|Failed screening|2|||
143037271|NCT00910663|515678743|FG000|Period 1|Withdrawal by Subject|0|||
143238832|NCT02113982|516429798|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
143238833|NCT02113982|516429799|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
143238834|NCT02113982|516429800|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
143238835|NCT02113982|516429801|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
143238836|NCT02113982|516429802|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
143238837|NCT02113982|516429803|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
143037272|NCT00910663|515678744|FG001|Period 1|Withdrawal by Subject|1|||
143364085|NCT03686683|516875531|FG001|Overall Study|Noncompliance|0|||
143495763|NCT00132730|517357716|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
143495764|NCT00132730|517357717|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
143495765|NCT00132730|517357718|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
143495766|NCT00132730|517357713|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
143495767|NCT00132730|517357714|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
143495768|NCT00132730|517357715|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
143495769|NCT00132730|517357716|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
143495770|NCT00132730|517357717|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
143495771|NCT00132730|517357718|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
143495772|NCT00132730|517357713|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
143495773|NCT00132730|517357714|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
143495774|NCT00132730|517357715|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
143495775|NCT00132730|517357716|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
143495776|NCT00132730|517357717|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
143495777|NCT00132730|517357718|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
143495778|NCT01192347|517357719|FG000|Overall Study|Death|3|||
143495779|NCT01192347|517357719|FG000|Overall Study|Lost to Follow-up|3|||
143495780|NCT01192347|517357719|FG000|Overall Study|Withdrawal by Subject|1|||
143495781|NCT01192347|517357719|FG000|Overall Study|Adverse Event|1|||
143495782|NCT01192347|517357719|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
143495783|NCT01192347|517357719|FG000|Overall Study|Patient seen in different hospital|1|||
143495784|NCT01192347|517357719|FG000|Overall Study|Patient not visiting hospital regularly|1|||
143495785|NCT01192347|517357719|FG000|Overall Study|Patient did not show up for visits|1|||
143495786|NCT02623335|517357720|FG000|Overall Study|Death|8|||
143495787|NCT02623335|517357721|FG001|Overall Study|Death|7|||
143495788|NCT02623335|517357720|FG000|Overall Study|Lost to Follow-up|15|||
143495789|NCT02623335|517357721|FG001|Overall Study|Lost to Follow-up|23|||
143495790|NCT02623335|517357720|FG000|Overall Study|Withdrawal by Subject|2|||
143495791|NCT02623335|517357721|FG001|Overall Study|Withdrawal by Subject|5|||
143495792|NCT02623335|517357720|FG000|Overall Study|Protocol Violation|2|||
143495793|NCT02623335|517357721|FG001|Overall Study|Protocol Violation|1|||
143495794|NCT03739528|517357722|FG000|Overall Study|Not treated|8|||
143495795|NCT03739528|517357723|FG001|Overall Study|Not treated|12|||
143495796|NCT03739528|517357722|FG000|Overall Study|Treatment and study discontinued|6|||
143495797|NCT03739528|517357723|FG001|Overall Study|Treatment and study discontinued|2|||
143495798|NCT03739528|517357722|FG000|Overall Study|Treatment discontinued + study completed|1|||
143495799|NCT03739528|517357723|FG001|Overall Study|Treatment discontinued + study completed|3|||
143495800|NCT00179959|517357724|FG000|Overall Study|Lost to Follow-up|3|||
143495801|NCT00179959|517357725|FG001|Overall Study|Lost to Follow-up|1|||
143495802|NCT00179959|517357724|FG000|Overall Study|Withdrawal by Subject|3|||
143495803|NCT00179959|517357725|FG001|Overall Study|Withdrawal by Subject|2|||
143495804|NCT01262976|517357726|FG000|Up to Month 2|Serious Adverse Event|0|||
143495805|NCT01262976|517357727|FG001|Up to Month 2|Serious Adverse Event|0|||
143495806|NCT01262976|517357728|FG002|Up to Month 2|Serious Adverse Event|1|||
143495807|NCT01262976|517357729|FG003|Up to Month 2|Serious Adverse Event|0|||
143495808|NCT01262976|517357730|FG004|Up to Month 2|Serious Adverse Event|0|||
143495809|NCT01262976|517357731|FG005|Up to Month 2|Serious Adverse Event|0|||
143495810|NCT01262976|517357726|FG000|Up to Month 2|Withdrawal by Subject|1|||
143495811|NCT01262976|517357727|FG001|Up to Month 2|Withdrawal by Subject|0|||
143495812|NCT01262976|517357728|FG002|Up to Month 2|Withdrawal by Subject|0|||
143495813|NCT01262976|517357729|FG003|Up to Month 2|Withdrawal by Subject|0|||
143495814|NCT01262976|517357730|FG004|Up to Month 2|Withdrawal by Subject|0|||
143495815|NCT01262976|517357731|FG005|Up to Month 2|Withdrawal by Subject|0|||
143495816|NCT01262976|517357726|FG000|Up to Month 2|Migrated/moved from study area|0|||
143495817|NCT01262976|517357727|FG001|Up to Month 2|Migrated/moved from study area|1|||
143495818|NCT01262976|517357728|FG002|Up to Month 2|Migrated/moved from study area|0|||
143495819|NCT01262976|517357729|FG003|Up to Month 2|Migrated/moved from study area|0|||
143495820|NCT01262976|517357730|FG004|Up to Month 2|Migrated/moved from study area|1|||
143495821|NCT01262976|517357731|FG005|Up to Month 2|Migrated/moved from study area|1|||
143495822|NCT01262976|517357726|FG000|Up to Month 2|Lost to Follow-up|1|||
143495823|NCT01262976|517357727|FG001|Up to Month 2|Lost to Follow-up|0|||
143495824|NCT01262976|517357728|FG002|Up to Month 2|Lost to Follow-up|0|||
143495825|NCT01262976|517357729|FG003|Up to Month 2|Lost to Follow-up|1|||
143495826|NCT01262976|517357730|FG004|Up to Month 2|Lost to Follow-up|1|||
143495827|NCT01262976|517357731|FG005|Up to Month 2|Lost to Follow-up|1|||
143495828|NCT01262976|517357726|FG000|Up to Month 2|Other|1|||
143495829|NCT01262976|517357727|FG001|Up to Month 2|Other|0|||
143495830|NCT01262976|517357728|FG002|Up to Month 2|Other|0|||
143495831|NCT01262976|517357729|FG003|Up to Month 2|Other|1|||
143495832|NCT01262976|517357730|FG004|Up to Month 2|Other|0|||
143495833|NCT01262976|517357731|FG005|Up to Month 2|Other|2|||
143495834|NCT01262976|517357726|FG000|Up to Month 7|Serious Adverse Event|0|||
143495835|NCT01262976|517357727|FG001|Up to Month 7|Serious Adverse Event|0|||
143495836|NCT01262976|517357728|FG002|Up to Month 7|Serious Adverse Event|2|||
143495837|NCT01262976|517357729|FG003|Up to Month 7|Serious Adverse Event|0|||
143495838|NCT01262976|517357730|FG004|Up to Month 7|Serious Adverse Event|0|||
143495839|NCT01262976|517357731|FG005|Up to Month 7|Serious Adverse Event|0|||
143495840|NCT01262976|517357726|FG000|Up to Month 7|Withdrawal by Subject|1|||
143495841|NCT01262976|517357727|FG001|Up to Month 7|Withdrawal by Subject|0|||
143495842|NCT01262976|517357728|FG002|Up to Month 7|Withdrawal by Subject|0|||
143495843|NCT01262976|517357729|FG003|Up to Month 7|Withdrawal by Subject|0|||
143495844|NCT01262976|517357730|FG004|Up to Month 7|Withdrawal by Subject|0|||
143495845|NCT01262976|517357731|FG005|Up to Month 7|Withdrawal by Subject|0|||
143495846|NCT01262976|517357726|FG000|Up to Month 7|Migrated/moved from study area|0|||
143495847|NCT01262976|517357727|FG001|Up to Month 7|Migrated/moved from study area|0|||
143495848|NCT01262976|517357728|FG002|Up to Month 7|Migrated/moved from study area|1|||
143495849|NCT01262976|517357729|FG003|Up to Month 7|Migrated/moved from study area|3|||
143495850|NCT01262976|517357730|FG004|Up to Month 7|Migrated/moved from study area|1|||
143495851|NCT01262976|517357731|FG005|Up to Month 7|Migrated/moved from study area|1|||
143495852|NCT01262976|517357726|FG000|Up to Month 7|Lost to Follow-up|1|||
143495853|NCT01262976|517357727|FG001|Up to Month 7|Lost to Follow-up|0|||
143495854|NCT01262976|517357728|FG002|Up to Month 7|Lost to Follow-up|1|||
143495855|NCT01262976|517357729|FG003|Up to Month 7|Lost to Follow-up|3|||
143495856|NCT01262976|517357730|FG004|Up to Month 7|Lost to Follow-up|1|||
143495857|NCT01262976|517357731|FG005|Up to Month 7|Lost to Follow-up|3|||
143495858|NCT01262976|517357726|FG000|Up to Month 7|Other|3|||
143495859|NCT01262976|517357727|FG001|Up to Month 7|Other|0|||
143495860|NCT01262976|517357728|FG002|Up to Month 7|Other|2|||
143495861|NCT01262976|517357729|FG003|Up to Month 7|Other|0|||
143495862|NCT01262976|517357730|FG004|Up to Month 7|Other|0|||
143495863|NCT01262976|517357731|FG005|Up to Month 7|Other|0|||
143495864|NCT01262976|517357726|FG000|Up to Year 1|Serious Adverse Event|0|||
143495865|NCT01262976|517357727|FG001|Up to Year 1|Serious Adverse Event|0|||
143495866|NCT01262976|517357728|FG002|Up to Year 1|Serious Adverse Event|2|||
143495867|NCT01262976|517357729|FG003|Up to Year 1|Serious Adverse Event|0|||
143495868|NCT01262976|517357730|FG004|Up to Year 1|Serious Adverse Event|0|||
143495869|NCT01262976|517357731|FG005|Up to Year 1|Serious Adverse Event|0|||
143495870|NCT01262976|517357726|FG000|Up to Year 1|Withdrawal by Subject|1|||
143495871|NCT01262976|517357727|FG001|Up to Year 1|Withdrawal by Subject|0|||
143495872|NCT01262976|517357728|FG002|Up to Year 1|Withdrawal by Subject|0|||
143495873|NCT01262976|517357729|FG003|Up to Year 1|Withdrawal by Subject|0|||
143495874|NCT01262976|517357730|FG004|Up to Year 1|Withdrawal by Subject|0|||
143495875|NCT01262976|517357731|FG005|Up to Year 1|Withdrawal by Subject|0|||
143495876|NCT01262976|517357726|FG000|Up to Year 1|Migrated/moved from study area|1|||
143495877|NCT01262976|517357727|FG001|Up to Year 1|Migrated/moved from study area|0|||
143495878|NCT01262976|517357728|FG002|Up to Year 1|Migrated/moved from study area|0|||
143495879|NCT01262976|517357729|FG003|Up to Year 1|Migrated/moved from study area|3|||
143495880|NCT01262976|517357730|FG004|Up to Year 1|Migrated/moved from study area|3|||
143495881|NCT01262976|517357731|FG005|Up to Year 1|Migrated/moved from study area|2|||
143495882|NCT01262976|517357726|FG000|Up to Year 1|Lost to Follow-up|4|||
143495883|NCT01262976|517357727|FG001|Up to Year 1|Lost to Follow-up|0|||
143495884|NCT01262976|517357728|FG002|Up to Year 1|Lost to Follow-up|0|||
143495885|NCT01262976|517357729|FG003|Up to Year 1|Lost to Follow-up|1|||
143495886|NCT01262976|517357730|FG004|Up to Year 1|Lost to Follow-up|6|||
143495887|NCT01262976|517357731|FG005|Up to Year 1|Lost to Follow-up|5|||
143495888|NCT01262976|517357726|FG000|Up to Year 1|Other|3|||
143495889|NCT01262976|517357727|FG001|Up to Year 1|Other|1|||
143495890|NCT01262976|517357728|FG002|Up to Year 1|Other|0|||
143495891|NCT01262976|517357729|FG003|Up to Year 1|Other|0|||
143495892|NCT01262976|517357730|FG004|Up to Year 1|Other|2|||
143495893|NCT01262976|517357731|FG005|Up to Year 1|Other|1|||
143037273|NCT02726581|515678745|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
143037274|NCT02726581|515678746|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
143037275|NCT02726581|515678747|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
143037276|NCT02726581|515678745|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
143037277|NCT02726581|515678746|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
143037278|NCT02726581|515678747|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
143037279|NCT02726581|515678745|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
143495894|NCT01262976|517357726|FG000|Up to Year 1|Subjects with unknown completion status|0|||
143495895|NCT01262976|517357727|FG001|Up to Year 1|Subjects with unknown completion status|0|||
143495896|NCT01262976|517357728|FG002|Up to Year 1|Subjects with unknown completion status|1|||
143495897|NCT01262976|517357729|FG003|Up to Year 1|Subjects with unknown completion status|0|||
143495898|NCT01262976|517357730|FG004|Up to Year 1|Subjects with unknown completion status|0|||
143495899|NCT01262976|517357731|FG005|Up to Year 1|Subjects with unknown completion status|1|||
143495900|NCT01262976|517357726|FG000|Up to Year 2|Serious Adverse Event|0|||
143495901|NCT01262976|517357727|FG001|Up to Year 2|Serious Adverse Event|0|||
143495902|NCT01262976|517357728|FG002|Up to Year 2|Serious Adverse Event|2|||
143495903|NCT01262976|517357729|FG003|Up to Year 2|Serious Adverse Event|0|||
143161380|NCT00147537|516135556|FG005|Phase 2|Other|0|||
143161381|NCT00147537|516135557|FG006|Phase 2|Other|0|||
143161382|NCT00147537|516135558|FG007|Phase 2|Other|0|||
143161383|NCT00147537|516135559|FG008|Phase 2|Other|0|||
143161384|NCT00147537|516135560|FG009|Phase 2|Other|47|||
143238838|NCT02113982|516429804|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
143238839|NCT02113982|516429805|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
143238840|NCT02113982|516429806|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
143238841|NCT02113982|516429807|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
143238842|NCT02113982|516429808|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
143238843|NCT02113982|516429809|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
143238844|NCT02113982|516429810|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
143238845|NCT02113982|516429811|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
143238846|NCT02113982|516429798|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
143238847|NCT02113982|516429799|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
143238848|NCT02113982|516429800|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
143238849|NCT02113982|516429801|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
143238850|NCT02113982|516429802|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
143238851|NCT02113982|516429803|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
143238852|NCT02113982|516429804|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
143238853|NCT02113982|516429805|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
143238854|NCT02113982|516429806|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
143238855|NCT02113982|516429807|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
143238856|NCT02113982|516429808|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
143238857|NCT02113982|516429809|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
143238858|NCT02113982|516429810|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
143238859|NCT02113982|516429811|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
143238860|NCT02113982|516429798|FG000|Stage 1: Dose Escalation|Transplant|0|||
143238861|NCT02113982|516429799|FG001|Stage 1: Dose Escalation|Transplant|1|||
143495904|NCT01262976|517357730|FG004|Up to Year 2|Serious Adverse Event|0|||
143037280|NCT02726581|515678746|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
143037281|NCT02726581|515678747|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
143037282|NCT02726581|515678745|FG000|Treatment Period|Disease progression|47|||
143037283|NCT02726581|515678746|FG001|Treatment Period|Disease progression|50|||
143037284|NCT02726581|515678747|FG002|Treatment Period|Disease progression|16|||
143037285|NCT02726581|515678745|FG000|Treatment Period|Other reasons|9|||
143037286|NCT02726581|515678746|FG001|Treatment Period|Other reasons|8|||
143037287|NCT02726581|515678747|FG002|Treatment Period|Other reasons|2|||
143037288|NCT02726581|515678745|FG000|Treatment Period|Study drug toxicity|6|||
143037289|NCT02726581|515678746|FG001|Treatment Period|Study drug toxicity|3|||
143037290|NCT02726581|515678747|FG002|Treatment Period|Study drug toxicity|2|||
143037291|NCT02726581|515678745|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
143161385|NCT00147537|516135561|FG010|Phase 2|Other|12|||
143161386|NCT00147537|516135551|FG000|Phase 2|Withdrawal by Subject|0|||
143161387|NCT00147537|516135552|FG001|Phase 2|Withdrawal by Subject|0|||
143161388|NCT00147537|516135553|FG002|Phase 2|Withdrawal by Subject|0|||
143161389|NCT00147537|516135554|FG003|Phase 2|Withdrawal by Subject|0|||
143161390|NCT00147537|516135555|FG004|Phase 2|Withdrawal by Subject|0|||
143161391|NCT00147537|516135556|FG005|Phase 2|Withdrawal by Subject|0|||
143161392|NCT00147537|516135557|FG006|Phase 2|Withdrawal by Subject|0|||
143161393|NCT00147537|516135558|FG007|Phase 2|Withdrawal by Subject|0|||
143161394|NCT00147537|516135559|FG008|Phase 2|Withdrawal by Subject|0|||
143161395|NCT00147537|516135560|FG009|Phase 2|Withdrawal by Subject|16|||
143161396|NCT00147537|516135561|FG010|Phase 2|Withdrawal by Subject|4|||
143161397|NCT00147537|516135551|FG000|Phase 2|Randomized but not treated|0|||
143238862|NCT02113982|516429800|FG002|Stage 1: Dose Escalation|Transplant|0|||
143238863|NCT02113982|516429801|FG003|Stage 1: Dose Escalation|Transplant|0|||
143238864|NCT02113982|516429802|FG004|Stage 1: Dose Escalation|Transplant|0|||
143364086|NCT03686683|516875530|FG000|Overall Study|Physician Decision|1|||
143364087|NCT03686683|516875531|FG001|Overall Study|Physician Decision|1|||
143364088|NCT03686683|516875530|FG000|Overall Study|Screen fail post-randomization|1|||
143364089|NCT03686683|516875531|FG001|Overall Study|Screen fail post-randomization|0|||
143364090|NCT03686683|516875530|FG000|Overall Study|Protocol Violation|3|||
143364091|NCT03686683|516875531|FG001|Overall Study|Protocol Violation|0|||
143495905|NCT01262976|517357731|FG005|Up to Year 2|Serious Adverse Event|0|||
143495906|NCT01262976|517357726|FG000|Up to Year 2|Withdrawal by Subject|1|||
143495907|NCT01262976|517357727|FG001|Up to Year 2|Withdrawal by Subject|0|||
143037292|NCT02726581|515678746|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
143037293|NCT02726581|515678747|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
143037294|NCT02726581|515678745|FG000|Treatment Period|Participant withdrew consent|3|||
143037295|NCT02726581|515678746|FG001|Treatment Period|Participant withdrew consent|1|||
143161398|NCT00147537|516135552|FG001|Phase 2|Randomized but not treated|0|||
143161399|NCT00147537|516135553|FG002|Phase 2|Randomized but not treated|0|||
143161400|NCT00147537|516135554|FG003|Phase 2|Randomized but not treated|0|||
143161401|NCT00147537|516135555|FG004|Phase 2|Randomized but not treated|0|||
143364092|NCT03686683|516875530|FG000|Overall Study|No data available|1|||
143364093|NCT03686683|516875531|FG001|Overall Study|No data available|0|||
143364094|NCT04296942|516875532|FG000|Overall Study|Study closure by sponsor|1|||
143364095|NCT04296942|516875533|FG001|Overall Study|Study closure by sponsor|0|||
143364096|NCT04296942|516875534|FG002|Overall Study|Study closure by sponsor|0|||
143364097|NCT01579578|516875546|FG000|Overall Study|Death|4|||
143364098|NCT01579578|516875547|FG001|Overall Study|Death|1|||
143364099|NCT01579578|516875546|FG000|Overall Study|Lost to Follow-up|1|||
143364100|NCT01579578|516875547|FG001|Overall Study|Lost to Follow-up|1|||
143364101|NCT01579578|516875546|FG000|Overall Study|Withdrawal by Subject|2|||
143364102|NCT01579578|516875547|FG001|Overall Study|Withdrawal by Subject|1|||
143364103|NCT01579578|516875546|FG000|Overall Study|Eligibility criteria|3|||
143364104|NCT01579578|516875547|FG001|Overall Study|Eligibility criteria|9|||
143364105|NCT01579578|516875546|FG000|Overall Study|Ongoing|3|||
143364106|NCT01579578|516875547|FG001|Overall Study|Ongoing|0|||
143364107|NCT01770860|516875548|FG000|Overall Study|Withdrawal by Subject|4|||
143364108|NCT01770860|516875548|FG000|Overall Study|Lost to Follow-up|1|||
143364109|NCT01770860|516875548|FG000|Overall Study|Administrative decision made by the PI|1|||
143364110|NCT01528709|516875549|FG000|Overall Study|Death|2|||
143364111|NCT01528709|516875550|FG001|Overall Study|Death|0|||
143037296|NCT02726581|515678747|FG002|Treatment Period|Participant withdrew consent|1|||
143037297|NCT02726581|515678745|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
143161402|NCT00147537|516135556|FG005|Phase 2|Randomized but not treated|0|||
143161403|NCT00147537|516135557|FG006|Phase 2|Randomized but not treated|0|||
143161404|NCT00147537|516135558|FG007|Phase 2|Randomized but not treated|0|||
143161405|NCT00147537|516135559|FG008|Phase 2|Randomized but not treated|0|||
143161406|NCT00147537|516135560|FG009|Phase 2|Randomized but not treated|1|||
143161407|NCT00147537|516135561|FG010|Phase 2|Randomized but not treated|1|||
143161408|NCT01089543|516135562|FG000|Overall Study|Withdrawal by Subject|2|||
143161409|NCT01089543|516135563|FG001|Overall Study|Withdrawal by Subject|3|||
143161410|NCT01089543|516135564|FG002|Overall Study|Withdrawal by Subject|3|||
143161411|NCT01089543|516135565|FG003|Overall Study|Withdrawal by Subject|1|||
143161412|NCT01089543|516135562|FG000|Overall Study|Physician Decision|1|||
143161413|NCT01089543|516135563|FG001|Overall Study|Physician Decision|0|||
143161414|NCT01089543|516135564|FG002|Overall Study|Physician Decision|0|||
143161415|NCT01089543|516135565|FG003|Overall Study|Physician Decision|1|||
143161416|NCT01089543|516135562|FG000|Overall Study|Adverse Event|0|||
143161417|NCT01089543|516135563|FG001|Overall Study|Adverse Event|1|||
143161418|NCT01089543|516135564|FG002|Overall Study|Adverse Event|0|||
143161419|NCT01089543|516135565|FG003|Overall Study|Adverse Event|0|||
143161420|NCT01905267|516135570|FG000|Overall Study|Physician Decision|2|||
143161421|NCT01905267|516135571|FG001|Overall Study|Physician Decision|2|||
143161422|NCT02991859|516135572|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
143161423|NCT02991859|516135573|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
143161424|NCT02991859|516135574|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
143161425|NCT02991859|516135575|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
143161426|NCT02991859|516135576|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
143161427|NCT02991859|516135577|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
143161428|NCT02991859|516135578|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
143161429|NCT02991859|516135579|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
143161430|NCT02991859|516135580|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
143161431|NCT02991859|516135581|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
143161432|NCT02991859|516135582|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
143161433|NCT02991859|516135583|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
143364112|NCT01528709|516875549|FG000|Overall Study|Withdrawal by Subject|10|||
143364113|NCT01528709|516875550|FG001|Overall Study|Withdrawal by Subject|15|||
143364114|NCT01528709|516875549|FG000|Overall Study|allergy|1|||
143364115|NCT01528709|516875550|FG001|Overall Study|allergy|0|||
143037298|NCT02726581|515678746|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
143037299|NCT02726581|515678747|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
143037300|NCT02726581|515678745|FG000|Treatment Period|Maximum clinical benefit|0|||
143037301|NCT02726581|515678746|FG001|Treatment Period|Maximum clinical benefit|2|||
143037302|NCT02726581|515678747|FG002|Treatment Period|Maximum clinical benefit|0|||
143037303|NCT02726581|515678745|FG000|Treatment Period|Death|1|||
143037304|NCT02726581|515678746|FG001|Treatment Period|Death|0|||
143037305|NCT02726581|515678747|FG002|Treatment Period|Death|0|||
143037306|NCT02726581|515678745|FG000|Treatment Period|Poor/non-compliance|1|||
143037307|NCT02726581|515678746|FG001|Treatment Period|Poor/non-compliance|0|||
143037308|NCT02726581|515678747|FG002|Treatment Period|Poor/non-compliance|0|||
143037309|NCT02726581|515678745|FG000|Treatment Period|Participant no longer meets study criteria|0|||
143037310|NCT02726581|515678746|FG001|Treatment Period|Participant no longer meets study criteria|1|||
143037311|NCT02726581|515678747|FG002|Treatment Period|Participant no longer meets study criteria|0|||
143037312|NCT02865850|515678748|FG000|Overall Study|Death|15|||
143037313|NCT02865850|515678749|FG001|Overall Study|Death|19|||
143495908|NCT01262976|517357728|FG002|Up to Year 2|Withdrawal by Subject|0|||
143495909|NCT01262976|517357729|FG003|Up to Year 2|Withdrawal by Subject|0|||
143495910|NCT01262976|517357730|FG004|Up to Year 2|Withdrawal by Subject|0|||
143495911|NCT01262976|517357731|FG005|Up to Year 2|Withdrawal by Subject|0|||
143495912|NCT01262976|517357726|FG000|Up to Year 2|Migrated/moved from study area|0|||
143495913|NCT01262976|517357727|FG001|Up to Year 2|Migrated/moved from study area|0|||
143495914|NCT01262976|517357728|FG002|Up to Year 2|Migrated/moved from study area|0|||
143495915|NCT01262976|517357729|FG003|Up to Year 2|Migrated/moved from study area|2|||
143495916|NCT01262976|517357730|FG004|Up to Year 2|Migrated/moved from study area|1|||
143495917|NCT01262976|517357731|FG005|Up to Year 2|Migrated/moved from study area|2|||
143495918|NCT01262976|517357726|FG000|Up to Year 2|Lost to Follow-up|1|||
143495919|NCT01262976|517357727|FG001|Up to Year 2|Lost to Follow-up|1|||
143495920|NCT01262976|517357728|FG002|Up to Year 2|Lost to Follow-up|2|||
143495921|NCT01262976|517357729|FG003|Up to Year 2|Lost to Follow-up|2|||
143495922|NCT01262976|517357730|FG004|Up to Year 2|Lost to Follow-up|3|||
143495923|NCT01262976|517357731|FG005|Up to Year 2|Lost to Follow-up|3|||
143495924|NCT01262976|517357726|FG000|Up to Year 2|Subjects with unknown completion status|0|||
143495925|NCT01262976|517357727|FG001|Up to Year 2|Subjects with unknown completion status|0|||
143495926|NCT01262976|517357728|FG002|Up to Year 2|Subjects with unknown completion status|1|||
143037314|NCT02865850|515678748|FG000|Overall Study|Withdrawal by Subject|3|||
143037315|NCT02865850|515678749|FG001|Overall Study|Withdrawal by Subject|2|||
143037316|NCT02865850|515678748|FG000|Overall Study|Lost to Follow-up|3|||
143037317|NCT02865850|515678749|FG001|Overall Study|Lost to Follow-up|2|||
143037318|NCT01844375|515678753|FG000|Overall Study|Protocol Violation|1|||
143495927|NCT01262976|517357729|FG003|Up to Year 2|Subjects with unknown completion status|0|||
143495928|NCT01262976|517357730|FG004|Up to Year 2|Subjects with unknown completion status|0|||
143495929|NCT01262976|517357731|FG005|Up to Year 2|Subjects with unknown completion status|0|||
143495930|NCT01262976|517357726|FG000|Up to Year 2|Other|3|||
143495931|NCT01262976|517357727|FG001|Up to Year 2|Other|0|||
143495932|NCT01262976|517357728|FG002|Up to Year 2|Other|0|||
143495933|NCT01262976|517357729|FG003|Up to Year 2|Other|0|||
143495934|NCT01262976|517357730|FG004|Up to Year 2|Other|0|||
143495935|NCT01262976|517357731|FG005|Up to Year 2|Other|0|||
143495936|NCT01262976|517357726|FG000|Up to Year 3|Serious Adverse Event|0|||
143495937|NCT01262976|517357727|FG001|Up to Year 3|Serious Adverse Event|0|||
143495938|NCT01262976|517357728|FG002|Up to Year 3|Serious Adverse Event|2|||
143495939|NCT01262976|517357729|FG003|Up to Year 3|Serious Adverse Event|0|||
143495940|NCT01262976|517357730|FG004|Up to Year 3|Serious Adverse Event|0|||
143495941|NCT01262976|517357731|FG005|Up to Year 3|Serious Adverse Event|0|||
143495942|NCT01262976|517357726|FG000|Up to Year 3|Withdrawal by Subject|1|||
143495943|NCT01262976|517357727|FG001|Up to Year 3|Withdrawal by Subject|0|||
143495944|NCT01262976|517357728|FG002|Up to Year 3|Withdrawal by Subject|0|||
143495945|NCT01262976|517357729|FG003|Up to Year 3|Withdrawal by Subject|0|||
143495946|NCT01262976|517357730|FG004|Up to Year 3|Withdrawal by Subject|0|||
143495947|NCT01262976|517357731|FG005|Up to Year 3|Withdrawal by Subject|0|||
143495948|NCT01262976|517357726|FG000|Up to Year 3|Migrated/moved from study area|0|||
143495949|NCT01262976|517357727|FG001|Up to Year 3|Migrated/moved from study area|0|||
143495950|NCT01262976|517357728|FG002|Up to Year 3|Migrated/moved from study area|0|||
143495951|NCT01262976|517357729|FG003|Up to Year 3|Migrated/moved from study area|2|||
143495952|NCT01262976|517357730|FG004|Up to Year 3|Migrated/moved from study area|1|||
143495953|NCT01262976|517357731|FG005|Up to Year 3|Migrated/moved from study area|1|||
143495954|NCT01262976|517357726|FG000|Up to Year 3|Lost to Follow-up|2|||
143495955|NCT01262976|517357727|FG001|Up to Year 3|Lost to Follow-up|2|||
143495956|NCT01262976|517357728|FG002|Up to Year 3|Lost to Follow-up|4|||
143495957|NCT01262976|517357729|FG003|Up to Year 3|Lost to Follow-up|3|||
143495958|NCT01262976|517357730|FG004|Up to Year 3|Lost to Follow-up|1|||
143495959|NCT01262976|517357731|FG005|Up to Year 3|Lost to Follow-up|3|||
143495960|NCT01262976|517357726|FG000|Up to Year 3|Subjects with unknown completion status|0|||
143495961|NCT01262976|517357727|FG001|Up to Year 3|Subjects with unknown completion status|0|||
143495962|NCT01262976|517357728|FG002|Up to Year 3|Subjects with unknown completion status|1|||
143495963|NCT01262976|517357729|FG003|Up to Year 3|Subjects with unknown completion status|0|||
143037319|NCT01844375|515678754|FG001|Overall Study|Protocol Violation|1|||
143037320|NCT02193165|515678756|FG000|4 Week Product Use|Lost to Follow-up|1|||
143495964|NCT01262976|517357730|FG004|Up to Year 3|Subjects with unknown completion status|0|||
143495965|NCT01262976|517357731|FG005|Up to Year 3|Subjects with unknown completion status|0|||
143495966|NCT01262976|517357726|FG000|Up to Year 3|Other|3|||
143495967|NCT01262976|517357727|FG001|Up to Year 3|Other|0|||
143037321|NCT02193165|515678757|FG001|4 Week Product Use|Lost to Follow-up|1|||
143161434|NCT02991859|516135584|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
143495968|NCT01262976|517357728|FG002|Up to Year 3|Other|0|||
143495969|NCT01262976|517357729|FG003|Up to Year 3|Other|0|||
143495970|NCT01262976|517357730|FG004|Up to Year 3|Other|0|||
143037322|NCT02193165|515678758|FG002|4 Week Product Use|Lost to Follow-up|1|||
143037323|NCT02193165|515678756|FG000|6 Week Product Use|Lost to Follow-up|0|||
143037324|NCT02193165|515678757|FG001|6 Week Product Use|Lost to Follow-up|1|||
143037325|NCT02193165|515678758|FG002|6 Week Product Use|Lost to Follow-up|0|||
143037326|NCT04239872|515678759|FG000|Overall Study|Lost to Follow-up|0|||
143037327|NCT04239872|515678760|FG001|Overall Study|Lost to Follow-up|1|||
143238865|NCT02113982|516429803|FG005|Stage 1: Dose Escalation|Transplant|1|||
143238866|NCT02113982|516429804|FG006|Stage 1: Dose Escalation|Transplant|0|||
143161435|NCT02991859|516135585|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
143161436|NCT02991859|516135586|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
143161437|NCT02991859|516135587|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
143161438|NCT02991859|516135588|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
143161439|NCT02991859|516135572|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
143161440|NCT02991859|516135573|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
143161441|NCT02991859|516135574|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
143161442|NCT02991859|516135575|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
143161443|NCT02991859|516135576|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
143161444|NCT02991859|516135577|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
143161445|NCT02991859|516135578|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
143161446|NCT02991859|516135579|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
143161447|NCT02991859|516135580|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
143161448|NCT02991859|516135581|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
143161449|NCT02991859|516135582|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
143161450|NCT02991859|516135583|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
143161451|NCT02991859|516135584|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
143161452|NCT02991859|516135585|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
143161453|NCT02991859|516135586|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
143238867|NCT02113982|516429805|FG007|Stage 1: Dose Escalation|Transplant|0|||
143161454|NCT02991859|516135587|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
143161455|NCT02991859|516135588|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
143161456|NCT02991859|516135572|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
143161457|NCT02991859|516135573|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
143161458|NCT02991859|516135574|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
143161459|NCT02991859|516135575|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
143161460|NCT02991859|516135576|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
143161461|NCT02991859|516135577|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
143161462|NCT02991859|516135578|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
143161463|NCT02991859|516135579|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
143161464|NCT02991859|516135580|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
143161465|NCT02991859|516135581|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
143161466|NCT02991859|516135582|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
143161467|NCT02991859|516135583|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
143161468|NCT02991859|516135584|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
143161469|NCT02991859|516135585|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
143161470|NCT02991859|516135586|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
143161471|NCT02991859|516135587|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
143161472|NCT02991859|516135588|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
143161473|NCT02991859|516135572|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
143161474|NCT02991859|516135573|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
143161475|NCT02991859|516135574|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
143161476|NCT02991859|516135575|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
143161477|NCT02991859|516135576|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
143161478|NCT02991859|516135577|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
143161479|NCT02991859|516135578|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
143161480|NCT02991859|516135579|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
143161481|NCT02991859|516135580|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
143161482|NCT02991859|516135581|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
143161483|NCT02991859|516135582|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
143161484|NCT02991859|516135583|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
143161485|NCT02991859|516135584|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
143161486|NCT02991859|516135585|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
143161487|NCT02991859|516135586|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
143161488|NCT02991859|516135587|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
143161489|NCT02991859|516135588|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
143161490|NCT02991859|516135572|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
143161491|NCT02991859|516135573|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
143161492|NCT02991859|516135574|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
143161493|NCT02991859|516135575|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
143238868|NCT02113982|516429806|FG008|Stage 1: Dose Escalation|Transplant|0|||
143238869|NCT02113982|516429807|FG009|Stage 1: Dose Escalation|Transplant|0|||
143037328|NCT01173692|515678761|FG000|Overall Study|Adverse Event|1|||
143238870|NCT02113982|516429808|FG010|Stage 1: Dose Escalation|Transplant|0|||
143238871|NCT02113982|516429809|FG011|Stage 1: Dose Escalation|Transplant|0|||
143238872|NCT02113982|516429810|FG012|Stage 1: Dose Escalation|Transplant|0|||
143238873|NCT02113982|516429811|FG013|Stage 1: Dose Escalation|Transplant|0|||
143238874|NCT02113982|516429798|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
143238875|NCT02113982|516429799|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
143238876|NCT02113982|516429800|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
143238877|NCT02113982|516429801|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
143238878|NCT02113982|516429802|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
143238879|NCT02113982|516429803|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
143238880|NCT02113982|516429804|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
143238881|NCT02113982|516429805|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
143238882|NCT02113982|516429806|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
143238883|NCT02113982|516429807|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
143238884|NCT02113982|516429808|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
143238885|NCT02113982|516429809|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
143238886|NCT02113982|516429810|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
143238887|NCT02113982|516429811|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
143238888|NCT02113982|516429798|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
143238889|NCT02113982|516429799|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
143238890|NCT02113982|516429800|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
143238891|NCT02113982|516429801|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
143238892|NCT02113982|516429802|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
143238893|NCT02113982|516429803|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
143238894|NCT02113982|516429804|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
143238895|NCT02113982|516429805|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
143238896|NCT02113982|516429806|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
143238897|NCT02113982|516429807|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
143238898|NCT02113982|516429808|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
143238899|NCT02113982|516429809|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
143238900|NCT02113982|516429810|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
143238901|NCT02113982|516429811|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
143238902|NCT02113982|516429798|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
143238903|NCT02113982|516429799|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
143238904|NCT02113982|516429800|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
143238905|NCT02113982|516429801|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
143238906|NCT02113982|516429802|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
143238907|NCT02113982|516429803|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
143238908|NCT02113982|516429804|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
143238909|NCT02113982|516429805|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
143238910|NCT02113982|516429806|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
143238911|NCT02113982|516429807|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
143238912|NCT02113982|516429808|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
143238913|NCT02113982|516429809|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
143238914|NCT02113982|516429810|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
143238915|NCT02113982|516429811|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
143238916|NCT02113982|516429798|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
143238917|NCT02113982|516429799|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
143238918|NCT02113982|516429800|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
143238919|NCT02113982|516429801|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
143238920|NCT02113982|516429802|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
143238921|NCT02113982|516429803|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
143238922|NCT02113982|516429804|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
143238923|NCT02113982|516429805|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
143238924|NCT02113982|516429806|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
143238925|NCT02113982|516429807|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
143238926|NCT02113982|516429808|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
143238927|NCT02113982|516429809|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
143238928|NCT02113982|516429810|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
143238929|NCT02113982|516429811|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
143238930|NCT02113982|516429798|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
143238931|NCT02113982|516429799|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
143495971|NCT01262976|517357731|FG005|Up to Year 3|Other|0|||
143495972|NCT02400255|517357732|FG000|Overall Study|Relapse|4|||
143238932|NCT02113982|516429800|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
143238933|NCT02113982|516429801|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
143238934|NCT02113982|516429802|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
143238935|NCT02113982|516429803|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
143238936|NCT02113982|516429804|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
143238937|NCT02113982|516429805|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
143238938|NCT02113982|516429806|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
143495973|NCT02400255|517357733|FG001|Overall Study|Relapse|1|||
143495974|NCT02400255|517357734|FG002|Overall Study|Relapse|1|||
143495975|NCT02400255|517357735|FG003|Overall Study|Relapse|2|||
143495976|NCT02400255|517357732|FG000|Overall Study|Adverse Event|6|||
143495977|NCT02400255|517357733|FG001|Overall Study|Adverse Event|3|||
143495978|NCT02400255|517357734|FG002|Overall Study|Adverse Event|0|||
143495979|NCT02400255|517357735|FG003|Overall Study|Adverse Event|0|||
143495980|NCT02400255|517357732|FG000|Overall Study|Physician Decision|6|||
143495981|NCT02400255|517357733|FG001|Overall Study|Physician Decision|0|||
143495982|NCT02400255|517357734|FG002|Overall Study|Physician Decision|0|||
143495983|NCT02400255|517357735|FG003|Overall Study|Physician Decision|0|||
143495984|NCT02400255|517357732|FG000|Overall Study|Loss of insurance|1|||
143495985|NCT02400255|517357733|FG001|Overall Study|Loss of insurance|0|||
143495986|NCT02400255|517357734|FG002|Overall Study|Loss of insurance|0|||
143495987|NCT02400255|517357735|FG003|Overall Study|Loss of insurance|0|||
143495988|NCT03261531|517357736|FG000|Overall Study|Withdrawal by Subject|4|||
143495989|NCT03543410|517357740|FG000|Overall Study|Adverse Event|10|||
143495990|NCT03543410|517357741|FG001|Overall Study|Adverse Event|8|||
143495991|NCT03543410|517357742|FG002|Overall Study|Adverse Event|2|||
143495992|NCT03543410|517357740|FG000|Overall Study|Lack of Efficacy|0|||
143495993|NCT03543410|517357741|FG001|Overall Study|Lack of Efficacy|1|||
143495994|NCT03543410|517357742|FG002|Overall Study|Lack of Efficacy|0|||
143495995|NCT03543410|517357740|FG000|Overall Study|Lost to Follow-up|0|||
143495996|NCT03543410|517357741|FG001|Overall Study|Lost to Follow-up|1|||
143495997|NCT03543410|517357742|FG002|Overall Study|Lost to Follow-up|0|||
143495998|NCT03543410|517357740|FG000|Overall Study|Withdrawal by Subject|5|||
143495999|NCT03543410|517357741|FG001|Overall Study|Withdrawal by Subject|2|||
143496000|NCT03543410|517357742|FG002|Overall Study|Withdrawal by Subject|8|||
143496001|NCT03543410|517357740|FG000|Overall Study|Protocol Violation|0|||
143496002|NCT03543410|517357741|FG001|Overall Study|Protocol Violation|1|||
143496003|NCT03543410|517357742|FG002|Overall Study|Protocol Violation|0|||
143496004|NCT03543410|517357740|FG000|Overall Study|Due to COVID-19|4|||
143496005|NCT03543410|517357741|FG001|Overall Study|Due to COVID-19|0|||
143496006|NCT03543410|517357742|FG002|Overall Study|Due to COVID-19|2|||
143496007|NCT03543410|517357740|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
143496008|NCT03543410|517357741|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
143037329|NCT01173692|515678762|FG001|Overall Study|Adverse Event|2|||
143037330|NCT01173692|515678761|FG000|Overall Study|Withdrawal by Subject|1|||
143037331|NCT01173692|515678762|FG001|Overall Study|Withdrawal by Subject|3|||
143037332|NCT01472341|515678763|FG000|Overall Study|Started insulin therapy|55|||
143037333|NCT01472341|515678763|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
143037334|NCT01472341|515678763|FG000|Overall Study|Withdrawal by Subject|39|||
143037335|NCT01472341|515678763|FG000|Overall Study|Lost to Follow-up|52|||
143037336|NCT01472341|515678763|FG000|Overall Study|Laboratory parameters unavailable|25|||
143037337|NCT01472341|515678763|FG000|Overall Study|Death|9|||
143037338|NCT01546545|515678768|FG000|Overall Study|Withdrawal by Subject|1|||
143037339|NCT04060147|515678769|FG000|Overall Study|Withdrew consent|1|||
143037340|NCT00610363|515678770|FG000|Overall Study|Non-compliance with protocol|0|||
143037341|NCT00610363|515678771|FG001|Overall Study|Non-compliance with protocol|1|||
143037342|NCT00610363|515678770|FG000|Overall Study|Adverse Event|3|||
143037343|NCT00610363|515678771|FG001|Overall Study|Adverse Event|1|||
143037344|NCT00610363|515678770|FG000|Overall Study|Lack of Efficacy|2|||
143037345|NCT00610363|515678771|FG001|Overall Study|Lack of Efficacy|0|||
143037346|NCT00610363|515678770|FG000|Overall Study|Lost to Follow-up|4|||
143037347|NCT00610363|515678771|FG001|Overall Study|Lost to Follow-up|0|||
143037348|NCT00610363|515678770|FG000|Overall Study|Withdrawal by Subject|1|||
143037349|NCT00610363|515678771|FG001|Overall Study|Withdrawal by Subject|0|||
143037350|NCT00610363|515678770|FG000|Overall Study|Other than specified above|1|||
143037351|NCT00610363|515678771|FG001|Overall Study|Other than specified above|1|||
143037352|NCT03204539|515678772|FG000|Overall Study|Loss of funding|0|||
143037353|NCT03204539|515678773|FG001|Overall Study|Loss of funding|1|||
143161494|NCT02991859|516135576|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
143161495|NCT02991859|516135577|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
143161496|NCT02991859|516135578|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
143037354|NCT02008565|515678777|FG000|Overall Study|Protocol Violation|1|||
143037355|NCT02008565|515678778|FG001|Overall Study|Protocol Violation|1|||
143037356|NCT02008565|515678779|FG002|Overall Study|Protocol Violation|2|||
143037357|NCT02008565|515678780|FG003|Overall Study|Protocol Violation|0|||
143037358|NCT00268905|515678781|FG000|Overall Study|Adverse Event|3|||
143161497|NCT02991859|516135579|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
143364116|NCT01237678|516875552|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
143364117|NCT01237678|516875553|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
143496009|NCT03543410|517357742|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
143496010|NCT03543410|517357740|FG000|Overall Study|Not Due to COVID-19|2|||
143496011|NCT03543410|517357741|FG001|Overall Study|Not Due to COVID-19|0|||
143496012|NCT03543410|517357742|FG002|Overall Study|Not Due to COVID-19|1|||
143496013|NCT02883244|517357743|FG000|Overall Study|Lost to Follow-up|0|||
143496014|NCT02883244|517357744|FG001|Overall Study|Lost to Follow-up|1|||
143037359|NCT00268905|515678782|FG001|Overall Study|Adverse Event|0|||
143496015|NCT00820755|517357745|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
143496016|NCT00820755|517357746|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
143496017|NCT00820755|517357747|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
143496018|NCT00820755|517357745|FG000|Period 1: Combination Therapy Phase|Death|28|||
143496019|NCT00820755|517357746|FG001|Period 1: Combination Therapy Phase|Death|0|||
143496020|NCT00820755|517357747|FG002|Period 1: Combination Therapy Phase|Death|0|||
143496021|NCT00820755|517357745|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
143496022|NCT00820755|517357746|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
143496023|NCT00820755|517357747|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
143496024|NCT00820755|517357745|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
143496025|NCT00820755|517357746|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
143496026|NCT00820755|517357747|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
143496027|NCT00820755|517357745|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
143496028|NCT00820755|517357746|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
143496029|NCT00820755|517357747|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
143496030|NCT00820755|517357745|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
143496031|NCT00820755|517357746|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
143496032|NCT00820755|517357747|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
143496033|NCT00820755|517357745|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
143496034|NCT00820755|517357746|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
143496035|NCT00820755|517357747|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
143161498|NCT02991859|516135580|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
143161499|NCT02991859|516135581|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
143161500|NCT02991859|516135582|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
143161501|NCT02991859|516135583|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
143161502|NCT02991859|516135584|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
143161503|NCT02991859|516135585|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
143161504|NCT02991859|516135586|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
143161505|NCT02991859|516135587|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
143161506|NCT02991859|516135588|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
143161507|NCT02614066|516135590|FG000|Overall Study|Death|6|||
143161508|NCT02614066|516135591|FG001|Overall Study|Death|14|||
143161509|NCT02614066|516135592|FG002|Overall Study|Death|11|||
143161510|NCT02614066|516135593|FG003|Overall Study|Death|29|||
143161511|NCT02614066|516135590|FG000|Overall Study|Full consent withdrawn|0|||
143161512|NCT02614066|516135591|FG001|Overall Study|Full consent withdrawn|1|||
143161513|NCT02614066|516135592|FG002|Overall Study|Full consent withdrawn|0|||
143161514|NCT02614066|516135593|FG003|Overall Study|Full consent withdrawn|8|||
143161515|NCT02614066|516135590|FG000|Overall Study|Lost to Follow-up|0|||
143161516|NCT02614066|516135591|FG001|Overall Study|Lost to Follow-up|2|||
143161517|NCT02614066|516135592|FG002|Overall Study|Lost to Follow-up|2|||
143161518|NCT02614066|516135593|FG003|Overall Study|Lost to Follow-up|2|||
143161519|NCT02614066|516135590|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
143161520|NCT02614066|516135591|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
143161521|NCT02614066|516135592|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
143238939|NCT02113982|516429807|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
143238940|NCT02113982|516429808|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
143238941|NCT02113982|516429809|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
143238942|NCT02113982|516429810|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
143496036|NCT00820755|517357745|FG000|Period 1: Combination Therapy Phase|Other|11|||
143496037|NCT00820755|517357746|FG001|Period 1: Combination Therapy Phase|Other|0|||
143496038|NCT00820755|517357747|FG002|Period 1: Combination Therapy Phase|Other|0|||
143496039|NCT00820755|517357745|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
143496040|NCT00820755|517357746|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
143496041|NCT00820755|517357747|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
143496042|NCT03604445|517357750|FG000|Overall Study|Death|0|||
143496043|NCT03604445|517357751|FG001|Overall Study|Death|0|||
143496044|NCT03604445|517357752|FG002|Overall Study|Death|0|||
143496045|NCT03604445|517357753|FG003|Overall Study|Death|0|||
143496046|NCT03604445|517357754|FG004|Overall Study|Death|0|||
143496047|NCT03604445|517357755|FG005|Overall Study|Death|0|||
143496048|NCT03604445|517357756|FG006|Overall Study|Death|0|||
143496049|NCT03604445|517357757|FG007|Overall Study|Death|0|||
143496050|NCT03604445|517357758|FG008|Overall Study|Death|1|||
143496051|NCT03604445|517357750|FG000|Overall Study|Withdrawal by Subject|0|||
143496052|NCT03604445|517357751|FG001|Overall Study|Withdrawal by Subject|0|||
143496053|NCT03604445|517357752|FG002|Overall Study|Withdrawal by Subject|0|||
143496054|NCT03604445|517357753|FG003|Overall Study|Withdrawal by Subject|0|||
143496055|NCT03604445|517357754|FG004|Overall Study|Withdrawal by Subject|0|||
143161522|NCT02614066|516135593|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
143496056|NCT03604445|517357755|FG005|Overall Study|Withdrawal by Subject|0|||
143496057|NCT03604445|517357756|FG006|Overall Study|Withdrawal by Subject|1|||
143496058|NCT03604445|517357757|FG007|Overall Study|Withdrawal by Subject|0|||
143496059|NCT03604445|517357758|FG008|Overall Study|Withdrawal by Subject|0|||
143496060|NCT03604445|517357750|FG000|Overall Study|Missing visit|0|||
143496061|NCT03604445|517357751|FG001|Overall Study|Missing visit|0|||
143496062|NCT03604445|517357752|FG002|Overall Study|Missing visit|0|||
143496063|NCT03604445|517357753|FG003|Overall Study|Missing visit|0|||
143496064|NCT03604445|517357754|FG004|Overall Study|Missing visit|0|||
143496065|NCT03604445|517357755|FG005|Overall Study|Missing visit|1|||
143496066|NCT03604445|517357756|FG006|Overall Study|Missing visit|0|||
143496067|NCT03604445|517357757|FG007|Overall Study|Missing visit|1|||
143496068|NCT03604445|517357758|FG008|Overall Study|Missing visit|0|||
143496069|NCT03604445|517357750|FG000|Overall Study|Adverse Event|0|||
143496070|NCT03604445|517357751|FG001|Overall Study|Adverse Event|0|||
143496071|NCT03604445|517357752|FG002|Overall Study|Adverse Event|0|||
143496072|NCT03604445|517357753|FG003|Overall Study|Adverse Event|1|||
143496073|NCT03604445|517357754|FG004|Overall Study|Adverse Event|0|||
143496074|NCT03604445|517357755|FG005|Overall Study|Adverse Event|0|||
143496075|NCT03604445|517357756|FG006|Overall Study|Adverse Event|0|||
143496076|NCT03604445|517357757|FG007|Overall Study|Adverse Event|0|||
143496077|NCT03604445|517357758|FG008|Overall Study|Adverse Event|1|||
143496078|NCT00773279|517357759|FG000|Period 1|Adverse Event|2|||
143496079|NCT00773279|517357760|FG001|Period 1|Adverse Event|1|||
143496080|NCT00773279|517357759|FG000|Period 1|Lack of Efficacy|0|||
143496081|NCT00773279|517357760|FG001|Period 1|Lack of Efficacy|2|||
143496082|NCT00773279|517357759|FG000|Period 1|Unclassified|5|||
143496083|NCT00773279|517357760|FG001|Period 1|Unclassified|1|||
143496084|NCT00773279|517357759|FG000|Period 2|Adverse Event|0|||
143496085|NCT00773279|517357760|FG001|Period 2|Adverse Event|1|||
143496086|NCT00773279|517357759|FG000|Period 2|Lack of Efficacy|1|||
143496087|NCT00773279|517357760|FG001|Period 2|Lack of Efficacy|0|||
143496088|NCT00773279|517357759|FG000|Period 2|Protocol Violation|0|||
143496089|NCT00773279|517357760|FG001|Period 2|Protocol Violation|3|||
143496090|NCT00773279|517357759|FG000|Period 2|Unclassified|2|||
143496091|NCT00773279|517357760|FG001|Period 2|Unclassified|2|||
143496092|NCT01818726|517357764|FG000|Overall Study|Administrative reasons|5|||
143496093|NCT01818726|517357765|FG001|Overall Study|Administrative reasons|1|||
143496094|NCT01818726|517357764|FG000|Overall Study|Withdrawal by Subject|0|||
143496095|NCT01818726|517357765|FG001|Overall Study|Withdrawal by Subject|1|||
143496096|NCT01818726|517357764|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
143496097|NCT01818726|517357765|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
143496098|NCT02551159|517357766|FG000|Overall Study|Death|352|||
143496099|NCT02551159|517357767|FG001|Overall Study|Death|174|||
143496100|NCT02551159|517357768|FG002|Overall Study|Death|161|||
143496101|NCT02551159|517357766|FG000|Overall Study|Withdrawal by Subject|8|||
143496102|NCT02551159|517357767|FG001|Overall Study|Withdrawal by Subject|5|||
143496103|NCT02551159|517357768|FG002|Overall Study|Withdrawal by Subject|16|||
143037360|NCT00268905|515678783|FG002|Overall Study|Adverse Event|4|||
143037361|NCT00268905|515678781|FG000|Overall Study|Lost to Follow-up|0|||
143037362|NCT00268905|515678782|FG001|Overall Study|Lost to Follow-up|1|||
143037363|NCT00268905|515678783|FG002|Overall Study|Lost to Follow-up|0|||
143496104|NCT02551159|517357766|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
143037364|NCT00268905|515678781|FG000|Overall Study|Withdrawal by Subject|0|||
143161523|NCT02614066|516135590|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
143161524|NCT02614066|516135591|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
143161525|NCT02614066|516135592|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
143161526|NCT02614066|516135593|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
143161527|NCT02614066|516135590|FG000|Overall Study|Reason not specified|0|||
143161528|NCT02614066|516135591|FG001|Overall Study|Reason not specified|2|||
143161529|NCT02614066|516135592|FG002|Overall Study|Reason not specified|1|||
143496105|NCT02551159|517357767|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
143037365|NCT00268905|515678782|FG001|Overall Study|Withdrawal by Subject|0|||
143037366|NCT00268905|515678783|FG002|Overall Study|Withdrawal by Subject|3|||
143496106|NCT02551159|517357768|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
143496107|NCT02175680|517357769|FG000|Overall Study|non-compliance|1|||
143496108|NCT02175680|517357769|FG000|Overall Study|other non-medical reason|1|||
143496109|NCT01469000|517357773|FG000|Overall Study|Withdrawal by Subject|16|||
143037367|NCT00268905|515678781|FG000|Overall Study|Progressive Disease|28|||
143496110|NCT01469000|517357774|FG001|Overall Study|Withdrawal by Subject|3|||
143496111|NCT01469000|517357773|FG000|Overall Study|Sponsor Decision|4|||
143496112|NCT01469000|517357774|FG001|Overall Study|Sponsor Decision|1|||
143496113|NCT02183519|517357779|FG000|Overall Study|computer error|3|||
143496114|NCT02183519|517357780|FG001|Overall Study|computer error|0|||
143496115|NCT02183519|517357779|FG000|Overall Study|Did not respond to cough inducter|0|||
143496116|NCT02183519|517357780|FG001|Overall Study|Did not respond to cough inducter|3|||
143496117|NCT05168267|517357781|FG000|Overall Study|Withdrawal by Subject|2|||
143037368|NCT00268905|515678782|FG001|Overall Study|Progressive Disease|4|||
143037369|NCT00268905|515678783|FG002|Overall Study|Progressive Disease|3|||
143037370|NCT00268905|515678781|FG000|Overall Study|Physician Decision|3|||
143037371|NCT00268905|515678782|FG001|Overall Study|Physician Decision|0|||
143037372|NCT00268905|515678783|FG002|Overall Study|Physician Decision|1|||
143037373|NCT00268905|515678781|FG000|Overall Study|Clinical Progression|9|||
143037374|NCT00268905|515678782|FG001|Overall Study|Clinical Progression|4|||
143037375|NCT00268905|515678783|FG002|Overall Study|Clinical Progression|1|||
143037376|NCT03966365|515678784|FG000|Overall Study|Protocol Violation|1|||
143037377|NCT03966365|515678785|FG001|Overall Study|Protocol Violation|0|||
143037378|NCT00319735|515678788|FG000|Overall Study|Death|2|||
143037379|NCT01223365|515678789|FG000|Open-label Titration Period|Enrolled but not treated|1|||
143037380|NCT01223365|515678789|FG000|Open-label Titration Period|Adverse Event|23|||
143037381|NCT01223365|515678789|FG000|Open-label Titration Period|Lack of Efficacy|3|||
143037382|NCT01223365|515678789|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
143037383|NCT01223365|515678789|FG000|Open-label Titration Period|Protocol Violation|1|||
143037384|NCT01223365|515678789|FG000|Open-label Titration Period|Lost to Follow-up|2|||
143037385|NCT01223365|515678789|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
143037386|NCT01223365|515678789|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
143037387|NCT01223365|515678789|FG000|Open-label Titration Period|Starting physical therapy|1|||
143037388|NCT01223365|515678789|FG000|Open-label Treatment Period|Adverse Event|39|||
143037389|NCT01223365|515678789|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
143037390|NCT01223365|515678789|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
143037391|NCT01223365|515678789|FG000|Open-label Treatment Period|Protocol Violation|15|||
143037392|NCT01223365|515678789|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
143037393|NCT01223365|515678789|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
143037394|NCT01223365|515678789|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
143037395|NCT01223365|515678789|FG000|Open-label Treatment Period|Moved out of area|2|||
143037396|NCT01223365|515678789|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
143037397|NCT01223365|515678789|FG000|Open-label Treatment Period|"Out of window"|1|||
143037398|NCT01223365|515678789|FG000|Open-label Treatment Period|Starting physical therapy|1|||
143037399|NCT01223365|515678789|FG000|Open-label Treatment Period|Physician Decision|2|||
143037400|NCT03567174|515678790|FG000|Overall Study|Death|24|||
143037401|NCT03567174|515678791|FG001|Overall Study|Death|31|||
143037402|NCT03567174|515678790|FG000|Overall Study|Lost to Follow-up|165|||
143037403|NCT03567174|515678791|FG001|Overall Study|Lost to Follow-up|174|||
143037404|NCT02140060|515678792|FG000|Overall Study|Adverse Event|0|||
143037405|NCT02140060|515678793|FG001|Overall Study|Adverse Event|0|||
143037406|NCT02140060|515678794|FG002|Overall Study|Adverse Event|0|||
143037407|NCT02140060|515678795|FG003|Overall Study|Adverse Event|1|||
143037408|NCT02140060|515678796|FG004|Overall Study|Adverse Event|1|||
143037409|NCT02140060|515678797|FG005|Overall Study|Adverse Event|1|||
143037410|NCT02140060|515678792|FG000|Overall Study|Lack of Efficacy|0|||
143037411|NCT02140060|515678793|FG001|Overall Study|Lack of Efficacy|0|||
143037412|NCT02140060|515678794|FG002|Overall Study|Lack of Efficacy|0|||
143037413|NCT02140060|515678795|FG003|Overall Study|Lack of Efficacy|1|||
143037414|NCT02140060|515678796|FG004|Overall Study|Lack of Efficacy|0|||
143037415|NCT02140060|515678797|FG005|Overall Study|Lack of Efficacy|0|||
143037416|NCT06358820|515680589|FG000|Overall Study|Adverse Event|11|||
143037417|NCT06358820|515680589|FG000|Overall Study|kidney transplantation|3|||
143037418|NCT06358820|515680589|FG000|Overall Study|patient voluntary withdrawal|6|||
143037419|NCT06358820|515680589|FG000|Overall Study|Physician Decision|1|||
143037420|NCT01124175|515680590|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
143037421|NCT01124175|515680591|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
143037422|NCT02028715|515680594|FG000|Overall Study|Adverse Event|2|||
143037423|NCT02028715|515680595|FG001|Overall Study|Adverse Event|2|||
143037424|NCT02028715|515680594|FG000|Overall Study|Physician Decision|1|||
143037425|NCT02028715|515680595|FG001|Overall Study|Physician Decision|0|||
143037426|NCT02028715|515680594|FG000|Overall Study|Did not complete satisfaction surveys|2|||
143037427|NCT02028715|515680595|FG001|Overall Study|Did not complete satisfaction surveys|2|||
143037428|NCT02533258|515680596|FG000|Overall Study|Adverse Event|1|||
143161530|NCT02614066|516135593|FG003|Overall Study|Reason not specified|1|||
143161531|NCT02774278|516135595|FG000|Overall Study|Lack of Efficacy|199|||
143161532|NCT02774278|516135595|FG000|Overall Study|Death|29|||
143161533|NCT02774278|516135595|FG000|Overall Study|Adverse event/intercurrent illness|16|||
143161534|NCT02774278|516135595|FG000|Overall Study|Refused treatment/did not cooperate|9|||
143161535|NCT02774278|516135595|FG000|Overall Study|Administrative reasons|6|||
143161536|NCT02774278|516135595|FG000|Overall Study|Withdrawal by Subject|3|||
143161537|NCT02774278|516135595|FG000|Overall Study|Protocol Violation|2|||
143037429|NCT02533258|515680596|FG000|Overall Study|Death|2|||
143037430|NCT02533258|515680596|FG000|Overall Study|Other|1|||
143037431|NCT02533258|515680596|FG000|Overall Study|Economic factor|1|||
143037432|NCT02533258|515680596|FG000|Overall Study|Progression of pleural effusion|1|||
143037433|NCT02533258|515680596|FG000|Overall Study|Lack of Efficacy|2|||
143161538|NCT00553475|516135597|FG000|Overall Study|Adverse Event|7|||
143161539|NCT00553475|516135598|FG001|Overall Study|Adverse Event|17|||
143037434|NCT03785548|515680599|FG000|Overall Study|age > 80|1|||
143037435|NCT03785548|515680600|FG001|Overall Study|age > 80|0|||
143037436|NCT03785548|515680599|FG000|Overall Study|no Postop queries|1|||
143037437|NCT03785548|515680600|FG001|Overall Study|no Postop queries|0|||
143037438|NCT00667862|515680601|FG000|Overall Study|Adverse Event|9|||
143037439|NCT00667862|515680601|FG000|Overall Study|Death|1|||
143037440|NCT00667862|515680601|FG000|Overall Study|Disease Progression|22|||
143037441|NCT00667862|515680601|FG000|Overall Study|Withdrawal by Subject|3|||
143037442|NCT00905346|515680605|FG000|Period 1|Withdrawal by Subject|1|||
143037443|NCT00905346|515680606|FG001|Period 1|Withdrawal by Subject|0|||
143037444|NCT01435265|515680607|FG000|Overall Study|Lost to Follow-up|0|||
143037445|NCT01435265|515680608|FG001|Overall Study|Lost to Follow-up|1|||
143037446|NCT03351335|515680609|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
143037447|NCT03351335|515680610|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
143037448|NCT03351335|515680611|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
143037449|NCT04605094|515680612|FG000|Overall Study|Adverse Event|2|||
143037450|NCT04605094|515680613|FG001|Overall Study|Adverse Event|2|||
143037451|NCT04605094|515680612|FG000|Overall Study|Lost to Follow-up|1|||
143037452|NCT04605094|515680613|FG001|Overall Study|Lost to Follow-up|4|||
143037453|NCT04605094|515680612|FG000|Overall Study|Physician Decision|2|||
143037454|NCT04605094|515680613|FG001|Overall Study|Physician Decision|2|||
143037455|NCT04605094|515680612|FG000|Overall Study|Study terminated by Sponsor|31|||
143037456|NCT04605094|515680613|FG001|Overall Study|Study terminated by Sponsor|33|||
143037457|NCT04605094|515680612|FG000|Overall Study|Withdrawal by Subject|22|||
143037458|NCT04605094|515680613|FG001|Overall Study|Withdrawal by Subject|19|||
143037459|NCT04605094|515680612|FG000|Overall Study|Other|1|||
143037460|NCT04605094|515680613|FG001|Overall Study|Other|1|||
143037461|NCT01900691|515680614|FG000|Overall Study|Death|7|||
143037462|NCT01900691|515680614|FG000|Overall Study|Lost to Follow-up|4|||
143037463|NCT01900691|515680614|FG000|Overall Study|Study Device Not Placed|3|||
143037464|NCT01900691|515680614|FG000|Overall Study|Non study stent placed|2|||
143037465|NCT01900691|515680614|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
143037466|NCT01900691|515680614|FG000|Overall Study|Complete stent migration through digestive tract|1|||
143037467|NCT00469417|515680617|FG000|Overall Study|Treatment failure all lesions|18|||
143037468|NCT00469417|515680618|FG001|Overall Study|Treatment failure all lesions|11|||
143037469|NCT00469417|515680617|FG000|Overall Study|Consent withdrawn|1|||
143037470|NCT00469417|515680618|FG001|Overall Study|Consent withdrawn|1|||
143037471|NCT00469417|515680617|FG000|Overall Study|Adverse Event|8|||
143037472|NCT00469417|515680618|FG001|Overall Study|Adverse Event|2|||
143037473|NCT00469417|515680617|FG000|Overall Study|Lost to Follow-up|1|||
143037474|NCT00469417|515680618|FG001|Overall Study|Lost to Follow-up|2|||
143037475|NCT00469417|515680617|FG000|Overall Study|Intercurrent disease|0|||
143037476|NCT00469417|515680618|FG001|Overall Study|Intercurrent disease|1|||
143037477|NCT00469417|515680617|FG000|Overall Study|Randomized but not treated|2|||
143037478|NCT00469417|515680618|FG001|Overall Study|Randomized but not treated|0|||
143037479|NCT02128997|515680622|FG000|Overall Study|Lost to Follow-up|6|||
143037480|NCT02128997|515680623|FG001|Overall Study|Lost to Follow-up|11|||
143037481|NCT04123548|515680624|FG000|Overall Study|Withdrawal by Subject|1|||
143037482|NCT04123548|515680624|FG000|Overall Study|Lost to Follow-up|8|||
143037483|NCT04123548|515680624|FG000|Overall Study|Death|4|||
143037484|NCT04123548|515680624|FG000|Overall Study|Reason Not Specified|1|||
143037485|NCT00418184|515680627|FG000|Double-blind Phase|Withdrawal by Subject|22|||
143037486|NCT00418184|515680628|FG001|Double-blind Phase|Withdrawal by Subject|9|||
143037487|NCT00418184|515680627|FG000|Double-blind Phase|Adverse Event|2|||
143037488|NCT00418184|515680628|FG001|Double-blind Phase|Adverse Event|1|||
143037489|NCT00418184|515680627|FG000|Double-blind Phase|Poor compliance|3|||
143037490|NCT00418184|515680628|FG001|Double-blind Phase|Poor compliance|1|||
143037491|NCT01247701|515680629|FG000|Overall Study|Death|2|||
143037492|NCT01247701|515680629|FG000|Overall Study|Relapsed|8|||
143161540|NCT00553475|516135599|FG002|Overall Study|Adverse Event|13|||
143161541|NCT00553475|516135597|FG000|Overall Study|Lack of Efficacy|7|||
143161542|NCT00553475|516135598|FG001|Overall Study|Lack of Efficacy|1|||
143037493|NCT00096447|515680630|FG000|Overall Study|Never treated|1|||
143037494|NCT01034358|515680631|FG000|Overall Study|Withdrawal by Subject|1|||
143037495|NCT01034358|515680631|FG000|Overall Study|Protocol Violation|1|||
143161543|NCT00553475|516135599|FG002|Overall Study|Lack of Efficacy|0|||
143161544|NCT00553475|516135597|FG000|Overall Study|Withdrawal by Subject|1|||
143161545|NCT00553475|516135598|FG001|Overall Study|Withdrawal by Subject|1|||
143161546|NCT00553475|516135599|FG002|Overall Study|Withdrawal by Subject|0|||
143161547|NCT00553475|516135597|FG000|Overall Study|Physician Decision|1|||
143037496|NCT01838941|515680632|FG000|Overall Study|Adverse Event|1|||
143037497|NCT01838941|515680632|FG000|Overall Study|Withdrawal by Subject|1|||
143037498|NCT02822235|515680633|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
143037499|NCT02822235|515680634|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
143037500|NCT02822235|515680633|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
143161548|NCT00553475|516135598|FG001|Overall Study|Physician Decision|0|||
143161549|NCT00553475|516135599|FG002|Overall Study|Physician Decision|0|||
143037501|NCT02822235|515680634|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
143037502|NCT02822235|515680633|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
143037503|NCT02822235|515680634|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
143037504|NCT02822235|515680633|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
143037505|NCT02822235|515680634|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
143037506|NCT02822235|515680633|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
143037507|NCT02822235|515680634|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
143037508|NCT02822235|515680633|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
143037509|NCT02822235|515680634|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
143037510|NCT00834743|515680637|FG000|Second Intervention|Withdrawal by Subject|1|||
143037511|NCT00834743|515680638|FG001|Second Intervention|Withdrawal by Subject|0|||
143037512|NCT00627016|515680639|FG000|Overall Study|Adverse Event|1|||
143037513|NCT00627016|515680640|FG001|Overall Study|Adverse Event|1|||
143161550|NCT00553475|516135597|FG000|Overall Study|Due to moving|0|||
143161551|NCT00553475|516135598|FG001|Overall Study|Due to moving|1|||
143161552|NCT00553475|516135599|FG002|Overall Study|Due to moving|0|||
143161553|NCT01623154|516135600|FG000|Overall Study|Did not drink Pranactin Citric|4|||
143161554|NCT01569763|516137579|FG000|Overall Study|Lack of Efficacy|2|||
143161555|NCT01569763|516137580|FG001|Overall Study|Lack of Efficacy|7|||
143161556|NCT01569763|516137579|FG000|Overall Study|Adverse Event|1|||
143161557|NCT01569763|516137580|FG001|Overall Study|Adverse Event|0|||
143161558|NCT02469961|516137587|FG000|Overall Study|Physician Decision|4|||
143161559|NCT02469961|516137588|FG001|Overall Study|Physician Decision|1|||
143161560|NCT00368849|516137593|FG000|Overall Study|Withdrawal by Subject|0|||
143161561|NCT00368849|516137594|FG001|Overall Study|Withdrawal by Subject|1|||
143161562|NCT00368849|516137593|FG000|Overall Study|Physician Decision|0|||
143161563|NCT00368849|516137594|FG001|Overall Study|Physician Decision|1|||
143161564|NCT01699685|516137598|FG000|Period 1|Adverse Event|1|||
143161565|NCT01699685|516137599|FG001|Period 1|Adverse Event|1|||
143161566|NCT01699685|516137598|FG000|Period 1|Medical or ethical, noncompliance|2|||
143161567|NCT01699685|516137599|FG001|Period 1|Medical or ethical, noncompliance|0|||
143161568|NCT01699685|516137598|FG000|Period 1|Other|0|||
143161569|NCT01699685|516137599|FG001|Period 1|Other|1|||
143161570|NCT01699685|516137598|FG000|Period 1|Patient request|0|||
143161571|NCT01699685|516137599|FG001|Period 1|Patient request|1|||
143161572|NCT01699685|516137598|FG000|Period 2|Lost to Follow-up|1|||
143161573|NCT01699685|516137599|FG001|Period 2|Lost to Follow-up|0|||
143161574|NCT03635996|516137600|FG000|Overall Study|Study terminated by Sponsor|94|||
143161575|NCT03635996|516137600|FG000|Overall Study|Withdrawal by Subject|20|||
143161576|NCT03635996|516137600|FG000|Overall Study|Ablation|26|||
143161577|NCT03635996|516137600|FG000|Overall Study|Adverse Event|7|||
143161578|NCT03635996|516137600|FG000|Overall Study|Physician Decision|3|||
143161579|NCT03635996|516137600|FG000|Overall Study|Prohibited medication|5|||
143161580|NCT03635996|516137600|FG000|Overall Study|Did not meet eligibility criteria|5|||
143161581|NCT03635996|516137600|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
143161582|NCT03635996|516137600|FG000|Overall Study|Protocol Violation|1|||
143161583|NCT03635996|516137600|FG000|Overall Study|Lost to Follow-up|1|||
143161584|NCT05058456|516137601|FG000|Overall Study|Death|1|||
143161585|NCT05058456|516137601|FG000|Overall Study|End of Study data not yet due for release|34|||
143161586|NCT03211858|516137602|FG000|Overall Study|Adverse Event|8|||
143161587|NCT03211858|516137603|FG001|Overall Study|Adverse Event|6|||
143161588|NCT03211858|516137602|FG000|Overall Study|Lack of Efficacy|0|||
143161589|NCT03211858|516137603|FG001|Overall Study|Lack of Efficacy|4|||
143161590|NCT03211858|516137602|FG000|Overall Study|Poor compliance to protocol|6|||
143161591|NCT03211858|516137603|FG001|Overall Study|Poor compliance to protocol|2|||
143161592|NCT03211858|516137602|FG000|Overall Study|Non-serious Hypoglycemia|1|||
143161593|NCT03211858|516137603|FG001|Overall Study|Non-serious Hypoglycemia|0|||
143161594|NCT03211858|516137602|FG000|Overall Study|Other than specified above|22|||
143161595|NCT03211858|516137603|FG001|Overall Study|Other than specified above|21|||
143161596|NCT01832038|516137604|FG000|Overall Study|Death|5|||
143161597|NCT01832038|516137604|FG000|Overall Study|Adverse Event|50|||
143161598|NCT01832038|516137604|FG000|Overall Study|Lack of Efficacy|81|||
143496118|NCT05168267|517357782|FG001|Overall Study|Withdrawal by Subject|1|||
143496119|NCT05168267|517357781|FG000|Overall Study|Withdrawn by Therapist|1|||
143496120|NCT05168267|517357782|FG001|Overall Study|Withdrawn by Therapist|1|||
143496121|NCT05168267|517357781|FG000|Overall Study|Left Facility|1|||
143496122|NCT05168267|517357782|FG001|Overall Study|Left Facility|0|||
143496123|NCT00695565|517357783|FG000|Overall Study|Lost to Follow-up|4|||
143496124|NCT00695565|517357784|FG001|Overall Study|Lost to Follow-up|4|||
143037514|NCT00627016|515680639|FG000|Overall Study|Protocol Violation|0|||
143161599|NCT01832038|516137604|FG000|Overall Study|Protocol Violation|7|||
143161600|NCT01832038|516137604|FG000|Overall Study|Lost to Follow-up|10|||
143161601|NCT01832038|516137604|FG000|Overall Study|Withdrawal by Subject|49|||
143496125|NCT00695565|517357783|FG000|Overall Study|Adverse Event|3|||
143161602|NCT01832038|516137604|FG000|Overall Study|Visit non-compliance|2|||
143496126|NCT00695565|517357784|FG001|Overall Study|Adverse Event|1|||
143496127|NCT00695565|517357783|FG000|Overall Study|Protocol Violation|3|||
143496128|NCT00695565|517357784|FG001|Overall Study|Protocol Violation|1|||
143496129|NCT00695565|517357783|FG000|Overall Study|Withdrawal by Subject|1|||
143496130|NCT00695565|517357784|FG001|Overall Study|Withdrawal by Subject|1|||
143496131|NCT00695565|517357783|FG000|Overall Study|Lack of Efficacy|1|||
143496132|NCT00695565|517357784|FG001|Overall Study|Lack of Efficacy|1|||
143496133|NCT00695565|517357783|FG000|Overall Study|Subject did not follow instructions|1|||
143496134|NCT00695565|517357784|FG001|Overall Study|Subject did not follow instructions|1|||
143496135|NCT01106846|517357785|FG000|Overall Study|Change in surgical procedure|0|||
143496136|NCT01106846|517357786|FG001|Overall Study|Change in surgical procedure|1|||
143496137|NCT01634555|517357789|FG000|Overall Study|Adverse Event|3|||
143496138|NCT01634555|517357789|FG000|Overall Study|Physician Decision|1|||
143496139|NCT01738971|517357790|FG000|Overall Study|Lost to Follow-up|19|||
143496140|NCT01738971|517357791|FG001|Overall Study|Lost to Follow-up|30|||
143496141|NCT01738971|517357792|FG002|Overall Study|Lost to Follow-up|17|||
143496142|NCT04698629|517357797|FG000|Overall Study|Adverse Event|1|||
143496143|NCT03344003|517357798|FG000|Overall Study|Switched to alternative treatment|1|||
143496144|NCT03344003|517357799|FG001|Overall Study|Switched to alternative treatment|0|||
143496145|NCT03344003|517357798|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
143496146|NCT03344003|517357799|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
143496147|NCT06228586|517357800|FG000|Overall Study|Withdrawal by Participant or Parent/Guardian|3|||
143496148|NCT06228586|517357801|FG001|Overall Study|Withdrawal by Participant or Parent/Guardian|1|||
143496149|NCT01182428|517357802|FG000|Overall Study|Physician Decision|1|||
143496150|NCT01182428|517357803|FG001|Overall Study|Physician Decision|0|||
143496151|NCT01182428|517357802|FG000|Overall Study|Lost to Follow-up|9|||
143496152|NCT01182428|517357803|FG001|Overall Study|Lost to Follow-up|1|||
143496153|NCT01182428|517357802|FG000|Overall Study|Withdrawal by Subject|1|||
143496154|NCT01182428|517357803|FG001|Overall Study|Withdrawal by Subject|0|||
143496155|NCT03631706|517357806|FG000|Overall Study|Randomized, not treated|1|||
143496156|NCT03631706|517357807|FG001|Overall Study|Randomized, not treated|0|||
143496157|NCT00865020|517357812|FG000|Overall Study|Withdrawal by Subject|22|||
143496158|NCT00865020|517357813|FG001|Overall Study|Withdrawal by Subject|16|||
143496159|NCT00865020|517357812|FG000|Overall Study|Adverse Event|9|||
143496160|NCT00865020|517357813|FG001|Overall Study|Adverse Event|14|||
143496161|NCT00865020|517357812|FG000|Overall Study|Abnormal test procedure result(s)|6|||
143496162|NCT00865020|517357813|FG001|Overall Study|Abnormal test procedure result(s)|8|||
143496163|NCT00865020|517357812|FG000|Overall Study|Lost to Follow-up|6|||
143496164|NCT00865020|517357813|FG001|Overall Study|Lost to Follow-up|4|||
143496165|NCT00865020|517357812|FG000|Overall Study|Protocol deviation|4|||
143037515|NCT00627016|515680640|FG001|Overall Study|Protocol Violation|2|||
143037516|NCT00627016|515680639|FG000|Overall Study|Lost to Follow-up|0|||
143037517|NCT00627016|515680640|FG001|Overall Study|Lost to Follow-up|1|||
143037518|NCT00627016|515680639|FG000|Overall Study|Withdrawal by Subject|2|||
143037519|NCT00627016|515680640|FG001|Overall Study|Withdrawal by Subject|1|||
143037520|NCT00627016|515680639|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
143037521|NCT00627016|515680640|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
143037522|NCT00627016|515680639|FG000|Overall Study|Lack of Efficacy|1|||
143037523|NCT00627016|515680640|FG001|Overall Study|Lack of Efficacy|0|||
143496166|NCT00865020|517357813|FG001|Overall Study|Protocol deviation|1|||
143496167|NCT00865020|517357812|FG000|Overall Study|Administrative problems|0|||
143496168|NCT00865020|517357813|FG001|Overall Study|Administrative problems|2|||
143496169|NCT00865020|517357812|FG000|Overall Study|Abnormal laboratory value(s)|0|||
143496170|NCT00865020|517357813|FG001|Overall Study|Abnormal laboratory value(s)|1|||
143496171|NCT00865020|517357812|FG000|Overall Study|Death|0|||
143496172|NCT00865020|517357813|FG001|Overall Study|Death|1|||
143496173|NCT00865020|517357812|FG000|Overall Study|Randomized but discontinued|2|||
143496174|NCT00865020|517357813|FG001|Overall Study|Randomized but discontinued|4|||
143496175|NCT06272370|517359389|FG000|Overall Study|Lost to Follow-up|0|||
143496176|NCT06272370|517359390|FG001|Overall Study|Lost to Follow-up|3|||
143496177|NCT06272370|517359391|FG002|Overall Study|Lost to Follow-up|1|||
143496178|NCT06272370|517359392|FG003|Overall Study|Lost to Follow-up|1|||
143496179|NCT02363478|517359393|FG000|Overall Study|Lost to Follow-up|4|||
143496180|NCT02363478|517359393|FG000|Overall Study|Adverse Event|4|||
143496181|NCT02527707|517359394|FG000|Overall Study|Adverse Event|1|||
143496182|NCT02527707|517359394|FG000|Overall Study|Adverse Event|1|||
143496183|NCT00542997|517359395|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
143496184|NCT00542997|517359395|FG000|Wash in / Wash Out Period|Adverse Event|3|||
143037524|NCT00627016|515680639|FG000|Overall Study|Placed on Excluded Drugs|1|||
143161603|NCT01832038|516137604|FG000|Overall Study|Subject refused to return visit|2|||
143161604|NCT01832038|516137604|FG000|Overall Study|Not convenient to come back to site|2|||
143037525|NCT00627016|515680640|FG001|Overall Study|Placed on Excluded Drugs|0|||
143161605|NCT01832038|516137604|FG000|Overall Study|Participant was asked to quit|5|||
143161606|NCT01832038|516137604|FG000|Overall Study|Back home|1|||
143496185|NCT00542997|517359395|FG000|Efficacy Period|Adverse Event|3|||
143496186|NCT00352534|517359396|FG000|Initial Staging|Ineligible|8|||
143496187|NCT00352534|517359397|FG001|Initial Staging|Ineligible|9|||
143496188|NCT00352534|517359398|FG002|Initial Staging|Ineligible|0|||
143496189|NCT00352534|517359399|FG003|Initial Staging|Ineligible|0|||
143496190|NCT00352534|517359400|FG004|Initial Staging|Ineligible|0|||
143496191|NCT00352534|517359401|FG005|Initial Staging|Ineligible|0|||
143496192|NCT00352534|517359402|FG006|Initial Staging|Ineligible|0|||
143496193|NCT00352534|517359396|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
143496194|NCT00352534|517359397|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
143496195|NCT00352534|517359398|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
143496196|NCT00352534|517359399|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
143496197|NCT00352534|517359400|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
143496198|NCT00352534|517359401|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
143496199|NCT00352534|517359402|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
143496200|NCT00352534|517359396|FG000|Final Risk Group Assignment|Physician Decision|0|||
143496201|NCT00352534|517359397|FG001|Final Risk Group Assignment|Physician Decision|0|||
143496202|NCT00352534|517359398|FG002|Final Risk Group Assignment|Physician Decision|0|||
143496203|NCT00352534|517359399|FG003|Final Risk Group Assignment|Physician Decision|0|||
143496204|NCT00352534|517359400|FG004|Final Risk Group Assignment|Physician Decision|0|||
143496205|NCT00352534|517359401|FG005|Final Risk Group Assignment|Physician Decision|8|||
143037526|NCT00627016|515680639|FG000|Overall Study|Pregnancy|1|||
143037527|NCT00627016|515680640|FG001|Overall Study|Pregnancy|0|||
143037528|NCT01534663|515680641|FG000|Overall Study|Lost to Follow-up|0|||
143037529|NCT01534663|515680642|FG001|Overall Study|Lost to Follow-up|2|||
143037530|NCT01534663|515680641|FG000|Overall Study|Adverse Event|2|||
143037531|NCT01534663|515680642|FG001|Overall Study|Adverse Event|1|||
143037532|NCT04088760|515680645|FG000|Overall Study|Physician Decision|1|||
143037533|NCT00377260|515680646|FG000|Overall Study|Lost to Follow-up|0|||
143037534|NCT00377260|515680647|FG001|Overall Study|Lost to Follow-up|1|||
143037535|NCT00377260|515680646|FG000|Overall Study|Withdrawal by Subject|2|||
143037536|NCT00377260|515680647|FG001|Overall Study|Withdrawal by Subject|4|||
143037537|NCT00829530|515680648|FG000|First Intervention|Adverse Event|0|||
143037538|NCT00829530|515680649|FG001|First Intervention|Adverse Event|1|||
143037539|NCT00829530|515680648|FG000|First Intervention|Intolerance to Venopuncture|0|||
143037540|NCT00829530|515680649|FG001|First Intervention|Intolerance to Venopuncture|1|||
143037541|NCT00829530|515680648|FG000|Second Intervention|Intolerance to Venopuncture|1|||
143037542|NCT00829530|515680649|FG001|Second Intervention|Intolerance to Venopuncture|0|||
143037543|NCT01391793|515680650|FG000|Overall Study|Ineligible|3|||
143037544|NCT01391793|515680651|FG001|Overall Study|Ineligible|0|||
143037545|NCT01391793|515680650|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
143037546|NCT01391793|515680651|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
143161607|NCT01832038|516137604|FG000|Overall Study|Pregnancy|1|||
143161608|NCT01832038|516137604|FG000|Overall Study|Low compliance|3|||
143161609|NCT01832038|516137604|FG000|Overall Study|Prohibit procedure|2|||
143161610|NCT01832038|516137604|FG000|Overall Study|Not possible to visit the hospital|1|||
143161611|NCT01832038|516137604|FG000|Overall Study|Changes of implementation system|3|||
143161612|NCT01832038|516137604|FG000|Overall Study|Plan to pregnancy|7|||
143161613|NCT01832038|516137604|FG000|Overall Study|Bad mood and has suicidal thought|1|||
143161614|NCT01832038|516137604|FG000|Overall Study|Prohibited concomitant medication|1|||
143161615|NCT01832038|516137604|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
143161616|NCT01832038|516137604|FG000|Overall Study|Subject considered the efficacy was poor|1|||
143161617|NCT03400787|516137606|FG000|Overall Study|Lost to Follow-up|1|||
143161618|NCT03400787|516137607|FG001|Overall Study|Lost to Follow-up|0|||
143161619|NCT03400787|516137606|FG000|Overall Study|Death|1|||
143161620|NCT03400787|516137607|FG001|Overall Study|Death|0|||
143161621|NCT03400787|516137606|FG000|Overall Study|Protocol Violation|0|||
143161622|NCT03400787|516137607|FG001|Overall Study|Protocol Violation|2|||
143161623|NCT03400787|516137606|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
143161624|NCT03400787|516137607|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
143161625|NCT02595437|516137613|FG000|Triferic Via IV|Withdrawal by Subject|1|||
143161626|NCT01423084|516137614|FG000|Overall Study|Adverse Event|0|||
143161627|NCT01423084|516137615|FG001|Overall Study|Adverse Event|1|||
143161628|NCT01423084|516137614|FG000|Overall Study|Withdrawal by Subject|2|||
143161629|NCT01423084|516137615|FG001|Overall Study|Withdrawal by Subject|3|||
143161630|NCT02837952|516137619|FG000|Overall Study|Adverse Event|0|||
143238943|NCT02113982|516429811|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
143496206|NCT00352534|517359402|FG006|Final Risk Group Assignment|Physician Decision|0|||
143037547|NCT01391793|515680650|FG000|Overall Study|No DMSA|73|||
143037548|NCT01391793|515680651|FG001|Overall Study|No DMSA|57|||
143037549|NCT01015625|515680652|FG000|Overall Study|Lost to Follow-up|3|||
143161631|NCT02837952|516137620|FG001|Overall Study|Adverse Event|1|||
143161632|NCT02837952|516137619|FG000|Overall Study|Withdrawal by Subject|4|||
143161633|NCT02837952|516137620|FG001|Overall Study|Withdrawal by Subject|5|||
143496207|NCT00352534|517359396|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
143037550|NCT01015625|515680653|FG001|Overall Study|Lost to Follow-up|1|||
143037551|NCT01015625|515680652|FG000|Overall Study|Withdrawal by Subject|2|||
143037552|NCT01015625|515680653|FG001|Overall Study|Withdrawal by Subject|3|||
143037553|NCT01015625|515680652|FG000|Overall Study|Physician Decision|2|||
143161634|NCT02837952|516137619|FG000|Overall Study|Medication Error|1|||
143496208|NCT00352534|517359397|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
143496209|NCT00352534|517359398|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
143496210|NCT00352534|517359399|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
143496211|NCT00352534|517359400|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
143496212|NCT00352534|517359401|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
143496213|NCT00352534|517359402|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
143496214|NCT00352534|517359396|FG000|Final Risk Group Assignment|Ineligible|0|||
143496215|NCT00352534|517359397|FG001|Final Risk Group Assignment|Ineligible|0|||
143496216|NCT00352534|517359398|FG002|Final Risk Group Assignment|Ineligible|3|||
143496217|NCT00352534|517359399|FG003|Final Risk Group Assignment|Ineligible|1|||
143496218|NCT00352534|517359400|FG004|Final Risk Group Assignment|Ineligible|0|||
143496219|NCT00352534|517359401|FG005|Final Risk Group Assignment|Ineligible|13|||
143496220|NCT00352534|517359402|FG006|Final Risk Group Assignment|Ineligible|0|||
143161635|NCT02837952|516137620|FG001|Overall Study|Medication Error|0|||
143161636|NCT02070380|516137621|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
143161637|NCT02070380|516137622|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
143161638|NCT02070380|516137623|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
143161639|NCT02070380|516137624|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
143161640|NCT02070380|516137621|FG000|Second Injection|Image sets missing or technically inadeq|0|||
143161641|NCT02070380|516137622|FG001|Second Injection|Image sets missing or technically inadeq|1|||
143161642|NCT02070380|516137623|FG002|Second Injection|Image sets missing or technically inadeq|0|||
143161643|NCT02070380|516137624|FG003|Second Injection|Image sets missing or technically inadeq|0|||
143161644|NCT02070380|516137621|FG000|Second Injection|Protocol Violation|0|||
143161645|NCT02070380|516137622|FG001|Second Injection|Protocol Violation|1|||
143161646|NCT02070380|516137623|FG002|Second Injection|Protocol Violation|1|||
143161647|NCT02070380|516137624|FG003|Second Injection|Protocol Violation|5|||
143161648|NCT01791205|516137636|FG000|Phase II|Lack of Efficacy|6|||
143161649|NCT01791205|516137637|FG001|Phase II|Lack of Efficacy|0|||
143161650|NCT01791205|516137636|FG000|Phase II|Adverse Event|2|||
143161651|NCT01791205|516137637|FG001|Phase II|Adverse Event|0|||
143161652|NCT01791205|516137636|FG000|Phase II|Safety|1|||
143161653|NCT01791205|516137637|FG001|Phase II|Safety|0|||
143161654|NCT01791205|516137636|FG000|Phase II|Lost to Follow-up|1|||
143161655|NCT01791205|516137637|FG001|Phase II|Lost to Follow-up|0|||
143161656|NCT01791205|516137636|FG000|Phase II|Remission of disease|1|||
143496221|NCT00352534|517359396|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
143496222|NCT00352534|517359397|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
143496223|NCT00352534|517359398|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
143496224|NCT00352534|517359399|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
143496225|NCT00352534|517359400|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
143496226|NCT00352534|517359401|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
143496227|NCT00352534|517359402|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
143496228|NCT00352534|517359396|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
143496229|NCT00352534|517359397|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
143496230|NCT00352534|517359398|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
143496231|NCT00352534|517359399|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
143496232|NCT00352534|517359400|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
143496233|NCT00352534|517359401|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
143496234|NCT00352534|517359402|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
143496235|NCT00352534|517359396|FG000|Final Risk Group Assignment|Death|0|||
143496236|NCT00352534|517359397|FG001|Final Risk Group Assignment|Death|0|||
143496237|NCT00352534|517359398|FG002|Final Risk Group Assignment|Death|0|||
143496238|NCT00352534|517359399|FG003|Final Risk Group Assignment|Death|0|||
143496239|NCT00352534|517359400|FG004|Final Risk Group Assignment|Death|0|||
143496240|NCT00352534|517359401|FG005|Final Risk Group Assignment|Death|2|||
143496241|NCT00352534|517359402|FG006|Final Risk Group Assignment|Death|0|||
143496242|NCT02324270|517359405|FG000|Overall Study|Withdrawal by Subject|0|||
143496243|NCT02324270|517359406|FG001|Overall Study|Withdrawal by Subject|1|||
143496244|NCT02324270|517359407|FG002|Overall Study|Withdrawal by Subject|0|||
143496245|NCT02324270|517359405|FG000|Overall Study|Lost to Follow-up|4|||
143496246|NCT02324270|517359406|FG001|Overall Study|Lost to Follow-up|3|||
143496247|NCT02324270|517359407|FG002|Overall Study|Lost to Follow-up|4|||
143496248|NCT02324270|517359405|FG000|Overall Study|Protocol Violation|0|||
143496249|NCT02324270|517359406|FG001|Overall Study|Protocol Violation|1|||
143496250|NCT02324270|517359407|FG002|Overall Study|Protocol Violation|1|||
143496251|NCT02324270|517359405|FG000|Overall Study|Non Compliance with Study Drug|1|||
143496252|NCT02324270|517359406|FG001|Overall Study|Non Compliance with Study Drug|2|||
143496253|NCT02324270|517359407|FG002|Overall Study|Non Compliance with Study Drug|0|||
143496254|NCT00546364|517359408|FG000|Overall Study|Disease progression|5|||
143161657|NCT01791205|516137637|FG001|Phase II|Remission of disease|0|||
143161658|NCT01791205|516137636|FG000|Phase II|Physician's decision|1|||
143161659|NCT01791205|516137637|FG001|Phase II|Physician's decision|0|||
143161660|NCT02242903|516137638|FG000|Overall Study|Withdrawal by Subject|1|||
143496255|NCT00546364|517359409|FG001|Overall Study|Disease progression|11|||
143496256|NCT00546364|517359410|FG002|Overall Study|Disease progression|8|||
143037554|NCT01015625|515680653|FG001|Overall Study|Physician Decision|0|||
143037555|NCT01015625|515680652|FG000|Overall Study|Death|30|||
143037556|NCT01015625|515680653|FG001|Overall Study|Death|22|||
143037557|NCT03107091|515680655|FG000|Overall Study|Physician Decision|1|||
143037558|NCT00105196|515680660|FG000|Overall Study|Lack of Efficacy|2|||
143037559|NCT00105196|515680661|FG001|Overall Study|Lack of Efficacy|3|||
143037560|NCT00105196|515680660|FG000|Overall Study|Adverse Event|11|||
143037561|NCT00105196|515680661|FG001|Overall Study|Adverse Event|3|||
143037562|NCT00105196|515680660|FG000|Overall Study|Withdrawal by Subject|6|||
143037563|NCT00105196|515680661|FG001|Overall Study|Withdrawal by Subject|6|||
143037564|NCT00105196|515680660|FG000|Overall Study|Lost to Follow-up|3|||
143037565|NCT00105196|515680661|FG001|Overall Study|Lost to Follow-up|2|||
143037566|NCT00105196|515680660|FG000|Overall Study|Poor/noncompliance|3|||
143037567|NCT00105196|515680661|FG001|Overall Study|Poor/noncompliance|4|||
143037568|NCT00105196|515680660|FG000|Overall Study|Protocol Violation|5|||
143037569|NCT00105196|515680661|FG001|Overall Study|Protocol Violation|2|||
143037570|NCT00105196|515680660|FG000|Overall Study|pending surgery|0|||
143037571|NCT00105196|515680661|FG001|Overall Study|pending surgery|1|||
143037572|NCT00105196|515680660|FG000|Overall Study|marijuana use|0|||
143037573|NCT00105196|515680661|FG001|Overall Study|marijuana use|1|||
143037574|NCT00105196|515680660|FG000|Overall Study|Subject became unblinded|0|||
143037575|NCT00105196|515680661|FG001|Overall Study|Subject became unblinded|1|||
143037576|NCT03025880|515680662|FG000|Overall Study|Adverse Event|1|||
143037577|NCT03025880|515680663|FG001|Overall Study|Adverse Event|0|||
143037578|NCT03025880|515680662|FG000|Overall Study|Death|1|||
143037579|NCT03025880|515680663|FG001|Overall Study|Death|1|||
143037580|NCT03025880|515680662|FG000|Overall Study|Withdrawal by Subject|0|||
143037581|NCT03025880|515680663|FG001|Overall Study|Withdrawal by Subject|1|||
143037582|NCT03025880|515680662|FG000|Overall Study|Physician Decision|0|||
143037583|NCT03025880|515680663|FG001|Overall Study|Physician Decision|1|||
143037584|NCT03025880|515680662|FG000|Overall Study|Progressive Disease|12|||
143037585|NCT03025880|515680663|FG001|Overall Study|Progressive Disease|19|||
143037586|NCT02924883|515680668|FG000|Overall Study|Death|39|||
143037587|NCT02924883|515680669|FG001|Overall Study|Death|20|||
143037588|NCT02924883|515680668|FG000|Overall Study|Lost to Follow-up|1|||
143037589|NCT02924883|515680669|FG001|Overall Study|Lost to Follow-up|0|||
143037590|NCT02924883|515680668|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
143037591|NCT02924883|515680669|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
143037592|NCT02924883|515680668|FG000|Overall Study|Protocol Violation|1|||
143037593|NCT02924883|515680669|FG001|Overall Study|Protocol Violation|0|||
143037594|NCT02924883|515680668|FG000|Overall Study|Withdrawal by Subject|22|||
143037595|NCT02924883|515680669|FG001|Overall Study|Withdrawal by Subject|16|||
143037596|NCT02924883|515680668|FG000|Overall Study|Progressive Disease|1|||
143037597|NCT02924883|515680669|FG001|Overall Study|Progressive Disease|0|||
143037598|NCT02924883|515680668|FG000|Overall Study|Study Terminated by Sponsor|69|||
143037599|NCT02924883|515680669|FG001|Overall Study|Study Terminated by Sponsor|32|||
143037600|NCT01544127|515680670|FG000|Overall Study|Lost to Follow-up|4|||
143037601|NCT01544127|515680671|FG001|Overall Study|Lost to Follow-up|2|||
143037602|NCT01544127|515680672|FG002|Overall Study|Lost to Follow-up|9|||
143037603|NCT01544127|515680670|FG000|Overall Study|Withdrawal by Subject|2|||
143037604|NCT01544127|515680671|FG001|Overall Study|Withdrawal by Subject|2|||
143238944|NCT02113982|516429798|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
143238945|NCT02113982|516429799|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
143238946|NCT02113982|516429800|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
143238947|NCT02113982|516429801|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
143238948|NCT02113982|516429802|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
143238949|NCT02113982|516429803|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
143037605|NCT01544127|515680672|FG002|Overall Study|Withdrawal by Subject|1|||
143037606|NCT01544127|515680670|FG000|Overall Study|Discharged out of catchment area|1|||
143037607|NCT01544127|515680671|FG001|Overall Study|Discharged out of catchment area|1|||
143037608|NCT01544127|515680672|FG002|Overall Study|Discharged out of catchment area|1|||
143037609|NCT01544127|515680670|FG000|Overall Study|Death|1|||
143037610|NCT01544127|515680671|FG001|Overall Study|Death|0|||
143037611|NCT01544127|515680672|FG002|Overall Study|Death|0|||
143238950|NCT02113982|516429804|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
143496257|NCT00546364|517359408|FG000|Overall Study|Completed and off treatment|1|||
143037612|NCT01544127|515680670|FG000|Overall Study|Jail or Prison|1|||
143037613|NCT01544127|515680671|FG001|Overall Study|Jail or Prison|1|||
143037614|NCT01544127|515680672|FG002|Overall Study|Jail or Prison|2|||
143037615|NCT01544127|515680670|FG000|Overall Study|Became Psychotic|1|||
143037616|NCT01544127|515680671|FG001|Overall Study|Became Psychotic|0|||
143037617|NCT01544127|515680672|FG002|Overall Study|Became Psychotic|0|||
143037618|NCT01544127|515680670|FG000|Overall Study|Researcher withdrew|1|||
143037619|NCT01544127|515680671|FG001|Overall Study|Researcher withdrew|0|||
143037620|NCT01544127|515680672|FG002|Overall Study|Researcher withdrew|0|||
143037621|NCT01544127|515680670|FG000|Overall Study|Went active duty|0|||
143037622|NCT01544127|515680671|FG001|Overall Study|Went active duty|0|||
143037623|NCT01544127|515680672|FG002|Overall Study|Went active duty|1|||
143037624|NCT01256684|515680673|FG000|Overall Study|Adverse Event|1|||
143037625|NCT01256684|515680674|FG001|Overall Study|Adverse Event|4|||
143037626|NCT01256684|515680675|FG002|Overall Study|Adverse Event|2|||
143037627|NCT01256684|515680673|FG000|Overall Study|Withdrawal by Subject|4|||
143037628|NCT01256684|515680674|FG001|Overall Study|Withdrawal by Subject|0|||
143037629|NCT01256684|515680675|FG002|Overall Study|Withdrawal by Subject|2|||
143238951|NCT02113982|516429805|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
143238952|NCT02113982|516429806|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
143238953|NCT02113982|516429807|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
143238954|NCT02113982|516429808|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
143238955|NCT02113982|516429809|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
143238956|NCT02113982|516429810|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
143238957|NCT02113982|516429811|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
143238958|NCT02113982|516429798|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
143238959|NCT02113982|516429799|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
143238960|NCT02113982|516429800|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
143238961|NCT02113982|516429801|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
143238962|NCT02113982|516429802|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
143238963|NCT02113982|516429803|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
143238964|NCT02113982|516429804|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
143238965|NCT02113982|516429805|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
143238966|NCT02113982|516429806|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
143238967|NCT02113982|516429807|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
143238968|NCT02113982|516429808|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
143238969|NCT02113982|516429809|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
143238970|NCT02113982|516429810|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
143238971|NCT02113982|516429811|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
143238972|NCT02113982|516429798|FG000|Stage 2: Cohort Expansion|Transplant|0|||
143238973|NCT02113982|516429799|FG001|Stage 2: Cohort Expansion|Transplant|0|||
143238974|NCT02113982|516429800|FG002|Stage 2: Cohort Expansion|Transplant|0|||
143238975|NCT02113982|516429801|FG003|Stage 2: Cohort Expansion|Transplant|0|||
143238976|NCT02113982|516429802|FG004|Stage 2: Cohort Expansion|Transplant|0|||
143238977|NCT02113982|516429803|FG005|Stage 2: Cohort Expansion|Transplant|0|||
143238978|NCT02113982|516429804|FG006|Stage 2: Cohort Expansion|Transplant|0|||
143238979|NCT02113982|516429805|FG007|Stage 2: Cohort Expansion|Transplant|0|||
143238980|NCT02113982|516429806|FG008|Stage 2: Cohort Expansion|Transplant|0|||
143238981|NCT02113982|516429807|FG009|Stage 2: Cohort Expansion|Transplant|4|||
143238982|NCT02113982|516429808|FG010|Stage 2: Cohort Expansion|Transplant|2|||
143238983|NCT02113982|516429809|FG011|Stage 2: Cohort Expansion|Transplant|0|||
143238984|NCT02113982|516429810|FG012|Stage 2: Cohort Expansion|Transplant|0|||
143238985|NCT02113982|516429811|FG013|Stage 2: Cohort Expansion|Transplant|0|||
143238986|NCT02113982|516429798|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
143238987|NCT02113982|516429799|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
143238988|NCT02113982|516429800|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
143238989|NCT02113982|516429801|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
143238990|NCT02113982|516429802|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
143238991|NCT02113982|516429803|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
143238992|NCT02113982|516429804|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
143238993|NCT02113982|516429805|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
143238994|NCT02113982|516429806|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
143238995|NCT02113982|516429807|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
143238996|NCT02113982|516429808|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
143238997|NCT02113982|516429809|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
143496258|NCT00546364|517359409|FG001|Overall Study|Completed and off treatment|0|||
143496259|NCT00546364|517359410|FG002|Overall Study|Completed and off treatment|2|||
143496260|NCT00546364|517359408|FG000|Overall Study|Administrative reason by sponsor|1|||
143496261|NCT00546364|517359409|FG001|Overall Study|Administrative reason by sponsor|0|||
143496262|NCT00546364|517359410|FG002|Overall Study|Administrative reason by sponsor|0|||
143037630|NCT01256684|515680673|FG000|Overall Study|Physician Decision|0|||
143238998|NCT02113982|516429810|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
143496263|NCT00546364|517359408|FG000|Overall Study|Poor compliance/noncompliance|0|||
143037631|NCT01256684|515680674|FG001|Overall Study|Physician Decision|1|||
143037632|NCT01256684|515680675|FG002|Overall Study|Physician Decision|0|||
143037633|NCT01256684|515680673|FG000|Overall Study|Lack of Efficacy|0|||
143037634|NCT01256684|515680674|FG001|Overall Study|Lack of Efficacy|1|||
143037635|NCT01256684|515680675|FG002|Overall Study|Lack of Efficacy|1|||
143037636|NCT01256684|515680673|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
143037637|NCT01256684|515680674|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
143037638|NCT01256684|515680675|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
143037639|NCT02914600|515680676|FG000|Overall Study|Adverse Event|298|||
143037640|NCT02914600|515680677|FG001|Overall Study|Adverse Event|35|||
143238999|NCT02113982|516429811|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
143239000|NCT02113982|516429798|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
143239001|NCT02113982|516429799|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
143239002|NCT02113982|516429800|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
143239003|NCT02113982|516429801|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
143239004|NCT02113982|516429802|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
143239005|NCT02113982|516429803|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
143239006|NCT02113982|516429804|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
143239007|NCT02113982|516429805|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
143239008|NCT02113982|516429806|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
143239009|NCT02113982|516429807|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
143037641|NCT02914600|515680678|FG002|Overall Study|Adverse Event|25|||
143037642|NCT02914600|515680676|FG000|Overall Study|Sponsors decision|287|||
143037643|NCT02914600|515680677|FG001|Overall Study|Sponsors decision|41|||
143037644|NCT02914600|515680678|FG002|Overall Study|Sponsors decision|12|||
143037645|NCT02914600|515680676|FG000|Overall Study|Withdrawal by Subject|158|||
143037646|NCT02914600|515680677|FG001|Overall Study|Withdrawal by Subject|20|||
143037647|NCT02914600|515680678|FG002|Overall Study|Withdrawal by Subject|18|||
143037648|NCT02914600|515680676|FG000|Overall Study|Investigators discretion|169|||
143239010|NCT02113982|516429808|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
143239011|NCT02113982|516429809|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
143239012|NCT02113982|516429810|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
143239013|NCT02113982|516429811|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
143239014|NCT02113982|516429798|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
143239015|NCT02113982|516429799|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
143239016|NCT02113982|516429800|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
143239017|NCT02113982|516429801|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
143239018|NCT02113982|516429802|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
143239019|NCT02113982|516429803|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
143239020|NCT02113982|516429804|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
143239021|NCT02113982|516429805|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
143239022|NCT02113982|516429806|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
143239023|NCT02113982|516429807|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
143239024|NCT02113982|516429808|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
143239025|NCT02113982|516429809|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
143239026|NCT02113982|516429810|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
143239027|NCT02113982|516429811|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
143239028|NCT02113982|516429798|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
143239029|NCT02113982|516429799|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
143239030|NCT02113982|516429800|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
143239031|NCT02113982|516429801|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
143239032|NCT02113982|516429802|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
143239033|NCT02113982|516429803|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
143239034|NCT02113982|516429804|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
143239035|NCT02113982|516429805|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
143239036|NCT02113982|516429806|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
143239037|NCT02113982|516429807|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
143239038|NCT02113982|516429808|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
143239039|NCT02113982|516429809|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
143239040|NCT02113982|516429810|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
143239041|NCT02113982|516429811|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
143239042|NCT02113982|516429798|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
143239043|NCT02113982|516429799|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
143239044|NCT02113982|516429800|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
143239045|NCT02113982|516429801|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
143239046|NCT02113982|516429802|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
143239047|NCT02113982|516429803|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
143239048|NCT02113982|516429804|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
143496264|NCT00546364|517359409|FG001|Overall Study|Poor compliance/noncompliance|0|||
143496265|NCT00546364|517359410|FG002|Overall Study|Poor compliance/noncompliance|1|||
143037649|NCT02914600|515680677|FG001|Overall Study|Investigators discretion|14|||
143037650|NCT02914600|515680678|FG002|Overall Study|Investigators discretion|13|||
143239049|NCT02113982|516429805|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
143239050|NCT02113982|516429806|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
143239051|NCT02113982|516429807|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
143239052|NCT02113982|516429808|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
143239053|NCT02113982|516429809|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
143239054|NCT02113982|516429810|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
143239055|NCT02113982|516429811|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
143239056|NCT02113982|516429798|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
143364118|NCT01237678|516875554|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
143364119|NCT01237678|516875552|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
143037651|NCT02914600|515680676|FG000|Overall Study|Lost to Follow-up|10|||
143496266|NCT00546364|517359408|FG000|Overall Study|No longer meets study criteria|1|||
143496267|NCT00546364|517359409|FG001|Overall Study|No longer meets study criteria|1|||
143496268|NCT00546364|517359410|FG002|Overall Study|No longer meets study criteria|0|||
143496269|NCT00546364|517359408|FG000|Overall Study|Withdrawal by Subject|5|||
143496270|NCT00546364|517359409|FG001|Overall Study|Withdrawal by Subject|6|||
143496271|NCT00546364|517359410|FG002|Overall Study|Withdrawal by Subject|3|||
143496272|NCT00546364|517359408|FG000|Overall Study|Prior taxotere|1|||
143496273|NCT00546364|517359409|FG001|Overall Study|Prior taxotere|0|||
143496274|NCT00546364|517359410|FG002|Overall Study|Prior taxotere|0|||
143496275|NCT00546364|517359408|FG000|Overall Study|Mixed response|1|||
143496276|NCT00546364|517359409|FG001|Overall Study|Mixed response|0|||
143496277|NCT00546364|517359410|FG002|Overall Study|Mixed response|0|||
143496278|NCT00546364|517359408|FG000|Overall Study|Palliative treatment|1|||
143496279|NCT00546364|517359409|FG001|Overall Study|Palliative treatment|0|||
143496280|NCT00546364|517359410|FG002|Overall Study|Palliative treatment|1|||
143496281|NCT00546364|517359408|FG000|Overall Study|Target lesions resected|1|||
143496282|NCT00546364|517359409|FG001|Overall Study|Target lesions resected|0|||
143496283|NCT00546364|517359410|FG002|Overall Study|Target lesions resected|0|||
143496284|NCT00546364|517359408|FG000|Overall Study|Physician Decision|0|||
143496285|NCT00546364|517359409|FG001|Overall Study|Physician Decision|0|||
143496286|NCT00546364|517359410|FG002|Overall Study|Physician Decision|1|||
143496287|NCT00546364|517359408|FG000|Overall Study|Sponsor decision|0|||
143496288|NCT00546364|517359409|FG001|Overall Study|Sponsor decision|0|||
143496289|NCT00546364|517359410|FG002|Overall Study|Sponsor decision|1|||
143496290|NCT03521791|517359411|FG000|Overall Study|Protocol Violation|7|||
143496291|NCT03521791|517359412|FG001|Overall Study|Protocol Violation|17|||
143496292|NCT02090855|517359413|FG000|Overall Study|no evaluable Standard of Truth results|2|||
143496293|NCT00680836|517359414|FG000|Overall Study|Withdrawal by Subject|3|||
143496294|NCT00680836|517359415|FG001|Overall Study|Withdrawal by Subject|0|||
143496295|NCT00680836|517359414|FG000|Overall Study|Lost to Follow-up|3|||
143496296|NCT00680836|517359415|FG001|Overall Study|Lost to Follow-up|1|||
143496297|NCT00680836|517359414|FG000|Overall Study|Physician Decision|2|||
143496298|NCT00680836|517359415|FG001|Overall Study|Physician Decision|1|||
143496299|NCT03786432|517359416|FG000|Overall Study|Screen Failure after consent|1|||
143496300|NCT03786432|517359416|FG000|Overall Study|Lost to Follow-up|4|||
143496301|NCT03786432|517359416|FG000|Overall Study|did not complete 12 month CT scan|1|||
143496302|NCT03038308|517359417|FG000|Overall Study|Surgical resection|1|||
143496303|NCT03038308|517359417|FG000|Overall Study|Withdrawal by Subject|2|||
143496304|NCT03038308|517359417|FG000|Overall Study|Lost to Follow-up|1|||
143496305|NCT00544869|517359419|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
143496306|NCT00544869|517359420|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
143496307|NCT00544869|517359421|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
143496308|NCT00544869|517359419|FG000|Overall Study|Adverse Event|6|||
143496309|NCT00544869|517359420|FG001|Overall Study|Adverse Event|1|||
143496310|NCT00544869|517359421|FG002|Overall Study|Adverse Event|0|||
143496311|NCT00544869|517359419|FG000|Overall Study|Lack of Efficacy|1|||
143496312|NCT00544869|517359420|FG001|Overall Study|Lack of Efficacy|1|||
143496313|NCT00544869|517359421|FG002|Overall Study|Lack of Efficacy|0|||
143496314|NCT00544869|517359419|FG000|Overall Study|Physician Decision|2|||
143496315|NCT00544869|517359420|FG001|Overall Study|Physician Decision|0|||
143496316|NCT00544869|517359421|FG002|Overall Study|Physician Decision|0|||
143496317|NCT01475734|517359422|FG000|Overall Study|Withdrawal by Subject|1|||
143496318|NCT01475734|517359423|FG001|Overall Study|Withdrawal by Subject|0|||
143496319|NCT01475734|517359422|FG000|Overall Study|Protocol Violation|1|||
143496320|NCT01475734|517359423|FG001|Overall Study|Protocol Violation|0|||
143496321|NCT01475734|517359422|FG000|Overall Study|Physician Decision|0|||
143496322|NCT01475734|517359423|FG001|Overall Study|Physician Decision|1|||
143496323|NCT00771472|517359424|FG000|Overall Study|Physician Decision|2|||
143496324|NCT00771472|517359425|FG001|Overall Study|Physician Decision|3|||
143496325|NCT00771472|517359424|FG000|Overall Study|Progressive Disease|3|||
143037652|NCT02914600|515680677|FG001|Overall Study|Lost to Follow-up|4|||
143496326|NCT00771472|517359425|FG001|Overall Study|Progressive Disease|1|||
143496327|NCT00771472|517359424|FG000|Overall Study|Protocol Violation|1|||
143496328|NCT00771472|517359425|FG001|Overall Study|Protocol Violation|0|||
143037653|NCT02914600|515680678|FG002|Overall Study|Lost to Follow-up|0|||
143037654|NCT02914600|515680676|FG000|Overall Study|Pregnancy|8|||
143037655|NCT02914600|515680677|FG001|Overall Study|Pregnancy|0|||
143496329|NCT00880750|517359428|FG000|First Intervention|Adverse Event|1|||
143037656|NCT02914600|515680678|FG002|Overall Study|Pregnancy|0|||
143037657|NCT02914600|515680676|FG000|Overall Study|Protocol Violation|5|||
143496330|NCT00880750|517359429|FG001|First Intervention|Adverse Event|0|||
143496331|NCT00880750|517359428|FG000|First Intervention|Unable to collect urine|4|||
143496332|NCT00880750|517359429|FG001|First Intervention|Unable to collect urine|0|||
143496333|NCT00880750|517359428|FG000|First Intervention|Non-compliance with meals|0|||
143496334|NCT00880750|517359429|FG001|First Intervention|Non-compliance with meals|1|||
143496335|NCT00880750|517359428|FG000|First Intervention|Withdrawal by Subject|2|||
143496336|NCT00880750|517359429|FG001|First Intervention|Withdrawal by Subject|0|||
143496337|NCT00880750|517359428|FG000|First Intervention|Lost to Follow-up|2|||
143239057|NCT02113982|516429799|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
143239058|NCT02113982|516429800|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
143239059|NCT02113982|516429801|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
143239060|NCT02113982|516429802|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
143239061|NCT02113982|516429803|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
143239062|NCT02113982|516429804|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
143239063|NCT02113982|516429805|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
143239064|NCT02113982|516429806|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
143239065|NCT02113982|516429807|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
143239066|NCT02113982|516429808|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
143239067|NCT02113982|516429809|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
143239068|NCT02113982|516429810|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
143239069|NCT02113982|516429811|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
143239070|NCT02113982|516429798|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
143239071|NCT02113982|516429799|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
143239072|NCT02113982|516429800|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
143239073|NCT02113982|516429801|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
143239074|NCT02113982|516429802|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
143239075|NCT02113982|516429803|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
143239076|NCT02113982|516429804|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
143239077|NCT02113982|516429805|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
143239078|NCT02113982|516429806|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
143239079|NCT02113982|516429807|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
143239080|NCT02113982|516429808|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
143239081|NCT02113982|516429809|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
143239082|NCT02113982|516429810|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
143239083|NCT02113982|516429811|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
143239084|NCT02113982|516429798|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
143239085|NCT02113982|516429799|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
143239086|NCT02113982|516429800|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
143239087|NCT02113982|516429801|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
143239088|NCT02113982|516429802|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
143239089|NCT02113982|516429803|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
143239090|NCT02113982|516429804|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
143239091|NCT02113982|516429805|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
143239092|NCT02113982|516429806|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
143239093|NCT02113982|516429807|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
143239094|NCT02113982|516429808|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
143239095|NCT02113982|516429809|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
143239096|NCT02113982|516429810|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
143239097|NCT02113982|516429811|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
143239098|NCT02113982|516429798|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
143239099|NCT02113982|516429799|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
143239100|NCT02113982|516429800|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
143239101|NCT02113982|516429801|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
143239102|NCT02113982|516429802|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
143239103|NCT02113982|516429803|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
143239104|NCT02113982|516429804|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
143239105|NCT02113982|516429805|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
143239106|NCT02113982|516429806|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
143239107|NCT02113982|516429807|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
143239108|NCT02113982|516429808|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
143239109|NCT02113982|516429809|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
143239110|NCT02113982|516429810|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
143239111|NCT02113982|516429811|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
143239112|NCT02113982|516429798|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
143239113|NCT02113982|516429799|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
143239114|NCT02113982|516429800|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
143239115|NCT02113982|516429801|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
143239116|NCT02113982|516429802|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
143239117|NCT02113982|516429803|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
143239118|NCT02113982|516429804|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
143239119|NCT02113982|516429805|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
143239120|NCT02113982|516429806|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
143239121|NCT02113982|516429807|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
143239122|NCT02113982|516429808|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
143239123|NCT02113982|516429809|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
143239124|NCT02113982|516429810|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
143037658|NCT02914600|515680677|FG001|Overall Study|Protocol Violation|3|||
143037659|NCT02914600|515680678|FG002|Overall Study|Protocol Violation|0|||
143037660|NCT02914600|515680676|FG000|Overall Study|Non-compliance with study drug|6|||
143037661|NCT02914600|515680677|FG001|Overall Study|Non-compliance with study drug|1|||
143037662|NCT02914600|515680678|FG002|Overall Study|Non-compliance with study drug|0|||
143037663|NCT02914600|515680676|FG000|Overall Study|Death|3|||
143037664|NCT02914600|515680677|FG001|Overall Study|Death|1|||
143037665|NCT02914600|515680678|FG002|Overall Study|Death|1|||
143037666|NCT02914600|515680676|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
143037667|NCT02914600|515680677|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
143037668|NCT02914600|515680678|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
143037669|NCT02914600|515680676|FG000|Overall Study|Enrolled but not treated|1|||
143037670|NCT02914600|515680677|FG001|Overall Study|Enrolled but not treated|0|||
143037671|NCT02914600|515680678|FG002|Overall Study|Enrolled but not treated|0|||
143037672|NCT01536405|515680680|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
143037673|NCT01536405|515680681|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
143037674|NCT01536405|515680680|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
143037675|NCT01536405|515680681|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
143239125|NCT02113982|516429811|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
143496338|NCT00880750|517359429|FG001|First Intervention|Lost to Follow-up|0|||
143496339|NCT00880750|517359428|FG000|Second Intervention|Withdrawal by Subject|2|||
143496340|NCT00880750|517359429|FG001|Second Intervention|Withdrawal by Subject|2|||
143496341|NCT00880750|517359428|FG000|Second Intervention|Protocol Violation|1|||
143037676|NCT01536405|515680680|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
143037677|NCT01536405|515680681|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
143037678|NCT01536405|515680680|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
143037679|NCT01536405|515680681|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
143037680|NCT01536405|515680680|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
143037681|NCT01536405|515680681|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
143037682|NCT01536405|515680680|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
143037683|NCT01536405|515680681|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
143037684|NCT01536405|515680680|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
143037685|NCT01536405|515680681|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
143037686|NCT01536405|515680680|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
143037687|NCT01536405|515680681|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
143037688|NCT01536405|515680680|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
143037689|NCT01536405|515680681|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
143037690|NCT01536405|515680680|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
143037691|NCT01536405|515680681|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
143037692|NCT01536405|515680680|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
143037693|NCT01536405|515680681|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
143037694|NCT01536405|515680680|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
143037695|NCT01536405|515680681|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
143037696|NCT01536405|515680680|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
143037697|NCT01536405|515680681|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
143037698|NCT02336165|515680682|FG000|Overall Study|Death|3|||
143037699|NCT02336165|515680683|FG001|Overall Study|Death|0|||
143037700|NCT02336165|515680684|FG002|Overall Study|Death|0|||
143037701|NCT02336165|515680685|FG003|Overall Study|Death|0|||
143037702|NCT02336165|515680686|FG004|Overall Study|Death|1|||
143037703|NCT02336165|515680682|FG000|Overall Study|Physician Decision|2|||
143037704|NCT02336165|515680683|FG001|Overall Study|Physician Decision|2|||
143037705|NCT02336165|515680684|FG002|Overall Study|Physician Decision|1|||
143037706|NCT02336165|515680685|FG003|Overall Study|Physician Decision|1|||
143037707|NCT02336165|515680686|FG004|Overall Study|Physician Decision|0|||
143037708|NCT02336165|515680682|FG000|Overall Study|Withdrawal by Subject|0|||
143037709|NCT02336165|515680683|FG001|Overall Study|Withdrawal by Subject|0|||
143037710|NCT02336165|515680684|FG002|Overall Study|Withdrawal by Subject|1|||
143037711|NCT02336165|515680685|FG003|Overall Study|Withdrawal by Subject|0|||
143037712|NCT02336165|515680686|FG004|Overall Study|Withdrawal by Subject|1|||
143037713|NCT02336165|515680682|FG000|Overall Study|Adverse Event|4|||
143037714|NCT02336165|515680683|FG001|Overall Study|Adverse Event|1|||
143037715|NCT02336165|515680684|FG002|Overall Study|Adverse Event|2|||
143037716|NCT02336165|515680685|FG003|Overall Study|Adverse Event|4|||
143037717|NCT02336165|515680686|FG004|Overall Study|Adverse Event|1|||
143037718|NCT02336165|515680682|FG000|Overall Study|Progressive disease|23|||
143037719|NCT02336165|515680683|FG001|Overall Study|Progressive disease|22|||
143037720|NCT02336165|515680684|FG002|Overall Study|Progressive disease|27|||
143037721|NCT02336165|515680685|FG003|Overall Study|Progressive disease|24|||
143037722|NCT02336165|515680686|FG004|Overall Study|Progressive disease|19|||
143037723|NCT02336165|515680682|FG000|Overall Study|Non-compliance|1|||
143037724|NCT02336165|515680683|FG001|Overall Study|Non-compliance|0|||
143496342|NCT00880750|517359429|FG001|Second Intervention|Protocol Violation|0|||
143037725|NCT02336165|515680684|FG002|Overall Study|Non-compliance|0|||
143037726|NCT02336165|515680685|FG003|Overall Study|Non-compliance|1|||
143037727|NCT02336165|515680686|FG004|Overall Study|Non-compliance|0|||
143037728|NCT02336165|515680682|FG000|Overall Study|Other|1|||
143037729|NCT02336165|515680683|FG001|Overall Study|Other|0|||
143037730|NCT02336165|515680684|FG002|Overall Study|Other|0|||
143037731|NCT02336165|515680685|FG003|Overall Study|Other|1|||
143037732|NCT02336165|515680686|FG004|Overall Study|Other|0|||
143037733|NCT00301366|515680687|FG000|Overall Study|Adverse Event|1|||
143037734|NCT00552669|515680692|FG000|Overall Study|Death|3|||
143037735|NCT00552669|515680693|FG001|Overall Study|Death|7|||
143037736|NCT04786184|515680694|FG000|Overall Study|Adverse Event|4|||
143037737|NCT04786184|515680695|FG001|Overall Study|Adverse Event|0|||
143037738|NCT04786184|515680694|FG000|Overall Study|Withdrawal by Subject|3|||
143037739|NCT04786184|515680695|FG001|Overall Study|Withdrawal by Subject|1|||
143037740|NCT04786184|515680694|FG000|Overall Study|Lost to Follow-up|4|||
143037741|NCT04786184|515680695|FG001|Overall Study|Lost to Follow-up|2|||
143037742|NCT02514122|515680696|FG000|Overall Study|Withdrawal by Subject|2|||
143037743|NCT02514122|515680697|FG001|Overall Study|Withdrawal by Subject|0|||
143037744|NCT00579670|515680698|FG000|Overall Study|Death|1|||
143037745|NCT00579670|515680699|FG001|Overall Study|Death|0|||
143037746|NCT00579670|515680700|FG002|Overall Study|Death|0|||
143037747|NCT00579670|515680701|FG003|Overall Study|Death|0|||
143037748|NCT00579670|515680702|FG004|Overall Study|Death|0|||
143037749|NCT00579670|515680698|FG000|Overall Study|Adverse Event|1|||
143037750|NCT00579670|515680699|FG001|Overall Study|Adverse Event|0|||
143037751|NCT00579670|515680700|FG002|Overall Study|Adverse Event|1|||
143037752|NCT00579670|515680701|FG003|Overall Study|Adverse Event|2|||
143037753|NCT00579670|515680702|FG004|Overall Study|Adverse Event|0|||
143037754|NCT00579670|515680698|FG000|Overall Study|Lack of Efficacy|0|||
143037755|NCT00579670|515680699|FG001|Overall Study|Lack of Efficacy|0|||
143037756|NCT00579670|515680700|FG002|Overall Study|Lack of Efficacy|1|||
143037757|NCT00579670|515680701|FG003|Overall Study|Lack of Efficacy|14|||
143037758|NCT00579670|515680702|FG004|Overall Study|Lack of Efficacy|0|||
143037759|NCT00579670|515680698|FG000|Overall Study|Lost to Follow-up|0|||
143037760|NCT00579670|515680699|FG001|Overall Study|Lost to Follow-up|1|||
143037761|NCT00579670|515680700|FG002|Overall Study|Lost to Follow-up|0|||
143037762|NCT00579670|515680701|FG003|Overall Study|Lost to Follow-up|4|||
143037763|NCT00579670|515680702|FG004|Overall Study|Lost to Follow-up|0|||
143037764|NCT00579670|515680698|FG000|Overall Study|Other|0|||
143037765|NCT00579670|515680699|FG001|Overall Study|Other|0|||
143037766|NCT00579670|515680700|FG002|Overall Study|Other|1|||
143037767|NCT00579670|515680701|FG003|Overall Study|Other|2|||
143037768|NCT00579670|515680702|FG004|Overall Study|Other|0|||
143037769|NCT00579670|515680698|FG000|Overall Study|Withdrawal by Subject|0|||
143037770|NCT00579670|515680699|FG001|Overall Study|Withdrawal by Subject|0|||
143037771|NCT00579670|515680700|FG002|Overall Study|Withdrawal by Subject|1|||
143037772|NCT00579670|515680701|FG003|Overall Study|Withdrawal by Subject|0|||
143037773|NCT00579670|515680702|FG004|Overall Study|Withdrawal by Subject|0|||
143161661|NCT02242903|516137639|FG001|Overall Study|Withdrawal by Subject|0|||
143161662|NCT02242903|516137640|FG002|Overall Study|Withdrawal by Subject|0|||
143161663|NCT02242903|516137641|FG003|Overall Study|Withdrawal by Subject|0|||
143161664|NCT02242903|516137642|FG004|Overall Study|Withdrawal by Subject|0|||
143161665|NCT02242903|516137643|FG005|Overall Study|Withdrawal by Subject|0|||
143161666|NCT02242903|516137644|FG006|Overall Study|Withdrawal by Subject|0|||
143161667|NCT03436420|516137645|FG000|Overall Study|Lack of Efficacy|3|||
143161668|NCT01061710|516137647|FG000|Overall Study|Protocol Violation|14|||
143161669|NCT00281580|516137648|FG000|Overall Study|Adverse Event|2|||
143161670|NCT00281580|516137649|FG001|Overall Study|Adverse Event|0|||
143161671|NCT00281580|516137650|FG002|Overall Study|Adverse Event|2|||
143239126|NCT02113982|516429798|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
143161672|NCT00281580|516137651|FG003|Overall Study|Adverse Event|4|||
143161673|NCT00281580|516137652|FG004|Overall Study|Adverse Event|1|||
143161674|NCT00281580|516137653|FG005|Overall Study|Adverse Event|0|||
143161675|NCT00281580|516137654|FG006|Overall Study|Adverse Event|1|||
143161676|NCT00281580|516137655|FG007|Overall Study|Adverse Event|0|||
143161677|NCT00281580|516137656|FG008|Overall Study|Adverse Event|1|||
143161678|NCT00281580|516137657|FG009|Overall Study|Adverse Event|6|||
143161679|NCT00281580|516137658|FG010|Overall Study|Adverse Event|0|||
143161680|NCT00281580|516137659|FG011|Overall Study|Adverse Event|5|||
143161681|NCT00281580|516137660|FG012|Overall Study|Adverse Event|8|||
143037774|NCT00550537|515680706|FG000|Overall Study|Death|18|||
143037775|NCT00550537|515680706|FG000|Overall Study|Adverse Event|20|||
143037776|NCT00550537|515680706|FG000|Overall Study|Disease progression before|46|||
143037777|NCT00550537|515680706|FG000|Overall Study|Withdrawal by Subject|7|||
143037778|NCT00550537|515680706|FG000|Overall Study|Change in treatment plan|4|||
143037779|NCT00550537|515680706|FG000|Overall Study|Other complicating ilness|3|||
143037780|NCT00550537|515680706|FG000|Overall Study|Declining performance status|2|||
143161682|NCT00281580|516137661|FG013|Overall Study|Adverse Event|2|||
143037781|NCT00550537|515680706|FG000|Overall Study|Treated closer to home|4|||
143037782|NCT00617305|515680707|FG000|Overall Study|Adverse Event|4|||
143037783|NCT00617305|515680708|FG001|Overall Study|Adverse Event|0|||
143037784|NCT00617305|515680709|FG002|Overall Study|Adverse Event|0|||
143037785|NCT00617305|515680707|FG000|Overall Study|Death|1|||
143037786|NCT00617305|515680708|FG001|Overall Study|Death|0|||
143037787|NCT00617305|515680709|FG002|Overall Study|Death|0|||
143037788|NCT00617305|515680707|FG000|Overall Study|Physician Decision|1|||
143037789|NCT00617305|515680708|FG001|Overall Study|Physician Decision|0|||
143037790|NCT00617305|515680709|FG002|Overall Study|Physician Decision|0|||
143037791|NCT00617305|515680707|FG000|Overall Study|Protocol Violation|1|||
143037792|NCT00617305|515680708|FG001|Overall Study|Protocol Violation|0|||
143037793|NCT00617305|515680709|FG002|Overall Study|Protocol Violation|1|||
143037794|NCT00617305|515680707|FG000|Overall Study|Withdrawal by Subject|1|||
143037795|NCT00617305|515680708|FG001|Overall Study|Withdrawal by Subject|0|||
143037796|NCT00617305|515680709|FG002|Overall Study|Withdrawal by Subject|0|||
143037797|NCT04185909|515680710|FG000|Overall Study|Lost to Follow-up|1|||
143037798|NCT00857623|515680711|FG000|Overall Study|Adverse Event|5|||
143037799|NCT00857623|515680712|FG001|Overall Study|Adverse Event|2|||
143037800|NCT00857623|515680711|FG000|Overall Study|Study-specific discontinuation criteria|5|||
143037801|NCT00857623|515680712|FG001|Overall Study|Study-specific discontinuation criteria|3|||
143037802|NCT00857623|515680711|FG000|Overall Study|Withdrawal by Subject|2|||
143037803|NCT00857623|515680712|FG001|Overall Study|Withdrawal by Subject|1|||
143037804|NCT00857623|515680711|FG000|Overall Study|Lack of Efficacy|1|||
143037805|NCT00857623|515680712|FG001|Overall Study|Lack of Efficacy|1|||
143037806|NCT00857623|515680711|FG000|Overall Study|Severe non-compliance to protocol|1|||
143037807|NCT00857623|515680712|FG001|Overall Study|Severe non-compliance to protocol|1|||
143037808|NCT00857623|515680711|FG000|Overall Study|Intake of prohibited medication|0|||
143037809|NCT00857623|515680712|FG001|Overall Study|Intake of prohibited medication|1|||
143037810|NCT00857623|515680711|FG000|Overall Study|Positive for HEP C|0|||
143037811|NCT00857623|515680712|FG001|Overall Study|Positive for HEP C|1|||
143037812|NCT02193178|515680713|FG000|Overall Study|Lost to Follow-up|1|||
143037813|NCT02193178|515680713|FG000|Overall Study|Dry eyes|1|||
143037814|NCT03435081|515680714|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
143037815|NCT03435081|515680715|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
143037816|NCT03435081|515680716|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
143037817|NCT03435081|515680714|FG000|Week 0 to Week 16|Adverse Event|2|||
143037818|NCT03435081|515680715|FG001|Week 0 to Week 16|Adverse Event|2|||
143037819|NCT03435081|515680716|FG002|Week 0 to Week 16|Adverse Event|2|||
143037820|NCT03435081|515680714|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
143037821|NCT03435081|515680715|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
143037822|NCT03435081|515680716|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
143037823|NCT03435081|515680714|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
143037824|NCT03435081|515680715|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
143037825|NCT03435081|515680716|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
143037826|NCT03435081|515680714|FG000|Week 0 to Week 16|Pregnancy|1|||
143037827|NCT03435081|515680715|FG001|Week 0 to Week 16|Pregnancy|0|||
143037828|NCT03435081|515680716|FG002|Week 0 to Week 16|Pregnancy|0|||
143037829|NCT03435081|515680714|FG000|Week 0 to Week 16|Non-compliance|1|||
143037830|NCT03435081|515680715|FG001|Week 0 to Week 16|Non-compliance|0|||
143037831|NCT03435081|515680716|FG002|Week 0 to Week 16|Non-compliance|2|||
143037832|NCT03435081|515680714|FG000|Week 0 to Week 16|Inadequate Response|0|||
143037833|NCT03435081|515680715|FG001|Week 0 to Week 16|Inadequate Response|1|||
143037834|NCT03435081|515680716|FG002|Week 0 to Week 16|Inadequate Response|0|||
143037835|NCT03435081|515680714|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
143037836|NCT03435081|515680715|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
143037837|NCT03435081|515680716|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
143037838|NCT03435081|515680714|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
143037839|NCT03435081|515680715|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
143037840|NCT03435081|515680716|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
143037841|NCT03435081|515680714|FG000|Week 16 to Week 104|Adverse Event|1|||
143037842|NCT03435081|515680715|FG001|Week 16 to Week 104|Adverse Event|0|||
143037843|NCT03435081|515680716|FG002|Week 16 to Week 104|Adverse Event|2|||
143037844|NCT03435081|515680714|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
143037845|NCT03435081|515680715|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
143037846|NCT03435081|515680716|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
143496343|NCT00880750|517359428|FG000|Second Intervention|Unable to collect urine|1|||
143496344|NCT00880750|517359429|FG001|Second Intervention|Unable to collect urine|0|||
143496345|NCT00667576|517359436|FG000|Overall Study|Withdrawal by Subject|1|||
143037847|NCT03435081|515680714|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
143496346|NCT00667576|517359437|FG001|Overall Study|Withdrawal by Subject|0|||
143496347|NCT00667576|517359438|FG002|Overall Study|Withdrawal by Subject|1|||
143364120|NCT01237678|516875553|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
143037848|NCT03435081|515680715|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
143037849|NCT03435081|515680716|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
143037850|NCT03435081|515680714|FG000|Week 16 to Week 104|Non--Compliance|0|||
143037851|NCT03435081|515680715|FG001|Week 16 to Week 104|Non--Compliance|0|||
143037852|NCT03435081|515680716|FG002|Week 16 to Week 104|Non--Compliance|1|||
143037853|NCT00420238|515680719|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
143037854|NCT00420238|515680720|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
143037855|NCT00420238|515680719|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
143037856|NCT00420238|515680720|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
143037857|NCT00420238|515680719|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
143037858|NCT00420238|515680720|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
143037859|NCT00420238|515680719|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
143037860|NCT00420238|515680720|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
143037861|NCT00420238|515680719|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
143037862|NCT00420238|515680720|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
143037863|NCT00420238|515680719|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
143037864|NCT00420238|515680720|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
143037865|NCT04510285|515680721|FG000|Overall Study|Death|1|||
143037866|NCT01417078|515680722|FG000|Overall Study|Withdrawal by Subject|1|||
143037867|NCT00626548|515680723|FG000|Overall Study|Adverse Event|164|||
143037868|NCT00626548|515680724|FG001|Overall Study|Adverse Event|44|||
143037869|NCT00626548|515680723|FG000|Overall Study|Withdrawal by Subject|42|||
143037870|NCT00626548|515680724|FG001|Overall Study|Withdrawal by Subject|46|||
143037871|NCT00626548|515680723|FG000|Overall Study|Protocol Violation|4|||
143037872|NCT00626548|515680724|FG001|Overall Study|Protocol Violation|11|||
143037873|NCT00626548|515680723|FG000|Overall Study|Lost to Follow-up|2|||
143037874|NCT00626548|515680724|FG001|Overall Study|Lost to Follow-up|2|||
143037875|NCT00626548|515680723|FG000|Overall Study|Other termination reason|493|||
143037876|NCT00626548|515680724|FG001|Overall Study|Other termination reason|613|||
143037877|NCT00048581|515680725|FG000|Double-Blind Period|Adverse Event|9|||
143037878|NCT00048581|515680726|FG001|Double-Blind Period|Adverse Event|5|||
143037879|NCT00048581|515680727|FG002|Double-Blind Period|Adverse Event|0|||
143037880|NCT00048581|515680725|FG000|Double-Blind Period|Lack of Efficacy|14|||
143037881|NCT00048581|515680726|FG001|Double-Blind Period|Lack of Efficacy|27|||
143037882|NCT00048581|515680727|FG002|Double-Blind Period|Lack of Efficacy|0|||
143037883|NCT00048581|515680725|FG000|Double-Blind Period|Lost to Follow-up|5|||
143037884|NCT00048581|515680726|FG001|Double-Blind Period|Lost to Follow-up|0|||
143037885|NCT00048581|515680727|FG002|Double-Blind Period|Lost to Follow-up|0|||
143037886|NCT00048581|515680725|FG000|Double-Blind Period|Withdrawal by Subject|5|||
143037887|NCT00048581|515680726|FG001|Double-Blind Period|Withdrawal by Subject|2|||
143037888|NCT00048581|515680727|FG002|Double-Blind Period|Withdrawal by Subject|0|||
143037889|NCT00048581|515680725|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
143037890|NCT00048581|515680726|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
143037891|NCT00048581|515680727|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
143037892|NCT00048581|515680725|FG000|Double-Blind Period|Investigator Decision|1|||
143037893|NCT00048581|515680726|FG001|Double-Blind Period|Investigator Decision|0|||
143037894|NCT00048581|515680727|FG002|Double-Blind Period|Investigator Decision|0|||
143037895|NCT00048581|515680725|FG000|Open-Label Period|Death|0|||
143037896|NCT00048581|515680726|FG001|Open-Label Period|Death|0|||
143037897|NCT00048581|515680727|FG002|Open-Label Period|Death|4|||
143037898|NCT00048581|515680725|FG000|Open-Label Period|Adverse Event|0|||
143037899|NCT00048581|515680726|FG001|Open-Label Period|Adverse Event|0|||
143037900|NCT00048581|515680727|FG002|Open-Label Period|Adverse Event|37|||
143037901|NCT00048581|515680725|FG000|Open-Label Period|Lack of Efficacy|0|||
143037902|NCT00048581|515680726|FG001|Open-Label Period|Lack of Efficacy|0|||
143037903|NCT00048581|515680727|FG002|Open-Label Period|Lack of Efficacy|69|||
143037904|NCT00048581|515680725|FG000|Open-Label Period|Lost to Follow-up|0|||
143037905|NCT00048581|515680726|FG001|Open-Label Period|Lost to Follow-up|0|||
143037906|NCT00048581|515680727|FG002|Open-Label Period|Lost to Follow-up|14|||
143037907|NCT00048581|515680725|FG000|Open-Label Period|Withdrawal by Subject|0|||
143037908|NCT00048581|515680726|FG001|Open-Label Period|Withdrawal by Subject|0|||
143037909|NCT00048581|515680727|FG002|Open-Label Period|Withdrawal by Subject|20|||
143037910|NCT00048581|515680725|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
143037911|NCT00048581|515680726|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
143161683|NCT00281580|516137662|FG014|Overall Study|Adverse Event|3|||
143161684|NCT00281580|516137663|FG015|Overall Study|Adverse Event|3|||
143037912|NCT00048581|515680727|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
143037913|NCT00048581|515680725|FG000|Open-Label Period|Poor/Non-compliance|0|||
143037914|NCT00048581|515680726|FG001|Open-Label Period|Poor/Non-compliance|0|||
143037915|NCT00048581|515680727|FG002|Open-Label Period|Poor/Non-compliance|5|||
143037916|NCT00048581|515680725|FG000|Open-Label Period|Pregnancy|0|||
143037917|NCT00048581|515680726|FG001|Open-Label Period|Pregnancy|0|||
143037918|NCT00048581|515680727|FG002|Open-Label Period|Pregnancy|7|||
143037919|NCT00048581|515680725|FG000|Open-Label Period|Study Site Closure|0|||
143037920|NCT00048581|515680726|FG001|Open-Label Period|Study Site Closure|0|||
143037921|NCT00048581|515680727|FG002|Open-Label Period|Study Site Closure|2|||
143037922|NCT00048581|515680725|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
143037923|NCT00048581|515680726|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
143239127|NCT02113982|516429799|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
143239128|NCT02113982|516429800|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
143239129|NCT02113982|516429801|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
143239130|NCT02113982|516429802|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
143239131|NCT02113982|516429803|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
143239132|NCT02113982|516429804|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
143239133|NCT02113982|516429805|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
143239134|NCT02113982|516429806|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
143239135|NCT02113982|516429807|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
143239136|NCT02113982|516429808|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
143239137|NCT02113982|516429809|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
143239138|NCT02113982|516429810|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
143239139|NCT02113982|516429811|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
143239140|NCT02113982|516429798|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
143364121|NCT01237678|516875554|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
143364122|NCT01237678|516875552|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
143364123|NCT01237678|516875553|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
143037924|NCT00048581|515680727|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
143037925|NCT00048581|515680725|FG000|Open-Label Period|Problem With Transportation To Site|0|||
143037926|NCT00048581|515680726|FG001|Open-Label Period|Problem With Transportation To Site|0|||
143037927|NCT00048581|515680727|FG002|Open-Label Period|Problem With Transportation To Site|1|||
143037928|NCT00048581|515680725|FG000|Open-Label Period|Primary Investigator Retired|0|||
143037929|NCT00048581|515680726|FG001|Open-Label Period|Primary Investigator Retired|0|||
143037930|NCT00048581|515680727|FG002|Open-Label Period|Primary Investigator Retired|2|||
143037931|NCT00048581|515680725|FG000|Open-Label Period|Study Ended By Sponsor|0|||
143037932|NCT00048581|515680726|FG001|Open-Label Period|Study Ended By Sponsor|0|||
143037933|NCT00048581|515680727|FG002|Open-Label Period|Study Ended By Sponsor|1|||
143037934|NCT01406795|515680728|FG000|Overall Study|Withdrawal by Subject|1|||
143037935|NCT02421952|515680729|FG000|Overall Study|Diary Not Returned|93|||
143037936|NCT02421952|515680729|FG000|Overall Study|Failed seriation task|13|||
143037937|NCT02421952|515680729|FG000|Overall Study|Subject uncooperative for baseline test|2|||
143037938|NCT02421952|515680729|FG000|Overall Study|Surgery cancelled|1|||
143037939|NCT01294787|515682733|FG000|Period 1|Adverse Event|0|||
143037940|NCT01294787|515682734|FG001|Period 1|Adverse Event|0|||
143037941|NCT01294787|515682735|FG002|Period 1|Adverse Event|0|||
143037942|NCT01294787|515682736|FG003|Period 1|Adverse Event|0|||
143037943|NCT01294787|515682737|FG004|Period 1|Adverse Event|1|||
143037944|NCT01294787|515682738|FG005|Period 1|Adverse Event|0|||
143037945|NCT01294787|515682733|FG000|Period 1|Withdrawal by Subject|0|||
143037946|NCT01294787|515682734|FG001|Period 1|Withdrawal by Subject|0|||
143037947|NCT01294787|515682735|FG002|Period 1|Withdrawal by Subject|0|||
143037948|NCT01294787|515682736|FG003|Period 1|Withdrawal by Subject|1|||
143037949|NCT01294787|515682737|FG004|Period 1|Withdrawal by Subject|1|||
143037950|NCT01294787|515682738|FG005|Period 1|Withdrawal by Subject|1|||
143037951|NCT01294787|515682733|FG000|Period 1|Administrative problem|0|||
143037952|NCT01294787|515682734|FG001|Period 1|Administrative problem|0|||
143037953|NCT01294787|515682735|FG002|Period 1|Administrative problem|1|||
143037954|NCT01294787|515682736|FG003|Period 1|Administrative problem|0|||
143037955|NCT01294787|515682737|FG004|Period 1|Administrative problem|0|||
143037956|NCT01294787|515682738|FG005|Period 1|Administrative problem|1|||
143037957|NCT01294787|515682733|FG000|Period 2|Adverse Event|0|||
143037958|NCT01294787|515682734|FG001|Period 2|Adverse Event|3|||
143037959|NCT01294787|515682735|FG002|Period 2|Adverse Event|0|||
143037960|NCT01294787|515682736|FG003|Period 2|Adverse Event|1|||
143037961|NCT01294787|515682737|FG004|Period 2|Adverse Event|0|||
143037962|NCT01294787|515682738|FG005|Period 2|Adverse Event|0|||
143037963|NCT01294787|515682733|FG000|Period 2|No longer needs study drug|0|||
143037964|NCT01294787|515682734|FG001|Period 2|No longer needs study drug|0|||
143037965|NCT01294787|515682735|FG002|Period 2|No longer needs study drug|0|||
143037966|NCT01294787|515682736|FG003|Period 2|No longer needs study drug|1|||
143037967|NCT01294787|515682737|FG004|Period 2|No longer needs study drug|0|||
143037968|NCT01294787|515682738|FG005|Period 2|No longer needs study drug|0|||
143037969|NCT01294787|515682733|FG000|Period 3|Adverse Event|0|||
143037970|NCT01294787|515682734|FG001|Period 3|Adverse Event|0|||
143037971|NCT01294787|515682735|FG002|Period 3|Adverse Event|0|||
143037972|NCT01294787|515682736|FG003|Period 3|Adverse Event|0|||
143037973|NCT01294787|515682737|FG004|Period 3|Adverse Event|1|||
143037974|NCT01294787|515682738|FG005|Period 3|Adverse Event|0|||
143037975|NCT05376319|515682739|FG000|Overall Study|Funding termination|2|||
143037976|NCT05376319|515682740|FG001|Overall Study|Funding termination|4|||
143037977|NCT01948258|515682743|FG000|Overall Study|Pregnancy|41|||
143037978|NCT01948258|515682743|FG000|Overall Study|Did not complete by cut-off date|35|||
143239141|NCT02113982|516429799|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
143239142|NCT02113982|516429800|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
143239143|NCT02113982|516429801|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
143239144|NCT02113982|516429802|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
143037979|NCT01948258|515682743|FG000|Overall Study|Lost to Follow-up|27|||
143037980|NCT01948258|515682743|FG000|Overall Study|Withdrawal by SPD|8|||
143037981|NCT01948258|515682743|FG000|Overall Study|Withdrawal by Subject|6|||
143037982|NCT01948258|515682743|FG000|Overall Study|Health Care Professional|43|||
143037983|NCT01948258|515682743|FG000|Overall Study|Removed from statistical analysis|2|||
143037984|NCT01466166|515682747|FG000|Overall Study|Death|1|||
143037985|NCT01466166|515682747|FG000|Overall Study|Lost to Follow-up|7|||
143037986|NCT01466166|515682747|FG000|Overall Study|Infusion Reaction (IR)|27|||
143037987|NCT01466166|515682747|FG000|Overall Study|Adverse Event (Other than IR)|11|||
143037988|NCT01466166|515682747|FG000|Overall Study|Elevated Serum Uric Acid|78|||
143037989|NCT01466166|515682747|FG000|Overall Study|Withdrawal by Subject|13|||
143037990|NCT01466166|515682747|FG000|Overall Study|Sponsor Decision|4|||
143037991|NCT01466166|515682747|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
143037992|NCT01466166|515682747|FG000|Overall Study|Other|20|||
143037993|NCT01340495|515682754|FG000|Overall Study|Withdrawal by Subject|1|||
143037994|NCT00070291|515682755|FG000|Step 1|Withdrawal by Subject|1|||
143037995|NCT00070291|515682755|FG000|Step 1|Adverse Event|1|||
143037996|NCT00070291|515682755|FG000|Step 2|Adverse Event|1|||
143037997|NCT02262377|515682756|FG000|Overall Study|Lost to Follow-up|5|||
143037998|NCT02262377|515682757|FG001|Overall Study|Lost to Follow-up|6|||
143037999|NCT02262377|515682756|FG000|Overall Study|Found ineligible after enrollment|3|||
143038000|NCT02262377|515682757|FG001|Overall Study|Found ineligible after enrollment|0|||
143038001|NCT02262377|515682756|FG000|Overall Study|Withdrawal by Subject|4|||
143038002|NCT02262377|515682757|FG001|Overall Study|Withdrawal by Subject|0|||
143038003|NCT00520130|515682758|FG000|Overall Study|Disease progression on study|4|||
143038004|NCT00520130|515682759|FG001|Overall Study|Disease progression on study|0|||
143038005|NCT00520130|515682758|FG000|Overall Study|Physician Decision|1|||
143038006|NCT00520130|515682759|FG001|Overall Study|Physician Decision|1|||
143038007|NCT01591785|515682761|FG000|Overall Study|worsening condition|1|||
143038008|NCT01591785|515682762|FG001|Overall Study|worsening condition|2|||
143038009|NCT01591785|515682761|FG000|Overall Study|Protocol Violation|2|||
143038010|NCT01591785|515682762|FG001|Overall Study|Protocol Violation|0|||
143038011|NCT01591785|515682761|FG000|Overall Study|Lost to Follow-up|1|||
143038012|NCT01591785|515682762|FG001|Overall Study|Lost to Follow-up|0|||
143038013|NCT02495857|515682768|FG000|Overall Study|Adverse Event|5|||
143038014|NCT02495857|515682769|FG001|Overall Study|Adverse Event|0|||
143496348|NCT00667576|517359439|FG003|Overall Study|Withdrawal by Subject|1|||
143496349|NCT00667576|517359440|FG004|Overall Study|Withdrawal by Subject|1|||
143496350|NCT00667576|517359436|FG000|Overall Study|Adverse Event|1|||
143496351|NCT00667576|517359437|FG001|Overall Study|Adverse Event|1|||
143496352|NCT00667576|517359438|FG002|Overall Study|Adverse Event|0|||
143038015|NCT02495857|515682770|FG002|Overall Study|Adverse Event|1|||
143038016|NCT02495857|515682768|FG000|Overall Study|Withdrawal by Subject|9|||
143038017|NCT02495857|515682769|FG001|Overall Study|Withdrawal by Subject|6|||
143038018|NCT02495857|515682770|FG002|Overall Study|Withdrawal by Subject|10|||
143038019|NCT02495857|515682768|FG000|Overall Study|Physician Decision|0|||
143038020|NCT02495857|515682769|FG001|Overall Study|Physician Decision|1|||
143038021|NCT02495857|515682770|FG002|Overall Study|Physician Decision|0|||
143038022|NCT02495857|515682768|FG000|Overall Study|Protocol Violation|1|||
143038023|NCT02495857|515682769|FG001|Overall Study|Protocol Violation|1|||
143038024|NCT02495857|515682770|FG002|Overall Study|Protocol Violation|2|||
143038025|NCT02495857|515682768|FG000|Overall Study|Lost to Follow-up|4|||
143038026|NCT02495857|515682769|FG001|Overall Study|Lost to Follow-up|5|||
143038027|NCT02495857|515682770|FG002|Overall Study|Lost to Follow-up|3|||
143038028|NCT02495857|515682768|FG000|Overall Study|Other|3|||
143038029|NCT02495857|515682769|FG001|Overall Study|Other|3|||
143038030|NCT02495857|515682770|FG002|Overall Study|Other|2|||
143038031|NCT00396279|515682771|FG000|Overall Study|Ongoing in study|26|||
143038032|NCT00396279|515682771|FG000|Overall Study|Disease progression|2|||
143038033|NCT00396279|515682771|FG000|Overall Study|Withdrawal by Subject|1|||
143038034|NCT00396279|515682771|FG000|Overall Study|Physician Decision|1|||
143038035|NCT01882257|515682772|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
143038036|NCT01882257|515682773|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
143038037|NCT01882257|515682774|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
143038038|NCT01882257|515682772|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
143038039|NCT01882257|515682773|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
143038040|NCT01882257|515682774|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
143038041|NCT02724462|515682776|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
143038042|NCT02724462|515682777|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
143038043|NCT02724462|515682776|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
143038044|NCT02724462|515682777|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
143038045|NCT02724462|515682776|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
143038046|NCT02724462|515682777|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
143038047|NCT02724462|515682776|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
143038048|NCT02724462|515682777|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
143038049|NCT02724462|515682776|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
143038050|NCT02724462|515682777|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
143496353|NCT00667576|517359439|FG003|Overall Study|Adverse Event|0|||
143496354|NCT00667576|517359440|FG004|Overall Study|Adverse Event|0|||
143496355|NCT00667576|517359436|FG000|Overall Study|Lost to Follow-up|0|||
143038051|NCT02724462|515682776|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
143038052|NCT02724462|515682777|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
143038053|NCT01954394|515682778|FG000|Overall Study|Enrolled but not treated|1|||
143038054|NCT01954394|515682779|FG001|Overall Study|Enrolled but not treated|0|||
143038055|NCT01954394|515682778|FG000|Overall Study|Adverse Event|10|||
143038056|NCT01954394|515682779|FG001|Overall Study|Adverse Event|23|||
143038057|NCT01954394|515682778|FG000|Overall Study|Poor compliance to protocol|7|||
143038058|NCT01954394|515682779|FG001|Overall Study|Poor compliance to protocol|7|||
143038059|NCT01954394|515682778|FG000|Overall Study|Participant Moved|0|||
143496356|NCT00667576|517359437|FG001|Overall Study|Lost to Follow-up|0|||
143496357|NCT00667576|517359438|FG002|Overall Study|Lost to Follow-up|1|||
143496358|NCT00667576|517359439|FG003|Overall Study|Lost to Follow-up|0|||
143496359|NCT00667576|517359440|FG004|Overall Study|Lost to Follow-up|0|||
143496360|NCT00667576|517359436|FG000|Overall Study|Protocol Violation|0|||
143496361|NCT00667576|517359437|FG001|Overall Study|Protocol Violation|0|||
143496362|NCT00667576|517359438|FG002|Overall Study|Protocol Violation|0|||
143496363|NCT00667576|517359439|FG003|Overall Study|Protocol Violation|1|||
143496364|NCT00667576|517359440|FG004|Overall Study|Protocol Violation|0|||
143496365|NCT00667576|517359436|FG000|Overall Study|Physician Decision|0|||
143496366|NCT00667576|517359437|FG001|Overall Study|Physician Decision|0|||
143496367|NCT00667576|517359438|FG002|Overall Study|Physician Decision|0|||
143496368|NCT00667576|517359439|FG003|Overall Study|Physician Decision|1|||
143496369|NCT00667576|517359440|FG004|Overall Study|Physician Decision|0|||
143496370|NCT00667576|517359436|FG000|Overall Study|Missed Visit|0|||
143496371|NCT00667576|517359437|FG001|Overall Study|Missed Visit|0|||
143496372|NCT00667576|517359438|FG002|Overall Study|Missed Visit|0|||
143496373|NCT00667576|517359439|FG003|Overall Study|Missed Visit|1|||
143496374|NCT00667576|517359440|FG004|Overall Study|Missed Visit|0|||
143496375|NCT03968419|517359441|FG000|Treatment Period|Adverse Event|0|||
143496376|NCT03968419|517359442|FG001|Treatment Period|Adverse Event|0|||
143496377|NCT03968419|517359443|FG002|Treatment Period|Adverse Event|1|||
143496378|NCT03968419|517359441|FG000|Safety Follow-up Period|Death|3|||
143496379|NCT03968419|517359442|FG001|Safety Follow-up Period|Death|2|||
143496380|NCT03968419|517359443|FG002|Safety Follow-up Period|Death|1|||
143496381|NCT03968419|517359441|FG000|Safety Follow-up Period|Subject Decision|2|||
143496382|NCT03968419|517359442|FG001|Safety Follow-up Period|Subject Decision|1|||
143496383|NCT03968419|517359443|FG002|Safety Follow-up Period|Subject Decision|0|||
143496384|NCT01390389|517359444|FG000|Overall Study|Withdrawal by Subject|2|||
143496385|NCT01390389|517359445|FG001|Overall Study|Withdrawal by Subject|0|||
143496386|NCT01390389|517359444|FG000|Overall Study|Screen Fail|2|||
143496387|NCT01390389|517359445|FG001|Overall Study|Screen Fail|1|||
143496388|NCT03593915|517359446|FG000|Overall Study|Adverse Event|0|||
143496389|NCT03593915|517359447|FG001|Overall Study|Adverse Event|0|||
143496390|NCT03593915|517359448|FG002|Overall Study|Adverse Event|0|||
143496391|NCT03593915|517359449|FG003|Overall Study|Adverse Event|1|||
143496392|NCT03593915|517359450|FG004|Overall Study|Adverse Event|0|||
143496393|NCT03593915|517359451|FG005|Overall Study|Adverse Event|0|||
143496394|NCT03593915|517359446|FG000|Overall Study|Physician Decision|0|||
143496395|NCT03593915|517359447|FG001|Overall Study|Physician Decision|0|||
143496396|NCT03593915|517359448|FG002|Overall Study|Physician Decision|0|||
143496397|NCT03593915|517359449|FG003|Overall Study|Physician Decision|0|||
143496398|NCT03593915|517359450|FG004|Overall Study|Physician Decision|0|||
143496399|NCT03593915|517359451|FG005|Overall Study|Physician Decision|1|||
143496400|NCT01246206|517359452|FG000|Overall Study|Patient did not receive study regiments.|1|||
143038060|NCT01954394|515682779|FG001|Overall Study|Participant Moved|4|||
143038061|NCT01954394|515682778|FG000|Overall Study|Related to Study Drug administration|2|||
143496401|NCT02002975|517359453|FG000|Overall Study|Case Report Forms Uncollected|135|||
143496402|NCT02002975|517359453|FG000|Overall Study|Protocol Deviation|437|||
143496403|NCT04660643|517359454|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
143496404|NCT04660643|517359455|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
143496405|NCT04660643|517359456|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
143496406|NCT04660643|517359454|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
143496407|NCT04660643|517359455|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
143496408|NCT04660643|517359456|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
143496409|NCT04660643|517359454|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
143496410|NCT04660643|517359455|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
143496411|NCT04660643|517359456|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
143496412|NCT04660643|517359454|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
143496413|NCT04660643|517359455|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
143496414|NCT04660643|517359456|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
143496415|NCT04660643|517359454|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
143496416|NCT04660643|517359455|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
143496417|NCT04660643|517359456|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
143496418|NCT04660643|517359454|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
143038062|NCT01954394|515682779|FG001|Overall Study|Related to Study Drug administration|2|||
143038063|NCT01954394|515682778|FG000|Overall Study|Other than specified above|10|||
143038064|NCT01954394|515682779|FG001|Overall Study|Other than specified above|21|||
143038065|NCT00909610|515682780|FG000|Period: First Intervention|Adverse Event|0|||
143038066|NCT00909610|515682781|FG001|Period: First Intervention|Adverse Event|1|||
143038067|NCT00909610|515682780|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
143038068|NCT00909610|515682781|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
143038069|NCT00909610|515682780|FG000|Period: Second Intervention|Adverse Event|1|||
143038070|NCT00909610|515682781|FG001|Period: Second Intervention|Adverse Event|0|||
143038071|NCT00851877|515682796|FG000|Phase I-1|Death|1|||
143038072|NCT00851877|515682797|FG001|Phase I-1|Death|0|||
143038073|NCT00851877|515682798|FG002|Phase I-1|Death|0|||
143038074|NCT00851877|515682796|FG000|Phase II|Withdrawal by Subject|0|||
143038075|NCT00851877|515682797|FG001|Phase II|Withdrawal by Subject|0|||
143038076|NCT00851877|515682798|FG002|Phase II|Withdrawal by Subject|3|||
143038077|NCT00620074|515682799|FG000|Overall Study|Adverse Event|1|||
143038078|NCT00829673|515682800|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
143038079|NCT00829673|515682801|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
143038080|NCT04166630|515682803|FG000|Overall Study|Withdrawal by Subject|0|||
143038081|NCT04166630|515682804|FG001|Overall Study|Withdrawal by Subject|1|||
143038082|NCT03214952|515682807|FG000|Overall Study|Protocol Deviation|45|||
143038083|NCT03214952|515682807|FG000|Overall Study|Case Report Forms Uncollected|13|||
143038084|NCT00829790|515682808|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
143038085|NCT00829790|515682809|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
143038086|NCT03769896|515682810|FG000|Open-label Phase|Lack of Efficacy|5|||
143038087|NCT03769896|515682811|FG001|Open-label Phase|Lack of Efficacy|0|||
143038088|NCT03769896|515682810|FG000|Open-label Phase|Adverse Event|3|||
143038089|NCT03769896|515682811|FG001|Open-label Phase|Adverse Event|0|||
143038090|NCT03769896|515682810|FG000|Open-label Phase|Withdrawal by Subject|1|||
143038091|NCT03769896|515682811|FG001|Open-label Phase|Withdrawal by Subject|0|||
143496419|NCT04660643|517359455|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
143038092|NCT04112823|515682816|FG000|Overall Study|Lost to Follow-up|2|||
143038093|NCT04112823|515682817|FG001|Overall Study|Lost to Follow-up|3|||
143038094|NCT00625443|515682819|FG000|Overall Study|Adverse Event|1|||
143161685|NCT00281580|516137648|FG000|Overall Study|Protocol Violation|0|||
143161686|NCT00281580|516137649|FG001|Overall Study|Protocol Violation|0|||
143161687|NCT00281580|516137650|FG002|Overall Study|Protocol Violation|1|||
143161688|NCT00281580|516137651|FG003|Overall Study|Protocol Violation|1|||
143161689|NCT00281580|516137652|FG004|Overall Study|Protocol Violation|0|||
143161690|NCT00281580|516137653|FG005|Overall Study|Protocol Violation|0|||
143161691|NCT00281580|516137654|FG006|Overall Study|Protocol Violation|1|||
143161692|NCT00281580|516137655|FG007|Overall Study|Protocol Violation|0|||
143161693|NCT00281580|516137656|FG008|Overall Study|Protocol Violation|2|||
143161694|NCT00281580|516137657|FG009|Overall Study|Protocol Violation|0|||
143161695|NCT00281580|516137658|FG010|Overall Study|Protocol Violation|1|||
143161696|NCT00281580|516137659|FG011|Overall Study|Protocol Violation|2|||
143161697|NCT00281580|516137660|FG012|Overall Study|Protocol Violation|0|||
143161698|NCT00281580|516137661|FG013|Overall Study|Protocol Violation|1|||
143161699|NCT00281580|516137662|FG014|Overall Study|Protocol Violation|1|||
143161700|NCT00281580|516137663|FG015|Overall Study|Protocol Violation|3|||
143161701|NCT00281580|516137648|FG000|Overall Study|Withdrawal by Subject|3|||
143161702|NCT00281580|516137649|FG001|Overall Study|Withdrawal by Subject|0|||
143161703|NCT00281580|516137650|FG002|Overall Study|Withdrawal by Subject|1|||
143161704|NCT00281580|516137651|FG003|Overall Study|Withdrawal by Subject|1|||
143161705|NCT00281580|516137652|FG004|Overall Study|Withdrawal by Subject|1|||
143161706|NCT00281580|516137653|FG005|Overall Study|Withdrawal by Subject|2|||
143161707|NCT00281580|516137654|FG006|Overall Study|Withdrawal by Subject|2|||
143161708|NCT00281580|516137655|FG007|Overall Study|Withdrawal by Subject|0|||
143161709|NCT00281580|516137656|FG008|Overall Study|Withdrawal by Subject|1|||
143161710|NCT00281580|516137657|FG009|Overall Study|Withdrawal by Subject|4|||
143161711|NCT00281580|516137658|FG010|Overall Study|Withdrawal by Subject|1|||
143161712|NCT00281580|516137659|FG011|Overall Study|Withdrawal by Subject|1|||
143161713|NCT00281580|516137660|FG012|Overall Study|Withdrawal by Subject|2|||
143161714|NCT00281580|516137661|FG013|Overall Study|Withdrawal by Subject|2|||
143161715|NCT00281580|516137662|FG014|Overall Study|Withdrawal by Subject|1|||
143038095|NCT00625443|515682820|FG001|Overall Study|Adverse Event|4|||
143038096|NCT00625443|515682821|FG002|Overall Study|Adverse Event|0|||
143038097|NCT00625443|515682819|FG000|Overall Study|Non-compliance with protocol|0|||
143038098|NCT00625443|515682820|FG001|Overall Study|Non-compliance with protocol|1|||
143161716|NCT00281580|516137663|FG015|Overall Study|Withdrawal by Subject|5|||
143161717|NCT00281580|516137648|FG000|Overall Study|Lack of Efficacy|2|||
143161718|NCT00281580|516137649|FG001|Overall Study|Lack of Efficacy|1|||
143161719|NCT00281580|516137650|FG002|Overall Study|Lack of Efficacy|1|||
143496420|NCT04660643|517359456|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
143496421|NCT04660643|517359454|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
143496422|NCT04660643|517359455|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
143038099|NCT00625443|515682821|FG002|Overall Study|Non-compliance with protocol|0|||
143038100|NCT00625443|515682819|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
143038101|NCT00625443|515682820|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
143038102|NCT00625443|515682821|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
143038103|NCT00625443|515682819|FG000|Overall Study|Withdrawal by Subject|0|||
143038104|NCT00625443|515682820|FG001|Overall Study|Withdrawal by Subject|1|||
143038105|NCT00625443|515682821|FG002|Overall Study|Withdrawal by Subject|2|||
143038106|NCT00625443|515682819|FG000|Overall Study|Physician Decision|0|||
143038107|NCT00625443|515682820|FG001|Overall Study|Physician Decision|4|||
143038108|NCT00625443|515682821|FG002|Overall Study|Physician Decision|2|||
143038109|NCT00625443|515682819|FG000|Overall Study|Other|0|||
143038110|NCT00625443|515682820|FG001|Overall Study|Other|1|||
143038111|NCT00625443|515682821|FG002|Overall Study|Other|1|||
143038112|NCT02728102|515682822|FG000|Overall Study|Death|3|||
143038113|NCT02728102|515682823|FG001|Overall Study|Death|0|||
143038114|NCT02728102|515682824|FG002|Overall Study|Death|1|||
143038115|NCT02728102|515682822|FG000|Overall Study|Withdrawal by Subject|0|||
143038116|NCT02728102|515682823|FG001|Overall Study|Withdrawal by Subject|2|||
143038117|NCT02728102|515682824|FG002|Overall Study|Withdrawal by Subject|3|||
143038118|NCT02728102|515682822|FG000|Overall Study|Physician Decision|1|||
143496423|NCT04660643|517359456|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
143038119|NCT02728102|515682823|FG001|Overall Study|Physician Decision|1|||
143038120|NCT02728102|515682824|FG002|Overall Study|Physician Decision|0|||
143038121|NCT02728102|515682822|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
143038122|NCT02728102|515682823|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
143038123|NCT02728102|515682824|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
143038124|NCT02728102|515682822|FG000|Overall Study|Covid|0|||
143038125|NCT02728102|515682823|FG001|Overall Study|Covid|0|||
143038126|NCT02728102|515682824|FG002|Overall Study|Covid|1|||
143038127|NCT01182415|515682825|FG000|Overall Study|Lost to Follow-up|1|||
143038128|NCT00102440|515682826|FG000|Overall Study|Lost to Follow-up|25|||
143038129|NCT00102440|515682827|FG001|Overall Study|Lost to Follow-up|18|||
143038130|NCT00102440|515682828|FG002|Overall Study|Lost to Follow-up|21|||
143038131|NCT00102440|515682826|FG000|Overall Study|Adverse Event|16|||
143038132|NCT00102440|515682827|FG001|Overall Study|Adverse Event|23|||
143038133|NCT00102440|515682828|FG002|Overall Study|Adverse Event|8|||
143038134|NCT00102440|515682826|FG000|Overall Study|Gout Flare|10|||
143038135|NCT00102440|515682827|FG001|Overall Study|Gout Flare|28|||
143038136|NCT00102440|515682828|FG002|Overall Study|Gout Flare|9|||
143038137|NCT00102440|515682826|FG000|Overall Study|Personal Reason(s)|19|||
143038138|NCT00102440|515682827|FG001|Overall Study|Personal Reason(s)|13|||
143038139|NCT00102440|515682828|FG002|Overall Study|Personal Reason(s)|13|||
143038140|NCT00102440|515682826|FG000|Overall Study|Other|11|||
143038141|NCT00102440|515682827|FG001|Overall Study|Other|14|||
143038142|NCT00102440|515682828|FG002|Overall Study|Other|14|||
143038143|NCT00102440|515682826|FG000|Overall Study|Protocol Violation|7|||
143038144|NCT00102440|515682827|FG001|Overall Study|Protocol Violation|2|||
143038145|NCT00102440|515682828|FG002|Overall Study|Protocol Violation|1|||
143038146|NCT00772941|515682829|FG000|Overall Study|CRFs not available|195|||
143038147|NCT00772941|515682829|FG000|Overall Study|Study not completed|16|||
143038148|NCT00772941|515682829|FG000|Overall Study|Missed Visits|374|||
143038149|NCT00772941|515682829|FG000|Overall Study|Poor Compliance|7|||
143038150|NCT00772941|515682829|FG000|Overall Study|GPSP Violation|90|||
143038151|NCT01745120|515682830|FG000|Overall Study|Investigator decision|1|||
143038152|NCT01745120|515682831|FG001|Overall Study|Investigator decision|0|||
143038153|NCT01702987|515682832|FG000|Overall Study|Withdrawal by Subject|1|||
143038154|NCT01702987|515682833|FG001|Overall Study|Withdrawal by Subject|0|||
143038155|NCT01675765|515682834|FG000|Overall Study|Progressive disease|4|||
143038156|NCT01675765|515682835|FG001|Overall Study|Progressive disease|4|||
143038157|NCT01675765|515682834|FG000|Overall Study|Adverse Event|1|||
143038158|NCT01675765|515682835|FG001|Overall Study|Adverse Event|2|||
143038159|NCT01675765|515682834|FG000|Overall Study|Withdrawal by Subject|2|||
143038160|NCT01675765|515682835|FG001|Overall Study|Withdrawal by Subject|0|||
143038161|NCT01675765|515682834|FG000|Overall Study|Death|1|||
143038162|NCT01675765|515682835|FG001|Overall Study|Death|0|||
143038163|NCT01675765|515682834|FG000|Overall Study|Clinical progression|3|||
143038164|NCT01675765|515682835|FG001|Overall Study|Clinical progression|2|||
143038165|NCT03965091|515682836|FG000|Overall Study|Adverse Event|0|||
143038166|NCT03965091|515682837|FG001|Overall Study|Adverse Event|2|||
143496424|NCT04660643|517359454|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
143038167|NCT03965091|515682838|FG002|Overall Study|Adverse Event|3|||
143038168|NCT03965091|515682836|FG000|Overall Study|Withdrawal by Subject|11|||
143038169|NCT03965091|515682837|FG001|Overall Study|Withdrawal by Subject|3|||
143038170|NCT03965091|515682838|FG002|Overall Study|Withdrawal by Subject|5|||
143038171|NCT03965091|515682836|FG000|Overall Study|Non-compliance with study drug|0|||
143161720|NCT00281580|516137651|FG003|Overall Study|Lack of Efficacy|6|||
143496425|NCT04660643|517359455|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
143496426|NCT04660643|517359456|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
143496427|NCT04660643|517359454|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
143496428|NCT04660643|517359455|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
143496429|NCT04660643|517359456|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
143496430|NCT04660643|517359454|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
143496431|NCT04660643|517359455|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
143496432|NCT04660643|517359456|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
143496433|NCT04660643|517359454|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
143496434|NCT04660643|517359455|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
143496435|NCT04660643|517359456|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
143496436|NCT04660643|517359454|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
143496437|NCT04660643|517359455|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
143496438|NCT04660643|517359456|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
143496439|NCT04660643|517359454|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
143496440|NCT04660643|517359455|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
143496441|NCT04660643|517359456|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
143496442|NCT04660643|517359454|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
143496443|NCT04660643|517359455|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
143496444|NCT04660643|517359456|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
143496445|NCT04660643|517359454|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
143496446|NCT04660643|517359455|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
143496447|NCT04660643|517359456|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
143496448|NCT04660643|517359454|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
143496449|NCT04660643|517359455|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
143496450|NCT04660643|517359456|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
143496451|NCT01430442|517359459|FG000|Overall Study|Subject Withdrew Consent|3|||
143496452|NCT01430442|517359460|FG001|Overall Study|Subject Withdrew Consent|0|||
143496453|NCT01430442|517359461|FG002|Overall Study|Subject Withdrew Consent|1|||
143496454|NCT01430442|517359462|FG003|Overall Study|Subject Withdrew Consent|0|||
143496455|NCT01430442|517359463|FG004|Overall Study|Subject Withdrew Consent|2|||
143496456|NCT01430442|517359464|FG005|Overall Study|Subject Withdrew Consent|1|||
143496457|NCT01430442|517359465|FG006|Overall Study|Subject Withdrew Consent|5|||
143496458|NCT01430442|517359466|FG007|Overall Study|Subject Withdrew Consent|2|||
143496459|NCT01430442|517359459|FG000|Overall Study|Lost to Follow-up|2|||
143161721|NCT00281580|516137652|FG004|Overall Study|Lack of Efficacy|2|||
143161722|NCT00281580|516137653|FG005|Overall Study|Lack of Efficacy|0|||
143161723|NCT00281580|516137654|FG006|Overall Study|Lack of Efficacy|0|||
143161724|NCT00281580|516137655|FG007|Overall Study|Lack of Efficacy|0|||
143161725|NCT00281580|516137656|FG008|Overall Study|Lack of Efficacy|0|||
143161726|NCT00281580|516137657|FG009|Overall Study|Lack of Efficacy|0|||
143161727|NCT00281580|516137658|FG010|Overall Study|Lack of Efficacy|0|||
143161728|NCT00281580|516137659|FG011|Overall Study|Lack of Efficacy|1|||
143161729|NCT00281580|516137660|FG012|Overall Study|Lack of Efficacy|0|||
143161730|NCT00281580|516137661|FG013|Overall Study|Lack of Efficacy|2|||
143161731|NCT00281580|516137662|FG014|Overall Study|Lack of Efficacy|1|||
143161732|NCT00281580|516137663|FG015|Overall Study|Lack of Efficacy|0|||
143161733|NCT00281580|516137648|FG000|Overall Study|Lost to Follow-up|0|||
143161734|NCT00281580|516137649|FG001|Overall Study|Lost to Follow-up|0|||
143161735|NCT00281580|516137650|FG002|Overall Study|Lost to Follow-up|0|||
143161736|NCT00281580|516137651|FG003|Overall Study|Lost to Follow-up|3|||
143161737|NCT00281580|516137652|FG004|Overall Study|Lost to Follow-up|0|||
143161738|NCT00281580|516137653|FG005|Overall Study|Lost to Follow-up|1|||
143161739|NCT00281580|516137654|FG006|Overall Study|Lost to Follow-up|0|||
143161740|NCT00281580|516137655|FG007|Overall Study|Lost to Follow-up|1|||
143161741|NCT00281580|516137656|FG008|Overall Study|Lost to Follow-up|2|||
143161742|NCT00281580|516137657|FG009|Overall Study|Lost to Follow-up|1|||
143161743|NCT00281580|516137658|FG010|Overall Study|Lost to Follow-up|1|||
143161744|NCT00281580|516137659|FG011|Overall Study|Lost to Follow-up|0|||
143161745|NCT00281580|516137660|FG012|Overall Study|Lost to Follow-up|1|||
143161746|NCT00281580|516137661|FG013|Overall Study|Lost to Follow-up|0|||
143161747|NCT00281580|516137662|FG014|Overall Study|Lost to Follow-up|0|||
143161748|NCT00281580|516137663|FG015|Overall Study|Lost to Follow-up|0|||
143161749|NCT00281580|516137648|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
143161750|NCT00281580|516137649|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
143161751|NCT00281580|516137650|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
143161752|NCT00281580|516137651|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
143161753|NCT00281580|516137652|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
143161754|NCT00281580|516137653|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
143161755|NCT00281580|516137654|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
143496460|NCT01430442|517359460|FG001|Overall Study|Lost to Follow-up|0|||
143496461|NCT01430442|517359461|FG002|Overall Study|Lost to Follow-up|1|||
143496462|NCT01430442|517359462|FG003|Overall Study|Lost to Follow-up|2|||
143496463|NCT01430442|517359463|FG004|Overall Study|Lost to Follow-up|2|||
143496464|NCT01430442|517359464|FG005|Overall Study|Lost to Follow-up|1|||
143496465|NCT01430442|517359465|FG006|Overall Study|Lost to Follow-up|5|||
143496466|NCT01430442|517359466|FG007|Overall Study|Lost to Follow-up|1|||
143496467|NCT01430442|517359459|FG000|Overall Study|Pregnancy|1|||
143496468|NCT01430442|517359460|FG001|Overall Study|Pregnancy|0|||
143496469|NCT01430442|517359461|FG002|Overall Study|Pregnancy|0|||
143496470|NCT01430442|517359462|FG003|Overall Study|Pregnancy|0|||
143496471|NCT01430442|517359463|FG004|Overall Study|Pregnancy|0|||
143496472|NCT01430442|517359464|FG005|Overall Study|Pregnancy|1|||
143496473|NCT01430442|517359465|FG006|Overall Study|Pregnancy|0|||
143496474|NCT01430442|517359466|FG007|Overall Study|Pregnancy|0|||
143496475|NCT01430442|517359459|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
143496476|NCT01430442|517359460|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
143496477|NCT01430442|517359461|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
143496478|NCT01430442|517359462|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
143496479|NCT01430442|517359463|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
143496480|NCT01430442|517359464|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
143496481|NCT01430442|517359465|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
143496482|NCT01430442|517359466|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
143496483|NCT00167245|517359471|FG000|Overall Study|Lost to Follow-up|20|||
143496484|NCT00167245|517359472|FG001|Overall Study|Lost to Follow-up|31|||
143496485|NCT00167245|517359471|FG000|Overall Study|Withdrawal by Subject|5|||
143496486|NCT00167245|517359472|FG001|Overall Study|Withdrawal by Subject|8|||
143496487|NCT00167245|517359471|FG000|Overall Study|Incarcerated|3|||
143496488|NCT00167245|517359472|FG001|Overall Study|Incarcerated|2|||
143496489|NCT00167245|517359471|FG000|Overall Study|Drowsy|1|||
143496490|NCT00167245|517359472|FG001|Overall Study|Drowsy|0|||
143496491|NCT01871090|517359475|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
143496492|NCT01871090|517359476|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
143496493|NCT01871090|517359475|FG000|Overall Study|Interrogation not completed correctly|1|||
143496494|NCT01871090|517359476|FG001|Overall Study|Interrogation not completed correctly|0|||
143496495|NCT01871090|517359475|FG000|Overall Study|Subject Non-Compliance|0|||
143496496|NCT01871090|517359476|FG001|Overall Study|Subject Non-Compliance|1|||
143496497|NCT01231555|517359477|FG000|Overall Study|Study terminated|8|||
143496498|NCT01231555|517359478|FG001|Overall Study|Study terminated|5|||
143496499|NCT01231555|517359479|FG002|Overall Study|Study terminated|8|||
143496500|NCT01231555|517359477|FG000|Overall Study|Withdrawal by Subject|0|||
143496501|NCT01231555|517359478|FG001|Overall Study|Withdrawal by Subject|2|||
143496502|NCT01231555|517359479|FG002|Overall Study|Withdrawal by Subject|0|||
143496503|NCT01773421|517359480|FG000|Treatment Phase|Other|0|||
143496504|NCT01773421|517359481|FG001|Treatment Phase|Other|0|||
143496505|NCT01773421|517359482|FG002|Treatment Phase|Other|2|||
143038172|NCT03965091|515682837|FG001|Overall Study|Non-compliance with study drug|0|||
143038173|NCT03965091|515682838|FG002|Overall Study|Non-compliance with study drug|1|||
143038174|NCT03965091|515682836|FG000|Overall Study|Lost to Follow-up|1|||
143038175|NCT03965091|515682837|FG001|Overall Study|Lost to Follow-up|1|||
143038176|NCT03965091|515682838|FG002|Overall Study|Lost to Follow-up|1|||
143038177|NCT03965091|515682836|FG000|Overall Study|Lack of Efficacy|2|||
143038178|NCT03965091|515682837|FG001|Overall Study|Lack of Efficacy|0|||
143038179|NCT03965091|515682838|FG002|Overall Study|Lack of Efficacy|0|||
143038180|NCT03965091|515682836|FG000|Overall Study|Other than specified|9|||
143038181|NCT03965091|515682837|FG001|Overall Study|Other than specified|11|||
143038182|NCT03965091|515682838|FG002|Overall Study|Other than specified|8|||
143038183|NCT01185821|515682842|FG000|Overall Study|Abnormal laboratory value(s)|1|||
143038184|NCT01185821|515682843|FG001|Overall Study|Abnormal laboratory value(s)|2|||
143038185|NCT01185821|515682844|FG002|Overall Study|Abnormal laboratory value(s)|1|||
143161756|NCT00281580|516137655|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
143161757|NCT00281580|516137656|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
143161758|NCT00281580|516137657|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
143161759|NCT00281580|516137658|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
143496506|NCT01773421|517359483|FG003|Treatment Phase|Other|0|||
143496507|NCT01773421|517359484|FG004|Treatment Phase|Other|0|||
143496508|NCT01773421|517359485|FG005|Treatment Phase|Other|0|||
143496509|NCT01773421|517359486|FG006|Treatment Phase|Other|0|||
143038186|NCT01185821|515682845|FG003|Overall Study|Abnormal laboratory value(s)|0|||
143496510|NCT01773421|517359480|FG000|Treatment Phase|Adverse Event|0|||
143496511|NCT01773421|517359481|FG001|Treatment Phase|Adverse Event|0|||
143496512|NCT01773421|517359482|FG002|Treatment Phase|Adverse Event|3|||
143496513|NCT01773421|517359483|FG003|Treatment Phase|Adverse Event|1|||
143496514|NCT01773421|517359484|FG004|Treatment Phase|Adverse Event|0|||
143038187|NCT01185821|515682846|FG004|Overall Study|Abnormal laboratory value(s)|0|||
143496515|NCT01773421|517359485|FG005|Treatment Phase|Adverse Event|0|||
143496516|NCT01773421|517359486|FG006|Treatment Phase|Adverse Event|0|||
143496517|NCT01773421|517359480|FG000|Treatment Phase|Withdrawal by Subject|0|||
143496518|NCT01773421|517359481|FG001|Treatment Phase|Withdrawal by Subject|0|||
143496519|NCT01773421|517359482|FG002|Treatment Phase|Withdrawal by Subject|1|||
143496520|NCT01773421|517359483|FG003|Treatment Phase|Withdrawal by Subject|1|||
143496521|NCT01773421|517359484|FG004|Treatment Phase|Withdrawal by Subject|0|||
143496522|NCT01773421|517359485|FG005|Treatment Phase|Withdrawal by Subject|0|||
143496523|NCT01773421|517359486|FG006|Treatment Phase|Withdrawal by Subject|0|||
143496524|NCT01773421|517359480|FG000|Extension Phase|Other|0|||
143496525|NCT01773421|517359481|FG001|Extension Phase|Other|0|||
143496526|NCT01773421|517359482|FG002|Extension Phase|Other|0|||
143496527|NCT01773421|517359483|FG003|Extension Phase|Other|0|||
143496528|NCT01773421|517359484|FG004|Extension Phase|Other|1|||
143496529|NCT01773421|517359485|FG005|Extension Phase|Other|2|||
143496530|NCT01773421|517359486|FG006|Extension Phase|Other|0|||
143496531|NCT01773421|517359480|FG000|Extension Phase|Adverse Event|0|||
143496532|NCT01773421|517359481|FG001|Extension Phase|Adverse Event|0|||
143496533|NCT01773421|517359482|FG002|Extension Phase|Adverse Event|0|||
143496534|NCT01773421|517359483|FG003|Extension Phase|Adverse Event|0|||
143496535|NCT01773421|517359484|FG004|Extension Phase|Adverse Event|2|||
143496536|NCT01773421|517359485|FG005|Extension Phase|Adverse Event|0|||
143496537|NCT01773421|517359486|FG006|Extension Phase|Adverse Event|0|||
143496538|NCT00688909|517359487|FG000|Overall Study|Adverse Event|28|||
143496539|NCT00688909|517359487|FG000|Overall Study|Patient withdrew consent|2|||
143496540|NCT00688909|517359487|FG000|Overall Study|Administrative problems|1|||
143496541|NCT00688909|517359487|FG000|Overall Study|Protocol Violation|2|||
143038188|NCT01185821|515682842|FG000|Overall Study|Protocol Violation|0|||
143038189|NCT01185821|515682843|FG001|Overall Study|Protocol Violation|0|||
143038190|NCT01185821|515682844|FG002|Overall Study|Protocol Violation|0|||
143038191|NCT01185821|515682845|FG003|Overall Study|Protocol Violation|1|||
143038192|NCT01185821|515682846|FG004|Overall Study|Protocol Violation|1|||
143038193|NCT01185821|515682842|FG000|Overall Study|Abnormal test procedure result|0|||
143038194|NCT01185821|515682843|FG001|Overall Study|Abnormal test procedure result|0|||
143038195|NCT01185821|515682844|FG002|Overall Study|Abnormal test procedure result|0|||
143038196|NCT01185821|515682845|FG003|Overall Study|Abnormal test procedure result|0|||
143038197|NCT01185821|515682846|FG004|Overall Study|Abnormal test procedure result|1|||
143038198|NCT01185821|515682842|FG000|Overall Study|Death|0|||
143038199|NCT01185821|515682843|FG001|Overall Study|Death|1|||
143038200|NCT01185821|515682844|FG002|Overall Study|Death|0|||
143038201|NCT01185821|515682845|FG003|Overall Study|Death|0|||
143038202|NCT01185821|515682846|FG004|Overall Study|Death|0|||
143038203|NCT01185821|515682842|FG000|Overall Study|Condition no longer required study drug|0|||
143161760|NCT00281580|516137659|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
143161761|NCT00281580|516137660|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
143161762|NCT00281580|516137661|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
143161763|NCT00281580|516137662|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
143161764|NCT00281580|516137663|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
143161765|NCT02771145|516137668|FG000|Overall Study|Adverse Event|3|||
143161766|NCT02771145|516137668|FG000|Overall Study|Lost to Follow-up|1|||
143161767|NCT04135352|516137670|FG000|Overall Study|Not treated-randomization error|0|||
143161768|NCT04135352|516137671|FG001|Overall Study|Not treated-randomization error|0|||
143161769|NCT04135352|516137672|FG002|Overall Study|Not treated-randomization error|1|||
143161770|NCT04135352|516137673|FG003|Overall Study|Not treated-randomization error|0|||
143161771|NCT04135352|516137674|FG004|Overall Study|Not treated-randomization error|0|||
143161772|NCT04135352|516137675|FG005|Overall Study|Not treated-randomization error|0|||
143161773|NCT04135352|516137676|FG006|Overall Study|Not treated-randomization error|0|||
143161774|NCT04135352|516137677|FG007|Overall Study|Not treated-randomization error|0|||
143161775|NCT04135352|516137670|FG000|Overall Study|Withdrawal by Subject|0|||
143161776|NCT04135352|516137671|FG001|Overall Study|Withdrawal by Subject|0|||
143161777|NCT04135352|516137672|FG002|Overall Study|Withdrawal by Subject|2|||
143161778|NCT04135352|516137673|FG003|Overall Study|Withdrawal by Subject|0|||
143161779|NCT04135352|516137674|FG004|Overall Study|Withdrawal by Subject|0|||
143161780|NCT04135352|516137675|FG005|Overall Study|Withdrawal by Subject|0|||
143161781|NCT04135352|516137676|FG006|Overall Study|Withdrawal by Subject|0|||
143161782|NCT04135352|516137677|FG007|Overall Study|Withdrawal by Subject|0|||
143161783|NCT04135352|516137670|FG000|Overall Study|Sponsor Decision|0|||
143496542|NCT00669617|517359491|FG000|Period 1|Withdrawal by Subject|0|||
143038204|NCT01185821|515682843|FG001|Overall Study|Condition no longer required study drug|0|||
143161784|NCT04135352|516137671|FG001|Overall Study|Sponsor Decision|0|||
143161785|NCT04135352|516137672|FG002|Overall Study|Sponsor Decision|2|||
143496543|NCT00669617|517359492|FG001|Period 1|Withdrawal by Subject|0|||
143496544|NCT00669617|517359493|FG002|Period 1|Withdrawal by Subject|1|||
143496545|NCT00669617|517359494|FG003|Period 1|Withdrawal by Subject|0|||
143496546|NCT00669617|517359495|FG004|Period 1|Withdrawal by Subject|0|||
143496547|NCT00669617|517359491|FG000|Period 1|Protocol Deviation|0|||
143161786|NCT04135352|516137673|FG003|Overall Study|Sponsor Decision|5|||
143496548|NCT00669617|517359492|FG001|Period 1|Protocol Deviation|0|||
143496549|NCT00669617|517359493|FG002|Period 1|Protocol Deviation|0|||
143038205|NCT01185821|515682844|FG002|Overall Study|Condition no longer required study drug|0|||
143038206|NCT01185821|515682845|FG003|Overall Study|Condition no longer required study drug|0|||
143038207|NCT01185821|515682846|FG004|Overall Study|Condition no longer required study drug|1|||
143038208|NCT01185821|515682842|FG000|Overall Study|Adverse Event|2|||
143038209|NCT01185821|515682843|FG001|Overall Study|Adverse Event|3|||
143038210|NCT01185821|515682844|FG002|Overall Study|Adverse Event|1|||
143038211|NCT01185821|515682845|FG003|Overall Study|Adverse Event|2|||
143038212|NCT01185821|515682846|FG004|Overall Study|Adverse Event|5|||
143038213|NCT01185821|515682842|FG000|Overall Study|Lack of Efficacy|0|||
143038214|NCT01185821|515682843|FG001|Overall Study|Lack of Efficacy|0|||
143038215|NCT01185821|515682844|FG002|Overall Study|Lack of Efficacy|3|||
143038216|NCT01185821|515682845|FG003|Overall Study|Lack of Efficacy|0|||
143038217|NCT01185821|515682846|FG004|Overall Study|Lack of Efficacy|9|||
143038218|NCT01185821|515682842|FG000|Overall Study|Withdrawal by Subject|3|||
143038219|NCT01185821|515682843|FG001|Overall Study|Withdrawal by Subject|2|||
143038220|NCT01185821|515682844|FG002|Overall Study|Withdrawal by Subject|2|||
143038221|NCT01185821|515682845|FG003|Overall Study|Withdrawal by Subject|1|||
143038222|NCT01185821|515682846|FG004|Overall Study|Withdrawal by Subject|3|||
143038223|NCT01185821|515682842|FG000|Overall Study|Lost to Follow-up|1|||
143038224|NCT01185821|515682843|FG001|Overall Study|Lost to Follow-up|1|||
143038225|NCT01185821|515682844|FG002|Overall Study|Lost to Follow-up|2|||
143038226|NCT01185821|515682845|FG003|Overall Study|Lost to Follow-up|1|||
143038227|NCT01185821|515682846|FG004|Overall Study|Lost to Follow-up|2|||
143038228|NCT01185821|515682842|FG000|Overall Study|Administrative problems|0|||
143161787|NCT04135352|516137674|FG004|Overall Study|Sponsor Decision|1|||
143161788|NCT04135352|516137675|FG005|Overall Study|Sponsor Decision|4|||
143161789|NCT04135352|516137676|FG006|Overall Study|Sponsor Decision|0|||
143161790|NCT04135352|516137677|FG007|Overall Study|Sponsor Decision|0|||
143161791|NCT04135352|516137670|FG000|Overall Study|Physician Decision|0|||
143161792|NCT04135352|516137671|FG001|Overall Study|Physician Decision|0|||
143161793|NCT04135352|516137672|FG002|Overall Study|Physician Decision|1|||
143161794|NCT04135352|516137673|FG003|Overall Study|Physician Decision|0|||
143161795|NCT04135352|516137674|FG004|Overall Study|Physician Decision|1|||
143161796|NCT04135352|516137675|FG005|Overall Study|Physician Decision|0|||
143161797|NCT04135352|516137676|FG006|Overall Study|Physician Decision|0|||
143161798|NCT04135352|516137677|FG007|Overall Study|Physician Decision|0|||
143161799|NCT04135352|516137670|FG000|Overall Study|Death|3|||
143161800|NCT04135352|516137671|FG001|Overall Study|Death|4|||
143161801|NCT04135352|516137672|FG002|Overall Study|Death|7|||
143161802|NCT04135352|516137673|FG003|Overall Study|Death|0|||
143161803|NCT04135352|516137674|FG004|Overall Study|Death|3|||
143161804|NCT04135352|516137675|FG005|Overall Study|Death|1|||
143161805|NCT04135352|516137676|FG006|Overall Study|Death|0|||
143161806|NCT04135352|516137677|FG007|Overall Study|Death|0|||
143161807|NCT01260311|516137682|FG000|Overall Study|Adverse Event|11|||
143161808|NCT01260311|516137682|FG000|Overall Study|Lack of Efficacy|4|||
143161809|NCT01260311|516137682|FG000|Overall Study|Lost to Follow-up|25|||
143161810|NCT01260311|516137682|FG000|Overall Study|Withdrawal by Subject|6|||
143161811|NCT01260311|516137682|FG000|Overall Study|Financial Constraints|77|||
143161812|NCT01260311|516137682|FG000|Overall Study|Gone to Province|2|||
143161813|NCT01260311|516137682|FG000|Overall Study|Medication Stopped|1|||
143161814|NCT01260311|516137682|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
143161815|NCT01714063|516137685|FG000|Overall Study|Equipment malfunction|2|||
143161816|NCT03878602|516137686|FG000|Overall Study|cord blood donation|7|||
143161817|NCT03878602|516137687|FG001|Overall Study|cord blood donation|1|||
143161818|NCT03878602|516137686|FG000|Overall Study|incomplete data collection|2|||
143161819|NCT03878602|516137687|FG001|Overall Study|incomplete data collection|0|||
143161820|NCT00066170|516137688|FG000|Overall Study|Adverse Event|2|||
143161821|NCT00066170|516137689|FG001|Overall Study|Adverse Event|4|||
143161822|NCT00066170|516137690|FG002|Overall Study|Adverse Event|1|||
143161823|NCT00066170|516137691|FG003|Overall Study|Adverse Event|7|||
143161824|NCT00066170|516137688|FG000|Overall Study|Serious Adverse Event|0|||
143161825|NCT00066170|516137689|FG001|Overall Study|Serious Adverse Event|0|||
143161826|NCT00066170|516137690|FG002|Overall Study|Serious Adverse Event|1|||
143161827|NCT00066170|516137691|FG003|Overall Study|Serious Adverse Event|1|||
143038229|NCT01185821|515682843|FG001|Overall Study|Administrative problems|0|||
143038230|NCT01185821|515682844|FG002|Overall Study|Administrative problems|1|||
143038231|NCT01185821|515682845|FG003|Overall Study|Administrative problems|1|||
143038232|NCT01185821|515682846|FG004|Overall Study|Administrative problems|2|||
143038233|NCT01534520|515682847|FG000|Overall Study|Adverse Event|0|||
143038234|NCT01534520|515682848|FG001|Overall Study|Adverse Event|1|||
143038235|NCT01059903|515682857|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
143038236|NCT01059903|515682858|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
143161828|NCT00066170|516137688|FG000|Overall Study|Lost to Follow-up|0|||
143161829|NCT00066170|516137689|FG001|Overall Study|Lost to Follow-up|1|||
143161830|NCT00066170|516137690|FG002|Overall Study|Lost to Follow-up|0|||
143161831|NCT00066170|516137691|FG003|Overall Study|Lost to Follow-up|0|||
143161832|NCT00066170|516137688|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
143161833|NCT00066170|516137689|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
143496550|NCT00669617|517359494|FG003|Period 1|Protocol Deviation|0|||
143496551|NCT00669617|517359495|FG004|Period 1|Protocol Deviation|1|||
143496552|NCT00669617|517359491|FG000|Period 3|Lost to Follow-up|1|||
143496553|NCT00669617|517359492|FG001|Period 3|Lost to Follow-up|0|||
143496554|NCT00669617|517359493|FG002|Period 3|Lost to Follow-up|0|||
143496555|NCT00669617|517359494|FG003|Period 3|Lost to Follow-up|0|||
143496556|NCT00669617|517359495|FG004|Period 3|Lost to Follow-up|0|||
143038237|NCT00385593|515682859|FG000|Overall Study|Adverse Event|3|||
143038238|NCT00385593|515682860|FG001|Overall Study|Adverse Event|2|||
143038239|NCT00385593|515682859|FG000|Overall Study|Withdrawal by Subject|17|||
143038240|NCT00385593|515682860|FG001|Overall Study|Withdrawal by Subject|7|||
143038241|NCT00385593|515682859|FG000|Overall Study|Lost to Follow-up|12|||
143038242|NCT00385593|515682860|FG001|Overall Study|Lost to Follow-up|8|||
143038243|NCT00385593|515682859|FG000|Overall Study|Protocol Violation|7|||
143038244|NCT00385593|515682860|FG001|Overall Study|Protocol Violation|4|||
143038245|NCT00385593|515682859|FG000|Overall Study|Several reasons|17|||
143038246|NCT00385593|515682860|FG001|Overall Study|Several reasons|15|||
143038247|NCT00385593|515682859|FG000|Overall Study|Incorrect inclusion|2|||
143038248|NCT00385593|515682860|FG001|Overall Study|Incorrect inclusion|0|||
143038249|NCT00385593|515682859|FG000|Overall Study|Incorrect randomization|0|||
143038250|NCT00385593|515682860|FG001|Overall Study|Incorrect randomization|1|||
143038251|NCT03725605|515682861|FG000|Overall Study|Unsuccessful TIL expansion|2|||
143038252|NCT03555305|515682862|FG000|Period 1|Physician Decision|0|||
143038253|NCT03555305|515682863|FG001|Period 1|Physician Decision|1|||
143038254|NCT03555305|515682862|FG000|Period 1|Adverse Event|0|||
143038255|NCT03555305|515682863|FG001|Period 1|Adverse Event|1|||
143038256|NCT03586726|515682871|FG000|Overall Study|Withdrawal by Subject|1|||
143038257|NCT03135834|515682872|FG000|Stage 1|Adverse Event|1|||
143038258|NCT03135834|515682873|FG001|Stage 1|Adverse Event|2|||
143038259|NCT03135834|515682874|FG002|Stage 1|Adverse Event|2|||
143038260|NCT03135834|515682875|FG003|Stage 1|Adverse Event|1|||
143038261|NCT03135834|515682872|FG000|Stage 1|Death|1|||
143038262|NCT03135834|515682873|FG001|Stage 1|Death|0|||
143038263|NCT03135834|515682874|FG002|Stage 1|Death|0|||
143038264|NCT03135834|515682875|FG003|Stage 1|Death|0|||
143038265|NCT03135834|515682872|FG000|Stage 1|Lost to Follow-up|17|||
143038266|NCT03135834|515682873|FG001|Stage 1|Lost to Follow-up|24|||
143038267|NCT03135834|515682874|FG002|Stage 1|Lost to Follow-up|21|||
143038268|NCT03135834|515682875|FG003|Stage 1|Lost to Follow-up|38|||
143038269|NCT03135834|515682872|FG000|Stage 1|No longer met eligibility criteria|1|||
143038270|NCT03135834|515682873|FG001|Stage 1|No longer met eligibility criteria|6|||
143038271|NCT03135834|515682874|FG002|Stage 1|No longer met eligibility criteria|2|||
143038272|NCT03135834|515682875|FG003|Stage 1|No longer met eligibility criteria|5|||
143038273|NCT03135834|515682872|FG000|Stage 1|Other|0|||
143038274|NCT03135834|515682873|FG001|Stage 1|Other|2|||
143038275|NCT03135834|515682874|FG002|Stage 1|Other|1|||
143038276|NCT03135834|515682875|FG003|Stage 1|Other|0|||
143038277|NCT03135834|515682872|FG000|Stage 1|Physician Decision|0|||
143038278|NCT03135834|515682873|FG001|Stage 1|Physician Decision|1|||
143038279|NCT03135834|515682874|FG002|Stage 1|Physician Decision|0|||
143038280|NCT03135834|515682875|FG003|Stage 1|Physician Decision|0|||
143038281|NCT03135834|515682872|FG000|Stage 1|Pregnancy|0|||
143038282|NCT03135834|515682873|FG001|Stage 1|Pregnancy|4|||
143038283|NCT03135834|515682874|FG002|Stage 1|Pregnancy|2|||
143038284|NCT03135834|515682875|FG003|Stage 1|Pregnancy|4|||
143038285|NCT03135834|515682872|FG000|Stage 1|Protocol Violation|1|||
143038286|NCT03135834|515682873|FG001|Stage 1|Protocol Violation|1|||
143038287|NCT03135834|515682874|FG002|Stage 1|Protocol Violation|2|||
143038288|NCT03135834|515682875|FG003|Stage 1|Protocol Violation|1|||
143038289|NCT03135834|515682872|FG000|Stage 1|Withdrawal by parent/guardian|2|||
143038290|NCT03135834|515682873|FG001|Stage 1|Withdrawal by parent/guardian|10|||
143038291|NCT03135834|515682874|FG002|Stage 1|Withdrawal by parent/guardian|2|||
143038292|NCT03135834|515682875|FG003|Stage 1|Withdrawal by parent/guardian|1|||
143496557|NCT00623831|517359496|FG000|Overall Study|Withdrawal by Subject|1|||
143496558|NCT00623831|517359497|FG001|Overall Study|Withdrawal by Subject|0|||
143496559|NCT00623831|517359496|FG000|Overall Study|Progressive Disease|0|||
143496560|NCT00623831|517359497|FG001|Overall Study|Progressive Disease|1|||
143038293|NCT03135834|515682872|FG000|Stage 1|Withdrawal by Subject|16|||
143038294|NCT03135834|515682873|FG001|Stage 1|Withdrawal by Subject|22|||
143038295|NCT03135834|515682874|FG002|Stage 1|Withdrawal by Subject|7|||
143038296|NCT03135834|515682875|FG003|Stage 1|Withdrawal by Subject|10|||
143038297|NCT03135834|515682872|FG000|Stage 1|Randomized but not Vaccinated|0|||
143038298|NCT03135834|515682873|FG001|Stage 1|Randomized but not Vaccinated|3|||
143038299|NCT03135834|515682874|FG002|Stage 1|Randomized but not Vaccinated|1|||
143038300|NCT03135834|515682875|FG003|Stage 1|Randomized but not Vaccinated|6|||
143038301|NCT03135834|515682872|FG000|Stage 2|Lost to Follow-up|0|||
143038302|NCT03135834|515682873|FG001|Stage 2|Lost to Follow-up|1|||
143038303|NCT03135834|515682874|FG002|Stage 2|Lost to Follow-up|0|||
143038304|NCT03135834|515682875|FG003|Stage 2|Lost to Follow-up|0|||
143038305|NCT03135834|515682872|FG000|Stage 2|Withdrawal by Subject|0|||
143038306|NCT03135834|515682873|FG001|Stage 2|Withdrawal by Subject|1|||
143038307|NCT03135834|515682874|FG002|Stage 2|Withdrawal by Subject|0|||
143038308|NCT03135834|515682875|FG003|Stage 2|Withdrawal by Subject|0|||
143038309|NCT03135834|515682872|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
143038310|NCT03135834|515682873|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
143038311|NCT03135834|515682874|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
143038312|NCT03135834|515682875|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
143038313|NCT03135834|515682872|FG000|Stage 2|Did not receive Booster Vaccination|1|||
143038314|NCT03135834|515682873|FG001|Stage 2|Did not receive Booster Vaccination|1|||
143038315|NCT03135834|515682874|FG002|Stage 2|Did not receive Booster Vaccination|0|||
143038316|NCT03135834|515682875|FG003|Stage 2|Did not receive Booster Vaccination|0|||
143038317|NCT00965185|515682876|FG000|Overall Study|Lost to Follow-up|2|||
143038318|NCT00965185|515682877|FG001|Overall Study|Lost to Follow-up|0|||
143038319|NCT00965185|515682876|FG000|Overall Study|Withdrawal by Subject|0|||
143038320|NCT00965185|515682877|FG001|Overall Study|Withdrawal by Subject|1|||
143038321|NCT02100228|515682878|FG000|Overall Study|Other|19|||
143038322|NCT02100228|515682879|FG001|Overall Study|Other|19|||
143038323|NCT02100228|515682878|FG000|Overall Study|Administrative reason|0|||
143038324|NCT02100228|515682879|FG001|Overall Study|Administrative reason|1|||
143038325|NCT02100228|515682878|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
143038326|NCT02100228|515682879|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
143038327|NCT02100228|515682878|FG000|Overall Study|Non-compliance|0|||
143038328|NCT02100228|515682879|FG001|Overall Study|Non-compliance|3|||
143038329|NCT02100228|515682878|FG000|Overall Study|Lost to Follow-up|0|||
143038330|NCT02100228|515682879|FG001|Overall Study|Lost to Follow-up|1|||
143038331|NCT02100228|515682878|FG000|Overall Study|Withdrawal by Subject|27|||
143038332|NCT02100228|515682879|FG001|Overall Study|Withdrawal by Subject|37|||
143038333|NCT02100228|515682878|FG000|Overall Study|Adverse Event|16|||
143038334|NCT02100228|515682879|FG001|Overall Study|Adverse Event|12|||
143038335|NCT02100228|515682878|FG000|Overall Study|Death|1|||
143038336|NCT02100228|515682879|FG001|Overall Study|Death|1|||
143038337|NCT00214422|515682880|FG000|Overall Study|Physician Decision|2|||
143038338|NCT00214422|515682881|FG001|Overall Study|Physician Decision|0|||
143038339|NCT00214422|515682882|FG002|Overall Study|Physician Decision|0|||
143038340|NCT00214422|515682880|FG000|Overall Study|Developed esophageal ca|1|||
143038341|NCT00214422|515682881|FG001|Overall Study|Developed esophageal ca|0|||
143038342|NCT00214422|515682882|FG002|Overall Study|Developed esophageal ca|0|||
143038343|NCT00214422|515682880|FG000|Overall Study|Pt taken off study|1|||
143038344|NCT00214422|515682881|FG001|Overall Study|Pt taken off study|1|||
143038345|NCT00214422|515682882|FG002|Overall Study|Pt taken off study|0|||
143038346|NCT00214422|515682880|FG000|Overall Study|Disease progression on study|1|||
143038347|NCT00214422|515682881|FG001|Overall Study|Disease progression on study|0|||
143038348|NCT00214422|515682882|FG002|Overall Study|Disease progression on study|0|||
143038349|NCT00214422|515682880|FG000|Overall Study|Unable to make a radiation treatment|0|||
143038350|NCT00214422|515682881|FG001|Overall Study|Unable to make a radiation treatment|0|||
143038351|NCT00214422|515682882|FG002|Overall Study|Unable to make a radiation treatment|1|||
143038352|NCT02612337|515682884|FG000|Overall Study|Lack of Efficacy|1|||
143038353|NCT02612337|515682885|FG001|Overall Study|Lack of Efficacy|0|||
143038354|NCT02612337|515682884|FG000|Overall Study|Withdrawal by Subject|2|||
143038355|NCT02612337|515682885|FG001|Overall Study|Withdrawal by Subject|2|||
143038356|NCT02612337|515682884|FG000|Overall Study|Did not receive study drug|0|||
143038357|NCT02612337|515682885|FG001|Overall Study|Did not receive study drug|1|||
143038358|NCT00854100|515682888|FG000|Overall Study|Inability to complete the study visits|0|||
143038359|NCT00854100|515682889|FG001|Overall Study|Inability to complete the study visits|0|||
143038360|NCT00854100|515682890|FG002|Overall Study|Inability to complete the study visits|1|||
143038361|NCT00854100|515682888|FG000|Overall Study|Lost to Follow-up|2|||
143161834|NCT00066170|516137690|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
143161835|NCT00066170|516137691|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
143161836|NCT00066170|516137688|FG000|Overall Study|Protocol Violation|3|||
143161837|NCT00066170|516137689|FG001|Overall Study|Protocol Violation|0|||
143161838|NCT00066170|516137690|FG002|Overall Study|Protocol Violation|0|||
143161839|NCT00066170|516137691|FG003|Overall Study|Protocol Violation|0|||
143038362|NCT00854100|515682889|FG001|Overall Study|Lost to Follow-up|0|||
143038363|NCT00854100|515682890|FG002|Overall Study|Lost to Follow-up|3|||
143038364|NCT00854100|515682888|FG000|Overall Study|Withdrawal by Subject|3|||
143038365|NCT00854100|515682889|FG001|Overall Study|Withdrawal by Subject|1|||
143038366|NCT00854100|515682890|FG002|Overall Study|Withdrawal by Subject|2|||
143161840|NCT00066170|516137688|FG000|Overall Study|Other|1|||
143161841|NCT00066170|516137689|FG001|Overall Study|Other|5|||
143161842|NCT00066170|516137690|FG002|Overall Study|Other|2|||
143038367|NCT00854100|515682888|FG000|Overall Study|Protocol Violation|2|||
143038368|NCT00854100|515682889|FG001|Overall Study|Protocol Violation|4|||
143038369|NCT00854100|515682890|FG002|Overall Study|Protocol Violation|3|||
143038370|NCT00854100|515682888|FG000|Overall Study|Adverse Event|2|||
143038371|NCT00854100|515682889|FG001|Overall Study|Adverse Event|1|||
143038372|NCT00854100|515682890|FG002|Overall Study|Adverse Event|2|||
143038373|NCT02216071|515682902|FG000|Overall Study|Withdrawal by Subject|7|||
143161843|NCT00066170|516137691|FG003|Overall Study|Other|0|||
143038374|NCT02216071|515682903|FG001|Overall Study|Withdrawal by Subject|2|||
143038375|NCT02216071|515682902|FG000|Overall Study|Lost to Follow-up|3|||
143038376|NCT02216071|515682903|FG001|Overall Study|Lost to Follow-up|3|||
143038377|NCT02216071|515682902|FG000|Overall Study|Protocol Violation|3|||
143038378|NCT02216071|515682903|FG001|Overall Study|Protocol Violation|5|||
143038379|NCT02216071|515682902|FG000|Overall Study|Other|2|||
143038380|NCT02216071|515682903|FG001|Overall Study|Other|2|||
143038381|NCT04753437|515682904|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
143038382|NCT04753437|515682905|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
143038383|NCT04753437|515682904|FG000|Overall Study|Liver Function Test Abnormalities|2|||
143496561|NCT01276821|517359498|FG000|Overall Study|Protocol Violation|0|||
143496562|NCT01276821|517359499|FG001|Overall Study|Protocol Violation|1|||
143496563|NCT01748071|517359502|FG000|Overall Study|Adverse Event|2|||
143496564|NCT01748071|517359503|FG001|Overall Study|Adverse Event|2|||
143496565|NCT01748071|517359504|FG002|Overall Study|Adverse Event|0|||
143496566|NCT00700180|517359505|FG000|Overall Study|Death|99|||
143496567|NCT00700180|517359506|FG001|Overall Study|Death|114|||
143496568|NCT00700180|517359505|FG000|Overall Study|Alive on treatment|5|||
143496569|NCT00700180|517359506|FG001|Overall Study|Alive on treatment|3|||
143496570|NCT00700180|517359505|FG000|Overall Study|Alive in follow-up|46|||
143496571|NCT00700180|517359506|FG001|Overall Study|Alive in follow-up|27|||
143496572|NCT00700180|517359505|FG000|Overall Study|Lost to Follow-up|4|||
143496573|NCT00700180|517359506|FG001|Overall Study|Lost to Follow-up|5|||
143496574|NCT01613326|517359507|FG000|Overall Study|Adverse Event|7|||
143496575|NCT01613326|517359508|FG001|Overall Study|Adverse Event|5|||
143496576|NCT01613326|517359507|FG000|Overall Study|Withdrawal by Subject|3|||
143496577|NCT01613326|517359508|FG001|Overall Study|Withdrawal by Subject|4|||
143496578|NCT01613326|517359507|FG000|Overall Study|Abnormal test procedure result(s)|2|||
143496579|NCT01613326|517359508|FG001|Overall Study|Abnormal test procedure result(s)|0|||
143496580|NCT01613326|517359507|FG000|Overall Study|inability to use device|1|||
143496581|NCT01613326|517359508|FG001|Overall Study|inability to use device|0|||
143038384|NCT04753437|515682905|FG001|Overall Study|Liver Function Test Abnormalities|4|||
143038385|NCT04915755|515684238|FG000|Overall Study|Physician Decision|3|||
143038386|NCT04915755|515684239|FG001|Overall Study|Physician Decision|2|||
143038387|NCT04915755|515684238|FG000|Overall Study|Withdrawal by Subject|1|||
143038388|NCT04915755|515684239|FG001|Overall Study|Withdrawal by Subject|1|||
143161844|NCT01370642|516137693|FG000|Overall Study|Adverse Event|2|||
143161845|NCT01370642|516137694|FG001|Overall Study|Adverse Event|1|||
143161846|NCT01370642|516137695|FG002|Overall Study|Adverse Event|1|||
143161847|NCT01370642|516137693|FG000|Overall Study|Detectable HCV RNA|0|||
143161848|NCT01370642|516137694|FG001|Overall Study|Detectable HCV RNA|0|||
143161849|NCT01370642|516137695|FG002|Overall Study|Detectable HCV RNA|22|||
143161850|NCT01370642|516137693|FG000|Overall Study|Lost to Follow-up|0|||
143161851|NCT01370642|516137694|FG001|Overall Study|Lost to Follow-up|0|||
143161852|NCT01370642|516137695|FG002|Overall Study|Lost to Follow-up|1|||
143161853|NCT01370642|516137693|FG000|Overall Study|Physician Decision|4|||
143161854|NCT01370642|516137694|FG001|Overall Study|Physician Decision|1|||
143161855|NCT01370642|516137695|FG002|Overall Study|Physician Decision|2|||
143161856|NCT01370642|516137693|FG000|Overall Study|Withdrawal by Subject|2|||
143161857|NCT01370642|516137694|FG001|Overall Study|Withdrawal by Subject|4|||
143161858|NCT01370642|516137695|FG002|Overall Study|Withdrawal by Subject|3|||
143161859|NCT00987935|516137702|FG000|Overall Study|Progressive disease|3|||
143161860|NCT00987935|516137703|FG001|Overall Study|Progressive disease|2|||
143161861|NCT00987935|516137704|FG002|Overall Study|Progressive disease|3|||
143161862|NCT00987935|516137705|FG003|Overall Study|Progressive disease|2|||
143161863|NCT00987935|516137706|FG004|Overall Study|Progressive disease|5|||
143161864|NCT00987935|516137707|FG005|Overall Study|Progressive disease|3|||
143161865|NCT00987935|516137708|FG006|Overall Study|Progressive disease|9|||
143161866|NCT00987935|516137709|FG007|Overall Study|Progressive disease|48|||
143161867|NCT00987935|516137710|FG008|Overall Study|Progressive disease|23|||
143161868|NCT00987935|516137702|FG000|Overall Study|Adverse Event|0|||
143161869|NCT00987935|516137703|FG001|Overall Study|Adverse Event|1|||
143161870|NCT00987935|516137704|FG002|Overall Study|Adverse Event|0|||
143161871|NCT00987935|516137705|FG003|Overall Study|Adverse Event|1|||
143161872|NCT00987935|516137706|FG004|Overall Study|Adverse Event|1|||
143161873|NCT00987935|516137707|FG005|Overall Study|Adverse Event|0|||
143161874|NCT00987935|516137708|FG006|Overall Study|Adverse Event|2|||
143161875|NCT00987935|516137709|FG007|Overall Study|Adverse Event|10|||
143161876|NCT00987935|516137710|FG008|Overall Study|Adverse Event|6|||
143161877|NCT00987935|516137702|FG000|Overall Study|Refused to continue taking trial med.|1|||
143161878|NCT00987935|516137703|FG001|Overall Study|Refused to continue taking trial med.|0|||
143038389|NCT04915755|515684238|FG000|Overall Study|Ongoing for PACT|3|||
143161879|NCT00987935|516137704|FG002|Overall Study|Refused to continue taking trial med.|0|||
143161880|NCT00987935|516137705|FG003|Overall Study|Refused to continue taking trial med.|0|||
143161881|NCT00987935|516137706|FG004|Overall Study|Refused to continue taking trial med.|1|||
143161882|NCT00987935|516137707|FG005|Overall Study|Refused to continue taking trial med.|0|||
143161883|NCT00987935|516137708|FG006|Overall Study|Refused to continue taking trial med.|4|||
143161884|NCT00987935|516137709|FG007|Overall Study|Refused to continue taking trial med.|4|||
143038390|NCT04915755|515684239|FG001|Overall Study|Ongoing for PACT|2|||
143038391|NCT04915755|515684238|FG000|Overall Study|Other|7|||
143038392|NCT04915755|515684239|FG001|Overall Study|Other|11|||
143038393|NCT04089735|515684240|FG000|Overall Study|Adverse Event|1|||
143038394|NCT04089735|515684241|FG001|Overall Study|Adverse Event|0|||
143038395|NCT04089735|515684242|FG002|Overall Study|Adverse Event|1|||
143038396|NCT04089735|515684243|FG003|Overall Study|Adverse Event|1|||
143038397|NCT04089735|515684244|FG004|Overall Study|Adverse Event|0|||
143038398|NCT04089735|515684245|FG005|Overall Study|Adverse Event|0|||
143038399|NCT04089735|515684240|FG000|Overall Study|Physician Decision|0|||
143038400|NCT04089735|515684241|FG001|Overall Study|Physician Decision|3|||
143038401|NCT04089735|515684242|FG002|Overall Study|Physician Decision|0|||
143038402|NCT04089735|515684243|FG003|Overall Study|Physician Decision|0|||
143038403|NCT04089735|515684244|FG004|Overall Study|Physician Decision|0|||
143038404|NCT04089735|515684245|FG005|Overall Study|Physician Decision|0|||
143038405|NCT04089735|515684240|FG000|Overall Study|Withdrawal by Subject|0|||
143038406|NCT04089735|515684241|FG001|Overall Study|Withdrawal by Subject|0|||
143038407|NCT04089735|515684242|FG002|Overall Study|Withdrawal by Subject|1|||
143038408|NCT04089735|515684243|FG003|Overall Study|Withdrawal by Subject|0|||
143038409|NCT04089735|515684244|FG004|Overall Study|Withdrawal by Subject|0|||
143038410|NCT04089735|515684245|FG005|Overall Study|Withdrawal by Subject|0|||
143038411|NCT04089735|515684240|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
143038412|NCT04089735|515684241|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
143038413|NCT04089735|515684242|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
143038414|NCT04089735|515684243|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
143038415|NCT04089735|515684244|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
143038416|NCT04089735|515684245|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
143038417|NCT02246166|515684246|FG000|Overall Study|Protocol Violation|1|||
143038418|NCT02246166|515684247|FG001|Overall Study|Protocol Violation|0|||
143038419|NCT02587962|515684250|FG000|Overall Study|Adverse Event|0|||
143038420|NCT02587962|515684251|FG001|Overall Study|Adverse Event|0|||
143038421|NCT02587962|515684252|FG002|Overall Study|Adverse Event|1|||
143038422|NCT02587962|515684253|FG003|Overall Study|Adverse Event|0|||
143038423|NCT02587962|515684254|FG004|Overall Study|Adverse Event|0|||
143038424|NCT02587962|515684250|FG000|Overall Study|Withdrawal by Subject|0|||
143038425|NCT02587962|515684251|FG001|Overall Study|Withdrawal by Subject|0|||
143038426|NCT02587962|515684252|FG002|Overall Study|Withdrawal by Subject|1|||
143038427|NCT02587962|515684253|FG003|Overall Study|Withdrawal by Subject|1|||
143038428|NCT02587962|515684254|FG004|Overall Study|Withdrawal by Subject|4|||
143038429|NCT02587962|515684250|FG000|Overall Study|Radiological progression|2|||
143038430|NCT02587962|515684251|FG001|Overall Study|Radiological progression|2|||
143038431|NCT02587962|515684252|FG002|Overall Study|Radiological progression|2|||
143038432|NCT02587962|515684253|FG003|Overall Study|Radiological progression|5|||
143038433|NCT02587962|515684254|FG004|Overall Study|Radiological progression|10|||
143038434|NCT02587962|515684250|FG000|Overall Study|Clinical progression|0|||
143038435|NCT02587962|515684251|FG001|Overall Study|Clinical progression|1|||
143038436|NCT02587962|515684252|FG002|Overall Study|Clinical progression|2|||
143038437|NCT02587962|515684253|FG003|Overall Study|Clinical progression|0|||
143038438|NCT02587962|515684254|FG004|Overall Study|Clinical progression|1|||
143038439|NCT01185548|515684255|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
143038440|NCT00086996|515684257|FG000|Overall Study|Adverse Event|29|||
143038441|NCT00086996|515684257|FG000|Overall Study|Death|4|||
143038442|NCT00086996|515684257|FG000|Overall Study|progression/relapse|7|||
143038443|NCT00086996|515684257|FG000|Overall Study|Withdrawal by Subject|13|||
143038444|NCT00086996|515684257|FG000|Overall Study|Other|6|||
143038445|NCT00086996|515684257|FG000|Overall Study|not eligible|5|||
143038446|NCT01422538|515684261|FG000|Overall Study|Lost to Follow-up|0|||
143161885|NCT00987935|516137710|FG008|Overall Study|Refused to continue taking trial med.|2|||
143161886|NCT00987935|516137702|FG000|Overall Study|Reason other than those specified above|0|||
143161887|NCT00987935|516137703|FG001|Overall Study|Reason other than those specified above|0|||
143161888|NCT00987935|516137704|FG002|Overall Study|Reason other than those specified above|0|||
143161889|NCT00987935|516137705|FG003|Overall Study|Reason other than those specified above|0|||
143161890|NCT00987935|516137706|FG004|Overall Study|Reason other than those specified above|0|||
143161891|NCT00987935|516137707|FG005|Overall Study|Reason other than those specified above|0|||
143161892|NCT00987935|516137708|FG006|Overall Study|Reason other than those specified above|0|||
143161893|NCT00987935|516137709|FG007|Overall Study|Reason other than those specified above|0|||
143161894|NCT00987935|516137710|FG008|Overall Study|Reason other than those specified above|1|||
143038447|NCT01422538|515684262|FG001|Overall Study|Lost to Follow-up|1|||
143038448|NCT01422538|515684263|FG002|Overall Study|Lost to Follow-up|1|||
143038449|NCT01422538|515684261|FG000|Overall Study|Missed visit|0|||
143038450|NCT01422538|515684262|FG001|Overall Study|Missed visit|1|||
143038451|NCT01422538|515684263|FG002|Overall Study|Missed visit|1|||
143038452|NCT00004562|515684264|FG000|Overall Study|Lost to Follow-up|102|||
143038453|NCT00004562|515684265|FG001|Overall Study|Lost to Follow-up|91|||
143038454|NCT02770820|515684266|FG000|Overall Study|Death|1|||
143038455|NCT02770820|515684266|FG000|Overall Study|Physician Decision|2|||
143038456|NCT02331394|515684267|FG000|Overall Study|Disease progression|1|||
143038457|NCT03195491|515684270|FG000|Overall Study|Study drug toxicity|25|||
143038458|NCT03195491|515684271|FG001|Overall Study|Study drug toxicity|3|||
143038459|NCT03195491|515684270|FG000|Overall Study|Maximum clinical benefit|5|||
143038460|NCT03195491|515684271|FG001|Overall Study|Maximum clinical benefit|0|||
143038461|NCT03195491|515684270|FG000|Overall Study|Lost to Follow-up|1|||
143038462|NCT03195491|515684271|FG001|Overall Study|Lost to Follow-up|0|||
143038463|NCT03195491|515684270|FG000|Overall Study|Death|3|||
143038464|NCT03195491|515684271|FG001|Overall Study|Death|0|||
143038465|NCT03195491|515684270|FG000|Overall Study|Adverse event unrelated to study drug|19|||
143038466|NCT03195491|515684271|FG001|Overall Study|Adverse event unrelated to study drug|2|||
143038467|NCT03195491|515684270|FG000|Overall Study|Disease progression|266|||
143038468|NCT03195491|515684271|FG001|Overall Study|Disease progression|8|||
143239145|NCT02113982|516429803|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
143239146|NCT02113982|516429804|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
143239147|NCT02113982|516429805|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
143239148|NCT02113982|516429806|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
143239149|NCT02113982|516429807|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
143239150|NCT02113982|516429808|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
143239151|NCT02113982|516429809|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
143239152|NCT02113982|516429810|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
143239153|NCT02113982|516429811|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
143239154|NCT02113982|516429798|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
143239155|NCT02113982|516429799|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
143239156|NCT02113982|516429800|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
143239157|NCT02113982|516429801|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
143239158|NCT02113982|516429802|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
143239159|NCT02113982|516429803|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
143239160|NCT02113982|516429804|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
143239161|NCT02113982|516429805|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
143239162|NCT02113982|516429806|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
143239163|NCT02113982|516429807|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
143239164|NCT02113982|516429808|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
143239165|NCT02113982|516429809|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
143239166|NCT02113982|516429810|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
143239167|NCT02113982|516429811|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
143239168|NCT01600716|516429812|FG000|Overall Study|Other Reasons|3|||
143239169|NCT01600716|516429813|FG001|Overall Study|Other Reasons|1|||
143239170|NCT01600716|516429812|FG000|Overall Study|Personal Reasons|0|||
143239171|NCT01600716|516429813|FG001|Overall Study|Personal Reasons|2|||
143239172|NCT01600716|516429812|FG000|Overall Study|Lost to Follow-up|0|||
143239173|NCT01600716|516429813|FG001|Overall Study|Lost to Follow-up|2|||
143239174|NCT01600716|516429812|FG000|Overall Study|Pregnancy|1|||
143239175|NCT01600716|516429813|FG001|Overall Study|Pregnancy|0|||
143239176|NCT01600716|516429812|FG000|Overall Study|Lack of Efficacy|2|||
143239177|NCT01600716|516429813|FG001|Overall Study|Lack of Efficacy|1|||
143239178|NCT01600716|516429812|FG000|Overall Study|Adverse Event|1|||
143239179|NCT01600716|516429813|FG001|Overall Study|Adverse Event|1|||
143239180|NCT00865566|516429819|FG000|Overall Study|Death|1|||
143239181|NCT00865566|516429820|FG001|Overall Study|Death|11|||
143239182|NCT00865566|516429819|FG000|Overall Study|Lost to Follow-up|314|||
143239183|NCT00865566|516429820|FG001|Overall Study|Lost to Follow-up|315|||
143239184|NCT00865566|516429819|FG000|Overall Study|Withdrawal by Subject|45|||
143239185|NCT00865566|516429820|FG001|Overall Study|Withdrawal by Subject|65|||
143239186|NCT00865566|516429819|FG000|Overall Study|Physician Decision|0|||
143496582|NCT01613326|517359507|FG000|Overall Study|Lack of Efficacy|0|||
143239187|NCT00865566|516429820|FG001|Overall Study|Physician Decision|1|||
143239188|NCT00865566|516429819|FG000|Overall Study|Participant relocated|78|||
143239189|NCT00865566|516429820|FG001|Overall Study|Participant relocated|107|||
143239190|NCT00865566|516429819|FG000|Overall Study|Participant unable to adhere|27|||
143239191|NCT00865566|516429820|FG001|Overall Study|Participant unable to adhere|42|||
143239192|NCT00865566|516429819|FG000|Overall Study|Other; N=245 due to early study closure|154|||
143239193|NCT00865566|516429820|FG001|Overall Study|Other; N=245 due to early study closure|139|||
143496583|NCT01613326|517359508|FG001|Overall Study|Lack of Efficacy|1|||
143038469|NCT03195491|515684270|FG000|Overall Study|Other reasons|10|||
143038470|NCT03195491|515684271|FG001|Overall Study|Other reasons|0|||
143038471|NCT03195491|515684270|FG000|Overall Study|Participant withdrew consent|8|||
143038472|NCT03195491|515684271|FG001|Overall Study|Participant withdrew consent|1|||
143038473|NCT03195491|515684270|FG000|Overall Study|Participant no longer meets study criteria|0|||
143038474|NCT03195491|515684271|FG001|Overall Study|Participant no longer meets study criteria|1|||
143038475|NCT03195491|515684270|FG000|Overall Study|Participant request to discontinue study treatment|10|||
143038476|NCT03195491|515684271|FG001|Overall Study|Participant request to discontinue study treatment|0|||
143038477|NCT01263704|515684272|FG000|Overall Study|Progressive disease|18|||
143038478|NCT01263704|515684272|FG000|Overall Study|Adverse Event|3|||
143038479|NCT01263704|515684272|FG000|Overall Study|Death|2|||
143038480|NCT01263704|515684272|FG000|Overall Study|Patient withdrew consent|2|||
143038481|NCT01263704|515684272|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
143038482|NCT01263704|515684272|FG000|Overall Study|Lost to Follow-up|1|||
143038483|NCT01263704|515684272|FG000|Overall Study|Colon metastases|1|||
143038484|NCT01263704|515684272|FG000|Overall Study|Principal Investigator (PI) decision|1|||
143038485|NCT02459951|515684273|FG000|Overall Study|Unable to meet holding requirement|1|||
143038486|NCT02255097|515684276|FG000|Overall Study|Death|151|||
143038487|NCT02255097|515684276|FG000|Overall Study|Lost to Follow-up|5|||
143038488|NCT02255097|515684276|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
143038489|NCT02255097|515684276|FG000|Overall Study|Withdrawal by Subject|7|||
143038490|NCT02255097|515684276|FG000|Overall Study|Allocated but not treated|1|||
143038491|NCT01602419|515684283|FG000|Overall Study|Not treated with Wilate|9|||
143038492|NCT01602419|515684283|FG000|Overall Study|Adverse Drug Reaction|4|||
143038493|NCT01602419|515684283|FG000|Overall Study|Insurance issues|3|||
143038494|NCT01602419|515684283|FG000|Overall Study|Changed treatment centre|1|||
143038495|NCT01602419|515684283|FG000|Overall Study|Treatment centre closed|1|||
143038496|NCT01602419|515684283|FG000|Overall Study|Withdrawal by Subject|5|||
143038497|NCT01602419|515684283|FG000|Overall Study|Lost to Follow-up|6|||
143038498|NCT01792635|515684284|FG000|Part B|Adverse Event|0|||
143038499|NCT01792635|515684285|FG001|Part B|Adverse Event|0|||
143038500|NCT01792635|515684286|FG002|Part B|Adverse Event|1|||
143038501|NCT01792635|515684284|FG000|Part B|Study terminated|0|||
143038502|NCT01792635|515684285|FG001|Part B|Study terminated|4|||
143038503|NCT01792635|515684286|FG002|Part B|Study terminated|3|||
143038504|NCT01010542|515684289|FG000|Overall Study|Adverse Event|0|||
143038505|NCT01010542|515684290|FG001|Overall Study|Adverse Event|1|||
143038506|NCT01010542|515684291|FG002|Overall Study|Adverse Event|0|||
143038507|NCT01010542|515684289|FG000|Overall Study|Lost to Follow-up|0|||
143038508|NCT01010542|515684290|FG001|Overall Study|Lost to Follow-up|1|||
143038509|NCT01010542|515684291|FG002|Overall Study|Lost to Follow-up|0|||
143038510|NCT01010542|515684289|FG000|Overall Study|Withdrawal by Subject|0|||
143038511|NCT01010542|515684290|FG001|Overall Study|Withdrawal by Subject|3|||
143038512|NCT01010542|515684291|FG002|Overall Study|Withdrawal by Subject|2|||
143038513|NCT00850174|515684292|FG000|Washout: One Week|Withdrawal by Subject|0|||
143038514|NCT00850174|515684293|FG001|Washout: One Week|Withdrawal by Subject|2|||
143038515|NCT00850174|515684292|FG000|Second Intervention|Withdrawal by Subject|1|||
143038516|NCT00850174|515684293|FG001|Second Intervention|Withdrawal by Subject|0|||
143038517|NCT01363765|515684296|FG000|Overall Study|non-diagnostic|2621|||
143038518|NCT01363765|515684297|FG001|Overall Study|non-diagnostic|1124|||
143038519|NCT01363765|515684296|FG000|Overall Study|duplicate records|736|||
143038520|NCT01363765|515684297|FG001|Overall Study|duplicate records|3177|||
143038521|NCT01363765|515684296|FG000|Overall Study|non-resident|156|||
143038522|NCT01363765|515684297|FG001|Overall Study|non-resident|76|||
143038523|NCT01363765|515684296|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
143038524|NCT01363765|515684297|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
143161895|NCT00452530|516137711|FG000|Overall Study|Death|1|||
143161896|NCT00452530|516137712|FG001|Overall Study|Death|0|||
143161897|NCT00452530|516137711|FG000|Overall Study|Adverse Event|40|||
143161898|NCT00452530|516137712|FG001|Overall Study|Adverse Event|44|||
143161899|NCT00452530|516137711|FG000|Overall Study|Withdrawal by Subject|68|||
143161900|NCT00452530|516137712|FG001|Overall Study|Withdrawal by Subject|57|||
143161901|NCT00452530|516137711|FG000|Overall Study|Lost to Follow-up|1|||
143161902|NCT00452530|516137712|FG001|Overall Study|Lost to Follow-up|0|||
143161903|NCT00452530|516137711|FG000|Overall Study|Poor compliance/noncompliance|1|||
143161904|NCT00452530|516137712|FG001|Overall Study|Poor compliance/noncompliance|2|||
143161905|NCT00452530|516137711|FG000|Overall Study|No longer met study criteria|18|||
143161906|NCT00452530|516137712|FG001|Overall Study|No longer met study criteria|22|||
143161907|NCT00452530|516137711|FG000|Overall Study|Other|7|||
143161908|NCT00452530|516137712|FG001|Overall Study|Other|11|||
143161909|NCT02191397|516137713|FG000|Overall Study|Adverse Event|28|||
143161910|NCT02191397|516137714|FG001|Overall Study|Adverse Event|17|||
143161911|NCT02191397|516137713|FG000|Overall Study|Lack of Efficacy|10|||
143038525|NCT01363765|515684296|FG000|Overall Study|smear during intervention|2170|||
143038526|NCT01363765|515684297|FG001|Overall Study|smear during intervention|0|||
143038527|NCT02682784|515684302|FG000|Overall Study|Withdrawal by Subject|0|||
143038528|NCT02682784|515684303|FG001|Overall Study|Withdrawal by Subject|2|||
143038529|NCT02682784|515684304|FG002|Overall Study|Withdrawal by Subject|1|||
143038530|NCT02682784|515684305|FG003|Overall Study|Withdrawal by Subject|2|||
143038531|NCT02682784|515684302|FG000|Overall Study|Physician Decision|1|||
143038532|NCT02682784|515684303|FG001|Overall Study|Physician Decision|0|||
143161912|NCT02191397|516137714|FG001|Overall Study|Lack of Efficacy|5|||
143161913|NCT02191397|516137713|FG000|Overall Study|Protocol Violation|0|||
143161914|NCT02191397|516137714|FG001|Overall Study|Protocol Violation|3|||
143038533|NCT02682784|515684304|FG002|Overall Study|Physician Decision|1|||
143038534|NCT02682784|515684305|FG003|Overall Study|Physician Decision|1|||
143038535|NCT00389064|515684306|FG000|Overall Study|Adverse Event|11|||
143038536|NCT00389064|515684307|FG001|Overall Study|Adverse Event|3|||
143038537|NCT00389064|515684306|FG000|Overall Study|Lack of Efficacy|3|||
143038538|NCT00389064|515684307|FG001|Overall Study|Lack of Efficacy|14|||
143038539|NCT00389064|515684306|FG000|Overall Study|Withdrawal by Subject|17|||
143038540|NCT00389064|515684307|FG001|Overall Study|Withdrawal by Subject|27|||
143038541|NCT00389064|515684306|FG000|Overall Study|Physician Decision|2|||
143038542|NCT00389064|515684307|FG001|Overall Study|Physician Decision|2|||
143038543|NCT00389064|515684306|FG000|Overall Study|Lost to Follow-up|1|||
143038544|NCT00389064|515684307|FG001|Overall Study|Lost to Follow-up|2|||
143239194|NCT00865566|516429819|FG000|Overall Study|HIV infection|5|||
143239195|NCT00865566|516429820|FG001|Overall Study|HIV infection|7|||
143239196|NCT00118417|516429821|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
143239197|NCT00118417|516429822|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
143239198|NCT00118417|516429821|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
143239199|NCT00118417|516429822|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
143239200|NCT00118417|516429821|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
143239201|NCT00118417|516429822|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
143239202|NCT00118417|516429821|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
143239203|NCT00118417|516429822|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
143239204|NCT00118417|516429821|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
143239205|NCT00118417|516429822|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
143239206|NCT00785785|516429823|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
143239207|NCT00785785|516429824|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
143239208|NCT00785785|516429823|FG000|Core Phase up to 36 Months|Adverse Event|31|||
143239209|NCT00785785|516429824|FG001|Core Phase up to 36 Months|Adverse Event|21|||
143239210|NCT00785785|516429823|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
143239211|NCT00785785|516429824|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
143239212|NCT00785785|516429823|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
143239213|NCT00785785|516429824|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
143239214|NCT00785785|516429823|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
143239215|NCT00785785|516429824|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
143239216|NCT00785785|516429823|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
143239217|NCT00785785|516429824|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
143239218|NCT00785785|516429823|FG000|Core Phase up to 36 Months|Administrative problems|3|||
143239219|NCT00785785|516429824|FG001|Core Phase up to 36 Months|Administrative problems|3|||
143239220|NCT00785785|516429823|FG000|Core Phase up to 36 Months|Death|5|||
143239221|NCT00785785|516429824|FG001|Core Phase up to 36 Months|Death|8|||
143239222|NCT00785785|516429823|FG000|Core Phase up to 36 Months|Disease progression|139|||
143239223|NCT00785785|516429824|FG001|Core Phase up to 36 Months|Disease progression|119|||
143239224|NCT00785785|516429823|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
143239225|NCT00785785|516429824|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
143239226|NCT00785785|516429823|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
143239227|NCT00785785|516429824|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
143239228|NCT00785785|516429823|FG000|Optional Extension Phase|Adverse Event|4|||
143239229|NCT00785785|516429824|FG001|Optional Extension Phase|Adverse Event|5|||
143239230|NCT00785785|516429823|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
143239231|NCT00785785|516429824|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
143239232|NCT00785785|516429823|FG000|Optional Extension Phase|Lost to Follow-up|1|||
143239233|NCT00785785|516429824|FG001|Optional Extension Phase|Lost to Follow-up|0|||
143239234|NCT00785785|516429823|FG000|Optional Extension Phase|Administrative problems|2|||
143239235|NCT00785785|516429824|FG001|Optional Extension Phase|Administrative problems|0|||
143239236|NCT00785785|516429823|FG000|Optional Extension Phase|Death|1|||
143239237|NCT00785785|516429824|FG001|Optional Extension Phase|Death|5|||
143496584|NCT01613326|517359507|FG000|Overall Study|Lost to Follow-up|0|||
143038545|NCT00389064|515684306|FG000|Overall Study|Protocol Violation|2|||
143038546|NCT00389064|515684307|FG001|Overall Study|Protocol Violation|0|||
143038547|NCT00389064|515684306|FG000|Overall Study|Multiple Reasons|9|||
143038548|NCT00389064|515684307|FG001|Overall Study|Multiple Reasons|11|||
143038549|NCT03500692|515684312|FG000|Overall Study|Death|163|||
143038550|NCT03500692|515684312|FG000|Overall Study|Lost to Follow-up|75|||
143038551|NCT03500692|515684312|FG000|Overall Study|Termination Reasons|3|||
143038552|NCT04149964|515684313|FG000|Overall Study|Lost to Follow-up|19|||
143239238|NCT00785785|516429823|FG000|Optional Extension Phase|Disease progression|22|||
143239239|NCT00785785|516429824|FG001|Optional Extension Phase|Disease progression|70|||
143496585|NCT01613326|517359508|FG001|Overall Study|Lost to Follow-up|1|||
143038553|NCT04149964|515684314|FG001|Overall Study|Lost to Follow-up|18|||
143239240|NCT00785785|516429823|FG000|Optional Extension Phase|Protocol deviation|0|||
143239241|NCT00785785|516429824|FG001|Optional Extension Phase|Protocol deviation|2|||
143239242|NCT00785785|516429823|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
143038554|NCT05275205|515684321|FG000|Overall Study|Adverse Event|1|||
143496586|NCT01613326|517359507|FG000|Overall Study|Administrative|0|||
143364124|NCT01237678|516875554|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
143364125|NCT01237678|516875552|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
143364126|NCT01237678|516875553|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
143364127|NCT01237678|516875554|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
143364128|NCT01237678|516875552|FG000|Phase II|Adverse Event|0|||
143364129|NCT01237678|516875553|FG001|Phase II|Adverse Event|39|||
143038555|NCT05275205|515684322|FG001|Overall Study|Adverse Event|2|||
143038556|NCT05275205|515684321|FG000|Overall Study|Physician Decision|1|||
143038557|NCT05275205|515684322|FG001|Overall Study|Physician Decision|1|||
143038558|NCT05275205|515684321|FG000|Overall Study|Withdrawal by Subject|2|||
143038559|NCT05275205|515684322|FG001|Overall Study|Withdrawal by Subject|3|||
143038560|NCT05275205|515684321|FG000|Overall Study|Death|1|||
143038561|NCT05275205|515684322|FG001|Overall Study|Death|0|||
143038562|NCT05275205|515684321|FG000|Overall Study|Patient unable to attend visits|1|||
143038563|NCT05275205|515684322|FG001|Overall Study|Patient unable to attend visits|0|||
143038564|NCT03041025|515684324|FG000|Overall Study|Adverse Event|0|||
143038565|NCT03041025|515684325|FG001|Overall Study|Adverse Event|0|||
143038566|NCT03041025|515684326|FG002|Overall Study|Adverse Event|1|||
143038567|NCT03041025|515684324|FG000|Overall Study|Lost to Follow-up|1|||
143038568|NCT03041025|515684325|FG001|Overall Study|Lost to Follow-up|0|||
143038569|NCT03041025|515684326|FG002|Overall Study|Lost to Follow-up|0|||
143038570|NCT03041025|515684324|FG000|Overall Study|Withdrawal by Subject|0|||
143038571|NCT03041025|515684325|FG001|Overall Study|Withdrawal by Subject|0|||
143038572|NCT03041025|515684326|FG002|Overall Study|Withdrawal by Subject|1|||
143038573|NCT02963259|515684328|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
143038574|NCT02963259|515684328|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
143038575|NCT02963259|515684328|FG000|Overall Study|Death|1|||
143038576|NCT02963259|515684328|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
143038577|NCT03243630|515684329|FG000|Overall Study|Protocol Violation|1|||
143038578|NCT03243630|515684329|FG000|Overall Study|Physician Decision|1|||
143038579|NCT00939003|515684332|FG000|Double-blind Treatment Period|Adverse Event|1|||
143038580|NCT00939003|515684333|FG001|Double-blind Treatment Period|Adverse Event|1|||
143038581|NCT00939003|515684332|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
143038582|NCT00939003|515684333|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
143038583|NCT00939003|515684332|FG000|Double-blind Treatment Period|Pregnancy|0|||
143038584|NCT00939003|515684333|FG001|Double-blind Treatment Period|Pregnancy|1|||
143038585|NCT00939003|515684332|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
143038586|NCT00939003|515684333|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
143038587|NCT00939003|515684332|FG000|Open-label Treatment Period|Adverse Event|4|||
143038588|NCT00939003|515684333|FG001|Open-label Treatment Period|Adverse Event|8|||
143038589|NCT00939003|515684332|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
143038590|NCT00939003|515684333|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
143038591|NCT00939003|515684332|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
143038592|NCT00939003|515684333|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
143038593|NCT00939003|515684332|FG000|Open-label Treatment Period|Pregnancy|1|||
143038594|NCT00939003|515684333|FG001|Open-label Treatment Period|Pregnancy|1|||
143038595|NCT00939003|515684332|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
143038596|NCT00939003|515684333|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
143038597|NCT00939003|515684332|FG000|Open-label Treatment Period|Site Closure|3|||
143038598|NCT00939003|515684333|FG001|Open-label Treatment Period|Site Closure|4|||
143038599|NCT02131129|515684334|FG000|Overall Study|Withdrawal by Subject|1|||
143038600|NCT02131129|515684335|FG001|Overall Study|Withdrawal by Subject|0|||
143038601|NCT03707912|515684336|FG000|Overall Study|Violation of inclusion criteria|1|||
143038602|NCT03707912|515684337|FG001|Overall Study|Violation of inclusion criteria|0|||
143038603|NCT02865122|515684338|FG000|Overall Study|Adverse Event|1|||
143161915|NCT02191397|516137713|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
143161916|NCT02191397|516137714|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
143161917|NCT02191397|516137713|FG000|Overall Study|Lost to Follow-up|10|||
143038604|NCT02865122|515684339|FG001|Overall Study|Adverse Event|0|||
143038605|NCT02865122|515684340|FG002|Overall Study|Adverse Event|0|||
143038606|NCT03880266|515684341|FG000|Overall Study|Withdrawal by Subject|0|||
143038607|NCT03880266|515684342|FG001|Overall Study|Withdrawal by Subject|1|||
143161918|NCT02191397|516137714|FG001|Overall Study|Lost to Follow-up|11|||
143161919|NCT02191397|516137713|FG000|Overall Study|Physician Decision|8|||
143161920|NCT02191397|516137714|FG001|Overall Study|Physician Decision|3|||
143161921|NCT02191397|516137713|FG000|Overall Study|Withdrawal by Subject|22|||
143161922|NCT02191397|516137714|FG001|Overall Study|Withdrawal by Subject|27|||
143161923|NCT03888482|516137715|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
143038608|NCT03880266|515684343|FG002|Overall Study|Withdrawal by Subject|1|||
143496587|NCT01613326|517359508|FG001|Overall Study|Administrative|2|||
143038609|NCT03880266|515684344|FG003|Overall Study|Withdrawal by Subject|0|||
143038610|NCT03880266|515684345|FG004|Overall Study|Withdrawal by Subject|0|||
143161924|NCT03888482|516137716|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
143161925|NCT03888482|516137715|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
143038611|NCT03880266|515684346|FG005|Overall Study|Withdrawal by Subject|0|||
143038612|NCT03880266|515684347|FG006|Overall Study|Withdrawal by Subject|0|||
143038613|NCT03880266|515684348|FG007|Overall Study|Withdrawal by Subject|0|||
143038614|NCT01577381|515684354|FG000|Overall Study|Discontinued|2|||
143038615|NCT01577381|515684355|FG001|Overall Study|Discontinued|1|||
143038616|NCT01577381|515684356|FG002|Overall Study|Discontinued|2|||
143038617|NCT01577381|515684357|FG003|Overall Study|Discontinued|2|||
143038618|NCT01577381|515684354|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
143038619|NCT01577381|515684355|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
143364130|NCT01237678|516875554|FG002|Phase II|Adverse Event|9|||
143364131|NCT01237678|516875552|FG000|Phase II|Death|0|||
143364132|NCT01237678|516875553|FG001|Phase II|Death|0|||
143364133|NCT01237678|516875554|FG002|Phase II|Death|2|||
143038620|NCT01577381|515684356|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
143364134|NCT01237678|516875552|FG000|Phase II|Lack of Efficacy|0|||
143496588|NCT01613326|517359507|FG000|Overall Study|Protocol Violation|0|||
143496589|NCT01613326|517359508|FG001|Overall Study|Protocol Violation|1|||
143038621|NCT01577381|515684357|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
143038622|NCT02186821|515684358|FG000|Overall Study|Adverse Event|9|||
143038623|NCT02186821|515684358|FG000|Overall Study|Death|2|||
143038624|NCT02186821|515684358|FG000|Overall Study|Disease progression|32|||
143038625|NCT02186821|515684358|FG000|Overall Study|Protocol Violation|1|||
143161926|NCT03888482|516137716|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
143161927|NCT01189227|516137717|FG000|Overall Study|Study terminated due to low accrual|6|||
143161928|NCT01189227|516137718|FG001|Overall Study|Study terminated due to low accrual|3|||
143161929|NCT03211832|516137719|FG000|Overall Study|No longer with agency|32|||
143161930|NCT03211832|516137720|FG001|Overall Study|No longer with agency|49|||
143161931|NCT03211832|516137721|FG002|Overall Study|No longer with agency|30|||
143161932|NCT03211832|516137719|FG000|Overall Study|Declined survey|3|||
143161933|NCT03211832|516137720|FG001|Overall Study|Declined survey|3|||
143161934|NCT03211832|516137721|FG002|Overall Study|Declined survey|2|||
143161935|NCT03211832|516137719|FG000|Overall Study|Not available during data collection|1|||
143161936|NCT03211832|516137720|FG001|Overall Study|Not available during data collection|0|||
143161937|NCT03211832|516137721|FG002|Overall Study|Not available during data collection|2|||
143161938|NCT00563316|516137722|FG000|Overall Study|Adverse Event|2|||
143161939|NCT00563316|516137722|FG000|Overall Study|Physician Decision|1|||
143161940|NCT00563316|516137722|FG000|Overall Study|Lost to Follow-up|2|||
143161941|NCT00563316|516137722|FG000|Overall Study|Death|1|||
143161942|NCT00563316|516137722|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
143161943|NCT00563316|516137722|FG000|Overall Study|Other|1|||
143161944|NCT00425854|516137726|FG000|Overall Study|Progressive Disease|19|||
143161945|NCT00425854|516137727|FG001|Overall Study|Progressive Disease|12|||
143161946|NCT00425854|516137726|FG000|Overall Study|Dose reduction toxicity AE|8|||
143161947|NCT00425854|516137727|FG001|Overall Study|Dose reduction toxicity AE|7|||
143161948|NCT00425854|516137726|FG000|Overall Study|Other Adverse Event|2|||
143161949|NCT00425854|516137727|FG001|Overall Study|Other Adverse Event|2|||
143161950|NCT01630811|516137733|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
143161951|NCT01630811|516137734|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
143161952|NCT04818086|516137737|FG000|Overall Study|Physician Decision|1|||
143161953|NCT04818086|516137738|FG001|Overall Study|Physician Decision|0|||
143161954|NCT04818086|516137737|FG000|Overall Study|Withdrawal by Subject|0|||
143161955|NCT04818086|516137738|FG001|Overall Study|Withdrawal by Subject|1|||
143161956|NCT01725308|516137740|FG000|Treatment Period I|Did Not Receive Drug|1|||
143161957|NCT01725308|516137741|FG001|Treatment Period I|Did Not Receive Drug|0|||
143161958|NCT01725308|516137742|FG002|Treatment Period I|Did Not Receive Drug|0|||
143161959|NCT01725308|516137740|FG000|Treatment Period I|Adverse Event|5|||
143161960|NCT01725308|516137741|FG001|Treatment Period I|Adverse Event|4|||
143161961|NCT01725308|516137742|FG002|Treatment Period I|Adverse Event|21|||
143161962|NCT01725308|516137740|FG000|Treatment Period I|Insufficient Response|7|||
143364135|NCT01237678|516875553|FG001|Phase II|Lack of Efficacy|25|||
143038626|NCT02186821|515684358|FG000|Overall Study|Physician Decision|1|||
143038627|NCT02186821|515684358|FG000|Overall Study|Study terminated by sponsor|2|||
143038628|NCT01313780|515684359|FG000|Overall Study|Lack of Efficacy|4|||
143038629|NCT01313780|515684360|FG001|Overall Study|Lack of Efficacy|2|||
143038630|NCT01313780|515684359|FG000|Overall Study|Adverse Event|6|||
143038631|NCT01313780|515684360|FG001|Overall Study|Adverse Event|11|||
143161963|NCT01725308|516137741|FG001|Treatment Period I|Insufficient Response|0|||
143161964|NCT01725308|516137742|FG002|Treatment Period I|Insufficient Response|5|||
143161965|NCT01725308|516137740|FG000|Treatment Period I|Worsening of the Target Disease|8|||
143161966|NCT01725308|516137741|FG001|Treatment Period I|Worsening of the Target Disease|0|||
143161967|NCT01725308|516137742|FG002|Treatment Period I|Worsening of the Target Disease|2|||
143161968|NCT01725308|516137740|FG000|Treatment Period I|Changes in the Episodes|3|||
143161969|NCT01725308|516137741|FG001|Treatment Period I|Changes in the Episodes|0|||
143161970|NCT01725308|516137742|FG002|Treatment Period I|Changes in the Episodes|2|||
143161971|NCT01725308|516137740|FG000|Treatment Period I|Withdrawal of Consent|12|||
143364136|NCT01237678|516875554|FG002|Phase II|Lack of Efficacy|3|||
143364137|NCT01237678|516875552|FG000|Phase II|Withdrawal by Subject|0|||
143038632|NCT01313780|515684359|FG000|Overall Study|Withdrawal by Subject|2|||
143038633|NCT01313780|515684360|FG001|Overall Study|Withdrawal by Subject|8|||
143038634|NCT01313780|515684359|FG000|Overall Study|Protocol Violation|10|||
143038635|NCT01313780|515684360|FG001|Overall Study|Protocol Violation|4|||
143038636|NCT01313780|515684359|FG000|Overall Study|missing data|3|||
143038637|NCT01313780|515684360|FG001|Overall Study|missing data|3|||
143038638|NCT05369208|515685562|FG000|Core Phase|Prohibited Medication Required|2|||
143038639|NCT05369208|515685562|FG000|Core Phase|Adverse Event|1|||
143038640|NCT05369208|515685562|FG000|Core Phase|Lack of Efficacy|1|||
143038641|NCT01066143|515685563|FG000|Overall Study|ineligible for the study|8|||
143038642|NCT00371839|515685566|FG000|Overall Study|Death|4|||
143038643|NCT00371839|515685567|FG001|Overall Study|Death|0|||
143038644|NCT00371839|515685568|FG002|Overall Study|Death|0|||
143038645|NCT00371839|515685566|FG000|Overall Study|Withdrawal by Subject|7|||
143038646|NCT00371839|515685567|FG001|Overall Study|Withdrawal by Subject|4|||
143038647|NCT00371839|515685568|FG002|Overall Study|Withdrawal by Subject|0|||
143038648|NCT00371839|515685566|FG000|Overall Study|Lost to Follow-up|6|||
143038649|NCT00371839|515685567|FG001|Overall Study|Lost to Follow-up|3|||
143038650|NCT00371839|515685568|FG002|Overall Study|Lost to Follow-up|2|||
143038651|NCT01149473|515685570|FG000|First Intervention|Adverse Event|1|||
143038652|NCT01149473|515685571|FG001|First Intervention|Adverse Event|1|||
143038653|NCT01149473|515685570|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
143038654|NCT01149473|515685571|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
143038655|NCT01083693|515685579|FG000|Overall Study|Adverse Event|1|||
143038656|NCT01083693|515685580|FG001|Overall Study|Adverse Event|1|||
143038657|NCT01083693|515685581|FG002|Overall Study|Adverse Event|0|||
143038658|NCT01083693|515685579|FG000|Overall Study|Lost to Follow-up|2|||
143038659|NCT01083693|515685580|FG001|Overall Study|Lost to Follow-up|0|||
143038660|NCT01083693|515685581|FG002|Overall Study|Lost to Follow-up|2|||
143038661|NCT01083693|515685579|FG000|Overall Study|Lack of effectiveness|13|||
143038662|NCT01083693|515685580|FG001|Overall Study|Lack of effectiveness|2|||
143038663|NCT01083693|515685581|FG002|Overall Study|Lack of effectiveness|2|||
143038664|NCT01083693|515685579|FG000|Overall Study|Patient Moved|0|||
143038665|NCT01083693|515685580|FG001|Overall Study|Patient Moved|1|||
143038666|NCT01083693|515685581|FG002|Overall Study|Patient Moved|0|||
143038667|NCT01083693|515685579|FG000|Overall Study|Complete remission|0|||
143038668|NCT01083693|515685580|FG001|Overall Study|Complete remission|1|||
143038669|NCT01083693|515685581|FG002|Overall Study|Complete remission|0|||
143038670|NCT01083693|515685579|FG000|Overall Study|Other medical condition/surgery|1|||
143038671|NCT01083693|515685580|FG001|Overall Study|Other medical condition/surgery|1|||
143038672|NCT01083693|515685581|FG002|Overall Study|Other medical condition/surgery|0|||
143038673|NCT01083693|515685579|FG000|Overall Study|Withdrawal by Subject|3|||
143038674|NCT01083693|515685580|FG001|Overall Study|Withdrawal by Subject|0|||
143038675|NCT01083693|515685581|FG002|Overall Study|Withdrawal by Subject|2|||
143038676|NCT01083693|515685579|FG000|Overall Study|Reason unknown|0|||
143038677|NCT01083693|515685580|FG001|Overall Study|Reason unknown|0|||
143038678|NCT01083693|515685581|FG002|Overall Study|Reason unknown|1|||
143038679|NCT04567186|515685582|FG000|Period 1|COVID-19 related|1|||
143038680|NCT04567186|515685583|FG001|Period 1|COVID-19 related|0|||
143038681|NCT04567186|515685582|FG000|Period 1|Protocol Violation|0|||
143038682|NCT04567186|515685583|FG001|Period 1|Protocol Violation|1|||
143038683|NCT04567186|515685582|FG000|Period 1|Adverse Event|0|||
143038684|NCT04567186|515685583|FG001|Period 1|Adverse Event|2|||
143038685|NCT04567186|515685582|FG000|Period 2|COVID-19 Related|0|||
143038686|NCT04567186|515685583|FG001|Period 2|COVID-19 Related|1|||
143038687|NCT04567186|515685582|FG000|Period 2|Protocol Violation|0|||
143161972|NCT01725308|516137741|FG001|Treatment Period I|Withdrawal of Consent|7|||
143161973|NCT01725308|516137742|FG002|Treatment Period I|Withdrawal of Consent|5|||
143161974|NCT01725308|516137740|FG000|Treatment Period I|Lost to Follow-up|3|||
143161975|NCT01725308|516137741|FG001|Treatment Period I|Lost to Follow-up|2|||
143161976|NCT01725308|516137742|FG002|Treatment Period I|Lost to Follow-up|2|||
143161977|NCT01725308|516137740|FG000|Treatment Period I|Protocol Deviations|3|||
143161978|NCT01725308|516137741|FG001|Treatment Period I|Protocol Deviations|1|||
143161979|NCT01725308|516137742|FG002|Treatment Period I|Protocol Deviations|1|||
143161980|NCT01725308|516137740|FG000|Treatment Period I|Miscellaneous|2|||
143161981|NCT01725308|516137741|FG001|Treatment Period I|Miscellaneous|0|||
143161982|NCT01725308|516137742|FG002|Treatment Period I|Miscellaneous|3|||
143038688|NCT04567186|515685583|FG001|Period 2|Protocol Violation|1|||
143161983|NCT01725308|516137740|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
143161984|NCT01725308|516137741|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
143038689|NCT04567186|515685582|FG000|Period 2|Lost to Follow-up|0|||
143038690|NCT04567186|515685583|FG001|Period 2|Lost to Follow-up|1|||
143038691|NCT04567186|515685582|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
143038692|NCT04567186|515685583|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
143038693|NCT04274686|515685586|FG000|Overall Study|Physician Decision|1|||
143038694|NCT04274686|515685587|FG001|Overall Study|Physician Decision|0|||
143038695|NCT00376623|515685588|FG000|Overall Study|Progressive disease|35|||
143038696|NCT00376623|515685589|FG001|Overall Study|Progressive disease|22|||
143038697|NCT00376623|515685590|FG002|Overall Study|Progressive disease|17|||
143038698|NCT00376623|515685588|FG000|Overall Study|Lost to Follow-up|0|||
143038699|NCT00376623|515685589|FG001|Overall Study|Lost to Follow-up|1|||
143038700|NCT00376623|515685590|FG002|Overall Study|Lost to Follow-up|0|||
143038701|NCT00376623|515685588|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
143038702|NCT00376623|515685589|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
143038703|NCT00376623|515685590|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
143038704|NCT00376623|515685588|FG000|Overall Study|Not treated with BI 2536|1|||
143038705|NCT00376623|515685589|FG001|Overall Study|Not treated with BI 2536|0|||
143038706|NCT00376623|515685590|FG002|Overall Study|Not treated with BI 2536|0|||
143038707|NCT00376623|515685588|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
143038708|NCT00376623|515685589|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
143038709|NCT00376623|515685590|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
143038710|NCT00376623|515685588|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
143038711|NCT00376623|515685589|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
143038712|NCT00376623|515685590|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
143038713|NCT00376623|515685588|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
143038714|NCT00376623|515685589|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
143038715|NCT00376623|515685590|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
143038716|NCT00376623|515685588|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
143038717|NCT00376623|515685589|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
143038718|NCT00376623|515685590|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
143038719|NCT00376623|515685588|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
143038720|NCT00376623|515685589|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
143038721|NCT00376623|515685590|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
143038722|NCT00376623|515685588|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
143038723|NCT00376623|515685589|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
143038724|NCT00376623|515685590|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
143038725|NCT00376623|515685588|FG000|Overall Study|Increase of tumour markers|0|||
143038726|NCT00376623|515685589|FG001|Overall Study|Increase of tumour markers|1|||
143161985|NCT01725308|516137742|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
143161986|NCT01725308|516137740|FG000|Treatment Period II|Did Not Receive Drug|4|||
143161987|NCT01725308|516137741|FG001|Treatment Period II|Did Not Receive Drug|0|||
143161988|NCT01725308|516137742|FG002|Treatment Period II|Did Not Receive Drug|0|||
143161989|NCT01725308|516137740|FG000|Treatment Period II|Adverse Event|13|||
143161990|NCT01725308|516137741|FG001|Treatment Period II|Adverse Event|8|||
143161991|NCT01725308|516137742|FG002|Treatment Period II|Adverse Event|20|||
143161992|NCT01725308|516137740|FG000|Treatment Period II|Insufficient Response|2|||
143496590|NCT03980938|517359511|FG000|Treatment Period 1|Study Terminated|1|||
143496591|NCT03980938|517359512|FG001|Treatment Period 1|Study Terminated|1|||
143496592|NCT03980938|517359511|FG000|Treatment Period 2|Study Terminated|2|||
143496593|NCT03980938|517359512|FG001|Treatment Period 2|Study Terminated|2|||
143496594|NCT00605267|517359513|FG000|Overall Study|Adverse Event|0|||
143161993|NCT01725308|516137741|FG001|Treatment Period II|Insufficient Response|4|||
143161994|NCT01725308|516137742|FG002|Treatment Period II|Insufficient Response|6|||
143161995|NCT01725308|516137740|FG000|Treatment Period II|Worsening of the Target Disease|1|||
143161996|NCT01725308|516137741|FG001|Treatment Period II|Worsening of the Target Disease|4|||
143161997|NCT01725308|516137742|FG002|Treatment Period II|Worsening of the Target Disease|2|||
143161998|NCT01725308|516137740|FG000|Treatment Period II|Changes in the Episodes|1|||
143161999|NCT01725308|516137741|FG001|Treatment Period II|Changes in the Episodes|0|||
143162000|NCT01725308|516137742|FG002|Treatment Period II|Changes in the Episodes|5|||
143162001|NCT01725308|516137740|FG000|Treatment Period II|Withdrawal of Consent|28|||
143162002|NCT01725308|516137741|FG001|Treatment Period II|Withdrawal of Consent|2|||
143162003|NCT01725308|516137742|FG002|Treatment Period II|Withdrawal of Consent|16|||
143162004|NCT01725308|516137740|FG000|Treatment Period II|Lost to Follow-up|1|||
143162005|NCT01725308|516137741|FG001|Treatment Period II|Lost to Follow-up|5|||
143364138|NCT01237678|516875553|FG001|Phase II|Withdrawal by Subject|1|||
143496595|NCT00605267|517359514|FG001|Overall Study|Adverse Event|1|||
143496596|NCT00605267|517359513|FG000|Overall Study|Lack of Efficacy|1|||
143038727|NCT00376623|515685590|FG002|Overall Study|Increase of tumour markers|0|||
143038728|NCT00376623|515685588|FG000|Overall Study|Bone metastasis|1|||
143038729|NCT00376623|515685589|FG001|Overall Study|Bone metastasis|0|||
143038730|NCT00376623|515685590|FG002|Overall Study|Bone metastasis|0|||
143038731|NCT02098876|515685591|FG000|Overall Study|Withdrawal by Subject|5|||
143038732|NCT02098876|515685592|FG001|Overall Study|Withdrawal by Subject|5|||
143038733|NCT01061866|515685593|FG000|Overall Study|Adverse Event|2|||
143162006|NCT01725308|516137742|FG002|Treatment Period II|Lost to Follow-up|3|||
143496597|NCT00605267|517359514|FG001|Overall Study|Lack of Efficacy|5|||
143239243|NCT00785785|516429824|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
143239244|NCT02282605|516429825|FG000|Overall Study|negative SA result on Day -1|3|||
143239245|NCT02282605|516429826|FG001|Overall Study|negative SA result on Day -1|0|||
143239246|NCT02282605|516429827|FG002|Overall Study|negative SA result on Day -1|0|||
143239247|NCT02215252|516429832|FG000|Overall Study|Adverse Event|1|||
143239248|NCT02215252|516429833|FG001|Overall Study|Adverse Event|5|||
143239249|NCT02215252|516429834|FG002|Overall Study|Adverse Event|2|||
143239250|NCT02215252|516429832|FG000|Overall Study|Lost to Follow-up|0|||
143239251|NCT02215252|516429833|FG001|Overall Study|Lost to Follow-up|0|||
143239252|NCT02215252|516429834|FG002|Overall Study|Lost to Follow-up|1|||
143239253|NCT02215252|516429832|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
143239254|NCT02215252|516429833|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
143239255|NCT02215252|516429834|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
143239256|NCT02215252|516429832|FG000|Overall Study|Protocol Violation|0|||
143239257|NCT02215252|516429833|FG001|Overall Study|Protocol Violation|1|||
143239258|NCT02215252|516429834|FG002|Overall Study|Protocol Violation|0|||
143239259|NCT02215252|516429832|FG000|Overall Study|Withdrawal by Subject|1|||
143239260|NCT02215252|516429833|FG001|Overall Study|Withdrawal by Subject|0|||
143239261|NCT02215252|516429834|FG002|Overall Study|Withdrawal by Subject|0|||
143239262|NCT02215252|516429832|FG000|Overall Study|Other|0|||
143239263|NCT02215252|516429833|FG001|Overall Study|Other|1|||
143239264|NCT02215252|516429834|FG002|Overall Study|Other|1|||
143239265|NCT00956007|516429835|FG000|Overall Study|Protocol Violation|27|||
143239266|NCT00956007|516429836|FG001|Overall Study|Protocol Violation|23|||
143239267|NCT01750229|516429837|FG000|Randomized Crossover Phase|Adverse Event|1|||
143239268|NCT01750229|516429837|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
143239269|NCT01750229|516429837|FG000|Long-term Follow-up Phase|Adverse Event|2|||
143496598|NCT00605267|517359513|FG000|Overall Study|Withdrawal by Subject|2|||
143496599|NCT00605267|517359514|FG001|Overall Study|Withdrawal by Subject|3|||
143496600|NCT00840827|517359515|FG000|Overall Study|Adverse Event|1|||
143496601|NCT00840827|517359515|FG000|Overall Study|Lack of Efficacy|4|||
143162007|NCT01725308|516137740|FG000|Treatment Period II|Protocol Deviations|0|||
143162008|NCT01725308|516137741|FG001|Treatment Period II|Protocol Deviations|0|||
143162009|NCT01725308|516137742|FG002|Treatment Period II|Protocol Deviations|1|||
143162010|NCT01725308|516137740|FG000|Treatment Period II|Miscellaneous|5|||
143162011|NCT01725308|516137741|FG001|Treatment Period II|Miscellaneous|3|||
143162012|NCT01725308|516137742|FG002|Treatment Period II|Miscellaneous|7|||
143162013|NCT06048705|516137746|FG000|Overall Study|Physician Decision|1|||
143162014|NCT06048705|516137747|FG001|Overall Study|Physician Decision|0|||
143162015|NCT06048705|516137748|FG002|Overall Study|Physician Decision|0|||
143162016|NCT06048705|516137746|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
143162017|NCT06048705|516137747|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
143162018|NCT06048705|516137748|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
143162019|NCT06048705|516137746|FG000|Overall Study|Death prior to lymphodepletion|0|||
143162020|NCT06048705|516137747|FG001|Overall Study|Death prior to lymphodepletion|0|||
143162021|NCT06048705|516137748|FG002|Overall Study|Death prior to lymphodepletion|1|||
143162022|NCT00215657|516137749|FG000|Overall Study|Adverse Event|5|||
143162023|NCT00215657|516137750|FG001|Overall Study|Adverse Event|1|||
143162024|NCT00215657|516137751|FG002|Overall Study|Adverse Event|3|||
143162025|NCT00215657|516137752|FG003|Overall Study|Adverse Event|0|||
143162026|NCT00215657|516137753|FG004|Overall Study|Adverse Event|3|||
143162027|NCT00215657|516137754|FG005|Overall Study|Adverse Event|1|||
143162028|NCT00215657|516137755|FG006|Overall Study|Adverse Event|0|||
143162029|NCT00215657|516137756|FG007|Overall Study|Adverse Event|3|||
143162030|NCT00215657|516137749|FG000|Overall Study|Withdrawal by Subject|6|||
143162031|NCT00215657|516137750|FG001|Overall Study|Withdrawal by Subject|3|||
143162032|NCT00215657|516137751|FG002|Overall Study|Withdrawal by Subject|3|||
143162033|NCT00215657|516137752|FG003|Overall Study|Withdrawal by Subject|1|||
143162034|NCT00215657|516137753|FG004|Overall Study|Withdrawal by Subject|6|||
143162035|NCT00215657|516137754|FG005|Overall Study|Withdrawal by Subject|1|||
143162036|NCT00215657|516137755|FG006|Overall Study|Withdrawal by Subject|10|||
143162037|NCT00215657|516137756|FG007|Overall Study|Withdrawal by Subject|3|||
143496602|NCT00840827|517359515|FG000|Overall Study|Physician Decision|1|||
143162038|NCT00215657|516137749|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
143162039|NCT00215657|516137750|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
143162040|NCT00215657|516137751|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
143496603|NCT01445535|517359516|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
143162041|NCT00215657|516137752|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
143239270|NCT01750229|516429837|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
143239271|NCT01285323|516429840|FG000|Overall Study|Adverse Event|9|||
143239272|NCT01285323|516429841|FG001|Overall Study|Adverse Event|8|||
143239273|NCT01285323|516429840|FG000|Overall Study|Lack of Efficacy|4|||
143239274|NCT01285323|516429841|FG001|Overall Study|Lack of Efficacy|2|||
143162042|NCT00215657|516137753|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
143162043|NCT00215657|516137754|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
143038734|NCT01270503|515685594|FG000|Overall Study|Lost to Follow-up|1|||
143038735|NCT03020615|515685595|FG000|Overall Study|Physician Decision|3|||
143038736|NCT03020615|515685596|FG001|Overall Study|Physician Decision|1|||
143038737|NCT03020615|515685597|FG002|Overall Study|Physician Decision|2|||
143038738|NCT03020615|515685595|FG000|Overall Study|Parent/guardian/patient choice|3|||
143038739|NCT03020615|515685596|FG001|Overall Study|Parent/guardian/patient choice|0|||
143038740|NCT03020615|515685597|FG002|Overall Study|Parent/guardian/patient choice|4|||
143038741|NCT03020615|515685595|FG000|Overall Study|Screen failure|0|||
143038742|NCT03020615|515685596|FG001|Overall Study|Screen failure|0|||
143038743|NCT03020615|515685597|FG002|Overall Study|Screen failure|1|||
143038744|NCT03020615|515685595|FG000|Overall Study|Death|1|||
143038745|NCT03020615|515685596|FG001|Overall Study|Death|0|||
143038746|NCT03020615|515685597|FG002|Overall Study|Death|0|||
143038747|NCT03020615|515685595|FG000|Overall Study|Lost to Follow-up|0|||
143038748|NCT03020615|515685596|FG001|Overall Study|Lost to Follow-up|1|||
143038749|NCT03020615|515685597|FG002|Overall Study|Lost to Follow-up|0|||
143038750|NCT00252720|515685599|FG000|Overall Study|Withdrawal by Subject|95|||
143038751|NCT00252720|515685600|FG001|Overall Study|Withdrawal by Subject|97|||
143038752|NCT00252720|515685599|FG000|Overall Study|Death|7|||
143038753|NCT00252720|515685600|FG001|Overall Study|Death|8|||
143038754|NCT00252720|515685599|FG000|Overall Study|Moving|23|||
143038755|NCT00252720|515685600|FG001|Overall Study|Moving|42|||
143038756|NCT00252720|515685599|FG000|Overall Study|Mainly patients lost to follow-up|7|||
143038757|NCT00252720|515685600|FG001|Overall Study|Mainly patients lost to follow-up|18|||
143038758|NCT02077465|515685603|FG000|Overall Study|Withdrew Consent|0|||
143038759|NCT02077465|515685604|FG001|Overall Study|Withdrew Consent|1|||
143038760|NCT02077465|515685603|FG000|Overall Study|Lost to Follow-up|1|||
143038761|NCT02077465|515685604|FG001|Overall Study|Lost to Follow-up|0|||
143038762|NCT02481830|515685605|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
143038763|NCT02481830|515685606|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
143038764|NCT02481830|515685605|FG000|Pre-treatment|Withdrawal by Subject|0|||
143038765|NCT02481830|515685606|FG001|Pre-treatment|Withdrawal by Subject|10|||
143038766|NCT02481830|515685605|FG000|Pre-treatment|Disease Progression|1|||
143038767|NCT02481830|515685606|FG001|Pre-treatment|Disease Progression|1|||
143038768|NCT02481830|515685605|FG000|Pre-treatment|Other reasons|0|||
143038769|NCT02481830|515685606|FG001|Pre-treatment|Other reasons|1|||
143038770|NCT02481830|515685605|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
143038771|NCT02481830|515685606|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
143038772|NCT02481830|515685605|FG000|Treatment|Disease Progression|233|||
143038773|NCT02481830|515685606|FG001|Treatment|Disease Progression|171|||
143038774|NCT02481830|515685605|FG000|Treatment|Study drug toxicity|18|||
143038775|NCT02481830|515685606|FG001|Treatment|Study drug toxicity|38|||
143038776|NCT02481830|515685605|FG000|Treatment|Death|1|||
143038777|NCT02481830|515685606|FG001|Treatment|Death|1|||
143038778|NCT02481830|515685605|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
143038779|NCT02481830|515685606|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
143038780|NCT02481830|515685605|FG000|Treatment|Participants request to discontinue Study treatment|6|||
143038781|NCT02481830|515685606|FG001|Treatment|Participants request to discontinue Study treatment|34|||
143038782|NCT02481830|515685605|FG000|Treatment|Withdrawal by Subject|2|||
143038783|NCT02481830|515685606|FG001|Treatment|Withdrawal by Subject|3|||
143038784|NCT02481830|515685605|FG000|Treatment|Lost to Follow-up|1|||
143038785|NCT02481830|515685606|FG001|Treatment|Lost to Follow-up|0|||
143038786|NCT02481830|515685605|FG000|Treatment|Maximum Clinical Benefit|0|||
143038787|NCT02481830|515685606|FG001|Treatment|Maximum Clinical Benefit|5|||
143038788|NCT02481830|515685605|FG000|Treatment|Administrative reason by sponsor|1|||
143038789|NCT02481830|515685606|FG001|Treatment|Administrative reason by sponsor|1|||
143038790|NCT02481830|515685605|FG000|Treatment|Other reasons|6|||
143038791|NCT02481830|515685606|FG001|Treatment|Other reasons|1|||
143038792|NCT04627038|515685607|FG000|Overall Study|Adverse Event|36|||
143038793|NCT04627038|515685608|FG001|Overall Study|Adverse Event|8|||
143038794|NCT04627038|515685607|FG000|Overall Study|Lost to Follow-up|1|||
143038795|NCT04627038|515685608|FG001|Overall Study|Lost to Follow-up|0|||
143038796|NCT04627038|515685607|FG000|Overall Study|Physician Decision|0|||
143038797|NCT04627038|515685608|FG001|Overall Study|Physician Decision|1|||
143038798|NCT04627038|515685607|FG000|Overall Study|Protocol Violation|3|||
143038799|NCT04627038|515685608|FG001|Overall Study|Protocol Violation|1|||
143038800|NCT04627038|515685607|FG000|Overall Study|Withdrawal by Subject|13|||
143038801|NCT04627038|515685608|FG001|Overall Study|Withdrawal by Subject|3|||
143038802|NCT04627038|515685607|FG000|Overall Study|Non-compliance with study drug|0|||
143038803|NCT04627038|515685608|FG001|Overall Study|Non-compliance with study drug|1|||
143038804|NCT04627038|515685607|FG000|Overall Study|Prohibited Concomitant Medication|1|||
143038805|NCT04627038|515685608|FG001|Overall Study|Prohibited Concomitant Medication|0|||
143038806|NCT03956862|515685609|FG000|Overall Study|Lost to Follow-up|1|||
143038807|NCT03956862|515685610|FG001|Overall Study|Lost to Follow-up|1|||
143038808|NCT03956862|515685609|FG000|Overall Study|Withdrawal by Subject|1|||
143038809|NCT03956862|515685610|FG001|Overall Study|Withdrawal by Subject|1|||
143038810|NCT02017223|515685614|FG000|Overall Study|Algorithm problems|2|||
143038811|NCT00365846|515685619|FG000|Overall Study|Lost to Follow-up|1|||
143496604|NCT01445535|517359517|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
143496605|NCT01445535|517359518|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
143496606|NCT01445535|517359519|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
143496607|NCT01445535|517359516|FG000|Overall Study|Disease progression|1|||
143496608|NCT01445535|517359517|FG001|Overall Study|Disease progression|0|||
143496609|NCT01445535|517359518|FG002|Overall Study|Disease progression|1|||
143496610|NCT01445535|517359519|FG003|Overall Study|Disease progression|0|||
143496611|NCT01445535|517359516|FG000|Overall Study|PI discretion|0|||
143496612|NCT01445535|517359517|FG001|Overall Study|PI discretion|0|||
143496613|NCT01445535|517359518|FG002|Overall Study|PI discretion|0|||
143496614|NCT01445535|517359519|FG003|Overall Study|PI discretion|1|||
143496615|NCT03569202|517359525|FG000|Part 3|Physician Decision|1|||
143496616|NCT03569202|517359526|FG001|Part 3|Physician Decision|0|||
143496617|NCT03569202|517359525|FG000|Part 3|Other|1|||
143496618|NCT03569202|517359526|FG001|Part 3|Other|1|||
143496619|NCT00420511|517359527|FG000|Overall Study|Adverse Event|1|||
143496620|NCT00420511|517359528|FG001|Overall Study|Adverse Event|1|||
143496621|NCT00420511|517359527|FG000|Overall Study|Lost to Follow-up|1|||
143162044|NCT00215657|516137755|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
143162045|NCT00215657|516137756|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
143162046|NCT00215657|516137749|FG000|Overall Study|Insufficient testosterone response|5|||
143162047|NCT00215657|516137750|FG001|Overall Study|Insufficient testosterone response|4|||
143162048|NCT00215657|516137751|FG002|Overall Study|Insufficient testosterone response|1|||
143162049|NCT00215657|516137752|FG003|Overall Study|Insufficient testosterone response|12|||
143162050|NCT00215657|516137753|FG004|Overall Study|Insufficient testosterone response|8|||
143162051|NCT00215657|516137754|FG005|Overall Study|Insufficient testosterone response|12|||
143162052|NCT00215657|516137755|FG006|Overall Study|Insufficient testosterone response|4|||
143162053|NCT00215657|516137756|FG007|Overall Study|Insufficient testosterone response|7|||
143162054|NCT00215657|516137749|FG000|Overall Study|Other|3|||
143162055|NCT00215657|516137750|FG001|Overall Study|Other|1|||
143162056|NCT00215657|516137751|FG002|Overall Study|Other|2|||
143162057|NCT00215657|516137752|FG003|Overall Study|Other|3|||
143162058|NCT00215657|516137753|FG004|Overall Study|Other|5|||
143162059|NCT00215657|516137754|FG005|Overall Study|Other|4|||
143162060|NCT00215657|516137755|FG006|Overall Study|Other|6|||
143162061|NCT00215657|516137756|FG007|Overall Study|Other|1|||
143162062|NCT01185366|516137761|FG000|First Line Therapy|Insurance Coverage Denied|1|||
143162063|NCT01185366|516137762|FG001|First Line Therapy|Insurance Coverage Denied|1|||
143162064|NCT01185366|516137761|FG000|First Line Therapy|Withdrawal by Subject|1|||
143162065|NCT01185366|516137762|FG001|First Line Therapy|Withdrawal by Subject|0|||
143162066|NCT01185366|516137761|FG000|First Line Therapy|Lack of Metastatic Site|1|||
143162067|NCT01185366|516137762|FG001|First Line Therapy|Lack of Metastatic Site|0|||
143162068|NCT01185366|516137761|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
143162069|NCT01185366|516137762|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
143162070|NCT01185366|516137761|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
143162071|NCT01185366|516137762|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
143162072|NCT01185366|516137761|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
143162073|NCT01185366|516137762|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
143162074|NCT01185366|516137761|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
143162075|NCT01185366|516137762|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
143162076|NCT01539525|516137763|FG000|Overall Study|Lost to Follow-up|19|||
143162077|NCT01539525|516137764|FG001|Overall Study|Lost to Follow-up|12|||
143162078|NCT01539525|516137765|FG002|Overall Study|Lost to Follow-up|11|||
143162079|NCT01539525|516137763|FG000|Overall Study|Withdrawal by Subject|0|||
143162080|NCT01539525|516137764|FG001|Overall Study|Withdrawal by Subject|3|||
143162081|NCT01539525|516137765|FG002|Overall Study|Withdrawal by Subject|2|||
143162082|NCT01539525|516137763|FG000|Overall Study|Protocol Violation|1|||
143162083|NCT01539525|516137764|FG001|Overall Study|Protocol Violation|1|||
143162084|NCT01539525|516137765|FG002|Overall Study|Protocol Violation|4|||
143162085|NCT02205359|516137766|FG000|Overall Study|Death|293|||
143162086|NCT02205359|516137767|FG001|Overall Study|Death|327|||
143162087|NCT02205359|516137766|FG000|Overall Study|Lost to Follow-up|182|||
143162088|NCT02205359|516137767|FG001|Overall Study|Lost to Follow-up|162|||
143162089|NCT02205359|516137766|FG000|Overall Study|Physician Decision|51|||
143162090|NCT02205359|516137767|FG001|Overall Study|Physician Decision|53|||
143162091|NCT02205359|516137766|FG000|Overall Study|Withdrawal by Subject|167|||
143496622|NCT00420511|517359528|FG001|Overall Study|Lost to Follow-up|0|||
143496623|NCT02415712|517359529|FG000|Overall Study|Protocol Violation|16|||
143496624|NCT01668654|517359530|FG000|Overall Study|Study Closed/Terminated|3|||
143496625|NCT01668654|517359530|FG000|Overall Study|Withdrawal by Subject|1|||
143496626|NCT04557384|517359531|FG000|Overall Study|Study Terminated by Sponsor|1|||
143496627|NCT04557384|517359531|FG000|Overall Study|Death|1|||
143496628|NCT00454779|517359533|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
143162092|NCT02205359|516137767|FG001|Overall Study|Withdrawal by Subject|169|||
143496629|NCT00454779|517359534|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
143496630|NCT00454779|517359533|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
143038812|NCT02057458|515685625|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
143038813|NCT02057458|515685626|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
143038814|NCT02057458|515685627|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
143038815|NCT02057458|515685625|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
143038816|NCT02057458|515685626|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
143038817|NCT02057458|515685627|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
143038818|NCT02057458|515685625|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
143038819|NCT02057458|515685626|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
143038820|NCT02057458|515685627|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
143038821|NCT04263649|515685628|FG000|Overall Study|Adverse Event|53|||
143038822|NCT04263649|515685628|FG000|Overall Study|Lost to Follow-up|3|||
143038823|NCT04263649|515685628|FG000|Overall Study|Death|29|||
143038824|NCT04263649|515685628|FG000|Overall Study|Device deficiency|19|||
143038825|NCT04263649|515685628|FG000|Overall Study|other reasons|11|||
143038826|NCT05169710|515685631|FG000|Overall Study|Adverse Event|1|||
143038827|NCT05169710|515685632|FG001|Overall Study|Adverse Event|2|||
143162093|NCT02792257|516137768|FG000|Overall Study|Lost to Follow-up|3|||
143162094|NCT02792257|516137769|FG001|Overall Study|Lost to Follow-up|4|||
143162095|NCT02792257|516137768|FG000|Overall Study|Allergy|0|||
143162096|NCT02792257|516137769|FG001|Overall Study|Allergy|1|||
143162097|NCT02792257|516137768|FG000|Overall Study|Protocol Violation|2|||
143162098|NCT02792257|516137769|FG001|Overall Study|Protocol Violation|0|||
143162099|NCT02792257|516137768|FG000|Overall Study|Excessive Agitation|0|||
143162100|NCT02792257|516137769|FG001|Overall Study|Excessive Agitation|1|||
143162101|NCT02792257|516137768|FG000|Overall Study|Not Feeling Well|0|||
143162102|NCT02792257|516137769|FG001|Overall Study|Not Feeling Well|1|||
143162103|NCT02496156|516137770|FG000|Overall Study|Lost to Follow-up|5|||
143162104|NCT02496156|516137771|FG001|Overall Study|Lost to Follow-up|0|||
143162105|NCT02496156|516137770|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
143162106|NCT02496156|516137771|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
143162107|NCT02457546|516139596|FG000|Overall Study|Other reasons|4|||
143162108|NCT02457546|516139597|FG001|Overall Study|Other reasons|1|||
143162109|NCT02457546|516139596|FG000|Overall Study|Refused to complete study/procedures|1|||
143162110|NCT02457546|516139597|FG001|Overall Study|Refused to complete study/procedures|1|||
143162111|NCT02457546|516139596|FG000|Overall Study|Lost to Follow-up|4|||
143162112|NCT02457546|516139597|FG001|Overall Study|Lost to Follow-up|1|||
143162113|NCT02457546|516139596|FG000|Overall Study|Adverse Event|0|||
143162114|NCT02457546|516139597|FG001|Overall Study|Adverse Event|1|||
143162115|NCT01897896|516139598|FG000|Overall Study|Death|1|||
143162116|NCT01897896|516139599|FG001|Overall Study|Death|0|||
143162117|NCT01897896|516139598|FG000|Overall Study|Adverse Event|11|||
143162118|NCT01897896|516139599|FG001|Overall Study|Adverse Event|1|||
143162119|NCT01897896|516139598|FG000|Overall Study|Lost to Follow-up|1|||
143162120|NCT01897896|516139599|FG001|Overall Study|Lost to Follow-up|0|||
143162121|NCT01897896|516139598|FG000|Overall Study|Non-compliance with study drug dosing|1|||
143162122|NCT01897896|516139599|FG001|Overall Study|Non-compliance with study drug dosing|1|||
143162123|NCT01897896|516139598|FG000|Overall Study|Withdrawal by Subject|7|||
143162124|NCT01897896|516139599|FG001|Overall Study|Withdrawal by Subject|1|||
143162125|NCT01897896|516139598|FG000|Overall Study|Require drug that interfere with study|1|||
143162126|NCT01897896|516139599|FG001|Overall Study|Require drug that interfere with study|4|||
143162127|NCT01897896|516139598|FG000|Overall Study|Protocol Violation|1|||
143162128|NCT01897896|516139599|FG001|Overall Study|Protocol Violation|1|||
143162129|NCT01897896|516139598|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
143162130|NCT01897896|516139599|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
143162131|NCT01897896|516139598|FG000|Overall Study|Caregiver can no longer participate|0|||
143162132|NCT01897896|516139599|FG001|Overall Study|Caregiver can no longer participate|2|||
143162133|NCT01897896|516139598|FG000|Overall Study|Other than specified|2|||
143162134|NCT01897896|516139599|FG001|Overall Study|Other than specified|1|||
143162135|NCT05069415|516139600|FG000|Overall Study|Withdrawal by Subject|2|||
143162136|NCT05069415|516139601|FG001|Overall Study|Withdrawal by Subject|0|||
143162137|NCT05069415|516139600|FG000|Overall Study|Adverse Event|2|||
143162138|NCT05069415|516139601|FG001|Overall Study|Adverse Event|0|||
143162139|NCT03160573|516139604|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
143162140|NCT03160573|516139605|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
143364139|NCT01237678|516875554|FG002|Phase II|Withdrawal by Subject|5|||
143038828|NCT05169710|515685633|FG002|Overall Study|Adverse Event|2|||
143162141|NCT03160573|516139606|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
143162142|NCT03160573|516139607|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
143162143|NCT00101400|516139608|FG000|Survival Follow-Up|Alive|7|||
143162144|NCT05333965|516139612|FG000|First Intervention|Adverse Event|0|||
143162145|NCT05333965|516139613|FG001|First Intervention|Adverse Event|1|||
143162146|NCT05333965|516139612|FG000|First Intervention|Withdrawal by Subject|0|||
143162147|NCT05333965|516139613|FG001|First Intervention|Withdrawal by Subject|1|||
143162148|NCT01730729|516139616|FG000|Overall Study|Adverse Event|1|||
143162149|NCT01730729|516139616|FG000|Overall Study|Death|1|||
143496631|NCT00454779|517359534|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
143496632|NCT00454779|517359533|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
143496633|NCT00454779|517359534|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
143496634|NCT00454779|517359533|FG000|First-line Treatment Phase|Protocol Violation|0|||
143038829|NCT05169710|515685631|FG000|Overall Study|Lost to Follow-up|0|||
143038830|NCT05169710|515685632|FG001|Overall Study|Lost to Follow-up|0|||
143038831|NCT05169710|515685633|FG002|Overall Study|Lost to Follow-up|1|||
143038832|NCT05169710|515685631|FG000|Overall Study|Withdrawal by Subject|2|||
143038833|NCT05169710|515685632|FG001|Overall Study|Withdrawal by Subject|1|||
143038834|NCT05169710|515685633|FG002|Overall Study|Withdrawal by Subject|0|||
143038835|NCT05169710|515685631|FG000|Overall Study|Other Study Discontinuation Reason|0|||
143038836|NCT05169710|515685632|FG001|Overall Study|Other Study Discontinuation Reason|2|||
143038837|NCT05169710|515685633|FG002|Overall Study|Other Study Discontinuation Reason|0|||
143038838|NCT00836056|515685639|FG000|First Intervention|Adverse Event|1|||
143162150|NCT01730729|516139616|FG000|Overall Study|Progressive Disease|12|||
143162151|NCT00871000|516139617|FG000|Overall Study|Withdrawal by Subject|1|||
143162152|NCT00871000|516139618|FG001|Overall Study|Withdrawal by Subject|0|||
143162153|NCT01052428|516139619|FG000|Overall Study|Death|1|||
143162154|NCT01052428|516139620|FG001|Overall Study|Death|0|||
143162155|NCT01052428|516139619|FG000|Overall Study|Withdrawal by Subject|0|||
143162156|NCT01052428|516139620|FG001|Overall Study|Withdrawal by Subject|1|||
143162157|NCT02402907|516139625|FG000|Overall Study|Delivered vaginally|9|||
143162158|NCT02402907|516139626|FG001|Overall Study|Delivered vaginally|3|||
143162159|NCT02402907|516139625|FG000|Overall Study|Delivered outside of Sinai|1|||
143162160|NCT02402907|516139626|FG001|Overall Study|Delivered outside of Sinai|1|||
143162161|NCT02402907|516139625|FG000|Overall Study|Lost to follow up after C-Section|10|||
143162162|NCT02402907|516139626|FG001|Overall Study|Lost to follow up after C-Section|23|||
143162163|NCT03574389|516139627|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
143162164|NCT03574389|516139628|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
143162165|NCT03574389|516139629|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
143162166|NCT03574389|516139630|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
143162167|NCT03574389|516139631|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
143162168|NCT03574389|516139632|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
143162169|NCT03574389|516139633|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
143162170|NCT03574389|516139627|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
143162171|NCT03574389|516139628|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
143162172|NCT03574389|516139629|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
143162173|NCT03574389|516139630|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
143162174|NCT03574389|516139631|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
143162175|NCT03574389|516139632|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
143162176|NCT03574389|516139633|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
143162177|NCT03574389|516139627|FG000|Vaccination Period|Other|6|||
143162178|NCT03574389|516139628|FG001|Vaccination Period|Other|0|||
143162179|NCT03574389|516139629|FG002|Vaccination Period|Other|0|||
143162180|NCT03574389|516139630|FG003|Vaccination Period|Other|0|||
143162181|NCT03574389|516139631|FG004|Vaccination Period|Other|0|||
143162182|NCT03574389|516139632|FG005|Vaccination Period|Other|0|||
143162183|NCT03574389|516139633|FG006|Vaccination Period|Other|0|||
143162184|NCT03574389|516139627|FG000|Vaccination Period|Adverse Event|0|||
143162185|NCT03574389|516139628|FG001|Vaccination Period|Adverse Event|1|||
143162186|NCT03574389|516139629|FG002|Vaccination Period|Adverse Event|0|||
143162187|NCT03574389|516139630|FG003|Vaccination Period|Adverse Event|0|||
143162188|NCT03574389|516139631|FG004|Vaccination Period|Adverse Event|0|||
143162189|NCT03574389|516139632|FG005|Vaccination Period|Adverse Event|0|||
143162190|NCT03574389|516139633|FG006|Vaccination Period|Adverse Event|0|||
143162191|NCT03574389|516139627|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
143162192|NCT03574389|516139628|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
143162193|NCT03574389|516139629|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
143162194|NCT03574389|516139630|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
143162195|NCT03574389|516139631|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
143162196|NCT03574389|516139632|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
143162197|NCT03574389|516139633|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
143162198|NCT01682603|516139634|FG000|Overall Study|Lost to Follow-up|3|||
143162199|NCT02462057|516139635|FG000|Overall Study|Left Vitality|32|||
143162200|NCT02462057|516139636|FG001|Overall Study|Left Vitality|27|||
143162201|NCT02462057|516139637|FG002|Overall Study|Left Vitality|23|||
143162202|NCT02462057|516139638|FG003|Overall Study|Left Vitality|35|||
143162203|NCT02462057|516139639|FG004|Overall Study|Left Vitality|33|||
143162204|NCT02462057|516139635|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
143162205|NCT02462057|516139636|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
143162206|NCT02462057|516139637|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
143162207|NCT02462057|516139638|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
143162208|NCT02462057|516139639|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
143496635|NCT00454779|517359534|FG001|First-line Treatment Phase|Protocol Violation|1|||
143038839|NCT00836056|515685640|FG001|First Intervention|Adverse Event|0|||
143038840|NCT00846495|515685641|FG000|Overall Study|Lost to Follow-up|1|||
143038841|NCT00846495|515685642|FG001|Overall Study|Lost to Follow-up|0|||
143162209|NCT01908699|516139640|FG000|Overall Study|Adverse Event|8|||
143162210|NCT01908699|516139641|FG001|Overall Study|Adverse Event|12|||
143162211|NCT01908699|516139640|FG000|Overall Study|Lack of Efficacy|2|||
143162212|NCT01908699|516139641|FG001|Overall Study|Lack of Efficacy|2|||
143162213|NCT01908699|516139640|FG000|Overall Study|Lost to Follow-up|2|||
143162214|NCT01908699|516139641|FG001|Overall Study|Lost to Follow-up|4|||
143162215|NCT01908699|516139640|FG000|Overall Study|Physician Decision|8|||
143162216|NCT01908699|516139641|FG001|Overall Study|Physician Decision|8|||
143162217|NCT01908699|516139640|FG000|Overall Study|Withdrawal by Subject|15|||
143162218|NCT01908699|516139641|FG001|Overall Study|Withdrawal by Subject|10|||
143162219|NCT01908699|516139640|FG000|Overall Study|Pregnancy|0|||
143162220|NCT01908699|516139641|FG001|Overall Study|Pregnancy|1|||
143162221|NCT01908699|516139640|FG000|Overall Study|Randomized in Error|1|||
143162222|NCT01908699|516139641|FG001|Overall Study|Randomized in Error|0|||
143162223|NCT01908699|516139640|FG000|Overall Study|Death|9|||
143162224|NCT01908699|516139641|FG001|Overall Study|Death|12|||
143162225|NCT01908699|516139640|FG000|Overall Study|Progressive Disease|30|||
143162226|NCT01908699|516139641|FG001|Overall Study|Progressive Disease|29|||
143162227|NCT01697501|516139642|FG000|Overall Study|Protocol Violation|2|||
143162228|NCT00159874|516139645|FG000|Overall Study|Adverse Event|2|||
143162229|NCT00159874|516139646|FG001|Overall Study|Adverse Event|2|||
143162230|NCT00159874|516139647|FG002|Overall Study|Adverse Event|5|||
143162231|NCT00159874|516139648|FG003|Overall Study|Adverse Event|1|||
143162232|NCT00159874|516139649|FG004|Overall Study|Adverse Event|1|||
143162233|NCT00159874|516139650|FG005|Overall Study|Adverse Event|2|||
143162234|NCT00159874|516139651|FG006|Overall Study|Adverse Event|0|||
143162235|NCT00159874|516139645|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
143162236|NCT00159874|516139646|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
143162237|NCT00159874|516139647|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
143162238|NCT00159874|516139648|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
143162239|NCT00159874|516139649|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
143162240|NCT00159874|516139650|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
143162241|NCT00159874|516139651|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
143162242|NCT00159874|516139645|FG000|Overall Study|Lack of Efficacy|2|||
143162243|NCT00159874|516139646|FG001|Overall Study|Lack of Efficacy|0|||
143162244|NCT00159874|516139647|FG002|Overall Study|Lack of Efficacy|1|||
143162245|NCT00159874|516139648|FG003|Overall Study|Lack of Efficacy|1|||
143162246|NCT00159874|516139649|FG004|Overall Study|Lack of Efficacy|0|||
143162247|NCT00159874|516139650|FG005|Overall Study|Lack of Efficacy|3|||
143162248|NCT00159874|516139651|FG006|Overall Study|Lack of Efficacy|0|||
143162249|NCT00159874|516139645|FG000|Overall Study|Lost to Follow-up|1|||
143162250|NCT00159874|516139646|FG001|Overall Study|Lost to Follow-up|0|||
143162251|NCT00159874|516139647|FG002|Overall Study|Lost to Follow-up|3|||
143162252|NCT00159874|516139648|FG003|Overall Study|Lost to Follow-up|0|||
143162253|NCT00159874|516139649|FG004|Overall Study|Lost to Follow-up|1|||
143162254|NCT00159874|516139650|FG005|Overall Study|Lost to Follow-up|2|||
143162255|NCT00159874|516139651|FG006|Overall Study|Lost to Follow-up|1|||
143162256|NCT00159874|516139645|FG000|Overall Study|Other|8|||
143162257|NCT00159874|516139646|FG001|Overall Study|Other|8|||
143162258|NCT00159874|516139647|FG002|Overall Study|Other|8|||
143162259|NCT00159874|516139648|FG003|Overall Study|Other|0|||
143162260|NCT00159874|516139649|FG004|Overall Study|Other|2|||
143162261|NCT00159874|516139650|FG005|Overall Study|Other|1|||
143162262|NCT00159874|516139651|FG006|Overall Study|Other|3|||
143162263|NCT00159874|516139645|FG000|Overall Study|Protocol Violation|0|||
143162264|NCT00159874|516139646|FG001|Overall Study|Protocol Violation|5|||
143162265|NCT00159874|516139647|FG002|Overall Study|Protocol Violation|2|||
143162266|NCT00159874|516139648|FG003|Overall Study|Protocol Violation|0|||
143162267|NCT00159874|516139649|FG004|Overall Study|Protocol Violation|0|||
143162268|NCT00159874|516139650|FG005|Overall Study|Protocol Violation|0|||
143239275|NCT01285323|516429840|FG000|Overall Study|Withdrawal by Subject|15|||
143162269|NCT00159874|516139651|FG006|Overall Study|Protocol Violation|0|||
143162270|NCT00159874|516139645|FG000|Overall Study|Death|3|||
143162271|NCT00159874|516139646|FG001|Overall Study|Death|8|||
143162272|NCT00159874|516139647|FG002|Overall Study|Death|15|||
143162273|NCT00159874|516139648|FG003|Overall Study|Death|0|||
143162274|NCT00159874|516139649|FG004|Overall Study|Death|1|||
143239276|NCT01285323|516429841|FG001|Overall Study|Withdrawal by Subject|11|||
143162275|NCT00159874|516139650|FG005|Overall Study|Death|2|||
143162276|NCT00159874|516139651|FG006|Overall Study|Death|0|||
143162277|NCT00159874|516139645|FG000|Overall Study|Withdrawal by Subject|2|||
143162278|NCT00159874|516139646|FG001|Overall Study|Withdrawal by Subject|6|||
143162279|NCT00159874|516139647|FG002|Overall Study|Withdrawal by Subject|8|||
143162280|NCT00159874|516139648|FG003|Overall Study|Withdrawal by Subject|4|||
143162281|NCT00159874|516139649|FG004|Overall Study|Withdrawal by Subject|3|||
143162282|NCT00159874|516139650|FG005|Overall Study|Withdrawal by Subject|2|||
143162283|NCT00159874|516139651|FG006|Overall Study|Withdrawal by Subject|1|||
143162284|NCT00159874|516139645|FG000|Overall Study|Pregnancy|1|||
143496636|NCT00454779|517359533|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
143038842|NCT00846495|515685641|FG000|Overall Study|Adverse Event|5|||
143038843|NCT00846495|515685642|FG001|Overall Study|Adverse Event|1|||
143038844|NCT00846495|515685641|FG000|Overall Study|Lack of Efficacy|1|||
143038845|NCT00846495|515685642|FG001|Overall Study|Lack of Efficacy|2|||
143038846|NCT00846495|515685641|FG000|Overall Study|Physician Decision|1|||
143038847|NCT00846495|515685642|FG001|Overall Study|Physician Decision|0|||
143038848|NCT01001208|515685643|FG000|Overall Study|Adverse Event|10|||
143038849|NCT01001208|515685644|FG001|Overall Study|Adverse Event|5|||
143038850|NCT01001208|515685643|FG000|Overall Study|Lost to Follow-up|5|||
143038851|NCT01001208|515685644|FG001|Overall Study|Lost to Follow-up|9|||
143038852|NCT01001208|515685643|FG000|Overall Study|Physician Decision|1|||
143038853|NCT01001208|515685644|FG001|Overall Study|Physician Decision|0|||
143038854|NCT01001208|515685643|FG000|Overall Study|Withdrawal by Subject|4|||
143038855|NCT01001208|515685644|FG001|Overall Study|Withdrawal by Subject|5|||
143038856|NCT01001208|515685643|FG000|Overall Study|Ineligibility Determined|4|||
143038857|NCT01001208|515685644|FG001|Overall Study|Ineligibility Determined|2|||
143038858|NCT01001208|515685643|FG000|Overall Study|Noncompliance|4|||
143038859|NCT01001208|515685644|FG001|Overall Study|Noncompliance|7|||
143038860|NCT01001208|515685643|FG000|Overall Study|Disease Progression|0|||
143038861|NCT01001208|515685644|FG001|Overall Study|Disease Progression|3|||
143038862|NCT01001208|515685643|FG000|Overall Study|Other|0|||
143038863|NCT01001208|515685644|FG001|Overall Study|Other|2|||
143038864|NCT02158663|515685645|FG000|Overall Study|Withdrawal by Subject|5|||
143038865|NCT02158663|515685646|FG001|Overall Study|Withdrawal by Subject|4|||
143038866|NCT01265056|515685647|FG000|Initial Study Period|Withdrawal by Subject|1|||
143038867|NCT01265056|515685648|FG001|Initial Study Period|Withdrawal by Subject|1|||
143038868|NCT01265056|515685647|FG000|Initial Study Period|Withdrawal by Subject|1|||
143038869|NCT01265056|515685648|FG001|Initial Study Period|Withdrawal by Subject|1|||
143038870|NCT01265056|515685647|FG000|Follow up|Lost to Follow-up|7|||
143038871|NCT01265056|515685648|FG001|Follow up|Lost to Follow-up|3|||
143038872|NCT02711852|515685654|FG000|Overall Study|Death|5|||
143038873|NCT02711852|515685654|FG000|Overall Study|Lost to Follow-up|1|||
143038874|NCT02711852|515685654|FG000|Overall Study|Completed follow-up|3|||
143038875|NCT02711852|515685654|FG000|Overall Study|Withdrawal by Subject|1|||
143038876|NCT02601560|515685655|FG000|Overall Study|Other|0|||
143038877|NCT02601560|515685656|FG001|Overall Study|Other|0|||
143038878|NCT02601560|515685657|FG002|Overall Study|Other|0|||
143038879|NCT02601560|515685658|FG003|Overall Study|Other|0|||
143038880|NCT02601560|515685659|FG004|Overall Study|Other|0|||
143038881|NCT02601560|515685660|FG005|Overall Study|Other|0|||
143038882|NCT02601560|515685661|FG006|Overall Study|Other|1|||
143038883|NCT02601560|515685662|FG007|Overall Study|Other|0|||
143038884|NCT02392000|515685668|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
143038885|NCT02392000|515685668|FG000|Overall Study|Withdrawal by Subject|1|||
143038886|NCT02392000|515685668|FG000|Overall Study|Lost to Follow-up|8|||
143038887|NCT04384978|515685669|FG000|Overall Study|Withdrawal by Subject|4|||
143038888|NCT04384978|515685670|FG001|Overall Study|Withdrawal by Subject|0|||
143038889|NCT03420300|515685678|FG000|Overall Study|Death|2|||
143038890|NCT02032888|515685689|FG000|Treatment Period|Poor compliance/noncompliance|1|||
143038891|NCT02032888|515685690|FG001|Treatment Period|Poor compliance/noncompliance|1|||
143038892|NCT02032888|515685691|FG002|Treatment Period|Poor compliance/noncompliance|0|||
143038893|NCT02032888|515685689|FG000|Treatment Period|Other|1|||
143038894|NCT02032888|515685690|FG001|Treatment Period|Other|1|||
143038895|NCT02032888|515685691|FG002|Treatment Period|Other|0|||
143038896|NCT02032888|515685689|FG000|Follow-up Period|Lost to Follow-up|1|||
143038897|NCT02032888|515685690|FG001|Follow-up Period|Lost to Follow-up|1|||
143038898|NCT02032888|515685691|FG002|Follow-up Period|Lost to Follow-up|0|||
143038899|NCT02032888|515685689|FG000|Follow-up Period|Death|1|||
143496637|NCT00454779|517359534|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
143496638|NCT00454779|517359533|FG000|First-line Treatment Phase|Ongoing|1|||
143038900|NCT02032888|515685690|FG001|Follow-up Period|Death|1|||
143038901|NCT02032888|515685691|FG002|Follow-up Period|Death|0|||
143496639|NCT00454779|517359534|FG001|First-line Treatment Phase|Ongoing|0|||
143496640|NCT00454779|517359533|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
143038902|NCT02032888|515685689|FG000|Follow-up Period|Other|1|||
143038903|NCT02032888|515685690|FG001|Follow-up Period|Other|0|||
143038904|NCT02032888|515685691|FG002|Follow-up Period|Other|0|||
143038905|NCT01697696|515685692|FG000|Overall Study|Study terminated by sponsor|0|||
143038906|NCT01697696|515685693|FG001|Overall Study|Study terminated by sponsor|3|||
143038907|NCT01697696|515685692|FG000|Overall Study|Protocol deviation|1|||
143038908|NCT01697696|515685693|FG001|Overall Study|Protocol deviation|0|||
143038909|NCT01697696|515685692|FG000|Overall Study|Physician Decision|1|||
143038910|NCT01697696|515685693|FG001|Overall Study|Physician Decision|0|||
143364140|NCT01237678|516875552|FG000|Phase II|Completed Cycles 4-6|0|||
143038911|NCT01697696|515685692|FG000|Overall Study|Death|4|||
143038912|NCT01697696|515685693|FG001|Overall Study|Death|2|||
143038913|NCT01697696|515685692|FG000|Overall Study|Lost to Follow-up|10|||
143038914|NCT01697696|515685693|FG001|Overall Study|Lost to Follow-up|7|||
143496641|NCT00454779|517359534|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
143496642|NCT00454779|517359533|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
143496643|NCT00454779|517359534|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
143496644|NCT00454779|517359533|FG000|Second-line Treatment Phase|Ongoing|0|||
143496645|NCT00454779|517359534|FG001|Second-line Treatment Phase|Ongoing|1|||
143496646|NCT00254566|517359537|FG000|Overall Study|Death|1|||
143496647|NCT00254566|517359538|FG001|Overall Study|Death|0|||
143496648|NCT00254566|517359537|FG000|Overall Study|Adverse Event|5|||
143496649|NCT00254566|517359538|FG001|Overall Study|Adverse Event|4|||
143496650|NCT00254566|517359537|FG000|Overall Study|Lack of Efficacy|12|||
143496651|NCT00254566|517359538|FG001|Overall Study|Lack of Efficacy|9|||
143496652|NCT00254566|517359537|FG000|Overall Study|Other|1|||
143496653|NCT00254566|517359538|FG001|Overall Study|Other|5|||
143496654|NCT00254566|517359537|FG000|Overall Study|Withdrawal by Subject|5|||
143038915|NCT01697696|515685692|FG000|Overall Study|Subject/guardian decision|31|||
143038916|NCT01697696|515685693|FG001|Overall Study|Subject/guardian decision|35|||
143496655|NCT00254566|517359538|FG001|Overall Study|Withdrawal by Subject|6|||
143496656|NCT00254566|517359537|FG000|Overall Study|Lost to Follow-up|7|||
143496657|NCT00254566|517359538|FG001|Overall Study|Lost to Follow-up|2|||
143496658|NCT00059202|517359539|FG000|Overall Study|Withdrawal by Subject|5|||
143496659|NCT00059202|517359540|FG001|Overall Study|Withdrawal by Subject|9|||
143496660|NCT00059202|517359539|FG000|Overall Study|Protocol Violation|1|||
143496661|NCT00059202|517359540|FG001|Overall Study|Protocol Violation|3|||
143496662|NCT00059202|517359539|FG000|Overall Study|drug toxicity|0|||
143038917|NCT02272777|515685694|FG000|Overall Study|Adverse Event|0|||
143038918|NCT02272777|515685695|FG001|Overall Study|Adverse Event|1|||
143038919|NCT02272777|515685694|FG000|Overall Study|Withdrawal by Subject|0|||
143038920|NCT02272777|515685695|FG001|Overall Study|Withdrawal by Subject|3|||
143038921|NCT02272777|515685694|FG000|Overall Study|Lost to Follow-up|2|||
143038922|NCT02272777|515685695|FG001|Overall Study|Lost to Follow-up|0|||
143038923|NCT02272777|515685694|FG000|Overall Study|Other|2|||
143038924|NCT02272777|515685695|FG001|Overall Study|Other|0|||
143038925|NCT03020641|515685696|FG000|Overall Study|Lost to Follow-up|0|||
143038926|NCT03020641|515685697|FG001|Overall Study|Lost to Follow-up|1|||
143038927|NCT03020641|515685696|FG000|Overall Study|Converted to open surgery|2|||
143038928|NCT03020641|515685697|FG001|Overall Study|Converted to open surgery|1|||
143038929|NCT03020641|515685696|FG000|Overall Study|for surgery not performed|0|||
143038930|NCT03020641|515685697|FG001|Overall Study|for surgery not performed|1|||
143038931|NCT04611789|515685698|FG000|Overall Study|Lost to Follow-up|1|||
143038932|NCT04611789|515685699|FG001|Overall Study|Lost to Follow-up|0|||
143038933|NCT04611789|515685700|FG002|Overall Study|Lost to Follow-up|0|||
143038934|NCT05472038|515687005|FG000|Overall Study|Adverse Event|0|||
143038935|NCT05472038|515687006|FG001|Overall Study|Adverse Event|0|||
143038936|NCT05472038|515687007|FG002|Overall Study|Adverse Event|1|||
143038937|NCT05472038|515687008|FG003|Overall Study|Adverse Event|0|||
143038938|NCT05472038|515687009|FG004|Overall Study|Adverse Event|0|||
143038939|NCT05472038|515687010|FG005|Overall Study|Adverse Event|0|||
143038940|NCT05472038|515687011|FG006|Overall Study|Adverse Event|0|||
143038941|NCT05472038|515687012|FG007|Overall Study|Adverse Event|0|||
143038942|NCT05472038|515687013|FG008|Overall Study|Adverse Event|0|||
143038943|NCT05472038|515687014|FG009|Overall Study|Adverse Event|0|||
143038944|NCT05472038|515687015|FG010|Overall Study|Adverse Event|0|||
143038945|NCT05472038|515687016|FG011|Overall Study|Adverse Event|0|||
143038946|NCT05472038|515687005|FG000|Overall Study|Death|0|||
143038947|NCT05472038|515687006|FG001|Overall Study|Death|0|||
143038948|NCT05472038|515687007|FG002|Overall Study|Death|0|||
143038949|NCT05472038|515687008|FG003|Overall Study|Death|0|||
143038950|NCT05472038|515687009|FG004|Overall Study|Death|0|||
143038951|NCT05472038|515687010|FG005|Overall Study|Death|1|||
143038952|NCT05472038|515687011|FG006|Overall Study|Death|0|||
143038953|NCT05472038|515687012|FG007|Overall Study|Death|0|||
143038954|NCT05472038|515687013|FG008|Overall Study|Death|0|||
143038955|NCT05472038|515687014|FG009|Overall Study|Death|0|||
143038956|NCT05472038|515687015|FG010|Overall Study|Death|0|||
143496663|NCT00059202|517359540|FG001|Overall Study|drug toxicity|3|||
143038957|NCT05472038|515687016|FG011|Overall Study|Death|0|||
143038958|NCT05472038|515687005|FG000|Overall Study|Lost to Follow-up|1|||
143496664|NCT00548548|517359543|FG000|Overall Study|Death|345|||
143496665|NCT00548548|517359544|FG001|Overall Study|Death|348|||
143496666|NCT00548548|517359543|FG000|Overall Study|Lost to Follow-up|17|||
143496667|NCT00548548|517359544|FG001|Overall Study|Lost to Follow-up|18|||
143496668|NCT01705691|517359546|FG000|Overall Study|Death|1|||
143496669|NCT01705691|517359547|FG001|Overall Study|Death|2|||
143038959|NCT05472038|515687006|FG001|Overall Study|Lost to Follow-up|3|||
143038960|NCT05472038|515687007|FG002|Overall Study|Lost to Follow-up|3|||
143038961|NCT05472038|515687008|FG003|Overall Study|Lost to Follow-up|9|||
143038962|NCT05472038|515687009|FG004|Overall Study|Lost to Follow-up|2|||
143038963|NCT05472038|515687010|FG005|Overall Study|Lost to Follow-up|2|||
143038964|NCT05472038|515687011|FG006|Overall Study|Lost to Follow-up|1|||
143038965|NCT05472038|515687012|FG007|Overall Study|Lost to Follow-up|0|||
143038966|NCT05472038|515687013|FG008|Overall Study|Lost to Follow-up|1|||
143038967|NCT05472038|515687014|FG009|Overall Study|Lost to Follow-up|0|||
143038968|NCT05472038|515687015|FG010|Overall Study|Lost to Follow-up|2|||
143038969|NCT05472038|515687016|FG011|Overall Study|Lost to Follow-up|1|||
143038970|NCT05472038|515687005|FG000|Overall Study|Physician Decision|0|||
143038971|NCT05472038|515687006|FG001|Overall Study|Physician Decision|0|||
143038972|NCT05472038|515687007|FG002|Overall Study|Physician Decision|0|||
143038973|NCT05472038|515687008|FG003|Overall Study|Physician Decision|0|||
143038974|NCT05472038|515687009|FG004|Overall Study|Physician Decision|1|||
143038975|NCT05472038|515687010|FG005|Overall Study|Physician Decision|0|||
143038976|NCT05472038|515687011|FG006|Overall Study|Physician Decision|0|||
143038977|NCT05472038|515687012|FG007|Overall Study|Physician Decision|0|||
143038978|NCT05472038|515687013|FG008|Overall Study|Physician Decision|0|||
143038979|NCT05472038|515687014|FG009|Overall Study|Physician Decision|0|||
143038980|NCT05472038|515687015|FG010|Overall Study|Physician Decision|0|||
143038981|NCT05472038|515687016|FG011|Overall Study|Physician Decision|0|||
143038982|NCT05472038|515687005|FG000|Overall Study|Withdrawal by Subject|1|||
143038983|NCT05472038|515687006|FG001|Overall Study|Withdrawal by Subject|3|||
143038984|NCT05472038|515687007|FG002|Overall Study|Withdrawal by Subject|1|||
143038985|NCT05472038|515687008|FG003|Overall Study|Withdrawal by Subject|6|||
143038986|NCT05472038|515687009|FG004|Overall Study|Withdrawal by Subject|1|||
143038987|NCT05472038|515687010|FG005|Overall Study|Withdrawal by Subject|3|||
143038988|NCT05472038|515687011|FG006|Overall Study|Withdrawal by Subject|0|||
143038989|NCT05472038|515687012|FG007|Overall Study|Withdrawal by Subject|2|||
143038990|NCT05472038|515687013|FG008|Overall Study|Withdrawal by Subject|3|||
143038991|NCT05472038|515687014|FG009|Overall Study|Withdrawal by Subject|1|||
143038992|NCT05472038|515687015|FG010|Overall Study|Withdrawal by Subject|2|||
143038993|NCT05472038|515687016|FG011|Overall Study|Withdrawal by Subject|2|||
143038994|NCT05472038|515687005|FG000|Overall Study|Protocol Violation|0|||
143038995|NCT05472038|515687006|FG001|Overall Study|Protocol Violation|0|||
143038996|NCT05472038|515687007|FG002|Overall Study|Protocol Violation|0|||
143038997|NCT05472038|515687008|FG003|Overall Study|Protocol Violation|0|||
143038998|NCT05472038|515687009|FG004|Overall Study|Protocol Violation|0|||
143038999|NCT05472038|515687010|FG005|Overall Study|Protocol Violation|0|||
143039000|NCT05472038|515687011|FG006|Overall Study|Protocol Violation|0|||
143039001|NCT05472038|515687012|FG007|Overall Study|Protocol Violation|1|||
143039002|NCT05472038|515687013|FG008|Overall Study|Protocol Violation|1|||
143039003|NCT05472038|515687014|FG009|Overall Study|Protocol Violation|1|||
143039004|NCT05472038|515687015|FG010|Overall Study|Protocol Violation|1|||
143039005|NCT05472038|515687016|FG011|Overall Study|Protocol Violation|1|||
143039006|NCT05472038|515687005|FG000|Overall Study|Not vaccinated|0|||
143039007|NCT05472038|515687006|FG001|Overall Study|Not vaccinated|0|||
143039008|NCT05472038|515687007|FG002|Overall Study|Not vaccinated|0|||
143039009|NCT05472038|515687008|FG003|Overall Study|Not vaccinated|1|||
143039010|NCT05472038|515687009|FG004|Overall Study|Not vaccinated|0|||
143162285|NCT00159874|516139646|FG001|Overall Study|Pregnancy|1|||
143162286|NCT00159874|516139647|FG002|Overall Study|Pregnancy|0|||
143162287|NCT00159874|516139648|FG003|Overall Study|Pregnancy|0|||
143162288|NCT00159874|516139649|FG004|Overall Study|Pregnancy|0|||
143162289|NCT00159874|516139650|FG005|Overall Study|Pregnancy|0|||
143162290|NCT00159874|516139651|FG006|Overall Study|Pregnancy|0|||
143162291|NCT03596983|516139656|FG000|Overall Study|Withdrawal by Subject|3|||
143496670|NCT01705691|517359546|FG000|Overall Study|Withdrawal by Subject|1|||
143496671|NCT01705691|517359547|FG001|Overall Study|Withdrawal by Subject|2|||
143496672|NCT01705691|517359546|FG000|Overall Study|Lost to Follow-up|1|||
143162292|NCT03473301|516139657|FG000|Overall Study|Protocol Violation|4|||
143364141|NCT01237678|516875553|FG001|Phase II|Completed Cycles 4-6|11|||
143496673|NCT01705691|517359547|FG001|Overall Study|Lost to Follow-up|1|||
143496674|NCT01705691|517359546|FG000|Overall Study|Other|0|||
143496675|NCT01705691|517359547|FG001|Overall Study|Other|1|||
143496676|NCT02658448|517359548|FG000|Overall Study|Lost to Follow-up|1|||
143496677|NCT03106779|517359549|FG000|Overall Study|Lack of Efficacy|33|||
143496678|NCT03106779|517359550|FG001|Overall Study|Lack of Efficacy|24|||
143496679|NCT03106779|517359549|FG000|Overall Study|Adverse Event|8|||
143496680|NCT03106779|517359550|FG001|Overall Study|Adverse Event|16|||
143039011|NCT05472038|515687010|FG005|Overall Study|Not vaccinated|0|||
143039012|NCT05472038|515687011|FG006|Overall Study|Not vaccinated|0|||
143039013|NCT05472038|515687012|FG007|Overall Study|Not vaccinated|0|||
143039014|NCT05472038|515687013|FG008|Overall Study|Not vaccinated|0|||
143039015|NCT05472038|515687014|FG009|Overall Study|Not vaccinated|0|||
143039016|NCT05472038|515687015|FG010|Overall Study|Not vaccinated|0|||
143039017|NCT05472038|515687016|FG011|Overall Study|Not vaccinated|0|||
143039018|NCT04934722|515687019|FG000|Overall Study|Death|4|||
143039019|NCT04934722|515687020|FG001|Overall Study|Death|3|||
143039020|NCT04934722|515687019|FG000|Overall Study|Participants Ongoing|88|||
143039021|NCT04934722|515687020|FG001|Overall Study|Participants Ongoing|91|||
143039022|NCT03235739|515687023|FG000|Overall Study|Withdrawal by Subject|2|||
143162293|NCT03473301|516139658|FG001|Overall Study|Protocol Violation|0|||
143162294|NCT03473301|516139659|FG002|Overall Study|Protocol Violation|0|||
143496681|NCT03106779|517359549|FG000|Overall Study|Physician Decision|10|||
143496682|NCT03106779|517359550|FG001|Overall Study|Physician Decision|6|||
143496683|NCT03106779|517359549|FG000|Overall Study|Patient/guardian decision|4|||
143496684|NCT03106779|517359550|FG001|Overall Study|Patient/guardian decision|3|||
143496685|NCT03106779|517359549|FG000|Overall Study|Progressive disease|1|||
143496686|NCT03106779|517359550|FG001|Overall Study|Progressive disease|3|||
143496687|NCT03106779|517359549|FG000|Overall Study|Lost to Follow-up|1|||
143496688|NCT03106779|517359550|FG001|Overall Study|Lost to Follow-up|2|||
143496689|NCT03106779|517359549|FG000|Overall Study|Death|1|||
143496690|NCT03106779|517359550|FG001|Overall Study|Death|0|||
143496691|NCT03106779|517359549|FG000|Overall Study|Protocol Violation|1|||
143496692|NCT03106779|517359550|FG001|Overall Study|Protocol Violation|0|||
143496693|NCT03106779|517359549|FG000|Overall Study|Not treated|1|||
143496694|NCT03106779|517359550|FG001|Overall Study|Not treated|0|||
143496695|NCT04088409|517359551|FG000|Part A|Withdrawal by Subject|2|||
143496696|NCT04088409|517359552|FG001|Part A|Withdrawal by Subject|1|||
143496697|NCT04088409|517359551|FG000|Part A|Did Not Meet Randomization Criteria|2|||
143496698|NCT04088409|517359552|FG001|Part A|Did Not Meet Randomization Criteria|0|||
143496699|NCT04088409|517359551|FG000|Part A|Lack of Efficacy|9|||
143496700|NCT04088409|517359552|FG001|Part A|Lack of Efficacy|0|||
143496701|NCT04088409|517359551|FG000|Part A|Lost to Follow-up|1|||
143496702|NCT04088409|517359552|FG001|Part A|Lost to Follow-up|0|||
143496703|NCT04088409|517359551|FG000|Part A|Adverse Event|1|||
143496704|NCT04088409|517359552|FG001|Part A|Adverse Event|0|||
143496705|NCT04088409|517359551|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
143496706|NCT04088409|517359552|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
143496707|NCT04088409|517359551|FG000|Part B|Ongoing Treatment|10|||
143496708|NCT04088409|517359552|FG001|Part B|Ongoing Treatment|0|||
143496709|NCT02288247|517359553|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
143496710|NCT02288247|517359554|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
143496711|NCT02288247|517359553|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
143496712|NCT02288247|517359554|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
143496713|NCT02288247|517359553|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
143496714|NCT02288247|517359554|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
143496715|NCT02288247|517359553|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
143496716|NCT02288247|517359554|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
143496717|NCT02288247|517359553|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
143496718|NCT02288247|517359554|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
143496719|NCT02288247|517359553|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
143496720|NCT02288247|517359554|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
143496721|NCT02288247|517359553|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
143496722|NCT02288247|517359554|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
143496723|NCT02288247|517359553|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
143496724|NCT02288247|517359554|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
143496725|NCT02288247|517359553|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
143496726|NCT02288247|517359554|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
143496727|NCT02288247|517359553|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
143496728|NCT02288247|517359554|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
143496729|NCT02288247|517359553|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
143496730|NCT02288247|517359554|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
143496731|NCT02288247|517359553|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
143496732|NCT02288247|517359554|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
143496733|NCT02288247|517359553|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
143496734|NCT02288247|517359554|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
143496735|NCT02288247|517359553|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
143496736|NCT02288247|517359554|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
143039023|NCT03235739|515687024|FG001|Overall Study|Withdrawal by Subject|2|||
143039024|NCT03235739|515687023|FG000|Overall Study|Physician Decision|0|||
143039025|NCT03235739|515687024|FG001|Overall Study|Physician Decision|1|||
143039026|NCT00467896|515687025|FG000|Overall Study|Consent Withdrawal|18|||
143039027|NCT00467896|515687025|FG000|Overall Study|Adverse Event|7|||
143162295|NCT03473301|516139657|FG000|Overall Study|Withdrawal by Subject|0|||
143162296|NCT03473301|516139658|FG001|Overall Study|Withdrawal by Subject|1|||
143162297|NCT03473301|516139659|FG002|Overall Study|Withdrawal by Subject|0|||
143162298|NCT03473301|516139657|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
143496737|NCT02288247|517359553|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
143496738|NCT02288247|517359554|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
143496739|NCT02288247|517359553|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
143496740|NCT02288247|517359554|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
143496741|NCT04652804|517359555|FG000|Overall Study|Ineligible post randomization|1|||
143496742|NCT04652804|517359556|FG001|Overall Study|Ineligible post randomization|0|||
143496743|NCT04652804|517359557|FG002|Overall Study|Ineligible post randomization|1|||
143239277|NCT01285323|516429840|FG000|Overall Study|Protocol Violation|1|||
143039028|NCT00467896|515687025|FG000|Overall Study|Serious Adverse Event|13|||
143039029|NCT00467896|515687025|FG000|Overall Study|Non-compliance|3|||
143039030|NCT00467896|515687025|FG000|Overall Study|Changed therapy|2|||
143039031|NCT00467896|515687025|FG000|Overall Study|Patient received transplant|2|||
143039032|NCT00467896|515687025|FG000|Overall Study|Patient had atrial septostomy|1|||
143239278|NCT01285323|516429841|FG001|Overall Study|Protocol Violation|2|||
143239279|NCT01285323|516429840|FG000|Overall Study|Non-compliance with study procedures|2|||
143239280|NCT01285323|516429841|FG001|Overall Study|Non-compliance with study procedures|3|||
143239281|NCT01285323|516429840|FG000|Overall Study|Lost to Follow-up|1|||
143239282|NCT01285323|516429841|FG001|Overall Study|Lost to Follow-up|1|||
143239283|NCT01285323|516429840|FG000|Overall Study|Other|1|||
143239284|NCT01285323|516429841|FG001|Overall Study|Other|3|||
143239285|NCT02606643|516429842|FG000|Overall Study|did not meet inclusion criteria|1|||
143239286|NCT02606643|516429843|FG001|Overall Study|did not meet inclusion criteria|3|||
143239287|NCT00803569|516429846|FG000|Overall Study|Progressive Disease|3|||
143239288|NCT00803569|516429846|FG000|Overall Study|Noncompliance|1|||
143239289|NCT01208207|516429850|FG000|Part I|Adverse Event|19|||
143239290|NCT01208207|516429851|FG001|Part I|Adverse Event|2|||
143239291|NCT01208207|516429852|FG002|Part I|Adverse Event|6|||
143239292|NCT01208207|516429853|FG003|Part I|Adverse Event|0|||
143239293|NCT01208207|516429854|FG004|Part I|Adverse Event|0|||
143239294|NCT01208207|516429855|FG005|Part I|Adverse Event|0|||
143239295|NCT01208207|516429856|FG006|Part I|Adverse Event|0|||
143239296|NCT01208207|516429850|FG000|Part I|Lack of Efficacy|21|||
143239297|NCT01208207|516429851|FG001|Part I|Lack of Efficacy|3|||
143239298|NCT01208207|516429852|FG002|Part I|Lack of Efficacy|2|||
143239299|NCT01208207|516429853|FG003|Part I|Lack of Efficacy|0|||
143239300|NCT01208207|516429854|FG004|Part I|Lack of Efficacy|0|||
143239301|NCT01208207|516429855|FG005|Part I|Lack of Efficacy|0|||
143239302|NCT01208207|516429856|FG006|Part I|Lack of Efficacy|0|||
143239303|NCT01208207|516429850|FG000|Part I|Lost to Follow-up|6|||
143239304|NCT01208207|516429851|FG001|Part I|Lost to Follow-up|1|||
143239305|NCT01208207|516429852|FG002|Part I|Lost to Follow-up|0|||
143239306|NCT01208207|516429853|FG003|Part I|Lost to Follow-up|0|||
143239307|NCT01208207|516429854|FG004|Part I|Lost to Follow-up|0|||
143239308|NCT01208207|516429855|FG005|Part I|Lost to Follow-up|0|||
143239309|NCT01208207|516429856|FG006|Part I|Lost to Follow-up|0|||
143239310|NCT01208207|516429850|FG000|Part I|Non-Compliance With Study Drug|1|||
143239311|NCT01208207|516429851|FG001|Part I|Non-Compliance With Study Drug|0|||
143239312|NCT01208207|516429852|FG002|Part I|Non-Compliance With Study Drug|1|||
143239313|NCT01208207|516429853|FG003|Part I|Non-Compliance With Study Drug|0|||
143239314|NCT01208207|516429854|FG004|Part I|Non-Compliance With Study Drug|0|||
143239315|NCT01208207|516429855|FG005|Part I|Non-Compliance With Study Drug|0|||
143239316|NCT01208207|516429856|FG006|Part I|Non-Compliance With Study Drug|0|||
143239317|NCT01208207|516429850|FG000|Part I|Physician Decision|0|||
143239318|NCT01208207|516429851|FG001|Part I|Physician Decision|1|||
143239319|NCT01208207|516429852|FG002|Part I|Physician Decision|0|||
143239320|NCT01208207|516429853|FG003|Part I|Physician Decision|0|||
143239321|NCT01208207|516429854|FG004|Part I|Physician Decision|0|||
143239322|NCT01208207|516429855|FG005|Part I|Physician Decision|0|||
143239323|NCT01208207|516429856|FG006|Part I|Physician Decision|0|||
143239324|NCT01208207|516429850|FG000|Part I|Progressive Disease|1|||
143239325|NCT01208207|516429851|FG001|Part I|Progressive Disease|0|||
143239326|NCT01208207|516429852|FG002|Part I|Progressive Disease|0|||
143239327|NCT01208207|516429853|FG003|Part I|Progressive Disease|0|||
143239328|NCT01208207|516429854|FG004|Part I|Progressive Disease|0|||
143239329|NCT01208207|516429855|FG005|Part I|Progressive Disease|0|||
143239330|NCT01208207|516429856|FG006|Part I|Progressive Disease|0|||
143239331|NCT01208207|516429850|FG000|Part I|Protocol Violation|8|||
143039033|NCT00467896|515687025|FG000|Overall Study|Patient weaned off iloprost|1|||
143039034|NCT00467896|515687025|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
143039035|NCT00467896|515687025|FG000|Overall Study|Started intravenous prostacyclin|1|||
143039036|NCT00467896|515687025|FG000|Overall Study|Started inhaled Remodulin|1|||
143039037|NCT00467896|515687025|FG000|Overall Study|Patient had no improvement|1|||
143039038|NCT03772522|515687026|FG000|Pre-intervention|Withdrawal by Subject|3|||
143239332|NCT01208207|516429851|FG001|Part I|Protocol Violation|0|||
143239333|NCT01208207|516429852|FG002|Part I|Protocol Violation|2|||
143239334|NCT01208207|516429853|FG003|Part I|Protocol Violation|0|||
143239335|NCT01208207|516429854|FG004|Part I|Protocol Violation|0|||
143239336|NCT01208207|516429855|FG005|Part I|Protocol Violation|0|||
143039039|NCT03772522|515687027|FG001|Pre-intervention|Withdrawal by Subject|4|||
143239337|NCT01208207|516429856|FG006|Part I|Protocol Violation|0|||
143239338|NCT01208207|516429850|FG000|Part I|Withdrawal by Subject|14|||
143239339|NCT01208207|516429851|FG001|Part I|Withdrawal by Subject|4|||
143039040|NCT03772522|515687026|FG000|Intervention|Withdrawal by Subject|1|||
143039041|NCT03772522|515687027|FG001|Intervention|Withdrawal by Subject|0|||
143239340|NCT01208207|516429852|FG002|Part I|Withdrawal by Subject|4|||
143239341|NCT01208207|516429853|FG003|Part I|Withdrawal by Subject|0|||
143496744|NCT04652804|517359558|FG003|Overall Study|Ineligible post randomization|0|||
143239342|NCT01208207|516429854|FG004|Part I|Withdrawal by Subject|0|||
143239343|NCT01208207|516429855|FG005|Part I|Withdrawal by Subject|0|||
143039042|NCT03772522|515687026|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
143039043|NCT03772522|515687027|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
143039044|NCT03818581|515687030|FG000|Overall Study|Adverse Event|1|||
143039045|NCT03818581|515687031|FG001|Overall Study|Adverse Event|0|||
143039046|NCT03818581|515687032|FG002|Overall Study|Adverse Event|0|||
143039047|NCT03818581|515687033|FG003|Overall Study|Adverse Event|0|||
143039048|NCT03818581|515687034|FG004|Overall Study|Adverse Event|0|||
143162299|NCT03473301|516139658|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
143162300|NCT03473301|516139659|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
143162301|NCT04829214|516139660|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
143162302|NCT04829214|516139661|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
143162303|NCT04829214|516139660|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
143162304|NCT04829214|516139661|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
143162305|NCT05287685|516139662|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
143162306|NCT05287685|516139663|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
143162307|NCT05287685|516139662|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
143162308|NCT05287685|516139663|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
143162309|NCT04008069|516139664|FG000|Open-Label Period|Adverse Event|1|||
143162310|NCT04008069|516139665|FG001|Open-Label Period|Adverse Event|0|||
143162311|NCT04008069|516139666|FG002|Open-Label Period|Adverse Event|0|||
143162312|NCT04008069|516139664|FG000|Open-Label Period|Lack of Efficacy|4|||
143162313|NCT04008069|516139665|FG001|Open-Label Period|Lack of Efficacy|0|||
143162314|NCT04008069|516139666|FG002|Open-Label Period|Lack of Efficacy|0|||
143162315|NCT04008069|516139664|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
143162316|NCT04008069|516139665|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
143162317|NCT04008069|516139666|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
143162318|NCT04008069|516139664|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
143162319|NCT04008069|516139665|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
143364142|NCT01237678|516875554|FG002|Phase II|Completed Cycles 4-6|21|||
143496745|NCT04652804|517359559|FG004|Overall Study|Ineligible post randomization|1|||
143496746|NCT04652804|517359560|FG005|Overall Study|Ineligible post randomization|1|||
143496747|NCT04652804|517359555|FG000|Overall Study|Missing SVR lab results|2|||
143496748|NCT04652804|517359556|FG001|Overall Study|Missing SVR lab results|0|||
143496749|NCT04652804|517359557|FG002|Overall Study|Missing SVR lab results|0|||
143496750|NCT04652804|517359558|FG003|Overall Study|Missing SVR lab results|0|||
143496751|NCT04652804|517359559|FG004|Overall Study|Missing SVR lab results|0|||
143496752|NCT04652804|517359560|FG005|Overall Study|Missing SVR lab results|0|||
143496753|NCT00584194|517359561|FG000|Overall Study|Other|135|||
143496754|NCT04093531|517359562|FG000|Overall Study|failed screening|4|||
143496755|NCT00841763|517359563|FG000|Overall Study|Withdrawal by Subject|60|||
143496756|NCT00841763|517359564|FG001|Overall Study|Withdrawal by Subject|17|||
143496757|NCT00841763|517359565|FG002|Overall Study|Withdrawal by Subject|4|||
143496758|NCT00841763|517359566|FG003|Overall Study|Withdrawal by Subject|1|||
143496759|NCT00841763|517359563|FG000|Overall Study|Adverse Event|9|||
143496760|NCT00841763|517359564|FG001|Overall Study|Adverse Event|10|||
143496761|NCT00841763|517359565|FG002|Overall Study|Adverse Event|3|||
143496762|NCT00841763|517359566|FG003|Overall Study|Adverse Event|2|||
143496763|NCT00841763|517359563|FG000|Overall Study|Lost to Follow-up|63|||
143496764|NCT00841763|517359564|FG001|Overall Study|Lost to Follow-up|25|||
143496765|NCT00841763|517359565|FG002|Overall Study|Lost to Follow-up|0|||
143496766|NCT00841763|517359566|FG003|Overall Study|Lost to Follow-up|0|||
143496767|NCT00841763|517359563|FG000|Overall Study|Protocol Violation|20|||
143496768|NCT00841763|517359564|FG001|Overall Study|Protocol Violation|3|||
143496769|NCT00841763|517359565|FG002|Overall Study|Protocol Violation|1|||
143496770|NCT00841763|517359566|FG003|Overall Study|Protocol Violation|0|||
143496771|NCT00841763|517359563|FG000|Overall Study|Administrative Reasons|3|||
143496772|NCT00841763|517359564|FG001|Overall Study|Administrative Reasons|1|||
143496773|NCT00841763|517359565|FG002|Overall Study|Administrative Reasons|0|||
143496774|NCT00841763|517359566|FG003|Overall Study|Administrative Reasons|0|||
143496775|NCT00841763|517359563|FG000|Overall Study|Unable to Classify|7|||
143496776|NCT00841763|517359564|FG001|Overall Study|Unable to Classify|1|||
143496777|NCT00841763|517359565|FG002|Overall Study|Unable to Classify|0|||
143496778|NCT00841763|517359566|FG003|Overall Study|Unable to Classify|0|||
143496779|NCT03555266|517359572|FG000|Overall Study|Protocol Violation|6|||
143496780|NCT03555266|517359573|FG001|Overall Study|Protocol Violation|4|||
143496781|NCT01727258|517359574|FG000|Overall Study|Adverse Event|0|||
143496782|NCT01727258|517359575|FG001|Overall Study|Adverse Event|2|||
143039049|NCT03818581|515687030|FG000|Overall Study|Covid-19|2|||
143039050|NCT03818581|515687031|FG001|Overall Study|Covid-19|0|||
143496783|NCT01727258|517359576|FG002|Overall Study|Adverse Event|0|||
143496784|NCT01727258|517359574|FG000|Overall Study|Noncompliance with Study Drug|0|||
143496785|NCT01727258|517359575|FG001|Overall Study|Noncompliance with Study Drug|0|||
143496786|NCT01727258|517359576|FG002|Overall Study|Noncompliance with Study Drug|1|||
143496787|NCT01727258|517359574|FG000|Overall Study|Withdrawal by Subject|1|||
143496788|NCT01727258|517359575|FG001|Overall Study|Withdrawal by Subject|1|||
143496789|NCT01727258|517359576|FG002|Overall Study|Withdrawal by Subject|0|||
143496790|NCT01727258|517359574|FG000|Overall Study|Lost to Follow-up|1|||
143496791|NCT01727258|517359575|FG001|Overall Study|Lost to Follow-up|0|||
143496792|NCT01727258|517359576|FG002|Overall Study|Lost to Follow-up|0|||
143496793|NCT00200057|517361427|FG000|Overall Study|Lack of Efficacy|3|||
143496794|NCT00200057|517361427|FG000|Overall Study|Exited due to terminal illness of PI|2|||
143496795|NCT00200057|517361427|FG000|Overall Study|Withdrawal by Subject|1|||
143496796|NCT00200057|517361427|FG000|Overall Study|Change in medical condition|1|||
143496797|NCT00200057|517361427|FG000|Overall Study|Infection|1|||
143496798|NCT00200057|517361427|FG000|Overall Study|Death|1|||
143496799|NCT01583179|517361428|FG000|Overall Study|Screen failure|1|||
143496800|NCT01583179|517361429|FG001|Overall Study|Screen failure|2|||
143496801|NCT00772629|517361430|FG000|Overall Study|Subject was not vaccinated|1|||
143496802|NCT00772629|517361431|FG001|Overall Study|Subject was not vaccinated|0|||
143496803|NCT00568555|517361432|FG000|Overall Study|Withdrawal by Subject|1|||
143496804|NCT00568555|517361433|FG001|Overall Study|Withdrawal by Subject|1|||
143496805|NCT02472847|517361434|FG000|Overall Study|Withdrawal by Subject|1|||
143496806|NCT02472847|517361435|FG001|Overall Study|Withdrawal by Subject|5|||
143496807|NCT04173741|517361436|FG000|Overall Study|IVC measurement cannot be done|1|||
143496808|NCT04173741|517361437|FG001|Overall Study|IVC measurement cannot be done|1|||
143496809|NCT04233229|517361438|FG000|Overall Study|Withdrawal by Subject|0|||
143496810|NCT04233229|517361439|FG001|Overall Study|Withdrawal by Subject|1|||
143496811|NCT04233229|517361438|FG000|Overall Study|Exclusion criterion found the day after initiation visit|1|||
143496812|NCT04233229|517361439|FG001|Overall Study|Exclusion criterion found the day after initiation visit|0|||
143496813|NCT04233229|517361438|FG000|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|0|||
143496814|NCT04233229|517361439|FG001|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|2|||
143496815|NCT00927368|517361440|FG000|Overall Study|enrollment in another study|1|||
143496816|NCT00927368|517361441|FG001|Overall Study|enrollment in another study|1|||
143496817|NCT00927368|517361442|FG002|Overall Study|enrollment in another study|2|||
143496818|NCT00927368|517361440|FG000|Overall Study|Lost to Follow-up|4|||
143496819|NCT00927368|517361441|FG001|Overall Study|Lost to Follow-up|0|||
143496820|NCT00927368|517361442|FG002|Overall Study|Lost to Follow-up|0|||
143496821|NCT00927368|517361440|FG000|Overall Study|equipment failure|1|||
143496822|NCT00927368|517361441|FG001|Overall Study|equipment failure|0|||
143496823|NCT00927368|517361442|FG002|Overall Study|equipment failure|0|||
143496824|NCT00927368|517361440|FG000|Overall Study|ineligible post randomization|0|||
143496825|NCT00927368|517361441|FG001|Overall Study|ineligible post randomization|3|||
143496826|NCT00927368|517361442|FG002|Overall Study|ineligible post randomization|1|||
143162320|NCT04008069|516139666|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
143162321|NCT00511199|516139667|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
143162322|NCT00511199|516139668|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
143162323|NCT00511199|516139667|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
143162324|NCT00511199|516139668|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
143162325|NCT00511199|516139667|FG000|Overall Study|Withdrawal of Informed Consent|19|||
143162326|NCT00511199|516139668|FG001|Overall Study|Withdrawal of Informed Consent|4|||
143162327|NCT00511199|516139667|FG000|Overall Study|Pregnancy|6|||
143162328|NCT00511199|516139668|FG001|Overall Study|Pregnancy|3|||
143162329|NCT00511199|516139667|FG000|Overall Study|Pregnancy Wish|16|||
143162330|NCT00511199|516139668|FG001|Overall Study|Pregnancy Wish|8|||
143162331|NCT00511199|516139667|FG000|Overall Study|Lost to Follow-up|40|||
143162332|NCT00511199|516139668|FG001|Overall Study|Lost to Follow-up|17|||
143364143|NCT01237678|516875552|FG000|Phase II|Sponsor Decision/Study Closed|0|||
143364144|NCT01237678|516875553|FG001|Phase II|Sponsor Decision/Study Closed|18|||
143496827|NCT00927368|517361440|FG000|Overall Study|cancellation of surgery|0|||
143496828|NCT00927368|517361441|FG001|Overall Study|cancellation of surgery|1|||
143496829|NCT00927368|517361442|FG002|Overall Study|cancellation of surgery|2|||
143496830|NCT00364689|517361443|FG000|Overall Study|Lost to Follow-up|1|||
143496831|NCT01114529|517361451|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
143496832|NCT01114529|517361452|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
143496833|NCT01114529|517361453|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
143496834|NCT01114529|517361451|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
143496835|NCT01114529|517361452|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
143496836|NCT01114529|517361453|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
143496837|NCT01114529|517361451|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
143496838|NCT01114529|517361452|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
143496839|NCT01114529|517361453|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
143496840|NCT01114529|517361451|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
143496841|NCT01114529|517361452|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
143162333|NCT00511199|516139667|FG000|Overall Study|Other Reason|78|||
143162334|NCT00511199|516139668|FG001|Overall Study|Other Reason|37|||
143162335|NCT02134028|516139669|FG000|Overall Study|Lack of Efficacy|1|||
143162336|NCT02134028|516139670|FG001|Overall Study|Lack of Efficacy|0|||
143364145|NCT01237678|516875554|FG002|Phase II|Sponsor Decision/Study Closed|7|||
143496842|NCT01114529|517361453|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
143496843|NCT01114529|517361451|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
143496844|NCT01114529|517361452|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
143496845|NCT01114529|517361453|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
143496846|NCT01114529|517361451|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
143496847|NCT01114529|517361452|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
143496848|NCT01114529|517361453|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
143496849|NCT01114529|517361451|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
143496850|NCT01114529|517361452|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
143496851|NCT01114529|517361453|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
143496852|NCT01114529|517361451|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
143496853|NCT01114529|517361452|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
143496854|NCT01114529|517361453|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
143496855|NCT01114529|517361451|FG000|Completed Study Medication at Month 24|Death|2|||
143496856|NCT01114529|517361452|FG001|Completed Study Medication at Month 24|Death|1|||
143496857|NCT01114529|517361453|FG002|Completed Study Medication at Month 24|Death|2|||
143496858|NCT01114529|517361451|FG000|Completed Study Medication at Month 24|Graft loss|0|||
143496859|NCT01114529|517361452|FG001|Completed Study Medication at Month 24|Graft loss|2|||
143496860|NCT01114529|517361453|FG002|Completed Study Medication at Month 24|Graft loss|0|||
143496861|NCT01114529|517361451|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
143496862|NCT01114529|517361452|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
143496863|NCT01114529|517361453|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
143496864|NCT01114529|517361451|FG000|Completed Study Medication at Month 24|Missing|2|||
143496865|NCT01114529|517361452|FG001|Completed Study Medication at Month 24|Missing|0|||
143496866|NCT01114529|517361453|FG002|Completed Study Medication at Month 24|Missing|0|||
143496867|NCT01114529|517361451|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
143496868|NCT01114529|517361452|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
143496869|NCT01114529|517361453|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
143039051|NCT03818581|515687032|FG002|Overall Study|Covid-19|0|||
143039052|NCT03818581|515687033|FG003|Overall Study|Covid-19|0|||
143039053|NCT03818581|515687034|FG004|Overall Study|Covid-19|1|||
143039054|NCT03818581|515687030|FG000|Overall Study|Withdrawal by Subject|0|||
143162337|NCT02134028|516139671|FG002|Overall Study|Lack of Efficacy|3|||
143162338|NCT02134028|516139672|FG003|Overall Study|Lack of Efficacy|2|||
143162339|NCT02134028|516139673|FG004|Overall Study|Lack of Efficacy|1|||
143162340|NCT02134028|516139674|FG005|Overall Study|Lack of Efficacy|2|||
143162341|NCT02134028|516139675|FG006|Overall Study|Lack of Efficacy|1|||
143496870|NCT01114529|517361451|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
143496871|NCT01114529|517361452|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
143496872|NCT01114529|517361453|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
143496873|NCT01114529|517361451|FG000|Completed Study Phase at Month 24|Death|8|||
143162342|NCT02134028|516139676|FG007|Overall Study|Lack of Efficacy|0|||
143162343|NCT02134028|516139669|FG000|Overall Study|Poor compliance to protocol|1|||
143162344|NCT02134028|516139670|FG001|Overall Study|Poor compliance to protocol|1|||
143162345|NCT02134028|516139671|FG002|Overall Study|Poor compliance to protocol|3|||
143162346|NCT02134028|516139672|FG003|Overall Study|Poor compliance to protocol|7|||
143162347|NCT02134028|516139673|FG004|Overall Study|Poor compliance to protocol|1|||
143496874|NCT01114529|517361452|FG001|Completed Study Phase at Month 24|Death|5|||
143496875|NCT01114529|517361453|FG002|Completed Study Phase at Month 24|Death|4|||
143496876|NCT01114529|517361451|FG000|Completed Study Phase at Month 24|Other|2|||
143496877|NCT01114529|517361452|FG001|Completed Study Phase at Month 24|Other|0|||
143496878|NCT01114529|517361453|FG002|Completed Study Phase at Month 24|Other|0|||
143496879|NCT01114529|517361451|FG000|Completed Study Phase at Month 24|Missing|2|||
143496880|NCT01114529|517361452|FG001|Completed Study Phase at Month 24|Missing|0|||
143496881|NCT01114529|517361453|FG002|Completed Study Phase at Month 24|Missing|0|||
143496882|NCT01482910|517361455|FG000|Overall Study|Adverse Event|6|||
143496883|NCT01482910|517361456|FG001|Overall Study|Adverse Event|5|||
143496884|NCT01482910|517361455|FG000|Overall Study|Lost to Follow-up|0|||
143496885|NCT01482910|517361456|FG001|Overall Study|Lost to Follow-up|1|||
143496886|NCT01482910|517361455|FG000|Overall Study|Protocol Violation|1|||
143496887|NCT01482910|517361456|FG001|Overall Study|Protocol Violation|1|||
143496888|NCT01482910|517361455|FG000|Overall Study|Withdrawal by Subject|7|||
143496889|NCT01482910|517361456|FG001|Overall Study|Withdrawal by Subject|2|||
143496890|NCT01482910|517361455|FG000|Overall Study|Death|1|||
143496891|NCT01482910|517361456|FG001|Overall Study|Death|0|||
143496892|NCT00272987|517361457|FG000|Overall Study|Adverse Event|1|||
143496893|NCT00272987|517361458|FG001|Overall Study|Adverse Event|0|||
143496894|NCT00272987|517361459|FG002|Overall Study|Adverse Event|0|||
143162348|NCT02134028|516139674|FG005|Overall Study|Poor compliance to protocol|1|||
143162349|NCT02134028|516139675|FG006|Overall Study|Poor compliance to protocol|0|||
143162350|NCT02134028|516139676|FG007|Overall Study|Poor compliance to protocol|0|||
143496895|NCT00272987|517361457|FG000|Overall Study|Lost to Follow-up|3|||
143039055|NCT03818581|515687031|FG001|Overall Study|Withdrawal by Subject|0|||
143039056|NCT03818581|515687032|FG002|Overall Study|Withdrawal by Subject|0|||
143039057|NCT03818581|515687033|FG003|Overall Study|Withdrawal by Subject|0|||
143039058|NCT03818581|515687034|FG004|Overall Study|Withdrawal by Subject|1|||
143039059|NCT03818581|515687030|FG000|Overall Study|No longer met study criteria|0|||
143039060|NCT03818581|515687031|FG001|Overall Study|No longer met study criteria|0|||
143039061|NCT03818581|515687032|FG002|Overall Study|No longer met study criteria|0|||
143039062|NCT03818581|515687033|FG003|Overall Study|No longer met study criteria|0|||
143039063|NCT03818581|515687034|FG004|Overall Study|No longer met study criteria|1|||
143039064|NCT00218257|515687035|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
143039065|NCT00218257|515687036|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
143039066|NCT03874715|515687040|FG000|Overall Study|Adverse Event|2|||
143039067|NCT03874715|515687041|FG001|Overall Study|Adverse Event|0|||
143039068|NCT03874715|515687040|FG000|Overall Study|Poor compliance to protocol|5|||
143039069|NCT03874715|515687041|FG001|Overall Study|Poor compliance to protocol|1|||
143039070|NCT03874715|515687040|FG000|Overall Study|Withdrawal by Subject|1|||
143039071|NCT03874715|515687041|FG001|Overall Study|Withdrawal by Subject|0|||
143039072|NCT03874715|515687040|FG000|Overall Study|Other-unspecified|1|||
143039073|NCT03874715|515687041|FG001|Overall Study|Other-unspecified|0|||
143039074|NCT00328926|515687044|FG000|Overall Study|Pregnancy|2|||
143039075|NCT00328926|515687045|FG001|Overall Study|Pregnancy|1|||
143039076|NCT00328926|515687046|FG002|Overall Study|Pregnancy|0|||
143039077|NCT00328926|515687044|FG000|Overall Study|Lost to Follow-up|0|||
143039078|NCT00328926|515687045|FG001|Overall Study|Lost to Follow-up|1|||
143039079|NCT00328926|515687046|FG002|Overall Study|Lost to Follow-up|0|||
143039080|NCT00328926|515687044|FG000|Overall Study|Death|0|||
143039081|NCT00328926|515687045|FG001|Overall Study|Death|0|||
143039082|NCT00328926|515687046|FG002|Overall Study|Death|1|||
143039083|NCT00328926|515687044|FG000|Overall Study|In vitro fertilization treatment|0|||
143039084|NCT00328926|515687045|FG001|Overall Study|In vitro fertilization treatment|0|||
143039085|NCT00328926|515687046|FG002|Overall Study|In vitro fertilization treatment|1|||
143039086|NCT00328926|515687044|FG000|Overall Study|Lack of ovarian response|0|||
143039087|NCT00328926|515687045|FG001|Overall Study|Lack of ovarian response|1|||
143039088|NCT00328926|515687046|FG002|Overall Study|Lack of ovarian response|0|||
143039089|NCT02956460|515687047|FG000|Lens 1|Lost to Follow-up|1|||
143039090|NCT02956460|515687048|FG001|Lens 1|Lost to Follow-up|0|||
143039091|NCT00834249|515687049|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
143039092|NCT00834249|515687050|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
143039093|NCT00834249|515687049|FG000|Second Intervention|Adverse Event|1|||
143039094|NCT00834249|515687050|FG001|Second Intervention|Adverse Event|0|||
143039095|NCT03450057|515687051|FG000|Overall Study|Death|17|||
143039096|NCT03450057|515687051|FG000|Overall Study|ICF withdrawal|4|||
143039097|NCT03450057|515687051|FG000|Overall Study|Lost to Follow-up|2|||
143039098|NCT00573066|515687052|FG000|Overall Study|Exclusion criteria|18|||
143039099|NCT00573066|515687052|FG000|Overall Study|IV malfunction|1|||
143039100|NCT00573066|515687052|FG000|Overall Study|Postoperative bleeding|1|||
143039101|NCT04129346|515687053|FG000|Overall Study|Death|1|||
143039102|NCT04129346|515687054|FG001|Overall Study|Death|0|||
143039103|NCT05755282|515687055|FG000|Overall Study|Protocol Violation|0|||
143039104|NCT05755282|515687056|FG001|Overall Study|Protocol Violation|1|||
143039105|NCT01015703|515687057|FG000|Overall Study|Withdrawal by Subject|0|||
143039106|NCT01015703|515687058|FG001|Overall Study|Withdrawal by Subject|1|||
143039107|NCT01015703|515687059|FG002|Overall Study|Withdrawal by Subject|0|||
143039108|NCT01015703|515687060|FG003|Overall Study|Withdrawal by Subject|0|||
143039109|NCT01015703|515687061|FG004|Overall Study|Withdrawal by Subject|0|||
143039110|NCT01015703|515687057|FG000|Overall Study|Adverse Event|1|||
143039111|NCT01015703|515687058|FG001|Overall Study|Adverse Event|0|||
143039112|NCT01015703|515687059|FG002|Overall Study|Adverse Event|0|||
143039113|NCT01015703|515687060|FG003|Overall Study|Adverse Event|0|||
143039114|NCT01015703|515687061|FG004|Overall Study|Adverse Event|0|||
143039115|NCT01015703|515687057|FG000|Overall Study|Protocol Violation|1|||
143162351|NCT02134028|516139669|FG000|Overall Study|Other unspecified|4|||
143162352|NCT02134028|516139670|FG001|Overall Study|Other unspecified|22|||
143162353|NCT02134028|516139671|FG002|Overall Study|Other unspecified|33|||
143162354|NCT02134028|516139672|FG003|Overall Study|Other unspecified|64|||
143039116|NCT01015703|515687058|FG001|Overall Study|Protocol Violation|0|||
143039117|NCT01015703|515687059|FG002|Overall Study|Protocol Violation|0|||
143039118|NCT01015703|515687060|FG003|Overall Study|Protocol Violation|0|||
143039119|NCT01015703|515687061|FG004|Overall Study|Protocol Violation|0|||
143039120|NCT02646124|515687062|FG000|Overall Study|Lost to Follow-up|0|||
143039121|NCT02646124|515687063|FG001|Overall Study|Lost to Follow-up|2|||
143039122|NCT03154047|515687065|FG000|Overall Study|Death|1|||
143039123|NCT03154047|515687065|FG000|Overall Study|Study terminated by sponsor|76|||
143039124|NCT03154047|515687065|FG000|Overall Study|Withdrawal by Subject|3|||
143039125|NCT00857454|515687066|FG000|Overall Study|Withdrawal by Subject|2|||
143039126|NCT00857454|515687066|FG000|Overall Study|Lost to Follow-up|1|||
143039127|NCT00857454|515687066|FG000|Overall Study|Adverse Event|2|||
143162355|NCT02134028|516139673|FG004|Overall Study|Other unspecified|8|||
143162356|NCT02134028|516139674|FG005|Overall Study|Other unspecified|6|||
143039128|NCT00857454|515687066|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
143039129|NCT00857454|515687066|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
143039130|NCT00857454|515687066|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
143039131|NCT00365365|515687067|FG000|Overall Study|Randomized but not treated|0|||
143039132|NCT00365365|515687068|FG001|Overall Study|Randomized but not treated|2|||
143039133|NCT00365365|515687069|FG002|Overall Study|Randomized but not treated|0|||
143039134|NCT00365365|515687067|FG000|Overall Study|Poor compliance to protocol|0|||
143039135|NCT00365365|515687068|FG001|Overall Study|Poor compliance to protocol|1|||
143039136|NCT00365365|515687069|FG002|Overall Study|Poor compliance to protocol|0|||
143039137|NCT00365365|515687067|FG000|Overall Study|Lost to Follow-up|3|||
143039138|NCT00365365|515687068|FG001|Overall Study|Lost to Follow-up|3|||
143039139|NCT00365365|515687069|FG002|Overall Study|Lost to Follow-up|3|||
143039140|NCT00365365|515687067|FG000|Overall Study|Death|1|||
143039141|NCT00365365|515687068|FG001|Overall Study|Death|3|||
143039142|NCT00365365|515687069|FG002|Overall Study|Death|0|||
143039143|NCT00365365|515687067|FG000|Overall Study|Subject's request|11|||
143039144|NCT00365365|515687068|FG001|Overall Study|Subject's request|13|||
143039145|NCT00365365|515687069|FG002|Overall Study|Subject's request|1|||
143039146|NCT00365365|515687067|FG000|Overall Study|Disease progression/relapse|9|||
143039147|NCT00365365|515687068|FG001|Overall Study|Disease progression/relapse|6|||
143039148|NCT00365365|515687069|FG002|Overall Study|Disease progression/relapse|7|||
143039149|NCT00365365|515687067|FG000|Overall Study|Adverse Event|6|||
143039150|NCT00365365|515687068|FG001|Overall Study|Adverse Event|6|||
143039151|NCT00365365|515687069|FG002|Overall Study|Adverse Event|3|||
143039152|NCT00365365|515687067|FG000|Overall Study|Moved|2|||
143039153|NCT00365365|515687068|FG001|Overall Study|Moved|0|||
143039154|NCT00365365|515687069|FG002|Overall Study|Moved|0|||
143039155|NCT00365365|515687067|FG000|Overall Study|New cancer|1|||
143039156|NCT00365365|515687068|FG001|Overall Study|New cancer|0|||
143039157|NCT00365365|515687069|FG002|Overall Study|New cancer|0|||
143039158|NCT00365365|515687067|FG000|Overall Study|Withdrew consent|1|||
143039159|NCT00365365|515687068|FG001|Overall Study|Withdrew consent|1|||
143039160|NCT00365365|515687069|FG002|Overall Study|Withdrew consent|0|||
143039161|NCT00365365|515687067|FG000|Overall Study|Second malignancy|0|||
143039162|NCT00365365|515687068|FG001|Overall Study|Second malignancy|1|||
143039163|NCT00365365|515687069|FG002|Overall Study|Second malignancy|0|||
143039164|NCT00365365|515687067|FG000|Overall Study|Patient/physician decision|0|||
143039165|NCT00365365|515687068|FG001|Overall Study|Patient/physician decision|0|||
143039166|NCT00365365|515687069|FG002|Overall Study|Patient/physician decision|1|||
143039167|NCT04247282|515687073|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
143039168|NCT04247282|515687074|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
143039169|NCT04247282|515687075|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
143039170|NCT04247282|515687076|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
143039171|NCT04247282|515687073|FG000|Overall Study|Refused further treatment|0|||
143039172|NCT04247282|515687074|FG001|Overall Study|Refused further treatment|1|||
143039173|NCT04247282|515687075|FG002|Overall Study|Refused further treatment|0|||
143039174|NCT04247282|515687076|FG003|Overall Study|Refused further treatment|0|||
143039175|NCT03687736|515687077|FG000|Overall Study|Lost to Follow-up|7|||
143039176|NCT03687736|515687077|FG000|Overall Study|Withdrawal by Subject|3|||
143039177|NCT03496623|515687080|FG000|Run-In Period (2 Weeks)|Death|1|||
143039178|NCT03496623|515687081|FG001|Run-In Period (2 Weeks)|Death|0|||
143039179|NCT03496623|515687082|FG002|Run-In Period (2 Weeks)|Death|0|||
143039180|NCT03496623|515687083|FG003|Run-In Period (2 Weeks)|Death|0|||
143039181|NCT03496623|515687084|FG004|Run-In Period (2 Weeks)|Death|0|||
143039182|NCT03496623|515687080|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
143039183|NCT03496623|515687081|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
143039184|NCT03496623|515687082|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
143039185|NCT03496623|515687083|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
143039186|NCT03496623|515687084|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
143039187|NCT03496623|515687080|FG000|Period 1 (12 Weeks)|Death|0|||
143039188|NCT03496623|515687081|FG001|Period 1 (12 Weeks)|Death|3|||
143039189|NCT03496623|515687082|FG002|Period 1 (12 Weeks)|Death|0|||
143039190|NCT03496623|515687083|FG003|Period 1 (12 Weeks)|Death|0|||
143039191|NCT03496623|515687084|FG004|Period 1 (12 Weeks)|Death|0|||
143039192|NCT03496623|515687080|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
143039193|NCT03496623|515687081|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
143039194|NCT03496623|515687082|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
143039195|NCT03496623|515687083|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
143039196|NCT03496623|515687084|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
143039197|NCT03496623|515687080|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
143039198|NCT03496623|515687081|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
143039199|NCT03496623|515687082|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
143039200|NCT03496623|515687083|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
143039201|NCT03496623|515687084|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
143039202|NCT03496623|515687080|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
143162357|NCT02134028|516139675|FG006|Overall Study|Other unspecified|2|||
143496896|NCT00272987|517361458|FG001|Overall Study|Lost to Follow-up|1|||
143496897|NCT00272987|517361459|FG002|Overall Study|Lost to Follow-up|1|||
143496898|NCT00272987|517361457|FG000|Overall Study|Withdrawal by Subject|1|||
143496899|NCT00272987|517361458|FG001|Overall Study|Withdrawal by Subject|0|||
143039203|NCT03496623|515687081|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
143039204|NCT03496623|515687082|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
143039205|NCT03496623|515687083|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
143039206|NCT03496623|515687084|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
143039207|NCT03496623|515687080|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
143039208|NCT03496623|515687081|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
143039209|NCT03496623|515687082|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
143039210|NCT03496623|515687083|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
143039211|NCT03496623|515687084|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
143039212|NCT03496623|515687080|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
143039213|NCT03496623|515687081|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
143039214|NCT03496623|515687082|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
143039215|NCT03496623|515687083|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
143239344|NCT01208207|516429856|FG006|Part I|Withdrawal by Subject|0|||
143239345|NCT01208207|516429850|FG000|Part II|Withdrawal by Subject|0|||
143239346|NCT01208207|516429851|FG001|Part II|Withdrawal by Subject|0|||
143239347|NCT01208207|516429852|FG002|Part II|Withdrawal by Subject|0|||
143239348|NCT01208207|516429853|FG003|Part II|Withdrawal by Subject|10|||
143239349|NCT01208207|516429854|FG004|Part II|Withdrawal by Subject|9|||
143239350|NCT01208207|516429855|FG005|Part II|Withdrawal by Subject|3|||
143239351|NCT01208207|516429856|FG006|Part II|Withdrawal by Subject|5|||
143239352|NCT01208207|516429850|FG000|Part II|Adverse Event|0|||
143239353|NCT01208207|516429851|FG001|Part II|Adverse Event|0|||
143239354|NCT01208207|516429852|FG002|Part II|Adverse Event|0|||
143239355|NCT01208207|516429853|FG003|Part II|Adverse Event|5|||
143039216|NCT03496623|515687084|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
143039217|NCT03496623|515687080|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
143039218|NCT03496623|515687081|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
143039219|NCT03496623|515687082|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
143039220|NCT03496623|515687083|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
143039221|NCT03496623|515687084|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
143039222|NCT02543203|515687085|FG000|Overall Study|Unpalatable Fragrance|2|||
143039223|NCT02543203|515687086|FG001|Overall Study|Unpalatable Fragrance|2|||
143039224|NCT02543203|515687085|FG000|Overall Study|Lost to Follow-up|1|||
143039225|NCT02543203|515687086|FG001|Overall Study|Lost to Follow-up|0|||
143039226|NCT02543203|515687085|FG000|Overall Study|Increased Irritability|1|||
143239356|NCT01208207|516429854|FG004|Part II|Adverse Event|9|||
143239357|NCT01208207|516429855|FG005|Part II|Adverse Event|4|||
143239358|NCT01208207|516429856|FG006|Part II|Adverse Event|2|||
143239359|NCT01208207|516429850|FG000|Part II|Lack of Efficacy|0|||
143239360|NCT01208207|516429851|FG001|Part II|Lack of Efficacy|0|||
143239361|NCT01208207|516429852|FG002|Part II|Lack of Efficacy|0|||
143496900|NCT00272987|517361459|FG002|Overall Study|Withdrawal by Subject|3|||
143496901|NCT00272987|517361457|FG000|Overall Study|Sponsor Terminated study|0|||
143496902|NCT00272987|517361458|FG001|Overall Study|Sponsor Terminated study|1|||
143496903|NCT00272987|517361459|FG002|Overall Study|Sponsor Terminated study|1|||
143496904|NCT00272987|517361457|FG000|Overall Study|Disease progression|1|||
143496905|NCT00272987|517361458|FG001|Overall Study|Disease progression|1|||
143496906|NCT00272987|517361459|FG002|Overall Study|Disease progression|2|||
143496907|NCT00272987|517361457|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
143496908|NCT00272987|517361458|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
143496909|NCT00272987|517361459|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
143496910|NCT00272987|517361457|FG000|Overall Study|Death|1|||
143496911|NCT00272987|517361458|FG001|Overall Study|Death|0|||
143496912|NCT00272987|517361459|FG002|Overall Study|Death|0|||
143496913|NCT00331409|517361460|FG000|Overall Study|Lack of Efficacy|4|||
143496914|NCT03222349|517361464|FG000|Overall Study|Treatment B not done|5|||
143039227|NCT02543203|515687086|FG001|Overall Study|Increased Irritability|0|||
143039228|NCT02543203|515687085|FG000|Overall Study|Family|1|||
143039229|NCT02543203|515687086|FG001|Overall Study|Family|2|||
143039230|NCT02543203|515687085|FG000|Overall Study|Negative Behavior|1|||
143239362|NCT01208207|516429853|FG003|Part II|Lack of Efficacy|6|||
143364146|NCT01237678|516875552|FG000|Phase II|Randomized but were not treated|0|||
143364147|NCT01237678|516875553|FG001|Phase II|Randomized but were not treated|4|||
143496915|NCT03222349|517361465|FG001|Overall Study|Treatment B not done|0|||
143496916|NCT03222349|517361464|FG000|Overall Study|Lost to Follow-up|1|||
143496917|NCT03222349|517361465|FG001|Overall Study|Lost to Follow-up|2|||
143039231|NCT02543203|515687086|FG001|Overall Study|Negative Behavior|0|||
143039232|NCT02543203|515687085|FG000|Overall Study|Withdrawal by Subject|0|||
143239363|NCT01208207|516429854|FG004|Part II|Lack of Efficacy|4|||
143239364|NCT01208207|516429855|FG005|Part II|Lack of Efficacy|3|||
143239365|NCT01208207|516429856|FG006|Part II|Lack of Efficacy|3|||
143239366|NCT01208207|516429850|FG000|Part II|Lost to Follow-up|0|||
143239367|NCT01208207|516429851|FG001|Part II|Lost to Follow-up|0|||
143239368|NCT01208207|516429852|FG002|Part II|Lost to Follow-up|0|||
143039233|NCT02543203|515687086|FG001|Overall Study|Withdrawal by Subject|1|||
143039234|NCT00089661|515687087|FG000|Overall Study|Adverse Event|0|||
143039235|NCT00089661|515687088|FG001|Overall Study|Adverse Event|2|||
143039236|NCT00089661|515687087|FG000|Overall Study|Death|1|||
143039237|NCT00089661|515687088|FG001|Overall Study|Death|0|||
143039238|NCT00089661|515687087|FG000|Overall Study|Lost to Follow-up|0|||
143039239|NCT00089661|515687088|FG001|Overall Study|Lost to Follow-up|3|||
143039240|NCT00089661|515687087|FG000|Overall Study|Withdrawal by Subject|11|||
143039241|NCT00089661|515687088|FG001|Overall Study|Withdrawal by Subject|9|||
143039242|NCT00089661|515687087|FG000|Overall Study|Disease progression|1|||
143239369|NCT01208207|516429853|FG003|Part II|Lost to Follow-up|4|||
143239370|NCT01208207|516429854|FG004|Part II|Lost to Follow-up|0|||
143039243|NCT00089661|515687088|FG001|Overall Study|Disease progression|3|||
143039244|NCT00089661|515687087|FG000|Overall Study|Ineligibility determined|4|||
143039245|NCT00089661|515687088|FG001|Overall Study|Ineligibility determined|4|||
143039246|NCT00089661|515687087|FG000|Overall Study|Noncompliance|2|||
143039247|NCT00089661|515687088|FG001|Overall Study|Noncompliance|4|||
143039248|NCT00089661|515687087|FG000|Overall Study|Other|2|||
143239371|NCT01208207|516429855|FG005|Part II|Lost to Follow-up|2|||
143239372|NCT01208207|516429856|FG006|Part II|Lost to Follow-up|1|||
143239373|NCT01208207|516429850|FG000|Part II|Non-Compliance With Study Drug|0|||
143239374|NCT01208207|516429851|FG001|Part II|Non-Compliance With Study Drug|0|||
143239375|NCT01208207|516429852|FG002|Part II|Non-Compliance With Study Drug|0|||
143239376|NCT01208207|516429853|FG003|Part II|Non-Compliance With Study Drug|4|||
143239377|NCT01208207|516429854|FG004|Part II|Non-Compliance With Study Drug|1|||
143239378|NCT01208207|516429855|FG005|Part II|Non-Compliance With Study Drug|1|||
143239379|NCT01208207|516429856|FG006|Part II|Non-Compliance With Study Drug|0|||
143239380|NCT01208207|516429850|FG000|Part II|Physician Decision|0|||
143239381|NCT01208207|516429851|FG001|Part II|Physician Decision|0|||
143239382|NCT01208207|516429852|FG002|Part II|Physician Decision|0|||
143239383|NCT01208207|516429853|FG003|Part II|Physician Decision|1|||
143239384|NCT01208207|516429854|FG004|Part II|Physician Decision|0|||
143239385|NCT01208207|516429855|FG005|Part II|Physician Decision|2|||
143239386|NCT01208207|516429856|FG006|Part II|Physician Decision|0|||
143239387|NCT01208207|516429850|FG000|Part II|Protocol Violation|0|||
143239388|NCT01208207|516429851|FG001|Part II|Protocol Violation|0|||
143239389|NCT01208207|516429852|FG002|Part II|Protocol Violation|0|||
143239390|NCT01208207|516429853|FG003|Part II|Protocol Violation|1|||
143239391|NCT01208207|516429854|FG004|Part II|Protocol Violation|0|||
143239392|NCT01208207|516429855|FG005|Part II|Protocol Violation|0|||
143239393|NCT01208207|516429856|FG006|Part II|Protocol Violation|0|||
143239394|NCT01208207|516429850|FG000|Part II|Technical Problems|0|||
143239395|NCT01208207|516429851|FG001|Part II|Technical Problems|0|||
143239396|NCT01208207|516429852|FG002|Part II|Technical Problems|0|||
143239397|NCT01208207|516429853|FG003|Part II|Technical Problems|1|||
143239398|NCT01208207|516429854|FG004|Part II|Technical Problems|0|||
143239399|NCT01208207|516429855|FG005|Part II|Technical Problems|1|||
143239400|NCT01208207|516429856|FG006|Part II|Technical Problems|0|||
143239401|NCT01134055|516429864|FG000|Overall Study|Adverse Event|5|||
143496918|NCT03222349|517361464|FG000|Overall Study|Withdrawal by Subject|1|||
143496919|NCT03222349|517361465|FG001|Overall Study|Withdrawal by Subject|0|||
143496920|NCT03222349|517361464|FG000|Overall Study|Treatment A not done|0|||
143496921|NCT03222349|517361465|FG001|Overall Study|Treatment A not done|5|||
143496922|NCT03222349|517361464|FG000|Overall Study|Study terminated by sponsor|1|||
143496923|NCT03222349|517361465|FG001|Overall Study|Study terminated by sponsor|0|||
143496924|NCT02614079|517361466|FG000|Overall Study|Withdrawal by Subject|1|||
143496925|NCT03072160|517361469|FG000|Overall Study|Adverse Event|3|||
143496926|NCT03072160|517361470|FG001|Overall Study|Adverse Event|1|||
143496927|NCT03072160|517361469|FG000|Overall Study|Refused further treatment|6|||
143496928|NCT03072160|517361470|FG001|Overall Study|Refused further treatment|1|||
143039249|NCT00089661|515687088|FG001|Overall Study|Other|1|||
143039250|NCT03375463|515687090|FG000|Period 1|Lost to Follow-up|0|||
143364148|NCT01237678|516875554|FG002|Phase II|Randomized but were not treated|3|||
143496929|NCT03072160|517361469|FG000|Overall Study|Physician Decision|1|||
143239402|NCT01134055|516429865|FG001|Overall Study|Adverse Event|2|||
143239403|NCT01134055|516429866|FG002|Overall Study|Adverse Event|2|||
143239404|NCT01134055|516429867|FG003|Overall Study|Adverse Event|2|||
143239405|NCT01134055|516429868|FG004|Overall Study|Adverse Event|5|||
143364149|NCT03398356|516875559|FG000|Before Treatment|Lost to Follow-up|1|||
143039251|NCT03375463|515687091|FG001|Period 1|Lost to Follow-up|0|||
143039252|NCT03375463|515687092|FG002|Period 1|Lost to Follow-up|1|||
143039253|NCT03375463|515687093|FG003|Period 1|Lost to Follow-up|0|||
143039254|NCT03375463|515687094|FG004|Period 1|Lost to Follow-up|0|||
143239406|NCT01134055|516429869|FG005|Overall Study|Adverse Event|7|||
143239407|NCT01134055|516429870|FG006|Overall Study|Adverse Event|2|||
143239408|NCT01134055|516429864|FG000|Overall Study|Lost to Follow-up|0|||
143239409|NCT01134055|516429865|FG001|Overall Study|Lost to Follow-up|1|||
143239410|NCT01134055|516429866|FG002|Overall Study|Lost to Follow-up|0|||
143239411|NCT01134055|516429867|FG003|Overall Study|Lost to Follow-up|1|||
143239412|NCT01134055|516429868|FG004|Overall Study|Lost to Follow-up|0|||
143239413|NCT01134055|516429869|FG005|Overall Study|Lost to Follow-up|0|||
143239414|NCT01134055|516429870|FG006|Overall Study|Lost to Follow-up|0|||
143239415|NCT01134055|516429864|FG000|Overall Study|Withdrawal by Subject|3|||
143239416|NCT01134055|516429865|FG001|Overall Study|Withdrawal by Subject|3|||
143239417|NCT01134055|516429866|FG002|Overall Study|Withdrawal by Subject|1|||
143239418|NCT01134055|516429867|FG003|Overall Study|Withdrawal by Subject|2|||
143239419|NCT01134055|516429868|FG004|Overall Study|Withdrawal by Subject|0|||
143239420|NCT01134055|516429869|FG005|Overall Study|Withdrawal by Subject|0|||
143239421|NCT01134055|516429870|FG006|Overall Study|Withdrawal by Subject|8|||
143239422|NCT01134055|516429864|FG000|Overall Study|Protocol Violation|0|||
143239423|NCT01134055|516429865|FG001|Overall Study|Protocol Violation|0|||
143239424|NCT01134055|516429866|FG002|Overall Study|Protocol Violation|0|||
143239425|NCT01134055|516429867|FG003|Overall Study|Protocol Violation|1|||
143239426|NCT01134055|516429868|FG004|Overall Study|Protocol Violation|1|||
143239427|NCT01134055|516429869|FG005|Overall Study|Protocol Violation|0|||
143039255|NCT03375463|515687095|FG005|Period 1|Lost to Follow-up|0|||
143039256|NCT03375463|515687090|FG000|Period 1|Adverse Event|0|||
143039257|NCT03375463|515687091|FG001|Period 1|Adverse Event|0|||
143039258|NCT03375463|515687092|FG002|Period 1|Adverse Event|0|||
143039259|NCT03375463|515687093|FG003|Period 1|Adverse Event|0|||
143039260|NCT03375463|515687094|FG004|Period 1|Adverse Event|1|||
143039261|NCT03375463|515687095|FG005|Period 1|Adverse Event|0|||
143039262|NCT03375463|515687090|FG000|Period 2|Lost to Follow-up|1|||
143039263|NCT03375463|515687091|FG001|Period 2|Lost to Follow-up|1|||
143039264|NCT03375463|515687092|FG002|Period 2|Lost to Follow-up|0|||
143039265|NCT03375463|515687093|FG003|Period 2|Lost to Follow-up|0|||
143039266|NCT03375463|515687094|FG004|Period 2|Lost to Follow-up|0|||
143039267|NCT03375463|515687095|FG005|Period 2|Lost to Follow-up|0|||
143039268|NCT01827163|515687096|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
143039269|NCT01827163|515687096|FG000|Overall Study|Adverse Event|9|||
143039270|NCT02714062|515687100|FG000|Overall Study|Adverse Event|0|||
143039271|NCT02714062|515687101|FG001|Overall Study|Adverse Event|0|||
143039272|NCT02714062|515687102|FG002|Overall Study|Adverse Event|2|||
143039273|NCT02714062|515687100|FG000|Overall Study|Withdrawal by Subject|1|||
143039274|NCT02714062|515687101|FG001|Overall Study|Withdrawal by Subject|0|||
143039275|NCT02714062|515687102|FG002|Overall Study|Withdrawal by Subject|1|||
143039276|NCT02714062|515687100|FG000|Overall Study|Protocol Violation|0|||
143039277|NCT02714062|515687101|FG001|Overall Study|Protocol Violation|1|||
143039278|NCT02714062|515687102|FG002|Overall Study|Protocol Violation|0|||
143039279|NCT02294604|515687105|FG000|Overall Study|Did not provide samples for culture|0|||
143039280|NCT02294604|515687106|FG001|Overall Study|Did not provide samples for culture|1|||
143039281|NCT02294604|515687107|FG002|Overall Study|Did not provide samples for culture|0|||
143039282|NCT02294604|515687105|FG000|Overall Study|Culture contamination|1|||
143039283|NCT02294604|515687106|FG001|Overall Study|Culture contamination|2|||
143039284|NCT02294604|515687107|FG002|Overall Study|Culture contamination|0|||
143039285|NCT01900626|515687118|FG000|Overall Study|study was closed due to low enrollment|1|||
143039286|NCT01900626|515687119|FG001|Overall Study|study was closed due to low enrollment|1|||
143039287|NCT04533594|515687120|FG000|Overall Study|Death|26|||
143039288|NCT01401647|515687123|FG000|Overall Study|Withdrawal by Subject|1|||
143039289|NCT01401647|515687124|FG001|Overall Study|Withdrawal by Subject|5|||
143039290|NCT01401647|515687125|FG002|Overall Study|Withdrawal by Subject|2|||
143039291|NCT01401647|515687123|FG000|Overall Study|Lost to Follow-up|3|||
143039292|NCT01401647|515687124|FG001|Overall Study|Lost to Follow-up|3|||
143039293|NCT01401647|515687125|FG002|Overall Study|Lost to Follow-up|1|||
143039294|NCT00473330|515687126|FG000|Core Study|Adverse Event|4|||
143039295|NCT00473330|515687127|FG001|Core Study|Adverse Event|4|||
143039296|NCT00473330|515687128|FG002|Core Study|Adverse Event|1|||
143039297|NCT00473330|515687126|FG000|Core Study|Death|6|||
143039298|NCT00473330|515687127|FG001|Core Study|Death|4|||
143364150|NCT03398356|516875560|FG001|Before Treatment|Lost to Follow-up|2|||
143364151|NCT03398356|516875561|FG002|Before Treatment|Lost to Follow-up|0|||
143364152|NCT03398356|516875559|FG000|Before Treatment|drug intolerance|2|||
143039299|NCT00473330|515687128|FG002|Core Study|Death|4|||
143039300|NCT00473330|515687126|FG000|Core Study|Lost to Follow-up|5|||
143039301|NCT00473330|515687127|FG001|Core Study|Lost to Follow-up|5|||
143039302|NCT00473330|515687128|FG002|Core Study|Lost to Follow-up|10|||
143039303|NCT00473330|515687126|FG000|Core Study|Physician Decision|2|||
143039304|NCT00473330|515687127|FG001|Core Study|Physician Decision|1|||
143039305|NCT00473330|515687128|FG002|Core Study|Physician Decision|3|||
143239428|NCT01134055|516429870|FG006|Overall Study|Protocol Violation|0|||
143239429|NCT01134055|516429864|FG000|Overall Study|Physician Decision|0|||
143239430|NCT01134055|516429865|FG001|Overall Study|Physician Decision|0|||
143364153|NCT03398356|516875560|FG001|Before Treatment|drug intolerance|1|||
143039306|NCT00473330|515687126|FG000|Core Study|Subject Non-compliance|1|||
143039307|NCT00473330|515687127|FG001|Core Study|Subject Non-compliance|2|||
143039308|NCT00473330|515687128|FG002|Core Study|Subject Non-compliance|1|||
143039309|NCT00473330|515687126|FG000|Core Study|Subject Required Other Therapy|0|||
143039310|NCT00473330|515687127|FG001|Core Study|Subject Required Other Therapy|1|||
143239431|NCT01134055|516429866|FG002|Overall Study|Physician Decision|0|||
143239432|NCT01134055|516429867|FG003|Overall Study|Physician Decision|0|||
143496930|NCT03072160|517361470|FG001|Overall Study|Physician Decision|0|||
143496931|NCT03072160|517361469|FG000|Overall Study|Disease progression on study|1|||
143496932|NCT03072160|517361470|FG001|Overall Study|Disease progression on study|1|||
143496933|NCT03072160|517361469|FG000|Overall Study|No contact|0|||
143496934|NCT03072160|517361470|FG001|Overall Study|No contact|1|||
143496935|NCT00395967|517361471|FG000|Treatment Period|Failed Mobilization|1|||
143496936|NCT00395967|517361471|FG000|Follow-up Period|Death|1|||
143496937|NCT00395967|517361471|FG000|Follow-up Period|Lost to Follow-up|1|||
143496938|NCT01109940|517361472|FG000|Overall Study|Administrative problems|2|||
143496939|NCT01109940|517361473|FG001|Overall Study|Administrative problems|0|||
143496940|NCT01109940|517361474|FG002|Overall Study|Administrative problems|0|||
143496941|NCT01109940|517361475|FG003|Overall Study|Administrative problems|0|||
143496942|NCT01109940|517361472|FG000|Overall Study|Serious Adverse Event|2|||
143496943|NCT01109940|517361473|FG001|Overall Study|Serious Adverse Event|1|||
143496944|NCT01109940|517361474|FG002|Overall Study|Serious Adverse Event|0|||
143496945|NCT01109940|517361475|FG003|Overall Study|Serious Adverse Event|0|||
143496946|NCT01109940|517361472|FG000|Overall Study|Lost to Follow-up|1|||
143496947|NCT01109940|517361473|FG001|Overall Study|Lost to Follow-up|0|||
143496948|NCT01109940|517361474|FG002|Overall Study|Lost to Follow-up|0|||
143496949|NCT01109940|517361475|FG003|Overall Study|Lost to Follow-up|0|||
143496950|NCT01109940|517361472|FG000|Overall Study|Patient withdrew consent|1|||
143496951|NCT01109940|517361473|FG001|Overall Study|Patient withdrew consent|1|||
143496952|NCT01109940|517361474|FG002|Overall Study|Patient withdrew consent|0|||
143496953|NCT01109940|517361475|FG003|Overall Study|Patient withdrew consent|0|||
143496954|NCT01109940|517361472|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
143496955|NCT01109940|517361473|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
143039311|NCT00473330|515687128|FG002|Core Study|Subject Required Other Therapy|3|||
143039312|NCT00473330|515687126|FG000|Core Study|Subject's Decision|9|||
143039313|NCT00473330|515687127|FG001|Core Study|Subject's Decision|8|||
143039314|NCT00473330|515687128|FG002|Core Study|Subject's Decision|19|||
143039315|NCT00473330|515687126|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
143039316|NCT00473330|515687127|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
143039317|NCT00473330|515687128|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
143039318|NCT00473330|515687126|FG000|Open-label Extension Through Month 48|Death|2|||
143039319|NCT00473330|515687127|FG001|Open-label Extension Through Month 48|Death|0|||
143039320|NCT00473330|515687128|FG002|Open-label Extension Through Month 48|Death|0|||
143039321|NCT00473330|515687126|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
143162358|NCT02134028|516139676|FG007|Overall Study|Other unspecified|1|||
143162359|NCT02134028|516139669|FG000|Overall Study|Adverse Event|3|||
143162360|NCT02134028|516139670|FG001|Overall Study|Adverse Event|19|||
143162361|NCT02134028|516139671|FG002|Overall Study|Adverse Event|13|||
143162362|NCT02134028|516139672|FG003|Overall Study|Adverse Event|32|||
143162363|NCT02134028|516139673|FG004|Overall Study|Adverse Event|4|||
143162364|NCT02134028|516139674|FG005|Overall Study|Adverse Event|5|||
143162365|NCT02134028|516139675|FG006|Overall Study|Adverse Event|1|||
143162366|NCT02134028|516139676|FG007|Overall Study|Adverse Event|2|||
143162367|NCT00489359|516139677|FG000|Overall Study|Death|0|||
143162368|NCT00489359|516139678|FG001|Overall Study|Death|2|||
143162369|NCT00489359|516139677|FG000|Overall Study|Progressive Disease|5|||
143162370|NCT00489359|516139678|FG001|Overall Study|Progressive Disease|6|||
143162371|NCT00489359|516139677|FG000|Overall Study|Lost to Follow-up|1|||
143162372|NCT00489359|516139678|FG001|Overall Study|Lost to Follow-up|0|||
143162373|NCT00489359|516139677|FG000|Overall Study|Withdrawal by Subject|1|||
143162374|NCT00489359|516139678|FG001|Overall Study|Withdrawal by Subject|5|||
143162375|NCT00489359|516139677|FG000|Overall Study|Adverse Event|0|||
143239433|NCT01134055|516429868|FG004|Overall Study|Physician Decision|0|||
143239434|NCT01134055|516429869|FG005|Overall Study|Physician Decision|0|||
143496956|NCT01109940|517361474|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
143496957|NCT01109940|517361475|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
143496958|NCT03653390|517361476|FG000|Overall Study|Lost to Follow-up|12|||
143496959|NCT03653390|517361477|FG001|Overall Study|Lost to Follow-up|8|||
143496960|NCT03653390|517361478|FG002|Overall Study|Lost to Follow-up|7|||
143496961|NCT03653390|517361476|FG000|Overall Study|Withdrawal by Subject|6|||
143496962|NCT03653390|517361477|FG001|Overall Study|Withdrawal by Subject|1|||
143039322|NCT00473330|515687127|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
143039323|NCT00473330|515687128|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
143496963|NCT03653390|517361478|FG002|Overall Study|Withdrawal by Subject|1|||
143496964|NCT03653390|517361476|FG000|Overall Study|Death|1|||
143496965|NCT03653390|517361477|FG001|Overall Study|Death|0|||
143496966|NCT03653390|517361478|FG002|Overall Study|Death|0|||
143039324|NCT00473330|515687126|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
143039325|NCT00473330|515687127|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
143162376|NCT00489359|516139678|FG001|Overall Study|Adverse Event|16|||
143162377|NCT03180138|516139679|FG000|Overall Study|Mobile-phone could not be verified|2|||
143162378|NCT03180138|516139680|FG001|Overall Study|Mobile-phone could not be verified|13|||
143162379|NCT03180138|516139681|FG002|Overall Study|Mobile-phone could not be verified|15|||
143496967|NCT03653390|517361476|FG000|Overall Study|Paper Survey Lost|1|||
143496968|NCT03653390|517361477|FG001|Overall Study|Paper Survey Lost|0|||
143496969|NCT03653390|517361478|FG002|Overall Study|Paper Survey Lost|0|||
143496970|NCT02769624|517361479|FG000|Overall Study|Lost to Follow-up|0|||
143496971|NCT02769624|517361480|FG001|Overall Study|Lost to Follow-up|1|||
143496972|NCT00448708|517361482|FG000|Overall Study|Death|21|||
143496973|NCT00448708|517361483|FG001|Overall Study|Death|17|||
143496974|NCT00448708|517361482|FG000|Overall Study|Withdrawal by Subject|8|||
143496975|NCT00448708|517361483|FG001|Overall Study|Withdrawal by Subject|4|||
143496976|NCT00448708|517361482|FG000|Overall Study|Lost to Follow-up|6|||
143496977|NCT00448708|517361483|FG001|Overall Study|Lost to Follow-up|8|||
143496978|NCT00448708|517361482|FG000|Overall Study|not listed|0|||
143496979|NCT00448708|517361483|FG001|Overall Study|not listed|2|||
143496980|NCT00236080|517361484|FG000|Overall Study|Adverse Event|0|||
143496981|NCT00236080|517361485|FG001|Overall Study|Adverse Event|0|||
143496982|NCT00236080|517361486|FG002|Overall Study|Adverse Event|3|||
143496983|NCT00236080|517361487|FG003|Overall Study|Adverse Event|1|||
143496984|NCT00236080|517361488|FG004|Overall Study|Adverse Event|0|||
143496985|NCT00236080|517361484|FG000|Overall Study|Lost to Follow-up|0|||
143496986|NCT00236080|517361485|FG001|Overall Study|Lost to Follow-up|1|||
143496987|NCT00236080|517361486|FG002|Overall Study|Lost to Follow-up|0|||
143496988|NCT00236080|517361487|FG003|Overall Study|Lost to Follow-up|0|||
143496989|NCT00236080|517361488|FG004|Overall Study|Lost to Follow-up|0|||
143496990|NCT00236080|517361484|FG000|Overall Study|Physician Decision|1|||
143496991|NCT00236080|517361485|FG001|Overall Study|Physician Decision|0|||
143496992|NCT00236080|517361486|FG002|Overall Study|Physician Decision|1|||
143496993|NCT00236080|517361487|FG003|Overall Study|Physician Decision|1|||
143496994|NCT00236080|517361488|FG004|Overall Study|Physician Decision|1|||
143496995|NCT00236080|517361484|FG000|Overall Study|Withdrawal by Subject|1|||
143496996|NCT00236080|517361485|FG001|Overall Study|Withdrawal by Subject|0|||
143496997|NCT00236080|517361486|FG002|Overall Study|Withdrawal by Subject|0|||
143496998|NCT00236080|517361487|FG003|Overall Study|Withdrawal by Subject|0|||
143496999|NCT00236080|517361488|FG004|Overall Study|Withdrawal by Subject|0|||
143497000|NCT00236080|517361484|FG000|Overall Study|Miscellaneous|0|||
143497001|NCT00236080|517361485|FG001|Overall Study|Miscellaneous|0|||
143497002|NCT00236080|517361486|FG002|Overall Study|Miscellaneous|1|||
143497003|NCT00236080|517361487|FG003|Overall Study|Miscellaneous|0|||
143497004|NCT00236080|517361488|FG004|Overall Study|Miscellaneous|0|||
143497005|NCT01214044|517361489|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
143497006|NCT01214044|517361489|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
143497007|NCT01214044|517361489|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
143497008|NCT01214044|517361489|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
143497009|NCT01214044|517361489|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
143497010|NCT01214044|517361489|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
143497011|NCT00408694|517361490|FG000|Overall Study|Ineligible|1|||
143497012|NCT00408694|517361490|FG000|Overall Study|No protocol treatment|1|||
143497013|NCT01961544|517361491|FG000|Overall Study|Protocol Violation|1|||
143497014|NCT01961544|517361491|FG000|Overall Study|Withdrawal by Subject|7|||
143497015|NCT01961544|517361491|FG000|Overall Study|Adverse Event|1|||
143497016|NCT01961544|517361491|FG000|Overall Study|Physician Decision|2|||
143497017|NCT01961544|517361491|FG000|Overall Study|Poor Tolerance|1|||
143497018|NCT01961544|517361491|FG000|Overall Study|Aggravation of Steral Pain|1|||
143497019|NCT02908516|517361494|FG000|Overall Study|Study Terminated|3|||
143162380|NCT03180138|516139679|FG000|Overall Study|No prior immunization records|17|||
143162381|NCT03180138|516139680|FG001|Overall Study|No prior immunization records|0|||
143162382|NCT03180138|516139681|FG002|Overall Study|No prior immunization records|6|||
143497020|NCT02908516|517361495|FG001|Overall Study|Study Terminated|3|||
143497021|NCT01225562|517361496|FG000|Overall Study|Withdrawal by Subject|52|||
143497022|NCT01225562|517361497|FG001|Overall Study|Withdrawal by Subject|50|||
143162383|NCT03180138|516139679|FG000|Overall Study|Found to be >24 mon after randomization|3|||
143162384|NCT03180138|516139680|FG001|Overall Study|Found to be >24 mon after randomization|0|||
143162385|NCT03180138|516139681|FG002|Overall Study|Found to be >24 mon after randomization|3|||
143497023|NCT01225562|517361498|FG002|Overall Study|Withdrawal by Subject|52|||
143497024|NCT01225562|517361496|FG000|Overall Study|Lost to Follow-up|3|||
143497025|NCT01225562|517361497|FG001|Overall Study|Lost to Follow-up|6|||
143497026|NCT01225562|517361498|FG002|Overall Study|Lost to Follow-up|1|||
143497027|NCT01481896|517361499|FG000|Overall Study|Lost to Follow-up|12|||
143497028|NCT02251912|517361500|FG000|Overall Study|Withdrawal by Subject|2|||
143497029|NCT02251912|517361501|FG001|Overall Study|Withdrawal by Subject|3|||
143497030|NCT02251912|517361500|FG000|Overall Study|Adverse Event|0|||
143497031|NCT02251912|517361501|FG001|Overall Study|Adverse Event|2|||
143497032|NCT01162421|517361502|FG000|Overall Study|Did not receive study drug|2|||
143497033|NCT01162421|517361503|FG001|Overall Study|Did not receive study drug|1|||
143497034|NCT01162421|517361502|FG000|Overall Study|Adverse Event|2|||
143497035|NCT01162421|517361503|FG001|Overall Study|Adverse Event|5|||
143497036|NCT01162421|517361502|FG000|Overall Study|Lost to Follow-up|0|||
143497037|NCT01162421|517361503|FG001|Overall Study|Lost to Follow-up|2|||
143497038|NCT01162421|517361502|FG000|Overall Study|Lack of Efficacy|2|||
143497039|NCT01162421|517361503|FG001|Overall Study|Lack of Efficacy|2|||
143497040|NCT01162421|517361502|FG000|Overall Study|Other|2|||
143497041|NCT01162421|517361503|FG001|Overall Study|Other|3|||
143497042|NCT03336502|517361504|FG000|Overall Study|Physician Decision|0|||
143497043|NCT03336502|517361505|FG001|Overall Study|Physician Decision|1|||
143497044|NCT03336502|517361504|FG000|Overall Study|Prohibited Drugs|1|||
143497045|NCT03336502|517361505|FG001|Overall Study|Prohibited Drugs|1|||
143497046|NCT03336502|517361504|FG000|Overall Study|Death|1|||
143497047|NCT03336502|517361505|FG001|Overall Study|Death|2|||
143497048|NCT03336502|517361504|FG000|Overall Study|Adverse Event|2|||
143497049|NCT03336502|517361505|FG001|Overall Study|Adverse Event|5|||
143497050|NCT00480857|517361507|FG000|Overall Study|Lack of Efficacy|2|||
143497051|NCT00611247|517361508|FG000|Overall Study|Death|1|||
143497052|NCT00611247|517361509|FG001|Overall Study|Death|5|||
143497053|NCT00611247|517361508|FG000|Overall Study|Lack of Efficacy|1|||
143497054|NCT00611247|517361509|FG001|Overall Study|Lack of Efficacy|16|||
143497055|NCT01107444|517361510|FG000|Overall Study|Withdrawal by Subject|8|||
143497056|NCT01107444|517361511|FG001|Overall Study|Withdrawal by Subject|12|||
143497057|NCT01107444|517361510|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
143497058|NCT01107444|517361511|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
143497059|NCT01948830|517361514|FG000|Overall Study|Physician Decision|1|||
143497060|NCT01948830|517361515|FG001|Overall Study|Physician Decision|3|||
143497061|NCT01948830|517361514|FG000|Overall Study|Protocol deviation|1|||
143497062|NCT01948830|517361515|FG001|Overall Study|Protocol deviation|2|||
143497063|NCT01948830|517361514|FG000|Overall Study|Lost to Follow-up|5|||
143497064|NCT01948830|517361515|FG001|Overall Study|Lost to Follow-up|4|||
143039326|NCT00473330|515687128|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
143039327|NCT00473330|515687126|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
143039328|NCT00473330|515687127|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
143039329|NCT00473330|515687128|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
143039330|NCT00473330|515687126|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
143039331|NCT00473330|515687127|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
143162386|NCT01903733|516139683|FG000|Overall Study|Death|23|||
143497065|NCT01948830|517361514|FG000|Overall Study|Withdrawal by Subject|14|||
143497066|NCT01948830|517361515|FG001|Overall Study|Withdrawal by Subject|17|||
143497067|NCT01948830|517361514|FG000|Overall Study|Adverse Event|9|||
143497068|NCT01948830|517361515|FG001|Overall Study|Adverse Event|2|||
143162387|NCT01903733|516139684|FG001|Overall Study|Death|54|||
143162388|NCT01903733|516139685|FG002|Overall Study|Death|30|||
143162389|NCT01903733|516139686|FG003|Overall Study|Death|98|||
143162390|NCT01903733|516139683|FG000|Overall Study|Participant refused further follow-up|35|||
143162391|NCT01903733|516139684|FG001|Overall Study|Participant refused further follow-up|38|||
143162392|NCT01903733|516139685|FG002|Overall Study|Participant refused further follow-up|13|||
143162393|NCT01903733|516139686|FG003|Overall Study|Participant refused further follow-up|9|||
143162394|NCT01903733|516139683|FG000|Overall Study|Lost to Follow-up|18|||
143162395|NCT01903733|516139684|FG001|Overall Study|Lost to Follow-up|19|||
143162396|NCT01903733|516139685|FG002|Overall Study|Lost to Follow-up|6|||
143162397|NCT01903733|516139686|FG003|Overall Study|Lost to Follow-up|9|||
143162398|NCT01903733|516139683|FG000|Overall Study|Other|10|||
143162399|NCT01903733|516139684|FG001|Overall Study|Other|15|||
143162400|NCT01903733|516139685|FG002|Overall Study|Other|12|||
143162401|NCT01903733|516139686|FG003|Overall Study|Other|3|||
143162402|NCT01903733|516139683|FG000|Overall Study|Missing|2|||
143162403|NCT01903733|516139684|FG001|Overall Study|Missing|0|||
143162404|NCT01903733|516139685|FG002|Overall Study|Missing|0|||
143162405|NCT01903733|516139686|FG003|Overall Study|Missing|0|||
143162406|NCT01903733|516139683|FG000|Overall Study|Investigator request|18|||
143162407|NCT01903733|516139684|FG001|Overall Study|Investigator request|0|||
143162408|NCT01903733|516139685|FG002|Overall Study|Investigator request|0|||
143162409|NCT01903733|516139686|FG003|Overall Study|Investigator request|0|||
143162410|NCT00728182|516139692|FG000|Overall Study|Adverse Event|1|||
143162411|NCT00728182|516139693|FG001|Overall Study|Adverse Event|0|||
143162412|NCT00728182|516139692|FG000|Overall Study|Lost to Follow-up|2|||
143162413|NCT00728182|516139693|FG001|Overall Study|Lost to Follow-up|0|||
143162414|NCT00728182|516139692|FG000|Overall Study|Death|0|||
143497069|NCT01948830|517361514|FG000|Overall Study|Death|3|||
143497070|NCT01948830|517361515|FG001|Overall Study|Death|4|||
143497071|NCT00243659|517361516|FG000|Overall Study|Withdrawal by Subject|1|||
143497072|NCT00243659|517361517|FG001|Overall Study|Withdrawal by Subject|1|||
143162415|NCT00728182|516139693|FG001|Overall Study|Death|2|||
143162416|NCT00728182|516139692|FG000|Overall Study|Protocol Noncompliance|0|||
143162417|NCT00728182|516139693|FG001|Overall Study|Protocol Noncompliance|1|||
143162418|NCT03721107|516139694|FG000|Overall Study|Adverse Event|1|||
143162419|NCT03721107|516139695|FG001|Overall Study|Adverse Event|1|||
143162420|NCT03721107|516139696|FG002|Overall Study|Adverse Event|6|||
143497073|NCT00243659|517361516|FG000|Overall Study|Protocol Violation|1|||
143497074|NCT00243659|517361517|FG001|Overall Study|Protocol Violation|2|||
143497075|NCT01890421|517361518|FG000|Overall Study|Adverse Event|1|||
143497076|NCT01890421|517361518|FG000|Overall Study|Other reason|10|||
143039332|NCT00473330|515687128|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
143039333|NCT00473330|515687126|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
143039334|NCT00473330|515687127|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
143039335|NCT00473330|515687128|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
143039336|NCT00473330|515687126|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
143039337|NCT00473330|515687127|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
143039338|NCT00473330|515687128|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
143039339|NCT00473330|515687126|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
143039340|NCT00473330|515687127|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
143039341|NCT00473330|515687128|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
143039342|NCT00473330|515687126|FG000|Open-label Extension Through Month 60|Death|2|||
143039343|NCT00473330|515687127|FG001|Open-label Extension Through Month 60|Death|2|||
143039344|NCT00473330|515687128|FG002|Open-label Extension Through Month 60|Death|1|||
143039345|NCT00473330|515687126|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
143039346|NCT00473330|515687127|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
143039347|NCT00473330|515687128|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
143039348|NCT00473330|515687126|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
143039349|NCT00473330|515687127|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
143039350|NCT00473330|515687128|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
143039351|NCT00473330|515687126|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
143039352|NCT00473330|515687127|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
143039353|NCT00473330|515687128|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
143039354|NCT00473330|515687126|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
143039355|NCT00473330|515687127|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
143039356|NCT00473330|515687128|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
143039357|NCT00473330|515687126|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
143039358|NCT00473330|515687127|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
143039359|NCT00473330|515687128|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
143039360|NCT00473330|515687126|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
143039361|NCT00473330|515687127|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
143039362|NCT00473330|515687128|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
143039363|NCT01975948|515687129|FG000|Overall Study|Withdrawal by Subject|17|||
143039364|NCT01975948|515687130|FG001|Overall Study|Withdrawal by Subject|21|||
143039365|NCT01975948|515687131|FG002|Overall Study|Withdrawal by Subject|7|||
143039366|NCT01975948|515687132|FG003|Overall Study|Withdrawal by Subject|6|||
143039367|NCT01079988|515687133|FG000|Overall Study|Lost to Follow-up|0|||
143039368|NCT01079988|515687134|FG001|Overall Study|Lost to Follow-up|0|||
143039369|NCT01079988|515687135|FG002|Overall Study|Lost to Follow-up|0|||
143039370|NCT01079988|515687136|FG003|Overall Study|Lost to Follow-up|1|||
143039371|NCT01079988|515687137|FG004|Overall Study|Lost to Follow-up|0|||
143162421|NCT03721107|516139697|FG003|Overall Study|Adverse Event|5|||
143162422|NCT03721107|516139694|FG000|Overall Study|Lost to Follow-up|2|||
143162423|NCT03721107|516139695|FG001|Overall Study|Lost to Follow-up|0|||
143162424|NCT03721107|516139696|FG002|Overall Study|Lost to Follow-up|3|||
143162425|NCT03721107|516139697|FG003|Overall Study|Lost to Follow-up|0|||
143162426|NCT03721107|516139694|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
143162427|NCT03721107|516139695|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
143162428|NCT03721107|516139696|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
143162429|NCT03721107|516139697|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
143162430|NCT03721107|516139694|FG000|Overall Study|Physician Decision|0|||
143162431|NCT03721107|516139695|FG001|Overall Study|Physician Decision|1|||
143162432|NCT03721107|516139696|FG002|Overall Study|Physician Decision|0|||
143162433|NCT03721107|516139697|FG003|Overall Study|Physician Decision|0|||
143162434|NCT03721107|516139694|FG000|Overall Study|Pregnancy|0|||
143162435|NCT03721107|516139695|FG001|Overall Study|Pregnancy|0|||
143162436|NCT03721107|516139696|FG002|Overall Study|Pregnancy|1|||
143162437|NCT03721107|516139697|FG003|Overall Study|Pregnancy|0|||
143162438|NCT03721107|516139694|FG000|Overall Study|Withdrawal by Subject|1|||
143162439|NCT03721107|516139695|FG001|Overall Study|Withdrawal by Subject|1|||
143162440|NCT03721107|516139696|FG002|Overall Study|Withdrawal by Subject|5|||
143162441|NCT03721107|516139697|FG003|Overall Study|Withdrawal by Subject|5|||
143162442|NCT03721107|516139694|FG000|Overall Study|Other|1|||
143239435|NCT01134055|516429870|FG006|Overall Study|Physician Decision|1|||
143039372|NCT01079988|515687133|FG000|Overall Study|Lack of Efficacy|1|||
143039373|NCT01079988|515687134|FG001|Overall Study|Lack of Efficacy|0|||
143162443|NCT03721107|516139695|FG001|Overall Study|Other|0|||
143162444|NCT03721107|516139696|FG002|Overall Study|Other|0|||
143162445|NCT03721107|516139697|FG003|Overall Study|Other|1|||
143162446|NCT02294019|516139698|FG000|Overall Study|Adverse Event|2|||
143497077|NCT00268242|517361519|FG000|Overall Study|Death|1|||
143497078|NCT03969888|517361523|FG000|Overall Study|Never Received Study Drug|0|||
143162447|NCT02294019|516139698|FG000|Overall Study|Protocol Violation|68|||
143162448|NCT02294019|516139698|FG000|Overall Study|Lost to Follow-up|31|||
143162449|NCT02294019|516139698|FG000|Overall Study|Other|1|||
143162450|NCT02294019|516139698|FG000|Overall Study|Withdrawal by Subject|1|||
143162451|NCT02554474|516139699|FG000|Overall Study|Protocol Violation|1|||
143162452|NCT02554474|516139700|FG001|Overall Study|Protocol Violation|1|||
143162453|NCT02554474|516139699|FG000|Overall Study|Health issue not related to the study|1|||
143162454|NCT02554474|516139700|FG001|Overall Study|Health issue not related to the study|0|||
143162455|NCT02554474|516139699|FG000|Overall Study|Withdrawal by Subject|1|||
143162456|NCT02554474|516139700|FG001|Overall Study|Withdrawal by Subject|1|||
143162457|NCT03511209|516139703|FG000|Overall Study|Withdrawal by Subject|2|||
143162458|NCT03511209|516139704|FG001|Overall Study|Withdrawal by Subject|4|||
143162459|NCT03511209|516139703|FG000|Overall Study|Death|1|||
143162460|NCT03511209|516139704|FG001|Overall Study|Death|0|||
143162461|NCT03511209|516139703|FG000|Overall Study|Lost to Follow-up|0|||
143162462|NCT03511209|516139704|FG001|Overall Study|Lost to Follow-up|2|||
143162463|NCT00962650|516139709|FG000|Overall Study|Transgastric DP was not completed|2|||
143162464|NCT00127933|516139716|FG000|Overall Study|Randomized but not dosed|1|||
143162465|NCT00127933|516139717|FG001|Overall Study|Randomized but not dosed|0|||
143162466|NCT01783938|516139723|FG000|Overall Study|Disease Progression|18|||
143162467|NCT01783938|516139724|FG001|Overall Study|Disease Progression|41|||
143162468|NCT01783938|516139723|FG000|Overall Study|Study Drug Toxicity|27|||
143162469|NCT01783938|516139724|FG001|Overall Study|Study Drug Toxicity|14|||
143162470|NCT01783938|516139723|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
143162471|NCT01783938|516139724|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
143162472|NCT01783938|516139723|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
143162473|NCT01783938|516139724|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
143162474|NCT01783938|516139723|FG000|Overall Study|Participant Withdrew Consent|2|||
143162475|NCT01783938|516139724|FG001|Overall Study|Participant Withdrew Consent|0|||
143162476|NCT01783938|516139723|FG000|Overall Study|Maximum Clinical Benefit|1|||
143162477|NCT01783938|516139724|FG001|Overall Study|Maximum Clinical Benefit|0|||
143162478|NCT01783938|516139723|FG000|Overall Study|Other Reasons|3|||
143162479|NCT01783938|516139724|FG001|Overall Study|Other Reasons|1|||
143162480|NCT03111732|516139725|FG000|Overall Study|Enrolled in different study|1|||
143162481|NCT03111732|516139725|FG000|Overall Study|Progressive disease|3|||
143162482|NCT03111732|516139725|FG000|Overall Study|Withdrawal by Subject|1|||
143162483|NCT03072875|516139729|FG000|Overall Study|Lost to Follow-up|1|||
143162484|NCT00401830|516139730|FG000|Overall Study|Adverse Event|10|||
143162485|NCT00401830|516139731|FG001|Overall Study|Adverse Event|18|||
143162486|NCT00401830|516139730|FG000|Overall Study|Lack of Efficacy|11|||
143162487|NCT00401830|516139731|FG001|Overall Study|Lack of Efficacy|5|||
143162488|NCT00401830|516139730|FG000|Overall Study|Withdrawal by Subject|4|||
143162489|NCT00401830|516139731|FG001|Overall Study|Withdrawal by Subject|3|||
143162490|NCT00401830|516139730|FG000|Overall Study|Protocol Violation|3|||
143162491|NCT00401830|516139731|FG001|Overall Study|Protocol Violation|3|||
143162492|NCT00401830|516139730|FG000|Overall Study|Non-compliance with drug study|1|||
143162493|NCT00401830|516139731|FG001|Overall Study|Non-compliance with drug study|0|||
143162494|NCT00401830|516139730|FG000|Overall Study|Lost to Follow-up|1|||
143162495|NCT00401830|516139731|FG001|Overall Study|Lost to Follow-up|3|||
143162496|NCT00401830|516139730|FG000|Overall Study|Other: Personal / Family problems|1|||
143162497|NCT00401830|516139731|FG001|Overall Study|Other: Personal / Family problems|0|||
143162498|NCT01943825|516139732|FG000|Overall Study|Lost to Follow-up|9|||
143162499|NCT01943825|516139733|FG001|Overall Study|Lost to Follow-up|3|||
143162500|NCT01943825|516139734|FG002|Overall Study|Lost to Follow-up|12|||
143162501|NCT01943825|516139735|FG003|Overall Study|Lost to Follow-up|8|||
143162502|NCT01943825|516139732|FG000|Overall Study|Withdrawal by Subject|1|||
143162503|NCT01943825|516139733|FG001|Overall Study|Withdrawal by Subject|0|||
143162504|NCT01943825|516139734|FG002|Overall Study|Withdrawal by Subject|3|||
143162505|NCT01943825|516139735|FG003|Overall Study|Withdrawal by Subject|2|||
143162506|NCT01943825|516139732|FG000|Overall Study|Other than specified above|0|||
143162507|NCT01943825|516139733|FG001|Overall Study|Other than specified above|1|||
143162508|NCT01943825|516139734|FG002|Overall Study|Other than specified above|0|||
143162509|NCT01943825|516139735|FG003|Overall Study|Other than specified above|1|||
143162510|NCT00089583|516139744|FG000|Overall Study|Adverse Event|0|||
143162511|NCT00089583|516139745|FG001|Overall Study|Adverse Event|3|||
143162512|NCT00089583|516139744|FG000|Overall Study|Insufficient Viral Load Response|5|||
143162513|NCT00089583|516139745|FG001|Overall Study|Insufficient Viral Load Response|5|||
143162514|NCT00089583|516139744|FG000|Overall Study|Withdrawal by Subject|0|||
143162515|NCT00089583|516139745|FG001|Overall Study|Withdrawal by Subject|4|||
143162516|NCT00089583|516139744|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
143162517|NCT00089583|516139745|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
143162518|NCT00089583|516139744|FG000|Overall Study|Participant Refused Study Medication|0|||
143162519|NCT00089583|516139745|FG001|Overall Study|Participant Refused Study Medication|2|||
143497079|NCT03969888|517361524|FG001|Overall Study|Never Received Study Drug|0|||
143239436|NCT03486834|516429876|FG000|Overall Study|Withdrawal by Subject|46|||
143162520|NCT00089583|516139744|FG000|Overall Study|Non-Compliance|0|||
143162521|NCT00089583|516139745|FG001|Overall Study|Non-Compliance|4|||
143162522|NCT00089583|516139744|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
143162523|NCT00089583|516139745|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
143162524|NCT00089583|516139744|FG000|Overall Study|Participant Management Criteria Met|0|||
143162525|NCT00089583|516139745|FG001|Overall Study|Participant Management Criteria Met|1|||
143162526|NCT00089583|516139744|FG000|Overall Study|Reason Not Provided|0|||
143162527|NCT00089583|516139745|FG001|Overall Study|Reason Not Provided|1|||
143162528|NCT00089583|516139744|FG000|Overall Study|Protocol Violation|0|||
143162529|NCT00089583|516139745|FG001|Overall Study|Protocol Violation|3|||
143162530|NCT00089583|516139744|FG000|Overall Study|Principal Investigator Decision|0|||
143162531|NCT00089583|516139745|FG001|Overall Study|Principal Investigator Decision|10|||
143162532|NCT00089583|516139744|FG000|Overall Study|Start of Disallowed Medication|0|||
143162533|NCT00089583|516139745|FG001|Overall Study|Start of Disallowed Medication|1|||
143162534|NCT00089583|516139744|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
143162535|NCT00089583|516139745|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
143162536|NCT00089583|516139744|FG000|Overall Study|Participant Incarcerated|0|||
143162537|NCT00089583|516139745|FG001|Overall Study|Participant Incarcerated|1|||
143162538|NCT03810495|516139746|FG000|Overall Study|Lost to Follow-up|2|||
143162539|NCT03810495|516139746|FG000|Overall Study|Withdrawal by Subject|1|||
143162540|NCT00530257|516141576|FG000|Overall Study|Lost to Follow-up|1|||
143162541|NCT05130281|516141577|FG000|Overall Study|Withdrawal by Subject|0|||
143162542|NCT05130281|516141578|FG001|Overall Study|Withdrawal by Subject|0|||
143162543|NCT05130281|516141579|FG002|Overall Study|Withdrawal by Subject|1|||
143162544|NCT03810365|516141581|FG000|Overall Study|Lost to Follow-up|2|||
143162545|NCT03810365|516141582|FG001|Overall Study|Lost to Follow-up|2|||
143162546|NCT03810365|516141581|FG000|Overall Study|Withdrawal by Subject|4|||
143162547|NCT03810365|516141582|FG001|Overall Study|Withdrawal by Subject|5|||
143162548|NCT00107614|516141585|FG000|Overall Study|Physician Decision|10|||
143162549|NCT00107614|516141585|FG000|Overall Study|Death|2|||
143162550|NCT02144337|516141586|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
143162551|NCT02144337|516141587|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
143162552|NCT02144337|516141586|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
143162553|NCT02144337|516141587|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
143162554|NCT02144337|516141586|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
143162555|NCT02144337|516141587|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
143162556|NCT02144337|516141586|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
143162557|NCT02144337|516141587|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
143162558|NCT02144337|516141586|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
143162559|NCT02144337|516141587|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
143162560|NCT01500135|516141588|FG000|Overall Study|Withdrawal of Consent|4|||
143162561|NCT01500135|516141589|FG001|Overall Study|Withdrawal of Consent|0|||
143162562|NCT01500135|516141588|FG000|Overall Study|Lost to Follow-up|6|||
143162563|NCT01500135|516141589|FG001|Overall Study|Lost to Follow-up|4|||
143162564|NCT01500135|516141588|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
143162565|NCT01500135|516141589|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
143162566|NCT01500135|516141588|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
143162567|NCT01500135|516141589|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
143162568|NCT01500135|516141588|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
143162569|NCT01500135|516141589|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
143162570|NCT01500135|516141588|FG000|Overall Study|Participant was a Safety Concern|1|||
143162571|NCT01500135|516141589|FG001|Overall Study|Participant was a Safety Concern|0|||
143162572|NCT01500135|516141588|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
143162573|NCT01500135|516141589|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
143162574|NCT01661595|516141590|FG000|Phase 1: Week 0-4|Adverse Event|1|||
143162575|NCT01661595|516141591|FG001|Phase 1: Week 0-4|Adverse Event|0|||
143162576|NCT01661595|516141592|FG002|Phase 1: Week 0-4|Adverse Event|0|||
143162577|NCT01661595|516141593|FG003|Phase 1: Week 0-4|Adverse Event|0|||
143162578|NCT01661595|516141590|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
143162579|NCT01661595|516141591|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
143162580|NCT01661595|516141592|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
143162581|NCT01661595|516141593|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
143162582|NCT01633112|516141594|FG000|Overall Study|Lack of Efficacy|1|||
143162583|NCT01633112|516141595|FG001|Overall Study|Lack of Efficacy|6|||
143162584|NCT01633112|516141596|FG002|Overall Study|Lack of Efficacy|13|||
143239437|NCT03486834|516429877|FG001|Overall Study|Withdrawal by Subject|46|||
143162585|NCT01633112|516141594|FG000|Overall Study|Abnormal laboratory value(s)|3|||
143162586|NCT01633112|516141595|FG001|Overall Study|Abnormal laboratory value(s)|1|||
143162587|NCT01633112|516141596|FG002|Overall Study|Abnormal laboratory value(s)|0|||
143162588|NCT01633112|516141594|FG000|Overall Study|Abnormal test procedure result(s)|0|||
143162589|NCT01633112|516141595|FG001|Overall Study|Abnormal test procedure result(s)|1|||
143162590|NCT01633112|516141596|FG002|Overall Study|Abnormal test procedure result(s)|0|||
143497080|NCT03969888|517361525|FG002|Overall Study|Never Received Study Drug|1|||
143497081|NCT03969888|517361526|FG003|Overall Study|Never Received Study Drug|0|||
143497082|NCT03969888|517361527|FG004|Overall Study|Never Received Study Drug|0|||
143497083|NCT03969888|517361528|FG005|Overall Study|Never Received Study Drug|0|||
143497084|NCT03969888|517361529|FG006|Overall Study|Never Received Study Drug|1|||
143497085|NCT03969888|517361530|FG007|Overall Study|Never Received Study Drug|0|||
143497086|NCT03969888|517361523|FG000|Overall Study|Reason Not Specified|0|||
143497087|NCT03969888|517361524|FG001|Overall Study|Reason Not Specified|0|||
143497088|NCT03969888|517361525|FG002|Overall Study|Reason Not Specified|0|||
143497089|NCT03969888|517361526|FG003|Overall Study|Reason Not Specified|0|||
143497090|NCT03969888|517361527|FG004|Overall Study|Reason Not Specified|0|||
143497091|NCT03969888|517361528|FG005|Overall Study|Reason Not Specified|0|||
143497092|NCT03969888|517361529|FG006|Overall Study|Reason Not Specified|0|||
143497093|NCT03969888|517361530|FG007|Overall Study|Reason Not Specified|1|||
143497094|NCT00091832|517361532|FG000|Overall Study|Physician Decision|1|||
143497095|NCT00091832|517361533|FG001|Overall Study|Physician Decision|0|||
143497096|NCT00091832|517361534|FG002|Overall Study|Physician Decision|0|||
143497097|NCT00091832|517361535|FG003|Overall Study|Physician Decision|0|||
143497098|NCT00091832|517361536|FG004|Overall Study|Physician Decision|0|||
143497099|NCT00091832|517361537|FG005|Overall Study|Physician Decision|0|||
143497100|NCT00091832|517361532|FG000|Overall Study|Adverse Event|0|||
143497101|NCT00091832|517361533|FG001|Overall Study|Adverse Event|0|||
143497102|NCT00091832|517361534|FG002|Overall Study|Adverse Event|0|||
143497103|NCT00091832|517361535|FG003|Overall Study|Adverse Event|1|||
143497104|NCT00091832|517361536|FG004|Overall Study|Adverse Event|3|||
143497105|NCT00091832|517361537|FG005|Overall Study|Adverse Event|0|||
143497106|NCT00091832|517361532|FG000|Overall Study|Withdrawal by Subject|4|||
143497107|NCT00091832|517361533|FG001|Overall Study|Withdrawal by Subject|5|||
143497108|NCT00091832|517361534|FG002|Overall Study|Withdrawal by Subject|0|||
143497109|NCT00091832|517361535|FG003|Overall Study|Withdrawal by Subject|1|||
143497110|NCT00091832|517361536|FG004|Overall Study|Withdrawal by Subject|3|||
143497111|NCT00091832|517361537|FG005|Overall Study|Withdrawal by Subject|1|||
143497112|NCT00091832|517361532|FG000|Overall Study|Death|6|||
143497113|NCT00091832|517361533|FG001|Overall Study|Death|4|||
143497114|NCT00091832|517361534|FG002|Overall Study|Death|5|||
143497115|NCT00091832|517361535|FG003|Overall Study|Death|8|||
143039374|NCT01079988|515687135|FG002|Overall Study|Lack of Efficacy|0|||
143039375|NCT01079988|515687136|FG003|Overall Study|Lack of Efficacy|0|||
143239438|NCT03486834|516429878|FG002|Overall Study|Withdrawal by Subject|52|||
143239439|NCT03486834|516429876|FG000|Overall Study|Adverse Event|8|||
143239440|NCT03486834|516429877|FG001|Overall Study|Adverse Event|7|||
143497116|NCT00091832|517361536|FG004|Overall Study|Death|5|||
143497117|NCT00091832|517361537|FG005|Overall Study|Death|6|||
143497118|NCT00091832|517361532|FG000|Overall Study|Disease Progression|2|||
143497119|NCT00091832|517361533|FG001|Overall Study|Disease Progression|0|||
143039376|NCT01079988|515687137|FG004|Overall Study|Lack of Efficacy|0|||
143162591|NCT01633112|516141594|FG000|Overall Study|Administrative problems|1|||
143162592|NCT01633112|516141595|FG001|Overall Study|Administrative problems|2|||
143162593|NCT01633112|516141596|FG002|Overall Study|Administrative problems|5|||
143162594|NCT01633112|516141594|FG000|Overall Study|Adverse Event|16|||
143162595|NCT01633112|516141595|FG001|Overall Study|Adverse Event|18|||
143162596|NCT01633112|516141596|FG002|Overall Study|Adverse Event|20|||
143162597|NCT01633112|516141594|FG000|Overall Study|Lost to Follow-up|7|||
143162598|NCT01633112|516141595|FG001|Overall Study|Lost to Follow-up|19|||
143162599|NCT01633112|516141596|FG002|Overall Study|Lost to Follow-up|6|||
143162600|NCT01633112|516141594|FG000|Overall Study|Protocol Violation|4|||
143162601|NCT01633112|516141595|FG001|Overall Study|Protocol Violation|0|||
143162602|NCT01633112|516141596|FG002|Overall Study|Protocol Violation|2|||
143162603|NCT01633112|516141594|FG000|Overall Study|Subject no longer requires study drug|0|||
143162604|NCT01633112|516141595|FG001|Overall Study|Subject no longer requires study drug|0|||
143162605|NCT01633112|516141596|FG002|Overall Study|Subject no longer requires study drug|1|||
143239441|NCT03486834|516429878|FG002|Overall Study|Adverse Event|0|||
143039377|NCT01079988|515687133|FG000|Overall Study|Other|0|||
143039378|NCT01079988|515687134|FG001|Overall Study|Other|0|||
143039379|NCT01079988|515687135|FG002|Overall Study|Other|0|||
143162606|NCT01633112|516141594|FG000|Overall Study|Withdrawal by Subject|20|||
143162607|NCT01633112|516141595|FG001|Overall Study|Withdrawal by Subject|12|||
143039380|NCT01079988|515687136|FG003|Overall Study|Other|2|||
143162608|NCT01633112|516141596|FG002|Overall Study|Withdrawal by Subject|41|||
143239442|NCT03486834|516429876|FG000|Overall Study|Lost to Follow-up|41|||
143497120|NCT00091832|517361534|FG002|Overall Study|Disease Progression|0|||
143497121|NCT00091832|517361535|FG003|Overall Study|Disease Progression|1|||
143497122|NCT00091832|517361536|FG004|Overall Study|Disease Progression|1|||
143497123|NCT00091832|517361537|FG005|Overall Study|Disease Progression|2|||
143497124|NCT00091832|517361532|FG000|Overall Study|Ineligibility Determined|0|||
143497125|NCT00091832|517361533|FG001|Overall Study|Ineligibility Determined|0|||
143497126|NCT00091832|517361534|FG002|Overall Study|Ineligibility Determined|1|||
143497127|NCT00091832|517361535|FG003|Overall Study|Ineligibility Determined|0|||
143497128|NCT00091832|517361536|FG004|Overall Study|Ineligibility Determined|1|||
143497129|NCT00091832|517361537|FG005|Overall Study|Ineligibility Determined|0|||
143497130|NCT00091832|517361532|FG000|Overall Study|Lost to Follow-up|1|||
143497131|NCT00091832|517361533|FG001|Overall Study|Lost to Follow-up|0|||
143497132|NCT00091832|517361534|FG002|Overall Study|Lost to Follow-up|3|||
143497133|NCT00091832|517361535|FG003|Overall Study|Lost to Follow-up|3|||
143497134|NCT00091832|517361536|FG004|Overall Study|Lost to Follow-up|2|||
143497135|NCT00091832|517361537|FG005|Overall Study|Lost to Follow-up|1|||
143497136|NCT00091832|517361532|FG000|Overall Study|Noncompliance|0|||
143497137|NCT00091832|517361533|FG001|Overall Study|Noncompliance|1|||
143497138|NCT00091832|517361534|FG002|Overall Study|Noncompliance|0|||
143497139|NCT00091832|517361535|FG003|Overall Study|Noncompliance|0|||
143497140|NCT00091832|517361536|FG004|Overall Study|Noncompliance|0|||
143497141|NCT00091832|517361537|FG005|Overall Study|Noncompliance|0|||
143497142|NCT00091832|517361532|FG000|Overall Study|Other|0|||
143497143|NCT00091832|517361533|FG001|Overall Study|Other|1|||
143497144|NCT00091832|517361534|FG002|Overall Study|Other|2|||
143497145|NCT00091832|517361535|FG003|Overall Study|Other|0|||
143497146|NCT00091832|517361536|FG004|Overall Study|Other|0|||
143497147|NCT00091832|517361537|FG005|Overall Study|Other|0|||
143497148|NCT00091832|517361532|FG000|Overall Study|Protocol Violation|0|||
143497149|NCT00091832|517361533|FG001|Overall Study|Protocol Violation|0|||
143497150|NCT00091832|517361534|FG002|Overall Study|Protocol Violation|1|||
143497151|NCT00091832|517361535|FG003|Overall Study|Protocol Violation|0|||
143497152|NCT00091832|517361536|FG004|Overall Study|Protocol Violation|0|||
143497153|NCT00091832|517361537|FG005|Overall Study|Protocol Violation|1|||
143497154|NCT01557166|517361540|FG000|Overall Study|Adverse Event|20|||
143497155|NCT01557166|517361541|FG001|Overall Study|Adverse Event|6|||
143497156|NCT01557166|517361540|FG000|Overall Study|Lack of Efficacy|2|||
143497157|NCT01557166|517361541|FG001|Overall Study|Lack of Efficacy|1|||
143497158|NCT01557166|517361540|FG000|Overall Study|Protocol Violation|8|||
143497159|NCT01557166|517361541|FG001|Overall Study|Protocol Violation|5|||
143497160|NCT01557166|517361540|FG000|Overall Study|Withdrawn consent|12|||
143497161|NCT01557166|517361541|FG001|Overall Study|Withdrawn consent|20|||
143497162|NCT01557166|517361540|FG000|Overall Study|Target dose not tolerated|1|||
143497163|NCT01557166|517361541|FG001|Overall Study|Target dose not tolerated|0|||
143497164|NCT01557166|517361540|FG000|Overall Study|Psychiatric disorder|1|||
143497165|NCT01557166|517361541|FG001|Overall Study|Psychiatric disorder|0|||
143497166|NCT01557166|517361540|FG000|Overall Study|Unclassified|2|||
143497167|NCT01557166|517361541|FG001|Overall Study|Unclassified|5|||
143497168|NCT00946309|517361542|FG000|Overall Study|Protocol Violation|1|||
143497169|NCT00946309|517361543|FG001|Overall Study|Protocol Violation|0|||
143497170|NCT00946309|517361542|FG000|Overall Study|Lost to Follow-up|0|||
143497171|NCT00946309|517361543|FG001|Overall Study|Lost to Follow-up|1|||
143497172|NCT00946309|517361542|FG000|Overall Study|Procedure cancelled/discontinued|0|||
143497173|NCT00946309|517361543|FG001|Overall Study|Procedure cancelled/discontinued|3|||
143497174|NCT04506294|517361544|FG000|Overall Study|Lost to Follow-up|70|||
143497175|NCT04506294|517361545|FG001|Overall Study|Lost to Follow-up|20|||
143497176|NCT04506294|517361544|FG000|Overall Study|Withdrawal by Subject|16|||
143497177|NCT04506294|517361545|FG001|Overall Study|Withdrawal by Subject|2|||
143497178|NCT01465659|517361547|FG000|Completed 1 Cycle of Treatment|Death|0|||
143497179|NCT01465659|517361548|FG001|Completed 1 Cycle of Treatment|Death|1|||
143497180|NCT01465659|517361549|FG002|Completed 1 Cycle of Treatment|Death|0|||
143497181|NCT01465659|517361550|FG003|Completed 1 Cycle of Treatment|Death|0|||
143497182|NCT01465659|517361547|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
143497183|NCT01465659|517361548|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
143497184|NCT01465659|517361549|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
143497185|NCT01465659|517361550|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
143497186|NCT01465659|517361547|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
143497187|NCT01465659|517361548|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
143497188|NCT01465659|517361549|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
143497189|NCT01465659|517361550|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
143497190|NCT01465659|517361547|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
143497191|NCT01465659|517361548|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
143497192|NCT01465659|517361549|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
143497193|NCT01465659|517361550|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
143497194|NCT01465659|517361547|FG000|Completed Follow for 1 Year|Death|6|||
143497195|NCT01465659|517361548|FG001|Completed Follow for 1 Year|Death|3|||
143497196|NCT01465659|517361549|FG002|Completed Follow for 1 Year|Death|2|||
143497197|NCT01465659|517361550|FG003|Completed Follow for 1 Year|Death|4|||
143497198|NCT02445586|517361556|FG000|Overall Study|Death|14|||
143497199|NCT02445586|517361556|FG000|Overall Study|Withdrawal by Subject|13|||
143497200|NCT02445586|517361556|FG000|Overall Study|Disease Progression|10|||
143497201|NCT02445586|517361556|FG000|Overall Study|Protocol Violation|1|||
143497202|NCT02445586|517361556|FG000|Overall Study|Medical Condition|1|||
143497203|NCT00428597|517361557|FG000|Overall Study|Randomized but not treated|3|||
143497204|NCT00428597|517361558|FG001|Overall Study|Randomized but not treated|3|||
143497205|NCT00428597|517361557|FG000|Overall Study|Objective Progression or Relapse|19|||
143039381|NCT01079988|515687137|FG004|Overall Study|Other|1|||
143039382|NCT00537979|515687138|FG000|Overall Study|Adverse Event|2|||
143039383|NCT00537979|515687139|FG001|Overall Study|Adverse Event|2|||
143039384|NCT00537979|515687138|FG000|Overall Study|Withdrawal by Subject|1|||
143039385|NCT00537979|515687139|FG001|Overall Study|Withdrawal by Subject|4|||
143039386|NCT00537979|515687138|FG000|Overall Study|Lost to Follow-up|1|||
143039387|NCT00537979|515687139|FG001|Overall Study|Lost to Follow-up|4|||
143039388|NCT00537979|515687138|FG000|Overall Study|Lack of Efficacy|0|||
143039389|NCT00537979|515687139|FG001|Overall Study|Lack of Efficacy|1|||
143039390|NCT00537979|515687138|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
143039391|NCT00537979|515687139|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
143039392|NCT00537979|515687138|FG000|Overall Study|Death|0|||
143039393|NCT00537979|515687139|FG001|Overall Study|Death|3|||
143039394|NCT00537979|515687138|FG000|Overall Study|Kidney transplant|0|||
143039395|NCT00537979|515687139|FG001|Overall Study|Kidney transplant|3|||
143039396|NCT00537979|515687138|FG000|Overall Study|Heart failure|0|||
143039397|NCT00537979|515687139|FG001|Overall Study|Heart failure|1|||
143039398|NCT03459807|515687140|FG000|Overall Study|Withdrawal due to transplant|0|||
143039399|NCT03459807|515687141|FG001|Overall Study|Withdrawal due to transplant|1|||
143039400|NCT00833937|515687142|FG000|Washout|Withdrawal by Subject|1|||
143039401|NCT00833937|515687143|FG001|Washout|Withdrawal by Subject|0|||
143039402|NCT00576056|515687151|FG000|Overall Study|Adverse Event|1|||
143039403|NCT00576056|515687151|FG000|Overall Study|Death|1|||
143039404|NCT00576056|515687151|FG000|Overall Study|Lack of Efficacy|1|||
143039405|NCT00576056|515687151|FG000|Overall Study|Withdrawal by Subject|2|||
143039406|NCT00576056|515687151|FG000|Overall Study|did not meet eligibility criteria|8|||
143039407|NCT00576056|515687151|FG000|Overall Study|Physician Decision|1|||
143039408|NCT00858845|515687152|FG000|Overall Study|Patient underwent heart transplant.|0|||
143039409|NCT00858845|515687153|FG001|Overall Study|Patient underwent heart transplant.|1|||
143039410|NCT02335658|515687154|FG000|Overall Study|Adverse Event|18|||
143039411|NCT02335658|515687155|FG001|Overall Study|Adverse Event|12|||
143039412|NCT02335658|515687154|FG000|Overall Study|Lack of Efficacy|4|||
143039413|NCT02335658|515687155|FG001|Overall Study|Lack of Efficacy|5|||
143039414|NCT02335658|515687154|FG000|Overall Study|Pregnancy|1|||
143039415|NCT02335658|515687155|FG001|Overall Study|Pregnancy|0|||
143039416|NCT02335658|515687154|FG000|Overall Study|Withdrawal by Subject|13|||
143039417|NCT02335658|515687155|FG001|Overall Study|Withdrawal by Subject|21|||
143039418|NCT02335658|515687154|FG000|Overall Study|non-compliance|2|||
143039419|NCT02335658|515687155|FG001|Overall Study|non-compliance|3|||
143039420|NCT02335658|515687154|FG000|Overall Study|other reason|2|||
143039421|NCT02335658|515687155|FG001|Overall Study|other reason|3|||
143162609|NCT01633112|516141594|FG000|Overall Study|missing Study Completion CRF|1|||
143162610|NCT01633112|516141595|FG001|Overall Study|missing Study Completion CRF|1|||
143162611|NCT01633112|516141596|FG002|Overall Study|missing Study Completion CRF|4|||
143162612|NCT01959919|516141597|FG000|Overall Study|Did not meet the eligibility criteria|2|||
143162613|NCT03439072|516141598|FG000|Overall Study|Withdrawal by Subject|2|||
143162614|NCT03439072|516141599|FG001|Overall Study|Withdrawal by Subject|3|||
143162615|NCT03439072|516141598|FG000|Overall Study|Physician Decision|0|||
143162616|NCT03439072|516141599|FG001|Overall Study|Physician Decision|1|||
143162617|NCT02003898|516141603|FG000|Overall Study|Death|3|||
143162618|NCT02003898|516141603|FG000|Overall Study|Lost to Follow-up|12|||
143162619|NCT02003898|516141603|FG000|Overall Study|Withdrawal by Subject|52|||
143162620|NCT01537432|516141606|FG000|Overall Study|Lost to Follow-up|3|||
143162621|NCT01537432|516141607|FG001|Overall Study|Lost to Follow-up|1|||
143162622|NCT01537432|516141606|FG000|Overall Study|Withdrawal by Subject|0|||
143162623|NCT01537432|516141607|FG001|Overall Study|Withdrawal by Subject|1|||
143162624|NCT01537432|516141606|FG000|Overall Study|Administrative problems|1|||
143162625|NCT01537432|516141607|FG001|Overall Study|Administrative problems|0|||
143162626|NCT01537432|516141606|FG000|Overall Study|Adverse Event|1|||
143162627|NCT01537432|516141607|FG001|Overall Study|Adverse Event|0|||
143162628|NCT01537432|516141606|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
143039422|NCT01880593|515687156|FG000|Overall Study|Adverse Event|1|||
143039423|NCT01880593|515687157|FG001|Overall Study|Adverse Event|0|||
143039424|NCT01880593|515687156|FG000|Overall Study|Lack of Efficacy|1|||
143039425|NCT01880593|515687157|FG001|Overall Study|Lack of Efficacy|5|||
143039426|NCT01880593|515687156|FG000|Overall Study|Withdrawal by Subject|6|||
143039427|NCT01880593|515687157|FG001|Overall Study|Withdrawal by Subject|1|||
143039428|NCT02024932|515687158|FG000|Overall Study|Adverse Event|2|||
143039429|NCT02024932|515687159|FG001|Overall Study|Adverse Event|3|||
143039430|NCT02024932|515687160|FG002|Overall Study|Adverse Event|0|||
143039431|NCT02024932|515687161|FG003|Overall Study|Adverse Event|0|||
143162629|NCT01537432|516141607|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
143162630|NCT00128492|516141608|FG000|Overall Study|AE unrelated to study|2|||
143162631|NCT00128492|516141609|FG001|Overall Study|AE unrelated to study|9|||
143162632|NCT00128492|516141608|FG000|Overall Study|Study drug intolerance (AE)|2|||
143364154|NCT03398356|516875561|FG002|Before Treatment|drug intolerance|0|||
143039432|NCT02024932|515687162|FG004|Overall Study|Adverse Event|2|||
143162633|NCT00128492|516141609|FG001|Overall Study|Study drug intolerance (AE)|8|||
143039433|NCT02024932|515687163|FG005|Overall Study|Adverse Event|0|||
143039434|NCT02024932|515687158|FG000|Overall Study|Abnormal laboratory value|0|||
143039435|NCT02024932|515687159|FG001|Overall Study|Abnormal laboratory value|0|||
143039436|NCT02024932|515687160|FG002|Overall Study|Abnormal laboratory value|0|||
143039437|NCT02024932|515687161|FG003|Overall Study|Abnormal laboratory value|2|||
143039438|NCT02024932|515687162|FG004|Overall Study|Abnormal laboratory value|0|||
143039439|NCT02024932|515687163|FG005|Overall Study|Abnormal laboratory value|0|||
143039440|NCT00727961|515687165|FG000|Overall Study|Lost to Follow-up|1|||
143039441|NCT00727961|515687165|FG000|Overall Study|Adverse Event|4|||
143039442|NCT00727961|515687165|FG000|Overall Study|Patient's refusal|2|||
143039443|NCT00727961|515687165|FG000|Overall Study|Progression|30|||
143039444|NCT00837486|515687166|FG000|Blinded-treatment Phase|Physician Decision|1|||
143039445|NCT00837486|515687167|FG001|Blinded-treatment Phase|Physician Decision|0|||
143039446|NCT00837486|515687166|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
143162634|NCT00128492|516141608|FG000|Overall Study|AE related to study|1|||
143162635|NCT00128492|516141609|FG001|Overall Study|AE related to study|4|||
143162636|NCT00128492|516141608|FG000|Overall Study|Death|1|||
143162637|NCT00128492|516141609|FG001|Overall Study|Death|0|||
143162638|NCT00128492|516141608|FG000|Overall Study|Lost to Follow-up|1|||
143497206|NCT00428597|517361558|FG001|Overall Study|Objective Progression or Relapse|47|||
143497207|NCT00428597|517361557|FG000|Overall Study|Study Terminated by Sponsor|41|||
143497208|NCT00428597|517361558|FG001|Overall Study|Study Terminated by Sponsor|16|||
143497209|NCT00428597|517361557|FG000|Overall Study|Adverse Event|15|||
143497210|NCT00428597|517361558|FG001|Overall Study|Adverse Event|7|||
143497211|NCT00428597|517361557|FG000|Overall Study|Global Deterioration of Health Status|1|||
143497212|NCT00428597|517361558|FG001|Overall Study|Global Deterioration of Health Status|5|||
143497213|NCT00428597|517361557|FG000|Overall Study|Protocol Violation|2|||
143497214|NCT00428597|517361558|FG001|Overall Study|Protocol Violation|1|||
143162639|NCT00128492|516141609|FG001|Overall Study|Lost to Follow-up|5|||
143162640|NCT00128492|516141608|FG000|Overall Study|Noncompliance|0|||
143162641|NCT00128492|516141609|FG001|Overall Study|Noncompliance|5|||
143162642|NCT00128492|516141608|FG000|Overall Study|Personal or administrative|10|||
143162643|NCT00128492|516141609|FG001|Overall Study|Personal or administrative|22|||
143162644|NCT00128492|516141608|FG000|Overall Study|Withdrawal by Subject|3|||
143162645|NCT00128492|516141609|FG001|Overall Study|Withdrawal by Subject|5|||
143162646|NCT00128492|516141608|FG000|Overall Study|Pregnancy|0|||
143162647|NCT00128492|516141609|FG001|Overall Study|Pregnancy|1|||
143162648|NCT01104870|516141610|FG000|Overall Study|Adverse Event|1|||
143162649|NCT01104870|516141611|FG001|Overall Study|Adverse Event|1|||
143162650|NCT01104870|516141612|FG002|Overall Study|Adverse Event|0|||
143162651|NCT01104870|516141610|FG000|Overall Study|Death|0|||
143162652|NCT01104870|516141611|FG001|Overall Study|Death|0|||
143162653|NCT01104870|516141612|FG002|Overall Study|Death|1|||
143162654|NCT01104870|516141610|FG000|Overall Study|Withdrawal by Subject|0|||
143162655|NCT01104870|516141611|FG001|Overall Study|Withdrawal by Subject|0|||
143162656|NCT01104870|516141612|FG002|Overall Study|Withdrawal by Subject|1|||
143162657|NCT00276380|516141617|FG000|Overall Study|Adverse Event|5|||
143162658|NCT00276380|516141618|FG001|Overall Study|Adverse Event|3|||
143162659|NCT00276380|516141617|FG000|Overall Study|Lost to Follow-up|1|||
143162660|NCT00276380|516141618|FG001|Overall Study|Lost to Follow-up|1|||
143162661|NCT00276380|516141617|FG000|Overall Study|Withdrawal by Subject|3|||
143162662|NCT00276380|516141618|FG001|Overall Study|Withdrawal by Subject|6|||
143162663|NCT00276380|516141617|FG000|Overall Study|Death|5|||
143162664|NCT00276380|516141618|FG001|Overall Study|Death|3|||
143162665|NCT00276380|516141617|FG000|Overall Study|Abnormal aPPT Levels|0|||
143162666|NCT00276380|516141618|FG001|Overall Study|Abnormal aPPT Levels|1|||
143162667|NCT02150863|516141619|FG000|Overall Study|Lost to Follow-up|0|||
143162668|NCT02150863|516141620|FG001|Overall Study|Lost to Follow-up|1|||
143162669|NCT02150863|516141621|FG002|Overall Study|Lost to Follow-up|0|||
143497215|NCT00428597|517361557|FG000|Overall Study|Withdrawal by Subject|2|||
143497216|NCT00428597|517361558|FG001|Overall Study|Withdrawal by Subject|1|||
143497217|NCT00428597|517361557|FG000|Overall Study|Other|1|||
143497218|NCT00428597|517361558|FG001|Overall Study|Other|1|||
143039447|NCT00837486|515687167|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
143039448|NCT00837486|515687166|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
143039449|NCT00837486|515687167|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
143162670|NCT01651208|516141622|FG000|Overall Study|Lost to Follow-up|14|||
143162671|NCT01651208|516141623|FG001|Overall Study|Lost to Follow-up|16|||
143497219|NCT00428597|517361557|FG000|Overall Study|Lost to Follow-up|0|||
143162672|NCT02314247|516141625|FG000|Overall Study|Adverse Event|2|||
143162673|NCT02314247|516141626|FG001|Overall Study|Adverse Event|1|||
143162674|NCT02314247|516141627|FG002|Overall Study|Adverse Event|0|||
143162675|NCT02314247|516141625|FG000|Overall Study|Withdrawal by Subject|1|||
143162676|NCT02314247|516141626|FG001|Overall Study|Withdrawal by Subject|3|||
143162677|NCT02314247|516141627|FG002|Overall Study|Withdrawal by Subject|1|||
143162678|NCT02314247|516141625|FG000|Overall Study|Progression of Disease|6|||
143162679|NCT02314247|516141626|FG001|Overall Study|Progression of Disease|2|||
143497220|NCT00428597|517361558|FG001|Overall Study|Lost to Follow-up|1|||
143497221|NCT00428597|517361557|FG000|Overall Study|Pregnancy|1|||
143497222|NCT00428597|517361558|FG001|Overall Study|Pregnancy|0|||
143497223|NCT00428597|517361557|FG000|Overall Study|Death|1|||
143497224|NCT00428597|517361558|FG001|Overall Study|Death|3|||
143497225|NCT00769119|517361564|FG000|Overall Study|Voluntary discontinuation|0|||
143497226|NCT00769119|517361565|FG001|Overall Study|Voluntary discontinuation|2|||
143497227|NCT00769119|517361564|FG000|Overall Study|Adverse Event|1|||
143364155|NCT03398356|516875559|FG000|Before Treatment|Withdrawal by Subject|0|||
143364156|NCT03398356|516875560|FG001|Before Treatment|Withdrawal by Subject|5|||
143364157|NCT03398356|516875561|FG002|Before Treatment|Withdrawal by Subject|0|||
143364158|NCT03398356|516875559|FG000|Before Treatment|Physician Decision|0|||
143364159|NCT03398356|516875560|FG001|Before Treatment|Physician Decision|0|||
143497228|NCT00769119|517361565|FG001|Overall Study|Adverse Event|1|||
143497229|NCT00769119|517361564|FG000|Overall Study|Disallowed medication|1|||
143497230|NCT00769119|517361565|FG001|Overall Study|Disallowed medication|0|||
143497231|NCT00686647|517361566|FG000|Overall Study|Lost to Follow-up|1|||
143497232|NCT00686647|517361566|FG000|Overall Study|Death|1|||
143497233|NCT01116544|517361568|FG000|Overall Study|Protocol Violation|1|||
143497234|NCT01116544|517361569|FG001|Overall Study|Protocol Violation|0|||
143497235|NCT01116544|517361568|FG000|Overall Study|Withdrawal by Subject|1|||
143497236|NCT01116544|517361569|FG001|Overall Study|Withdrawal by Subject|1|||
143497237|NCT00578643|517361570|FG000|Overall Study|Death|1|||
143497238|NCT00578643|517361570|FG000|Overall Study|Lost to Follow-up|1|||
143497239|NCT01725750|517361571|FG000|Overall Study|Adverse Event|1|||
143497240|NCT01725750|517361572|FG001|Overall Study|Adverse Event|0|||
143497241|NCT01725750|517361571|FG000|Overall Study|Lost to Follow-up|1|||
143497242|NCT01725750|517361572|FG001|Overall Study|Lost to Follow-up|1|||
143497243|NCT01725750|517361571|FG000|Overall Study|Withdrawal by Subject|0|||
143497244|NCT01725750|517361572|FG001|Overall Study|Withdrawal by Subject|9|||
143497245|NCT03828487|517361577|FG000|Overall Study|Physician Decision|1|||
143497246|NCT01990261|517361580|FG000|Overall Study|Death Before Treatment Start|2|||
143497247|NCT01990261|517361580|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
143162680|NCT02314247|516141627|FG002|Overall Study|Progression of Disease|0|||
143162681|NCT01953354|516141628|FG000|Overall Study|Withdrawal by Subject|0|||
143162682|NCT01953354|516141629|FG001|Overall Study|Withdrawal by Subject|1|||
143162683|NCT01953354|516141628|FG000|Overall Study|Decision of Sponsor|0|||
143162684|NCT01953354|516141629|FG001|Overall Study|Decision of Sponsor|1|||
143162685|NCT01953354|516141628|FG000|Overall Study|Disease Exacerbation|1|||
143162686|NCT01953354|516141629|FG001|Overall Study|Disease Exacerbation|0|||
143162687|NCT02571244|516141630|FG000|Overall Study|Lost to Follow-up|0|||
143162688|NCT02571244|516141631|FG001|Overall Study|Lost to Follow-up|1|||
143162689|NCT02571244|516141630|FG000|Overall Study|Unable to reach out post discharge|3|||
143162690|NCT02571244|516141631|FG001|Overall Study|Unable to reach out post discharge|0|||
143162691|NCT01570192|516141632|FG000|Overall Study|no qualifying organism|6|||
143162692|NCT01570192|516141633|FG001|Overall Study|no qualifying organism|12|||
143162693|NCT01570192|516141632|FG000|Overall Study|changed to palliative care|1|||
143162694|NCT01570192|516141633|FG001|Overall Study|changed to palliative care|0|||
143162695|NCT01570192|516141632|FG000|Overall Study|Physician Decision|0|||
143162696|NCT01570192|516141633|FG001|Overall Study|Physician Decision|1|||
143162697|NCT02965976|516141634|FG000|Overall Study|Withdrawal by Subject|2|||
143162698|NCT02965976|516141635|FG001|Overall Study|Withdrawal by Subject|0|||
143162699|NCT00806026|516141636|FG000|Overall Study|Death|0|||
143162700|NCT00806026|516141637|FG001|Overall Study|Death|0|||
143162701|NCT00806026|516141638|FG002|Overall Study|Death|0|||
143162702|NCT00806026|516141639|FG003|Overall Study|Death|1|||
143162703|NCT00806026|516141640|FG004|Overall Study|Death|0|||
143162704|NCT00806026|516141641|FG005|Overall Study|Death|0|||
143162705|NCT00806026|516141636|FG000|Overall Study|Did not meet entrance criteria|4|||
143364160|NCT03398356|516875561|FG002|Before Treatment|Physician Decision|11|||
143364161|NCT03398356|516875559|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
143497248|NCT01990261|517361580|FG000|Overall Study|Death From other Causes|1|||
143497249|NCT01990261|517361580|FG000|Overall Study|Disease Progression (PD)|8|||
143497250|NCT01990261|517361580|FG000|Overall Study|PD Before Treatment Start|1|||
143497251|NCT01990261|517361580|FG000|Overall Study|Dossier not Approved|1|||
143364162|NCT03398356|516875560|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
143364163|NCT03398356|516875561|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
143497252|NCT01990261|517361580|FG000|Overall Study|Lost to Follow-up|2|||
143497253|NCT04949841|517361581|FG000|Overall Study|Adverse Event|7|||
143162706|NCT00806026|516141637|FG001|Overall Study|Did not meet entrance criteria|1|||
143162707|NCT00806026|516141638|FG002|Overall Study|Did not meet entrance criteria|2|||
143497254|NCT04949841|517361581|FG000|Overall Study|Death|1|||
143162708|NCT00806026|516141639|FG003|Overall Study|Did not meet entrance criteria|1|||
143162709|NCT00806026|516141640|FG004|Overall Study|Did not meet entrance criteria|0|||
143162710|NCT00806026|516141641|FG005|Overall Study|Did not meet entrance criteria|0|||
143162711|NCT00806026|516141636|FG000|Overall Study|Lack of Efficacy|5|||
143497255|NCT04949841|517361581|FG000|Overall Study|Withdrawal by Subject|52|||
143497256|NCT04949841|517361581|FG000|Overall Study|Pregnancy|4|||
143497257|NCT04949841|517361581|FG000|Overall Study|Lost to Follow-up|9|||
143497258|NCT04949841|517361581|FG000|Overall Study|Lack of Efficacy|55|||
143497259|NCT04949841|517361581|FG000|Overall Study|Various reasons|9|||
143497260|NCT03179436|517361582|FG000|Overall Study|Withdrawal by Subject|1|||
143497261|NCT03179436|517361583|FG001|Overall Study|Withdrawal by Subject|0|||
143497262|NCT03179436|517361584|FG002|Overall Study|Withdrawal by Subject|0|||
143497263|NCT03179436|517361585|FG003|Overall Study|Withdrawal by Subject|4|||
143497264|NCT03179436|517361586|FG004|Overall Study|Withdrawal by Subject|2|||
143162712|NCT00806026|516141637|FG001|Overall Study|Lack of Efficacy|18|||
143162713|NCT00806026|516141638|FG002|Overall Study|Lack of Efficacy|13|||
143162714|NCT00806026|516141639|FG003|Overall Study|Lack of Efficacy|4|||
143162715|NCT00806026|516141640|FG004|Overall Study|Lack of Efficacy|8|||
143162716|NCT00806026|516141641|FG005|Overall Study|Lack of Efficacy|7|||
143162717|NCT00806026|516141636|FG000|Overall Study|Lost to Follow-up|8|||
143162718|NCT00806026|516141637|FG001|Overall Study|Lost to Follow-up|15|||
143162719|NCT00806026|516141638|FG002|Overall Study|Lost to Follow-up|8|||
143162720|NCT00806026|516141639|FG003|Overall Study|Lost to Follow-up|2|||
143162721|NCT00806026|516141640|FG004|Overall Study|Lost to Follow-up|6|||
143162722|NCT00806026|516141641|FG005|Overall Study|Lost to Follow-up|6|||
143162723|NCT00806026|516141636|FG000|Overall Study|Withdrawal by Subject|14|||
143162724|NCT00806026|516141637|FG001|Overall Study|Withdrawal by Subject|17|||
143162725|NCT00806026|516141638|FG002|Overall Study|Withdrawal by Subject|9|||
143162726|NCT00806026|516141639|FG003|Overall Study|Withdrawal by Subject|2|||
143162727|NCT00806026|516141640|FG004|Overall Study|Withdrawal by Subject|5|||
143162728|NCT00806026|516141641|FG005|Overall Study|Withdrawal by Subject|3|||
143162729|NCT00806026|516141636|FG000|Overall Study|Other|3|||
143162730|NCT00806026|516141637|FG001|Overall Study|Other|6|||
143162731|NCT00806026|516141638|FG002|Overall Study|Other|8|||
143162732|NCT00806026|516141639|FG003|Overall Study|Other|2|||
143162733|NCT00806026|516141640|FG004|Overall Study|Other|0|||
143162734|NCT00806026|516141641|FG005|Overall Study|Other|4|||
143162735|NCT00806026|516141636|FG000|Overall Study|Protocol Violation|6|||
143162736|NCT00806026|516141637|FG001|Overall Study|Protocol Violation|9|||
143162737|NCT00806026|516141638|FG002|Overall Study|Protocol Violation|9|||
143162738|NCT00806026|516141639|FG003|Overall Study|Protocol Violation|0|||
143162739|NCT00806026|516141640|FG004|Overall Study|Protocol Violation|2|||
143162740|NCT00806026|516141641|FG005|Overall Study|Protocol Violation|3|||
143162741|NCT00806026|516141636|FG000|Overall Study|Adverse Event|52|||
143162742|NCT00806026|516141637|FG001|Overall Study|Adverse Event|35|||
143162743|NCT00806026|516141638|FG002|Overall Study|Adverse Event|44|||
143162744|NCT00806026|516141639|FG003|Overall Study|Adverse Event|17|||
143162745|NCT00806026|516141640|FG004|Overall Study|Adverse Event|9|||
143162746|NCT00806026|516141641|FG005|Overall Study|Adverse Event|9|||
143162747|NCT01687595|516141642|FG000|Overall Study|Withdrawal by Subject|8|||
143162748|NCT01687595|516141643|FG001|Overall Study|Withdrawal by Subject|0|||
143162749|NCT01687595|516141642|FG000|Overall Study|Lost to Follow-up|3|||
143162750|NCT01687595|516141643|FG001|Overall Study|Lost to Follow-up|1|||
143162751|NCT01687595|516141642|FG000|Overall Study|Investigator's decision|1|||
143162752|NCT01687595|516141643|FG001|Overall Study|Investigator's decision|0|||
143162753|NCT01687595|516141642|FG000|Overall Study|Sponsor's decision|1|||
143162754|NCT01687595|516141643|FG001|Overall Study|Sponsor's decision|0|||
143162755|NCT01687595|516141642|FG000|Overall Study|Noncompliance|1|||
143162756|NCT01687595|516141643|FG001|Overall Study|Noncompliance|2|||
143162757|NCT01687595|516141642|FG000|Overall Study|Other than specified|56|||
143162758|NCT01687595|516141643|FG001|Overall Study|Other than specified|7|||
143162759|NCT04191733|516141644|FG000|Overall Study|Withdrawn due to study closure|13|||
143162760|NCT04191733|516141645|FG001|Overall Study|Withdrawn due to study closure|14|||
143162761|NCT04191733|516141644|FG000|Overall Study|Withdrawal by Subject|2|||
143162762|NCT04191733|516141645|FG001|Overall Study|Withdrawal by Subject|4|||
143162763|NCT04191733|516141644|FG000|Overall Study|Physician Decision|1|||
143162764|NCT04191733|516141645|FG001|Overall Study|Physician Decision|1|||
143162765|NCT04191733|516141644|FG000|Overall Study|Lost to Follow-up|5|||
143162766|NCT04191733|516141645|FG001|Overall Study|Lost to Follow-up|6|||
143162767|NCT04191733|516141644|FG000|Overall Study|Death|0|||
143162768|NCT04191733|516141645|FG001|Overall Study|Death|1|||
143364164|NCT00619151|516875568|FG000|Overall Study|Study terminated prior to followup|1|||
143364165|NCT00619151|516875569|FG001|Overall Study|Study terminated prior to followup|0|||
143497265|NCT03179436|517361587|FG005|Overall Study|Withdrawal by Subject|2|||
143162769|NCT02633527|516141646|FG000|Overall Study|Failed to meet eligibility|0|||
143162770|NCT02633527|516141647|FG001|Overall Study|Failed to meet eligibility|1|||
143162771|NCT02633527|516141648|FG002|Overall Study|Failed to meet eligibility|1|||
143162772|NCT02633527|516141649|FG003|Overall Study|Failed to meet eligibility|0|||
143162773|NCT02633527|516141650|FG004|Overall Study|Failed to meet eligibility|1|||
143162774|NCT02633527|516141646|FG000|Overall Study|Adverse Event|0|||
143162775|NCT02633527|516141647|FG001|Overall Study|Adverse Event|4|||
143162776|NCT02633527|516141648|FG002|Overall Study|Adverse Event|3|||
143162777|NCT02633527|516141649|FG003|Overall Study|Adverse Event|1|||
143162778|NCT02633527|516141650|FG004|Overall Study|Adverse Event|5|||
143162779|NCT02633527|516141646|FG000|Overall Study|Lost to Follow-up|1|||
143162780|NCT02633527|516141647|FG001|Overall Study|Lost to Follow-up|2|||
143039450|NCT00837486|515687166|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
143039451|NCT00837486|515687167|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
143039452|NCT01802320|515687168|FG000|Overall Study|Death|1|||
143039453|NCT01802320|515687168|FG000|Overall Study|Withdrawal by Subject|1|||
143039454|NCT00462345|515689085|FG000|Overall Study|Withdrawal by Subject|2|||
143039455|NCT00462345|515689085|FG000|Overall Study|Did not complete second course|1|||
143039456|NCT02869867|515689086|FG000|Overall Study|Protocol Violation|1|||
143039457|NCT02869867|515689087|FG001|Overall Study|Protocol Violation|0|||
143039458|NCT02869867|515689086|FG000|Overall Study|Lost to Follow-up|5|||
143039459|NCT02869867|515689087|FG001|Overall Study|Lost to Follow-up|5|||
143039460|NCT02096211|515689088|FG000|Overall Study|Death|2|||
143039461|NCT02096211|515689088|FG000|Overall Study|Withdrawal by Subject|8|||
143039462|NCT02096211|515689088|FG000|Overall Study|Revision of implant|7|||
143039463|NCT02096211|515689088|FG000|Overall Study|Lost to Follow-up|43|||
143039464|NCT01439880|515689093|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
143039465|NCT01439880|515689094|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
143039466|NCT01439880|515689093|FG000|SOC-controlled Period (Year 1)|Death|2|||
143039467|NCT01439880|515689094|FG001|SOC-controlled Period (Year 1)|Death|1|||
143039468|NCT01439880|515689093|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
143039469|NCT01439880|515689094|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
143039470|NCT01439880|515689093|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
143039471|NCT01439880|515689094|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
143039472|NCT01439880|515689093|FG000|SOC-controlled Period (Year 1)|Other|8|||
143039473|NCT01439880|515689094|FG001|SOC-controlled Period (Year 1)|Other|13|||
143039474|NCT01439880|515689093|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
143039475|NCT01439880|515689094|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
143039476|NCT01439880|515689093|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
143039477|NCT01439880|515689094|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
143039478|NCT01439880|515689093|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
143039479|NCT01439880|515689094|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
143039480|NCT01439880|515689093|FG000|All-IP Period (Years 2 to 5)|Death|3|||
143039481|NCT01439880|515689094|FG001|All-IP Period (Years 2 to 5)|Death|13|||
143039482|NCT01439880|515689093|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
143039483|NCT01439880|515689094|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
143039484|NCT01439880|515689093|FG000|All-IP Period (Years 2 to 5)|Other|14|||
143039485|NCT01439880|515689094|FG001|All-IP Period (Years 2 to 5)|Other|31|||
143039486|NCT01439880|515689093|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
143039487|NCT01439880|515689094|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
143039488|NCT00461786|515689097|FG000|Overall Study|Entry Criteria Not Met|2|||
143162781|NCT02633527|516141648|FG002|Overall Study|Lost to Follow-up|5|||
143162782|NCT02633527|516141649|FG003|Overall Study|Lost to Follow-up|5|||
143162783|NCT02633527|516141650|FG004|Overall Study|Lost to Follow-up|4|||
143162784|NCT02633527|516141646|FG000|Overall Study|Withdrawal by Subject|0|||
143162785|NCT02633527|516141647|FG001|Overall Study|Withdrawal by Subject|3|||
143162786|NCT02633527|516141648|FG002|Overall Study|Withdrawal by Subject|5|||
143162787|NCT02633527|516141649|FG003|Overall Study|Withdrawal by Subject|4|||
143162788|NCT02633527|516141650|FG004|Overall Study|Withdrawal by Subject|4|||
143162789|NCT02633527|516141646|FG000|Overall Study|Protocol Violation|0|||
143162790|NCT02633527|516141647|FG001|Overall Study|Protocol Violation|1|||
143162791|NCT02633527|516141648|FG002|Overall Study|Protocol Violation|1|||
143162792|NCT02633527|516141649|FG003|Overall Study|Protocol Violation|1|||
143162793|NCT02633527|516141650|FG004|Overall Study|Protocol Violation|1|||
143162794|NCT02633527|516141646|FG000|Overall Study|Physician Decision|0|||
143162795|NCT02633527|516141647|FG001|Overall Study|Physician Decision|0|||
143162796|NCT02633527|516141648|FG002|Overall Study|Physician Decision|0|||
143162797|NCT02633527|516141649|FG003|Overall Study|Physician Decision|0|||
143162798|NCT02633527|516141650|FG004|Overall Study|Physician Decision|1|||
143162799|NCT02633527|516141646|FG000|Overall Study|Administrative reason|1|||
143162800|NCT02633527|516141647|FG001|Overall Study|Administrative reason|0|||
143162801|NCT02633527|516141648|FG002|Overall Study|Administrative reason|0|||
143162802|NCT02633527|516141649|FG003|Overall Study|Administrative reason|1|||
143039489|NCT00461786|515689097|FG000|Overall Study|Inevaluable (Never Treated)|1|||
143039490|NCT00835991|515689100|FG000|First Intervention|Adverse Event|0|||
143039491|NCT00835991|515689101|FG001|First Intervention|Adverse Event|1|||
143039492|NCT00835991|515689100|FG000|Washout|Protocol Violation|0|||
143039493|NCT00835991|515689101|FG001|Washout|Protocol Violation|2|||
143039494|NCT00835991|515689100|FG000|Washout|Withdrawal by Subject|3|||
143039495|NCT00835991|515689101|FG001|Washout|Withdrawal by Subject|1|||
143039496|NCT02269657|515689102|FG000|Overall Study|Protocol Violation|3|||
143039497|NCT02440711|515689105|FG000|Second Intervention|Lost to Follow-up|1|||
143162803|NCT02633527|516141650|FG004|Overall Study|Administrative reason|0|||
143162804|NCT02633527|516141646|FG000|Overall Study|Multiple reasons|1|||
143162805|NCT02633527|516141647|FG001|Overall Study|Multiple reasons|0|||
143162806|NCT02633527|516141648|FG002|Overall Study|Multiple reasons|2|||
143162807|NCT02633527|516141649|FG003|Overall Study|Multiple reasons|2|||
143162808|NCT02633527|516141650|FG004|Overall Study|Multiple reasons|1|||
143497266|NCT03179436|517361588|FG006|Overall Study|Withdrawal by Subject|5|||
143497267|NCT03179436|517361589|FG007|Overall Study|Withdrawal by Subject|0|||
143497268|NCT03179436|517361590|FG008|Overall Study|Withdrawal by Subject|3|||
143497269|NCT03179436|517361591|FG009|Overall Study|Withdrawal by Subject|0|||
143497270|NCT03179436|517361592|FG010|Overall Study|Withdrawal by Subject|0|||
143497271|NCT03179436|517361593|FG011|Overall Study|Withdrawal by Subject|0|||
143497272|NCT03179436|517361582|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
143497273|NCT03179436|517361583|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
143497274|NCT03179436|517361584|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
143497275|NCT03179436|517361585|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
143497276|NCT03179436|517361586|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
143497277|NCT03179436|517361587|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
143497278|NCT03179436|517361588|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
143497279|NCT03179436|517361589|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
143497280|NCT03179436|517361590|FG008|Overall Study|Withdrawal by Parent/Guardian|0|||
143497281|NCT03179436|517361591|FG009|Overall Study|Withdrawal by Parent/Guardian|0|||
143497282|NCT03179436|517361592|FG010|Overall Study|Withdrawal by Parent/Guardian|0|||
143497283|NCT03179436|517361593|FG011|Overall Study|Withdrawal by Parent/Guardian|0|||
143497284|NCT03179436|517361582|FG000|Overall Study|Sponsor Decision|0|||
143497285|NCT03179436|517361583|FG001|Overall Study|Sponsor Decision|0|||
143497286|NCT03179436|517361584|FG002|Overall Study|Sponsor Decision|1|||
143497287|NCT03179436|517361585|FG003|Overall Study|Sponsor Decision|3|||
143497288|NCT03179436|517361586|FG004|Overall Study|Sponsor Decision|9|||
143497289|NCT03179436|517361587|FG005|Overall Study|Sponsor Decision|7|||
143497290|NCT03179436|517361588|FG006|Overall Study|Sponsor Decision|2|||
143497291|NCT03179436|517361589|FG007|Overall Study|Sponsor Decision|4|||
143497292|NCT03179436|517361590|FG008|Overall Study|Sponsor Decision|23|||
143497293|NCT03179436|517361591|FG009|Overall Study|Sponsor Decision|6|||
143497294|NCT03179436|517361592|FG010|Overall Study|Sponsor Decision|7|||
143497295|NCT03179436|517361593|FG011|Overall Study|Sponsor Decision|5|||
143497296|NCT03179436|517361582|FG000|Overall Study|Randomized by Mistake without Study Treatment|0|||
143497297|NCT03179436|517361583|FG001|Overall Study|Randomized by Mistake without Study Treatment|1|||
143497298|NCT03179436|517361584|FG002|Overall Study|Randomized by Mistake without Study Treatment|0|||
143497299|NCT03179436|517361585|FG003|Overall Study|Randomized by Mistake without Study Treatment|0|||
143497300|NCT03179436|517361586|FG004|Overall Study|Randomized by Mistake without Study Treatment|0|||
143497301|NCT03179436|517361587|FG005|Overall Study|Randomized by Mistake without Study Treatment|1|||
143497302|NCT03179436|517361588|FG006|Overall Study|Randomized by Mistake without Study Treatment|0|||
143497303|NCT03179436|517361589|FG007|Overall Study|Randomized by Mistake without Study Treatment|0|||
143497304|NCT03179436|517361590|FG008|Overall Study|Randomized by Mistake without Study Treatment|0|||
143497305|NCT03179436|517361591|FG009|Overall Study|Randomized by Mistake without Study Treatment|0|||
143497306|NCT03179436|517361592|FG010|Overall Study|Randomized by Mistake without Study Treatment|0|||
143497307|NCT03179436|517361593|FG011|Overall Study|Randomized by Mistake without Study Treatment|0|||
143497308|NCT03179436|517361582|FG000|Overall Study|Lost to Follow-up|1|||
143497309|NCT03179436|517361583|FG001|Overall Study|Lost to Follow-up|0|||
143497310|NCT03179436|517361584|FG002|Overall Study|Lost to Follow-up|0|||
143497311|NCT03179436|517361585|FG003|Overall Study|Lost to Follow-up|1|||
143497312|NCT03179436|517361586|FG004|Overall Study|Lost to Follow-up|0|||
143497313|NCT03179436|517361587|FG005|Overall Study|Lost to Follow-up|1|||
143497314|NCT03179436|517361588|FG006|Overall Study|Lost to Follow-up|0|||
143497315|NCT03179436|517361589|FG007|Overall Study|Lost to Follow-up|0|||
143497316|NCT03179436|517361590|FG008|Overall Study|Lost to Follow-up|1|||
143497317|NCT03179436|517361591|FG009|Overall Study|Lost to Follow-up|1|||
143497318|NCT03179436|517361592|FG010|Overall Study|Lost to Follow-up|0|||
143497319|NCT03179436|517361593|FG011|Overall Study|Lost to Follow-up|0|||
143497320|NCT03179436|517361582|FG000|Overall Study|Death|12|||
143497321|NCT03179436|517361583|FG001|Overall Study|Death|17|||
143497322|NCT03179436|517361584|FG002|Overall Study|Death|7|||
143497323|NCT03179436|517361585|FG003|Overall Study|Death|32|||
143497324|NCT03179436|517361586|FG004|Overall Study|Death|29|||
143497325|NCT03179436|517361587|FG005|Overall Study|Death|30|||
143497326|NCT03179436|517361588|FG006|Overall Study|Death|33|||
143497327|NCT03179436|517361589|FG007|Overall Study|Death|9|||
143497328|NCT03179436|517361590|FG008|Overall Study|Death|84|||
143497329|NCT03179436|517361591|FG009|Overall Study|Death|33|||
143497330|NCT03179436|517361592|FG010|Overall Study|Death|22|||
143497331|NCT03179436|517361593|FG011|Overall Study|Death|15|||
143497332|NCT02447848|517361602|FG000|Overall Study|Patient discharged|3|||
143497333|NCT02447848|517361602|FG000|Overall Study|Lack of Efficacy|4|||
143497334|NCT02447848|517361602|FG000|Overall Study|Withdrawal by Subject|4|||
143497335|NCT02307370|517361603|FG000|Overall Study|Death|5|||
143497336|NCT02307370|517361603|FG000|Overall Study|Lost to Follow-up|1|||
143497337|NCT02307370|517361603|FG000|Overall Study|Withdrawal by Subject|1|||
143497338|NCT02307370|517361603|FG000|Overall Study|Declined Addendum ICF|6|||
143162809|NCT02100644|516141651|FG000|LTG Escalation Phase|Adverse Event|9|||
143162810|NCT02100644|516141652|FG001|LTG Escalation Phase|Adverse Event|0|||
143364166|NCT01982760|516875570|FG000|Overall Study|Physician Decision|1|||
143497339|NCT02307370|517361603|FG000|Overall Study|No response during telephone contact|5|||
143497340|NCT02307370|517361603|FG000|Overall Study|Protocol Violation|1|||
143497341|NCT05888103|517364392|FG000|Overall Study|Participant decision|3|||
143497342|NCT05888103|517364393|FG001|Overall Study|Participant decision|3|||
143497343|NCT02949128|517364394|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
143497344|NCT02949128|517364394|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
143497345|NCT02949128|517364394|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
143497346|NCT02949128|517364394|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
143497347|NCT02949128|517364394|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
143497348|NCT02949128|517364394|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
143497349|NCT02949128|517364394|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
143497350|NCT02949128|517364394|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
143497351|NCT02949128|517364394|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
143497352|NCT02949128|517364394|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
143497353|NCT01602341|517364395|FG000|Overall Study|Adverse Event|0|||
143497354|NCT01602341|517364396|FG001|Overall Study|Adverse Event|1|||
143497355|NCT02152345|517364397|FG000|Overall Study|Case Cancellations|2|||
143497356|NCT02152345|517364398|FG001|Overall Study|Case Cancellations|4|||
143497357|NCT02152345|517364397|FG000|Overall Study|Withdrawal by Subject|2|||
143497358|NCT02152345|517364398|FG001|Overall Study|Withdrawal by Subject|1|||
143497359|NCT02554929|517364400|FG000|Overall Study|Lost to Follow-up|4|||
143497360|NCT02554929|517364401|FG001|Overall Study|Lost to Follow-up|4|||
143497361|NCT02554929|517364400|FG000|Overall Study|Withdrawal by Subject|2|||
143497362|NCT02554929|517364401|FG001|Overall Study|Withdrawal by Subject|8|||
143497363|NCT01916980|517364402|FG000|Overall Study|Adverse Event|4|||
143497364|NCT01916980|517364403|FG001|Overall Study|Adverse Event|2|||
143497365|NCT01916980|517364402|FG000|Overall Study|Lack of Efficacy|2|||
143497366|NCT01916980|517364403|FG001|Overall Study|Lack of Efficacy|2|||
143497367|NCT01916980|517364402|FG000|Overall Study|Withdrawal by Subject|1|||
143039498|NCT02440711|515689106|FG001|Second Intervention|Lost to Follow-up|0|||
143039499|NCT02146105|515689113|FG000|Overall Study|Adverse Event|1|||
143039500|NCT02146105|515689113|FG000|Overall Study|Withdrawal by Subject|5|||
143039501|NCT03935880|515689115|FG000|Overall Study|Lost to Follow-up|0|||
143039502|NCT03935880|515689116|FG001|Overall Study|Lost to Follow-up|1|||
143039503|NCT02476994|515689117|FG000|Overall Study|Based on feedback from FDA|1|||
143039504|NCT02476994|515689118|FG001|Overall Study|Based on feedback from FDA|0|||
143039505|NCT02563561|515689119|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
143039506|NCT02563561|515689120|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
143039507|NCT02563561|515689121|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
143039508|NCT02563561|515689119|FG000|Overall Study|Withdrew of Consent|1|||
143039509|NCT02563561|515689120|FG001|Overall Study|Withdrew of Consent|1|||
143039510|NCT02563561|515689121|FG002|Overall Study|Withdrew of Consent|2|||
143039511|NCT02563561|515689119|FG000|Overall Study|Lost to Follow-up|1|||
143039512|NCT02563561|515689120|FG001|Overall Study|Lost to Follow-up|1|||
143039513|NCT02563561|515689121|FG002|Overall Study|Lost to Follow-up|0|||
143039514|NCT02563561|515689119|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
143039515|NCT02563561|515689120|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
143039516|NCT02563561|515689121|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
143039517|NCT02563561|515689119|FG000|Overall Study|Investigator Decision|3|||
143364167|NCT01982760|516875571|FG001|Overall Study|Physician Decision|0|||
143497368|NCT01916980|517364403|FG001|Overall Study|Withdrawal by Subject|0|||
143497369|NCT00483327|517364411|FG000|Overall Study|Adverse Event|1|||
143497370|NCT00483327|517364411|FG000|Overall Study|Withdrawal by Subject|3|||
143497371|NCT00483327|517364411|FG000|Overall Study|Lost to Follow-up|4|||
143497372|NCT00483327|517364411|FG000|Overall Study|Patient Non Compliance|2|||
143497373|NCT00618722|517364412|FG000|Overall Study|Refusal of Treatment|0|||
143497374|NCT00618722|517364413|FG001|Overall Study|Refusal of Treatment|0|||
143497375|NCT00618722|517364414|FG002|Overall Study|Refusal of Treatment|1|||
143497376|NCT00618722|517364415|FG003|Overall Study|Refusal of Treatment|0|||
143497377|NCT00618722|517364412|FG000|Overall Study|Patient Request|1|||
143497378|NCT00618722|517364413|FG001|Overall Study|Patient Request|1|||
143497379|NCT00618722|517364414|FG002|Overall Study|Patient Request|1|||
143497380|NCT00618722|517364415|FG003|Overall Study|Patient Request|1|||
143497381|NCT00618722|517364412|FG000|Overall Study|Inability to Complete Study Procedure|0|||
143497382|NCT00618722|517364413|FG001|Overall Study|Inability to Complete Study Procedure|1|||
143497383|NCT00618722|517364414|FG002|Overall Study|Inability to Complete Study Procedure|0|||
143497384|NCT00618722|517364415|FG003|Overall Study|Inability to Complete Study Procedure|0|||
143497385|NCT00618722|517364412|FG000|Overall Study|Lost to Follow-up|2|||
143497386|NCT00618722|517364413|FG001|Overall Study|Lost to Follow-up|0|||
143497387|NCT00618722|517364414|FG002|Overall Study|Lost to Follow-up|0|||
143497388|NCT00618722|517364415|FG003|Overall Study|Lost to Follow-up|2|||
143497389|NCT00618722|517364412|FG000|Overall Study|Miscellaneous Reasons|0|||
143497390|NCT00618722|517364413|FG001|Overall Study|Miscellaneous Reasons|0|||
143497391|NCT00618722|517364414|FG002|Overall Study|Miscellaneous Reasons|1|||
143497392|NCT00618722|517364415|FG003|Overall Study|Miscellaneous Reasons|1|||
143497393|NCT05512949|517364416|FG000|Overall Study|Lost to Follow-up|4|||
143497394|NCT05512949|517364417|FG001|Overall Study|Lost to Follow-up|6|||
143497395|NCT05512949|517364418|FG002|Overall Study|Lost to Follow-up|2|||
143497396|NCT05512949|517364416|FG000|Overall Study|Protocol Violation|0|||
143497397|NCT05512949|517364417|FG001|Overall Study|Protocol Violation|0|||
143497398|NCT05512949|517364418|FG002|Overall Study|Protocol Violation|1|||
143497399|NCT05512949|517364416|FG000|Overall Study|Withdrawal by Subject|1|||
143497400|NCT05512949|517364417|FG001|Overall Study|Withdrawal by Subject|1|||
143497401|NCT05512949|517364418|FG002|Overall Study|Withdrawal by Subject|2|||
143497402|NCT05512949|517364416|FG000|Overall Study|Completion status unknown|1|||
143497403|NCT05512949|517364417|FG001|Overall Study|Completion status unknown|3|||
143497404|NCT05512949|517364418|FG002|Overall Study|Completion status unknown|0|||
143497405|NCT03988907|517364419|FG000|Overall Study|Unable to complete visit|0|||
143497406|NCT03988907|517364420|FG001|Overall Study|Unable to complete visit|1|||
143497407|NCT02810964|517364421|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
143497408|NCT02810964|517364422|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
143497409|NCT02810964|517364421|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
143497410|NCT02810964|517364422|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
143497411|NCT02810964|517364421|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
143497412|NCT02810964|517364422|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
143497413|NCT02810964|517364421|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
143497414|NCT02810964|517364422|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
143497415|NCT03523351|517364423|FG000|Overall Study|Death|13|||
143497416|NCT03523351|517364424|FG001|Overall Study|Death|11|||
143497417|NCT03523351|517364423|FG000|Overall Study|Lost to Follow-up|2|||
143497418|NCT03523351|517364424|FG001|Overall Study|Lost to Follow-up|3|||
143497419|NCT03523351|517364423|FG000|Overall Study|Withdrawal by Subject|4|||
143497420|NCT03523351|517364424|FG001|Overall Study|Withdrawal by Subject|0|||
143039518|NCT02563561|515689120|FG001|Overall Study|Investigator Decision|4|||
143039519|NCT02563561|515689121|FG002|Overall Study|Investigator Decision|2|||
143039520|NCT02563561|515689119|FG000|Overall Study|Sponsor Decision|5|||
143039521|NCT02563561|515689120|FG001|Overall Study|Sponsor Decision|2|||
143039522|NCT02563561|515689121|FG002|Overall Study|Sponsor Decision|4|||
143039523|NCT02563561|515689119|FG000|Overall Study|Other|1|||
143039524|NCT02563561|515689120|FG001|Overall Study|Other|5|||
143039525|NCT02563561|515689121|FG002|Overall Study|Other|2|||
143039526|NCT02718326|515689124|FG000|Overall Study|Adverse Event|4|||
143039527|NCT02718326|515689125|FG001|Overall Study|Adverse Event|9|||
143039528|NCT02718326|515689126|FG002|Overall Study|Adverse Event|0|||
143039529|NCT02718326|515689124|FG000|Overall Study|Death|8|||
143039530|NCT02718326|515689125|FG001|Overall Study|Death|1|||
143039531|NCT02718326|515689126|FG002|Overall Study|Death|2|||
143039532|NCT02718326|515689124|FG000|Overall Study|Withdrawal by Subject|4|||
143039533|NCT02718326|515689125|FG001|Overall Study|Withdrawal by Subject|9|||
143039534|NCT02718326|515689126|FG002|Overall Study|Withdrawal by Subject|6|||
143039535|NCT02718326|515689124|FG000|Overall Study|Lost to Follow-up|18|||
143039536|NCT02718326|515689125|FG001|Overall Study|Lost to Follow-up|5|||
143039537|NCT02718326|515689126|FG002|Overall Study|Lost to Follow-up|14|||
143039538|NCT02718326|515689124|FG000|Overall Study|Protocol Deviation|1|||
143039539|NCT02718326|515689125|FG001|Overall Study|Protocol Deviation|0|||
143039540|NCT02718326|515689126|FG002|Overall Study|Protocol Deviation|0|||
143039541|NCT02718326|515689124|FG000|Overall Study|Pregnancy|1|||
143039542|NCT02718326|515689125|FG001|Overall Study|Pregnancy|0|||
143039543|NCT02718326|515689126|FG002|Overall Study|Pregnancy|0|||
143039544|NCT03122535|515689127|FG000|Overall Study|Lost to Follow-up|68|||
143039545|NCT03122535|515689128|FG001|Overall Study|Lost to Follow-up|68|||
143039546|NCT03122535|515689127|FG000|Overall Study|Physician Decision|3|||
143039547|NCT03122535|515689128|FG001|Overall Study|Physician Decision|3|||
143039548|NCT03122535|515689127|FG000|Overall Study|Withdrawal by Subject|2|||
143039549|NCT03122535|515689128|FG001|Overall Study|Withdrawal by Subject|2|||
143039550|NCT00418561|515689131|FG000|Overall Study|Participant's (guardian's) decision|0|||
143039551|NCT00418561|515689132|FG001|Overall Study|Participant's (guardian's) decision|1|||
143039552|NCT00418561|515689133|FG002|Overall Study|Participant's (guardian's) decision|0|||
143039553|NCT01693523|515689134|FG000|Overall Study|Adverse Event|2|||
143039554|NCT01693523|515689135|FG001|Overall Study|Adverse Event|1|||
143039555|NCT01693523|515689136|FG002|Overall Study|Adverse Event|0|||
143039556|NCT01693523|515689134|FG000|Overall Study|Death|0|||
143039557|NCT01693523|515689135|FG001|Overall Study|Death|1|||
143039558|NCT01693523|515689136|FG002|Overall Study|Death|1|||
143039559|NCT01693523|515689134|FG000|Overall Study|Lost to Follow-up|0|||
143039560|NCT01693523|515689135|FG001|Overall Study|Lost to Follow-up|0|||
143039561|NCT01693523|515689136|FG002|Overall Study|Lost to Follow-up|4|||
143039562|NCT01693523|515689134|FG000|Overall Study|Physician Decision|0|||
143039563|NCT01693523|515689135|FG001|Overall Study|Physician Decision|0|||
143039564|NCT01693523|515689136|FG002|Overall Study|Physician Decision|1|||
143039565|NCT01693523|515689134|FG000|Overall Study|Withdrawal by Subject|1|||
143039566|NCT01693523|515689135|FG001|Overall Study|Withdrawal by Subject|2|||
143039567|NCT01693523|515689136|FG002|Overall Study|Withdrawal by Subject|2|||
143039568|NCT01693523|515689134|FG000|Overall Study|Lack of compliance study medication|1|||
143039569|NCT01693523|515689135|FG001|Overall Study|Lack of compliance study medication|2|||
143039570|NCT01693523|515689136|FG002|Overall Study|Lack of compliance study medication|0|||
143039571|NCT01693523|515689134|FG000|Overall Study|Chemotherapy was held|1|||
143039572|NCT01693523|515689135|FG001|Overall Study|Chemotherapy was held|2|||
143039573|NCT01693523|515689136|FG002|Overall Study|Chemotherapy was held|0|||
143039574|NCT00834418|515689137|FG000|Overall Study|Adverse Event|0|||
143039575|NCT00834418|515689138|FG001|Overall Study|Adverse Event|2|||
143039576|NCT01705574|515689139|FG000|Double-Blind Phase|Lost to Follow-up|12|||
143039577|NCT01705574|515689140|FG001|Double-Blind Phase|Lost to Follow-up|16|||
143039578|NCT01705574|515689141|FG002|Double-Blind Phase|Lost to Follow-up|0|||
143039579|NCT01705574|515689142|FG003|Double-Blind Phase|Lost to Follow-up|0|||
143039580|NCT01705574|515689139|FG000|Double-Blind Phase|Adverse Event|3|||
143039581|NCT01705574|515689140|FG001|Double-Blind Phase|Adverse Event|10|||
143039582|NCT01705574|515689141|FG002|Double-Blind Phase|Adverse Event|0|||
143039583|NCT01705574|515689142|FG003|Double-Blind Phase|Adverse Event|0|||
143039584|NCT01705574|515689139|FG000|Double-Blind Phase|Withdrew Consent|8|||
143039585|NCT01705574|515689140|FG001|Double-Blind Phase|Withdrew Consent|5|||
143039586|NCT01705574|515689141|FG002|Double-Blind Phase|Withdrew Consent|0|||
143039587|NCT01705574|515689142|FG003|Double-Blind Phase|Withdrew Consent|0|||
143039588|NCT01705574|515689139|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
143039589|NCT01705574|515689140|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
143039590|NCT01705574|515689141|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
143039591|NCT01705574|515689142|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
143039592|NCT01705574|515689139|FG000|Double-Blind Phase|Pregnancy|1|||
143039593|NCT01705574|515689140|FG001|Double-Blind Phase|Pregnancy|1|||
143039594|NCT01705574|515689141|FG002|Double-Blind Phase|Pregnancy|0|||
143039595|NCT01705574|515689142|FG003|Double-Blind Phase|Pregnancy|0|||
143039596|NCT01705574|515689139|FG000|Double-Blind Phase|Protocol Violation|1|||
143497421|NCT03523351|517364423|FG000|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|0|||
143497422|NCT03523351|517364424|FG001|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|2|||
143497423|NCT01097629|517364431|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
143497424|NCT01097629|517364432|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
143497425|NCT01097629|517364433|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
143497426|NCT01097629|517364434|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
143497427|NCT01097629|517364435|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
143497428|NCT01097629|517364436|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
143497429|NCT01097629|517364437|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
143497430|NCT01097629|517364438|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
143497431|NCT01097629|517364431|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
143497432|NCT01097629|517364432|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
143497433|NCT01097629|517364433|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
143497434|NCT01097629|517364434|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
143497435|NCT01097629|517364435|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
143497436|NCT01097629|517364436|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
143497437|NCT01097629|517364437|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
143497438|NCT01097629|517364438|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
143039597|NCT01705574|515689140|FG001|Double-Blind Phase|Protocol Violation|0|||
143039598|NCT01705574|515689141|FG002|Double-Blind Phase|Protocol Violation|0|||
143039599|NCT01705574|515689142|FG003|Double-Blind Phase|Protocol Violation|0|||
143039600|NCT01705574|515689139|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
143039601|NCT01705574|515689140|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
143039602|NCT01705574|515689141|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
143039603|NCT01705574|515689142|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
143039604|NCT01705574|515689139|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
143039605|NCT01705574|515689140|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
143039606|NCT01705574|515689141|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
143039607|NCT01705574|515689142|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
143039608|NCT01705574|515689139|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
143039609|NCT01705574|515689140|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
143039610|NCT01705574|515689141|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
143039611|NCT01705574|515689142|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
143039612|NCT01705574|515689139|FG000|Open-Label Extension Phase|Adverse Event|3|||
143039613|NCT01705574|515689140|FG001|Open-Label Extension Phase|Adverse Event|0|||
143039614|NCT01705574|515689141|FG002|Open-Label Extension Phase|Adverse Event|0|||
143039615|NCT01705574|515689142|FG003|Open-Label Extension Phase|Adverse Event|1|||
143039616|NCT01705574|515689139|FG000|Open-Label Extension Phase|Death|2|||
143039617|NCT01705574|515689140|FG001|Open-Label Extension Phase|Death|0|||
143039618|NCT01705574|515689141|FG002|Open-Label Extension Phase|Death|1|||
143039619|NCT01705574|515689142|FG003|Open-Label Extension Phase|Death|0|||
143039620|NCT01705574|515689139|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
143039621|NCT01705574|515689140|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
143039622|NCT01705574|515689141|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
143039623|NCT01705574|515689142|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
143039624|NCT01705574|515689139|FG000|Open-Label Extension Phase|Physician Decision|0|||
143039625|NCT01705574|515689140|FG001|Open-Label Extension Phase|Physician Decision|0|||
143039626|NCT01705574|515689141|FG002|Open-Label Extension Phase|Physician Decision|2|||
143162811|NCT02100644|516141653|FG002|LTG Escalation Phase|Adverse Event|0|||
143162812|NCT02100644|516141651|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
143162813|NCT02100644|516141652|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
143162814|NCT02100644|516141653|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
143162815|NCT02100644|516141651|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
143162816|NCT02100644|516141652|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
143162817|NCT02100644|516141653|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
143497439|NCT01097629|517364431|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
143497440|NCT01097629|517364432|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
143497441|NCT01097629|517364433|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
143497442|NCT01097629|517364434|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
143497443|NCT01097629|517364435|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
143039627|NCT01705574|515689142|FG003|Open-Label Extension Phase|Physician Decision|0|||
143039628|NCT01705574|515689139|FG000|Open-Label Extension Phase|Pregnancy|0|||
143039629|NCT01705574|515689140|FG001|Open-Label Extension Phase|Pregnancy|0|||
143039630|NCT01705574|515689141|FG002|Open-Label Extension Phase|Pregnancy|1|||
143039631|NCT01705574|515689142|FG003|Open-Label Extension Phase|Pregnancy|1|||
143039632|NCT02472366|515689143|FG000|Overall Study|Lost to Follow-up|1|||
143039633|NCT02472366|515689144|FG001|Overall Study|Lost to Follow-up|0|||
143039634|NCT02678286|515689147|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
143039635|NCT02678286|515689148|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
143039636|NCT02678286|515689147|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
143039637|NCT02678286|515689148|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
143039638|NCT02678286|515689147|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
143039639|NCT02678286|515689148|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
143039640|NCT02678286|515689147|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
143039641|NCT02678286|515689148|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
143239443|NCT03486834|516429877|FG001|Overall Study|Lost to Follow-up|24|||
143239444|NCT03486834|516429878|FG002|Overall Study|Lost to Follow-up|39|||
143239445|NCT03486834|516429876|FG000|Overall Study|Non-compliance with Study Drug|2|||
143239446|NCT03486834|516429877|FG001|Overall Study|Non-compliance with Study Drug|2|||
143239447|NCT03486834|516429878|FG002|Overall Study|Non-compliance with Study Drug|0|||
143239448|NCT03486834|516429876|FG000|Overall Study|Physician Decision|5|||
143239449|NCT03486834|516429877|FG001|Overall Study|Physician Decision|2|||
143239450|NCT03486834|516429878|FG002|Overall Study|Physician Decision|3|||
143239451|NCT03486834|516429876|FG000|Overall Study|Pregnancy|10|||
143239452|NCT03486834|516429877|FG001|Overall Study|Pregnancy|12|||
143239453|NCT03486834|516429878|FG002|Overall Study|Pregnancy|12|||
143239454|NCT03486834|516429876|FG000|Overall Study|Protocol Deviation|2|||
143239455|NCT03486834|516429877|FG001|Overall Study|Protocol Deviation|3|||
143039642|NCT02678286|515689147|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
143039643|NCT02678286|515689148|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
143039644|NCT00635492|515689150|FG000|Overall Study|Death|12|||
143039645|NCT00635492|515689151|FG001|Overall Study|Death|40|||
143039646|NCT00635492|515689150|FG000|Overall Study|Lost to Follow-up|151|||
143039647|NCT00635492|515689151|FG001|Overall Study|Lost to Follow-up|172|||
143039648|NCT00635492|515689150|FG000|Overall Study|Physician Decision|32|||
143039649|NCT00635492|515689151|FG001|Overall Study|Physician Decision|22|||
143039650|NCT00635492|515689150|FG000|Overall Study|Sponsor decision|2|||
143039651|NCT00635492|515689151|FG001|Overall Study|Sponsor decision|3|||
143039652|NCT00635492|515689150|FG000|Overall Study|Withdrawal by Subject|82|||
143039653|NCT00635492|515689151|FG001|Overall Study|Withdrawal by Subject|45|||
143039654|NCT00467363|515689152|FG000|Overall Study|Lost to Follow-up|80|||
143039655|NCT00467363|515689153|FG001|Overall Study|Lost to Follow-up|70|||
143039656|NCT03500341|515689155|FG000|Overall Study|Withdrawn prior to Completion|2|||
143039657|NCT02576938|515689156|FG000|Overall Study|Adverse Event|5|||
143039658|NCT02576938|515689157|FG001|Overall Study|Adverse Event|3|||
143039659|NCT02576938|515689158|FG002|Overall Study|Adverse Event|6|||
143039660|NCT02576938|515689156|FG000|Overall Study|Protocol Violation|1|||
143039661|NCT02576938|515689157|FG001|Overall Study|Protocol Violation|1|||
143039662|NCT02576938|515689158|FG002|Overall Study|Protocol Violation|1|||
143039663|NCT02576938|515689156|FG000|Overall Study|Withdrawal by Subject|3|||
143039664|NCT02576938|515689157|FG001|Overall Study|Withdrawal by Subject|2|||
143039665|NCT02576938|515689158|FG002|Overall Study|Withdrawal by Subject|4|||
143039666|NCT02576938|515689156|FG000|Overall Study|Lack of Efficacy|9|||
143162818|NCT00478140|516141654|FG000|Overall Study|Clinical Disease Progression|1|||
143162819|NCT02913326|516141663|FG000|Overall Study|Reason not listed|0|||
143162820|NCT02913326|516141664|FG001|Overall Study|Reason not listed|1|||
143162821|NCT02913326|516141663|FG000|Overall Study|Lost to Follow-up|0|||
143162822|NCT02913326|516141664|FG001|Overall Study|Lost to Follow-up|1|||
143162823|NCT02913326|516141663|FG000|Overall Study|Adverse Event|1|||
143162824|NCT02913326|516141664|FG001|Overall Study|Adverse Event|0|||
143162825|NCT02971137|516141669|FG000|Overall Study|Lost to Follow-up|44|||
143162826|NCT02971137|516141670|FG001|Overall Study|Lost to Follow-up|56|||
143162827|NCT05259722|516141674|FG000|Overall Study|Adverse Event|2|||
143239456|NCT03486834|516429878|FG002|Overall Study|Protocol Deviation|3|||
143239457|NCT03486834|516429876|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
143039667|NCT02576938|515689157|FG001|Overall Study|Lack of Efficacy|4|||
143039668|NCT02576938|515689158|FG002|Overall Study|Lack of Efficacy|0|||
143039669|NCT02576938|515689156|FG000|Overall Study|Lost to Follow-up|2|||
143039670|NCT02576938|515689157|FG001|Overall Study|Lost to Follow-up|0|||
143039671|NCT02576938|515689158|FG002|Overall Study|Lost to Follow-up|1|||
143039672|NCT02576938|515689156|FG000|Overall Study|Physician Decision|0|||
143039673|NCT02576938|515689157|FG001|Overall Study|Physician Decision|1|||
143162828|NCT05259722|516141675|FG001|Overall Study|Adverse Event|24|||
143162829|NCT05259722|516141674|FG000|Overall Study|Lost to Follow-up|5|||
143239458|NCT03486834|516429877|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
143239459|NCT03486834|516429878|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
143497444|NCT01097629|517364436|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
143497445|NCT01097629|517364437|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
143039674|NCT02576938|515689158|FG002|Overall Study|Physician Decision|0|||
143039675|NCT02576938|515689156|FG000|Overall Study|Met Exclusion Criteria|0|||
143039676|NCT02576938|515689157|FG001|Overall Study|Met Exclusion Criteria|1|||
143039677|NCT02576938|515689158|FG002|Overall Study|Met Exclusion Criteria|0|||
143039678|NCT04400890|515689165|FG000|Overall Study|Withdrawal by Subject|3|||
143039679|NCT04400890|515689166|FG001|Overall Study|Withdrawal by Subject|2|||
143039680|NCT03546842|515689167|FG000|Overall Study|Protocol Violation|1|||
143039681|NCT03546842|515689167|FG000|Overall Study|Withdrawal by Subject|2|||
143039682|NCT01474551|515689171|FG000|Overall Study|Death|1|||
143039683|NCT03197883|515689172|FG000|Overall Study|Adverse Event|1|||
143039684|NCT03197883|515689173|FG001|Overall Study|Adverse Event|1|||
143039685|NCT03197883|515689172|FG000|Overall Study|Lost to Follow-up|1|||
143162830|NCT05259722|516141675|FG001|Overall Study|Lost to Follow-up|1|||
143162831|NCT05259722|516141674|FG000|Overall Study|Lack of Efficacy|8|||
143162832|NCT05259722|516141675|FG001|Overall Study|Lack of Efficacy|26|||
143162833|NCT05259722|516141674|FG000|Overall Study|Withdrawal by Subject|15|||
143162834|NCT05259722|516141675|FG001|Overall Study|Withdrawal by Subject|33|||
143162835|NCT05259722|516141674|FG000|Overall Study|Various reasons|3|||
143162836|NCT05259722|516141675|FG001|Overall Study|Various reasons|9|||
143162837|NCT05259722|516141674|FG000|Overall Study|Not exposed to IMP|1|||
143162838|NCT05259722|516141675|FG001|Overall Study|Not exposed to IMP|12|||
143162839|NCT05259722|516141674|FG000|Overall Study|Discontinuation of IMP, related to COVID-19|1|||
143162840|NCT05259722|516141675|FG001|Overall Study|Discontinuation of IMP, related to COVID-19|0|||
143162841|NCT00968968|516141676|FG000|Overall Study|Study closed/terminated|10|||
143162842|NCT00968968|516141677|FG001|Overall Study|Study closed/terminated|10|||
143162843|NCT00968968|516141676|FG000|Overall Study|Protocol defined stopping criteria|3|||
143162844|NCT00968968|516141677|FG001|Overall Study|Protocol defined stopping criteria|1|||
143162845|NCT00968968|516141676|FG000|Overall Study|Withdrawal by Subject|2|||
143162846|NCT00968968|516141677|FG001|Overall Study|Withdrawal by Subject|0|||
143162847|NCT00968968|516141676|FG000|Overall Study|Physician Decision|1|||
143162848|NCT00968968|516141677|FG001|Overall Study|Physician Decision|2|||
143162849|NCT00968968|516141676|FG000|Overall Study|Lost to Follow-up|0|||
143162850|NCT00968968|516141677|FG001|Overall Study|Lost to Follow-up|1|||
143162851|NCT03624036|516141678|FG000|Overall Study|Death|2|||
143162852|NCT03624036|516141679|FG001|Overall Study|Death|3|||
143162853|NCT03624036|516141680|FG002|Overall Study|Death|0|||
143162854|NCT03624036|516141681|FG003|Overall Study|Death|1|||
143162855|NCT03624036|516141678|FG000|Overall Study|Withdrawal by Subject|1|||
143162856|NCT03624036|516141679|FG001|Overall Study|Withdrawal by Subject|0|||
143162857|NCT03624036|516141680|FG002|Overall Study|Withdrawal by Subject|1|||
143162858|NCT03624036|516141681|FG003|Overall Study|Withdrawal by Subject|0|||
143162859|NCT03624036|516141678|FG000|Overall Study|Enrolled but Never Treated|1|||
143162860|NCT03624036|516141679|FG001|Overall Study|Enrolled but Never Treated|0|||
143162861|NCT03624036|516141680|FG002|Overall Study|Enrolled but Never Treated|0|||
143162862|NCT03624036|516141681|FG003|Overall Study|Enrolled but Never Treated|0|||
143162863|NCT03624036|516141678|FG000|Overall Study|Reason not Specified|3|||
143162864|NCT03624036|516141679|FG001|Overall Study|Reason not Specified|0|||
143162865|NCT03624036|516141680|FG002|Overall Study|Reason not Specified|2|||
143162866|NCT03624036|516141681|FG003|Overall Study|Reason not Specified|2|||
143162867|NCT00498485|516141684|FG000|Overall Study|Adverse Event|1|||
143162868|NCT00498485|516141685|FG001|Overall Study|Adverse Event|5|||
143162869|NCT03478787|516141686|FG000|Overall Study|Adverse Event|5|||
143162870|NCT03478787|516141687|FG001|Overall Study|Adverse Event|1|||
143162871|NCT03478787|516141686|FG000|Overall Study|Protocol Violation|3|||
143162872|NCT03478787|516141687|FG001|Overall Study|Protocol Violation|0|||
143162873|NCT03478787|516141686|FG000|Overall Study|Lack of Efficacy|7|||
143162874|NCT03478787|516141687|FG001|Overall Study|Lack of Efficacy|1|||
143162875|NCT03478787|516141686|FG000|Overall Study|Lost to Follow-up|9|||
143162876|NCT03478787|516141687|FG001|Overall Study|Lost to Follow-up|5|||
143162877|NCT03478787|516141686|FG000|Overall Study|Withdrawal by Subject|2|||
143162878|NCT03478787|516141687|FG001|Overall Study|Withdrawal by Subject|6|||
143162879|NCT03478787|516141686|FG000|Overall Study|Other, Not Specified|3|||
143162880|NCT03478787|516141687|FG001|Overall Study|Other, Not Specified|0|||
143162881|NCT00452400|516141688|FG000|Overall Study|Adverse Event|1|||
143497446|NCT01097629|517364438|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
143497447|NCT01097629|517364431|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
143039686|NCT03197883|515689173|FG001|Overall Study|Lost to Follow-up|0|||
143039687|NCT03197883|515689172|FG000|Overall Study|Protocol Violation|1|||
143162882|NCT00452400|516141689|FG001|Overall Study|Adverse Event|1|||
143497448|NCT01097629|517364432|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
143039688|NCT03197883|515689173|FG001|Overall Study|Protocol Violation|0|||
143162883|NCT00452400|516141690|FG002|Overall Study|Adverse Event|5|||
143162884|NCT00452400|516141691|FG003|Overall Study|Adverse Event|0|||
143162885|NCT00452400|516141692|FG004|Overall Study|Adverse Event|2|||
143162886|NCT00452400|516141688|FG000|Overall Study|Protocol Violation|0|||
143039689|NCT03197883|515689172|FG000|Overall Study|Other (Not Specified)|0|||
143039690|NCT03197883|515689173|FG001|Overall Study|Other (Not Specified)|5|||
143039691|NCT03686033|515689174|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
143039692|NCT03686033|515689175|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
143039693|NCT03686033|515689176|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
143039694|NCT03686033|515689177|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
143039695|NCT03686033|515689178|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
143039696|NCT03686033|515689179|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
143039697|NCT01045161|515689180|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
143039698|NCT01045161|515689181|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
143039699|NCT01045161|515689182|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
143039700|NCT01045161|515689180|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
143039701|NCT01045161|515689181|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
143039702|NCT01045161|515689182|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
143039703|NCT01045161|515689180|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
143039704|NCT01045161|515689181|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
143039705|NCT01045161|515689182|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
143039706|NCT01045161|515689180|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
143039707|NCT01045161|515689181|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
143039708|NCT01045161|515689182|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
143162887|NCT00452400|516141689|FG001|Overall Study|Protocol Violation|0|||
143162888|NCT00452400|516141690|FG002|Overall Study|Protocol Violation|1|||
143162889|NCT00452400|516141691|FG003|Overall Study|Protocol Violation|0|||
143162890|NCT00452400|516141692|FG004|Overall Study|Protocol Violation|0|||
143162891|NCT00452400|516141688|FG000|Overall Study|Lost to Follow-up|1|||
143162892|NCT00452400|516141689|FG001|Overall Study|Lost to Follow-up|0|||
143162893|NCT00452400|516141690|FG002|Overall Study|Lost to Follow-up|0|||
143162894|NCT00452400|516141691|FG003|Overall Study|Lost to Follow-up|0|||
143162895|NCT00452400|516141692|FG004|Overall Study|Lost to Follow-up|0|||
143162896|NCT00452400|516141688|FG000|Overall Study|Withdrawal by Subject|1|||
143162897|NCT00452400|516141689|FG001|Overall Study|Withdrawal by Subject|0|||
143162898|NCT00452400|516141690|FG002|Overall Study|Withdrawal by Subject|1|||
143162899|NCT00452400|516141691|FG003|Overall Study|Withdrawal by Subject|0|||
143162900|NCT00452400|516141692|FG004|Overall Study|Withdrawal by Subject|0|||
143162901|NCT00452400|516141688|FG000|Overall Study|Lack of Efficacy|2|||
143162902|NCT00452400|516141689|FG001|Overall Study|Lack of Efficacy|0|||
143162903|NCT00452400|516141690|FG002|Overall Study|Lack of Efficacy|0|||
143162904|NCT00452400|516141691|FG003|Overall Study|Lack of Efficacy|0|||
143162905|NCT00452400|516141692|FG004|Overall Study|Lack of Efficacy|0|||
143162906|NCT00452400|516141688|FG000|Overall Study|Other reasons not listed above|0|||
143162907|NCT00452400|516141689|FG001|Overall Study|Other reasons not listed above|0|||
143162908|NCT00452400|516141690|FG002|Overall Study|Other reasons not listed above|0|||
143162909|NCT00452400|516141691|FG003|Overall Study|Other reasons not listed above|1|||
143162910|NCT00452400|516141692|FG004|Overall Study|Other reasons not listed above|1|||
143162911|NCT01712074|516141695|FG000|Placebo Run-in Period|Adverse Event|2|||
143162912|NCT01712074|516141696|FG001|Placebo Run-in Period|Adverse Event|0|||
143162913|NCT01712074|516141697|FG002|Placebo Run-in Period|Adverse Event|0|||
143162914|NCT01712074|516141695|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
143162915|NCT01712074|516141696|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
143162916|NCT01712074|516141697|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
143162917|NCT01712074|516141695|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
143162918|NCT01712074|516141696|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
143162919|NCT01712074|516141697|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
143162920|NCT01712074|516141695|FG000|Placebo Run-in Period|Other|1|||
143162921|NCT01712074|516141696|FG001|Placebo Run-in Period|Other|0|||
143162922|NCT01712074|516141697|FG002|Placebo Run-in Period|Other|0|||
143162923|NCT01712074|516141695|FG000|Placebo Run-in Period|No longer willing to participate|1|||
143162924|NCT01712074|516141696|FG001|Placebo Run-in Period|No longer willing to participate|0|||
143162925|NCT01712074|516141697|FG002|Placebo Run-in Period|No longer willing to participate|0|||
143162926|NCT01712074|516141695|FG000|Double Blind Period|Adverse Event|0|||
143162927|NCT01712074|516141696|FG001|Double Blind Period|Adverse Event|2|||
143162928|NCT01712074|516141697|FG002|Double Blind Period|Adverse Event|1|||
143162929|NCT01712074|516141695|FG000|Double Blind Period|No longer willing to participate|0|||
143162930|NCT01712074|516141696|FG001|Double Blind Period|No longer willing to participate|2|||
143162931|NCT01712074|516141697|FG002|Double Blind Period|No longer willing to participate|4|||
143039709|NCT01045161|515689180|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
143162932|NCT01712074|516141695|FG000|Double Blind Period|Death|0|||
143162933|NCT01712074|516141696|FG001|Double Blind Period|Death|1|||
143162934|NCT01712074|516141697|FG002|Double Blind Period|Death|0|||
143162935|NCT01712074|516141695|FG000|Double Blind Period|Lost to Follow-up|0|||
143162936|NCT01712074|516141696|FG001|Double Blind Period|Lost to Follow-up|2|||
143162937|NCT01712074|516141697|FG002|Double Blind Period|Lost to Follow-up|1|||
143162938|NCT01712074|516141695|FG000|Double Blind Period|Other|0|||
143162939|NCT01712074|516141696|FG001|Double Blind Period|Other|4|||
143162940|NCT01712074|516141697|FG002|Double Blind Period|Other|1|||
143162941|NCT01712074|516141695|FG000|Double Blind Period|Protocol Violation|0|||
143162942|NCT01712074|516141696|FG001|Double Blind Period|Protocol Violation|0|||
143162943|NCT01712074|516141697|FG002|Double Blind Period|Protocol Violation|1|||
143162944|NCT01712074|516141695|FG000|Double Blind Period|No longer met eligibility criteria|0|||
143162945|NCT01712074|516141696|FG001|Double Blind Period|No longer met eligibility criteria|3|||
143162946|NCT01712074|516141697|FG002|Double Blind Period|No longer met eligibility criteria|0|||
143162947|NCT03378635|516141698|FG000|Overall Study|Adverse Event|1|||
143162948|NCT03378635|516141699|FG001|Overall Study|Adverse Event|0|||
143162949|NCT03378635|516141700|FG002|Overall Study|Adverse Event|0|||
143162950|NCT03378635|516141698|FG000|Overall Study|Withdrawal by Subject|1|||
143162951|NCT03378635|516141699|FG001|Overall Study|Withdrawal by Subject|0|||
143162952|NCT03378635|516141700|FG002|Overall Study|Withdrawal by Subject|0|||
143162953|NCT02539394|516141701|FG000|Overall Study|Protocol Violation|1|||
143162954|NCT02539394|516141702|FG001|Overall Study|Protocol Violation|3|||
143162955|NCT02539394|516141701|FG000|Overall Study|Lost to Follow-up|1|||
143162956|NCT02539394|516141702|FG001|Overall Study|Lost to Follow-up|2|||
143162957|NCT02539394|516141701|FG000|Overall Study|Incomplete dataset|6|||
143162958|NCT02539394|516141702|FG001|Overall Study|Incomplete dataset|6|||
143162959|NCT02413346|516141703|FG000|Overall Study|Adverse Event|6|||
143162960|NCT02413346|516141704|FG001|Overall Study|Adverse Event|6|||
143162961|NCT02413346|516141703|FG000|Overall Study|Withdrawal by Subject|30|||
143162962|NCT02413346|516141704|FG001|Overall Study|Withdrawal by Subject|40|||
143162963|NCT02413346|516141703|FG000|Overall Study|Lost to Follow-up|17|||
143162964|NCT02413346|516141704|FG001|Overall Study|Lost to Follow-up|21|||
143162965|NCT02413346|516141703|FG000|Overall Study|Protocol Violation|2|||
143162966|NCT02413346|516141704|FG001|Overall Study|Protocol Violation|0|||
143162967|NCT02413346|516141703|FG000|Overall Study|Other Miscellaneous Reasons|4|||
143162968|NCT02413346|516141704|FG001|Overall Study|Other Miscellaneous Reasons|3|||
143162969|NCT01694771|516141724|FG000|Overall Study|Adverse Event|18|||
143162970|NCT01694771|516141725|FG001|Overall Study|Adverse Event|16|||
143162971|NCT01694771|516141724|FG000|Overall Study|Lack of Efficacy|1|||
143162972|NCT01694771|516141725|FG001|Overall Study|Lack of Efficacy|0|||
143162973|NCT01694771|516141724|FG000|Overall Study|Non compliance protocol|7|||
143162974|NCT01694771|516141725|FG001|Overall Study|Non compliance protocol|6|||
143162975|NCT01694771|516141724|FG000|Overall Study|Lost to Follow-up|2|||
143162976|NCT01694771|516141725|FG001|Overall Study|Lost to Follow-up|3|||
143162977|NCT01694771|516141724|FG000|Overall Study|Consent withdrawn|7|||
143162978|NCT01694771|516141725|FG001|Overall Study|Consent withdrawn|9|||
143162979|NCT01694771|516141724|FG000|Overall Study|Other reasons|5|||
143162980|NCT01694771|516141725|FG001|Overall Study|Other reasons|6|||
143162981|NCT00890097|516141726|FG000|Overall Study|Adverse Event|21|||
143162982|NCT00890097|516141727|FG001|Overall Study|Adverse Event|32|||
143162983|NCT00890097|516141728|FG002|Overall Study|Adverse Event|28|||
143162984|NCT00890097|516141726|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
143162985|NCT00890097|516141727|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
143162986|NCT00890097|516141728|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
143162987|NCT00890097|516141726|FG000|Overall Study|Withdrew Consent|9|||
143162988|NCT00890097|516141727|FG001|Overall Study|Withdrew Consent|6|||
143162989|NCT00890097|516141728|FG002|Overall Study|Withdrew Consent|9|||
143162990|NCT00890097|516141726|FG000|Overall Study|Lost to Follow-up|5|||
143162991|NCT00890097|516141727|FG001|Overall Study|Lost to Follow-up|5|||
143162992|NCT00890097|516141728|FG002|Overall Study|Lost to Follow-up|5|||
143162993|NCT00890097|516141726|FG000|Overall Study|Noncompliance|0|||
143162994|NCT00890097|516141727|FG001|Overall Study|Noncompliance|4|||
143162995|NCT00890097|516141728|FG002|Overall Study|Noncompliance|4|||
143162996|NCT00890097|516141726|FG000|Overall Study|Sponsor Decision|7|||
143162997|NCT00890097|516141727|FG001|Overall Study|Sponsor Decision|11|||
143162998|NCT00890097|516141728|FG002|Overall Study|Sponsor Decision|7|||
143162999|NCT00890097|516141726|FG000|Overall Study|Did not attend final visit|2|||
143163000|NCT00890097|516141727|FG001|Overall Study|Did not attend final visit|3|||
143163001|NCT00890097|516141728|FG002|Overall Study|Did not attend final visit|0|||
143497449|NCT01097629|517364433|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
143497450|NCT01097629|517364434|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
143163002|NCT00890097|516141726|FG000|Overall Study|Subject Decision|3|||
143163003|NCT00890097|516141727|FG001|Overall Study|Subject Decision|2|||
143163004|NCT00890097|516141728|FG002|Overall Study|Subject Decision|6|||
143163005|NCT00890097|516141726|FG000|Overall Study|Randomization Error|2|||
143163006|NCT00890097|516141727|FG001|Overall Study|Randomization Error|0|||
143163007|NCT00890097|516141728|FG002|Overall Study|Randomization Error|0|||
143163008|NCT00890097|516141726|FG000|Overall Study|Failed inclusion criteria|3|||
143163009|NCT00890097|516141727|FG001|Overall Study|Failed inclusion criteria|4|||
143163010|NCT00890097|516141728|FG002|Overall Study|Failed inclusion criteria|0|||
143163011|NCT00890097|516141726|FG000|Overall Study|Transportation|0|||
143163012|NCT00890097|516141727|FG001|Overall Study|Transportation|2|||
143163013|NCT00890097|516141728|FG002|Overall Study|Transportation|0|||
143497451|NCT01097629|517364435|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
143497452|NCT01097629|517364436|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
143497453|NCT01097629|517364437|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
143497454|NCT01097629|517364438|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
143497455|NCT01097629|517364431|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
143497456|NCT01097629|517364432|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
143497457|NCT01097629|517364433|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
143497458|NCT01097629|517364434|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
143497459|NCT01097629|517364435|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
143497460|NCT01097629|517364436|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
143497461|NCT01097629|517364437|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
143497462|NCT01097629|517364438|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
143497463|NCT01097629|517364431|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
143497464|NCT01097629|517364432|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
143039710|NCT01045161|515689181|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
143039711|NCT01045161|515689182|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
143039712|NCT01045161|515689180|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
143039713|NCT01045161|515689181|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
143039714|NCT01045161|515689182|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
143039715|NCT01045161|515689180|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
143039716|NCT01045161|515689181|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
143039717|NCT01045161|515689182|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
143163014|NCT00890097|516141726|FG000|Overall Study|Subject Moved|0|||
143163015|NCT00890097|516141727|FG001|Overall Study|Subject Moved|4|||
143163016|NCT00890097|516141728|FG002|Overall Study|Subject Moved|0|||
143163017|NCT00890097|516141726|FG000|Overall Study|Protocol Deviation|1|||
143163018|NCT00890097|516141727|FG001|Overall Study|Protocol Deviation|1|||
143163019|NCT00890097|516141728|FG002|Overall Study|Protocol Deviation|1|||
143163020|NCT00289900|516141731|FG000|Overall Study|Adverse Event|28|||
143163021|NCT00289900|516141732|FG001|Overall Study|Adverse Event|40|||
143163022|NCT00289900|516141733|FG002|Overall Study|Adverse Event|13|||
143163023|NCT00289900|516141734|FG003|Overall Study|Adverse Event|19|||
143163024|NCT00289900|516141735|FG004|Overall Study|Adverse Event|20|||
143163025|NCT00289900|516141736|FG005|Overall Study|Adverse Event|33|||
143163026|NCT00289900|516141731|FG000|Overall Study|Lost to Follow-up|7|||
143163027|NCT00289900|516141732|FG001|Overall Study|Lost to Follow-up|7|||
143163028|NCT00289900|516141733|FG002|Overall Study|Lost to Follow-up|8|||
143163029|NCT00289900|516141734|FG003|Overall Study|Lost to Follow-up|8|||
143163030|NCT00289900|516141735|FG004|Overall Study|Lost to Follow-up|4|||
143163031|NCT00289900|516141736|FG005|Overall Study|Lost to Follow-up|8|||
143163032|NCT00289900|516141731|FG000|Overall Study|Participant had flushing|18|||
143163033|NCT00289900|516141732|FG001|Overall Study|Participant had flushing|42|||
143163034|NCT00289900|516141733|FG002|Overall Study|Participant had flushing|1|||
143163035|NCT00289900|516141734|FG003|Overall Study|Participant had flushing|2|||
143163036|NCT00289900|516141735|FG004|Overall Study|Participant had flushing|0|||
143163037|NCT00289900|516141736|FG005|Overall Study|Participant had flushing|4|||
143163038|NCT00289900|516141731|FG000|Overall Study|Other|0|||
143163039|NCT00289900|516141732|FG001|Overall Study|Other|0|||
143163040|NCT00289900|516141733|FG002|Overall Study|Other|0|||
143163041|NCT00289900|516141734|FG003|Overall Study|Other|5|||
143163042|NCT00289900|516141735|FG004|Overall Study|Other|1|||
143163043|NCT00289900|516141736|FG005|Overall Study|Other|0|||
143163044|NCT00289900|516141731|FG000|Overall Study|Participant moved|1|||
143163045|NCT00289900|516141732|FG001|Overall Study|Participant moved|0|||
143163046|NCT00289900|516141733|FG002|Overall Study|Participant moved|0|||
143163047|NCT00289900|516141734|FG003|Overall Study|Participant moved|1|||
143163048|NCT00289900|516141735|FG004|Overall Study|Participant moved|1|||
143163049|NCT00289900|516141736|FG005|Overall Study|Participant moved|1|||
143163050|NCT00289900|516141731|FG000|Overall Study|Withdrawal by Subject|10|||
143163051|NCT00289900|516141732|FG001|Overall Study|Withdrawal by Subject|21|||
143163052|NCT00289900|516141733|FG002|Overall Study|Withdrawal by Subject|8|||
143163053|NCT00289900|516141734|FG003|Overall Study|Withdrawal by Subject|18|||
143163054|NCT00289900|516141735|FG004|Overall Study|Withdrawal by Subject|12|||
143163055|NCT00289900|516141736|FG005|Overall Study|Withdrawal by Subject|11|||
143163056|NCT00289900|516141731|FG000|Overall Study|Protocol Violation|3|||
143163057|NCT00289900|516141732|FG001|Overall Study|Protocol Violation|9|||
143163058|NCT00289900|516141733|FG002|Overall Study|Protocol Violation|2|||
143364168|NCT00821236|516875572|FG000|Overall Study|Lost to Follow-up|3|||
143497465|NCT01097629|517364433|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
143497466|NCT01097629|517364434|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
143497467|NCT01097629|517364435|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
143497468|NCT01097629|517364436|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
143497469|NCT01097629|517364437|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
143497470|NCT01097629|517364438|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
143497471|NCT01097629|517364431|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
143497472|NCT01097629|517364432|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
143497473|NCT01097629|517364433|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
143497474|NCT01097629|517364434|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
143497475|NCT01097629|517364435|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
143497476|NCT01097629|517364436|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
143497477|NCT01097629|517364437|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
143497478|NCT01097629|517364438|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
143497479|NCT01097629|517364431|FG000|DB RO Phase|Withdrawal by Subject|0|||
143497480|NCT01097629|517364432|FG001|DB RO Phase|Withdrawal by Subject|0|||
143497481|NCT01097629|517364433|FG002|DB RO Phase|Withdrawal by Subject|0|||
143497482|NCT01097629|517364434|FG003|DB RO Phase|Withdrawal by Subject|0|||
143497483|NCT01097629|517364435|FG004|DB RO Phase|Withdrawal by Subject|0|||
143497484|NCT01097629|517364436|FG005|DB RO Phase|Withdrawal by Subject|0|||
143497485|NCT01097629|517364437|FG006|DB RO Phase|Withdrawal by Subject|0|||
143497486|NCT01097629|517364438|FG007|DB RO Phase|Withdrawal by Subject|1|||
143497487|NCT01097629|517364431|FG000|DB RO Phase|Protocol Violation|0|||
143497488|NCT01097629|517364432|FG001|DB RO Phase|Protocol Violation|0|||
143497489|NCT01097629|517364433|FG002|DB RO Phase|Protocol Violation|0|||
143497490|NCT01097629|517364434|FG003|DB RO Phase|Protocol Violation|1|||
143497491|NCT01097629|517364435|FG004|DB RO Phase|Protocol Violation|0|||
143497492|NCT01097629|517364436|FG005|DB RO Phase|Protocol Violation|1|||
143497493|NCT01097629|517364437|FG006|DB RO Phase|Protocol Violation|1|||
143497494|NCT01097629|517364438|FG007|DB RO Phase|Protocol Violation|0|||
143497495|NCT01097629|517364431|FG000|DB RO Phase|Lost to Follow-up|0|||
143497496|NCT01097629|517364432|FG001|DB RO Phase|Lost to Follow-up|0|||
143497497|NCT01097629|517364433|FG002|DB RO Phase|Lost to Follow-up|0|||
143497498|NCT01097629|517364434|FG003|DB RO Phase|Lost to Follow-up|0|||
143497499|NCT01097629|517364435|FG004|DB RO Phase|Lost to Follow-up|0|||
143497500|NCT01097629|517364436|FG005|DB RO Phase|Lost to Follow-up|0|||
143497501|NCT01097629|517364437|FG006|DB RO Phase|Lost to Follow-up|2|||
143239460|NCT03486834|516429876|FG000|Overall Study|Randomized but not treated|4|||
143239461|NCT03486834|516429877|FG001|Overall Study|Randomized but not treated|4|||
143239462|NCT03486834|516429878|FG002|Overall Study|Randomized but not treated|1|||
143239463|NCT03313037|516429884|FG000|Overall Study|Protocol Violation|4|||
143239464|NCT03313037|516429885|FG001|Overall Study|Protocol Violation|1|||
143239465|NCT03313037|516429884|FG000|Overall Study|Other|1|||
143239466|NCT03313037|516429885|FG001|Overall Study|Other|1|||
143239467|NCT03313037|516429884|FG000|Overall Study|Withdrawal by Subject|4|||
143239468|NCT03313037|516429885|FG001|Overall Study|Withdrawal by Subject|3|||
143239469|NCT03313037|516429884|FG000|Overall Study|No longer meets eligibility criteria|1|||
143239470|NCT03313037|516429885|FG001|Overall Study|No longer meets eligibility criteria|7|||
143239471|NCT03313037|516429884|FG000|Overall Study|Lost to Follow-up|9|||
143239472|NCT03313037|516429885|FG001|Overall Study|Lost to Follow-up|8|||
143239473|NCT03313037|516429884|FG000|Overall Study|Randomized but not treated|1|||
143239474|NCT03313037|516429885|FG001|Overall Study|Randomized but not treated|0|||
143239475|NCT02760498|516429886|FG000|Overall Study|Adverse Event|3|||
143239476|NCT02760498|516429887|FG001|Overall Study|Adverse Event|3|||
143239477|NCT02760498|516429888|FG002|Overall Study|Adverse Event|1|||
143239478|NCT02760498|516429889|FG003|Overall Study|Adverse Event|1|||
143239479|NCT02760498|516429890|FG004|Overall Study|Adverse Event|0|||
143239480|NCT02760498|516429891|FG005|Overall Study|Adverse Event|6|||
143239481|NCT02760498|516429886|FG000|Overall Study|Death|7|||
143239482|NCT02760498|516429887|FG001|Overall Study|Death|5|||
143239483|NCT02760498|516429888|FG002|Overall Study|Death|5|||
143239484|NCT02760498|516429889|FG003|Overall Study|Death|7|||
143239485|NCT02760498|516429890|FG004|Overall Study|Death|0|||
143239486|NCT02760498|516429891|FG005|Overall Study|Death|23|||
143497502|NCT01097629|517364438|FG007|DB RO Phase|Lost to Follow-up|0|||
143497503|NCT00132041|517364440|FG000|Baseline|Ineligible|6|||
143497504|NCT00132041|517364440|FG000|3 Months Post Ablation|Transplant|1|||
143497505|NCT00132041|517364440|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
143497506|NCT00132041|517364440|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
143497507|NCT00132041|517364440|FG000|6 Months Post Ablation|Death|2|||
143497508|NCT00132041|517364440|FG000|6 Months Post Ablation|Transplant|6|||
143497509|NCT00132041|517364440|FG000|9 Months Post Ablation|Death|1|||
143497510|NCT00132041|517364440|FG000|9 Months Post Ablation|Transplant|1|||
143497511|NCT00132041|517364440|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
143497512|NCT00132041|517364440|FG000|12 Months Post Ablation|Death|1|||
143239487|NCT02760498|516429886|FG000|Overall Study|Lost to Follow-up|0|||
143239488|NCT02760498|516429887|FG001|Overall Study|Lost to Follow-up|0|||
143239489|NCT02760498|516429888|FG002|Overall Study|Lost to Follow-up|0|||
143239490|NCT02760498|516429889|FG003|Overall Study|Lost to Follow-up|0|||
143497513|NCT00132041|517364440|FG000|12 Months Post Ablation|Transplant|1|||
143497514|NCT00132041|517364440|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
143497515|NCT00132041|517364440|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
143497516|NCT00132041|517364440|FG000|15 Months Post Ablation|Death|1|||
143497517|NCT00132041|517364440|FG000|15 Months Post Ablation|Transplant|5|||
143039718|NCT01045161|515689180|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
143039719|NCT01045161|515689181|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
143039720|NCT01045161|515689182|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
143039721|NCT01045161|515689180|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
143039722|NCT01045161|515689181|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
143039723|NCT01045161|515689182|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
143039724|NCT01045161|515689180|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
143039725|NCT01045161|515689181|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
143039726|NCT01045161|515689182|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
143039727|NCT01045161|515689180|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
143163059|NCT00289900|516141734|FG003|Overall Study|Protocol Violation|6|||
143497518|NCT00132041|517364440|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
143497519|NCT00132041|517364440|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
143497520|NCT00132041|517364440|FG000|18 Months Post Ablation|Transplant|1|||
143163060|NCT00289900|516141735|FG004|Overall Study|Protocol Violation|7|||
143163061|NCT00289900|516141736|FG005|Overall Study|Protocol Violation|4|||
143163062|NCT00289900|516141731|FG000|Overall Study|site terminated|1|||
143163063|NCT00289900|516141732|FG001|Overall Study|site terminated|0|||
143163064|NCT00289900|516141733|FG002|Overall Study|site terminated|1|||
143163065|NCT00289900|516141734|FG003|Overall Study|site terminated|0|||
143163066|NCT00289900|516141735|FG004|Overall Study|site terminated|0|||
143163067|NCT00289900|516141736|FG005|Overall Study|site terminated|0|||
143163068|NCT00289900|516141731|FG000|Overall Study|Not treated|0|||
143163069|NCT00289900|516141732|FG001|Overall Study|Not treated|1|||
143163070|NCT00289900|516141733|FG002|Overall Study|Not treated|0|||
143163071|NCT00289900|516141734|FG003|Overall Study|Not treated|0|||
143163072|NCT00289900|516141735|FG004|Overall Study|Not treated|0|||
143163073|NCT00289900|516141736|FG005|Overall Study|Not treated|0|||
143163074|NCT01703221|516141737|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
143163075|NCT01703221|516141738|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
143163076|NCT01703221|516141739|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
143163077|NCT01703221|516141737|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
143163078|NCT01703221|516141738|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
143163079|NCT01703221|516141739|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
143163080|NCT01703221|516141737|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
143163081|NCT01703221|516141738|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
143163082|NCT01703221|516141739|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
143163083|NCT01703221|516141737|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
143163084|NCT01703221|516141738|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
143163085|NCT01703221|516141739|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
143163086|NCT01703221|516141737|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
143163087|NCT01703221|516141738|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
143163088|NCT01703221|516141739|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
143163089|NCT01703221|516141737|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
143163090|NCT01703221|516141738|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
143163091|NCT01703221|516141739|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
143163092|NCT01703221|516141737|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
143163093|NCT01703221|516141738|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
143163094|NCT01703221|516141739|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
143163095|NCT01703221|516141737|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
143163096|NCT01703221|516141738|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
143163097|NCT01703221|516141739|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
143163098|NCT01152385|516141740|FG000|Overall Study|Withdrawal by Subject|3|||
143163099|NCT01152385|516141741|FG001|Overall Study|Withdrawal by Subject|1|||
143163100|NCT01152385|516141742|FG002|Overall Study|Withdrawal by Subject|1|||
143163101|NCT01152385|516141743|FG003|Overall Study|Withdrawal by Subject|1|||
143163102|NCT01152385|516141740|FG000|Overall Study|Protocol Violation|0|||
143163103|NCT01152385|516141741|FG001|Overall Study|Protocol Violation|0|||
143163104|NCT01152385|516141742|FG002|Overall Study|Protocol Violation|0|||
143163105|NCT01152385|516141743|FG003|Overall Study|Protocol Violation|1|||
143163106|NCT01152385|516141740|FG000|Overall Study|Adverse Event|1|||
143163107|NCT01152385|516141741|FG001|Overall Study|Adverse Event|1|||
143163108|NCT01152385|516141742|FG002|Overall Study|Adverse Event|0|||
143163109|NCT01152385|516141743|FG003|Overall Study|Adverse Event|0|||
143163110|NCT01152385|516141740|FG000|Overall Study|Study-specific withdrawal criteria|1|||
143163111|NCT01152385|516141741|FG001|Overall Study|Study-specific withdrawal criteria|1|||
143163112|NCT01152385|516141742|FG002|Overall Study|Study-specific withdrawal criteria|2|||
143239491|NCT02760498|516429890|FG004|Overall Study|Lost to Follow-up|0|||
143163113|NCT01152385|516141743|FG003|Overall Study|Study-specific withdrawal criteria|0|||
143163114|NCT01152385|516141740|FG000|Overall Study|Other|4|||
143163115|NCT01152385|516141741|FG001|Overall Study|Other|3|||
143163116|NCT01152385|516141742|FG002|Overall Study|Other|2|||
143163117|NCT01152385|516141743|FG003|Overall Study|Other|3|||
143497521|NCT00132041|517364440|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
143497522|NCT00132041|517364440|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
143163118|NCT03878069|516141744|FG000|Overall Study|Death|0|||
143163119|NCT03878069|516141745|FG001|Overall Study|Death|1|||
143163120|NCT03878069|516141746|FG002|Overall Study|Death|0|||
143163121|NCT03449147|516141747|FG000|52-week Treatment Period|Death|0|||
143163122|NCT03449147|516141748|FG001|52-week Treatment Period|Death|1|||
143163123|NCT03449147|516141749|FG002|52-week Treatment Period|Death|0|||
143163124|NCT03449147|516141747|FG000|52-week Treatment Period|Lost to Follow-up|6|||
143163125|NCT03449147|516141748|FG001|52-week Treatment Period|Lost to Follow-up|2|||
143163126|NCT03449147|516141749|FG002|52-week Treatment Period|Lost to Follow-up|5|||
143163127|NCT03449147|516141747|FG000|52-week Treatment Period|Other|0|||
143163128|NCT03449147|516141748|FG001|52-week Treatment Period|Other|1|||
143163129|NCT03449147|516141749|FG002|52-week Treatment Period|Other|2|||
143163130|NCT03449147|516141747|FG000|52-week Treatment Period|Physician Decision|1|||
143163131|NCT03449147|516141748|FG001|52-week Treatment Period|Physician Decision|0|||
143163132|NCT03449147|516141749|FG002|52-week Treatment Period|Physician Decision|3|||
143163133|NCT03449147|516141747|FG000|52-week Treatment Period|Screen Failure|1|||
143163134|NCT03449147|516141748|FG001|52-week Treatment Period|Screen Failure|2|||
143163135|NCT03449147|516141749|FG002|52-week Treatment Period|Screen Failure|0|||
143163136|NCT03449147|516141747|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
143163137|NCT03449147|516141748|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
143163138|NCT03449147|516141749|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
143163139|NCT03449147|516141747|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
143163140|NCT03449147|516141748|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
143163141|NCT03449147|516141749|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
143163142|NCT03449147|516141747|FG000|12-Week Off-Treatment Durability Period|Other|0|||
143163143|NCT03449147|516141748|FG001|12-Week Off-Treatment Durability Period|Other|1|||
143163144|NCT03449147|516141749|FG002|12-Week Off-Treatment Durability Period|Other|0|||
143163145|NCT00974233|516141753|FG000|Induction Chemoimmunotherapy|Death|2|||
143163146|NCT00974233|516141753|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
143163147|NCT00974233|516141753|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
143163148|NCT00974233|516141753|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
143163149|NCT00974233|516141753|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
143163150|NCT00974233|516141753|FG000|Maintenance Lenalidomide|Adverse Event|8|||
143163151|NCT02113878|516143880|FG000|Overall Study|Adverse Event|1|||
143163152|NCT02113878|516143881|FG001|Overall Study|Adverse Event|0|||
143163153|NCT02113878|516143880|FG000|Overall Study|Withdrawal by Subject|1|||
143163154|NCT02113878|516143881|FG001|Overall Study|Withdrawal by Subject|0|||
143163155|NCT02113878|516143880|FG000|Overall Study|patient non-compliance|1|||
143163156|NCT02113878|516143881|FG001|Overall Study|patient non-compliance|0|||
143163157|NCT06844812|516143884|FG000|Overall Study|Lost to Follow-up|5|||
143163158|NCT06844812|516143884|FG000|Overall Study|stigmatization concerns|2|||
143163159|NCT06844812|516143884|FG000|Overall Study|medication refusal|2|||
143163160|NCT06844812|516143884|FG000|Overall Study|concerns about possible side effects|2|||
143163161|NCT06844812|516143884|FG000|Overall Study|wanting to seek another specialist opinion|2|||
143163162|NCT06844812|516143884|FG000|Overall Study|side effects (dizziness)|1|||
143163163|NCT00449787|516143907|FG000|Overall Study|Lost to Follow-up|10|||
143163164|NCT00449787|516143908|FG001|Overall Study|Lost to Follow-up|8|||
143163165|NCT00449787|516143907|FG000|Overall Study|Did not require medication|95|||
143163166|NCT00449787|516143908|FG001|Overall Study|Did not require medication|92|||
143163167|NCT03701074|516143909|FG000|Overall Study|Physician Decision|1|||
143163168|NCT03701074|516143910|FG001|Overall Study|Physician Decision|0|||
143163169|NCT00912509|516143911|FG000|Overall Study|Lost to Follow-up|1|||
143163170|NCT00912509|516143912|FG001|Overall Study|Lost to Follow-up|0|||
143163171|NCT00912509|516143911|FG000|Overall Study|Lack of Efficacy|4|||
143163172|NCT00912509|516143912|FG001|Overall Study|Lack of Efficacy|3|||
143163173|NCT01034657|516143913|FG000|Core Phase|Withdrawal by Subject|1|||
143163174|NCT01034657|516143914|FG001|Core Phase|Withdrawal by Subject|0|||
143163175|NCT01034657|516143915|FG002|Core Phase|Withdrawal by Subject|0|||
143163176|NCT01034657|516143913|FG000|Core Phase|Lack of Efficacy|2|||
143163177|NCT01034657|516143914|FG001|Core Phase|Lack of Efficacy|0|||
143163178|NCT01034657|516143915|FG002|Core Phase|Lack of Efficacy|0|||
143163179|NCT01034657|516143913|FG000|Core Phase|Abnormal laboratory value|1|||
143163180|NCT01034657|516143914|FG001|Core Phase|Abnormal laboratory value|0|||
143163181|NCT01034657|516143915|FG002|Core Phase|Abnormal laboratory value|0|||
143163182|NCT01034657|516143913|FG000|Core Phase|Adverse Event|8|||
143163183|NCT01034657|516143914|FG001|Core Phase|Adverse Event|0|||
143163184|NCT01034657|516143915|FG002|Core Phase|Adverse Event|0|||
143163185|NCT01034657|516143913|FG000|Core Phase|Protocol Violation|2|||
143163186|NCT01034657|516143914|FG001|Core Phase|Protocol Violation|0|||
143163187|NCT01034657|516143915|FG002|Core Phase|Protocol Violation|0|||
143163188|NCT01034657|516143913|FG000|Randomized Phase|Withdrawal by Subject|0|||
143163189|NCT01034657|516143914|FG001|Randomized Phase|Withdrawal by Subject|2|||
143163190|NCT01034657|516143915|FG002|Randomized Phase|Withdrawal by Subject|0|||
143039728|NCT01045161|515689181|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
143039729|NCT01045161|515689182|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
143039730|NCT01045161|515689180|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
143039731|NCT01045161|515689181|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
143039732|NCT01045161|515689182|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
143039733|NCT01045161|515689180|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
143039734|NCT01045161|515689181|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
143039735|NCT01045161|515689182|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
143039736|NCT01045161|515689180|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
143039737|NCT01045161|515689181|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
143039738|NCT01045161|515689182|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
143039739|NCT01854047|515689183|FG000|Overall Study|Lack of Efficacy|1|||
143039740|NCT01854047|515689184|FG001|Overall Study|Lack of Efficacy|0|||
143039741|NCT01854047|515689185|FG002|Overall Study|Lack of Efficacy|0|||
143039742|NCT01854047|515689186|FG003|Overall Study|Lack of Efficacy|0|||
143039743|NCT01854047|515689187|FG004|Overall Study|Lack of Efficacy|0|||
143039744|NCT01854047|515689183|FG000|Overall Study|Poor compliance to protocol|3|||
143039745|NCT01854047|515689184|FG001|Overall Study|Poor compliance to protocol|0|||
143039746|NCT01854047|515689185|FG002|Overall Study|Poor compliance to protocol|2|||
143039747|NCT01854047|515689186|FG003|Overall Study|Poor compliance to protocol|0|||
143039748|NCT01854047|515689187|FG004|Overall Study|Poor compliance to protocol|0|||
143039749|NCT01854047|515689183|FG000|Overall Study|Adverse Event|5|||
143039750|NCT01854047|515689184|FG001|Overall Study|Adverse Event|4|||
143039751|NCT01854047|515689185|FG002|Overall Study|Adverse Event|6|||
143039752|NCT01854047|515689186|FG003|Overall Study|Adverse Event|10|||
143039753|NCT01854047|515689187|FG004|Overall Study|Adverse Event|7|||
143039754|NCT01854047|515689183|FG000|Overall Study|Randomized but not treated|0|||
143039755|NCT01854047|515689184|FG001|Overall Study|Randomized but not treated|1|||
143039756|NCT01854047|515689185|FG002|Overall Study|Randomized but not treated|2|||
143039757|NCT01854047|515689186|FG003|Overall Study|Randomized but not treated|0|||
143039758|NCT01854047|515689187|FG004|Overall Study|Randomized but not treated|4|||
143039759|NCT01854047|515689183|FG000|Overall Study|Other than specified above|3|||
143039760|NCT01854047|515689184|FG001|Overall Study|Other than specified above|3|||
143039761|NCT01854047|515689185|FG002|Overall Study|Other than specified above|3|||
143039762|NCT01854047|515689186|FG003|Overall Study|Other than specified above|5|||
143039763|NCT01854047|515689187|FG004|Overall Study|Other than specified above|8|||
143039764|NCT03031847|515689189|FG000|Overall Study|Death|1|||
143039765|NCT03031847|515689190|FG001|Overall Study|Death|1|||
143039766|NCT03031847|515689191|FG002|Overall Study|Death|2|||
143039767|NCT03031847|515689192|FG003|Overall Study|Death|3|||
143039768|NCT03031847|515689189|FG000|Overall Study|Lost to Follow-up|1|||
143039769|NCT03031847|515689190|FG001|Overall Study|Lost to Follow-up|1|||
143039770|NCT03031847|515689191|FG002|Overall Study|Lost to Follow-up|2|||
143039771|NCT03031847|515689192|FG003|Overall Study|Lost to Follow-up|3|||
143039772|NCT01353664|515689193|FG000|Overall Study|Other|3|||
143039773|NCT01353664|515689193|FG000|Overall Study|Disease Progression|16|||
143039774|NCT02089997|515689196|FG000|Overall Study|Case report forms uncollected|99|||
143039775|NCT02089997|515689196|FG000|Overall Study|Protocol Violation|147|||
143039776|NCT02242201|515689203|FG000|Overall Study|preoperative identified neuropathy|2|||
143039777|NCT02242201|515689204|FG001|Overall Study|preoperative identified neuropathy|0|||
143039778|NCT02242201|515689205|FG002|Overall Study|preoperative identified neuropathy|0|||
143039779|NCT02242201|515689203|FG000|Overall Study|planned post-op anticoagulation|1|||
143039780|NCT02242201|515689204|FG001|Overall Study|planned post-op anticoagulation|0|||
143039781|NCT02242201|515689205|FG002|Overall Study|planned post-op anticoagulation|0|||
143039782|NCT02242201|515689203|FG000|Overall Study|changed surgical procedure|1|||
143039783|NCT02242201|515689204|FG001|Overall Study|changed surgical procedure|0|||
143039784|NCT02242201|515689205|FG002|Overall Study|changed surgical procedure|0|||
143039785|NCT02242201|515689203|FG000|Overall Study|postponed surgery|0|||
143039786|NCT02242201|515689204|FG001|Overall Study|postponed surgery|0|||
143163191|NCT01034657|516143913|FG000|Randomized Phase|Lack of Efficacy|5|||
143163192|NCT01034657|516143914|FG001|Randomized Phase|Lack of Efficacy|1|||
143163193|NCT01034657|516143915|FG002|Randomized Phase|Lack of Efficacy|0|||
143163194|NCT01034657|516143913|FG000|Randomized Phase|Abnormal laboratory value|0|||
143163195|NCT01034657|516143914|FG001|Randomized Phase|Abnormal laboratory value|1|||
143163196|NCT01034657|516143915|FG002|Randomized Phase|Abnormal laboratory value|0|||
143163197|NCT01034657|516143913|FG000|Randomized Phase|Adverse Event|0|||
143163198|NCT01034657|516143914|FG001|Randomized Phase|Adverse Event|2|||
143039787|NCT02242201|515689205|FG002|Overall Study|postponed surgery|1|||
143039788|NCT02242201|515689203|FG000|Overall Study|preoperative opioid consumption|0|||
143039789|NCT02242201|515689204|FG001|Overall Study|preoperative opioid consumption|1|||
143039790|NCT02242201|515689205|FG002|Overall Study|preoperative opioid consumption|0|||
143163199|NCT01034657|516143915|FG002|Randomized Phase|Adverse Event|1|||
143163200|NCT02715856|516143916|FG000|Overall Study|Software Issues|12|||
143039791|NCT02374853|515689208|FG000|Overall Study|Surgery Cancelled|5|||
143039792|NCT02374853|515689209|FG001|Overall Study|Surgery Cancelled|11|||
143039793|NCT02281084|515689210|FG000|Overall Study|Death|21|||
143039794|NCT02281084|515689211|FG001|Overall Study|Death|18|||
143039795|NCT02281084|515689212|FG002|Overall Study|Death|3|||
143039796|NCT02281084|515689213|FG003|Overall Study|Death|5|||
143039797|NCT02281084|515689210|FG000|Overall Study|Adverse Event|1|||
143039798|NCT02281084|515689211|FG001|Overall Study|Adverse Event|0|||
143039799|NCT02281084|515689212|FG002|Overall Study|Adverse Event|0|||
143039800|NCT02281084|515689213|FG003|Overall Study|Adverse Event|0|||
143039801|NCT02281084|515689210|FG000|Overall Study|Withdrawal by Subject|2|||
143039802|NCT02281084|515689211|FG001|Overall Study|Withdrawal by Subject|2|||
143039803|NCT02281084|515689212|FG002|Overall Study|Withdrawal by Subject|0|||
143039804|NCT02281084|515689213|FG003|Overall Study|Withdrawal by Subject|0|||
143039805|NCT02281084|515689210|FG000|Overall Study|Site Closure by Sponsor|5|||
143039806|NCT02281084|515689211|FG001|Overall Study|Site Closure by Sponsor|1|||
143039807|NCT02281084|515689212|FG002|Overall Study|Site Closure by Sponsor|2|||
143039808|NCT02281084|515689213|FG003|Overall Study|Site Closure by Sponsor|0|||
143039809|NCT02305758|515689214|FG000|Overall Study|Death|27|||
143039810|NCT02305758|515689215|FG001|Overall Study|Death|27|||
143039811|NCT02305758|515689214|FG000|Overall Study|Withdrew consent|9|||
143039812|NCT02305758|515689215|FG001|Overall Study|Withdrew consent|2|||
143039813|NCT02305758|515689214|FG000|Overall Study|Lost to Follow-up|6|||
143039814|NCT02305758|515689215|FG001|Overall Study|Lost to Follow-up|1|||
143039815|NCT02305758|515689214|FG000|Overall Study|Study Terminated by Sponsor|21|||
143039816|NCT02305758|515689215|FG001|Overall Study|Study Terminated by Sponsor|34|||
143039817|NCT02305758|515689214|FG000|Overall Study|Other, not specified|2|||
143039818|NCT02305758|515689215|FG001|Overall Study|Other, not specified|1|||
143039819|NCT01424644|515689216|FG000|Overall Study|Adverse Event|2|||
143039820|NCT01424644|515689217|FG001|Overall Study|Adverse Event|0|||
143039821|NCT01424644|515689216|FG000|Overall Study|Withdrawal by Subject|9|||
143039822|NCT01424644|515689217|FG001|Overall Study|Withdrawal by Subject|12|||
143039823|NCT01424644|515689216|FG000|Overall Study|Lost to Follow-up|16|||
143039824|NCT01424644|515689217|FG001|Overall Study|Lost to Follow-up|12|||
143497523|NCT03609619|517364441|FG000|Overall Study|Adverse Event|1|||
143039825|NCT01424644|515689216|FG000|Overall Study|Protocol Violation|4|||
143039826|NCT01424644|515689217|FG001|Overall Study|Protocol Violation|3|||
143039827|NCT01424644|515689216|FG000|Overall Study|Administrative Reason|1|||
143039828|NCT01424644|515689217|FG001|Overall Study|Administrative Reason|0|||
143039829|NCT01424644|515689216|FG000|Overall Study|Unable to Classify|1|||
143039830|NCT01424644|515689217|FG001|Overall Study|Unable to Classify|0|||
143039831|NCT05593965|515689220|FG000|1st Intervention (1 Day)|Technical error|1|||
143039832|NCT05593965|515689221|FG001|1st Intervention (1 Day)|Technical error|0|||
143039833|NCT03616106|515689222|FG000|Overall Study|Removed by PI|6|||
143039834|NCT03616106|515689223|FG001|Overall Study|Removed by PI|0|||
143039835|NCT03616106|515689222|FG000|Overall Study|Withdrawal by Subject|1|||
143039836|NCT03616106|515689223|FG001|Overall Study|Withdrawal by Subject|1|||
143039837|NCT03616106|515689222|FG000|Overall Study|Lost to Follow-up|7|||
143163201|NCT02715856|516143917|FG001|Overall Study|Software Issues|7|||
143163202|NCT02715856|516143916|FG000|Overall Study|Death|6|||
143497524|NCT03609619|517364442|FG001|Overall Study|Adverse Event|0|||
143497525|NCT03609619|517364441|FG000|Overall Study|Lack of Efficacy|1|||
143497526|NCT03609619|517364442|FG001|Overall Study|Lack of Efficacy|2|||
143163203|NCT02715856|516143917|FG001|Overall Study|Death|5|||
143497527|NCT03609619|517364441|FG000|Overall Study|Protocol Violation|5|||
143039838|NCT03616106|515689223|FG001|Overall Study|Lost to Follow-up|0|||
143039839|NCT02066922|515689241|FG000|Overall Study|Adverse Event|1|||
143163204|NCT02715856|516143916|FG000|Overall Study|Non- Compliant|0|||
143163205|NCT02715856|516143917|FG001|Overall Study|Non- Compliant|40|||
143163206|NCT02094885|516143918|FG000|Overall Study|Death|1|||
143163207|NCT02094885|516143919|FG001|Overall Study|Death|5|||
143163208|NCT02094885|516143918|FG000|Overall Study|Withdrawn due to age|1|||
143163209|NCT02094885|516143919|FG001|Overall Study|Withdrawn due to age|0|||
143163210|NCT05166902|516143920|FG000|First Intervention|Lost to Follow-up|0|||
143163211|NCT05166902|516143921|FG001|First Intervention|Lost to Follow-up|1|||
143163212|NCT01998477|516143922|FG000|Overall Study|Lost to Follow-up|4|||
143163213|NCT01998477|516143923|FG001|Overall Study|Lost to Follow-up|5|||
143163214|NCT01998477|516143922|FG000|Overall Study|Withdrawal by Subject|6|||
143163215|NCT01998477|516143923|FG001|Overall Study|Withdrawal by Subject|0|||
143163216|NCT00779909|516143924|FG000|Overall Study|Lost to Follow-up|1|||
143497528|NCT03609619|517364442|FG001|Overall Study|Protocol Violation|0|||
143039840|NCT00440297|515689242|FG000|Overall Study|Adverse Event|8|||
143039841|NCT00440297|515689243|FG001|Overall Study|Adverse Event|5|||
143039842|NCT00440297|515689242|FG000|Overall Study|Lost to Follow-up|1|||
143039843|NCT00440297|515689243|FG001|Overall Study|Lost to Follow-up|0|||
143163217|NCT00779909|516143925|FG001|Overall Study|Lost to Follow-up|0|||
143497529|NCT03609619|517364441|FG000|Overall Study|Withdrawal by Subject|2|||
143039844|NCT00440297|515689242|FG000|Overall Study|Physician Decision|1|||
143163218|NCT00779909|516143926|FG002|Overall Study|Lost to Follow-up|0|||
143497530|NCT03609619|517364442|FG001|Overall Study|Withdrawal by Subject|3|||
143039845|NCT00440297|515689243|FG001|Overall Study|Physician Decision|0|||
143497531|NCT03609619|517364441|FG000|Overall Study|Lost to Follow-up|1|||
143039846|NCT00440297|515689242|FG000|Overall Study|Protocol Violation|11|||
143039847|NCT00440297|515689243|FG001|Overall Study|Protocol Violation|7|||
143039848|NCT00440297|515689242|FG000|Overall Study|Withdrawal by Subject|1|||
143039849|NCT00440297|515689243|FG001|Overall Study|Withdrawal by Subject|6|||
143039850|NCT00440297|515689242|FG000|Overall Study|Randomized by mistake|1|||
143039851|NCT00440297|515689243|FG001|Overall Study|Randomized by mistake|0|||
143039852|NCT02445339|515689244|FG000|Overall Study|Physician Decision|1|||
143039853|NCT02445339|515689245|FG001|Overall Study|Physician Decision|0|||
143039854|NCT02445339|515689244|FG000|Overall Study|Lost to Follow-up|11|||
143039855|NCT02445339|515689245|FG001|Overall Study|Lost to Follow-up|15|||
143039856|NCT03206177|515689246|FG000|Overall Study|Withdrawal by Subject|1|||
143039857|NCT03238781|515689247|FG000|Overall Study|Adverse Event|1|||
143039858|NCT03238781|515689248|FG001|Overall Study|Adverse Event|1|||
143039859|NCT03238781|515689249|FG002|Overall Study|Adverse Event|2|||
143039860|NCT03238781|515689247|FG000|Overall Study|Lost to Follow-up|2|||
143039861|NCT03238781|515689248|FG001|Overall Study|Lost to Follow-up|1|||
143039862|NCT03238781|515689249|FG002|Overall Study|Lost to Follow-up|2|||
143039863|NCT03238781|515689247|FG000|Overall Study|Withdrawal by Subject|23|||
143039864|NCT03238781|515689248|FG001|Overall Study|Withdrawal by Subject|14|||
143039865|NCT03238781|515689249|FG002|Overall Study|Withdrawal by Subject|16|||
143039866|NCT03238781|515689247|FG000|Overall Study|Decision by sponsor|0|||
143039867|NCT03238781|515689248|FG001|Overall Study|Decision by sponsor|1|||
143039868|NCT03238781|515689249|FG002|Overall Study|Decision by sponsor|0|||
143039869|NCT03161405|515689250|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
143039870|NCT02655679|515689251|FG000|Overall Study|Adverse Event|0|||
143039871|NCT02655679|515689252|FG001|Overall Study|Adverse Event|1|||
143039872|NCT02655679|515689253|FG002|Overall Study|Adverse Event|0|||
143039873|NCT02655679|515689254|FG003|Overall Study|Adverse Event|0|||
143039874|NCT02655679|515689255|FG004|Overall Study|Adverse Event|0|||
143039875|NCT02655679|515689251|FG000|Overall Study|Withdrawal by Subject|1|||
143039876|NCT02655679|515689252|FG001|Overall Study|Withdrawal by Subject|1|||
143039877|NCT02655679|515689253|FG002|Overall Study|Withdrawal by Subject|0|||
143039878|NCT02655679|515689254|FG003|Overall Study|Withdrawal by Subject|3|||
143039879|NCT02655679|515689255|FG004|Overall Study|Withdrawal by Subject|1|||
143039880|NCT02655679|515689251|FG000|Overall Study|Inability to Comply with the Protocol|1|||
143039881|NCT02655679|515689252|FG001|Overall Study|Inability to Comply with the Protocol|0|||
143039882|NCT02655679|515689253|FG002|Overall Study|Inability to Comply with the Protocol|0|||
143039883|NCT02655679|515689254|FG003|Overall Study|Inability to Comply with the Protocol|0|||
143039884|NCT02655679|515689255|FG004|Overall Study|Inability to Comply with the Protocol|0|||
143039885|NCT02655679|515689251|FG000|Overall Study|Lost to Follow-up|0|||
143039886|NCT02655679|515689252|FG001|Overall Study|Lost to Follow-up|1|||
143039887|NCT02655679|515689253|FG002|Overall Study|Lost to Follow-up|1|||
143039888|NCT02655679|515689254|FG003|Overall Study|Lost to Follow-up|1|||
143039889|NCT02655679|515689255|FG004|Overall Study|Lost to Follow-up|0|||
143039890|NCT02655679|515689251|FG000|Overall Study|Other Miscellaneous Reasons|1|||
143039891|NCT02655679|515689252|FG001|Overall Study|Other Miscellaneous Reasons|0|||
143039892|NCT02655679|515689253|FG002|Overall Study|Other Miscellaneous Reasons|0|||
143039893|NCT02655679|515689254|FG003|Overall Study|Other Miscellaneous Reasons|0|||
143039894|NCT02655679|515689255|FG004|Overall Study|Other Miscellaneous Reasons|0|||
143039895|NCT01421277|515689256|FG000|Overall Study|Lack of qualifying event|0|||
143039896|NCT01421277|515689257|FG001|Overall Study|Lack of qualifying event|61|||
143039897|NCT01421277|515689256|FG000|Overall Study|Incomplete baseline data|0|||
143039898|NCT01421277|515689257|FG001|Overall Study|Incomplete baseline data|31|||
143039899|NCT02039908|515689258|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
143039900|NCT02039908|515689259|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
143239492|NCT02760498|516429891|FG005|Overall Study|Lost to Follow-up|3|||
143239493|NCT02760498|516429886|FG000|Overall Study|Non-compliance with study drug|0|||
143239494|NCT02760498|516429887|FG001|Overall Study|Non-compliance with study drug|2|||
143239495|NCT02760498|516429888|FG002|Overall Study|Non-compliance with study drug|0|||
143239496|NCT02760498|516429889|FG003|Overall Study|Non-compliance with study drug|0|||
143239497|NCT02760498|516429890|FG004|Overall Study|Non-compliance with study drug|0|||
143239498|NCT02760498|516429891|FG005|Overall Study|Non-compliance with study drug|0|||
143239499|NCT02760498|516429886|FG000|Overall Study|Participant decision|1|||
143239500|NCT02760498|516429887|FG001|Overall Study|Participant decision|4|||
143239501|NCT02760498|516429888|FG002|Overall Study|Participant decision|2|||
143239502|NCT02760498|516429889|FG003|Overall Study|Participant decision|2|||
143039901|NCT02039908|515689260|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
143039902|NCT02039908|515689261|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
143039903|NCT02039908|515689258|FG000|Phase 1-Summer|Protocol Violation|6|||
143039904|NCT02039908|515689259|FG001|Phase 1-Summer|Protocol Violation|0|||
143039905|NCT02039908|515689260|FG002|Phase 1-Summer|Protocol Violation|0|||
143039906|NCT02039908|515689261|FG003|Phase 1-Summer|Protocol Violation|0|||
143039907|NCT02039908|515689258|FG000|Phase 2-School Year|Lost to Follow-up|0|||
143039908|NCT02039908|515689259|FG001|Phase 2-School Year|Lost to Follow-up|0|||
143039909|NCT02039908|515689260|FG002|Phase 2-School Year|Lost to Follow-up|1|||
143239503|NCT02760498|516429890|FG004|Overall Study|Participant decision|1|||
143497532|NCT03609619|517364442|FG001|Overall Study|Lost to Follow-up|1|||
143497533|NCT05162066|517364443|FG000|Overall Study|Adverse Event|1|||
143497534|NCT05162066|517364444|FG001|Overall Study|Adverse Event|0|||
143039910|NCT02039908|515689261|FG003|Phase 2-School Year|Lost to Follow-up|3|||
143039911|NCT02039908|515689258|FG000|Phase 2-School Year|Protocol Violation|0|||
143039912|NCT02039908|515689259|FG001|Phase 2-School Year|Protocol Violation|0|||
143039913|NCT02039908|515689260|FG002|Phase 2-School Year|Protocol Violation|3|||
143039914|NCT02039908|515689261|FG003|Phase 2-School Year|Protocol Violation|0|||
143039915|NCT02039908|515689258|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
143039916|NCT02039908|515689259|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
143039917|NCT02039908|515689260|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
143039918|NCT02039908|515689261|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
143039919|NCT01597245|515689262|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
143039920|NCT01597245|515689263|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
143039921|NCT01597245|515689264|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
143039922|NCT01597245|515689265|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
143039923|NCT01597245|515689266|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
143039924|NCT01597245|515689267|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
143039925|NCT01597245|515689268|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
143039926|NCT01597245|515689269|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
143039927|NCT01597245|515689270|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
143039928|NCT01597245|515689271|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
143039929|NCT01597245|515689272|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
143039930|NCT01597245|515689273|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
143039931|NCT01597245|515689274|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
143039932|NCT01597245|515689275|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
143039933|NCT01597245|515689276|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
143039934|NCT01597245|515689277|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
143039935|NCT01597245|515689278|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
143163219|NCT00779909|516143927|FG003|Overall Study|Lost to Follow-up|1|||
143163220|NCT00779909|516143924|FG000|Overall Study|Withdrawal by Subject|0|||
143163221|NCT00779909|516143925|FG001|Overall Study|Withdrawal by Subject|1|||
143163222|NCT00779909|516143926|FG002|Overall Study|Withdrawal by Subject|0|||
143163223|NCT00779909|516143927|FG003|Overall Study|Withdrawal by Subject|0|||
143163224|NCT02872142|516143931|FG000|Overall Study|Adverse Event|2|||
143163225|NCT02872142|516143931|FG000|Overall Study|Death|1|||
143163226|NCT02872142|516143931|FG000|Overall Study|Participant Decision|3|||
143163227|NCT03627468|516143935|FG000|Overall Study|Adverse Event|5|||
143163228|NCT03627468|516143936|FG001|Overall Study|Adverse Event|33|||
143163229|NCT03627468|516143935|FG000|Overall Study|Withdrawal by Subject|13|||
143163230|NCT03627468|516143936|FG001|Overall Study|Withdrawal by Subject|23|||
143163231|NCT03627468|516143935|FG000|Overall Study|Physician Decision|1|||
143163232|NCT03627468|516143936|FG001|Overall Study|Physician Decision|0|||
143163233|NCT03627468|516143935|FG000|Overall Study|Protocol Violation|0|||
143163234|NCT03627468|516143936|FG001|Overall Study|Protocol Violation|2|||
143163235|NCT03627468|516143935|FG000|Overall Study|Lost to Follow-up|10|||
143163236|NCT03627468|516143936|FG001|Overall Study|Lost to Follow-up|16|||
143163237|NCT03627468|516143935|FG000|Overall Study|Death|1|||
143163238|NCT03627468|516143936|FG001|Overall Study|Death|0|||
143163239|NCT03627468|516143935|FG000|Overall Study|Pregnancy|1|||
143163240|NCT03627468|516143936|FG001|Overall Study|Pregnancy|1|||
143163241|NCT03627468|516143935|FG000|Overall Study|Lack of Efficacy|0|||
143163242|NCT03627468|516143936|FG001|Overall Study|Lack of Efficacy|2|||
143163243|NCT03627468|516143935|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
143163244|NCT03627468|516143936|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
143163245|NCT05122143|516143937|FG000|Overall Study|Adverse Event|1|||
143163246|NCT05122143|516143938|FG001|Overall Study|Adverse Event|0|||
143163247|NCT05122143|516143939|FG002|Overall Study|Adverse Event|0|||
143163248|NCT05122143|516143940|FG003|Overall Study|Adverse Event|0|||
143163249|NCT05122143|516143941|FG004|Overall Study|Adverse Event|1|||
143163250|NCT05122143|516143942|FG005|Overall Study|Adverse Event|0|||
143163251|NCT05122143|516143937|FG000|Overall Study|Protocol non-compliance|0|||
143163252|NCT05122143|516143938|FG001|Overall Study|Protocol non-compliance|0|||
143039936|NCT01597245|515689279|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
143039937|NCT01597245|515689280|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
143163253|NCT05122143|516143939|FG002|Overall Study|Protocol non-compliance|1|||
143163254|NCT05122143|516143940|FG003|Overall Study|Protocol non-compliance|0|||
143163255|NCT05122143|516143941|FG004|Overall Study|Protocol non-compliance|0|||
143163256|NCT05122143|516143942|FG005|Overall Study|Protocol non-compliance|0|||
143163257|NCT05122143|516143937|FG000|Overall Study|Covid contact|0|||
143163258|NCT05122143|516143938|FG001|Overall Study|Covid contact|0|||
143163259|NCT05122143|516143939|FG002|Overall Study|Covid contact|0|||
143163260|NCT05122143|516143940|FG003|Overall Study|Covid contact|0|||
143497535|NCT05162066|517364445|FG002|Overall Study|Adverse Event|0|||
143497536|NCT05162066|517364443|FG000|Overall Study|Perceived lack of efficacy|1|||
143163261|NCT05122143|516143941|FG004|Overall Study|Covid contact|1|||
143039938|NCT01597245|515689281|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
143039939|NCT01597245|515689282|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
143039940|NCT01597245|515689262|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
143039941|NCT01597245|515689263|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
143039942|NCT01597245|515689264|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
143039943|NCT01597245|515689265|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
143039944|NCT01597245|515689266|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
143039945|NCT01597245|515689267|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
143039946|NCT01597245|515689268|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
143039947|NCT01597245|515689269|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
143039948|NCT01597245|515689270|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
143039949|NCT01597245|515689271|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
143039950|NCT01597245|515689272|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
143039951|NCT01597245|515689273|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
143039952|NCT01597245|515689274|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
143039953|NCT01597245|515689275|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
143039954|NCT01597245|515689276|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
143039955|NCT01597245|515689277|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
143039956|NCT01597245|515689278|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
143039957|NCT01597245|515689279|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
143039958|NCT01597245|515689280|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
143039959|NCT01597245|515689281|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
143039960|NCT01597245|515689282|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
143039961|NCT01597245|515689262|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
143039962|NCT01597245|515689263|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
143039963|NCT01597245|515689264|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
143039964|NCT01597245|515689265|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
143039965|NCT01597245|515689266|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
143039966|NCT01597245|515689267|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
143039967|NCT01597245|515689268|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
143039968|NCT01597245|515689269|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
143039969|NCT01597245|515689270|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
143039970|NCT01597245|515689271|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
143039971|NCT01597245|515689272|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
143039972|NCT01597245|515689273|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
143039973|NCT01597245|515689274|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
143163262|NCT05122143|516143942|FG005|Overall Study|Covid contact|0|||
143163263|NCT00692237|516143943|FG000|Overall Study|Withdrawal by Subject|1|||
143163264|NCT00692237|516143944|FG001|Overall Study|Withdrawal by Subject|3|||
143163265|NCT00692237|516143943|FG000|Overall Study|Adverse Event|0|||
143163266|NCT00692237|516143944|FG001|Overall Study|Adverse Event|1|||
143163267|NCT00309946|516143945|FG000|Overall Study|Withdrawal by Subject|1|||
143163268|NCT02244957|516143946|FG000|Overall Study|Lack of Efficacy|1|||
143163269|NCT02244957|516143947|FG001|Overall Study|Lack of Efficacy|0|||
143163270|NCT01347086|516143950|FG000|Overall Study|failed screening visit|0|||
143163271|NCT01347086|516143951|FG001|Overall Study|failed screening visit|0|||
143163272|NCT01347086|516143952|FG002|Overall Study|failed screening visit|1|||
143163273|NCT01347086|516143953|FG003|Overall Study|failed screening visit|0|||
143163274|NCT01347086|516143954|FG004|Overall Study|failed screening visit|0|||
143163275|NCT01347086|516143955|FG005|Overall Study|failed screening visit|0|||
143163276|NCT01347086|516143956|FG006|Overall Study|failed screening visit|1|||
143163277|NCT01347086|516143957|FG007|Overall Study|failed screening visit|1|||
143163278|NCT01347086|516143958|FG008|Overall Study|failed screening visit|0|||
143163279|NCT01347086|516143959|FG009|Overall Study|failed screening visit|1|||
143163280|NCT00395447|516143960|FG000|Overall Study|Death|37|||
143163281|NCT00395447|516143961|FG001|Overall Study|Death|32|||
143163282|NCT00395447|516143960|FG000|Overall Study|Lost to Follow-up|52|||
143163283|NCT00395447|516143961|FG001|Overall Study|Lost to Follow-up|43|||
143163284|NCT00395447|516143960|FG000|Overall Study|Withdrawal by Subject|24|||
143163285|NCT00395447|516143961|FG001|Overall Study|Withdrawal by Subject|19|||
143163286|NCT00395447|516143960|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
143163287|NCT00395447|516143961|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
143163288|NCT02624687|516143962|FG000|Overall Study|Withdrawal by Subject|1|||
143163289|NCT02624687|516143963|FG001|Overall Study|Withdrawal by Subject|1|||
143163290|NCT02624687|516143962|FG000|Overall Study|medical leave from work|0|||
143163291|NCT02624687|516143963|FG001|Overall Study|medical leave from work|1|||
143163292|NCT03111108|516143964|FG000|Overall Study|Death|0|||
143163293|NCT03111108|516143965|FG001|Overall Study|Death|1|||
143163294|NCT03111108|516143964|FG000|Overall Study|Withdrawal by Subject|1|||
143163295|NCT03111108|516143965|FG001|Overall Study|Withdrawal by Subject|0|||
143163296|NCT00347269|516143966|FG000|Overall Study|Lost to Follow-up|74|||
143039974|NCT01597245|515689275|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
143039975|NCT01597245|515689276|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
143039976|NCT01597245|515689277|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
143039977|NCT01597245|515689278|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
143039978|NCT01597245|515689279|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
143039979|NCT01597245|515689280|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
143039980|NCT01597245|515689281|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
143039981|NCT01597245|515689282|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
143039982|NCT01597245|515689262|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
143039983|NCT01597245|515689263|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
143039984|NCT01597245|515689264|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
143039985|NCT01597245|515689265|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
143039986|NCT01597245|515689266|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
143039987|NCT01597245|515689267|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
143039988|NCT01597245|515689268|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
143039989|NCT01597245|515689269|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
143039990|NCT01597245|515689270|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
143039991|NCT01597245|515689271|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
143039992|NCT01597245|515689272|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
143039993|NCT01597245|515689273|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
143039994|NCT01597245|515689274|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
143039995|NCT01597245|515689275|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
143039996|NCT01597245|515689276|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
143039997|NCT01597245|515689277|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
143039998|NCT01597245|515689278|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
143039999|NCT01597245|515689279|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
143040000|NCT01597245|515689280|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
143040001|NCT01597245|515689281|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
143040002|NCT01597245|515689282|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
143040003|NCT01597245|515689262|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
143040004|NCT01597245|515689263|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
143040005|NCT01597245|515689264|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
143040006|NCT01597245|515689265|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
143040007|NCT01597245|515689266|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
143040008|NCT01597245|515689267|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
143040009|NCT01597245|515689268|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
143040010|NCT01597245|515689269|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
143040011|NCT01597245|515689270|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
143040012|NCT01597245|515689271|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
143040013|NCT01597245|515689272|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
143040014|NCT01597245|515689273|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
143040015|NCT01597245|515689274|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
143040016|NCT01597245|515689275|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
143040017|NCT01597245|515689276|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
143040018|NCT01597245|515689277|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
143040019|NCT01597245|515689278|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
143040020|NCT01597245|515689279|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
143040021|NCT01597245|515689280|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
143040022|NCT01597245|515689281|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
143040023|NCT01597245|515689282|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
143040024|NCT01597245|515689262|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
143040025|NCT01597245|515689263|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
143040026|NCT01597245|515689264|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
143040027|NCT01597245|515689265|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
143040028|NCT01597245|515689266|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
143040029|NCT01597245|515689267|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
143040030|NCT01597245|515689268|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
143040031|NCT01597245|515689269|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
143040032|NCT01597245|515689270|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
143040033|NCT01597245|515689271|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
143040034|NCT01597245|515689272|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
143040035|NCT01597245|515689273|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
143040036|NCT01597245|515689274|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
143163297|NCT00347269|516143967|FG001|Overall Study|Lost to Follow-up|65|||
143163298|NCT00347269|516143966|FG000|Overall Study|Withdrawal by Subject|18|||
143163299|NCT00347269|516143967|FG001|Overall Study|Withdrawal by Subject|38|||
143040037|NCT01597245|515689275|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
143040038|NCT01597245|515689276|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
143040039|NCT01597245|515689277|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
143040040|NCT01597245|515689278|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
143040041|NCT01597245|515689279|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
143040042|NCT01597245|515689280|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
143040043|NCT01597245|515689281|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
143040044|NCT01597245|515689282|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
143040045|NCT01597245|515689262|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
143040046|NCT01597245|515689263|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
143040047|NCT01597245|515689264|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
143040048|NCT01597245|515689265|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
143040049|NCT01597245|515689266|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
143040050|NCT01597245|515689267|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
143040051|NCT01597245|515689268|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
143040052|NCT01597245|515689269|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
143040053|NCT01597245|515689270|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
143040054|NCT01597245|515689271|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
143040055|NCT01597245|515689272|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
143040056|NCT01597245|515689273|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
143040057|NCT01597245|515689274|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
143040058|NCT01597245|515689275|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
143040059|NCT01597245|515689276|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
143040060|NCT01597245|515689277|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
143040061|NCT01597245|515689278|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
143040062|NCT01597245|515689279|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
143040063|NCT01597245|515689280|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
143040064|NCT01597245|515689281|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
143497537|NCT05162066|517364444|FG001|Overall Study|Perceived lack of efficacy|0|||
143040065|NCT01597245|515689282|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
143040066|NCT01597245|515689262|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
143040067|NCT01597245|515689263|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
143040068|NCT01597245|515689264|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
143040069|NCT01597245|515689265|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
143040070|NCT01597245|515689266|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
143040071|NCT01597245|515689267|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
143163300|NCT00347269|516143966|FG000|Overall Study|Death|2|||
143163301|NCT00347269|516143967|FG001|Overall Study|Death|3|||
143163302|NCT01853280|516143968|FG000|Overall Study|Lack of Efficacy|2|||
143163303|NCT01853280|516143969|FG001|Overall Study|Lack of Efficacy|2|||
143163304|NCT01853280|516143968|FG000|Overall Study|Lost to Follow-up|0|||
143163305|NCT01853280|516143969|FG001|Overall Study|Lost to Follow-up|1|||
143163306|NCT01853280|516143968|FG000|Overall Study|Physician Decision|0|||
143163307|NCT01853280|516143969|FG001|Overall Study|Physician Decision|1|||
143163308|NCT01853280|516143968|FG000|Overall Study|Withdrawal by Subject|0|||
143163309|NCT01853280|516143969|FG001|Overall Study|Withdrawal by Subject|1|||
143163310|NCT01853280|516143968|FG000|Overall Study|Ineligible|0|||
143163311|NCT01853280|516143969|FG001|Overall Study|Ineligible|1|||
143163312|NCT00104884|516143970|FG000|Overall Study|Disease progression|4|||
143163313|NCT03032484|516143971|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
143163314|NCT03032484|516143972|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
143497538|NCT05162066|517364445|FG002|Overall Study|Perceived lack of efficacy|0|||
143040072|NCT01597245|515689268|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
143040073|NCT01597245|515689269|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
143040074|NCT01597245|515689270|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
143040075|NCT01597245|515689271|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
143040076|NCT01597245|515689272|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
143040077|NCT01597245|515689273|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
143040078|NCT01597245|515689274|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
143040079|NCT01597245|515689275|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
143040080|NCT01597245|515689276|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
143040081|NCT01597245|515689277|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
143040082|NCT01597245|515689278|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
143497539|NCT01171820|517364446|FG000|Overall Study|Death|3|||
143497540|NCT01171820|517364447|FG001|Overall Study|Death|3|||
143040083|NCT01597245|515689279|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
143163315|NCT03032484|516143971|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
143163316|NCT03032484|516143972|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
143497541|NCT01171820|517364446|FG000|Overall Study|Lost to Follow-up|0|||
143239504|NCT02760498|516429891|FG005|Overall Study|Participant decision|6|||
143239505|NCT02760498|516429886|FG000|Overall Study|Sponsor decision|0|||
143239506|NCT02760498|516429887|FG001|Overall Study|Sponsor decision|0|||
143239507|NCT02760498|516429888|FG002|Overall Study|Sponsor decision|0|||
143239508|NCT02760498|516429889|FG003|Overall Study|Sponsor decision|3|||
143239509|NCT02760498|516429890|FG004|Overall Study|Sponsor decision|0|||
143239510|NCT02760498|516429891|FG005|Overall Study|Sponsor decision|0|||
143239511|NCT02760498|516429886|FG000|Overall Study|Physician Decision|3|||
143239512|NCT02760498|516429887|FG001|Overall Study|Physician Decision|4|||
143239513|NCT02760498|516429888|FG002|Overall Study|Physician Decision|1|||
143239514|NCT02760498|516429889|FG003|Overall Study|Physician Decision|4|||
143239515|NCT02760498|516429890|FG004|Overall Study|Physician Decision|0|||
143239516|NCT02760498|516429891|FG005|Overall Study|Physician Decision|2|||
143239517|NCT02760498|516429886|FG000|Overall Study|Disease progression|21|||
143239518|NCT02760498|516429887|FG001|Overall Study|Disease progression|19|||
143239519|NCT02760498|516429888|FG002|Overall Study|Disease progression|20|||
143239520|NCT02760498|516429889|FG003|Overall Study|Disease progression|18|||
143239521|NCT02760498|516429890|FG004|Overall Study|Disease progression|4|||
143239522|NCT02760498|516429891|FG005|Overall Study|Disease progression|55|||
143239523|NCT02760498|516429886|FG000|Overall Study|Withdrawal by Subject|4|||
143239524|NCT02760498|516429887|FG001|Overall Study|Withdrawal by Subject|7|||
143239525|NCT02760498|516429888|FG002|Overall Study|Withdrawal by Subject|5|||
143239526|NCT02760498|516429889|FG003|Overall Study|Withdrawal by Subject|1|||
143239527|NCT02760498|516429890|FG004|Overall Study|Withdrawal by Subject|0|||
143239528|NCT02760498|516429891|FG005|Overall Study|Withdrawal by Subject|6|||
143239529|NCT02760498|516429886|FG000|Overall Study|Other than specified|1|||
143239530|NCT02760498|516429887|FG001|Overall Study|Other than specified|6|||
143239531|NCT02760498|516429888|FG002|Overall Study|Other than specified|0|||
143239532|NCT02760498|516429889|FG003|Overall Study|Other than specified|3|||
143239533|NCT02760498|516429890|FG004|Overall Study|Other than specified|1|||
143239534|NCT02760498|516429891|FG005|Overall Study|Other than specified|0|||
143239535|NCT02760498|516429886|FG000|Overall Study|Not treated|0|||
143239536|NCT02760498|516429887|FG001|Overall Study|Not treated|0|||
143239537|NCT02760498|516429888|FG002|Overall Study|Not treated|0|||
143239538|NCT02760498|516429889|FG003|Overall Study|Not treated|0|||
143239539|NCT02760498|516429890|FG004|Overall Study|Not treated|0|||
143239540|NCT02760498|516429891|FG005|Overall Study|Not treated|2|||
143239541|NCT00771758|516429892|FG000|Overall Study|Adverse Event|2|||
143239542|NCT00771758|516429893|FG001|Overall Study|Adverse Event|8|||
143239543|NCT00771758|516429894|FG002|Overall Study|Adverse Event|1|||
143239544|NCT00771758|516429892|FG000|Overall Study|Lack of Efficacy|0|||
143239545|NCT00771758|516429893|FG001|Overall Study|Lack of Efficacy|2|||
143239546|NCT00771758|516429894|FG002|Overall Study|Lack of Efficacy|1|||
143239547|NCT00771758|516429892|FG000|Overall Study|Lost to Follow-up|1|||
143239548|NCT00771758|516429893|FG001|Overall Study|Lost to Follow-up|0|||
143239549|NCT00771758|516429894|FG002|Overall Study|Lost to Follow-up|0|||
143239550|NCT00771758|516429892|FG000|Overall Study|Protocol Violation|1|||
143239551|NCT00771758|516429893|FG001|Overall Study|Protocol Violation|0|||
143239552|NCT00771758|516429894|FG002|Overall Study|Protocol Violation|0|||
143239553|NCT00771758|516429892|FG000|Overall Study|Withdrawal by Subject|1|||
143239554|NCT00771758|516429893|FG001|Overall Study|Withdrawal by Subject|0|||
143239555|NCT00771758|516429894|FG002|Overall Study|Withdrawal by Subject|0|||
143239556|NCT00771758|516429892|FG000|Overall Study|Other|3|||
143239557|NCT00771758|516429893|FG001|Overall Study|Other|2|||
143239558|NCT00771758|516429894|FG002|Overall Study|Other|0|||
143239559|NCT00935584|516429897|FG000|Overall Study|Withdrawal by Subject|9|||
143239560|NCT00935584|516429898|FG001|Overall Study|Withdrawal by Subject|0|||
143239561|NCT00935584|516429897|FG000|Overall Study|Death|3|||
143239562|NCT00935584|516429898|FG001|Overall Study|Death|0|||
143239563|NCT00935584|516429897|FG000|Overall Study|Lost to Follow-up|8|||
143239564|NCT00935584|516429898|FG001|Overall Study|Lost to Follow-up|0|||
143239565|NCT00935584|516429897|FG000|Overall Study|No show|9|||
143239566|NCT00935584|516429898|FG001|Overall Study|No show|0|||
143239567|NCT00935584|516429897|FG000|Overall Study|Relocated|3|||
143239568|NCT00935584|516429898|FG001|Overall Study|Relocated|0|||
143239569|NCT00935584|516429897|FG000|Overall Study|Patient changed provider|3|||
143239570|NCT00935584|516429898|FG001|Overall Study|Patient changed provider|0|||
143040084|NCT01597245|515689280|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
143239571|NCT00935584|516429897|FG000|Overall Study|Provider dropped out of study|14|||
143239572|NCT00935584|516429898|FG001|Overall Study|Provider dropped out of study|4|||
143239573|NCT00687193|516429900|FG000|Overall Study|Adverse Event|0|||
143239574|NCT00687193|516429901|FG001|Overall Study|Adverse Event|1|||
143239575|NCT00687193|516429902|FG002|Overall Study|Adverse Event|2|||
143239576|NCT00687193|516429903|FG003|Overall Study|Adverse Event|3|||
143239577|NCT00687193|516429904|FG004|Overall Study|Adverse Event|0|||
143239578|NCT00687193|516429905|FG005|Overall Study|Adverse Event|2|||
143239579|NCT00687193|516429900|FG000|Overall Study|Lack of Efficacy|1|||
143239580|NCT00687193|516429901|FG001|Overall Study|Lack of Efficacy|1|||
143239581|NCT00687193|516429902|FG002|Overall Study|Lack of Efficacy|0|||
143239582|NCT00687193|516429903|FG003|Overall Study|Lack of Efficacy|0|||
143040085|NCT01597245|515689281|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
143239583|NCT00687193|516429904|FG004|Overall Study|Lack of Efficacy|0|||
143239584|NCT00687193|516429905|FG005|Overall Study|Lack of Efficacy|2|||
143239585|NCT00687193|516429900|FG000|Overall Study|Protocol Violation|1|||
143239586|NCT00687193|516429901|FG001|Overall Study|Protocol Violation|2|||
143239587|NCT00687193|516429902|FG002|Overall Study|Protocol Violation|0|||
143239588|NCT00687193|516429903|FG003|Overall Study|Protocol Violation|1|||
143239589|NCT00687193|516429904|FG004|Overall Study|Protocol Violation|2|||
143239590|NCT00687193|516429905|FG005|Overall Study|Protocol Violation|0|||
143239591|NCT01394016|516429906|FG000|Overall Study|Progressive Disease|2|||
143239592|NCT01394016|516429907|FG001|Overall Study|Progressive Disease|0|||
143239593|NCT01394016|516429908|FG002|Overall Study|Progressive Disease|0|||
143239594|NCT01394016|516429909|FG003|Overall Study|Progressive Disease|0|||
143239595|NCT01394016|516429910|FG004|Overall Study|Progressive Disease|0|||
143040086|NCT01597245|515689282|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
143040087|NCT01597245|515689262|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
143040088|NCT01597245|515689263|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
143040089|NCT01597245|515689264|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
143040090|NCT01597245|515689265|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
143040091|NCT01597245|515689266|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
143040092|NCT01597245|515689267|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
143040093|NCT01597245|515689268|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
143040094|NCT01597245|515689269|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
143040095|NCT01597245|515689270|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
143040096|NCT01597245|515689271|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
143040097|NCT01597245|515689272|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
143040098|NCT01597245|515689273|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
143040099|NCT01597245|515689274|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
143040100|NCT01597245|515689275|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
143040101|NCT01597245|515689276|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
143040102|NCT01597245|515689277|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
143040103|NCT01597245|515689278|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
143040104|NCT01597245|515689279|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
143040105|NCT01597245|515689280|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
143040106|NCT01597245|515689281|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
143040107|NCT01597245|515689282|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
143040108|NCT01597245|515689262|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
143040109|NCT01597245|515689263|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
143040110|NCT01597245|515689264|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
143040111|NCT01597245|515689265|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
143040112|NCT01597245|515689266|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
143040113|NCT01597245|515689267|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
143040114|NCT01597245|515689268|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
143040115|NCT01597245|515689269|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
143040116|NCT01597245|515689270|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
143040117|NCT01597245|515689271|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
143040118|NCT01597245|515689272|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
143040119|NCT01597245|515689273|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
143040120|NCT01597245|515689274|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
143040121|NCT01597245|515689275|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
143040122|NCT01597245|515689276|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
143040123|NCT01597245|515689277|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
143040124|NCT01597245|515689278|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
143040125|NCT01597245|515689279|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
143040126|NCT01597245|515689280|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
143040127|NCT01597245|515689281|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
143040128|NCT01597245|515689282|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
143040129|NCT01597245|515689262|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
143040130|NCT01597245|515689263|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
143040131|NCT01597245|515689264|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
143239596|NCT01394016|516429911|FG005|Overall Study|Progressive Disease|0|||
143364169|NCT01582243|516875574|FG000|Overall Study|Withdrawal by Subject|1|||
143364170|NCT01582243|516875574|FG000|Overall Study|Adverse Event|1|||
143040132|NCT01597245|515689265|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
143239597|NCT01394016|516429912|FG006|Overall Study|Progressive Disease|0|||
143239598|NCT01394016|516429913|FG007|Overall Study|Progressive Disease|0|||
143239599|NCT01394016|516429914|FG008|Overall Study|Progressive Disease|0|||
143239600|NCT01394016|516429915|FG009|Overall Study|Progressive Disease|0|||
143239601|NCT01394016|516429916|FG010|Overall Study|Progressive Disease|0|||
143040133|NCT01597245|515689266|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
143040134|NCT01597245|515689267|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
143040135|NCT01597245|515689268|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
143040136|NCT01597245|515689269|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
143040137|NCT01597245|515689270|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
143040138|NCT01597245|515689271|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
143040139|NCT01597245|515689272|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
143040140|NCT01597245|515689273|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
143040141|NCT01597245|515689274|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
143040142|NCT01597245|515689275|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
143040143|NCT01597245|515689276|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
143040144|NCT01597245|515689277|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
143040145|NCT01597245|515689278|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
143040146|NCT01597245|515689279|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
143040147|NCT01597245|515689280|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
143040148|NCT01597245|515689281|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
143040149|NCT01597245|515689282|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
143040150|NCT01597245|515689262|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
143040151|NCT01597245|515689263|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
143040152|NCT01597245|515689264|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
143040153|NCT01597245|515689265|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
143040154|NCT01597245|515689266|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
143040155|NCT01597245|515689267|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
143040156|NCT01597245|515689268|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
143040157|NCT01597245|515689269|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
143040158|NCT01597245|515689270|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
143040159|NCT01597245|515689271|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
143040160|NCT01597245|515689272|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
143040161|NCT01597245|515689273|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
143040162|NCT01597245|515689274|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
143040163|NCT01597245|515689275|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
143040164|NCT01597245|515689276|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
143040165|NCT01597245|515689277|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
143163317|NCT03654326|516143973|FG000|Overall Study|Withdrawal by Subject|5|||
143163318|NCT03654326|516143974|FG001|Overall Study|Withdrawal by Subject|3|||
143163319|NCT03654326|516143973|FG000|Overall Study|Physician Decision|0|||
143163320|NCT03654326|516143974|FG001|Overall Study|Physician Decision|1|||
143163321|NCT03654326|516143973|FG000|Overall Study|Unable to adhere to study schedule|0|||
143163322|NCT03654326|516143974|FG001|Overall Study|Unable to adhere to study schedule|1|||
143040166|NCT01597245|515689278|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
143040167|NCT01597245|515689279|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
143040168|NCT01597245|515689280|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
143163323|NCT03654326|516143973|FG000|Overall Study|Lost to Follow-up|1|||
143163324|NCT03654326|516143974|FG001|Overall Study|Lost to Follow-up|1|||
143163325|NCT01689649|516143977|FG000|Overall Study|Lack of Efficacy|3|||
143163326|NCT01689649|516143977|FG000|Overall Study|Non-compliance|11|||
143163327|NCT01689649|516143977|FG000|Overall Study|Protocol Violation|3|||
143163328|NCT01689649|516143977|FG000|Overall Study|Lost to Follow-up|5|||
143163329|NCT00835549|516143978|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
143163330|NCT00835549|516143979|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
143163331|NCT04893811|516143980|FG000|Vaccination Phase|Death|1|||
143163332|NCT04893811|516143981|FG001|Vaccination Phase|Death|0|||
143163333|NCT04893811|516143980|FG000|Vaccination Phase|Lost to Follow-up|1|||
143163334|NCT04893811|516143981|FG001|Vaccination Phase|Lost to Follow-up|1|||
143163335|NCT04893811|516143980|FG000|Vaccination Phase|Protocol Violation|2|||
143163336|NCT04893811|516143981|FG001|Vaccination Phase|Protocol Violation|0|||
143364171|NCT01582243|516875574|FG000|Overall Study|Lost to Follow-up|1|||
143040169|NCT01597245|515689281|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
143040170|NCT01597245|515689282|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
143040171|NCT01597245|515689262|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
143040172|NCT01597245|515689263|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
143040173|NCT01597245|515689264|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
143163337|NCT04893811|516143980|FG000|Vaccination Phase|Withdrawal by Subject|2|||
143163338|NCT04893811|516143981|FG001|Vaccination Phase|Withdrawal by Subject|1|||
143163339|NCT04893811|516143980|FG000|Vaccination Phase|Other|0|||
143163340|NCT04893811|516143981|FG001|Vaccination Phase|Other|1|||
143239602|NCT01394016|516429917|FG011|Overall Study|Progressive Disease|0|||
143497542|NCT01171820|517364447|FG001|Overall Study|Lost to Follow-up|1|||
143040174|NCT01597245|515689265|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
143040175|NCT01597245|515689266|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
143040176|NCT01597245|515689267|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
143040177|NCT01597245|515689268|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
143040178|NCT01597245|515689269|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
143040179|NCT01597245|515689270|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
143040180|NCT01597245|515689271|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
143040181|NCT01597245|515689272|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
143040182|NCT01597245|515689273|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
143040183|NCT01597245|515689274|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
143040184|NCT01597245|515689275|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
143040185|NCT01597245|515689276|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
143040186|NCT01597245|515689277|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
143040187|NCT01597245|515689278|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
143040188|NCT01597245|515689279|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
143040189|NCT01597245|515689280|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
143040190|NCT01597245|515689281|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
143040191|NCT01597245|515689282|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
143040192|NCT01597245|515689262|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
143040193|NCT01597245|515689263|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
143040194|NCT01597245|515689264|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
143040195|NCT01597245|515689265|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
143497543|NCT01171820|517364446|FG000|Overall Study|Withdrawal by Subject|2|||
143497544|NCT01171820|517364447|FG001|Overall Study|Withdrawal by Subject|0|||
143497545|NCT01171820|517364446|FG000|Overall Study|Physician Decision|0|||
143497546|NCT01171820|517364447|FG001|Overall Study|Physician Decision|1|||
143497547|NCT01171820|517364446|FG000|Overall Study|1-Year Missed Visit|1|||
143497548|NCT01171820|517364447|FG001|Overall Study|1-Year Missed Visit|1|||
143497549|NCT03969875|517364448|FG000|Overall Study|did not receive allocated intervention|3|||
143040196|NCT01597245|515689266|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
143040197|NCT01597245|515689267|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
143163341|NCT04893811|516143980|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
143163342|NCT04893811|516143981|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
143163343|NCT04893811|516143980|FG000|Follow-up Phase|Lost to Follow-up|0|||
143163344|NCT04893811|516143981|FG001|Follow-up Phase|Lost to Follow-up|1|||
143163345|NCT00835042|516143982|FG000|First Intervention|Withdrawal by Subject|3|||
143163346|NCT00835042|516143983|FG001|First Intervention|Withdrawal by Subject|0|||
143163347|NCT00835042|516143982|FG000|First Intervention|Adverse Event|1|||
143163348|NCT00835042|516143983|FG001|First Intervention|Adverse Event|2|||
143163349|NCT00835042|516143982|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
143163350|NCT00835042|516143983|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
143163351|NCT02662582|516143997|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
143163352|NCT02662582|516143998|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
143163353|NCT02662582|516143997|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
143163354|NCT02662582|516143998|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
143163355|NCT02662582|516143997|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
143163356|NCT02662582|516143998|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
143163357|NCT02662582|516143997|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
143163358|NCT02662582|516143998|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
143163359|NCT04064567|516143999|FG000|Overall Study|Lost to Follow-up|23|||
143163360|NCT04064567|516144000|FG001|Overall Study|Lost to Follow-up|22|||
143163361|NCT04064567|516143999|FG000|Overall Study|Withdrawal by Subject|0|||
143163362|NCT04064567|516144000|FG001|Overall Study|Withdrawal by Subject|1|||
143163363|NCT04064567|516143999|FG000|Overall Study|Reincarcerated|7|||
143163364|NCT04064567|516144000|FG001|Overall Study|Reincarcerated|10|||
143163365|NCT04064567|516143999|FG000|Overall Study|Moved out of U.S.|0|||
143163366|NCT04064567|516144000|FG001|Overall Study|Moved out of U.S.|1|||
143163367|NCT02758626|516144004|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
143163368|NCT02758626|516144005|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
143163369|NCT02758626|516144004|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
143163370|NCT02758626|516144005|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
143239603|NCT01394016|516429918|FG012|Overall Study|Progressive Disease|0|||
143239604|NCT01394016|516429919|FG013|Overall Study|Progressive Disease|0|||
143239605|NCT01394016|516429920|FG014|Overall Study|Progressive Disease|0|||
143163371|NCT02758626|516144004|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
143163372|NCT02758626|516144005|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
143239606|NCT01394016|516429921|FG015|Overall Study|Progressive Disease|0|||
143497550|NCT03969875|517364449|FG001|Overall Study|did not receive allocated intervention|3|||
143497551|NCT03969875|517364450|FG002|Overall Study|did not receive allocated intervention|4|||
143497552|NCT03969875|517364448|FG000|Overall Study|Protocol Violation|4|||
143497553|NCT03969875|517364449|FG001|Overall Study|Protocol Violation|2|||
143497554|NCT03969875|517364450|FG002|Overall Study|Protocol Violation|2|||
143497555|NCT01307033|517364451|FG000|8-week Double-blind Period|Adverse Event|2|||
143497556|NCT01307033|517364452|FG001|8-week Double-blind Period|Adverse Event|0|||
143497557|NCT01307033|517364453|FG002|8-week Double-blind Period|Adverse Event|0|||
143040198|NCT01597245|515689268|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
143163373|NCT02758626|516144004|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
143163374|NCT02758626|516144005|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
143163375|NCT02739828|516144011|FG000|Overall Study|Adverse Event|1|||
143163376|NCT02739828|516144011|FG000|Overall Study|Lost to Follow-up|4|||
143163377|NCT05451329|516144013|FG000|Overall Study|Adverse Event|1|||
143163378|NCT05451329|516144014|FG001|Overall Study|Adverse Event|1|||
143163379|NCT05451329|516144015|FG002|Overall Study|Adverse Event|0|||
143163380|NCT05451329|516144013|FG000|Overall Study|Withdrawal by Subject|1|||
143163381|NCT05451329|516144014|FG001|Overall Study|Withdrawal by Subject|0|||
143163382|NCT05451329|516144015|FG002|Overall Study|Withdrawal by Subject|0|||
143163383|NCT05451329|516144013|FG000|Overall Study|Investigational Product Lot exchange|1|||
143163384|NCT05451329|516144014|FG001|Overall Study|Investigational Product Lot exchange|1|||
143163385|NCT05451329|516144015|FG002|Overall Study|Investigational Product Lot exchange|0|||
143163386|NCT02176525|516144018|FG000|Overall Study|Adverse Event|0|||
143163387|NCT02176525|516144019|FG001|Overall Study|Adverse Event|0|||
143163388|NCT02176525|516144020|FG002|Overall Study|Adverse Event|0|||
143163389|NCT02176525|516144021|FG003|Overall Study|Adverse Event|1|||
143163390|NCT02176525|516144022|FG004|Overall Study|Adverse Event|1|||
143163391|NCT02176525|516144023|FG005|Overall Study|Adverse Event|0|||
143163392|NCT02176525|516144024|FG006|Overall Study|Adverse Event|1|||
143163393|NCT02176525|516144025|FG007|Overall Study|Adverse Event|0|||
143163394|NCT02176525|516144018|FG000|Overall Study|not treated|1|||
143163395|NCT02176525|516144019|FG001|Overall Study|not treated|0|||
143163396|NCT02176525|516144020|FG002|Overall Study|not treated|0|||
143163397|NCT02176525|516144021|FG003|Overall Study|not treated|0|||
143163398|NCT02176525|516144022|FG004|Overall Study|not treated|0|||
143163399|NCT02176525|516144023|FG005|Overall Study|not treated|1|||
143163400|NCT02176525|516144024|FG006|Overall Study|not treated|0|||
143163401|NCT02176525|516144025|FG007|Overall Study|not treated|0|||
143163402|NCT02852005|516144026|FG000|Overall Study|Lost to Follow-up|0|||
143163403|NCT02852005|516144027|FG001|Overall Study|Lost to Follow-up|0|||
143163404|NCT02852005|516144028|FG002|Overall Study|Lost to Follow-up|0|||
143163405|NCT02852005|516144029|FG003|Overall Study|Lost to Follow-up|0|||
143163406|NCT02852005|516144030|FG004|Overall Study|Lost to Follow-up|1|||
143163407|NCT02852005|516144026|FG000|Overall Study|Withdrawal by Subject|1|||
143163408|NCT02852005|516144027|FG001|Overall Study|Withdrawal by Subject|0|||
143163409|NCT02852005|516144028|FG002|Overall Study|Withdrawal by Subject|0|||
143163410|NCT02852005|516144029|FG003|Overall Study|Withdrawal by Subject|0|||
143163411|NCT02852005|516144030|FG004|Overall Study|Withdrawal by Subject|0|||
143163412|NCT04629521|516144031|FG000|Overall Study|Death|1|||
143163413|NCT04629521|516144031|FG000|Overall Study|Lost to Follow-up|3|||
143163414|NCT04629521|516144031|FG000|Overall Study|Subject withdrew consent|3|||
143163415|NCT04629521|516144031|FG000|Overall Study|Enrolled in error|1|||
143163416|NCT01898091|516144035|FG000|Overall Study|Lost to Follow-up|1|||
143163417|NCT01898091|516144036|FG001|Overall Study|Lost to Follow-up|1|||
143163418|NCT01898091|516144035|FG000|Overall Study|Withdrawal by Subject|1|||
143163419|NCT01898091|516144036|FG001|Overall Study|Withdrawal by Subject|5|||
143163420|NCT02369159|516144039|FG000|Overall Study|Adverse Event|0|||
143163421|NCT02369159|516144040|FG001|Overall Study|Adverse Event|1|||
143163422|NCT02369159|516144039|FG000|Overall Study|Lost to Follow-up|1|||
143163423|NCT02369159|516144040|FG001|Overall Study|Lost to Follow-up|1|||
143163424|NCT02369159|516144039|FG000|Overall Study|Withdrawal by Subject|7|||
143163425|NCT02369159|516144040|FG001|Overall Study|Withdrawal by Subject|0|||
143163426|NCT01514422|516144043|FG000|Overall Study|Lost to Follow-up|1|||
143163427|NCT03382873|516144044|FG000|Overall Study|Lost to Follow-up|9|||
143163428|NCT03382873|516144045|FG001|Overall Study|Lost to Follow-up|10|||
143163429|NCT03382873|516144044|FG000|Overall Study|Withdrawal by Subject|6|||
143163430|NCT03382873|516144045|FG001|Overall Study|Withdrawal by Subject|11|||
143163431|NCT03382873|516144044|FG000|Overall Study|Visit not completed due to pandemic|16|||
143163432|NCT03382873|516144045|FG001|Overall Study|Visit not completed due to pandemic|41|||
143239607|NCT01394016|516429922|FG016|Overall Study|Progressive Disease|0|||
143239608|NCT01394016|516429923|FG017|Overall Study|Progressive Disease|0|||
143497558|NCT01307033|517364454|FG003|8-week Double-blind Period|Adverse Event|0|||
143497559|NCT01307033|517364451|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
143497560|NCT01307033|517364452|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
143163433|NCT02757963|516144055|FG000|Overall Study|Adverse Event|3|||
143163434|NCT02757963|516144055|FG000|Overall Study|Reached Stopping Criteria|1054|||
143163435|NCT02757963|516144055|FG000|Overall Study|Lost to Follow-up|5|||
143163436|NCT02757963|516144055|FG000|Overall Study|Physician Decision|1|||
143163437|NCT02757963|516144055|FG000|Overall Study|Withdrawal by Subject|34|||
143163438|NCT00911157|516144056|FG000|Overall Study|Adverse Event|4|||
143497561|NCT01307033|517364453|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
143497562|NCT01307033|517364454|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
143497563|NCT01307033|517364451|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
143497564|NCT01307033|517364452|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
143497565|NCT01307033|517364453|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
143163439|NCT00911157|516144057|FG001|Overall Study|Adverse Event|1|||
143163440|NCT00911157|516144056|FG000|Overall Study|Withdrawal by Subject|1|||
143163441|NCT00911157|516144057|FG001|Overall Study|Withdrawal by Subject|1|||
143163442|NCT00911157|516144056|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
143163443|NCT00911157|516144057|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
143163444|NCT00911157|516144056|FG000|Overall Study|Need to treat for lung cancer|1|||
143163445|NCT00911157|516144057|FG001|Overall Study|Need to treat for lung cancer|0|||
143163446|NCT03769467|516144058|FG000|Overall Study|Adverse Event|1|||
143163447|NCT03769467|516144059|FG001|Overall Study|Adverse Event|1|||
143163448|NCT03769467|516144060|FG002|Overall Study|Adverse Event|0|||
143163449|NCT03769467|516144058|FG000|Overall Study|Death|3|||
143163450|NCT03769467|516144059|FG001|Overall Study|Death|3|||
143163451|NCT03769467|516144060|FG002|Overall Study|Death|0|||
143163452|NCT03769467|516144058|FG000|Overall Study|Study Terminated By Sponsor|2|||
143163453|NCT03769467|516144059|FG001|Overall Study|Study Terminated By Sponsor|1|||
143163454|NCT03769467|516144060|FG002|Overall Study|Study Terminated By Sponsor|0|||
143163455|NCT03769467|516144058|FG000|Overall Study|Withdrawal by Subject|0|||
143163456|NCT03769467|516144059|FG001|Overall Study|Withdrawal by Subject|1|||
143163457|NCT03769467|516144060|FG002|Overall Study|Withdrawal by Subject|0|||
143163458|NCT04565756|516144061|FG000|Overall Study|Withdrawal by Subject|0|||
143163459|NCT04565756|516144062|FG001|Overall Study|Withdrawal by Subject|0|||
143163460|NCT04565756|516144063|FG002|Overall Study|Withdrawal by Subject|0|||
143163461|NCT04565756|516144064|FG003|Overall Study|Withdrawal by Subject|0|||
143163462|NCT04565756|516144065|FG004|Overall Study|Withdrawal by Subject|1|||
143163463|NCT04565756|516144066|FG005|Overall Study|Withdrawal by Subject|0|||
143163464|NCT04565756|516144061|FG000|Overall Study|Protocol Violation|0|||
143163465|NCT04565756|516144062|FG001|Overall Study|Protocol Violation|0|||
143163466|NCT04565756|516144063|FG002|Overall Study|Protocol Violation|0|||
143163467|NCT04565756|516144064|FG003|Overall Study|Protocol Violation|0|||
143163468|NCT04565756|516144065|FG004|Overall Study|Protocol Violation|0|||
143163469|NCT04565756|516144066|FG005|Overall Study|Protocol Violation|1|||
143163470|NCT00420056|516144067|FG000|Overall Study|Objective progression or relapse|17|||
143163471|NCT01390584|516144072|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
143163472|NCT01390584|516144073|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
143163473|NCT01390584|516144074|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
143163474|NCT00025233|516144075|FG000|Overall Study|Ineligible: wrong cell type|1|||
143163475|NCT00025233|516144075|FG000|Overall Study|Ineligible: wrong primary|1|||
143163476|NCT00025233|516144075|FG000|Overall Study|Ineligible: improper prior treatment|1|||
143163477|NCT00025233|516144075|FG000|Overall Study|Never treated|1|||
143163478|NCT01316900|516144076|FG000|Overall Study|Adverse Event|10|||
143163479|NCT01316900|516144077|FG001|Overall Study|Adverse Event|10|||
143163480|NCT01316900|516144078|FG002|Overall Study|Adverse Event|15|||
143163481|NCT01316900|516144079|FG003|Overall Study|Adverse Event|9|||
143163482|NCT01316900|516144076|FG000|Overall Study|Lack of Efficacy|17|||
143163483|NCT01316900|516144077|FG001|Overall Study|Lack of Efficacy|9|||
143163484|NCT01316900|516144078|FG002|Overall Study|Lack of Efficacy|5|||
143163485|NCT01316900|516144079|FG003|Overall Study|Lack of Efficacy|7|||
143163486|NCT01316900|516144076|FG000|Overall Study|Protocol Violation|7|||
143163487|NCT01316900|516144077|FG001|Overall Study|Protocol Violation|1|||
143163488|NCT01316900|516144078|FG002|Overall Study|Protocol Violation|4|||
143163489|NCT01316900|516144079|FG003|Overall Study|Protocol Violation|0|||
143163490|NCT01316900|516144076|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
143163491|NCT01316900|516144077|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
143163492|NCT01316900|516144078|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
143163493|NCT01316900|516144079|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
143163494|NCT01316900|516144076|FG000|Overall Study|Lost to Follow-up|1|||
143163495|NCT01316900|516144077|FG001|Overall Study|Lost to Follow-up|0|||
143163496|NCT01316900|516144078|FG002|Overall Study|Lost to Follow-up|1|||
143163497|NCT01316900|516144079|FG003|Overall Study|Lost to Follow-up|1|||
143497566|NCT01307033|517364454|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
143163498|NCT01316900|516144076|FG000|Overall Study|Withdrawal by Subject|7|||
143163499|NCT01316900|516144077|FG001|Overall Study|Withdrawal by Subject|8|||
143163500|NCT01316900|516144078|FG002|Overall Study|Withdrawal by Subject|6|||
143163501|NCT01316900|516144079|FG003|Overall Study|Withdrawal by Subject|9|||
143163502|NCT00562861|516144080|FG000|Overall Study|Adverse Event|1|||
143163503|NCT00562861|516144081|FG001|Overall Study|Adverse Event|1|||
143163504|NCT00562861|516144080|FG000|Overall Study|Lack of Efficacy|5|||
143163505|NCT00562861|516144081|FG001|Overall Study|Lack of Efficacy|5|||
143163506|NCT00562861|516144080|FG000|Overall Study|noncompliance, moved|7|||
143163507|NCT00562861|516144081|FG001|Overall Study|noncompliance, moved|2|||
143497567|NCT01307033|517364451|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
143163508|NCT00562861|516144080|FG000|Overall Study|Lost to Follow-up|7|||
143497568|NCT01307033|517364452|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
143497569|NCT01307033|517364453|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
143497570|NCT01307033|517364454|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
143497571|NCT01307033|517364451|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
143497572|NCT01307033|517364452|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
143040199|NCT01597245|515689269|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
143040200|NCT01597245|515689270|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
143163509|NCT00562861|516144081|FG001|Overall Study|Lost to Follow-up|3|||
143163510|NCT02916433|516144082|FG000|Overall Study|Withdrawal by Subject|1|||
143163511|NCT02916433|516144083|FG001|Overall Study|Withdrawal by Subject|0|||
143163512|NCT02916433|516144082|FG000|Overall Study|Physician Decision|1|||
143163513|NCT02916433|516144083|FG001|Overall Study|Physician Decision|0|||
143163514|NCT04349098|516144084|FG000|Overall Study|Death|16|||
143163515|NCT04349098|516144085|FG001|Overall Study|Death|8|||
143163516|NCT04349098|516144084|FG000|Overall Study|Lost to Follow-up|11|||
143163517|NCT04349098|516144085|FG001|Overall Study|Lost to Follow-up|8|||
143163518|NCT04349098|516144084|FG000|Overall Study|Withdrawal by Subject|8|||
143163519|NCT04349098|516144085|FG001|Overall Study|Withdrawal by Subject|5|||
143163520|NCT04349098|516144084|FG000|Overall Study|Other|3|||
143163521|NCT04349098|516144085|FG001|Overall Study|Other|5|||
143163522|NCT02656173|516144086|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
143163523|NCT02656173|516144087|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
143163524|NCT02656173|516144086|FG000|Overall Study|Adverse Event|7|||
143163525|NCT02656173|516144087|FG001|Overall Study|Adverse Event|5|||
143163526|NCT02656173|516144086|FG000|Overall Study|Withdrawal by Subject|1|||
143163527|NCT02656173|516144087|FG001|Overall Study|Withdrawal by Subject|3|||
143163528|NCT02656173|516144086|FG000|Overall Study|Protocol Violation|0|||
143163529|NCT02656173|516144087|FG001|Overall Study|Protocol Violation|1|||
143163530|NCT02656173|516144086|FG000|Overall Study|Miscellaneous|2|||
143163531|NCT02656173|516144087|FG001|Overall Study|Miscellaneous|0|||
143163532|NCT03927846|516144088|FG000|Overall Study|Lost to Follow-up|10|||
143163533|NCT03927846|516144089|FG001|Overall Study|Lost to Follow-up|11|||
143163534|NCT00992394|516144090|FG000|Overall Study|Lack of Efficacy|6|||
143163535|NCT00992394|516144091|FG001|Overall Study|Lack of Efficacy|3|||
143163536|NCT00992394|516144090|FG000|Overall Study|Adverse Event|4|||
143163537|NCT00992394|516144091|FG001|Overall Study|Adverse Event|5|||
143163538|NCT00992394|516144090|FG000|Overall Study|Withdrawal by Subject|8|||
143163539|NCT00992394|516144091|FG001|Overall Study|Withdrawal by Subject|2|||
143163540|NCT00992394|516144090|FG000|Overall Study|Physician Decision|1|||
143163541|NCT00992394|516144091|FG001|Overall Study|Physician Decision|0|||
143163542|NCT00992394|516144090|FG000|Overall Study|Protocol Violation|2|||
143163543|NCT00992394|516144091|FG001|Overall Study|Protocol Violation|4|||
143163544|NCT00992394|516144090|FG000|Overall Study|Lost to Follow-up|2|||
143163545|NCT00992394|516144091|FG001|Overall Study|Lost to Follow-up|0|||
143163546|NCT00992394|516144090|FG000|Overall Study|Other event|1|||
143163547|NCT00992394|516144091|FG001|Overall Study|Other event|0|||
143163548|NCT02371889|516145362|FG000|Overall Study|Adverse medication effect|11|||
143163549|NCT02371889|516145363|FG001|Overall Study|Adverse medication effect|2|||
143163550|NCT02371889|516145362|FG000|Overall Study|Lost to Follow-up|6|||
143163551|NCT02371889|516145363|FG001|Overall Study|Lost to Follow-up|5|||
143163552|NCT02371889|516145362|FG000|Overall Study|Personal time constraints|2|||
143163553|NCT02371889|516145363|FG001|Overall Study|Personal time constraints|4|||
143163554|NCT02371889|516145362|FG000|Overall Study|Lack of Efficacy|0|||
143163555|NCT02371889|516145363|FG001|Overall Study|Lack of Efficacy|2|||
143163556|NCT02371889|516145362|FG000|Overall Study|Relapse|0|||
143163557|NCT02371889|516145363|FG001|Overall Study|Relapse|1|||
143163558|NCT05520333|516145364|FG000|Overall Study|Lost to Follow-up|3|||
143163559|NCT05520333|516145365|FG001|Overall Study|Lost to Follow-up|6|||
143163560|NCT00203242|516145366|FG000|Overall Study|Lost to Follow-up|1|||
143163561|NCT05538728|516145367|FG000|Overall Study|Withdrawal by Subject|1|||
143163562|NCT05538728|516145368|FG001|Overall Study|Withdrawal by Subject|1|||
143163563|NCT01517178|516145369|FG000|Period 1|Adverse Event|1|||
143163564|NCT01517178|516145370|FG001|Period 1|Adverse Event|2|||
143163565|NCT01517178|516145369|FG000|Period 1|Lack of Efficacy|0|||
143163566|NCT01517178|516145370|FG001|Period 1|Lack of Efficacy|1|||
143163567|NCT01517178|516145369|FG000|Period 1|E.g. study termination|3|||
143163568|NCT01517178|516145370|FG001|Period 1|E.g. study termination|1|||
143163569|NCT01517178|516145369|FG000|Period 1|Withdrawal by Subject|0|||
143163570|NCT01517178|516145370|FG001|Period 1|Withdrawal by Subject|1|||
143163571|NCT01517178|516145369|FG000|Period 2|Adverse Event|1|||
143163572|NCT01517178|516145370|FG001|Period 2|Adverse Event|0|||
143163573|NCT01517178|516145369|FG000|Period 2|Withdrawal by Subject|3|||
143163574|NCT01517178|516145370|FG001|Period 2|Withdrawal by Subject|0|||
143163575|NCT01517178|516145369|FG000|Period 2|E.g. study termination|2|||
143163576|NCT01517178|516145370|FG001|Period 2|E.g. study termination|2|||
143163577|NCT01772693|516145371|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
143163578|NCT01772693|516145372|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
143163579|NCT01772693|516145371|FG000|Overall Study|Withdrawal by Subject|2|||
143239609|NCT01394016|516429924|FG018|Overall Study|Progressive Disease|0|||
143239610|NCT01394016|516429906|FG000|Overall Study|Withdrawal by Subject|0|||
143239611|NCT01394016|516429907|FG001|Overall Study|Withdrawal by Subject|0|||
143239612|NCT01394016|516429908|FG002|Overall Study|Withdrawal by Subject|0|||
143239613|NCT01394016|516429909|FG003|Overall Study|Withdrawal by Subject|0|||
143239614|NCT01394016|516429910|FG004|Overall Study|Withdrawal by Subject|0|||
143239615|NCT01394016|516429911|FG005|Overall Study|Withdrawal by Subject|0|||
143239616|NCT01394016|516429912|FG006|Overall Study|Withdrawal by Subject|0|||
143239617|NCT01394016|516429913|FG007|Overall Study|Withdrawal by Subject|1|||
143239618|NCT01394016|516429914|FG008|Overall Study|Withdrawal by Subject|1|||
143239619|NCT01394016|516429915|FG009|Overall Study|Withdrawal by Subject|1|||
143239620|NCT01394016|516429916|FG010|Overall Study|Withdrawal by Subject|4|||
143239621|NCT01394016|516429917|FG011|Overall Study|Withdrawal by Subject|0|||
143239622|NCT01394016|516429918|FG012|Overall Study|Withdrawal by Subject|0|||
143239623|NCT01394016|516429919|FG013|Overall Study|Withdrawal by Subject|3|||
143239624|NCT01394016|516429920|FG014|Overall Study|Withdrawal by Subject|1|||
143239625|NCT01394016|516429921|FG015|Overall Study|Withdrawal by Subject|3|||
143239626|NCT01394016|516429922|FG016|Overall Study|Withdrawal by Subject|1|||
143239627|NCT01394016|516429923|FG017|Overall Study|Withdrawal by Subject|1|||
143239628|NCT01394016|516429924|FG018|Overall Study|Withdrawal by Subject|2|||
143239629|NCT01394016|516429906|FG000|Overall Study|Adverse Event|0|||
143239630|NCT01394016|516429907|FG001|Overall Study|Adverse Event|0|||
143239631|NCT01394016|516429908|FG002|Overall Study|Adverse Event|0|||
143239632|NCT01394016|516429909|FG003|Overall Study|Adverse Event|0|||
143239633|NCT01394016|516429910|FG004|Overall Study|Adverse Event|0|||
143239634|NCT01394016|516429911|FG005|Overall Study|Adverse Event|0|||
143239635|NCT01394016|516429912|FG006|Overall Study|Adverse Event|0|||
143239636|NCT01394016|516429913|FG007|Overall Study|Adverse Event|0|||
143239637|NCT01394016|516429914|FG008|Overall Study|Adverse Event|0|||
143239638|NCT01394016|516429915|FG009|Overall Study|Adverse Event|1|||
143239639|NCT01394016|516429916|FG010|Overall Study|Adverse Event|0|||
143239640|NCT01394016|516429917|FG011|Overall Study|Adverse Event|0|||
143239641|NCT01394016|516429918|FG012|Overall Study|Adverse Event|0|||
143239642|NCT01394016|516429919|FG013|Overall Study|Adverse Event|0|||
143239643|NCT01394016|516429920|FG014|Overall Study|Adverse Event|0|||
143239644|NCT01394016|516429921|FG015|Overall Study|Adverse Event|0|||
143239645|NCT01394016|516429922|FG016|Overall Study|Adverse Event|1|||
143239646|NCT01394016|516429923|FG017|Overall Study|Adverse Event|1|||
143239647|NCT01394016|516429924|FG018|Overall Study|Adverse Event|0|||
143239648|NCT01394016|516429906|FG000|Overall Study|Sponsor Decision|0|||
143239649|NCT01394016|516429907|FG001|Overall Study|Sponsor Decision|0|||
143239650|NCT01394016|516429908|FG002|Overall Study|Sponsor Decision|0|||
143239651|NCT01394016|516429909|FG003|Overall Study|Sponsor Decision|0|||
143239652|NCT01394016|516429910|FG004|Overall Study|Sponsor Decision|0|||
143239653|NCT01394016|516429911|FG005|Overall Study|Sponsor Decision|0|||
143239654|NCT01394016|516429912|FG006|Overall Study|Sponsor Decision|0|||
143239655|NCT01394016|516429913|FG007|Overall Study|Sponsor Decision|0|||
143497573|NCT01307033|517364453|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
143497574|NCT01307033|517364454|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
143497575|NCT01307033|517364451|FG000|44-week Open-label Extension|Adverse Event|0|||
143497576|NCT01307033|517364452|FG001|44-week Open-label Extension|Adverse Event|0|||
143497577|NCT01307033|517364453|FG002|44-week Open-label Extension|Adverse Event|2|||
143497578|NCT01307033|517364454|FG003|44-week Open-label Extension|Adverse Event|1|||
143497579|NCT01307033|517364451|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
143497580|NCT01307033|517364452|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
143497581|NCT01307033|517364453|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
143497582|NCT01307033|517364454|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
143497583|NCT01307033|517364451|FG000|44-week Open-label Extension|Physician Decision|0|||
143497584|NCT01307033|517364452|FG001|44-week Open-label Extension|Physician Decision|0|||
143497585|NCT01307033|517364453|FG002|44-week Open-label Extension|Physician Decision|1|||
143497586|NCT01307033|517364454|FG003|44-week Open-label Extension|Physician Decision|0|||
143497587|NCT01307033|517364451|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
143239656|NCT01394016|516429914|FG008|Overall Study|Sponsor Decision|0|||
143497588|NCT01307033|517364452|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
143239657|NCT01394016|516429915|FG009|Overall Study|Sponsor Decision|0|||
143239658|NCT01394016|516429916|FG010|Overall Study|Sponsor Decision|0|||
143364172|NCT03382821|516875575|FG000|Overall Study|Did not receive allocated intervention.|0|||
143497589|NCT01307033|517364453|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
143497590|NCT01307033|517364454|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
143239659|NCT01394016|516429917|FG011|Overall Study|Sponsor Decision|0|||
143239660|NCT01394016|516429918|FG012|Overall Study|Sponsor Decision|1|||
143239661|NCT01394016|516429919|FG013|Overall Study|Sponsor Decision|0|||
143239662|NCT01394016|516429920|FG014|Overall Study|Sponsor Decision|0|||
143239663|NCT01394016|516429921|FG015|Overall Study|Sponsor Decision|0|||
143239664|NCT01394016|516429922|FG016|Overall Study|Sponsor Decision|0|||
143040201|NCT01597245|515689271|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
143239665|NCT01394016|516429923|FG017|Overall Study|Sponsor Decision|0|||
143239666|NCT01394016|516429924|FG018|Overall Study|Sponsor Decision|0|||
143239667|NCT01394016|516429906|FG000|Overall Study|Lost to Follow-up|0|||
143239668|NCT01394016|516429907|FG001|Overall Study|Lost to Follow-up|0|||
143239669|NCT01394016|516429908|FG002|Overall Study|Lost to Follow-up|0|||
143239670|NCT01394016|516429909|FG003|Overall Study|Lost to Follow-up|0|||
143239671|NCT01394016|516429910|FG004|Overall Study|Lost to Follow-up|0|||
143239672|NCT01394016|516429911|FG005|Overall Study|Lost to Follow-up|0|||
143239673|NCT01394016|516429912|FG006|Overall Study|Lost to Follow-up|0|||
143239674|NCT01394016|516429913|FG007|Overall Study|Lost to Follow-up|0|||
143239675|NCT01394016|516429914|FG008|Overall Study|Lost to Follow-up|0|||
143239676|NCT01394016|516429915|FG009|Overall Study|Lost to Follow-up|0|||
143239677|NCT01394016|516429916|FG010|Overall Study|Lost to Follow-up|0|||
143040202|NCT01597245|515689272|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
143040203|NCT01597245|515689273|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
143040204|NCT01597245|515689274|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
143040205|NCT01597245|515689275|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
143040206|NCT01597245|515689276|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
143040207|NCT01597245|515689277|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
143040208|NCT01597245|515689278|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
143040209|NCT01597245|515689279|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
143040210|NCT01597245|515689280|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
143239678|NCT01394016|516429917|FG011|Overall Study|Lost to Follow-up|0|||
143239679|NCT01394016|516429918|FG012|Overall Study|Lost to Follow-up|0|||
143239680|NCT01394016|516429919|FG013|Overall Study|Lost to Follow-up|0|||
143239681|NCT01394016|516429920|FG014|Overall Study|Lost to Follow-up|0|||
143239682|NCT01394016|516429921|FG015|Overall Study|Lost to Follow-up|0|||
143239683|NCT01394016|516429922|FG016|Overall Study|Lost to Follow-up|0|||
143239684|NCT01394016|516429923|FG017|Overall Study|Lost to Follow-up|0|||
143239685|NCT01394016|516429924|FG018|Overall Study|Lost to Follow-up|1|||
143239686|NCT03534804|516429925|FG000|Overall Study|Withdrawal by Subject|1|||
143239687|NCT00174187|516429929|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
143239688|NCT00174187|516429930|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
143239689|NCT00174187|516429931|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
143239690|NCT00174187|516429929|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
143239691|NCT00174187|516429930|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
143239692|NCT00174187|516429931|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
143239693|NCT00174187|516429929|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
143239694|NCT00174187|516429930|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
143239695|NCT00174187|516429931|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
143239696|NCT00174187|516429929|FG000|Period 1 (up to 3 Years)|Other|0|||
143239697|NCT00174187|516429930|FG001|Period 1 (up to 3 Years)|Other|1|||
143239698|NCT00174187|516429931|FG002|Period 1 (up to 3 Years)|Other|0|||
143239699|NCT00174187|516429929|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
143239700|NCT00174187|516429930|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
143239701|NCT00174187|516429931|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
143239702|NCT00174187|516429929|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
143239703|NCT00174187|516429930|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
143239704|NCT00174187|516429931|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
143239705|NCT00174187|516429929|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
143239706|NCT00174187|516429930|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
143239707|NCT00174187|516429931|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
143239708|NCT00174187|516429929|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
143239709|NCT00174187|516429930|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
143239710|NCT00174187|516429931|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
143239711|NCT00174187|516429929|FG000|Period 2 (After 3 Years)|Other|0|||
143239712|NCT00174187|516429930|FG001|Period 2 (After 3 Years)|Other|0|||
143239713|NCT00174187|516429931|FG002|Period 2 (After 3 Years)|Other|5|||
143239714|NCT01198977|516429932|FG000|Overall Study|Lost to Follow-up|1|||
143239715|NCT01198977|516429933|FG001|Overall Study|Lost to Follow-up|0|||
143239716|NCT03863080|516429934|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
143239717|NCT03863080|516429935|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
143239718|NCT03863080|516429936|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
143239719|NCT03863080|516429937|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
143239720|NCT03863080|516429934|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
143497591|NCT01307033|517364451|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
143239721|NCT03863080|516429935|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
143239722|NCT03863080|516429936|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
143239723|NCT03863080|516429937|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
143040211|NCT01597245|515689281|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
143239724|NCT03863080|516429934|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
143239725|NCT03863080|516429935|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
143239726|NCT03863080|516429936|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
143239727|NCT03863080|516429937|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
143239728|NCT01285557|516429938|FG000|Overall Study|Death|173|||
143239729|NCT01285557|516429939|FG001|Overall Study|Death|90|||
143239730|NCT01285557|516429938|FG000|Overall Study|Lost to Follow-up|6|||
143239731|NCT01285557|516429939|FG001|Overall Study|Lost to Follow-up|2|||
143239732|NCT01285557|516429938|FG000|Overall Study|Withdrew Consent|6|||
143239733|NCT01285557|516429939|FG001|Overall Study|Withdrew Consent|1|||
143239734|NCT01285557|516429938|FG000|Overall Study|Sponsor Study Termination|23|||
143239735|NCT01285557|516429939|FG001|Overall Study|Sponsor Study Termination|13|||
143239736|NCT01285557|516429938|FG000|Overall Study|Randomized but not treated|1|||
143239737|NCT01285557|516429939|FG001|Overall Study|Randomized but not treated|1|||
143239738|NCT01285557|516429938|FG000|Overall Study|Study follow-up ongoing|28|||
143239739|NCT01285557|516429939|FG001|Overall Study|Study follow-up ongoing|14|||
143239740|NCT01285557|516429938|FG000|Overall Study|Sponsor Decision|2|||
143239741|NCT01285557|516429939|FG001|Overall Study|Sponsor Decision|1|||
143239742|NCT02484391|516429950|FG000|Overall Study|Lack of Efficacy|15|||
143239743|NCT02484391|516429951|FG001|Overall Study|Lack of Efficacy|14|||
143239744|NCT02484391|516429952|FG002|Overall Study|Lack of Efficacy|3|||
143239745|NCT02484391|516429950|FG000|Overall Study|Lost to Follow-up|0|||
143239746|NCT02484391|516429951|FG001|Overall Study|Lost to Follow-up|0|||
143239747|NCT02484391|516429952|FG002|Overall Study|Lost to Follow-up|2|||
143239748|NCT02484391|516429950|FG000|Overall Study|Physician Decision|1|||
143239749|NCT02484391|516429951|FG001|Overall Study|Physician Decision|3|||
143239750|NCT02484391|516429952|FG002|Overall Study|Physician Decision|0|||
143239751|NCT02484391|516429950|FG000|Overall Study|Went to Transplant|5|||
143239752|NCT02484391|516429951|FG001|Overall Study|Went to Transplant|3|||
143239753|NCT02484391|516429952|FG002|Overall Study|Went to Transplant|2|||
143239754|NCT01646125|516431882|FG000|Overall Study|Untreated|2|||
143239755|NCT01646125|516431883|FG001|Overall Study|Untreated|5|||
143239756|NCT01646125|516431882|FG000|Overall Study|Adverse Event|2|||
143239757|NCT01646125|516431883|FG001|Overall Study|Adverse Event|1|||
143239758|NCT01646125|516431882|FG000|Overall Study|Death|1|||
143239759|NCT01646125|516431883|FG001|Overall Study|Death|1|||
143239760|NCT01646125|516431882|FG000|Overall Study|Physician Decision|1|||
143239761|NCT01646125|516431883|FG001|Overall Study|Physician Decision|3|||
143239762|NCT01646125|516431882|FG000|Overall Study|Progressive disease|22|||
143239763|NCT01646125|516431883|FG001|Overall Study|Progressive disease|16|||
143239764|NCT01646125|516431882|FG000|Overall Study|Study terminated by sponsor|2|||
143239765|NCT01646125|516431883|FG001|Overall Study|Study terminated by sponsor|1|||
143239766|NCT01646125|516431882|FG000|Overall Study|Subject/Guardian decision|1|||
143239767|NCT01646125|516431883|FG001|Overall Study|Subject/Guardian decision|1|||
143239768|NCT00918255|516431888|FG000|Overall Study|Adverse Event|1|||
143239769|NCT00918255|516431889|FG001|Overall Study|Adverse Event|0|||
143239770|NCT00918255|516431890|FG002|Overall Study|Adverse Event|0|||
143239771|NCT00918255|516431888|FG000|Overall Study|Withdrawal by Subject|1|||
143239772|NCT00918255|516431889|FG001|Overall Study|Withdrawal by Subject|0|||
143239773|NCT00918255|516431890|FG002|Overall Study|Withdrawal by Subject|2|||
143239774|NCT00918255|516431888|FG000|Overall Study|Lack of Efficacy|1|||
143239775|NCT00918255|516431889|FG001|Overall Study|Lack of Efficacy|0|||
143239776|NCT00918255|516431890|FG002|Overall Study|Lack of Efficacy|0|||
143239777|NCT00918255|516431888|FG000|Overall Study|Lost to Follow-up|1|||
143239778|NCT00918255|516431889|FG001|Overall Study|Lost to Follow-up|0|||
143040212|NCT01597245|515689282|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
143040213|NCT01597245|515689262|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
143040214|NCT01597245|515689263|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
143040215|NCT01597245|515689264|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
143040216|NCT01597245|515689265|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
143040217|NCT01597245|515689266|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
143040218|NCT01597245|515689267|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
143239779|NCT00918255|516431890|FG002|Overall Study|Lost to Follow-up|2|||
143239780|NCT00918255|516431888|FG000|Overall Study|Exceeded allowed number of interventions|0|||
143497592|NCT01307033|517364452|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
143239781|NCT00918255|516431889|FG001|Overall Study|Exceeded allowed number of interventions|0|||
143239782|NCT00918255|516431890|FG002|Overall Study|Exceeded allowed number of interventions|1|||
143239783|NCT00918255|516431888|FG000|Overall Study|Non-compliance|1|||
143239784|NCT00918255|516431889|FG001|Overall Study|Non-compliance|0|||
143239785|NCT00918255|516431890|FG002|Overall Study|Non-compliance|0|||
143239786|NCT00918255|516431888|FG000|Overall Study|Investigator discretion|1|||
143239787|NCT00918255|516431889|FG001|Overall Study|Investigator discretion|0|||
143239788|NCT00918255|516431890|FG002|Overall Study|Investigator discretion|0|||
143497593|NCT01307033|517364453|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
143239789|NCT00068692|516431892|FG000|Step 1: Registration|Disese progression/relapse|5|||
143239790|NCT00068692|516431893|FG001|Step 1: Registration|Disese progression/relapse|0|||
143239791|NCT00068692|516431894|FG002|Step 1: Registration|Disese progression/relapse|0|||
143239792|NCT00068692|516431895|FG003|Step 1: Registration|Disese progression/relapse|0|||
143239793|NCT00068692|516431896|FG004|Step 1: Registration|Disese progression/relapse|0|||
143239794|NCT00068692|516431897|FG005|Step 1: Registration|Disese progression/relapse|0|||
143239795|NCT00068692|516431898|FG006|Step 1: Registration|Disese progression/relapse|0|||
143239796|NCT00068692|516431899|FG007|Step 1: Registration|Disese progression/relapse|0|||
143239797|NCT00068692|516431892|FG000|Step 1: Registration|Adverse Event|7|||
143239798|NCT00068692|516431893|FG001|Step 1: Registration|Adverse Event|0|||
143239799|NCT00068692|516431894|FG002|Step 1: Registration|Adverse Event|0|||
143239800|NCT00068692|516431895|FG003|Step 1: Registration|Adverse Event|0|||
143239801|NCT00068692|516431896|FG004|Step 1: Registration|Adverse Event|0|||
143239802|NCT00068692|516431897|FG005|Step 1: Registration|Adverse Event|0|||
143239803|NCT00068692|516431898|FG006|Step 1: Registration|Adverse Event|0|||
143239804|NCT00068692|516431899|FG007|Step 1: Registration|Adverse Event|0|||
143239805|NCT00068692|516431892|FG000|Step 1: Registration|Death|1|||
143239806|NCT00068692|516431893|FG001|Step 1: Registration|Death|0|||
143239807|NCT00068692|516431894|FG002|Step 1: Registration|Death|0|||
143239808|NCT00068692|516431895|FG003|Step 1: Registration|Death|0|||
143239809|NCT00068692|516431896|FG004|Step 1: Registration|Death|0|||
143239810|NCT00068692|516431897|FG005|Step 1: Registration|Death|0|||
143239811|NCT00068692|516431898|FG006|Step 1: Registration|Death|0|||
143239812|NCT00068692|516431899|FG007|Step 1: Registration|Death|0|||
143239813|NCT00068692|516431892|FG000|Step 1: Registration|Withdrawal by Subject|11|||
143239814|NCT00068692|516431893|FG001|Step 1: Registration|Withdrawal by Subject|0|||
143239815|NCT00068692|516431894|FG002|Step 1: Registration|Withdrawal by Subject|0|||
143239816|NCT00068692|516431895|FG003|Step 1: Registration|Withdrawal by Subject|0|||
143239817|NCT00068692|516431896|FG004|Step 1: Registration|Withdrawal by Subject|0|||
143239818|NCT00068692|516431897|FG005|Step 1: Registration|Withdrawal by Subject|0|||
143239819|NCT00068692|516431898|FG006|Step 1: Registration|Withdrawal by Subject|0|||
143239820|NCT00068692|516431899|FG007|Step 1: Registration|Withdrawal by Subject|0|||
143239821|NCT00068692|516431892|FG000|Step 1: Registration|Alternative therapy|2|||
143239822|NCT00068692|516431893|FG001|Step 1: Registration|Alternative therapy|0|||
143239823|NCT00068692|516431894|FG002|Step 1: Registration|Alternative therapy|0|||
143239824|NCT00068692|516431895|FG003|Step 1: Registration|Alternative therapy|0|||
143239825|NCT00068692|516431896|FG004|Step 1: Registration|Alternative therapy|0|||
143239826|NCT00068692|516431897|FG005|Step 1: Registration|Alternative therapy|0|||
143239827|NCT00068692|516431898|FG006|Step 1: Registration|Alternative therapy|0|||
143239828|NCT00068692|516431899|FG007|Step 1: Registration|Alternative therapy|0|||
143239829|NCT00068692|516431892|FG000|Step 1: Registration|Complicating disease|2|||
143239830|NCT00068692|516431893|FG001|Step 1: Registration|Complicating disease|0|||
143239831|NCT00068692|516431894|FG002|Step 1: Registration|Complicating disease|0|||
143239832|NCT00068692|516431895|FG003|Step 1: Registration|Complicating disease|0|||
143239833|NCT00068692|516431896|FG004|Step 1: Registration|Complicating disease|0|||
143239834|NCT00068692|516431897|FG005|Step 1: Registration|Complicating disease|0|||
143239835|NCT00068692|516431898|FG006|Step 1: Registration|Complicating disease|0|||
143239836|NCT00068692|516431899|FG007|Step 1: Registration|Complicating disease|0|||
143239837|NCT00068692|516431892|FG000|Step 1: Registration|Protocol Violation|1|||
143239838|NCT00068692|516431893|FG001|Step 1: Registration|Protocol Violation|0|||
143239839|NCT00068692|516431894|FG002|Step 1: Registration|Protocol Violation|0|||
143239840|NCT00068692|516431895|FG003|Step 1: Registration|Protocol Violation|0|||
143239841|NCT00068692|516431896|FG004|Step 1: Registration|Protocol Violation|0|||
143239842|NCT00068692|516431897|FG005|Step 1: Registration|Protocol Violation|0|||
143239843|NCT00068692|516431898|FG006|Step 1: Registration|Protocol Violation|0|||
143239844|NCT00068692|516431899|FG007|Step 1: Registration|Protocol Violation|0|||
143239845|NCT00068692|516431892|FG000|Step 1: Registration|Not eligible|6|||
143239846|NCT00068692|516431893|FG001|Step 1: Registration|Not eligible|0|||
143239847|NCT00068692|516431894|FG002|Step 1: Registration|Not eligible|0|||
143239848|NCT00068692|516431895|FG003|Step 1: Registration|Not eligible|0|||
143239849|NCT00068692|516431896|FG004|Step 1: Registration|Not eligible|0|||
143239850|NCT00068692|516431897|FG005|Step 1: Registration|Not eligible|0|||
143239851|NCT00068692|516431898|FG006|Step 1: Registration|Not eligible|0|||
143239852|NCT00068692|516431899|FG007|Step 1: Registration|Not eligible|0|||
143239853|NCT00068692|516431892|FG000|Step 1: Registration|Other|2|||
143239854|NCT00068692|516431893|FG001|Step 1: Registration|Other|0|||
143239855|NCT00068692|516431894|FG002|Step 1: Registration|Other|0|||
143239856|NCT00068692|516431895|FG003|Step 1: Registration|Other|0|||
143239857|NCT00068692|516431896|FG004|Step 1: Registration|Other|0|||
143364173|NCT03382821|516875576|FG001|Overall Study|Did not receive allocated intervention.|3|||
143239858|NCT00068692|516431897|FG005|Step 1: Registration|Other|0|||
143239859|NCT00068692|516431898|FG006|Step 1: Registration|Other|0|||
143239860|NCT00068692|516431899|FG007|Step 1: Registration|Other|0|||
143239861|NCT00068692|516431892|FG000|Step 1: Registration|Not start protocol therapy|3|||
143239862|NCT00068692|516431893|FG001|Step 1: Registration|Not start protocol therapy|0|||
143364174|NCT02397889|516875578|FG000|Overall Study|Physician Decision|1|||
143364175|NCT02397889|516875579|FG001|Overall Study|Physician Decision|0|||
143239863|NCT00068692|516431894|FG002|Step 1: Registration|Not start protocol therapy|0|||
143163580|NCT01772693|516145372|FG001|Overall Study|Withdrawal by Subject|0|||
143163581|NCT01772693|516145371|FG000|Overall Study|Alternative Treatment|2|||
143163582|NCT01772693|516145372|FG001|Overall Study|Alternative Treatment|0|||
143163583|NCT00756314|516145380|FG000|Overall Study|Lost to Follow-up|2|||
143163584|NCT00756314|516145381|FG001|Overall Study|Lost to Follow-up|59|||
143163585|NCT02605967|516145382|FG000|Overall Study|subject / guardian decision|1|||
143163586|NCT02605967|516145383|FG001|Overall Study|subject / guardian decision|2|||
143163587|NCT02605967|516145382|FG000|Overall Study|Physician Decision|10|||
143163588|NCT02605967|516145383|FG001|Overall Study|Physician Decision|1|||
143163589|NCT02605967|516145382|FG000|Overall Study|Death|4|||
143163590|NCT02605967|516145383|FG001|Overall Study|Death|2|||
143163591|NCT02605967|516145382|FG000|Overall Study|Adverse Event|1|||
143163592|NCT02605967|516145383|FG001|Overall Study|Adverse Event|0|||
143163593|NCT02605967|516145382|FG000|Overall Study|progressive disease|66|||
143163594|NCT02605967|516145383|FG001|Overall Study|progressive disease|35|||
143163595|NCT01903720|516145385|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
143163596|NCT01903720|516145385|FG000|Overall Study|Adverse Event|1|||
143163597|NCT01903720|516145385|FG000|Overall Study|Rescinding of informed consent|2|||
143163598|NCT01903720|516145385|FG000|Overall Study|Lost to Follow-up|2|||
143163599|NCT01903720|516145385|FG000|Overall Study|Treatment with alternative drug|1|||
143163600|NCT02202577|516145389|FG000|Overall Study|Lost to Follow-up|6|||
143163601|NCT02202577|516145390|FG001|Overall Study|Lost to Follow-up|16|||
143163602|NCT02202577|516145389|FG000|Overall Study|Protocol Violation|7|||
143163603|NCT02202577|516145390|FG001|Overall Study|Protocol Violation|3|||
143163604|NCT01618708|516145391|FG000|Overall Study|Adverse Event|10|||
143163605|NCT01618708|516145392|FG001|Overall Study|Adverse Event|10|||
143163606|NCT01618708|516145391|FG000|Overall Study|Lost to Follow-up|3|||
143163607|NCT01618708|516145392|FG001|Overall Study|Lost to Follow-up|3|||
143163608|NCT01618708|516145391|FG000|Overall Study|Withdrawal by Subject|17|||
143163609|NCT01618708|516145392|FG001|Overall Study|Withdrawal by Subject|22|||
143163610|NCT01618708|516145391|FG000|Overall Study|Lack of Efficacy|8|||
143163611|NCT01618708|516145392|FG001|Overall Study|Lack of Efficacy|8|||
143163612|NCT01618708|516145391|FG000|Overall Study|Technical problems|2|||
143163613|NCT01618708|516145392|FG001|Overall Study|Technical problems|0|||
143163614|NCT01618708|516145391|FG000|Overall Study|Other than specified above|1|||
143163615|NCT01618708|516145392|FG001|Overall Study|Other than specified above|1|||
143163616|NCT01618708|516145391|FG000|Overall Study|Randomized but not treated|3|||
143163617|NCT01618708|516145392|FG001|Overall Study|Randomized but not treated|2|||
143163618|NCT00489476|516145396|FG000|Overall Study|Lost to Follow-up|0|||
143163619|NCT00489476|516145397|FG001|Overall Study|Lost to Follow-up|1|||
143163620|NCT00489476|516145398|FG002|Overall Study|Lost to Follow-up|0|||
143163621|NCT00489476|516145399|FG003|Overall Study|Lost to Follow-up|0|||
143163622|NCT01421459|516145400|FG000|Overall Study|Adverse Event|6|||
143163623|NCT01421459|516145401|FG001|Overall Study|Adverse Event|10|||
143163624|NCT01421459|516145400|FG000|Overall Study|Death|1|||
143163625|NCT01421459|516145401|FG001|Overall Study|Death|1|||
143163626|NCT01421459|516145400|FG000|Overall Study|Lack of Efficacy|1|||
143163627|NCT01421459|516145401|FG001|Overall Study|Lack of Efficacy|2|||
143163628|NCT01421459|516145400|FG000|Overall Study|Lost to Follow-up|8|||
143163629|NCT01421459|516145401|FG001|Overall Study|Lost to Follow-up|9|||
143163630|NCT01421459|516145400|FG000|Overall Study|Physician Decision|9|||
143163631|NCT01421459|516145401|FG001|Overall Study|Physician Decision|9|||
143163632|NCT01421459|516145400|FG000|Overall Study|Protocol Violation|8|||
143163633|NCT01421459|516145401|FG001|Overall Study|Protocol Violation|5|||
143163634|NCT01421459|516145400|FG000|Overall Study|Withdrawal by Subject|12|||
143163635|NCT01421459|516145401|FG001|Overall Study|Withdrawal by Subject|16|||
143163636|NCT04003142|516145404|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
143163637|NCT04003142|516145405|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
143163638|NCT04003142|516145406|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
143163639|NCT04003142|516145407|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
143163640|NCT04003142|516145408|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
143163641|NCT04003142|516145404|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
143163642|NCT04003142|516145405|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
143163643|NCT04003142|516145406|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
143163644|NCT04003142|516145407|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
143163645|NCT04003142|516145408|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
143163646|NCT04003142|516145404|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
143163647|NCT04003142|516145405|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
143163648|NCT04003142|516145406|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
143163649|NCT04003142|516145407|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
143364176|NCT04668144|516875592|FG000|Overall Study|Protocol Violation|0|||
143163650|NCT04003142|516145408|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
143163651|NCT04003142|516145404|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
143163652|NCT04003142|516145405|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
143163653|NCT04003142|516145406|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
143364177|NCT04668144|516875593|FG001|Overall Study|Protocol Violation|1|||
143040219|NCT01597245|515689268|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
143040220|NCT01597245|515689269|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
143163654|NCT04003142|516145407|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
143163655|NCT04003142|516145408|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
143163656|NCT04003142|516145404|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
143163657|NCT04003142|516145405|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
143163658|NCT04003142|516145406|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
143163659|NCT04003142|516145407|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
143163660|NCT04003142|516145408|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
143163661|NCT04003142|516145404|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
143163662|NCT04003142|516145405|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
143163663|NCT04003142|516145406|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
143163664|NCT04003142|516145407|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
143163665|NCT04003142|516145408|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
143163666|NCT04003142|516145404|FG000|Extension Period (40 Weeks)|Death|0|||
143163667|NCT04003142|516145405|FG001|Extension Period (40 Weeks)|Death|0|||
143163668|NCT04003142|516145406|FG002|Extension Period (40 Weeks)|Death|0|||
143163669|NCT04003142|516145407|FG003|Extension Period (40 Weeks)|Death|0|||
143163670|NCT04003142|516145408|FG004|Extension Period (40 Weeks)|Death|1|||
143163671|NCT04003142|516145404|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
143163672|NCT04003142|516145405|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
143163673|NCT04003142|516145406|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
143163674|NCT04003142|516145407|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
143163675|NCT04003142|516145408|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
143163676|NCT04003142|516145404|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
143163677|NCT04003142|516145405|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
143163678|NCT04003142|516145406|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
143163679|NCT04003142|516145407|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
143163680|NCT04003142|516145408|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
143163681|NCT04003142|516145404|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
143163682|NCT04003142|516145405|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
143163683|NCT04003142|516145406|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
143163684|NCT04003142|516145407|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
143163685|NCT04003142|516145408|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
143163686|NCT04003142|516145404|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
143163687|NCT04003142|516145405|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
143163688|NCT04003142|516145406|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
143163689|NCT04003142|516145407|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
143163690|NCT04003142|516145408|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
143163691|NCT03996395|516145410|FG000|Overall Study|Lost to Follow-up|4|||
143163692|NCT03996395|516145410|FG000|Overall Study|Withdrawal by Subject|1|||
143163693|NCT03996395|516145410|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
143163694|NCT01887600|516145415|FG000|Overall Study|Death|39|||
143163695|NCT01887600|516145416|FG001|Overall Study|Death|16|||
143163696|NCT01887600|516145415|FG000|Overall Study|Lack of Efficacy|3|||
143163697|NCT01887600|516145416|FG001|Overall Study|Lack of Efficacy|26|||
143163698|NCT01887600|516145415|FG000|Overall Study|Lost to Follow-up|5|||
143163699|NCT01887600|516145416|FG001|Overall Study|Lost to Follow-up|1|||
143163700|NCT01887600|516145415|FG000|Overall Study|Physician Decision|7|||
143163701|NCT01887600|516145416|FG001|Overall Study|Physician Decision|8|||
143163702|NCT01887600|516145415|FG000|Overall Study|Protocol Deviation|3|||
143163703|NCT01887600|516145416|FG001|Overall Study|Protocol Deviation|0|||
143163704|NCT01887600|516145415|FG000|Overall Study|Withdrawal by Subject|58|||
143163705|NCT01887600|516145416|FG001|Overall Study|Withdrawal by Subject|52|||
143163706|NCT01887600|516145415|FG000|Overall Study|Adverse Event|21|||
143163707|NCT01887600|516145416|FG001|Overall Study|Adverse Event|9|||
143163708|NCT01887600|516145415|FG000|Overall Study|Non-compliance with study drug|3|||
143163709|NCT01887600|516145416|FG001|Overall Study|Non-compliance with study drug|0|||
143163710|NCT01887600|516145415|FG000|Overall Study|Miscellaneous|6|||
143239864|NCT00068692|516431895|FG003|Step 1: Registration|Not start protocol therapy|0|||
143239865|NCT00068692|516431896|FG004|Step 1: Registration|Not start protocol therapy|0|||
143239866|NCT00068692|516431897|FG005|Step 1: Registration|Not start protocol therapy|0|||
143239867|NCT00068692|516431898|FG006|Step 1: Registration|Not start protocol therapy|0|||
143239868|NCT00068692|516431899|FG007|Step 1: Registration|Not start protocol therapy|0|||
143239869|NCT00068692|516431892|FG000|Step 1: Registration|Registered but not randomized|0|||
143163711|NCT01887600|516145416|FG001|Overall Study|Miscellaneous|2|||
143239870|NCT00068692|516431893|FG001|Step 1: Registration|Registered but not randomized|1|||
143163712|NCT01887600|516145415|FG000|Overall Study|Progressive Disease|1|||
143163713|NCT01887600|516145416|FG001|Overall Study|Progressive Disease|0|||
143163714|NCT03688139|516145417|FG000|Overall Study|Lost to Follow-up|2|||
143163715|NCT03688139|516145418|FG001|Overall Study|Lost to Follow-up|0|||
143163716|NCT03688139|516145417|FG000|Overall Study|Physician Decision|0|||
143163717|NCT03688139|516145418|FG001|Overall Study|Physician Decision|1|||
143163718|NCT03688139|516145417|FG000|Overall Study|Withdrawal by Subject|2|||
143239871|NCT00068692|516431894|FG002|Step 1: Registration|Registered but not randomized|0|||
143239872|NCT00068692|516431895|FG003|Step 1: Registration|Registered but not randomized|0|||
143239873|NCT00068692|516431896|FG004|Step 1: Registration|Registered but not randomized|0|||
143239874|NCT00068692|516431897|FG005|Step 1: Registration|Registered but not randomized|0|||
143239875|NCT00068692|516431898|FG006|Step 1: Registration|Registered but not randomized|0|||
143239876|NCT00068692|516431899|FG007|Step 1: Registration|Registered but not randomized|0|||
143239877|NCT00068692|516431892|FG000|Step 2: Randomization|Disesae progression/replase|0|||
143239878|NCT00068692|516431893|FG001|Step 2: Randomization|Disesae progression/replase|0|||
143239879|NCT00068692|516431894|FG002|Step 2: Randomization|Disesae progression/replase|1|||
143239880|NCT00068692|516431895|FG003|Step 2: Randomization|Disesae progression/replase|1|||
143239881|NCT00068692|516431896|FG004|Step 2: Randomization|Disesae progression/replase|0|||
143239882|NCT00068692|516431897|FG005|Step 2: Randomization|Disesae progression/replase|0|||
143239883|NCT00068692|516431898|FG006|Step 2: Randomization|Disesae progression/replase|0|||
143239884|NCT00068692|516431899|FG007|Step 2: Randomization|Disesae progression/replase|0|||
143239885|NCT00068692|516431892|FG000|Step 2: Randomization|Adverse Event|0|||
143239886|NCT00068692|516431893|FG001|Step 2: Randomization|Adverse Event|0|||
143239887|NCT00068692|516431894|FG002|Step 2: Randomization|Adverse Event|4|||
143239888|NCT00068692|516431895|FG003|Step 2: Randomization|Adverse Event|2|||
143239889|NCT00068692|516431896|FG004|Step 2: Randomization|Adverse Event|2|||
143239890|NCT00068692|516431897|FG005|Step 2: Randomization|Adverse Event|3|||
143239891|NCT00068692|516431898|FG006|Step 2: Randomization|Adverse Event|4|||
143239892|NCT00068692|516431899|FG007|Step 2: Randomization|Adverse Event|4|||
143239893|NCT00068692|516431892|FG000|Step 2: Randomization|Death|0|||
143239894|NCT00068692|516431893|FG001|Step 2: Randomization|Death|0|||
143239895|NCT00068692|516431894|FG002|Step 2: Randomization|Death|0|||
143239896|NCT00068692|516431895|FG003|Step 2: Randomization|Death|0|||
143239897|NCT00068692|516431896|FG004|Step 2: Randomization|Death|1|||
143239898|NCT00068692|516431897|FG005|Step 2: Randomization|Death|0|||
143239899|NCT00068692|516431898|FG006|Step 2: Randomization|Death|0|||
143239900|NCT00068692|516431899|FG007|Step 2: Randomization|Death|1|||
143239901|NCT00068692|516431892|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
143239902|NCT00068692|516431893|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
143239903|NCT00068692|516431894|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
143239904|NCT00068692|516431895|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
143239905|NCT00068692|516431896|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
143239906|NCT00068692|516431897|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
143239907|NCT00068692|516431898|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
143239908|NCT00068692|516431899|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
143239909|NCT00068692|516431892|FG000|Step 2: Randomization|alternative therapy|0|||
143239910|NCT00068692|516431893|FG001|Step 2: Randomization|alternative therapy|0|||
143239911|NCT00068692|516431894|FG002|Step 2: Randomization|alternative therapy|0|||
143239912|NCT00068692|516431895|FG003|Step 2: Randomization|alternative therapy|1|||
143239913|NCT00068692|516431896|FG004|Step 2: Randomization|alternative therapy|1|||
143239914|NCT00068692|516431897|FG005|Step 2: Randomization|alternative therapy|0|||
143239915|NCT00068692|516431898|FG006|Step 2: Randomization|alternative therapy|0|||
143239916|NCT00068692|516431899|FG007|Step 2: Randomization|alternative therapy|0|||
143239917|NCT00068692|516431892|FG000|Step 2: Randomization|Physician Decision|0|||
143239918|NCT00068692|516431893|FG001|Step 2: Randomization|Physician Decision|0|||
143239919|NCT00068692|516431894|FG002|Step 2: Randomization|Physician Decision|0|||
143239920|NCT00068692|516431895|FG003|Step 2: Randomization|Physician Decision|1|||
143239921|NCT00068692|516431896|FG004|Step 2: Randomization|Physician Decision|1|||
143239922|NCT00068692|516431897|FG005|Step 2: Randomization|Physician Decision|0|||
143239923|NCT00068692|516431898|FG006|Step 2: Randomization|Physician Decision|0|||
143239924|NCT00068692|516431899|FG007|Step 2: Randomization|Physician Decision|0|||
143239925|NCT00068692|516431892|FG000|Step 2: Randomization|Other|0|||
143239926|NCT00068692|516431893|FG001|Step 2: Randomization|Other|0|||
143239927|NCT00068692|516431894|FG002|Step 2: Randomization|Other|0|||
143239928|NCT00068692|516431895|FG003|Step 2: Randomization|Other|1|||
143239929|NCT00068692|516431896|FG004|Step 2: Randomization|Other|0|||
143239930|NCT00068692|516431897|FG005|Step 2: Randomization|Other|1|||
143239931|NCT00068692|516431898|FG006|Step 2: Randomization|Other|0|||
143239932|NCT00068692|516431899|FG007|Step 2: Randomization|Other|0|||
143239933|NCT00068692|516431892|FG000|Step 2: Randomization|never start protocol therapy|0|||
143239934|NCT00068692|516431893|FG001|Step 2: Randomization|never start protocol therapy|0|||
143239935|NCT00068692|516431894|FG002|Step 2: Randomization|never start protocol therapy|1|||
143239936|NCT00068692|516431895|FG003|Step 2: Randomization|never start protocol therapy|0|||
143239937|NCT00068692|516431896|FG004|Step 2: Randomization|never start protocol therapy|1|||
143239938|NCT00068692|516431897|FG005|Step 2: Randomization|never start protocol therapy|0|||
143040221|NCT01597245|515689270|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
143040222|NCT01597245|515689271|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
143239939|NCT00068692|516431898|FG006|Step 2: Randomization|never start protocol therapy|0|||
143239940|NCT00068692|516431899|FG007|Step 2: Randomization|never start protocol therapy|0|||
143239941|NCT00248040|516431901|FG000|Overall Study|transplantectomy|2|||
143497594|NCT01307033|517364454|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
143497595|NCT01307033|517364451|FG000|44-week Open-label Extension|Death|0|||
143497596|NCT01307033|517364452|FG001|44-week Open-label Extension|Death|0|||
143497597|NCT01307033|517364453|FG002|44-week Open-label Extension|Death|0|||
143497598|NCT01307033|517364454|FG003|44-week Open-label Extension|Death|1|||
143497599|NCT03502330|517364456|FG000|Overall Study|Adverse Event|2|||
143497600|NCT03502330|517364457|FG001|Overall Study|Adverse Event|1|||
143497601|NCT03502330|517364458|FG002|Overall Study|Adverse Event|0|||
143497602|NCT03502330|517364459|FG003|Overall Study|Adverse Event|0|||
143497603|NCT03502330|517364460|FG004|Overall Study|Adverse Event|1|||
143497604|NCT03502330|517364461|FG005|Overall Study|Adverse Event|0|||
143497605|NCT03502330|517364462|FG006|Overall Study|Adverse Event|1|||
143497606|NCT03502330|517364463|FG007|Overall Study|Adverse Event|1|||
143497607|NCT03502330|517364464|FG008|Overall Study|Adverse Event|0|||
143497608|NCT03502330|517364456|FG000|Overall Study|Lack of Efficacy|1|||
143497609|NCT03502330|517364457|FG001|Overall Study|Lack of Efficacy|5|||
143497610|NCT03502330|517364458|FG002|Overall Study|Lack of Efficacy|3|||
143497611|NCT03502330|517364459|FG003|Overall Study|Lack of Efficacy|5|||
143497612|NCT03502330|517364460|FG004|Overall Study|Lack of Efficacy|1|||
143497613|NCT03502330|517364461|FG005|Overall Study|Lack of Efficacy|5|||
143497614|NCT03502330|517364462|FG006|Overall Study|Lack of Efficacy|5|||
143497615|NCT03502330|517364463|FG007|Overall Study|Lack of Efficacy|6|||
143497616|NCT03502330|517364464|FG008|Overall Study|Lack of Efficacy|0|||
143497617|NCT03502330|517364456|FG000|Overall Study|Physician Decision|0|||
143497618|NCT03502330|517364457|FG001|Overall Study|Physician Decision|0|||
143497619|NCT03502330|517364458|FG002|Overall Study|Physician Decision|0|||
143497620|NCT03502330|517364459|FG003|Overall Study|Physician Decision|0|||
143497621|NCT03502330|517364460|FG004|Overall Study|Physician Decision|1|||
143497622|NCT03502330|517364461|FG005|Overall Study|Physician Decision|0|||
143497623|NCT03502330|517364462|FG006|Overall Study|Physician Decision|0|||
143497624|NCT03502330|517364463|FG007|Overall Study|Physician Decision|0|||
143497625|NCT03502330|517364464|FG008|Overall Study|Physician Decision|0|||
143497626|NCT03502330|517364456|FG000|Overall Study|Withdrawal by Subject|0|||
143040223|NCT01597245|515689272|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
143497627|NCT03502330|517364457|FG001|Overall Study|Withdrawal by Subject|0|||
143497628|NCT03502330|517364458|FG002|Overall Study|Withdrawal by Subject|0|||
143497629|NCT03502330|517364459|FG003|Overall Study|Withdrawal by Subject|0|||
143497630|NCT03502330|517364460|FG004|Overall Study|Withdrawal by Subject|0|||
143497631|NCT03502330|517364461|FG005|Overall Study|Withdrawal by Subject|1|||
143497632|NCT03502330|517364462|FG006|Overall Study|Withdrawal by Subject|0|||
143040224|NCT01597245|515689273|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
143040225|NCT01597245|515689274|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
143040226|NCT01597245|515689275|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
143163719|NCT03688139|516145418|FG001|Overall Study|Withdrawal by Subject|3|||
143163720|NCT00231465|516145419|FG000|Overall Study|Completed only one cycle|1|||
143163721|NCT00231465|516145419|FG000|Overall Study|Did not have follow up CT scans|1|||
143163722|NCT01720602|516145425|FG000|Overall Study|Adverse Event|3|||
143163723|NCT01720602|516145425|FG000|Overall Study|Progressive disease on therapy|2|||
143163724|NCT02268851|516145428|FG000|Overall Study|Death|0|||
143163725|NCT02268851|516145429|FG001|Overall Study|Death|0|||
143163726|NCT02268851|516145430|FG002|Overall Study|Death|0|||
143163727|NCT02268851|516145431|FG003|Overall Study|Death|1|||
143163728|NCT02268851|516145432|FG004|Overall Study|Death|2|||
143163729|NCT02268851|516145433|FG005|Overall Study|Death|1|||
143163730|NCT02268851|516145428|FG000|Overall Study|Adverse Event|0|||
143163731|NCT02268851|516145429|FG001|Overall Study|Adverse Event|0|||
143163732|NCT02268851|516145430|FG002|Overall Study|Adverse Event|0|||
143163733|NCT02268851|516145431|FG003|Overall Study|Adverse Event|0|||
143163734|NCT02268851|516145432|FG004|Overall Study|Adverse Event|2|||
143163735|NCT02268851|516145433|FG005|Overall Study|Adverse Event|2|||
143239942|NCT00248040|516431902|FG001|Overall Study|transplantectomy|1|||
143239943|NCT00248040|516431903|FG002|Overall Study|transplantectomy|3|||
143239944|NCT00248040|516431901|FG000|Overall Study|transplant cancelled post treat start|1|||
143239945|NCT00248040|516431902|FG001|Overall Study|transplant cancelled post treat start|0|||
143364178|NCT04668144|516875594|FG002|Overall Study|Protocol Violation|2|||
143163736|NCT02268851|516145428|FG000|Overall Study|Withdrawal by Subject|0|||
143163737|NCT02268851|516145429|FG001|Overall Study|Withdrawal by Subject|0|||
143497633|NCT03502330|517364463|FG007|Overall Study|Withdrawal by Subject|1|||
143497634|NCT03502330|517364464|FG008|Overall Study|Withdrawal by Subject|0|||
143497635|NCT03502330|517364456|FG000|Overall Study|Death|0|||
143497636|NCT03502330|517364457|FG001|Overall Study|Death|0|||
143497637|NCT03502330|517364458|FG002|Overall Study|Death|0|||
143497638|NCT03502330|517364459|FG003|Overall Study|Death|0|||
143497639|NCT03502330|517364460|FG004|Overall Study|Death|0|||
143497640|NCT03502330|517364461|FG005|Overall Study|Death|0|||
143497641|NCT03502330|517364462|FG006|Overall Study|Death|2|||
143497642|NCT03502330|517364463|FG007|Overall Study|Death|0|||
143497643|NCT03502330|517364464|FG008|Overall Study|Death|0|||
143497644|NCT02804763|517364466|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
143497645|NCT02804763|517364467|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
143497646|NCT02804763|517364468|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
143497647|NCT02804763|517364469|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
143497648|NCT02804763|517364466|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
143497649|NCT02804763|517364467|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
143497650|NCT02804763|517364468|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
143497651|NCT02804763|517364469|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
143497652|NCT02804763|517364466|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
143497653|NCT02804763|517364467|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
143497654|NCT02804763|517364468|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
143497655|NCT02804763|517364469|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
143497656|NCT02804763|517364466|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
143497657|NCT02804763|517364467|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
143497658|NCT02804763|517364468|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
143497659|NCT02804763|517364469|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
143497660|NCT02804763|517364466|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
143497661|NCT02804763|517364467|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
143497662|NCT02804763|517364468|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
143497663|NCT02804763|517364469|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
143497664|NCT02804763|517364466|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
143497665|NCT02804763|517364467|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
143497666|NCT02804763|517364468|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
143497667|NCT02804763|517364469|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
143497668|NCT00860158|517364472|FG000|Overall Study|Study Terminated|1|||
143497669|NCT00066690|517364475|FG000|Overall Study|Adverse Event|145|||
143497670|NCT00066690|517364476|FG001|Overall Study|Adverse Event|58|||
143497671|NCT00066690|517364477|FG002|Overall Study|Adverse Event|126|||
143497672|NCT00066690|517364475|FG000|Overall Study|Death|3|||
143497673|NCT00066690|517364476|FG001|Overall Study|Death|0|||
143497674|NCT00066690|517364477|FG002|Overall Study|Death|2|||
143497675|NCT00066690|517364475|FG000|Overall Study|Lack of Efficacy|114|||
143497676|NCT00066690|517364476|FG001|Overall Study|Lack of Efficacy|110|||
143497677|NCT00066690|517364477|FG002|Overall Study|Lack of Efficacy|76|||
143497678|NCT00066690|517364475|FG000|Overall Study|Lost to Follow-up|40|||
143497679|NCT00066690|517364476|FG001|Overall Study|Lost to Follow-up|21|||
143497680|NCT00066690|517364477|FG002|Overall Study|Lost to Follow-up|29|||
143497681|NCT00066690|517364475|FG000|Overall Study|Withdrawal by Subject|50|||
143497682|NCT00066690|517364476|FG001|Overall Study|Withdrawal by Subject|55|||
143497683|NCT00066690|517364477|FG002|Overall Study|Withdrawal by Subject|49|||
143497684|NCT00066690|517364475|FG000|Overall Study|Treatment Ongoing|246|||
143239946|NCT00248040|516431903|FG002|Overall Study|transplant cancelled post treat start|0|||
143239947|NCT00248040|516431901|FG000|Overall Study|Death|0|||
143239948|NCT00248040|516431902|FG001|Overall Study|Death|0|||
143239949|NCT00248040|516431903|FG002|Overall Study|Death|1|||
143239950|NCT03557034|516431906|FG000|Overall Study|Withdrawal by Subject|1|||
143239951|NCT03557034|516431907|FG001|Overall Study|Withdrawal by Subject|0|||
143239952|NCT02978781|516431910|FG000|Part A|Adverse Event|1|||
143239953|NCT02978781|516431911|FG001|Part A|Adverse Event|1|||
143239954|NCT02978781|516431912|FG002|Part A|Adverse Event|0|||
143239955|NCT02978781|516431913|FG003|Part A|Adverse Event|0|||
143239956|NCT02978781|516431914|FG004|Part A|Adverse Event|0|||
143497685|NCT00066690|517364476|FG001|Overall Study|Treatment Ongoing|278|||
143497686|NCT00066690|517364477|FG002|Overall Study|Treatment Ongoing|282|||
143497687|NCT02939131|517364478|FG000|Overall Study|Unable to get to clinic|6|||
143497688|NCT02939131|517364479|FG001|Overall Study|Unable to get to clinic|4|||
143497689|NCT02939131|517364478|FG000|Overall Study|Lost to Follow-up|2|||
143497690|NCT02939131|517364479|FG001|Overall Study|Lost to Follow-up|4|||
143497691|NCT02939131|517364478|FG000|Overall Study|severe debilitation|1|||
143497692|NCT02939131|517364479|FG001|Overall Study|severe debilitation|0|||
143497693|NCT02939131|517364478|FG000|Overall Study|Other|0|||
143497694|NCT02939131|517364479|FG001|Overall Study|Other|1|||
143497695|NCT02939131|517364478|FG000|Overall Study|not willing to adhere to protocol|2|||
143497696|NCT02939131|517364479|FG001|Overall Study|not willing to adhere to protocol|0|||
143497697|NCT03588741|517364480|FG000|Overall Study|Withdrawal by Subject|1|||
143497698|NCT00793793|517364482|FG000|Overall Study|Adverse Event|0|||
143497699|NCT00793793|517364483|FG001|Overall Study|Adverse Event|0|||
143239957|NCT02978781|516431910|FG000|Part A|Withdrawal by Subject|0|||
143239958|NCT02978781|516431911|FG001|Part A|Withdrawal by Subject|1|||
143364179|NCT00916006|516875595|FG000|Overall Study|Adverse Event|1|||
143239959|NCT02978781|516431912|FG002|Part A|Withdrawal by Subject|0|||
143364180|NCT00916006|516875596|FG001|Overall Study|Adverse Event|1|||
143364181|NCT00916006|516875595|FG000|Overall Study|Withdrawal by Subject|2|||
143239960|NCT02978781|516431913|FG003|Part A|Withdrawal by Subject|0|||
143239961|NCT02978781|516431914|FG004|Part A|Withdrawal by Subject|0|||
143364182|NCT00916006|516875596|FG001|Overall Study|Withdrawal by Subject|5|||
143364183|NCT00916006|516875595|FG000|Overall Study|Protocol Violation|0|||
143364184|NCT00916006|516875596|FG001|Overall Study|Protocol Violation|1|||
143364185|NCT00832780|516875599|FG000|Overall Study|Death|16|||
143364186|NCT00832780|516875599|FG000|Overall Study|Lost to Follow-up|4|||
143364187|NCT00832780|516875599|FG000|Overall Study|no reason given|2|||
143364188|NCT00832780|516875599|FG000|Overall Study|other complicating condition|2|||
143364189|NCT00832780|516875599|FG000|Overall Study|Physician Decision|1|||
143364190|NCT04863898|516875604|FG000|Overall Study|Away from study clinic during intervention training period|2|||
143364191|NCT04863898|516875604|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
143364192|NCT04863898|516875604|FG000|Overall Study|Lost to Follow-up|3|||
143364193|NCT04863898|516875604|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
143364194|NCT04863898|516875604|FG000|Overall Study|No longer employed at clinic|3|||
143364195|NCT02487446|516875605|FG000|Period 1|Physician Decision|0|||
143364196|NCT02487446|516875606|FG001|Period 1|Physician Decision|1|||
143364197|NCT02487446|516875605|FG000|Period 1|Lack of Efficacy|1|||
143364198|NCT02487446|516875606|FG001|Period 1|Lack of Efficacy|0|||
143364199|NCT02487446|516875605|FG000|Period 1|Protocol deviation|3|||
143364200|NCT02487446|516875606|FG001|Period 1|Protocol deviation|2|||
143364201|NCT02487446|516875605|FG000|Period 1|Lost to Follow-up|2|||
143364202|NCT02487446|516875606|FG001|Period 1|Lost to Follow-up|0|||
143364203|NCT02487446|516875605|FG000|Period 1|Withdrawal by Subject|2|||
143364204|NCT02487446|516875606|FG001|Period 1|Withdrawal by Subject|0|||
143364205|NCT02487446|516875605|FG000|Period 1|Adverse Event|5|||
143364206|NCT02487446|516875606|FG001|Period 1|Adverse Event|5|||
143364207|NCT02487446|516875605|FG000|Washout|Lost to Follow-up|0|||
143364208|NCT02487446|516875606|FG001|Washout|Lost to Follow-up|2|||
143364209|NCT02487446|516875605|FG000|Washout|Withdrawal by Subject|1|||
143364210|NCT02487446|516875606|FG001|Washout|Withdrawal by Subject|4|||
143364211|NCT02487446|516875605|FG000|Washout|Adverse Event|2|||
143364212|NCT02487446|516875606|FG001|Washout|Adverse Event|2|||
143163738|NCT02268851|516145430|FG002|Overall Study|Withdrawal by Subject|0|||
143163739|NCT02268851|516145431|FG003|Overall Study|Withdrawal by Subject|2|||
143163740|NCT02268851|516145432|FG004|Overall Study|Withdrawal by Subject|0|||
143163741|NCT02268851|516145433|FG005|Overall Study|Withdrawal by Subject|1|||
143163742|NCT02268851|516145428|FG000|Overall Study|Progressive Disease|1|||
143163743|NCT02268851|516145429|FG001|Overall Study|Progressive Disease|3|||
143163744|NCT02268851|516145430|FG002|Overall Study|Progressive Disease|0|||
143163745|NCT02268851|516145431|FG003|Overall Study|Progressive Disease|0|||
143163746|NCT02268851|516145432|FG004|Overall Study|Progressive Disease|1|||
143163747|NCT02268851|516145433|FG005|Overall Study|Progressive Disease|4|||
143163748|NCT02268851|516145428|FG000|Overall Study|Physician Decision|0|||
143163749|NCT02268851|516145429|FG001|Overall Study|Physician Decision|0|||
143163750|NCT02268851|516145430|FG002|Overall Study|Physician Decision|1|||
143163751|NCT02268851|516145431|FG003|Overall Study|Physician Decision|0|||
143163752|NCT02268851|516145432|FG004|Overall Study|Physician Decision|0|||
143239962|NCT02978781|516431910|FG000|Part B|Withdrawal by Subject|0|||
143239963|NCT02978781|516431911|FG001|Part B|Withdrawal by Subject|0|||
143239964|NCT02978781|516431912|FG002|Part B|Withdrawal by Subject|0|||
143239965|NCT02978781|516431913|FG003|Part B|Withdrawal by Subject|1|||
143239966|NCT02978781|516431914|FG004|Part B|Withdrawal by Subject|0|||
143239967|NCT02978781|516431910|FG000|Part C|Adverse Event|0|||
143239968|NCT02978781|516431911|FG001|Part C|Adverse Event|0|||
143239969|NCT02978781|516431912|FG002|Part C|Adverse Event|0|||
143239970|NCT02978781|516431913|FG003|Part C|Adverse Event|0|||
143239971|NCT02978781|516431914|FG004|Part C|Adverse Event|2|||
143239972|NCT02978781|516431910|FG000|Part C|Withdrawal by Subject|0|||
143239973|NCT02978781|516431911|FG001|Part C|Withdrawal by Subject|0|||
143239974|NCT02978781|516431912|FG002|Part C|Withdrawal by Subject|0|||
143239975|NCT02978781|516431913|FG003|Part C|Withdrawal by Subject|0|||
143239976|NCT02978781|516431914|FG004|Part C|Withdrawal by Subject|1|||
143239977|NCT02978781|516431910|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
143239978|NCT02978781|516431911|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
143239979|NCT02978781|516431912|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
143239980|NCT02978781|516431913|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
143239981|NCT02978781|516431914|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
143364213|NCT02487446|516875605|FG000|Period 2|Protocol deviation|0|||
143364214|NCT02487446|516875606|FG001|Period 2|Protocol deviation|1|||
143364215|NCT02487446|516875605|FG000|Period 2|Lost to Follow-up|1|||
143364216|NCT02487446|516875606|FG001|Period 2|Lost to Follow-up|1|||
143364217|NCT02487446|516875605|FG000|Period 2|Withdrawal by Subject|1|||
143239982|NCT01528969|516431917|FG000|Overall Study|absent from the school at baseline|2|||
143364218|NCT02487446|516875606|FG001|Period 2|Withdrawal by Subject|1|||
143364219|NCT02487446|516875605|FG000|Period 2|Adverse Event|6|||
143163753|NCT02268851|516145433|FG005|Overall Study|Physician Decision|1|||
143163754|NCT02268851|516145428|FG000|Overall Study|Patient Compliance|0|||
143163755|NCT02268851|516145429|FG001|Overall Study|Patient Compliance|0|||
143239983|NCT01528969|516431918|FG001|Overall Study|absent from the school at baseline|0|||
143040227|NCT01597245|515689276|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
143040228|NCT01597245|515689277|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
143040229|NCT01597245|515689278|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
143040230|NCT01597245|515689279|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
143040231|NCT01597245|515689280|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
143040232|NCT01597245|515689281|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
143040233|NCT01597245|515689282|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
143040234|NCT01597245|515689262|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
143040235|NCT01597245|515689263|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
143040236|NCT01597245|515689264|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
143040237|NCT01597245|515689265|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
143040238|NCT01597245|515689266|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
143040239|NCT01597245|515689267|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
143040240|NCT01597245|515689268|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
143040241|NCT01597245|515689269|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
143040242|NCT01597245|515689270|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
143040243|NCT01597245|515689271|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
143040244|NCT01597245|515689272|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
143040245|NCT01597245|515689273|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
143040246|NCT01597245|515689274|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
143040247|NCT01597245|515689275|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
143040248|NCT01597245|515689276|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
143040249|NCT01597245|515689277|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
143040250|NCT01597245|515689278|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
143040251|NCT01597245|515689279|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
143040252|NCT01597245|515689280|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
143163756|NCT02268851|516145430|FG002|Overall Study|Patient Compliance|0|||
143163757|NCT02268851|516145431|FG003|Overall Study|Patient Compliance|0|||
143163758|NCT02268851|516145432|FG004|Overall Study|Patient Compliance|1|||
143163759|NCT02268851|516145433|FG005|Overall Study|Patient Compliance|1|||
143163760|NCT02268851|516145428|FG000|Overall Study|Co-Morbid Condition|0|||
143163761|NCT02268851|516145429|FG001|Overall Study|Co-Morbid Condition|0|||
143163762|NCT02268851|516145430|FG002|Overall Study|Co-Morbid Condition|0|||
143163763|NCT02268851|516145431|FG003|Overall Study|Co-Morbid Condition|0|||
143163764|NCT02268851|516145432|FG004|Overall Study|Co-Morbid Condition|1|||
143163765|NCT02268851|516145433|FG005|Overall Study|Co-Morbid Condition|1|||
143163766|NCT01472835|516145438|FG000|Overall Study|Lost to Follow-up|2|||
143163767|NCT01472835|516145439|FG001|Overall Study|Lost to Follow-up|0|||
143163768|NCT03425188|516145440|FG000|Overall Study|Withdrawal by Subject|1|||
143163769|NCT01835431|516145441|FG000|Overall Study|Adverse Event|1|||
143163770|NCT01835431|516145442|FG001|Overall Study|Adverse Event|0|||
143163771|NCT01835431|516145441|FG000|Overall Study|other|0|||
143163772|NCT01835431|516145442|FG001|Overall Study|other|2|||
143163773|NCT01835431|516145441|FG000|Overall Study|Withdrawal by Subject|6|||
143163774|NCT01835431|516145442|FG001|Overall Study|Withdrawal by Subject|10|||
143163775|NCT01835431|516145441|FG000|Overall Study|Protocol Violation|1|||
143163776|NCT01835431|516145442|FG001|Overall Study|Protocol Violation|0|||
143163777|NCT00655356|516145447|FG000|Overall Study|Withdrawal by Subject|3|||
143163778|NCT00655356|516145448|FG001|Overall Study|Withdrawal by Subject|4|||
143163779|NCT00655356|516145447|FG000|Overall Study|Sponsor Request|10|||
143163780|NCT00655356|516145448|FG001|Overall Study|Sponsor Request|4|||
143163781|NCT00655356|516145447|FG000|Overall Study|Adverse Event|1|||
143163782|NCT00655356|516145448|FG001|Overall Study|Adverse Event|1|||
143163783|NCT00655356|516145447|FG000|Overall Study|Protocol Violation|2|||
143163784|NCT00655356|516145448|FG001|Overall Study|Protocol Violation|1|||
143163785|NCT00655356|516145447|FG000|Overall Study|Other Reason|1|||
143163786|NCT00655356|516145448|FG001|Overall Study|Other Reason|0|||
143040253|NCT01597245|515689281|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
143040254|NCT01597245|515689282|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
143040255|NCT01597245|515689262|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
143040256|NCT01597245|515689263|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
143040257|NCT01597245|515689264|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
143163787|NCT01684033|516145449|FG000|Period 1, First 30 Days|Adverse Event|1|||
143163788|NCT01684033|516145450|FG001|Period 1, First 30 Days|Adverse Event|1|||
143163789|NCT01684033|516145449|FG000|Period 1, First 30 Days|Noncompliance|1|||
143163790|NCT01684033|516145450|FG001|Period 1, First 30 Days|Noncompliance|0|||
143163791|NCT01684033|516145449|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
143163792|NCT01684033|516145450|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
143163793|NCT01684033|516145449|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
143163794|NCT01684033|516145450|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
143040258|NCT01597245|515689265|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
143040259|NCT01597245|515689266|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
143040260|NCT01597245|515689267|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
143040261|NCT01597245|515689268|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
143040262|NCT01597245|515689269|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
143040263|NCT01597245|515689270|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
143040264|NCT01597245|515689271|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
143040265|NCT01597245|515689272|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
143040266|NCT01597245|515689273|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
143040267|NCT01597245|515689274|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
143040268|NCT01597245|515689275|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
143040269|NCT01597245|515689276|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
143040270|NCT01597245|515689277|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
143040271|NCT01597245|515689278|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
143040272|NCT01597245|515689279|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
143040273|NCT01597245|515689280|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
143040274|NCT01597245|515689281|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
143040275|NCT01597245|515689282|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
143040276|NCT01597245|515689262|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
143163795|NCT01684033|516145449|FG000|Period 2, Second 30 Days|Adverse Event|1|||
143163796|NCT01684033|516145450|FG001|Period 2, Second 30 Days|Adverse Event|0|||
143163797|NCT01044459|516145451|FG000|Overall Study|Withdrawal by Subject|21|||
143163798|NCT01044459|516145452|FG001|Overall Study|Withdrawal by Subject|28|||
143163799|NCT01044459|516145451|FG000|Overall Study|Terminated by Sponsor|22|||
143163800|NCT01044459|516145452|FG001|Overall Study|Terminated by Sponsor|21|||
143163801|NCT01044459|516145451|FG000|Overall Study|Adverse Event|22|||
143163802|NCT01044459|516145452|FG001|Overall Study|Adverse Event|20|||
143163803|NCT01044459|516145451|FG000|Overall Study|Lack of Efficacy|23|||
143163804|NCT01044459|516145452|FG001|Overall Study|Lack of Efficacy|12|||
143163805|NCT01044459|516145451|FG000|Overall Study|Protocol Violation|11|||
143163806|NCT01044459|516145452|FG001|Overall Study|Protocol Violation|16|||
143163807|NCT01044459|516145451|FG000|Overall Study|Other Reason|7|||
143163808|NCT01044459|516145452|FG001|Overall Study|Other Reason|14|||
143163809|NCT01044459|516145451|FG000|Overall Study|COPD exacerbation|9|||
143163810|NCT01044459|516145452|FG001|Overall Study|COPD exacerbation|8|||
143163811|NCT01044459|516145451|FG000|Overall Study|Lost to Follow-up|18|||
143163812|NCT01044459|516145452|FG001|Overall Study|Lost to Follow-up|12|||
143163813|NCT04105725|516145453|FG000|Primary Intervention|Lost to Follow-up|0|||
143163814|NCT04105725|516145454|FG001|Primary Intervention|Lost to Follow-up|2|||
143163815|NCT04105725|516145453|FG000|Primary Intervention|Withdrawal by Subject|0|||
143163816|NCT04105725|516145454|FG001|Primary Intervention|Withdrawal by Subject|1|||
143163817|NCT05346640|516145455|FG000|Overall Study|Lack of Efficacy|2|||
143163818|NCT05346640|516145455|FG000|Overall Study|Lost to Follow-up|14|||
143163819|NCT05346640|516145455|FG000|Overall Study|Protocol Violation|4|||
143163820|NCT05346640|516145455|FG000|Overall Study|Withdrawal by Subject|2|||
143163821|NCT05346640|516145455|FG000|Overall Study|Physiological Complications|3|||
143163822|NCT05346640|516145455|FG000|Overall Study|Other Reason|3|||
143239984|NCT01383356|516431921|FG000|Period 1|Adverse Event|5|||
143040277|NCT01597245|515689263|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
143163823|NCT00480025|516145456|FG000|Overall Study|Protocol Violation|12|||
143163824|NCT00480025|516145457|FG001|Overall Study|Protocol Violation|7|||
143163825|NCT00480025|516145456|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
143163826|NCT00480025|516145457|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
143163827|NCT00480025|516145456|FG000|Overall Study|Disease Progression / Recurrence|449|||
143163828|NCT00480025|516145457|FG001|Overall Study|Disease Progression / Recurrence|224|||
143163829|NCT00480025|516145456|FG000|Overall Study|Adverse Event|44|||
143163830|NCT00480025|516145457|FG001|Overall Study|Adverse Event|12|||
143163831|NCT00480025|516145456|FG000|Overall Study|Other|70|||
143163832|NCT00480025|516145457|FG001|Overall Study|Other|29|||
143163833|NCT00480025|516145456|FG000|Overall Study|SAE including intercurrent illness|76|||
143163834|NCT00480025|516145457|FG001|Overall Study|SAE including intercurrent illness|42|||
143163835|NCT04634331|516145458|FG000|Overall Study|Withdrawal by Subject|2|||
143239985|NCT01383356|516431922|FG001|Period 1|Adverse Event|3|||
143163836|NCT04634331|516145459|FG001|Overall Study|Withdrawal by Subject|2|||
143163837|NCT03726879|516145461|FG000|Overall Study|Death|11|||
143163838|NCT03726879|516145462|FG001|Overall Study|Death|13|||
143163839|NCT03726879|516145461|FG000|Overall Study|Physician Decision|0|||
143163840|NCT03726879|516145462|FG001|Overall Study|Physician Decision|2|||
143040278|NCT01597245|515689264|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
143040279|NCT01597245|515689265|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
143040280|NCT01597245|515689266|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
143040281|NCT01597245|515689267|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
143040282|NCT01597245|515689268|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
143040283|NCT01597245|515689269|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
143040284|NCT01597245|515689270|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
143040285|NCT01597245|515689271|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
143040286|NCT01597245|515689272|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
143040287|NCT01597245|515689273|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
143040288|NCT01597245|515689274|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
143040289|NCT01597245|515689275|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
143040290|NCT01597245|515689276|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
143040291|NCT01597245|515689277|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
143040292|NCT01597245|515689278|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
143040293|NCT01597245|515689279|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
143040294|NCT01597245|515689280|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
143040295|NCT01597245|515689281|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
143040296|NCT01597245|515689282|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
143040297|NCT01597245|515689262|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
143040298|NCT01597245|515689263|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
143040299|NCT01597245|515689264|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
143040300|NCT01597245|515689265|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
143040301|NCT01597245|515689266|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
143040302|NCT01597245|515689267|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
143040303|NCT01597245|515689268|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
143040304|NCT01597245|515689269|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
143040305|NCT01597245|515689270|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
143040306|NCT01597245|515689271|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
143040307|NCT01597245|515689272|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
143163841|NCT03726879|516145461|FG000|Overall Study|Protocol Violation|0|||
143163842|NCT03726879|516145462|FG001|Overall Study|Protocol Violation|1|||
143163843|NCT03726879|516145461|FG000|Overall Study|Withdrawal by Subject|5|||
143163844|NCT03726879|516145462|FG001|Overall Study|Withdrawal by Subject|6|||
143163845|NCT03726879|516145461|FG000|Overall Study|TSH result is unstable|0|||
143163846|NCT03726879|516145462|FG001|Overall Study|TSH result is unstable|1|||
143163847|NCT03726879|516145461|FG000|Overall Study|Disease relapse|1|||
143163848|NCT03726879|516145462|FG001|Overall Study|Disease relapse|0|||
143163849|NCT03726879|516145461|FG000|Overall Study|Lost to Follow-up|3|||
143497700|NCT00793793|517364484|FG002|Overall Study|Adverse Event|1|||
143497701|NCT00793793|517364485|FG003|Overall Study|Adverse Event|1|||
143497702|NCT00793793|517364486|FG004|Overall Study|Adverse Event|0|||
143163850|NCT03726879|516145462|FG001|Overall Study|Lost to Follow-up|0|||
143163851|NCT02766478|516145464|FG000|Overall Study|Withdrawal by Subject|1|||
143163852|NCT02766478|516145465|FG001|Overall Study|Withdrawal by Subject|1|||
143163853|NCT01093573|516145466|FG000|Overall Study|Physician Decision|0|||
143163854|NCT01093573|516145467|FG001|Overall Study|Physician Decision|0|||
143163855|NCT01093573|516145468|FG002|Overall Study|Physician Decision|1|||
143364220|NCT02487446|516875606|FG001|Period 2|Adverse Event|2|||
143040308|NCT01597245|515689273|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
143040309|NCT01597245|515689274|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
143040310|NCT01597245|515689275|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
143040311|NCT01597245|515689276|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
143163856|NCT01093573|516145466|FG000|Overall Study|Insurance Denied|0|||
143163857|NCT01093573|516145467|FG001|Overall Study|Insurance Denied|0|||
143163858|NCT01093573|516145468|FG002|Overall Study|Insurance Denied|1|||
143163859|NCT05626686|516145469|FG000|Overall Study|Protocol Violation|3|||
143163860|NCT05626686|516145469|FG000|Overall Study|Withdrawal by Subject|3|||
143163861|NCT00507507|516145470|FG000|Treatment Period|Lost to Follow-up|0|||
143163862|NCT00507507|516145471|FG001|Treatment Period|Lost to Follow-up|2|||
143364221|NCT01822821|516875607|FG000|Overall Study|Eligible surgery cancelled|1|||
143497703|NCT00793793|517364487|FG005|Overall Study|Adverse Event|1|||
143497704|NCT00793793|517364488|FG006|Overall Study|Adverse Event|2|||
143040312|NCT01597245|515689277|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
143163863|NCT00507507|516145470|FG000|Treatment Period|Physician Decision|4|||
143163864|NCT00507507|516145471|FG001|Treatment Period|Physician Decision|1|||
143163865|NCT00507507|516145470|FG000|Treatment Period|Protocol Violation|1|||
143163866|NCT00507507|516145471|FG001|Treatment Period|Protocol Violation|2|||
143163867|NCT00507507|516145470|FG000|Treatment Period|Adverse Event|1|||
143163868|NCT00507507|516145471|FG001|Treatment Period|Adverse Event|1|||
143497705|NCT00793793|517364489|FG007|Overall Study|Adverse Event|0|||
143497706|NCT00793793|517364490|FG008|Overall Study|Adverse Event|0|||
143497707|NCT00793793|517364491|FG009|Overall Study|Adverse Event|0|||
143497708|NCT00793793|517364492|FG010|Overall Study|Adverse Event|0|||
143497709|NCT00793793|517364493|FG011|Overall Study|Adverse Event|2|||
143497710|NCT00793793|517364482|FG000|Overall Study|Protocol Violation|0|||
143497711|NCT00793793|517364483|FG001|Overall Study|Protocol Violation|0|||
143497712|NCT00793793|517364484|FG002|Overall Study|Protocol Violation|0|||
143497713|NCT00793793|517364485|FG003|Overall Study|Protocol Violation|1|||
143497714|NCT00793793|517364486|FG004|Overall Study|Protocol Violation|0|||
143497715|NCT00793793|517364487|FG005|Overall Study|Protocol Violation|0|||
143497716|NCT00793793|517364488|FG006|Overall Study|Protocol Violation|0|||
143497717|NCT00793793|517364489|FG007|Overall Study|Protocol Violation|0|||
143497718|NCT00793793|517364490|FG008|Overall Study|Protocol Violation|0|||
143497719|NCT00793793|517364491|FG009|Overall Study|Protocol Violation|0|||
143497720|NCT00793793|517364492|FG010|Overall Study|Protocol Violation|0|||
143497721|NCT00793793|517364493|FG011|Overall Study|Protocol Violation|0|||
143497722|NCT00793793|517364482|FG000|Overall Study|Lost to Follow-up|0|||
143163869|NCT00507507|516145470|FG000|Treatment Period|Withdrawal by Subject|46|||
143163870|NCT00507507|516145471|FG001|Treatment Period|Withdrawal by Subject|47|||
143163871|NCT00507507|516145470|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
143163872|NCT00507507|516145471|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
143497723|NCT00793793|517364483|FG001|Overall Study|Lost to Follow-up|0|||
143497724|NCT00793793|517364484|FG002|Overall Study|Lost to Follow-up|1|||
143497725|NCT00793793|517364485|FG003|Overall Study|Lost to Follow-up|0|||
143497726|NCT00793793|517364486|FG004|Overall Study|Lost to Follow-up|0|||
143497727|NCT00793793|517364487|FG005|Overall Study|Lost to Follow-up|0|||
143497728|NCT00793793|517364488|FG006|Overall Study|Lost to Follow-up|0|||
143497729|NCT00793793|517364489|FG007|Overall Study|Lost to Follow-up|0|||
143497730|NCT00793793|517364490|FG008|Overall Study|Lost to Follow-up|1|||
143163873|NCT00507507|516145470|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
143163874|NCT00507507|516145471|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
143163875|NCT00507507|516145470|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
143163876|NCT00507507|516145471|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
143163877|NCT01412983|516145473|FG000|1st Period|Ineligible|0|||
143163878|NCT01412983|516145474|FG001|1st Period|Ineligible|1|||
143163879|NCT01412983|516145473|FG000|1st Period|Positive slit lamp finding|0|||
143163880|NCT01412983|516145474|FG001|1st Period|Positive slit lamp finding|1|||
143163881|NCT01412983|516145473|FG000|1st Period|Unacceptable lens movement|0|||
143163882|NCT01412983|516145474|FG001|1st Period|Unacceptable lens movement|1|||
143163883|NCT01412983|516145473|FG000|1st Period|Inability to maintain wear|0|||
143163884|NCT01412983|516145474|FG001|1st Period|Inability to maintain wear|1|||
143163885|NCT00834587|516145478|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
143163886|NCT00834587|516145479|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
143163887|NCT00176254|516145480|FG000|Overall Study|Lost to Follow-up|1|||
143163888|NCT03289741|516145481|FG000|Overall Study|Adverse Event|1|||
143163889|NCT03289741|516145482|FG001|Overall Study|Adverse Event|1|||
143163890|NCT03289741|516145481|FG000|Overall Study|Physician Decision|2|||
143163891|NCT03289741|516145482|FG001|Overall Study|Physician Decision|2|||
143163892|NCT03289741|516145481|FG000|Overall Study|Withdrawal by Subject|1|||
143163893|NCT03289741|516145482|FG001|Overall Study|Withdrawal by Subject|0|||
143163894|NCT02536339|516145484|FG000|Overall Study|Death|20|||
143163895|NCT02536339|516145484|FG000|Overall Study|Withdrawal by Subject|3|||
143163896|NCT02536339|516145484|FG000|Overall Study|Lost to Follow-up|2|||
143163897|NCT02536339|516145484|FG000|Overall Study|Treatment discontinued|2|||
143163898|NCT02536339|516145484|FG000|Overall Study|Physician Decision|1|||
143497731|NCT00793793|517364491|FG009|Overall Study|Lost to Follow-up|3|||
143497732|NCT00793793|517364492|FG010|Overall Study|Lost to Follow-up|1|||
143497733|NCT00793793|517364493|FG011|Overall Study|Lost to Follow-up|0|||
143497734|NCT00793793|517364482|FG000|Overall Study|Withdrawal by Subject|0|||
143497735|NCT00793793|517364483|FG001|Overall Study|Withdrawal by Subject|0|||
143497736|NCT00793793|517364484|FG002|Overall Study|Withdrawal by Subject|0|||
143497737|NCT00793793|517364485|FG003|Overall Study|Withdrawal by Subject|0|||
143497738|NCT00793793|517364486|FG004|Overall Study|Withdrawal by Subject|1|||
143497739|NCT00793793|517364487|FG005|Overall Study|Withdrawal by Subject|0|||
143497740|NCT00793793|517364488|FG006|Overall Study|Withdrawal by Subject|0|||
143497741|NCT00793793|517364489|FG007|Overall Study|Withdrawal by Subject|0|||
143497742|NCT00793793|517364490|FG008|Overall Study|Withdrawal by Subject|1|||
143497743|NCT00793793|517364491|FG009|Overall Study|Withdrawal by Subject|0|||
143497744|NCT00793793|517364492|FG010|Overall Study|Withdrawal by Subject|0|||
143497745|NCT00793793|517364493|FG011|Overall Study|Withdrawal by Subject|0|||
143163899|NCT02037984|516145486|FG000|Overall Study|Lack of Efficacy|0|||
143163900|NCT02037984|516145487|FG001|Overall Study|Lack of Efficacy|0|||
143163901|NCT02037984|516145488|FG002|Overall Study|Lack of Efficacy|3|||
143163902|NCT02037984|516145489|FG003|Overall Study|Lack of Efficacy|10|||
143163903|NCT02037984|516145490|FG004|Overall Study|Lack of Efficacy|2|||
143040313|NCT01597245|515689278|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
143040314|NCT01597245|515689279|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
143040315|NCT01597245|515689280|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
143040316|NCT01597245|515689281|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
143040317|NCT01597245|515689282|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
143040318|NCT01597245|515689262|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
143040319|NCT01597245|515689263|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
143040320|NCT01597245|515689264|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
143040321|NCT01597245|515689265|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
143040322|NCT01597245|515689266|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
143040323|NCT01597245|515689267|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
143040324|NCT01597245|515689268|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
143040325|NCT01597245|515689269|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
143040326|NCT01597245|515689270|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
143040327|NCT01597245|515689271|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
143040328|NCT01597245|515689272|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
143040329|NCT01597245|515689273|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
143163904|NCT02037984|516145491|FG005|Overall Study|Lack of Efficacy|2|||
143163905|NCT02037984|516145492|FG006|Overall Study|Lack of Efficacy|4|||
143163906|NCT02037984|516145493|FG007|Overall Study|Lack of Efficacy|3|||
143163907|NCT02037984|516145486|FG000|Overall Study|Lost to Follow-up|1|||
143163908|NCT02037984|516145487|FG001|Overall Study|Lost to Follow-up|0|||
143163909|NCT02037984|516145488|FG002|Overall Study|Lost to Follow-up|3|||
143163910|NCT02037984|516145489|FG003|Overall Study|Lost to Follow-up|5|||
143163911|NCT02037984|516145490|FG004|Overall Study|Lost to Follow-up|2|||
143163912|NCT02037984|516145491|FG005|Overall Study|Lost to Follow-up|2|||
143163913|NCT02037984|516145492|FG006|Overall Study|Lost to Follow-up|2|||
143163914|NCT02037984|516145493|FG007|Overall Study|Lost to Follow-up|4|||
143163915|NCT02037984|516145486|FG000|Overall Study|Physician Decision|0|||
143163916|NCT02037984|516145487|FG001|Overall Study|Physician Decision|0|||
143163917|NCT02037984|516145488|FG002|Overall Study|Physician Decision|0|||
143163918|NCT02037984|516145489|FG003|Overall Study|Physician Decision|0|||
143163919|NCT02037984|516145490|FG004|Overall Study|Physician Decision|0|||
143163920|NCT02037984|516145491|FG005|Overall Study|Physician Decision|0|||
143163921|NCT02037984|516145492|FG006|Overall Study|Physician Decision|1|||
143163922|NCT02037984|516145493|FG007|Overall Study|Physician Decision|0|||
143163923|NCT02037984|516145486|FG000|Overall Study|Protocol Violation|0|||
143163924|NCT02037984|516145487|FG001|Overall Study|Protocol Violation|0|||
143163925|NCT02037984|516145488|FG002|Overall Study|Protocol Violation|0|||
143163926|NCT02037984|516145489|FG003|Overall Study|Protocol Violation|0|||
143163927|NCT02037984|516145490|FG004|Overall Study|Protocol Violation|0|||
143163928|NCT02037984|516145491|FG005|Overall Study|Protocol Violation|1|||
143163929|NCT02037984|516145492|FG006|Overall Study|Protocol Violation|2|||
143163930|NCT02037984|516145493|FG007|Overall Study|Protocol Violation|0|||
143163931|NCT02037984|516145486|FG000|Overall Study|Technical Problems|0|||
143163932|NCT02037984|516145487|FG001|Overall Study|Technical Problems|0|||
143163933|NCT02037984|516145488|FG002|Overall Study|Technical Problems|3|||
143163934|NCT02037984|516145489|FG003|Overall Study|Technical Problems|3|||
143163935|NCT02037984|516145490|FG004|Overall Study|Technical Problems|2|||
143163936|NCT02037984|516145491|FG005|Overall Study|Technical Problems|3|||
143163937|NCT02037984|516145492|FG006|Overall Study|Technical Problems|4|||
143163938|NCT02037984|516145493|FG007|Overall Study|Technical Problems|2|||
143163939|NCT02037984|516145486|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
143040330|NCT01597245|515689274|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
143163940|NCT02037984|516145487|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
143163941|NCT02037984|516145488|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
143163942|NCT02037984|516145489|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
143163943|NCT02037984|516145490|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
143163944|NCT02037984|516145491|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
143163945|NCT02037984|516145492|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
143163946|NCT02037984|516145493|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
143163947|NCT02037984|516145486|FG000|Overall Study|Withdrawal by Subject|0|||
143163948|NCT02037984|516145487|FG001|Overall Study|Withdrawal by Subject|0|||
143163949|NCT02037984|516145488|FG002|Overall Study|Withdrawal by Subject|0|||
143163950|NCT02037984|516145489|FG003|Overall Study|Withdrawal by Subject|1|||
143163951|NCT02037984|516145490|FG004|Overall Study|Withdrawal by Subject|1|||
143163952|NCT02037984|516145491|FG005|Overall Study|Withdrawal by Subject|3|||
143163953|NCT02037984|516145492|FG006|Overall Study|Withdrawal by Subject|0|||
143163954|NCT02037984|516145493|FG007|Overall Study|Withdrawal by Subject|1|||
143163955|NCT01251965|516147002|FG000|Overall Study|Participant/physician decision|1|||
143163956|NCT01251965|516147003|FG001|Overall Study|Participant/physician decision|2|||
143163957|NCT01251965|516147004|FG002|Overall Study|Participant/physician decision|0|||
143163958|NCT01251965|516147002|FG000|Overall Study|Death|0|||
143163959|NCT01251965|516147003|FG001|Overall Study|Death|0|||
143497746|NCT00793793|517364482|FG000|Overall Study|reason not specified|0|||
143497747|NCT00793793|517364483|FG001|Overall Study|reason not specified|1|||
143497748|NCT00793793|517364484|FG002|Overall Study|reason not specified|0|||
143497749|NCT00793793|517364485|FG003|Overall Study|reason not specified|1|||
143497750|NCT00793793|517364486|FG004|Overall Study|reason not specified|1|||
143497751|NCT00793793|517364487|FG005|Overall Study|reason not specified|1|||
143497752|NCT00793793|517364488|FG006|Overall Study|reason not specified|2|||
143497753|NCT00793793|517364489|FG007|Overall Study|reason not specified|0|||
143497754|NCT00793793|517364490|FG008|Overall Study|reason not specified|7|||
143497755|NCT00793793|517364491|FG009|Overall Study|reason not specified|6|||
143497756|NCT00793793|517364492|FG010|Overall Study|reason not specified|2|||
143497757|NCT00793793|517364493|FG011|Overall Study|reason not specified|4|||
143497758|NCT01552902|517364495|FG000|Overall Study|Adverse Event|1|||
143497759|NCT01552902|517364496|FG001|Overall Study|Adverse Event|15|||
143497760|NCT01552902|517364497|FG002|Overall Study|Adverse Event|14|||
143497761|NCT01552902|517364495|FG000|Overall Study|Protocol Violation|3|||
143497762|NCT01552902|517364496|FG001|Overall Study|Protocol Violation|3|||
143497763|NCT01552902|517364497|FG002|Overall Study|Protocol Violation|3|||
143497764|NCT01552902|517364495|FG000|Overall Study|Lack of Efficacy|4|||
143497765|NCT01552902|517364496|FG001|Overall Study|Lack of Efficacy|3|||
143497766|NCT01552902|517364497|FG002|Overall Study|Lack of Efficacy|1|||
143497767|NCT01552902|517364495|FG000|Overall Study|Withdrawal by Subject|1|||
143497768|NCT01552902|517364496|FG001|Overall Study|Withdrawal by Subject|9|||
143497769|NCT01552902|517364497|FG002|Overall Study|Withdrawal by Subject|6|||
143497770|NCT01552902|517364495|FG000|Overall Study|Lost to Follow-up|1|||
143497771|NCT01552902|517364496|FG001|Overall Study|Lost to Follow-up|3|||
143497772|NCT01552902|517364497|FG002|Overall Study|Lost to Follow-up|6|||
143497773|NCT01552902|517364495|FG000|Overall Study|Other|3|||
143497774|NCT01552902|517364496|FG001|Overall Study|Other|4|||
143497775|NCT01552902|517364497|FG002|Overall Study|Other|3|||
143497776|NCT01940484|517364500|FG000|Overall Study|Withdrawal by Subject|3|||
143497777|NCT01940484|517364500|FG000|Overall Study|Underwent transplantation|4|||
143497778|NCT01940484|517364500|FG000|Overall Study|Death|2|||
143497779|NCT01940484|517364500|FG000|Overall Study|Adverse Event|1|||
143497780|NCT03118947|517364509|FG000|Overall Study|Adverse Event|7|||
143497781|NCT03118947|517364509|FG000|Overall Study|Death|3|||
143497782|NCT03118947|517364509|FG000|Overall Study|Lack of Efficacy|4|||
143497783|NCT03118947|517364509|FG000|Overall Study|Non-compliance with study drug|1|||
143497784|NCT03118947|517364509|FG000|Overall Study|Protocol Violation|2|||
143497785|NCT03118947|517364509|FG000|Overall Study|Withdrawal by Subject|3|||
143497786|NCT03118947|517364509|FG000|Overall Study|Withdrawal by caregiver|3|||
143497787|NCT03118947|517364509|FG000|Overall Study|Change in patient's living situation|4|||
143497788|NCT03118947|517364509|FG000|Overall Study|Lost to Follow-up|2|||
143497789|NCT04451330|517364512|FG000|Overall Study|Adverse Event|1|||
143497790|NCT04451330|517364513|FG001|Overall Study|Adverse Event|2|||
143497791|NCT04451330|517364512|FG000|Overall Study|Lost to Follow-up|5|||
143497792|NCT04451330|517364513|FG001|Overall Study|Lost to Follow-up|0|||
143497793|NCT04451330|517364512|FG000|Overall Study|Withdrawal by Subject|3|||
143497794|NCT04451330|517364513|FG001|Overall Study|Withdrawal by Subject|1|||
143497795|NCT04451330|517364512|FG000|Overall Study|Withdrawal by parent/guardian|1|||
143497796|NCT04451330|517364513|FG001|Overall Study|Withdrawal by parent/guardian|0|||
143497797|NCT04451330|517364512|FG000|Overall Study|Other than specified|0|||
143497798|NCT04451330|517364513|FG001|Overall Study|Other than specified|1|||
143497799|NCT05099640|517364514|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
143497800|NCT05099640|517364515|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
143497801|NCT05099640|517364516|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
143497802|NCT05099640|517364514|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
143497803|NCT05099640|517364515|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
143497804|NCT05099640|517364516|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
143497805|NCT05099640|517364514|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
143497806|NCT05099640|517364515|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
143497807|NCT05099640|517364516|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
143497808|NCT05099640|517364514|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
143497809|NCT05099640|517364515|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
143497810|NCT05099640|517364516|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
143497811|NCT05099640|517364514|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
143497812|NCT05099640|517364515|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
143497813|NCT05099640|517364516|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
143497814|NCT05099640|517364514|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
143497815|NCT05099640|517364515|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
143497816|NCT05099640|517364516|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
143497817|NCT02690194|517364517|FG000|Overall Study|Withdrawal by Subject|1|||
143497818|NCT02690194|517364518|FG001|Overall Study|Withdrawal by Subject|4|||
143497819|NCT02690194|517364519|FG002|Overall Study|Withdrawal by Subject|0|||
143497820|NCT01552681|517364520|FG000|Overall Study|Withdrawal by Subject|4|||
143497821|NCT01552681|517364521|FG001|Overall Study|Withdrawal by Subject|0|||
143497822|NCT01552681|517364520|FG000|Overall Study|Physician Decision|1|||
143497823|NCT01552681|517364521|FG001|Overall Study|Physician Decision|0|||
143497824|NCT01552681|517364520|FG000|Overall Study|Subject moved away|0|||
143497825|NCT01552681|517364521|FG001|Overall Study|Subject moved away|1|||
143497826|NCT01987908|517364522|FG000|Placebo Lead-in Period|Adverse Event|2|||
143497827|NCT01987908|517364523|FG001|Placebo Lead-in Period|Adverse Event|0|||
143497828|NCT01987908|517364524|FG002|Placebo Lead-in Period|Adverse Event|0|||
143497829|NCT01987908|517364522|FG000|Placebo Lead-in Period|Physician Decision|2|||
143497830|NCT01987908|517364523|FG001|Placebo Lead-in Period|Physician Decision|0|||
143497831|NCT01987908|517364524|FG002|Placebo Lead-in Period|Physician Decision|0|||
143497832|NCT01987908|517364522|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
143497833|NCT01987908|517364523|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
143497834|NCT01987908|517364524|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
143497835|NCT01987908|517364522|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
143239986|NCT01383356|516431921|FG000|Period 1|Non-compliance|3|||
143239987|NCT01383356|516431922|FG001|Period 1|Non-compliance|0|||
143239988|NCT01383356|516431921|FG000|Period 1|Out of Range Mid-study-Test|0|||
143239989|NCT01383356|516431922|FG001|Period 1|Out of Range Mid-study-Test|1|||
143239990|NCT01383356|516431921|FG000|Period 1|Personal|0|||
143239991|NCT01383356|516431922|FG001|Period 1|Personal|2|||
143239992|NCT03584789|516431923|FG000|Overall Study|refused EHR permission|19|||
143239993|NCT03584789|516431924|FG001|Overall Study|refused EHR permission|28|||
143239994|NCT03584789|516431925|FG002|Overall Study|refused EHR permission|23|||
143239995|NCT03584789|516431923|FG000|Overall Study|patients tied to a provider who retired|0|||
143239996|NCT03584789|516431924|FG001|Overall Study|patients tied to a provider who retired|0|||
143239997|NCT03584789|516431925|FG002|Overall Study|patients tied to a provider who retired|3|||
143239998|NCT02035267|516431926|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
143239999|NCT02035267|516431927|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
143240000|NCT02035267|516431928|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
143240001|NCT02035267|516431929|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
143240002|NCT02035267|516431926|FG000|Overall Study|Adverse Event|0|||
143240003|NCT02035267|516431927|FG001|Overall Study|Adverse Event|0|||
143240004|NCT02035267|516431928|FG002|Overall Study|Adverse Event|1|||
143240005|NCT02035267|516431929|FG003|Overall Study|Adverse Event|0|||
143240006|NCT02035267|516431926|FG000|Overall Study|Lost to Follow-up|0|||
143240007|NCT02035267|516431927|FG001|Overall Study|Lost to Follow-up|0|||
143497836|NCT01987908|517364523|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
143497837|NCT01987908|517364524|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
143497838|NCT01987908|517364522|FG000|Treatment Period|Adverse Event|0|||
143497839|NCT01987908|517364523|FG001|Treatment Period|Adverse Event|1|||
143497840|NCT01987908|517364524|FG002|Treatment Period|Adverse Event|1|||
143497841|NCT01987908|517364522|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
143497842|NCT01987908|517364523|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
143497843|NCT01987908|517364524|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
143497844|NCT01987908|517364522|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
143497845|NCT01987908|517364523|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
143497846|NCT01987908|517364524|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
143497847|NCT00189462|517364525|FG000|Overall Study|Lack of Efficacy|5|||
143497848|NCT00189462|517364526|FG001|Overall Study|Lack of Efficacy|1|||
143497849|NCT00189462|517364525|FG000|Overall Study|Lost to Follow-up|18|||
143497850|NCT00189462|517364526|FG001|Overall Study|Lost to Follow-up|20|||
143497851|NCT02772757|517364528|FG000|Overall Study|Withdrawal by Subject|1|||
143497852|NCT02772757|517364529|FG001|Overall Study|Withdrawal by Subject|0|||
143497853|NCT02772757|517364530|FG002|Overall Study|Withdrawal by Subject|1|||
143497854|NCT02772757|517364528|FG000|Overall Study|Protocol Violation|0|||
143497855|NCT02772757|517364529|FG001|Overall Study|Protocol Violation|0|||
143497856|NCT02772757|517364530|FG002|Overall Study|Protocol Violation|1|||
143497857|NCT02772757|517364528|FG000|Overall Study|Physician Decision|0|||
143497858|NCT02772757|517364529|FG001|Overall Study|Physician Decision|3|||
143497859|NCT02772757|517364530|FG002|Overall Study|Physician Decision|3|||
143497860|NCT04698525|517364531|FG000|Overall Study|Lost to Follow-up|1|||
143497861|NCT04698525|517364532|FG001|Overall Study|Lost to Follow-up|2|||
143497862|NCT04698525|517364531|FG000|Overall Study|Three suffered of Covid-19|2|||
143497863|NCT04698525|517364532|FG001|Overall Study|Three suffered of Covid-19|1|||
143497864|NCT00441792|517364533|FG000|Overall Study|Lost to Follow-up|0|||
143497865|NCT00441792|517364534|FG001|Overall Study|Lost to Follow-up|2|||
143497866|NCT03665285|517364537|FG000|Overall Study|Started New Anticancer Treatment|1|||
143497867|NCT03665285|517364538|FG001|Overall Study|Started New Anticancer Treatment|1|||
143240008|NCT02035267|516431928|FG002|Overall Study|Lost to Follow-up|0|||
143240009|NCT02035267|516431929|FG003|Overall Study|Lost to Follow-up|1|||
143240010|NCT02035267|516431926|FG000|Overall Study|Other unspecified|0|||
143497868|NCT03665285|517364539|FG002|Overall Study|Started New Anticancer Treatment|2|||
143040331|NCT01597245|515689275|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
143040332|NCT01597245|515689276|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
143040333|NCT01597245|515689277|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
143040334|NCT01597245|515689278|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
143040335|NCT01597245|515689279|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
143040336|NCT01597245|515689280|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
143040337|NCT01597245|515689281|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
143040338|NCT01597245|515689282|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
143040339|NCT01597245|515689262|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
143040340|NCT01597245|515689263|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
143040341|NCT01597245|515689264|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
143040342|NCT01597245|515689265|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
143040343|NCT01597245|515689266|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
143040344|NCT01597245|515689267|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
143040345|NCT01597245|515689268|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
143040346|NCT01597245|515689269|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
143040347|NCT01597245|515689270|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
143040348|NCT01597245|515689271|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
143040349|NCT01597245|515689272|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
143040350|NCT01597245|515689273|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
143040351|NCT01597245|515689274|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
143040352|NCT01597245|515689275|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
143040353|NCT01597245|515689276|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
143040354|NCT01597245|515689277|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
143040355|NCT01597245|515689278|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
143040356|NCT01597245|515689279|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
143040357|NCT01597245|515689280|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
143040358|NCT01597245|515689281|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
143040359|NCT01597245|515689282|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
143040360|NCT01597245|515689262|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
143040361|NCT01597245|515689263|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
143040362|NCT01597245|515689264|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
143040363|NCT01597245|515689265|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
143040364|NCT01597245|515689266|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
143040365|NCT01597245|515689267|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
143040366|NCT01597245|515689268|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
143040367|NCT01597245|515689269|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
143040368|NCT01597245|515689270|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
143040369|NCT01597245|515689271|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
143240011|NCT02035267|516431927|FG001|Overall Study|Other unspecified|1|||
143240012|NCT02035267|516431928|FG002|Overall Study|Other unspecified|0|||
143240013|NCT02035267|516431929|FG003|Overall Study|Other unspecified|0|||
143240014|NCT00602472|516431930|FG000|Overall Study|Adverse Event|5|||
143240015|NCT00602472|516431931|FG001|Overall Study|Adverse Event|23|||
143240016|NCT00602472|516431930|FG000|Overall Study|Protocol Violation|4|||
143240017|NCT00602472|516431931|FG001|Overall Study|Protocol Violation|19|||
143364222|NCT01822821|516875608|FG001|Overall Study|Eligible surgery cancelled|1|||
143364223|NCT01822821|516875607|FG000|Overall Study|Other reasons|1|||
143364224|NCT01822821|516875608|FG001|Overall Study|Other reasons|0|||
143364225|NCT02320253|516875609|FG000|Overall Study|Withdrawal by Subject|3|||
143364226|NCT02320253|516875610|FG001|Overall Study|Withdrawal by Subject|0|||
143364227|NCT02320253|516875611|FG002|Overall Study|Withdrawal by Subject|0|||
143364228|NCT02320253|516875609|FG000|Overall Study|Lost to Follow-up|2|||
143364229|NCT02320253|516875610|FG001|Overall Study|Lost to Follow-up|2|||
143364230|NCT02320253|516875611|FG002|Overall Study|Lost to Follow-up|1|||
143364231|NCT02320253|516875609|FG000|Overall Study|Death|1|||
143040370|NCT01597245|515689272|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
143040371|NCT01597245|515689273|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
143240018|NCT00602472|516431930|FG000|Overall Study|Withdrawal by Subject|8|||
143240019|NCT00602472|516431931|FG001|Overall Study|Withdrawal by Subject|14|||
143040372|NCT01597245|515689274|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
143040373|NCT01597245|515689275|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
143364232|NCT02320253|516875610|FG001|Overall Study|Death|0|||
143364233|NCT02320253|516875611|FG002|Overall Study|Death|1|||
143364234|NCT05750745|516875612|FG000|Overall Study|Adverse Event|1|||
143040374|NCT01597245|515689276|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
143364235|NCT05750745|516875613|FG001|Overall Study|Adverse Event|0|||
143240020|NCT00602472|516431930|FG000|Overall Study|Other incl. lack of efficacy|4|||
143364236|NCT05750745|516875614|FG002|Overall Study|Adverse Event|0|||
143364237|NCT05750745|516875612|FG000|Overall Study|Protocol Violation|1|||
143040375|NCT01597245|515689277|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
143040376|NCT01597245|515689278|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
143040377|NCT01597245|515689279|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
143040378|NCT01597245|515689280|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
143040379|NCT01597245|515689281|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
143040380|NCT01597245|515689282|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
143040381|NCT01597245|515689262|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
143040382|NCT01597245|515689263|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
143040383|NCT01597245|515689264|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
143040384|NCT01597245|515689265|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
143040385|NCT01597245|515689266|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
143040386|NCT01597245|515689267|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
143040387|NCT01597245|515689268|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
143040388|NCT01597245|515689269|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
143040389|NCT01597245|515689270|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
143040390|NCT01597245|515689271|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
143040391|NCT01597245|515689272|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
143040392|NCT01597245|515689273|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
143040393|NCT01597245|515689274|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
143040394|NCT01597245|515689275|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
143040395|NCT01597245|515689276|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
143040396|NCT01597245|515689277|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
143040397|NCT01597245|515689278|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
143163960|NCT01251965|516147004|FG002|Overall Study|Death|11|||
143163961|NCT05401409|516147005|FG000|Overall Study|Lost to Follow-up|1|||
143040398|NCT01597245|515689279|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
143040399|NCT01597245|515689280|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
143040400|NCT01597245|515689281|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
143040401|NCT01597245|515689282|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
143163962|NCT05401409|516147006|FG001|Overall Study|Lost to Follow-up|0|||
143163963|NCT02410200|516147007|FG000|Overall Study|Adverse Event|2|||
143163964|NCT00866775|516147008|FG000|Overall Study|Adverse Event|5|||
143163965|NCT00866775|516147009|FG001|Overall Study|Adverse Event|19|||
143163966|NCT00866775|516147008|FG000|Overall Study|Death|1|||
143163967|NCT00866775|516147009|FG001|Overall Study|Death|0|||
143163968|NCT00866775|516147008|FG000|Overall Study|Lost to Follow-up|0|||
143163969|NCT00866775|516147009|FG001|Overall Study|Lost to Follow-up|4|||
143163970|NCT00866775|516147008|FG000|Overall Study|Physician Decision|0|||
143163971|NCT00866775|516147009|FG001|Overall Study|Physician Decision|3|||
143163972|NCT00866775|516147008|FG000|Overall Study|Protocol Violation|3|||
143163973|NCT00866775|516147009|FG001|Overall Study|Protocol Violation|4|||
143163974|NCT00866775|516147008|FG000|Overall Study|Withdrawal by Subject|4|||
143163975|NCT00866775|516147009|FG001|Overall Study|Withdrawal by Subject|4|||
143163976|NCT00866775|516147008|FG000|Overall Study|met exit criteria|23|||
143163977|NCT00866775|516147009|FG001|Overall Study|met exit criteria|17|||
143163978|NCT00866775|516147008|FG000|Overall Study|discontinued due to communication error|0|||
143163979|NCT00866775|516147009|FG001|Overall Study|discontinued due to communication error|1|||
143163980|NCT02336555|516147011|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
143163981|NCT02336555|516147012|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
143163982|NCT02336555|516147011|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
143163983|NCT02336555|516147012|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
143163984|NCT02336555|516147011|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
143163985|NCT02336555|516147012|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
143163986|NCT00993473|516147013|FG000|Overall Study|Adverse Event|0|||
143163987|NCT00993473|516147014|FG001|Overall Study|Adverse Event|2|||
143163988|NCT00993473|516147013|FG000|Overall Study|Protocol Violation|1|||
143163989|NCT00993473|516147014|FG001|Overall Study|Protocol Violation|2|||
143163990|NCT00993473|516147013|FG000|Overall Study|Lost to Follow-up|1|||
143163991|NCT00993473|516147014|FG001|Overall Study|Lost to Follow-up|0|||
143163992|NCT00993473|516147013|FG000|Overall Study|Withdrawal by Subject|1|||
143163993|NCT00993473|516147014|FG001|Overall Study|Withdrawal by Subject|5|||
143163994|NCT00993473|516147013|FG000|Overall Study|Technical problem with CGM device|0|||
143240021|NCT00602472|516431931|FG001|Overall Study|Other incl. lack of efficacy|2|||
143240022|NCT00823615|516431934|FG000|Period 2|Lost to Follow-up|2|||
143040402|NCT01597245|515689262|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
143040403|NCT01597245|515689263|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
143163995|NCT00993473|516147014|FG001|Overall Study|Technical problem with CGM device|1|||
143240023|NCT00823615|516431935|FG001|Period 2|Lost to Follow-up|0|||
143163996|NCT00993473|516147013|FG000|Overall Study|Family event|1|||
143163997|NCT00993473|516147014|FG001|Overall Study|Family event|0|||
143163998|NCT03682367|516147019|FG000|Overall Study|Protocol Violation|2|||
143040404|NCT01597245|515689264|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
143040405|NCT01597245|515689265|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
143163999|NCT03682367|516147020|FG001|Overall Study|Protocol Violation|1|||
143164000|NCT03682367|516147019|FG000|Overall Study|Closed Study Early|0|||
143164001|NCT03682367|516147020|FG001|Overall Study|Closed Study Early|3|||
143164002|NCT03707821|516147021|FG000|Overall Study|Protocol Violation|0|||
143164003|NCT03707821|516147022|FG001|Overall Study|Protocol Violation|1|||
143164004|NCT03707821|516147021|FG000|Overall Study|Unsatisfactory Visual Response|1|||
143164005|NCT03707821|516147022|FG001|Overall Study|Unsatisfactory Visual Response|0|||
143164006|NCT03707821|516147021|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
143164007|NCT03707821|516147022|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
143164008|NCT00889005|516147023|FG000|Overall Study|Lost to Follow-up|4|||
143164009|NCT00889005|516147024|FG001|Overall Study|Lost to Follow-up|2|||
143164010|NCT00889005|516147023|FG000|Overall Study|Withdrawal by Subject|4|||
143164011|NCT00889005|516147024|FG001|Overall Study|Withdrawal by Subject|0|||
143164012|NCT00266032|516147025|FG000|Treatment|Adverse Event|42|||
143164013|NCT00266032|516147026|FG001|Treatment|Adverse Event|26|||
143164014|NCT00266032|516147027|FG002|Treatment|Adverse Event|10|||
143164015|NCT00266032|516147025|FG000|Treatment|Lost to Follow-up|19|||
143164016|NCT00266032|516147026|FG001|Treatment|Lost to Follow-up|4|||
143164017|NCT00266032|516147027|FG002|Treatment|Lost to Follow-up|2|||
143164018|NCT00266032|516147025|FG000|Treatment|Pregnancy|3|||
143164019|NCT00266032|516147026|FG001|Treatment|Pregnancy|2|||
143164020|NCT00266032|516147027|FG002|Treatment|Pregnancy|2|||
143164021|NCT00266032|516147025|FG000|Treatment|Protocol Violation|6|||
143164022|NCT00266032|516147026|FG001|Treatment|Protocol Violation|14|||
143164023|NCT00266032|516147027|FG002|Treatment|Protocol Violation|13|||
143164024|NCT00266032|516147025|FG000|Treatment|Withdrawal by Subject|28|||
143164025|NCT00266032|516147026|FG001|Treatment|Withdrawal by Subject|13|||
143164026|NCT00266032|516147027|FG002|Treatment|Withdrawal by Subject|12|||
143164027|NCT00266032|516147025|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
143164028|NCT00266032|516147026|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
143164029|NCT00266032|516147027|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
143164030|NCT00266032|516147025|FG000|Open-label Safety Extension|Adverse Event|5|||
143164031|NCT00266032|516147026|FG001|Open-label Safety Extension|Adverse Event|0|||
143164032|NCT00266032|516147027|FG002|Open-label Safety Extension|Adverse Event|4|||
143164033|NCT00266032|516147025|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
143164034|NCT00266032|516147026|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
143164035|NCT00266032|516147027|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
143164036|NCT00266032|516147025|FG000|Open-label Safety Extension|Pregnancy|4|||
143164037|NCT00266032|516147026|FG001|Open-label Safety Extension|Pregnancy|1|||
143164038|NCT00266032|516147027|FG002|Open-label Safety Extension|Pregnancy|2|||
143164039|NCT00266032|516147025|FG000|Open-label Safety Extension|Protocol Violation|1|||
143164040|NCT00266032|516147026|FG001|Open-label Safety Extension|Protocol Violation|3|||
143164041|NCT00266032|516147027|FG002|Open-label Safety Extension|Protocol Violation|2|||
143164042|NCT00266032|516147025|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
143164043|NCT00266032|516147026|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
143164044|NCT00266032|516147027|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
143164045|NCT00266032|516147025|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
143164046|NCT00266032|516147026|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
143164047|NCT00266032|516147027|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
143164048|NCT00124657|516147028|FG000|Overall Study|Toxicity|0|||
143164049|NCT00124657|516147029|FG001|Overall Study|Toxicity|0|||
143240024|NCT00823615|516431934|FG000|Period 2|Time/Job Conflict|1|||
143240025|NCT00823615|516431935|FG001|Period 2|Time/Job Conflict|2|||
143240026|NCT00098813|516431936|FG000|Overall Study|Death|8|||
143240027|NCT00098813|516431936|FG000|Overall Study|Protocol Violation|1|||
143240028|NCT00098813|516431936|FG000|Overall Study|Withdrawal by Subject|7|||
143240029|NCT00098813|516431936|FG000|Overall Study|Progression of Disease|1|||
143240030|NCT00098813|516431936|FG000|Overall Study|Other complicating disease|1|||
143240031|NCT00098813|516431936|FG000|Overall Study|Reversal of RAI resistance|1|||
143240032|NCT03926611|516431938|FG000|Overall Study|Adverse Event|0|||
143240033|NCT03926611|516431939|FG001|Overall Study|Adverse Event|0|||
143240034|NCT03926611|516431940|FG002|Overall Study|Adverse Event|0|||
143240035|NCT03926611|516431941|FG003|Overall Study|Adverse Event|3|||
143040406|NCT01597245|515689266|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
143240036|NCT03926611|516431942|FG004|Overall Study|Adverse Event|1|||
143240037|NCT03926611|516431943|FG005|Overall Study|Adverse Event|3|||
143240038|NCT03926611|516431944|FG006|Overall Study|Adverse Event|0|||
143240039|NCT03926611|516431938|FG000|Overall Study|Lack of Efficacy|1|||
143240040|NCT03926611|516431939|FG001|Overall Study|Lack of Efficacy|2|||
143240041|NCT03926611|516431940|FG002|Overall Study|Lack of Efficacy|0|||
143164050|NCT00124657|516147030|FG002|Overall Study|Toxicity|1|||
143164051|NCT00124657|516147028|FG000|Overall Study|Non-compliance|1|||
143164052|NCT00124657|516147029|FG001|Overall Study|Non-compliance|0|||
143164053|NCT00124657|516147030|FG002|Overall Study|Non-compliance|4|||
143497869|NCT03665285|517364540|FG003|Overall Study|Started New Anticancer Treatment|4|||
143040407|NCT01597245|515689267|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
143040408|NCT01597245|515689268|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
143040409|NCT01597245|515689269|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
143040410|NCT01597245|515689270|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
143040411|NCT01597245|515689271|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
143040412|NCT01597245|515689272|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
143040413|NCT01597245|515689273|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
143040414|NCT01597245|515689274|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
143040415|NCT01597245|515689275|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
143040416|NCT01597245|515689276|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
143040417|NCT01597245|515689277|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
143040418|NCT01597245|515689278|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
143040419|NCT01597245|515689279|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
143040420|NCT01597245|515689280|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
143040421|NCT01597245|515689281|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
143040422|NCT01597245|515689282|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
143040423|NCT01597245|515689262|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
143040424|NCT01597245|515689263|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
143040425|NCT01597245|515689264|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
143040426|NCT01597245|515689265|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
143040427|NCT01597245|515689266|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
143040428|NCT01597245|515689267|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
143040429|NCT01597245|515689268|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
143040430|NCT01597245|515689269|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
143040431|NCT01597245|515689270|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
143040432|NCT01597245|515689271|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
143040433|NCT01597245|515689272|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
143040434|NCT01597245|515689273|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
143040435|NCT01597245|515689274|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
143040436|NCT01597245|515689275|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
143040437|NCT01597245|515689276|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
143040438|NCT01597245|515689277|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
143040439|NCT01597245|515689278|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
143040440|NCT01597245|515689279|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
143040441|NCT01597245|515689280|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
143040442|NCT01597245|515689281|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
143040443|NCT01597245|515689282|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
143040444|NCT01597245|515689262|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
143040445|NCT01597245|515689263|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
143040446|NCT01597245|515689264|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
143040447|NCT01597245|515689265|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
143040448|NCT01597245|515689266|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
143040449|NCT01597245|515689267|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
143040450|NCT01597245|515689268|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
143040451|NCT01597245|515689269|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
143040452|NCT01597245|515689270|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
143040453|NCT01597245|515689271|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
143040454|NCT01597245|515689272|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
143040455|NCT01597245|515689273|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
143040456|NCT01597245|515689274|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
143040457|NCT01597245|515689275|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
143040458|NCT01597245|515689276|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
143040459|NCT01597245|515689277|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
143040460|NCT01597245|515689278|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
143040461|NCT01597245|515689279|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
143040462|NCT01597245|515689280|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
143164054|NCT00124657|516147028|FG000|Overall Study|Progressive disease|14|||
143164055|NCT00124657|516147029|FG001|Overall Study|Progressive disease|5|||
143164056|NCT00124657|516147030|FG002|Overall Study|Progressive disease|27|||
143164057|NCT00124657|516147028|FG000|Overall Study|Intercurrent illness|1|||
143164058|NCT00124657|516147029|FG001|Overall Study|Intercurrent illness|0|||
143164059|NCT00124657|516147030|FG002|Overall Study|Intercurrent illness|0|||
143164060|NCT01475825|516147035|FG000|Overall Study|Adverse Event|41|||
143164061|NCT01475825|516147036|FG001|Overall Study|Adverse Event|15|||
143040463|NCT01597245|515689281|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
143040464|NCT01597245|515689282|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
143040465|NCT01597245|515689262|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
143040466|NCT01597245|515689263|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
143040467|NCT01597245|515689264|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
143040468|NCT01597245|515689265|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
143240042|NCT03926611|516431941|FG003|Overall Study|Lack of Efficacy|0|||
143240043|NCT03926611|516431942|FG004|Overall Study|Lack of Efficacy|1|||
143240044|NCT03926611|516431943|FG005|Overall Study|Lack of Efficacy|0|||
143240045|NCT03926611|516431944|FG006|Overall Study|Lack of Efficacy|1|||
143240046|NCT03926611|516431938|FG000|Overall Study|Physician Decision|0|||
143240047|NCT03926611|516431939|FG001|Overall Study|Physician Decision|0|||
143240048|NCT03926611|516431940|FG002|Overall Study|Physician Decision|0|||
143240049|NCT03926611|516431941|FG003|Overall Study|Physician Decision|0|||
143240050|NCT03926611|516431942|FG004|Overall Study|Physician Decision|0|||
143240051|NCT03926611|516431943|FG005|Overall Study|Physician Decision|1|||
143240052|NCT03926611|516431944|FG006|Overall Study|Physician Decision|0|||
143240053|NCT03926611|516431938|FG000|Overall Study|Protocol Violation|1|||
143240054|NCT03926611|516431939|FG001|Overall Study|Protocol Violation|0|||
143240055|NCT03926611|516431940|FG002|Overall Study|Protocol Violation|0|||
143240056|NCT03926611|516431941|FG003|Overall Study|Protocol Violation|1|||
143240057|NCT03926611|516431942|FG004|Overall Study|Protocol Violation|1|||
143240058|NCT03926611|516431943|FG005|Overall Study|Protocol Violation|1|||
143240059|NCT03926611|516431944|FG006|Overall Study|Protocol Violation|1|||
143240060|NCT03926611|516431938|FG000|Overall Study|Technical problems|0|||
143240061|NCT03926611|516431939|FG001|Overall Study|Technical problems|0|||
143164062|NCT01475825|516147037|FG002|Overall Study|Adverse Event|27|||
143164063|NCT01475825|516147038|FG003|Overall Study|Adverse Event|11|||
143164064|NCT01475825|516147035|FG000|Overall Study|Death|1|||
143164065|NCT01475825|516147036|FG001|Overall Study|Death|0|||
143164066|NCT01475825|516147037|FG002|Overall Study|Death|1|||
143164067|NCT01475825|516147038|FG003|Overall Study|Death|0|||
143164068|NCT01475825|516147035|FG000|Overall Study|Lack of Efficacy|0|||
143164069|NCT01475825|516147036|FG001|Overall Study|Lack of Efficacy|0|||
143164070|NCT01475825|516147037|FG002|Overall Study|Lack of Efficacy|1|||
143164071|NCT01475825|516147038|FG003|Overall Study|Lack of Efficacy|0|||
143164072|NCT01475825|516147035|FG000|Overall Study|Lost to Follow-up|0|||
143164073|NCT01475825|516147036|FG001|Overall Study|Lost to Follow-up|0|||
143164074|NCT01475825|516147037|FG002|Overall Study|Lost to Follow-up|3|||
143164075|NCT01475825|516147038|FG003|Overall Study|Lost to Follow-up|1|||
143164076|NCT01475825|516147035|FG000|Overall Study|Non-compliance with Study Drug|1|||
143164077|NCT01475825|516147036|FG001|Overall Study|Non-compliance with Study Drug|2|||
143164078|NCT01475825|516147037|FG002|Overall Study|Non-compliance with Study Drug|4|||
143164079|NCT01475825|516147038|FG003|Overall Study|Non-compliance with Study Drug|0|||
143164080|NCT01475825|516147035|FG000|Overall Study|Other: Not available|0|||
143164081|NCT01475825|516147036|FG001|Overall Study|Other: Not available|0|||
143164082|NCT01475825|516147037|FG002|Overall Study|Other: Not available|2|||
143164083|NCT01475825|516147038|FG003|Overall Study|Other: Not available|0|||
143164084|NCT01475825|516147035|FG000|Overall Study|Protocol Violation|1|||
143164085|NCT01475825|516147036|FG001|Overall Study|Protocol Violation|0|||
143164086|NCT01475825|516147037|FG002|Overall Study|Protocol Violation|0|||
143164087|NCT01475825|516147038|FG003|Overall Study|Protocol Violation|0|||
143164088|NCT01475825|516147035|FG000|Overall Study|Physician Decision|0|||
143164089|NCT01475825|516147036|FG001|Overall Study|Physician Decision|1|||
143164090|NCT01475825|516147037|FG002|Overall Study|Physician Decision|0|||
143164091|NCT01475825|516147038|FG003|Overall Study|Physician Decision|0|||
143164092|NCT01475825|516147035|FG000|Overall Study|Withdrawal by Subject|8|||
143240062|NCT03926611|516431940|FG002|Overall Study|Technical problems|0|||
143240063|NCT03926611|516431941|FG003|Overall Study|Technical problems|0|||
143240064|NCT03926611|516431942|FG004|Overall Study|Technical problems|0|||
143240065|NCT03926611|516431943|FG005|Overall Study|Technical problems|1|||
143040469|NCT01597245|515689266|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
143040470|NCT01597245|515689267|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
143164093|NCT01475825|516147036|FG001|Overall Study|Withdrawal by Subject|3|||
143164094|NCT01475825|516147037|FG002|Overall Study|Withdrawal by Subject|11|||
143164095|NCT01475825|516147038|FG003|Overall Study|Withdrawal by Subject|7|||
143164096|NCT01475825|516147035|FG000|Overall Study|Did not enter OLC|15|||
143164097|NCT01475825|516147036|FG001|Overall Study|Did not enter OLC|11|||
143164098|NCT01475825|516147037|FG002|Overall Study|Did not enter OLC|15|||
143164099|NCT01475825|516147038|FG003|Overall Study|Did not enter OLC|11|||
143164100|NCT04157738|516147039|FG000|Overall Study|Moved out of state|0|||
143164101|NCT04157738|516147040|FG001|Overall Study|Moved out of state|2|||
143164102|NCT04157738|516147039|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
143164103|NCT04157738|516147040|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
143164104|NCT00160563|516147041|FG000|Overall Study|Adverse Event|1|||
143164105|NCT00160563|516147042|FG001|Overall Study|Adverse Event|1|||
143240066|NCT03926611|516431944|FG006|Overall Study|Technical problems|0|||
143040471|NCT01597245|515689268|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
143040472|NCT01597245|515689269|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
143040473|NCT01597245|515689270|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
143040474|NCT01597245|515689271|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
143040475|NCT01597245|515689272|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
143040476|NCT01597245|515689273|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
143040477|NCT01597245|515689274|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
143040478|NCT01597245|515689275|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
143040479|NCT01597245|515689276|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
143040480|NCT01597245|515689277|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
143040481|NCT01597245|515689278|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
143040482|NCT01597245|515689279|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
143040483|NCT01597245|515689280|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
143040484|NCT01597245|515689281|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
143040485|NCT01597245|515689282|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
143040486|NCT01597245|515689262|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
143040487|NCT01597245|515689263|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
143040488|NCT01597245|515689264|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
143040489|NCT01597245|515689265|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
143040490|NCT01597245|515689266|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
143040491|NCT01597245|515689267|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
143040492|NCT01597245|515689268|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
143040493|NCT01597245|515689269|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
143040494|NCT01597245|515689270|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
143040495|NCT01597245|515689271|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
143040496|NCT01597245|515689272|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
143164106|NCT00160563|516147043|FG002|Overall Study|Adverse Event|1|||
143164107|NCT00160563|516147041|FG000|Overall Study|Lost to Follow-up|1|||
143164108|NCT00160563|516147042|FG001|Overall Study|Lost to Follow-up|1|||
143164109|NCT00160563|516147043|FG002|Overall Study|Lost to Follow-up|2|||
143164110|NCT00160563|516147041|FG000|Overall Study|Protocol Violation|0|||
143164111|NCT00160563|516147042|FG001|Overall Study|Protocol Violation|0|||
143164112|NCT00160563|516147043|FG002|Overall Study|Protocol Violation|3|||
143164113|NCT00160563|516147041|FG000|Overall Study|Withdrawal by Subject|1|||
143164114|NCT00160563|516147042|FG001|Overall Study|Withdrawal by Subject|2|||
143164115|NCT00160563|516147043|FG002|Overall Study|Withdrawal by Subject|3|||
143164116|NCT00160563|516147041|FG000|Overall Study|Other (listed in the study report)|48|||
143164117|NCT00160563|516147042|FG001|Overall Study|Other (listed in the study report)|40|||
143164118|NCT00160563|516147043|FG002|Overall Study|Other (listed in the study report)|81|||
143164119|NCT00160563|516147041|FG000|Overall Study|Missing reason|0|||
143164120|NCT00160563|516147042|FG001|Overall Study|Missing reason|1|||
143164121|NCT00160563|516147043|FG002|Overall Study|Missing reason|0|||
143164122|NCT03766906|516147048|FG000|Overall Study|Withdrawal by Subject|6|||
143164123|NCT01047540|516147051|FG000|Overall Study|Protocol Violation|1|||
143164124|NCT01047540|516147052|FG001|Overall Study|Protocol Violation|0|||
143164125|NCT01047540|516147053|FG002|Overall Study|Protocol Violation|0|||
143164126|NCT01047540|516147054|FG003|Overall Study|Protocol Violation|0|||
143164127|NCT01047540|516147055|FG004|Overall Study|Protocol Violation|0|||
143164128|NCT01047540|516147051|FG000|Overall Study|Lost to Follow-up|1|||
143164129|NCT01047540|516147052|FG001|Overall Study|Lost to Follow-up|0|||
143164130|NCT01047540|516147053|FG002|Overall Study|Lost to Follow-up|0|||
143240067|NCT03926611|516431938|FG000|Overall Study|Withdrawal by Subject|1|||
143497870|NCT03665285|517364541|FG004|Overall Study|Started New Anticancer Treatment|1|||
143040497|NCT01597245|515689273|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
143040498|NCT01597245|515689274|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
143164131|NCT01047540|516147054|FG003|Overall Study|Lost to Follow-up|0|||
143164132|NCT01047540|516147055|FG004|Overall Study|Lost to Follow-up|0|||
143164133|NCT01047540|516147051|FG000|Overall Study|Withdrawal by Subject|1|||
143164134|NCT01047540|516147052|FG001|Overall Study|Withdrawal by Subject|0|||
143164135|NCT01047540|516147053|FG002|Overall Study|Withdrawal by Subject|3|||
143164136|NCT01047540|516147054|FG003|Overall Study|Withdrawal by Subject|0|||
143164137|NCT01047540|516147055|FG004|Overall Study|Withdrawal by Subject|1|||
143164138|NCT01047540|516147051|FG000|Overall Study|Pregnancy|1|||
143164139|NCT01047540|516147052|FG001|Overall Study|Pregnancy|0|||
143164140|NCT01047540|516147053|FG002|Overall Study|Pregnancy|0|||
143164141|NCT01047540|516147054|FG003|Overall Study|Pregnancy|0|||
143164142|NCT01047540|516147055|FG004|Overall Study|Pregnancy|0|||
143164143|NCT01047540|516147051|FG000|Overall Study|Adverse Event|1|||
143164144|NCT01047540|516147052|FG001|Overall Study|Adverse Event|0|||
143164145|NCT01047540|516147053|FG002|Overall Study|Adverse Event|0|||
143164146|NCT01047540|516147054|FG003|Overall Study|Adverse Event|0|||
143164147|NCT01047540|516147055|FG004|Overall Study|Adverse Event|0|||
143040499|NCT01597245|515689275|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
143040500|NCT01597245|515689276|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
143040501|NCT01597245|515689277|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
143040502|NCT01597245|515689278|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
143040503|NCT01597245|515689279|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
143040504|NCT01597245|515689280|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
143040505|NCT01597245|515689281|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
143040506|NCT01597245|515689282|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
143040507|NCT01597245|515689262|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
143040508|NCT01597245|515689263|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
143040509|NCT01597245|515689264|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
143040510|NCT01597245|515689265|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
143040511|NCT01597245|515689266|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
143040512|NCT01597245|515689267|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
143040513|NCT01597245|515689268|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
143040514|NCT01597245|515689269|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
143040515|NCT01597245|515689270|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
143040516|NCT01597245|515689271|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
143040517|NCT01597245|515689272|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
143040518|NCT01597245|515689273|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
143040519|NCT01597245|515689274|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
143040520|NCT01597245|515689275|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
143040521|NCT01597245|515689276|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
143040522|NCT01597245|515689277|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
143040523|NCT01597245|515689278|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
143040524|NCT01597245|515689279|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
143040525|NCT01597245|515689280|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
143040526|NCT01597245|515689281|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
143040527|NCT01597245|515689282|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
143040528|NCT01597245|515689262|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
143040529|NCT01597245|515689263|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
143040530|NCT01597245|515689264|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
143040531|NCT01597245|515689265|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
143040532|NCT01597245|515689266|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
143040533|NCT01597245|515689267|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
143040534|NCT01597245|515689268|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
143040535|NCT01597245|515689269|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
143040536|NCT01597245|515689270|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
143040537|NCT01597245|515689271|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
143040538|NCT01597245|515689272|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
143040539|NCT01597245|515689273|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
143040540|NCT01597245|515689274|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
143040541|NCT01597245|515689275|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
143040542|NCT01597245|515689276|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
143040543|NCT01597245|515689277|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
143040544|NCT01597245|515689278|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
143040545|NCT01597245|515689279|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
143040546|NCT01597245|515689280|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
143040547|NCT01597245|515689281|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
143164148|NCT03760081|516147058|FG000|Overall Study|Miscellaneous|0|||
143164149|NCT03760081|516147059|FG001|Overall Study|Miscellaneous|1|||
143164150|NCT03760081|516147058|FG000|Overall Study|Progressive Disease|5|||
143497871|NCT03665285|517364542|FG005|Overall Study|Started New Anticancer Treatment|1|||
143497872|NCT03665285|517364543|FG006|Overall Study|Started New Anticancer Treatment|2|||
143040548|NCT01597245|515689282|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
143040549|NCT01597245|515689262|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
143164151|NCT03760081|516147059|FG001|Overall Study|Progressive Disease|10|||
143164152|NCT03760081|516147058|FG000|Overall Study|Death|1|||
143497873|NCT03665285|517364544|FG007|Overall Study|Started New Anticancer Treatment|15|||
143497874|NCT03665285|517364545|FG008|Overall Study|Started New Anticancer Treatment|1|||
143497875|NCT03665285|517364537|FG000|Overall Study|Disease Progression|0|||
143497876|NCT03665285|517364538|FG001|Overall Study|Disease Progression|0|||
143497877|NCT03665285|517364539|FG002|Overall Study|Disease Progression|3|||
143497878|NCT03665285|517364540|FG003|Overall Study|Disease Progression|1|||
143164153|NCT03760081|516147059|FG001|Overall Study|Death|1|||
143240068|NCT03926611|516431939|FG001|Overall Study|Withdrawal by Subject|1|||
143240069|NCT03926611|516431940|FG002|Overall Study|Withdrawal by Subject|1|||
143240070|NCT03926611|516431941|FG003|Overall Study|Withdrawal by Subject|0|||
143240071|NCT03926611|516431942|FG004|Overall Study|Withdrawal by Subject|0|||
143240072|NCT03926611|516431943|FG005|Overall Study|Withdrawal by Subject|1|||
143240073|NCT03926611|516431944|FG006|Overall Study|Withdrawal by Subject|3|||
143240074|NCT03926611|516431938|FG000|Overall Study|Covid-19 pandemic|0|||
143240075|NCT03926611|516431939|FG001|Overall Study|Covid-19 pandemic|0|||
143240076|NCT03926611|516431940|FG002|Overall Study|Covid-19 pandemic|1|||
143240077|NCT03926611|516431941|FG003|Overall Study|Covid-19 pandemic|0|||
143240078|NCT03926611|516431942|FG004|Overall Study|Covid-19 pandemic|1|||
143240079|NCT03926611|516431943|FG005|Overall Study|Covid-19 pandemic|2|||
143240080|NCT03926611|516431944|FG006|Overall Study|Covid-19 pandemic|0|||
143240081|NCT00084136|516431947|FG000|PI Comparison|Death|10|||
143240082|NCT00084136|516431948|FG001|PI Comparison|Death|9|||
143240083|NCT00084136|516431949|FG002|PI Comparison|Death|0|||
143240084|NCT00084136|516431947|FG000|PI Comparison|Lost to Follow-up|11|||
143240085|NCT00084136|516431948|FG001|PI Comparison|Lost to Follow-up|8|||
143240086|NCT00084136|516431949|FG002|PI Comparison|Lost to Follow-up|0|||
143240087|NCT00084136|516431947|FG000|PI Comparison|Withdrawal by Subject|33|||
143240088|NCT00084136|516431948|FG001|PI Comparison|Withdrawal by Subject|30|||
143240089|NCT00084136|516431949|FG002|PI Comparison|Withdrawal by Subject|0|||
143240090|NCT00084136|516431947|FG000|PI Comparison|Clinic site closed|1|||
143240091|NCT00084136|516431948|FG001|PI Comparison|Clinic site closed|0|||
143240092|NCT00084136|516431949|FG002|PI Comparison|Clinic site closed|0|||
143240093|NCT00084136|516431947|FG000|NRTI Comparison|Death|20|||
143240094|NCT00084136|516431948|FG001|NRTI Comparison|Death|0|||
143240095|NCT00084136|516431949|FG002|NRTI Comparison|Death|18|||
143240096|NCT00084136|516431947|FG000|NRTI Comparison|Lost to Follow-up|14|||
143240097|NCT00084136|516431948|FG001|NRTI Comparison|Lost to Follow-up|0|||
143240098|NCT00084136|516431949|FG002|NRTI Comparison|Lost to Follow-up|12|||
143240099|NCT00084136|516431947|FG000|NRTI Comparison|Withdrawal by Subject|54|||
143240100|NCT00084136|516431948|FG001|NRTI Comparison|Withdrawal by Subject|0|||
143240101|NCT00084136|516431949|FG002|NRTI Comparison|Withdrawal by Subject|38|||
143240102|NCT00084136|516431947|FG000|NRTI Comparison|Clinic site closed|12|||
143240103|NCT00084136|516431948|FG001|NRTI Comparison|Clinic site closed|0|||
143240104|NCT00084136|516431949|FG002|NRTI Comparison|Clinic site closed|14|||
143240105|NCT00084136|516431947|FG000|NRTI Comparison|Not reason above|1|||
143240106|NCT00084136|516431948|FG001|NRTI Comparison|Not reason above|0|||
143240107|NCT00084136|516431949|FG002|NRTI Comparison|Not reason above|0|||
143240108|NCT02230670|516431950|FG000|Overall Study|Adverse Event|1|||
143240109|NCT02230670|516431951|FG001|Overall Study|Adverse Event|2|||
143240110|NCT02230670|516431950|FG000|Overall Study|Withdrawal by Subject|2|||
143240111|NCT02230670|516431951|FG001|Overall Study|Withdrawal by Subject|2|||
143240112|NCT02230670|516431950|FG000|Overall Study|Physician Decision|0|||
143240113|NCT02230670|516431951|FG001|Overall Study|Physician Decision|1|||
143240114|NCT02230670|516431950|FG000|Overall Study|Protocol Violation|0|||
143240115|NCT02230670|516431951|FG001|Overall Study|Protocol Violation|1|||
143240116|NCT02230670|516431950|FG000|Overall Study|Progression to Child-Pugh C|1|||
143240117|NCT02230670|516431951|FG001|Overall Study|Progression to Child-Pugh C|2|||
143240118|NCT01524796|516431954|FG000|Overall Study|Adverse Event|13|||
143240119|NCT01524796|516431954|FG000|Overall Study|Lack of Efficacy|3|||
143240120|NCT01524796|516431954|FG000|Overall Study|Lost to Follow-up|1|||
143240121|NCT01524796|516431954|FG000|Overall Study|The price|1|||
143040550|NCT01597245|515689263|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
143240122|NCT01524796|516431954|FG000|Overall Study|Withdrawal by Subject|4|||
143240123|NCT01524796|516431954|FG000|Overall Study|Move|1|||
143240124|NCT01524796|516431954|FG000|Overall Study|Deterioration of pains|1|||
143240125|NCT01524796|516431954|FG000|Overall Study|Gall stone surgery|1|||
143240126|NCT01524796|516431954|FG000|Overall Study|Nervous about confidentiality|1|||
143497879|NCT03665285|517364541|FG004|Overall Study|Disease Progression|0|||
143497880|NCT03665285|517364542|FG005|Overall Study|Disease Progression|0|||
143497881|NCT03665285|517364543|FG006|Overall Study|Disease Progression|0|||
143240127|NCT01524796|516431954|FG000|Overall Study|Switch to carbamazapine|1|||
143240128|NCT01524796|516431954|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
143240129|NCT00836693|516431955|FG000|Overall Study|Adverse Event|4|||
143240130|NCT00836693|516431956|FG001|Overall Study|Adverse Event|1|||
143240131|NCT00836693|516431955|FG000|Overall Study|Sponsor Decision|0|||
143240132|NCT00836693|516431956|FG001|Overall Study|Sponsor Decision|1|||
143240133|NCT00836693|516431955|FG000|Overall Study|Physician Decision|2|||
143240134|NCT00836693|516431956|FG001|Overall Study|Physician Decision|0|||
143364238|NCT05750745|516875613|FG001|Overall Study|Protocol Violation|0|||
143364239|NCT05750745|516875614|FG002|Overall Study|Protocol Violation|0|||
143497882|NCT03665285|517364544|FG007|Overall Study|Disease Progression|7|||
143497883|NCT03665285|517364545|FG008|Overall Study|Disease Progression|1|||
143240135|NCT00836693|516431955|FG000|Overall Study|Withdrawal by Subject|9|||
143364240|NCT05750745|516875612|FG000|Overall Study|Withdrawal by Subject|0|||
143240136|NCT00836693|516431956|FG001|Overall Study|Withdrawal by Subject|4|||
143240137|NCT00836693|516431955|FG000|Overall Study|Protocol Violation|1|||
143040551|NCT01597245|515689264|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
143040552|NCT01597245|515689265|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
143040553|NCT01597245|515689266|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
143040554|NCT01597245|515689267|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
143040555|NCT01597245|515689268|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
143040556|NCT01597245|515689269|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
143040557|NCT01597245|515689270|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
143040558|NCT01597245|515689271|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
143040559|NCT01597245|515689272|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
143040560|NCT01597245|515689273|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
143040561|NCT01597245|515689274|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
143040562|NCT01597245|515689275|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
143040563|NCT01597245|515689276|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
143040564|NCT01597245|515689277|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
143040565|NCT01597245|515689278|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
143040566|NCT01597245|515689279|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
143040567|NCT01597245|515689280|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
143040568|NCT01597245|515689281|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
143040569|NCT01597245|515689282|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
143040570|NCT01597245|515689262|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
143040571|NCT01597245|515689263|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
143040572|NCT01597245|515689264|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
143040573|NCT01597245|515689265|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
143040574|NCT01597245|515689266|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
143040575|NCT01597245|515689267|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
143040576|NCT01597245|515689268|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
143040577|NCT01597245|515689269|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
143040578|NCT01597245|515689270|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
143040579|NCT01597245|515689271|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
143040580|NCT01597245|515689272|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
143040581|NCT01597245|515689273|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
143040582|NCT01597245|515689274|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
143040583|NCT01597245|515689275|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
143040584|NCT01597245|515689276|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
143040585|NCT01597245|515689277|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
143040586|NCT01597245|515689278|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
143040587|NCT01597245|515689279|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
143040588|NCT01597245|515689280|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
143040589|NCT01597245|515689281|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
143040590|NCT01597245|515689282|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
143040591|NCT01597245|515689262|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
143040592|NCT01597245|515689263|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
143040593|NCT01597245|515689264|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
143040594|NCT01597245|515689265|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
143040595|NCT01597245|515689266|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
143040596|NCT01597245|515689267|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
143040597|NCT01597245|515689268|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
143164154|NCT01725282|516147060|FG000|Overall Study|Adverse Event|1|||
143164155|NCT01725282|516147061|FG001|Overall Study|Adverse Event|3|||
143497884|NCT03665285|517364537|FG000|Overall Study|Hospice|0|||
143497885|NCT03665285|517364538|FG001|Overall Study|Hospice|0|||
143497886|NCT03665285|517364539|FG002|Overall Study|Hospice|0|||
143497887|NCT03665285|517364540|FG003|Overall Study|Hospice|0|||
143164156|NCT01725282|516147062|FG002|Overall Study|Adverse Event|6|||
143164157|NCT01725282|516147063|FG003|Overall Study|Adverse Event|4|||
143164158|NCT01725282|516147060|FG000|Overall Study|Exacerbation of Target Disease|1|||
143164159|NCT01725282|516147061|FG001|Overall Study|Exacerbation of Target Disease|0|||
143164160|NCT01725282|516147062|FG002|Overall Study|Exacerbation of Target Disease|0|||
143164161|NCT01725282|516147063|FG003|Overall Study|Exacerbation of Target Disease|1|||
143164162|NCT01725282|516147060|FG000|Overall Study|Met Exclusion Criteria|0|||
143164163|NCT01725282|516147061|FG001|Overall Study|Met Exclusion Criteria|0|||
143497888|NCT03665285|517364541|FG004|Overall Study|Hospice|0|||
143497889|NCT03665285|517364542|FG005|Overall Study|Hospice|0|||
143164164|NCT01725282|516147062|FG002|Overall Study|Met Exclusion Criteria|1|||
143164165|NCT01725282|516147063|FG003|Overall Study|Met Exclusion Criteria|0|||
143497890|NCT03665285|517364543|FG006|Overall Study|Hospice|0|||
143040598|NCT01597245|515689269|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
143040599|NCT01597245|515689270|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
143040600|NCT01597245|515689271|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
143040601|NCT01597245|515689272|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
143240138|NCT00836693|516431956|FG001|Overall Study|Protocol Violation|0|||
143240139|NCT00836693|516431955|FG000|Overall Study|Lost to Follow-up|1|||
143240140|NCT00836693|516431956|FG001|Overall Study|Lost to Follow-up|0|||
143240141|NCT02612779|516431957|FG000|Overall Study|Administrative reason by sponsor|4|||
143240142|NCT02612779|516431958|FG001|Overall Study|Administrative reason by sponsor|1|||
143240143|NCT02612779|516431957|FG000|Overall Study|No longer meet study criteria|0|||
143240144|NCT02612779|516431958|FG001|Overall Study|No longer meet study criteria|1|||
143240145|NCT02612779|516431957|FG000|Overall Study|Disease progression|29|||
143240146|NCT02612779|516431958|FG001|Overall Study|Disease progression|2|||
143240147|NCT02612779|516431957|FG000|Overall Study|Study drug toxicity|10|||
143240148|NCT02612779|516431958|FG001|Overall Study|Study drug toxicity|1|||
143240149|NCT02612779|516431957|FG000|Overall Study|Death|1|||
143240150|NCT02612779|516431958|FG001|Overall Study|Death|0|||
143240151|NCT02612779|516431957|FG000|Overall Study|Adverse event unrelated to study drug|5|||
143240152|NCT02612779|516431958|FG001|Overall Study|Adverse event unrelated to study drug|0|||
143240153|NCT02612779|516431957|FG000|Overall Study|Participant withdrew consent|4|||
143240154|NCT02612779|516431958|FG001|Overall Study|Participant withdrew consent|0|||
143240155|NCT02612779|516431957|FG000|Overall Study|Lost to Follow-up|1|||
143240156|NCT02612779|516431958|FG001|Overall Study|Lost to Follow-up|0|||
143240157|NCT02612779|516431957|FG000|Overall Study|Maximum clinical benefit|10|||
143240158|NCT02612779|516431958|FG001|Overall Study|Maximum clinical benefit|1|||
143240159|NCT02612779|516431957|FG000|Overall Study|Other reasons|4|||
143240160|NCT02612779|516431958|FG001|Overall Study|Other reasons|0|||
143240161|NCT01002339|516431959|FG000|Overall Study|Withdrawal by Subject|0|||
143240162|NCT01002339|516431960|FG001|Overall Study|Withdrawal by Subject|1|||
143040602|NCT01597245|515689273|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
143040603|NCT01597245|515689274|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
143040604|NCT01597245|515689275|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
143040605|NCT01597245|515689276|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
143040606|NCT01597245|515689277|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
143040607|NCT01597245|515689278|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
143040608|NCT01597245|515689279|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
143040609|NCT01597245|515689280|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
143040610|NCT01597245|515689281|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
143040611|NCT01597245|515689282|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
143240163|NCT01002339|516431961|FG002|Overall Study|Withdrawal by Subject|0|||
143240164|NCT01002339|516431959|FG000|Overall Study|Incorrect treatment assignment|0|||
143240165|NCT01002339|516431960|FG001|Overall Study|Incorrect treatment assignment|0|||
143240166|NCT01002339|516431961|FG002|Overall Study|Incorrect treatment assignment|1|||
143240167|NCT01002339|516431959|FG000|Overall Study|Protocol Violation|0|||
143240168|NCT01002339|516431960|FG001|Overall Study|Protocol Violation|0|||
143240169|NCT01002339|516431961|FG002|Overall Study|Protocol Violation|2|||
143240170|NCT01002339|516431959|FG000|Overall Study|Lung cancer detected before transplant|0|||
143240171|NCT01002339|516431960|FG001|Overall Study|Lung cancer detected before transplant|0|||
143040612|NCT01597245|515689262|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
143040613|NCT01597245|515689263|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
143040614|NCT01597245|515689264|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
143040615|NCT01597245|515689265|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
143040616|NCT01597245|515689266|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
143040617|NCT01597245|515689267|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
143040618|NCT01597245|515689268|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
143040619|NCT01597245|515689269|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
143040620|NCT01597245|515689270|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
143040621|NCT01597245|515689271|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
143040622|NCT01597245|515689272|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
143040623|NCT01597245|515689273|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
143040624|NCT01597245|515689274|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
143040625|NCT01597245|515689275|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
143040626|NCT01597245|515689276|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
143240172|NCT01002339|516431961|FG002|Overall Study|Lung cancer detected before transplant|1|||
143240173|NCT01002339|516431959|FG000|Overall Study|Randomized. Not transplanted|0|||
143240174|NCT01002339|516431960|FG001|Overall Study|Randomized. Not transplanted|0|||
143240175|NCT01002339|516431961|FG002|Overall Study|Randomized. Not transplanted|1|||
143240176|NCT00892099|516431962|FG000|Overall Study|Death|1|||
143240177|NCT00892099|516431963|FG001|Overall Study|Death|0|||
143240178|NCT00892099|516431964|FG002|Overall Study|Death|1|||
143240179|NCT00892099|516431962|FG000|Overall Study|Adverse Event|1|||
143040627|NCT01597245|515689277|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
143040628|NCT01597245|515689278|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
143040629|NCT01597245|515689279|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
143040630|NCT01597245|515689280|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
143040631|NCT01597245|515689281|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
143040632|NCT01597245|515689282|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
143040633|NCT00731783|515689283|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
143040634|NCT00731783|515689284|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
143040635|NCT00731783|515689283|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
143040636|NCT00731783|515689284|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
143040637|NCT00731783|515689283|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
143040638|NCT00731783|515689284|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
143040639|NCT00731783|515689283|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
143040640|NCT00731783|515689284|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
143040641|NCT01796171|515690727|FG000|Enrolled|Death|0|||
143040642|NCT01796171|515690728|FG001|Enrolled|Death|0|||
143040643|NCT01796171|515690729|FG002|Enrolled|Death|0|||
143040644|NCT01796171|515690730|FG003|Enrolled|Death|0|||
143040645|NCT01796171|515690731|FG004|Enrolled|Death|0|||
143040646|NCT01796171|515690732|FG005|Enrolled|Death|0|||
143040647|NCT01796171|515690733|FG006|Enrolled|Death|0|||
143040648|NCT01796171|515690734|FG007|Enrolled|Death|0|||
143040649|NCT01796171|515690735|FG008|Enrolled|Death|0|||
143040650|NCT01796171|515690736|FG009|Enrolled|Death|0|||
143040651|NCT01796171|515690737|FG010|Enrolled|Death|0|||
143040652|NCT01796171|515690738|FG011|Enrolled|Death|0|||
143497891|NCT03665285|517364544|FG007|Overall Study|Hospice|2|||
143040653|NCT01796171|515690739|FG012|Enrolled|Death|0|||
143040654|NCT01796171|515690740|FG013|Enrolled|Death|0|||
143040655|NCT01796171|515690741|FG014|Enrolled|Death|1|||
143040656|NCT01796171|515690727|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
143040657|NCT01796171|515690728|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
143040658|NCT01796171|515690729|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
143040659|NCT01796171|515690730|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
143040660|NCT01796171|515690731|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
143040661|NCT01796171|515690732|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
143040662|NCT01796171|515690733|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
143040663|NCT01796171|515690734|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
143040664|NCT01796171|515690735|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
143040665|NCT01796171|515690736|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
143040666|NCT01796171|515690737|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
143040667|NCT01796171|515690738|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
143040668|NCT01796171|515690739|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
143040669|NCT01796171|515690740|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
143040670|NCT01796171|515690741|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
143040671|NCT01796171|515690727|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
143040672|NCT01796171|515690728|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
143040673|NCT01796171|515690729|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
143040674|NCT01796171|515690730|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
143040675|NCT01796171|515690731|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
143040676|NCT01796171|515690732|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
143040677|NCT01796171|515690733|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
143040678|NCT01796171|515690734|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
143040679|NCT01796171|515690735|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
143040680|NCT01796171|515690736|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
143040681|NCT01796171|515690737|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
143040682|NCT01796171|515690738|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
143164166|NCT01725282|516147060|FG000|Overall Study|Study Site Withdrawal|0|||
143164167|NCT01725282|516147061|FG001|Overall Study|Study Site Withdrawal|1|||
143164168|NCT01725282|516147062|FG002|Overall Study|Study Site Withdrawal|0|||
143164169|NCT01725282|516147063|FG003|Overall Study|Study Site Withdrawal|0|||
143164170|NCT01725282|516147060|FG000|Overall Study|Withdrawal by Subject|0|||
143164171|NCT01725282|516147061|FG001|Overall Study|Withdrawal by Subject|0|||
143164172|NCT01725282|516147062|FG002|Overall Study|Withdrawal by Subject|1|||
143164173|NCT01725282|516147063|FG003|Overall Study|Withdrawal by Subject|1|||
143164174|NCT01725282|516147060|FG000|Overall Study|Lack of Efficacy|0|||
143164175|NCT01725282|516147061|FG001|Overall Study|Lack of Efficacy|1|||
143164176|NCT01725282|516147062|FG002|Overall Study|Lack of Efficacy|0|||
143164177|NCT01725282|516147063|FG003|Overall Study|Lack of Efficacy|1|||
143164178|NCT05524948|516147066|FG000|Overall Study|Withdrawal by Subject|1|||
143164179|NCT05524948|516147067|FG001|Overall Study|Withdrawal by Subject|0|||
143164180|NCT05524948|516147066|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
143497892|NCT03665285|517364545|FG008|Overall Study|Hospice|0|||
143497893|NCT03665285|517364537|FG000|Overall Study|Withdrawal by Subject|0|||
143497894|NCT03665285|517364538|FG001|Overall Study|Withdrawal by Subject|0|||
143497895|NCT03665285|517364539|FG002|Overall Study|Withdrawal by Subject|0|||
143040683|NCT01796171|515690739|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
143040684|NCT01796171|515690740|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
143040685|NCT01796171|515690741|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
143040686|NCT01796171|515690727|FG000|Treatment Period With Betalutin|Progressive disease|0|||
143040687|NCT01796171|515690728|FG001|Treatment Period With Betalutin|Progressive disease|1|||
143040688|NCT01796171|515690729|FG002|Treatment Period With Betalutin|Progressive disease|0|||
143040689|NCT01796171|515690730|FG003|Treatment Period With Betalutin|Progressive disease|0|||
143040690|NCT01796171|515690731|FG004|Treatment Period With Betalutin|Progressive disease|0|||
143040691|NCT01796171|515690732|FG005|Treatment Period With Betalutin|Progressive disease|0|||
143040692|NCT01796171|515690733|FG006|Treatment Period With Betalutin|Progressive disease|0|||
143040693|NCT01796171|515690734|FG007|Treatment Period With Betalutin|Progressive disease|0|||
143040694|NCT01796171|515690735|FG008|Treatment Period With Betalutin|Progressive disease|0|||
143040695|NCT01796171|515690736|FG009|Treatment Period With Betalutin|Progressive disease|0|||
143040696|NCT01796171|515690737|FG010|Treatment Period With Betalutin|Progressive disease|0|||
143040697|NCT01796171|515690738|FG011|Treatment Period With Betalutin|Progressive disease|0|||
143040698|NCT01796171|515690739|FG012|Treatment Period With Betalutin|Progressive disease|0|||
143040699|NCT01796171|515690740|FG013|Treatment Period With Betalutin|Progressive disease|0|||
143040700|NCT01796171|515690741|FG014|Treatment Period With Betalutin|Progressive disease|0|||
143040701|NCT01796171|515690727|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
143040702|NCT01796171|515690728|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
143040703|NCT01796171|515690729|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
143040704|NCT01796171|515690730|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
143040705|NCT01796171|515690731|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
143040706|NCT01796171|515690732|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
143040707|NCT01796171|515690733|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
143040708|NCT01796171|515690734|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
143040709|NCT01796171|515690735|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
143040710|NCT01796171|515690736|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
143040711|NCT01796171|515690737|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
143040712|NCT01796171|515690738|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
143040713|NCT01796171|515690739|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
143040714|NCT01796171|515690740|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
143040715|NCT01796171|515690741|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
143040716|NCT01796171|515690727|FG000|Treatment Period With Betalutin|Physician Decision|0|||
143040717|NCT01796171|515690728|FG001|Treatment Period With Betalutin|Physician Decision|0|||
143040718|NCT01796171|515690729|FG002|Treatment Period With Betalutin|Physician Decision|0|||
143040719|NCT01796171|515690730|FG003|Treatment Period With Betalutin|Physician Decision|0|||
143040720|NCT01796171|515690731|FG004|Treatment Period With Betalutin|Physician Decision|0|||
143040721|NCT01796171|515690732|FG005|Treatment Period With Betalutin|Physician Decision|0|||
143040722|NCT01796171|515690733|FG006|Treatment Period With Betalutin|Physician Decision|0|||
143040723|NCT01796171|515690734|FG007|Treatment Period With Betalutin|Physician Decision|0|||
143040724|NCT01796171|515690735|FG008|Treatment Period With Betalutin|Physician Decision|0|||
143040725|NCT01796171|515690736|FG009|Treatment Period With Betalutin|Physician Decision|0|||
143040726|NCT01796171|515690737|FG010|Treatment Period With Betalutin|Physician Decision|5|||
143040727|NCT01796171|515690738|FG011|Treatment Period With Betalutin|Physician Decision|1|||
143040728|NCT01796171|515690739|FG012|Treatment Period With Betalutin|Physician Decision|1|||
143040729|NCT01796171|515690740|FG013|Treatment Period With Betalutin|Physician Decision|0|||
143040730|NCT01796171|515690741|FG014|Treatment Period With Betalutin|Physician Decision|0|||
143040731|NCT01796171|515690727|FG000|Treatment Period With Betalutin|Death|0|||
143040732|NCT01796171|515690728|FG001|Treatment Period With Betalutin|Death|0|||
143040733|NCT01796171|515690729|FG002|Treatment Period With Betalutin|Death|0|||
143040734|NCT01796171|515690730|FG003|Treatment Period With Betalutin|Death|0|||
143040735|NCT01796171|515690731|FG004|Treatment Period With Betalutin|Death|0|||
143040736|NCT01796171|515690732|FG005|Treatment Period With Betalutin|Death|0|||
143040737|NCT01796171|515690733|FG006|Treatment Period With Betalutin|Death|0|||
143040738|NCT01796171|515690734|FG007|Treatment Period With Betalutin|Death|0|||
143040739|NCT01796171|515690735|FG008|Treatment Period With Betalutin|Death|0|||
143040740|NCT01796171|515690736|FG009|Treatment Period With Betalutin|Death|0|||
143040741|NCT01796171|515690737|FG010|Treatment Period With Betalutin|Death|2|||
143240180|NCT00892099|516431963|FG001|Overall Study|Adverse Event|0|||
143240181|NCT00892099|516431964|FG002|Overall Study|Adverse Event|0|||
143040742|NCT01796171|515690738|FG011|Treatment Period With Betalutin|Death|0|||
143040743|NCT01796171|515690739|FG012|Treatment Period With Betalutin|Death|0|||
143040744|NCT01796171|515690740|FG013|Treatment Period With Betalutin|Death|0|||
143040745|NCT01796171|515690741|FG014|Treatment Period With Betalutin|Death|0|||
143040746|NCT01796171|515690727|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
143240182|NCT00892099|516431962|FG000|Overall Study|replocated|1|||
143240183|NCT00892099|516431963|FG001|Overall Study|replocated|0|||
143240184|NCT00892099|516431964|FG002|Overall Study|replocated|2|||
143240185|NCT00892099|516431962|FG000|Overall Study|Prolonged hospitalization|1|||
143240186|NCT00892099|516431963|FG001|Overall Study|Prolonged hospitalization|0|||
143240187|NCT00892099|516431964|FG002|Overall Study|Prolonged hospitalization|1|||
143240188|NCT00892099|516431962|FG000|Overall Study|no further details|1|||
143240189|NCT00892099|516431963|FG001|Overall Study|no further details|0|||
143240190|NCT00892099|516431964|FG002|Overall Study|no further details|1|||
143240191|NCT00892099|516431962|FG000|Overall Study|kidney function recovered|0|||
143497896|NCT03665285|517364540|FG003|Overall Study|Withdrawal by Subject|0|||
143497897|NCT03665285|517364541|FG004|Overall Study|Withdrawal by Subject|1|||
143497898|NCT03665285|517364542|FG005|Overall Study|Withdrawal by Subject|0|||
143497899|NCT03665285|517364543|FG006|Overall Study|Withdrawal by Subject|0|||
143497900|NCT03665285|517364544|FG007|Overall Study|Withdrawal by Subject|2|||
143497901|NCT03665285|517364545|FG008|Overall Study|Withdrawal by Subject|0|||
143497902|NCT03665285|517364537|FG000|Overall Study|Physician Decision|0|||
143497903|NCT03665285|517364538|FG001|Overall Study|Physician Decision|0|||
143497904|NCT03665285|517364539|FG002|Overall Study|Physician Decision|0|||
143497905|NCT03665285|517364540|FG003|Overall Study|Physician Decision|0|||
143497906|NCT03665285|517364541|FG004|Overall Study|Physician Decision|0|||
143497907|NCT03665285|517364542|FG005|Overall Study|Physician Decision|0|||
143497908|NCT03665285|517364543|FG006|Overall Study|Physician Decision|0|||
143497909|NCT03665285|517364544|FG007|Overall Study|Physician Decision|2|||
143497910|NCT03665285|517364545|FG008|Overall Study|Physician Decision|0|||
143497911|NCT00888355|517364546|FG000|Overall Study|Adverse Event|10|||
143497912|NCT00888355|517364547|FG001|Overall Study|Adverse Event|0|||
143497913|NCT00888355|517364548|FG002|Overall Study|Adverse Event|3|||
143497914|NCT00888355|517364549|FG003|Overall Study|Adverse Event|3|||
143497915|NCT00888355|517364546|FG000|Overall Study|Lack of Efficacy|9|||
143497916|NCT00888355|517364547|FG001|Overall Study|Lack of Efficacy|2|||
143497917|NCT00888355|517364548|FG002|Overall Study|Lack of Efficacy|5|||
143497918|NCT00888355|517364549|FG003|Overall Study|Lack of Efficacy|2|||
143497919|NCT00888355|517364546|FG000|Overall Study|Lost to Follow-up|0|||
143497920|NCT00888355|517364547|FG001|Overall Study|Lost to Follow-up|2|||
143497921|NCT00888355|517364548|FG002|Overall Study|Lost to Follow-up|2|||
143497922|NCT00888355|517364549|FG003|Overall Study|Lost to Follow-up|0|||
143497923|NCT00888355|517364546|FG000|Overall Study|Protocol Violation|3|||
143497924|NCT00888355|517364547|FG001|Overall Study|Protocol Violation|2|||
143497925|NCT00888355|517364548|FG002|Overall Study|Protocol Violation|1|||
143497926|NCT00888355|517364549|FG003|Overall Study|Protocol Violation|2|||
143497927|NCT00888355|517364546|FG000|Overall Study|Withdrawal by Subject|0|||
143497928|NCT00888355|517364547|FG001|Overall Study|Withdrawal by Subject|3|||
143497929|NCT00888355|517364548|FG002|Overall Study|Withdrawal by Subject|1|||
143497930|NCT00888355|517364549|FG003|Overall Study|Withdrawal by Subject|3|||
143497931|NCT00354601|517364553|FG000|Overall Study|Protocol Violation|1|||
143497932|NCT00354601|517364553|FG000|Overall Study|progression|1|||
143497933|NCT03603652|517364554|FG000|Overall Study|Death|2|||
143497934|NCT03213366|517364557|FG000|Overall Study|Lost to Follow-up|9|||
143497935|NCT03213366|517364558|FG001|Overall Study|Lost to Follow-up|4|||
143497936|NCT02532855|517364559|FG000|Overall Study|Lost to Follow-up|4|||
143497937|NCT02532855|517364560|FG001|Overall Study|Lost to Follow-up|3|||
143497938|NCT02532855|517364559|FG000|Overall Study|Withdrawal by Subject|4|||
143497939|NCT02532855|517364560|FG001|Overall Study|Withdrawal by Subject|8|||
143497940|NCT00666926|517364561|FG000|Overall Study|Adverse Event|0|||
143497941|NCT00666926|517364562|FG001|Overall Study|Adverse Event|0|||
143497942|NCT00666926|517364563|FG002|Overall Study|Adverse Event|0|||
143497943|NCT00666926|517364564|FG003|Overall Study|Adverse Event|0|||
143497944|NCT00666926|517364565|FG004|Overall Study|Adverse Event|0|||
143497945|NCT00666926|517364566|FG005|Overall Study|Adverse Event|0|||
143040747|NCT01796171|515690728|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
143240192|NCT00892099|516431963|FG001|Overall Study|kidney function recovered|1|||
143240193|NCT00892099|516431964|FG002|Overall Study|kidney function recovered|0|||
143364241|NCT05750745|516875613|FG001|Overall Study|Withdrawal by Subject|1|||
143497946|NCT00666926|517364567|FG006|Overall Study|Adverse Event|0|||
143497947|NCT00666926|517364568|FG007|Overall Study|Adverse Event|0|||
143497948|NCT00666926|517364569|FG008|Overall Study|Adverse Event|0|||
143497949|NCT00666926|517364570|FG009|Overall Study|Adverse Event|2|||
143497950|NCT00666926|517364571|FG010|Overall Study|Adverse Event|2|||
143497951|NCT00666926|517364572|FG011|Overall Study|Adverse Event|2|||
143497952|NCT00666926|517364573|FG012|Overall Study|Adverse Event|0|||
143497953|NCT00666926|517364574|FG013|Overall Study|Adverse Event|1|||
143497954|NCT00666926|517364575|FG014|Overall Study|Adverse Event|0|||
143497955|NCT00666926|517364576|FG015|Overall Study|Adverse Event|0|||
143497956|NCT00666926|517364561|FG000|Overall Study|Laboratory abnormality|0|||
143497957|NCT00666926|517364562|FG001|Overall Study|Laboratory abnormality|0|||
143497958|NCT00666926|517364563|FG002|Overall Study|Laboratory abnormality|0|||
143040748|NCT01796171|515690729|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
143040749|NCT01796171|515690730|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
143040750|NCT01796171|515690731|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
143040751|NCT01796171|515690732|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
143040752|NCT01796171|515690733|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
143040753|NCT01796171|515690734|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
143040754|NCT01796171|515690735|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
143040755|NCT01796171|515690736|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
143040756|NCT01796171|515690737|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
143040757|NCT01796171|515690738|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
143164181|NCT05524948|516147067|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
143164182|NCT01682720|516147077|FG000|Overall Study|Randomized but Not Treated|0|||
143164183|NCT01682720|516147078|FG001|Overall Study|Randomized but Not Treated|1|||
143164184|NCT01682720|516147079|FG002|Overall Study|Randomized but Not Treated|1|||
143164185|NCT01682720|516147080|FG003|Overall Study|Randomized but Not Treated|0|||
143164186|NCT01682720|516147077|FG000|Overall Study|Terminated by Sponsor|83|||
143164187|NCT01682720|516147078|FG001|Overall Study|Terminated by Sponsor|0|||
143164188|NCT01682720|516147079|FG002|Overall Study|Terminated by Sponsor|0|||
143164189|NCT01682720|516147080|FG003|Overall Study|Terminated by Sponsor|0|||
143164190|NCT01682720|516147077|FG000|Overall Study|Efficacy Failure|0|||
143164191|NCT01682720|516147078|FG001|Overall Study|Efficacy Failure|3|||
143164192|NCT01682720|516147079|FG002|Overall Study|Efficacy Failure|3|||
143164193|NCT01682720|516147080|FG003|Overall Study|Efficacy Failure|30|||
143164194|NCT01682720|516147077|FG000|Overall Study|Lost to Follow-up|1|||
143164195|NCT01682720|516147078|FG001|Overall Study|Lost to Follow-up|1|||
143164196|NCT01682720|516147079|FG002|Overall Study|Lost to Follow-up|0|||
143164197|NCT01682720|516147080|FG003|Overall Study|Lost to Follow-up|6|||
143164198|NCT01682720|516147077|FG000|Overall Study|Subject Withdrew Consent|0|||
143164199|NCT01682720|516147078|FG001|Overall Study|Subject Withdrew Consent|0|||
143164200|NCT01682720|516147079|FG002|Overall Study|Subject Withdrew Consent|2|||
143164201|NCT01682720|516147080|FG003|Overall Study|Subject Withdrew Consent|2|||
143164202|NCT01682720|516147077|FG000|Overall Study|Adverse Event|1|||
143164203|NCT01682720|516147078|FG001|Overall Study|Adverse Event|0|||
143164204|NCT01682720|516147079|FG002|Overall Study|Adverse Event|1|||
143164205|NCT01682720|516147080|FG003|Overall Study|Adverse Event|1|||
143164206|NCT04204902|516147083|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
143164207|NCT04204902|516147084|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
143164208|NCT01166646|516147085|FG000|Overall Study|Protocol Violation|0|||
143164209|NCT01166646|516147086|FG001|Overall Study|Protocol Violation|1|||
143164210|NCT01166646|516147085|FG000|Overall Study|Adverse Event|1|||
143164211|NCT01166646|516147086|FG001|Overall Study|Adverse Event|0|||
143164212|NCT02420314|516147087|FG000|Overall Study|Withdrawal by Subject|1|||
143164213|NCT02420314|516147087|FG000|Overall Study|Protocol Violation|1|||
143164214|NCT03760068|516147088|FG000|Overall Study|Withdrawal by Subject|7|||
143164215|NCT03760068|516147089|FG001|Overall Study|Withdrawal by Subject|8|||
143164216|NCT03760068|516147088|FG000|Overall Study|Adverse Event|1|||
143164217|NCT03760068|516147089|FG001|Overall Study|Adverse Event|2|||
143164218|NCT03760068|516147088|FG000|Overall Study|Administrative Decision by Sponsor|0|||
143164219|NCT03760068|516147089|FG001|Overall Study|Administrative Decision by Sponsor|2|||
143164220|NCT03760068|516147088|FG000|Overall Study|Physician Decision|1|||
143164221|NCT03760068|516147089|FG001|Overall Study|Physician Decision|2|||
143164222|NCT03760068|516147088|FG000|Overall Study|Lost to Follow-up|4|||
143164223|NCT03760068|516147089|FG001|Overall Study|Lost to Follow-up|9|||
143164224|NCT03760068|516147088|FG000|Overall Study|Subject Moved Out of State|1|||
143164225|NCT03760068|516147089|FG001|Overall Study|Subject Moved Out of State|0|||
143164226|NCT05430919|516147090|FG000|Overall Study|Protocol Violation|0|||
143164227|NCT05430919|516147091|FG001|Overall Study|Protocol Violation|0|||
143164228|NCT05430919|516147092|FG002|Overall Study|Protocol Violation|1|||
143164229|NCT05430919|516147093|FG003|Overall Study|Protocol Violation|0|||
143164230|NCT05430919|516147090|FG000|Overall Study|Lost to Follow-up|0|||
143164231|NCT05430919|516147091|FG001|Overall Study|Lost to Follow-up|1|||
143164232|NCT05430919|516147092|FG002|Overall Study|Lost to Follow-up|0|||
143164233|NCT05430919|516147093|FG003|Overall Study|Lost to Follow-up|0|||
143164234|NCT05430919|516147090|FG000|Overall Study|Withdrawal by Subject|3|||
143164235|NCT05430919|516147091|FG001|Overall Study|Withdrawal by Subject|0|||
143164236|NCT05430919|516147092|FG002|Overall Study|Withdrawal by Subject|0|||
143164237|NCT05430919|516147093|FG003|Overall Study|Withdrawal by Subject|1|||
143164238|NCT03777020|516147098|FG000|Overall Study|Withdrawal by Subject|4|||
143164239|NCT03777020|516147099|FG001|Overall Study|Withdrawal by Subject|4|||
143164240|NCT03777020|516147098|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
143164241|NCT03777020|516147099|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
143164242|NCT01767857|516147100|FG000|Overall Study|Adverse Event|27|||
143164243|NCT01767857|516147101|FG001|Overall Study|Adverse Event|7|||
143164244|NCT01767857|516147100|FG000|Overall Study|Death|28|||
143164245|NCT01767857|516147101|FG001|Overall Study|Death|13|||
143164246|NCT01767857|516147100|FG000|Overall Study|Lack of Efficacy|299|||
143040758|NCT01796171|515690739|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
143040759|NCT01796171|515690740|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
143040760|NCT01796171|515690741|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
143040761|NCT01796171|515690727|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
143040762|NCT01796171|515690728|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
143040763|NCT01796171|515690729|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
143040764|NCT01796171|515690730|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
143040765|NCT01796171|515690731|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
143040766|NCT01796171|515690732|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
143164247|NCT01767857|516147101|FG001|Overall Study|Lack of Efficacy|151|||
143164248|NCT01767857|516147100|FG000|Overall Study|Lost to Follow-up|1|||
143164249|NCT01767857|516147101|FG001|Overall Study|Lost to Follow-up|1|||
143164250|NCT01767857|516147100|FG000|Overall Study|Withdrawal by Subject|38|||
143164251|NCT01767857|516147101|FG001|Overall Study|Withdrawal by Subject|18|||
143164252|NCT01767857|516147100|FG000|Overall Study|Physician Decision|17|||
143164253|NCT01767857|516147101|FG001|Overall Study|Physician Decision|10|||
143164254|NCT01767857|516147100|FG000|Overall Study|Protocol Terminated|1|||
143164255|NCT01767857|516147101|FG001|Overall Study|Protocol Terminated|0|||
143164256|NCT01767857|516147100|FG000|Overall Study|Randomized But Never Treated|19|||
143164257|NCT01767857|516147101|FG001|Overall Study|Randomized But Never Treated|13|||
143164258|NCT04126174|516147104|FG000|Overall Study|Lost to Follow-up|3|||
143164259|NCT04126174|516147105|FG001|Overall Study|Lost to Follow-up|3|||
143164260|NCT02899754|516147120|FG000|Overall Study|Lost to Follow-up|7|||
143164261|NCT02899754|516147121|FG001|Overall Study|Lost to Follow-up|9|||
143164262|NCT03769116|516147128|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
143164263|NCT03769116|516147129|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
143164264|NCT03769116|516147128|FG000|Part 3 - Open Label|Physician Decision|1|||
143164265|NCT03769116|516147129|FG001|Part 3 - Open Label|Physician Decision|0|||
143164266|NCT03769116|516147128|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
143164267|NCT03769116|516147129|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
143164268|NCT02181413|516147130|FG000|Overall Study|Withdrawal by Subject|45|||
143164269|NCT02181413|516147131|FG001|Overall Study|Withdrawal by Subject|61|||
143164270|NCT02181413|516147130|FG000|Overall Study|Reason Not Specified|2|||
143164271|NCT02181413|516147131|FG001|Overall Study|Reason Not Specified|5|||
143164272|NCT02181413|516147130|FG000|Overall Study|Lost to Follow-up|8|||
143164273|NCT02181413|516147131|FG001|Overall Study|Lost to Follow-up|7|||
143164274|NCT04755231|516147133|FG000|Overall Study|Lost to Follow-up|5|||
143164275|NCT04755231|516147133|FG000|Overall Study|Withdrawal by Subject|5|||
143164276|NCT04754399|516147134|FG000|Overall Study|Adverse Event|5|||
143164277|NCT04754399|516147134|FG000|Overall Study|Withdrawal by Subject|6|||
143164278|NCT00561821|516147140|FG000|Overall Study|Not treated|0|||
143164279|NCT00561821|516147141|FG001|Overall Study|Not treated|0|||
143164280|NCT00561821|516147142|FG002|Overall Study|Not treated|1|||
143164281|NCT00561821|516147143|FG003|Overall Study|Not treated|0|||
143164282|NCT00561821|516147140|FG000|Overall Study|Withdrawal by Subject|0|||
143164283|NCT00561821|516147141|FG001|Overall Study|Withdrawal by Subject|1|||
143164284|NCT00561821|516147142|FG002|Overall Study|Withdrawal by Subject|0|||
143164285|NCT00561821|516147143|FG003|Overall Study|Withdrawal by Subject|2|||
143164286|NCT00561821|516147140|FG000|Overall Study|Reasons not related to trial|2|||
143164287|NCT00561821|516147141|FG001|Overall Study|Reasons not related to trial|1|||
143164288|NCT00561821|516147142|FG002|Overall Study|Reasons not related to trial|0|||
143164289|NCT00561821|516147143|FG003|Overall Study|Reasons not related to trial|0|||
143164290|NCT00561821|516147140|FG000|Overall Study|Other (reason not specified)|1|||
143164291|NCT00561821|516147141|FG001|Overall Study|Other (reason not specified)|1|||
143164292|NCT00561821|516147142|FG002|Overall Study|Other (reason not specified)|0|||
143164293|NCT00561821|516147143|FG003|Overall Study|Other (reason not specified)|0|||
143164294|NCT00561821|516147140|FG000|Overall Study|Adverse Event|2|||
143164295|NCT00561821|516147141|FG001|Overall Study|Adverse Event|3|||
143164296|NCT00561821|516147142|FG002|Overall Study|Adverse Event|1|||
143164297|NCT00561821|516147143|FG003|Overall Study|Adverse Event|1|||
143164298|NCT01657942|516147144|FG000|Overall Study|Alternative Treatment|7|||
143164299|NCT01657942|516147144|FG000|Overall Study|Lost to Follow-up|1|||
143164300|NCT01197300|516148566|FG000|Overall Study|Lost to Follow-up|0|||
143164301|NCT01197300|516148567|FG001|Overall Study|Lost to Follow-up|1|||
143164302|NCT01197300|516148566|FG000|Overall Study|Protocol Violation|0|||
143164303|NCT01197300|516148567|FG001|Overall Study|Protocol Violation|1|||
143164304|NCT00590317|516148572|FG000|Overall Study|Lack of Efficacy|1|||
143164305|NCT00590317|516148573|FG001|Overall Study|Lack of Efficacy|5|||
143164306|NCT04616196|516148577|FG000|Overall Study|Progressive Disease|3|||
143164307|NCT04616196|516148578|FG001|Overall Study|Progressive Disease|0|||
143164308|NCT04616196|516148579|FG002|Overall Study|Progressive Disease|4|||
143164309|NCT04616196|516148580|FG003|Overall Study|Progressive Disease|1|||
143164310|NCT04616196|516148577|FG000|Overall Study|Death|2|||
143164311|NCT04616196|516148578|FG001|Overall Study|Death|4|||
143164312|NCT04616196|516148579|FG002|Overall Study|Death|1|||
143164313|NCT04616196|516148580|FG003|Overall Study|Death|0|||
143164314|NCT04616196|516148577|FG000|Overall Study|Withdrawal by Subject|0|||
143040767|NCT01796171|515690733|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
143040768|NCT01796171|515690734|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
143040769|NCT01796171|515690735|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
143040770|NCT01796171|515690736|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
143040771|NCT01796171|515690737|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
143040772|NCT01796171|515690738|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
143040773|NCT01796171|515690739|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
143040774|NCT01796171|515690740|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
143040775|NCT01796171|515690741|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
143040776|NCT01796171|515690727|FG000|Follow-up Period|Start of further anticancer therapy|4|||
143040777|NCT01796171|515690728|FG001|Follow-up Period|Start of further anticancer therapy|25|||
143040778|NCT01796171|515690729|FG002|Follow-up Period|Start of further anticancer therapy|2|||
143040779|NCT01796171|515690730|FG003|Follow-up Period|Start of further anticancer therapy|1|||
143040780|NCT01796171|515690731|FG004|Follow-up Period|Start of further anticancer therapy|2|||
143040781|NCT01796171|515690732|FG005|Follow-up Period|Start of further anticancer therapy|2|||
143040782|NCT01796171|515690733|FG006|Follow-up Period|Start of further anticancer therapy|1|||
143040783|NCT01796171|515690734|FG007|Follow-up Period|Start of further anticancer therapy|15|||
143040784|NCT01796171|515690735|FG008|Follow-up Period|Start of further anticancer therapy|2|||
143040785|NCT01796171|515690736|FG009|Follow-up Period|Start of further anticancer therapy|0|||
143040786|NCT01796171|515690737|FG010|Follow-up Period|Start of further anticancer therapy|0|||
143040787|NCT01796171|515690738|FG011|Follow-up Period|Start of further anticancer therapy|0|||
143040788|NCT01796171|515690739|FG012|Follow-up Period|Start of further anticancer therapy|0|||
143040789|NCT01796171|515690740|FG013|Follow-up Period|Start of further anticancer therapy|0|||
143040790|NCT01796171|515690741|FG014|Follow-up Period|Start of further anticancer therapy|0|||
143040791|NCT01796171|515690727|FG000|Follow-up Period|Progressive disease|0|||
143040792|NCT01796171|515690728|FG001|Follow-up Period|Progressive disease|1|||
143040793|NCT01796171|515690729|FG002|Follow-up Period|Progressive disease|0|||
143040794|NCT01796171|515690730|FG003|Follow-up Period|Progressive disease|0|||
143040795|NCT01796171|515690731|FG004|Follow-up Period|Progressive disease|0|||
143040796|NCT01796171|515690732|FG005|Follow-up Period|Progressive disease|0|||
143040797|NCT01796171|515690733|FG006|Follow-up Period|Progressive disease|0|||
143040798|NCT01796171|515690734|FG007|Follow-up Period|Progressive disease|3|||
143040799|NCT01796171|515690735|FG008|Follow-up Period|Progressive disease|0|||
143040800|NCT01796171|515690736|FG009|Follow-up Period|Progressive disease|0|||
143040801|NCT01796171|515690737|FG010|Follow-up Period|Progressive disease|0|||
143040802|NCT01796171|515690738|FG011|Follow-up Period|Progressive disease|0|||
143040803|NCT01796171|515690739|FG012|Follow-up Period|Progressive disease|0|||
143040804|NCT01796171|515690740|FG013|Follow-up Period|Progressive disease|0|||
143040805|NCT01796171|515690741|FG014|Follow-up Period|Progressive disease|0|||
143040806|NCT01796171|515690727|FG000|Follow-up Period|Physician Decision|0|||
143040807|NCT01796171|515690728|FG001|Follow-up Period|Physician Decision|2|||
143040808|NCT01796171|515690729|FG002|Follow-up Period|Physician Decision|0|||
143040809|NCT01796171|515690730|FG003|Follow-up Period|Physician Decision|0|||
143040810|NCT01796171|515690731|FG004|Follow-up Period|Physician Decision|0|||
143040811|NCT01796171|515690732|FG005|Follow-up Period|Physician Decision|0|||
143040812|NCT01796171|515690733|FG006|Follow-up Period|Physician Decision|0|||
143040813|NCT01796171|515690734|FG007|Follow-up Period|Physician Decision|0|||
143040814|NCT01796171|515690735|FG008|Follow-up Period|Physician Decision|0|||
143040815|NCT01796171|515690736|FG009|Follow-up Period|Physician Decision|0|||
143040816|NCT01796171|515690737|FG010|Follow-up Period|Physician Decision|5|||
143040817|NCT01796171|515690738|FG011|Follow-up Period|Physician Decision|0|||
143040818|NCT01796171|515690739|FG012|Follow-up Period|Physician Decision|0|||
143040819|NCT01796171|515690740|FG013|Follow-up Period|Physician Decision|0|||
143040820|NCT01796171|515690741|FG014|Follow-up Period|Physician Decision|0|||
143040821|NCT01796171|515690727|FG000|Follow-up Period|Withdrawal by Subject|0|||
143040822|NCT01796171|515690728|FG001|Follow-up Period|Withdrawal by Subject|1|||
143240194|NCT00892099|516431962|FG000|Overall Study|investigator decision|0|||
143497959|NCT00666926|517364564|FG003|Overall Study|Laboratory abnormality|0|||
143497960|NCT00666926|517364565|FG004|Overall Study|Laboratory abnormality|0|||
143497961|NCT00666926|517364566|FG005|Overall Study|Laboratory abnormality|0|||
143040823|NCT01796171|515690729|FG002|Follow-up Period|Withdrawal by Subject|0|||
143040824|NCT01796171|515690730|FG003|Follow-up Period|Withdrawal by Subject|0|||
143040825|NCT01796171|515690731|FG004|Follow-up Period|Withdrawal by Subject|0|||
143040826|NCT01796171|515690732|FG005|Follow-up Period|Withdrawal by Subject|1|||
143040827|NCT01796171|515690733|FG006|Follow-up Period|Withdrawal by Subject|0|||
143040828|NCT01796171|515690734|FG007|Follow-up Period|Withdrawal by Subject|0|||
143040829|NCT01796171|515690735|FG008|Follow-up Period|Withdrawal by Subject|0|||
143040830|NCT01796171|515690736|FG009|Follow-up Period|Withdrawal by Subject|0|||
143240195|NCT00892099|516431963|FG001|Overall Study|investigator decision|0|||
143240196|NCT00892099|516431964|FG002|Overall Study|investigator decision|1|||
143497962|NCT00666926|517364567|FG006|Overall Study|Laboratory abnormality|0|||
143497963|NCT00666926|517364568|FG007|Overall Study|Laboratory abnormality|0|||
143040831|NCT01796171|515690737|FG010|Follow-up Period|Withdrawal by Subject|3|||
143040832|NCT01796171|515690738|FG011|Follow-up Period|Withdrawal by Subject|1|||
143040833|NCT01796171|515690739|FG012|Follow-up Period|Withdrawal by Subject|0|||
143040834|NCT01796171|515690740|FG013|Follow-up Period|Withdrawal by Subject|0|||
143040835|NCT01796171|515690741|FG014|Follow-up Period|Withdrawal by Subject|0|||
143040836|NCT01796171|515690727|FG000|Follow-up Period|Death|0|||
143040837|NCT01796171|515690728|FG001|Follow-up Period|Death|0|||
143040838|NCT01796171|515690729|FG002|Follow-up Period|Death|0|||
143040839|NCT01796171|515690730|FG003|Follow-up Period|Death|0|||
143040840|NCT01796171|515690731|FG004|Follow-up Period|Death|0|||
143040841|NCT01796171|515690732|FG005|Follow-up Period|Death|0|||
143040842|NCT01796171|515690733|FG006|Follow-up Period|Death|1|||
143040843|NCT01796171|515690734|FG007|Follow-up Period|Death|0|||
143040844|NCT01796171|515690735|FG008|Follow-up Period|Death|0|||
143040845|NCT01796171|515690736|FG009|Follow-up Period|Death|0|||
143040846|NCT01796171|515690737|FG010|Follow-up Period|Death|17|||
143040847|NCT01796171|515690738|FG011|Follow-up Period|Death|9|||
143040848|NCT01796171|515690739|FG012|Follow-up Period|Death|1|||
143040849|NCT01796171|515690740|FG013|Follow-up Period|Death|0|||
143040850|NCT01796171|515690741|FG014|Follow-up Period|Death|0|||
143040851|NCT01796171|515690727|FG000|Follow-up Period|Patient transferred to other hospital|0|||
143040852|NCT01796171|515690728|FG001|Follow-up Period|Patient transferred to other hospital|1|||
143040853|NCT01796171|515690729|FG002|Follow-up Period|Patient transferred to other hospital|0|||
143040854|NCT01796171|515690730|FG003|Follow-up Period|Patient transferred to other hospital|0|||
143040855|NCT01796171|515690731|FG004|Follow-up Period|Patient transferred to other hospital|0|||
143040856|NCT01796171|515690732|FG005|Follow-up Period|Patient transferred to other hospital|0|||
143040857|NCT01796171|515690733|FG006|Follow-up Period|Patient transferred to other hospital|0|||
143040858|NCT01796171|515690734|FG007|Follow-up Period|Patient transferred to other hospital|0|||
143040859|NCT01796171|515690735|FG008|Follow-up Period|Patient transferred to other hospital|0|||
143040860|NCT01796171|515690736|FG009|Follow-up Period|Patient transferred to other hospital|0|||
143040861|NCT01796171|515690737|FG010|Follow-up Period|Patient transferred to other hospital|0|||
143040862|NCT01796171|515690738|FG011|Follow-up Period|Patient transferred to other hospital|0|||
143040863|NCT01796171|515690739|FG012|Follow-up Period|Patient transferred to other hospital|0|||
143040864|NCT01796171|515690740|FG013|Follow-up Period|Patient transferred to other hospital|0|||
143040865|NCT01796171|515690741|FG014|Follow-up Period|Patient transferred to other hospital|0|||
143040866|NCT01796171|515690727|FG000|Follow-up Period|Sponsor Decision|0|||
143164315|NCT04616196|516148578|FG001|Overall Study|Withdrawal by Subject|2|||
143164316|NCT04616196|516148579|FG002|Overall Study|Withdrawal by Subject|0|||
143164317|NCT04616196|516148580|FG003|Overall Study|Withdrawal by Subject|0|||
143164318|NCT04616196|516148577|FG000|Overall Study|Lost to Follow-up|1|||
143164319|NCT04616196|516148578|FG001|Overall Study|Lost to Follow-up|0|||
143164320|NCT04616196|516148579|FG002|Overall Study|Lost to Follow-up|0|||
143164321|NCT04616196|516148580|FG003|Overall Study|Lost to Follow-up|0|||
143164322|NCT04616196|516148577|FG000|Overall Study|Sponsor request|2|||
143164323|NCT04616196|516148578|FG001|Overall Study|Sponsor request|1|||
143164324|NCT04616196|516148579|FG002|Overall Study|Sponsor request|1|||
143164325|NCT04616196|516148580|FG003|Overall Study|Sponsor request|2|||
143164326|NCT00003907|516148582|FG000|Overall Study|Adverse Event|2|||
143164327|NCT00003907|516148583|FG001|Overall Study|Adverse Event|11|||
143164328|NCT00003907|516148582|FG000|Overall Study|Death|2|||
143164329|NCT00003907|516148583|FG001|Overall Study|Death|0|||
143164330|NCT00003907|516148582|FG000|Overall Study|Withdrawal by Subject|1|||
143164331|NCT00003907|516148583|FG001|Overall Study|Withdrawal by Subject|3|||
143164332|NCT00003907|516148582|FG000|Overall Study|Progressive disease|4|||
143164333|NCT00003907|516148583|FG001|Overall Study|Progressive disease|4|||
143164334|NCT00003907|516148582|FG000|Overall Study|Complicating disease|1|||
143164335|NCT00003907|516148583|FG001|Overall Study|Complicating disease|0|||
143164336|NCT00003907|516148582|FG000|Overall Study|Other|1|||
143164337|NCT00003907|516148583|FG001|Overall Study|Other|3|||
143164338|NCT00003907|516148582|FG000|Overall Study|ineligible or not treated|2|||
143164339|NCT00003907|516148583|FG001|Overall Study|ineligible or not treated|2|||
143164340|NCT01050218|516148586|FG000|Overall Study|Adverse Event|37|||
143164341|NCT01050218|516148586|FG000|Overall Study|Lack of Efficacy|8|||
143164342|NCT01050218|516148586|FG000|Overall Study|Protocol Violation|3|||
143164343|NCT01050218|516148586|FG000|Overall Study|Withdrawal by Subject|18|||
143164344|NCT01050218|516148586|FG000|Overall Study|Discontinued by sponsor|18|||
143164345|NCT01050218|516148586|FG000|Overall Study|Compliance|2|||
143164346|NCT01050218|516148586|FG000|Overall Study|Failed to return|7|||
143164347|NCT01050218|516148586|FG000|Overall Study|Serious Adverse Event|1|||
143164348|NCT01050218|516148586|FG000|Overall Study|Family emergency|1|||
143040867|NCT01796171|515690728|FG001|Follow-up Period|Sponsor Decision|0|||
143040868|NCT01796171|515690729|FG002|Follow-up Period|Sponsor Decision|0|||
143040869|NCT01796171|515690730|FG003|Follow-up Period|Sponsor Decision|0|||
143040870|NCT01796171|515690731|FG004|Follow-up Period|Sponsor Decision|0|||
143040871|NCT01796171|515690732|FG005|Follow-up Period|Sponsor Decision|0|||
143040872|NCT01796171|515690733|FG006|Follow-up Period|Sponsor Decision|0|||
143040873|NCT01796171|515690734|FG007|Follow-up Period|Sponsor Decision|0|||
143164349|NCT00770679|516148592|FG000|Overall Study|Lost to Follow-up|3|||
143040874|NCT01796171|515690735|FG008|Follow-up Period|Sponsor Decision|0|||
143040875|NCT01796171|515690736|FG009|Follow-up Period|Sponsor Decision|0|||
143040876|NCT01796171|515690737|FG010|Follow-up Period|Sponsor Decision|40|||
143040877|NCT01796171|515690738|FG011|Follow-up Period|Sponsor Decision|15|||
143040878|NCT01796171|515690739|FG012|Follow-up Period|Sponsor Decision|7|||
143497964|NCT00666926|517364569|FG008|Overall Study|Laboratory abnormality|0|||
143497965|NCT00666926|517364570|FG009|Overall Study|Laboratory abnormality|0|||
143040879|NCT01796171|515690740|FG013|Follow-up Period|Sponsor Decision|0|||
143040880|NCT01796171|515690741|FG014|Follow-up Period|Sponsor Decision|0|||
143040881|NCT00829309|515690742|FG000|Washout: 7 Days|Protocol Violation|1|||
143040882|NCT00829309|515690743|FG001|Washout: 7 Days|Protocol Violation|0|||
143040883|NCT00777023|515690745|FG000|Overall Study|Adverse Event|15|||
143040884|NCT00777023|515690746|FG001|Overall Study|Adverse Event|21|||
143040885|NCT00777023|515690747|FG002|Overall Study|Adverse Event|8|||
143040886|NCT00777023|515690745|FG000|Overall Study|Lack of Efficacy|1|||
143040887|NCT00777023|515690746|FG001|Overall Study|Lack of Efficacy|0|||
143040888|NCT00777023|515690747|FG002|Overall Study|Lack of Efficacy|14|||
143040889|NCT00777023|515690745|FG000|Overall Study|Protocol Violation|2|||
143040890|NCT00777023|515690746|FG001|Overall Study|Protocol Violation|1|||
143040891|NCT00777023|515690747|FG002|Overall Study|Protocol Violation|1|||
143040892|NCT00777023|515690745|FG000|Overall Study|Lost to Follow-up|2|||
143040893|NCT00777023|515690746|FG001|Overall Study|Lost to Follow-up|3|||
143040894|NCT00777023|515690747|FG002|Overall Study|Lost to Follow-up|3|||
143040895|NCT00777023|515690745|FG000|Overall Study|Death|0|||
143497966|NCT00666926|517364571|FG010|Overall Study|Laboratory abnormality|1|||
143040896|NCT00777023|515690746|FG001|Overall Study|Death|1|||
143040897|NCT00777023|515690747|FG002|Overall Study|Death|0|||
143040898|NCT00777023|515690745|FG000|Overall Study|Withdrawal by Subject|7|||
143040899|NCT00777023|515690746|FG001|Overall Study|Withdrawal by Subject|7|||
143040900|NCT00777023|515690747|FG002|Overall Study|Withdrawal by Subject|8|||
143040901|NCT00777023|515690745|FG000|Overall Study|Missing data|1|||
143040902|NCT00777023|515690746|FG001|Overall Study|Missing data|1|||
143040903|NCT00777023|515690747|FG002|Overall Study|Missing data|0|||
143040904|NCT00777023|515690745|FG000|Overall Study|Reasons not specified|4|||
143040905|NCT00777023|515690746|FG001|Overall Study|Reasons not specified|4|||
143040906|NCT00777023|515690747|FG002|Overall Study|Reasons not specified|2|||
143040907|NCT00777023|515690745|FG000|Overall Study|Last dose date unknown|3|||
143040908|NCT00777023|515690746|FG001|Overall Study|Last dose date unknown|3|||
143040909|NCT00777023|515690747|FG002|Overall Study|Last dose date unknown|1|||
143040910|NCT02659150|515690750|FG000|Subject Enrollment|Physician Decision|3|||
143040911|NCT02659150|515690750|FG000|Subject Enrollment|Withdrawal by Subject|2|||
143040912|NCT02659150|515690750|FG000|Baseline Imaging|Withdrawal by Subject|1|||
143040913|NCT02659150|515690750|FG000|Baseline Imaging|Physician Decision|1|||
143040914|NCT02659150|515690750|FG000|Study Drug Dosing|Adverse Event|1|||
143040915|NCT03699020|515690753|FG000|Overall Study|Withdrawal by Subject|3|||
143040916|NCT03699020|515690754|FG001|Overall Study|Withdrawal by Subject|2|||
143040917|NCT02246920|515690755|FG000|Overall Study|Adverse Event|3|||
143040918|NCT02246920|515690756|FG001|Overall Study|Adverse Event|1|||
143040919|NCT02246920|515690757|FG002|Overall Study|Adverse Event|1|||
143040920|NCT02246920|515690755|FG000|Overall Study|Lost to Follow-up|2|||
143040921|NCT02246920|515690756|FG001|Overall Study|Lost to Follow-up|1|||
143040922|NCT02246920|515690757|FG002|Overall Study|Lost to Follow-up|0|||
143164350|NCT00770679|516148592|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
143164351|NCT00414609|516148593|FG000|Core Study|Adverse Event|9|||
143164352|NCT00414609|516148594|FG001|Core Study|Adverse Event|11|||
143164353|NCT00414609|516148595|FG002|Core Study|Adverse Event|0|||
143164354|NCT00414609|516148593|FG000|Core Study|Abnormal laboratory values|0|||
143497967|NCT00666926|517364572|FG011|Overall Study|Laboratory abnormality|0|||
143040923|NCT02246920|515690755|FG000|Overall Study|Protocol Violation|2|||
143040924|NCT02246920|515690756|FG001|Overall Study|Protocol Violation|5|||
143164355|NCT00414609|516148594|FG001|Core Study|Abnormal laboratory values|1|||
143164356|NCT00414609|516148595|FG002|Core Study|Abnormal laboratory values|0|||
143164357|NCT00414609|516148593|FG000|Core Study|Abnormal test procedure results|1|||
143164358|NCT00414609|516148594|FG001|Core Study|Abnormal test procedure results|1|||
143164359|NCT00414609|516148595|FG002|Core Study|Abnormal test procedure results|0|||
143164360|NCT00414609|516148593|FG000|Core Study|Protocol deviation|0|||
143497968|NCT00666926|517364573|FG012|Overall Study|Laboratory abnormality|0|||
143040925|NCT02246920|515690757|FG002|Overall Study|Protocol Violation|1|||
143040926|NCT02246920|515690755|FG000|Overall Study|Withdrawal by Subject|0|||
143497969|NCT00666926|517364574|FG013|Overall Study|Laboratory abnormality|0|||
143040927|NCT02246920|515690756|FG001|Overall Study|Withdrawal by Subject|0|||
143497970|NCT00666926|517364575|FG014|Overall Study|Laboratory abnormality|0|||
143497971|NCT00666926|517364576|FG015|Overall Study|Laboratory abnormality|1|||
143040928|NCT02246920|515690757|FG002|Overall Study|Withdrawal by Subject|1|||
143040929|NCT01313273|515690760|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
143040930|NCT01313273|515690761|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
143040931|NCT01313273|515690760|FG000|Overall Study|Withdrawal by Subject|1|||
143040932|NCT01313273|515690761|FG001|Overall Study|Withdrawal by Subject|0|||
143040933|NCT01313273|515690760|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
143040934|NCT01313273|515690761|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
143040935|NCT01273805|515690762|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
143040936|NCT01273805|515690763|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
143040937|NCT02647944|515690764|FG000|Overall Study|Withdrawal by Subject|0|||
143040938|NCT02647944|515690765|FG001|Overall Study|Withdrawal by Subject|3|||
143040939|NCT02647944|515690764|FG000|Overall Study|Adverse Event|2|||
143040940|NCT02647944|515690765|FG001|Overall Study|Adverse Event|0|||
143040941|NCT02760368|515690766|FG000|Overall Study|Withdrawal by Subject|8|||
143040942|NCT02760368|515690767|FG001|Overall Study|Withdrawal by Subject|12|||
143040943|NCT02760368|515690768|FG002|Overall Study|Withdrawal by Subject|9|||
143040944|NCT02760368|515690766|FG000|Overall Study|Screen Failure|0|||
143040945|NCT02760368|515690767|FG001|Overall Study|Screen Failure|0|||
143040946|NCT02760368|515690768|FG002|Overall Study|Screen Failure|1|||
143040947|NCT02760368|515690766|FG000|Overall Study|Death|0|||
143040948|NCT02760368|515690767|FG001|Overall Study|Death|1|||
143040949|NCT02760368|515690768|FG002|Overall Study|Death|0|||
143040950|NCT02760368|515690766|FG000|Overall Study|Withdrawal by Sponsor|0|||
143040951|NCT02760368|515690767|FG001|Overall Study|Withdrawal by Sponsor|0|||
143040952|NCT02760368|515690768|FG002|Overall Study|Withdrawal by Sponsor|1|||
143040953|NCT00794963|515690769|FG000|Overall Study|Withdrawal by Subject|1|||
143040954|NCT00794963|515690770|FG001|Overall Study|Withdrawal by Subject|4|||
143040955|NCT01037114|515690771|FG000|Year 20|Others|1|||
143040956|NCT03620747|515690773|FG000|Overall Study|Participant decision|7|||
143040957|NCT03620747|515690773|FG000|Overall Study|Adverse Event|6|||
143040958|NCT03620747|515690773|FG000|Overall Study|Lack of Efficacy|1|||
143040959|NCT03620747|515690773|FG000|Overall Study|Poor compliance to protocol|2|||
143040960|NCT03620747|515690773|FG000|Overall Study|Other-unspecified|3|||
143040961|NCT01513174|515690776|FG000|Overall Study|Inclusion Error|1|||
143040962|NCT01513174|515690777|FG001|Overall Study|Inclusion Error|7|||
143040963|NCT01513174|515690776|FG000|Overall Study|Not receive study treatment|3|||
143040964|NCT01513174|515690777|FG001|Overall Study|Not receive study treatment|1|||
143040965|NCT01200810|515690786|FG000|Overall Study|Physician Decision|1|||
143040966|NCT01200810|515690787|FG001|Overall Study|Physician Decision|0|||
143040967|NCT01200810|515690786|FG000|Overall Study|Withdrawal by Subject|1|||
143164361|NCT00414609|516148594|FG001|Core Study|Protocol deviation|1|||
143164362|NCT00414609|516148595|FG002|Core Study|Protocol deviation|0|||
143164363|NCT00414609|516148593|FG000|Core Study|Patient withdrew consent|10|||
143164364|NCT00414609|516148594|FG001|Core Study|Patient withdrew consent|11|||
143164365|NCT00414609|516148595|FG002|Core Study|Patient withdrew consent|0|||
143164366|NCT00414609|516148593|FG000|Core Study|Lost to Follow-up|7|||
143164367|NCT00414609|516148594|FG001|Core Study|Lost to Follow-up|4|||
143164368|NCT00414609|516148595|FG002|Core Study|Lost to Follow-up|0|||
143164369|NCT00414609|516148593|FG000|Core Study|Administrative problems|0|||
143164370|NCT00414609|516148594|FG001|Core Study|Administrative problems|2|||
143164371|NCT00414609|516148595|FG002|Core Study|Administrative problems|0|||
143164372|NCT00414609|516148593|FG000|Core Study|Death|7|||
143164373|NCT00414609|516148594|FG001|Core Study|Death|14|||
143164374|NCT00414609|516148595|FG002|Core Study|Death|0|||
143164375|NCT00414609|516148593|FG000|Extension Study|Adverse Event|0|||
143164376|NCT00414609|516148594|FG001|Extension Study|Adverse Event|0|||
143164377|NCT00414609|516148595|FG002|Extension Study|Adverse Event|14|||
143164378|NCT00414609|516148593|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
143164379|NCT00414609|516148594|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
143164380|NCT00414609|516148595|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
143164381|NCT00414609|516148593|FG000|Extension Study|Withdrawal by Subject|0|||
143164382|NCT00414609|516148594|FG001|Extension Study|Withdrawal by Subject|0|||
143497972|NCT00666926|517364561|FG000|Overall Study|Lack of Efficacy|0|||
143497973|NCT00666926|517364562|FG001|Overall Study|Lack of Efficacy|0|||
143040968|NCT01200810|515690787|FG001|Overall Study|Withdrawal by Subject|2|||
143040969|NCT01200810|515690786|FG000|Overall Study|Sponsor stopped making study drug|3|||
143040970|NCT01200810|515690787|FG001|Overall Study|Sponsor stopped making study drug|3|||
143040971|NCT00904215|515690789|FG000|Overall Study|Adverse Event|25|||
143040972|NCT00904215|515690789|FG000|Overall Study|Protocol Violation|10|||
143164383|NCT00414609|516148595|FG002|Extension Study|Withdrawal by Subject|13|||
143164384|NCT00414609|516148593|FG000|Extension Study|Lost to Follow-up|0|||
143164385|NCT00414609|516148594|FG001|Extension Study|Lost to Follow-up|0|||
143164386|NCT00414609|516148595|FG002|Extension Study|Lost to Follow-up|10|||
143164387|NCT00414609|516148593|FG000|Extension Study|Administrative problems|0|||
143164388|NCT00414609|516148594|FG001|Extension Study|Administrative problems|0|||
143164389|NCT00414609|516148595|FG002|Extension Study|Administrative problems|1|||
143164390|NCT00414609|516148593|FG000|Extension Study|Death|0|||
143164391|NCT00414609|516148594|FG001|Extension Study|Death|0|||
143164392|NCT00414609|516148595|FG002|Extension Study|Death|17|||
143164393|NCT01514357|516148601|FG000|Overall Study|Screen failure|2|||
143497974|NCT00666926|517364563|FG002|Overall Study|Lack of Efficacy|0|||
143040973|NCT00904215|515690789|FG000|Overall Study|Lost to Follow-up|63|||
143040974|NCT00904215|515690789|FG000|Overall Study|Withdrawal by Subject|9|||
143240197|NCT00892099|516431962|FG000|Overall Study|Lost to Follow-up|0|||
143240198|NCT00892099|516431963|FG001|Overall Study|Lost to Follow-up|0|||
143240199|NCT00892099|516431964|FG002|Overall Study|Lost to Follow-up|1|||
143240200|NCT02346721|516431965|FG000|Overall Study|Withdrew Consent|3|||
143240201|NCT02346721|516431965|FG000|Overall Study|Lack of Efficacy|1|||
143240202|NCT00790842|516431966|FG000|Dose Level 1|Adverse Event|1|||
143240203|NCT00790842|516431967|FG001|Dose Level 1|Adverse Event|0|||
143240204|NCT00790842|516431968|FG002|Dose Level 1|Adverse Event|0|||
143240205|NCT00790842|516431969|FG003|Dose Level 1|Adverse Event|2|||
143240206|NCT00790842|516431970|FG004|Dose Level 1|Adverse Event|0|||
143240207|NCT00790842|516431971|FG005|Dose Level 1|Adverse Event|0|||
143240208|NCT00790842|516431972|FG006|Dose Level 1|Adverse Event|0|||
143240209|NCT00790842|516431973|FG007|Dose Level 1|Adverse Event|1|||
143240210|NCT00790842|516431974|FG008|Dose Level 1|Adverse Event|0|||
143240211|NCT00790842|516431975|FG009|Dose Level 1|Adverse Event|0|||
143240212|NCT00790842|516431976|FG010|Dose Level 1|Adverse Event|0|||
143240213|NCT00790842|516431966|FG000|Dose Level 1|Physician Decision|1|||
143240214|NCT00790842|516431967|FG001|Dose Level 1|Physician Decision|0|||
143240215|NCT00790842|516431968|FG002|Dose Level 1|Physician Decision|0|||
143240216|NCT00790842|516431969|FG003|Dose Level 1|Physician Decision|0|||
143240217|NCT00790842|516431970|FG004|Dose Level 1|Physician Decision|0|||
143240218|NCT00790842|516431971|FG005|Dose Level 1|Physician Decision|0|||
143240219|NCT00790842|516431972|FG006|Dose Level 1|Physician Decision|0|||
143240220|NCT00790842|516431973|FG007|Dose Level 1|Physician Decision|1|||
143240221|NCT00790842|516431974|FG008|Dose Level 1|Physician Decision|0|||
143240222|NCT00790842|516431975|FG009|Dose Level 1|Physician Decision|0|||
143240223|NCT00790842|516431976|FG010|Dose Level 1|Physician Decision|0|||
143240224|NCT00790842|516431966|FG000|Dose Level 1|Withdrawal by Subject|1|||
143240225|NCT00790842|516431967|FG001|Dose Level 1|Withdrawal by Subject|0|||
143240226|NCT00790842|516431968|FG002|Dose Level 1|Withdrawal by Subject|0|||
143240227|NCT00790842|516431969|FG003|Dose Level 1|Withdrawal by Subject|0|||
143040975|NCT00904215|515690789|FG000|Overall Study|Other|28|||
143040976|NCT00960297|515690790|FG000|Overall Study|Physician Decision|1|||
143240228|NCT00790842|516431970|FG004|Dose Level 1|Withdrawal by Subject|0|||
143240229|NCT00790842|516431971|FG005|Dose Level 1|Withdrawal by Subject|0|||
143240230|NCT00790842|516431972|FG006|Dose Level 1|Withdrawal by Subject|0|||
143240231|NCT00790842|516431973|FG007|Dose Level 1|Withdrawal by Subject|0|||
143240232|NCT00790842|516431974|FG008|Dose Level 1|Withdrawal by Subject|0|||
143240233|NCT00790842|516431975|FG009|Dose Level 1|Withdrawal by Subject|0|||
143240234|NCT00790842|516431976|FG010|Dose Level 1|Withdrawal by Subject|0|||
143240235|NCT00790842|516431966|FG000|Dose Level 2|Death|0|||
143240236|NCT00790842|516431967|FG001|Dose Level 2|Death|1|||
143240237|NCT00790842|516431968|FG002|Dose Level 2|Death|0|||
143240238|NCT00790842|516431969|FG003|Dose Level 2|Death|0|||
143240239|NCT00790842|516431970|FG004|Dose Level 2|Death|1|||
143240240|NCT00790842|516431971|FG005|Dose Level 2|Death|0|||
143240241|NCT00790842|516431972|FG006|Dose Level 2|Death|0|||
143240242|NCT00790842|516431973|FG007|Dose Level 2|Death|0|||
143240243|NCT00790842|516431974|FG008|Dose Level 2|Death|0|||
143240244|NCT00790842|516431975|FG009|Dose Level 2|Death|0|||
143240245|NCT00790842|516431976|FG010|Dose Level 2|Death|0|||
143240246|NCT00790842|516431966|FG000|Dose Level 2|Physician Decision|0|||
143240247|NCT00790842|516431967|FG001|Dose Level 2|Physician Decision|1|||
143240248|NCT00790842|516431968|FG002|Dose Level 2|Physician Decision|0|||
143240249|NCT00790842|516431969|FG003|Dose Level 2|Physician Decision|0|||
143240250|NCT00790842|516431970|FG004|Dose Level 2|Physician Decision|0|||
143240251|NCT00790842|516431971|FG005|Dose Level 2|Physician Decision|0|||
143240252|NCT00790842|516431972|FG006|Dose Level 2|Physician Decision|0|||
143240253|NCT00790842|516431973|FG007|Dose Level 2|Physician Decision|0|||
143240254|NCT00790842|516431974|FG008|Dose Level 2|Physician Decision|0|||
143240255|NCT00790842|516431975|FG009|Dose Level 2|Physician Decision|0|||
143240256|NCT00790842|516431976|FG010|Dose Level 2|Physician Decision|0|||
143240257|NCT00790842|516431966|FG000|Dose Level 2|Withdrawal by Subject|0|||
143240258|NCT00790842|516431967|FG001|Dose Level 2|Withdrawal by Subject|1|||
143240259|NCT00790842|516431968|FG002|Dose Level 2|Withdrawal by Subject|0|||
143240260|NCT00790842|516431969|FG003|Dose Level 2|Withdrawal by Subject|0|||
143240261|NCT00790842|516431970|FG004|Dose Level 2|Withdrawal by Subject|0|||
143240262|NCT00790842|516431971|FG005|Dose Level 2|Withdrawal by Subject|0|||
143240263|NCT00790842|516431972|FG006|Dose Level 2|Withdrawal by Subject|0|||
143240264|NCT00790842|516431973|FG007|Dose Level 2|Withdrawal by Subject|0|||
143240265|NCT00790842|516431974|FG008|Dose Level 2|Withdrawal by Subject|0|||
143240266|NCT00790842|516431975|FG009|Dose Level 2|Withdrawal by Subject|0|||
143240267|NCT00790842|516431976|FG010|Dose Level 2|Withdrawal by Subject|0|||
143240268|NCT00790842|516431966|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
143240269|NCT00790842|516431967|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
143240270|NCT00790842|516431968|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
143240271|NCT00790842|516431969|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
143240272|NCT00790842|516431970|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
143240273|NCT00790842|516431971|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
143497975|NCT00666926|517364564|FG003|Overall Study|Lack of Efficacy|0|||
143497976|NCT00666926|517364565|FG004|Overall Study|Lack of Efficacy|0|||
143497977|NCT00666926|517364566|FG005|Overall Study|Lack of Efficacy|1|||
143497978|NCT00666926|517364567|FG006|Overall Study|Lack of Efficacy|0|||
143497979|NCT00666926|517364568|FG007|Overall Study|Lack of Efficacy|0|||
143497980|NCT00666926|517364569|FG008|Overall Study|Lack of Efficacy|0|||
143040977|NCT00960297|515690790|FG000|Overall Study|Venous port infection|1|||
143040978|NCT00960297|515690790|FG000|Overall Study|Disease progression|1|||
143040979|NCT00968812|515690799|FG000|Overall Study|Adverse Event|30|||
143040980|NCT00968812|515690800|FG001|Overall Study|Adverse Event|46|||
143040981|NCT00968812|515690801|FG002|Overall Study|Adverse Event|33|||
143040982|NCT00968812|515690799|FG000|Overall Study|Death|2|||
143040983|NCT00968812|515690800|FG001|Overall Study|Death|2|||
143040984|NCT00968812|515690801|FG002|Overall Study|Death|1|||
143040985|NCT00968812|515690799|FG000|Overall Study|Lack of Efficacy|9|||
143040986|NCT00968812|515690800|FG001|Overall Study|Lack of Efficacy|7|||
143040987|NCT00968812|515690801|FG002|Overall Study|Lack of Efficacy|16|||
143040988|NCT00968812|515690799|FG000|Overall Study|Lost to Follow-up|17|||
143040989|NCT00968812|515690800|FG001|Overall Study|Lost to Follow-up|12|||
143040990|NCT00968812|515690801|FG002|Overall Study|Lost to Follow-up|11|||
143040991|NCT00968812|515690799|FG000|Overall Study|Physician Decision|8|||
143040992|NCT00968812|515690800|FG001|Overall Study|Physician Decision|5|||
143040993|NCT00968812|515690801|FG002|Overall Study|Physician Decision|9|||
143040994|NCT00968812|515690799|FG000|Overall Study|Protocol Violation|7|||
143040995|NCT00968812|515690800|FG001|Overall Study|Protocol Violation|4|||
143040996|NCT00968812|515690801|FG002|Overall Study|Protocol Violation|3|||
143040997|NCT00968812|515690799|FG000|Overall Study|Withdrawal by Subject|17|||
143040998|NCT00968812|515690800|FG001|Overall Study|Withdrawal by Subject|23|||
143040999|NCT00968812|515690801|FG002|Overall Study|Withdrawal by Subject|25|||
143041000|NCT00968812|515690799|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
143041001|NCT00968812|515690800|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
143041002|NCT00968812|515690801|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
143164394|NCT01514357|516148602|FG001|Overall Study|Screen failure|0|||
143164395|NCT01514357|516148601|FG000|Overall Study|Withdrawal by Subject|2|||
143164396|NCT01514357|516148602|FG001|Overall Study|Withdrawal by Subject|0|||
143164397|NCT00752219|516148603|FG000|Overall Study|Clinical failure|0|||
143164398|NCT00752219|516148604|FG001|Overall Study|Clinical failure|1|||
143164399|NCT00752219|516148603|FG000|Overall Study|Adverse Event|5|||
143164400|NCT00752219|516148604|FG001|Overall Study|Adverse Event|3|||
143164401|NCT00752219|516148603|FG000|Overall Study|Protocol deviation|1|||
143164402|NCT00752219|516148604|FG001|Overall Study|Protocol deviation|0|||
143164403|NCT00752219|516148603|FG000|Overall Study|Lost to Follow-up|1|||
143164404|NCT00752219|516148604|FG001|Overall Study|Lost to Follow-up|2|||
143164405|NCT00752219|516148603|FG000|Overall Study|Randomized but not treated|1|||
143164406|NCT00752219|516148604|FG001|Overall Study|Randomized but not treated|0|||
143164407|NCT00752219|516148603|FG000|Overall Study|Other|3|||
143164408|NCT00752219|516148604|FG001|Overall Study|Other|0|||
143164409|NCT04691115|516148605|FG000|Overall Study|Withdrawal by Subject|0|||
143164410|NCT04691115|516148606|FG001|Overall Study|Withdrawal by Subject|0|||
143164411|NCT04691115|516148607|FG002|Overall Study|Withdrawal by Subject|0|||
143164412|NCT04691115|516148608|FG003|Overall Study|Withdrawal by Subject|0|||
143164413|NCT04691115|516148609|FG004|Overall Study|Withdrawal by Subject|0|||
143164414|NCT04691115|516148610|FG005|Overall Study|Withdrawal by Subject|1|||
143164415|NCT04691115|516148611|FG006|Overall Study|Withdrawal by Subject|0|||
143041003|NCT00968812|515690799|FG000|Overall Study|Noncompliance with study drug|4|||
143041004|NCT00968812|515690800|FG001|Overall Study|Noncompliance with study drug|1|||
143041005|NCT00968812|515690801|FG002|Overall Study|Noncompliance with study drug|6|||
143041006|NCT00968812|515690799|FG000|Overall Study|Unable to take rescue therapy|12|||
143041007|NCT00968812|515690800|FG001|Overall Study|Unable to take rescue therapy|12|||
143164416|NCT04691115|516148612|FG007|Overall Study|Withdrawal by Subject|0|||
143164417|NCT04691115|516148613|FG008|Overall Study|Withdrawal by Subject|0|||
143164418|NCT04691115|516148614|FG009|Overall Study|Withdrawal by Subject|0|||
143164419|NCT04691115|516148615|FG010|Overall Study|Withdrawal by Subject|0|||
143164420|NCT04691115|516148616|FG011|Overall Study|Withdrawal by Subject|0|||
143164421|NCT04691115|516148617|FG012|Overall Study|Withdrawal by Subject|0|||
143164422|NCT04691115|516148618|FG013|Overall Study|Withdrawal by Subject|0|||
143164423|NCT00836901|516148624|FG000|First Intervention|Withdrawal by Subject|1|||
143164424|NCT00836901|516148625|FG001|First Intervention|Withdrawal by Subject|0|||
143164425|NCT00830336|516148626|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
143164426|NCT00830336|516148627|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
143164427|NCT00867334|516148628|FG000|Overall Study|Withdrawal by Subject|0|||
143164428|NCT00867334|516148629|FG001|Overall Study|Withdrawal by Subject|1|||
143164429|NCT00867334|516148628|FG000|Overall Study|Withdrawal by Subject|1|||
143164430|NCT00867334|516148629|FG001|Overall Study|Withdrawal by Subject|0|||
143164431|NCT00867334|516148628|FG000|Overall Study|Withdrawal by Subject|1|||
143164432|NCT00867334|516148629|FG001|Overall Study|Withdrawal by Subject|0|||
143497981|NCT00666926|517364570|FG009|Overall Study|Lack of Efficacy|0|||
143041008|NCT00968812|515690801|FG002|Overall Study|Unable to take rescue therapy|17|||
143041009|NCT00968812|515690799|FG000|Overall Study|Other|25|||
143041010|NCT00968812|515690800|FG001|Overall Study|Other|37|||
143041011|NCT00968812|515690801|FG002|Overall Study|Other|40|||
143041012|NCT02937870|515690804|FG000|Overall Study|Adverse Event|1|||
143041013|NCT02937870|515690804|FG000|Overall Study|Protocol Deviation|2|||
143041014|NCT00609674|515690805|FG000|Overall Study|Adverse Event|1|||
143041015|NCT00609674|515690806|FG001|Overall Study|Adverse Event|1|||
143041016|NCT00609674|515690805|FG000|Overall Study|Protocol Violation|3|||
143041017|NCT00609674|515690806|FG001|Overall Study|Protocol Violation|5|||
143041018|NCT00609674|515690805|FG000|Overall Study|Lost to Follow-up|1|||
143041019|NCT00609674|515690806|FG001|Overall Study|Lost to Follow-up|0|||
143041020|NCT00609674|515690805|FG000|Overall Study|Withdrew consent|2|||
143041021|NCT00609674|515690806|FG001|Overall Study|Withdrew consent|1|||
143041022|NCT03098394|515690807|FG000|Overall Study|Pregnancy|0|||
143041023|NCT03098394|515690808|FG001|Overall Study|Pregnancy|1|||
143041024|NCT00244764|515690809|FG000|Overall Study|Adverse Event|37|||
143041025|NCT00244764|515690809|FG000|Overall Study|Lost to Follow-up|23|||
143041026|NCT00244764|515690809|FG000|Overall Study|Withdrawal by Subject|12|||
143041027|NCT00244764|515690809|FG000|Overall Study|Disease Progression|13|||
143041028|NCT00244764|515690809|FG000|Overall Study|Protocol Violation|2|||
143041029|NCT00244764|515690809|FG000|Overall Study|Death|1|||
143041030|NCT00244764|515690809|FG000|Overall Study|Off Study Medication for >21 Days|1|||
143041031|NCT00244764|515690809|FG000|Overall Study|Declining Performance Status|1|||
143041032|NCT00244764|515690809|FG000|Overall Study|Participant was Hospitalized until Death|1|||
143041033|NCT00244764|515690809|FG000|Overall Study|Primary Investigator Discretion|2|||
143041034|NCT00244764|515690809|FG000|Overall Study|Sponsor Terminated Study|2|||
143041035|NCT00244764|515690809|FG000|Overall Study|Developed Secondary Malignancy|1|||
143041036|NCT00003659|515690813|FG000|Overall Study|Withdrawal by Subject|3|||
143041037|NCT04022954|515690814|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
143041038|NCT04022954|515690814|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
143041039|NCT04022954|515690814|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
143041040|NCT02648438|515690816|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
143041041|NCT02648438|515690817|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
143041042|NCT02648438|515690818|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
143041043|NCT02648438|515690816|FG000|Overall Study|Protocol Violation|2|||
143041044|NCT02648438|515690817|FG001|Overall Study|Protocol Violation|0|||
143041045|NCT02648438|515690818|FG002|Overall Study|Protocol Violation|0|||
143041046|NCT02648438|515690816|FG000|Overall Study|Withdrawal by Subject|1|||
143041047|NCT02648438|515690817|FG001|Overall Study|Withdrawal by Subject|1|||
143041048|NCT02648438|515690818|FG002|Overall Study|Withdrawal by Subject|0|||
143041049|NCT03138967|515690819|FG000|Overall Study|Death|0|||
143041050|NCT03138967|515690820|FG001|Overall Study|Death|1|||
143041051|NCT03138967|515690819|FG000|Overall Study|Physician Decision|1|||
143041052|NCT03138967|515690820|FG001|Overall Study|Physician Decision|3|||
143240274|NCT00790842|516431972|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
143240275|NCT00790842|516431973|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
143240276|NCT00790842|516431974|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
143240277|NCT00790842|516431975|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
143240278|NCT00790842|516431976|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
143240279|NCT00790842|516431966|FG000|Dose Level 3|Adverse Event|0|||
143240280|NCT00790842|516431967|FG001|Dose Level 3|Adverse Event|0|||
143240281|NCT00790842|516431968|FG002|Dose Level 3|Adverse Event|1|||
143240282|NCT00790842|516431969|FG003|Dose Level 3|Adverse Event|0|||
143240283|NCT00790842|516431970|FG004|Dose Level 3|Adverse Event|0|||
143497982|NCT00666926|517364571|FG010|Overall Study|Lack of Efficacy|0|||
143497983|NCT00666926|517364572|FG011|Overall Study|Lack of Efficacy|1|||
143041053|NCT04604275|515690821|FG000|Washout-1 Week|Withdrawal by Subject|1|||
143497984|NCT00666926|517364573|FG012|Overall Study|Lack of Efficacy|0|||
143497985|NCT00666926|517364574|FG013|Overall Study|Lack of Efficacy|0|||
143041054|NCT04604275|515690822|FG001|Washout-1 Week|Withdrawal by Subject|0|||
143041055|NCT05615935|515690823|FG000|Overall Study|Lost to Follow-up|1|||
143240284|NCT00790842|516431971|FG005|Dose Level 3|Adverse Event|0|||
143240285|NCT00790842|516431972|FG006|Dose Level 3|Adverse Event|0|||
143240286|NCT00790842|516431973|FG007|Dose Level 3|Adverse Event|0|||
143240287|NCT00790842|516431974|FG008|Dose Level 3|Adverse Event|0|||
143041056|NCT05615935|515690824|FG001|Overall Study|Lost to Follow-up|1|||
143041057|NCT03925532|515690825|FG000|Overall Study|Lost to Follow-up|1|||
143041058|NCT02689505|515690826|FG000|Overall Study|Progressive disease|2|||
143041059|NCT02689505|515690827|FG001|Overall Study|Progressive disease|2|||
143041060|NCT02689505|515690828|FG002|Overall Study|Progressive disease|3|||
143041061|NCT02689505|515690829|FG003|Overall Study|Progressive disease|9|||
143041062|NCT02689505|515690830|FG004|Overall Study|Progressive disease|1|||
143041063|NCT02689505|515690826|FG000|Overall Study|Dose Limiting Toxicity|0|||
143497986|NCT00666926|517364575|FG014|Overall Study|Lack of Efficacy|0|||
143041064|NCT02689505|515690827|FG001|Overall Study|Dose Limiting Toxicity|1|||
143240288|NCT00790842|516431975|FG009|Dose Level 3|Adverse Event|0|||
143497987|NCT00666926|517364576|FG015|Overall Study|Lack of Efficacy|0|||
143240289|NCT00790842|516431976|FG010|Dose Level 3|Adverse Event|0|||
143240290|NCT00790842|516431966|FG000|Dose Level 3|Withdrawal by Subject|0|||
143240291|NCT00790842|516431967|FG001|Dose Level 3|Withdrawal by Subject|0|||
143041065|NCT02689505|515690828|FG002|Overall Study|Dose Limiting Toxicity|0|||
143041066|NCT02689505|515690829|FG003|Overall Study|Dose Limiting Toxicity|0|||
143041067|NCT02689505|515690830|FG004|Overall Study|Dose Limiting Toxicity|2|||
143041068|NCT02689505|515690826|FG000|Overall Study|Other AE or clinical progression|0|||
143041069|NCT02689505|515690827|FG001|Overall Study|Other AE or clinical progression|2|||
143041070|NCT02689505|515690828|FG002|Overall Study|Other AE or clinical progression|0|||
143041071|NCT02689505|515690829|FG003|Overall Study|Other AE or clinical progression|2|||
143041072|NCT02689505|515690830|FG004|Overall Study|Other AE or clinical progression|0|||
143041073|NCT00723710|515690834|FG000|Overall Study|Disease progression|48|||
143041074|NCT00723710|515690834|FG000|Overall Study|Adverse Event|88|||
143041075|NCT00723710|515690834|FG000|Overall Study|Withdrawal by Subject|36|||
143041076|NCT00723710|515690834|FG000|Overall Study|Physician Decision|2|||
143041077|NCT04405570|515690835|FG000|Overall Study|Adverse Event|0|||
143041078|NCT04405570|515690836|FG001|Overall Study|Adverse Event|1|||
143041079|NCT04405570|515690837|FG002|Overall Study|Adverse Event|1|||
143041080|NCT04405570|515690838|FG003|Overall Study|Adverse Event|1|||
143041081|NCT04405570|515690835|FG000|Overall Study|Lost to Follow-up|0|||
143041082|NCT04405570|515690836|FG001|Overall Study|Lost to Follow-up|1|||
143041083|NCT04405570|515690837|FG002|Overall Study|Lost to Follow-up|0|||
143041084|NCT04405570|515690838|FG003|Overall Study|Lost to Follow-up|0|||
143041085|NCT04405570|515690835|FG000|Overall Study|Physician Decision|0|||
143041086|NCT04405570|515690836|FG001|Overall Study|Physician Decision|0|||
143041087|NCT04405570|515690837|FG002|Overall Study|Physician Decision|1|||
143041088|NCT04405570|515690838|FG003|Overall Study|Physician Decision|0|||
143041089|NCT04405570|515690835|FG000|Overall Study|Withdrawal by Subject|0|||
143041090|NCT04405570|515690836|FG001|Overall Study|Withdrawal by Subject|1|||
143041091|NCT04405570|515690837|FG002|Overall Study|Withdrawal by Subject|1|||
143041092|NCT04405570|515690838|FG003|Overall Study|Withdrawal by Subject|0|||
143041093|NCT04405570|515690835|FG000|Overall Study|Randomized not dosed|0|||
143041094|NCT04405570|515690836|FG001|Overall Study|Randomized not dosed|2|||
143041095|NCT04405570|515690837|FG002|Overall Study|Randomized not dosed|0|||
143041096|NCT04405570|515690838|FG003|Overall Study|Randomized not dosed|0|||
143041097|NCT04499963|515690839|FG000|Overall Study|Adverse Event|3|||
143041098|NCT04499963|515690840|FG001|Overall Study|Adverse Event|0|||
143041099|NCT04499963|515690839|FG000|Overall Study|Death|3|||
143041100|NCT04499963|515690840|FG001|Overall Study|Death|0|||
143041101|NCT04499963|515690839|FG000|Overall Study|Lack of Efficacy|7|||
143041102|NCT04499963|515690840|FG001|Overall Study|Lack of Efficacy|0|||
143041103|NCT04499963|515690839|FG000|Overall Study|Lost to Follow-up|2|||
143041104|NCT04499963|515690840|FG001|Overall Study|Lost to Follow-up|0|||
143041105|NCT01005745|515690841|FG000|Overall Study|No TIL growth|1|||
143041106|NCT01005745|515690841|FG000|Overall Study|Disease progressed during TIL growth|3|||
143041107|NCT01005745|515690841|FG000|Overall Study|Death prior to treatment|1|||
143041108|NCT01005745|515690841|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
143041109|NCT01208337|515690849|FG000|Overall Study|Death|3|||
143041110|NCT03663179|515690850|FG000|Overall Study|Withdrawal by Subject|2|||
143041111|NCT03663179|515690851|FG001|Overall Study|Withdrawal by Subject|0|||
143041112|NCT03663179|515690850|FG000|Overall Study|Lost to Follow-up|1|||
143041113|NCT03663179|515690851|FG001|Overall Study|Lost to Follow-up|1|||
143041114|NCT03663179|515690850|FG000|Overall Study|Revealed exclusionary condition|1|||
143041115|NCT03663179|515690851|FG001|Overall Study|Revealed exclusionary condition|0|||
143041116|NCT01615198|515690855|FG000|Overall Study|Withdrawal by Subject|5|||
143041117|NCT01615198|515690856|FG001|Overall Study|Withdrawal by Subject|5|||
143240292|NCT00790842|516431968|FG002|Dose Level 3|Withdrawal by Subject|3|||
143240293|NCT00790842|516431969|FG003|Dose Level 3|Withdrawal by Subject|0|||
143240294|NCT00790842|516431970|FG004|Dose Level 3|Withdrawal by Subject|0|||
143240295|NCT00790842|516431971|FG005|Dose Level 3|Withdrawal by Subject|0|||
143240296|NCT00790842|516431972|FG006|Dose Level 3|Withdrawal by Subject|0|||
143240297|NCT00790842|516431973|FG007|Dose Level 3|Withdrawal by Subject|0|||
143041118|NCT01615198|515690855|FG000|Overall Study|Protocol deviation|1|||
143041119|NCT01615198|515690856|FG001|Overall Study|Protocol deviation|1|||
143041120|NCT01615198|515690855|FG000|Overall Study|Physician Decision|5|||
143041121|NCT01615198|515690856|FG001|Overall Study|Physician Decision|1|||
143041122|NCT01615198|515690855|FG000|Overall Study|Lost to Follow-up|1|||
143041123|NCT01615198|515690856|FG001|Overall Study|Lost to Follow-up|1|||
143041124|NCT01615198|515690855|FG000|Overall Study|Lack of Efficacy|1|||
143041125|NCT01615198|515690856|FG001|Overall Study|Lack of Efficacy|6|||
143041126|NCT01615198|515690855|FG000|Overall Study|Adverse Event|11|||
143041127|NCT01615198|515690856|FG001|Overall Study|Adverse Event|5|||
143041128|NCT01686438|515690857|FG000|Overall Study|Lost to Follow-up|8|||
143240298|NCT00790842|516431974|FG008|Dose Level 3|Withdrawal by Subject|0|||
143240299|NCT00790842|516431975|FG009|Dose Level 3|Withdrawal by Subject|2|||
143240300|NCT00790842|516431976|FG010|Dose Level 3|Withdrawal by Subject|0|||
143041129|NCT01686438|515690858|FG001|Overall Study|Lost to Follow-up|9|||
143041130|NCT01686438|515690859|FG002|Overall Study|Lost to Follow-up|10|||
143497988|NCT00666926|517364561|FG000|Overall Study|Lost to Follow-up|0|||
143497989|NCT00666926|517364562|FG001|Overall Study|Lost to Follow-up|0|||
143497990|NCT00666926|517364563|FG002|Overall Study|Lost to Follow-up|0|||
143497991|NCT00666926|517364564|FG003|Overall Study|Lost to Follow-up|1|||
143497992|NCT00666926|517364565|FG004|Overall Study|Lost to Follow-up|0|||
143497993|NCT00666926|517364566|FG005|Overall Study|Lost to Follow-up|0|||
143497994|NCT00666926|517364567|FG006|Overall Study|Lost to Follow-up|0|||
143497995|NCT00666926|517364568|FG007|Overall Study|Lost to Follow-up|0|||
143497996|NCT00666926|517364569|FG008|Overall Study|Lost to Follow-up|0|||
143497997|NCT00666926|517364570|FG009|Overall Study|Lost to Follow-up|0|||
143497998|NCT00666926|517364571|FG010|Overall Study|Lost to Follow-up|0|||
143497999|NCT00666926|517364572|FG011|Overall Study|Lost to Follow-up|0|||
143498000|NCT00666926|517364573|FG012|Overall Study|Lost to Follow-up|0|||
143498001|NCT00666926|517364574|FG013|Overall Study|Lost to Follow-up|0|||
143498002|NCT00666926|517364575|FG014|Overall Study|Lost to Follow-up|0|||
143498003|NCT00666926|517364576|FG015|Overall Study|Lost to Follow-up|0|||
143498004|NCT00666926|517364561|FG000|Overall Study|Other|2|||
143498005|NCT00666926|517364562|FG001|Overall Study|Other|4|||
143498006|NCT00666926|517364563|FG002|Overall Study|Other|3|||
143498007|NCT00666926|517364564|FG003|Overall Study|Other|3|||
143498008|NCT00666926|517364565|FG004|Overall Study|Other|3|||
143498009|NCT00666926|517364566|FG005|Overall Study|Other|3|||
143498010|NCT00666926|517364567|FG006|Overall Study|Other|4|||
143498011|NCT00666926|517364568|FG007|Overall Study|Other|0|||
143498012|NCT00666926|517364569|FG008|Overall Study|Other|3|||
143498013|NCT00666926|517364570|FG009|Overall Study|Other|5|||
143498014|NCT00666926|517364571|FG010|Overall Study|Other|3|||
143498015|NCT00666926|517364572|FG011|Overall Study|Other|26|||
143498016|NCT00666926|517364573|FG012|Overall Study|Other|3|||
143498017|NCT00666926|517364574|FG013|Overall Study|Other|2|||
143498018|NCT00666926|517364575|FG014|Overall Study|Other|4|||
143498019|NCT00666926|517364576|FG015|Overall Study|Other|4|||
143498020|NCT00666926|517364561|FG000|Overall Study|Withdrawal by Subject|0|||
143498021|NCT00666926|517364562|FG001|Overall Study|Withdrawal by Subject|0|||
143498022|NCT00666926|517364563|FG002|Overall Study|Withdrawal by Subject|0|||
143498023|NCT00666926|517364564|FG003|Overall Study|Withdrawal by Subject|0|||
143498024|NCT00666926|517364565|FG004|Overall Study|Withdrawal by Subject|0|||
143498025|NCT00666926|517364566|FG005|Overall Study|Withdrawal by Subject|0|||
143498026|NCT00666926|517364567|FG006|Overall Study|Withdrawal by Subject|0|||
143498027|NCT00666926|517364568|FG007|Overall Study|Withdrawal by Subject|1|||
143498028|NCT00666926|517364569|FG008|Overall Study|Withdrawal by Subject|0|||
143498029|NCT00666926|517364570|FG009|Overall Study|Withdrawal by Subject|3|||
143498030|NCT00666926|517364571|FG010|Overall Study|Withdrawal by Subject|0|||
143498031|NCT00666926|517364572|FG011|Overall Study|Withdrawal by Subject|3|||
143498032|NCT00666926|517364573|FG012|Overall Study|Withdrawal by Subject|0|||
143498033|NCT00666926|517364574|FG013|Overall Study|Withdrawal by Subject|1|||
143498034|NCT00666926|517364575|FG014|Overall Study|Withdrawal by Subject|3|||
143164433|NCT01148771|516148632|FG000|Washout Period|Withdrawal by Subject|0|||
143164434|NCT01148771|516148633|FG001|Washout Period|Withdrawal by Subject|1|||
143164435|NCT01437189|516148641|FG000|Overall Study|Adverse Event|3|||
143164436|NCT01437189|516148641|FG000|Overall Study|Lack of Efficacy|4|||
143164437|NCT01437189|516148641|FG000|Overall Study|Withdrawal by Subject|8|||
143498035|NCT00666926|517364576|FG015|Overall Study|Withdrawal by Subject|3|||
143498036|NCT00666926|517364561|FG000|Overall Study|Death|0|||
143498037|NCT00666926|517364562|FG001|Overall Study|Death|0|||
143498038|NCT00666926|517364563|FG002|Overall Study|Death|0|||
143498039|NCT00666926|517364564|FG003|Overall Study|Death|0|||
143498040|NCT00666926|517364565|FG004|Overall Study|Death|0|||
143498041|NCT00666926|517364566|FG005|Overall Study|Death|0|||
143498042|NCT00666926|517364567|FG006|Overall Study|Death|0|||
143164438|NCT01229111|516148642|FG000|Overall Study|Death|1|||
143164439|NCT04102514|516148643|FG000|Overall Study|Death|3|||
143164440|NCT04102514|516148644|FG001|Overall Study|Death|0|||
143498043|NCT00666926|517364568|FG007|Overall Study|Death|0|||
143498044|NCT00666926|517364569|FG008|Overall Study|Death|0|||
143498045|NCT00666926|517364570|FG009|Overall Study|Death|0|||
143498046|NCT00666926|517364571|FG010|Overall Study|Death|0|||
143498047|NCT00666926|517364572|FG011|Overall Study|Death|1|||
143498048|NCT00666926|517364573|FG012|Overall Study|Death|0|||
143164441|NCT04102514|516148645|FG002|Overall Study|Death|0|||
143498049|NCT00666926|517364574|FG013|Overall Study|Death|0|||
143164442|NCT04102514|516148646|FG003|Overall Study|Death|0|||
143164443|NCT04102514|516148643|FG000|Overall Study|Lost to Follow-up|0|||
143164444|NCT04102514|516148644|FG001|Overall Study|Lost to Follow-up|0|||
143164445|NCT04102514|516148645|FG002|Overall Study|Lost to Follow-up|3|||
143498050|NCT00666926|517364575|FG014|Overall Study|Death|0|||
143498051|NCT00666926|517364576|FG015|Overall Study|Death|0|||
143498052|NCT01960855|517364577|FG000|Overall Study|Subject noncompliant|1|||
143498053|NCT01960855|517364578|FG001|Overall Study|Subject noncompliant|0|||
143498054|NCT01960855|517364579|FG002|Overall Study|Subject noncompliant|0|||
143498055|NCT01960855|517364580|FG003|Overall Study|Subject noncompliant|0|||
143498056|NCT01960855|517364581|FG004|Overall Study|Subject noncompliant|0|||
143041131|NCT01686438|515690857|FG000|Overall Study|Adverse Event|0|||
143041132|NCT01686438|515690858|FG001|Overall Study|Adverse Event|0|||
143041133|NCT01686438|515690859|FG002|Overall Study|Adverse Event|1|||
143041134|NCT01686438|515690857|FG000|Overall Study|Protocol Violation|0|||
143041135|NCT01686438|515690858|FG001|Overall Study|Protocol Violation|0|||
143041136|NCT01686438|515690859|FG002|Overall Study|Protocol Violation|1|||
143041137|NCT01686438|515690857|FG000|Overall Study|Withdrawal by Subject|0|||
143041138|NCT01686438|515690858|FG001|Overall Study|Withdrawal by Subject|0|||
143041139|NCT01686438|515690859|FG002|Overall Study|Withdrawal by Subject|1|||
143041140|NCT00984126|515690860|FG000|Overall Study|Protocol Violation|0|||
143041141|NCT00984126|515690861|FG001|Overall Study|Protocol Violation|0|||
143041142|NCT00984126|515690862|FG002|Overall Study|Protocol Violation|1|||
143041143|NCT00984126|515690863|FG003|Overall Study|Protocol Violation|2|||
143041144|NCT00984126|515690860|FG000|Overall Study|Adverse Event|0|||
143041145|NCT00984126|515690861|FG001|Overall Study|Adverse Event|0|||
143041146|NCT00984126|515690862|FG002|Overall Study|Adverse Event|0|||
143041147|NCT00984126|515690863|FG003|Overall Study|Adverse Event|2|||
143041148|NCT00984126|515690860|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
143041149|NCT00984126|515690861|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
143041150|NCT00984126|515690862|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
143041151|NCT00984126|515690863|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
143041152|NCT00984126|515690860|FG000|Overall Study|Withdrawal criteria|0|||
143041153|NCT00984126|515690861|FG001|Overall Study|Withdrawal criteria|1|||
143041154|NCT00984126|515690862|FG002|Overall Study|Withdrawal criteria|3|||
143041155|NCT00984126|515690863|FG003|Overall Study|Withdrawal criteria|9|||
143498057|NCT01960855|517364577|FG000|Overall Study|Adverse Event|2|||
143498058|NCT01960855|517364578|FG001|Overall Study|Adverse Event|0|||
143041156|NCT01029340|515690867|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
143041157|NCT01029340|515690868|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
143041158|NCT01029340|515690869|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
143041159|NCT01029340|515690870|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
143041160|NCT01029340|515690871|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
143498059|NCT01960855|517364579|FG002|Overall Study|Adverse Event|6|||
143498060|NCT01960855|517364580|FG003|Overall Study|Adverse Event|2|||
143498061|NCT01960855|517364581|FG004|Overall Study|Adverse Event|2|||
143041161|NCT01029340|515690872|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
143041162|NCT01029340|515690867|FG000|Part B Treatment Period|Protocol Violation|0|||
143041163|NCT01029340|515690868|FG001|Part B Treatment Period|Protocol Violation|0|||
143041164|NCT01029340|515690869|FG002|Part B Treatment Period|Protocol Violation|1|||
143041165|NCT01029340|515690870|FG003|Part B Treatment Period|Protocol Violation|0|||
143041166|NCT01029340|515690871|FG004|Part B Treatment Period|Protocol Violation|0|||
143164446|NCT04102514|516148646|FG003|Overall Study|Lost to Follow-up|0|||
143164447|NCT04102514|516148643|FG000|Overall Study|Physician Decision|0|||
143164448|NCT04102514|516148644|FG001|Overall Study|Physician Decision|0|||
143164449|NCT04102514|516148645|FG002|Overall Study|Physician Decision|1|||
143164450|NCT04102514|516148646|FG003|Overall Study|Physician Decision|0|||
143164451|NCT04102514|516148643|FG000|Overall Study|Withdrawal by Subject|7|||
143164452|NCT04102514|516148644|FG001|Overall Study|Withdrawal by Subject|13|||
143164453|NCT04102514|516148645|FG002|Overall Study|Withdrawal by Subject|7|||
143164454|NCT04102514|516148646|FG003|Overall Study|Withdrawal by Subject|14|||
143164455|NCT04102514|516148643|FG000|Overall Study|Moved to longterm care facility|6|||
143164456|NCT04102514|516148644|FG001|Overall Study|Moved to longterm care facility|0|||
143164457|NCT04102514|516148645|FG002|Overall Study|Moved to longterm care facility|4|||
143164458|NCT04102514|516148646|FG003|Overall Study|Moved to longterm care facility|0|||
143164459|NCT03268499|516148647|FG000|Overall Study|Withdrawal by Subject|2|||
143164460|NCT03268499|516148648|FG001|Overall Study|Withdrawal by Subject|1|||
143164461|NCT03533491|516148657|FG000|Overall Study|Lost to Follow-up|2|||
143164462|NCT05071027|516148666|FG000|Overall Study|Lost to Follow-up|1|||
143164463|NCT05071027|516148667|FG001|Overall Study|Lost to Follow-up|4|||
143164464|NCT04576481|516148668|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
143164465|NCT04576481|516148669|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
143164466|NCT04576481|516148670|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
143164467|NCT04576481|516148671|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
143164468|NCT05463952|516148676|FG000|Treatment|Progressive disease|4|||
143164469|NCT05463952|516148676|FG000|Treatment|Ongoing|2|||
143164470|NCT05261490|516148678|FG000|Overall Study|Other|1|||
143164471|NCT05261490|516148679|FG001|Overall Study|Other|0|||
143164472|NCT05261490|516148680|FG002|Overall Study|Other|0|||
143164473|NCT05261490|516148678|FG000|Overall Study|Study Terminated by Sponsor|1|||
143164474|NCT05261490|516148679|FG001|Overall Study|Study Terminated by Sponsor|1|||
143164475|NCT05261490|516148680|FG002|Overall Study|Study Terminated by Sponsor|4|||
143164476|NCT05261490|516148678|FG000|Overall Study|Death|1|||
143164477|NCT05261490|516148679|FG001|Overall Study|Death|2|||
143164478|NCT05261490|516148680|FG002|Overall Study|Death|0|||
143041167|NCT01029340|515690872|FG005|Part B Treatment Period|Protocol Violation|0|||
143041168|NCT01029340|515690867|FG000|Extension Period|Adverse Event|0|||
143498062|NCT01960855|517364577|FG000|Overall Study|Lack of Efficacy|1|||
143498063|NCT01960855|517364578|FG001|Overall Study|Lack of Efficacy|1|||
143498064|NCT01960855|517364579|FG002|Overall Study|Lack of Efficacy|0|||
143498065|NCT01960855|517364580|FG003|Overall Study|Lack of Efficacy|0|||
143498066|NCT01960855|517364581|FG004|Overall Study|Lack of Efficacy|0|||
143498067|NCT01960855|517364577|FG000|Overall Study|Other|2|||
143498068|NCT01960855|517364578|FG001|Overall Study|Other|1|||
143498069|NCT01960855|517364579|FG002|Overall Study|Other|1|||
143498070|NCT01960855|517364580|FG003|Overall Study|Other|1|||
143498071|NCT01960855|517364581|FG004|Overall Study|Other|0|||
143498072|NCT01960855|517364577|FG000|Overall Study|Consent withdrawn by subject|3|||
143498073|NCT01960855|517364578|FG001|Overall Study|Consent withdrawn by subject|1|||
143498074|NCT01960855|517364579|FG002|Overall Study|Consent withdrawn by subject|2|||
143498075|NCT01960855|517364580|FG003|Overall Study|Consent withdrawn by subject|1|||
143498076|NCT01960855|517364581|FG004|Overall Study|Consent withdrawn by subject|1|||
143498077|NCT01960855|517364577|FG000|Overall Study|Lost to Follow-up|2|||
143498078|NCT01960855|517364578|FG001|Overall Study|Lost to Follow-up|1|||
143041169|NCT01029340|515690868|FG001|Extension Period|Adverse Event|0|||
143041170|NCT01029340|515690869|FG002|Extension Period|Adverse Event|0|||
143041171|NCT01029340|515690870|FG003|Extension Period|Adverse Event|0|||
143041172|NCT01029340|515690871|FG004|Extension Period|Adverse Event|0|||
143041173|NCT01029340|515690872|FG005|Extension Period|Adverse Event|1|||
143041174|NCT01029340|515690867|FG000|Extension Period|starting another study|0|||
143041175|NCT01029340|515690868|FG001|Extension Period|starting another study|0|||
143041176|NCT01029340|515690869|FG002|Extension Period|starting another study|0|||
143041177|NCT01029340|515690870|FG003|Extension Period|starting another study|0|||
143041178|NCT01029340|515690871|FG004|Extension Period|starting another study|0|||
143041179|NCT01029340|515690872|FG005|Extension Period|starting another study|8|||
143041180|NCT01029340|515690867|FG000|Extension Period|non-compliance|0|||
143041181|NCT01029340|515690868|FG001|Extension Period|non-compliance|0|||
143041182|NCT01029340|515690869|FG002|Extension Period|non-compliance|0|||
143041183|NCT01029340|515690870|FG003|Extension Period|non-compliance|0|||
143041184|NCT01029340|515690871|FG004|Extension Period|non-compliance|0|||
143041185|NCT01029340|515690872|FG005|Extension Period|non-compliance|1|||
143041186|NCT01029340|515690867|FG000|Extension Period|Withdrawal by Subject|0|||
143041187|NCT01029340|515690868|FG001|Extension Period|Withdrawal by Subject|0|||
143498079|NCT01960855|517364579|FG002|Overall Study|Lost to Follow-up|0|||
143498080|NCT01960855|517364580|FG003|Overall Study|Lost to Follow-up|0|||
143498081|NCT01960855|517364581|FG004|Overall Study|Lost to Follow-up|2|||
143498082|NCT02058147|517364582|FG000|Overall Study|Randomized but not treated|0|||
143498083|NCT02058147|517364583|FG001|Overall Study|Randomized but not treated|0|||
143498084|NCT02058147|517364584|FG002|Overall Study|Randomized but not treated|1|||
143498085|NCT02058147|517364582|FG000|Overall Study|Adverse Event|12|||
143498086|NCT02058147|517364583|FG001|Overall Study|Adverse Event|9|||
143498087|NCT02058147|517364584|FG002|Overall Study|Adverse Event|21|||
143041188|NCT01029340|515690869|FG002|Extension Period|Withdrawal by Subject|0|||
143041189|NCT01029340|515690870|FG003|Extension Period|Withdrawal by Subject|0|||
143041190|NCT01029340|515690871|FG004|Extension Period|Withdrawal by Subject|0|||
143164479|NCT00456365|516148688|FG000|Overall Study|Lost to Follow-up|1|||
143164480|NCT00456365|516148689|FG001|Overall Study|Lost to Follow-up|3|||
143164481|NCT00456365|516148688|FG000|Overall Study|Withdrawal by Subject|4|||
143041191|NCT01029340|515690872|FG005|Extension Period|Withdrawal by Subject|1|||
143041192|NCT01029340|515690867|FG000|Extension Period|Physician Decision|0|||
143041193|NCT01029340|515690868|FG001|Extension Period|Physician Decision|0|||
143164482|NCT00456365|516148689|FG001|Overall Study|Withdrawal by Subject|7|||
143164483|NCT00456365|516148688|FG000|Overall Study|Pregnancy|1|||
143164484|NCT00456365|516148689|FG001|Overall Study|Pregnancy|1|||
143164485|NCT00456365|516148688|FG000|Overall Study|oncologic diagnosis|1|||
143164486|NCT00456365|516148689|FG001|Overall Study|oncologic diagnosis|1|||
143164487|NCT06091956|516148690|FG000|Overall Study|Withdrawal by Subject|1|||
143164488|NCT06091956|516148690|FG000|Overall Study|Complicating Disease|1|||
143164489|NCT01681849|516148700|FG000|Overall Study|Protocol Violation|2|||
143164490|NCT01681849|516148701|FG001|Overall Study|Protocol Violation|0|||
143164491|NCT01681849|516148702|FG002|Overall Study|Protocol Violation|0|||
143164492|NCT01681849|516148700|FG000|Overall Study|Withdrawal by Subject|3|||
143164493|NCT01681849|516148701|FG001|Overall Study|Withdrawal by Subject|5|||
143164494|NCT01681849|516148702|FG002|Overall Study|Withdrawal by Subject|33|||
143164495|NCT01681849|516148700|FG000|Overall Study|Lost to Follow-up|3|||
143164496|NCT01681849|516148701|FG001|Overall Study|Lost to Follow-up|2|||
143041194|NCT01029340|515690869|FG002|Extension Period|Physician Decision|0|||
143041195|NCT01029340|515690870|FG003|Extension Period|Physician Decision|0|||
143041196|NCT01029340|515690871|FG004|Extension Period|Physician Decision|0|||
143041197|NCT01029340|515690872|FG005|Extension Period|Physician Decision|1|||
143498088|NCT02058147|517364582|FG000|Overall Study|Lack of Efficacy|1|||
143498089|NCT02058147|517364583|FG001|Overall Study|Lack of Efficacy|0|||
143498090|NCT02058147|517364584|FG002|Overall Study|Lack of Efficacy|3|||
143498091|NCT02058147|517364582|FG000|Overall Study|Poor compliance to protocol|8|||
143498092|NCT02058147|517364583|FG001|Overall Study|Poor compliance to protocol|9|||
143498093|NCT02058147|517364584|FG002|Overall Study|Poor compliance to protocol|4|||
143164497|NCT01681849|516148702|FG002|Overall Study|Lost to Follow-up|6|||
143164498|NCT04525183|516148705|FG000|Overall Study|Withdrawal by Subject|0|||
143164499|NCT04525183|516148706|FG001|Overall Study|Withdrawal by Subject|0|||
143164500|NCT04525183|516148707|FG002|Overall Study|Withdrawal by Subject|3|||
143164501|NCT04525183|516148705|FG000|Overall Study|Study non-compliance|0|||
143164502|NCT04525183|516148706|FG001|Overall Study|Study non-compliance|0|||
143164503|NCT04525183|516148707|FG002|Overall Study|Study non-compliance|1|||
143164504|NCT04525183|516148705|FG000|Overall Study|Recurrent disease before starting on study|0|||
143164505|NCT04525183|516148706|FG001|Overall Study|Recurrent disease before starting on study|0|||
143164506|NCT04525183|516148707|FG002|Overall Study|Recurrent disease before starting on study|1|||
143164507|NCT01335685|516148708|FG000|Overall Study|Study Terminated by Sponsor|2|||
143164508|NCT01335685|516148709|FG001|Overall Study|Study Terminated by Sponsor|1|||
143164509|NCT01335685|516148710|FG002|Overall Study|Study Terminated by Sponsor|1|||
143164510|NCT01335685|516148711|FG003|Overall Study|Study Terminated by Sponsor|10|||
143164511|NCT01335685|516148712|FG004|Overall Study|Study Terminated by Sponsor|0|||
143164512|NCT01335685|516148713|FG005|Overall Study|Study Terminated by Sponsor|4|||
143164513|NCT01335685|516148714|FG006|Overall Study|Study Terminated by Sponsor|2|||
143164514|NCT01335685|516148715|FG007|Overall Study|Study Terminated by Sponsor|3|||
143164515|NCT01335685|516148708|FG000|Overall Study|Withdrawal by Subject|1|||
143164516|NCT01335685|516148709|FG001|Overall Study|Withdrawal by Subject|0|||
143164517|NCT01335685|516148710|FG002|Overall Study|Withdrawal by Subject|0|||
143164518|NCT01335685|516148711|FG003|Overall Study|Withdrawal by Subject|1|||
143164519|NCT01335685|516148712|FG004|Overall Study|Withdrawal by Subject|0|||
143164520|NCT01335685|516148713|FG005|Overall Study|Withdrawal by Subject|0|||
143164521|NCT01335685|516148714|FG006|Overall Study|Withdrawal by Subject|0|||
143164522|NCT01335685|516148715|FG007|Overall Study|Withdrawal by Subject|0|||
143164523|NCT01335685|516148708|FG000|Overall Study|Reason not Specified|0|||
143164524|NCT01335685|516148709|FG001|Overall Study|Reason not Specified|0|||
143164525|NCT01335685|516148710|FG002|Overall Study|Reason not Specified|1|||
143164526|NCT01335685|516148711|FG003|Overall Study|Reason not Specified|0|||
143164527|NCT01335685|516148712|FG004|Overall Study|Reason not Specified|0|||
143164528|NCT01335685|516148713|FG005|Overall Study|Reason not Specified|1|||
143164529|NCT01335685|516148714|FG006|Overall Study|Reason not Specified|0|||
143164530|NCT01335685|516148715|FG007|Overall Study|Reason not Specified|0|||
143164531|NCT03460704|516148716|FG000|Overall Study|Withdrawal by Subject|11|||
143164532|NCT03460704|516148717|FG001|Overall Study|Withdrawal by Subject|14|||
143164533|NCT03460704|516148716|FG000|Overall Study|Study terminated by the Sponsor|29|||
143164534|NCT03460704|516148717|FG001|Overall Study|Study terminated by the Sponsor|19|||
143164535|NCT03460704|516148716|FG000|Overall Study|Adverse Event|10|||
143164536|NCT03460704|516148717|FG001|Overall Study|Adverse Event|5|||
143164537|NCT03460704|516148716|FG000|Overall Study|Death|3|||
143164538|NCT03460704|516148717|FG001|Overall Study|Death|2|||
143164539|NCT03460704|516148716|FG000|Overall Study|Non-Compliance with Study Drug|3|||
143164540|NCT03460704|516148717|FG001|Overall Study|Non-Compliance with Study Drug|0|||
143498094|NCT02058147|517364582|FG000|Overall Study|Other than specified|8|||
143498095|NCT02058147|517364583|FG001|Overall Study|Other than specified|9|||
143164541|NCT03460704|516148716|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
143164542|NCT03460704|516148717|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
143498096|NCT02058147|517364584|FG002|Overall Study|Other than specified|0|||
143498097|NCT01014585|517364587|FG000|Overall Study|Adverse Event|0|||
143498098|NCT01014585|517364588|FG001|Overall Study|Adverse Event|2|||
143164543|NCT03460704|516148716|FG000|Overall Study|Other|2|||
143164544|NCT03460704|516148717|FG001|Overall Study|Other|1|||
143164545|NCT04439903|516148718|FG000|Overall Study|Withdrawal by Subject|2|||
143164546|NCT04439903|516148718|FG000|Overall Study|Screen Failure|1|||
143164547|NCT04818229|516148719|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
143498099|NCT01014585|517364589|FG002|Overall Study|Adverse Event|0|||
143498100|NCT01014585|517364590|FG003|Overall Study|Adverse Event|3|||
143498101|NCT01014585|517364587|FG000|Overall Study|Withdrawal by Subject|2|||
143498102|NCT01014585|517364588|FG001|Overall Study|Withdrawal by Subject|0|||
143498103|NCT01014585|517364589|FG002|Overall Study|Withdrawal by Subject|1|||
143240301|NCT00790842|516431966|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
143240302|NCT00790842|516431967|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
143240303|NCT00790842|516431968|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
143240304|NCT00790842|516431969|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
143240305|NCT00790842|516431970|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
143240306|NCT00790842|516431971|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
143240307|NCT00790842|516431972|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
143240308|NCT00790842|516431973|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
143240309|NCT00790842|516431974|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
143240310|NCT00790842|516431975|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
143240311|NCT00790842|516431976|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
143240312|NCT00790842|516431966|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
143240313|NCT00790842|516431967|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
143240314|NCT00790842|516431968|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
143240315|NCT00790842|516431969|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
143240316|NCT00790842|516431970|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
143240317|NCT00790842|516431971|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
143240318|NCT00790842|516431972|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
143240319|NCT00790842|516431973|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
143240320|NCT00790842|516431974|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
143498104|NCT01014585|517364590|FG003|Overall Study|Withdrawal by Subject|3|||
143498105|NCT01014585|517364587|FG000|Overall Study|Lost to Follow-up|0|||
143498106|NCT01014585|517364588|FG001|Overall Study|Lost to Follow-up|0|||
143240321|NCT00790842|516431975|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
143240322|NCT00790842|516431976|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
143240323|NCT00790842|516431966|FG000|Dose Level 4|Adverse Event|0|||
143240324|NCT00790842|516431967|FG001|Dose Level 4|Adverse Event|0|||
143240325|NCT00790842|516431968|FG002|Dose Level 4|Adverse Event|0|||
143240326|NCT00790842|516431969|FG003|Dose Level 4|Adverse Event|0|||
143240327|NCT00790842|516431970|FG004|Dose Level 4|Adverse Event|0|||
143240328|NCT00790842|516431971|FG005|Dose Level 4|Adverse Event|0|||
143240329|NCT00790842|516431972|FG006|Dose Level 4|Adverse Event|1|||
143240330|NCT00790842|516431973|FG007|Dose Level 4|Adverse Event|0|||
143240331|NCT00790842|516431974|FG008|Dose Level 4|Adverse Event|0|||
143240332|NCT00790842|516431975|FG009|Dose Level 4|Adverse Event|0|||
143240333|NCT00790842|516431976|FG010|Dose Level 4|Adverse Event|0|||
143240334|NCT00790842|516431966|FG000|Dose Level 4|Physician Decision|0|||
143240335|NCT00790842|516431967|FG001|Dose Level 4|Physician Decision|0|||
143240336|NCT00790842|516431968|FG002|Dose Level 4|Physician Decision|0|||
143240337|NCT00790842|516431969|FG003|Dose Level 4|Physician Decision|0|||
143240338|NCT00790842|516431970|FG004|Dose Level 4|Physician Decision|0|||
143240339|NCT00790842|516431971|FG005|Dose Level 4|Physician Decision|0|||
143240340|NCT00790842|516431972|FG006|Dose Level 4|Physician Decision|1|||
143240341|NCT00790842|516431973|FG007|Dose Level 4|Physician Decision|0|||
143240342|NCT00790842|516431974|FG008|Dose Level 4|Physician Decision|0|||
143240343|NCT00790842|516431975|FG009|Dose Level 4|Physician Decision|0|||
143240344|NCT00790842|516431976|FG010|Dose Level 4|Physician Decision|1|||
143240345|NCT00790842|516431966|FG000|Dose Level 4|Withdrawal by Subject|0|||
143240346|NCT00790842|516431967|FG001|Dose Level 4|Withdrawal by Subject|0|||
143240347|NCT00790842|516431968|FG002|Dose Level 4|Withdrawal by Subject|0|||
143240348|NCT00790842|516431969|FG003|Dose Level 4|Withdrawal by Subject|0|||
143240349|NCT00790842|516431970|FG004|Dose Level 4|Withdrawal by Subject|0|||
143498107|NCT01014585|517364589|FG002|Overall Study|Lost to Follow-up|0|||
143498108|NCT01014585|517364590|FG003|Overall Study|Lost to Follow-up|2|||
143498109|NCT01014585|517364587|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
143498110|NCT01014585|517364588|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
143498111|NCT01014585|517364589|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
143498112|NCT01014585|517364590|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
143498113|NCT02154425|517364591|FG000|Screening Period|Adverse Event|1|||
143498114|NCT04178772|517364592|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
143240350|NCT00790842|516431971|FG005|Dose Level 4|Withdrawal by Subject|0|||
143240351|NCT00790842|516431972|FG006|Dose Level 4|Withdrawal by Subject|0|||
143240352|NCT00790842|516431973|FG007|Dose Level 4|Withdrawal by Subject|0|||
143240353|NCT00790842|516431974|FG008|Dose Level 4|Withdrawal by Subject|0|||
143240354|NCT00790842|516431975|FG009|Dose Level 4|Withdrawal by Subject|0|||
143240355|NCT00790842|516431976|FG010|Dose Level 4|Withdrawal by Subject|1|||
143240356|NCT00790842|516431966|FG000|Expansion Cohort|Adverse Event|0|||
143240357|NCT00790842|516431967|FG001|Expansion Cohort|Adverse Event|0|||
143240358|NCT00790842|516431968|FG002|Expansion Cohort|Adverse Event|0|||
143240359|NCT00790842|516431969|FG003|Expansion Cohort|Adverse Event|0|||
143240360|NCT00790842|516431970|FG004|Expansion Cohort|Adverse Event|0|||
143240361|NCT00790842|516431971|FG005|Expansion Cohort|Adverse Event|0|||
143240362|NCT00790842|516431972|FG006|Expansion Cohort|Adverse Event|1|||
143240363|NCT00790842|516431973|FG007|Expansion Cohort|Adverse Event|0|||
143240364|NCT00790842|516431974|FG008|Expansion Cohort|Adverse Event|0|||
143240365|NCT00790842|516431975|FG009|Expansion Cohort|Adverse Event|0|||
143240366|NCT00790842|516431976|FG010|Expansion Cohort|Adverse Event|0|||
143240367|NCT00790842|516431966|FG000|Expansion Cohort|Death|0|||
143240368|NCT00790842|516431967|FG001|Expansion Cohort|Death|0|||
143240369|NCT00790842|516431968|FG002|Expansion Cohort|Death|2|||
143240370|NCT00790842|516431969|FG003|Expansion Cohort|Death|0|||
143240371|NCT00790842|516431970|FG004|Expansion Cohort|Death|0|||
143240372|NCT00790842|516431971|FG005|Expansion Cohort|Death|0|||
143240373|NCT00790842|516431972|FG006|Expansion Cohort|Death|0|||
143240374|NCT00790842|516431973|FG007|Expansion Cohort|Death|0|||
143240375|NCT00790842|516431974|FG008|Expansion Cohort|Death|0|||
143240376|NCT00790842|516431975|FG009|Expansion Cohort|Death|0|||
143240377|NCT00790842|516431976|FG010|Expansion Cohort|Death|0|||
143240378|NCT00790842|516431966|FG000|Expansion Cohort|Physician Decision|0|||
143240379|NCT00790842|516431967|FG001|Expansion Cohort|Physician Decision|0|||
143240380|NCT00790842|516431968|FG002|Expansion Cohort|Physician Decision|1|||
143240381|NCT00790842|516431969|FG003|Expansion Cohort|Physician Decision|0|||
143240382|NCT00790842|516431970|FG004|Expansion Cohort|Physician Decision|0|||
143240383|NCT00790842|516431971|FG005|Expansion Cohort|Physician Decision|0|||
143240384|NCT00790842|516431972|FG006|Expansion Cohort|Physician Decision|0|||
143240385|NCT00790842|516431973|FG007|Expansion Cohort|Physician Decision|0|||
143240386|NCT00790842|516431974|FG008|Expansion Cohort|Physician Decision|0|||
143240387|NCT00790842|516431975|FG009|Expansion Cohort|Physician Decision|0|||
143240388|NCT00790842|516431976|FG010|Expansion Cohort|Physician Decision|0|||
143240389|NCT00790842|516431966|FG000|Expansion Cohort|Withdrawal by Subject|0|||
143240390|NCT00790842|516431967|FG001|Expansion Cohort|Withdrawal by Subject|0|||
143240391|NCT00790842|516431968|FG002|Expansion Cohort|Withdrawal by Subject|3|||
143240392|NCT00790842|516431969|FG003|Expansion Cohort|Withdrawal by Subject|0|||
143240393|NCT00790842|516431970|FG004|Expansion Cohort|Withdrawal by Subject|0|||
143240394|NCT00790842|516431971|FG005|Expansion Cohort|Withdrawal by Subject|0|||
143240395|NCT00790842|516431972|FG006|Expansion Cohort|Withdrawal by Subject|0|||
143240396|NCT00790842|516431973|FG007|Expansion Cohort|Withdrawal by Subject|0|||
143240397|NCT00790842|516431974|FG008|Expansion Cohort|Withdrawal by Subject|0|||
143240398|NCT00790842|516431975|FG009|Expansion Cohort|Withdrawal by Subject|0|||
143240399|NCT00790842|516431976|FG010|Expansion Cohort|Withdrawal by Subject|0|||
143240400|NCT00790842|516431966|FG000|Expansion Cohort|Study Closure|0|||
143240401|NCT00790842|516431967|FG001|Expansion Cohort|Study Closure|0|||
143240402|NCT00790842|516431968|FG002|Expansion Cohort|Study Closure|1|||
143240403|NCT00790842|516431969|FG003|Expansion Cohort|Study Closure|0|||
143240404|NCT00790842|516431970|FG004|Expansion Cohort|Study Closure|0|||
143240405|NCT00790842|516431971|FG005|Expansion Cohort|Study Closure|0|||
143240406|NCT00790842|516431972|FG006|Expansion Cohort|Study Closure|0|||
143240407|NCT00790842|516431973|FG007|Expansion Cohort|Study Closure|0|||
143240408|NCT00790842|516431974|FG008|Expansion Cohort|Study Closure|0|||
143240409|NCT00790842|516431975|FG009|Expansion Cohort|Study Closure|0|||
143240410|NCT00790842|516431976|FG010|Expansion Cohort|Study Closure|0|||
143240411|NCT05029362|516431977|FG000|Overall Study|Lost to Follow-up|9|||
143240412|NCT00885170|516431982|FG000|Overall Study|Adverse Event|12|||
143240413|NCT00885170|516431983|FG001|Overall Study|Adverse Event|4|||
143240414|NCT00885170|516431982|FG000|Overall Study|Excessive bone loss|6|||
143240415|NCT00885170|516431983|FG001|Overall Study|Excessive bone loss|3|||
143240416|NCT00885170|516431982|FG000|Overall Study|Lost to Follow-up|2|||
143240417|NCT00885170|516431983|FG001|Overall Study|Lost to Follow-up|1|||
143240418|NCT00885170|516431982|FG000|Overall Study|Physician Decision|2|||
143240419|NCT00885170|516431983|FG001|Overall Study|Physician Decision|1|||
143240420|NCT00885170|516431982|FG000|Overall Study|Protocol Violation|3|||
143498115|NCT04178772|517364592|FG000|Overall Study|study terminated early due to COVID-19|7|||
143498116|NCT02817087|517364596|FG000|Overall Study|Withdrawal by Subject|2|||
143498117|NCT02817087|517364597|FG001|Overall Study|Withdrawal by Subject|0|||
143498118|NCT05900115|517366241|FG000|Overall Study|Lost to Follow-up|129|||
143240421|NCT00885170|516431983|FG001|Overall Study|Protocol Violation|1|||
143240422|NCT00885170|516431982|FG000|Overall Study|Withdrawal by Subject|13|||
143240423|NCT00885170|516431983|FG001|Overall Study|Withdrawal by Subject|13|||
143240424|NCT03771664|516431984|FG000|Overall Study|Adverse Event|1|||
143240425|NCT03771664|516431985|FG001|Overall Study|Adverse Event|0|||
143240426|NCT03771664|516431984|FG000|Overall Study|Lost to Follow-up|1|||
143240427|NCT03771664|516431985|FG001|Overall Study|Lost to Follow-up|0|||
143240428|NCT03771664|516431984|FG000|Overall Study|Withdrawal by Participant|1|||
143240429|NCT03771664|516431985|FG001|Overall Study|Withdrawal by Participant|4|||
143240430|NCT03771664|516431984|FG000|Overall Study|Randomized but not Treated|0|||
143240431|NCT03771664|516431985|FG001|Overall Study|Randomized but not Treated|1|||
143240432|NCT00561925|516431987|FG000|14 Day Lead-In Period|Adverse Event|38|||
143498119|NCT05900115|517366242|FG001|Overall Study|Lost to Follow-up|98|||
143041198|NCT01864174|515690873|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
143041199|NCT01864174|515690874|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
143041200|NCT01864174|515690873|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
143041201|NCT01864174|515690874|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
143041202|NCT01864174|515690873|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
143041203|NCT01864174|515690874|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
143041204|NCT01864174|515690873|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
143041205|NCT01864174|515690874|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
143041206|NCT01864174|515690873|FG000|Double Blind - Compliant Randomized|Death|1|||
143041207|NCT01864174|515690874|FG001|Double Blind - Compliant Randomized|Death|0|||
143041208|NCT01864174|515690873|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
143041209|NCT01864174|515690874|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
143041210|NCT01864174|515690873|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
143041211|NCT01864174|515690874|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
143041212|NCT01864174|515690873|FG000|Double Blind - Compliant Randomized|Other|6|||
143041213|NCT01864174|515690874|FG001|Double Blind - Compliant Randomized|Other|10|||
143041214|NCT01864174|515690873|FG000|Off Treatment Follow-Up|Other|2|||
143240433|NCT00561925|516431988|FG001|14 Day Lead-In Period|Adverse Event|0|||
143041215|NCT01864174|515690874|FG001|Off Treatment Follow-Up|Other|0|||
143041216|NCT01864174|515690873|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
143041217|NCT01864174|515690874|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
143041218|NCT02648347|515690875|FG000|Overall Study|Death|174|||
143041219|NCT02648347|515690876|FG001|Overall Study|Death|167|||
143041220|NCT02648347|515690875|FG000|Overall Study|Withdrawal by Subject|16|||
143041221|NCT02648347|515690876|FG001|Overall Study|Withdrawal by Subject|9|||
143041222|NCT02648347|515690875|FG000|Overall Study|Lost to Follow-up|18|||
143041223|NCT02648347|515690876|FG001|Overall Study|Lost to Follow-up|21|||
143041224|NCT02648347|515690875|FG000|Overall Study|Missing|1|||
143041225|NCT02648347|515690876|FG001|Overall Study|Missing|0|||
143240434|NCT00561925|516431989|FG002|14 Day Lead-In Period|Adverse Event|0|||
143240435|NCT00561925|516431990|FG003|14 Day Lead-In Period|Adverse Event|0|||
143240436|NCT00561925|516431991|FG004|14 Day Lead-In Period|Adverse Event|0|||
143041226|NCT01723397|515690881|FG000|Study Period 1|Protocol Violation|0|||
143041227|NCT01723397|515690882|FG001|Study Period 1|Protocol Violation|1|||
143041228|NCT01723397|515690881|FG000|Study Period 2|Protocol Violation|0|||
143041229|NCT01723397|515690882|FG001|Study Period 2|Protocol Violation|1|||
143041230|NCT02739997|515690885|FG000|Overall Study|Death|1|||
143041231|NCT02739997|515690885|FG000|Overall Study|Withdrawal by Subject|1|||
143041232|NCT00468286|515690889|FG000|Overall Study|Adverse Event|1|||
143041233|NCT00468286|515690890|FG001|Overall Study|Adverse Event|6|||
143041234|NCT00468286|515690889|FG000|Overall Study|Protocol Violation|2|||
143041235|NCT00468286|515690890|FG001|Overall Study|Protocol Violation|2|||
143041236|NCT00468286|515690889|FG000|Overall Study|Withdrawal by Subject|4|||
143041237|NCT00468286|515690890|FG001|Overall Study|Withdrawal by Subject|3|||
143041238|NCT00468286|515690889|FG000|Overall Study|Physician Decision|0|||
143041239|NCT00468286|515690890|FG001|Overall Study|Physician Decision|1|||
143041240|NCT02196675|515690891|FG000|Overall Study|Withdrawal by Subject|1|||
143041241|NCT02196675|515690892|FG001|Overall Study|Withdrawal by Subject|0|||
143041242|NCT02196675|515690893|FG002|Overall Study|Withdrawal by Subject|0|||
143041243|NCT02196675|515690891|FG000|Overall Study|Intra-operative surgical exclusion|1|||
143041244|NCT02196675|515690892|FG001|Overall Study|Intra-operative surgical exclusion|1|||
143041245|NCT02196675|515690893|FG002|Overall Study|Intra-operative surgical exclusion|0|||
143041246|NCT02196675|515690891|FG000|Overall Study|Protocol Violation|0|||
143041247|NCT02196675|515690892|FG001|Overall Study|Protocol Violation|1|||
143041248|NCT02196675|515690893|FG002|Overall Study|Protocol Violation|0|||
143041249|NCT02196675|515690891|FG000|Overall Study|Death|0|||
143041250|NCT02196675|515690892|FG001|Overall Study|Death|0|||
143041251|NCT02196675|515690893|FG002|Overall Study|Death|1|||
143041252|NCT00465270|515690894|FG000|Overall Study|Death|7|||
143041253|NCT00465270|515690895|FG001|Overall Study|Death|11|||
143041254|NCT00465270|515690894|FG000|Overall Study|Withdrawal by Subject|34|||
143041255|NCT00465270|515690895|FG001|Overall Study|Withdrawal by Subject|78|||
143041256|NCT00465270|515690894|FG000|Overall Study|Lost to Follow-up|60|||
143041257|NCT00465270|515690895|FG001|Overall Study|Lost to Follow-up|67|||
143041258|NCT00465270|515690894|FG000|Overall Study|Investigator request|3|||
143041259|NCT00465270|515690895|FG001|Overall Study|Investigator request|4|||
143041260|NCT02388191|515690897|FG000|Overall Study|Patient did not receive IUD|1|||
143041261|NCT02388191|515690898|FG001|Overall Study|Patient did not receive IUD|0|||
143041262|NCT02847650|515692324|FG000|Overall Study|Adverse Event|2|||
143041263|NCT02847650|515692325|FG001|Overall Study|Adverse Event|4|||
143041264|NCT02847650|515692324|FG000|Overall Study|Lost to Follow-up|1|||
143041265|NCT02847650|515692325|FG001|Overall Study|Lost to Follow-up|0|||
143041266|NCT02847650|515692324|FG000|Overall Study|Protocol Violation|0|||
143041267|NCT02847650|515692325|FG001|Overall Study|Protocol Violation|1|||
143041268|NCT02847650|515692324|FG000|Overall Study|Withdrawal by Subject|1|||
143041269|NCT02847650|515692325|FG001|Overall Study|Withdrawal by Subject|1|||
143041270|NCT02175095|515692328|FG000|Overall Study|Withdrawal by Subject|3|||
143041271|NCT03255733|515692329|FG000|Overall Study|Lost to Follow-up|4|||
143041272|NCT02378935|515692330|FG000|Overall Study|Lack of Efficacy|10|||
143041273|NCT02378935|515692331|FG001|Overall Study|Lack of Efficacy|0|||
143164548|NCT04818229|516148720|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
143164549|NCT04818229|516148721|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
143164550|NCT04818229|516148719|FG000|Overall Study|Adverse Event|3|||
143164551|NCT04818229|516148720|FG001|Overall Study|Adverse Event|1|||
143164552|NCT04818229|516148721|FG002|Overall Study|Adverse Event|1|||
143164553|NCT04818229|516148719|FG000|Overall Study|Withdrawal by Subject|0|||
143164554|NCT04818229|516148720|FG001|Overall Study|Withdrawal by Subject|0|||
143164555|NCT04818229|516148721|FG002|Overall Study|Withdrawal by Subject|2|||
143164556|NCT04818229|516148719|FG000|Overall Study|Lost to Follow-up|0|||
143164557|NCT04818229|516148720|FG001|Overall Study|Lost to Follow-up|0|||
143164558|NCT04818229|516148721|FG002|Overall Study|Lost to Follow-up|1|||
143164559|NCT01691092|516148724|FG000|Overall Study|Lost to Follow-up|10|||
143164560|NCT01691092|516148724|FG000|Overall Study|Physician Decision|4|||
143164561|NCT01691092|516148724|FG000|Overall Study|Withdrawal by Subject|3|||
143164562|NCT01691092|516148724|FG000|Overall Study|non-compliance|3|||
143164563|NCT01691092|516148724|FG000|Overall Study|used for different study|2|||
143164564|NCT01691092|516148724|FG000|Overall Study|screen fail|19|||
143164565|NCT00581100|516150021|FG000|Overall Study|Death|1|||
143164566|NCT00581100|516150022|FG001|Overall Study|Death|0|||
143164567|NCT00581100|516150021|FG000|Overall Study|Adverse Event|2|||
143164568|NCT00581100|516150022|FG001|Overall Study|Adverse Event|1|||
143164569|NCT00581100|516150021|FG000|Overall Study|Withdrawal by Subject|1|||
143164570|NCT00581100|516150022|FG001|Overall Study|Withdrawal by Subject|4|||
143240437|NCT00561925|516431987|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
143240438|NCT00561925|516431988|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
143364242|NCT05750745|516875614|FG002|Overall Study|Withdrawal by Subject|0|||
143041274|NCT02378935|515692332|FG002|Overall Study|Lack of Efficacy|2|||
143041275|NCT02378935|515692333|FG003|Overall Study|Lack of Efficacy|6|||
143041276|NCT02378935|515692334|FG004|Overall Study|Lack of Efficacy|0|||
143041277|NCT02378935|515692335|FG005|Overall Study|Lack of Efficacy|0|||
143041278|NCT02378935|515692336|FG006|Overall Study|Lack of Efficacy|0|||
143041279|NCT02378935|515692330|FG000|Overall Study|Death|0|||
143041280|NCT02378935|515692331|FG001|Overall Study|Death|0|||
143041281|NCT02378935|515692332|FG002|Overall Study|Death|1|||
143041282|NCT02378935|515692333|FG003|Overall Study|Death|0|||
143041283|NCT02378935|515692334|FG004|Overall Study|Death|0|||
143041284|NCT02378935|515692335|FG005|Overall Study|Death|0|||
143041285|NCT02378935|515692336|FG006|Overall Study|Death|0|||
143041286|NCT00272779|515692337|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
143041287|NCT00272779|515692338|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
143041288|NCT00272779|515692337|FG000|Baseline Through Week 48|Death before Week 48|4|||
143041289|NCT00272779|515692338|FG001|Baseline Through Week 48|Death before Week 48|4|||
143041290|NCT00272779|515692337|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
143041291|NCT00272779|515692338|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
143041292|NCT00272779|515692337|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
143041293|NCT00272779|515692338|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
143041294|NCT00272779|515692337|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
143041295|NCT00272779|515692338|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
143041296|NCT00272779|515692337|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
143041297|NCT00272779|515692338|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
143041298|NCT00272779|515692337|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
143041299|NCT00272779|515692338|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
143041300|NCT00272779|515692337|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
143041301|NCT00272779|515692338|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
143041302|NCT00272779|515692337|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
143041303|NCT00272779|515692338|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
143041304|NCT00272779|515692337|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
143041305|NCT00272779|515692338|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
143041306|NCT00272779|515692337|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
143041307|NCT00272779|515692338|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
143041308|NCT00272779|515692337|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
143041309|NCT00272779|515692338|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
143041310|NCT00272779|515692337|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
143041311|NCT00272779|515692338|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
143041312|NCT00272779|515692337|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
143041313|NCT00272779|515692338|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
143041314|NCT00272779|515692337|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
143164571|NCT00581100|516150021|FG000|Overall Study|Other|3|||
143164572|NCT00581100|516150022|FG001|Overall Study|Other|0|||
143041315|NCT00272779|515692338|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
143041316|NCT00272779|515692337|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
143164573|NCT04129398|516150025|FG000|Overall Study|Physician Decision|2|||
143164574|NCT03058952|516150026|FG000|Overall Study|Adverse Event|1|||
143164575|NCT03058952|516150027|FG001|Overall Study|Adverse Event|0|||
143164576|NCT03058952|516150026|FG000|Overall Study|Lost to Follow-up|15|||
143164577|NCT03058952|516150027|FG001|Overall Study|Lost to Follow-up|15|||
143164578|NCT03058952|516150026|FG000|Overall Study|Withdrawal by Subject|7|||
143164579|NCT03058952|516150027|FG001|Overall Study|Withdrawal by Subject|11|||
143164580|NCT04744831|516150028|FG000|Overall Study|Progressive Disease|31|||
143164581|NCT04744831|516150029|FG001|Overall Study|Progressive Disease|27|||
143164582|NCT04744831|516150030|FG002|Overall Study|Progressive Disease|25|||
143164583|NCT04744831|516150028|FG000|Overall Study|Adverse Event|3|||
143164584|NCT04744831|516150029|FG001|Overall Study|Adverse Event|3|||
143164585|NCT04744831|516150030|FG002|Overall Study|Adverse Event|3|||
143164586|NCT04744831|516150028|FG000|Overall Study|Clinical Progression|3|||
143164587|NCT04744831|516150029|FG001|Overall Study|Clinical Progression|2|||
143164588|NCT04744831|516150030|FG002|Overall Study|Clinical Progression|5|||
143164589|NCT04744831|516150028|FG000|Overall Study|Other|0|||
143164590|NCT04744831|516150029|FG001|Overall Study|Other|2|||
143164591|NCT04744831|516150030|FG002|Overall Study|Other|1|||
143164592|NCT04744831|516150028|FG000|Overall Study|Death|0|||
143164593|NCT04744831|516150029|FG001|Overall Study|Death|2|||
143164594|NCT04744831|516150030|FG002|Overall Study|Death|1|||
143164595|NCT03443401|516150039|FG000|Overall Study|Lost to Follow-up|13|||
143164596|NCT03443401|516150039|FG000|Overall Study|Influential outlier|1|||
143164597|NCT02363283|516150040|FG000|Overall Study|Withdrawal by Subject|1|||
143164598|NCT02363283|516150040|FG000|Overall Study|Not eligible due to transaminitis|1|||
143164599|NCT01394185|516150046|FG000|Overall Study|Withdrawal by Subject|2|||
143164600|NCT01394185|516150047|FG001|Overall Study|Withdrawal by Subject|0|||
143164601|NCT01394185|516150048|FG002|Overall Study|Withdrawal by Subject|0|||
143164602|NCT01394185|516150049|FG003|Overall Study|Withdrawal by Subject|0|||
143164603|NCT01394185|516150050|FG004|Overall Study|Withdrawal by Subject|1|||
143164604|NCT01394185|516150051|FG005|Overall Study|Withdrawal by Subject|0|||
143164605|NCT01394185|516150046|FG000|Overall Study|Change in protocol|3|||
143164606|NCT01394185|516150047|FG001|Overall Study|Change in protocol|0|||
143164607|NCT01394185|516150048|FG002|Overall Study|Change in protocol|0|||
143164608|NCT01394185|516150049|FG003|Overall Study|Change in protocol|0|||
143164609|NCT01394185|516150050|FG004|Overall Study|Change in protocol|3|||
143164610|NCT01394185|516150051|FG005|Overall Study|Change in protocol|0|||
143164611|NCT01394185|516150046|FG000|Overall Study|Protocol Violation|1|||
143164612|NCT01394185|516150047|FG001|Overall Study|Protocol Violation|0|||
143164613|NCT01394185|516150048|FG002|Overall Study|Protocol Violation|0|||
143164614|NCT01394185|516150049|FG003|Overall Study|Protocol Violation|1|||
143164615|NCT01394185|516150050|FG004|Overall Study|Protocol Violation|0|||
143164616|NCT01394185|516150051|FG005|Overall Study|Protocol Violation|1|||
143164617|NCT02904265|516150052|FG000|Overall Study|Physician Decision|1|||
143164618|NCT02904265|516150053|FG001|Overall Study|Physician Decision|2|||
143164619|NCT02579759|516150054|FG000|Overall Study|Protocol Violation|2|||
143164620|NCT02579759|516150055|FG001|Overall Study|Protocol Violation|0|||
143164621|NCT02579759|516150056|FG002|Overall Study|Protocol Violation|0|||
143164622|NCT02579759|516150054|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
143164623|NCT02579759|516150055|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
143164624|NCT02579759|516150056|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
143164625|NCT02579759|516150054|FG000|Overall Study|BfArM hold|13|||
143164626|NCT02579759|516150055|FG001|Overall Study|BfArM hold|12|||
143164627|NCT02579759|516150056|FG002|Overall Study|BfArM hold|12|||
143498120|NCT00388947|517366243|FG000|Overall Study|Protocol Violation|47|||
143498121|NCT04187092|517366244|FG000|Overall Study|Lost to Follow-up|1|||
143498122|NCT04187092|517366245|FG001|Overall Study|Lost to Follow-up|1|||
143498123|NCT04187092|517366244|FG000|Overall Study|Withdrawal by Subject|1|||
143498124|NCT04187092|517366245|FG001|Overall Study|Withdrawal by Subject|1|||
143164628|NCT02579759|516150054|FG000|Overall Study|Sponsor stopped Dose 2|0|||
143164629|NCT02579759|516150055|FG001|Overall Study|Sponsor stopped Dose 2|41|||
143164630|NCT02579759|516150056|FG002|Overall Study|Sponsor stopped Dose 2|0|||
143164631|NCT02579759|516150054|FG000|Overall Study|Non compliance|0|||
143164632|NCT02579759|516150055|FG001|Overall Study|Non compliance|1|||
143164633|NCT02579759|516150056|FG002|Overall Study|Non compliance|0|||
143164634|NCT02579759|516150054|FG000|Overall Study|Pregnancy|0|||
143164635|NCT02579759|516150055|FG001|Overall Study|Pregnancy|1|||
143164636|NCT02579759|516150056|FG002|Overall Study|Pregnancy|0|||
143164637|NCT02579759|516150054|FG000|Overall Study|Inclusion/exclusion criteria|0|||
143164638|NCT02579759|516150055|FG001|Overall Study|Inclusion/exclusion criteria|0|||
143498125|NCT04187092|517366244|FG000|Overall Study|Adverse Event|0|||
143498126|NCT04187092|517366245|FG001|Overall Study|Adverse Event|1|||
143498127|NCT00670007|517366249|FG000|Overall Study|Drug abuse|1|||
143164639|NCT02579759|516150056|FG002|Overall Study|Inclusion/exclusion criteria|1|||
143164640|NCT02579759|516150054|FG000|Overall Study|Adverse Event|4|||
143164641|NCT02579759|516150055|FG001|Overall Study|Adverse Event|3|||
143240439|NCT00561925|516431989|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
143240440|NCT00561925|516431990|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
143240441|NCT00561925|516431991|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
143240442|NCT00561925|516431987|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
143240443|NCT00561925|516431988|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
143240444|NCT00561925|516431989|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
143240445|NCT00561925|516431990|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
143240446|NCT00561925|516431991|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
143240447|NCT00561925|516431987|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
143240448|NCT00561925|516431988|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
143240449|NCT00561925|516431989|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
143240450|NCT00561925|516431990|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
143240451|NCT00561925|516431991|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
143240452|NCT00561925|516431987|FG000|14 Day Lead-In Period|Other|5|||
143240453|NCT00561925|516431988|FG001|14 Day Lead-In Period|Other|0|||
143240454|NCT00561925|516431989|FG002|14 Day Lead-In Period|Other|0|||
143240455|NCT00561925|516431990|FG003|14 Day Lead-In Period|Other|0|||
143240456|NCT00561925|516431991|FG004|14 Day Lead-In Period|Other|0|||
143240457|NCT00561925|516431987|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
143240458|NCT00561925|516431988|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
143240459|NCT00561925|516431989|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
143240460|NCT00561925|516431990|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
143240461|NCT00561925|516431991|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
143240462|NCT00561925|516431987|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
143240463|NCT00561925|516431988|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
143240464|NCT00561925|516431989|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
143240465|NCT00561925|516431990|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
143240466|NCT00561925|516431991|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
143240467|NCT00561925|516431987|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
143240468|NCT00561925|516431988|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
143240469|NCT00561925|516431989|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
143240470|NCT00561925|516431990|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
143240471|NCT00561925|516431991|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
143240472|NCT00561925|516431987|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
143240473|NCT00561925|516431988|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
143240474|NCT00561925|516431989|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
143240475|NCT00561925|516431990|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
143240476|NCT00561925|516431991|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
143240477|NCT00561925|516431987|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
143240478|NCT00561925|516431988|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
143240479|NCT00561925|516431989|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
143240480|NCT00561925|516431990|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
143240481|NCT00561925|516431991|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
143240482|NCT00561925|516431987|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
143240483|NCT00561925|516431988|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
143240484|NCT00561925|516431989|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
143240485|NCT00561925|516431990|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
143240486|NCT00561925|516431991|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
143240487|NCT00561925|516431987|FG000|144-week Double-blind, Double-dummy|Death|0|||
143240488|NCT00561925|516431988|FG001|144-week Double-blind, Double-dummy|Death|6|||
143240489|NCT00561925|516431989|FG002|144-week Double-blind, Double-dummy|Death|3|||
143240490|NCT00561925|516431990|FG003|144-week Double-blind, Double-dummy|Death|0|||
143240491|NCT00561925|516431991|FG004|144-week Double-blind, Double-dummy|Death|0|||
143240492|NCT00561925|516431987|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
143240493|NCT00561925|516431988|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
143240494|NCT00561925|516431989|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
143240495|NCT00561925|516431990|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
143240496|NCT00561925|516431991|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
143240497|NCT00561925|516431987|FG000|144-week Double-blind, Double-dummy|Other|0|||
143240498|NCT00561925|516431988|FG001|144-week Double-blind, Double-dummy|Other|8|||
143240499|NCT00561925|516431989|FG002|144-week Double-blind, Double-dummy|Other|11|||
143240500|NCT00561925|516431990|FG003|144-week Double-blind, Double-dummy|Other|0|||
143240501|NCT00561925|516431991|FG004|144-week Double-blind, Double-dummy|Other|0|||
143240502|NCT00561925|516431987|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
143240503|NCT00561925|516431988|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
143240504|NCT00561925|516431989|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
143240505|NCT00561925|516431990|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
143240506|NCT00561925|516431991|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
143240507|NCT00684021|516431994|FG000|Overall Study|MRI Contraindicated|1|||
143041317|NCT00272779|515692338|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
143041318|NCT00272779|515692337|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
143041319|NCT00272779|515692338|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
143041320|NCT00272779|515692337|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
143041321|NCT00272779|515692338|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
143041322|NCT00272779|515692337|FG000|Baseline Through Week 48|Continuing treatment|385|||
143041323|NCT00272779|515692338|FG001|Baseline Through Week 48|Continuing treatment|368|||
143041324|NCT00272779|515692337|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
143041325|NCT00272779|515692338|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
143164642|NCT02579759|516150056|FG002|Overall Study|Adverse Event|1|||
143164643|NCT02579759|516150054|FG000|Overall Study|Withdrawal by Subject|3|||
143164644|NCT02579759|516150055|FG001|Overall Study|Withdrawal by Subject|3|||
143164645|NCT02579759|516150056|FG002|Overall Study|Withdrawal by Subject|5|||
143164646|NCT02579759|516150054|FG000|Overall Study|Lost to Follow-up|2|||
143164647|NCT02579759|516150055|FG001|Overall Study|Lost to Follow-up|2|||
143164648|NCT02579759|516150056|FG002|Overall Study|Lost to Follow-up|2|||
143164649|NCT00267488|516150065|FG000|Overall Study|Sponsor Terminated Study|9|||
143164650|NCT00267488|516150065|FG000|Overall Study|Protocol Violation|1|||
143164651|NCT00267488|516150065|FG000|Overall Study|Other (Disease Progression)|1|||
143164652|NCT01149460|516150070|FG000|Overall Study|Withdrawal by Subject|0|||
143164653|NCT01149460|516150071|FG001|Overall Study|Withdrawal by Subject|2|||
143164654|NCT02801578|516150079|FG000|Overall Study|Adverse Event|2|||
143164655|NCT00668642|516150083|FG000|First Off-cycle|Cancer progression|1|||
143164656|NCT00668642|516150084|FG001|First Off-cycle|Cancer progression|0|||
143164657|NCT00668642|516150083|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
143164658|NCT00668642|516150084|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
143164659|NCT03412591|516150085|FG000|Overall Study|Withdrawal by Subject|1|||
143164660|NCT03412591|516150086|FG001|Overall Study|Withdrawal by Subject|8|||
143164661|NCT03412591|516150085|FG000|Overall Study|Adverse Event|0|||
143164662|NCT03412591|516150086|FG001|Overall Study|Adverse Event|1|||
143164663|NCT00129974|516150089|FG000|Overall Study|Other|1|||
143164664|NCT00814983|516150090|FG000|Overall Study|Screen failure|1|||
143164665|NCT00814983|516150091|FG001|Overall Study|Screen failure|0|||
143164666|NCT00814983|516150090|FG000|Overall Study|Withdrawal by Subject|1|||
143164667|NCT00814983|516150091|FG001|Overall Study|Withdrawal by Subject|0|||
143164668|NCT00814983|516150090|FG000|Overall Study|Graft failure|1|||
143164669|NCT00814983|516150091|FG001|Overall Study|Graft failure|0|||
143164670|NCT01935947|516150092|FG000|Overall Study|Adverse Event|0|||
143164671|NCT01935947|516150093|FG001|Overall Study|Adverse Event|2|||
143164672|NCT01935947|516150094|FG002|Overall Study|Adverse Event|0|||
143164673|NCT01935947|516150092|FG000|Overall Study|Diease Progression|2|||
143164674|NCT01935947|516150093|FG001|Overall Study|Diease Progression|2|||
143164675|NCT01935947|516150094|FG002|Overall Study|Diease Progression|2|||
143164676|NCT01935947|516150092|FG000|Overall Study|Death|1|||
143164677|NCT01935947|516150093|FG001|Overall Study|Death|0|||
143164678|NCT01935947|516150094|FG002|Overall Study|Death|0|||
143164679|NCT03427619|516150095|FG000|Overall Study|Physician Decision|3|||
143164680|NCT03427619|516150095|FG000|Overall Study|Withdrawal by Subject|4|||
143164681|NCT03427619|516150095|FG000|Overall Study|Lost to Follow-up|5|||
143164682|NCT03427619|516150095|FG000|Overall Study|Administrative|4|||
143164683|NCT03427619|516150095|FG000|Overall Study|Other|2|||
143164684|NCT03427619|516150095|FG000|Overall Study|Unknown or Missing Completion Status|48|||
143164685|NCT00425555|516150098|FG000|Overall Study|Withdrawal by Subject|11|||
143164686|NCT00425555|516150099|FG001|Overall Study|Withdrawal by Subject|8|||
143164687|NCT00425555|516150098|FG000|Overall Study|Lost to Follow-up|0|||
143164688|NCT00425555|516150099|FG001|Overall Study|Lost to Follow-up|1|||
143164689|NCT00425555|516150098|FG000|Overall Study|Administrative problems|3|||
143164690|NCT00425555|516150099|FG001|Overall Study|Administrative problems|0|||
143164691|NCT00425555|516150098|FG000|Overall Study|Death|1|||
143164692|NCT00425555|516150099|FG001|Overall Study|Death|2|||
143164693|NCT00425555|516150098|FG000|Overall Study|New cancer therapy|2|||
143164694|NCT00425555|516150099|FG001|Overall Study|New cancer therapy|1|||
143164695|NCT00425555|516150098|FG000|Overall Study|Disease progression|36|||
143164696|NCT00425555|516150099|FG001|Overall Study|Disease progression|33|||
143164697|NCT00425555|516150098|FG000|Overall Study|Adverse Event|25|||
143164698|NCT00425555|516150099|FG001|Overall Study|Adverse Event|15|||
143164699|NCT00425555|516150098|FG000|Overall Study|Protocol Violation|1|||
143164700|NCT00425555|516150099|FG001|Overall Study|Protocol Violation|0|||
143164701|NCT03464461|516150102|FG000|Overall Study|exclusionary medication given ,|1|||
143164702|NCT03464461|516150103|FG001|Overall Study|exclusionary medication given ,|2|||
143041326|NCT00272779|515692337|FG000|Baseline Through Week 48|Never treated|2|||
143041327|NCT00272779|515692338|FG001|Baseline Through Week 48|Never treated|3|||
143164703|NCT03464461|516150104|FG002|Overall Study|exclusionary medication given ,|0|||
143164704|NCT03464461|516150102|FG000|Overall Study|Physician Decision|0|||
143164705|NCT03464461|516150103|FG001|Overall Study|Physician Decision|1|||
143164706|NCT03464461|516150104|FG002|Overall Study|Physician Decision|0|||
143240508|NCT00684021|516431995|FG001|Overall Study|MRI Contraindicated|1|||
143041328|NCT00272779|515692337|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
143041329|NCT00272779|515692338|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
143041330|NCT00272779|515692337|FG000|Baseline Through Week 96|Death before Week 96|6|||
143041331|NCT00272779|515692338|FG001|Baseline Through Week 96|Death before Week 96|5|||
143041332|NCT00272779|515692337|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
143041333|NCT00272779|515692338|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
143041334|NCT00272779|515692337|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
143041335|NCT00272779|515692338|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
143041336|NCT00272779|515692337|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
143041337|NCT00272779|515692338|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
143041338|NCT00272779|515692337|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
143041339|NCT00272779|515692338|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
143041340|NCT00272779|515692337|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
143041341|NCT00272779|515692338|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
143041342|NCT00272779|515692337|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
143041343|NCT00272779|515692338|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
143041344|NCT00272779|515692337|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
143041345|NCT00272779|515692338|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
143041346|NCT00272779|515692337|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
143041347|NCT00272779|515692338|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
143041348|NCT00272779|515692337|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
143041349|NCT00272779|515692338|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
143041350|NCT00272779|515692337|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
143041351|NCT00272779|515692338|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
143041352|NCT00272779|515692337|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
143041353|NCT00272779|515692338|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
143041354|NCT00272779|515692337|FG000|Baseline Through Week 96|Never treated|2|||
143041355|NCT00272779|515692338|FG001|Baseline Through Week 96|Never treated|3|||
143041356|NCT00272779|515692337|FG000|Baseline Through Week 96|Continuing on treatment|61|||
143041357|NCT00272779|515692338|FG001|Baseline Through Week 96|Continuing on treatment|38|||
143041358|NCT00984022|515692339|FG000|Overall Study|Lost to Follow-up|10|||
143041359|NCT00984022|515692340|FG001|Overall Study|Lost to Follow-up|14|||
143041360|NCT00573443|515692341|FG000|Double-Blind Phase|Lost to Follow-up|1|||
143041361|NCT00573443|515692342|FG001|Double-Blind Phase|Lost to Follow-up|3|||
143041362|NCT00573443|515692343|FG002|Double-Blind Phase|Lost to Follow-up|2|||
143041363|NCT00573443|515692341|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
143041364|NCT00573443|515692342|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
143041365|NCT00573443|515692343|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
143041366|NCT00573443|515692341|FG000|Double-Blind Phase|Adverse Event|1|||
143041367|NCT00573443|515692342|FG001|Double-Blind Phase|Adverse Event|5|||
143041368|NCT00573443|515692343|FG002|Double-Blind Phase|Adverse Event|0|||
143041369|NCT00573443|515692341|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
143041370|NCT00573443|515692342|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
143041371|NCT00573443|515692343|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
143041372|NCT00573443|515692341|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
143041373|NCT00573443|515692342|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
143041374|NCT00573443|515692343|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
143041375|NCT00573443|515692341|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
143041376|NCT00573443|515692342|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
143041377|NCT00573443|515692343|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
143041378|NCT00573443|515692341|FG000|Double-Blind Phase|Protocol Violation|0|||
143041379|NCT00573443|515692342|FG001|Double-Blind Phase|Protocol Violation|2|||
143041380|NCT00573443|515692343|FG002|Double-Blind Phase|Protocol Violation|1|||
143041381|NCT00573443|515692341|FG000|Double-Blind Phase|Other|0|||
143041382|NCT00573443|515692342|FG001|Double-Blind Phase|Other|2|||
143041383|NCT00573443|515692343|FG002|Double-Blind Phase|Other|3|||
143041384|NCT00573443|515692341|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
143041385|NCT00573443|515692342|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
143041386|NCT00573443|515692343|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
143041387|NCT00573443|515692341|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
143041388|NCT00573443|515692342|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
143041389|NCT00573443|515692343|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
143041390|NCT00573443|515692341|FG000|Open-Label Extension Phase|Adverse Event|3|||
143041391|NCT00573443|515692342|FG001|Open-Label Extension Phase|Adverse Event|0|||
143041392|NCT00573443|515692343|FG002|Open-Label Extension Phase|Adverse Event|0|||
143041393|NCT00573443|515692341|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
143041394|NCT00573443|515692342|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
143041395|NCT00573443|515692343|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
143041396|NCT00573443|515692341|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
143041397|NCT00573443|515692342|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
143041398|NCT00573443|515692343|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
143041399|NCT00573443|515692341|FG000|Open-Label Extension Phase|Protocol Violation|2|||
143041400|NCT00573443|515692342|FG001|Open-Label Extension Phase|Protocol Violation|0|||
143041401|NCT00573443|515692343|FG002|Open-Label Extension Phase|Protocol Violation|0|||
143041402|NCT00573443|515692341|FG000|Open-Label Extension Phase|Other|2|||
143041403|NCT00573443|515692342|FG001|Open-Label Extension Phase|Other|0|||
143041404|NCT00573443|515692343|FG002|Open-Label Extension Phase|Other|0|||
143041405|NCT00448019|515692345|FG000|Overall Study|Withdrawal by Subject|3|||
143041406|NCT00448019|515692345|FG000|Overall Study|Disease progression|1|||
143041407|NCT00448019|515692345|FG000|Overall Study|Death|2|||
143041408|NCT00448019|515692345|FG000|Overall Study|Insurance Issues|1|||
143041409|NCT02902211|515692353|FG000|First Three Months|Withdrawal by Subject|7|||
143041410|NCT02902211|515692354|FG001|First Three Months|Withdrawal by Subject|3|||
143041411|NCT03181594|515692355|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
143041412|NCT03181594|515692355|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
143041413|NCT03181594|515692355|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
143041414|NCT03181594|515692355|FG000|Initial Study Protocol (12-month FU)|Death|1|||
143041415|NCT03181594|515692355|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
143041416|NCT03181594|515692355|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
143041417|NCT00838630|515692357|FG000|First Intervention|Adverse Event|1|||
143041418|NCT00838630|515692358|FG001|First Intervention|Adverse Event|0|||
143041419|NCT00838630|515692357|FG000|Washout: 7 Days|Protocol Violation|1|||
143041420|NCT00838630|515692358|FG001|Washout: 7 Days|Protocol Violation|0|||
143041421|NCT00640562|515692359|FG000|Overall Study|Adverse Event|8|||
143041422|NCT00640562|515692360|FG001|Overall Study|Adverse Event|5|||
143041423|NCT00640562|515692359|FG000|Overall Study|Lack of Efficacy|1|||
143041424|NCT00640562|515692360|FG001|Overall Study|Lack of Efficacy|4|||
143041425|NCT00640562|515692359|FG000|Overall Study|Protocol Violation|2|||
143041426|NCT00640562|515692360|FG001|Overall Study|Protocol Violation|4|||
143041427|NCT00640562|515692359|FG000|Overall Study|Withdrawal by Subject|6|||
143041428|NCT00640562|515692360|FG001|Overall Study|Withdrawal by Subject|10|||
143041429|NCT00640562|515692359|FG000|Overall Study|Known risperidone intolerance|0|||
143041430|NCT00640562|515692360|FG001|Overall Study|Known risperidone intolerance|1|||
143041431|NCT00640562|515692359|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
143041432|NCT00640562|515692360|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
143041433|NCT00640562|515692359|FG000|Overall Study|Low study drug dose|0|||
143041434|NCT00640562|515692360|FG001|Overall Study|Low study drug dose|1|||
143041435|NCT00640562|515692359|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
143041436|NCT00640562|515692360|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
143041437|NCT00571064|515692364|FG000|Overall Study|Adverse Event|13|||
143041438|NCT00571064|515692364|FG000|Overall Study|Protocol Violation|4|||
143041439|NCT00571064|515692364|FG000|Overall Study|Withdrawal by Subject|2|||
143041440|NCT00571064|515692364|FG000|Overall Study|Other|2|||
143041441|NCT02159950|515692374|FG000|Overall Study|Adverse Event|0|||
143041442|NCT02159950|515692375|FG001|Overall Study|Adverse Event|1|||
143041443|NCT02159950|515692374|FG000|Overall Study|Progression|0|||
143041444|NCT02159950|515692375|FG001|Overall Study|Progression|1|||
143041445|NCT03017885|515692376|FG000|Overall Study|Adverse Event|2|||
143041446|NCT03017885|515692377|FG001|Overall Study|Adverse Event|0|||
143041447|NCT03017885|515692378|FG002|Overall Study|Adverse Event|0|||
143041448|NCT03017885|515692379|FG003|Overall Study|Adverse Event|0|||
143041449|NCT03017885|515692380|FG004|Overall Study|Adverse Event|0|||
143041450|NCT03017885|515692381|FG005|Overall Study|Adverse Event|0|||
143041451|NCT03017885|515692376|FG000|Overall Study|Progression of disease|4|||
143041452|NCT03017885|515692377|FG001|Overall Study|Progression of disease|3|||
143041453|NCT03017885|515692378|FG002|Overall Study|Progression of disease|4|||
143041454|NCT03017885|515692379|FG003|Overall Study|Progression of disease|0|||
143041455|NCT03017885|515692380|FG004|Overall Study|Progression of disease|0|||
143041456|NCT03017885|515692381|FG005|Overall Study|Progression of disease|0|||
143164707|NCT00595075|516150105|FG000|Overall Study|Withdrawal by Subject|1|||
143164708|NCT00595075|516150106|FG001|Overall Study|Withdrawal by Subject|0|||
143041457|NCT03017885|515692376|FG000|Overall Study|Other than listed|1|||
143041458|NCT03017885|515692377|FG001|Overall Study|Other than listed|2|||
143041459|NCT03017885|515692378|FG002|Overall Study|Other than listed|1|||
143041460|NCT03017885|515692379|FG003|Overall Study|Other than listed|0|||
143041461|NCT03017885|515692380|FG004|Overall Study|Other than listed|0|||
143041462|NCT03017885|515692381|FG005|Overall Study|Other than listed|0|||
143041463|NCT03017885|515692376|FG000|Overall Study|Lost to Follow-up|2|||
143164709|NCT04661839|516150107|FG000|Overall Study|Not Treated|0|||
143041464|NCT03017885|515692377|FG001|Overall Study|Lost to Follow-up|0|||
143041465|NCT03017885|515692378|FG002|Overall Study|Lost to Follow-up|3|||
143041466|NCT03017885|515692379|FG003|Overall Study|Lost to Follow-up|0|||
143041467|NCT03017885|515692380|FG004|Overall Study|Lost to Follow-up|0|||
143041468|NCT03017885|515692381|FG005|Overall Study|Lost to Follow-up|0|||
143041469|NCT03017885|515692376|FG000|Overall Study|Change to other anti-cancer therapy|0|||
143041470|NCT03017885|515692377|FG001|Overall Study|Change to other anti-cancer therapy|0|||
143041471|NCT03017885|515692378|FG002|Overall Study|Change to other anti-cancer therapy|1|||
143041472|NCT03017885|515692379|FG003|Overall Study|Change to other anti-cancer therapy|0|||
143041473|NCT03017885|515692380|FG004|Overall Study|Change to other anti-cancer therapy|0|||
143041474|NCT03017885|515692381|FG005|Overall Study|Change to other anti-cancer therapy|0|||
143041475|NCT02258074|515692385|FG000|Overall Study|Withdrawal by Subject|1|||
143041476|NCT02258074|515692386|FG001|Overall Study|Withdrawal by Subject|0|||
143041477|NCT02258074|515692387|FG002|Overall Study|Withdrawal by Subject|0|||
143041478|NCT02258074|515692388|FG003|Overall Study|Withdrawal by Subject|0|||
143041479|NCT03552393|515692393|FG000|Core Period|Kidney Transplant|1|||
143041480|NCT03552393|515692393|FG000|Core Period|Prohibited Medication|1|||
143041481|NCT03552393|515692393|FG000|Safety Extension Period|Kidney Transplant|4|||
143041482|NCT02009163|515692395|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
143498128|NCT00670007|517366249|FG000|Overall Study|Lung transplant|1|||
143498129|NCT00670007|517366249|FG000|Overall Study|Travel/Vacation|1|||
143498130|NCT00670007|517366249|FG000|Overall Study|Adverse event, serious fatal|1|||
143498131|NCT00670007|517366249|FG000|Overall Study|Adverse Event|1|||
143498132|NCT00670007|517366249|FG000|Overall Study|Withdrawal by Subject|4|||
143498133|NCT00956943|517366251|FG000|Overall Study|Lost to Follow-up|9|||
143498134|NCT00956943|517366252|FG001|Overall Study|Lost to Follow-up|10|||
143498135|NCT02613208|517366253|FG000|Overall Study|Withdrawal by Subject|1|||
143498136|NCT02613208|517366253|FG000|Overall Study|Change of address|2|||
143498137|NCT02613208|517366253|FG000|Overall Study|Physician Decision|2|||
143498138|NCT02613208|517366253|FG000|Overall Study|Lost to Follow-up|5|||
143498139|NCT02613208|517366253|FG000|Overall Study|Death|37|||
143498140|NCT02327260|517366254|FG000|Overall Study|Lost to Follow-up|2|||
143498141|NCT02327260|517366255|FG001|Overall Study|Lost to Follow-up|3|||
143498142|NCT02327260|517366256|FG002|Overall Study|Lost to Follow-up|2|||
143498143|NCT02327260|517366254|FG000|Overall Study|invalid phone number|1|||
143498144|NCT02327260|517366255|FG001|Overall Study|invalid phone number|1|||
143498145|NCT02327260|517366256|FG002|Overall Study|invalid phone number|0|||
143498146|NCT02327260|517366254|FG000|Overall Study|non-adherence to protocol|2|||
143498147|NCT02327260|517366255|FG001|Overall Study|non-adherence to protocol|0|||
143498148|NCT02327260|517366256|FG002|Overall Study|non-adherence to protocol|0|||
143498149|NCT02327260|517366254|FG000|Overall Study|cognitive concerns|1|||
143498150|NCT02327260|517366255|FG001|Overall Study|cognitive concerns|0|||
143498151|NCT02327260|517366256|FG002|Overall Study|cognitive concerns|0|||
143498152|NCT05499520|517366259|FG000|Overall Study|Lost to Follow-up|0|||
143498153|NCT05499520|517366260|FG001|Overall Study|Lost to Follow-up|0|||
143498154|NCT05499520|517366261|FG002|Overall Study|Lost to Follow-up|38|||
143498155|NCT05499520|517366262|FG003|Overall Study|Lost to Follow-up|41|||
143498156|NCT05499520|517366263|FG004|Overall Study|Lost to Follow-up|46|||
143498157|NCT05499520|517366264|FG005|Overall Study|Lost to Follow-up|0|||
143498158|NCT05499520|517366265|FG006|Overall Study|Lost to Follow-up|31|||
143498159|NCT05499520|517366266|FG007|Overall Study|Lost to Follow-up|45|||
143498160|NCT05499520|517366267|FG008|Overall Study|Lost to Follow-up|42|||
143498161|NCT05499520|517366268|FG009|Overall Study|Lost to Follow-up|0|||
143498162|NCT05499520|517366269|FG010|Overall Study|Lost to Follow-up|0|||
143498163|NCT05499520|517366270|FG011|Overall Study|Lost to Follow-up|37|||
143498164|NCT05499520|517366271|FG012|Overall Study|Lost to Follow-up|53|||
143498165|NCT05499520|517366272|FG013|Overall Study|Lost to Follow-up|49|||
143498166|NCT05499520|517366273|FG014|Overall Study|Lost to Follow-up|0|||
143498167|NCT05499520|517366274|FG015|Overall Study|Lost to Follow-up|36|||
143498168|NCT05499520|517366275|FG016|Overall Study|Lost to Follow-up|58|||
143041483|NCT02009163|515692396|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
143041484|NCT02009163|515692397|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
143041485|NCT02009163|515692395|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
143041486|NCT02009163|515692396|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
143041487|NCT02009163|515692397|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
143498169|NCT05499520|517366276|FG017|Overall Study|Lost to Follow-up|53|||
143498170|NCT00270894|517366277|FG000|Overall Study|Adverse Event|1|||
143041488|NCT02009163|515692395|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
143240509|NCT00684021|516431996|FG002|Overall Study|MRI Contraindicated|1|||
143498171|NCT00270894|517366277|FG000|Overall Study|Withdrawal by Subject|1|||
143498172|NCT01070329|517366278|FG000|Overall Study|Adverse Event|13|||
143498173|NCT01070329|517366279|FG001|Overall Study|Adverse Event|10|||
143498174|NCT01070329|517366278|FG000|Overall Study|Lost to Follow-up|22|||
143498175|NCT01070329|517366279|FG001|Overall Study|Lost to Follow-up|12|||
143498176|NCT01070329|517366278|FG000|Overall Study|Withdrawal by Subject|9|||
143498177|NCT01070329|517366279|FG001|Overall Study|Withdrawal by Subject|11|||
143498178|NCT01070329|517366278|FG000|Overall Study|Protocol Violation|3|||
143498179|NCT01070329|517366279|FG001|Overall Study|Protocol Violation|8|||
143498180|NCT01070329|517366278|FG000|Overall Study|Lack of Efficacy|2|||
143498181|NCT01070329|517366279|FG001|Overall Study|Lack of Efficacy|6|||
143498182|NCT01070329|517366278|FG000|Overall Study|Physician Decision|2|||
143041489|NCT02009163|515692396|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
143041490|NCT02009163|515692397|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
143041491|NCT02009163|515692395|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
143041492|NCT02009163|515692396|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
143041493|NCT02009163|515692397|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
143041494|NCT02009163|515692395|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
143041495|NCT02009163|515692396|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
143041496|NCT02009163|515692397|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
143041497|NCT02009163|515692395|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
143041498|NCT02009163|515692396|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
143041499|NCT02009163|515692397|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
143041500|NCT02009163|515692395|FG000|Open-label Period (Non-randomized)|Other|13|||
143041501|NCT02009163|515692396|FG001|Open-label Period (Non-randomized)|Other|0|||
143041502|NCT02009163|515692397|FG002|Open-label Period (Non-randomized)|Other|0|||
143041503|NCT02009163|515692395|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
143041504|NCT02009163|515692396|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
143041505|NCT02009163|515692397|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
143041506|NCT02009163|515692395|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
143041507|NCT02009163|515692396|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
143041508|NCT02009163|515692397|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
143041509|NCT02009163|515692395|FG000|Randomized-withdrawal Period|Adverse Event|0|||
143041510|NCT02009163|515692396|FG001|Randomized-withdrawal Period|Adverse Event|0|||
143041511|NCT02009163|515692397|FG002|Randomized-withdrawal Period|Adverse Event|6|||
143041512|NCT02009163|515692395|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
143041513|NCT02009163|515692396|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
143041514|NCT02009163|515692397|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
143041515|NCT02009163|515692395|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
143041516|NCT02009163|515692396|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
143041517|NCT02009163|515692397|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
143041518|NCT02009163|515692395|FG000|Randomized-withdrawal Period|Pregnancy|0|||
143041519|NCT02009163|515692396|FG001|Randomized-withdrawal Period|Pregnancy|0|||
143041520|NCT02009163|515692397|FG002|Randomized-withdrawal Period|Pregnancy|2|||
143041521|NCT02009163|515692395|FG000|Randomized-withdrawal Period|Other|0|||
143041522|NCT02009163|515692396|FG001|Randomized-withdrawal Period|Other|9|||
143041523|NCT02009163|515692397|FG002|Randomized-withdrawal Period|Other|5|||
143041524|NCT02453386|515692400|FG000|Overall Study|Adverse Event|22|||
143041525|NCT02453386|515692401|FG001|Overall Study|Adverse Event|30|||
143041526|NCT02453386|515692402|FG002|Overall Study|Adverse Event|15|||
143041527|NCT02453386|515692400|FG000|Overall Study|Protocol Violation|1|||
143041528|NCT02453386|515692401|FG001|Overall Study|Protocol Violation|0|||
143041529|NCT02453386|515692402|FG002|Overall Study|Protocol Violation|1|||
143041530|NCT02453386|515692400|FG000|Overall Study|Withdrawal by Subject|10|||
143041531|NCT02453386|515692401|FG001|Overall Study|Withdrawal by Subject|9|||
143041532|NCT02453386|515692402|FG002|Overall Study|Withdrawal by Subject|9|||
143041533|NCT02453386|515692400|FG000|Overall Study|Sponsor Terminated Study|14|||
143041534|NCT02453386|515692401|FG001|Overall Study|Sponsor Terminated Study|8|||
143041535|NCT02453386|515692402|FG002|Overall Study|Sponsor Terminated Study|11|||
143041536|NCT02453386|515692400|FG000|Overall Study|Subject Terminated by Sponsor|1|||
143041537|NCT02453386|515692401|FG001|Overall Study|Subject Terminated by Sponsor|1|||
143041538|NCT02453386|515692402|FG002|Overall Study|Subject Terminated by Sponsor|1|||
143041539|NCT02453386|515692400|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
143041540|NCT02453386|515692401|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
143041541|NCT02453386|515692402|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
143041542|NCT02453386|515692400|FG000|Overall Study|Lost to Follow-up|0|||
143041543|NCT02453386|515692401|FG001|Overall Study|Lost to Follow-up|0|||
143041544|NCT02453386|515692402|FG002|Overall Study|Lost to Follow-up|1|||
143164710|NCT04661839|516150108|FG001|Overall Study|Not Treated|0|||
143164711|NCT04661839|516150109|FG002|Overall Study|Not Treated|1|||
143164712|NCT04661839|516150110|FG003|Overall Study|Not Treated|0|||
143164713|NCT04661839|516150107|FG000|Overall Study|Lost to Follow-up|1|||
143164714|NCT04661839|516150108|FG001|Overall Study|Lost to Follow-up|0|||
143164715|NCT04661839|516150109|FG002|Overall Study|Lost to Follow-up|0|||
143164716|NCT04661839|516150110|FG003|Overall Study|Lost to Follow-up|1|||
143041545|NCT02453386|515692400|FG000|Overall Study|Other|1|||
143041546|NCT02453386|515692401|FG001|Overall Study|Other|0|||
143041547|NCT02453386|515692402|FG002|Overall Study|Other|1|||
143041548|NCT00838279|515692403|FG000|Washout|Protocol Violation|1|||
143041549|NCT00838279|515692404|FG001|Washout|Protocol Violation|0|||
143041550|NCT00838279|515692403|FG000|Washout|Withdrawal by Subject|0|||
143041551|NCT00838279|515692404|FG001|Washout|Withdrawal by Subject|1|||
143164717|NCT01946880|516150111|FG000|Overall Study|Lost to Follow-up|1|||
143164718|NCT01946880|516150112|FG001|Overall Study|Lost to Follow-up|0|||
143164719|NCT01946880|516150111|FG000|Overall Study|Physician Decision|1|||
143041552|NCT04608188|515692405|FG000|Overall Study|Withdrawal by Subject|4|||
143164720|NCT01946880|516150112|FG001|Overall Study|Physician Decision|1|||
143041553|NCT04608188|515692406|FG001|Overall Study|Withdrawal by Subject|8|||
143041554|NCT01415986|515692407|FG000|Overall Study|Lost to Follow-up|1|||
143041555|NCT03792477|515692408|FG000|Overall Study|Adverse Event|0|||
143041556|NCT03792477|515692409|FG001|Overall Study|Adverse Event|0|||
143041557|NCT03792477|515692410|FG002|Overall Study|Adverse Event|0|||
143041558|NCT03792477|515692411|FG003|Overall Study|Adverse Event|1|||
143041559|NCT03792477|515692412|FG004|Overall Study|Adverse Event|0|||
143041560|NCT03792477|515692408|FG000|Overall Study|Lost to Follow-up|0|||
143041561|NCT03792477|515692409|FG001|Overall Study|Lost to Follow-up|0|||
143041562|NCT03792477|515692410|FG002|Overall Study|Lost to Follow-up|2|||
143041563|NCT03792477|515692411|FG003|Overall Study|Lost to Follow-up|0|||
143041564|NCT03792477|515692412|FG004|Overall Study|Lost to Follow-up|0|||
143041565|NCT03792477|515692408|FG000|Overall Study|Other|0|||
143041566|NCT03792477|515692409|FG001|Overall Study|Other|0|||
143041567|NCT03792477|515692410|FG002|Overall Study|Other|0|||
143041568|NCT03792477|515692411|FG003|Overall Study|Other|0|||
143041569|NCT03792477|515692412|FG004|Overall Study|Other|1|||
143041570|NCT00840411|515692413|FG000|First Intervention|Adverse Event|1|||
143041571|NCT00840411|515692414|FG001|First Intervention|Adverse Event|0|||
143041572|NCT00840411|515692413|FG000|Washout|Withdrawal by Subject|1|||
143041573|NCT00840411|515692414|FG001|Washout|Withdrawal by Subject|0|||
143041574|NCT03233724|515692428|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
143041575|NCT03233724|515692429|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
143041576|NCT03233724|515692430|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
143041577|NCT03233724|515692431|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
143041578|NCT03233724|515692432|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
143041579|NCT03233724|515692428|FG000|Phase I Dose Escalation|Best interest of participant|1|||
143041580|NCT03233724|515692429|FG001|Phase I Dose Escalation|Best interest of participant|1|||
143041581|NCT03233724|515692430|FG002|Phase I Dose Escalation|Best interest of participant|1|||
143041582|NCT03233724|515692431|FG003|Phase I Dose Escalation|Best interest of participant|0|||
143041583|NCT03233724|515692432|FG004|Phase I Dose Escalation|Best interest of participant|0|||
143041584|NCT03233724|515692428|FG000|Phase I Dose Escalation|Physician Decision|0|||
143041585|NCT03233724|515692429|FG001|Phase I Dose Escalation|Physician Decision|0|||
143041586|NCT03233724|515692430|FG002|Phase I Dose Escalation|Physician Decision|1|||
143041587|NCT03233724|515692431|FG003|Phase I Dose Escalation|Physician Decision|0|||
143041588|NCT03233724|515692432|FG004|Phase I Dose Escalation|Physician Decision|0|||
143041589|NCT03233724|515692428|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
143041590|NCT03233724|515692429|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
143041591|NCT03233724|515692430|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
143041592|NCT03233724|515692431|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
143041593|NCT03233724|515692432|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
143041594|NCT03122457|515692435|FG000|Overall Study|Withdrawal by Subject|6|||
143041595|NCT00651820|515692436|FG000|Overall Study|Lost to Follow-up|2|||
143041596|NCT01921062|515692437|FG000|Overall Study|Withdrawal by Subject|0|||
143041597|NCT01921062|515692438|FG001|Overall Study|Withdrawal by Subject|7|||
143041598|NCT01921062|515692437|FG000|Overall Study|Adverse Event|5|||
143041599|NCT01921062|515692438|FG001|Overall Study|Adverse Event|6|||
143041600|NCT01921062|515692437|FG000|Overall Study|Protocol Violation|0|||
143041601|NCT01921062|515692438|FG001|Overall Study|Protocol Violation|1|||
143041602|NCT01921062|515692437|FG000|Overall Study|VMIQ score > 72|4|||
143041603|NCT01921062|515692438|FG001|Overall Study|VMIQ score > 72|1|||
143041604|NCT01921062|515692437|FG000|Overall Study|Logistic error|0|||
143041605|NCT01921062|515692438|FG001|Overall Study|Logistic error|1|||
143041606|NCT01911676|515692439|FG000|Period 1 of Study|Withdrawal by Subject|4|||
143041607|NCT01911676|515692440|FG001|Period 1 of Study|Withdrawal by Subject|2|||
143041608|NCT01911676|515692441|FG002|Period 1 of Study|Withdrawal by Subject|1|||
143041609|NCT01911676|515692442|FG003|Period 1 of Study|Withdrawal by Subject|2|||
143041610|NCT01911676|515692439|FG000|Period 1 of Study|Physician Decision|2|||
143041611|NCT01911676|515692440|FG001|Period 1 of Study|Physician Decision|0|||
143041612|NCT01911676|515692441|FG002|Period 1 of Study|Physician Decision|0|||
143041613|NCT01911676|515692442|FG003|Period 1 of Study|Physician Decision|1|||
143041614|NCT01911676|515692439|FG000|Period 2 of Study|Physician Decision|2|||
143041615|NCT01911676|515692440|FG001|Period 2 of Study|Physician Decision|0|||
143041616|NCT01911676|515692441|FG002|Period 2 of Study|Physician Decision|0|||
143041617|NCT01911676|515692442|FG003|Period 2 of Study|Physician Decision|1|||
143041618|NCT01911676|515692439|FG000|Period 2 of Study|Lost to Follow-up|0|||
143041619|NCT01911676|515692440|FG001|Period 2 of Study|Lost to Follow-up|0|||
143041620|NCT01911676|515692441|FG002|Period 2 of Study|Lost to Follow-up|0|||
143041621|NCT01911676|515692442|FG003|Period 2 of Study|Lost to Follow-up|1|||
143041622|NCT03173547|515692444|FG000|Overall Study|Adverse Event|2|||
143041623|NCT03173547|515692445|FG001|Overall Study|Adverse Event|0|||
143041624|NCT03173547|515692444|FG000|Overall Study|Withdrawal by Subject|2|||
143041625|NCT03173547|515692445|FG001|Overall Study|Withdrawal by Subject|2|||
143041626|NCT02605928|515692446|FG000|Overall Study|Model tuning phase|28|||
143041627|NCT02605928|515692446|FG000|Overall Study|Lack of Efficacy|5|||
143041628|NCT04659603|515692456|FG000|Overall Study|Study terminated by sponsor|0|||
143041629|NCT04659603|515692457|FG001|Overall Study|Study terminated by sponsor|0|||
143041630|NCT04659603|515692458|FG002|Overall Study|Study terminated by sponsor|2|||
143041631|NCT04659603|515692456|FG000|Overall Study|Withdrawal by Subject|0|||
143041632|NCT04659603|515692457|FG001|Overall Study|Withdrawal by Subject|5|||
143041633|NCT04659603|515692458|FG002|Overall Study|Withdrawal by Subject|0|||
143041634|NCT04659603|515692456|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
143041635|NCT04659603|515692457|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
143041636|NCT04659603|515692458|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
143041637|NCT01231906|515692461|FG000|Overall Study|Lack of Efficacy|75|||
143041638|NCT01231906|515692462|FG001|Overall Study|Lack of Efficacy|68|||
143041639|NCT01231906|515692461|FG000|Overall Study|Lost to Follow-up|1|||
143041640|NCT01231906|515692462|FG001|Overall Study|Lost to Follow-up|0|||
143041641|NCT01231906|515692461|FG000|Overall Study|Physician Decision|34|||
143041642|NCT01231906|515692462|FG001|Overall Study|Physician Decision|24|||
143041643|NCT01231906|515692461|FG000|Overall Study|Withdrawal by Subject|0|||
143041644|NCT01231906|515692462|FG001|Overall Study|Withdrawal by Subject|4|||
143041645|NCT01231906|515692461|FG000|Overall Study|Ineligible|10|||
143041646|NCT01231906|515692462|FG001|Overall Study|Ineligible|3|||
143041647|NCT01231906|515692461|FG000|Overall Study|No treatment|1|||
143041648|NCT01231906|515692462|FG001|Overall Study|No treatment|2|||
143041649|NCT02441309|515692465|FG000|Overall Study|Disease progression|2|||
143041650|NCT02441309|515692466|FG001|Overall Study|Disease progression|1|||
143041651|NCT02441309|515692467|FG002|Overall Study|Disease progression|2|||
143041652|NCT02441309|515692465|FG000|Overall Study|Adverse Event|0|||
143041653|NCT02441309|515692466|FG001|Overall Study|Adverse Event|1|||
143041654|NCT02441309|515692467|FG002|Overall Study|Adverse Event|0|||
143041655|NCT02441309|515692465|FG000|Overall Study|Withdrawal by Subject|1|||
143041656|NCT02441309|515692466|FG001|Overall Study|Withdrawal by Subject|0|||
143041657|NCT02441309|515692467|FG002|Overall Study|Withdrawal by Subject|1|||
143041658|NCT00095212|515692468|FG000|Overall Study|Withdrawal by Subject|1|||
143041659|NCT00095212|515692469|FG001|Overall Study|Withdrawal by Subject|3|||
143041660|NCT03681470|515692470|FG000|Overall Study|Lack of Efficacy|3|||
143041661|NCT03681470|515692470|FG000|Overall Study|Lost to Follow-up|1|||
143041662|NCT03681470|515692470|FG000|Overall Study|Protocol Violation|3|||
143041663|NCT03681470|515692470|FG000|Overall Study|Withdrawal by Subject|1|||
143041664|NCT01136174|515692471|FG000|Overall Study|Adverse Event|0|||
143041665|NCT01136174|515692472|FG001|Overall Study|Adverse Event|0|||
143041666|NCT01136174|515692473|FG002|Overall Study|Adverse Event|0|||
143041667|NCT01136174|515692474|FG003|Overall Study|Adverse Event|4|||
143041668|NCT00811655|515692475|FG000|Overall Study|Physician Decision|1|||
143041669|NCT02820350|515692476|FG000|Overall Study|Withdrawal by Subject|3|||
143041670|NCT02820350|515692476|FG000|Overall Study|Death|4|||
143041671|NCT01754597|515692477|FG000|Overall Study|Dosage of NT-proBNP not performed|6|||
143041672|NCT01754597|515692478|FG001|Overall Study|Dosage of NT-proBNP not performed|5|||
143041673|NCT00819741|515692481|FG000|Overall Study|Adverse Event|5|||
143041674|NCT00819741|515692482|FG001|Overall Study|Adverse Event|2|||
143041675|NCT00819741|515692481|FG000|Overall Study|Lack of Efficacy|0|||
143041676|NCT00819741|515692482|FG001|Overall Study|Lack of Efficacy|2|||
143041677|NCT00819741|515692481|FG000|Overall Study|Lost to Follow-up|3|||
143041678|NCT00819741|515692482|FG001|Overall Study|Lost to Follow-up|1|||
143041679|NCT00819741|515692481|FG000|Overall Study|Protocol Violation|3|||
143041680|NCT00819741|515692482|FG001|Overall Study|Protocol Violation|4|||
143041681|NCT00819741|515692481|FG000|Overall Study|Withdrawal by Subject|2|||
143041682|NCT00819741|515692482|FG001|Overall Study|Withdrawal by Subject|2|||
143041683|NCT00819741|515692481|FG000|Overall Study|Unclassified|6|||
143041684|NCT00819741|515692482|FG001|Overall Study|Unclassified|0|||
143041685|NCT00819741|515692481|FG000|Overall Study|Reasons unknown|3|||
143041686|NCT00819741|515692482|FG001|Overall Study|Reasons unknown|3|||
143041687|NCT00119015|515692483|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
143041688|NCT00119015|515692484|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
143041689|NCT00119015|515692485|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
143041690|NCT02674152|515693948|FG000|Overall Study|Personal Reasons|1|||
143041691|NCT02674152|515693949|FG001|Overall Study|Personal Reasons|0|||
143041692|NCT02674152|515693950|FG002|Overall Study|Personal Reasons|0|||
143041693|NCT02674152|515693951|FG003|Overall Study|Personal Reasons|1|||
143041694|NCT02674152|515693952|FG004|Overall Study|Personal Reasons|1|||
143041695|NCT02674152|515693948|FG000|Overall Study|Other adverse event or clinical progression|0|||
143041696|NCT02674152|515693949|FG001|Overall Study|Other adverse event or clinical progression|1|||
143041697|NCT02674152|515693950|FG002|Overall Study|Other adverse event or clinical progression|0|||
143041698|NCT02674152|515693951|FG003|Overall Study|Other adverse event or clinical progression|3|||
143041699|NCT02674152|515693952|FG004|Overall Study|Other adverse event or clinical progression|0|||
143041700|NCT02674152|515693948|FG000|Overall Study|Dose-limiting toxicity|0|||
143041701|NCT02674152|515693949|FG001|Overall Study|Dose-limiting toxicity|0|||
143041702|NCT02674152|515693950|FG002|Overall Study|Dose-limiting toxicity|0|||
143041703|NCT02674152|515693951|FG003|Overall Study|Dose-limiting toxicity|0|||
143041704|NCT02674152|515693952|FG004|Overall Study|Dose-limiting toxicity|1|||
143041705|NCT02674152|515693948|FG000|Overall Study|Progressive Disease|2|||
143041706|NCT02674152|515693949|FG001|Overall Study|Progressive Disease|1|||
143041707|NCT02674152|515693950|FG002|Overall Study|Progressive Disease|1|||
143041708|NCT02674152|515693951|FG003|Overall Study|Progressive Disease|13|||
143041709|NCT02674152|515693952|FG004|Overall Study|Progressive Disease|2|||
143041710|NCT02674152|515693948|FG000|Overall Study|Adverse Event|0|||
143041711|NCT02674152|515693949|FG001|Overall Study|Adverse Event|0|||
143041712|NCT02674152|515693950|FG002|Overall Study|Adverse Event|1|||
143041713|NCT02674152|515693951|FG003|Overall Study|Adverse Event|0|||
143041714|NCT02674152|515693952|FG004|Overall Study|Adverse Event|1|||
143041715|NCT02571907|515693953|FG000|Overall Study|Death|4|||
143041716|NCT02571907|515693953|FG000|Overall Study|Lost to Follow-up|3|||
143041717|NCT02571907|515693953|FG000|Overall Study|Withdrawal by Subject|3|||
143041718|NCT05265624|515693954|FG000|Overall Study|Lost to Follow-up|3|||
143041719|NCT05265624|515693955|FG001|Overall Study|Lost to Follow-up|0|||
143041720|NCT05265624|515693954|FG000|Overall Study|Withdrawal by Subject|1|||
143041721|NCT05265624|515693955|FG001|Overall Study|Withdrawal by Subject|0|||
143041722|NCT03697109|515693956|FG000|Open-label (OL) Phase|Adverse Event|24|||
143041723|NCT03697109|515693957|FG001|Open-label (OL) Phase|Adverse Event|0|||
143041724|NCT03697109|515693958|FG002|Open-label (OL) Phase|Adverse Event|0|||
143041725|NCT03697109|515693956|FG000|Open-label (OL) Phase|Lost to Follow-up|2|||
143041726|NCT03697109|515693957|FG001|Open-label (OL) Phase|Lost to Follow-up|0|||
143041727|NCT03697109|515693958|FG002|Open-label (OL) Phase|Lost to Follow-up|0|||
143041728|NCT03697109|515693956|FG000|Open-label (OL) Phase|Lack of Efficacy|6|||
143041729|NCT03697109|515693957|FG001|Open-label (OL) Phase|Lack of Efficacy|0|||
143041730|NCT03697109|515693958|FG002|Open-label (OL) Phase|Lack of Efficacy|0|||
143041731|NCT03697109|515693956|FG000|Open-label (OL) Phase|Withdrawal by Subject|21|||
143041732|NCT03697109|515693957|FG001|Open-label (OL) Phase|Withdrawal by Subject|0|||
143041733|NCT03697109|515693958|FG002|Open-label (OL) Phase|Withdrawal by Subject|0|||
143041734|NCT03697109|515693956|FG000|Open-label (OL) Phase|Physician Decision|2|||
143041735|NCT03697109|515693957|FG001|Open-label (OL) Phase|Physician Decision|0|||
143041736|NCT03697109|515693958|FG002|Open-label (OL) Phase|Physician Decision|0|||
143041737|NCT03697109|515693956|FG000|Open-label (OL) Phase|Death|2|||
143041738|NCT03697109|515693957|FG001|Open-label (OL) Phase|Death|0|||
143041739|NCT03697109|515693958|FG002|Open-label (OL) Phase|Death|0|||
143041740|NCT03697109|515693956|FG000|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
143041741|NCT03697109|515693957|FG001|Randomized-withdrawal (RW) Phase|Adverse Event|1|||
143041742|NCT03697109|515693958|FG002|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
143041743|NCT03697109|515693956|FG000|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
143041744|NCT03697109|515693957|FG001|Randomized-withdrawal (RW) Phase|Lack of Efficacy|1|||
143041745|NCT03697109|515693958|FG002|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
143041746|NCT03697109|515693956|FG000|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|0|||
143041747|NCT03697109|515693957|FG001|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
143041748|NCT03697109|515693958|FG002|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
143041749|NCT03032172|515693959|FG000|Treatment Period|Adverse Event|0|||
143041750|NCT03032172|515693960|FG001|Treatment Period|Adverse Event|1|||
143041751|NCT03032172|515693961|FG002|Treatment Period|Adverse Event|0|||
143041752|NCT03032172|515693962|FG003|Treatment Period|Adverse Event|0|||
143041753|NCT03032172|515693963|FG004|Treatment Period|Adverse Event|0|||
143041754|NCT03032172|515693964|FG005|Treatment Period|Adverse Event|0|||
143041755|NCT03032172|515693965|FG006|Treatment Period|Adverse Event|0|||
143041756|NCT03032172|515693966|FG007|Treatment Period|Adverse Event|0|||
143041757|NCT03032172|515693959|FG000|Treatment Period|Lack of Efficacy|0|||
143041758|NCT03032172|515693960|FG001|Treatment Period|Lack of Efficacy|1|||
143041759|NCT03032172|515693961|FG002|Treatment Period|Lack of Efficacy|0|||
143041760|NCT03032172|515693962|FG003|Treatment Period|Lack of Efficacy|0|||
143041761|NCT03032172|515693963|FG004|Treatment Period|Lack of Efficacy|0|||
143041762|NCT03032172|515693964|FG005|Treatment Period|Lack of Efficacy|0|||
143041763|NCT03032172|515693965|FG006|Treatment Period|Lack of Efficacy|0|||
143041764|NCT03032172|515693966|FG007|Treatment Period|Lack of Efficacy|0|||
143041765|NCT03032172|515693959|FG000|Treatment Period|Non-compliance With Study Drug|0|||
143041766|NCT03032172|515693960|FG001|Treatment Period|Non-compliance With Study Drug|1|||
143041767|NCT03032172|515693961|FG002|Treatment Period|Non-compliance With Study Drug|0|||
143041768|NCT03032172|515693962|FG003|Treatment Period|Non-compliance With Study Drug|0|||
143041769|NCT03032172|515693963|FG004|Treatment Period|Non-compliance With Study Drug|0|||
143041770|NCT03032172|515693964|FG005|Treatment Period|Non-compliance With Study Drug|0|||
143041771|NCT03032172|515693965|FG006|Treatment Period|Non-compliance With Study Drug|0|||
143164721|NCT01946880|516150111|FG000|Overall Study|Withdrawal by Subject|3|||
143164722|NCT01946880|516150112|FG001|Overall Study|Withdrawal by Subject|2|||
143041772|NCT03032172|515693966|FG007|Treatment Period|Non-compliance With Study Drug|0|||
143041773|NCT03032172|515693959|FG000|Treatment Period|Reason Not Specified|0|||
143041774|NCT03032172|515693960|FG001|Treatment Period|Reason Not Specified|4|||
143041775|NCT03032172|515693961|FG002|Treatment Period|Reason Not Specified|1|||
143041776|NCT03032172|515693962|FG003|Treatment Period|Reason Not Specified|0|||
143041777|NCT03032172|515693963|FG004|Treatment Period|Reason Not Specified|0|||
143041778|NCT03032172|515693964|FG005|Treatment Period|Reason Not Specified|0|||
143041779|NCT03032172|515693965|FG006|Treatment Period|Reason Not Specified|0|||
143041780|NCT03032172|515693966|FG007|Treatment Period|Reason Not Specified|0|||
143041781|NCT03032172|515693959|FG000|Treatment Period|Physician Decision|0|||
143041782|NCT03032172|515693960|FG001|Treatment Period|Physician Decision|2|||
143041783|NCT03032172|515693961|FG002|Treatment Period|Physician Decision|1|||
143041784|NCT03032172|515693962|FG003|Treatment Period|Physician Decision|0|||
143041785|NCT03032172|515693963|FG004|Treatment Period|Physician Decision|0|||
143041786|NCT03032172|515693964|FG005|Treatment Period|Physician Decision|0|||
143041787|NCT03032172|515693965|FG006|Treatment Period|Physician Decision|0|||
143041788|NCT03032172|515693966|FG007|Treatment Period|Physician Decision|0|||
143041789|NCT03032172|515693959|FG000|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
143041790|NCT03032172|515693960|FG001|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
143041791|NCT03032172|515693961|FG002|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|2|||
143041792|NCT03032172|515693962|FG003|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
143041793|NCT03032172|515693963|FG004|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
143041794|NCT03032172|515693964|FG005|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
143041795|NCT03032172|515693965|FG006|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
143041796|NCT03032172|515693966|FG007|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
143041797|NCT03032172|515693959|FG000|Treatment Period|Withdrawal by Subject|2|||
143041798|NCT03032172|515693960|FG001|Treatment Period|Withdrawal by Subject|0|||
143041799|NCT03032172|515693961|FG002|Treatment Period|Withdrawal by Subject|3|||
143041800|NCT03032172|515693962|FG003|Treatment Period|Withdrawal by Subject|0|||
143041801|NCT03032172|515693963|FG004|Treatment Period|Withdrawal by Subject|0|||
143041802|NCT03032172|515693964|FG005|Treatment Period|Withdrawal by Subject|0|||
143041803|NCT03032172|515693965|FG006|Treatment Period|Withdrawal by Subject|0|||
143041804|NCT03032172|515693966|FG007|Treatment Period|Withdrawal by Subject|0|||
143041805|NCT03032172|515693959|FG000|Open-label Extension Period|Death|0|||
143041806|NCT03032172|515693960|FG001|Open-label Extension Period|Death|0|||
143041807|NCT03032172|515693961|FG002|Open-label Extension Period|Death|0|||
143041808|NCT03032172|515693962|FG003|Open-label Extension Period|Death|0|||
143041809|NCT03032172|515693963|FG004|Open-label Extension Period|Death|0|||
143041810|NCT03032172|515693964|FG005|Open-label Extension Period|Death|0|||
143041811|NCT03032172|515693965|FG006|Open-label Extension Period|Death|0|||
143041812|NCT03032172|515693966|FG007|Open-label Extension Period|Death|2|||
143041813|NCT03032172|515693959|FG000|Open-label Extension Period|Reason Not Specified|0|||
143041814|NCT03032172|515693960|FG001|Open-label Extension Period|Reason Not Specified|0|||
143041815|NCT03032172|515693961|FG002|Open-label Extension Period|Reason Not Specified|0|||
143041816|NCT03032172|515693962|FG003|Open-label Extension Period|Reason Not Specified|0|||
143041817|NCT03032172|515693963|FG004|Open-label Extension Period|Reason Not Specified|0|||
143041818|NCT03032172|515693964|FG005|Open-label Extension Period|Reason Not Specified|5|||
143041819|NCT03032172|515693965|FG006|Open-label Extension Period|Reason Not Specified|3|||
143041820|NCT03032172|515693966|FG007|Open-label Extension Period|Reason Not Specified|0|||
143041821|NCT03032172|515693959|FG000|Open-label Extension Period|Pregnancy|0|||
143041822|NCT03032172|515693960|FG001|Open-label Extension Period|Pregnancy|0|||
143041823|NCT03032172|515693961|FG002|Open-label Extension Period|Pregnancy|0|||
143041824|NCT03032172|515693962|FG003|Open-label Extension Period|Pregnancy|0|||
143041825|NCT03032172|515693963|FG004|Open-label Extension Period|Pregnancy|0|||
143041826|NCT03032172|515693964|FG005|Open-label Extension Period|Pregnancy|0|||
143041827|NCT03032172|515693965|FG006|Open-label Extension Period|Pregnancy|1|||
143041828|NCT03032172|515693966|FG007|Open-label Extension Period|Pregnancy|0|||
143041829|NCT03032172|515693959|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
143041830|NCT03032172|515693960|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
143041831|NCT03032172|515693961|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
143041832|NCT03032172|515693962|FG003|Open-label Extension Period|Withdrawal by Subject|0|||
143041833|NCT03032172|515693963|FG004|Open-label Extension Period|Withdrawal by Subject|1|||
143041834|NCT03032172|515693964|FG005|Open-label Extension Period|Withdrawal by Subject|7|||
143041835|NCT03032172|515693965|FG006|Open-label Extension Period|Withdrawal by Subject|11|||
143041836|NCT03032172|515693966|FG007|Open-label Extension Period|Withdrawal by Subject|4|||
143041837|NCT06284525|515693968|FG000|Overall Study|Withdrawal by Subject|1|||
143041838|NCT00834522|515693969|FG000|Washout|Adverse Event|1|||
143041839|NCT00834522|515693970|FG001|Washout|Adverse Event|0|||
143041840|NCT00834522|515693969|FG000|Washout|Withdrawal by Subject|2|||
143041841|NCT00834522|515693970|FG001|Washout|Withdrawal by Subject|1|||
143041842|NCT04516967|515693971|FG000|Core Phase|Adverse Event|2|||
143041843|NCT04516967|515693972|FG001|Core Phase|Adverse Event|1|||
143041844|NCT04516967|515693973|FG002|Core Phase|Adverse Event|0|||
143240510|NCT00684021|516431997|FG003|Overall Study|MRI Contraindicated|0|||
143041845|NCT04516967|515693971|FG000|Core Phase|Physician Decision|1|||
143041846|NCT04516967|515693972|FG001|Core Phase|Physician Decision|1|||
143041847|NCT04516967|515693973|FG002|Core Phase|Physician Decision|0|||
143041848|NCT04516967|515693971|FG000|Core Phase|Lack of Efficacy|7|||
143041849|NCT04516967|515693972|FG001|Core Phase|Lack of Efficacy|18|||
143041850|NCT04516967|515693973|FG002|Core Phase|Lack of Efficacy|0|||
143041851|NCT03165994|515693974|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
143041852|NCT03165994|515693974|FG000|Overall Study|Death|2|||
143041853|NCT03165994|515693974|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
143041854|NCT03165994|515693974|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
143041855|NCT03165994|515693974|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
143041856|NCT03165994|515693974|FG000|Overall Study|Miscellaneous|1|||
143041857|NCT00519194|515693975|FG000|Overall Study|Withdrawal by Subject|9|||
143041858|NCT00519194|515693975|FG000|Overall Study|Death|9|||
143041859|NCT00519194|515693975|FG000|Overall Study|Lost to Follow-up|3|||
143041860|NCT00934050|515693978|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
143041861|NCT00934050|515693979|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
143041862|NCT00934050|515693980|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
143041863|NCT00934050|515693981|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
143041864|NCT00934050|515693982|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
143041865|NCT00934050|515693983|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
143041866|NCT00934050|515693978|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
143041867|NCT00934050|515693979|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
143041868|NCT00934050|515693980|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
143041869|NCT00934050|515693981|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
143041870|NCT00934050|515693982|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
143041871|NCT00934050|515693983|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
143041872|NCT00934050|515693978|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
143041873|NCT00934050|515693979|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
143041874|NCT00934050|515693980|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
143041875|NCT00934050|515693981|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
143041876|NCT00934050|515693982|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
143041877|NCT00934050|515693983|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
143041878|NCT00934050|515693978|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
143041879|NCT00934050|515693979|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
143041880|NCT00934050|515693980|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
143041881|NCT00934050|515693981|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
143041882|NCT00934050|515693982|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
143041883|NCT00934050|515693983|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
143041884|NCT00934050|515693978|FG000|Enrolled After 15 Dec 2009|Death|0|||
143041885|NCT00934050|515693979|FG001|Enrolled After 15 Dec 2009|Death|0|||
143041886|NCT00934050|515693980|FG002|Enrolled After 15 Dec 2009|Death|0|||
143041887|NCT00934050|515693981|FG003|Enrolled After 15 Dec 2009|Death|0|||
143041888|NCT00934050|515693982|FG004|Enrolled After 15 Dec 2009|Death|0|||
143041889|NCT00934050|515693983|FG005|Enrolled After 15 Dec 2009|Death|1|||
143041890|NCT00934050|515693978|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
143041891|NCT00934050|515693979|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
143041892|NCT00934050|515693980|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
143041893|NCT00934050|515693981|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
143041894|NCT00934050|515693982|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
143041895|NCT00934050|515693983|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
143240511|NCT00684021|516431994|FG000|Overall Study|MRI not performed|0|||
143240512|NCT00684021|516431995|FG001|Overall Study|MRI not performed|1|||
143240513|NCT00684021|516431996|FG002|Overall Study|MRI not performed|1|||
143240514|NCT00684021|516431997|FG003|Overall Study|MRI not performed|2|||
143041896|NCT00934050|515693978|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
143041897|NCT00934050|515693979|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
143041898|NCT00934050|515693980|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
143041899|NCT00934050|515693981|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
143041900|NCT00934050|515693982|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
143041901|NCT00934050|515693983|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
143041902|NCT02149420|515693984|FG000|Core Study|Administrative problems|0|||
143041903|NCT02149420|515693985|FG001|Core Study|Administrative problems|1|||
143041904|NCT02149420|515693986|FG002|Core Study|Administrative problems|2|||
143041905|NCT02149420|515693984|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
143041906|NCT02149420|515693985|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
143041907|NCT02149420|515693986|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
143041908|NCT00834067|515693987|FG000|Washout of 21 Days|Protocol Violation|0|||
143240515|NCT00684021|516431994|FG000|Overall Study|Death|1|||
143240516|NCT00684021|516431995|FG001|Overall Study|Death|0|||
143041909|NCT00834067|515693988|FG001|Washout of 21 Days|Protocol Violation|1|||
143041910|NCT00440518|515693990|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
143041911|NCT00440518|515693991|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
143041912|NCT00440518|515693992|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
143041913|NCT00440518|515693990|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
143041914|NCT00440518|515693991|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
143041915|NCT00440518|515693992|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
143041916|NCT00440518|515693990|FG000|Randomized /Titration Period|Protocol Deviation|1|||
143041917|NCT00440518|515693991|FG001|Randomized /Titration Period|Protocol Deviation|0|||
143041918|NCT00440518|515693992|FG002|Randomized /Titration Period|Protocol Deviation|0|||
143041919|NCT00440518|515693990|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
143041920|NCT00440518|515693991|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
143041921|NCT00440518|515693992|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
143041922|NCT00440518|515693990|FG000|Randomized /Titration Period|Other|1|||
143041923|NCT00440518|515693991|FG001|Randomized /Titration Period|Other|0|||
143041924|NCT00440518|515693992|FG002|Randomized /Titration Period|Other|0|||
143041925|NCT00440518|515693990|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
143041926|NCT00440518|515693991|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
143041927|NCT00440518|515693992|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
143041928|NCT00440518|515693990|FG000|Randomized /Titration Period|Adverse Event|2|||
143041929|NCT00440518|515693991|FG001|Randomized /Titration Period|Adverse Event|3|||
143041930|NCT00440518|515693992|FG002|Randomized /Titration Period|Adverse Event|0|||
143041931|NCT00440518|515693990|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
143041932|NCT00440518|515693991|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
143041933|NCT00440518|515693992|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
143041934|NCT00440518|515693990|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
143041935|NCT00440518|515693991|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
143041936|NCT00440518|515693992|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
143041937|NCT00440518|515693990|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
143041938|NCT00440518|515693991|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
143041939|NCT00440518|515693992|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
143041940|NCT00440518|515693990|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
143041941|NCT00440518|515693991|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
143041942|NCT00440518|515693992|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
143041943|NCT00440518|515693990|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
143041944|NCT00440518|515693991|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
143041945|NCT00440518|515693992|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
143041946|NCT00440518|515693990|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
143041947|NCT00440518|515693991|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
143041948|NCT00440518|515693992|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
143041949|NCT03570749|515693993|FG000|Overall Study|Ongoing|26|||
143041950|NCT03570749|515693994|FG001|Overall Study|Ongoing|25|||
143041951|NCT03570749|515693995|FG002|Overall Study|Ongoing|25|||
143041952|NCT03570749|515693996|FG003|Overall Study|Ongoing|26|||
143041953|NCT03570749|515693997|FG004|Overall Study|Ongoing|140|||
143041954|NCT03570749|515693998|FG005|Overall Study|Ongoing|142|||
143041955|NCT03570749|515693999|FG006|Overall Study|Ongoing|220|||
143041956|NCT03570749|515693993|FG000|Overall Study|Adverse Event|0|||
143041957|NCT03570749|515693994|FG001|Overall Study|Adverse Event|0|||
143041958|NCT03570749|515693995|FG002|Overall Study|Adverse Event|0|||
143041959|NCT03570749|515693996|FG003|Overall Study|Adverse Event|0|||
143041960|NCT03570749|515693997|FG004|Overall Study|Adverse Event|2|||
143041961|NCT03570749|515693998|FG005|Overall Study|Adverse Event|3|||
143041962|NCT03570749|515693999|FG006|Overall Study|Adverse Event|6|||
143041963|NCT03570749|515693993|FG000|Overall Study|Lack of Efficacy|0|||
143041964|NCT03570749|515693994|FG001|Overall Study|Lack of Efficacy|0|||
143041965|NCT03570749|515693995|FG002|Overall Study|Lack of Efficacy|0|||
143041966|NCT03570749|515693996|FG003|Overall Study|Lack of Efficacy|0|||
143041967|NCT03570749|515693997|FG004|Overall Study|Lack of Efficacy|8|||
143041968|NCT03570749|515693998|FG005|Overall Study|Lack of Efficacy|2|||
143041969|NCT03570749|515693999|FG006|Overall Study|Lack of Efficacy|7|||
143498183|NCT01070329|517366279|FG001|Overall Study|Physician Decision|1|||
143498184|NCT01070329|517366278|FG000|Overall Study|Entry Criteria Not Met|1|||
143041970|NCT03570749|515693993|FG000|Overall Study|Lost to Follow-up|0|||
143041971|NCT03570749|515693994|FG001|Overall Study|Lost to Follow-up|0|||
143498185|NCT01070329|517366279|FG001|Overall Study|Entry Criteria Not Met|0|||
143041972|NCT03570749|515693995|FG002|Overall Study|Lost to Follow-up|0|||
143498186|NCT01070329|517366278|FG000|Overall Study|Sponsor Decision|0|||
143041973|NCT03570749|515693996|FG003|Overall Study|Lost to Follow-up|0|||
143041974|NCT03570749|515693997|FG004|Overall Study|Lost to Follow-up|5|||
143041975|NCT03570749|515693998|FG005|Overall Study|Lost to Follow-up|10|||
143041976|NCT03570749|515693999|FG006|Overall Study|Lost to Follow-up|10|||
143041977|NCT03570749|515693993|FG000|Overall Study|Pregnancy|0|||
143041978|NCT03570749|515693994|FG001|Overall Study|Pregnancy|0|||
143041979|NCT03570749|515693995|FG002|Overall Study|Pregnancy|0|||
143041980|NCT03570749|515693996|FG003|Overall Study|Pregnancy|0|||
143041981|NCT03570749|515693997|FG004|Overall Study|Pregnancy|0|||
143041982|NCT03570749|515693998|FG005|Overall Study|Pregnancy|1|||
143041983|NCT03570749|515693999|FG006|Overall Study|Pregnancy|1|||
143041984|NCT03570749|515693993|FG000|Overall Study|Screen Fail|0|||
143041985|NCT03570749|515693994|FG001|Overall Study|Screen Fail|0|||
143041986|NCT03570749|515693995|FG002|Overall Study|Screen Fail|0|||
143041987|NCT03570749|515693996|FG003|Overall Study|Screen Fail|0|||
143041988|NCT03570749|515693997|FG004|Overall Study|Screen Fail|0|||
143041989|NCT03570749|515693998|FG005|Overall Study|Screen Fail|0|||
143041990|NCT03570749|515693999|FG006|Overall Study|Screen Fail|1|||
143041991|NCT03570749|515693993|FG000|Overall Study|Withdrawal by Subject|2|||
143041992|NCT03570749|515693994|FG001|Overall Study|Withdrawal by Subject|3|||
143041993|NCT03570749|515693995|FG002|Overall Study|Withdrawal by Subject|2|||
143041994|NCT03570749|515693996|FG003|Overall Study|Withdrawal by Subject|1|||
143041995|NCT03570749|515693997|FG004|Overall Study|Withdrawal by Subject|17|||
143041996|NCT03570749|515693998|FG005|Overall Study|Withdrawal by Subject|12|||
143041997|NCT03570749|515693999|FG006|Overall Study|Withdrawal by Subject|15|||
143041998|NCT03570749|515693993|FG000|Overall Study|Other|0|||
143041999|NCT03570749|515693994|FG001|Overall Study|Other|0|||
143042000|NCT03570749|515693995|FG002|Overall Study|Other|0|||
143042001|NCT03570749|515693996|FG003|Overall Study|Other|0|||
143042002|NCT03570749|515693997|FG004|Overall Study|Other|17|||
143042003|NCT03570749|515693998|FG005|Overall Study|Other|14|||
143042004|NCT03570749|515693999|FG006|Overall Study|Other|21|||
143042005|NCT00561015|515694000|FG000|Overall Study|Adverse Event|0|||
143042006|NCT00561015|515694001|FG001|Overall Study|Adverse Event|0|||
143042007|NCT00561015|515694002|FG002|Overall Study|Adverse Event|0|||
143042008|NCT00561015|515694003|FG003|Overall Study|Adverse Event|0|||
143042009|NCT00561015|515694004|FG004|Overall Study|Adverse Event|1|||
143042010|NCT00561015|515694005|FG005|Overall Study|Adverse Event|0|||
143042011|NCT00561015|515694000|FG000|Overall Study|Lost to Follow-up|2|||
143042012|NCT00561015|515694001|FG001|Overall Study|Lost to Follow-up|0|||
143042013|NCT00561015|515694002|FG002|Overall Study|Lost to Follow-up|0|||
143042014|NCT00561015|515694003|FG003|Overall Study|Lost to Follow-up|1|||
143042015|NCT00561015|515694004|FG004|Overall Study|Lost to Follow-up|0|||
143042016|NCT00561015|515694005|FG005|Overall Study|Lost to Follow-up|3|||
143042017|NCT00561015|515694000|FG000|Overall Study|Participant non-compliance|2|||
143042018|NCT00561015|515694001|FG001|Overall Study|Participant non-compliance|0|||
143042019|NCT00561015|515694002|FG002|Overall Study|Participant non-compliance|0|||
143164723|NCT01946880|516150111|FG000|Overall Study|Met Primary Endpoint|1|||
143164724|NCT01946880|516150112|FG001|Overall Study|Met Primary Endpoint|0|||
143164725|NCT01946880|516150111|FG000|Overall Study|Personal and Family Issues|1|||
143164726|NCT01946880|516150112|FG001|Overall Study|Personal and Family Issues|0|||
143164727|NCT03163667|516150117|FG000|Overall Study|Death|15|||
143164728|NCT03163667|516150118|FG001|Overall Study|Death|27|||
143164729|NCT03163667|516150117|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
143164730|NCT03163667|516150118|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
143164731|NCT00979407|516150119|FG000|Overall Study|Withdrawal by Subject|3|||
143164732|NCT00979407|516150120|FG001|Overall Study|Withdrawal by Subject|4|||
143164733|NCT00979407|516150119|FG000|Overall Study|Lost to Follow-up|3|||
143164734|NCT00979407|516150120|FG001|Overall Study|Lost to Follow-up|3|||
143164735|NCT00803049|516150124|FG000|Overall Study|Adverse Event|21|||
143164736|NCT00803049|516150125|FG001|Overall Study|Adverse Event|33|||
143164737|NCT00803049|516150126|FG002|Overall Study|Adverse Event|13|||
143164738|NCT00803049|516150127|FG003|Overall Study|Adverse Event|27|||
143164739|NCT00803049|516150124|FG000|Overall Study|Lack of Efficacy|10|||
143164740|NCT00803049|516150125|FG001|Overall Study|Lack of Efficacy|19|||
143164741|NCT00803049|516150126|FG002|Overall Study|Lack of Efficacy|6|||
143164742|NCT00803049|516150127|FG003|Overall Study|Lack of Efficacy|13|||
143164743|NCT00803049|516150124|FG000|Overall Study|Lost to Follow-up|0|||
143164744|NCT00803049|516150125|FG001|Overall Study|Lost to Follow-up|2|||
143240517|NCT00684021|516431996|FG002|Overall Study|Death|0|||
143042020|NCT00561015|515694003|FG003|Overall Study|Participant non-compliance|0|||
143042021|NCT00561015|515694004|FG004|Overall Study|Participant non-compliance|0|||
143042022|NCT00561015|515694005|FG005|Overall Study|Participant non-compliance|0|||
143042023|NCT03616535|515694006|FG000|Overall Study|Death|2|||
143042024|NCT03616535|515694007|FG001|Overall Study|Death|0|||
143042025|NCT03616535|515694008|FG002|Overall Study|Death|0|||
143042026|NCT03616535|515694009|FG003|Overall Study|Death|1|||
143042027|NCT03616535|515694006|FG000|Overall Study|Lost to Follow-up|2|||
143042028|NCT03616535|515694007|FG001|Overall Study|Lost to Follow-up|1|||
143042029|NCT03616535|515694008|FG002|Overall Study|Lost to Follow-up|0|||
143042030|NCT03616535|515694009|FG003|Overall Study|Lost to Follow-up|2|||
143042031|NCT03616535|515694006|FG000|Overall Study|Withdrawal by Subject|1|||
143164745|NCT00803049|516150126|FG002|Overall Study|Lost to Follow-up|0|||
143164746|NCT00803049|516150127|FG003|Overall Study|Lost to Follow-up|3|||
143164747|NCT00803049|516150124|FG000|Overall Study|Death|2|||
143164748|NCT00803049|516150125|FG001|Overall Study|Death|1|||
143164749|NCT00803049|516150126|FG002|Overall Study|Death|0|||
143164750|NCT00803049|516150127|FG003|Overall Study|Death|2|||
143164751|NCT00803049|516150124|FG000|Overall Study|Progressive Disease|6|||
143164752|NCT00803049|516150125|FG001|Overall Study|Progressive Disease|10|||
143164753|NCT00803049|516150126|FG002|Overall Study|Progressive Disease|6|||
143164754|NCT00803049|516150127|FG003|Overall Study|Progressive Disease|6|||
143164755|NCT00803049|516150124|FG000|Overall Study|Withdrawal by Subject|19|||
143164756|NCT00803049|516150125|FG001|Overall Study|Withdrawal by Subject|43|||
143164757|NCT00803049|516150126|FG002|Overall Study|Withdrawal by Subject|16|||
143164758|NCT00803049|516150127|FG003|Overall Study|Withdrawal by Subject|44|||
143164759|NCT00803049|516150124|FG000|Overall Study|Protocol Violation|0|||
143164760|NCT00803049|516150125|FG001|Overall Study|Protocol Violation|1|||
143164761|NCT00803049|516150126|FG002|Overall Study|Protocol Violation|1|||
143164762|NCT00803049|516150127|FG003|Overall Study|Protocol Violation|0|||
143164763|NCT00803049|516150124|FG000|Overall Study|Randomized and Not Treated|0|||
143164764|NCT00803049|516150125|FG001|Overall Study|Randomized and Not Treated|0|||
143164765|NCT00803049|516150126|FG002|Overall Study|Randomized and Not Treated|0|||
143164766|NCT00803049|516150127|FG003|Overall Study|Randomized and Not Treated|2|||
143164767|NCT00803049|516150124|FG000|Overall Study|Other than Specified Above|3|||
143164768|NCT00803049|516150125|FG001|Overall Study|Other than Specified Above|9|||
143164769|NCT00803049|516150126|FG002|Overall Study|Other than Specified Above|2|||
143164770|NCT00803049|516150127|FG003|Overall Study|Other than Specified Above|5|||
143164771|NCT01422382|516150128|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
143042032|NCT03616535|515694007|FG001|Overall Study|Withdrawal by Subject|2|||
143042033|NCT03616535|515694008|FG002|Overall Study|Withdrawal by Subject|5|||
143164772|NCT04082364|516150131|FG000|Overall Study|Death|23|||
143164773|NCT04082364|516150132|FG001|Overall Study|Death|1|||
143498187|NCT01070329|517366279|FG001|Overall Study|Sponsor Decision|1|||
143498188|NCT05195528|517366284|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
143498189|NCT05195528|517366285|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
143498190|NCT05195528|517366286|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
143498191|NCT05195528|517366287|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
143498192|NCT05195528|517366288|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
143042034|NCT03616535|515694009|FG003|Overall Study|Withdrawal by Subject|1|||
143042035|NCT03616535|515694006|FG000|Overall Study|Not specified or change in eligibility|2|||
143042036|NCT03616535|515694007|FG001|Overall Study|Not specified or change in eligibility|3|||
143042037|NCT03616535|515694008|FG002|Overall Study|Not specified or change in eligibility|3|||
143042038|NCT03616535|515694009|FG003|Overall Study|Not specified or change in eligibility|1|||
143042039|NCT00583453|515694012|FG000|Overall Study|discontinued intervention|0|||
143042040|NCT00583453|515694013|FG001|Overall Study|discontinued intervention|2|||
143042041|NCT00905606|515694014|FG000|Period 1|Adverse Event|0|||
143042042|NCT00905606|515694015|FG001|Period 1|Adverse Event|1|||
143042043|NCT00905606|515694014|FG000|Washout|Withdrawal by Subject|1|||
143042044|NCT00905606|515694015|FG001|Washout|Withdrawal by Subject|0|||
143042045|NCT00804856|515694018|FG000|Overall Study|Progressive Disease|3|||
143042046|NCT00804856|515694019|FG001|Overall Study|Progressive Disease|2|||
143042047|NCT00804856|515694020|FG002|Overall Study|Progressive Disease|4|||
143042048|NCT00804856|515694021|FG003|Overall Study|Progressive Disease|6|||
143042049|NCT00804856|515694022|FG004|Overall Study|Progressive Disease|4|||
143498193|NCT05195528|517366284|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
143498194|NCT05195528|517366285|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
143498195|NCT05195528|517366286|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
143498196|NCT05195528|517366287|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
143042050|NCT00804856|515694023|FG005|Overall Study|Progressive Disease|1|||
143164774|NCT04082364|516150133|FG002|Overall Study|Death|1|||
143164775|NCT04082364|516150134|FG003|Overall Study|Death|2|||
143164776|NCT04082364|516150135|FG004|Overall Study|Death|1|||
143164777|NCT04082364|516150131|FG000|Overall Study|Lost to Follow-up|1|||
143164778|NCT04082364|516150132|FG001|Overall Study|Lost to Follow-up|0|||
143164779|NCT04082364|516150133|FG002|Overall Study|Lost to Follow-up|0|||
143164780|NCT04082364|516150134|FG003|Overall Study|Lost to Follow-up|0|||
143164781|NCT04082364|516150135|FG004|Overall Study|Lost to Follow-up|1|||
143042051|NCT00804856|515694024|FG006|Overall Study|Progressive Disease|8|||
143042052|NCT00804856|515694025|FG007|Overall Study|Progressive Disease|2|||
143164782|NCT04082364|516150131|FG000|Overall Study|Physician Decision|1|||
143042053|NCT00804856|515694026|FG008|Overall Study|Progressive Disease|4|||
143042054|NCT00804856|515694027|FG009|Overall Study|Progressive Disease|5|||
143164783|NCT04082364|516150132|FG001|Overall Study|Physician Decision|1|||
143164784|NCT04082364|516150133|FG002|Overall Study|Physician Decision|0|||
143164785|NCT04082364|516150134|FG003|Overall Study|Physician Decision|2|||
143164786|NCT04082364|516150135|FG004|Overall Study|Physician Decision|1|||
143164787|NCT04082364|516150131|FG000|Overall Study|Withdrawal by Subject|1|||
143164788|NCT04082364|516150132|FG001|Overall Study|Withdrawal by Subject|1|||
143164789|NCT04082364|516150133|FG002|Overall Study|Withdrawal by Subject|0|||
143042055|NCT00804856|515694028|FG010|Overall Study|Progressive Disease|12|||
143042056|NCT00804856|515694029|FG011|Overall Study|Progressive Disease|2|||
143042057|NCT00804856|515694030|FG012|Overall Study|Progressive Disease|2|||
143042058|NCT00804856|515694031|FG013|Overall Study|Progressive Disease|26|||
143042059|NCT00804856|515694032|FG014|Overall Study|Progressive Disease|20|||
143042060|NCT00804856|515694018|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
143042061|NCT00804856|515694019|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
143042062|NCT00804856|515694020|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
143042063|NCT00804856|515694021|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
143042064|NCT00804856|515694022|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
143042065|NCT00804856|515694023|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
143042066|NCT00804856|515694024|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
143042067|NCT00804856|515694025|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
143042068|NCT00804856|515694026|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
143042069|NCT00804856|515694027|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
143164790|NCT04082364|516150134|FG003|Overall Study|Withdrawal by Subject|0|||
143164791|NCT04082364|516150135|FG004|Overall Study|Withdrawal by Subject|1|||
143164792|NCT04082364|516150131|FG000|Overall Study|Follow-up terminated by Sponsor|5|||
143164793|NCT04082364|516150132|FG001|Overall Study|Follow-up terminated by Sponsor|0|||
143164794|NCT04082364|516150133|FG002|Overall Study|Follow-up terminated by Sponsor|2|||
143498197|NCT05195528|517366288|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
143240518|NCT00684021|516431997|FG003|Overall Study|Death|0|||
143498198|NCT05195528|517366284|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
143498199|NCT05195528|517366285|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
143498200|NCT05195528|517366286|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
143498201|NCT05195528|517366287|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
143498202|NCT05195528|517366288|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
143498203|NCT05195528|517366284|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
143498204|NCT05195528|517366285|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
143498205|NCT05195528|517366286|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
143498206|NCT05195528|517366287|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
143498207|NCT05195528|517366288|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
143498208|NCT05195528|517366284|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
143498209|NCT05195528|517366285|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
143498210|NCT05195528|517366286|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
143498211|NCT05195528|517366287|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
143498212|NCT05195528|517366288|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
143498213|NCT05195528|517366284|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
143498214|NCT05195528|517366285|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
143498215|NCT05195528|517366286|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
143498216|NCT05195528|517366287|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
143498217|NCT05195528|517366288|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
143498218|NCT05195528|517366284|FG000|Placebo-controlled Treatment Period|Other|0|||
143498219|NCT05195528|517366285|FG001|Placebo-controlled Treatment Period|Other|0|||
143498220|NCT05195528|517366286|FG002|Placebo-controlled Treatment Period|Other|1|||
143498221|NCT05195528|517366287|FG003|Placebo-controlled Treatment Period|Other|0|||
143498222|NCT05195528|517366288|FG004|Placebo-controlled Treatment Period|Other|0|||
143498223|NCT05195528|517366284|FG000|Extension Period|PTE or AE or SAE|0|||
143498224|NCT05195528|517366285|FG001|Extension Period|PTE or AE or SAE|4|||
143498225|NCT05195528|517366286|FG002|Extension Period|PTE or AE or SAE|5|||
143498226|NCT05195528|517366287|FG003|Extension Period|PTE or AE or SAE|4|||
143498227|NCT05195528|517366288|FG004|Extension Period|PTE or AE or SAE|4|||
143498228|NCT05195528|517366284|FG000|Extension Period|Protocol Violation|0|||
143498229|NCT05195528|517366285|FG001|Extension Period|Protocol Violation|2|||
143498230|NCT05195528|517366286|FG002|Extension Period|Protocol Violation|1|||
143498231|NCT05195528|517366287|FG003|Extension Period|Protocol Violation|0|||
143498232|NCT05195528|517366288|FG004|Extension Period|Protocol Violation|1|||
143498233|NCT05195528|517366284|FG000|Extension Period|Lost to Follow-up|0|||
143498234|NCT05195528|517366285|FG001|Extension Period|Lost to Follow-up|6|||
143498235|NCT05195528|517366286|FG002|Extension Period|Lost to Follow-up|13|||
143498236|NCT05195528|517366287|FG003|Extension Period|Lost to Follow-up|3|||
143498237|NCT05195528|517366288|FG004|Extension Period|Lost to Follow-up|7|||
143498238|NCT05195528|517366284|FG000|Extension Period|Withdrawal by Subject|0|||
143498239|NCT05195528|517366285|FG001|Extension Period|Withdrawal by Subject|12|||
143498240|NCT05195528|517366286|FG002|Extension Period|Withdrawal by Subject|9|||
143498241|NCT05195528|517366287|FG003|Extension Period|Withdrawal by Subject|6|||
143498242|NCT05195528|517366288|FG004|Extension Period|Withdrawal by Subject|5|||
143498243|NCT05195528|517366284|FG000|Extension Period|Lack of Efficacy|0|||
143498244|NCT05195528|517366285|FG001|Extension Period|Lack of Efficacy|3|||
143498245|NCT05195528|517366286|FG002|Extension Period|Lack of Efficacy|0|||
143498246|NCT05195528|517366287|FG003|Extension Period|Lack of Efficacy|0|||
143498247|NCT05195528|517366288|FG004|Extension Period|Lack of Efficacy|2|||
143042070|NCT00804856|515694028|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
143042071|NCT00804856|515694029|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
143042072|NCT00804856|515694030|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
143042073|NCT00804856|515694031|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
143042074|NCT00804856|515694032|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
143042075|NCT00804856|515694018|FG000|Overall Study|Other Adverse Event|1|||
143042076|NCT00804856|515694019|FG001|Overall Study|Other Adverse Event|1|||
143042077|NCT00804856|515694020|FG002|Overall Study|Other Adverse Event|1|||
143042078|NCT00804856|515694021|FG003|Overall Study|Other Adverse Event|2|||
143042079|NCT00804856|515694022|FG004|Overall Study|Other Adverse Event|2|||
143042080|NCT00804856|515694023|FG005|Overall Study|Other Adverse Event|1|||
143042081|NCT00804856|515694024|FG006|Overall Study|Other Adverse Event|3|||
143042082|NCT00804856|515694025|FG007|Overall Study|Other Adverse Event|0|||
143498248|NCT05195528|517366284|FG000|Extension Period|Not Treated|0|||
143042083|NCT00804856|515694026|FG008|Overall Study|Other Adverse Event|0|||
143042084|NCT00804856|515694027|FG009|Overall Study|Other Adverse Event|1|||
143042085|NCT00804856|515694028|FG010|Overall Study|Other Adverse Event|5|||
143042086|NCT00804856|515694029|FG011|Overall Study|Other Adverse Event|2|||
143042087|NCT00804856|515694030|FG012|Overall Study|Other Adverse Event|0|||
143042088|NCT00804856|515694031|FG013|Overall Study|Other Adverse Event|6|||
143042089|NCT00804856|515694032|FG014|Overall Study|Other Adverse Event|13|||
143042090|NCT00804856|515694018|FG000|Overall Study|Non compliance with protocol|0|||
143042091|NCT00804856|515694019|FG001|Overall Study|Non compliance with protocol|0|||
143042092|NCT00804856|515694020|FG002|Overall Study|Non compliance with protocol|0|||
143042093|NCT00804856|515694021|FG003|Overall Study|Non compliance with protocol|0|||
143042094|NCT00804856|515694022|FG004|Overall Study|Non compliance with protocol|0|||
143042095|NCT00804856|515694023|FG005|Overall Study|Non compliance with protocol|0|||
143042096|NCT00804856|515694024|FG006|Overall Study|Non compliance with protocol|0|||
143042097|NCT00804856|515694025|FG007|Overall Study|Non compliance with protocol|0|||
143042098|NCT00804856|515694026|FG008|Overall Study|Non compliance with protocol|0|||
143042099|NCT00804856|515694027|FG009|Overall Study|Non compliance with protocol|0|||
143042100|NCT00804856|515694028|FG010|Overall Study|Non compliance with protocol|0|||
143042101|NCT00804856|515694029|FG011|Overall Study|Non compliance with protocol|0|||
143042102|NCT00804856|515694030|FG012|Overall Study|Non compliance with protocol|0|||
143042103|NCT00804856|515694031|FG013|Overall Study|Non compliance with protocol|2|||
143042104|NCT00804856|515694032|FG014|Overall Study|Non compliance with protocol|0|||
143042105|NCT00804856|515694018|FG000|Overall Study|Refused to continue medication|0|||
143042106|NCT00804856|515694019|FG001|Overall Study|Refused to continue medication|0|||
143042107|NCT00804856|515694020|FG002|Overall Study|Refused to continue medication|0|||
143042108|NCT00804856|515694021|FG003|Overall Study|Refused to continue medication|1|||
143042109|NCT00804856|515694022|FG004|Overall Study|Refused to continue medication|1|||
143042110|NCT00804856|515694023|FG005|Overall Study|Refused to continue medication|0|||
143042111|NCT00804856|515694024|FG006|Overall Study|Refused to continue medication|0|||
143042112|NCT00804856|515694025|FG007|Overall Study|Refused to continue medication|0|||
143042113|NCT00804856|515694026|FG008|Overall Study|Refused to continue medication|0|||
143042114|NCT00804856|515694027|FG009|Overall Study|Refused to continue medication|0|||
143042115|NCT00804856|515694028|FG010|Overall Study|Refused to continue medication|3|||
143042116|NCT00804856|515694029|FG011|Overall Study|Refused to continue medication|0|||
143042117|NCT00804856|515694030|FG012|Overall Study|Refused to continue medication|1|||
143042118|NCT00804856|515694031|FG013|Overall Study|Refused to continue medication|1|||
143042119|NCT00804856|515694032|FG014|Overall Study|Refused to continue medication|5|||
143042120|NCT00804856|515694018|FG000|Overall Study|Other reason than listed above|0|||
143042121|NCT00804856|515694019|FG001|Overall Study|Other reason than listed above|0|||
143042122|NCT00804856|515694020|FG002|Overall Study|Other reason than listed above|0|||
143042123|NCT00804856|515694021|FG003|Overall Study|Other reason than listed above|0|||
143164795|NCT04082364|516150134|FG003|Overall Study|Follow-up terminated by Sponsor|3|||
143164796|NCT04082364|516150135|FG004|Overall Study|Follow-up terminated by Sponsor|2|||
143164797|NCT04082364|516150131|FG000|Overall Study|Disease progression|0|||
143164798|NCT04082364|516150132|FG001|Overall Study|Disease progression|0|||
143164799|NCT04082364|516150133|FG002|Overall Study|Disease progression|0|||
143164800|NCT04082364|516150134|FG003|Overall Study|Disease progression|1|||
143498249|NCT05195528|517366285|FG001|Extension Period|Not Treated|0|||
143042124|NCT00804856|515694022|FG004|Overall Study|Other reason than listed above|0|||
143042125|NCT00804856|515694023|FG005|Overall Study|Other reason than listed above|1|||
143042126|NCT00804856|515694024|FG006|Overall Study|Other reason than listed above|0|||
143042127|NCT00804856|515694025|FG007|Overall Study|Other reason than listed above|0|||
143042128|NCT00804856|515694026|FG008|Overall Study|Other reason than listed above|1|||
143042129|NCT00804856|515694027|FG009|Overall Study|Other reason than listed above|0|||
143042130|NCT00804856|515694028|FG010|Overall Study|Other reason than listed above|3|||
143042131|NCT00804856|515694029|FG011|Overall Study|Other reason than listed above|1|||
143164801|NCT04082364|516150135|FG004|Overall Study|Disease progression|0|||
143164802|NCT03186378|516150136|FG000|Overall Study|Lost to Follow-up|1|||
143164803|NCT03186378|516150137|FG001|Overall Study|Lost to Follow-up|0|||
143042132|NCT00804856|515694030|FG012|Overall Study|Other reason than listed above|1|||
143042133|NCT00804856|515694031|FG013|Overall Study|Other reason than listed above|10|||
143042134|NCT00804856|515694032|FG014|Overall Study|Other reason than listed above|3|||
143042135|NCT03247972|515694038|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
143042136|NCT03247972|515694038|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
143042137|NCT00448591|515694039|FG000|Overall Study|Withdrawal by Subject|178|||
143042138|NCT00448591|515694039|FG000|Overall Study|Progressive Disease|1382|||
143042139|NCT00448591|515694039|FG000|Overall Study|Adverse Event|382|||
143042140|NCT00448591|515694039|FG000|Overall Study|Protocol Violation|41|||
143042141|NCT00448591|515694039|FG000|Overall Study|Lost to Follow-up|19|||
143498250|NCT05195528|517366286|FG002|Extension Period|Not Treated|2|||
143498251|NCT05195528|517366287|FG003|Extension Period|Not Treated|3|||
143042142|NCT00448591|515694039|FG000|Overall Study|Treatment Regimen Completed|70|||
143042143|NCT00448591|515694039|FG000|Overall Study|Other|154|||
143042144|NCT00448591|515694039|FG000|Overall Study|Termination of Study|70|||
143042145|NCT01518972|515694043|FG000|Overall Study|Lost to Follow-up|2|||
143042146|NCT01518972|515694044|FG001|Overall Study|Lost to Follow-up|1|||
143042147|NCT01518972|515694043|FG000|Overall Study|Withdrawal by Subject|1|||
143042148|NCT01518972|515694044|FG001|Overall Study|Withdrawal by Subject|0|||
143042149|NCT01518972|515694043|FG000|Overall Study|Moved from area|1|||
143042150|NCT01518972|515694044|FG001|Overall Study|Moved from area|0|||
143042151|NCT01518972|515694043|FG000|Overall Study|Transportation problems|1|||
143042152|NCT01518972|515694044|FG001|Overall Study|Transportation problems|0|||
143042153|NCT01518972|515694043|FG000|Overall Study|Exclusionary medical condition|1|||
143042154|NCT01518972|515694044|FG001|Overall Study|Exclusionary medical condition|0|||
143042155|NCT01518972|515694043|FG000|Overall Study|Missed safety visits|0|||
143042156|NCT01518972|515694044|FG001|Overall Study|Missed safety visits|1|||
143042157|NCT01518972|515694043|FG000|Overall Study|Exclusionary medication|0|||
143042158|NCT01518972|515694044|FG001|Overall Study|Exclusionary medication|1|||
143042159|NCT01518972|515694043|FG000|Overall Study|Declined medication starting on day 12|0|||
143042160|NCT01518972|515694044|FG001|Overall Study|Declined medication starting on day 12|1|||
143042161|NCT05446870|515694045|FG000|Overall Study|Death|6|||
143042162|NCT05446870|515694046|FG001|Overall Study|Death|5|||
143042163|NCT05446870|515694045|FG000|Overall Study|Lost to Follow-up|0|||
143042164|NCT05446870|515694046|FG001|Overall Study|Lost to Follow-up|1|||
143042165|NCT05446870|515694045|FG000|Overall Study|Physician Decision|52|||
143042166|NCT05446870|515694046|FG001|Overall Study|Physician Decision|53|||
143042167|NCT05446870|515694045|FG000|Overall Study|Withdrawal by Subject|3|||
143042168|NCT05446870|515694046|FG001|Overall Study|Withdrawal by Subject|3|||
143042169|NCT04108858|515694048|FG000|Overall Study|Adverse Event|1|||
143042170|NCT00359281|515694051|FG000|Overall Study|Adverse Event|1|||
143042171|NCT00359281|515694052|FG001|Overall Study|Adverse Event|0|||
143042172|NCT00359281|515694053|FG002|Overall Study|Adverse Event|0|||
143042173|NCT00359281|515694054|FG003|Overall Study|Adverse Event|0|||
143042174|NCT00359281|515694055|FG004|Overall Study|Adverse Event|0|||
143042175|NCT00359281|515694056|FG005|Overall Study|Adverse Event|0|||
143042176|NCT00359281|515694057|FG006|Overall Study|Adverse Event|1|||
143042177|NCT00359281|515694058|FG007|Overall Study|Adverse Event|0|||
143042178|NCT00359281|515694059|FG008|Overall Study|Adverse Event|0|||
143042179|NCT00359281|515694051|FG000|Overall Study|Withdrawal by Subject|0|||
143042180|NCT00359281|515694052|FG001|Overall Study|Withdrawal by Subject|0|||
143042181|NCT00359281|515694053|FG002|Overall Study|Withdrawal by Subject|0|||
143042182|NCT00359281|515694054|FG003|Overall Study|Withdrawal by Subject|0|||
143042183|NCT00359281|515694055|FG004|Overall Study|Withdrawal by Subject|0|||
143042184|NCT00359281|515694056|FG005|Overall Study|Withdrawal by Subject|0|||
143042185|NCT00359281|515694057|FG006|Overall Study|Withdrawal by Subject|1|||
143240519|NCT00724698|516431998|FG000|Overall Study|Adverse Event|9|||
143498252|NCT05195528|517366288|FG004|Extension Period|Not Treated|0|||
143498253|NCT05195528|517366284|FG000|Extension Period|Other|0|||
143498254|NCT05195528|517366285|FG001|Extension Period|Other|1|||
143498255|NCT05195528|517366286|FG002|Extension Period|Other|1|||
143498256|NCT05195528|517366287|FG003|Extension Period|Other|0|||
143042186|NCT00359281|515694058|FG007|Overall Study|Withdrawal by Subject|0|||
143042187|NCT00359281|515694059|FG008|Overall Study|Withdrawal by Subject|0|||
143042188|NCT01218867|515694070|FG000|Overall Study|Death during treatment|0|||
143042189|NCT01218867|515694071|FG001|Overall Study|Death during treatment|0|||
143042190|NCT01218867|515694072|FG002|Overall Study|Death during treatment|0|||
143042191|NCT01218867|515694073|FG003|Overall Study|Death during treatment|0|||
143042192|NCT01218867|515694074|FG004|Overall Study|Death during treatment|0|||
143042193|NCT01218867|515694075|FG005|Overall Study|Death during treatment|0|||
143042194|NCT01218867|515694076|FG006|Overall Study|Death during treatment|1|||
143042195|NCT01218867|515694077|FG007|Overall Study|Death during treatment|0|||
143042196|NCT01218867|515694078|FG008|Overall Study|Death during treatment|0|||
143042197|NCT01218867|515694079|FG009|Overall Study|Death during treatment|0|||
143042198|NCT01218867|515694080|FG010|Overall Study|Death during treatment|0|||
143042199|NCT04419311|515694083|FG000|Overall Study|Lost to Follow-up|1|||
143498257|NCT05195528|517366288|FG004|Extension Period|Other|0|||
143042200|NCT04419311|515694084|FG001|Overall Study|Lost to Follow-up|0|||
143042201|NCT00657553|515694085|FG000|Overall Study|low accrual, no analysis run|5|||
143042202|NCT00657553|515694086|FG001|Overall Study|low accrual, no analysis run|5|||
143042203|NCT01169558|515694087|FG000|Overall Study|Disease progression|98|||
143042204|NCT01169558|515694087|FG000|Overall Study|Adverse Event|25|||
143042205|NCT01169558|515694087|FG000|Overall Study|Withdrawal of Consent|8|||
143042206|NCT01169558|515694087|FG000|Overall Study|Medical Decision|7|||
143042207|NCT01169558|515694087|FG000|Overall Study|Stable Disease|4|||
143042208|NCT01169558|515694087|FG000|Overall Study|Lost to Follow-up|4|||
143042209|NCT01169558|515694087|FG000|Overall Study|Need for Surgery|4|||
143042210|NCT01169558|515694087|FG000|Overall Study|Non-compliance|2|||
143042211|NCT01169558|515694087|FG000|Overall Study|Protocol Violation|2|||
143042212|NCT01169558|515694087|FG000|Overall Study|Partial response|2|||
143042213|NCT00838539|515694088|FG000|Overall Study|Disease Progression|2|||
143042214|NCT00838539|515694089|FG001|Overall Study|Disease Progression|4|||
143042215|NCT00838539|515694090|FG002|Overall Study|Disease Progression|3|||
143042216|NCT00838539|515694091|FG003|Overall Study|Disease Progression|2|||
143042217|NCT00838539|515694092|FG004|Overall Study|Disease Progression|4|||
143042218|NCT00838539|515694093|FG005|Overall Study|Disease Progression|2|||
143042219|NCT00838539|515694094|FG006|Overall Study|Disease Progression|3|||
143042220|NCT00838539|515694095|FG007|Overall Study|Disease Progression|4|||
143042221|NCT00838539|515694096|FG008|Overall Study|Disease Progression|4|||
143042222|NCT00838539|515694097|FG009|Overall Study|Disease Progression|5|||
143042223|NCT00838539|515694098|FG010|Overall Study|Disease Progression|1|||
143042224|NCT00838539|515694099|FG011|Overall Study|Disease Progression|4|||
143042225|NCT00838539|515694088|FG000|Overall Study|Adverse Event|1|||
143042226|NCT00838539|515694089|FG001|Overall Study|Adverse Event|1|||
143042227|NCT00838539|515694090|FG002|Overall Study|Adverse Event|1|||
143042228|NCT00838539|515694091|FG003|Overall Study|Adverse Event|1|||
143042229|NCT00838539|515694092|FG004|Overall Study|Adverse Event|2|||
143042230|NCT00838539|515694093|FG005|Overall Study|Adverse Event|1|||
143042231|NCT00838539|515694094|FG006|Overall Study|Adverse Event|0|||
143042232|NCT00838539|515694095|FG007|Overall Study|Adverse Event|2|||
143042233|NCT00838539|515694096|FG008|Overall Study|Adverse Event|0|||
143042234|NCT00838539|515694097|FG009|Overall Study|Adverse Event|1|||
143042235|NCT00838539|515694098|FG010|Overall Study|Adverse Event|2|||
143042236|NCT00838539|515694099|FG011|Overall Study|Adverse Event|0|||
143042237|NCT00838539|515694088|FG000|Overall Study|Withdrawal by Subject|0|||
143042238|NCT00838539|515694089|FG001|Overall Study|Withdrawal by Subject|1|||
143042239|NCT00838539|515694090|FG002|Overall Study|Withdrawal by Subject|0|||
143042240|NCT00838539|515694091|FG003|Overall Study|Withdrawal by Subject|0|||
143042241|NCT00838539|515694092|FG004|Overall Study|Withdrawal by Subject|0|||
143042242|NCT00838539|515694093|FG005|Overall Study|Withdrawal by Subject|0|||
143042243|NCT00838539|515694094|FG006|Overall Study|Withdrawal by Subject|0|||
143042244|NCT00838539|515694095|FG007|Overall Study|Withdrawal by Subject|0|||
143042245|NCT00838539|515694096|FG008|Overall Study|Withdrawal by Subject|0|||
143042246|NCT00838539|515694097|FG009|Overall Study|Withdrawal by Subject|1|||
143042247|NCT00838539|515694098|FG010|Overall Study|Withdrawal by Subject|2|||
143042248|NCT00838539|515694099|FG011|Overall Study|Withdrawal by Subject|0|||
143042249|NCT00838539|515694088|FG000|Overall Study|Death|0|||
143042250|NCT00838539|515694089|FG001|Overall Study|Death|0|||
143042251|NCT00838539|515694090|FG002|Overall Study|Death|0|||
143042252|NCT00838539|515694091|FG003|Overall Study|Death|0|||
143042253|NCT00838539|515694092|FG004|Overall Study|Death|0|||
143042254|NCT00838539|515694093|FG005|Overall Study|Death|0|||
143042255|NCT00838539|515694094|FG006|Overall Study|Death|1|||
143042256|NCT00838539|515694095|FG007|Overall Study|Death|0|||
143164804|NCT02514746|516150138|FG000|Overall Study|Chronically Ill|1|||
143164805|NCT02514746|516150139|FG001|Overall Study|Chronically Ill|2|||
143164806|NCT02514746|516150138|FG000|Overall Study|Physician Decision|4|||
143164807|NCT02514746|516150139|FG001|Overall Study|Physician Decision|2|||
143164808|NCT02514746|516150138|FG000|Overall Study|Withdrawal by Subject|12|||
143042257|NCT00838539|515694096|FG008|Overall Study|Death|0|||
143164809|NCT02514746|516150139|FG001|Overall Study|Withdrawal by Subject|10|||
143164810|NCT02514746|516150138|FG000|Overall Study|Other|5|||
143164811|NCT02514746|516150139|FG001|Overall Study|Other|1|||
143164812|NCT04042311|516150140|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
143240520|NCT00724698|516431998|FG000|Overall Study|Failure of Therapy|4|||
143240521|NCT00724698|516431998|FG000|Overall Study|Poor Compliance|16|||
143042258|NCT00838539|515694097|FG009|Overall Study|Death|0|||
143164813|NCT04042311|516150140|FG000|Overall Study|Unable to tolerate|4|||
143042259|NCT00838539|515694098|FG010|Overall Study|Death|0|||
143042260|NCT00838539|515694099|FG011|Overall Study|Death|0|||
143042261|NCT00838539|515694088|FG000|Overall Study|Physician Decision|0|||
143042262|NCT00838539|515694089|FG001|Overall Study|Physician Decision|0|||
143042263|NCT00838539|515694090|FG002|Overall Study|Physician Decision|0|||
143042264|NCT00838539|515694091|FG003|Overall Study|Physician Decision|0|||
143042265|NCT00838539|515694092|FG004|Overall Study|Physician Decision|0|||
143042266|NCT00838539|515694093|FG005|Overall Study|Physician Decision|0|||
143042267|NCT00838539|515694094|FG006|Overall Study|Physician Decision|0|||
143042268|NCT00838539|515694095|FG007|Overall Study|Physician Decision|0|||
143042269|NCT00838539|515694096|FG008|Overall Study|Physician Decision|1|||
143042270|NCT00838539|515694097|FG009|Overall Study|Physician Decision|0|||
143042271|NCT00838539|515694098|FG010|Overall Study|Physician Decision|0|||
143042272|NCT00838539|515694099|FG011|Overall Study|Physician Decision|0|||
143042273|NCT00838539|515694088|FG000|Overall Study|Clinical Progression|0|||
143042274|NCT00838539|515694089|FG001|Overall Study|Clinical Progression|0|||
143042275|NCT00838539|515694090|FG002|Overall Study|Clinical Progression|0|||
143042276|NCT00838539|515694091|FG003|Overall Study|Clinical Progression|0|||
143042277|NCT00838539|515694092|FG004|Overall Study|Clinical Progression|0|||
143042278|NCT00838539|515694093|FG005|Overall Study|Clinical Progression|0|||
143042279|NCT00838539|515694094|FG006|Overall Study|Clinical Progression|1|||
143042280|NCT00838539|515694095|FG007|Overall Study|Clinical Progression|0|||
143042281|NCT00838539|515694096|FG008|Overall Study|Clinical Progression|0|||
143042282|NCT00838539|515694097|FG009|Overall Study|Clinical Progression|0|||
143042283|NCT00838539|515694098|FG010|Overall Study|Clinical Progression|0|||
143042284|NCT00838539|515694099|FG011|Overall Study|Clinical Progression|0|||
143042285|NCT00838539|515694088|FG000|Overall Study|Symptomatic Deterioration|0|||
143042286|NCT00838539|515694089|FG001|Overall Study|Symptomatic Deterioration|0|||
143042287|NCT00838539|515694090|FG002|Overall Study|Symptomatic Deterioration|1|||
143164814|NCT04042311|516150140|FG000|Overall Study|Concurrent illness|2|||
143164815|NCT04042311|516150140|FG000|Overall Study|Adverse Event|2|||
143164816|NCT04042311|516150140|FG000|Overall Study|No longer meeting inclusion criteria|2|||
143164817|NCT04042311|516150140|FG000|Overall Study|No reason given|1|||
143164818|NCT04042311|516150140|FG000|Overall Study|Withdrawal by Subject|4|||
143164819|NCT05021224|516150141|FG000|Overall Study|Did not complete all survey items|4|||
143164820|NCT05021224|516150142|FG001|Overall Study|Did not complete all survey items|1|||
143164821|NCT05021224|516150143|FG002|Overall Study|Did not complete all survey items|0|||
143164822|NCT05021224|516150144|FG003|Overall Study|Did not complete all survey items|2|||
143164823|NCT05375929|516150145|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
143164824|NCT05375929|516150146|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
143164825|NCT05375929|516150147|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
143164826|NCT05375929|516150148|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
143164827|NCT05375929|516150145|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
143164828|NCT05375929|516150146|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
143164829|NCT05375929|516150147|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
143164830|NCT05375929|516150148|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
143164831|NCT05375929|516150145|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
143164832|NCT05375929|516150146|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
143164833|NCT05375929|516150147|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
143164834|NCT05375929|516150148|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
143164835|NCT05375929|516150145|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
143164836|NCT05375929|516150146|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
143164837|NCT05375929|516150147|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
143164838|NCT05375929|516150148|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
143164839|NCT05375929|516150145|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
143164840|NCT05375929|516150146|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
143164841|NCT05375929|516150147|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
143164842|NCT05375929|516150148|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
143164843|NCT05375929|516150145|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
143164844|NCT05375929|516150146|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
143164845|NCT05375929|516150147|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
143164846|NCT05375929|516150148|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
143164847|NCT05375929|516150145|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
143164848|NCT05375929|516150146|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
143164849|NCT05375929|516150147|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
143164850|NCT05375929|516150148|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
143164851|NCT05375929|516150145|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
143164852|NCT05375929|516150146|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
143164853|NCT05375929|516150147|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
143164854|NCT05375929|516150148|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
143164855|NCT05375929|516150145|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
143164856|NCT05375929|516150146|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
143164857|NCT05375929|516150147|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
143364243|NCT01304706|516876931|FG000|Overall Study|Adverse Event|2|||
143042288|NCT00838539|515694091|FG003|Overall Study|Symptomatic Deterioration|1|||
143042289|NCT00838539|515694092|FG004|Overall Study|Symptomatic Deterioration|0|||
143042290|NCT00838539|515694093|FG005|Overall Study|Symptomatic Deterioration|1|||
143042291|NCT00838539|515694094|FG006|Overall Study|Symptomatic Deterioration|0|||
143042292|NCT00838539|515694095|FG007|Overall Study|Symptomatic Deterioration|0|||
143042293|NCT00838539|515694096|FG008|Overall Study|Symptomatic Deterioration|0|||
143042294|NCT00838539|515694097|FG009|Overall Study|Symptomatic Deterioration|1|||
143042295|NCT00838539|515694098|FG010|Overall Study|Symptomatic Deterioration|0|||
143042296|NCT00838539|515694099|FG011|Overall Study|Symptomatic Deterioration|0|||
143042297|NCT05323396|515694100|FG000|Overall Study|Lost to Follow-up|1|||
143042298|NCT05323396|515694101|FG001|Overall Study|Lost to Follow-up|35|||
143042299|NCT05323396|515694100|FG000|Overall Study|Pregnancy|1|||
143042300|NCT05323396|515694101|FG001|Overall Study|Pregnancy|0|||
143042301|NCT01110005|515694102|FG000|Overall Study|ineligible|1|||
143042302|NCT01110005|515694103|FG001|Overall Study|ineligible|2|||
143042303|NCT01110005|515694102|FG000|Overall Study|missing consent|3|||
143042304|NCT01110005|515694103|FG001|Overall Study|missing consent|2|||
143042305|NCT01110005|515694102|FG000|Overall Study|Withdrawal by Subject|0|||
143042306|NCT01110005|515694103|FG001|Overall Study|Withdrawal by Subject|1|||
143042307|NCT02658084|515694108|FG000|Overall Study|Withdrawal by Subject|1|||
143042308|NCT02658084|515694109|FG001|Overall Study|Withdrawal by Subject|0|||
143042309|NCT02658084|515694108|FG000|Overall Study|Study Termination|1|||
143042310|NCT02658084|515694109|FG001|Overall Study|Study Termination|0|||
143042311|NCT03290781|515694111|FG000|Overall Study|Adverse Event|5|||
143042312|NCT03290781|515694112|FG001|Overall Study|Adverse Event|7|||
143042313|NCT03290781|515694113|FG002|Overall Study|Adverse Event|4|||
143042314|NCT03290781|515694114|FG003|Overall Study|Adverse Event|1|||
143042315|NCT03290781|515694115|FG004|Overall Study|Adverse Event|0|||
143042316|NCT03290781|515694116|FG005|Overall Study|Adverse Event|0|||
143042317|NCT03290781|515694117|FG006|Overall Study|Adverse Event|0|||
143042318|NCT03290781|515694111|FG000|Overall Study|Death|0|||
143042319|NCT03290781|515694112|FG001|Overall Study|Death|0|||
143042320|NCT03290781|515694113|FG002|Overall Study|Death|1|||
143042321|NCT03290781|515694114|FG003|Overall Study|Death|0|||
143042322|NCT03290781|515694115|FG004|Overall Study|Death|1|||
143042323|NCT03290781|515694116|FG005|Overall Study|Death|0|||
143042324|NCT03290781|515694117|FG006|Overall Study|Death|0|||
143042325|NCT03290781|515694111|FG000|Overall Study|Withdrawal by Subject|6|||
143042326|NCT03290781|515694112|FG001|Overall Study|Withdrawal by Subject|5|||
143042327|NCT03290781|515694113|FG002|Overall Study|Withdrawal by Subject|9|||
143042328|NCT03290781|515694114|FG003|Overall Study|Withdrawal by Subject|10|||
143042329|NCT03290781|515694115|FG004|Overall Study|Withdrawal by Subject|1|||
143042330|NCT03290781|515694116|FG005|Overall Study|Withdrawal by Subject|2|||
143042331|NCT03290781|515694117|FG006|Overall Study|Withdrawal by Subject|0|||
143042332|NCT03290781|515694111|FG000|Overall Study|Physician Decision|0|||
143042333|NCT03290781|515694112|FG001|Overall Study|Physician Decision|1|||
143042334|NCT03290781|515694113|FG002|Overall Study|Physician Decision|0|||
143042335|NCT03290781|515694114|FG003|Overall Study|Physician Decision|0|||
143042336|NCT03290781|515694115|FG004|Overall Study|Physician Decision|0|||
143042337|NCT03290781|515694116|FG005|Overall Study|Physician Decision|0|||
143042338|NCT03290781|515694117|FG006|Overall Study|Physician Decision|0|||
143042339|NCT03290781|515694111|FG000|Overall Study|Site Terminated by Sponsor|1|||
143042340|NCT03290781|515694112|FG001|Overall Study|Site Terminated by Sponsor|0|||
143042341|NCT03290781|515694113|FG002|Overall Study|Site Terminated by Sponsor|2|||
143042342|NCT03290781|515694114|FG003|Overall Study|Site Terminated by Sponsor|1|||
143240522|NCT00724698|516431998|FG000|Overall Study|Lost to Follow-up|36|||
143240523|NCT00724698|516431998|FG000|Overall Study|No Info|25|||
143240524|NCT04041414|516431999|FG000|Overall Study|Lost to Follow-up|1|||
143240525|NCT04041414|516432000|FG001|Overall Study|Lost to Follow-up|2|||
143240526|NCT00734539|516432008|FG000|Main Study|Death|33|||
143240527|NCT00734539|516432009|FG001|Main Study|Death|32|||
143240528|NCT00734539|516432008|FG000|Main Study|Physician Decision|2|||
143240529|NCT00734539|516432009|FG001|Main Study|Physician Decision|0|||
143240530|NCT00734539|516432008|FG000|Main Study|Withdrawal by Subject|1|||
143240531|NCT00734539|516432009|FG001|Main Study|Withdrawal by Subject|3|||
143240532|NCT00734539|516432008|FG000|Main Study|Enrolled in error; ineligible|1|||
143240533|NCT00734539|516432009|FG001|Main Study|Enrolled in error; ineligible|0|||
143240534|NCT01454102|516432017|FG000|Overall Study|Continuing in the treatment period|0|||
143042343|NCT03290781|515694115|FG004|Overall Study|Site Terminated by Sponsor|0|||
143042344|NCT03290781|515694116|FG005|Overall Study|Site Terminated by Sponsor|0|||
143042345|NCT03290781|515694117|FG006|Overall Study|Site Terminated by Sponsor|0|||
143240535|NCT01454102|516432018|FG001|Overall Study|Continuing in the treatment period|0|||
143240536|NCT01454102|516432019|FG002|Overall Study|Continuing in the treatment period|0|||
143364244|NCT01304706|516876931|FG000|Overall Study|Lack of Efficacy|1|||
143042346|NCT03290781|515694111|FG000|Overall Study|Lost to Follow-up|0|||
143042347|NCT03290781|515694112|FG001|Overall Study|Lost to Follow-up|0|||
143042348|NCT03290781|515694113|FG002|Overall Study|Lost to Follow-up|0|||
143042349|NCT03290781|515694114|FG003|Overall Study|Lost to Follow-up|1|||
143042350|NCT03290781|515694115|FG004|Overall Study|Lost to Follow-up|0|||
143042351|NCT03290781|515694116|FG005|Overall Study|Lost to Follow-up|0|||
143042352|NCT03290781|515694117|FG006|Overall Study|Lost to Follow-up|0|||
143042353|NCT03290781|515694111|FG000|Overall Study|Protocol Deviation|2|||
143240537|NCT01454102|516432020|FG003|Overall Study|Continuing in the treatment period|0|||
143240538|NCT01454102|516432021|FG004|Overall Study|Continuing in the treatment period|3|||
143042354|NCT03290781|515694112|FG001|Overall Study|Protocol Deviation|0|||
143042355|NCT03290781|515694113|FG002|Overall Study|Protocol Deviation|0|||
143042356|NCT03290781|515694114|FG003|Overall Study|Protocol Deviation|1|||
143042357|NCT03290781|515694115|FG004|Overall Study|Protocol Deviation|0|||
143042358|NCT03290781|515694116|FG005|Overall Study|Protocol Deviation|0|||
143042359|NCT03290781|515694117|FG006|Overall Study|Protocol Deviation|0|||
143042360|NCT03290781|515694111|FG000|Overall Study|Disease Relapse|32|||
143042361|NCT03290781|515694112|FG001|Overall Study|Disease Relapse|5|||
143042362|NCT03290781|515694113|FG002|Overall Study|Disease Relapse|38|||
143042363|NCT03290781|515694114|FG003|Overall Study|Disease Relapse|7|||
143042364|NCT03290781|515694115|FG004|Overall Study|Disease Relapse|3|||
143042365|NCT03290781|515694116|FG005|Overall Study|Disease Relapse|1|||
143042366|NCT03290781|515694117|FG006|Overall Study|Disease Relapse|4|||
143042367|NCT03290781|515694111|FG000|Overall Study|Other|3|||
143042368|NCT03290781|515694112|FG001|Overall Study|Other|0|||
143042369|NCT03290781|515694113|FG002|Overall Study|Other|2|||
143042370|NCT03290781|515694114|FG003|Overall Study|Other|2|||
143042371|NCT03290781|515694115|FG004|Overall Study|Other|0|||
143042372|NCT03290781|515694116|FG005|Overall Study|Other|0|||
143042373|NCT03290781|515694117|FG006|Overall Study|Other|0|||
143042374|NCT01588236|515694122|FG000|Overall Study|Adverse Event|5|||
143042375|NCT01588236|515694123|FG001|Overall Study|Adverse Event|4|||
143042376|NCT01588236|515694124|FG002|Overall Study|Adverse Event|1|||
143042377|NCT01588236|515694122|FG000|Overall Study|Lost to Follow-up|8|||
143042378|NCT01588236|515694123|FG001|Overall Study|Lost to Follow-up|13|||
143042379|NCT01588236|515694124|FG002|Overall Study|Lost to Follow-up|6|||
143042380|NCT01588236|515694122|FG000|Overall Study|Physician Decision|1|||
143042381|NCT01588236|515694123|FG001|Overall Study|Physician Decision|2|||
143042382|NCT01588236|515694124|FG002|Overall Study|Physician Decision|0|||
143042383|NCT01588236|515694122|FG000|Overall Study|Protocol Violation|0|||
143042384|NCT01588236|515694123|FG001|Overall Study|Protocol Violation|1|||
143042385|NCT01588236|515694124|FG002|Overall Study|Protocol Violation|1|||
143042386|NCT01588236|515694122|FG000|Overall Study|Withdrawal by Subject|14|||
143042387|NCT01588236|515694123|FG001|Overall Study|Withdrawal by Subject|16|||
143042388|NCT01588236|515694124|FG002|Overall Study|Withdrawal by Subject|18|||
143042389|NCT01588236|515694122|FG000|Overall Study|Exclusion Criteria met during study|2|||
143042390|NCT01588236|515694123|FG001|Overall Study|Exclusion Criteria met during study|1|||
143042391|NCT01588236|515694124|FG002|Overall Study|Exclusion Criteria met during study|0|||
143042392|NCT01588236|515694122|FG000|Overall Study|sponsor decision|1|||
143042393|NCT01588236|515694123|FG001|Overall Study|sponsor decision|6|||
143042394|NCT01588236|515694124|FG002|Overall Study|sponsor decision|2|||
143042395|NCT00001703|515695493|FG000|Overall Study|progressed disease|2|||
143042396|NCT00001703|515695493|FG000|Overall Study|No evidence of disease|1|||
143042397|NCT00001703|515695493|FG000|Overall Study|recurrent disease|2|||
143042398|NCT03071575|515695494|FG000|Overall Study|Death|0|||
143042399|NCT03071575|515695495|FG001|Overall Study|Death|1|||
143042400|NCT03071575|515695494|FG000|Overall Study|Lost to Follow-up|5|||
143042401|NCT03071575|515695495|FG001|Overall Study|Lost to Follow-up|11|||
143042402|NCT03071575|515695494|FG000|Overall Study|Withdrawal by Subject|4|||
143042403|NCT03071575|515695495|FG001|Overall Study|Withdrawal by Subject|2|||
143042404|NCT00834795|515695496|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
143042405|NCT00834795|515695497|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
143042406|NCT00834795|515695496|FG000|Second Intervention|Adverse Event|1|||
143042407|NCT00834795|515695497|FG001|Second Intervention|Adverse Event|0|||
143042408|NCT00579345|515695498|FG000|Overall Study|Withdrawal by Subject|2|||
143042409|NCT00579345|515695499|FG001|Overall Study|Withdrawal by Subject|0|||
143042410|NCT00579345|515695500|FG002|Overall Study|Withdrawal by Subject|0|||
143042411|NCT00579345|515695501|FG003|Overall Study|Withdrawal by Subject|0|||
143042412|NCT00579345|515695502|FG004|Overall Study|Withdrawal by Subject|0|||
143042413|NCT00579345|515695503|FG005|Overall Study|Withdrawal by Subject|0|||
143042414|NCT00579345|515695504|FG006|Overall Study|Withdrawal by Subject|0|||
143042415|NCT00579345|515695505|FG007|Overall Study|Withdrawal by Subject|1|||
143240539|NCT01454102|516432022|FG005|Overall Study|Continuing in the treatment period|3|||
143240540|NCT01454102|516432023|FG006|Overall Study|Continuing in the treatment period|2|||
143042416|NCT00579345|515695498|FG000|Overall Study|Lost to Follow-up|1|||
143042417|NCT00579345|515695499|FG001|Overall Study|Lost to Follow-up|0|||
143042418|NCT00579345|515695500|FG002|Overall Study|Lost to Follow-up|0|||
143042419|NCT00579345|515695501|FG003|Overall Study|Lost to Follow-up|0|||
143042420|NCT00579345|515695502|FG004|Overall Study|Lost to Follow-up|0|||
143042421|NCT00579345|515695503|FG005|Overall Study|Lost to Follow-up|0|||
143042422|NCT00579345|515695504|FG006|Overall Study|Lost to Follow-up|0|||
143042423|NCT00579345|515695505|FG007|Overall Study|Lost to Follow-up|0|||
143042424|NCT00579345|515695498|FG000|Overall Study|Adverse Event|0|||
143042425|NCT00579345|515695499|FG001|Overall Study|Adverse Event|0|||
143042426|NCT00579345|515695500|FG002|Overall Study|Adverse Event|1|||
143042427|NCT00579345|515695501|FG003|Overall Study|Adverse Event|0|||
143042428|NCT00579345|515695502|FG004|Overall Study|Adverse Event|0|||
143042429|NCT00579345|515695503|FG005|Overall Study|Adverse Event|0|||
143042430|NCT00579345|515695504|FG006|Overall Study|Adverse Event|0|||
143042431|NCT00579345|515695505|FG007|Overall Study|Adverse Event|0|||
143042432|NCT00579345|515695498|FG000|Overall Study|Protocol Violation|1|||
143042433|NCT00579345|515695499|FG001|Overall Study|Protocol Violation|0|||
143042434|NCT00579345|515695500|FG002|Overall Study|Protocol Violation|0|||
143042435|NCT00579345|515695501|FG003|Overall Study|Protocol Violation|0|||
143042436|NCT00579345|515695502|FG004|Overall Study|Protocol Violation|0|||
143042437|NCT00579345|515695503|FG005|Overall Study|Protocol Violation|0|||
143042438|NCT00579345|515695504|FG006|Overall Study|Protocol Violation|0|||
143042439|NCT00579345|515695505|FG007|Overall Study|Protocol Violation|1|||
143042440|NCT00579345|515695498|FG000|Overall Study|Death|1|||
143042441|NCT00579345|515695499|FG001|Overall Study|Death|1|||
143042442|NCT00579345|515695500|FG002|Overall Study|Death|1|||
143042443|NCT00579345|515695501|FG003|Overall Study|Death|1|||
143042444|NCT00579345|515695502|FG004|Overall Study|Death|0|||
143042445|NCT00579345|515695503|FG005|Overall Study|Death|0|||
143042446|NCT00579345|515695504|FG006|Overall Study|Death|0|||
143042447|NCT00579345|515695505|FG007|Overall Study|Death|0|||
143042448|NCT03447353|515695509|FG000|Overall Study|Failure at Screening Visit|2|||
143042449|NCT03447353|515695509|FG000|Overall Study|Lost to Follow-up|4|||
143042450|NCT03447353|515695509|FG000|Overall Study|Scheduling Conflicts|3|||
143042451|NCT03447353|515695509|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
143042452|NCT01376037|515695510|FG000|Overall Study|Lost to Follow-up|0|||
143042453|NCT01376037|515695511|FG001|Overall Study|Lost to Follow-up|2|||
143042454|NCT01701674|515695512|FG000|Overall Study|Unable to safely complete treatment|1|||
143042455|NCT05604170|515695513|FG000|Overall Study|Lack of Efficacy|5|||
143042456|NCT05604170|515695513|FG000|Overall Study|Adverse Event|6|||
143042457|NCT05604170|515695513|FG000|Overall Study|Physician Decision|6|||
143042458|NCT05604170|515695513|FG000|Overall Study|Lost to Follow-up|6|||
143042459|NCT05604170|515695513|FG000|Overall Study|Withdrawal by Subject|11|||
143042460|NCT05604170|515695513|FG000|Overall Study|Early study termination by sponsor|77|||
143042461|NCT05604170|515695513|FG000|Overall Study|Other|6|||
143042462|NCT01111461|515695514|FG000|Overall Study|Adverse Event|32|||
143042463|NCT01111461|515695514|FG000|Overall Study|Participant choice|11|||
143042464|NCT01111461|515695514|FG000|Overall Study|Lost to Follow-up|1|||
143042465|NCT01111461|515695514|FG000|Overall Study|Withdrawal by Subject|1|||
143042466|NCT01111461|515695514|FG000|Overall Study|Other|6|||
143042467|NCT03635320|515695515|FG000|Overall Study|not implanted the device|1|||
143042468|NCT03635320|515695516|FG001|Overall Study|not implanted the device|2|||
143042469|NCT03635320|515695515|FG000|Overall Study|Withdrawal by Subject|11|||
143042470|NCT03635320|515695516|FG001|Overall Study|Withdrawal by Subject|6|||
143042471|NCT01558635|515695518|FG000|Overall Study|Death|1|||
143042472|NCT01558635|515695518|FG000|Overall Study|Withdrawal by Subject|2|||
143042473|NCT01558635|515695518|FG000|Overall Study|Physician Decision|1|||
143042474|NCT01558635|515695518|FG000|Overall Study|Subject received other treatment|1|||
143042475|NCT01558635|515695518|FG000|Overall Study|Reveal XT was explanted|1|||
143042476|NCT03868891|515695519|FG000|Overall Study|Adverse Event|1|||
143042477|NCT03868891|515695520|FG001|Overall Study|Adverse Event|0|||
143042478|NCT03868891|515695519|FG000|Overall Study|Lost to Follow-up|2|||
143042479|NCT03868891|515695520|FG001|Overall Study|Lost to Follow-up|1|||
143042480|NCT03868891|515695519|FG000|Overall Study|COVID-19 Restrictions|1|||
143042481|NCT03868891|515695520|FG001|Overall Study|COVID-19 Restrictions|2|||
143240541|NCT01454102|516432024|FG007|Overall Study|Continuing in the treatment period|0|||
143498258|NCT00950170|517366289|FG000|Overall Study|Parent/Legal Guardian Request|1|||
143498259|NCT00950170|517366289|FG000|Overall Study|Adverse Event|2|||
143498260|NCT00950170|517366289|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
143498261|NCT02487108|517366290|FG000|Overall Study|Adverse Event|1|||
143042482|NCT01175018|515695523|FG000|Overall Study|Adverse Event|3|||
143042483|NCT01175018|515695524|FG001|Overall Study|Adverse Event|1|||
143042484|NCT03872128|515695531|FG000|Overall Study|Dropped out before treatment|1|||
143042485|NCT03872128|515695532|FG001|Overall Study|Dropped out before treatment|0|||
143042486|NCT03872128|515695533|FG002|Overall Study|Dropped out before treatment|4|||
143042487|NCT03872128|515695531|FG000|Overall Study|Lost to Follow-up|2|||
143042488|NCT03872128|515695532|FG001|Overall Study|Lost to Follow-up|5|||
143042489|NCT03872128|515695533|FG002|Overall Study|Lost to Follow-up|8|||
143042490|NCT03285594|515695537|FG000|Overall Study|At the Participant's Own Request|10|||
143042491|NCT03285594|515695538|FG001|Overall Study|At the Participant's Own Request|5|||
143042492|NCT03285594|515695539|FG002|Overall Study|At the Participant's Own Request|21|||
143042493|NCT03285594|515695537|FG000|Overall Study|Adverse Event|2|||
143042494|NCT03285594|515695538|FG001|Overall Study|Adverse Event|2|||
143042495|NCT03285594|515695539|FG002|Overall Study|Adverse Event|6|||
143042496|NCT03285594|515695537|FG000|Overall Study|Poor Compliance to Protocol|0|||
143042497|NCT03285594|515695538|FG001|Overall Study|Poor Compliance to Protocol|0|||
143042498|NCT03285594|515695539|FG002|Overall Study|Poor Compliance to Protocol|1|||
143042499|NCT03285594|515695537|FG000|Overall Study|Lost to Follow-up|0|||
143042500|NCT03285594|515695538|FG001|Overall Study|Lost to Follow-up|0|||
143042501|NCT03285594|515695539|FG002|Overall Study|Lost to Follow-up|1|||
143042502|NCT03285594|515695537|FG000|Overall Study|Reason Not Specified|3|||
143042503|NCT03285594|515695538|FG001|Overall Study|Reason Not Specified|4|||
143364245|NCT01304706|516876931|FG000|Overall Study|Death|3|||
143042504|NCT03285594|515695539|FG002|Overall Study|Reason Not Specified|8|||
143042505|NCT02601625|515695540|FG000|Overall Study|Lost to Follow-up|0|||
143042506|NCT02601625|515695541|FG001|Overall Study|Lost to Follow-up|0|||
143042507|NCT02601625|515695542|FG002|Overall Study|Lost to Follow-up|1|||
143042508|NCT02601625|515695543|FG003|Overall Study|Lost to Follow-up|1|||
143042509|NCT01289262|515695546|FG000|Overall Study|Lost to Follow-up|29|||
143042510|NCT01289262|515695547|FG001|Overall Study|Lost to Follow-up|16|||
143042511|NCT01289262|515695546|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
143042512|NCT01289262|515695547|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
143042513|NCT04887415|515695548|FG000|Overall Study|Lost to Follow-up|2|||
143042514|NCT01250912|515695549|FG000|Overall Study|Lost to Follow-up|1|||
143042515|NCT05646251|515695550|FG000|Overall Study|Physician Decision|1|||
143042516|NCT05646251|515695551|FG001|Overall Study|Physician Decision|0|||
143042517|NCT05646251|515695552|FG002|Overall Study|Physician Decision|2|||
143042518|NCT00773253|515695554|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
143042519|NCT00773253|515695555|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
143042520|NCT01566721|515695556|FG000|Treatment Period|Withdrawal by Subject|35|||
143042521|NCT01566721|515695557|FG001|Treatment Period|Withdrawal by Subject|9|||
143042522|NCT01566721|515695556|FG000|Treatment Period|Disease Progression/Recurrence|37|||
143042523|NCT01566721|515695557|FG001|Treatment Period|Disease Progression/Recurrence|13|||
143042524|NCT01566721|515695556|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
143042525|NCT01566721|515695557|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
143042526|NCT01566721|515695556|FG000|Treatment Period|Other|13|||
143042527|NCT01566721|515695557|FG001|Treatment Period|Other|2|||
143042528|NCT01566721|515695556|FG000|Treatment Period|Lack of Compliance|5|||
143042529|NCT01566721|515695557|FG001|Treatment Period|Lack of Compliance|1|||
143042530|NCT01566721|515695556|FG000|Treatment Period|Adverse Event|100|||
143042531|NCT01566721|515695557|FG001|Treatment Period|Adverse Event|30|||
143042532|NCT01566721|515695556|FG000|Treatment Period|Pregnancy|1|||
143042533|NCT01566721|515695557|FG001|Treatment Period|Pregnancy|0|||
143042534|NCT01566721|515695556|FG000|Safety Follow-up|Physician Decision|6|||
143042535|NCT01566721|515695557|FG001|Safety Follow-up|Physician Decision|4|||
143042536|NCT01566721|515695556|FG000|Safety Follow-up|Lost to Follow-up|101|||
143042537|NCT01566721|515695557|FG001|Safety Follow-up|Lost to Follow-up|48|||
143042538|NCT01566721|515695556|FG000|Safety Follow-up|Withdrawal by Subject|155|||
143042539|NCT01566721|515695557|FG001|Safety Follow-up|Withdrawal by Subject|49|||
143042540|NCT01566721|515695556|FG000|Safety Follow-up|Death|28|||
143042541|NCT01566721|515695557|FG001|Safety Follow-up|Death|4|||
143042542|NCT01566721|515695556|FG000|Safety Follow-up|Non-compliance|7|||
143042543|NCT01566721|515695557|FG001|Safety Follow-up|Non-compliance|3|||
143042544|NCT01566721|515695556|FG000|Safety Follow-up|Protocol Violation|7|||
143042545|NCT01566721|515695557|FG001|Safety Follow-up|Protocol Violation|0|||
143042546|NCT01566721|515695556|FG000|Safety Follow-up|Site closure|2|||
143042547|NCT01566721|515695557|FG001|Safety Follow-up|Site closure|3|||
143042548|NCT01566721|515695556|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
143042549|NCT01566721|515695557|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
143042550|NCT01566721|515695556|FG000|Safety Follow-up|Missing|7|||
143042551|NCT01566721|515695557|FG001|Safety Follow-up|Missing|2|||
143042552|NCT01566721|515695556|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
143042553|NCT01566721|515695557|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
143042554|NCT01566721|515695556|FG000|Safety Follow-up|Sponsor decision|1|||
143042555|NCT01566721|515695557|FG001|Safety Follow-up|Sponsor decision|0|||
143042556|NCT01566721|515695556|FG000|Safety Follow-up|Adverse Event|8|||
143042557|NCT01566721|515695557|FG001|Safety Follow-up|Adverse Event|4|||
143042558|NCT00446563|515695558|FG000|Overall Study|Adverse Event|4|||
143042559|NCT00446563|515695559|FG001|Overall Study|Adverse Event|3|||
143042560|NCT00446563|515695558|FG000|Overall Study|Abnormal laboratory value(s)|0|||
143042561|NCT00446563|515695559|FG001|Overall Study|Abnormal laboratory value(s)|1|||
143164858|NCT05375929|516150148|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
143164859|NCT05375929|516150145|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
143164860|NCT05375929|516150146|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
143164861|NCT05375929|516150147|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
143164862|NCT05375929|516150148|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
143164863|NCT03973489|516150149|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
143164864|NCT03973489|516150150|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
143164865|NCT03973489|516150151|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
143164866|NCT03973489|516150152|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
143042562|NCT00446563|515695558|FG000|Overall Study|Abnormal test procedure result(s)|1|||
143042563|NCT00446563|515695559|FG001|Overall Study|Abnormal test procedure result(s)|0|||
143042564|NCT00446563|515695558|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
143042565|NCT00446563|515695559|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
143042566|NCT00446563|515695558|FG000|Overall Study|Withdrawal by Subject|2|||
143042567|NCT00446563|515695559|FG001|Overall Study|Withdrawal by Subject|1|||
143042568|NCT00446563|515695558|FG000|Overall Study|Administrative problems|0|||
143042569|NCT00446563|515695559|FG001|Overall Study|Administrative problems|1|||
143042570|NCT03273153|515695560|FG000|Overall Study|Adverse Event|1|||
143042571|NCT03273153|515695561|FG001|Overall Study|Adverse Event|2|||
143042572|NCT03273153|515695560|FG000|Overall Study|Missing|0|||
143042573|NCT03273153|515695561|FG001|Overall Study|Missing|2|||
143042574|NCT03273153|515695560|FG000|Overall Study|Other|3|||
143042575|NCT03273153|515695561|FG001|Overall Study|Other|2|||
143042576|NCT03273153|515695560|FG000|Overall Study|Symptomatic Deterioration|0|||
143042577|NCT03273153|515695561|FG001|Overall Study|Symptomatic Deterioration|1|||
143042578|NCT03273153|515695560|FG000|Overall Study|Progressive Disease|6|||
143042579|NCT03273153|515695561|FG001|Overall Study|Progressive Disease|5|||
143042580|NCT03273153|515695560|FG000|Overall Study|Physician Decision|1|||
143042581|NCT03273153|515695561|FG001|Overall Study|Physician Decision|3|||
143042582|NCT03273153|515695560|FG000|Overall Study|Study Terminated by Sponsor|112|||
143042583|NCT03273153|515695561|FG001|Overall Study|Study Terminated by Sponsor|102|||
143042584|NCT03273153|515695560|FG000|Overall Study|Withdrawal by Subject|26|||
143042585|NCT03273153|515695561|FG001|Overall Study|Withdrawal by Subject|25|||
143042586|NCT03273153|515695560|FG000|Overall Study|Protocol Deviation|3|||
143042587|NCT03273153|515695561|FG001|Overall Study|Protocol Deviation|0|||
143042588|NCT03273153|515695560|FG000|Overall Study|Lost to Follow-up|6|||
143042589|NCT03273153|515695561|FG001|Overall Study|Lost to Follow-up|11|||
143042590|NCT03273153|515695560|FG000|Overall Study|Death|66|||
143042591|NCT03273153|515695561|FG001|Overall Study|Death|69|||
143042592|NCT02409355|515695566|FG000|Overall Study|Withdrawal by Subject|1|||
143042593|NCT02409355|515695567|FG001|Overall Study|Withdrawal by Subject|0|||
143042594|NCT02409355|515695566|FG000|Overall Study|Death|1|||
143042595|NCT02409355|515695567|FG001|Overall Study|Death|1|||
143042596|NCT02409355|515695566|FG000|Overall Study|Study terminated by Sponsor|2|||
143042597|NCT02409355|515695567|FG001|Overall Study|Study terminated by Sponsor|3|||
143042598|NCT01237054|515695568|FG000|Overall Study|imaging 10C0096|1|||
143042599|NCT01908205|515695569|FG000|Overall Study|Lost to Follow-up|2|||
143042600|NCT01908205|515695570|FG001|Overall Study|Lost to Follow-up|0|||
143042601|NCT01908205|515695569|FG000|Overall Study|Withdrawal by Subject|3|||
143042602|NCT01908205|515695570|FG001|Overall Study|Withdrawal by Subject|1|||
143042603|NCT03134222|515695575|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
143042604|NCT03134222|515695576|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
143042605|NCT03134222|515695577|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
143042606|NCT03134222|515695578|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
143042607|NCT03134222|515695579|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
143042608|NCT03134222|515695575|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
143042609|NCT03134222|515695576|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
143042610|NCT03134222|515695577|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
143042611|NCT03134222|515695578|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
143042612|NCT03134222|515695579|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
143042613|NCT03134222|515695575|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
143042614|NCT03134222|515695576|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
143042615|NCT03134222|515695577|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
143042616|NCT03134222|515695578|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
143042617|NCT03134222|515695579|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
143042618|NCT03134222|515695575|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
143042619|NCT03134222|515695576|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
143042620|NCT03134222|515695577|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
143042621|NCT03134222|515695578|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
143042622|NCT03134222|515695579|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
143498262|NCT02487108|517366291|FG001|Overall Study|Adverse Event|6|||
143498263|NCT02487108|517366292|FG002|Overall Study|Adverse Event|12|||
143498264|NCT02487108|517366293|FG003|Overall Study|Adverse Event|6|||
143498265|NCT02487108|517366290|FG000|Overall Study|Withdrawal by Subject|8|||
143498266|NCT02487108|517366291|FG001|Overall Study|Withdrawal by Subject|5|||
143498267|NCT02487108|517366292|FG002|Overall Study|Withdrawal by Subject|5|||
143498268|NCT02487108|517366293|FG003|Overall Study|Withdrawal by Subject|0|||
143498269|NCT02487108|517366290|FG000|Overall Study|Non-compliance to study medication|3|||
143042623|NCT03134222|515695575|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
143042624|NCT03134222|515695576|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
143042625|NCT03134222|515695577|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
143042626|NCT03134222|515695578|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
143042627|NCT03134222|515695579|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
143042628|NCT03134222|515695575|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
143042629|NCT03134222|515695576|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
143042630|NCT03134222|515695577|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
143498270|NCT02487108|517366291|FG001|Overall Study|Non-compliance to study medication|2|||
143498271|NCT02487108|517366292|FG002|Overall Study|Non-compliance to study medication|5|||
143498272|NCT02487108|517366293|FG003|Overall Study|Non-compliance to study medication|4|||
143042631|NCT03134222|515695578|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
143042632|NCT03134222|515695579|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
143042633|NCT03134222|515695575|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
143042634|NCT03134222|515695576|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
143042635|NCT03134222|515695577|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
143042636|NCT03134222|515695578|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
143042637|NCT03134222|515695579|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
143042638|NCT03134222|515695575|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
143042639|NCT03134222|515695576|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
143042640|NCT03134222|515695577|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
143042641|NCT03134222|515695578|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
143042642|NCT03134222|515695579|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
143042643|NCT02530905|515695584|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
143042644|NCT02530905|515695585|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
143042645|NCT02530905|515695586|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
143042646|NCT04646213|515695588|FG000|Overall Study|Physician Decision|3|||
143042647|NCT04646213|515695588|FG000|Overall Study|Withdrawal by Subject|2|||
143042648|NCT00415363|515695593|FG000|Overall Study|Withdrawal by Subject|4|||
143042649|NCT00415363|515695594|FG001|Overall Study|Withdrawal by Subject|4|||
143042650|NCT00415363|515695593|FG000|Overall Study|Adverse Event|4|||
143042651|NCT00415363|515695594|FG001|Overall Study|Adverse Event|4|||
143042652|NCT00415363|515695593|FG000|Overall Study|Lost to Follow-up|2|||
143042653|NCT00415363|515695594|FG001|Overall Study|Lost to Follow-up|1|||
143042654|NCT00415363|515695593|FG000|Overall Study|Physician Decision|3|||
143042655|NCT00415363|515695594|FG001|Overall Study|Physician Decision|1|||
143042656|NCT00415363|515695593|FG000|Overall Study|Death|16|||
143042657|NCT00415363|515695594|FG001|Overall Study|Death|12|||
143042658|NCT00415363|515695593|FG000|Overall Study|Progressive disease|26|||
143042659|NCT00415363|515695594|FG001|Overall Study|Progressive disease|32|||
143042660|NCT03123471|515695597|FG000|Placebo-controlled Phase|Adverse Event|3|||
143042661|NCT03123471|515695598|FG001|Placebo-controlled Phase|Adverse Event|8|||
143042662|NCT03123471|515695597|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
143042663|NCT03123471|515695598|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
143042664|NCT03123471|515695597|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
143042665|NCT03123471|515695598|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
143042666|NCT03123471|515695597|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
143042667|NCT03123471|515695598|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
143042668|NCT03123471|515695597|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
143042669|NCT03123471|515695598|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
143042670|NCT03123471|515695597|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
143240542|NCT01454102|516432025|FG008|Overall Study|Continuing in the treatment period|1|||
143240543|NCT01454102|516432026|FG009|Overall Study|Continuing in the treatment period|0|||
143240544|NCT01454102|516432027|FG010|Overall Study|Continuing in the treatment period|0|||
143240545|NCT01454102|516432028|FG011|Overall Study|Continuing in the treatment period|4|||
143240546|NCT01454102|516432029|FG012|Overall Study|Continuing in the treatment period|7|||
143240547|NCT01454102|516432030|FG013|Overall Study|Continuing in the treatment period|4|||
143240548|NCT01454102|516432031|FG014|Overall Study|Continuing in the treatment period|3|||
143240549|NCT01454102|516432032|FG015|Overall Study|Continuing in the treatment period|1|||
143240550|NCT01782378|516432037|FG000|First Series|Lost to Follow-up|7|||
143042671|NCT03123471|515695598|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
143042672|NCT03123471|515695597|FG000|Placebo-controlled Phase|Miscellaneous|0|||
143042673|NCT03123471|515695598|FG001|Placebo-controlled Phase|Miscellaneous|1|||
143042674|NCT03123471|515695597|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
143042675|NCT03123471|515695598|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
143042676|NCT03123471|515695597|FG000|Apremilast Extension Phase|Adverse Event|1|||
143042677|NCT03123471|515695598|FG001|Apremilast Extension Phase|Adverse Event|5|||
143042678|NCT03123471|515695597|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
143042679|NCT03123471|515695598|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
143164867|NCT03973489|516150153|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
143164868|NCT03973489|516150154|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
143164869|NCT03973489|516150155|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
143164870|NCT03973489|516150156|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
143164871|NCT03973489|516150149|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
143164872|NCT03973489|516150150|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
143164873|NCT03973489|516150151|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
143164874|NCT03973489|516150152|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
143164875|NCT03973489|516150153|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
143240551|NCT01782378|516432038|FG001|First Series|Lost to Follow-up|8|||
143240552|NCT01782378|516432037|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
143042680|NCT03123471|515695597|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
143498273|NCT02487108|517366290|FG000|Overall Study|Protocol Violation|1|||
143498274|NCT02487108|517366291|FG001|Overall Study|Protocol Violation|1|||
143042681|NCT03123471|515695598|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
143042682|NCT01686477|515695599|FG000|Feeding Intervention|Death|1|||
143042683|NCT01686477|515695600|FG001|Feeding Intervention|Death|0|||
143042684|NCT01686477|515695601|FG002|Feeding Intervention|Death|1|||
143042685|NCT01686477|515695599|FG000|Feeding Intervention|Withdrawal by Subject|0|||
143042686|NCT01686477|515695600|FG001|Feeding Intervention|Withdrawal by Subject|6|||
143042687|NCT01686477|515695601|FG002|Feeding Intervention|Withdrawal by Subject|0|||
143042688|NCT01686477|515695599|FG000|Feeding Intervention|Physician Decision|1|||
143042689|NCT01686477|515695600|FG001|Feeding Intervention|Physician Decision|2|||
143042690|NCT01686477|515695601|FG002|Feeding Intervention|Physician Decision|0|||
143042691|NCT01686477|515695599|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
143042692|NCT01686477|515695600|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
143042693|NCT01686477|515695601|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
143042694|NCT01686477|515695599|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
143042695|NCT01686477|515695600|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
143042696|NCT01686477|515695601|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
143042697|NCT01686477|515695599|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
143042698|NCT01686477|515695600|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
143042699|NCT01686477|515695601|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
143042700|NCT01686477|515695599|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
143042701|NCT01686477|515695600|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
143042702|NCT01686477|515695601|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
143042703|NCT01686477|515695599|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
143042704|NCT01686477|515695600|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
143042705|NCT01686477|515695601|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
143042706|NCT01686477|515695599|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
143042707|NCT01686477|515695600|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
143042708|NCT01686477|515695601|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
143042709|NCT01686477|515695599|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
143042710|NCT01686477|515695600|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
143042711|NCT01686477|515695601|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
143042712|NCT05341622|515695603|FG000|Overall Study|Death|0|||
143042713|NCT05341622|515695604|FG001|Overall Study|Death|0|||
143042714|NCT05341622|515695605|FG002|Overall Study|Death|0|||
143042715|NCT05341622|515695606|FG003|Overall Study|Death|0|||
143042716|NCT05341622|515695607|FG004|Overall Study|Death|1|||
143042717|NCT05341622|515695608|FG005|Overall Study|Death|0|||
143042718|NCT05341622|515695609|FG006|Overall Study|Death|0|||
143042719|NCT05341622|515695610|FG007|Overall Study|Death|1|||
143042720|NCT05341622|515695603|FG000|Overall Study|Invalid Address|0|||
143042721|NCT05341622|515695604|FG001|Overall Study|Invalid Address|1|||
143042722|NCT05341622|515695605|FG002|Overall Study|Invalid Address|0|||
143042723|NCT05341622|515695606|FG003|Overall Study|Invalid Address|0|||
143042724|NCT05341622|515695607|FG004|Overall Study|Invalid Address|0|||
143042725|NCT05341622|515695608|FG005|Overall Study|Invalid Address|0|||
143042726|NCT05341622|515695609|FG006|Overall Study|Invalid Address|0|||
143042727|NCT05341622|515695610|FG007|Overall Study|Invalid Address|0|||
143042728|NCT05341622|515695603|FG000|Overall Study|Ineligible|26|||
143042729|NCT05341622|515695604|FG001|Overall Study|Ineligible|21|||
143042730|NCT05341622|515695605|FG002|Overall Study|Ineligible|28|||
143042731|NCT05341622|515695606|FG003|Overall Study|Ineligible|24|||
143164876|NCT03973489|516150154|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
143498275|NCT02487108|517366292|FG002|Overall Study|Protocol Violation|2|||
143164877|NCT03973489|516150155|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
143164878|NCT03973489|516150156|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
143164879|NCT03973489|516150149|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
143164880|NCT03973489|516150150|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
143164881|NCT03973489|516150151|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
143164882|NCT03973489|516150152|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
143164883|NCT03973489|516150153|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
143164884|NCT03973489|516150154|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
143164885|NCT03973489|516150155|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
143498276|NCT02487108|517366293|FG003|Overall Study|Protocol Violation|0|||
143498277|NCT02487108|517366290|FG000|Overall Study|Non-compliance to study procedures|0|||
143498278|NCT02487108|517366291|FG001|Overall Study|Non-compliance to study procedures|0|||
143498279|NCT02487108|517366292|FG002|Overall Study|Non-compliance to study procedures|0|||
143042732|NCT05341622|515695607|FG004|Overall Study|Ineligible|29|||
143042733|NCT05341622|515695608|FG005|Overall Study|Ineligible|31|||
143042734|NCT05341622|515695609|FG006|Overall Study|Ineligible|28|||
143042735|NCT05341622|515695610|FG007|Overall Study|Ineligible|26|||
143042736|NCT02957942|515695611|FG000|Overall Study|Withdrawal by Subject|0|||
143042737|NCT02957942|515695612|FG001|Overall Study|Withdrawal by Subject|1|||
143042738|NCT02957942|515695611|FG000|Overall Study|Practicing experiment protocol|0|||
143042739|NCT02957942|515695612|FG001|Overall Study|Practicing experiment protocol|6|||
143042740|NCT01249651|515695616|FG000|Overall Study|Withdrawal by Subject|4|||
143042741|NCT01249651|515695616|FG000|Overall Study|Adverse Event|1|||
143042742|NCT01249651|515695616|FG000|Overall Study|Protocol Violation|1|||
143042743|NCT01249651|515695616|FG000|Overall Study|Sponsor Decision|1|||
143042744|NCT02430480|515695628|FG000|Overall Study|Death|1|||
143042745|NCT02430480|515695628|FG000|Overall Study|Anesthesia concerns|1|||
143042746|NCT02430480|515695628|FG000|Overall Study|Progressed on treatment|1|||
143042747|NCT03761173|515695629|FG000|Overall Study|Lost to Follow-up|93|||
143042748|NCT03761173|515695629|FG000|Overall Study|Withdrawal by Subject|74|||
143042749|NCT03761173|515695629|FG000|Overall Study|Death|45|||
143042750|NCT03761173|515695629|FG000|Overall Study|Withdrawal for Other Reasons|29|||
143042751|NCT03761173|515695629|FG000|Overall Study|Protocol Violation|1|||
143042752|NCT00316186|515695630|FG000|Overall Study|Adverse Event|6|||
143042753|NCT00316186|515695630|FG000|Overall Study|Disease Progression|4|||
143042754|NCT00316186|515695630|FG000|Overall Study|Lost to Follow-up|1|||
143042755|NCT00316186|515695630|FG000|Overall Study|Other|1|||
143042756|NCT01963728|515695633|FG000|Overall Study|Study terminated early|0|||
143042757|NCT01963728|515695634|FG001|Overall Study|Study terminated early|1|||
143042758|NCT02057835|515697364|FG000|Overall Study|Withdrawal by Subject|0|||
143042759|NCT02057835|515697365|FG001|Overall Study|Withdrawal by Subject|2|||
143042760|NCT02057835|515697366|FG002|Overall Study|Withdrawal by Subject|0|||
143042761|NCT02057835|515697367|FG003|Overall Study|Withdrawal by Subject|0|||
143042762|NCT02057835|515697368|FG004|Overall Study|Withdrawal by Subject|0|||
143042763|NCT02057835|515697369|FG005|Overall Study|Withdrawal by Subject|0|||
143042764|NCT02057835|515697370|FG006|Overall Study|Withdrawal by Subject|0|||
143042765|NCT02057835|515697371|FG007|Overall Study|Withdrawal by Subject|0|||
143042766|NCT02057835|515697372|FG008|Overall Study|Withdrawal by Subject|0|||
143042767|NCT02057835|515697373|FG009|Overall Study|Withdrawal by Subject|0|||
143042768|NCT02267187|515697377|FG000|Overall Study|Physician Decision|2|||
143042769|NCT02267187|515697377|FG000|Overall Study|Screen fail|3|||
143042770|NCT02222818|515697378|FG000|Period 1|Eligibility criteria not met|0|||
143042771|NCT02222818|515697379|FG001|Period 1|Eligibility criteria not met|3|||
143042772|NCT04299087|515697380|FG000|Overall Study|Lost to Follow-up|2|||
143498280|NCT02487108|517366293|FG003|Overall Study|Non-compliance to study procedures|1|||
143042773|NCT04299087|515697381|FG001|Overall Study|Lost to Follow-up|1|||
143042774|NCT03025087|515697382|FG000|Overall Study|Physician Decision|3|||
143042775|NCT03025087|515697383|FG001|Overall Study|Physician Decision|3|||
143042776|NCT03025087|515697384|FG002|Overall Study|Physician Decision|0|||
143042777|NCT03025087|515697385|FG003|Overall Study|Physician Decision|0|||
143042778|NCT03025087|515697386|FG004|Overall Study|Physician Decision|0|||
143042779|NCT03025087|515697382|FG000|Overall Study|Withdrawal by Subject|1|||
143042780|NCT03025087|515697383|FG001|Overall Study|Withdrawal by Subject|1|||
143042781|NCT03025087|515697384|FG002|Overall Study|Withdrawal by Subject|0|||
143042782|NCT03025087|515697385|FG003|Overall Study|Withdrawal by Subject|0|||
143042783|NCT03025087|515697386|FG004|Overall Study|Withdrawal by Subject|0|||
143042784|NCT03025087|515697382|FG000|Overall Study|Unable to complete MRI|2|||
143042785|NCT03025087|515697383|FG001|Overall Study|Unable to complete MRI|2|||
143042786|NCT03025087|515697384|FG002|Overall Study|Unable to complete MRI|0|||
143042787|NCT03025087|515697385|FG003|Overall Study|Unable to complete MRI|0|||
143042788|NCT03025087|515697386|FG004|Overall Study|Unable to complete MRI|0|||
143164886|NCT03973489|516150156|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
143164887|NCT03973489|516150149|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
143164888|NCT03973489|516150150|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
143164889|NCT03973489|516150151|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
143164890|NCT03973489|516150152|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
143498281|NCT02487108|517366290|FG000|Overall Study|Other than specified|3|||
143498282|NCT02487108|517366291|FG001|Overall Study|Other than specified|2|||
143498283|NCT02487108|517366292|FG002|Overall Study|Other than specified|2|||
143042789|NCT00508651|515697387|FG000|Overall Study|Lost to Follow-up|3|||
143042790|NCT00508651|515697388|FG001|Overall Study|Lost to Follow-up|1|||
143164891|NCT03973489|516150153|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
143364246|NCT01304706|516876931|FG000|Overall Study|Withdrawal by Subject|3|||
143498284|NCT02487108|517366293|FG003|Overall Study|Other than specified|0|||
143042791|NCT00508651|515697387|FG000|Overall Study|Withdrawal by Subject|1|||
143042792|NCT00508651|515697388|FG001|Overall Study|Withdrawal by Subject|1|||
143498285|NCT01254669|517366294|FG000|Overall Study|Withdrawal by Subject|0|||
143042793|NCT02545283|515697395|FG000|Overall Study|Lost to Follow-up|2|||
143042794|NCT02545283|515697396|FG001|Overall Study|Lost to Follow-up|4|||
143042795|NCT02545283|515697395|FG000|Overall Study|Withdrawal by Subject|5|||
143042796|NCT02545283|515697396|FG001|Overall Study|Withdrawal by Subject|9|||
143042797|NCT02545283|515697395|FG000|Overall Study|Death|109|||
143042798|NCT02545283|515697396|FG001|Overall Study|Death|211|||
143042799|NCT02545283|515697395|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
143042800|NCT02545283|515697396|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
143042801|NCT02545283|515697395|FG000|Overall Study|Study Terminated By Sponsor|33|||
143042802|NCT02545283|515697396|FG001|Overall Study|Study Terminated By Sponsor|71|||
143042803|NCT02436005|515697397|FG000|Second Intervention|Adverse Event|0|||
143042804|NCT02436005|515697398|FG001|Second Intervention|Adverse Event|1|||
143042805|NCT00455312|515697399|FG000|Overall Study|Death|0|||
143042806|NCT00455312|515697400|FG001|Overall Study|Death|1|||
143042807|NCT03343535|515697401|FG000|Overall Study|Lost to Follow-up|1|||
143042808|NCT03343535|515697401|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
143042809|NCT03343535|515697401|FG000|Overall Study|Death|12|||
143042810|NCT02838420|515697405|FG000|Overall Study|Ongoing in Study|113|||
143042811|NCT02838420|515697406|FG001|Overall Study|Ongoing in Study|45|||
143042812|NCT02838420|515697405|FG000|Overall Study|Lost to Follow-up|1|||
143042813|NCT02838420|515697406|FG001|Overall Study|Lost to Follow-up|0|||
143042814|NCT02838420|515697405|FG000|Overall Study|Withdrawal by Subject|3|||
143042815|NCT02838420|515697406|FG001|Overall Study|Withdrawal by Subject|4|||
143042816|NCT02838420|515697405|FG000|Overall Study|Death|8|||
143042817|NCT02838420|515697406|FG001|Overall Study|Death|13|||
143042818|NCT03419403|515697407|FG000|Overall Study|Withdrawal by Subject|5|||
143240553|NCT01782378|516432038|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
143042819|NCT03419403|515697408|FG001|Overall Study|Withdrawal by Subject|2|||
143042820|NCT03419403|515697409|FG002|Overall Study|Withdrawal by Subject|5|||
143042821|NCT03419403|515697410|FG003|Overall Study|Withdrawal by Subject|1|||
143042822|NCT03419403|515697407|FG000|Overall Study|Progressive disease (per protocol)|0|||
143240554|NCT01782378|516432037|FG000|Second Series|Lost to Follow-up|8|||
143240555|NCT01782378|516432038|FG001|Second Series|Lost to Follow-up|7|||
143240556|NCT01782378|516432037|FG000|Second Series|Did not choose to complete S2 Optional|18|||
143240557|NCT01782378|516432038|FG001|Second Series|Did not choose to complete S2 Optional|0|||
143240558|NCT00830440|516432039|FG000|Overall Study|Protocol Violation|1|||
143240559|NCT00830440|516432040|FG001|Overall Study|Protocol Violation|0|||
143240560|NCT00830440|516432039|FG000|Overall Study|Withdrawal by Subject|1|||
143240561|NCT00830440|516432040|FG001|Overall Study|Withdrawal by Subject|0|||
143498286|NCT01254669|517366295|FG001|Overall Study|Withdrawal by Subject|1|||
143042823|NCT03419403|515697408|FG001|Overall Study|Progressive disease (per protocol)|2|||
143042824|NCT03419403|515697409|FG002|Overall Study|Progressive disease (per protocol)|2|||
143042825|NCT03419403|515697410|FG003|Overall Study|Progressive disease (per protocol)|0|||
143042826|NCT03419403|515697407|FG000|Overall Study|Other, not specified|6|||
143042827|NCT03419403|515697408|FG001|Overall Study|Other, not specified|4|||
143042828|NCT03419403|515697409|FG002|Overall Study|Other, not specified|5|||
143042829|NCT03419403|515697410|FG003|Overall Study|Other, not specified|1|||
143042830|NCT03419403|515697407|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
143042831|NCT03419403|515697408|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
143042832|NCT03419403|515697409|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
143042833|NCT03419403|515697410|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
143042834|NCT00796653|515697411|FG000|Overall Study|Adverse Event|19|||
143042835|NCT00796653|515697412|FG001|Overall Study|Adverse Event|16|||
143042836|NCT00796653|515697413|FG002|Overall Study|Adverse Event|16|||
143042837|NCT00796653|515697414|FG003|Overall Study|Adverse Event|16|||
143042838|NCT00796653|515697411|FG000|Overall Study|Lost to Follow-up|2|||
143042839|NCT00796653|515697412|FG001|Overall Study|Lost to Follow-up|1|||
143042840|NCT00796653|515697413|FG002|Overall Study|Lost to Follow-up|2|||
143042841|NCT00796653|515697414|FG003|Overall Study|Lost to Follow-up|3|||
143042842|NCT00796653|515697411|FG000|Overall Study|Withdrawal by Subject|16|||
143042843|NCT00796653|515697412|FG001|Overall Study|Withdrawal by Subject|8|||
143042844|NCT00796653|515697413|FG002|Overall Study|Withdrawal by Subject|8|||
143042845|NCT00796653|515697414|FG003|Overall Study|Withdrawal by Subject|13|||
143042846|NCT00796653|515697411|FG000|Overall Study|Lack of Efficacy|8|||
143042847|NCT00796653|515697412|FG001|Overall Study|Lack of Efficacy|1|||
143042848|NCT00796653|515697413|FG002|Overall Study|Lack of Efficacy|3|||
143042849|NCT00796653|515697414|FG003|Overall Study|Lack of Efficacy|2|||
143042850|NCT00796653|515697411|FG000|Overall Study|Non compliance with protocol|2|||
143042851|NCT00796653|515697412|FG001|Overall Study|Non compliance with protocol|2|||
143042852|NCT00796653|515697413|FG002|Overall Study|Non compliance with protocol|0|||
143240562|NCT00830440|516432039|FG000|Overall Study|unsuccessful procedure|4|||
143240563|NCT00830440|516432040|FG001|Overall Study|unsuccessful procedure|0|||
143042853|NCT00796653|515697414|FG003|Overall Study|Non compliance with protocol|2|||
143042854|NCT00796653|515697411|FG000|Overall Study|Other reason not described above|4|||
143498287|NCT01254669|517366294|FG000|Overall Study|time constraint|2|||
143498288|NCT01254669|517366295|FG001|Overall Study|time constraint|2|||
143498289|NCT01254669|517366294|FG000|Overall Study|called to clinic during intervention|1|||
143498290|NCT01254669|517366295|FG001|Overall Study|called to clinic during intervention|1|||
143042855|NCT00796653|515697412|FG001|Overall Study|Other reason not described above|9|||
143042856|NCT00796653|515697413|FG002|Overall Study|Other reason not described above|7|||
143240564|NCT00830440|516432039|FG000|Overall Study|Adverse Event|2|||
143240565|NCT00830440|516432040|FG001|Overall Study|Adverse Event|0|||
143498291|NCT00400400|517366296|FG000|Overall Study|Adverse Event|9|||
143498292|NCT00400400|517366297|FG001|Overall Study|Adverse Event|8|||
143042857|NCT00796653|515697414|FG003|Overall Study|Other reason not described above|4|||
143042858|NCT01940341|515697417|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
143042859|NCT01940341|515697418|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
143042860|NCT01940341|515697419|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
143042861|NCT01940341|515697420|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
143042862|NCT01940341|515697417|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
143042863|NCT01940341|515697418|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
143042864|NCT01940341|515697419|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
143042865|NCT01940341|515697420|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
143042866|NCT01940341|515697417|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
143042867|NCT01940341|515697418|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
143042868|NCT01940341|515697419|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
143042869|NCT01940341|515697420|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
143042870|NCT01940341|515697417|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
143042871|NCT01940341|515697418|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
143042872|NCT01940341|515697419|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
143042873|NCT01940341|515697420|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
143042874|NCT01940341|515697417|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
143042875|NCT01940341|515697418|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
143042876|NCT01940341|515697419|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
143042877|NCT01940341|515697420|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
143042878|NCT01940341|515697417|FG000|Period 1: Double-blind Phase|Death|0|||
143042879|NCT01940341|515697418|FG001|Period 1: Double-blind Phase|Death|1|||
143042880|NCT01940341|515697419|FG002|Period 1: Double-blind Phase|Death|0|||
143042881|NCT01940341|515697420|FG003|Period 1: Double-blind Phase|Death|0|||
143042882|NCT01940341|515697417|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
143042883|NCT01940341|515697418|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
143042884|NCT01940341|515697419|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
143042885|NCT01940341|515697420|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
143042886|NCT01940341|515697417|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
143042887|NCT01940341|515697418|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
143042888|NCT01940341|515697419|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
143042889|NCT01940341|515697420|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
143042890|NCT01940341|515697417|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
143042891|NCT01940341|515697418|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
143042892|NCT01940341|515697419|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
143042893|NCT01940341|515697420|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
143042894|NCT01940341|515697417|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
143042895|NCT01940341|515697418|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
143042896|NCT01940341|515697419|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
143042897|NCT01940341|515697420|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
143042898|NCT01940341|515697417|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
143042899|NCT01940341|515697418|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
143042900|NCT01940341|515697419|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
143042901|NCT01940341|515697420|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
143042902|NCT01940341|515697417|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
143042903|NCT01940341|515697418|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
143042904|NCT01940341|515697419|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
143042905|NCT01940341|515697420|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
143042906|NCT01940341|515697417|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
143042907|NCT01940341|515697418|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
143042908|NCT01940341|515697419|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
143042909|NCT01940341|515697420|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
143042910|NCT01940341|515697417|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
143042911|NCT01940341|515697418|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
143042912|NCT01940341|515697419|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
143042913|NCT01940341|515697420|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
143042914|NCT01940341|515697417|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
143042915|NCT01940341|515697418|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
143042916|NCT01940341|515697419|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
143042917|NCT01940341|515697420|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
143364247|NCT01304706|516876931|FG000|Overall Study|Lost to Follow-up|7|||
143042918|NCT01940341|515697417|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
143042919|NCT01940341|515697418|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
143042920|NCT01940341|515697419|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
143042921|NCT01940341|515697420|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
143042922|NCT01940341|515697417|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
143042923|NCT01940341|515697418|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
143042924|NCT01940341|515697419|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
143042925|NCT01940341|515697420|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
143042926|NCT01940341|515697417|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
143042927|NCT01940341|515697418|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
143042928|NCT01940341|515697419|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
143042929|NCT01940341|515697420|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
143042930|NCT01940341|515697417|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
143042931|NCT01940341|515697418|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
143042932|NCT01940341|515697419|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
143042933|NCT01940341|515697420|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
143042934|NCT02414152|515697421|FG000|Overall Study|Withdrawal by Subject|1|||
143042935|NCT02414152|515697421|FG000|Overall Study|Lack of Efficacy|1|||
143042936|NCT01576042|515697425|FG000|Overall Study|Physician Decision|2|||
143042937|NCT01576042|515697426|FG001|Overall Study|Physician Decision|0|||
143042938|NCT00835536|515697429|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
143042939|NCT00835536|515697430|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
143042940|NCT03769025|515697434|FG000|Overall Study|Withdrawal by Subject|1|||
143042941|NCT03769025|515697435|FG001|Overall Study|Withdrawal by Subject|1|||
143042942|NCT03769025|515697434|FG000|Overall Study|Lost to Follow-up|4|||
143042943|NCT03769025|515697435|FG001|Overall Study|Lost to Follow-up|3|||
143042944|NCT02911701|515697440|FG000|Overall Study|Withdrawal by Subject|2|||
143042945|NCT02911701|515697441|FG001|Overall Study|Withdrawal by Subject|4|||
143042946|NCT02911701|515697440|FG000|Overall Study|Adverse Event|1|||
143042947|NCT02911701|515697441|FG001|Overall Study|Adverse Event|0|||
143042948|NCT01302548|515697442|FG000|Overall Study|Lost to Follow-up|2|||
143042949|NCT01302548|515697443|FG001|Overall Study|Lost to Follow-up|1|||
143042950|NCT03482882|515697444|FG000|Overall Study|Adverse Event|3|||
143042951|NCT03482882|515697444|FG000|Overall Study|Lost to Follow-up|1|||
143042952|NCT03482882|515697444|FG000|Overall Study|Protocol Violation|2|||
143042953|NCT03482882|515697444|FG000|Overall Study|Not further specified|1|||
143042954|NCT03801707|515697448|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
143042955|NCT00787254|515697449|FG000|Overall Study|Adverse Event|24|||
143042956|NCT00787254|515697450|FG001|Overall Study|Adverse Event|23|||
143042957|NCT00787254|515697449|FG000|Overall Study|Protocol Violation|26|||
143042958|NCT00787254|515697450|FG001|Overall Study|Protocol Violation|23|||
143042959|NCT00787254|515697449|FG000|Overall Study|Withdrawal by Subject|16|||
143042960|NCT00787254|515697450|FG001|Overall Study|Withdrawal by Subject|11|||
143042961|NCT00787254|515697449|FG000|Overall Study|Lack of Efficacy|4|||
143042962|NCT00787254|515697450|FG001|Overall Study|Lack of Efficacy|15|||
143042963|NCT00787254|515697449|FG000|Overall Study|NSAIDs discontinuation|1|||
143042964|NCT00787254|515697450|FG001|Overall Study|NSAIDs discontinuation|2|||
143042965|NCT00787254|515697449|FG000|Overall Study|Institution closed|1|||
143042966|NCT00787254|515697450|FG001|Overall Study|Institution closed|0|||
143042967|NCT00787254|515697449|FG000|Overall Study|Physician Decision|4|||
143042968|NCT00787254|515697450|FG001|Overall Study|Physician Decision|8|||
143042969|NCT04544410|515697453|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
143042970|NCT04544410|515697454|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
143042971|NCT04544410|515697453|FG000|Double-blind Treatment Period|Adverse Event|1|||
143042972|NCT04544410|515697454|FG001|Double-blind Treatment Period|Adverse Event|0|||
143042973|NCT04544410|515697453|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
143042974|NCT04544410|515697454|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
143042975|NCT04544410|515697453|FG000|Double-blind Treatment Period|Protocol Violation|1|||
143042976|NCT04544410|515697454|FG001|Double-blind Treatment Period|Protocol Violation|0|||
143042977|NCT04544410|515697453|FG000|Open-Label Treatment Period|Study Terminated|15|||
143042978|NCT04544410|515697454|FG001|Open-Label Treatment Period|Study Terminated|19|||
143042979|NCT04544410|515697453|FG000|Open-Label Treatment Period|Withdrawal by Subject|6|||
143164892|NCT03973489|516150154|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
143164893|NCT03973489|516150155|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
143164894|NCT03973489|516150156|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
143164895|NCT03973489|516150149|FG000|Second Intervention (1 Day)|Adverse Event|0|||
143164896|NCT03973489|516150150|FG001|Second Intervention (1 Day)|Adverse Event|0|||
143164897|NCT03973489|516150151|FG002|Second Intervention (1 Day)|Adverse Event|0|||
143042980|NCT04544410|515697454|FG001|Open-Label Treatment Period|Withdrawal by Subject|5|||
143042981|NCT04544410|515697453|FG000|Open-Label Treatment Period|Adverse Event|0|||
143042982|NCT04544410|515697454|FG001|Open-Label Treatment Period|Adverse Event|1|||
143498293|NCT00400400|517366296|FG000|Overall Study|Protocol Violation|2|||
143042983|NCT04544410|515697453|FG000|Open-Label Treatment Period|Physician Decision|1|||
143042984|NCT04544410|515697454|FG001|Open-Label Treatment Period|Physician Decision|0|||
143042985|NCT04544410|515697453|FG000|Open-Label Treatment Period|Other|0|||
143042986|NCT04544410|515697454|FG001|Open-Label Treatment Period|Other|1|||
143042987|NCT04493684|515697455|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
143042988|NCT04493684|515697456|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
143042989|NCT04493684|515697457|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
143042990|NCT04493684|515697458|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
143042991|NCT04493684|515697459|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
143042992|NCT04493684|515697460|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
143042993|NCT04493684|515697461|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
143042994|NCT04493684|515697462|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
143042995|NCT04493684|515697463|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
143042996|NCT04493684|515697464|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
143042997|NCT04493684|515697465|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
143042998|NCT04493684|515697466|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
143042999|NCT04493684|515697467|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
143043000|NCT04493684|515697468|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
143043001|NCT04493684|515697469|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
143043002|NCT04493684|515697470|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
143043003|NCT04493684|515697471|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
143043004|NCT04493684|515697455|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
143043005|NCT04493684|515697456|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
143043006|NCT04493684|515697457|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
143043007|NCT04493684|515697458|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
143043008|NCT04493684|515697459|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
143043009|NCT04493684|515697460|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
143043010|NCT04493684|515697461|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
143043011|NCT04493684|515697462|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
143043012|NCT04493684|515697463|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
143043013|NCT04493684|515697464|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
143043014|NCT04493684|515697465|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
143043015|NCT04493684|515697466|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
143164898|NCT03973489|516150152|FG003|Second Intervention (1 Day)|Adverse Event|1|||
143164899|NCT03973489|516150153|FG004|Second Intervention (1 Day)|Adverse Event|0|||
143164900|NCT03973489|516150154|FG005|Second Intervention (1 Day)|Adverse Event|0|||
143164901|NCT03973489|516150155|FG006|Second Intervention (1 Day)|Adverse Event|0|||
143498294|NCT00400400|517366297|FG001|Overall Study|Protocol Violation|0|||
143498295|NCT00400400|517366296|FG000|Overall Study|Withdrawal by Subject|1|||
143498296|NCT00400400|517366297|FG001|Overall Study|Withdrawal by Subject|3|||
143498297|NCT00400400|517366296|FG000|Overall Study|Administrative Problem|1|||
143498298|NCT00400400|517366297|FG001|Overall Study|Administrative Problem|0|||
143498299|NCT00400400|517366296|FG000|Overall Study|Lost to Follow-up|0|||
143498300|NCT00400400|517366297|FG001|Overall Study|Lost to Follow-up|1|||
143498301|NCT00400400|517366296|FG000|Overall Study|Did not receive study drug|1|||
143498302|NCT00400400|517366297|FG001|Overall Study|Did not receive study drug|3|||
143164902|NCT03973489|516150156|FG007|Second Intervention (1 Day)|Adverse Event|0|||
143164903|NCT03301415|516150157|FG000|Overall Study|Lost to Follow-up|2|||
143164904|NCT03301415|516150157|FG000|Overall Study|Unable to comply with visit schedule|2|||
143164905|NCT03247673|516150158|FG000|Overall Study|Withdrawal by Subject|1|||
143164906|NCT03247673|516150159|FG001|Overall Study|Withdrawal by Subject|0|||
143164907|NCT03247673|516150160|FG002|Overall Study|Withdrawal by Subject|3|||
143164908|NCT03247673|516150158|FG000|Overall Study|Lost to Follow-up|0|||
143164909|NCT03247673|516150159|FG001|Overall Study|Lost to Follow-up|0|||
143164910|NCT03247673|516150160|FG002|Overall Study|Lost to Follow-up|1|||
143164911|NCT02184442|516150164|FG000|Overall Study|Death|61|||
143164912|NCT02184442|516150165|FG001|Overall Study|Death|65|||
143164913|NCT02184442|516150164|FG000|Overall Study|Withdrawal by Subject|3|||
143164914|NCT02184442|516150165|FG001|Overall Study|Withdrawal by Subject|11|||
143164915|NCT00908141|516150168|FG000|Overall Study|Withdrawal by Subject|0|||
143164916|NCT00908141|516150169|FG001|Overall Study|Withdrawal by Subject|1|||
143164917|NCT03379870|516151471|FG000|Overall Study|Lost to Follow-up|1|||
143164918|NCT03379870|516151472|FG001|Overall Study|Lost to Follow-up|0|||
143164919|NCT03379870|516151471|FG000|Overall Study|Protocol Violation|1|||
143164920|NCT03379870|516151472|FG001|Overall Study|Protocol Violation|1|||
143164921|NCT00980044|516151473|FG000|Overall Study|Withdrawal by Subject|5|||
143164922|NCT00980044|516151474|FG001|Overall Study|Withdrawal by Subject|7|||
143164923|NCT00980044|516151475|FG002|Overall Study|Withdrawal by Subject|3|||
143498303|NCT00648167|517366298|FG000|Overall Study|Adverse Event|6|||
143498304|NCT00648167|517366298|FG000|Overall Study|unable to swallow tablets|1|||
143498305|NCT01688050|517366299|FG000|Overall Study|Death|7|||
143498306|NCT01688050|517366299|FG000|Overall Study|Conversion to open repair|1|||
143043016|NCT04493684|515697467|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
143043017|NCT04493684|515697468|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
143043018|NCT04493684|515697469|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
143043019|NCT04493684|515697470|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
143043020|NCT04493684|515697471|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
143043021|NCT04493684|515697455|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
143043022|NCT04493684|515697456|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
143043023|NCT04493684|515697457|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
143043024|NCT04493684|515697458|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
143043025|NCT04493684|515697459|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
143043026|NCT04493684|515697460|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
143043027|NCT04493684|515697461|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
143043028|NCT04493684|515697462|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
143043029|NCT04493684|515697463|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
143043030|NCT04493684|515697464|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
143043031|NCT04493684|515697465|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
143043032|NCT04493684|515697466|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
143043033|NCT04493684|515697467|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
143043034|NCT04493684|515697468|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
143043035|NCT04493684|515697469|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
143043036|NCT04493684|515697470|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
143043037|NCT04493684|515697471|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
143043038|NCT04493684|515697455|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
143043039|NCT04493684|515697456|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
143043040|NCT04493684|515697457|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
143043041|NCT04493684|515697458|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
143043042|NCT04493684|515697459|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
143043043|NCT04493684|515697460|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
143043044|NCT04493684|515697461|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
143043045|NCT04493684|515697462|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
143043046|NCT04493684|515697463|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
143164924|NCT00980044|516151473|FG000|Overall Study|Protocol Violation|0|||
143164925|NCT00980044|516151474|FG001|Overall Study|Protocol Violation|0|||
143164926|NCT00980044|516151475|FG002|Overall Study|Protocol Violation|2|||
143164927|NCT00185614|516151478|FG000|Inter-treatment Period|Physician Decision|1|||
143164928|NCT00185614|516151478|FG000|Inter-treatment Period|Relapse|2|||
143164929|NCT00185614|516151478|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
143164930|NCT00137449|516151483|FG000|Overall Study|Disease Progression|8|||
143164931|NCT00137449|516151484|FG001|Overall Study|Disease Progression|13|||
143164932|NCT00137449|516151483|FG000|Overall Study|Death|4|||
143164933|NCT00137449|516151484|FG001|Overall Study|Death|3|||
143164934|NCT00137449|516151483|FG000|Overall Study|Adverse Event|3|||
143164935|NCT00137449|516151484|FG001|Overall Study|Adverse Event|1|||
143164936|NCT00137449|516151483|FG000|Overall Study|Withdrawal by Subject|1|||
143164937|NCT00137449|516151484|FG001|Overall Study|Withdrawal by Subject|1|||
143164938|NCT02096354|516151488|FG000|Overall Study|Physician Decision|4|||
143164939|NCT02096354|516151489|FG001|Overall Study|Physician Decision|5|||
143164940|NCT02096354|516151490|FG002|Overall Study|Physician Decision|0|||
143164941|NCT02096354|516151488|FG000|Overall Study|Withdrawal by Subject|3|||
143164942|NCT02096354|516151489|FG001|Overall Study|Withdrawal by Subject|1|||
143164943|NCT02096354|516151490|FG002|Overall Study|Withdrawal by Subject|0|||
143164944|NCT02096354|516151488|FG000|Overall Study|Adverse Event|7|||
143164945|NCT02096354|516151489|FG001|Overall Study|Adverse Event|4|||
143164946|NCT02096354|516151490|FG002|Overall Study|Adverse Event|0|||
143164947|NCT02096354|516151488|FG000|Overall Study|Ineligible|0|||
143164948|NCT02096354|516151489|FG001|Overall Study|Ineligible|0|||
143164949|NCT02096354|516151490|FG002|Overall Study|Ineligible|11|||
143164950|NCT02951819|516151491|FG000|Overall Study|Death|9|||
143164951|NCT02951819|516151492|FG001|Overall Study|Death|7|||
143164952|NCT02951819|516151491|FG000|Overall Study|Withdrawal by Subject|3|||
143164953|NCT02951819|516151492|FG001|Overall Study|Withdrawal by Subject|0|||
143164954|NCT02951819|516151491|FG000|Overall Study|Adverse Event|1|||
143164955|NCT02951819|516151492|FG001|Overall Study|Adverse Event|0|||
143498307|NCT01688050|517366299|FG000|Overall Study|Lost to Follow-up|13|||
143164956|NCT02951819|516151491|FG000|Overall Study|Lack of Efficacy|4|||
143164957|NCT02951819|516151492|FG001|Overall Study|Lack of Efficacy|0|||
143164958|NCT02951819|516151491|FG000|Overall Study|Lost to Follow-up|1|||
143164959|NCT02951819|516151492|FG001|Overall Study|Lost to Follow-up|0|||
143164960|NCT02951819|516151491|FG000|Overall Study|Progressive Disease|1|||
143364248|NCT01304706|516876931|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
143498308|NCT01688050|517366299|FG000|Overall Study|Withdrawal by Subject|10|||
143043047|NCT04493684|515697464|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
143043048|NCT04493684|515697465|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
143043049|NCT04493684|515697466|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
143043050|NCT04493684|515697467|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
143164961|NCT02951819|516151492|FG001|Overall Study|Progressive Disease|0|||
143164962|NCT02951819|516151491|FG000|Overall Study|Other|9|||
143164963|NCT02951819|516151492|FG001|Overall Study|Other|0|||
143164964|NCT03715829|516151493|FG000|Dose Ranging Period|Adverse Event|2|||
143043051|NCT04493684|515697468|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
143043052|NCT04493684|515697469|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
143043053|NCT04493684|515697470|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
143043054|NCT04493684|515697471|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
143043055|NCT04493684|515697455|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
143043056|NCT04493684|515697456|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
143043057|NCT04493684|515697457|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
143043058|NCT04493684|515697458|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
143043059|NCT04493684|515697459|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
143043060|NCT04493684|515697460|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
143043061|NCT04493684|515697461|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
143043062|NCT04493684|515697462|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
143043063|NCT04493684|515697463|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
143043064|NCT04493684|515697464|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
143043065|NCT04493684|515697465|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
143043066|NCT04493684|515697466|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
143043067|NCT04493684|515697467|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
143043068|NCT04493684|515697468|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
143043069|NCT04493684|515697469|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
143043070|NCT04493684|515697470|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
143043071|NCT04493684|515697471|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
143043072|NCT04493684|515697455|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
143043073|NCT04493684|515697456|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
143043074|NCT04493684|515697457|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
143043075|NCT04493684|515697458|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
143043076|NCT04493684|515697459|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
143043077|NCT04493684|515697460|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
143043078|NCT04493684|515697461|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
143043079|NCT04493684|515697462|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
143043080|NCT04493684|515697463|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
143043081|NCT04493684|515697464|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
143043082|NCT04493684|515697465|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
143043083|NCT04493684|515697466|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
143043084|NCT04493684|515697467|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
143043085|NCT04493684|515697468|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
143043086|NCT04493684|515697469|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
143043087|NCT04493684|515697470|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
143043088|NCT04493684|515697471|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
143043089|NCT04493684|515697455|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
143043090|NCT04493684|515697456|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
143043091|NCT04493684|515697457|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
143043092|NCT04493684|515697458|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
143164965|NCT03715829|516151494|FG001|Dose Ranging Period|Adverse Event|4|||
143164966|NCT03715829|516151495|FG002|Dose Ranging Period|Adverse Event|5|||
143164967|NCT03715829|516151496|FG003|Dose Ranging Period|Adverse Event|2|||
143164968|NCT03715829|516151497|FG004|Dose Ranging Period|Adverse Event|3|||
143164969|NCT03715829|516151498|FG005|Dose Ranging Period|Adverse Event|3|||
143164970|NCT03715829|516151499|FG006|Dose Ranging Period|Adverse Event|0|||
143164971|NCT03715829|516151500|FG007|Dose Ranging Period|Adverse Event|0|||
143164972|NCT03715829|516151501|FG008|Dose Ranging Period|Adverse Event|0|||
143164973|NCT03715829|516151502|FG009|Dose Ranging Period|Adverse Event|0|||
143164974|NCT03715829|516151503|FG010|Dose Ranging Period|Adverse Event|0|||
143164975|NCT03715829|516151493|FG000|Dose Ranging Period|Lack of Efficacy|0|||
143164976|NCT03715829|516151494|FG001|Dose Ranging Period|Lack of Efficacy|1|||
143164977|NCT03715829|516151495|FG002|Dose Ranging Period|Lack of Efficacy|0|||
143043093|NCT04493684|515697459|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
143164978|NCT03715829|516151496|FG003|Dose Ranging Period|Lack of Efficacy|1|||
143240566|NCT02592798|516432041|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
143240567|NCT02592798|516432042|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
143240568|NCT02592798|516432041|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
143240569|NCT02592798|516432042|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
143240570|NCT02592798|516432041|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
143240571|NCT02592798|516432042|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
143240572|NCT02592798|516432041|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
143240573|NCT02592798|516432042|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
143240574|NCT02592798|516432041|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
143240575|NCT02592798|516432042|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
143240576|NCT02592798|516432041|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
143240577|NCT02592798|516432042|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
143240578|NCT02592798|516432041|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
143240579|NCT02592798|516432042|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
143240580|NCT02592798|516432041|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
143240581|NCT02592798|516432042|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
143240582|NCT02592798|516432041|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
143240583|NCT02592798|516432042|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
143240584|NCT02592798|516432041|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
143240585|NCT02592798|516432042|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
143240586|NCT02592798|516432041|FG000|Transition From DB2 to OLE|Other reasons|1|||
143240587|NCT02592798|516432042|FG001|Transition From DB2 to OLE|Other reasons|0|||
143240588|NCT02592798|516432041|FG000|Open Label Period (OLE)|Other reasons|0|||
143240589|NCT02592798|516432042|FG001|Open Label Period (OLE)|Other reasons|2|||
143240590|NCT02592798|516432041|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
143240591|NCT02592798|516432042|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
143240592|NCT02592798|516432041|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
143240593|NCT02592798|516432042|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
143240594|NCT02592798|516432041|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
143240595|NCT02592798|516432042|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
143240596|NCT02592798|516432041|FG000|Open Label Period (OLE)|Adverse Event|0|||
143240597|NCT02592798|516432042|FG001|Open Label Period (OLE)|Adverse Event|1|||
143240598|NCT00942604|516432043|FG000|Overall Study|Protocol Violation|1|||
143240599|NCT00942604|516432044|FG001|Overall Study|Protocol Violation|1|||
143240600|NCT00942604|516432043|FG000|Overall Study|Adverse Event|0|||
143240601|NCT00942604|516432044|FG001|Overall Study|Adverse Event|1|||
143240602|NCT00942604|516432043|FG000|Overall Study|Withdrawal by Subject|0|||
143240603|NCT00942604|516432044|FG001|Overall Study|Withdrawal by Subject|1|||
143240604|NCT00942604|516432043|FG000|Overall Study|Patient relocation|1|||
143043094|NCT04493684|515697460|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
143164979|NCT03715829|516151497|FG004|Dose Ranging Period|Lack of Efficacy|0|||
143164980|NCT03715829|516151498|FG005|Dose Ranging Period|Lack of Efficacy|0|||
143164981|NCT03715829|516151499|FG006|Dose Ranging Period|Lack of Efficacy|0|||
143164982|NCT03715829|516151500|FG007|Dose Ranging Period|Lack of Efficacy|0|||
143164983|NCT03715829|516151501|FG008|Dose Ranging Period|Lack of Efficacy|0|||
143164984|NCT03715829|516151502|FG009|Dose Ranging Period|Lack of Efficacy|0|||
143164985|NCT03715829|516151503|FG010|Dose Ranging Period|Lack of Efficacy|0|||
143164986|NCT03715829|516151493|FG000|Dose Ranging Period|Lost to Follow-up|2|||
143164987|NCT03715829|516151494|FG001|Dose Ranging Period|Lost to Follow-up|0|||
143164988|NCT03715829|516151495|FG002|Dose Ranging Period|Lost to Follow-up|1|||
143164989|NCT03715829|516151496|FG003|Dose Ranging Period|Lost to Follow-up|1|||
143164990|NCT03715829|516151497|FG004|Dose Ranging Period|Lost to Follow-up|1|||
143164991|NCT03715829|516151498|FG005|Dose Ranging Period|Lost to Follow-up|2|||
143164992|NCT03715829|516151499|FG006|Dose Ranging Period|Lost to Follow-up|0|||
143164993|NCT03715829|516151500|FG007|Dose Ranging Period|Lost to Follow-up|0|||
143164994|NCT03715829|516151501|FG008|Dose Ranging Period|Lost to Follow-up|0|||
143164995|NCT03715829|516151502|FG009|Dose Ranging Period|Lost to Follow-up|0|||
143164996|NCT03715829|516151503|FG010|Dose Ranging Period|Lost to Follow-up|0|||
143164997|NCT03715829|516151493|FG000|Dose Ranging Period|Protocol Violation|0|||
143164998|NCT03715829|516151494|FG001|Dose Ranging Period|Protocol Violation|0|||
143164999|NCT03715829|516151495|FG002|Dose Ranging Period|Protocol Violation|0|||
143240605|NCT00942604|516432044|FG001|Overall Study|Patient relocation|1|||
143240606|NCT01188343|516432045|FG000|Overall Study|Not vaccinated|0|||
143240607|NCT01188343|516432046|FG001|Overall Study|Not vaccinated|2|||
143240608|NCT01188343|516432047|FG002|Overall Study|Not vaccinated|1|||
143240609|NCT01188343|516432045|FG000|Overall Study|Withdrawal by Subject|1|||
143043095|NCT04493684|515697461|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
143165000|NCT03715829|516151496|FG003|Dose Ranging Period|Protocol Violation|1|||
143165001|NCT03715829|516151497|FG004|Dose Ranging Period|Protocol Violation|0|||
143165002|NCT03715829|516151498|FG005|Dose Ranging Period|Protocol Violation|0|||
143165003|NCT03715829|516151499|FG006|Dose Ranging Period|Protocol Violation|0|||
143165004|NCT03715829|516151500|FG007|Dose Ranging Period|Protocol Violation|0|||
143165005|NCT03715829|516151501|FG008|Dose Ranging Period|Protocol Violation|0|||
143043096|NCT04493684|515697462|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
143043097|NCT04493684|515697463|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
143043098|NCT04493684|515697464|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
143043099|NCT04493684|515697465|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
143043100|NCT04493684|515697466|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
143043101|NCT04493684|515697467|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
143043102|NCT04493684|515697468|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
143043103|NCT04493684|515697469|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
143043104|NCT04493684|515697470|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
143043105|NCT04493684|515697471|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
143043106|NCT04493684|515697455|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
143043107|NCT04493684|515697456|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
143043108|NCT04493684|515697457|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
143043109|NCT04493684|515697458|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
143043110|NCT04493684|515697459|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
143043111|NCT04493684|515697460|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
143043112|NCT04493684|515697461|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
143043113|NCT04493684|515697462|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
143043114|NCT04493684|515697463|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
143043115|NCT04493684|515697464|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
143043116|NCT04493684|515697465|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
143043117|NCT04493684|515697466|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
143043118|NCT04493684|515697467|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
143043119|NCT04493684|515697468|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
143043120|NCT04493684|515697469|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
143043121|NCT04493684|515697470|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
143043122|NCT04493684|515697471|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
143043123|NCT05152576|515697474|FG000|Overall Study|Lost to Follow-up|3|||
143043124|NCT05152576|515697475|FG001|Overall Study|Lost to Follow-up|0|||
143043125|NCT05152576|515697476|FG002|Overall Study|Lost to Follow-up|0|||
143043126|NCT05152576|515697477|FG003|Overall Study|Lost to Follow-up|1|||
143043127|NCT05152576|515697474|FG000|Overall Study|Withdrawal by Subject|0|||
143043128|NCT05152576|515697475|FG001|Overall Study|Withdrawal by Subject|1|||
143043129|NCT05152576|515697476|FG002|Overall Study|Withdrawal by Subject|0|||
143043130|NCT05152576|515697477|FG003|Overall Study|Withdrawal by Subject|1|||
143043131|NCT05152576|515697474|FG000|Overall Study|Other|2|||
143043132|NCT05152576|515697475|FG001|Overall Study|Other|0|||
143043133|NCT05152576|515697476|FG002|Overall Study|Other|0|||
143043134|NCT05152576|515697477|FG003|Overall Study|Other|0|||
143043135|NCT00859430|515697478|FG000|First Intervention|Withdrawal by Subject|0|||
143043136|NCT00859430|515697479|FG001|First Intervention|Withdrawal by Subject|1|||
143043137|NCT04115293|515699190|FG000|Overall Study|Adverse Event|0|||
143043138|NCT04115293|515699191|FG001|Overall Study|Adverse Event|2|||
143043139|NCT04115293|515699190|FG000|Overall Study|Withdrawal by Subject|2|||
143043140|NCT04115293|515699191|FG001|Overall Study|Withdrawal by Subject|1|||
143043141|NCT04115293|515699190|FG000|Overall Study|Physician Decision|1|||
143043142|NCT04115293|515699191|FG001|Overall Study|Physician Decision|0|||
143043143|NCT04115293|515699190|FG000|Overall Study|Death|1|||
143043144|NCT04115293|515699191|FG001|Overall Study|Death|1|||
143043145|NCT02286739|515699192|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
143043146|NCT02286739|515699193|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
143043147|NCT02286739|515699192|FG000|Overall Study|No Verasense type documented|0|||
143043148|NCT02286739|515699193|FG001|Overall Study|No Verasense type documented|23|||
143043149|NCT02286739|515699192|FG000|Overall Study|Adverse Event|1|||
143043150|NCT02286739|515699193|FG001|Overall Study|Adverse Event|2|||
143043151|NCT02286739|515699192|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
143043152|NCT02286739|515699193|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
143043153|NCT02635750|515699201|FG000|Part 1, Period 2|Adverse Event|1|||
143043154|NCT02635750|515699202|FG001|Part 1, Period 2|Adverse Event|0|||
143043155|NCT02635750|515699203|FG002|Part 1, Period 2|Adverse Event|0|||
143043156|NCT02642653|515699208|FG000|Overall Study|Adverse Event|2|||
143043157|NCT02642653|515699209|FG001|Overall Study|Adverse Event|0|||
143043158|NCT02875392|515699210|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
143043159|NCT02875392|515699211|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
143043160|NCT00834717|515699217|FG000|First Intervention|Adverse Event|1|||
143043161|NCT00834717|515699218|FG001|First Intervention|Adverse Event|0|||
143043162|NCT00834717|515699217|FG000|First Intervention|Withdrawal by Subject|0|||
143043163|NCT00834717|515699218|FG001|First Intervention|Withdrawal by Subject|1|||
143043164|NCT00594035|515699221|FG000|Overall Study|Lost to Follow-up|1|||
143043165|NCT00594035|515699222|FG001|Overall Study|Lost to Follow-up|1|||
143043166|NCT00594035|515699221|FG000|Overall Study|Withdrawal by Subject|1|||
143043167|NCT00594035|515699222|FG001|Overall Study|Withdrawal by Subject|0|||
143043168|NCT00594035|515699221|FG000|Overall Study|Subject transferred to nursing home|0|||
143043169|NCT00594035|515699222|FG001|Overall Study|Subject transferred to nursing home|1|||
143043170|NCT00594035|515699221|FG000|Overall Study|Subject couldn't return due to job|0|||
143043171|NCT00594035|515699222|FG001|Overall Study|Subject couldn't return due to job|1|||
143043172|NCT00795821|515699223|FG000|Acute Treatment Phase|Adverse Event|23|||
143043173|NCT00795821|515699224|FG001|Acute Treatment Phase|Adverse Event|4|||
143043174|NCT00795821|515699223|FG000|Acute Treatment Phase|Death|1|||
143043175|NCT00795821|515699224|FG001|Acute Treatment Phase|Death|0|||
143043176|NCT00795821|515699223|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
143043177|NCT00795821|515699224|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
143043178|NCT00795821|515699223|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
143043179|NCT00795821|515699224|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
143043180|NCT00795821|515699223|FG000|Acute Treatment Phase|Physician Decision|1|||
143043181|NCT00795821|515699224|FG001|Acute Treatment Phase|Physician Decision|1|||
143043182|NCT00795821|515699223|FG000|Acute Treatment Phase|Protocol Violation|1|||
143043183|NCT00795821|515699224|FG001|Acute Treatment Phase|Protocol Violation|2|||
143043184|NCT00795821|515699223|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
143043185|NCT00795821|515699224|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
143043186|NCT00795821|515699223|FG000|Long-term Extension Phase|Adverse Event|25|||
143043187|NCT00795821|515699224|FG001|Long-term Extension Phase|Adverse Event|32|||
143043188|NCT00795821|515699223|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
143043189|NCT00795821|515699224|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
143043190|NCT00795821|515699223|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
143043191|NCT00795821|515699224|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
143043192|NCT00795821|515699223|FG000|Long-term Extension Phase|Physician Decision|1|||
143043193|NCT00795821|515699224|FG001|Long-term Extension Phase|Physician Decision|2|||
143043194|NCT00795821|515699223|FG000|Long-term Extension Phase|Protocol Violation|3|||
143043195|NCT00795821|515699224|FG001|Long-term Extension Phase|Protocol Violation|5|||
143043196|NCT00795821|515699223|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
143165006|NCT03715829|516151502|FG009|Dose Ranging Period|Protocol Violation|0|||
143165007|NCT03715829|516151503|FG010|Dose Ranging Period|Protocol Violation|0|||
143165008|NCT03715829|516151493|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
143165009|NCT03715829|516151494|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
143165010|NCT03715829|516151495|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
143165011|NCT03715829|516151496|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
143165012|NCT03715829|516151497|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
143165013|NCT03715829|516151498|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
143165014|NCT03715829|516151499|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
143165015|NCT03715829|516151500|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
143165016|NCT03715829|516151501|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
143165017|NCT03715829|516151502|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
143165018|NCT03715829|516151503|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
143165019|NCT03715829|516151493|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
143165020|NCT03715829|516151494|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
143165021|NCT03715829|516151495|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
143165022|NCT03715829|516151496|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
143165023|NCT03715829|516151497|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
143165024|NCT03715829|516151498|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
143165025|NCT03715829|516151499|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
143165026|NCT03715829|516151500|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
143165027|NCT03715829|516151501|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
143165028|NCT03715829|516151502|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
143165029|NCT03715829|516151503|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
143165030|NCT03715829|516151493|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
143165031|NCT03715829|516151494|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
143165032|NCT03715829|516151495|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
143165033|NCT03715829|516151496|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
143165034|NCT03715829|516151497|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
143165035|NCT03715829|516151498|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
143364249|NCT01251614|516876934|FG000|Overall Study|Adverse Event|1|||
143043197|NCT00795821|515699224|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
143043198|NCT00795821|515699223|FG000|Taper Phase|Adverse Event|2|||
143043199|NCT00795821|515699224|FG001|Taper Phase|Adverse Event|0|||
143043200|NCT00795821|515699223|FG000|Taper Phase|Lost to Follow-up|1|||
143043201|NCT00795821|515699224|FG001|Taper Phase|Lost to Follow-up|0|||
143043202|NCT00795821|515699223|FG000|Taper Phase|Physician Decision|2|||
143043203|NCT00795821|515699224|FG001|Taper Phase|Physician Decision|0|||
143043204|NCT00795821|515699223|FG000|Taper Phase|Withdrawal by Subject|4|||
143043205|NCT00795821|515699224|FG001|Taper Phase|Withdrawal by Subject|0|||
143043206|NCT00712959|515699231|FG000|Overall Study|Protocol Violation|3|||
143043207|NCT00712959|515699232|FG001|Overall Study|Protocol Violation|1|||
143043208|NCT00712959|515699231|FG000|Overall Study|Lost to Follow-up|13|||
143043209|NCT00712959|515699232|FG001|Overall Study|Lost to Follow-up|2|||
143043210|NCT00712959|515699231|FG000|Overall Study|Withdrawal by Subject|3|||
143043211|NCT00712959|515699232|FG001|Overall Study|Withdrawal by Subject|0|||
143043212|NCT02328040|515699236|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
143043213|NCT02328040|515699237|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
143043214|NCT02301975|515699243|FG000|Overall Study|Adverse Event|8|||
143043215|NCT02301975|515699244|FG001|Overall Study|Adverse Event|3|||
143043216|NCT02301975|515699245|FG002|Overall Study|Adverse Event|2|||
143043217|NCT02301975|515699243|FG000|Overall Study|Lack of Efficacy|1|||
143043218|NCT02301975|515699244|FG001|Overall Study|Lack of Efficacy|1|||
143043219|NCT02301975|515699245|FG002|Overall Study|Lack of Efficacy|1|||
143043220|NCT02301975|515699243|FG000|Overall Study|Protocol Violation|3|||
143043221|NCT02301975|515699244|FG001|Overall Study|Protocol Violation|5|||
143043222|NCT02301975|515699245|FG002|Overall Study|Protocol Violation|3|||
143043223|NCT02301975|515699243|FG000|Overall Study|Lost to Follow-up|0|||
143043224|NCT02301975|515699244|FG001|Overall Study|Lost to Follow-up|2|||
143043225|NCT02301975|515699245|FG002|Overall Study|Lost to Follow-up|2|||
143043226|NCT02301975|515699243|FG000|Overall Study|Physician Decision|4|||
143043227|NCT02301975|515699244|FG001|Overall Study|Physician Decision|2|||
143043228|NCT02301975|515699245|FG002|Overall Study|Physician Decision|3|||
143043229|NCT02301975|515699243|FG000|Overall Study|Withdrawal by Subject|15|||
143043230|NCT02301975|515699244|FG001|Overall Study|Withdrawal by Subject|12|||
143043231|NCT02301975|515699245|FG002|Overall Study|Withdrawal by Subject|11|||
143043232|NCT04278560|515699247|FG000|Overall Study|Adverse Event|1|||
143043233|NCT04278560|515699248|FG001|Overall Study|Adverse Event|2|||
143043234|NCT04278560|515699247|FG000|Overall Study|Withdrawal by Subject|0|||
143043235|NCT04278560|515699248|FG001|Overall Study|Withdrawal by Subject|1|||
143043236|NCT00163657|515699249|FG000|Overall Study|Death|12|||
143043237|NCT00163657|515699250|FG001|Overall Study|Death|14|||
143043238|NCT00163657|515699251|FG002|Overall Study|Death|19|||
143043239|NCT00163657|515699249|FG000|Overall Study|graft loss|4|||
143043240|NCT00163657|515699250|FG001|Overall Study|graft loss|1|||
143043241|NCT00163657|515699251|FG002|Overall Study|graft loss|2|||
143043242|NCT00163657|515699249|FG000|Overall Study|Withdrawal by Subject|2|||
143043243|NCT00163657|515699250|FG001|Overall Study|Withdrawal by Subject|3|||
143043244|NCT00163657|515699251|FG002|Overall Study|Withdrawal by Subject|2|||
143043245|NCT00163657|515699249|FG000|Overall Study|Physician Decision|0|||
143043246|NCT00163657|515699250|FG001|Overall Study|Physician Decision|1|||
143043247|NCT00163657|515699251|FG002|Overall Study|Physician Decision|1|||
143043248|NCT00163657|515699249|FG000|Overall Study|Non Compliance|1|||
143043249|NCT00163657|515699250|FG001|Overall Study|Non Compliance|0|||
143043250|NCT00163657|515699251|FG002|Overall Study|Non Compliance|0|||
143043251|NCT00163657|515699249|FG000|Overall Study|Lost to Follow-up|1|||
143043252|NCT00163657|515699250|FG001|Overall Study|Lost to Follow-up|3|||
143498309|NCT02789657|517366302|FG000|Overall Study|Withdrawal by Subject|2|||
143498310|NCT02789657|517366303|FG001|Overall Study|Withdrawal by Subject|0|||
143498311|NCT02789657|517366304|FG002|Overall Study|Withdrawal by Subject|0|||
143498312|NCT02789657|517366305|FG003|Overall Study|Withdrawal by Subject|0|||
143498313|NCT03882424|517366306|FG000|Overall Study|Lost to Follow-up|3|||
143498314|NCT03882424|517366307|FG001|Overall Study|Lost to Follow-up|0|||
143043253|NCT00163657|515699251|FG002|Overall Study|Lost to Follow-up|10|||
143043254|NCT00163657|515699249|FG000|Overall Study|Other reason|0|||
143043255|NCT00163657|515699250|FG001|Overall Study|Other reason|1|||
143043256|NCT00163657|515699251|FG002|Overall Study|Other reason|3|||
143043257|NCT01319383|515699252|FG000|Overall Study|No ex vivo or in vivo response|4|||
143043258|NCT01319383|515699253|FG001|Overall Study|No ex vivo or in vivo response|0|||
143043259|NCT01319383|515699252|FG000|Overall Study|Physician Decision|3|||
143043260|NCT01319383|515699253|FG001|Overall Study|Physician Decision|0|||
143043261|NCT01319383|515699252|FG000|Overall Study|Lack of Efficacy|5|||
143043262|NCT01319383|515699253|FG001|Overall Study|Lack of Efficacy|9|||
143043263|NCT01319383|515699252|FG000|Overall Study|No in vivo response to interval doses|0|||
143043264|NCT01319383|515699253|FG001|Overall Study|No in vivo response to interval doses|1|||
143043265|NCT03600805|515699266|FG000|Overall Study|Adverse Event|2|||
143043266|NCT03600805|515699267|FG001|Overall Study|Adverse Event|1|||
143043267|NCT03600805|515699268|FG002|Overall Study|Adverse Event|1|||
143043268|NCT03600805|515699269|FG003|Overall Study|Adverse Event|7|||
143043269|NCT03600805|515699266|FG000|Overall Study|Lack of Efficacy|2|||
143043270|NCT03600805|515699267|FG001|Overall Study|Lack of Efficacy|1|||
143043271|NCT03600805|515699268|FG002|Overall Study|Lack of Efficacy|0|||
143498315|NCT03882424|517366308|FG002|Overall Study|Lost to Follow-up|0|||
143498316|NCT03882424|517366306|FG000|Overall Study|schedule conflict|1|||
143498317|NCT03882424|517366307|FG001|Overall Study|schedule conflict|0|||
143498318|NCT03882424|517366308|FG002|Overall Study|schedule conflict|0|||
143498319|NCT00510276|517366310|FG000|Acute Double-Blind Phase|Adverse Event|21|||
143498320|NCT00510276|517366311|FG001|Acute Double-Blind Phase|Adverse Event|6|||
143498321|NCT00510276|517366310|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
143498322|NCT00510276|517366311|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
143498323|NCT00510276|517366310|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
143498324|NCT00510276|517366311|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
143498325|NCT00510276|517366310|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
143498326|NCT00510276|517366311|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
143498327|NCT00510276|517366310|FG000|Acute Double-Blind Phase|Physician Decision|0|||
143498328|NCT00510276|517366311|FG001|Acute Double-Blind Phase|Physician Decision|3|||
143498329|NCT00510276|517366310|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
143498330|NCT00510276|517366311|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
143043272|NCT03600805|515699269|FG003|Overall Study|Lack of Efficacy|0|||
143043273|NCT03600805|515699266|FG000|Overall Study|Withdrawal by Subject|1|||
143043274|NCT03600805|515699267|FG001|Overall Study|Withdrawal by Subject|0|||
143043275|NCT03600805|515699268|FG002|Overall Study|Withdrawal by Subject|0|||
143043276|NCT03600805|515699269|FG003|Overall Study|Withdrawal by Subject|1|||
143043277|NCT03600805|515699266|FG000|Overall Study|Other unspecified|14|||
143043278|NCT03600805|515699267|FG001|Overall Study|Other unspecified|6|||
143043279|NCT03600805|515699268|FG002|Overall Study|Other unspecified|7|||
143043280|NCT03600805|515699269|FG003|Overall Study|Other unspecified|11|||
143043281|NCT06195579|515699270|FG000|Overall Study|Withdrawal by Subject|1|||
143043282|NCT03123094|515699272|FG000|Overall Study|Withdrawal by Subject|0|||
143043283|NCT03123094|515699273|FG001|Overall Study|Withdrawal by Subject|2|||
143043284|NCT03123094|515699274|FG002|Overall Study|Withdrawal by Subject|1|||
143043285|NCT03123094|515699275|FG003|Overall Study|Withdrawal by Subject|0|||
143043286|NCT03123094|515699276|FG004|Overall Study|Withdrawal by Subject|1|||
143043287|NCT01735994|515699277|FG000|Overall Study|Withdrawal by Subject|6|||
143043288|NCT01735994|515699278|FG001|Overall Study|Withdrawal by Subject|4|||
143043289|NCT01735994|515699277|FG000|Overall Study|Injury|2|||
143043290|NCT01735994|515699278|FG001|Overall Study|Injury|0|||
143043291|NCT01735994|515699277|FG000|Overall Study|Kicked off team|5|||
143043292|NCT01735994|515699278|FG001|Overall Study|Kicked off team|0|||
143498331|NCT00510276|517366310|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
143498332|NCT00510276|517366311|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
143498333|NCT00510276|517366310|FG000|Acute Double-Blind Phase|Subject Decision|26|||
143498334|NCT00510276|517366311|FG001|Acute Double-Blind Phase|Subject Decision|28|||
143498335|NCT00510276|517366310|FG000|Extension Open-Label Phase|Adverse Event|9|||
143498336|NCT00510276|517366311|FG001|Extension Open-Label Phase|Adverse Event|18|||
143043293|NCT01735994|515699277|FG000|Overall Study|Lost to Follow-up|50|||
143043294|NCT01735994|515699278|FG001|Overall Study|Lost to Follow-up|62|||
143043295|NCT04994535|515699279|FG000|Overall Study|Lost to Follow-up|7|||
143043296|NCT04994535|515699280|FG001|Overall Study|Lost to Follow-up|7|||
143043297|NCT04994535|515699279|FG000|Overall Study|Withdrawal by Subject|10|||
143165036|NCT03715829|516151499|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
143165037|NCT03715829|516151500|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
143165038|NCT03715829|516151501|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
143165039|NCT03715829|516151502|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
143165040|NCT03715829|516151503|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
143165041|NCT03715829|516151493|FG000|Dose Ranging Period|Other|0|||
143165042|NCT03715829|516151494|FG001|Dose Ranging Period|Other|0|||
143165043|NCT03715829|516151495|FG002|Dose Ranging Period|Other|2|||
143165044|NCT03715829|516151496|FG003|Dose Ranging Period|Other|0|||
143165045|NCT03715829|516151497|FG004|Dose Ranging Period|Other|0|||
143165046|NCT03715829|516151498|FG005|Dose Ranging Period|Other|3|||
143165047|NCT03715829|516151499|FG006|Dose Ranging Period|Other|0|||
143165048|NCT03715829|516151500|FG007|Dose Ranging Period|Other|0|||
143165049|NCT03715829|516151501|FG008|Dose Ranging Period|Other|0|||
143498337|NCT00510276|517366310|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
143364250|NCT01251614|516876935|FG001|Overall Study|Adverse Event|0|||
143498338|NCT00510276|517366311|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
143043298|NCT04994535|515699280|FG001|Overall Study|Withdrawal by Subject|7|||
143043299|NCT04994535|515699279|FG000|Overall Study|Other|1|||
143043300|NCT04994535|515699280|FG001|Overall Study|Other|1|||
143043301|NCT01158118|515699281|FG000|Overall Study|Screen failure|1|||
143043302|NCT01158118|515699282|FG001|Overall Study|Screen failure|0|||
143165050|NCT03715829|516151502|FG009|Dose Ranging Period|Other|0|||
143165051|NCT03715829|516151503|FG010|Dose Ranging Period|Other|0|||
143165052|NCT03715829|516151493|FG000|Extension Period|Adverse Event|0|||
143165053|NCT03715829|516151494|FG001|Extension Period|Adverse Event|0|||
143498339|NCT00510276|517366310|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
143498340|NCT00510276|517366311|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
143498341|NCT00510276|517366310|FG000|Extension Open-Label Phase|Physician Decision|2|||
143498342|NCT00510276|517366311|FG001|Extension Open-Label Phase|Physician Decision|3|||
143043303|NCT01158118|515699281|FG000|Overall Study|Donor match was a screen failure|0|||
143043304|NCT01158118|515699282|FG001|Overall Study|Donor match was a screen failure|1|||
143043305|NCT01158118|515699281|FG000|Overall Study|Suffered stroke prior to transplant|0|||
143043306|NCT01158118|515699282|FG001|Overall Study|Suffered stroke prior to transplant|1|||
143043307|NCT01158118|515699281|FG000|Overall Study|Death|0|||
143043308|NCT01158118|515699282|FG001|Overall Study|Death|1|||
143043309|NCT00905840|515699285|FG000|Overall Study|Lost to Follow-up|11|||
143043310|NCT00905840|515699285|FG000|Overall Study|Death|3|||
143043311|NCT00905840|515699285|FG000|Overall Study|Withdrawal by Subject|1|||
143043312|NCT00905840|515699285|FG000|Overall Study|Adverse Event|1|||
143043313|NCT02682238|515699289|FG000|Overall Study|Lost to Follow-up|0|||
143043314|NCT02682238|515699290|FG001|Overall Study|Lost to Follow-up|2|||
143043315|NCT02682238|515699289|FG000|Overall Study|Withdrawal by Subject|1|||
143043316|NCT02682238|515699290|FG001|Overall Study|Withdrawal by Subject|0|||
143043317|NCT02682238|515699289|FG000|Overall Study|Adverse Event|1|||
143043318|NCT02682238|515699290|FG001|Overall Study|Adverse Event|0|||
143043319|NCT02682238|515699289|FG000|Overall Study|Non-compliance with Study Drug|1|||
143043320|NCT02682238|515699290|FG001|Overall Study|Non-compliance with Study Drug|0|||
143043321|NCT02682238|515699289|FG000|Overall Study|Non-compliance with Protocol|0|||
143043322|NCT02682238|515699290|FG001|Overall Study|Non-compliance with Protocol|2|||
143165054|NCT03715829|516151495|FG002|Extension Period|Adverse Event|0|||
143165055|NCT03715829|516151496|FG003|Extension Period|Adverse Event|0|||
143165056|NCT03715829|516151497|FG004|Extension Period|Adverse Event|0|||
143165057|NCT03715829|516151498|FG005|Extension Period|Adverse Event|0|||
143165058|NCT03715829|516151499|FG006|Extension Period|Adverse Event|3|||
143165059|NCT03715829|516151500|FG007|Extension Period|Adverse Event|1|||
143165060|NCT03715829|516151501|FG008|Extension Period|Adverse Event|6|||
143165061|NCT03715829|516151502|FG009|Extension Period|Adverse Event|0|||
143165062|NCT03715829|516151503|FG010|Extension Period|Adverse Event|0|||
143165063|NCT03715829|516151493|FG000|Extension Period|Lack of Efficacy|0|||
143165064|NCT03715829|516151494|FG001|Extension Period|Lack of Efficacy|0|||
143165065|NCT03715829|516151495|FG002|Extension Period|Lack of Efficacy|0|||
143165066|NCT03715829|516151496|FG003|Extension Period|Lack of Efficacy|0|||
143165067|NCT03715829|516151497|FG004|Extension Period|Lack of Efficacy|0|||
143165068|NCT03715829|516151498|FG005|Extension Period|Lack of Efficacy|0|||
143165069|NCT03715829|516151499|FG006|Extension Period|Lack of Efficacy|1|||
143165070|NCT03715829|516151500|FG007|Extension Period|Lack of Efficacy|9|||
143165071|NCT03715829|516151501|FG008|Extension Period|Lack of Efficacy|2|||
143165072|NCT03715829|516151502|FG009|Extension Period|Lack of Efficacy|0|||
143165073|NCT03715829|516151503|FG010|Extension Period|Lack of Efficacy|0|||
143165074|NCT03715829|516151493|FG000|Extension Period|Lost to Follow-up|0|||
143165075|NCT03715829|516151494|FG001|Extension Period|Lost to Follow-up|0|||
143165076|NCT03715829|516151495|FG002|Extension Period|Lost to Follow-up|0|||
143165077|NCT03715829|516151496|FG003|Extension Period|Lost to Follow-up|0|||
143165078|NCT03715829|516151497|FG004|Extension Period|Lost to Follow-up|0|||
143165079|NCT03715829|516151498|FG005|Extension Period|Lost to Follow-up|0|||
143165080|NCT03715829|516151499|FG006|Extension Period|Lost to Follow-up|0|||
143165081|NCT03715829|516151500|FG007|Extension Period|Lost to Follow-up|0|||
143165082|NCT03715829|516151501|FG008|Extension Period|Lost to Follow-up|2|||
143165083|NCT03715829|516151502|FG009|Extension Period|Lost to Follow-up|0|||
143165084|NCT03715829|516151503|FG010|Extension Period|Lost to Follow-up|0|||
143165085|NCT03715829|516151493|FG000|Extension Period|Protocol Violation|0|||
143165086|NCT03715829|516151494|FG001|Extension Period|Protocol Violation|0|||
143165087|NCT03715829|516151495|FG002|Extension Period|Protocol Violation|0|||
143165088|NCT03715829|516151496|FG003|Extension Period|Protocol Violation|0|||
143165089|NCT03715829|516151497|FG004|Extension Period|Protocol Violation|0|||
143165090|NCT03715829|516151498|FG005|Extension Period|Protocol Violation|0|||
143165091|NCT03715829|516151499|FG006|Extension Period|Protocol Violation|0|||
143165092|NCT03715829|516151500|FG007|Extension Period|Protocol Violation|0|||
143043323|NCT01370317|515699291|FG000|Overall Study|Participant withdrew consent|1|||
143043324|NCT01370317|515699292|FG001|Overall Study|Participant withdrew consent|0|||
143043325|NCT01370317|515699291|FG000|Overall Study|Protocol deviation|0|||
143043326|NCT01370317|515699292|FG001|Overall Study|Protocol deviation|1|||
143043327|NCT03128723|515699293|FG000|Overall Study|Withdrawal by Subject|2|||
143165093|NCT03715829|516151501|FG008|Extension Period|Protocol Violation|1|||
143165094|NCT03715829|516151502|FG009|Extension Period|Protocol Violation|0|||
143043328|NCT02909907|515699295|FG000|Overall Study|Withdrawal by Subject|0|||
143165095|NCT03715829|516151503|FG010|Extension Period|Protocol Violation|0|||
143165096|NCT03715829|516151493|FG000|Extension Period|Withdrawal by Subject|0|||
143165097|NCT03715829|516151494|FG001|Extension Period|Withdrawal by Subject|0|||
143165098|NCT03715829|516151495|FG002|Extension Period|Withdrawal by Subject|0|||
143165099|NCT03715829|516151496|FG003|Extension Period|Withdrawal by Subject|0|||
143165100|NCT03715829|516151497|FG004|Extension Period|Withdrawal by Subject|0|||
143165101|NCT03715829|516151498|FG005|Extension Period|Withdrawal by Subject|0|||
143165102|NCT03715829|516151499|FG006|Extension Period|Withdrawal by Subject|3|||
143165103|NCT03715829|516151500|FG007|Extension Period|Withdrawal by Subject|3|||
143165104|NCT03715829|516151501|FG008|Extension Period|Withdrawal by Subject|12|||
143043329|NCT02909907|515699296|FG001|Overall Study|Withdrawal by Subject|1|||
143043330|NCT00075478|515699297|FG000|Overall Study|not eligible|1|||
143043331|NCT00075478|515699298|FG001|Overall Study|not eligible|0|||
143043332|NCT00075478|515699297|FG000|Overall Study|Physician Decision|0|||
143043333|NCT00075478|515699298|FG001|Overall Study|Physician Decision|1|||
143043334|NCT02075463|515699302|FG000|Overall Study|Adverse Event|3|||
143043335|NCT02075463|515699302|FG000|Overall Study|Par. reached stopping criteria|4|||
143043336|NCT02075463|515699302|FG000|Overall Study|Withdrawal by Subject|1|||
143240610|NCT01188343|516432046|FG001|Overall Study|Withdrawal by Subject|24|||
143240611|NCT01188343|516432047|FG002|Overall Study|Withdrawal by Subject|0|||
143240612|NCT01143246|516432048|FG000|Overall Study|Adverse Event|24|||
143240613|NCT01143246|516432049|FG001|Overall Study|Adverse Event|28|||
143240614|NCT01143246|516432048|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
143240615|NCT01143246|516432049|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
143240616|NCT01143246|516432048|FG000|Overall Study|Lost to Follow-up|0|||
143240617|NCT01143246|516432049|FG001|Overall Study|Lost to Follow-up|1|||
143240618|NCT01143246|516432048|FG000|Overall Study|Death|16|||
143240619|NCT01143246|516432049|FG001|Overall Study|Death|15|||
143240620|NCT01143246|516432048|FG000|Overall Study|Reason not Specified|3|||
143240621|NCT01143246|516432049|FG001|Overall Study|Reason not Specified|5|||
143240622|NCT03987503|516432051|FG000|Overall Study|Lost to Follow-up|20|||
143240623|NCT03987503|516432051|FG000|Overall Study|Withdrawal by Subject|2|||
143240624|NCT02745119|516432057|FG000|Overall Study|Adverse Event|1|||
143240625|NCT02745119|516432058|FG001|Overall Study|Adverse Event|0|||
143240626|NCT02745119|516432059|FG002|Overall Study|Adverse Event|1|||
143240627|NCT02745119|516432060|FG003|Overall Study|Adverse Event|3|||
143240628|NCT02745119|516432057|FG000|Overall Study|Death|3|||
143240629|NCT02745119|516432058|FG001|Overall Study|Death|3|||
143240630|NCT02745119|516432059|FG002|Overall Study|Death|0|||
143240631|NCT02745119|516432060|FG003|Overall Study|Death|4|||
143240632|NCT02745119|516432057|FG000|Overall Study|Lost to Follow-up|0|||
143240633|NCT02745119|516432058|FG001|Overall Study|Lost to Follow-up|0|||
143240634|NCT02745119|516432059|FG002|Overall Study|Lost to Follow-up|0|||
143240635|NCT02745119|516432060|FG003|Overall Study|Lost to Follow-up|1|||
143240636|NCT02745119|516432057|FG000|Overall Study|Protocol Deviation|0|||
143240637|NCT02745119|516432058|FG001|Overall Study|Protocol Deviation|0|||
143240638|NCT02745119|516432059|FG002|Overall Study|Protocol Deviation|0|||
143240639|NCT02745119|516432060|FG003|Overall Study|Protocol Deviation|1|||
143240640|NCT02745119|516432057|FG000|Overall Study|Withdrawal by Subject|7|||
143240641|NCT02745119|516432058|FG001|Overall Study|Withdrawal by Subject|15|||
143240642|NCT02745119|516432059|FG002|Overall Study|Withdrawal by Subject|8|||
143240643|NCT02745119|516432060|FG003|Overall Study|Withdrawal by Subject|14|||
143240644|NCT02745119|516432057|FG000|Overall Study|Study Terminated by Sponsor|134|||
143240645|NCT02745119|516432058|FG001|Overall Study|Study Terminated by Sponsor|252|||
143240646|NCT02745119|516432059|FG002|Overall Study|Study Terminated by Sponsor|135|||
143240647|NCT02745119|516432060|FG003|Overall Study|Study Terminated by Sponsor|251|||
143240648|NCT02745119|516432057|FG000|Overall Study|Physician Decision|0|||
143240649|NCT02745119|516432058|FG001|Overall Study|Physician Decision|2|||
143240650|NCT02745119|516432059|FG002|Overall Study|Physician Decision|2|||
143240651|NCT02745119|516432060|FG003|Overall Study|Physician Decision|2|||
143240652|NCT02745119|516432057|FG000|Overall Study|Reason Not Specified|0|||
143240653|NCT02745119|516432058|FG001|Overall Study|Reason Not Specified|2|||
143240654|NCT02745119|516432059|FG002|Overall Study|Reason Not Specified|0|||
143240655|NCT02745119|516432060|FG003|Overall Study|Reason Not Specified|1|||
143240656|NCT00888940|516432061|FG000|Overall Study|Adverse Event|12|||
143240657|NCT00888940|516432062|FG001|Overall Study|Adverse Event|3|||
143240658|NCT00888940|516432061|FG000|Overall Study|Lost to Follow-up|5|||
143043337|NCT00673660|515699306|FG000|Overall Study|Lost to Follow-up|107|||
143043338|NCT01527006|515699307|FG000|Core Study|Adverse Event|0|||
143364251|NCT01251614|516876936|FG002|Overall Study|Adverse Event|1|||
143043339|NCT01527006|515699308|FG001|Core Study|Adverse Event|2|||
143043340|NCT01527006|515699307|FG000|Core Study|Lost to Follow-up|0|||
143043341|NCT01527006|515699308|FG001|Core Study|Lost to Follow-up|1|||
143240659|NCT00888940|516432062|FG001|Overall Study|Lost to Follow-up|5|||
143240660|NCT00888940|516432061|FG000|Overall Study|Randomized Not Treated|11|||
143364252|NCT01251614|516876934|FG000|Overall Study|Lack of Efficacy|1|||
143043342|NCT01527006|515699307|FG000|Core Study|Subject Choice|1|||
143240661|NCT00888940|516432062|FG001|Overall Study|Randomized Not Treated|13|||
143165105|NCT03715829|516151502|FG009|Extension Period|Withdrawal by Subject|3|||
143165106|NCT03715829|516151503|FG010|Extension Period|Withdrawal by Subject|0|||
143165107|NCT03715829|516151493|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
143165108|NCT03715829|516151494|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
143165109|NCT03715829|516151495|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
143165110|NCT03715829|516151496|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
143165111|NCT03715829|516151497|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
143165112|NCT03715829|516151498|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
143165113|NCT03715829|516151499|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
143165114|NCT03715829|516151500|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
143165115|NCT03715829|516151501|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
143165116|NCT03715829|516151502|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
143165117|NCT03715829|516151503|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
143165118|NCT03715829|516151493|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
143165119|NCT03715829|516151494|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
143165120|NCT03715829|516151495|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
143165121|NCT03715829|516151496|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
143165122|NCT03715829|516151497|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
143165123|NCT03715829|516151498|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
143165124|NCT03715829|516151499|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
143165125|NCT03715829|516151500|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
143165126|NCT03715829|516151501|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
143165127|NCT03715829|516151502|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
143165128|NCT03715829|516151503|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
143165129|NCT03715829|516151493|FG000|Extension Period|Other|0|||
143165130|NCT03715829|516151494|FG001|Extension Period|Other|0|||
143165131|NCT03715829|516151495|FG002|Extension Period|Other|0|||
143165132|NCT03715829|516151496|FG003|Extension Period|Other|0|||
143165133|NCT03715829|516151497|FG004|Extension Period|Other|0|||
143165134|NCT03715829|516151498|FG005|Extension Period|Other|0|||
143165135|NCT03715829|516151499|FG006|Extension Period|Other|1|||
143165136|NCT03715829|516151500|FG007|Extension Period|Other|2|||
143165137|NCT03715829|516151501|FG008|Extension Period|Other|4|||
143165138|NCT03715829|516151502|FG009|Extension Period|Other|0|||
143165139|NCT03715829|516151503|FG010|Extension Period|Other|0|||
143165140|NCT03579719|516151506|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
143165141|NCT01443026|516151507|FG000|Overall Study|Physician Decision|1|||
143165142|NCT01443026|516151508|FG001|Overall Study|Physician Decision|0|||
143165143|NCT01443026|516151507|FG000|Overall Study|Death|0|||
143165144|NCT01443026|516151508|FG001|Overall Study|Death|1|||
143165145|NCT01443026|516151507|FG000|Overall Study|Withdrawal by Subject|0|||
143165146|NCT01443026|516151508|FG001|Overall Study|Withdrawal by Subject|3|||
143165147|NCT01443026|516151507|FG000|Overall Study|Lost to Follow-up|2|||
143165148|NCT01443026|516151508|FG001|Overall Study|Lost to Follow-up|1|||
143165149|NCT00069953|516151509|FG000|Overall Study|Protocol Violation|2|||
143165150|NCT02034565|516151510|FG000|Overall Study|Adverse Event|1|||
143165151|NCT02034565|516151511|FG001|Overall Study|Adverse Event|0|||
143165152|NCT00581919|516151512|FG000|Overall Study|Adverse Event|8|||
143165153|NCT00581919|516151512|FG000|Overall Study|Death|1|||
143165154|NCT00581919|516151512|FG000|Overall Study|Disease Progression|10|||
143498343|NCT00510276|517366310|FG000|Extension Open-Label Phase|Protocol Violation|0|||
143498344|NCT00510276|517366311|FG001|Extension Open-Label Phase|Protocol Violation|1|||
143498345|NCT00510276|517366310|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
143498346|NCT00510276|517366311|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
143498347|NCT00510276|517366310|FG000|Extension Open-Label Phase|Subject Decision|7|||
143498348|NCT00510276|517366311|FG001|Extension Open-Label Phase|Subject Decision|9|||
143498349|NCT03486392|517366312|FG000|Overall Study|Lost to Follow-up|0|||
143498350|NCT03486392|517366313|FG001|Overall Study|Lost to Follow-up|0|||
143498351|NCT03486392|517366314|FG002|Overall Study|Lost to Follow-up|8|||
143498352|NCT03486392|517366315|FG003|Overall Study|Lost to Follow-up|5|||
143498353|NCT03486392|517366316|FG004|Overall Study|Lost to Follow-up|2|||
143498354|NCT03486392|517366312|FG000|Overall Study|Withdrawal by Subject|3|||
143498355|NCT03486392|517366313|FG001|Overall Study|Withdrawal by Subject|0|||
143498356|NCT03486392|517366314|FG002|Overall Study|Withdrawal by Subject|6|||
143498357|NCT03486392|517366315|FG003|Overall Study|Withdrawal by Subject|4|||
143498358|NCT03486392|517366316|FG004|Overall Study|Withdrawal by Subject|1|||
143165155|NCT00581919|516151512|FG000|Overall Study|Physician Decision|1|||
143165156|NCT00581919|516151512|FG000|Overall Study|Other Complicating Disease|1|||
143165157|NCT00581919|516151512|FG000|Overall Study|Started Non-Protocol Therapy|2|||
143165158|NCT00581919|516151512|FG000|Overall Study|Withdrawal by Subject|1|||
143165159|NCT01646216|516151513|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
143498359|NCT03486392|517366312|FG000|Overall Study|Death|0|||
143498360|NCT03486392|517366313|FG001|Overall Study|Death|0|||
143043343|NCT01527006|515699308|FG001|Core Study|Subject Choice|0|||
143043344|NCT01527006|515699307|FG000|Core Study|Inadequate Therapeutic Effect|1|||
143165160|NCT01646216|516151514|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
143165161|NCT01646216|516151513|FG000|Overall Study|Did not complete training|0|||
143165162|NCT01646216|516151514|FG001|Overall Study|Did not complete training|2|||
143165163|NCT01646216|516151513|FG000|Overall Study|Investigator decision|1|||
143165164|NCT01646216|516151514|FG001|Overall Study|Investigator decision|1|||
143165165|NCT00113373|516151517|FG000|Overall Study|Ineligible: wrong primary|1|||
143165166|NCT00113373|516151517|FG000|Overall Study|Ineligible: second primary|1|||
143165167|NCT00113373|516151517|FG000|Overall Study|Never Treated|1|||
143165168|NCT02395627|516151518|FG000|Overall Study|Withdrawal by Subject|0|||
143165169|NCT02395627|516151519|FG001|Overall Study|Withdrawal by Subject|2|||
143165170|NCT02395627|516151520|FG002|Overall Study|Withdrawal by Subject|0|||
143165171|NCT02395627|516151518|FG000|Overall Study|Did not receive pembrolizumab|3|||
143165172|NCT02395627|516151519|FG001|Overall Study|Did not receive pembrolizumab|1|||
143165173|NCT02395627|516151520|FG002|Overall Study|Did not receive pembrolizumab|0|||
143165174|NCT03253627|516151522|FG000|Overall Study|Lost to Follow-up|1|||
143165175|NCT03253627|516151523|FG001|Overall Study|Lost to Follow-up|2|||
143165176|NCT03253627|516151522|FG000|Overall Study|Withdrawal by Subject|0|||
143165177|NCT03253627|516151523|FG001|Overall Study|Withdrawal by Subject|2|||
143165178|NCT03253627|516151522|FG000|Overall Study|Inability to complete MRI|1|||
143165179|NCT03253627|516151523|FG001|Overall Study|Inability to complete MRI|0|||
143165180|NCT03829683|516151524|FG000|Overall Study|Lost to Follow-up|1|||
143165181|NCT03829683|516151525|FG001|Overall Study|Lost to Follow-up|0|||
143165182|NCT03829683|516151524|FG000|Overall Study|Physician Decision|3|||
143165183|NCT03829683|516151525|FG001|Overall Study|Physician Decision|1|||
143165184|NCT03829683|516151524|FG000|Overall Study|Withdrawal by Subject|0|||
143165185|NCT03829683|516151525|FG001|Overall Study|Withdrawal by Subject|1|||
143165186|NCT03829683|516151524|FG000|Overall Study|Discharge from hospital|1|||
143165187|NCT03829683|516151525|FG001|Overall Study|Discharge from hospital|0|||
143165188|NCT00855166|516151526|FG000|Overall Study|Adverse Event|0|||
143165189|NCT00855166|516151527|FG001|Overall Study|Adverse Event|2|||
143165190|NCT00855166|516151526|FG000|Overall Study|Death|0|||
143165191|NCT00855166|516151527|FG001|Overall Study|Death|1|||
143165192|NCT00855166|516151526|FG000|Overall Study|Withdrawal by Subject|1|||
143165193|NCT00855166|516151527|FG001|Overall Study|Withdrawal by Subject|4|||
143165194|NCT00855166|516151526|FG000|Overall Study|Poor/non-compliance|2|||
143165195|NCT00855166|516151527|FG001|Overall Study|Poor/non-compliance|0|||
143165196|NCT00855166|516151526|FG000|Overall Study|Administrative reasons by sponsor|1|||
143165197|NCT00855166|516151527|FG001|Overall Study|Administrative reasons by sponsor|0|||
143165198|NCT00855166|516151526|FG000|Overall Study|Subject no longer meets study criteria|1|||
143165199|NCT00855166|516151527|FG001|Overall Study|Subject no longer meets study criteria|1|||
143165200|NCT04806373|516151533|FG000|Overall Study|Withdrawal by Subject|1|||
143165201|NCT04806373|516151534|FG001|Overall Study|Withdrawal by Subject|1|||
143165202|NCT05810597|516151535|FG000|Period 1|Adverse Event|2|||
143165203|NCT05810597|516151536|FG001|Period 1|Adverse Event|0|||
143165204|NCT05810597|516151535|FG000|Period 1|Physician Decision|1|||
143165205|NCT05810597|516151536|FG001|Period 1|Physician Decision|0|||
143165206|NCT02061085|516151541|FG000|Overall Study|Adverse Event|8|||
143165207|NCT04903093|516151542|FG000|Overall Study|Withdrawal by Subject|0|||
143165208|NCT04903093|516151543|FG001|Overall Study|Withdrawal by Subject|0|||
143165209|NCT04903093|516151544|FG002|Overall Study|Withdrawal by Subject|0|||
143165210|NCT04903093|516151545|FG003|Overall Study|Withdrawal by Subject|1|||
143165211|NCT04903093|516151546|FG004|Overall Study|Withdrawal by Subject|0|||
143165212|NCT04903093|516151547|FG005|Overall Study|Withdrawal by Subject|0|||
143165213|NCT02412436|516151557|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
143165214|NCT02412436|516151557|FG000|Overall Study|Lost to Follow-up|6|||
143165215|NCT02412436|516151557|FG000|Overall Study|Unable to get to clinic|3|||
143165216|NCT02412436|516151557|FG000|Overall Study|Death|1|||
143165217|NCT02412436|516151557|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
143165218|NCT00392288|516151558|FG000|Overall Study|Adverse Event|17|||
143165219|NCT00392288|516151559|FG001|Overall Study|Adverse Event|7|||
143165220|NCT00392288|516151560|FG002|Overall Study|Adverse Event|8|||
143165221|NCT00392288|516151558|FG000|Overall Study|Lack of Efficacy|8|||
143165222|NCT00392288|516151559|FG001|Overall Study|Lack of Efficacy|5|||
143165223|NCT00392288|516151560|FG002|Overall Study|Lack of Efficacy|3|||
143165224|NCT00392288|516151558|FG000|Overall Study|Protocol Violation|1|||
143165225|NCT00392288|516151559|FG001|Overall Study|Protocol Violation|3|||
143165226|NCT00392288|516151560|FG002|Overall Study|Protocol Violation|1|||
143165227|NCT00392288|516151558|FG000|Overall Study|Lost to Follow-up|1|||
143165228|NCT00392288|516151559|FG001|Overall Study|Lost to Follow-up|1|||
143165229|NCT00392288|516151560|FG002|Overall Study|Lost to Follow-up|1|||
143165230|NCT00392288|516151558|FG000|Overall Study|Withdrawal by Subject|1|||
143165231|NCT00392288|516151559|FG001|Overall Study|Withdrawal by Subject|0|||
143165232|NCT00392288|516151560|FG002|Overall Study|Withdrawal by Subject|2|||
143165233|NCT00392288|516151558|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
143165234|NCT00392288|516151559|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
143165235|NCT00392288|516151560|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
143165236|NCT00392288|516151558|FG000|Overall Study|Other|3|||
143165237|NCT00392288|516151559|FG001|Overall Study|Other|4|||
143165238|NCT00392288|516151560|FG002|Overall Study|Other|1|||
143165239|NCT02544763|516151561|FG000|Overall Study|Adverse Event|8|||
143165240|NCT02544763|516151562|FG001|Overall Study|Adverse Event|8|||
143165241|NCT02544763|516151563|FG002|Overall Study|Adverse Event|0|||
143165242|NCT02544763|516151561|FG000|Overall Study|Withdrawn by parent/guardian|1|||
143165243|NCT02544763|516151562|FG001|Overall Study|Withdrawn by parent/guardian|1|||
143165244|NCT02544763|516151563|FG002|Overall Study|Withdrawn by parent/guardian|1|||
143165245|NCT02544763|516151561|FG000|Overall Study|Met withdrawal criteria|0|||
143165246|NCT02544763|516151562|FG001|Overall Study|Met withdrawal criteria|2|||
143165247|NCT02544763|516151563|FG002|Overall Study|Met withdrawal criteria|0|||
143165248|NCT02544763|516151561|FG000|Overall Study|Physician Decision|0|||
143165249|NCT02544763|516151562|FG001|Overall Study|Physician Decision|1|||
143165250|NCT02544763|516151563|FG002|Overall Study|Physician Decision|0|||
143165251|NCT02544763|516151561|FG000|Overall Study|Difficulties taking IMP|1|||
143165252|NCT02544763|516151562|FG001|Overall Study|Difficulties taking IMP|0|||
143165253|NCT02544763|516151563|FG002|Overall Study|Difficulties taking IMP|0|||
143165254|NCT01111552|516151564|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
143165255|NCT01111552|516151565|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
143165256|NCT01111552|516151566|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
143165257|NCT01111552|516151567|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
143165258|NCT01111552|516151568|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
143165259|NCT01111552|516151564|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
143165260|NCT01111552|516151565|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
143165261|NCT01111552|516151566|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
143165262|NCT01111552|516151567|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
143165263|NCT01111552|516151568|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
143165264|NCT01111552|516151564|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
143165265|NCT01111552|516151565|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
143165266|NCT01111552|516151566|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
143165267|NCT01111552|516151567|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
143165268|NCT01111552|516151568|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
143165269|NCT01111552|516151564|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
143498361|NCT03486392|517366314|FG002|Overall Study|Death|0|||
143165270|NCT01111552|516151565|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
143165271|NCT01111552|516151566|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
143165272|NCT01111552|516151567|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
143165273|NCT01111552|516151568|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
143165274|NCT01111552|516151564|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
143165275|NCT01111552|516151565|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
143165276|NCT01111552|516151566|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
143165277|NCT01111552|516151567|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
143165278|NCT01111552|516151568|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
143165279|NCT01111552|516151564|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
143165280|NCT01111552|516151565|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
143165281|NCT01111552|516151566|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
143165282|NCT01111552|516151567|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
143165283|NCT01111552|516151568|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
143165284|NCT01111552|516151564|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
143165285|NCT01111552|516151565|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
143165286|NCT01111552|516151566|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
143165287|NCT01111552|516151567|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
143165288|NCT01111552|516151568|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
143165289|NCT01111552|516151564|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
143165290|NCT01111552|516151565|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
143165291|NCT01111552|516151566|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
143165292|NCT01111552|516151567|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
143165293|NCT01111552|516151568|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
143165294|NCT01111552|516151564|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
143165295|NCT01111552|516151565|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
143165296|NCT01111552|516151566|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
143165297|NCT01111552|516151567|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
143165298|NCT01111552|516151568|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
143165299|NCT01111552|516151564|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
143165300|NCT01111552|516151565|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
143165301|NCT01111552|516151566|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
143165302|NCT01111552|516151567|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
143165303|NCT01111552|516151568|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
143165304|NCT01111552|516151564|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
143165305|NCT01111552|516151565|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
143165306|NCT01111552|516151566|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
143165307|NCT01111552|516151567|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
143165308|NCT01111552|516151568|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
143165309|NCT01111552|516151564|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
143165310|NCT01111552|516151565|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
143165311|NCT01111552|516151566|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
143165312|NCT01111552|516151567|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
143165313|NCT01111552|516151568|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
143165314|NCT01111552|516151564|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
143165315|NCT01111552|516151565|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
143165316|NCT01111552|516151566|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
143165317|NCT01111552|516151567|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
143165318|NCT01111552|516151568|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
143165319|NCT01111552|516151564|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
143165320|NCT01111552|516151565|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
143165321|NCT01111552|516151566|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
143165322|NCT01111552|516151567|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
143165323|NCT01111552|516151568|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
143165324|NCT01027351|516151570|FG000|Overall Study|Withdrawal by Subject|1|||
143165325|NCT01027351|516151571|FG001|Overall Study|Withdrawal by Subject|0|||
143165326|NCT01027351|516151572|FG002|Overall Study|Withdrawal by Subject|1|||
143165327|NCT01027351|516151573|FG003|Overall Study|Withdrawal by Subject|0|||
143165328|NCT01027351|516151574|FG004|Overall Study|Withdrawal by Subject|3|||
143165329|NCT01027351|516151575|FG005|Overall Study|Withdrawal by Subject|5|||
143165330|NCT01027351|516151570|FG000|Overall Study|Lost to Follow-up|1|||
143165331|NCT01027351|516151571|FG001|Overall Study|Lost to Follow-up|1|||
143165332|NCT01027351|516151572|FG002|Overall Study|Lost to Follow-up|0|||
143498362|NCT03486392|517366315|FG003|Overall Study|Death|0|||
143498363|NCT03486392|517366316|FG004|Overall Study|Death|1|||
143498364|NCT01318122|517366317|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
143498365|NCT01318122|517366318|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
143498366|NCT01318122|517366319|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
143498367|NCT01318122|517366320|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
143498368|NCT01318122|517366317|FG000|Enrolled - Long-Term Extension Study|Other|1|||
143498369|NCT01318122|517366318|FG001|Enrolled - Long-Term Extension Study|Other|0|||
143498370|NCT01318122|517366319|FG002|Enrolled - Long-Term Extension Study|Other|0|||
143498371|NCT01318122|517366320|FG003|Enrolled - Long-Term Extension Study|Other|0|||
143498372|NCT01318122|517366317|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
143498373|NCT01318122|517366318|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
143498374|NCT01318122|517366319|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
143498375|NCT01318122|517366320|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
143498376|NCT01318122|517366317|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
143498377|NCT01318122|517366318|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
143498378|NCT01318122|517366319|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
143498379|NCT01318122|517366320|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
143498380|NCT01318122|517366317|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
143498381|NCT01318122|517366318|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
143498382|NCT01318122|517366319|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
143498383|NCT01318122|517366320|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
143498384|NCT01318122|517366317|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
143498385|NCT01318122|517366318|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
143498386|NCT01318122|517366319|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
143498387|NCT01318122|517366320|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
143498388|NCT01486199|517366321|FG000|Two Year Period Between Study Days|Physician Decision|1|||
143498389|NCT01486199|517366322|FG001|Two Year Period Between Study Days|Physician Decision|0|||
143498390|NCT00130286|517366326|FG000|Overall Study|Withdrawal by Subject|0|||
143498391|NCT00130286|517366327|FG001|Overall Study|Withdrawal by Subject|1|||
143498392|NCT00130286|517366328|FG002|Overall Study|Withdrawal by Subject|2|||
143498393|NCT00130286|517366329|FG003|Overall Study|Withdrawal by Subject|2|||
143498394|NCT00130286|517366326|FG000|Overall Study|Adverse Event|0|||
143498395|NCT00130286|517366327|FG001|Overall Study|Adverse Event|0|||
143498396|NCT00130286|517366328|FG002|Overall Study|Adverse Event|2|||
143498397|NCT00130286|517366329|FG003|Overall Study|Adverse Event|0|||
143498398|NCT00130286|517366326|FG000|Overall Study|Missing lab specimens|0|||
143498399|NCT00130286|517366327|FG001|Overall Study|Missing lab specimens|2|||
143498400|NCT00130286|517366328|FG002|Overall Study|Missing lab specimens|0|||
143498401|NCT00130286|517366329|FG003|Overall Study|Missing lab specimens|0|||
143498402|NCT02211261|517366336|FG000|Overall Study|Withdrawal by Subject|0|||
143165333|NCT01027351|516151573|FG003|Overall Study|Lost to Follow-up|1|||
143165334|NCT01027351|516151574|FG004|Overall Study|Lost to Follow-up|6|||
143165335|NCT01027351|516151575|FG005|Overall Study|Lost to Follow-up|0|||
143165336|NCT01027351|516151570|FG000|Overall Study|Inappropriate enrollment|0|||
143165337|NCT01027351|516151571|FG001|Overall Study|Inappropriate enrollment|0|||
143165338|NCT01027351|516151572|FG002|Overall Study|Inappropriate enrollment|0|||
143165339|NCT01027351|516151573|FG003|Overall Study|Inappropriate enrollment|0|||
143165340|NCT01027351|516151574|FG004|Overall Study|Inappropriate enrollment|1|||
143165341|NCT01027351|516151575|FG005|Overall Study|Inappropriate enrollment|0|||
143165342|NCT01027351|516151570|FG000|Overall Study|Protocol Violation|1|||
143165343|NCT01027351|516151571|FG001|Overall Study|Protocol Violation|0|||
143165344|NCT01027351|516151572|FG002|Overall Study|Protocol Violation|0|||
143165345|NCT01027351|516151573|FG003|Overall Study|Protocol Violation|1|||
143165346|NCT01027351|516151574|FG004|Overall Study|Protocol Violation|1|||
143165347|NCT01027351|516151575|FG005|Overall Study|Protocol Violation|0|||
143165348|NCT04650893|516151576|FG000|Overall Study|Lost to Follow-up|11|||
143165349|NCT04650893|516151577|FG001|Overall Study|Lost to Follow-up|10|||
143165350|NCT04650893|516151578|FG002|Overall Study|Lost to Follow-up|11|||
143165351|NCT04090749|516151581|FG000|Open Label Pilot|Lost to Follow-up|1|||
143364253|NCT01251614|516876935|FG001|Overall Study|Lack of Efficacy|9|||
143498403|NCT02211261|517366337|FG001|Overall Study|Withdrawal by Subject|0|||
143498404|NCT02211261|517366338|FG002|Overall Study|Withdrawal by Subject|1|||
143498405|NCT02211261|517366339|FG003|Overall Study|Withdrawal by Subject|0|||
143498406|NCT02211261|517366340|FG004|Overall Study|Withdrawal by Subject|2|||
143498407|NCT02211261|517366341|FG005|Overall Study|Withdrawal by Subject|0|||
143498408|NCT02211261|517366342|FG006|Overall Study|Withdrawal by Subject|0|||
143498409|NCT02211261|517366343|FG007|Overall Study|Withdrawal by Subject|0|||
143498410|NCT02211261|517366344|FG008|Overall Study|Withdrawal by Subject|0|||
143165352|NCT04090749|516151582|FG001|Open Label Pilot|Lost to Follow-up|0|||
143165353|NCT04090749|516151583|FG002|Open Label Pilot|Lost to Follow-up|0|||
143165354|NCT04090749|516151581|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
143165355|NCT04090749|516151582|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
143364254|NCT01251614|516876936|FG002|Overall Study|Lack of Efficacy|4|||
143498411|NCT02211261|517366345|FG009|Overall Study|Withdrawal by Subject|0|||
143498412|NCT02211261|517366346|FG010|Overall Study|Withdrawal by Subject|0|||
143498413|NCT02211261|517366336|FG000|Overall Study|Other|0|||
143498414|NCT02211261|517366337|FG001|Overall Study|Other|0|||
143165356|NCT04090749|516151583|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
143165357|NCT04090749|516151581|FG000|Pilot Trial|Lost to Follow-up|0|||
143165358|NCT04090749|516151582|FG001|Pilot Trial|Lost to Follow-up|1|||
143165359|NCT04090749|516151583|FG002|Pilot Trial|Lost to Follow-up|1|||
143165360|NCT02528305|516151584|FG000|Overall Study|Withdrawal by Subject|1|||
143165361|NCT02528305|516151584|FG000|Overall Study|Adverse Event|1|||
143165362|NCT02528305|516151584|FG000|Overall Study|Physician Decision|1|||
143165363|NCT04091438|516151585|FG000|Treatment Period 1 (1 Day)|Other|1|||
143165364|NCT04091438|516151586|FG001|Treatment Period 1 (1 Day)|Other|0|||
143165365|NCT04091438|516151585|FG000|Washout Period (1 Day)|Protocol deviation|0|||
143165366|NCT04091438|516151586|FG001|Washout Period (1 Day)|Protocol deviation|1|||
143165367|NCT04091438|516151585|FG000|Washout Period (1 Day)|Other|0|||
143165368|NCT04091438|516151586|FG001|Washout Period (1 Day)|Other|1|||
143165369|NCT02691494|516151591|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
143165370|NCT02691494|516151592|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
143165371|NCT02691494|516151593|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
143165372|NCT02691494|516151591|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
143165373|NCT02691494|516151592|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
143165374|NCT02691494|516151593|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
143165375|NCT02691494|516151591|FG000|Post-Treatment Follow-Up Period|Other|2|||
143165376|NCT02691494|516151592|FG001|Post-Treatment Follow-Up Period|Other|1|||
143165377|NCT02691494|516151593|FG002|Post-Treatment Follow-Up Period|Other|1|||
143165378|NCT02691494|516151591|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
143165379|NCT02691494|516151592|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
143165380|NCT02691494|516151593|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
143165381|NCT02691494|516151591|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
143165382|NCT02691494|516151592|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
143165383|NCT02691494|516151593|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
143165384|NCT00773461|516151594|FG000|Overall Study|Adverse Event|1|||
143165385|NCT00773461|516151595|FG001|Overall Study|Adverse Event|3|||
143165386|NCT00773461|516151594|FG000|Overall Study|Withdrawal by Subject|4|||
143165387|NCT00773461|516151595|FG001|Overall Study|Withdrawal by Subject|1|||
143165388|NCT03249558|516151596|FG000|Overall Study|Lost to Follow-up|2|||
143165389|NCT03249558|516151597|FG001|Overall Study|Lost to Follow-up|1|||
143165390|NCT03249558|516151598|FG002|Overall Study|Lost to Follow-up|4|||
143165391|NCT03249558|516151596|FG000|Overall Study|Physician Decision|1|||
143165392|NCT03249558|516151597|FG001|Overall Study|Physician Decision|0|||
143165393|NCT03249558|516151598|FG002|Overall Study|Physician Decision|0|||
143165394|NCT03249558|516151596|FG000|Overall Study|Withdrawal by Subject|6|||
143165395|NCT03249558|516151597|FG001|Overall Study|Withdrawal by Subject|5|||
143165396|NCT03249558|516151598|FG002|Overall Study|Withdrawal by Subject|7|||
143165397|NCT03249558|516151596|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
143165398|NCT03249558|516151597|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
143165399|NCT03249558|516151598|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
143165400|NCT03249558|516151596|FG000|Overall Study|Protocol Violation|1|||
143165401|NCT03249558|516151597|FG001|Overall Study|Protocol Violation|1|||
143165402|NCT03249558|516151598|FG002|Overall Study|Protocol Violation|2|||
143165403|NCT02657356|516153485|FG000|Overall Study|Death|1|||
143165404|NCT02657356|516153486|FG001|Overall Study|Death|0|||
143165405|NCT02657356|516153485|FG000|Overall Study|Withdrawal by Subject|5|||
143165406|NCT02657356|516153486|FG001|Overall Study|Withdrawal by Subject|6|||
143165407|NCT02657356|516153485|FG000|Overall Study|Terminated by Sponsor|8|||
143165408|NCT02657356|516153486|FG001|Overall Study|Terminated by Sponsor|5|||
143165409|NCT02657356|516153485|FG000|Overall Study|Rolled over to EAP study|6|||
143165410|NCT02657356|516153486|FG001|Overall Study|Rolled over to EAP study|4|||
143165411|NCT02471144|516153489|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
143165412|NCT02471144|516153490|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
143165413|NCT02471144|516153491|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
143165414|NCT02471144|516153492|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
143165415|NCT02471144|516153493|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
143364255|NCT01251614|516876934|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
143364256|NCT01251614|516876935|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
143165416|NCT02471144|516153494|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
143165417|NCT02471144|516153495|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
143165418|NCT02471144|516153496|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
143165419|NCT02471144|516153497|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
143165420|NCT02471144|516153498|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
143165421|NCT02471144|516153499|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
143364257|NCT01251614|516876936|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
143165422|NCT02471144|516153489|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
143165423|NCT02471144|516153490|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
143165424|NCT02471144|516153491|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
143165425|NCT02471144|516153492|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
143165426|NCT02471144|516153493|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
143165427|NCT02471144|516153494|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
143165428|NCT02471144|516153495|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
143165429|NCT02471144|516153496|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
143165430|NCT02471144|516153497|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
143165431|NCT02471144|516153498|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
143165432|NCT02471144|516153499|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
143165433|NCT02471144|516153489|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
143165434|NCT02471144|516153490|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
143165435|NCT02471144|516153491|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
143165436|NCT02471144|516153492|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
143165437|NCT02471144|516153493|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
143165438|NCT02471144|516153494|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
143165439|NCT02471144|516153495|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
143165440|NCT02471144|516153496|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
143165441|NCT02471144|516153497|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
143165442|NCT02471144|516153498|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
143165443|NCT02471144|516153499|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
143165444|NCT02471144|516153489|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
143165445|NCT02471144|516153490|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
143165446|NCT02471144|516153491|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
143165447|NCT02471144|516153492|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
143165448|NCT02471144|516153493|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
143165449|NCT02471144|516153494|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
143165450|NCT02471144|516153495|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
143165451|NCT02471144|516153496|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
143165452|NCT02471144|516153497|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
143165453|NCT02471144|516153498|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
143165454|NCT02471144|516153499|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
143165455|NCT02471144|516153489|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
143165456|NCT02471144|516153490|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
143165457|NCT02471144|516153491|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
143165458|NCT02471144|516153492|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
143165459|NCT02471144|516153493|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
143165460|NCT02471144|516153494|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
143165461|NCT02471144|516153495|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
143165462|NCT02471144|516153496|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
143165463|NCT02471144|516153497|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
143165464|NCT02471144|516153498|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
143165465|NCT02471144|516153499|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
143165466|NCT02471144|516153489|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
143165467|NCT02471144|516153490|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
143165468|NCT02471144|516153491|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
143165469|NCT02471144|516153492|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
143165470|NCT02471144|516153493|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
143165471|NCT02471144|516153494|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
143165472|NCT02471144|516153495|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
143165473|NCT02471144|516153496|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
143165474|NCT02471144|516153497|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
143165475|NCT02471144|516153498|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
143165476|NCT02471144|516153499|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
143165477|NCT02471144|516153489|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
143165478|NCT02471144|516153490|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
143165479|NCT02471144|516153491|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
143165480|NCT02471144|516153492|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
143165481|NCT02471144|516153493|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
143165482|NCT02471144|516153494|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
143165483|NCT02471144|516153495|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
143165484|NCT02471144|516153496|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
143165485|NCT02471144|516153497|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
143165486|NCT02471144|516153498|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
143498415|NCT02211261|517366338|FG002|Overall Study|Other|0|||
143165487|NCT02471144|516153499|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
143165488|NCT02471144|516153489|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
143165489|NCT02471144|516153490|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
143165490|NCT02471144|516153491|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
143165491|NCT02471144|516153492|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
143165492|NCT02471144|516153493|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
143165493|NCT02471144|516153494|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
143165494|NCT02471144|516153495|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
143165495|NCT02471144|516153496|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
143165496|NCT02471144|516153497|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
143165497|NCT02471144|516153498|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
143165498|NCT02471144|516153499|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
143165499|NCT02471144|516153489|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
143165500|NCT02471144|516153490|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
143165501|NCT02471144|516153491|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
143165502|NCT02471144|516153492|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
143165503|NCT02471144|516153493|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
143165504|NCT02471144|516153494|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
143165505|NCT02471144|516153495|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
143165506|NCT02471144|516153496|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
143165507|NCT02471144|516153497|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
143165508|NCT02471144|516153498|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
143165509|NCT02471144|516153499|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
143165510|NCT02471144|516153489|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
143165511|NCT02471144|516153490|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
143165512|NCT02471144|516153491|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
143165513|NCT02471144|516153492|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
143165514|NCT02471144|516153493|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
143165515|NCT02471144|516153494|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
143165516|NCT02471144|516153495|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
143165517|NCT02471144|516153496|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
143165518|NCT02471144|516153497|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
143165519|NCT02471144|516153498|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
143165520|NCT02471144|516153499|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
143165521|NCT02471144|516153489|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
143165522|NCT02471144|516153490|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
143165523|NCT02471144|516153491|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
143165524|NCT02471144|516153492|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
143165525|NCT02471144|516153493|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
143165526|NCT02471144|516153494|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
143165527|NCT02471144|516153495|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
143165528|NCT02471144|516153496|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
143165529|NCT02471144|516153497|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
143165530|NCT02471144|516153498|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
143165531|NCT02471144|516153499|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
143165532|NCT02471144|516153489|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
143165533|NCT02471144|516153490|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
143165534|NCT02471144|516153491|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
143165535|NCT02471144|516153492|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
143165536|NCT02471144|516153493|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
143165537|NCT02471144|516153494|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
143165538|NCT02471144|516153495|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
143165539|NCT02471144|516153496|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
143165540|NCT02471144|516153497|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
143165541|NCT02471144|516153498|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
143165542|NCT02471144|516153499|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
143165543|NCT02471144|516153489|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
143165544|NCT02471144|516153490|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
143165545|NCT02471144|516153491|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
143165546|NCT02471144|516153492|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
143165547|NCT02471144|516153493|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
143165548|NCT02471144|516153494|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
143165549|NCT02471144|516153495|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
143498416|NCT02211261|517366339|FG003|Overall Study|Other|0|||
143165550|NCT02471144|516153496|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
143165551|NCT02471144|516153497|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
143165552|NCT02471144|516153498|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
143165553|NCT02471144|516153499|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
143165554|NCT02471144|516153489|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
143165555|NCT02471144|516153490|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
143165556|NCT02471144|516153491|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
143165557|NCT02471144|516153492|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
143165558|NCT02471144|516153493|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
143165559|NCT02471144|516153494|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
143165560|NCT02471144|516153495|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
143165561|NCT02471144|516153496|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
143165562|NCT02471144|516153497|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
143165563|NCT02471144|516153498|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
143165564|NCT02471144|516153499|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
143165565|NCT04280783|516153500|FG000|Overall Study|Family issues unrelated to the study.|1|||
143165566|NCT04280783|516153501|FG001|Overall Study|Family issues unrelated to the study.|0|||
143165567|NCT04280783|516153500|FG000|Overall Study|Withdrawal by Subject|0|||
143165568|NCT04280783|516153501|FG001|Overall Study|Withdrawal by Subject|1|||
143165569|NCT04110145|516153502|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
143165570|NCT04110145|516153503|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
143165571|NCT04110145|516153504|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
143165572|NCT04110145|516153505|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
143165573|NCT04110145|516153506|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
143165574|NCT02254291|516153507|FG000|Overall Study|Withdrawal by Subject|0|||
143165575|NCT02254291|516153508|FG001|Overall Study|Withdrawal by Subject|3|||
143165576|NCT02254291|516153509|FG002|Overall Study|Withdrawal by Subject|1|||
143165577|NCT02254291|516153507|FG000|Overall Study|Missing follow-up information|0|||
143165578|NCT02254291|516153508|FG001|Overall Study|Missing follow-up information|0|||
143165579|NCT02254291|516153509|FG002|Overall Study|Missing follow-up information|1|||
143165580|NCT00833703|516153514|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
143165581|NCT00833703|516153515|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
143165582|NCT01557569|516153516|FG000|Overall Study|Adverse Event|2|||
143165583|NCT01557569|516153517|FG001|Overall Study|Adverse Event|0|||
143165584|NCT01557569|516153516|FG000|Overall Study|high blood pressure|0|||
143165585|NCT01557569|516153517|FG001|Overall Study|high blood pressure|1|||
143165586|NCT01557569|516153516|FG000|Overall Study|Withdrawal by Subject|3|||
143165587|NCT01557569|516153517|FG001|Overall Study|Withdrawal by Subject|5|||
143165588|NCT01557569|516153516|FG000|Overall Study|noncompliance with rules of residential|0|||
143165589|NCT01557569|516153517|FG001|Overall Study|noncompliance with rules of residential|1|||
143165590|NCT02254460|516153518|FG000|Overall Study|Adverse Event|1|||
143165591|NCT02254460|516153519|FG001|Overall Study|Adverse Event|0|||
143165592|NCT01904279|516153523|FG000|Overall Study|Lack of Efficacy|2|||
143165593|NCT01904279|516153524|FG001|Overall Study|Lack of Efficacy|3|||
143165594|NCT01904279|516153523|FG000|Overall Study|Withdrawal by Subject|1|||
143165595|NCT01904279|516153524|FG001|Overall Study|Withdrawal by Subject|0|||
143165596|NCT03257657|516153527|FG000|Overall Study|Lost to Follow-up|0|||
143165597|NCT03257657|516153528|FG001|Overall Study|Lost to Follow-up|3|||
143165598|NCT03257657|516153527|FG000|Overall Study|Withdrawn|0|||
143165599|NCT03257657|516153528|FG001|Overall Study|Withdrawn|1|||
143165600|NCT03257657|516153527|FG000|Overall Study|Noted not eligible right after enrolled|0|||
143165601|NCT03257657|516153528|FG001|Overall Study|Noted not eligible right after enrolled|1|||
143165602|NCT01356940|516153531|FG000|First Intervention (28 Days)|Adverse Event|1|||
143165603|NCT01356940|516153532|FG001|First Intervention (28 Days)|Adverse Event|0|||
143165604|NCT01356940|516153531|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
143165605|NCT01356940|516153532|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
143165606|NCT02272985|516153538|FG000|Overall Study|Withdrawal by Subject|1|||
143165607|NCT02272985|516153538|FG000|Overall Study|hip fracture|1|||
143165608|NCT02272985|516153538|FG000|Overall Study|kidney transplantation|1|||
143165609|NCT02263547|516153543|FG000|Overall Study|Adverse Event|1|||
143165610|NCT02263547|516153543|FG000|Overall Study|Lost to Follow-up|2|||
143165611|NCT00505687|516153546|FG000|Overall Study|Important protocol violation|2|||
143165612|NCT00505687|516153546|FG000|Overall Study|Lack of Efficacy|15|||
143165613|NCT00505687|516153546|FG000|Overall Study|Adverse Event|48|||
143165614|NCT00505687|516153546|FG000|Overall Study|Subject withdrew consent|15|||
143165615|NCT00505687|516153546|FG000|Overall Study|Lost to Follow-up|1|||
143165616|NCT00505687|516153546|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
143165617|NCT00505687|516153546|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
143165618|NCT00505687|516153546|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
143165619|NCT00505687|516153546|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
143165620|NCT00505687|516153546|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
143240662|NCT03815929|516432065|FG000|Overall Study|Lost to Follow-up|2|||
143240663|NCT03815929|516432066|FG001|Overall Study|Lost to Follow-up|1|||
143240664|NCT03815929|516432067|FG002|Overall Study|Lost to Follow-up|0|||
143240665|NCT03815929|516432065|FG000|Overall Study|Physician Decision|2|||
143240666|NCT03815929|516432066|FG001|Overall Study|Physician Decision|2|||
143240667|NCT03815929|516432067|FG002|Overall Study|Physician Decision|0|||
143240668|NCT03815929|516432065|FG000|Overall Study|Withdrawal by Subject|0|||
143240669|NCT03815929|516432066|FG001|Overall Study|Withdrawal by Subject|0|||
143240670|NCT03815929|516432067|FG002|Overall Study|Withdrawal by Subject|1|||
143240671|NCT02205736|516432068|FG000|Overall Study|Lost to Follow-up|106|||
143240672|NCT03326713|516432069|FG000|Overall Study|Death|2|||
143240673|NCT03326713|516432070|FG001|Overall Study|Death|1|||
143240674|NCT03326713|516432071|FG002|Overall Study|Death|0|||
143240675|NCT03326713|516432069|FG000|Overall Study|Lost to Follow-up|20|||
143240676|NCT03326713|516432070|FG001|Overall Study|Lost to Follow-up|21|||
143240677|NCT03326713|516432071|FG002|Overall Study|Lost to Follow-up|33|||
143240678|NCT03326713|516432069|FG000|Overall Study|Withdrawal by Subject|1|||
143240679|NCT03326713|516432070|FG001|Overall Study|Withdrawal by Subject|2|||
143240680|NCT03326713|516432071|FG002|Overall Study|Withdrawal by Subject|11|||
143240681|NCT03326713|516432069|FG000|Overall Study|Found Ineligible|11|||
143240682|NCT03326713|516432070|FG001|Overall Study|Found Ineligible|11|||
143240683|NCT03326713|516432071|FG002|Overall Study|Found Ineligible|8|||
143240684|NCT03067077|516432072|FG000|Overall Study|Did not receive surgery|4|||
143240685|NCT03067077|516432073|FG001|Overall Study|Did not receive surgery|5|||
143240686|NCT03067077|516432072|FG000|Overall Study|Lost to Follow-up|3|||
143240687|NCT03067077|516432073|FG001|Overall Study|Lost to Follow-up|2|||
143240688|NCT01648751|516432087|FG000|Overall Study|Withdrawal by Subject|2|||
143240689|NCT01648751|516432088|FG001|Overall Study|Withdrawal by Subject|3|||
143240690|NCT04721977|516432090|FG000|Overall Study|Death|15|||
143240691|NCT04721977|516432090|FG000|Overall Study|Ongoing|51|||
143240692|NCT02017405|516432091|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
143240693|NCT02017405|516432092|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
143240694|NCT02017405|516432093|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
143240695|NCT02017405|516432094|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
143240696|NCT02017405|516432095|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
143240697|NCT02017405|516432096|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
143240698|NCT02017405|516432091|FG000|Open-label Phase|Adverse Event|1|||
143240699|NCT02017405|516432092|FG001|Open-label Phase|Adverse Event|1|||
143240700|NCT02017405|516432093|FG002|Open-label Phase|Adverse Event|0|||
143240701|NCT02017405|516432094|FG003|Open-label Phase|Adverse Event|0|||
143240702|NCT02017405|516432095|FG004|Open-label Phase|Adverse Event|0|||
143240703|NCT02017405|516432096|FG005|Open-label Phase|Adverse Event|0|||
143240704|NCT02864394|516432098|FG000|Overall Study|Death|184|||
143240705|NCT02864394|516432099|FG001|Overall Study|Death|189|||
143240706|NCT02864394|516432098|FG000|Overall Study|Lost to Follow-up|0|||
143240707|NCT02864394|516432099|FG001|Overall Study|Lost to Follow-up|2|||
143240708|NCT02864394|516432098|FG000|Overall Study|Sponsor Decision|26|||
143240709|NCT02864394|516432099|FG001|Overall Study|Sponsor Decision|11|||
143240710|NCT02864394|516432098|FG000|Overall Study|Withdrawal by Subject|3|||
143240711|NCT02864394|516432099|FG001|Overall Study|Withdrawal by Subject|10|||
143240712|NCT04730804|516432100|FG000|Overall Study|Physician Decision|0|||
143240713|NCT04730804|516432101|FG001|Overall Study|Physician Decision|0|||
143240714|NCT04730804|516432102|FG002|Overall Study|Physician Decision|0|||
143240715|NCT04730804|516432103|FG003|Overall Study|Physician Decision|0|||
143240716|NCT04730804|516432104|FG004|Overall Study|Physician Decision|0|||
143240717|NCT04730804|516432105|FG005|Overall Study|Physician Decision|1|||
143240718|NCT04730804|516432100|FG000|Overall Study|Withdrawal by Subject|0|||
143240719|NCT04730804|516432101|FG001|Overall Study|Withdrawal by Subject|0|||
143240720|NCT04730804|516432102|FG002|Overall Study|Withdrawal by Subject|0|||
143240721|NCT04730804|516432103|FG003|Overall Study|Withdrawal by Subject|0|||
143498417|NCT02211261|517366340|FG004|Overall Study|Other|0|||
143498418|NCT02211261|517366341|FG005|Overall Study|Other|1|||
143498419|NCT02211261|517366342|FG006|Overall Study|Other|0|||
143498420|NCT02211261|517366343|FG007|Overall Study|Other|0|||
143498421|NCT02211261|517366344|FG008|Overall Study|Other|0|||
143240722|NCT04730804|516432104|FG004|Overall Study|Withdrawal by Subject|1|||
143240723|NCT04730804|516432105|FG005|Overall Study|Withdrawal by Subject|2|||
143240724|NCT04953728|516433381|FG000|Overall Study|Withdrawal by Subject|3|||
143240725|NCT04953728|516433381|FG000|Overall Study|Physician Decision|1|||
143240726|NCT00904033|516433384|FG000|Overall Study|Withdrawal by Subject|1|||
143240727|NCT00904033|516433385|FG001|Overall Study|Withdrawal by Subject|1|||
143240728|NCT00904033|516433386|FG002|Overall Study|Withdrawal by Subject|0|||
143240729|NCT00904033|516433387|FG003|Overall Study|Withdrawal by Subject|0|||
143240730|NCT00904033|516433384|FG000|Overall Study|Physician Decision|0|||
143240731|NCT00904033|516433385|FG001|Overall Study|Physician Decision|0|||
143240732|NCT00904033|516433386|FG002|Overall Study|Physician Decision|1|||
143240733|NCT00904033|516433387|FG003|Overall Study|Physician Decision|0|||
143498422|NCT02211261|517366345|FG009|Overall Study|Other|2|||
143498423|NCT02211261|517366346|FG010|Overall Study|Other|0|||
143043345|NCT01527006|515699308|FG001|Core Study|Inadequate Therapeutic Effect|0|||
143043346|NCT01527006|515699307|FG000|Core Study|Withdrawal by Subject|0|||
143043347|NCT01527006|515699308|FG001|Core Study|Withdrawal by Subject|1|||
143043348|NCT01527006|515699307|FG000|Core Study|Other|0|||
143043349|NCT01527006|515699308|FG001|Core Study|Other|2|||
143043350|NCT01527006|515699307|FG000|Extension Phase|Adverse Event|4|||
143165621|NCT00505687|516153546|FG000|Overall Study|Other: Disease Progression|1|||
143165622|NCT00505687|516153546|FG000|Overall Study|Other: As Per Sponsor|8|||
143165623|NCT03283241|516153547|FG000|Overall Study|Adverse Event|4|||
143165624|NCT03283241|516153548|FG001|Overall Study|Adverse Event|1|||
143165625|NCT03283241|516153547|FG000|Overall Study|Withdrawal by Subject|0|||
143165626|NCT03283241|516153548|FG001|Overall Study|Withdrawal by Subject|1|||
143165627|NCT03283241|516153547|FG000|Overall Study|Subject relocated to Finland|0|||
143165628|NCT03283241|516153548|FG001|Overall Study|Subject relocated to Finland|1|||
143165629|NCT00666263|516153551|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
143165630|NCT00666263|516153552|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
143165631|NCT00666263|516153551|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
143165632|NCT00666263|516153552|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
143165633|NCT00666263|516153551|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
143165634|NCT00666263|516153552|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
143165635|NCT00586157|516153553|FG000|First Intervention|Worsening behavior|1|||
143165636|NCT00586157|516153554|FG001|First Intervention|Worsening behavior|0|||
143165637|NCT00586157|516153553|FG000|Second Intervention|Withdrawal by Subject|1|||
143165638|NCT00586157|516153554|FG001|Second Intervention|Withdrawal by Subject|0|||
143165639|NCT00586157|516153553|FG000|Second Intervention|Worsening behavior|1|||
143165640|NCT00586157|516153554|FG001|Second Intervention|Worsening behavior|0|||
143165641|NCT00586157|516153553|FG000|Second Intervention|Adverse Event|0|||
143165642|NCT00586157|516153554|FG001|Second Intervention|Adverse Event|1|||
143165643|NCT02014467|516153556|FG000|Overall Study|Adverse Event|4|||
143165644|NCT02014467|516153557|FG001|Overall Study|Adverse Event|0|||
143165645|NCT02014467|516153556|FG000|Overall Study|Protocol Violation|3|||
143165646|NCT02014467|516153557|FG001|Overall Study|Protocol Violation|0|||
143165647|NCT02014467|516153556|FG000|Overall Study|Physician Decision|2|||
143165648|NCT02014467|516153557|FG001|Overall Study|Physician Decision|3|||
143165649|NCT02014467|516153556|FG000|Overall Study|Withdrawal by Subject|16|||
143165650|NCT02014467|516153557|FG001|Overall Study|Withdrawal by Subject|4|||
143165651|NCT00619918|516153558|FG000|Overall Study|Withdrawal by Subject|4|||
143165652|NCT00619918|516153559|FG001|Overall Study|Withdrawal by Subject|3|||
143165653|NCT00619918|516153558|FG000|Overall Study|Physician Decision|2|||
143165654|NCT00619918|516153559|FG001|Overall Study|Physician Decision|4|||
143165655|NCT00619918|516153558|FG000|Overall Study|Transfer to outside facility|3|||
143165656|NCT00619918|516153559|FG001|Overall Study|Transfer to outside facility|3|||
143165657|NCT00619918|516153558|FG000|Overall Study|Left before receiving first dose|7|||
143165658|NCT00619918|516153559|FG001|Overall Study|Left before receiving first dose|6|||
143165659|NCT00619918|516153558|FG000|Overall Study|ICU admission|4|||
143165660|NCT00619918|516153559|FG001|Overall Study|ICU admission|6|||
143165661|NCT05418426|516153560|FG000|Overall Study|Adverse Event|0|||
143165662|NCT05418426|516153561|FG001|Overall Study|Adverse Event|1|||
143165663|NCT05418426|516153562|FG002|Overall Study|Adverse Event|0|||
143165664|NCT05418426|516153560|FG000|Overall Study|Withdrawal by Subject|0|||
143165665|NCT05418426|516153561|FG001|Overall Study|Withdrawal by Subject|1|||
143165666|NCT05418426|516153562|FG002|Overall Study|Withdrawal by Subject|0|||
143165667|NCT05418426|516153560|FG000|Overall Study|Protocol Violation|0|||
143165668|NCT05418426|516153561|FG001|Overall Study|Protocol Violation|0|||
143165669|NCT05418426|516153562|FG002|Overall Study|Protocol Violation|1|||
143165670|NCT03647137|516153565|FG000|Overall Study|Scan Limitation|2|||
143165671|NCT03647137|516153566|FG001|Overall Study|Scan Limitation|1|||
143165672|NCT03647137|516153567|FG002|Overall Study|Scan Limitation|1|||
143165673|NCT03647137|516153568|FG003|Overall Study|Scan Limitation|2|||
143165674|NCT01813357|516153574|FG000|Overall Study|Lost to Follow-up|5|||
143165675|NCT01813357|516153575|FG001|Overall Study|Lost to Follow-up|6|||
143165676|NCT03773562|516153576|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
143165677|NCT03773562|516153576|FG000|Overall Study|Lost to Follow-up|10|||
143165678|NCT03773562|516153576|FG000|Overall Study|Withdrawal by Subject|1|||
143165679|NCT03131479|516153577|FG000|Overall Study|Adverse Event|0|||
143165680|NCT03131479|516153578|FG001|Overall Study|Adverse Event|0|||
143165681|NCT03131479|516153579|FG002|Overall Study|Adverse Event|1|||
143165682|NCT03131479|516153580|FG003|Overall Study|Adverse Event|1|||
143165683|NCT03131479|516153581|FG004|Overall Study|Adverse Event|0|||
143165684|NCT03131479|516153577|FG000|Overall Study|Subject/Guardian Decision|0|||
143165685|NCT03131479|516153578|FG001|Overall Study|Subject/Guardian Decision|0|||
143043351|NCT01527006|515699308|FG001|Extension Phase|Adverse Event|2|||
143165686|NCT03131479|516153579|FG002|Overall Study|Subject/Guardian Decision|0|||
143165687|NCT03131479|516153580|FG003|Overall Study|Subject/Guardian Decision|1|||
143165688|NCT03131479|516153581|FG004|Overall Study|Subject/Guardian Decision|0|||
143165689|NCT01272219|516153582|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
143043352|NCT01527006|515699307|FG000|Extension Phase|Lost to Follow-up|0|||
143165690|NCT01272219|516153583|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
143165691|NCT01272219|516153584|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
143165692|NCT01272219|516153585|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
143165693|NCT01272219|516153586|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
143165694|NCT01272219|516153587|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
143165695|NCT01272219|516153582|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
143165696|NCT01272219|516153583|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
143165697|NCT01272219|516153584|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
143165698|NCT01272219|516153585|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
143165699|NCT01272219|516153586|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
143165700|NCT01272219|516153587|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
143165701|NCT01272219|516153582|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
143165702|NCT01272219|516153583|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
143165703|NCT01272219|516153584|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
143165704|NCT01272219|516153585|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
143165705|NCT01272219|516153586|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
143165706|NCT01272219|516153587|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
143165707|NCT01272219|516153582|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
143165708|NCT01272219|516153583|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
143165709|NCT01272219|516153584|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
143165710|NCT01272219|516153585|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
143165711|NCT01272219|516153586|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
143165712|NCT01272219|516153587|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
143165713|NCT01272219|516153582|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
143165714|NCT01272219|516153583|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
143165715|NCT01272219|516153584|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
143165716|NCT01272219|516153585|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
143165717|NCT01272219|516153586|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
143165718|NCT01272219|516153587|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
143165719|NCT01272219|516153582|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
143165720|NCT01272219|516153583|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
143165721|NCT01272219|516153584|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
143165722|NCT01272219|516153585|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
143165723|NCT01272219|516153586|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
143165724|NCT01272219|516153587|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
143165725|NCT01272219|516153582|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
143165726|NCT01272219|516153583|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
143165727|NCT01272219|516153584|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
143165728|NCT01272219|516153585|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
143165729|NCT01272219|516153586|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
143165730|NCT01272219|516153587|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
143165731|NCT01272219|516153582|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
143165732|NCT01272219|516153583|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
143165733|NCT01272219|516153584|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
143165734|NCT01272219|516153585|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
143165735|NCT01272219|516153586|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
143165736|NCT01272219|516153587|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
143165737|NCT01272219|516153582|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
143165738|NCT01272219|516153583|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
143165739|NCT01272219|516153584|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
143165740|NCT01272219|516153585|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
143165741|NCT01272219|516153586|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
143165742|NCT01272219|516153587|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
143165743|NCT01272219|516153582|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
143165744|NCT01272219|516153583|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
143165745|NCT01272219|516153584|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
143165746|NCT01272219|516153585|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
143165747|NCT01272219|516153586|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
143364258|NCT01251614|516876934|FG000|Overall Study|Pregnancy|0|||
143043353|NCT01527006|515699308|FG001|Extension Phase|Lost to Follow-up|1|||
143364259|NCT01251614|516876935|FG001|Overall Study|Pregnancy|0|||
143165748|NCT01272219|516153587|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
143165749|NCT01272219|516153582|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
143165750|NCT01272219|516153583|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
143165751|NCT01272219|516153584|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
143165752|NCT01272219|516153585|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
143165753|NCT01272219|516153586|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
143165754|NCT01272219|516153587|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
143165755|NCT01272219|516153582|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
143165756|NCT01272219|516153583|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
143165757|NCT01272219|516153584|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
143165758|NCT01272219|516153585|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
143165759|NCT01272219|516153586|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
143165760|NCT01272219|516153587|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
143165761|NCT01272219|516153582|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
143165762|NCT01272219|516153583|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
143165763|NCT01272219|516153584|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
143165764|NCT01272219|516153585|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
143165765|NCT01272219|516153586|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
143165766|NCT01272219|516153587|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
143165767|NCT01272219|516153582|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
143165768|NCT01272219|516153583|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
143165769|NCT01272219|516153584|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
143165770|NCT01272219|516153585|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
143165771|NCT01272219|516153586|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
143165772|NCT01272219|516153587|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
143165773|NCT01272219|516153582|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
143165774|NCT01272219|516153583|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
143165775|NCT01272219|516153584|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
143165776|NCT01272219|516153585|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
143165777|NCT01272219|516153586|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
143165778|NCT01272219|516153587|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
143165779|NCT01272219|516153582|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
143165780|NCT01272219|516153583|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
143165781|NCT01272219|516153584|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
143165782|NCT01272219|516153585|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
143165783|NCT01272219|516153586|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
143165784|NCT01272219|516153587|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
143165785|NCT01491919|516153588|FG000|Overall Study|Insufficient PK sampling|1|||
143165786|NCT01491919|516153589|FG001|Overall Study|Insufficient PK sampling|2|||
143165787|NCT01491919|516153590|FG002|Overall Study|Insufficient PK sampling|1|||
143165788|NCT04003389|516153591|FG000|Overall Study|Adverse Event|27|||
143165789|NCT04003389|516153592|FG001|Overall Study|Adverse Event|34|||
143165790|NCT04003389|516153593|FG002|Overall Study|Adverse Event|28|||
143165791|NCT04003389|516153591|FG000|Overall Study|Lost to Follow-up|39|||
143165792|NCT04003389|516153592|FG001|Overall Study|Lost to Follow-up|30|||
143165793|NCT04003389|516153593|FG002|Overall Study|Lost to Follow-up|33|||
143165794|NCT04003389|516153591|FG000|Overall Study|Protocol Violation|1|||
143165795|NCT04003389|516153592|FG001|Overall Study|Protocol Violation|6|||
143165796|NCT04003389|516153593|FG002|Overall Study|Protocol Violation|5|||
143165797|NCT04003389|516153591|FG000|Overall Study|Withdrawal by Subject|119|||
143165798|NCT04003389|516153592|FG001|Overall Study|Withdrawal by Subject|79|||
143165799|NCT04003389|516153593|FG002|Overall Study|Withdrawal by Subject|85|||
143165800|NCT04003389|516153591|FG000|Overall Study|Miscellaneous|14|||
143165801|NCT04003389|516153592|FG001|Overall Study|Miscellaneous|11|||
143165802|NCT04003389|516153593|FG002|Overall Study|Miscellaneous|14|||
143165803|NCT04003389|516153591|FG000|Overall Study|Participant did not receive study drug|1|||
143165804|NCT04003389|516153592|FG001|Overall Study|Participant did not receive study drug|0|||
143165805|NCT04003389|516153593|FG002|Overall Study|Participant did not receive study drug|0|||
143165806|NCT03204812|516153594|FG000|Overall Study|Adverse Event|3|||
143165807|NCT04309500|516153598|FG000|Overall Study|Lost to Follow-up|1|||
143165808|NCT04309500|516153599|FG001|Overall Study|Lost to Follow-up|0|||
143165809|NCT04309500|516153600|FG002|Overall Study|Lost to Follow-up|0|||
143165810|NCT04309500|516153601|FG003|Overall Study|Lost to Follow-up|0|||
143165811|NCT00913835|516153603|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
143165812|NCT00913835|516153604|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
143165813|NCT00913835|516153603|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
143165814|NCT00913835|516153604|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
143165815|NCT00913835|516153603|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
143364260|NCT01251614|516876936|FG002|Overall Study|Pregnancy|2|||
143364261|NCT01251614|516876934|FG000|Overall Study|Loss of Disease Control|0|||
143364262|NCT01251614|516876935|FG001|Overall Study|Loss of Disease Control|1|||
143240734|NCT00904033|516433384|FG000|Overall Study|Unable to obtain final blood draw|0|||
143240735|NCT00904033|516433385|FG001|Overall Study|Unable to obtain final blood draw|0|||
143240736|NCT00904033|516433386|FG002|Overall Study|Unable to obtain final blood draw|0|||
143240737|NCT00904033|516433387|FG003|Overall Study|Unable to obtain final blood draw|2|||
143240738|NCT03252925|516433388|FG000|Overall Study|Withdrawal by Subject|1|||
143240739|NCT03252925|516433389|FG001|Overall Study|Withdrawal by Subject|0|||
143240740|NCT03252925|516433388|FG000|Overall Study|Protocol Violation|6|||
143240741|NCT03252925|516433389|FG001|Overall Study|Protocol Violation|0|||
143240742|NCT03252925|516433388|FG000|Overall Study|Adverse Event|1|||
143498424|NCT02211261|517366336|FG000|Overall Study|Lost to Follow-up|0|||
143498425|NCT02211261|517366337|FG001|Overall Study|Lost to Follow-up|0|||
143498426|NCT02211261|517366338|FG002|Overall Study|Lost to Follow-up|0|||
143498427|NCT02211261|517366339|FG003|Overall Study|Lost to Follow-up|0|||
143240743|NCT03252925|516433389|FG001|Overall Study|Adverse Event|0|||
143240744|NCT03252925|516433388|FG000|Overall Study|Lost to Follow-up|6|||
143240745|NCT03252925|516433389|FG001|Overall Study|Lost to Follow-up|6|||
143240746|NCT00521404|516433390|FG000|Overall Study|Adverse Event|13|||
143240747|NCT00521404|516433390|FG000|Overall Study|Disease Progression|33|||
143240748|NCT00521404|516433390|FG000|Overall Study|Investigator decision|5|||
143240749|NCT00521404|516433390|FG000|Overall Study|Withdrawal of consent|3|||
143240750|NCT00521404|516433390|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
143240751|NCT00521404|516433390|FG000|Overall Study|Other|7|||
143240752|NCT01908803|516433391|FG000|Overall Study|Adverse Event|1|||
143240753|NCT01908803|516433392|FG001|Overall Study|Adverse Event|0|||
143240754|NCT01908803|516433391|FG000|Overall Study|Physician Decision|0|||
143240755|NCT01908803|516433392|FG001|Overall Study|Physician Decision|1|||
143240756|NCT01908803|516433391|FG000|Overall Study|Withdrawal by Subject|1|||
143240757|NCT01908803|516433392|FG001|Overall Study|Withdrawal by Subject|0|||
143240758|NCT01908803|516433391|FG000|Overall Study|Randomization Error|1|||
143240759|NCT01908803|516433392|FG001|Overall Study|Randomization Error|0|||
143240760|NCT01908803|516433391|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
143240761|NCT01908803|516433392|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
143240762|NCT02968004|516433393|FG000|Main Study Phase|Adverse Event|1|||
143240763|NCT02968004|516433394|FG001|Main Study Phase|Adverse Event|0|||
143240764|NCT02968004|516433393|FG000|Main Study Phase|Withdrawal by Subject|0|||
143240765|NCT02968004|516433394|FG001|Main Study Phase|Withdrawal by Subject|1|||
143240766|NCT02968004|516433393|FG000|Open Label Extension (OLE) Year 1|Adverse Event|0|||
143240767|NCT02968004|516433394|FG001|Open Label Extension (OLE) Year 1|Adverse Event|6|||
143240768|NCT02968004|516433393|FG000|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
143240769|NCT02968004|516433394|FG001|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
143240770|NCT02968004|516433393|FG000|Open Label Extension (OLE) Year 1|Miscellaneous|0|||
143240771|NCT02968004|516433394|FG001|Open Label Extension (OLE) Year 1|Miscellaneous|1|||
143240772|NCT02968004|516433393|FG000|Open Label Extension (OLE) Year 2|Adverse Event|1|||
143240773|NCT02968004|516433394|FG001|Open Label Extension (OLE) Year 2|Adverse Event|1|||
143240774|NCT02968004|516433393|FG000|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
143240775|NCT02968004|516433394|FG001|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
143240776|NCT02968004|516433393|FG000|Open Label Extension (OLE) Year 2|Miscellaneous|0|||
143240777|NCT02968004|516433394|FG001|Open Label Extension (OLE) Year 2|Miscellaneous|1|||
143240778|NCT02968004|516433393|FG000|Open Label Extension (OLE) Year 3|Adverse Event|1|||
143240779|NCT02968004|516433394|FG001|Open Label Extension (OLE) Year 3|Adverse Event|0|||
143240780|NCT02968004|516433393|FG000|Open Label Extension (OLE) Year 3|Withdrawal by Subject|2|||
143240781|NCT02968004|516433394|FG001|Open Label Extension (OLE) Year 3|Withdrawal by Subject|1|||
143240782|NCT02968004|516433393|FG000|Open Label Extension (OLE) Year 3|Prohibited Treatments|0|||
143240783|NCT02968004|516433394|FG001|Open Label Extension (OLE) Year 3|Prohibited Treatments|1|||
143240784|NCT02968004|516433393|FG000|Open Label Extension (OLE) Year 3|Local Crisis|1|||
143240785|NCT02968004|516433394|FG001|Open Label Extension (OLE) Year 3|Local Crisis|0|||
143240786|NCT02968004|516433393|FG000|Open Label Extension (OLE) Year 4|Withdrawal by Subject|3|||
143498428|NCT02211261|517366340|FG004|Overall Study|Lost to Follow-up|0|||
143498429|NCT02211261|517366341|FG005|Overall Study|Lost to Follow-up|0|||
143498430|NCT02211261|517366342|FG006|Overall Study|Lost to Follow-up|0|||
143498431|NCT02211261|517366343|FG007|Overall Study|Lost to Follow-up|1|||
143498432|NCT02211261|517366344|FG008|Overall Study|Lost to Follow-up|0|||
143498433|NCT02211261|517366345|FG009|Overall Study|Lost to Follow-up|0|||
143240787|NCT02968004|516433394|FG001|Open Label Extension (OLE) Year 4|Withdrawal by Subject|4|||
143240788|NCT02968004|516433393|FG000|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|0|||
143240789|NCT02968004|516433394|FG001|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|1|||
143240790|NCT02968004|516433393|FG000|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|27|||
143498434|NCT02211261|517366346|FG010|Overall Study|Lost to Follow-up|0|||
143043354|NCT01527006|515699307|FG000|Extension Phase|Subject Choice|1|||
143240791|NCT02968004|516433394|FG001|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|21|||
143240792|NCT02968004|516433393|FG000|Open Label Extension (OLE) Year 4|Bone Age Reached|3|||
143240793|NCT02968004|516433394|FG001|Open Label Extension (OLE) Year 4|Bone Age Reached|1|||
143498435|NCT01737931|517366347|FG000|Overall Study|Withdrawal by Subject|0|||
143240794|NCT02968004|516433393|FG000|Open Label Extension (OLE) Year 4|Local Crisis|10|||
143240795|NCT02968004|516433394|FG001|Open Label Extension (OLE) Year 4|Local Crisis|9|||
143240796|NCT02968004|516433393|FG000|Open Label Extension (OLE) Year 4|Miscellaneous|2|||
143240797|NCT02968004|516433394|FG001|Open Label Extension (OLE) Year 4|Miscellaneous|0|||
143240798|NCT02968004|516433393|FG000|Open Label Extension (OLE) Year 5|Withdrawal by Subject|1|||
143240799|NCT02968004|516433394|FG001|Open Label Extension (OLE) Year 5|Withdrawal by Subject|0|||
143240800|NCT02968004|516433393|FG000|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|2|||
143240801|NCT02968004|516433394|FG001|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|6|||
143240802|NCT02968004|516433393|FG000|Open Label Extension (OLE) Year 5|Bone Age Reached,|1|||
143240803|NCT02968004|516433394|FG001|Open Label Extension (OLE) Year 5|Bone Age Reached,|0|||
143498436|NCT01737931|517366348|FG001|Overall Study|Withdrawal by Subject|1|||
143498437|NCT01737931|517366349|FG002|Overall Study|Withdrawal by Subject|1|||
143498438|NCT01737931|517366347|FG000|Overall Study|Physician Decision|0|||
143498439|NCT01737931|517366348|FG001|Overall Study|Physician Decision|1|||
143498440|NCT01737931|517366349|FG002|Overall Study|Physician Decision|0|||
143498441|NCT00880256|517366350|FG000|Overall Study|Lost to Follow-up|28|||
143165816|NCT00913835|516153604|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
143165817|NCT00913835|516153603|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
143165818|NCT00913835|516153604|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
143165819|NCT00913835|516153603|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
143165820|NCT00913835|516153604|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
143165821|NCT00637156|516153607|FG000|Overall Study|Withdrawal by Subject|0|||
143165822|NCT00637156|516153608|FG001|Overall Study|Withdrawal by Subject|7|||
143165823|NCT00637156|516153607|FG000|Overall Study|Death|0|||
143165824|NCT00637156|516153608|FG001|Overall Study|Death|1|||
143165825|NCT00637156|516153607|FG000|Overall Study|Lost to Follow-up|10|||
143165826|NCT00637156|516153608|FG001|Overall Study|Lost to Follow-up|16|||
143165827|NCT00461812|516153609|FG000|Overall Study|study terminated|10|||
143165828|NCT01308788|516153610|FG000|2-year Treatment|medication change by treating physician|4|||
143165829|NCT01308788|516153611|FG001|2-year Treatment|medication change by treating physician|11|||
143165830|NCT00322218|516153612|FG000|Overall Study|Death|3|||
143165831|NCT00322218|516153613|FG001|Overall Study|Death|6|||
143165832|NCT03193437|516153620|FG000|Overall Study|Adverse Event|4|||
143165833|NCT03193437|516153620|FG000|Overall Study|Withdrawal by Subject|2|||
143165834|NCT03193437|516153620|FG000|Overall Study|Disease Progression|2|||
143165835|NCT02414841|516153623|FG000|Overall Study|Withdrawal by Subject|7|||
143165836|NCT02414841|516153624|FG001|Overall Study|Withdrawal by Subject|5|||
143165837|NCT02414841|516153623|FG000|Overall Study|Lost to Follow-up|13|||
143165838|NCT02414841|516153624|FG001|Overall Study|Lost to Follow-up|6|||
143165839|NCT02414841|516153623|FG000|Overall Study|Death|17|||
143165840|NCT02414841|516153624|FG001|Overall Study|Death|14|||
143165841|NCT02414841|516153623|FG000|Overall Study|Received a Kidney Transplant|13|||
143165842|NCT02414841|516153624|FG001|Overall Study|Received a Kidney Transplant|4|||
143165843|NCT02414841|516153623|FG000|Overall Study|Randomized But Not Treated|6|||
143165844|NCT02414841|516153624|FG001|Overall Study|Randomized But Not Treated|4|||
143165845|NCT03941093|516153634|FG000|Overall Study|Protocol Violation|0|||
143165846|NCT03941093|516153635|FG001|Overall Study|Protocol Violation|1|||
143165847|NCT03941093|516153634|FG000|Overall Study|Withdrawal by Subject|9|||
143165848|NCT03941093|516153635|FG001|Overall Study|Withdrawal by Subject|6|||
143165849|NCT03648372|516153644|FG000|Overall Study|Withdrawal by Subject|2|||
143165850|NCT03648372|516153645|FG001|Overall Study|Withdrawal by Subject|0|||
143165851|NCT03648372|516153646|FG002|Overall Study|Withdrawal by Subject|0|||
143165852|NCT03648372|516153647|FG003|Overall Study|Withdrawal by Subject|0|||
143165853|NCT03648372|516153648|FG004|Overall Study|Withdrawal by Subject|0|||
143165854|NCT03648372|516153649|FG005|Overall Study|Withdrawal by Subject|1|||
143165855|NCT03648372|516153650|FG006|Overall Study|Withdrawal by Subject|2|||
143165856|NCT03648372|516153651|FG007|Overall Study|Withdrawal by Subject|0|||
143165857|NCT03648372|516153652|FG008|Overall Study|Withdrawal by Subject|0|||
143165858|NCT03648372|516153653|FG009|Overall Study|Withdrawal by Subject|0|||
143165859|NCT03648372|516153654|FG010|Overall Study|Withdrawal by Subject|2|||
143165860|NCT03648372|516153655|FG011|Overall Study|Withdrawal by Subject|0|||
143165861|NCT03648372|516153656|FG012|Overall Study|Withdrawal by Subject|2|||
143240804|NCT02968004|516433393|FG000|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|1|||
143498442|NCT00802360|517366351|FG000|Overall Study|Stimulation failure|4|||
143498443|NCT00802360|517366352|FG001|Overall Study|Stimulation failure|0|||
143498444|NCT00802360|517366353|FG002|Overall Study|Stimulation failure|3|||
143498445|NCT00802360|517366354|FG003|Overall Study|Stimulation failure|3|||
143165862|NCT03648372|516153657|FG013|Overall Study|Withdrawal by Subject|0|||
143165863|NCT03648372|516153658|FG014|Overall Study|Withdrawal by Subject|0|||
143165864|NCT03648372|516153659|FG015|Overall Study|Withdrawal by Subject|0|||
143165865|NCT03648372|516153660|FG016|Overall Study|Withdrawal by Subject|1|||
143165866|NCT03648372|516153661|FG017|Overall Study|Withdrawal by Subject|0|||
143165867|NCT03648372|516153662|FG018|Overall Study|Withdrawal by Subject|0|||
143165868|NCT03648372|516153663|FG019|Overall Study|Withdrawal by Subject|0|||
143165869|NCT03648372|516153664|FG020|Overall Study|Withdrawal by Subject|0|||
143165870|NCT03648372|516153644|FG000|Overall Study|Progressive Disease|2|||
143165871|NCT03648372|516153645|FG001|Overall Study|Progressive Disease|3|||
143165872|NCT03648372|516153646|FG002|Overall Study|Progressive Disease|4|||
143165873|NCT03648372|516153647|FG003|Overall Study|Progressive Disease|3|||
143165874|NCT03648372|516153648|FG004|Overall Study|Progressive Disease|2|||
143165875|NCT03648372|516153649|FG005|Overall Study|Progressive Disease|2|||
143165876|NCT03648372|516153650|FG006|Overall Study|Progressive Disease|3|||
143165877|NCT03648372|516153651|FG007|Overall Study|Progressive Disease|3|||
143165878|NCT03648372|516153652|FG008|Overall Study|Progressive Disease|5|||
143165879|NCT03648372|516153653|FG009|Overall Study|Progressive Disease|5|||
143165880|NCT03648372|516153654|FG010|Overall Study|Progressive Disease|2|||
143165881|NCT03648372|516153655|FG011|Overall Study|Progressive Disease|3|||
143165882|NCT03648372|516153656|FG012|Overall Study|Progressive Disease|3|||
143165883|NCT03648372|516153657|FG013|Overall Study|Progressive Disease|3|||
143165884|NCT03648372|516153658|FG014|Overall Study|Progressive Disease|6|||
143165885|NCT03648372|516153659|FG015|Overall Study|Progressive Disease|0|||
143165886|NCT03648372|516153660|FG016|Overall Study|Progressive Disease|0|||
143165887|NCT03648372|516153661|FG017|Overall Study|Progressive Disease|0|||
143165888|NCT03648372|516153662|FG018|Overall Study|Progressive Disease|0|||
143165889|NCT03648372|516153663|FG019|Overall Study|Progressive Disease|0|||
143165890|NCT03648372|516153664|FG020|Overall Study|Progressive Disease|0|||
143165891|NCT03648372|516153644|FG000|Overall Study|Other|0|||
143165892|NCT03648372|516153645|FG001|Overall Study|Other|0|||
143165893|NCT03648372|516153646|FG002|Overall Study|Other|0|||
143165894|NCT03648372|516153647|FG003|Overall Study|Other|0|||
143165895|NCT03648372|516153648|FG004|Overall Study|Other|1|||
143165896|NCT03648372|516153649|FG005|Overall Study|Other|0|||
143165897|NCT03648372|516153650|FG006|Overall Study|Other|0|||
143165898|NCT03648372|516153651|FG007|Overall Study|Other|0|||
143165899|NCT03648372|516153652|FG008|Overall Study|Other|0|||
143165900|NCT03648372|516153653|FG009|Overall Study|Other|0|||
143165901|NCT03648372|516153654|FG010|Overall Study|Other|1|||
143165902|NCT03648372|516153655|FG011|Overall Study|Other|2|||
143165903|NCT03648372|516153656|FG012|Overall Study|Other|1|||
143165904|NCT03648372|516153657|FG013|Overall Study|Other|3|||
143165905|NCT03648372|516153658|FG014|Overall Study|Other|0|||
143165906|NCT03648372|516153659|FG015|Overall Study|Other|5|||
143165907|NCT03648372|516153660|FG016|Overall Study|Other|1|||
143165908|NCT03648372|516153661|FG017|Overall Study|Other|5|||
143165909|NCT03648372|516153662|FG018|Overall Study|Other|0|||
143165910|NCT03648372|516153663|FG019|Overall Study|Other|1|||
143165911|NCT03648372|516153664|FG020|Overall Study|Other|0|||
143165912|NCT03648372|516153644|FG000|Overall Study|Lost to Follow-up|0|||
143165913|NCT03648372|516153645|FG001|Overall Study|Lost to Follow-up|0|||
143165914|NCT03648372|516153646|FG002|Overall Study|Lost to Follow-up|0|||
143165915|NCT03648372|516153647|FG003|Overall Study|Lost to Follow-up|0|||
143165916|NCT03648372|516153648|FG004|Overall Study|Lost to Follow-up|0|||
143165917|NCT03648372|516153649|FG005|Overall Study|Lost to Follow-up|0|||
143165918|NCT03648372|516153650|FG006|Overall Study|Lost to Follow-up|0|||
143165919|NCT03648372|516153651|FG007|Overall Study|Lost to Follow-up|0|||
143165920|NCT03648372|516153652|FG008|Overall Study|Lost to Follow-up|0|||
143165921|NCT03648372|516153653|FG009|Overall Study|Lost to Follow-up|0|||
143165922|NCT03648372|516153654|FG010|Overall Study|Lost to Follow-up|0|||
143165923|NCT03648372|516153655|FG011|Overall Study|Lost to Follow-up|0|||
143165924|NCT03648372|516153656|FG012|Overall Study|Lost to Follow-up|0|||
143165925|NCT03648372|516153657|FG013|Overall Study|Lost to Follow-up|1|||
143165926|NCT03648372|516153658|FG014|Overall Study|Lost to Follow-up|0|||
143165927|NCT03648372|516153659|FG015|Overall Study|Lost to Follow-up|1|||
143498446|NCT00802360|517366351|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
143165928|NCT03648372|516153660|FG016|Overall Study|Lost to Follow-up|0|||
143165929|NCT03648372|516153661|FG017|Overall Study|Lost to Follow-up|1|||
143165930|NCT03648372|516153662|FG018|Overall Study|Lost to Follow-up|0|||
143165931|NCT03648372|516153663|FG019|Overall Study|Lost to Follow-up|0|||
143165932|NCT03648372|516153664|FG020|Overall Study|Lost to Follow-up|0|||
143165933|NCT03648372|516153644|FG000|Overall Study|Start of a New Systemic Treatment|0|||
143165934|NCT03648372|516153645|FG001|Overall Study|Start of a New Systemic Treatment|0|||
143165935|NCT03648372|516153646|FG002|Overall Study|Start of a New Systemic Treatment|0|||
143165936|NCT03648372|516153647|FG003|Overall Study|Start of a New Systemic Treatment|0|||
143165937|NCT03648372|516153648|FG004|Overall Study|Start of a New Systemic Treatment|0|||
143165938|NCT03648372|516153649|FG005|Overall Study|Start of a New Systemic Treatment|0|||
143165939|NCT03648372|516153650|FG006|Overall Study|Start of a New Systemic Treatment|0|||
143165940|NCT03648372|516153651|FG007|Overall Study|Start of a New Systemic Treatment|2|||
143165941|NCT03648372|516153652|FG008|Overall Study|Start of a New Systemic Treatment|0|||
143165942|NCT03648372|516153653|FG009|Overall Study|Start of a New Systemic Treatment|0|||
143165943|NCT03648372|516153654|FG010|Overall Study|Start of a New Systemic Treatment|1|||
143165944|NCT03648372|516153655|FG011|Overall Study|Start of a New Systemic Treatment|0|||
143240805|NCT02968004|516433394|FG001|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|0|||
143165945|NCT03648372|516153656|FG012|Overall Study|Start of a New Systemic Treatment|0|||
143165946|NCT03648372|516153657|FG013|Overall Study|Start of a New Systemic Treatment|0|||
143240806|NCT02968004|516433393|FG000|Open Label Extension (OLE) Year 5|Local Crisis|1|||
143240807|NCT02968004|516433394|FG001|Open Label Extension (OLE) Year 5|Local Crisis|0|||
143240808|NCT00419952|516433395|FG000|Overall Study|Adverse Event|8|||
143043355|NCT01527006|515699308|FG001|Extension Phase|Subject Choice|1|||
143043356|NCT01527006|515699307|FG000|Extension Phase|Inadequate therapeutic effect|1|||
143043357|NCT01527006|515699308|FG001|Extension Phase|Inadequate therapeutic effect|1|||
143043358|NCT01527006|515699307|FG000|Extension Phase|Other|0|||
143043359|NCT01527006|515699308|FG001|Extension Phase|Other|3|||
143043360|NCT00834340|515699313|FG000|Washout|Adverse Event|1|||
143043361|NCT00834340|515699314|FG001|Washout|Adverse Event|0|||
143043362|NCT00834340|515699313|FG000|Washout|Withdrawal by Subject|1|||
143043363|NCT00834340|515699314|FG001|Washout|Withdrawal by Subject|0|||
143043364|NCT02294786|515699319|FG000|Overall Study|Withdrawal by Subject|0|||
143043365|NCT02294786|515699320|FG001|Overall Study|Withdrawal by Subject|1|||
143043366|NCT02294786|515699319|FG000|Overall Study|Physician Decision|6|||
143043367|NCT02294786|515699320|FG001|Overall Study|Physician Decision|7|||
143043368|NCT02294786|515699319|FG000|Overall Study|Lost to Follow-up|1|||
143043369|NCT02294786|515699320|FG001|Overall Study|Lost to Follow-up|2|||
143043370|NCT02294786|515699319|FG000|Overall Study|Protocol Violation|1|||
143043371|NCT02294786|515699320|FG001|Overall Study|Protocol Violation|0|||
143043372|NCT02294786|515699319|FG000|Overall Study|Adverse Event|1|||
143043373|NCT02294786|515699320|FG001|Overall Study|Adverse Event|1|||
143043374|NCT02294786|515699319|FG000|Overall Study|Death|2|||
143043375|NCT02294786|515699320|FG001|Overall Study|Death|3|||
143043376|NCT01778010|515699321|FG000|Overall Study|Withdrawal by Subject|2|||
143043377|NCT01778010|515699321|FG000|Overall Study|abnormal ECG before meds|1|||
143043378|NCT01778010|515699321|FG000|Overall Study|Arrested|1|||
143043379|NCT01778010|515699321|FG000|Overall Study|rash while on placebo|1|||
143043380|NCT04238754|515699327|FG000|Washout - 1 Week|Lost to Follow-up|1|||
143043381|NCT04238754|515699328|FG001|Washout - 1 Week|Lost to Follow-up|0|||
143043382|NCT01667679|515699332|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
143043383|NCT01667679|515699333|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
143043384|NCT01667679|515699332|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
143043385|NCT01667679|515699333|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
143043386|NCT01667679|515699332|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
143043387|NCT01667679|515699333|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
143043388|NCT01667679|515699332|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
143043389|NCT01667679|515699333|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
143043390|NCT01667679|515699332|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
143043391|NCT01667679|515699333|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
143043392|NCT01667679|515699332|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
143043393|NCT01667679|515699333|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
143043394|NCT01667679|515699332|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
143043395|NCT01667679|515699333|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
143043396|NCT01667679|515699332|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
143043397|NCT01667679|515699333|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
143043398|NCT01667679|515699332|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
143043399|NCT01667679|515699333|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
143043400|NCT01667679|515699332|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
143043401|NCT01667679|515699333|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
143165947|NCT03648372|516153658|FG014|Overall Study|Start of a New Systemic Treatment|0|||
143165948|NCT03648372|516153659|FG015|Overall Study|Start of a New Systemic Treatment|0|||
143165949|NCT03648372|516153660|FG016|Overall Study|Start of a New Systemic Treatment|0|||
143165950|NCT03648372|516153661|FG017|Overall Study|Start of a New Systemic Treatment|0|||
143165951|NCT03648372|516153662|FG018|Overall Study|Start of a New Systemic Treatment|0|||
143165952|NCT03648372|516153663|FG019|Overall Study|Start of a New Systemic Treatment|0|||
143165953|NCT03648372|516153664|FG020|Overall Study|Start of a New Systemic Treatment|0|||
143240809|NCT00419952|516433396|FG001|Overall Study|Adverse Event|10|||
143240810|NCT00419952|516433395|FG000|Overall Study|Withdrawal by Subject|44|||
143240811|NCT00419952|516433396|FG001|Overall Study|Withdrawal by Subject|43|||
143165954|NCT04191135|516153665|FG000|Induction Treatment|Not Treated|2|||
143043402|NCT01667679|515699332|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
143240812|NCT00419952|516433395|FG000|Overall Study|Lost to Follow-up|43|||
143043403|NCT01667679|515699333|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
143043404|NCT01667679|515699332|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
143043405|NCT01667679|515699333|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
143165955|NCT04191135|516153666|FG001|Induction Treatment|Not Treated|0|||
143165956|NCT04191135|516153667|FG002|Induction Treatment|Not Treated|0|||
143043406|NCT01667679|515699332|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
143043407|NCT01667679|515699333|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
143043408|NCT01667679|515699332|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
143043409|NCT01667679|515699333|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
143043410|NCT01667679|515699332|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
143043411|NCT01667679|515699333|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
143043412|NCT01667679|515699332|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
143043413|NCT01667679|515699333|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
143043414|NCT01667679|515699332|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
143043415|NCT01667679|515699333|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
143043416|NCT01667679|515699332|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
143043417|NCT01667679|515699333|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
143043418|NCT01667679|515699332|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
143043419|NCT01667679|515699333|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
143043420|NCT01667679|515699332|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
143043421|NCT01667679|515699333|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
143043422|NCT01667679|515699332|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
143043423|NCT01667679|515699333|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
143043424|NCT02159183|515699334|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
143043425|NCT02159183|515699335|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
143043426|NCT02159183|515699334|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
143043427|NCT02159183|515699335|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
143043428|NCT02159183|515699334|FG000|Analysis After the 36 Months Follow-up|Death|0|||
143043429|NCT02159183|515699335|FG001|Analysis After the 36 Months Follow-up|Death|1|||
143043430|NCT02159183|515699334|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
143043431|NCT02159183|515699335|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
143043432|NCT02159183|515699334|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
143043433|NCT02159183|515699335|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
143043434|NCT03637764|515699336|FG000|Overall Study|Adverse Event|2|||
143043435|NCT03637764|515699337|FG001|Overall Study|Adverse Event|0|||
143043436|NCT03637764|515699338|FG002|Overall Study|Adverse Event|0|||
143043437|NCT03637764|515699339|FG003|Overall Study|Adverse Event|1|||
143043438|NCT03637764|515699336|FG000|Overall Study|Progressive Disease|23|||
143043439|NCT03637764|515699337|FG001|Overall Study|Progressive Disease|23|||
143043440|NCT03637764|515699338|FG002|Overall Study|Progressive Disease|18|||
143043441|NCT03637764|515699339|FG003|Overall Study|Progressive Disease|31|||
143043442|NCT03637764|515699336|FG000|Overall Study|Withdrawal by Subject|1|||
143043443|NCT03637764|515699337|FG001|Overall Study|Withdrawal by Subject|3|||
143498447|NCT00802360|517366352|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
143043444|NCT03637764|515699338|FG002|Overall Study|Withdrawal by Subject|0|||
143043445|NCT03637764|515699339|FG003|Overall Study|Withdrawal by Subject|1|||
143043446|NCT01983969|515699341|FG000|Overall Study|Disease Progression|0|||
143043447|NCT01983969|515699342|FG001|Overall Study|Disease Progression|1|||
143043448|NCT01983969|515699343|FG002|Overall Study|Disease Progression|0|||
143043449|NCT00268203|515699344|FG000|Overall Study|Lost to Follow-up|92|||
143043450|NCT00268203|515699344|FG000|Overall Study|Withdrawal by Subject|9|||
143043451|NCT00268203|515699344|FG000|Overall Study|Received Other NHL Therapy|7|||
143043452|NCT00268203|515699344|FG000|Overall Study|Progressive Disease|359|||
143043453|NCT00268203|515699344|FG000|Overall Study|Death|84|||
143043454|NCT00268203|515699344|FG000|Overall Study|Reason Not Specified|34|||
143043455|NCT00268203|515699344|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
143043456|NCT00950989|515699345|FG000|Overall Study|Death|0|||
143043457|NCT00950989|515699346|FG001|Overall Study|Death|0|||
143043458|NCT00950989|515699347|FG002|Overall Study|Death|1|||
143043459|NCT00950989|515699348|FG003|Overall Study|Death|0|||
143043460|NCT00950989|515699345|FG000|Overall Study|Administrative Decision|0|||
143043461|NCT00950989|515699346|FG001|Overall Study|Administrative Decision|1|||
143043462|NCT00950989|515699347|FG002|Overall Study|Administrative Decision|0|||
143043463|NCT00950989|515699348|FG003|Overall Study|Administrative Decision|0|||
143043464|NCT00950989|515699345|FG000|Overall Study|Disease Progression|0|||
143043465|NCT00950989|515699346|FG001|Overall Study|Disease Progression|0|||
143043466|NCT00950989|515699347|FG002|Overall Study|Disease Progression|1|||
143043467|NCT00950989|515699348|FG003|Overall Study|Disease Progression|0|||
143043468|NCT00950989|515699345|FG000|Overall Study|Withdrawal by Subject|2|||
143043469|NCT00950989|515699346|FG001|Overall Study|Withdrawal by Subject|1|||
143043470|NCT00950989|515699347|FG002|Overall Study|Withdrawal by Subject|0|||
143043471|NCT00950989|515699348|FG003|Overall Study|Withdrawal by Subject|0|||
143043472|NCT00950989|515699345|FG000|Overall Study|Adverse Event|2|||
143043473|NCT00950989|515699346|FG001|Overall Study|Adverse Event|1|||
143043474|NCT00950989|515699347|FG002|Overall Study|Adverse Event|1|||
143043475|NCT00950989|515699348|FG003|Overall Study|Adverse Event|0|||
143043476|NCT00813592|515699349|FG000|Overall Study|Disease assessment was not completed per|2|||
143043477|NCT03873272|515699352|FG000|Overall Study|Withdrawal by Subject|2|||
143043478|NCT03873272|515699353|FG001|Overall Study|Withdrawal by Subject|0|||
143043479|NCT03873272|515699354|FG002|Overall Study|Withdrawal by Subject|1|||
143043480|NCT03873272|515699352|FG000|Overall Study|Death|0|||
143043481|NCT03873272|515699353|FG001|Overall Study|Death|2|||
143043482|NCT03873272|515699354|FG002|Overall Study|Death|1|||
143043483|NCT01660243|515700932|FG000|Overall Study|Adverse Event|1|||
143043484|NCT01660243|515700933|FG001|Overall Study|Adverse Event|0|||
143043485|NCT01660243|515700934|FG002|Overall Study|Adverse Event|1|||
143043486|NCT01660243|515700935|FG003|Overall Study|Adverse Event|0|||
143043487|NCT01660243|515700932|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
143043488|NCT01660243|515700933|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
143043489|NCT01660243|515700934|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
143043490|NCT01660243|515700935|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
143043491|NCT01660243|515700932|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
143043492|NCT01660243|515700933|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
143043493|NCT01660243|515700934|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
143498448|NCT00802360|517366353|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
143498449|NCT00802360|517366354|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
143114901|NCT02326298|515962464|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
143114902|NCT02326298|515962465|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
143114903|NCT02326298|515962466|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
143114904|NCT02326298|515962467|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
143114905|NCT02326298|515962468|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
143114906|NCT02326298|515962469|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
143114907|NCT02326298|515962470|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
143114908|NCT02326298|515962471|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
143114909|NCT02326298|515962458|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
143114910|NCT02326298|515962459|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
143114911|NCT02326298|515962460|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
143114912|NCT02326298|515962461|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
143114913|NCT02326298|515962462|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
143114914|NCT02326298|515962463|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
143114915|NCT02326298|515962464|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
143114916|NCT02326298|515962465|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
143114917|NCT02326298|515962466|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
143114918|NCT02326298|515962467|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
143114919|NCT02326298|515962468|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
143114920|NCT02326298|515962469|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
143114921|NCT02326298|515962470|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
143114922|NCT02326298|515962471|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
143114923|NCT02326298|515962458|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
143114924|NCT02326298|515962459|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
143114925|NCT02326298|515962460|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
143114926|NCT02326298|515962461|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
143114927|NCT02326298|515962462|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
143114928|NCT02326298|515962463|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
143114929|NCT02326298|515962464|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
143114930|NCT02326298|515962465|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
143114931|NCT02326298|515962466|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
143114932|NCT02326298|515962467|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
143114933|NCT02326298|515962468|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
143114934|NCT02326298|515962469|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
143114935|NCT02326298|515962470|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
143114936|NCT02326298|515962471|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
143114937|NCT02326298|515962458|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
143114938|NCT02326298|515962459|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
143114939|NCT02326298|515962460|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
143114940|NCT02326298|515962461|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
143114941|NCT02326298|515962462|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
143114942|NCT02326298|515962463|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
143114943|NCT02326298|515962464|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
143114944|NCT02326298|515962465|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
143114945|NCT02326298|515962466|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
143240813|NCT00419952|516433396|FG001|Overall Study|Lost to Follow-up|34|||
143240814|NCT00419952|516433395|FG000|Overall Study|Protocol Violation|32|||
143240815|NCT00419952|516433396|FG001|Overall Study|Protocol Violation|24|||
143240816|NCT00419952|516433395|FG000|Overall Study|Pregnancy|4|||
143240817|NCT00419952|516433396|FG001|Overall Study|Pregnancy|2|||
143240818|NCT00419952|516433395|FG000|Overall Study|Physician Decision|1|||
143240819|NCT00419952|516433396|FG001|Overall Study|Physician Decision|3|||
143240820|NCT00419952|516433395|FG000|Overall Study|Incorrectly enrolled|10|||
143240821|NCT00419952|516433396|FG001|Overall Study|Incorrectly enrolled|3|||
143240822|NCT00419952|516433395|FG000|Overall Study|Intake of prohibited medication|2|||
143240823|NCT00419952|516433396|FG001|Overall Study|Intake of prohibited medication|2|||
143240824|NCT00419952|516433395|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
143240825|NCT00419952|516433396|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
143240826|NCT00419952|516433395|FG000|Overall Study|Diary or medication non-compliance|2|||
143240827|NCT00419952|516433396|FG001|Overall Study|Diary or medication non-compliance|4|||
143240828|NCT00419952|516433395|FG000|Overall Study|Abnormal ECG|1|||
143240829|NCT00419952|516433396|FG001|Overall Study|Abnormal ECG|0|||
143240830|NCT03126591|516433397|FG000|Overall Study|Death|6|||
143240831|NCT03126591|516433398|FG001|Overall Study|Death|3|||
143240832|NCT03126591|516433399|FG002|Overall Study|Death|17|||
143240833|NCT03126591|516433397|FG000|Overall Study|Progressive Disease|0|||
143240834|NCT03126591|516433398|FG001|Overall Study|Progressive Disease|1|||
143240835|NCT03126591|516433399|FG002|Overall Study|Progressive Disease|2|||
143240836|NCT03126591|516433397|FG000|Overall Study|Terminated by Sponsor|0|||
143240837|NCT03126591|516433398|FG001|Overall Study|Terminated by Sponsor|1|||
143240838|NCT03126591|516433399|FG002|Overall Study|Terminated by Sponsor|4|||
143240839|NCT03126591|516433397|FG000|Overall Study|Withdrawal by Subject|1|||
143240840|NCT03126591|516433398|FG001|Overall Study|Withdrawal by Subject|1|||
143240841|NCT03126591|516433399|FG002|Overall Study|Withdrawal by Subject|4|||
143240842|NCT03722238|516433400|FG000|Overall Study|Protocol Violation|1|||
143240843|NCT03722238|516433401|FG001|Overall Study|Protocol Violation|0|||
143240844|NCT03722238|516433400|FG000|Overall Study|Physician Decision|1|||
143240845|NCT03722238|516433401|FG001|Overall Study|Physician Decision|0|||
143240846|NCT03722238|516433400|FG000|Overall Study|Death|1|||
143240847|NCT03722238|516433401|FG001|Overall Study|Death|0|||
143240848|NCT03722238|516433400|FG000|Overall Study|Lost to Follow-up|6|||
143240849|NCT03722238|516433401|FG001|Overall Study|Lost to Follow-up|0|||
143240850|NCT03722238|516433400|FG000|Overall Study|Partial missing data|44|||
143240851|NCT03722238|516433401|FG001|Overall Study|Partial missing data|1|||
143043494|NCT01660243|515700935|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
143043495|NCT01660243|515700932|FG000|Overall Study|Randomization error|0|||
143043496|NCT01660243|515700933|FG001|Overall Study|Randomization error|0|||
143043497|NCT01660243|515700934|FG002|Overall Study|Randomization error|0|||
143043498|NCT01660243|515700935|FG003|Overall Study|Randomization error|1|||
143165957|NCT04191135|516153665|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
143165958|NCT04191135|516153666|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
143165959|NCT04191135|516153667|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
143240852|NCT03722238|516433400|FG000|Overall Study|Withdrawal by Subject|2|||
143240853|NCT03722238|516433401|FG001|Overall Study|Withdrawal by Subject|0|||
143240854|NCT03722238|516433400|FG000|Overall Study|Other|4|||
143240855|NCT03722238|516433401|FG001|Overall Study|Other|0|||
143043499|NCT02255149|515700948|FG000|Overall Study|Lost to Follow-up|2|||
143165960|NCT04191135|516153665|FG000|Induction Treatment|Adverse Event|25|||
143165961|NCT04191135|516153666|FG001|Induction Treatment|Adverse Event|0|||
143165962|NCT04191135|516153667|FG002|Induction Treatment|Adverse Event|0|||
143165963|NCT04191135|516153665|FG000|Induction Treatment|Clinical Progression|8|||
143165964|NCT04191135|516153666|FG001|Induction Treatment|Clinical Progression|0|||
143165965|NCT04191135|516153667|FG002|Induction Treatment|Clinical Progression|0|||
143165966|NCT04191135|516153665|FG000|Induction Treatment|Excluded Medication|1|||
143240856|NCT03722238|516433400|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
143240857|NCT03722238|516433401|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
143240858|NCT03722238|516433400|FG000|Overall Study|Did not meet risk classification group criteria|90|||
143240859|NCT03722238|516433401|FG001|Overall Study|Did not meet risk classification group criteria|0|||
143240860|NCT03722238|516433400|FG000|Overall Study|Did not sign consent|17|||
143240861|NCT03722238|516433401|FG001|Overall Study|Did not sign consent|0|||
143043500|NCT02255149|515700948|FG000|Overall Study|Withdrawal by Subject|1|||
143043501|NCT02255149|515700948|FG000|Overall Study|Withdrawal by PI|1|||
143165967|NCT04191135|516153666|FG001|Induction Treatment|Excluded Medication|0|||
143165968|NCT04191135|516153667|FG002|Induction Treatment|Excluded Medication|0|||
143165969|NCT04191135|516153665|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
143240862|NCT03722238|516433400|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
143240863|NCT03722238|516433401|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
143240864|NCT03722238|516433400|FG000|Overall Study|Not willing to purchase study medication|142|||
143043502|NCT02255149|515700948|FG000|Overall Study|Implant Failure|1|||
143043503|NCT03502811|515700949|FG000|Overall Study|Death|157|||
143043504|NCT03502811|515700949|FG000|Overall Study|Withdrawal by Subject|105|||
143043505|NCT03502811|515700949|FG000|Overall Study|Lost to Follow-up|26|||
143043506|NCT03502811|515700949|FG000|Overall Study|No Visits (Missed)|31|||
143043507|NCT00395694|515700953|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
143043508|NCT00395694|515700954|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
143043509|NCT00395694|515700953|FG000|Continuation Phase|Adverse Event|1|||
143043510|NCT00395694|515700954|FG001|Continuation Phase|Adverse Event|0|||
143043511|NCT00395694|515700953|FG000|Continuation Phase|Lack of Efficacy|12|||
143043512|NCT00395694|515700954|FG001|Continuation Phase|Lack of Efficacy|11|||
143043513|NCT00395694|515700953|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
143043514|NCT00395694|515700954|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
143043515|NCT00395694|515700953|FG000|Continuation Phase|Poor Compliance|1|||
143043516|NCT00395694|515700954|FG001|Continuation Phase|Poor Compliance|0|||
143043517|NCT00395694|515700953|FG000|Continuation Phase|Withdrawal by Subject|0|||
143043518|NCT00395694|515700954|FG001|Continuation Phase|Withdrawal by Subject|2|||
143043519|NCT02699866|515700955|FG000|Overall Study|Withdrawal by Subject|3|||
143043520|NCT02699866|515700955|FG000|Overall Study|Physician Decision|2|||
143043521|NCT02699866|515700955|FG000|Overall Study|Adverse Event|3|||
143043522|NCT02849457|515700956|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
143043523|NCT02849457|515700957|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
143043524|NCT02849457|515700958|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
143043525|NCT02849457|515700959|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
143043526|NCT00392665|515700960|FG000|Overall Study|Death|16|||
143043527|NCT00392665|515700961|FG001|Overall Study|Death|14|||
143043528|NCT00392665|515700960|FG000|Overall Study|Lost to Follow-up|1|||
143043529|NCT00392665|515700961|FG001|Overall Study|Lost to Follow-up|1|||
143043530|NCT01294917|515700968|FG000|Overall Study|Relocation|5|||
143043531|NCT01294917|515700968|FG000|Overall Study|Inconvenience|1|||
143043532|NCT01244620|515700971|FG000|Overall Study|Study terminated|4|||
143043533|NCT01244620|515700972|FG001|Overall Study|Study terminated|4|||
143043534|NCT01244620|515700973|FG002|Overall Study|Study terminated|4|||
143043535|NCT01244620|515700974|FG003|Overall Study|Study terminated|4|||
143043536|NCT00840073|515700975|FG000|Second Intervention|Missed 72 hour blood draw|1|||
143043537|NCT00840073|515700976|FG001|Second Intervention|Missed 72 hour blood draw|1|||
143043538|NCT01663233|515700977|FG000|Overall Study|Withdrawal by Subject|3|||
143043539|NCT01663233|515700978|FG001|Overall Study|Withdrawal by Subject|2|||
143043540|NCT01663233|515700977|FG000|Overall Study|Protocol Deviation|1|||
143043541|NCT01663233|515700978|FG001|Overall Study|Protocol Deviation|4|||
143043542|NCT01663233|515700977|FG000|Overall Study|Lost to Follow-up|0|||
143043543|NCT01663233|515700978|FG001|Overall Study|Lost to Follow-up|1|||
143043544|NCT02558491|515700981|FG000|First Invention|Withdrawal by Subject|3|||
143043545|NCT02558491|515700982|FG001|First Invention|Withdrawal by Subject|1|||
143043546|NCT02558491|515700981|FG000|First Invention|Data collection issues|1|||
143043547|NCT02558491|515700982|FG001|First Invention|Data collection issues|0|||
143043548|NCT02558491|515700981|FG000|First Invention|Stopping criteria|0|||
143043549|NCT02558491|515700982|FG001|First Invention|Stopping criteria|1|||
143043550|NCT02558491|515700981|FG000|First Invention|Changed parameters during trial|1|||
143043551|NCT02558491|515700982|FG001|First Invention|Changed parameters during trial|0|||
143498450|NCT00802360|517366351|FG000|Overall Study|Cycle cancelled|0|||
143498451|NCT00802360|517366352|FG001|Overall Study|Cycle cancelled|1|||
143043552|NCT02558491|515700981|FG000|Second Intervention|Withdrawal by Subject|1|||
143043553|NCT02558491|515700982|FG001|Second Intervention|Withdrawal by Subject|0|||
143043554|NCT02558491|515700981|FG000|Second Intervention|Stopping Criteria|1|||
143043555|NCT02558491|515700982|FG001|Second Intervention|Stopping Criteria|0|||
143043556|NCT03733444|515700985|FG000|Overall Study|Adverse Event|8|||
143043557|NCT03733444|515700986|FG001|Overall Study|Adverse Event|10|||
143043558|NCT03733444|515700987|FG002|Overall Study|Adverse Event|5|||
143043559|NCT03733444|515700985|FG000|Overall Study|Death|20|||
143043560|NCT03733444|515700986|FG001|Overall Study|Death|19|||
143043561|NCT03733444|515700987|FG002|Overall Study|Death|11|||
143043562|NCT03733444|515700985|FG000|Overall Study|Lost to Follow-up|3|||
143498452|NCT00802360|517366353|FG002|Overall Study|Cycle cancelled|1|||
143043563|NCT03733444|515700986|FG001|Overall Study|Lost to Follow-up|0|||
143043564|NCT03733444|515700987|FG002|Overall Study|Lost to Follow-up|1|||
143043565|NCT03733444|515700985|FG000|Overall Study|Lack of Efficacy|0|||
143043566|NCT03733444|515700986|FG001|Overall Study|Lack of Efficacy|1|||
143043567|NCT03733444|515700987|FG002|Overall Study|Lack of Efficacy|1|||
143043568|NCT03733444|515700985|FG000|Overall Study|Physician Decision|2|||
143498453|NCT00802360|517366354|FG003|Overall Study|Cycle cancelled|1|||
143043569|NCT03733444|515700986|FG001|Overall Study|Physician Decision|1|||
143043570|NCT03733444|515700987|FG002|Overall Study|Physician Decision|0|||
143043571|NCT03733444|515700985|FG000|Overall Study|Protocol Violation|2|||
143165970|NCT04191135|516153666|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
143165971|NCT04191135|516153667|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
143165972|NCT04191135|516153665|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
143165973|NCT04191135|516153666|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
143165974|NCT04191135|516153667|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
143165975|NCT04191135|516153665|FG000|Induction Treatment|Physician Decision|2|||
143165976|NCT04191135|516153666|FG001|Induction Treatment|Physician Decision|0|||
143165977|NCT04191135|516153667|FG002|Induction Treatment|Physician Decision|0|||
143165978|NCT04191135|516153665|FG000|Induction Treatment|Progressive Disease|135|||
143165979|NCT04191135|516153666|FG001|Induction Treatment|Progressive Disease|0|||
143165980|NCT04191135|516153667|FG002|Induction Treatment|Progressive Disease|0|||
143165981|NCT04191135|516153665|FG000|Induction Treatment|Protocol Violation|10|||
143165982|NCT04191135|516153666|FG001|Induction Treatment|Protocol Violation|0|||
143165983|NCT04191135|516153667|FG002|Induction Treatment|Protocol Violation|0|||
143165984|NCT04191135|516153665|FG000|Induction Treatment|Withdrawal by Subject|4|||
143165985|NCT04191135|516153666|FG001|Induction Treatment|Withdrawal by Subject|0|||
143165986|NCT04191135|516153667|FG002|Induction Treatment|Withdrawal by Subject|0|||
143165987|NCT04191135|516153665|FG000|Randomized Treatment|Death|0|||
143165988|NCT04191135|516153666|FG001|Randomized Treatment|Death|50|||
143165989|NCT04191135|516153667|FG002|Randomized Treatment|Death|54|||
143165990|NCT04191135|516153665|FG000|Randomized Treatment|Lost to Follow-up|0|||
143165991|NCT04191135|516153666|FG001|Randomized Treatment|Lost to Follow-up|0|||
143165992|NCT04191135|516153667|FG002|Randomized Treatment|Lost to Follow-up|1|||
143165993|NCT04191135|516153665|FG000|Randomized Treatment|Withdrawal by Subject|0|||
143165994|NCT04191135|516153666|FG001|Randomized Treatment|Withdrawal by Subject|2|||
143165995|NCT04191135|516153667|FG002|Randomized Treatment|Withdrawal by Subject|0|||
143165996|NCT04191135|516153665|FG000|Randomized Treatment|Ongoing in Trial|0|||
143165997|NCT04191135|516153666|FG001|Randomized Treatment|Ongoing in Trial|83|||
143165998|NCT04191135|516153667|FG002|Randomized Treatment|Ongoing in Trial|81|||
143165999|NCT05654181|516155003|FG000|Overall Study|Adverse Event|1|||
143166000|NCT05654181|516155004|FG001|Overall Study|Adverse Event|0|||
143166001|NCT05654181|516155005|FG002|Overall Study|Adverse Event|0|||
143166002|NCT05654181|516155006|FG003|Overall Study|Adverse Event|0|||
143166003|NCT05654181|516155007|FG004|Overall Study|Adverse Event|0|||
143166004|NCT05654181|516155008|FG005|Overall Study|Adverse Event|0|||
143166005|NCT05654181|516155009|FG006|Overall Study|Adverse Event|0|||
143166006|NCT05654181|516155010|FG007|Overall Study|Adverse Event|1|||
143166007|NCT05654181|516155011|FG008|Overall Study|Adverse Event|0|||
143166008|NCT05654181|516155012|FG009|Overall Study|Adverse Event|0|||
143166009|NCT05654181|516155003|FG000|Overall Study|Withdrawal by Subject|0|||
143166010|NCT05654181|516155004|FG001|Overall Study|Withdrawal by Subject|0|||
143166011|NCT05654181|516155005|FG002|Overall Study|Withdrawal by Subject|0|||
143166012|NCT05654181|516155006|FG003|Overall Study|Withdrawal by Subject|0|||
143166013|NCT05654181|516155007|FG004|Overall Study|Withdrawal by Subject|0|||
143166014|NCT05654181|516155008|FG005|Overall Study|Withdrawal by Subject|0|||
143166015|NCT05654181|516155009|FG006|Overall Study|Withdrawal by Subject|0|||
143166016|NCT05654181|516155010|FG007|Overall Study|Withdrawal by Subject|1|||
143166017|NCT05654181|516155011|FG008|Overall Study|Withdrawal by Subject|0|||
143166018|NCT05654181|516155012|FG009|Overall Study|Withdrawal by Subject|0|||
143166019|NCT05654181|516155003|FG000|Overall Study|Other|0|||
143166020|NCT05654181|516155004|FG001|Overall Study|Other|0|||
143166021|NCT05654181|516155005|FG002|Overall Study|Other|0|||
143166022|NCT05654181|516155006|FG003|Overall Study|Other|0|||
143166023|NCT05654181|516155007|FG004|Overall Study|Other|1|||
143166024|NCT05654181|516155008|FG005|Overall Study|Other|1|||
143498454|NCT00802360|517366351|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
143498455|NCT00802360|517366352|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
143498456|NCT00802360|517366353|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
143498457|NCT00802360|517366354|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
143498458|NCT00802360|517366351|FG000|Overall Study|No positive serum pregnancy|17|||
143498459|NCT00802360|517366352|FG001|Overall Study|No positive serum pregnancy|20|||
143498460|NCT00802360|517366353|FG002|Overall Study|No positive serum pregnancy|14|||
143498461|NCT00802360|517366354|FG003|Overall Study|No positive serum pregnancy|10|||
143498462|NCT00802360|517366351|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
143166025|NCT05654181|516155009|FG006|Overall Study|Other|0|||
143166026|NCT05654181|516155010|FG007|Overall Study|Other|0|||
143166027|NCT05654181|516155011|FG008|Overall Study|Other|0|||
143166028|NCT05654181|516155012|FG009|Overall Study|Other|0|||
143166029|NCT04101331|516155013|FG000|Overall Study|Adverse Event|9|||
143166030|NCT04101331|516155013|FG000|Overall Study|Disease progression|82|||
143166031|NCT04101331|516155013|FG000|Overall Study|Withdrawal by Subject|1|||
143166032|NCT04101331|516155013|FG000|Overall Study|Investigator decision|6|||
143166033|NCT04101331|516155013|FG000|Overall Study|Death|6|||
143166034|NCT04101331|516155013|FG000|Overall Study|Allogenic transplant|1|||
143166035|NCT01444781|516155014|FG000|Overall Study|Lost to Follow-up|0|||
143166036|NCT01444781|516155015|FG001|Overall Study|Lost to Follow-up|3|||
143043572|NCT03733444|515700986|FG001|Overall Study|Protocol Violation|1|||
143043573|NCT03733444|515700987|FG002|Overall Study|Protocol Violation|0|||
143043574|NCT03733444|515700985|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
143043575|NCT03733444|515700986|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
143043576|NCT03733444|515700987|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
143043577|NCT03733444|515700985|FG000|Overall Study|Study Terminated by Sponsor|203|||
143043578|NCT03733444|515700986|FG001|Overall Study|Study Terminated by Sponsor|209|||
143043579|NCT03733444|515700987|FG002|Overall Study|Study Terminated by Sponsor|221|||
143043580|NCT03733444|515700985|FG000|Overall Study|Withdrawal by Subject|19|||
143043581|NCT03733444|515700986|FG001|Overall Study|Withdrawal by Subject|18|||
143043582|NCT03733444|515700987|FG002|Overall Study|Withdrawal by Subject|16|||
143043583|NCT03733444|515700985|FG000|Overall Study|Miscellaneous|1|||
143043584|NCT03733444|515700986|FG001|Overall Study|Miscellaneous|0|||
143043585|NCT03733444|515700987|FG002|Overall Study|Miscellaneous|1|||
143043586|NCT03733444|515700985|FG000|Overall Study|Not Treated|1|||
143043587|NCT03733444|515700986|FG001|Overall Study|Not Treated|2|||
143043588|NCT03733444|515700987|FG002|Overall Study|Not Treated|1|||
143043589|NCT00556322|515700988|FG000|Overall Study|Insufficient therapeutic response|158|||
143043590|NCT00556322|515700989|FG001|Overall Study|Insufficient therapeutic response|168|||
143043591|NCT00556322|515700988|FG000|Overall Study|Adverse Event|7|||
143043592|NCT00556322|515700989|FG001|Overall Study|Adverse Event|4|||
143043593|NCT00556322|515700988|FG000|Overall Study|Other|4|||
143043594|NCT00556322|515700989|FG001|Overall Study|Other|1|||
143043595|NCT00556322|515700988|FG000|Overall Study|Lost to Follow-up|5|||
143043596|NCT00556322|515700989|FG001|Overall Study|Lost to Follow-up|3|||
143043597|NCT00556322|515700988|FG000|Overall Study|Withdrawal by Subject|19|||
143166037|NCT01444781|516155016|FG002|Overall Study|Lost to Follow-up|1|||
143166038|NCT01444781|516155014|FG000|Overall Study|Withdrawal by Subject|3|||
143166039|NCT01444781|516155015|FG001|Overall Study|Withdrawal by Subject|1|||
143166040|NCT01444781|516155016|FG002|Overall Study|Withdrawal by Subject|2|||
143166041|NCT02489279|516155017|FG000|Overall Study|Lost to Follow-up|12|||
143043598|NCT00556322|515700989|FG001|Overall Study|Withdrawal by Subject|7|||
143043599|NCT00556322|515700988|FG000|Overall Study|Protocol Violation|5|||
143043600|NCT00556322|515700989|FG001|Overall Study|Protocol Violation|1|||
143043601|NCT00556322|515700988|FG000|Overall Study|Ongoing at data cutoff|3|||
143043602|NCT00556322|515700989|FG001|Overall Study|Ongoing at data cutoff|5|||
143043603|NCT00556322|515700988|FG000|Overall Study|Death|20|||
143043604|NCT00556322|515700989|FG001|Overall Study|Death|14|||
143043605|NCT01788423|515700990|FG000|Overall Study|See Comments in Completed (above)|0|||
143043606|NCT01788423|515700991|FG001|Overall Study|See Comments in Completed (above)|4|||
143043607|NCT01788423|515700992|FG002|Overall Study|See Comments in Completed (above)|5|||
143043608|NCT00835263|515700993|FG000|Second Intervention|Adverse Event|1|||
143043609|NCT00835263|515700994|FG001|Second Intervention|Adverse Event|0|||
143043610|NCT03987191|515700997|FG000|Overall Study|COVID-19 related research disruption|0|||
143043611|NCT03987191|515700998|FG001|Overall Study|COVID-19 related research disruption|2|||
143043612|NCT01020474|515700999|FG000|Overall Study|Adverse Event|4|||
143043613|NCT01020474|515701000|FG001|Overall Study|Adverse Event|4|||
143043614|NCT01020474|515700999|FG000|Overall Study|Protocol Violation|0|||
143043615|NCT01020474|515701000|FG001|Overall Study|Protocol Violation|2|||
143043616|NCT01020474|515700999|FG000|Overall Study|Withdrawal by Subject|5|||
143043617|NCT01020474|515701000|FG001|Overall Study|Withdrawal by Subject|7|||
143043618|NCT01020474|515700999|FG000|Overall Study|Other Reasons|1|||
143043619|NCT01020474|515701000|FG001|Overall Study|Other Reasons|1|||
143043620|NCT01020474|515700999|FG000|Overall Study|Insufficient Clinical Response|0|||
143043621|NCT01020474|515701000|FG001|Overall Study|Insufficient Clinical Response|3|||
143043622|NCT00705666|515701008|FG000|Overall Study|No post-treatment questionnaire|279|||
143043623|NCT00705666|515701008|FG000|Overall Study|Withdrawal by Subject|21|||
143043624|NCT00705666|515701008|FG000|Overall Study|Physician Decision|7|||
143043625|NCT00705666|515701008|FG000|Overall Study|Lost to Follow-up|5|||
143043626|NCT00705666|515701008|FG000|Overall Study|Death|1|||
143043627|NCT00705666|515701008|FG000|Overall Study|Adverse Event|4|||
143043628|NCT00705666|515701008|FG000|Overall Study|Other|12|||
143043629|NCT00705666|515701008|FG000|Overall Study|Other|2|||
143043630|NCT00705666|515701008|FG000|Overall Study|Lack of data|3|||
143043631|NCT00705666|515701008|FG000|Overall Study|Untreated|5|||
143043632|NCT02105272|515701010|FG000|Overall Study|Adverse Event|1|||
143043633|NCT02105272|515701011|FG001|Overall Study|Adverse Event|2|||
143043634|NCT02105272|515701010|FG000|Overall Study|Physician Decision|0|||
143043635|NCT02105272|515701011|FG001|Overall Study|Physician Decision|1|||
143043636|NCT02105272|515701010|FG000|Overall Study|Protocol Violation|2|||
143043637|NCT02105272|515701011|FG001|Overall Study|Protocol Violation|0|||
143043638|NCT02105272|515701010|FG000|Overall Study|Withdrawal by Subject|2|||
143043639|NCT02105272|515701011|FG001|Overall Study|Withdrawal by Subject|0|||
143043640|NCT03406156|515701021|FG000|Overall Study|Death|9|||
143043641|NCT03406156|515701022|FG001|Overall Study|Death|3|||
143166042|NCT02489279|516155018|FG001|Overall Study|Lost to Follow-up|10|||
143166043|NCT01432444|516155019|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
143043642|NCT03406156|515701021|FG000|Overall Study|Withdrawal by Subject|1|||
143043643|NCT03406156|515701022|FG001|Overall Study|Withdrawal by Subject|2|||
143043644|NCT03406156|515701021|FG000|Overall Study|COVID-19 infection|1|||
143043645|NCT03406156|515701022|FG001|Overall Study|COVID-19 infection|0|||
143043646|NCT03406156|515701021|FG000|Overall Study|Non-compliance with study procedures|1|||
143043647|NCT03406156|515701022|FG001|Overall Study|Non-compliance with study procedures|1|||
143043648|NCT03406156|515701021|FG000|Overall Study|Lost to Follow-up|0|||
143043649|NCT03406156|515701022|FG001|Overall Study|Lost to Follow-up|2|||
143043650|NCT03406156|515701021|FG000|Overall Study|Other, not specified|72|||
143043651|NCT03406156|515701022|FG001|Overall Study|Other, not specified|28|||
143043652|NCT02964039|515701024|FG000|Overall Study|Medical reason unrelated to study participation|1|||
143043653|NCT02964039|515701025|FG001|Overall Study|Medical reason unrelated to study participation|0|||
143043654|NCT02964039|515701026|FG002|Overall Study|Medical reason unrelated to study participation|3|||
143043655|NCT02964039|515701024|FG000|Overall Study|Research shutdown due to pandemic|2|||
143043656|NCT02964039|515701025|FG001|Overall Study|Research shutdown due to pandemic|0|||
143043657|NCT02964039|515701026|FG002|Overall Study|Research shutdown due to pandemic|1|||
143043658|NCT02964039|515701024|FG000|Overall Study|Withdrawal by Subject|0|||
143043659|NCT02964039|515701025|FG001|Overall Study|Withdrawal by Subject|1|||
143043660|NCT02964039|515701026|FG002|Overall Study|Withdrawal by Subject|0|||
143043661|NCT02964039|515701024|FG000|Overall Study|Lost to Follow-up|1|||
143043662|NCT02964039|515701025|FG001|Overall Study|Lost to Follow-up|0|||
143043663|NCT02964039|515701026|FG002|Overall Study|Lost to Follow-up|1|||
143043664|NCT05479058|515701027|FG000|Overall Study|Withdrawal by Subject|1|||
143043665|NCT05479058|515701028|FG001|Overall Study|Withdrawal by Subject|1|||
143043666|NCT05479058|515701027|FG000|Overall Study|Study terminated by sponsor|10|||
143043667|NCT05479058|515701028|FG001|Overall Study|Study terminated by sponsor|10|||
143043668|NCT05630885|515701029|FG000|Study Completion|Took prohibited medications|2|||
143043669|NCT05630885|515701030|FG001|Study Completion|Took prohibited medications|0|||
143043670|NCT05630885|515701029|FG000|Study Completion|Non-compliance with study drug|1|||
143043671|NCT05630885|515701030|FG001|Study Completion|Non-compliance with study drug|0|||
143043672|NCT05630885|515701029|FG000|Study Completion|Adverse Event|1|||
143043673|NCT05630885|515701030|FG001|Study Completion|Adverse Event|0|||
143043674|NCT05630885|515701029|FG000|Efficacy Analysis Population Set|Took prohibited medications|3|||
143043675|NCT05630885|515701030|FG001|Efficacy Analysis Population Set|Took prohibited medications|1|||
143043676|NCT05630885|515701029|FG000|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|8|||
143043677|NCT05630885|515701030|FG001|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|1|||
143043678|NCT01103713|515701033|FG000|Overall Study|Lost to Follow-up|2|||
143043679|NCT01103713|515701033|FG000|Overall Study|Withdrawal by Subject|8|||
143043680|NCT01103713|515701033|FG000|Overall Study|Study terminated by sponsor|2|||
143043681|NCT01103713|515701033|FG000|Overall Study|Other|1|||
143043682|NCT02645409|515701036|FG000|Overall Study|Withdrawal by Subject|3|||
143043683|NCT02645409|515701037|FG001|Overall Study|Withdrawal by Subject|0|||
143043684|NCT02645409|515701036|FG000|Overall Study|Physician Decision|1|||
143043685|NCT02645409|515701037|FG001|Overall Study|Physician Decision|0|||
143043686|NCT02089685|515701042|FG000|Overall Study|Adverse Event|1|||
143043687|NCT02089685|515701043|FG001|Overall Study|Adverse Event|0|||
143043688|NCT02089685|515701044|FG002|Overall Study|Adverse Event|0|||
143043689|NCT02089685|515701045|FG003|Overall Study|Adverse Event|0|||
143043690|NCT02089685|515701046|FG004|Overall Study|Adverse Event|1|||
143043691|NCT02089685|515701047|FG005|Overall Study|Adverse Event|0|||
143043692|NCT02089685|515701042|FG000|Overall Study|Clinical Progression|4|||
143043693|NCT02089685|515701043|FG001|Overall Study|Clinical Progression|0|||
143043694|NCT02089685|515701044|FG002|Overall Study|Clinical Progression|0|||
143043695|NCT02089685|515701045|FG003|Overall Study|Clinical Progression|5|||
143043696|NCT02089685|515701046|FG004|Overall Study|Clinical Progression|1|||
143043697|NCT02089685|515701047|FG005|Overall Study|Clinical Progression|2|||
143043698|NCT02089685|515701042|FG000|Overall Study|Excluded Medication|1|||
143043699|NCT02089685|515701043|FG001|Overall Study|Excluded Medication|0|||
143043700|NCT02089685|515701044|FG002|Overall Study|Excluded Medication|0|||
143043701|NCT02089685|515701045|FG003|Overall Study|Excluded Medication|11|||
143043702|NCT02089685|515701046|FG004|Overall Study|Excluded Medication|2|||
143043703|NCT02089685|515701047|FG005|Overall Study|Excluded Medication|1|||
143043704|NCT02089685|515701042|FG000|Overall Study|Progressive disease|13|||
143043705|NCT02089685|515701043|FG001|Overall Study|Progressive disease|10|||
143498463|NCT00802360|517366352|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
143498464|NCT00802360|517366353|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
143498465|NCT00802360|517366354|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
143043706|NCT02089685|515701044|FG002|Overall Study|Progressive disease|3|||
143043707|NCT02089685|515701045|FG003|Overall Study|Progressive disease|51|||
143043708|NCT02089685|515701046|FG004|Overall Study|Progressive disease|17|||
143043709|NCT02089685|515701047|FG005|Overall Study|Progressive disease|12|||
143043710|NCT02089685|515701042|FG000|Overall Study|Follow up ended by sponsor|2|||
143043711|NCT02089685|515701043|FG001|Overall Study|Follow up ended by sponsor|2|||
143043712|NCT02089685|515701044|FG002|Overall Study|Follow up ended by sponsor|0|||
143043713|NCT02089685|515701045|FG003|Overall Study|Follow up ended by sponsor|70|||
143043714|NCT02089685|515701046|FG004|Overall Study|Follow up ended by sponsor|26|||
143043715|NCT02089685|515701047|FG005|Overall Study|Follow up ended by sponsor|26|||
143043716|NCT02089685|515701042|FG000|Overall Study|Withdrawal by Subject|0|||
143043717|NCT02089685|515701043|FG001|Overall Study|Withdrawal by Subject|2|||
143043718|NCT02089685|515701044|FG002|Overall Study|Withdrawal by Subject|0|||
143043719|NCT02089685|515701045|FG003|Overall Study|Withdrawal by Subject|8|||
143043720|NCT02089685|515701046|FG004|Overall Study|Withdrawal by Subject|1|||
143043721|NCT02089685|515701047|FG005|Overall Study|Withdrawal by Subject|1|||
143043722|NCT02089685|515701042|FG000|Overall Study|Status not recorded|1|||
143043723|NCT02089685|515701043|FG001|Overall Study|Status not recorded|0|||
143043724|NCT02089685|515701044|FG002|Overall Study|Status not recorded|0|||
143043725|NCT02089685|515701045|FG003|Overall Study|Status not recorded|0|||
143043726|NCT02089685|515701046|FG004|Overall Study|Status not recorded|1|||
143043727|NCT02089685|515701047|FG005|Overall Study|Status not recorded|0|||
143043728|NCT02089685|515701042|FG000|Overall Study|Death|0|||
143043729|NCT02089685|515701043|FG001|Overall Study|Death|0|||
143043730|NCT02089685|515701044|FG002|Overall Study|Death|0|||
143043731|NCT02089685|515701045|FG003|Overall Study|Death|7|||
143043732|NCT02089685|515701046|FG004|Overall Study|Death|2|||
143043733|NCT02089685|515701047|FG005|Overall Study|Death|5|||
143043734|NCT02089685|515701042|FG000|Overall Study|Lost to Follow-up|0|||
143043735|NCT02089685|515701043|FG001|Overall Study|Lost to Follow-up|0|||
143043736|NCT02089685|515701044|FG002|Overall Study|Lost to Follow-up|0|||
143043737|NCT02089685|515701045|FG003|Overall Study|Lost to Follow-up|1|||
143043738|NCT02089685|515701046|FG004|Overall Study|Lost to Follow-up|0|||
143043739|NCT02089685|515701047|FG005|Overall Study|Lost to Follow-up|0|||
143043740|NCT02089685|515701042|FG000|Overall Study|Physician Decision|0|||
143043741|NCT02089685|515701043|FG001|Overall Study|Physician Decision|0|||
143043742|NCT02089685|515701044|FG002|Overall Study|Physician Decision|0|||
143043743|NCT02089685|515701045|FG003|Overall Study|Physician Decision|0|||
143043744|NCT02089685|515701046|FG004|Overall Study|Physician Decision|0|||
143043745|NCT02089685|515701047|FG005|Overall Study|Physician Decision|4|||
143043746|NCT02089685|515701042|FG000|Overall Study|Screen failure|1|||
143043747|NCT02089685|515701043|FG001|Overall Study|Screen failure|0|||
143043748|NCT02089685|515701044|FG002|Overall Study|Screen failure|0|||
143043749|NCT02089685|515701045|FG003|Overall Study|Screen failure|0|||
143043750|NCT02089685|515701046|FG004|Overall Study|Screen failure|0|||
143043751|NCT02089685|515701047|FG005|Overall Study|Screen failure|0|||
143043752|NCT00318461|515701048|FG000|Double-Blind, 6 Months|Adverse Event|11|||
143043753|NCT00318461|515701049|FG001|Double-Blind, 6 Months|Adverse Event|23|||
143043754|NCT00318461|515701050|FG002|Double-Blind, 6 Months|Adverse Event|29|||
143043755|NCT00318461|515701051|FG003|Double-Blind, 6 Months|Adverse Event|2|||
143043756|NCT00318461|515701052|FG004|Double-Blind, 6 Months|Adverse Event|8|||
143043757|NCT00318461|515701048|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
143043758|NCT00318461|515701049|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
143043759|NCT00318461|515701050|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
143364263|NCT01251614|516876936|FG002|Overall Study|Loss of Disease Control|0|||
143043760|NCT00318461|515701051|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
143043761|NCT00318461|515701052|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
143043762|NCT00318461|515701048|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
143043763|NCT00318461|515701049|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
143043764|NCT00318461|515701050|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
143043765|NCT00318461|515701051|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
143043766|NCT00318461|515701052|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
143043767|NCT00318461|515701048|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
143043768|NCT00318461|515701049|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
143043769|NCT00318461|515701050|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
143043770|NCT00318461|515701051|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
143043771|NCT00318461|515701052|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
143043772|NCT00318461|515701048|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
143043773|NCT00318461|515701049|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
143043774|NCT00318461|515701050|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
143043775|NCT00318461|515701051|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
143043776|NCT00318461|515701052|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
143043777|NCT00318461|515701048|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
143043778|NCT00318461|515701049|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
143043779|NCT00318461|515701050|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
143043780|NCT00318461|515701051|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
143043781|NCT00318461|515701052|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
143043782|NCT00318461|515701048|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
143043783|NCT00318461|515701049|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
143043784|NCT00318461|515701050|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
143043785|NCT00318461|515701051|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
143043786|NCT00318461|515701052|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
143043787|NCT00318461|515701048|FG000|Double-Blind, 6 Months|Move|0|||
143043788|NCT00318461|515701049|FG001|Double-Blind, 6 Months|Move|1|||
143043789|NCT00318461|515701050|FG002|Double-Blind, 6 Months|Move|0|||
143043790|NCT00318461|515701051|FG003|Double-Blind, 6 Months|Move|0|||
143043791|NCT00318461|515701052|FG004|Double-Blind, 6 Months|Move|0|||
143043792|NCT00318461|515701048|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
143043793|NCT00318461|515701049|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
143043794|NCT00318461|515701050|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
143043795|NCT00318461|515701051|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
143043796|NCT00318461|515701052|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
143043797|NCT00318461|515701048|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
143043798|NCT00318461|515701049|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
143043799|NCT00318461|515701050|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
143043800|NCT00318461|515701051|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
143043801|NCT00318461|515701052|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
143043802|NCT00318461|515701048|FG000|Double-Blind, 6 Months|Work commitment|0|||
143043803|NCT00318461|515701049|FG001|Double-Blind, 6 Months|Work commitment|0|||
143043804|NCT00318461|515701050|FG002|Double-Blind, 6 Months|Work commitment|0|||
143043805|NCT00318461|515701051|FG003|Double-Blind, 6 Months|Work commitment|0|||
143043806|NCT00318461|515701052|FG004|Double-Blind, 6 Months|Work commitment|1|||
143043807|NCT00318461|515701048|FG000|Double-Blind, 6 Months|Investigator decision|0|||
143043808|NCT00318461|515701049|FG001|Double-Blind, 6 Months|Investigator decision|0|||
143043809|NCT00318461|515701050|FG002|Double-Blind, 6 Months|Investigator decision|0|||
143043810|NCT00318461|515701051|FG003|Double-Blind, 6 Months|Investigator decision|0|||
143043811|NCT00318461|515701052|FG004|Double-Blind, 6 Months|Investigator decision|1|||
143043812|NCT00318461|515701048|FG000|Double-Blind, 6 Months|Lack of time|1|||
143043813|NCT00318461|515701049|FG001|Double-Blind, 6 Months|Lack of time|0|||
143043814|NCT00318461|515701050|FG002|Double-Blind, 6 Months|Lack of time|0|||
143043815|NCT00318461|515701051|FG003|Double-Blind, 6 Months|Lack of time|0|||
143240865|NCT03722238|516433401|FG001|Overall Study|Not willing to purchase study medication|0|||
143498466|NCT00802360|517366351|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
143498467|NCT00802360|517366352|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
143498468|NCT00802360|517366353|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
143498469|NCT00802360|517366354|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
143498470|NCT00802360|517366351|FG000|Overall Study|Other|2|||
143498471|NCT00802360|517366352|FG001|Overall Study|Other|3|||
143498472|NCT00802360|517366353|FG002|Overall Study|Other|6|||
143498473|NCT00802360|517366354|FG003|Overall Study|Other|3|||
143498474|NCT02041962|517366355|FG000|Overall Study|Lost Aetna Coverage|43|||
143240866|NCT03722238|516433400|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
143240867|NCT03722238|516433401|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
143240868|NCT02158546|516433408|FG000|Overall Study|Physician Decision|0|||
143240869|NCT02158546|516433409|FG001|Overall Study|Physician Decision|1|||
143240870|NCT02158546|516433410|FG002|Overall Study|Physician Decision|0|||
143240871|NCT02158546|516433411|FG003|Overall Study|Physician Decision|0|||
143240872|NCT02158546|516433408|FG000|Overall Study|Non-compliance|0|||
143240873|NCT02158546|516433409|FG001|Overall Study|Non-compliance|1|||
143240874|NCT02158546|516433410|FG002|Overall Study|Non-compliance|0|||
143240875|NCT02158546|516433411|FG003|Overall Study|Non-compliance|1|||
143240876|NCT02158546|516433408|FG000|Overall Study|Failure to meet eligibility criteria|0|||
143240877|NCT02158546|516433409|FG001|Overall Study|Failure to meet eligibility criteria|1|||
143240878|NCT02158546|516433410|FG002|Overall Study|Failure to meet eligibility criteria|0|||
143498475|NCT02041962|517366356|FG001|Overall Study|Lost Aetna Coverage|40|||
143498476|NCT02041962|517366355|FG000|Overall Study|Death|1|||
143498477|NCT02041962|517366356|FG001|Overall Study|Death|1|||
143498478|NCT02041962|517366355|FG000|Overall Study|Lost to Follow-up|37|||
143498479|NCT02041962|517366356|FG001|Overall Study|Lost to Follow-up|32|||
143498480|NCT02041962|517366355|FG000|Overall Study|Withdrawal by Subject|0|||
143498481|NCT02041962|517366356|FG001|Overall Study|Withdrawal by Subject|11|||
143043816|NCT00318461|515701052|FG004|Double-Blind, 6 Months|Lack of time|0|||
143043817|NCT00318461|515701048|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
143043818|NCT00318461|515701049|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
143240879|NCT02158546|516433411|FG003|Overall Study|Failure to meet eligibility criteria|0|||
143240880|NCT02158546|516433408|FG000|Overall Study|Lack of Efficacy|1|||
143240881|NCT02158546|516433409|FG001|Overall Study|Lack of Efficacy|1|||
143043819|NCT00318461|515701050|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
143240882|NCT02158546|516433410|FG002|Overall Study|Lack of Efficacy|0|||
143364264|NCT01251614|516876934|FG000|Overall Study|Withdrawal by Subject|0|||
143498482|NCT02601573|517366365|FG000|Overall Study|Lost to Follow-up|0|||
143498483|NCT02601573|517366366|FG001|Overall Study|Lost to Follow-up|3|||
143043820|NCT00318461|515701051|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
143240883|NCT02158546|516433411|FG003|Overall Study|Lack of Efficacy|0|||
143240884|NCT02158546|516433408|FG000|Overall Study|Adverse Event|2|||
143240885|NCT02158546|516433409|FG001|Overall Study|Adverse Event|2|||
143240886|NCT02158546|516433410|FG002|Overall Study|Adverse Event|0|||
143498484|NCT02601573|517366367|FG002|Overall Study|Lost to Follow-up|1|||
143240887|NCT02158546|516433411|FG003|Overall Study|Adverse Event|0|||
143240888|NCT02158546|516433408|FG000|Overall Study|Withdrawal by Subject|6|||
143240889|NCT02158546|516433409|FG001|Overall Study|Withdrawal by Subject|2|||
143240890|NCT02158546|516433410|FG002|Overall Study|Withdrawal by Subject|1|||
143240891|NCT02158546|516433411|FG003|Overall Study|Withdrawal by Subject|0|||
143240892|NCT02158546|516433408|FG000|Overall Study|Lost to Follow-up|5|||
143240893|NCT02158546|516433409|FG001|Overall Study|Lost to Follow-up|4|||
143240894|NCT02158546|516433410|FG002|Overall Study|Lost to Follow-up|0|||
143240895|NCT02158546|516433411|FG003|Overall Study|Lost to Follow-up|1|||
143240896|NCT02158546|516433408|FG000|Overall Study|Site Excluded|5|||
143240897|NCT02158546|516433409|FG001|Overall Study|Site Excluded|5|||
143240898|NCT02158546|516433410|FG002|Overall Study|Site Excluded|3|||
143240899|NCT02158546|516433411|FG003|Overall Study|Site Excluded|4|||
143240900|NCT02351817|516433412|FG000|Period 1|Adverse Event|1|||
143364265|NCT01251614|516876935|FG001|Overall Study|Withdrawal by Subject|2|||
143498485|NCT02601573|517366368|FG003|Overall Study|Lost to Follow-up|0|||
143498486|NCT02601573|517366369|FG004|Overall Study|Lost to Follow-up|2|||
143498487|NCT02601573|517366365|FG000|Overall Study|Withdrawal by Subject|0|||
143498488|NCT02601573|517366366|FG001|Overall Study|Withdrawal by Subject|1|||
143498489|NCT02601573|517366367|FG002|Overall Study|Withdrawal by Subject|0|||
143498490|NCT02601573|517366368|FG003|Overall Study|Withdrawal by Subject|1|||
143498491|NCT02601573|517366369|FG004|Overall Study|Withdrawal by Subject|0|||
143498492|NCT03310970|517366370|FG000|Overall Study|Withdrawal by Subject|0|||
143498493|NCT03310970|517366371|FG001|Overall Study|Withdrawal by Subject|1|||
143498494|NCT01133171|517366372|FG000|Overall Study|Withdrawal by Subject|1|||
143498495|NCT01133171|517366373|FG001|Overall Study|Withdrawal by Subject|2|||
143498496|NCT01133171|517366374|FG002|Overall Study|Withdrawal by Subject|0|||
143498497|NCT02526550|517366375|FG000|Overall Study|Lost to Follow-up|1|||
143498498|NCT04062214|517366376|FG000|Week 12|Death|1|||
143498499|NCT04062214|517366377|FG001|Week 12|Death|1|||
143498500|NCT04062214|517366376|FG000|Week 12|Withdrawal by Subject|14|||
143498501|NCT04062214|517366377|FG001|Week 12|Withdrawal by Subject|13|||
143498502|NCT04062214|517366376|FG000|Week 12|Lost to Follow-up|55|||
143498503|NCT04062214|517366377|FG001|Week 12|Lost to Follow-up|68|||
143498504|NCT04062214|517366376|FG000|Week 12|Intermittent missing|31|||
143498505|NCT04062214|517366377|FG001|Week 12|Intermittent missing|29|||
143166044|NCT01432444|516155020|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
143166045|NCT01432444|516155021|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
143166046|NCT01432444|516155019|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
143166047|NCT01432444|516155020|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
143166048|NCT01432444|516155021|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
143166049|NCT01432444|516155019|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
143166050|NCT01432444|516155020|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
143166051|NCT01432444|516155021|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
143166052|NCT01432444|516155019|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
143166053|NCT01432444|516155020|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
143166054|NCT01432444|516155021|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
143166055|NCT01432444|516155019|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
143166056|NCT01432444|516155020|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
143166057|NCT01432444|516155021|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
143166058|NCT01432444|516155019|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
143166059|NCT01432444|516155020|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
143166060|NCT01432444|516155021|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
143166061|NCT01432444|516155019|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
143166062|NCT01432444|516155020|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
143166063|NCT01432444|516155021|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
143166064|NCT01432444|516155019|FG000|Treatment Phase|Lost to Follow-up|0|||
143498506|NCT04062214|517366376|FG000|Week 36|Withdrawal by Subject|4|||
143498507|NCT04062214|517366377|FG001|Week 36|Withdrawal by Subject|5|||
143498508|NCT04062214|517366376|FG000|Week 36|Lost to Follow-up|50|||
143498509|NCT04062214|517366377|FG001|Week 36|Lost to Follow-up|46|||
143498510|NCT04062214|517366376|FG000|Week 36|Death|0|||
143498511|NCT04062214|517366377|FG001|Week 36|Death|1|||
143498512|NCT00464178|517366386|FG000|Overall Study|Protocol Violation|1|||
143498513|NCT00464178|517366386|FG000|Overall Study|Withdrawal by Subject|1|||
143498514|NCT01446419|517366387|FG000|Overall Study|Death|1|||
143498515|NCT01446419|517366388|FG001|Overall Study|Death|0|||
143498516|NCT01446419|517366387|FG000|Overall Study|Withdrawal by Subject|1|||
143498517|NCT01446419|517366388|FG001|Overall Study|Withdrawal by Subject|1|||
143166065|NCT01432444|516155020|FG001|Treatment Phase|Lost to Follow-up|33|||
143240901|NCT02351817|516433413|FG001|Period 1|Adverse Event|2|||
143240902|NCT02351817|516433412|FG000|Period 1|Lack of Efficacy|0|||
143240903|NCT02351817|516433413|FG001|Period 1|Lack of Efficacy|1|||
143498518|NCT01446419|517366387|FG000|Overall Study|Terminated per protocol|3|||
143240904|NCT02351817|516433412|FG000|Period 2|Adverse Event|0|||
143498519|NCT01446419|517366388|FG001|Overall Study|Terminated per protocol|0|||
143498520|NCT02542072|517366391|FG000|First Intervention (1 Month)|Adverse Event|1|||
143498521|NCT02542072|517366392|FG001|First Intervention (1 Month)|Adverse Event|1|||
143498522|NCT02542072|517366391|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
143498523|NCT02542072|517366392|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
143498524|NCT02542072|517366391|FG000|First Intervention (1 Month)|Lens discomfort|1|||
143498525|NCT02542072|517366392|FG001|First Intervention (1 Month)|Lens discomfort|2|||
143498526|NCT02542072|517366391|FG000|First Intervention (1 Month)|Protocol Violation|1|||
143498527|NCT02542072|517366392|FG001|First Intervention (1 Month)|Protocol Violation|0|||
143498528|NCT02542072|517366391|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
143498529|NCT02542072|517366392|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
143498530|NCT02542072|517366391|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
143498531|NCT02542072|517366392|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
143498532|NCT00654498|517366393|FG000|Overall Study|Not Treated|1|||
143498533|NCT00654498|517366394|FG001|Overall Study|Not Treated|0|||
143498534|NCT00654498|517366393|FG000|Overall Study|Adverse Event|6|||
143498535|NCT00654498|517366394|FG001|Overall Study|Adverse Event|1|||
143498536|NCT00654498|517366393|FG000|Overall Study|Protocol Violation|1|||
143498537|NCT00654498|517366394|FG001|Overall Study|Protocol Violation|1|||
143498538|NCT00654498|517366393|FG000|Overall Study|Lost to Follow-up|1|||
143498539|NCT00654498|517366394|FG001|Overall Study|Lost to Follow-up|5|||
143498540|NCT00654498|517366393|FG000|Overall Study|Withdrawal by Subject|1|||
143498541|NCT00654498|517366394|FG001|Overall Study|Withdrawal by Subject|0|||
143498542|NCT00654498|517366393|FG000|Overall Study|Other reason not defined above|4|||
143498543|NCT00654498|517366394|FG001|Overall Study|Other reason not defined above|5|||
143498544|NCT02474329|517366396|FG000|Overall Study|Withdraw or did not contribute data.|13|||
143498545|NCT01583374|517366400|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
143498546|NCT01583374|517366401|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
143498547|NCT01583374|517366402|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
143498548|NCT01583374|517366403|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
143498549|NCT01583374|517366404|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
143498550|NCT01583374|517366405|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
143498551|NCT01583374|517366406|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
143498552|NCT01583374|517366407|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
143498553|NCT01583374|517366408|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
143498554|NCT01583374|517366400|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
143498555|NCT01583374|517366401|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
143043821|NCT00318461|515701052|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
143043822|NCT00318461|515701048|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
143043823|NCT00318461|515701049|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
143043824|NCT00318461|515701050|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
143043825|NCT00318461|515701051|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
143043826|NCT00318461|515701052|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
143166066|NCT01432444|516155021|FG002|Treatment Phase|Lost to Follow-up|0|||
143166067|NCT01432444|516155019|FG000|Treatment Phase|Adverse Event|0|||
143166068|NCT01432444|516155020|FG001|Treatment Phase|Adverse Event|37|||
143166069|NCT01432444|516155021|FG002|Treatment Phase|Adverse Event|0|||
143166070|NCT01432444|516155019|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
143166071|NCT01432444|516155020|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
143166072|NCT01432444|516155021|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
143166073|NCT01432444|516155019|FG000|Treatment Phase|Physician Decision|0|||
143166074|NCT01432444|516155020|FG001|Treatment Phase|Physician Decision|5|||
143166075|NCT01432444|516155021|FG002|Treatment Phase|Physician Decision|0|||
143166076|NCT01432444|516155019|FG000|Treatment Phase|Withdrawal by Subject|0|||
143166077|NCT01432444|516155020|FG001|Treatment Phase|Withdrawal by Subject|41|||
143166078|NCT01432444|516155021|FG002|Treatment Phase|Withdrawal by Subject|0|||
143166079|NCT01432444|516155019|FG000|Treatment Phase|Protocol Deviation|0|||
143166080|NCT01432444|516155020|FG001|Treatment Phase|Protocol Deviation|3|||
143498556|NCT01583374|517366402|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
143498557|NCT01583374|517366403|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
143498558|NCT01583374|517366404|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
143498559|NCT01583374|517366405|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
143498560|NCT01583374|517366406|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
143498561|NCT01583374|517366407|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
143498562|NCT01583374|517366408|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
143498563|NCT01583374|517366400|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
143498564|NCT01583374|517366401|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
143498565|NCT01583374|517366402|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
143166081|NCT01432444|516155021|FG002|Treatment Phase|Protocol Deviation|0|||
143166082|NCT01432444|516155019|FG000|Treatment Phase|Lack of Efficacy|0|||
143240905|NCT02351817|516433413|FG001|Period 2|Adverse Event|2|||
143043827|NCT00318461|515701048|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
143043828|NCT00318461|515701049|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
143043829|NCT00318461|515701050|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
143043830|NCT00318461|515701051|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
143043831|NCT00318461|515701052|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
143043832|NCT00318461|515701048|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
143043833|NCT00318461|515701049|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
143043834|NCT00318461|515701050|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
143043835|NCT00318461|515701051|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
143043836|NCT00318461|515701052|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
143043837|NCT00318461|515701048|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
143043838|NCT00318461|515701049|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
143043839|NCT00318461|515701050|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
143043840|NCT00318461|515701051|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
143043841|NCT00318461|515701052|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
143043842|NCT00318461|515701048|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
143043843|NCT00318461|515701049|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
143043844|NCT00318461|515701050|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
143043845|NCT00318461|515701051|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
143043846|NCT00318461|515701052|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
143043847|NCT00318461|515701048|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
143043848|NCT00318461|515701049|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
143043849|NCT00318461|515701050|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
143043850|NCT00318461|515701051|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
143043851|NCT00318461|515701052|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
143043852|NCT00318461|515701048|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
143043853|NCT00318461|515701049|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
143043854|NCT00318461|515701050|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
143043855|NCT00318461|515701051|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
143043856|NCT00318461|515701052|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
143043857|NCT00505622|515701058|FG000|Overall Study|Adverse Event|5|||
143043858|NCT00505622|515701059|FG001|Overall Study|Adverse Event|6|||
143240906|NCT02351817|516433412|FG000|Period 2|Protocol Violation|1|||
143240907|NCT02351817|516433413|FG001|Period 2|Protocol Violation|0|||
143498566|NCT01583374|517366403|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
143498567|NCT01583374|517366404|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
143498568|NCT01583374|517366405|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
143498569|NCT01583374|517366406|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
143498570|NCT01583374|517366407|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
143498571|NCT01583374|517366408|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
143498572|NCT01583374|517366400|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
143498573|NCT01583374|517366401|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
143498574|NCT01583374|517366402|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
143240908|NCT02488915|516433416|FG000|Overall Study|Death|21|||
143240909|NCT02488915|516433416|FG000|Overall Study|Lost to Follow-up|4|||
143498575|NCT01583374|517366403|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
143498576|NCT01583374|517366404|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
143498577|NCT01583374|517366405|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
143498578|NCT01583374|517366406|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
143240910|NCT02488915|516433416|FG000|Overall Study|Withdrawal by Subject|1|||
143240911|NCT01532986|516433417|FG000|Overall Study|Death|9|||
143240912|NCT01532986|516433418|FG001|Overall Study|Death|9|||
143240913|NCT01532986|516433417|FG000|Overall Study|Withdrawal by Subject|7|||
143240914|NCT01532986|516433418|FG001|Overall Study|Withdrawal by Subject|10|||
143498579|NCT01583374|517366407|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
143498580|NCT01583374|517366408|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
143498581|NCT01583374|517366400|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
143498582|NCT01583374|517366401|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
143498583|NCT01583374|517366402|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
143498584|NCT01583374|517366403|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
143498585|NCT01583374|517366404|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
143498586|NCT01583374|517366405|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
143498587|NCT01583374|517366406|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
143240915|NCT01532986|516433417|FG000|Overall Study|Physician Decision|7|||
143240916|NCT01532986|516433418|FG001|Overall Study|Physician Decision|5|||
143240917|NCT02120898|516433419|FG000|Overall Study|Withdrawal by Subject|4|||
143240918|NCT02120898|516433420|FG001|Overall Study|Withdrawal by Subject|2|||
143364266|NCT01251614|516876936|FG002|Overall Study|Withdrawal by Subject|1|||
143498588|NCT01583374|517366407|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
143498589|NCT01583374|517366408|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
143498590|NCT01583374|517366400|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
143498591|NCT01583374|517366401|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
143364267|NCT01251614|516876934|FG000|Overall Study|Lost to Follow-up|0|||
143364268|NCT01251614|516876935|FG001|Overall Study|Lost to Follow-up|1|||
143498592|NCT01583374|517366402|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
143498593|NCT01583374|517366403|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
143498594|NCT01583374|517366404|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
143498595|NCT01583374|517366405|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
143498596|NCT01583374|517366406|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
143498597|NCT01583374|517366407|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
143498598|NCT01583374|517366408|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
143498599|NCT01583374|517366400|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
143498600|NCT01583374|517366401|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
143498601|NCT01583374|517366402|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
143498602|NCT01583374|517366403|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
143498603|NCT01583374|517366404|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
143498604|NCT01583374|517366405|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
143498605|NCT01583374|517366406|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
143498606|NCT01583374|517366407|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
143498607|NCT01583374|517366408|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
143498608|NCT01583374|517366400|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
143498609|NCT01583374|517366401|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
143498610|NCT01583374|517366402|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
143498611|NCT01583374|517366403|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
143498612|NCT01583374|517366404|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
143498613|NCT01583374|517366405|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
143498614|NCT01583374|517366406|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
143498615|NCT01583374|517366407|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
143498616|NCT01583374|517366408|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
143498617|NCT01583374|517366400|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
143498618|NCT01583374|517366401|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
143498619|NCT01583374|517366402|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
143498620|NCT01583374|517366403|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
143498621|NCT01583374|517366404|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
143498622|NCT01583374|517366405|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
143498623|NCT01583374|517366406|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
143498624|NCT01583374|517366407|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
143498625|NCT01583374|517366408|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
143498626|NCT01583374|517366400|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
143498627|NCT01583374|517366401|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
143498628|NCT01583374|517366402|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
143498629|NCT01583374|517366403|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
143498630|NCT01583374|517366404|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
143498631|NCT01583374|517366405|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
143498632|NCT01583374|517366406|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
143498633|NCT01583374|517366407|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
143498634|NCT01583374|517366408|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
143498635|NCT01583374|517366400|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
143498636|NCT01583374|517366401|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
143498637|NCT01583374|517366402|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
143498638|NCT01583374|517366403|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
143498639|NCT01583374|517366404|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
143166083|NCT01432444|516155020|FG001|Treatment Phase|Lack of Efficacy|10|||
143166084|NCT01432444|516155021|FG002|Treatment Phase|Lack of Efficacy|0|||
143166085|NCT01432444|516155019|FG000|Extension Phase|Lost to Follow-up|0|||
143166086|NCT01432444|516155020|FG001|Extension Phase|Lost to Follow-up|0|||
143166087|NCT01432444|516155021|FG002|Extension Phase|Lost to Follow-up|17|||
143166088|NCT01432444|516155019|FG000|Extension Phase|Adverse Event|0|||
143166089|NCT01432444|516155020|FG001|Extension Phase|Adverse Event|0|||
143166090|NCT01432444|516155021|FG002|Extension Phase|Adverse Event|10|||
143166091|NCT01432444|516155019|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
143166092|NCT01432444|516155020|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
143166093|NCT01432444|516155021|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
143166094|NCT01432444|516155019|FG000|Extension Phase|Met Withdrawal Criteria|0|||
143166095|NCT01432444|516155020|FG001|Extension Phase|Met Withdrawal Criteria|0|||
143166096|NCT01432444|516155021|FG002|Extension Phase|Met Withdrawal Criteria|144|||
143498640|NCT01583374|517366405|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
143498641|NCT01583374|517366406|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
143498642|NCT01583374|517366407|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
143498643|NCT01583374|517366408|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
143498644|NCT01583374|517366400|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
143498645|NCT01583374|517366401|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
143498646|NCT01583374|517366402|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
143498647|NCT01583374|517366403|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
143498648|NCT01583374|517366404|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
143498649|NCT01583374|517366405|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
143498650|NCT01583374|517366406|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
143043859|NCT00505622|515701060|FG002|Overall Study|Adverse Event|4|||
143043860|NCT00505622|515701058|FG000|Overall Study|Protocol Violation|1|||
143498651|NCT01583374|517366407|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
143166097|NCT01432444|516155019|FG000|Extension Phase|Physician Decision|0|||
143166098|NCT01432444|516155020|FG001|Extension Phase|Physician Decision|0|||
143166099|NCT01432444|516155021|FG002|Extension Phase|Physician Decision|1|||
143166100|NCT01432444|516155019|FG000|Extension Phase|Withdrawal by Subject|0|||
143166101|NCT01432444|516155020|FG001|Extension Phase|Withdrawal by Subject|0|||
143166102|NCT01432444|516155021|FG002|Extension Phase|Withdrawal by Subject|13|||
143166103|NCT02301897|516155022|FG000|Treatment Course 1|Non-Compliance|0|||
143166104|NCT02301897|516155023|FG001|Treatment Course 1|Non-Compliance|0|||
143166105|NCT02301897|516155024|FG002|Treatment Course 1|Non-Compliance|1|||
143166106|NCT02301897|516155022|FG000|Treatment Course 1|Adverse Event|1|||
143166107|NCT02301897|516155023|FG001|Treatment Course 1|Adverse Event|1|||
143166108|NCT02301897|516155024|FG002|Treatment Course 1|Adverse Event|0|||
143166109|NCT02301897|516155022|FG000|Treatment Course 1|Lost to Follow-up|1|||
143166110|NCT02301897|516155023|FG001|Treatment Course 1|Lost to Follow-up|2|||
143166111|NCT02301897|516155024|FG002|Treatment Course 1|Lost to Follow-up|1|||
143166112|NCT02301897|516155022|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
143166113|NCT02301897|516155023|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
143166114|NCT02301897|516155024|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
143166115|NCT02301897|516155022|FG000|Treatment Course 1|Withdrawal by Subject|0|||
143166116|NCT02301897|516155023|FG001|Treatment Course 1|Withdrawal by Subject|0|||
143166117|NCT02301897|516155024|FG002|Treatment Course 1|Withdrawal by Subject|2|||
143166118|NCT02301897|516155022|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
143166119|NCT02301897|516155023|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
143166120|NCT02301897|516155024|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
143166121|NCT02301897|516155022|FG000|Treatment Course 2|Lost to Follow-up|0|||
143166122|NCT02301897|516155023|FG001|Treatment Course 2|Lost to Follow-up|2|||
143166123|NCT02301897|516155024|FG002|Treatment Course 2|Lost to Follow-up|0|||
143166124|NCT02301897|516155022|FG000|Treatment Course 2|Pregnancy|0|||
143166125|NCT02301897|516155023|FG001|Treatment Course 2|Pregnancy|1|||
143166126|NCT02301897|516155024|FG002|Treatment Course 2|Pregnancy|1|||
143166127|NCT02301897|516155022|FG000|Treatment Course 2|Withdrawal by Subject|0|||
143166128|NCT02301897|516155023|FG001|Treatment Course 2|Withdrawal by Subject|2|||
143166129|NCT02301897|516155024|FG002|Treatment Course 2|Withdrawal by Subject|0|||
143166130|NCT02301897|516155022|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
143166131|NCT02301897|516155023|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
143166132|NCT02301897|516155024|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
143166133|NCT02439957|516155025|FG000|Overall Study|Study Terminated|3|||
143166134|NCT02439957|516155026|FG001|Overall Study|Study Terminated|3|||
143166135|NCT01230060|516155027|FG000|Overall Study|Withdrawal by Subject|1|||
143166136|NCT03802916|516155028|FG000|Overall Study|Adverse Event|0|||
143166137|NCT03802916|516155029|FG001|Overall Study|Adverse Event|1|||
143166138|NCT03802916|516155028|FG000|Overall Study|Withdrawal by Subject|0|||
143166139|NCT03802916|516155029|FG001|Overall Study|Withdrawal by Subject|1|||
143166140|NCT00480532|516155032|FG000|Overall Study|Withdrawal by Subject|2|||
143166141|NCT00480532|516155033|FG001|Overall Study|Withdrawal by Subject|4|||
143166142|NCT00480532|516155034|FG002|Overall Study|Withdrawal by Subject|3|||
143498652|NCT01583374|517366408|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
143166143|NCT00480532|516155035|FG003|Overall Study|Withdrawal by Subject|1|||
143166144|NCT00480532|516155032|FG000|Overall Study|Protocol Violation|0|||
143166145|NCT00480532|516155033|FG001|Overall Study|Protocol Violation|0|||
143166146|NCT00480532|516155034|FG002|Overall Study|Protocol Violation|1|||
143166147|NCT00480532|516155035|FG003|Overall Study|Protocol Violation|0|||
143166148|NCT00831389|516155036|FG000|Overall Study|Withdrawal by Subject|0|||
143043861|NCT00505622|515701059|FG001|Overall Study|Protocol Violation|1|||
143166149|NCT00831389|516155037|FG001|Overall Study|Withdrawal by Subject|1|||
143166150|NCT00278161|516155039|FG000|Overall Study|Death|11|||
143166151|NCT01817777|516155040|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
143166152|NCT01817777|516155041|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
143166153|NCT01817777|516155042|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
143364269|NCT01251614|516876936|FG002|Overall Study|Lost to Follow-up|0|||
143498653|NCT01583374|517366400|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
143498654|NCT01583374|517366401|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
143498655|NCT01583374|517366402|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
143498656|NCT01583374|517366403|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
143498657|NCT01583374|517366404|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
143498658|NCT01583374|517366405|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
143498659|NCT01583374|517366406|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
143498660|NCT01583374|517366407|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
143498661|NCT01583374|517366408|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
143498662|NCT01583374|517366400|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
143498663|NCT01583374|517366401|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
143498664|NCT01583374|517366402|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
143498665|NCT01583374|517366403|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
143498666|NCT01583374|517366404|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
143498667|NCT01583374|517366405|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
143498668|NCT01583374|517366406|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
143498669|NCT01583374|517366407|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
143498670|NCT01583374|517366408|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
143498671|NCT01583374|517366400|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
143498672|NCT01583374|517366401|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
143498673|NCT01583374|517366402|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
143498674|NCT01583374|517366403|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
143498675|NCT01583374|517366404|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
143498676|NCT01583374|517366405|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
143498677|NCT01583374|517366406|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
143498678|NCT01583374|517366407|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
143498679|NCT01583374|517366408|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
143498680|NCT01583374|517366400|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
143498681|NCT01583374|517366401|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
143498682|NCT01583374|517366402|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
143498683|NCT01583374|517366403|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
143498684|NCT01583374|517366404|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
143498685|NCT01583374|517366405|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
143498686|NCT01583374|517366406|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
143498687|NCT01583374|517366407|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
143498688|NCT01583374|517366408|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
143498689|NCT01583374|517366400|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
143498690|NCT01583374|517366401|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
143498691|NCT01583374|517366402|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
143498692|NCT01583374|517366403|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
143498693|NCT01583374|517366404|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
143498694|NCT01583374|517366405|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
143166154|NCT01817777|516155040|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
143166155|NCT01817777|516155041|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
143166156|NCT01817777|516155042|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
143166157|NCT01817777|516155040|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
143166158|NCT01817777|516155041|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
143166159|NCT01817777|516155042|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
143166160|NCT01817777|516155040|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
143166161|NCT01817777|516155041|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
143166162|NCT01817777|516155042|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
143166163|NCT01817777|516155040|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
143166164|NCT01817777|516155041|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
143166165|NCT01817777|516155042|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
143166166|NCT00443456|516155043|FG000|Overall Study|Adverse Event|16|||
143166167|NCT00443456|516155043|FG000|Overall Study|Move|1|||
143166168|NCT00443456|516155043|FG000|Overall Study|Withdrawal by Subject|1|||
143166169|NCT03242434|516155044|FG000|Overall Study|Death|0|||
143166170|NCT03242434|516155045|FG001|Overall Study|Death|2|||
143166171|NCT02157610|516155046|FG000|Overall Study|Death|4|||
143166172|NCT02157610|516155047|FG001|Overall Study|Death|4|||
143166173|NCT01592747|516155048|FG000|Overall Study|Loss of Therapeutic Response|107|||
143166174|NCT01592747|516155049|FG001|Overall Study|Loss of Therapeutic Response|108|||
143166175|NCT01592747|516155050|FG002|Overall Study|Loss of Therapeutic Response|100|||
143166176|NCT01592747|516155048|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
143166177|NCT01592747|516155049|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
143498695|NCT01583374|517366406|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
143498696|NCT01583374|517366407|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
143498697|NCT01583374|517366408|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
143043862|NCT00505622|515701060|FG002|Overall Study|Protocol Violation|0|||
143043863|NCT00505622|515701058|FG000|Overall Study|Withdrawal by Subject|0|||
143240919|NCT02120898|516433421|FG002|Overall Study|Withdrawal by Subject|2|||
143240920|NCT02120898|516433419|FG000|Overall Study|Non-compliance with study drug|3|||
143240921|NCT02120898|516433420|FG001|Overall Study|Non-compliance with study drug|0|||
143240922|NCT02120898|516433421|FG002|Overall Study|Non-compliance with study drug|0|||
143240923|NCT02120898|516433419|FG000|Overall Study|Adverse Event|1|||
143240924|NCT02120898|516433420|FG001|Overall Study|Adverse Event|2|||
143240925|NCT02120898|516433421|FG002|Overall Study|Adverse Event|1|||
143240926|NCT02120898|516433419|FG000|Overall Study|Protocol Violation|1|||
143240927|NCT02120898|516433420|FG001|Overall Study|Protocol Violation|2|||
143240928|NCT02120898|516433421|FG002|Overall Study|Protocol Violation|0|||
143240929|NCT02120898|516433419|FG000|Overall Study|Lost to Follow-up|0|||
143240930|NCT02120898|516433420|FG001|Overall Study|Lost to Follow-up|0|||
143240931|NCT02120898|516433421|FG002|Overall Study|Lost to Follow-up|1|||
143240932|NCT04313244|516433422|FG000|Overall Study|Withdrawal of Consent|3|||
143240933|NCT04313244|516433423|FG001|Overall Study|Withdrawal of Consent|3|||
143240934|NCT04313244|516433422|FG000|Overall Study|Met Exclusion Criteria|1|||
143240935|NCT04313244|516433423|FG001|Overall Study|Met Exclusion Criteria|0|||
143240936|NCT04313244|516433422|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
143240937|NCT04313244|516433423|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
143240938|NCT00891904|516433424|FG000|Overall Study|Death|1|||
143240939|NCT00891904|516433424|FG000|Overall Study|Adverse Event|1|||
143240940|NCT00927953|516433425|FG000|Overall Study|Death|2|||
143240941|NCT00927953|516433426|FG001|Overall Study|Death|1|||
143240942|NCT02976038|516433427|FG000|Overall Study|Physician Decision|22|||
143240943|NCT02976038|516433427|FG000|Overall Study|Withdrawal by Subject|3|||
143240944|NCT02976038|516433427|FG000|Overall Study|Lost to Follow-up|2|||
143240945|NCT02976038|516433427|FG000|Overall Study|Adverse Event|1|||
143240946|NCT01046396|516433428|FG000|Overall Study|Withdrawal by Subject|5|||
143240947|NCT02177032|516433431|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
143240948|NCT02177032|516433432|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
143240949|NCT02177032|516433433|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
143240950|NCT02177032|516433434|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
143240951|NCT02177032|516433431|FG000|Overall Study|Lost to Follow-up|0|||
143240952|NCT02177032|516433432|FG001|Overall Study|Lost to Follow-up|2|||
143240953|NCT02177032|516433433|FG002|Overall Study|Lost to Follow-up|0|||
143240954|NCT02177032|516433434|FG003|Overall Study|Lost to Follow-up|0|||
143240955|NCT02177032|516433431|FG000|Overall Study|OTHER|2|||
143240956|NCT02177032|516433432|FG001|Overall Study|OTHER|0|||
143240957|NCT02177032|516433433|FG002|Overall Study|OTHER|1|||
143240958|NCT02177032|516433434|FG003|Overall Study|OTHER|0|||
143240959|NCT02177032|516433431|FG000|Overall Study|Withdrawal by Subject|1|||
143240960|NCT02177032|516433432|FG001|Overall Study|Withdrawal by Subject|0|||
143240961|NCT02177032|516433433|FG002|Overall Study|Withdrawal by Subject|1|||
143240962|NCT02177032|516433434|FG003|Overall Study|Withdrawal by Subject|0|||
143240963|NCT00665652|516433435|FG000|Overall Study|Adverse Event|4|||
143240964|NCT00665652|516433435|FG000|Overall Study|Death|1|||
143240965|NCT00665652|516433435|FG000|Overall Study|No longer met inclusion criteria.|1|||
143240966|NCT02161016|516433436|FG000|Overall Study|withdrawn by IRB|1|||
143240967|NCT02556177|516433437|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
143240968|NCT02556177|516433438|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
143240969|NCT00658359|516433439|FG000|Overall Study|Death|3|||
143043864|NCT00505622|515701059|FG001|Overall Study|Withdrawal by Subject|3|||
143240970|NCT00658359|516433440|FG001|Overall Study|Death|1|||
143240971|NCT00658359|516433441|FG002|Overall Study|Death|2|||
143240972|NCT00658359|516433439|FG000|Overall Study|Adverse Event|13|||
143240973|NCT00658359|516433440|FG001|Overall Study|Adverse Event|6|||
143240974|NCT00658359|516433441|FG002|Overall Study|Adverse Event|9|||
143240975|NCT00658359|516433439|FG000|Overall Study|Protocol Violation|1|||
143240976|NCT00658359|516433440|FG001|Overall Study|Protocol Violation|0|||
143240977|NCT00658359|516433441|FG002|Overall Study|Protocol Violation|0|||
143240978|NCT00658359|516433439|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
143240979|NCT00658359|516433440|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
143240980|NCT00658359|516433441|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
143240981|NCT00658359|516433439|FG000|Overall Study|Withdrawal by Subject|7|||
143498698|NCT01583374|517366400|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
143498699|NCT01583374|517366401|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
143498700|NCT01583374|517366402|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
143240982|NCT00658359|516433440|FG001|Overall Study|Withdrawal by Subject|4|||
143240983|NCT00658359|516433441|FG002|Overall Study|Withdrawal by Subject|2|||
143240984|NCT00658359|516433439|FG000|Overall Study|Lost to Follow-up|2|||
143240985|NCT00658359|516433440|FG001|Overall Study|Lost to Follow-up|2|||
143240986|NCT00658359|516433441|FG002|Overall Study|Lost to Follow-up|4|||
143498701|NCT01583374|517366403|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
143498702|NCT01583374|517366404|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
143498703|NCT01583374|517366405|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
143498704|NCT01583374|517366406|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
143498705|NCT01583374|517366407|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
143498706|NCT01583374|517366408|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
143498707|NCT01583374|517366400|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
143498708|NCT01583374|517366401|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
143498709|NCT01583374|517366402|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
143498710|NCT01583374|517366403|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
143498711|NCT01583374|517366404|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
143498712|NCT01583374|517366405|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
143498713|NCT01583374|517366406|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
143498714|NCT01583374|517366407|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
143498715|NCT01583374|517366408|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
143498716|NCT01506882|517366409|FG000|Overall Study|Lack of Efficacy|4|||
143498717|NCT01506882|517366410|FG001|Overall Study|Lack of Efficacy|3|||
143043865|NCT00505622|515701060|FG002|Overall Study|Withdrawal by Subject|2|||
143043866|NCT00505622|515701058|FG000|Overall Study|Study termination by sponsor|115|||
143043867|NCT00505622|515701059|FG001|Overall Study|Study termination by sponsor|98|||
143043868|NCT00505622|515701060|FG002|Overall Study|Study termination by sponsor|90|||
143043869|NCT03084471|515701063|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
143043870|NCT03084471|515701063|FG000|Overall Study|Condition under investigation worsened|84|||
143043871|NCT03084471|515701063|FG000|Overall Study|Lack of therapeutic response|2|||
143043872|NCT03084471|515701063|FG000|Overall Study|Protocol Violation|1|||
143043873|NCT03084471|515701063|FG000|Overall Study|Adverse Event|73|||
143043874|NCT03084471|515701063|FG000|Overall Study|Withdrawal by Subject|12|||
143043875|NCT03084471|515701063|FG000|Overall Study|Disease relapse|181|||
143043876|NCT03084471|515701063|FG000|Overall Study|Subjective disease progression|359|||
143043877|NCT03084471|515701063|FG000|Overall Study|Other (as recorded)|33|||
143043878|NCT03084471|515701063|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
143043879|NCT01848938|515701072|FG000|Overall Study|Lost to Follow-up|1|||
143043880|NCT01848938|515701073|FG001|Overall Study|Lost to Follow-up|1|||
143043881|NCT01757392|515701074|FG000|Overall Study|Withdrawal by Subject|1|||
143043882|NCT01757392|515701074|FG000|Overall Study|Screen Fail|3|||
143043883|NCT00207090|515701077|FG000|Overall Study|Study drug toxicity|3|||
143043884|NCT00207090|515701077|FG000|Overall Study|Chest wall mass larger|1|||
143043885|NCT00207090|515701077|FG000|Overall Study|Disease progression/relapse|2|||
143043886|NCT00207090|515701077|FG000|Overall Study|Physician Decision|1|||
143043887|NCT00841698|515701080|FG000|First Intervention|Withdrawal by Subject|1|||
143043888|NCT00841698|515701081|FG001|First Intervention|Withdrawal by Subject|0|||
143043889|NCT01929863|515701086|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
143043890|NCT01929863|515701087|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
143043891|NCT01929863|515701086|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
143043892|NCT01929863|515701087|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
143043893|NCT01929863|515701086|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
143043894|NCT01929863|515701087|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
143043895|NCT00251979|515701088|FG000|Overall Study|Protocol Violation|3|||
143043896|NCT00251979|515701089|FG001|Overall Study|Protocol Violation|5|||
143043897|NCT00251979|515701088|FG000|Overall Study|Adverse Event|11|||
143043898|NCT00251979|515701089|FG001|Overall Study|Adverse Event|17|||
143043899|NCT00251979|515701088|FG000|Overall Study|Withdrawal by Subject|13|||
143043900|NCT00251979|515701089|FG001|Overall Study|Withdrawal by Subject|7|||
143043901|NCT00251979|515701088|FG000|Overall Study|Lost to Follow-up|8|||
143043902|NCT00251979|515701089|FG001|Overall Study|Lost to Follow-up|6|||
143043903|NCT00251979|515701088|FG000|Overall Study|Death|3|||
143043904|NCT00251979|515701089|FG001|Overall Study|Death|5|||
143043905|NCT01878292|515701097|FG000|Randomized|Protocol Violation|1|||
143043906|NCT01878292|515701098|FG001|Randomized|Protocol Violation|0|||
143043907|NCT01878292|515701099|FG002|Randomized|Protocol Violation|0|||
143043908|NCT01878292|515701097|FG000|Randomized|Lost to Follow-up|1|||
143043909|NCT01878292|515701098|FG001|Randomized|Lost to Follow-up|0|||
143043910|NCT01878292|515701099|FG002|Randomized|Lost to Follow-up|0|||
143043911|NCT01878292|515701097|FG000|Randomized|Adverse Event|1|||
143043912|NCT01878292|515701098|FG001|Randomized|Adverse Event|0|||
143043913|NCT01878292|515701099|FG002|Randomized|Adverse Event|0|||
143240987|NCT00658359|516433439|FG000|Overall Study|Lack of Efficacy|0|||
143498718|NCT01506882|517366409|FG000|Overall Study|Lost to Follow-up|1|||
143498719|NCT01506882|517366410|FG001|Overall Study|Lost to Follow-up|0|||
143043914|NCT01878292|515701097|FG000|Double-blind Treatment Period|Other Reasons|2|||
143043915|NCT01878292|515701098|FG001|Double-blind Treatment Period|Other Reasons|0|||
143043916|NCT01878292|515701099|FG002|Double-blind Treatment Period|Other Reasons|0|||
143043917|NCT01878292|515701097|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
143498720|NCT01506882|517366409|FG000|Overall Study|Withdrawal by Subject|9|||
143498721|NCT01506882|517366410|FG001|Overall Study|Withdrawal by Subject|3|||
143498722|NCT01506882|517366409|FG000|Overall Study|SAE, non-fatal|2|||
143498723|NCT01506882|517366410|FG001|Overall Study|SAE, non-fatal|0|||
143498724|NCT01506882|517366409|FG000|Overall Study|AE, non-serious non-fatal|3|||
143498725|NCT01506882|517366410|FG001|Overall Study|AE, non-serious non-fatal|1|||
143498726|NCT01506882|517366409|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
143498727|NCT01506882|517366410|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
143498728|NCT01506882|517366409|FG000|Overall Study|Other Reason|2|||
143498729|NCT01506882|517366410|FG001|Overall Study|Other Reason|0|||
143498730|NCT00821678|517366412|FG000|Overall Study|Withdrawal by Subject|8|||
143498731|NCT00821678|517366413|FG001|Overall Study|Withdrawal by Subject|0|||
143498732|NCT00821678|517366412|FG000|Overall Study|Lost to Follow-up|13|||
143498733|NCT00821678|517366413|FG001|Overall Study|Lost to Follow-up|12|||
143498734|NCT00821678|517366412|FG000|Overall Study|Death|0|||
143498735|NCT00821678|517366413|FG001|Overall Study|Death|2|||
143498736|NCT00778830|517368405|FG000|Overall Study|Ongoing at data cut-off|0|||
143498737|NCT00778830|517368406|FG001|Overall Study|Ongoing at data cut-off|1|||
143498738|NCT01891643|517368407|FG000|Overall Study|Adverse event unrelated to study drug|2|||
143043918|NCT01878292|515701098|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
143240988|NCT00658359|516433440|FG001|Overall Study|Lack of Efficacy|1|||
143240989|NCT00658359|516433441|FG002|Overall Study|Lack of Efficacy|0|||
143240990|NCT00705016|516433444|FG000|Overall Study|Adverse Event|6|||
143240991|NCT00705016|516433445|FG001|Overall Study|Adverse Event|11|||
143240992|NCT00705016|516433446|FG002|Overall Study|Adverse Event|10|||
143240993|NCT00705016|516433444|FG000|Overall Study|Death|5|||
143240994|NCT00705016|516433445|FG001|Overall Study|Death|7|||
143240995|NCT00705016|516433446|FG002|Overall Study|Death|5|||
143240996|NCT00705016|516433444|FG000|Overall Study|Protocol Violation|0|||
143240997|NCT00705016|516433445|FG001|Overall Study|Protocol Violation|1|||
143240998|NCT00705016|516433446|FG002|Overall Study|Protocol Violation|1|||
143240999|NCT00705016|516433444|FG000|Overall Study|Withdrawal by Subject|4|||
143241000|NCT00705016|516433445|FG001|Overall Study|Withdrawal by Subject|3|||
143241001|NCT00705016|516433446|FG002|Overall Study|Withdrawal by Subject|2|||
143241002|NCT00705016|516433444|FG000|Overall Study|Progressive Disease|33|||
143241003|NCT00705016|516433445|FG001|Overall Study|Progressive Disease|29|||
143241004|NCT00705016|516433446|FG002|Overall Study|Progressive Disease|33|||
143241005|NCT00705016|516433444|FG000|Overall Study|Symptomatic Deterioration|3|||
143241006|NCT00705016|516433445|FG001|Overall Study|Symptomatic Deterioration|1|||
143241007|NCT00705016|516433446|FG002|Overall Study|Symptomatic Deterioration|1|||
143241008|NCT00705016|516433444|FG000|Overall Study|Other|9|||
143241009|NCT00705016|516433445|FG001|Overall Study|Other|6|||
143241010|NCT00705016|516433446|FG002|Overall Study|Other|6|||
143241011|NCT00363480|516433447|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
143241012|NCT00363480|516433447|FG000|Overall Study|Adverse Event|4|||
143241013|NCT00363480|516433447|FG000|Overall Study|Lost to Follow-up|5|||
143241014|NCT00363480|516433447|FG000|Overall Study|Withdrawal by Subject|5|||
143241015|NCT00363480|516433447|FG000|Overall Study|Non-compliance of subject|1|||
143241016|NCT00363480|516433447|FG000|Overall Study|Participant discontinued on its own|1|||
143241017|NCT00432172|516433453|FG000|Overall Study|Physician Decision|0|||
143241018|NCT00432172|516433454|FG001|Overall Study|Physician Decision|0|||
143241019|NCT00432172|516433455|FG002|Overall Study|Physician Decision|2|||
143241020|NCT00432172|516433456|FG003|Overall Study|Physician Decision|0|||
143241021|NCT00432172|516433453|FG000|Overall Study|Adverse Event|4|||
143241022|NCT00432172|516433454|FG001|Overall Study|Adverse Event|2|||
143241023|NCT00432172|516433455|FG002|Overall Study|Adverse Event|4|||
143241024|NCT00432172|516433456|FG003|Overall Study|Adverse Event|3|||
143241025|NCT00432172|516433453|FG000|Overall Study|Disease progression|0|||
143498739|NCT01891643|517368408|FG001|Overall Study|Adverse event unrelated to study drug|5|||
143498740|NCT01891643|517368407|FG000|Overall Study|Disease Progression|4|||
143498741|NCT01891643|517368408|FG001|Overall Study|Disease Progression|3|||
143498742|NCT01891643|517368407|FG000|Overall Study|Study Drug Toxicity|3|||
143498743|NCT01891643|517368408|FG001|Overall Study|Study Drug Toxicity|0|||
143043919|NCT01878292|515701099|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
143241026|NCT00432172|516433454|FG001|Overall Study|Disease progression|2|||
143043920|NCT01878292|515701097|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
143241027|NCT00432172|516433455|FG002|Overall Study|Disease progression|5|||
143241028|NCT00432172|516433456|FG003|Overall Study|Disease progression|1|||
143241029|NCT00432172|516433453|FG000|Overall Study|Withdrawal by Subject|0|||
143241030|NCT00432172|516433454|FG001|Overall Study|Withdrawal by Subject|1|||
143241031|NCT00432172|516433455|FG002|Overall Study|Withdrawal by Subject|0|||
143241032|NCT00432172|516433456|FG003|Overall Study|Withdrawal by Subject|2|||
143241033|NCT00432172|516433453|FG000|Overall Study|No treatment received|2|||
143498744|NCT01891643|517368407|FG000|Overall Study|Maximum Clinical Benefit|0|||
143498745|NCT01891643|517368408|FG001|Overall Study|Maximum Clinical Benefit|1|||
143364270|NCT00093795|516876937|FG000|Overall Study|No follow up data|20|||
143043921|NCT01878292|515701098|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
143241034|NCT00432172|516433454|FG001|Overall Study|No treatment received|2|||
143498746|NCT01891643|517368407|FG000|Overall Study|Poor/Non-compliance|0|||
143498747|NCT01891643|517368408|FG001|Overall Study|Poor/Non-compliance|1|||
143498748|NCT01891643|517368407|FG000|Overall Study|Participant request to discontinue|1|||
143498749|NCT01891643|517368408|FG001|Overall Study|Participant request to discontinue|0|||
143498750|NCT02591615|517368409|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
143498751|NCT02591615|517368410|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
143498752|NCT02591615|517368411|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
143043922|NCT01878292|515701099|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
143043923|NCT01878292|515701097|FG000|Double-blind Treatment Period|Protocol Violation|3|||
143043924|NCT01878292|515701098|FG001|Double-blind Treatment Period|Protocol Violation|4|||
143043925|NCT01878292|515701099|FG002|Double-blind Treatment Period|Protocol Violation|2|||
143043926|NCT01878292|515701097|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
143043927|NCT01878292|515701098|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
143043928|NCT01878292|515701099|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
143043929|NCT01878292|515701097|FG000|Double-blind Treatment Period|Adverse Event|4|||
143498753|NCT02591615|517368412|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
143498754|NCT02591615|517368409|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
143498755|NCT02591615|517368410|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
143498756|NCT02591615|517368411|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
143498757|NCT02591615|517368412|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
143498758|NCT02591615|517368409|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
143498759|NCT02591615|517368410|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
143498760|NCT02591615|517368411|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
143498761|NCT02591615|517368412|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
143498762|NCT02591615|517368409|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
143498763|NCT02591615|517368410|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
143498764|NCT02591615|517368411|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
143498765|NCT02591615|517368412|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
143498766|NCT02591615|517368409|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
143498767|NCT02591615|517368410|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
143498768|NCT02591615|517368411|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
143043930|NCT01878292|515701098|FG001|Double-blind Treatment Period|Adverse Event|9|||
143043931|NCT01878292|515701099|FG002|Double-blind Treatment Period|Adverse Event|8|||
143043932|NCT01878292|515701097|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
143043933|NCT01878292|515701098|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
143043934|NCT01878292|515701099|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
143043935|NCT02619682|515701100|FG000|Overall Study|Withdrawal by Subject|3|||
143043936|NCT02619682|515701100|FG000|Overall Study|Lack of Efficacy|8|||
143043937|NCT02619682|515701100|FG000|Overall Study|new secondary cancer|1|||
143043938|NCT02619682|515701100|FG000|Overall Study|post surgery complications|2|||
143043939|NCT05776901|515702758|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
143043940|NCT00665925|515702760|FG000|Overall Study|Lack of Efficacy|10|||
143043941|NCT00665925|515702761|FG001|Overall Study|Lack of Efficacy|8|||
143043942|NCT00665925|515702762|FG002|Overall Study|Lack of Efficacy|9|||
143043943|NCT00665925|515702763|FG003|Overall Study|Lack of Efficacy|8|||
143043944|NCT00665925|515702760|FG000|Overall Study|Lost to Follow-up|1|||
143043945|NCT00665925|515702761|FG001|Overall Study|Lost to Follow-up|2|||
143043946|NCT00665925|515702762|FG002|Overall Study|Lost to Follow-up|2|||
143043947|NCT00665925|515702763|FG003|Overall Study|Lost to Follow-up|2|||
143043948|NCT00665925|515702760|FG000|Overall Study|Withdrawal by Subject|2|||
143043949|NCT00665925|515702761|FG001|Overall Study|Withdrawal by Subject|2|||
143166178|NCT01592747|516155050|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
143166179|NCT01592747|516155048|FG000|Overall Study|Adverse Event|1|||
143166180|NCT01592747|516155049|FG001|Overall Study|Adverse Event|0|||
143498769|NCT02591615|517368412|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
143498770|NCT02591615|517368409|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
143166181|NCT01592747|516155050|FG002|Overall Study|Adverse Event|0|||
143166182|NCT01592747|516155048|FG000|Overall Study|Protocol Violation|4|||
143166183|NCT01592747|516155049|FG001|Overall Study|Protocol Violation|0|||
143166184|NCT01592747|516155050|FG002|Overall Study|Protocol Violation|4|||
143166185|NCT01592747|516155048|FG000|Overall Study|Lack of Efficacy|0|||
143498771|NCT02591615|517368410|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
143498772|NCT02591615|517368411|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
143043950|NCT00665925|515702762|FG002|Overall Study|Withdrawal by Subject|3|||
143043951|NCT00665925|515702763|FG003|Overall Study|Withdrawal by Subject|2|||
143043952|NCT00665925|515702760|FG000|Overall Study|Physician Decision|0|||
143043953|NCT00665925|515702761|FG001|Overall Study|Physician Decision|0|||
143166186|NCT01592747|516155049|FG001|Overall Study|Lack of Efficacy|1|||
143166187|NCT01592747|516155050|FG002|Overall Study|Lack of Efficacy|0|||
143166188|NCT01592747|516155048|FG000|Overall Study|Withdrawal by Subject|2|||
143166189|NCT01592747|516155049|FG001|Overall Study|Withdrawal by Subject|0|||
143166190|NCT01592747|516155050|FG002|Overall Study|Withdrawal by Subject|2|||
143043954|NCT00665925|515702762|FG002|Overall Study|Physician Decision|1|||
143043955|NCT00665925|515702763|FG003|Overall Study|Physician Decision|2|||
143043956|NCT00665925|515702760|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
143498773|NCT02591615|517368412|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
143498774|NCT02591615|517368409|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
143498775|NCT02591615|517368410|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
143498776|NCT02591615|517368411|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
143498777|NCT02591615|517368412|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
143498778|NCT02591615|517368409|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
143498779|NCT02591615|517368410|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
143498780|NCT02591615|517368411|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
143498781|NCT02591615|517368412|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
143498782|NCT02591615|517368409|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
143043957|NCT00665925|515702761|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
143364271|NCT00093795|516876938|FG001|Overall Study|No follow up data|16|||
143364272|NCT00093795|516876939|FG002|Overall Study|No follow up data|17|||
143043958|NCT00665925|515702762|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
143043959|NCT00665925|515702763|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
143043960|NCT00665925|515702760|FG000|Overall Study|Adverse Event|1|||
143043961|NCT00665925|515702761|FG001|Overall Study|Adverse Event|5|||
143043962|NCT00665925|515702762|FG002|Overall Study|Adverse Event|10|||
143043963|NCT00665925|515702763|FG003|Overall Study|Adverse Event|5|||
143043964|NCT00665925|515702760|FG000|Overall Study|Enrolled by mistake|0|||
143498783|NCT02591615|517368410|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
143498784|NCT02591615|517368411|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
143498785|NCT02591615|517368412|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
143498786|NCT02591615|517368409|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
143498787|NCT02591615|517368410|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
143498788|NCT02591615|517368411|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
143043965|NCT00665925|515702761|FG001|Overall Study|Enrolled by mistake|0|||
143043966|NCT00665925|515702762|FG002|Overall Study|Enrolled by mistake|0|||
143166191|NCT01592747|516155048|FG000|Overall Study|Lost to Follow-up|1|||
143166192|NCT01592747|516155049|FG001|Overall Study|Lost to Follow-up|0|||
143166193|NCT01592747|516155050|FG002|Overall Study|Lost to Follow-up|1|||
143166194|NCT01592747|516155048|FG000|Overall Study|Other Reasons|1|||
143166195|NCT01592747|516155049|FG001|Overall Study|Other Reasons|1|||
143166196|NCT01592747|516155050|FG002|Overall Study|Other Reasons|0|||
143166197|NCT02367885|516155051|FG000|Overall Study|Lost to Follow-up|1|||
143166198|NCT02367885|516155052|FG001|Overall Study|Lost to Follow-up|0|||
143166199|NCT02367885|516155053|FG002|Overall Study|Lost to Follow-up|0|||
143166200|NCT02367885|516155051|FG000|Overall Study|Withdrawal by Subject|1|||
143166201|NCT02367885|516155052|FG001|Overall Study|Withdrawal by Subject|0|||
143498789|NCT02591615|517368412|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
143498790|NCT02591615|517368409|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
143498791|NCT02591615|517368410|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
143498792|NCT02591615|517368411|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
143498793|NCT02591615|517368412|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
143166202|NCT02367885|516155053|FG002|Overall Study|Withdrawal by Subject|0|||
143166203|NCT01602484|516155054|FG000|Overall Study|Airway issues unrelated to study|0|||
143364273|NCT02790606|516876947|FG000|Overall Study|Death|27|||
143043967|NCT00665925|515702763|FG003|Overall Study|Enrolled by mistake|1|||
143166204|NCT01602484|516155055|FG001|Overall Study|Airway issues unrelated to study|1|||
143043968|NCT00665925|515702760|FG000|Overall Study|Due to exclusion criteria|1|||
143166205|NCT01378195|516155056|FG000|Overall Study|Lost to Follow-up|29|||
143166206|NCT01378195|516155057|FG001|Overall Study|Lost to Follow-up|18|||
143043969|NCT00665925|515702761|FG001|Overall Study|Due to exclusion criteria|0|||
143043970|NCT00665925|515702762|FG002|Overall Study|Due to exclusion criteria|0|||
143043971|NCT00665925|515702763|FG003|Overall Study|Due to exclusion criteria|0|||
143043972|NCT01531894|515702776|FG000|Overall Study|Physician Decision|8|||
143043973|NCT01531894|515702776|FG000|Overall Study|Death|1|||
143043974|NCT03086460|515702777|FG000|Study Participants|Lost to Follow-up|2|||
143043975|NCT03086460|515702777|FG000|Study Participants|Protocol Violation|1|||
143043976|NCT03086460|515702777|FG000|Study Participants|Withdrawal by Subject|6|||
143043977|NCT03086460|515702777|FG000|Treatment A|Lost to Follow-up|1|||
143043978|NCT03086460|515702777|FG000|Treatment A|Protocol Violation|1|||
143043979|NCT03086460|515702777|FG000|Treatment A|Withdrawal by Subject|2|||
143043980|NCT03086460|515702777|FG000|Treatment C|Withdrawal by Subject|2|||
143043981|NCT03086460|515702777|FG000|Treatment E|Lost to Follow-up|1|||
143166207|NCT05763381|516155063|FG000|Overall Study|Lost to Follow-up|2|||
143043982|NCT03086460|515702777|FG000|Treatment E|Withdrawal by Subject|3|||
143043983|NCT01987765|515702778|FG000|Overall Study|Protocol Violation|65|||
143166208|NCT05763381|516155064|FG001|Overall Study|Lost to Follow-up|3|||
143166209|NCT05763381|516155063|FG000|Overall Study|Withdrawal by Subject|1|||
143498794|NCT02591615|517368409|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
143498795|NCT02591615|517368410|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
143498796|NCT02591615|517368411|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
143498797|NCT02591615|517368412|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
143498798|NCT02591615|517368409|FG000|Maintenance MK-3475|Adverse Event|0|||
143498799|NCT02591615|517368410|FG001|Maintenance MK-3475|Adverse Event|3|||
143498800|NCT02591615|517368411|FG002|Maintenance MK-3475|Adverse Event|1|||
143498801|NCT02591615|517368412|FG003|Maintenance MK-3475|Adverse Event|2|||
143498802|NCT02591615|517368409|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
143498803|NCT02591615|517368410|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
143498804|NCT02591615|517368411|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
143498805|NCT02591615|517368412|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
143498806|NCT02591615|517368409|FG000|Maintenance MK-3475|Death|0|||
143043984|NCT01987765|515702778|FG000|Overall Study|Lost to Follow-up|37|||
143166210|NCT05763381|516155064|FG001|Overall Study|Withdrawal by Subject|2|||
143166211|NCT01674062|516155068|FG000|Overall Study|Insufficient Therapeutic Response|56|||
143166212|NCT01674062|516155069|FG001|Overall Study|Insufficient Therapeutic Response|26|||
143166213|NCT01674062|516155068|FG000|Overall Study|Other|8|||
143166214|NCT01674062|516155069|FG001|Overall Study|Other|1|||
143166215|NCT01674062|516155068|FG000|Overall Study|Adverse Event|1|||
143166216|NCT01674062|516155069|FG001|Overall Study|Adverse Event|1|||
143166217|NCT01674062|516155068|FG000|Overall Study|Death|0|||
143166218|NCT01674062|516155069|FG001|Overall Study|Death|1|||
143166219|NCT01674062|516155068|FG000|Overall Study|Programming Error|1|||
143166220|NCT01674062|516155069|FG001|Overall Study|Programming Error|0|||
143166221|NCT04620668|516155070|FG000|Overall Study|Withdrawal by Subject|2|||
143166222|NCT04620668|516155071|FG001|Overall Study|Withdrawal by Subject|0|||
143166223|NCT04620668|516155070|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
143166224|NCT04620668|516155071|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
143166225|NCT04620668|516155070|FG000|Overall Study|Removed before analysis: missing data|2|||
143166226|NCT04620668|516155071|FG001|Overall Study|Removed before analysis: missing data|0|||
143166227|NCT04620668|516155070|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
143166228|NCT04620668|516155071|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
143166229|NCT04620668|516155070|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
143166230|NCT04620668|516155071|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
143166231|NCT00829868|516155073|FG000|Washout|Physician Decision|1|||
143166232|NCT00829868|516155074|FG001|Washout|Physician Decision|0|||
143364274|NCT02790606|516876947|FG000|Overall Study|Lost to Follow-up|4|||
143498807|NCT02591615|517368410|FG001|Maintenance MK-3475|Death|1|||
143498808|NCT02591615|517368411|FG002|Maintenance MK-3475|Death|1|||
143498809|NCT02591615|517368412|FG003|Maintenance MK-3475|Death|0|||
143498810|NCT02591615|517368409|FG000|Maintenance MK-3475|Physician discretion|0|||
143498811|NCT02591615|517368410|FG001|Maintenance MK-3475|Physician discretion|0|||
143498812|NCT02591615|517368411|FG002|Maintenance MK-3475|Physician discretion|1|||
143498813|NCT02591615|517368412|FG003|Maintenance MK-3475|Physician discretion|0|||
143043985|NCT03049748|515702781|FG000|Overall Study|Lost to Follow-up|1|||
143043986|NCT03049748|515702782|FG001|Overall Study|Lost to Follow-up|0|||
143166233|NCT02799043|516155075|FG000|Overall Study|Adverse Event|0|||
143166234|NCT02799043|516155076|FG001|Overall Study|Adverse Event|1|||
143166235|NCT02799043|516155075|FG000|Overall Study|Death|1|||
143166236|NCT02799043|516155076|FG001|Overall Study|Death|1|||
143166237|NCT02799043|516155075|FG000|Overall Study|Lost to Follow-up|3|||
143166238|NCT02799043|516155076|FG001|Overall Study|Lost to Follow-up|6|||
143498814|NCT02591615|517368409|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
143043987|NCT03049748|515702781|FG000|Overall Study|Death|3|||
143498815|NCT02591615|517368410|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
143498816|NCT02591615|517368411|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
143498817|NCT02591615|517368412|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
143498818|NCT02591615|517368409|FG000|Maintenance MK-3475|In active treatment|2|||
143498819|NCT02591615|517368410|FG001|Maintenance MK-3475|In active treatment|0|||
143498820|NCT02591615|517368411|FG002|Maintenance MK-3475|In active treatment|0|||
143498821|NCT02591615|517368412|FG003|Maintenance MK-3475|In active treatment|1|||
143498822|NCT02663895|517368419|FG000|Overall Study|Adverse Event|3|||
143498823|NCT02663895|517368419|FG000|Overall Study|Physician Decision|2|||
143498824|NCT02663895|517368419|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
143498825|NCT02663895|517368419|FG000|Overall Study|Withdrawal by Subject|1|||
143498826|NCT00809328|517368423|FG000|Overall Study|Lack of Efficacy|18|||
143241035|NCT00432172|516433455|FG002|Overall Study|No treatment received|0|||
143241036|NCT00432172|516433456|FG003|Overall Study|No treatment received|1|||
143241037|NCT02536963|516433457|FG000|Overall Study|Withdrawal by Subject|18|||
143241038|NCT00515619|516433458|FG000|Overall Study|Adverse Event|34|||
143241039|NCT00515619|516433458|FG000|Overall Study|Lack of Efficacy|92|||
143241040|NCT00515619|516433458|FG000|Overall Study|Withdrawal by Subject|66|||
143241041|NCT00515619|516433458|FG000|Overall Study|Protocol Violation|3|||
143241042|NCT00515619|516433458|FG000|Overall Study|Lost to Follow-up|4|||
143241043|NCT00515619|516433458|FG000|Overall Study|Unsatisfactory compliance|6|||
143241044|NCT00515619|516433458|FG000|Overall Study|Other: Site discontinuing trials|2|||
143241045|NCT00515619|516433458|FG000|Overall Study|Other: Subject cannot attend visits|2|||
143241046|NCT00515619|516433458|FG000|Overall Study|Other: Subject required surgery|1|||
143241047|NCT00515619|516433458|FG000|Overall Study|Other: Subject moved to another country|1|||
143241048|NCT00515619|516433458|FG000|Overall Study|Other: Investigator decision|1|||
143241049|NCT00515619|516433458|FG000|Overall Study|Other: Subject became pregnant|1|||
143241050|NCT00515619|516433458|FG000|Overall Study|Other: Request from sponsor|1|||
143241051|NCT00515619|516433458|FG000|Overall Study|Other: Drug available on license|1|||
143241052|NCT00515619|516433458|FG000|Overall Study|Other: Subject interested in other AED|1|||
143241053|NCT02447003|516433463|FG000|Overall Study|Other|0|||
143241054|NCT02447003|516433464|FG001|Overall Study|Other|4|||
143241055|NCT02447003|516433463|FG000|Overall Study|Site discontinued|0|||
143241056|NCT02447003|516433464|FG001|Overall Study|Site discontinued|2|||
143241057|NCT02447003|516433463|FG000|Overall Study|Physician Decision|0|||
143241058|NCT02447003|516433464|FG001|Overall Study|Physician Decision|1|||
143241059|NCT02447003|516433463|FG000|Overall Study|Withdrawal by Subject|4|||
143241060|NCT02447003|516433464|FG001|Overall Study|Withdrawal by Subject|3|||
143241061|NCT02447003|516433463|FG000|Overall Study|Sponsor Decision|6|||
143241062|NCT02447003|516433464|FG001|Overall Study|Sponsor Decision|11|||
143241063|NCT02447003|516433463|FG000|Overall Study|Progressive Disease|1|||
143241064|NCT02447003|516433464|FG001|Overall Study|Progressive Disease|0|||
143241065|NCT02447003|516433463|FG000|Overall Study|Lost to Follow-up|5|||
143241066|NCT02447003|516433464|FG001|Overall Study|Lost to Follow-up|0|||
143241067|NCT02447003|516433463|FG000|Overall Study|Death|154|||
143241068|NCT02447003|516433464|FG001|Overall Study|Death|63|||
143241069|NCT04161157|516433465|FG000|Overall Study|Lost to Follow-up|4|||
143241070|NCT04161157|516433465|FG000|Overall Study|Death|3|||
143241071|NCT04161157|516433465|FG000|Overall Study|Ineligible|2|||
143241072|NCT04161157|516433465|FG000|Overall Study|Withdrawal by Subject|4|||
143241073|NCT00670748|516433467|FG000|Overall Study|Death during treatment|1|||
143241074|NCT00670748|516433468|FG001|Overall Study|Death during treatment|1|||
143241075|NCT00670748|516433469|FG002|Overall Study|Death during treatment|1|||
143241076|NCT00670748|516433470|FG003|Overall Study|Death during treatment|0|||
143241077|NCT00670748|516433467|FG000|Overall Study|Not off study|2|||
143241078|NCT00670748|516433468|FG001|Overall Study|Not off study|1|||
143498827|NCT00809328|517368423|FG000|Overall Study|Adverse Event|6|||
143498828|NCT00809328|517368423|FG000|Overall Study|Protocol Violation|3|||
143241079|NCT00670748|516433469|FG002|Overall Study|Not off study|1|||
143241080|NCT00670748|516433470|FG003|Overall Study|Not off study|1|||
143241081|NCT03467750|516433476|FG000|Overall Study|Surgery canceled|1|||
143241082|NCT03467750|516433477|FG001|Overall Study|Surgery canceled|0|||
143241083|NCT03467750|516433476|FG000|Overall Study|Protocol Violation|1|||
143241084|NCT03467750|516433477|FG001|Overall Study|Protocol Violation|1|||
143498829|NCT00809328|517368423|FG000|Overall Study|Withdrawal by Subject|2|||
143498830|NCT02911688|517368424|FG000|Washout|Lost to Follow-up|1|||
143498831|NCT02911688|517368425|FG001|Washout|Lost to Follow-up|1|||
143498832|NCT02911688|517368424|FG000|Washout|Withdrawal by Subject|0|||
143498833|NCT02911688|517368425|FG001|Washout|Withdrawal by Subject|1|||
143498834|NCT01400932|517368428|FG000|Overall Study|Adverse Event|10|||
143498835|NCT01400932|517368429|FG001|Overall Study|Adverse Event|5|||
143241085|NCT03467750|516433476|FG000|Overall Study|Withdrawal by Subject|0|||
143241086|NCT03467750|516433477|FG001|Overall Study|Withdrawal by Subject|1|||
143241087|NCT05673876|516433478|FG000|Overall Study|Death|3|||
143241088|NCT05673876|516433479|FG001|Overall Study|Death|1|||
143241089|NCT05673876|516433478|FG000|Overall Study|Study Terminated by Sponsor|0|||
143498836|NCT01400932|517368428|FG000|Overall Study|Lack of Efficacy|0|||
143498837|NCT01400932|517368429|FG001|Overall Study|Lack of Efficacy|3|||
143498838|NCT01400932|517368428|FG000|Overall Study|Withdrawal by Subject|2|||
143498839|NCT01400932|517368429|FG001|Overall Study|Withdrawal by Subject|6|||
143498840|NCT01400932|517368428|FG000|Overall Study|Lost to Follow-up|1|||
143498841|NCT01400932|517368429|FG001|Overall Study|Lost to Follow-up|0|||
143498842|NCT01400932|517368428|FG000|Overall Study|Protocol Deviation|0|||
143498843|NCT01400932|517368429|FG001|Overall Study|Protocol Deviation|1|||
143498844|NCT01400932|517368428|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
143166239|NCT02799043|516155075|FG000|Overall Study|Withdrawal by Subject|4|||
143166240|NCT02799043|516155076|FG001|Overall Study|Withdrawal by Subject|4|||
143166241|NCT02799043|516155075|FG000|Overall Study|Moved to different country|0|||
143166242|NCT02799043|516155076|FG001|Overall Study|Moved to different country|1|||
143166243|NCT02799043|516155075|FG000|Overall Study|Trial Screen Failure|1|||
143166244|NCT02799043|516155076|FG001|Overall Study|Trial Screen Failure|0|||
143166245|NCT02799043|516155075|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
143166246|NCT02799043|516155076|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
143166247|NCT01922895|516155079|FG000|Overall Study|Death|0|||
143166248|NCT01922895|516155080|FG001|Overall Study|Death|1|||
143166249|NCT01922895|516155079|FG000|Overall Study|Withdrawal by Subject|1|||
143166250|NCT01922895|516155080|FG001|Overall Study|Withdrawal by Subject|2|||
143166251|NCT01922895|516155079|FG000|Overall Study|Lost to Follow-up|5|||
143166252|NCT01922895|516155080|FG001|Overall Study|Lost to Follow-up|11|||
143166253|NCT01916226|516155081|FG000|Overall Study|Adverse Event|1|||
143166254|NCT01916226|516155082|FG001|Overall Study|Adverse Event|0|||
143166255|NCT01916226|516155083|FG002|Overall Study|Adverse Event|1|||
143166256|NCT01916226|516155084|FG003|Overall Study|Adverse Event|1|||
143166257|NCT01916226|516155081|FG000|Overall Study|Lack of Efficacy|0|||
143166258|NCT01916226|516155082|FG001|Overall Study|Lack of Efficacy|0|||
143166259|NCT01916226|516155083|FG002|Overall Study|Lack of Efficacy|2|||
143166260|NCT01916226|516155084|FG003|Overall Study|Lack of Efficacy|1|||
143166261|NCT01916226|516155081|FG000|Overall Study|Protocol Violation|0|||
143166262|NCT01916226|516155082|FG001|Overall Study|Protocol Violation|1|||
143166263|NCT01916226|516155083|FG002|Overall Study|Protocol Violation|0|||
143166264|NCT01916226|516155084|FG003|Overall Study|Protocol Violation|1|||
143166265|NCT01916226|516155081|FG000|Overall Study|Physician Decision|0|||
143166266|NCT01916226|516155082|FG001|Overall Study|Physician Decision|0|||
143166267|NCT01916226|516155083|FG002|Overall Study|Physician Decision|0|||
143166268|NCT01916226|516155084|FG003|Overall Study|Physician Decision|1|||
143166269|NCT04079920|516155087|FG000|Overall Study|Adverse event, not related to study drug|2|||
143166270|NCT04079920|516155087|FG000|Overall Study|Adverse event related to study drug|10|||
143166271|NCT04079920|516155087|FG000|Overall Study|Death|2|||
143166272|NCT04079920|516155087|FG000|Overall Study|Lost to Follow-up|22|||
143166273|NCT04079920|516155087|FG000|Overall Study|Physician Decision|1|||
143166274|NCT04079920|516155087|FG000|Overall Study|Withdrawal by Subject|11|||
143166275|NCT00680914|516155090|FG000|Overall Study|Consent withdrawal|6|||
143166276|NCT00680914|516155091|FG001|Overall Study|Consent withdrawal|3|||
143166277|NCT00680914|516155090|FG000|Overall Study|Lost to Follow-up|4|||
143166278|NCT00680914|516155091|FG001|Overall Study|Lost to Follow-up|0|||
143166279|NCT00680914|516155090|FG000|Overall Study|serious adverse event (SAE)|0|||
143166280|NCT00680914|516155091|FG001|Overall Study|serious adverse event (SAE)|1|||
143166281|NCT01848457|516155092|FG000|Overall Study|Death|1|||
143166282|NCT01848457|516155093|FG001|Overall Study|Death|0|||
143166283|NCT01848457|516155094|FG002|Overall Study|Death|0|||
143166284|NCT01848457|516155095|FG003|Overall Study|Death|0|||
143166285|NCT00522379|516155096|FG000|Overall Study|Adverse Event|12|||
143166286|NCT00522379|516155097|FG001|Overall Study|Adverse Event|15|||
143166287|NCT00522379|516155098|FG002|Overall Study|Adverse Event|12|||
143498845|NCT01400932|517368429|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
143043988|NCT03049748|515702782|FG001|Overall Study|Death|0|||
143043989|NCT03049748|515702781|FG000|Overall Study|Withdrawal by Subject|0|||
143043990|NCT03049748|515702782|FG001|Overall Study|Withdrawal by Subject|3|||
143043991|NCT03049748|515702781|FG000|Overall Study|Protocol Violation|0|||
143166288|NCT00522379|516155099|FG003|Overall Study|Adverse Event|5|||
143166289|NCT00522379|516155100|FG004|Overall Study|Adverse Event|17|||
143166290|NCT00522379|516155096|FG000|Overall Study|Lack of Efficacy|3|||
143166291|NCT00522379|516155097|FG001|Overall Study|Lack of Efficacy|0|||
143166292|NCT00522379|516155098|FG002|Overall Study|Lack of Efficacy|2|||
143364275|NCT02790606|516876947|FG000|Overall Study|Physician Decision|3|||
143498846|NCT04656990|517368430|FG000|Baseline|pandemic|20|||
143498847|NCT04656990|517368431|FG001|Baseline|pandemic|24|||
143498848|NCT04656990|517368430|FG000|Follow Up Period|Lost to Follow-up|61|||
143043992|NCT03049748|515702782|FG001|Overall Study|Protocol Violation|2|||
143166293|NCT00522379|516155099|FG003|Overall Study|Lack of Efficacy|2|||
143166294|NCT00522379|516155100|FG004|Overall Study|Lack of Efficacy|7|||
143498849|NCT04656990|517368431|FG001|Follow Up Period|Lost to Follow-up|73|||
143498850|NCT03244059|517368432|FG000|Specific Aim 1|Physician Decision|1|||
143166295|NCT00522379|516155096|FG000|Overall Study|Withdrawal by Subject|2|||
143166296|NCT00522379|516155097|FG001|Overall Study|Withdrawal by Subject|3|||
143166297|NCT00522379|516155098|FG002|Overall Study|Withdrawal by Subject|1|||
143166298|NCT00522379|516155099|FG003|Overall Study|Withdrawal by Subject|2|||
143166299|NCT00522379|516155100|FG004|Overall Study|Withdrawal by Subject|0|||
143166300|NCT00522379|516155096|FG000|Overall Study|Protocol Violation|1|||
143166301|NCT00522379|516155097|FG001|Overall Study|Protocol Violation|1|||
143166302|NCT00522379|516155098|FG002|Overall Study|Protocol Violation|2|||
143166303|NCT00522379|516155099|FG003|Overall Study|Protocol Violation|0|||
143166304|NCT00522379|516155100|FG004|Overall Study|Protocol Violation|0|||
143166305|NCT00522379|516155096|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
143166306|NCT00522379|516155097|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
143166307|NCT00522379|516155098|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
143166308|NCT00522379|516155099|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
143166309|NCT00522379|516155100|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
143166310|NCT00522379|516155096|FG000|Overall Study|Lost to Follow-up|1|||
143166311|NCT00522379|516155097|FG001|Overall Study|Lost to Follow-up|0|||
143166312|NCT00522379|516155098|FG002|Overall Study|Lost to Follow-up|4|||
143166313|NCT00522379|516155099|FG003|Overall Study|Lost to Follow-up|2|||
143166314|NCT00522379|516155100|FG004|Overall Study|Lost to Follow-up|2|||
143166315|NCT00522379|516155096|FG000|Overall Study|Randomization error|0|||
143166316|NCT00522379|516155097|FG001|Overall Study|Randomization error|0|||
143166317|NCT00522379|516155098|FG002|Overall Study|Randomization error|0|||
143166318|NCT00522379|516155099|FG003|Overall Study|Randomization error|0|||
143166319|NCT00522379|516155100|FG004|Overall Study|Randomization error|1|||
143166320|NCT00522379|516155096|FG000|Overall Study|Dispensing error|1|||
143166321|NCT00522379|516155097|FG001|Overall Study|Dispensing error|0|||
143166322|NCT00522379|516155098|FG002|Overall Study|Dispensing error|0|||
143166323|NCT00522379|516155099|FG003|Overall Study|Dispensing error|1|||
143166324|NCT00522379|516155100|FG004|Overall Study|Dispensing error|0|||
143166325|NCT00522379|516155096|FG000|Overall Study|Subject Moved|1|||
143166326|NCT00522379|516155097|FG001|Overall Study|Subject Moved|1|||
143166327|NCT00522379|516155098|FG002|Overall Study|Subject Moved|0|||
143166328|NCT00522379|516155099|FG003|Overall Study|Subject Moved|0|||
143166329|NCT00522379|516155100|FG004|Overall Study|Subject Moved|0|||
143166330|NCT00522379|516155096|FG000|Overall Study|Sponsor Request|0|||
143166331|NCT00522379|516155097|FG001|Overall Study|Sponsor Request|1|||
143166332|NCT00522379|516155098|FG002|Overall Study|Sponsor Request|0|||
143166333|NCT00522379|516155099|FG003|Overall Study|Sponsor Request|0|||
143166334|NCT00522379|516155100|FG004|Overall Study|Sponsor Request|0|||
143166335|NCT00522379|516155096|FG000|Overall Study|Family Problem|0|||
143166336|NCT00522379|516155097|FG001|Overall Study|Family Problem|0|||
143166337|NCT00522379|516155098|FG002|Overall Study|Family Problem|1|||
143166338|NCT00522379|516155099|FG003|Overall Study|Family Problem|0|||
143166339|NCT00522379|516155100|FG004|Overall Study|Family Problem|0|||
143166340|NCT00522379|516155096|FG000|Overall Study|Site Closed|0|||
143166341|NCT00522379|516155097|FG001|Overall Study|Site Closed|0|||
143166342|NCT00522379|516155098|FG002|Overall Study|Site Closed|0|||
143166343|NCT00522379|516155099|FG003|Overall Study|Site Closed|1|||
143166344|NCT00522379|516155100|FG004|Overall Study|Site Closed|0|||
143166345|NCT00522379|516155096|FG000|Overall Study|Subject Withdrawal|0|||
143166346|NCT00522379|516155097|FG001|Overall Study|Subject Withdrawal|0|||
143166347|NCT00522379|516155098|FG002|Overall Study|Subject Withdrawal|0|||
143166348|NCT00522379|516155099|FG003|Overall Study|Subject Withdrawal|1|||
143166349|NCT00522379|516155100|FG004|Overall Study|Subject Withdrawal|0|||
143166350|NCT00967499|516155101|FG000|Overall Study|Adverse Event|0|||
143166351|NCT00967499|516155102|FG001|Overall Study|Adverse Event|1|||
143166352|NCT00967499|516155101|FG000|Overall Study|Protocol Violation|1|||
143166353|NCT00967499|516155102|FG001|Overall Study|Protocol Violation|0|||
143166354|NCT00967499|516155101|FG000|Overall Study|Sponsor Decision|1|||
143166355|NCT00967499|516155102|FG001|Overall Study|Sponsor Decision|0|||
143166356|NCT00967499|516155101|FG000|Overall Study|Randomized but not treated|63|||
143166357|NCT00967499|516155102|FG001|Overall Study|Randomized but not treated|59|||
143166358|NCT04629196|516155106|FG000|Overall Study|Subject discontinued study drug|1|||
143166359|NCT04629196|516155107|FG001|Overall Study|Subject discontinued study drug|0|||
143166360|NCT04629196|516155106|FG000|Overall Study|Subject study drug dosing increased|1|||
143166361|NCT04629196|516155107|FG001|Overall Study|Subject study drug dosing increased|1|||
143166362|NCT04629196|516155106|FG000|Overall Study|Withdrawal by Subject|1|||
143166363|NCT04629196|516155107|FG001|Overall Study|Withdrawal by Subject|2|||
143166364|NCT01450631|516155111|FG000|Overall Study|Lost to Follow-up|2|||
143166365|NCT01450631|516155112|FG001|Overall Study|Lost to Follow-up|4|||
143498851|NCT03244059|517368433|FG001|Specific Aim 1|Physician Decision|0|||
143498852|NCT03244059|517368432|FG000|Specific Aim 2|Physician Decision|1|||
143498853|NCT03244059|517368433|FG001|Specific Aim 2|Physician Decision|0|||
143498854|NCT00282243|517368434|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
143498855|NCT00282243|517368434|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
143498856|NCT00282243|517368434|FG000|Extension Treatment Period|Adverse Event|15|||
143498857|NCT00282243|517368434|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
143498858|NCT00282243|517368434|FG000|Extension Treatment Period|Non-compliance|2|||
143498859|NCT00282243|517368434|FG000|Extension Treatment Period|Physician Decision|1|||
143498860|NCT02863848|517368435|FG000|Overall Study|Lost to Follow-up|1|||
143498861|NCT02863848|517368436|FG001|Overall Study|Lost to Follow-up|1|||
143498862|NCT02863848|517368435|FG000|Overall Study|Protocol Violation|1|||
143498863|NCT02863848|517368436|FG001|Overall Study|Protocol Violation|2|||
143498864|NCT00686127|517368437|FG000|Overall Study|Withdrawal by Subject|14|||
143498865|NCT00686127|517368438|FG001|Overall Study|Withdrawal by Subject|6|||
143498866|NCT03706365|517368441|FG000|Overall Study|Lost to Follow-up|7|||
143498867|NCT03706365|517368442|FG001|Overall Study|Lost to Follow-up|0|||
143498868|NCT03706365|517368441|FG000|Overall Study|Withdrawal by Subject|17|||
143498869|NCT03706365|517368442|FG001|Overall Study|Withdrawal by Subject|15|||
143498870|NCT03706365|517368441|FG000|Overall Study|On Study Treatment|51|||
143498871|NCT03706365|517368442|FG001|Overall Study|On Study Treatment|51|||
143498872|NCT03116113|517368443|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
143498873|NCT03116113|517368444|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
143498874|NCT03116113|517368445|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
143498875|NCT03116113|517368446|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
143498876|NCT03116113|517368447|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
143498877|NCT03116113|517368448|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
143498878|NCT03116113|517368449|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
143498879|NCT03116113|517368450|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
143498880|NCT03116113|517368451|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
143498881|NCT02159807|517368452|FG000|Overall Study|Adverse Event|0|||
143498882|NCT02159807|517368453|FG001|Overall Study|Adverse Event|0|||
143498883|NCT02159807|517368454|FG002|Overall Study|Adverse Event|1|||
143498884|NCT02159807|517368452|FG000|Overall Study|No CSF|1|||
143498885|NCT02159807|517368453|FG001|Overall Study|No CSF|1|||
143498886|NCT02159807|517368454|FG002|Overall Study|No CSF|1|||
143498887|NCT02159807|517368452|FG000|Overall Study|elevated blood pressure|0|||
143498888|NCT02159807|517368453|FG001|Overall Study|elevated blood pressure|0|||
143498889|NCT02159807|517368454|FG002|Overall Study|elevated blood pressure|1|||
143498890|NCT00600171|517368455|FG000|Overall Study|Adverse Event|0|||
143498891|NCT00600171|517368456|FG001|Overall Study|Adverse Event|1|||
143498892|NCT00600171|517368457|FG002|Overall Study|Adverse Event|0|||
143498893|NCT00600171|517368458|FG003|Overall Study|Adverse Event|0|||
143498894|NCT00600171|517368459|FG004|Overall Study|Adverse Event|1|||
143498895|NCT00600171|517368460|FG005|Overall Study|Adverse Event|0|||
143498896|NCT00600171|517368455|FG000|Overall Study|Lack of Efficacy|9|||
143498897|NCT00600171|517368456|FG001|Overall Study|Lack of Efficacy|12|||
143043993|NCT03049748|515702781|FG000|Overall Study|Moved out of state (relocation)|0|||
143043994|NCT03049748|515702782|FG001|Overall Study|Moved out of state (relocation)|1|||
143166366|NCT01450631|516155111|FG000|Overall Study|Withdrawal by Subject|1|||
143166367|NCT01450631|516155112|FG001|Overall Study|Withdrawal by Subject|0|||
143166368|NCT00323622|516155115|FG000|Overall Study|Other|30|||
143498898|NCT00600171|517368457|FG002|Overall Study|Lack of Efficacy|3|||
143498899|NCT00600171|517368458|FG003|Overall Study|Lack of Efficacy|5|||
143498900|NCT00600171|517368459|FG004|Overall Study|Lack of Efficacy|4|||
143498901|NCT00600171|517368460|FG005|Overall Study|Lack of Efficacy|0|||
143498902|NCT00600171|517368455|FG000|Overall Study|Protocol Violation|1|||
143498903|NCT00600171|517368456|FG001|Overall Study|Protocol Violation|2|||
143498904|NCT00600171|517368457|FG002|Overall Study|Protocol Violation|0|||
143498905|NCT00600171|517368458|FG003|Overall Study|Protocol Violation|1|||
143498906|NCT00600171|517368459|FG004|Overall Study|Protocol Violation|0|||
143498907|NCT00600171|517368460|FG005|Overall Study|Protocol Violation|0|||
143498908|NCT00600171|517368455|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
143498909|NCT00600171|517368456|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
143498910|NCT00600171|517368457|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
143498911|NCT00600171|517368458|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
143498912|NCT00600171|517368459|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
143498913|NCT00600171|517368460|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
143498914|NCT00600171|517368455|FG000|Overall Study|Withdrawal by Subject|3|||
143498915|NCT00600171|517368456|FG001|Overall Study|Withdrawal by Subject|0|||
143498916|NCT00600171|517368457|FG002|Overall Study|Withdrawal by Subject|0|||
143498917|NCT00600171|517368458|FG003|Overall Study|Withdrawal by Subject|1|||
143498918|NCT00600171|517368459|FG004|Overall Study|Withdrawal by Subject|1|||
143498919|NCT00600171|517368460|FG005|Overall Study|Withdrawal by Subject|1|||
143498920|NCT00600171|517368455|FG000|Overall Study|Physician Decision|0|||
143498921|NCT00600171|517368456|FG001|Overall Study|Physician Decision|1|||
143498922|NCT00600171|517368457|FG002|Overall Study|Physician Decision|0|||
143498923|NCT00600171|517368458|FG003|Overall Study|Physician Decision|1|||
143498924|NCT00600171|517368459|FG004|Overall Study|Physician Decision|0|||
143498925|NCT00600171|517368460|FG005|Overall Study|Physician Decision|2|||
143498926|NCT00600171|517368455|FG000|Overall Study|Lost to Follow-up|0|||
143498927|NCT00600171|517368456|FG001|Overall Study|Lost to Follow-up|0|||
143498928|NCT00600171|517368457|FG002|Overall Study|Lost to Follow-up|0|||
143498929|NCT00600171|517368458|FG003|Overall Study|Lost to Follow-up|1|||
143498930|NCT00600171|517368459|FG004|Overall Study|Lost to Follow-up|0|||
143498931|NCT00600171|517368460|FG005|Overall Study|Lost to Follow-up|0|||
143498932|NCT02367521|517368461|FG000|Overall Study|severe headache after intervention|2|||
143498933|NCT02367521|517368462|FG001|Overall Study|severe headache after intervention|0|||
143498934|NCT02367521|517368461|FG000|Overall Study|unable to find transportation|2|||
143498935|NCT02367521|517368462|FG001|Overall Study|unable to find transportation|0|||
143498936|NCT00542191|517368466|FG000|Overall Study|Death|3|||
143498937|NCT00469612|517368467|FG000|Overall Study|Study terminated before data collected|2|||
143498938|NCT00469612|517368468|FG001|Overall Study|Study terminated before data collected|0|||
143498939|NCT00883493|517368469|FG000|Overall Study|Adverse Event|11|||
143498940|NCT00883493|517368470|FG001|Overall Study|Adverse Event|12|||
143043995|NCT00604162|515702785|FG000|Overall Study|Physician Decision|3|||
143043996|NCT00604162|515702785|FG000|Overall Study|Withdrawal by Subject|1|||
143043997|NCT00736190|515702792|FG000|Overall Study|Pregnancy|1|||
143043998|NCT00736190|515702792|FG000|Overall Study|Withdrawal by Subject|1|||
143043999|NCT00736190|515702792|FG000|Overall Study|Adverse Event|1|||
143044000|NCT00824291|515702793|FG000|Overall Study|Adverse Event|15|||
143044001|NCT00824291|515702794|FG001|Overall Study|Adverse Event|6|||
143044002|NCT00824291|515702793|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
143044003|NCT00824291|515702794|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
143044004|NCT00824291|515702793|FG000|Overall Study|Lost to Follow-up|11|||
143044005|NCT00824291|515702794|FG001|Overall Study|Lost to Follow-up|9|||
143044006|NCT00824291|515702793|FG000|Overall Study|Non-compliance|1|||
143044007|NCT00824291|515702794|FG001|Overall Study|Non-compliance|1|||
143044008|NCT00824291|515702793|FG000|Overall Study|Protocol Violation|4|||
143044009|NCT00824291|515702794|FG001|Overall Study|Protocol Violation|1|||
143044010|NCT00824291|515702793|FG000|Overall Study|Withdrawal by Subject|14|||
143044011|NCT00824291|515702794|FG001|Overall Study|Withdrawal by Subject|8|||
143044012|NCT00824291|515702793|FG000|Overall Study|Lack of Efficacy|7|||
143044013|NCT00824291|515702794|FG001|Overall Study|Lack of Efficacy|8|||
143044014|NCT00824291|515702793|FG000|Overall Study|Participant on prohibited medication|1|||
143044015|NCT00824291|515702794|FG001|Overall Study|Participant on prohibited medication|0|||
143044016|NCT00123734|515702795|FG000|Overall Study|Death|3|||
143044017|NCT00123734|515702795|FG000|Overall Study|Lost to Follow-up|3|||
143044018|NCT00123734|515702795|FG000|Overall Study|Dropout|1|||
143044019|NCT00123734|515702795|FG000|Overall Study|Withdrawal by Subject|1|||
143044020|NCT00113386|515702796|FG000|Overall Study|Withdrawal by Subject|1|||
143044021|NCT00113386|515702797|FG001|Overall Study|Withdrawal by Subject|0|||
143044022|NCT00113386|515702796|FG000|Overall Study|Physician Decision|0|||
143044023|NCT00113386|515702797|FG001|Overall Study|Physician Decision|1|||
143044024|NCT00113386|515702796|FG000|Overall Study|Toxicity|3|||
143044025|NCT00113386|515702797|FG001|Overall Study|Toxicity|0|||
143044026|NCT00113386|515702796|FG000|Overall Study|Ineligible|1|||
143044027|NCT00113386|515702797|FG001|Overall Study|Ineligible|2|||
143044028|NCT00113386|515702796|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
143044029|NCT00113386|515702797|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
143044030|NCT01648582|515702798|FG000|Overall Study|Adverse Event|6|||
143044031|NCT01648582|515702799|FG001|Overall Study|Adverse Event|11|||
143044032|NCT01648582|515702800|FG002|Overall Study|Adverse Event|2|||
143044033|NCT01648582|515702798|FG000|Overall Study|Lost to Follow-up|9|||
143166369|NCT00323622|516155116|FG001|Overall Study|Other|91|||
143166370|NCT00323622|516155117|FG002|Overall Study|Other|4|||
143166371|NCT00323622|516155118|FG003|Overall Study|Other|12|||
143166372|NCT00323622|516155119|FG004|Overall Study|Other|32|||
143166373|NCT00323622|516155120|FG005|Overall Study|Other|74|||
143166374|NCT00323622|516155121|FG006|Overall Study|Other|5|||
143166375|NCT00323622|516155122|FG007|Overall Study|Other|13|||
143498941|NCT00883493|517368469|FG000|Overall Study|Lack of Efficacy|4|||
143498942|NCT00883493|517368470|FG001|Overall Study|Lack of Efficacy|3|||
143498943|NCT00883493|517368469|FG000|Overall Study|Lost to Follow-up|7|||
143498944|NCT00883493|517368470|FG001|Overall Study|Lost to Follow-up|6|||
143498945|NCT00883493|517368469|FG000|Overall Study|Withdrawal by Subject|11|||
143498946|NCT00883493|517368470|FG001|Overall Study|Withdrawal by Subject|20|||
143498947|NCT00883493|517368469|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
143044034|NCT01648582|515702799|FG001|Overall Study|Lost to Follow-up|6|||
143044035|NCT01648582|515702800|FG002|Overall Study|Lost to Follow-up|8|||
143044036|NCT01648582|515702798|FG000|Overall Study|Protocol Violation|1|||
143166376|NCT00323622|516155115|FG000|Overall Study|Death|1|||
143166377|NCT00323622|516155116|FG001|Overall Study|Death|1|||
143166378|NCT00323622|516155117|FG002|Overall Study|Death|0|||
143044037|NCT01648582|515702799|FG001|Overall Study|Protocol Violation|2|||
143044038|NCT01648582|515702800|FG002|Overall Study|Protocol Violation|1|||
143044039|NCT01648582|515702798|FG000|Overall Study|Withdrawal by Subject|15|||
143044040|NCT01648582|515702799|FG001|Overall Study|Withdrawal by Subject|17|||
143044041|NCT01648582|515702800|FG002|Overall Study|Withdrawal by Subject|17|||
143044042|NCT01648582|515702798|FG000|Overall Study|Physician Decision|0|||
143044043|NCT01648582|515702799|FG001|Overall Study|Physician Decision|1|||
143044044|NCT01648582|515702800|FG002|Overall Study|Physician Decision|3|||
143044045|NCT01648582|515702798|FG000|Overall Study|Death|1|||
143044046|NCT01648582|515702799|FG001|Overall Study|Death|0|||
143044047|NCT01648582|515702800|FG002|Overall Study|Death|0|||
143044048|NCT01648582|515702798|FG000|Overall Study|Sponsor Decision|0|||
143044049|NCT01648582|515702799|FG001|Overall Study|Sponsor Decision|1|||
143044050|NCT01648582|515702800|FG002|Overall Study|Sponsor Decision|1|||
143044051|NCT04408794|515702801|FG000|Overall Study|Adverse Event|43|||
143044052|NCT04408794|515702801|FG000|Overall Study|Infrequent study drug usage|43|||
143044053|NCT04408794|515702801|FG000|Overall Study|Lack of Efficacy|61|||
143044054|NCT04408794|515702801|FG000|Overall Study|Lost to Follow-up|33|||
143044055|NCT04408794|515702801|FG000|Overall Study|Non-compliance|6|||
143044056|NCT04408794|515702801|FG000|Overall Study|Physician Decision|1|||
143044057|NCT04408794|515702801|FG000|Overall Study|Pregnancy|6|||
143044058|NCT04408794|515702801|FG000|Overall Study|Protocol Deviation|9|||
143044059|NCT04408794|515702801|FG000|Overall Study|Sheehan-STS Result|1|||
143044060|NCT04408794|515702801|FG000|Overall Study|Withdrawal by Subject|57|||
143044061|NCT04408794|515702801|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
143044062|NCT04408794|515702801|FG000|Overall Study|Never Treated Migraine|5|||
143044063|NCT00927069|515702802|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
143044064|NCT00927069|515702803|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
143044065|NCT00927069|515702804|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
143044066|NCT00927069|515702805|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
143044067|NCT00927069|515702802|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
143044068|NCT00927069|515702803|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
143044069|NCT00927069|515702804|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
143044070|NCT00927069|515702805|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
143044071|NCT00927069|515702802|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
143044072|NCT00927069|515702803|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
143044073|NCT00927069|515702804|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
143044074|NCT00927069|515702805|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
143044075|NCT00927069|515702802|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
143044076|NCT00927069|515702803|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
143044077|NCT00927069|515702804|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
143044078|NCT00927069|515702805|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
143166379|NCT00323622|516155118|FG003|Overall Study|Death|0|||
143166380|NCT00323622|516155119|FG004|Overall Study|Death|7|||
143166381|NCT00323622|516155120|FG005|Overall Study|Death|0|||
143166382|NCT00323622|516155121|FG006|Overall Study|Death|0|||
143166383|NCT00323622|516155122|FG007|Overall Study|Death|2|||
143166384|NCT00835354|516155123|FG000|First Intervention|Adverse Event|0|||
143166385|NCT00835354|516155124|FG001|First Intervention|Adverse Event|1|||
143166386|NCT02097225|516155129|FG000|Dose Level 4|Adverse Event|0|||
143166387|NCT02097225|516155130|FG001|Dose Level 4|Adverse Event|0|||
143166388|NCT02097225|516155131|FG002|Dose Level 4|Adverse Event|0|||
143166389|NCT02097225|516155132|FG003|Dose Level 4|Adverse Event|0|||
143166390|NCT02097225|516155133|FG004|Dose Level 4|Adverse Event|1|||
143166391|NCT01852214|516155135|FG000|Period 1|Adverse Event|1|||
143166392|NCT01852214|516155136|FG001|Period 1|Adverse Event|2|||
143166393|NCT01852214|516155135|FG000|Period 1|Withdrawal by Subject|0|||
143166394|NCT01852214|516155136|FG001|Period 1|Withdrawal by Subject|1|||
143166395|NCT01852214|516155135|FG000|Washout Period|Withdrawal by Subject|0|||
143044079|NCT00927069|515702802|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
143044080|NCT00927069|515702803|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
143044081|NCT00927069|515702804|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
143044082|NCT00927069|515702805|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
143166396|NCT01852214|516155136|FG001|Washout Period|Withdrawal by Subject|1|||
143166397|NCT00421408|516155137|FG000|Overall Study|Lost to Follow-up|30|||
143166398|NCT00421408|516155138|FG001|Overall Study|Lost to Follow-up|20|||
143044083|NCT02321098|515702807|FG000|12 Weeks Treament|Lost to Follow-up|1|||
143044084|NCT02321098|515702808|FG001|12 Weeks Treament|Lost to Follow-up|1|||
143044085|NCT02321098|515702809|FG002|12 Weeks Treament|Lost to Follow-up|0|||
143044086|NCT02321098|515702807|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
143044087|NCT02321098|515702808|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
143044088|NCT02321098|515702809|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
143044089|NCT02321098|515702807|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
143166399|NCT00421408|516155137|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
143166400|NCT00421408|516155138|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
143166401|NCT00787800|516155141|FG000|Overall Study|Withdrawal by Subject|3|||
143166402|NCT00787800|516155142|FG001|Overall Study|Withdrawal by Subject|5|||
143044090|NCT02321098|515702808|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
143044091|NCT02321098|515702809|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
143044092|NCT02321098|515702807|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
143044093|NCT02321098|515702808|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
143044094|NCT02321098|515702809|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
143044095|NCT00834431|515702810|FG000|First Intervention|Adverse Event|0|||
143044096|NCT00834431|515702811|FG001|First Intervention|Adverse Event|1|||
143044097|NCT00834431|515702810|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
143044098|NCT00834431|515702811|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
143044099|NCT03249454|515702812|FG000|Overall Study|Withdrawal by Subject|0|||
143044100|NCT03249454|515702813|FG001|Overall Study|Withdrawal by Subject|0|||
143044101|NCT03249454|515702814|FG002|Overall Study|Withdrawal by Subject|0|||
143044102|NCT03249454|515702815|FG003|Overall Study|Withdrawal by Subject|0|||
143044103|NCT03249454|515702816|FG004|Overall Study|Withdrawal by Subject|0|||
143044104|NCT03249454|515702817|FG005|Overall Study|Withdrawal by Subject|0|||
143044105|NCT03249454|515702818|FG006|Overall Study|Withdrawal by Subject|0|||
143044106|NCT03249454|515702819|FG007|Overall Study|Withdrawal by Subject|0|||
143044107|NCT03249454|515702820|FG008|Overall Study|Withdrawal by Subject|0|||
143044108|NCT03249454|515702821|FG009|Overall Study|Withdrawal by Subject|1|||
143044109|NCT03249454|515702822|FG010|Overall Study|Withdrawal by Subject|1|||
143044110|NCT01913405|515702823|FG000|Overall Study|Withdrawal by Subject|1|||
143044111|NCT01913405|515702823|FG000|Overall Study|Adverse Event|1|||
143044112|NCT03261167|515702824|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
143044113|NCT03261167|515702825|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
143044114|NCT03261167|515702824|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
143044115|NCT03261167|515702825|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
143044116|NCT03261167|515702824|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
143044117|NCT03261167|515702825|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
143044118|NCT03261167|515702824|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
143044119|NCT03261167|515702825|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
143044120|NCT03261167|515702824|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
143044121|NCT03261167|515702825|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
143044122|NCT03669861|515702826|FG000|Overall Study|Disease Flare|5|||
143044123|NCT03669861|515702826|FG000|Overall Study|Lack of Efficacy|2|||
143044124|NCT02760927|515702827|FG000|Overall Study|Tube Slippage from Device|1|||
143044125|NCT03930732|515702828|FG000|Overall Study|Adverse Event|9|||
143166403|NCT00787800|516155141|FG000|Overall Study|Death|0|||
143166404|NCT00787800|516155142|FG001|Overall Study|Death|2|||
143166405|NCT03768336|516156528|FG000|Overall Study|Lost to Follow-up|3|||
143166406|NCT03768336|516156529|FG001|Overall Study|Lost to Follow-up|2|||
143166407|NCT03768336|516156528|FG000|Overall Study|Became Ineligible|2|||
143166408|NCT03768336|516156529|FG001|Overall Study|Became Ineligible|0|||
143166409|NCT03768336|516156528|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
143166410|NCT03768336|516156529|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
143166411|NCT03768336|516156528|FG000|Overall Study|Missed final survey (post-treatment|0|||
143166412|NCT03768336|516156529|FG001|Overall Study|Missed final survey (post-treatment|1|||
143166413|NCT06790303|516156530|FG000|Overall Study|Study Terminated by sponsor|4|||
143166414|NCT06790303|516156530|FG000|Overall Study|Death|4|||
143166415|NCT00337168|516156531|FG000|Overall Study|Death|5|||
143166416|NCT00337168|516156531|FG000|Overall Study|Not protocol specified|2|||
143166417|NCT00337168|516156531|FG000|Overall Study|Did not start therapy|1|||
143166418|NCT01225952|516156532|FG000|Overall Study|Lost to Follow-up|1|||
143166419|NCT01225952|516156533|FG001|Overall Study|Lost to Follow-up|0|||
143166420|NCT01225952|516156534|FG002|Overall Study|Lost to Follow-up|0|||
143166421|NCT01225952|516156532|FG000|Overall Study|Study Eye Explanted|0|||
143166422|NCT01225952|516156533|FG001|Overall Study|Study Eye Explanted|0|||
143166423|NCT01225952|516156534|FG002|Overall Study|Study Eye Explanted|1|||
143166424|NCT01225952|516156532|FG000|Overall Study|Withdrawal by Subject|4|||
143166425|NCT01225952|516156533|FG001|Overall Study|Withdrawal by Subject|4|||
143166426|NCT01225952|516156534|FG002|Overall Study|Withdrawal by Subject|5|||
143166427|NCT01225952|516156532|FG000|Overall Study|Surgical complications|1|||
143166428|NCT01225952|516156533|FG001|Overall Study|Surgical complications|0|||
143166429|NCT01225952|516156534|FG002|Overall Study|Surgical complications|0|||
143166430|NCT01217892|516156538|FG000|Overall Study|Adverse Event|1|||
143166431|NCT01217892|516156539|FG001|Overall Study|Adverse Event|1|||
143166432|NCT01217892|516156540|FG002|Overall Study|Adverse Event|1|||
143166433|NCT01217892|516156541|FG003|Overall Study|Adverse Event|0|||
143166434|NCT01217892|516156538|FG000|Overall Study|Withdrawal by Subject|0|||
143498948|NCT00883493|517368470|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
143498949|NCT00883493|517368469|FG000|Overall Study|Study specific disc. criteria|2|||
143498950|NCT00883493|517368470|FG001|Overall Study|Study specific disc. criteria|0|||
143044126|NCT03930732|515702829|FG001|Overall Study|Adverse Event|7|||
143044127|NCT03930732|515702828|FG000|Overall Study|Poor compliance to protocol|0|||
143044128|NCT03930732|515702829|FG001|Overall Study|Poor compliance to protocol|1|||
143044129|NCT03930732|515702828|FG000|Overall Study|Withdrawal by Subject|23|||
143044130|NCT03930732|515702829|FG001|Overall Study|Withdrawal by Subject|11|||
143044131|NCT03930732|515702828|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
143044132|NCT03930732|515702829|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
143044133|NCT03930732|515702828|FG000|Overall Study|Other reason not related to COVID-19|5|||
143044134|NCT03930732|515702829|FG001|Overall Study|Other reason not related to COVID-19|8|||
143044135|NCT00185458|515702832|FG000|Contraception Phase|Adverse Event|37|||
143044136|NCT00185458|515702832|FG000|Contraception Phase|Lost to Follow-up|10|||
143044137|NCT00185458|515702832|FG000|Contraception Phase|Protocol Violation|2|||
143044138|NCT00185458|515702832|FG000|Contraception Phase|Physician Decision|2|||
143044139|NCT00185458|515702832|FG000|Contraception Phase|Withdrawal by Subject|7|||
143498951|NCT00883493|517368469|FG000|Overall Study|Other|5|||
143498952|NCT00883493|517368470|FG001|Overall Study|Other|3|||
143498953|NCT01061008|517368475|FG000|Overall Study|Badiocephalic fistula failed|3|||
143498954|NCT01061008|517368476|FG001|Overall Study|Badiocephalic fistula failed|2|||
143498955|NCT01061008|517368475|FG000|Overall Study|Death|1|||
143498956|NCT01061008|517368476|FG001|Overall Study|Death|0|||
143498957|NCT01061008|517368475|FG000|Overall Study|Withdrawal by Subject|1|||
143498958|NCT01061008|517368476|FG001|Overall Study|Withdrawal by Subject|3|||
143498959|NCT01061008|517368475|FG000|Overall Study|Unable to exercise following surgery|1|||
143498960|NCT01061008|517368476|FG001|Overall Study|Unable to exercise following surgery|0|||
143498961|NCT01061008|517368475|FG000|Overall Study|Adverse Event|0|||
143498962|NCT01061008|517368476|FG001|Overall Study|Adverse Event|1|||
143498963|NCT02024971|517368478|FG000|Overall Study|Data Not Available|30|||
143498964|NCT02024971|517368478|FG000|Overall Study|Lost to Follow-up|6|||
143498965|NCT02908100|517368479|FG000|Overall Study|Adverse Event|7|||
143498966|NCT02908100|517368480|FG001|Overall Study|Adverse Event|6|||
143044140|NCT00185458|515702832|FG000|HRT Phase|Adverse Event|18|||
143044141|NCT00185458|515702832|FG000|HRT Phase|Lost to Follow-up|4|||
143044142|NCT00185458|515702832|FG000|HRT Phase|Protocol Violation|2|||
143044143|NCT00185458|515702832|FG000|HRT Phase|Withdrawal by Subject|3|||
143044144|NCT00429416|515702833|FG000|Overall Study|Death|1|||
143241090|NCT05673876|516433479|FG001|Overall Study|Study Terminated by Sponsor|1|||
143241091|NCT05673876|516433478|FG000|Overall Study|Physician Decision|0|||
143241092|NCT05673876|516433479|FG001|Overall Study|Physician Decision|1|||
143498967|NCT02908100|517368481|FG002|Overall Study|Adverse Event|9|||
143498968|NCT02908100|517368479|FG000|Overall Study|Death|2|||
143498969|NCT02908100|517368480|FG001|Overall Study|Death|0|||
143498970|NCT02908100|517368481|FG002|Overall Study|Death|0|||
143498971|NCT02908100|517368479|FG000|Overall Study|Lack of Efficacy|2|||
143498972|NCT02908100|517368480|FG001|Overall Study|Lack of Efficacy|3|||
143498973|NCT02908100|517368481|FG002|Overall Study|Lack of Efficacy|3|||
143498974|NCT02908100|517368479|FG000|Overall Study|Lost to Follow-up|0|||
143498975|NCT02908100|517368480|FG001|Overall Study|Lost to Follow-up|1|||
143498976|NCT02908100|517368481|FG002|Overall Study|Lost to Follow-up|2|||
143498977|NCT02908100|517368479|FG000|Overall Study|Non-Compliance With Study Drug|1|||
143498978|NCT02908100|517368480|FG001|Overall Study|Non-Compliance With Study Drug|1|||
143498979|NCT02908100|517368481|FG002|Overall Study|Non-Compliance With Study Drug|2|||
143498980|NCT02908100|517368479|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
143498981|NCT02908100|517368480|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
143498982|NCT02908100|517368481|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
143498983|NCT02908100|517368479|FG000|Overall Study|Physician Decision|0|||
143498984|NCT02908100|517368480|FG001|Overall Study|Physician Decision|1|||
143498985|NCT02908100|517368481|FG002|Overall Study|Physician Decision|0|||
143498986|NCT02908100|517368479|FG000|Overall Study|Pregnancy|1|||
143498987|NCT02908100|517368480|FG001|Overall Study|Pregnancy|2|||
143498988|NCT02908100|517368481|FG002|Overall Study|Pregnancy|0|||
143044145|NCT00830024|515702834|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
143241093|NCT04922216|516433482|FG000|Overall Study|Withdrawal by Subject|0|||
143241094|NCT04922216|516433483|FG001|Overall Study|Withdrawal by Subject|1|||
143044146|NCT00830024|515702835|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
143241095|NCT04922216|516433484|FG002|Overall Study|Withdrawal by Subject|0|||
143498989|NCT02908100|517368479|FG000|Overall Study|Withdrawal by Subject|8|||
143498990|NCT02908100|517368480|FG001|Overall Study|Withdrawal by Subject|7|||
143498991|NCT02908100|517368481|FG002|Overall Study|Withdrawal by Subject|5|||
143498992|NCT02908100|517368479|FG000|Overall Study|Randomised in Error|1|||
143498993|NCT02908100|517368480|FG001|Overall Study|Randomised in Error|0|||
143241096|NCT04922216|516433485|FG003|Overall Study|Withdrawal by Subject|0|||
143498994|NCT02908100|517368481|FG002|Overall Study|Randomised in Error|0|||
143498995|NCT05254418|517368483|FG000|Overall Study|Adverse Event|2|||
143044147|NCT03804983|515702839|FG000|Overall Study|Adverse Event|0|||
143044148|NCT03804983|515702840|FG001|Overall Study|Adverse Event|1|||
143241097|NCT04922216|516433486|FG004|Overall Study|Withdrawal by Subject|0|||
143498996|NCT02631538|517368484|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
143498997|NCT02631538|517368485|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
143498998|NCT02631538|517368486|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
143498999|NCT02631538|517368487|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
143499000|NCT02631538|517368484|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
143499001|NCT02631538|517368485|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
143499002|NCT02631538|517368486|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
143499003|NCT02631538|517368487|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
143499004|NCT02631538|517368484|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
143499005|NCT02631538|517368485|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
143499006|NCT02631538|517368486|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
143499007|NCT02631538|517368487|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
143499008|NCT02631538|517368484|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
143499009|NCT02631538|517368485|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
143499010|NCT02631538|517368486|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
143499011|NCT02631538|517368487|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
143499012|NCT02631538|517368484|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
143044149|NCT03804983|515702839|FG000|Overall Study|Family Obligation|1|||
143044150|NCT03804983|515702840|FG001|Overall Study|Family Obligation|0|||
143044151|NCT03600376|515702841|FG000|Overall Study|Adverse Event|1|||
143166435|NCT01217892|516156539|FG001|Overall Study|Withdrawal by Subject|2|||
143166436|NCT01217892|516156540|FG002|Overall Study|Withdrawal by Subject|1|||
143499013|NCT02631538|517368485|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
143499014|NCT02631538|517368486|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
143499015|NCT02631538|517368487|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
143499016|NCT02631538|517368484|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
143499017|NCT02631538|517368485|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
143499018|NCT02631538|517368486|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
143499019|NCT02631538|517368487|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
143499020|NCT01554579|517368488|FG000|Overall Study|Adverse Event|6|||
143499021|NCT01554579|517368489|FG001|Overall Study|Adverse Event|25|||
143499022|NCT01554579|517368488|FG000|Overall Study|Lack of Efficacy|2|||
143499023|NCT01554579|517368489|FG001|Overall Study|Lack of Efficacy|1|||
143499024|NCT01554579|517368488|FG000|Overall Study|Withdrawal by Subject|2|||
143499025|NCT01554579|517368489|FG001|Overall Study|Withdrawal by Subject|1|||
143499026|NCT00234039|517368490|FG000|Overall Study|Adverse Event|2|||
143499027|NCT00234039|517368490|FG000|Overall Study|Progression/relapse|34|||
143499028|NCT00234039|517368490|FG000|Overall Study|Other - Not Protocol Specified|3|||
143499029|NCT00234039|517368490|FG000|Overall Study|Ineligible|9|||
143499030|NCT00234039|517368490|FG000|Overall Study|No Protocol Treatment Received|2|||
143499031|NCT01808612|517368491|FG000|Treatment Period|Adverse Event|8|||
143499032|NCT01808612|517368492|FG001|Treatment Period|Adverse Event|4|||
143499033|NCT01808612|517368493|FG002|Treatment Period|Adverse Event|3|||
143499034|NCT01808612|517368491|FG000|Treatment Period|Lost to Follow-up|2|||
143499035|NCT01808612|517368492|FG001|Treatment Period|Lost to Follow-up|2|||
143499036|NCT01808612|517368493|FG002|Treatment Period|Lost to Follow-up|1|||
143499037|NCT01808612|517368491|FG000|Treatment Period|Protocol Violation|1|||
143499038|NCT01808612|517368492|FG001|Treatment Period|Protocol Violation|0|||
143499039|NCT01808612|517368493|FG002|Treatment Period|Protocol Violation|0|||
143044152|NCT03600376|515702842|FG001|Overall Study|Adverse Event|1|||
143166437|NCT01217892|516156541|FG003|Overall Study|Withdrawal by Subject|0|||
143166438|NCT01217892|516156538|FG000|Overall Study|Lab value|1|||
143166439|NCT01217892|516156539|FG001|Overall Study|Lab value|0|||
143166440|NCT01217892|516156540|FG002|Overall Study|Lab value|1|||
143166441|NCT01217892|516156541|FG003|Overall Study|Lab value|0|||
143166442|NCT01217892|516156538|FG000|Overall Study|Subject no longer meets study criteria|5|||
143166443|NCT01217892|516156539|FG001|Overall Study|Subject no longer meets study criteria|2|||
143166444|NCT01217892|516156540|FG002|Overall Study|Subject no longer meets study criteria|4|||
143166445|NCT01217892|516156541|FG003|Overall Study|Subject no longer meets study criteria|8|||
143166446|NCT01217892|516156538|FG000|Overall Study|Incorrect enrollment|0|||
143166447|NCT01217892|516156539|FG001|Overall Study|Incorrect enrollment|1|||
143166448|NCT01217892|516156540|FG002|Overall Study|Incorrect enrollment|1|||
143166449|NCT01217892|516156541|FG003|Overall Study|Incorrect enrollment|0|||
143166450|NCT01217892|516156538|FG000|Overall Study|Poor/Non-Compliance|0|||
143166451|NCT01217892|516156539|FG001|Overall Study|Poor/Non-Compliance|0|||
143166452|NCT01217892|516156540|FG002|Overall Study|Poor/Non-Compliance|1|||
143166453|NCT01217892|516156541|FG003|Overall Study|Poor/Non-Compliance|0|||
143166454|NCT01052779|516156542|FG000|Overall Study|Adverse Event|1|||
143166455|NCT01052779|516156543|FG001|Overall Study|Adverse Event|4|||
143499040|NCT01808612|517368491|FG000|Treatment Period|Withdrawal by Subject|1|||
143499041|NCT01808612|517368492|FG001|Treatment Period|Withdrawal by Subject|0|||
143044153|NCT03600376|515702841|FG000|Overall Study|Transferred to other facility|1|||
143166456|NCT01052779|516156542|FG000|Overall Study|Withdrawal by Subject|1|||
143241098|NCT04922216|516433487|FG005|Overall Study|Withdrawal by Subject|0|||
143044154|NCT03600376|515702842|FG001|Overall Study|Transferred to other facility|0|||
143166457|NCT01052779|516156543|FG001|Overall Study|Withdrawal by Subject|2|||
143499042|NCT01808612|517368493|FG002|Treatment Period|Withdrawal by Subject|4|||
143499043|NCT01808612|517368491|FG000|Treatment Period|Physician Decision|1|||
143499044|NCT01808612|517368492|FG001|Treatment Period|Physician Decision|0|||
143499045|NCT01808612|517368493|FG002|Treatment Period|Physician Decision|4|||
143499046|NCT01808612|517368491|FG000|Treatment Period|Sponsor Decision|1|||
143499047|NCT01808612|517368492|FG001|Treatment Period|Sponsor Decision|0|||
143499048|NCT01808612|517368493|FG002|Treatment Period|Sponsor Decision|0|||
143499049|NCT01808612|517368491|FG000|Treatment Period|Lack of Efficacy|1|||
143166458|NCT01052779|516156542|FG000|Overall Study|Other-Protocol Violation|1|||
143166459|NCT01052779|516156543|FG001|Overall Study|Other-Protocol Violation|1|||
143166460|NCT01052779|516156542|FG000|Overall Study|Other-Surgery|0|||
143166461|NCT01052779|516156543|FG001|Overall Study|Other-Surgery|2|||
143499050|NCT01808612|517368492|FG001|Treatment Period|Lack of Efficacy|1|||
143499051|NCT01808612|517368493|FG002|Treatment Period|Lack of Efficacy|2|||
143499052|NCT01808612|517368491|FG000|Discontinuation Period|Adverse Event|1|||
143499053|NCT01808612|517368492|FG001|Discontinuation Period|Adverse Event|0|||
143499054|NCT01808612|517368493|FG002|Discontinuation Period|Adverse Event|0|||
143499055|NCT01808612|517368491|FG000|Discontinuation Period|Physician Decision|1|||
143499056|NCT01808612|517368492|FG001|Discontinuation Period|Physician Decision|0|||
143499057|NCT01808612|517368493|FG002|Discontinuation Period|Physician Decision|0|||
143499058|NCT01808612|517368491|FG000|Discontinuation Period|Lost to Follow-up|0|||
143499059|NCT01808612|517368492|FG001|Discontinuation Period|Lost to Follow-up|1|||
143499060|NCT01808612|517368493|FG002|Discontinuation Period|Lost to Follow-up|0|||
143499061|NCT00110019|517368494|FG000|Overall Study|Lack of Efficacy|253|||
143499062|NCT00110019|517368495|FG001|Overall Study|Lack of Efficacy|285|||
143499063|NCT00110019|517368494|FG000|Overall Study|Adverse Event|61|||
143499064|NCT00110019|517368495|FG001|Overall Study|Adverse Event|40|||
143499065|NCT00110019|517368494|FG000|Overall Study|Death|13|||
143499066|NCT00110019|517368495|FG001|Overall Study|Death|15|||
143499067|NCT00110019|517368494|FG000|Overall Study|Withdrawal by Subject|21|||
143499068|NCT00110019|517368495|FG001|Overall Study|Withdrawal by Subject|9|||
143499069|NCT00110019|517368494|FG000|Overall Study|alternative therapy|5|||
143499070|NCT00110019|517368495|FG001|Overall Study|alternative therapy|1|||
143499071|NCT00110019|517368494|FG000|Overall Study|complicating disease|1|||
143499072|NCT00110019|517368495|FG001|Overall Study|complicating disease|1|||
143499073|NCT00110019|517368494|FG000|Overall Study|symptom deterioration|13|||
143499074|NCT00110019|517368495|FG001|Overall Study|symptom deterioration|16|||
143499075|NCT00110019|517368494|FG000|Overall Study|Not start protocol therapy|17|||
143499076|NCT00110019|517368495|FG001|Overall Study|Not start protocol therapy|16|||
143499077|NCT00110019|517368494|FG000|Overall Study|other reasons|22|||
143499078|NCT00110019|517368495|FG001|Overall Study|other reasons|30|||
143499079|NCT01046695|517368496|FG000|Overall Study|Subject had a pacemaker|0|||
143499080|NCT01046695|517368497|FG001|Overall Study|Subject had a pacemaker|1|||
143499081|NCT01046695|517368496|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
143499082|NCT01046695|517368497|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
143166462|NCT01052779|516156542|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
143166463|NCT01052779|516156543|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
143166464|NCT04507763|516156544|FG000|Overall Study|Participants did not meet entrance criteria|201|||
143166465|NCT01905540|516156545|FG000|Period 3|Other|1|||
143166466|NCT01905540|516156546|FG001|Period 3|Other|0|||
143166467|NCT01905540|516156547|FG002|Period 3|Other|1|||
143166468|NCT01905540|516156548|FG003|Period 3|Other|1|||
143166469|NCT02853136|516156549|FG000|Wash-out|Adverse Event|0|||
143166470|NCT02853136|516156550|FG001|Wash-out|Adverse Event|0|||
143166471|NCT02853136|516156551|FG002|Wash-out|Adverse Event|0|||
143166472|NCT02853136|516156552|FG003|Wash-out|Adverse Event|1|||
143166473|NCT00841815|516156553|FG000|Washout|Withdrawal by Subject|0|||
143166474|NCT00841815|516156554|FG001|Washout|Withdrawal by Subject|1|||
143166475|NCT03787615|516156558|FG000|Overall Study|Withdrawal by Subject|2|||
143166476|NCT03787615|516156558|FG000|Overall Study|Lost to Follow-up|2|||
143499083|NCT02239263|517368498|FG000|Overall Study|Protocol Violation|6|||
143499084|NCT04426695|517368499|FG000|Overall Study|Death|2|||
143499085|NCT04426695|517368500|FG001|Overall Study|Death|0|||
143499086|NCT04426695|517368501|FG002|Overall Study|Death|1|||
143499087|NCT04426695|517368502|FG003|Overall Study|Death|27|||
143499088|NCT04426695|517368503|FG004|Overall Study|Death|25|||
143499089|NCT04426695|517368504|FG005|Overall Study|Death|21|||
143044155|NCT03600376|515702841|FG000|Overall Study|Investigator Decision|0|||
143166477|NCT00605189|516156560|FG000|Overall Study|Adverse Event|1|||
143166478|NCT00605189|516156561|FG001|Overall Study|Adverse Event|0|||
143166479|NCT00605189|516156562|FG002|Overall Study|Adverse Event|0|||
143166480|NCT00605189|516156560|FG000|Overall Study|Other|2|||
143166481|NCT00605189|516156561|FG001|Overall Study|Other|2|||
143241099|NCT04922216|516433488|FG006|Overall Study|Withdrawal by Subject|0|||
143499090|NCT04426695|517368505|FG006|Overall Study|Death|42|||
143499091|NCT04426695|517368506|FG007|Overall Study|Death|23|||
143499092|NCT04426695|517368507|FG008|Overall Study|Death|37|||
143499093|NCT04426695|517368508|FG009|Overall Study|Death|14|||
143499094|NCT04426695|517368509|FG010|Overall Study|Death|8|||
143499095|NCT04426695|517368510|FG011|Overall Study|Death|7|||
143499096|NCT04426695|517368511|FG012|Overall Study|Death|13|||
143499097|NCT04426695|517368512|FG013|Overall Study|Death|25|||
143499098|NCT04426695|517368513|FG014|Overall Study|Death|19|||
143499099|NCT04426695|517368514|FG015|Overall Study|Death|7|||
143499100|NCT04426695|517368515|FG016|Overall Study|Death|8|||
143499101|NCT04426695|517368516|FG017|Overall Study|Death|4|||
143499102|NCT04426695|517368499|FG000|Overall Study|Lost to Follow-up|2|||
143499103|NCT04426695|517368500|FG001|Overall Study|Lost to Follow-up|4|||
143499104|NCT04426695|517368501|FG002|Overall Study|Lost to Follow-up|1|||
143499105|NCT04426695|517368502|FG003|Overall Study|Lost to Follow-up|19|||
143499106|NCT04426695|517368503|FG004|Overall Study|Lost to Follow-up|10|||
143499107|NCT04426695|517368504|FG005|Overall Study|Lost to Follow-up|14|||
143499108|NCT04426695|517368505|FG006|Overall Study|Lost to Follow-up|5|||
143499109|NCT04426695|517368506|FG007|Overall Study|Lost to Follow-up|14|||
143499110|NCT04426695|517368507|FG008|Overall Study|Lost to Follow-up|10|||
143499111|NCT04426695|517368508|FG009|Overall Study|Lost to Follow-up|11|||
143499112|NCT04426695|517368509|FG010|Overall Study|Lost to Follow-up|12|||
143499113|NCT04426695|517368510|FG011|Overall Study|Lost to Follow-up|6|||
143499114|NCT04426695|517368511|FG012|Overall Study|Lost to Follow-up|2|||
143499115|NCT04426695|517368512|FG013|Overall Study|Lost to Follow-up|2|||
143499116|NCT04426695|517368513|FG014|Overall Study|Lost to Follow-up|2|||
143499117|NCT04426695|517368514|FG015|Overall Study|Lost to Follow-up|0|||
143499118|NCT04426695|517368515|FG016|Overall Study|Lost to Follow-up|0|||
143499119|NCT04426695|517368516|FG017|Overall Study|Lost to Follow-up|0|||
143499120|NCT04426695|517368499|FG000|Overall Study|Participant Decision|1|||
143499121|NCT04426695|517368500|FG001|Overall Study|Participant Decision|2|||
143166482|NCT00605189|516156562|FG002|Overall Study|Other|0|||
143166483|NCT02697448|516156563|FG000|Overall Study|Protocol Violation|2|||
143166484|NCT02697448|516156564|FG001|Overall Study|Protocol Violation|4|||
143166485|NCT02697448|516156563|FG000|Overall Study|Clinical concerns during ablation|1|||
143166486|NCT02697448|516156564|FG001|Overall Study|Clinical concerns during ablation|1|||
143166487|NCT02697448|516156563|FG000|Overall Study|No data collected|2|||
143166488|NCT02697448|516156564|FG001|Overall Study|No data collected|0|||
143166489|NCT03685149|516156565|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
143166490|NCT03685149|516156566|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
143166491|NCT03685149|516156565|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
143166492|NCT03685149|516156566|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
143166493|NCT03685149|516156565|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
143166494|NCT03685149|516156566|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
143166495|NCT02655601|516156567|FG000|Overall Study|Adverse Event|0|||
143166496|NCT02655601|516156568|FG001|Overall Study|Adverse Event|0|||
143166497|NCT02655601|516156569|FG002|Overall Study|Adverse Event|0|||
143166498|NCT02655601|516156570|FG003|Overall Study|Adverse Event|1|||
143166499|NCT02655601|516156571|FG004|Overall Study|Adverse Event|1|||
143166500|NCT02655601|516156572|FG005|Overall Study|Adverse Event|0|||
143166501|NCT02655601|516156567|FG000|Overall Study|Physician Decision|0|||
143166502|NCT02655601|516156568|FG001|Overall Study|Physician Decision|0|||
143166503|NCT02655601|516156569|FG002|Overall Study|Physician Decision|0|||
143166504|NCT02655601|516156570|FG003|Overall Study|Physician Decision|0|||
143166505|NCT02655601|516156571|FG004|Overall Study|Physician Decision|1|||
143241100|NCT04922216|516433489|FG007|Overall Study|Withdrawal by Subject|2|||
143499122|NCT04426695|517368501|FG002|Overall Study|Participant Decision|2|||
143499123|NCT04426695|517368502|FG003|Overall Study|Participant Decision|12|||
143499124|NCT04426695|517368503|FG004|Overall Study|Participant Decision|18|||
143499125|NCT04426695|517368504|FG005|Overall Study|Participant Decision|22|||
143499126|NCT04426695|517368505|FG006|Overall Study|Participant Decision|13|||
143499127|NCT04426695|517368506|FG007|Overall Study|Participant Decision|13|||
143499128|NCT04426695|517368507|FG008|Overall Study|Participant Decision|10|||
143499129|NCT04426695|517368508|FG009|Overall Study|Participant Decision|15|||
143499130|NCT04426695|517368509|FG010|Overall Study|Participant Decision|16|||
143499131|NCT04426695|517368510|FG011|Overall Study|Participant Decision|17|||
143166506|NCT02655601|516156572|FG005|Overall Study|Physician Decision|1|||
143166507|NCT02655601|516156567|FG000|Overall Study|Withdrawal by Subject|0|||
143166508|NCT02655601|516156568|FG001|Overall Study|Withdrawal by Subject|0|||
143166509|NCT02655601|516156569|FG002|Overall Study|Withdrawal by Subject|0|||
143166510|NCT02655601|516156570|FG003|Overall Study|Withdrawal by Subject|0|||
143499132|NCT04426695|517368511|FG012|Overall Study|Participant Decision|2|||
143166511|NCT02655601|516156571|FG004|Overall Study|Withdrawal by Subject|4|||
143166512|NCT02655601|516156572|FG005|Overall Study|Withdrawal by Subject|8|||
143166513|NCT02655601|516156567|FG000|Overall Study|Treatment delayed too long per protocol due to adverse events|1|||
143499133|NCT04426695|517368512|FG013|Overall Study|Participant Decision|1|||
143499134|NCT04426695|517368513|FG014|Overall Study|Participant Decision|2|||
143499135|NCT04426695|517368514|FG015|Overall Study|Participant Decision|0|||
143499136|NCT04426695|517368515|FG016|Overall Study|Participant Decision|0|||
143499137|NCT04426695|517368516|FG017|Overall Study|Participant Decision|0|||
143499138|NCT04426695|517368499|FG000|Overall Study|Adverse Event|0|||
143499139|NCT04426695|517368500|FG001|Overall Study|Adverse Event|0|||
143499140|NCT04426695|517368501|FG002|Overall Study|Adverse Event|0|||
143499141|NCT04426695|517368502|FG003|Overall Study|Adverse Event|0|||
143499142|NCT04426695|517368503|FG004|Overall Study|Adverse Event|0|||
143499143|NCT04426695|517368504|FG005|Overall Study|Adverse Event|0|||
143499144|NCT04426695|517368505|FG006|Overall Study|Adverse Event|0|||
143499145|NCT04426695|517368506|FG007|Overall Study|Adverse Event|1|||
143499146|NCT04426695|517368507|FG008|Overall Study|Adverse Event|0|||
143499147|NCT04426695|517368508|FG009|Overall Study|Adverse Event|0|||
143499148|NCT04426695|517368509|FG010|Overall Study|Adverse Event|1|||
143499149|NCT04426695|517368510|FG011|Overall Study|Adverse Event|1|||
143499150|NCT04426695|517368511|FG012|Overall Study|Adverse Event|0|||
143499151|NCT04426695|517368512|FG013|Overall Study|Adverse Event|0|||
143499152|NCT04426695|517368513|FG014|Overall Study|Adverse Event|0|||
143499153|NCT04426695|517368514|FG015|Overall Study|Adverse Event|0|||
143499154|NCT04426695|517368515|FG016|Overall Study|Adverse Event|0|||
143499155|NCT04426695|517368516|FG017|Overall Study|Adverse Event|0|||
143499156|NCT04426695|517368499|FG000|Overall Study|Sponsor Request|0|||
143499157|NCT04426695|517368500|FG001|Overall Study|Sponsor Request|0|||
143044156|NCT03600376|515702842|FG001|Overall Study|Investigator Decision|4|||
143044157|NCT03600376|515702841|FG000|Overall Study|Determined to be ineligible for study|0|||
143241101|NCT04922216|516433490|FG008|Overall Study|Withdrawal by Subject|0|||
143241102|NCT04922216|516433491|FG009|Overall Study|Withdrawal by Subject|0|||
143241103|NCT04922216|516433492|FG010|Overall Study|Withdrawal by Subject|0|||
143241104|NCT04922216|516433493|FG011|Overall Study|Withdrawal by Subject|0|||
143241105|NCT04922216|516433494|FG012|Overall Study|Withdrawal by Subject|1|||
143241106|NCT04922216|516433495|FG013|Overall Study|Withdrawal by Subject|1|||
143241107|NCT04922216|516433496|FG014|Overall Study|Withdrawal by Subject|1|||
143241108|NCT04922216|516433497|FG015|Overall Study|Withdrawal by Subject|0|||
143241109|NCT04922216|516433498|FG016|Overall Study|Withdrawal by Subject|0|||
143241110|NCT04922216|516433499|FG017|Overall Study|Withdrawal by Subject|1|||
143241111|NCT04922216|516433500|FG018|Overall Study|Withdrawal by Subject|1|||
143241112|NCT04922216|516433501|FG019|Overall Study|Withdrawal by Subject|1|||
143241113|NCT04922216|516433502|FG020|Overall Study|Withdrawal by Subject|1|||
143241114|NCT04922216|516433503|FG021|Overall Study|Withdrawal by Subject|0|||
143241115|NCT04922216|516433504|FG022|Overall Study|Withdrawal by Subject|0|||
143241116|NCT04922216|516433505|FG023|Overall Study|Withdrawal by Subject|2|||
143241117|NCT04922216|516433506|FG024|Overall Study|Withdrawal by Subject|0|||
143241118|NCT04922216|516433507|FG025|Overall Study|Withdrawal by Subject|0|||
143241119|NCT04922216|516433508|FG026|Overall Study|Withdrawal by Subject|1|||
143241120|NCT04922216|516433509|FG027|Overall Study|Withdrawal by Subject|0|||
143241121|NCT04922216|516433510|FG028|Overall Study|Withdrawal by Subject|0|||
143044158|NCT03600376|515702842|FG001|Overall Study|Determined to be ineligible for study|1|||
143044159|NCT02152163|515702843|FG000|Overall Study|Physician Decision|12|||
143044160|NCT02152163|515702844|FG001|Overall Study|Physician Decision|13|||
143044161|NCT00424047|515702848|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
143044162|NCT00424047|515702849|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
143044163|NCT00424047|515702848|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
143044164|NCT00424047|515702849|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
143044165|NCT00424047|515702848|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
143241122|NCT04922216|516433511|FG029|Overall Study|Withdrawal by Subject|0|||
143241123|NCT04922216|516433512|FG030|Overall Study|Withdrawal by Subject|1|||
143241124|NCT04922216|516433513|FG031|Overall Study|Withdrawal by Subject|0|||
143241125|NCT04922216|516433482|FG000|Overall Study|Lost to Follow-up|1|||
143241126|NCT04922216|516433483|FG001|Overall Study|Lost to Follow-up|0|||
143241127|NCT04922216|516433484|FG002|Overall Study|Lost to Follow-up|2|||
143241128|NCT04922216|516433485|FG003|Overall Study|Lost to Follow-up|0|||
143241129|NCT04922216|516433486|FG004|Overall Study|Lost to Follow-up|0|||
143241130|NCT04922216|516433487|FG005|Overall Study|Lost to Follow-up|2|||
143241131|NCT04922216|516433488|FG006|Overall Study|Lost to Follow-up|0|||
143241132|NCT04922216|516433489|FG007|Overall Study|Lost to Follow-up|1|||
143241133|NCT04922216|516433490|FG008|Overall Study|Lost to Follow-up|1|||
143241134|NCT04922216|516433491|FG009|Overall Study|Lost to Follow-up|2|||
143241135|NCT04922216|516433492|FG010|Overall Study|Lost to Follow-up|2|||
143241136|NCT04922216|516433493|FG011|Overall Study|Lost to Follow-up|1|||
143241137|NCT04922216|516433494|FG012|Overall Study|Lost to Follow-up|1|||
143241138|NCT04922216|516433495|FG013|Overall Study|Lost to Follow-up|0|||
143241139|NCT04922216|516433496|FG014|Overall Study|Lost to Follow-up|1|||
143241140|NCT04922216|516433497|FG015|Overall Study|Lost to Follow-up|0|||
143241141|NCT04922216|516433498|FG016|Overall Study|Lost to Follow-up|0|||
143241142|NCT04922216|516433499|FG017|Overall Study|Lost to Follow-up|2|||
143241143|NCT04922216|516433500|FG018|Overall Study|Lost to Follow-up|1|||
143241144|NCT04922216|516433501|FG019|Overall Study|Lost to Follow-up|0|||
143241145|NCT04922216|516433502|FG020|Overall Study|Lost to Follow-up|1|||
143241146|NCT04922216|516433503|FG021|Overall Study|Lost to Follow-up|0|||
143241147|NCT04922216|516433504|FG022|Overall Study|Lost to Follow-up|2|||
143499158|NCT04426695|517368501|FG002|Overall Study|Sponsor Request|0|||
143241148|NCT04922216|516433505|FG023|Overall Study|Lost to Follow-up|1|||
143241149|NCT04922216|516433506|FG024|Overall Study|Lost to Follow-up|0|||
143241150|NCT04922216|516433507|FG025|Overall Study|Lost to Follow-up|2|||
143241151|NCT04922216|516433508|FG026|Overall Study|Lost to Follow-up|0|||
143241152|NCT04922216|516433509|FG027|Overall Study|Lost to Follow-up|0|||
143241153|NCT04922216|516433510|FG028|Overall Study|Lost to Follow-up|1|||
143241154|NCT04922216|516433511|FG029|Overall Study|Lost to Follow-up|0|||
143241155|NCT04922216|516433512|FG030|Overall Study|Lost to Follow-up|2|||
143241156|NCT04922216|516433513|FG031|Overall Study|Lost to Follow-up|1|||
143241157|NCT03278249|516433514|FG000|Overall Study|Withdrawal by Subject|2|||
143241158|NCT03278249|516433514|FG000|Overall Study|Lost to Follow-up|1|||
143241159|NCT02374450|516433515|FG000|Overall Study|Protocol Violation|0|||
143241160|NCT02374450|516433516|FG001|Overall Study|Protocol Violation|1|||
143241161|NCT02374450|516433517|FG002|Overall Study|Protocol Violation|0|||
143241162|NCT02374450|516433515|FG000|Overall Study|Withdrawal by Subject|91|||
143241163|NCT02374450|516433516|FG001|Overall Study|Withdrawal by Subject|110|||
143241164|NCT02374450|516433517|FG002|Overall Study|Withdrawal by Subject|4|||
143241165|NCT02374450|516433515|FG000|Overall Study|Lost to Follow-up|168|||
143241166|NCT02374450|516433516|FG001|Overall Study|Lost to Follow-up|194|||
143241167|NCT02374450|516433517|FG002|Overall Study|Lost to Follow-up|138|||
143241168|NCT02374450|516433515|FG000|Overall Study|Death|173|||
143241169|NCT02374450|516433516|FG001|Overall Study|Death|185|||
143241170|NCT02374450|516433517|FG002|Overall Study|Death|81|||
143241171|NCT02374450|516433515|FG000|Overall Study|Migrated from the study area|538|||
143241172|NCT02374450|516433516|FG001|Overall Study|Migrated from the study area|648|||
143241173|NCT02374450|516433517|FG002|Overall Study|Migrated from the study area|181|||
143241174|NCT02374450|516433515|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
143241175|NCT02374450|516433516|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
143241176|NCT02374450|516433517|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
143241177|NCT02374450|516433515|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
143241178|NCT02374450|516433516|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
143241179|NCT02374450|516433517|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
143241180|NCT02374450|516433515|FG000|Overall Study|Other|0|||
143044166|NCT00424047|515702849|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
143044167|NCT00424047|515702848|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
143241181|NCT02374450|516433516|FG001|Overall Study|Other|21|||
143241182|NCT02374450|516433517|FG002|Overall Study|Other|79|||
143241183|NCT01590888|516434505|FG000|Overall Study|Adverse Event|3|||
143241184|NCT01590888|516434506|FG001|Overall Study|Adverse Event|0|||
143241185|NCT01590888|516434507|FG002|Overall Study|Adverse Event|1|||
143241186|NCT01590888|516434505|FG000|Overall Study|Lost to Follow-up|1|||
143241187|NCT01590888|516434506|FG001|Overall Study|Lost to Follow-up|0|||
143241188|NCT01590888|516434507|FG002|Overall Study|Lost to Follow-up|0|||
143241189|NCT02331277|516434508|FG000|Overall Study|Withdrawal by Subject|1|||
143241190|NCT02331277|516434509|FG001|Overall Study|Withdrawal by Subject|0|||
143241191|NCT00990704|516434512|FG000|Overall Study|Adverse Event|1|||
143241192|NCT00990704|516434513|FG001|Overall Study|Adverse Event|1|||
143241193|NCT00990704|516434512|FG000|Overall Study|Physician Decision|0|||
143241194|NCT00990704|516434513|FG001|Overall Study|Physician Decision|1|||
143044168|NCT00424047|515702849|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
143044169|NCT00424047|515702848|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
143044170|NCT00424047|515702849|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
143044171|NCT00424047|515702848|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
143044172|NCT00424047|515702849|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
143044173|NCT00424047|515702848|FG000|On Study at Time of Unblinding|Adverse Event|22|||
143044174|NCT00424047|515702849|FG001|On Study at Time of Unblinding|Adverse Event|12|||
143044175|NCT00424047|515702848|FG000|On Study at Time of Unblinding|Progression of disease|92|||
143044176|NCT00424047|515702849|FG001|On Study at Time of Unblinding|Progression of disease|128|||
143044177|NCT00424047|515702848|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
143241195|NCT01399372|516434514|FG000|Overall Study|Protocol Violation|3|||
143241196|NCT01399372|516434515|FG001|Overall Study|Protocol Violation|1|||
143241197|NCT01376804|516434516|FG000|Treatment Period|Withdrawal by Subject|1|||
143241198|NCT01376804|516434516|FG000|Treatment Period|Adverse Event|6|||
143241199|NCT01376804|516434516|FG000|Treatment Period|Patient did not receive study drug|1|||
143241200|NCT01071798|516434517|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
143241201|NCT01071798|516434517|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
143241202|NCT01071798|516434517|FG000|Participants Who Received One Cycle|Patient requirement|20|||
143241203|NCT01071798|516434517|FG000|Participants Who Received One Cycle|Death|5|||
143241204|NCT01071798|516434517|FG000|Participants Who Received One Cycle|Change of therapy|6|||
143241205|NCT01071798|516434517|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
143241206|NCT01071798|516434517|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
143241207|NCT01071798|516434517|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
143044178|NCT00424047|515702849|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
143044179|NCT00424047|515702848|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
143241208|NCT01071798|516434517|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
143241209|NCT01071798|516434517|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
143241210|NCT00123422|516434524|FG000|Overall Study|Physician Decision|2|||
143241211|NCT00123422|516434525|FG001|Overall Study|Physician Decision|2|||
143241212|NCT00123422|516434526|FG002|Overall Study|Physician Decision|6|||
143044180|NCT00424047|515702849|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
143044181|NCT00424047|515702848|FG000|On Study at Time of Unblinding|Death|11|||
143044182|NCT00424047|515702849|FG001|On Study at Time of Unblinding|Death|11|||
143044183|NCT00424047|515702848|FG000|On Study at Time of Unblinding|Other|5|||
143044184|NCT00424047|515702849|FG001|On Study at Time of Unblinding|Other|4|||
143044185|NCT00424047|515702848|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
143044186|NCT00424047|515702849|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
143044187|NCT00424047|515702848|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
143044188|NCT00424047|515702849|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
143044189|NCT00424047|515702848|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
143044190|NCT00424047|515702849|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
143044191|NCT00424047|515702848|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
143044192|NCT00424047|515702849|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
143044193|NCT00424047|515702848|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
143044194|NCT00424047|515702849|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
143044195|NCT02358538|515702851|FG000|Through Week 26|Adverse Event|0|||
143044196|NCT02358538|515702852|FG001|Through Week 26|Adverse Event|1|||
143044197|NCT02358538|515702853|FG002|Through Week 26|Adverse Event|1|||
143044198|NCT02358538|515702854|FG003|Through Week 26|Adverse Event|2|||
143044199|NCT02358538|515702851|FG000|Through Week 26|Lack of Efficacy|1|||
143044200|NCT02358538|515702852|FG001|Through Week 26|Lack of Efficacy|1|||
143044201|NCT02358538|515702853|FG002|Through Week 26|Lack of Efficacy|3|||
143044202|NCT02358538|515702854|FG003|Through Week 26|Lack of Efficacy|3|||
143044203|NCT02358538|515702851|FG000|Through Week 26|Withdrawal by Subject|1|||
143241213|NCT00123422|516434524|FG000|Overall Study|Withdrawal by Subject|1|||
143241214|NCT00123422|516434525|FG001|Overall Study|Withdrawal by Subject|2|||
143241215|NCT00123422|516434526|FG002|Overall Study|Withdrawal by Subject|2|||
143241216|NCT00123422|516434524|FG000|Overall Study|Lost to Follow-up|1|||
143241217|NCT00123422|516434525|FG001|Overall Study|Lost to Follow-up|2|||
143241218|NCT00123422|516434526|FG002|Overall Study|Lost to Follow-up|2|||
143241219|NCT03809104|516434528|FG000|Overall Study|Withdrawal by Subject|3|||
143241220|NCT00043979|516434529|FG000|Period 1|recipient with progressive disease|7|||
143241221|NCT00043979|516434530|FG001|Period 1|recipient with progressive disease|4|||
143241222|NCT00043979|516434531|FG002|Period 1|recipient with progressive disease|3|||
143241223|NCT02004093|516434535|FG000|Overall Study|Death|2|||
143241224|NCT02004093|516434536|FG001|Overall Study|Death|1|||
143241225|NCT02004093|516434535|FG000|Overall Study|Lack of Efficacy|66|||
143241226|NCT02004093|516434536|FG001|Overall Study|Lack of Efficacy|62|||
143241227|NCT02004093|516434535|FG000|Overall Study|Protocol Violation|0|||
143241228|NCT02004093|516434536|FG001|Overall Study|Protocol Violation|1|||
143241229|NCT02004093|516434535|FG000|Overall Study|Lost to Follow-up|0|||
143241230|NCT02004093|516434536|FG001|Overall Study|Lost to Follow-up|1|||
143044204|NCT02358538|515702852|FG001|Through Week 26|Withdrawal by Subject|0|||
143044205|NCT02358538|515702853|FG002|Through Week 26|Withdrawal by Subject|0|||
143044206|NCT02358538|515702854|FG003|Through Week 26|Withdrawal by Subject|0|||
143044207|NCT02358538|515702851|FG000|Through Week 26|Non-Compliance|0|||
143044208|NCT02358538|515702852|FG001|Through Week 26|Non-Compliance|0|||
143044209|NCT02358538|515702853|FG002|Through Week 26|Non-Compliance|1|||
143044210|NCT02358538|515702854|FG003|Through Week 26|Non-Compliance|0|||
143044211|NCT02358538|515702851|FG000|Through Week 26|Family did not see benefit from IP|1|||
143044212|NCT02358538|515702852|FG001|Through Week 26|Family did not see benefit from IP|0|||
143044213|NCT02358538|515702853|FG002|Through Week 26|Family did not see benefit from IP|0|||
143044214|NCT02358538|515702854|FG003|Through Week 26|Family did not see benefit from IP|0|||
143044215|NCT02358538|515702851|FG000|52 Week Extension Period|Lack of Efficacy|0|||
143364276|NCT02790606|516876947|FG000|Overall Study|Withdrawal by Subject|1|||
143241231|NCT02004093|516434535|FG000|Overall Study|Withdrawal by Subject|3|||
143241232|NCT02004093|516434536|FG001|Overall Study|Withdrawal by Subject|7|||
143241233|NCT02004093|516434535|FG000|Overall Study|Other|3|||
143241234|NCT02004093|516434536|FG001|Overall Study|Other|1|||
143241235|NCT01411891|516434537|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
143241236|NCT01411891|516434538|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
143241237|NCT02558296|516434542|FG000|Completed the Study Through Week 24|Adverse Event|9|||
143241238|NCT02558296|516434543|FG001|Completed the Study Through Week 24|Adverse Event|3|||
143044216|NCT02358538|515702852|FG001|52 Week Extension Period|Lack of Efficacy|0|||
143044217|NCT02358538|515702853|FG002|52 Week Extension Period|Lack of Efficacy|2|||
143044218|NCT02358538|515702854|FG003|52 Week Extension Period|Lack of Efficacy|4|||
143044219|NCT02178787|515702855|FG000|Overall Study|Lost to Follow-up|1|||
143044220|NCT02178787|515702856|FG001|Overall Study|Lost to Follow-up|0|||
143241239|NCT02558296|516434542|FG000|Completed the Study Through Week 24|Death|7|||
143166514|NCT02655601|516156568|FG001|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
143166515|NCT02655601|516156569|FG002|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
143166516|NCT02655601|516156570|FG003|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
143166517|NCT02655601|516156571|FG004|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
143166518|NCT02655601|516156572|FG005|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
143166519|NCT01969409|516156575|FG000|Overall Study|Death|2|||
143166520|NCT01969409|516156576|FG001|Overall Study|Death|2|||
143166521|NCT01969409|516156575|FG000|Overall Study|Transplant|1|||
143166522|NCT01969409|516156576|FG001|Overall Study|Transplant|1|||
143241240|NCT02558296|516434543|FG001|Completed the Study Through Week 24|Death|7|||
143241241|NCT02558296|516434542|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
143241242|NCT02558296|516434543|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
143241243|NCT02558296|516434542|FG000|Completed the Study Through Week 24|Physician Decision|1|||
143241244|NCT02558296|516434543|FG001|Completed the Study Through Week 24|Physician Decision|0|||
143241245|NCT02558296|516434542|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
143241246|NCT02558296|516434543|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
143241247|NCT02558296|516434542|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
143241248|NCT02558296|516434543|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
143241249|NCT02558296|516434542|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
143241250|NCT02558296|516434543|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
143241251|NCT02558296|516434542|FG000|Completed the Study|Adverse Event|14|||
143241252|NCT02558296|516434543|FG001|Completed the Study|Adverse Event|5|||
143241253|NCT02558296|516434542|FG000|Completed the Study|Death|39|||
143241254|NCT02558296|516434543|FG001|Completed the Study|Death|25|||
143241255|NCT02558296|516434542|FG000|Completed the Study|Lost to Follow-up|31|||
143241256|NCT02558296|516434543|FG001|Completed the Study|Lost to Follow-up|23|||
143241257|NCT02558296|516434542|FG000|Completed the Study|Physician Decision|6|||
143241258|NCT02558296|516434543|FG001|Completed the Study|Physician Decision|0|||
143241259|NCT02558296|516434542|FG000|Completed the Study|Protocol Violation|2|||
143241260|NCT02558296|516434543|FG001|Completed the Study|Protocol Violation|1|||
143241261|NCT02558296|516434542|FG000|Completed the Study|Withdrawal by Subject|53|||
143241262|NCT02558296|516434543|FG001|Completed the Study|Withdrawal by Subject|31|||
143241263|NCT02558296|516434542|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
143241264|NCT02558296|516434543|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
143241265|NCT02919995|516434545|FG000|Overall Study|Adverse Event|0|||
143241266|NCT02919995|516434546|FG001|Overall Study|Adverse Event|0|||
143241267|NCT02919995|516434547|FG002|Overall Study|Adverse Event|0|||
143241268|NCT02919995|516434548|FG003|Overall Study|Adverse Event|0|||
143241269|NCT02919995|516434549|FG004|Overall Study|Adverse Event|0|||
143241270|NCT02919995|516434550|FG005|Overall Study|Adverse Event|1|||
143241271|NCT01821118|516434552|FG000|Overall Study|Death|0|||
143241272|NCT01821118|516434553|FG001|Overall Study|Death|1|||
143241273|NCT00380367|516434554|FG000|Overall Study|Lost to Follow-up|1|||
143241274|NCT00380367|516434554|FG000|Overall Study|Withdrawal by Subject|1|||
143241275|NCT01605799|516434555|FG000|Overall Study|Withdrawal by Subject|2|||
143241276|NCT01605799|516434556|FG001|Overall Study|Withdrawal by Subject|1|||
143241277|NCT02504151|516434559|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
143241278|NCT02504151|516434560|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
143241279|NCT02504151|516434559|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
143241280|NCT02504151|516434560|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
143241281|NCT02504151|516434559|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
143241282|NCT02504151|516434560|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
143241283|NCT02504151|516434559|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
143241284|NCT02504151|516434560|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
143241285|NCT02557139|516434563|FG000|Overall Study|Significant liver elevation|1|||
143241286|NCT02557139|516434564|FG001|Overall Study|Significant liver elevation|0|||
143241287|NCT02557139|516434565|FG002|Overall Study|Significant liver elevation|1|||
143241288|NCT02557139|516434563|FG000|Overall Study|Withdrawal by Subject|1|||
143241289|NCT02557139|516434564|FG001|Overall Study|Withdrawal by Subject|0|||
143241290|NCT02557139|516434565|FG002|Overall Study|Withdrawal by Subject|0|||
143241291|NCT02557139|516434563|FG000|Overall Study|Illness of prohibited medication|0|||
143166523|NCT01969409|516156575|FG000|Overall Study|Withdrawal by Subject|0|||
143241292|NCT02557139|516434564|FG001|Overall Study|Illness of prohibited medication|0|||
143241293|NCT02557139|516434565|FG002|Overall Study|Illness of prohibited medication|1|||
143241294|NCT03853109|516434567|FG000|Overall Study|Withdrawal by Subject|0|||
143241295|NCT03853109|516434568|FG001|Overall Study|Withdrawal by Subject|0|||
143241296|NCT03853109|516434569|FG002|Overall Study|Withdrawal by Subject|1|||
143241297|NCT03853109|516434570|FG003|Overall Study|Withdrawal by Subject|2|||
143241298|NCT03853109|516434571|FG004|Overall Study|Withdrawal by Subject|1|||
143241299|NCT03853109|516434572|FG005|Overall Study|Withdrawal by Subject|4|||
143166524|NCT01969409|516156576|FG001|Overall Study|Withdrawal by Subject|1|||
143044221|NCT02178787|515702855|FG000|Overall Study|Withdrawal by Subject|0|||
143044222|NCT02178787|515702856|FG001|Overall Study|Withdrawal by Subject|2|||
143044223|NCT02178787|515702855|FG000|Overall Study|No TCD window|3|||
143044224|NCT02178787|515702856|FG001|Overall Study|No TCD window|7|||
143241300|NCT03853109|516434573|FG006|Overall Study|Withdrawal by Subject|5|||
143241301|NCT03853109|516434574|FG007|Overall Study|Withdrawal by Subject|3|||
143241302|NCT03853109|516434567|FG000|Overall Study|Decision by Sponsor|0|||
143241303|NCT03853109|516434568|FG001|Overall Study|Decision by Sponsor|0|||
143241304|NCT03853109|516434569|FG002|Overall Study|Decision by Sponsor|1|||
143241305|NCT03853109|516434570|FG003|Overall Study|Decision by Sponsor|0|||
143241306|NCT03853109|516434571|FG004|Overall Study|Decision by Sponsor|1|||
143241307|NCT03853109|516434572|FG005|Overall Study|Decision by Sponsor|1|||
143241308|NCT03853109|516434573|FG006|Overall Study|Decision by Sponsor|10|||
143241309|NCT03853109|516434574|FG007|Overall Study|Decision by Sponsor|2|||
143241310|NCT03853109|516434567|FG000|Overall Study|Lost to Follow-up|0|||
143241311|NCT03853109|516434568|FG001|Overall Study|Lost to Follow-up|0|||
143241312|NCT03853109|516434569|FG002|Overall Study|Lost to Follow-up|0|||
143241313|NCT03853109|516434570|FG003|Overall Study|Lost to Follow-up|0|||
143241314|NCT03853109|516434571|FG004|Overall Study|Lost to Follow-up|1|||
143241315|NCT03853109|516434572|FG005|Overall Study|Lost to Follow-up|3|||
143241316|NCT03853109|516434573|FG006|Overall Study|Lost to Follow-up|0|||
143241317|NCT03853109|516434574|FG007|Overall Study|Lost to Follow-up|0|||
143241318|NCT03853109|516434567|FG000|Overall Study|Death|2|||
143241319|NCT03853109|516434568|FG001|Overall Study|Death|5|||
143241320|NCT03853109|516434569|FG002|Overall Study|Death|8|||
143241321|NCT03853109|516434570|FG003|Overall Study|Death|10|||
143241322|NCT03853109|516434571|FG004|Overall Study|Death|3|||
143241323|NCT03853109|516434572|FG005|Overall Study|Death|20|||
143241324|NCT03853109|516434573|FG006|Overall Study|Death|10|||
143241325|NCT03853109|516434574|FG007|Overall Study|Death|5|||
143241326|NCT04634253|516434575|FG000|Overall Study|Adverse Event|1|||
143241327|NCT04634253|516434576|FG001|Overall Study|Adverse Event|1|||
143241328|NCT04634253|516434577|FG002|Overall Study|Adverse Event|0|||
143241329|NCT04634253|516434575|FG000|Overall Study|Physician Decision|0|||
143241330|NCT04634253|516434576|FG001|Overall Study|Physician Decision|1|||
143241331|NCT04634253|516434577|FG002|Overall Study|Physician Decision|0|||
143241332|NCT04634253|516434575|FG000|Overall Study|Withdrawal by Subject|1|||
143241333|NCT04634253|516434576|FG001|Overall Study|Withdrawal by Subject|0|||
143241334|NCT04634253|516434577|FG002|Overall Study|Withdrawal by Subject|3|||
143241335|NCT01526733|516434578|FG000|Phase 1|Protocol Violation|1|||
143241336|NCT01526733|516434579|FG001|Phase 1|Protocol Violation|0|||
143241337|NCT01526733|516434578|FG000|Phase 1|Withdrawal by Subject|1|||
143241338|NCT01526733|516434579|FG001|Phase 1|Withdrawal by Subject|1|||
143241339|NCT01457703|516434580|FG000|Overall Study|Screen Failure|5|||
143241340|NCT01457703|516434581|FG001|Overall Study|Screen Failure|7|||
143241341|NCT01457703|516434580|FG000|Overall Study|Withdrawal by Subject|1|||
143241342|NCT01457703|516434581|FG001|Overall Study|Withdrawal by Subject|4|||
143241343|NCT00949702|516434582|FG000|Overall Study|Death|40|||
143241344|NCT00949702|516434582|FG000|Overall Study|Disease progression|7|||
143241345|NCT00949702|516434582|FG000|Overall Study|Withdrawal of consent|1|||
143241346|NCT03133793|516434587|FG000|Overall Study|Withdrawal by Subject|0|||
143241347|NCT03133793|516434588|FG001|Overall Study|Withdrawal by Subject|4|||
143241348|NCT03133793|516434589|FG002|Overall Study|Withdrawal by Subject|2|||
143241349|NCT03133793|516434590|FG003|Overall Study|Withdrawal by Subject|4|||
143241350|NCT03133793|516434587|FG000|Overall Study|Lost to Follow-up|1|||
143241351|NCT03133793|516434588|FG001|Overall Study|Lost to Follow-up|0|||
143241352|NCT03133793|516434589|FG002|Overall Study|Lost to Follow-up|2|||
143241353|NCT03133793|516434590|FG003|Overall Study|Lost to Follow-up|0|||
143241354|NCT03133793|516434587|FG000|Overall Study|Death|0|||
143241355|NCT03133793|516434588|FG001|Overall Study|Death|0|||
143241356|NCT03133793|516434589|FG002|Overall Study|Death|0|||
143241357|NCT03133793|516434590|FG003|Overall Study|Death|1|||
143241358|NCT02141204|516434591|FG000|Overall Study|Lost to Follow-up|2|||
143241359|NCT02141204|516434592|FG001|Overall Study|Lost to Follow-up|1|||
143241360|NCT02141204|516434591|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
143241361|NCT02141204|516434592|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
143241362|NCT02141204|516434591|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
143241363|NCT02141204|516434592|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
143241364|NCT02141204|516434591|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
143241365|NCT02141204|516434592|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
143241366|NCT02379091|516434597|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
143241367|NCT02379091|516434598|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
143044225|NCT02178787|515702855|FG000|Overall Study|Physician Decision|1|||
143241368|NCT02379091|516434599|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
143241369|NCT02379091|516434600|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
143241370|NCT02379091|516434597|FG000|Overall Study|Principal Investigator Discretion|0|||
143241371|NCT02379091|516434598|FG001|Overall Study|Principal Investigator Discretion|1|||
143241372|NCT02379091|516434599|FG002|Overall Study|Principal Investigator Discretion|0|||
143241373|NCT02379091|516434600|FG003|Overall Study|Principal Investigator Discretion|0|||
143241374|NCT02379091|516434597|FG000|Overall Study|Lost to Follow-up|0|||
143241375|NCT02379091|516434598|FG001|Overall Study|Lost to Follow-up|0|||
143241376|NCT02379091|516434599|FG002|Overall Study|Lost to Follow-up|0|||
143241377|NCT02379091|516434600|FG003|Overall Study|Lost to Follow-up|1|||
143241378|NCT02379091|516434597|FG000|Overall Study|Voluntary Withdrawal|2|||
143241379|NCT02379091|516434598|FG001|Overall Study|Voluntary Withdrawal|5|||
143241380|NCT02379091|516434599|FG002|Overall Study|Voluntary Withdrawal|2|||
143241381|NCT02379091|516434600|FG003|Overall Study|Voluntary Withdrawal|4|||
143241382|NCT02379091|516434597|FG000|Overall Study|Study Termination|7|||
143241383|NCT02379091|516434598|FG001|Overall Study|Study Termination|2|||
143241384|NCT02379091|516434599|FG002|Overall Study|Study Termination|5|||
143241385|NCT02379091|516434600|FG003|Overall Study|Study Termination|8|||
143241386|NCT02379091|516434597|FG000|Overall Study|Lack of Efficacy|3|||
143241387|NCT02379091|516434598|FG001|Overall Study|Lack of Efficacy|0|||
143044226|NCT02178787|515702856|FG001|Overall Study|Physician Decision|0|||
143241388|NCT02379091|516434599|FG002|Overall Study|Lack of Efficacy|0|||
143044227|NCT02554890|515702857|FG000|Double-blind|Adverse Event|45|||
143241389|NCT02379091|516434600|FG003|Overall Study|Lack of Efficacy|0|||
143241390|NCT02129699|516434601|FG000|Overall Study|Did not start treatment|3|||
143241391|NCT02129699|516434602|FG001|Overall Study|Did not start treatment|2|||
143241392|NCT04949490|516434607|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
143241393|NCT04949490|516434608|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
143241394|NCT04949490|516434609|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
143241395|NCT04949490|516434610|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
143241396|NCT04949490|516434611|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
143241397|NCT04949490|516434612|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
143241398|NCT04949490|516434607|FG000|Group A and Group B|Withdrawal by Subject|0|||
143241399|NCT04949490|516434608|FG001|Group A and Group B|Withdrawal by Subject|0|||
143241400|NCT04949490|516434609|FG002|Group A and Group B|Withdrawal by Subject|1|||
143241401|NCT04949490|516434610|FG003|Group A and Group B|Withdrawal by Subject|0|||
143241402|NCT04949490|516434611|FG004|Group A and Group B|Withdrawal by Subject|0|||
143241403|NCT04949490|516434612|FG005|Group A and Group B|Withdrawal by Subject|0|||
143241404|NCT04949490|516434607|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
143241405|NCT04949490|516434608|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
143241406|NCT04949490|516434609|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
143241407|NCT04949490|516434610|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
143241408|NCT04949490|516434611|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
143241409|NCT04949490|516434612|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
143241410|NCT04949490|516434607|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
143241411|NCT04949490|516434608|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
143241412|NCT04949490|516434609|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
143241413|NCT04949490|516434610|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
143241414|NCT04949490|516434611|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
143241415|NCT04949490|516434612|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
143241416|NCT04988477|516434613|FG000|Overall Study|Death|1|||
143241417|NCT04988477|516434614|FG001|Overall Study|Death|0|||
143241418|NCT04988477|516434615|FG002|Overall Study|Death|0|||
143241419|NCT04988477|516434613|FG000|Overall Study|Lost to Follow-up|5|||
143241420|NCT04988477|516434614|FG001|Overall Study|Lost to Follow-up|2|||
143241421|NCT04988477|516434615|FG002|Overall Study|Lost to Follow-up|0|||
143241422|NCT04988477|516434613|FG000|Overall Study|Withdrawal by Subject|2|||
143241423|NCT04988477|516434614|FG001|Overall Study|Withdrawal by Subject|0|||
143241424|NCT04988477|516434615|FG002|Overall Study|Withdrawal by Subject|0|||
143241425|NCT02202759|516435858|FG000|Overall Study|Study Terminated by Sponsor|3|||
143241426|NCT02202759|516435859|FG001|Overall Study|Study Terminated by Sponsor|3|||
143241427|NCT02202759|516435860|FG002|Overall Study|Study Terminated by Sponsor|3|||
143044228|NCT02554890|515702858|FG001|Double-blind|Adverse Event|51|||
143044229|NCT02554890|515702857|FG000|Double-blind|Death|6|||
143044230|NCT02554890|515702858|FG001|Double-blind|Death|4|||
143241428|NCT02202759|516435858|FG000|Overall Study|Withdrawal by Subject|2|||
143241429|NCT02202759|516435859|FG001|Overall Study|Withdrawal by Subject|1|||
143241430|NCT02202759|516435860|FG002|Overall Study|Withdrawal by Subject|1|||
143241431|NCT02202759|516435858|FG000|Overall Study|Reason not Specified|4|||
143241432|NCT02202759|516435859|FG001|Overall Study|Reason not Specified|11|||
143241433|NCT02202759|516435860|FG002|Overall Study|Reason not Specified|10|||
143241434|NCT01987453|516435861|FG000|Overall Study|Death|0|||
143241435|NCT01987453|516435862|FG001|Overall Study|Death|0|||
143241436|NCT01987453|516435863|FG002|Overall Study|Death|1|||
143241437|NCT01987453|516435861|FG000|Overall Study|Lack of Efficacy|1|||
143241438|NCT01987453|516435862|FG001|Overall Study|Lack of Efficacy|12|||
143241439|NCT01987453|516435863|FG002|Overall Study|Lack of Efficacy|0|||
143241440|NCT02105662|516435864|FG000|Overall Study|Lost to Follow-up|5|||
143241441|NCT02105662|516435864|FG000|Overall Study|Withdrawal by Subject|1|||
143241442|NCT01705509|516435866|FG000|Inclusion CPET|Screen Failure|5|||
143241443|NCT01705509|516435866|FG000|Inclusion CPET|Withdrawal by Subject|2|||
143241444|NCT01705509|516435866|FG000|CPET w/ Ranexa|Screen Failure|2|||
143241445|NCT02736890|516435867|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
143241446|NCT02736890|516435868|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
143241447|NCT02736890|516435867|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
143241448|NCT02736890|516435868|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
143241449|NCT02904954|516435869|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
143241450|NCT02904954|516435870|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
143241451|NCT02904954|516435869|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
143241452|NCT02904954|516435870|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
143241453|NCT02904954|516435869|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
143241454|NCT02904954|516435870|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
143241455|NCT02904954|516435869|FG000|Adjuvant Durvalumab|Recurrence|2|||
143241456|NCT02904954|516435870|FG001|Adjuvant Durvalumab|Recurrence|0|||
143241457|NCT02904954|516435869|FG000|Adjuvant Durvalumab|Adverse Event|2|||
143241458|NCT02904954|516435870|FG001|Adjuvant Durvalumab|Adverse Event|6|||
143241459|NCT02904954|516435869|FG000|Adjuvant Durvalumab|Participant wishes|12|||
143241460|NCT02904954|516435870|FG001|Adjuvant Durvalumab|Participant wishes|7|||
143241461|NCT02904954|516435869|FG000|Adjuvant Durvalumab|Physician Decision|2|||
143241462|NCT02904954|516435870|FG001|Adjuvant Durvalumab|Physician Decision|1|||
143241463|NCT02904954|516435869|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
143241464|NCT02904954|516435870|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
143044231|NCT02554890|515702857|FG000|Double-blind|Protocol Violation|1|||
143044232|NCT02554890|515702858|FG001|Double-blind|Protocol Violation|1|||
143044233|NCT02554890|515702857|FG000|Double-blind|Physician Decision|4|||
143044234|NCT02554890|515702858|FG001|Double-blind|Physician Decision|3|||
143044235|NCT02554890|515702857|FG000|Double-blind|Subject/Guardian decision|21|||
143044236|NCT02554890|515702858|FG001|Double-blind|Subject/Guardian decision|16|||
143044237|NCT02554890|515702857|FG000|Double-blind|Lost to Follow-up|7|||
143044238|NCT02554890|515702858|FG001|Double-blind|Lost to Follow-up|5|||
143241465|NCT02904954|516435869|FG000|Adjuvant Durvalumab|Death|0|||
143241466|NCT02904954|516435870|FG001|Adjuvant Durvalumab|Death|1|||
143241467|NCT02904954|516435869|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
143241468|NCT02904954|516435870|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
143241469|NCT05097963|516435871|FG000|Overall Study|Protocol Violation|13|||
143241470|NCT05097963|516435871|FG000|Overall Study|Withdrawal by Subject|21|||
143241471|NCT03349034|516435874|FG000|Overall Study|catheters dislodged during transport|2|||
143241472|NCT03349034|516435875|FG001|Overall Study|catheters dislodged during transport|0|||
143241473|NCT03349034|516435874|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
143241474|NCT03349034|516435875|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
143241475|NCT03349034|516435874|FG000|Overall Study|soft tissue flap used|1|||
143241476|NCT03349034|516435875|FG001|Overall Study|soft tissue flap used|0|||
143241477|NCT03349034|516435874|FG000|Overall Study|Other|0|||
143241478|NCT03349034|516435875|FG001|Overall Study|Other|1|||
143241479|NCT01177397|516435876|FG000|Overall Study|Protocol Violation|0|||
143241480|NCT01177397|516435877|FG001|Overall Study|Protocol Violation|0|||
143241481|NCT01177397|516435878|FG002|Overall Study|Protocol Violation|0|||
143241482|NCT01177397|516435879|FG003|Overall Study|Protocol Violation|0|||
143241483|NCT01177397|516435880|FG004|Overall Study|Protocol Violation|0|||
143241484|NCT01177397|516435881|FG005|Overall Study|Protocol Violation|1|||
143241485|NCT01177397|516435882|FG006|Overall Study|Protocol Violation|0|||
143241486|NCT01177397|516435883|FG007|Overall Study|Protocol Violation|0|||
143241487|NCT01177397|516435884|FG008|Overall Study|Protocol Violation|0|||
143241488|NCT01177397|516435885|FG009|Overall Study|Protocol Violation|0|||
143241489|NCT01177397|516435886|FG010|Overall Study|Protocol Violation|0|||
143241490|NCT01177397|516435887|FG011|Overall Study|Protocol Violation|0|||
143241491|NCT01177397|516435876|FG000|Overall Study|Lost to Follow-up|0|||
143241492|NCT01177397|516435877|FG001|Overall Study|Lost to Follow-up|0|||
143241493|NCT01177397|516435878|FG002|Overall Study|Lost to Follow-up|0|||
143241494|NCT01177397|516435879|FG003|Overall Study|Lost to Follow-up|0|||
143241495|NCT01177397|516435880|FG004|Overall Study|Lost to Follow-up|1|||
143044239|NCT02554890|515702857|FG000|Double-blind|Technical problems|1|||
143044240|NCT02554890|515702858|FG001|Double-blind|Technical problems|0|||
143044241|NCT02554890|515702857|FG000|Double-blind|Withdrawal by Subject|5|||
143044242|NCT02554890|515702858|FG001|Double-blind|Withdrawal by Subject|6|||
143241496|NCT01177397|516435881|FG005|Overall Study|Lost to Follow-up|0|||
143241497|NCT01177397|516435882|FG006|Overall Study|Lost to Follow-up|0|||
143241498|NCT01177397|516435883|FG007|Overall Study|Lost to Follow-up|2|||
143241499|NCT01177397|516435884|FG008|Overall Study|Lost to Follow-up|0|||
143364277|NCT02735915|516876948|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
143241500|NCT01177397|516435885|FG009|Overall Study|Lost to Follow-up|0|||
143241501|NCT01177397|516435886|FG010|Overall Study|Lost to Follow-up|0|||
143241502|NCT01177397|516435887|FG011|Overall Study|Lost to Follow-up|0|||
143241503|NCT01177397|516435876|FG000|Overall Study|Death|0|||
143241504|NCT01177397|516435877|FG001|Overall Study|Death|0|||
143241505|NCT01177397|516435878|FG002|Overall Study|Death|1|||
143044243|NCT02554890|515702857|FG000|Double-blind|Noncompliance with study treatment|6|||
143241506|NCT01177397|516435879|FG003|Overall Study|Death|1|||
143241507|NCT01177397|516435880|FG004|Overall Study|Death|0|||
143241508|NCT01177397|516435881|FG005|Overall Study|Death|0|||
143241509|NCT01177397|516435882|FG006|Overall Study|Death|0|||
143241510|NCT01177397|516435883|FG007|Overall Study|Death|5|||
143241511|NCT01177397|516435884|FG008|Overall Study|Death|2|||
143241512|NCT01177397|516435885|FG009|Overall Study|Death|1|||
143241513|NCT01177397|516435886|FG010|Overall Study|Death|0|||
143241514|NCT01177397|516435887|FG011|Overall Study|Death|0|||
143241515|NCT01177397|516435876|FG000|Overall Study|Withdrawal by Subject|0|||
143241516|NCT01177397|516435877|FG001|Overall Study|Withdrawal by Subject|0|||
143241517|NCT01177397|516435878|FG002|Overall Study|Withdrawal by Subject|1|||
143241518|NCT01177397|516435879|FG003|Overall Study|Withdrawal by Subject|1|||
143241519|NCT01177397|516435880|FG004|Overall Study|Withdrawal by Subject|1|||
143241520|NCT01177397|516435881|FG005|Overall Study|Withdrawal by Subject|2|||
143241521|NCT01177397|516435882|FG006|Overall Study|Withdrawal by Subject|0|||
143241522|NCT01177397|516435883|FG007|Overall Study|Withdrawal by Subject|5|||
143241523|NCT01177397|516435884|FG008|Overall Study|Withdrawal by Subject|9|||
143241524|NCT01177397|516435885|FG009|Overall Study|Withdrawal by Subject|1|||
143166525|NCT01554904|516156577|FG000|Overall Study|Withdrawal by Subject|3|||
143166526|NCT01554904|516156577|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
143166527|NCT01051661|516156578|FG000|Overall Study|Adverse Event|1|||
143166528|NCT01051661|516156579|FG001|Overall Study|Adverse Event|1|||
143166529|NCT01051661|516156580|FG002|Overall Study|Adverse Event|1|||
143166530|NCT01051661|516156581|FG003|Overall Study|Adverse Event|1|||
143166531|NCT01051661|516156582|FG004|Overall Study|Adverse Event|0|||
143166532|NCT01051661|516156583|FG005|Overall Study|Adverse Event|0|||
143166533|NCT01051661|516156578|FG000|Overall Study|Lost to Follow-up|13|||
143166534|NCT01051661|516156579|FG001|Overall Study|Lost to Follow-up|22|||
143166535|NCT01051661|516156580|FG002|Overall Study|Lost to Follow-up|15|||
143166536|NCT01051661|516156581|FG003|Overall Study|Lost to Follow-up|17|||
143166537|NCT01051661|516156582|FG004|Overall Study|Lost to Follow-up|10|||
143166538|NCT01051661|516156583|FG005|Overall Study|Lost to Follow-up|24|||
143166539|NCT01051661|516156578|FG000|Overall Study|Migrated/moved from study area|1|||
143166540|NCT01051661|516156579|FG001|Overall Study|Migrated/moved from study area|6|||
143166541|NCT01051661|516156580|FG002|Overall Study|Migrated/moved from study area|6|||
143166542|NCT01051661|516156581|FG003|Overall Study|Migrated/moved from study area|8|||
143166543|NCT01051661|516156582|FG004|Overall Study|Migrated/moved from study area|7|||
143166544|NCT01051661|516156583|FG005|Overall Study|Migrated/moved from study area|3|||
143166545|NCT01051661|516156578|FG000|Overall Study|Refused blood sampling|0|||
143166546|NCT01051661|516156579|FG001|Overall Study|Refused blood sampling|0|||
143166547|NCT01051661|516156580|FG002|Overall Study|Refused blood sampling|0|||
143166548|NCT01051661|516156581|FG003|Overall Study|Refused blood sampling|0|||
143166549|NCT01051661|516156582|FG004|Overall Study|Refused blood sampling|0|||
143166550|NCT01051661|516156583|FG005|Overall Study|Refused blood sampling|1|||
143166551|NCT01051661|516156578|FG000|Overall Study|Data not reliable|1|||
143166552|NCT01051661|516156579|FG001|Overall Study|Data not reliable|0|||
143166553|NCT01051661|516156580|FG002|Overall Study|Data not reliable|0|||
143166554|NCT01051661|516156581|FG003|Overall Study|Data not reliable|0|||
143166555|NCT01051661|516156582|FG004|Overall Study|Data not reliable|0|||
143166556|NCT01051661|516156583|FG005|Overall Study|Data not reliable|1|||
143166557|NCT01051661|516156578|FG000|Overall Study|Unable to attend visit(s)|2|||
143166558|NCT01051661|516156579|FG001|Overall Study|Unable to attend visit(s)|4|||
143166559|NCT01051661|516156580|FG002|Overall Study|Unable to attend visit(s)|2|||
143166560|NCT01051661|516156581|FG003|Overall Study|Unable to attend visit(s)|1|||
143166561|NCT01051661|516156582|FG004|Overall Study|Unable to attend visit(s)|3|||
143166562|NCT01051661|516156583|FG005|Overall Study|Unable to attend visit(s)|2|||
143166563|NCT01051661|516156578|FG000|Overall Study|Consent not received from both parents|0|||
143166564|NCT01051661|516156579|FG001|Overall Study|Consent not received from both parents|0|||
143166565|NCT01051661|516156580|FG002|Overall Study|Consent not received from both parents|0|||
143166566|NCT01051661|516156581|FG003|Overall Study|Consent not received from both parents|0|||
143166567|NCT01051661|516156582|FG004|Overall Study|Consent not received from both parents|0|||
143166568|NCT01051661|516156583|FG005|Overall Study|Consent not received from both parents|1|||
143166569|NCT01051661|516156578|FG000|Overall Study|Failure to comply with protocol|0|||
143166570|NCT01051661|516156579|FG001|Overall Study|Failure to comply with protocol|0|||
143166571|NCT01051661|516156580|FG002|Overall Study|Failure to comply with protocol|2|||
143166572|NCT01051661|516156581|FG003|Overall Study|Failure to comply with protocol|0|||
143166573|NCT01051661|516156582|FG004|Overall Study|Failure to comply with protocol|0|||
143241525|NCT01177397|516435886|FG010|Overall Study|Withdrawal by Subject|1|||
143241526|NCT01177397|516435887|FG011|Overall Study|Withdrawal by Subject|0|||
143241527|NCT01177397|516435876|FG000|Overall Study|Adverse Event|0|||
143241528|NCT01177397|516435877|FG001|Overall Study|Adverse Event|0|||
143241529|NCT01177397|516435878|FG002|Overall Study|Adverse Event|1|||
143166574|NCT01051661|516156583|FG005|Overall Study|Failure to comply with protocol|0|||
143166575|NCT01051661|516156578|FG000|Overall Study|Subject lost legal representation|0|||
143166576|NCT01051661|516156579|FG001|Overall Study|Subject lost legal representation|0|||
143241530|NCT01177397|516435879|FG003|Overall Study|Adverse Event|2|||
143241531|NCT01177397|516435880|FG004|Overall Study|Adverse Event|0|||
143241532|NCT01177397|516435881|FG005|Overall Study|Adverse Event|12|||
143241533|NCT01177397|516435882|FG006|Overall Study|Adverse Event|1|||
143241534|NCT01177397|516435883|FG007|Overall Study|Adverse Event|14|||
143241535|NCT01177397|516435884|FG008|Overall Study|Adverse Event|8|||
143241536|NCT01177397|516435885|FG009|Overall Study|Adverse Event|6|||
143241537|NCT01177397|516435886|FG010|Overall Study|Adverse Event|3|||
143241538|NCT01177397|516435887|FG011|Overall Study|Adverse Event|7|||
143241539|NCT01177397|516435876|FG000|Overall Study|Disease progression|1|||
143241540|NCT01177397|516435877|FG001|Overall Study|Disease progression|2|||
143241541|NCT01177397|516435878|FG002|Overall Study|Disease progression|5|||
143241542|NCT01177397|516435879|FG003|Overall Study|Disease progression|5|||
143241543|NCT01177397|516435880|FG004|Overall Study|Disease progression|4|||
143241544|NCT01177397|516435881|FG005|Overall Study|Disease progression|10|||
143241545|NCT01177397|516435882|FG006|Overall Study|Disease progression|10|||
143241546|NCT01177397|516435883|FG007|Overall Study|Disease progression|21|||
143241547|NCT01177397|516435884|FG008|Overall Study|Disease progression|18|||
143241548|NCT01177397|516435885|FG009|Overall Study|Disease progression|12|||
143241549|NCT01177397|516435886|FG010|Overall Study|Disease progression|10|||
143241550|NCT01177397|516435887|FG011|Overall Study|Disease progression|8|||
143241551|NCT01177397|516435876|FG000|Overall Study|Other reasons|0|||
143241552|NCT01177397|516435877|FG001|Overall Study|Other reasons|0|||
143241553|NCT01177397|516435878|FG002|Overall Study|Other reasons|1|||
143241554|NCT01177397|516435879|FG003|Overall Study|Other reasons|0|||
143241555|NCT01177397|516435880|FG004|Overall Study|Other reasons|1|||
143241556|NCT01177397|516435881|FG005|Overall Study|Other reasons|1|||
143241557|NCT01177397|516435882|FG006|Overall Study|Other reasons|2|||
143241558|NCT01177397|516435883|FG007|Overall Study|Other reasons|6|||
143241559|NCT01177397|516435884|FG008|Overall Study|Other reasons|10|||
143241560|NCT01177397|516435885|FG009|Overall Study|Other reasons|8|||
143241561|NCT01177397|516435886|FG010|Overall Study|Other reasons|0|||
143241562|NCT01177397|516435887|FG011|Overall Study|Other reasons|2|||
143241563|NCT01039376|516435888|FG000|Overall Study|Lost to Follow-up|5|||
143241564|NCT01039376|516435889|FG001|Overall Study|Lost to Follow-up|12|||
143241565|NCT01039376|516435888|FG000|Overall Study|Physician Decision|15|||
143241566|NCT01039376|516435889|FG001|Overall Study|Physician Decision|10|||
143241567|NCT01039376|516435888|FG000|Overall Study|Withdrawal by Subject|20|||
143241568|NCT01039376|516435889|FG001|Overall Study|Withdrawal by Subject|32|||
143241569|NCT01039376|516435888|FG000|Overall Study|Study terminated by Sponsor|90|||
143241570|NCT01039376|516435889|FG001|Overall Study|Study terminated by Sponsor|72|||
143241571|NCT04555616|516435890|FG000|Overall Study|Death|1|||
143241572|NCT04555616|516435891|FG001|Overall Study|Death|0|||
143241573|NCT04555616|516435892|FG002|Overall Study|Death|1|||
143241574|NCT04555616|516435890|FG000|Overall Study|Withdrawal by Subject|2|||
143241575|NCT04555616|516435891|FG001|Overall Study|Withdrawal by Subject|1|||
143241576|NCT04555616|516435892|FG002|Overall Study|Withdrawal by Subject|0|||
143241577|NCT01554241|516435893|FG000|Overall Study|Death|3|||
143241578|NCT01554241|516435894|FG001|Overall Study|Death|1|||
143241579|NCT01554241|516435895|FG002|Overall Study|Death|1|||
143241580|NCT01554241|516435896|FG003|Overall Study|Death|0|||
143241581|NCT01554241|516435893|FG000|Overall Study|protocol specified renal stone|0|||
143241582|NCT01554241|516435894|FG001|Overall Study|protocol specified renal stone|0|||
143241583|NCT01554241|516435895|FG002|Overall Study|protocol specified renal stone|0|||
143241584|NCT01554241|516435896|FG003|Overall Study|protocol specified renal stone|1|||
143241585|NCT01554241|516435893|FG000|Overall Study|protocol specified change in eGFR|0|||
143241586|NCT01554241|516435894|FG001|Overall Study|protocol specified change in eGFR|0|||
143241587|NCT01554241|516435895|FG002|Overall Study|protocol specified change in eGFR|1|||
143241588|NCT01554241|516435896|FG003|Overall Study|protocol specified change in eGFR|0|||
143241589|NCT01554241|516435893|FG000|Overall Study|Withdrawal by Subject|0|||
143241590|NCT01554241|516435894|FG001|Overall Study|Withdrawal by Subject|0|||
143241591|NCT01554241|516435895|FG002|Overall Study|Withdrawal by Subject|2|||
143241592|NCT01554241|516435896|FG003|Overall Study|Withdrawal by Subject|0|||
143241593|NCT02118961|516435897|FG000|Overall Study|Withdrawal by Subject|1|||
143241594|NCT02118961|516435898|FG001|Overall Study|Withdrawal by Subject|0|||
143241595|NCT01106690|516435901|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
143241596|NCT01106690|516435902|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
143364278|NCT02735915|516876948|FG000|Overall Study|Withdrawal following SAE|2|||
143241597|NCT01106690|516435903|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
143241598|NCT01106690|516435901|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
143241599|NCT01106690|516435902|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
143241600|NCT01106690|516435903|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
143241601|NCT01106690|516435901|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
143241602|NCT01106690|516435902|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
143241603|NCT01106690|516435903|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
143241604|NCT01106690|516435901|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
143241605|NCT01106690|516435902|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
143241606|NCT01106690|516435903|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
143241607|NCT01106690|516435901|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
143241608|NCT01106690|516435902|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
143241609|NCT01106690|516435903|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
143241610|NCT01106690|516435901|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
143241611|NCT01106690|516435902|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
143241612|NCT01106690|516435903|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
143241613|NCT01106690|516435901|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
143241614|NCT01106690|516435902|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
143241615|NCT01106690|516435903|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
143241616|NCT01106690|516435901|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
143241617|NCT01106690|516435902|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
143241618|NCT01106690|516435903|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
143241619|NCT01106690|516435901|FG000|Core Period: Baseline to Week 26|Other|10|||
143241620|NCT01106690|516435902|FG001|Core Period: Baseline to Week 26|Other|2|||
143241621|NCT01106690|516435903|FG002|Core Period: Baseline to Week 26|Other|6|||
143241622|NCT01106690|516435901|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
143241623|NCT01106690|516435902|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
143241624|NCT01106690|516435903|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
143241625|NCT01106690|516435901|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
143241626|NCT01106690|516435902|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
143241627|NCT01106690|516435903|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
143241628|NCT01106690|516435901|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
143241629|NCT01106690|516435902|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
143241630|NCT01106690|516435903|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
143241631|NCT01106690|516435901|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
143241632|NCT01106690|516435902|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
143241633|NCT01106690|516435903|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
143241634|NCT01106690|516435901|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
143241635|NCT01106690|516435902|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
143241636|NCT01106690|516435903|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
143241637|NCT01106690|516435901|FG000|Extension Period: Week 26 to Week 52|Other|8|||
143241638|NCT01106690|516435902|FG001|Extension Period: Week 26 to Week 52|Other|3|||
143241639|NCT01106690|516435903|FG002|Extension Period: Week 26 to Week 52|Other|4|||
143241640|NCT01106690|516435901|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
143241641|NCT01106690|516435902|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
143241642|NCT01106690|516435903|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
143241643|NCT00998296|516435904|FG000|Overall Study|Progressive disease|0|||
143241644|NCT00998296|516435905|FG001|Overall Study|Progressive disease|1|||
143241645|NCT00998296|516435906|FG002|Overall Study|Progressive disease|0|||
143241646|NCT00998296|516435907|FG003|Overall Study|Progressive disease|0|||
143241647|NCT00998296|516435908|FG004|Overall Study|Progressive disease|0|||
143241648|NCT00998296|516435909|FG005|Overall Study|Progressive disease|0|||
143241649|NCT00998296|516435910|FG006|Overall Study|Progressive disease|1|||
143241650|NCT00998296|516435911|FG007|Overall Study|Progressive disease|0|||
143241651|NCT00998296|516435912|FG008|Overall Study|Progressive disease|0|||
143241652|NCT00998296|516435913|FG009|Overall Study|Progressive disease|14|||
143241653|NCT00998296|516435914|FG010|Overall Study|Progressive disease|5|||
143241654|NCT00998296|516435904|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
143241655|NCT00998296|516435905|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
143166577|NCT01051661|516156580|FG002|Overall Study|Subject lost legal representation|0|||
143166578|NCT01051661|516156581|FG003|Overall Study|Subject lost legal representation|0|||
143166579|NCT01051661|516156582|FG004|Overall Study|Subject lost legal representation|1|||
143166580|NCT01051661|516156583|FG005|Overall Study|Subject lost legal representation|0|||
143166581|NCT01051661|516156578|FG000|Overall Study|Protocol Violation|0|||
143166582|NCT01051661|516156579|FG001|Overall Study|Protocol Violation|0|||
143166583|NCT01051661|516156580|FG002|Overall Study|Protocol Violation|0|||
143166584|NCT01051661|516156581|FG003|Overall Study|Protocol Violation|1|||
143166585|NCT01051661|516156582|FG004|Overall Study|Protocol Violation|2|||
143166586|NCT01051661|516156583|FG005|Overall Study|Protocol Violation|1|||
143166587|NCT01051661|516156578|FG000|Overall Study|Withdrawal by Subject|16|||
143166588|NCT01051661|516156579|FG001|Overall Study|Withdrawal by Subject|30|||
143166589|NCT01051661|516156580|FG002|Overall Study|Withdrawal by Subject|13|||
143166590|NCT01051661|516156581|FG003|Overall Study|Withdrawal by Subject|28|||
143166591|NCT01051661|516156582|FG004|Overall Study|Withdrawal by Subject|12|||
143166592|NCT01051661|516156583|FG005|Overall Study|Withdrawal by Subject|34|||
143166593|NCT00209131|516156585|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
143241656|NCT00998296|516435906|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
143241657|NCT00998296|516435907|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
143241658|NCT00998296|516435908|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
143241659|NCT00998296|516435909|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
143241660|NCT00998296|516435910|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
143241661|NCT00998296|516435911|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
143241662|NCT00998296|516435912|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
143241663|NCT00998296|516435913|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
143241664|NCT00998296|516435914|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
143241665|NCT00998296|516435904|FG000|Overall Study|Other adverse event|0|||
143241666|NCT00998296|516435905|FG001|Overall Study|Other adverse event|0|||
143241667|NCT00998296|516435906|FG002|Overall Study|Other adverse event|0|||
143241668|NCT00998296|516435907|FG003|Overall Study|Other adverse event|0|||
143241669|NCT00998296|516435908|FG004|Overall Study|Other adverse event|1|||
143241670|NCT00998296|516435909|FG005|Overall Study|Other adverse event|0|||
143241671|NCT00998296|516435910|FG006|Overall Study|Other adverse event|0|||
143241672|NCT00998296|516435911|FG007|Overall Study|Other adverse event|0|||
143241673|NCT00998296|516435912|FG008|Overall Study|Other adverse event|0|||
143241674|NCT00998296|516435913|FG009|Overall Study|Other adverse event|1|||
143241675|NCT00998296|516435914|FG010|Overall Study|Other adverse event|2|||
143241676|NCT00998296|516435904|FG000|Overall Study|Refused to continue taking trial med.|0|||
143241677|NCT00998296|516435905|FG001|Overall Study|Refused to continue taking trial med.|0|||
143241678|NCT00998296|516435906|FG002|Overall Study|Refused to continue taking trial med.|0|||
143241679|NCT00998296|516435907|FG003|Overall Study|Refused to continue taking trial med.|0|||
143241680|NCT00998296|516435908|FG004|Overall Study|Refused to continue taking trial med.|0|||
143241681|NCT00998296|516435909|FG005|Overall Study|Refused to continue taking trial med.|0|||
143241682|NCT00998296|516435910|FG006|Overall Study|Refused to continue taking trial med.|0|||
143241683|NCT00998296|516435911|FG007|Overall Study|Refused to continue taking trial med.|0|||
143241684|NCT00998296|516435912|FG008|Overall Study|Refused to continue taking trial med.|0|||
143241685|NCT00998296|516435913|FG009|Overall Study|Refused to continue taking trial med.|2|||
143241686|NCT00998296|516435914|FG010|Overall Study|Refused to continue taking trial med.|0|||
143241687|NCT00998296|516435904|FG000|Overall Study|Reason other than those specified above|0|||
143241688|NCT00998296|516435905|FG001|Overall Study|Reason other than those specified above|0|||
143241689|NCT00998296|516435906|FG002|Overall Study|Reason other than those specified above|0|||
143241690|NCT00998296|516435907|FG003|Overall Study|Reason other than those specified above|0|||
143241691|NCT00998296|516435908|FG004|Overall Study|Reason other than those specified above|0|||
143241692|NCT00998296|516435909|FG005|Overall Study|Reason other than those specified above|0|||
143241693|NCT00998296|516435910|FG006|Overall Study|Reason other than those specified above|0|||
143241694|NCT00998296|516435911|FG007|Overall Study|Reason other than those specified above|0|||
143241695|NCT00998296|516435912|FG008|Overall Study|Reason other than those specified above|0|||
143241696|NCT00998296|516435913|FG009|Overall Study|Reason other than those specified above|1|||
143241697|NCT00998296|516435914|FG010|Overall Study|Reason other than those specified above|0|||
143241698|NCT04396639|516435915|FG000|Overall Study|Withdrawal by Subject|1|||
143241699|NCT04396639|516435915|FG000|Overall Study|Other|1|||
143241700|NCT01544335|516435916|FG000|Overall Study|Lost to Follow-up|27|||
143241701|NCT01544335|516435916|FG000|Overall Study|Death|4|||
143241702|NCT01544335|516435916|FG000|Overall Study|Disease progression|3|||
143241703|NCT01544335|516435916|FG000|Overall Study|Baseline Measurements not Available|19|||
143241704|NCT05021978|516435924|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
143241705|NCT05021978|516435925|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
143241706|NCT05021978|516435926|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
143241707|NCT05021978|516435927|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
143241708|NCT05021978|516435924|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
143241709|NCT05021978|516435925|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
143241710|NCT05021978|516435926|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
143241711|NCT05021978|516435927|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
143241712|NCT00196313|516435928|FG000|Overall Study|Protocol Violation|2|||
143241713|NCT00196313|516435929|FG001|Overall Study|Protocol Violation|3|||
143241714|NCT00196313|516435928|FG000|Overall Study|Withdrawal by Subject|3|||
143241715|NCT00196313|516435929|FG001|Overall Study|Withdrawal by Subject|1|||
143241716|NCT00196313|516435928|FG000|Overall Study|Adverse Event|3|||
143241717|NCT00196313|516435929|FG001|Overall Study|Adverse Event|1|||
143241718|NCT00196313|516435928|FG000|Overall Study|Subject Pregnant|1|||
143241719|NCT00196313|516435929|FG001|Overall Study|Subject Pregnant|1|||
143241720|NCT00196313|516435928|FG000|Overall Study|Lost to Follow-up|2|||
143241721|NCT00196313|516435929|FG001|Overall Study|Lost to Follow-up|2|||
143241722|NCT03096288|516435931|FG000|Overall Study|Withdrawal by Subject|0|||
143241723|NCT03096288|516435932|FG001|Overall Study|Withdrawal by Subject|1|||
143241724|NCT03096288|516435933|FG002|Overall Study|Withdrawal by Subject|0|||
143241725|NCT03096288|516435934|FG003|Overall Study|Withdrawal by Subject|1|||
143241726|NCT04085289|516435937|FG000|Overall Study|Withdrawal by Subject|0|||
143241727|NCT04085289|516435938|FG001|Overall Study|Withdrawal by Subject|0|||
143241728|NCT04085289|516435939|FG002|Overall Study|Withdrawal by Subject|1|||
143241729|NCT00414596|516435940|FG000|Overall Study|Protocol Violation|2|||
143241730|NCT04614974|516435942|FG000|Overall Study|Lost to Follow-up|14|||
143241731|NCT04614974|516435943|FG001|Overall Study|Lost to Follow-up|11|||
143241732|NCT02754440|516435945|FG000|Overall Study|Protocol Violation|3|||
143241733|NCT02754440|516435946|FG001|Overall Study|Protocol Violation|2|||
143241734|NCT02754440|516435947|FG002|Overall Study|Protocol Violation|2|||
143241735|NCT02754440|516435948|FG003|Overall Study|Protocol Violation|6|||
143241736|NCT02754440|516435945|FG000|Overall Study|Adverse Event|3|||
143241737|NCT02754440|516435946|FG001|Overall Study|Adverse Event|1|||
143241738|NCT02754440|516435947|FG002|Overall Study|Adverse Event|0|||
143241739|NCT02754440|516435948|FG003|Overall Study|Adverse Event|9|||
143241740|NCT02754440|516435945|FG000|Overall Study|Withdrawal by Subject|0|||
143241741|NCT02754440|516435946|FG001|Overall Study|Withdrawal by Subject|0|||
143241742|NCT02754440|516435947|FG002|Overall Study|Withdrawal by Subject|0|||
143241743|NCT02754440|516435948|FG003|Overall Study|Withdrawal by Subject|1|||
143241744|NCT02754440|516435945|FG000|Overall Study|Equipment failure|0|||
143241745|NCT02754440|516435946|FG001|Overall Study|Equipment failure|5|||
143241746|NCT02754440|516435947|FG002|Overall Study|Equipment failure|5|||
143241747|NCT02754440|516435948|FG003|Overall Study|Equipment failure|7|||
143241748|NCT02754440|516435945|FG000|Overall Study|Subject issues not resulting in AE|0|||
143241749|NCT02754440|516435946|FG001|Overall Study|Subject issues not resulting in AE|0|||
143241750|NCT02754440|516435947|FG002|Overall Study|Subject issues not resulting in AE|0|||
143241751|NCT02754440|516435948|FG003|Overall Study|Subject issues not resulting in AE|12|||
143241752|NCT01146795|516435949|FG000|Overall Study|Withdrawal by Subject|4|||
143241753|NCT01146795|516435949|FG000|Overall Study|Adverse Event|6|||
143241754|NCT01146795|516435949|FG000|Overall Study|Still in treatment at study closure|10|||
143241755|NCT05375760|516435950|FG000|Overall Study|Adverse Event|1|||
143241756|NCT05375760|516435951|FG001|Overall Study|Adverse Event|0|||
143241757|NCT05375760|516435950|FG000|Overall Study|Death|0|||
143241758|NCT05375760|516435951|FG001|Overall Study|Death|1|||
143241759|NCT05375760|516435950|FG000|Overall Study|Lost to Follow-up|6|||
143241760|NCT05375760|516435951|FG001|Overall Study|Lost to Follow-up|6|||
143241761|NCT05375760|516435950|FG000|Overall Study|Withdrawal by Subject|17|||
143241762|NCT05375760|516435951|FG001|Overall Study|Withdrawal by Subject|19|||
143241763|NCT05375760|516435950|FG000|Overall Study|Dosing halted by FDA|96|||
143241764|NCT05375760|516435951|FG001|Overall Study|Dosing halted by FDA|100|||
143241765|NCT05375760|516435950|FG000|Overall Study|Not compliant with study visit|2|||
143241766|NCT05375760|516435951|FG001|Overall Study|Not compliant with study visit|0|||
143241767|NCT05375760|516435950|FG000|Overall Study|Physician Decision|1|||
143241768|NCT05375760|516435951|FG001|Overall Study|Physician Decision|0|||
143241769|NCT05375760|516435950|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
143241770|NCT05375760|516435951|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
143241771|NCT05375760|516435950|FG000|Overall Study|Participant moved|1|||
143241772|NCT05375760|516435951|FG001|Overall Study|Participant moved|0|||
143241773|NCT04269889|516435952|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|14|||
143241774|NCT01721044|516435955|FG000|Treatment Period|Adverse Event|7|||
143241775|NCT01721044|516435956|FG001|Treatment Period|Adverse Event|7|||
143241776|NCT01721044|516435957|FG002|Treatment Period|Adverse Event|10|||
143241777|NCT01721044|516435955|FG000|Treatment Period|Death|0|||
143241778|NCT01721044|516435956|FG001|Treatment Period|Death|0|||
143241779|NCT01721044|516435957|FG002|Treatment Period|Death|1|||
143241780|NCT01721044|516435955|FG000|Treatment Period|Lack of Efficacy|16|||
143241781|NCT01721044|516435956|FG001|Treatment Period|Lack of Efficacy|4|||
143241782|NCT01721044|516435957|FG002|Treatment Period|Lack of Efficacy|4|||
143241783|NCT01721044|516435955|FG000|Treatment Period|Lost to Follow-up|0|||
143241784|NCT01721044|516435956|FG001|Treatment Period|Lost to Follow-up|0|||
143241785|NCT01721044|516435957|FG002|Treatment Period|Lost to Follow-up|1|||
143241786|NCT01721044|516435955|FG000|Treatment Period|Physician Decision|1|||
143241787|NCT01721044|516435956|FG001|Treatment Period|Physician Decision|0|||
143241788|NCT01721044|516435957|FG002|Treatment Period|Physician Decision|2|||
143241789|NCT01721044|516435955|FG000|Treatment Period|Protocol Violation|1|||
143241790|NCT01721044|516435956|FG001|Treatment Period|Protocol Violation|0|||
143241791|NCT01721044|516435957|FG002|Treatment Period|Protocol Violation|0|||
143241792|NCT01721044|516435955|FG000|Treatment Period|Withdrawal by Subject|7|||
143241793|NCT01721044|516435956|FG001|Treatment Period|Withdrawal by Subject|6|||
143241794|NCT01721044|516435957|FG002|Treatment Period|Withdrawal by Subject|1|||
143241795|NCT03155841|516435958|FG000|Overall Study|Protocol Violation|3|||
143241796|NCT03155841|516435959|FG001|Overall Study|Protocol Violation|4|||
143241797|NCT01499355|516435960|FG000|Run-In Period|Study Termination|15|||
143241798|NCT01499355|516435961|FG001|Run-In Period|Study Termination|0|||
143241799|NCT01499355|516435962|FG002|Run-In Period|Study Termination|0|||
143241800|NCT01499355|516435963|FG003|Run-In Period|Study Termination|0|||
143241801|NCT01499355|516435960|FG000|Run-In Period|Other|3|||
143241802|NCT01499355|516435961|FG001|Run-In Period|Other|0|||
143241803|NCT01499355|516435962|FG002|Run-In Period|Other|0|||
143241804|NCT01499355|516435963|FG003|Run-In Period|Other|0|||
143241805|NCT01499355|516435960|FG000|Run-In Period|Death|2|||
143241806|NCT01499355|516435961|FG001|Run-In Period|Death|0|||
143241807|NCT01499355|516435962|FG002|Run-In Period|Death|0|||
143241808|NCT01499355|516435963|FG003|Run-In Period|Death|0|||
143241809|NCT01499355|516435960|FG000|Run-In Period|Investigator Decision|2|||
143241810|NCT01499355|516435961|FG001|Run-In Period|Investigator Decision|0|||
143241811|NCT01499355|516435962|FG002|Run-In Period|Investigator Decision|0|||
143241812|NCT01499355|516435963|FG003|Run-In Period|Investigator Decision|0|||
143241813|NCT01499355|516435960|FG000|Run-In Period|Consent Withdrawn|1|||
143241814|NCT01499355|516435961|FG001|Run-In Period|Consent Withdrawn|0|||
143241815|NCT01499355|516435962|FG002|Run-In Period|Consent Withdrawn|0|||
143241816|NCT01499355|516435963|FG003|Run-In Period|Consent Withdrawn|0|||
143241817|NCT01499355|516435960|FG000|Run-In Period|Adverse Event|8|||
143241818|NCT01499355|516435961|FG001|Run-In Period|Adverse Event|0|||
143241819|NCT01499355|516435962|FG002|Run-In Period|Adverse Event|0|||
143241820|NCT01499355|516435963|FG003|Run-In Period|Adverse Event|0|||
143241821|NCT01499355|516435960|FG000|Double-Blind Period|Adverse Event|0|||
143241822|NCT01499355|516435961|FG001|Double-Blind Period|Adverse Event|2|||
143241823|NCT01499355|516435962|FG002|Double-Blind Period|Adverse Event|3|||
143241824|NCT01499355|516435963|FG003|Double-Blind Period|Adverse Event|2|||
143241825|NCT01499355|516435960|FG000|Double-Blind Period|Study Termination|0|||
143241826|NCT01499355|516435961|FG001|Double-Blind Period|Study Termination|18|||
143241827|NCT01499355|516435962|FG002|Double-Blind Period|Study Termination|16|||
143241828|NCT01499355|516435963|FG003|Double-Blind Period|Study Termination|14|||
143241829|NCT01499355|516435960|FG000|Double-Blind Period|Other|0|||
143241830|NCT01499355|516435961|FG001|Double-Blind Period|Other|1|||
143241831|NCT01499355|516435962|FG002|Double-Blind Period|Other|2|||
143241832|NCT01499355|516435963|FG003|Double-Blind Period|Other|2|||
143241833|NCT01499355|516435960|FG000|Double-Blind Period|Death|0|||
143241834|NCT01499355|516435961|FG001|Double-Blind Period|Death|1|||
143241835|NCT01499355|516435962|FG002|Double-Blind Period|Death|0|||
143241836|NCT01499355|516435963|FG003|Double-Blind Period|Death|0|||
143241837|NCT01499355|516435960|FG000|Double-Blind Period|Investigator Decision|0|||
143241838|NCT01499355|516435961|FG001|Double-Blind Period|Investigator Decision|0|||
143241839|NCT01499355|516435962|FG002|Double-Blind Period|Investigator Decision|3|||
143241840|NCT01499355|516435963|FG003|Double-Blind Period|Investigator Decision|3|||
143241841|NCT01499355|516435960|FG000|Double-Blind Period|Consent Withdrawn|0|||
143241842|NCT01499355|516435961|FG001|Double-Blind Period|Consent Withdrawn|0|||
143241843|NCT01499355|516435962|FG002|Double-Blind Period|Consent Withdrawn|1|||
143241844|NCT01499355|516435963|FG003|Double-Blind Period|Consent Withdrawn|2|||
143241845|NCT01499355|516435960|FG000|Double-Blind Period|Lost to Follow-up|0|||
143241846|NCT01499355|516435961|FG001|Double-Blind Period|Lost to Follow-up|1|||
143241847|NCT01499355|516435962|FG002|Double-Blind Period|Lost to Follow-up|0|||
143241848|NCT01499355|516435963|FG003|Double-Blind Period|Lost to Follow-up|0|||
143241849|NCT04032093|516435964|FG000|Overall Study|Lost to Follow-up|7|||
143241850|NCT04032093|516435965|FG001|Overall Study|Lost to Follow-up|7|||
143241851|NCT04032093|516435966|FG002|Overall Study|Lost to Follow-up|6|||
143241852|NCT04032093|516435967|FG003|Overall Study|Lost to Follow-up|10|||
143241853|NCT04032093|516435968|FG004|Overall Study|Lost to Follow-up|13|||
143241854|NCT04032093|516435969|FG005|Overall Study|Lost to Follow-up|7|||
143241855|NCT04032093|516435970|FG006|Overall Study|Lost to Follow-up|7|||
143241856|NCT04032093|516435971|FG007|Overall Study|Lost to Follow-up|5|||
143241857|NCT04032093|516435972|FG008|Overall Study|Lost to Follow-up|9|||
143241858|NCT04032093|516435973|FG009|Overall Study|Lost to Follow-up|12|||
143241859|NCT04032093|516435964|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
143364279|NCT02735915|516876948|FG000|Overall Study|Withdrawal by Subject|1|||
143166594|NCT00209131|516156586|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
143166595|NCT05360784|516156587|FG000|Overall Study|Discontinued|25|||
143166596|NCT05360784|516156588|FG001|Overall Study|Discontinued|11|||
143166597|NCT02796651|516156589|FG000|Overall Study|Adverse Event|6|||
143166598|NCT02796651|516156589|FG000|Overall Study|Lost to Follow-up|1|||
143166599|NCT02796651|516156589|FG000|Overall Study|Withdrawal by Subject|4|||
143166600|NCT02796651|516156589|FG000|Overall Study|Protocol Violation|4|||
143166601|NCT02796651|516156589|FG000|Overall Study|Lack of Efficacy|1|||
143166602|NCT02796651|516156589|FG000|Overall Study|Other|10|||
143166603|NCT05142306|516156593|FG000|Overall Study|Withdrawal by Subject|0|||
143166604|NCT05142306|516156594|FG001|Overall Study|Withdrawal by Subject|0|||
143166605|NCT05142306|516156595|FG002|Overall Study|Withdrawal by Subject|1|||
143166606|NCT02251041|516156596|FG000|Overall Study|Did not receive intervention|15|||
143166607|NCT02251041|516156597|FG001|Overall Study|Did not receive intervention|4|||
143166608|NCT04918771|516156598|FG000|Overall Study|Withdrawal by Subject|4|||
143166609|NCT04918771|516156599|FG001|Overall Study|Withdrawal by Subject|5|||
143166610|NCT04918771|516156598|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
143166611|NCT04918771|516156599|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
143166612|NCT05014919|516156602|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
143166613|NCT05014919|516156603|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
143166614|NCT05014919|516156604|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
143166615|NCT05014919|516156602|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
143166616|NCT05014919|516156603|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
143166617|NCT05014919|516156604|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
143166618|NCT05014919|516156602|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
143166619|NCT05014919|516156603|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
143166620|NCT05014919|516156604|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
143166621|NCT05014919|516156602|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
143166622|NCT05014919|516156603|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
143166623|NCT05014919|516156604|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
143166624|NCT05014919|516156602|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
143166625|NCT05014919|516156603|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
143166626|NCT05014919|516156604|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
143166627|NCT05014919|516156602|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
143166628|NCT05014919|516156603|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
143166629|NCT05014919|516156604|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
143166630|NCT05014919|516156602|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
143166631|NCT05014919|516156603|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
143166632|NCT05014919|516156604|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
143166633|NCT05014919|516156602|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
143166634|NCT05014919|516156603|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
143166635|NCT05014919|516156604|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
143166636|NCT02971163|516156605|FG000|Overall Study|Lost to Follow-up|4|||
143166637|NCT02971163|516156606|FG001|Overall Study|Lost to Follow-up|2|||
143166638|NCT02940223|516156615|FG000|Overall Study|Failed Requirement|2|||
143166639|NCT02940223|516156616|FG001|Overall Study|Failed Requirement|0|||
143166640|NCT05305651|516156617|FG000|Overall Study|Death|1|||
143166641|NCT05305651|516156617|FG000|Overall Study|Withdrawal by Subject|4|||
143166642|NCT05305651|516156617|FG000|Overall Study|Lost to Follow-up|4|||
143166643|NCT02871219|516156620|FG000|Overall Study|Adverse Event|15|||
143166644|NCT02871219|516156620|FG000|Overall Study|Death|3|||
143166645|NCT02871219|516156620|FG000|Overall Study|Progression|3|||
143166646|NCT02871219|516156620|FG000|Overall Study|Infections|7|||
143166647|NCT02871219|516156620|FG000|Overall Study|Infusion Related|4|||
143166648|NCT02298946|516156621|FG000|Overall Study|Did not receive treatment|2|||
143166649|NCT02298946|516156622|FG001|Overall Study|Did not receive treatment|0|||
143166650|NCT02298946|516156621|FG000|Overall Study|Unevaluable|2|||
143166651|NCT02298946|516156622|FG001|Overall Study|Unevaluable|1|||
143166652|NCT00050011|516156623|FG000|Overall Study|Adverse Event|41|||
143166653|NCT00050011|516156624|FG001|Overall Study|Adverse Event|46|||
143166654|NCT00050011|516156623|FG000|Overall Study|Abnormal laboratory value(s)|1|||
143166655|NCT00050011|516156624|FG001|Overall Study|Abnormal laboratory value(s)|1|||
143166656|NCT00050011|516156623|FG000|Overall Study|Abnormal test procedure results|0|||
143166657|NCT00050011|516156624|FG001|Overall Study|Abnormal test procedure results|1|||
143166658|NCT00050011|516156623|FG000|Overall Study|Lack of Efficacy|16|||
143166659|NCT00050011|516156624|FG001|Overall Study|Lack of Efficacy|21|||
143166660|NCT00050011|516156623|FG000|Overall Study|Participant condition no longer required|1|||
143166661|NCT00050011|516156624|FG001|Overall Study|Participant condition no longer required|0|||
143166662|NCT00050011|516156623|FG000|Overall Study|Protocol Violation|4|||
143166663|NCT00050011|516156624|FG001|Overall Study|Protocol Violation|10|||
143166664|NCT00050011|516156623|FG000|Overall Study|Withdrawal by Subject|34|||
143166665|NCT00050011|516156624|FG001|Overall Study|Withdrawal by Subject|26|||
143166666|NCT00050011|516156623|FG000|Overall Study|Lost to Follow-up|7|||
143166667|NCT00050011|516156624|FG001|Overall Study|Lost to Follow-up|9|||
143166668|NCT00050011|516156623|FG000|Overall Study|Administrative problems|10|||
143166669|NCT00050011|516156624|FG001|Overall Study|Administrative problems|6|||
143166670|NCT00050011|516156623|FG000|Overall Study|Death|7|||
143166671|NCT00050011|516156624|FG001|Overall Study|Death|4|||
143166672|NCT00050011|516156623|FG000|Overall Study|Unknown - Reason is missing|0|||
143166673|NCT00050011|516156624|FG001|Overall Study|Unknown - Reason is missing|2|||
143166674|NCT05535972|516156625|FG000|Overall Study|Withdrawal by Subject|31|||
143166675|NCT05535972|516156625|FG000|Overall Study|Lost to Follow-up|5|||
143166676|NCT05535972|516156625|FG000|Overall Study|Adverse Event|6|||
143166677|NCT05535972|516156625|FG000|Overall Study|Protocol Deviation|2|||
143166678|NCT04197583|516156628|FG000|Overall Study|Study Stent Replacement|34|||
143166679|NCT04197583|516156629|FG001|Overall Study|Study Stent Replacement|8|||
143166680|NCT04197583|516156628|FG000|Overall Study|Lost to Follow-up|14|||
143166681|NCT04197583|516156629|FG001|Overall Study|Lost to Follow-up|3|||
143166682|NCT04197583|516156628|FG000|Overall Study|Death|3|||
143166683|NCT04197583|516156629|FG001|Overall Study|Death|0|||
143166684|NCT04197583|516156628|FG000|Overall Study|Physician Decision|1|||
143166685|NCT04197583|516156629|FG001|Overall Study|Physician Decision|0|||
143166686|NCT04197583|516156628|FG000|Overall Study|Withdrawal by Subject|1|||
143166687|NCT04197583|516156629|FG001|Overall Study|Withdrawal by Subject|1|||
143166688|NCT04197583|516156628|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
143166689|NCT04197583|516156629|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
143166690|NCT04197583|516156628|FG000|Overall Study|Screen Failure|0|||
143166691|NCT04197583|516156629|FG001|Overall Study|Screen Failure|20|||
143241860|NCT04032093|516435965|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
143241861|NCT04032093|516435966|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
143241862|NCT04032093|516435967|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
143241863|NCT04032093|516435968|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
143241864|NCT04032093|516435969|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
143241865|NCT04032093|516435970|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
143166692|NCT05487378|516156630|FG000|1st Intervention (1week)|Withdrawal by Subject|2|||
143166693|NCT05487378|516156631|FG001|1st Intervention (1week)|Withdrawal by Subject|0|||
143166694|NCT05487378|516156630|FG000|2nd Intervention (1 Week)|Withdrawal by Subject|0|||
143166695|NCT05487378|516156631|FG001|2nd Intervention (1 Week)|Withdrawal by Subject|1|||
143166696|NCT01385995|516156633|FG000|Period 1, 2 Months|Physician Decision|1|||
143166697|NCT01385995|516156634|FG001|Period 1, 2 Months|Physician Decision|0|||
143241866|NCT04032093|516435971|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
143241867|NCT04032093|516435972|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
143241868|NCT04032093|516435973|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
143241869|NCT04032093|516435964|FG000|Overall Study|Other|1|||
143241870|NCT04032093|516435965|FG001|Overall Study|Other|0|||
143241871|NCT04032093|516435966|FG002|Overall Study|Other|0|||
143241872|NCT04032093|516435967|FG003|Overall Study|Other|1|||
143241873|NCT04032093|516435968|FG004|Overall Study|Other|1|||
143241874|NCT04032093|516435969|FG005|Overall Study|Other|0|||
143241875|NCT04032093|516435970|FG006|Overall Study|Other|0|||
143241876|NCT04032093|516435971|FG007|Overall Study|Other|0|||
143241877|NCT04032093|516435972|FG008|Overall Study|Other|0|||
143241878|NCT04032093|516435973|FG009|Overall Study|Other|1|||
143241879|NCT04032093|516435964|FG000|Overall Study|Withdrawal by Subject|1|||
143241880|NCT04032093|516435965|FG001|Overall Study|Withdrawal by Subject|3|||
143241881|NCT04032093|516435966|FG002|Overall Study|Withdrawal by Subject|2|||
143241882|NCT04032093|516435967|FG003|Overall Study|Withdrawal by Subject|2|||
143241883|NCT04032093|516435968|FG004|Overall Study|Withdrawal by Subject|3|||
143241884|NCT04032093|516435969|FG005|Overall Study|Withdrawal by Subject|0|||
143241885|NCT04032093|516435970|FG006|Overall Study|Withdrawal by Subject|0|||
143166698|NCT00112385|516156635|FG000|Overall Study|Lost to Follow-up|1|||
143166699|NCT00112385|516156636|FG001|Overall Study|Lost to Follow-up|0|||
143166700|NCT00112385|516156635|FG000|Overall Study|Withdrawal by Subject|0|||
143166701|NCT00112385|516156636|FG001|Overall Study|Withdrawal by Subject|1|||
143166702|NCT02613507|516156645|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
143166703|NCT02613507|516156646|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
143241886|NCT04032093|516435971|FG007|Overall Study|Withdrawal by Subject|0|||
143241887|NCT04032093|516435972|FG008|Overall Study|Withdrawal by Subject|0|||
143241888|NCT04032093|516435973|FG009|Overall Study|Withdrawal by Subject|0|||
143241889|NCT04032093|516435964|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
143241890|NCT04032093|516435965|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
143241891|NCT04032093|516435966|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
143241892|NCT04032093|516435967|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
143241893|NCT04032093|516435968|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
143241894|NCT04032093|516435969|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
143241895|NCT04032093|516435970|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
143241896|NCT04032093|516435971|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
143241897|NCT04032093|516435972|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
143241898|NCT04032093|516435973|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
143241899|NCT04032093|516435964|FG000|Overall Study|Adverse Event|0|||
143241900|NCT04032093|516435965|FG001|Overall Study|Adverse Event|0|||
143241901|NCT04032093|516435966|FG002|Overall Study|Adverse Event|0|||
143241902|NCT04032093|516435967|FG003|Overall Study|Adverse Event|0|||
143241903|NCT04032093|516435968|FG004|Overall Study|Adverse Event|0|||
143241904|NCT04032093|516435969|FG005|Overall Study|Adverse Event|0|||
143241905|NCT04032093|516435970|FG006|Overall Study|Adverse Event|0|||
143241906|NCT04032093|516435971|FG007|Overall Study|Adverse Event|0|||
143241907|NCT04032093|516435972|FG008|Overall Study|Adverse Event|0|||
143241908|NCT04032093|516435973|FG009|Overall Study|Adverse Event|1|||
143241909|NCT04032093|516435964|FG000|Overall Study|Physician Decision|0|||
143241910|NCT04032093|516435965|FG001|Overall Study|Physician Decision|0|||
143241911|NCT04032093|516435966|FG002|Overall Study|Physician Decision|0|||
143241912|NCT04032093|516435967|FG003|Overall Study|Physician Decision|0|||
143241913|NCT04032093|516435968|FG004|Overall Study|Physician Decision|0|||
143241914|NCT04032093|516435969|FG005|Overall Study|Physician Decision|1|||
143241915|NCT04032093|516435970|FG006|Overall Study|Physician Decision|0|||
143241916|NCT04032093|516435971|FG007|Overall Study|Physician Decision|0|||
143241917|NCT04032093|516435972|FG008|Overall Study|Physician Decision|0|||
143241918|NCT04032093|516435973|FG009|Overall Study|Physician Decision|0|||
143241919|NCT01654302|516435975|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
143241920|NCT01654302|516435976|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
143241921|NCT02668393|516435984|FG000|Overall Study|Progressive disease|6|||
143241922|NCT02668393|516435985|FG001|Overall Study|Progressive disease|3|||
143241923|NCT02668393|516435984|FG000|Overall Study|Adverse Event|0|||
143241924|NCT02668393|516435985|FG001|Overall Study|Adverse Event|2|||
143241925|NCT02668393|516435984|FG000|Overall Study|Withdrawal from the trial|0|||
143241926|NCT02668393|516435985|FG001|Overall Study|Withdrawal from the trial|1|||
143241927|NCT02668393|516435984|FG000|Overall Study|Lack of benefit and side effects|1|||
143241928|NCT02668393|516435985|FG001|Overall Study|Lack of benefit and side effects|0|||
143241929|NCT00606593|516435986|FG000|Overall Study|Adverse Event|0|||
143241930|NCT00606593|516435987|FG001|Overall Study|Adverse Event|0|||
143241931|NCT00606593|516435988|FG002|Overall Study|Adverse Event|0|||
143241932|NCT00606593|516435989|FG003|Overall Study|Adverse Event|1|||
143241933|NCT00606593|516435990|FG004|Overall Study|Adverse Event|1|||
143241934|NCT00606593|516435991|FG005|Overall Study|Adverse Event|0|||
143241935|NCT00606593|516435992|FG006|Overall Study|Adverse Event|1|||
143241936|NCT00606593|516435993|FG007|Overall Study|Adverse Event|2|||
143241937|NCT00606593|516435994|FG008|Overall Study|Adverse Event|1|||
143241938|NCT00606593|516435995|FG009|Overall Study|Adverse Event|0|||
143241939|NCT00606593|516435986|FG000|Overall Study|Withdrawal of consent|1|||
143241940|NCT00606593|516435987|FG001|Overall Study|Withdrawal of consent|0|||
143241941|NCT00606593|516435988|FG002|Overall Study|Withdrawal of consent|1|||
143241942|NCT00606593|516435989|FG003|Overall Study|Withdrawal of consent|0|||
143241943|NCT00606593|516435990|FG004|Overall Study|Withdrawal of consent|0|||
143044244|NCT02554890|515702858|FG001|Double-blind|Noncompliance with study treatment|5|||
143044245|NCT02554890|515702857|FG000|Open-label|Adverse Event|0|||
143044246|NCT02554890|515702858|FG001|Open-label|Adverse Event|30|||
143044247|NCT02554890|515702857|FG000|Open-label|Death|0|||
143044248|NCT02554890|515702858|FG001|Open-label|Death|1|||
143044249|NCT02554890|515702857|FG000|Open-label|Physician Decision|0|||
143044250|NCT02554890|515702858|FG001|Open-label|Physician Decision|1|||
143044251|NCT02554890|515702857|FG000|Open-label|Subject/Guardian decision|0|||
143044252|NCT02554890|515702858|FG001|Open-label|Subject/Guardian decision|11|||
143241944|NCT00606593|516435991|FG005|Overall Study|Withdrawal of consent|0|||
143241945|NCT00606593|516435992|FG006|Overall Study|Withdrawal of consent|0|||
143241946|NCT00606593|516435993|FG007|Overall Study|Withdrawal of consent|0|||
143241947|NCT00606593|516435994|FG008|Overall Study|Withdrawal of consent|0|||
143241948|NCT00606593|516435995|FG009|Overall Study|Withdrawal of consent|0|||
143241949|NCT00606593|516435986|FG000|Overall Study|Administrative/Other|0|||
143241950|NCT00606593|516435987|FG001|Overall Study|Administrative/Other|0|||
143044253|NCT02554890|515702857|FG000|Open-label|Lost to Follow-up|0|||
143241951|NCT00606593|516435988|FG002|Overall Study|Administrative/Other|1|||
143241952|NCT00606593|516435989|FG003|Overall Study|Administrative/Other|0|||
143241953|NCT00606593|516435990|FG004|Overall Study|Administrative/Other|0|||
143241954|NCT00606593|516435991|FG005|Overall Study|Administrative/Other|0|||
143241955|NCT00606593|516435992|FG006|Overall Study|Administrative/Other|0|||
143241956|NCT00606593|516435993|FG007|Overall Study|Administrative/Other|0|||
143241957|NCT00606593|516435994|FG008|Overall Study|Administrative/Other|0|||
143241958|NCT00606593|516435995|FG009|Overall Study|Administrative/Other|0|||
143241959|NCT03181529|516435996|FG000|Overall Study|Withdrawal by Subject|1|||
143241960|NCT03181529|516435997|FG001|Overall Study|Withdrawal by Subject|1|||
143241961|NCT03181529|516435996|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
143044254|NCT02554890|515702858|FG001|Open-label|Lost to Follow-up|7|||
143044255|NCT02554890|515702857|FG000|Open-label|Technical problems|0|||
143044256|NCT02554890|515702858|FG001|Open-label|Technical problems|1|||
143166704|NCT02613507|516156645|FG000|Pre-Treamtent|Participant withdrew consent|0|||
143166705|NCT02613507|516156646|FG001|Pre-Treamtent|Participant withdrew consent|4|||
143166706|NCT02613507|516156645|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
143166707|NCT02613507|516156646|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
143166708|NCT02613507|516156645|FG000|Treatment|Not reported|3|||
143166709|NCT02613507|516156646|FG001|Treatment|Not reported|0|||
143166710|NCT02613507|516156645|FG000|Treatment|Other reasons|8|||
143166711|NCT02613507|516156646|FG001|Treatment|Other reasons|0|||
143166712|NCT02613507|516156645|FG000|Treatment|Participant no longer meets criteria|3|||
143166713|NCT02613507|516156646|FG001|Treatment|Participant no longer meets criteria|0|||
143166714|NCT02613507|516156645|FG000|Treatment|Maximum clinical benefit|5|||
143166715|NCT02613507|516156646|FG001|Treatment|Maximum clinical benefit|10|||
143166716|NCT02613507|516156645|FG000|Treatment|Lost to Follow-up|1|||
143166717|NCT02613507|516156646|FG001|Treatment|Lost to Follow-up|0|||
143166718|NCT02613507|516156645|FG000|Treatment|Participant withdrew consent|0|||
143166719|NCT02613507|516156646|FG001|Treatment|Participant withdrew consent|2|||
143166720|NCT02613507|516156645|FG000|Treatment|Participant request to discontinue study treatment|13|||
143166721|NCT02613507|516156646|FG001|Treatment|Participant request to discontinue study treatment|17|||
143166722|NCT02613507|516156645|FG000|Treatment|Adverse event unrelated to study drug|20|||
143166723|NCT02613507|516156646|FG001|Treatment|Adverse event unrelated to study drug|3|||
143166724|NCT02613507|516156645|FG000|Treatment|Death|2|||
143166725|NCT02613507|516156646|FG001|Treatment|Death|0|||
143166726|NCT02613507|516156645|FG000|Treatment|Study drug toxicity|19|||
143166727|NCT02613507|516156646|FG001|Treatment|Study drug toxicity|14|||
143166728|NCT02613507|516156645|FG000|Treatment|Disease progression|263|||
143166729|NCT02613507|516156646|FG001|Treatment|Disease progression|110|||
143166730|NCT03514134|516158165|FG000|Overall Study|Lost to Follow-up|0|||
143166731|NCT03514134|516158166|FG001|Overall Study|Lost to Follow-up|1|||
143166732|NCT00003645|516158167|FG000|Overall Study|Death|4|||
143166733|NCT00003645|516158168|FG001|Overall Study|Death|1|||
143166734|NCT00003645|516158167|FG000|Overall Study|Lost to Follow-up|7|||
143166735|NCT00003645|516158168|FG001|Overall Study|Lost to Follow-up|8|||
143166736|NCT00003645|516158167|FG000|Overall Study|Withdrawal by Subject|1|||
143166737|NCT00003645|516158168|FG001|Overall Study|Withdrawal by Subject|3|||
143166738|NCT00500331|516158177|FG000|Overall Study|Adverse Event|0|||
143166739|NCT00500331|516158178|FG001|Overall Study|Adverse Event|2|||
143166740|NCT00500331|516158179|FG002|Overall Study|Adverse Event|0|||
143166741|NCT00500331|516158180|FG003|Overall Study|Adverse Event|1|||
143364280|NCT05328973|516876949|FG000|Overall Study|Withdrawal by Subject|0|||
143241962|NCT03181529|516435997|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
143241963|NCT00787644|516435998|FG000|Overall Study|Lost to Follow-up|1|||
143241964|NCT00787644|516435999|FG001|Overall Study|Lost to Follow-up|1|||
143241965|NCT00787644|516435998|FG000|Overall Study|Withdrawal by Subject|1|||
143241966|NCT00787644|516435999|FG001|Overall Study|Withdrawal by Subject|1|||
143241967|NCT00759941|516436000|FG000|Overall Study|Use of medication|1|||
143241968|NCT00759941|516436001|FG001|Overall Study|Use of medication|0|||
143241969|NCT00759941|516436000|FG000|Overall Study|Adverse Event|1|||
143241970|NCT00759941|516436001|FG001|Overall Study|Adverse Event|0|||
143241971|NCT00759941|516436000|FG000|Overall Study|Exited in error by site|1|||
143241972|NCT00759941|516436001|FG001|Overall Study|Exited in error by site|1|||
143241973|NCT05615922|516436003|FG000|Overall Study|Lost to Follow-up|1|||
143241974|NCT06083506|516436004|FG000|Overall Study|Physician Decision|2|||
143241975|NCT06083506|516436004|FG000|Overall Study|Lack of Efficacy|1|||
143241976|NCT05307692|516436006|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
143241977|NCT05307692|516436007|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
143241978|NCT05307692|516436008|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
143241979|NCT05307692|516436009|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
143241980|NCT05307692|516436006|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
143241981|NCT05307692|516436007|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
143241982|NCT05307692|516436008|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
143364281|NCT05328973|516876950|FG001|Overall Study|Withdrawal by Subject|1|||
143166742|NCT00500331|516158181|FG004|Overall Study|Adverse Event|2|||
143166743|NCT00500331|516158182|FG005|Overall Study|Adverse Event|2|||
143166744|NCT00500331|516158183|FG006|Overall Study|Adverse Event|0|||
143364282|NCT00409708|516876955|FG000|Treatment|Abnormal test procedure result(s)|1|||
143044257|NCT02554890|515702857|FG000|Open-label|Withdrawal by Subject|0|||
143166745|NCT00500331|516158177|FG000|Overall Study|Lost to Follow-up|1|||
143166746|NCT00500331|516158178|FG001|Overall Study|Lost to Follow-up|1|||
143166747|NCT00500331|516158179|FG002|Overall Study|Lost to Follow-up|1|||
143166748|NCT00500331|516158180|FG003|Overall Study|Lost to Follow-up|2|||
143166749|NCT00500331|516158181|FG004|Overall Study|Lost to Follow-up|1|||
143166750|NCT00500331|516158182|FG005|Overall Study|Lost to Follow-up|0|||
143044258|NCT02554890|515702858|FG001|Open-label|Withdrawal by Subject|1|||
143044259|NCT03649477|515702861|FG000|Overall Study|Adverse Event|2|||
143044260|NCT03649477|515702862|FG001|Overall Study|Adverse Event|0|||
143044261|NCT03649477|515702863|FG002|Overall Study|Adverse Event|0|||
143044262|NCT03114891|515702871|FG000|First Treatment Round|Lost to Follow-up|0|||
143044263|NCT03114891|515702872|FG001|First Treatment Round|Lost to Follow-up|1|||
143044264|NCT03114891|515702873|FG002|First Treatment Round|Lost to Follow-up|1|||
143044265|NCT03114891|515702874|FG003|First Treatment Round|Lost to Follow-up|0|||
143044266|NCT03114891|515702871|FG000|First Treatment Round|Withdrawal by Subject|0|||
143044267|NCT03114891|515702872|FG001|First Treatment Round|Withdrawal by Subject|2|||
143044268|NCT03114891|515702873|FG002|First Treatment Round|Withdrawal by Subject|0|||
143044269|NCT03114891|515702874|FG003|First Treatment Round|Withdrawal by Subject|1|||
143044270|NCT03114891|515702871|FG000|3 Week Break|Lost to Follow-up|1|||
143044271|NCT03114891|515702872|FG001|3 Week Break|Lost to Follow-up|0|||
143166751|NCT00500331|516158183|FG006|Overall Study|Lost to Follow-up|0|||
143166752|NCT00500331|516158177|FG000|Overall Study|Protocol Violation|3|||
143166753|NCT00500331|516158178|FG001|Overall Study|Protocol Violation|1|||
143166754|NCT00500331|516158179|FG002|Overall Study|Protocol Violation|1|||
143166755|NCT00500331|516158180|FG003|Overall Study|Protocol Violation|0|||
143166756|NCT00500331|516158181|FG004|Overall Study|Protocol Violation|1|||
143166757|NCT00500331|516158182|FG005|Overall Study|Protocol Violation|1|||
143166758|NCT00500331|516158183|FG006|Overall Study|Protocol Violation|1|||
143166759|NCT00500331|516158177|FG000|Overall Study|Withdrawal by Subject|4|||
143166760|NCT00500331|516158178|FG001|Overall Study|Withdrawal by Subject|0|||
143166761|NCT00500331|516158179|FG002|Overall Study|Withdrawal by Subject|1|||
143166762|NCT00500331|516158180|FG003|Overall Study|Withdrawal by Subject|5|||
143166763|NCT00500331|516158181|FG004|Overall Study|Withdrawal by Subject|0|||
143166764|NCT00500331|516158182|FG005|Overall Study|Withdrawal by Subject|1|||
143166765|NCT00500331|516158183|FG006|Overall Study|Withdrawal by Subject|1|||
143166766|NCT00500331|516158177|FG000|Overall Study|Lack of Efficacy|3|||
143166767|NCT00500331|516158178|FG001|Overall Study|Lack of Efficacy|1|||
143166768|NCT00500331|516158179|FG002|Overall Study|Lack of Efficacy|0|||
143166769|NCT00500331|516158180|FG003|Overall Study|Lack of Efficacy|0|||
143166770|NCT00500331|516158181|FG004|Overall Study|Lack of Efficacy|0|||
143166771|NCT00500331|516158182|FG005|Overall Study|Lack of Efficacy|0|||
143166772|NCT00500331|516158183|FG006|Overall Study|Lack of Efficacy|0|||
143166773|NCT00500331|516158177|FG000|Overall Study|Liver function test abnormality|0|||
143166774|NCT00500331|516158178|FG001|Overall Study|Liver function test abnormality|0|||
143166775|NCT00500331|516158179|FG002|Overall Study|Liver function test abnormality|1|||
143166776|NCT00500331|516158180|FG003|Overall Study|Liver function test abnormality|0|||
143166777|NCT00500331|516158181|FG004|Overall Study|Liver function test abnormality|0|||
143166778|NCT00500331|516158182|FG005|Overall Study|Liver function test abnormality|0|||
143166779|NCT00500331|516158183|FG006|Overall Study|Liver function test abnormality|0|||
143166780|NCT00500331|516158177|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
143166781|NCT00500331|516158178|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
143166782|NCT00500331|516158179|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
143166783|NCT00500331|516158180|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
143166784|NCT00500331|516158181|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
143166785|NCT00500331|516158182|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
143166786|NCT00500331|516158183|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
143166787|NCT00500331|516158177|FG000|Overall Study|Didn't return for continuation of study|1|||
143166788|NCT00500331|516158178|FG001|Overall Study|Didn't return for continuation of study|0|||
143166789|NCT00500331|516158179|FG002|Overall Study|Didn't return for continuation of study|0|||
143166790|NCT00500331|516158180|FG003|Overall Study|Didn't return for continuation of study|0|||
143166791|NCT00500331|516158181|FG004|Overall Study|Didn't return for continuation of study|0|||
143166792|NCT00500331|516158182|FG005|Overall Study|Didn't return for continuation of study|0|||
143166793|NCT00500331|516158183|FG006|Overall Study|Didn't return for continuation of study|0|||
143166794|NCT00500331|516158177|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
143166795|NCT00500331|516158178|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
143166796|NCT00500331|516158179|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
143166797|NCT00500331|516158180|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
143166798|NCT00500331|516158181|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
143166799|NCT00500331|516158182|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
143166800|NCT00500331|516158183|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
143166801|NCT00500331|516158177|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
143166802|NCT00500331|516158178|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
143166803|NCT00500331|516158179|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
143166804|NCT00500331|516158180|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
143166805|NCT00500331|516158181|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
143166806|NCT00500331|516158182|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
143241983|NCT05307692|516436009|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
143241984|NCT05307692|516436006|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
143241985|NCT05307692|516436007|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
143241986|NCT05307692|516436008|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
143241987|NCT05307692|516436009|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
143241988|NCT05307692|516436006|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
143241989|NCT05307692|516436007|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
143241990|NCT05307692|516436008|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
143241991|NCT05307692|516436009|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
143241992|NCT05307692|516436006|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
143241993|NCT05307692|516436007|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
143241994|NCT05307692|516436008|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
143241995|NCT05307692|516436009|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
143241996|NCT05307692|516436006|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
143241997|NCT05307692|516436007|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
143241998|NCT05307692|516436008|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
143241999|NCT05307692|516436009|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
143242000|NCT05307692|516436006|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
143242001|NCT05307692|516436007|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
143242002|NCT05307692|516436008|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
143242003|NCT05307692|516436009|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
143242004|NCT05307692|516436006|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
143242005|NCT05307692|516436007|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
143242006|NCT05307692|516436008|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
143242007|NCT05307692|516436009|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
143242008|NCT02991768|516436011|FG000|Overall Study|Physician Decision|4|||
143242009|NCT03529422|516436012|FG000|Overall Study|Withdrawal by Subject|1|||
143242010|NCT03529422|516436012|FG000|Overall Study|Protocol Violation|1|||
143242011|NCT03529422|516436012|FG000|Overall Study|Disease progression|2|||
143242012|NCT02000115|516436015|FG000|Overall Study|Death|56|||
143242013|NCT02000115|516436016|FG001|Overall Study|Death|45|||
143242014|NCT02000115|516436017|FG002|Overall Study|Death|0|||
143242015|NCT02000115|516436018|FG003|Overall Study|Death|0|||
143242016|NCT02000115|516436015|FG000|Overall Study|Missed Visit|6|||
143242017|NCT02000115|516436016|FG001|Overall Study|Missed Visit|8|||
143242018|NCT02000115|516436017|FG002|Overall Study|Missed Visit|1|||
143242019|NCT02000115|516436018|FG003|Overall Study|Missed Visit|0|||
143242020|NCT02000115|516436015|FG000|Overall Study|Protocol Violation|2|||
143242021|NCT02000115|516436016|FG001|Overall Study|Protocol Violation|1|||
143242022|NCT02000115|516436017|FG002|Overall Study|Protocol Violation|0|||
143242023|NCT02000115|516436018|FG003|Overall Study|Protocol Violation|0|||
143242024|NCT02000115|516436015|FG000|Overall Study|Physician Decision|2|||
143242025|NCT02000115|516436016|FG001|Overall Study|Physician Decision|0|||
143242026|NCT02000115|516436017|FG002|Overall Study|Physician Decision|0|||
143242027|NCT02000115|516436018|FG003|Overall Study|Physician Decision|0|||
143242028|NCT02000115|516436015|FG000|Overall Study|Withdrawal by Subject|11|||
143242029|NCT02000115|516436016|FG001|Overall Study|Withdrawal by Subject|11|||
143242030|NCT02000115|516436017|FG002|Overall Study|Withdrawal by Subject|0|||
143242031|NCT02000115|516436018|FG003|Overall Study|Withdrawal by Subject|0|||
143242032|NCT02000115|516436015|FG000|Overall Study|Lost to Follow-up|0|||
143242033|NCT02000115|516436016|FG001|Overall Study|Lost to Follow-up|1|||
143242034|NCT02000115|516436017|FG002|Overall Study|Lost to Follow-up|0|||
143242035|NCT02000115|516436018|FG003|Overall Study|Lost to Follow-up|0|||
143242036|NCT02000115|516436015|FG000|Overall Study|Non-compliance|2|||
143242037|NCT02000115|516436016|FG001|Overall Study|Non-compliance|1|||
143242038|NCT02000115|516436017|FG002|Overall Study|Non-compliance|0|||
143242039|NCT02000115|516436018|FG003|Overall Study|Non-compliance|0|||
143242040|NCT02000115|516436015|FG000|Overall Study|Withdrawn on day of randomization|0|||
143242041|NCT02000115|516436016|FG001|Overall Study|Withdrawn on day of randomization|1|||
143364283|NCT00409708|516876956|FG001|Treatment|Abnormal test procedure result(s)|0|||
143364284|NCT00409708|516876955|FG000|Treatment|Lack of Efficacy|0|||
143364285|NCT00409708|516876956|FG001|Treatment|Lack of Efficacy|1|||
143242042|NCT02000115|516436017|FG002|Overall Study|Withdrawn on day of randomization|0|||
143242043|NCT02000115|516436018|FG003|Overall Study|Withdrawn on day of randomization|0|||
143242044|NCT02000115|516436015|FG000|Overall Study|Still on Study|0|||
143242045|NCT02000115|516436016|FG001|Overall Study|Still on Study|0|||
143242046|NCT02000115|516436017|FG002|Overall Study|Still on Study|0|||
143242047|NCT02000115|516436018|FG003|Overall Study|Still on Study|53|||
143242048|NCT05006573|516436021|FG000|Double-blind Treatment Period|Physician Decision|2|||
143242049|NCT05006573|516436022|FG001|Double-blind Treatment Period|Physician Decision|0|||
143242050|NCT05006573|516436021|FG000|Double-blind Treatment Period|Study terminated by sponsor|1|||
143364286|NCT00409708|516876955|FG000|Treatment|Protocol Violation|6|||
143242051|NCT05006573|516436022|FG001|Double-blind Treatment Period|Study terminated by sponsor|0|||
143242052|NCT05006573|516436021|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
143242053|NCT05006573|516436022|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
143242054|NCT05006573|516436021|FG000|Double-blind Treatment Period|Protocol Violation|2|||
143242055|NCT05006573|516436022|FG001|Double-blind Treatment Period|Protocol Violation|0|||
143242056|NCT05006573|516436021|FG000|Double-blind Treatment Period|Subject decision without consent withdrawn|0|||
143242057|NCT05006573|516436022|FG001|Double-blind Treatment Period|Subject decision without consent withdrawn|1|||
143242058|NCT05006573|516436021|FG000|Open-label Extension Period|Subject decision without consent withdrawn|0|||
143242059|NCT05006573|516436022|FG001|Open-label Extension Period|Subject decision without consent withdrawn|1|||
143242060|NCT04500158|516436023|FG000|Overall Study|Physician Decision|17|||
143242061|NCT04500158|516436024|FG001|Overall Study|Physician Decision|11|||
143242062|NCT03493464|516436027|FG000|Overall Study|Surgery not performed|1|||
143242063|NCT03219528|516437799|FG000|Overall Study|Lost to Follow-up|5|||
143242064|NCT03219528|516437800|FG001|Overall Study|Lost to Follow-up|4|||
143242065|NCT03219528|516437799|FG000|Overall Study|Withdrawal by Subject|4|||
143242066|NCT03219528|516437800|FG001|Overall Study|Withdrawal by Subject|4|||
143242067|NCT00241839|516437801|FG000|Overall Study|Withdrawal by Subject|18|||
143242068|NCT00241839|516437802|FG001|Overall Study|Withdrawal by Subject|17|||
143242069|NCT00241839|516437801|FG000|Overall Study|Adverse Event|1|||
143242070|NCT00241839|516437802|FG001|Overall Study|Adverse Event|1|||
143242071|NCT04639258|516437805|FG000|Overall Study|Screen failure|5|||
143242072|NCT04639258|516437805|FG000|Overall Study|Physician Decision|2|||
143242073|NCT04639258|516437805|FG000|Overall Study|Early study termination|3|||
143242074|NCT04639258|516437805|FG000|Overall Study|Withdrawal by Subject|1|||
143242075|NCT01635153|516437806|FG000|Overall Study|Lost to Follow-up|40|||
143242076|NCT01635153|516437807|FG001|Overall Study|Lost to Follow-up|43|||
143242077|NCT02560558|516437808|FG000|Overall Study|Adverse Event|1|||
143242078|NCT02560558|516437809|FG001|Overall Study|Adverse Event|0|||
143242079|NCT02560558|516437808|FG000|Overall Study|Death|0|||
143242080|NCT02560558|516437809|FG001|Overall Study|Death|2|||
143242081|NCT02560558|516437808|FG000|Overall Study|Lost to Follow-up|0|||
143242082|NCT02560558|516437809|FG001|Overall Study|Lost to Follow-up|4|||
143242083|NCT02560558|516437808|FG000|Overall Study|Protocol Violation|3|||
143242084|NCT02560558|516437809|FG001|Overall Study|Protocol Violation|0|||
143242085|NCT02560558|516437808|FG000|Overall Study|Withdrawal by Subject|3|||
143242086|NCT02560558|516437809|FG001|Overall Study|Withdrawal by Subject|0|||
143242087|NCT00297258|516437820|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
143242088|NCT00297258|516437820|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
143242089|NCT00297258|516437820|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
143242090|NCT00297258|516437820|FG000|Overall Study|Intercurrent Illness|3|||
143242091|NCT00297258|516437820|FG000|Overall Study|Intercurrent Death|2|||
143242092|NCT00297258|516437820|FG000|Overall Study|Deteriorization of General Condition|1|||
143242093|NCT00297258|516437820|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
143242094|NCT00297258|516437820|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
143242095|NCT00297258|516437820|FG000|Overall Study|Switch to Commercial Treatment|1|||
143242096|NCT00297258|516437820|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
143242097|NCT01263197|516437822|FG000|First Intervention (Period 1)|Adverse Event|0|||
143166807|NCT00500331|516158183|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
143166808|NCT00500331|516158177|FG000|Overall Study|Participant was randomized by mistake|1|||
143166809|NCT00500331|516158178|FG001|Overall Study|Participant was randomized by mistake|0|||
143166810|NCT00500331|516158179|FG002|Overall Study|Participant was randomized by mistake|0|||
143166811|NCT00500331|516158180|FG003|Overall Study|Participant was randomized by mistake|0|||
143166812|NCT00500331|516158181|FG004|Overall Study|Participant was randomized by mistake|0|||
143166813|NCT00500331|516158182|FG005|Overall Study|Participant was randomized by mistake|0|||
143166814|NCT00500331|516158183|FG006|Overall Study|Participant was randomized by mistake|0|||
143166815|NCT00500331|516158177|FG000|Overall Study|Diabetologist nurse in the study|0|||
143166816|NCT00500331|516158178|FG001|Overall Study|Diabetologist nurse in the study|0|||
143166817|NCT00500331|516158179|FG002|Overall Study|Diabetologist nurse in the study|1|||
143166818|NCT00500331|516158180|FG003|Overall Study|Diabetologist nurse in the study|0|||
143166819|NCT00500331|516158181|FG004|Overall Study|Diabetologist nurse in the study|0|||
143166820|NCT00500331|516158182|FG005|Overall Study|Diabetologist nurse in the study|0|||
143166821|NCT00500331|516158183|FG006|Overall Study|Diabetologist nurse in the study|0|||
143166822|NCT00500331|516158177|FG000|Overall Study|State ban of biological samples export|0|||
143242098|NCT01263197|516437823|FG001|First Intervention (Period 1)|Adverse Event|0|||
143242099|NCT01263197|516437824|FG002|First Intervention (Period 1)|Adverse Event|0|||
143242100|NCT01263197|516437825|FG003|First Intervention (Period 1)|Adverse Event|0|||
143242101|NCT01263197|516437826|FG004|First Intervention (Period 1)|Adverse Event|0|||
143242102|NCT01263197|516437827|FG005|First Intervention (Period 1)|Adverse Event|1|||
143242103|NCT01263197|516437822|FG000|Washout Period 1|Protocol Violation|0|||
143242104|NCT01263197|516437823|FG001|Washout Period 1|Protocol Violation|0|||
143242105|NCT01263197|516437824|FG002|Washout Period 1|Protocol Violation|0|||
143242106|NCT01263197|516437825|FG003|Washout Period 1|Protocol Violation|0|||
143242107|NCT01263197|516437826|FG004|Washout Period 1|Protocol Violation|1|||
143242108|NCT01263197|516437827|FG005|Washout Period 1|Protocol Violation|0|||
143242109|NCT01263197|516437822|FG000|Washout Period 2|Physician Decision|0|||
143242110|NCT01263197|516437823|FG001|Washout Period 2|Physician Decision|0|||
143242111|NCT01263197|516437824|FG002|Washout Period 2|Physician Decision|0|||
143242112|NCT01263197|516437825|FG003|Washout Period 2|Physician Decision|0|||
143242113|NCT01263197|516437826|FG004|Washout Period 2|Physician Decision|0|||
143242114|NCT01263197|516437827|FG005|Washout Period 2|Physician Decision|1|||
143242115|NCT01263197|516437822|FG000|Washout Period 2|Protocol Violation|0|||
143242116|NCT01263197|516437823|FG001|Washout Period 2|Protocol Violation|0|||
143242117|NCT01263197|516437824|FG002|Washout Period 2|Protocol Violation|0|||
143242118|NCT01263197|516437825|FG003|Washout Period 2|Protocol Violation|1|||
143242119|NCT01263197|516437826|FG004|Washout Period 2|Protocol Violation|0|||
143242120|NCT01263197|516437827|FG005|Washout Period 2|Protocol Violation|0|||
143242121|NCT01263197|516437822|FG000|Third Intervention (Period 3)|Adverse Event|0|||
143242122|NCT01263197|516437823|FG001|Third Intervention (Period 3)|Adverse Event|1|||
143242123|NCT01263197|516437824|FG002|Third Intervention (Period 3)|Adverse Event|0|||
143242124|NCT01263197|516437825|FG003|Third Intervention (Period 3)|Adverse Event|0|||
143242125|NCT01263197|516437826|FG004|Third Intervention (Period 3)|Adverse Event|0|||
143242126|NCT01263197|516437827|FG005|Third Intervention (Period 3)|Adverse Event|0|||
143242127|NCT01470326|516437828|FG000|Overall Study|Protocol Violation|32|||
143242128|NCT01470326|516437828|FG000|Overall Study|No Drug Administration Information|2|||
143242129|NCT01470326|516437828|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
143242130|NCT01967576|516437829|FG000|Overall Study|Withdrawal by Subject|3|||
143242131|NCT01967576|516437829|FG000|Overall Study|Progressed/Removed from treatment|1|||
143242132|NCT01967576|516437829|FG000|Overall Study|Study closing at site|1|||
143242133|NCT01967576|516437829|FG000|Overall Study|Adverse Event|1|||
143242134|NCT01967576|516437829|FG000|Overall Study|Refused further treatment|1|||
143242135|NCT03388164|516437832|FG000|Overall Study|Withdrawal by Subject|3|||
143242136|NCT03388164|516437833|FG001|Overall Study|Withdrawal by Subject|1|||
143242137|NCT03967444|516437834|FG000|Overall Study|Lost to Follow-up|1|||
143242138|NCT03967444|516437835|FG001|Overall Study|Lost to Follow-up|2|||
143242139|NCT00345358|516437841|FG000|Primary Vaccination Phase|Other|0|||
143242140|NCT00345358|516437842|FG001|Primary Vaccination Phase|Other|1|||
143242141|NCT00345358|516437843|FG002|Primary Vaccination Phase|Other|1|||
143242142|NCT00345358|516437844|FG003|Primary Vaccination Phase|Other|0|||
143242143|NCT00345358|516437841|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
143242144|NCT00345358|516437842|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
143242145|NCT00345358|516437843|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
143242146|NCT00345358|516437844|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
143242147|NCT00345358|516437841|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
143242148|NCT00345358|516437842|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
143242149|NCT00345358|516437843|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
143242150|NCT00345358|516437844|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
143242151|NCT00345358|516437841|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
143242152|NCT00345358|516437842|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
143242153|NCT00345358|516437843|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
143242154|NCT00345358|516437844|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
143242155|NCT00345358|516437841|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
143242156|NCT00345358|516437842|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
143242157|NCT00345358|516437843|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
143242158|NCT00345358|516437844|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
143242159|NCT00345358|516437841|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
143242160|NCT00345358|516437842|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
143242161|NCT00345358|516437843|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
143242162|NCT00345358|516437844|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
143242163|NCT00346697|516437845|FG000|Overall Study|Lost to Follow-up|0|||
143242164|NCT00346697|516437846|FG001|Overall Study|Lost to Follow-up|1|||
143242165|NCT00686686|516437847|FG000|Overall Study|Non-compliance|1|||
143242166|NCT00686686|516437847|FG000|Overall Study|Adverse Event|2|||
143242167|NCT00686686|516437847|FG000|Overall Study|Lost to Follow-up|3|||
143242168|NCT00477386|516437856|FG000|Overall Study|Adverse Event|4|||
143242169|NCT00477386|516437857|FG001|Overall Study|Adverse Event|8|||
143242170|NCT00477386|516437856|FG000|Overall Study|Disease progression, relapse|3|||
143242171|NCT00477386|516437857|FG001|Overall Study|Disease progression, relapse|4|||
143242172|NCT00477386|516437856|FG000|Overall Study|Disease progression, refractory|1|||
143242173|NCT00477386|516437857|FG001|Overall Study|Disease progression, refractory|3|||
143242174|NCT00477386|516437856|FG000|Overall Study|Other|1|||
143242175|NCT00477386|516437857|FG001|Overall Study|Other|2|||
143242176|NCT00477386|516437856|FG000|Overall Study|Physician Decision|1|||
143242177|NCT00477386|516437857|FG001|Overall Study|Physician Decision|0|||
143242178|NCT00477386|516437856|FG000|Overall Study|Withdrawal by Subject|1|||
143242179|NCT00477386|516437857|FG001|Overall Study|Withdrawal by Subject|0|||
143242180|NCT01254422|516437858|FG000|Overall Study|Protocol Violation|1|||
143242181|NCT01254422|516437859|FG001|Overall Study|Protocol Violation|0|||
143242182|NCT01254422|516437858|FG000|Overall Study|Adverse Event|1|||
143242183|NCT01254422|516437859|FG001|Overall Study|Adverse Event|0|||
143242184|NCT01254422|516437858|FG000|Overall Study|Serious adverse event|0|||
143242185|NCT01254422|516437859|FG001|Overall Study|Serious adverse event|1|||
143242186|NCT01254422|516437858|FG000|Overall Study|Lost to Follow-up|1|||
143242187|NCT01254422|516437859|FG001|Overall Study|Lost to Follow-up|0|||
143242188|NCT02207088|516437860|FG000|Overall Study|Adverse Event|2|||
143242189|NCT00643162|516437861|FG000|Overall Study|Withdrawal by Subject|1|||
143242190|NCT00643162|516437862|FG001|Overall Study|Withdrawal by Subject|1|||
143242191|NCT00318643|516437865|FG000|Overall Study|Adverse Event|0|||
143242192|NCT00318643|516437866|FG001|Overall Study|Adverse Event|0|||
143242193|NCT00318643|516437867|FG002|Overall Study|Adverse Event|0|||
143242194|NCT00318643|516437868|FG003|Overall Study|Adverse Event|0|||
143242195|NCT00318643|516437869|FG004|Overall Study|Adverse Event|1|||
143242196|NCT00318643|516437865|FG000|Overall Study|Participant's Decision|0|||
143242197|NCT00318643|516437866|FG001|Overall Study|Participant's Decision|0|||
143242198|NCT00318643|516437867|FG002|Overall Study|Participant's Decision|0|||
143242199|NCT00318643|516437868|FG003|Overall Study|Participant's Decision|0|||
143242200|NCT00318643|516437869|FG004|Overall Study|Participant's Decision|1|||
143242201|NCT00318643|516437865|FG000|Overall Study|Investigator's Decision|0|||
143242202|NCT00318643|516437866|FG001|Overall Study|Investigator's Decision|0|||
143242203|NCT00318643|516437867|FG002|Overall Study|Investigator's Decision|0|||
143242204|NCT00318643|516437868|FG003|Overall Study|Investigator's Decision|0|||
143242205|NCT00318643|516437869|FG004|Overall Study|Investigator's Decision|1|||
143242206|NCT02691507|516437870|FG000|Overall Study|Missed Visit 3|0|||
143242207|NCT02691507|516437871|FG001|Overall Study|Missed Visit 3|1|||
143242208|NCT01812252|516437872|FG000|Overall Study|Persistent Disease|1|||
143242209|NCT01812252|516437873|FG001|Overall Study|Persistent Disease|0|||
143242210|NCT01812252|516437872|FG000|Overall Study|Not transplanted|11|||
143242211|NCT01812252|516437873|FG001|Overall Study|Not transplanted|11|||
143242212|NCT01812252|516437872|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
143242213|NCT01812252|516437873|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
143242214|NCT01812252|516437872|FG000|Overall Study|Withdrawal by Subject|1|||
143242215|NCT01812252|516437873|FG001|Overall Study|Withdrawal by Subject|1|||
143242216|NCT01812252|516437872|FG000|Overall Study|Screen Failure|1|||
143242217|NCT01812252|516437873|FG001|Overall Study|Screen Failure|0|||
143242218|NCT03023397|516437874|FG000|Run-In|Failed screening allergen challenge|1|||
143242219|NCT03023397|516437875|FG001|Run-In|Failed screening allergen challenge|0|||
143242220|NCT03023397|516437876|FG002|Run-In|Failed screening allergen challenge|0|||
143242221|NCT03023397|516437874|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
143242222|NCT03023397|516437875|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
143242223|NCT03023397|516437876|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
143242224|NCT01519921|516437880|FG000|Overall Study|Adverse Event|10|||
143242225|NCT01519921|516437881|FG001|Overall Study|Adverse Event|9|||
143242226|NCT01519921|516437880|FG000|Overall Study|Lack of Efficacy|4|||
143242227|NCT01519921|516437881|FG001|Overall Study|Lack of Efficacy|3|||
143242228|NCT01519921|516437880|FG000|Overall Study|Withdrawal by Subject|3|||
143242229|NCT01519921|516437881|FG001|Overall Study|Withdrawal by Subject|0|||
143242230|NCT01519921|516437880|FG000|Overall Study|Lost to Follow-up|2|||
143242231|NCT01519921|516437881|FG001|Overall Study|Lost to Follow-up|1|||
143242232|NCT01519921|516437880|FG000|Overall Study|Treatment refusal|2|||
143242233|NCT01519921|516437881|FG001|Overall Study|Treatment refusal|1|||
143242234|NCT01519921|516437880|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
143242235|NCT01519921|516437881|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
143242236|NCT02952820|516437886|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
143242237|NCT02952820|516437887|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
143242238|NCT02952820|516437888|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
143242239|NCT02952820|516437886|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
143242240|NCT02952820|516437887|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
143242241|NCT02952820|516437888|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
143242242|NCT02952820|516437886|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
143242243|NCT02952820|516437887|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
143242244|NCT02952820|516437888|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
143242245|NCT02952820|516437886|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
143242246|NCT02952820|516437887|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
143242247|NCT02952820|516437888|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
143242248|NCT02952820|516437886|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
143242249|NCT02952820|516437887|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
143242250|NCT02952820|516437888|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
143166823|NCT00500331|516158178|FG001|Overall Study|State ban of biological samples export|0|||
143166824|NCT00500331|516158179|FG002|Overall Study|State ban of biological samples export|0|||
143166825|NCT00500331|516158180|FG003|Overall Study|State ban of biological samples export|1|||
143166826|NCT00500331|516158181|FG004|Overall Study|State ban of biological samples export|0|||
143166827|NCT00500331|516158182|FG005|Overall Study|State ban of biological samples export|0|||
143166828|NCT00500331|516158183|FG006|Overall Study|State ban of biological samples export|0|||
143166829|NCT00500331|516158177|FG000|Overall Study|Protocol violated|0|||
143166830|NCT00500331|516158178|FG001|Overall Study|Protocol violated|0|||
143166831|NCT00500331|516158179|FG002|Overall Study|Protocol violated|0|||
143166832|NCT00500331|516158180|FG003|Overall Study|Protocol violated|1|||
143166833|NCT00500331|516158181|FG004|Overall Study|Protocol violated|0|||
143166834|NCT00500331|516158182|FG005|Overall Study|Protocol violated|0|||
143166835|NCT00500331|516158183|FG006|Overall Study|Protocol violated|0|||
143166836|NCT03345550|516158184|FG000|Overall Study|Withdrawal by Subject|1|||
143166837|NCT03345550|516158185|FG001|Overall Study|Withdrawal by Subject|0|||
143166838|NCT03345550|516158184|FG000|Overall Study|Lost to Follow-up|4|||
143166839|NCT03345550|516158185|FG001|Overall Study|Lost to Follow-up|5|||
143166840|NCT03033784|516158189|FG000|Overall Study|Anxiety related to MRI scanner|0|||
143166841|NCT03033784|516158190|FG001|Overall Study|Anxiety related to MRI scanner|1|||
143166842|NCT03033784|516158191|FG002|Overall Study|Anxiety related to MRI scanner|0|||
143166843|NCT03033784|516158192|FG003|Overall Study|Anxiety related to MRI scanner|0|||
143166844|NCT03033784|516158193|FG004|Overall Study|Anxiety related to MRI scanner|0|||
143166845|NCT03033784|516158194|FG005|Overall Study|Anxiety related to MRI scanner|0|||
143166846|NCT03033784|516158195|FG006|Overall Study|Anxiety related to MRI scanner|0|||
143166847|NCT03033784|516158196|FG007|Overall Study|Anxiety related to MRI scanner|0|||
143166848|NCT03033784|516158197|FG008|Overall Study|Anxiety related to MRI scanner|0|||
143166849|NCT03033784|516158198|FG009|Overall Study|Anxiety related to MRI scanner|0|||
143166850|NCT03033784|516158199|FG010|Overall Study|Anxiety related to MRI scanner|0|||
143166851|NCT03033784|516158200|FG011|Overall Study|Anxiety related to MRI scanner|0|||
143166852|NCT03033784|516158201|FG012|Overall Study|Anxiety related to MRI scanner|0|||
143166853|NCT03033784|516158189|FG000|Overall Study|Withdrawal by Subject|0|||
143166854|NCT03033784|516158190|FG001|Overall Study|Withdrawal by Subject|0|||
143166855|NCT03033784|516158191|FG002|Overall Study|Withdrawal by Subject|0|||
143166856|NCT03033784|516158192|FG003|Overall Study|Withdrawal by Subject|0|||
143166857|NCT03033784|516158193|FG004|Overall Study|Withdrawal by Subject|0|||
143166858|NCT03033784|516158194|FG005|Overall Study|Withdrawal by Subject|0|||
143166859|NCT03033784|516158195|FG006|Overall Study|Withdrawal by Subject|0|||
143166860|NCT03033784|516158196|FG007|Overall Study|Withdrawal by Subject|0|||
143166861|NCT03033784|516158197|FG008|Overall Study|Withdrawal by Subject|0|||
143166862|NCT03033784|516158198|FG009|Overall Study|Withdrawal by Subject|0|||
143166863|NCT03033784|516158199|FG010|Overall Study|Withdrawal by Subject|0|||
143166864|NCT03033784|516158200|FG011|Overall Study|Withdrawal by Subject|0|||
143166865|NCT03033784|516158201|FG012|Overall Study|Withdrawal by Subject|2|||
143166866|NCT03332056|516158202|FG000|Overall Study|Incomplete questionnaires|8|||
143166867|NCT03332056|516158203|FG001|Overall Study|Incomplete questionnaires|9|||
143166868|NCT03332056|516158202|FG000|Overall Study|Passed stone prior to surgery date|1|||
143166869|NCT03332056|516158203|FG001|Overall Study|Passed stone prior to surgery date|0|||
143166870|NCT03332056|516158202|FG000|Overall Study|Did not require a ureteral stent|0|||
143166871|NCT03332056|516158203|FG001|Overall Study|Did not require a ureteral stent|1|||
143166872|NCT02374255|516158204|FG000|Overall Study|Withdrawal by Subject|2|||
143166873|NCT02374255|516158205|FG001|Overall Study|Withdrawal by Subject|0|||
143166874|NCT02374255|516158206|FG002|Overall Study|Withdrawal by Subject|0|||
143166875|NCT02374255|516158207|FG003|Overall Study|Withdrawal by Subject|0|||
143166876|NCT02093520|516158208|FG000|Overall Study|Not treated|6|||
143166877|NCT02093520|516158209|FG001|Overall Study|Not treated|22|||
143166878|NCT03014089|516158210|FG000|Overall Study|Withdrawal by Subject|0|||
143166879|NCT03014089|516158211|FG001|Overall Study|Withdrawal by Subject|1|||
143166880|NCT03014089|516158212|FG002|Overall Study|Withdrawal by Subject|1|||
143166881|NCT03014089|516158213|FG003|Overall Study|Withdrawal by Subject|1|||
143166882|NCT03014089|516158210|FG000|Overall Study|Lost to Follow-up|1|||
143166883|NCT03014089|516158211|FG001|Overall Study|Lost to Follow-up|0|||
143166884|NCT03014089|516158212|FG002|Overall Study|Lost to Follow-up|0|||
143166885|NCT03014089|516158213|FG003|Overall Study|Lost to Follow-up|0|||
143166886|NCT03014089|516158210|FG000|Overall Study|Adverse Event|1|||
143166887|NCT03014089|516158211|FG001|Overall Study|Adverse Event|0|||
143166888|NCT03014089|516158212|FG002|Overall Study|Adverse Event|1|||
143166889|NCT03014089|516158213|FG003|Overall Study|Adverse Event|0|||
143166890|NCT00851084|516158214|FG000|Overall Study|Randomized but not treated|1|||
143166891|NCT00851084|516158215|FG001|Overall Study|Randomized but not treated|0|||
143166892|NCT00851084|516158214|FG000|Overall Study|Adverse Event|26|||
143166893|NCT00851084|516158215|FG001|Overall Study|Adverse Event|36|||
143166894|NCT00851084|516158214|FG000|Overall Study|Disease progression|52|||
143166895|NCT00851084|516158215|FG001|Overall Study|Disease progression|47|||
143166896|NCT00851084|516158214|FG000|Overall Study|Poor compliance to protocol|1|||
143166897|NCT00851084|516158215|FG001|Overall Study|Poor compliance to protocol|1|||
143242251|NCT02952820|516437886|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
143242252|NCT02952820|516437887|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
143242253|NCT02952820|516437888|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
143242254|NCT02952820|516437886|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
143242255|NCT02952820|516437887|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
143242256|NCT02952820|516437888|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
143364287|NCT00409708|516876956|FG001|Treatment|Protocol Violation|2|||
143364288|NCT00409708|516876955|FG000|Treatment|Withdrawal by Subject|3|||
143242257|NCT02952820|516437886|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
143242258|NCT02952820|516437887|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
143242259|NCT02952820|516437888|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
143242260|NCT02952820|516437886|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
143242261|NCT02952820|516437887|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
143242262|NCT02952820|516437888|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
143242263|NCT02952820|516437886|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
143242264|NCT02952820|516437887|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
143242265|NCT02952820|516437888|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
143242266|NCT02952820|516437886|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
143242267|NCT02952820|516437887|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
143242268|NCT02952820|516437888|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
143242269|NCT02952820|516437886|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
143242270|NCT02952820|516437887|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
143242271|NCT02952820|516437888|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
143242272|NCT02952820|516437886|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
143242273|NCT02952820|516437887|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
143242274|NCT02952820|516437888|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
143242275|NCT02952820|516437886|FG000|Active Treatment Period (6 Months)|Not treated|0|||
143242276|NCT02952820|516437887|FG001|Active Treatment Period (6 Months)|Not treated|0|||
143242277|NCT02952820|516437888|FG002|Active Treatment Period (6 Months)|Not treated|1|||
143242278|NCT04139018|516437889|FG000|Overall Study|Screen fail|1|||
143166898|NCT00851084|516158214|FG000|Overall Study|Physician Decision|13|||
143166899|NCT00851084|516158215|FG001|Overall Study|Physician Decision|14|||
143166900|NCT00851084|516158214|FG000|Overall Study|Consent withdrawn|0|||
143166901|NCT00851084|516158215|FG001|Overall Study|Consent withdrawn|2|||
143166902|NCT00851084|516158214|FG000|Overall Study|Withdrawal by Subject|11|||
143166903|NCT00851084|516158215|FG001|Overall Study|Withdrawal by Subject|12|||
143166904|NCT00851084|516158214|FG000|Overall Study|Metastatic surgery|6|||
143166905|NCT00851084|516158215|FG001|Overall Study|Metastatic surgery|6|||
143166906|NCT00851084|516158214|FG000|Overall Study|Other|7|||
143166907|NCT00851084|516158215|FG001|Overall Study|Other|1|||
143166908|NCT00321932|516158216|FG000|Overall Study|Death|3|||
143166909|NCT00321932|516158217|FG001|Overall Study|Death|6|||
143166910|NCT00321932|516158216|FG000|Overall Study|Withdrawal by Subject|3|||
143166911|NCT00321932|516158217|FG001|Overall Study|Withdrawal by Subject|6|||
143166912|NCT00321932|516158216|FG000|Overall Study|Early relapse|2|||
143166913|NCT00321932|516158217|FG001|Overall Study|Early relapse|8|||
143166914|NCT00321932|516158216|FG000|Overall Study|Missing data|2|||
143166915|NCT00321932|516158217|FG001|Overall Study|Missing data|1|||
143166916|NCT00734032|516158218|FG000|Overall Study|Adverse Event|0|||
143166917|NCT00734032|516158219|FG001|Overall Study|Adverse Event|1|||
143166918|NCT00734032|516158220|FG002|Overall Study|Adverse Event|0|||
143166919|NCT00734032|516158221|FG003|Overall Study|Adverse Event|0|||
143166920|NCT00959049|516158226|FG000|Overall Study|Adverse Event|1|||
143166921|NCT00959049|516158227|FG001|Overall Study|Adverse Event|0|||
143166922|NCT00959049|516158228|FG002|Overall Study|Adverse Event|0|||
143166923|NCT00959049|516158229|FG003|Overall Study|Adverse Event|0|||
143242279|NCT04139018|516437890|FG001|Overall Study|Screen fail|0|||
143242280|NCT04139018|516437889|FG000|Overall Study|Withdrawal by Subject|2|||
143242281|NCT04139018|516437890|FG001|Overall Study|Withdrawal by Subject|0|||
143242282|NCT04139018|516437889|FG000|Overall Study|Lost to Follow-up|0|||
143242283|NCT04139018|516437890|FG001|Overall Study|Lost to Follow-up|1|||
143242284|NCT03614156|516437907|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
143242285|NCT03614156|516437908|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
143242286|NCT03614156|516437909|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
143242287|NCT03614156|516437910|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
143166924|NCT00959049|516158230|FG004|Overall Study|Adverse Event|0|||
143242288|NCT03614156|516437907|FG000|Open-Label Treatment Period|Adverse Event|7|||
143166925|NCT00959049|516158231|FG005|Overall Study|Adverse Event|0|||
143166926|NCT00959049|516158226|FG000|Overall Study|Lost to Follow-up|17|||
143166927|NCT00959049|516158227|FG001|Overall Study|Lost to Follow-up|5|||
143166928|NCT00959049|516158228|FG002|Overall Study|Lost to Follow-up|1|||
143166929|NCT00959049|516158229|FG003|Overall Study|Lost to Follow-up|10|||
143166930|NCT00959049|516158230|FG004|Overall Study|Lost to Follow-up|9|||
143242289|NCT03614156|516437908|FG001|Open-Label Treatment Period|Adverse Event|0|||
143242290|NCT03614156|516437909|FG002|Open-Label Treatment Period|Adverse Event|0|||
143242291|NCT03614156|516437910|FG003|Open-Label Treatment Period|Adverse Event|0|||
143242292|NCT03614156|516437907|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
143242293|NCT03614156|516437908|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
143242294|NCT03614156|516437909|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
143242295|NCT03614156|516437910|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
143242296|NCT03614156|516437907|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
143242297|NCT03614156|516437908|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
143242298|NCT03614156|516437909|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
143242299|NCT03614156|516437910|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
143242300|NCT03614156|516437907|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
143242301|NCT03614156|516437908|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
143242302|NCT03614156|516437909|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
143242303|NCT03614156|516437910|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
143242304|NCT03614156|516437907|FG000|Open-Label Treatment Period|Protocol Violation|2|||
143242305|NCT03614156|516437908|FG001|Open-Label Treatment Period|Protocol Violation|0|||
143242306|NCT03614156|516437909|FG002|Open-Label Treatment Period|Protocol Violation|0|||
143242307|NCT03614156|516437910|FG003|Open-Label Treatment Period|Protocol Violation|0|||
143242308|NCT03614156|516437907|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
143242309|NCT03614156|516437908|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
143242310|NCT03614156|516437909|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
143242311|NCT03614156|516437910|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
143242312|NCT03614156|516437907|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
143242313|NCT03614156|516437908|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
143242314|NCT03614156|516437909|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
143242315|NCT03614156|516437910|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
143242316|NCT03614156|516437907|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
143242317|NCT03614156|516437908|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
143242318|NCT03614156|516437909|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
143242319|NCT03614156|516437910|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
143242320|NCT03614156|516437907|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
143242321|NCT03614156|516437908|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
143242322|NCT03614156|516437909|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
143242323|NCT03614156|516437910|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
143242324|NCT03614156|516437907|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
143242325|NCT03614156|516437908|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
143242326|NCT03614156|516437909|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
143242327|NCT03614156|516437910|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
143242328|NCT03614156|516437907|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
143044272|NCT03114891|515702873|FG002|3 Week Break|Lost to Follow-up|0|||
143044273|NCT03114891|515702874|FG003|3 Week Break|Lost to Follow-up|1|||
143242329|NCT03614156|516437908|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
143166931|NCT00959049|516158231|FG005|Overall Study|Lost to Follow-up|1|||
143166932|NCT00959049|516158226|FG000|Overall Study|Contraindicated medication|0|||
143166933|NCT00959049|516158227|FG001|Overall Study|Contraindicated medication|0|||
143166934|NCT00959049|516158228|FG002|Overall Study|Contraindicated medication|0|||
143166935|NCT00959049|516158229|FG003|Overall Study|Contraindicated medication|1|||
143166936|NCT00959049|516158230|FG004|Overall Study|Contraindicated medication|0|||
143166937|NCT00959049|516158231|FG005|Overall Study|Contraindicated medication|0|||
143166938|NCT00959049|516158226|FG000|Overall Study|Withdrawal by Subject|0|||
143166939|NCT00959049|516158227|FG001|Overall Study|Withdrawal by Subject|2|||
143166940|NCT00959049|516158228|FG002|Overall Study|Withdrawal by Subject|0|||
143166941|NCT00959049|516158229|FG003|Overall Study|Withdrawal by Subject|0|||
143044274|NCT03114891|515702871|FG000|3 Week Break|Withdrawal by Subject|0|||
143166942|NCT00959049|516158230|FG004|Overall Study|Withdrawal by Subject|0|||
143044275|NCT03114891|515702872|FG001|3 Week Break|Withdrawal by Subject|1|||
143242330|NCT03614156|516437909|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
143242331|NCT03614156|516437910|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
143242332|NCT03614156|516437907|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
143242333|NCT03614156|516437908|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
143242334|NCT03614156|516437909|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
143242335|NCT03614156|516437910|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
143242336|NCT03614156|516437907|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
143242337|NCT03614156|516437908|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
143242338|NCT03614156|516437909|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
143242339|NCT03614156|516437910|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
143242340|NCT03614156|516437907|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
143242341|NCT03614156|516437908|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
143242342|NCT03614156|516437909|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
143242343|NCT03614156|516437910|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
143242344|NCT03614156|516437907|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
143242345|NCT03614156|516437908|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
143242346|NCT03614156|516437909|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
143242347|NCT03614156|516437910|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
143242348|NCT03614156|516437907|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
143242349|NCT03614156|516437908|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
143242350|NCT03614156|516437909|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
143242351|NCT03614156|516437910|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
143242352|NCT01094119|516437911|FG000|Overall Study|Lack of Efficacy|2|||
143242353|NCT01094119|516437912|FG001|Overall Study|Lack of Efficacy|4|||
143242354|NCT01587924|516437913|FG000|Overall Study|Adverse Event|0|||
143242355|NCT01587924|516437914|FG001|Overall Study|Adverse Event|2|||
143242356|NCT01587924|516437915|FG002|Overall Study|Adverse Event|0|||
143242357|NCT01587924|516437916|FG003|Overall Study|Adverse Event|0|||
143242358|NCT01587924|516437913|FG000|Overall Study|Protocol Violation|2|||
143242359|NCT01587924|516437914|FG001|Overall Study|Protocol Violation|1|||
143242360|NCT01587924|516437915|FG002|Overall Study|Protocol Violation|2|||
143242361|NCT01587924|516437916|FG003|Overall Study|Protocol Violation|1|||
143242362|NCT01587924|516437913|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
143242363|NCT01587924|516437914|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
143044276|NCT03114891|515702873|FG002|3 Week Break|Withdrawal by Subject|0|||
143044277|NCT03114891|515702874|FG003|3 Week Break|Withdrawal by Subject|0|||
143044278|NCT03114891|515702871|FG000|Second Treatment Round|Lost to Follow-up|1|||
143044279|NCT03114891|515702872|FG001|Second Treatment Round|Lost to Follow-up|0|||
143044280|NCT03114891|515702873|FG002|Second Treatment Round|Lost to Follow-up|0|||
143044281|NCT03114891|515702874|FG003|Second Treatment Round|Lost to Follow-up|0|||
143044282|NCT03114891|515702871|FG000|Second Treatment Round|Physician Decision|1|||
143044283|NCT03114891|515702872|FG001|Second Treatment Round|Physician Decision|0|||
143044284|NCT03114891|515702873|FG002|Second Treatment Round|Physician Decision|0|||
143044285|NCT03114891|515702874|FG003|Second Treatment Round|Physician Decision|0|||
143044286|NCT00682461|515704258|FG000|Overall Study|Adverse Event|5|||
143044287|NCT00682461|515704259|FG001|Overall Study|Adverse Event|7|||
143044288|NCT00682461|515704258|FG000|Overall Study|Lost to Follow-up|8|||
143044289|NCT00682461|515704259|FG001|Overall Study|Lost to Follow-up|5|||
143044290|NCT00682461|515704258|FG000|Overall Study|Withdrawal by Subject|12|||
143044291|NCT00682461|515704259|FG001|Overall Study|Withdrawal by Subject|19|||
143044292|NCT03599193|515704260|FG000|Overall Study|Adverse Event|0|||
143044293|NCT03599193|515704261|FG001|Overall Study|Adverse Event|2|||
143044294|NCT03599193|515704260|FG000|Overall Study|Withdrawal by Subject|1|||
143044295|NCT03599193|515704261|FG001|Overall Study|Withdrawal by Subject|0|||
143044296|NCT03599193|515704260|FG000|Overall Study|Protocol Violation|1|||
143044297|NCT03599193|515704261|FG001|Overall Study|Protocol Violation|0|||
143044298|NCT03599193|515704260|FG000|Overall Study|Lost to Follow-up|0|||
143044299|NCT03599193|515704261|FG001|Overall Study|Lost to Follow-up|1|||
143044300|NCT00835705|515704262|FG000|First Intervention|Difficulty with vein|1|||
143044301|NCT00835705|515704263|FG001|First Intervention|Difficulty with vein|0|||
143242364|NCT01587924|516437915|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
143242365|NCT01587924|516437916|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
143242366|NCT01587924|516437913|FG000|Overall Study|Withdrawal by Subject|0|||
143242367|NCT01587924|516437914|FG001|Overall Study|Withdrawal by Subject|1|||
143242368|NCT01587924|516437915|FG002|Overall Study|Withdrawal by Subject|1|||
143242369|NCT01587924|516437916|FG003|Overall Study|Withdrawal by Subject|0|||
143044302|NCT00835705|515704262|FG000|Second Intervention|Difficulty with vein|1|||
143044303|NCT00835705|515704263|FG001|Second Intervention|Difficulty with vein|0|||
143044304|NCT01750294|515704264|FG000|Overall Study|Withdrawal by Subject|1|||
143242370|NCT01696188|516437917|FG000|Overall Study|Protocol Violation|1|||
143242371|NCT01696188|516437918|FG001|Overall Study|Protocol Violation|1|||
143242372|NCT00960999|516437919|FG000|Overall Study|Withdrawal by Subject|1|||
143242373|NCT00960999|516437920|FG001|Overall Study|Withdrawal by Subject|0|||
143044305|NCT01750294|515704264|FG000|Overall Study|Safety Endpoint|1|||
143166943|NCT00959049|516158231|FG005|Overall Study|Withdrawal by Subject|0|||
143166944|NCT00095576|516158238|FG000|Overall Study|Adverse Event|5|||
143166945|NCT00095576|516158239|FG001|Overall Study|Adverse Event|3|||
143166946|NCT00095576|516158238|FG000|Overall Study|Lost to Follow-up|233|||
143166947|NCT00095576|516158239|FG001|Overall Study|Lost to Follow-up|229|||
143166948|NCT00095576|516158238|FG000|Overall Study|Protocol Violation|1|||
143166949|NCT00095576|516158239|FG001|Overall Study|Protocol Violation|0|||
143242374|NCT00960999|516437919|FG000|Overall Study|Protocol Violation|5|||
143242375|NCT00960999|516437920|FG001|Overall Study|Protocol Violation|2|||
143242376|NCT00960999|516437919|FG000|Overall Study|RT dose constraints not met|2|||
143242377|NCT00960999|516437920|FG001|Overall Study|RT dose constraints not met|0|||
143242378|NCT02425943|516437921|FG000|Overall Study|Adverse Event|3|||
143242379|NCT02425943|516437922|FG001|Overall Study|Adverse Event|1|||
143242380|NCT02425943|516437921|FG000|Overall Study|Lost to Follow-up|59|||
143242381|NCT02425943|516437922|FG001|Overall Study|Lost to Follow-up|37|||
143242382|NCT02425943|516437921|FG000|Overall Study|Protocol Violation|4|||
143242383|NCT02425943|516437922|FG001|Overall Study|Protocol Violation|1|||
143242384|NCT02425943|516437921|FG000|Overall Study|Withdrawal by Subject|64|||
143242385|NCT02425943|516437922|FG001|Overall Study|Withdrawal by Subject|31|||
143242386|NCT02425943|516437921|FG000|Overall Study|Other|6|||
143242387|NCT02425943|516437922|FG001|Overall Study|Other|0|||
143242388|NCT01106248|516437925|FG000|Overall Study|Adverse Event|1|||
143242389|NCT01106248|516437925|FG000|Overall Study|Administrative|2|||
143242390|NCT00357903|516437926|FG000|Overall Study|Adverse Event|87|||
143242391|NCT00357903|516437927|FG001|Overall Study|Adverse Event|4|||
143242392|NCT00357903|516437926|FG000|Overall Study|Death|33|||
143242393|NCT00357903|516437927|FG001|Overall Study|Death|0|||
143242394|NCT00357903|516437926|FG000|Overall Study|Lost to Follow-up|23|||
143242395|NCT00357903|516437927|FG001|Overall Study|Lost to Follow-up|4|||
143242396|NCT00357903|516437926|FG000|Overall Study|Physician Decision|39|||
143242397|NCT00357903|516437927|FG001|Overall Study|Physician Decision|5|||
143242398|NCT00357903|516437926|FG000|Overall Study|Withdrawal by Subject|57|||
143242399|NCT00357903|516437927|FG001|Overall Study|Withdrawal by Subject|7|||
143242400|NCT00357903|516437926|FG000|Overall Study|Completed month 12 only|0|||
143242401|NCT00357903|516437927|FG001|Overall Study|Completed month 12 only|1|||
143242402|NCT00357903|516437926|FG000|Overall Study|Protocol issues|14|||
143242403|NCT00357903|516437927|FG001|Overall Study|Protocol issues|3|||
143242404|NCT00357903|516437926|FG000|Overall Study|Response status|61|||
143242405|NCT00357903|516437927|FG001|Overall Study|Response status|9|||
143242406|NCT00357903|516437926|FG000|Overall Study|Other|49|||
143242407|NCT00357903|516437927|FG001|Overall Study|Other|10|||
143242408|NCT01967238|516437928|FG000|Overall Study|Adverse Event|1|||
143242409|NCT01967238|516437929|FG001|Overall Study|Adverse Event|1|||
143242410|NCT01967238|516437930|FG002|Overall Study|Adverse Event|0|||
143242411|NCT01967238|516437928|FG000|Overall Study|Lost to Follow-up|1|||
143242412|NCT01967238|516437929|FG001|Overall Study|Lost to Follow-up|0|||
143242413|NCT01967238|516437930|FG002|Overall Study|Lost to Follow-up|1|||
143242414|NCT01967238|516437928|FG000|Overall Study|Withdrawal by Subject|0|||
143242415|NCT01967238|516437929|FG001|Overall Study|Withdrawal by Subject|0|||
143242416|NCT01967238|516437930|FG002|Overall Study|Withdrawal by Subject|1|||
143242417|NCT02807402|516437937|FG000|Overall Study|Failure to Return|1|||
143242418|NCT02807402|516437937|FG000|Overall Study|Death|3|||
143242419|NCT02807402|516437937|FG000|Overall Study|Other|2|||
143242420|NCT01104311|516437938|FG000|Overall Study|Withdrawal by Subject|6|||
143242421|NCT01104311|516437939|FG001|Overall Study|Withdrawal by Subject|6|||
143242422|NCT01104311|516437938|FG000|Overall Study|Protocol Violation|0|||
143242423|NCT01104311|516437939|FG001|Overall Study|Protocol Violation|1|||
143242424|NCT01104311|516437938|FG000|Overall Study|Physician Decision|2|||
143242425|NCT01104311|516437939|FG001|Overall Study|Physician Decision|2|||
143242426|NCT01104311|516437938|FG000|Overall Study|low compliance|1|||
143166950|NCT00095576|516158238|FG000|Overall Study|Withdrawal by Subject|34|||
143166951|NCT00095576|516158239|FG001|Overall Study|Withdrawal by Subject|47|||
143242427|NCT01104311|516437939|FG001|Overall Study|low compliance|1|||
143242428|NCT01104311|516437938|FG000|Overall Study|Adverse Event|1|||
143242429|NCT01104311|516437939|FG001|Overall Study|Adverse Event|2|||
143242430|NCT04774094|516437946|FG000|Overall Study|Other|2|||
143242431|NCT04774094|516437946|FG000|Overall Study|Withdrawal by Subject|9|||
143166952|NCT00095576|516158238|FG000|Overall Study|Option to switch to a rollover study|1097|||
143242432|NCT04774094|516437946|FG000|Overall Study|Lost to Follow-up|7|||
143242433|NCT04774094|516437946|FG000|Overall Study|Lack of Efficacy|5|||
143242434|NCT04774094|516437946|FG000|Overall Study|Death|17|||
143242435|NCT04774094|516437946|FG000|Overall Study|Adverse Event|4|||
143242436|NCT05232682|516437949|FG000|Overall Study|Lost to Follow-up|2|||
143242437|NCT01442103|516439557|FG000|Overall Study|Lost to Follow-up|2|||
143242438|NCT01938716|516439566|FG000|Overall Study|Physician Decision|2|||
143242439|NCT01938716|516439566|FG000|Overall Study|Withdrawal by Subject|2|||
143242440|NCT01358721|516439567|FG000|Overall Study|Withdrawal by Subject|0|||
143242441|NCT01358721|516439568|FG001|Overall Study|Withdrawal by Subject|0|||
143242442|NCT01358721|516439569|FG002|Overall Study|Withdrawal by Subject|0|||
143242443|NCT01358721|516439570|FG003|Overall Study|Withdrawal by Subject|1|||
143242444|NCT01358721|516439567|FG000|Overall Study|Death|0|||
143364289|NCT00409708|516876956|FG001|Treatment|Withdrawal by Subject|8|||
143242445|NCT01358721|516439568|FG001|Overall Study|Death|2|||
143242446|NCT01358721|516439569|FG002|Overall Study|Death|0|||
143242447|NCT01358721|516439570|FG003|Overall Study|Death|0|||
143242448|NCT01358721|516439567|FG000|Overall Study|Study Drug Toxicity|1|||
143242449|NCT01358721|516439568|FG001|Overall Study|Study Drug Toxicity|3|||
143242450|NCT01358721|516439569|FG002|Overall Study|Study Drug Toxicity|4|||
143242451|NCT01358721|516439570|FG003|Overall Study|Study Drug Toxicity|5|||
143242452|NCT01358721|516439567|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
143242453|NCT01358721|516439568|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
143242454|NCT01358721|516439569|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
143242455|NCT01358721|516439570|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
143242456|NCT01358721|516439567|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
143242457|NCT01358721|516439568|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
143242458|NCT01358721|516439569|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
143242459|NCT01358721|516439570|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
143242460|NCT01358721|516439567|FG000|Overall Study|Adverse Event related to study drug|1|||
143242461|NCT01358721|516439568|FG001|Overall Study|Adverse Event related to study drug|0|||
143242462|NCT01358721|516439569|FG002|Overall Study|Adverse Event related to study drug|0|||
143242463|NCT01358721|516439570|FG003|Overall Study|Adverse Event related to study drug|1|||
143242464|NCT01358721|516439567|FG000|Overall Study|Disease Progression|19|||
143242465|NCT01358721|516439568|FG001|Overall Study|Disease Progression|15|||
143242466|NCT01358721|516439569|FG002|Overall Study|Disease Progression|17|||
143242467|NCT01358721|516439570|FG003|Overall Study|Disease Progression|15|||
143242468|NCT01358721|516439567|FG000|Overall Study|Out of State/Unmet Criteria|0|||
143242469|NCT01358721|516439568|FG001|Overall Study|Out of State/Unmet Criteria|0|||
143242470|NCT01358721|516439569|FG002|Overall Study|Out of State/Unmet Criteria|1|||
143242471|NCT01358721|516439570|FG003|Overall Study|Out of State/Unmet Criteria|0|||
143242472|NCT02446899|516439575|FG000|Overall Study|Adverse Event|4|||
143242473|NCT02446899|516439576|FG001|Overall Study|Adverse Event|7|||
143242474|NCT02446899|516439575|FG000|Overall Study|Condition Under Investigation Worsened|1|||
143242475|NCT02446899|516439576|FG001|Overall Study|Condition Under Investigation Worsened|4|||
143242476|NCT02446899|516439575|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
143242477|NCT02446899|516439576|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
143242478|NCT02446899|516439575|FG000|Overall Study|Lack of Efficacy|2|||
143242479|NCT02446899|516439576|FG001|Overall Study|Lack of Efficacy|8|||
143166953|NCT00095576|516158239|FG001|Overall Study|Option to switch to a rollover study|1099|||
143166954|NCT00095576|516158238|FG000|Overall Study|Site terminated|75|||
143166955|NCT00095576|516158239|FG001|Overall Study|Site terminated|67|||
143166956|NCT00095576|516158238|FG000|Overall Study|Subject moved|30|||
143166957|NCT00095576|516158239|FG001|Overall Study|Subject moved|36|||
143166958|NCT03673176|516158240|FG000|Overall Study|Death prior to intervention|1|||
143166959|NCT03673176|516158240|FG000|Overall Study|Death following intervention|3|||
143166960|NCT03673176|516158240|FG000|Overall Study|Withdrawal by Subject|1|||
143166961|NCT02378480|516158241|FG000|Overall Study|Physician Decision|1|||
143166962|NCT02378480|516158242|FG001|Overall Study|Physician Decision|1|||
143166963|NCT02378480|516158241|FG000|Overall Study|Death|1|||
143166964|NCT02378480|516158242|FG001|Overall Study|Death|2|||
143166965|NCT02378480|516158241|FG000|Overall Study|Randomized, but Not Treated|6|||
143166966|NCT02378480|516158242|FG001|Overall Study|Randomized, but Not Treated|4|||
143166967|NCT02378480|516158241|FG000|Overall Study|Adverse Event|0|||
143166968|NCT02378480|516158242|FG001|Overall Study|Adverse Event|1|||
143166969|NCT02378480|516158241|FG000|Overall Study|Missed EOT/PTE Visit|1|||
143166970|NCT02378480|516158242|FG001|Overall Study|Missed EOT/PTE Visit|2|||
143166971|NCT02378480|516158241|FG000|Overall Study|Withdrawal by Subject|9|||
143166972|NCT02378480|516158242|FG001|Overall Study|Withdrawal by Subject|4|||
143166973|NCT02378480|516158241|FG000|Overall Study|Lost to Follow-up|10|||
143166974|NCT02378480|516158242|FG001|Overall Study|Lost to Follow-up|18|||
143166975|NCT03663582|516158243|FG000|Overall Study|Physician Decision|1|||
143166976|NCT03847519|516158244|FG000|Overall Study|Death|5|||
143166977|NCT03847519|516158245|FG001|Overall Study|Death|8|||
143166978|NCT03847519|516158246|FG002|Overall Study|Death|1|||
143166979|NCT03847519|516158244|FG000|Overall Study|Lost to Follow-up|1|||
143166980|NCT03847519|516158245|FG001|Overall Study|Lost to Follow-up|2|||
143166981|NCT03847519|516158246|FG002|Overall Study|Lost to Follow-up|0|||
143166982|NCT03847519|516158244|FG000|Overall Study|Study Terminated by Sponsor|0|||
143166983|NCT03847519|516158245|FG001|Overall Study|Study Terminated by Sponsor|3|||
143166984|NCT03847519|516158246|FG002|Overall Study|Study Terminated by Sponsor|2|||
143166985|NCT02743962|516158247|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
143166986|NCT02743962|516158248|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
143166987|NCT00725985|516158252|FG000|ITP- Treatment Disposition|Adverse Event|20|||
143242480|NCT02446899|516439575|FG000|Overall Study|Lost to Follow-up|1|||
143242481|NCT02446899|516439576|FG001|Overall Study|Lost to Follow-up|3|||
143364290|NCT00409708|516876955|FG000|Treatment|Lost to Follow-up|0|||
143242482|NCT02446899|516439575|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
143242483|NCT02446899|516439576|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
143242484|NCT02446899|516439575|FG000|Overall Study|Withdrawal by Subject|11|||
143242485|NCT02446899|516439576|FG001|Overall Study|Withdrawal by Subject|19|||
143242486|NCT02446899|516439575|FG000|Overall Study|Miscellaneous|5|||
143242487|NCT02446899|516439576|FG001|Overall Study|Miscellaneous|4|||
143242488|NCT02446899|516439575|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
143242489|NCT02446899|516439576|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
143242490|NCT02863419|516439584|FG000|Overall Study|Lost to Follow-up|0|||
143242491|NCT02863419|516439585|FG001|Overall Study|Lost to Follow-up|1|||
143242492|NCT02863419|516439586|FG002|Overall Study|Lost to Follow-up|4|||
143242493|NCT02863419|516439584|FG000|Overall Study|Withdrawal by Subject|5|||
143242494|NCT02863419|516439585|FG001|Overall Study|Withdrawal by Subject|5|||
143242495|NCT02863419|516439586|FG002|Overall Study|Withdrawal by Subject|3|||
143242496|NCT02863419|516439584|FG000|Overall Study|Died|3|||
143242497|NCT02863419|516439585|FG001|Overall Study|Died|4|||
143242498|NCT02863419|516439586|FG002|Overall Study|Died|1|||
143242499|NCT02454517|516439593|FG000|Overall Study|Withdrawal by Subject|3|||
143242500|NCT02454517|516439594|FG001|Overall Study|Withdrawal by Subject|0|||
143242501|NCT02454517|516439593|FG000|Overall Study|Lost to Follow-up|4|||
143242502|NCT02454517|516439594|FG001|Overall Study|Lost to Follow-up|7|||
143242503|NCT02454517|516439593|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
143242504|NCT02454517|516439594|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
143242505|NCT00473382|516439595|FG000|Core Study|Adverse Event|3|||
143242506|NCT00473382|516439596|FG001|Core Study|Adverse Event|1|||
143242507|NCT00473382|516439597|FG002|Core Study|Adverse Event|1|||
143242508|NCT00473382|516439595|FG000|Core Study|Death|3|||
143242509|NCT00473382|516439596|FG001|Core Study|Death|5|||
143242510|NCT00473382|516439597|FG002|Core Study|Death|10|||
143242511|NCT00473382|516439595|FG000|Core Study|Lost to Follow-up|3|||
143242512|NCT00473382|516439596|FG001|Core Study|Lost to Follow-up|3|||
143242513|NCT00473382|516439597|FG002|Core Study|Lost to Follow-up|3|||
143242514|NCT00473382|516439595|FG000|Core Study|Physician Decision|1|||
143242515|NCT00473382|516439596|FG001|Core Study|Physician Decision|2|||
143242516|NCT00473382|516439597|FG002|Core Study|Physician Decision|2|||
143242517|NCT00473382|516439595|FG000|Core Study|Subject non-compliance|5|||
143242518|NCT00473382|516439596|FG001|Core Study|Subject non-compliance|2|||
143242519|NCT00473382|516439597|FG002|Core Study|Subject non-compliance|1|||
143242520|NCT00473382|516439595|FG000|Core Study|Subject needed other treatment|1|||
143242521|NCT00473382|516439596|FG001|Core Study|Subject needed other treatment|3|||
143242522|NCT00473382|516439597|FG002|Core Study|Subject needed other treatment|2|||
143242523|NCT00473382|516439595|FG000|Core Study|Subject's decision|12|||
143242524|NCT00473382|516439596|FG001|Core Study|Subject's decision|11|||
143242525|NCT00473382|516439597|FG002|Core Study|Subject's decision|10|||
143242526|NCT00473382|516439595|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
143242527|NCT00473382|516439596|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
143242528|NCT00473382|516439597|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
143242529|NCT00473382|516439595|FG000|Open-label Extension Through Month 48|Death|1|||
143242530|NCT00473382|516439596|FG001|Open-label Extension Through Month 48|Death|3|||
143242531|NCT00473382|516439597|FG002|Open-label Extension Through Month 48|Death|3|||
143242532|NCT00473382|516439595|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
143242533|NCT00473382|516439596|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
143242534|NCT00473382|516439597|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
143242535|NCT00473382|516439595|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
143242536|NCT00473382|516439596|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
143242537|NCT00473382|516439597|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
143242538|NCT00473382|516439595|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
143242539|NCT00473382|516439596|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
143242540|NCT00473382|516439597|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
143242541|NCT00473382|516439595|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
143242542|NCT00473382|516439596|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
143242543|NCT00473382|516439597|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
143242544|NCT00473382|516439595|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
143242545|NCT00473382|516439596|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
143242546|NCT00473382|516439597|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
143242547|NCT00473382|516439595|FG000|Open-label Extension Through Month 60|Death|1|||
143242548|NCT00473382|516439596|FG001|Open-label Extension Through Month 60|Death|7|||
143242549|NCT00473382|516439597|FG002|Open-label Extension Through Month 60|Death|4|||
143242550|NCT00473382|516439595|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
143242551|NCT00473382|516439596|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
143242552|NCT00473382|516439597|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
143364291|NCT00409708|516876956|FG001|Treatment|Lost to Follow-up|6|||
143364292|NCT00409708|516876955|FG000|Treatment|Administrative problems|5|||
143242553|NCT00473382|516439595|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
143242554|NCT00473382|516439596|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
143242555|NCT00473382|516439597|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
143242556|NCT00473382|516439595|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
143242557|NCT00473382|516439596|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
143242558|NCT00473382|516439597|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
143242559|NCT00473382|516439595|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
143242560|NCT00473382|516439596|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
143242561|NCT00473382|516439597|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
143242562|NCT01189032|516439598|FG000|Overall Study|Adverse Event|1|||
143242563|NCT01189032|516439599|FG001|Overall Study|Adverse Event|3|||
143242564|NCT01189032|516439600|FG002|Overall Study|Adverse Event|4|||
143242565|NCT01189032|516439598|FG000|Overall Study|Lack of Efficacy|2|||
143242566|NCT01189032|516439599|FG001|Overall Study|Lack of Efficacy|3|||
143242567|NCT01189032|516439600|FG002|Overall Study|Lack of Efficacy|0|||
143242568|NCT01189032|516439598|FG000|Overall Study|Withdrawal by Subject|1|||
143242569|NCT01189032|516439599|FG001|Overall Study|Withdrawal by Subject|0|||
143242570|NCT01189032|516439600|FG002|Overall Study|Withdrawal by Subject|1|||
143242571|NCT01189032|516439598|FG000|Overall Study|Protocol Violation|1|||
143242572|NCT01189032|516439599|FG001|Overall Study|Protocol Violation|1|||
143242573|NCT01189032|516439600|FG002|Overall Study|Protocol Violation|1|||
143242574|NCT01166282|516439601|FG000|Open-label Period|Adverse Event|0|||
143166988|NCT00725985|516158253|FG001|ITP- Treatment Disposition|Adverse Event|10|||
143166989|NCT00725985|516158254|FG002|ITP- Treatment Disposition|Adverse Event|5|||
143166990|NCT00725985|516158255|FG003|ITP- Treatment Disposition|Adverse Event|0|||
143166991|NCT00725985|516158256|FG004|ITP- Treatment Disposition|Adverse Event|0|||
143166992|NCT00725985|516158257|FG005|ITP- Treatment Disposition|Adverse Event|0|||
143166993|NCT00725985|516158258|FG006|ITP- Treatment Disposition|Adverse Event|0|||
143166994|NCT00725985|516158259|FG007|ITP- Treatment Disposition|Adverse Event|0|||
143166995|NCT00725985|516158260|FG008|ITP- Treatment Disposition|Adverse Event|0|||
143166996|NCT00725985|516158261|FG009|ITP- Treatment Disposition|Adverse Event|0|||
143166997|NCT00725985|516158262|FG010|ITP- Treatment Disposition|Adverse Event|0|||
143166998|NCT00725985|516158263|FG011|ITP- Treatment Disposition|Adverse Event|0|||
143166999|NCT00725985|516158252|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
143167000|NCT00725985|516158253|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
143167001|NCT00725985|516158254|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
143167002|NCT00725985|516158255|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
143167003|NCT00725985|516158256|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
143167004|NCT00725985|516158257|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
143167005|NCT00725985|516158258|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
143167006|NCT00725985|516158259|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
143167007|NCT00725985|516158260|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
143167008|NCT00725985|516158261|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
143167009|NCT00725985|516158262|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
143167010|NCT00725985|516158263|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
143167011|NCT00725985|516158252|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
143167012|NCT00725985|516158253|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
143167013|NCT00725985|516158254|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
143167014|NCT00725985|516158255|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
143167015|NCT00725985|516158256|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
143167016|NCT00725985|516158257|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
143167017|NCT00725985|516158258|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
143167018|NCT00725985|516158259|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
143167019|NCT00725985|516158260|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
143167020|NCT00725985|516158261|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
143167021|NCT00725985|516158262|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
143242575|NCT01166282|516439602|FG001|Open-label Period|Adverse Event|0|||
143242576|NCT01166282|516439603|FG002|Open-label Period|Adverse Event|6|||
143242577|NCT01166282|516439601|FG000|Open-label Period|Withdrawal by Subject|0|||
143242578|NCT01166282|516439602|FG001|Open-label Period|Withdrawal by Subject|0|||
143242579|NCT01166282|516439603|FG002|Open-label Period|Withdrawal by Subject|4|||
143242580|NCT01166282|516439601|FG000|Open-label Period|Lack of Efficacy|0|||
143242581|NCT01166282|516439602|FG001|Open-label Period|Lack of Efficacy|0|||
143242582|NCT01166282|516439603|FG002|Open-label Period|Lack of Efficacy|2|||
143242583|NCT01166282|516439601|FG000|Open-label Period|Remission|0|||
143242584|NCT01166282|516439602|FG001|Open-label Period|Remission|0|||
143167022|NCT00725985|516158263|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
143167023|NCT00725985|516158252|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
143167024|NCT00725985|516158253|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
143167025|NCT00725985|516158254|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
143242585|NCT01166282|516439603|FG002|Open-label Period|Remission|4|||
143167026|NCT00725985|516158255|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
143167027|NCT00725985|516158256|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
143167028|NCT00725985|516158257|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
143167029|NCT00725985|516158258|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
143167030|NCT00725985|516158259|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
143167031|NCT00725985|516158260|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
143167032|NCT00725985|516158261|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
143167033|NCT00725985|516158262|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
143167034|NCT00725985|516158263|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
143167035|NCT00725985|516158252|FG000|ITP- Treatment Disposition|Other|50|||
143167036|NCT00725985|516158253|FG001|ITP- Treatment Disposition|Other|38|||
143167037|NCT00725985|516158254|FG002|ITP- Treatment Disposition|Other|24|||
143167038|NCT00725985|516158255|FG003|ITP- Treatment Disposition|Other|0|||
143167039|NCT00725985|516158256|FG004|ITP- Treatment Disposition|Other|0|||
143167040|NCT00725985|516158257|FG005|ITP- Treatment Disposition|Other|0|||
143167041|NCT00725985|516158258|FG006|ITP- Treatment Disposition|Other|0|||
143167042|NCT00725985|516158259|FG007|ITP- Treatment Disposition|Other|0|||
143167043|NCT00725985|516158260|FG008|ITP- Treatment Disposition|Other|0|||
143167044|NCT00725985|516158261|FG009|ITP- Treatment Disposition|Other|0|||
143167045|NCT00725985|516158262|FG010|ITP- Treatment Disposition|Other|0|||
143167046|NCT00725985|516158263|FG011|ITP- Treatment Disposition|Other|0|||
143167047|NCT00725985|516158252|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
143167048|NCT00725985|516158253|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
143167049|NCT00725985|516158254|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
143167050|NCT00725985|516158255|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
143167051|NCT00725985|516158256|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
143167052|NCT00725985|516158257|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
143167053|NCT00725985|516158258|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
143167054|NCT00725985|516158259|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
143242586|NCT01166282|516439601|FG000|Open-label Period|Irregular Compliance|0|||
143167055|NCT00725985|516158260|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
143242587|NCT01166282|516439602|FG001|Open-label Period|Irregular Compliance|0|||
143242588|NCT01166282|516439603|FG002|Open-label Period|Irregular Compliance|1|||
143242589|NCT02577718|516439604|FG000|Overall Study|Death|6|||
143242590|NCT02577718|516439604|FG000|Overall Study|Withdrawal by Subject|2|||
143242591|NCT01995838|516439605|FG000|Overall Study|Lost to Follow-up|0|||
143242592|NCT01995838|516439606|FG001|Overall Study|Lost to Follow-up|1|||
143242593|NCT01995838|516439607|FG002|Overall Study|Lost to Follow-up|0|||
143167056|NCT00725985|516158261|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
143242594|NCT01995838|516439608|FG003|Overall Study|Lost to Follow-up|0|||
143242595|NCT01995838|516439609|FG004|Overall Study|Lost to Follow-up|0|||
143242596|NCT01995838|516439610|FG005|Overall Study|Lost to Follow-up|0|||
143242597|NCT01995838|516439611|FG006|Overall Study|Lost to Follow-up|1|||
143242598|NCT01995838|516439605|FG000|Overall Study|Participant choice|2|||
143242599|NCT01995838|516439606|FG001|Overall Study|Participant choice|0|||
143242600|NCT01995838|516439607|FG002|Overall Study|Participant choice|0|||
143242601|NCT01995838|516439608|FG003|Overall Study|Participant choice|0|||
143242602|NCT01995838|516439609|FG004|Overall Study|Participant choice|0|||
143242603|NCT01995838|516439610|FG005|Overall Study|Participant choice|1|||
143242604|NCT01995838|516439611|FG006|Overall Study|Participant choice|1|||
143242605|NCT01995838|516439605|FG000|Overall Study|Adverse Event|0|||
143242606|NCT01995838|516439606|FG001|Overall Study|Adverse Event|0|||
143242607|NCT01995838|516439607|FG002|Overall Study|Adverse Event|0|||
143242608|NCT01995838|516439608|FG003|Overall Study|Adverse Event|0|||
143242609|NCT01995838|516439609|FG004|Overall Study|Adverse Event|0|||
143242610|NCT01995838|516439610|FG005|Overall Study|Adverse Event|0|||
143242611|NCT01995838|516439611|FG006|Overall Study|Adverse Event|1|||
143242612|NCT01995838|516439605|FG000|Overall Study|Withdrawal by Subject|0|||
143167057|NCT00725985|516158262|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
143167058|NCT00725985|516158263|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
143167059|NCT00725985|516158252|FG000|OLMP (Up to 96 Weeks)|Death|0|||
143167060|NCT00725985|516158253|FG001|OLMP (Up to 96 Weeks)|Death|0|||
143167061|NCT00725985|516158254|FG002|OLMP (Up to 96 Weeks)|Death|0|||
143167062|NCT00725985|516158255|FG003|OLMP (Up to 96 Weeks)|Death|0|||
143167063|NCT00725985|516158256|FG004|OLMP (Up to 96 Weeks)|Death|1|||
143167064|NCT00725985|516158257|FG005|OLMP (Up to 96 Weeks)|Death|0|||
143167065|NCT00725985|516158258|FG006|OLMP (Up to 96 Weeks)|Death|0|||
143167066|NCT00725985|516158259|FG007|OLMP (Up to 96 Weeks)|Death|0|||
143167067|NCT00725985|516158260|FG008|OLMP (Up to 96 Weeks)|Death|0|||
143167068|NCT00725985|516158261|FG009|OLMP (Up to 96 Weeks)|Death|0|||
143167069|NCT00725985|516158262|FG010|OLMP (Up to 96 Weeks)|Death|0|||
143167070|NCT00725985|516158263|FG011|OLMP (Up to 96 Weeks)|Death|0|||
143167071|NCT00725985|516158252|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
143167072|NCT00725985|516158253|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
143242613|NCT01995838|516439606|FG001|Overall Study|Withdrawal by Subject|0|||
143242614|NCT01995838|516439607|FG002|Overall Study|Withdrawal by Subject|0|||
143242615|NCT01995838|516439608|FG003|Overall Study|Withdrawal by Subject|0|||
143242616|NCT01995838|516439609|FG004|Overall Study|Withdrawal by Subject|1|||
143044306|NCT04035187|515704265|FG000|Overall Study|Withdrawal by Subject|2|||
143044307|NCT04035187|515704266|FG001|Overall Study|Withdrawal by Subject|1|||
143044308|NCT04035187|515704267|FG002|Overall Study|Withdrawal by Subject|0|||
143044309|NCT04035187|515704268|FG003|Overall Study|Withdrawal by Subject|0|||
143044310|NCT04035187|515704265|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
143044311|NCT04035187|515704266|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
143044312|NCT04035187|515704267|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
143044313|NCT04035187|515704268|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
143044314|NCT01116739|515704269|FG000|Overall Study|Child had 2 years of HS|110|||
143044315|NCT01116739|515704270|FG001|Overall Study|Child had 2 years of HS|128|||
143167073|NCT00725985|516158254|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
143167074|NCT00725985|516158255|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
143167075|NCT00725985|516158256|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
143167076|NCT00725985|516158257|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
143167077|NCT00725985|516158258|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
143167078|NCT00725985|516158259|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
143167079|NCT00725985|516158260|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
143167080|NCT00725985|516158261|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
143167081|NCT00725985|516158262|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
143167082|NCT00725985|516158263|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
143167083|NCT00725985|516158252|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
143167084|NCT00725985|516158253|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
143167085|NCT00725985|516158254|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
143167086|NCT00725985|516158255|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
143167087|NCT00725985|516158256|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
143167088|NCT00725985|516158257|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
143167089|NCT00725985|516158258|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
143167090|NCT00725985|516158259|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
143167091|NCT00725985|516158260|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
143167092|NCT00725985|516158261|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
143167093|NCT00725985|516158262|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
143167094|NCT00725985|516158263|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
143167095|NCT00725985|516158252|FG000|OLMP (Up to 96 Weeks)|Other|0|||
143167096|NCT00725985|516158253|FG001|OLMP (Up to 96 Weeks)|Other|0|||
143167097|NCT00725985|516158254|FG002|OLMP (Up to 96 Weeks)|Other|0|||
143167098|NCT00725985|516158255|FG003|OLMP (Up to 96 Weeks)|Other|15|||
143167099|NCT00725985|516158256|FG004|OLMP (Up to 96 Weeks)|Other|20|||
143167100|NCT00725985|516158257|FG005|OLMP (Up to 96 Weeks)|Other|44|||
143167101|NCT00725985|516158258|FG006|OLMP (Up to 96 Weeks)|Other|0|||
143167102|NCT00725985|516158259|FG007|OLMP (Up to 96 Weeks)|Other|0|||
143167103|NCT00725985|516158260|FG008|OLMP (Up to 96 Weeks)|Other|0|||
143167104|NCT00725985|516158261|FG009|OLMP (Up to 96 Weeks)|Other|0|||
143167105|NCT00725985|516158262|FG010|OLMP (Up to 96 Weeks)|Other|0|||
143167106|NCT00725985|516158263|FG011|OLMP (Up to 96 Weeks)|Other|0|||
143167107|NCT00725985|516158252|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
143167108|NCT00725985|516158253|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
143167109|NCT00725985|516158254|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
143167110|NCT00725985|516158255|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
143167111|NCT00725985|516158256|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
143167112|NCT00725985|516158257|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
143167113|NCT00725985|516158258|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
143167114|NCT00725985|516158259|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
143167115|NCT00725985|516158260|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
143167116|NCT00725985|516158261|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
143167117|NCT00725985|516158262|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
143167118|NCT00725985|516158263|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
143167119|NCT00725985|516158252|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
143167120|NCT00725985|516158253|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
143167121|NCT00725985|516158254|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
143167122|NCT00725985|516158255|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
143167123|NCT00725985|516158256|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
143167124|NCT00725985|516158257|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
143167125|NCT00725985|516158258|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
143167126|NCT00725985|516158259|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
143167127|NCT00725985|516158260|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
143167128|NCT00725985|516158261|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
143167129|NCT00725985|516158262|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
143167130|NCT00725985|516158263|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
143167131|NCT00725985|516158252|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
143167132|NCT00725985|516158253|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
143242617|NCT01995838|516439610|FG005|Overall Study|Withdrawal by Subject|0|||
143242618|NCT01995838|516439611|FG006|Overall Study|Withdrawal by Subject|0|||
143242619|NCT01995838|516439605|FG000|Overall Study|Other|3|||
143242620|NCT01995838|516439606|FG001|Overall Study|Other|1|||
143242621|NCT01995838|516439607|FG002|Overall Study|Other|0|||
143242622|NCT01995838|516439608|FG003|Overall Study|Other|2|||
143242623|NCT01995838|516439609|FG004|Overall Study|Other|1|||
143242624|NCT01995838|516439610|FG005|Overall Study|Other|1|||
143242625|NCT01995838|516439611|FG006|Overall Study|Other|2|||
143242626|NCT00275509|516439616|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
143242627|NCT00275509|516439617|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
143242628|NCT02819804|516439618|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
143242629|NCT03196349|516439619|FG000|Overall Study|Did not receive study drug|0|||
143242630|NCT03196349|516439620|FG001|Overall Study|Did not receive study drug|1|||
143242631|NCT03196349|516439621|FG002|Overall Study|Did not receive study drug|2|||
143364293|NCT00409708|516876956|FG001|Treatment|Administrative problems|0|||
143242632|NCT03196349|516439619|FG000|Overall Study|No data entered|2|||
143044316|NCT01116739|515704269|FG000|Overall Study|Withdrawal by Subject|6|||
143044317|NCT01116739|515704270|FG001|Overall Study|Withdrawal by Subject|0|||
143044318|NCT01116739|515704269|FG000|Overall Study|child too young|2|||
143044319|NCT01116739|515704270|FG001|Overall Study|child too young|6|||
143044320|NCT01116739|515704269|FG000|Overall Study|child not enrolled in head start|10|||
143044321|NCT01116739|515704270|FG001|Overall Study|child not enrolled in head start|2|||
143044322|NCT01116739|515704269|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
143044323|NCT01116739|515704270|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
143044324|NCT05511935|515704271|FG000|Overall Study|Lost to Follow-up|9|||
143044325|NCT05511935|515704272|FG001|Overall Study|Lost to Follow-up|27|||
143044326|NCT05090839|515704273|FG000|Overall Study|Lost to Follow-up|2|||
143044327|NCT05090839|515704274|FG001|Overall Study|Lost to Follow-up|3|||
143044328|NCT05090839|515704275|FG002|Overall Study|Lost to Follow-up|1|||
143044329|NCT05090839|515704276|FG003|Overall Study|Lost to Follow-up|1|||
143044330|NCT05710718|515704277|FG000|Overall Study|Withdrawal by Subject|5|||
143044331|NCT05710718|515704278|FG001|Overall Study|Withdrawal by Subject|1|||
143044332|NCT05710718|515704277|FG000|Overall Study|Lost to Follow-up|0|||
143044333|NCT05710718|515704278|FG001|Overall Study|Lost to Follow-up|1|||
143044334|NCT05710718|515704277|FG000|Overall Study|Death|0|||
143044335|NCT05710718|515704278|FG001|Overall Study|Death|1|||
143044336|NCT00334815|515704279|FG000|Overall Study|Adverse Event|3|||
143044337|NCT00334815|515704280|FG001|Overall Study|Adverse Event|2|||
143044338|NCT00334815|515704279|FG000|Overall Study|Death|0|||
143044339|NCT00334815|515704280|FG001|Overall Study|Death|2|||
143044340|NCT00334815|515704279|FG000|Overall Study|Progression|1|||
143044341|NCT00334815|515704280|FG001|Overall Study|Progression|0|||
143044342|NCT00334815|515704279|FG000|Overall Study|ineligible|1|||
143044343|NCT00334815|515704280|FG001|Overall Study|ineligible|1|||
143044344|NCT00334815|515704279|FG000|Overall Study|patient refused treatment|0|||
143044345|NCT00334815|515704280|FG001|Overall Study|patient refused treatment|1|||
143044346|NCT00334815|515704279|FG000|Overall Study|Physician Decision|2|||
143044347|NCT00334815|515704280|FG001|Overall Study|Physician Decision|4|||
143044348|NCT03121586|515704281|FG000|Overall Study|Study terminated by sponsor|0|||
143044349|NCT03121586|515704282|FG001|Overall Study|Study terminated by sponsor|0|||
143044350|NCT03121586|515704283|FG002|Overall Study|Study terminated by sponsor|99|||
143044351|NCT03121586|515704281|FG000|Overall Study|Withdrawal by Subject|37|||
143044352|NCT03121586|515704282|FG001|Overall Study|Withdrawal by Subject|14|||
143044353|NCT03121586|515704283|FG002|Overall Study|Withdrawal by Subject|9|||
143044354|NCT03121586|515704281|FG000|Overall Study|Not further specified|6|||
143044355|NCT03121586|515704282|FG001|Overall Study|Not further specified|11|||
143044356|NCT03121586|515704283|FG002|Overall Study|Not further specified|10|||
143044357|NCT03121586|515704281|FG000|Overall Study|Adverse Event|16|||
143044358|NCT03121586|515704282|FG001|Overall Study|Adverse Event|5|||
143044359|NCT03121586|515704283|FG002|Overall Study|Adverse Event|6|||
143044360|NCT03121586|515704281|FG000|Overall Study|Protocol Violation|0|||
143044361|NCT03121586|515704282|FG001|Overall Study|Protocol Violation|5|||
143044362|NCT03121586|515704283|FG002|Overall Study|Protocol Violation|0|||
143044363|NCT03121586|515704281|FG000|Overall Study|Lack of Efficacy|3|||
143044364|NCT03121586|515704282|FG001|Overall Study|Lack of Efficacy|3|||
143044365|NCT03121586|515704283|FG002|Overall Study|Lack of Efficacy|1|||
143044366|NCT03121586|515704281|FG000|Overall Study|Physician Decision|2|||
143044367|NCT03121586|515704282|FG001|Overall Study|Physician Decision|2|||
143044368|NCT03121586|515704283|FG002|Overall Study|Physician Decision|0|||
143044369|NCT03121586|515704281|FG000|Overall Study|Noncompliance with study drug|5|||
143044370|NCT03121586|515704282|FG001|Overall Study|Noncompliance with study drug|3|||
143044371|NCT03121586|515704283|FG002|Overall Study|Noncompliance with study drug|5|||
143044372|NCT03121586|515704281|FG000|Overall Study|Lost to Follow-up|4|||
143044373|NCT03121586|515704282|FG001|Overall Study|Lost to Follow-up|2|||
143044374|NCT03121586|515704283|FG002|Overall Study|Lost to Follow-up|0|||
143044375|NCT03121586|515704281|FG000|Overall Study|Death|2|||
143044376|NCT03121586|515704282|FG001|Overall Study|Death|0|||
143044377|NCT03121586|515704283|FG002|Overall Study|Death|0|||
143044378|NCT06381102|515704284|FG000|Washout 5 Days|Withdrawal by Subject|0|||
143044379|NCT06381102|515704285|FG001|Washout 5 Days|Withdrawal by Subject|2|||
143167133|NCT00725985|516158254|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
143167134|NCT00725985|516158255|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
143044380|NCT02832063|515704287|FG000|Overall Study|Adverse Event|2|||
143044381|NCT02832063|515704288|FG001|Overall Study|Adverse Event|1|||
143044382|NCT02832063|515704287|FG000|Overall Study|Physician Decision|5|||
143044383|NCT02832063|515704288|FG001|Overall Study|Physician Decision|7|||
143044384|NCT02832063|515704287|FG000|Overall Study|Lost to Follow-up|15|||
143044385|NCT02832063|515704288|FG001|Overall Study|Lost to Follow-up|8|||
143044386|NCT02832063|515704287|FG000|Overall Study|Withdrawal by Subject|10|||
143044387|NCT02832063|515704288|FG001|Overall Study|Withdrawal by Subject|21|||
143044388|NCT02832063|515704287|FG000|Overall Study|Other|2|||
143044389|NCT02832063|515704288|FG001|Overall Study|Other|1|||
143167135|NCT00725985|516158256|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
143044390|NCT03733730|515704289|FG000|Overall Study|Lost to Follow-up|1|||
143044391|NCT03733730|515704290|FG001|Overall Study|Lost to Follow-up|32|||
143044392|NCT03733730|515704289|FG000|Overall Study|Other|1|||
143044393|NCT03733730|515704290|FG001|Overall Study|Other|0|||
143044394|NCT03733730|515704289|FG000|Overall Study|Adverse Event|0|||
143044395|NCT03733730|515704290|FG001|Overall Study|Adverse Event|4|||
143044396|NCT03733730|515704289|FG000|Overall Study|Death|0|||
143044397|NCT03733730|515704290|FG001|Overall Study|Death|5|||
143044398|NCT03733730|515704289|FG000|Overall Study|Withdrawal by Subject|0|||
143044399|NCT03733730|515704290|FG001|Overall Study|Withdrawal by Subject|8|||
143044400|NCT01528696|515704291|FG000|Overall Study|See detailed description|18|||
143044401|NCT01528696|515704292|FG001|Overall Study|See detailed description|19|||
143044402|NCT00835575|515704294|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
143044403|NCT00835575|515704295|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
143044404|NCT01440803|515704296|FG000|Overall Study|Met study stopping rule|2|||
143044405|NCT01440803|515704297|FG001|Overall Study|Met study stopping rule|1|||
143044406|NCT01440803|515704296|FG000|Overall Study|Lost to Follow-up|0|||
143044407|NCT01440803|515704297|FG001|Overall Study|Lost to Follow-up|2|||
143044408|NCT01440803|515704296|FG000|Overall Study|Withdrawal by Subject|0|||
143044409|NCT01440803|515704297|FG001|Overall Study|Withdrawal by Subject|1|||
143044410|NCT03606174|515704298|FG000|Overall Study|Death|37|||
143044411|NCT03606174|515704299|FG001|Overall Study|Death|15|||
143044412|NCT03606174|515704300|FG002|Overall Study|Death|15|||
143044413|NCT03606174|515704301|FG003|Overall Study|Death|7|||
143044414|NCT03606174|515704302|FG004|Overall Study|Death|35|||
143044415|NCT03606174|515704303|FG005|Overall Study|Death|12|||
143044416|NCT03606174|515704304|FG006|Overall Study|Death|35|||
143044417|NCT03606174|515704305|FG007|Overall Study|Death|8|||
143044418|NCT03606174|515704306|FG008|Overall Study|Death|5|||
143044419|NCT03606174|515704307|FG009|Overall Study|Death|3|||
143044420|NCT03606174|515704308|FG010|Overall Study|Death|0|||
143044421|NCT03606174|515704298|FG000|Overall Study|Lost to Follow-up|0|||
143044422|NCT03606174|515704299|FG001|Overall Study|Lost to Follow-up|0|||
143044423|NCT03606174|515704300|FG002|Overall Study|Lost to Follow-up|0|||
143044424|NCT03606174|515704301|FG003|Overall Study|Lost to Follow-up|0|||
143044425|NCT03606174|515704302|FG004|Overall Study|Lost to Follow-up|1|||
143044426|NCT03606174|515704303|FG005|Overall Study|Lost to Follow-up|1|||
143044427|NCT03606174|515704304|FG006|Overall Study|Lost to Follow-up|0|||
143044428|NCT03606174|515704305|FG007|Overall Study|Lost to Follow-up|0|||
143044429|NCT03606174|515704306|FG008|Overall Study|Lost to Follow-up|0|||
143044430|NCT03606174|515704307|FG009|Overall Study|Lost to Follow-up|0|||
143044431|NCT03606174|515704308|FG010|Overall Study|Lost to Follow-up|0|||
143044432|NCT03606174|515704298|FG000|Overall Study|Withdrawal by Subject|6|||
143044433|NCT03606174|515704299|FG001|Overall Study|Withdrawal by Subject|0|||
143044434|NCT03606174|515704300|FG002|Overall Study|Withdrawal by Subject|0|||
143044435|NCT03606174|515704301|FG003|Overall Study|Withdrawal by Subject|1|||
143044436|NCT03606174|515704302|FG004|Overall Study|Withdrawal by Subject|2|||
143044437|NCT03606174|515704303|FG005|Overall Study|Withdrawal by Subject|1|||
143044438|NCT03606174|515704304|FG006|Overall Study|Withdrawal by Subject|4|||
143044439|NCT03606174|515704305|FG007|Overall Study|Withdrawal by Subject|0|||
143044440|NCT03606174|515704306|FG008|Overall Study|Withdrawal by Subject|0|||
143044441|NCT03606174|515704307|FG009|Overall Study|Withdrawal by Subject|0|||
143167136|NCT00725985|516158257|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
143167137|NCT00725985|516158258|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
143167138|NCT00725985|516158259|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
143167139|NCT00725985|516158260|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
143167140|NCT00725985|516158261|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
143167141|NCT00725985|516158262|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
143167142|NCT00725985|516158263|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
143167143|NCT00725985|516158252|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
143167144|NCT00725985|516158253|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
143167145|NCT00725985|516158254|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
143167146|NCT00725985|516158255|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
143167147|NCT00725985|516158256|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
143167148|NCT00725985|516158257|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
143167149|NCT00725985|516158258|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
143167150|NCT00725985|516158259|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
143167151|NCT00725985|516158260|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
143167152|NCT00725985|516158261|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
143167153|NCT00725985|516158262|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
143167154|NCT00725985|516158263|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
143167155|NCT03729609|516158264|FG000|Overall Study|Protocol Violation|1|||
143167156|NCT03412929|516158268|FG000|Overall Study|Protocol Violation|3|||
143167157|NCT01381679|516158271|FG000|Overall Study|Adverse Event|3|||
143167158|NCT01381679|516158271|FG000|Overall Study|Lost to Follow-up|885|||
143167159|NCT04023487|516158272|FG000|Overall Study|Lost to Follow-up|5|||
143167160|NCT04023487|516158273|FG001|Overall Study|Lost to Follow-up|4|||
143167161|NCT04023487|516158272|FG000|Overall Study|Pregnancy|1|||
143167162|NCT04023487|516158273|FG001|Overall Study|Pregnancy|2|||
143167163|NCT04023487|516158272|FG000|Overall Study|Withdrawal by Subject|4|||
143167164|NCT04023487|516158273|FG001|Overall Study|Withdrawal by Subject|5|||
143242633|NCT03196349|516439620|FG001|Overall Study|No data entered|4|||
143242634|NCT03196349|516439621|FG002|Overall Study|No data entered|0|||
143242635|NCT03196349|516439619|FG000|Overall Study|Study Terminated early|15|||
143242636|NCT03196349|516439620|FG001|Overall Study|Study Terminated early|9|||
143242637|NCT03196349|516439621|FG002|Overall Study|Study Terminated early|11|||
143242638|NCT02892448|516439628|FG000|Overall Study|Screening failure|2|||
143242639|NCT02892448|516439629|FG001|Overall Study|Screening failure|2|||
143242640|NCT02892448|516439630|FG002|Overall Study|Screening failure|1|||
143242641|NCT00499083|516439631|FG000|Overall Study|Not evaluable|3|||
143242642|NCT01012440|516439632|FG000|Overall Study|Withdrawal by Subject|2|||
143242643|NCT00131248|516439633|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
143242644|NCT00131248|516439634|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
143242645|NCT02284243|516439635|FG000|Overall Study|Lack of Efficacy|3|||
143242646|NCT02284243|516439636|FG001|Overall Study|Lack of Efficacy|3|||
143242647|NCT02284243|516439635|FG000|Overall Study|Adverse Event|1|||
143242648|NCT02284243|516439636|FG001|Overall Study|Adverse Event|0|||
143242649|NCT00541385|516439638|FG000|Overall Study|Adverse Event|6|||
143242650|NCT00541385|516439639|FG001|Overall Study|Adverse Event|3|||
143242651|NCT00541385|516439638|FG000|Overall Study|Withdrawal by Subject|2|||
143242652|NCT00541385|516439639|FG001|Overall Study|Withdrawal by Subject|2|||
143242653|NCT00541385|516439638|FG000|Overall Study|Lost to Follow-up|6|||
143242654|NCT00541385|516439639|FG001|Overall Study|Lost to Follow-up|1|||
143242655|NCT00541385|516439638|FG000|Overall Study|Parasite reappearance/malaria|67|||
143242656|NCT00541385|516439639|FG001|Overall Study|Parasite reappearance/malaria|32|||
143242657|NCT02699749|516439641|FG000|Overall Study|Other|0|||
143242658|NCT02699749|516439642|FG001|Overall Study|Other|0|||
143242659|NCT02699749|516439643|FG002|Overall Study|Other|2|||
143242660|NCT02699749|516439644|FG003|Overall Study|Other|0|||
143242661|NCT02699749|516439645|FG004|Overall Study|Other|0|||
143242662|NCT02699749|516439646|FG005|Overall Study|Other|1|||
143242663|NCT02699749|516439647|FG006|Overall Study|Other|1|||
143242664|NCT02699749|516439648|FG007|Overall Study|Other|0|||
143242665|NCT02699749|516439649|FG008|Overall Study|Other|0|||
143242666|NCT02699749|516439650|FG009|Overall Study|Other|0|||
143242667|NCT02699749|516439651|FG010|Overall Study|Other|1|||
143242668|NCT02699749|516439652|FG011|Overall Study|Other|0|||
143242669|NCT02699749|516439653|FG012|Overall Study|Other|0|||
143242670|NCT02699749|516439654|FG013|Overall Study|Other|0|||
143242671|NCT02699749|516439641|FG000|Overall Study|Progressive Disease|3|||
143242672|NCT02699749|516439642|FG001|Overall Study|Progressive Disease|3|||
143242673|NCT02699749|516439643|FG002|Overall Study|Progressive Disease|14|||
143242674|NCT02699749|516439644|FG003|Overall Study|Progressive Disease|3|||
143242675|NCT02699749|516439645|FG004|Overall Study|Progressive Disease|3|||
143242676|NCT02699749|516439646|FG005|Overall Study|Progressive Disease|7|||
143242677|NCT02699749|516439647|FG006|Overall Study|Progressive Disease|5|||
143242678|NCT02699749|516439648|FG007|Overall Study|Progressive Disease|5|||
143242679|NCT02699749|516439649|FG008|Overall Study|Progressive Disease|6|||
143242680|NCT02699749|516439650|FG009|Overall Study|Progressive Disease|6|||
143242681|NCT02699749|516439651|FG010|Overall Study|Progressive Disease|5|||
143242682|NCT02699749|516439652|FG011|Overall Study|Progressive Disease|4|||
143242683|NCT02699749|516439653|FG012|Overall Study|Progressive Disease|3|||
143242684|NCT02699749|516439654|FG013|Overall Study|Progressive Disease|5|||
143242685|NCT02699749|516439641|FG000|Overall Study|Death|0|||
143242686|NCT02699749|516439642|FG001|Overall Study|Death|0|||
143242687|NCT02699749|516439643|FG002|Overall Study|Death|0|||
143242688|NCT02699749|516439644|FG003|Overall Study|Death|0|||
143242689|NCT02699749|516439645|FG004|Overall Study|Death|0|||
143242690|NCT02699749|516439646|FG005|Overall Study|Death|0|||
143242691|NCT02699749|516439647|FG006|Overall Study|Death|0|||
143242692|NCT02699749|516439648|FG007|Overall Study|Death|0|||
143242693|NCT02699749|516439649|FG008|Overall Study|Death|0|||
143242694|NCT02699749|516439650|FG009|Overall Study|Death|0|||
143242695|NCT02699749|516439651|FG010|Overall Study|Death|0|||
143242696|NCT02699749|516439652|FG011|Overall Study|Death|0|||
143242697|NCT02699749|516439653|FG012|Overall Study|Death|0|||
143242698|NCT02699749|516439654|FG013|Overall Study|Death|1|||
143242699|NCT02699749|516439641|FG000|Overall Study|Lost to Follow-up|0|||
143242700|NCT02699749|516439642|FG001|Overall Study|Lost to Follow-up|0|||
143242701|NCT02699749|516439643|FG002|Overall Study|Lost to Follow-up|0|||
143242702|NCT02699749|516439644|FG003|Overall Study|Lost to Follow-up|0|||
143242703|NCT02699749|516439645|FG004|Overall Study|Lost to Follow-up|0|||
143242704|NCT02699749|516439646|FG005|Overall Study|Lost to Follow-up|1|||
143242705|NCT02699749|516439647|FG006|Overall Study|Lost to Follow-up|0|||
143242706|NCT02699749|516439648|FG007|Overall Study|Lost to Follow-up|1|||
143242707|NCT02699749|516439649|FG008|Overall Study|Lost to Follow-up|0|||
143242708|NCT02699749|516439650|FG009|Overall Study|Lost to Follow-up|0|||
143242709|NCT02699749|516439651|FG010|Overall Study|Lost to Follow-up|0|||
143242710|NCT02699749|516439652|FG011|Overall Study|Lost to Follow-up|0|||
143242711|NCT02699749|516439653|FG012|Overall Study|Lost to Follow-up|0|||
143242712|NCT02699749|516439654|FG013|Overall Study|Lost to Follow-up|0|||
143242713|NCT02377817|516439655|FG000|Overall Study|Transportation/childcare barriers.|2|||
143242714|NCT02377817|516439656|FG001|Overall Study|Transportation/childcare barriers.|0|||
143044442|NCT03606174|515704308|FG010|Overall Study|Withdrawal by Subject|1|||
143044443|NCT03606174|515704298|FG000|Overall Study|Study Terminated by Sponsor|5|||
143044444|NCT03606174|515704299|FG001|Overall Study|Study Terminated by Sponsor|7|||
143044445|NCT03606174|515704300|FG002|Overall Study|Study Terminated by Sponsor|3|||
143044446|NCT03606174|515704301|FG003|Overall Study|Study Terminated by Sponsor|0|||
143044447|NCT03606174|515704302|FG004|Overall Study|Study Terminated by Sponsor|11|||
143044448|NCT03606174|515704303|FG005|Overall Study|Study Terminated by Sponsor|6|||
143044449|NCT03606174|515704304|FG006|Overall Study|Study Terminated by Sponsor|12|||
143044450|NCT03606174|515704305|FG007|Overall Study|Study Terminated by Sponsor|1|||
143044451|NCT03606174|515704306|FG008|Overall Study|Study Terminated by Sponsor|3|||
143044452|NCT03606174|515704307|FG009|Overall Study|Study Terminated by Sponsor|1|||
143044453|NCT03606174|515704308|FG010|Overall Study|Study Terminated by Sponsor|2|||
143044454|NCT03606174|515704298|FG000|Overall Study|Miscellaneous|1|||
143044455|NCT03606174|515704299|FG001|Overall Study|Miscellaneous|1|||
143044456|NCT03606174|515704300|FG002|Overall Study|Miscellaneous|0|||
143044457|NCT03606174|515704301|FG003|Overall Study|Miscellaneous|1|||
143044458|NCT03606174|515704302|FG004|Overall Study|Miscellaneous|4|||
143044459|NCT03606174|515704303|FG005|Overall Study|Miscellaneous|7|||
143044460|NCT03606174|515704304|FG006|Overall Study|Miscellaneous|5|||
143044461|NCT03606174|515704305|FG007|Overall Study|Miscellaneous|0|||
143044462|NCT03606174|515704306|FG008|Overall Study|Miscellaneous|0|||
143044463|NCT03606174|515704307|FG009|Overall Study|Miscellaneous|0|||
143044464|NCT03606174|515704308|FG010|Overall Study|Miscellaneous|1|||
143044465|NCT01609257|515704309|FG000|Overall Study|Lost to Follow-up|2|||
143044466|NCT01609257|515704310|FG001|Overall Study|Lost to Follow-up|1|||
143044467|NCT01609257|515704309|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
143044468|NCT01609257|515704310|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
143044469|NCT01609257|515704309|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
143044470|NCT01609257|515704310|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
143044471|NCT03499353|515704313|FG000|Treatment|Adverse Event|3|||
143044472|NCT03499353|515704313|FG000|Treatment|Progressive Disease|10|||
143044473|NCT03499353|515704313|FG000|Treatment|Other|1|||
143044474|NCT03499353|515704313|FG000|Treatment|Withdrawal by Subject|2|||
143044475|NCT03499353|515704313|FG000|Long-Term Follow-up|Death|2|||
143044476|NCT03499353|515704313|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
143044477|NCT03499353|515704313|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
143044478|NCT00469898|515704316|FG000|Overall Study|Adverse Event|7|||
143044479|NCT00469898|515704316|FG000|Overall Study|Withdrawal by Subject|4|||
143044480|NCT00469898|515704316|FG000|Overall Study|Death|4|||
143044481|NCT00469898|515704316|FG000|Overall Study|Disease progression|9|||
143044482|NCT00469898|515704316|FG000|Overall Study|Decreased performance status|1|||
143044483|NCT03246503|515704317|FG000|Overall Study|Lost to Follow-up|23|||
143044484|NCT03246503|515704317|FG000|Overall Study|Withdrawal by Subject|20|||
143044485|NCT03246503|515704317|FG000|Overall Study|Physician Decision|5|||
143044486|NCT03246503|515704317|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
143044487|NCT05014828|515704318|FG000|Overall Study|Study Completed by Sponsor|16|||
143044488|NCT05014828|515704319|FG001|Overall Study|Study Completed by Sponsor|16|||
143044489|NCT05014828|515704320|FG002|Overall Study|Study Completed by Sponsor|3|||
143044490|NCT05014828|515704321|FG003|Overall Study|Study Completed by Sponsor|3|||
143044491|NCT05014828|515704318|FG000|Overall Study|Death|11|||
143044492|NCT05014828|515704319|FG001|Overall Study|Death|6|||
143044493|NCT05014828|515704320|FG002|Overall Study|Death|0|||
143044494|NCT05014828|515704321|FG003|Overall Study|Death|0|||
143044495|NCT05014828|515704318|FG000|Overall Study|Lost to Follow-up|0|||
143044496|NCT05014828|515704319|FG001|Overall Study|Lost to Follow-up|0|||
143044497|NCT05014828|515704320|FG002|Overall Study|Lost to Follow-up|2|||
143044498|NCT05014828|515704321|FG003|Overall Study|Lost to Follow-up|0|||
143044499|NCT05014828|515704318|FG000|Overall Study|Miscellaneous.|0|||
143044500|NCT05014828|515704319|FG001|Overall Study|Miscellaneous.|1|||
143044501|NCT05014828|515704320|FG002|Overall Study|Miscellaneous.|0|||
143044502|NCT05014828|515704321|FG003|Overall Study|Miscellaneous.|0|||
143044503|NCT01058668|515704324|FG000|Double-blind Treatment Phase|Adverse Event|8|||
143044504|NCT01058668|515704325|FG001|Double-blind Treatment Phase|Adverse Event|15|||
143044505|NCT01058668|515704326|FG002|Double-blind Treatment Phase|Adverse Event|25|||
143044506|NCT01058668|515704324|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
143044507|NCT01058668|515704325|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
143044508|NCT01058668|515704326|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
143044509|NCT01058668|515704324|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
143364294|NCT00409708|516876955|FG000|Washout|Lack of Efficacy|9|||
143044510|NCT01058668|515704325|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
143044511|NCT01058668|515704326|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
143044512|NCT01058668|515704324|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
143044513|NCT01058668|515704325|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
143044514|NCT01058668|515704326|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
143044515|NCT01058668|515704324|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
143044516|NCT01058668|515704325|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
143044517|NCT01058668|515704326|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
143044518|NCT01058668|515704324|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
143044519|NCT01058668|515704325|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
143044520|NCT01058668|515704326|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
143044521|NCT03437265|515704327|FG000|Overall Study|Protocol Violation|6|||
143044522|NCT00316277|515704330|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
143044523|NCT00316277|515704331|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
143044524|NCT00316277|515704330|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
143044525|NCT00316277|515704331|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
143044526|NCT00316277|515704330|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
143044527|NCT00316277|515704331|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
143044528|NCT00316277|515704330|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
143044529|NCT00316277|515704331|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
143044530|NCT00316277|515704330|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
143044531|NCT00316277|515704331|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
143044532|NCT01444378|515704338|FG000|Overall Study|Lost to Follow-up|1|||
143044533|NCT01444378|515704338|FG000|Overall Study|Withdrawal by Subject|1|||
143044534|NCT01444378|515704338|FG000|Overall Study|Death|3|||
143044535|NCT01444378|515704338|FG000|Overall Study|Administrative Closure Of The Study|2|||
143044536|NCT01444378|515704338|FG000|Overall Study|Missed Visits|10|||
143044537|NCT02911792|515704339|FG000|Overall Study|Lost to Follow-up|3|||
143044538|NCT02911792|515704340|FG001|Overall Study|Lost to Follow-up|3|||
143044539|NCT02911792|515704341|FG002|Overall Study|Lost to Follow-up|3|||
143044540|NCT02911792|515704342|FG003|Overall Study|Lost to Follow-up|3|||
143044541|NCT00796328|515704343|FG000|Overall Study|experienced hypotension requiring tx|6|||
143044542|NCT03199963|515704344|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
143044543|NCT03199963|515704345|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
143044544|NCT03199963|515704344|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
143044545|NCT03199963|515704345|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
143044546|NCT03199963|515704344|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
143044547|NCT03199963|515704345|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
143044548|NCT03199963|515704344|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
143044549|NCT03199963|515704345|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
143044550|NCT03199963|515704344|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
143044551|NCT03199963|515704345|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
143044552|NCT03199963|515704344|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
143044553|NCT03199963|515704345|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
143044554|NCT00466167|515704346|FG000|Overall Study|Adverse Event|8|||
143044555|NCT00466167|515704347|FG001|Overall Study|Adverse Event|8|||
143044556|NCT00466167|515704348|FG002|Overall Study|Adverse Event|7|||
143044557|NCT00466167|515704346|FG000|Overall Study|Lack of Efficacy|2|||
143044558|NCT00466167|515704347|FG001|Overall Study|Lack of Efficacy|0|||
143044559|NCT00466167|515704348|FG002|Overall Study|Lack of Efficacy|3|||
143044560|NCT00466167|515704346|FG000|Overall Study|Protocol Violation|1|||
143044561|NCT00466167|515704347|FG001|Overall Study|Protocol Violation|1|||
143044562|NCT00466167|515704348|FG002|Overall Study|Protocol Violation|2|||
143044563|NCT00466167|515704346|FG000|Overall Study|Lost to Follow-up|3|||
143044564|NCT00466167|515704347|FG001|Overall Study|Lost to Follow-up|2|||
143044565|NCT00466167|515704348|FG002|Overall Study|Lost to Follow-up|2|||
143044566|NCT00466167|515704346|FG000|Overall Study|Withdrawal by Subject|4|||
143167165|NCT04023487|516158272|FG000|Overall Study|Partially completed testing|8|||
143167166|NCT04023487|516158273|FG001|Overall Study|Partially completed testing|4|||
143167167|NCT05473715|516158276|FG000|Overall Study|Trial terminate|2|||
143167168|NCT05473715|516158277|FG001|Overall Study|Trial terminate|1|||
143167169|NCT02592863|516158279|FG000|Overall Study|Withdrawal by Subject|2|||
143167170|NCT02592863|516158280|FG001|Overall Study|Withdrawal by Subject|2|||
143044567|NCT00466167|515704347|FG001|Overall Study|Withdrawal by Subject|1|||
143044568|NCT00466167|515704348|FG002|Overall Study|Withdrawal by Subject|6|||
143044569|NCT00466167|515704346|FG000|Overall Study|patient did not meet inclusion criteria|1|||
143044570|NCT00466167|515704347|FG001|Overall Study|patient did not meet inclusion criteria|0|||
143044571|NCT00466167|515704348|FG002|Overall Study|patient did not meet inclusion criteria|1|||
143044572|NCT00466167|515704346|FG000|Overall Study|Not treated|1|||
143044573|NCT00466167|515704347|FG001|Overall Study|Not treated|0|||
143167171|NCT02592863|516158279|FG000|Overall Study|Lost to Follow-up|1|||
143167172|NCT02592863|516158280|FG001|Overall Study|Lost to Follow-up|1|||
143167173|NCT02743221|516158281|FG000|Overall Study|Progressive disease|29|||
143167174|NCT02743221|516158282|FG001|Overall Study|Progressive disease|38|||
143167175|NCT02743221|516158281|FG000|Overall Study|Adverse Event|17|||
143167176|NCT02743221|516158282|FG001|Overall Study|Adverse Event|14|||
143167177|NCT02743221|516158281|FG000|Overall Study|non medical reason|8|||
143167178|NCT02743221|516158282|FG001|Overall Study|non medical reason|2|||
143167179|NCT02743221|516158281|FG000|Overall Study|Physician Decision|2|||
143044574|NCT00466167|515704348|FG002|Overall Study|Not treated|0|||
143044575|NCT03256695|515704351|FG000|Overall Study|Adverse Event|8|||
143044576|NCT03256695|515704351|FG000|Overall Study|Death|2|||
143044577|NCT03256695|515704351|FG000|Overall Study|Withdrawal by Subject|14|||
143044578|NCT03256695|515704351|FG000|Overall Study|Non-compliance with study drug|1|||
143044579|NCT03256695|515704351|FG000|Overall Study|Lost to Follow-up|3|||
143044580|NCT03256695|515704351|FG000|Overall Study|Lack of Efficacy|3|||
143044581|NCT03256695|515704351|FG000|Overall Study|Protocol Violation|5|||
143044582|NCT03256695|515704351|FG000|Overall Study|Other than specified|3|||
143044583|NCT01370733|515704356|FG000|Overall Study|Withdrawal by Subject|8|||
143044584|NCT01370733|515704357|FG001|Overall Study|Withdrawal by Subject|8|||
143044585|NCT01370733|515704356|FG000|Overall Study|Lost to Follow-up|3|||
143044586|NCT01370733|515704357|FG001|Overall Study|Lost to Follow-up|0|||
143044587|NCT01370733|515704356|FG000|Overall Study|Adverse Event|2|||
143044588|NCT01370733|515704357|FG001|Overall Study|Adverse Event|4|||
143044589|NCT01370733|515704356|FG000|Overall Study|Lack of Efficacy|3|||
143044590|NCT01370733|515704357|FG001|Overall Study|Lack of Efficacy|5|||
143044591|NCT01370733|515704356|FG000|Overall Study|Physician Decision|0|||
143044592|NCT01370733|515704357|FG001|Overall Study|Physician Decision|2|||
143044593|NCT01370733|515704356|FG000|Overall Study|Protocol Violation|1|||
143044594|NCT01370733|515704357|FG001|Overall Study|Protocol Violation|3|||
143044595|NCT06539676|515704360|FG000|Overall Study|Early study termination|1|||
143044596|NCT06539676|515704361|FG001|Overall Study|Early study termination|0|||
143044597|NCT06539676|515704362|FG002|Overall Study|Early study termination|6|||
143044598|NCT00835692|515704363|FG000|First Intervention|Withdrawal by Subject|1|||
143044599|NCT00835692|515704364|FG001|First Intervention|Withdrawal by Subject|0|||
143044600|NCT04078022|515704367|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
143044601|NCT04078022|515704368|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
143044602|NCT03808376|515704371|FG000|Overall Study|Withdrawal by Subject|10|||
143044603|NCT00700739|515704372|FG000|Overall Study|Lost to Follow-up|4|||
143044604|NCT00700739|515704373|FG001|Overall Study|Lost to Follow-up|4|||
143044605|NCT01348789|515704375|FG000|Overall Study|Protocol Violation|2|||
143044606|NCT01348789|515704375|FG000|Overall Study|Withdrawal by Subject|2|||
143044607|NCT00323882|515704376|FG000|Overall Study|Adverse Event|2|||
143044608|NCT00323882|515704377|FG001|Overall Study|Adverse Event|1|||
143044609|NCT00323882|515704378|FG002|Overall Study|Adverse Event|1|||
143044610|NCT00323882|515704379|FG003|Overall Study|Adverse Event|1|||
143044611|NCT00323882|515704380|FG004|Overall Study|Adverse Event|3|||
143044612|NCT00323882|515704376|FG000|Overall Study|Disease Progression|6|||
143044613|NCT00323882|515704377|FG001|Overall Study|Disease Progression|4|||
143044614|NCT00323882|515704378|FG002|Overall Study|Disease Progression|10|||
143044615|NCT00323882|515704379|FG003|Overall Study|Disease Progression|5|||
143044616|NCT00323882|515704380|FG004|Overall Study|Disease Progression|22|||
143044617|NCT00323882|515704376|FG000|Overall Study|Death|0|||
143044618|NCT00323882|515704377|FG001|Overall Study|Death|1|||
143044619|NCT00323882|515704378|FG002|Overall Study|Death|1|||
143044620|NCT00323882|515704379|FG003|Overall Study|Death|0|||
143044621|NCT00323882|515704380|FG004|Overall Study|Death|5|||
143044622|NCT00323882|515704376|FG000|Overall Study|Lost to Follow-up|0|||
143044623|NCT00323882|515704377|FG001|Overall Study|Lost to Follow-up|0|||
143044624|NCT00323882|515704378|FG002|Overall Study|Lost to Follow-up|1|||
143044625|NCT00323882|515704379|FG003|Overall Study|Lost to Follow-up|0|||
143044626|NCT00323882|515704380|FG004|Overall Study|Lost to Follow-up|1|||
143044627|NCT00323882|515704376|FG000|Overall Study|Other|0|||
143044628|NCT00323882|515704377|FG001|Overall Study|Other|0|||
143044629|NCT00323882|515704378|FG002|Overall Study|Other|0|||
143044630|NCT00323882|515704379|FG003|Overall Study|Other|1|||
143044631|NCT00323882|515704380|FG004|Overall Study|Other|1|||
143044632|NCT03503318|515704384|FG000|Overall Study|Death|1|||
143044633|NCT03503318|515704385|FG001|Overall Study|Death|0|||
143044634|NCT03503318|515704386|FG002|Overall Study|Death|4|||
143044635|NCT03503318|515704384|FG000|Overall Study|Adverse Event|3|||
143044636|NCT03503318|515704385|FG001|Overall Study|Adverse Event|4|||
143167180|NCT02743221|516158282|FG001|Overall Study|Physician Decision|5|||
143044637|NCT03503318|515704386|FG002|Overall Study|Adverse Event|2|||
143044638|NCT03503318|515704384|FG000|Overall Study|Withdrawal by Subject|12|||
143044639|NCT03503318|515704385|FG001|Overall Study|Withdrawal by Subject|17|||
143044640|NCT03503318|515704386|FG002|Overall Study|Withdrawal by Subject|16|||
143167181|NCT02743221|516158281|FG000|Overall Study|Patient not eligible, not treated|0|||
143044641|NCT03503318|515704384|FG000|Overall Study|Protocol Violation|5|||
143044642|NCT03503318|515704385|FG001|Overall Study|Protocol Violation|0|||
143044643|NCT03503318|515704386|FG002|Overall Study|Protocol Violation|3|||
143044644|NCT03503318|515704384|FG000|Overall Study|Lost to Follow-up|17|||
143044645|NCT03503318|515704385|FG001|Overall Study|Lost to Follow-up|15|||
143044646|NCT03503318|515704386|FG002|Overall Study|Lost to Follow-up|12|||
143044647|NCT03503318|515704384|FG000|Overall Study|Other than specified|1|||
143044648|NCT03503318|515704385|FG001|Overall Study|Other than specified|3|||
143044649|NCT03503318|515704386|FG002|Overall Study|Other than specified|3|||
143044650|NCT06999265|515704389|FG000|Overall Study|Lost to Follow-up|1|||
143044651|NCT06999265|515704390|FG001|Overall Study|Lost to Follow-up|1|||
143044652|NCT01154231|515704394|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
143044653|NCT01154231|515704394|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
143044654|NCT01030133|515704395|FG000|Overall Study|failed to experience pain at level 7/10|2|||
143044655|NCT01030133|515704396|FG001|Overall Study|failed to experience pain at level 7/10|2|||
143044656|NCT01097577|515704404|FG000|Overall Study|Adverse Event|0|||
143044657|NCT01097577|515704405|FG001|Overall Study|Adverse Event|1|||
143044658|NCT01958294|515705943|FG000|Overall Study|Clinical Circumstances|2|||
143167182|NCT02743221|516158282|FG001|Overall Study|Patient not eligible, not treated|1|||
143167183|NCT03528902|516158285|FG000|Overall Study|Adverse Event|1|||
143167184|NCT03528902|516158286|FG001|Overall Study|Adverse Event|0|||
143167185|NCT03411044|516158287|FG000|Overall Study|Death|30|||
143167186|NCT03411044|516158287|FG000|Overall Study|Withdrawal by Subject|48|||
143167187|NCT03411044|516158287|FG000|Overall Study|Lost to Follow-up|78|||
143167188|NCT03411044|516158287|FG000|Overall Study|Adverse Event|30|||
143167189|NCT03411044|516158287|FG000|Overall Study|Missing status|4|||
143044659|NCT01624233|515705944|FG000|Period 2 - Induction|Adverse Event|1|||
143044660|NCT01624233|515705944|FG000|Period 3 - Maintenance|Adverse Event|2|||
143044661|NCT01624233|515705944|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
143044662|NCT01624233|515705944|FG000|Period 3 - Maintenance|Physician Decision|2|||
143044663|NCT01624233|515705944|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
143044664|NCT01624233|515705944|FG000|Period 4 - Drug Free Period|Relapsed|61|||
143044665|NCT01624233|515705944|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
143044666|NCT01624233|515705944|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
143044667|NCT01624233|515705944|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
143044668|NCT01624233|515705944|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
143044669|NCT01624233|515705944|FG000|Period 6: Follow-up|Adverse Event|3|||
143044670|NCT01624233|515705944|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
143044671|NCT01624233|515705944|FG000|Period 6: Follow-up|Physician Decision|1|||
143044672|NCT01624233|515705944|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
143044673|NCT01056484|515705949|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
143044674|NCT01056484|515705950|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
143044675|NCT01056484|515705949|FG000|Randomized Controlled Trial|Physician Decision|1|||
143044676|NCT01056484|515705950|FG001|Randomized Controlled Trial|Physician Decision|0|||
143044677|NCT01056484|515705949|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
143044678|NCT01056484|515705950|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
143242715|NCT02377817|516439655|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
143242716|NCT02377817|516439656|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
143044679|NCT00446966|515705953|FG000|Overall Study|Lost to Follow-up|10|||
143044680|NCT00446966|515705954|FG001|Overall Study|Lost to Follow-up|7|||
143044681|NCT00443651|515705955|FG000|Overall Study|Death|1|||
143044682|NCT00443651|515705956|FG001|Overall Study|Death|5|||
143044683|NCT00443651|515705955|FG000|Overall Study|Adverse Event|5|||
143167190|NCT02609503|516158289|FG000|Overall Study|Adverse Event|1|||
143167191|NCT02609503|516158289|FG000|Overall Study|Death|1|||
143167192|NCT02609503|516158289|FG000|Overall Study|Withdrawal by Subject|1|||
143167193|NCT02609503|516158289|FG000|Overall Study|Disease progression|1|||
143167194|NCT03900650|516158293|FG000|Overall Study|Withdrawal by Subject|1|||
143167195|NCT03900650|516158294|FG001|Overall Study|Withdrawal by Subject|1|||
143167196|NCT03900650|516158295|FG002|Overall Study|Withdrawal by Subject|0|||
143167197|NCT03900650|516158296|FG003|Overall Study|Withdrawal by Subject|0|||
143167198|NCT03900650|516158293|FG000|Overall Study|Withdrawn by staff|1|||
143167199|NCT03900650|516158294|FG001|Overall Study|Withdrawn by staff|0|||
143167200|NCT03900650|516158295|FG002|Overall Study|Withdrawn by staff|0|||
143167201|NCT03900650|516158296|FG003|Overall Study|Withdrawn by staff|0|||
143167202|NCT02457065|516158297|FG000|Overall Study|Lost to Follow-up|9|||
143167203|NCT02457065|516158298|FG001|Overall Study|Lost to Follow-up|11|||
143242717|NCT02839200|516439657|FG000|Overall Study|Withdrawal by Subject|2|||
143242718|NCT02839200|516439658|FG001|Overall Study|Withdrawal by Subject|0|||
143242719|NCT02839200|516439659|FG002|Overall Study|Withdrawal by Subject|1|||
143044684|NCT00443651|515705956|FG001|Overall Study|Adverse Event|6|||
143044685|NCT00443651|515705955|FG000|Overall Study|Lost to Follow-up|18|||
143044686|NCT00443651|515705956|FG001|Overall Study|Lost to Follow-up|12|||
143044687|NCT00443651|515705955|FG000|Overall Study|Patient's/Guardian's Decision|58|||
143044688|NCT00443651|515705956|FG001|Overall Study|Patient's/Guardian's Decision|30|||
143044689|NCT00443651|515705955|FG000|Overall Study|Physician Decision|13|||
143044690|NCT00443651|515705956|FG001|Overall Study|Physician Decision|4|||
143167204|NCT04642079|516158304|FG000|Overall Study|Lost to Follow-up|2|||
143167205|NCT04642079|516158305|FG001|Overall Study|Lost to Follow-up|5|||
143167206|NCT04642079|516158306|FG002|Overall Study|Lost to Follow-up|2|||
143167207|NCT04642079|516158307|FG003|Overall Study|Lost to Follow-up|0|||
143167208|NCT04642079|516158304|FG000|Overall Study|Withdrawal by Subject|0|||
143044691|NCT00443651|515705955|FG000|Overall Study|Pregnancy|0|||
143044692|NCT00443651|515705956|FG001|Overall Study|Pregnancy|1|||
143044693|NCT00859521|515705961|FG000|Washout|Withdrawal by Subject|0|||
143044694|NCT00859521|515705962|FG001|Washout|Withdrawal by Subject|1|||
143044695|NCT02125461|515705963|FG000|Overall Study|Withdrawal by Subject|30|||
143044696|NCT02125461|515705964|FG001|Overall Study|Withdrawal by Subject|16|||
143044697|NCT02125461|515705963|FG000|Overall Study|Lost to Follow-up|8|||
143044698|NCT02125461|515705964|FG001|Overall Study|Lost to Follow-up|3|||
143044699|NCT02125461|515705963|FG000|Overall Study|Death|260|||
143044700|NCT02125461|515705964|FG001|Overall Study|Death|149|||
143044701|NCT02125461|515705963|FG000|Overall Study|Missing Termination Reason|0|||
143044702|NCT02125461|515705964|FG001|Overall Study|Missing Termination Reason|1|||
143044703|NCT02888756|515705968|FG000|Analytical Treatment Interruption|Physician Decision|10|||
143044704|NCT02888756|515705969|FG001|Analytical Treatment Interruption|Physician Decision|6|||
143044705|NCT02888756|515705970|FG002|Analytical Treatment Interruption|Physician Decision|5|||
143044706|NCT01547286|515705977|FG000|Overall Study|Did not meet all eligibility criteria|1|||
143044707|NCT01547286|515705977|FG000|Overall Study|Physician Decision|1|||
143044708|NCT03415308|515705978|FG000|Overall Study|Lost to Follow-up|0|||
143044709|NCT03415308|515705979|FG001|Overall Study|Lost to Follow-up|0|||
143044710|NCT03415308|515705980|FG002|Overall Study|Lost to Follow-up|1|||
143044711|NCT03415308|515705978|FG000|Overall Study|Scheduling Conflicts|0|||
143044712|NCT03415308|515705979|FG001|Overall Study|Scheduling Conflicts|0|||
143044713|NCT03415308|515705980|FG002|Overall Study|Scheduling Conflicts|7|||
143044714|NCT01471353|515705982|FG000|Overall Study|remain on study|3|||
143044715|NCT01695239|515705983|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
143044716|NCT01695239|515705984|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
143044717|NCT01695239|515705985|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
143044718|NCT01695239|515705986|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
143044719|NCT01695239|515705987|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
143044720|NCT01695239|515705988|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
143044721|NCT01695239|515705989|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
143044722|NCT01695239|515705990|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
143044723|NCT01695239|515705991|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
143044724|NCT01695239|515705992|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
143044725|NCT01695239|515705993|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
143044726|NCT01695239|515705994|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
143044727|NCT01695239|515705995|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
143044728|NCT01695239|515705996|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
143044729|NCT01695239|515705983|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
143044730|NCT01695239|515705984|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
143044731|NCT01695239|515705985|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
143044732|NCT01695239|515705986|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
143044733|NCT01695239|515705987|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
143044734|NCT01695239|515705988|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
143044735|NCT01695239|515705989|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
143044736|NCT01695239|515705990|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
143044737|NCT01695239|515705991|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
143044738|NCT01695239|515705992|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
143044739|NCT01695239|515705993|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
143044740|NCT01695239|515705994|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
143044741|NCT01695239|515705995|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
143044742|NCT01695239|515705996|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
143167209|NCT04642079|516158305|FG001|Overall Study|Withdrawal by Subject|4|||
143167210|NCT04642079|516158306|FG002|Overall Study|Withdrawal by Subject|1|||
143167211|NCT04642079|516158307|FG003|Overall Study|Withdrawal by Subject|2|||
143044743|NCT01695239|515705983|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
143044744|NCT01695239|515705984|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
143044745|NCT01695239|515705985|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
143044746|NCT01695239|515705986|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
143044747|NCT01695239|515705987|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
143044748|NCT01695239|515705988|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
143044749|NCT01695239|515705989|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
143044750|NCT01695239|515705990|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
143044751|NCT01695239|515705991|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
143044752|NCT01695239|515705992|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
143044753|NCT01695239|515705993|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
143044754|NCT01695239|515705994|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
143044755|NCT01695239|515705995|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
143167212|NCT04642079|516158304|FG000|Overall Study|Other|0|||
143242720|NCT02839200|516439660|FG003|Overall Study|Withdrawal by Subject|0|||
143242721|NCT02839200|516439661|FG004|Overall Study|Withdrawal by Subject|0|||
143242722|NCT02839200|516439662|FG005|Overall Study|Withdrawal by Subject|1|||
143242723|NCT02839200|516439657|FG000|Overall Study|Lost to Follow-up|2|||
143242724|NCT02839200|516439658|FG001|Overall Study|Lost to Follow-up|0|||
143242725|NCT02839200|516439659|FG002|Overall Study|Lost to Follow-up|0|||
143242726|NCT02839200|516439660|FG003|Overall Study|Lost to Follow-up|0|||
143242727|NCT02839200|516439661|FG004|Overall Study|Lost to Follow-up|1|||
143242728|NCT02839200|516439662|FG005|Overall Study|Lost to Follow-up|0|||
143242729|NCT02839200|516439657|FG000|Overall Study|Adverse Event|0|||
143242730|NCT02839200|516439658|FG001|Overall Study|Adverse Event|0|||
143242731|NCT02839200|516439659|FG002|Overall Study|Adverse Event|0|||
143242732|NCT02839200|516439660|FG003|Overall Study|Adverse Event|0|||
143242733|NCT02839200|516439661|FG004|Overall Study|Adverse Event|1|||
143242734|NCT02839200|516439662|FG005|Overall Study|Adverse Event|0|||
143242735|NCT02839200|516439657|FG000|Overall Study|Randomized in error|0|||
143242736|NCT02839200|516439658|FG001|Overall Study|Randomized in error|1|||
143242737|NCT02839200|516439659|FG002|Overall Study|Randomized in error|0|||
143242738|NCT02839200|516439660|FG003|Overall Study|Randomized in error|0|||
143242739|NCT02839200|516439661|FG004|Overall Study|Randomized in error|0|||
143242740|NCT02839200|516439662|FG005|Overall Study|Randomized in error|0|||
143242741|NCT02565108|516439663|FG000|Overall Study|Adverse Event|1|||
143242742|NCT02565108|516439664|FG001|Overall Study|Adverse Event|0|||
143242743|NCT02565108|516439663|FG000|Overall Study|Withdrew Consent|1|||
143242744|NCT02565108|516439664|FG001|Overall Study|Withdrew Consent|0|||
143242745|NCT01310075|516439665|FG000|Overall Study|Lost to Follow-up|1|||
143242746|NCT01310075|516439666|FG001|Overall Study|Lost to Follow-up|0|||
143242747|NCT01310075|516439665|FG000|Overall Study|Physician Decision|10|||
143242748|NCT01310075|516439666|FG001|Overall Study|Physician Decision|7|||
143242749|NCT01310075|516439665|FG000|Overall Study|Protocol Violation|2|||
143242750|NCT01310075|516439666|FG001|Overall Study|Protocol Violation|2|||
143242751|NCT01310075|516439665|FG000|Overall Study|Withdrawal by Subject|1|||
143242752|NCT01310075|516439666|FG001|Overall Study|Withdrawal by Subject|1|||
143242753|NCT04287517|516439668|FG000|Overall Study|Withdrawal by Subject|1|||
143242754|NCT04287517|516439669|FG001|Overall Study|Withdrawal by Subject|1|||
143242755|NCT02721966|516439670|FG000|Overall Study|Protocol Violation|1|||
143242756|NCT02721966|516439671|FG001|Overall Study|Protocol Violation|0|||
143242757|NCT02721966|516439672|FG002|Overall Study|Protocol Violation|0|||
143242758|NCT02721966|516439673|FG003|Overall Study|Protocol Violation|0|||
143242759|NCT02721966|516439674|FG004|Overall Study|Protocol Violation|0|||
143242760|NCT02721966|516439670|FG000|Overall Study|Withdrawal by Subject|9|||
143242761|NCT02721966|516439671|FG001|Overall Study|Withdrawal by Subject|2|||
143242762|NCT02721966|516439672|FG002|Overall Study|Withdrawal by Subject|3|||
143242763|NCT02721966|516439673|FG003|Overall Study|Withdrawal by Subject|7|||
143242764|NCT02721966|516439674|FG004|Overall Study|Withdrawal by Subject|0|||
143242765|NCT02721966|516439670|FG000|Overall Study|Adverse Event|4|||
143242766|NCT02721966|516439671|FG001|Overall Study|Adverse Event|4|||
143242767|NCT02721966|516439672|FG002|Overall Study|Adverse Event|3|||
143242768|NCT02721966|516439673|FG003|Overall Study|Adverse Event|0|||
143242769|NCT02721966|516439674|FG004|Overall Study|Adverse Event|0|||
143242770|NCT02721966|516439670|FG000|Overall Study|Death|1|||
143242771|NCT02721966|516439671|FG001|Overall Study|Death|0|||
143242772|NCT02721966|516439672|FG002|Overall Study|Death|0|||
143242773|NCT02721966|516439673|FG003|Overall Study|Death|0|||
143242774|NCT02721966|516439674|FG004|Overall Study|Death|0|||
143242775|NCT02721966|516439670|FG000|Overall Study|Lack of Efficacy|7|||
143242776|NCT02721966|516439671|FG001|Overall Study|Lack of Efficacy|4|||
143242777|NCT02721966|516439672|FG002|Overall Study|Lack of Efficacy|0|||
143242778|NCT02721966|516439673|FG003|Overall Study|Lack of Efficacy|0|||
143242779|NCT02721966|516439674|FG004|Overall Study|Lack of Efficacy|0|||
143242780|NCT02721966|516439670|FG000|Overall Study|Lost to Follow-up|0|||
143242781|NCT02721966|516439671|FG001|Overall Study|Lost to Follow-up|0|||
143242782|NCT02721966|516439672|FG002|Overall Study|Lost to Follow-up|3|||
143242783|NCT02721966|516439673|FG003|Overall Study|Lost to Follow-up|0|||
143242784|NCT02721966|516439674|FG004|Overall Study|Lost to Follow-up|0|||
143242785|NCT02721966|516439670|FG000|Overall Study|Physician Decision|1|||
143242786|NCT02721966|516439671|FG001|Overall Study|Physician Decision|1|||
143242787|NCT02721966|516439672|FG002|Overall Study|Physician Decision|0|||
143242788|NCT02721966|516439673|FG003|Overall Study|Physician Decision|0|||
143364295|NCT00409708|516876956|FG001|Washout|Lack of Efficacy|1|||
143242789|NCT02721966|516439674|FG004|Overall Study|Physician Decision|0|||
143242790|NCT02721966|516439670|FG000|Overall Study|Pregnancy|1|||
143242791|NCT02721966|516439671|FG001|Overall Study|Pregnancy|0|||
143242792|NCT02721966|516439672|FG002|Overall Study|Pregnancy|0|||
143242793|NCT02721966|516439673|FG003|Overall Study|Pregnancy|0|||
143242794|NCT02721966|516439674|FG004|Overall Study|Pregnancy|0|||
143242795|NCT02721966|516439670|FG000|Overall Study|Did not continue to period 2|5|||
143242796|NCT02721966|516439671|FG001|Overall Study|Did not continue to period 2|12|||
143242797|NCT02721966|516439672|FG002|Overall Study|Did not continue to period 2|0|||
143242798|NCT02721966|516439673|FG003|Overall Study|Did not continue to period 2|0|||
143044756|NCT01695239|515705996|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
143044757|NCT01695239|515705983|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
143044758|NCT01695239|515705984|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
143044759|NCT01695239|515705985|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
143044760|NCT01695239|515705986|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
143044761|NCT01695239|515705987|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
143044762|NCT01695239|515705988|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
143044763|NCT01695239|515705989|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
143044764|NCT01695239|515705990|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
143044765|NCT01695239|515705991|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
143044766|NCT01695239|515705992|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
143044767|NCT01695239|515705993|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
143044768|NCT01695239|515705994|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
143044769|NCT01695239|515705995|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
143044770|NCT01695239|515705996|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
143044771|NCT01695239|515705983|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
143044772|NCT01695239|515705984|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
143044773|NCT01695239|515705985|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
143044774|NCT01695239|515705986|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
143044775|NCT01695239|515705987|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
143044776|NCT01695239|515705988|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
143044777|NCT01695239|515705989|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
143044778|NCT01695239|515705990|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
143044779|NCT01695239|515705991|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
143044780|NCT01695239|515705992|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
143044781|NCT01695239|515705993|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
143044782|NCT01695239|515705994|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
143044783|NCT01695239|515705995|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
143044784|NCT01695239|515705996|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
143044785|NCT01695239|515705983|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
143044786|NCT01695239|515705984|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
143044787|NCT01695239|515705985|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
143044788|NCT01695239|515705986|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
143044789|NCT01695239|515705987|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
143044790|NCT01695239|515705988|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
143044791|NCT01695239|515705989|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
143044792|NCT01695239|515705990|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
143044793|NCT01695239|515705991|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
143044794|NCT01695239|515705992|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
143044795|NCT01695239|515705993|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
143167213|NCT04642079|516158305|FG001|Overall Study|Other|0|||
143167214|NCT04642079|516158306|FG002|Overall Study|Other|0|||
143167215|NCT04642079|516158307|FG003|Overall Study|Other|1|||
143167216|NCT04642079|516158304|FG000|Overall Study|No longer met eligibility criteria|1|||
143167217|NCT04642079|516158305|FG001|Overall Study|No longer met eligibility criteria|0|||
143167218|NCT04642079|516158306|FG002|Overall Study|No longer met eligibility criteria|1|||
143167219|NCT04642079|516158307|FG003|Overall Study|No longer met eligibility criteria|1|||
143167220|NCT04875533|516158316|FG000|Overall Study|Adverse Event|6|||
143167221|NCT04875533|516158317|FG001|Overall Study|Adverse Event|4|||
143167222|NCT04875533|516158316|FG000|Overall Study|Protocol Violation|4|||
143167223|NCT04875533|516158317|FG001|Overall Study|Protocol Violation|0|||
143167224|NCT04875533|516158316|FG000|Overall Study|Withdrawal by Subject|8|||
143167225|NCT04875533|516158317|FG001|Overall Study|Withdrawal by Subject|5|||
143167226|NCT04875533|516158316|FG000|Overall Study|No longer meets eligibility criteria|1|||
143167227|NCT04875533|516158317|FG001|Overall Study|No longer meets eligibility criteria|0|||
143167228|NCT04875533|516158316|FG000|Overall Study|Other|0|||
143167229|NCT04875533|516158317|FG001|Overall Study|Other|2|||
143167230|NCT00539500|516158318|FG000|Overall Study|Disease Progression|1|||
143167231|NCT00539500|516158318|FG000|Overall Study|Lost to Follow-up|2|||
143167232|NCT02904096|516158319|FG000|Overall Study|Adverse Event|1|||
143167233|NCT02904096|516158320|FG001|Overall Study|Adverse Event|0|||
143167234|NCT02904096|516158319|FG000|Overall Study|Withdrawal by Subject|4|||
143167235|NCT02904096|516158320|FG001|Overall Study|Withdrawal by Subject|3|||
143167236|NCT02904096|516158319|FG000|Overall Study|Lost to Follow-up|10|||
143167237|NCT02904096|516158320|FG001|Overall Study|Lost to Follow-up|17|||
143167238|NCT02904096|516158319|FG000|Overall Study|Non-compliant|3|||
143167239|NCT02904096|516158320|FG001|Overall Study|Non-compliant|1|||
143167240|NCT02904096|516158319|FG000|Overall Study|Sponsor instructed|1|||
143167241|NCT02904096|516158320|FG001|Overall Study|Sponsor instructed|0|||
143167242|NCT00526799|516158321|FG000|Overall Study|Withdrawal by Subject|1|||
143044796|NCT01695239|515705994|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
143044797|NCT01695239|515705995|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
143044798|NCT01695239|515705996|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
143044799|NCT01695239|515705983|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
143044800|NCT01695239|515705984|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
143044801|NCT01695239|515705985|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
143044802|NCT01695239|515705986|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
143044803|NCT01695239|515705987|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
143044804|NCT01695239|515705988|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
143044805|NCT01695239|515705989|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
143044806|NCT01695239|515705990|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
143044807|NCT01695239|515705991|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
143044808|NCT01695239|515705992|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
143044809|NCT01695239|515705993|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
143044810|NCT01695239|515705994|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
143044811|NCT01695239|515705995|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
143044812|NCT01695239|515705996|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
143044813|NCT01695239|515705983|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
143044814|NCT01695239|515705984|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
143044815|NCT01695239|515705985|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
143044816|NCT01695239|515705986|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
143044817|NCT01695239|515705987|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
143044818|NCT01695239|515705988|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
143044819|NCT01695239|515705989|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
143044820|NCT01695239|515705990|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
143044821|NCT01695239|515705991|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
143044822|NCT01695239|515705992|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
143044823|NCT01695239|515705993|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
143044824|NCT01695239|515705994|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
143044825|NCT01695239|515705995|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
143044826|NCT01695239|515705996|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
143044827|NCT01695239|515705983|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
143044828|NCT01695239|515705984|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
143044829|NCT01695239|515705985|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
143044830|NCT01695239|515705986|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
143044831|NCT01695239|515705987|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
143167243|NCT00526799|516158322|FG001|Overall Study|Withdrawal by Subject|0|||
143167244|NCT00526799|516158321|FG000|Overall Study|Intercurrent Complicating Disease|0|||
143167245|NCT00526799|516158322|FG001|Overall Study|Intercurrent Complicating Disease|1|||
143167246|NCT04134936|516158327|FG000|Overall Study|Adverse Event|3|||
143167247|NCT04134936|516158328|FG001|Overall Study|Adverse Event|2|||
143167248|NCT04134936|516158327|FG000|Overall Study|Withdrawal by Subject|2|||
143242799|NCT02721966|516439674|FG004|Overall Study|Did not continue to period 2|5|||
143242800|NCT03857867|516439675|FG000|Overall Study|Physician Decision|1|||
143242801|NCT01286480|516439676|FG000|Overall Study|Withdrawal by Subject|5|||
143242802|NCT01286480|516439677|FG001|Overall Study|Withdrawal by Subject|3|||
143242803|NCT00834093|516439678|FG000|Overall Study|Progressive Disease|3|||
143242804|NCT00834093|516439678|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
143242805|NCT01578486|516439679|FG000|Overall Study|Physician Decision|3|||
143242806|NCT01578486|516439679|FG000|Overall Study|Withdrawal by Subject|2|||
143242807|NCT00607373|516439680|FG000|Treatment Period|Adverse Event|0|||
143242808|NCT00607373|516439681|FG001|Treatment Period|Adverse Event|4|||
143242809|NCT00607373|516439680|FG000|Treatment Period|Physician Decision|0|||
143242810|NCT00607373|516439681|FG001|Treatment Period|Physician Decision|1|||
143242811|NCT00607373|516439680|FG000|Treatment Period|Withdrawal by Subject|0|||
143242812|NCT00607373|516439681|FG001|Treatment Period|Withdrawal by Subject|1|||
143242813|NCT00607373|516439680|FG000|Follow-up Period|Other|0|||
143242814|NCT00607373|516439681|FG001|Follow-up Period|Other|1|||
143242815|NCT00607373|516439680|FG000|Follow-up Period|Protocol Violation|0|||
143044832|NCT01695239|515705988|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
143167249|NCT04134936|516158328|FG001|Overall Study|Withdrawal by Subject|3|||
143167250|NCT04134936|516158327|FG000|Overall Study|Physician Decision|0|||
143167251|NCT04134936|516158328|FG001|Overall Study|Physician Decision|1|||
143167252|NCT04134936|516158327|FG000|Overall Study|Progressive disease, joined another trial|1|||
143167253|NCT04134936|516158328|FG001|Overall Study|Progressive disease, joined another trial|0|||
143242816|NCT00607373|516439681|FG001|Follow-up Period|Protocol Violation|1|||
143242817|NCT00607373|516439680|FG000|Follow-up Period|Withdrawal by Subject|1|||
143242818|NCT00607373|516439681|FG001|Follow-up Period|Withdrawal by Subject|3|||
143242819|NCT02170077|516439682|FG000|Overall Study|Withdrawal by Subject|3|||
143242820|NCT02170077|516439683|FG001|Overall Study|Withdrawal by Subject|4|||
143242821|NCT02170077|516439684|FG002|Overall Study|Withdrawal by Subject|2|||
143242822|NCT02170077|516439682|FG000|Overall Study|Adverse Event|4|||
143242823|NCT02170077|516439683|FG001|Overall Study|Adverse Event|4|||
143242824|NCT02170077|516439684|FG002|Overall Study|Adverse Event|4|||
143242825|NCT02170077|516439682|FG000|Overall Study|Lost to Follow-up|0|||
143242826|NCT02170077|516439683|FG001|Overall Study|Lost to Follow-up|1|||
143242827|NCT02170077|516439684|FG002|Overall Study|Lost to Follow-up|0|||
143242828|NCT02170077|516439682|FG000|Overall Study|Exclusion criteria|2|||
143242829|NCT02170077|516439683|FG001|Overall Study|Exclusion criteria|2|||
143242830|NCT02170077|516439684|FG002|Overall Study|Exclusion criteria|5|||
143242831|NCT02170077|516439682|FG000|Overall Study|Exacerbation of seizures|0|||
143242832|NCT02170077|516439683|FG001|Overall Study|Exacerbation of seizures|2|||
143242833|NCT02170077|516439684|FG002|Overall Study|Exacerbation of seizures|1|||
143242834|NCT01958164|516439685|FG000|Overall Study|Adverse Event|0|||
143242835|NCT01958164|516439686|FG001|Overall Study|Adverse Event|2|||
143242836|NCT01958164|516439685|FG000|Overall Study|Lost to Follow-up|2|||
143044833|NCT01695239|515705989|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
143044834|NCT01695239|515705990|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
143044835|NCT01695239|515705991|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
143044836|NCT01695239|515705992|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
143044837|NCT01695239|515705993|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
143044838|NCT01695239|515705994|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
143044839|NCT01695239|515705995|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
143242837|NCT01958164|516439686|FG001|Overall Study|Lost to Follow-up|3|||
143242838|NCT01780974|516439689|FG000|Overall Study|Death|1|||
143242839|NCT01780974|516439690|FG001|Overall Study|Death|0|||
143242840|NCT01780974|516439689|FG000|Overall Study|Adverse Event|1|||
143242841|NCT01780974|516439690|FG001|Overall Study|Adverse Event|3|||
143242842|NCT01724346|516439691|FG000|Overall Study|Death|42|||
143242843|NCT01724346|516439692|FG001|Overall Study|Death|42|||
143242844|NCT01724346|516439691|FG000|Overall Study|Lost to Follow-up|5|||
143242845|NCT01724346|516439692|FG001|Overall Study|Lost to Follow-up|1|||
143242846|NCT01724346|516439691|FG000|Overall Study|Withdrawal by Subject|27|||
143242847|NCT01724346|516439692|FG001|Overall Study|Withdrawal by Subject|19|||
143242848|NCT01724346|516439691|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
143242849|NCT01724346|516439692|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
143242850|NCT00525161|516439695|FG000|Overall Study|Adverse Event|1|||
143242851|NCT01076361|516439696|FG000|Overall Study|22 leads were excluded from analysis|21|||
143242852|NCT01642589|516439699|FG000|Overall Study|Withdrawal by Subject|1|||
143242853|NCT01642589|516439700|FG001|Overall Study|Withdrawal by Subject|1|||
143242854|NCT02581410|516439701|FG000|Vaccination Phase|Adverse Event|2|||
143242855|NCT02581410|516439702|FG001|Vaccination Phase|Adverse Event|1|||
143242856|NCT02581410|516439701|FG000|Vaccination Phase|Withdrawal by Subject|0|||
143242857|NCT02581410|516439702|FG001|Vaccination Phase|Withdrawal by Subject|1|||
143242858|NCT02581410|516439701|FG000|Vaccination Phase|Migrated/moved from study area|0|||
143242859|NCT02581410|516439702|FG001|Vaccination Phase|Migrated/moved from study area|1|||
143242860|NCT02581410|516439701|FG000|End of Study Phase|Adverse Event|4|||
143242861|NCT02581410|516439702|FG001|End of Study Phase|Adverse Event|3|||
143242862|NCT02581410|516439701|FG000|End of Study Phase|Withdrawal by Subject|1|||
143242863|NCT02581410|516439702|FG001|End of Study Phase|Withdrawal by Subject|2|||
143242864|NCT02581410|516439701|FG000|End of Study Phase|Migrated/moved from study area|0|||
143242865|NCT02581410|516439702|FG001|End of Study Phase|Migrated/moved from study area|3|||
143242866|NCT02581410|516439701|FG000|End of Study Phase|Lost to Follow-up|0|||
143242867|NCT02581410|516439702|FG001|End of Study Phase|Lost to Follow-up|2|||
143242868|NCT02581410|516439701|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
143242869|NCT02581410|516439702|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
143242870|NCT02908672|516439703|FG000|Run-in Period|Death|12|||
143242871|NCT02908672|516439704|FG001|Run-in Period|Death|10|||
143242872|NCT02908672|516439705|FG002|Run-in Period|Death|0|||
143242873|NCT02908672|516439706|FG003|Run-in Period|Death|0|||
143242874|NCT02908672|516439703|FG000|Run-in Period|Lost to Follow-up|1|||
143242875|NCT02908672|516439704|FG001|Run-in Period|Lost to Follow-up|1|||
143044840|NCT01695239|515705996|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
143044841|NCT01695239|515705983|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
143242876|NCT02908672|516439705|FG002|Run-in Period|Lost to Follow-up|0|||
143242877|NCT02908672|516439706|FG003|Run-in Period|Lost to Follow-up|0|||
143242878|NCT02908672|516439703|FG000|Run-in Period|Reason Not Specified|2|||
143242879|NCT02908672|516439704|FG001|Run-in Period|Reason Not Specified|0|||
143242880|NCT02908672|516439705|FG002|Run-in Period|Reason Not Specified|0|||
143242881|NCT02908672|516439706|FG003|Run-in Period|Reason Not Specified|0|||
143242882|NCT02908672|516439703|FG000|Run-in Period|Protocol Violation|1|||
143242883|NCT02908672|516439704|FG001|Run-in Period|Protocol Violation|1|||
143242884|NCT02908672|516439705|FG002|Run-in Period|Protocol Violation|0|||
143242885|NCT02908672|516439706|FG003|Run-in Period|Protocol Violation|0|||
143044842|NCT01695239|515705984|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
143044843|NCT01695239|515705985|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
143044844|NCT01695239|515705986|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
143044845|NCT01695239|515705987|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
143044846|NCT01695239|515705988|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
143044847|NCT01695239|515705989|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
143044848|NCT01695239|515705990|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
143044849|NCT01695239|515705991|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
143044850|NCT01695239|515705992|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
143044851|NCT01695239|515705993|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
143044852|NCT01695239|515705994|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
143044853|NCT01695239|515705995|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
143044854|NCT01695239|515705996|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
143044855|NCT01695239|515705983|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
143044856|NCT01695239|515705984|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
143044857|NCT01695239|515705985|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
143044858|NCT01695239|515705986|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
143044859|NCT01695239|515705987|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
143044860|NCT01695239|515705988|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
143044861|NCT01695239|515705989|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
143044862|NCT01695239|515705990|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
143044863|NCT01695239|515705991|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
143044864|NCT01695239|515705992|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
143044865|NCT01695239|515705993|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
143044866|NCT01695239|515705994|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
143044867|NCT01695239|515705995|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
143044868|NCT01695239|515705996|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
143044869|NCT01695239|515705983|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
143044870|NCT01695239|515705984|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
143044871|NCT01695239|515705985|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
143044872|NCT01695239|515705986|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
143044873|NCT01695239|515705987|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
143044874|NCT01695239|515705988|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
143044875|NCT01695239|515705989|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
143044876|NCT01695239|515705990|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
143044877|NCT01695239|515705991|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
143044878|NCT01695239|515705992|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
143044879|NCT01695239|515705993|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
143242886|NCT02908672|516439703|FG000|Run-in Period|Study Ended by Sponsor|5|||
143242887|NCT02908672|516439704|FG001|Run-in Period|Study Ended by Sponsor|1|||
143242888|NCT02908672|516439705|FG002|Run-in Period|Study Ended by Sponsor|0|||
143242889|NCT02908672|516439706|FG003|Run-in Period|Study Ended by Sponsor|0|||
143242890|NCT02908672|516439703|FG000|Run-in Period|Withdrawal by Subject|3|||
143242891|NCT02908672|516439704|FG001|Run-in Period|Withdrawal by Subject|9|||
143242892|NCT02908672|516439705|FG002|Run-in Period|Withdrawal by Subject|0|||
143242893|NCT02908672|516439706|FG003|Run-in Period|Withdrawal by Subject|0|||
143242894|NCT02908672|516439703|FG000|Triple Combination Period|Death|0|||
143242895|NCT02908672|516439704|FG001|Triple Combination Period|Death|0|||
143242896|NCT02908672|516439705|FG002|Triple Combination Period|Death|150|||
143242897|NCT02908672|516439706|FG003|Triple Combination Period|Death|127|||
143242898|NCT02908672|516439703|FG000|Triple Combination Period|Lost to Follow-up|0|||
143242899|NCT02908672|516439704|FG001|Triple Combination Period|Lost to Follow-up|0|||
143242900|NCT02908672|516439705|FG002|Triple Combination Period|Lost to Follow-up|6|||
143242901|NCT02908672|516439706|FG003|Triple Combination Period|Lost to Follow-up|8|||
143242902|NCT02908672|516439703|FG000|Triple Combination Period|Reason Not Specified|0|||
143242903|NCT02908672|516439704|FG001|Triple Combination Period|Reason Not Specified|0|||
143242904|NCT02908672|516439705|FG002|Triple Combination Period|Reason Not Specified|0|||
143242905|NCT02908672|516439706|FG003|Triple Combination Period|Reason Not Specified|1|||
143242906|NCT02908672|516439703|FG000|Triple Combination Period|Physician Decision|0|||
143242907|NCT02908672|516439704|FG001|Triple Combination Period|Physician Decision|0|||
143242908|NCT02908672|516439705|FG002|Triple Combination Period|Physician Decision|1|||
143242909|NCT02908672|516439706|FG003|Triple Combination Period|Physician Decision|1|||
143242910|NCT02908672|516439703|FG000|Triple Combination Period|Study Ended by Sponsor|0|||
143242911|NCT02908672|516439704|FG001|Triple Combination Period|Study Ended by Sponsor|0|||
143242912|NCT02908672|516439705|FG002|Triple Combination Period|Study Ended by Sponsor|61|||
143242913|NCT02908672|516439706|FG003|Triple Combination Period|Study Ended by Sponsor|77|||
143242914|NCT02908672|516439703|FG000|Triple Combination Period|Withdrawal by Subject|0|||
143242915|NCT02908672|516439704|FG001|Triple Combination Period|Withdrawal by Subject|0|||
143044880|NCT01695239|515705994|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
143044881|NCT01695239|515705995|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
143044882|NCT01695239|515705996|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
143044883|NCT01695239|515705983|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
143044884|NCT01695239|515705984|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
143044885|NCT01695239|515705985|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
143044886|NCT01695239|515705986|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
143044887|NCT01695239|515705987|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
143044888|NCT01695239|515705988|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
143044889|NCT01695239|515705989|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
143044890|NCT01695239|515705990|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
143044891|NCT01695239|515705991|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
143044892|NCT01695239|515705992|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
143044893|NCT01695239|515705993|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
143044894|NCT01695239|515705994|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
143044895|NCT01695239|515705995|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
143044896|NCT01695239|515705996|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
143044897|NCT01695239|515705983|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
143044898|NCT01695239|515705984|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
143044899|NCT01695239|515705985|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
143044900|NCT01695239|515705986|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
143044901|NCT01695239|515705987|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
143044902|NCT01695239|515705988|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
143044903|NCT01695239|515705989|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
143044904|NCT01695239|515705990|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
143044905|NCT01695239|515705991|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
143044906|NCT01695239|515705992|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
143044907|NCT01695239|515705993|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
143044908|NCT01695239|515705994|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
143044909|NCT01695239|515705995|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
143044910|NCT01695239|515705996|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
143044911|NCT01695239|515705983|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
143044912|NCT01695239|515705984|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
143044913|NCT01695239|515705985|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
143044914|NCT01695239|515705986|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
143044915|NCT01695239|515705987|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
143044916|NCT01695239|515705988|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
143044917|NCT01695239|515705989|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
143044918|NCT01695239|515705990|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
143044919|NCT01695239|515705991|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
143044920|NCT01695239|515705992|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
143044921|NCT01695239|515705993|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
143044922|NCT01695239|515705994|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
143044923|NCT01695239|515705995|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
143044924|NCT01695239|515705996|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
143044925|NCT01695239|515705983|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
143167254|NCT04134936|516158327|FG000|Overall Study|Progressive disease|1|||
143167255|NCT04134936|516158328|FG001|Overall Study|Progressive disease|0|||
143167256|NCT03518060|516158329|FG000|Overall Study|Death|1|||
143167257|NCT03518060|516158329|FG000|Overall Study|Poor adherence|1|||
143167258|NCT03518060|516158329|FG000|Overall Study|Withdrawal of informed consent|2|||
143242916|NCT02908672|516439705|FG002|Triple Combination Period|Withdrawal by Subject|13|||
143242917|NCT02908672|516439706|FG003|Triple Combination Period|Withdrawal by Subject|16|||
143242918|NCT02876601|516439710|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
143242919|NCT02876601|516439711|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
143242920|NCT02876601|516439712|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
143242921|NCT02876601|516439713|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
143044926|NCT01695239|515705984|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
143167259|NCT03518060|516158329|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
143167260|NCT03518060|516158329|FG000|Overall Study|Physician Decision|7|||
143167261|NCT03518060|516158329|FG000|Overall Study|Adverse drug reactions|23|||
143167262|NCT03518060|516158329|FG000|Overall Study|Withdrawal by Subject|25|||
143242922|NCT03207763|516441030|FG000|Overall Study|Lost to Follow-up|1|||
143044927|NCT01695239|515705985|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
143044928|NCT01695239|515705986|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
143167263|NCT03518060|516158329|FG000|Overall Study|Lost to Follow-up|13|||
143044929|NCT01695239|515705987|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
143044930|NCT01695239|515705988|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
143044931|NCT01695239|515705989|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
143044932|NCT01695239|515705990|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
143044933|NCT01695239|515705991|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
143044934|NCT01695239|515705992|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
143044935|NCT01695239|515705993|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
143044936|NCT01695239|515705994|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
143044937|NCT01695239|515705995|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
143044938|NCT01695239|515705996|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
143044939|NCT01695239|515705983|FG000|Extension Long-Term Extension Periods|Death|0|||
143044940|NCT01695239|515705984|FG001|Extension Long-Term Extension Periods|Death|0|||
143242923|NCT03207763|516441031|FG001|Overall Study|Lost to Follow-up|0|||
143242924|NCT02605122|516441032|FG000|Overall Study|Withdrawal by Subject|4|||
143242925|NCT02605122|516441033|FG001|Overall Study|Withdrawal by Subject|1|||
143242926|NCT02605122|516441032|FG000|Overall Study|Lost to Follow-up|1|||
143242927|NCT02605122|516441033|FG001|Overall Study|Lost to Follow-up|1|||
143242928|NCT03751657|516441034|FG000|Overall Study|Physician Decision|0|||
143242929|NCT03751657|516441035|FG001|Overall Study|Physician Decision|1|||
143242930|NCT03751657|516441034|FG000|Overall Study|Withdrawal by Subject|1|||
143242931|NCT03751657|516441035|FG001|Overall Study|Withdrawal by Subject|1|||
143242932|NCT03751657|516441034|FG000|Overall Study|Lost to Follow-up|2|||
143242933|NCT03751657|516441035|FG001|Overall Study|Lost to Follow-up|1|||
143242934|NCT03894813|516441042|FG000|Overall Study|Adverse Event|1|||
143242935|NCT03894813|516441043|FG001|Overall Study|Adverse Event|1|||
143242936|NCT03894813|516441042|FG000|Overall Study|Lack of Efficacy|3|||
143242937|NCT03894813|516441043|FG001|Overall Study|Lack of Efficacy|3|||
143242938|NCT03894813|516441042|FG000|Overall Study|Lost to Follow-up|1|||
143242939|NCT03894813|516441043|FG001|Overall Study|Lost to Follow-up|0|||
143242940|NCT03894813|516441042|FG000|Overall Study|Pregnancy|2|||
143242941|NCT03894813|516441043|FG001|Overall Study|Pregnancy|1|||
143242942|NCT03894813|516441042|FG000|Overall Study|Protocol Violation|3|||
143242943|NCT03894813|516441043|FG001|Overall Study|Protocol Violation|7|||
143242944|NCT03894813|516441042|FG000|Overall Study|Withdrawal by Subject|1|||
143242945|NCT03894813|516441043|FG001|Overall Study|Withdrawal by Subject|3|||
143242946|NCT03894813|516441042|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
143242947|NCT03894813|516441043|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
143242948|NCT00807001|516441045|FG000|Overall Study|Non-compliance|0|||
143242949|NCT00807001|516441046|FG001|Overall Study|Non-compliance|1|||
143242950|NCT00807001|516441047|FG002|Overall Study|Non-compliance|0|||
143242951|NCT00807001|516441048|FG003|Overall Study|Non-compliance|0|||
143242952|NCT00807001|516441049|FG004|Overall Study|Non-compliance|0|||
143242953|NCT02873702|516441068|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
143242954|NCT02873702|516441069|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
143242955|NCT02873702|516441070|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
143242956|NCT02873702|516441071|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
143242957|NCT02873702|516441068|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
143242958|NCT02873702|516441069|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
143242959|NCT02873702|516441070|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
143242960|NCT02873702|516441071|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
143242961|NCT02873702|516441068|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
143242962|NCT02873702|516441069|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
143242963|NCT02873702|516441070|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
143242964|NCT02873702|516441071|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
143242965|NCT02873702|516441068|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
143044941|NCT01695239|515705985|FG002|Extension Long-Term Extension Periods|Death|0|||
143044942|NCT01695239|515705986|FG003|Extension Long-Term Extension Periods|Death|0|||
143044943|NCT01695239|515705987|FG004|Extension Long-Term Extension Periods|Death|0|||
143242966|NCT02873702|516441069|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
143044944|NCT01695239|515705988|FG005|Extension Long-Term Extension Periods|Death|0|||
143044945|NCT01695239|515705989|FG006|Extension Long-Term Extension Periods|Death|0|||
143044946|NCT01695239|515705990|FG007|Extension Long-Term Extension Periods|Death|0|||
143044947|NCT01695239|515705991|FG008|Extension Long-Term Extension Periods|Death|1|||
143242967|NCT02873702|516441070|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
143242968|NCT02873702|516441071|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
143364296|NCT00409708|516876955|FG000|Washout|Protocol Violation|0|||
143242969|NCT02873702|516441068|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
143242970|NCT02873702|516441069|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
143242971|NCT02873702|516441070|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
143364297|NCT00409708|516876956|FG001|Washout|Protocol Violation|1|||
143242972|NCT02873702|516441071|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
143242973|NCT01255436|516441079|FG000|Overall Study|Lost to Follow-up|178|||
143242974|NCT01255436|516441080|FG001|Overall Study|Lost to Follow-up|191|||
143242975|NCT01255436|516441079|FG000|Overall Study|Death, stroke, or MI|4|||
143242976|NCT01255436|516441080|FG001|Overall Study|Death, stroke, or MI|3|||
143242977|NCT00001213|516441081|FG000|Overall Study|Death|18|||
143242978|NCT01499277|516441084|FG000|Overall Study|Adverse Event|3|||
143242979|NCT01499277|516441085|FG001|Overall Study|Adverse Event|6|||
143242980|NCT01499277|516441084|FG000|Overall Study|Death|3|||
143242981|NCT01499277|516441085|FG001|Overall Study|Death|2|||
143242982|NCT01499277|516441084|FG000|Overall Study|Lost to Follow-up|15|||
143242983|NCT01499277|516441085|FG001|Overall Study|Lost to Follow-up|8|||
143242984|NCT01499277|516441084|FG000|Overall Study|Protocol Violation|2|||
143242985|NCT01499277|516441085|FG001|Overall Study|Protocol Violation|3|||
143242986|NCT01499277|516441084|FG000|Overall Study|Withdrawal by Subject|16|||
143242987|NCT01499277|516441085|FG001|Overall Study|Withdrawal by Subject|6|||
143242988|NCT01499277|516441084|FG000|Overall Study|Lack of therapeutic response and other|8|||
143242989|NCT01499277|516441085|FG001|Overall Study|Lack of therapeutic response and other|7|||
143242990|NCT00372593|516441086|FG000|Overall Study|Adverse Event|43|||
143242991|NCT00372593|516441087|FG001|Overall Study|Adverse Event|45|||
143242992|NCT00372593|516441088|FG002|Overall Study|Adverse Event|0|||
143242993|NCT00372593|516441086|FG000|Overall Study|Death|16|||
143242994|NCT00372593|516441087|FG001|Overall Study|Death|20|||
143242995|NCT00372593|516441088|FG002|Overall Study|Death|1|||
143242996|NCT00372593|516441086|FG000|Overall Study|Lack of Efficacy|82|||
143242997|NCT00372593|516441087|FG001|Overall Study|Lack of Efficacy|71|||
143242998|NCT00372593|516441088|FG002|Overall Study|Lack of Efficacy|2|||
143242999|NCT00372593|516441086|FG000|Overall Study|Lost to Follow-up|1|||
143243000|NCT00372593|516441087|FG001|Overall Study|Lost to Follow-up|0|||
143243001|NCT00372593|516441088|FG002|Overall Study|Lost to Follow-up|0|||
143243002|NCT00372593|516441086|FG000|Overall Study|Physician Decision|42|||
143243003|NCT00372593|516441087|FG001|Overall Study|Physician Decision|41|||
143243004|NCT00372593|516441088|FG002|Overall Study|Physician Decision|0|||
143243005|NCT00372593|516441086|FG000|Overall Study|Ineligible|20|||
143243006|NCT00372593|516441087|FG001|Overall Study|Ineligible|21|||
143243007|NCT00372593|516441088|FG002|Overall Study|Ineligible|1|||
143243008|NCT02974543|516441089|FG000|Overall Study|Withdrawal by Subject|1|||
143243009|NCT02974543|516441090|FG001|Overall Study|Withdrawal by Subject|0|||
143243010|NCT00742235|516441091|FG000|Overall Study|Lost to Follow-up|0|||
143243011|NCT00742235|516441092|FG001|Overall Study|Lost to Follow-up|31|||
143243012|NCT03534180|516441093|FG000|Overall Study|Withdrawal by Subject|1|||
143243013|NCT00220636|516441094|FG000|Overall Study|Withdrawal by Subject|4|||
143243014|NCT01237899|516441097|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
143243015|NCT01237899|516441098|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
143243016|NCT01237899|516441099|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
143243017|NCT01237899|516441100|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
143243018|NCT01237899|516441101|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
143243019|NCT01237899|516441102|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
143243020|NCT01237899|516441103|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
143243021|NCT01237899|516441104|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
143243022|NCT01237899|516441105|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
143243023|NCT01237899|516441106|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
143243024|NCT01237899|516441107|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
143243025|NCT00790088|516441108|FG000|Overall Study|Protocol Violation|11|||
143243026|NCT00790088|516441108|FG000|Overall Study|Withdrawal by Subject|17|||
143243027|NCT00790088|516441108|FG000|Overall Study|Lost to Follow-up|7|||
143243028|NCT00790088|516441108|FG000|Overall Study|Physician Decision|4|||
143243029|NCT05661409|516441109|FG000|Overall Study|Drug administered, but monitor disconnected|1|||
143243030|NCT05661409|516441110|FG001|Overall Study|Drug administered, but monitor disconnected|0|||
143243031|NCT05661409|516441111|FG002|Overall Study|Drug administered, but monitor disconnected|0|||
143364298|NCT00409708|516876955|FG000|Washout|Withdrawal by Subject|11|||
143044948|NCT01695239|515705992|FG009|Extension Long-Term Extension Periods|Death|0|||
143044949|NCT01695239|515705993|FG010|Extension Long-Term Extension Periods|Death|0|||
143044950|NCT01695239|515705994|FG011|Extension Long-Term Extension Periods|Death|0|||
143044951|NCT01695239|515705995|FG012|Extension Long-Term Extension Periods|Death|0|||
143243032|NCT05661409|516441112|FG003|Overall Study|Drug administered, but monitor disconnected|0|||
143243033|NCT05661409|516441113|FG004|Overall Study|Drug administered, but monitor disconnected|0|||
143243034|NCT05661409|516441114|FG005|Overall Study|Drug administered, but monitor disconnected|0|||
143243035|NCT05661409|516441109|FG000|Overall Study|No TOFR data; problem with the monitor|0|||
143243036|NCT05661409|516441110|FG001|Overall Study|No TOFR data; problem with the monitor|1|||
143243037|NCT05661409|516441111|FG002|Overall Study|No TOFR data; problem with the monitor|0|||
143243038|NCT05661409|516441112|FG003|Overall Study|No TOFR data; problem with the monitor|0|||
143243039|NCT05661409|516441113|FG004|Overall Study|No TOFR data; problem with the monitor|0|||
143243040|NCT05661409|516441114|FG005|Overall Study|No TOFR data; problem with the monitor|0|||
143243041|NCT05661409|516441109|FG000|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
143243042|NCT05661409|516441110|FG001|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
143243043|NCT05661409|516441111|FG002|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
143044952|NCT01695239|515705996|FG013|Extension Long-Term Extension Periods|Death|0|||
143044953|NCT01695239|515705983|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
143044954|NCT01695239|515705984|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
143044955|NCT01695239|515705985|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
143044956|NCT01695239|515705986|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
143044957|NCT01695239|515705987|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
143044958|NCT01695239|515705988|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
143044959|NCT01695239|515705989|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
143044960|NCT01695239|515705990|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
143044961|NCT01695239|515705991|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
143167264|NCT02679274|516158331|FG000|Overall Study|Withdrawal by Subject|1|||
143167265|NCT02679274|516158332|FG001|Overall Study|Withdrawal by Subject|0|||
143167266|NCT04976855|516158333|FG000|Part I|Withdrawal by Subject|0|||
143167267|NCT04976855|516158334|FG001|Part I|Withdrawal by Subject|1|||
143167268|NCT04976855|516158335|FG002|Part I|Withdrawal by Subject|0|||
143167269|NCT04976855|516158336|FG003|Part I|Withdrawal by Subject|0|||
143167270|NCT04976855|516158337|FG004|Part I|Withdrawal by Subject|0|||
143167271|NCT04976855|516158338|FG005|Part I|Withdrawal by Subject|0|||
143167272|NCT04976855|516158339|FG006|Part I|Withdrawal by Subject|0|||
143167273|NCT04976855|516158333|FG000|Part II|Adverse Event|0|||
143167274|NCT04976855|516158334|FG001|Part II|Adverse Event|0|||
143167275|NCT04976855|516158335|FG002|Part II|Adverse Event|0|||
143167276|NCT04976855|516158336|FG003|Part II|Adverse Event|1|||
143167277|NCT04976855|516158337|FG004|Part II|Adverse Event|0|||
143167278|NCT04976855|516158338|FG005|Part II|Adverse Event|0|||
143167279|NCT04976855|516158339|FG006|Part II|Adverse Event|0|||
143167280|NCT04976855|516158333|FG000|Part II|Withdrawal by Subject|0|||
143167281|NCT04976855|516158334|FG001|Part II|Withdrawal by Subject|0|||
143167282|NCT04976855|516158335|FG002|Part II|Withdrawal by Subject|0|||
143167283|NCT04976855|516158336|FG003|Part II|Withdrawal by Subject|0|||
143167284|NCT04976855|516158337|FG004|Part II|Withdrawal by Subject|1|||
143167285|NCT04976855|516158338|FG005|Part II|Withdrawal by Subject|0|||
143167286|NCT04976855|516158339|FG006|Part II|Withdrawal by Subject|0|||
143167287|NCT04976855|516158333|FG000|Part II|Lost to Follow-up|0|||
143167288|NCT04976855|516158334|FG001|Part II|Lost to Follow-up|0|||
143167289|NCT04976855|516158335|FG002|Part II|Lost to Follow-up|0|||
143167290|NCT04976855|516158336|FG003|Part II|Lost to Follow-up|0|||
143167291|NCT04976855|516158337|FG004|Part II|Lost to Follow-up|0|||
143167292|NCT04976855|516158338|FG005|Part II|Lost to Follow-up|1|||
143167293|NCT04976855|516158339|FG006|Part II|Lost to Follow-up|0|||
143167294|NCT00835172|516158346|FG000|Washout|Protocol Violation|0|||
143167295|NCT00835172|516158347|FG001|Washout|Protocol Violation|1|||
143167296|NCT00964678|516158355|FG000|Overall Study|Physician Decision|4|||
143167297|NCT03359395|516158356|FG000|First Intervention A / B|Withdrawal by Subject|1|||
143167298|NCT03359395|516158357|FG001|First Intervention A / B|Withdrawal by Subject|0|||
143167299|NCT03359395|516158356|FG000|First Intervention A / B|Lost to Follow-up|2|||
143167300|NCT03359395|516158357|FG001|First Intervention A / B|Lost to Follow-up|3|||
143167301|NCT03359395|516158356|FG000|Second Intervention B/A|Exclusion criteria|0|||
143167302|NCT03359395|516158357|FG001|Second Intervention B/A|Exclusion criteria|1|||
143167303|NCT03359395|516158356|FG000|Second Intervention B/A|Lost to Follow-up|3|||
143167304|NCT03359395|516158357|FG001|Second Intervention B/A|Lost to Follow-up|2|||
143167305|NCT03360344|516160256|FG000|Overall Study|Withdrawal by Subject|0|||
143167306|NCT03360344|516160257|FG001|Overall Study|Withdrawal by Subject|1|||
143167307|NCT03360344|516160258|FG002|Overall Study|Withdrawal by Subject|1|||
143167308|NCT00133705|516160259|FG000|Overall Study|Withdrawal by Subject|2|||
143167309|NCT00133705|516160260|FG001|Overall Study|Withdrawal by Subject|3|||
143167310|NCT03468998|516160261|FG000|Overall Study|Withdrawal by Subject|1|||
143167311|NCT03468998|516160262|FG001|Overall Study|Withdrawal by Subject|1|||
143167312|NCT03468998|516160263|FG002|Overall Study|Withdrawal by Subject|0|||
143167313|NCT03468998|516160264|FG003|Overall Study|Withdrawal by Subject|4|||
143167314|NCT03468998|516160265|FG004|Overall Study|Withdrawal by Subject|1|||
143167315|NCT03468998|516160266|FG005|Overall Study|Withdrawal by Subject|0|||
143167316|NCT01892189|516160269|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
143044962|NCT01695239|515705992|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
143044963|NCT01695239|515705993|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
143167317|NCT01892189|516160270|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
143167318|NCT01892189|516160271|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
143167319|NCT01892189|516160272|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
143167320|NCT01892189|516160273|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
143167321|NCT01892189|516160274|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
143167322|NCT01892189|516160275|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
143167323|NCT01892189|516160276|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
143167324|NCT01892189|516160277|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
143167325|NCT01892189|516160269|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
143167326|NCT01892189|516160270|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
143167327|NCT01892189|516160271|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
143243044|NCT05661409|516441112|FG003|Overall Study|TOFR≥0.9 at time of drug admin.|1|||
143044964|NCT01695239|515705994|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
143044965|NCT01695239|515705995|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
143044966|NCT01695239|515705996|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
143044967|NCT01695239|515705983|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
143044968|NCT01695239|515705984|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
143044969|NCT01695239|515705985|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
143044970|NCT01695239|515705986|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
143044971|NCT01695239|515705987|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
143044972|NCT01695239|515705988|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
143044973|NCT01695239|515705989|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
143044974|NCT01695239|515705990|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
143044975|NCT01695239|515705991|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
143044976|NCT01695239|515705992|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
143044977|NCT01695239|515705993|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
143044978|NCT01695239|515705994|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
143044979|NCT01695239|515705995|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
143044980|NCT01695239|515705996|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
143044981|NCT01695239|515705983|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
143044982|NCT01695239|515705984|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
143044983|NCT01695239|515705985|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
143044984|NCT01695239|515705986|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
143044985|NCT01695239|515705987|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
143044986|NCT01695239|515705988|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
143044987|NCT01695239|515705989|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
143044988|NCT01695239|515705990|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
143044989|NCT01695239|515705991|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
143044990|NCT01695239|515705992|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
143044991|NCT01695239|515705993|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
143044992|NCT01695239|515705994|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
143167328|NCT01892189|516160272|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
143167329|NCT01892189|516160273|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
143167330|NCT01892189|516160274|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
143167331|NCT01892189|516160275|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
143167332|NCT01892189|516160276|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
143167333|NCT01892189|516160277|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
143167334|NCT01892189|516160269|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
143167335|NCT01892189|516160270|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
143167336|NCT01892189|516160271|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
143167337|NCT01892189|516160272|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
143167338|NCT01892189|516160273|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
143167339|NCT01892189|516160274|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
143167340|NCT01892189|516160275|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
143167341|NCT01892189|516160276|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
143167342|NCT01892189|516160277|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
143167343|NCT02989857|516160278|FG000|Randomization Phase|Not Treated|3|||
143167344|NCT02989857|516160279|FG001|Randomization Phase|Not Treated|2|||
143167345|NCT02989857|516160280|FG002|Randomization Phase|Not Treated|0|||
143167346|NCT01992757|516160283|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
143167347|NCT03440411|516160284|FG000|Overall Study|Adverse Event|0|||
143167348|NCT03440411|516160285|FG001|Overall Study|Adverse Event|0|||
143167349|NCT03440411|516160286|FG002|Overall Study|Adverse Event|1|||
143167350|NCT03440411|516160287|FG003|Overall Study|Adverse Event|0|||
143167351|NCT03440411|516160284|FG000|Overall Study|PD|2|||
143167352|NCT03440411|516160285|FG001|Overall Study|PD|1|||
143167353|NCT03440411|516160286|FG002|Overall Study|PD|1|||
143167354|NCT03440411|516160287|FG003|Overall Study|PD|1|||
143044993|NCT01695239|515705995|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
143044994|NCT01695239|515705996|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
143044995|NCT01695239|515705983|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
143044996|NCT01695239|515705984|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
143044997|NCT01695239|515705985|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
143167355|NCT03440411|516160284|FG000|Overall Study|Withdrawal by Subject|1|||
143167356|NCT03440411|516160285|FG001|Overall Study|Withdrawal by Subject|0|||
143167357|NCT03440411|516160286|FG002|Overall Study|Withdrawal by Subject|0|||
143167358|NCT03440411|516160287|FG003|Overall Study|Withdrawal by Subject|0|||
143167359|NCT03440411|516160284|FG000|Overall Study|Closed study by sponsor|0|||
143167360|NCT03440411|516160285|FG001|Overall Study|Closed study by sponsor|0|||
143167361|NCT03440411|516160286|FG002|Overall Study|Closed study by sponsor|0|||
143167362|NCT03440411|516160287|FG003|Overall Study|Closed study by sponsor|1|||
143364299|NCT00409708|516876956|FG001|Washout|Withdrawal by Subject|5|||
143044998|NCT01695239|515705986|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
143044999|NCT01695239|515705987|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
143045000|NCT01695239|515705988|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
143243045|NCT05661409|516441113|FG004|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
143045001|NCT01695239|515705989|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
143045002|NCT01695239|515705990|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
143045003|NCT01695239|515705991|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
143045004|NCT01695239|515705992|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
143045005|NCT01695239|515705993|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
143045006|NCT01695239|515705994|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
143045007|NCT01695239|515705995|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
143045008|NCT01695239|515705996|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
143045009|NCT03913377|515705998|FG000|Period 1|Test Article no longer available|0|||
143045010|NCT03913377|515705999|FG001|Period 1|Test Article no longer available|1|||
143045011|NCT03913377|515706000|FG002|Period 1|Test Article no longer available|0|||
143045012|NCT03913377|515705998|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
143045013|NCT03913377|515705999|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
143045014|NCT03913377|515706000|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
143045015|NCT03552484|515706001|FG000|Overall Study|Death|6|||
143045016|NCT03552484|515706002|FG001|Overall Study|Death|4|||
143045017|NCT03552484|515706001|FG000|Overall Study|Lost to Follow-up|0|||
143045018|NCT03552484|515706002|FG001|Overall Study|Lost to Follow-up|16|||
143045019|NCT01592240|515706003|FG000|Overall Study|Adverse Event|1|||
143045020|NCT01592240|515706004|FG001|Overall Study|Adverse Event|0|||
143045021|NCT01592240|515706005|FG002|Overall Study|Adverse Event|0|||
143045022|NCT01592240|515706006|FG003|Overall Study|Adverse Event|1|||
143045023|NCT01592240|515706007|FG004|Overall Study|Adverse Event|1|||
143045024|NCT01592240|515706008|FG005|Overall Study|Adverse Event|0|||
143045025|NCT01592240|515706009|FG006|Overall Study|Adverse Event|0|||
143045026|NCT01592240|515706003|FG000|Overall Study|Death|0|||
143045027|NCT01592240|515706004|FG001|Overall Study|Death|1|||
143045028|NCT01592240|515706005|FG002|Overall Study|Death|0|||
143045029|NCT01592240|515706006|FG003|Overall Study|Death|0|||
143045030|NCT01592240|515706007|FG004|Overall Study|Death|0|||
143045031|NCT01592240|515706008|FG005|Overall Study|Death|0|||
143045032|NCT01592240|515706009|FG006|Overall Study|Death|0|||
143045033|NCT01592240|515706003|FG000|Overall Study|Lost to Follow-up|1|||
143045034|NCT01592240|515706004|FG001|Overall Study|Lost to Follow-up|3|||
143045035|NCT01592240|515706005|FG002|Overall Study|Lost to Follow-up|1|||
143045036|NCT01592240|515706006|FG003|Overall Study|Lost to Follow-up|0|||
143243046|NCT05661409|516441114|FG005|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
143167363|NCT00688740|516160288|FG000|Overall Study|Adverse Event|45|||
143167364|NCT00688740|516160289|FG001|Overall Study|Adverse Event|8|||
143167365|NCT00688740|516160288|FG000|Overall Study|Death|2|||
143167366|NCT00688740|516160289|FG001|Overall Study|Death|2|||
143167367|NCT00688740|516160288|FG000|Overall Study|Lost to Follow-up|0|||
143167368|NCT00688740|516160289|FG001|Overall Study|Lost to Follow-up|1|||
143167369|NCT00688740|516160288|FG000|Overall Study|Consent Withdrawn|17|||
143167370|NCT00688740|516160289|FG001|Overall Study|Consent Withdrawn|17|||
143167371|NCT00688740|516160288|FG000|Overall Study|Breast Cancer Relapse|1|||
143167372|NCT00688740|516160289|FG001|Overall Study|Breast Cancer Relapse|4|||
143167373|NCT00688740|516160288|FG000|Overall Study|Violation of Inclusion Criteria|1|||
143167374|NCT00688740|516160289|FG001|Overall Study|Violation of Inclusion Criteria|3|||
143167375|NCT01344356|516160290|FG000|Overall Study|Physician Decision|0|||
143167376|NCT01344356|516160291|FG001|Overall Study|Physician Decision|3|||
143167377|NCT01344356|516160290|FG000|Overall Study|Lost to Follow-up|0|||
143167378|NCT01344356|516160291|FG001|Overall Study|Lost to Follow-up|6|||
143167379|NCT00567502|516160294|FG000|Overall Study|Lost to Follow-up|91|||
143167380|NCT00567502|516160295|FG001|Overall Study|Lost to Follow-up|14|||
143167381|NCT00567502|516160296|FG002|Overall Study|Lost to Follow-up|351|||
143243047|NCT05661409|516441109|FG000|Overall Study|Lost TOFR data prior to time study drug given|0|||
143243048|NCT05661409|516441110|FG001|Overall Study|Lost TOFR data prior to time study drug given|0|||
143045037|NCT01592240|515706007|FG004|Overall Study|Lost to Follow-up|3|||
143167382|NCT00567502|516160297|FG003|Overall Study|Lost to Follow-up|2|||
143045038|NCT01592240|515706008|FG005|Overall Study|Lost to Follow-up|2|||
143045039|NCT01592240|515706009|FG006|Overall Study|Lost to Follow-up|0|||
143167383|NCT00567502|516160294|FG000|Overall Study|Death|65|||
143167384|NCT00567502|516160295|FG001|Overall Study|Death|16|||
143167385|NCT00567502|516160296|FG002|Overall Study|Death|360|||
143045040|NCT01592240|515706003|FG000|Overall Study|Protocol Violation|0|||
143045041|NCT01592240|515706004|FG001|Overall Study|Protocol Violation|0|||
143045042|NCT01592240|515706005|FG002|Overall Study|Protocol Violation|0|||
143045043|NCT01592240|515706006|FG003|Overall Study|Protocol Violation|0|||
143167386|NCT00567502|516160297|FG003|Overall Study|Death|5|||
143167387|NCT00567502|516160294|FG000|Overall Study|Other|64|||
143045044|NCT01592240|515706007|FG004|Overall Study|Protocol Violation|0|||
143045045|NCT01592240|515706008|FG005|Overall Study|Protocol Violation|1|||
143045046|NCT01592240|515706009|FG006|Overall Study|Protocol Violation|0|||
143045047|NCT01592240|515706003|FG000|Overall Study|Withdrawal by Subject|0|||
143045048|NCT01592240|515706004|FG001|Overall Study|Withdrawal by Subject|4|||
143045049|NCT01592240|515706005|FG002|Overall Study|Withdrawal by Subject|4|||
143243049|NCT05661409|516441111|FG002|Overall Study|Lost TOFR data prior to time study drug given|0|||
143243050|NCT05661409|516441112|FG003|Overall Study|Lost TOFR data prior to time study drug given|0|||
143243051|NCT05661409|516441113|FG004|Overall Study|Lost TOFR data prior to time study drug given|0|||
143243052|NCT05661409|516441114|FG005|Overall Study|Lost TOFR data prior to time study drug given|1|||
143243053|NCT05661409|516441109|FG000|Overall Study|Miscommu-nication about administration|0|||
143243054|NCT05661409|516441110|FG001|Overall Study|Miscommu-nication about administration|0|||
143243055|NCT05661409|516441111|FG002|Overall Study|Miscommu-nication about administration|0|||
143045050|NCT01592240|515706006|FG003|Overall Study|Withdrawal by Subject|1|||
143045051|NCT01592240|515706007|FG004|Overall Study|Withdrawal by Subject|3|||
143045052|NCT01592240|515706008|FG005|Overall Study|Withdrawal by Subject|0|||
143045053|NCT01592240|515706009|FG006|Overall Study|Withdrawal by Subject|2|||
143045054|NCT01592240|515706003|FG000|Overall Study|Other|0|||
143045055|NCT01592240|515706004|FG001|Overall Study|Other|3|||
143045056|NCT01592240|515706005|FG002|Overall Study|Other|1|||
143045057|NCT01592240|515706006|FG003|Overall Study|Other|1|||
143045058|NCT01592240|515706007|FG004|Overall Study|Other|0|||
143045059|NCT01592240|515706008|FG005|Overall Study|Other|0|||
143045060|NCT01592240|515706009|FG006|Overall Study|Other|1|||
143045061|NCT01592240|515706003|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
143045062|NCT01592240|515706004|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
143167388|NCT00567502|516160295|FG001|Overall Study|Other|2|||
143167389|NCT00567502|516160296|FG002|Overall Study|Other|134|||
143167390|NCT00567502|516160297|FG003|Overall Study|Other|6|||
143167391|NCT00567502|516160294|FG000|Overall Study|Participant request|12|||
143167392|NCT00567502|516160295|FG001|Overall Study|Participant request|1|||
143045063|NCT01592240|515706005|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
143167393|NCT00567502|516160296|FG002|Overall Study|Participant request|33|||
143167394|NCT00567502|516160297|FG003|Overall Study|Participant request|1|||
143167395|NCT00567502|516160294|FG000|Overall Study|Sponsor request|9|||
143167396|NCT00567502|516160295|FG001|Overall Study|Sponsor request|0|||
143167397|NCT00567502|516160296|FG002|Overall Study|Sponsor request|30|||
143167398|NCT00567502|516160297|FG003|Overall Study|Sponsor request|1|||
143167399|NCT00567502|516160294|FG000|Overall Study|Never Initiated Treatment|0|||
143167400|NCT00567502|516160295|FG001|Overall Study|Never Initiated Treatment|0|||
143167401|NCT00567502|516160296|FG002|Overall Study|Never Initiated Treatment|0|||
143167402|NCT00567502|516160297|FG003|Overall Study|Never Initiated Treatment|72|||
143167403|NCT00856557|516160298|FG000|Overall Study|No patients with contextual flags|12|||
143167404|NCT00856557|516160299|FG001|Overall Study|No patients with contextual flags|16|||
143167405|NCT01285102|516160302|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
143167406|NCT00557440|516160312|FG000|Treatment Period 1|Adverse Event|0|||
143167407|NCT00557440|516160313|FG001|Treatment Period 1|Adverse Event|0|||
143167408|NCT00557440|516160314|FG002|Treatment Period 1|Adverse Event|1|||
143167409|NCT03524157|516160315|FG000|Overall Study|cytology not readable|0|||
143167410|NCT03524157|516160316|FG001|Overall Study|cytology not readable|0|||
143167411|NCT03524157|516160317|FG002|Overall Study|cytology not readable|1|||
143167412|NCT00863304|516160320|FG000|Overall Study|Adverse Event|10|||
143167413|NCT00863304|516160321|FG001|Overall Study|Adverse Event|4|||
143167414|NCT00863304|516160322|FG002|Overall Study|Adverse Event|14|||
143167415|NCT00863304|516160323|FG003|Overall Study|Adverse Event|16|||
143167416|NCT00863304|516160320|FG000|Overall Study|Lost to Follow-up|1|||
143167417|NCT00863304|516160321|FG001|Overall Study|Lost to Follow-up|5|||
143167418|NCT00863304|516160322|FG002|Overall Study|Lost to Follow-up|4|||
143167419|NCT00863304|516160323|FG003|Overall Study|Lost to Follow-up|2|||
143167420|NCT00863304|516160320|FG000|Overall Study|Lack of Efficacy|57|||
143167421|NCT00863304|516160321|FG001|Overall Study|Lack of Efficacy|26|||
143167422|NCT00863304|516160322|FG002|Overall Study|Lack of Efficacy|30|||
143243056|NCT05661409|516441112|FG003|Overall Study|Miscommu-nication about administration|0|||
143243057|NCT05661409|516441113|FG004|Overall Study|Miscommu-nication about administration|0|||
143045064|NCT01592240|515706006|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
143167423|NCT00863304|516160323|FG003|Overall Study|Lack of Efficacy|28|||
143167424|NCT00863304|516160320|FG000|Overall Study|Withdrawal by Subject|19|||
143167425|NCT00863304|516160321|FG001|Overall Study|Withdrawal by Subject|14|||
143167426|NCT00863304|516160322|FG002|Overall Study|Withdrawal by Subject|20|||
143167427|NCT00863304|516160323|FG003|Overall Study|Withdrawal by Subject|18|||
143167428|NCT00863304|516160320|FG000|Overall Study|Other|1|||
143364300|NCT00409708|516876955|FG000|Washout|Lost to Follow-up|1|||
143045065|NCT01592240|515706007|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
143167429|NCT00863304|516160321|FG001|Overall Study|Other|0|||
143167430|NCT00863304|516160322|FG002|Overall Study|Other|0|||
143167431|NCT00863304|516160323|FG003|Overall Study|Other|1|||
143167432|NCT00863304|516160320|FG000|Overall Study|Protocol Violation|2|||
143243058|NCT05661409|516441114|FG005|Overall Study|Miscommu-nication about administration|1|||
143243059|NCT04730271|516441115|FG000|Overall Study|Adverse Event|0|||
143243060|NCT04730271|516441116|FG001|Overall Study|Adverse Event|2|||
143243061|NCT04730271|516441115|FG000|Overall Study|Withdrawal by Subject|1|||
143243062|NCT04730271|516441116|FG001|Overall Study|Withdrawal by Subject|1|||
143243063|NCT04730271|516441115|FG000|Overall Study|Protocol Violation|7|||
143243064|NCT04730271|516441116|FG001|Overall Study|Protocol Violation|13|||
143243065|NCT04730271|516441115|FG000|Overall Study|Lost to Follow-up|3|||
143243066|NCT04730271|516441116|FG001|Overall Study|Lost to Follow-up|3|||
143243067|NCT04730271|516441115|FG000|Overall Study|Death|1|||
143243068|NCT04730271|516441116|FG001|Overall Study|Death|0|||
143243069|NCT02223858|516441122|FG000|Overall Study|Death|1|||
143243070|NCT02223858|516441123|FG001|Overall Study|Death|1|||
143243071|NCT02223858|516441122|FG000|Overall Study|Lost to Follow-up|6|||
143243072|NCT02223858|516441123|FG001|Overall Study|Lost to Follow-up|11|||
143243073|NCT02223858|516441122|FG000|Overall Study|Withdrawal by Subject|8|||
143243074|NCT02223858|516441123|FG001|Overall Study|Withdrawal by Subject|5|||
143243075|NCT02223858|516441122|FG000|Overall Study|Refused|9|||
143243076|NCT02223858|516441123|FG001|Overall Study|Refused|9|||
143243077|NCT04455815|516441124|FG000|Randomisation Phase|Adverse Event|1|||
143243078|NCT04455815|516441125|FG001|Randomisation Phase|Adverse Event|0|||
143243079|NCT04455815|516441124|FG000|Treatment Phase|Adverse Event|0|||
143243080|NCT04455815|516441125|FG001|Treatment Phase|Adverse Event|1|||
143243081|NCT04455815|516441124|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
143243082|NCT04455815|516441125|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
143243083|NCT04455815|516441124|FG000|Treatment Phase|Withdrawal by Subject|1|||
143243084|NCT04455815|516441125|FG001|Treatment Phase|Withdrawal by Subject|1|||
143243085|NCT02106390|516441126|FG000|Overall Study|Withdrawal by Subject|15|||
143243086|NCT02106390|516441127|FG001|Overall Study|Withdrawal by Subject|16|||
143243087|NCT02106390|516441128|FG002|Overall Study|Withdrawal by Subject|15|||
143243088|NCT02106390|516441126|FG000|Overall Study|Lost to Follow-up|25|||
143243089|NCT02106390|516441127|FG001|Overall Study|Lost to Follow-up|20|||
143243090|NCT02106390|516441128|FG002|Overall Study|Lost to Follow-up|13|||
143243091|NCT02106390|516441126|FG000|Overall Study|Other: Administrative Reason|8|||
143243092|NCT02106390|516441127|FG001|Overall Study|Other: Administrative Reason|5|||
143243093|NCT02106390|516441128|FG002|Overall Study|Other: Administrative Reason|12|||
143243094|NCT02106390|516441126|FG000|Overall Study|Other: Unspecified|1|||
143243095|NCT02106390|516441127|FG001|Overall Study|Other: Unspecified|4|||
143243096|NCT02106390|516441128|FG002|Overall Study|Other: Unspecified|2|||
143243097|NCT02106390|516441126|FG000|Overall Study|Adverse Event|0|||
143364301|NCT00409708|516876956|FG001|Washout|Lost to Follow-up|3|||
143167433|NCT00863304|516160321|FG001|Overall Study|Protocol Violation|6|||
143167434|NCT00863304|516160322|FG002|Overall Study|Protocol Violation|2|||
143167435|NCT00863304|516160323|FG003|Overall Study|Protocol Violation|0|||
143167436|NCT00863304|516160320|FG000|Overall Study|Randomized, but not Treated|3|||
143167437|NCT00863304|516160321|FG001|Overall Study|Randomized, but not Treated|1|||
143167438|NCT00863304|516160322|FG002|Overall Study|Randomized, but not Treated|4|||
143167439|NCT00863304|516160323|FG003|Overall Study|Randomized, but not Treated|1|||
143167440|NCT00863304|516160320|FG000|Overall Study|Entered extension study|101|||
143167441|NCT00863304|516160321|FG001|Overall Study|Entered extension study|129|||
143167442|NCT00863304|516160322|FG002|Overall Study|Entered extension study|113|||
143167443|NCT00863304|516160323|FG003|Overall Study|Entered extension study|125|||
143167444|NCT02327169|516160324|FG000|Overall Study|Progressive Disease|1|||
143167445|NCT02327169|516160325|FG001|Overall Study|Progressive Disease|3|||
143167446|NCT02327169|516160326|FG002|Overall Study|Progressive Disease|4|||
143167447|NCT02327169|516160327|FG003|Overall Study|Progressive Disease|3|||
143167448|NCT02327169|516160328|FG004|Overall Study|Progressive Disease|4|||
143167449|NCT02327169|516160329|FG005|Overall Study|Progressive Disease|3|||
143167450|NCT02327169|516160330|FG006|Overall Study|Progressive Disease|3|||
143167451|NCT02327169|516160331|FG007|Overall Study|Progressive Disease|3|||
143167452|NCT02327169|516160332|FG008|Overall Study|Progressive Disease|4|||
143167453|NCT02327169|516160333|FG009|Overall Study|Progressive Disease|4|||
143167454|NCT02327169|516160334|FG010|Overall Study|Progressive Disease|4|||
143167455|NCT02327169|516160335|FG011|Overall Study|Progressive Disease|3|||
143167456|NCT02327169|516160336|FG012|Overall Study|Progressive Disease|1|||
143167457|NCT02327169|516160337|FG013|Overall Study|Progressive Disease|3|||
143243098|NCT02106390|516441127|FG001|Overall Study|Adverse Event|2|||
143243099|NCT02106390|516441128|FG002|Overall Study|Adverse Event|1|||
143243100|NCT02106390|516441126|FG000|Overall Study|Protocol Violation|0|||
143243101|NCT02106390|516441127|FG001|Overall Study|Protocol Violation|1|||
143243102|NCT02106390|516441128|FG002|Overall Study|Protocol Violation|0|||
143243103|NCT00831181|516441133|FG000|Overall Study|Adverse Event|12|||
143243104|NCT02362282|516441134|FG000|Overall Study|Withdrawal by Subject|1|||
143243105|NCT02362282|516441135|FG001|Overall Study|Withdrawal by Subject|0|||
143167458|NCT02327169|516160338|FG014|Overall Study|Progressive Disease|3|||
143167459|NCT02327169|516160324|FG000|Overall Study|Adverse Event|2|||
143167460|NCT02327169|516160325|FG001|Overall Study|Adverse Event|0|||
143243106|NCT00439517|516441137|FG000|Overall Study|Subject on treatment|1|||
143167461|NCT02327169|516160326|FG002|Overall Study|Adverse Event|1|||
143045066|NCT01592240|515706008|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
143045067|NCT01592240|515706009|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
143045068|NCT01205035|515706017|FG000|Overall Study|Withdrawal by Subject|1|||
143045069|NCT01205035|515706018|FG001|Overall Study|Withdrawal by Subject|0|||
143045070|NCT01205035|515706017|FG000|Overall Study|Physician Decision|1|||
143167462|NCT02327169|516160327|FG003|Overall Study|Adverse Event|0|||
143167463|NCT02327169|516160328|FG004|Overall Study|Adverse Event|1|||
143167464|NCT02327169|516160329|FG005|Overall Study|Adverse Event|0|||
143167465|NCT02327169|516160330|FG006|Overall Study|Adverse Event|0|||
143167466|NCT02327169|516160331|FG007|Overall Study|Adverse Event|0|||
143167467|NCT02327169|516160332|FG008|Overall Study|Adverse Event|0|||
143167468|NCT02327169|516160333|FG009|Overall Study|Adverse Event|2|||
143167469|NCT02327169|516160334|FG010|Overall Study|Adverse Event|0|||
143167470|NCT02327169|516160335|FG011|Overall Study|Adverse Event|3|||
143167471|NCT02327169|516160336|FG012|Overall Study|Adverse Event|0|||
143167472|NCT02327169|516160337|FG013|Overall Study|Adverse Event|2|||
143167473|NCT02327169|516160338|FG014|Overall Study|Adverse Event|1|||
143167474|NCT02327169|516160324|FG000|Overall Study|Symptomatic Deterioration|0|||
143167475|NCT02327169|516160325|FG001|Overall Study|Symptomatic Deterioration|0|||
143167476|NCT02327169|516160326|FG002|Overall Study|Symptomatic Deterioration|1|||
143167477|NCT02327169|516160327|FG003|Overall Study|Symptomatic Deterioration|0|||
143167478|NCT02327169|516160328|FG004|Overall Study|Symptomatic Deterioration|1|||
143167479|NCT02327169|516160329|FG005|Overall Study|Symptomatic Deterioration|1|||
143167480|NCT02327169|516160330|FG006|Overall Study|Symptomatic Deterioration|0|||
143167481|NCT02327169|516160331|FG007|Overall Study|Symptomatic Deterioration|0|||
143167482|NCT02327169|516160332|FG008|Overall Study|Symptomatic Deterioration|2|||
143167483|NCT02327169|516160333|FG009|Overall Study|Symptomatic Deterioration|1|||
143167484|NCT02327169|516160334|FG010|Overall Study|Symptomatic Deterioration|0|||
143167485|NCT02327169|516160335|FG011|Overall Study|Symptomatic Deterioration|0|||
143167486|NCT02327169|516160336|FG012|Overall Study|Symptomatic Deterioration|0|||
143167487|NCT02327169|516160337|FG013|Overall Study|Symptomatic Deterioration|2|||
143167488|NCT02327169|516160338|FG014|Overall Study|Symptomatic Deterioration|1|||
143167489|NCT02327169|516160324|FG000|Overall Study|Reason Not Specified|0|||
143167490|NCT02327169|516160325|FG001|Overall Study|Reason Not Specified|0|||
143167491|NCT02327169|516160326|FG002|Overall Study|Reason Not Specified|1|||
143167492|NCT02327169|516160327|FG003|Overall Study|Reason Not Specified|0|||
143167493|NCT02327169|516160328|FG004|Overall Study|Reason Not Specified|0|||
143167494|NCT02327169|516160329|FG005|Overall Study|Reason Not Specified|0|||
143167495|NCT02327169|516160330|FG006|Overall Study|Reason Not Specified|0|||
143167496|NCT02327169|516160331|FG007|Overall Study|Reason Not Specified|0|||
143167497|NCT02327169|516160332|FG008|Overall Study|Reason Not Specified|0|||
143167498|NCT02327169|516160333|FG009|Overall Study|Reason Not Specified|1|||
143167499|NCT02327169|516160334|FG010|Overall Study|Reason Not Specified|2|||
143167500|NCT02327169|516160335|FG011|Overall Study|Reason Not Specified|1|||
143167501|NCT02327169|516160336|FG012|Overall Study|Reason Not Specified|0|||
143167502|NCT02327169|516160337|FG013|Overall Study|Reason Not Specified|0|||
143045071|NCT01205035|515706018|FG001|Overall Study|Physician Decision|0|||
143045072|NCT02663349|515706019|FG000|Overall Study|Withdrawal by Subject|6|||
143167503|NCT02327169|516160338|FG014|Overall Study|Reason Not Specified|2|||
143167504|NCT02327169|516160324|FG000|Overall Study|Withdrawal by Subject|1|||
143167505|NCT02327169|516160325|FG001|Overall Study|Withdrawal by Subject|0|||
143167506|NCT02327169|516160326|FG002|Overall Study|Withdrawal by Subject|0|||
143167507|NCT02327169|516160327|FG003|Overall Study|Withdrawal by Subject|0|||
143167508|NCT02327169|516160328|FG004|Overall Study|Withdrawal by Subject|1|||
143167509|NCT02327169|516160329|FG005|Overall Study|Withdrawal by Subject|0|||
143167510|NCT02327169|516160330|FG006|Overall Study|Withdrawal by Subject|0|||
143167511|NCT02327169|516160331|FG007|Overall Study|Withdrawal by Subject|1|||
143167512|NCT02327169|516160332|FG008|Overall Study|Withdrawal by Subject|0|||
143167513|NCT02327169|516160333|FG009|Overall Study|Withdrawal by Subject|0|||
143167514|NCT02327169|516160334|FG010|Overall Study|Withdrawal by Subject|0|||
143167515|NCT02327169|516160335|FG011|Overall Study|Withdrawal by Subject|0|||
143167516|NCT02327169|516160336|FG012|Overall Study|Withdrawal by Subject|0|||
143167517|NCT02327169|516160337|FG013|Overall Study|Withdrawal by Subject|0|||
143167518|NCT02327169|516160338|FG014|Overall Study|Withdrawal by Subject|3|||
143167519|NCT02327169|516160324|FG000|Overall Study|Lost to Follow-up|0|||
143167520|NCT02327169|516160325|FG001|Overall Study|Lost to Follow-up|0|||
143167521|NCT02327169|516160326|FG002|Overall Study|Lost to Follow-up|0|||
143167522|NCT02327169|516160327|FG003|Overall Study|Lost to Follow-up|0|||
143167523|NCT02327169|516160328|FG004|Overall Study|Lost to Follow-up|1|||
143167524|NCT02327169|516160329|FG005|Overall Study|Lost to Follow-up|0|||
143167525|NCT02327169|516160330|FG006|Overall Study|Lost to Follow-up|0|||
143167526|NCT02327169|516160331|FG007|Overall Study|Lost to Follow-up|0|||
143167527|NCT02327169|516160332|FG008|Overall Study|Lost to Follow-up|0|||
143167528|NCT02327169|516160333|FG009|Overall Study|Lost to Follow-up|0|||
143167529|NCT02327169|516160334|FG010|Overall Study|Lost to Follow-up|0|||
143167530|NCT02327169|516160335|FG011|Overall Study|Lost to Follow-up|0|||
143167531|NCT02327169|516160336|FG012|Overall Study|Lost to Follow-up|0|||
143167532|NCT02327169|516160337|FG013|Overall Study|Lost to Follow-up|0|||
143167533|NCT02327169|516160338|FG014|Overall Study|Lost to Follow-up|0|||
143167534|NCT03931330|516160339|FG000|Overall Study|Physician Decision|1|||
143167535|NCT02919618|516160342|FG000|Overall Study|Death|1|||
143167536|NCT04770285|516160344|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
143167537|NCT04770285|516160345|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
143167538|NCT04770285|516160344|FG000|Overall Study|Lack of Efficacy|0|||
143167539|NCT04770285|516160345|FG001|Overall Study|Lack of Efficacy|1|||
143167540|NCT04770285|516160344|FG000|Overall Study|Lost to Follow-up|11|||
143167541|NCT04770285|516160345|FG001|Overall Study|Lost to Follow-up|8|||
143167542|NCT04770285|516160344|FG000|Overall Study|Protocol Deviation|6|||
143167543|NCT04770285|516160345|FG001|Overall Study|Protocol Deviation|6|||
143167544|NCT04770285|516160344|FG000|Overall Study|Technical Problem|0|||
143167545|NCT04770285|516160345|FG001|Overall Study|Technical Problem|1|||
143167546|NCT04770285|516160344|FG000|Overall Study|Withdrawal by Subject|9|||
143167547|NCT04770285|516160345|FG001|Overall Study|Withdrawal by Subject|8|||
143167548|NCT04770285|516160344|FG000|Overall Study|Reason Not Specified|0|||
143167549|NCT04770285|516160345|FG001|Overall Study|Reason Not Specified|1|||
143167550|NCT03766399|516160346|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
143167551|NCT03766399|516160347|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
143167552|NCT03766399|516160348|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
143167553|NCT03766399|516160349|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
143167554|NCT03766399|516160350|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
143167555|NCT03766399|516160351|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
143167556|NCT03766399|516160352|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
143167557|NCT03766399|516160353|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
143167558|NCT03766399|516160354|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
143167559|NCT03766399|516160355|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
143167560|NCT03766399|516160356|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
143167561|NCT03766399|516160357|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
143167562|NCT03766399|516160358|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
143167563|NCT03766399|516160359|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
143167564|NCT03766399|516160360|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
143167565|NCT03766399|516160361|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
143167566|NCT03766399|516160362|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
143167567|NCT03766399|516160363|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
143167568|NCT05030766|516160364|FG000|Phase 1 Participants|Lost to Follow-up|12|||
143167569|NCT05030766|516160365|FG001|Phase 1 Participants|Lost to Follow-up|22|||
143167570|NCT05030766|516160366|FG002|Phase 1 Participants|Lost to Follow-up|0|||
143167571|NCT05030766|516160367|FG003|Phase 1 Participants|Lost to Follow-up|0|||
143167572|NCT05030766|516160364|FG000|Phase 1 Participants|Did not attend sessions after being randomized|16|||
143167573|NCT05030766|516160365|FG001|Phase 1 Participants|Did not attend sessions after being randomized|9|||
143167574|NCT05030766|516160366|FG002|Phase 1 Participants|Did not attend sessions after being randomized|0|||
143167575|NCT05030766|516160367|FG003|Phase 1 Participants|Did not attend sessions after being randomized|0|||
143167576|NCT05030766|516160364|FG000|Phase 2 Participants|Lost to Follow-up|0|||
143167577|NCT05030766|516160365|FG001|Phase 2 Participants|Lost to Follow-up|0|||
143167578|NCT05030766|516160366|FG002|Phase 2 Participants|Lost to Follow-up|6|||
143167579|NCT05030766|516160367|FG003|Phase 2 Participants|Lost to Follow-up|2|||
143167580|NCT00645658|516160368|FG000|Overall Study|Withdrawal by Subject|1|||
143167581|NCT00645658|516160369|FG001|Overall Study|Withdrawal by Subject|0|||
143167582|NCT00645658|516160368|FG000|Overall Study|Did not complete all assesments|0|||
143167583|NCT00645658|516160369|FG001|Overall Study|Did not complete all assesments|2|||
143167584|NCT00023595|516160376|FG000|5 Year Follow up|Lost to Follow-up|2|||
143167585|NCT00023595|516160377|FG001|5 Year Follow up|Lost to Follow-up|2|||
143167586|NCT00023595|516160378|FG002|5 Year Follow up|Lost to Follow-up|1|||
143167587|NCT00023595|516160379|FG003|5 Year Follow up|Lost to Follow-up|7|||
143167588|NCT00023595|516160380|FG004|5 Year Follow up|Lost to Follow-up|3|||
143167589|NCT00023595|516160376|FG000|10 Year Follow up|Lost to Follow-up|12|||
143167590|NCT00023595|516160377|FG001|10 Year Follow up|Lost to Follow-up|10|||
143167591|NCT00023595|516160378|FG002|10 Year Follow up|Lost to Follow-up|3|||
143167592|NCT00023595|516160379|FG003|10 Year Follow up|Lost to Follow-up|0|||
143167593|NCT00023595|516160380|FG004|10 Year Follow up|Lost to Follow-up|0|||
143364302|NCT00946114|516876957|FG000|Overall Study|Death|5|||
143167594|NCT05889468|516160381|FG000|Overall Study|Lost to Follow-up|9|||
143167595|NCT05889468|516160382|FG001|Overall Study|Lost to Follow-up|2|||
143167596|NCT05889468|516160381|FG000|Overall Study|Withdrawal by Subject|2|||
143167597|NCT05889468|516160382|FG001|Overall Study|Withdrawal by Subject|2|||
143167598|NCT02014376|516160389|FG000|Overall Study|Adverse Event|1|||
143167599|NCT02014376|516160390|FG001|Overall Study|Adverse Event|1|||
143167600|NCT02014376|516160391|FG002|Overall Study|Adverse Event|0|||
143167601|NCT02014376|516160389|FG000|Overall Study|Lost to Follow-up|2|||
143167602|NCT02014376|516160390|FG001|Overall Study|Lost to Follow-up|0|||
143167603|NCT02014376|516160391|FG002|Overall Study|Lost to Follow-up|0|||
143243107|NCT00439517|516441138|FG001|Overall Study|Subject on treatment|0|||
143243108|NCT00439517|516441137|FG000|Overall Study|Subject in survival follow-up|1|||
143243109|NCT00439517|516441138|FG001|Overall Study|Subject in survival follow-up|0|||
143243110|NCT00594815|516441139|FG000|Overall Study|Never Treated|3|||
143243111|NCT00594815|516441139|FG000|Overall Study|Withdrawal by Subject|2|||
143243112|NCT00594815|516441139|FG000|Overall Study|Toxicity|4|||
143243113|NCT03214666|516441140|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
143243114|NCT03214666|516441141|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
143243115|NCT03214666|516441142|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
143243116|NCT03214666|516441143|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
143243117|NCT03214666|516441144|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
143243118|NCT03214666|516441145|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
143243119|NCT01216189|516441148|FG000|Overall Study|Lost to Follow-up|21|||
143243120|NCT01216189|516441149|FG001|Overall Study|Lost to Follow-up|3|||
143243121|NCT01216189|516441148|FG000|Overall Study|Death|4|||
143243122|NCT01216189|516441149|FG001|Overall Study|Death|2|||
143243123|NCT01733680|516441152|FG000|Overall Study|Withdrawal by Subject|0|||
143243124|NCT01733680|516441153|FG001|Overall Study|Withdrawal by Subject|1|||
143243125|NCT01932437|516441154|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
143243126|NCT01932437|516441155|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
143243127|NCT01932437|516441156|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
143243128|NCT01932437|516441157|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
143243129|NCT01932437|516441158|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
143243130|NCT01932437|516441159|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
143243131|NCT04411667|516441160|FG000|Overall Study|Physician Decision|1|||
143243132|NCT04411667|516441161|FG001|Overall Study|Physician Decision|0|||
143243133|NCT03895840|516441164|FG000|Overall Study|Withdrawal by Subject|21|||
143243134|NCT01931566|516441165|FG000|Overall Study|Randomized But Not Treated|6|||
143243135|NCT01931566|516441166|FG001|Overall Study|Randomized But Not Treated|9|||
143243136|NCT01931566|516441167|FG002|Overall Study|Randomized But Not Treated|14|||
143243137|NCT01931566|516441165|FG000|Overall Study|Adverse Event|37|||
143243138|NCT01931566|516441166|FG001|Overall Study|Adverse Event|167|||
143243139|NCT01931566|516441167|FG002|Overall Study|Adverse Event|132|||
143243140|NCT01931566|516441165|FG000|Overall Study|Major Protocol Deviation|5|||
143243141|NCT01931566|516441166|FG001|Overall Study|Major Protocol Deviation|14|||
143243142|NCT01931566|516441167|FG002|Overall Study|Major Protocol Deviation|21|||
143243143|NCT01931566|516441165|FG000|Overall Study|Lost to Follow-up|3|||
143243144|NCT01931566|516441166|FG001|Overall Study|Lost to Follow-up|26|||
143243145|NCT01931566|516441167|FG002|Overall Study|Lost to Follow-up|23|||
143243146|NCT01931566|516441165|FG000|Overall Study|Voluntary Withdrawal|78|||
143243147|NCT01931566|516441166|FG001|Overall Study|Voluntary Withdrawal|245|||
143243148|NCT01931566|516441167|FG002|Overall Study|Voluntary Withdrawal|225|||
143243149|NCT01931566|516441165|FG000|Overall Study|Study Termination|289|||
143243150|NCT01931566|516441166|FG001|Overall Study|Study Termination|968|||
143243151|NCT01931566|516441167|FG002|Overall Study|Study Termination|1037|||
143243152|NCT01931566|516441165|FG000|Overall Study|Reason Not Specified|11|||
143243153|NCT01931566|516441166|FG001|Overall Study|Reason Not Specified|47|||
143243154|NCT01931566|516441167|FG002|Overall Study|Reason Not Specified|53|||
143243155|NCT01931566|516441165|FG000|Overall Study|Missing|0|||
143243156|NCT01931566|516441166|FG001|Overall Study|Missing|0|||
143243157|NCT01931566|516441167|FG002|Overall Study|Missing|1|||
143243158|NCT01599637|516441168|FG000|Overall Study|administrative problems|0|||
143243159|NCT01599637|516441169|FG001|Overall Study|administrative problems|2|||
143243160|NCT01599637|516441170|FG002|Overall Study|administrative problems|0|||
143243161|NCT01599637|516441168|FG000|Overall Study|Adverse Event|1|||
143243162|NCT01599637|516441169|FG001|Overall Study|Adverse Event|0|||
143243163|NCT01599637|516441170|FG002|Overall Study|Adverse Event|0|||
143243164|NCT00760617|516441172|FG000|Overall Study|Adverse Event|5|||
143243165|NCT00760617|516441173|FG001|Overall Study|Adverse Event|2|||
143243166|NCT00760617|516441174|FG002|Overall Study|Adverse Event|0|||
143243167|NCT00760617|516441172|FG000|Overall Study|Lost to Follow-up|0|||
143243168|NCT00760617|516441173|FG001|Overall Study|Lost to Follow-up|0|||
143243169|NCT00760617|516441174|FG002|Overall Study|Lost to Follow-up|5|||
143243170|NCT04476797|516441175|FG000|Overall Study|Withdrawal by Subject|1|||
143243171|NCT04476797|516441176|FG001|Overall Study|Withdrawal by Subject|0|||
143243172|NCT04476797|516441177|FG002|Overall Study|Withdrawal by Subject|0|||
143243173|NCT04476797|516441175|FG000|Overall Study|Death|0|||
143243174|NCT04476797|516441176|FG001|Overall Study|Death|1|||
143243175|NCT04476797|516441177|FG002|Overall Study|Death|2|||
143243176|NCT04476797|516441175|FG000|Overall Study|Sponsor Terminated Study|0|||
143243177|NCT04476797|516441176|FG001|Overall Study|Sponsor Terminated Study|18|||
143243178|NCT04476797|516441177|FG002|Overall Study|Sponsor Terminated Study|17|||
143243179|NCT02991040|516441180|FG000|Overall Study|Withdrawal by Subject|2|||
143243180|NCT02991040|516441180|FG000|Overall Study|Lost to Follow-up|2|||
143243181|NCT03070964|516441182|FG000|Overall Study|Progressive disease|8|||
143243182|NCT03070964|516441182|FG000|Overall Study|Treatment-unrelated adverse event|2|||
143243183|NCT03070964|516441182|FG000|Overall Study|Never treated|1|||
143243184|NCT03070964|516441182|FG000|Overall Study|Physician Decision|1|||
143243185|NCT03070964|516441182|FG000|Overall Study|Withdrawal by Subject|1|||
143243186|NCT03070964|516441182|FG000|Overall Study|Adverse Event|1|||
143243187|NCT01869764|516441183|FG000|Overall Study|Withdrawal by Subject|0|||
143243188|NCT01869764|516441184|FG001|Overall Study|Withdrawal by Subject|2|||
143243189|NCT01626872|516441185|FG000|Overall Study|Physician Decision|13|||
143243190|NCT01626872|516441186|FG001|Overall Study|Physician Decision|9|||
143243191|NCT01626872|516441187|FG002|Overall Study|Physician Decision|6|||
143243192|NCT01626872|516441185|FG000|Overall Study|Withdrawal by Subject|19|||
143243193|NCT01626872|516441186|FG001|Overall Study|Withdrawal by Subject|27|||
143243194|NCT01626872|516441187|FG002|Overall Study|Withdrawal by Subject|8|||
143243195|NCT01626872|516441185|FG000|Overall Study|Adverse Event (including Death)|20|||
143243196|NCT01626872|516441186|FG001|Overall Study|Adverse Event (including Death)|28|||
143243197|NCT01626872|516441187|FG002|Overall Study|Adverse Event (including Death)|8|||
143243198|NCT01626872|516441185|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
143243199|NCT01626872|516441186|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
143243200|NCT01626872|516441187|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
143243201|NCT00750438|516441192|FG000|Overall Study|Protocol Violation|4|||
143243202|NCT00750438|516441193|FG001|Overall Study|Protocol Violation|1|||
143243203|NCT00750438|516441192|FG000|Overall Study|Physician Decision|2|||
143243204|NCT00750438|516441193|FG001|Overall Study|Physician Decision|2|||
143243205|NCT00750438|516441192|FG000|Overall Study|Withdrawal by Subject|1|||
143243206|NCT00750438|516441193|FG001|Overall Study|Withdrawal by Subject|1|||
143243207|NCT03848728|516441194|FG000|Overall Study|Death|16|||
143243208|NCT03848728|516441195|FG001|Overall Study|Death|13|||
143243209|NCT03848728|516441194|FG000|Overall Study|Outmigrated to non-study community|98|||
143243210|NCT03848728|516441195|FG001|Overall Study|Outmigrated to non-study community|106|||
143243211|NCT03848728|516441194|FG000|Overall Study|Transfered to non-study clinic|32|||
143243212|NCT03848728|516441195|FG001|Overall Study|Transfered to non-study clinic|48|||
143243213|NCT03848728|516441194|FG000|Overall Study|Withdrawal by Subject|1|||
143243214|NCT03848728|516441195|FG001|Overall Study|Withdrawal by Subject|0|||
143243215|NCT00536744|516441196|FG000|Overall Study|Adverse Event|13|||
143243216|NCT00536744|516441197|FG001|Overall Study|Adverse Event|10|||
143243217|NCT00536744|516441196|FG000|Overall Study|Death|2|||
143243218|NCT00536744|516441197|FG001|Overall Study|Death|1|||
143243219|NCT00536744|516441196|FG000|Overall Study|Physician Decision|3|||
143243220|NCT00536744|516441197|FG001|Overall Study|Physician Decision|1|||
143243221|NCT00536744|516441196|FG000|Overall Study|Lost to Follow-up|3|||
143243222|NCT00536744|516441197|FG001|Overall Study|Lost to Follow-up|5|||
143243223|NCT00536744|516441196|FG000|Overall Study|Withdrawal by Subject|7|||
143243224|NCT00536744|516441197|FG001|Overall Study|Withdrawal by Subject|8|||
143243225|NCT00536744|516441196|FG000|Overall Study|PI tried alternative treatment|1|||
143243226|NCT00536744|516441197|FG001|Overall Study|PI tried alternative treatment|3|||
143243227|NCT03805659|516442778|FG000|Overall Study|Withdrawal by Subject|0|||
143243228|NCT03805659|516442779|FG001|Overall Study|Withdrawal by Subject|1|||
143243229|NCT02273596|516442781|FG000|24-Week Treatment Period|Adverse Event|3|||
143243230|NCT02273596|516442781|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
143243231|NCT02273596|516442781|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
143243232|NCT02273596|516442781|FG000|24-Week Treatment Period|Physician Decision|1|||
143243233|NCT02273596|516442781|FG000|24-Week Treatment Period|Protocol Deviation|1|||
143243234|NCT02273596|516442781|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
143243235|NCT02273596|516442781|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
143243236|NCT02273596|516442781|FG000|Extension Period|Lost to Follow-up|1|||
143243237|NCT02273596|516442781|FG000|Extension Period|Protocol Deviation|1|||
143243238|NCT01596062|516442782|FG000|Overall Study|Adverse Event|1|||
143243239|NCT01596062|516442783|FG001|Overall Study|Adverse Event|0|||
143243240|NCT01596062|516442784|FG002|Overall Study|Adverse Event|2|||
143243241|NCT01596062|516442782|FG000|Overall Study|Lack of Efficacy|0|||
143243242|NCT01596062|516442783|FG001|Overall Study|Lack of Efficacy|0|||
143243243|NCT01596062|516442784|FG002|Overall Study|Lack of Efficacy|1|||
143243244|NCT02139592|516442785|FG000|Overall Study|Case Report Forms Uncollected|8|||
143243245|NCT00145158|516442787|FG000|Overall Study|premature withdrawal|2|||
143243246|NCT00145158|516442788|FG001|Overall Study|premature withdrawal|3|||
143243247|NCT03180840|516442789|FG000|Overall Study|Withdrawal by Subject|1|||
143243248|NCT01227018|516442793|FG000|Overall Study|Disease progression|9|||
143243249|NCT01227018|516442793|FG000|Overall Study|Toxicity|2|||
143243250|NCT01227018|516442793|FG000|Overall Study|Withdrew after beginning treatment|4|||
143243251|NCT02948634|516442794|FG000|Overall Study|Lack of efficacy and study suspended|10|||
143243252|NCT02948634|516442795|FG001|Overall Study|Lack of efficacy and study suspended|2|||
143243253|NCT01413204|516442798|FG000|Overall Study|Adverse Event|1|||
143243254|NCT01413204|516442799|FG001|Overall Study|Adverse Event|2|||
143243255|NCT01413204|516442800|FG002|Overall Study|Adverse Event|2|||
143243256|NCT01413204|516442798|FG000|Overall Study|Physician Decision|3|||
143243257|NCT01413204|516442799|FG001|Overall Study|Physician Decision|0|||
143243258|NCT01413204|516442800|FG002|Overall Study|Physician Decision|2|||
143243259|NCT01413204|516442798|FG000|Overall Study|Withdrawal by Subject|1|||
143243260|NCT01413204|516442799|FG001|Overall Study|Withdrawal by Subject|4|||
143243261|NCT01413204|516442800|FG002|Overall Study|Withdrawal by Subject|4|||
143045073|NCT01896934|515706022|FG000|Overall Study|Adverse Event|1|||
143045074|NCT01896934|515706022|FG000|Overall Study|Withdrawal by Subject|1|||
143045075|NCT02197416|515706023|FG000|Overall Study|Other reasons|0|||
143045076|NCT02197416|515706024|FG001|Overall Study|Other reasons|2|||
143045077|NCT02197416|515706025|FG002|Overall Study|Other reasons|5|||
143045078|NCT02197416|515706023|FG000|Overall Study|Withdrawal by Subject|0|||
143243262|NCT01413204|516442798|FG000|Overall Study|Clearly not eligible for the study|0|||
143243263|NCT01413204|516442799|FG001|Overall Study|Clearly not eligible for the study|0|||
143045079|NCT02197416|515706024|FG001|Overall Study|Withdrawal by Subject|2|||
143045080|NCT02197416|515706025|FG002|Overall Study|Withdrawal by Subject|1|||
143045081|NCT02197416|515706023|FG000|Overall Study|Protocol Violation|1|||
143045082|NCT02197416|515706024|FG001|Overall Study|Protocol Violation|0|||
143045083|NCT02197416|515706025|FG002|Overall Study|Protocol Violation|1|||
143045084|NCT02197416|515706023|FG000|Overall Study|Adverse Event|0|||
143045085|NCT02197416|515706024|FG001|Overall Study|Adverse Event|0|||
143243264|NCT01413204|516442800|FG002|Overall Study|Clearly not eligible for the study|1|||
143243265|NCT01413204|516442798|FG000|Overall Study|Fasting plasma glucose level increased|1|||
143243266|NCT01413204|516442799|FG001|Overall Study|Fasting plasma glucose level increased|0|||
143243267|NCT01413204|516442800|FG002|Overall Study|Fasting plasma glucose level increased|10|||
143243268|NCT00753649|516442801|FG000|Overall Study|Migrated/moved from study area|1|||
143243269|NCT00753649|516442802|FG001|Overall Study|Migrated/moved from study area|0|||
143243270|NCT00753649|516442801|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
143243271|NCT00753649|516442802|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
143243272|NCT00753649|516442801|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
143243273|NCT00753649|516442802|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
143243274|NCT00753649|516442801|FG000|Overall Study|Protocol Violation|2|||
143243275|NCT00753649|516442802|FG001|Overall Study|Protocol Violation|0|||
143243276|NCT00499616|516442803|FG000|Overall Study|Death|1|||
143243277|NCT00499616|516442804|FG001|Overall Study|Death|5|||
143243278|NCT00499616|516442805|FG002|Overall Study|Death|3|||
143243279|NCT00499616|516442806|FG003|Overall Study|Death|1|||
143243280|NCT00499616|516442803|FG000|Overall Study|Lack of Efficacy|5|||
143045086|NCT02197416|515706025|FG002|Overall Study|Adverse Event|1|||
143045087|NCT00716625|515706026|FG000|Overall Study|Safety was not Assessable|1|||
143045088|NCT01492439|515706027|FG000|Overall Study|Withdrew from RTE|4|||
143045089|NCT01492439|515706028|FG001|Overall Study|Withdrew from RTE|9|||
143045090|NCT01204294|515706030|FG000|Overall Study|Adverse Event|2|||
143045091|NCT01204294|515706031|FG001|Overall Study|Adverse Event|6|||
143045092|NCT01204294|515706032|FG002|Overall Study|Adverse Event|0|||
143243281|NCT00499616|516442804|FG001|Overall Study|Lack of Efficacy|0|||
143243282|NCT00499616|516442805|FG002|Overall Study|Lack of Efficacy|19|||
143243283|NCT00499616|516442806|FG003|Overall Study|Lack of Efficacy|0|||
143243284|NCT00499616|516442803|FG000|Overall Study|Lost to Follow-up|0|||
143243285|NCT00499616|516442804|FG001|Overall Study|Lost to Follow-up|0|||
143243286|NCT00499616|516442805|FG002|Overall Study|Lost to Follow-up|1|||
143243287|NCT00499616|516442806|FG003|Overall Study|Lost to Follow-up|0|||
143243288|NCT00499616|516442803|FG000|Overall Study|Physician Decision|6|||
143243289|NCT00499616|516442804|FG001|Overall Study|Physician Decision|16|||
143243290|NCT00499616|516442805|FG002|Overall Study|Physician Decision|9|||
143243291|NCT00499616|516442806|FG003|Overall Study|Physician Decision|0|||
143243292|NCT00499616|516442803|FG000|Overall Study|Withdrawal by Subject|1|||
143243293|NCT00499616|516442804|FG001|Overall Study|Withdrawal by Subject|0|||
143243294|NCT00499616|516442805|FG002|Overall Study|Withdrawal by Subject|1|||
143045093|NCT01204294|515706033|FG003|Overall Study|Adverse Event|7|||
143243295|NCT00499616|516442806|FG003|Overall Study|Withdrawal by Subject|0|||
143243296|NCT00499616|516442803|FG000|Overall Study|Ineligible|1|||
143243297|NCT00499616|516442804|FG001|Overall Study|Ineligible|2|||
143243298|NCT00499616|516442805|FG002|Overall Study|Ineligible|0|||
143243299|NCT00499616|516442806|FG003|Overall Study|Ineligible|15|||
143243300|NCT00499616|516442803|FG000|Overall Study|Not evaluable|0|||
143243301|NCT00499616|516442804|FG001|Overall Study|Not evaluable|0|||
143243302|NCT00499616|516442805|FG002|Overall Study|Not evaluable|0|||
143243303|NCT00499616|516442806|FG003|Overall Study|Not evaluable|41|||
143045094|NCT01204294|515706034|FG004|Overall Study|Adverse Event|1|||
143045095|NCT01204294|515706035|FG005|Overall Study|Adverse Event|4|||
143045096|NCT01204294|515706036|FG006|Overall Study|Adverse Event|0|||
143243304|NCT00499616|516442803|FG000|Overall Study|Patient/Parent Refusal|1|||
143243305|NCT00499616|516442804|FG001|Overall Study|Patient/Parent Refusal|5|||
143243306|NCT00499616|516442805|FG002|Overall Study|Patient/Parent Refusal|3|||
143243307|NCT00499616|516442806|FG003|Overall Study|Patient/Parent Refusal|0|||
143045097|NCT01204294|515706030|FG000|Overall Study|Protocol Violation|1|||
143045098|NCT01204294|515706031|FG001|Overall Study|Protocol Violation|0|||
143045099|NCT01204294|515706032|FG002|Overall Study|Protocol Violation|2|||
143243308|NCT04816669|516442809|FG000|Part 1|Adverse Event|1|||
143045100|NCT01204294|515706033|FG003|Overall Study|Protocol Violation|1|||
143045101|NCT01204294|515706034|FG004|Overall Study|Protocol Violation|0|||
143045102|NCT01204294|515706035|FG005|Overall Study|Protocol Violation|0|||
143045103|NCT01204294|515706036|FG006|Overall Study|Protocol Violation|0|||
143045104|NCT01204294|515706030|FG000|Overall Study|Withdrawal by Subject|0|||
143045105|NCT01204294|515706031|FG001|Overall Study|Withdrawal by Subject|2|||
143045106|NCT01204294|515706032|FG002|Overall Study|Withdrawal by Subject|2|||
143045107|NCT01204294|515706033|FG003|Overall Study|Withdrawal by Subject|1|||
143045108|NCT01204294|515706034|FG004|Overall Study|Withdrawal by Subject|1|||
143045109|NCT01204294|515706035|FG005|Overall Study|Withdrawal by Subject|1|||
143045110|NCT01204294|515706036|FG006|Overall Study|Withdrawal by Subject|2|||
143045111|NCT01204294|515706030|FG000|Overall Study|Lack of Efficacy|0|||
143045112|NCT01204294|515706031|FG001|Overall Study|Lack of Efficacy|0|||
143045113|NCT01204294|515706032|FG002|Overall Study|Lack of Efficacy|0|||
143045114|NCT01204294|515706033|FG003|Overall Study|Lack of Efficacy|2|||
143045115|NCT01204294|515706034|FG004|Overall Study|Lack of Efficacy|0|||
143045116|NCT01204294|515706035|FG005|Overall Study|Lack of Efficacy|0|||
143045117|NCT01204294|515706036|FG006|Overall Study|Lack of Efficacy|0|||
143045118|NCT01204294|515706030|FG000|Overall Study|Other (house moving)|0|||
143045119|NCT01204294|515706031|FG001|Overall Study|Other (house moving)|0|||
143045120|NCT01204294|515706032|FG002|Overall Study|Other (house moving)|1|||
143045121|NCT01204294|515706033|FG003|Overall Study|Other (house moving)|0|||
143045122|NCT01204294|515706034|FG004|Overall Study|Other (house moving)|0|||
143045123|NCT01204294|515706035|FG005|Overall Study|Other (house moving)|0|||
143045124|NCT01204294|515706036|FG006|Overall Study|Other (house moving)|0|||
143045125|NCT04590027|515706037|FG000|Overall Study|Lost to Follow-up|17|||
143045126|NCT04590027|515706038|FG001|Overall Study|Lost to Follow-up|14|||
143045127|NCT04590027|515706037|FG000|Overall Study|Protocol Violation|0|||
143045128|NCT04590027|515706038|FG001|Overall Study|Protocol Violation|3|||
143045129|NCT00933686|515706039|FG000|Overall Study|Protocol Violation|0|||
143045130|NCT00933686|515706040|FG001|Overall Study|Protocol Violation|1|||
143045131|NCT00933686|515706039|FG000|Overall Study|Lost to Follow-up|2|||
143045132|NCT00933686|515706040|FG001|Overall Study|Lost to Follow-up|2|||
143045133|NCT00933686|515706039|FG000|Overall Study|Withdrawal by Subject|6|||
143045134|NCT00933686|515706040|FG001|Overall Study|Withdrawal by Subject|5|||
143045135|NCT00933686|515706039|FG000|Overall Study|Adverse Event|1|||
143045136|NCT00933686|515706040|FG001|Overall Study|Adverse Event|1|||
143045137|NCT00933686|515706039|FG000|Overall Study|Physician Decision|1|||
143045138|NCT00933686|515706040|FG001|Overall Study|Physician Decision|0|||
143045139|NCT00933686|515706039|FG000|Overall Study|Failure to show up at endpoint visits|0|||
143045140|NCT00933686|515706040|FG001|Overall Study|Failure to show up at endpoint visits|2|||
143045141|NCT01383486|515706041|FG000|Overall Study|Lost to Follow-up|10|||
143045142|NCT01383486|515706041|FG000|Overall Study|Incomplete information for analysis|2|||
143045143|NCT01383486|515706041|FG000|Overall Study|Did not take any product|6|||
143045144|NCT00245063|515706042|FG000|Overall Study|Adverse Event|6|||
143045145|NCT00245063|515706043|FG001|Overall Study|Adverse Event|5|||
143045146|NCT00245063|515706042|FG000|Overall Study|Death|1|||
143045147|NCT00245063|515706043|FG001|Overall Study|Death|0|||
143045148|NCT05099380|515706045|FG000|Overall Study|Subject enrolled in error|1|||
143045149|NCT05099380|515706046|FG001|Overall Study|Subject enrolled in error|0|||
143045150|NCT05099380|515706045|FG000|Overall Study|Study Procedure|1|||
143045151|NCT05099380|515706046|FG001|Overall Study|Study Procedure|0|||
143045152|NCT05099380|515706045|FG000|Overall Study|Protocol Violation|1|||
143045153|NCT05099380|515706046|FG001|Overall Study|Protocol Violation|0|||
143045154|NCT05099380|515706045|FG000|Overall Study|Adverse Event|1|||
143045155|NCT05099380|515706046|FG001|Overall Study|Adverse Event|1|||
143045156|NCT05099380|515706045|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
143045157|NCT05099380|515706046|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
143045158|NCT01839279|515706047|FG000|Overall Study|Adverse Event|4|||
143045159|NCT01839279|515706048|FG001|Overall Study|Adverse Event|1|||
143045160|NCT01839279|515706049|FG002|Overall Study|Adverse Event|1|||
143045161|NCT01839279|515706047|FG000|Overall Study|Withdrawal by Subject|4|||
143045162|NCT01839279|515706048|FG001|Overall Study|Withdrawal by Subject|1|||
143045163|NCT01839279|515706049|FG002|Overall Study|Withdrawal by Subject|1|||
143045164|NCT01839279|515706047|FG000|Overall Study|Classified as 'Other'|5|||
143045165|NCT01839279|515706048|FG001|Overall Study|Classified as 'Other'|0|||
143045166|NCT01839279|515706049|FG002|Overall Study|Classified as 'Other'|0|||
143045167|NCT00840216|515706053|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
143045168|NCT00840216|515706054|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
143045169|NCT03673670|515706055|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
143045170|NCT03673670|515706056|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
143045171|NCT03673670|515706057|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
143045172|NCT03673670|515706058|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
143045173|NCT03673670|515706059|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
143045174|NCT03673670|515706060|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
143045175|NCT03673670|515706055|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
143045176|NCT03673670|515706056|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
143243309|NCT04816669|516442810|FG001|Part 1|Adverse Event|1|||
143243310|NCT04816669|516442811|FG002|Part 1|Adverse Event|0|||
143243311|NCT04816669|516442812|FG003|Part 1|Adverse Event|0|||
143243312|NCT04816669|516442809|FG000|Part 1|Lost to Follow-up|2|||
143243313|NCT04816669|516442810|FG001|Part 1|Lost to Follow-up|2|||
143243314|NCT04816669|516442811|FG002|Part 1|Lost to Follow-up|0|||
143243315|NCT04816669|516442812|FG003|Part 1|Lost to Follow-up|0|||
143243316|NCT04816669|516442809|FG000|Part 1|Protocol Violation|0|||
143243317|NCT04816669|516442810|FG001|Part 1|Protocol Violation|1|||
143243318|NCT04816669|516442811|FG002|Part 1|Protocol Violation|0|||
143243319|NCT04816669|516442812|FG003|Part 1|Protocol Violation|0|||
143243320|NCT04816669|516442809|FG000|Part 1|Withdrawal by Subject|1|||
143243321|NCT04816669|516442810|FG001|Part 1|Withdrawal by Subject|2|||
143243322|NCT04816669|516442811|FG002|Part 1|Withdrawal by Subject|0|||
143243323|NCT04816669|516442812|FG003|Part 1|Withdrawal by Subject|0|||
143243324|NCT04816669|516442809|FG000|Part 2|Other|0|||
143045177|NCT03673670|515706057|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
143045178|NCT03673670|515706058|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
143045179|NCT03673670|515706059|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
143045180|NCT03673670|515706060|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
143045181|NCT03673670|515706055|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
143045182|NCT03673670|515706056|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
143045183|NCT03673670|515706057|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
143045184|NCT03673670|515706058|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
143045185|NCT03673670|515706059|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
143045186|NCT03673670|515706060|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
143045187|NCT03673670|515706055|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
143045188|NCT03673670|515706056|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
143045189|NCT03673670|515706057|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
143045190|NCT03673670|515706058|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
143045191|NCT03673670|515706059|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
143045192|NCT03673670|515706060|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
143045193|NCT03673670|515706055|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
143045194|NCT03673670|515706056|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
143045195|NCT03673670|515706057|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
143045196|NCT03673670|515706058|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
143045197|NCT03673670|515706059|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
143045198|NCT03673670|515706060|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
143045199|NCT03673670|515706055|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
143045200|NCT03673670|515706056|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
143045201|NCT03673670|515706057|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
143045202|NCT03673670|515706058|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
143045203|NCT03673670|515706059|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
143045204|NCT03673670|515706060|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
143045205|NCT03673670|515706055|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
143045206|NCT03673670|515706056|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
143045207|NCT03673670|515706057|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
143045208|NCT03673670|515706058|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
143243325|NCT04816669|516442810|FG001|Part 2|Other|0|||
143243326|NCT04816669|516442811|FG002|Part 2|Other|1|||
143243327|NCT04816669|516442812|FG003|Part 2|Other|0|||
143243328|NCT04816669|516442809|FG000|Part 2|Withdrawal by Subject|0|||
143243329|NCT04816669|516442810|FG001|Part 2|Withdrawal by Subject|0|||
143243330|NCT04816669|516442811|FG002|Part 2|Withdrawal by Subject|0|||
143045209|NCT03673670|515706059|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
143045210|NCT03673670|515706060|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
143045211|NCT03276754|515706061|FG000|Overall Study|Withdrawal of informed consent|4|||
143045212|NCT03276754|515706061|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
143045213|NCT03276754|515706061|FG000|Overall Study|Lost to Follow-up|27|||
143045214|NCT03276754|515706061|FG000|Overall Study|No data reported at Month 24|31|||
143045215|NCT03276754|515706061|FG000|Overall Study|Death|39|||
143045216|NCT02294981|515706062|FG000|Overall Study|Lost to Follow-up|1|||
143045217|NCT00191815|515706063|FG000|Overall Study|Adverse Event|2|||
143045218|NCT00191815|515706063|FG000|Overall Study|Disease progression or relapse|24|||
143045219|NCT00191815|515706063|FG000|Overall Study|Death|2|||
143045220|NCT00191815|515706063|FG000|Overall Study|Protocol Violation|3|||
143045221|NCT00191815|515706063|FG000|Overall Study|Physician Decision|2|||
143045222|NCT00191815|515706063|FG000|Overall Study|Withdrawal by Subject|7|||
143045223|NCT03644550|515706064|FG000|Overall Study|Withdrawal by Subject|3|||
143045224|NCT03644550|515706064|FG000|Overall Study|Progressive disease|15|||
143045225|NCT01794845|515706065|FG000|Overall Study|Withdrawal by Subject|1|||
143243331|NCT04816669|516442812|FG003|Part 2|Withdrawal by Subject|1|||
143243332|NCT04816669|516442809|FG000|Part 2|Lost to Follow-up|0|||
143243333|NCT04816669|516442810|FG001|Part 2|Lost to Follow-up|0|||
143243334|NCT04816669|516442811|FG002|Part 2|Lost to Follow-up|1|||
143243335|NCT04816669|516442812|FG003|Part 2|Lost to Follow-up|0|||
143045226|NCT02139826|515706068|FG000|Overall Study|Adverse Event|1|||
143045227|NCT00436163|515706069|FG000|Overall Study|Lost to Follow-up|2|||
143045228|NCT00436163|515706069|FG000|Overall Study|Adverse Event|1|||
143045229|NCT04063878|515706070|FG000|Overall Study|Withdrawal by Subject|2|||
143045230|NCT04063878|515706070|FG000|Overall Study|Subject not fulfilling study eligibility criteria|14|||
143045231|NCT01841554|515706071|FG000|Overall Study|Death|7|||
143045232|NCT01841554|515706071|FG000|Overall Study|No Implantation|1|||
143045233|NCT01841554|515706071|FG000|Overall Study|Discontinued Follow Up|5|||
143045234|NCT01841554|515706071|FG000|Overall Study|Study exit due to secondary intervention|6|||
143045235|NCT00796562|515706072|FG000|Overall Study|Death|49|||
143045236|NCT03100344|515706077|FG000|Overall Study|Adverse Event|0|||
143045237|NCT03100344|515706078|FG001|Overall Study|Adverse Event|3|||
143045238|NCT03100344|515706079|FG002|Overall Study|Adverse Event|2|||
143045239|NCT03100344|515706080|FG003|Overall Study|Adverse Event|3|||
143045240|NCT03100344|515706077|FG000|Overall Study|Lack of Efficacy|2|||
143045241|NCT03100344|515706078|FG001|Overall Study|Lack of Efficacy|0|||
143045242|NCT03100344|515706079|FG002|Overall Study|Lack of Efficacy|0|||
143045243|NCT03100344|515706080|FG003|Overall Study|Lack of Efficacy|0|||
143045244|NCT03100344|515706077|FG000|Overall Study|Protocol Violation|1|||
143045245|NCT03100344|515706078|FG001|Overall Study|Protocol Violation|0|||
143045246|NCT03100344|515706079|FG002|Overall Study|Protocol Violation|0|||
143045247|NCT03100344|515706080|FG003|Overall Study|Protocol Violation|0|||
143045248|NCT03100344|515706077|FG000|Overall Study|Withdrawal by Subject|10|||
143045249|NCT03100344|515706078|FG001|Overall Study|Withdrawal by Subject|7|||
143045250|NCT03100344|515706079|FG002|Overall Study|Withdrawal by Subject|4|||
143045251|NCT03100344|515706080|FG003|Overall Study|Withdrawal by Subject|8|||
143045252|NCT03100344|515706077|FG000|Overall Study|Lost to Follow-up|1|||
143045253|NCT03100344|515706078|FG001|Overall Study|Lost to Follow-up|1|||
143045254|NCT03100344|515706079|FG002|Overall Study|Lost to Follow-up|1|||
143045255|NCT03100344|515706080|FG003|Overall Study|Lost to Follow-up|1|||
143045256|NCT00730691|515706083|FG000|Overall Study|Adverse Event|4|||
143045257|NCT00730691|515706084|FG001|Overall Study|Adverse Event|8|||
143045258|NCT00730691|515706085|FG002|Overall Study|Adverse Event|11|||
143045259|NCT00730691|515706086|FG003|Overall Study|Adverse Event|11|||
143045260|NCT00730691|515706087|FG004|Overall Study|Adverse Event|23|||
143045261|NCT00730691|515706083|FG000|Overall Study|Lack of Efficacy|4|||
143045262|NCT00730691|515706084|FG001|Overall Study|Lack of Efficacy|4|||
143045263|NCT00730691|515706085|FG002|Overall Study|Lack of Efficacy|2|||
143045264|NCT00730691|515706086|FG003|Overall Study|Lack of Efficacy|1|||
143045265|NCT00730691|515706087|FG004|Overall Study|Lack of Efficacy|1|||
143045266|NCT00730691|515706083|FG000|Overall Study|Non-compliance with Study Drug|6|||
143045267|NCT00730691|515706084|FG001|Overall Study|Non-compliance with Study Drug|1|||
143045268|NCT00730691|515706085|FG002|Overall Study|Non-compliance with Study Drug|6|||
143045269|NCT00730691|515706086|FG003|Overall Study|Non-compliance with Study Drug|3|||
143045270|NCT00730691|515706087|FG004|Overall Study|Non-compliance with Study Drug|3|||
143045271|NCT00730691|515706083|FG000|Overall Study|Protocol Deviations|3|||
143045272|NCT00730691|515706084|FG001|Overall Study|Protocol Deviations|5|||
143045273|NCT00730691|515706085|FG002|Overall Study|Protocol Deviations|3|||
143045274|NCT00730691|515706086|FG003|Overall Study|Protocol Deviations|7|||
143045275|NCT00730691|515706087|FG004|Overall Study|Protocol Deviations|5|||
143045276|NCT00730691|515706083|FG000|Overall Study|Withdrawal of Consent|7|||
143045277|NCT00730691|515706084|FG001|Overall Study|Withdrawal of Consent|9|||
143045278|NCT00730691|515706085|FG002|Overall Study|Withdrawal of Consent|3|||
143045279|NCT00730691|515706086|FG003|Overall Study|Withdrawal of Consent|6|||
143045280|NCT00730691|515706087|FG004|Overall Study|Withdrawal of Consent|3|||
143045281|NCT00730691|515706083|FG000|Overall Study|Lost to Follow-up|11|||
143045282|NCT00730691|515706084|FG001|Overall Study|Lost to Follow-up|8|||
143243336|NCT01229267|516442813|FG000|Overall Study|Adverse Event|4|||
143243337|NCT01229267|516442814|FG001|Overall Study|Adverse Event|6|||
143243338|NCT01229267|516442815|FG002|Overall Study|Adverse Event|3|||
143243339|NCT01229267|516442816|FG003|Overall Study|Adverse Event|2|||
143045283|NCT00730691|515706085|FG002|Overall Study|Lost to Follow-up|13|||
143045284|NCT00730691|515706086|FG003|Overall Study|Lost to Follow-up|15|||
143045285|NCT00730691|515706087|FG004|Overall Study|Lost to Follow-up|13|||
143045286|NCT00730691|515706083|FG000|Overall Study|Other|1|||
143045287|NCT00730691|515706084|FG001|Overall Study|Other|1|||
143045288|NCT00730691|515706085|FG002|Overall Study|Other|1|||
143045289|NCT00730691|515706086|FG003|Overall Study|Other|2|||
143045290|NCT00730691|515706087|FG004|Overall Study|Other|2|||
143045291|NCT03578809|515707462|FG000|Overall Study|Death|0|||
143045292|NCT03578809|515707463|FG001|Overall Study|Death|2|||
143045293|NCT03578809|515707464|FG002|Overall Study|Death|0|||
143045294|NCT03578809|515707465|FG003|Overall Study|Death|1|||
143045295|NCT03578809|515707462|FG000|Overall Study|Lost to Follow-up|0|||
143045296|NCT03578809|515707463|FG001|Overall Study|Lost to Follow-up|1|||
143045297|NCT03578809|515707464|FG002|Overall Study|Lost to Follow-up|0|||
143243340|NCT01229267|516442817|FG004|Overall Study|Adverse Event|10|||
143045298|NCT03578809|515707465|FG003|Overall Study|Lost to Follow-up|0|||
143045299|NCT03578809|515707462|FG000|Overall Study|Withdrawal by Subject|3|||
143045300|NCT03578809|515707463|FG001|Overall Study|Withdrawal by Subject|5|||
143045301|NCT03578809|515707464|FG002|Overall Study|Withdrawal by Subject|2|||
143045302|NCT03578809|515707465|FG003|Overall Study|Withdrawal by Subject|0|||
143045303|NCT03578809|515707462|FG000|Overall Study|Other|3|||
143045304|NCT03578809|515707463|FG001|Overall Study|Other|6|||
143045305|NCT03578809|515707464|FG002|Overall Study|Other|2|||
143045306|NCT03578809|515707465|FG003|Overall Study|Other|8|||
143045307|NCT01952691|515707466|FG000|Overall Study|Lost to Follow-up|2|||
143045308|NCT00199901|515707467|FG000|Overall Study|Protocol Violation|2|||
143045309|NCT00199901|515707468|FG001|Overall Study|Protocol Violation|0|||
143045310|NCT00199901|515707467|FG000|Overall Study|Withdrawal by Subject|1|||
143045311|NCT00199901|515707468|FG001|Overall Study|Withdrawal by Subject|0|||
143045312|NCT00199901|515707467|FG000|Overall Study|Progressive Disease|24|||
143045313|NCT00199901|515707468|FG001|Overall Study|Progressive Disease|24|||
143045314|NCT02566850|515707475|FG000|Overall Study|Protocol Violation|1|||
143045315|NCT00830258|515707476|FG000|First Intervention|Adverse Event|1|||
143045316|NCT00830258|515707477|FG001|First Intervention|Adverse Event|0|||
143045317|NCT00830258|515707476|FG000|Washout: 7 Days|Protocol Violation|1|||
143045318|NCT00830258|515707477|FG001|Washout: 7 Days|Protocol Violation|0|||
143045319|NCT00798603|515707478|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
143045320|NCT00798603|515707478|FG000|Overall Study|Withdrawal by Subject|10|||
143045321|NCT00798603|515707478|FG000|Overall Study|Adverse Event|22|||
143045322|NCT00798603|515707478|FG000|Overall Study|Physician Decision|1|||
143045323|NCT00798603|515707478|FG000|Overall Study|Lack of insurance coverage|1|||
143045324|NCT00373256|515707479|FG000|Overall Study|Adverse Event (AE)|1|||
143045325|NCT00373256|515707480|FG001|Overall Study|Adverse Event (AE)|5|||
143045326|NCT00373256|515707479|FG000|Overall Study|Lost to Follow-up|2|||
143045327|NCT00373256|515707480|FG001|Overall Study|Lost to Follow-up|1|||
143045328|NCT00373256|515707479|FG000|Overall Study|Death|9|||
143045329|NCT00373256|515707480|FG001|Overall Study|Death|8|||
143045330|NCT00373256|515707479|FG000|Overall Study|Objective Progression or Relapse|111|||
143045331|NCT00373256|515707480|FG001|Overall Study|Objective Progression or Relapse|104|||
143045332|NCT00373256|515707479|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
143045333|NCT00373256|515707480|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
143045334|NCT00373256|515707479|FG000|Overall Study|Other|73|||
143045335|NCT00373256|515707480|FG001|Overall Study|Other|107|||
143045336|NCT00373256|515707479|FG000|Overall Study|Protocol Violation|0|||
143045337|NCT00373256|515707480|FG001|Overall Study|Protocol Violation|2|||
143045338|NCT00373256|515707479|FG000|Overall Study|Study Terminated by Sponsor|41|||
143045339|NCT00373256|515707480|FG001|Overall Study|Study Terminated by Sponsor|13|||
143045340|NCT04372238|515707481|FG000|Overall Study|Duplicate|3|||
143045341|NCT04372238|515707482|FG001|Overall Study|Duplicate|3|||
143045342|NCT04372238|515707481|FG000|Overall Study|Did not consent for data linkage|6|||
143045343|NCT04372238|515707482|FG001|Overall Study|Did not consent for data linkage|10|||
143045344|NCT04241458|515707483|FG000|Overall Study|Withdrawal by Subject|0|||
143045345|NCT04241458|515707484|FG001|Overall Study|Withdrawal by Subject|0|||
143045346|NCT04241458|515707485|FG002|Overall Study|Withdrawal by Subject|0|||
143045347|NCT04241458|515707486|FG003|Overall Study|Withdrawal by Subject|0|||
143045348|NCT04241458|515707487|FG004|Overall Study|Withdrawal by Subject|1|||
143045349|NCT06144424|515707488|FG000|Overall Study|Withdrawal by Subject|2|||
143045350|NCT06144424|515707489|FG001|Overall Study|Withdrawal by Subject|0|||
143045351|NCT06144424|515707488|FG000|Overall Study|Incarceration|1|||
143045352|NCT06144424|515707489|FG001|Overall Study|Incarceration|0|||
143045353|NCT00772603|515707490|FG000|Overall Study|Withdrawal by Subject|11|||
143045354|NCT00772603|515707491|FG001|Overall Study|Withdrawal by Subject|10|||
143045355|NCT00772603|515707492|FG002|Overall Study|Withdrawal by Subject|6|||
143045356|NCT00772603|515707490|FG000|Overall Study|Adverse Event|37|||
143045357|NCT00772603|515707491|FG001|Overall Study|Adverse Event|18|||
143045358|NCT00772603|515707492|FG002|Overall Study|Adverse Event|10|||
143045359|NCT00772603|515707490|FG000|Overall Study|Subject Non-compliance|1|||
143045360|NCT00772603|515707491|FG001|Overall Study|Subject Non-compliance|6|||
143045361|NCT00772603|515707492|FG002|Overall Study|Subject Non-compliance|4|||
143045362|NCT00772603|515707490|FG000|Overall Study|Protocol Violation|0|||
143045363|NCT00772603|515707491|FG001|Overall Study|Protocol Violation|1|||
143045364|NCT00772603|515707492|FG002|Overall Study|Protocol Violation|1|||
143045365|NCT00772603|515707490|FG000|Overall Study|Lost to Follow-up|1|||
143045366|NCT00772603|515707491|FG001|Overall Study|Lost to Follow-up|5|||
143045367|NCT00772603|515707492|FG002|Overall Study|Lost to Follow-up|2|||
143045368|NCT00772603|515707490|FG000|Overall Study|Physician Decision|0|||
143045369|NCT00772603|515707491|FG001|Overall Study|Physician Decision|0|||
143045370|NCT00772603|515707492|FG002|Overall Study|Physician Decision|1|||
143045371|NCT00772603|515707490|FG000|Overall Study|Other|2|||
143045372|NCT00772603|515707491|FG001|Overall Study|Other|0|||
143045373|NCT00772603|515707492|FG002|Overall Study|Other|2|||
143045374|NCT01564394|515707495|FG000|Overall Study|Withdrawal by Subject|6|||
143045375|NCT01564394|515707496|FG001|Overall Study|Withdrawal by Subject|10|||
143045376|NCT05239195|515707501|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
143045377|NCT05239195|515707502|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
143045378|NCT02241551|515707505|FG000|Overall Study|Adverse Event|1|||
143045379|NCT02241551|515707506|FG001|Overall Study|Adverse Event|0|||
143045380|NCT00081653|515707507|FG000|Overall Study|Adverse Event|23|||
143045381|NCT00081653|515707508|FG001|Overall Study|Adverse Event|17|||
143045382|NCT00081653|515707507|FG000|Overall Study|Lost to Follow-up|2|||
143045383|NCT00081653|515707508|FG001|Overall Study|Lost to Follow-up|4|||
143045384|NCT00081653|515707507|FG000|Overall Study|Refused Treatment|18|||
143045385|NCT00081653|515707508|FG001|Overall Study|Refused Treatment|14|||
143045386|NCT00081653|515707507|FG000|Overall Study|Low bone mineral density|1|||
143045387|NCT00081653|515707508|FG001|Overall Study|Low bone mineral density|0|||
143045388|NCT00081653|515707507|FG000|Overall Study|Bone loss|2|||
143045389|NCT00081653|515707508|FG001|Overall Study|Bone loss|0|||
143045390|NCT00081653|515707507|FG000|Overall Study|Participant leaving country|1|||
143045391|NCT00081653|515707508|FG001|Overall Study|Participant leaving country|0|||
143045392|NCT00081653|515707507|FG000|Overall Study|Loss of bone mass|0|||
143045393|NCT00081653|515707508|FG001|Overall Study|Loss of bone mass|2|||
143045394|NCT00928057|515707513|FG000|Overall Study|Adverse Event|1|||
143045395|NCT00928057|515707514|FG001|Overall Study|Adverse Event|2|||
143045396|NCT00928057|515707513|FG000|Overall Study|Withdrawal by Subject|1|||
143045397|NCT00928057|515707514|FG001|Overall Study|Withdrawal by Subject|0|||
143045398|NCT00928057|515707513|FG000|Overall Study|Lost to Follow-up|0|||
143045399|NCT00928057|515707514|FG001|Overall Study|Lost to Follow-up|1|||
143045400|NCT00928057|515707513|FG000|Overall Study|Protocol Violation|0|||
143045401|NCT00928057|515707514|FG001|Overall Study|Protocol Violation|1|||
143045402|NCT02751424|515707521|FG000|Part 2|Adverse Event|0|||
143045403|NCT02751424|515707522|FG001|Part 2|Adverse Event|0|||
143045404|NCT02751424|515707523|FG002|Part 2|Adverse Event|0|||
143045405|NCT02751424|515707524|FG003|Part 2|Adverse Event|0|||
143045406|NCT02751424|515707525|FG004|Part 2|Adverse Event|0|||
143045407|NCT02751424|515707526|FG005|Part 2|Adverse Event|0|||
143045408|NCT02751424|515707527|FG006|Part 2|Adverse Event|0|||
143045409|NCT02751424|515707528|FG007|Part 2|Adverse Event|5|||
143045410|NCT02751424|515707529|FG008|Part 2|Adverse Event|0|||
143045411|NCT03206749|515707530|FG000|Overall Study|Withdrawal of consent|5|||
143045412|NCT03206749|515707531|FG001|Overall Study|Withdrawal of consent|3|||
143045413|NCT03206749|515707532|FG002|Overall Study|Withdrawal of consent|6|||
143045414|NCT03206749|515707530|FG000|Overall Study|Lost to Follow-up|0|||
143045415|NCT03206749|515707531|FG001|Overall Study|Lost to Follow-up|0|||
143045416|NCT03206749|515707532|FG002|Overall Study|Lost to Follow-up|1|||
143045417|NCT03779334|515707535|FG000|Overall Study|Withdrawal by Subject|3|||
143045418|NCT03779334|515707536|FG001|Overall Study|Withdrawal by Subject|0|||
143045419|NCT03779334|515707537|FG002|Overall Study|Withdrawal by Subject|0|||
143045420|NCT03779334|515707535|FG000|Overall Study|Ongoing in Study|5|||
143045421|NCT03779334|515707536|FG001|Overall Study|Ongoing in Study|13|||
143045422|NCT03779334|515707537|FG002|Overall Study|Ongoing in Study|5|||
143045423|NCT00848536|515707538|FG000|Overall Study|Adverse Event|2|||
143045424|NCT00848536|515707539|FG001|Overall Study|Adverse Event|2|||
143045425|NCT00848536|515707538|FG000|Overall Study|Withdrawal by Subject|0|||
143167604|NCT00721110|516160396|FG000|Overall Study|Ultram use|1|||
143167605|NCT00721110|516160397|FG001|Overall Study|Ultram use|0|||
143167606|NCT00721110|516160398|FG002|Overall Study|Ultram use|0|||
143167607|NCT00721110|516160399|FG003|Overall Study|Ultram use|0|||
143167608|NCT00721110|516160396|FG000|Overall Study|vertical incision|0|||
143167609|NCT00721110|516160397|FG001|Overall Study|vertical incision|0|||
143167610|NCT00721110|516160398|FG002|Overall Study|vertical incision|1|||
143167611|NCT00721110|516160399|FG003|Overall Study|vertical incision|0|||
143167612|NCT01979185|516160406|FG000|Period 2|Other|0|||
143167613|NCT01979185|516160407|FG001|Period 2|Other|1|||
143167614|NCT00980798|516160408|FG000|Overall Study|Adverse Event|7|||
143167615|NCT00980798|516160409|FG001|Overall Study|Adverse Event|36|||
143167616|NCT00980798|516160408|FG000|Overall Study|Lack of Efficacy|16|||
143167617|NCT00980798|516160409|FG001|Overall Study|Lack of Efficacy|5|||
143167618|NCT00980798|516160408|FG000|Overall Study|Lost to Follow-up|0|||
143167619|NCT00980798|516160409|FG001|Overall Study|Lost to Follow-up|1|||
143167620|NCT00980798|516160408|FG000|Overall Study|Physician Decision|2|||
143167621|NCT00980798|516160409|FG001|Overall Study|Physician Decision|1|||
143167622|NCT00980798|516160408|FG000|Overall Study|Withdrawal by Subject|8|||
143167623|NCT00980798|516160409|FG001|Overall Study|Withdrawal by Subject|11|||
143045426|NCT00848536|515707539|FG001|Overall Study|Withdrawal by Subject|1|||
143045427|NCT00848536|515707538|FG000|Overall Study|Protocol Violation|0|||
143045428|NCT00848536|515707539|FG001|Overall Study|Protocol Violation|1|||
143045429|NCT00848536|515707538|FG000|Overall Study|Noncompliance|1|||
143045430|NCT00848536|515707539|FG001|Overall Study|Noncompliance|0|||
143045431|NCT00848536|515707538|FG000|Overall Study|Inadequate Control of IOP|1|||
143045432|NCT00848536|515707539|FG001|Overall Study|Inadequate Control of IOP|1|||
143045433|NCT00848536|515707538|FG000|Overall Study|Patient Moved|0|||
143045434|NCT00848536|515707539|FG001|Overall Study|Patient Moved|2|||
143045435|NCT01175135|515707542|FG000|Overall Study|Adverse Event|2|||
143045436|NCT01175135|515707543|FG001|Overall Study|Adverse Event|5|||
143045437|NCT01175135|515707544|FG002|Overall Study|Adverse Event|3|||
143167624|NCT00980798|516160408|FG000|Overall Study|Other|0|||
143167625|NCT00980798|516160409|FG001|Overall Study|Other|1|||
143045438|NCT01175135|515707545|FG003|Overall Study|Adverse Event|4|||
143045439|NCT01175135|515707542|FG000|Overall Study|Death|1|||
143045440|NCT01175135|515707543|FG001|Overall Study|Death|0|||
143045441|NCT01175135|515707544|FG002|Overall Study|Death|0|||
143045442|NCT01175135|515707545|FG003|Overall Study|Death|0|||
143045443|NCT01175135|515707542|FG000|Overall Study|Lack of Efficacy|4|||
143045444|NCT01175135|515707543|FG001|Overall Study|Lack of Efficacy|5|||
143045445|NCT01175135|515707544|FG002|Overall Study|Lack of Efficacy|0|||
143045446|NCT01175135|515707545|FG003|Overall Study|Lack of Efficacy|5|||
143045447|NCT01175135|515707542|FG000|Overall Study|Lost to Follow-up|1|||
143045448|NCT01175135|515707543|FG001|Overall Study|Lost to Follow-up|2|||
143045449|NCT01175135|515707544|FG002|Overall Study|Lost to Follow-up|0|||
143045450|NCT01175135|515707545|FG003|Overall Study|Lost to Follow-up|0|||
143045451|NCT01175135|515707542|FG000|Overall Study|Protocol Violation|1|||
143045452|NCT01175135|515707543|FG001|Overall Study|Protocol Violation|1|||
143045453|NCT01175135|515707544|FG002|Overall Study|Protocol Violation|0|||
143045454|NCT01175135|515707545|FG003|Overall Study|Protocol Violation|0|||
143045455|NCT01175135|515707542|FG000|Overall Study|Withdrawal by Subject|4|||
143045456|NCT01175135|515707543|FG001|Overall Study|Withdrawal by Subject|8|||
143045457|NCT01175135|515707544|FG002|Overall Study|Withdrawal by Subject|5|||
143045458|NCT01175135|515707545|FG003|Overall Study|Withdrawal by Subject|5|||
143045459|NCT01175135|515707542|FG000|Overall Study|Other|3|||
143045460|NCT01175135|515707543|FG001|Overall Study|Other|1|||
143045461|NCT01175135|515707544|FG002|Overall Study|Other|3|||
143045462|NCT01175135|515707545|FG003|Overall Study|Other|0|||
143045463|NCT01175135|515707542|FG000|Overall Study|Randomized But Not Treated|0|||
143045464|NCT01175135|515707543|FG001|Overall Study|Randomized But Not Treated|0|||
143045465|NCT01175135|515707544|FG002|Overall Study|Randomized But Not Treated|1|||
143045466|NCT01175135|515707545|FG003|Overall Study|Randomized But Not Treated|0|||
143045467|NCT01572662|515707549|FG000|Overall Study|Withdrawal by Subject|1|||
143045468|NCT01572662|515707550|FG001|Overall Study|Withdrawal by Subject|0|||
143045469|NCT01572662|515707549|FG000|Overall Study|Physician Decision|0|||
143045470|NCT01572662|515707550|FG001|Overall Study|Physician Decision|1|||
143045471|NCT03446768|515707551|FG000|Overall Study|Withdrawal by Subject|0|||
143045472|NCT03446768|515707552|FG001|Overall Study|Withdrawal by Subject|1|||
143045473|NCT00107991|515707553|FG000|Eligibility Assessment|Disease not severe enough|7|||
143045474|NCT00107991|515707553|FG000|Eligibility Assessment|Unwilling to participate|7|||
143045475|NCT00107991|515707553|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
143045476|NCT00107991|515707553|FG000|Eligibility Assessment|Abnormal labs|2|||
143045477|NCT00107991|515707553|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
143045478|NCT00107991|515707553|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
143045479|NCT00107991|515707553|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
143045480|NCT00107991|515707553|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
143045481|NCT00107991|515707553|FG000|12 Week Treatment Period|Adverse Event|1|||
143045482|NCT00107991|515707553|FG000|12 Week Treatment Period|Protocol Violation|1|||
143045483|NCT00107991|515707553|FG000|12 Week Treatment Period|Incarcerated|1|||
143045484|NCT00107991|515707553|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
143045485|NCT04547192|515707554|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
143045486|NCT04547192|515707555|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
143045487|NCT04547192|515707556|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
143045488|NCT04547192|515707557|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
143045489|NCT04547192|515707554|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
143045490|NCT04547192|515707555|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
143045491|NCT04547192|515707556|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
143045492|NCT04547192|515707557|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
143045493|NCT04547192|515707554|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
143045494|NCT04547192|515707555|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
143045495|NCT04547192|515707556|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
143045496|NCT04547192|515707557|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
143045497|NCT04547192|515707554|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
143045498|NCT04547192|515707555|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
143045499|NCT04547192|515707556|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
143045500|NCT04547192|515707557|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
143045501|NCT04547192|515707554|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
143045502|NCT04547192|515707555|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
143045503|NCT04547192|515707556|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
143045504|NCT04547192|515707557|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
143045505|NCT01535222|515707558|FG000|Overall Study|Inclusion/exclusion|0|||
143243341|NCT01229267|516442813|FG000|Overall Study|Death|40|||
143045506|NCT01535222|515707559|FG001|Overall Study|Inclusion/exclusion|0|||
143045507|NCT01535222|515707560|FG002|Overall Study|Inclusion/exclusion|1|||
143045508|NCT01535222|515707561|FG003|Overall Study|Inclusion/exclusion|0|||
143045509|NCT01535222|515707562|FG004|Overall Study|Inclusion/exclusion|0|||
143045510|NCT01535222|515707563|FG005|Overall Study|Inclusion/exclusion|0|||
143045511|NCT00935012|515707566|FG000|Overall Study|Death|19|||
143045512|NCT00935012|515707566|FG000|Overall Study|Withdrawal by Subject|3|||
143045513|NCT00935012|515707566|FG000|Overall Study|Other|5|||
143045514|NCT00935012|515707566|FG000|Overall Study|Adverse Event|2|||
143045515|NCT01442155|515707567|FG000|Overall Study|Complete remission|35|||
143045516|NCT01442155|515707567|FG000|Overall Study|Recurrence|26|||
143045517|NCT01442155|515707567|FG000|Overall Study|Adverse Event|2|||
143045518|NCT01442155|515707567|FG000|Overall Study|Lost to Follow-up|2|||
143045519|NCT01590563|515707574|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
143045520|NCT01604941|515707579|FG000|Overall Study|Adverse Event|1|||
143045521|NCT01604941|515707580|FG001|Overall Study|Adverse Event|2|||
143045522|NCT01604941|515707581|FG002|Overall Study|Adverse Event|0|||
143045523|NCT01604941|515707582|FG003|Overall Study|Adverse Event|0|||
143045524|NCT01604941|515707583|FG004|Overall Study|Adverse Event|1|||
143045525|NCT01604941|515707584|FG005|Overall Study|Adverse Event|5|||
143045526|NCT01604941|515707579|FG000|Overall Study|Non-compliance|1|||
143045527|NCT01604941|515707580|FG001|Overall Study|Non-compliance|0|||
143045528|NCT01604941|515707581|FG002|Overall Study|Non-compliance|0|||
143045529|NCT01604941|515707582|FG003|Overall Study|Non-compliance|0|||
143045530|NCT01604941|515707583|FG004|Overall Study|Non-compliance|0|||
143045531|NCT01604941|515707584|FG005|Overall Study|Non-compliance|0|||
143045532|NCT01604941|515707579|FG000|Overall Study|Participant Decision|0|||
143045533|NCT01604941|515707580|FG001|Overall Study|Participant Decision|0|||
143045534|NCT01604941|515707581|FG002|Overall Study|Participant Decision|0|||
143045535|NCT01604941|515707582|FG003|Overall Study|Participant Decision|0|||
143045536|NCT01604941|515707583|FG004|Overall Study|Participant Decision|0|||
143167626|NCT03034044|516160417|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
143167627|NCT03164356|516160428|FG000|Overall Study|Lost to Follow-up|1|||
143167628|NCT03164356|516160429|FG001|Overall Study|Lost to Follow-up|1|||
143167629|NCT03164356|516160430|FG002|Overall Study|Lost to Follow-up|2|||
143167630|NCT03164356|516160431|FG003|Overall Study|Lost to Follow-up|1|||
143167631|NCT03164356|516160428|FG000|Overall Study|Physician Decision|0|||
143167632|NCT03164356|516160429|FG001|Overall Study|Physician Decision|0|||
143167633|NCT03164356|516160430|FG002|Overall Study|Physician Decision|3|||
143167634|NCT03164356|516160431|FG003|Overall Study|Physician Decision|0|||
143167635|NCT03164356|516160428|FG000|Overall Study|Protocol Violation|2|||
143167636|NCT03164356|516160429|FG001|Overall Study|Protocol Violation|1|||
143167637|NCT03164356|516160430|FG002|Overall Study|Protocol Violation|0|||
143167638|NCT03164356|516160431|FG003|Overall Study|Protocol Violation|0|||
143167639|NCT03164356|516160428|FG000|Overall Study|Withdrawal by Subject|1|||
143167640|NCT03164356|516160429|FG001|Overall Study|Withdrawal by Subject|0|||
143167641|NCT03164356|516160430|FG002|Overall Study|Withdrawal by Subject|0|||
143167642|NCT03164356|516160431|FG003|Overall Study|Withdrawal by Subject|0|||
143167643|NCT03164356|516160428|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
143167644|NCT03164356|516160429|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
143167645|NCT03164356|516160430|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
143167646|NCT03164356|516160431|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
143167647|NCT03164356|516160428|FG000|Overall Study|Subject Incarcerated|0|||
143167648|NCT03164356|516160429|FG001|Overall Study|Subject Incarcerated|1|||
143167649|NCT03164356|516160430|FG002|Overall Study|Subject Incarcerated|0|||
143167650|NCT03164356|516160431|FG003|Overall Study|Subject Incarcerated|0|||
143167651|NCT03164356|516160428|FG000|Overall Study|Prosthetist unable to participate|0|||
143167652|NCT03164356|516160429|FG001|Overall Study|Prosthetist unable to participate|2|||
143167653|NCT03164356|516160430|FG002|Overall Study|Prosthetist unable to participate|1|||
143167654|NCT03164356|516160431|FG003|Overall Study|Prosthetist unable to participate|0|||
143167655|NCT05943990|516160438|FG000|Overall Study|Study Terminated by Sponsor|0|||
143167656|NCT05943990|516160439|FG001|Overall Study|Study Terminated by Sponsor|0|||
143167657|NCT05943990|516160440|FG002|Overall Study|Study Terminated by Sponsor|1|||
143167658|NCT00791648|516161577|FG000|Overall Study|Physician Decision|0|||
143167659|NCT00791648|516161578|FG001|Overall Study|Physician Decision|1|||
143167660|NCT00791648|516161577|FG000|Overall Study|Withdrawal by Subject|0|||
143167661|NCT00791648|516161578|FG001|Overall Study|Withdrawal by Subject|1|||
143167662|NCT00462826|516161579|FG000|Overall Study|Ineligible - second primary|1|||
143045537|NCT01604941|515707584|FG005|Overall Study|Participant Decision|2|||
143045538|NCT01604941|515707579|FG000|Overall Study|Early Study Termination|9|||
143045539|NCT01604941|515707580|FG001|Overall Study|Early Study Termination|2|||
143045540|NCT01604941|515707581|FG002|Overall Study|Early Study Termination|3|||
143045541|NCT01604941|515707582|FG003|Overall Study|Early Study Termination|3|||
143167663|NCT00462826|516161579|FG000|Overall Study|Ineligible - wrong cell type|1|||
143167664|NCT00462826|516161579|FG000|Overall Study|Ineligible - wrong primary|2|||
143167665|NCT00462826|516161579|FG000|Overall Study|Never treated|1|||
143167666|NCT03977155|516161580|FG000|Overall Study|Adverse Event|3|||
143167667|NCT03977155|516161581|FG001|Overall Study|Adverse Event|0|||
143167668|NCT03977155|516161582|FG002|Overall Study|Adverse Event|0|||
143167669|NCT03977155|516161580|FG000|Overall Study|Lost to Follow-up|0|||
143167670|NCT03977155|516161581|FG001|Overall Study|Lost to Follow-up|1|||
143167671|NCT03977155|516161582|FG002|Overall Study|Lost to Follow-up|0|||
143045542|NCT01604941|515707583|FG004|Overall Study|Early Study Termination|0|||
143045543|NCT01604941|515707584|FG005|Overall Study|Early Study Termination|0|||
143045544|NCT02699463|515707585|FG000|Overall Study|Lost to Follow-up|11|||
143045545|NCT02699463|515707586|FG001|Overall Study|Lost to Follow-up|8|||
143045546|NCT02699463|515707585|FG000|Overall Study|Withdrawal by Subject|4|||
143045547|NCT02699463|515707586|FG001|Overall Study|Withdrawal by Subject|1|||
143045548|NCT02488239|515707587|FG000|Overall Study|Death|3|||
143045549|NCT02488239|515707587|FG000|Overall Study|Withdrawal by Subject|3|||
143045550|NCT02488239|515707587|FG000|Overall Study|Physician Decision|2|||
143045551|NCT02488239|515707587|FG000|Overall Study|Consent ineligible|1|||
143045552|NCT02488239|515707587|FG000|Overall Study|Did not undergo implant procedure|1|||
143045553|NCT00909038|515707590|FG000|Overall Study|Protocol Violation|187|||
143045554|NCT00909038|515707590|FG000|Overall Study|Non-evaluable Subjects|230|||
143045555|NCT00909753|515707593|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
143045556|NCT00909753|515707594|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
143045557|NCT00909753|515707593|FG000|Period: Second Intervention|Protocol Violation|1|||
143045558|NCT00909753|515707594|FG001|Period: Second Intervention|Protocol Violation|0|||
143045559|NCT00841542|515707595|FG000|Period 1|Adverse Event|1|||
143045560|NCT00841542|515707596|FG001|Period 1|Adverse Event|0|||
143045561|NCT04345653|515707597|FG000|Overall Study|Withdrawal by Subject|2|||
143045562|NCT03214588|515707598|FG000|Overall Study|Adverse Event|1|||
143045563|NCT03214588|515707599|FG001|Overall Study|Adverse Event|0|||
143045564|NCT03214588|515707600|FG002|Overall Study|Adverse Event|2|||
143045565|NCT03214588|515707598|FG000|Overall Study|Reason Not Specified|0|||
143045566|NCT03214588|515707599|FG001|Overall Study|Reason Not Specified|1|||
143045567|NCT03214588|515707600|FG002|Overall Study|Reason Not Specified|0|||
143045568|NCT01316055|515707605|FG000|Overall Study|Lost to Follow-up|1|||
143045569|NCT01316055|515707606|FG001|Overall Study|Lost to Follow-up|0|||
143045570|NCT01316055|515707607|FG002|Overall Study|Lost to Follow-up|0|||
143045571|NCT00003470|515707608|FG000|Overall Study|Not evaluable|6|||
143045572|NCT01825798|515707610|FG000|Overall Study|Adverse Event|1|||
143045573|NCT01825798|515707611|FG001|Overall Study|Adverse Event|5|||
143045574|NCT01825798|515707610|FG000|Overall Study|Lost to Follow-up|1|||
143045575|NCT01825798|515707611|FG001|Overall Study|Lost to Follow-up|0|||
143045576|NCT00834873|515707617|FG000|First Intervention|Adverse Event|0|||
143045577|NCT00834873|515707618|FG001|First Intervention|Adverse Event|1|||
143045578|NCT00312897|515707620|FG000|Overall Study|Adverse Event|1|||
143045579|NCT00312897|515707621|FG001|Overall Study|Adverse Event|0|||
143045580|NCT00312897|515707620|FG000|Overall Study|Lost to Follow-up|2|||
143243342|NCT01229267|516442814|FG001|Overall Study|Death|37|||
143243343|NCT01229267|516442815|FG002|Overall Study|Death|35|||
143243344|NCT01229267|516442816|FG003|Overall Study|Death|13|||
143243345|NCT01229267|516442817|FG004|Overall Study|Death|103|||
143243346|NCT01229267|516442813|FG000|Overall Study|Withdrawal by Subject|23|||
143243347|NCT01229267|516442814|FG001|Overall Study|Withdrawal by Subject|22|||
143045581|NCT00312897|515707621|FG001|Overall Study|Lost to Follow-up|0|||
143243348|NCT01229267|516442815|FG002|Overall Study|Withdrawal by Subject|32|||
143243349|NCT01229267|516442816|FG003|Overall Study|Withdrawal by Subject|14|||
143243350|NCT01229267|516442817|FG004|Overall Study|Withdrawal by Subject|59|||
143243351|NCT01229267|516442813|FG000|Overall Study|Protocol Violation|0|||
143243352|NCT01229267|516442814|FG001|Overall Study|Protocol Violation|1|||
143243353|NCT01229267|516442815|FG002|Overall Study|Protocol Violation|0|||
143243354|NCT01229267|516442816|FG003|Overall Study|Protocol Violation|0|||
143243355|NCT01229267|516442817|FG004|Overall Study|Protocol Violation|0|||
143045582|NCT00312897|515707620|FG000|Overall Study|Physician Decision|1|||
143045583|NCT00312897|515707621|FG001|Overall Study|Physician Decision|0|||
143045584|NCT00312897|515707620|FG000|Overall Study|Withdrawal by Subject|1|||
143243356|NCT01229267|516442813|FG000|Overall Study|Progressive disease|0|||
143243357|NCT01229267|516442814|FG001|Overall Study|Progressive disease|0|||
143243358|NCT01229267|516442815|FG002|Overall Study|Progressive disease|0|||
143243359|NCT01229267|516442816|FG003|Overall Study|Progressive disease|0|||
143243360|NCT01229267|516442817|FG004|Overall Study|Progressive disease|1|||
143243361|NCT01229267|516442813|FG000|Overall Study|Physician Decision|8|||
143243362|NCT01229267|516442814|FG001|Overall Study|Physician Decision|11|||
143243363|NCT01229267|516442815|FG002|Overall Study|Physician Decision|8|||
143243364|NCT01229267|516442816|FG003|Overall Study|Physician Decision|3|||
143243365|NCT01229267|516442817|FG004|Overall Study|Physician Decision|25|||
143243366|NCT01229267|516442813|FG000|Overall Study|Lost to Follow-up|6|||
143045585|NCT00312897|515707621|FG001|Overall Study|Withdrawal by Subject|3|||
143045586|NCT00312897|515707620|FG000|Overall Study|Pregnancy|1|||
143045587|NCT00312897|515707621|FG001|Overall Study|Pregnancy|0|||
143045588|NCT00312897|515707620|FG000|Overall Study|discontinued prior to getting treatment|0|||
143045589|NCT00312897|515707621|FG001|Overall Study|discontinued prior to getting treatment|3|||
143045590|NCT04198363|515707622|FG000|Overall Study|Adverse Event|1|||
143045591|NCT04198363|515707623|FG001|Overall Study|Adverse Event|1|||
143045592|NCT04198363|515707622|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
143045593|NCT04198363|515707623|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
143045594|NCT04198363|515707622|FG000|Overall Study|Reason not Specified|1|||
143045595|NCT04198363|515707623|FG001|Overall Study|Reason not Specified|0|||
143045596|NCT00836472|515709402|FG000|Washout|Adverse Event|1|||
143045597|NCT00836472|515709403|FG001|Washout|Adverse Event|2|||
143045598|NCT00836472|515709402|FG000|Washout|Withdrawal by Subject|1|||
143045599|NCT00836472|515709403|FG001|Washout|Withdrawal by Subject|1|||
143045600|NCT01015287|515709404|FG000|Overall Study|Death|21|||
143045601|NCT01015287|515709405|FG001|Overall Study|Death|16|||
143045602|NCT01015287|515709404|FG000|Overall Study|Adverse Event|1|||
143045603|NCT01015287|515709405|FG001|Overall Study|Adverse Event|0|||
143045604|NCT01015287|515709404|FG000|Overall Study|Sponsor Decision|3|||
143045605|NCT01015287|515709405|FG001|Overall Study|Sponsor Decision|7|||
143045606|NCT01015287|515709404|FG000|Overall Study|Physician Decision|19|||
143045607|NCT01015287|515709405|FG001|Overall Study|Physician Decision|21|||
143045608|NCT01015287|515709404|FG000|Overall Study|Withdrawal by Subject|14|||
143045609|NCT01015287|515709405|FG001|Overall Study|Withdrawal by Subject|19|||
143045610|NCT01015287|515709404|FG000|Overall Study|Entry Criteria not Met|11|||
143045611|NCT01015287|515709405|FG001|Overall Study|Entry Criteria not Met|14|||
143045612|NCT01015287|515709404|FG000|Overall Study|Lost to Follow-up|2|||
143045613|NCT01015287|515709405|FG001|Overall Study|Lost to Follow-up|1|||
143045614|NCT01015287|515709404|FG000|Overall Study|Protocol Violation|1|||
143045615|NCT01015287|515709405|FG001|Overall Study|Protocol Violation|1|||
143045616|NCT01117623|515709406|FG000|Overall Study|Adverse Event|0|||
143045617|NCT01117623|515709407|FG001|Overall Study|Adverse Event|2|||
143045618|NCT01117623|515709408|FG002|Overall Study|Adverse Event|4|||
143045619|NCT01117623|515709409|FG003|Overall Study|Adverse Event|0|||
143045620|NCT01117623|515709410|FG004|Overall Study|Adverse Event|2|||
143045621|NCT01117623|515709411|FG005|Overall Study|Adverse Event|0|||
143045622|NCT01117623|515709412|FG006|Overall Study|Adverse Event|0|||
143045623|NCT01117623|515709413|FG007|Overall Study|Adverse Event|2|||
143045624|NCT01117623|515709406|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
143045625|NCT01117623|515709407|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
143045626|NCT01117623|515709408|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
143045627|NCT01117623|515709409|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
143045628|NCT01117623|515709410|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
143045629|NCT01117623|515709411|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
143045630|NCT01117623|515709412|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
143045631|NCT01117623|515709413|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
143045632|NCT01117623|515709406|FG000|Overall Study|Withdrawal by Subject|0|||
143045633|NCT01117623|515709407|FG001|Overall Study|Withdrawal by Subject|0|||
143045634|NCT01117623|515709408|FG002|Overall Study|Withdrawal by Subject|2|||
143045635|NCT01117623|515709409|FG003|Overall Study|Withdrawal by Subject|0|||
143045636|NCT01117623|515709410|FG004|Overall Study|Withdrawal by Subject|0|||
143167672|NCT03977155|516161580|FG000|Overall Study|Withdrawal by Subject|1|||
143167673|NCT03977155|516161581|FG001|Overall Study|Withdrawal by Subject|1|||
143167674|NCT03977155|516161582|FG002|Overall Study|Withdrawal by Subject|2|||
143167675|NCT03977155|516161580|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
143167676|NCT03977155|516161581|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
143167677|NCT03977155|516161582|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
143167678|NCT00936936|516161583|FG000|Overall Study|Adverse Event|7|||
143167679|NCT00936936|516161584|FG001|Overall Study|Adverse Event|1|||
143167680|NCT00936936|516161583|FG000|Overall Study|Disease Progression|2|||
143167681|NCT00936936|516161584|FG001|Overall Study|Disease Progression|2|||
143167682|NCT00936936|516161583|FG000|Overall Study|Unrelated|3|||
143167683|NCT00936936|516161584|FG001|Overall Study|Unrelated|1|||
143167684|NCT02278003|516161586|FG000|Overall Study|Withdrawal by Subject|11|||
143167685|NCT02278003|516161587|FG001|Overall Study|Withdrawal by Subject|0|||
143167686|NCT02278003|516161586|FG000|Overall Study|Not Treated|1|||
143167687|NCT02278003|516161587|FG001|Overall Study|Not Treated|0|||
143167688|NCT02278003|516161586|FG000|Overall Study|Recognition task improperly completed|7|||
143167689|NCT02278003|516161587|FG001|Overall Study|Recognition task improperly completed|0|||
143167690|NCT01373281|516161588|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
143167691|NCT01373281|516161589|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
143167692|NCT01373281|516161588|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
143167693|NCT01373281|516161589|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
143364303|NCT00946114|516876958|FG001|Overall Study|Death|2|||
143045637|NCT01117623|515709411|FG005|Overall Study|Withdrawal by Subject|1|||
143045638|NCT01117623|515709412|FG006|Overall Study|Withdrawal by Subject|1|||
143045639|NCT01117623|515709413|FG007|Overall Study|Withdrawal by Subject|1|||
143045640|NCT01117623|515709406|FG000|Overall Study|Non-compliance with study medication|0|||
143167694|NCT01373281|516161588|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
143167695|NCT01373281|516161589|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
143167696|NCT01373281|516161588|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
143167697|NCT01373281|516161589|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
143364304|NCT00946114|516876957|FG000|Overall Study|Other|1|||
143045641|NCT01117623|515709407|FG001|Overall Study|Non-compliance with study medication|0|||
143045642|NCT01117623|515709408|FG002|Overall Study|Non-compliance with study medication|0|||
143045643|NCT01117623|515709409|FG003|Overall Study|Non-compliance with study medication|0|||
143045644|NCT01117623|515709410|FG004|Overall Study|Non-compliance with study medication|0|||
143045645|NCT01117623|515709411|FG005|Overall Study|Non-compliance with study medication|0|||
143045646|NCT01117623|515709412|FG006|Overall Study|Non-compliance with study medication|0|||
143045647|NCT01117623|515709413|FG007|Overall Study|Non-compliance with study medication|1|||
143045648|NCT01117623|515709406|FG000|Overall Study|Invest. text: completed all planned txs|0|||
143045649|NCT01117623|515709407|FG001|Overall Study|Invest. text: completed all planned txs|0|||
143045650|NCT01117623|515709408|FG002|Overall Study|Invest. text: completed all planned txs|0|||
143045651|NCT01117623|515709409|FG003|Overall Study|Invest. text: completed all planned txs|0|||
143045652|NCT01117623|515709410|FG004|Overall Study|Invest. text: completed all planned txs|0|||
143045653|NCT01117623|515709411|FG005|Overall Study|Invest. text: completed all planned txs|1|||
143045654|NCT01117623|515709412|FG006|Overall Study|Invest. text: completed all planned txs|0|||
143045655|NCT01117623|515709413|FG007|Overall Study|Invest. text: completed all planned txs|0|||
143045656|NCT02451696|515709414|FG000|Overall Study|Surgery postponed|1|||
143045657|NCT02451696|515709415|FG001|Overall Study|Surgery postponed|0|||
143045658|NCT01557751|515709416|FG000|Overall Study|Physician Decision|3|||
143045659|NCT02752074|515709417|FG000|Overall Study|Lost to Follow-up|1|||
143045660|NCT02752074|515709418|FG001|Overall Study|Lost to Follow-up|4|||
143045661|NCT02752074|515709417|FG000|Overall Study|Death|146|||
143045662|NCT02752074|515709418|FG001|Overall Study|Death|129|||
143045663|NCT02752074|515709417|FG000|Overall Study|Withdrawal by Subject|9|||
143045664|NCT02752074|515709418|FG001|Overall Study|Withdrawal by Subject|10|||
143045665|NCT00488774|515709419|FG000|Overall Study|Withdrawal of consent|2|||
143045666|NCT00488774|515709420|FG001|Overall Study|Withdrawal of consent|2|||
143045667|NCT00488774|515709421|FG002|Overall Study|Withdrawal of consent|2|||
143045668|NCT00488774|515709422|FG003|Overall Study|Withdrawal of consent|0|||
143045669|NCT00488774|515709419|FG000|Overall Study|Other|6|||
143045670|NCT00488774|515709420|FG001|Overall Study|Other|3|||
143045671|NCT00488774|515709421|FG002|Overall Study|Other|2|||
143045672|NCT00488774|515709422|FG003|Overall Study|Other|2|||
143045673|NCT00488774|515709419|FG000|Overall Study|Lost to Follow-up|0|||
143045674|NCT00488774|515709420|FG001|Overall Study|Lost to Follow-up|0|||
143045675|NCT00488774|515709421|FG002|Overall Study|Lost to Follow-up|1|||
143045676|NCT00488774|515709422|FG003|Overall Study|Lost to Follow-up|1|||
143045677|NCT05523895|515709423|FG000|Overall Study|Adverse Event|2|||
143045678|NCT05523895|515709424|FG001|Overall Study|Adverse Event|1|||
143045679|NCT05523895|515709425|FG002|Overall Study|Adverse Event|1|||
143045680|NCT05523895|515709423|FG000|Overall Study|Lost to Follow-up|0|||
143045681|NCT05523895|515709424|FG001|Overall Study|Lost to Follow-up|1|||
143045682|NCT05523895|515709425|FG002|Overall Study|Lost to Follow-up|2|||
143045683|NCT05523895|515709423|FG000|Overall Study|Noncompliance with study drug|1|||
143045684|NCT05523895|515709424|FG001|Overall Study|Noncompliance with study drug|1|||
143045685|NCT05523895|515709425|FG002|Overall Study|Noncompliance with study drug|1|||
143045686|NCT05523895|515709423|FG000|Overall Study|Protocol Violation|0|||
143045687|NCT05523895|515709424|FG001|Overall Study|Protocol Violation|2|||
143045688|NCT05523895|515709425|FG002|Overall Study|Protocol Violation|0|||
143045689|NCT05523895|515709423|FG000|Overall Study|Withdrawal by Subject|1|||
143045690|NCT05523895|515709424|FG001|Overall Study|Withdrawal by Subject|3|||
143045691|NCT05523895|515709425|FG002|Overall Study|Withdrawal by Subject|1|||
143045692|NCT05523895|515709423|FG000|Overall Study|Not further specified|0|||
143045693|NCT05523895|515709424|FG001|Overall Study|Not further specified|3|||
143045694|NCT05523895|515709425|FG002|Overall Study|Not further specified|1|||
143045695|NCT03674892|515709426|FG000|Overall Study|Lack of Efficacy|5|||
143045696|NCT03674892|515709426|FG000|Overall Study|Lost to Follow-up|3|||
143045697|NCT03674892|515709426|FG000|Overall Study|Migraine|2|||
143045698|NCT03674892|515709426|FG000|Overall Study|Excessive Tearing|1|||
143045699|NCT03674892|515709426|FG000|Overall Study|Increased Eye Pain|1|||
143167698|NCT01373281|516161588|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
143167699|NCT01373281|516161589|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
143167700|NCT01373281|516161588|FG000|Surveillance Expansion Period|Protocol Violation|9|||
143167701|NCT01373281|516161589|FG001|Surveillance Expansion Period|Protocol Violation|1|||
143167702|NCT01373281|516161588|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
143167703|NCT01373281|516161589|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
143167704|NCT01373281|516161588|FG000|Surveillance Expansion Period|Serious adverse event|3|||
143167705|NCT01373281|516161589|FG001|Surveillance Expansion Period|Serious adverse event|4|||
143167706|NCT01397253|516161590|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
143167707|NCT01397253|516161591|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
143045700|NCT03674892|515709426|FG000|Overall Study|Increased Facial Pain|1|||
143045701|NCT03674892|515709426|FG000|Overall Study|Sinus Irritation|1|||
143045702|NCT03674892|515709426|FG000|Overall Study|Sinus Infection|1|||
143045703|NCT01959672|515709429|FG000|Overall Study|Death|1|||
143045704|NCT02842853|515709430|FG000|Overall Study|Non-compliance with the protocol|3|||
143045705|NCT02842853|515709431|FG001|Overall Study|Non-compliance with the protocol|7|||
143045706|NCT02842853|515709432|FG002|Overall Study|Non-compliance with the protocol|2|||
143045707|NCT02842853|515709433|FG003|Overall Study|Non-compliance with the protocol|5|||
143045708|NCT02842853|515709430|FG000|Overall Study|Subject met exclusion criteria|0|||
143045709|NCT02842853|515709431|FG001|Overall Study|Subject met exclusion criteria|1|||
143045710|NCT02842853|515709432|FG002|Overall Study|Subject met exclusion criteria|0|||
143045711|NCT02842853|515709433|FG003|Overall Study|Subject met exclusion criteria|0|||
143045712|NCT02842853|515709430|FG000|Overall Study|Withdrawal by Subject|11|||
143045713|NCT02842853|515709431|FG001|Overall Study|Withdrawal by Subject|13|||
143045714|NCT02842853|515709432|FG002|Overall Study|Withdrawal by Subject|9|||
143045715|NCT02842853|515709433|FG003|Overall Study|Withdrawal by Subject|8|||
143045716|NCT02842853|515709430|FG000|Overall Study|Lost to Follow-up|9|||
143045717|NCT02842853|515709431|FG001|Overall Study|Lost to Follow-up|13|||
143045718|NCT02842853|515709432|FG002|Overall Study|Lost to Follow-up|10|||
143045719|NCT02842853|515709433|FG003|Overall Study|Lost to Follow-up|11|||
143045720|NCT04089553|515709434|FG000|Overall Study|Death|1|||
143045721|NCT04089553|515709435|FG001|Overall Study|Death|1|||
143045722|NCT04089553|515709434|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
143045723|NCT04089553|515709435|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
143045724|NCT04089553|515709434|FG000|Overall Study|Withdrawal by Subject|3|||
143045725|NCT04089553|515709435|FG001|Overall Study|Withdrawal by Subject|3|||
143045726|NCT04089553|515709434|FG000|Overall Study|Physician Decision|1|||
143045727|NCT04089553|515709435|FG001|Overall Study|Physician Decision|0|||
143045728|NCT04089553|515709434|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
143045729|NCT04089553|515709435|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
143045730|NCT04089553|515709434|FG000|Overall Study|Other|1|||
143045731|NCT04089553|515709435|FG001|Overall Study|Other|0|||
143045732|NCT04089553|515709434|FG000|Overall Study|Adverse Event|1|||
143045733|NCT04089553|515709435|FG001|Overall Study|Adverse Event|1|||
143045734|NCT01403194|515709443|FG000|Overall Study|Screen Failure|2|||
143045735|NCT01403194|515709443|FG000|Overall Study|Lost to Follow-up|8|||
143045736|NCT03364192|515709444|FG000|Overall Study|Ineligible|10|||
143045737|NCT03364192|515709444|FG000|Overall Study|Withdrawal by Subject|5|||
143045738|NCT03364192|515709444|FG000|Overall Study|Lost to Follow-up|1|||
143045739|NCT00274651|515709447|FG000|Overall Study|Adverse Event|6|||
143045740|NCT00274651|515709448|FG001|Overall Study|Adverse Event|3|||
143045741|NCT00274651|515709447|FG000|Overall Study|Lack of Efficacy|13|||
143045742|NCT00274651|515709448|FG001|Overall Study|Lack of Efficacy|6|||
143045743|NCT00274651|515709447|FG000|Overall Study|Death|1|||
143045744|NCT00274651|515709448|FG001|Overall Study|Death|3|||
143045745|NCT00274651|515709447|FG000|Overall Study|Withdrawal by Subject|0|||
143045746|NCT00274651|515709448|FG001|Overall Study|Withdrawal by Subject|1|||
143045747|NCT00274651|515709447|FG000|Overall Study|Physician Decision|8|||
143045748|NCT00274651|515709448|FG001|Overall Study|Physician Decision|7|||
143045749|NCT00918645|515709449|FG000|Overall Study|Withdrawal by Subject|1|||
143045750|NCT03236311|515709450|FG000|Overall Study|Study terminated by sponsor|0|||
143045751|NCT03236311|515709451|FG001|Overall Study|Study terminated by sponsor|2|||
143045752|NCT03236311|515709450|FG000|Overall Study|Adverse Event|0|||
143045753|NCT03236311|515709451|FG001|Overall Study|Adverse Event|1|||
143045754|NCT01895335|515709457|FG000|Overall Study|Adverse Event|106|||
143045755|NCT01895335|515709457|FG000|Overall Study|Lack of Efficacy|53|||
143045756|NCT01895335|515709457|FG000|Overall Study|Poor Compliance to Protocol|11|||
143045757|NCT01895335|515709457|FG000|Overall Study|Included But Not treated|1|||
143045758|NCT01895335|515709457|FG000|Overall Study|Other than Specified Above|44|||
143045759|NCT01647828|515709458|FG000|Overall Study|Death|3|||
143045760|NCT01647828|515709459|FG001|Overall Study|Death|4|||
143045761|NCT01647828|515709460|FG002|Overall Study|Death|4|||
143045762|NCT01647828|515709461|FG003|Overall Study|Death|5|||
143045763|NCT01647828|515709462|FG004|Overall Study|Death|6|||
143045764|NCT01647828|515709463|FG005|Overall Study|Death|3|||
143045765|NCT01647828|515709464|FG006|Overall Study|Death|10|||
143045766|NCT01647828|515709465|FG007|Overall Study|Death|60|||
143045767|NCT01647828|515709466|FG008|Overall Study|Death|71|||
143045768|NCT01647828|515709458|FG000|Overall Study|Withdrawal by Subject|2|||
143045769|NCT01647828|515709459|FG001|Overall Study|Withdrawal by Subject|0|||
143045770|NCT01647828|515709460|FG002|Overall Study|Withdrawal by Subject|0|||
143045771|NCT01647828|515709461|FG003|Overall Study|Withdrawal by Subject|1|||
143045772|NCT01647828|515709462|FG004|Overall Study|Withdrawal by Subject|0|||
143045773|NCT01647828|515709463|FG005|Overall Study|Withdrawal by Subject|0|||
143045774|NCT01647828|515709464|FG006|Overall Study|Withdrawal by Subject|1|||
143045775|NCT01647828|515709465|FG007|Overall Study|Withdrawal by Subject|0|||
143045776|NCT01647828|515709466|FG008|Overall Study|Withdrawal by Subject|2|||
143045777|NCT01647828|515709458|FG000|Overall Study|Study terminated by Sponsor|0|||
143243367|NCT01229267|516442814|FG001|Overall Study|Lost to Follow-up|5|||
143045778|NCT01647828|515709459|FG001|Overall Study|Study terminated by Sponsor|0|||
143045779|NCT01647828|515709460|FG002|Overall Study|Study terminated by Sponsor|0|||
143045780|NCT01647828|515709461|FG003|Overall Study|Study terminated by Sponsor|0|||
143045781|NCT01647828|515709462|FG004|Overall Study|Study terminated by Sponsor|0|||
143045782|NCT01647828|515709463|FG005|Overall Study|Study terminated by Sponsor|0|||
143045783|NCT01647828|515709464|FG006|Overall Study|Study terminated by Sponsor|1|||
143045784|NCT01647828|515709465|FG007|Overall Study|Study terminated by Sponsor|26|||
143045785|NCT01647828|515709466|FG008|Overall Study|Study terminated by Sponsor|16|||
143045786|NCT01647828|515709458|FG000|Overall Study|Lost to Follow-up|0|||
143045787|NCT01647828|515709459|FG001|Overall Study|Lost to Follow-up|0|||
143045788|NCT01647828|515709460|FG002|Overall Study|Lost to Follow-up|0|||
143045789|NCT01647828|515709461|FG003|Overall Study|Lost to Follow-up|0|||
143045790|NCT01647828|515709462|FG004|Overall Study|Lost to Follow-up|0|||
143045791|NCT01647828|515709463|FG005|Overall Study|Lost to Follow-up|0|||
143045792|NCT01647828|515709464|FG006|Overall Study|Lost to Follow-up|0|||
143045793|NCT01647828|515709465|FG007|Overall Study|Lost to Follow-up|2|||
143045794|NCT01647828|515709466|FG008|Overall Study|Lost to Follow-up|0|||
143045795|NCT00418938|515709467|FG000|Overall Study|Reimbursement|1|||
143045796|NCT00418938|515709468|FG001|Overall Study|Reimbursement|0|||
143045797|NCT00418938|515709467|FG000|Overall Study|Administrative decision|3|||
143045798|NCT00418938|515709468|FG001|Overall Study|Administrative decision|3|||
143045799|NCT00418938|515709467|FG000|Overall Study|Withdrawal by Subject|16|||
143045800|NCT00418938|515709468|FG001|Overall Study|Withdrawal by Subject|15|||
143045801|NCT00418938|515709467|FG000|Overall Study|Lost to Follow-up|1|||
143045802|NCT00418938|515709468|FG001|Overall Study|Lost to Follow-up|3|||
143045803|NCT00418938|515709467|FG000|Overall Study|Adverse Event|1|||
143045804|NCT00418938|515709468|FG001|Overall Study|Adverse Event|1|||
143045805|NCT00418938|515709467|FG000|Overall Study|On-going|1|||
143045806|NCT00418938|515709468|FG001|Overall Study|On-going|1|||
143045807|NCT00418938|515709467|FG000|Overall Study|Ineligibility Determined|1|||
143045808|NCT00418938|515709468|FG001|Overall Study|Ineligibility Determined|0|||
143045809|NCT00463684|515709471|FG000|Overall Study|Withdrawal by Subject|1|||
143045810|NCT00463684|515709471|FG000|Overall Study|Lost to Follow-up|3|||
143045811|NCT00115063|515709472|FG000|Overall Study|Lost to Follow-up|98|||
143045812|NCT00115063|515709473|FG001|Overall Study|Lost to Follow-up|104|||
143045813|NCT00115063|515709472|FG000|Overall Study|Death|1|||
143045814|NCT00115063|515709473|FG001|Overall Study|Death|0|||
143045815|NCT00205777|515709475|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
143045816|NCT00205777|515709476|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
143045817|NCT00205777|515709477|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
143045818|NCT00205777|515709478|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
143045819|NCT00205777|515709479|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
143243368|NCT01229267|516442815|FG002|Overall Study|Lost to Follow-up|8|||
143243369|NCT01229267|516442816|FG003|Overall Study|Lost to Follow-up|3|||
143243370|NCT01229267|516442817|FG004|Overall Study|Lost to Follow-up|22|||
143243371|NCT00867815|516442820|FG000|Overall Study|Lost to Follow-up|1|||
143243372|NCT01864603|516442821|FG000|Stage 2|DSMB design modification|86056|||
143243373|NCT01864603|516442822|FG001|Stage 2|DSMB design modification|92558|||
143243374|NCT04050202|516442823|FG000|Overall Study|Lost to Follow-up|2|||
143243375|NCT00433004|516442826|FG000|Overall Study|Lost to Follow-up|5|||
143243376|NCT00433004|516442827|FG001|Overall Study|Lost to Follow-up|7|||
143243377|NCT00330967|516442828|FG000|Overall Study|Withdrawal by Subject|0|||
143045820|NCT00205777|515709480|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
143045821|NCT00205777|515709475|FG000|Core Study (Up to 3 Years)|Death|9|||
143243378|NCT00330967|516442829|FG001|Overall Study|Withdrawal by Subject|5|||
143243379|NCT00330967|516442828|FG000|Overall Study|Physician Decision|0|||
143243380|NCT00330967|516442829|FG001|Overall Study|Physician Decision|9|||
143243381|NCT02636595|516442830|FG000|Overall Study|Lost to Follow-up|1|||
143243382|NCT02636595|516442830|FG000|Overall Study|Other|1|||
143243383|NCT02015637|516442831|FG000|Overall Study|Lost to Follow-up|3|||
143243384|NCT02015637|516442832|FG001|Overall Study|Lost to Follow-up|5|||
143045822|NCT00205777|515709476|FG001|Core Study (Up to 3 Years)|Death|7|||
143045823|NCT00205777|515709477|FG002|Core Study (Up to 3 Years)|Death|14|||
143045824|NCT00205777|515709478|FG003|Core Study (Up to 3 Years)|Death|7|||
143045825|NCT00205777|515709479|FG004|Core Study (Up to 3 Years)|Death|0|||
143045826|NCT00205777|515709480|FG005|Core Study (Up to 3 Years)|Death|0|||
143045827|NCT00205777|515709475|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
143045828|NCT00205777|515709476|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
143045829|NCT00205777|515709477|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
143045830|NCT00205777|515709478|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
143045831|NCT00205777|515709479|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
143045832|NCT00205777|515709480|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
143243385|NCT02015637|516442831|FG000|Overall Study|Adverse Event|3|||
143243386|NCT02015637|516442832|FG001|Overall Study|Adverse Event|0|||
143045833|NCT00205777|515709475|FG000|Core Study (Up to 3 Years)|Other Event|49|||
143045834|NCT00205777|515709476|FG001|Core Study (Up to 3 Years)|Other Event|52|||
143045835|NCT00205777|515709477|FG002|Core Study (Up to 3 Years)|Other Event|41|||
143045836|NCT00205777|515709478|FG003|Core Study (Up to 3 Years)|Other Event|58|||
143045837|NCT00205777|515709479|FG004|Core Study (Up to 3 Years)|Other Event|0|||
143045838|NCT00205777|515709480|FG005|Core Study (Up to 3 Years)|Other Event|0|||
143045839|NCT00205777|515709475|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
143045840|NCT00205777|515709476|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
143045841|NCT00205777|515709477|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
143045842|NCT00205777|515709478|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
143045843|NCT00205777|515709479|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
143045844|NCT00205777|515709480|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
143045845|NCT00205777|515709475|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
143045846|NCT00205777|515709476|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
143045847|NCT00205777|515709477|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
143045848|NCT00205777|515709478|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
143045849|NCT00205777|515709479|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
143045850|NCT00205777|515709480|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
143045851|NCT00205777|515709475|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
143045852|NCT00205777|515709476|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
143045853|NCT00205777|515709477|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
143243387|NCT02015637|516442831|FG000|Overall Study|Did not take study drug|2|||
143243388|NCT02015637|516442832|FG001|Overall Study|Did not take study drug|0|||
143243389|NCT03198507|516442833|FG000|Overall Study|Withdrawal by Subject|1|||
143243390|NCT03198507|516442834|FG001|Overall Study|Withdrawal by Subject|0|||
143243391|NCT02194985|516442836|FG000|Overall Study|Adverse Event|1|||
143243392|NCT02194985|516442836|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
143243393|NCT02194985|516442836|FG000|Overall Study|Physician Decision|4|||
143243394|NCT02194985|516442836|FG000|Overall Study|Lost to Follow-up|1|||
143243395|NCT02194985|516442836|FG000|Overall Study|Withdrawal by Subject|2|||
143243396|NCT00976560|516442847|FG000|Overall Study|Adverse Event|5|||
143243397|NCT00976560|516442848|FG001|Overall Study|Adverse Event|5|||
143243398|NCT00976560|516442847|FG000|Overall Study|Lack of Efficacy|3|||
143243399|NCT00976560|516442848|FG001|Overall Study|Lack of Efficacy|5|||
143243400|NCT00976560|516442847|FG000|Overall Study|Protocol Violation|1|||
143243401|NCT00976560|516442848|FG001|Overall Study|Protocol Violation|0|||
143243402|NCT00976560|516442847|FG000|Overall Study|Lost to Follow-up|1|||
143243403|NCT00976560|516442848|FG001|Overall Study|Lost to Follow-up|0|||
143243404|NCT00976560|516442847|FG000|Overall Study|Physician Decision|2|||
143243405|NCT00976560|516442848|FG001|Overall Study|Physician Decision|0|||
143243406|NCT00976560|516442847|FG000|Overall Study|Withdrawal by Subject|2|||
143243407|NCT00976560|516442848|FG001|Overall Study|Withdrawal by Subject|3|||
143243408|NCT00074490|516442849|FG000|Overall Study|Progressive malignancy|0|||
143243409|NCT00074490|516442850|FG001|Overall Study|Progressive malignancy|7|||
143243410|NCT00074490|516442851|FG002|Overall Study|Progressive malignancy|0|||
143243411|NCT00074490|516442852|FG003|Overall Study|Progressive malignancy|0|||
143243412|NCT00074490|516442853|FG004|Overall Study|Progressive malignancy|3|||
143243413|NCT00074490|516442854|FG005|Overall Study|Progressive malignancy|0|||
143243414|NCT04139798|516442857|FG000|Overall Study|Withdrawal by Subject|6|||
143243415|NCT04139798|516442858|FG001|Overall Study|Withdrawal by Subject|5|||
143243416|NCT04139798|516442857|FG000|Overall Study|Lost to Follow-up|2|||
143243417|NCT04139798|516442858|FG001|Overall Study|Lost to Follow-up|5|||
143243418|NCT04139798|516442857|FG000|Overall Study|Discontinued|4|||
143243419|NCT04139798|516442858|FG001|Overall Study|Discontinued|2|||
143243420|NCT04139798|516442857|FG000|Overall Study|Adverse Event|1|||
143243421|NCT04139798|516442858|FG001|Overall Study|Adverse Event|3|||
143243422|NCT04139798|516442857|FG000|Overall Study|Protocol Violation|1|||
143243423|NCT04139798|516442858|FG001|Overall Study|Protocol Violation|0|||
143243424|NCT02395081|516442861|FG000|Overall Study|Withdrawal by Subject|1|||
143243425|NCT02395081|516442862|FG001|Overall Study|Withdrawal by Subject|1|||
143243426|NCT02395081|516442863|FG002|Overall Study|Withdrawal by Subject|0|||
143243427|NCT02395081|516442861|FG000|Overall Study|Moved where blood couldn't be collected|4|||
143243428|NCT02395081|516442862|FG001|Overall Study|Moved where blood couldn't be collected|1|||
143243429|NCT02395081|516442863|FG002|Overall Study|Moved where blood couldn't be collected|3|||
143243430|NCT02395081|516442861|FG000|Overall Study|Fetal Loss|2|||
143243431|NCT02395081|516442862|FG001|Overall Study|Fetal Loss|3|||
143243432|NCT02395081|516442863|FG002|Overall Study|Fetal Loss|1|||
143243433|NCT04625101|516442864|FG000|Overall Study|Withdrawal by Subject|0|||
143243434|NCT04625101|516442865|FG001|Overall Study|Withdrawal by Subject|1|||
143243435|NCT04625101|516442864|FG000|Overall Study|Protocol Deviation|1|||
143243436|NCT04625101|516442865|FG001|Overall Study|Protocol Deviation|0|||
143243437|NCT01209325|516442868|FG000|Overall Study|Lost to Follow-up|24|||
143243438|NCT01209325|516442868|FG000|Overall Study|Adverse Event|1|||
143243439|NCT01209325|516442868|FG000|Overall Study|Relocated|3|||
143243440|NCT01209325|516442868|FG000|Overall Study|Refusal after starting therapy|8|||
143243441|NCT01209325|516442868|FG000|Overall Study|Protocol Violation|4|||
143243442|NCT01209325|516442868|FG000|Overall Study|Refusal prior to therapy|1|||
143243443|NCT01209325|516442868|FG000|Overall Study|Incarceration|2|||
143243444|NCT05340478|516442871|FG000|Overall Study|Scheduling Issues|10|||
143243445|NCT05340478|516442872|FG001|Overall Study|Scheduling Issues|4|||
143243446|NCT05340478|516442871|FG000|Overall Study|Neither member of dyad started treatment|2|||
143243447|NCT05340478|516442872|FG001|Overall Study|Neither member of dyad started treatment|2|||
143243448|NCT05340478|516442871|FG000|Overall Study|Withdrawn from study|2|||
143045854|NCT00205777|515709478|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
143243449|NCT05340478|516442872|FG001|Overall Study|Withdrawn from study|2|||
143364305|NCT00946114|516876958|FG001|Overall Study|Other|0|||
143045855|NCT00205777|515709479|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
143045856|NCT00205777|515709480|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
143045857|NCT00205777|515709475|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
143045858|NCT00205777|515709476|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
143045859|NCT00205777|515709477|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
143045860|NCT00205777|515709478|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
143045861|NCT00205777|515709479|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
143045862|NCT00205777|515709480|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
143045863|NCT00205777|515709475|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
143045864|NCT00205777|515709476|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
143045865|NCT00205777|515709477|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
143045866|NCT00205777|515709478|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
143045867|NCT00205777|515709479|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
143045868|NCT00205777|515709480|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
143045869|NCT00205777|515709475|FG000|Completed Core Study, Entered SE I|Other Event|52|||
143045870|NCT00205777|515709476|FG001|Completed Core Study, Entered SE I|Other Event|46|||
143045871|NCT00205777|515709477|FG002|Completed Core Study, Entered SE I|Other Event|47|||
143045872|NCT00205777|515709478|FG003|Completed Core Study, Entered SE I|Other Event|50|||
143045873|NCT00205777|515709479|FG004|Completed Core Study, Entered SE I|Other Event|0|||
143045874|NCT00205777|515709480|FG005|Completed Core Study, Entered SE I|Other Event|0|||
143045875|NCT00205777|515709475|FG000|Study Extension I|Adverse Event|57|||
143045876|NCT00205777|515709476|FG001|Study Extension I|Adverse Event|0|||
143045877|NCT00205777|515709477|FG002|Study Extension I|Adverse Event|0|||
143045878|NCT00205777|515709478|FG003|Study Extension I|Adverse Event|61|||
143045879|NCT00205777|515709479|FG004|Study Extension I|Adverse Event|58|||
143045880|NCT00205777|515709480|FG005|Study Extension I|Adverse Event|0|||
143045881|NCT00205777|515709475|FG000|Study Extension I|Death|5|||
143045882|NCT00205777|515709476|FG001|Study Extension I|Death|0|||
143045883|NCT00205777|515709477|FG002|Study Extension I|Death|0|||
143045884|NCT00205777|515709478|FG003|Study Extension I|Death|1|||
143045885|NCT00205777|515709479|FG004|Study Extension I|Death|2|||
143045886|NCT00205777|515709480|FG005|Study Extension I|Death|0|||
143045887|NCT00205777|515709475|FG000|Study Extension I|Withdrawal by Subject|99|||
143045888|NCT00205777|515709476|FG001|Study Extension I|Withdrawal by Subject|0|||
143045889|NCT00205777|515709477|FG002|Study Extension I|Withdrawal by Subject|0|||
143045890|NCT00205777|515709478|FG003|Study Extension I|Withdrawal by Subject|106|||
143045891|NCT00205777|515709479|FG004|Study Extension I|Withdrawal by Subject|89|||
143045892|NCT00205777|515709480|FG005|Study Extension I|Withdrawal by Subject|0|||
143045893|NCT00205777|515709475|FG000|Study Extension I|Protocol Violation|4|||
143045894|NCT00205777|515709476|FG001|Study Extension I|Protocol Violation|0|||
143045895|NCT00205777|515709477|FG002|Study Extension I|Protocol Violation|0|||
143045896|NCT00205777|515709478|FG003|Study Extension I|Protocol Violation|8|||
143045897|NCT00205777|515709479|FG004|Study Extension I|Protocol Violation|8|||
143045898|NCT00205777|515709480|FG005|Study Extension I|Protocol Violation|0|||
143045899|NCT00205777|515709475|FG000|Study Extension I|Lack of Efficacy|0|||
143045900|NCT00205777|515709476|FG001|Study Extension I|Lack of Efficacy|0|||
143045901|NCT00205777|515709477|FG002|Study Extension I|Lack of Efficacy|0|||
143045902|NCT00205777|515709478|FG003|Study Extension I|Lack of Efficacy|1|||
143045903|NCT00205777|515709479|FG004|Study Extension I|Lack of Efficacy|2|||
143045904|NCT00205777|515709480|FG005|Study Extension I|Lack of Efficacy|0|||
143045905|NCT00205777|515709475|FG000|Study Extension I|Failed to return|15|||
143045906|NCT00205777|515709476|FG001|Study Extension I|Failed to return|0|||
143045907|NCT00205777|515709477|FG002|Study Extension I|Failed to return|0|||
143045908|NCT00205777|515709478|FG003|Study Extension I|Failed to return|17|||
143045909|NCT00205777|515709479|FG004|Study Extension I|Failed to return|13|||
143045910|NCT00205777|515709480|FG005|Study Extension I|Failed to return|0|||
143045911|NCT00205777|515709475|FG000|Study Extension I|Other Event|34|||
143045912|NCT00205777|515709476|FG001|Study Extension I|Other Event|0|||
143045913|NCT00205777|515709477|FG002|Study Extension I|Other Event|0|||
143045914|NCT00205777|515709478|FG003|Study Extension I|Other Event|34|||
143045915|NCT00205777|515709479|FG004|Study Extension I|Other Event|29|||
143045916|NCT00205777|515709480|FG005|Study Extension I|Other Event|0|||
143045917|NCT00205777|515709475|FG000|Study Extension I|Withdrawn as per protocol|0|||
143045918|NCT00205777|515709476|FG001|Study Extension I|Withdrawn as per protocol|0|||
143045919|NCT00205777|515709477|FG002|Study Extension I|Withdrawn as per protocol|1070|||
143167708|NCT03502681|516161596|FG000|Overall Study|Adverse Event|1|||
143167709|NCT03502681|516161597|FG001|Overall Study|Adverse Event|1|||
143167710|NCT03502681|516161596|FG000|Overall Study|Disease Progression|2|||
143167711|NCT03502681|516161597|FG001|Overall Study|Disease Progression|1|||
143045920|NCT00205777|515709478|FG003|Study Extension I|Withdrawn as per protocol|0|||
143045921|NCT00205777|515709479|FG004|Study Extension I|Withdrawn as per protocol|0|||
143045922|NCT00205777|515709480|FG005|Study Extension I|Withdrawn as per protocol|0|||
143045923|NCT00205777|515709475|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
143167712|NCT00488293|516161600|FG000|Overall Study|Lost to Follow-up|28|||
143167713|NCT00488293|516161601|FG001|Overall Study|Lost to Follow-up|25|||
143243450|NCT05340478|516442871|FG000|Overall Study|Lost to Follow-up|1|||
143243451|NCT05340478|516442872|FG001|Overall Study|Lost to Follow-up|4|||
143243452|NCT01918306|516442873|FG000|Overall Study|progresive disease|4|||
143243453|NCT01918306|516442874|FG001|Overall Study|progresive disease|0|||
143243454|NCT01918306|516442875|FG002|Overall Study|progresive disease|1|||
143045924|NCT00205777|515709476|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
143045925|NCT00205777|515709477|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
143045926|NCT00205777|515709478|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
143045927|NCT00205777|515709479|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
143045928|NCT00205777|515709480|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
143045929|NCT00205777|515709475|FG000|Study Extension II|Adverse Event|0|||
143045930|NCT00205777|515709476|FG001|Study Extension II|Adverse Event|0|||
143045931|NCT00205777|515709477|FG002|Study Extension II|Adverse Event|0|||
143045932|NCT00205777|515709478|FG003|Study Extension II|Adverse Event|14|||
143045933|NCT00205777|515709479|FG004|Study Extension II|Adverse Event|0|||
143045934|NCT00205777|515709480|FG005|Study Extension II|Adverse Event|30|||
143045935|NCT00205777|515709475|FG000|Study Extension II|Death|0|||
143045936|NCT00205777|515709476|FG001|Study Extension II|Death|0|||
143045937|NCT00205777|515709477|FG002|Study Extension II|Death|0|||
143045938|NCT00205777|515709478|FG003|Study Extension II|Death|2|||
143045939|NCT00205777|515709479|FG004|Study Extension II|Death|0|||
143045940|NCT00205777|515709480|FG005|Study Extension II|Death|5|||
143045941|NCT00205777|515709475|FG000|Study Extension II|Withdrawal by Subject|0|||
143045942|NCT00205777|515709476|FG001|Study Extension II|Withdrawal by Subject|0|||
143045943|NCT00205777|515709477|FG002|Study Extension II|Withdrawal by Subject|0|||
143045944|NCT00205777|515709478|FG003|Study Extension II|Withdrawal by Subject|35|||
143045945|NCT00205777|515709479|FG004|Study Extension II|Withdrawal by Subject|0|||
143045946|NCT00205777|515709480|FG005|Study Extension II|Withdrawal by Subject|59|||
143045947|NCT00205777|515709475|FG000|Study Extension II|Protocol Violation|0|||
143045948|NCT00205777|515709476|FG001|Study Extension II|Protocol Violation|0|||
143243455|NCT01918306|516442876|FG003|Overall Study|progresive disease|1|||
143243456|NCT01918306|516442873|FG000|Overall Study|Withdrawal by Subject|0|||
143167714|NCT00488293|516161600|FG000|Overall Study|Withdrawal by Subject|5|||
143167715|NCT00488293|516161601|FG001|Overall Study|Withdrawal by Subject|3|||
143167716|NCT00488293|516161600|FG000|Overall Study|Death|2|||
143045949|NCT00205777|515709477|FG002|Study Extension II|Protocol Violation|0|||
143045950|NCT00205777|515709478|FG003|Study Extension II|Protocol Violation|1|||
143045951|NCT00205777|515709479|FG004|Study Extension II|Protocol Violation|0|||
143045952|NCT00205777|515709480|FG005|Study Extension II|Protocol Violation|10|||
143045953|NCT00205777|515709475|FG000|Study Extension II|Lack of Efficacy|0|||
143045954|NCT00205777|515709476|FG001|Study Extension II|Lack of Efficacy|0|||
143045955|NCT00205777|515709477|FG002|Study Extension II|Lack of Efficacy|0|||
143167717|NCT00488293|516161601|FG001|Overall Study|Death|1|||
143167718|NCT00488293|516161600|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
143045956|NCT00205777|515709478|FG003|Study Extension II|Lack of Efficacy|0|||
143045957|NCT00205777|515709479|FG004|Study Extension II|Lack of Efficacy|0|||
143045958|NCT00205777|515709480|FG005|Study Extension II|Lack of Efficacy|1|||
143045959|NCT00205777|515709475|FG000|Study Extension II|Failed to return|0|||
143045960|NCT00205777|515709476|FG001|Study Extension II|Failed to return|0|||
143045961|NCT00205777|515709477|FG002|Study Extension II|Failed to return|0|||
143045962|NCT00205777|515709478|FG003|Study Extension II|Failed to return|14|||
143045963|NCT00205777|515709479|FG004|Study Extension II|Failed to return|0|||
143045964|NCT00205777|515709480|FG005|Study Extension II|Failed to return|26|||
143045965|NCT00205777|515709475|FG000|Study Extension II|Other Event|0|||
143045966|NCT00205777|515709476|FG001|Study Extension II|Other Event|0|||
143045967|NCT00205777|515709477|FG002|Study Extension II|Other Event|0|||
143045968|NCT00205777|515709478|FG003|Study Extension II|Other Event|12|||
143045969|NCT00205777|515709479|FG004|Study Extension II|Other Event|0|||
143045970|NCT00205777|515709480|FG005|Study Extension II|Other Event|20|||
143045971|NCT00205777|515709475|FG000|Study Extension II|Enrolled but not treated|0|||
143045972|NCT00205777|515709476|FG001|Study Extension II|Enrolled but not treated|0|||
143167719|NCT00488293|516161601|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
143045973|NCT00205777|515709477|FG002|Study Extension II|Enrolled but not treated|0|||
143045974|NCT00205777|515709478|FG003|Study Extension II|Enrolled but not treated|71|||
143045975|NCT00205777|515709479|FG004|Study Extension II|Enrolled but not treated|0|||
143167720|NCT03436732|516161602|FG000|Overall Study|Not treated-enrolled in different study|1|||
143167721|NCT03436732|516161603|FG001|Overall Study|Not treated-enrolled in different study|0|||
143045976|NCT00205777|515709480|FG005|Study Extension II|Enrolled but not treated|131|||
143167722|NCT03436732|516161602|FG000|Overall Study|Off study after cycle 1|1|||
143243457|NCT01918306|516442874|FG001|Overall Study|Withdrawal by Subject|0|||
143243458|NCT01918306|516442875|FG002|Overall Study|Withdrawal by Subject|0|||
143045977|NCT02462837|515709481|FG000|Overall Study|pt developed hives|1|||
143243459|NCT01918306|516442876|FG003|Overall Study|Withdrawal by Subject|2|||
143045978|NCT02462837|515709482|FG001|Overall Study|pt developed hives|0|||
143045979|NCT02462837|515709481|FG000|Overall Study|Withdrawal by Subject|1|||
143045980|NCT02462837|515709482|FG001|Overall Study|Withdrawal by Subject|0|||
143045981|NCT01075282|515709486|FG000|Overall Study|Withdrawal by Subject|11|||
143045982|NCT01075282|515709487|FG001|Overall Study|Withdrawal by Subject|7|||
143045983|NCT01075282|515709488|FG002|Overall Study|Withdrawal by Subject|11|||
143045984|NCT01075282|515709486|FG000|Overall Study|Adverse Event|9|||
143045985|NCT01075282|515709487|FG001|Overall Study|Adverse Event|8|||
143045986|NCT01075282|515709488|FG002|Overall Study|Adverse Event|5|||
143045987|NCT01075282|515709486|FG000|Overall Study|Entry Criteria Not Met|3|||
143045988|NCT01075282|515709487|FG001|Overall Study|Entry Criteria Not Met|2|||
143045989|NCT01075282|515709488|FG002|Overall Study|Entry Criteria Not Met|0|||
143045990|NCT01075282|515709486|FG000|Overall Study|Lost to Follow-up|3|||
143243460|NCT01918306|516442873|FG000|Overall Study|neutropenia|1|||
143243461|NCT01918306|516442874|FG001|Overall Study|neutropenia|0|||
143243462|NCT01918306|516442875|FG002|Overall Study|neutropenia|0|||
143243463|NCT01918306|516442876|FG003|Overall Study|neutropenia|0|||
143045991|NCT01075282|515709487|FG001|Overall Study|Lost to Follow-up|3|||
143045992|NCT01075282|515709488|FG002|Overall Study|Lost to Follow-up|3|||
143045993|NCT01075282|515709486|FG000|Overall Study|Physician Decision|3|||
143045994|NCT01075282|515709487|FG001|Overall Study|Physician Decision|3|||
143045995|NCT01075282|515709488|FG002|Overall Study|Physician Decision|3|||
143045996|NCT01075282|515709486|FG000|Overall Study|Lack of Efficacy|1|||
143045997|NCT01075282|515709487|FG001|Overall Study|Lack of Efficacy|1|||
143045998|NCT01075282|515709488|FG002|Overall Study|Lack of Efficacy|0|||
143045999|NCT01075282|515709486|FG000|Overall Study|Treatment Non-compliance|1|||
143046000|NCT01075282|515709487|FG001|Overall Study|Treatment Non-compliance|2|||
143046001|NCT01075282|515709488|FG002|Overall Study|Treatment Non-compliance|2|||
143046002|NCT01075282|515709486|FG000|Overall Study|Protocol Violation|0|||
143046003|NCT01075282|515709487|FG001|Overall Study|Protocol Violation|2|||
143046004|NCT01075282|515709488|FG002|Overall Study|Protocol Violation|1|||
143046005|NCT01075282|515709486|FG000|Overall Study|Death|0|||
143167723|NCT03436732|516161603|FG001|Overall Study|Off study after cycle 1|0|||
143167724|NCT03436732|516161602|FG000|Overall Study|Adverse Event|2|||
143167725|NCT03436732|516161603|FG001|Overall Study|Adverse Event|0|||
143167726|NCT03436732|516161602|FG000|Overall Study|Death|0|||
143167727|NCT03436732|516161603|FG001|Overall Study|Death|1|||
143167728|NCT00939185|516161604|FG000|Overall Study|Adverse Event|3|||
143167729|NCT00939185|516161604|FG000|Overall Study|Lack of Efficacy|1|||
143167730|NCT00939185|516161604|FG000|Overall Study|Lost to Follow-up|6|||
143167731|NCT00939185|516161604|FG000|Overall Study|Other|3|||
143167732|NCT00939185|516161604|FG000|Overall Study|Withdrawal by Subject|2|||
143167733|NCT00939185|516161604|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
143167734|NCT00363298|516161605|FG000|First Study Week|Lack of Efficacy|6|||
143167735|NCT00363298|516161606|FG001|First Study Week|Lack of Efficacy|5|||
143167736|NCT00363298|516161605|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
143167737|NCT00363298|516161606|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
143167738|NCT03552029|516161610|FG000|Overall Study|Death|3|||
143167739|NCT03552029|516161611|FG001|Overall Study|Death|0|||
143167740|NCT03552029|516161610|FG000|Overall Study|Adverse Event|1|||
143167741|NCT03552029|516161611|FG001|Overall Study|Adverse Event|0|||
143167742|NCT03552029|516161610|FG000|Overall Study|Lack of Efficacy|0|||
143167743|NCT03552029|516161611|FG001|Overall Study|Lack of Efficacy|2|||
143167744|NCT03552029|516161610|FG000|Overall Study|Physician Decision|0|||
143167745|NCT03552029|516161611|FG001|Overall Study|Physician Decision|1|||
143167746|NCT03552029|516161610|FG000|Overall Study|Study terminated by Sponsor|0|||
143167747|NCT03552029|516161611|FG001|Overall Study|Study terminated by Sponsor|1|||
143167748|NCT03552029|516161610|FG000|Overall Study|Other|0|||
143167749|NCT03552029|516161611|FG001|Overall Study|Other|2|||
143243464|NCT01918306|516442873|FG000|Overall Study|Lack of Efficacy|1|||
143243465|NCT01918306|516442874|FG001|Overall Study|Lack of Efficacy|0|||
143243466|NCT01918306|516442875|FG002|Overall Study|Lack of Efficacy|0|||
143243467|NCT01918306|516442876|FG003|Overall Study|Lack of Efficacy|0|||
143243468|NCT01918306|516442873|FG000|Overall Study|progress disease, crossover|0|||
143046006|NCT01075282|515709487|FG001|Overall Study|Death|1|||
143046007|NCT01075282|515709488|FG002|Overall Study|Death|2|||
143046008|NCT02336074|515709490|FG000|Overall Study|Adverse Event|0|||
143167750|NCT00836706|516161616|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
143167751|NCT00836706|516161617|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
143167752|NCT03895372|516161624|FG000|Investigational Treatment Period|Adverse Event|1|||
143167753|NCT03895372|516161625|FG001|Investigational Treatment Period|Adverse Event|0|||
143167754|NCT03895372|516161626|FG002|Investigational Treatment Period|Adverse Event|0|||
143167755|NCT03895372|516161627|FG003|Investigational Treatment Period|Adverse Event|0|||
143243469|NCT01918306|516442874|FG001|Overall Study|progress disease, crossover|0|||
143243470|NCT01918306|516442875|FG002|Overall Study|progress disease, crossover|1|||
143243471|NCT01918306|516442876|FG003|Overall Study|progress disease, crossover|0|||
143167756|NCT03895372|516161628|FG004|Investigational Treatment Period|Adverse Event|0|||
143243472|NCT02506244|516442881|FG000|Overall Study|Did not undergo active monitoring|458|||
143243473|NCT02506244|516442882|FG001|Overall Study|Did not undergo active monitoring|459|||
143243474|NCT02506244|516442883|FG002|Overall Study|Did not undergo active monitoring|0|||
143243475|NCT00092443|516442884|FG000|Overall Study|Adverse Event|9|||
143243476|NCT00092443|516442885|FG001|Overall Study|Adverse Event|13|||
143243477|NCT00092443|516442884|FG000|Overall Study|Lost to Follow-up|7|||
143243478|NCT00092443|516442885|FG001|Overall Study|Lost to Follow-up|3|||
143243479|NCT00092443|516442884|FG000|Overall Study|Protocol Violation|11|||
143243480|NCT00092443|516442885|FG001|Overall Study|Protocol Violation|9|||
143243481|NCT00092443|516442884|FG000|Overall Study|Withdrawal by Subject|9|||
143243482|NCT00092443|516442885|FG001|Overall Study|Withdrawal by Subject|11|||
143243483|NCT00092443|516442884|FG000|Overall Study|Moved|5|||
143243484|NCT00092443|516442885|FG001|Overall Study|Moved|5|||
143046009|NCT02336074|515709491|FG001|Overall Study|Adverse Event|2|||
143046010|NCT00624286|515709494|FG000|Overall Study|Protocol Deviation|7|||
143046011|NCT00624286|515709495|FG001|Overall Study|Protocol Deviation|9|||
143046012|NCT00624286|515709494|FG000|Overall Study|Adverse Event|6|||
143046013|NCT00624286|515709495|FG001|Overall Study|Adverse Event|3|||
143046014|NCT00624286|515709494|FG000|Overall Study|Withdrawal by Subject|5|||
143046015|NCT00624286|515709495|FG001|Overall Study|Withdrawal by Subject|4|||
143046016|NCT00624286|515709494|FG000|Overall Study|Lost to Follow-up|3|||
143046017|NCT00624286|515709495|FG001|Overall Study|Lost to Follow-up|2|||
143046018|NCT00624286|515709494|FG000|Overall Study|Administrative problems|3|||
143046019|NCT00624286|515709495|FG001|Overall Study|Administrative problems|0|||
143046020|NCT00624286|515709494|FG000|Overall Study|Lack of Efficacy|1|||
143046021|NCT00624286|515709495|FG001|Overall Study|Lack of Efficacy|6|||
143046022|NCT00624286|515709494|FG000|Overall Study|Not stated|0|||
143046023|NCT00624286|515709495|FG001|Overall Study|Not stated|1|||
143046024|NCT00624286|515709494|FG000|Overall Study|Abnormal test procedure result(s)|0|||
143046025|NCT00624286|515709495|FG001|Overall Study|Abnormal test procedure result(s)|1|||
143046026|NCT00624286|515709494|FG000|Overall Study|Death|0|||
143046027|NCT00624286|515709495|FG001|Overall Study|Death|1|||
143046028|NCT00863330|515709498|FG000|Overall Study|study terminated early due to administra|6|||
143046029|NCT04404725|515709499|FG000|First Intervention|Withdrawal by Subject|0|||
143046030|NCT04404725|515709500|FG001|First Intervention|Withdrawal by Subject|2|||
143046031|NCT04404725|515709499|FG000|Second Intervention|Adverse Event|1|||
143046032|NCT04404725|515709500|FG001|Second Intervention|Adverse Event|1|||
143167757|NCT03895372|516161629|FG005|Investigational Treatment Period|Adverse Event|0|||
143167758|NCT03895372|516161630|FG006|Investigational Treatment Period|Adverse Event|4|||
143167759|NCT03895372|516161631|FG007|Investigational Treatment Period|Adverse Event|3|||
143167760|NCT03895372|516161624|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
143167761|NCT03895372|516161625|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
143167762|NCT03895372|516161626|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
143167763|NCT03895372|516161627|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
143167764|NCT03895372|516161628|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
143167765|NCT03895372|516161629|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
143167766|NCT03895372|516161630|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
143167767|NCT03895372|516161631|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
143167768|NCT03895372|516161624|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
143167769|NCT03895372|516161625|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
143167770|NCT03895372|516161626|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
143167771|NCT03895372|516161627|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
143167772|NCT03895372|516161628|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
143167773|NCT03895372|516161629|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
143167774|NCT03895372|516161630|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
143167775|NCT03895372|516161631|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
143167776|NCT03895372|516161624|FG000|Investigational Treatment Period|Other|0|||
143167777|NCT03895372|516161625|FG001|Investigational Treatment Period|Other|0|||
143167778|NCT03895372|516161626|FG002|Investigational Treatment Period|Other|0|||
143167779|NCT03895372|516161627|FG003|Investigational Treatment Period|Other|0|||
143167780|NCT03895372|516161628|FG004|Investigational Treatment Period|Other|0|||
143167781|NCT03895372|516161629|FG005|Investigational Treatment Period|Other|1|||
143167782|NCT03895372|516161630|FG006|Investigational Treatment Period|Other|0|||
143167783|NCT03895372|516161631|FG007|Investigational Treatment Period|Other|2|||
143167784|NCT03895372|516161624|FG000|Investigational Treatment Period|Protocol Violation|0|||
143243485|NCT00092443|516442884|FG000|Overall Study|Other|17|||
143167785|NCT03895372|516161625|FG001|Investigational Treatment Period|Protocol Violation|0|||
143167786|NCT03895372|516161626|FG002|Investigational Treatment Period|Protocol Violation|0|||
143243486|NCT00092443|516442885|FG001|Overall Study|Other|13|||
143243487|NCT01160822|516442886|FG000|Overall Study|Adverse Event|0|||
143046033|NCT04404725|515709499|FG000|Second Intervention|Withdrawal by Subject|0|||
143243488|NCT01160822|516442887|FG001|Overall Study|Adverse Event|0|||
143046034|NCT04404725|515709500|FG001|Second Intervention|Withdrawal by Subject|1|||
143046035|NCT02055547|515709502|FG000|Overall Study|Protocol Violation|0|||
143046036|NCT02055547|515709503|FG001|Overall Study|Protocol Violation|0|||
143046037|NCT02055547|515709504|FG002|Overall Study|Protocol Violation|1|||
143243489|NCT01160822|516442888|FG002|Overall Study|Adverse Event|0|||
143243490|NCT01160822|516442889|FG003|Overall Study|Adverse Event|0|||
143243491|NCT01160822|516442890|FG004|Overall Study|Adverse Event|1|||
143243492|NCT01160822|516442891|FG005|Overall Study|Adverse Event|2|||
143243493|NCT01160822|516442892|FG006|Overall Study|Adverse Event|5|||
143243494|NCT01160822|516442886|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
143243495|NCT01160822|516442887|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
143243496|NCT01160822|516442888|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
143243497|NCT01160822|516442889|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
143243498|NCT01160822|516442890|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
143243499|NCT01160822|516442891|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
143243500|NCT01160822|516442892|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
143243501|NCT01160822|516442886|FG000|Overall Study|Withdrawal by Subject|0|||
143243502|NCT01160822|516442887|FG001|Overall Study|Withdrawal by Subject|0|||
143243503|NCT01160822|516442888|FG002|Overall Study|Withdrawal by Subject|0|||
143243504|NCT01160822|516442889|FG003|Overall Study|Withdrawal by Subject|0|||
143243505|NCT01160822|516442890|FG004|Overall Study|Withdrawal by Subject|0|||
143243506|NCT01160822|516442891|FG005|Overall Study|Withdrawal by Subject|0|||
143243507|NCT01160822|516442892|FG006|Overall Study|Withdrawal by Subject|1|||
143243508|NCT01160822|516442886|FG000|Overall Study|Lost to Follow-up|0|||
143243509|NCT01160822|516442887|FG001|Overall Study|Lost to Follow-up|0|||
143243510|NCT01160822|516442888|FG002|Overall Study|Lost to Follow-up|0|||
143243511|NCT01160822|516442889|FG003|Overall Study|Lost to Follow-up|0|||
143243512|NCT01160822|516442890|FG004|Overall Study|Lost to Follow-up|1|||
143243513|NCT01160822|516442891|FG005|Overall Study|Lost to Follow-up|0|||
143243514|NCT01160822|516442892|FG006|Overall Study|Lost to Follow-up|0|||
143243515|NCT01160822|516442886|FG000|Overall Study|Administrative problems|0|||
143243516|NCT01160822|516442887|FG001|Overall Study|Administrative problems|0|||
143243517|NCT01160822|516442888|FG002|Overall Study|Administrative problems|0|||
143243518|NCT01160822|516442889|FG003|Overall Study|Administrative problems|0|||
143243519|NCT01160822|516442890|FG004|Overall Study|Administrative problems|1|||
143243520|NCT01160822|516442891|FG005|Overall Study|Administrative problems|0|||
143243521|NCT01160822|516442892|FG006|Overall Study|Administrative problems|0|||
143243522|NCT01160822|516442886|FG000|Overall Study|Protocol deviation|0|||
143243523|NCT01160822|516442887|FG001|Overall Study|Protocol deviation|0|||
143243524|NCT01160822|516442888|FG002|Overall Study|Protocol deviation|0|||
143243525|NCT01160822|516442889|FG003|Overall Study|Protocol deviation|0|||
143243526|NCT01160822|516442890|FG004|Overall Study|Protocol deviation|2|||
143243527|NCT01160822|516442891|FG005|Overall Study|Protocol deviation|0|||
143243528|NCT01160822|516442892|FG006|Overall Study|Protocol deviation|0|||
143243529|NCT00314795|516442896|FG000|Overall Study|Adverse Event|8|||
143243530|NCT00314795|516442896|FG000|Overall Study|Death|4|||
143243531|NCT00314795|516442896|FG000|Overall Study|Reason not Specified|3|||
143243532|NCT00314795|516442896|FG000|Overall Study|Renal Transplant|3|||
143243533|NCT00314795|516442896|FG000|Overall Study|Participants Withdrew Consent|2|||
143243534|NCT04717336|516442898|FG000|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
143243535|NCT04717336|516442899|FG001|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
143243536|NCT04717336|516442898|FG000|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
143243537|NCT04717336|516442899|FG001|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
143243538|NCT02039843|516442900|FG000|Randomization and Observation Period|Adverse Event|2|||
143243539|NCT02039843|516442901|FG001|Randomization and Observation Period|Adverse Event|0|||
143243540|NCT02039843|516442900|FG000|Randomization and Observation Period|Death|1|||
143243541|NCT02039843|516442901|FG001|Randomization and Observation Period|Death|0|||
143243542|NCT02039843|516442900|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
143243543|NCT02039843|516442901|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
143243544|NCT02039843|516442900|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
143243545|NCT02039843|516442901|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
143243546|NCT02039843|516442900|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
143243547|NCT02039843|516442901|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
143243548|NCT02039843|516442900|FG000|Pairing With a Study Dog|Death|1|||
143243549|NCT02039843|516442901|FG001|Pairing With a Study Dog|Death|0|||
143243550|NCT02039843|516442900|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
143243551|NCT02039843|516442901|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
143243552|NCT02039843|516442900|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
143243553|NCT02039843|516442901|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
143243554|NCT02039843|516442900|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
143243555|NCT02039843|516442901|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
143243556|NCT02963506|516442908|FG000|Double-Blind Period|Adverse Event|0|||
143243557|NCT02963506|516442909|FG001|Double-Blind Period|Adverse Event|0|||
143243558|NCT02963506|516442910|FG002|Double-Blind Period|Adverse Event|1|||
143243559|NCT02963506|516442911|FG003|Double-Blind Period|Adverse Event|0|||
143243560|NCT02963506|516442912|FG004|Double-Blind Period|Adverse Event|0|||
143243561|NCT02963506|516442913|FG005|Double-Blind Period|Adverse Event|0|||
143046038|NCT02055547|515709505|FG003|Overall Study|Protocol Violation|0|||
143046039|NCT02055547|515709506|FG004|Overall Study|Protocol Violation|0|||
143046040|NCT02055547|515709507|FG005|Overall Study|Protocol Violation|0|||
143046041|NCT02055547|515709508|FG006|Overall Study|Protocol Violation|1|||
143046042|NCT02055547|515709509|FG007|Overall Study|Protocol Violation|0|||
143046043|NCT02055547|515709510|FG008|Overall Study|Protocol Violation|0|||
143046044|NCT02055547|515709511|FG009|Overall Study|Protocol Violation|0|||
143046045|NCT02055547|515709512|FG010|Overall Study|Protocol Violation|0|||
143046046|NCT02055547|515709513|FG011|Overall Study|Protocol Violation|0|||
143046047|NCT02055547|515709514|FG012|Overall Study|Protocol Violation|0|||
143046048|NCT02055547|515709515|FG013|Overall Study|Protocol Violation|0|||
143046049|NCT02055547|515709516|FG014|Overall Study|Protocol Violation|0|||
143046050|NCT02055547|515709517|FG015|Overall Study|Protocol Violation|0|||
143046051|NCT02055547|515709518|FG016|Overall Study|Protocol Violation|0|||
143046052|NCT02055547|515709519|FG017|Overall Study|Protocol Violation|0|||
143046053|NCT02055547|515709520|FG018|Overall Study|Protocol Violation|0|||
143046054|NCT02055547|515709502|FG000|Overall Study|Physician Decision|0|||
143046055|NCT02055547|515709503|FG001|Overall Study|Physician Decision|1|||
143046056|NCT02055547|515709504|FG002|Overall Study|Physician Decision|1|||
143046057|NCT02055547|515709505|FG003|Overall Study|Physician Decision|0|||
143046058|NCT02055547|515709506|FG004|Overall Study|Physician Decision|1|||
143046059|NCT02055547|515709507|FG005|Overall Study|Physician Decision|0|||
143243562|NCT02963506|516442914|FG006|Double-Blind Period|Adverse Event|0|||
143243563|NCT02963506|516442915|FG007|Double-Blind Period|Adverse Event|0|||
143243564|NCT02963506|516442916|FG008|Double-Blind Period|Adverse Event|0|||
143243565|NCT02963506|516442917|FG009|Double-Blind Period|Adverse Event|0|||
143243566|NCT02963506|516442918|FG010|Double-Blind Period|Adverse Event|0|||
143243567|NCT02963506|516442919|FG011|Double-Blind Period|Adverse Event|0|||
143243568|NCT02963506|516442920|FG012|Double-Blind Period|Adverse Event|0|||
143243569|NCT02963506|516442908|FG000|Double-Blind Period|Death|0|||
143243570|NCT02963506|516442909|FG001|Double-Blind Period|Death|0|||
143243571|NCT02963506|516442910|FG002|Double-Blind Period|Death|0|||
143046060|NCT02055547|515709508|FG006|Overall Study|Physician Decision|0|||
143046061|NCT02055547|515709509|FG007|Overall Study|Physician Decision|0|||
143046062|NCT02055547|515709510|FG008|Overall Study|Physician Decision|0|||
143046063|NCT02055547|515709511|FG009|Overall Study|Physician Decision|1|||
143046064|NCT02055547|515709512|FG010|Overall Study|Physician Decision|1|||
143046065|NCT02055547|515709513|FG011|Overall Study|Physician Decision|0|||
143243572|NCT02963506|516442911|FG003|Double-Blind Period|Death|1|||
143046066|NCT02055547|515709514|FG012|Overall Study|Physician Decision|0|||
143046067|NCT02055547|515709515|FG013|Overall Study|Physician Decision|0|||
143046068|NCT02055547|515709516|FG014|Overall Study|Physician Decision|0|||
143046069|NCT02055547|515709517|FG015|Overall Study|Physician Decision|0|||
143046070|NCT02055547|515709518|FG016|Overall Study|Physician Decision|0|||
143046071|NCT02055547|515709519|FG017|Overall Study|Physician Decision|0|||
143046072|NCT02055547|515709520|FG018|Overall Study|Physician Decision|0|||
143046073|NCT02055547|515709502|FG000|Overall Study|Adverse Event|0|||
143046074|NCT02055547|515709503|FG001|Overall Study|Adverse Event|0|||
143046075|NCT02055547|515709504|FG002|Overall Study|Adverse Event|0|||
143046076|NCT02055547|515709505|FG003|Overall Study|Adverse Event|0|||
143046077|NCT02055547|515709506|FG004|Overall Study|Adverse Event|0|||
143046078|NCT02055547|515709507|FG005|Overall Study|Adverse Event|0|||
143046079|NCT02055547|515709508|FG006|Overall Study|Adverse Event|1|||
143046080|NCT02055547|515709509|FG007|Overall Study|Adverse Event|0|||
143046081|NCT02055547|515709510|FG008|Overall Study|Adverse Event|1|||
143046082|NCT02055547|515709511|FG009|Overall Study|Adverse Event|0|||
143046083|NCT02055547|515709512|FG010|Overall Study|Adverse Event|0|||
143046084|NCT02055547|515709513|FG011|Overall Study|Adverse Event|0|||
143046085|NCT02055547|515709514|FG012|Overall Study|Adverse Event|0|||
143046086|NCT02055547|515709515|FG013|Overall Study|Adverse Event|0|||
143046087|NCT02055547|515709516|FG014|Overall Study|Adverse Event|0|||
143046088|NCT02055547|515709517|FG015|Overall Study|Adverse Event|0|||
143046089|NCT02055547|515709518|FG016|Overall Study|Adverse Event|0|||
143046090|NCT02055547|515709519|FG017|Overall Study|Adverse Event|0|||
143046091|NCT02055547|515709520|FG018|Overall Study|Adverse Event|0|||
143046092|NCT02055547|515709502|FG000|Overall Study|Withdrawal by Subject|0|||
143046093|NCT02055547|515709503|FG001|Overall Study|Withdrawal by Subject|0|||
143046094|NCT02055547|515709504|FG002|Overall Study|Withdrawal by Subject|0|||
143046095|NCT02055547|515709505|FG003|Overall Study|Withdrawal by Subject|0|||
143046096|NCT02055547|515709506|FG004|Overall Study|Withdrawal by Subject|0|||
143046097|NCT02055547|515709507|FG005|Overall Study|Withdrawal by Subject|1|||
143046098|NCT02055547|515709508|FG006|Overall Study|Withdrawal by Subject|0|||
143046099|NCT02055547|515709509|FG007|Overall Study|Withdrawal by Subject|0|||
143046100|NCT02055547|515709510|FG008|Overall Study|Withdrawal by Subject|1|||
143046101|NCT02055547|515709511|FG009|Overall Study|Withdrawal by Subject|0|||
143046102|NCT02055547|515709512|FG010|Overall Study|Withdrawal by Subject|0|||
143046103|NCT02055547|515709513|FG011|Overall Study|Withdrawal by Subject|0|||
143046104|NCT02055547|515709514|FG012|Overall Study|Withdrawal by Subject|0|||
143046105|NCT02055547|515709515|FG013|Overall Study|Withdrawal by Subject|1|||
143243573|NCT02963506|516442912|FG004|Double-Blind Period|Death|0|||
143243574|NCT02963506|516442913|FG005|Double-Blind Period|Death|0|||
143046106|NCT02055547|515709516|FG014|Overall Study|Withdrawal by Subject|0|||
143046107|NCT02055547|515709517|FG015|Overall Study|Withdrawal by Subject|1|||
143046108|NCT02055547|515709518|FG016|Overall Study|Withdrawal by Subject|0|||
143046109|NCT02055547|515709519|FG017|Overall Study|Withdrawal by Subject|0|||
143046110|NCT02055547|515709520|FG018|Overall Study|Withdrawal by Subject|0|||
143046111|NCT02055547|515709502|FG000|Overall Study|Lost to Follow-up|0|||
143046112|NCT02055547|515709503|FG001|Overall Study|Lost to Follow-up|0|||
143046113|NCT02055547|515709504|FG002|Overall Study|Lost to Follow-up|1|||
143046114|NCT02055547|515709505|FG003|Overall Study|Lost to Follow-up|0|||
143046115|NCT02055547|515709506|FG004|Overall Study|Lost to Follow-up|0|||
143046116|NCT02055547|515709507|FG005|Overall Study|Lost to Follow-up|0|||
143046117|NCT02055547|515709508|FG006|Overall Study|Lost to Follow-up|0|||
143046118|NCT02055547|515709509|FG007|Overall Study|Lost to Follow-up|0|||
143046119|NCT02055547|515709510|FG008|Overall Study|Lost to Follow-up|0|||
143046120|NCT02055547|515709511|FG009|Overall Study|Lost to Follow-up|0|||
143046121|NCT02055547|515709512|FG010|Overall Study|Lost to Follow-up|0|||
143046122|NCT02055547|515709513|FG011|Overall Study|Lost to Follow-up|0|||
143046123|NCT02055547|515709514|FG012|Overall Study|Lost to Follow-up|0|||
143046124|NCT02055547|515709515|FG013|Overall Study|Lost to Follow-up|0|||
143046125|NCT02055547|515709516|FG014|Overall Study|Lost to Follow-up|0|||
143046126|NCT02055547|515709517|FG015|Overall Study|Lost to Follow-up|0|||
143046127|NCT02055547|515709518|FG016|Overall Study|Lost to Follow-up|0|||
143046128|NCT02055547|515709519|FG017|Overall Study|Lost to Follow-up|0|||
143046129|NCT02055547|515709520|FG018|Overall Study|Lost to Follow-up|0|||
143046130|NCT02911025|515709523|FG000|Overall Study|Lost to Follow-up|3|||
143046131|NCT03719040|515709524|FG000|Overall Study|Withdrawal by Subject|177|||
143046132|NCT03719040|515709524|FG000|Overall Study|Lost to Follow-up|26|||
143046133|NCT06647173|515709527|FG000|Overall Study|Lost to Follow-up|24|||
143046134|NCT02923349|515709528|FG000|Overall Study|Other|1|||
143046135|NCT02923349|515709529|FG001|Overall Study|Other|2|||
143046136|NCT02923349|515709530|FG002|Overall Study|Other|4|||
143046137|NCT02923349|515709531|FG003|Overall Study|Other|1|||
143046138|NCT02923349|515709532|FG004|Overall Study|Other|3|||
143046139|NCT02923349|515709533|FG005|Overall Study|Other|0|||
143046140|NCT02923349|515709534|FG006|Overall Study|Other|1|||
143046141|NCT02923349|515709528|FG000|Overall Study|Withdrawal by Subject|2|||
143046142|NCT02923349|515709529|FG001|Overall Study|Withdrawal by Subject|2|||
143046143|NCT02923349|515709530|FG002|Overall Study|Withdrawal by Subject|8|||
143046144|NCT02923349|515709531|FG003|Overall Study|Withdrawal by Subject|10|||
143046145|NCT02923349|515709532|FG004|Overall Study|Withdrawal by Subject|12|||
143046146|NCT02923349|515709533|FG005|Overall Study|Withdrawal by Subject|3|||
143046147|NCT02923349|515709534|FG006|Overall Study|Withdrawal by Subject|0|||
143046148|NCT02923349|515709528|FG000|Overall Study|Physician Decision|0|||
143046149|NCT02923349|515709529|FG001|Overall Study|Physician Decision|0|||
143046150|NCT02923349|515709530|FG002|Overall Study|Physician Decision|0|||
143046151|NCT02923349|515709531|FG003|Overall Study|Physician Decision|1|||
143046152|NCT02923349|515709532|FG004|Overall Study|Physician Decision|1|||
143046153|NCT02923349|515709533|FG005|Overall Study|Physician Decision|0|||
143046154|NCT02923349|515709534|FG006|Overall Study|Physician Decision|2|||
143046155|NCT02923349|515709528|FG000|Overall Study|Lost to Follow-up|0|||
143046156|NCT02923349|515709529|FG001|Overall Study|Lost to Follow-up|0|||
143046157|NCT02923349|515709530|FG002|Overall Study|Lost to Follow-up|3|||
143046158|NCT02923349|515709531|FG003|Overall Study|Lost to Follow-up|0|||
143046159|NCT02923349|515709532|FG004|Overall Study|Lost to Follow-up|1|||
143046160|NCT02923349|515709533|FG005|Overall Study|Lost to Follow-up|1|||
143046161|NCT02923349|515709534|FG006|Overall Study|Lost to Follow-up|0|||
143046162|NCT02923349|515709528|FG000|Overall Study|Death|1|||
143046163|NCT02923349|515709529|FG001|Overall Study|Death|0|||
143046164|NCT02923349|515709530|FG002|Overall Study|Death|2|||
143046165|NCT02923349|515709531|FG003|Overall Study|Death|4|||
143046166|NCT02923349|515709532|FG004|Overall Study|Death|2|||
143046167|NCT02923349|515709533|FG005|Overall Study|Death|3|||
143046168|NCT02923349|515709534|FG006|Overall Study|Death|0|||
143046169|NCT02751827|515709535|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
143046170|NCT02751827|515709536|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
143046171|NCT02751827|515709537|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
143046172|NCT01248728|515709538|FG000|Overall Study|Adverse Event|1|||
143046173|NCT01248728|515709539|FG001|Overall Study|Adverse Event|1|||
143046174|NCT01248728|515709538|FG000|Overall Study|Withdrawal by Subject|2|||
143046175|NCT01248728|515709539|FG001|Overall Study|Withdrawal by Subject|1|||
143046176|NCT01248728|515709538|FG000|Overall Study|Lack of Efficacy|1|||
143046177|NCT01248728|515709539|FG001|Overall Study|Lack of Efficacy|0|||
143046178|NCT01838681|515709540|FG000|Period A|Adverse Event|39|||
143046179|NCT01838681|515709541|FG001|Period A|Adverse Event|0|||
143046180|NCT01838681|515709542|FG002|Period A|Adverse Event|0|||
143046181|NCT01838681|515709543|FG003|Period A|Adverse Event|0|||
143046182|NCT01838681|515709540|FG000|Period A|Lack of Efficacy|21|||
143046183|NCT01838681|515709541|FG001|Period A|Lack of Efficacy|0|||
143046184|NCT01838681|515709542|FG002|Period A|Lack of Efficacy|0|||
143046185|NCT01838681|515709543|FG003|Period A|Lack of Efficacy|0|||
143046186|NCT01838681|515709540|FG000|Period A|Early response|148|||
143046187|NCT01838681|515709541|FG001|Period A|Early response|0|||
143046188|NCT01838681|515709542|FG002|Period A|Early response|0|||
143046189|NCT01838681|515709543|FG003|Period A|Early response|0|||
143046190|NCT01838681|515709540|FG000|Period A|Withdrawal by Subject|70|||
143046191|NCT01838681|515709541|FG001|Period A|Withdrawal by Subject|0|||
143046192|NCT01838681|515709542|FG002|Period A|Withdrawal by Subject|0|||
143046193|NCT01838681|515709543|FG003|Period A|Withdrawal by Subject|0|||
143046194|NCT01838681|515709540|FG000|Period A|Protocol Violation|16|||
143046195|NCT01838681|515709541|FG001|Period A|Protocol Violation|0|||
143046196|NCT01838681|515709542|FG002|Period A|Protocol Violation|0|||
143046197|NCT01838681|515709543|FG003|Period A|Protocol Violation|0|||
143046198|NCT01838681|515709540|FG000|Period A|Non-compliance with IMP|6|||
143046199|NCT01838681|515709541|FG001|Period A|Non-compliance with IMP|0|||
143046200|NCT01838681|515709542|FG002|Period A|Non-compliance with IMP|0|||
143046201|NCT01838681|515709543|FG003|Period A|Non-compliance with IMP|0|||
143046202|NCT01838681|515709540|FG000|Period A|Lost to Follow-up|4|||
143046203|NCT01838681|515709541|FG001|Period A|Lost to Follow-up|0|||
143046204|NCT01838681|515709542|FG002|Period A|Lost to Follow-up|0|||
143046205|NCT01838681|515709543|FG003|Period A|Lost to Follow-up|0|||
143046206|NCT01838681|515709540|FG000|Period A|Withdrawal before treatment|4|||
143046207|NCT01838681|515709541|FG001|Period A|Withdrawal before treatment|0|||
143046208|NCT01838681|515709542|FG002|Period A|Withdrawal before treatment|0|||
143046209|NCT01838681|515709543|FG003|Period A|Withdrawal before treatment|0|||
143046210|NCT01838681|515709540|FG000|Period A|Administrative or other reasons|17|||
143046211|NCT01838681|515709541|FG001|Period A|Administrative or other reasons|0|||
143046212|NCT01838681|515709542|FG002|Period A|Administrative or other reasons|0|||
143046213|NCT01838681|515709543|FG003|Period A|Administrative or other reasons|0|||
143046214|NCT01838681|515709540|FG000|Period B/A+|Adverse Event|0|||
143046215|NCT01838681|515709541|FG001|Period B/A+|Adverse Event|13|||
143046216|NCT01838681|515709542|FG002|Period B/A+|Adverse Event|27|||
143046217|NCT01838681|515709543|FG003|Period B/A+|Adverse Event|16|||
143046218|NCT01838681|515709540|FG000|Period B/A+|Lack of Efficacy|0|||
143046219|NCT01838681|515709541|FG001|Period B/A+|Lack of Efficacy|9|||
143046220|NCT01838681|515709542|FG002|Period B/A+|Lack of Efficacy|11|||
143046221|NCT01838681|515709543|FG003|Period B/A+|Lack of Efficacy|6|||
143046222|NCT01838681|515709540|FG000|Period B/A+|Withdrawal by Subject|0|||
143046223|NCT01838681|515709541|FG001|Period B/A+|Withdrawal by Subject|28|||
143046224|NCT01838681|515709542|FG002|Period B/A+|Withdrawal by Subject|35|||
143046225|NCT01838681|515709543|FG003|Period B/A+|Withdrawal by Subject|47|||
143046226|NCT01838681|515709540|FG000|Period B/A+|Protocol Violation|0|||
143046227|NCT01838681|515709541|FG001|Period B/A+|Protocol Violation|1|||
143046228|NCT01838681|515709542|FG002|Period B/A+|Protocol Violation|4|||
143046229|NCT01838681|515709543|FG003|Period B/A+|Protocol Violation|6|||
143046230|NCT01838681|515709540|FG000|Period B/A+|Non-compliance with IMP|0|||
143046231|NCT01838681|515709541|FG001|Period B/A+|Non-compliance with IMP|2|||
143046232|NCT01838681|515709542|FG002|Period B/A+|Non-compliance with IMP|3|||
143046233|NCT01838681|515709543|FG003|Period B/A+|Non-compliance with IMP|3|||
143046234|NCT01838681|515709540|FG000|Period B/A+|Lost to Follow-up|0|||
143046235|NCT01838681|515709541|FG001|Period B/A+|Lost to Follow-up|2|||
143046236|NCT01838681|515709542|FG002|Period B/A+|Lost to Follow-up|5|||
143046237|NCT01838681|515709543|FG003|Period B/A+|Lost to Follow-up|11|||
143046238|NCT01838681|515709540|FG000|Period B/A+|Withdrawal before treatment|0|||
143046239|NCT01838681|515709541|FG001|Period B/A+|Withdrawal before treatment|1|||
143046240|NCT01838681|515709542|FG002|Period B/A+|Withdrawal before treatment|0|||
143046241|NCT01838681|515709543|FG003|Period B/A+|Withdrawal before treatment|0|||
143046242|NCT01838681|515709540|FG000|Period B/A+|Administrative or other reasons|0|||
143046243|NCT01838681|515709541|FG001|Period B/A+|Administrative or other reasons|6|||
143046244|NCT01838681|515709542|FG002|Period B/A+|Administrative or other reasons|10|||
143046245|NCT01838681|515709543|FG003|Period B/A+|Administrative or other reasons|28|||
143046246|NCT01473953|515709544|FG000|Overall Study|Other|1|||
143046247|NCT01473953|515709545|FG001|Overall Study|Other|0|||
143046248|NCT01473953|515709546|FG002|Overall Study|Other|0|||
143046249|NCT01473953|515709547|FG003|Overall Study|Other|0|||
143046250|NCT01473953|515709548|FG004|Overall Study|Other|0|||
143046251|NCT04633564|515709549|FG000|Period 1|Adverse Event|28|||
143046252|NCT04633564|515709550|FG001|Period 1|Adverse Event|19|||
143046253|NCT04633564|515709549|FG000|Period 1|Death|8|||
143046254|NCT04633564|515709550|FG001|Period 1|Death|7|||
143046255|NCT04633564|515709549|FG000|Period 1|Lost to Follow-up|3|||
143046256|NCT04633564|515709550|FG001|Period 1|Lost to Follow-up|5|||
143046257|NCT04633564|515709549|FG000|Period 1|Physician Decision|4|||
143046258|NCT04633564|515709550|FG001|Period 1|Physician Decision|12|||
143046259|NCT04633564|515709549|FG000|Period 1|Protocol Violation|0|||
143046260|NCT04633564|515709550|FG001|Period 1|Protocol Violation|1|||
143046261|NCT04633564|515709549|FG000|Period 1|Withdrawal by Subject|10|||
143046262|NCT04633564|515709550|FG001|Period 1|Withdrawal by Subject|8|||
143046263|NCT04633564|515709549|FG000|Period 1|Progressive disease|47|||
143046264|NCT04633564|515709550|FG001|Period 1|Progressive disease|51|||
143046265|NCT04633564|515709549|FG000|Period 1|Terminated by Sponsor|8|||
143046266|NCT04633564|515709550|FG001|Period 1|Terminated by Sponsor|6|||
143046267|NCT04633564|515709549|FG000|Period 2|Adverse Event|3|||
143046268|NCT04633564|515709550|FG001|Period 2|Adverse Event|4|||
143046269|NCT04633564|515709549|FG000|Period 2|Death|0|||
143046270|NCT04633564|515709550|FG001|Period 2|Death|2|||
143046271|NCT04633564|515709549|FG000|Period 2|Lost to Follow-up|0|||
143046272|NCT04633564|515709550|FG001|Period 2|Lost to Follow-up|1|||
143046273|NCT04633564|515709549|FG000|Period 2|Physician Decision|2|||
143046274|NCT04633564|515709550|FG001|Period 2|Physician Decision|4|||
143046275|NCT04633564|515709549|FG000|Period 2|Withdrawal by Subject|5|||
143046276|NCT04633564|515709550|FG001|Period 2|Withdrawal by Subject|1|||
143046277|NCT04633564|515709549|FG000|Period 2|Progressive Disease|74|||
143046278|NCT04633564|515709550|FG001|Period 2|Progressive Disease|82|||
143046279|NCT04633564|515709549|FG000|Period 2|Terminated by Sponsor|9|||
143046280|NCT04633564|515709550|FG001|Period 2|Terminated by Sponsor|3|||
143046281|NCT01010503|515709551|FG000|Overall Study|Adverse Event|1|||
143046282|NCT01010503|515709551|FG000|Overall Study|Death|1|||
143046283|NCT01279486|515709554|FG000|Overall Study|Lost to Follow-up|1|||
143046284|NCT03067987|515709559|FG000|Overall Study|Lost to Follow-up|7|||
143046285|NCT03067987|515709560|FG001|Overall Study|Lost to Follow-up|10|||
143167787|NCT03895372|516161627|FG003|Investigational Treatment Period|Protocol Violation|1|||
143167788|NCT03895372|516161628|FG004|Investigational Treatment Period|Protocol Violation|0|||
143167789|NCT03895372|516161629|FG005|Investigational Treatment Period|Protocol Violation|0|||
143167790|NCT03895372|516161630|FG006|Investigational Treatment Period|Protocol Violation|0|||
143167791|NCT03895372|516161631|FG007|Investigational Treatment Period|Protocol Violation|0|||
143167792|NCT03895372|516161624|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
143167793|NCT03895372|516161625|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
143167794|NCT03895372|516161626|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
143167795|NCT03895372|516161627|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
143167796|NCT03895372|516161628|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
143167797|NCT03895372|516161629|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
143167798|NCT03895372|516161630|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
143167799|NCT03895372|516161631|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
143167800|NCT03895372|516161624|FG000|Extension Treatment Period|Adverse Event|0|||
143167801|NCT03895372|516161625|FG001|Extension Treatment Period|Adverse Event|1|||
143167802|NCT03895372|516161626|FG002|Extension Treatment Period|Adverse Event|0|||
143167803|NCT03895372|516161627|FG003|Extension Treatment Period|Adverse Event|1|||
143167804|NCT03895372|516161628|FG004|Extension Treatment Period|Adverse Event|0|||
143167805|NCT03895372|516161629|FG005|Extension Treatment Period|Adverse Event|0|||
143167806|NCT03895372|516161630|FG006|Extension Treatment Period|Adverse Event|3|||
143167807|NCT03895372|516161631|FG007|Extension Treatment Period|Adverse Event|3|||
143167808|NCT03895372|516161624|FG000|Extension Treatment Period|Other|1|||
143167809|NCT03895372|516161625|FG001|Extension Treatment Period|Other|3|||
143167810|NCT03895372|516161626|FG002|Extension Treatment Period|Other|0|||
143167811|NCT03895372|516161627|FG003|Extension Treatment Period|Other|0|||
143167812|NCT03895372|516161628|FG004|Extension Treatment Period|Other|1|||
143167813|NCT03895372|516161629|FG005|Extension Treatment Period|Other|0|||
143167814|NCT03895372|516161630|FG006|Extension Treatment Period|Other|0|||
143167815|NCT03895372|516161631|FG007|Extension Treatment Period|Other|2|||
143167816|NCT03895372|516161624|FG000|Extension Treatment Period|Pregnancy|0|||
143167817|NCT03895372|516161625|FG001|Extension Treatment Period|Pregnancy|0|||
143167818|NCT03895372|516161626|FG002|Extension Treatment Period|Pregnancy|0|||
143167819|NCT03895372|516161627|FG003|Extension Treatment Period|Pregnancy|0|||
143167820|NCT03895372|516161628|FG004|Extension Treatment Period|Pregnancy|1|||
143167821|NCT03895372|516161629|FG005|Extension Treatment Period|Pregnancy|0|||
143167822|NCT03895372|516161630|FG006|Extension Treatment Period|Pregnancy|0|||
143167823|NCT03895372|516161631|FG007|Extension Treatment Period|Pregnancy|0|||
143167824|NCT03895372|516161624|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
143167825|NCT03895372|516161625|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
143167826|NCT03895372|516161626|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
143046286|NCT03067987|515709559|FG000|Overall Study|Protocol Violation|1|||
143046287|NCT03067987|515709560|FG001|Overall Study|Protocol Violation|2|||
143167827|NCT03895372|516161627|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
143167828|NCT03895372|516161628|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
143167829|NCT03895372|516161629|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
143167830|NCT03895372|516161630|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
143167831|NCT03895372|516161631|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
143167832|NCT01472185|516161634|FG000|Overall Study|Randomized but Not Treated|0|||
143167833|NCT01472185|516161635|FG001|Overall Study|Randomized but Not Treated|1|||
143167834|NCT01472185|516161634|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
143167835|NCT01472185|516161635|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
143167836|NCT01472185|516161634|FG000|Overall Study|Hyperglycemia|5|||
143167837|NCT01472185|516161635|FG001|Overall Study|Hyperglycemia|2|||
143046288|NCT03067987|515709559|FG000|Overall Study|Withdrawal by Subject|2|||
143046289|NCT03067987|515709560|FG001|Overall Study|Withdrawal by Subject|1|||
143046290|NCT04827394|515709563|FG000|Overall Study|Physician Decision|0|||
143046291|NCT04827394|515709564|FG001|Overall Study|Physician Decision|2|||
143046292|NCT03500094|515709565|FG000|Overall Study|Withdrawal by Subject|1|||
143046293|NCT03500094|515709565|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
143046294|NCT03500094|515709565|FG000|Overall Study|Lost to Follow-up|1|||
143046295|NCT01404988|515709566|FG000|Overall Study|Death|2|||
143046296|NCT01404988|515709567|FG001|Overall Study|Death|0|||
143046297|NCT01404988|515709568|FG002|Overall Study|Death|2|||
143046298|NCT01404988|515709566|FG000|Overall Study|Adverse Event|1|||
143046299|NCT01404988|515709567|FG001|Overall Study|Adverse Event|0|||
143046300|NCT01404988|515709568|FG002|Overall Study|Adverse Event|0|||
143046301|NCT01404988|515709566|FG000|Overall Study|Withdrawal by Subject|2|||
143046302|NCT01404988|515709567|FG001|Overall Study|Withdrawal by Subject|2|||
143046303|NCT01404988|515709568|FG002|Overall Study|Withdrawal by Subject|0|||
143046304|NCT01404988|515709566|FG000|Overall Study|Lost to Follow-up|1|||
143046305|NCT01404988|515709567|FG001|Overall Study|Lost to Follow-up|2|||
143046306|NCT01404988|515709568|FG002|Overall Study|Lost to Follow-up|1|||
143046307|NCT00829764|515709569|FG000|First Intervention|Adverse Event|1|||
143046308|NCT00829764|515709570|FG001|First Intervention|Adverse Event|0|||
143046309|NCT00829764|515709569|FG000|First Intervention|Withdrawal by Subject|1|||
143046310|NCT00829764|515709570|FG001|First Intervention|Withdrawal by Subject|1|||
143046311|NCT00477594|515709571|FG000|Year 1 and Year 2|Adverse Event|4|||
143046312|NCT00477594|515709572|FG001|Year 1 and Year 2|Adverse Event|2|||
143046313|NCT00477594|515709571|FG000|Year 1 and Year 2|Physician Decision|2|||
143046314|NCT00477594|515709572|FG001|Year 1 and Year 2|Physician Decision|1|||
143046315|NCT00477594|515709571|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
143046316|NCT00477594|515709572|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
143046317|NCT00477594|515709571|FG000|Year 1 and Year 2|Other|1|||
143046318|NCT00477594|515709572|FG001|Year 1 and Year 2|Other|0|||
143046319|NCT00477594|515709571|FG000|Year 3|Adverse Event|1|||
143046320|NCT00477594|515709572|FG001|Year 3|Adverse Event|0|||
143046321|NCT00477594|515709571|FG000|Year 3|Withdrawal by Subject|1|||
143046322|NCT00477594|515709572|FG001|Year 3|Withdrawal by Subject|0|||
143046323|NCT00477594|515709571|FG000|Follow-up Period|Withdrawal by Subject|2|||
143046324|NCT00477594|515709572|FG001|Follow-up Period|Withdrawal by Subject|1|||
143046325|NCT00477594|515709571|FG000|Follow-up Period|Other|1|||
143046326|NCT00477594|515709572|FG001|Follow-up Period|Other|0|||
143046327|NCT03669250|515711226|FG000|Overall Study|Adverse Event|0|||
143046328|NCT03669250|515711227|FG001|Overall Study|Adverse Event|0|||
143046329|NCT03669250|515711228|FG002|Overall Study|Adverse Event|0|||
143046330|NCT03669250|515711229|FG003|Overall Study|Adverse Event|0|||
143046331|NCT03669250|515711230|FG004|Overall Study|Adverse Event|1|||
143046332|NCT03669250|515711231|FG005|Overall Study|Adverse Event|0|||
143046333|NCT03669250|515711226|FG000|Overall Study|Withdrawal by Subject|0|||
143046334|NCT03669250|515711227|FG001|Overall Study|Withdrawal by Subject|1|||
143046335|NCT03669250|515711228|FG002|Overall Study|Withdrawal by Subject|0|||
143046336|NCT03669250|515711229|FG003|Overall Study|Withdrawal by Subject|1|||
143046337|NCT03669250|515711230|FG004|Overall Study|Withdrawal by Subject|0|||
143243575|NCT02963506|516442914|FG006|Double-Blind Period|Death|0|||
143243576|NCT02963506|516442915|FG007|Double-Blind Period|Death|0|||
143243577|NCT02963506|516442916|FG008|Double-Blind Period|Death|0|||
143243578|NCT02963506|516442917|FG009|Double-Blind Period|Death|0|||
143243579|NCT02963506|516442918|FG010|Double-Blind Period|Death|0|||
143243580|NCT02963506|516442919|FG011|Double-Blind Period|Death|0|||
143243581|NCT02963506|516442920|FG012|Double-Blind Period|Death|0|||
143243582|NCT02963506|516442908|FG000|Double-Blind Period|Lost to Follow-up|0|||
143243583|NCT02963506|516442909|FG001|Double-Blind Period|Lost to Follow-up|1|||
143243584|NCT02963506|516442910|FG002|Double-Blind Period|Lost to Follow-up|0|||
143243585|NCT02963506|516442911|FG003|Double-Blind Period|Lost to Follow-up|0|||
143243586|NCT02963506|516442912|FG004|Double-Blind Period|Lost to Follow-up|0|||
143243587|NCT02963506|516442913|FG005|Double-Blind Period|Lost to Follow-up|0|||
143243588|NCT02963506|516442914|FG006|Double-Blind Period|Lost to Follow-up|0|||
143243589|NCT02963506|516442915|FG007|Double-Blind Period|Lost to Follow-up|0|||
143243590|NCT02963506|516442916|FG008|Double-Blind Period|Lost to Follow-up|0|||
143243591|NCT02963506|516442917|FG009|Double-Blind Period|Lost to Follow-up|0|||
143243592|NCT02963506|516442918|FG010|Double-Blind Period|Lost to Follow-up|0|||
143243593|NCT02963506|516442919|FG011|Double-Blind Period|Lost to Follow-up|0|||
143243594|NCT02963506|516442920|FG012|Double-Blind Period|Lost to Follow-up|0|||
143243595|NCT02963506|516442908|FG000|Double-Blind Period|Withdrawal by Subject|0|||
143243596|NCT02963506|516442909|FG001|Double-Blind Period|Withdrawal by Subject|0|||
143243597|NCT02963506|516442910|FG002|Double-Blind Period|Withdrawal by Subject|1|||
143046338|NCT03669250|515711231|FG005|Overall Study|Withdrawal by Subject|0|||
143046339|NCT05041361|515711234|FG000|Overall Study|Lost to Follow-up|1|||
143046340|NCT05041361|515711235|FG001|Overall Study|Lost to Follow-up|3|||
143046341|NCT01642277|515711236|FG000|Overall Study|Adverse Event|10|||
143046342|NCT01642277|515711237|FG001|Overall Study|Adverse Event|0|||
143046343|NCT01642277|515711236|FG000|Overall Study|Physician Decision|2|||
143046344|NCT01642277|515711237|FG001|Overall Study|Physician Decision|0|||
143046345|NCT01642277|515711236|FG000|Overall Study|Protocol Violation|1|||
143046346|NCT01642277|515711237|FG001|Overall Study|Protocol Violation|0|||
143046347|NCT01642277|515711236|FG000|Overall Study|Withdrawal by Subject|11|||
143046348|NCT01642277|515711237|FG001|Overall Study|Withdrawal by Subject|0|||
143046349|NCT03679598|515711238|FG000|Overall Study|Adverse Event|2|||
143046350|NCT03679598|515711239|FG001|Overall Study|Adverse Event|0|||
143046351|NCT03605342|515711240|FG000|Overall Study|Withdrawal by Subject|9|||
143046352|NCT03605342|515711241|FG001|Overall Study|Withdrawal by Subject|7|||
143046353|NCT03605342|515711240|FG000|Overall Study|Lost to Follow-up|1|||
143046354|NCT03605342|515711241|FG001|Overall Study|Lost to Follow-up|1|||
143046355|NCT04692155|515711246|FG000|Overall Study|Death|1|||
143046356|NCT02554877|515711247|FG000|Overall Study|Adverse Event|2|||
143046357|NCT02554877|515711248|FG001|Overall Study|Adverse Event|0|||
143046358|NCT02554877|515711249|FG002|Overall Study|Adverse Event|0|||
143046359|NCT02554877|515711250|FG003|Overall Study|Adverse Event|1|||
143046360|NCT02554877|515711247|FG000|Overall Study|Lost to Follow-up|1|||
143046361|NCT02554877|515711248|FG001|Overall Study|Lost to Follow-up|1|||
143046362|NCT02554877|515711249|FG002|Overall Study|Lost to Follow-up|1|||
143046363|NCT02554877|515711250|FG003|Overall Study|Lost to Follow-up|2|||
143046364|NCT02554877|515711247|FG000|Overall Study|Did not meet entrance criteria|0|||
143046365|NCT02554877|515711248|FG001|Overall Study|Did not meet entrance criteria|0|||
143046366|NCT02554877|515711249|FG002|Overall Study|Did not meet entrance criteria|1|||
143046367|NCT02554877|515711250|FG003|Overall Study|Did not meet entrance criteria|0|||
143046368|NCT02554877|515711247|FG000|Overall Study|No longer met eligibility criteria|1|||
143046369|NCT02554877|515711248|FG001|Overall Study|No longer met eligibility criteria|0|||
143046370|NCT02554877|515711249|FG002|Overall Study|No longer met eligibility criteria|1|||
143046371|NCT02554877|515711250|FG003|Overall Study|No longer met eligibility criteria|1|||
143046372|NCT02554877|515711247|FG000|Overall Study|Protocol Violation|3|||
143046373|NCT02554877|515711248|FG001|Overall Study|Protocol Violation|1|||
143046374|NCT02554877|515711249|FG002|Overall Study|Protocol Violation|1|||
143046375|NCT02554877|515711250|FG003|Overall Study|Protocol Violation|0|||
143046376|NCT02554877|515711247|FG000|Overall Study|Other|1|||
143046377|NCT02554877|515711248|FG001|Overall Study|Other|3|||
143046378|NCT02554877|515711249|FG002|Overall Study|Other|0|||
143046379|NCT02554877|515711250|FG003|Overall Study|Other|3|||
143046380|NCT02554877|515711247|FG000|Overall Study|Insufficient clinical response|4|||
143046381|NCT02554877|515711248|FG001|Overall Study|Insufficient clinical response|0|||
143046382|NCT02554877|515711249|FG002|Overall Study|Insufficient clinical response|0|||
143046383|NCT02554877|515711250|FG003|Overall Study|Insufficient clinical response|0|||
143046384|NCT02554877|515711247|FG000|Overall Study|No longer willing to participate|0|||
143046385|NCT02554877|515711248|FG001|Overall Study|No longer willing to participate|2|||
143046386|NCT02554877|515711249|FG002|Overall Study|No longer willing to participate|2|||
143046387|NCT02554877|515711250|FG003|Overall Study|No longer willing to participate|0|||
143046388|NCT04474405|515711251|FG000|Overall Study|Withdrawal by Subject|0|||
143046389|NCT04474405|515711252|FG001|Overall Study|Withdrawal by Subject|0|||
143046390|NCT04474405|515711253|FG002|Overall Study|Withdrawal by Subject|1|||
143046391|NCT04474405|515711254|FG003|Overall Study|Withdrawal by Subject|0|||
143046392|NCT04474405|515711255|FG004|Overall Study|Withdrawal by Subject|1|||
143046393|NCT04474405|515711256|FG005|Overall Study|Withdrawal by Subject|0|||
143046394|NCT04474405|515711251|FG000|Overall Study|Other|0|||
143046395|NCT04474405|515711252|FG001|Overall Study|Other|0|||
143167838|NCT01472185|516161634|FG000|Overall Study|Investigator's Discretion|3|||
143167839|NCT01472185|516161635|FG001|Overall Study|Investigator's Discretion|1|||
143167840|NCT01472185|516161634|FG000|Overall Study|Lost to Follow-up|4|||
143167841|NCT01472185|516161635|FG001|Overall Study|Lost to Follow-up|1|||
143167842|NCT01472185|516161634|FG000|Overall Study|Protocol Violation|5|||
143046396|NCT04474405|515711253|FG002|Overall Study|Other|0|||
143046397|NCT04474405|515711254|FG003|Overall Study|Other|0|||
143046398|NCT04474405|515711255|FG004|Overall Study|Other|3|||
143046399|NCT04474405|515711256|FG005|Overall Study|Other|0|||
143046400|NCT05133180|515711257|FG000|Overall Study|Withdrawal of consent|1|||
143046401|NCT05133180|515711258|FG001|Overall Study|Withdrawal of consent|1|||
143046402|NCT05133180|515711257|FG000|Overall Study|Lost to Follow-up|1|||
143046403|NCT05133180|515711258|FG001|Overall Study|Lost to Follow-up|1|||
143046404|NCT05133180|515711257|FG000|Overall Study|Documented disease progression|0|||
143046405|NCT05133180|515711258|FG001|Overall Study|Documented disease progression|1|||
143046406|NCT03366792|515711259|FG000|Overall Study|Withdrawal by Subject|7|||
143167843|NCT01472185|516161635|FG001|Overall Study|Protocol Violation|1|||
143046407|NCT03366792|515711259|FG000|Overall Study|Lost to Follow-up|2|||
143046408|NCT03366792|515711259|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
143046409|NCT03366792|515711259|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
143167844|NCT01472185|516161634|FG000|Overall Study|Subject Noncompliance|8|||
143046410|NCT01808651|515711260|FG000|Study Period 1|Lost to Follow-up|1|||
143046411|NCT01808651|515711261|FG001|Study Period 1|Lost to Follow-up|3|||
143167845|NCT01472185|516161635|FG001|Overall Study|Subject Noncompliance|15|||
143046412|NCT01808651|515711262|FG002|Study Period 1|Lost to Follow-up|0|||
143046413|NCT01808651|515711260|FG000|Study Period 1|Protocol Violation|1|||
143167846|NCT01472185|516161634|FG000|Overall Study|Subject Withdrew Consent|6|||
143046414|NCT01808651|515711261|FG001|Study Period 1|Protocol Violation|0|||
143046415|NCT01808651|515711262|FG002|Study Period 1|Protocol Violation|1|||
143243598|NCT02963506|516442911|FG003|Double-Blind Period|Withdrawal by Subject|1|||
143243599|NCT02963506|516442912|FG004|Double-Blind Period|Withdrawal by Subject|0|||
143046416|NCT01808651|515711260|FG000|Study Period 1|Physician Decision|3|||
143046417|NCT01808651|515711261|FG001|Study Period 1|Physician Decision|2|||
143046418|NCT01808651|515711262|FG002|Study Period 1|Physician Decision|0|||
143243600|NCT02963506|516442913|FG005|Double-Blind Period|Withdrawal by Subject|0|||
143243601|NCT02963506|516442914|FG006|Double-Blind Period|Withdrawal by Subject|0|||
143243602|NCT02963506|516442915|FG007|Double-Blind Period|Withdrawal by Subject|0|||
143243603|NCT02963506|516442916|FG008|Double-Blind Period|Withdrawal by Subject|0|||
143243604|NCT02963506|516442917|FG009|Double-Blind Period|Withdrawal by Subject|0|||
143243605|NCT02963506|516442918|FG010|Double-Blind Period|Withdrawal by Subject|0|||
143243606|NCT02963506|516442919|FG011|Double-Blind Period|Withdrawal by Subject|0|||
143243607|NCT02963506|516442920|FG012|Double-Blind Period|Withdrawal by Subject|0|||
143243608|NCT02963506|516442908|FG000|Double-Blind Period|No compliance|0|||
143243609|NCT02963506|516442909|FG001|Double-Blind Period|No compliance|1|||
143243610|NCT02963506|516442910|FG002|Double-Blind Period|No compliance|0|||
143243611|NCT02963506|516442911|FG003|Double-Blind Period|No compliance|0|||
143046419|NCT01808651|515711260|FG000|Study Period 1|Lack of Efficacy|2|||
143046420|NCT01808651|515711261|FG001|Study Period 1|Lack of Efficacy|1|||
143046421|NCT01808651|515711262|FG002|Study Period 1|Lack of Efficacy|0|||
143046422|NCT01808651|515711260|FG000|Study Period 1|Adverse Event|10|||
143046423|NCT01808651|515711261|FG001|Study Period 1|Adverse Event|4|||
143046424|NCT01808651|515711262|FG002|Study Period 1|Adverse Event|1|||
143046425|NCT01808651|515711260|FG000|Study Period 1|Participant Decision|9|||
143046426|NCT01808651|515711261|FG001|Study Period 1|Participant Decision|7|||
143046427|NCT01808651|515711262|FG002|Study Period 1|Participant Decision|3|||
143046428|NCT04002648|515711271|FG000|Overall Study|Lost to Follow-up|2|||
143046429|NCT04002648|515711272|FG001|Overall Study|Lost to Follow-up|0|||
143046430|NCT03325881|515711275|FG000|Overall Study|Protocol Violation|0|||
143046431|NCT03325881|515711276|FG001|Overall Study|Protocol Violation|1|||
143046432|NCT03325881|515711275|FG000|Overall Study|Withdrawal by Subject|0|||
143046433|NCT03325881|515711276|FG001|Overall Study|Withdrawal by Subject|2|||
143243612|NCT02963506|516442912|FG004|Double-Blind Period|No compliance|0|||
143243613|NCT02963506|516442913|FG005|Double-Blind Period|No compliance|0|||
143243614|NCT02963506|516442914|FG006|Double-Blind Period|No compliance|0|||
143243615|NCT02963506|516442915|FG007|Double-Blind Period|No compliance|0|||
143243616|NCT02963506|516442916|FG008|Double-Blind Period|No compliance|0|||
143243617|NCT02963506|516442917|FG009|Double-Blind Period|No compliance|0|||
143243618|NCT02963506|516442918|FG010|Double-Blind Period|No compliance|0|||
143243619|NCT02963506|516442919|FG011|Double-Blind Period|No compliance|0|||
143243620|NCT02963506|516442920|FG012|Double-Blind Period|No compliance|0|||
143243621|NCT02963506|516442908|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
143046434|NCT03325881|515711275|FG000|Overall Study|Lack of Efficacy|2|||
143046435|NCT03325881|515711276|FG001|Overall Study|Lack of Efficacy|0|||
143046436|NCT03325881|515711275|FG000|Overall Study|Not treated|1|||
143046437|NCT03325881|515711276|FG001|Overall Study|Not treated|0|||
143046438|NCT00606281|515711280|FG000|Overall Study|Adverse Event|11|||
143046439|NCT00606281|515711281|FG001|Overall Study|Adverse Event|12|||
143046440|NCT00606281|515711280|FG000|Overall Study|Death|1|||
143046441|NCT00606281|515711281|FG001|Overall Study|Death|0|||
143046442|NCT00606281|515711280|FG000|Overall Study|Lack of Efficacy|28|||
143046443|NCT00606281|515711281|FG001|Overall Study|Lack of Efficacy|35|||
143046444|NCT00606281|515711280|FG000|Overall Study|Physician Decision|0|||
143046445|NCT00606281|515711281|FG001|Overall Study|Physician Decision|1|||
143046446|NCT00606281|515711280|FG000|Overall Study|Protocol Violation|3|||
143046447|NCT00606281|515711281|FG001|Overall Study|Protocol Violation|3|||
143046448|NCT00606281|515711280|FG000|Overall Study|Withdrawal by Subject|11|||
143046449|NCT00606281|515711281|FG001|Overall Study|Withdrawal by Subject|13|||
143046450|NCT00606281|515711280|FG000|Overall Study|Progression to depressive phase|1|||
143046451|NCT00606281|515711281|FG001|Overall Study|Progression to depressive phase|1|||
143046452|NCT00606281|515711280|FG000|Overall Study|Change of residence or other commitments|1|||
143243622|NCT02963506|516442909|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
143243623|NCT02963506|516442910|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
143243624|NCT02963506|516442911|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
143243625|NCT02963506|516442912|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
143243626|NCT02963506|516442913|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
143243627|NCT02963506|516442914|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
143243628|NCT02963506|516442915|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
143046453|NCT00606281|515711281|FG001|Overall Study|Change of residence or other commitments|1|||
143046454|NCT00829712|515711282|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
143046455|NCT00829712|515711283|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
143046456|NCT02280863|515711284|FG000|Integrated Platform|Met stopping criteria|0|||
143046457|NCT02280863|515711285|FG001|Integrated Platform|Met stopping criteria|1|||
143046458|NCT00263588|515711286|FG000|Overall Study|Death|54|||
143046459|NCT00263588|515711287|FG001|Overall Study|Death|90|||
143046460|NCT00263588|515711286|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
143046461|NCT00263588|515711287|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
143046462|NCT00263588|515711286|FG000|Overall Study|Lost to Follow-up|7|||
143046463|NCT00263588|515711287|FG001|Overall Study|Lost to Follow-up|10|||
143046464|NCT00263588|515711286|FG000|Overall Study|Withdrawal by Subject|3|||
143046465|NCT00263588|515711287|FG001|Overall Study|Withdrawal by Subject|4|||
143046466|NCT00263588|515711286|FG000|Overall Study|Protocol Violation|0|||
143046467|NCT00263588|515711287|FG001|Overall Study|Protocol Violation|1|||
143046468|NCT00263588|515711286|FG000|Overall Study|Investigator decision|7|||
143046469|NCT00263588|515711287|FG001|Overall Study|Investigator decision|15|||
143046470|NCT00263588|515711286|FG000|Overall Study|Sponsor terminated study|0|||
143046471|NCT00263588|515711287|FG001|Overall Study|Sponsor terminated study|1|||
143046472|NCT00807495|515711288|FG000|Overall Study|Adverse Event|6|||
143046473|NCT00807495|515711289|FG001|Overall Study|Adverse Event|3|||
143046474|NCT00807495|515711290|FG002|Overall Study|Adverse Event|1|||
143046475|NCT00807495|515711291|FG003|Overall Study|Adverse Event|1|||
143046476|NCT00807495|515711292|FG004|Overall Study|Adverse Event|2|||
143046477|NCT00807495|515711288|FG000|Overall Study|Withdrawal by Patient|2|||
143046478|NCT00807495|515711289|FG001|Overall Study|Withdrawal by Patient|0|||
143046479|NCT00807495|515711290|FG002|Overall Study|Withdrawal by Patient|1|||
143046480|NCT00807495|515711291|FG003|Overall Study|Withdrawal by Patient|0|||
143046481|NCT00807495|515711292|FG004|Overall Study|Withdrawal by Patient|0|||
143046482|NCT00807495|515711288|FG000|Overall Study|Reason Not Specified|0|||
143046483|NCT00807495|515711289|FG001|Overall Study|Reason Not Specified|3|||
143046484|NCT00807495|515711290|FG002|Overall Study|Reason Not Specified|2|||
143046485|NCT00807495|515711291|FG003|Overall Study|Reason Not Specified|0|||
143046486|NCT00807495|515711292|FG004|Overall Study|Reason Not Specified|3|||
143046487|NCT01174186|515711293|FG000|Overall Study|Lost to Follow-up|0|||
143046488|NCT01174186|515711294|FG001|Overall Study|Lost to Follow-up|1|||
143046489|NCT01174186|515711293|FG000|Overall Study|Withdrawal by Subject|0|||
143046490|NCT01174186|515711294|FG001|Overall Study|Withdrawal by Subject|2|||
143046491|NCT05274763|515711295|FG000|Overall Study|Lost to Follow-up|1|||
143046492|NCT00918684|515711296|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
143046493|NCT00918684|515711296|FG000|Treatment Phase|Lack of Efficacy|6|||
143046494|NCT00918684|515711296|FG000|Treatment Phase|Lost to Follow-up|2|||
143046495|NCT00918684|515711296|FG000|Treatment Phase|Physician Decision|8|||
143046496|NCT00918684|515711296|FG000|Treatment Phase|Protocol Violation|1|||
143046497|NCT00918684|515711296|FG000|Treatment Phase|Withdrawal by Subject|8|||
143046498|NCT01051349|515711298|FG000|Overall Study|Adverse Event|88|||
143046499|NCT01051349|515711298|FG000|Overall Study|Consent Withdrawn|54|||
143046500|NCT01051349|515711298|FG000|Overall Study|Investigator Decision|6|||
143046501|NCT01051349|515711298|FG000|Overall Study|Lost to Follow-up|6|||
143046502|NCT01051349|515711298|FG000|Overall Study|Subject non-compliance|7|||
143046503|NCT01051349|515711298|FG000|Overall Study|Reason not Specified|12|||
143046504|NCT00484679|515711299|FG000|Overall Study|Withdrawal by Subject|3|||
143046505|NCT00402103|515711300|FG000|Overall Study|Adverse Event|60|||
143046506|NCT00402103|515711301|FG001|Overall Study|Adverse Event|7|||
143046507|NCT00402103|515711300|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
143046508|NCT00402103|515711301|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
143046509|NCT00402103|515711300|FG000|Overall Study|Condition no longer requires study drug|2|||
143046510|NCT00402103|515711301|FG001|Overall Study|Condition no longer requires study drug|0|||
143046511|NCT00402103|515711300|FG000|Overall Study|Protocol Deviation|8|||
143046512|NCT00402103|515711301|FG001|Overall Study|Protocol Deviation|0|||
143046513|NCT00402103|515711300|FG000|Overall Study|Patient withdrew consent|12|||
143046514|NCT00402103|515711301|FG001|Overall Study|Patient withdrew consent|1|||
143046515|NCT00402103|515711300|FG000|Overall Study|Lost to Follow-up|6|||
143046516|NCT00402103|515711301|FG001|Overall Study|Lost to Follow-up|3|||
143046517|NCT00402103|515711300|FG000|Overall Study|Administrative problems|2|||
143046518|NCT00402103|515711301|FG001|Overall Study|Administrative problems|0|||
143046519|NCT00367133|515711302|FG000|2 Years|Death|20|||
143046520|NCT00367133|515711303|FG001|2 Years|Death|12|||
143046521|NCT00367133|515711304|FG002|2 Years|Death|12|||
143046522|NCT00367133|515711302|FG000|2 Years|Dropped|34|||
143046523|NCT00367133|515711303|FG001|2 Years|Dropped|19|||
143046524|NCT00367133|515711304|FG002|2 Years|Dropped|33|||
143046525|NCT00367133|515711302|FG000|2 Years|Missed visit|4|||
143046526|NCT00367133|515711303|FG001|2 Years|Missed visit|5|||
143046527|NCT00367133|515711304|FG002|2 Years|Missed visit|4|||
143167847|NCT01472185|516161635|FG001|Overall Study|Subject Withdrew Consent|3|||
143046528|NCT02679729|515711310|FG000|Overall Study|Lost to Follow-up|0|||
143046529|NCT02679729|515711311|FG001|Overall Study|Lost to Follow-up|1|||
143046530|NCT02679729|515711312|FG002|Overall Study|Lost to Follow-up|0|||
143167848|NCT01309230|516161636|FG000|Overall Study|Withdrawal by Subject|0|||
143046531|NCT02679729|515711313|FG003|Overall Study|Lost to Follow-up|0|||
143046532|NCT02679729|515711314|FG004|Overall Study|Lost to Follow-up|1|||
143046533|NCT02679729|515711315|FG005|Overall Study|Lost to Follow-up|0|||
143046534|NCT02679729|515711316|FG006|Overall Study|Lost to Follow-up|0|||
143046535|NCT02679729|515711317|FG007|Overall Study|Lost to Follow-up|0|||
143046536|NCT02679729|515711318|FG008|Overall Study|Lost to Follow-up|0|||
143046537|NCT02679729|515711310|FG000|Overall Study|Participant decision|0|||
143046538|NCT02679729|515711311|FG001|Overall Study|Participant decision|1|||
143046539|NCT02679729|515711312|FG002|Overall Study|Participant decision|0|||
143046540|NCT02679729|515711313|FG003|Overall Study|Participant decision|0|||
143046541|NCT02679729|515711314|FG004|Overall Study|Participant decision|0|||
143046542|NCT02679729|515711315|FG005|Overall Study|Participant decision|0|||
143046543|NCT02679729|515711316|FG006|Overall Study|Participant decision|1|||
143046544|NCT02679729|515711317|FG007|Overall Study|Participant decision|0|||
143046545|NCT02679729|515711318|FG008|Overall Study|Participant decision|0|||
143046546|NCT03488108|515711321|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
143046547|NCT03488108|515711322|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
143046548|NCT03488108|515711321|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
143046549|NCT03488108|515711322|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
143046550|NCT01442376|515711327|FG000|Overall Study|Adverse Event|0|||
143046551|NCT01442376|515711328|FG001|Overall Study|Adverse Event|3|||
143046552|NCT01442376|515711329|FG002|Overall Study|Adverse Event|2|||
143046553|NCT01442376|515711327|FG000|Overall Study|Death|0|||
143046554|NCT01442376|515711328|FG001|Overall Study|Death|1|||
143046555|NCT01442376|515711329|FG002|Overall Study|Death|1|||
143046556|NCT01442376|515711327|FG000|Overall Study|Withdrawal of consent|0|||
143046557|NCT01442376|515711328|FG001|Overall Study|Withdrawal of consent|0|||
143167849|NCT01309230|516161637|FG001|Overall Study|Withdrawal by Subject|2|||
143167850|NCT01309230|516161636|FG000|Overall Study|Observation arm closed|0|||
143167851|NCT01309230|516161637|FG001|Overall Study|Observation arm closed|2|||
143167852|NCT00427700|516161638|FG000|Overall Study|Lost to Follow-up|2|||
143167853|NCT00427700|516161639|FG001|Overall Study|Lost to Follow-up|5|||
143167854|NCT00427700|516161638|FG000|Overall Study|no induction of menses|1|||
143167855|NCT00427700|516161639|FG001|Overall Study|no induction of menses|4|||
143167856|NCT00427700|516161638|FG000|Overall Study|Pregnancy|0|||
143167857|NCT00427700|516161639|FG001|Overall Study|Pregnancy|2|||
143167858|NCT00815633|516161642|FG000|Overall Study|study terminated|1|||
143046558|NCT01442376|515711329|FG002|Overall Study|Withdrawal of consent|1|||
143046559|NCT01442376|515711327|FG000|Overall Study|Patients not treated|2|||
143046560|NCT01442376|515711328|FG001|Overall Study|Patients not treated|3|||
143046561|NCT01442376|515711329|FG002|Overall Study|Patients not treated|1|||
143046562|NCT01442376|515711327|FG000|Overall Study|Not eligible for subsequent cycles|1|||
143046563|NCT01442376|515711328|FG001|Overall Study|Not eligible for subsequent cycles|2|||
143046564|NCT01442376|515711329|FG002|Overall Study|Not eligible for subsequent cycles|0|||
143046565|NCT00858780|515711330|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
143046566|NCT00858780|515711331|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
143046567|NCT00858780|515711332|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
143046568|NCT00858780|515711333|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
143046569|NCT00858780|515711334|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
143046570|NCT00858780|515711330|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
143046571|NCT00858780|515711331|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
143167859|NCT01362790|516161643|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
143167860|NCT01362790|516161644|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
143167861|NCT01362790|516161645|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
143167862|NCT01362790|516161646|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
143046572|NCT00858780|515711332|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
143046573|NCT00858780|515711333|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
143046574|NCT00858780|515711334|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
143046575|NCT00858780|515711330|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
143046576|NCT00858780|515711331|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
143167863|NCT01362790|516161647|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
143167864|NCT01362790|516161648|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
143167865|NCT01362790|516161649|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
143167866|NCT01362790|516161643|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
143167867|NCT01362790|516161644|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
143243629|NCT02963506|516442916|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
143243630|NCT02963506|516442917|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
143046577|NCT00858780|515711332|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
143046578|NCT00858780|515711333|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
143046579|NCT00858780|515711334|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
143046580|NCT00858780|515711330|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
143046581|NCT00858780|515711331|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
143046582|NCT00858780|515711332|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
143167868|NCT01362790|516161645|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
143167869|NCT01362790|516161646|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
143046583|NCT00858780|515711333|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
143046584|NCT00858780|515711334|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
143046585|NCT00858780|515711330|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
143046586|NCT00858780|515711331|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
143046587|NCT00858780|515711332|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
143046588|NCT00858780|515711333|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
143046589|NCT00858780|515711334|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
143046590|NCT00858780|515711330|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
143046591|NCT00858780|515711331|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
143046592|NCT00858780|515711332|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
143046593|NCT00858780|515711333|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
143046594|NCT00858780|515711334|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
143046595|NCT01075516|515711335|FG000|Overall Study|Death|5|||
143046596|NCT01075516|515711336|FG001|Overall Study|Death|9|||
143046597|NCT01075516|515711335|FG000|Overall Study|Lost to Follow-up|10|||
143046598|NCT01075516|515711336|FG001|Overall Study|Lost to Follow-up|2|||
143046599|NCT01075516|515711335|FG000|Overall Study|Withdrawal by Subject|3|||
143046600|NCT01075516|515711336|FG001|Overall Study|Withdrawal by Subject|5|||
143046601|NCT02252016|515711337|FG000|Overall Study|Lost to Follow-up|2|||
143046602|NCT02252016|515711338|FG001|Overall Study|Lost to Follow-up|1|||
143046603|NCT02252016|515711337|FG000|Overall Study|Physician Decision|1|||
143046604|NCT02252016|515711338|FG001|Overall Study|Physician Decision|0|||
143046605|NCT02252016|515711337|FG000|Overall Study|Withdrawal by Subject|0|||
143046606|NCT02252016|515711338|FG001|Overall Study|Withdrawal by Subject|2|||
143046607|NCT02615249|515711339|FG000|Overall Study|Withdrawal by Subject|1|||
143046608|NCT05098743|515711340|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
143046609|NCT05098743|515711341|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
143046610|NCT05098743|515711340|FG000|Overall Study|Lost to Follow-up|1|||
143046611|NCT05098743|515711341|FG001|Overall Study|Lost to Follow-up|2|||
143046612|NCT01456221|515711342|FG000|Overall Study|Withdrawal by Subject|56|||
143046613|NCT01456221|515711343|FG001|Overall Study|Withdrawal by Subject|49|||
143046614|NCT01456221|515711342|FG000|Overall Study|Lost to Follow-up|1|||
143046615|NCT01456221|515711343|FG001|Overall Study|Lost to Follow-up|4|||
143046616|NCT01456221|515711342|FG000|Overall Study|Received medication|3|||
143046617|NCT01456221|515711343|FG001|Overall Study|Received medication|2|||
143046618|NCT01456221|515711342|FG000|Overall Study|Incomplete data|4|||
143046619|NCT01456221|515711343|FG001|Overall Study|Incomplete data|2|||
143046620|NCT00112437|515711345|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
143046621|NCT00112437|515711346|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
143046622|NCT00112437|515711347|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
143046623|NCT00112437|515711348|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
143046624|NCT00112437|515711349|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
143046625|NCT00112437|515711350|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
143046626|NCT00112437|515711351|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
143046627|NCT00112437|515711352|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
143046628|NCT00112437|515711353|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
143046629|NCT00112437|515711354|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
143046630|NCT00112437|515711355|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
143046631|NCT00112437|515711356|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
143046632|NCT00112437|515711357|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
143046633|NCT00112437|515711358|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
143046634|NCT00112437|515711359|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
143046635|NCT00112437|515711360|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
143046636|NCT00112437|515711361|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
143046637|NCT00112437|515711362|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
143046638|NCT00112437|515711363|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
143046639|NCT00112437|515711364|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
143046640|NCT00112437|515711365|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
143046641|NCT00112437|515711366|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
143167870|NCT01362790|516161647|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
143046642|NCT00112437|515711367|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
143167871|NCT01362790|516161648|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
143167872|NCT01362790|516161649|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
143046643|NCT00112437|515711368|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
143046644|NCT00112437|515711369|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
143046645|NCT00112437|515711370|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
143046646|NCT00112437|515711345|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
143046647|NCT00112437|515711346|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
143046648|NCT00112437|515711347|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
143167873|NCT01362790|516161643|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
143167874|NCT01362790|516161644|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
143167875|NCT01362790|516161645|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
143046649|NCT00112437|515711348|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
143046650|NCT00112437|515711349|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
143046651|NCT00112437|515711350|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
143046652|NCT00112437|515711351|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
143046653|NCT00112437|515711352|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
143046654|NCT00112437|515711353|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
143046655|NCT00112437|515711354|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
143046656|NCT00112437|515711355|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
143046657|NCT00112437|515711356|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
143046658|NCT00112437|515711357|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
143046659|NCT00112437|515711358|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
143046660|NCT00112437|515711359|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
143046661|NCT00112437|515711360|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
143046662|NCT00112437|515711361|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
143046663|NCT00112437|515711362|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
143046664|NCT00112437|515711363|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
143046665|NCT00112437|515711364|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
143046666|NCT00112437|515711365|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
143046667|NCT00112437|515711366|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
143046668|NCT00112437|515711367|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
143046669|NCT00112437|515711368|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
143046670|NCT00112437|515711369|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
143046671|NCT00112437|515711370|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
143046672|NCT00112437|515711345|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
143046673|NCT00112437|515711346|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
143046674|NCT00112437|515711347|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
143046675|NCT00112437|515711348|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
143046676|NCT00112437|515711349|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
143046677|NCT00112437|515711350|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
143046678|NCT00112437|515711351|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
143046679|NCT00112437|515711352|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
143046680|NCT00112437|515711353|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
143046681|NCT00112437|515711354|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
143046682|NCT00112437|515711355|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
143046683|NCT00112437|515711356|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
143046684|NCT00112437|515711357|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
143046685|NCT00112437|515711358|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
143046686|NCT00112437|515711359|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
143046687|NCT00112437|515711360|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
143046688|NCT00112437|515711361|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
143046689|NCT00112437|515711362|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
143046690|NCT00112437|515711363|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
143046691|NCT00112437|515711364|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
143046692|NCT00112437|515711365|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
143243631|NCT02963506|516442918|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
143243632|NCT02963506|516442919|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
143243633|NCT02963506|516442920|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
143243634|NCT02963506|516442908|FG000|Dose-Blind Period|Adverse Event|0|||
143243635|NCT02963506|516442909|FG001|Dose-Blind Period|Adverse Event|0|||
143046693|NCT00112437|515711366|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
143167876|NCT01362790|516161646|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
143167877|NCT01362790|516161647|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
143167878|NCT01362790|516161648|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
143167879|NCT01362790|516161649|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
143167880|NCT01362790|516161643|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
143167881|NCT01362790|516161644|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
143167882|NCT01362790|516161645|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
143167883|NCT01362790|516161646|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
143167884|NCT01362790|516161647|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
143167885|NCT01362790|516161648|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
143167886|NCT01362790|516161649|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
143167887|NCT01362790|516161643|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
143167888|NCT01362790|516161644|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
143167889|NCT01362790|516161645|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
143167890|NCT01362790|516161646|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
143167891|NCT01362790|516161647|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
143167892|NCT01362790|516161648|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
143167893|NCT01362790|516161649|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
143167894|NCT01362790|516161643|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
143167895|NCT01362790|516161644|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
143243636|NCT02963506|516442910|FG002|Dose-Blind Period|Adverse Event|0|||
143046694|NCT00112437|515711367|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
143046695|NCT00112437|515711368|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
143046696|NCT00112437|515711369|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
143046697|NCT00112437|515711370|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
143046698|NCT00112437|515711345|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
143046699|NCT00112437|515711346|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
143046700|NCT00112437|515711347|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
143046701|NCT00112437|515711348|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
143046702|NCT00112437|515711349|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
143046703|NCT00112437|515711350|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
143046704|NCT00112437|515711351|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
143046705|NCT00112437|515711352|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
143046706|NCT00112437|515711353|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
143046707|NCT00112437|515711354|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
143046708|NCT00112437|515711355|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
143046709|NCT00112437|515711356|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
143046710|NCT00112437|515711357|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
143046711|NCT00112437|515711358|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
143046712|NCT00112437|515711359|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
143046713|NCT00112437|515711360|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
143046714|NCT00112437|515711361|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
143046715|NCT00112437|515711362|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
143046716|NCT00112437|515711363|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
143046717|NCT00112437|515711364|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
143046718|NCT00112437|515711365|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
143046719|NCT00112437|515711366|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
143046720|NCT00112437|515711367|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
143046721|NCT00112437|515711368|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
143046722|NCT00112437|515711369|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
143046723|NCT00112437|515711370|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
143046724|NCT00112437|515711345|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
143046725|NCT00112437|515711346|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
143046726|NCT00112437|515711347|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
143046727|NCT00112437|515711348|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
143046728|NCT00112437|515711349|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
143046729|NCT00112437|515711350|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
143046730|NCT00112437|515711351|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
143046731|NCT00112437|515711352|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
143046732|NCT00112437|515711353|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
143046733|NCT00112437|515711354|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
143046734|NCT00112437|515711355|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
143046735|NCT00112437|515711356|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
143046736|NCT00112437|515711357|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
143046737|NCT00112437|515711358|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
143046738|NCT00112437|515711359|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
143046739|NCT00112437|515711360|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
143046740|NCT00112437|515711361|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
143046741|NCT00112437|515711362|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
143046742|NCT00112437|515711363|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
143046743|NCT00112437|515711364|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
143046744|NCT00112437|515711365|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
143046745|NCT00112437|515711366|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
143046746|NCT00112437|515711367|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
143046747|NCT00112437|515711368|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
143046748|NCT00112437|515711369|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
143046749|NCT00112437|515711370|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
143046750|NCT00112437|515711345|FG000|Year 1 (12-Month Base Study)|moved|0|||
143046751|NCT00112437|515711346|FG001|Year 1 (12-Month Base Study)|moved|1|||
143046752|NCT00112437|515711347|FG002|Year 1 (12-Month Base Study)|moved|1|||
143167896|NCT01362790|516161645|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
143167897|NCT01362790|516161646|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
143167898|NCT01362790|516161647|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
143167899|NCT01362790|516161648|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
143167900|NCT01362790|516161649|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
143046753|NCT00112437|515711348|FG003|Year 1 (12-Month Base Study)|moved|0|||
143046754|NCT00112437|515711349|FG004|Year 1 (12-Month Base Study)|moved|0|||
143167901|NCT01362790|516161643|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
143167902|NCT01362790|516161644|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
143167903|NCT01362790|516161645|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
143046755|NCT00112437|515711350|FG005|Year 1 (12-Month Base Study)|moved|0|||
143046756|NCT00112437|515711351|FG006|Year 1 (12-Month Base Study)|moved|0|||
143046757|NCT00112437|515711352|FG007|Year 1 (12-Month Base Study)|moved|0|||
143046758|NCT00112437|515711353|FG008|Year 1 (12-Month Base Study)|moved|0|||
143046759|NCT00112437|515711354|FG009|Year 1 (12-Month Base Study)|moved|0|||
143046760|NCT00112437|515711355|FG010|Year 1 (12-Month Base Study)|moved|0|||
143046761|NCT00112437|515711356|FG011|Year 1 (12-Month Base Study)|moved|0|||
143046762|NCT00112437|515711357|FG012|Year 1 (12-Month Base Study)|moved|0|||
143046763|NCT00112437|515711358|FG013|Year 1 (12-Month Base Study)|moved|0|||
143046764|NCT00112437|515711359|FG014|Year 1 (12-Month Base Study)|moved|0|||
143046765|NCT00112437|515711360|FG015|Year 1 (12-Month Base Study)|moved|0|||
143046766|NCT00112437|515711361|FG016|Year 1 (12-Month Base Study)|moved|0|||
143046767|NCT00112437|515711362|FG017|Year 1 (12-Month Base Study)|moved|0|||
143046768|NCT00112437|515711363|FG018|Year 1 (12-Month Base Study)|moved|0|||
143046769|NCT00112437|515711364|FG019|Year 1 (12-Month Base Study)|moved|0|||
143046770|NCT00112437|515711365|FG020|Year 1 (12-Month Base Study)|moved|0|||
143046771|NCT00112437|515711366|FG021|Year 1 (12-Month Base Study)|moved|0|||
143046772|NCT00112437|515711367|FG022|Year 1 (12-Month Base Study)|moved|0|||
143046773|NCT00112437|515711368|FG023|Year 1 (12-Month Base Study)|moved|0|||
143046774|NCT00112437|515711369|FG024|Year 1 (12-Month Base Study)|moved|0|||
143046775|NCT00112437|515711370|FG025|Year 1 (12-Month Base Study)|moved|0|||
143046776|NCT00112437|515711345|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
143046777|NCT00112437|515711346|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
143046778|NCT00112437|515711347|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
143046779|NCT00112437|515711348|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
143046780|NCT00112437|515711349|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
143046781|NCT00112437|515711350|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
143046782|NCT00112437|515711351|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
143046783|NCT00112437|515711352|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
143046784|NCT00112437|515711353|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
143046785|NCT00112437|515711354|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
143046786|NCT00112437|515711355|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
143046787|NCT00112437|515711356|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
143046788|NCT00112437|515711357|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
143046789|NCT00112437|515711358|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
143046790|NCT00112437|515711359|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
143046791|NCT00112437|515711360|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
143046792|NCT00112437|515711361|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
143046793|NCT00112437|515711362|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
143046794|NCT00112437|515711363|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
143046795|NCT00112437|515711364|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
143046796|NCT00112437|515711365|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
143046797|NCT00112437|515711366|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
143046798|NCT00112437|515711367|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
143046799|NCT00112437|515711368|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
143046800|NCT00112437|515711369|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
143167904|NCT01362790|516161646|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
143167905|NCT01362790|516161647|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
143167906|NCT01362790|516161648|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
143167907|NCT01362790|516161649|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
143167908|NCT01362790|516161643|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
143167909|NCT01362790|516161644|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
143167910|NCT01362790|516161645|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
143167911|NCT01362790|516161646|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
143167912|NCT01362790|516161647|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
143167913|NCT01362790|516161648|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
143167914|NCT01362790|516161649|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
143167915|NCT01362790|516161643|FG000|Pilot Phase & Phase 2|Death on study|0|||
143167916|NCT01362790|516161644|FG001|Pilot Phase & Phase 2|Death on study|0|||
143167917|NCT01362790|516161645|FG002|Pilot Phase & Phase 2|Death on study|0|||
143167918|NCT01362790|516161646|FG003|Pilot Phase & Phase 2|Death on study|1|||
143167919|NCT01362790|516161647|FG004|Pilot Phase & Phase 2|Death on study|0|||
143167920|NCT01362790|516161648|FG005|Pilot Phase & Phase 2|Death on study|0|||
143167921|NCT01362790|516161649|FG006|Pilot Phase & Phase 2|Death on study|0|||
143167922|NCT01362790|516161643|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
143046801|NCT00112437|515711370|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
143046802|NCT00112437|515711345|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
143046803|NCT00112437|515711346|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
143046804|NCT00112437|515711347|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
143046805|NCT00112437|515711348|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
143046806|NCT00112437|515711349|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
143046807|NCT00112437|515711350|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
143046808|NCT00112437|515711351|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
143046809|NCT00112437|515711352|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
143046810|NCT00112437|515711353|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
143046811|NCT00112437|515711354|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
143046812|NCT00112437|515711355|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
143046813|NCT00112437|515711356|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
143046814|NCT00112437|515711357|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
143046815|NCT00112437|515711358|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
143046816|NCT00112437|515711359|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
143046817|NCT00112437|515711360|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
143046818|NCT00112437|515711361|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
143046819|NCT00112437|515711362|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
143046820|NCT00112437|515711363|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
143046821|NCT00112437|515711364|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
143046822|NCT00112437|515711365|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
143046823|NCT00112437|515711366|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
143046824|NCT00112437|515711367|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
143046825|NCT00112437|515711368|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
143046826|NCT00112437|515711369|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
143046827|NCT00112437|515711370|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
143046828|NCT00112437|515711345|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
143046829|NCT00112437|515711346|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
143046830|NCT00112437|515711347|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
143046831|NCT00112437|515711348|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
143046832|NCT00112437|515711349|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
143046833|NCT00112437|515711350|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
143046834|NCT00112437|515711351|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
143046835|NCT00112437|515711352|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
143046836|NCT00112437|515711353|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
143046837|NCT00112437|515711354|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
143046838|NCT00112437|515711355|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
143046839|NCT00112437|515711356|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
143046840|NCT00112437|515711357|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
143046841|NCT00112437|515711358|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
143046842|NCT00112437|515711359|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
143046843|NCT00112437|515711360|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
143046844|NCT00112437|515711361|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
143046845|NCT00112437|515711362|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
143046846|NCT00112437|515711363|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
143046847|NCT00112437|515711364|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
143046848|NCT00112437|515711365|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
143046849|NCT00112437|515711366|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
143046850|NCT00112437|515711367|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
143046851|NCT00112437|515711368|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
143046852|NCT00112437|515711369|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
143046853|NCT00112437|515711370|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
143046854|NCT00112437|515711345|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
143046855|NCT00112437|515711346|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
143046856|NCT00112437|515711347|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
143046857|NCT00112437|515711348|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
143046858|NCT00112437|515711349|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
143046859|NCT00112437|515711350|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
143046860|NCT00112437|515711351|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
143046861|NCT00112437|515711352|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
143046862|NCT00112437|515711353|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
143046863|NCT00112437|515711354|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
143046864|NCT00112437|515711355|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
143046865|NCT00112437|515711356|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
143046866|NCT00112437|515711357|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
143046867|NCT00112437|515711358|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
143046868|NCT00112437|515711359|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
143243637|NCT02963506|516442911|FG003|Dose-Blind Period|Adverse Event|0|||
143243638|NCT02963506|516442912|FG004|Dose-Blind Period|Adverse Event|0|||
143243639|NCT02963506|516442913|FG005|Dose-Blind Period|Adverse Event|1|||
143243640|NCT02963506|516442914|FG006|Dose-Blind Period|Adverse Event|3|||
143243641|NCT02963506|516442915|FG007|Dose-Blind Period|Adverse Event|2|||
143243642|NCT02963506|516442916|FG008|Dose-Blind Period|Adverse Event|2|||
143243643|NCT02963506|516442917|FG009|Dose-Blind Period|Adverse Event|2|||
143243644|NCT02963506|516442918|FG010|Dose-Blind Period|Adverse Event|1|||
143243645|NCT02963506|516442919|FG011|Dose-Blind Period|Adverse Event|1|||
143243646|NCT02963506|516442920|FG012|Dose-Blind Period|Adverse Event|6|||
143243647|NCT02963506|516442908|FG000|Dose-Blind Period|Lack of Efficacy|0|||
143243648|NCT02963506|516442909|FG001|Dose-Blind Period|Lack of Efficacy|0|||
143243649|NCT02963506|516442910|FG002|Dose-Blind Period|Lack of Efficacy|0|||
143243650|NCT02963506|516442911|FG003|Dose-Blind Period|Lack of Efficacy|0|||
143243651|NCT02963506|516442912|FG004|Dose-Blind Period|Lack of Efficacy|0|||
143243652|NCT02963506|516442913|FG005|Dose-Blind Period|Lack of Efficacy|0|||
143243653|NCT02963506|516442914|FG006|Dose-Blind Period|Lack of Efficacy|0|||
143243654|NCT02963506|516442915|FG007|Dose-Blind Period|Lack of Efficacy|1|||
143243655|NCT02963506|516442916|FG008|Dose-Blind Period|Lack of Efficacy|0|||
143243656|NCT02963506|516442917|FG009|Dose-Blind Period|Lack of Efficacy|1|||
143243657|NCT02963506|516442918|FG010|Dose-Blind Period|Lack of Efficacy|0|||
143243658|NCT02963506|516442919|FG011|Dose-Blind Period|Lack of Efficacy|0|||
143243659|NCT02963506|516442920|FG012|Dose-Blind Period|Lack of Efficacy|0|||
143243660|NCT02963506|516442908|FG000|Dose-Blind Period|Lost to Follow-up|0|||
143243661|NCT02963506|516442909|FG001|Dose-Blind Period|Lost to Follow-up|0|||
143243662|NCT02963506|516442910|FG002|Dose-Blind Period|Lost to Follow-up|0|||
143243663|NCT02963506|516442911|FG003|Dose-Blind Period|Lost to Follow-up|0|||
143243664|NCT02963506|516442912|FG004|Dose-Blind Period|Lost to Follow-up|0|||
143243665|NCT02963506|516442913|FG005|Dose-Blind Period|Lost to Follow-up|1|||
143243666|NCT02963506|516442914|FG006|Dose-Blind Period|Lost to Follow-up|0|||
143243667|NCT02963506|516442915|FG007|Dose-Blind Period|Lost to Follow-up|0|||
143243668|NCT02963506|516442916|FG008|Dose-Blind Period|Lost to Follow-up|1|||
143243669|NCT02963506|516442917|FG009|Dose-Blind Period|Lost to Follow-up|0|||
143243670|NCT02963506|516442918|FG010|Dose-Blind Period|Lost to Follow-up|0|||
143243671|NCT02963506|516442919|FG011|Dose-Blind Period|Lost to Follow-up|1|||
143243672|NCT02963506|516442920|FG012|Dose-Blind Period|Lost to Follow-up|0|||
143243673|NCT02963506|516442908|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
143243674|NCT02963506|516442909|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
143243675|NCT02963506|516442910|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
143243676|NCT02963506|516442911|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
143243677|NCT02963506|516442912|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
143243678|NCT02963506|516442913|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
143243679|NCT02963506|516442914|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
143243680|NCT02963506|516442915|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
143243681|NCT02963506|516442916|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
143243682|NCT02963506|516442917|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
143243683|NCT02963506|516442918|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
143243684|NCT02963506|516442919|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
143243685|NCT02963506|516442920|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
143243686|NCT02963506|516442908|FG000|Dose-Blind Period|Sponsor decision|0|||
143243687|NCT02963506|516442909|FG001|Dose-Blind Period|Sponsor decision|0|||
143243688|NCT02963506|516442910|FG002|Dose-Blind Period|Sponsor decision|0|||
143243689|NCT02963506|516442911|FG003|Dose-Blind Period|Sponsor decision|0|||
143243690|NCT02963506|516442912|FG004|Dose-Blind Period|Sponsor decision|0|||
143243691|NCT02963506|516442913|FG005|Dose-Blind Period|Sponsor decision|1|||
143243692|NCT02963506|516442914|FG006|Dose-Blind Period|Sponsor decision|0|||
143243693|NCT02963506|516442915|FG007|Dose-Blind Period|Sponsor decision|0|||
143243694|NCT02963506|516442916|FG008|Dose-Blind Period|Sponsor decision|0|||
143243695|NCT02963506|516442917|FG009|Dose-Blind Period|Sponsor decision|0|||
143243696|NCT02963506|516442918|FG010|Dose-Blind Period|Sponsor decision|0|||
143243697|NCT02963506|516442919|FG011|Dose-Blind Period|Sponsor decision|0|||
143243698|NCT02963506|516442920|FG012|Dose-Blind Period|Sponsor decision|0|||
143243699|NCT02963506|516442908|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
143243700|NCT02963506|516442909|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
143243701|NCT02963506|516442910|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
143364306|NCT00946114|516876957|FG000|Overall Study|Withdrawal by Subject|2|||
143243702|NCT02963506|516442911|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
143243703|NCT02963506|516442912|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
143243704|NCT02963506|516442913|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
143243705|NCT02963506|516442914|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
143243706|NCT02963506|516442915|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
143364307|NCT00946114|516876958|FG001|Overall Study|Withdrawal by Subject|0|||
143243707|NCT02963506|516442916|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
143243708|NCT02963506|516442917|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
143243709|NCT02963506|516442918|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
143046869|NCT00112437|515711360|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
143046870|NCT00112437|515711361|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
143046871|NCT00112437|515711362|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
143046872|NCT00112437|515711363|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
143046873|NCT00112437|515711364|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
143046874|NCT00112437|515711365|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
143046875|NCT00112437|515711366|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
143046876|NCT00112437|515711367|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
143046877|NCT00112437|515711368|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
143046878|NCT00112437|515711369|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
143046879|NCT00112437|515711370|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
143046880|NCT00112437|515711345|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
143046881|NCT00112437|515711346|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
143046882|NCT00112437|515711347|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
143046883|NCT00112437|515711348|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
143046884|NCT00112437|515711349|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
143046885|NCT00112437|515711350|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
143046886|NCT00112437|515711351|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
143046887|NCT00112437|515711352|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
143046888|NCT00112437|515711353|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
143046889|NCT00112437|515711354|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
143046890|NCT00112437|515711355|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
143046891|NCT00112437|515711356|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
143046892|NCT00112437|515711357|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
143046893|NCT00112437|515711358|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
143046894|NCT00112437|515711359|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
143046895|NCT00112437|515711360|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
143046896|NCT00112437|515711361|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
143046897|NCT00112437|515711362|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
143046898|NCT00112437|515711363|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
143046899|NCT00112437|515711364|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
143046900|NCT00112437|515711365|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
143046901|NCT00112437|515711366|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
143046902|NCT00112437|515711367|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
143046903|NCT00112437|515711368|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
143046904|NCT00112437|515711369|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
143046905|NCT00112437|515711370|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
143046906|NCT00112437|515711345|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
143046907|NCT00112437|515711346|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
143046908|NCT00112437|515711347|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
143046909|NCT00112437|515711348|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
143046910|NCT00112437|515711349|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
143046911|NCT00112437|515711350|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
143046912|NCT00112437|515711351|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
143046913|NCT00112437|515711352|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
143046914|NCT00112437|515711353|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
143046915|NCT00112437|515711354|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
143046916|NCT00112437|515711355|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
143046917|NCT00112437|515711356|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
143046918|NCT00112437|515711357|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
143046919|NCT00112437|515711358|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
143046920|NCT00112437|515711359|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
143167923|NCT01362790|516161644|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
143167924|NCT01362790|516161645|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
143167925|NCT01362790|516161646|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
143167926|NCT01362790|516161647|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
143167927|NCT01362790|516161648|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
143167928|NCT01362790|516161649|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
143167929|NCT01362790|516161643|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
143167930|NCT01362790|516161644|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
143167931|NCT01362790|516161645|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
143167932|NCT01362790|516161646|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
143046921|NCT00112437|515711360|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
143046922|NCT00112437|515711361|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
143046923|NCT00112437|515711362|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
143046924|NCT00112437|515711363|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
143046925|NCT00112437|515711364|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
143046926|NCT00112437|515711365|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
143046927|NCT00112437|515711366|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
143243710|NCT02963506|516442919|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
143046928|NCT00112437|515711367|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
143046929|NCT00112437|515711368|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
143046930|NCT00112437|515711369|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
143046931|NCT00112437|515711370|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
143046932|NCT00112437|515711345|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
143046933|NCT00112437|515711346|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
143046934|NCT00112437|515711347|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
143046935|NCT00112437|515711348|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
143046936|NCT00112437|515711349|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
143046937|NCT00112437|515711350|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
143046938|NCT00112437|515711351|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
143046939|NCT00112437|515711352|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
143046940|NCT00112437|515711353|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
143046941|NCT00112437|515711354|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
143046942|NCT00112437|515711355|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
143046943|NCT00112437|515711356|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
143046944|NCT00112437|515711357|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
143046945|NCT00112437|515711358|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
143046946|NCT00112437|515711359|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
143046947|NCT00112437|515711360|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
143046948|NCT00112437|515711361|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
143046949|NCT00112437|515711362|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
143046950|NCT00112437|515711363|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
143046951|NCT00112437|515711364|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
143046952|NCT00112437|515711365|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
143046953|NCT00112437|515711366|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
143046954|NCT00112437|515711367|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
143046955|NCT00112437|515711368|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
143046956|NCT00112437|515711369|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
143046957|NCT00112437|515711370|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
143046958|NCT00112437|515711345|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
143046959|NCT00112437|515711346|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
143046960|NCT00112437|515711347|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
143046961|NCT00112437|515711348|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
143046962|NCT00112437|515711349|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
143046963|NCT00112437|515711350|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
143046964|NCT00112437|515711351|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
143046965|NCT00112437|515711352|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
143046966|NCT00112437|515711353|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
143046967|NCT00112437|515711354|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
143046968|NCT00112437|515711355|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
143046969|NCT00112437|515711356|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
143046970|NCT00112437|515711357|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
143046971|NCT00112437|515711358|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
143046972|NCT00112437|515711359|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
143046973|NCT00112437|515711360|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
143046974|NCT00112437|515711361|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
143046975|NCT00112437|515711362|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
143046976|NCT00112437|515711363|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
143046977|NCT00112437|515711364|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
143046978|NCT00112437|515711365|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
143167933|NCT01362790|516161647|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
143046979|NCT00112437|515711366|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
143046980|NCT00112437|515711367|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
143167934|NCT01362790|516161648|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
143167935|NCT01362790|516161649|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
143167936|NCT01362790|516161643|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
143167937|NCT01362790|516161644|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
143167938|NCT01362790|516161645|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
143364308|NCT00723294|516876959|FG000|Overall Study|Lobular histology|2|||
143046981|NCT00112437|515711368|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
143046982|NCT00112437|515711369|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
143046983|NCT00112437|515711370|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
143167939|NCT01362790|516161646|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
143167940|NCT01362790|516161647|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
143167941|NCT01362790|516161648|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
143243711|NCT02963506|516442920|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
143243712|NCT00630838|516442925|FG000|Overall Study|Death|0|||
143243713|NCT00630838|516442926|FG001|Overall Study|Death|1|||
143243714|NCT00630838|516442925|FG000|Overall Study|Lost to Follow-up|0|||
143243715|NCT00630838|516442926|FG001|Overall Study|Lost to Follow-up|1|||
143243716|NCT00928408|516442927|FG000|Overall Study|Other|2|||
143243717|NCT00928408|516442927|FG000|Overall Study|Withdrawal by Subject|4|||
143243718|NCT00928408|516442927|FG000|Overall Study|Death|5|||
143243719|NCT00928408|516442927|FG000|Overall Study|Lost to Follow-up|12|||
143243720|NCT01108185|516442931|FG000|Overall Study|Non-compliance|15|||
143243721|NCT01108185|516442931|FG000|Overall Study|Lost to Follow-up|12|||
143243722|NCT01185080|516442936|FG000|Overall Study|Adverse Event|1|||
143243723|NCT01185080|516442937|FG001|Overall Study|Adverse Event|1|||
143243724|NCT01185080|516442938|FG002|Overall Study|Adverse Event|0|||
143243725|NCT01185080|516442936|FG000|Overall Study|Personal reasons|0|||
143243726|NCT01185080|516442937|FG001|Overall Study|Personal reasons|0|||
143243727|NCT01185080|516442938|FG002|Overall Study|Personal reasons|1|||
143243728|NCT00256997|516442941|FG000|Overall Study|Protocol Violation|1|||
143243729|NCT00256997|516442942|FG001|Overall Study|Protocol Violation|4|||
143243730|NCT00256997|516442941|FG000|Overall Study|Lack of Efficacy|1|||
143243731|NCT00256997|516442942|FG001|Overall Study|Lack of Efficacy|4|||
143243732|NCT00256997|516442941|FG000|Overall Study|Death|2|||
143243733|NCT00256997|516442942|FG001|Overall Study|Death|0|||
143243734|NCT00256997|516442941|FG000|Overall Study|Adverse Event|4|||
143243735|NCT00256997|516442942|FG001|Overall Study|Adverse Event|0|||
143243736|NCT00256997|516442941|FG000|Overall Study|Lost to Follow-up|3|||
143243737|NCT00256997|516442942|FG001|Overall Study|Lost to Follow-up|5|||
143243738|NCT00256997|516442941|FG000|Overall Study|Withdrawal by Subject|13|||
143243739|NCT00256997|516442942|FG001|Overall Study|Withdrawal by Subject|3|||
143243740|NCT00256997|516442941|FG000|Overall Study|Started but not treated|2|||
143243741|NCT00256997|516442942|FG001|Overall Study|Started but not treated|0|||
143243742|NCT00256997|516442941|FG000|Overall Study|Other|5|||
143243743|NCT00256997|516442942|FG001|Overall Study|Other|8|||
143046984|NCT00112437|515711345|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
143046985|NCT00112437|515711346|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
143046986|NCT00112437|515711347|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
143046987|NCT00112437|515711348|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
143046988|NCT00112437|515711349|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
143046989|NCT00112437|515711350|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
143046990|NCT00112437|515711351|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
143046991|NCT00112437|515711352|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
143046992|NCT00112437|515711353|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
143046993|NCT00112437|515711354|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
143046994|NCT00112437|515711355|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
143046995|NCT00112437|515711356|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
143046996|NCT00112437|515711357|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
143046997|NCT00112437|515711358|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
143243744|NCT00256997|516442941|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
143243745|NCT00256997|516442942|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
143243746|NCT00256997|516442941|FG000|Overall Study|Participant Non-compliant|3|||
143243747|NCT00256997|516442942|FG001|Overall Study|Participant Non-compliant|6|||
143243748|NCT00256997|516442941|FG000|Overall Study|Investigator Withdrew Participant|2|||
143243749|NCT00256997|516442942|FG001|Overall Study|Investigator Withdrew Participant|1|||
143243750|NCT02736578|516442943|FG000|Overall Study|Adverse Event|1|||
143243751|NCT02736578|516442944|FG001|Overall Study|Adverse Event|0|||
143243752|NCT00354432|516442945|FG000|Overall Study|Adverse Event|3|||
143243753|NCT00354432|516442946|FG001|Overall Study|Adverse Event|1|||
143243754|NCT00354432|516442947|FG002|Overall Study|Adverse Event|5|||
143243755|NCT00354432|516442948|FG003|Overall Study|Adverse Event|5|||
143243756|NCT00354432|516442945|FG000|Overall Study|Off/Toxicity|3|||
143243757|NCT00354432|516442946|FG001|Overall Study|Off/Toxicity|7|||
143243758|NCT00354432|516442947|FG002|Overall Study|Off/Toxicity|5|||
143243759|NCT00354432|516442948|FG003|Overall Study|Off/Toxicity|5|||
143243760|NCT00802945|516442949|FG000|Overall Study|Death|27|||
143243761|NCT00802945|516442950|FG001|Overall Study|Death|23|||
143046998|NCT00112437|515711359|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
143046999|NCT00112437|515711360|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
143243762|NCT00802945|516442949|FG000|Overall Study|Terminated by sponsor|8|||
143243763|NCT00802945|516442950|FG001|Overall Study|Terminated by sponsor|12|||
143243764|NCT03843541|516442951|FG000|Overall Study|Adverse Event|4|||
143243765|NCT03843541|516442952|FG001|Overall Study|Adverse Event|2|||
143243766|NCT03843541|516442953|FG002|Overall Study|Adverse Event|3|||
143243767|NCT03843541|516442951|FG000|Overall Study|Death|1|||
143243768|NCT03843541|516442952|FG001|Overall Study|Death|0|||
143243769|NCT03843541|516442953|FG002|Overall Study|Death|0|||
143243770|NCT03843541|516442951|FG000|Overall Study|Lack of adherence to study medication|0|||
143499159|NCT04426695|517368502|FG003|Overall Study|Sponsor Request|0|||
143047000|NCT00112437|515711361|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
143047001|NCT00112437|515711362|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
143047002|NCT00112437|515711363|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
143047003|NCT00112437|515711364|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
143047004|NCT00112437|515711365|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
143047005|NCT00112437|515711366|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
143243771|NCT03843541|516442952|FG001|Overall Study|Lack of adherence to study medication|0|||
143243772|NCT03843541|516442953|FG002|Overall Study|Lack of adherence to study medication|1|||
143243773|NCT03843541|516442951|FG000|Overall Study|Physician Decision|1|||
143243774|NCT03843541|516442952|FG001|Overall Study|Physician Decision|2|||
143243775|NCT03843541|516442953|FG002|Overall Study|Physician Decision|2|||
143243776|NCT03843541|516442951|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
143047006|NCT00112437|515711367|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
143047007|NCT00112437|515711368|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
143047008|NCT00112437|515711369|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
143047009|NCT00112437|515711370|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
143047010|NCT00112437|515711345|FG000|Year 2 (12-Month Extension)|Moved|0|||
143047011|NCT00112437|515711346|FG001|Year 2 (12-Month Extension)|Moved|0|||
143047012|NCT00112437|515711347|FG002|Year 2 (12-Month Extension)|Moved|0|||
143047013|NCT00112437|515711348|FG003|Year 2 (12-Month Extension)|Moved|0|||
143047014|NCT00112437|515711349|FG004|Year 2 (12-Month Extension)|Moved|0|||
143047015|NCT00112437|515711350|FG005|Year 2 (12-Month Extension)|Moved|0|||
143047016|NCT00112437|515711351|FG006|Year 2 (12-Month Extension)|Moved|0|||
143047017|NCT00112437|515711352|FG007|Year 2 (12-Month Extension)|Moved|0|||
143047018|NCT00112437|515711353|FG008|Year 2 (12-Month Extension)|Moved|0|||
143047019|NCT00112437|515711354|FG009|Year 2 (12-Month Extension)|Moved|1|||
143047020|NCT00112437|515711355|FG010|Year 2 (12-Month Extension)|Moved|0|||
143047021|NCT00112437|515711356|FG011|Year 2 (12-Month Extension)|Moved|0|||
143047022|NCT00112437|515711357|FG012|Year 2 (12-Month Extension)|Moved|0|||
143047023|NCT00112437|515711358|FG013|Year 2 (12-Month Extension)|Moved|0|||
143047024|NCT00112437|515711359|FG014|Year 2 (12-Month Extension)|Moved|0|||
143047025|NCT00112437|515711360|FG015|Year 2 (12-Month Extension)|Moved|0|||
143047026|NCT00112437|515711361|FG016|Year 2 (12-Month Extension)|Moved|0|||
143047027|NCT00112437|515711362|FG017|Year 2 (12-Month Extension)|Moved|0|||
143047028|NCT00112437|515711363|FG018|Year 2 (12-Month Extension)|Moved|0|||
143047029|NCT00112437|515711364|FG019|Year 2 (12-Month Extension)|Moved|0|||
143047030|NCT00112437|515711365|FG020|Year 2 (12-Month Extension)|Moved|0|||
143047031|NCT00112437|515711366|FG021|Year 2 (12-Month Extension)|Moved|0|||
143047032|NCT00112437|515711367|FG022|Year 2 (12-Month Extension)|Moved|0|||
143047033|NCT00112437|515711368|FG023|Year 2 (12-Month Extension)|Moved|0|||
143047034|NCT00112437|515711369|FG024|Year 2 (12-Month Extension)|Moved|0|||
143047035|NCT00112437|515711370|FG025|Year 2 (12-Month Extension)|Moved|0|||
143047036|NCT00112437|515711345|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
143047037|NCT00112437|515711346|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
143167942|NCT01362790|516161649|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
143167943|NCT02226653|516161651|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
143167944|NCT02226653|516161652|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
143167945|NCT02226653|516161651|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
143167946|NCT02226653|516161652|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
143167947|NCT00759395|516161653|FG000|Overall Study|Adverse Event|1|||
143167948|NCT00759395|516161654|FG001|Overall Study|Adverse Event|0|||
143167949|NCT00759395|516161653|FG000|Overall Study|Withdrawal by Subject|1|||
143167950|NCT00759395|516161654|FG001|Overall Study|Withdrawal by Subject|0|||
143167951|NCT00759395|516161653|FG000|Overall Study|Lack of Efficacy|0|||
143243777|NCT03843541|516442952|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
143243778|NCT03843541|516442953|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
143047038|NCT00112437|515711347|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
143047039|NCT00112437|515711348|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
143047040|NCT00112437|515711349|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
143047041|NCT00112437|515711350|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
143047042|NCT00112437|515711351|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
143047043|NCT00112437|515711352|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
143047044|NCT00112437|515711353|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
143047045|NCT00112437|515711354|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
143047046|NCT00112437|515711355|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
143047047|NCT00112437|515711356|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
143047048|NCT00112437|515711357|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
143047049|NCT00112437|515711358|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
143047050|NCT00112437|515711359|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
143167952|NCT00759395|516161654|FG001|Overall Study|Lack of Efficacy|2|||
143047051|NCT00112437|515711360|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
143047052|NCT00112437|515711361|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
143047053|NCT00112437|515711362|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
143167953|NCT01435356|516161659|FG000|Overall Study|Adverse Event|2|||
143167954|NCT01435356|516161660|FG001|Overall Study|Adverse Event|0|||
143047054|NCT00112437|515711363|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
143047055|NCT00112437|515711364|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
143047056|NCT00112437|515711365|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
143047057|NCT00112437|515711366|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
143047058|NCT00112437|515711367|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
143047059|NCT00112437|515711368|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
143047060|NCT00112437|515711369|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
143047061|NCT00112437|515711370|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
143047062|NCT00112437|515711345|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
143047063|NCT00112437|515711346|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
143047064|NCT00112437|515711347|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
143047065|NCT00112437|515711348|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
143047066|NCT00112437|515711349|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
143047067|NCT00112437|515711350|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
143047068|NCT00112437|515711351|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
143047069|NCT00112437|515711352|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
143047070|NCT00112437|515711353|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
143047071|NCT00112437|515711354|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
143047072|NCT00112437|515711355|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
143047073|NCT00112437|515711356|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
143047074|NCT00112437|515711357|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
143047075|NCT00112437|515711358|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
143047076|NCT00112437|515711359|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
143047077|NCT00112437|515711360|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
143047078|NCT00112437|515711361|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
143047079|NCT00112437|515711362|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
143047080|NCT00112437|515711363|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
143047081|NCT00112437|515711364|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
143047082|NCT00112437|515711365|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
143047083|NCT00112437|515711366|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
143047084|NCT00112437|515711367|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
143047085|NCT00112437|515711368|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
143047086|NCT00112437|515711369|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
143047087|NCT00112437|515711370|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
143047088|NCT00112437|515711345|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
143047089|NCT00112437|515711346|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
143047090|NCT00112437|515711347|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
143047091|NCT00112437|515711348|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
143047092|NCT00112437|515711349|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
143047093|NCT00112437|515711350|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
143047094|NCT00112437|515711351|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
143047095|NCT00112437|515711352|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
143047096|NCT00112437|515711353|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
143047097|NCT00112437|515711354|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
143047098|NCT00112437|515711355|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
143047099|NCT00112437|515711356|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
143047100|NCT00112437|515711357|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
143047101|NCT00112437|515711358|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
143047102|NCT00112437|515711359|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
143047103|NCT00112437|515711360|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
143047104|NCT00112437|515711361|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
143047105|NCT00112437|515711362|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
143047106|NCT00112437|515711363|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
143047107|NCT00112437|515711364|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
143047108|NCT00112437|515711365|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
143047109|NCT00112437|515711366|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
143047110|NCT00112437|515711367|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
143047111|NCT00112437|515711368|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
143047112|NCT00112437|515711369|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
143047113|NCT00112437|515711370|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
143047114|NCT00112437|515711345|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
143047115|NCT00112437|515711346|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
143047116|NCT00112437|515711347|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
143047117|NCT00112437|515711348|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
143047118|NCT00112437|515711349|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
143047119|NCT00112437|515711350|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
143047120|NCT00112437|515711351|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
143047121|NCT00112437|515711352|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
143047122|NCT00112437|515711353|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
143047123|NCT00112437|515711354|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
143499160|NCT04426695|517368503|FG004|Overall Study|Sponsor Request|0|||
143047124|NCT00112437|515711355|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
143047125|NCT00112437|515711356|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
143047126|NCT00112437|515711357|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
143047127|NCT00112437|515711358|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
143047128|NCT00112437|515711359|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
143047129|NCT00112437|515711360|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
143047130|NCT00112437|515711361|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
143047131|NCT00112437|515711362|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
143047132|NCT00112437|515711363|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
143047133|NCT00112437|515711364|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
143047134|NCT00112437|515711365|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
143047135|NCT00112437|515711366|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
143047136|NCT00112437|515711367|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
143047137|NCT00112437|515711368|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
143047138|NCT00112437|515711369|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
143047139|NCT00112437|515711370|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
143047140|NCT00112437|515711345|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
143047141|NCT00112437|515711346|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
143047142|NCT00112437|515711347|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
143047143|NCT00112437|515711348|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
143047144|NCT00112437|515711349|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
143047145|NCT00112437|515711350|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
143047146|NCT00112437|515711351|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
143047147|NCT00112437|515711352|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
143047148|NCT00112437|515711353|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
143047149|NCT00112437|515711354|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
143047150|NCT00112437|515711355|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
143047151|NCT00112437|515711356|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
143047152|NCT00112437|515711357|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
143047153|NCT00112437|515711358|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
143047154|NCT00112437|515711359|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
143047155|NCT00112437|515711360|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
143047156|NCT00112437|515711361|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
143047157|NCT00112437|515711362|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
143047158|NCT00112437|515711363|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
143047159|NCT00112437|515711364|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
143047160|NCT00112437|515711365|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
143047161|NCT00112437|515711366|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
143047162|NCT00112437|515711367|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
143047163|NCT00112437|515711368|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
143047164|NCT00112437|515711369|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
143047165|NCT00112437|515711370|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
143047166|NCT00112437|515711345|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
143047167|NCT00112437|515711346|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
143047168|NCT00112437|515711347|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
143047169|NCT00112437|515711348|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
143047170|NCT00112437|515711349|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
143047171|NCT00112437|515711350|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
143047172|NCT00112437|515711351|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
143047173|NCT00112437|515711352|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
143047174|NCT00112437|515711353|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
143047175|NCT00112437|515711354|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
143047176|NCT00112437|515711355|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
143047177|NCT00112437|515711356|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
143047178|NCT00112437|515711357|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
143047179|NCT00112437|515711358|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
143047180|NCT00112437|515711359|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
143047181|NCT00112437|515711360|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
143047182|NCT00112437|515711361|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
143047183|NCT00112437|515711362|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
143047184|NCT00112437|515711363|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
143047185|NCT00112437|515711364|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
143047186|NCT00112437|515711365|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
143047187|NCT00112437|515711366|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
143047188|NCT00112437|515711367|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
143047189|NCT00112437|515711368|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
143499161|NCT04426695|517368504|FG005|Overall Study|Sponsor Request|0|||
143047190|NCT00112437|515711369|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
143047191|NCT00112437|515711370|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
143047192|NCT00112437|515711345|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
143047193|NCT00112437|515711346|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
143047194|NCT00112437|515711347|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
143167955|NCT01435356|516161659|FG000|Overall Study|Disease progression/recurrence|17|||
143167956|NCT01435356|516161660|FG001|Overall Study|Disease progression/recurrence|10|||
143167957|NCT01435356|516161659|FG000|Overall Study|Protocol Violation|0|||
143167958|NCT01435356|516161660|FG001|Overall Study|Protocol Violation|1|||
143167959|NCT01435356|516161659|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
143167960|NCT01435356|516161660|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
143167961|NCT01435356|516161659|FG000|Overall Study|Withdrawal by Subject|1|||
143167962|NCT01435356|516161660|FG001|Overall Study|Withdrawal by Subject|1|||
143167963|NCT01435356|516161659|FG000|Overall Study|Facial palsy|1|||
143167964|NCT01435356|516161660|FG001|Overall Study|Facial palsy|0|||
143167965|NCT01435356|516161659|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
143167966|NCT01435356|516161660|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
143167967|NCT01435356|516161659|FG000|Overall Study|Physician Decision|1|||
143167968|NCT01435356|516161660|FG001|Overall Study|Physician Decision|0|||
143167969|NCT01435356|516161659|FG000|Overall Study|Patient decision|3|||
143167970|NCT01435356|516161660|FG001|Overall Study|Patient decision|0|||
143167971|NCT01435356|516161659|FG000|Overall Study|Patient moved to another city|1|||
143167972|NCT01435356|516161660|FG001|Overall Study|Patient moved to another city|1|||
143167973|NCT00437073|516161661|FG000|Overall Study|Sponsor Terminated Study|1|||
143167974|NCT00437073|516161662|FG001|Overall Study|Sponsor Terminated Study|0|||
143167975|NCT00437073|516161661|FG000|Overall Study|Physician Decision|0|||
143167976|NCT00437073|516161662|FG001|Overall Study|Physician Decision|1|||
143167977|NCT03485157|516161663|FG000|Double Blind Phase|Lost to Follow-up|4|||
143167978|NCT03485157|516161664|FG001|Double Blind Phase|Lost to Follow-up|4|||
143167979|NCT03485157|516161663|FG000|Double Blind Phase|Adverse Event|2|||
143167980|NCT03485157|516161664|FG001|Double Blind Phase|Adverse Event|1|||
143167981|NCT03485157|516161663|FG000|Double Blind Phase|Withdrawal by Subject|6|||
143167982|NCT03485157|516161664|FG001|Double Blind Phase|Withdrawal by Subject|9|||
143167983|NCT03485157|516161663|FG000|Double Blind Phase|Removal by PI|3|||
143167984|NCT03485157|516161664|FG001|Double Blind Phase|Removal by PI|7|||
143167985|NCT03485157|516161663|FG000|Open Label Phase|Lost to Follow-up|1|||
143167986|NCT03485157|516161664|FG001|Open Label Phase|Lost to Follow-up|2|||
143167987|NCT03485157|516161663|FG000|Open Label Phase|Adverse Event|0|||
143167988|NCT03485157|516161664|FG001|Open Label Phase|Adverse Event|1|||
143167989|NCT03485157|516161663|FG000|Open Label Phase|Withdrawal by Subject|1|||
143047195|NCT00112437|515711348|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
143047196|NCT00112437|515711349|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
143047197|NCT00112437|515711350|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
143047198|NCT00112437|515711351|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
143047199|NCT00112437|515711352|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
143047200|NCT00112437|515711353|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
143047201|NCT00112437|515711354|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
143047202|NCT00112437|515711355|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
143047203|NCT00112437|515711356|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
143047204|NCT00112437|515711357|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
143047205|NCT00112437|515711358|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
143047206|NCT00112437|515711359|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
143047207|NCT00112437|515711360|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
143047208|NCT00112437|515711361|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
143047209|NCT00112437|515711362|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
143047210|NCT00112437|515711363|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
143047211|NCT00112437|515711364|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
143047212|NCT00112437|515711365|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
143047213|NCT00112437|515711366|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
143047214|NCT00112437|515711367|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
143047215|NCT00112437|515711368|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
143047216|NCT00112437|515711369|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
143047217|NCT00112437|515711370|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
143047218|NCT00112437|515711345|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
143047219|NCT00112437|515711346|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
143047220|NCT00112437|515711347|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
143047221|NCT00112437|515711348|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
143047222|NCT00112437|515711349|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
143047223|NCT00112437|515711350|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
143047224|NCT00112437|515711351|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
143047225|NCT00112437|515711352|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
143047226|NCT00112437|515711353|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
143047227|NCT00112437|515711354|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
143047228|NCT00112437|515711355|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
143047229|NCT00112437|515711356|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
143047230|NCT00112437|515711357|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
143047231|NCT00112437|515711358|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
143047232|NCT00112437|515711359|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
143047233|NCT00112437|515711360|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
143047234|NCT00112437|515711361|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
143047235|NCT00112437|515711362|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
143047236|NCT00112437|515711363|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
143047237|NCT00112437|515711364|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
143047238|NCT00112437|515711365|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
143047239|NCT00112437|515711366|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
143047240|NCT00112437|515711367|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
143047241|NCT00112437|515711368|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
143047242|NCT00112437|515711369|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
143047243|NCT00112437|515711370|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
143047244|NCT00112437|515711345|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
143047245|NCT00112437|515711346|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
143047246|NCT00112437|515711347|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
143047247|NCT00112437|515711348|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
143047248|NCT00112437|515711349|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
143243779|NCT03843541|516442951|FG000|Overall Study|Withdrawal by Subject|6|||
143243780|NCT03843541|516442952|FG001|Overall Study|Withdrawal by Subject|9|||
143243781|NCT03843541|516442953|FG002|Overall Study|Withdrawal by Subject|7|||
143243782|NCT03843541|516442951|FG000|Overall Study|Administration of rescue mucolytic|0|||
143243783|NCT03843541|516442952|FG001|Overall Study|Administration of rescue mucolytic|0|||
143243784|NCT03843541|516442953|FG002|Overall Study|Administration of rescue mucolytic|1|||
143047249|NCT00112437|515711350|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
143047250|NCT00112437|515711351|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
143047251|NCT00112437|515711352|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
143047252|NCT00112437|515711353|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
143047253|NCT00112437|515711354|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
143047254|NCT00112437|515711355|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
143499162|NCT04426695|517368505|FG006|Overall Study|Sponsor Request|1|||
143047255|NCT00112437|515711356|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
143047256|NCT00112437|515711357|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
143047257|NCT00112437|515711358|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
143047258|NCT00112437|515711359|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
143047259|NCT00112437|515711360|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
143047260|NCT00112437|515711361|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
143047261|NCT00112437|515711362|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
143047262|NCT00112437|515711363|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
143047263|NCT00112437|515711364|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
143047264|NCT00112437|515711365|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
143047265|NCT00112437|515711366|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
143047266|NCT00112437|515711367|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
143047267|NCT00112437|515711368|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
143047268|NCT00112437|515711369|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
143047269|NCT00112437|515711370|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
143047270|NCT00112437|515711345|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
143047271|NCT00112437|515711346|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
143047272|NCT00112437|515711347|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
143047273|NCT00112437|515711348|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
143047274|NCT00112437|515711349|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
143047275|NCT00112437|515711350|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
143047276|NCT00112437|515711351|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
143047277|NCT00112437|515711352|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
143047278|NCT00112437|515711353|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
143047279|NCT00112437|515711354|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
143047280|NCT00112437|515711355|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
143047281|NCT00112437|515711356|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
143047282|NCT00112437|515711357|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
143047283|NCT00112437|515711358|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
143047284|NCT00112437|515711359|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
143047285|NCT00112437|515711360|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
143047286|NCT00112437|515711361|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
143047287|NCT00112437|515711362|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
143047288|NCT00112437|515711363|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
143047289|NCT00112437|515711364|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
143047290|NCT00112437|515711365|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
143047291|NCT00112437|515711366|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
143047292|NCT00112437|515711367|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
143047293|NCT00112437|515711368|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
143047294|NCT00112437|515711369|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
143047295|NCT00112437|515711370|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
143047296|NCT00112437|515711345|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
143047297|NCT00112437|515711346|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
143047298|NCT00112437|515711347|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
143047299|NCT00112437|515711348|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
143047300|NCT00112437|515711349|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
143047301|NCT00112437|515711350|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
143047302|NCT00112437|515711351|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
143047303|NCT00112437|515711352|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
143047304|NCT00112437|515711353|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
143047305|NCT00112437|515711354|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
143047306|NCT00112437|515711355|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
143047307|NCT00112437|515711356|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
143047308|NCT00112437|515711357|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
143047309|NCT00112437|515711358|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
143047310|NCT00112437|515711359|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
143047311|NCT00112437|515711360|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
143047312|NCT00112437|515711361|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
143047313|NCT00112437|515711362|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
143047314|NCT00112437|515711363|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
143047315|NCT00112437|515711364|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
143047316|NCT00112437|515711365|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
143047317|NCT00112437|515711366|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
143047318|NCT00112437|515711367|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
143047319|NCT00112437|515711368|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
143047320|NCT00112437|515711369|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
143047321|NCT00112437|515711370|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
143047322|NCT00112437|515711345|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
143047323|NCT00112437|515711346|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
143047324|NCT00112437|515711347|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
143047325|NCT00112437|515711348|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
143047326|NCT00112437|515711349|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
143047327|NCT00112437|515711350|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
143047328|NCT00112437|515711351|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
143047329|NCT00112437|515711352|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
143047330|NCT00112437|515711353|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
143243785|NCT03843541|516442951|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
143243786|NCT03843541|516442952|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
143243787|NCT03843541|516442953|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
143243788|NCT04163016|516442955|FG000|Enrollment|Adverse Event|1|||
143243789|NCT04163016|516442956|FG001|Enrollment|Adverse Event|0|||
143243790|NCT04163016|516442957|FG002|Enrollment|Adverse Event|0|||
143243791|NCT04163016|516442958|FG003|Enrollment|Adverse Event|0|||
143243792|NCT04163016|516442955|FG000|Treatment|Adverse Event|0|||
143243793|NCT04163016|516442956|FG001|Treatment|Adverse Event|1|||
143243794|NCT04163016|516442957|FG002|Treatment|Adverse Event|0|||
143243795|NCT04163016|516442958|FG003|Treatment|Adverse Event|0|||
143243796|NCT04163016|516442955|FG000|Treatment|Withdrawal by Subject|0|||
143243797|NCT04163016|516442956|FG001|Treatment|Withdrawal by Subject|2|||
143243798|NCT04163016|516442957|FG002|Treatment|Withdrawal by Subject|0|||
143243799|NCT04163016|516442958|FG003|Treatment|Withdrawal by Subject|0|||
143243800|NCT04163016|516442955|FG000|Treatment|Indeterminate TB-test|0|||
143047331|NCT00112437|515711354|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
143047332|NCT00112437|515711355|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
143047333|NCT00112437|515711356|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
143243801|NCT04163016|516442956|FG001|Treatment|Indeterminate TB-test|0|||
143243802|NCT04163016|516442957|FG002|Treatment|Indeterminate TB-test|0|||
143243803|NCT04163016|516442958|FG003|Treatment|Indeterminate TB-test|1|||
143243804|NCT04163016|516442955|FG000|Treatment|Participant did not want to continue in study|0|||
143243805|NCT04163016|516442956|FG001|Treatment|Participant did not want to continue in study|0|||
143243806|NCT04163016|516442957|FG002|Treatment|Participant did not want to continue in study|0|||
143243807|NCT04163016|516442958|FG003|Treatment|Participant did not want to continue in study|1|||
143243808|NCT02930018|516442959|FG000|Overall Study|Lost to Follow-up|1|||
143243809|NCT02930018|516442960|FG001|Overall Study|Lost to Follow-up|1|||
143243810|NCT02930018|516442959|FG000|Overall Study|Withdrawal by Subject|5|||
143243811|NCT02930018|516442960|FG001|Overall Study|Withdrawal by Subject|2|||
143243812|NCT03773796|516444727|FG000|Overall Study|Adverse Event|1|||
143243813|NCT03773796|516444727|FG000|Overall Study|Withdrawal by Subject|1|||
143243814|NCT03773796|516444727|FG000|Overall Study|Lack of Efficacy|1|||
143047334|NCT00112437|515711357|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
143047335|NCT00112437|515711358|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
143243815|NCT02604160|516444729|FG000|Overall Study|Protocol Violation|0|||
143243816|NCT02604160|516444730|FG001|Overall Study|Protocol Violation|1|||
143243817|NCT02604160|516444729|FG000|Overall Study|Physician Decision|0|||
143243818|NCT02604160|516444730|FG001|Overall Study|Physician Decision|1|||
143167990|NCT03485157|516161664|FG001|Open Label Phase|Withdrawal by Subject|2|||
143167991|NCT03485157|516161663|FG000|Open Label Phase|Removal by PI|2|||
143167992|NCT03485157|516161664|FG001|Open Label Phase|Removal by PI|0|||
143167993|NCT05205616|516161665|FG000|Overall Study|Lost to Follow-up|4|||
143167994|NCT05205616|516161666|FG001|Overall Study|Lost to Follow-up|4|||
143167995|NCT02657343|516161669|FG000|Overall Study|Death|0|||
143167996|NCT02657343|516161670|FG001|Overall Study|Death|2|||
143167997|NCT02657343|516161671|FG002|Overall Study|Death|0|||
143167998|NCT02657343|516161672|FG003|Overall Study|Death|0|||
143167999|NCT02657343|516161673|FG004|Overall Study|Death|0|||
143168000|NCT02657343|516161674|FG005|Overall Study|Death|0|||
143168001|NCT02657343|516161669|FG000|Overall Study|Patient went to hospice|1|||
143168002|NCT02657343|516161670|FG001|Overall Study|Patient went to hospice|0|||
143168003|NCT02657343|516161671|FG002|Overall Study|Patient went to hospice|0|||
143168004|NCT02657343|516161672|FG003|Overall Study|Patient went to hospice|0|||
143168005|NCT02657343|516161673|FG004|Overall Study|Patient went to hospice|0|||
143168006|NCT02657343|516161674|FG005|Overall Study|Patient went to hospice|0|||
143168007|NCT02657343|516161669|FG000|Overall Study|Withdrawal by Subject|0|||
143168008|NCT02657343|516161670|FG001|Overall Study|Withdrawal by Subject|0|||
143168009|NCT02657343|516161671|FG002|Overall Study|Withdrawal by Subject|0|||
143168010|NCT02657343|516161672|FG003|Overall Study|Withdrawal by Subject|0|||
143168011|NCT02657343|516161673|FG004|Overall Study|Withdrawal by Subject|1|||
143168012|NCT02657343|516161674|FG005|Overall Study|Withdrawal by Subject|0|||
143168013|NCT02011542|516161676|FG000|Overall Study|Physician Decision|1|||
143243819|NCT02255435|516444731|FG000|Overall Study|Patient's Limited Time Availability|0|||
143047336|NCT00112437|515711359|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
143047337|NCT00112437|515711360|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
143047338|NCT00112437|515711361|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
143047339|NCT00112437|515711362|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
143047340|NCT00112437|515711363|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
143047341|NCT00112437|515711364|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
143047342|NCT00112437|515711365|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
143047343|NCT00112437|515711366|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
143047344|NCT00112437|515711367|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
143047345|NCT00112437|515711368|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
143047346|NCT00112437|515711369|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
143047347|NCT00112437|515711370|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
143047348|NCT00112437|515711345|FG000|Years 6-10 (60-Month Extension)|Death|0|||
143047349|NCT00112437|515711346|FG001|Years 6-10 (60-Month Extension)|Death|0|||
143047350|NCT00112437|515711347|FG002|Years 6-10 (60-Month Extension)|Death|0|||
143047351|NCT00112437|515711348|FG003|Years 6-10 (60-Month Extension)|Death|0|||
143047352|NCT00112437|515711349|FG004|Years 6-10 (60-Month Extension)|Death|0|||
143047353|NCT00112437|515711350|FG005|Years 6-10 (60-Month Extension)|Death|0|||
143047354|NCT00112437|515711351|FG006|Years 6-10 (60-Month Extension)|Death|0|||
143047355|NCT00112437|515711352|FG007|Years 6-10 (60-Month Extension)|Death|0|||
143047356|NCT00112437|515711353|FG008|Years 6-10 (60-Month Extension)|Death|0|||
143047357|NCT00112437|515711354|FG009|Years 6-10 (60-Month Extension)|Death|0|||
143047358|NCT00112437|515711355|FG010|Years 6-10 (60-Month Extension)|Death|0|||
143047359|NCT00112437|515711356|FG011|Years 6-10 (60-Month Extension)|Death|0|||
143047360|NCT00112437|515711357|FG012|Years 6-10 (60-Month Extension)|Death|0|||
143047361|NCT00112437|515711358|FG013|Years 6-10 (60-Month Extension)|Death|0|||
143047362|NCT00112437|515711359|FG014|Years 6-10 (60-Month Extension)|Death|0|||
143047363|NCT00112437|515711360|FG015|Years 6-10 (60-Month Extension)|Death|0|||
143047364|NCT00112437|515711361|FG016|Years 6-10 (60-Month Extension)|Death|0|||
143243820|NCT02255435|516444732|FG001|Overall Study|Patient's Limited Time Availability|0|||
143243821|NCT02255435|516444733|FG002|Overall Study|Patient's Limited Time Availability|0|||
143243822|NCT02255435|516444734|FG003|Overall Study|Patient's Limited Time Availability|0|||
143243823|NCT02255435|516444735|FG004|Overall Study|Patient's Limited Time Availability|0|||
143243824|NCT02255435|516444736|FG005|Overall Study|Patient's Limited Time Availability|0|||
143243825|NCT02255435|516444737|FG006|Overall Study|Patient's Limited Time Availability|0|||
143047365|NCT00112437|515711362|FG017|Years 6-10 (60-Month Extension)|Death|0|||
143047366|NCT00112437|515711363|FG018|Years 6-10 (60-Month Extension)|Death|0|||
143047367|NCT00112437|515711364|FG019|Years 6-10 (60-Month Extension)|Death|0|||
143047368|NCT00112437|515711365|FG020|Years 6-10 (60-Month Extension)|Death|0|||
143047369|NCT00112437|515711366|FG021|Years 6-10 (60-Month Extension)|Death|0|||
143047370|NCT00112437|515711367|FG022|Years 6-10 (60-Month Extension)|Death|0|||
143047371|NCT00112437|515711368|FG023|Years 6-10 (60-Month Extension)|Death|2|||
143168014|NCT01299961|516161677|FG000|Overall Study|Adverse Event|3|||
143499163|NCT04426695|517368506|FG007|Overall Study|Sponsor Request|0|||
143047372|NCT00112437|515711369|FG024|Years 6-10 (60-Month Extension)|Death|0|||
143168015|NCT01299961|516161677|FG000|Overall Study|Lack of Efficacy|2|||
143168016|NCT01299961|516161677|FG000|Overall Study|Lost to Follow-up|1|||
143168017|NCT00663260|516161679|FG000|Overall Study|Lack of Efficacy|2|||
143168018|NCT00663260|516161680|FG001|Overall Study|Lack of Efficacy|0|||
143168019|NCT00663260|516161681|FG002|Overall Study|Lack of Efficacy|0|||
143168020|NCT00663260|516161679|FG000|Overall Study|Adverse Event|12|||
143047373|NCT00112437|515711370|FG025|Years 6-10 (60-Month Extension)|Death|0|||
143047374|NCT00112437|515711345|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
143047375|NCT00112437|515711346|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
143047376|NCT00112437|515711347|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
143047377|NCT00112437|515711348|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
143047378|NCT00112437|515711349|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
143047379|NCT00112437|515711350|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
143047380|NCT00112437|515711351|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
143047381|NCT00112437|515711352|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
143047382|NCT00112437|515711353|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
143047383|NCT00112437|515711354|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
143047384|NCT00112437|515711355|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
143047385|NCT00112437|515711356|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
143047386|NCT00112437|515711357|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
143047387|NCT00112437|515711358|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
143047388|NCT00112437|515711359|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
143047389|NCT00112437|515711360|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
143047390|NCT00112437|515711361|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
143047391|NCT00112437|515711362|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
143047392|NCT00112437|515711363|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
143047393|NCT00112437|515711364|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
143047394|NCT00112437|515711365|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
143047395|NCT00112437|515711366|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
143047396|NCT00112437|515711367|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
143047397|NCT00112437|515711368|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
143047398|NCT00112437|515711369|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
143047399|NCT00112437|515711370|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
143047400|NCT00112437|515711345|FG000|Years 6-10 (60-Month Extension)|Other|0|||
143047401|NCT00112437|515711346|FG001|Years 6-10 (60-Month Extension)|Other|0|||
143047402|NCT00112437|515711347|FG002|Years 6-10 (60-Month Extension)|Other|0|||
143047403|NCT00112437|515711348|FG003|Years 6-10 (60-Month Extension)|Other|0|||
143047404|NCT00112437|515711349|FG004|Years 6-10 (60-Month Extension)|Other|0|||
143047405|NCT00112437|515711350|FG005|Years 6-10 (60-Month Extension)|Other|0|||
143047406|NCT00112437|515711351|FG006|Years 6-10 (60-Month Extension)|Other|0|||
143168021|NCT00663260|516161680|FG001|Overall Study|Adverse Event|7|||
143168022|NCT00663260|516161681|FG002|Overall Study|Adverse Event|6|||
143168023|NCT00663260|516161679|FG000|Overall Study|Withdrawal by Subject|3|||
143168024|NCT00663260|516161680|FG001|Overall Study|Withdrawal by Subject|1|||
143168025|NCT00663260|516161681|FG002|Overall Study|Withdrawal by Subject|6|||
143168026|NCT00663260|516161679|FG000|Overall Study|Death|1|||
143168027|NCT00663260|516161680|FG001|Overall Study|Death|0|||
143168028|NCT00663260|516161681|FG002|Overall Study|Death|1|||
143047407|NCT00112437|515711352|FG007|Years 6-10 (60-Month Extension)|Other|0|||
143047408|NCT00112437|515711353|FG008|Years 6-10 (60-Month Extension)|Other|0|||
143047409|NCT00112437|515711354|FG009|Years 6-10 (60-Month Extension)|Other|0|||
143047410|NCT00112437|515711355|FG010|Years 6-10 (60-Month Extension)|Other|0|||
143047411|NCT00112437|515711356|FG011|Years 6-10 (60-Month Extension)|Other|0|||
143047412|NCT00112437|515711357|FG012|Years 6-10 (60-Month Extension)|Other|0|||
143168029|NCT00663260|516161679|FG000|Overall Study|Lost to Follow-up|0|||
143168030|NCT00663260|516161680|FG001|Overall Study|Lost to Follow-up|1|||
143168031|NCT00663260|516161681|FG002|Overall Study|Lost to Follow-up|0|||
143047413|NCT00112437|515711358|FG013|Years 6-10 (60-Month Extension)|Other|0|||
143047414|NCT00112437|515711359|FG014|Years 6-10 (60-Month Extension)|Other|0|||
143047415|NCT00112437|515711360|FG015|Years 6-10 (60-Month Extension)|Other|0|||
143047416|NCT00112437|515711361|FG016|Years 6-10 (60-Month Extension)|Other|0|||
143047417|NCT00112437|515711362|FG017|Years 6-10 (60-Month Extension)|Other|0|||
143047418|NCT00112437|515711363|FG018|Years 6-10 (60-Month Extension)|Other|0|||
143047419|NCT00112437|515711364|FG019|Years 6-10 (60-Month Extension)|Other|0|||
143047420|NCT00112437|515711365|FG020|Years 6-10 (60-Month Extension)|Other|0|||
143047421|NCT00112437|515711366|FG021|Years 6-10 (60-Month Extension)|Other|0|||
143047422|NCT00112437|515711367|FG022|Years 6-10 (60-Month Extension)|Other|0|||
143047423|NCT00112437|515711368|FG023|Years 6-10 (60-Month Extension)|Other|0|||
143047424|NCT00112437|515711369|FG024|Years 6-10 (60-Month Extension)|Other|1|||
143047425|NCT00112437|515711370|FG025|Years 6-10 (60-Month Extension)|Other|0|||
143047426|NCT00112437|515711345|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
143047427|NCT00112437|515711346|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
143047428|NCT00112437|515711347|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
143047429|NCT00112437|515711348|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
143047430|NCT00112437|515711349|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
143047431|NCT00112437|515711350|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
143047432|NCT00112437|515711351|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
143047433|NCT00112437|515711352|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
143047434|NCT00112437|515711353|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
143047435|NCT00112437|515711354|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
143047436|NCT00112437|515711355|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
143047437|NCT00112437|515711356|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
143047438|NCT00112437|515711357|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
143047439|NCT00112437|515711358|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
143047440|NCT00112437|515711359|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
143047441|NCT00112437|515711360|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
143047442|NCT00112437|515711361|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
143047443|NCT00112437|515711362|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
143047444|NCT00112437|515711363|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
143047445|NCT00112437|515711364|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
143047446|NCT00112437|515711365|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
143047447|NCT00112437|515711366|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
143047448|NCT00112437|515711367|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
143047449|NCT00112437|515711368|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
143168032|NCT00663260|516161679|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
143168033|NCT00663260|516161680|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
143168034|NCT00663260|516161681|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
143168035|NCT03620981|516161682|FG000|Overall Study|Adverse Event|14|||
143168036|NCT03620981|516161683|FG001|Overall Study|Adverse Event|38|||
143168037|NCT03620981|516161684|FG002|Overall Study|Adverse Event|25|||
143168038|NCT03620981|516161682|FG000|Overall Study|Lack of Efficacy|2|||
143168039|NCT03620981|516161683|FG001|Overall Study|Lack of Efficacy|1|||
143168040|NCT03620981|516161684|FG002|Overall Study|Lack of Efficacy|1|||
143168041|NCT03620981|516161682|FG000|Overall Study|Physician Decision|7|||
143168042|NCT03620981|516161683|FG001|Overall Study|Physician Decision|4|||
143168043|NCT03620981|516161684|FG002|Overall Study|Physician Decision|4|||
143047450|NCT00112437|515711369|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
143047451|NCT00112437|515711370|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
143047452|NCT00112437|515711345|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
143047453|NCT00112437|515711346|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
143047454|NCT00112437|515711347|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
143047455|NCT00112437|515711348|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
143047456|NCT00112437|515711349|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
143047457|NCT00112437|515711350|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
143047458|NCT00112437|515711351|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
143047459|NCT00112437|515711352|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
143047460|NCT00112437|515711353|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
143047461|NCT00112437|515711354|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
143047462|NCT00112437|515711355|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
143047463|NCT00112437|515711356|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
143499164|NCT04426695|517368507|FG008|Overall Study|Sponsor Request|0|||
143047464|NCT00112437|515711357|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
143047465|NCT00112437|515711358|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
143168044|NCT03620981|516161682|FG000|Overall Study|Protocol Violation|1|||
143168045|NCT03620981|516161683|FG001|Overall Study|Protocol Violation|2|||
143168046|NCT03620981|516161684|FG002|Overall Study|Protocol Violation|1|||
143168047|NCT03620981|516161682|FG000|Overall Study|Withdrawal by Legal Representative|2|||
143047466|NCT00112437|515711359|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
143047467|NCT00112437|515711360|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
143047468|NCT00112437|515711361|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
143047469|NCT00112437|515711362|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
143047470|NCT00112437|515711363|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
143047471|NCT00112437|515711364|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
143047472|NCT00112437|515711365|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
143047473|NCT00112437|515711366|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
143047474|NCT00112437|515711367|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
143047475|NCT00112437|515711368|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
143047476|NCT00112437|515711369|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
143047477|NCT00112437|515711370|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
143047478|NCT01120028|515711378|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
143047479|NCT01120028|515711379|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
143047480|NCT01120028|515711380|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
143047481|NCT01120028|515711381|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
143047482|NCT01120028|515711378|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
143047483|NCT01120028|515711379|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
143047484|NCT01120028|515711380|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
143047485|NCT01120028|515711381|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
143047486|NCT03250117|515711382|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
143047487|NCT03250117|515711383|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
143047488|NCT03250117|515711384|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
143047489|NCT03250117|515711385|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
143047490|NCT02011945|515711386|FG000|Overall Study|Participant requested to Discontinue|0|||
143047491|NCT02011945|515711387|FG001|Overall Study|Participant requested to Discontinue|1|||
143047492|NCT02011945|515711388|FG002|Overall Study|Participant requested to Discontinue|1|||
143047493|NCT02011945|515711386|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
143047494|NCT02011945|515711387|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
143047495|NCT02011945|515711388|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
143047496|NCT02011945|515711386|FG000|Overall Study|Study Drug Toxicity|0|||
143047497|NCT02011945|515711387|FG001|Overall Study|Study Drug Toxicity|0|||
143047498|NCT02011945|515711388|FG002|Overall Study|Study Drug Toxicity|1|||
143047499|NCT02011945|515711386|FG000|Overall Study|Treatment Failure|0|||
143047500|NCT02011945|515711387|FG001|Overall Study|Treatment Failure|7|||
143047501|NCT02011945|515711388|FG002|Overall Study|Treatment Failure|6|||
143047502|NCT02011945|515711386|FG000|Overall Study|No Longer Meets Study Criteria|1|||
143047503|NCT02011945|515711387|FG001|Overall Study|No Longer Meets Study Criteria|0|||
143047504|NCT02011945|515711388|FG002|Overall Study|No Longer Meets Study Criteria|0|||
143047505|NCT02011945|515711386|FG000|Overall Study|Proceeded to stem cell transplant|0|||
143047506|NCT02011945|515711387|FG001|Overall Study|Proceeded to stem cell transplant|0|||
143047507|NCT02011945|515711388|FG002|Overall Study|Proceeded to stem cell transplant|1|||
143047508|NCT02011945|515711386|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
143047509|NCT02011945|515711387|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
143047510|NCT02011945|515711388|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
143047511|NCT00902538|515711389|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
143243826|NCT02255435|516444738|FG007|Overall Study|Patient's Limited Time Availability|1|||
143243827|NCT02255435|516444739|FG008|Overall Study|Patient's Limited Time Availability|0|||
143243828|NCT02255435|516444740|FG009|Overall Study|Patient's Limited Time Availability|0|||
143243829|NCT02255435|516444731|FG000|Overall Study|Withdrawal by Subject|0|||
143047512|NCT00902538|515711390|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
143047513|NCT00902538|515711391|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
143047514|NCT00902538|515711392|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
143047515|NCT00902538|515711393|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
143047516|NCT00902538|515711394|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
143047517|NCT00902538|515711389|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
143047518|NCT00902538|515711390|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
143047519|NCT00902538|515711391|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
143047520|NCT00902538|515711392|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
143047521|NCT00902538|515711393|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
143047522|NCT00902538|515711394|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
143047523|NCT00902538|515711389|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
143243830|NCT02255435|516444732|FG001|Overall Study|Withdrawal by Subject|0|||
143243831|NCT02255435|516444733|FG002|Overall Study|Withdrawal by Subject|0|||
143243832|NCT02255435|516444734|FG003|Overall Study|Withdrawal by Subject|0|||
143243833|NCT02255435|516444735|FG004|Overall Study|Withdrawal by Subject|0|||
143243834|NCT02255435|516444736|FG005|Overall Study|Withdrawal by Subject|0|||
143047524|NCT00902538|515711390|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
143047525|NCT00902538|515711391|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
143047526|NCT00902538|515711392|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
143047527|NCT00902538|515711393|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
143047528|NCT00902538|515711394|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
143047529|NCT00902538|515711389|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
143047530|NCT00902538|515711390|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
143047531|NCT00902538|515711391|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
143047532|NCT00902538|515711392|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
143047533|NCT00902538|515711393|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
143047534|NCT00902538|515711394|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
143168048|NCT03620981|516161683|FG001|Overall Study|Withdrawal by Legal Representative|1|||
143168049|NCT03620981|516161684|FG002|Overall Study|Withdrawal by Legal Representative|1|||
143168050|NCT03620981|516161682|FG000|Overall Study|Withdrawal by Care Giver|2|||
143243835|NCT02255435|516444737|FG006|Overall Study|Withdrawal by Subject|0|||
143243836|NCT02255435|516444738|FG007|Overall Study|Withdrawal by Subject|0|||
143243837|NCT02255435|516444739|FG008|Overall Study|Withdrawal by Subject|1|||
143243838|NCT02255435|516444740|FG009|Overall Study|Withdrawal by Subject|4|||
143243839|NCT02255435|516444731|FG000|Overall Study|Administrative reasons|0|||
143243840|NCT02255435|516444732|FG001|Overall Study|Administrative reasons|0|||
143243841|NCT02255435|516444733|FG002|Overall Study|Administrative reasons|0|||
143243842|NCT02255435|516444734|FG003|Overall Study|Administrative reasons|0|||
143243843|NCT02255435|516444735|FG004|Overall Study|Administrative reasons|0|||
143243844|NCT02255435|516444736|FG005|Overall Study|Administrative reasons|0|||
143243845|NCT02255435|516444737|FG006|Overall Study|Administrative reasons|0|||
143243846|NCT02255435|516444738|FG007|Overall Study|Administrative reasons|0|||
143243847|NCT02255435|516444739|FG008|Overall Study|Administrative reasons|0|||
143243848|NCT02255435|516444740|FG009|Overall Study|Administrative reasons|2|||
143243849|NCT02687191|516444741|FG000|Overall Study|Death|0|||
143243850|NCT02687191|516444742|FG001|Overall Study|Death|1|||
143243851|NCT02687191|516444743|FG002|Overall Study|Death|1|||
143243852|NCT02687191|516444744|FG003|Overall Study|Death|0|||
143243853|NCT02687191|516444745|FG004|Overall Study|Death|1|||
143243854|NCT02687191|516444746|FG005|Overall Study|Death|1|||
143243855|NCT02687191|516444741|FG000|Overall Study|Withdrawal by Subject|0|||
143243856|NCT02687191|516444742|FG001|Overall Study|Withdrawal by Subject|0|||
143243857|NCT02687191|516444743|FG002|Overall Study|Withdrawal by Subject|0|||
143243858|NCT02687191|516444744|FG003|Overall Study|Withdrawal by Subject|1|||
143243859|NCT02687191|516444745|FG004|Overall Study|Withdrawal by Subject|0|||
143243860|NCT02687191|516444746|FG005|Overall Study|Withdrawal by Subject|0|||
143243861|NCT01788358|516444747|FG000|Overall Study|Other|11|||
143243862|NCT01788358|516444747|FG000|Overall Study|Logistical difficulties|1|||
143243863|NCT01788358|516444747|FG000|Overall Study|Lost to Follow-up|5|||
143243864|NCT01788358|516444747|FG000|Overall Study|Protocol Violation|3|||
143243865|NCT01788358|516444747|FG000|Overall Study|Withdrawal by Subject|26|||
143243866|NCT01788358|516444747|FG000|Overall Study|Lack of Efficacy|1|||
143243867|NCT01788358|516444747|FG000|Overall Study|Adverse Event|51|||
143243868|NCT00859456|516444749|FG000|Overall Study|Adverse Event|3|||
143243869|NCT00859456|516444749|FG000|Overall Study|Progressive disease|2|||
143243870|NCT00859456|516444749|FG000|Overall Study|Non-compliance|3|||
143243871|NCT02578706|516444754|FG000|Overall Study|Withdrawal by Subject|1|||
143243872|NCT02578706|516444755|FG001|Overall Study|Withdrawal by Subject|0|||
143243873|NCT02578706|516444756|FG002|Overall Study|Withdrawal by Subject|0|||
143243874|NCT02578706|516444754|FG000|Overall Study|Lost to Follow-up|0|||
143243875|NCT02578706|516444755|FG001|Overall Study|Lost to Follow-up|4|||
143243876|NCT02578706|516444756|FG002|Overall Study|Lost to Follow-up|0|||
143243877|NCT02578706|516444754|FG000|Overall Study|Physician Decision|0|||
143168051|NCT03620981|516161683|FG001|Overall Study|Withdrawal by Care Giver|0|||
143168052|NCT03620981|516161684|FG002|Overall Study|Withdrawal by Care Giver|1|||
143168053|NCT03620981|516161682|FG000|Overall Study|Non-compliance with Study Drug|1|||
143168054|NCT03620981|516161683|FG001|Overall Study|Non-compliance with Study Drug|1|||
143168055|NCT03620981|516161684|FG002|Overall Study|Non-compliance with Study Drug|0|||
143168056|NCT02607722|516161685|FG000|Overall Study|No data reliability|1|||
143168057|NCT02607722|516161685|FG000|Overall Study|no patient visit|18|||
143243878|NCT02578706|516444755|FG001|Overall Study|Physician Decision|1|||
143364309|NCT00723294|516876959|FG000|Overall Study|>25% intraductal component|1|||
143047535|NCT00902538|515711389|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
143047536|NCT00902538|515711390|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
143168058|NCT02607722|516161685|FG000|Overall Study|missing info in CRF|13|||
143168059|NCT02607722|516161685|FG000|Overall Study|Withdrawal by Subject|616|||
143243879|NCT02578706|516444756|FG002|Overall Study|Physician Decision|0|||
143243880|NCT05782179|516444763|FG000|Overall Study|Adverse Event|0|||
143243881|NCT05782179|516444764|FG001|Overall Study|Adverse Event|0|||
143243882|NCT05782179|516444765|FG002|Overall Study|Adverse Event|2|||
143243883|NCT05782179|516444766|FG003|Overall Study|Adverse Event|0|||
143047537|NCT00902538|515711391|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
143047538|NCT00902538|515711392|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
143047539|NCT00902538|515711393|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
143047540|NCT00902538|515711394|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
143047541|NCT00902538|515711389|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
143047542|NCT00902538|515711390|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
143047543|NCT00902538|515711391|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
143047544|NCT00902538|515711392|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
143047545|NCT00902538|515711393|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
143047546|NCT00902538|515711394|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
143047547|NCT00902538|515711389|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
143047548|NCT00902538|515711390|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
143047549|NCT00902538|515711391|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
143047550|NCT00902538|515711392|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
143047551|NCT00902538|515711393|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
143047552|NCT00902538|515711394|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
143047553|NCT00902538|515711389|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
143047554|NCT00902538|515711390|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
143047555|NCT00902538|515711391|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
143047556|NCT00902538|515711392|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
143047557|NCT00902538|515711393|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
143047558|NCT00902538|515711394|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
143047559|NCT00902538|515711389|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
143047560|NCT00902538|515711390|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
143047561|NCT00902538|515711391|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
143047562|NCT00902538|515711392|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
143047563|NCT00902538|515711393|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
143047564|NCT00902538|515711394|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
143047565|NCT00902538|515711389|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
143047566|NCT00902538|515711390|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
143047567|NCT00902538|515711391|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
143047568|NCT00902538|515711392|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
143047569|NCT00902538|515711393|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
143047570|NCT00902538|515711394|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
143047571|NCT00902538|515711389|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
143047572|NCT00902538|515711390|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
143047573|NCT00902538|515711391|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
143047574|NCT00902538|515711392|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
143047575|NCT00902538|515711393|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
143047576|NCT00902538|515711394|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
143047577|NCT00902538|515711389|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
143047578|NCT00902538|515711390|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
143047579|NCT00902538|515711391|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
143047580|NCT00902538|515711392|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
143047581|NCT00902538|515711393|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
143047582|NCT00902538|515711394|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
143047583|NCT00902538|515711389|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
143047584|NCT00902538|515711390|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
143047585|NCT00902538|515711391|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
143047586|NCT00902538|515711392|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
143047587|NCT00902538|515711393|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
143168060|NCT02607722|516161685|FG000|Overall Study|Lost to Follow-up|312|||
143168061|NCT02607722|516161685|FG000|Overall Study|Improved|22|||
143168062|NCT02607722|516161685|FG000|Overall Study|Lack of Efficacy|316|||
143168063|NCT02607722|516161685|FG000|Overall Study|Adverse Event|2553|||
143168064|NCT02607722|516161685|FG000|Overall Study|Not treated|1|||
143168065|NCT02607722|516161685|FG000|Overall Study|No CRF collected|138|||
143168066|NCT02607722|516161685|FG000|Overall Study|without CRF|4225|||
143168067|NCT02607722|516161685|FG000|Overall Study|Physician Decision|367|||
143168068|NCT02135133|516161686|FG000|Overall Study|Adverse Event|10|||
143168069|NCT02135133|516161686|FG000|Overall Study|regulatory mandate|5|||
143168070|NCT03238196|516161687|FG000|Overall Study|Adverse Event|3|||
143243884|NCT05782179|516444767|FG004|Overall Study|Adverse Event|0|||
143364310|NCT00723294|516876959|FG000|Overall Study|No MRI tumor enhancement|1|||
143168071|NCT03238196|516161688|FG001|Overall Study|Adverse Event|0|||
143168072|NCT03238196|516161689|FG002|Overall Study|Adverse Event|2|||
143168073|NCT03238196|516161690|FG003|Overall Study|Adverse Event|2|||
143168074|NCT03238196|516161687|FG000|Overall Study|Withdrawal by Subject|4|||
143168075|NCT03238196|516161688|FG001|Overall Study|Withdrawal by Subject|1|||
143047588|NCT00902538|515711394|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
143047589|NCT00902538|515711389|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
143047590|NCT00902538|515711390|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
143047591|NCT00902538|515711391|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
143047592|NCT00902538|515711392|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
143047593|NCT00902538|515711393|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
143047594|NCT00902538|515711394|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
143047595|NCT00902538|515711389|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
143047596|NCT00902538|515711390|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
143047597|NCT00902538|515711391|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
143047598|NCT00902538|515711392|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
143047599|NCT00902538|515711393|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
143047600|NCT00902538|515711394|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
143047601|NCT00902538|515711389|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
143047602|NCT00902538|515711390|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
143047603|NCT00902538|515711391|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
143047604|NCT00902538|515711392|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
143047605|NCT00902538|515711393|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
143047606|NCT00902538|515711394|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
143047607|NCT00902538|515711389|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
143047608|NCT00902538|515711390|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
143047609|NCT00902538|515711391|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
143047610|NCT00902538|515711392|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
143047611|NCT00902538|515711393|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
143047612|NCT00902538|515711394|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
143047613|NCT03531827|515711395|FG000|Overall Study|Adverse Event|2|||
143047614|NCT03531827|515711396|FG001|Overall Study|Adverse Event|0|||
143047615|NCT03531827|515711395|FG000|Overall Study|Progressive disease|1|||
143047616|NCT03531827|515711396|FG001|Overall Study|Progressive disease|0|||
143047617|NCT00849797|515711399|FG000|First Intervention|bad veins|1|||
143047618|NCT00849797|515711400|FG001|First Intervention|bad veins|0|||
143047619|NCT00849797|515711399|FG000|First Intervention|Adverse Event|0|||
143047620|NCT00849797|515711400|FG001|First Intervention|Adverse Event|1|||
143047621|NCT00849797|515711399|FG000|Washout: One Week|Withdrawal by Subject|0|||
143047622|NCT00849797|515711400|FG001|Washout: One Week|Withdrawal by Subject|2|||
143047623|NCT00679081|515711401|FG000|Overall Study|Lost to Follow-up|1|||
143047624|NCT00725322|515711402|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
143047625|NCT00725322|515711403|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
143047626|NCT00725322|515711402|FG000|Washout (28 Days)|Protocol Violation|0|||
143047627|NCT00725322|515711403|FG001|Washout (28 Days)|Protocol Violation|1|||
143047628|NCT04594252|515711405|FG000|Overall Study|Adverse Event|0|||
143047629|NCT04594252|515711406|FG001|Overall Study|Adverse Event|2|||
143047630|NCT02488109|515713572|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
143047631|NCT02488109|515713573|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
143047632|NCT02488109|515713572|FG000|12-month Follow-Up|Lost to Follow-up|4|||
143047633|NCT02488109|515713573|FG001|12-month Follow-Up|Lost to Follow-up|7|||
143243885|NCT05782179|516444768|FG005|Overall Study|Adverse Event|0|||
143243886|NCT03682770|516444774|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
143243887|NCT03682770|516444775|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
143243888|NCT03682770|516444776|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
143243889|NCT03682770|516444777|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
143243890|NCT03682770|516444778|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
143047634|NCT02302716|515713574|FG000|Overall Study|Adverse Event|1|||
143047635|NCT02302716|515713575|FG001|Overall Study|Adverse Event|1|||
143047636|NCT02302716|515713574|FG000|Overall Study|Death|0|||
143047637|NCT02302716|515713575|FG001|Overall Study|Death|1|||
143047638|NCT02302716|515713574|FG000|Overall Study|Lack of Efficacy|0|||
143047639|NCT02302716|515713575|FG001|Overall Study|Lack of Efficacy|1|||
143047640|NCT02302716|515713574|FG000|Overall Study|Lost to Follow-up|2|||
143047641|NCT02302716|515713575|FG001|Overall Study|Lost to Follow-up|4|||
143047642|NCT02302716|515713574|FG000|Overall Study|Physician Decision|3|||
143047643|NCT02302716|515713575|FG001|Overall Study|Physician Decision|4|||
143047644|NCT02302716|515713574|FG000|Overall Study|Withdrawal by Subject|13|||
143047645|NCT02302716|515713575|FG001|Overall Study|Withdrawal by Subject|7|||
143047646|NCT02302716|515713574|FG000|Overall Study|Protocol Violation|0|||
143047647|NCT02302716|515713575|FG001|Overall Study|Protocol Violation|1|||
143047648|NCT04102345|515713579|FG000|Overall Study|Withdrawal by Subject|1|||
143047649|NCT04102345|515713580|FG001|Overall Study|Withdrawal by Subject|0|||
143047650|NCT02727192|515713592|FG000|Overall Study|Lost to Follow-up|1|||
143047651|NCT02727192|515713593|FG001|Overall Study|Lost to Follow-up|0|||
143047652|NCT02727192|515713594|FG002|Overall Study|Lost to Follow-up|0|||
143243891|NCT03682770|516444779|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
143243892|NCT03682770|516444780|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
143243893|NCT03682770|516444774|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
143243894|NCT03682770|516444775|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
143243895|NCT03682770|516444776|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
143243896|NCT03682770|516444777|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
143243897|NCT03682770|516444778|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
143243898|NCT03682770|516444779|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
143243899|NCT03682770|516444780|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
143243900|NCT03682770|516444774|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
143243901|NCT03682770|516444775|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
143243902|NCT03682770|516444776|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
143243903|NCT03682770|516444777|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
143243904|NCT03682770|516444778|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
143243905|NCT03682770|516444779|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
143243906|NCT03682770|516444780|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
143243907|NCT03682770|516444774|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
143243908|NCT03682770|516444775|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
143243909|NCT03682770|516444776|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
143243910|NCT03682770|516444777|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
143243911|NCT03682770|516444778|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
143243912|NCT03682770|516444779|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
143243913|NCT03682770|516444780|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
143243914|NCT03682770|516444774|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
143243915|NCT03682770|516444775|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
143243916|NCT03682770|516444776|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
143243917|NCT03682770|516444777|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
143243918|NCT03682770|516444778|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
143243919|NCT03682770|516444779|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
143243920|NCT03682770|516444780|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
143243921|NCT03682770|516444774|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
143243922|NCT03682770|516444775|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
143243923|NCT03682770|516444776|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
143243924|NCT03682770|516444777|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
143243925|NCT03682770|516444778|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
143243926|NCT03682770|516444779|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
143243927|NCT03682770|516444780|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
143243928|NCT03682770|516444774|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
143243929|NCT03682770|516444775|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
143243930|NCT03682770|516444776|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
143243931|NCT03682770|516444777|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
143243932|NCT03682770|516444778|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
143243933|NCT03682770|516444779|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
143243934|NCT03682770|516444780|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
143243935|NCT03682770|516444774|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
143243936|NCT03682770|516444775|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
143243937|NCT03682770|516444776|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
143243938|NCT03682770|516444777|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
143243939|NCT03682770|516444778|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
143243940|NCT03682770|516444779|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
143243941|NCT03682770|516444780|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
143243942|NCT03682770|516444774|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
143243943|NCT03682770|516444775|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
143243944|NCT03682770|516444776|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
143243945|NCT03682770|516444777|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
143243946|NCT03682770|516444778|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
143243947|NCT03682770|516444779|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
143243948|NCT03682770|516444780|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
143243949|NCT03682770|516444774|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
143243950|NCT03682770|516444775|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
143243951|NCT03682770|516444776|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
143243952|NCT03682770|516444777|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
143243953|NCT03682770|516444778|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
143243954|NCT03682770|516444779|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
143243955|NCT03682770|516444780|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
143047653|NCT02392195|515713598|FG000|Overall Study|Lost to Follow-up|4|||
143047654|NCT02392195|515713598|FG000|Overall Study|Withdrawal by Subject|4|||
143047655|NCT00545792|515713601|FG000|Overall Study|Withdrawal by Subject|1|||
143047656|NCT03428750|515713602|FG000|Overall Study|Withdrawal by Subject|11|||
143047657|NCT03428750|515713603|FG001|Overall Study|Withdrawal by Subject|10|||
143047658|NCT03428750|515713602|FG000|Overall Study|Lost to Follow-up|3|||
143168076|NCT03238196|516161689|FG002|Overall Study|Withdrawal by Subject|1|||
143168077|NCT03238196|516161690|FG003|Overall Study|Withdrawal by Subject|0|||
143168078|NCT03238196|516161687|FG000|Overall Study|Disease progression|14|||
143168079|NCT03238196|516161688|FG001|Overall Study|Disease progression|2|||
143168080|NCT03238196|516161689|FG002|Overall Study|Disease progression|3|||
143168081|NCT03238196|516161690|FG003|Overall Study|Disease progression|2|||
143168082|NCT03238196|516161687|FG000|Overall Study|Still on treatment|1|||
143168083|NCT03238196|516161688|FG001|Overall Study|Still on treatment|0|||
143168084|NCT03238196|516161689|FG002|Overall Study|Still on treatment|0|||
143243956|NCT03682770|516444774|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
143047659|NCT03428750|515713603|FG001|Overall Study|Lost to Follow-up|9|||
143047660|NCT03428750|515713602|FG000|Overall Study|Adverse Event|9|||
143047661|NCT03428750|515713603|FG001|Overall Study|Adverse Event|1|||
143047662|NCT03428750|515713602|FG000|Overall Study|Protocol Violation|1|||
143047663|NCT03428750|515713603|FG001|Overall Study|Protocol Violation|0|||
143047664|NCT03428750|515713602|FG000|Overall Study|Administrative|0|||
143047665|NCT03428750|515713603|FG001|Overall Study|Administrative|1|||
143047666|NCT01919112|515713604|FG000|Secondary Analysis-day 30|Death|1|||
143047667|NCT01919112|515713605|FG001|Secondary Analysis-day 30|Death|1|||
143047668|NCT01919112|515713606|FG002|Secondary Analysis-day 30|Death|1|||
143047669|NCT01919112|515713604|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
143047670|NCT01919112|515713605|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
143047671|NCT01919112|515713606|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
143243957|NCT03682770|516444775|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
143243958|NCT03682770|516444776|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
143243959|NCT03682770|516444777|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
143243960|NCT03682770|516444778|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
143243961|NCT03682770|516444779|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
143243962|NCT03682770|516444780|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
143243963|NCT03682770|516444774|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
143243964|NCT03682770|516444775|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
143243965|NCT03682770|516444776|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
143243966|NCT03682770|516444777|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
143243967|NCT03682770|516444778|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
143243968|NCT03682770|516444779|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
143243969|NCT03682770|516444780|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
143243970|NCT01491607|516444781|FG000|Overall Study|Lost to Follow-up|7|||
143243971|NCT01491607|516444781|FG000|Overall Study|Withdrawal by Subject|3|||
143243972|NCT01317277|516444782|FG000|Overall Study|Lost to Follow-up|3|||
143243973|NCT01317277|516444783|FG001|Overall Study|Lost to Follow-up|1|||
143243974|NCT01317277|516444782|FG000|Overall Study|Lost MEMS|1|||
143243975|NCT01317277|516444783|FG001|Overall Study|Lost MEMS|1|||
143243976|NCT01317277|516444782|FG000|Overall Study|Unable to comply with intervention|1|||
143243977|NCT01317277|516444783|FG001|Overall Study|Unable to comply with intervention|0|||
143243978|NCT01317277|516444782|FG000|Overall Study|Withdrawal by Subject|1|||
143243979|NCT01317277|516444783|FG001|Overall Study|Withdrawal by Subject|0|||
143243980|NCT01317277|516444782|FG000|Overall Study|Adverse Event|1|||
143243981|NCT01317277|516444783|FG001|Overall Study|Adverse Event|0|||
143243982|NCT00774566|516444784|FG000|Overall Study|Protocol Violation|18|||
143243983|NCT00774566|516444785|FG001|Overall Study|Protocol Violation|15|||
143243984|NCT04896073|516444792|FG000|Overall Study|Screen failure|0|||
143243985|NCT04896073|516444793|FG001|Overall Study|Screen failure|2|||
143243986|NCT04896073|516444792|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
143243987|NCT04896073|516444793|FG001|Overall Study|Participant declined to participate (before treatment started)|2|||
143364311|NCT00723294|516876959|FG000|Overall Study|1.0-Tesla MRI|1|||
143047672|NCT04194801|515713609|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
143168085|NCT03238196|516161690|FG003|Overall Study|Still on treatment|0|||
143047673|NCT04194801|515713610|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
143168086|NCT05081843|516161691|FG000|Overall Study|Lost to Follow-up|135|||
143364312|NCT00723294|516876959|FG000|Overall Study|No cryoabalation|2|||
143047674|NCT04194801|515713611|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
143047675|NCT04194801|515713609|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
143047676|NCT04194801|515713610|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
143168087|NCT05081843|516161692|FG001|Overall Study|Lost to Follow-up|145|||
143168088|NCT02402647|516161693|FG000|Overall Study|Lost to Follow-up|13|||
143243988|NCT02999672|516444794|FG000|Overall Study|Death|0|||
143243989|NCT02999672|516444795|FG001|Overall Study|Death|1|||
143243990|NCT02999672|516444794|FG000|Overall Study|Study Terminated by Sponsor|0|||
143047677|NCT04194801|515713611|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
143047678|NCT04194801|515713609|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
143047679|NCT04194801|515713610|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
143047680|NCT04194801|515713611|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
143047681|NCT04194801|515713609|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
143047682|NCT04194801|515713610|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
143047683|NCT04194801|515713611|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
143047684|NCT04194801|515713609|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
143047685|NCT04194801|515713610|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
143047686|NCT04194801|515713611|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
143047687|NCT04194801|515713609|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
143047688|NCT04194801|515713610|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
143047689|NCT04194801|515713611|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
143047690|NCT04194801|515713609|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
143047691|NCT04194801|515713610|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
143047692|NCT04194801|515713611|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
143047693|NCT04194801|515713609|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
143047694|NCT04194801|515713610|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
143047695|NCT04194801|515713611|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
143047696|NCT04194801|515713609|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
143047697|NCT04194801|515713610|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
143047698|NCT04194801|515713611|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
143047699|NCT04194801|515713609|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
143047700|NCT04194801|515713610|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
143047701|NCT04194801|515713611|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
143047702|NCT04194801|515713609|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
143047703|NCT04194801|515713610|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
143047704|NCT04194801|515713611|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
143047705|NCT04194801|515713609|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
143047706|NCT04194801|515713610|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
143047707|NCT04194801|515713611|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
143047708|NCT04194801|515713609|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
143047709|NCT04194801|515713610|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
143047710|NCT04194801|515713611|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
143047711|NCT04194801|515713609|FG000|Part Ib/II End of Study|Death|2|||
143047712|NCT04194801|515713610|FG001|Part Ib/II End of Study|Death|3|||
143047713|NCT04194801|515713611|FG002|Part Ib/II End of Study|Death|3|||
143047714|NCT04194801|515713609|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
143047715|NCT04194801|515713610|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
143047716|NCT04194801|515713611|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
143047717|NCT04194801|515713609|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
143047718|NCT04194801|515713610|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
143047719|NCT04194801|515713611|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
143047720|NCT04194801|515713609|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
143047721|NCT04194801|515713610|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
143047722|NCT04194801|515713611|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
143047723|NCT04194801|515713609|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
143047724|NCT04194801|515713610|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
143047725|NCT04194801|515713611|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
143047726|NCT03827395|515713612|FG000|Overall Study|Lost to Follow-up|1|||
143047727|NCT03827395|515713613|FG001|Overall Study|Lost to Follow-up|0|||
143047728|NCT03827395|515713612|FG000|Overall Study|Protocol Violation|1|||
143047729|NCT03827395|515713613|FG001|Overall Study|Protocol Violation|0|||
143047730|NCT03827395|515713612|FG000|Overall Study|Became ineligible after enrollment|1|||
143047731|NCT03827395|515713613|FG001|Overall Study|Became ineligible after enrollment|2|||
143047732|NCT04723693|515713614|FG000|Overall Study|Withdrawal by Subject|2|||
143047733|NCT00294047|515713615|FG000|Month 48|Adverse Event|28|||
143047734|NCT00294047|515713616|FG001|Month 48|Adverse Event|13|||
143047735|NCT00294047|515713615|FG000|Month 48|Protocol Violation|4|||
143047736|NCT00294047|515713616|FG001|Month 48|Protocol Violation|4|||
143047737|NCT00294047|515713615|FG000|Month 48|Withdrawal by Subject|111|||
143047738|NCT00294047|515713616|FG001|Month 48|Withdrawal by Subject|115|||
143047739|NCT00294047|515713615|FG000|Month 48|Lost to Follow-up|272|||
143047740|NCT00294047|515713616|FG001|Month 48|Lost to Follow-up|287|||
143047741|NCT00294047|515713615|FG000|Month 48|Other|10|||
143047742|NCT00294047|515713616|FG001|Month 48|Other|14|||
143047743|NCT00294047|515713615|FG000|Month 84|Adverse Event|4|||
143047744|NCT00294047|515713616|FG001|Month 84|Adverse Event|2|||
143047745|NCT00294047|515713615|FG000|Month 84|Protocol Violation|1|||
143047746|NCT00294047|515713616|FG001|Month 84|Protocol Violation|1|||
143047747|NCT00294047|515713615|FG000|Month 84|Withdrawal by Subject|33|||
143047748|NCT00294047|515713616|FG001|Month 84|Withdrawal by Subject|31|||
143047749|NCT00294047|515713615|FG000|Month 84|Lost to Follow-up|187|||
143047750|NCT00294047|515713616|FG001|Month 84|Lost to Follow-up|190|||
143047751|NCT00294047|515713615|FG000|Month 84|Absent Cervix|2|||
143047752|NCT00294047|515713616|FG001|Month 84|Absent Cervix|0|||
143047753|NCT00294047|515713615|FG000|Month 84|Work related reasons|4|||
143047754|NCT00294047|515713616|FG001|Month 84|Work related reasons|2|||
143047755|NCT00294047|515713615|FG000|Month 84|Center closed, subject did not transfer|1|||
143047756|NCT00294047|515713616|FG001|Month 84|Center closed, subject did not transfer|0|||
143047757|NCT00294047|515713615|FG000|Month 84|Family problems|2|||
143047758|NCT00294047|515713616|FG001|Month 84|Family problems|2|||
143047759|NCT00294047|515713615|FG000|Month 84|Lack of time|3|||
143047760|NCT00294047|515713616|FG001|Month 84|Lack of time|1|||
143047761|NCT00294047|515713615|FG000|Month 84|Personal reason|2|||
143047762|NCT00294047|515713616|FG001|Month 84|Personal reason|4|||
143047763|NCT00294047|515713615|FG000|Month 84|Subject does not want male physician|1|||
143047764|NCT00294047|515713616|FG001|Month 84|Subject does not want male physician|0|||
143047765|NCT00294047|515713615|FG000|Month 84|Transport reimbursement delayed|0|||
143047766|NCT00294047|515713616|FG001|Month 84|Transport reimbursement delayed|1|||
143047767|NCT00294047|515713615|FG000|Month 84|Unable to reach study site|1|||
143047768|NCT00294047|515713616|FG001|Month 84|Unable to reach study site|0|||
143047769|NCT00294047|515713615|FG000|Month 84|Under investigation locally|1|||
143047770|NCT00294047|515713616|FG001|Month 84|Under investigation locally|0|||
143047771|NCT00294047|515713615|FG000|Month 84|Visit missed|0|||
143047772|NCT00294047|515713616|FG001|Month 84|Visit missed|1|||
143047773|NCT00294047|515713615|FG000|Month 84|No consent for Month 84 Follow-up|731|||
143047774|NCT00294047|515713616|FG001|Month 84|No consent for Month 84 Follow-up|754|||
143047775|NCT02157974|515713617|FG000|Overall Study|Withdrawal by Subject|0|||
143047776|NCT02157974|515713618|FG001|Overall Study|Withdrawal by Subject|1|||
143047777|NCT02157974|515713619|FG002|Overall Study|Withdrawal by Subject|0|||
143047778|NCT02157974|515713620|FG003|Overall Study|Withdrawal by Subject|0|||
143047779|NCT02157974|515713621|FG004|Overall Study|Withdrawal by Subject|0|||
143047780|NCT02157974|515713617|FG000|Overall Study|Screen Failure|0|||
143047781|NCT02157974|515713618|FG001|Overall Study|Screen Failure|1|||
143047782|NCT02157974|515713619|FG002|Overall Study|Screen Failure|0|||
143047783|NCT02157974|515713620|FG003|Overall Study|Screen Failure|0|||
143047784|NCT02157974|515713621|FG004|Overall Study|Screen Failure|0|||
143047785|NCT02157974|515713617|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
143047786|NCT02157974|515713618|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
143047787|NCT02157974|515713619|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
143047788|NCT02157974|515713620|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
143047789|NCT02157974|515713621|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
143047790|NCT00506831|515713624|FG000|Overall Study|Death|1|||
143047791|NCT00506831|515713624|FG000|Overall Study|Withdrawal by Subject|1|||
143047792|NCT01410227|515713628|FG000|Overall Study|Adverse Event|1|||
143047793|NCT01410227|515713629|FG001|Overall Study|Adverse Event|0|||
143047794|NCT01410227|515713630|FG002|Overall Study|Adverse Event|0|||
143047795|NCT01410227|515713631|FG003|Overall Study|Adverse Event|0|||
143047796|NCT01410227|515713628|FG000|Overall Study|Withdrawal by Subject|3|||
143047797|NCT01410227|515713629|FG001|Overall Study|Withdrawal by Subject|0|||
143047798|NCT01410227|515713630|FG002|Overall Study|Withdrawal by Subject|1|||
143047799|NCT01410227|515713631|FG003|Overall Study|Withdrawal by Subject|0|||
143047800|NCT01410227|515713628|FG000|Overall Study|Pregnancy|0|||
143047801|NCT01410227|515713629|FG001|Overall Study|Pregnancy|0|||
143047802|NCT01410227|515713630|FG002|Overall Study|Pregnancy|0|||
143047803|NCT01410227|515713631|FG003|Overall Study|Pregnancy|1|||
143047804|NCT01410227|515713628|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
143047805|NCT01410227|515713629|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
143047806|NCT01410227|515713630|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
143047807|NCT01410227|515713631|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
143047808|NCT00585286|515713633|FG000|Overall Study|Lost to Follow-up|1|||
143047809|NCT00608322|515713635|FG000|Overall Study|Death|2|||
143047810|NCT00608322|515713636|FG001|Overall Study|Death|1|||
143047811|NCT03497130|515713637|FG000|Overall Study|Lost to Follow-up|1|||
143047812|NCT03497130|515713638|FG001|Overall Study|Lost to Follow-up|1|||
143047813|NCT05752721|515713642|FG000|Overall Study|Lost to Follow-up|22|||
143047814|NCT05752721|515713643|FG001|Overall Study|Lost to Follow-up|20|||
143047815|NCT05752721|515713642|FG000|Overall Study|Withdrawal by Subject|15|||
143047816|NCT05752721|515713643|FG001|Overall Study|Withdrawal by Subject|12|||
143047817|NCT00216736|515713655|FG000|Overall Study|Lost to Follow-up|1|||
143047818|NCT00216736|515713656|FG001|Overall Study|Lost to Follow-up|1|||
143047819|NCT02622386|515713657|FG000|First Assignment|Withdrawal by Subject|3|||
143047820|NCT02622386|515713658|FG001|First Assignment|Withdrawal by Subject|2|||
143047821|NCT02622386|515713657|FG000|Washout|Withdrawal by Subject|4|||
143047822|NCT02622386|515713658|FG001|Washout|Withdrawal by Subject|4|||
143047823|NCT02622386|515713657|FG000|Second Assignment|Withdrawal by Subject|0|||
143243991|NCT02999672|516444795|FG001|Overall Study|Study Terminated by Sponsor|1|||
143243992|NCT02999672|516444794|FG000|Overall Study|Progressive Disease|9|||
143243993|NCT02999672|516444795|FG001|Overall Study|Progressive Disease|5|||
143243994|NCT02999672|516444794|FG000|Overall Study|Adverse Event|4|||
143243995|NCT02999672|516444795|FG001|Overall Study|Adverse Event|0|||
143243996|NCT03565497|516444796|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
143243997|NCT03565497|516444797|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
143243998|NCT03565497|516444798|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
143243999|NCT03565497|516444796|FG000|Overall Study|Lost to Follow-up|1|||
143244000|NCT03565497|516444797|FG001|Overall Study|Lost to Follow-up|1|||
143244001|NCT03565497|516444798|FG002|Overall Study|Lost to Follow-up|2|||
143244002|NCT03565497|516444796|FG000|Overall Study|Withdrawal by Subject|1|||
143244003|NCT03565497|516444797|FG001|Overall Study|Withdrawal by Subject|1|||
143244004|NCT03565497|516444798|FG002|Overall Study|Withdrawal by Subject|1|||
143244005|NCT01385176|516444799|FG000|Randomization Phase|Death|1|||
143244006|NCT01385176|516444800|FG001|Randomization Phase|Death|2|||
143244007|NCT01385176|516444799|FG000|6-18 Month All VNS Active|Death|1|||
143244008|NCT01385176|516444800|FG001|6-18 Month All VNS Active|Death|2|||
143244009|NCT01385176|516444799|FG000|6-18 Month All VNS Active|Physician Decision|0|||
143244010|NCT01385176|516444800|FG001|6-18 Month All VNS Active|Physician Decision|1|||
143244011|NCT01385176|516444799|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
143244012|NCT01385176|516444800|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
143244013|NCT01385176|516444799|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
143244014|NCT01385176|516444800|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
143244015|NCT01075685|516444801|FG000|Overall Study|Protocol Violation|9|||
143244016|NCT01075685|516444802|FG001|Overall Study|Protocol Violation|1|||
143244017|NCT01075685|516444801|FG000|Overall Study|Withdrawal by Subject|20|||
143244018|NCT01075685|516444802|FG001|Overall Study|Withdrawal by Subject|5|||
143244019|NCT01075685|516444801|FG000|Overall Study|Lost to Follow-up|563|||
143244020|NCT01075685|516444802|FG001|Overall Study|Lost to Follow-up|220|||
143244021|NCT02858362|516444805|FG000|Overall Study|Protocol Violation|0|||
143244022|NCT02858362|516444806|FG001|Overall Study|Protocol Violation|1|||
143244023|NCT02858362|516444807|FG002|Overall Study|Protocol Violation|0|||
143244024|NCT02858362|516444805|FG000|Overall Study|Withdrawal by Subject|1|||
143244025|NCT02858362|516444806|FG001|Overall Study|Withdrawal by Subject|0|||
143244026|NCT02858362|516444807|FG002|Overall Study|Withdrawal by Subject|0|||
143244027|NCT02858362|516444805|FG000|Overall Study|Early Study Termination|0|||
143244028|NCT02858362|516444806|FG001|Overall Study|Early Study Termination|0|||
143244029|NCT02858362|516444807|FG002|Overall Study|Early Study Termination|3|||
143244030|NCT02858362|516444805|FG000|Overall Study|Lost to Follow-up|1|||
143244031|NCT02858362|516444806|FG001|Overall Study|Lost to Follow-up|0|||
143244032|NCT02858362|516444807|FG002|Overall Study|Lost to Follow-up|0|||
143244033|NCT00392769|516444808|FG000|Overall Study|Clinical Deterioration|9|||
143244034|NCT00392769|516444808|FG000|Overall Study|Adverse Event|1|||
143244035|NCT02561832|516444809|FG000|Overall Study|Withdrawal by Subject|1|||
143244036|NCT02561832|516444810|FG001|Overall Study|Withdrawal by Subject|1|||
143244037|NCT02561832|516444809|FG000|Overall Study|Adverse Event|3|||
143244038|NCT02561832|516444810|FG001|Overall Study|Adverse Event|0|||
143244039|NCT02561832|516444809|FG000|Overall Study|Disease progression|3|||
143244040|NCT02561832|516444810|FG001|Overall Study|Disease progression|3|||
143244041|NCT02304367|516444814|FG000|Overall Study|Lack of Response to Bruosumab|1|||
143244042|NCT02304367|516444814|FG000|Overall Study|Sponsor Decision|3|||
143244043|NCT02304367|516444814|FG000|Overall Study|Death|2|||
143244044|NCT02304367|516444814|FG000|Overall Study|Physician Decision|1|||
143244045|NCT02304367|516444814|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
143244046|NCT03599089|516444815|FG000|Overall Study|Lost to Follow-up|1|||
143244047|NCT03599089|516444816|FG001|Overall Study|Lost to Follow-up|0|||
143244048|NCT03599089|516444817|FG002|Overall Study|Lost to Follow-up|0|||
143244049|NCT03599089|516444818|FG003|Overall Study|Lost to Follow-up|0|||
143244050|NCT03599089|516444815|FG000|Overall Study|Withdrawal by Subject|2|||
143244051|NCT03599089|516444816|FG001|Overall Study|Withdrawal by Subject|1|||
143244052|NCT03599089|516444817|FG002|Overall Study|Withdrawal by Subject|0|||
143244053|NCT03599089|516444818|FG003|Overall Study|Withdrawal by Subject|0|||
143244054|NCT03599089|516444815|FG000|Overall Study|Lack of Efficacy|0|||
143244055|NCT03599089|516444816|FG001|Overall Study|Lack of Efficacy|0|||
143244056|NCT03599089|516444817|FG002|Overall Study|Lack of Efficacy|1|||
143244057|NCT03599089|516444818|FG003|Overall Study|Lack of Efficacy|2|||
143244058|NCT02500797|516444819|FG000|Overall Study|Cancel (rapid disease progression)|0|||
143244059|NCT02500797|516444820|FG001|Overall Study|Cancel (rapid disease progression)|0|||
143244060|NCT02500797|516444821|FG002|Overall Study|Cancel (rapid disease progression)|0|||
143244061|NCT02500797|516444822|FG003|Overall Study|Cancel (rapid disease progression)|0|||
143244062|NCT02500797|516444823|FG004|Overall Study|Cancel (rapid disease progression)|1|||
143244063|NCT02500797|516444824|FG005|Overall Study|Cancel (rapid disease progression)|1|||
143244064|NCT02500797|516444825|FG006|Overall Study|Cancel (rapid disease progression)|0|||
143244065|NCT02500797|516444826|FG007|Overall Study|Cancel (rapid disease progression)|0|||
143244066|NCT02500797|516444819|FG000|Overall Study|Withdrawal by Subject|1|||
143047824|NCT02622386|515713658|FG001|Second Assignment|Withdrawal by Subject|2|||
143047825|NCT02890992|515713659|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
143047826|NCT02890992|515713660|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
143244067|NCT02500797|516444820|FG001|Overall Study|Withdrawal by Subject|0|||
143244068|NCT02500797|516444821|FG002|Overall Study|Withdrawal by Subject|0|||
143047827|NCT02890992|515713661|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
143244069|NCT02500797|516444822|FG003|Overall Study|Withdrawal by Subject|0|||
143047828|NCT02890992|515713662|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
143047829|NCT02890992|515713663|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
143047830|NCT02890992|515713664|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
143047831|NCT02890992|515713665|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
143047832|NCT02890992|515713666|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
143047833|NCT02890992|515713659|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
143047834|NCT02890992|515713660|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
143168089|NCT02402647|516161694|FG001|Overall Study|Lost to Follow-up|7|||
143168090|NCT02402647|516161693|FG000|Overall Study|Protocol Violation|1|||
143168091|NCT02402647|516161694|FG001|Overall Study|Protocol Violation|1|||
143168092|NCT02402647|516161693|FG000|Overall Study|scheduled and timed out|2|||
143168093|NCT02402647|516161694|FG001|Overall Study|scheduled and timed out|1|||
143168094|NCT02402647|516161693|FG000|Overall Study|medical illness|2|||
143168095|NCT02402647|516161694|FG001|Overall Study|medical illness|4|||
143168096|NCT02402647|516161693|FG000|Overall Study|Moved|2|||
143168097|NCT02402647|516161694|FG001|Overall Study|Moved|0|||
143168098|NCT02402647|516161693|FG000|Overall Study|loved one illness|1|||
143168099|NCT02402647|516161694|FG001|Overall Study|loved one illness|0|||
143168100|NCT02402647|516161693|FG000|Overall Study|deceased preexisting condition|2|||
143168101|NCT02402647|516161694|FG001|Overall Study|deceased preexisting condition|0|||
143168102|NCT02402647|516161693|FG000|Overall Study|Other|2|||
143168103|NCT02402647|516161694|FG001|Overall Study|Other|1|||
143168104|NCT01969058|516161696|FG000|Overall Study|Withdrawal by Subject|2|||
143168105|NCT01969058|516161697|FG001|Overall Study|Withdrawal by Subject|0|||
143168106|NCT01969058|516161696|FG000|Overall Study|Adverse Event|1|||
143168107|NCT01969058|516161697|FG001|Overall Study|Adverse Event|0|||
143168108|NCT02520154|516161698|FG000|Overall Study|Death|1|||
143168109|NCT02520154|516161698|FG000|Overall Study|Withdrawal by Subject|2|||
143168110|NCT02520154|516161698|FG000|Overall Study|Physician Decision|2|||
143168111|NCT04976777|516162992|FG000|Overall Study|COVID-19 Infection|1|||
143168112|NCT04976777|516162993|FG001|Overall Study|COVID-19 Infection|0|||
143168113|NCT00633126|516162996|FG000|Overall Study|Did not receive full dose|1|||
143168114|NCT02332928|516163008|FG000|Overall Study|Withdrawal by Subject|0|||
143168115|NCT02332928|516163009|FG001|Overall Study|Withdrawal by Subject|2|||
143168116|NCT02332928|516163008|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
143168117|NCT02332928|516163009|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
143168118|NCT04484857|516163016|FG000|Overall Study|Adverse Event|2|||
143168119|NCT04484857|516163016|FG000|Overall Study|Death|10|||
143168120|NCT04484857|516163016|FG000|Overall Study|Withdrawal by Subject|3|||
143168121|NCT04484857|516163016|FG000|Overall Study|Transferred/Relocation|5|||
143168122|NCT04484857|516163016|FG000|Overall Study|Kidney Transplant|7|||
143168123|NCT04484857|516163016|FG000|Overall Study|Other than specified|4|||
143168124|NCT04484857|516163016|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
143168125|NCT01425814|516163017|FG000|Period 1|Stability criteria not fulfilled|0|||
143168126|NCT01425814|516163018|FG001|Period 1|Stability criteria not fulfilled|1|||
143168127|NCT01425814|516163019|FG002|Period 1|Stability criteria not fulfilled|0|||
143168128|NCT01425814|516163020|FG003|Period 1|Stability criteria not fulfilled|0|||
143168129|NCT01425814|516163021|FG004|Period 1|Stability criteria not fulfilled|0|||
143168130|NCT01425814|516163022|FG005|Period 1|Stability criteria not fulfilled|0|||
143168131|NCT01425814|516163017|FG000|Period 2|Stability criteria not fulfilled|0|||
143168132|NCT01425814|516163018|FG001|Period 2|Stability criteria not fulfilled|1|||
143168133|NCT01425814|516163019|FG002|Period 2|Stability criteria not fulfilled|0|||
143168134|NCT01425814|516163020|FG003|Period 2|Stability criteria not fulfilled|0|||
143168135|NCT01425814|516163021|FG004|Period 2|Stability criteria not fulfilled|0|||
143168136|NCT01425814|516163022|FG005|Period 2|Stability criteria not fulfilled|0|||
143244070|NCT02500797|516444823|FG004|Overall Study|Withdrawal by Subject|0|||
143168137|NCT01425814|516163017|FG000|Period 3|Adverse Event|0|||
143168138|NCT01425814|516163018|FG001|Period 3|Adverse Event|0|||
143168139|NCT01425814|516163019|FG002|Period 3|Adverse Event|0|||
143168140|NCT01425814|516163020|FG003|Period 3|Adverse Event|0|||
143168141|NCT01425814|516163021|FG004|Period 3|Adverse Event|0|||
143168142|NCT01425814|516163022|FG005|Period 3|Adverse Event|1|||
143168143|NCT01425814|516163017|FG000|Period 4|Adverse Event|1|||
143168144|NCT01425814|516163018|FG001|Period 4|Adverse Event|0|||
143168145|NCT01425814|516163019|FG002|Period 4|Adverse Event|1|||
143168146|NCT01425814|516163020|FG003|Period 4|Adverse Event|0|||
143168147|NCT01425814|516163021|FG004|Period 4|Adverse Event|0|||
143168148|NCT01425814|516163022|FG005|Period 4|Adverse Event|0|||
143244071|NCT02500797|516444824|FG005|Overall Study|Withdrawal by Subject|0|||
143244072|NCT02500797|516444825|FG006|Overall Study|Withdrawal by Subject|0|||
143244073|NCT02500797|516444826|FG007|Overall Study|Withdrawal by Subject|0|||
143244074|NCT00060840|516444827|FG000|Overall Study|Change in surgical plan|2|||
143244075|NCT00060840|516444828|FG001|Overall Study|Change in surgical plan|6|||
143244076|NCT00060840|516444827|FG000|Overall Study|Death|0|||
143244077|NCT00060840|516444828|FG001|Overall Study|Death|1|||
143244078|NCT00060840|516444827|FG000|Overall Study|Withdrawal by Subject|0|||
143244079|NCT00060840|516444828|FG001|Overall Study|Withdrawal by Subject|1|||
143244080|NCT00060840|516444827|FG000|Overall Study|Subinvestigator unavailable|0|||
143244081|NCT00060840|516444828|FG001|Overall Study|Subinvestigator unavailable|1|||
143244082|NCT00060840|516444827|FG000|Overall Study|Physician Decision|1|||
143244083|NCT00060840|516444828|FG001|Overall Study|Physician Decision|0|||
143244084|NCT00060840|516444827|FG000|Overall Study|Other|1|||
143244085|NCT00060840|516444828|FG001|Overall Study|Other|0|||
143244086|NCT00357006|516444833|FG000|Overall Study|Lost to Follow-up|1|||
143244087|NCT00357006|516444834|FG001|Overall Study|Lost to Follow-up|2|||
143244088|NCT00357006|516444835|FG002|Overall Study|Lost to Follow-up|1|||
143244089|NCT00357006|516444833|FG000|Overall Study|Withdrawal by Subject|1|||
143244090|NCT00357006|516444834|FG001|Overall Study|Withdrawal by Subject|3|||
143047835|NCT02890992|515713661|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
143047836|NCT02890992|515713662|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
143047837|NCT02890992|515713663|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
143047838|NCT02890992|515713664|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
143047839|NCT02890992|515713665|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
143047840|NCT02890992|515713666|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
143047841|NCT02890992|515713659|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
143047842|NCT02890992|515713660|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
143047843|NCT02890992|515713661|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
143047844|NCT02890992|515713662|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
143047845|NCT02890992|515713663|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
143047846|NCT02890992|515713664|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
143047847|NCT02890992|515713665|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
143047848|NCT02890992|515713666|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
143047849|NCT03158727|515713667|FG000|Overall Study|Withdrawal by Subject|2|||
143047850|NCT03158727|515713668|FG001|Overall Study|Withdrawal by Subject|6|||
143047851|NCT03158727|515713667|FG000|Overall Study|Death|11|||
143047852|NCT03158727|515713668|FG001|Overall Study|Death|12|||
143047853|NCT03158727|515713667|FG000|Overall Study|Lost to Follow-up|1|||
143047854|NCT03158727|515713668|FG001|Overall Study|Lost to Follow-up|0|||
143047855|NCT03158727|515713667|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
143047856|NCT03158727|515713668|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
143244091|NCT00357006|516444835|FG002|Overall Study|Withdrawal by Subject|2|||
143244092|NCT03710161|516444836|FG000|Overall Study|Study halted due to COVID pandemic|3|||
143244093|NCT03710161|516444837|FG001|Overall Study|Study halted due to COVID pandemic|2|||
143244094|NCT01469377|516444839|FG000|Overall Study|Protocol Deviation|7|||
143244095|NCT01469377|516444840|FG001|Overall Study|Protocol Deviation|10|||
143244096|NCT01469377|516444841|FG002|Overall Study|Protocol Deviation|10|||
143244097|NCT01469377|516444839|FG000|Overall Study|Lost to Follow-up|3|||
143244098|NCT01469377|516444840|FG001|Overall Study|Lost to Follow-up|2|||
143244099|NCT01469377|516444841|FG002|Overall Study|Lost to Follow-up|5|||
143244100|NCT01469377|516444839|FG000|Overall Study|Withdrawal of Consent|12|||
143244101|NCT01469377|516444840|FG001|Overall Study|Withdrawal of Consent|14|||
143244102|NCT01469377|516444841|FG002|Overall Study|Withdrawal of Consent|15|||
143244103|NCT01469377|516444839|FG000|Overall Study|Adverse Event|8|||
143244104|NCT01469377|516444840|FG001|Overall Study|Adverse Event|18|||
143244105|NCT01469377|516444841|FG002|Overall Study|Adverse Event|36|||
143244106|NCT01469377|516444839|FG000|Overall Study|Insufficient Therapeutic Response|3|||
143244107|NCT01469377|516444840|FG001|Overall Study|Insufficient Therapeutic Response|4|||
143244108|NCT01469377|516444841|FG002|Overall Study|Insufficient Therapeutic Response|0|||
143244109|NCT01469377|516444839|FG000|Overall Study|Other Miscellaneous Reasons|2|||
143244110|NCT01469377|516444840|FG001|Overall Study|Other Miscellaneous Reasons|0|||
143244111|NCT01469377|516444841|FG002|Overall Study|Other Miscellaneous Reasons|0|||
143244112|NCT01354314|516444843|FG000|Overall Study|Lost to Follow-up|1|||
143244113|NCT01354314|516444844|FG001|Overall Study|Lost to Follow-up|0|||
143244114|NCT01354314|516444845|FG002|Overall Study|Lost to Follow-up|1|||
143244115|NCT01354314|516444846|FG003|Overall Study|Lost to Follow-up|1|||
143244116|NCT01354314|516444843|FG000|Overall Study|Withdrawal by Subject|0|||
143244117|NCT01354314|516444844|FG001|Overall Study|Withdrawal by Subject|0|||
143244118|NCT01354314|516444845|FG002|Overall Study|Withdrawal by Subject|1|||
143244119|NCT01354314|516444846|FG003|Overall Study|Withdrawal by Subject|0|||
143244120|NCT01354314|516444843|FG000|Overall Study|Adverse Event|0|||
143244121|NCT01354314|516444844|FG001|Overall Study|Adverse Event|0|||
143364313|NCT00723294|516876959|FG000|Overall Study|Did not undergo surgery|1|||
143499165|NCT04426695|517368508|FG009|Overall Study|Sponsor Request|0|||
143244122|NCT01354314|516444845|FG002|Overall Study|Adverse Event|0|||
143047857|NCT03158727|515713667|FG000|Overall Study|Visit 11 not done by mistake|0|||
143047858|NCT03158727|515713668|FG001|Overall Study|Visit 11 not done by mistake|1|||
143047859|NCT03158727|515713667|FG000|Overall Study|Enrolled, not treated|1|||
143047860|NCT03158727|515713668|FG001|Overall Study|Enrolled, not treated|0|||
143047861|NCT00669162|515713669|FG000|Overall Study|Withdrawal by Subject|1|||
143047862|NCT02412852|515713670|FG000|Overall Study|Withdrawal by Subject|0|||
143047863|NCT02412852|515713671|FG001|Overall Study|Withdrawal by Subject|1|||
143047864|NCT02412852|515713672|FG002|Overall Study|Withdrawal by Subject|0|||
143047865|NCT02412852|515713673|FG003|Overall Study|Withdrawal by Subject|0|||
143168149|NCT01425814|516163017|FG000|Period 5|Stability criteria not fulfilled|0|||
143168150|NCT01425814|516163018|FG001|Period 5|Stability criteria not fulfilled|0|||
143168151|NCT01425814|516163019|FG002|Period 5|Stability criteria not fulfilled|1|||
143168152|NCT01425814|516163020|FG003|Period 5|Stability criteria not fulfilled|0|||
143168153|NCT01425814|516163021|FG004|Period 5|Stability criteria not fulfilled|0|||
143168154|NCT01425814|516163022|FG005|Period 5|Stability criteria not fulfilled|1|||
143168155|NCT03243084|516163024|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
143168156|NCT03243084|516163025|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
143168157|NCT03322566|516163026|FG000|Overall Study|Death|34|||
143168158|NCT03322566|516163027|FG001|Overall Study|Death|35|||
143168159|NCT03322566|516163028|FG002|Overall Study|Death|23|||
143047866|NCT02412852|515713670|FG000|Overall Study|Physician Decision|0|||
143047867|NCT02412852|515713671|FG001|Overall Study|Physician Decision|0|||
143047868|NCT02412852|515713672|FG002|Overall Study|Physician Decision|0|||
143047869|NCT02412852|515713673|FG003|Overall Study|Physician Decision|1|||
143047870|NCT00985439|515713674|FG000|Overall Study|Adverse Event|0|||
143047871|NCT00985439|515713675|FG001|Overall Study|Adverse Event|0|||
143047872|NCT00985439|515713676|FG002|Overall Study|Adverse Event|1|||
143047873|NCT00985439|515713677|FG003|Overall Study|Adverse Event|0|||
143047874|NCT00418145|515713678|FG000|Overall Study|study terminated|6|||
143047875|NCT01906372|515713679|FG000|Overall Study|Withdrawal by Subject|2|||
143047876|NCT03629054|515713680|FG000|Period 2 (4 Days)|Not treated|0|||
143047877|NCT03629054|515713681|FG001|Period 2 (4 Days)|Not treated|1|||
143047878|NCT00847535|515713682|FG000|Overall Study|Withdrawal by Subject|2|||
143047879|NCT00847535|515713683|FG001|Overall Study|Withdrawal by Subject|1|||
143047880|NCT00847535|515713684|FG002|Overall Study|Withdrawal by Subject|1|||
143047881|NCT00847535|515713682|FG000|Overall Study|Lost to Follow-up|0|||
143047882|NCT00847535|515713683|FG001|Overall Study|Lost to Follow-up|1|||
143047883|NCT00847535|515713684|FG002|Overall Study|Lost to Follow-up|0|||
143047884|NCT01190865|515713709|FG000|Overall Study|Withdrawal by Subject|1|||
143047885|NCT01190865|515713709|FG000|Overall Study|Non-compliance|2|||
143047886|NCT03498560|515713711|FG000|Overall Study|Found Ineligible|2|||
143047887|NCT03498560|515713711|FG000|Overall Study|Withdrawal by Subject|14|||
143047888|NCT03498560|515713711|FG000|Overall Study|Lost to Follow-up|4|||
143047889|NCT03498560|515713711|FG000|Overall Study|Death|1|||
143047890|NCT01395017|515713714|FG000|Overall Study|Lost to Follow-up|1|||
143047891|NCT01395017|515713715|FG001|Overall Study|Lost to Follow-up|0|||
143047892|NCT01395017|515713714|FG000|Overall Study|Adverse Event|26|||
143047893|NCT01395017|515713715|FG001|Overall Study|Adverse Event|12|||
143047894|NCT01395017|515713714|FG000|Overall Study|Physician Decision|11|||
143047895|NCT01395017|515713715|FG001|Overall Study|Physician Decision|15|||
143047896|NCT01395017|515713714|FG000|Overall Study|Withdrawal by Subject|14|||
143047897|NCT01395017|515713715|FG001|Overall Study|Withdrawal by Subject|8|||
143047898|NCT01395017|515713714|FG000|Overall Study|Protocol deviation|1|||
143047899|NCT01395017|515713715|FG001|Overall Study|Protocol deviation|2|||
143047900|NCT01395017|515713714|FG000|Overall Study|Death|4|||
143047901|NCT01395017|515713715|FG001|Overall Study|Death|3|||
143047902|NCT01395017|515713714|FG000|Overall Study|Disease progression|42|||
143047903|NCT01395017|515713715|FG001|Overall Study|Disease progression|58|||
143047904|NCT01395017|515713714|FG000|Overall Study|Sponsor discontinued study|1|||
143047905|NCT01395017|515713715|FG001|Overall Study|Sponsor discontinued study|4|||
143047906|NCT03218787|515713721|FG000|Overall Study|Lost to Follow-up|12|||
143047907|NCT03218787|515713721|FG000|Overall Study|Withdrawal by Subject|72|||
143047908|NCT03218787|515713721|FG000|Overall Study|Physician Decision|11|||
143047909|NCT03218787|515713721|FG000|Overall Study|Death|111|||
143047910|NCT01229150|515713724|FG000|Overall Study|Toxicity|2|||
143047911|NCT01229150|515713725|FG001|Overall Study|Toxicity|2|||
143047912|NCT01229150|515713726|FG002|Overall Study|Toxicity|0|||
143047913|NCT01229150|515713727|FG003|Overall Study|Toxicity|0|||
143047914|NCT01494532|515713728|FG000|Overall Study|Adverse Event|4|||
143168160|NCT03322566|516163026|FG000|Overall Study|Physician Decision|6|||
143499166|NCT04426695|517368509|FG010|Overall Study|Sponsor Request|0|||
143244123|NCT01354314|516444846|FG003|Overall Study|Adverse Event|1|||
143047915|NCT01494532|515713729|FG001|Overall Study|Adverse Event|1|||
143047916|NCT01494532|515713730|FG002|Overall Study|Adverse Event|8|||
143168161|NCT03322566|516163027|FG001|Overall Study|Physician Decision|7|||
143244124|NCT01354314|516444843|FG000|Overall Study|Protocol Violation|1|||
143047917|NCT01494532|515713731|FG003|Overall Study|Adverse Event|6|||
143047918|NCT01494532|515713732|FG004|Overall Study|Adverse Event|5|||
143047919|NCT01494532|515713733|FG005|Overall Study|Adverse Event|0|||
143047920|NCT01494532|515713728|FG000|Overall Study|Lack of Efficacy|0|||
143047921|NCT01494532|515713729|FG001|Overall Study|Lack of Efficacy|0|||
143047922|NCT01494532|515713730|FG002|Overall Study|Lack of Efficacy|0|||
143047923|NCT01494532|515713731|FG003|Overall Study|Lack of Efficacy|0|||
143047924|NCT01494532|515713732|FG004|Overall Study|Lack of Efficacy|2|||
143047925|NCT01494532|515713733|FG005|Overall Study|Lack of Efficacy|0|||
143047926|NCT01494532|515713728|FG000|Overall Study|Protocol deviation|2|||
143047927|NCT01494532|515713729|FG001|Overall Study|Protocol deviation|1|||
143047928|NCT01494532|515713730|FG002|Overall Study|Protocol deviation|3|||
143047929|NCT01494532|515713731|FG003|Overall Study|Protocol deviation|2|||
143047930|NCT01494532|515713732|FG004|Overall Study|Protocol deviation|3|||
143047931|NCT01494532|515713733|FG005|Overall Study|Protocol deviation|0|||
143047932|NCT01494532|515713728|FG000|Overall Study|Protocol-defined stopping criteria|0|||
143047933|NCT01494532|515713729|FG001|Overall Study|Protocol-defined stopping criteria|0|||
143047934|NCT01494532|515713730|FG002|Overall Study|Protocol-defined stopping criteria|1|||
143047935|NCT01494532|515713731|FG003|Overall Study|Protocol-defined stopping criteria|0|||
143047936|NCT01494532|515713732|FG004|Overall Study|Protocol-defined stopping criteria|0|||
143047937|NCT01494532|515713733|FG005|Overall Study|Protocol-defined stopping criteria|0|||
143047938|NCT01494532|515713728|FG000|Overall Study|Lost to Follow-up|1|||
143047939|NCT01494532|515713729|FG001|Overall Study|Lost to Follow-up|0|||
143047940|NCT01494532|515713730|FG002|Overall Study|Lost to Follow-up|0|||
143047941|NCT01494532|515713731|FG003|Overall Study|Lost to Follow-up|2|||
143047942|NCT01494532|515713732|FG004|Overall Study|Lost to Follow-up|0|||
143047943|NCT01494532|515713733|FG005|Overall Study|Lost to Follow-up|0|||
143047944|NCT01494532|515713728|FG000|Overall Study|Physician Decision|0|||
143047945|NCT01494532|515713729|FG001|Overall Study|Physician Decision|1|||
143047946|NCT01494532|515713730|FG002|Overall Study|Physician Decision|1|||
143047947|NCT01494532|515713731|FG003|Overall Study|Physician Decision|2|||
143047948|NCT01494532|515713732|FG004|Overall Study|Physician Decision|0|||
143047949|NCT01494532|515713733|FG005|Overall Study|Physician Decision|0|||
143047950|NCT01494532|515713728|FG000|Overall Study|Withdrawal by Subject|3|||
143047951|NCT01494532|515713729|FG001|Overall Study|Withdrawal by Subject|1|||
143047952|NCT01494532|515713730|FG002|Overall Study|Withdrawal by Subject|4|||
143047953|NCT01494532|515713731|FG003|Overall Study|Withdrawal by Subject|3|||
143047954|NCT01494532|515713732|FG004|Overall Study|Withdrawal by Subject|2|||
143047955|NCT01494532|515713733|FG005|Overall Study|Withdrawal by Subject|0|||
143047956|NCT03506633|515715569|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
143047957|NCT03506633|515715570|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
143047958|NCT00640341|515715571|FG000|Overall Study|Adverse Event|0|||
143047959|NCT00640341|515715572|FG001|Overall Study|Adverse Event|0|||
143047960|NCT00640341|515715573|FG002|Overall Study|Adverse Event|1|||
143047961|NCT00640341|515715571|FG000|Overall Study|Positive Slit Lamp Findings|0|||
143047962|NCT00640341|515715572|FG001|Overall Study|Positive Slit Lamp Findings|0|||
143047963|NCT00640341|515715573|FG002|Overall Study|Positive Slit Lamp Findings|1|||
143047964|NCT00640341|515715571|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
143047965|NCT00640341|515715572|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
143047966|NCT00640341|515715573|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
143047967|NCT00640341|515715571|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
143047968|NCT00640341|515715572|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
143047969|NCT00640341|515715573|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
143047970|NCT00640341|515715571|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
143047971|NCT00640341|515715572|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
143047972|NCT00640341|515715573|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
143047973|NCT00640341|515715571|FG000|Overall Study|Lost to Follow-up|2|||
143047974|NCT00640341|515715572|FG001|Overall Study|Lost to Follow-up|0|||
143047975|NCT00640341|515715573|FG002|Overall Study|Lost to Follow-up|0|||
143047976|NCT00640341|515715571|FG000|Overall Study|Withdrawal by Subject|4|||
143047977|NCT00640341|515715572|FG001|Overall Study|Withdrawal by Subject|0|||
143047978|NCT00640341|515715573|FG002|Overall Study|Withdrawal by Subject|1|||
143047979|NCT00640341|515715571|FG000|Overall Study|Unacceptable Lens Movement|1|||
143047980|NCT00640341|515715572|FG001|Overall Study|Unacceptable Lens Movement|0|||
143047981|NCT00640341|515715573|FG002|Overall Study|Unacceptable Lens Movement|0|||
143047982|NCT00640341|515715571|FG000|Overall Study|Poor fit/Uncomfortable|4|||
143047983|NCT00640341|515715572|FG001|Overall Study|Poor fit/Uncomfortable|0|||
143047984|NCT00640341|515715573|FG002|Overall Study|Poor fit/Uncomfortable|0|||
143244125|NCT01354314|516444844|FG001|Overall Study|Protocol Violation|1|||
143047985|NCT00640341|515715571|FG000|Overall Study|Ineligable at Baseline|5|||
143047986|NCT00640341|515715572|FG001|Overall Study|Ineligable at Baseline|3|||
143244126|NCT01354314|516444845|FG002|Overall Study|Protocol Violation|0|||
143244127|NCT01354314|516444846|FG003|Overall Study|Protocol Violation|0|||
143047987|NCT00640341|515715573|FG002|Overall Study|Ineligable at Baseline|2|||
143047988|NCT00640341|515715571|FG000|Overall Study|Adverse event and positive slit lamp|1|||
143047989|NCT00640341|515715572|FG001|Overall Study|Adverse event and positive slit lamp|0|||
143047990|NCT00640341|515715573|FG002|Overall Study|Adverse event and positive slit lamp|0|||
143047991|NCT03247686|515715577|FG000|Overall Study|Withdrawal by Subject|1|||
143244128|NCT01354314|516444843|FG000|Overall Study|Less than 90% Adherence|4|||
143047992|NCT03247686|515715578|FG001|Overall Study|Withdrawal by Subject|2|||
143047993|NCT01109849|515715581|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
143047994|NCT01109849|515715582|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
143047995|NCT01109849|515715583|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
143047996|NCT01109849|515715584|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
143047997|NCT01109849|515715585|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
143047998|NCT01109849|515715581|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
143047999|NCT01109849|515715582|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
143048000|NCT01109849|515715583|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
143048001|NCT01109849|515715584|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
143048002|NCT01109849|515715585|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
143048003|NCT01109849|515715581|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
143168162|NCT03322566|516163028|FG002|Overall Study|Physician Decision|2|||
143168163|NCT03322566|516163026|FG000|Overall Study|Withdrawal by Subject|4|||
143168164|NCT03322566|516163027|FG001|Overall Study|Withdrawal by Subject|3|||
143168165|NCT03322566|516163028|FG002|Overall Study|Withdrawal by Subject|6|||
143168166|NCT03322566|516163026|FG000|Overall Study|Lost to Follow-up|0|||
143168167|NCT03322566|516163027|FG001|Overall Study|Lost to Follow-up|0|||
143168168|NCT03322566|516163028|FG002|Overall Study|Lost to Follow-up|1|||
143168169|NCT03322566|516163026|FG000|Overall Study|Study terminated by sponsor|1|||
143168170|NCT03322566|516163027|FG001|Overall Study|Study terminated by sponsor|0|||
143168171|NCT03322566|516163028|FG002|Overall Study|Study terminated by sponsor|1|||
143168172|NCT00478257|516163036|FG000|Overall Study|Withdrawal by Subject|8|||
143168173|NCT00478257|516163037|FG001|Overall Study|Withdrawal by Subject|3|||
143168174|NCT01182350|516163038|FG000|Overall Study|Adverse Event|5|||
143168175|NCT01182350|516163039|FG001|Overall Study|Adverse Event|0|||
143168176|NCT01182350|516163040|FG002|Overall Study|Adverse Event|0|||
143168177|NCT01182350|516163041|FG003|Overall Study|Adverse Event|0|||
143168178|NCT01182350|516163042|FG004|Overall Study|Adverse Event|0|||
143168179|NCT01182350|516163038|FG000|Overall Study|Disease Progression|15|||
143168180|NCT01182350|516163039|FG001|Overall Study|Disease Progression|12|||
143168181|NCT01182350|516163040|FG002|Overall Study|Disease Progression|0|||
143168182|NCT01182350|516163041|FG003|Overall Study|Disease Progression|1|||
143168183|NCT01182350|516163042|FG004|Overall Study|Disease Progression|0|||
143168184|NCT01182350|516163038|FG000|Overall Study|Death|0|||
143168185|NCT01182350|516163039|FG001|Overall Study|Death|1|||
143168186|NCT01182350|516163040|FG002|Overall Study|Death|1|||
143168187|NCT01182350|516163041|FG003|Overall Study|Death|0|||
143168188|NCT01182350|516163042|FG004|Overall Study|Death|0|||
143168189|NCT01182350|516163038|FG000|Overall Study|Withdrawal by Subject|3|||
143168190|NCT01182350|516163039|FG001|Overall Study|Withdrawal by Subject|1|||
143168191|NCT01182350|516163040|FG002|Overall Study|Withdrawal by Subject|0|||
143168192|NCT01182350|516163041|FG003|Overall Study|Withdrawal by Subject|1|||
143168193|NCT01182350|516163042|FG004|Overall Study|Withdrawal by Subject|0|||
143168194|NCT01182350|516163038|FG000|Overall Study|Alternative Therapy|2|||
143168195|NCT01182350|516163039|FG001|Overall Study|Alternative Therapy|0|||
143168196|NCT01182350|516163040|FG002|Overall Study|Alternative Therapy|1|||
143168197|NCT01182350|516163041|FG003|Overall Study|Alternative Therapy|0|||
143168198|NCT01182350|516163042|FG004|Overall Study|Alternative Therapy|0|||
143168199|NCT01182350|516163038|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
143168200|NCT01182350|516163039|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
143168201|NCT01182350|516163040|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
143168202|NCT01182350|516163041|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
143168203|NCT01182350|516163042|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
143168204|NCT01182350|516163038|FG000|Overall Study|Unevaluable for Biopsy|0|||
143168205|NCT01182350|516163039|FG001|Overall Study|Unevaluable for Biopsy|0|||
143168206|NCT01182350|516163040|FG002|Overall Study|Unevaluable for Biopsy|0|||
143168207|NCT01182350|516163041|FG003|Overall Study|Unevaluable for Biopsy|0|||
143168208|NCT01182350|516163042|FG004|Overall Study|Unevaluable for Biopsy|3|||
143168209|NCT03605693|516163045|FG000|Overall Study|Lost to Follow-up|4|||
143168210|NCT03605693|516163046|FG001|Overall Study|Lost to Follow-up|0|||
143168211|NCT03605693|516163045|FG000|Overall Study|Physician Decision|1|||
143168212|NCT03605693|516163046|FG001|Overall Study|Physician Decision|0|||
143168213|NCT03093415|516163047|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
143168214|NCT03093415|516163048|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
143168215|NCT03093415|516163049|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
143168216|NCT03093415|516163047|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
143168217|NCT03093415|516163048|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
143168218|NCT03093415|516163049|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
143168219|NCT03093415|516163047|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
143168220|NCT03093415|516163048|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
143048004|NCT01109849|515715582|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
143048005|NCT01109849|515715583|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
143048006|NCT01109849|515715584|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
143048007|NCT01109849|515715585|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
143048008|NCT01109849|515715581|FG000|Initial Randomization: ADHD Treatment|move away|2|||
143048009|NCT01109849|515715582|FG001|Initial Randomization: ADHD Treatment|move away|7|||
143048010|NCT01109849|515715583|FG002|Initial Randomization: ADHD Treatment|move away|0|||
143048011|NCT01109849|515715584|FG003|Initial Randomization: ADHD Treatment|move away|0|||
143048012|NCT01109849|515715585|FG004|Initial Randomization: ADHD Treatment|move away|0|||
143048013|NCT01109849|515715581|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
143048014|NCT01109849|515715582|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
143048015|NCT01109849|515715583|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
143048016|NCT01109849|515715584|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
143048017|NCT01109849|515715585|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
143048018|NCT01109849|515715581|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
143048019|NCT01109849|515715582|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
143048020|NCT01109849|515715583|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
143048021|NCT01109849|515715584|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
143048022|NCT01109849|515715585|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
143048023|NCT01541215|515715593|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
143048024|NCT01541215|515715594|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
143048025|NCT01541215|515715593|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
143048026|NCT01541215|515715594|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
143048027|NCT01541215|515715593|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
143048028|NCT01541215|515715594|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
143048029|NCT01541215|515715593|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
143048030|NCT01541215|515715594|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
143048031|NCT01541215|515715593|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
143048032|NCT01541215|515715594|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
143048033|NCT01541215|515715593|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
143048034|NCT01541215|515715594|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
143048035|NCT00557245|515715598|FG000|Overall Study|Lost to Follow-up|7|||
143048036|NCT00557245|515715599|FG001|Overall Study|Lost to Follow-up|8|||
143048037|NCT00557245|515715600|FG002|Overall Study|Lost to Follow-up|10|||
143048038|NCT00557245|515715598|FG000|Overall Study|Ineligible|5|||
143048039|NCT00557245|515715599|FG001|Overall Study|Ineligible|4|||
143048040|NCT00557245|515715600|FG002|Overall Study|Ineligible|2|||
143048041|NCT02316223|515715604|FG000|Overall Study|Lack of Efficacy|0|||
143048042|NCT02316223|515715605|FG001|Overall Study|Lack of Efficacy|1|||
143048043|NCT02316223|515715606|FG002|Overall Study|Lack of Efficacy|1|||
143048044|NCT02316223|515715604|FG000|Overall Study|Lost to Follow-up|27|||
143048045|NCT02316223|515715605|FG001|Overall Study|Lost to Follow-up|34|||
143048046|NCT02316223|515715606|FG002|Overall Study|Lost to Follow-up|36|||
143048047|NCT02316223|515715604|FG000|Overall Study|COPD Diagnosis|3|||
143048048|NCT02316223|515715605|FG001|Overall Study|COPD Diagnosis|2|||
143048049|NCT02316223|515715606|FG002|Overall Study|COPD Diagnosis|3|||
143048050|NCT02316223|515715604|FG000|Overall Study|Reside outside study area|1|||
143048051|NCT02316223|515715605|FG001|Overall Study|Reside outside study area|1|||
143048052|NCT02316223|515715606|FG002|Overall Study|Reside outside study area|1|||
143048053|NCT02316223|515715604|FG000|Overall Study|No asthma|2|||
143048054|NCT02316223|515715605|FG001|Overall Study|No asthma|0|||
143048055|NCT02316223|515715606|FG002|Overall Study|No asthma|0|||
143048056|NCT02316223|515715604|FG000|Overall Study|Discontinued by PI|11|||
143048057|NCT02316223|515715605|FG001|Overall Study|Discontinued by PI|19|||
143048058|NCT02316223|515715606|FG002|Overall Study|Discontinued by PI|3|||
143048059|NCT00521586|515715608|FG000|Initial Vaccination (Year 0)|Subject request|8|||
143048060|NCT00521586|515715609|FG001|Initial Vaccination (Year 0)|Subject request|11|||
143048061|NCT00521586|515715608|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
143048062|NCT00521586|515715609|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
143048063|NCT00521586|515715608|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
143048064|NCT00521586|515715609|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
143048065|NCT00521586|515715608|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
143048066|NCT00521586|515715609|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
143048067|NCT00521586|515715608|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
143048068|NCT00521586|515715609|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
143048069|NCT00521586|515715608|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
143048070|NCT00521586|515715609|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
143048071|NCT00521586|515715608|FG000|Initial Vaccination (Year 0)|Death|1|||
143048072|NCT00521586|515715609|FG001|Initial Vaccination (Year 0)|Death|0|||
143048073|NCT00521586|515715608|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
143048074|NCT00521586|515715609|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
143048075|NCT00521586|515715608|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
143499167|NCT04426695|517368510|FG011|Overall Study|Sponsor Request|0|||
143244129|NCT01354314|516444844|FG001|Overall Study|Less than 90% Adherence|2|||
143244130|NCT01354314|516444845|FG002|Overall Study|Less than 90% Adherence|6|||
143244131|NCT01354314|516444846|FG003|Overall Study|Less than 90% Adherence|4|||
143048076|NCT00521586|515715609|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
143048077|NCT00521586|515715608|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
143048078|NCT00521586|515715609|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
143048079|NCT00521586|515715608|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
143048080|NCT00521586|515715609|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
143048081|NCT00521586|515715608|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
143048082|NCT00521586|515715609|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
143048083|NCT00521586|515715608|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
143048084|NCT00521586|515715609|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
143048085|NCT00521586|515715608|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
143048086|NCT00521586|515715609|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
143048087|NCT00521586|515715608|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
143048088|NCT00521586|515715609|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
143048089|NCT00521586|515715608|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
143048090|NCT00521586|515715609|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
143048091|NCT00521586|515715608|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
143048092|NCT00521586|515715609|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
143048093|NCT00521586|515715608|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
143048094|NCT00521586|515715609|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
143048095|NCT00521586|515715608|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
143048096|NCT00521586|515715609|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
143048097|NCT00828321|515715610|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
143048098|NCT00828321|515715611|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
143048099|NCT00828321|515715610|FG000|Second Intervention|Protocol Violation|0|||
143048100|NCT00828321|515715611|FG001|Second Intervention|Protocol Violation|1|||
143048101|NCT02997176|515715612|FG000|Overall Study|Adverse Event|0|||
143168221|NCT03093415|516163049|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
143168222|NCT03093415|516163047|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
143168223|NCT03093415|516163048|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
143244132|NCT00714870|516444847|FG000|Overall Study|Lost to Follow-up|22|||
143244133|NCT00714870|516444848|FG001|Overall Study|Lost to Follow-up|5|||
143244134|NCT00714870|516444847|FG000|Overall Study|patient unable to come b/c back pain|1|||
143244135|NCT00714870|516444848|FG001|Overall Study|patient unable to come b/c back pain|0|||
143244136|NCT00714870|516444847|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
143244137|NCT00714870|516444848|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
143244138|NCT03399552|516444849|FG000|Overall Study|No evidence of disease|1|||
143244139|NCT03399552|516444849|FG000|Overall Study|Unevaluable|1|||
143244140|NCT02357368|516444850|FG000|Overall Study|Lost to Follow-up|0|||
143244141|NCT02357368|516444851|FG001|Overall Study|Lost to Follow-up|0|||
143244142|NCT02357368|516444852|FG002|Overall Study|Lost to Follow-up|0|||
143244143|NCT02357368|516444853|FG003|Overall Study|Lost to Follow-up|1|||
143244144|NCT02357368|516444850|FG000|Overall Study|Pregnancy|3|||
143244145|NCT02357368|516444851|FG001|Overall Study|Pregnancy|2|||
143244146|NCT02357368|516444852|FG002|Overall Study|Pregnancy|0|||
143244147|NCT02357368|516444853|FG003|Overall Study|Pregnancy|0|||
143244148|NCT02357368|516444850|FG000|Overall Study|Withdrawal by Subject|3|||
143244149|NCT02357368|516444851|FG001|Overall Study|Withdrawal by Subject|1|||
143244150|NCT02357368|516444852|FG002|Overall Study|Withdrawal by Subject|1|||
143244151|NCT02357368|516444853|FG003|Overall Study|Withdrawal by Subject|2|||
143244152|NCT04672655|516444869|FG000|Overall Study|Lost to Follow-up|12|||
143244153|NCT04672655|516444870|FG001|Overall Study|Lost to Follow-up|17|||
143244154|NCT04672655|516444869|FG000|Overall Study|Withdrawal by Subject|1|||
143244155|NCT04672655|516444870|FG001|Overall Study|Withdrawal by Subject|0|||
143244156|NCT04672655|516444869|FG000|Overall Study|Withdrawal by Study|1|||
143168224|NCT03093415|516163049|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
143168225|NCT03093415|516163047|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
143168226|NCT03093415|516163048|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
143168227|NCT03093415|516163049|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
143168228|NCT03093415|516163047|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
143168229|NCT03093415|516163048|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
143168230|NCT03093415|516163049|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
143168231|NCT03093415|516163047|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
143244157|NCT04672655|516444870|FG001|Overall Study|Withdrawal by Study|0|||
143244158|NCT03892967|516444876|FG000|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1283|||
143259576|NCT02241889|516505783|FG002|Overall Study|Withdrawal by Subject|0|||
143259577|NCT02241889|516505784|FG003|Overall Study|Withdrawal by Subject|0|||
143244159|NCT03892967|516444877|FG001|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1728|||
143244160|NCT03892967|516444878|FG002|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1823|||
143244161|NCT03892967|516444879|FG003|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1443|||
143499168|NCT04426695|517368511|FG012|Overall Study|Sponsor Request|0|||
143499169|NCT04426695|517368512|FG013|Overall Study|Sponsor Request|0|||
143048102|NCT02997176|515715613|FG001|Overall Study|Adverse Event|0|||
143048103|NCT02997176|515715614|FG002|Overall Study|Adverse Event|0|||
143048104|NCT02997176|515715615|FG003|Overall Study|Adverse Event|8|||
143048105|NCT02997176|515715612|FG000|Overall Study|Progressive Disease|1|||
143048106|NCT02997176|515715613|FG001|Overall Study|Progressive Disease|0|||
143048107|NCT02997176|515715614|FG002|Overall Study|Progressive Disease|1|||
143048108|NCT02997176|515715615|FG003|Overall Study|Progressive Disease|1|||
143048109|NCT02997176|515715612|FG000|Overall Study|Death|0|||
143048110|NCT02997176|515715613|FG001|Overall Study|Death|0|||
143048111|NCT02997176|515715614|FG002|Overall Study|Death|1|||
143048112|NCT02997176|515715615|FG003|Overall Study|Death|1|||
143048113|NCT02997176|515715612|FG000|Overall Study|Withdrawal by Subject|0|||
143048114|NCT02997176|515715613|FG001|Overall Study|Withdrawal by Subject|2|||
143048115|NCT02997176|515715614|FG002|Overall Study|Withdrawal by Subject|0|||
143048116|NCT02997176|515715615|FG003|Overall Study|Withdrawal by Subject|1|||
143048117|NCT00385736|515715620|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
143048118|NCT00385736|515715621|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
143048119|NCT00385736|515715622|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
143048120|NCT00385736|515715620|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
143048121|NCT00385736|515715621|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
143048122|NCT00385736|515715622|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
143048123|NCT00385736|515715620|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
143048124|NCT00385736|515715621|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
143048125|NCT00385736|515715622|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
143048126|NCT00385736|515715620|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
143048127|NCT00385736|515715621|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
143048128|NCT00385736|515715622|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
143048129|NCT00385736|515715620|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
143048130|NCT00385736|515715621|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
143048131|NCT00385736|515715622|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
143048132|NCT00385736|515715620|FG000|Efficacy Analysis Set - Induction|Other|0|||
143048133|NCT00385736|515715621|FG001|Efficacy Analysis Set - Induction|Other|0|||
143048134|NCT00385736|515715622|FG002|Efficacy Analysis Set - Induction|Other|1|||
143048135|NCT00385736|515715620|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
143048136|NCT00385736|515715621|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
143048137|NCT00385736|515715622|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
143048138|NCT00385736|515715620|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
143048139|NCT00385736|515715621|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
143048140|NCT00385736|515715622|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
143048141|NCT00385736|515715620|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
143048142|NCT00385736|515715621|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
143048143|NCT00385736|515715622|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
143048144|NCT00385736|515715620|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
143048145|NCT00385736|515715621|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
143048146|NCT00385736|515715622|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
143048147|NCT00385736|515715620|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
143048148|NCT00385736|515715621|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
143048149|NCT00385736|515715622|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
143048150|NCT00385736|515715620|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
143048151|NCT00385736|515715621|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
143048152|NCT00385736|515715622|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
143048153|NCT00385736|515715620|FG000|Safety Analysis Set|Adverse Event|23|||
143048154|NCT00385736|515715621|FG001|Safety Analysis Set|Adverse Event|15|||
143048155|NCT00385736|515715622|FG002|Safety Analysis Set|Adverse Event|23|||
143048156|NCT00385736|515715620|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
143048157|NCT00385736|515715621|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
143259578|NCT02241889|516505785|FG004|Overall Study|Withdrawal by Subject|0|||
143048158|NCT00385736|515715622|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
143048159|NCT00385736|515715620|FG000|Safety Analysis Set|Lost to Follow-up|0|||
143048160|NCT00385736|515715621|FG001|Safety Analysis Set|Lost to Follow-up|2|||
143048161|NCT00385736|515715622|FG002|Safety Analysis Set|Lost to Follow-up|2|||
143048162|NCT00385736|515715620|FG000|Safety Analysis Set|Lack of Efficacy|38|||
143048163|NCT00385736|515715621|FG001|Safety Analysis Set|Lack of Efficacy|16|||
143048164|NCT00385736|515715622|FG002|Safety Analysis Set|Lack of Efficacy|31|||
143048165|NCT00385736|515715620|FG000|Safety Analysis Set|Protocol Violation|2|||
143048166|NCT00385736|515715621|FG001|Safety Analysis Set|Protocol Violation|1|||
143048167|NCT00385736|515715622|FG002|Safety Analysis Set|Protocol Violation|6|||
143048168|NCT00385736|515715620|FG000|Safety Analysis Set|Other|1|||
143048169|NCT00385736|515715621|FG001|Safety Analysis Set|Other|4|||
143048170|NCT00385736|515715622|FG002|Safety Analysis Set|Other|4|||
143048171|NCT05497557|515715623|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
143048172|NCT05497557|515715624|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
143048173|NCT05497557|515715625|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
143168232|NCT03093415|516163048|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
143168233|NCT03093415|516163049|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
143168234|NCT03093415|516163047|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
143168235|NCT03093415|516163048|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
143168236|NCT03093415|516163049|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
143168237|NCT03093415|516163047|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
143168238|NCT03093415|516163048|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
143168239|NCT03093415|516163049|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
143168240|NCT03093415|516163047|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
143168241|NCT03093415|516163048|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
143168242|NCT03093415|516163049|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
143168243|NCT03093415|516163047|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
143168244|NCT03093415|516163048|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
143168245|NCT03093415|516163049|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
143168246|NCT03559530|516163050|FG000|Overall Study|non-location of medical records|44|||
143168247|NCT03559530|516163051|FG001|Overall Study|non-location of medical records|0|||
143168248|NCT03559530|516163050|FG000|Overall Study|culture results not considered for treat|29|||
143168249|NCT03559530|516163051|FG001|Overall Study|culture results not considered for treat|0|||
143168250|NCT03559530|516163050|FG000|Overall Study|duplicate cases|8|||
143168251|NCT03559530|516163051|FG001|Overall Study|duplicate cases|0|||
143168252|NCT03559530|516163050|FG000|Overall Study|other species of Acinetobacte|7|||
143168253|NCT03559530|516163051|FG001|Overall Study|other species of Acinetobacte|0|||
143168254|NCT03559530|516163050|FG000|Overall Study|contamination / colonization|3|||
143168255|NCT03559530|516163051|FG001|Overall Study|contamination / colonization|0|||
143168256|NCT01646827|516163052|FG000|Overall Study|Lost to Follow-up|0|||
143168257|NCT01646827|516163053|FG001|Overall Study|Lost to Follow-up|3|||
143168258|NCT01646827|516163052|FG000|Overall Study|Physician Decision|1|||
143168259|NCT01646827|516163053|FG001|Overall Study|Physician Decision|2|||
143168260|NCT01646827|516163052|FG000|Overall Study|Withdrawal by Subject|1|||
143168261|NCT01646827|516163053|FG001|Overall Study|Withdrawal by Subject|0|||
143168262|NCT03038087|516163058|FG000|Overall Study|lost data|1|||
143168263|NCT01605097|516163059|FG000|Overall Study|Protocol Violation|1|||
143168264|NCT03078868|516163060|FG000|Overall Study|Physician Decision|3|||
143168265|NCT00635050|516163063|FG000|Overall Study|Withdrawal by Subject|1|||
143168266|NCT03038620|516163064|FG000|Overall Study|Lost to Follow-up|18|||
143168267|NCT03038620|516163065|FG001|Overall Study|Lost to Follow-up|23|||
143168268|NCT03038620|516163064|FG000|Overall Study|Withdrawal by Subject|0|||
143168269|NCT03038620|516163065|FG001|Overall Study|Withdrawal by Subject|15|||
143168270|NCT03038620|516163064|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
143168271|NCT03038620|516163065|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
143168272|NCT00086515|516163066|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
143168273|NCT00086515|516163067|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
143168274|NCT00086515|516163066|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
143168275|NCT00086515|516163067|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
143168276|NCT00086515|516163066|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
143168277|NCT00086515|516163067|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
143168278|NCT00086515|516163066|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
143168279|NCT00086515|516163067|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
143168280|NCT00086515|516163066|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
143168281|NCT00086515|516163067|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
143168282|NCT00086515|516163066|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
143168283|NCT00086515|516163067|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
143168284|NCT00086515|516163066|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
143168285|NCT00086515|516163067|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
143168286|NCT00086515|516163066|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
143168287|NCT00086515|516163067|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
143168288|NCT00086515|516163066|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
143499170|NCT04426695|517368513|FG014|Overall Study|Sponsor Request|0|||
143499171|NCT04426695|517368514|FG015|Overall Study|Sponsor Request|0|||
143499172|NCT04426695|517368515|FG016|Overall Study|Sponsor Request|0|||
143499173|NCT04426695|517368516|FG017|Overall Study|Sponsor Request|0|||
143048174|NCT01380782|515715628|FG000|Overall Study|Adverse Event|0|||
143048175|NCT01380782|515715629|FG001|Overall Study|Adverse Event|1|||
143048176|NCT01380782|515715630|FG002|Overall Study|Adverse Event|0|||
143048177|NCT01380782|515715631|FG003|Overall Study|Adverse Event|0|||
143048178|NCT01380782|515715628|FG000|Overall Study|Death|1|||
143048179|NCT01380782|515715629|FG001|Overall Study|Death|0|||
143048180|NCT01380782|515715630|FG002|Overall Study|Death|0|||
143048181|NCT01380782|515715631|FG003|Overall Study|Death|0|||
143048182|NCT01380782|515715628|FG000|Overall Study|Lack of Efficacy|10|||
143048183|NCT01380782|515715629|FG001|Overall Study|Lack of Efficacy|9|||
143048184|NCT01380782|515715630|FG002|Overall Study|Lack of Efficacy|10|||
143048185|NCT01380782|515715631|FG003|Overall Study|Lack of Efficacy|3|||
143048186|NCT01380782|515715628|FG000|Overall Study|Physician Decision|1|||
143048187|NCT01380782|515715629|FG001|Overall Study|Physician Decision|0|||
143048188|NCT01380782|515715630|FG002|Overall Study|Physician Decision|0|||
143048189|NCT01380782|515715631|FG003|Overall Study|Physician Decision|0|||
143048190|NCT01380782|515715628|FG000|Overall Study|Withdrawal by Subject|0|||
143048191|NCT01380782|515715629|FG001|Overall Study|Withdrawal by Subject|0|||
143048192|NCT01380782|515715630|FG002|Overall Study|Withdrawal by Subject|1|||
143048193|NCT01380782|515715631|FG003|Overall Study|Withdrawal by Subject|1|||
143048194|NCT03676634|515715632|FG000|Overall Study|Red blood cell loss|1|||
143048195|NCT03676634|515715632|FG000|Overall Study|Out-of-limit pulse|2|||
143048196|NCT03131895|515715635|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
143048197|NCT03131895|515715636|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
143048198|NCT03131895|515715637|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
143048199|NCT03131895|515715638|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
143048200|NCT03131895|515715635|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
143048201|NCT03131895|515715636|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
143048202|NCT03131895|515715637|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
143048203|NCT03131895|515715638|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
143048204|NCT03131895|515715635|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
143048205|NCT03131895|515715636|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
143048206|NCT03131895|515715637|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
143048207|NCT03131895|515715638|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
143048208|NCT03131895|515715635|FG000|Washout Period (at Least 5 Days)|Other|0|||
143048209|NCT03131895|515715636|FG001|Washout Period (at Least 5 Days)|Other|0|||
143048210|NCT03131895|515715637|FG002|Washout Period (at Least 5 Days)|Other|2|||
143048211|NCT03131895|515715638|FG003|Washout Period (at Least 5 Days)|Other|0|||
143048212|NCT03131895|515715635|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
143048213|NCT03131895|515715636|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
143048214|NCT03131895|515715637|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
143048215|NCT03131895|515715638|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
143048216|NCT03131895|515715635|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
143048217|NCT03131895|515715636|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
143048218|NCT03131895|515715637|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
143048219|NCT03131895|515715638|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
143048220|NCT00540423|515715639|FG000|Double-Blind Treatment Period|Adverse Event|0|||
143048221|NCT00540423|515715640|FG001|Double-Blind Treatment Period|Adverse Event|1|||
143048222|NCT00540423|515715641|FG002|Double-Blind Treatment Period|Adverse Event|0|||
143048223|NCT00540423|515715639|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
143048224|NCT00540423|515715640|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
143048225|NCT00540423|515715641|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
143048226|NCT02213263|515715646|FG000|Overall Study|Insufficient clinical response|4|||
143048227|NCT02213263|515715647|FG001|Overall Study|Insufficient clinical response|3|||
143048228|NCT02213263|515715646|FG000|Overall Study|Lost to Follow-up|0|||
143048229|NCT02213263|515715647|FG001|Overall Study|Lost to Follow-up|1|||
143048230|NCT02213263|515715646|FG000|Overall Study|No longer willing to participate|3|||
143048231|NCT02213263|515715647|FG001|Overall Study|No longer willing to participate|4|||
143048232|NCT02213263|515715646|FG000|Overall Study|Progressive disease|20|||
143048233|NCT02213263|515715647|FG001|Overall Study|Progressive disease|14|||
143048234|NCT02213263|515715646|FG000|Overall Study|Protocol Violation|0|||
143048235|NCT02213263|515715647|FG001|Overall Study|Protocol Violation|1|||
143048236|NCT02213263|515715646|FG000|Overall Study|Adverse Event|1|||
143048237|NCT02213263|515715647|FG001|Overall Study|Adverse Event|3|||
143048238|NCT01188681|515715648|FG000|Overall Study|bladder cancer|0|||
143048239|NCT01188681|515715649|FG001|Overall Study|bladder cancer|0|||
143048240|NCT01188681|515715650|FG002|Overall Study|bladder cancer|1|||
143048241|NCT01188681|515715651|FG003|Overall Study|bladder cancer|0|||
143499174|NCT04426695|517368499|FG000|Overall Study|Physician Decision|0|||
143048242|NCT01188681|515715648|FG000|Overall Study|Withdrawal by Subject|0|||
143048243|NCT01188681|515715649|FG001|Overall Study|Withdrawal by Subject|0|||
143048244|NCT01188681|515715650|FG002|Overall Study|Withdrawal by Subject|0|||
143048245|NCT01188681|515715651|FG003|Overall Study|Withdrawal by Subject|1|||
143048246|NCT00472212|515715652|FG000|Overall Study|Lost to Follow-up|6|||
143048247|NCT00472212|515715653|FG001|Overall Study|Lost to Follow-up|4|||
143048248|NCT03480763|515715658|FG000|Overall Study|Withdrawal by Subject|18|||
143048249|NCT03480763|515715659|FG001|Overall Study|Withdrawal by Subject|10|||
143048250|NCT03480763|515715658|FG000|Overall Study|Lost to Follow-up|4|||
143364314|NCT00723294|516876959|FG000|Overall Study|Treated prior to registration|1|||
143364315|NCT00723294|516876959|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
143048251|NCT03480763|515715659|FG001|Overall Study|Lost to Follow-up|7|||
143048252|NCT03480763|515715658|FG000|Overall Study|non-study pneumococcal vaccine|1|||
143048253|NCT03480763|515715659|FG001|Overall Study|non-study pneumococcal vaccine|0|||
143048254|NCT03480763|515715658|FG000|Overall Study|oncological treatment|0|||
143048255|NCT03480763|515715659|FG001|Overall Study|oncological treatment|2|||
143048256|NCT03480763|515715658|FG000|Overall Study|pain with vaccination|1|||
143048257|NCT03480763|515715659|FG001|Overall Study|pain with vaccination|0|||
143048258|NCT00924638|515715662|FG000|Overall Study|Death|3|||
143048259|NCT00924638|515715663|FG001|Overall Study|Death|2|||
143048260|NCT00924638|515715662|FG000|Overall Study|Lost to Follow-up|1|||
143048261|NCT00924638|515715663|FG001|Overall Study|Lost to Follow-up|1|||
143048262|NCT00924638|515715662|FG000|Overall Study|Withdrawal by Subject|5|||
143048263|NCT00924638|515715663|FG001|Overall Study|Withdrawal by Subject|7|||
143048264|NCT00924638|515715662|FG000|Overall Study|Physician Decision|3|||
143048265|NCT00924638|515715663|FG001|Overall Study|Physician Decision|3|||
143048266|NCT01252953|515715665|FG000|Overall Study|Withdrawal by Subject|16|||
143048267|NCT01252953|515715666|FG001|Overall Study|Withdrawal by Subject|17|||
143048268|NCT01252953|515715665|FG000|Overall Study|Lost to Follow-up|22|||
143048269|NCT01252953|515715666|FG001|Overall Study|Lost to Follow-up|21|||
143048270|NCT00958724|515715667|FG000|Overall Study|Disease Progression|6|||
143048271|NCT05604014|515715668|FG000|Overall Study|Lost to Follow-up|13|||
143048272|NCT00906399|515715670|FG000|Year 1|Randomized But Not Treated|0|||
143048273|NCT00906399|515715671|FG001|Year 1|Randomized But Not Treated|1|||
143048274|NCT00906399|515715672|FG002|Year 1|Randomized But Not Treated|3|||
143048275|NCT00906399|515715673|FG003|Year 1|Randomized But Not Treated|0|||
143048276|NCT00906399|515715674|FG004|Year 1|Randomized But Not Treated|0|||
143048277|NCT00906399|515715675|FG005|Year 1|Randomized But Not Treated|0|||
143048278|NCT00906399|515715676|FG006|Year 1|Randomized But Not Treated|0|||
143048279|NCT00906399|515715670|FG000|Year 1|Adverse Event|4|||
143048280|NCT00906399|515715671|FG001|Year 1|Adverse Event|22|||
143048281|NCT00906399|515715672|FG002|Year 1|Adverse Event|24|||
143048282|NCT00906399|515715673|FG003|Year 1|Adverse Event|0|||
143048283|NCT00906399|515715674|FG004|Year 1|Adverse Event|0|||
143048284|NCT00906399|515715675|FG005|Year 1|Adverse Event|0|||
143048285|NCT00906399|515715676|FG006|Year 1|Adverse Event|0|||
143048286|NCT00906399|515715670|FG000|Year 1|Lost to Follow-up|4|||
143048287|NCT00906399|515715671|FG001|Year 1|Lost to Follow-up|4|||
143048288|NCT00906399|515715672|FG002|Year 1|Lost to Follow-up|2|||
143048289|NCT00906399|515715673|FG003|Year 1|Lost to Follow-up|0|||
143048290|NCT00906399|515715674|FG004|Year 1|Lost to Follow-up|0|||
143048291|NCT00906399|515715675|FG005|Year 1|Lost to Follow-up|0|||
143048292|NCT00906399|515715676|FG006|Year 1|Lost to Follow-up|0|||
143048293|NCT00906399|515715670|FG000|Year 1|Withdrawal by Subject|30|||
143048294|NCT00906399|515715671|FG001|Year 1|Withdrawal by Subject|32|||
143048295|NCT00906399|515715672|FG002|Year 1|Withdrawal by Subject|36|||
143048296|NCT00906399|515715673|FG003|Year 1|Withdrawal by Subject|0|||
143048297|NCT00906399|515715674|FG004|Year 1|Withdrawal by Subject|0|||
143048298|NCT00906399|515715675|FG005|Year 1|Withdrawal by Subject|0|||
143048299|NCT00906399|515715676|FG006|Year 1|Withdrawal by Subject|0|||
143048300|NCT00906399|515715670|FG000|Year 1|Physician Decision|0|||
143048301|NCT00906399|515715671|FG001|Year 1|Physician Decision|1|||
143048302|NCT00906399|515715672|FG002|Year 1|Physician Decision|3|||
143048303|NCT00906399|515715673|FG003|Year 1|Physician Decision|0|||
143048304|NCT00906399|515715674|FG004|Year 1|Physician Decision|0|||
143048305|NCT00906399|515715675|FG005|Year 1|Physician Decision|0|||
143048306|NCT00906399|515715676|FG006|Year 1|Physician Decision|0|||
143048307|NCT00906399|515715670|FG000|Year 1|Death|2|||
143048308|NCT00906399|515715671|FG001|Year 1|Death|1|||
143048309|NCT00906399|515715672|FG002|Year 1|Death|1|||
143048310|NCT00906399|515715673|FG003|Year 1|Death|0|||
143168289|NCT00086515|516163067|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
143168290|NCT00086515|516163066|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
143168291|NCT00086515|516163067|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
143168292|NCT00086515|516163066|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
143168293|NCT00086515|516163067|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
143168294|NCT00086515|516163066|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
143168295|NCT00086515|516163067|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
143168296|NCT00086515|516163066|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
143168297|NCT00086515|516163067|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
143168298|NCT00086515|516163066|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
143048311|NCT00906399|515715674|FG004|Year 1|Death|0|||
143048312|NCT00906399|515715675|FG005|Year 1|Death|0|||
143048313|NCT00906399|515715676|FG006|Year 1|Death|0|||
143048314|NCT00906399|515715670|FG000|Year 1|Other|4|||
143048315|NCT00906399|515715671|FG001|Year 1|Other|2|||
143048316|NCT00906399|515715672|FG002|Year 1|Other|7|||
143048317|NCT00906399|515715673|FG003|Year 1|Other|0|||
143048318|NCT00906399|515715674|FG004|Year 1|Other|0|||
143048319|NCT00906399|515715675|FG005|Year 1|Other|0|||
143048320|NCT00906399|515715676|FG006|Year 1|Other|0|||
143048321|NCT00906399|515715670|FG000|Year 2|Adverse Event|0|||
143048322|NCT00906399|515715671|FG001|Year 2|Adverse Event|0|||
143048323|NCT00906399|515715672|FG002|Year 2|Adverse Event|0|||
143048324|NCT00906399|515715673|FG003|Year 2|Adverse Event|9|||
143048325|NCT00906399|515715674|FG004|Year 2|Adverse Event|8|||
143048326|NCT00906399|515715675|FG005|Year 2|Adverse Event|11|||
143048327|NCT00906399|515715676|FG006|Year 2|Adverse Event|6|||
143048328|NCT00906399|515715670|FG000|Year 2|Lost to Follow-up|0|||
143048329|NCT00906399|515715671|FG001|Year 2|Lost to Follow-up|0|||
143048330|NCT00906399|515715672|FG002|Year 2|Lost to Follow-up|0|||
143048331|NCT00906399|515715673|FG003|Year 2|Lost to Follow-up|1|||
143048332|NCT00906399|515715674|FG004|Year 2|Lost to Follow-up|4|||
143048333|NCT00906399|515715675|FG005|Year 2|Lost to Follow-up|2|||
143048334|NCT00906399|515715676|FG006|Year 2|Lost to Follow-up|4|||
143048335|NCT00906399|515715670|FG000|Year 2|Withdrawal by Subject|0|||
143048336|NCT00906399|515715671|FG001|Year 2|Withdrawal by Subject|0|||
143048337|NCT00906399|515715672|FG002|Year 2|Withdrawal by Subject|0|||
143048338|NCT00906399|515715673|FG003|Year 2|Withdrawal by Subject|17|||
143048339|NCT00906399|515715674|FG004|Year 2|Withdrawal by Subject|18|||
143048340|NCT00906399|515715675|FG005|Year 2|Withdrawal by Subject|27|||
143048341|NCT00906399|515715676|FG006|Year 2|Withdrawal by Subject|13|||
143048342|NCT00906399|515715670|FG000|Year 2|Physician Decision|0|||
143048343|NCT00906399|515715671|FG001|Year 2|Physician Decision|0|||
143048344|NCT00906399|515715672|FG002|Year 2|Physician Decision|0|||
143048345|NCT00906399|515715673|FG003|Year 2|Physician Decision|0|||
143048346|NCT00906399|515715674|FG004|Year 2|Physician Decision|2|||
143048347|NCT00906399|515715675|FG005|Year 2|Physician Decision|6|||
143048348|NCT00906399|515715676|FG006|Year 2|Physician Decision|3|||
143048349|NCT00906399|515715670|FG000|Year 2|Death|0|||
143048350|NCT00906399|515715671|FG001|Year 2|Death|0|||
143048351|NCT00906399|515715672|FG002|Year 2|Death|0|||
143048352|NCT00906399|515715673|FG003|Year 2|Death|1|||
143048353|NCT00906399|515715674|FG004|Year 2|Death|0|||
143048354|NCT00906399|515715675|FG005|Year 2|Death|0|||
143048355|NCT00906399|515715676|FG006|Year 2|Death|3|||
143048356|NCT00906399|515715670|FG000|Year 2|Other|0|||
143048357|NCT00906399|515715671|FG001|Year 2|Other|0|||
143048358|NCT00906399|515715672|FG002|Year 2|Other|0|||
143048359|NCT00906399|515715673|FG003|Year 2|Other|2|||
143048360|NCT00906399|515715674|FG004|Year 2|Other|3|||
143048361|NCT00906399|515715675|FG005|Year 2|Other|1|||
143048362|NCT00906399|515715676|FG006|Year 2|Other|0|||
143048363|NCT00748566|515715686|FG000|Overall Study|Adverse Event|49|||
143048364|NCT00748566|515715686|FG000|Overall Study|Death|1|||
143048365|NCT00748566|515715686|FG000|Overall Study|Lack of Efficacy|12|||
143048366|NCT00748566|515715686|FG000|Overall Study|Lost to Follow-up|1|||
143048367|NCT00748566|515715686|FG000|Overall Study|Protocol Violation|13|||
143168299|NCT00086515|516163067|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
143168300|NCT00086515|516163066|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
143168301|NCT00086515|516163067|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
143168302|NCT00086515|516163066|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
143168303|NCT00086515|516163067|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
143168304|NCT00086515|516163066|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
143168305|NCT00086515|516163067|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
143168306|NCT00086515|516163066|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
143244162|NCT03892967|516444880|FG004|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|728|||
143244163|NCT03892967|516444876|FG000|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|474|||
143244164|NCT03892967|516444877|FG001|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|726|||
143244165|NCT03892967|516444878|FG002|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|774|||
143048368|NCT00748566|515715686|FG000|Overall Study|Withdrawal by Subject|22|||
143048369|NCT00748566|515715686|FG000|Overall Study|Study terminated by sponsor|5|||
143048370|NCT00748566|515715686|FG000|Overall Study|Other|9|||
143048371|NCT02054715|515715690|FG000|Baseline/Follow-up 1|Refused|1|||
143048372|NCT02054715|515715691|FG001|Baseline/Follow-up 1|Refused|3|||
143048373|NCT02054715|515715690|FG000|Baseline/Follow-up 1|Medical|0|||
143048374|NCT02054715|515715691|FG001|Baseline/Follow-up 1|Medical|1|||
143048375|NCT02054715|515715690|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
143048376|NCT02054715|515715691|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
143048377|NCT02054715|515715690|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
143048378|NCT02054715|515715691|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
143048379|NCT02054715|515715690|FG000|Baseline/Follow-up 1|No Reason|0|||
143048380|NCT02054715|515715691|FG001|Baseline/Follow-up 1|No Reason|1|||
143048381|NCT02054715|515715690|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
143048382|NCT02054715|515715691|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
143048383|NCT02054715|515715690|FG000|Baseline/Follow-up 1|Ineligible|3|||
143048384|NCT02054715|515715691|FG001|Baseline/Follow-up 1|Ineligible|0|||
143048385|NCT02054715|515715690|FG000|Baseline/Follow-up 1|Hospitalization|1|||
143048386|NCT02054715|515715691|FG001|Baseline/Follow-up 1|Hospitalization|0|||
143048387|NCT02054715|515715690|FG000|Baseline/Follow-up 1|Changed Mind|1|||
143048388|NCT02054715|515715691|FG001|Baseline/Follow-up 1|Changed Mind|0|||
143048389|NCT02054715|515715690|FG000|Follow-up 2|Lost to Followup|3|||
143048390|NCT02054715|515715691|FG001|Follow-up 2|Lost to Followup|1|||
143048391|NCT02054715|515715690|FG000|Follow-up 2|Refused|3|||
143048392|NCT02054715|515715691|FG001|Follow-up 2|Refused|2|||
143048393|NCT02054715|515715690|FG000|Follow-up 2|Followup Not Completed|3|||
143048394|NCT02054715|515715691|FG001|Follow-up 2|Followup Not Completed|4|||
143048395|NCT02054715|515715690|FG000|Follow-up 2|Ineligible|4|||
143048396|NCT02054715|515715691|FG001|Follow-up 2|Ineligible|5|||
143048397|NCT02054715|515715690|FG000|Follow-up 2|Death|3|||
143048398|NCT02054715|515715691|FG001|Follow-up 2|Death|3|||
143048399|NCT02054715|515715690|FG000|Follow-up 2|Hospitalization|0|||
143048400|NCT02054715|515715691|FG001|Follow-up 2|Hospitalization|2|||
143048401|NCT02054715|515715690|FG000|Follow-up 2|Changed MD/Facility|0|||
143048402|NCT02054715|515715691|FG001|Follow-up 2|Changed MD/Facility|1|||
143048403|NCT02054715|515715690|FG000|Follow-up 2|Changed Mind|0|||
143048404|NCT02054715|515715691|FG001|Follow-up 2|Changed Mind|1|||
143048405|NCT02054715|515715690|FG000|Follow-up 2|No Reason|2|||
143048406|NCT02054715|515715691|FG001|Follow-up 2|No Reason|0|||
143048407|NCT02054715|515715690|FG000|Follow-up 2|Treatment Change or Delay|1|||
143048408|NCT02054715|515715691|FG001|Follow-up 2|Treatment Change or Delay|0|||
143048409|NCT00674128|515715697|FG000|Overall Study|Withdrawal by Subject|25|||
143048410|NCT00674128|515715698|FG001|Overall Study|Withdrawal by Subject|23|||
143048411|NCT04631562|515715699|FG000|Overall Study|Withdrawal by Subject|0|||
143048412|NCT04631562|515715700|FG001|Overall Study|Withdrawal by Subject|0|||
143048413|NCT04631562|515715701|FG002|Overall Study|Withdrawal by Subject|0|||
143048414|NCT04631562|515715702|FG003|Overall Study|Withdrawal by Subject|0|||
143048415|NCT04631562|515715703|FG004|Overall Study|Withdrawal by Subject|0|||
143048416|NCT04631562|515715704|FG005|Overall Study|Withdrawal by Subject|0|||
143048417|NCT04631562|515715705|FG006|Overall Study|Withdrawal by Subject|0|||
143048418|NCT04631562|515715706|FG007|Overall Study|Withdrawal by Subject|1|||
143048419|NCT04631562|515715707|FG008|Overall Study|Withdrawal by Subject|0|||
143048420|NCT04631562|515715699|FG000|Overall Study|Other|0|||
143048421|NCT04631562|515715700|FG001|Overall Study|Other|0|||
143048422|NCT04631562|515715701|FG002|Overall Study|Other|0|||
143048423|NCT04631562|515715702|FG003|Overall Study|Other|0|||
143048424|NCT04631562|515715703|FG004|Overall Study|Other|0|||
143048425|NCT04631562|515715704|FG005|Overall Study|Other|0|||
143048426|NCT04631562|515715705|FG006|Overall Study|Other|0|||
143048427|NCT04631562|515715706|FG007|Overall Study|Other|0|||
143048428|NCT04631562|515715707|FG008|Overall Study|Other|1|||
143048429|NCT04631562|515715699|FG000|Overall Study|Lost to Follow-up|0|||
143048430|NCT04631562|515715700|FG001|Overall Study|Lost to Follow-up|0|||
143048431|NCT04631562|515715701|FG002|Overall Study|Lost to Follow-up|0|||
143048432|NCT04631562|515715702|FG003|Overall Study|Lost to Follow-up|1|||
143048433|NCT04631562|515715703|FG004|Overall Study|Lost to Follow-up|0|||
143048434|NCT04631562|515715704|FG005|Overall Study|Lost to Follow-up|0|||
143048435|NCT04631562|515715705|FG006|Overall Study|Lost to Follow-up|0|||
143048436|NCT04631562|515715706|FG007|Overall Study|Lost to Follow-up|0|||
143048437|NCT04631562|515715707|FG008|Overall Study|Lost to Follow-up|0|||
143048438|NCT04631562|515715699|FG000|Overall Study|Adverse Event|0|||
143048439|NCT04631562|515715700|FG001|Overall Study|Adverse Event|0|||
143048440|NCT04631562|515715701|FG002|Overall Study|Adverse Event|0|||
143048441|NCT04631562|515715702|FG003|Overall Study|Adverse Event|0|||
143244166|NCT03892967|516444879|FG003|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|552|||
143244167|NCT03892967|516444880|FG004|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|366|||
143244168|NCT03892967|516444876|FG000|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|710|||
143244169|NCT03892967|516444877|FG001|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|993|||
143244170|NCT03892967|516444878|FG002|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|910|||
143244171|NCT03892967|516444879|FG003|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|739|||
143048442|NCT04631562|515715703|FG004|Overall Study|Adverse Event|0|||
143048443|NCT04631562|515715704|FG005|Overall Study|Adverse Event|0|||
143048444|NCT04631562|515715705|FG006|Overall Study|Adverse Event|1|||
143048445|NCT04631562|515715706|FG007|Overall Study|Adverse Event|0|||
143048446|NCT04631562|515715707|FG008|Overall Study|Adverse Event|0|||
143048447|NCT01559363|515715718|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
143048448|NCT01559363|515715719|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
143048449|NCT01559363|515715720|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
143048450|NCT01559363|515715721|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
143048451|NCT01559363|515715722|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
143048452|NCT01559363|515715723|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
143048453|NCT01559363|515715718|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
143048454|NCT01559363|515715719|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
143048455|NCT01559363|515715720|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
143048456|NCT01559363|515715721|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
143048457|NCT01559363|515715722|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
143048458|NCT01559363|515715723|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
143048459|NCT01559363|515715718|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
143048460|NCT01559363|515715719|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
143048461|NCT01559363|515715720|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
143048462|NCT01559363|515715721|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
143048463|NCT01559363|515715722|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
143048464|NCT01559363|515715723|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
143048465|NCT01559363|515715718|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
143048466|NCT01559363|515715719|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
143048467|NCT01559363|515715720|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
143048468|NCT01559363|515715721|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
143048469|NCT01559363|515715722|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
143048470|NCT01559363|515715723|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
143048471|NCT01559363|515715718|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
143048472|NCT01559363|515715719|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
143048473|NCT01559363|515715720|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
143048474|NCT01559363|515715721|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
143048475|NCT01559363|515715722|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
143048476|NCT01559363|515715723|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
143048477|NCT01559363|515715718|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
143048478|NCT01559363|515715719|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
143048479|NCT01559363|515715720|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
143048480|NCT01559363|515715721|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
143048481|NCT01559363|515715722|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
143048482|NCT01559363|515715723|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
143048483|NCT01559363|515715718|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
143048484|NCT01559363|515715719|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
143048485|NCT01559363|515715720|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
143048486|NCT01559363|515715721|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
143048487|NCT01559363|515715722|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
143048488|NCT01559363|515715723|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
143048489|NCT00562718|515715739|FG000|Overall Study|Death|1|||
143048490|NCT00562718|515715739|FG000|Overall Study|Withdrawal by Subject|3|||
143048491|NCT00562718|515715739|FG000|Overall Study|Adverse Event|4|||
143048492|NCT00562718|515715739|FG000|Overall Study|Lack of Efficacy|2|||
143048493|NCT00562718|515715739|FG000|Overall Study|not stated|1|||
143048494|NCT01151618|515715740|FG000|Overall Study|Adverse Event|2|||
143048495|NCT01151618|515715740|FG000|Overall Study|Withdrawal by Subject|7|||
143048496|NCT04025021|515715741|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
143048497|NCT04025021|515715742|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
143048498|NCT02227238|515715743|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
143048499|NCT02227238|515715744|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
143048500|NCT02227238|515715745|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
143048501|NCT02227238|515715743|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
143048502|NCT02227238|515715744|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
143048503|NCT02227238|515715745|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
143048504|NCT02227238|515715743|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
143048505|NCT02227238|515715744|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
143048506|NCT02227238|515715745|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
143048507|NCT02227238|515715743|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
143048508|NCT02227238|515715744|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
143048509|NCT02227238|515715745|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
143048510|NCT02227238|515715743|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
143048511|NCT02227238|515715744|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
143048512|NCT02227238|515715745|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
143048513|NCT02227238|515715743|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
143048514|NCT02227238|515715744|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
143048515|NCT02227238|515715745|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
143048516|NCT02227238|515715743|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
143048517|NCT02227238|515715744|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
143048518|NCT02227238|515715745|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
143114946|NCT02326298|515962467|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
143048519|NCT02227238|515715743|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
143048520|NCT02227238|515715744|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
143048521|NCT02227238|515715745|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
143048522|NCT02227238|515715743|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
143048523|NCT02227238|515715744|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
143048524|NCT02227238|515715745|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
143048525|NCT02227238|515715743|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
143048526|NCT02227238|515715744|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
143048527|NCT02227238|515715745|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
143048528|NCT02227238|515715743|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
143048529|NCT02227238|515715744|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
143048530|NCT02227238|515715745|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
143048531|NCT02227238|515715743|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
143048532|NCT02227238|515715744|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
143048533|NCT02227238|515715745|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
143048534|NCT02227238|515715743|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
143048535|NCT02227238|515715744|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
143048536|NCT02227238|515715745|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
143048537|NCT02227238|515715743|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
143048538|NCT02227238|515715744|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
143048539|NCT02227238|515715745|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
143048540|NCT00868998|515715747|FG000|Overall Study|Screen Failure|1|||
143048541|NCT00868998|515715747|FG000|Overall Study|Withdrawal by Subject|1|||
143048542|NCT00868998|515715747|FG000|Overall Study|Progression of disease|2|||
143048543|NCT00868998|515715747|FG000|Overall Study|Death|1|||
143048544|NCT00867360|515715752|FG000|Overall Study|Withdrawal by Subject|1|||
143048545|NCT00867360|515715753|FG001|Overall Study|Withdrawal by Subject|0|||
143048546|NCT00867360|515715752|FG000|Overall Study|Physician Decision|0|||
143048547|NCT00867360|515715753|FG001|Overall Study|Physician Decision|1|||
143048548|NCT01507662|515715754|FG000|Overall Study|Death|26|||
143048549|NCT01507662|515715755|FG001|Overall Study|Death|18|||
143048550|NCT01507662|515715754|FG000|Overall Study|Withdrawal by Subject|290|||
143048551|NCT01507662|515715755|FG001|Overall Study|Withdrawal by Subject|287|||
143048552|NCT01507662|515715754|FG000|Overall Study|Lost to Follow-up|498|||
143048553|NCT01507662|515715755|FG001|Overall Study|Lost to Follow-up|523|||
143048554|NCT01507662|515715754|FG000|Overall Study|Proxy interview done|2|||
143048555|NCT01507662|515715755|FG001|Overall Study|Proxy interview done|3|||
143048556|NCT01824576|515715758|FG000|Overall Study|Device deficiency|2|||
143048557|NCT03961204|515715759|FG000|Overall Study|Withdrawal by Subject|2|||
143048558|NCT03961204|515715759|FG000|Overall Study|Lost to Follow-up|3|||
143048559|NCT03961204|515715759|FG000|Overall Study|Other|1|||
143048560|NCT03961204|515715759|FG000|Overall Study|Missing|1|||
143048561|NCT00147498|515715760|FG000|Overall Study|Adverse Event|1|||
143048562|NCT00147498|515715761|FG001|Overall Study|Adverse Event|6|||
143048563|NCT00147498|515715762|FG002|Overall Study|Adverse Event|7|||
143048564|NCT00147498|515715763|FG003|Overall Study|Adverse Event|3|||
143048565|NCT00147498|515715760|FG000|Overall Study|Lack of Efficacy|1|||
143048566|NCT00147498|515715761|FG001|Overall Study|Lack of Efficacy|1|||
143048567|NCT00147498|515715762|FG002|Overall Study|Lack of Efficacy|1|||
143048568|NCT00147498|515715763|FG003|Overall Study|Lack of Efficacy|8|||
143048569|NCT00147498|515715760|FG000|Overall Study|Laboratory abnormality|0|||
143048570|NCT00147498|515715761|FG001|Overall Study|Laboratory abnormality|0|||
143048571|NCT00147498|515715762|FG002|Overall Study|Laboratory abnormality|2|||
143048572|NCT00147498|515715763|FG003|Overall Study|Laboratory abnormality|0|||
143048573|NCT00147498|515715760|FG000|Overall Study|Participant defaulted|0|||
143048574|NCT00147498|515715761|FG001|Overall Study|Participant defaulted|1|||
143048575|NCT00147498|515715762|FG002|Overall Study|Participant defaulted|4|||
143048576|NCT00147498|515715763|FG003|Overall Study|Participant defaulted|3|||
143048577|NCT00147498|515715760|FG000|Overall Study|Other|1|||
143048578|NCT00147498|515715761|FG001|Overall Study|Other|1|||
143048579|NCT00147498|515715762|FG002|Overall Study|Other|3|||
143048580|NCT00147498|515715763|FG003|Overall Study|Other|3|||
143048581|NCT02452463|515715764|FG000|Overall Study|Death|1|||
143048582|NCT02452463|515715765|FG001|Overall Study|Death|0|||
143048583|NCT02452463|515715766|FG002|Overall Study|Death|0|||
143048584|NCT02452463|515715764|FG000|Overall Study|Study Suspended|1|||
143048585|NCT02452463|515715765|FG001|Overall Study|Study Suspended|0|||
143048586|NCT02452463|515715766|FG002|Overall Study|Study Suspended|0|||
143048587|NCT02452463|515715764|FG000|Overall Study|Recommended by DSMB|0|||
143048588|NCT02452463|515715765|FG001|Overall Study|Recommended by DSMB|1|||
143048589|NCT02452463|515715766|FG002|Overall Study|Recommended by DSMB|0|||
143048590|NCT02452463|515715764|FG000|Overall Study|Withdrawal by Subject|0|||
143048591|NCT02452463|515715765|FG001|Overall Study|Withdrawal by Subject|1|||
143048592|NCT02452463|515715766|FG002|Overall Study|Withdrawal by Subject|0|||
143048593|NCT03969641|515717409|FG000|Overall Study|Lost to Follow-up|5|||
143048594|NCT03969641|515717410|FG001|Overall Study|Lost to Follow-up|3|||
143048595|NCT03969641|515717409|FG000|Overall Study|Withdrawal by Subject|1|||
143048596|NCT03969641|515717410|FG001|Overall Study|Withdrawal by Subject|2|||
143048597|NCT03969641|515717409|FG000|Overall Study|Found to be ineligible|1|||
143048598|NCT03969641|515717410|FG001|Overall Study|Found to be ineligible|1|||
143048599|NCT03969641|515717409|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
143048600|NCT03969641|515717410|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
143048601|NCT03969641|515717409|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
143048602|NCT03969641|515717410|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
143048603|NCT03969641|515717409|FG000|Overall Study|Elective termination|0|||
143048604|NCT03969641|515717410|FG001|Overall Study|Elective termination|1|||
143048605|NCT00754052|515717418|FG000|Overall Study|Study terminated by Sponsor|5|||
143048606|NCT00754052|515717419|FG001|Overall Study|Study terminated by Sponsor|3|||
143048607|NCT02658019|515717421|FG000|Overall Study|Adverse Event|1|||
143048608|NCT00529763|515717422|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
143048609|NCT00529763|515717423|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
143048610|NCT00529763|515717424|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
143048611|NCT00529763|515717422|FG000|Overall Study|Death|1|||
143048612|NCT00529763|515717423|FG001|Overall Study|Death|1|||
143048613|NCT00529763|515717424|FG002|Overall Study|Death|1|||
143048614|NCT00529763|515717422|FG000|Overall Study|Disease Progression|10|||
143048615|NCT00529763|515717423|FG001|Overall Study|Disease Progression|16|||
143048616|NCT00529763|515717424|FG002|Overall Study|Disease Progression|11|||
143048617|NCT00529763|515717422|FG000|Overall Study|Lost to Follow-up|1|||
143048618|NCT00529763|515717423|FG001|Overall Study|Lost to Follow-up|2|||
143048619|NCT00529763|515717424|FG002|Overall Study|Lost to Follow-up|3|||
143048620|NCT00529763|515717422|FG000|Overall Study|Stem Cell Transplant|0|||
143048621|NCT00529763|515717423|FG001|Overall Study|Stem Cell Transplant|3|||
143048622|NCT00529763|515717424|FG002|Overall Study|Stem Cell Transplant|1|||
143048623|NCT00529763|515717422|FG000|Overall Study|Study Drug Toxicity|3|||
143048624|NCT00529763|515717423|FG001|Overall Study|Study Drug Toxicity|6|||
143048625|NCT00529763|515717424|FG002|Overall Study|Study Drug Toxicity|4|||
143048626|NCT00529763|515717422|FG000|Overall Study|Participant Withdrew Consent|2|||
143048627|NCT00529763|515717423|FG001|Overall Study|Participant Withdrew Consent|3|||
143048628|NCT00529763|515717424|FG002|Overall Study|Participant Withdrew Consent|4|||
143048629|NCT00529763|515717422|FG000|Overall Study|Other reasons|2|||
143048630|NCT00529763|515717423|FG001|Overall Study|Other reasons|0|||
143048631|NCT00529763|515717424|FG002|Overall Study|Other reasons|2|||
143048632|NCT00529763|515717422|FG000|Overall Study|Participant request to discontinue treatment|1|||
143048633|NCT00529763|515717423|FG001|Overall Study|Participant request to discontinue treatment|1|||
143048634|NCT00529763|515717424|FG002|Overall Study|Participant request to discontinue treatment|3|||
143048635|NCT02986139|515717425|FG000|Overall Study|Sponsor Decision|1|||
143048636|NCT02986139|515717426|FG001|Overall Study|Sponsor Decision|2|||
143048637|NCT02986139|515717425|FG000|Overall Study|Withdrawal by Subject|0|||
143048638|NCT02986139|515717426|FG001|Overall Study|Withdrawal by Subject|1|||
143048639|NCT02986139|515717425|FG000|Overall Study|Lost to Follow-up|0|||
143048640|NCT02986139|515717426|FG001|Overall Study|Lost to Follow-up|1|||
143048641|NCT00414726|515717427|FG000|Overall Study|Withdrawal by Subject|0|||
143048642|NCT00414726|515717428|FG001|Overall Study|Withdrawal by Subject|1|||
143048643|NCT02107196|515717429|FG000|12-week Treatment Period|Adverse Event|6|||
143048644|NCT02107196|515717430|FG001|12-week Treatment Period|Adverse Event|3|||
143048645|NCT02107196|515717429|FG000|12-week Treatment Period|Lack of Efficacy|2|||
143048646|NCT02107196|515717430|FG001|12-week Treatment Period|Lack of Efficacy|1|||
143048647|NCT02107196|515717429|FG000|12-week Treatment Period|Lost to Follow-up|3|||
143048648|NCT02107196|515717430|FG001|12-week Treatment Period|Lost to Follow-up|6|||
143048649|NCT02107196|515717429|FG000|12-week Treatment Period|Physician Decision|0|||
143168307|NCT00086515|516163067|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
143168308|NCT00086515|516163066|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
143168309|NCT00086515|516163067|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
143168310|NCT00086515|516163066|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
143168311|NCT00086515|516163067|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
143168312|NCT00086515|516163066|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
143048650|NCT02107196|515717430|FG001|12-week Treatment Period|Physician Decision|1|||
143048651|NCT02107196|515717429|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
143048652|NCT02107196|515717430|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
143048653|NCT02107196|515717429|FG000|12-week Treatment Period|Protocol Violation|7|||
143048654|NCT02107196|515717430|FG001|12-week Treatment Period|Protocol Violation|8|||
143048655|NCT02107196|515717429|FG000|12-week Treatment Period|Reason Missing|11|||
143048656|NCT02107196|515717430|FG001|12-week Treatment Period|Reason Missing|8|||
143048657|NCT02107196|515717429|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
143048658|NCT02107196|515717430|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
143048659|NCT02107196|515717429|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
143048660|NCT02107196|515717430|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
143048661|NCT02107196|515717429|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
143048662|NCT02107196|515717430|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
143048663|NCT02107196|515717429|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
143244172|NCT03892967|516444880|FG004|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|280|||
143244173|NCT03892967|516444876|FG000|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|585|||
143048664|NCT02107196|515717430|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
143048665|NCT00516295|515717431|FG000|Overall Study|Lack of Efficacy|2|||
143048666|NCT00516295|515717432|FG001|Overall Study|Lack of Efficacy|0|||
143048667|NCT00516295|515717433|FG002|Overall Study|Lack of Efficacy|0|||
143048668|NCT00516295|515717431|FG000|Overall Study|Ineligible|1|||
143048669|NCT00516295|515717432|FG001|Overall Study|Ineligible|0|||
143048670|NCT00516295|515717433|FG002|Overall Study|Ineligible|0|||
143048671|NCT02034513|515717434|FG000|Overall Study|Adverse Event|11|||
143048672|NCT02034513|515717435|FG001|Overall Study|Adverse Event|10|||
143048673|NCT02034513|515717434|FG000|Overall Study|Lack of Efficacy|0|||
143048674|NCT02034513|515717435|FG001|Overall Study|Lack of Efficacy|1|||
143048675|NCT02034513|515717434|FG000|Overall Study|Lost to Follow-up|6|||
143048676|NCT02034513|515717435|FG001|Overall Study|Lost to Follow-up|7|||
143048677|NCT02034513|515717434|FG000|Overall Study|Pregnancy|0|||
143048678|NCT02034513|515717435|FG001|Overall Study|Pregnancy|3|||
143048679|NCT02034513|515717434|FG000|Overall Study|Protocol Violation|7|||
143048680|NCT02034513|515717435|FG001|Overall Study|Protocol Violation|10|||
143048681|NCT02034513|515717434|FG000|Overall Study|Withdrawal by Subject|25|||
143048682|NCT02034513|515717435|FG001|Overall Study|Withdrawal by Subject|25|||
143048683|NCT02034513|515717434|FG000|Overall Study|Unclassified|0|||
143048684|NCT02034513|515717435|FG001|Overall Study|Unclassified|1|||
143244174|NCT03892967|516444877|FG001|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|893|||
143244175|NCT03892967|516444878|FG002|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|962|||
143048685|NCT01630616|515717438|FG000|Overall Study|Adverse Event|0|||
143048686|NCT01630616|515717439|FG001|Overall Study|Adverse Event|0|||
143048687|NCT01630616|515717440|FG002|Overall Study|Adverse Event|0|||
143048688|NCT01630616|515717441|FG003|Overall Study|Adverse Event|1|||
143048689|NCT01630616|515717442|FG004|Overall Study|Adverse Event|0|||
143048690|NCT01630616|515717443|FG005|Overall Study|Adverse Event|0|||
143048691|NCT01630616|515717438|FG000|Overall Study|Withdrawal by Subject|0|||
143048692|NCT01630616|515717439|FG001|Overall Study|Withdrawal by Subject|0|||
143048693|NCT01630616|515717440|FG002|Overall Study|Withdrawal by Subject|0|||
143048694|NCT01630616|515717441|FG003|Overall Study|Withdrawal by Subject|2|||
143048695|NCT01630616|515717442|FG004|Overall Study|Withdrawal by Subject|0|||
143244176|NCT03892967|516444879|FG003|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|830|||
143244177|NCT03892967|516444880|FG004|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|315|||
143048696|NCT01630616|515717443|FG005|Overall Study|Withdrawal by Subject|0|||
143048697|NCT01993186|515717444|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
143048698|NCT01993186|515717445|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
143048699|NCT01993186|515717444|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
143048700|NCT01993186|515717445|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
143048701|NCT01993186|515717444|FG000|Open-Label Extension Period|Other, Not Specified|0|||
143048702|NCT01993186|515717445|FG001|Open-Label Extension Period|Other, Not Specified|1|||
143048703|NCT01993186|515717444|FG000|Open-Label Extension Period|Adverse Event|1|||
143048704|NCT01993186|515717445|FG001|Open-Label Extension Period|Adverse Event|0|||
143048705|NCT01993186|515717444|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
143048706|NCT01993186|515717445|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
143048707|NCT01993186|515717444|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
143048708|NCT01993186|515717445|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
143048709|NCT01993186|515717444|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
143048710|NCT01993186|515717445|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
143048711|NCT00691704|515717446|FG000|Induction Therapy|Disease Progression|1|||
143048712|NCT00691704|515717446|FG000|Induction Therapy|Active Hepatitis|1|||
143048713|NCT00691704|515717446|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
143048714|NCT00691704|515717446|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
143048715|NCT00691704|515717446|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
143048716|NCT04523480|515717448|FG000|Overall Study|Lost to Follow-up|30|||
143048717|NCT04523480|515717449|FG001|Overall Study|Lost to Follow-up|35|||
143048718|NCT04523480|515717450|FG002|Overall Study|Lost to Follow-up|0|||
143048719|NCT04406194|515717451|FG000|Period 1|Withdrawal by Subject|0|||
143499175|NCT04426695|517368500|FG001|Overall Study|Physician Decision|0|||
143048720|NCT04406194|515717452|FG001|Period 1|Withdrawal by Subject|1|||
143048721|NCT01701063|515717454|FG000|Overall Study|Lost to Follow-up|0|||
143499176|NCT04426695|517368501|FG002|Overall Study|Physician Decision|0|||
143499177|NCT04426695|517368502|FG003|Overall Study|Physician Decision|0|||
143499178|NCT04426695|517368503|FG004|Overall Study|Physician Decision|0|||
143048722|NCT01701063|515717455|FG001|Overall Study|Lost to Follow-up|1|||
143048723|NCT01701063|515717456|FG002|Overall Study|Lost to Follow-up|0|||
143048724|NCT01701063|515717454|FG000|Overall Study|Withdrawal by Subject|0|||
143048725|NCT01701063|515717455|FG001|Overall Study|Withdrawal by Subject|0|||
143048726|NCT01701063|515717456|FG002|Overall Study|Withdrawal by Subject|1|||
143048727|NCT01701063|515717454|FG000|Overall Study|Other|0|||
143048728|NCT01701063|515717455|FG001|Overall Study|Other|0|||
143048729|NCT01701063|515717456|FG002|Overall Study|Other|1|||
143048730|NCT02043132|515717457|FG000|Overall Study|Lost to Follow-up|1|||
143048731|NCT02043132|515717458|FG001|Overall Study|Lost to Follow-up|1|||
143048732|NCT02043132|515717457|FG000|Overall Study|screen failures|4|||
143048733|NCT02043132|515717458|FG001|Overall Study|screen failures|8|||
143048734|NCT00635648|515717461|FG000|Overall Study|Adverse Event|12|||
143048735|NCT00635648|515717461|FG000|Overall Study|Withdrawal by Subject|9|||
143244178|NCT03892967|516444876|FG000|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|508|||
143244179|NCT03892967|516444877|FG001|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|845|||
143244180|NCT03892967|516444878|FG002|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|1025|||
143244181|NCT03892967|516444879|FG003|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|751|||
143244182|NCT03892967|516444880|FG004|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|302|||
143244183|NCT03892967|516444876|FG000|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|797|||
143244184|NCT03892967|516444877|FG001|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1177|||
143244185|NCT03892967|516444878|FG002|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1398|||
143244186|NCT03892967|516444879|FG003|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1069|||
143244187|NCT03892967|516444880|FG004|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|486|||
143244188|NCT04434937|516444881|FG000|Overall Study|Death|4|||
143244189|NCT04434937|516444881|FG000|Overall Study|Withdrawal by Subject|1|||
143244190|NCT04434937|516444881|FG000|Overall Study|Transitioned to Rollover Study|19|||
143244191|NCT04434937|516444881|FG000|Overall Study|Progressive Disease|18|||
143244192|NCT03387085|516444886|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
143244193|NCT04193189|516444887|FG000|Overall Study|Lost to Follow-up|9|||
143244194|NCT04193189|516444888|FG001|Overall Study|Lost to Follow-up|7|||
143244195|NCT04193189|516444889|FG002|Overall Study|Lost to Follow-up|9|||
143244196|NCT04193189|516444890|FG003|Overall Study|Lost to Follow-up|0|||
143244197|NCT04193189|516444887|FG000|Overall Study|Withdrawal by Subject|1|||
143244198|NCT04193189|516444888|FG001|Overall Study|Withdrawal by Subject|2|||
143244199|NCT04193189|516444889|FG002|Overall Study|Withdrawal by Subject|2|||
143244200|NCT04193189|516444890|FG003|Overall Study|Withdrawal by Subject|0|||
143244201|NCT04193189|516444887|FG000|Overall Study|Death|1|||
143499179|NCT04426695|517368504|FG005|Overall Study|Physician Decision|0|||
143244202|NCT04193189|516444888|FG001|Overall Study|Death|1|||
143499180|NCT04426695|517368505|FG006|Overall Study|Physician Decision|0|||
143499181|NCT04426695|517368506|FG007|Overall Study|Physician Decision|0|||
143499182|NCT04426695|517368507|FG008|Overall Study|Physician Decision|0|||
143499183|NCT04426695|517368508|FG009|Overall Study|Physician Decision|1|||
143499184|NCT04426695|517368509|FG010|Overall Study|Physician Decision|0|||
143499185|NCT04426695|517368510|FG011|Overall Study|Physician Decision|0|||
143499186|NCT04426695|517368511|FG012|Overall Study|Physician Decision|1|||
143499187|NCT04426695|517368512|FG013|Overall Study|Physician Decision|0|||
143499188|NCT04426695|517368513|FG014|Overall Study|Physician Decision|0|||
143499189|NCT04426695|517368514|FG015|Overall Study|Physician Decision|0|||
143499190|NCT04426695|517368515|FG016|Overall Study|Physician Decision|0|||
143048736|NCT00635648|515717461|FG000|Overall Study|Physician Decision|4|||
143048737|NCT00635648|515717461|FG000|Overall Study|Rapid progression of baseline disease|4|||
143048738|NCT00635648|515717461|FG000|Overall Study|Use of other antifungal agent needed|1|||
143244203|NCT04193189|516444889|FG002|Overall Study|Death|0|||
143244204|NCT04193189|516444890|FG003|Overall Study|Death|0|||
143244205|NCT04193189|516444887|FG000|Overall Study|Protocol Violation|0|||
143244206|NCT04193189|516444888|FG001|Overall Study|Protocol Violation|0|||
143244207|NCT04193189|516444889|FG002|Overall Study|Protocol Violation|0|||
143244208|NCT04193189|516444890|FG003|Overall Study|Protocol Violation|1|||
143244209|NCT02656693|516446255|FG000|Overall Study|Pregnancy|1|||
143244210|NCT02656693|516446256|FG001|Overall Study|Pregnancy|1|||
143048739|NCT00635648|515717461|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
143048740|NCT00635648|515717461|FG000|Overall Study|Noncompliance with protocol|1|||
143048741|NCT00635648|515717461|FG000|Overall Study|Other reason|2|||
143048742|NCT01923740|515717462|FG000|Overall Study|Lost to Follow-up|4|||
143048743|NCT01923740|515717463|FG001|Overall Study|Lost to Follow-up|9|||
143499191|NCT04426695|517368516|FG017|Overall Study|Physician Decision|0|||
143499192|NCT04426695|517368499|FG000|Overall Study|Randomized but Never Treated|3|||
143499193|NCT04426695|517368500|FG001|Overall Study|Randomized but Never Treated|1|||
143499194|NCT04426695|517368501|FG002|Overall Study|Randomized but Never Treated|0|||
143048744|NCT01923740|515717462|FG000|Overall Study|Withdrawal by Subject|2|||
143048745|NCT01923740|515717463|FG001|Overall Study|Withdrawal by Subject|0|||
143048746|NCT02450539|515717464|FG000|Overall Study|Withdrawal by Subject|12|||
143048747|NCT02450539|515717465|FG001|Overall Study|Withdrawal by Subject|6|||
143048748|NCT02450539|515717464|FG000|Overall Study|Lost to Follow-up|4|||
143048749|NCT02450539|515717465|FG001|Overall Study|Lost to Follow-up|1|||
143048750|NCT00834444|515717466|FG000|First Intervention|Adverse Event|1|||
143048751|NCT00834444|515717467|FG001|First Intervention|Adverse Event|0|||
143048752|NCT00834444|515717466|FG000|First Intervention|Intolerance to Venopuncture|0|||
143048753|NCT00834444|515717467|FG001|First Intervention|Intolerance to Venopuncture|1|||
143048754|NCT00834444|515717466|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
143048755|NCT00834444|515717467|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
143048756|NCT00834444|515717466|FG000|Second Intervention|Adverse Event|1|||
143048757|NCT00834444|515717467|FG001|Second Intervention|Adverse Event|0|||
143048758|NCT01484912|515717473|FG000|Overall Study|Withdrawal by Subject|1|||
143048759|NCT01484912|515717474|FG001|Overall Study|Withdrawal by Subject|0|||
143048760|NCT01484912|515717473|FG000|Overall Study|Physician Decision|0|||
143048761|NCT01484912|515717474|FG001|Overall Study|Physician Decision|1|||
143048762|NCT00073307|515717491|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
143048763|NCT00073307|515717492|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
143048764|NCT00073307|515717493|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
143048765|NCT00073307|515717491|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
143048766|NCT00073307|515717492|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
143048767|NCT00073307|515717493|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
143048768|NCT00073307|515717491|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
143048769|NCT00073307|515717492|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
143048770|NCT00073307|515717493|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
143048771|NCT00073307|515717491|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
143048772|NCT00073307|515717492|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
143048773|NCT00073307|515717493|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
143048774|NCT00073307|515717491|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
143048775|NCT00073307|515717492|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
143048776|NCT00073307|515717493|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
143048777|NCT00073307|515717491|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
143048778|NCT00073307|515717492|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
143048779|NCT00073307|515717493|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
143048780|NCT00073307|515717491|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
143048781|NCT00073307|515717492|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
143048782|NCT00073307|515717493|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
143048783|NCT00073307|515717491|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
143048784|NCT00073307|515717492|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
143048785|NCT00073307|515717493|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
143048786|NCT00073307|515717491|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
143048787|NCT00073307|515717492|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
143048788|NCT00073307|515717493|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
143048789|NCT00073307|515717491|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
143048790|NCT00073307|515717492|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
143048791|NCT00073307|515717493|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
143048792|NCT00073307|515717491|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
143244211|NCT02656693|516446257|FG002|Overall Study|Pregnancy|1|||
143244212|NCT02656693|516446255|FG000|Overall Study|Bariatric surgery|0|||
143244213|NCT02656693|516446256|FG001|Overall Study|Bariatric surgery|1|||
143244214|NCT02656693|516446257|FG002|Overall Study|Bariatric surgery|2|||
143244215|NCT02269267|516446259|FG000|Overall Study|Death|5|||
143244216|NCT03085797|516446260|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
143244217|NCT03085797|516446261|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
143244218|NCT03085797|516446260|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
143244219|NCT03085797|516446261|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
143244220|NCT03085797|516446260|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
143244221|NCT03085797|516446261|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
143244222|NCT00337675|516446262|FG000|Overall Study|Adverse Event|10|||
143244223|NCT00337675|516446263|FG001|Overall Study|Adverse Event|9|||
143244224|NCT00337675|516446264|FG002|Overall Study|Adverse Event|19|||
143244225|NCT00337675|516446262|FG000|Overall Study|Lack of Efficacy|10|||
143244226|NCT00337675|516446263|FG001|Overall Study|Lack of Efficacy|7|||
143244227|NCT00337675|516446264|FG002|Overall Study|Lack of Efficacy|9|||
143244228|NCT00337675|516446262|FG000|Overall Study|Lost to Follow-up|22|||
143048793|NCT00073307|515717492|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
143048794|NCT00073307|515717493|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
143048795|NCT00073307|515717491|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
143048796|NCT00073307|515717492|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
143048797|NCT00073307|515717493|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
143048798|NCT00073307|515717491|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
143048799|NCT00073307|515717492|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
143048800|NCT00073307|515717493|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
143048801|NCT00073307|515717491|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
143048802|NCT00073307|515717492|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
143048803|NCT00073307|515717493|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
143048804|NCT00073307|515717491|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
143048805|NCT00073307|515717492|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
143048806|NCT00073307|515717493|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
143048807|NCT00073307|515717491|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
143048808|NCT00073307|515717492|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
143048809|NCT00073307|515717493|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
143048810|NCT00073307|515717491|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
143048811|NCT00073307|515717492|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
143048812|NCT00073307|515717493|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
143048813|NCT00073307|515717491|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
143048814|NCT00073307|515717492|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
143244229|NCT00337675|516446263|FG001|Overall Study|Lost to Follow-up|19|||
143048815|NCT00073307|515717493|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
143048816|NCT00073307|515717491|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
143048817|NCT00073307|515717492|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
143048818|NCT00073307|515717493|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
143048819|NCT01438060|515717494|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
143048820|NCT01438060|515717495|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
143048821|NCT01438060|515717494|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
143048822|NCT01438060|515717495|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
143048823|NCT01438060|515717494|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
143048824|NCT01438060|515717495|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
143048825|NCT01438060|515717494|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
143048826|NCT01438060|515717495|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
143048827|NCT01438060|515717494|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
143048828|NCT01438060|515717495|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
143048829|NCT01438060|515717494|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
143048830|NCT01438060|515717495|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
143048831|NCT01438060|515717494|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
143048832|NCT01438060|515717495|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
143048833|NCT01438060|515717494|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
143048834|NCT01438060|515717495|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
143048835|NCT01438060|515717494|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
143048836|NCT01438060|515717495|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
143048837|NCT01438060|515717494|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
143048838|NCT01438060|515717495|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
143048839|NCT01438060|515717494|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
143048840|NCT01438060|515717495|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
143048841|NCT01438060|515717494|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
143048842|NCT01438060|515717495|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
143048843|NCT01438060|515717494|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
143048844|NCT01438060|515717495|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
143048845|NCT01438060|515717494|FG000|On Study Beyond Week 140|Adverse Event|0|||
143048846|NCT01438060|515717495|FG001|On Study Beyond Week 140|Adverse Event|2|||
143048847|NCT01438060|515717494|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
143048848|NCT01438060|515717495|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
143048849|NCT01438060|515717494|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
143048850|NCT01438060|515717495|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
143048851|NCT01438060|515717494|FG000|On Study Beyond Week 140|Death|0|||
143048852|NCT01438060|515717495|FG001|On Study Beyond Week 140|Death|1|||
143244230|NCT00337675|516446264|FG002|Overall Study|Lost to Follow-up|17|||
143244231|NCT00337675|516446262|FG000|Overall Study|Physician Decision|9|||
143244232|NCT00337675|516446263|FG001|Overall Study|Physician Decision|17|||
143244233|NCT00337675|516446264|FG002|Overall Study|Physician Decision|14|||
143244234|NCT00337675|516446262|FG000|Overall Study|Protocol Violation|21|||
143244235|NCT00337675|516446263|FG001|Overall Study|Protocol Violation|24|||
143244236|NCT00337675|516446264|FG002|Overall Study|Protocol Violation|19|||
143244237|NCT00337675|516446262|FG000|Overall Study|Withdrawal by Subject|25|||
143244238|NCT00337675|516446263|FG001|Overall Study|Withdrawal by Subject|25|||
143244239|NCT00337675|516446264|FG002|Overall Study|Withdrawal by Subject|19|||
143244240|NCT00337675|516446262|FG000|Overall Study|Progressive Disease|0|||
143244241|NCT00337675|516446263|FG001|Overall Study|Progressive Disease|2|||
143244242|NCT00337675|516446264|FG002|Overall Study|Progressive Disease|0|||
143244243|NCT00337675|516446262|FG000|Overall Study|Trial Terminated|0|||
143048853|NCT01438060|515717494|FG000|On Study Beyond Week 140|Other Reason|0|||
143048854|NCT01438060|515717495|FG001|On Study Beyond Week 140|Other Reason|3|||
143048855|NCT03499873|515717496|FG000|Overall Study|Withdrawal by Subject|4|||
143048856|NCT03499873|515717497|FG001|Overall Study|Withdrawal by Subject|6|||
143048857|NCT03499873|515717498|FG002|Overall Study|Withdrawal by Subject|1|||
143048858|NCT03499873|515717496|FG000|Overall Study|Subjects condition worsened|0|||
143048859|NCT03499873|515717497|FG001|Overall Study|Subjects condition worsened|3|||
143048860|NCT03499873|515717498|FG002|Overall Study|Subjects condition worsened|11|||
143048861|NCT03499873|515717496|FG000|Overall Study|Adverse Event|8|||
143048862|NCT03499873|515717497|FG001|Overall Study|Adverse Event|3|||
143048863|NCT03499873|515717498|FG002|Overall Study|Adverse Event|6|||
143048864|NCT03499873|515717496|FG000|Overall Study|Physician Decision|1|||
143048865|NCT03499873|515717497|FG001|Overall Study|Physician Decision|0|||
143048866|NCT03499873|515717498|FG002|Overall Study|Physician Decision|0|||
143048867|NCT03499873|515717496|FG000|Overall Study|Administrative reasons|0|||
143048868|NCT03499873|515717497|FG001|Overall Study|Administrative reasons|1|||
143048869|NCT03499873|515717498|FG002|Overall Study|Administrative reasons|0|||
143048870|NCT03499873|515717496|FG000|Overall Study|Concomitant therapy|5|||
143048871|NCT03499873|515717497|FG001|Overall Study|Concomitant therapy|4|||
143048872|NCT03499873|515717498|FG002|Overall Study|Concomitant therapy|7|||
143048873|NCT03499873|515717496|FG000|Overall Study|Miscellaneous|1|||
143048874|NCT03499873|515717497|FG001|Overall Study|Miscellaneous|2|||
143048875|NCT03499873|515717498|FG002|Overall Study|Miscellaneous|2|||
143048876|NCT03499873|515717496|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
143048877|NCT03499873|515717497|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
143048878|NCT03499873|515717498|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
143048879|NCT01964950|515717499|FG000|Overall Study|Protocol Violation|25|||
143048880|NCT01297504|515717500|FG000|Overall Study|Invalid Consent|1|||
143048881|NCT01297504|515717500|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
143048882|NCT01297504|515717500|FG000|Overall Study|No Study Visits|4|||
143048883|NCT01297504|515717500|FG000|Overall Study|Death|3|||
143244244|NCT00337675|516446263|FG001|Overall Study|Trial Terminated|0|||
143244245|NCT00337675|516446264|FG002|Overall Study|Trial Terminated|2|||
143244246|NCT04269265|516446265|FG000|Overall Study|Physician Decision|1|||
143244247|NCT04269265|516446265|FG000|Overall Study|Withdrawal by Subject|1|||
143244248|NCT04269265|516446265|FG000|Overall Study|Overenrolled (sample size reached)|4|||
143244249|NCT04439136|516446266|FG000|Overall Study|Ineligible|1|||
143244250|NCT04439136|516446266|FG000|Overall Study|Never Started Treatment|2|||
143244251|NCT04439136|516446266|FG000|Overall Study|Adverse Event|4|||
143244252|NCT04439136|516446266|FG000|Overall Study|Death|3|||
143244253|NCT04439136|516446266|FG000|Overall Study|Disease Progression|27|||
143244254|NCT04439136|516446266|FG000|Overall Study|Alternative Therapy|1|||
143244255|NCT04439136|516446266|FG000|Overall Study|Increased Tumor Burden|1|||
143244256|NCT04439136|516446266|FG000|Overall Study|Symptomatic Detrioration|1|||
143244257|NCT02910986|516446270|FG000|Overall Study|non-Latina|14|||
143244258|NCT02910986|516446271|FG001|Overall Study|non-Latina|13|||
143244259|NCT02910986|516446272|FG002|Overall Study|non-Latina|12|||
143244260|NCT02910986|516446270|FG000|Overall Study|Failure to return T! survey|72|||
143244261|NCT02910986|516446271|FG001|Overall Study|Failure to return T! survey|84|||
143244262|NCT02910986|516446272|FG002|Overall Study|Failure to return T! survey|72|||
143244263|NCT02910986|516446270|FG000|Overall Study|T1 Survey not 14-180 post education|25|||
143244264|NCT02910986|516446271|FG001|Overall Study|T1 Survey not 14-180 post education|25|||
143244265|NCT02910986|516446272|FG002|Overall Study|T1 Survey not 14-180 post education|115|||
143244266|NCT02910986|516446270|FG000|Overall Study|Withdrew after randomization prior to start of intervention|0|||
143244267|NCT02910986|516446271|FG001|Overall Study|Withdrew after randomization prior to start of intervention|0|||
143048884|NCT01297504|515717500|FG000|Overall Study|Lost to Follow-up|43|||
143048885|NCT01297504|515717500|FG000|Overall Study|Withdrawal by Subject|9|||
143048886|NCT01297504|515717500|FG000|Overall Study|Site Closure|3|||
143048887|NCT01297504|515717500|FG000|Overall Study|Protocol Violation|3|||
143048888|NCT03602339|515717501|FG000|Overall Study|Withdrawal by Subject|9|||
143048889|NCT03602339|515717501|FG000|Overall Study|Physician Decision|2|||
143048890|NCT03602339|515717501|FG000|Overall Study|Other reason|4|||
143048891|NCT00829452|515717505|FG000|First Intervention|Withdrawal by Subject|0|||
143244268|NCT02910986|516446272|FG002|Overall Study|Withdrew after randomization prior to start of intervention|2|||
143244269|NCT06170242|516446276|FG000|Overall Study|Lost to Follow-up|0|||
143244270|NCT06170242|516446277|FG001|Overall Study|Lost to Follow-up|0|||
143244271|NCT06170242|516446278|FG002|Overall Study|Lost to Follow-up|1|||
143244272|NCT06170242|516446279|FG003|Overall Study|Lost to Follow-up|1|||
143364316|NCT00723294|516876959|FG000|Overall Study|Benign lesion|1|||
143048892|NCT00829452|515717506|FG001|First Intervention|Withdrawal by Subject|1|||
143048893|NCT00829452|515717505|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
143048894|NCT00829452|515717506|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
143048895|NCT00829452|515717505|FG000|Second Intervention|Physician Decision|0|||
143048896|NCT00829452|515717506|FG001|Second Intervention|Physician Decision|1|||
143048897|NCT00574847|515717509|FG000|Overall Study|Adverse Event|2|||
143048898|NCT00574847|515717510|FG001|Overall Study|Adverse Event|0|||
143048899|NCT00574847|515717509|FG000|Overall Study|Death|1|||
143048900|NCT00574847|515717510|FG001|Overall Study|Death|0|||
143048901|NCT00574847|515717509|FG000|Overall Study|Withdrawal by Subject|2|||
143048902|NCT00574847|515717510|FG001|Overall Study|Withdrawal by Subject|2|||
143048903|NCT00574847|515717509|FG000|Overall Study|Physician Decision|1|||
143048904|NCT00574847|515717510|FG001|Overall Study|Physician Decision|0|||
143048905|NCT00574847|515717509|FG000|Overall Study|Did not receive medication (declined)|2|||
143048906|NCT00574847|515717510|FG001|Overall Study|Did not receive medication (declined)|5|||
143048907|NCT02471807|515717511|FG000|Overall Study|Death|14|||
143048908|NCT02471807|515717511|FG000|Overall Study|Withdrawal by Subject|2|||
143048909|NCT02471807|515717511|FG000|Overall Study|Explant|5|||
143048910|NCT02471807|515717511|FG000|Overall Study|Lost to Follow-up|1|||
143048911|NCT00957021|515717514|FG000|Overall Study|Death|5|||
143364317|NCT00723294|516876959|FG000|Overall Study|Withdrawal by Subject|1|||
143364318|NCT00723294|516876959|FG000|Overall Study|No treatment due to probe failure|1|||
143364319|NCT01211665|516876960|FG000|Overall Study|Withdrawal by Subject|1|||
143364320|NCT01211665|516876961|FG001|Overall Study|Withdrawal by Subject|0|||
143364321|NCT01211665|516876960|FG000|Overall Study|Death|1|||
143364322|NCT01211665|516876961|FG001|Overall Study|Death|0|||
143364323|NCT00498186|516876966|FG000|Overall Study|Protocol Violation|10|||
143364324|NCT00498186|516876966|FG000|Overall Study|Lack of Efficacy|31|||
143364325|NCT00498186|516876966|FG000|Overall Study|Adverse Event|89|||
143364326|NCT00498186|516876966|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
143364327|NCT00498186|516876966|FG000|Overall Study|Withdrawal by Subject|18|||
143364328|NCT00498186|516876966|FG000|Overall Study|Lost to Follow-up|3|||
143364329|NCT00498186|516876966|FG000|Overall Study|Other|10|||
143364330|NCT00088465|516876967|FG000|Overall Study|Withdrawal by Subject|290|||
143364331|NCT00088465|516876967|FG000|Overall Study|Adverse Event|77|||
143364332|NCT00088465|516876967|FG000|Overall Study|Lost to Follow-up|57|||
143364333|NCT00088465|516876967|FG000|Overall Study|Physician Decision|45|||
143364334|NCT00088465|516876967|FG000|Overall Study|Sponsor Decision|37|||
143048912|NCT00957021|515717514|FG000|Overall Study|Lost to Follow-up|8|||
143048913|NCT00957021|515717514|FG000|Overall Study|Withdrawal by Subject|34|||
143048914|NCT00957021|515717514|FG000|Overall Study|No 2 yr ROM data|35|||
143048915|NCT00957021|515717514|FG000|Overall Study|Revised study component by 2 yr visit|8|||
143048916|NCT00957021|515717514|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
143048917|NCT00957021|515717514|FG000|Overall Study|Surgery Cancelled|9|||
143048918|NCT00957021|515717514|FG000|Overall Study|Termination due to language issue|2|||
143364335|NCT00088465|516876967|FG000|Overall Study|Lack of Efficacy|27|||
143364336|NCT00088465|516876967|FG000|Overall Study|Protocol Violation|17|||
143364337|NCT00088465|516876967|FG000|Overall Study|Death|11|||
143364338|NCT00448864|516876968|FG000|Overall Study|Death|1|||
143364339|NCT00448864|516876969|FG001|Overall Study|Death|0|||
143364340|NCT00448864|516876970|FG002|Overall Study|Death|0|||
143364341|NCT00448864|516876968|FG000|Overall Study|Lost to Follow-up|3|||
143499195|NCT04426695|517368502|FG003|Overall Study|Randomized but Never Treated|4|||
143499196|NCT04426695|517368503|FG004|Overall Study|Randomized but Never Treated|5|||
143499197|NCT04426695|517368504|FG005|Overall Study|Randomized but Never Treated|5|||
143499198|NCT04426695|517368505|FG006|Overall Study|Randomized but Never Treated|4|||
143499199|NCT04426695|517368506|FG007|Overall Study|Randomized but Never Treated|6|||
143499200|NCT04426695|517368507|FG008|Overall Study|Randomized but Never Treated|6|||
143499201|NCT04426695|517368508|FG009|Overall Study|Randomized but Never Treated|3|||
143499202|NCT04426695|517368509|FG010|Overall Study|Randomized but Never Treated|3|||
143499203|NCT04426695|517368510|FG011|Overall Study|Randomized but Never Treated|6|||
143499204|NCT04426695|517368511|FG012|Overall Study|Randomized but Never Treated|1|||
143499205|NCT04426695|517368512|FG013|Overall Study|Randomized but Never Treated|2|||
143499206|NCT04426695|517368513|FG014|Overall Study|Randomized but Never Treated|0|||
143499207|NCT04426695|517368514|FG015|Overall Study|Randomized but Never Treated|0|||
143499208|NCT04426695|517368515|FG016|Overall Study|Randomized but Never Treated|0|||
143499209|NCT04426695|517368516|FG017|Overall Study|Randomized but Never Treated|0|||
143499210|NCT04303000|517368517|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
143499211|NCT04303000|517368518|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
143499212|NCT04303000|517368519|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
143499213|NCT01058096|517368521|FG000|Double-blind Treatment Phase|Adverse Event|11|||
143499214|NCT01058096|517368522|FG001|Double-blind Treatment Phase|Adverse Event|15|||
143499215|NCT01058096|517368521|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
143499216|NCT01058096|517368522|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
143499217|NCT01058096|517368521|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
143048919|NCT01483820|515717515|FG000|Overall Study|Lack of Efficacy|6|||
143048920|NCT01483820|515717515|FG000|Overall Study|Adverse Event|1|||
143048921|NCT01483820|515717515|FG000|Overall Study|Death|1|||
143048922|NCT01004510|515717517|FG000|Overall Study|Adverse Event|1|||
143048923|NCT00999687|515717518|FG000|First Intervention|Withdrawal by Subject|1|||
143048924|NCT00999687|515717518|FG000|Second Intervention|Withdrawal by Subject|2|||
143048925|NCT00999687|515717518|FG000|Second Intervention|Lack of Efficacy|1|||
143048926|NCT03541252|515717521|FG000|Overall Study|Withdrawal by Subject|1|||
143048927|NCT00842309|515717528|FG000|Overall Study|Withdrawal by Subject|3|||
143048928|NCT00842309|515717529|FG001|Overall Study|Withdrawal by Subject|1|||
143048929|NCT01960296|515717530|FG000|Overall Study|Postponed surgery|1|||
143048930|NCT01960296|515717531|FG001|Overall Study|Postponed surgery|0|||
143048931|NCT01960296|515717530|FG000|Overall Study|Received different procedure|1|||
143048932|NCT01960296|515717531|FG001|Overall Study|Received different procedure|3|||
143048933|NCT02003391|515717532|FG000|Overall Study|Withdrawal by Subject|2|||
143048934|NCT02003391|515717533|FG001|Overall Study|Withdrawal by Subject|1|||
143048935|NCT02003391|515717532|FG000|Overall Study|Protocol Violation|0|||
143048936|NCT02003391|515717533|FG001|Overall Study|Protocol Violation|1|||
143168313|NCT00086515|516163067|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
143168314|NCT00086515|516163066|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
143168315|NCT00086515|516163067|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
143168316|NCT00086515|516163066|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
143168317|NCT00086515|516163067|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
143168318|NCT00086515|516163066|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
143168319|NCT00086515|516163067|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
143168320|NCT00086515|516163066|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
143168321|NCT00086515|516163067|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
143168322|NCT00086515|516163066|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
143168323|NCT00086515|516163067|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
143168324|NCT00086515|516163066|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
143168325|NCT00086515|516163067|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
143168326|NCT00086515|516163066|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
143168327|NCT00086515|516163067|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
143168328|NCT00086515|516163066|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
143168329|NCT00086515|516163067|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
143168330|NCT00086515|516163066|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
143168331|NCT00086515|516163067|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
143168332|NCT00086515|516163066|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
143168333|NCT00086515|516163067|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
143168334|NCT00982280|516163081|FG000|Observation Period|Not eligible to be dosed|19|||
143168335|NCT00982280|516163081|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
143168336|NCT00982280|516163081|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
143168337|NCT00982280|516163081|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
143168338|NCT00982280|516163081|FG000|Maintenance Period|Adverse Event|1|||
143168339|NCT02231580|516163087|FG000|Overall Study|Adverse Event|5|||
143168340|NCT02231580|516163088|FG001|Overall Study|Adverse Event|0|||
143168341|NCT03211416|516163095|FG000|Overall Study|Adverse Event|7|||
143168342|NCT03211416|516163095|FG000|Overall Study|Lack of Efficacy|2|||
143168343|NCT03211416|516163095|FG000|Overall Study|Physician Decision|1|||
143168344|NCT02420717|516163099|FG000|Overall Study|Did not receive all study medication|2|||
143168345|NCT02420717|516163100|FG001|Overall Study|Did not receive all study medication|0|||
143168346|NCT02420717|516163101|FG002|Overall Study|Did not receive all study medication|0|||
143168347|NCT04116489|516163102|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
143168348|NCT04116489|516163102|FG000|Overall Study|Withdrawal by Subject|1|||
143168349|NCT01107496|516163103|FG000|Overall Study|Adverse Event|1|||
143168350|NCT01107496|516163104|FG001|Overall Study|Adverse Event|0|||
143168351|NCT01107496|516163103|FG000|Overall Study|Lack of Efficacy|1|||
143168352|NCT01107496|516163104|FG001|Overall Study|Lack of Efficacy|0|||
143168353|NCT01107496|516163103|FG000|Overall Study|Protocol Violation|0|||
143168354|NCT01107496|516163104|FG001|Overall Study|Protocol Violation|1|||
143168355|NCT01107496|516163103|FG000|Overall Study|Lost to Follow-up|0|||
143168356|NCT01107496|516163104|FG001|Overall Study|Lost to Follow-up|1|||
143168357|NCT03559556|516163105|FG000|Overall Study|Withdrawal by Subject|1|||
143168358|NCT02255656|516163111|FG000|Overall Study|Adverse Event|11|||
143168359|NCT02255656|516163111|FG000|Overall Study|Poor compliance to protocol|3|||
143168360|NCT02255656|516163111|FG000|Overall Study|Lost to Follow-up|30|||
143168361|NCT02255656|516163111|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
143168362|NCT02255656|516163111|FG000|Overall Study|Other|126|||
143168363|NCT01877278|516163112|FG000|Overall Study|Lost to Follow-up|3|||
143048937|NCT02003391|515717532|FG000|Overall Study|Adverse Event|1|||
143048938|NCT02003391|515717533|FG001|Overall Study|Adverse Event|0|||
143048939|NCT03727139|515717534|FG000|Overall Study|Protocol Violation|60|||
143048940|NCT00243347|515717535|FG000|Overall Study|Lack of Efficacy|4|||
143168364|NCT01877278|516163113|FG001|Overall Study|Lost to Follow-up|3|||
143168365|NCT04727151|516163114|FG000|Overall Study|Death|0|||
143244273|NCT01662102|516446284|FG000|Overall Study|Sponsor's decision|1|||
143244274|NCT01662102|516446285|FG001|Overall Study|Sponsor's decision|0|||
143244275|NCT02586207|516446286|FG000|Overall Study|Physician Decision|1|||
143244276|NCT02586207|516446286|FG000|Overall Study|Withdrawal by Subject|1|||
143244277|NCT03527732|516446287|FG000|Overall Study|Lost to Follow-up|21|||
143244278|NCT03527732|516446288|FG001|Overall Study|Lost to Follow-up|23|||
143048941|NCT00243347|515717535|FG000|Overall Study|Adverse Event|2|||
143048942|NCT00243347|515717535|FG000|Overall Study|Death|1|||
143048943|NCT00243347|515717535|FG000|Overall Study|Withdrawal by Subject|5|||
143048944|NCT00243347|515717535|FG000|Overall Study|Condition worsened|7|||
143048945|NCT02264977|515717537|FG000|Overall Study|Death|3|||
143048946|NCT02264977|515717537|FG000|Overall Study|Physician Decision|1|||
143048947|NCT02264977|515717537|FG000|Overall Study|Refuse to return|1|||
143048948|NCT03573544|515717538|FG000|Overall Study|Adverse Event|0|||
143048949|NCT03573544|515717539|FG001|Overall Study|Adverse Event|0|||
143048950|NCT03573544|515717540|FG002|Overall Study|Adverse Event|0|||
143048951|NCT03573544|515717541|FG003|Overall Study|Adverse Event|3|||
143048952|NCT03573544|515717542|FG004|Overall Study|Adverse Event|1|||
143048953|NCT03573544|515717543|FG005|Overall Study|Adverse Event|0|||
143048954|NCT03573544|515717544|FG006|Overall Study|Adverse Event|2|||
143048955|NCT03573544|515717545|FG007|Overall Study|Adverse Event|0|||
143048956|NCT03573544|515717538|FG000|Overall Study|Physician Decision|0|||
143048957|NCT03573544|515717539|FG001|Overall Study|Physician Decision|0|||
143048958|NCT03573544|515717540|FG002|Overall Study|Physician Decision|0|||
143048959|NCT03573544|515717541|FG003|Overall Study|Physician Decision|0|||
143048960|NCT03573544|515717542|FG004|Overall Study|Physician Decision|0|||
143048961|NCT03573544|515717543|FG005|Overall Study|Physician Decision|0|||
143048962|NCT03573544|515717544|FG006|Overall Study|Physician Decision|1|||
143048963|NCT03573544|515717545|FG007|Overall Study|Physician Decision|0|||
143048964|NCT03573544|515717538|FG000|Overall Study|Withdrawal by Subject|2|||
143244279|NCT03527732|516446289|FG002|Overall Study|Lost to Follow-up|80|||
143244280|NCT03527732|516446290|FG003|Overall Study|Lost to Follow-up|62|||
143244281|NCT03527732|516446291|FG004|Overall Study|Lost to Follow-up|12|||
143244282|NCT03527732|516446292|FG005|Overall Study|Lost to Follow-up|20|||
143048965|NCT03573544|515717539|FG001|Overall Study|Withdrawal by Subject|0|||
143048966|NCT03573544|515717540|FG002|Overall Study|Withdrawal by Subject|0|||
143048967|NCT03573544|515717541|FG003|Overall Study|Withdrawal by Subject|1|||
143048968|NCT03573544|515717542|FG004|Overall Study|Withdrawal by Subject|1|||
143048969|NCT03573544|515717543|FG005|Overall Study|Withdrawal by Subject|1|||
143244283|NCT01262989|516446293|FG000|Period 1|Lost to Follow-up|1|||
143244284|NCT01262989|516446294|FG001|Period 1|Lost to Follow-up|1|||
143244285|NCT01262989|516446293|FG000|Period 1|Intercurrent disease|0|||
143244286|NCT01262989|516446294|FG001|Period 1|Intercurrent disease|1|||
143244287|NCT01262989|516446293|FG000|Period 1|Positive answer for exclusion criteria|0|||
143244288|NCT01262989|516446294|FG001|Period 1|Positive answer for exclusion criteria|1|||
143244289|NCT01262989|516446293|FG000|Period 2|Intercurrent disease|0|||
143244290|NCT01262989|516446294|FG001|Period 2|Intercurrent disease|1|||
143244291|NCT02306161|516446295|FG000|Overall Study|Death|1|||
143244292|NCT02306161|516446296|FG001|Overall Study|Death|3|||
143244293|NCT02306161|516446295|FG000|Overall Study|Lack of Efficacy|20|||
143244294|NCT02306161|516446296|FG001|Overall Study|Lack of Efficacy|43|||
143244295|NCT02306161|516446295|FG000|Overall Study|Physician Decision|30|||
143244296|NCT02306161|516446296|FG001|Overall Study|Physician Decision|18|||
143244297|NCT02306161|516446295|FG000|Overall Study|Withdrawal by Subject|4|||
143244298|NCT02306161|516446296|FG001|Overall Study|Withdrawal by Subject|0|||
143244299|NCT02306161|516446295|FG000|Overall Study|Ineligible|9|||
143244300|NCT02306161|516446296|FG001|Overall Study|Ineligible|5|||
143244301|NCT00470275|516446297|FG000|Overall Study|Death|1|||
143244302|NCT00470275|516446297|FG000|Overall Study|Lack of Efficacy|7|||
143244303|NCT00470275|516446297|FG000|Overall Study|Withdrawal by Subject|2|||
143048970|NCT03573544|515717544|FG006|Overall Study|Withdrawal by Subject|0|||
143048971|NCT03573544|515717545|FG007|Overall Study|Withdrawal by Subject|1|||
143048972|NCT03573544|515717538|FG000|Overall Study|Disease progression|3|||
143048973|NCT03573544|515717539|FG001|Overall Study|Disease progression|3|||
143048974|NCT03573544|515717540|FG002|Overall Study|Disease progression|6|||
143048975|NCT03573544|515717541|FG003|Overall Study|Disease progression|4|||
143048976|NCT03573544|515717542|FG004|Overall Study|Disease progression|5|||
143244304|NCT03048578|516446298|FG000|Overall Study|Withdrawal by Subject|5|||
143244305|NCT03048578|516446299|FG001|Overall Study|Withdrawal by Subject|6|||
143244306|NCT03048578|516446298|FG000|Overall Study|Lost to Follow-up|22|||
143244307|NCT03048578|516446299|FG001|Overall Study|Lost to Follow-up|10|||
143244308|NCT03048578|516446298|FG000|Overall Study|Adverse Event|1|||
143048977|NCT03573544|515717543|FG005|Overall Study|Disease progression|7|||
143048978|NCT03573544|515717544|FG006|Overall Study|Disease progression|6|||
143048979|NCT03573544|515717545|FG007|Overall Study|Disease progression|7|||
143048980|NCT03105297|515717549|FG000|Baseline Phase (Day 1)|Other|21|||
143048981|NCT03105297|515717549|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
143048982|NCT03105297|515717549|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
143048983|NCT00227370|515717551|FG000|Overall Study|Withdrawal by Subject|1|||
143048984|NCT00227370|515717552|FG001|Overall Study|Withdrawal by Subject|2|||
143048985|NCT00227370|515717551|FG000|Overall Study|Death|3|||
143048986|NCT00227370|515717552|FG001|Overall Study|Death|4|||
143048987|NCT00227370|515717551|FG000|Overall Study|Adverse Event|6|||
143048988|NCT00227370|515717552|FG001|Overall Study|Adverse Event|11|||
143048989|NCT00227370|515717551|FG000|Overall Study|Physician Decision|9|||
143048990|NCT00227370|515717552|FG001|Overall Study|Physician Decision|6|||
143048991|NCT00227370|515717551|FG000|Overall Study|Other reasons|2|||
143048992|NCT00227370|515717552|FG001|Overall Study|Other reasons|1|||
143048993|NCT03846193|515717553|FG000|Overall Study|Physician Decision|0|||
143048994|NCT03846193|515717554|FG001|Overall Study|Physician Decision|0|||
143168366|NCT04727151|516163115|FG001|Overall Study|Death|0|||
143168367|NCT04727151|516163116|FG002|Overall Study|Death|0|||
143168368|NCT04727151|516163117|FG003|Overall Study|Death|0|||
143168369|NCT04727151|516163118|FG004|Overall Study|Death|3|||
143168370|NCT04727151|516163114|FG000|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
143168371|NCT04727151|516163115|FG001|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
143168372|NCT04727151|516163116|FG002|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
143168373|NCT04727151|516163117|FG003|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
143168374|NCT04727151|516163118|FG004|Overall Study|failed to meet pre-treatment inclusion criteria|2|||
143168375|NCT01346592|516163119|FG000|Overall Study|Lost to Follow-up|62|||
143168376|NCT01346592|516163120|FG001|Overall Study|Lost to Follow-up|29|||
143168377|NCT01346592|516163121|FG002|Overall Study|Lost to Follow-up|29|||
143168378|NCT01346592|516163119|FG000|Overall Study|Protocol Violation|2|||
143168379|NCT01346592|516163120|FG001|Overall Study|Protocol Violation|1|||
143168380|NCT01346592|516163121|FG002|Overall Study|Protocol Violation|0|||
143168381|NCT01346592|516163119|FG000|Overall Study|Death|1|||
143168382|NCT01346592|516163120|FG001|Overall Study|Death|3|||
143168383|NCT01346592|516163121|FG002|Overall Study|Death|4|||
143168384|NCT01346592|516163119|FG000|Overall Study|Adverse Event|0|||
143168385|NCT01346592|516163120|FG001|Overall Study|Adverse Event|1|||
143168386|NCT01346592|516163121|FG002|Overall Study|Adverse Event|0|||
143168387|NCT01346592|516163119|FG000|Overall Study|Withdrawal by Subject|77|||
143168388|NCT01346592|516163120|FG001|Overall Study|Withdrawal by Subject|51|||
143168389|NCT01346592|516163121|FG002|Overall Study|Withdrawal by Subject|38|||
143168390|NCT01346592|516163119|FG000|Overall Study|Inappropriate enrollment|3|||
143168391|NCT01346592|516163120|FG001|Overall Study|Inappropriate enrollment|1|||
143168392|NCT01346592|516163121|FG002|Overall Study|Inappropriate enrollment|1|||
143168393|NCT01346592|516163119|FG000|Overall Study|Administrative reason|1|||
143168394|NCT01346592|516163120|FG001|Overall Study|Administrative reason|0|||
143168395|NCT01346592|516163121|FG002|Overall Study|Administrative reason|0|||
143168396|NCT01346592|516163119|FG000|Overall Study|Unable to Classify|7|||
143168397|NCT01346592|516163120|FG001|Overall Study|Unable to Classify|3|||
143168398|NCT01346592|516163121|FG002|Overall Study|Unable to Classify|6|||
143168399|NCT03510715|516163122|FG000|Overall Study|Adverse Event|1|||
143168400|NCT03510715|516163123|FG001|Overall Study|Adverse Event|0|||
143168401|NCT04144517|516163131|FG000|Overall Study|Physician Decision|0|||
143168402|NCT04144517|516163132|FG001|Overall Study|Physician Decision|1|||
143168403|NCT04144517|516163131|FG000|Overall Study|Other|2|||
143168404|NCT04144517|516163132|FG001|Overall Study|Other|2|||
143168405|NCT04144517|516163131|FG000|Overall Study|Death|6|||
143168406|NCT04144517|516163132|FG001|Overall Study|Death|3|||
143168407|NCT02495883|516163133|FG000|Overall Study|Excessive head motion|1|||
143168408|NCT02495883|516163134|FG001|Overall Study|Excessive head motion|0|||
143168409|NCT03557502|516163135|FG000|Protocol 2|Withdrawal by Subject|1|||
143168410|NCT03557502|516163136|FG001|Protocol 2|Withdrawal by Subject|1|||
143168411|NCT03557502|516163135|FG000|Protocol 2|Met exclusion criteria at Post timepoint|1|||
143168412|NCT03557502|516163136|FG001|Protocol 2|Met exclusion criteria at Post timepoint|1|||
143048995|NCT03846193|515717555|FG002|Overall Study|Physician Decision|1|||
143048996|NCT03846193|515717556|FG003|Overall Study|Physician Decision|0|||
143048997|NCT03846193|515717557|FG004|Overall Study|Physician Decision|0|||
143168413|NCT02296476|516165226|FG000|Overall Study|Disease Progression|6|||
143048998|NCT03846193|515717553|FG000|Overall Study|Lost to Follow-up|0|||
143048999|NCT03846193|515717554|FG001|Overall Study|Lost to Follow-up|0|||
143168414|NCT02296476|516165227|FG001|Overall Study|Disease Progression|4|||
143168415|NCT02296476|516165228|FG002|Overall Study|Disease Progression|2|||
143168416|NCT00442702|516165231|FG000|Titration Period|Adverse Event|2|||
143168417|NCT00442702|516165232|FG001|Titration Period|Adverse Event|0|||
143049000|NCT03846193|515717555|FG002|Overall Study|Lost to Follow-up|0|||
143168418|NCT00442702|516165231|FG000|Titration Period|Death|3|||
143168419|NCT00442702|516165232|FG001|Titration Period|Death|2|||
143168420|NCT00442702|516165231|FG000|Titration Period|Insufficient Therapeutic Response|1|||
143049001|NCT03846193|515717556|FG003|Overall Study|Lost to Follow-up|0|||
143049002|NCT03846193|515717557|FG004|Overall Study|Lost to Follow-up|1|||
143049003|NCT03846193|515717553|FG000|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
143049004|NCT03846193|515717554|FG001|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
143049005|NCT03846193|515717555|FG002|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
143049006|NCT03846193|515717556|FG003|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|2|||
143049007|NCT03846193|515717557|FG004|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
143049008|NCT01968031|515717562|FG000|Overall Study|Adverse Event|13|||
143049009|NCT01968031|515717563|FG001|Overall Study|Adverse Event|10|||
143049010|NCT01968031|515717564|FG002|Overall Study|Adverse Event|22|||
143049011|NCT01968031|515717562|FG000|Overall Study|Withdrawal by Subject|3|||
143168421|NCT00442702|516165232|FG001|Titration Period|Insufficient Therapeutic Response|0|||
143244309|NCT03048578|516446299|FG001|Overall Study|Adverse Event|2|||
143244310|NCT03048578|516446298|FG000|Overall Study|Terminated|3|||
143244311|NCT03048578|516446299|FG001|Overall Study|Terminated|2|||
143244312|NCT00526071|516446300|FG000|Overall Study|Adverse Event|1|||
143244313|NCT00526071|516446300|FG000|Overall Study|Withdrawal by Subject|1|||
143244314|NCT00526071|516446300|FG000|Overall Study|Lack of Response to Study Drug|4|||
143244315|NCT04995419|516446303|FG000|Overall Study|Withdrawal by Subject|3|||
143244316|NCT04995419|516446303|FG000|Overall Study|Progressive Disease|19|||
143244317|NCT04995419|516446303|FG000|Overall Study|Adverse Event|2|||
143244318|NCT04995419|516446303|FG000|Overall Study|Ongoing|16|||
143244319|NCT03306173|516446304|FG000|Overall Study|Lost to Follow-up|16|||
143244320|NCT03306173|516446305|FG001|Overall Study|Lost to Follow-up|23|||
143244321|NCT03306173|516446304|FG000|Overall Study|Withdrawal by Subject|4|||
143244322|NCT03306173|516446305|FG001|Overall Study|Withdrawal by Subject|3|||
143244323|NCT03306173|516446304|FG000|Overall Study|Discontinued|4|||
143244324|NCT03306173|516446305|FG001|Overall Study|Discontinued|4|||
143244325|NCT00125164|516446308|FG000|Overall Study|Adverse Event|0|||
143244326|NCT00125164|516446309|FG001|Overall Study|Adverse Event|0|||
143244327|NCT00125164|516446310|FG002|Overall Study|Adverse Event|2|||
143244328|NCT00125164|516446311|FG003|Overall Study|Adverse Event|4|||
143244329|NCT00125164|516446308|FG000|Overall Study|Lost to Follow-up|0|||
143244330|NCT00125164|516446309|FG001|Overall Study|Lost to Follow-up|0|||
143244331|NCT00125164|516446310|FG002|Overall Study|Lost to Follow-up|1|||
143168422|NCT00442702|516165231|FG000|Titration Period|Refused Treatment|4|||
143168423|NCT00442702|516165232|FG001|Titration Period|Refused Treatment|1|||
143168424|NCT00442702|516165231|FG000|Titration Period|Failure to return|1|||
143168425|NCT00442702|516165232|FG001|Titration Period|Failure to return|0|||
143168426|NCT00442702|516165231|FG000|Titration Period|Hospitalized in another hospital|1|||
143168427|NCT00442702|516165232|FG001|Titration Period|Hospitalized in another hospital|0|||
143168428|NCT00442702|516165231|FG000|Evaluation Period|Adverse Event|1|||
143168429|NCT00442702|516165232|FG001|Evaluation Period|Adverse Event|0|||
143168430|NCT00442702|516165231|FG000|Evaluation Period|Death|1|||
143168431|NCT00442702|516165232|FG001|Evaluation Period|Death|1|||
143168432|NCT00442702|516165231|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
143168433|NCT00442702|516165232|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
143168434|NCT00442702|516165231|FG000|Evaluation Period|Refused treatment|1|||
143168435|NCT00442702|516165232|FG001|Evaluation Period|Refused treatment|1|||
143168436|NCT00442702|516165231|FG000|Evaluation Period|Renal transplant|0|||
143168437|NCT00442702|516165232|FG001|Evaluation Period|Renal transplant|1|||
143168438|NCT00442702|516165231|FG000|Evaluation Period|Failure to return|1|||
143168439|NCT00442702|516165232|FG001|Evaluation Period|Failure to return|0|||
143168440|NCT00442702|516165231|FG000|Evaluation Period|Site closure|0|||
143168441|NCT00442702|516165232|FG001|Evaluation Period|Site closure|1|||
143168442|NCT03440385|516165244|FG000|Overall Study|Other Reason|4|||
143168443|NCT03440385|516165245|FG001|Overall Study|Other Reason|1|||
143168444|NCT03440385|516165244|FG000|Overall Study|Site Closed|1|||
143168445|NCT03440385|516165245|FG001|Overall Study|Site Closed|0|||
143168446|NCT03440385|516165244|FG000|Overall Study|Lost to Follow-up|2|||
143499218|NCT01058096|517368522|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
143244332|NCT00125164|516446311|FG003|Overall Study|Lost to Follow-up|1|||
143168447|NCT03440385|516165245|FG001|Overall Study|Lost to Follow-up|0|||
143244333|NCT00125164|516446308|FG000|Overall Study|Withdrawal by Subject|2|||
143244334|NCT00125164|516446309|FG001|Overall Study|Withdrawal by Subject|0|||
143244335|NCT00125164|516446310|FG002|Overall Study|Withdrawal by Subject|1|||
143244336|NCT00125164|516446311|FG003|Overall Study|Withdrawal by Subject|1|||
143244337|NCT01339052|516446312|FG000|Overall Study|Disease progression|13|||
143168448|NCT03440385|516165244|FG000|Overall Study|Withdrawal by Subject|12|||
143168449|NCT03440385|516165245|FG001|Overall Study|Withdrawal by Subject|6|||
143168450|NCT03440385|516165244|FG000|Overall Study|Lack of Efficacy|9|||
143168451|NCT03440385|516165245|FG001|Overall Study|Lack of Efficacy|2|||
143168452|NCT03440385|516165244|FG000|Overall Study|Adverse Event|15|||
143244338|NCT01339052|516446313|FG001|Overall Study|Disease progression|46|||
143244339|NCT01339052|516446312|FG000|Overall Study|Adverse Event|1|||
143244340|NCT01339052|516446313|FG001|Overall Study|Adverse Event|1|||
143049012|NCT01968031|515717563|FG001|Overall Study|Withdrawal by Subject|7|||
143049013|NCT01968031|515717564|FG002|Overall Study|Withdrawal by Subject|3|||
143049014|NCT01968031|515717562|FG000|Overall Study|Did not meet entry criteria|1|||
143049015|NCT01968031|515717563|FG001|Overall Study|Did not meet entry criteria|1|||
143049016|NCT01968031|515717564|FG002|Overall Study|Did not meet entry criteria|1|||
143049017|NCT01968031|515717562|FG000|Overall Study|Noncompliance|0|||
143049018|NCT01968031|515717563|FG001|Overall Study|Noncompliance|0|||
143049019|NCT01968031|515717564|FG002|Overall Study|Noncompliance|2|||
143049020|NCT01968031|515717562|FG000|Overall Study|Failed inclusion criteria|0|||
143049021|NCT01968031|515717563|FG001|Overall Study|Failed inclusion criteria|2|||
143049022|NCT01968031|515717564|FG002|Overall Study|Failed inclusion criteria|0|||
143049023|NCT01968031|515717562|FG000|Overall Study|Death|0|||
143049024|NCT01968031|515717563|FG001|Overall Study|Death|0|||
143049025|NCT01968031|515717564|FG002|Overall Study|Death|1|||
143049026|NCT01968031|515717562|FG000|Overall Study|Prohibited concomitant medication|1|||
143049027|NCT01968031|515717563|FG001|Overall Study|Prohibited concomitant medication|0|||
143049028|NCT01968031|515717564|FG002|Overall Study|Prohibited concomitant medication|0|||
143049029|NCT04573309|515719312|FG000|Overall Study|Protocol Violation|1|||
143049030|NCT04573309|515719313|FG001|Overall Study|Protocol Violation|0|||
143049031|NCT00258856|515719314|FG000|Overall Study|Lost to Follow-up|1|||
143049032|NCT00258856|515719315|FG001|Overall Study|Lost to Follow-up|0|||
143049033|NCT00258856|515719316|FG002|Overall Study|Lost to Follow-up|2|||
143049034|NCT00258856|515719317|FG003|Overall Study|Lost to Follow-up|0|||
143049035|NCT00258856|515719314|FG000|Overall Study|Non-compliance|2|||
143049036|NCT00258856|515719315|FG001|Overall Study|Non-compliance|0|||
143049037|NCT00258856|515719316|FG002|Overall Study|Non-compliance|0|||
143049038|NCT00258856|515719317|FG003|Overall Study|Non-compliance|1|||
143049039|NCT03234907|515719318|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
143049040|NCT03234907|515719319|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
143049041|NCT03234907|515719320|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
143049042|NCT03234907|515719321|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
143049043|NCT03234907|515719322|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
143049044|NCT03234907|515719323|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
143049045|NCT03234907|515719318|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
143049046|NCT03234907|515719319|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
143049047|NCT03234907|515719320|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
143049048|NCT03234907|515719321|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
143049049|NCT03234907|515719322|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
143049050|NCT03234907|515719323|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
143049051|NCT03234907|515719318|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
143049052|NCT03234907|515719319|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
143049053|NCT03234907|515719320|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
143049054|NCT03234907|515719321|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
143049055|NCT03234907|515719322|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
143049056|NCT03234907|515719323|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
143049057|NCT03234907|515719318|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
143168453|NCT03440385|516165245|FG001|Overall Study|Adverse Event|11|||
143168454|NCT04123704|516165246|FG000|Overall Study|Disease progression|2|||
143168455|NCT00730327|516165247|FG000|Overall Study|Lost to Follow-up|14|||
143168456|NCT00730327|516165248|FG001|Overall Study|Lost to Follow-up|16|||
143049058|NCT03234907|515719319|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
143049059|NCT03234907|515719320|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
143049060|NCT03234907|515719321|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
143049061|NCT03234907|515719322|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
143049062|NCT03234907|515719323|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
143049063|NCT03234907|515719318|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
143049064|NCT03234907|515719319|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
143049065|NCT03234907|515719320|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
143049066|NCT03234907|515719321|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
143049067|NCT03234907|515719322|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
143049068|NCT03234907|515719323|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
143049069|NCT03234907|515719318|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
143049070|NCT03234907|515719319|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
143049071|NCT03234907|515719320|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
143049072|NCT03234907|515719321|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
143049073|NCT03234907|515719322|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
143168457|NCT00730327|516165247|FG000|Overall Study|Adverse Event|8|||
143168458|NCT00730327|516165248|FG001|Overall Study|Adverse Event|1|||
143168459|NCT00730327|516165247|FG000|Overall Study|Withdrawal by Subject|3|||
143168460|NCT00730327|516165248|FG001|Overall Study|Withdrawal by Subject|13|||
143168461|NCT00730327|516165247|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
143364342|NCT00448864|516876969|FG001|Overall Study|Lost to Follow-up|1|||
143364343|NCT00448864|516876970|FG002|Overall Study|Lost to Follow-up|0|||
143364344|NCT00448864|516876968|FG000|Overall Study|Physician Decision|1|||
143364345|NCT00448864|516876969|FG001|Overall Study|Physician Decision|0|||
143364346|NCT00448864|516876970|FG002|Overall Study|Physician Decision|1|||
143364347|NCT00448864|516876968|FG000|Overall Study|Withdrawal by Subject|0|||
143364348|NCT00448864|516876969|FG001|Overall Study|Withdrawal by Subject|2|||
143364349|NCT00448864|516876970|FG002|Overall Study|Withdrawal by Subject|0|||
143364350|NCT00448864|516876968|FG000|Overall Study|Protocol Violation|0|||
143364351|NCT00448864|516876969|FG001|Overall Study|Protocol Violation|2|||
143364352|NCT00448864|516876970|FG002|Overall Study|Protocol Violation|0|||
143364353|NCT01390857|516876971|FG000|Overall Study|Protocol Violation|2|||
143364354|NCT01390857|516876971|FG000|Overall Study|Lost to Follow-up|1|||
143364355|NCT01390857|516876971|FG000|Overall Study|No Visit after the First Visit|7|||
143364356|NCT03929302|516876972|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
143364357|NCT03929302|516876973|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
143364358|NCT03929302|516876974|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
143364359|NCT03929302|516876972|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
143364360|NCT03929302|516876973|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
143364361|NCT03929302|516876974|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
143364362|NCT03929302|516876972|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
143364363|NCT03929302|516876973|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
143364364|NCT03929302|516876974|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
143364365|NCT02757885|516876975|FG000|Overall Study|Screen Failures|4|||
143364366|NCT02688621|516876976|FG000|Overall Study|Pregnancy|1|||
143364367|NCT02688621|516876977|FG001|Overall Study|Pregnancy|3|||
143364368|NCT02688621|516876976|FG000|Overall Study|Lost to Follow-up|38|||
143364369|NCT02688621|516876977|FG001|Overall Study|Lost to Follow-up|15|||
143364370|NCT02688621|516876976|FG000|Overall Study|Withdrawal by Subject|1|||
143364371|NCT02688621|516876977|FG001|Overall Study|Withdrawal by Subject|0|||
143364372|NCT00984282|516876978|FG000|Double Blind Treatment|Adverse Event|40|||
143364373|NCT00984282|516876979|FG001|Double Blind Treatment|Adverse Event|6|||
143364374|NCT00984282|516876978|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
143364375|NCT00984282|516876979|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
143364376|NCT00984282|516876978|FG000|Double Blind Treatment|Physician Decision|1|||
143364377|NCT00984282|516876979|FG001|Double Blind Treatment|Physician Decision|2|||
143364378|NCT00984282|516876978|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
143364379|NCT00984282|516876979|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
143364380|NCT00984282|516876978|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
143364381|NCT00984282|516876979|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
143364382|NCT00984282|516876978|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
143364383|NCT00984282|516876979|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
143364384|NCT00984282|516876978|FG000|Double Blind Treatment|Lost to Follow-up|3|||
143364385|NCT00984282|516876979|FG001|Double Blind Treatment|Lost to Follow-up|0|||
143364386|NCT00984282|516876978|FG000|Double Blind Treatment|Death|8|||
143364387|NCT00984282|516876979|FG001|Double Blind Treatment|Death|4|||
143364388|NCT00984282|516876978|FG000|Double Blind Treatment|Not treated|0|||
143364389|NCT00984282|516876979|FG001|Double Blind Treatment|Not treated|1|||
143364390|NCT00984282|516876978|FG000|Double Blind Treatment|Switched to commercial drug|6|||
143364391|NCT00984282|516876979|FG001|Double Blind Treatment|Switched to commercial drug|1|||
143364392|NCT00984282|516876978|FG000|Double Blind Treatment|protocol driven decision point|1|||
143364393|NCT00984282|516876979|FG001|Double Blind Treatment|protocol driven decision point|1|||
143364394|NCT00984282|516876978|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
143364395|NCT00984282|516876979|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
143364396|NCT00984282|516876978|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
143364397|NCT00984282|516876979|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
143364398|NCT00984282|516876978|FG000|Open-label Treatment|Adverse Event|20|||
143364399|NCT00984282|516876979|FG001|Open-label Treatment|Adverse Event|30|||
143364400|NCT00984282|516876978|FG000|Open-label Treatment|Withdrawal by Subject|6|||
143364401|NCT00984282|516876979|FG001|Open-label Treatment|Withdrawal by Subject|21|||
143364402|NCT00984282|516876978|FG000|Open-label Treatment|Death|7|||
143364403|NCT00984282|516876979|FG001|Open-label Treatment|Death|15|||
143364404|NCT00984282|516876978|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
143364405|NCT00984282|516876979|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
143364406|NCT00984282|516876978|FG000|Open-label Treatment|Lost to Follow-up|1|||
143364407|NCT00984282|516876979|FG001|Open-label Treatment|Lost to Follow-up|1|||
143364408|NCT00984282|516876978|FG000|Open-label Treatment|Patient convenience|1|||
143364409|NCT00984282|516876979|FG001|Open-label Treatment|Patient convenience|0|||
143364410|NCT00984282|516876978|FG000|Open-label Treatment|Non-compliant with study medication|1|||
143364411|NCT00984282|516876979|FG001|Open-label Treatment|Non-compliant with study medication|0|||
143364412|NCT00984282|516876978|FG000|Open-label Treatment|Target lesion removed|0|||
143364413|NCT00984282|516876979|FG001|Open-label Treatment|Target lesion removed|1|||
143364414|NCT00984282|516876978|FG000|Open-label Treatment|Protocol driven decision point|1|||
143364415|NCT00984282|516876979|FG001|Open-label Treatment|Protocol driven decision point|1|||
143364416|NCT00984282|516876978|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
143364417|NCT00984282|516876979|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
143364418|NCT00984282|516876978|FG000|Open-label Treatment|Switched to commercial drug|6|||
143364419|NCT00984282|516876979|FG001|Open-label Treatment|Switched to commercial drug|7|||
143364420|NCT00984282|516876978|FG000|Open-label Treatment|Physician Decision|1|||
143364421|NCT00984282|516876979|FG001|Open-label Treatment|Physician Decision|0|||
143364422|NCT00984282|516876978|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
143364423|NCT00984282|516876979|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
143364424|NCT00984282|516876978|FG000|Long Term Follow-up|Death|27|||
143364425|NCT00984282|516876979|FG001|Long Term Follow-up|Death|68|||
143364426|NCT00984282|516876978|FG000|Long Term Follow-up|Lost to Follow-up|3|||
143364427|NCT00984282|516876979|FG001|Long Term Follow-up|Lost to Follow-up|6|||
143364428|NCT00984282|516876978|FG000|Long Term Follow-up|Protocol driven decision point|25|||
143364429|NCT00984282|516876979|FG001|Long Term Follow-up|Protocol driven decision point|26|||
143364430|NCT00984282|516876978|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
143364431|NCT00984282|516876979|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
143364432|NCT00984282|516876978|FG000|Long Term Follow-up|Switched to commercial drug|4|||
143364433|NCT00984282|516876979|FG001|Long Term Follow-up|Switched to commercial drug|2|||
143364434|NCT00984282|516876978|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
143364435|NCT00984282|516876979|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
143364436|NCT02321540|516876980|FG000|Overall Study|Death|0|||
143364437|NCT02321540|516876981|FG001|Overall Study|Death|1|||
143364438|NCT02321540|516876980|FG000|Overall Study|Progression|3|||
143364439|NCT02321540|516876981|FG001|Overall Study|Progression|9|||
143364440|NCT00372567|516876983|FG000|Phase 3 Study|Adverse Event|5|||
143049074|NCT03234907|515719323|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
143049075|NCT03234907|515719318|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
143049076|NCT03234907|515719319|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
143049077|NCT03234907|515719320|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
143049078|NCT03234907|515719321|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
143049079|NCT03234907|515719322|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
143049080|NCT03234907|515719323|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
143049081|NCT02583048|515719325|FG000|Overall Study|Withdrawal by Subject|0|||
143049082|NCT02583048|515719326|FG001|Overall Study|Withdrawal by Subject|1|||
143049083|NCT02583048|515719327|FG002|Overall Study|Withdrawal by Subject|0|||
143049084|NCT02583048|515719325|FG000|Overall Study|Failed to meet eligibility criterion|0|||
143244341|NCT01339052|516446312|FG000|Overall Study|Withdrawal by Subject|0|||
143244342|NCT01339052|516446313|FG001|Overall Study|Withdrawal by Subject|3|||
143244343|NCT01339052|516446312|FG000|Overall Study|Physician Decision|1|||
143244344|NCT01339052|516446313|FG001|Overall Study|Physician Decision|0|||
143244345|NCT02637037|516446317|FG000|Overall Study|Positive drug screen at admission|1|||
143244346|NCT02637037|516446318|FG001|Overall Study|Positive drug screen at admission|0|||
143244347|NCT02637037|516446317|FG000|Overall Study|Withdrawal by Subject|2|||
143244348|NCT02637037|516446318|FG001|Overall Study|Withdrawal by Subject|1|||
143364441|NCT00372567|516876984|FG001|Phase 3 Study|Adverse Event|1|||
143364442|NCT00372567|516876985|FG002|Phase 3 Study|Adverse Event|1|||
143049085|NCT02583048|515719326|FG001|Overall Study|Failed to meet eligibility criterion|0|||
143049086|NCT02583048|515719327|FG002|Overall Study|Failed to meet eligibility criterion|1|||
143049087|NCT02578641|515719328|FG000|Overall Study|Adverse Event|5|||
143049088|NCT02578641|515719329|FG001|Overall Study|Adverse Event|15|||
143049089|NCT02578641|515719328|FG000|Overall Study|Death|16|||
143049090|NCT02578641|515719329|FG001|Overall Study|Death|8|||
143049091|NCT02578641|515719328|FG000|Overall Study|Lost to Follow-up|0|||
143049092|NCT02578641|515719329|FG001|Overall Study|Lost to Follow-up|1|||
143049093|NCT02578641|515719328|FG000|Overall Study|Withdrawal by Subject|14|||
143364443|NCT00372567|516876983|FG000|Phase 3 Study|Death|1|||
143364444|NCT00372567|516876984|FG001|Phase 3 Study|Death|1|||
143364445|NCT00372567|516876985|FG002|Phase 3 Study|Death|0|||
143364446|NCT00372567|516876983|FG000|Phase 3 Study|Protocol Violation|0|||
143049094|NCT02578641|515719329|FG001|Overall Study|Withdrawal by Subject|7|||
143049095|NCT02578641|515719328|FG000|Overall Study|Progressive Disease|69|||
143049096|NCT02578641|515719329|FG001|Overall Study|Progressive Disease|21|||
143049097|NCT02578641|515719328|FG000|Overall Study|No Study Drug|2|||
143244349|NCT02637037|516446317|FG000|Overall Study|Adverse Event|1|||
143364447|NCT00372567|516876984|FG001|Phase 3 Study|Protocol Violation|0|||
143364448|NCT00372567|516876985|FG002|Phase 3 Study|Protocol Violation|1|||
143364449|NCT00372567|516876983|FG000|Phase 3 Study|Objective progression or relapse|10|||
143364450|NCT00372567|516876984|FG001|Phase 3 Study|Objective progression or relapse|13|||
143364451|NCT00372567|516876985|FG002|Phase 3 Study|Objective progression or relapse|4|||
143049098|NCT02578641|515719329|FG001|Overall Study|No Study Drug|0|||
143049099|NCT02578641|515719328|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
143244350|NCT02637037|516446318|FG001|Overall Study|Adverse Event|0|||
143244351|NCT02023697|516446321|FG000|Treatment Period|Radiological progression|13|||
143244352|NCT02023697|516446322|FG001|Treatment Period|Radiological progression|17|||
143244353|NCT02023697|516446323|FG002|Treatment Period|Radiological progression|26|||
143244354|NCT02023697|516446321|FG000|Treatment Period|Never Treated|5|||
143244355|NCT02023697|516446322|FG001|Treatment Period|Never Treated|6|||
143244356|NCT02023697|516446323|FG002|Treatment Period|Never Treated|10|||
143244357|NCT02023697|516446321|FG000|Treatment Period|Adverse Event|13|||
143244358|NCT02023697|516446322|FG001|Treatment Period|Adverse Event|25|||
143244359|NCT02023697|516446323|FG002|Treatment Period|Adverse Event|23|||
143244360|NCT02023697|516446321|FG000|Treatment Period|Logistical difficulties|1|||
143244361|NCT02023697|516446322|FG001|Treatment Period|Logistical difficulties|1|||
143244362|NCT02023697|516446323|FG002|Treatment Period|Logistical difficulties|1|||
143244363|NCT02023697|516446321|FG000|Treatment Period|Clinical progression|10|||
143244364|NCT02023697|516446322|FG001|Treatment Period|Clinical progression|8|||
143244365|NCT02023697|516446323|FG002|Treatment Period|Clinical progression|28|||
143244366|NCT02023697|516446321|FG000|Treatment Period|Withdrawal by Subject|4|||
143244367|NCT02023697|516446322|FG001|Treatment Period|Withdrawal by Subject|5|||
143244368|NCT02023697|516446323|FG002|Treatment Period|Withdrawal by Subject|13|||
143244369|NCT02023697|516446321|FG000|Treatment Period|Safety outcome reached|0|||
143244370|NCT02023697|516446322|FG001|Treatment Period|Safety outcome reached|1|||
143244371|NCT02023697|516446323|FG002|Treatment Period|Safety outcome reached|0|||
143244372|NCT02023697|516446321|FG000|Treatment Period|Physician Decision|0|||
143244373|NCT02023697|516446322|FG001|Treatment Period|Physician Decision|0|||
143244374|NCT02023697|516446323|FG002|Treatment Period|Physician Decision|1|||
143244375|NCT02023697|516446321|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
143244376|NCT02023697|516446322|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
143244377|NCT02023697|516446323|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
143244378|NCT02023697|516446321|FG000|Active Follow-up Period|Lost to Follow-up|1|||
143244379|NCT02023697|516446322|FG001|Active Follow-up Period|Lost to Follow-up|1|||
143244380|NCT02023697|516446323|FG002|Active Follow-up Period|Lost to Follow-up|1|||
143244381|NCT02023697|516446321|FG000|Active Follow-up Period|Deterioration of general condition|1|||
143244382|NCT02023697|516446322|FG001|Active Follow-up Period|Deterioration of general condition|1|||
143244383|NCT02023697|516446323|FG002|Active Follow-up Period|Deterioration of general condition|1|||
143244384|NCT02023697|516446321|FG000|Active Follow-up Period|Other unspecified|2|||
143244385|NCT02023697|516446322|FG001|Active Follow-up Period|Other unspecified|0|||
143244386|NCT02023697|516446323|FG002|Active Follow-up Period|Other unspecified|1|||
143244387|NCT02023697|516446321|FG000|Active Follow-up Period|Clinical progression|0|||
143244388|NCT02023697|516446322|FG001|Active Follow-up Period|Clinical progression|2|||
143244389|NCT02023697|516446323|FG002|Active Follow-up Period|Clinical progression|1|||
143244390|NCT02023697|516446321|FG000|Active Follow-up Period|Radiological progression|0|||
143244391|NCT02023697|516446322|FG001|Active Follow-up Period|Radiological progression|0|||
143244392|NCT02023697|516446323|FG002|Active Follow-up Period|Radiological progression|1|||
143244393|NCT02023697|516446321|FG000|Active Follow-up Period|Death|83|||
143244394|NCT02023697|516446322|FG001|Active Follow-up Period|Death|82|||
143244395|NCT02023697|516446323|FG002|Active Follow-up Period|Death|87|||
143244396|NCT02023697|516446321|FG000|Long-term Follow-up Period|Death|9|||
143244397|NCT02023697|516446322|FG001|Long-term Follow-up Period|Death|6|||
143049100|NCT02578641|515719329|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
143049101|NCT02578641|515719328|FG000|Overall Study|Non-compliance with Study Schedule|1|||
143049102|NCT02578641|515719329|FG001|Overall Study|Non-compliance with Study Schedule|0|||
143049103|NCT02578641|515719328|FG000|Overall Study|Other|1|||
143049104|NCT02578641|515719329|FG001|Overall Study|Other|10|||
143049105|NCT02578641|515719328|FG000|Overall Study|Not treated|1|||
143049106|NCT02578641|515719329|FG001|Overall Study|Not treated|4|||
143049107|NCT02313558|515719333|FG000|Overall Study|Withdrawal by Subject|2|||
143049108|NCT02313558|515719334|FG001|Overall Study|Withdrawal by Subject|0|||
143049109|NCT02313558|515719333|FG000|Overall Study|Lost to Follow-up|4|||
143049110|NCT02313558|515719334|FG001|Overall Study|Lost to Follow-up|4|||
143244398|NCT02023697|516446323|FG002|Long-term Follow-up Period|Death|4|||
143244399|NCT02023697|516446321|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
143364452|NCT00372567|516876983|FG000|Phase 3 Study|Global deterioration of health status|0|||
143364453|NCT00372567|516876984|FG001|Phase 3 Study|Global deterioration of health status|1|||
143364454|NCT00372567|516876985|FG002|Phase 3 Study|Global deterioration of health status|0|||
143364455|NCT00372567|516876983|FG000|Phase 3 Study|Other|2|||
143049111|NCT04158687|515719335|FG000|Overall Study|Adverse Event|2|||
143049112|NCT04158687|515719336|FG001|Overall Study|Adverse Event|3|||
143049113|NCT04158687|515719337|FG002|Overall Study|Adverse Event|0|||
143049114|NCT04158687|515719338|FG003|Overall Study|Adverse Event|3|||
143244400|NCT02023697|516446322|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
143244401|NCT02023697|516446323|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
143244402|NCT02023697|516446321|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
143244403|NCT02023697|516446322|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
143244404|NCT02023697|516446323|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
143244405|NCT02023697|516446321|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
143049115|NCT04158687|515719335|FG000|Overall Study|Lost to Follow-up|5|||
143049116|NCT04158687|515719336|FG001|Overall Study|Lost to Follow-up|12|||
143049117|NCT04158687|515719337|FG002|Overall Study|Lost to Follow-up|4|||
143049118|NCT04158687|515719338|FG003|Overall Study|Lost to Follow-up|5|||
143049119|NCT04158687|515719335|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
143049120|NCT04158687|515719336|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
143049121|NCT04158687|515719337|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
143049122|NCT04158687|515719338|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
143049123|NCT04158687|515719335|FG000|Overall Study|Non-Compliance with Study Medication|2|||
143049124|NCT04158687|515719336|FG001|Overall Study|Non-Compliance with Study Medication|2|||
143049125|NCT04158687|515719337|FG002|Overall Study|Non-Compliance with Study Medication|3|||
143049126|NCT04158687|515719338|FG003|Overall Study|Non-Compliance with Study Medication|0|||
143049127|NCT04158687|515719335|FG000|Overall Study|Investigator Decision|0|||
143049128|NCT04158687|515719336|FG001|Overall Study|Investigator Decision|0|||
143049129|NCT04158687|515719337|FG002|Overall Study|Investigator Decision|2|||
143049130|NCT04158687|515719338|FG003|Overall Study|Investigator Decision|0|||
143049131|NCT04158687|515719335|FG000|Overall Study|Protocol Violation|0|||
143049132|NCT04158687|515719336|FG001|Overall Study|Protocol Violation|2|||
143049133|NCT04158687|515719337|FG002|Overall Study|Protocol Violation|1|||
143049134|NCT04158687|515719338|FG003|Overall Study|Protocol Violation|0|||
143244406|NCT02023697|516446322|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
143049135|NCT04158687|515719335|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
143049136|NCT04158687|515719336|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
143049137|NCT04158687|515719337|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
143049138|NCT04158687|515719338|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
143049139|NCT04158687|515719335|FG000|Overall Study|Reason not Specified|3|||
143049140|NCT04158687|515719336|FG001|Overall Study|Reason not Specified|2|||
143049141|NCT04158687|515719337|FG002|Overall Study|Reason not Specified|4|||
143049142|NCT04158687|515719338|FG003|Overall Study|Reason not Specified|4|||
143049143|NCT00640393|515719339|FG000|Part 1|Lost to Follow-up|2|||
143049144|NCT00640393|515719340|FG001|Part 1|Lost to Follow-up|0|||
143049145|NCT00640393|515719341|FG002|Part 1|Lost to Follow-up|0|||
143049146|NCT00640393|515719339|FG000|Part 1|Withdrawal by Subject|3|||
143049147|NCT00640393|515719340|FG001|Part 1|Withdrawal by Subject|0|||
143049148|NCT00640393|515719341|FG002|Part 1|Withdrawal by Subject|0|||
143049149|NCT00640393|515719339|FG000|Randomization|Withdrawn per protocol|17|||
143049150|NCT00640393|515719340|FG001|Randomization|Withdrawn per protocol|0|||
143049151|NCT00640393|515719341|FG002|Randomization|Withdrawn per protocol|0|||
143049152|NCT00640393|515719339|FG000|Randomization|Never randomized by site|2|||
143049153|NCT00640393|515719340|FG001|Randomization|Never randomized by site|0|||
143049154|NCT00640393|515719341|FG002|Randomization|Never randomized by site|0|||
143049155|NCT00640393|515719339|FG000|Part 2|Lost to Follow-up|0|||
143049156|NCT00640393|515719340|FG001|Part 2|Lost to Follow-up|2|||
143049157|NCT00640393|515719341|FG002|Part 2|Lost to Follow-up|2|||
143049158|NCT00640393|515719339|FG000|Part 2|Withdrawal by Subject|0|||
143049159|NCT00640393|515719340|FG001|Part 2|Withdrawal by Subject|6|||
143168462|NCT00730327|516165248|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
143168463|NCT02552225|516165249|FG000|Overall Study|Withdrawal by Subject|1|||
143168464|NCT02552225|516165250|FG001|Overall Study|Withdrawal by Subject|0|||
143168465|NCT03122184|516165251|FG000|Overall Study|Lost to Follow-up|4|||
143168466|NCT03122184|516165252|FG001|Overall Study|Lost to Follow-up|6|||
143168467|NCT03122184|516165251|FG000|Overall Study|Withdrawal by Subject|3|||
143168468|NCT03122184|516165252|FG001|Overall Study|Withdrawal by Subject|0|||
143168469|NCT03122184|516165251|FG000|Overall Study|Terminated due to cognitive problem|1|||
143168470|NCT03122184|516165252|FG001|Overall Study|Terminated due to cognitive problem|0|||
143168471|NCT02297516|516165255|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
143168472|NCT02297516|516165256|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
143168473|NCT02297516|516165255|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
143168474|NCT02297516|516165256|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
143244407|NCT02023697|516446323|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
143244408|NCT02023697|516446321|FG000|Long-term Follow-up Period|Technical problems|0|||
143244409|NCT02023697|516446322|FG001|Long-term Follow-up Period|Technical problems|0|||
143244410|NCT02023697|516446323|FG002|Long-term Follow-up Period|Technical problems|1|||
143049160|NCT00640393|515719341|FG002|Part 2|Withdrawal by Subject|1|||
143049161|NCT00640393|515719339|FG000|Part 2|Non-adherence|0|||
143049162|NCT00640393|515719340|FG001|Part 2|Non-adherence|1|||
143049163|NCT00640393|515719341|FG002|Part 2|Non-adherence|0|||
143049164|NCT00640393|515719339|FG000|Part 2|Adverse Event|0|||
143049165|NCT00640393|515719340|FG001|Part 2|Adverse Event|1|||
143049166|NCT00640393|515719341|FG002|Part 2|Adverse Event|0|||
143049167|NCT01911429|515719342|FG000|Overall Study|Adverse Event|5|||
143049168|NCT01911429|515719343|FG001|Overall Study|Adverse Event|3|||
143049169|NCT01911429|515719344|FG002|Overall Study|Adverse Event|9|||
143049170|NCT01911429|515719342|FG000|Overall Study|Lack of Efficacy|1|||
143049171|NCT01911429|515719343|FG001|Overall Study|Lack of Efficacy|2|||
143049172|NCT01911429|515719344|FG002|Overall Study|Lack of Efficacy|4|||
143049173|NCT01911429|515719342|FG000|Overall Study|Lost to Follow-up|0|||
143049174|NCT01911429|515719343|FG001|Overall Study|Lost to Follow-up|0|||
143049175|NCT01911429|515719344|FG002|Overall Study|Lost to Follow-up|1|||
143049176|NCT01911429|515719342|FG000|Overall Study|Protocol Violation|0|||
143049177|NCT01911429|515719343|FG001|Overall Study|Protocol Violation|0|||
143049178|NCT01911429|515719344|FG002|Overall Study|Protocol Violation|1|||
143049179|NCT01911429|515719342|FG000|Overall Study|Withdrawal by Subject|5|||
143049180|NCT01911429|515719343|FG001|Overall Study|Withdrawal by Subject|5|||
143049181|NCT01911429|515719344|FG002|Overall Study|Withdrawal by Subject|4|||
143049182|NCT01911429|515719342|FG000|Overall Study|Accidental randomization|0|||
143049183|NCT01911429|515719343|FG001|Overall Study|Accidental randomization|0|||
143049184|NCT01911429|515719344|FG002|Overall Study|Accidental randomization|1|||
143049185|NCT01911429|515719342|FG000|Overall Study|subject left study|1|||
143049186|NCT01911429|515719343|FG001|Overall Study|subject left study|0|||
143049187|NCT01911429|515719344|FG002|Overall Study|subject left study|0|||
143049188|NCT00198133|515719346|FG000|Overall Study|Disease progression|2|||
143049189|NCT00198133|515719347|FG001|Overall Study|Disease progression|5|||
143049190|NCT00198133|515719346|FG000|Overall Study|Adverse Event|1|||
143049191|NCT00198133|515719347|FG001|Overall Study|Adverse Event|3|||
143049192|NCT00198133|515719346|FG000|Overall Study|Withdrawal by Subject|1|||
143049193|NCT00198133|515719347|FG001|Overall Study|Withdrawal by Subject|0|||
143049194|NCT00198133|515719346|FG000|Overall Study|Physician Decision|1|||
143049195|NCT00198133|515719347|FG001|Overall Study|Physician Decision|0|||
143049196|NCT00835666|515719350|FG000|Washout|Protocol Violation|1|||
143049197|NCT00835666|515719351|FG001|Washout|Protocol Violation|0|||
143049198|NCT00835666|515719350|FG000|Washout|Withdrawal by Subject|1|||
143049199|NCT00835666|515719351|FG001|Washout|Withdrawal by Subject|0|||
143049200|NCT03707587|515719355|FG000|Overall Study|Death|0|||
143049201|NCT03707587|515719356|FG001|Overall Study|Death|1|||
143049202|NCT01537887|515719357|FG000|Period 1|Physician Decision|0|||
143049203|NCT01537887|515719358|FG001|Period 1|Physician Decision|0|||
143049204|NCT01537887|515719359|FG002|Period 1|Physician Decision|0|||
143049205|NCT01537887|515719360|FG003|Period 1|Physician Decision|0|||
143049206|NCT01537887|515719361|FG004|Period 1|Physician Decision|1|||
143049207|NCT01537887|515719362|FG005|Period 1|Physician Decision|1|||
143049208|NCT01537887|515719357|FG000|Period 1|Did not receive treatment|0|||
143049209|NCT01537887|515719358|FG001|Period 1|Did not receive treatment|0|||
143049210|NCT01537887|515719359|FG002|Period 1|Did not receive treatment|1|||
143049211|NCT01537887|515719360|FG003|Period 1|Did not receive treatment|0|||
143049212|NCT01537887|515719361|FG004|Period 1|Did not receive treatment|0|||
143049213|NCT01537887|515719362|FG005|Period 1|Did not receive treatment|0|||
143049214|NCT01537887|515719357|FG000|Period 2|Withdrawal by Subject|0|||
143049215|NCT01537887|515719358|FG001|Period 2|Withdrawal by Subject|1|||
143244411|NCT02023697|516446321|FG000|Long-term Follow-up Period|Other unspecified|6|||
143244412|NCT02023697|516446322|FG001|Long-term Follow-up Period|Other unspecified|3|||
143244413|NCT02023697|516446323|FG002|Long-term Follow-up Period|Other unspecified|5|||
143244414|NCT04939415|516446324|FG000|Overall Study|Withdrawal by Subject|1|||
143244415|NCT04939415|516446325|FG001|Overall Study|Withdrawal by Subject|3|||
143244416|NCT04939415|516446324|FG000|Overall Study|Lost to Follow-up|0|||
143244417|NCT04939415|516446325|FG001|Overall Study|Lost to Follow-up|2|||
143244418|NCT04308291|516446326|FG000|Run-In Phase|Withdrawal by Subject|4|||
143244419|NCT04308291|516446326|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
143244420|NCT04308291|516446326|FG000|Study Phase 6-M|Physician Decision|2|||
143244421|NCT04308291|516446326|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
143244422|NCT04308291|516446326|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
143244423|NCT04308291|516446326|FG000|Study Phase 12-M|Physician Decision|2|||
143244424|NCT04308291|516446326|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
143244425|NCT03610269|516446328|FG000|Overall Study|Physician Decision|10|||
143244426|NCT03610269|516446328|FG000|Overall Study|Protocol Violation|1|||
143244427|NCT03610269|516446328|FG000|Overall Study|Unable to draw blood|1|||
143499219|NCT01058096|517368521|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
143499220|NCT01058096|517368522|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
143049216|NCT01537887|515719359|FG002|Period 2|Withdrawal by Subject|0|||
143049217|NCT01537887|515719360|FG003|Period 2|Withdrawal by Subject|0|||
143049218|NCT01537887|515719361|FG004|Period 2|Withdrawal by Subject|0|||
143049219|NCT01537887|515719362|FG005|Period 2|Withdrawal by Subject|0|||
143049220|NCT01537887|515719357|FG000|Period 3|Adverse Event|0|||
143049221|NCT01537887|515719358|FG001|Period 3|Adverse Event|0|||
143049222|NCT01537887|515719359|FG002|Period 3|Adverse Event|1|||
143049223|NCT01537887|515719360|FG003|Period 3|Adverse Event|0|||
143049224|NCT01537887|515719361|FG004|Period 3|Adverse Event|0|||
143049225|NCT01537887|515719362|FG005|Period 3|Adverse Event|0|||
143049226|NCT01537887|515719357|FG000|Period 3|Withdrawal by Subject|0|||
143244428|NCT03610269|516446328|FG000|Overall Study|Screen fail|4|||
143244429|NCT00067002|516446331|FG000|Overall Study|Early Death|1|||
143244430|NCT00067002|516446332|FG001|Overall Study|Early Death|2|||
143244431|NCT00067002|516446331|FG000|Overall Study|Delayed|1|||
143049227|NCT01537887|515719358|FG001|Period 3|Withdrawal by Subject|1|||
143049228|NCT01537887|515719359|FG002|Period 3|Withdrawal by Subject|0|||
143049229|NCT01537887|515719360|FG003|Period 3|Withdrawal by Subject|0|||
143049230|NCT01537887|515719361|FG004|Period 3|Withdrawal by Subject|0|||
143049231|NCT01537887|515719362|FG005|Period 3|Withdrawal by Subject|0|||
143049232|NCT00731939|515719363|FG000|Overall Study|Adverse Event|6|||
143049233|NCT00731939|515719363|FG000|Overall Study|Lost to Follow-up|15|||
143049234|NCT00731939|515719363|FG000|Overall Study|Not implanted with study device|9|||
143049235|NCT00731939|515719363|FG000|Overall Study|Withdrawal by Subject|2|||
143244432|NCT00067002|516446332|FG001|Overall Study|Delayed|1|||
143244433|NCT00067002|516446331|FG000|Overall Study|Graft Failure|5|||
143244434|NCT00067002|516446332|FG001|Overall Study|Graft Failure|6|||
143049236|NCT00731939|515719363|FG000|Overall Study|Did not meet enrollment criteria|2|||
143049237|NCT00840203|515719364|FG000|First Intervention|Protocol Violation|1|||
143049238|NCT00840203|515719365|FG001|First Intervention|Protocol Violation|1|||
143049239|NCT00840203|515719364|FG000|Washout|Protocol Violation|1|||
143049240|NCT00840203|515719365|FG001|Washout|Protocol Violation|0|||
143049241|NCT02121184|515719366|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
143168475|NCT02297516|516165255|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
143168476|NCT02297516|516165256|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
143244435|NCT00611026|516446334|FG000|Randomized to Double-blind Treatment|Not treated|2|||
143499221|NCT01058096|517368521|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
143499222|NCT01058096|517368522|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
143168477|NCT00710593|516165257|FG000|Overall Study|Incarceration|1|||
143168478|NCT00710593|516165258|FG001|Overall Study|Incarceration|0|||
143168479|NCT00710593|516165257|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
143168480|NCT00710593|516165258|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
143168481|NCT00710593|516165257|FG000|Overall Study|Lost to Follow-up|3|||
143168482|NCT00710593|516165258|FG001|Overall Study|Lost to Follow-up|1|||
143168483|NCT00710593|516165257|FG000|Overall Study|Moved out of area|1|||
143168484|NCT00710593|516165258|FG001|Overall Study|Moved out of area|0|||
143168485|NCT00710593|516165257|FG000|Overall Study|Failure to adhere or complete study eval|1|||
143168486|NCT00710593|516165258|FG001|Overall Study|Failure to adhere or complete study eval|1|||
143168487|NCT00710593|516165257|FG000|Overall Study|Protocol Violation|1|||
143168488|NCT00710593|516165258|FG001|Overall Study|Protocol Violation|1|||
143168489|NCT00710593|516165257|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
143168490|NCT00710593|516165258|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
143168491|NCT04490278|516165259|FG000|Overall Study|Lost to Follow-up|6|||
143168492|NCT04734210|516165263|FG000|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
143168493|NCT04734210|516165264|FG001|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
143168494|NCT04734210|516165265|FG002|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|0|||
143168495|NCT04734210|516165263|FG000|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|1|||
143168496|NCT04734210|516165264|FG001|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
143168497|NCT04734210|516165265|FG002|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
143168498|NCT04734210|516165263|FG000|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|1|||
143168499|NCT04734210|516165264|FG001|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
143168500|NCT04734210|516165265|FG002|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
143168501|NCT04734210|516165263|FG000|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
143168502|NCT04734210|516165264|FG001|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
143168503|NCT04734210|516165265|FG002|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|1|||
143168504|NCT02684461|516165266|FG000|Overall Study|Adverse Event|1|||
143168505|NCT02684461|516165267|FG001|Overall Study|Adverse Event|0|||
143168506|NCT02684461|516165268|FG002|Overall Study|Adverse Event|0|||
143168507|NCT02684461|516165266|FG000|Overall Study|Lack of Efficacy|1|||
143168508|NCT02684461|516165267|FG001|Overall Study|Lack of Efficacy|2|||
143168509|NCT02684461|516165268|FG002|Overall Study|Lack of Efficacy|0|||
143168510|NCT03493958|516165269|FG000|Overall Study|Withdrawal by Subject|6|||
143168511|NCT03493958|516165269|FG000|Overall Study|Lost to Follow-up|7|||
143168512|NCT03493958|516165269|FG000|Overall Study|Did not complete all required study procedures|2|||
143168513|NCT01029535|516165270|FG000|Overall Study|Lost to Follow-up|24|||
143168514|NCT01029535|516165270|FG000|Overall Study|Protocol Violation|2|||
143244436|NCT00611026|516446335|FG001|Randomized to Double-blind Treatment|Not treated|1|||
143499223|NCT01058096|517368521|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
143499224|NCT01058096|517368522|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
143244437|NCT00611026|516446336|FG002|Randomized to Double-blind Treatment|Not treated|3|||
143049242|NCT02121184|515719367|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
143049243|NCT02121184|515719366|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
143049244|NCT02121184|515719367|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
143049245|NCT02121184|515719366|FG000|Overall Study|Emergency cesarean section required|0|||
143049246|NCT02121184|515719367|FG001|Overall Study|Emergency cesarean section required|2|||
143049247|NCT02121184|515719366|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
143049248|NCT02121184|515719367|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
143049249|NCT04411680|515719370|FG000|Treatment Period|Adverse Event|3|||
143049250|NCT04411680|515719371|FG001|Treatment Period|Adverse Event|0|||
143049251|NCT04411680|515719370|FG000|Treatment Period|Discharged from hospital|18|||
143049252|NCT04411680|515719371|FG001|Treatment Period|Discharged from hospital|7|||
143049253|NCT04411680|515719370|FG000|Treatment Period|Missed 1 or more doses|8|||
143049254|NCT04411680|515719371|FG001|Treatment Period|Missed 1 or more doses|0|||
143049255|NCT04411680|515719370|FG000|Treatment Period|Transferred to another hospital|0|||
143049256|NCT04411680|515719371|FG001|Treatment Period|Transferred to another hospital|1|||
143049257|NCT04411680|515719370|FG000|Follow up Period|Withdrawal by Subject|2|||
143049258|NCT04411680|515719371|FG001|Follow up Period|Withdrawal by Subject|0|||
143049259|NCT04411680|515719370|FG000|Follow up Period|Lost to Follow-up|5|||
143049260|NCT04411680|515719371|FG001|Follow up Period|Lost to Follow-up|6|||
143049261|NCT04411680|515719370|FG000|Follow up Period|Death|11|||
143049262|NCT04411680|515719371|FG001|Follow up Period|Death|8|||
143049263|NCT00989950|515719372|FG000|Randomized Phase|Protocol Violation|1|||
143049264|NCT00989950|515719373|FG001|Randomized Phase|Protocol Violation|0|||
143049265|NCT00989950|515719374|FG002|Randomized Phase|Protocol Violation|0|||
143049266|NCT00989950|515719375|FG003|Randomized Phase|Protocol Violation|0|||
143049267|NCT00989950|515719372|FG000|Randomized Phase|Adverse Event|0|||
143049268|NCT00989950|515719373|FG001|Randomized Phase|Adverse Event|1|||
143049269|NCT00989950|515719374|FG002|Randomized Phase|Adverse Event|0|||
143049270|NCT00989950|515719375|FG003|Randomized Phase|Adverse Event|0|||
143049271|NCT00101439|515719376|FG000|Period 2|Withdrawal by Subject|0|||
143049272|NCT00101439|515719377|FG001|Period 2|Withdrawal by Subject|2|||
143049273|NCT01867658|515719379|FG000|Overall Study|Withdrawal by Subject|6|||
143049274|NCT01867658|515719379|FG000|Overall Study|Death|2|||
143049275|NCT01867658|515719379|FG000|Overall Study|Subject could not be contacted|1|||
143049276|NCT03101358|515719380|FG000|Overall Study|Non-compliance with study schedule|1|||
143049277|NCT03101358|515719381|FG001|Overall Study|Non-compliance with study schedule|0|||
143049278|NCT03101358|515719382|FG002|Overall Study|Non-compliance with study schedule|0|||
143049279|NCT03101358|515719383|FG003|Overall Study|Non-compliance with study schedule|1|||
143049280|NCT03101358|515719380|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
143168515|NCT01029535|516165270|FG000|Overall Study|Participant Withdrew Consent|2|||
143168516|NCT01029535|516165270|FG000|Overall Study|Adverse Event|1|||
143168517|NCT01029535|516165270|FG000|Overall Study|Use of Another Treatment|1|||
143168518|NCT01029535|516165270|FG000|Overall Study|Death|1|||
143168519|NCT02095106|516165271|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
143168520|NCT02095106|516165272|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
143168521|NCT02314923|516165273|FG000|Overall Study|Death|0|||
143168522|NCT02314923|516165274|FG001|Overall Study|Death|0|||
143168523|NCT02314923|516165275|FG002|Overall Study|Death|0|||
143168524|NCT02314923|516165276|FG003|Overall Study|Death|1|||
143168525|NCT02314923|516165277|FG004|Overall Study|Death|0|||
143168526|NCT02314923|516165278|FG005|Overall Study|Death|0|||
143168527|NCT02314923|516165279|FG006|Overall Study|Death|0|||
143168528|NCT02314923|516165280|FG007|Overall Study|Death|0|||
143168529|NCT02314923|516165281|FG008|Overall Study|Death|0|||
143168530|NCT02314923|516165282|FG009|Overall Study|Death|0|||
143168531|NCT02314923|516165273|FG000|Overall Study|Lost to Follow-up|2|||
143168532|NCT02314923|516165274|FG001|Overall Study|Lost to Follow-up|3|||
143168533|NCT02314923|516165275|FG002|Overall Study|Lost to Follow-up|1|||
143168534|NCT02314923|516165276|FG003|Overall Study|Lost to Follow-up|0|||
143168535|NCT02314923|516165277|FG004|Overall Study|Lost to Follow-up|0|||
143168536|NCT02314923|516165278|FG005|Overall Study|Lost to Follow-up|0|||
143168537|NCT02314923|516165279|FG006|Overall Study|Lost to Follow-up|3|||
143168538|NCT02314923|516165280|FG007|Overall Study|Lost to Follow-up|4|||
143168539|NCT02314923|516165281|FG008|Overall Study|Lost to Follow-up|2|||
143049281|NCT03101358|515719381|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
143049282|NCT03101358|515719382|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
143049283|NCT03101358|515719383|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
143049284|NCT03101358|515719380|FG000|Overall Study|Physician Decision|1|||
143049285|NCT03101358|515719381|FG001|Overall Study|Physician Decision|0|||
143168540|NCT02314923|516165282|FG009|Overall Study|Lost to Follow-up|0|||
143168541|NCT02314923|516165273|FG000|Overall Study|Withdrawal by Subject|0|||
143168542|NCT02314923|516165274|FG001|Overall Study|Withdrawal by Subject|0|||
143168543|NCT02314923|516165275|FG002|Overall Study|Withdrawal by Subject|1|||
143168544|NCT02314923|516165276|FG003|Overall Study|Withdrawal by Subject|0|||
143168545|NCT02314923|516165277|FG004|Overall Study|Withdrawal by Subject|1|||
143168546|NCT02314923|516165278|FG005|Overall Study|Withdrawal by Subject|0|||
143049286|NCT03101358|515719382|FG002|Overall Study|Physician Decision|0|||
143049287|NCT03101358|515719383|FG003|Overall Study|Physician Decision|3|||
143049288|NCT03101358|515719380|FG000|Overall Study|Adverse Event|0|||
143049289|NCT03101358|515719381|FG001|Overall Study|Adverse Event|0|||
143049290|NCT03101358|515719382|FG002|Overall Study|Adverse Event|1|||
143049291|NCT03101358|515719383|FG003|Overall Study|Adverse Event|0|||
143049292|NCT03101358|515719380|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
143049293|NCT03101358|515719381|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
143049294|NCT03101358|515719382|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
143049295|NCT03101358|515719383|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
143049296|NCT03101358|515719380|FG000|Overall Study|Lost to Follow-up|1|||
143049297|NCT03101358|515719381|FG001|Overall Study|Lost to Follow-up|0|||
143049298|NCT03101358|515719382|FG002|Overall Study|Lost to Follow-up|0|||
143049299|NCT03101358|515719383|FG003|Overall Study|Lost to Follow-up|1|||
143049300|NCT02426918|515719384|FG000|Overall Study|Adverse Event|2|||
143049301|NCT02426918|515719385|FG001|Overall Study|Adverse Event|2|||
143049302|NCT02426918|515719386|FG002|Overall Study|Adverse Event|0|||
143049303|NCT02426918|515719384|FG000|Overall Study|Physician Decision|1|||
143049304|NCT02426918|515719385|FG001|Overall Study|Physician Decision|1|||
143049305|NCT02426918|515719386|FG002|Overall Study|Physician Decision|1|||
143049306|NCT02426918|515719384|FG000|Overall Study|Withdrawal by Subject|5|||
143049307|NCT02426918|515719385|FG001|Overall Study|Withdrawal by Subject|5|||
143049308|NCT02426918|515719386|FG002|Overall Study|Withdrawal by Subject|4|||
143049309|NCT02426918|515719384|FG000|Overall Study|Other|9|||
143049310|NCT02426918|515719385|FG001|Overall Study|Other|11|||
143049311|NCT02426918|515719386|FG002|Overall Study|Other|9|||
143049312|NCT02845336|515719387|FG000|Overall Study|Lost to Follow-up|3|||
143049313|NCT02845336|515719388|FG001|Overall Study|Lost to Follow-up|1|||
143049314|NCT02845336|515719387|FG000|Overall Study|Inability to get medication|2|||
143049315|NCT02845336|515719388|FG001|Overall Study|Inability to get medication|0|||
143049316|NCT01496118|515719389|FG000|Overall Study|Disease progression|3|||
143049317|NCT01496118|515719390|FG001|Overall Study|Disease progression|2|||
143049318|NCT01496118|515719391|FG002|Overall Study|Disease progression|3|||
143049319|NCT01496118|515719392|FG003|Overall Study|Disease progression|1|||
143049320|NCT01496118|515719393|FG004|Overall Study|Disease progression|2|||
143049321|NCT01496118|515719394|FG005|Overall Study|Disease progression|2|||
143049322|NCT01496118|515719395|FG006|Overall Study|Disease progression|14|||
143049323|NCT01496118|515719396|FG007|Overall Study|Disease progression|10|||
143049324|NCT01496118|515719389|FG000|Overall Study|Physician Decision|0|||
143049325|NCT01496118|515719390|FG001|Overall Study|Physician Decision|0|||
143049326|NCT01496118|515719391|FG002|Overall Study|Physician Decision|0|||
143049327|NCT01496118|515719392|FG003|Overall Study|Physician Decision|0|||
143049328|NCT01496118|515719393|FG004|Overall Study|Physician Decision|1|||
143049329|NCT01496118|515719394|FG005|Overall Study|Physician Decision|0|||
143049330|NCT01496118|515719395|FG006|Overall Study|Physician Decision|3|||
143049331|NCT01496118|515719396|FG007|Overall Study|Physician Decision|6|||
143049332|NCT01496118|515719389|FG000|Overall Study|Adverse Event|1|||
143049333|NCT01496118|515719390|FG001|Overall Study|Adverse Event|1|||
143049334|NCT01496118|515719391|FG002|Overall Study|Adverse Event|0|||
143049335|NCT01496118|515719392|FG003|Overall Study|Adverse Event|0|||
143049336|NCT01496118|515719393|FG004|Overall Study|Adverse Event|0|||
143049337|NCT01496118|515719394|FG005|Overall Study|Adverse Event|0|||
143049338|NCT01496118|515719395|FG006|Overall Study|Adverse Event|6|||
143168547|NCT02314923|516165279|FG006|Overall Study|Withdrawal by Subject|1|||
143168548|NCT02314923|516165280|FG007|Overall Study|Withdrawal by Subject|0|||
143168549|NCT02314923|516165281|FG008|Overall Study|Withdrawal by Subject|0|||
143168550|NCT02314923|516165282|FG009|Overall Study|Withdrawal by Subject|0|||
143168551|NCT02314923|516165273|FG000|Overall Study|Physician Decision|0|||
143168552|NCT02314923|516165274|FG001|Overall Study|Physician Decision|1|||
143168553|NCT02314923|516165275|FG002|Overall Study|Physician Decision|0|||
143168554|NCT02314923|516165276|FG003|Overall Study|Physician Decision|0|||
143049339|NCT01496118|515719396|FG007|Overall Study|Adverse Event|10|||
143049340|NCT01496118|515719389|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
143049341|NCT01496118|515719390|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
143049342|NCT01496118|515719391|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
143049343|NCT01496118|515719392|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
143049344|NCT01496118|515719393|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
143168555|NCT02314923|516165277|FG004|Overall Study|Physician Decision|0|||
143168556|NCT02314923|516165278|FG005|Overall Study|Physician Decision|0|||
143049345|NCT01496118|515719394|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
143049346|NCT01496118|515719395|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
143049347|NCT01496118|515719396|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
143049348|NCT01496118|515719389|FG000|Overall Study|Death|0|||
143049349|NCT01496118|515719390|FG001|Overall Study|Death|0|||
143049350|NCT01496118|515719391|FG002|Overall Study|Death|0|||
143049351|NCT01496118|515719392|FG003|Overall Study|Death|0|||
143049352|NCT01496118|515719393|FG004|Overall Study|Death|0|||
143049353|NCT01496118|515719394|FG005|Overall Study|Death|0|||
143049354|NCT01496118|515719395|FG006|Overall Study|Death|1|||
143049355|NCT01496118|515719396|FG007|Overall Study|Death|1|||
143049356|NCT01496118|515719389|FG000|Overall Study|Withdrawal by Subject|0|||
143049357|NCT01496118|515719390|FG001|Overall Study|Withdrawal by Subject|0|||
143049358|NCT01496118|515719391|FG002|Overall Study|Withdrawal by Subject|0|||
143049359|NCT01496118|515719392|FG003|Overall Study|Withdrawal by Subject|2|||
143049360|NCT01496118|515719393|FG004|Overall Study|Withdrawal by Subject|0|||
143049361|NCT01496118|515719394|FG005|Overall Study|Withdrawal by Subject|1|||
143049362|NCT01496118|515719395|FG006|Overall Study|Withdrawal by Subject|6|||
143049363|NCT01496118|515719396|FG007|Overall Study|Withdrawal by Subject|3|||
143049364|NCT00841659|515719397|FG000|Washout: 2 Weeks|Protocol Violation|1|||
143049365|NCT00841659|515719398|FG001|Washout: 2 Weeks|Protocol Violation|0|||
143049366|NCT02420353|515719399|FG000|Overall Study|Withdrawal by Subject|0|||
143049367|NCT02420353|515719400|FG001|Overall Study|Withdrawal by Subject|1|||
143049368|NCT03306277|515719406|FG000|Overall Study|Death|1|||
143049369|NCT03306277|515719406|FG000|Overall Study|Adverse Event|1|||
143049370|NCT03306277|515719406|FG000|Overall Study|Withdrawal by Subject|1|||
143049371|NCT01087502|515719418|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
143049372|NCT01087502|515719419|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
143049373|NCT01087502|515719418|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
143049374|NCT01087502|515719419|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
143049375|NCT01087502|515719418|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
143049376|NCT01087502|515719419|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
143049377|NCT01087502|515719418|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
143049378|NCT01087502|515719419|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
143049379|NCT01087502|515719418|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
143049380|NCT01087502|515719419|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
143049381|NCT01087502|515719418|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
143049382|NCT01087502|515719419|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
143049383|NCT01087502|515719418|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
143049384|NCT01087502|515719419|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
143049385|NCT01087502|515719418|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
143049386|NCT01087502|515719419|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
143049387|NCT01087502|515719418|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
143049388|NCT01087502|515719419|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
143049389|NCT01087502|515719418|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
143049390|NCT01087502|515719419|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
143049391|NCT01087502|515719418|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
143049392|NCT01087502|515719419|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
143049393|NCT01087502|515719418|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
143049394|NCT01087502|515719419|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
143049395|NCT01653704|515719420|FG000|Overall Study|Technical failure during recording|1|||
143049396|NCT01653704|515719421|FG001|Overall Study|Technical failure during recording|1|||
143049397|NCT01653704|515719420|FG000|Overall Study|Performance not reflective of training|1|||
143049398|NCT01653704|515719421|FG001|Overall Study|Performance not reflective of training|0|||
143049399|NCT02705716|515719422|FG000|Overall Study|Adverse Event|0|||
143049400|NCT02705716|515719423|FG001|Overall Study|Adverse Event|1|||
143049401|NCT02705716|515719422|FG000|Overall Study|Protocol Violation|3|||
143049402|NCT02705716|515719423|FG001|Overall Study|Protocol Violation|0|||
143168557|NCT02314923|516165279|FG006|Overall Study|Physician Decision|0|||
143168558|NCT02314923|516165280|FG007|Overall Study|Physician Decision|0|||
143168559|NCT02314923|516165281|FG008|Overall Study|Physician Decision|0|||
143168560|NCT02314923|516165282|FG009|Overall Study|Physician Decision|0|||
143168561|NCT02314923|516165273|FG000|Overall Study|Participant unavailable|0|||
143168562|NCT02314923|516165274|FG001|Overall Study|Participant unavailable|0|||
143168563|NCT02314923|516165275|FG002|Overall Study|Participant unavailable|0|||
143168564|NCT02314923|516165276|FG003|Overall Study|Participant unavailable|0|||
143168565|NCT02314923|516165277|FG004|Overall Study|Participant unavailable|0|||
143364456|NCT00372567|516876984|FG001|Phase 3 Study|Other|2|||
143049403|NCT02705716|515719422|FG000|Overall Study|Withdrawal of Consent|1|||
143049404|NCT02705716|515719423|FG001|Overall Study|Withdrawal of Consent|1|||
143049405|NCT01632306|515719424|FG000|Overall Study|Protocol Violation|1|||
143049406|NCT01632306|515719425|FG001|Overall Study|Protocol Violation|0|||
143049407|NCT01632306|515719426|FG002|Overall Study|Protocol Violation|0|||
143049408|NCT03966911|515719427|FG000|Overall Study|Adverse Event|1|||
143049409|NCT03966911|515719428|FG001|Overall Study|Adverse Event|1|||
143049410|NCT03966911|515719427|FG000|Overall Study|Withdrawal by Subject|8|||
143049411|NCT03966911|515719428|FG001|Overall Study|Withdrawal by Subject|2|||
143168566|NCT02314923|516165278|FG005|Overall Study|Participant unavailable|1|||
143168567|NCT02314923|516165279|FG006|Overall Study|Participant unavailable|0|||
143049412|NCT03966911|515719427|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
143049413|NCT03966911|515719428|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
143049414|NCT00380588|515719429|FG000|Overall Study|Unequivocal Disease Progression|25|||
143049415|NCT00380588|515719430|FG001|Overall Study|Unequivocal Disease Progression|34|||
143049416|NCT00380588|515719429|FG000|Overall Study|Next Cycle Not Started|4|||
143049417|NCT00380588|515719430|FG001|Overall Study|Next Cycle Not Started|0|||
143049418|NCT00380588|515719429|FG000|Overall Study|Adverse Event|7|||
143049419|NCT00380588|515719430|FG001|Overall Study|Adverse Event|3|||
143049420|NCT00380588|515719429|FG000|Overall Study|Withdrawal by Subject|1|||
143049421|NCT00380588|515719430|FG001|Overall Study|Withdrawal by Subject|3|||
143049422|NCT00380588|515719429|FG000|Overall Study|Physician Decision|2|||
143049423|NCT00380588|515719430|FG001|Overall Study|Physician Decision|0|||
143049424|NCT01986647|515719431|FG000|Overall Study|Lost to Follow-up|4|||
143049425|NCT01986647|515719432|FG001|Overall Study|Lost to Follow-up|1|||
143049426|NCT01986647|515719433|FG002|Overall Study|Lost to Follow-up|4|||
143049427|NCT01986647|515719434|FG003|Overall Study|Lost to Follow-up|4|||
143049428|NCT01986647|515719431|FG000|Overall Study|Withdrawal by Subject|1|||
143049429|NCT01986647|515719432|FG001|Overall Study|Withdrawal by Subject|3|||
143049430|NCT01986647|515719433|FG002|Overall Study|Withdrawal by Subject|2|||
143049431|NCT01986647|515719434|FG003|Overall Study|Withdrawal by Subject|3|||
143049432|NCT01986647|515719431|FG000|Overall Study|Health|5|||
143049433|NCT01986647|515719432|FG001|Overall Study|Health|3|||
143049434|NCT01986647|515719433|FG002|Overall Study|Health|6|||
143049435|NCT01986647|515719434|FG003|Overall Study|Health|4|||
143049436|NCT02905435|515719435|FG000|Overall Study|Death|2|||
143049437|NCT02905435|515719435|FG000|Overall Study|Physician Decision|1|||
143049438|NCT02905435|515719435|FG000|Overall Study|Lost to Follow-up|4|||
143049439|NCT04476277|515719441|FG000|Overall Study|Withdrawal by Subject|0|||
143049440|NCT04476277|515719442|FG001|Overall Study|Withdrawal by Subject|0|||
143049441|NCT04476277|515719443|FG002|Overall Study|Withdrawal by Subject|1|||
143049442|NCT04476277|515719444|FG003|Overall Study|Withdrawal by Subject|0|||
143049443|NCT02272803|515719445|FG000|Overall Study|Disease progression|16|||
143049444|NCT02272803|515719446|FG001|Overall Study|Disease progression|8|||
143049445|NCT02272803|515719445|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
143049446|NCT02272803|515719446|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
143049447|NCT02272803|515719445|FG000|Overall Study|Study drug toxicity|4|||
143049448|NCT02272803|515719446|FG001|Overall Study|Study drug toxicity|9|||
143049449|NCT02272803|515719445|FG000|Overall Study|Participant request to discontinue study treatment|3|||
143049450|NCT02272803|515719446|FG001|Overall Study|Participant request to discontinue study treatment|7|||
143049451|NCT02272803|515719445|FG000|Overall Study|Maximum clinical benefit|4|||
143049452|NCT02272803|515719446|FG001|Overall Study|Maximum clinical benefit|2|||
143049453|NCT02272803|515719445|FG000|Overall Study|Poor/non-compliance|2|||
143049454|NCT02272803|515719446|FG001|Overall Study|Poor/non-compliance|2|||
143049455|NCT02272803|515719445|FG000|Overall Study|Withdrawal by Subject|2|||
143049456|NCT02272803|515719446|FG001|Overall Study|Withdrawal by Subject|1|||
143049457|NCT02272803|515719445|FG000|Overall Study|Death|0|||
143049458|NCT02272803|515719446|FG001|Overall Study|Death|1|||
143049459|NCT02272803|515719445|FG000|Overall Study|Other reasons|1|||
143049460|NCT02272803|515719446|FG001|Overall Study|Other reasons|3|||
143049461|NCT02272803|515719445|FG000|Overall Study|Administrative reason by sponsor|5|||
143244438|NCT00611026|516446334|FG000|Double-blind Treatment Period|Death|1|||
143244439|NCT00611026|516446335|FG001|Double-blind Treatment Period|Death|0|||
143244440|NCT00611026|516446336|FG002|Double-blind Treatment Period|Death|0|||
143244441|NCT00611026|516446334|FG000|Double-blind Treatment Period|Adverse Event|9|||
143244442|NCT00611026|516446335|FG001|Double-blind Treatment Period|Adverse Event|28|||
143244443|NCT00611026|516446336|FG002|Double-blind Treatment Period|Adverse Event|46|||
143244444|NCT00611026|516446334|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
143244445|NCT00611026|516446335|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
143244446|NCT00611026|516446336|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
143244447|NCT00611026|516446334|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
143244448|NCT00611026|516446335|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
143244449|NCT00611026|516446336|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
143244450|NCT00611026|516446334|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
143244451|NCT00611026|516446335|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
143364457|NCT00372567|516876985|FG002|Phase 3 Study|Other|1|||
143244452|NCT00611026|516446336|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
143244453|NCT00611026|516446334|FG000|Double-blind Treatment Period|Other|13|||
143244454|NCT00611026|516446335|FG001|Double-blind Treatment Period|Other|20|||
143244455|NCT00611026|516446336|FG002|Double-blind Treatment Period|Other|18|||
143244456|NCT01147874|516446337|FG000|Overall Study|Adverse Event|5|||
143244457|NCT01147874|516446337|FG000|Overall Study|Investigator's Request|1|||
143244458|NCT01147874|516446337|FG000|Overall Study|Lost to Follow-up|25|||
143244459|NCT01147874|516446337|FG000|Overall Study|Other|5|||
143244460|NCT01147874|516446337|FG000|Overall Study|Protocol Violation|5|||
143168568|NCT02314923|516165280|FG007|Overall Study|Participant unavailable|0|||
143168569|NCT02314923|516165281|FG008|Overall Study|Participant unavailable|0|||
143168570|NCT02314923|516165282|FG009|Overall Study|Participant unavailable|0|||
143168571|NCT02314923|516165273|FG000|Overall Study|Screen failure|0|||
143168572|NCT02314923|516165274|FG001|Overall Study|Screen failure|0|||
143168573|NCT02314923|516165275|FG002|Overall Study|Screen failure|0|||
143168574|NCT02314923|516165276|FG003|Overall Study|Screen failure|0|||
143168575|NCT02314923|516165277|FG004|Overall Study|Screen failure|0|||
143168576|NCT02314923|516165278|FG005|Overall Study|Screen failure|0|||
143168577|NCT02314923|516165279|FG006|Overall Study|Screen failure|1|||
143168578|NCT02314923|516165280|FG007|Overall Study|Screen failure|0|||
143168579|NCT02314923|516165281|FG008|Overall Study|Screen failure|0|||
143168580|NCT02314923|516165282|FG009|Overall Study|Screen failure|0|||
143168581|NCT02314923|516165273|FG000|Overall Study|Participant relocation|1|||
143168582|NCT02314923|516165274|FG001|Overall Study|Participant relocation|0|||
143168583|NCT02314923|516165275|FG002|Overall Study|Participant relocation|0|||
143168584|NCT02314923|516165276|FG003|Overall Study|Participant relocation|0|||
143168585|NCT02314923|516165277|FG004|Overall Study|Participant relocation|0|||
143168586|NCT02314923|516165278|FG005|Overall Study|Participant relocation|0|||
143168587|NCT02314923|516165279|FG006|Overall Study|Participant relocation|0|||
143168588|NCT02314923|516165280|FG007|Overall Study|Participant relocation|1|||
143168589|NCT02314923|516165281|FG008|Overall Study|Participant relocation|0|||
143168590|NCT02314923|516165282|FG009|Overall Study|Participant relocation|0|||
143168591|NCT04476784|516165283|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
143168592|NCT04476784|516165284|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
143168593|NCT06582732|516165286|FG000|Initial Study Period|Adverse Event|0|||
143168594|NCT06582732|516165287|FG001|Initial Study Period|Adverse Event|0|||
143168595|NCT06582732|516165288|FG002|Initial Study Period|Adverse Event|0|||
143168596|NCT06582732|516165289|FG003|Initial Study Period|Adverse Event|2|||
143168597|NCT06582732|516165290|FG004|Initial Study Period|Adverse Event|0|||
143168598|NCT06582732|516165291|FG005|Initial Study Period|Adverse Event|0|||
143168599|NCT06582732|516165292|FG006|Initial Study Period|Adverse Event|0|||
143168600|NCT06582732|516165286|FG000|Initial Study Period|Death|1|||
143168601|NCT06582732|516165287|FG001|Initial Study Period|Death|0|||
143168602|NCT06582732|516165288|FG002|Initial Study Period|Death|0|||
143168603|NCT06582732|516165289|FG003|Initial Study Period|Death|0|||
143168604|NCT06582732|516165290|FG004|Initial Study Period|Death|1|||
143168605|NCT06582732|516165291|FG005|Initial Study Period|Death|0|||
143168606|NCT06582732|516165292|FG006|Initial Study Period|Death|0|||
143168607|NCT06582732|516165286|FG000|Initial Study Period|Lost to Follow-up|0|||
143168608|NCT06582732|516165287|FG001|Initial Study Period|Lost to Follow-up|0|||
143168609|NCT06582732|516165288|FG002|Initial Study Period|Lost to Follow-up|2|||
143168610|NCT06582732|516165289|FG003|Initial Study Period|Lost to Follow-up|0|||
143168611|NCT06582732|516165290|FG004|Initial Study Period|Lost to Follow-up|0|||
143168612|NCT06582732|516165291|FG005|Initial Study Period|Lost to Follow-up|0|||
143168613|NCT06582732|516165292|FG006|Initial Study Period|Lost to Follow-up|0|||
143168614|NCT06582732|516165286|FG000|Initial Study Period|Withdrawal by Subject|0|||
143168615|NCT06582732|516165287|FG001|Initial Study Period|Withdrawal by Subject|1|||
143168616|NCT06582732|516165288|FG002|Initial Study Period|Withdrawal by Subject|0|||
143168617|NCT06582732|516165289|FG003|Initial Study Period|Withdrawal by Subject|1|||
143168618|NCT06582732|516165290|FG004|Initial Study Period|Withdrawal by Subject|3|||
143244461|NCT01147874|516446337|FG000|Overall Study|Sponsor's Decision|2|||
143244462|NCT01147874|516446337|FG000|Overall Study|Withdrawal by Subject|24|||
143244463|NCT02175030|516446338|FG000|Overall Study|Failed screen after consent|7|||
143244464|NCT02175030|516446339|FG001|Overall Study|Failed screen after consent|6|||
143244465|NCT02175030|516446338|FG000|Overall Study|Failed IUD Insertion|20|||
143049462|NCT02272803|515719446|FG001|Overall Study|Administrative reason by sponsor|4|||
143168619|NCT06582732|516165291|FG005|Initial Study Period|Withdrawal by Subject|1|||
143168620|NCT06582732|516165292|FG006|Initial Study Period|Withdrawal by Subject|2|||
143168621|NCT06582732|516165286|FG000|Initial Study Period|Moved Away|0|||
143168622|NCT06582732|516165287|FG001|Initial Study Period|Moved Away|0|||
143168623|NCT06582732|516165288|FG002|Initial Study Period|Moved Away|0|||
143168624|NCT06582732|516165289|FG003|Initial Study Period|Moved Away|0|||
143168625|NCT06582732|516165290|FG004|Initial Study Period|Moved Away|1|||
143168626|NCT06582732|516165291|FG005|Initial Study Period|Moved Away|0|||
143244466|NCT02175030|516446339|FG001|Overall Study|Failed IUD Insertion|21|||
143244467|NCT02175030|516446338|FG000|Overall Study|Physician Decision|1|||
143244468|NCT02175030|516446339|FG001|Overall Study|Physician Decision|1|||
143364458|NCT00372567|516876983|FG000|Phase 3 Study|study terminated by sponsor|13|||
143364459|NCT00372567|516876984|FG001|Phase 3 Study|study terminated by sponsor|8|||
143364460|NCT00372567|516876985|FG002|Phase 3 Study|study terminated by sponsor|5|||
143364461|NCT00691028|516876986|FG000|Open-label Period|Adverse Event|0|||
143364462|NCT00691028|516876987|FG001|Open-label Period|Adverse Event|0|||
143364463|NCT00691028|516876988|FG002|Open-label Period|Adverse Event|0|||
143049463|NCT02611323|515719447|FG000|Overall Study|Death|3|||
143049464|NCT02611323|515719448|FG001|Overall Study|Death|1|||
143049465|NCT02611323|515719449|FG002|Overall Study|Death|0|||
143049466|NCT02611323|515719450|FG003|Overall Study|Death|0|||
143049467|NCT02611323|515719451|FG004|Overall Study|Death|1|||
143049468|NCT02611323|515719452|FG005|Overall Study|Death|1|||
143049469|NCT02611323|515719453|FG006|Overall Study|Death|8|||
143049470|NCT02611323|515719454|FG007|Overall Study|Death|0|||
143049471|NCT02611323|515719455|FG008|Overall Study|Death|4|||
143049472|NCT02611323|515719456|FG009|Overall Study|Death|6|||
143049473|NCT02611323|515719457|FG010|Overall Study|Death|26|||
143049474|NCT02611323|515719447|FG000|Overall Study|Lost to Follow-up|1|||
143049475|NCT02611323|515719448|FG001|Overall Study|Lost to Follow-up|0|||
143049476|NCT02611323|515719449|FG002|Overall Study|Lost to Follow-up|0|||
143049477|NCT02611323|515719450|FG003|Overall Study|Lost to Follow-up|0|||
143049478|NCT02611323|515719451|FG004|Overall Study|Lost to Follow-up|0|||
143049479|NCT02611323|515719452|FG005|Overall Study|Lost to Follow-up|0|||
143049480|NCT02611323|515719453|FG006|Overall Study|Lost to Follow-up|3|||
143049481|NCT02611323|515719454|FG007|Overall Study|Lost to Follow-up|0|||
143049482|NCT02611323|515719455|FG008|Overall Study|Lost to Follow-up|0|||
143049483|NCT02611323|515719456|FG009|Overall Study|Lost to Follow-up|0|||
143049484|NCT02611323|515719457|FG010|Overall Study|Lost to Follow-up|2|||
143049485|NCT02611323|515719447|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
143049486|NCT02611323|515719448|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
143049487|NCT02611323|515719449|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
143049488|NCT02611323|515719450|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
143049489|NCT02611323|515719451|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
143049490|NCT02611323|515719452|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
143049491|NCT02611323|515719453|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
143049492|NCT02611323|515719454|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
143049493|NCT02611323|515719455|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
143049494|NCT02611323|515719456|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
143049495|NCT02611323|515719457|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
143049496|NCT02611323|515719447|FG000|Overall Study|Progressive Disease|0|||
143049497|NCT02611323|515719448|FG001|Overall Study|Progressive Disease|0|||
143049498|NCT02611323|515719449|FG002|Overall Study|Progressive Disease|0|||
143049499|NCT02611323|515719450|FG003|Overall Study|Progressive Disease|0|||
143049500|NCT02611323|515719451|FG004|Overall Study|Progressive Disease|0|||
143049501|NCT02611323|515719452|FG005|Overall Study|Progressive Disease|0|||
143049502|NCT02611323|515719453|FG006|Overall Study|Progressive Disease|0|||
143049503|NCT02611323|515719454|FG007|Overall Study|Progressive Disease|0|||
143049504|NCT02611323|515719455|FG008|Overall Study|Progressive Disease|0|||
143049505|NCT02611323|515719456|FG009|Overall Study|Progressive Disease|0|||
143049506|NCT02611323|515719457|FG010|Overall Study|Progressive Disease|1|||
143049507|NCT02611323|515719447|FG000|Overall Study|Withdrawal by Subject|1|||
143049508|NCT02611323|515719448|FG001|Overall Study|Withdrawal by Subject|0|||
143049509|NCT02611323|515719449|FG002|Overall Study|Withdrawal by Subject|0|||
143049510|NCT02611323|515719450|FG003|Overall Study|Withdrawal by Subject|0|||
143049511|NCT02611323|515719451|FG004|Overall Study|Withdrawal by Subject|0|||
143049512|NCT02611323|515719452|FG005|Overall Study|Withdrawal by Subject|0|||
143049513|NCT02611323|515719453|FG006|Overall Study|Withdrawal by Subject|0|||
143049514|NCT02611323|515719454|FG007|Overall Study|Withdrawal by Subject|1|||
143049515|NCT02611323|515719455|FG008|Overall Study|Withdrawal by Subject|0|||
143049516|NCT02611323|515719456|FG009|Overall Study|Withdrawal by Subject|1|||
143049517|NCT02611323|515719457|FG010|Overall Study|Withdrawal by Subject|0|||
143049518|NCT00858403|515719458|FG000|Overall Study|Withdrawal by Subject|1|||
143049519|NCT00858403|515719458|FG000|Overall Study|Death|3|||
143049520|NCT00858403|515719458|FG000|Overall Study|Disease Progression|1|||
143049521|NCT02597049|515719459|FG000|Overall Study|Lost to Follow-up|0|||
143049522|NCT02597049|515719460|FG001|Overall Study|Lost to Follow-up|3|||
143049523|NCT02597049|515719461|FG002|Overall Study|Lost to Follow-up|2|||
143049524|NCT02597049|515719459|FG000|Overall Study|Withdrawal by Subject|2|||
143049525|NCT02597049|515719460|FG001|Overall Study|Withdrawal by Subject|2|||
143049526|NCT02597049|515719461|FG002|Overall Study|Withdrawal by Subject|1|||
143049527|NCT02597049|515719459|FG000|Overall Study|Adverse Event|2|||
143049528|NCT02597049|515719460|FG001|Overall Study|Adverse Event|0|||
143049529|NCT02597049|515719461|FG002|Overall Study|Adverse Event|0|||
143049530|NCT02597049|515719459|FG000|Overall Study|Death|2|||
143049531|NCT02597049|515719460|FG001|Overall Study|Death|0|||
143049532|NCT02597049|515719461|FG002|Overall Study|Death|0|||
143049533|NCT02597049|515719459|FG000|Overall Study|Noncompliant with Study Visits|1|||
143049534|NCT02597049|515719460|FG001|Overall Study|Noncompliant with Study Visits|0|||
143049535|NCT02597049|515719461|FG002|Overall Study|Noncompliant with Study Visits|0|||
143049536|NCT01899053|515719464|FG000|Overall Study|Progressive Disease|4|||
143049537|NCT01899053|515719465|FG001|Overall Study|Progressive Disease|0|||
143168627|NCT06582732|516165292|FG006|Initial Study Period|Moved Away|0|||
143168628|NCT02038647|516165293|FG000|Overall Study|Progressive Disease|50|||
143364464|NCT00691028|516876989|FG003|Open-label Period|Adverse Event|16|||
143168629|NCT02038647|516165294|FG001|Overall Study|Progressive Disease|59|||
143168630|NCT02038647|516165293|FG000|Overall Study|Adverse Event|18|||
143168631|NCT02038647|516165294|FG001|Overall Study|Adverse Event|10|||
143168632|NCT02038647|516165293|FG000|Overall Study|Symptomatic Deterioration|7|||
143168633|NCT02038647|516165294|FG001|Overall Study|Symptomatic Deterioration|7|||
143168634|NCT02038647|516165293|FG000|Overall Study|Withdrawal by Subject|5|||
143168635|NCT02038647|516165294|FG001|Overall Study|Withdrawal by Subject|2|||
143168636|NCT02038647|516165293|FG000|Overall Study|Not Reported|0|||
143168637|NCT02038647|516165294|FG001|Overall Study|Not Reported|1|||
143168638|NCT02038647|516165293|FG000|Overall Study|Ongoing at Datacut|9|||
143168639|NCT02038647|516165294|FG001|Overall Study|Ongoing at Datacut|10|||
143168640|NCT02082977|516165295|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
143168641|NCT02082977|516165296|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
143168642|NCT02082977|516165297|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
143168643|NCT02082977|516165298|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
143168644|NCT02082977|516165299|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
143168645|NCT02082977|516165300|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
143168646|NCT02082977|516165301|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
143168647|NCT02082977|516165302|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
143168648|NCT02082977|516165303|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
143168649|NCT02082977|516165304|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
143168650|NCT02082977|516165295|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
143168651|NCT02082977|516165296|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
143168652|NCT02082977|516165297|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
143168653|NCT02082977|516165298|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
143168654|NCT02082977|516165299|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
143168655|NCT02082977|516165300|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
143168656|NCT02082977|516165301|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
143168657|NCT02082977|516165302|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
143168658|NCT02082977|516165303|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
143168659|NCT02082977|516165304|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
143168660|NCT02082977|516165295|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
143168661|NCT02082977|516165296|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
143168662|NCT02082977|516165297|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
143168663|NCT02082977|516165298|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
143168664|NCT02082977|516165299|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
143168665|NCT02082977|516165300|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
143168666|NCT02082977|516165301|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
143168667|NCT02082977|516165302|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
143168668|NCT02082977|516165303|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
143168669|NCT02082977|516165304|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
143168670|NCT02082977|516165295|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
143168671|NCT02082977|516165296|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
143168672|NCT02082977|516165297|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
143168673|NCT02082977|516165298|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
143168674|NCT02082977|516165299|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
143168675|NCT02082977|516165300|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
143168676|NCT02082977|516165301|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
143168677|NCT02082977|516165302|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
143168678|NCT02082977|516165303|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
143168679|NCT02082977|516165304|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
143168680|NCT02082977|516165295|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
143168681|NCT02082977|516165296|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
143168682|NCT02082977|516165297|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
143168683|NCT02082977|516165298|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
143168684|NCT02082977|516165299|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
143168685|NCT02082977|516165300|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
143168686|NCT02082977|516165301|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
143244469|NCT02175030|516446338|FG000|Overall Study|Lost to Follow-up|6|||
143049538|NCT01899053|515719466|FG002|Overall Study|Progressive Disease|3|||
143049539|NCT01899053|515719467|FG003|Overall Study|Progressive Disease|0|||
143049540|NCT01899053|515719468|FG004|Overall Study|Progressive Disease|3|||
143168687|NCT02082977|516165302|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
143168688|NCT02082977|516165303|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
143168689|NCT02082977|516165304|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
143168690|NCT00049543|516165308|FG000|Overall Study|still on treatment|2|||
143168691|NCT00049543|516165309|FG001|Overall Study|still on treatment|9|||
143049541|NCT01899053|515719469|FG005|Overall Study|Progressive Disease|1|||
143049542|NCT01899053|515719470|FG006|Overall Study|Progressive Disease|1|||
143049543|NCT01899053|515719471|FG007|Overall Study|Progressive Disease|1|||
143049544|NCT01899053|515719472|FG008|Overall Study|Progressive Disease|4|||
143049545|NCT01899053|515719473|FG009|Overall Study|Progressive Disease|3|||
143049546|NCT01899053|515719474|FG010|Overall Study|Progressive Disease|12|||
143244470|NCT02175030|516446339|FG001|Overall Study|Lost to Follow-up|6|||
143244471|NCT02175030|516446338|FG000|Overall Study|Withdrawal by Subject|1|||
143244472|NCT02175030|516446339|FG001|Overall Study|Withdrawal by Subject|4|||
143244473|NCT02533453|516446340|FG000|Overall Study|Adverse Event|6|||
143244474|NCT02533453|516446340|FG000|Overall Study|Protocol Violation|1|||
143244475|NCT02533453|516446340|FG000|Overall Study|Withdrawal by Subject|2|||
143244476|NCT00068419|516446344|FG000|Overall Study|Adverse Event|3|||
143244477|NCT00068419|516446344|FG000|Overall Study|Lack of Efficacy|24|||
143244478|NCT00068419|516446344|FG000|Overall Study|Lost to Follow-up|1|||
143244479|NCT00068419|516446344|FG000|Overall Study|Physician Decision|7|||
143244480|NCT00068419|516446344|FG000|Overall Study|Withdrawal by Subject|14|||
143244481|NCT00068419|516446344|FG000|Overall Study|Ineligible|11|||
143244482|NCT00396253|516446354|FG000|Overall Study|Protocol Violation|1|||
143244483|NCT00396253|516446354|FG000|Overall Study|Withdrawal by Subject|7|||
143244484|NCT00396253|516446354|FG000|Overall Study|Death|3|||
143244485|NCT00396253|516446354|FG000|Overall Study|Physician Decision|1|||
143244486|NCT00396253|516446354|FG000|Overall Study|Change in eligibility status|1|||
143244487|NCT01500720|516446360|FG000|Overall Study|Randomized But Not Treated|1|||
143244488|NCT01500720|516446361|FG001|Overall Study|Randomized But Not Treated|1|||
143244489|NCT01500720|516446360|FG000|Overall Study|Other|4|||
143244490|NCT01500720|516446361|FG001|Overall Study|Other|8|||
143244491|NCT00740857|516446362|FG000|Overall Study|Withdrawal by Subject|1|||
143244492|NCT00740857|516446363|FG001|Overall Study|Withdrawal by Subject|0|||
143244493|NCT00740857|516446364|FG002|Overall Study|Withdrawal by Subject|0|||
143244494|NCT03532451|516446368|FG000|Overall Study|Withdrawal by Subject|0|||
143244495|NCT03532451|516446369|FG001|Overall Study|Withdrawal by Subject|1|||
143244496|NCT03532451|516446368|FG000|Overall Study|Did not undergo surgery|1|||
143244497|NCT03532451|516446369|FG001|Overall Study|Did not undergo surgery|1|||
143244498|NCT02527421|516446370|FG000|Overall Study|Withdrawal by Subject|1|||
143244499|NCT02527421|516446371|FG001|Overall Study|Withdrawal by Subject|0|||
143244500|NCT01615029|516446372|FG000|Overall Study|Adverse Event|0|||
143244501|NCT01615029|516446373|FG001|Overall Study|Adverse Event|0|||
143244502|NCT01615029|516446374|FG002|Overall Study|Adverse Event|0|||
143244503|NCT01615029|516446375|FG003|Overall Study|Adverse Event|0|||
143244504|NCT01615029|516446376|FG004|Overall Study|Adverse Event|1|||
143244505|NCT01615029|516446372|FG000|Overall Study|Death|0|||
143244506|NCT01615029|516446373|FG001|Overall Study|Death|0|||
143244507|NCT01615029|516446374|FG002|Overall Study|Death|0|||
143244508|NCT01615029|516446375|FG003|Overall Study|Death|0|||
143244509|NCT01615029|516446376|FG004|Overall Study|Death|1|||
143244510|NCT01615029|516446372|FG000|Overall Study|Lost to Follow-up|0|||
143244511|NCT01615029|516446373|FG001|Overall Study|Lost to Follow-up|0|||
143244512|NCT01615029|516446374|FG002|Overall Study|Lost to Follow-up|0|||
143244513|NCT01615029|516446375|FG003|Overall Study|Lost to Follow-up|0|||
143049547|NCT01899053|515719475|FG011|Overall Study|Progressive Disease|5|||
143049548|NCT01899053|515719476|FG012|Overall Study|Progressive Disease|8|||
143049549|NCT01899053|515719477|FG013|Overall Study|Progressive Disease|17|||
143049550|NCT01899053|515719464|FG000|Overall Study|Adverse Event|1|||
143049551|NCT01899053|515719465|FG001|Overall Study|Adverse Event|1|||
143049552|NCT01899053|515719466|FG002|Overall Study|Adverse Event|1|||
143049553|NCT01899053|515719467|FG003|Overall Study|Adverse Event|3|||
143049554|NCT01899053|515719468|FG004|Overall Study|Adverse Event|1|||
143244514|NCT01615029|516446376|FG004|Overall Study|Lost to Follow-up|1|||
143244515|NCT01615029|516446372|FG000|Overall Study|Progressive disease|2|||
143244516|NCT01615029|516446373|FG001|Overall Study|Progressive disease|1|||
143244517|NCT01615029|516446374|FG002|Overall Study|Progressive disease|1|||
143244518|NCT01615029|516446375|FG003|Overall Study|Progressive disease|1|||
143049555|NCT01899053|515719469|FG005|Overall Study|Adverse Event|1|||
143049556|NCT01899053|515719470|FG006|Overall Study|Adverse Event|1|||
143049557|NCT01899053|515719471|FG007|Overall Study|Adverse Event|0|||
143049558|NCT01899053|515719472|FG008|Overall Study|Adverse Event|2|||
143049559|NCT01899053|515719473|FG009|Overall Study|Adverse Event|0|||
143049560|NCT01899053|515719474|FG010|Overall Study|Adverse Event|3|||
143049561|NCT01899053|515719475|FG011|Overall Study|Adverse Event|1|||
143049562|NCT01899053|515719476|FG012|Overall Study|Adverse Event|2|||
143244519|NCT01615029|516446376|FG004|Overall Study|Progressive disease|5|||
143244520|NCT01615029|516446372|FG000|Overall Study|Physician Decision|0|||
143244521|NCT01615029|516446373|FG001|Overall Study|Physician Decision|0|||
143244522|NCT01615029|516446374|FG002|Overall Study|Physician Decision|0|||
143244523|NCT01615029|516446375|FG003|Overall Study|Physician Decision|0|||
143244524|NCT01615029|516446376|FG004|Overall Study|Physician Decision|1|||
143244525|NCT01615029|516446372|FG000|Overall Study|Ongoing|1|||
143244526|NCT01615029|516446373|FG001|Overall Study|Ongoing|2|||
143244527|NCT01615029|516446374|FG002|Overall Study|Ongoing|3|||
143244528|NCT01615029|516446375|FG003|Overall Study|Ongoing|2|||
143049563|NCT01899053|515719477|FG013|Overall Study|Adverse Event|2|||
143049564|NCT01899053|515719464|FG000|Overall Study|Reason Not Specified|0|||
143049565|NCT01899053|515719465|FG001|Overall Study|Reason Not Specified|0|||
143049566|NCT01899053|515719466|FG002|Overall Study|Reason Not Specified|0|||
143049567|NCT01899053|515719467|FG003|Overall Study|Reason Not Specified|0|||
143049568|NCT01899053|515719468|FG004|Overall Study|Reason Not Specified|0|||
143049569|NCT01899053|515719469|FG005|Overall Study|Reason Not Specified|0|||
143049570|NCT01899053|515719470|FG006|Overall Study|Reason Not Specified|1|||
143049571|NCT01899053|515719471|FG007|Overall Study|Reason Not Specified|0|||
143049572|NCT01899053|515719472|FG008|Overall Study|Reason Not Specified|0|||
143049573|NCT01899053|515719473|FG009|Overall Study|Reason Not Specified|0|||
143049574|NCT01899053|515719474|FG010|Overall Study|Reason Not Specified|0|||
143049575|NCT01899053|515719475|FG011|Overall Study|Reason Not Specified|0|||
143049576|NCT01899053|515719476|FG012|Overall Study|Reason Not Specified|1|||
143049577|NCT01899053|515719477|FG013|Overall Study|Reason Not Specified|0|||
143049578|NCT01899053|515719464|FG000|Overall Study|Withdrawal by Subject|1|||
143049579|NCT01899053|515719465|FG001|Overall Study|Withdrawal by Subject|1|||
143049580|NCT01899053|515719466|FG002|Overall Study|Withdrawal by Subject|2|||
143049581|NCT01899053|515719467|FG003|Overall Study|Withdrawal by Subject|0|||
143049582|NCT01899053|515719468|FG004|Overall Study|Withdrawal by Subject|2|||
143049583|NCT01899053|515719469|FG005|Overall Study|Withdrawal by Subject|0|||
143049584|NCT01899053|515719470|FG006|Overall Study|Withdrawal by Subject|0|||
143049585|NCT01899053|515719471|FG007|Overall Study|Withdrawal by Subject|1|||
143049586|NCT01899053|515719472|FG008|Overall Study|Withdrawal by Subject|0|||
143168692|NCT02106832|516165312|FG000|Overall Study|Adverse Event|1|||
143168693|NCT02106832|516165313|FG001|Overall Study|Adverse Event|2|||
143168694|NCT02106832|516165314|FG002|Overall Study|Adverse Event|3|||
143168695|NCT02106832|516165315|FG003|Overall Study|Adverse Event|0|||
143168696|NCT02106832|516165312|FG000|Overall Study|Death|4|||
143168697|NCT02106832|516165313|FG001|Overall Study|Death|4|||
143168698|NCT02106832|516165314|FG002|Overall Study|Death|1|||
143168699|NCT02106832|516165315|FG003|Overall Study|Death|4|||
143168700|NCT02106832|516165312|FG000|Overall Study|Deterioration of general conditions|0|||
143168701|NCT02106832|516165313|FG001|Overall Study|Deterioration of general conditions|0|||
143168702|NCT02106832|516165314|FG002|Overall Study|Deterioration of general conditions|1|||
143168703|NCT02106832|516165315|FG003|Overall Study|Deterioration of general conditions|0|||
143168704|NCT02106832|516165312|FG000|Overall Study|Lost to Follow-up|0|||
143168705|NCT02106832|516165313|FG001|Overall Study|Lost to Follow-up|1|||
143168706|NCT02106832|516165314|FG002|Overall Study|Lost to Follow-up|1|||
143168707|NCT02106832|516165315|FG003|Overall Study|Lost to Follow-up|3|||
143168708|NCT02106832|516165312|FG000|Overall Study|Physician Decision|1|||
143168709|NCT02106832|516165313|FG001|Overall Study|Physician Decision|0|||
143168710|NCT02106832|516165314|FG002|Overall Study|Physician Decision|0|||
143168711|NCT02106832|516165315|FG003|Overall Study|Physician Decision|0|||
143168712|NCT02106832|516165312|FG000|Overall Study|Protocol Violation|0|||
143168713|NCT02106832|516165313|FG001|Overall Study|Protocol Violation|0|||
143168714|NCT02106832|516165314|FG002|Overall Study|Protocol Violation|0|||
143168715|NCT02106832|516165315|FG003|Overall Study|Protocol Violation|1|||
143168716|NCT02106832|516165312|FG000|Overall Study|Withdrawal by Subject|17|||
143168717|NCT02106832|516165313|FG001|Overall Study|Withdrawal by Subject|17|||
143168718|NCT02106832|516165314|FG002|Overall Study|Withdrawal by Subject|10|||
143168719|NCT02106832|516165315|FG003|Overall Study|Withdrawal by Subject|7|||
143168720|NCT02106832|516165312|FG000|Overall Study|Technical problems|0|||
143168721|NCT02106832|516165313|FG001|Overall Study|Technical problems|1|||
143168722|NCT02106832|516165314|FG002|Overall Study|Technical problems|0|||
143168723|NCT02106832|516165315|FG003|Overall Study|Technical problems|0|||
143168724|NCT04716894|516165336|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
143168725|NCT04716894|516165336|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
143168726|NCT01849276|516165347|FG000|Followed for Survival for 5 Years|Death|1|||
143168727|NCT01849276|516165347|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
143168728|NCT01506726|516165348|FG000|Overall Study|Adverse Event|1|||
143168729|NCT01506726|516165349|FG001|Overall Study|Adverse Event|2|||
143364465|NCT00691028|516876986|FG000|Open-label Period|Withdrawal by Subject|0|||
143049587|NCT01899053|515719473|FG009|Overall Study|Withdrawal by Subject|0|||
143049588|NCT01899053|515719474|FG010|Overall Study|Withdrawal by Subject|0|||
143049589|NCT01899053|515719475|FG011|Overall Study|Withdrawal by Subject|0|||
143049590|NCT01899053|515719476|FG012|Overall Study|Withdrawal by Subject|1|||
143168730|NCT04724837|516165350|FG000|Overall Study|Other|4|||
143168731|NCT04724837|516165351|FG001|Overall Study|Other|16|||
143168732|NCT04724837|516165352|FG002|Overall Study|Other|0|||
143049591|NCT01899053|515719477|FG013|Overall Study|Withdrawal by Subject|1|||
143049592|NCT01899053|515719464|FG000|Overall Study|Protocol Violation|0|||
143168733|NCT04724837|516165350|FG000|Overall Study|Withdrawal by Subject|2|||
143168734|NCT04724837|516165351|FG001|Overall Study|Withdrawal by Subject|9|||
143168735|NCT04724837|516165352|FG002|Overall Study|Withdrawal by Subject|9|||
143168736|NCT04724837|516165350|FG000|Overall Study|Adverse Event|2|||
143168737|NCT04724837|516165351|FG001|Overall Study|Adverse Event|7|||
143049593|NCT01899053|515719465|FG001|Overall Study|Protocol Violation|0|||
143049594|NCT01899053|515719466|FG002|Overall Study|Protocol Violation|1|||
143049595|NCT01899053|515719467|FG003|Overall Study|Protocol Violation|0|||
143049596|NCT01899053|515719468|FG004|Overall Study|Protocol Violation|0|||
143049597|NCT01899053|515719469|FG005|Overall Study|Protocol Violation|0|||
143049598|NCT01899053|515719470|FG006|Overall Study|Protocol Violation|0|||
143049599|NCT01899053|515719471|FG007|Overall Study|Protocol Violation|0|||
143049600|NCT01899053|515719472|FG008|Overall Study|Protocol Violation|0|||
143049601|NCT01899053|515719473|FG009|Overall Study|Protocol Violation|0|||
143049602|NCT01899053|515719474|FG010|Overall Study|Protocol Violation|0|||
143049603|NCT01899053|515719475|FG011|Overall Study|Protocol Violation|0|||
143049604|NCT01899053|515719476|FG012|Overall Study|Protocol Violation|0|||
143049605|NCT01899053|515719477|FG013|Overall Study|Protocol Violation|0|||
143049606|NCT01899053|515719464|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
143049607|NCT01899053|515719465|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
143049608|NCT01899053|515719466|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
143049609|NCT01899053|515719467|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
143049610|NCT01899053|515719468|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
143049611|NCT01899053|515719469|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
143049612|NCT01899053|515719470|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
143049613|NCT01899053|515719471|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
143168738|NCT04724837|516165352|FG002|Overall Study|Adverse Event|4|||
143168739|NCT04724837|516165350|FG000|Overall Study|Lost to Follow-up|0|||
143168740|NCT04724837|516165351|FG001|Overall Study|Lost to Follow-up|1|||
143168741|NCT04724837|516165352|FG002|Overall Study|Lost to Follow-up|3|||
143168742|NCT04724837|516165350|FG000|Overall Study|Physician Decision|1|||
143168743|NCT04724837|516165351|FG001|Overall Study|Physician Decision|2|||
143168744|NCT04724837|516165352|FG002|Overall Study|Physician Decision|0|||
143168745|NCT04724837|516165350|FG000|Overall Study|Death|0|||
143168746|NCT04724837|516165351|FG001|Overall Study|Death|0|||
143168747|NCT04724837|516165352|FG002|Overall Study|Death|1|||
143168748|NCT04724837|516165350|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
143168749|NCT04724837|516165351|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
143168750|NCT04724837|516165352|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
143168751|NCT04724837|516165350|FG000|Overall Study|Study Terminated by Sponsor|0|||
143168752|NCT04724837|516165351|FG001|Overall Study|Study Terminated by Sponsor|1|||
143168753|NCT04724837|516165352|FG002|Overall Study|Study Terminated by Sponsor|0|||
143168754|NCT04347538|516165353|FG000|Overall Study|Lost to Follow-up|4|||
143168755|NCT04347538|516165354|FG001|Overall Study|Lost to Follow-up|5|||
143168756|NCT04347538|516165355|FG002|Overall Study|Lost to Follow-up|7|||
143168757|NCT02259231|516165356|FG000|Overall Study|Adverse Event|1|||
143168758|NCT02259231|516165357|FG001|Overall Study|Adverse Event|1|||
143168759|NCT02259231|516165358|FG002|Overall Study|Adverse Event|2|||
143168760|NCT02259231|516165359|FG003|Overall Study|Adverse Event|0|||
143168761|NCT02259231|516165360|FG004|Overall Study|Adverse Event|0|||
143168762|NCT02259231|516165361|FG005|Overall Study|Adverse Event|0|||
143168763|NCT02259231|516165362|FG006|Overall Study|Adverse Event|0|||
143168764|NCT02259231|516165356|FG000|Overall Study|Progressive Disease|4|||
143168765|NCT02259231|516165357|FG001|Overall Study|Progressive Disease|5|||
143168766|NCT02259231|516165358|FG002|Overall Study|Progressive Disease|4|||
143168767|NCT02259231|516165359|FG003|Overall Study|Progressive Disease|5|||
143168768|NCT02259231|516165360|FG004|Overall Study|Progressive Disease|4|||
143168769|NCT02259231|516165361|FG005|Overall Study|Progressive Disease|5|||
143168770|NCT02259231|516165362|FG006|Overall Study|Progressive Disease|4|||
143168771|NCT02259231|516165356|FG000|Overall Study|Sponsor termination of study|1|||
143049614|NCT01899053|515719472|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
143049615|NCT01899053|515719473|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
143049616|NCT01899053|515719474|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
143049617|NCT01899053|515719475|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
143049618|NCT01899053|515719476|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
143049619|NCT01899053|515719477|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
143049620|NCT01899053|515719464|FG000|Overall Study|Symptomatic Deterioration|0|||
143049621|NCT01899053|515719465|FG001|Overall Study|Symptomatic Deterioration|0|||
143049622|NCT01899053|515719466|FG002|Overall Study|Symptomatic Deterioration|0|||
143049623|NCT01899053|515719467|FG003|Overall Study|Symptomatic Deterioration|0|||
143049624|NCT01899053|515719468|FG004|Overall Study|Symptomatic Deterioration|0|||
143168772|NCT02259231|516165357|FG001|Overall Study|Sponsor termination of study|0|||
143168773|NCT02259231|516165358|FG002|Overall Study|Sponsor termination of study|0|||
143168774|NCT02259231|516165359|FG003|Overall Study|Sponsor termination of study|1|||
143049625|NCT01899053|515719469|FG005|Overall Study|Symptomatic Deterioration|1|||
143049626|NCT01899053|515719470|FG006|Overall Study|Symptomatic Deterioration|0|||
143168775|NCT02259231|516165360|FG004|Overall Study|Sponsor termination of study|2|||
143168776|NCT02259231|516165361|FG005|Overall Study|Sponsor termination of study|1|||
143168777|NCT02259231|516165362|FG006|Overall Study|Sponsor termination of study|1|||
143168778|NCT00847730|516165363|FG000|Overall Study|Multiple interruptions in therapy|8|||
143168779|NCT04938427|516165366|FG000|Overall Study|Adverse Event|5|||
143364466|NCT00691028|516876987|FG001|Open-label Period|Withdrawal by Subject|0|||
143364467|NCT00691028|516876988|FG002|Open-label Period|Withdrawal by Subject|0|||
143364468|NCT00691028|516876989|FG003|Open-label Period|Withdrawal by Subject|3|||
143364469|NCT00691028|516876986|FG000|Open-label Period|not come to a hospital|0|||
143049627|NCT01899053|515719471|FG007|Overall Study|Symptomatic Deterioration|1|||
143049628|NCT01899053|515719472|FG008|Overall Study|Symptomatic Deterioration|0|||
143049629|NCT01899053|515719473|FG009|Overall Study|Symptomatic Deterioration|0|||
143049630|NCT01899053|515719474|FG010|Overall Study|Symptomatic Deterioration|0|||
143049631|NCT01899053|515719475|FG011|Overall Study|Symptomatic Deterioration|1|||
143049632|NCT01899053|515719476|FG012|Overall Study|Symptomatic Deterioration|2|||
143364470|NCT00691028|516876987|FG001|Open-label Period|not come to a hospital|0|||
143364471|NCT00691028|516876988|FG002|Open-label Period|not come to a hospital|0|||
143364472|NCT00691028|516876989|FG003|Open-label Period|not come to a hospital|1|||
143364473|NCT00691028|516876986|FG000|Double-blind Period|Adverse Event|8|||
143364474|NCT00691028|516876987|FG001|Double-blind Period|Adverse Event|9|||
143364475|NCT00691028|516876988|FG002|Double-blind Period|Adverse Event|6|||
143364476|NCT00691028|516876989|FG003|Double-blind Period|Adverse Event|0|||
143364477|NCT00691028|516876986|FG000|Double-blind Period|Lack of Efficacy|4|||
143364478|NCT00691028|516876987|FG001|Double-blind Period|Lack of Efficacy|3|||
143364479|NCT00691028|516876988|FG002|Double-blind Period|Lack of Efficacy|2|||
143364480|NCT00691028|516876989|FG003|Double-blind Period|Lack of Efficacy|0|||
143364481|NCT00691028|516876986|FG000|Double-blind Period|Withdrawal by Subject|1|||
143364482|NCT00691028|516876987|FG001|Double-blind Period|Withdrawal by Subject|0|||
143364483|NCT00691028|516876988|FG002|Double-blind Period|Withdrawal by Subject|1|||
143364484|NCT00691028|516876989|FG003|Double-blind Period|Withdrawal by Subject|0|||
143364485|NCT00691028|516876986|FG000|Double-blind Period|not come to a hospital.|0|||
143364486|NCT00691028|516876987|FG001|Double-blind Period|not come to a hospital.|1|||
143364487|NCT00691028|516876988|FG002|Double-blind Period|not come to a hospital.|0|||
143364488|NCT00691028|516876989|FG003|Double-blind Period|not come to a hospital.|0|||
143364489|NCT01360840|516877000|FG000|Overall Study|Ongoing at data cut-off|10|||
143364490|NCT01360840|516877001|FG001|Overall Study|Ongoing at data cut-off|10|||
143364491|NCT01360840|516877002|FG002|Overall Study|Ongoing at data cut-off|9|||
143364492|NCT02950545|516877003|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
143364493|NCT02950545|516877004|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
143364494|NCT02950545|516877005|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
143364495|NCT02950545|516877006|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
143364496|NCT02950545|516877007|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
143364497|NCT02950545|516877008|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
143364498|NCT02950545|516877003|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
143364499|NCT02950545|516877004|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
143364500|NCT02950545|516877005|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
143364501|NCT02950545|516877006|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
143364502|NCT02950545|516877007|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
143364503|NCT02950545|516877008|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
143364504|NCT02950545|516877003|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
143364505|NCT02950545|516877004|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
143364506|NCT02950545|516877005|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
143364507|NCT02950545|516877006|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
143364508|NCT02950545|516877007|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
143364509|NCT02950545|516877008|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
143049633|NCT01899053|515719477|FG013|Overall Study|Symptomatic Deterioration|0|||
143049634|NCT01401062|515719478|FG000|Overall Study|Death|9|||
143049635|NCT01401062|515719479|FG001|Overall Study|Death|7|||
143049636|NCT01401062|515719478|FG000|Overall Study|Physician Decision|1|||
143049637|NCT01401062|515719479|FG001|Overall Study|Physician Decision|0|||
143049638|NCT01401062|515719478|FG000|Overall Study|Withdrawal by Subject|1|||
143049639|NCT01401062|515719479|FG001|Overall Study|Withdrawal by Subject|1|||
143049640|NCT01131260|515719482|FG000|Overall Study|Randomization error|5|||
143049641|NCT01131260|515719483|FG001|Overall Study|Randomization error|1|||
143168780|NCT04938427|516165367|FG001|Overall Study|Adverse Event|19|||
143364510|NCT02950545|516877003|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
143364511|NCT02950545|516877004|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
143364512|NCT02950545|516877005|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
143364513|NCT02950545|516877006|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
143364514|NCT02950545|516877007|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
143364515|NCT02950545|516877008|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
143499225|NCT00559273|517368523|FG000|Correction Period (20 Weeks)|Death|3|||
143499226|NCT00559273|517368524|FG001|Correction Period (20 Weeks)|Death|4|||
143499227|NCT00559273|517368523|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
143499228|NCT00559273|517368524|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
143499229|NCT00559273|517368523|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
143049642|NCT01131260|515719482|FG000|Overall Study|Declined to continue participation|8|||
143049643|NCT01131260|515719483|FG001|Overall Study|Declined to continue participation|13|||
143049644|NCT01131260|515719482|FG000|Overall Study|Physician Decision|22|||
143049645|NCT01131260|515719483|FG001|Overall Study|Physician Decision|24|||
143049646|NCT01131260|515719482|FG000|Overall Study|Technical problems|7|||
143049647|NCT01131260|515719483|FG001|Overall Study|Technical problems|6|||
143049648|NCT01131260|515719482|FG000|Overall Study|Staff error|2|||
143049649|NCT01131260|515719483|FG001|Overall Study|Staff error|1|||
143049650|NCT01131260|515719482|FG000|Overall Study|Ineligible|0|||
143049651|NCT01131260|515719483|FG001|Overall Study|Ineligible|2|||
143049652|NCT03684928|515719487|FG000|First Intervention|Lost to Follow-up|0|||
143049653|NCT03684928|515719488|FG001|First Intervention|Lost to Follow-up|1|||
143049654|NCT03684928|515719487|FG000|First Intervention|Withdrawal by Subject|0|||
143049655|NCT03684928|515719488|FG001|First Intervention|Withdrawal by Subject|2|||
143049656|NCT03684928|515719487|FG000|Second Intervention|Soft Tissue Injury|1|||
143049657|NCT03684928|515719488|FG001|Second Intervention|Soft Tissue Injury|0|||
143049658|NCT00840879|515719494|FG000|Second Intervention|Withdrawal by Subject|1|||
143049659|NCT00840879|515719495|FG001|Second Intervention|Withdrawal by Subject|0|||
143049660|NCT00874276|515719496|FG000|Overall Study|Withdrawal by Subject|1|||
143049661|NCT00874276|515719497|FG001|Overall Study|Withdrawal by Subject|1|||
143049662|NCT03733145|515719498|FG000|Overall Study|screenfail|3|||
143049663|NCT03733145|515719499|FG001|Overall Study|screenfail|3|||
143049664|NCT03733145|515719500|FG002|Overall Study|screenfail|2|||
143049665|NCT04236596|515719501|FG000|Overall Study|Withdrawal by Subject|1|||
143049666|NCT04236596|515719501|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
143049667|NCT04236596|515719501|FG000|Overall Study|Participants did not receive implant at all|4|||
143049668|NCT01691430|515720912|FG000|Overall Study|Death|17|||
143049669|NCT01691430|515720913|FG001|Overall Study|Death|16|||
143049670|NCT01691430|515720912|FG000|Overall Study|Withdrawal by Subject|5|||
143049671|NCT01691430|515720913|FG001|Overall Study|Withdrawal by Subject|1|||
143049672|NCT01691430|515720912|FG000|Overall Study|Lost to Follow-up|0|||
143049673|NCT01691430|515720913|FG001|Overall Study|Lost to Follow-up|3|||
143049674|NCT01894230|515720914|FG000|Overall Study|Lost to Follow-up|2|||
143049675|NCT01894230|515720915|FG001|Overall Study|Lost to Follow-up|2|||
143049676|NCT01894230|515720914|FG000|Overall Study|Withdrawal by Subject|4|||
143049677|NCT01894230|515720915|FG001|Overall Study|Withdrawal by Subject|4|||
143049678|NCT01894230|515720914|FG000|Overall Study|Non-adherent|0|||
143049679|NCT01894230|515720915|FG001|Overall Study|Non-adherent|1|||
143049680|NCT01894230|515720914|FG000|Overall Study|Death|1|||
143049681|NCT01894230|515720915|FG001|Overall Study|Death|0|||
143049682|NCT03119662|515720923|FG000|Overall Study|Withdrawal by Subject|0|||
143049683|NCT03119662|515720924|FG001|Overall Study|Withdrawal by Subject|1|||
143049684|NCT00757705|515720925|FG000|Overall Study|Adverse Event|19|||
143049685|NCT00757705|515720925|FG000|Overall Study|Lost to Follow-up|16|||
143049686|NCT00757705|515720925|FG000|Overall Study|Withdrawal by Subject|25|||
143049687|NCT00757705|515720925|FG000|Overall Study|Insufficient Response|26|||
143049688|NCT00757705|515720925|FG000|Overall Study|Ineligible to continue|8|||
143049689|NCT00757705|515720925|FG000|Overall Study|Non-compliant|9|||
143049690|NCT00757705|515720925|FG000|Overall Study|Other|18|||
143049691|NCT02817828|515720926|FG000|Overall Study|Lost to Follow-up|41|||
143049692|NCT02817828|515720926|FG000|Overall Study|Adverse event not related to bleeding|104|||
143049693|NCT02817828|515720926|FG000|Overall Study|Adverse event related to bleeding|53|||
143049694|NCT02817828|515720926|FG000|Overall Study|Protocol Violation|11|||
143049695|NCT02817828|515720926|FG000|Overall Study|Pregnancy|7|||
143049696|NCT02817828|515720926|FG000|Overall Study|Pregnancy wish|15|||
143049697|NCT02817828|515720926|FG000|Overall Study|Withdrawal by Subject|78|||
143049698|NCT02817828|515720926|FG000|Overall Study|Other|26|||
143049699|NCT00660660|515720927|FG000|Overall Study|Adverse Event|1|||
143049700|NCT00660660|515720928|FG001|Overall Study|Adverse Event|0|||
143049701|NCT00660660|515720927|FG000|Overall Study|Lost to Follow-up|0|||
143049702|NCT00660660|515720928|FG001|Overall Study|Lost to Follow-up|6|||
143049703|NCT00660660|515720927|FG000|Overall Study|Lack of Efficacy|0|||
143049704|NCT00660660|515720928|FG001|Overall Study|Lack of Efficacy|2|||
143049705|NCT00660660|515720927|FG000|Overall Study|Withdrawal by Subject|3|||
143049706|NCT00660660|515720928|FG001|Overall Study|Withdrawal by Subject|0|||
143049707|NCT00660660|515720927|FG000|Overall Study|Incorrect enrollment and other|0|||
143049708|NCT00660660|515720928|FG001|Overall Study|Incorrect enrollment and other|1|||
143049709|NCT00660660|515720927|FG000|Overall Study|New medication after randomization|1|||
143049710|NCT00660660|515720928|FG001|Overall Study|New medication after randomization|0|||
143049711|NCT00659815|515720929|FG000|Overall Study|Study related symptoms and complaints|2|||
143049712|NCT00659815|515720930|FG001|Overall Study|Study related symptoms and complaints|1|||
143049713|NCT00659815|515720929|FG000|Overall Study|Inability to maintain wearing schedule|1|||
143049714|NCT00659815|515720930|FG001|Overall Study|Inability to maintain wearing schedule|2|||
143049715|NCT00659815|515720929|FG000|Overall Study|Withdrawal by Subject|1|||
143049716|NCT00659815|515720930|FG001|Overall Study|Withdrawal by Subject|1|||
143049717|NCT02651987|515720931|FG000|Overall Study|Adverse Event|2|||
143049718|NCT02651987|515720932|FG001|Overall Study|Adverse Event|2|||
143049719|NCT02651987|515720931|FG000|Overall Study|Consent Withdrawn|2|||
143049720|NCT02651987|515720932|FG001|Overall Study|Consent Withdrawn|0|||
143049721|NCT02651987|515720931|FG000|Overall Study|Local PD|0|||
143049722|NCT02651987|515720932|FG001|Overall Study|Local PD|2|||
143049723|NCT02651987|515720931|FG000|Overall Study|Investigator Decision|1|||
143049724|NCT02651987|515720932|FG001|Overall Study|Investigator Decision|1|||
143049725|NCT04661202|515720933|FG000|Overall Study|Withdrawal by Subject|1|||
143049726|NCT04661202|515720934|FG001|Overall Study|Withdrawal by Subject|1|||
143049727|NCT04661202|515720933|FG000|Overall Study|Lack of Efficacy|2|||
143049728|NCT04661202|515720934|FG001|Overall Study|Lack of Efficacy|0|||
143049729|NCT02694536|515720940|FG000|Overall Study|Progressive Disease|40|||
143049730|NCT02694536|515720940|FG000|Overall Study|Lost to Follow-up|1|||
143049731|NCT02694536|515720940|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
143049732|NCT02694536|515720940|FG000|Overall Study|Withdrawal by Subject|8|||
143049733|NCT02694536|515720940|FG000|Overall Study|Death|8|||
143049734|NCT02694536|515720940|FG000|Overall Study|Other|22|||
143049735|NCT01741545|515720941|FG000|Treatment Period|Lack of Efficacy|0|||
143049736|NCT01741545|515720942|FG001|Treatment Period|Lack of Efficacy|1|||
143049737|NCT01741545|515720941|FG000|Treatment Period|Adverse event, non-fatal|1|||
143049738|NCT01741545|515720942|FG001|Treatment Period|Adverse event, non-fatal|3|||
143049739|NCT01741545|515720941|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
143049740|NCT01741545|515720942|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
143049741|NCT01741545|515720941|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
143049742|NCT01741545|515720942|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
143049743|NCT01853176|515720943|FG000|Overall Study|Study terminated|4|||
143049744|NCT01853176|515720944|FG001|Overall Study|Study terminated|0|||
143049745|NCT03599362|515720945|FG000|Overall Study|Screen Failure|3|||
143049746|NCT01370083|515720946|FG000|Overall Study|Lost to Follow-up|2|||
143049747|NCT01370083|515720947|FG001|Overall Study|Lost to Follow-up|0|||
143049748|NCT01370083|515720946|FG000|Overall Study|Adverse Event|0|||
143049749|NCT01370083|515720947|FG001|Overall Study|Adverse Event|1|||
143049750|NCT01266902|515720952|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
143049751|NCT01266902|515720953|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
143049752|NCT01266902|515720954|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
143049753|NCT01266902|515720952|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
143049754|NCT01266902|515720953|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
143049755|NCT01266902|515720954|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
143049756|NCT01266902|515720952|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
143049757|NCT01266902|515720953|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
143049758|NCT01266902|515720954|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
143049759|NCT01266902|515720952|FG000|Period 1 (Main Study)|Adverse Event|3|||
143049760|NCT01266902|515720953|FG001|Period 1 (Main Study)|Adverse Event|11|||
143049761|NCT01266902|515720954|FG002|Period 1 (Main Study)|Adverse Event|0|||
143049762|NCT01266902|515720952|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
143049763|NCT01266902|515720953|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
143049764|NCT01266902|515720954|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
143049765|NCT01266902|515720952|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
143049766|NCT01266902|515720953|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
143049767|NCT01266902|515720954|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
143168781|NCT04938427|516165366|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
143168782|NCT04938427|516165367|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
143168783|NCT04938427|516165366|FG000|Overall Study|Withdrawal by Subject|1|||
143364516|NCT02950545|516877003|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
143049768|NCT01266902|515720952|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
143049769|NCT01266902|515720953|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
143049770|NCT01266902|515720954|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
143049771|NCT01266902|515720952|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
143049772|NCT01266902|515720953|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
143049773|NCT01266902|515720954|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
143049774|NCT01266902|515720952|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
143049775|NCT01266902|515720953|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
143049776|NCT01266902|515720954|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
143049777|NCT01266902|515720952|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
143049778|NCT01266902|515720953|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
143049779|NCT01266902|515720954|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
143049780|NCT05562011|515720955|FG000|Overall Study|Withdrawal by Subject|3|||
143049781|NCT05562011|515720955|FG000|Overall Study|Lost to Follow-up|1|||
143049782|NCT05562011|515720955|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
143049783|NCT05562011|515720955|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
143049784|NCT05562011|515720955|FG000|Overall Study|Device malfunction|13|||
143049785|NCT04567329|515720956|FG000|Overall Study|Withdrawal by Subject|5|||
143049786|NCT04567329|515720957|FG001|Overall Study|Withdrawal by Subject|6|||
143364517|NCT02950545|516877004|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
143364518|NCT02950545|516877005|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
143049787|NCT04567329|515720956|FG000|Overall Study|Protocol Violation|2|||
143049788|NCT04567329|515720957|FG001|Overall Study|Protocol Violation|3|||
143049789|NCT04567329|515720956|FG000|Overall Study|Discontinued|2|||
143049790|NCT04567329|515720957|FG001|Overall Study|Discontinued|2|||
143049791|NCT04567329|515720956|FG000|Overall Study|Lost to Follow-up|0|||
143049792|NCT04567329|515720957|FG001|Overall Study|Lost to Follow-up|1|||
143049793|NCT04567329|515720956|FG000|Overall Study|Lack of Efficacy|0|||
143049794|NCT04567329|515720957|FG001|Overall Study|Lack of Efficacy|1|||
143049795|NCT02933060|515720958|FG000|Overall Study|Withdrawal by Subject|0|||
143049796|NCT02933060|515720959|FG001|Overall Study|Withdrawal by Subject|1|||
143049797|NCT01945580|515720960|FG000|Overall Study|Withdrawal by Subject|13|||
143049798|NCT01945580|515720961|FG001|Overall Study|Withdrawal by Subject|35|||
143049799|NCT01945580|515720960|FG000|Overall Study|Physician Decision|3|||
143049800|NCT01945580|515720961|FG001|Overall Study|Physician Decision|2|||
143049801|NCT01945580|515720960|FG000|Overall Study|Lost to Follow-up|26|||
143049802|NCT01945580|515720961|FG001|Overall Study|Lost to Follow-up|39|||
143049803|NCT01945580|515720960|FG000|Overall Study|Death|7|||
143049804|NCT01945580|515720961|FG001|Overall Study|Death|2|||
143049805|NCT01945580|515720960|FG000|Overall Study|Patient moved out of state|0|||
143049806|NCT01945580|515720961|FG001|Overall Study|Patient moved out of state|1|||
143049807|NCT01945580|515720960|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
143049808|NCT01945580|515720961|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
143049809|NCT01945580|515720960|FG000|Overall Study|Family illness - unable to return|0|||
143049810|NCT01945580|515720961|FG001|Overall Study|Family illness - unable to return|1|||
143049811|NCT01945580|515720960|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
143049812|NCT01945580|515720961|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
143049813|NCT01945580|515720960|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
143049814|NCT01945580|515720961|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
143049815|NCT01945580|515720960|FG000|Overall Study|Noncompliance with 36 month visit|1|||
143049816|NCT01945580|515720961|FG001|Overall Study|Noncompliance with 36 month visit|0|||
143049817|NCT01945580|515720960|FG000|Overall Study|The patient moved.|1|||
143049818|NCT01945580|515720961|FG001|Overall Study|The patient moved.|0|||
143049819|NCT01945580|515720960|FG000|Overall Study|No data available|0|||
143049820|NCT01945580|515720961|FG001|Overall Study|No data available|2|||
143049821|NCT01149057|515720972|FG000|Overall Study|Lack of Efficacy|16|||
143049822|NCT01149057|515720972|FG000|Overall Study|Adverse Event|13|||
143049823|NCT01149057|515720972|FG000|Overall Study|Withdrawal by Subject|9|||
143049824|NCT01149057|515720972|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
143049825|NCT01149057|515720972|FG000|Overall Study|B Cell Depletion|4|||
143049826|NCT01149057|515720972|FG000|Overall Study|Participant Non-Compliance|2|||
143049827|NCT01149057|515720972|FG000|Overall Study|Lost to Follow-up|1|||
143049828|NCT01149057|515720972|FG000|Overall Study|High Parathyroid Hormone Value|1|||
143049829|NCT01149057|515720972|FG000|Overall Study|Other|6|||
143049830|NCT04608448|515720973|FG000|Overall Study|Withdrawal by Subject|1|||
143049831|NCT04608448|515720973|FG000|Overall Study|Adverse Event|1|||
143049832|NCT00654186|515720974|FG000|Overall Study|Withdrawal by Subject|5|||
143049833|NCT01024855|515720977|FG000|Overall Study|Inclusion/exclusion criteria|1|||
143049834|NCT02436200|515720984|FG000|Overall Study|Significant outlier|1|||
143168784|NCT04938427|516165367|FG001|Overall Study|Withdrawal by Subject|0|||
143168785|NCT04938427|516165366|FG000|Overall Study|Reason Not Specified|2|||
143168786|NCT04938427|516165367|FG001|Overall Study|Reason Not Specified|1|||
143168787|NCT03633058|516165376|FG000|Overall Study|Adverse Event|0|||
143168788|NCT03633058|516165377|FG001|Overall Study|Adverse Event|0|||
143168789|NCT03633058|516165378|FG002|Overall Study|Adverse Event|1|||
143168790|NCT03633058|516165379|FG003|Overall Study|Adverse Event|0|||
143168791|NCT03312543|516165382|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
143168792|NCT03312543|516165383|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
143168793|NCT03312543|516165382|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
143168794|NCT03312543|516165383|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
143168795|NCT03312543|516165382|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
143168796|NCT03312543|516165383|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
143168797|NCT03312543|516165382|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
143168798|NCT03312543|516165383|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
143168799|NCT03312543|516165382|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
143049835|NCT00672984|515720985|FG000|First Intervention|Adverse Event|5|||
143168800|NCT03312543|516165383|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
143049836|NCT00672984|515720986|FG001|First Intervention|Adverse Event|0|||
143049837|NCT00672984|515720987|FG002|First Intervention|Adverse Event|0|||
143049838|NCT00672984|515720985|FG000|First Intervention|Withdrawal by Subject|1|||
143049839|NCT00672984|515720986|FG001|First Intervention|Withdrawal by Subject|2|||
143168801|NCT03312543|516165382|FG000|Regression (Week 12 to Week 24)|Death|0|||
143168802|NCT03312543|516165383|FG001|Regression (Week 12 to Week 24)|Death|1|||
143049840|NCT00672984|515720987|FG002|First Intervention|Withdrawal by Subject|2|||
143049841|NCT00672984|515720985|FG000|First Intervention|Sponsor decision|3|||
143049842|NCT00672984|515720986|FG001|First Intervention|Sponsor decision|0|||
143049843|NCT00672984|515720987|FG002|First Intervention|Sponsor decision|0|||
143049844|NCT00672984|515720985|FG000|Second Intervention|Non-compliance with facility policies|0|||
143049845|NCT00672984|515720986|FG001|Second Intervention|Non-compliance with facility policies|2|||
143049846|NCT00672984|515720987|FG002|Second Intervention|Non-compliance with facility policies|0|||
143049847|NCT00672984|515720985|FG000|Second Intervention|Withdrawal by Subject|0|||
143049848|NCT00672984|515720986|FG001|Second Intervention|Withdrawal by Subject|3|||
143049849|NCT00672984|515720987|FG002|Second Intervention|Withdrawal by Subject|0|||
143049850|NCT00672984|515720985|FG000|Second Intervention|Protocol Violation|0|||
143049851|NCT00672984|515720986|FG001|Second Intervention|Protocol Violation|1|||
143049852|NCT00672984|515720987|FG002|Second Intervention|Protocol Violation|1|||
143049853|NCT00672984|515720985|FG000|Third Intervention|Adverse Event|1|||
143049854|NCT00672984|515720986|FG001|Third Intervention|Adverse Event|0|||
143049855|NCT00672984|515720987|FG002|Third Intervention|Adverse Event|1|||
143049856|NCT01968551|515720988|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
143049857|NCT01968551|515720989|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
143049858|NCT01968551|515720990|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
143049859|NCT01968551|515720988|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
143049860|NCT01968551|515720989|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
143049861|NCT01968551|515720990|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
143049862|NCT01968551|515720988|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
143049863|NCT01968551|515720989|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
143049864|NCT01968551|515720990|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
143049865|NCT01968551|515720988|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
143049866|NCT01968551|515720989|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
143049867|NCT01968551|515720990|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
143049868|NCT01968551|515720988|FG000|Extension Phase|Adverse Event|0|||
143049869|NCT01968551|515720989|FG001|Extension Phase|Adverse Event|0|||
143049870|NCT01968551|515720990|FG002|Extension Phase|Adverse Event|2|||
143049871|NCT01968551|515720988|FG000|Extension Phase|Death|0|||
143049872|NCT01968551|515720989|FG001|Extension Phase|Death|1|||
143049873|NCT01968551|515720990|FG002|Extension Phase|Death|0|||
143049874|NCT01968551|515720988|FG000|Extension Phase|Withdrew Consent|0|||
143168803|NCT01722669|516165387|FG000|Overall Study|Withdrawal by Subject|0|||
143168804|NCT01722669|516165388|FG001|Overall Study|Withdrawal by Subject|0|||
143168805|NCT01722669|516165389|FG002|Overall Study|Withdrawal by Subject|0|||
143168806|NCT01722669|516165390|FG003|Overall Study|Withdrawal by Subject|0|||
143168807|NCT01722669|516165391|FG004|Overall Study|Withdrawal by Subject|0|||
143168808|NCT01722669|516165392|FG005|Overall Study|Withdrawal by Subject|2|||
143168809|NCT03781570|516165393|FG000|Overall Study|Technical Issues (equipment failure)|31|||
143168810|NCT03781570|516165393|FG000|Overall Study|Withdrawal by Subject|7|||
143168811|NCT03781570|516165393|FG000|Overall Study|Physical Constraints|11|||
143168812|NCT03709472|516165394|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
143168813|NCT03709472|516165395|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
143168814|NCT03709472|516165394|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
143168815|NCT03709472|516165395|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
143168816|NCT02496000|516165396|FG000|Overall Study|Withdrawal by Subject|1|||
143049875|NCT01968551|515720989|FG001|Extension Phase|Withdrew Consent|0|||
143049876|NCT01968551|515720990|FG002|Extension Phase|Withdrew Consent|1|||
143049877|NCT01968551|515720988|FG000|Extension Phase|Lost to Follow-up|1|||
143049878|NCT01968551|515720989|FG001|Extension Phase|Lost to Follow-up|0|||
143049879|NCT01968551|515720990|FG002|Extension Phase|Lost to Follow-up|1|||
143049880|NCT00819169|515720991|FG000|Overall Study|Withdrawal by Subject|2|||
143049881|NCT00819169|515720992|FG001|Overall Study|Withdrawal by Subject|0|||
143049882|NCT00819169|515720993|FG002|Overall Study|Withdrawal by Subject|0|||
143049883|NCT00819169|515720994|FG003|Overall Study|Withdrawal by Subject|1|||
143049884|NCT00819169|515720995|FG004|Overall Study|Withdrawal by Subject|1|||
143049885|NCT00819169|515720996|FG005|Overall Study|Withdrawal by Subject|1|||
143049886|NCT00819169|515720997|FG006|Overall Study|Withdrawal by Subject|5|||
143049887|NCT00819169|515720998|FG007|Overall Study|Withdrawal by Subject|1|||
143049888|NCT00819169|515720999|FG008|Overall Study|Withdrawal by Subject|4|||
143049889|NCT00819169|515720991|FG000|Overall Study|Lost to Follow-up|0|||
143049890|NCT00819169|515720992|FG001|Overall Study|Lost to Follow-up|2|||
143049891|NCT00819169|515720993|FG002|Overall Study|Lost to Follow-up|0|||
143049892|NCT00819169|515720994|FG003|Overall Study|Lost to Follow-up|1|||
143049893|NCT00819169|515720995|FG004|Overall Study|Lost to Follow-up|0|||
143168817|NCT02496000|516165397|FG001|Overall Study|Withdrawal by Subject|2|||
143168818|NCT02496000|516165398|FG002|Overall Study|Withdrawal by Subject|0|||
143049894|NCT00819169|515720996|FG005|Overall Study|Lost to Follow-up|6|||
143168819|NCT02496000|516165396|FG000|Overall Study|Lost to Follow-up|1|||
143168820|NCT02496000|516165397|FG001|Overall Study|Lost to Follow-up|0|||
143049895|NCT00819169|515720997|FG006|Overall Study|Lost to Follow-up|2|||
143049896|NCT00819169|515720998|FG007|Overall Study|Lost to Follow-up|2|||
143049897|NCT00819169|515720999|FG008|Overall Study|Lost to Follow-up|1|||
143049898|NCT00819169|515720991|FG000|Overall Study|Death|1|||
143049899|NCT00819169|515720992|FG001|Overall Study|Death|1|||
143049900|NCT00819169|515720993|FG002|Overall Study|Death|3|||
143049901|NCT00819169|515720994|FG003|Overall Study|Death|8|||
143049902|NCT00819169|515720995|FG004|Overall Study|Death|5|||
143049903|NCT00819169|515720996|FG005|Overall Study|Death|7|||
143049904|NCT00819169|515720997|FG006|Overall Study|Death|9|||
143049905|NCT00819169|515720998|FG007|Overall Study|Death|4|||
143049906|NCT00819169|515720999|FG008|Overall Study|Death|7|||
143049907|NCT00819169|515720991|FG000|Overall Study|Ineligibility determined|0|||
143049908|NCT00819169|515720992|FG001|Overall Study|Ineligibility determined|0|||
143049909|NCT00819169|515720993|FG002|Overall Study|Ineligibility determined|0|||
143049910|NCT00819169|515720994|FG003|Overall Study|Ineligibility determined|2|||
143049911|NCT00819169|515720995|FG004|Overall Study|Ineligibility determined|0|||
143049912|NCT00819169|515720996|FG005|Overall Study|Ineligibility determined|0|||
143049913|NCT00819169|515720997|FG006|Overall Study|Ineligibility determined|0|||
143049914|NCT00819169|515720998|FG007|Overall Study|Ineligibility determined|0|||
143049915|NCT00819169|515720999|FG008|Overall Study|Ineligibility determined|1|||
143049916|NCT00819169|515720991|FG000|Overall Study|Adverse Event|0|||
143049917|NCT00819169|515720992|FG001|Overall Study|Adverse Event|0|||
143049918|NCT00819169|515720993|FG002|Overall Study|Adverse Event|0|||
143049919|NCT00819169|515720994|FG003|Overall Study|Adverse Event|0|||
143049920|NCT00819169|515720995|FG004|Overall Study|Adverse Event|1|||
143049921|NCT00819169|515720996|FG005|Overall Study|Adverse Event|0|||
143049922|NCT00819169|515720997|FG006|Overall Study|Adverse Event|0|||
143049923|NCT00819169|515720998|FG007|Overall Study|Adverse Event|0|||
143049924|NCT00819169|515720999|FG008|Overall Study|Adverse Event|0|||
143049925|NCT00819169|515720991|FG000|Overall Study|Administrative Decision|0|||
143049926|NCT00819169|515720992|FG001|Overall Study|Administrative Decision|0|||
143049927|NCT00819169|515720993|FG002|Overall Study|Administrative Decision|0|||
143049928|NCT00819169|515720994|FG003|Overall Study|Administrative Decision|0|||
143049929|NCT00819169|515720995|FG004|Overall Study|Administrative Decision|1|||
143049930|NCT00819169|515720996|FG005|Overall Study|Administrative Decision|2|||
143049931|NCT00819169|515720997|FG006|Overall Study|Administrative Decision|0|||
143049932|NCT00819169|515720998|FG007|Overall Study|Administrative Decision|2|||
143049933|NCT00819169|515720999|FG008|Overall Study|Administrative Decision|0|||
143049934|NCT00406393|515721000|FG000|Overall Study|Did not undergo transplantation|2|||
143049935|NCT00406393|515721001|FG001|Overall Study|Did not undergo transplantation|1|||
143049936|NCT04060251|515721002|FG000|Overall Study|Study terminated due to low enrollment.|7|||
143049937|NCT04060251|515721003|FG001|Overall Study|Study terminated due to low enrollment.|5|||
143049938|NCT04060251|515721004|FG002|Overall Study|Study terminated due to low enrollment.|7|||
143049939|NCT04060251|515721002|FG000|Overall Study|Adverse Event|1|||
143049940|NCT04060251|515721003|FG001|Overall Study|Adverse Event|1|||
143049941|NCT04060251|515721004|FG002|Overall Study|Adverse Event|0|||
143049942|NCT00487435|515721005|FG000|Overall Study|Adverse Event|146|||
143049943|NCT00487435|515721005|FG000|Overall Study|Death|2|||
143049944|NCT00487435|515721005|FG000|Overall Study|Lack of Efficacy|33|||
143049945|NCT00487435|515721005|FG000|Overall Study|Lost to Follow-up|54|||
143049946|NCT00487435|515721005|FG000|Overall Study|Pregnancy|2|||
143049947|NCT00487435|515721005|FG000|Overall Study|Withdrawal by Subject|132|||
143049948|NCT00487435|515721005|FG000|Overall Study|Resolution Of Pain|1|||
143049949|NCT00487435|515721005|FG000|Overall Study|Study Medication Non-Compliant|32|||
143049950|NCT00487435|515721005|FG000|Overall Study|Other|83|||
143244529|NCT01615029|516446376|FG004|Overall Study|Ongoing|23|||
143244530|NCT05767749|516446377|FG000|Overall Study|Withdrawal by Subject|0|||
143244531|NCT05767749|516446378|FG001|Overall Study|Withdrawal by Subject|0|||
143244532|NCT05767749|516446379|FG002|Overall Study|Withdrawal by Subject|2|||
143244533|NCT05767749|516446380|FG003|Overall Study|Withdrawal by Subject|2|||
143049951|NCT01155531|515721006|FG000|Overall Study|Adverse Event|0|||
143049952|NCT01155531|515721007|FG001|Overall Study|Adverse Event|0|||
143049953|NCT01155531|515721008|FG002|Overall Study|Adverse Event|1|||
143049954|NCT01155531|515721009|FG003|Overall Study|Adverse Event|0|||
143049955|NCT01155531|515721006|FG000|Overall Study|Lost to Follow-up|0|||
143049956|NCT01155531|515721007|FG001|Overall Study|Lost to Follow-up|0|||
143049957|NCT01155531|515721008|FG002|Overall Study|Lost to Follow-up|0|||
143049958|NCT01155531|515721009|FG003|Overall Study|Lost to Follow-up|1|||
143049959|NCT01155531|515721006|FG000|Overall Study|Withdrawal by Subject|1|||
143049960|NCT01155531|515721007|FG001|Overall Study|Withdrawal by Subject|0|||
143049961|NCT01155531|515721008|FG002|Overall Study|Withdrawal by Subject|1|||
143049962|NCT01155531|515721009|FG003|Overall Study|Withdrawal by Subject|0|||
143049963|NCT00985751|515721012|FG000|Overall Study|Adverse Event|0|||
143049964|NCT00985751|515721013|FG001|Overall Study|Adverse Event|0|||
143049965|NCT00985751|515721014|FG002|Overall Study|Adverse Event|0|||
143049966|NCT00985751|515721015|FG003|Overall Study|Adverse Event|0|||
143049967|NCT00985751|515721016|FG004|Overall Study|Adverse Event|1|||
143049968|NCT01663896|515721017|FG000|Overall Study|Various reasons|43|||
143244534|NCT05767749|516446381|FG004|Overall Study|Withdrawal by Subject|2|||
143168821|NCT02496000|516165398|FG002|Overall Study|Lost to Follow-up|1|||
143168822|NCT02496000|516165396|FG000|Overall Study|Protocol Violation|0|||
143364519|NCT02950545|516877006|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
143364520|NCT02950545|516877007|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
143364521|NCT02950545|516877008|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
143364522|NCT00647348|516877010|FG000|Overall Study|Lost to Follow-up|3|||
143364523|NCT00647348|516877011|FG001|Overall Study|Lost to Follow-up|6|||
143364524|NCT04889118|516877012|FG000|Overall Study|Death|33|||
143364525|NCT04889118|516877013|FG001|Overall Study|Death|37|||
143364526|NCT04889118|516877012|FG000|Overall Study|Ongoing in Study|31|||
143364527|NCT04889118|516877013|FG001|Overall Study|Ongoing in Study|30|||
143364528|NCT00530777|516877014|FG000|Overall Study|Lost to Follow-up|0|||
143168823|NCT02496000|516165397|FG001|Overall Study|Protocol Violation|0|||
143168824|NCT02496000|516165398|FG002|Overall Study|Protocol Violation|1|||
143168825|NCT02496000|516165396|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
143168826|NCT02496000|516165397|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
143168827|NCT02496000|516165398|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
143168828|NCT02496000|516165396|FG000|Overall Study|undetermined|0|||
143168829|NCT02496000|516165397|FG001|Overall Study|undetermined|1|||
143168830|NCT02496000|516165398|FG002|Overall Study|undetermined|0|||
143168831|NCT02038036|516165399|FG000|Core Study|Adverse Event|7|||
143364529|NCT00530777|516877015|FG001|Overall Study|Lost to Follow-up|1|||
143364530|NCT00530777|516877014|FG000|Overall Study|Death|1|||
143168832|NCT02038036|516165400|FG001|Core Study|Adverse Event|7|||
143244535|NCT05767749|516446382|FG005|Overall Study|Withdrawal by Subject|2|||
143244536|NCT01077050|516447998|FG000|Overall Study|Subjects signed ICF could not be located|1|||
143364531|NCT00530777|516877015|FG001|Overall Study|Death|2|||
143244537|NCT01077050|516447998|FG000|Overall Study|Screen failure|8|||
143244538|NCT02102204|516448001|FG000|Overall Study|Withdrawal by Subject|137|||
143244539|NCT02102204|516448001|FG000|Overall Study|Death|92|||
143364532|NCT00530777|516877014|FG000|Overall Study|Physician Decision|1|||
143364533|NCT00530777|516877015|FG001|Overall Study|Physician Decision|0|||
143364534|NCT00530777|516877014|FG000|Overall Study|Withdrawal by Subject|0|||
143364535|NCT00530777|516877015|FG001|Overall Study|Withdrawal by Subject|1|||
143364536|NCT00530777|516877014|FG000|Overall Study|Unable to adhere to visit schedule|5|||
143364537|NCT00530777|516877015|FG001|Overall Study|Unable to adhere to visit schedule|1|||
143364538|NCT00282438|516877020|FG000|Overall Study|Lack of Efficacy|1|||
143364539|NCT00282438|516877021|FG001|Overall Study|Lack of Efficacy|0|||
143364540|NCT00282438|516877020|FG000|Overall Study|Death|0|||
143168833|NCT02038036|516165399|FG000|Core Study|Death|1|||
143244540|NCT02102204|516448001|FG000|Overall Study|Lost to Follow-up|65|||
143244541|NCT02102204|516448001|FG000|Overall Study|Sponsor Decision|5|||
143244542|NCT02102204|516448001|FG000|Overall Study|Ongoing|5|||
143244543|NCT00684060|516448002|FG000|Overall Study|Lost to Follow-up|1|||
143244544|NCT00684060|516448003|FG001|Overall Study|Lost to Follow-up|0|||
143244545|NCT00684060|516448002|FG000|Overall Study|New stenosis identified|1|||
143244546|NCT00684060|516448003|FG001|Overall Study|New stenosis identified|0|||
143244547|NCT00684060|516448002|FG000|Overall Study|Unable to collect MRI|1|||
143244548|NCT00684060|516448003|FG001|Overall Study|Unable to collect MRI|2|||
143244549|NCT00684060|516448002|FG000|Overall Study|Death|0|||
143244550|NCT00684060|516448003|FG001|Overall Study|Death|1|||
143244551|NCT00702715|516448008|FG000|Overall Study|Lost to Follow-up|1|||
143244552|NCT00702715|516448009|FG001|Overall Study|Lost to Follow-up|0|||
143244553|NCT02923921|516448010|FG000|Overall Study|Sponsor Decision|39|||
143244554|NCT02923921|516448011|FG001|Overall Study|Sponsor Decision|38|||
143244555|NCT02923921|516448010|FG000|Overall Study|Lost to Follow-up|1|||
143244556|NCT02923921|516448011|FG001|Overall Study|Lost to Follow-up|0|||
143244557|NCT02923921|516448010|FG000|Overall Study|Withdrawal by Subject|6|||
143244558|NCT02923921|516448011|FG001|Overall Study|Withdrawal by Subject|13|||
143364541|NCT00282438|516877021|FG001|Overall Study|Death|1|||
143364542|NCT01928940|516877027|FG000|Overall Study|Adverse Event|0|||
143499230|NCT00559273|517368524|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
143499231|NCT00559273|517368523|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
143168834|NCT02038036|516165400|FG001|Core Study|Death|1|||
143168835|NCT02038036|516165399|FG000|Core Study|Disease progression|2|||
143244559|NCT02923921|516448010|FG000|Overall Study|Unknown, Not Collected|7|||
143364543|NCT01928940|516877028|FG001|Overall Study|Adverse Event|1|||
143364544|NCT02954055|516877029|FG000|Overall Study|Did not initiate therapy|6|||
143168836|NCT02038036|516165400|FG001|Core Study|Disease progression|2|||
143168837|NCT02038036|516165399|FG000|Core Study|Lost to Follow-up|0|||
143364545|NCT02954055|516877030|FG001|Overall Study|Did not initiate therapy|1|||
143364546|NCT01352507|516877031|FG000|Treatment Period 1|Adverse Event|3|||
143364547|NCT01352507|516877032|FG001|Treatment Period 1|Adverse Event|0|||
143168838|NCT02038036|516165400|FG001|Core Study|Lost to Follow-up|1|||
143364548|NCT01352507|516877031|FG000|Treatment Period 1|Lost to Follow-up|3|||
143244560|NCT02923921|516448011|FG001|Overall Study|Unknown, Not Collected|6|||
143244561|NCT00854113|516448012|FG000|Overall Study|Adverse Event|0|||
143244562|NCT00854113|516448013|FG001|Overall Study|Adverse Event|0|||
143244563|NCT00854113|516448014|FG002|Overall Study|Adverse Event|0|||
143168839|NCT02038036|516165399|FG000|Core Study|Physician Decision|2|||
143168840|NCT02038036|516165400|FG001|Core Study|Physician Decision|1|||
143168841|NCT02038036|516165399|FG000|Core Study|Subject/guardian decision|0|||
143168842|NCT02038036|516165400|FG001|Core Study|Subject/guardian decision|1|||
143168843|NCT02038036|516165399|FG000|Core Study|Withdrawal by Subject|3|||
143168844|NCT02038036|516165400|FG001|Core Study|Withdrawal by Subject|1|||
143168845|NCT02038036|516165399|FG000|Crossover Period|Withdrawal by Subject|0|||
143168846|NCT02038036|516165400|FG001|Crossover Period|Withdrawal by Subject|3|||
143168847|NCT02038036|516165399|FG000|Crossover Period|Adverse Event|0|||
143168848|NCT02038036|516165400|FG001|Crossover Period|Adverse Event|9|||
143168849|NCT02038036|516165399|FG000|Crossover Period|Death|0|||
143168850|NCT02038036|516165400|FG001|Crossover Period|Death|2|||
143168851|NCT02038036|516165399|FG000|Crossover Period|Disease progression|0|||
143168852|NCT02038036|516165400|FG001|Crossover Period|Disease progression|3|||
143168853|NCT02038036|516165399|FG000|Crossover Period|Lost to Follow-up|0|||
143168854|NCT02038036|516165400|FG001|Crossover Period|Lost to Follow-up|1|||
143168855|NCT02038036|516165399|FG000|Crossover Period|Physician Decision|0|||
143168856|NCT02038036|516165400|FG001|Crossover Period|Physician Decision|2|||
143168857|NCT05318287|516165406|FG000|Overall Study|Lost to Follow-up|8|||
143168858|NCT02757768|516165414|FG000|Overall Study|Randomized Never Received Study Drug|3|||
143168859|NCT02757768|516165415|FG001|Overall Study|Randomized Never Received Study Drug|4|||
143168860|NCT02757768|516165414|FG000|Overall Study|Adverse Event|5|||
143168861|NCT02757768|516165415|FG001|Overall Study|Adverse Event|3|||
143168862|NCT02757768|516165414|FG000|Overall Study|Lack of Efficacy|2|||
143168863|NCT02757768|516165415|FG001|Overall Study|Lack of Efficacy|1|||
143168864|NCT02757768|516165414|FG000|Overall Study|Lost to Follow-up|1|||
143168865|NCT02757768|516165415|FG001|Overall Study|Lost to Follow-up|0|||
143168866|NCT02757768|516165414|FG000|Overall Study|Protocol Deviation|2|||
143168867|NCT02757768|516165415|FG001|Overall Study|Protocol Deviation|9|||
143168868|NCT02757768|516165414|FG000|Overall Study|Withdrawal by Subject|16|||
143168869|NCT02757768|516165415|FG001|Overall Study|Withdrawal by Subject|9|||
143168870|NCT02757768|516165414|FG000|Overall Study|Miscellaneous|4|||
143168871|NCT02757768|516165415|FG001|Overall Study|Miscellaneous|2|||
143168872|NCT05484895|516167255|FG000|Overall Study|Lost to Follow-up|63|||
143168873|NCT05484895|516167256|FG001|Overall Study|Lost to Follow-up|64|||
143168874|NCT01168596|516167257|FG000|Overall Study|Withdrawal by Subject|3|||
143168875|NCT01168596|516167258|FG001|Overall Study|Withdrawal by Subject|1|||
143168876|NCT00876447|516167259|FG000|Overall Study|Other miscellaneous reasons|3|||
143168877|NCT00876447|516167260|FG001|Overall Study|Other miscellaneous reasons|8|||
143244564|NCT00854113|516448015|FG003|Overall Study|Adverse Event|0|||
143244565|NCT00854113|516448016|FG004|Overall Study|Adverse Event|0|||
143244566|NCT00854113|516448017|FG005|Overall Study|Adverse Event|0|||
143244567|NCT00854113|516448018|FG006|Overall Study|Adverse Event|0|||
143244568|NCT00854113|516448019|FG007|Overall Study|Adverse Event|2|||
143168878|NCT00876447|516167259|FG000|Overall Study|Site closure|19|||
143168879|NCT00876447|516167260|FG001|Overall Study|Site closure|14|||
143168880|NCT00876447|516167259|FG000|Overall Study|Protocol Violation|9|||
143168881|NCT00876447|516167260|FG001|Overall Study|Protocol Violation|3|||
143168882|NCT00876447|516167259|FG000|Overall Study|Personal reasons|30|||
143168883|NCT00876447|516167260|FG001|Overall Study|Personal reasons|28|||
143168884|NCT00876447|516167259|FG000|Overall Study|Lost to Follow-up|6|||
143168885|NCT00876447|516167260|FG001|Overall Study|Lost to Follow-up|15|||
143168886|NCT00876447|516167259|FG000|Overall Study|Pregnancy|4|||
143168887|NCT00876447|516167260|FG001|Overall Study|Pregnancy|2|||
143168888|NCT00876447|516167259|FG000|Overall Study|Lack of Efficacy|5|||
143168889|NCT00876447|516167260|FG001|Overall Study|Lack of Efficacy|3|||
143168890|NCT00876447|516167259|FG000|Overall Study|Adverse Event|4|||
143168891|NCT00876447|516167260|FG001|Overall Study|Adverse Event|8|||
143168892|NCT00366457|516167267|FG000|Overall Study|never began study therapy|2|||
143168893|NCT02829996|516167268|FG000|Overall Study|Withdrawal by Subject|1|||
143168894|NCT02829996|516167269|FG001|Overall Study|Withdrawal by Subject|0|||
143168895|NCT02829996|516167270|FG002|Overall Study|Withdrawal by Subject|0|||
143244569|NCT00854113|516448020|FG008|Overall Study|Adverse Event|0|||
143499232|NCT00559273|517368524|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
143168896|NCT02829996|516167271|FG003|Overall Study|Withdrawal by Subject|0|||
143168897|NCT02829996|516167272|FG004|Overall Study|Withdrawal by Subject|0|||
143168898|NCT00189423|516167273|FG000|Overall Study|Death|746|||
143168899|NCT00189423|516167274|FG001|Overall Study|Death|747|||
143168900|NCT00189423|516167273|FG000|Overall Study|Withdrawal by Subject|9|||
143168901|NCT00189423|516167274|FG001|Overall Study|Withdrawal by Subject|9|||
143168902|NCT00189423|516167273|FG000|Overall Study|Lost to Follow-up|10|||
143168903|NCT00189423|516167274|FG001|Overall Study|Lost to Follow-up|10|||
143499233|NCT00559273|517368523|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
143168904|NCT01497197|516167275|FG000|Overall Study|Lost to Follow-up|1|||
143168905|NCT01497197|516167276|FG001|Overall Study|Lost to Follow-up|0|||
143168906|NCT01497197|516167275|FG000|Overall Study|Protocol Violation|0|||
143244570|NCT00854113|516448021|FG009|Overall Study|Adverse Event|0|||
143168907|NCT01497197|516167276|FG001|Overall Study|Protocol Violation|2|||
143244571|NCT00854113|516448022|FG010|Overall Study|Adverse Event|0|||
143049969|NCT01046084|515721022|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
143049970|NCT01046084|515721023|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
143049971|NCT00474188|515721024|FG000|Overall Study|Withdrawal by Subject|1|||
143049972|NCT00474188|515721024|FG000|Overall Study|Study discontinued by sponsor|5|||
143049973|NCT03614728|515721025|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
143049974|NCT03614728|515721026|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
143049975|NCT03614728|515721027|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
143049976|NCT03614728|515721028|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
143049977|NCT03614728|515721025|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
143049978|NCT03614728|515721026|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
143049979|NCT03614728|515721027|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
143049980|NCT03614728|515721028|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
143049981|NCT01962298|515721031|FG000|Overall Study|Protocol Violation|1|||
143049982|NCT01962298|515721032|FG001|Overall Study|Protocol Violation|0|||
143049983|NCT01962298|515721033|FG002|Overall Study|Protocol Violation|1|||
143049984|NCT01962298|515721034|FG003|Overall Study|Protocol Violation|1|||
143049985|NCT01962298|515721035|FG004|Overall Study|Protocol Violation|0|||
143049986|NCT01962298|515721031|FG000|Overall Study|Data quality insufficient|2|||
143049987|NCT01962298|515721032|FG001|Overall Study|Data quality insufficient|0|||
143049988|NCT01962298|515721033|FG002|Overall Study|Data quality insufficient|3|||
143049989|NCT01962298|515721034|FG003|Overall Study|Data quality insufficient|1|||
143049990|NCT01962298|515721035|FG004|Overall Study|Data quality insufficient|4|||
143049991|NCT01962298|515721031|FG000|Overall Study|Insufficient data|0|||
143049992|NCT01962298|515721032|FG001|Overall Study|Insufficient data|2|||
143049993|NCT01962298|515721033|FG002|Overall Study|Insufficient data|1|||
143049994|NCT01962298|515721034|FG003|Overall Study|Insufficient data|0|||
143049995|NCT01962298|515721035|FG004|Overall Study|Insufficient data|1|||
143049996|NCT01962298|515721031|FG000|Overall Study|Incorrect data recorded|0|||
143049997|NCT01962298|515721032|FG001|Overall Study|Incorrect data recorded|1|||
143049998|NCT01962298|515721033|FG002|Overall Study|Incorrect data recorded|0|||
143049999|NCT01962298|515721034|FG003|Overall Study|Incorrect data recorded|0|||
143050000|NCT01962298|515721035|FG004|Overall Study|Incorrect data recorded|0|||
143050001|NCT01962298|515721031|FG000|Overall Study|Physician Decision|0|||
143050002|NCT01962298|515721032|FG001|Overall Study|Physician Decision|1|||
143050003|NCT01962298|515721033|FG002|Overall Study|Physician Decision|0|||
143050004|NCT01962298|515721034|FG003|Overall Study|Physician Decision|0|||
143050005|NCT01962298|515721035|FG004|Overall Study|Physician Decision|1|||
143050006|NCT01576705|515721036|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
143050007|NCT01576705|515721037|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
143050008|NCT01576705|515721038|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
143050009|NCT01576705|515721039|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
143050010|NCT01576705|515721036|FG000|Overall Study|invalid ICF|0|||
143050011|NCT01576705|515721037|FG001|Overall Study|invalid ICF|1|||
143050012|NCT01576705|515721038|FG002|Overall Study|invalid ICF|0|||
143050013|NCT01576705|515721039|FG003|Overall Study|invalid ICF|0|||
143050014|NCT02896296|515721040|FG000|Overall Study|Adverse Event|1|||
143050015|NCT02896296|515721040|FG000|Overall Study|Lost to Follow-up|19|||
143050016|NCT02896296|515721040|FG000|Overall Study|Pregnancy|1|||
143050017|NCT02896296|515721040|FG000|Overall Study|Physician Decision|2|||
143050018|NCT02896296|515721040|FG000|Overall Study|Withdrawal by Subject|10|||
143050019|NCT02896296|515721040|FG000|Overall Study|Site closing|7|||
143050020|NCT02896296|515721040|FG000|Overall Study|Incarceration|1|||
143244572|NCT00854113|516448012|FG000|Overall Study|Withdrawal by Subject|0|||
143244573|NCT00854113|516448013|FG001|Overall Study|Withdrawal by Subject|0|||
143244574|NCT00854113|516448014|FG002|Overall Study|Withdrawal by Subject|0|||
143244575|NCT00854113|516448015|FG003|Overall Study|Withdrawal by Subject|0|||
143244576|NCT00854113|516448016|FG004|Overall Study|Withdrawal by Subject|0|||
143244577|NCT00854113|516448017|FG005|Overall Study|Withdrawal by Subject|0|||
143244578|NCT00854113|516448018|FG006|Overall Study|Withdrawal by Subject|0|||
143244579|NCT00854113|516448019|FG007|Overall Study|Withdrawal by Subject|1|||
143244580|NCT00854113|516448020|FG008|Overall Study|Withdrawal by Subject|1|||
143050021|NCT02896296|515721040|FG000|Overall Study|Relocation|1|||
143050022|NCT01018862|515721045|FG000|Overall Study|Adverse Event|2|||
143050023|NCT01018862|515721046|FG001|Overall Study|Adverse Event|0|||
143050024|NCT01018862|515721047|FG002|Overall Study|Adverse Event|6|||
143050025|NCT01018862|515721045|FG000|Overall Study|Lack of Efficacy|1|||
143050026|NCT01018862|515721046|FG001|Overall Study|Lack of Efficacy|0|||
143050027|NCT01018862|515721047|FG002|Overall Study|Lack of Efficacy|2|||
143050028|NCT01018862|515721045|FG000|Overall Study|Lost to Follow-up|3|||
143499234|NCT00559273|517368524|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
143050029|NCT01018862|515721046|FG001|Overall Study|Lost to Follow-up|1|||
143050030|NCT01018862|515721047|FG002|Overall Study|Lost to Follow-up|0|||
143050031|NCT01018862|515721045|FG000|Overall Study|Protocol Violation|1|||
143050032|NCT01018862|515721046|FG001|Overall Study|Protocol Violation|3|||
143050033|NCT01018862|515721047|FG002|Overall Study|Protocol Violation|3|||
143050034|NCT01018862|515721045|FG000|Overall Study|Withdrawal by Subject|1|||
143244581|NCT00854113|516448021|FG009|Overall Study|Withdrawal by Subject|0|||
143168908|NCT01497197|516167275|FG000|Overall Study|Withdrawal by Subject|2|||
143168909|NCT01497197|516167276|FG001|Overall Study|Withdrawal by Subject|1|||
143168910|NCT01497197|516167275|FG000|Overall Study|Excessive/lack of response to treatment|1|||
143168911|NCT01497197|516167276|FG001|Overall Study|Excessive/lack of response to treatment|0|||
143168912|NCT01497197|516167275|FG000|Overall Study|Risk of OHSS|1|||
143168913|NCT01497197|516167276|FG001|Overall Study|Risk of OHSS|0|||
143168914|NCT01497197|516167275|FG000|Overall Study|No oocytes retrieved|3|||
143168915|NCT01497197|516167276|FG001|Overall Study|No oocytes retrieved|2|||
143168916|NCT01497197|516167275|FG000|Overall Study|No fertilisation|6|||
143168917|NCT01497197|516167276|FG001|Overall Study|No fertilisation|5|||
143168918|NCT01497197|516167275|FG000|Overall Study|Intention to freeze all embryos|0|||
143168919|NCT01497197|516167276|FG001|Overall Study|Intention to freeze all embryos|1|||
143168920|NCT01497197|516167275|FG000|Overall Study|All embryos discarded|0|||
143168921|NCT01497197|516167276|FG001|Overall Study|All embryos discarded|3|||
143168922|NCT01497197|516167275|FG000|Overall Study|Other|3|||
143168923|NCT01497197|516167276|FG001|Overall Study|Other|1|||
143168924|NCT02390076|516167277|FG000|Overall Study|Lost to Follow-up|2|||
143168925|NCT02390076|516167278|FG001|Overall Study|Lost to Follow-up|1|||
143168926|NCT02390076|516167279|FG002|Overall Study|Lost to Follow-up|4|||
143168927|NCT04507204|516167280|FG000|Overall Study|Adverse Event|8|||
143168928|NCT04507204|516167281|FG001|Overall Study|Adverse Event|13|||
143168929|NCT04507204|516167280|FG000|Overall Study|Death|0|||
143168930|NCT04507204|516167281|FG001|Overall Study|Death|1|||
143168931|NCT04507204|516167280|FG000|Overall Study|Lost to Follow-up|15|||
143168932|NCT04507204|516167281|FG001|Overall Study|Lost to Follow-up|14|||
143168933|NCT04507204|516167280|FG000|Overall Study|Poor Compliance with Protocol|2|||
143168934|NCT04507204|516167281|FG001|Overall Study|Poor Compliance with Protocol|4|||
143168935|NCT04507204|516167280|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
143168936|NCT04507204|516167281|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
143168937|NCT04507204|516167280|FG000|Overall Study|Withdrawal of Patient Consent|21|||
143168938|NCT04507204|516167281|FG001|Overall Study|Withdrawal of Patient Consent|13|||
143168939|NCT01206517|516167284|FG000|Overall Study|Withdrawal by Subject|0|||
143168940|NCT01206517|516167285|FG001|Overall Study|Withdrawal by Subject|0|||
143168941|NCT01206517|516167286|FG002|Overall Study|Withdrawal by Subject|2|||
143168942|NCT01206517|516167287|FG003|Overall Study|Withdrawal by Subject|0|||
143168943|NCT01206517|516167288|FG004|Overall Study|Withdrawal by Subject|1|||
143168944|NCT01206517|516167289|FG005|Overall Study|Withdrawal by Subject|0|||
143168945|NCT01358734|516167293|FG000|Overall Study|Adverse Event|4|||
143168946|NCT01358734|516167294|FG001|Overall Study|Adverse Event|7|||
143168947|NCT01358734|516167295|FG002|Overall Study|Adverse Event|3|||
143168948|NCT01358734|516167293|FG000|Overall Study|Lack of Efficacy|0|||
143244582|NCT00854113|516448022|FG010|Overall Study|Withdrawal by Subject|0|||
143244583|NCT00796419|516448024|FG000|Overall Study|Death|0|||
143244584|NCT00796419|516448025|FG001|Overall Study|Death|1|||
143244585|NCT01250145|516448026|FG000|Overall Study|Adverse Event|2|||
143244586|NCT01250145|516448027|FG001|Overall Study|Adverse Event|1|||
143244587|NCT01250145|516448026|FG000|Overall Study|Withdrawal by Subject|0|||
143244588|NCT01250145|516448027|FG001|Overall Study|Withdrawal by Subject|4|||
143244589|NCT02840799|516448030|FG000|Phase 1|Physician Decision|1|||
143244590|NCT02840799|516448031|FG001|Phase 1|Physician Decision|3|||
143244591|NCT02840799|516448030|FG000|Phase 1|Withdrawal by Subject|4|||
143244592|NCT02840799|516448031|FG001|Phase 1|Withdrawal by Subject|0|||
143244593|NCT02840799|516448030|FG000|Phase 2 (Crossover)|Adverse Event|0|||
143244594|NCT02840799|516448031|FG001|Phase 2 (Crossover)|Adverse Event|1|||
143244595|NCT02840799|516448030|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
143244596|NCT02840799|516448031|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
143244597|NCT02565784|516448032|FG000|First Treatment|Adverse Event|1|||
143168949|NCT01358734|516167294|FG001|Overall Study|Lack of Efficacy|1|||
143244598|NCT02565784|516448032|FG000|First Treatment|Withdrawal by Subject|1|||
143244599|NCT02565784|516448032|FG000|Second Treatment|Withdrawal by Subject|2|||
143168950|NCT01358734|516167295|FG002|Overall Study|Lack of Efficacy|3|||
143168951|NCT01358734|516167293|FG000|Overall Study|Withdrawal by Subject|1|||
143168952|NCT01358734|516167294|FG001|Overall Study|Withdrawal by Subject|6|||
143168953|NCT01358734|516167295|FG002|Overall Study|Withdrawal by Subject|3|||
143168954|NCT01358734|516167293|FG000|Overall Study|Death|3|||
143168955|NCT01358734|516167294|FG001|Overall Study|Death|7|||
143168956|NCT01358734|516167295|FG002|Overall Study|Death|2|||
143168957|NCT01358734|516167293|FG000|Overall Study|Progressive Disease|5|||
143168958|NCT01358734|516167294|FG001|Overall Study|Progressive Disease|13|||
143168959|NCT01358734|516167295|FG002|Overall Study|Progressive Disease|16|||
143244600|NCT01069900|516448036|FG000|Overall Study|Technical problems|0|||
143244601|NCT01069900|516448037|FG001|Overall Study|Technical problems|1|||
143244602|NCT01069900|516448036|FG000|Overall Study|Lost to Follow-up|7|||
143244603|NCT01069900|516448037|FG001|Overall Study|Lost to Follow-up|1|||
143244604|NCT01069900|516448036|FG000|Overall Study|Withdrawal by Subject|6|||
143244605|NCT01069900|516448037|FG001|Overall Study|Withdrawal by Subject|1|||
143050035|NCT01018862|515721046|FG001|Overall Study|Withdrawal by Subject|2|||
143050036|NCT01018862|515721047|FG002|Overall Study|Withdrawal by Subject|1|||
143050037|NCT01018862|515721045|FG000|Overall Study|administrative problems|5|||
143050038|NCT01018862|515721046|FG001|Overall Study|administrative problems|4|||
143050039|NCT01018862|515721047|FG002|Overall Study|administrative problems|4|||
143050040|NCT01891357|515721048|FG000|Overall Study|Protocol Violation|3|||
143050041|NCT02957331|515721051|FG000|Overall Study|Protocol Violation|1|||
143050042|NCT02957331|515721052|FG001|Overall Study|Protocol Violation|0|||
143050043|NCT00202839|515722296|FG000|Overall Study|Adverse Event|1|||
143050044|NCT00202839|515722297|FG001|Overall Study|Adverse Event|5|||
143050045|NCT00202839|515722296|FG000|Overall Study|Physician Decision|12|||
143050046|NCT00202839|515722297|FG001|Overall Study|Physician Decision|0|||
143050047|NCT00202839|515722296|FG000|Overall Study|Withdrawal by Subject|6|||
143050048|NCT00202839|515722297|FG001|Overall Study|Withdrawal by Subject|2|||
143050049|NCT00202839|515722296|FG000|Overall Study|Protocol Violation|2|||
143050050|NCT00202839|515722297|FG001|Overall Study|Protocol Violation|1|||
143050051|NCT00202839|515722296|FG000|Overall Study|Lost to Follow-up|3|||
143050052|NCT00202839|515722297|FG001|Overall Study|Lost to Follow-up|2|||
143050053|NCT02485158|515722298|FG000|Overall Study|Withdrawal by Subject|3|||
143050054|NCT02485158|515722298|FG000|Overall Study|expected drug side effect|1|||
143050055|NCT02664415|515722299|FG000|Overall Study|Adverse Event|1|||
143050056|NCT02664415|515722300|FG001|Overall Study|Adverse Event|0|||
143050057|NCT00642993|515722301|FG000|Overall Study|Adverse Event|85|||
143050058|NCT00642993|515722302|FG001|Overall Study|Adverse Event|4|||
143050059|NCT00642993|515722301|FG000|Overall Study|Lost to Follow-up|8|||
143050060|NCT00642993|515722302|FG001|Overall Study|Lost to Follow-up|4|||
143050061|NCT00642993|515722301|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
143050062|NCT00642993|515722302|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
143050063|NCT00642993|515722301|FG000|Overall Study|Protocol Violation|1|||
143050064|NCT00642993|515722302|FG001|Overall Study|Protocol Violation|4|||
143050065|NCT00642993|515722301|FG000|Overall Study|Did not meet protocol eligibility|0|||
143050066|NCT00642993|515722302|FG001|Overall Study|Did not meet protocol eligibility|1|||
143050067|NCT00642993|515722301|FG000|Overall Study|Administrative|1|||
143050068|NCT00642993|515722302|FG001|Overall Study|Administrative|0|||
143050069|NCT01151280|515722303|FG000|Overall Study|Adverse Event|1|||
143050070|NCT01151280|515722303|FG000|Overall Study|Lack of Efficacy|3|||
143050071|NCT04408924|515722310|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
143050072|NCT04408924|515722310|FG000|Overall Study|Lost to Follow-up|3|||
143050073|NCT04408924|515722310|FG000|Overall Study|Withdrawal by Subject|5|||
143050074|NCT04408924|515722310|FG000|Overall Study|Sponsor Decision|2|||
143050075|NCT03540160|515722311|FG000|Overall Study|Protocol Violation|1|||
143050076|NCT03540160|515722311|FG000|Overall Study|Physician Decision|8|||
143050077|NCT03540160|515722311|FG000|Overall Study|Lack of Efficacy|60|||
143050078|NCT03540160|515722311|FG000|Overall Study|Pregnancy|1|||
143050079|NCT03540160|515722311|FG000|Overall Study|Adverse Event|20|||
143050080|NCT03540160|515722311|FG000|Overall Study|Withdrawal by Subject|68|||
143050081|NCT03540160|515722311|FG000|Overall Study|COVID-19|2|||
143050082|NCT03540160|515722311|FG000|Overall Study|Study Closure|10|||
143050083|NCT03540160|515722311|FG000|Overall Study|Lost to Follow-up|18|||
143050084|NCT03540160|515722311|FG000|Overall Study|Sponsor decision|191|||
143050085|NCT02704091|515722314|FG000|Overall Study|Adverse Event|4|||
143050086|NCT02704091|515722315|FG001|Overall Study|Adverse Event|3|||
143050087|NCT02704091|515722314|FG000|Overall Study|Protocol Violation|5|||
143050088|NCT02704091|515722315|FG001|Overall Study|Protocol Violation|3|||
143050089|NCT02704091|515722314|FG000|Overall Study|Consent withdrawn|4|||
143050090|NCT02704091|515722315|FG001|Overall Study|Consent withdrawn|4|||
143050091|NCT02704091|515722314|FG000|Overall Study|Lost to Follow-up|13|||
143050092|NCT02704091|515722315|FG001|Overall Study|Lost to Follow-up|5|||
143050093|NCT02704091|515722314|FG000|Overall Study|Other|2|||
143050094|NCT02704091|515722315|FG001|Overall Study|Other|8|||
143050095|NCT01634139|515722316|FG000|Overall Study|Non compliant with protocol|1|||
143050096|NCT01634139|515722317|FG001|Overall Study|Non compliant with protocol|0|||
143050097|NCT01634139|515722318|FG002|Overall Study|Non compliant with protocol|0|||
143050098|NCT01634139|515722316|FG000|Overall Study|Consent withdrawn not due to AE|4|||
143050099|NCT01634139|515722317|FG001|Overall Study|Consent withdrawn not due to AE|3|||
143050100|NCT01634139|515722318|FG002|Overall Study|Consent withdrawn not due to AE|2|||
143050101|NCT01634139|515722316|FG000|Overall Study|Other|4|||
143050102|NCT01634139|515722317|FG001|Overall Study|Other|0|||
143050103|NCT01634139|515722318|FG002|Overall Study|Other|3|||
143050104|NCT01634139|515722316|FG000|Overall Study|Lost to Follow-up|0|||
143050105|NCT01634139|515722317|FG001|Overall Study|Lost to Follow-up|2|||
143168960|NCT01358734|516167293|FG000|Overall Study|Non-compliance with study drug|0|||
143050106|NCT01634139|515722318|FG002|Overall Study|Lost to Follow-up|0|||
143050107|NCT01634139|515722316|FG000|Overall Study|Not treated|1|||
143050108|NCT01634139|515722317|FG001|Overall Study|Not treated|1|||
143050109|NCT01634139|515722318|FG002|Overall Study|Not treated|0|||
143050110|NCT00425308|515722319|FG000|Overall Study|Adverse Event|2|||
143050111|NCT00425308|515722320|FG001|Overall Study|Adverse Event|1|||
143050112|NCT00425308|515722319|FG000|Overall Study|Withdrawal by Subject|1|||
143050113|NCT00425308|515722320|FG001|Overall Study|Withdrawal by Subject|0|||
143050114|NCT00425308|515722319|FG000|Overall Study|Death|1|||
143050115|NCT00425308|515722320|FG001|Overall Study|Death|0|||
143050116|NCT05034874|515722323|FG000|Overall Study|Withdrawal by Subject|6|||
143050117|NCT05034874|515722324|FG001|Overall Study|Withdrawal by Subject|6|||
143050118|NCT05034874|515722323|FG000|Overall Study|Lost to Follow-up|18|||
143050119|NCT05034874|515722324|FG001|Overall Study|Lost to Follow-up|8|||
143050120|NCT05034874|515722323|FG000|Overall Study|Physician Decision|0|||
143050121|NCT05034874|515722324|FG001|Overall Study|Physician Decision|1|||
143050122|NCT05034874|515722323|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
143050123|NCT05034874|515722324|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
143050124|NCT05616728|515722329|FG000|Overall Study|Lost to Follow-up|0|||
143050125|NCT05616728|515722330|FG001|Overall Study|Lost to Follow-up|0|||
143050126|NCT05616728|515722331|FG002|Overall Study|Lost to Follow-up|1|||
143050127|NCT05616728|515722329|FG000|Overall Study|Withdrawal by Subject|1|||
143050128|NCT05616728|515722330|FG001|Overall Study|Withdrawal by Subject|1|||
143050129|NCT05616728|515722331|FG002|Overall Study|Withdrawal by Subject|0|||
143050130|NCT05616728|515722329|FG000|Overall Study|Physician Decision|1|||
143050131|NCT05616728|515722330|FG001|Overall Study|Physician Decision|1|||
143050132|NCT05616728|515722331|FG002|Overall Study|Physician Decision|1|||
143050133|NCT05616728|515722329|FG000|Overall Study|Other|0|||
143050134|NCT05616728|515722330|FG001|Overall Study|Other|2|||
143050135|NCT05616728|515722331|FG002|Overall Study|Other|0|||
143050136|NCT00577655|515722332|FG000|Overall Study|Patient Request|0|||
143050137|NCT00577655|515722333|FG001|Overall Study|Patient Request|2|||
143050138|NCT00577655|515722332|FG000|Overall Study|Protocol Violation|0|||
143050139|NCT00577655|515722333|FG001|Overall Study|Protocol Violation|1|||
143050140|NCT00577655|515722332|FG000|Overall Study|Lost to Follow-up|1|||
143050141|NCT00577655|515722333|FG001|Overall Study|Lost to Follow-up|1|||
143050142|NCT00875524|515722335|FG000|Overall Study|Serious adverse event|0|||
143050143|NCT00875524|515722336|FG001|Overall Study|Serious adverse event|1|||
143050144|NCT00875524|515722335|FG000|Overall Study|Protocol Violation|4|||
143050145|NCT00875524|515722336|FG001|Overall Study|Protocol Violation|0|||
143050146|NCT00875524|515722335|FG000|Overall Study|Lost to Follow-up|1|||
143050147|NCT00875524|515722336|FG001|Overall Study|Lost to Follow-up|0|||
143050148|NCT00875524|515722335|FG000|Overall Study|Withdrawal by Subject|3|||
143050149|NCT00875524|515722336|FG001|Overall Study|Withdrawal by Subject|5|||
143050150|NCT01370863|515722337|FG000|Overall Study|Adverse Event|1|||
143050151|NCT01370863|515722338|FG001|Overall Study|Adverse Event|1|||
143050152|NCT01370863|515722337|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
143050153|NCT01370863|515722338|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
143050154|NCT01370863|515722337|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
143050155|NCT01370863|515722338|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
143244606|NCT01069900|516448036|FG000|Overall Study|Protocol Violation|4|||
143244607|NCT01069900|516448037|FG001|Overall Study|Protocol Violation|1|||
143244608|NCT01069900|516448036|FG000|Overall Study|Insufficient Therapeutic effect|1|||
143244609|NCT01069900|516448037|FG001|Overall Study|Insufficient Therapeutic effect|0|||
143244610|NCT03887702|516448041|FG000|Overall Study|Study terminated|0|||
143244611|NCT03887702|516448042|FG001|Overall Study|Study terminated|0|||
143244612|NCT03887702|516448043|FG002|Overall Study|Study terminated|2|||
143244613|NCT03887702|516448044|FG003|Overall Study|Study terminated|2|||
143244614|NCT01675544|516448048|FG000|Overall Study|Withdrawal by Subject|2|||
143244615|NCT00476008|516448051|FG000|Overall Study|Adverse Event|4|||
143244616|NCT00476008|516448052|FG001|Overall Study|Adverse Event|4|||
143244617|NCT00476008|516448051|FG000|Overall Study|Placebo concerns|2|||
143244618|NCT00476008|516448052|FG001|Overall Study|Placebo concerns|2|||
143244619|NCT00476008|516448051|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
143364549|NCT01352507|516877032|FG001|Treatment Period 1|Lost to Follow-up|4|||
143364550|NCT01352507|516877031|FG000|Treatment Period 1|Withdrawal by Subject|7|||
143364551|NCT01352507|516877032|FG001|Treatment Period 1|Withdrawal by Subject|5|||
143499235|NCT00559273|517368523|FG000|Evaluation Period (8 Weeks)|Death|1|||
143050156|NCT00881751|515722339|FG000|Overall Study|Physician Decision|0|||
143050157|NCT00881751|515722340|FG001|Overall Study|Physician Decision|1|||
143050158|NCT00881751|515722339|FG000|Overall Study|Adverse Event|0|||
143050159|NCT00881751|515722340|FG001|Overall Study|Adverse Event|2|||
143050160|NCT00881751|515722339|FG000|Overall Study|Withdrawal by Subject|0|||
143050161|NCT00881751|515722340|FG001|Overall Study|Withdrawal by Subject|2|||
143050162|NCT00301964|515722343|FG000|Overall Study|Second primary|2|||
143050163|NCT00301964|515722343|FG000|Overall Study|Wrong primary|1|||
143050164|NCT00301964|515722343|FG000|Overall Study|Inadequate pathology|1|||
143050165|NCT02385708|515722344|FG000|Overall Study|Withdrawal by Subject|0|||
143050166|NCT02385708|515722345|FG001|Overall Study|Withdrawal by Subject|2|||
143050167|NCT02385708|515722344|FG000|Overall Study|Withdrawn - surgery canceled|2|||
143244620|NCT00476008|516448052|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
143244621|NCT00476008|516448051|FG000|Overall Study|Withdrawal by Subject|0|||
143244622|NCT00476008|516448052|FG001|Overall Study|Withdrawal by Subject|1|||
143244623|NCT00476008|516448051|FG000|Overall Study|Death|1|||
143499236|NCT00559273|517368524|FG001|Evaluation Period (8 Weeks)|Death|3|||
143050168|NCT02385708|515722345|FG001|Overall Study|Withdrawn - surgery canceled|5|||
143050169|NCT02385708|515722344|FG000|Overall Study|Investigator decision|5|||
143050170|NCT02385708|515722345|FG001|Overall Study|Investigator decision|7|||
143050171|NCT02385708|515722344|FG000|Overall Study|Protocol Violation|1|||
143050172|NCT02385708|515722345|FG001|Overall Study|Protocol Violation|1|||
143050173|NCT02637141|515722350|FG000|Overall Study|Adverse Event|1|||
143050174|NCT02637141|515722351|FG001|Overall Study|Adverse Event|1|||
143050175|NCT02637141|515722352|FG002|Overall Study|Adverse Event|0|||
143050176|NCT02637141|515722350|FG000|Overall Study|Withdrawal by Subject|1|||
143244624|NCT00476008|516448052|FG001|Overall Study|Death|0|||
143050177|NCT02637141|515722351|FG001|Overall Study|Withdrawal by Subject|1|||
143050178|NCT02637141|515722352|FG002|Overall Study|Withdrawal by Subject|1|||
143050179|NCT01868243|515722353|FG000|Overall Study|Death|0|||
143050180|NCT01868243|515722354|FG001|Overall Study|Death|1|||
143050181|NCT00379353|515722355|FG000|Overall Study|Hospitalization|3|||
143050182|NCT00379353|515722356|FG001|Overall Study|Hospitalization|3|||
143050183|NCT00379353|515722355|FG000|Overall Study|Withdrawal by Subject|5|||
143050184|NCT00379353|515722356|FG001|Overall Study|Withdrawal by Subject|2|||
143050185|NCT00379353|515722355|FG000|Overall Study|Death|1|||
143050186|NCT00379353|515722356|FG001|Overall Study|Death|0|||
143050187|NCT00379353|515722355|FG000|Overall Study|Cardiac Tamponade|1|||
143050188|NCT00379353|515722356|FG001|Overall Study|Cardiac Tamponade|0|||
143050189|NCT00379353|515722355|FG000|Overall Study|Non-compliance|1|||
143050190|NCT00379353|515722356|FG001|Overall Study|Non-compliance|0|||
143050191|NCT00379353|515722355|FG000|Overall Study|Conflicting drug treatment|0|||
143050192|NCT00379353|515722356|FG001|Overall Study|Conflicting drug treatment|1|||
143050193|NCT01958476|515722357|FG000|Overall Study|Parent requested exclusion from analysis|1|||
143050194|NCT01958476|515722358|FG001|Overall Study|Parent requested exclusion from analysis|0|||
143050195|NCT05412121|515722361|FG000|Overall Study|Withdrawal by Subject|4|||
143050196|NCT05412121|515722361|FG000|Overall Study|Physician Decision|1|||
143050197|NCT05412121|515722361|FG000|Overall Study|Lost to Follow-up|5|||
143050198|NCT01971645|515722362|FG000|Overall Study|Adverse Event|1|||
143050199|NCT01971645|515722363|FG001|Overall Study|Adverse Event|0|||
143050200|NCT01971645|515722364|FG002|Overall Study|Adverse Event|0|||
143050201|NCT01971645|515722362|FG000|Overall Study|Lost to Follow-up|1|||
143050202|NCT01971645|515722363|FG001|Overall Study|Lost to Follow-up|0|||
143050203|NCT01971645|515722364|FG002|Overall Study|Lost to Follow-up|1|||
143050204|NCT01971645|515722362|FG000|Overall Study|Protocol Violation|0|||
143050205|NCT01971645|515722363|FG001|Overall Study|Protocol Violation|0|||
143050206|NCT01971645|515722364|FG002|Overall Study|Protocol Violation|1|||
143050207|NCT00537095|515722365|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
143050208|NCT00537095|515722366|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
143050209|NCT00537095|515722365|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
143168961|NCT01358734|516167294|FG001|Overall Study|Non-compliance with study drug|0|||
143168962|NCT01358734|516167295|FG002|Overall Study|Non-compliance with study drug|1|||
143168963|NCT01358734|516167293|FG000|Overall Study|Other|2|||
143168964|NCT01358734|516167294|FG001|Overall Study|Other|5|||
143168965|NCT01358734|516167295|FG002|Overall Study|Other|4|||
143168966|NCT01358734|516167293|FG000|Overall Study|Protocol Violation|0|||
143168967|NCT01358734|516167294|FG001|Overall Study|Protocol Violation|0|||
143168968|NCT01358734|516167295|FG002|Overall Study|Protocol Violation|2|||
143168969|NCT01822925|516167296|FG000|Overall Study|Adverse Event|1|||
143168970|NCT01822925|516167297|FG001|Overall Study|Adverse Event|1|||
143168971|NCT01822925|516167298|FG002|Overall Study|Adverse Event|1|||
143168972|NCT01822925|516167299|FG003|Overall Study|Adverse Event|1|||
143168973|NCT01822925|516167296|FG000|Overall Study|Lost to Follow-up|0|||
143168974|NCT01822925|516167297|FG001|Overall Study|Lost to Follow-up|1|||
143168975|NCT01822925|516167298|FG002|Overall Study|Lost to Follow-up|0|||
143168976|NCT01822925|516167299|FG003|Overall Study|Lost to Follow-up|0|||
143168977|NCT01822925|516167296|FG000|Overall Study|Protocol Violation|1|||
143168978|NCT01822925|516167297|FG001|Overall Study|Protocol Violation|0|||
143168979|NCT01822925|516167298|FG002|Overall Study|Protocol Violation|0|||
143168980|NCT01822925|516167299|FG003|Overall Study|Protocol Violation|1|||
143364552|NCT01352507|516877031|FG000|Treatment Period 1|Physician Decision|1|||
143168981|NCT01822925|516167296|FG000|Overall Study|Withdrawal by Subject|2|||
143168982|NCT01822925|516167297|FG001|Overall Study|Withdrawal by Subject|0|||
143364553|NCT01352507|516877032|FG001|Treatment Period 1|Physician Decision|0|||
143050210|NCT00537095|515722366|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
143050211|NCT00537095|515722365|FG000|Randomized Treatment Period (433 Days)|Death|3|||
143050212|NCT00537095|515722366|FG001|Randomized Treatment Period (433 Days)|Death|1|||
143050213|NCT00537095|515722365|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
143050214|NCT00537095|515722366|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
143050215|NCT00537095|515722365|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
143168983|NCT01822925|516167298|FG002|Overall Study|Withdrawal by Subject|2|||
143168984|NCT01822925|516167299|FG003|Overall Study|Withdrawal by Subject|2|||
143244625|NCT01039519|516448057|FG000|Treatment|Progressive disease|20|||
143050216|NCT00537095|515722366|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
143050217|NCT00537095|515722365|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
143050218|NCT00537095|515722366|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
143050219|NCT00537095|515722365|FG000|Open-label Period (590 Days)|Adverse Event|2|||
143050220|NCT00537095|515722366|FG001|Open-label Period (590 Days)|Adverse Event|11|||
143050221|NCT00537095|515722365|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
143050222|NCT00537095|515722366|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
143050223|NCT00537095|515722365|FG000|Open-label Period (590 Days)|Death|2|||
143050224|NCT00537095|515722366|FG001|Open-label Period (590 Days)|Death|2|||
143050225|NCT00537095|515722365|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
143050226|NCT00537095|515722366|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
143050227|NCT00537095|515722365|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
143050228|NCT00537095|515722366|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
143050229|NCT00566722|515722367|FG000|Overall Study|Adverse Event|0|||
143050230|NCT00566722|515722368|FG001|Overall Study|Adverse Event|1|||
143050231|NCT00566722|515722369|FG002|Overall Study|Adverse Event|0|||
143050232|NCT00566722|515722367|FG000|Overall Study|Withdrawal by Subject|0|||
143168985|NCT01822925|516167296|FG000|Overall Study|Taking prohibited medication|2|||
143168986|NCT01822925|516167297|FG001|Overall Study|Taking prohibited medication|0|||
143168987|NCT01822925|516167298|FG002|Overall Study|Taking prohibited medication|0|||
143168988|NCT01822925|516167299|FG003|Overall Study|Taking prohibited medication|1|||
143168989|NCT00904371|516167305|FG000|Overall Study|Adverse Event|2|||
143168990|NCT00904371|516167305|FG000|Overall Study|Lost to Follow-up|4|||
143168991|NCT00904371|516167305|FG000|Overall Study|Discontinued at target blood pressure|2|||
143168992|NCT00904371|516167305|FG000|Overall Study|Continued with Tritace|1|||
143168993|NCT00553254|516167310|FG000|Overall Study|Death|3|||
143168994|NCT00553254|516167311|FG001|Overall Study|Death|6|||
143168995|NCT00553254|516167312|FG002|Overall Study|Death|25|||
143168996|NCT00553254|516167310|FG000|Overall Study|Lost to Follow-up|0|||
143168997|NCT00553254|516167311|FG001|Overall Study|Lost to Follow-up|0|||
143168998|NCT00553254|516167312|FG002|Overall Study|Lost to Follow-up|2|||
143244626|NCT01039519|516448057|FG000|Treatment|Treatment failure|2|||
143244627|NCT01039519|516448057|FG000|Treatment|Adverse Event|3|||
143244628|NCT01039519|516448057|FG000|Treatment|Physician Decision|2|||
143244629|NCT01039519|516448057|FG000|Survival Follow-up|Death|23|||
143244630|NCT01039519|516448057|FG000|Survival Follow-up|Sponsor decision|4|||
143244631|NCT00808080|516448062|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
143244632|NCT01837823|516448065|FG000|Overall Study|Lost to Follow-up|6|||
143244633|NCT03052400|516448066|FG000|Overall Study|Lost to Follow-up|1|||
143244634|NCT03052400|516448067|FG001|Overall Study|Lost to Follow-up|0|||
143244635|NCT03052400|516448066|FG000|Overall Study|Withdrawal by Subject|0|||
143244636|NCT03052400|516448067|FG001|Overall Study|Withdrawal by Subject|1|||
143244637|NCT00555061|516448068|FG000|Overall Study|Adverse Event|3|||
143244638|NCT00555061|516448068|FG000|Overall Study|Protocol Violation|1|||
143244639|NCT00555061|516448068|FG000|Overall Study|Lost to Follow-up|2|||
143244640|NCT00555061|516448068|FG000|Overall Study|Withdrawal by Subject|2|||
143244641|NCT00555061|516448068|FG000|Overall Study|Participant enrolled, but never treated|1|||
143244642|NCT03830892|516448070|FG000|Overall Study|Physician Decision|2|||
143244643|NCT03830892|516448071|FG001|Overall Study|Physician Decision|3|||
143244644|NCT03830892|516448070|FG000|Overall Study|Study terminated due to COVID|4|||
143244645|NCT03830892|516448071|FG001|Overall Study|Study terminated due to COVID|0|||
143244646|NCT03830892|516448070|FG000|Overall Study|Protocol Violation|0|||
143244647|NCT03830892|516448071|FG001|Overall Study|Protocol Violation|1|||
143244648|NCT03830892|516448070|FG000|Overall Study|Withdrawal by Subject|0|||
143244649|NCT03830892|516448071|FG001|Overall Study|Withdrawal by Subject|2|||
143050233|NCT00566722|515722368|FG001|Overall Study|Withdrawal by Subject|0|||
143050234|NCT00566722|515722369|FG002|Overall Study|Withdrawal by Subject|1|||
143050235|NCT00566722|515722367|FG000|Overall Study|Lost to Follow-up|1|||
143050236|NCT00566722|515722368|FG001|Overall Study|Lost to Follow-up|1|||
143050237|NCT00566722|515722369|FG002|Overall Study|Lost to Follow-up|1|||
143050238|NCT00566722|515722367|FG000|Overall Study|Lack of Efficacy|1|||
143050239|NCT00566722|515722368|FG001|Overall Study|Lack of Efficacy|2|||
143050240|NCT00566722|515722369|FG002|Overall Study|Lack of Efficacy|4|||
143050241|NCT00566722|515722367|FG000|Overall Study|Did not meet exclusion criteria|0|||
143050242|NCT00566722|515722368|FG001|Overall Study|Did not meet exclusion criteria|0|||
143050243|NCT00566722|515722369|FG002|Overall Study|Did not meet exclusion criteria|2|||
143168999|NCT00553254|516167310|FG000|Overall Study|Withdrawal by Subject|2|||
143169000|NCT00553254|516167311|FG001|Overall Study|Withdrawal by Subject|0|||
143244650|NCT03656562|516448072|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
143244651|NCT03656562|516448073|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
143244652|NCT03656562|516448074|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
143259579|NCT02241889|516505786|FG005|Overall Study|Withdrawal by Subject|1|||
143259580|NCT00773838|516505787|FG000|Overall Study|Adverse Event|29|||
143050244|NCT00566722|515722367|FG000|Overall Study|Serious adverse event|0|||
143050245|NCT00566722|515722368|FG001|Overall Study|Serious adverse event|1|||
143050246|NCT00566722|515722369|FG002|Overall Study|Serious adverse event|0|||
143050247|NCT00566722|515722367|FG000|Overall Study|Noncompliant with drug administration|0|||
143050248|NCT00566722|515722368|FG001|Overall Study|Noncompliant with drug administration|0|||
143050249|NCT00566722|515722369|FG002|Overall Study|Noncompliant with drug administration|1|||
143050250|NCT00714051|515722371|FG000|Overall Study|Withdrawal by Subject|1|||
143050251|NCT00714051|515722372|FG001|Overall Study|Withdrawal by Subject|0|||
143050252|NCT00714051|515722371|FG000|Overall Study|Death|0|||
143050253|NCT00714051|515722372|FG001|Overall Study|Death|1|||
143050254|NCT02119936|515722373|FG000|Overall Study|Lost to Follow-up|10|||
143050255|NCT01390948|515722374|FG000|Overall Study|End of Study|1|||
143050256|NCT01390948|515722375|FG001|Overall Study|End of Study|0|||
143050257|NCT01390948|515722376|FG002|Overall Study|End of Study|0|||
143050258|NCT01390948|515722374|FG000|Overall Study|Withdrew consent|2|||
143050259|NCT01390948|515722375|FG001|Overall Study|Withdrew consent|2|||
143050260|NCT01390948|515722376|FG002|Overall Study|Withdrew consent|0|||
143050261|NCT01390948|515722374|FG000|Overall Study|Progressive Disease|2|||
143050262|NCT01390948|515722375|FG001|Overall Study|Progressive Disease|5|||
143050263|NCT01390948|515722376|FG002|Overall Study|Progressive Disease|0|||
143050264|NCT01390948|515722374|FG000|Overall Study|Death during follow-up|10|||
143050265|NCT01390948|515722375|FG001|Overall Study|Death during follow-up|11|||
143050266|NCT01390948|515722376|FG002|Overall Study|Death during follow-up|1|||
143050267|NCT05315713|515722377|FG000|Overall Study|Death|5|||
143050268|NCT05315713|515722377|FG000|Overall Study|Progressive disease|1|||
143050269|NCT05315713|515722377|FG000|Overall Study|Withdrawal by Subject|1|||
143050270|NCT05315713|515722377|FG000|Overall Study|Study terminated by sponsor|1|||
143050271|NCT05740098|515722380|FG000|Overall Study|Lost to Follow-up|26|||
143050272|NCT05740098|515722381|FG001|Overall Study|Lost to Follow-up|17|||
143050273|NCT05740098|515722382|FG002|Overall Study|Lost to Follow-up|21|||
143050274|NCT03867760|515722383|FG000|Overall Study|Lost to Follow-up|2|||
143050275|NCT03867760|515722384|FG001|Overall Study|Lost to Follow-up|3|||
143050276|NCT03867760|515722383|FG000|Overall Study|Withdrawal by Subject|1|||
143050277|NCT03867760|515722384|FG001|Overall Study|Withdrawal by Subject|2|||
143050278|NCT03867760|515722383|FG000|Overall Study|subject could not meet study logistics|3|||
143050279|NCT03867760|515722384|FG001|Overall Study|subject could not meet study logistics|3|||
143050280|NCT01073631|515722385|FG000|Overall Study|Death|82|||
143050281|NCT01073631|515722385|FG000|Overall Study|Adverse Event|24|||
143050282|NCT01073631|515722385|FG000|Overall Study|Other|63|||
143050283|NCT01566435|515722392|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
143050284|NCT02535923|515722393|FG000|Overall Study|Lost to Follow-up|5|||
143050285|NCT02535923|515722394|FG001|Overall Study|Lost to Follow-up|5|||
143050286|NCT02535923|515722393|FG000|Overall Study|Withdrawal by Subject|4|||
143050287|NCT02535923|515722394|FG001|Overall Study|Withdrawal by Subject|3|||
143050288|NCT00685334|515722395|FG000|Overall Study|Withdrawal by Subject|5|||
143050289|NCT00685334|515722396|FG001|Overall Study|Withdrawal by Subject|6|||
143050290|NCT00685334|515722395|FG000|Overall Study|Lost to Follow-up|4|||
143050291|NCT00685334|515722396|FG001|Overall Study|Lost to Follow-up|0|||
143050292|NCT00685334|515722395|FG000|Overall Study|Chose to enter hospital|1|||
143050293|NCT00685334|515722396|FG001|Overall Study|Chose to enter hospital|1|||
143050294|NCT02588339|515722398|FG000|Overall Study|Withdrawal by Subject|1|||
143050295|NCT02588339|515722398|FG000|Overall Study|GVHD Progression prior to treatment|2|||
143050296|NCT02219009|515723735|FG000|Overall Study|Withdrawal by Subject|5|||
143050297|NCT02219009|515723736|FG001|Overall Study|Withdrawal by Subject|1|||
143050298|NCT02219009|515723735|FG000|Overall Study|Adverse Event|2|||
143050299|NCT02219009|515723736|FG001|Overall Study|Adverse Event|4|||
143050300|NCT02219009|515723735|FG000|Overall Study|Lost to Follow-up|2|||
143050301|NCT02219009|515723736|FG001|Overall Study|Lost to Follow-up|2|||
143050302|NCT02219009|515723735|FG000|Overall Study|Protocol deviation|1|||
143050303|NCT02219009|515723736|FG001|Overall Study|Protocol deviation|0|||
143244653|NCT03656562|516448075|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
143244654|NCT03656562|516448072|FG000|Overall Study|Physician Decision|1|||
143244655|NCT03656562|516448073|FG001|Overall Study|Physician Decision|2|||
143244656|NCT03656562|516448074|FG002|Overall Study|Physician Decision|0|||
143244657|NCT03656562|516448075|FG003|Overall Study|Physician Decision|0|||
143244658|NCT03656562|516448072|FG000|Overall Study|Subject Decision|3|||
143244659|NCT03656562|516448073|FG001|Overall Study|Subject Decision|5|||
143244660|NCT03656562|516448074|FG002|Overall Study|Subject Decision|0|||
143244661|NCT03656562|516448075|FG003|Overall Study|Subject Decision|2|||
143244662|NCT04849559|516448076|FG000|Overall Study|Withdrawal by Subject|2|||
143050304|NCT02219009|515723735|FG000|Overall Study|Physician Decision|0|||
143244663|NCT04849559|516448077|FG001|Overall Study|Withdrawal by Subject|1|||
143050305|NCT02219009|515723736|FG001|Overall Study|Physician Decision|1|||
143050306|NCT00660387|515723737|FG000|Overall Study|Adverse Event|1|||
143050307|NCT00660387|515723738|FG001|Overall Study|Adverse Event|2|||
143050308|NCT00660387|515723737|FG000|Overall Study|Lack of Efficacy|0|||
143050309|NCT00660387|515723738|FG001|Overall Study|Lack of Efficacy|1|||
143244664|NCT00478023|516448088|FG000|Overall Study|Adverse Event|11|||
143050310|NCT00660387|515723737|FG000|Overall Study|Protocol Violation|1|||
143050311|NCT00660387|515723738|FG001|Overall Study|Protocol Violation|0|||
143050312|NCT02966340|515723739|FG000|Overall Study|Adverse Event|0|||
143050313|NCT02966340|515723740|FG001|Overall Study|Adverse Event|1|||
143050314|NCT02966340|515723739|FG000|Overall Study|Lost to Follow-up|0|||
143050315|NCT02966340|515723740|FG001|Overall Study|Lost to Follow-up|1|||
143050316|NCT02966340|515723739|FG000|Overall Study|Withdrawal by Subject|1|||
143050317|NCT02966340|515723740|FG001|Overall Study|Withdrawal by Subject|0|||
143050318|NCT02966340|515723739|FG000|Overall Study|data acquisition error|1|||
143050319|NCT02966340|515723740|FG001|Overall Study|data acquisition error|0|||
143050320|NCT02966340|515723739|FG000|Overall Study|startle non-responder|1|||
143050321|NCT02966340|515723740|FG001|Overall Study|startle non-responder|1|||
143050322|NCT01098851|515723743|FG000|Overall Study|Equipment failure|1|||
143050323|NCT01098851|515723744|FG001|Overall Study|Equipment failure|0|||
143050324|NCT03087786|515723745|FG000|Overall Study|Withdrawal by Subject|2|||
143050325|NCT03087786|515723746|FG001|Overall Study|Withdrawal by Subject|0|||
143050326|NCT00960154|515723749|FG000|Overall Study|Study termination|25|||
143050327|NCT00960154|515723750|FG001|Overall Study|Study termination|25|||
143050328|NCT02308241|515723751|FG000|Overall Study|Withdrawal by Subject|3|||
143050329|NCT00486434|515723752|FG000|Overall Study|Withdrawal by Subject|34|||
143050330|NCT00486434|515723753|FG001|Overall Study|Withdrawal by Subject|39|||
143050331|NCT00486434|515723752|FG000|Overall Study|Adverse Event|118|||
143050332|NCT00486434|515723753|FG001|Overall Study|Adverse Event|44|||
143050333|NCT00486434|515723752|FG000|Overall Study|Protocol Violation|22|||
143050334|NCT00486434|515723753|FG001|Overall Study|Protocol Violation|21|||
143050335|NCT00486434|515723752|FG000|Overall Study|Lack of Efficacy|12|||
143050336|NCT00486434|515723753|FG001|Overall Study|Lack of Efficacy|19|||
143050337|NCT00486434|515723752|FG000|Overall Study|Lost to Follow-up|2|||
143050338|NCT00486434|515723753|FG001|Overall Study|Lost to Follow-up|3|||
143050339|NCT00486434|515723752|FG000|Overall Study|Death|1|||
143050340|NCT00486434|515723753|FG001|Overall Study|Death|2|||
143050341|NCT00486434|515723752|FG000|Overall Study|Personal reasons|5|||
143050342|NCT00486434|515723753|FG001|Overall Study|Personal reasons|6|||
143050343|NCT02218541|515723754|FG000|Overall Study|Lost to Follow-up|2|||
143050344|NCT02218541|515723755|FG001|Overall Study|Lost to Follow-up|1|||
143050345|NCT02218541|515723754|FG000|Overall Study|Implant Failure|4|||
143050346|NCT02218541|515723755|FG001|Overall Study|Implant Failure|1|||
143050347|NCT00856349|515723756|FG000|Overall Study|Death|418|||
143050348|NCT00856349|515723756|FG000|Overall Study|Withdrawal by Subject|116|||
143050349|NCT00856349|515723756|FG000|Overall Study|Lost to Follow-up|91|||
143050350|NCT00856349|515723756|FG000|Overall Study|Protocol Violation|38|||
143050351|NCT00856349|515723756|FG000|Overall Study|Physician Decision|13|||
143050352|NCT00856349|515723756|FG000|Overall Study|Subject relocation|104|||
143050353|NCT00856349|515723756|FG000|Overall Study|Device explant|33|||
143050354|NCT00856349|515723756|FG000|Overall Study|Site closure|78|||
143050355|NCT00856349|515723756|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
143050356|NCT02998541|515723766|FG000|Overall Study|Adverse Event|4|||
143050357|NCT02998541|515723767|FG001|Overall Study|Adverse Event|5|||
143050358|NCT02998541|515723768|FG002|Overall Study|Adverse Event|1|||
143050359|NCT02998541|515723766|FG000|Overall Study|Protocol Violation|1|||
143050360|NCT02998541|515723767|FG001|Overall Study|Protocol Violation|0|||
143050361|NCT02998541|515723768|FG002|Overall Study|Protocol Violation|0|||
143050362|NCT02998541|515723766|FG000|Overall Study|Withdrawal by Subject|3|||
143050363|NCT02998541|515723767|FG001|Overall Study|Withdrawal by Subject|1|||
143050364|NCT02998541|515723768|FG002|Overall Study|Withdrawal by Subject|0|||
143050365|NCT02998541|515723766|FG000|Overall Study|Lost to Follow-up|0|||
143050366|NCT02998541|515723767|FG001|Overall Study|Lost to Follow-up|3|||
143050367|NCT02998541|515723768|FG002|Overall Study|Lost to Follow-up|1|||
143050368|NCT02998541|515723766|FG000|Overall Study|Physician Decision|0|||
143050369|NCT02998541|515723767|FG001|Overall Study|Physician Decision|0|||
143169001|NCT00553254|516167312|FG002|Overall Study|Withdrawal by Subject|2|||
143169002|NCT00553254|516167310|FG000|Overall Study|Study terminated by Sponsor|0|||
143364554|NCT01352507|516877031|FG000|Washout Period|Withdrawal by Subject|0|||
143050370|NCT02998541|515723768|FG002|Overall Study|Physician Decision|3|||
143050371|NCT02998541|515723766|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
143169003|NCT00553254|516167311|FG001|Overall Study|Study terminated by Sponsor|0|||
143050372|NCT02998541|515723767|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
143050373|NCT02998541|515723768|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
143050374|NCT00183196|515723769|FG000|Overall Study|Withdrawal by Subject|18|||
143050375|NCT00183196|515723770|FG001|Overall Study|Withdrawal by Subject|11|||
143050376|NCT00183196|515723771|FG002|Overall Study|Withdrawal by Subject|13|||
143050377|NCT00183196|515723769|FG000|Overall Study|Adverse Event|1|||
143050378|NCT00183196|515723770|FG001|Overall Study|Adverse Event|2|||
143050379|NCT00183196|515723771|FG002|Overall Study|Adverse Event|2|||
143050380|NCT00183196|515723769|FG000|Overall Study|Legal event|1|||
143050381|NCT00183196|515723770|FG001|Overall Study|Legal event|1|||
143050382|NCT00183196|515723771|FG002|Overall Study|Legal event|1|||
143050383|NCT00183196|515723769|FG000|Overall Study|Required more intensive care|0|||
143050384|NCT00183196|515723770|FG001|Overall Study|Required more intensive care|1|||
143050385|NCT00183196|515723771|FG002|Overall Study|Required more intensive care|2|||
143050386|NCT01513239|515723772|FG000|Period 1: Main Phase|Adverse Event|1|||
143050387|NCT01513239|515723773|FG001|Period 1: Main Phase|Adverse Event|1|||
143050388|NCT01513239|515723774|FG002|Period 1: Main Phase|Adverse Event|2|||
143050389|NCT01513239|515723775|FG003|Period 1: Main Phase|Adverse Event|0|||
143050390|NCT01513239|515723776|FG004|Period 1: Main Phase|Adverse Event|0|||
143050391|NCT01513239|515723777|FG005|Period 1: Main Phase|Adverse Event|0|||
143050392|NCT01513239|515723772|FG000|Period 1: Main Phase|Death|29|||
143050393|NCT01513239|515723773|FG001|Period 1: Main Phase|Death|22|||
143050394|NCT01513239|515723774|FG002|Period 1: Main Phase|Death|32|||
143050395|NCT01513239|515723775|FG003|Period 1: Main Phase|Death|0|||
143050396|NCT01513239|515723776|FG004|Period 1: Main Phase|Death|0|||
143050397|NCT01513239|515723777|FG005|Period 1: Main Phase|Death|0|||
143050398|NCT01513239|515723772|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
143050399|NCT01513239|515723773|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
143050400|NCT01513239|515723774|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
143050401|NCT01513239|515723775|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
143050402|NCT01513239|515723776|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
143050403|NCT01513239|515723777|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
143050404|NCT01513239|515723772|FG000|Period 1: Main Phase|Physician Decision|4|||
143050405|NCT01513239|515723773|FG001|Period 1: Main Phase|Physician Decision|4|||
143050406|NCT01513239|515723774|FG002|Period 1: Main Phase|Physician Decision|4|||
143050407|NCT01513239|515723775|FG003|Period 1: Main Phase|Physician Decision|0|||
143050408|NCT01513239|515723776|FG004|Period 1: Main Phase|Physician Decision|0|||
143050409|NCT01513239|515723777|FG005|Period 1: Main Phase|Physician Decision|0|||
143050410|NCT01513239|515723772|FG000|Period 1: Main Phase|Protocol Violation|2|||
143050411|NCT01513239|515723773|FG001|Period 1: Main Phase|Protocol Violation|2|||
143050412|NCT01513239|515723774|FG002|Period 1: Main Phase|Protocol Violation|2|||
143050413|NCT01513239|515723775|FG003|Period 1: Main Phase|Protocol Violation|0|||
143050414|NCT01513239|515723776|FG004|Period 1: Main Phase|Protocol Violation|0|||
143050415|NCT01513239|515723777|FG005|Period 1: Main Phase|Protocol Violation|0|||
143050416|NCT01513239|515723772|FG000|Period 1: Main Phase|Technical Problems|1|||
143050417|NCT01513239|515723773|FG001|Period 1: Main Phase|Technical Problems|2|||
143050418|NCT01513239|515723774|FG002|Period 1: Main Phase|Technical Problems|0|||
143050419|NCT01513239|515723775|FG003|Period 1: Main Phase|Technical Problems|0|||
143050420|NCT01513239|515723776|FG004|Period 1: Main Phase|Technical Problems|0|||
143050421|NCT01513239|515723777|FG005|Period 1: Main Phase|Technical Problems|0|||
143050422|NCT01513239|515723772|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
143050423|NCT01513239|515723773|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
143050424|NCT01513239|515723774|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
143050425|NCT01513239|515723775|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
143050426|NCT01513239|515723776|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
143050427|NCT01513239|515723777|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
143050428|NCT01513239|515723772|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
143050429|NCT01513239|515723773|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
143050430|NCT01513239|515723774|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
143050431|NCT01513239|515723775|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
143050432|NCT01513239|515723776|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
143050433|NCT01513239|515723777|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
143050434|NCT01513239|515723772|FG000|Period 2: 9 Month Extension Phase|Death|0|||
143050435|NCT01513239|515723773|FG001|Period 2: 9 Month Extension Phase|Death|0|||
143050436|NCT01513239|515723774|FG002|Period 2: 9 Month Extension Phase|Death|0|||
143050437|NCT01513239|515723775|FG003|Period 2: 9 Month Extension Phase|Death|2|||
143050438|NCT01513239|515723776|FG004|Period 2: 9 Month Extension Phase|Death|5|||
143050439|NCT01513239|515723777|FG005|Period 2: 9 Month Extension Phase|Death|2|||
143050440|NCT01513239|515723772|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
143050441|NCT01513239|515723773|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
143050442|NCT01513239|515723774|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
143050443|NCT01513239|515723775|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
143050444|NCT01513239|515723776|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
143169004|NCT00553254|516167312|FG002|Overall Study|Study terminated by Sponsor|1|||
143169005|NCT00553254|516167310|FG000|Overall Study|Other|1|||
143169006|NCT00553254|516167311|FG001|Overall Study|Other|0|||
143050445|NCT01513239|515723777|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
143050446|NCT01513239|515723772|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
143050447|NCT01513239|515723773|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
143050448|NCT01513239|515723774|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
143050449|NCT01513239|515723775|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
143050450|NCT01513239|515723776|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
143050451|NCT01513239|515723777|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
143050452|NCT01513239|515723772|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
143050453|NCT01513239|515723773|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
143169007|NCT00553254|516167312|FG002|Overall Study|Other|13|||
143169008|NCT02546323|516167315|FG000|Overall Study|Withdrawal by Subject|36|||
143050454|NCT01513239|515723774|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
143050455|NCT01513239|515723775|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
143050456|NCT01513239|515723776|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
143050457|NCT01513239|515723777|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
143050458|NCT00396162|515723778|FG000|Overall Study|Withdrawal by Subject|2|||
143050459|NCT00396162|515723779|FG001|Overall Study|Withdrawal by Subject|3|||
143050460|NCT03387462|515723780|FG000|Overall Study|Lost to Follow-up|1|||
143050461|NCT01460628|515723781|FG000|Overall Study|Adverse Event|3|||
143050462|NCT01460628|515723781|FG000|Overall Study|Withdrawal by Subject|2|||
143050463|NCT01664039|515723783|FG000|Overall Study|Adverse Event|3|||
143050464|NCT01664039|515723784|FG001|Overall Study|Adverse Event|4|||
143050465|NCT01664039|515723783|FG000|Overall Study|Lost to Follow-up|1|||
143050466|NCT01664039|515723784|FG001|Overall Study|Lost to Follow-up|1|||
143050467|NCT01664039|515723783|FG000|Overall Study|Withdrawal by Subject|1|||
143050468|NCT01664039|515723784|FG001|Overall Study|Withdrawal by Subject|3|||
143050469|NCT01664039|515723783|FG000|Overall Study|Noncompliance|1|||
143050470|NCT01664039|515723784|FG001|Overall Study|Noncompliance|1|||
143050471|NCT01944722|515723787|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
143050472|NCT01944722|515723787|FG000|Overall Study|Specimen Shipping Issues|34|||
143050473|NCT01944722|515723787|FG000|Overall Study|Improper Storage/Transport|5|||
143050474|NCT01944722|515723787|FG000|Overall Study|Insufficient Volume for Test|1|||
143050475|NCT01944722|515723787|FG000|Overall Study|Missing Specimens|3|||
143050476|NCT01944722|515723787|FG000|Overall Study|Specimens Mislabeled|2|||
143050477|NCT01944722|515723787|FG000|Overall Study|Withdrawal by Subject|8|||
143050478|NCT01944722|515723787|FG000|Overall Study|NILM Subjects <30 years old|8106|||
143050479|NCT01944722|515723787|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
143169009|NCT02546323|516167316|FG001|Overall Study|Withdrawal by Subject|33|||
143169010|NCT02546323|516167315|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
143169011|NCT02546323|516167316|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
143050480|NCT01944722|515723787|FG000|Overall Study|>ASCUS Cytology|1122|||
143050481|NCT02906917|515723791|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
143050482|NCT02906917|515723792|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
143050483|NCT02906917|515723791|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
143050484|NCT02906917|515723792|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
143169012|NCT02546323|516167315|FG000|Overall Study|Adverse Event|17|||
143050485|NCT02906917|515723791|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
143050486|NCT02906917|515723792|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
143050487|NCT02906917|515723791|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
143050488|NCT02906917|515723792|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
143050489|NCT02906917|515723791|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
143050490|NCT02906917|515723792|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
143050491|NCT02906917|515723791|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
143050492|NCT02906917|515723792|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
143050493|NCT02906917|515723791|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
143050494|NCT02906917|515723792|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
143050495|NCT02906917|515723791|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
143050496|NCT02906917|515723792|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
143050497|NCT05387408|515723793|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
143050498|NCT03358147|515723797|FG000|Overall Study|Withdrawal by Subject|13|||
143050499|NCT03358147|515723798|FG001|Overall Study|Withdrawal by Subject|19|||
143050500|NCT03358147|515723799|FG002|Overall Study|Withdrawal by Subject|16|||
143050501|NCT03358147|515723800|FG003|Overall Study|Withdrawal by Subject|10|||
143050502|NCT03358147|515723801|FG004|Overall Study|Withdrawal by Subject|5|||
143050503|NCT03358147|515723797|FG000|Overall Study|Adverse Event|3|||
143050504|NCT03358147|515723798|FG001|Overall Study|Adverse Event|9|||
143050505|NCT03358147|515723799|FG002|Overall Study|Adverse Event|7|||
143050506|NCT03358147|515723800|FG003|Overall Study|Adverse Event|5|||
143050507|NCT03358147|515723801|FG004|Overall Study|Adverse Event|2|||
143050508|NCT03358147|515723797|FG000|Overall Study|Lost to Follow-up|4|||
143050509|NCT03358147|515723798|FG001|Overall Study|Lost to Follow-up|3|||
143050510|NCT03358147|515723799|FG002|Overall Study|Lost to Follow-up|7|||
143050511|NCT03358147|515723800|FG003|Overall Study|Lost to Follow-up|6|||
143050512|NCT03358147|515723801|FG004|Overall Study|Lost to Follow-up|4|||
143169013|NCT02546323|516167316|FG001|Overall Study|Adverse Event|11|||
143169014|NCT02546323|516167315|FG000|Overall Study|Patient Specific Reasons|1|||
143169015|NCT02546323|516167316|FG001|Overall Study|Patient Specific Reasons|2|||
143169016|NCT02546323|516167315|FG000|Overall Study|Lost to Follow-up|2|||
143169017|NCT02546323|516167316|FG001|Overall Study|Lost to Follow-up|3|||
143169018|NCT02546323|516167315|FG000|Overall Study|Non-compliance with Study Drug|2|||
143169019|NCT02546323|516167316|FG001|Overall Study|Non-compliance with Study Drug|2|||
143169020|NCT02546323|516167315|FG000|Overall Study|Met Withdrawal Criteria|2|||
143169021|NCT02546323|516167316|FG001|Overall Study|Met Withdrawal Criteria|14|||
143169022|NCT01055028|516167317|FG000|Screening|Screen Failure|1|||
143169023|NCT01055028|516167318|FG001|Screening|Screen Failure|1|||
143169024|NCT01055028|516167317|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
143169025|NCT01055028|516167318|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
143169026|NCT01055028|516167317|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
143169027|NCT01055028|516167318|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
143169028|NCT01055028|516167317|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
143169029|NCT01055028|516167318|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
143169030|NCT03331354|516167321|FG000|Overall Study|Withdrawal by Subject|1|||
143169031|NCT03331354|516167322|FG001|Overall Study|Withdrawal by Subject|3|||
143169032|NCT03331354|516167321|FG000|Overall Study|Lost to Follow-up|3|||
143169033|NCT03331354|516167322|FG001|Overall Study|Lost to Follow-up|3|||
143169034|NCT03331354|516167321|FG000|Overall Study|Found employment before initiated active intervention|0|||
143169035|NCT03331354|516167322|FG001|Overall Study|Found employment before initiated active intervention|4|||
143169036|NCT05134649|516167323|FG000|Overall Study|Lost to Follow-up|12|||
143169037|NCT05134649|516167323|FG000|Overall Study|Withdrawal by Subject|14|||
143169038|NCT05134649|516167323|FG000|Overall Study|Pregnancy|1|||
143169039|NCT05134649|516167323|FG000|Overall Study|Other, not specified|3|||
143169040|NCT05837481|516167326|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
143499237|NCT00559273|517368523|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
143499238|NCT00559273|517368524|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
143499239|NCT00559273|517368523|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
143499240|NCT00559273|517368524|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
143499241|NCT00559273|517368523|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
143050513|NCT03358147|515723797|FG000|Overall Study|Major Protocol Deviation|11|||
143169041|NCT05837481|516167327|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
143169042|NCT00105066|516167332|FG000|Overall Study|Adverse Event|2|||
143169043|NCT00105066|516167333|FG001|Overall Study|Adverse Event|5|||
143169044|NCT04380142|516167334|FG000|LD/CD Stabilization Period|Adverse Event|3|||
143169045|NCT04380142|516167335|FG001|LD/CD Stabilization Period|Adverse Event|0|||
143050514|NCT03358147|515723798|FG001|Overall Study|Major Protocol Deviation|3|||
143050515|NCT03358147|515723799|FG002|Overall Study|Major Protocol Deviation|2|||
143050516|NCT03358147|515723800|FG003|Overall Study|Major Protocol Deviation|3|||
143050517|NCT03358147|515723801|FG004|Overall Study|Major Protocol Deviation|1|||
143050518|NCT03358147|515723797|FG000|Overall Study|Protocol specified criteria|2|||
143050519|NCT03358147|515723798|FG001|Overall Study|Protocol specified criteria|3|||
143050520|NCT03358147|515723799|FG002|Overall Study|Protocol specified criteria|0|||
143050521|NCT03358147|515723800|FG003|Overall Study|Protocol specified criteria|3|||
143050522|NCT03358147|515723801|FG004|Overall Study|Protocol specified criteria|1|||
143050523|NCT03358147|515723797|FG000|Overall Study|Physician Decision|1|||
143050524|NCT03358147|515723798|FG001|Overall Study|Physician Decision|0|||
143050525|NCT03358147|515723799|FG002|Overall Study|Physician Decision|1|||
143050526|NCT03358147|515723800|FG003|Overall Study|Physician Decision|6|||
143050527|NCT03358147|515723801|FG004|Overall Study|Physician Decision|1|||
143050528|NCT03358147|515723797|FG000|Overall Study|Administrative reasons|0|||
143050529|NCT03358147|515723798|FG001|Overall Study|Administrative reasons|1|||
143050530|NCT03358147|515723799|FG002|Overall Study|Administrative reasons|0|||
143050531|NCT03358147|515723800|FG003|Overall Study|Administrative reasons|3|||
143050532|NCT03358147|515723801|FG004|Overall Study|Administrative reasons|0|||
143050533|NCT03358147|515723797|FG000|Overall Study|Lack of Efficacy|0|||
143050534|NCT03358147|515723798|FG001|Overall Study|Lack of Efficacy|1|||
143050535|NCT03358147|515723799|FG002|Overall Study|Lack of Efficacy|1|||
143050536|NCT03358147|515723800|FG003|Overall Study|Lack of Efficacy|0|||
143050537|NCT03358147|515723801|FG004|Overall Study|Lack of Efficacy|0|||
143050538|NCT02072096|515723802|FG000|Overall Study|Lack of Efficacy|18|||
143050539|NCT02072096|515723803|FG001|Overall Study|Lack of Efficacy|29|||
143050540|NCT02072096|515723802|FG000|Overall Study|Protocol Violation|7|||
143050541|NCT02072096|515723803|FG001|Overall Study|Protocol Violation|7|||
143050542|NCT02072096|515723802|FG000|Overall Study|Withdrawal by Subject|5|||
143050543|NCT02072096|515723803|FG001|Overall Study|Withdrawal by Subject|7|||
143050544|NCT02072096|515723802|FG000|Overall Study|Adverse Event|5|||
143050545|NCT02072096|515723803|FG001|Overall Study|Adverse Event|2|||
143050546|NCT02072096|515723802|FG000|Overall Study|No Reason Provided|4|||
143050547|NCT02072096|515723803|FG001|Overall Study|No Reason Provided|2|||
143050548|NCT02072096|515723802|FG000|Overall Study|Death|2|||
143050549|NCT02072096|515723803|FG001|Overall Study|Death|0|||
143050550|NCT02072096|515723802|FG000|Overall Study|Physician Decision|0|||
143050551|NCT02072096|515723803|FG001|Overall Study|Physician Decision|1|||
143050552|NCT02072096|515723802|FG000|Overall Study|Study Terminated by Sponsor|43|||
143050553|NCT02072096|515723803|FG001|Overall Study|Study Terminated by Sponsor|30|||
143050554|NCT02072096|515723802|FG000|Overall Study|Lost to Follow-up|1|||
143050555|NCT02072096|515723803|FG001|Overall Study|Lost to Follow-up|0|||
143050556|NCT04442503|515723811|FG000|Overall Study|Adverse Event|1|||
143050557|NCT04442503|515723812|FG001|Overall Study|Adverse Event|1|||
143050558|NCT04442503|515723811|FG000|Overall Study|Lost to Follow-up|8|||
143050559|NCT04442503|515723812|FG001|Overall Study|Lost to Follow-up|6|||
143050560|NCT04442503|515723811|FG000|Overall Study|Physician Decision|0|||
143050561|NCT04442503|515723812|FG001|Overall Study|Physician Decision|2|||
143050562|NCT04442503|515723811|FG000|Overall Study|Withdrawal by Subject|3|||
143050563|NCT04442503|515723812|FG001|Overall Study|Withdrawal by Subject|4|||
143050564|NCT04442503|515723811|FG000|Overall Study|Reason not Specified|0|||
143050565|NCT04442503|515723812|FG001|Overall Study|Reason not Specified|1|||
143050566|NCT04442503|515723811|FG000|Overall Study|Randomized but not Treated|3|||
143050567|NCT04442503|515723812|FG001|Overall Study|Randomized but not Treated|1|||
143050568|NCT00387153|515723813|FG000|Overall Study|Adverse Event|1|||
143050569|NCT00387153|515723813|FG000|Overall Study|Disease Progression|3|||
143050570|NCT00387153|515723813|FG000|Overall Study|Lack of Response|4|||
143050571|NCT00467597|515723814|FG000|Overall Study|Withdrawal by Subject|2|||
143050572|NCT00467597|515723815|FG001|Overall Study|Withdrawal by Subject|0|||
143050573|NCT02096705|515723816|FG000|Treatment|Adverse Event|6|||
143050574|NCT02096705|515723817|FG001|Treatment|Adverse Event|3|||
143050575|NCT02096705|515723816|FG000|Treatment|Subject request to discontinue treatment|1|||
143050576|NCT02096705|515723817|FG001|Treatment|Subject request to discontinue treatment|1|||
143050577|NCT02096705|515723816|FG000|Treatment|Withdrawal by Subject|1|||
143050578|NCT02096705|515723817|FG001|Treatment|Withdrawal by Subject|0|||
143050579|NCT02096705|515723816|FG000|Treatment|Other|1|||
143050580|NCT02096705|515723817|FG001|Treatment|Other|1|||
143050581|NCT02096705|515723816|FG000|Follow-up|Withdrawal by Subject|1|||
143050582|NCT02096705|515723817|FG001|Follow-up|Withdrawal by Subject|0|||
143050583|NCT02096705|515723816|FG000|Follow-up|Adverse Event|2|||
143050584|NCT02096705|515723817|FG001|Follow-up|Adverse Event|2|||
143050585|NCT02096705|515723816|FG000|Follow-up|Subjects not reporting status|1|||
143050586|NCT02096705|515723817|FG001|Follow-up|Subjects not reporting status|2|||
143050587|NCT01451541|515723818|FG000|Overall Study|Adverse Event|4|||
143050588|NCT01451541|515723819|FG001|Overall Study|Adverse Event|3|||
143050589|NCT01451541|515723820|FG002|Overall Study|Adverse Event|6|||
143050590|NCT01451541|515723818|FG000|Overall Study|Lack of Efficacy|2|||
143050591|NCT01451541|515723819|FG001|Overall Study|Lack of Efficacy|0|||
143050592|NCT01451541|515723820|FG002|Overall Study|Lack of Efficacy|0|||
143050593|NCT01451541|515723818|FG000|Overall Study|Lost to Follow-up|4|||
143050594|NCT01451541|515723819|FG001|Overall Study|Lost to Follow-up|4|||
143050595|NCT01451541|515723820|FG002|Overall Study|Lost to Follow-up|7|||
143050596|NCT01451541|515723818|FG000|Overall Study|Withdrawal by Subject|15|||
143050597|NCT01451541|515723819|FG001|Overall Study|Withdrawal by Subject|8|||
143050598|NCT01451541|515723820|FG002|Overall Study|Withdrawal by Subject|6|||
143050599|NCT01451541|515723818|FG000|Overall Study|randomization error, noncompliance|11|||
143050600|NCT01451541|515723819|FG001|Overall Study|randomization error, noncompliance|10|||
143050601|NCT01451541|515723820|FG002|Overall Study|randomization error, noncompliance|8|||
143050602|NCT03366428|515723823|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
143050603|NCT03366428|515723823|FG000|Overall Study|Adverse Event|12|||
143050604|NCT03366428|515723823|FG000|Overall Study|Clinical progression|2|||
143050605|NCT03366428|515723823|FG000|Overall Study|Withdrawal by Subject|4|||
143050606|NCT02166606|515723824|FG000|Overall Study|Adverse Event|3|||
143050607|NCT02166606|515723824|FG000|Overall Study|Death|31|||
143050608|NCT02166606|515723824|FG000|Overall Study|Protocol Violation|7|||
143050609|NCT02166606|515723824|FG000|Overall Study|Lost to Follow-up|30|||
143050610|NCT02166606|515723824|FG000|Overall Study|Withdrawal by Subject|1|||
143050611|NCT02166606|515723824|FG000|Overall Study|Physician Decision|1|||
143050612|NCT02166606|515723824|FG000|Overall Study|Device upgrade|1|||
143050613|NCT02166606|515723824|FG000|Overall Study|Enrolled after End of Enrollment|4|||
143050614|NCT02670551|515723825|FG000|Overall Study|Adverse Event|4|||
143050615|NCT02670551|515723826|FG001|Overall Study|Adverse Event|7|||
143050616|NCT02670551|515723827|FG002|Overall Study|Adverse Event|9|||
143050617|NCT02670551|515723825|FG000|Overall Study|Lack of Efficacy|2|||
143050618|NCT02670551|515723826|FG001|Overall Study|Lack of Efficacy|0|||
143050619|NCT02670551|515723827|FG002|Overall Study|Lack of Efficacy|3|||
143050620|NCT02670551|515723825|FG000|Overall Study|Withdrawal of Consent|6|||
143050621|NCT02670551|515723826|FG001|Overall Study|Withdrawal of Consent|3|||
143050622|NCT02670551|515723827|FG002|Overall Study|Withdrawal of Consent|8|||
143050623|NCT02670551|515723825|FG000|Overall Study|Lost to Follow-up|5|||
143050624|NCT02670551|515723826|FG001|Overall Study|Lost to Follow-up|7|||
143050625|NCT02670551|515723827|FG002|Overall Study|Lost to Follow-up|6|||
143050626|NCT02670551|515723825|FG000|Overall Study|Protocol Violation|1|||
143050627|NCT02670551|515723826|FG001|Overall Study|Protocol Violation|0|||
143050628|NCT02670551|515723827|FG002|Overall Study|Protocol Violation|0|||
143050629|NCT02670551|515723825|FG000|Overall Study|Noncompliance with study drug|3|||
143050630|NCT02670551|515723826|FG001|Overall Study|Noncompliance with study drug|3|||
143050631|NCT02670551|515723827|FG002|Overall Study|Noncompliance with study drug|2|||
143050632|NCT02670551|515723825|FG000|Overall Study|Other Miscellaneous Reasons|2|||
143050633|NCT02670551|515723826|FG001|Overall Study|Other Miscellaneous Reasons|3|||
143050634|NCT02670551|515723827|FG002|Overall Study|Other Miscellaneous Reasons|3|||
143050635|NCT02670551|515723825|FG000|Overall Study|Did Not Receive Treatment|5|||
143050636|NCT02670551|515723826|FG001|Overall Study|Did Not Receive Treatment|3|||
143050637|NCT02670551|515723827|FG002|Overall Study|Did Not Receive Treatment|0|||
143050638|NCT00533507|515723829|FG000|Overall Study|Withdrawal by Subject|1|||
143050639|NCT01929681|515723830|FG000|Overall Study|Withdrawal by Subject|1|||
143169046|NCT04380142|516167336|FG002|LD/CD Stabilization Period|Adverse Event|0|||
143169047|NCT04380142|516167334|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
143169048|NCT04380142|516167335|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
143169049|NCT04380142|516167336|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
143169050|NCT04380142|516167334|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
143169051|NCT04380142|516167335|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
143169052|NCT04380142|516167336|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
143169053|NCT04380142|516167334|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
143364555|NCT01352507|516877032|FG001|Washout Period|Withdrawal by Subject|1|||
143499242|NCT00559273|517368524|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
143499243|NCT04276207|517368525|FG000|Period 1|Withdrawal by Subject|0|||
143499244|NCT04276207|517368526|FG001|Period 1|Withdrawal by Subject|1|||
143050640|NCT01929681|515723831|FG001|Overall Study|Withdrawal by Subject|0|||
143050641|NCT01929681|515723830|FG000|Overall Study|Physician Decision|1|||
143050642|NCT01929681|515723831|FG001|Overall Study|Physician Decision|1|||
143050643|NCT02218216|515723832|FG000|Overall Study|Study terminated before completed|6|||
143050644|NCT02218216|515723833|FG001|Overall Study|Study terminated before completed|0|||
143050645|NCT02218216|515723834|FG002|Overall Study|Study terminated before completed|0|||
143050646|NCT00556673|515723840|FG000|Overall Study|Protocol deviation|3|||
143050647|NCT00556673|515723841|FG001|Overall Study|Protocol deviation|2|||
143050648|NCT01528735|515723842|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
143050649|NCT01528735|515723843|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
143050650|NCT01528735|515723842|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
143050651|NCT01528735|515723843|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
143050652|NCT00757172|515723844|FG000|Overall Study|Withdrawal by Subject|4|||
143050653|NCT00757172|515723844|FG000|Overall Study|Physician Decision|3|||
143050654|NCT00757172|515723844|FG000|Overall Study|Progression|4|||
143050655|NCT01426854|515723845|FG000|Overall Study|Adverse Event|1|||
143050656|NCT01426854|515723846|FG001|Overall Study|Adverse Event|5|||
143050657|NCT01426854|515723845|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
143050658|NCT01426854|515723846|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
143050659|NCT01426854|515723845|FG000|Overall Study|Lost to Follow-up|3|||
143050660|NCT01426854|515723846|FG001|Overall Study|Lost to Follow-up|0|||
143050661|NCT01426854|515723845|FG000|Overall Study|Noncompliance|0|||
143050662|NCT01426854|515723846|FG001|Overall Study|Noncompliance|1|||
143050663|NCT01426854|515723845|FG000|Overall Study|Treatment Failure|0|||
143050664|NCT01426854|515723846|FG001|Overall Study|Treatment Failure|16|||
143050665|NCT01426854|515723845|FG000|Overall Study|Protocol Deviation|0|||
143050666|NCT01426854|515723846|FG001|Overall Study|Protocol Deviation|1|||
143050667|NCT01426854|515723845|FG000|Overall Study|Other|3|||
143050668|NCT01426854|515723846|FG001|Overall Study|Other|2|||
143050669|NCT03555695|515723849|FG000|Overall Study|Withdrawal by Subject|1|||
143050670|NCT03555695|515723849|FG000|Overall Study|Lost to Follow-up|1|||
143050671|NCT03555695|515723849|FG000|Overall Study|appendicitis (unrelated)|1|||
143050672|NCT03555695|515723849|FG000|Overall Study|pre-existing sciatica|1|||
143050673|NCT01717040|515723851|FG000|Overall Study|Lost to Follow-up|2|||
143050674|NCT01717040|515723852|FG001|Overall Study|Lost to Follow-up|3|||
143050675|NCT01717040|515723851|FG000|Overall Study|Lack of Efficacy|1|||
143050676|NCT01717040|515723852|FG001|Overall Study|Lack of Efficacy|1|||
143050677|NCT01717040|515723851|FG000|Overall Study|Adverse Event|1|||
143050678|NCT01717040|515723852|FG001|Overall Study|Adverse Event|0|||
143050679|NCT01717040|515723851|FG000|Overall Study|Required Medication Change|0|||
143050680|NCT01717040|515723852|FG001|Overall Study|Required Medication Change|1|||
143050681|NCT01717040|515723851|FG000|Overall Study|New Substance Use Disorder|1|||
143050682|NCT01717040|515723852|FG001|Overall Study|New Substance Use Disorder|0|||
143050683|NCT04194151|515723853|FG000|Overall Study|Physician Decision|1|||
143050684|NCT04194151|515723854|FG001|Overall Study|Physician Decision|1|||
143050685|NCT04194151|515723855|FG002|Overall Study|Physician Decision|1|||
143050686|NCT04194151|515723856|FG003|Overall Study|Physician Decision|1|||
143050687|NCT04194151|515723857|FG004|Overall Study|Physician Decision|0|||
143050688|NCT04194151|515723858|FG005|Overall Study|Physician Decision|1|||
143050689|NCT04194151|515723853|FG000|Overall Study|Monitorization problem|0|||
143050690|NCT04194151|515723854|FG001|Overall Study|Monitorization problem|1|||
143050691|NCT04194151|515723855|FG002|Overall Study|Monitorization problem|0|||
143050692|NCT04194151|515723856|FG003|Overall Study|Monitorization problem|0|||
143050693|NCT04194151|515723857|FG004|Overall Study|Monitorization problem|0|||
143050694|NCT04194151|515723858|FG005|Overall Study|Monitorization problem|0|||
143050695|NCT01499043|515723859|FG000|Overall Study|Progressive disease (radiographic)|2|||
143050696|NCT01499043|515723859|FG000|Overall Study|Progressive disease (clinical)|1|||
143050697|NCT01499043|515723859|FG000|Overall Study|Withdrawal by Subject|2|||
143050698|NCT01499043|515723859|FG000|Overall Study|Adverse Event|1|||
143050699|NCT02286466|515723860|FG000|Overall Study|Death|1|||
143050700|NCT02286466|515723861|FG001|Overall Study|Death|3|||
143050701|NCT02286466|515723860|FG000|Overall Study|Withdrawal by Subject|5|||
143050702|NCT02286466|515723861|FG001|Overall Study|Withdrawal by Subject|2|||
143050703|NCT02286466|515723860|FG000|Overall Study|Lost to Follow-up|1|||
143050704|NCT02286466|515723861|FG001|Overall Study|Lost to Follow-up|4|||
143050705|NCT02286466|515723860|FG000|Overall Study|Declined Clinician Assessment|0|||
143169054|NCT04380142|516167335|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
143169055|NCT04380142|516167336|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
143169056|NCT04380142|516167334|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
143169057|NCT04380142|516167335|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
143169058|NCT04380142|516167336|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
143169059|NCT04380142|516167334|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
143169060|NCT04380142|516167335|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
143169061|NCT04380142|516167336|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
143169062|NCT04380142|516167334|FG000|Double-Blind Treatment Period|Adverse Event|0|||
143169063|NCT04380142|516167335|FG001|Double-Blind Treatment Period|Adverse Event|1|||
143050706|NCT02286466|515723861|FG001|Overall Study|Declined Clinician Assessment|1|||
143050707|NCT01912807|515723862|FG000|Overall Study|Did not meet elegibility criteria|6|||
143050708|NCT01912807|515723863|FG001|Overall Study|Did not meet elegibility criteria|4|||
143050709|NCT01912807|515723862|FG000|Overall Study|Lost to Follow-up|36|||
143050710|NCT01912807|515723863|FG001|Overall Study|Lost to Follow-up|37|||
143050711|NCT00903877|515723864|FG000|Overall Study|Did not meet study criteria|33|||
143050712|NCT00903877|515723864|FG000|Overall Study|Withdrawal by Subject|3|||
143244665|NCT00478023|516448089|FG001|Overall Study|Adverse Event|7|||
143050713|NCT00903877|515723864|FG000|Overall Study|Adverse Event|2|||
143050714|NCT00903877|515723864|FG000|Overall Study|Lost to Follow-up|1|||
143050715|NCT00903877|515723864|FG000|Overall Study|Participation put on hold|4|||
143050716|NCT00087529|515723865|FG000|Overall Study|Death|1|||
143050717|NCT00087529|515723866|FG001|Overall Study|Death|0|||
143050718|NCT00087529|515723865|FG000|Overall Study|Adverse Event|0|||
143050719|NCT00087529|515723866|FG001|Overall Study|Adverse Event|8|||
143050720|NCT00087529|515723865|FG000|Overall Study|Pregnancy|0|||
143050721|NCT00087529|515723866|FG001|Overall Study|Pregnancy|1|||
143050722|NCT00087529|515723865|FG000|Overall Study|Lost to Follow-up|2|||
143050723|NCT00087529|515723866|FG001|Overall Study|Lost to Follow-up|3|||
143244666|NCT00478023|516448090|FG002|Overall Study|Adverse Event|8|||
143244667|NCT00478023|516448091|FG003|Overall Study|Adverse Event|14|||
143244668|NCT00478023|516448092|FG004|Overall Study|Adverse Event|6|||
143244669|NCT00478023|516448088|FG000|Overall Study|Death|1|||
143244670|NCT00478023|516448089|FG001|Overall Study|Death|0|||
143050724|NCT00087529|515723865|FG000|Overall Study|Participant Decision|14|||
143050725|NCT00087529|515723866|FG001|Overall Study|Participant Decision|37|||
143050726|NCT00087529|515723865|FG000|Overall Study|Physician Decision|4|||
143050727|NCT00087529|515723866|FG001|Overall Study|Physician Decision|8|||
143050728|NCT00087529|515723865|FG000|Overall Study|Initiation of Excluded Therapy|0|||
143050729|NCT00087529|515723866|FG001|Overall Study|Initiation of Excluded Therapy|1|||
143050730|NCT00087529|515723865|FG000|Overall Study|Participant Noncompliance|0|||
143050731|NCT00087529|515723866|FG001|Overall Study|Participant Noncompliance|1|||
143050732|NCT00087529|515723865|FG000|Overall Study|Disease Progression|5|||
143050733|NCT00087529|515723866|FG001|Overall Study|Disease Progression|4|||
143050734|NCT00087529|515723865|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
143050735|NCT00087529|515723866|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
143050736|NCT03694197|515723875|FG000|Overall Study|Adverse Event|9|||
143050737|NCT03694197|515723875|FG000|Overall Study|Protocol became inconvenient to participate|1|||
143050738|NCT03694197|515723875|FG000|Overall Study|Physician Decision|4|||
143050739|NCT03694197|515723875|FG000|Overall Study|Study terminated by sponsor|1350|||
143050740|NCT03694197|515723875|FG000|Overall Study|Participant moved|5|||
143050741|NCT03694197|515723875|FG000|Overall Study|Participant withdrew consent|10|||
143050742|NCT03694197|515723875|FG000|Overall Study|Related to IMP administration|1|||
143050743|NCT03694197|515723875|FG000|Overall Study|Not disclosed|5|||
143050744|NCT02300987|515725445|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
143050745|NCT02300987|515725446|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
143050746|NCT02300987|515725445|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
143050747|NCT02300987|515725446|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
143244671|NCT00478023|516448090|FG002|Overall Study|Death|0|||
143244672|NCT00478023|516448091|FG003|Overall Study|Death|0|||
143244673|NCT00478023|516448092|FG004|Overall Study|Death|0|||
143244674|NCT00478023|516448088|FG000|Overall Study|Lack of Efficacy|11|||
143244675|NCT00478023|516448089|FG001|Overall Study|Lack of Efficacy|10|||
143244676|NCT00478023|516448090|FG002|Overall Study|Lack of Efficacy|4|||
143050748|NCT02300987|515725445|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
143050749|NCT02300987|515725446|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
143050750|NCT02300987|515725445|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
143169064|NCT04380142|516167336|FG002|Double-Blind Treatment Period|Adverse Event|14|||
143169065|NCT04380142|516167334|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
143169066|NCT04380142|516167335|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
143169067|NCT04380142|516167336|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
143169068|NCT04380142|516167334|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
143169069|NCT04380142|516167335|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
143169070|NCT04380142|516167336|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
143169071|NCT04380142|516167334|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
143169072|NCT04380142|516167335|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
143169073|NCT04380142|516167336|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
143169074|NCT04380142|516167334|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
143169075|NCT04380142|516167335|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
143169076|NCT04380142|516167336|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
143169077|NCT04380142|516167334|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
143169078|NCT04380142|516167335|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
143169079|NCT04380142|516167336|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
143169080|NCT01968980|516167341|FG000|Overall Study|Death|0|||
143169081|NCT01968980|516167342|FG001|Overall Study|Death|1|||
143169082|NCT01968980|516167341|FG000|Overall Study|Adverse Event|1|||
143169083|NCT01968980|516167342|FG001|Overall Study|Adverse Event|3|||
143169084|NCT01968980|516167341|FG000|Overall Study|Does not meet entry criteria|1|||
143169085|NCT01968980|516167342|FG001|Overall Study|Does not meet entry criteria|3|||
143169086|NCT01968980|516167341|FG000|Overall Study|Withdrawal by Subject|13|||
143169087|NCT01968980|516167342|FG001|Overall Study|Withdrawal by Subject|5|||
143169088|NCT01968980|516167341|FG000|Overall Study|Other unspecified|1|||
143169089|NCT01968980|516167342|FG001|Overall Study|Other unspecified|2|||
143169090|NCT00265122|516167343|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
143169091|NCT00265122|516167344|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
143169092|NCT00265122|516167345|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
143244677|NCT00478023|516448091|FG003|Overall Study|Lack of Efficacy|5|||
143050751|NCT02300987|515725446|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
143050752|NCT02300987|515725445|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
143050753|NCT02300987|515725446|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
143050754|NCT03086135|515725447|FG000|Overall Study|Adverse Event|1|||
143050755|NCT03086135|515725447|FG000|Overall Study|Lost to Follow-up|2|||
143050756|NCT02259348|515725448|FG000|Overall Study|Donors|6|||
143050757|NCT02259348|515725448|FG000|Overall Study|Death|4|||
143050758|NCT01622660|515725449|FG000|Overall Study|Adverse Event|1|||
143050759|NCT04211766|515725450|FG000|Overall Study|Withdrawal by Subject|5|||
143050760|NCT04211766|515725451|FG001|Overall Study|Withdrawal by Subject|1|||
143050761|NCT01120899|515725455|FG000|Overall Study|Withdrawal by Subject|3|||
143050762|NCT00820599|515725456|FG000|Overall Study|Death|129|||
143050763|NCT00820599|515725456|FG000|Overall Study|Withdrawal by Subject|2|||
143050764|NCT03686215|515725457|FG000|Overall Study|Adverse Event|0|||
143050765|NCT03686215|515725458|FG001|Overall Study|Adverse Event|0|||
143169093|NCT00265122|516167346|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
143169094|NCT00265122|516167347|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
143169095|NCT00265122|516167348|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
143050766|NCT03686215|515725459|FG002|Overall Study|Adverse Event|7|||
143050767|NCT03686215|515725457|FG000|Overall Study|Physician Decision|0|||
143050768|NCT03686215|515725458|FG001|Overall Study|Physician Decision|0|||
143050769|NCT03686215|515725459|FG002|Overall Study|Physician Decision|1|||
143050770|NCT03686215|515725457|FG000|Overall Study|Protocol Violation|0|||
143050771|NCT03686215|515725458|FG001|Overall Study|Protocol Violation|0|||
143050772|NCT03686215|515725459|FG002|Overall Study|Protocol Violation|4|||
143050773|NCT03686215|515725457|FG000|Overall Study|Device issue|1|||
143050774|NCT03686215|515725458|FG001|Overall Study|Device issue|0|||
143050775|NCT03686215|515725459|FG002|Overall Study|Device issue|2|||
143050776|NCT00927251|515725460|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
143050777|NCT00522041|515725463|FG000|Overall Study|Adverse Event|9|||
143050778|NCT00522041|515725464|FG001|Overall Study|Adverse Event|3|||
143050779|NCT00522041|515725463|FG000|Overall Study|Protocol Violation|2|||
143050780|NCT00522041|515725464|FG001|Overall Study|Protocol Violation|0|||
143050781|NCT00522041|515725463|FG000|Overall Study|Lost to Follow-up|1|||
143050782|NCT00522041|515725464|FG001|Overall Study|Lost to Follow-up|4|||
143050783|NCT00522041|515725463|FG000|Overall Study|Voluntary withdrawal|5|||
143050784|NCT00522041|515725464|FG001|Overall Study|Voluntary withdrawal|4|||
143050785|NCT00522041|515725463|FG000|Overall Study|Did not receive treatment|0|||
143050786|NCT00522041|515725464|FG001|Overall Study|Did not receive treatment|1|||
143050787|NCT02725515|515725465|FG000|Overall Study|Refused infusion (no study treatment)|1|||
143050788|NCT02725515|515725466|FG001|Overall Study|Refused infusion (no study treatment)|0|||
143050789|NCT02725515|515725465|FG000|Overall Study|Loss of Improvement per Protocol|14|||
143050790|NCT02725515|515725466|FG001|Overall Study|Loss of Improvement per Protocol|25|||
143050791|NCT02725515|515725465|FG000|Overall Study|Withdrawal by Subject|2|||
143050792|NCT02725515|515725466|FG001|Overall Study|Withdrawal by Subject|1|||
143050793|NCT02725515|515725465|FG000|Overall Study|Non-Compliance With Study Drug|0|||
143050794|NCT02725515|515725466|FG001|Overall Study|Non-Compliance With Study Drug|3|||
143050795|NCT02725515|515725465|FG000|Overall Study|Lost to Follow-up|1|||
143050796|NCT02725515|515725466|FG001|Overall Study|Lost to Follow-up|1|||
143050797|NCT02725515|515725465|FG000|Overall Study|Adverse Event|7|||
143050798|NCT02725515|515725466|FG001|Overall Study|Adverse Event|2|||
143050799|NCT02725515|515725465|FG000|Overall Study|No Documented Disease Improvement|0|||
143050800|NCT02725515|515725466|FG001|Overall Study|No Documented Disease Improvement|1|||
143050801|NCT02725515|515725465|FG000|Overall Study|Completed Study Under Original Protocol|0|||
143050802|NCT02725515|515725466|FG001|Overall Study|Completed Study Under Original Protocol|1|||
143050803|NCT02725515|515725465|FG000|Overall Study|Lack of Response|0|||
143050804|NCT02725515|515725466|FG001|Overall Study|Lack of Response|1|||
143050805|NCT00874549|515725467|FG000|Overall Study|Adverse Event|0|||
143050806|NCT00874549|515725468|FG001|Overall Study|Adverse Event|0|||
143050807|NCT00874549|515725469|FG002|Overall Study|Adverse Event|1|||
143050808|NCT00874549|515725470|FG003|Overall Study|Adverse Event|0|||
143050809|NCT00874549|515725467|FG000|Overall Study|Protocol Violation|1|||
143050810|NCT00874549|515725468|FG001|Overall Study|Protocol Violation|0|||
143050811|NCT00874549|515725469|FG002|Overall Study|Protocol Violation|2|||
143050812|NCT00874549|515725470|FG003|Overall Study|Protocol Violation|1|||
143050813|NCT00874549|515725467|FG000|Overall Study|Lost to Follow-up|0|||
143050814|NCT00874549|515725468|FG001|Overall Study|Lost to Follow-up|0|||
143050815|NCT00874549|515725469|FG002|Overall Study|Lost to Follow-up|1|||
143050816|NCT00874549|515725470|FG003|Overall Study|Lost to Follow-up|0|||
143050817|NCT00874549|515725467|FG000|Overall Study|Withdrawal by Subject|0|||
143050818|NCT00874549|515725468|FG001|Overall Study|Withdrawal by Subject|1|||
143050819|NCT00874549|515725469|FG002|Overall Study|Withdrawal by Subject|0|||
143050820|NCT00874549|515725470|FG003|Overall Study|Withdrawal by Subject|1|||
143050821|NCT01710358|515725472|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
143050822|NCT01710358|515725473|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
143050823|NCT01710358|515725474|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
143050824|NCT01710358|515725472|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
143050825|NCT01710358|515725473|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
143050826|NCT01710358|515725474|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
143050827|NCT01710358|515725472|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
143050828|NCT01710358|515725473|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
143050829|NCT01710358|515725474|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
143050830|NCT01710358|515725472|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
143050831|NCT01710358|515725473|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
143050832|NCT01710358|515725474|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
143050833|NCT01710358|515725472|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
143050834|NCT01710358|515725473|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
143050835|NCT01710358|515725474|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
143050836|NCT01710358|515725472|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
143050837|NCT01710358|515725473|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
143050838|NCT01710358|515725474|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
143050839|NCT01710358|515725472|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
143050840|NCT01710358|515725473|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
143050841|NCT01710358|515725474|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
143050842|NCT01710358|515725472|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
143050843|NCT01710358|515725473|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
143050844|NCT01710358|515725474|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
143050845|NCT01710358|515725472|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
143050846|NCT01710358|515725473|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
143050847|NCT01710358|515725474|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
143050848|NCT01710358|515725472|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
143050849|NCT01710358|515725473|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
143050850|NCT01710358|515725474|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
143050851|NCT01710358|515725472|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
143050852|NCT01710358|515725473|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
143050853|NCT01710358|515725474|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
143050854|NCT01710358|515725472|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
143050855|NCT01710358|515725473|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
143050856|NCT01710358|515725474|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
143050857|NCT01710358|515725472|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
143050858|NCT01710358|515725473|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
143050859|NCT01710358|515725474|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
143050860|NCT01710358|515725472|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
143050861|NCT01710358|515725473|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
143050862|NCT01710358|515725474|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
143050863|NCT01710358|515725472|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
143050864|NCT01710358|515725473|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
143050865|NCT01710358|515725474|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
143050866|NCT01710358|515725472|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
143050867|NCT01710358|515725473|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
143050868|NCT01710358|515725474|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
143050869|NCT01710358|515725472|FG000|Rescue Period|Adverse Event|0|||
143050870|NCT01710358|515725473|FG001|Rescue Period|Adverse Event|15|||
143050871|NCT01710358|515725474|FG002|Rescue Period|Adverse Event|0|||
143050872|NCT01710358|515725472|FG000|Rescue Period|Death|0|||
143050873|NCT01710358|515725473|FG001|Rescue Period|Death|1|||
143050874|NCT01710358|515725474|FG002|Rescue Period|Death|0|||
143050875|NCT01710358|515725472|FG000|Rescue Period|Lack of Efficacy|0|||
143050876|NCT01710358|515725473|FG001|Rescue Period|Lack of Efficacy|7|||
143050877|NCT01710358|515725474|FG002|Rescue Period|Lack of Efficacy|0|||
143050878|NCT01710358|515725472|FG000|Rescue Period|Withdrawal by Subject|0|||
143050879|NCT01710358|515725473|FG001|Rescue Period|Withdrawal by Subject|8|||
143050880|NCT01710358|515725474|FG002|Rescue Period|Withdrawal by Subject|0|||
143050881|NCT00084864|515725475|FG000|Overall Study|Adverse Event|1|||
143050882|NCT00084864|515725476|FG001|Overall Study|Adverse Event|0|||
143050883|NCT00084864|515725477|FG002|Overall Study|Adverse Event|0|||
143244678|NCT00478023|516448092|FG004|Overall Study|Lack of Efficacy|41|||
143244679|NCT00478023|516448088|FG000|Overall Study|Lost to Follow-up|3|||
143244680|NCT00478023|516448089|FG001|Overall Study|Lost to Follow-up|1|||
143244681|NCT00478023|516448090|FG002|Overall Study|Lost to Follow-up|1|||
143244682|NCT00478023|516448091|FG003|Overall Study|Lost to Follow-up|1|||
143244683|NCT00478023|516448092|FG004|Overall Study|Lost to Follow-up|0|||
143244684|NCT00478023|516448088|FG000|Overall Study|Withdrawal by Subject|2|||
143259581|NCT00773838|516505787|FG000|Overall Study|Lost to Follow-up|1|||
143050884|NCT00084864|515725478|FG003|Overall Study|Adverse Event|0|||
143050885|NCT01456962|515725488|FG000|Overall Study|Lost to Follow-up|2|||
143050886|NCT01456962|515725489|FG001|Overall Study|Lost to Follow-up|1|||
143050887|NCT01168856|515725496|FG000|Overall Study|Lost to Follow-up|4|||
143050888|NCT01168856|515725497|FG001|Overall Study|Lost to Follow-up|34|||
143050889|NCT01168856|515725496|FG000|Overall Study|Withdrawal by Subject|6|||
143050890|NCT01168856|515725497|FG001|Overall Study|Withdrawal by Subject|8|||
143050891|NCT01168856|515725496|FG000|Overall Study|Physician Decision|2|||
143050892|NCT01168856|515725497|FG001|Overall Study|Physician Decision|1|||
143050893|NCT01168856|515725496|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
143050894|NCT01168856|515725497|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
143050895|NCT01168856|515725496|FG000|Overall Study|Participant received anti-HCV treatment|1|||
143050896|NCT01168856|515725497|FG001|Overall Study|Participant received anti-HCV treatment|0|||
143050897|NCT01168856|515725496|FG000|Overall Study|Death|0|||
143050898|NCT01168856|515725497|FG001|Overall Study|Death|2|||
143050899|NCT01168856|515725496|FG000|Overall Study|Other|1|||
143050900|NCT01168856|515725497|FG001|Overall Study|Other|291|||
143050901|NCT01168856|515725496|FG000|Overall Study|Protocol Violation|4|||
143050902|NCT01168856|515725497|FG001|Overall Study|Protocol Violation|6|||
143050903|NCT00840658|515725498|FG000|Overall Study|Death|2|||
143050904|NCT00840658|515725499|FG001|Overall Study|Death|2|||
143050905|NCT00840658|515725500|FG002|Overall Study|Death|3|||
143050906|NCT00840658|515725501|FG003|Overall Study|Death|3|||
143050907|NCT00840658|515725498|FG000|Overall Study|Lost to Follow-up|3|||
143050908|NCT00840658|515725499|FG001|Overall Study|Lost to Follow-up|1|||
143050909|NCT00840658|515725500|FG002|Overall Study|Lost to Follow-up|2|||
143050910|NCT00840658|515725501|FG003|Overall Study|Lost to Follow-up|1|||
143050911|NCT05278858|515725502|FG000|Overall Study|Withdrawal by Subject|1|||
143050912|NCT00474058|515725503|FG000|Overall Study|Adverse Event|11|||
143050913|NCT00474058|515725504|FG001|Overall Study|Adverse Event|6|||
143050914|NCT00474058|515725503|FG000|Overall Study|Lack of Efficacy|0|||
143050915|NCT00474058|515725504|FG001|Overall Study|Lack of Efficacy|4|||
143050916|NCT00474058|515725503|FG000|Overall Study|Withdrawal by Subject|11|||
143050917|NCT00474058|515725504|FG001|Overall Study|Withdrawal by Subject|7|||
143050918|NCT00474058|515725503|FG000|Overall Study|Other|2|||
143050919|NCT00474058|515725504|FG001|Overall Study|Other|0|||
143050920|NCT02640235|515725505|FG000|Overall Study|Withdrawal by Subject|7|||
143050921|NCT02640235|515725506|FG001|Overall Study|Withdrawal by Subject|6|||
143050922|NCT02640235|515725505|FG000|Overall Study|Lost to Follow-up|4|||
143050923|NCT02640235|515725506|FG001|Overall Study|Lost to Follow-up|3|||
143050924|NCT02640235|515725505|FG000|Overall Study|Death|2|||
143050925|NCT02640235|515725506|FG001|Overall Study|Death|3|||
143050926|NCT02640235|515725505|FG000|Overall Study|Other|1|||
143050927|NCT02640235|515725506|FG001|Overall Study|Other|2|||
143050928|NCT00503867|515725509|FG000|Overall Study|Lost to Follow-up|1|||
143050929|NCT00503867|515725509|FG000|Overall Study|Adverse Event|1|||
143050930|NCT03504085|515725515|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
143050931|NCT03504085|515725516|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
143050932|NCT03504085|515725515|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
143050933|NCT03504085|515725516|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
143050934|NCT01143337|515725517|FG000|Overall Study|Adverse Event|3|||
143050935|NCT01143337|515725518|FG001|Overall Study|Adverse Event|9|||
143050936|NCT01143337|515725519|FG002|Overall Study|Adverse Event|5|||
143050937|NCT01143337|515725517|FG000|Overall Study|Lack of Efficacy|6|||
143050938|NCT01143337|515725518|FG001|Overall Study|Lack of Efficacy|2|||
143050939|NCT01143337|515725519|FG002|Overall Study|Lack of Efficacy|1|||
143050940|NCT01143337|515725517|FG000|Overall Study|Protocol Violation|1|||
143050941|NCT01143337|515725518|FG001|Overall Study|Protocol Violation|0|||
143050942|NCT01143337|515725519|FG002|Overall Study|Protocol Violation|0|||
143050943|NCT01143337|515725517|FG000|Overall Study|Withdrawal by Subject|0|||
143050944|NCT01143337|515725518|FG001|Overall Study|Withdrawal by Subject|0|||
143050945|NCT01143337|515725519|FG002|Overall Study|Withdrawal by Subject|1|||
143050946|NCT01143337|515725517|FG000|Overall Study|Other reason|0|||
143050947|NCT01143337|515725518|FG001|Overall Study|Other reason|0|||
143050948|NCT01143337|515725519|FG002|Overall Study|Other reason|5|||
143050949|NCT02761915|515725520|FG000|Overall Study|Death|3|||
143050950|NCT02761915|515725521|FG001|Overall Study|Death|1|||
143050951|NCT02761915|515725522|FG002|Overall Study|Death|1|||
143050952|NCT02761915|515725523|FG003|Overall Study|Death|1|||
143050953|NCT02761915|515725524|FG004|Overall Study|Death|0|||
143050954|NCT02761915|515725525|FG005|Overall Study|Death|1|||
143050955|NCT02761915|515725520|FG000|Overall Study|Withdrawal by Subject|1|||
143050956|NCT02761915|515725521|FG001|Overall Study|Withdrawal by Subject|0|||
143050957|NCT02761915|515725522|FG002|Overall Study|Withdrawal by Subject|0|||
143050958|NCT02761915|515725523|FG003|Overall Study|Withdrawal by Subject|0|||
143050959|NCT02761915|515725524|FG004|Overall Study|Withdrawal by Subject|1|||
143169096|NCT00265122|516167343|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
143169097|NCT00265122|516167344|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
143169098|NCT00265122|516167345|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
143169099|NCT00265122|516167346|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
143169100|NCT00265122|516167347|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
143169101|NCT00265122|516167348|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
143169102|NCT00265122|516167343|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
143169103|NCT00265122|516167344|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
143244685|NCT00478023|516448089|FG001|Overall Study|Withdrawal by Subject|3|||
143244686|NCT00478023|516448090|FG002|Overall Study|Withdrawal by Subject|2|||
143244687|NCT00478023|516448091|FG003|Overall Study|Withdrawal by Subject|4|||
143244688|NCT00478023|516448092|FG004|Overall Study|Withdrawal by Subject|5|||
143244689|NCT00478023|516448088|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
143050960|NCT02761915|515725525|FG005|Overall Study|Withdrawal by Subject|2|||
143050961|NCT02761915|515725520|FG000|Overall Study|Disease Progression|0|||
143050962|NCT02761915|515725521|FG001|Overall Study|Disease Progression|0|||
143050963|NCT02761915|515725522|FG002|Overall Study|Disease Progression|0|||
143050964|NCT02761915|515725523|FG003|Overall Study|Disease Progression|2|||
143244690|NCT00478023|516448089|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
143050965|NCT02761915|515725524|FG004|Overall Study|Disease Progression|2|||
143050966|NCT02761915|515725525|FG005|Overall Study|Disease Progression|2|||
143050967|NCT01926119|515725532|FG000|Overall Study|Withdrawal by Subject|1|||
143050968|NCT02654145|515725542|FG000|Overall Study|Lack of Efficacy|1|||
143050969|NCT02654145|515725542|FG000|Overall Study|Protocol Violation|1|||
143050970|NCT02654145|515725542|FG000|Overall Study|Withdrawal by Subject|5|||
143050971|NCT00009945|515725543|FG000|Overall Study|no follow up data|7|||
143050972|NCT00009945|515725544|FG001|Overall Study|no follow up data|5|||
143050973|NCT00354835|515725545|FG000|Overall Study|Death|1|||
143050974|NCT00354835|515725546|FG001|Overall Study|Death|1|||
143050975|NCT00354835|515725545|FG000|Overall Study|Physician Decision|8|||
143050976|NCT00354835|515725546|FG001|Overall Study|Physician Decision|13|||
143050977|NCT00354835|515725545|FG000|Overall Study|Withdrawal by Subject|2|||
143050978|NCT00354835|515725546|FG001|Overall Study|Withdrawal by Subject|1|||
143050979|NCT00354835|515725545|FG000|Overall Study|Ineligible|17|||
143050980|NCT00354835|515725546|FG001|Overall Study|Ineligible|16|||
143050981|NCT00354835|515725545|FG000|Overall Study|Disease progression or relapse|15|||
143050982|NCT00354835|515725546|FG001|Overall Study|Disease progression or relapse|22|||
143050983|NCT00354835|515725545|FG000|Overall Study|Adverse Event|6|||
143050984|NCT00354835|515725546|FG001|Overall Study|Adverse Event|0|||
143050985|NCT00354835|515725545|FG000|Overall Study|Refusal of further therapy|3|||
143050986|NCT00354835|515725546|FG001|Overall Study|Refusal of further therapy|8|||
143050987|NCT00645853|515725547|FG000|Overall Study|Adverse Event|18|||
143050988|NCT00645853|515725548|FG001|Overall Study|Adverse Event|7|||
143050989|NCT00645853|515725547|FG000|Overall Study|AZ study closure in Hungary|60|||
143050990|NCT00645853|515725548|FG001|Overall Study|AZ study closure in Hungary|40|||
143050991|NCT00645853|515725547|FG000|Overall Study|Withdrawal by Subject|5|||
143050992|NCT00645853|515725548|FG001|Overall Study|Withdrawal by Subject|2|||
143050993|NCT00645853|515725547|FG000|Overall Study|Protocol Violation|0|||
143169104|NCT00265122|516167345|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
143169105|NCT00265122|516167346|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
143169106|NCT00265122|516167347|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
143169107|NCT00265122|516167348|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
143169108|NCT00265122|516167343|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
143169109|NCT00265122|516167344|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
143169110|NCT00265122|516167345|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
143244691|NCT00478023|516448090|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
143244692|NCT00478023|516448091|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
143244693|NCT00478023|516448092|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
143244694|NCT05019521|516448096|FG000|Primary Evaluation Period (52 Weeks)|Adverse Event|7|||
143244695|NCT05019521|516448097|FG001|Primary Evaluation Period (52 Weeks)|Adverse Event|9|||
143244696|NCT05019521|516448098|FG002|Primary Evaluation Period (52 Weeks)|Adverse Event|8|||
143244697|NCT05019521|516448099|FG003|Primary Evaluation Period (52 Weeks)|Adverse Event|4|||
143244698|NCT05019521|516448100|FG004|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
143244699|NCT05019521|516448101|FG005|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
143244700|NCT05019521|516448102|FG006|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
143244701|NCT05019521|516448096|FG000|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
143244702|NCT05019521|516448097|FG001|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
143244703|NCT05019521|516448098|FG002|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
143259582|NCT00773838|516505787|FG000|Overall Study|Physician Decision|8|||
143259583|NCT00773838|516505787|FG000|Overall Study|Progressive Disease|82|||
143050994|NCT00645853|515725548|FG001|Overall Study|Protocol Violation|2|||
143050995|NCT00645853|515725547|FG000|Overall Study|Discontinuation criteria|2|||
143169111|NCT00265122|516167346|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
143169112|NCT00265122|516167347|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
143259584|NCT00773838|516505787|FG000|Overall Study|Protocol Violation|2|||
143259585|NCT00773838|516505787|FG000|Overall Study|Withdrawal by Subject|21|||
143050996|NCT00645853|515725548|FG001|Overall Study|Discontinuation criteria|2|||
143050997|NCT00645853|515725547|FG000|Overall Study|recall of ICF, planned operation, death|7|||
143050998|NCT00645853|515725548|FG001|Overall Study|recall of ICF, planned operation, death|4|||
143050999|NCT00295490|515725551|FG000|Overall Study|Protocol Violation|0|||
143169113|NCT00265122|516167348|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
143244704|NCT05019521|516448099|FG003|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
143244705|NCT05019521|516448100|FG004|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
143244706|NCT05019521|516448101|FG005|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
143244707|NCT05019521|516448102|FG006|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
143244708|NCT05019521|516448096|FG000|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|7|||
143244709|NCT05019521|516448097|FG001|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|13|||
143499245|NCT05655377|517368527|FG000|Overall Study|Withdrawal by Subject|2|||
143499246|NCT01256177|517368528|FG000|Overall Study|Withdrawal by Subject|23|||
143499247|NCT01256177|517368529|FG001|Overall Study|Withdrawal by Subject|22|||
143499248|NCT01256177|517368528|FG000|Overall Study|Lost to Follow-up|2|||
143499249|NCT01256177|517368529|FG001|Overall Study|Lost to Follow-up|2|||
143499250|NCT01256177|517368528|FG000|Overall Study|Adverse Event|8|||
143499251|NCT01256177|517368529|FG001|Overall Study|Adverse Event|9|||
143499252|NCT01256177|517368528|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
143499253|NCT01256177|517368529|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
143499254|NCT01256177|517368528|FG000|Overall Study|Condition under Investigation Worsened|1|||
143499255|NCT01256177|517368529|FG001|Overall Study|Condition under Investigation Worsened|0|||
143499256|NCT01256177|517368528|FG000|Overall Study|Lack of Efficacy|11|||
143499257|NCT01256177|517368529|FG001|Overall Study|Lack of Efficacy|2|||
143499258|NCT01256177|517368528|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
143499259|NCT01256177|517368529|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
143499260|NCT00849667|517368546|FG000|Overall Study|Withdrawal by Subject|16|||
143499261|NCT00849667|517368547|FG001|Overall Study|Withdrawal by Subject|33|||
143499262|NCT00849667|517368548|FG002|Overall Study|Withdrawal by Subject|35|||
143499263|NCT00849667|517368546|FG000|Overall Study|Lost to Follow-up|8|||
143499264|NCT00849667|517368547|FG001|Overall Study|Lost to Follow-up|8|||
143499265|NCT00849667|517368548|FG002|Overall Study|Lost to Follow-up|8|||
143499266|NCT00849667|517368546|FG000|Overall Study|Adverse Event|1|||
143499267|NCT00849667|517368547|FG001|Overall Study|Adverse Event|2|||
143499268|NCT00849667|517368548|FG002|Overall Study|Adverse Event|0|||
143499269|NCT00849667|517368546|FG000|Overall Study|Other|18|||
143499270|NCT00849667|517368547|FG001|Overall Study|Other|19|||
143499271|NCT00849667|517368548|FG002|Overall Study|Other|18|||
143499272|NCT00849667|517368546|FG000|Overall Study|Progressive disease|119|||
143499273|NCT00849667|517368547|FG001|Overall Study|Progressive disease|100|||
143499274|NCT00849667|517368548|FG002|Overall Study|Progressive disease|112|||
143499275|NCT00849667|517368546|FG000|Overall Study|Sponsor decision|208|||
143499276|NCT00849667|517368547|FG001|Overall Study|Sponsor decision|204|||
143499277|NCT00849667|517368548|FG002|Overall Study|Sponsor decision|190|||
143499278|NCT00849667|517368546|FG000|Overall Study|Investigator discretion|0|||
143499279|NCT00849667|517368547|FG001|Overall Study|Investigator discretion|0|||
143499280|NCT00849667|517368548|FG002|Overall Study|Investigator discretion|1|||
143499281|NCT00553462|517368549|FG000|Overall Study|Adverse Event|4|||
143499282|NCT00553462|517368549|FG000|Overall Study|Progression|4|||
143499283|NCT00553462|517368549|FG000|Overall Study|Withdrawal by Subject|5|||
143499284|NCT00553462|517368549|FG000|Overall Study|Physician Decision|1|||
143499285|NCT03075163|517368550|FG000|Overall Study|not eligible for treatment limb|138|||
143499286|NCT03075163|517368551|FG001|Overall Study|not eligible for treatment limb|138|||
143499287|NCT01500057|517368563|FG000|Overall Study|Lost to Follow-up|6|||
143499288|NCT01500057|517368564|FG001|Overall Study|Lost to Follow-up|4|||
143499289|NCT01731678|517368565|FG000|Overall Study|Withdrawal by Subject|3|||
143499290|NCT01731678|517368565|FG000|Overall Study|Did not meet inclusion criteria|1|||
143499291|NCT01731678|517368565|FG000|Overall Study|RMT too high, making TMS difficult|3|||
143499292|NCT02471716|517368571|FG000|Overall Study|Withdrawal by Subject|0|||
143499293|NCT02471716|517368572|FG001|Overall Study|Withdrawal by Subject|1|||
143499294|NCT02471716|517368573|FG002|Overall Study|Withdrawal by Subject|0|||
143499295|NCT02471716|517368574|FG003|Overall Study|Withdrawal by Subject|2|||
143499296|NCT02471716|517368575|FG004|Overall Study|Withdrawal by Subject|5|||
143499297|NCT02471716|517368571|FG000|Overall Study|Study Terminiated by sponsor|0|||
143499298|NCT02471716|517368572|FG001|Overall Study|Study Terminiated by sponsor|0|||
143499299|NCT02471716|517368573|FG002|Overall Study|Study Terminiated by sponsor|0|||
143499300|NCT02471716|517368574|FG003|Overall Study|Study Terminiated by sponsor|1|||
143499301|NCT02471716|517368575|FG004|Overall Study|Study Terminiated by sponsor|0|||
143499302|NCT02471716|517368571|FG000|Overall Study|Lost to Follow-up|0|||
143499303|NCT02471716|517368572|FG001|Overall Study|Lost to Follow-up|0|||
143499304|NCT02471716|517368573|FG002|Overall Study|Lost to Follow-up|0|||
143499305|NCT02471716|517368574|FG003|Overall Study|Lost to Follow-up|3|||
143499306|NCT02471716|517368575|FG004|Overall Study|Lost to Follow-up|2|||
143244710|NCT05019521|516448098|FG002|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|6|||
143499307|NCT02471716|517368571|FG000|Overall Study|Death|0|||
143499308|NCT02471716|517368572|FG001|Overall Study|Death|0|||
143499309|NCT02471716|517368573|FG002|Overall Study|Death|0|||
143499310|NCT02471716|517368574|FG003|Overall Study|Death|1|||
143499311|NCT02471716|517368575|FG004|Overall Study|Death|0|||
143499312|NCT02471716|517368571|FG000|Overall Study|Other|0|||
143051000|NCT00295490|515725552|FG001|Overall Study|Protocol Violation|0|||
143051001|NCT00295490|515725553|FG002|Overall Study|Protocol Violation|3|||
143051002|NCT00295490|515725554|FG003|Overall Study|Protocol Violation|3|||
143051003|NCT00295490|515725551|FG000|Overall Study|Withdrawal by Subject|0|||
143051004|NCT00295490|515725552|FG001|Overall Study|Withdrawal by Subject|2|||
143051005|NCT00295490|515725553|FG002|Overall Study|Withdrawal by Subject|0|||
143051006|NCT00295490|515725554|FG003|Overall Study|Withdrawal by Subject|1|||
143051007|NCT00295490|515725551|FG000|Overall Study|Lost to Follow-up|0|||
143051008|NCT00295490|515725552|FG001|Overall Study|Lost to Follow-up|0|||
143051009|NCT00295490|515725553|FG002|Overall Study|Lost to Follow-up|1|||
143051010|NCT00295490|515725554|FG003|Overall Study|Lost to Follow-up|0|||
143051011|NCT00295490|515725551|FG000|Overall Study|Adverse Event|1|||
143051012|NCT00295490|515725552|FG001|Overall Study|Adverse Event|0|||
143051013|NCT00295490|515725553|FG002|Overall Study|Adverse Event|0|||
143051014|NCT00295490|515725554|FG003|Overall Study|Adverse Event|0|||
143051015|NCT00295490|515725551|FG000|Overall Study|Other|0|||
143051016|NCT00295490|515725552|FG001|Overall Study|Other|2|||
143051017|NCT00295490|515725553|FG002|Overall Study|Other|0|||
143051018|NCT00295490|515725554|FG003|Overall Study|Other|1|||
143051019|NCT01597791|515725555|FG000|Overall Study|Physician Decision|2|||
143051020|NCT01597791|515725556|FG001|Overall Study|Physician Decision|1|||
143051021|NCT01597791|515725555|FG000|Overall Study|Cesarean Section|6|||
143051022|NCT01597791|515725556|FG001|Overall Study|Cesarean Section|7|||
143051023|NCT01597791|515725555|FG000|Overall Study|Subject withdrawal|0|||
143051024|NCT01597791|515725556|FG001|Overall Study|Subject withdrawal|1|||
143051025|NCT01597791|515725555|FG000|Overall Study|Protocol Violation|0|||
143051026|NCT01597791|515725556|FG001|Overall Study|Protocol Violation|1|||
143051027|NCT01728116|515725559|FG000|Overall Study|Sponsor Terminated Study|106|||
143051028|NCT01728116|515725560|FG001|Overall Study|Sponsor Terminated Study|35|||
143051029|NCT01728116|515725559|FG000|Overall Study|Withdrawal by Subject|16|||
143051030|NCT01728116|515725560|FG001|Overall Study|Withdrawal by Subject|9|||
143051031|NCT01728116|515725559|FG000|Overall Study|Adverse Event|13|||
143051032|NCT01728116|515725560|FG001|Overall Study|Adverse Event|0|||
143051033|NCT01728116|515725559|FG000|Overall Study|Procedure/device failure|7|||
143051034|NCT01728116|515725560|FG001|Overall Study|Procedure/device failure|0|||
143051035|NCT01728116|515725559|FG000|Overall Study|Lost to Follow-up|9|||
143051036|NCT01728116|515725560|FG001|Overall Study|Lost to Follow-up|2|||
143051037|NCT01728116|515725559|FG000|Overall Study|Physician Decision|2|||
143051038|NCT01728116|515725560|FG001|Overall Study|Physician Decision|0|||
143051039|NCT01728116|515725559|FG000|Overall Study|Subject Non-Compliance|2|||
143051040|NCT01728116|515725560|FG001|Overall Study|Subject Non-Compliance|0|||
143051041|NCT01728116|515725559|FG000|Overall Study|Inter-current finding at procedure|1|||
143051042|NCT01728116|515725560|FG001|Overall Study|Inter-current finding at procedure|0|||
143051043|NCT01728116|515725559|FG000|Overall Study|Incorrectly enrolled in Study|0|||
143051044|NCT01728116|515725560|FG001|Overall Study|Incorrectly enrolled in Study|1|||
143051045|NCT01728116|515725559|FG000|Overall Study|various not noted previously|5|||
143051046|NCT01728116|515725560|FG001|Overall Study|various not noted previously|0|||
143051047|NCT02377349|515725561|FG000|Overall Study|Serious Adverse Event|1|||
143051048|NCT02377349|515725562|FG001|Overall Study|Serious Adverse Event|0|||
143051049|NCT02377349|515725561|FG000|Overall Study|Protocol Violation|3|||
143051050|NCT02377349|515725562|FG001|Overall Study|Protocol Violation|2|||
143051051|NCT02377349|515725561|FG000|Overall Study|Withdrawal by Subject|5|||
143051052|NCT02377349|515725562|FG001|Overall Study|Withdrawal by Subject|3|||
143051053|NCT02377349|515725561|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
143051054|NCT02377349|515725562|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
143051055|NCT02377349|515725561|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
143051056|NCT02377349|515725562|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
143051057|NCT02377349|515725561|FG000|Overall Study|Other|0|||
143051058|NCT02377349|515725562|FG001|Overall Study|Other|1|||
143051059|NCT02943096|515725565|FG000|Overall Study|Lack of Efficacy|0|||
143051060|NCT02943096|515725566|FG001|Overall Study|Lack of Efficacy|1|||
143051061|NCT05065619|515725567|FG000|Up to Day 42|Lost to Follow-up|1|||
143051062|NCT05065619|515725568|FG001|Up to Day 42|Lost to Follow-up|0|||
143051063|NCT05065619|515725567|FG000|Up to Day 42|Withdrawal by Subject|1|||
143051064|NCT05065619|515725568|FG001|Up to Day 42|Withdrawal by Subject|0|||
143051065|NCT05065619|515725567|FG000|After Day 43|Lost to Follow-up|1|||
143051066|NCT05065619|515725568|FG001|After Day 43|Lost to Follow-up|0|||
143051067|NCT05065619|515725567|FG000|After Day 43|Physician Decision|3|||
143051068|NCT05065619|515725568|FG001|After Day 43|Physician Decision|0|||
143051069|NCT05065619|515725567|FG000|After Day 43|Withdrawal by Subject|1|||
143051070|NCT05065619|515725568|FG001|After Day 43|Withdrawal by Subject|2|||
143244711|NCT05019521|516448099|FG003|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|9|||
143051071|NCT05065619|515725567|FG000|After Day 43|Public vaccination|6|||
143051072|NCT05065619|515725568|FG001|After Day 43|Public vaccination|8|||
143051073|NCT05065619|515725567|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
143051074|NCT05065619|515725568|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
143051075|NCT05065619|515725567|FG000|After Day 43|Study Terminated by Sponsor|88|||
143051076|NCT05065619|515725568|FG001|After Day 43|Study Terminated by Sponsor|16|||
143051077|NCT00939523|515725569|FG000|Overall Study|Lack of Efficacy|1|||
143051078|NCT00939523|515725569|FG000|Overall Study|Physician Decision|2|||
143051079|NCT00570128|515725582|FG000|Overall Study|Adverse Event|1|||
143051080|NCT00570128|515725583|FG001|Overall Study|Adverse Event|0|||
143051081|NCT00570128|515725582|FG000|Overall Study|Lost to Follow-up|1|||
143051082|NCT00570128|515725583|FG001|Overall Study|Lost to Follow-up|0|||
143051083|NCT00570128|515725582|FG000|Overall Study|Withdrawal by Subject|2|||
143051084|NCT00570128|515725583|FG001|Overall Study|Withdrawal by Subject|0|||
143051085|NCT03868631|515725584|FG000|Baseline to Week 6|Adverse Event|0|||
143051086|NCT03868631|515725585|FG001|Baseline to Week 6|Adverse Event|3|||
143051087|NCT03868631|515725584|FG000|Baseline to Week 6|Protocol Violation|1|||
143051088|NCT03868631|515725585|FG001|Baseline to Week 6|Protocol Violation|1|||
143051089|NCT03868631|515725584|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
143051090|NCT03868631|515725585|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
143051091|NCT03868631|515725584|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
143051092|NCT03868631|515725585|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
143051093|NCT03868631|515725584|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
143051094|NCT03868631|515725585|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
143051095|NCT03868631|515725584|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
143051096|NCT03868631|515725585|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
143051097|NCT01942135|515725586|FG000|Overall Study|Adverse Event|21|||
143051098|NCT01942135|515725587|FG001|Overall Study|Adverse Event|7|||
143051099|NCT01942135|515725586|FG000|Overall Study|Global Deterioration of Health Status|9|||
143051100|NCT01942135|515725587|FG001|Overall Study|Global Deterioration of Health Status|6|||
143051101|NCT01942135|515725586|FG000|Overall Study|Randomized Not Treated|2|||
143051102|NCT01942135|515725587|FG001|Overall Study|Randomized Not Treated|2|||
143051103|NCT01942135|515725586|FG000|Overall Study|Death|2|||
143051104|NCT01942135|515725587|FG001|Overall Study|Death|1|||
143051105|NCT01942135|515725586|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
143051106|NCT01942135|515725587|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
143051107|NCT01942135|515725586|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
143051108|NCT01942135|515725587|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
143051109|NCT01942135|515725586|FG000|Overall Study|Withdrawal by Subject|4|||
143051110|NCT01942135|515725587|FG001|Overall Study|Withdrawal by Subject|3|||
143051111|NCT01942135|515725586|FG000|Overall Study|Protocol Violation|1|||
143051112|NCT01942135|515725587|FG001|Overall Study|Protocol Violation|0|||
143051113|NCT01942135|515725586|FG000|Overall Study|Other|19|||
143051114|NCT01942135|515725587|FG001|Overall Study|Other|4|||
143051115|NCT03193021|515725588|FG000|Overall Study|Lost to Follow-up|1|||
143051116|NCT03193021|515725589|FG001|Overall Study|Lost to Follow-up|1|||
143051117|NCT00835081|515725590|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
143051118|NCT00835081|515725591|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
143051119|NCT00421304|515725592|FG000|Overall Study|Lost to Follow-up|5|||
143051120|NCT00421304|515725593|FG001|Overall Study|Lost to Follow-up|2|||
143051121|NCT00421304|515725594|FG002|Overall Study|Lost to Follow-up|5|||
143051122|NCT00421304|515725592|FG000|Overall Study|Withdrawal by Subject|2|||
143051123|NCT00421304|515725593|FG001|Overall Study|Withdrawal by Subject|2|||
143169114|NCT00265122|516167343|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
143169115|NCT00265122|516167344|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
143169116|NCT00265122|516167345|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
143169117|NCT00265122|516167346|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
143169118|NCT00265122|516167347|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
143169119|NCT00265122|516167348|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
143169120|NCT00265122|516167343|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
143169121|NCT00265122|516167344|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
143169122|NCT00265122|516167345|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
143169123|NCT00265122|516167346|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
143169124|NCT00265122|516167347|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
143169125|NCT00265122|516167348|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
143169126|NCT04507269|516167357|FG000|Overall Study|Withdrawal by Subject|1|||
143169127|NCT04507269|516167358|FG001|Overall Study|Withdrawal by Subject|1|||
143051124|NCT00421304|515725594|FG002|Overall Study|Withdrawal by Subject|2|||
143051125|NCT00421304|515725592|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
143051126|NCT00421304|515725593|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
143051127|NCT00421304|515725594|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
143051128|NCT00421304|515725592|FG000|Overall Study|Did not attend Day 360 visit|0|||
143169128|NCT04507269|516167359|FG002|Overall Study|Withdrawal by Subject|0|||
143169129|NCT04507269|516167360|FG003|Overall Study|Withdrawal by Subject|0|||
143499313|NCT02471716|517368572|FG001|Overall Study|Other|0|||
143051129|NCT00421304|515725593|FG001|Overall Study|Did not attend Day 360 visit|0|||
143051130|NCT00421304|515725594|FG002|Overall Study|Did not attend Day 360 visit|1|||
143051131|NCT03196284|515725595|FG000|Main Part|Withdrawal by Subject|0|||
143051132|NCT03196284|515725596|FG001|Main Part|Withdrawal by Subject|1|||
143051133|NCT03196284|515725597|FG002|Main Part|Withdrawal by Subject|0|||
143051134|NCT03196284|515725595|FG000|Extension Part|Lack of Efficacy|0|||
143051135|NCT03196284|515725596|FG001|Extension Part|Lack of Efficacy|0|||
143051136|NCT03196284|515725597|FG002|Extension Part|Lack of Efficacy|1|||
143051137|NCT03196284|515725595|FG000|Extension Part|Withdrawal by Subject|0|||
143051138|NCT03196284|515725596|FG001|Extension Part|Withdrawal by Subject|0|||
143051139|NCT03196284|515725597|FG002|Extension Part|Withdrawal by Subject|1|||
143051140|NCT03196284|515725595|FG000|Extension Part|Physician Decision|0|||
143051141|NCT03196284|515725596|FG001|Extension Part|Physician Decision|0|||
143051142|NCT03196284|515725597|FG002|Extension Part|Physician Decision|1|||
143051143|NCT01139762|515725598|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
143051144|NCT01139762|515725599|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
143051145|NCT01139762|515725600|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
143051146|NCT01139762|515725598|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
143051147|NCT01139762|515725599|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
143051148|NCT01139762|515725600|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
143051149|NCT01139762|515725598|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
143051150|NCT01139762|515725599|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
143051151|NCT01139762|515725600|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
143051152|NCT01139762|515725598|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
143051153|NCT01139762|515725599|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
143051154|NCT01139762|515725600|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
143051155|NCT01139762|515725598|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
143051156|NCT01139762|515725599|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
143051157|NCT01139762|515725600|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
143051158|NCT01139762|515725598|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
143051159|NCT01139762|515725599|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
143051160|NCT01139762|515725600|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
143051161|NCT01139762|515725598|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
143051162|NCT01139762|515725599|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
143051163|NCT01139762|515725600|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
143051164|NCT01139762|515725598|FG000|Double-Blind Randomized Active Treatment|Death|0|||
143051165|NCT01139762|515725599|FG001|Double-Blind Randomized Active Treatment|Death|1|||
143051166|NCT01139762|515725600|FG002|Double-Blind Randomized Active Treatment|Death|1|||
143051167|NCT01139762|515725598|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
143051168|NCT01139762|515725599|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
143051169|NCT01139762|515725600|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
143051170|NCT01139762|515725598|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
143051171|NCT01139762|515725599|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
143051172|NCT01139762|515725600|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
143051173|NCT01139762|515725598|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
143051174|NCT01139762|515725599|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
143051175|NCT01139762|515725600|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
143051176|NCT01139762|515725598|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
143051177|NCT01139762|515725599|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
143051178|NCT01139762|515725600|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
143051179|NCT01139762|515725598|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
143051180|NCT01139762|515725599|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
143051181|NCT01139762|515725600|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
143051182|NCT01139762|515725598|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
143051183|NCT01139762|515725599|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
143051184|NCT01139762|515725600|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
143169130|NCT04507269|516167361|FG004|Overall Study|Withdrawal by Subject|0|||
143169131|NCT04507269|516167362|FG005|Overall Study|Withdrawal by Subject|0|||
143169132|NCT04507269|516167357|FG000|Overall Study|Lost to Follow-up|0|||
143051185|NCT01139762|515725598|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
143051186|NCT01139762|515725599|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
143169133|NCT04507269|516167358|FG001|Overall Study|Lost to Follow-up|0|||
143169134|NCT04507269|516167359|FG002|Overall Study|Lost to Follow-up|0|||
143169135|NCT04507269|516167360|FG003|Overall Study|Lost to Follow-up|0|||
143169136|NCT04507269|516167361|FG004|Overall Study|Lost to Follow-up|1|||
143169137|NCT04507269|516167362|FG005|Overall Study|Lost to Follow-up|0|||
143169138|NCT05852340|516167363|FG000|Period 5|Not completing the meal|0|||
143169139|NCT05852340|516167364|FG001|Period 5|Not completing the meal|1|||
143169140|NCT05852340|516167365|FG002|Period 5|Not completing the meal|0|||
143169141|NCT05852340|516167366|FG003|Period 5|Not completing the meal|0|||
143169142|NCT05852340|516167363|FG000|Period 5|Adverse Event|0|||
143169143|NCT05852340|516167364|FG001|Period 5|Adverse Event|0|||
143051187|NCT01139762|515725600|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
143051188|NCT04750239|515725601|FG000|Overall Study|Withdrawal by Subject|2|||
143051189|NCT04750239|515725601|FG000|Overall Study|Trial terminated by sponsor|1|||
143051190|NCT00919711|515725602|FG000|Overall Study|Withdrawal by Subject|15|||
143051191|NCT00919711|515725603|FG001|Overall Study|Withdrawal by Subject|7|||
143051192|NCT00919711|515725602|FG000|Overall Study|Adverse Event|13|||
143051193|NCT00919711|515725603|FG001|Overall Study|Adverse Event|3|||
143051194|NCT00919711|515725602|FG000|Overall Study|Other|1|||
143051195|NCT00919711|515725603|FG001|Overall Study|Other|2|||
143051196|NCT00919711|515725602|FG000|Overall Study|Administrative Decision|0|||
143051197|NCT00919711|515725603|FG001|Overall Study|Administrative Decision|1|||
143051198|NCT00919711|515725602|FG000|Overall Study|Lost to Follow-up|2|||
143051199|NCT00919711|515725603|FG001|Overall Study|Lost to Follow-up|0|||
143051200|NCT00919711|515725602|FG000|Overall Study|Death|1|||
143051201|NCT00919711|515725603|FG001|Overall Study|Death|0|||
143051202|NCT00919711|515725602|FG000|Overall Study|Noncompliance|1|||
143051203|NCT00919711|515725603|FG001|Overall Study|Noncompliance|0|||
143051204|NCT01253564|515725604|FG000|Overall Study|Disease Progression|22|||
143051205|NCT01253564|515725604|FG000|Overall Study|Withdrawal by Subject|1|||
143051206|NCT01253564|515725604|FG000|Overall Study|Serious Adverse Event|1|||
143051207|NCT00762411|515727292|FG000|Initial Treatment|Death|7|||
143051208|NCT00762411|515727293|FG001|Initial Treatment|Death|6|||
143051209|NCT00762411|515727292|FG000|Initial Treatment|Adverse Event|132|||
143051210|NCT00762411|515727293|FG001|Initial Treatment|Adverse Event|40|||
143051211|NCT00762411|515727292|FG000|Initial Treatment|Protocol Violation|4|||
143051212|NCT00762411|515727293|FG001|Initial Treatment|Protocol Violation|1|||
143051213|NCT00762411|515727292|FG000|Initial Treatment|Withdrawal by Subject|65|||
143051214|NCT00762411|515727293|FG001|Initial Treatment|Withdrawal by Subject|52|||
143051215|NCT00762411|515727292|FG000|Initial Treatment|Physician Decision|1|||
143051216|NCT00762411|515727293|FG001|Initial Treatment|Physician Decision|0|||
143051217|NCT00762411|515727292|FG000|Initial Treatment|Sponsor Decision|293|||
143051218|NCT00762411|515727293|FG001|Initial Treatment|Sponsor Decision|401|||
143051219|NCT00762411|515727292|FG000|Initial Treatment|Lost to Follow-up|5|||
143051220|NCT00762411|515727293|FG001|Initial Treatment|Lost to Follow-up|0|||
143051221|NCT00762411|515727292|FG000|Initial Treatment|Caregiver Decision|21|||
143051222|NCT00762411|515727293|FG001|Initial Treatment|Caregiver Decision|16|||
143051223|NCT00762411|515727292|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
143051224|NCT00762411|515727293|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
143051225|NCT00762411|515727292|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
143051226|NCT00762411|515727293|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
143051227|NCT00762411|515727292|FG000|Delayed Start|Adverse Event|0|||
143051228|NCT00762411|515727293|FG001|Delayed Start|Adverse Event|4|||
143051229|NCT00762411|515727292|FG000|Delayed Start|Protocol Violation|0|||
143051230|NCT00762411|515727293|FG001|Delayed Start|Protocol Violation|1|||
143051231|NCT00762411|515727292|FG000|Delayed Start|Sponsor Decision|16|||
143051232|NCT00762411|515727293|FG001|Delayed Start|Sponsor Decision|20|||
143051233|NCT00762411|515727292|FG000|Delayed Start|Caregiver Decision|1|||
143051234|NCT00762411|515727293|FG001|Delayed Start|Caregiver Decision|1|||
143051235|NCT00762411|515727292|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
143051236|NCT00762411|515727293|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
143051237|NCT00762411|515727292|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
143051238|NCT00762411|515727293|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
143051239|NCT00762411|515727292|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
143051240|NCT00762411|515727293|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
143051241|NCT00762411|515727292|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
143051242|NCT00762411|515727293|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
143051243|NCT00762411|515727292|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
143051244|NCT00762411|515727293|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
143051245|NCT00762411|515727292|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
143051246|NCT00762411|515727293|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
143499314|NCT02471716|517368573|FG002|Overall Study|Other|0|||
143051247|NCT01023061|515727294|FG000|Overall Study|Withdrawal prior to treatment|2|||
143051248|NCT04590781|515727295|FG000|Overall Study|Death|0|||
143051249|NCT04590781|515727296|FG001|Overall Study|Death|2|||
143051250|NCT04590781|515727295|FG000|Overall Study|Withdrawal by Subject|2|||
143051251|NCT04590781|515727296|FG001|Overall Study|Withdrawal by Subject|0|||
143051252|NCT01680016|515727297|FG000|Overall Study|Adverse Event|0|||
143051253|NCT01680016|515727298|FG001|Overall Study|Adverse Event|0|||
143051254|NCT01680016|515727299|FG002|Overall Study|Adverse Event|1|||
143051255|NCT01680016|515727300|FG003|Overall Study|Adverse Event|4|||
143499315|NCT02471716|517368574|FG003|Overall Study|Other|8|||
143051256|NCT01680016|515727297|FG000|Overall Study|The Subject went out of The Trial|1|||
143051257|NCT01680016|515727298|FG001|Overall Study|The Subject went out of The Trial|0|||
143051258|NCT01680016|515727299|FG002|Overall Study|The Subject went out of The Trial|3|||
143051259|NCT01680016|515727300|FG003|Overall Study|The Subject went out of The Trial|0|||
143051260|NCT01680016|515727297|FG000|Overall Study|Protocol Violation|0|||
143051261|NCT01680016|515727298|FG001|Overall Study|Protocol Violation|1|||
143051262|NCT01680016|515727299|FG002|Overall Study|Protocol Violation|0|||
143051263|NCT01680016|515727300|FG003|Overall Study|Protocol Violation|0|||
143051264|NCT01680016|515727297|FG000|Overall Study|Withdrawal by Subject|5|||
143051265|NCT01680016|515727298|FG001|Overall Study|Withdrawal by Subject|7|||
143051266|NCT01680016|515727299|FG002|Overall Study|Withdrawal by Subject|1|||
143051267|NCT01680016|515727300|FG003|Overall Study|Withdrawal by Subject|1|||
143051268|NCT01662024|515727303|FG000|Overall Study|Pregnancy|2|||
143051269|NCT01662024|515727303|FG000|Overall Study|Withdrawal by Subject|3|||
143051270|NCT00442351|515727304|FG000|Overall Study|Administrative|6|||
143051271|NCT00442351|515727305|FG001|Overall Study|Administrative|5|||
143051272|NCT00442351|515727304|FG000|Overall Study|Did not meet protocol eligibility|1|||
143051273|NCT00442351|515727305|FG001|Overall Study|Did not meet protocol eligibility|0|||
143051274|NCT00442351|515727304|FG000|Overall Study|Other|0|||
143051275|NCT00442351|515727305|FG001|Overall Study|Other|1|||
143051276|NCT01813435|515727307|FG000|Overall Study|did not finish experimental regimen|1902|||
143051277|NCT01813435|515727308|FG001|Overall Study|did not finish experimental regimen|770|||
143051278|NCT01813435|515727307|FG000|Overall Study|Lost to Follow-up|268|||
143051279|NCT01813435|515727308|FG001|Overall Study|Lost to Follow-up|237|||
143051280|NCT02435433|515727309|FG000|Overall Study|Withdrawal by Subject|2|||
143051281|NCT02435433|515727310|FG001|Overall Study|Withdrawal by Subject|3|||
143051282|NCT02435433|515727311|FG002|Overall Study|Withdrawal by Subject|1|||
143051283|NCT02435433|515727312|FG003|Overall Study|Withdrawal by Subject|0|||
143051284|NCT02435433|515727313|FG004|Overall Study|Withdrawal by Subject|0|||
143051285|NCT02435433|515727309|FG000|Overall Study|Lost to Follow-up|2|||
143051286|NCT02435433|515727310|FG001|Overall Study|Lost to Follow-up|2|||
143051287|NCT02435433|515727311|FG002|Overall Study|Lost to Follow-up|4|||
143051288|NCT02435433|515727312|FG003|Overall Study|Lost to Follow-up|1|||
143051289|NCT02435433|515727313|FG004|Overall Study|Lost to Follow-up|0|||
143051290|NCT01243151|515727314|FG000|Overall Study|Adverse Event|0|||
143051291|NCT01243151|515727315|FG001|Overall Study|Adverse Event|1|||
143051292|NCT01243151|515727316|FG002|Overall Study|Adverse Event|0|||
143051293|NCT01243151|515727317|FG003|Overall Study|Adverse Event|0|||
143051294|NCT01243151|515727318|FG004|Overall Study|Adverse Event|0|||
143051295|NCT01243151|515727314|FG000|Overall Study|Protocol Violation|0|||
143051296|NCT01243151|515727315|FG001|Overall Study|Protocol Violation|0|||
143051297|NCT01243151|515727316|FG002|Overall Study|Protocol Violation|1|||
143051298|NCT01243151|515727317|FG003|Overall Study|Protocol Violation|0|||
143051299|NCT01243151|515727318|FG004|Overall Study|Protocol Violation|0|||
143051300|NCT01243151|515727314|FG000|Overall Study|Other|0|||
143051301|NCT01243151|515727315|FG001|Overall Study|Other|0|||
143051302|NCT01243151|515727316|FG002|Overall Study|Other|0|||
143051303|NCT01243151|515727317|FG003|Overall Study|Other|1|||
143051304|NCT01243151|515727318|FG004|Overall Study|Other|0|||
143051305|NCT01243151|515727314|FG000|Overall Study|Randomized but not treated|0|||
143051306|NCT01243151|515727315|FG001|Overall Study|Randomized but not treated|0|||
143051307|NCT01243151|515727316|FG002|Overall Study|Randomized but not treated|0|||
143051308|NCT01243151|515727317|FG003|Overall Study|Randomized but not treated|1|||
143051309|NCT01243151|515727318|FG004|Overall Study|Randomized but not treated|0|||
143051310|NCT00969124|515727325|FG000|Overall Study|Protocol Violation|2|||
143051311|NCT00969124|515727325|FG000|Overall Study|Inadequate bowel preparation|15|||
143051312|NCT00969124|515727325|FG000|Overall Study|Inability to reach cecum|9|||
143051313|NCT00969124|515727325|FG000|Overall Study|Previously unrecognized disease|3|||
143051314|NCT00969124|515727325|FG000|Overall Study|Technical error|1|||
143051315|NCT00687739|515727326|FG000|Overall Study|Lost to Follow-up|2|||
143051316|NCT00687739|515727327|FG001|Overall Study|Lost to Follow-up|2|||
143051317|NCT00687739|515727328|FG002|Overall Study|Lost to Follow-up|1|||
143051318|NCT00687739|515727329|FG003|Overall Study|Lost to Follow-up|2|||
143051319|NCT00687739|515727326|FG000|Overall Study|Adverse Event|0|||
143051320|NCT00687739|515727327|FG001|Overall Study|Adverse Event|1|||
143051321|NCT00687739|515727328|FG002|Overall Study|Adverse Event|1|||
143051322|NCT00687739|515727329|FG003|Overall Study|Adverse Event|0|||
143051323|NCT00210639|515727334|FG000|Overall Study|Lost to Follow-up|37|||
143051324|NCT00210639|515727335|FG001|Overall Study|Lost to Follow-up|29|||
143051325|NCT00210639|515727334|FG000|Overall Study|Withdrawal by Subject|8|||
143051326|NCT00210639|515727335|FG001|Overall Study|Withdrawal by Subject|1|||
143051327|NCT00210639|515727334|FG000|Overall Study|Other|18|||
143051328|NCT00210639|515727335|FG001|Overall Study|Other|12|||
143051329|NCT02786953|515727340|FG000|Overall Study|Withdrawal by Subject|3|||
143051330|NCT02786953|515727341|FG001|Overall Study|Withdrawal by Subject|0|||
143051331|NCT02786953|515727340|FG000|Overall Study|Physician Decision|0|||
143051332|NCT02786953|515727341|FG001|Overall Study|Physician Decision|1|||
143051333|NCT00874822|515727344|FG000|Overall Study|excluded by criteria|8|||
143051334|NCT02854800|515727345|FG000|Overall Study|Protocol Violation|16|||
143051335|NCT02854800|515727346|FG001|Overall Study|Protocol Violation|11|||
143051336|NCT02854800|515727347|FG002|Overall Study|Protocol Violation|3|||
143051337|NCT02854800|515727345|FG000|Overall Study|Withdrawal by Subject|4|||
143051338|NCT02854800|515727346|FG001|Overall Study|Withdrawal by Subject|2|||
143051339|NCT02854800|515727347|FG002|Overall Study|Withdrawal by Subject|3|||
143051340|NCT03073798|515727356|FG000|Overall Study|Adverse Event|1|||
143051341|NCT03073798|515727356|FG000|Overall Study|Withdrawal by Subject|1|||
143051342|NCT01186458|515727357|FG000|Overall Study|Adverse Event|1|||
143051343|NCT00323258|515727358|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
143051344|NCT00323258|515727359|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
143051345|NCT00323258|515727358|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
143051346|NCT00323258|515727359|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
143051347|NCT00323258|515727358|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
143051348|NCT00323258|515727359|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
143051349|NCT00323258|515727358|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
143051350|NCT00323258|515727359|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
143051351|NCT00323258|515727358|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
143051352|NCT00323258|515727359|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
143051353|NCT00323258|515727358|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
143051354|NCT00323258|515727359|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
143051355|NCT00323258|515727358|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
143051356|NCT00323258|515727359|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
143051357|NCT00728754|515727360|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
143051358|NCT00728754|515727361|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
143051359|NCT00728754|515727360|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
143051360|NCT00728754|515727361|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
143051361|NCT00728754|515727360|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
143051362|NCT00728754|515727361|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
143051363|NCT01859598|515727362|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
143051364|NCT00573313|515727367|FG000|Overall Study|Protocol Violation|5|||
143051365|NCT00573313|515727368|FG001|Overall Study|Protocol Violation|0|||
143051366|NCT00573313|515727369|FG002|Overall Study|Protocol Violation|6|||
143051367|NCT00573313|515727370|FG003|Overall Study|Protocol Violation|0|||
143051368|NCT03255980|515727371|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
143051369|NCT03255980|515727372|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
143051370|NCT03255980|515727373|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
143051371|NCT03255980|515727374|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
143051372|NCT03255980|515727371|FG000|Overall Study|Adverse Event|1|||
143051373|NCT03255980|515727372|FG001|Overall Study|Adverse Event|1|||
143051374|NCT03255980|515727373|FG002|Overall Study|Adverse Event|0|||
143051375|NCT03255980|515727374|FG003|Overall Study|Adverse Event|1|||
143051376|NCT03255980|515727371|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
143051377|NCT03255980|515727372|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
143051378|NCT03255980|515727373|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
143051379|NCT03255980|515727374|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
143051380|NCT03255980|515727371|FG000|Overall Study|Lost to Follow-up|1|||
143051381|NCT03255980|515727372|FG001|Overall Study|Lost to Follow-up|1|||
143051382|NCT03255980|515727373|FG002|Overall Study|Lost to Follow-up|0|||
143051383|NCT03255980|515727374|FG003|Overall Study|Lost to Follow-up|3|||
143051384|NCT03255980|515727371|FG000|Overall Study|Withdrawal by Subject|0|||
143051385|NCT03255980|515727372|FG001|Overall Study|Withdrawal by Subject|1|||
143051386|NCT03255980|515727373|FG002|Overall Study|Withdrawal by Subject|0|||
143051387|NCT03255980|515727374|FG003|Overall Study|Withdrawal by Subject|3|||
143051388|NCT02611362|515727375|FG000|Overall Study|Withdrawal by Subject|7|||
143051389|NCT02611362|515727376|FG001|Overall Study|Withdrawal by Subject|2|||
143051390|NCT02611362|515727375|FG000|Overall Study|Lost to Follow-up|2|||
143051391|NCT02611362|515727376|FG001|Overall Study|Lost to Follow-up|4|||
143051392|NCT00354159|515727377|FG000|Randomized Study Period|Withdrawal by Subject|5|||
143051393|NCT00354159|515727378|FG001|Randomized Study Period|Withdrawal by Subject|3|||
143051394|NCT00354159|515727377|FG000|Randomized Study Period|Physician Decision|6|||
143051395|NCT00354159|515727378|FG001|Randomized Study Period|Physician Decision|10|||
143051396|NCT00354159|515727377|FG000|Randomized Study Period|Lost to Follow-up|4|||
143051397|NCT00354159|515727378|FG001|Randomized Study Period|Lost to Follow-up|0|||
143244712|NCT05019521|516448100|FG004|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
143051398|NCT00354159|515727377|FG000|Randomized Study Period|Death|7|||
143051399|NCT00354159|515727378|FG001|Randomized Study Period|Death|9|||
143051400|NCT00354159|515727377|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
143051401|NCT00354159|515727378|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
143051402|NCT00354159|515727377|FG000|Long-term Follow-up|Physician Decision|127|||
143051403|NCT00354159|515727378|FG001|Long-term Follow-up|Physician Decision|122|||
143051404|NCT00354159|515727377|FG000|Long-term Follow-up|Lost to Follow-up|1|||
143051405|NCT00354159|515727378|FG001|Long-term Follow-up|Lost to Follow-up|0|||
143051406|NCT00354159|515727377|FG000|Long-term Follow-up|Death|14|||
143051407|NCT00354159|515727378|FG001|Long-term Follow-up|Death|11|||
143051408|NCT00354159|515727377|FG000|Long-term Follow-up|Study Closed|29|||
143051409|NCT00354159|515727378|FG001|Long-term Follow-up|Study Closed|34|||
143051410|NCT02229084|515727380|FG000|Overall Study|Adverse Event|1|||
143051411|NCT02229084|515727381|FG001|Overall Study|Adverse Event|0|||
143051412|NCT02229084|515727382|FG002|Overall Study|Adverse Event|0|||
143051413|NCT02229084|515727383|FG003|Overall Study|Adverse Event|0|||
143051414|NCT02229084|515727384|FG004|Overall Study|Adverse Event|0|||
143051415|NCT02229084|515727385|FG005|Overall Study|Adverse Event|0|||
143051416|NCT02229084|515727386|FG006|Overall Study|Adverse Event|0|||
143051417|NCT02229084|515727380|FG000|Overall Study|Lost to Follow-up|0|||
143051418|NCT02229084|515727381|FG001|Overall Study|Lost to Follow-up|0|||
143051419|NCT02229084|515727382|FG002|Overall Study|Lost to Follow-up|1|||
143051420|NCT02229084|515727383|FG003|Overall Study|Lost to Follow-up|1|||
143051421|NCT02229084|515727384|FG004|Overall Study|Lost to Follow-up|0|||
143051422|NCT02229084|515727385|FG005|Overall Study|Lost to Follow-up|0|||
143051423|NCT02229084|515727386|FG006|Overall Study|Lost to Follow-up|1|||
143051424|NCT02229084|515727380|FG000|Overall Study|Physician Decision|0|||
143051425|NCT02229084|515727381|FG001|Overall Study|Physician Decision|0|||
143051426|NCT02229084|515727382|FG002|Overall Study|Physician Decision|0|||
143051427|NCT02229084|515727383|FG003|Overall Study|Physician Decision|1|||
143051428|NCT02229084|515727384|FG004|Overall Study|Physician Decision|3|||
143051429|NCT02229084|515727385|FG005|Overall Study|Physician Decision|0|||
143051430|NCT02229084|515727386|FG006|Overall Study|Physician Decision|1|||
143051431|NCT02229084|515727380|FG000|Overall Study|Withdrawal by Subject|0|||
143051432|NCT02229084|515727381|FG001|Overall Study|Withdrawal by Subject|0|||
143051433|NCT02229084|515727382|FG002|Overall Study|Withdrawal by Subject|1|||
143051434|NCT02229084|515727383|FG003|Overall Study|Withdrawal by Subject|0|||
143051435|NCT02229084|515727384|FG004|Overall Study|Withdrawal by Subject|1|||
143051436|NCT02229084|515727385|FG005|Overall Study|Withdrawal by Subject|1|||
143051437|NCT02229084|515727386|FG006|Overall Study|Withdrawal by Subject|1|||
143051438|NCT02229084|515727380|FG000|Overall Study|Death|0|||
143051439|NCT02229084|515727381|FG001|Overall Study|Death|0|||
143051440|NCT02229084|515727382|FG002|Overall Study|Death|0|||
143051441|NCT02229084|515727383|FG003|Overall Study|Death|0|||
143051442|NCT02229084|515727384|FG004|Overall Study|Death|0|||
143051443|NCT02229084|515727385|FG005|Overall Study|Death|0|||
143051444|NCT02229084|515727386|FG006|Overall Study|Death|1|||
143051445|NCT01532908|515727389|FG000|Overall Study|Not Transplanted|1|||
143051446|NCT01532908|515727390|FG001|Overall Study|Not Transplanted|0|||
143051447|NCT01559116|515727391|FG000|Overall Study|Adverse Event|10|||
143051448|NCT01559116|515727391|FG000|Overall Study|Lack of Efficacy|1|||
143051449|NCT01559116|515727391|FG000|Overall Study|Lost to Follow-up|1|||
143051450|NCT01559116|515727391|FG000|Overall Study|Protocol Violation|1|||
143051451|NCT01559116|515727391|FG000|Overall Study|Withdrawal by Subject|4|||
143051452|NCT01559116|515727391|FG000|Overall Study|other than stated above|9|||
143051453|NCT03480022|515727396|FG000|Overall Study|Pregnancy|2|||
143051454|NCT03480022|515727397|FG001|Overall Study|Pregnancy|0|||
143051455|NCT03480022|515727396|FG000|Overall Study|Adverse Event|6|||
143051456|NCT03480022|515727397|FG001|Overall Study|Adverse Event|0|||
143169144|NCT05852340|516167365|FG002|Period 5|Adverse Event|0|||
143169145|NCT05852340|516167366|FG003|Period 5|Adverse Event|1|||
143169146|NCT00071032|516167368|FG000|Overall Study|Lost to Follow-up|1|||
143169147|NCT00071032|516167369|FG001|Overall Study|Lost to Follow-up|1|||
143169148|NCT00071032|516167368|FG000|Overall Study|Withdrawal by Subject|8|||
143169149|NCT00071032|516167369|FG001|Overall Study|Withdrawal by Subject|6|||
143169150|NCT00071032|516167368|FG000|Overall Study|Missing Primary Outcome|0|||
143169151|NCT00071032|516167369|FG001|Overall Study|Missing Primary Outcome|1|||
143169152|NCT05852470|516167370|FG000|Overall Study|Withdrawal by Subject|0|||
143169153|NCT05852470|516167371|FG001|Overall Study|Withdrawal by Subject|1|||
143169154|NCT06071104|516167372|FG000|Overall Study|Non-ocular and non-device related adverse event|1|||
143169155|NCT01903863|516167373|FG000|Overall Study|Physician Decision|2|||
143051457|NCT03480022|515727396|FG000|Overall Study|Lack of Efficacy|0|||
143051458|NCT03480022|515727397|FG001|Overall Study|Lack of Efficacy|2|||
143051459|NCT03480022|515727396|FG000|Overall Study|Physician Decision|0|||
143051460|NCT03480022|515727397|FG001|Overall Study|Physician Decision|1|||
143051461|NCT03480022|515727396|FG000|Overall Study|Withdrawal by Subject|2|||
143051462|NCT03480022|515727397|FG001|Overall Study|Withdrawal by Subject|0|||
143169156|NCT01903863|516167374|FG001|Overall Study|Physician Decision|0|||
143169157|NCT05185453|516167383|FG000|Overall Study|Lost to Follow-up|13|||
143169158|NCT05185453|516167384|FG001|Overall Study|Lost to Follow-up|3|||
143169159|NCT03537508|516167397|FG000|Overall Study|Adverse Event|2|||
143051463|NCT03480022|515727396|FG000|Overall Study|Medication concerns|1|||
143051464|NCT03480022|515727397|FG001|Overall Study|Medication concerns|0|||
143051465|NCT03480022|515727396|FG000|Overall Study|Family member COVID exposure|0|||
143051466|NCT03480022|515727397|FG001|Overall Study|Family member COVID exposure|1|||
143051467|NCT00881569|515727398|FG000|Overall Study|Disease progression|1|||
143051468|NCT00881569|515727399|FG001|Overall Study|Disease progression|1|||
143051469|NCT03277248|515727404|FG000|Overall Study|Adverse Event|3|||
143051470|NCT03277248|515727405|FG001|Overall Study|Adverse Event|1|||
143051471|NCT03277248|515727404|FG000|Overall Study|Subject Withdrawal of Consent|6|||
143051472|NCT03277248|515727405|FG001|Overall Study|Subject Withdrawal of Consent|23|||
143051473|NCT03277248|515727404|FG000|Overall Study|Investigator/Sponsor Decision|2|||
143051474|NCT03277248|515727405|FG001|Overall Study|Investigator/Sponsor Decision|2|||
143051475|NCT03277248|515727404|FG000|Overall Study|Pregnancy|4|||
143051476|NCT03277248|515727405|FG001|Overall Study|Pregnancy|1|||
143051477|NCT03277248|515727404|FG000|Overall Study|Lost to Follow-up|0|||
143051478|NCT03277248|515727405|FG001|Overall Study|Lost to Follow-up|2|||
143051479|NCT03277248|515727404|FG000|Overall Study|Lack of Efficacy|0|||
143051480|NCT03277248|515727405|FG001|Overall Study|Lack of Efficacy|2|||
143051481|NCT03277248|515727404|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
143051482|NCT03277248|515727405|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
143051483|NCT01824498|515727412|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
143051484|NCT01824498|515727413|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
143051485|NCT01824498|515727414|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
143051486|NCT01824498|515727415|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
143051487|NCT01824498|515727416|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
143051488|NCT01824498|515727417|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
143051489|NCT03980522|515727421|FG000|Treatment Period|Adverse Event|1|||
143051490|NCT03980522|515727422|FG001|Treatment Period|Adverse Event|0|||
143051491|NCT03980522|515727423|FG002|Treatment Period|Adverse Event|0|||
143051492|NCT03980522|515727424|FG003|Treatment Period|Adverse Event|0|||
143051493|NCT03980522|515727425|FG004|Treatment Period|Adverse Event|0|||
143051494|NCT01874535|515727428|FG000|Overall Study|Lost to Follow-up|10|||
143051495|NCT01874535|515727429|FG001|Overall Study|Lost to Follow-up|9|||
143051496|NCT01874535|515727428|FG000|Overall Study|incomplete symptom resolution|45|||
143051497|NCT01874535|515727429|FG001|Overall Study|incomplete symptom resolution|35|||
143051498|NCT01215721|515727430|FG000|Overall Study|Adverse Event|2|||
143051499|NCT00045162|515727431|FG000|Overall Study|Ineligible|12|||
143051500|NCT00045162|515727432|FG001|Overall Study|Ineligible|8|||
143051501|NCT00045162|515727431|FG000|Overall Study|Not treated|7|||
143051502|NCT00045162|515727432|FG001|Overall Study|Not treated|2|||
143051503|NCT00045162|515727431|FG000|Overall Study|Adverse Event|55|||
143051504|NCT00045162|515727432|FG001|Overall Study|Adverse Event|50|||
143051505|NCT00045162|515727431|FG000|Overall Study|Lack of Efficacy|32|||
143051506|NCT00045162|515727432|FG001|Overall Study|Lack of Efficacy|29|||
143051507|NCT00045162|515727431|FG000|Overall Study|Death|10|||
143051508|NCT00045162|515727432|FG001|Overall Study|Death|10|||
143051509|NCT00045162|515727431|FG000|Overall Study|Withdrawal by Subject|5|||
143051510|NCT00045162|515727432|FG001|Overall Study|Withdrawal by Subject|3|||
143051511|NCT00045162|515727431|FG000|Overall Study|Other|21|||
143244713|NCT05019521|516448101|FG005|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
143244714|NCT05019521|516448102|FG006|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
143244715|NCT05019521|516448096|FG000|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
143244716|NCT05019521|516448097|FG001|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
143244717|NCT05019521|516448098|FG002|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
143244718|NCT05019521|516448099|FG003|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
143244719|NCT05019521|516448100|FG004|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
143244720|NCT05019521|516448101|FG005|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
143244721|NCT05019521|516448102|FG006|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
143244722|NCT05019521|516448096|FG000|Primary Evaluation Period (52 Weeks)|Death|0|||
143244723|NCT05019521|516448097|FG001|Primary Evaluation Period (52 Weeks)|Death|1|||
143244724|NCT05019521|516448098|FG002|Primary Evaluation Period (52 Weeks)|Death|0|||
143244725|NCT05019521|516448099|FG003|Primary Evaluation Period (52 Weeks)|Death|3|||
143244726|NCT05019521|516448100|FG004|Primary Evaluation Period (52 Weeks)|Death|0|||
143244727|NCT05019521|516448101|FG005|Primary Evaluation Period (52 Weeks)|Death|0|||
143244728|NCT05019521|516448102|FG006|Primary Evaluation Period (52 Weeks)|Death|0|||
143244729|NCT05019521|516448096|FG000|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
143244730|NCT05019521|516448097|FG001|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
143244731|NCT05019521|516448098|FG002|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
143244732|NCT05019521|516448099|FG003|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
143051512|NCT00045162|515727432|FG001|Overall Study|Other|16|||
143051513|NCT01044433|515727433|FG000|Overall Study|Lost to Follow-up|3|||
143051514|NCT01044433|515727433|FG000|Overall Study|Withdrawal by Subject|3|||
143051515|NCT01971554|515727436|FG000|Overall Study|Lost to Follow-up|1|||
143051516|NCT01971554|515727437|FG001|Overall Study|Lost to Follow-up|0|||
143051517|NCT01971554|515727438|FG002|Overall Study|Lost to Follow-up|0|||
143244733|NCT05019521|516448100|FG004|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
143051518|NCT01971554|515727439|FG003|Overall Study|Lost to Follow-up|0|||
143051519|NCT00494013|515727440|FG000|Overall Study|Adverse Event|0|||
143051520|NCT00494013|515727441|FG001|Overall Study|Adverse Event|1|||
143051521|NCT00494013|515727440|FG000|Overall Study|Entry Criteria Not Met|1|||
143051522|NCT00494013|515727441|FG001|Overall Study|Entry Criteria Not Met|4|||
143051523|NCT00494013|515727440|FG000|Overall Study|Lost to Follow-up|5|||
143051524|NCT00494013|515727441|FG001|Overall Study|Lost to Follow-up|6|||
143051525|NCT00494013|515727440|FG000|Overall Study|Physician Decision|3|||
143051526|NCT00494013|515727441|FG001|Overall Study|Physician Decision|5|||
143051527|NCT00494013|515727440|FG000|Overall Study|Protocol Violation|8|||
143051528|NCT00494013|515727441|FG001|Overall Study|Protocol Violation|5|||
143051529|NCT00494013|515727440|FG000|Overall Study|Withdrawal by Subject|13|||
143051530|NCT00494013|515727441|FG001|Overall Study|Withdrawal by Subject|14|||
143051531|NCT00494013|515727440|FG000|Overall Study|Sponsor Decision|0|||
143051532|NCT00494013|515727441|FG001|Overall Study|Sponsor Decision|1|||
143051533|NCT04203823|515727442|FG000|Overall Study|Withdrawal by Subject|2|||
143051534|NCT04203823|515727443|FG001|Overall Study|Withdrawal by Subject|2|||
143051535|NCT04203823|515727442|FG000|Overall Study|Adverse Event|1|||
143051536|NCT04203823|515727443|FG001|Overall Study|Adverse Event|1|||
143051537|NCT04203823|515727442|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
143051538|NCT04203823|515727443|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
143051539|NCT01675596|515727444|FG000|Overall Study|Death|6|||
143051540|NCT01675596|515727444|FG000|Overall Study|Exit with other reason|1|||
143051541|NCT01675596|515727444|FG000|Overall Study|Missed Visit|1|||
143244734|NCT05019521|516448101|FG005|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
143244735|NCT05019521|516448102|FG006|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
143244736|NCT05019521|516448096|FG000|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
143244737|NCT05019521|516448097|FG001|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
143244738|NCT05019521|516448098|FG002|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
143244739|NCT05019521|516448099|FG003|Primary Evaluation Period (52 Weeks)|Other Than Specified|2|||
143244740|NCT05019521|516448100|FG004|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
143244741|NCT05019521|516448101|FG005|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
143244742|NCT05019521|516448102|FG006|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
143244743|NCT05019521|516448096|FG000|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
143244744|NCT05019521|516448097|FG001|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
143244745|NCT05019521|516448098|FG002|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
143244746|NCT05019521|516448099|FG003|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
143244747|NCT05019521|516448100|FG004|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
143051542|NCT02614196|515727445|FG000|Double Blind Treatment Phase|Adverse Event|8|||
143051543|NCT02614196|515727446|FG001|Double Blind Treatment Phase|Adverse Event|5|||
143051544|NCT02614196|515727447|FG002|Double Blind Treatment Phase|Adverse Event|9|||
143051545|NCT02614196|515727448|FG003|Double Blind Treatment Phase|Adverse Event|0|||
143051546|NCT02614196|515727449|FG004|Double Blind Treatment Phase|Adverse Event|0|||
143051547|NCT02614196|515727450|FG005|Double Blind Treatment Phase|Adverse Event|0|||
143051548|NCT02614196|515727445|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
143051549|NCT02614196|515727446|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
143051550|NCT02614196|515727447|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
143051551|NCT02614196|515727448|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
143051552|NCT02614196|515727449|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
143051553|NCT02614196|515727450|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
143051554|NCT02614196|515727445|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
143051555|NCT02614196|515727446|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
143051556|NCT02614196|515727447|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
143051557|NCT02614196|515727448|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
143051558|NCT02614196|515727449|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
143051559|NCT02614196|515727450|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
143051560|NCT02614196|515727445|FG000|Double Blind Treatment Phase|Physician Decision|4|||
143051561|NCT02614196|515727446|FG001|Double Blind Treatment Phase|Physician Decision|0|||
143051562|NCT02614196|515727447|FG002|Double Blind Treatment Phase|Physician Decision|2|||
143051563|NCT02614196|515727448|FG003|Double Blind Treatment Phase|Physician Decision|0|||
143051564|NCT02614196|515727449|FG004|Double Blind Treatment Phase|Physician Decision|0|||
143051565|NCT02614196|515727450|FG005|Double Blind Treatment Phase|Physician Decision|0|||
143051566|NCT02614196|515727445|FG000|Double Blind Treatment Phase|Pregnancy|1|||
143051567|NCT02614196|515727446|FG001|Double Blind Treatment Phase|Pregnancy|2|||
143051568|NCT02614196|515727447|FG002|Double Blind Treatment Phase|Pregnancy|0|||
143244748|NCT05019521|516448101|FG005|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
143499316|NCT02471716|517368575|FG004|Overall Study|Other|9|||
143499317|NCT00508391|517368583|FG000|First Treatment|Withdrawal by Subject|6|||
143051569|NCT02614196|515727448|FG003|Double Blind Treatment Phase|Pregnancy|0|||
143051570|NCT02614196|515727449|FG004|Double Blind Treatment Phase|Pregnancy|0|||
143051571|NCT02614196|515727450|FG005|Double Blind Treatment Phase|Pregnancy|0|||
143051572|NCT02614196|515727445|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
143051573|NCT02614196|515727446|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
143051574|NCT02614196|515727447|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
143051575|NCT02614196|515727448|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
143244749|NCT05019521|516448102|FG006|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
143244750|NCT05019521|516448096|FG000|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
143051576|NCT02614196|515727449|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
143051577|NCT02614196|515727450|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
143051578|NCT02614196|515727445|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
143051579|NCT02614196|515727446|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
143051580|NCT02614196|515727447|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
143051581|NCT02614196|515727448|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
143051582|NCT02614196|515727449|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
143051583|NCT02614196|515727450|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
143051584|NCT02614196|515727445|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
143051585|NCT02614196|515727446|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
143051586|NCT02614196|515727447|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
143051587|NCT02614196|515727448|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
143051588|NCT02614196|515727449|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
143051589|NCT02614196|515727450|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
143051590|NCT02614196|515727445|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
143051591|NCT02614196|515727446|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
143051592|NCT02614196|515727447|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
143051593|NCT02614196|515727448|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
143051594|NCT02614196|515727449|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
143051595|NCT02614196|515727450|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
143051596|NCT02614196|515727445|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
143051597|NCT02614196|515727446|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
143051598|NCT02614196|515727447|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
143051599|NCT02614196|515727448|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
143051600|NCT02614196|515727449|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
143051601|NCT02614196|515727450|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
143051602|NCT02614196|515727445|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
143051603|NCT02614196|515727446|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
143051604|NCT02614196|515727447|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
143051605|NCT02614196|515727448|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
143051606|NCT02614196|515727449|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
143051607|NCT02614196|515727450|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
143051608|NCT02614196|515727445|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
143051609|NCT02614196|515727446|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
143051610|NCT02614196|515727447|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
143051611|NCT02614196|515727448|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
143051612|NCT02614196|515727449|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
143051613|NCT02614196|515727450|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
143051614|NCT02614196|515727445|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
143051615|NCT02614196|515727446|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
143051616|NCT02614196|515727447|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
143051617|NCT02614196|515727448|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
143051618|NCT02614196|515727449|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
143051619|NCT02614196|515727450|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
143051620|NCT01520987|515729056|FG000|Overall Study|Withdrawal by Subject|1|||
143051621|NCT01520987|515729057|FG001|Overall Study|Withdrawal by Subject|0|||
143051622|NCT01520987|515729058|FG002|Overall Study|Withdrawal by Subject|0|||
143051623|NCT01520987|515729059|FG003|Overall Study|Withdrawal by Subject|0|||
143051624|NCT01520987|515729060|FG004|Overall Study|Withdrawal by Subject|0|||
143051625|NCT01520987|515729061|FG005|Overall Study|Withdrawal by Subject|1|||
143051626|NCT01520987|515729062|FG006|Overall Study|Withdrawal by Subject|0|||
143244751|NCT05019521|516448097|FG001|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
143244752|NCT05019521|516448098|FG002|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
143244753|NCT05019521|516448099|FG003|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
143499318|NCT00508391|517368584|FG001|First Treatment|Withdrawal by Subject|3|||
143499319|NCT00508391|517368583|FG000|Second Treatment|Withdrawal by Subject|2|||
143499320|NCT00508391|517368584|FG001|Second Treatment|Withdrawal by Subject|0|||
143051627|NCT01520987|515729063|FG007|Overall Study|Withdrawal by Subject|0|||
143051628|NCT02005562|515729064|FG000|Overall Study|Death|2|||
143051629|NCT02005562|515729065|FG001|Overall Study|Death|2|||
143051630|NCT02005562|515729064|FG000|Overall Study|Graft loss|7|||
143499321|NCT02921425|517368585|FG000|Overall Study|Protocol Violation|9|||
143051631|NCT02005562|515729065|FG001|Overall Study|Graft loss|6|||
143051632|NCT02005562|515729064|FG000|Overall Study|Withdrawal by Subject|2|||
143051633|NCT02005562|515729065|FG001|Overall Study|Withdrawal by Subject|2|||
143051634|NCT02005562|515729064|FG000|Overall Study|No transplant|1|||
143051635|NCT02005562|515729065|FG001|Overall Study|No transplant|4|||
143051636|NCT02005562|515729064|FG000|Overall Study|Physician Decision|0|||
143051637|NCT02005562|515729065|FG001|Overall Study|Physician Decision|1|||
143051638|NCT04729101|515729066|FG000|Overall Study|Adverse Event|1|||
143051639|NCT04729101|515729067|FG001|Overall Study|Adverse Event|0|||
143051640|NCT04729101|515729066|FG000|Overall Study|Physician Decision|1|||
143051641|NCT04729101|515729067|FG001|Overall Study|Physician Decision|0|||
143051642|NCT04729101|515729066|FG000|Overall Study|Withdrawal by Subject|1|||
143051643|NCT04729101|515729067|FG001|Overall Study|Withdrawal by Subject|0|||
143051644|NCT02940522|515729068|FG000|Overall Study|Lost to Follow-up|1|||
143051645|NCT02940522|515729069|FG001|Overall Study|Lost to Follow-up|2|||
143051646|NCT02940522|515729068|FG000|Overall Study|Withdrawal by Subject|1|||
143051647|NCT02940522|515729069|FG001|Overall Study|Withdrawal by Subject|0|||
143051648|NCT00274625|515729070|FG000|Overall Study|Lost to Follow-up|46|||
143051649|NCT00274625|515729071|FG001|Overall Study|Lost to Follow-up|54|||
143051650|NCT00274625|515729070|FG000|Overall Study|Excluded from analysis|14|||
143051651|NCT00274625|515729071|FG001|Overall Study|Excluded from analysis|8|||
143051652|NCT02710214|515729075|FG000|Overall Study|Lost to Follow-up|1|||
143051653|NCT02710214|515729076|FG001|Overall Study|Lost to Follow-up|0|||
143051654|NCT02710214|515729075|FG000|Overall Study|Lack of Efficacy|0|||
143051655|NCT02710214|515729076|FG001|Overall Study|Lack of Efficacy|1|||
143051656|NCT02710214|515729075|FG000|Overall Study|Death|0|||
143051657|NCT02710214|515729076|FG001|Overall Study|Death|1|||
143051658|NCT01754376|515729077|FG000|Overall Study|Adverse Event|1|||
143051659|NCT01754376|515729077|FG000|Overall Study|Lack of Efficacy|2|||
143051660|NCT00544167|515729078|FG000|Overall Study|Adverse Event|21|||
143051661|NCT00544167|515729078|FG000|Overall Study|Physician Decision|8|||
143051662|NCT00735696|515729087|FG000|Overall Study|Withdrawal by Subject|1|||
143051663|NCT00735696|515729087|FG000|Overall Study|Enrolled but never Treated|1|||
143051664|NCT02274558|515729090|FG000|Overall Study|Adverse Event|2|||
143051665|NCT02274558|515729091|FG001|Overall Study|Adverse Event|4|||
143051666|NCT02274558|515729092|FG002|Overall Study|Adverse Event|2|||
143051667|NCT02274558|515729090|FG000|Overall Study|Non-compliance|2|||
143051668|NCT02274558|515729091|FG001|Overall Study|Non-compliance|1|||
143051669|NCT02274558|515729092|FG002|Overall Study|Non-compliance|0|||
143051670|NCT02274558|515729090|FG000|Overall Study|Withdrawal by Subject|1|||
143051671|NCT02274558|515729091|FG001|Overall Study|Withdrawal by Subject|5|||
143051672|NCT02274558|515729092|FG002|Overall Study|Withdrawal by Subject|4|||
143051673|NCT02274558|515729090|FG000|Overall Study|Death|0|||
143051674|NCT02274558|515729091|FG001|Overall Study|Death|0|||
143051675|NCT02274558|515729092|FG002|Overall Study|Death|1|||
143051676|NCT02274558|515729090|FG000|Overall Study|Lost to Follow-up|2|||
143051677|NCT02274558|515729091|FG001|Overall Study|Lost to Follow-up|1|||
143051678|NCT02274558|515729092|FG002|Overall Study|Lost to Follow-up|1|||
143051679|NCT02274558|515729090|FG000|Overall Study|Physician Decision|0|||
143051680|NCT02274558|515729091|FG001|Overall Study|Physician Decision|2|||
143051681|NCT02274558|515729092|FG002|Overall Study|Physician Decision|1|||
143051682|NCT02655224|515729093|FG000|Overall Study|Adverse Event|1|||
143051683|NCT02655224|515729094|FG001|Overall Study|Adverse Event|1|||
143051684|NCT02733627|515729101|FG000|Overall Study|Adverse Event|0|||
143051685|NCT02733627|515729102|FG001|Overall Study|Adverse Event|1|||
143051686|NCT02733627|515729103|FG002|Overall Study|Adverse Event|1|||
143169160|NCT03537508|516167398|FG001|Overall Study|Adverse Event|1|||
143169161|NCT03537508|516167397|FG000|Overall Study|Protocol Violation|65|||
143169162|NCT03537508|516167398|FG001|Overall Study|Protocol Violation|48|||
143169163|NCT03537508|516167397|FG000|Overall Study|Lost to Follow-up|86|||
143169164|NCT03537508|516167398|FG001|Overall Study|Lost to Follow-up|60|||
143169165|NCT03537508|516167397|FG000|Overall Study|Withdrawal by parent/guardian|263|||
143169166|NCT03537508|516167398|FG001|Overall Study|Withdrawal by parent/guardian|149|||
143169167|NCT01972659|516167399|FG000|Overall Study|Protocol Violation|2|||
143169168|NCT01972659|516167400|FG001|Overall Study|Protocol Violation|2|||
143169169|NCT01972659|516167399|FG000|Overall Study|problems realted to acceleromyograph|2|||
143169170|NCT01972659|516167400|FG001|Overall Study|problems realted to acceleromyograph|1|||
143169171|NCT05715827|516167405|FG000|Overall Study|Physician Decision|0|||
143169172|NCT05715827|516167406|FG001|Overall Study|Physician Decision|1|||
143051687|NCT02733627|515729104|FG003|Overall Study|Adverse Event|0|||
143051688|NCT02733627|515729101|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
143051689|NCT02733627|515729102|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
143051690|NCT02733627|515729103|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
143051691|NCT02733627|515729104|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
143051692|NCT00059332|515729105|FG000|Overall Study|Withdrawal by Subject|2|||
143051693|NCT00059332|515729106|FG001|Overall Study|Withdrawal by Subject|1|||
143051694|NCT00059332|515729105|FG000|Overall Study|Lost to Follow-up|1|||
143051695|NCT00059332|515729106|FG001|Overall Study|Lost to Follow-up|1|||
143051696|NCT01119625|515729107|FG000|Overall Study|Lost to Follow-up|1|||
143051697|NCT01119625|515729108|FG001|Overall Study|Lost to Follow-up|2|||
143051698|NCT01119625|515729107|FG000|Overall Study|Withdrawal by Subject|2|||
143051699|NCT01119625|515729108|FG001|Overall Study|Withdrawal by Subject|1|||
143169173|NCT05715827|516167405|FG000|Overall Study|console communication error|0|||
143051700|NCT01119625|515729107|FG000|Overall Study|Other|0|||
143051701|NCT01119625|515729108|FG001|Overall Study|Other|1|||
143051702|NCT01721772|515729109|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
143051703|NCT01721772|515729110|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
143051704|NCT01721772|515729109|FG000|Pre-Treatment|Poor/non-compliance|0|||
143051705|NCT01721772|515729110|FG001|Pre-Treatment|Poor/non-compliance|1|||
143051706|NCT01721772|515729109|FG000|Pre-Treatment|Participant withdrew consent|0|||
143051707|NCT01721772|515729110|FG001|Pre-Treatment|Participant withdrew consent|1|||
143051708|NCT01721772|515729109|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
143051709|NCT01721772|515729110|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
143051710|NCT01721772|515729109|FG000|Treatment|Disease progression|119|||
143051711|NCT01721772|515729110|FG001|Treatment|Disease progression|168|||
143051712|NCT01721772|515729109|FG000|Treatment|Study drug toxicity|19|||
143051713|NCT01721772|515729110|FG001|Treatment|Study drug toxicity|10|||
143051714|NCT01721772|515729109|FG000|Treatment|Adverse event unrelated to study drug|7|||
143051715|NCT01721772|515729110|FG001|Treatment|Adverse event unrelated to study drug|7|||
143051716|NCT01721772|515729109|FG000|Treatment|Maximum clinical benefit|16|||
143051717|NCT01721772|515729110|FG001|Treatment|Maximum clinical benefit|4|||
143051718|NCT01721772|515729109|FG000|Treatment|Other|19|||
143051719|NCT01721772|515729110|FG001|Treatment|Other|2|||
143051720|NCT01721772|515729109|FG000|Treatment|Participant withdrew consent|2|||
143051721|NCT01721772|515729110|FG001|Treatment|Participant withdrew consent|5|||
143051722|NCT01721772|515729109|FG000|Treatment|Participant request to discontinue study treatment|21|||
143051723|NCT01721772|515729110|FG001|Treatment|Participant request to discontinue study treatment|8|||
143051724|NCT01721772|515729109|FG000|Treatment|Death|1|||
143051725|NCT01721772|515729110|FG001|Treatment|Death|0|||
143051726|NCT01721772|515729109|FG000|Treatment|Not reported|1|||
143051727|NCT01721772|515729110|FG001|Treatment|Not reported|0|||
143051728|NCT01721772|515729109|FG000|Treatment|Poor/non-compliance|1|||
143051729|NCT01721772|515729110|FG001|Treatment|Poor/non-compliance|0|||
143051730|NCT01721772|515729109|FG000|Treatment|Lost to Follow-up|0|||
143051731|NCT01721772|515729110|FG001|Treatment|Lost to Follow-up|1|||
143051732|NCT04542694|515729111|FG000|Overall Study|The need for prohibited therapy|2|||
143051733|NCT04542694|515729112|FG001|Overall Study|The need for prohibited therapy|0|||
143051734|NCT04542694|515729111|FG000|Overall Study|Adverse Event|1|||
143051735|NCT04542694|515729112|FG001|Overall Study|Adverse Event|0|||
143051736|NCT04542694|515729111|FG000|Overall Study|Protocol Violation|1|||
143051737|NCT04542694|515729112|FG001|Overall Study|Protocol Violation|0|||
143051738|NCT00397254|515729115|FG000|Overall Study|Lost to Follow-up|2|||
143051739|NCT00397254|515729116|FG001|Overall Study|Lost to Follow-up|2|||
143051740|NCT02627963|515729119|FG000|Overall Study|Randomized but not treated|2|||
143051741|NCT02627963|515729120|FG001|Overall Study|Randomized but not treated|6|||
143051742|NCT04281472|515729121|FG000|Stage A|Lack of Efficacy|8|||
143051743|NCT04281472|515729122|FG001|Stage A|Lack of Efficacy|0|||
143051744|NCT04281472|515729123|FG002|Stage A|Lack of Efficacy|0|||
143051745|NCT04281472|515729121|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
143051746|NCT04281472|515729122|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
143051747|NCT04281472|515729123|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
143051748|NCT04281472|515729121|FG000|Stage A|Adverse Event|20|||
143051749|NCT04281472|515729122|FG001|Stage A|Adverse Event|0|||
143051750|NCT04281472|515729123|FG002|Stage A|Adverse Event|0|||
143051751|NCT04281472|515729121|FG000|Stage A|Death|1|||
143051752|NCT04281472|515729122|FG001|Stage A|Death|0|||
143051753|NCT04281472|515729123|FG002|Stage A|Death|0|||
143051754|NCT04281472|515729121|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
143051755|NCT04281472|515729122|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
143051756|NCT04281472|515729123|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
143051757|NCT04281472|515729121|FG000|Stage A|Lost to Follow-up|2|||
143051758|NCT04281472|515729122|FG001|Stage A|Lost to Follow-up|0|||
143051759|NCT04281472|515729123|FG002|Stage A|Lost to Follow-up|0|||
143051760|NCT04281472|515729121|FG000|Stage A|Non-compliance with study drug|1|||
143051761|NCT04281472|515729122|FG001|Stage A|Non-compliance with study drug|0|||
143051762|NCT04281472|515729123|FG002|Stage A|Non-compliance with study drug|0|||
143051763|NCT04281472|515729121|FG000|Stage A|Physician Decision|1|||
143051764|NCT04281472|515729122|FG001|Stage A|Physician Decision|0|||
143051765|NCT04281472|515729123|FG002|Stage A|Physician Decision|0|||
143051766|NCT04281472|515729121|FG000|Stage A|Prohibited medications|2|||
143051767|NCT04281472|515729122|FG001|Stage A|Prohibited medications|0|||
143051768|NCT04281472|515729123|FG002|Stage A|Prohibited medications|0|||
143051769|NCT04281472|515729121|FG000|Stage A|Withdrawal by Subject|11|||
143051770|NCT04281472|515729122|FG001|Stage A|Withdrawal by Subject|0|||
143051771|NCT04281472|515729123|FG002|Stage A|Withdrawal by Subject|0|||
143051772|NCT04281472|515729121|FG000|Stage A|Other|5|||
143051773|NCT04281472|515729122|FG001|Stage A|Other|0|||
143051774|NCT04281472|515729123|FG002|Stage A|Other|0|||
143051775|NCT04281472|515729121|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
143114947|NCT02326298|515962468|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
143499322|NCT01609842|517368589|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
143051776|NCT04281472|515729122|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
143051777|NCT04281472|515729123|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
143051778|NCT04281472|515729121|FG000|Stage B|Adverse Event|0|||
143051779|NCT04281472|515729122|FG001|Stage B|Adverse Event|3|||
143051780|NCT04281472|515729123|FG002|Stage B|Adverse Event|0|||
143051781|NCT04281472|515729121|FG000|Stage B|Death|0|||
143051782|NCT04281472|515729122|FG001|Stage B|Death|0|||
143051783|NCT04281472|515729123|FG002|Stage B|Death|1|||
143051784|NCT04281472|515729121|FG000|Stage B|Lack of Efficacy|0|||
143051785|NCT04281472|515729122|FG001|Stage B|Lack of Efficacy|0|||
143051786|NCT04281472|515729123|FG002|Stage B|Lack of Efficacy|1|||
143051787|NCT04281472|515729121|FG000|Stage B|Lost to Follow-up|0|||
143051788|NCT04281472|515729122|FG001|Stage B|Lost to Follow-up|0|||
143051789|NCT04281472|515729123|FG002|Stage B|Lost to Follow-up|2|||
143051790|NCT04281472|515729121|FG000|Stage B|Prohibited medications|0|||
143051791|NCT04281472|515729122|FG001|Stage B|Prohibited medications|2|||
143051792|NCT04281472|515729123|FG002|Stage B|Prohibited medications|1|||
143051793|NCT04281472|515729121|FG000|Stage B|Protocol Violation|0|||
143051794|NCT04281472|515729122|FG001|Stage B|Protocol Violation|1|||
143051795|NCT04281472|515729123|FG002|Stage B|Protocol Violation|1|||
143051796|NCT04281472|515729121|FG000|Stage B|Sponsor decision|0|||
143051797|NCT04281472|515729122|FG001|Stage B|Sponsor decision|0|||
143051798|NCT04281472|515729123|FG002|Stage B|Sponsor decision|1|||
143051799|NCT04281472|515729121|FG000|Stage B|Withdrawal by Subject|0|||
143051800|NCT04281472|515729122|FG001|Stage B|Withdrawal by Subject|3|||
143051801|NCT04281472|515729123|FG002|Stage B|Withdrawal by Subject|3|||
143051802|NCT04281472|515729121|FG000|Stage B|Other|0|||
143051803|NCT04281472|515729122|FG001|Stage B|Other|3|||
143051804|NCT04281472|515729123|FG002|Stage B|Other|0|||
143051805|NCT00152451|515729124|FG000|Overall Study|Adverse Event|4|||
143051806|NCT04697173|515729130|FG000|Overall Study|Withdrawal by Subject|34|||
143051807|NCT04697173|515729131|FG001|Overall Study|Withdrawal by Subject|38|||
143051808|NCT02372006|515729132|FG000|Overall Study|Progressive disease|8|||
143051809|NCT02372006|515729133|FG001|Overall Study|Progressive disease|7|||
143051810|NCT02372006|515729134|FG002|Overall Study|Progressive disease|34|||
143051811|NCT02372006|515729132|FG000|Overall Study|Dose limiting toxicity|0|||
143051812|NCT02372006|515729133|FG001|Overall Study|Dose limiting toxicity|1|||
143051813|NCT02372006|515729134|FG002|Overall Study|Dose limiting toxicity|0|||
143051814|NCT02372006|515729132|FG000|Overall Study|Adverse Event|0|||
143051815|NCT02372006|515729133|FG001|Overall Study|Adverse Event|0|||
143051816|NCT02372006|515729134|FG002|Overall Study|Adverse Event|3|||
143051817|NCT02372006|515729132|FG000|Overall Study|Withdrawal by Subject|0|||
143051818|NCT02372006|515729133|FG001|Overall Study|Withdrawal by Subject|1|||
143051819|NCT02372006|515729134|FG002|Overall Study|Withdrawal by Subject|1|||
143051820|NCT02372006|515729132|FG000|Overall Study|Other reason for not completing|0|||
143051821|NCT02372006|515729133|FG001|Overall Study|Other reason for not completing|0|||
143051822|NCT02372006|515729134|FG002|Overall Study|Other reason for not completing|1|||
143051823|NCT01055834|515729138|FG000|Treatment Period I|Adverse Event|1|||
143051824|NCT01055834|515729139|FG001|Treatment Period I|Adverse Event|0|||
143051825|NCT05004649|515729140|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
143169174|NCT05715827|516167406|FG001|Overall Study|console communication error|1|||
143169175|NCT00835367|516167422|FG000|Washout|Adverse Event|2|||
143169176|NCT00835367|516167423|FG001|Washout|Adverse Event|0|||
143169177|NCT00835367|516167422|FG000|Washout|Withdrawal by Subject|1|||
143169178|NCT00835367|516167423|FG001|Washout|Withdrawal by Subject|0|||
143169179|NCT00835367|516167422|FG000|Second Intervention|Adverse Event|1|||
143169180|NCT00835367|516167423|FG001|Second Intervention|Adverse Event|1|||
143169181|NCT04890509|516167424|FG000|Overall Study|Death|4|||
143169182|NCT04890509|516167425|FG001|Overall Study|Death|4|||
143169183|NCT04569084|516167426|FG000|Overall Study|Adverse Event|10|||
143169184|NCT04569084|516167427|FG001|Overall Study|Adverse Event|14|||
143169185|NCT04569084|516167426|FG000|Overall Study|Death|2|||
143244754|NCT05019521|516448100|FG004|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
143051826|NCT05004649|515729140|FG000|Overall Study|Lost to Follow-up|1|||
143051827|NCT05004649|515729140|FG000|Overall Study|Withdrawal by Subject|2|||
143051828|NCT05004649|515729140|FG000|Overall Study|COVID-19|1|||
143051829|NCT01717313|515729141|FG000|Phase A (Weeks 0 to 24)|Death|0|||
143051830|NCT01717313|515729142|FG001|Phase A (Weeks 0 to 24)|Death|1|||
143051831|NCT01717313|515729141|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
143051832|NCT01717313|515729142|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
143051833|NCT01717313|515729141|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
143051834|NCT01717313|515729142|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
143051835|NCT01717313|515729141|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
143051836|NCT01717313|515729142|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
143051837|NCT01717313|515729141|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
143051838|NCT01717313|515729142|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
143169186|NCT04569084|516167427|FG001|Overall Study|Death|3|||
143169187|NCT04569084|516167426|FG000|Overall Study|Lost to Follow-up|1|||
143244755|NCT05019521|516448101|FG005|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
143244756|NCT05019521|516448102|FG006|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
143244757|NCT05019521|516448096|FG000|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|3|||
143244758|NCT05019521|516448097|FG001|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
143244759|NCT05019521|516448098|FG002|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
143244760|NCT05019521|516448099|FG003|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
143244761|NCT05019521|516448100|FG004|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|5|||
143244762|NCT05019521|516448101|FG005|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
143244763|NCT05019521|516448102|FG006|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
143244764|NCT05019521|516448096|FG000|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
143244765|NCT05019521|516448097|FG001|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|1|||
143244766|NCT05019521|516448098|FG002|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|2|||
143244767|NCT05019521|516448099|FG003|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
143244768|NCT05019521|516448100|FG004|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
143244769|NCT05019521|516448101|FG005|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
143244770|NCT05019521|516448102|FG006|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
143244771|NCT05019521|516448096|FG000|Secondary Evaluation Period (52 Weeks)|Death|0|||
143244772|NCT05019521|516448097|FG001|Secondary Evaluation Period (52 Weeks)|Death|1|||
143244773|NCT05019521|516448098|FG002|Secondary Evaluation Period (52 Weeks)|Death|1|||
143244774|NCT05019521|516448099|FG003|Secondary Evaluation Period (52 Weeks)|Death|0|||
143244775|NCT05019521|516448100|FG004|Secondary Evaluation Period (52 Weeks)|Death|1|||
143244776|NCT05019521|516448101|FG005|Secondary Evaluation Period (52 Weeks)|Death|0|||
143244777|NCT05019521|516448102|FG006|Secondary Evaluation Period (52 Weeks)|Death|0|||
143244778|NCT05019521|516448096|FG000|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
143244779|NCT05019521|516448097|FG001|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
143244780|NCT05019521|516448098|FG002|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
143244781|NCT05019521|516448099|FG003|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
143244782|NCT05019521|516448100|FG004|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
143244783|NCT05019521|516448101|FG005|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
143244784|NCT05019521|516448102|FG006|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
143244785|NCT05019521|516448096|FG000|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
143244786|NCT05019521|516448097|FG001|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
143244787|NCT05019521|516448098|FG002|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
143244788|NCT05019521|516448099|FG003|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
143244789|NCT05019521|516448100|FG004|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
143244790|NCT05019521|516448101|FG005|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
143244791|NCT05019521|516448102|FG006|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
143244792|NCT05019521|516448096|FG000|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|49|||
143244793|NCT05019521|516448097|FG001|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|45|||
143244794|NCT05019521|516448098|FG002|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|53|||
143244795|NCT05019521|516448099|FG003|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|0|||
143244796|NCT05019521|516448100|FG004|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|13|||
143244797|NCT05019521|516448101|FG005|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|17|||
143244798|NCT05019521|516448102|FG006|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|14|||
143244799|NCT00885534|516448103|FG000|Overall Study|Patient deemed ineligible|1|||
143244800|NCT02453711|516448104|FG000|Overall Study|Withdrawal by Subject|5|||
143244801|NCT02453711|516448105|FG001|Overall Study|Withdrawal by Subject|4|||
143244802|NCT02453711|516448106|FG002|Overall Study|Withdrawal by Subject|6|||
143244803|NCT02453711|516448107|FG003|Overall Study|Withdrawal by Subject|4|||
143244804|NCT02453711|516448108|FG004|Overall Study|Withdrawal by Subject|1|||
143244805|NCT02453711|516448109|FG005|Overall Study|Withdrawal by Subject|1|||
143499323|NCT01609842|517368590|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
143499324|NCT01356589|517368591|FG000|Overall Study|Enrolled, but not treated|3|||
143051839|NCT01717313|515729141|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
143051840|NCT01717313|515729142|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
143051841|NCT01717313|515729141|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
143051842|NCT01717313|515729142|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
143051843|NCT01717313|515729141|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
143051844|NCT01717313|515729142|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
143051845|NCT01717313|515729141|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
143051846|NCT01717313|515729142|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
143051847|NCT04133311|515729144|FG000|Period 1 Double Masked Treatment Period|Death|1|||
143051848|NCT04133311|515729145|FG001|Period 1 Double Masked Treatment Period|Death|0|||
143499325|NCT01356589|517368591|FG000|Overall Study|Dose data not recorded|2|||
143051849|NCT04133311|515729146|FG002|Period 1 Double Masked Treatment Period|Death|0|||
143051850|NCT04133311|515729147|FG003|Period 1 Double Masked Treatment Period|Death|0|||
143051851|NCT04133311|515729144|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
143051852|NCT04133311|515729145|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
143051853|NCT04133311|515729146|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
143244806|NCT02453711|516448110|FG006|Overall Study|Withdrawal by Subject|0|||
143244807|NCT02453711|516448111|FG007|Overall Study|Withdrawal by Subject|1|||
143051854|NCT04133311|515729147|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
143051855|NCT04133311|515729144|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
143051856|NCT04133311|515729145|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
143051857|NCT04133311|515729146|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
143051858|NCT04133311|515729147|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
143051859|NCT04133311|515729144|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
143051860|NCT04133311|515729145|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
143051861|NCT04133311|515729146|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
143051862|NCT04133311|515729147|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
143051863|NCT04133311|515729144|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
143051864|NCT04133311|515729145|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
143051865|NCT04133311|515729146|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
143051866|NCT04133311|515729147|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
143051867|NCT04133311|515729144|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
143051868|NCT04133311|515729145|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
143051869|NCT04133311|515729146|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
143051870|NCT04133311|515729147|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
143051871|NCT04133311|515729144|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
143051872|NCT04133311|515729145|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
143051873|NCT04133311|515729146|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
143051874|NCT04133311|515729147|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
143051875|NCT04133311|515729144|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
143051876|NCT04133311|515729145|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
143051877|NCT04133311|515729146|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
143051878|NCT04133311|515729147|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
143051879|NCT03885934|515729153|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
143051880|NCT03885934|515729154|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
143051881|NCT03885934|515729155|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
143051882|NCT03885934|515729156|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
143051883|NCT03885934|515729157|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
143051884|NCT03885934|515729158|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
143051885|NCT04473326|515729159|FG000|Overall Study|Death|0|||
143051886|NCT04473326|515729160|FG001|Overall Study|Death|1|||
143051887|NCT04473326|515729159|FG000|Overall Study|Withdrawal by Subject|1|||
143051888|NCT04473326|515729160|FG001|Overall Study|Withdrawal by Subject|2|||
143051889|NCT04610580|515729173|FG000|Two-way Crossover Period|Adverse Event|1|||
143051890|NCT04610580|515729174|FG001|Two-way Crossover Period|Adverse Event|0|||
143051891|NCT04610580|515729175|FG002|Two-way Crossover Period|Adverse Event|0|||
143051892|NCT04610580|515729176|FG003|Two-way Crossover Period|Adverse Event|0|||
143051893|NCT04610580|515729177|FG004|Two-way Crossover Period|Adverse Event|0|||
143051894|NCT04610580|515729178|FG005|Two-way Crossover Period|Adverse Event|0|||
143169188|NCT04569084|516167427|FG001|Overall Study|Lost to Follow-up|1|||
143169189|NCT04569084|516167426|FG000|Overall Study|Physician Decision|3|||
143169190|NCT04569084|516167427|FG001|Overall Study|Physician Decision|3|||
143169191|NCT04569084|516167426|FG000|Overall Study|Protocol Violation|2|||
143169192|NCT04569084|516167427|FG001|Overall Study|Protocol Violation|1|||
143169193|NCT04569084|516167426|FG000|Overall Study|Withdrawal by Subject|20|||
143169194|NCT04569084|516167427|FG001|Overall Study|Withdrawal by Subject|21|||
143169195|NCT04569084|516167426|FG000|Overall Study|Study terminated by sponsor|26|||
143169196|NCT04569084|516167427|FG001|Overall Study|Study terminated by sponsor|23|||
143169197|NCT04569084|516167426|FG000|Overall Study|Other|3|||
143169198|NCT04569084|516167427|FG001|Overall Study|Other|5|||
143169199|NCT00618787|516167429|FG000|Overall Study|Adverse Event|0|||
143169200|NCT00618787|516167430|FG001|Overall Study|Adverse Event|1|||
143169201|NCT00618787|516167429|FG000|Overall Study|Withdrawal by Subject|2|||
143169202|NCT00618787|516167430|FG001|Overall Study|Withdrawal by Subject|1|||
143169203|NCT00618787|516167429|FG000|Overall Study|Lost to Follow-up|1|||
143169204|NCT00618787|516167430|FG001|Overall Study|Lost to Follow-up|0|||
143169205|NCT01107886|516167431|FG000|Overall Study|Lost to Follow-up|15|||
143169206|NCT01107886|516167432|FG001|Overall Study|Lost to Follow-up|13|||
143169207|NCT01107886|516167431|FG000|Overall Study|Withdrawal by Subject|180|||
143169208|NCT01107886|516167432|FG001|Overall Study|Withdrawal by Subject|196|||
143169209|NCT01107886|516167431|FG000|Overall Study|Administrative withdrawal of consent|7|||
143051895|NCT04610580|515729173|FG000|Two-way Crossover Period|Physician Decision|1|||
143051896|NCT04610580|515729174|FG001|Two-way Crossover Period|Physician Decision|0|||
143051897|NCT04610580|515729175|FG002|Two-way Crossover Period|Physician Decision|0|||
143051898|NCT04610580|515729176|FG003|Two-way Crossover Period|Physician Decision|0|||
143051899|NCT04610580|515729177|FG004|Two-way Crossover Period|Physician Decision|0|||
143051900|NCT04610580|515729178|FG005|Two-way Crossover Period|Physician Decision|0|||
143051901|NCT04610580|515729173|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
143051902|NCT04610580|515729174|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
143051903|NCT04610580|515729175|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
143051904|NCT04610580|515729176|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
143051905|NCT04610580|515729177|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
143051906|NCT04610580|515729178|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
143051907|NCT04610580|515729173|FG000|Two-way Crossover Period|Other than specified|0|||
143051908|NCT04610580|515729174|FG001|Two-way Crossover Period|Other than specified|1|||
143051909|NCT04610580|515729175|FG002|Two-way Crossover Period|Other than specified|0|||
143051910|NCT04610580|515729176|FG003|Two-way Crossover Period|Other than specified|0|||
143051911|NCT04610580|515729177|FG004|Two-way Crossover Period|Other than specified|0|||
143051912|NCT04610580|515729178|FG005|Two-way Crossover Period|Other than specified|0|||
143051913|NCT04610580|515729173|FG000|Washout Before Extension Period|Other than specified|0|||
143051914|NCT04610580|515729174|FG001|Washout Before Extension Period|Other than specified|1|||
143051915|NCT04610580|515729175|FG002|Washout Before Extension Period|Other than specified|0|||
143051916|NCT04610580|515729176|FG003|Washout Before Extension Period|Other than specified|0|||
143051917|NCT04610580|515729177|FG004|Washout Before Extension Period|Other than specified|0|||
143051918|NCT04610580|515729178|FG005|Washout Before Extension Period|Other than specified|0|||
143051919|NCT04610580|515729173|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
143051920|NCT04610580|515729174|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
143051921|NCT04610580|515729175|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
143051922|NCT04610580|515729176|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
143051923|NCT04610580|515729177|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
143051924|NCT04610580|515729178|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
143051925|NCT04610580|515729173|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
143051926|NCT04610580|515729174|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
143051927|NCT04610580|515729175|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
143051928|NCT04610580|515729176|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
143169210|NCT01107886|516167432|FG001|Overall Study|Administrative withdrawal of consent|5|||
143051929|NCT04610580|515729177|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
143051930|NCT04610580|515729178|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
143169211|NCT02776735|516167433|FG000|Overall Study|Adverse Event|0|||
143169212|NCT02776735|516167434|FG001|Overall Study|Adverse Event|0|||
143169213|NCT02776735|516167435|FG002|Overall Study|Adverse Event|0|||
143169214|NCT02776735|516167436|FG003|Overall Study|Adverse Event|1|||
143169215|NCT02776735|516167437|FG004|Overall Study|Adverse Event|0|||
143169216|NCT02776735|516167438|FG005|Overall Study|Adverse Event|1|||
143169217|NCT02776735|516167433|FG000|Overall Study|Lost to Follow-up|0|||
143169218|NCT02776735|516167434|FG001|Overall Study|Lost to Follow-up|0|||
143169219|NCT02776735|516167435|FG002|Overall Study|Lost to Follow-up|0|||
143169220|NCT02776735|516167436|FG003|Overall Study|Lost to Follow-up|1|||
143169221|NCT02776735|516167437|FG004|Overall Study|Lost to Follow-up|0|||
143169222|NCT02776735|516167438|FG005|Overall Study|Lost to Follow-up|0|||
143244808|NCT02453711|516448112|FG008|Overall Study|Withdrawal by Subject|7|||
143244809|NCT02453711|516448104|FG000|Overall Study|Lost to Follow-up|5|||
143244810|NCT02453711|516448105|FG001|Overall Study|Lost to Follow-up|3|||
143244811|NCT02453711|516448106|FG002|Overall Study|Lost to Follow-up|2|||
143244812|NCT02453711|516448107|FG003|Overall Study|Lost to Follow-up|3|||
143244813|NCT02453711|516448108|FG004|Overall Study|Lost to Follow-up|1|||
143244814|NCT02453711|516448109|FG005|Overall Study|Lost to Follow-up|5|||
143244815|NCT02453711|516448110|FG006|Overall Study|Lost to Follow-up|2|||
143244816|NCT02453711|516448111|FG007|Overall Study|Lost to Follow-up|6|||
143244817|NCT02453711|516448112|FG008|Overall Study|Lost to Follow-up|6|||
143244818|NCT02453711|516448104|FG000|Overall Study|Death|0|||
143244819|NCT02453711|516448105|FG001|Overall Study|Death|0|||
143244820|NCT02453711|516448106|FG002|Overall Study|Death|0|||
143244821|NCT02453711|516448107|FG003|Overall Study|Death|0|||
143244822|NCT02453711|516448108|FG004|Overall Study|Death|0|||
143051931|NCT02179190|515729179|FG000|Enrollment|Exit Prior to Device Attempt|11|||
143051932|NCT02179190|515729179|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
143169223|NCT02776735|516167433|FG000|Overall Study|Withdrawal by parent/guardian|0|||
143244823|NCT02453711|516448109|FG005|Overall Study|Death|0|||
143051933|NCT02179190|515729179|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
143169224|NCT02776735|516167434|FG001|Overall Study|Withdrawal by parent/guardian|0|||
143169225|NCT02776735|516167435|FG002|Overall Study|Withdrawal by parent/guardian|2|||
143244824|NCT02453711|516448110|FG006|Overall Study|Death|1|||
143244825|NCT02453711|516448111|FG007|Overall Study|Death|0|||
143051934|NCT02179190|515729179|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
143051935|NCT02179190|515729179|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
143051936|NCT02179190|515729179|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
143051937|NCT01993940|515729180|FG000|Overall Study|Adverse Event|16|||
143051938|NCT01993940|515729181|FG001|Overall Study|Adverse Event|11|||
143051939|NCT01993940|515729180|FG000|Overall Study|Withdrawal by Subject|15|||
143051940|NCT01993940|515729181|FG001|Overall Study|Withdrawal by Subject|19|||
143051941|NCT01993940|515729180|FG000|Overall Study|Lost to Follow-up|2|||
143051942|NCT01993940|515729181|FG001|Overall Study|Lost to Follow-up|5|||
143051943|NCT01993940|515729180|FG000|Overall Study|Protocol Violation|5|||
143051944|NCT01993940|515729181|FG001|Overall Study|Protocol Violation|8|||
143051945|NCT01993940|515729180|FG000|Overall Study|Death|1|||
143051946|NCT01993940|515729181|FG001|Overall Study|Death|0|||
143051947|NCT01993940|515729180|FG000|Overall Study|Other - Miscellaneous|1|||
143051948|NCT01993940|515729181|FG001|Overall Study|Other - Miscellaneous|1|||
143051949|NCT04164758|515729186|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
143051950|NCT04164758|515729187|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
143051951|NCT04164758|515729188|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
143051952|NCT04164758|515729186|FG000|Overall Study|Adverse Event|0|||
143051953|NCT04164758|515729187|FG001|Overall Study|Adverse Event|1|||
143051954|NCT04164758|515729188|FG002|Overall Study|Adverse Event|0|||
143051955|NCT01670097|515729189|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
143051956|NCT01670097|515729190|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
143051957|NCT01670097|515729189|FG000|Overall Study|Study burden|1|||
143051958|NCT01670097|515729190|FG001|Overall Study|Study burden|0|||
143051959|NCT01670097|515729189|FG000|Overall Study|COPD exacerbation|0|||
143051960|NCT01670097|515729190|FG001|Overall Study|COPD exacerbation|1|||
143051961|NCT01670097|515729189|FG000|Overall Study|Neutropenia|0|||
143051962|NCT01670097|515729190|FG001|Overall Study|Neutropenia|1|||
143051963|NCT01670097|515729189|FG000|Overall Study|Clinical deterioration|0|||
143051964|NCT01670097|515729190|FG001|Overall Study|Clinical deterioration|1|||
143051965|NCT01670097|515729189|FG000|Overall Study|Disease progression|0|||
143051966|NCT01670097|515729190|FG001|Overall Study|Disease progression|1|||
143051967|NCT03259165|515729191|FG000|Overall Study|COVID 19 pandemic|1|||
143051968|NCT03259165|515729192|FG001|Overall Study|COVID 19 pandemic|1|||
143051969|NCT01949532|515729195|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
143051970|NCT01949532|515729196|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
143051971|NCT03732833|515729201|FG000|Overall Study|Adverse Event|0|||
143051972|NCT03732833|515729202|FG001|Overall Study|Adverse Event|3|||
143051973|NCT03732833|515729203|FG002|Overall Study|Adverse Event|1|||
143169226|NCT02776735|516167436|FG003|Overall Study|Withdrawal by parent/guardian|2|||
143169227|NCT02776735|516167437|FG004|Overall Study|Withdrawal by parent/guardian|0|||
143169228|NCT02776735|516167438|FG005|Overall Study|Withdrawal by parent/guardian|0|||
143169229|NCT02776735|516167433|FG000|Overall Study|Withdrawal by Subject|1|||
143169230|NCT02776735|516167434|FG001|Overall Study|Withdrawal by Subject|0|||
143499326|NCT04343651|517368592|FG000|Overall Study|Physician Decision|2|||
143499327|NCT04343651|517368593|FG001|Overall Study|Physician Decision|1|||
143499328|NCT04343651|517368592|FG000|Overall Study|Lost to Follow-up|2|||
143499329|NCT04343651|517368593|FG001|Overall Study|Lost to Follow-up|1|||
143051974|NCT03732833|515729201|FG000|Overall Study|Withdrawal by Subject|11|||
143169231|NCT02776735|516167435|FG002|Overall Study|Withdrawal by Subject|0|||
143169232|NCT02776735|516167436|FG003|Overall Study|Withdrawal by Subject|0|||
143169233|NCT02776735|516167437|FG004|Overall Study|Withdrawal by Subject|0|||
143169234|NCT02776735|516167438|FG005|Overall Study|Withdrawal by Subject|1|||
143169235|NCT02776735|516167433|FG000|Overall Study|Other|0|||
143169236|NCT02776735|516167434|FG001|Overall Study|Other|0|||
143169237|NCT02776735|516167435|FG002|Overall Study|Other|3|||
143169238|NCT02776735|516167436|FG003|Overall Study|Other|0|||
143169239|NCT02776735|516167437|FG004|Overall Study|Other|0|||
143169240|NCT02776735|516167438|FG005|Overall Study|Other|0|||
143169241|NCT03759379|516169811|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
143169242|NCT03759379|516169812|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
143499330|NCT04343651|517368592|FG000|Overall Study|Protocol Violation|4|||
143499331|NCT04343651|517368593|FG001|Overall Study|Protocol Violation|6|||
143169243|NCT03759379|516169811|FG000|Treatment Period|Death|2|||
143169244|NCT03759379|516169812|FG001|Treatment Period|Death|3|||
143169245|NCT03759379|516169811|FG000|Treatment Period|Lost to Follow-up|1|||
143051975|NCT03732833|515729202|FG001|Overall Study|Withdrawal by Subject|13|||
143051976|NCT03732833|515729203|FG002|Overall Study|Withdrawal by Subject|8|||
143051977|NCT03732833|515729201|FG000|Overall Study|Lost to Follow-up|3|||
143051978|NCT03732833|515729202|FG001|Overall Study|Lost to Follow-up|5|||
143051979|NCT03732833|515729203|FG002|Overall Study|Lost to Follow-up|4|||
143051980|NCT03732833|515729201|FG000|Overall Study|Pregnancy|0|||
143051981|NCT03732833|515729202|FG001|Overall Study|Pregnancy|2|||
143051982|NCT03732833|515729203|FG002|Overall Study|Pregnancy|0|||
143051983|NCT03732833|515729201|FG000|Overall Study|Physician Decision|2|||
143051984|NCT03732833|515729202|FG001|Overall Study|Physician Decision|3|||
143169246|NCT03759379|516169812|FG001|Treatment Period|Lost to Follow-up|0|||
143051985|NCT03732833|515729203|FG002|Overall Study|Physician Decision|1|||
143051986|NCT03732833|515729201|FG000|Overall Study|Covid-19 related and other reasons|2|||
143051987|NCT03732833|515729202|FG001|Overall Study|Covid-19 related and other reasons|7|||
143051988|NCT03732833|515729203|FG002|Overall Study|Covid-19 related and other reasons|3|||
143051989|NCT05665387|515729204|FG000|Overall Study|Withdrawal by Subject|1|||
143051990|NCT05665387|515729205|FG001|Overall Study|Withdrawal by Subject|0|||
143051991|NCT05665387|515729206|FG002|Overall Study|Withdrawal by Subject|1|||
143051992|NCT02311894|515729207|FG000|Overall Study|Discontinued in error|1|||
143051993|NCT02311894|515729207|FG000|Overall Study|Lost to Follow-up|1|||
143051994|NCT02311894|515729207|FG000|Overall Study|Adverse Event|1|||
143051995|NCT02311894|515729207|FG000|Overall Study|Withdrawal by Subject|1|||
143051996|NCT00884390|515729208|FG000|Overall Study|Adverse Event|0|||
143051997|NCT00884390|515729209|FG001|Overall Study|Adverse Event|1|||
143051998|NCT00884390|515729208|FG000|Overall Study|Lost to Follow-up|0|||
143051999|NCT00884390|515729209|FG001|Overall Study|Lost to Follow-up|1|||
143052000|NCT00884390|515729208|FG000|Overall Study|Physician Decision|2|||
143052001|NCT00884390|515729209|FG001|Overall Study|Physician Decision|1|||
143052002|NCT00884390|515729208|FG000|Overall Study|Protocol Violation|4|||
143052003|NCT00884390|515729209|FG001|Overall Study|Protocol Violation|1|||
143052004|NCT00884390|515729208|FG000|Overall Study|Withdrawal by Subject|4|||
143052005|NCT00884390|515729209|FG001|Overall Study|Withdrawal by Subject|1|||
143052006|NCT00884390|515729208|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
143052007|NCT00884390|515729209|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
143052008|NCT00884390|515729208|FG000|Overall Study|Other|11|||
143052009|NCT00884390|515729209|FG001|Overall Study|Other|1|||
143052010|NCT00751023|515729210|FG000|Overall Study|Lost to Follow-up|11|||
143052011|NCT00751023|515729211|FG001|Overall Study|Lost to Follow-up|7|||
143052012|NCT01691612|515729212|FG000|Overall Study|deemed ineligible after 1st visit|6|||
143052013|NCT01691612|515729212|FG000|Overall Study|Adverse Event|1|||
143052014|NCT02623218|515729214|FG000|Overall Study|Lost to Follow-up|0|||
143052015|NCT02623218|515729215|FG001|Overall Study|Lost to Follow-up|1|||
143052016|NCT02623218|515729216|FG002|Overall Study|Lost to Follow-up|0|||
143052017|NCT02623218|515729217|FG003|Overall Study|Lost to Follow-up|0|||
143052018|NCT02623218|515729218|FG004|Overall Study|Lost to Follow-up|0|||
143052019|NCT00826241|515729223|FG000|Overall Study|Withdrawal from Follow-up|1|||
143052020|NCT00826241|515729223|FG000|Overall Study|Withdrew consent|2|||
143052021|NCT00826241|515729223|FG000|Overall Study|Death|4|||
143052022|NCT00826241|515729223|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
143052023|NCT00826241|515729223|FG000|Overall Study|Non-compliance|1|||
143052024|NCT00826241|515729223|FG000|Overall Study|Progression of disease|1|||
143052025|NCT00826241|515729223|FG000|Overall Study|Patient refused follow-up|3|||
143052026|NCT00826241|515729223|FG000|Overall Study|Lost to Follow-up|9|||
143052027|NCT00826241|515729223|FG000|Overall Study|Could not obtain records|1|||
143052028|NCT00826241|515729223|FG000|Overall Study|Screen failure|2|||
143052029|NCT00826241|515729223|FG000|Overall Study|Pt unable to proceed to registration|1|||
143052030|NCT00826241|515729223|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
143052031|NCT00024258|515729226|FG000|Overall Study|Withdrawal by Subject|1|||
143052032|NCT00024258|515729226|FG000|Overall Study|Disease Progression|8|||
143052033|NCT00950300|515729227|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
143499332|NCT04343651|517368592|FG000|Overall Study|Missing|3|||
143499333|NCT04343651|517368593|FG001|Overall Study|Missing|9|||
143499334|NCT04343651|517368592|FG000|Overall Study|Withdrawal by Subject|0|||
143499335|NCT04343651|517368593|FG001|Overall Study|Withdrawal by Subject|4|||
143499336|NCT04343651|517368592|FG000|Overall Study|Death|0|||
143499337|NCT04343651|517368593|FG001|Overall Study|Death|1|||
143499338|NCT04343651|517368592|FG000|Overall Study|Did not start treatment|1|||
143499339|NCT04343651|517368593|FG001|Overall Study|Did not start treatment|1|||
143499340|NCT04343651|517368592|FG000|Overall Study|Patient did not complete visits 3-6|0|||
143499341|NCT04343651|517368593|FG001|Overall Study|Patient did not complete visits 3-6|1|||
143052034|NCT00950300|515729228|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
143052035|NCT00950300|515729227|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
143052036|NCT00950300|515729228|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
143052037|NCT00950300|515729227|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
143052038|NCT00950300|515729228|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
143052039|NCT00950300|515729227|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
143052040|NCT00950300|515729228|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
143052041|NCT00950300|515729227|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
143052042|NCT00950300|515729228|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
143052043|NCT00950300|515729227|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
143052044|NCT00950300|515729228|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
143499342|NCT01445678|517368594|FG000|Overall Study|Adverse Event|12|||
143499343|NCT01445678|517368595|FG001|Overall Study|Adverse Event|8|||
143052045|NCT00950300|515729227|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
143052046|NCT00950300|515729228|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
143052047|NCT00950300|515729227|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
143052048|NCT00950300|515729228|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
143052049|NCT00950300|515729227|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
143052050|NCT00950300|515729228|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
143052051|NCT00950300|515729227|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
143052052|NCT00950300|515729228|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
143052053|NCT00950300|515729227|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
143052054|NCT00950300|515729228|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
143052055|NCT00950300|515729227|FG000|TFFU Period|Death|4|||
143052056|NCT00950300|515729228|FG001|TFFU Period|Death|1|||
143052057|NCT00950300|515729227|FG000|TFFU Period|Refused Treatment|10|||
143052058|NCT00950300|515729228|FG001|TFFU Period|Refused Treatment|11|||
143499344|NCT01445678|517368594|FG000|Overall Study|Lack of Efficacy|0|||
143499345|NCT01445678|517368595|FG001|Overall Study|Lack of Efficacy|2|||
143499346|NCT01445678|517368594|FG000|Overall Study|Lost to Follow-up|8|||
143499347|NCT01445678|517368595|FG001|Overall Study|Lost to Follow-up|5|||
143499348|NCT01445678|517368594|FG000|Overall Study|Protocol Violation|1|||
143499349|NCT01445678|517368595|FG001|Overall Study|Protocol Violation|1|||
143499350|NCT01445678|517368594|FG000|Overall Study|Withdrawal by Subject|9|||
143499351|NCT01445678|517368595|FG001|Overall Study|Withdrawal by Subject|5|||
143499352|NCT00925600|517370399|FG000|Overall Study|Withdrawal by Subject|16|||
143499353|NCT00925600|517370400|FG001|Overall Study|Withdrawal by Subject|14|||
143499354|NCT00925600|517370399|FG000|Overall Study|Death|4|||
143499355|NCT00925600|517370400|FG001|Overall Study|Death|3|||
143499356|NCT00925600|517370399|FG000|Overall Study|Lost to Follow-up|2|||
143499357|NCT00925600|517370400|FG001|Overall Study|Lost to Follow-up|2|||
143499358|NCT00925600|517370399|FG000|Overall Study|Disease Progression|1|||
143499359|NCT00925600|517370400|FG001|Overall Study|Disease Progression|3|||
143499360|NCT00925600|517370399|FG000|Overall Study|Administrative Decision|1|||
143499361|NCT00925600|517370400|FG001|Overall Study|Administrative Decision|1|||
143499362|NCT00925600|517370399|FG000|Overall Study|Noncompliance|2|||
143499363|NCT00925600|517370400|FG001|Overall Study|Noncompliance|0|||
143499364|NCT00925600|517370399|FG000|Overall Study|Ineligibility Determined|2|||
143499365|NCT00925600|517370400|FG001|Overall Study|Ineligibility Determined|0|||
143499366|NCT00925600|517370399|FG000|Overall Study|Protocol Deviation|0|||
143499367|NCT00925600|517370400|FG001|Overall Study|Protocol Deviation|1|||
143499368|NCT00925600|517370399|FG000|Overall Study|Requirement for Alternative Therapy|0|||
143499369|NCT00925600|517370400|FG001|Overall Study|Requirement for Alternative Therapy|1|||
143499370|NCT00925600|517370399|FG000|Overall Study|Other|3|||
143499371|NCT00925600|517370400|FG001|Overall Study|Other|1|||
143499372|NCT00925600|517370399|FG000|Overall Study|Adverse Event|1|||
143499373|NCT00925600|517370400|FG001|Overall Study|Adverse Event|2|||
143499374|NCT00127127|517370405|FG000|Overall Study|Adverse Event|0|||
143499375|NCT00127127|517370406|FG001|Overall Study|Adverse Event|2|||
143499376|NCT00127127|517370407|FG002|Overall Study|Adverse Event|0|||
143499377|NCT00127127|517370408|FG003|Overall Study|Adverse Event|1|||
143499378|NCT00127127|517370405|FG000|Overall Study|Lack of Efficacy|1|||
143499379|NCT00127127|517370406|FG001|Overall Study|Lack of Efficacy|3|||
143499380|NCT00127127|517370407|FG002|Overall Study|Lack of Efficacy|0|||
143499381|NCT00127127|517370408|FG003|Overall Study|Lack of Efficacy|2|||
143499382|NCT01059448|517370409|FG000|Overall Study|Adverse Event|1|||
143499383|NCT01059448|517370410|FG001|Overall Study|Adverse Event|3|||
143499384|NCT01059448|517370411|FG002|Overall Study|Adverse Event|0|||
143499385|NCT01059448|517370412|FG003|Overall Study|Adverse Event|1|||
143499386|NCT01059448|517370409|FG000|Overall Study|Withdrawal by Subject|2|||
143499387|NCT01059448|517370410|FG001|Overall Study|Withdrawal by Subject|0|||
143499388|NCT01059448|517370411|FG002|Overall Study|Withdrawal by Subject|2|||
143499389|NCT01059448|517370412|FG003|Overall Study|Withdrawal by Subject|4|||
143499390|NCT01059448|517370409|FG000|Overall Study|Disease Progression|2|||
143499391|NCT01059448|517370410|FG001|Overall Study|Disease Progression|1|||
143499392|NCT01059448|517370411|FG002|Overall Study|Disease Progression|4|||
143499393|NCT01059448|517370412|FG003|Overall Study|Disease Progression|2|||
143499394|NCT01059448|517370409|FG000|Overall Study|Administrative Decision|43|||
143499395|NCT01059448|517370410|FG001|Overall Study|Administrative Decision|49|||
143052059|NCT00950300|515729227|FG000|TFFU Period|Failure to Return|16|||
143052060|NCT00950300|515729228|FG001|TFFU Period|Failure to Return|16|||
143499396|NCT01059448|517370411|FG002|Overall Study|Administrative Decision|45|||
143499397|NCT01059448|517370412|FG003|Overall Study|Administrative Decision|46|||
143499398|NCT01059448|517370409|FG000|Overall Study|Lost to Follow-up|0|||
143052061|NCT00950300|515729227|FG000|TFFU Period|Recurrence of Disease|63|||
143052062|NCT00950300|515729228|FG001|TFFU Period|Recurrence of Disease|72|||
143499399|NCT01059448|517370410|FG001|Overall Study|Lost to Follow-up|0|||
143499400|NCT01059448|517370411|FG002|Overall Study|Lost to Follow-up|2|||
143499401|NCT01059448|517370412|FG003|Overall Study|Lost to Follow-up|0|||
143499402|NCT01059448|517370409|FG000|Overall Study|Death|0|||
143499403|NCT01059448|517370410|FG001|Overall Study|Death|1|||
143499404|NCT01059448|517370411|FG002|Overall Study|Death|0|||
143499405|NCT01059448|517370412|FG003|Overall Study|Death|0|||
143499406|NCT01059448|517370409|FG000|Overall Study|Other|1|||
143499407|NCT01059448|517370410|FG001|Overall Study|Other|1|||
143499408|NCT01059448|517370411|FG002|Overall Study|Other|0|||
143499409|NCT01059448|517370412|FG003|Overall Study|Other|1|||
143499410|NCT04188197|517370415|FG000|Overall Study|Lost to Follow-up|4|||
143499411|NCT04188197|517370416|FG001|Overall Study|Lost to Follow-up|1|||
143499412|NCT04188197|517370415|FG000|Overall Study|Withdrawal by Subject|1|||
143499413|NCT04188197|517370416|FG001|Overall Study|Withdrawal by Subject|1|||
143499414|NCT04188197|517370415|FG000|Overall Study|Pregnancy|0|||
143499415|NCT04188197|517370416|FG001|Overall Study|Pregnancy|1|||
143499416|NCT00851903|517370418|FG000|Overall Study|Withdrawal by Subject|2|||
143499417|NCT06441877|517370421|FG000|Overall Study|Withdrawal by Subject|0|||
143499418|NCT06441877|517370422|FG001|Overall Study|Withdrawal by Subject|2|||
143499419|NCT06441877|517370423|FG002|Overall Study|Withdrawal by Subject|0|||
143499420|NCT06441877|517370424|FG003|Overall Study|Withdrawal by Subject|0|||
143499421|NCT02720757|517370425|FG000|Overall Study|Other reason|5|||
143499422|NCT02720757|517370425|FG000|Overall Study|Loss of contact|4|||
143499423|NCT02720757|517370425|FG000|Overall Study|Informed consent withdrawal|1|||
143499424|NCT02720757|517370425|FG000|Overall Study|Patients wish to withdraw|2|||
143499425|NCT02720757|517370425|FG000|Overall Study|Missing|3|||
143499426|NCT02720757|517370425|FG000|Overall Study|General exclusion|3|||
143499427|NCT00289913|517370426|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
143499428|NCT00289913|517370427|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
143499429|NCT00289913|517370428|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
143499430|NCT00289913|517370429|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
143499431|NCT00289913|517370430|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
143499432|NCT00289913|517370426|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
143499433|NCT00289913|517370427|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
143499434|NCT00289913|517370428|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
143499435|NCT00289913|517370429|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
143499436|NCT00289913|517370430|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
143499437|NCT00289913|517370426|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
143499438|NCT00289913|517370427|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
143499439|NCT00289913|517370428|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
143499440|NCT00289913|517370429|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
143499441|NCT00289913|517370430|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
143499442|NCT00289913|517370426|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
143169247|NCT03759379|516169811|FG000|Treatment Period|Physician Decision|0|||
143169248|NCT03759379|516169812|FG001|Treatment Period|Physician Decision|1|||
143169249|NCT02333799|516169813|FG000|Treatment Period|Withdrawal by Subject|1|||
143169250|NCT02333799|516169813|FG000|Treatment Period|Death|6|||
143169251|NCT02333799|516169813|FG000|6 Month Follow Up Period|Physician Decision|1|||
143169252|NCT02333799|516169813|FG000|6 Month Follow Up Period|Death|1|||
143169253|NCT02333799|516169813|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
143169254|NCT02333799|516169813|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
143169255|NCT02538614|516169814|FG000|Overall Study|Progressive Disease|2|||
143169256|NCT04622592|516169820|FG000|Overall Study|Death|0|||
143169257|NCT04622592|516169821|FG001|Overall Study|Death|0|||
143169258|NCT04622592|516169822|FG002|Overall Study|Death|1|||
143169259|NCT04622592|516169823|FG003|Overall Study|Death|0|||
143169260|NCT04622592|516169824|FG004|Overall Study|Death|0|||
143169261|NCT04622592|516169825|FG005|Overall Study|Death|0|||
143169262|NCT04622592|516169826|FG006|Overall Study|Death|0|||
143169263|NCT04622592|516169827|FG007|Overall Study|Death|1|||
143169264|NCT04622592|516169820|FG000|Overall Study|Lost to Follow-up|0|||
143169265|NCT04622592|516169821|FG001|Overall Study|Lost to Follow-up|0|||
143169266|NCT04622592|516169822|FG002|Overall Study|Lost to Follow-up|0|||
143169267|NCT04622592|516169823|FG003|Overall Study|Lost to Follow-up|3|||
143169268|NCT04622592|516169824|FG004|Overall Study|Lost to Follow-up|1|||
143169269|NCT04622592|516169825|FG005|Overall Study|Lost to Follow-up|0|||
143169270|NCT04622592|516169826|FG006|Overall Study|Lost to Follow-up|2|||
143169271|NCT04622592|516169827|FG007|Overall Study|Lost to Follow-up|2|||
143169272|NCT04622592|516169820|FG000|Overall Study|Physician Decision|0|||
143169273|NCT04622592|516169821|FG001|Overall Study|Physician Decision|0|||
143169274|NCT04622592|516169822|FG002|Overall Study|Physician Decision|0|||
143169275|NCT04622592|516169823|FG003|Overall Study|Physician Decision|0|||
143169276|NCT04622592|516169824|FG004|Overall Study|Physician Decision|1|||
143169277|NCT04622592|516169825|FG005|Overall Study|Physician Decision|0|||
143499443|NCT00289913|517370427|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
143499444|NCT00289913|517370428|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
143052063|NCT00950300|515729227|FG000|TFFU Period|Other|4|||
143052064|NCT00950300|515729228|FG001|TFFU Period|Other|3|||
143052065|NCT00950300|515729227|FG000|SFU Period|Death|44|||
143052066|NCT00950300|515729228|FG001|SFU Period|Death|42|||
143052067|NCT00950300|515729227|FG000|SFU Period|Lost to Follow-up|30|||
143052068|NCT00950300|515729228|FG001|SFU Period|Lost to Follow-up|28|||
143052069|NCT00950300|515729227|FG000|SFU Period|Withdrawal by Subject|4|||
143052070|NCT00950300|515729228|FG001|SFU Period|Withdrawal by Subject|8|||
143052071|NCT00438633|515729230|FG000|Overall Study|Withdrawal by Subject|1|||
143052072|NCT00438633|515729231|FG001|Overall Study|Withdrawal by Subject|0|||
143052073|NCT00438633|515729230|FG000|Overall Study|Lost to Follow-up|15|||
143052074|NCT00438633|515729231|FG001|Overall Study|Lost to Follow-up|17|||
143052075|NCT02832167|515730749|FG000|Treatment Period 1|Disease progression|90|||
143052076|NCT02832167|515730749|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
143052077|NCT02832167|515730749|FG000|Treatment Period 1|Death|2|||
143052078|NCT02832167|515730749|FG000|Treatment Period 1|Study Drug Toxicity|6|||
143052079|NCT02832167|515730749|FG000|Treatment Period 1|Participant request to discontinue|9|||
143052080|NCT02832167|515730749|FG000|Treatment Period 1|No longer meet study criteria|1|||
143052081|NCT02832167|515730749|FG000|Treatment Period 1|Participant withdrew consent|3|||
143052082|NCT02832167|515730749|FG000|Treatment Period 1|Other reasons|6|||
143052083|NCT02832167|515730749|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
143052084|NCT02832167|515730749|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
143052085|NCT02832167|515730749|FG000|Transition From Period 1 to Period 2|Death|2|||
143052086|NCT02832167|515730749|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
143052087|NCT02832167|515730749|FG000|Treatment Period 2|Disease progression|69|||
143499445|NCT00289913|517370429|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
143499446|NCT00289913|517370430|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
143499447|NCT00289913|517370426|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
143499448|NCT00289913|517370427|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
143499449|NCT00289913|517370428|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
143499450|NCT00289913|517370429|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
143499451|NCT00289913|517370430|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
143499452|NCT00289913|517370426|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
143499453|NCT00289913|517370427|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
143499454|NCT00289913|517370428|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
143499455|NCT00289913|517370429|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
143499456|NCT00289913|517370430|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
143499457|NCT00289913|517370426|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
143499458|NCT00289913|517370427|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
143499459|NCT00289913|517370428|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
143499460|NCT00289913|517370429|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
143499461|NCT00289913|517370430|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
143499462|NCT00289913|517370426|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
143499463|NCT00289913|517370427|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
143499464|NCT00289913|517370428|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
143499465|NCT00289913|517370429|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
143499466|NCT00289913|517370430|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
143499467|NCT00289913|517370426|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
143499468|NCT00289913|517370427|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
143499469|NCT00289913|517370428|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
143499470|NCT00289913|517370429|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
143499471|NCT00289913|517370430|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
143499472|NCT00289913|517370426|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
143499473|NCT00289913|517370427|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
143499474|NCT00289913|517370428|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
143499475|NCT00289913|517370429|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
143499476|NCT00289913|517370430|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
143499477|NCT00289913|517370426|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
143499478|NCT00289913|517370427|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
143499479|NCT00289913|517370428|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
143499480|NCT00289913|517370429|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
143499481|NCT00289913|517370430|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
143499482|NCT00289913|517370426|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
143499483|NCT00289913|517370427|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
143052088|NCT02832167|515730749|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
143052089|NCT02832167|515730749|FG000|Treatment Period 2|Maximum clinical benefit|1|||
143052090|NCT02832167|515730749|FG000|Treatment Period 2|Study Drug Toxicity|5|||
143244826|NCT02453711|516448112|FG008|Overall Study|Death|0|||
143052091|NCT02832167|515730749|FG000|Treatment Period 2|Participant request to discontinue|2|||
143052092|NCT02832167|515730749|FG000|Treatment Period 2|Participant withdrew consent|3|||
143052093|NCT02832167|515730749|FG000|Treatment Period 2|Other reasons|3|||
143052094|NCT04556734|515730750|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
143052095|NCT04556734|515730751|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
143052096|NCT04556734|515730752|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
143052097|NCT04556734|515730753|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
143052098|NCT04556734|515730754|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
143052099|NCT04556734|515730755|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
143052100|NCT04556734|515730756|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
143052101|NCT04556734|515730757|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
143052102|NCT04556734|515730750|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
143052103|NCT04556734|515730751|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
143052104|NCT04556734|515730752|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
143052105|NCT04556734|515730753|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
143052106|NCT04556734|515730754|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
143052107|NCT04556734|515730755|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
143052108|NCT04556734|515730756|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
143052109|NCT04556734|515730757|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
143052110|NCT04556734|515730750|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
143052111|NCT04556734|515730751|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
143052112|NCT04556734|515730752|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
143052113|NCT04556734|515730753|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
143052114|NCT04556734|515730754|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
143052115|NCT04556734|515730755|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
143052116|NCT04556734|515730756|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
143052117|NCT04556734|515730757|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
143052118|NCT04556734|515730750|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
143052119|NCT04556734|515730751|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
143052120|NCT04556734|515730752|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
143052121|NCT04556734|515730753|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
143052122|NCT04556734|515730754|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
143052123|NCT04556734|515730755|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
143052124|NCT04556734|515730756|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
143052125|NCT04556734|515730757|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
143052126|NCT04556734|515730750|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
143052127|NCT04556734|515730751|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
143052128|NCT04556734|515730752|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
143052129|NCT04556734|515730753|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
143052130|NCT04556734|515730754|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
143052131|NCT04556734|515730755|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
143052132|NCT04556734|515730756|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
143052133|NCT04556734|515730757|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
143052134|NCT04556734|515730750|FG000|OLE Period (28 Weeks)|Not reported|0|||
143052135|NCT04556734|515730751|FG001|OLE Period (28 Weeks)|Not reported|0|||
143052136|NCT04556734|515730752|FG002|OLE Period (28 Weeks)|Not reported|0|||
143052137|NCT04556734|515730753|FG003|OLE Period (28 Weeks)|Not reported|0|||
143052138|NCT04556734|515730754|FG004|OLE Period (28 Weeks)|Not reported|0|||
143052139|NCT04556734|515730755|FG005|OLE Period (28 Weeks)|Not reported|1|||
143052140|NCT04556734|515730756|FG006|OLE Period (28 Weeks)|Not reported|0|||
143052141|NCT04556734|515730757|FG007|OLE Period (28 Weeks)|Not reported|0|||
143052142|NCT04556734|515730750|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
143052143|NCT04556734|515730751|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
143052144|NCT04556734|515730752|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
143052145|NCT04556734|515730753|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
143052146|NCT04556734|515730754|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
143052147|NCT04556734|515730755|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
143052148|NCT04556734|515730756|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
143052149|NCT04556734|515730757|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
143052150|NCT04556734|515730750|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
143244827|NCT02453711|516448104|FG000|Overall Study|Unclassified|1|||
143244828|NCT02453711|516448105|FG001|Overall Study|Unclassified|0|||
143499484|NCT00289913|517370428|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
143499485|NCT00289913|517370429|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
143052151|NCT04556734|515730751|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
143052152|NCT04556734|515730752|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
143052153|NCT04556734|515730753|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
143052154|NCT04556734|515730754|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
143052155|NCT04556734|515730755|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
143052156|NCT04556734|515730756|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
143052157|NCT04556734|515730757|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
143052158|NCT04556734|515730750|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
143052159|NCT04556734|515730751|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
143052160|NCT04556734|515730752|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
143052161|NCT04556734|515730753|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
143052162|NCT04556734|515730754|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
143052163|NCT04556734|515730755|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
143052164|NCT04556734|515730756|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
143052165|NCT04556734|515730757|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
143052166|NCT04264819|515730758|FG000|Overall Study|Physician Decision|19|||
143052167|NCT04264819|515730758|FG000|Overall Study|Adverse Event|12|||
143052168|NCT04264819|515730758|FG000|Overall Study|Withdrawal by Subject|11|||
143052169|NCT04264819|515730758|FG000|Overall Study|Lost to Follow-up|2|||
143052170|NCT04264819|515730758|FG000|Overall Study|Death|2|||
143052171|NCT02846883|515730766|FG000|Overall Study|Death|0|||
143052172|NCT02846883|515730767|FG001|Overall Study|Death|1|||
143052173|NCT02846883|515730768|FG002|Overall Study|Death|1|||
143052174|NCT02846883|515730766|FG000|Overall Study|Lost to Follow-up|0|||
143052175|NCT02846883|515730767|FG001|Overall Study|Lost to Follow-up|0|||
143052176|NCT02846883|515730768|FG002|Overall Study|Lost to Follow-up|1|||
143052177|NCT02846883|515730766|FG000|Overall Study|Withdrawal by Subject|1|||
143052178|NCT02846883|515730767|FG001|Overall Study|Withdrawal by Subject|0|||
143052179|NCT02846883|515730768|FG002|Overall Study|Withdrawal by Subject|0|||
143052180|NCT02846883|515730766|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
143052181|NCT02846883|515730767|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
143052182|NCT02846883|515730768|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
143052183|NCT02846883|515730766|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
143244829|NCT02453711|516448106|FG002|Overall Study|Unclassified|1|||
143244830|NCT02453711|516448107|FG003|Overall Study|Unclassified|0|||
143244831|NCT02453711|516448108|FG004|Overall Study|Unclassified|0|||
143244832|NCT02453711|516448109|FG005|Overall Study|Unclassified|0|||
143244833|NCT02453711|516448110|FG006|Overall Study|Unclassified|0|||
143244834|NCT02453711|516448111|FG007|Overall Study|Unclassified|0|||
143244835|NCT02453711|516448112|FG008|Overall Study|Unclassified|0|||
143244836|NCT01273519|516448114|FG000|Overall Study|Adverse Event|3|||
143244837|NCT01273519|516448115|FG001|Overall Study|Adverse Event|0|||
143244838|NCT01273519|516448116|FG002|Overall Study|Adverse Event|0|||
143244839|NCT01273519|516448114|FG000|Overall Study|Lost to Follow-up|2|||
143244840|NCT01273519|516448115|FG001|Overall Study|Lost to Follow-up|1|||
143499486|NCT00289913|517370430|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
143499487|NCT00289913|517370426|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
143052184|NCT02846883|515730767|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
143052185|NCT02846883|515730768|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
143052186|NCT04768296|515730772|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
143052187|NCT04768296|515730773|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
143052188|NCT01453153|515730784|FG000|Overall Study|Physician Decision|0|||
143052189|NCT01453153|515730785|FG001|Overall Study|Physician Decision|0|||
143052190|NCT01453153|515730786|FG002|Overall Study|Physician Decision|1|||
143052191|NCT01453153|515730784|FG000|Overall Study|Progressive Disease|3|||
143052192|NCT01453153|515730785|FG001|Overall Study|Progressive Disease|2|||
143052193|NCT01453153|515730786|FG002|Overall Study|Progressive Disease|16|||
143052194|NCT01453153|515730784|FG000|Overall Study|Withdrawal by Subject|0|||
143052195|NCT01453153|515730785|FG001|Overall Study|Withdrawal by Subject|1|||
143052196|NCT01453153|515730786|FG002|Overall Study|Withdrawal by Subject|2|||
143052197|NCT01453153|515730784|FG000|Overall Study|Adverse Event|1|||
143052198|NCT01453153|515730785|FG001|Overall Study|Adverse Event|1|||
143052199|NCT01453153|515730786|FG002|Overall Study|Adverse Event|1|||
143052200|NCT03035890|515730787|FG000|Overall Study|Death|1|||
143052201|NCT03243396|515730788|FG000|Overall Study|Lost to Follow-up|2|||
143052202|NCT03243396|515730789|FG001|Overall Study|Lost to Follow-up|3|||
143052203|NCT03243396|515730790|FG002|Overall Study|Lost to Follow-up|15|||
143052204|NCT03243396|515730791|FG003|Overall Study|Lost to Follow-up|8|||
143052205|NCT03243396|515730792|FG004|Overall Study|Lost to Follow-up|1|||
143052206|NCT03243396|515730793|FG005|Overall Study|Lost to Follow-up|4|||
143052207|NCT03243396|515730794|FG006|Overall Study|Lost to Follow-up|9|||
143052208|NCT00452348|515730797|FG000|Overall Study|Adverse Event|6|||
143052209|NCT00452348|515730798|FG001|Overall Study|Adverse Event|9|||
143052210|NCT00452348|515730797|FG000|Overall Study|Lack of Efficacy|10|||
143052211|NCT00452348|515730798|FG001|Overall Study|Lack of Efficacy|9|||
143052212|NCT00452348|515730797|FG000|Overall Study|Lost to Follow-up|14|||
143052213|NCT00452348|515730798|FG001|Overall Study|Lost to Follow-up|8|||
143052214|NCT00452348|515730797|FG000|Overall Study|Protocol Violation|22|||
143244841|NCT01273519|516448116|FG002|Overall Study|Lost to Follow-up|3|||
143244842|NCT01273519|516448114|FG000|Overall Study|Lack of Efficacy|8|||
143052215|NCT00452348|515730798|FG001|Overall Study|Protocol Violation|28|||
143052216|NCT00452348|515730797|FG000|Overall Study|Withdrawal by Subject|18|||
143052217|NCT00452348|515730798|FG001|Overall Study|Withdrawal by Subject|21|||
143052218|NCT00452348|515730797|FG000|Overall Study|Other|9|||
143052219|NCT00452348|515730798|FG001|Overall Study|Other|9|||
143052220|NCT01490190|515730799|FG000|Overall Study|Withdrawal by Subject|9|||
143052221|NCT01490190|515730799|FG000|Overall Study|Adverse Event|17|||
143052222|NCT01490190|515730799|FG000|Overall Study|Protocol Violation|5|||
143052223|NCT01490190|515730799|FG000|Overall Study|Lost to Follow-up|13|||
143052224|NCT01490190|515730799|FG000|Overall Study|Relocation|1|||
143052225|NCT01490190|515730799|FG000|Overall Study|Inconvenience|1|||
143052226|NCT01490190|515730799|FG000|Overall Study|Ring expulsion|2|||
143052227|NCT03167606|515730808|FG000|Overall Study|Lost to Follow-up|73|||
143052228|NCT03167606|515730809|FG001|Overall Study|Lost to Follow-up|64|||
143052229|NCT03167606|515730808|FG000|Overall Study|Withdrawal by Subject|6|||
143052230|NCT03167606|515730809|FG001|Overall Study|Withdrawal by Subject|5|||
143052231|NCT03167606|515730808|FG000|Overall Study|Withdrawal by Investigator|0|||
143052232|NCT03167606|515730809|FG001|Overall Study|Withdrawal by Investigator|2|||
143052233|NCT02483416|515730810|FG000|Overall Study|Other reason|0|||
143052234|NCT02483416|515730811|FG001|Overall Study|Other reason|1|||
143052235|NCT02483416|515730810|FG000|Overall Study|Treatment stop|3|||
143052236|NCT02483416|515730811|FG001|Overall Study|Treatment stop|0|||
143052237|NCT02587143|515730813|FG000|Overall Study|Adverse Event|1|||
143052238|NCT02587143|515730814|FG001|Overall Study|Adverse Event|0|||
143052239|NCT02754492|515730817|FG000|Overall Study|Protocol Violation|2|||
143052240|NCT02754492|515730818|FG001|Overall Study|Protocol Violation|2|||
143052241|NCT02754492|515730819|FG002|Overall Study|Protocol Violation|0|||
143052242|NCT02754492|515730820|FG003|Overall Study|Protocol Violation|1|||
143052243|NCT02754492|515730817|FG000|Overall Study|Withdrawal by Subject|2|||
143052244|NCT02754492|515730818|FG001|Overall Study|Withdrawal by Subject|0|||
143052245|NCT02754492|515730819|FG002|Overall Study|Withdrawal by Subject|0|||
143052246|NCT02754492|515730820|FG003|Overall Study|Withdrawal by Subject|0|||
143052247|NCT02754492|515730817|FG000|Overall Study|Equipment malfuntion|0|||
143052248|NCT02754492|515730818|FG001|Overall Study|Equipment malfuntion|0|||
143052249|NCT02754492|515730819|FG002|Overall Study|Equipment malfuntion|2|||
143052250|NCT02754492|515730820|FG003|Overall Study|Equipment malfuntion|5|||
143052251|NCT02754492|515730817|FG000|Overall Study|Adverse Event|0|||
143052252|NCT02754492|515730818|FG001|Overall Study|Adverse Event|0|||
143052253|NCT02754492|515730819|FG002|Overall Study|Adverse Event|0|||
143052254|NCT02754492|515730820|FG003|Overall Study|Adverse Event|13|||
143052255|NCT02754492|515730817|FG000|Overall Study|Venous access issues not resulting in AE|0|||
143052256|NCT02754492|515730818|FG001|Overall Study|Venous access issues not resulting in AE|0|||
143052257|NCT02754492|515730819|FG002|Overall Study|Venous access issues not resulting in AE|0|||
143052258|NCT02754492|515730820|FG003|Overall Study|Venous access issues not resulting in AE|4|||
143052259|NCT00487695|515730821|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
143244843|NCT01273519|516448115|FG001|Overall Study|Lack of Efficacy|3|||
143244844|NCT01273519|516448116|FG002|Overall Study|Lack of Efficacy|4|||
143244845|NCT01273519|516448114|FG000|Overall Study|Other|6|||
143244846|NCT01273519|516448115|FG001|Overall Study|Other|1|||
143244847|NCT01273519|516448116|FG002|Overall Study|Other|1|||
143244848|NCT04292899|516448117|FG000|Overall Study|Death|21|||
143244849|NCT04292899|516448118|FG001|Overall Study|Death|28|||
143244850|NCT04292899|516448119|FG002|Overall Study|Death|188|||
143244851|NCT04292899|516448120|FG003|Overall Study|Death|371|||
143244852|NCT04292899|516448117|FG000|Overall Study|Lost to Follow-up|8|||
143244853|NCT04292899|516448118|FG001|Overall Study|Lost to Follow-up|4|||
143244854|NCT04292899|516448119|FG002|Overall Study|Lost to Follow-up|22|||
143364556|NCT01352507|516877031|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
143364557|NCT01352507|516877032|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
143499488|NCT00289913|517370427|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
143499489|NCT00289913|517370428|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
143499490|NCT00289913|517370429|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
143499491|NCT00289913|517370430|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
143052260|NCT00487695|515730822|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
143052261|NCT00487695|515730821|FG000|First Procedure|active wheezing (did not have procedure)|1|||
143052262|NCT00487695|515730822|FG001|First Procedure|active wheezing (did not have procedure)|0|||
143052263|NCT00487695|515730821|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
143052264|NCT00487695|515730822|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
143244855|NCT04292899|516448120|FG003|Overall Study|Lost to Follow-up|235|||
143244856|NCT04292899|516448117|FG000|Overall Study|Withdrew consent|1|||
143244857|NCT04292899|516448118|FG001|Overall Study|Withdrew consent|0|||
143052265|NCT00487695|515730821|FG000|Second Procedure|active wheezing|0|||
143052266|NCT00487695|515730822|FG001|Second Procedure|active wheezing|1|||
143052267|NCT00487695|515730821|FG000|Second Procedure|Withdrawal by Subject|1|||
143052268|NCT00487695|515730822|FG001|Second Procedure|Withdrawal by Subject|2|||
143052269|NCT00981799|515730825|FG000|Overall Study|Adverse Event|1|||
143052270|NCT00981799|515730826|FG001|Overall Study|Adverse Event|1|||
143052271|NCT00981799|515730827|FG002|Overall Study|Adverse Event|0|||
143244858|NCT04292899|516448119|FG002|Overall Study|Withdrew consent|11|||
143052272|NCT00981799|515730828|FG003|Overall Study|Adverse Event|0|||
143052273|NCT02167594|515730829|FG000|Overall Study|Withdrawal by Subject|2|||
143052274|NCT02167594|515730830|FG001|Overall Study|Withdrawal by Subject|0|||
143052275|NCT02167594|515730831|FG002|Overall Study|Withdrawal by Subject|0|||
143052276|NCT02167594|515730829|FG000|Overall Study|Death|0|||
143052277|NCT02167594|515730830|FG001|Overall Study|Death|1|||
143052278|NCT02167594|515730831|FG002|Overall Study|Death|0|||
143052279|NCT01943435|515730838|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
143052280|NCT01943435|515730839|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
143052281|NCT01943435|515730840|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
143052282|NCT01943435|515730838|FG000|Intervention Period|Withdrawal by Subject|3|||
143052283|NCT01943435|515730839|FG001|Intervention Period|Withdrawal by Subject|3|||
143052284|NCT01943435|515730840|FG002|Intervention Period|Withdrawal by Subject|4|||
143052285|NCT01943435|515730838|FG000|2 Month Follow up|Lost to Follow-up|2|||
143052286|NCT01943435|515730839|FG001|2 Month Follow up|Lost to Follow-up|3|||
143052287|NCT01943435|515730840|FG002|2 Month Follow up|Lost to Follow-up|0|||
143052288|NCT01943435|515730838|FG000|6 Month Follow up|Lost to Follow-up|12|||
143052289|NCT01943435|515730839|FG001|6 Month Follow up|Lost to Follow-up|7|||
143052290|NCT01943435|515730840|FG002|6 Month Follow up|Lost to Follow-up|15|||
143052291|NCT02046122|515730849|FG000|Overall Study|Physician Decision|8|||
143052292|NCT02046122|515730849|FG000|Overall Study|Withdrawal by Subject|1|||
143052293|NCT02985398|515730850|FG000|Overall Study|Adverse Event|1|||
143052294|NCT02985398|515730850|FG000|Overall Study|Lost to Follow-up|4|||
143052295|NCT02985398|515730850|FG000|Overall Study|Withdrawal by Subject|8|||
143052296|NCT02985398|515730850|FG000|Overall Study|Study Burden|9|||
143052297|NCT01726803|515730851|FG000|Overall Study|Lost to Follow-up|6|||
143052298|NCT01726803|515730852|FG001|Overall Study|Lost to Follow-up|1|||
143052299|NCT01726803|515730851|FG000|Overall Study|Withdrawal by Subject|1|||
143052300|NCT01726803|515730852|FG001|Overall Study|Withdrawal by Subject|0|||
143052301|NCT01277510|515730854|FG000|Double-blind Phase|Non-compliance|0|||
143052302|NCT01277510|515730855|FG001|Double-blind Phase|Non-compliance|1|||
143052303|NCT01277510|515730854|FG000|Double-blind Phase|Adverse Event|1|||
143052304|NCT01277510|515730855|FG001|Double-blind Phase|Adverse Event|0|||
143052305|NCT01277510|515730854|FG000|Double-blind Phase|Withdrawal by Subject|2|||
143052306|NCT01277510|515730855|FG001|Double-blind Phase|Withdrawal by Subject|0|||
143052307|NCT01277510|515730854|FG000|Double-blind Phase|Administrative decision|7|||
143052308|NCT01277510|515730855|FG001|Double-blind Phase|Administrative decision|9|||
143052309|NCT01277510|515730854|FG000|Double-blind Phase|Death|0|||
143052310|NCT01277510|515730855|FG001|Double-blind Phase|Death|1|||
143052311|NCT01277510|515730854|FG000|Double-blind Phase|Protocol-specified criteria|2|||
143052312|NCT01277510|515730855|FG001|Double-blind Phase|Protocol-specified criteria|6|||
143052313|NCT01277510|515730854|FG000|Double-blind Phase|Other|1|||
143052314|NCT01277510|515730855|FG001|Double-blind Phase|Other|1|||
143052315|NCT01277510|515730854|FG000|Open-label Phase|Administrative decision|4|||
143052316|NCT01277510|515730855|FG001|Open-label Phase|Administrative decision|3|||
143052317|NCT01277510|515730854|FG000|Open-label Phase|Protocol-specified criteria|1|||
143052318|NCT01277510|515730855|FG001|Open-label Phase|Protocol-specified criteria|0|||
143052319|NCT01277510|515730854|FG000|Open-label Phase|Never received investigational product|2|||
143052320|NCT01277510|515730855|FG001|Open-label Phase|Never received investigational product|0|||
143052321|NCT01970592|515730856|FG000|Overall Study|Withdrawal by Subject|4|||
143052322|NCT01970592|515730856|FG000|Overall Study|Physician Decision|1|||
143052323|NCT01970592|515730856|FG000|Overall Study|Adverse Event|1|||
143052324|NCT01320722|515730857|FG000|Overall Study|Did not Receive Intervention|3|||
143052325|NCT01320722|515730858|FG001|Overall Study|Did not Receive Intervention|2|||
143499492|NCT00289913|517370426|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
143499493|NCT00289913|517370427|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
143499494|NCT00289913|517370428|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
143499495|NCT00289913|517370429|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
143052326|NCT01320722|515730859|FG002|Overall Study|Did not Receive Intervention|1|||
143052327|NCT01320722|515730860|FG003|Overall Study|Did not Receive Intervention|1|||
143052328|NCT01320722|515730861|FG004|Overall Study|Did not Receive Intervention|2|||
143052329|NCT01320722|515730857|FG000|Overall Study|Lost to Follow-up|0|||
143052330|NCT01320722|515730858|FG001|Overall Study|Lost to Follow-up|1|||
143052331|NCT01320722|515730859|FG002|Overall Study|Lost to Follow-up|0|||
143052332|NCT01320722|515730860|FG003|Overall Study|Lost to Follow-up|1|||
143052333|NCT01320722|515730861|FG004|Overall Study|Lost to Follow-up|3|||
143052334|NCT01320722|515730857|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
143052335|NCT01320722|515730858|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
143052336|NCT01320722|515730859|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
143052337|NCT01320722|515730860|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
143052338|NCT01320722|515730861|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
143052339|NCT01320722|515730857|FG000|Overall Study|Participant Developed a Rash|0|||
143052340|NCT01320722|515730858|FG001|Overall Study|Participant Developed a Rash|0|||
143052341|NCT01320722|515730859|FG002|Overall Study|Participant Developed a Rash|2|||
143052342|NCT01320722|515730860|FG003|Overall Study|Participant Developed a Rash|1|||
143052343|NCT01320722|515730861|FG004|Overall Study|Participant Developed a Rash|1|||
143052344|NCT01320722|515730857|FG000|Overall Study|Non-compliant with Medication|0|||
143052345|NCT01320722|515730858|FG001|Overall Study|Non-compliant with Medication|0|||
143052346|NCT01320722|515730859|FG002|Overall Study|Non-compliant with Medication|1|||
143052347|NCT01320722|515730860|FG003|Overall Study|Non-compliant with Medication|0|||
143052348|NCT01320722|515730861|FG004|Overall Study|Non-compliant with Medication|0|||
143052349|NCT01320722|515730857|FG000|Overall Study|Adverse Event|0|||
143052350|NCT01320722|515730858|FG001|Overall Study|Adverse Event|0|||
143052351|NCT01320722|515730859|FG002|Overall Study|Adverse Event|3|||
143052352|NCT01320722|515730860|FG003|Overall Study|Adverse Event|6|||
143052353|NCT01320722|515730861|FG004|Overall Study|Adverse Event|0|||
143052354|NCT01320722|515730857|FG000|Overall Study|Not Compliant with Study Procedures|0|||
143052355|NCT01320722|515730858|FG001|Overall Study|Not Compliant with Study Procedures|0|||
143052356|NCT01320722|515730859|FG002|Overall Study|Not Compliant with Study Procedures|0|||
143052357|NCT01320722|515730860|FG003|Overall Study|Not Compliant with Study Procedures|4|||
143052358|NCT01320722|515730861|FG004|Overall Study|Not Compliant with Study Procedures|0|||
143052359|NCT01320722|515730857|FG000|Overall Study|Pregnancy|0|||
143052360|NCT01320722|515730858|FG001|Overall Study|Pregnancy|0|||
143052361|NCT01320722|515730859|FG002|Overall Study|Pregnancy|0|||
143052362|NCT01320722|515730860|FG003|Overall Study|Pregnancy|1|||
143052363|NCT01320722|515730861|FG004|Overall Study|Pregnancy|0|||
143052364|NCT01320722|515730857|FG000|Overall Study|Started an Exclusionary Medication|0|||
143052365|NCT01320722|515730858|FG001|Overall Study|Started an Exclusionary Medication|0|||
143052366|NCT01320722|515730859|FG002|Overall Study|Started an Exclusionary Medication|0|||
143052367|NCT01320722|515730860|FG003|Overall Study|Started an Exclusionary Medication|0|||
143052368|NCT01320722|515730861|FG004|Overall Study|Started an Exclusionary Medication|1|||
143052369|NCT01320722|515730857|FG000|Overall Study|Withdrew due to Health Condition|0|||
143052370|NCT01320722|515730858|FG001|Overall Study|Withdrew due to Health Condition|0|||
143052371|NCT01320722|515730859|FG002|Overall Study|Withdrew due to Health Condition|0|||
143052372|NCT01320722|515730860|FG003|Overall Study|Withdrew due to Health Condition|0|||
143052373|NCT01320722|515730861|FG004|Overall Study|Withdrew due to Health Condition|1|||
143052374|NCT00021541|515730862|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
143052375|NCT00021541|515730863|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
143052376|NCT00021541|515730862|FG000|Period 1-First Treatment|Adverse Event|2|||
143052377|NCT00021541|515730863|FG001|Period 1-First Treatment|Adverse Event|1|||
143052378|NCT00021541|515730862|FG000|Period 1-First Treatment|non-adherence|3|||
143052379|NCT00021541|515730863|FG001|Period 1-First Treatment|non-adherence|0|||
143052380|NCT00021541|515730862|FG000|Period 1-First Treatment|Death|1|||
143052381|NCT00021541|515730863|FG001|Period 1-First Treatment|Death|0|||
143052382|NCT00021541|515730862|FG000|Period 1-First Treatment|Pts that did not progress|2|||
143052383|NCT00021541|515730863|FG001|Period 1-First Treatment|Pts that did not progress|2|||
143052384|NCT00021541|515730862|FG000|Period 1-First Treatment|Ineligible|0|||
143052385|NCT00021541|515730863|FG001|Period 1-First Treatment|Ineligible|2|||
143052386|NCT00021541|515730862|FG000|Period 2-crossover|refused phase B|2|||
143052387|NCT00021541|515730863|FG001|Period 2-crossover|refused phase B|2|||
143052388|NCT00021541|515730862|FG000|Period 2-crossover|Withdrawal by Subject|3|||
143052389|NCT00021541|515730863|FG001|Period 2-crossover|Withdrawal by Subject|4|||
143052390|NCT00021541|515730862|FG000|Period 2-crossover|Adverse Event|2|||
143052391|NCT00021541|515730863|FG001|Period 2-crossover|Adverse Event|2|||
143052392|NCT00021541|515730862|FG000|Period 2-crossover|non-adherence|1|||
143052393|NCT00021541|515730863|FG001|Period 2-crossover|non-adherence|0|||
143052394|NCT00021541|515730862|FG000|Period 2-crossover|Pts that did not progress|2|||
143052395|NCT00021541|515730863|FG001|Period 2-crossover|Pts that did not progress|3|||
143052396|NCT01341405|515730870|FG000|Overall Study|Adverse Event|0|||
143169278|NCT04622592|516169826|FG006|Overall Study|Physician Decision|0|||
143169279|NCT04622592|516169827|FG007|Overall Study|Physician Decision|0|||
143169280|NCT04622592|516169820|FG000|Overall Study|Withdrawal by Subject|1|||
143169281|NCT04622592|516169821|FG001|Overall Study|Withdrawal by Subject|0|||
143169282|NCT04622592|516169822|FG002|Overall Study|Withdrawal by Subject|2|||
143169283|NCT04622592|516169823|FG003|Overall Study|Withdrawal by Subject|0|||
143169284|NCT04622592|516169824|FG004|Overall Study|Withdrawal by Subject|0|||
143169285|NCT04622592|516169825|FG005|Overall Study|Withdrawal by Subject|0|||
143169286|NCT04622592|516169826|FG006|Overall Study|Withdrawal by Subject|1|||
143052397|NCT01341405|515730871|FG001|Overall Study|Adverse Event|1|||
143052398|NCT01341405|515730872|FG002|Overall Study|Adverse Event|1|||
143052399|NCT01341405|515730870|FG000|Overall Study|Withdrawal by Subject|3|||
143052400|NCT01341405|515730871|FG001|Overall Study|Withdrawal by Subject|2|||
143169287|NCT04622592|516169827|FG007|Overall Study|Withdrawal by Subject|4|||
143169288|NCT04622592|516169820|FG000|Overall Study|Other than specified above|0|||
143052401|NCT01341405|515730872|FG002|Overall Study|Withdrawal by Subject|1|||
143052402|NCT05263505|515730873|FG000|Overall Study|Adverse Event|0|||
143052403|NCT05263505|515730874|FG001|Overall Study|Adverse Event|1|||
143052404|NCT02616380|515730875|FG000|Overall Study|Lost to Follow-up|1|||
143052405|NCT02616380|515730875|FG000|Overall Study|Other|2|||
143052406|NCT03407729|515730876|FG000|Overall Study|Lost to Follow-up|2|||
143052407|NCT03407729|515730877|FG001|Overall Study|Lost to Follow-up|0|||
143052408|NCT03407729|515730876|FG000|Overall Study|Unable to schedule|0|||
143052409|NCT03407729|515730877|FG001|Overall Study|Unable to schedule|3|||
143052410|NCT01050764|515730878|FG000|Overall Study|Death, before HSCT|1|||
143052411|NCT01050764|515730878|FG000|Overall Study|Donor mobilization failure, death|1|||
143052412|NCT01050764|515730878|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
143052413|NCT01898598|515730883|FG000|Overall Study|Adverse Event|1|||
143052414|NCT01898598|515730884|FG001|Overall Study|Adverse Event|0|||
143052415|NCT01898598|515730883|FG000|Overall Study|Withdrawal by Subject|3|||
143052416|NCT01898598|515730884|FG001|Overall Study|Withdrawal by Subject|0|||
143052417|NCT01898598|515730883|FG000|Overall Study|Lost to Follow-up|0|||
143052418|NCT01898598|515730884|FG001|Overall Study|Lost to Follow-up|1|||
143052419|NCT01898598|515730883|FG000|Overall Study|Other|0|||
143052420|NCT01898598|515730884|FG001|Overall Study|Other|1|||
143052421|NCT01596127|515730889|FG000|Overall Study|Patient Ineligible|1|||
143052422|NCT01539239|515730890|FG000|Overall Study|Death|5|||
143052423|NCT01539239|515730891|FG001|Overall Study|Death|5|||
143052424|NCT01539239|515730890|FG000|Overall Study|Lost to Follow-up|7|||
143052425|NCT01539239|515730891|FG001|Overall Study|Lost to Follow-up|12|||
143052426|NCT01562613|515730892|FG000|Overall Study|Lost to Follow-up|2|||
143052427|NCT01562613|515730892|FG000|Overall Study|Withdrawal by Subject|2|||
143052428|NCT00633022|515730895|FG000|Overall Study|Adverse Event|1|||
143052429|NCT00633022|515730896|FG001|Overall Study|Adverse Event|0|||
143052430|NCT00633022|515730897|FG002|Overall Study|Adverse Event|5|||
143052431|NCT00633022|515730895|FG000|Overall Study|Physician Decision|0|||
143052432|NCT00633022|515730896|FG001|Overall Study|Physician Decision|1|||
143052433|NCT00633022|515730897|FG002|Overall Study|Physician Decision|0|||
143052434|NCT04388787|515730899|FG000|Blinded Period|Patient could not follow instructions|1|||
143052435|NCT04388787|515730899|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
143052436|NCT00663234|515730900|FG000|Overall Study|Not willing to adhere to requirements|1|||
143052437|NCT01751087|515730901|FG000|Overall Study|Withdrawal by Subject|1|||
143052438|NCT01751087|515730902|FG001|Overall Study|Withdrawal by Subject|0|||
143052439|NCT01751087|515730903|FG002|Overall Study|Withdrawal by Subject|0|||
143052440|NCT01751087|515730901|FG000|Overall Study|Physician Decision|0|||
143052441|NCT01751087|515730902|FG001|Overall Study|Physician Decision|0|||
143052442|NCT01751087|515730903|FG002|Overall Study|Physician Decision|1|||
143052443|NCT05135273|515732365|FG000|Overall Study|Recruited into the army|0|||
143052444|NCT05135273|515732366|FG001|Overall Study|Recruited into the army|0|||
143052445|NCT05135273|515732367|FG002|Overall Study|Recruited into the army|0|||
143244859|NCT04292899|516448120|FG003|Overall Study|Withdrew consent|32|||
143244860|NCT04292899|516448117|FG000|Overall Study|Adverse Event|2|||
143244861|NCT04292899|516448118|FG001|Overall Study|Adverse Event|1|||
143244862|NCT04292899|516448119|FG002|Overall Study|Adverse Event|2|||
143499496|NCT00289913|517370430|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
143499497|NCT00289913|517370426|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
143244863|NCT04292899|516448120|FG003|Overall Study|Adverse Event|2|||
143244864|NCT04292899|516448117|FG000|Overall Study|Investigator's Discretion|0|||
143244865|NCT04292899|516448118|FG001|Overall Study|Investigator's Discretion|0|||
143244866|NCT04292899|516448119|FG002|Overall Study|Investigator's Discretion|0|||
143244867|NCT04292899|516448120|FG003|Overall Study|Investigator's Discretion|3|||
143244868|NCT04292899|516448117|FG000|Overall Study|Non-compliance With Study Drug|0|||
143244869|NCT04292899|516448118|FG001|Overall Study|Non-compliance With Study Drug|0|||
143244870|NCT04292899|516448119|FG002|Overall Study|Non-compliance With Study Drug|0|||
143244871|NCT04292899|516448120|FG003|Overall Study|Non-compliance With Study Drug|1|||
143244872|NCT04292899|516448117|FG000|Overall Study|Protocol Violation|0|||
143244873|NCT04292899|516448118|FG001|Overall Study|Protocol Violation|0|||
143244874|NCT04292899|516448119|FG002|Overall Study|Protocol Violation|0|||
143244875|NCT04292899|516448120|FG003|Overall Study|Protocol Violation|1|||
143244876|NCT03695367|516448121|FG000|Overall Study|Missed the Day 28 visit.|1|||
143244877|NCT03695367|516448122|FG001|Overall Study|Missed the Day 28 visit.|0|||
143244878|NCT03695367|516448121|FG000|Overall Study|Lost to Follow-up|0|||
143244879|NCT03695367|516448122|FG001|Overall Study|Lost to Follow-up|1|||
143244880|NCT03695367|516448121|FG000|Overall Study|Withdrawal by Subject|0|||
143499498|NCT00289913|517370427|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
143052446|NCT05135273|515732368|FG003|Overall Study|Recruited into the army|0|||
143052447|NCT05135273|515732369|FG004|Overall Study|Recruited into the army|1|||
143052448|NCT05135273|515732370|FG005|Overall Study|Recruited into the army|0|||
143052449|NCT05135273|515732371|FG006|Overall Study|Recruited into the army|0|||
143052450|NCT05135273|515732372|FG007|Overall Study|Recruited into the army|0|||
143052451|NCT05135273|515732365|FG000|Overall Study|Moved away from study site|0|||
143052452|NCT05135273|515732366|FG001|Overall Study|Moved away from study site|0|||
143052453|NCT05135273|515732367|FG002|Overall Study|Moved away from study site|0|||
143244881|NCT03695367|516448122|FG001|Overall Study|Withdrawal by Subject|1|||
143244882|NCT03695367|516448121|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
143244883|NCT03695367|516448122|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
143244884|NCT01032889|516448123|FG000|Overall Study|Adverse Event|2|||
143052454|NCT05135273|515732368|FG003|Overall Study|Moved away from study site|0|||
143052455|NCT05135273|515732369|FG004|Overall Study|Moved away from study site|0|||
143052456|NCT05135273|515732370|FG005|Overall Study|Moved away from study site|1|||
143052457|NCT05135273|515732371|FG006|Overall Study|Moved away from study site|1|||
143052458|NCT05135273|515732372|FG007|Overall Study|Moved away from study site|0|||
143052459|NCT05135273|515732365|FG000|Overall Study|Travel|0|||
143052460|NCT05135273|515732366|FG001|Overall Study|Travel|0|||
143052461|NCT05135273|515732367|FG002|Overall Study|Travel|0|||
143052462|NCT05135273|515732368|FG003|Overall Study|Travel|0|||
143052463|NCT05135273|515732369|FG004|Overall Study|Travel|0|||
143052464|NCT05135273|515732370|FG005|Overall Study|Travel|0|||
143052465|NCT05135273|515732371|FG006|Overall Study|Travel|0|||
143052466|NCT05135273|515732372|FG007|Overall Study|Travel|1|||
143052467|NCT01958060|515732380|FG000|Overall Study|Not treated|2|||
143052468|NCT01958060|515732381|FG001|Overall Study|Not treated|0|||
143052469|NCT01958060|515732382|FG002|Overall Study|Not treated|0|||
143052470|NCT01958060|515732383|FG003|Overall Study|Not treated|0|||
143052471|NCT01958060|515732384|FG004|Overall Study|Not treated|1|||
143052472|NCT01958060|515732385|FG005|Overall Study|Not treated|0|||
143052473|NCT01705717|515732386|FG000|Overall Study|Adverse Event|2|||
143052474|NCT01705717|515732387|FG001|Overall Study|Adverse Event|2|||
143052475|NCT01705717|515732386|FG000|Overall Study|Lack of Efficacy|0|||
143052476|NCT01705717|515732387|FG001|Overall Study|Lack of Efficacy|1|||
143052477|NCT01705717|515732386|FG000|Overall Study|Other|0|||
143052478|NCT01705717|515732387|FG001|Overall Study|Other|2|||
143052479|NCT01350934|515732397|FG000|Base Study|Adverse Event|6|||
143244885|NCT01032889|516448124|FG001|Overall Study|Adverse Event|2|||
143052480|NCT01350934|515732398|FG001|Base Study|Adverse Event|0|||
143052481|NCT01350934|515732397|FG000|Base Study|Lost to Follow-up|1|||
143052482|NCT01350934|515732398|FG001|Base Study|Lost to Follow-up|0|||
143052483|NCT01350934|515732397|FG000|Base Study|Protocol Violation|1|||
143052484|NCT01350934|515732398|FG001|Base Study|Protocol Violation|1|||
143052485|NCT01350934|515732397|FG000|Base Study|Withdrawal by Subject|1|||
143052486|NCT01350934|515732398|FG001|Base Study|Withdrawal by Subject|2|||
143052487|NCT01350934|515732397|FG000|Base Study|Non-Compliance With Study Drug|2|||
143052488|NCT01350934|515732398|FG001|Base Study|Non-Compliance With Study Drug|0|||
143052489|NCT01350934|515732397|FG000|Extension Study|Adverse Event|2|||
143052490|NCT01350934|515732398|FG001|Extension Study|Adverse Event|1|||
143052491|NCT01350934|515732397|FG000|Extension Study|Lost to Follow-up|2|||
143052492|NCT01350934|515732398|FG001|Extension Study|Lost to Follow-up|0|||
143052493|NCT01350934|515732397|FG000|Extension Study|Protocol Violation|1|||
143052494|NCT01350934|515732398|FG001|Extension Study|Protocol Violation|1|||
143052495|NCT01350934|515732397|FG000|Extension Study|Lack of Efficacy|0|||
143052496|NCT01350934|515732398|FG001|Extension Study|Lack of Efficacy|1|||
143052497|NCT01350934|515732397|FG000|Extension Study|Withdrawal by Subject|0|||
143052498|NCT01350934|515732398|FG001|Extension Study|Withdrawal by Subject|1|||
143052499|NCT00799708|515732406|FG000|Overall Study|non-compliance|1|||
143052500|NCT00799708|515732407|FG001|Overall Study|non-compliance|0|||
143052501|NCT00799708|515732408|FG002|Overall Study|non-compliance|0|||
143052502|NCT00880334|515732409|FG000|Randomized Phase|Physician Decision|1|||
143052503|NCT00880334|515732410|FG001|Randomized Phase|Physician Decision|0|||
143052504|NCT00880334|515732409|FG000|Randomized Phase|Withdrawal by Subject|2|||
143052505|NCT00880334|515732410|FG001|Randomized Phase|Withdrawal by Subject|1|||
143052506|NCT00880334|515732409|FG000|Randomized Phase|Inadequate Labs|1|||
143052507|NCT00880334|515732410|FG001|Randomized Phase|Inadequate Labs|1|||
143052508|NCT00880334|515732409|FG000|Randomized Phase|Brain Metastasis|0|||
143052509|NCT00880334|515732410|FG001|Randomized Phase|Brain Metastasis|1|||
143052510|NCT00880334|515732409|FG000|Randomized Phase|Crossover Participants|0|||
143052511|NCT00880334|515732410|FG001|Randomized Phase|Crossover Participants|37|||
143052512|NCT02473393|515732411|FG000|Overall Study|Adverse Event|0|||
143052513|NCT02473393|515732412|FG001|Overall Study|Adverse Event|0|||
143052514|NCT02473393|515732413|FG002|Overall Study|Adverse Event|1|||
143052515|NCT02473393|515732414|FG003|Overall Study|Adverse Event|0|||
143052516|NCT02473393|515732411|FG000|Overall Study|Withdrawal by Subject|0|||
143052517|NCT02473393|515732412|FG001|Overall Study|Withdrawal by Subject|0|||
143052518|NCT02473393|515732413|FG002|Overall Study|Withdrawal by Subject|1|||
143052519|NCT02473393|515732414|FG003|Overall Study|Withdrawal by Subject|1|||
143052520|NCT00611884|515732418|FG000|Overall Study|Adverse Event|1|||
143052521|NCT00611884|515732419|FG001|Overall Study|Adverse Event|0|||
143052522|NCT00611884|515732420|FG002|Overall Study|Adverse Event|0|||
143052523|NCT00611884|515732421|FG003|Overall Study|Adverse Event|1|||
143052524|NCT00611884|515732418|FG000|Overall Study|Non-Compliance|1|||
143052525|NCT00611884|515732419|FG001|Overall Study|Non-Compliance|4|||
143052526|NCT00611884|515732420|FG002|Overall Study|Non-Compliance|2|||
143052527|NCT00611884|515732421|FG003|Overall Study|Non-Compliance|2|||
143052528|NCT00611884|515732418|FG000|Overall Study|Lack of Efficacy|0|||
143052529|NCT00611884|515732419|FG001|Overall Study|Lack of Efficacy|1|||
143052530|NCT00611884|515732420|FG002|Overall Study|Lack of Efficacy|0|||
143052531|NCT00611884|515732421|FG003|Overall Study|Lack of Efficacy|0|||
143052532|NCT00611884|515732418|FG000|Overall Study|Unclassified|7|||
143052533|NCT00611884|515732419|FG001|Overall Study|Unclassified|4|||
143052534|NCT00611884|515732420|FG002|Overall Study|Unclassified|2|||
143052535|NCT00611884|515732421|FG003|Overall Study|Unclassified|3|||
143052536|NCT03433703|515732422|FG000|Overall Study|Study terminated by Sponsor|2|||
143052537|NCT01617096|515732429|FG000|Overall Study|Withdrawal by Subject|96|||
143052538|NCT01617096|515732430|FG001|Overall Study|Withdrawal by Subject|81|||
143052539|NCT01617096|515732429|FG000|Overall Study|Lost to Follow-up|37|||
143052540|NCT01617096|515732430|FG001|Overall Study|Lost to Follow-up|32|||
143052541|NCT01617096|515732429|FG000|Overall Study|Physician Decision|10|||
143052542|NCT01617096|515732430|FG001|Overall Study|Physician Decision|18|||
143052543|NCT01617096|515732429|FG000|Overall Study|Death|4|||
143052544|NCT01617096|515732430|FG001|Overall Study|Death|3|||
143052545|NCT01617096|515732429|FG000|Overall Study|Other|1|||
143052546|NCT01617096|515732430|FG001|Overall Study|Other|3|||
143052547|NCT04535986|515732435|FG000|Overall Study|Death|4|||
143052548|NCT04535986|515732436|FG001|Overall Study|Death|5|||
143052549|NCT04535986|515732435|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
143052550|NCT04535986|515732436|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
143052551|NCT04535986|515732435|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
143052552|NCT04535986|515732436|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
143052553|NCT04535986|515732435|FG000|Overall Study|Adverse Event|10|||
143052554|NCT04535986|515732436|FG001|Overall Study|Adverse Event|1|||
143052555|NCT04535986|515732435|FG000|Overall Study|Lack of Efficacy|3|||
143052556|NCT04535986|515732436|FG001|Overall Study|Lack of Efficacy|2|||
143052557|NCT04535986|515732435|FG000|Overall Study|Investigator discretion|3|||
143052558|NCT04535986|515732436|FG001|Overall Study|Investigator discretion|0|||
143052559|NCT04535986|515732435|FG000|Overall Study|Withdrawal by Subject|32|||
143052560|NCT04535986|515732436|FG001|Overall Study|Withdrawal by Subject|14|||
143052561|NCT04535986|515732435|FG000|Overall Study|Lost to Follow-up|5|||
143052562|NCT04535986|515732436|FG001|Overall Study|Lost to Follow-up|3|||
143052563|NCT04535986|515732435|FG000|Overall Study|Other|7|||
143052564|NCT04535986|515732436|FG001|Overall Study|Other|3|||
143052565|NCT01196390|515732437|FG000|Overall Study|Protocol Violation|4|||
143052566|NCT01196390|515732438|FG001|Overall Study|Protocol Violation|5|||
143052567|NCT03141151|515732448|FG000|Overall Study|Lost to Follow-up|3|||
143052568|NCT03141151|515732449|FG001|Overall Study|Lost to Follow-up|2|||
143052569|NCT03141151|515732448|FG000|Overall Study|Withdrawal by Subject|3|||
143052570|NCT03141151|515732449|FG001|Overall Study|Withdrawal by Subject|2|||
143052571|NCT04561115|515732450|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
143052572|NCT04561115|515732451|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
143052573|NCT04561115|515732450|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
143052574|NCT04561115|515732451|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
143244886|NCT01032889|516448125|FG002|Overall Study|Adverse Event|0|||
143244887|NCT01032889|516448123|FG000|Overall Study|Withdrawal of Consent|1|||
143052575|NCT04561115|515732450|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
143052576|NCT04561115|515732451|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
143052577|NCT00743145|515732452|FG000|Overall Study|Withdrawal by Subject|1|||
143052578|NCT00743145|515732452|FG000|Overall Study|Adverse Event|2|||
143052579|NCT00743145|515732452|FG000|Overall Study|Pregnancy|1|||
143052580|NCT01745094|515732453|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
143244888|NCT01032889|516448124|FG001|Overall Study|Withdrawal of Consent|2|||
143244889|NCT01032889|516448125|FG002|Overall Study|Withdrawal of Consent|1|||
143244890|NCT01032889|516448123|FG000|Overall Study|Patient Request|0|||
143244891|NCT01032889|516448124|FG001|Overall Study|Patient Request|1|||
143244892|NCT01032889|516448125|FG002|Overall Study|Patient Request|0|||
143244893|NCT01032889|516448123|FG000|Overall Study|Lost to Follow-up|1|||
143244894|NCT01032889|516448124|FG001|Overall Study|Lost to Follow-up|1|||
143244895|NCT01032889|516448125|FG002|Overall Study|Lost to Follow-up|0|||
143244896|NCT01032889|516448123|FG000|Overall Study|Lack of Submental Fat|2|||
143244897|NCT01032889|516448124|FG001|Overall Study|Lack of Submental Fat|8|||
143499499|NCT00289913|517370428|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
143499500|NCT00289913|517370429|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
143499501|NCT00289913|517370430|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
143052581|NCT01745094|515732454|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
143052582|NCT01745094|515732455|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
143052583|NCT01745094|515732456|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
143052584|NCT01745094|515732453|FG000|Overall Study|Adverse Event|0|||
143244898|NCT01032889|516448125|FG002|Overall Study|Lack of Submental Fat|1|||
143244899|NCT01032889|516448123|FG000|Overall Study|Miscellaneous Reasons|2|||
143244900|NCT01032889|516448124|FG001|Overall Study|Miscellaneous Reasons|1|||
143052585|NCT01745094|515732454|FG001|Overall Study|Adverse Event|0|||
143052586|NCT01745094|515732455|FG002|Overall Study|Adverse Event|3|||
143052587|NCT01745094|515732456|FG003|Overall Study|Adverse Event|0|||
143052588|NCT01745094|515732453|FG000|Overall Study|Withdrawal by Subject|2|||
143052589|NCT01745094|515732454|FG001|Overall Study|Withdrawal by Subject|0|||
143052590|NCT01745094|515732455|FG002|Overall Study|Withdrawal by Subject|1|||
143052591|NCT01745094|515732456|FG003|Overall Study|Withdrawal by Subject|2|||
143052592|NCT01745094|515732453|FG000|Overall Study|Protocol Violation|1|||
143052593|NCT01745094|515732454|FG001|Overall Study|Protocol Violation|0|||
143052594|NCT01745094|515732455|FG002|Overall Study|Protocol Violation|3|||
143052595|NCT01745094|515732456|FG003|Overall Study|Protocol Violation|1|||
143052596|NCT01745094|515732453|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
143052597|NCT01745094|515732454|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
143052598|NCT01745094|515732455|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
143052599|NCT01745094|515732456|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
143052600|NCT01745094|515732453|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
143052601|NCT01745094|515732454|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
143052602|NCT01745094|515732455|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
143052603|NCT01745094|515732456|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
143052604|NCT01745094|515732453|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
143052605|NCT01745094|515732454|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
143052606|NCT01745094|515732455|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
143052607|NCT01745094|515732456|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
143052608|NCT01097694|515732457|FG000|Overall Study|Adverse Event|5|||
143052609|NCT01097694|515732458|FG001|Overall Study|Adverse Event|0|||
143052610|NCT01097694|515732457|FG000|Overall Study|Lost to Follow-up|0|||
143052611|NCT01097694|515732458|FG001|Overall Study|Lost to Follow-up|3|||
143052612|NCT01097694|515732457|FG000|Overall Study|Withdrawal by Subject|3|||
143052613|NCT01097694|515732458|FG001|Overall Study|Withdrawal by Subject|1|||
143052614|NCT03922750|515732459|FG000|Overall Study|Unclassified|0|||
143052615|NCT03922750|515732460|FG001|Overall Study|Unclassified|0|||
143052616|NCT03922750|515732461|FG002|Overall Study|Unclassified|1|||
143052617|NCT03922750|515732459|FG000|Overall Study|Adverse Event|0|||
143052618|NCT03922750|515732460|FG001|Overall Study|Adverse Event|1|||
143052619|NCT03922750|515732461|FG002|Overall Study|Adverse Event|0|||
143052620|NCT00283842|515732466|FG000|Overall Study|Adverse Event|8|||
143052621|NCT00283842|515732467|FG001|Overall Study|Adverse Event|7|||
143052622|NCT00283842|515732468|FG002|Overall Study|Adverse Event|21|||
143052623|NCT00283842|515732469|FG003|Overall Study|Adverse Event|21|||
143052624|NCT00283842|515732470|FG004|Overall Study|Adverse Event|5|||
143052625|NCT00283842|515732466|FG000|Overall Study|Protocol Violation|1|||
143052626|NCT00283842|515732467|FG001|Overall Study|Protocol Violation|5|||
143052627|NCT00283842|515732468|FG002|Overall Study|Protocol Violation|4|||
143052628|NCT00283842|515732469|FG003|Overall Study|Protocol Violation|0|||
143052629|NCT00283842|515732470|FG004|Overall Study|Protocol Violation|0|||
143052630|NCT00283842|515732466|FG000|Overall Study|Protocol deviation|0|||
143052631|NCT00283842|515732467|FG001|Overall Study|Protocol deviation|0|||
143052632|NCT00283842|515732468|FG002|Overall Study|Protocol deviation|0|||
143052633|NCT00283842|515732469|FG003|Overall Study|Protocol deviation|0|||
143052634|NCT00283842|515732470|FG004|Overall Study|Protocol deviation|2|||
143052635|NCT00283842|515732466|FG000|Overall Study|Withdrawal by Subject|2|||
143052636|NCT00283842|515732467|FG001|Overall Study|Withdrawal by Subject|1|||
143052637|NCT00283842|515732468|FG002|Overall Study|Withdrawal by Subject|1|||
143052638|NCT00283842|515732469|FG003|Overall Study|Withdrawal by Subject|5|||
143052639|NCT00283842|515732470|FG004|Overall Study|Withdrawal by Subject|4|||
143052640|NCT00283842|515732466|FG000|Overall Study|Lack of Efficacy|1|||
143052641|NCT00283842|515732467|FG001|Overall Study|Lack of Efficacy|3|||
143052642|NCT00283842|515732468|FG002|Overall Study|Lack of Efficacy|1|||
143499502|NCT00289913|517370426|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
143499503|NCT00289913|517370427|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
143499504|NCT00289913|517370428|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
143499505|NCT00289913|517370429|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
143499506|NCT00289913|517370430|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
143052643|NCT00283842|515732469|FG003|Overall Study|Lack of Efficacy|0|||
143052644|NCT00283842|515732470|FG004|Overall Study|Lack of Efficacy|3|||
143052645|NCT00283842|515732466|FG000|Overall Study|Lost to Follow-up|0|||
143052646|NCT00283842|515732467|FG001|Overall Study|Lost to Follow-up|2|||
143052647|NCT00283842|515732468|FG002|Overall Study|Lost to Follow-up|4|||
143052648|NCT00283842|515732469|FG003|Overall Study|Lost to Follow-up|1|||
143052649|NCT00283842|515732470|FG004|Overall Study|Lost to Follow-up|1|||
143052650|NCT01567527|515732471|FG000|Conversion Phase.|Protocol deviation|3|||
143052651|NCT01567527|515732472|FG001|Conversion Phase.|Protocol deviation|0|||
143052652|NCT01567527|515732473|FG002|Conversion Phase.|Protocol deviation|0|||
143052653|NCT01567527|515732474|FG003|Conversion Phase.|Protocol deviation|0|||
143052654|NCT01567527|515732475|FG004|Conversion Phase.|Protocol deviation|0|||
143052655|NCT01567527|515732471|FG000|Conversion Phase.|Met withdrawal criteria|10|||
143052656|NCT01567527|515732472|FG001|Conversion Phase.|Met withdrawal criteria|0|||
143052657|NCT01567527|515732473|FG002|Conversion Phase.|Met withdrawal criteria|0|||
143052658|NCT01567527|515732474|FG003|Conversion Phase.|Met withdrawal criteria|0|||
143052659|NCT01567527|515732475|FG004|Conversion Phase.|Met withdrawal criteria|0|||
143052660|NCT01567527|515732471|FG000|Conversion Phase.|Withdrawal by Subject|32|||
143052661|NCT01567527|515732472|FG001|Conversion Phase.|Withdrawal by Subject|0|||
143052662|NCT01567527|515732473|FG002|Conversion Phase.|Withdrawal by Subject|0|||
143052663|NCT01567527|515732474|FG003|Conversion Phase.|Withdrawal by Subject|0|||
143052664|NCT01567527|515732475|FG004|Conversion Phase.|Withdrawal by Subject|0|||
143052665|NCT01567527|515732471|FG000|Conversion Phase.|Lost to Follow-up|16|||
143052666|NCT01567527|515732472|FG001|Conversion Phase.|Lost to Follow-up|0|||
143052667|NCT01567527|515732473|FG002|Conversion Phase.|Lost to Follow-up|0|||
143052668|NCT01567527|515732474|FG003|Conversion Phase.|Lost to Follow-up|0|||
143052669|NCT01567527|515732475|FG004|Conversion Phase.|Lost to Follow-up|0|||
143052670|NCT01567527|515732471|FG000|Conversion Phase.|Lack of Efficacy|2|||
143052671|NCT01567527|515732472|FG001|Conversion Phase.|Lack of Efficacy|0|||
143052672|NCT01567527|515732473|FG002|Conversion Phase.|Lack of Efficacy|0|||
143052673|NCT01567527|515732474|FG003|Conversion Phase.|Lack of Efficacy|0|||
143052674|NCT01567527|515732475|FG004|Conversion Phase.|Lack of Efficacy|0|||
143052675|NCT01567527|515732471|FG000|Conversion Phase.|Adverse Event|33|||
143052676|NCT01567527|515732472|FG001|Conversion Phase.|Adverse Event|0|||
143052677|NCT01567527|515732473|FG002|Conversion Phase.|Adverse Event|0|||
143052678|NCT01567527|515732474|FG003|Conversion Phase.|Adverse Event|0|||
143052679|NCT01567527|515732475|FG004|Conversion Phase.|Adverse Event|0|||
143052680|NCT01567527|515732471|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
143052681|NCT01567527|515732472|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
143052682|NCT01567527|515732473|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
143052683|NCT01567527|515732474|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
143052684|NCT01567527|515732475|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
143052685|NCT01567527|515732471|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
143052686|NCT01567527|515732472|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
143052687|NCT01567527|515732473|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
143052688|NCT01567527|515732474|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
143052689|NCT01567527|515732475|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
143052690|NCT01567527|515732471|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
143052691|NCT01567527|515732472|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
143052692|NCT01567527|515732473|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
143052693|NCT01567527|515732474|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
143052694|NCT01567527|515732475|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
143052695|NCT01567527|515732471|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
143052696|NCT01567527|515732472|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
143052697|NCT01567527|515732473|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
143052698|NCT01567527|515732474|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
143052699|NCT01567527|515732475|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
143052700|NCT01567527|515732471|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
143052701|NCT01567527|515732472|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
143052702|NCT01567527|515732473|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
143052703|NCT01567527|515732474|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
143052704|NCT01567527|515732475|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
143052705|NCT01567527|515732471|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
143052706|NCT01567527|515732472|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
143052707|NCT01567527|515732473|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
143052708|NCT01567527|515732474|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
143052709|NCT01567527|515732475|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
143052710|NCT01567527|515732471|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
143052711|NCT01567527|515732472|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
143052712|NCT01567527|515732473|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
143052713|NCT01567527|515732474|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
143052714|NCT01567527|515732475|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
143052715|NCT01567527|515732471|FG000|IM Depot Stabilization.|Protocol deviation|0|||
143052716|NCT01567527|515732472|FG001|IM Depot Stabilization.|Protocol deviation|0|||
143052717|NCT01567527|515732473|FG002|IM Depot Stabilization.|Protocol deviation|5|||
143052718|NCT01567527|515732474|FG003|IM Depot Stabilization.|Protocol deviation|0|||
143169289|NCT04622592|516169821|FG001|Overall Study|Other than specified above|0|||
143169290|NCT04622592|516169822|FG002|Overall Study|Other than specified above|1|||
143169291|NCT04622592|516169823|FG003|Overall Study|Other than specified above|0|||
143052719|NCT01567527|515732475|FG004|IM Depot Stabilization.|Protocol deviation|0|||
143052720|NCT01567527|515732471|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
143169292|NCT04622592|516169824|FG004|Overall Study|Other than specified above|0|||
143499507|NCT00289913|517370426|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
143499508|NCT00289913|517370427|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
143499509|NCT00289913|517370428|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
143499510|NCT00289913|517370429|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
143499511|NCT00289913|517370430|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
143499512|NCT00289913|517370426|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
143499513|NCT00289913|517370427|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
143499514|NCT00289913|517370428|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
143499515|NCT00289913|517370429|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
143499516|NCT00289913|517370430|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
143499517|NCT00289913|517370426|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
143499518|NCT00289913|517370427|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
143499519|NCT00289913|517370428|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
143499520|NCT00289913|517370429|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
143499521|NCT00289913|517370430|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
143052721|NCT01567527|515732472|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
143052722|NCT01567527|515732473|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
143052723|NCT01567527|515732474|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
143052724|NCT01567527|515732475|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
143052725|NCT01567527|515732471|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
143052726|NCT01567527|515732472|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
143052727|NCT01567527|515732473|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
143052728|NCT01567527|515732474|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
143052729|NCT01567527|515732475|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
143052730|NCT01567527|515732471|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
143169293|NCT04622592|516169825|FG005|Overall Study|Other than specified above|0|||
143169294|NCT04622592|516169826|FG006|Overall Study|Other than specified above|0|||
143169295|NCT04622592|516169827|FG007|Overall Study|Other than specified above|0|||
143169296|NCT00565747|516169834|FG000|Overall Study|No embryo transfer|67|||
143169297|NCT00565747|516169835|FG001|Overall Study|No embryo transfer|73|||
143169298|NCT00183248|516169836|FG000|Overall Study|Lost to Follow-up|0|||
143169299|NCT00183248|516169837|FG001|Overall Study|Lost to Follow-up|1|||
143169300|NCT00183248|516169836|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
143169301|NCT00183248|516169837|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
143169302|NCT03580044|516169840|FG000|Overall Study|Death|2|||
143169303|NCT03580044|516169841|FG001|Overall Study|Death|1|||
143169304|NCT03580044|516169840|FG000|Overall Study|Withdrawal by Subject|1|||
143169305|NCT03580044|516169841|FG001|Overall Study|Withdrawal by Subject|1|||
143169306|NCT04903288|516169847|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
143169307|NCT04903288|516169847|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
143169308|NCT04903288|516169847|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
143169309|NCT04903288|516169847|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
143169310|NCT04617860|516169859|FG000|Overall Study|Adverse Event|0|||
143169311|NCT04617860|516169860|FG001|Overall Study|Adverse Event|2|||
143169312|NCT04617860|516169861|FG002|Overall Study|Adverse Event|2|||
143169313|NCT04617860|516169859|FG000|Overall Study|Withdrawal by Subject|0|||
143169314|NCT04617860|516169860|FG001|Overall Study|Withdrawal by Subject|0|||
143169315|NCT04617860|516169861|FG002|Overall Study|Withdrawal by Subject|2|||
143169316|NCT04617860|516169859|FG000|Overall Study|Physician Decision|0|||
143169317|NCT04617860|516169860|FG001|Overall Study|Physician Decision|1|||
143169318|NCT04617860|516169861|FG002|Overall Study|Physician Decision|0|||
143169319|NCT04617860|516169859|FG000|Overall Study|Sponsor Decision|0|||
143169320|NCT04617860|516169860|FG001|Overall Study|Sponsor Decision|3|||
143169321|NCT04617860|516169861|FG002|Overall Study|Sponsor Decision|1|||
143169322|NCT04617860|516169859|FG000|Overall Study|Termination of Study by Sponsor|8|||
143169323|NCT04617860|516169860|FG001|Overall Study|Termination of Study by Sponsor|4|||
143169324|NCT04617860|516169861|FG002|Overall Study|Termination of Study by Sponsor|13|||
143169325|NCT02300233|516169864|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
143169326|NCT02300233|516169865|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
143169327|NCT02300233|516169866|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
143169328|NCT02300233|516169864|FG000|Overall Study|Withdrawal by Subject|1|||
143169329|NCT02300233|516169865|FG001|Overall Study|Withdrawal by Subject|0|||
143169330|NCT02300233|516169866|FG002|Overall Study|Withdrawal by Subject|3|||
143169331|NCT02300233|516169864|FG000|Overall Study|Investigator Judgement|0|||
143499522|NCT00289913|517370426|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
143169332|NCT02300233|516169865|FG001|Overall Study|Investigator Judgement|0|||
143169333|NCT02300233|516169866|FG002|Overall Study|Investigator Judgement|1|||
143169334|NCT02300233|516169864|FG000|Overall Study|Reason Not Specified|0|||
143169335|NCT02300233|516169865|FG001|Overall Study|Reason Not Specified|0|||
143499523|NCT00289913|517370427|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
143052731|NCT01567527|515732472|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
143052732|NCT01567527|515732473|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
143052733|NCT01567527|515732474|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
143052734|NCT01567527|515732475|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
143052735|NCT01567527|515732471|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
143052736|NCT01567527|515732472|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
143052737|NCT01567527|515732473|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
143052738|NCT01567527|515732474|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
143052739|NCT01567527|515732475|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
143052740|NCT01567527|515732471|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
143052741|NCT01567527|515732472|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
143052742|NCT01567527|515732473|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
143052743|NCT01567527|515732474|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
143052744|NCT01567527|515732475|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
143052745|NCT01567527|515732471|FG000|IM Depot Stabilization.|Adverse Event|0|||
143052746|NCT01567527|515732472|FG001|IM Depot Stabilization.|Adverse Event|0|||
143052747|NCT01567527|515732473|FG002|IM Depot Stabilization.|Adverse Event|37|||
143052748|NCT01567527|515732474|FG003|IM Depot Stabilization.|Adverse Event|0|||
143052749|NCT01567527|515732475|FG004|IM Depot Stabilization.|Adverse Event|0|||
143052750|NCT01567527|515732471|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
143052751|NCT01567527|515732472|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
143052752|NCT01567527|515732473|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
143052753|NCT01567527|515732474|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
143052754|NCT01567527|515732475|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
143052755|NCT01567527|515732471|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
143052756|NCT01567527|515732472|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
143052757|NCT01567527|515732473|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
143052758|NCT01567527|515732474|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
143052759|NCT01567527|515732475|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
143052760|NCT01567527|515732471|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
143052761|NCT01567527|515732472|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
143052762|NCT01567527|515732473|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
143052763|NCT01567527|515732474|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
143052764|NCT01567527|515732475|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
143052765|NCT01567527|515732471|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
143052766|NCT01567527|515732472|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
143052767|NCT01567527|515732473|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
143052768|NCT01567527|515732474|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
143052769|NCT01567527|515732475|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
143052770|NCT01567527|515732471|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
143052771|NCT01567527|515732472|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
143052772|NCT01567527|515732473|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
143052773|NCT01567527|515732474|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
143052774|NCT01567527|515732475|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
143052775|NCT01567527|515732471|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
143052776|NCT01567527|515732472|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
143052777|NCT01567527|515732473|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
143052778|NCT01567527|515732474|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
143052779|NCT01567527|515732475|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
143052780|NCT01567527|515732471|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
143052781|NCT01567527|515732472|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
143052782|NCT01567527|515732473|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
143052783|NCT01567527|515732474|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
143052784|NCT01567527|515732475|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
143052785|NCT01567527|515732471|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
143052786|NCT01567527|515732472|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
143052787|NCT01567527|515732473|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
143052788|NCT01567527|515732474|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
143052789|NCT01567527|515732475|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
143052790|NCT01567527|515732471|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
143052791|NCT01567527|515732472|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
143052792|NCT01567527|515732473|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
143052793|NCT01567527|515732474|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
143364558|NCT01352507|516877031|FG000|Treatment Period 2|Withdrawal by Subject|4|||
143364559|NCT01352507|516877032|FG001|Treatment Period 2|Withdrawal by Subject|3|||
143364560|NCT01352507|516877031|FG000|Treatment Period 2|Lack of Efficacy|1|||
143364561|NCT01352507|516877032|FG001|Treatment Period 2|Lack of Efficacy|0|||
143364562|NCT01119703|516877033|FG000|Overall Study|Adverse Event|0|||
143364563|NCT01119703|516877034|FG001|Overall Study|Adverse Event|1|||
143364564|NCT02096003|516877035|FG000|Overall Study|Protocol Violation|0|||
143364565|NCT02096003|516877036|FG001|Overall Study|Protocol Violation|2|||
143364566|NCT02096003|516877035|FG000|Overall Study|additional surgery|2|||
143364567|NCT02096003|516877036|FG001|Overall Study|additional surgery|1|||
143364568|NCT01511250|516877037|FG000|Overall Study|Withdrawal of Consent|1|||
143364569|NCT01511250|516877038|FG001|Overall Study|Withdrawal of Consent|0|||
143364570|NCT01511250|516877039|FG002|Overall Study|Withdrawal of Consent|0|||
143364571|NCT01511250|516877040|FG003|Overall Study|Withdrawal of Consent|0|||
143364572|NCT01511250|516877041|FG004|Overall Study|Withdrawal of Consent|0|||
143364573|NCT01511250|516877042|FG005|Overall Study|Withdrawal of Consent|0|||
143364574|NCT01511250|516877043|FG006|Overall Study|Withdrawal of Consent|0|||
143364575|NCT01511250|516877044|FG007|Overall Study|Withdrawal of Consent|1|||
143364576|NCT01511250|516877045|FG008|Overall Study|Withdrawal of Consent|1|||
143364577|NCT01511250|516877046|FG009|Overall Study|Withdrawal of Consent|0|||
143364578|NCT01511250|516877037|FG000|Overall Study|Sponsor/Investigator Decision|1|||
143364579|NCT01511250|516877038|FG001|Overall Study|Sponsor/Investigator Decision|0|||
143364580|NCT01511250|516877039|FG002|Overall Study|Sponsor/Investigator Decision|0|||
143364581|NCT01511250|516877040|FG003|Overall Study|Sponsor/Investigator Decision|0|||
143364582|NCT01511250|516877041|FG004|Overall Study|Sponsor/Investigator Decision|0|||
143364583|NCT01511250|516877042|FG005|Overall Study|Sponsor/Investigator Decision|0|||
143364584|NCT01511250|516877043|FG006|Overall Study|Sponsor/Investigator Decision|0|||
143364585|NCT01511250|516877044|FG007|Overall Study|Sponsor/Investigator Decision|0|||
143364586|NCT01511250|516877045|FG008|Overall Study|Sponsor/Investigator Decision|0|||
143364587|NCT01511250|516877046|FG009|Overall Study|Sponsor/Investigator Decision|0|||
143364588|NCT01511250|516877037|FG000|Overall Study|Lost to Follow-up|7|||
143364589|NCT01511250|516877038|FG001|Overall Study|Lost to Follow-up|3|||
143364590|NCT01511250|516877039|FG002|Overall Study|Lost to Follow-up|3|||
143364591|NCT01511250|516877040|FG003|Overall Study|Lost to Follow-up|3|||
143364592|NCT01511250|516877041|FG004|Overall Study|Lost to Follow-up|0|||
143364593|NCT01511250|516877042|FG005|Overall Study|Lost to Follow-up|0|||
143364594|NCT01511250|516877043|FG006|Overall Study|Lost to Follow-up|2|||
143364595|NCT01511250|516877044|FG007|Overall Study|Lost to Follow-up|3|||
143364596|NCT01511250|516877045|FG008|Overall Study|Lost to Follow-up|13|||
143364597|NCT01511250|516877046|FG009|Overall Study|Lost to Follow-up|5|||
143364598|NCT01511250|516877037|FG000|Overall Study|Protocol Violation|0|||
143364599|NCT01511250|516877038|FG001|Overall Study|Protocol Violation|2|||
143364600|NCT01511250|516877039|FG002|Overall Study|Protocol Violation|1|||
143364601|NCT01511250|516877040|FG003|Overall Study|Protocol Violation|0|||
143364602|NCT01511250|516877041|FG004|Overall Study|Protocol Violation|0|||
143364603|NCT01511250|516877042|FG005|Overall Study|Protocol Violation|0|||
143364604|NCT01511250|516877043|FG006|Overall Study|Protocol Violation|0|||
143364605|NCT01511250|516877044|FG007|Overall Study|Protocol Violation|0|||
143364606|NCT01511250|516877045|FG008|Overall Study|Protocol Violation|0|||
143364607|NCT01511250|516877046|FG009|Overall Study|Protocol Violation|0|||
143364608|NCT03178201|516877047|FG000|Overall Study|Off study|5|||
143364609|NCT01763047|516877048|FG000|Period 1|Test Article Not Available|4|||
143052794|NCT01567527|515732475|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
143052795|NCT02004691|515732476|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
143244901|NCT01032889|516448125|FG002|Overall Study|Miscellaneous Reasons|1|||
143244902|NCT00828204|516448128|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
143244903|NCT00828204|516448129|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
143244904|NCT00828204|516448128|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
143244905|NCT00828204|516448129|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
143244906|NCT00828204|516448128|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
143244907|NCT00828204|516448129|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
143244908|NCT00828204|516448128|FG000|Main Study: After Study Restart|Adverse Event|0|||
143244909|NCT00828204|516448129|FG001|Main Study: After Study Restart|Adverse Event|2|||
143244910|NCT00828204|516448128|FG000|Main Study: After Study Restart|Noncompliance|0|||
143244911|NCT00828204|516448129|FG001|Main Study: After Study Restart|Noncompliance|1|||
143244912|NCT00828204|516448128|FG000|Extension Study|Lost to Follow-up|0|||
143244913|NCT00828204|516448129|FG001|Extension Study|Lost to Follow-up|1|||
143244914|NCT00828204|516448128|FG000|Extension Study|Physician Decision|0|||
143364610|NCT01763047|516877049|FG001|Period 1|Test Article Not Available|1|||
143364611|NCT01763047|516877048|FG000|Period 1|Protocol Violation|4|||
143364612|NCT01763047|516877049|FG001|Period 1|Protocol Violation|4|||
143052796|NCT02004691|515732477|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
143244915|NCT00828204|516448129|FG001|Extension Study|Physician Decision|2|||
143364613|NCT01763047|516877048|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
143364614|NCT01763047|516877049|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
143499524|NCT00289913|517370428|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
143499525|NCT00289913|517370429|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
143052797|NCT02004691|515732476|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
143052798|NCT02004691|515732477|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
143052799|NCT02004691|515732476|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
143052800|NCT02004691|515732477|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
143052801|NCT02004691|515732476|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
143052802|NCT02004691|515732477|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
143364615|NCT01763047|516877048|FG000|Period 1|Adverse Event|0|||
143364616|NCT01763047|516877049|FG001|Period 1|Adverse Event|1|||
143364617|NCT01763047|516877048|FG000|Period 1|Unsatisfactory Visual Response|0|||
143364618|NCT01763047|516877049|FG001|Period 1|Unsatisfactory Visual Response|3|||
143364619|NCT01763047|516877048|FG000|Period 1|Lens Power Not Available|0|||
143364620|NCT01763047|516877049|FG001|Period 1|Lens Power Not Available|1|||
143364621|NCT01763047|516877048|FG000|Period 1|Study Site office Closed|0|||
143364622|NCT01763047|516877049|FG001|Period 1|Study Site office Closed|1|||
143364623|NCT01763047|516877048|FG000|Period 2|Lens Discomfort|1|||
143364624|NCT01763047|516877049|FG001|Period 2|Lens Discomfort|0|||
143364625|NCT01763047|516877048|FG000|Period 2|No longer meets Eligibility Criteria|1|||
143364626|NCT01763047|516877049|FG001|Period 2|No longer meets Eligibility Criteria|0|||
143364627|NCT01763047|516877048|FG000|Period 2|Study Site office Closed|1|||
143364628|NCT01763047|516877049|FG001|Period 2|Study Site office Closed|1|||
143364629|NCT01763047|516877048|FG000|Period 2|Unsatisfactory Visual Response|1|||
143364630|NCT01763047|516877049|FG001|Period 2|Unsatisfactory Visual Response|1|||
143364631|NCT01763047|516877048|FG000|Period 2|Protocol Violation|0|||
143364632|NCT01763047|516877049|FG001|Period 2|Protocol Violation|2|||
143364633|NCT01763047|516877048|FG000|Period 2|Unsatisfactory lens Fitting|0|||
143364634|NCT01763047|516877049|FG001|Period 2|Unsatisfactory lens Fitting|1|||
143364635|NCT01008748|516877056|FG000|Overall Study|Lost to Follow-up|80|||
143364636|NCT01008748|516877056|FG000|Overall Study|Other|1|||
143364637|NCT00359619|516878660|FG000|Overall Study|Adverse Event|0|||
143364638|NCT00359619|516878661|FG001|Overall Study|Adverse Event|0|||
143364639|NCT00359619|516878662|FG002|Overall Study|Adverse Event|1|||
143364640|NCT00359619|516878663|FG003|Overall Study|Adverse Event|0|||
143364641|NCT00359619|516878664|FG004|Overall Study|Adverse Event|0|||
143364642|NCT00359619|516878665|FG005|Overall Study|Adverse Event|0|||
143364643|NCT00359619|516878666|FG006|Overall Study|Adverse Event|1|||
143364644|NCT00359619|516878660|FG000|Overall Study|Withdrawal by Subject|3|||
143364645|NCT00359619|516878661|FG001|Overall Study|Withdrawal by Subject|1|||
143364646|NCT00359619|516878662|FG002|Overall Study|Withdrawal by Subject|4|||
143364647|NCT00359619|516878663|FG003|Overall Study|Withdrawal by Subject|2|||
143364648|NCT00359619|516878664|FG004|Overall Study|Withdrawal by Subject|2|||
143364649|NCT00359619|516878665|FG005|Overall Study|Withdrawal by Subject|0|||
143364650|NCT00359619|516878666|FG006|Overall Study|Withdrawal by Subject|3|||
143364651|NCT00359619|516878660|FG000|Overall Study|Other|1|||
143364652|NCT00359619|516878661|FG001|Overall Study|Other|0|||
143364653|NCT00359619|516878662|FG002|Overall Study|Other|0|||
143364654|NCT00359619|516878663|FG003|Overall Study|Other|0|||
143364655|NCT00359619|516878664|FG004|Overall Study|Other|0|||
143364656|NCT00359619|516878665|FG005|Overall Study|Other|0|||
143364657|NCT00359619|516878666|FG006|Overall Study|Other|0|||
143499526|NCT00289913|517370430|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
143499527|NCT00289913|517370426|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
143499528|NCT00289913|517370427|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
143499529|NCT00289913|517370428|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
143499530|NCT00289913|517370429|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
143499531|NCT00289913|517370430|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
143499532|NCT00289913|517370426|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
143052803|NCT02004691|515732476|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
143052804|NCT02004691|515732477|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
143052805|NCT02004691|515732476|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
143052806|NCT02004691|515732477|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
143052807|NCT02472639|515732478|FG000|Overall Study|Physician Decision|4|||
143364658|NCT00359619|516878660|FG000|Overall Study|Lost to Follow-up|4|||
143364659|NCT00359619|516878661|FG001|Overall Study|Lost to Follow-up|4|||
143364660|NCT00359619|516878662|FG002|Overall Study|Lost to Follow-up|2|||
143364661|NCT00359619|516878663|FG003|Overall Study|Lost to Follow-up|1|||
143364662|NCT00359619|516878664|FG004|Overall Study|Lost to Follow-up|1|||
143364663|NCT00359619|516878665|FG005|Overall Study|Lost to Follow-up|5|||
143364664|NCT00359619|516878666|FG006|Overall Study|Lost to Follow-up|0|||
143364665|NCT01419717|516878667|FG000|Overall Study|Protocol-specified Criteria|62|||
143499533|NCT00289913|517370427|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
143499534|NCT00289913|517370428|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
143364666|NCT01419717|516878667|FG000|Overall Study|Adverse Event|19|||
143364667|NCT01419717|516878667|FG000|Overall Study|Death|17|||
143052808|NCT02472639|515732479|FG001|Overall Study|Physician Decision|3|||
143052809|NCT01685008|515732481|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
143052810|NCT01685008|515732482|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
143052811|NCT01685008|515732483|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
143052812|NCT01685008|515732484|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
143052813|NCT01685008|515732481|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
143052814|NCT01685008|515732482|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
143052815|NCT01685008|515732483|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
143052816|NCT01685008|515732484|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
143052817|NCT01685008|515732481|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
143052818|NCT01685008|515732482|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
143052819|NCT01685008|515732483|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
143052820|NCT01685008|515732484|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
143052821|NCT01685008|515732481|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
143052822|NCT01685008|515732482|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
143052823|NCT01685008|515732483|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
143052824|NCT01685008|515732484|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
143052825|NCT01685008|515732481|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
143052826|NCT01685008|515732482|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
143052827|NCT01685008|515732483|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
143052828|NCT01685008|515732484|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
143052829|NCT04049097|515732485|FG000|Overall Study|Adverse Event|18|||
143052830|NCT04049097|515732485|FG000|Overall Study|Death|2|||
143052831|NCT04049097|515732485|FG000|Overall Study|Lost to Follow-up|1|||
143499535|NCT00289913|517370429|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
143499536|NCT00289913|517370430|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
143499537|NCT00289913|517370426|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
143499538|NCT00289913|517370427|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
143499539|NCT00289913|517370428|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
143499540|NCT00289913|517370429|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
143499541|NCT00289913|517370430|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
143052832|NCT04049097|515732485|FG000|Overall Study|Physician Decision|2|||
143052833|NCT04049097|515732485|FG000|Overall Study|Withdrawal by Subject|9|||
143052834|NCT04049097|515732485|FG000|Overall Study|Protocol Violation|2|||
143052835|NCT04049097|515732485|FG000|Overall Study|Other|1|||
143052836|NCT04049097|515732485|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
143052837|NCT02005276|515732490|FG000|Overall Study|No longer interested|5|||
143052838|NCT02005276|515732491|FG001|Overall Study|No longer interested|2|||
143052839|NCT02005276|515732492|FG002|Overall Study|No longer interested|3|||
143052840|NCT02005276|515732493|FG003|Overall Study|No longer interested|3|||
143052841|NCT01091363|515732494|FG000|Overall Study|Withdrawal by Subject|11|||
143052842|NCT01091363|515732495|FG001|Overall Study|Withdrawal by Subject|15|||
143052843|NCT01091363|515732494|FG000|Overall Study|Lost to Follow-up|2|||
143052844|NCT01091363|515732495|FG001|Overall Study|Lost to Follow-up|2|||
143052845|NCT03828539|515732496|FG000|Overall Study|Adverse Event|3|||
143052846|NCT03828539|515732497|FG001|Overall Study|Adverse Event|12|||
143052847|NCT03828539|515732496|FG000|Overall Study|Patient's/guardian's decision|3|||
143052848|NCT03828539|515732497|FG001|Overall Study|Patient's/guardian's decision|5|||
143052849|NCT03828539|515732496|FG000|Overall Study|Lost to Follow-up|4|||
143052850|NCT03828539|515732497|FG001|Overall Study|Lost to Follow-up|2|||
143052851|NCT03828539|515732496|FG000|Overall Study|Protocol Violation|3|||
143052852|NCT03828539|515732497|FG001|Overall Study|Protocol Violation|2|||
143052853|NCT03828539|515732496|FG000|Overall Study|Withdrawal of informed consent|2|||
143052854|NCT03828539|515732497|FG001|Overall Study|Withdrawal of informed consent|1|||
143052855|NCT03828539|515732496|FG000|Overall Study|New therapy for study indication|1|||
143052856|NCT03828539|515732497|FG001|Overall Study|New therapy for study indication|0|||
143052857|NCT03833427|515732499|FG000|Overall Study|Death|4|||
143052858|NCT03833427|515732500|FG001|Overall Study|Death|2|||
143052859|NCT03833427|515732501|FG002|Overall Study|Death|9|||
143499542|NCT00289913|517370426|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
143052860|NCT03833427|515732502|FG003|Overall Study|Death|11|||
143499543|NCT00289913|517370427|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
143052861|NCT03833427|515732503|FG004|Overall Study|Death|0|||
143052862|NCT03833427|515732504|FG005|Overall Study|Death|0|||
143052863|NCT03833427|515732505|FG006|Overall Study|Death|0|||
143052864|NCT03833427|515732499|FG000|Overall Study|Withdrawal by Subject|0|||
143052865|NCT03833427|515732500|FG001|Overall Study|Withdrawal by Subject|1|||
143052866|NCT03833427|515732501|FG002|Overall Study|Withdrawal by Subject|1|||
143052867|NCT03833427|515732502|FG003|Overall Study|Withdrawal by Subject|0|||
143244916|NCT01737502|516448132|FG000|Phase I|Disease progression|2|||
143499544|NCT00289913|517370428|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
143052868|NCT03833427|515732503|FG004|Overall Study|Withdrawal by Subject|0|||
143052869|NCT03833427|515732504|FG005|Overall Study|Withdrawal by Subject|0|||
143052870|NCT03833427|515732505|FG006|Overall Study|Withdrawal by Subject|0|||
143052871|NCT03833427|515732499|FG000|Overall Study|Sponsor Decision|0|||
143052872|NCT03833427|515732500|FG001|Overall Study|Sponsor Decision|0|||
143052873|NCT03833427|515732501|FG002|Overall Study|Sponsor Decision|1|||
143052874|NCT03833427|515732502|FG003|Overall Study|Sponsor Decision|3|||
143052875|NCT03833427|515732503|FG004|Overall Study|Sponsor Decision|0|||
143052876|NCT03833427|515732504|FG005|Overall Study|Sponsor Decision|0|||
143052877|NCT03833427|515732505|FG006|Overall Study|Sponsor Decision|0|||
143052878|NCT03201003|515732521|FG000|Overall Study|Adverse Event|14|||
143052879|NCT03201003|515732522|FG001|Overall Study|Adverse Event|1|||
143052880|NCT03201003|515732521|FG000|Overall Study|Other reasons|5|||
143052881|NCT03201003|515732522|FG001|Overall Study|Other reasons|1|||
143052882|NCT03201003|515732521|FG000|Overall Study|Withdrawal by Subject|4|||
143052883|NCT03201003|515732522|FG001|Overall Study|Withdrawal by Subject|1|||
143052884|NCT03201003|515732521|FG000|Overall Study|Lost to Follow-up|2|||
143052885|NCT03201003|515732522|FG001|Overall Study|Lost to Follow-up|0|||
143052886|NCT03201003|515732521|FG000|Overall Study|Protocol Violation|1|||
143052887|NCT03201003|515732522|FG001|Overall Study|Protocol Violation|0|||
143052888|NCT00834613|515732523|FG000|First Intervention|Protocol Violation|1|||
143052889|NCT00834613|515732524|FG001|First Intervention|Protocol Violation|0|||
143052890|NCT00697619|515732525|FG000|Overall Study|Lack of Efficacy|2|||
143052891|NCT00697619|515732526|FG001|Overall Study|Lack of Efficacy|2|||
143052892|NCT00697619|515732525|FG000|Overall Study|Adverse Event|4|||
143052893|NCT00697619|515732526|FG001|Overall Study|Adverse Event|6|||
143052894|NCT01188226|515734225|FG000|Overall Study|Withdrawal by Subject|4|||
143052895|NCT04832971|515734226|FG000|Overall Study|Death|1|||
143052896|NCT04832971|515734227|FG001|Overall Study|Death|0|||
143052897|NCT04832971|515734228|FG002|Overall Study|Death|0|||
143052898|NCT04832971|515734229|FG003|Overall Study|Death|0|||
143052899|NCT04832971|515734226|FG000|Overall Study|Lost to Follow-up|1|||
143052900|NCT04832971|515734227|FG001|Overall Study|Lost to Follow-up|1|||
143052901|NCT04832971|515734228|FG002|Overall Study|Lost to Follow-up|1|||
143052902|NCT04832971|515734229|FG003|Overall Study|Lost to Follow-up|0|||
143052903|NCT04832971|515734226|FG000|Overall Study|Withdrawal by Subject|1|||
143052904|NCT04832971|515734227|FG001|Overall Study|Withdrawal by Subject|3|||
143052905|NCT04832971|515734228|FG002|Overall Study|Withdrawal by Subject|2|||
143052906|NCT04832971|515734229|FG003|Overall Study|Withdrawal by Subject|2|||
143052907|NCT04832971|515734226|FG000|Overall Study|Other, Not Specified|0|||
143052908|NCT04832971|515734227|FG001|Overall Study|Other, Not Specified|0|||
143052909|NCT04832971|515734228|FG002|Overall Study|Other, Not Specified|1|||
143052910|NCT04832971|515734229|FG003|Overall Study|Other, Not Specified|0|||
143052911|NCT04980456|515734230|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
143052912|NCT04980456|515734231|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
143052913|NCT04980456|515734230|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
143052914|NCT04980456|515734231|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
143052915|NCT04980456|515734230|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
143052916|NCT04980456|515734231|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
143052917|NCT04980456|515734230|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
143052918|NCT04980456|515734231|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
143052919|NCT02293460|515734232|FG000|Overall Study|Protocol Violation|1|||
143052920|NCT02293460|515734232|FG000|Overall Study|Lack of Efficacy|2|||
143052921|NCT02293460|515734232|FG000|Overall Study|Adverse Event|2|||
143052922|NCT02293460|515734232|FG000|Overall Study|Withdrawal by Subject|1|||
143052923|NCT00500318|515734234|FG000|Overall Study|Adverse Event|3|||
143052924|NCT00500318|515734235|FG001|Overall Study|Adverse Event|8|||
143052925|NCT00500318|515734234|FG000|Overall Study|Protocol Violation|1|||
143052926|NCT00500318|515734235|FG001|Overall Study|Protocol Violation|3|||
143052927|NCT00500318|515734234|FG000|Overall Study|Withdrawal by Subject|1|||
143052928|NCT00500318|515734235|FG001|Overall Study|Withdrawal by Subject|2|||
143052929|NCT00500318|515734234|FG000|Overall Study|Lack of Efficacy|0|||
143052930|NCT00500318|515734235|FG001|Overall Study|Lack of Efficacy|3|||
143052931|NCT00500318|515734234|FG000|Overall Study|Other Reason|0|||
143052932|NCT00500318|515734235|FG001|Overall Study|Other Reason|1|||
143052933|NCT01074008|515734258|FG000|Overall Study|Adverse Event|0|||
143052934|NCT01074008|515734259|FG001|Overall Study|Adverse Event|1|||
143052935|NCT01074008|515734260|FG002|Overall Study|Adverse Event|0|||
143052936|NCT01074008|515734261|FG003|Overall Study|Adverse Event|0|||
143052937|NCT01074008|515734262|FG004|Overall Study|Adverse Event|0|||
143052938|NCT01074008|515734263|FG005|Overall Study|Adverse Event|0|||
143052939|NCT01074008|515734264|FG006|Overall Study|Adverse Event|0|||
143052940|NCT01074008|515734265|FG007|Overall Study|Adverse Event|0|||
143052941|NCT01074008|515734266|FG008|Overall Study|Adverse Event|0|||
143052942|NCT01074008|515734258|FG000|Overall Study|Withdrawal by Subject|1|||
143052943|NCT01074008|515734259|FG001|Overall Study|Withdrawal by Subject|1|||
143052944|NCT01074008|515734260|FG002|Overall Study|Withdrawal by Subject|1|||
143052945|NCT01074008|515734261|FG003|Overall Study|Withdrawal by Subject|0|||
143052946|NCT01074008|515734262|FG004|Overall Study|Withdrawal by Subject|1|||
143364668|NCT01419717|516878667|FG000|Overall Study|Withdrawal by Subject|10|||
143364669|NCT01419717|516878667|FG000|Overall Study|Disease Progression|9|||
143364670|NCT01419717|516878667|FG000|Overall Study|Other|4|||
143364671|NCT01419717|516878667|FG000|Overall Study|Lost to Follow-up|2|||
143364672|NCT01419717|516878667|FG000|Overall Study|Administrative Decision|1|||
143364673|NCT01419717|516878667|FG000|Overall Study|Noncompliance|1|||
143364674|NCT02857283|516878668|FG000|First Exposure|Withdrawal by Subject|1|||
143364675|NCT02857283|516878669|FG001|First Exposure|Withdrawal by Subject|0|||
143364676|NCT00613301|516878670|FG000|Overall Study|Adverse Event|49|||
143364677|NCT00613301|516878670|FG000|Overall Study|Lost to Follow-up|88|||
143364678|NCT00613301|516878670|FG000|Overall Study|Withdrawal by Subject|5|||
143364679|NCT00613301|516878670|FG000|Overall Study|Death|6|||
143364680|NCT00613301|516878670|FG000|Overall Study|Lack of Efficacy|13|||
143364681|NCT00613301|516878670|FG000|Overall Study|Physician Decision|2|||
143364682|NCT00613301|516878670|FG000|Overall Study|No data was collected|53|||
143364683|NCT00613301|516878670|FG000|Overall Study|Irregularly enrolled patients|12|||
143364684|NCT00587288|516878671|FG000|Overall Study|Adverse Event|0|||
143364685|NCT00587288|516878672|FG001|Overall Study|Adverse Event|1|||
143364686|NCT00587288|516878671|FG000|Overall Study|Lack of Efficacy|2|||
143364687|NCT00587288|516878672|FG001|Overall Study|Lack of Efficacy|8|||
143364688|NCT00587288|516878671|FG000|Overall Study|Protocol Violation|1|||
143364689|NCT00587288|516878672|FG001|Overall Study|Protocol Violation|0|||
143364690|NCT02347943|516878677|FG000|Overall Study|Study was cancelled|140|||
143052947|NCT01074008|515734263|FG005|Overall Study|Withdrawal by Subject|0|||
143052948|NCT01074008|515734264|FG006|Overall Study|Withdrawal by Subject|0|||
143052949|NCT01074008|515734265|FG007|Overall Study|Withdrawal by Subject|0|||
143052950|NCT01074008|515734266|FG008|Overall Study|Withdrawal by Subject|0|||
143052951|NCT01074008|515734258|FG000|Overall Study|Lost to Follow-up|0|||
143052952|NCT01074008|515734259|FG001|Overall Study|Lost to Follow-up|1|||
143052953|NCT01074008|515734260|FG002|Overall Study|Lost to Follow-up|1|||
143052954|NCT01074008|515734261|FG003|Overall Study|Lost to Follow-up|1|||
143052955|NCT01074008|515734262|FG004|Overall Study|Lost to Follow-up|1|||
143052956|NCT01074008|515734263|FG005|Overall Study|Lost to Follow-up|0|||
143052957|NCT01074008|515734264|FG006|Overall Study|Lost to Follow-up|1|||
143052958|NCT01074008|515734265|FG007|Overall Study|Lost to Follow-up|0|||
143052959|NCT01074008|515734266|FG008|Overall Study|Lost to Follow-up|4|||
143052960|NCT00224484|515734267|FG000|Overall Study|Serious Adverse Event|1|||
143052961|NCT00224484|515734268|FG001|Overall Study|Serious Adverse Event|1|||
143052962|NCT00224484|515734269|FG002|Overall Study|Serious Adverse Event|0|||
143052963|NCT00224484|515734267|FG000|Overall Study|Non-Serious Adverse Event|5|||
143052964|NCT00224484|515734268|FG001|Overall Study|Non-Serious Adverse Event|7|||
143052965|NCT00224484|515734269|FG002|Overall Study|Non-Serious Adverse Event|3|||
143052966|NCT00224484|515734267|FG000|Overall Study|Protocol Violation|2|||
143052967|NCT00224484|515734268|FG001|Overall Study|Protocol Violation|2|||
143052968|NCT00224484|515734269|FG002|Overall Study|Protocol Violation|0|||
143052969|NCT00224484|515734267|FG000|Overall Study|Withdrawal by Subject|49|||
143052970|NCT00224484|515734268|FG001|Overall Study|Withdrawal by Subject|18|||
143052971|NCT00224484|515734269|FG002|Overall Study|Withdrawal by Subject|16|||
143052972|NCT00224484|515734267|FG000|Overall Study|Migrated/moved from study area|18|||
143052973|NCT00224484|515734268|FG001|Overall Study|Migrated/moved from study area|5|||
143052974|NCT00224484|515734269|FG002|Overall Study|Migrated/moved from study area|5|||
143052975|NCT00224484|515734267|FG000|Overall Study|Lost to Follow-up|66|||
143052976|NCT00224484|515734268|FG001|Overall Study|Lost to Follow-up|28|||
143052977|NCT00224484|515734269|FG002|Overall Study|Lost to Follow-up|36|||
143052978|NCT00224484|515734267|FG000|Overall Study|Reason not specified|5|||
143052979|NCT00224484|515734268|FG001|Overall Study|Reason not specified|4|||
143052980|NCT00224484|515734269|FG002|Overall Study|Reason not specified|2|||
143052981|NCT02805309|515734272|FG000|Overall Study|Lost to Follow-up|2|||
143052982|NCT02805309|515734273|FG001|Overall Study|Lost to Follow-up|2|||
143052983|NCT02805309|515734274|FG002|Overall Study|Lost to Follow-up|2|||
143052984|NCT02805309|515734272|FG000|Overall Study|Post-Randomization Exclusion|0|||
143364691|NCT02347943|516878678|FG001|Overall Study|Study was cancelled|67|||
143364692|NCT02347943|516878679|FG002|Overall Study|Study was cancelled|45|||
143052985|NCT02805309|515734273|FG001|Overall Study|Post-Randomization Exclusion|2|||
143052986|NCT02805309|515734274|FG002|Overall Study|Post-Randomization Exclusion|1|||
143364693|NCT02072226|516878680|FG000|Overall Study|Lost to Follow-up|11|||
143052987|NCT00108628|515734277|FG000|Overall Study|Withdrawal by Subject|17|||
143052988|NCT00108628|515734278|FG001|Overall Study|Withdrawal by Subject|9|||
143052989|NCT00108628|515734277|FG000|Overall Study|Lack of Efficacy|2|||
143052990|NCT00108628|515734278|FG001|Overall Study|Lack of Efficacy|1|||
143052991|NCT00108628|515734277|FG000|Overall Study|Death|1|||
143052992|NCT00108628|515734278|FG001|Overall Study|Death|0|||
143244917|NCT01737502|516448133|FG001|Phase I|Disease progression|3|||
143052993|NCT03547635|515734279|FG000|Overall Study|Adverse Event|5|||
143052994|NCT03547635|515734280|FG001|Overall Study|Adverse Event|2|||
143364694|NCT02072226|516878681|FG001|Overall Study|Lost to Follow-up|7|||
143052995|NCT03547635|515734281|FG002|Overall Study|Adverse Event|3|||
143364695|NCT02072226|516878680|FG000|Overall Study|Patient Non-compliance|2|||
143052996|NCT03547635|515734279|FG000|Overall Study|Lost to Follow-up|1|||
143052997|NCT03547635|515734280|FG001|Overall Study|Lost to Follow-up|3|||
143052998|NCT03547635|515734281|FG002|Overall Study|Lost to Follow-up|4|||
143052999|NCT03547635|515734279|FG000|Overall Study|Withdrawal by Subject|1|||
143053000|NCT03547635|515734280|FG001|Overall Study|Withdrawal by Subject|0|||
143053001|NCT03547635|515734281|FG002|Overall Study|Withdrawal by Subject|0|||
143053002|NCT03547635|515734279|FG000|Overall Study|Withdrawal By PI|0|||
143053003|NCT03547635|515734280|FG001|Overall Study|Withdrawal By PI|1|||
143053004|NCT03547635|515734281|FG002|Overall Study|Withdrawal By PI|0|||
143053005|NCT03547635|515734279|FG000|Overall Study|Withdrawal by Sponsor|0|||
143053006|NCT03547635|515734280|FG001|Overall Study|Withdrawal by Sponsor|0|||
143053007|NCT03547635|515734281|FG002|Overall Study|Withdrawal by Sponsor|1|||
143053008|NCT03547635|515734279|FG000|Overall Study|Errant Randomization before Treatment|0|||
143053009|NCT03547635|515734280|FG001|Overall Study|Errant Randomization before Treatment|1|||
143053010|NCT03547635|515734281|FG002|Overall Study|Errant Randomization before Treatment|0|||
143053011|NCT03547635|515734279|FG000|Overall Study|Withdrawal by Subject|1|||
143053012|NCT03547635|515734280|FG001|Overall Study|Withdrawal by Subject|0|||
143053013|NCT03547635|515734281|FG002|Overall Study|Withdrawal by Subject|0|||
143053014|NCT01011335|515734282|FG000|Overall Study|Lost to Follow-up|0|||
143053015|NCT01011335|515734283|FG001|Overall Study|Lost to Follow-up|0|||
143053016|NCT01011335|515734284|FG002|Overall Study|Lost to Follow-up|1|||
143053017|NCT01011335|515734285|FG003|Overall Study|Lost to Follow-up|1|||
143053018|NCT01011335|515734286|FG004|Overall Study|Lost to Follow-up|1|||
143053019|NCT01011335|515734287|FG005|Overall Study|Lost to Follow-up|1|||
143053020|NCT01011335|515734288|FG006|Overall Study|Lost to Follow-up|2|||
143053021|NCT01011335|515734289|FG007|Overall Study|Lost to Follow-up|2|||
143053022|NCT01011335|515734290|FG008|Overall Study|Lost to Follow-up|1|||
143499545|NCT00289913|517370429|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
143499546|NCT00289913|517370430|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
143499547|NCT00289913|517370426|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
143499548|NCT00289913|517370427|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
143499549|NCT00289913|517370428|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
143499550|NCT00289913|517370429|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
143499551|NCT00289913|517370430|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
143499552|NCT00289913|517370426|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
143499553|NCT00289913|517370427|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
143499554|NCT00289913|517370428|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
143499555|NCT00289913|517370429|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
143499556|NCT00289913|517370430|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
143499557|NCT00289913|517370426|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
143499558|NCT00289913|517370427|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
143499559|NCT00289913|517370428|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
143499560|NCT00289913|517370429|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
143499561|NCT00289913|517370430|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
143499562|NCT00289913|517370426|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
143499563|NCT00289913|517370427|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
143499564|NCT00289913|517370428|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
143499565|NCT00289913|517370429|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
143499566|NCT00289913|517370430|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
143499567|NCT00289913|517370426|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
143499568|NCT00289913|517370427|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
143499569|NCT00289913|517370428|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
143499570|NCT00289913|517370429|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
143499571|NCT00289913|517370430|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
143499572|NCT00289913|517370426|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
143499573|NCT00289913|517370427|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
143499574|NCT00289913|517370428|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
143499575|NCT00289913|517370429|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
143499576|NCT00289913|517370430|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
143499577|NCT00289913|517370426|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
143499578|NCT00289913|517370427|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
143499579|NCT00289913|517370428|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
143499580|NCT00289913|517370429|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
143499581|NCT00289913|517370430|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
143053023|NCT01011335|515734291|FG009|Overall Study|Lost to Follow-up|0|||
143053024|NCT01011335|515734292|FG010|Overall Study|Lost to Follow-up|0|||
143053025|NCT01011335|515734293|FG011|Overall Study|Lost to Follow-up|1|||
143053026|NCT01011335|515734294|FG012|Overall Study|Lost to Follow-up|2|||
143053027|NCT01011335|515734282|FG000|Overall Study|Protocol Violation|0|||
143053028|NCT01011335|515734283|FG001|Overall Study|Protocol Violation|1|||
143053029|NCT01011335|515734284|FG002|Overall Study|Protocol Violation|0|||
143053030|NCT01011335|515734285|FG003|Overall Study|Protocol Violation|0|||
143053031|NCT01011335|515734286|FG004|Overall Study|Protocol Violation|0|||
143053032|NCT01011335|515734287|FG005|Overall Study|Protocol Violation|0|||
143053033|NCT01011335|515734288|FG006|Overall Study|Protocol Violation|0|||
143053034|NCT01011335|515734289|FG007|Overall Study|Protocol Violation|0|||
143053035|NCT01011335|515734290|FG008|Overall Study|Protocol Violation|0|||
143053036|NCT01011335|515734291|FG009|Overall Study|Protocol Violation|0|||
143053037|NCT01011335|515734292|FG010|Overall Study|Protocol Violation|0|||
143053038|NCT01011335|515734293|FG011|Overall Study|Protocol Violation|0|||
143053039|NCT01011335|515734294|FG012|Overall Study|Protocol Violation|0|||
143053040|NCT01011335|515734282|FG000|Overall Study|Moved/deployed or no booster|1|||
143053041|NCT01011335|515734283|FG001|Overall Study|Moved/deployed or no booster|0|||
143053042|NCT01011335|515734284|FG002|Overall Study|Moved/deployed or no booster|0|||
143053043|NCT01011335|515734285|FG003|Overall Study|Moved/deployed or no booster|1|||
143053044|NCT01011335|515734286|FG004|Overall Study|Moved/deployed or no booster|0|||
143053045|NCT01011335|515734287|FG005|Overall Study|Moved/deployed or no booster|0|||
143053046|NCT01011335|515734288|FG006|Overall Study|Moved/deployed or no booster|1|||
143053047|NCT01011335|515734289|FG007|Overall Study|Moved/deployed or no booster|0|||
143053048|NCT01011335|515734290|FG008|Overall Study|Moved/deployed or no booster|1|||
143053049|NCT01011335|515734291|FG009|Overall Study|Moved/deployed or no booster|0|||
143053050|NCT01011335|515734292|FG010|Overall Study|Moved/deployed or no booster|2|||
143053051|NCT01011335|515734293|FG011|Overall Study|Moved/deployed or no booster|0|||
143053052|NCT01011335|515734294|FG012|Overall Study|Moved/deployed or no booster|0|||
143053053|NCT01011335|515734282|FG000|Overall Study|Adverse Event|0|||
143053054|NCT01011335|515734283|FG001|Overall Study|Adverse Event|0|||
143053055|NCT01011335|515734284|FG002|Overall Study|Adverse Event|0|||
143053056|NCT01011335|515734285|FG003|Overall Study|Adverse Event|0|||
143053057|NCT01011335|515734286|FG004|Overall Study|Adverse Event|0|||
143053058|NCT01011335|515734287|FG005|Overall Study|Adverse Event|0|||
143053059|NCT01011335|515734288|FG006|Overall Study|Adverse Event|0|||
143053060|NCT01011335|515734289|FG007|Overall Study|Adverse Event|0|||
143053061|NCT01011335|515734290|FG008|Overall Study|Adverse Event|0|||
143053062|NCT01011335|515734291|FG009|Overall Study|Adverse Event|0|||
143053063|NCT01011335|515734292|FG010|Overall Study|Adverse Event|4|||
143053064|NCT01011335|515734293|FG011|Overall Study|Adverse Event|0|||
143053065|NCT01011335|515734294|FG012|Overall Study|Adverse Event|1|||
143053066|NCT02415387|515734299|FG000|Overall Study|Withdrawal by Subject|6|||
143053067|NCT02415387|515734300|FG001|Overall Study|Withdrawal by Subject|1|||
143053068|NCT02415387|515734299|FG000|Overall Study|blood draw problem|0|||
143053069|NCT02415387|515734300|FG001|Overall Study|blood draw problem|1|||
143053070|NCT02415387|515734299|FG000|Overall Study|Protocol Violation|1|||
143053071|NCT02415387|515734300|FG001|Overall Study|Protocol Violation|0|||
143053072|NCT01765751|515734301|FG000|Overall Study|Lost to Follow-up|0|||
143053073|NCT01765751|515734302|FG001|Overall Study|Lost to Follow-up|2|||
143053074|NCT01765751|515734303|FG002|Overall Study|Lost to Follow-up|1|||
143053075|NCT03343639|515734304|FG000|Overall Study|Withdrawal by Subject|10|||
143053076|NCT03343639|515734305|FG001|Overall Study|Withdrawal by Subject|6|||
143053077|NCT03343639|515734304|FG000|Overall Study|Lost to Follow-up|4|||
143053078|NCT03343639|515734305|FG001|Overall Study|Lost to Follow-up|5|||
143053079|NCT03343639|515734304|FG000|Overall Study|Protocol Violation|0|||
143053080|NCT03343639|515734305|FG001|Overall Study|Protocol Violation|1|||
143053081|NCT02460835|515734308|FG000|Overall Study|Disease progression prior to treatment|3|||
143053082|NCT02460835|515734308|FG000|Overall Study|Unable to complete planning scans|2|||
143053083|NCT02460835|515734308|FG000|Overall Study|Decrease in performance status|1|||
143053084|NCT02460835|515734308|FG000|Overall Study|Withdrawal by Subject|3|||
143053085|NCT02460835|515734308|FG000|Overall Study|Underwent fractionated RT|10|||
143053086|NCT02460835|515734308|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
143053087|NCT01257581|515734309|FG000|Overall Study|Early Termination|3|||
143053088|NCT01257581|515734310|FG001|Overall Study|Early Termination|1|||
143169336|NCT02300233|516169866|FG002|Overall Study|Reason Not Specified|5|||
143169337|NCT02507934|516169867|FG000|Overall Study|Lost to Follow-up|2|||
143053089|NCT01257581|515734311|FG002|Overall Study|Early Termination|2|||
143169338|NCT02507934|516169868|FG001|Overall Study|Lost to Follow-up|0|||
143053090|NCT01257581|515734309|FG000|Overall Study|Death|2|||
143053091|NCT01257581|515734310|FG001|Overall Study|Death|2|||
143053092|NCT01257581|515734311|FG002|Overall Study|Death|4|||
143053093|NCT01157234|515734312|FG000|Overall Study|Withdrawal by Subject|1|||
143053094|NCT01157234|515734313|FG001|Overall Study|Withdrawal by Subject|0|||
143053095|NCT00517192|515734320|FG000|Overall Study|Adverse Event|1|||
143053096|NCT00517192|515734321|FG001|Overall Study|Adverse Event|1|||
143053097|NCT00517192|515734320|FG000|Overall Study|Lost to Follow-up|1|||
143053098|NCT00517192|515734321|FG001|Overall Study|Lost to Follow-up|1|||
143053099|NCT00517192|515734320|FG000|Overall Study|Withdrawal by Subject|1|||
143053100|NCT00517192|515734321|FG001|Overall Study|Withdrawal by Subject|0|||
143053101|NCT00517192|515734320|FG000|Overall Study|Early termination of the trial|16|||
143244918|NCT01737502|516448132|FG000|Phase I|Complicating disease|1|||
143053102|NCT00517192|515734321|FG001|Overall Study|Early termination of the trial|18|||
143053103|NCT02246764|515734331|FG000|Overall Study|Adverse Event|15|||
143053104|NCT02246764|515734332|FG001|Overall Study|Adverse Event|29|||
143053105|NCT02246764|515734333|FG002|Overall Study|Adverse Event|1|||
143053106|NCT02246764|515734331|FG000|Overall Study|Withdrawal by Subject|0|||
143053107|NCT02246764|515734332|FG001|Overall Study|Withdrawal by Subject|0|||
143053108|NCT02246764|515734333|FG002|Overall Study|Withdrawal by Subject|1|||
143053109|NCT02246764|515734331|FG000|Overall Study|Disallowed Concomitant Medication|1|||
143053110|NCT02246764|515734332|FG001|Overall Study|Disallowed Concomitant Medication|0|||
143053111|NCT02246764|515734333|FG002|Overall Study|Disallowed Concomitant Medication|0|||
143053112|NCT02246764|515734331|FG000|Overall Study|Physician Decision|0|||
143053113|NCT02246764|515734332|FG001|Overall Study|Physician Decision|2|||
143053114|NCT02246764|515734333|FG002|Overall Study|Physician Decision|1|||
143053115|NCT02246764|515734331|FG000|Overall Study|Protocol Violation|2|||
143053116|NCT02246764|515734332|FG001|Overall Study|Protocol Violation|1|||
143053117|NCT02246764|515734333|FG002|Overall Study|Protocol Violation|1|||
143053118|NCT00413049|515734338|FG000|Overall Study|Adverse Event|10|||
143053119|NCT00413049|515734339|FG001|Overall Study|Adverse Event|8|||
143053120|NCT00413049|515734338|FG000|Overall Study|Withdrawal by Subject|7|||
143053121|NCT00413049|515734339|FG001|Overall Study|Withdrawal by Subject|5|||
143053122|NCT00413049|515734338|FG000|Overall Study|Lost to Follow-up|2|||
143053123|NCT00413049|515734339|FG001|Overall Study|Lost to Follow-up|3|||
143053124|NCT00413049|515734338|FG000|Overall Study|Protocol Violation|3|||
143053125|NCT00413049|515734339|FG001|Overall Study|Protocol Violation|1|||
143053126|NCT00413049|515734338|FG000|Overall Study|Subject no longer requires study drug|0|||
143053127|NCT00413049|515734339|FG001|Overall Study|Subject no longer requires study drug|1|||
143053128|NCT00413049|515734338|FG000|Overall Study|Abnormal laboratory value(s)|1|||
143053129|NCT00413049|515734339|FG001|Overall Study|Abnormal laboratory value(s)|0|||
143053130|NCT00413049|515734338|FG000|Overall Study|Lack of Efficacy|1|||
143053131|NCT00413049|515734339|FG001|Overall Study|Lack of Efficacy|0|||
143053132|NCT03314857|515734342|FG000|Overall Study|Death|4|||
143053133|NCT03314857|515734342|FG000|Overall Study|Physician Decision|1|||
143053134|NCT01408888|515734345|FG000|First Intervention|Adverse Event|0|||
143053135|NCT01408888|515734346|FG001|First Intervention|Adverse Event|1|||
143053136|NCT01408888|515734345|FG000|First Intervention|Withdrawal by Subject|0|||
143053137|NCT01408888|515734346|FG001|First Intervention|Withdrawal by Subject|2|||
143053138|NCT01408888|515734345|FG000|Second Intervention|Withdrawal by Subject|1|||
143053139|NCT01408888|515734346|FG001|Second Intervention|Withdrawal by Subject|0|||
143053140|NCT01408888|515734345|FG000|Second Intervention|Adverse Event|1|||
143053141|NCT01408888|515734346|FG001|Second Intervention|Adverse Event|0|||
143053142|NCT00695110|515734349|FG000|Treatment Period 1|Adverse Event|1|||
143053143|NCT00695110|515734349|FG000|Treatment Period 1|Withdrawal by Subject|2|||
143053144|NCT00695110|515734349|FG000|Treatment Period 3|Withdrawal by Subject|1|||
143053145|NCT00695110|515734349|FG000|Treatment Period 4|Adverse Event|1|||
143053146|NCT02340780|515734351|FG000|Overall Study|Ineligible|1|||
143053147|NCT01211262|515734352|FG000|Overall Study|Progressive Disease|18|||
143053148|NCT01211262|515734353|FG001|Overall Study|Progressive Disease|9|||
143053149|NCT01211262|515734352|FG000|Overall Study|Adverse Event|4|||
143053150|NCT01211262|515734353|FG001|Overall Study|Adverse Event|0|||
143053151|NCT01211262|515734352|FG000|Overall Study|Withdrawal of Consent|1|||
143053152|NCT01211262|515734353|FG001|Overall Study|Withdrawal of Consent|0|||
143053153|NCT01211262|515734352|FG000|Overall Study|Other|0|||
143053154|NCT01211262|515734353|FG001|Overall Study|Other|1|||
143053155|NCT02151149|515734358|FG000|Treatment Period|Death|2|||
143053156|NCT02151149|515734359|FG001|Treatment Period|Death|3|||
143053157|NCT02151149|515734358|FG000|Treatment Period|Adverse Event|17|||
143053158|NCT02151149|515734359|FG001|Treatment Period|Adverse Event|14|||
143053159|NCT02151149|515734358|FG000|Treatment Period|Progressive Disease|25|||
143053160|NCT02151149|515734359|FG001|Treatment Period|Progressive Disease|24|||
143053161|NCT02151149|515734358|FG000|Treatment Period|Symptomatic Deterioration|2|||
143053162|NCT02151149|515734359|FG001|Treatment Period|Symptomatic Deterioration|10|||
143053163|NCT02151149|515734358|FG000|Treatment Period|Withdrawal by Subject|13|||
143053164|NCT02151149|515734359|FG001|Treatment Period|Withdrawal by Subject|11|||
143053165|NCT02151149|515734358|FG000|Treatment Period|Miscellaneous|8|||
143053166|NCT02151149|515734359|FG001|Treatment Period|Miscellaneous|7|||
143053167|NCT02151149|515734358|FG000|Treatment Period|Participants randomized but not treated|3|||
143053168|NCT02151149|515734359|FG001|Treatment Period|Participants randomized but not treated|2|||
143053169|NCT02151149|515734358|FG000|Follow-Up Period|Lost to Follow-up|2|||
143053170|NCT02151149|515734359|FG001|Follow-Up Period|Lost to Follow-up|3|||
143053171|NCT02151149|515734358|FG000|Follow-Up Period|Death|37|||
143053172|NCT02151149|515734359|FG001|Follow-Up Period|Death|34|||
143053173|NCT00057941|515734360|FG000|Overall Study|Death|1|||
143053174|NCT00057941|515734361|FG001|Overall Study|Death|2|||
143053175|NCT00057941|515734360|FG000|Overall Study|Adverse Event|7|||
143053176|NCT00057941|515734361|FG001|Overall Study|Adverse Event|9|||
143053177|NCT00057941|515734360|FG000|Overall Study|Lack of Efficacy|54|||
143053178|NCT00057941|515734361|FG001|Overall Study|Lack of Efficacy|53|||
143053179|NCT00057941|515734360|FG000|Overall Study|Withdrawal by Subject|6|||
143499582|NCT02357420|517370431|FG000|Overall Study|Adverse Event|3|||
143499583|NCT02357420|517370432|FG001|Overall Study|Adverse Event|3|||
143499584|NCT02357420|517370433|FG002|Overall Study|Adverse Event|8|||
143499585|NCT02357420|517370434|FG003|Overall Study|Adverse Event|9|||
143499586|NCT02357420|517370431|FG000|Overall Study|Investigator Decision|1|||
143499587|NCT02357420|517370432|FG001|Overall Study|Investigator Decision|0|||
143499588|NCT02357420|517370433|FG002|Overall Study|Investigator Decision|0|||
143499589|NCT02357420|517370434|FG003|Overall Study|Investigator Decision|0|||
143499590|NCT02357420|517370431|FG000|Overall Study|Prohibited Medication|1|||
143499591|NCT02357420|517370432|FG001|Overall Study|Prohibited Medication|1|||
143499592|NCT02357420|517370433|FG002|Overall Study|Prohibited Medication|0|||
143499593|NCT02357420|517370434|FG003|Overall Study|Prohibited Medication|0|||
143499594|NCT02357420|517370431|FG000|Overall Study|Protocol Non-compliance|0|||
143499595|NCT02357420|517370432|FG001|Overall Study|Protocol Non-compliance|0|||
143499596|NCT02357420|517370433|FG002|Overall Study|Protocol Non-compliance|0|||
143499597|NCT02357420|517370434|FG003|Overall Study|Protocol Non-compliance|1|||
143499598|NCT02357420|517370431|FG000|Overall Study|Withdrawn Consent|4|||
143499599|NCT02357420|517370432|FG001|Overall Study|Withdrawn Consent|8|||
143499600|NCT02357420|517370433|FG002|Overall Study|Withdrawn Consent|6|||
143499601|NCT02357420|517370434|FG003|Overall Study|Withdrawn Consent|6|||
143499602|NCT02357420|517370431|FG000|Overall Study|Lost to Follow-up|3|||
143499603|NCT02357420|517370432|FG001|Overall Study|Lost to Follow-up|0|||
143499604|NCT02357420|517370433|FG002|Overall Study|Lost to Follow-up|2|||
143499605|NCT02357420|517370434|FG003|Overall Study|Lost to Follow-up|3|||
143499606|NCT01262625|517370437|FG000|Overall Study|Administrative Error|1|||
143499607|NCT01262625|517370438|FG001|Overall Study|Administrative Error|1|||
143499608|NCT01262625|517370437|FG000|Overall Study|Site Closed|1|||
143499609|NCT01262625|517370438|FG001|Overall Study|Site Closed|0|||
143499610|NCT01869348|517370439|FG000|Overall Study|Withdrawal by Subject|1|||
143499611|NCT01869348|517370440|FG001|Overall Study|Withdrawal by Subject|1|||
143053180|NCT00057941|515734361|FG001|Overall Study|Withdrawal by Subject|1|||
143053181|NCT00057941|515734360|FG000|Overall Study|still on treatment|3|||
143053182|NCT00057941|515734361|FG001|Overall Study|still on treatment|1|||
143053183|NCT00057941|515734360|FG000|Overall Study|insurance, symptomatic deterioration|1|||
143053184|NCT00057941|515734361|FG001|Overall Study|insurance, symptomatic deterioration|3|||
143053185|NCT00057941|515734360|FG000|Overall Study|Ineligible|2|||
143053186|NCT00057941|515734361|FG001|Overall Study|Ineligible|5|||
143053187|NCT02760433|515734362|FG000|Overall Study|Lost to Follow-up|1|||
143053188|NCT02760433|515734363|FG001|Overall Study|Lost to Follow-up|0|||
143053189|NCT02760433|515734364|FG002|Overall Study|Lost to Follow-up|1|||
143053190|NCT02760433|515734365|FG003|Overall Study|Lost to Follow-up|0|||
143053191|NCT02760433|515734366|FG004|Overall Study|Lost to Follow-up|0|||
143053192|NCT02760433|515734362|FG000|Overall Study|Withdrawal by Subject|23|||
143053193|NCT02760433|515734363|FG001|Overall Study|Withdrawal by Subject|9|||
143053194|NCT02760433|515734364|FG002|Overall Study|Withdrawal by Subject|0|||
143053195|NCT02760433|515734365|FG003|Overall Study|Withdrawal by Subject|2|||
143053196|NCT02760433|515734366|FG004|Overall Study|Withdrawal by Subject|9|||
143053197|NCT02760433|515734362|FG000|Overall Study|Lack of Response At Week 14|0|||
143169339|NCT02507934|516169867|FG000|Overall Study|Withdrawal by Subject|2|||
143169340|NCT02507934|516169868|FG001|Overall Study|Withdrawal by Subject|0|||
143169341|NCT02836249|516169869|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
143169342|NCT02836249|516169870|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
143169343|NCT02836249|516169871|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
143169344|NCT02836249|516169872|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
143169345|NCT02836249|516169869|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
143169346|NCT02836249|516169870|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
143169347|NCT02836249|516169871|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
143169348|NCT02836249|516169872|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
143169349|NCT02836249|516169869|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
143169350|NCT02836249|516169870|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
143169351|NCT02836249|516169871|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
143169352|NCT02836249|516169872|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
143169353|NCT02836249|516169869|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
143169354|NCT02836249|516169870|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
143169355|NCT02836249|516169871|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
143169356|NCT02836249|516169872|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
143169357|NCT02836249|516169869|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
143244919|NCT01737502|516448133|FG001|Phase I|Complicating disease|0|||
143053198|NCT02760433|515734363|FG001|Overall Study|Lack of Response At Week 14|0|||
143053199|NCT02760433|515734364|FG002|Overall Study|Lack of Response At Week 14|0|||
143053200|NCT02760433|515734365|FG003|Overall Study|Lack of Response At Week 14|0|||
143499612|NCT04398732|517370442|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
143499613|NCT01299727|517370443|FG000|Overall Study|Withdrawal by Subject|1|||
143053201|NCT02760433|515734366|FG004|Overall Study|Lack of Response At Week 14|1|||
143053202|NCT02760433|515734362|FG000|Overall Study|Subject refused to continue the study|1|||
143053203|NCT02760433|515734363|FG001|Overall Study|Subject refused to continue the study|0|||
143053204|NCT02760433|515734364|FG002|Overall Study|Subject refused to continue the study|0|||
143053205|NCT02760433|515734365|FG003|Overall Study|Subject refused to continue the study|0|||
143053206|NCT02760433|515734366|FG004|Overall Study|Subject refused to continue the study|0|||
143053207|NCT02760433|515734362|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
143053208|NCT02760433|515734363|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
143053209|NCT02760433|515734364|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
143053210|NCT02760433|515734365|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
143053211|NCT02760433|515734366|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
143053212|NCT02760433|515734362|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
143053213|NCT02760433|515734363|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
143053214|NCT02760433|515734364|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
143053215|NCT02760433|515734365|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
143053216|NCT02760433|515734366|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
143053217|NCT00766493|515734367|FG000|30 Days Post-Procedure|Discontinued|7|||
143053218|NCT00766493|515734367|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
143053219|NCT00766493|515734367|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
143053220|NCT03439085|515734368|FG000|Overall Study|Death|2|||
143053221|NCT03439085|515734368|FG000|Overall Study|Screen Failure|20|||
143053222|NCT01863433|515734369|FG000|Overall Study|Protocol Violation|1|||
143053223|NCT03950674|515734370|FG000|Overall Study|Death|16|||
143053224|NCT03950674|515734371|FG001|Overall Study|Death|15|||
143053225|NCT03950674|515734370|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
143053226|NCT03950674|515734371|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
143053227|NCT02224053|515734374|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
143053228|NCT02224053|515734374|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
143053229|NCT02224053|515734374|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
143053230|NCT02224053|515734374|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
143053231|NCT02224053|515734374|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
143053232|NCT01499160|515734376|FG000|Overall Study|Adverse Event|1|||
143053233|NCT01499160|515734376|FG000|Overall Study|Withdrawal by Subject|1|||
143053234|NCT03428945|515734377|FG000|Overall Study|Lost to Follow-up|5|||
143053235|NCT03428945|515734378|FG001|Overall Study|Lost to Follow-up|3|||
143053236|NCT03428945|515734377|FG000|Overall Study|Withdrawal by Subject|10|||
143053237|NCT03428945|515734378|FG001|Overall Study|Withdrawal by Subject|10|||
143053238|NCT00982228|515734379|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
143053239|NCT00982228|515734380|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
143053240|NCT00982228|515734379|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
143053241|NCT00982228|515734380|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
143053242|NCT00982228|515734379|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
143053243|NCT00982228|515734380|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
143053244|NCT00982228|515734379|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
143053245|NCT00982228|515734380|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
143053246|NCT00982228|515734379|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
143053247|NCT00982228|515734380|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
143053248|NCT00982228|515734379|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
143053249|NCT00982228|515734380|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
143053250|NCT00982228|515734379|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
143053251|NCT00982228|515734380|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
143053252|NCT00982228|515734379|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
143053253|NCT00982228|515734380|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
143053254|NCT00982228|515734379|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
143053255|NCT00982228|515734380|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
143053256|NCT00982228|515734379|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
143053257|NCT00982228|515734380|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
143053258|NCT01438476|515734381|FG000|Overall Study|Protocol Violation|1|||
143053259|NCT01438476|515734382|FG001|Overall Study|Protocol Violation|0|||
143053260|NCT01438476|515734381|FG000|Overall Study|Withdrawal by Subject|1|||
143053261|NCT01438476|515734382|FG001|Overall Study|Withdrawal by Subject|0|||
143053262|NCT01438476|515734381|FG000|Overall Study|No Surgery- Disease|8|||
143053263|NCT01438476|515734382|FG001|Overall Study|No Surgery- Disease|10|||
143053264|NCT01438476|515734381|FG000|Overall Study|Communication barrier|0|||
143053265|NCT01438476|515734382|FG001|Overall Study|Communication barrier|1|||
143053266|NCT00360490|515734385|FG000|Overall Study|Adverse Event|4|||
143053267|NCT00360490|515734386|FG001|Overall Study|Adverse Event|2|||
143053268|NCT00360490|515734385|FG000|Overall Study|Lost to Follow-up|2|||
143053269|NCT00360490|515734386|FG001|Overall Study|Lost to Follow-up|1|||
143053270|NCT00360490|515734385|FG000|Overall Study|Physician Decision|2|||
143053271|NCT00360490|515734386|FG001|Overall Study|Physician Decision|1|||
143053272|NCT00360490|515734385|FG000|Overall Study|Protocol Violation|0|||
143053273|NCT00360490|515734386|FG001|Overall Study|Protocol Violation|4|||
143053274|NCT00360490|515734385|FG000|Overall Study|Withdrawal by Subject|1|||
143053275|NCT00360490|515734386|FG001|Overall Study|Withdrawal by Subject|3|||
143053276|NCT02289820|515734387|FG000|Overall Study|Withdrawal by Subject|2|||
143053277|NCT02289820|515734388|FG001|Overall Study|Withdrawal by Subject|1|||
143053278|NCT02289820|515734389|FG002|Overall Study|Withdrawal by Subject|2|||
143053279|NCT02289820|515734390|FG003|Overall Study|Withdrawal by Subject|1|||
143053280|NCT02289820|515734391|FG004|Overall Study|Withdrawal by Subject|0|||
143053281|NCT02289820|515734392|FG005|Overall Study|Withdrawal by Subject|0|||
143053282|NCT02289820|515734393|FG006|Overall Study|Withdrawal by Subject|1|||
143053283|NCT02289820|515734387|FG000|Overall Study|Death|0|||
143053284|NCT02289820|515734388|FG001|Overall Study|Death|0|||
143053285|NCT02289820|515734389|FG002|Overall Study|Death|1|||
143053286|NCT02289820|515734390|FG003|Overall Study|Death|0|||
143053287|NCT02289820|515734391|FG004|Overall Study|Death|0|||
143053288|NCT02289820|515734392|FG005|Overall Study|Death|0|||
143053289|NCT02289820|515734393|FG006|Overall Study|Death|0|||
143053290|NCT02289820|515734387|FG000|Overall Study|Lost to Follow-up|0|||
143053291|NCT02289820|515734388|FG001|Overall Study|Lost to Follow-up|0|||
143053292|NCT02289820|515734389|FG002|Overall Study|Lost to Follow-up|3|||
143053293|NCT02289820|515734390|FG003|Overall Study|Lost to Follow-up|1|||
143053294|NCT02289820|515734391|FG004|Overall Study|Lost to Follow-up|0|||
143053295|NCT02289820|515734392|FG005|Overall Study|Lost to Follow-up|1|||
143053296|NCT02289820|515734393|FG006|Overall Study|Lost to Follow-up|1|||
143053297|NCT02289820|515734387|FG000|Overall Study|withdrawal of consent|0|||
143053298|NCT02289820|515734388|FG001|Overall Study|withdrawal of consent|1|||
143053299|NCT02289820|515734389|FG002|Overall Study|withdrawal of consent|0|||
143053300|NCT02289820|515734390|FG003|Overall Study|withdrawal of consent|0|||
143053301|NCT02289820|515734391|FG004|Overall Study|withdrawal of consent|0|||
143053302|NCT02289820|515734392|FG005|Overall Study|withdrawal of consent|0|||
143053303|NCT02289820|515734393|FG006|Overall Study|withdrawal of consent|0|||
143053304|NCT03919695|515734394|FG000|3-month Follow-up|Death|1|||
143053305|NCT03919695|515734395|FG001|3-month Follow-up|Death|1|||
143053306|NCT03919695|515734394|FG000|3-month Follow-up|unable to contact|0|||
143053307|NCT03919695|515734395|FG001|3-month Follow-up|unable to contact|3|||
143053308|NCT03919695|515734394|FG000|3-month Follow-up|in prison|0|||
143053309|NCT03919695|515734395|FG001|3-month Follow-up|in prison|1|||
143053310|NCT03919695|515734394|FG000|6-month Follow-up|Death|0|||
143053311|NCT03919695|515734395|FG001|6-month Follow-up|Death|1|||
143053312|NCT03919695|515734394|FG000|6-month Follow-up|Lost to Follow-up|1|||
143053313|NCT03919695|515734395|FG001|6-month Follow-up|Lost to Follow-up|2|||
143053314|NCT03919695|515734394|FG000|6-month Follow-up|in prison|0|||
143053315|NCT03919695|515734395|FG001|6-month Follow-up|in prison|2|||
143053316|NCT03919695|515734394|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
143053317|NCT03919695|515734395|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
143053318|NCT03919695|515734394|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
143053319|NCT03919695|515734395|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
143053320|NCT00860262|515734400|FG000|Overall Study|Adverse Event|9|||
143053321|NCT00860262|515734401|FG001|Overall Study|Adverse Event|6|||
143053322|NCT00860262|515734402|FG002|Overall Study|Adverse Event|7|||
143053323|NCT00860262|515734400|FG000|Overall Study|Protocol Violation|0|||
143053324|NCT00860262|515734401|FG001|Overall Study|Protocol Violation|1|||
143053325|NCT00860262|515734402|FG002|Overall Study|Protocol Violation|0|||
143053326|NCT00860262|515734400|FG000|Overall Study|Lost to Follow-up|2|||
143053327|NCT00860262|515734401|FG001|Overall Study|Lost to Follow-up|0|||
143053328|NCT00860262|515734402|FG002|Overall Study|Lost to Follow-up|1|||
143053329|NCT00860262|515734400|FG000|Overall Study|Withdrawal by Subject|4|||
143053330|NCT00860262|515734401|FG001|Overall Study|Withdrawal by Subject|8|||
143053331|NCT00860262|515734402|FG002|Overall Study|Withdrawal by Subject|6|||
143053332|NCT00860262|515734400|FG000|Overall Study|Lack of Efficacy|0|||
143053333|NCT00860262|515734401|FG001|Overall Study|Lack of Efficacy|4|||
143053334|NCT00860262|515734402|FG002|Overall Study|Lack of Efficacy|3|||
143053335|NCT00860262|515734400|FG000|Overall Study|Other|5|||
143053336|NCT00860262|515734401|FG001|Overall Study|Other|3|||
143053337|NCT00860262|515734402|FG002|Overall Study|Other|1|||
143053338|NCT02387762|515734405|FG000|Overall Study|Withdrawal by Subject|1|||
143053339|NCT02387762|515734406|FG001|Overall Study|Withdrawal by Subject|0|||
143053340|NCT01160640|515734410|FG000|Overall Study|Physician Decision|3|||
143053341|NCT01160640|515734411|FG001|Overall Study|Physician Decision|3|||
143053342|NCT01160640|515734410|FG000|Overall Study|Incarceration|1|||
143053343|NCT01160640|515734411|FG001|Overall Study|Incarceration|0|||
143053344|NCT01160640|515734410|FG000|Overall Study|Withdrawal by Subject|0|||
143053345|NCT01160640|515734411|FG001|Overall Study|Withdrawal by Subject|3|||
143053346|NCT00724958|515734416|FG000|Overall Study|Adverse Event|28|||
143053347|NCT00724958|515734416|FG000|Overall Study|Loss of Response|40|||
143053348|NCT00724958|515734416|FG000|Overall Study|No Response|18|||
143053349|NCT00724958|515734416|FG000|Overall Study|Remission|7|||
143053350|NCT00724958|515734416|FG000|Overall Study|Other Reason|76|||
143053351|NCT00724958|515734416|FG000|Overall Study|No documentation for end of therapy|13|||
143053352|NCT04773600|515734418|FG000|Overall Study|Withdrawal by Subject|15|||
143053353|NCT04773600|515734419|FG001|Overall Study|Withdrawal by Subject|9|||
143053354|NCT04773600|515734418|FG000|Overall Study|Lost to Follow-up|10|||
143053355|NCT04773600|515734419|FG001|Overall Study|Lost to Follow-up|6|||
143053356|NCT04773600|515734418|FG000|Overall Study|Adverse Event|8|||
143053357|NCT04773600|515734419|FG001|Overall Study|Adverse Event|2|||
143053358|NCT04773600|515734418|FG000|Overall Study|Lack of Efficacy|2|||
143053359|NCT04773600|515734419|FG001|Overall Study|Lack of Efficacy|3|||
143053360|NCT04773600|515734418|FG000|Overall Study|Noncompliance|2|||
143053361|NCT04773600|515734419|FG001|Overall Study|Noncompliance|0|||
143053362|NCT04773600|515734418|FG000|Overall Study|Protocol Violation|2|||
143053363|NCT04773600|515734419|FG001|Overall Study|Protocol Violation|0|||
143053364|NCT04773600|515734418|FG000|Overall Study|Physician Decision|0|||
143053365|NCT04773600|515734419|FG001|Overall Study|Physician Decision|1|||
143053366|NCT04773600|515734418|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
143053367|NCT04773600|515734419|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
143053368|NCT04773600|515734418|FG000|Overall Study|Emergency Travel Out of Country|1|||
143053369|NCT04773600|515734419|FG001|Overall Study|Emergency Travel Out of Country|0|||
143053370|NCT01636934|515736047|FG000|Overall Study|Withdrawal by Subject|3|||
143053371|NCT01636934|515736048|FG001|Overall Study|Withdrawal by Subject|2|||
143053372|NCT01636934|515736047|FG000|Overall Study|Chemo cancel|1|||
143053373|NCT01636934|515736048|FG001|Overall Study|Chemo cancel|0|||
143053374|NCT01636934|515736047|FG000|Overall Study|Too ill to continue|1|||
143053375|NCT01636934|515736048|FG001|Overall Study|Too ill to continue|0|||
143053376|NCT01636934|515736047|FG000|Overall Study|Never started study medication|1|||
143053377|NCT01636934|515736048|FG001|Overall Study|Never started study medication|1|||
143053378|NCT03687242|515736053|FG000|Overall Study|Adverse Event|1|||
143053379|NCT00377156|515736056|FG000|Overall Study|Death|23|||
143053380|NCT00377156|515736057|FG001|Overall Study|Death|19|||
143053381|NCT00377156|515736056|FG000|Overall Study|Withdrawal by Subject|16|||
143053382|NCT00377156|515736057|FG001|Overall Study|Withdrawal by Subject|24|||
143053383|NCT00377156|515736056|FG000|Overall Study|Had follow-up <90 d|3|||
143053384|NCT00377156|515736057|FG001|Overall Study|Had follow-up <90 d|6|||
143053385|NCT00377156|515736056|FG000|Overall Study|Cancellation|1|||
143053386|NCT00377156|515736057|FG001|Overall Study|Cancellation|0|||
143053387|NCT00377156|515736056|FG000|Overall Study|Refused testing|0|||
143053388|NCT00377156|515736057|FG001|Overall Study|Refused testing|1|||
143053389|NCT00377156|515736056|FG000|Overall Study|Ineligible|0|||
143053390|NCT00377156|515736057|FG001|Overall Study|Ineligible|1|||
143053391|NCT00377156|515736056|FG000|Overall Study|Disability or language problem|0|||
143053392|NCT00377156|515736057|FG001|Overall Study|Disability or language problem|1|||
143053393|NCT00377156|515736056|FG000|Overall Study|Other|5|||
143053394|NCT00377156|515736057|FG001|Overall Study|Other|2|||
143053395|NCT00288704|515736058|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
143053396|NCT00288704|515736059|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
143053397|NCT00288704|515736060|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
143053398|NCT00288704|515736058|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
143053399|NCT00288704|515736059|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
143053400|NCT00288704|515736060|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
143053401|NCT00288704|515736058|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
143053402|NCT00288704|515736059|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
143053403|NCT00288704|515736060|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
143053404|NCT00288704|515736058|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
143053405|NCT00288704|515736059|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
143053406|NCT00288704|515736060|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
143053407|NCT00288704|515736058|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
143053408|NCT00288704|515736059|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
143053409|NCT00288704|515736060|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
143053410|NCT00288704|515736058|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
143053411|NCT00288704|515736059|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
143053412|NCT00288704|515736060|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
143053413|NCT00288704|515736058|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
143053414|NCT00288704|515736059|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
143053415|NCT00288704|515736060|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
143053416|NCT01579006|515736061|FG000|Overall Study|Lack of Efficacy|10|||
143053417|NCT01579006|515736061|FG000|Overall Study|Adverse Event|13|||
143053418|NCT01579006|515736061|FG000|Overall Study|Withdrawal by Subject|5|||
143169358|NCT02836249|516169870|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
143169359|NCT02836249|516169871|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
143053419|NCT01579006|515736061|FG000|Overall Study|Non-compliance|3|||
143053420|NCT01579006|515736061|FG000|Overall Study|Due to participant's health fund|1|||
143053421|NCT01579006|515736061|FG000|Overall Study|Scheduled surgery|1|||
143053422|NCT01802216|515736064|FG000|4 Month Visit|Participant did not show to visit|3|||
143053423|NCT01802216|515736065|FG001|4 Month Visit|Participant did not show to visit|4|||
143053424|NCT01802216|515736064|FG000|8 Month Visit|Participant did not show to visit|3|||
143053425|NCT01802216|515736065|FG001|8 Month Visit|Participant did not show to visit|5|||
143053426|NCT01802216|515736064|FG000|12 Month Visit|Participant did not show to visit|3|||
143053427|NCT01802216|515736065|FG001|12 Month Visit|Participant did not show to visit|4|||
143053428|NCT05061992|515736066|FG000|Overall Study|Excess bowel movements|1|||
143053429|NCT05061992|515736067|FG001|Overall Study|Excess bowel movements|0|||
143053430|NCT05061992|515736066|FG000|Overall Study|Complications of Medical Care|1|||
143053431|NCT05061992|515736067|FG001|Overall Study|Complications of Medical Care|0|||
143053432|NCT05061992|515736066|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
143053433|NCT05061992|515736067|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
143053434|NCT05061992|515736066|FG000|Overall Study|Withdrawal by Subject|0|||
143053435|NCT05061992|515736067|FG001|Overall Study|Withdrawal by Subject|1|||
143053436|NCT02697617|515736068|FG000|Overall Study|Withdrawal by Subject|0|||
143053437|NCT02697617|515736069|FG001|Overall Study|Withdrawal by Subject|2|||
143053438|NCT02697617|515736068|FG000|Overall Study|Pregnancy|1|||
143053439|NCT02697617|515736069|FG001|Overall Study|Pregnancy|0|||
143053440|NCT05393271|515736072|FG000|Overall Study|Physician Decision|0|||
143053441|NCT05393271|515736073|FG001|Overall Study|Physician Decision|0|||
143053442|NCT05393271|515736074|FG002|Overall Study|Physician Decision|0|||
143053443|NCT05393271|515736075|FG003|Overall Study|Physician Decision|0|||
143053444|NCT05393271|515736076|FG004|Overall Study|Physician Decision|0|||
143053445|NCT05393271|515736077|FG005|Overall Study|Physician Decision|0|||
143053446|NCT05393271|515736078|FG006|Overall Study|Physician Decision|1|||
143053447|NCT05393271|515736079|FG007|Overall Study|Physician Decision|0|||
143053448|NCT05393271|515736080|FG008|Overall Study|Physician Decision|0|||
143053449|NCT05393271|515736081|FG009|Overall Study|Physician Decision|0|||
143053450|NCT05393271|515736082|FG010|Overall Study|Physician Decision|0|||
143053451|NCT02104817|515736085|FG000|Overall Study|Death|363|||
143053452|NCT02104817|515736086|FG001|Overall Study|Death|330|||
143053453|NCT02104817|515736085|FG000|Overall Study|Lost to Follow-up|3|||
143053454|NCT02104817|515736086|FG001|Overall Study|Lost to Follow-up|2|||
143053455|NCT02104817|515736085|FG000|Overall Study|Protocol Violation|0|||
143053456|NCT02104817|515736086|FG001|Overall Study|Protocol Violation|1|||
143053457|NCT02104817|515736085|FG000|Overall Study|Study terminated by sponsor|5854|||
143053458|NCT02104817|515736086|FG001|Overall Study|Study terminated by sponsor|5901|||
143053459|NCT02104817|515736085|FG000|Overall Study|Withdrawal by Subject|111|||
143053460|NCT02104817|515736086|FG001|Overall Study|Withdrawal by Subject|78|||
143053461|NCT02104817|515736085|FG000|Overall Study|Other reasons|128|||
143053462|NCT02104817|515736086|FG001|Overall Study|Other reasons|135|||
143053463|NCT02575339|515736087|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
143053464|NCT02575339|515736088|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
143053465|NCT02575339|515736089|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
143053466|NCT02575339|515736087|FG000|Study Treatment|Disease Progression|5|||
143053467|NCT02575339|515736088|FG001|Study Treatment|Disease Progression|2|||
143053468|NCT02575339|515736089|FG002|Study Treatment|Disease Progression|0|||
143053469|NCT02575339|515736087|FG000|Study Treatment|Adverse Event|1|||
143053470|NCT02575339|515736088|FG001|Study Treatment|Adverse Event|2|||
143053471|NCT02575339|515736089|FG002|Study Treatment|Adverse Event|0|||
143053472|NCT02575339|515736087|FG000|Follow up|Death|6|||
143053473|NCT02575339|515736088|FG001|Follow up|Death|2|||
143053474|NCT02575339|515736089|FG002|Follow up|Death|0|||
143053475|NCT02575339|515736087|FG000|Follow up|Study Terminated|0|||
143053476|NCT02575339|515736088|FG001|Follow up|Study Terminated|2|||
143053477|NCT02575339|515736089|FG002|Follow up|Study Terminated|0|||
143053478|NCT02575339|515736087|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
143053479|NCT02575339|515736088|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
143053480|NCT02575339|515736089|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
143499614|NCT01299727|517370444|FG001|Overall Study|Withdrawal by Subject|0|||
143053481|NCT04675775|515736090|FG000|Overall Study|Withdrawal by Subject|7|||
143053482|NCT04633642|515736091|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
143499615|NCT01299727|517370445|FG002|Overall Study|Withdrawal by Subject|0|||
143053483|NCT04633642|515736092|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
143053484|NCT01957150|515736093|FG000|Overall Study|Adverse Event|23|||
143053485|NCT01957150|515736094|FG001|Overall Study|Adverse Event|20|||
143053486|NCT01957150|515736093|FG000|Overall Study|Withdrawal by Subject|13|||
143053487|NCT01957150|515736094|FG001|Overall Study|Withdrawal by Subject|17|||
143053488|NCT01957150|515736093|FG000|Overall Study|Physician Decision|3|||
143053489|NCT01957150|515736094|FG001|Overall Study|Physician Decision|6|||
143053490|NCT01957150|515736093|FG000|Overall Study|Lost to Follow-up|4|||
143053491|NCT01957150|515736094|FG001|Overall Study|Lost to Follow-up|4|||
143053492|NCT01957150|515736093|FG000|Overall Study|Protocol Violation|1|||
143244920|NCT01737502|516448132|FG000|Phase II|Adverse Event|0|||
143244921|NCT01737502|516448133|FG001|Phase II|Adverse Event|3|||
143244922|NCT01737502|516448132|FG000|Phase II|Disease progression|0|||
143244923|NCT01737502|516448133|FG001|Phase II|Disease progression|18|||
143244924|NCT01737502|516448132|FG000|Phase II|Death|0|||
143244925|NCT01737502|516448133|FG001|Phase II|Death|1|||
143244926|NCT01737502|516448132|FG000|Phase II|Transition to hospice care|0|||
143244927|NCT01737502|516448133|FG001|Phase II|Transition to hospice care|1|||
143244928|NCT00560352|516448136|FG000|Overall Study|Adverse event unrelated to study drug|2|||
143244929|NCT00560352|516448137|FG001|Overall Study|Adverse event unrelated to study drug|1|||
143244930|NCT00560352|516448138|FG002|Overall Study|Adverse event unrelated to study drug|1|||
143244931|NCT00560352|516448136|FG000|Overall Study|Study drug toxicity|3|||
143244932|NCT00560352|516448137|FG001|Overall Study|Study drug toxicity|0|||
143244933|NCT00560352|516448138|FG002|Overall Study|Study drug toxicity|1|||
143244934|NCT00560352|516448136|FG000|Overall Study|Disease progression|0|||
143244935|NCT00560352|516448137|FG001|Overall Study|Disease progression|1|||
143244936|NCT00560352|516448138|FG002|Overall Study|Disease progression|1|||
143244937|NCT00560352|516448136|FG000|Overall Study|Withdrawal by Subject|1|||
143244938|NCT00560352|516448137|FG001|Overall Study|Withdrawal by Subject|1|||
143244939|NCT00560352|516448138|FG002|Overall Study|Withdrawal by Subject|1|||
143244940|NCT00560352|516448136|FG000|Overall Study|Maximum clinical benefit|1|||
143244941|NCT00560352|516448137|FG001|Overall Study|Maximum clinical benefit|0|||
143244942|NCT00560352|516448138|FG002|Overall Study|Maximum clinical benefit|0|||
143244943|NCT00114517|516448142|FG000|Overall Study|Adverse Event|6|||
143244944|NCT00114517|516448143|FG001|Overall Study|Adverse Event|1|||
143244945|NCT00114517|516448144|FG002|Overall Study|Adverse Event|6|||
143244946|NCT00114517|516448145|FG003|Overall Study|Adverse Event|3|||
143244947|NCT00114517|516448142|FG000|Overall Study|Lost to Follow-up|2|||
143244948|NCT00114517|516448143|FG001|Overall Study|Lost to Follow-up|2|||
143244949|NCT00114517|516448144|FG002|Overall Study|Lost to Follow-up|2|||
143244950|NCT00114517|516448145|FG003|Overall Study|Lost to Follow-up|1|||
143244951|NCT00114517|516448142|FG000|Overall Study|Too busy|3|||
143244952|NCT00114517|516448143|FG001|Overall Study|Too busy|1|||
143244953|NCT00114517|516448144|FG002|Overall Study|Too busy|1|||
143244954|NCT00114517|516448145|FG003|Overall Study|Too busy|2|||
143244955|NCT00114517|516448142|FG000|Overall Study|Moved from area|0|||
143244956|NCT00114517|516448143|FG001|Overall Study|Moved from area|3|||
143244957|NCT00114517|516448144|FG002|Overall Study|Moved from area|2|||
143244958|NCT00114517|516448145|FG003|Overall Study|Moved from area|1|||
143244959|NCT00114517|516448142|FG000|Overall Study|Did not want estradiol|1|||
143244960|NCT00114517|516448143|FG001|Overall Study|Did not want estradiol|1|||
143244961|NCT00114517|516448144|FG002|Overall Study|Did not want estradiol|0|||
143244962|NCT00114517|516448145|FG003|Overall Study|Did not want estradiol|0|||
143244963|NCT00114517|516448142|FG000|Overall Study|Armed-services duty|0|||
143244964|NCT00114517|516448143|FG001|Overall Study|Armed-services duty|1|||
143244965|NCT00114517|516448144|FG002|Overall Study|Armed-services duty|0|||
143244966|NCT00114517|516448145|FG003|Overall Study|Armed-services duty|1|||
143244967|NCT00114517|516448142|FG000|Overall Study|Competing family issue|0|||
143244968|NCT00114517|516448143|FG001|Overall Study|Competing family issue|1|||
143244969|NCT00114517|516448144|FG002|Overall Study|Competing family issue|0|||
143244970|NCT00114517|516448145|FG003|Overall Study|Competing family issue|1|||
143244971|NCT00114517|516448142|FG000|Overall Study|Physician Decision|0|||
143244972|NCT00114517|516448143|FG001|Overall Study|Physician Decision|1|||
143244973|NCT00114517|516448144|FG002|Overall Study|Physician Decision|0|||
143244974|NCT00114517|516448145|FG003|Overall Study|Physician Decision|0|||
143244975|NCT00114517|516448142|FG000|Overall Study|Lost interest|0|||
143244976|NCT00114517|516448143|FG001|Overall Study|Lost interest|0|||
143244977|NCT00114517|516448144|FG002|Overall Study|Lost interest|1|||
143244978|NCT00114517|516448145|FG003|Overall Study|Lost interest|0|||
143244979|NCT00114517|516448142|FG000|Overall Study|Weight increase|0|||
143244980|NCT00114517|516448143|FG001|Overall Study|Weight increase|0|||
143244981|NCT00114517|516448144|FG002|Overall Study|Weight increase|1|||
143244982|NCT00114517|516448145|FG003|Overall Study|Weight increase|0|||
143244983|NCT00114517|516448142|FG000|Overall Study|Concern about blood clots|0|||
143244984|NCT00114517|516448143|FG001|Overall Study|Concern about blood clots|0|||
143244985|NCT00114517|516448144|FG002|Overall Study|Concern about blood clots|1|||
143244986|NCT00114517|516448145|FG003|Overall Study|Concern about blood clots|0|||
143244987|NCT00114517|516448142|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
143244988|NCT00114517|516448143|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
143244989|NCT00114517|516448144|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
143244990|NCT00114517|516448145|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
143244991|NCT02741518|516449573|FG000|Overall Study|Withdrawal by Subject|1|||
143244992|NCT02741518|516449574|FG001|Overall Study|Withdrawal by Subject|1|||
143244993|NCT01349049|516449575|FG000|Overall Study|Disease progression|3|||
143244994|NCT01349049|516449576|FG001|Overall Study|Disease progression|5|||
143244995|NCT01349049|516449577|FG002|Overall Study|Disease progression|3|||
143244996|NCT01349049|516449578|FG003|Overall Study|Disease progression|2|||
143244997|NCT01349049|516449579|FG004|Overall Study|Disease progression|2|||
143053493|NCT01957150|515736094|FG001|Overall Study|Protocol Violation|0|||
143053494|NCT01957150|515736093|FG000|Overall Study|Lack of Efficacy|11|||
143053495|NCT01957150|515736094|FG001|Overall Study|Lack of Efficacy|11|||
143053496|NCT03223909|515736095|FG000|Overall Study|Protocol Violation|48|||
143053497|NCT03223909|515736096|FG001|Overall Study|Protocol Violation|45|||
143053498|NCT03223909|515736097|FG002|Overall Study|Protocol Violation|16|||
143053499|NCT00668395|515736100|FG000|Overall Study|Withdrawal by Subject|4|||
143053500|NCT00668395|515736101|FG001|Overall Study|Withdrawal by Subject|4|||
143053501|NCT00668395|515736102|FG002|Overall Study|Withdrawal by Subject|1|||
143053502|NCT00668395|515736100|FG000|Overall Study|Adverse Event|1|||
143053503|NCT00668395|515736101|FG001|Overall Study|Adverse Event|1|||
143053504|NCT00668395|515736102|FG002|Overall Study|Adverse Event|0|||
143053505|NCT00668395|515736100|FG000|Overall Study|Physician Decision|1|||
143053506|NCT00668395|515736101|FG001|Overall Study|Physician Decision|1|||
143053507|NCT00668395|515736102|FG002|Overall Study|Physician Decision|0|||
143053508|NCT00697827|515736103|FG000|Overall Study|enrolled but not treated|2|||
143053509|NCT00697827|515736104|FG001|Overall Study|enrolled but not treated|1|||
143053510|NCT00550147|515736105|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
143053511|NCT00550147|515736105|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
143053512|NCT00550147|515736105|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
143053513|NCT00550147|515736105|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
143053514|NCT00550147|515736105|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
143053515|NCT00046839|515736106|FG000|Overall Study|Ineligible / No protocol treatment|0|||
143053516|NCT00046839|515736107|FG001|Overall Study|Ineligible / No protocol treatment|2|||
143053517|NCT00046839|515736106|FG000|Overall Study|Withdrawal of consent|1|||
143053518|NCT00046839|515736107|FG001|Overall Study|Withdrawal of consent|0|||
143053519|NCT01963260|515736111|FG000|Overall Study|Withdrawal by Subject|2|||
143053520|NCT01963260|515736112|FG001|Overall Study|Withdrawal by Subject|0|||
143053521|NCT01963260|515736113|FG002|Overall Study|Withdrawal by Subject|0|||
143053522|NCT01963260|515736114|FG003|Overall Study|Withdrawal by Subject|1|||
143053523|NCT01963260|515736115|FG004|Overall Study|Withdrawal by Subject|2|||
143053524|NCT01963260|515736116|FG005|Overall Study|Withdrawal by Subject|0|||
143053525|NCT01963260|515736117|FG006|Overall Study|Withdrawal by Subject|0|||
143053526|NCT01963260|515736118|FG007|Overall Study|Withdrawal by Subject|0|||
143053527|NCT01963260|515736119|FG008|Overall Study|Withdrawal by Subject|0|||
143053528|NCT01963260|515736120|FG009|Overall Study|Withdrawal by Subject|0|||
143053529|NCT00160524|515736121|FG000|Overall Study|Adverse Event|119|||
143053530|NCT00160524|515736121|FG000|Overall Study|Adverse Event and Other|94|||
143053531|NCT00160524|515736121|FG000|Overall Study|Protocol Violation|16|||
143053532|NCT00160524|515736121|FG000|Overall Study|Protocol Violation and Other|2|||
143053533|NCT00160524|515736121|FG000|Overall Study|Withdrawal by Subject|141|||
143053534|NCT00160524|515736121|FG000|Overall Study|Withdrawal by Subject and Other|17|||
143053535|NCT00160524|515736121|FG000|Overall Study|Physician Decision|27|||
143053536|NCT00160524|515736121|FG000|Overall Study|Physician Decision and Other|6|||
143053537|NCT00160524|515736121|FG000|Overall Study|Lost to Follow-up|13|||
143053538|NCT00160524|515736121|FG000|Overall Study|Lost to Follow-up and Other|1|||
143053539|NCT00160524|515736121|FG000|Overall Study|Lack of Efficacy|21|||
143053540|NCT00160524|515736121|FG000|Overall Study|Lack of Efficacy and Other|1|||
143053541|NCT00160524|515736121|FG000|Overall Study|Other|20|||
143053542|NCT04892147|515736123|FG000|Overall Study|Withdrawal by Subject|2|||
143053543|NCT04892147|515736124|FG001|Overall Study|Withdrawal by Subject|0|||
143053544|NCT01067521|515736125|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
143053545|NCT01067521|515736126|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
143053546|NCT01067521|515736125|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
143053547|NCT01067521|515736126|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
143053548|NCT01067521|515736125|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
143053549|NCT01067521|515736126|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
143053550|NCT01067521|515736125|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
143053551|NCT01067521|515736126|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
143053552|NCT01067521|515736125|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
143053553|NCT01067521|515736126|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
143053554|NCT01067521|515736125|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
143053555|NCT01067521|515736126|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
143244998|NCT01349049|516449580|FG005|Overall Study|Disease progression|2|||
143053556|NCT01067521|515736125|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
143053557|NCT01067521|515736126|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
143053558|NCT01067521|515736125|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
143053559|NCT01067521|515736126|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
143053560|NCT01067521|515736125|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
143053561|NCT01067521|515736126|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
143053562|NCT01067521|515736125|FG000|Open-Label Period|Death|3|||
143053563|NCT01067521|515736126|FG001|Open-Label Period|Death|1|||
143053564|NCT01067521|515736125|FG000|Open-Label Period|Adverse Event|30|||
143499616|NCT01299727|517370443|FG000|Overall Study|Adverse Event|0|||
143499617|NCT01299727|517370444|FG001|Overall Study|Adverse Event|0|||
143499618|NCT01299727|517370445|FG002|Overall Study|Adverse Event|1|||
143499619|NCT01299727|517370443|FG000|Overall Study|Completed the Treatment Period|3|||
143499620|NCT01299727|517370444|FG001|Overall Study|Completed the Treatment Period|4|||
143499621|NCT01299727|517370445|FG002|Overall Study|Completed the Treatment Period|3|||
143053565|NCT01067521|515736126|FG001|Open-Label Period|Adverse Event|28|||
143053566|NCT01067521|515736125|FG000|Open-Label Period|Withdrawal by Subject|160|||
143053567|NCT01067521|515736126|FG001|Open-Label Period|Withdrawal by Subject|88|||
143053568|NCT01067521|515736125|FG000|Open-Label Period|Physician Decision|13|||
143499622|NCT00944034|517370450|FG000|Overall Study|Inappropriate enrollment|0|||
143053569|NCT01067521|515736126|FG001|Open-Label Period|Physician Decision|11|||
143053570|NCT01067521|515736125|FG000|Open-Label Period|Non-compliance with study drug|5|||
143053571|NCT01067521|515736126|FG001|Open-Label Period|Non-compliance with study drug|0|||
143053572|NCT01067521|515736125|FG000|Open-Label Period|Protocol Violation|3|||
143053573|NCT01067521|515736126|FG001|Open-Label Period|Protocol Violation|0|||
143053574|NCT01067521|515736125|FG000|Open-Label Period|Pregnancy|14|||
143053575|NCT01067521|515736126|FG001|Open-Label Period|Pregnancy|8|||
143053576|NCT01067521|515736125|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
143053577|NCT01067521|515736126|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
143053578|NCT01067521|515736125|FG000|Open-Label Period|Lost to Follow-up|21|||
143499623|NCT00944034|517370451|FG001|Overall Study|Inappropriate enrollment|1|||
143053579|NCT01067521|515736126|FG001|Open-Label Period|Lost to Follow-up|20|||
143053580|NCT01547728|515736127|FG000|Overall Study|Change in procedure and equipment|1|||
143053581|NCT01547728|515736127|FG000|Overall Study|Drug not ready for subject|1|||
143053582|NCT01547728|515736127|FG000|Overall Study|Screen failure|39|||
143169360|NCT02836249|516169872|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
143169361|NCT02836249|516169869|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
143169362|NCT02836249|516169870|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
143169363|NCT02836249|516169871|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
143169364|NCT02836249|516169872|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
143169365|NCT02836249|516169869|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
143169366|NCT02836249|516169870|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
143169367|NCT02836249|516169871|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
143169368|NCT02836249|516169872|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
143169369|NCT02836249|516169869|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
143169370|NCT02836249|516169870|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
143169371|NCT02836249|516169871|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
143169372|NCT02836249|516169872|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
143169373|NCT02836249|516169869|FG000|Open-Label TAF Treatment Phase|Death|0|||
143169374|NCT02836249|516169870|FG001|Open-Label TAF Treatment Phase|Death|0|||
143169375|NCT02836249|516169871|FG002|Open-Label TAF Treatment Phase|Death|1|||
143169376|NCT02836249|516169872|FG003|Open-Label TAF Treatment Phase|Death|0|||
143169377|NCT02836249|516169869|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
143169378|NCT02836249|516169870|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
143169379|NCT02836249|516169871|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
143169380|NCT02836249|516169872|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
143169381|NCT02836249|516169869|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
143169382|NCT02836249|516169870|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
143169383|NCT02836249|516169871|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
143169384|NCT02836249|516169872|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
143169385|NCT04752566|516169873|FG000|Overall Study|Protocol Violation|0|||
143169386|NCT04752566|516169874|FG001|Overall Study|Protocol Violation|1|||
143169387|NCT04752566|516169873|FG000|Overall Study|Death|1|||
143169388|NCT04752566|516169874|FG001|Overall Study|Death|0|||
143169389|NCT04752566|516169873|FG000|Overall Study|Adverse Event|1|||
143169390|NCT04752566|516169874|FG001|Overall Study|Adverse Event|0|||
143169391|NCT04752566|516169873|FG000|Overall Study|Withdrawal by Subject|2|||
143169392|NCT04752566|516169874|FG001|Overall Study|Withdrawal by Subject|0|||
143169393|NCT04752566|516169873|FG000|Overall Study|Physician Decision|1|||
143169394|NCT04752566|516169874|FG001|Overall Study|Physician Decision|1|||
143169395|NCT00928668|516169875|FG000|Overall Study|Adverse Event|1|||
143169396|NCT00928668|516169876|FG001|Overall Study|Adverse Event|0|||
143169397|NCT00928668|516169877|FG002|Overall Study|Adverse Event|0|||
143169398|NCT00928668|516169878|FG003|Overall Study|Adverse Event|0|||
143169399|NCT00928668|516169879|FG004|Overall Study|Adverse Event|0|||
143169400|NCT00928668|516169875|FG000|Overall Study|Protocol Violation|0|||
143169401|NCT00928668|516169876|FG001|Overall Study|Protocol Violation|0|||
143244999|NCT01349049|516449581|FG006|Overall Study|Disease progression|3|||
143169402|NCT00928668|516169877|FG002|Overall Study|Protocol Violation|0|||
143169403|NCT00928668|516169878|FG003|Overall Study|Protocol Violation|0|||
143169404|NCT00928668|516169879|FG004|Overall Study|Protocol Violation|1|||
143169405|NCT00928668|516169875|FG000|Overall Study|Withdrawal by Subject|0|||
143169406|NCT00928668|516169876|FG001|Overall Study|Withdrawal by Subject|1|||
143499624|NCT00944034|517370452|FG002|Overall Study|Inappropriate enrollment|0|||
143053583|NCT03448692|515736128|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
143053584|NCT03448692|515736129|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
143053585|NCT03448692|515736128|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
143053586|NCT03448692|515736129|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
143053587|NCT03448692|515736128|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
143053588|NCT03448692|515736129|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
143053589|NCT03448692|515736128|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
143053590|NCT03448692|515736129|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
143053591|NCT03448692|515736128|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
143053592|NCT03448692|515736129|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
143053593|NCT02786927|515736136|FG000|Overall Study|Adverse Event|1|||
143053594|NCT02786927|515736136|FG000|Overall Study|Protocol Violation|4|||
143053595|NCT01801917|515736137|FG000|Period 1 - Randomized|Adverse Event|1|||
143053596|NCT01801917|515736138|FG001|Period 1 - Randomized|Adverse Event|0|||
143053597|NCT01801917|515736139|FG002|Period 1 - Randomized|Adverse Event|1|||
143053598|NCT01801917|515736140|FG003|Period 1 - Randomized|Adverse Event|0|||
143053599|NCT01924364|515736141|FG000|Overall Study|Physician Decision|3|||
143053600|NCT00265785|515736142|FG000|Overall Study|Adverse Event|4|||
143053601|NCT00265785|515736142|FG000|Overall Study|Withdrawal by Subject|3|||
143053602|NCT00265785|515736142|FG000|Overall Study|Progression/Relapse|15|||
143053603|NCT00265785|515736142|FG000|Overall Study|Not protocol specified|2|||
143053604|NCT00265785|515736142|FG000|Overall Study|Ineligible|1|||
143053605|NCT00265785|515736142|FG000|Overall Study|Did not receive protocol treatment|2|||
143053606|NCT01688882|515736143|FG000|Overall Study|Adverse Event|1|||
143053607|NCT01688882|515736144|FG001|Overall Study|Adverse Event|0|||
143053608|NCT01688882|515736143|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
143053609|NCT01688882|515736144|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
143053610|NCT01688882|515736143|FG000|Overall Study|Administrative problems|1|||
143053611|NCT01688882|515736144|FG001|Overall Study|Administrative problems|0|||
143053612|NCT02416934|515736145|FG000|Overall Study|given steroids|1|||
143053613|NCT02416934|515736146|FG001|Overall Study|given steroids|2|||
143053614|NCT02416934|515736145|FG000|Overall Study|Lost to Follow-up|0|||
143053615|NCT02416934|515736146|FG001|Overall Study|Lost to Follow-up|2|||
143053616|NCT02416934|515736145|FG000|Overall Study|Withdrawal by Subject|1|||
143053617|NCT02416934|515736146|FG001|Overall Study|Withdrawal by Subject|0|||
143053618|NCT02416934|515736145|FG000|Overall Study|recruited during continuing renewal proc|0|||
143053619|NCT02416934|515736146|FG001|Overall Study|recruited during continuing renewal proc|1|||
143053620|NCT02416934|515736145|FG000|Overall Study|Protocol Violation|0|||
143053621|NCT02416934|515736146|FG001|Overall Study|Protocol Violation|1|||
143053622|NCT02416934|515736145|FG000|Overall Study|surgery started late|0|||
143053623|NCT02416934|515736146|FG001|Overall Study|surgery started late|1|||
143053624|NCT02416934|515736145|FG000|Overall Study|re-operation|1|||
143053625|NCT02416934|515736146|FG001|Overall Study|re-operation|0|||
143053626|NCT00124618|515736147|FG000|Overall Study|Ineligible|1|||
143053627|NCT00593827|515736148|FG000|Overall Study|On Active Treatment/Pending|0|||
143053628|NCT00593827|515736149|FG001|Overall Study|On Active Treatment/Pending|2|||
143053629|NCT02169336|515736152|FG000|Overall Study|Lack of Efficacy|1|||
143053630|NCT02169336|515736153|FG001|Overall Study|Lack of Efficacy|1|||
143053631|NCT02169336|515736154|FG002|Overall Study|Lack of Efficacy|0|||
143053632|NCT02169336|515736152|FG000|Overall Study|Adverse Event|2|||
143053633|NCT02169336|515736153|FG001|Overall Study|Adverse Event|3|||
143053634|NCT02169336|515736154|FG002|Overall Study|Adverse Event|1|||
143053635|NCT02169336|515736152|FG000|Overall Study|Withdrawal by Subject|1|||
143053636|NCT02169336|515736153|FG001|Overall Study|Withdrawal by Subject|0|||
143245000|NCT01349049|516449582|FG007|Overall Study|Disease progression|2|||
143245001|NCT01349049|516449583|FG008|Overall Study|Disease progression|33|||
143053637|NCT02169336|515736154|FG002|Overall Study|Withdrawal by Subject|0|||
143053638|NCT02169336|515736152|FG000|Overall Study|Physician Decision|0|||
143053639|NCT02169336|515736153|FG001|Overall Study|Physician Decision|0|||
143053640|NCT02169336|515736154|FG002|Overall Study|Physician Decision|1|||
143053641|NCT02169336|515736152|FG000|Overall Study|Subject declined to continue dosing|0|||
143053642|NCT02169336|515736153|FG001|Overall Study|Subject declined to continue dosing|0|||
143053643|NCT02169336|515736154|FG002|Overall Study|Subject declined to continue dosing|1|||
143053644|NCT01598896|515736158|FG000|Overall Study|Withdrawal by Subject|0|||
143245002|NCT01349049|516449575|FG000|Overall Study|Adverse Event|0|||
143053645|NCT01598896|515736159|FG001|Overall Study|Withdrawal by Subject|1|||
143053646|NCT01598896|515736158|FG000|Overall Study|Lack of Efficacy|0|||
143053647|NCT01598896|515736159|FG001|Overall Study|Lack of Efficacy|1|||
143053648|NCT01120691|515736162|FG000|Overall Study|Adverse Event|59|||
143053649|NCT01120691|515736163|FG001|Overall Study|Adverse Event|67|||
143053650|NCT01120691|515736164|FG002|Overall Study|Adverse Event|47|||
143053651|NCT01120691|515736162|FG000|Overall Study|Subject withdrew consent|33|||
143053652|NCT01120691|515736163|FG001|Overall Study|Subject withdrew consent|50|||
143053653|NCT01120691|515736164|FG002|Overall Study|Subject withdrew consent|44|||
143053654|NCT01120691|515736162|FG000|Overall Study|Death|21|||
143053655|NCT01120691|515736163|FG001|Overall Study|Death|22|||
143053656|NCT01120691|515736164|FG002|Overall Study|Death|24|||
143053657|NCT01120691|515736162|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
143053658|NCT01120691|515736163|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
143053659|NCT01120691|515736164|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
143053660|NCT01120691|515736162|FG000|Overall Study|Administrative problems|15|||
143053661|NCT01120691|515736163|FG001|Overall Study|Administrative problems|8|||
143053662|NCT01120691|515736164|FG002|Overall Study|Administrative problems|9|||
143053663|NCT01120691|515736162|FG000|Overall Study|Protocol deviation|13|||
143053664|NCT01120691|515736163|FG001|Overall Study|Protocol deviation|12|||
143053665|NCT01120691|515736164|FG002|Overall Study|Protocol deviation|12|||
143053666|NCT01120691|515736162|FG000|Overall Study|Lost to Follow-up|5|||
143053667|NCT01120691|515736163|FG001|Overall Study|Lost to Follow-up|6|||
143053668|NCT01120691|515736164|FG002|Overall Study|Lost to Follow-up|4|||
143053669|NCT01120691|515736162|FG000|Overall Study|Abnormal test procedure result(s)|3|||
143053670|NCT01120691|515736163|FG001|Overall Study|Abnormal test procedure result(s)|2|||
143053671|NCT01120691|515736164|FG002|Overall Study|Abnormal test procedure result(s)|1|||
143053672|NCT01120691|515736162|FG000|Overall Study|Patient's inability to use the device|3|||
143053673|NCT01120691|515736163|FG001|Overall Study|Patient's inability to use the device|1|||
143053674|NCT01120691|515736164|FG002|Overall Study|Patient's inability to use the device|0|||
143053675|NCT01120691|515736162|FG000|Overall Study|Abnormal laboratory value(s)|1|||
143053676|NCT01120691|515736163|FG001|Overall Study|Abnormal laboratory value(s)|3|||
143053677|NCT01120691|515736164|FG002|Overall Study|Abnormal laboratory value(s)|4|||
143053678|NCT00642811|515736165|FG000|Overall Study|Adverse Event|2|||
143053679|NCT00642811|515736166|FG001|Overall Study|Adverse Event|3|||
143053680|NCT00642811|515736167|FG002|Overall Study|Adverse Event|0|||
143053681|NCT00642811|515736168|FG003|Overall Study|Adverse Event|0|||
143053682|NCT00642811|515736169|FG004|Overall Study|Adverse Event|0|||
143053683|NCT00642811|515736170|FG005|Overall Study|Adverse Event|1|||
143053684|NCT00642811|515736165|FG000|Overall Study|Developement of discontinuation criteria|0|||
143053685|NCT00642811|515736166|FG001|Overall Study|Developement of discontinuation criteria|0|||
143053686|NCT00642811|515736167|FG002|Overall Study|Developement of discontinuation criteria|0|||
143053687|NCT00642811|515736168|FG003|Overall Study|Developement of discontinuation criteria|0|||
143053688|NCT00642811|515736169|FG004|Overall Study|Developement of discontinuation criteria|1|||
143053689|NCT00642811|515736170|FG005|Overall Study|Developement of discontinuation criteria|0|||
143053690|NCT00642811|515736165|FG000|Overall Study|Severe Non-compliance to protocol|1|||
143053691|NCT00642811|515736166|FG001|Overall Study|Severe Non-compliance to protocol|0|||
143053692|NCT00642811|515736167|FG002|Overall Study|Severe Non-compliance to protocol|0|||
143053693|NCT00642811|515736168|FG003|Overall Study|Severe Non-compliance to protocol|0|||
143053694|NCT00642811|515736169|FG004|Overall Study|Severe Non-compliance to protocol|0|||
143053695|NCT00642811|515736170|FG005|Overall Study|Severe Non-compliance to protocol|0|||
143053696|NCT00642811|515736165|FG000|Overall Study|Other|0|||
143053697|NCT00642811|515736166|FG001|Overall Study|Other|1|||
143053698|NCT00642811|515736167|FG002|Overall Study|Other|0|||
143053699|NCT00642811|515736168|FG003|Overall Study|Other|1|||
143053700|NCT00642811|515736169|FG004|Overall Study|Other|0|||
143053701|NCT00642811|515736170|FG005|Overall Study|Other|0|||
143053702|NCT04553406|515736174|FG000|Overall Study|Study Discontinuation|0|||
143053703|NCT04553406|515736175|FG001|Overall Study|Study Discontinuation|1|||
143053704|NCT03370510|515736176|FG000|Overall Study|COVID-19|2|||
143053705|NCT03370510|515736177|FG001|Overall Study|COVID-19|0|||
143053706|NCT00772148|515736178|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
143499625|NCT00944034|517370453|FG003|Overall Study|Inappropriate enrollment|1|||
143499626|NCT00944034|517370454|FG004|Overall Study|Inappropriate enrollment|2|||
143053707|NCT00772148|515736179|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
143053708|NCT00772148|515736178|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
143053709|NCT00772148|515736179|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
143053710|NCT00772148|515736178|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
143053711|NCT00772148|515736179|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
143053712|NCT00772148|515736178|FG000|Maintenance Phase (Week 52)|Death|2|||
143053713|NCT00772148|515736179|FG001|Maintenance Phase (Week 52)|Death|2|||
143053714|NCT00772148|515736178|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
143053715|NCT00772148|515736179|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
143053716|NCT00772148|515736178|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
143245003|NCT01349049|516449576|FG001|Overall Study|Adverse Event|1|||
143053717|NCT00772148|515736179|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
143053718|NCT00772148|515736178|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
143053719|NCT00772148|515736179|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
143053720|NCT01525628|515736182|FG000|Overall Study|Adverse Event|1|||
143053721|NCT01525628|515736183|FG001|Overall Study|Adverse Event|1|||
143053722|NCT01525628|515736184|FG002|Overall Study|Adverse Event|2|||
143053723|NCT01525628|515736185|FG003|Overall Study|Adverse Event|0|||
143053724|NCT01525628|515736186|FG004|Overall Study|Adverse Event|1|||
143053725|NCT01525628|515736182|FG000|Overall Study|Lack of Efficacy|0|||
143053726|NCT01525628|515736183|FG001|Overall Study|Lack of Efficacy|2|||
143053727|NCT01525628|515736184|FG002|Overall Study|Lack of Efficacy|2|||
143053728|NCT01525628|515736185|FG003|Overall Study|Lack of Efficacy|1|||
143053729|NCT01525628|515736186|FG004|Overall Study|Lack of Efficacy|2|||
143053730|NCT01525628|515736182|FG000|Overall Study|Protocol Violation|0|||
143053731|NCT01525628|515736183|FG001|Overall Study|Protocol Violation|0|||
143053732|NCT01525628|515736184|FG002|Overall Study|Protocol Violation|1|||
143053733|NCT01525628|515736185|FG003|Overall Study|Protocol Violation|0|||
143053734|NCT01525628|515736186|FG004|Overall Study|Protocol Violation|0|||
143053735|NCT01525628|515736182|FG000|Overall Study|Lost to Follow-up|1|||
143053736|NCT01525628|515736183|FG001|Overall Study|Lost to Follow-up|1|||
143053737|NCT01525628|515736184|FG002|Overall Study|Lost to Follow-up|0|||
143053738|NCT01525628|515736185|FG003|Overall Study|Lost to Follow-up|0|||
143053739|NCT01525628|515736186|FG004|Overall Study|Lost to Follow-up|0|||
143053740|NCT01525628|515736182|FG000|Overall Study|Withdrawal by Subject|0|||
143053741|NCT01525628|515736183|FG001|Overall Study|Withdrawal by Subject|1|||
143053742|NCT01525628|515736184|FG002|Overall Study|Withdrawal by Subject|0|||
143053743|NCT01525628|515736185|FG003|Overall Study|Withdrawal by Subject|0|||
143053744|NCT01525628|515736186|FG004|Overall Study|Withdrawal by Subject|0|||
143053745|NCT01525628|515736182|FG000|Overall Study|Other reason not defined above|0|||
143053746|NCT01525628|515736183|FG001|Overall Study|Other reason not defined above|0|||
143053747|NCT01525628|515736184|FG002|Overall Study|Other reason not defined above|0|||
143053748|NCT01525628|515736185|FG003|Overall Study|Other reason not defined above|3|||
143053749|NCT01525628|515736186|FG004|Overall Study|Other reason not defined above|0|||
143053750|NCT03573336|515736187|FG000|Overall Study|Study terminated|2|||
143053751|NCT03573336|515736188|FG001|Overall Study|Study terminated|4|||
143053752|NCT03573336|515736189|FG002|Overall Study|Study terminated|2|||
143053753|NCT00239005|515736190|FG000|Overall Study|Adverse Event|6|||
143053754|NCT00239005|515736191|FG001|Overall Study|Adverse Event|6|||
143053755|NCT00239005|515736190|FG000|Overall Study|Withdrawal by Subject|3|||
143053756|NCT00239005|515736191|FG001|Overall Study|Withdrawal by Subject|4|||
143053757|NCT00239005|515736190|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
143053758|NCT00239005|515736191|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
143053759|NCT00239005|515736190|FG000|Overall Study|Protocol Violation|1|||
143053760|NCT00239005|515736191|FG001|Overall Study|Protocol Violation|0|||
143053761|NCT00239005|515736190|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
143053762|NCT00239005|515736191|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
143053763|NCT00239005|515736190|FG000|Overall Study|Lost to Follow-up|0|||
143053764|NCT00239005|515736191|FG001|Overall Study|Lost to Follow-up|1|||
143053765|NCT02614898|515736192|FG000|Overall Study|Participated until study termination|10|||
143053766|NCT02614898|515736193|FG001|Overall Study|Participated until study termination|26|||
143053767|NCT02614898|515736192|FG000|Overall Study|Lost to Follow-up|0|||
143053768|NCT02614898|515736193|FG001|Overall Study|Lost to Follow-up|2|||
143053769|NCT02614898|515736192|FG000|Overall Study|Physician Decision|1|||
143053770|NCT02614898|515736193|FG001|Overall Study|Physician Decision|8|||
143053771|NCT02614898|515736192|FG000|Overall Study|Study Terminated by Sponsor|3|||
143053772|NCT02614898|515736193|FG001|Overall Study|Study Terminated by Sponsor|0|||
143245004|NCT01349049|516449577|FG002|Overall Study|Adverse Event|0|||
143245005|NCT01349049|516449578|FG003|Overall Study|Adverse Event|0|||
143053773|NCT02614898|515736192|FG000|Overall Study|Withdrawal by Subject|0|||
143053774|NCT02614898|515736193|FG001|Overall Study|Withdrawal by Subject|2|||
143245006|NCT01349049|516449579|FG004|Overall Study|Adverse Event|0|||
143245007|NCT01349049|516449580|FG005|Overall Study|Adverse Event|3|||
143245008|NCT01349049|516449581|FG006|Overall Study|Adverse Event|1|||
143053775|NCT02614898|515736192|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
143245009|NCT01349049|516449582|FG007|Overall Study|Adverse Event|0|||
143245010|NCT01349049|516449583|FG008|Overall Study|Adverse Event|4|||
143053776|NCT02614898|515736193|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
143053777|NCT02614898|515736192|FG000|Overall Study|Other-Additional Information Unavailable|0|||
143245011|NCT01349049|516449575|FG000|Overall Study|Physician Decision|0|||
143053778|NCT02614898|515736193|FG001|Overall Study|Other-Additional Information Unavailable|11|||
143053779|NCT02614898|515736192|FG000|Overall Study|Missing|0|||
143053780|NCT02614898|515736193|FG001|Overall Study|Missing|1|||
143053781|NCT03382041|515736194|FG000|Overall Study|Consent Form Lost|2|||
143053782|NCT03382041|515736195|FG001|Overall Study|Consent Form Lost|1|||
143053783|NCT03382041|515736194|FG000|Overall Study|Withdrawal by Subject|1|||
143053784|NCT03382041|515736195|FG001|Overall Study|Withdrawal by Subject|4|||
143053785|NCT03382041|515736194|FG000|Overall Study|Lost to Follow-up|1|||
143053786|NCT03382041|515736195|FG001|Overall Study|Lost to Follow-up|4|||
143053787|NCT00787605|515736196|FG000|Overall Study|Administrative Problems|3|||
143053788|NCT00787605|515736197|FG001|Overall Study|Administrative Problems|0|||
143053789|NCT00787605|515736196|FG000|Overall Study|Adverse Event|14|||
143053790|NCT00787605|515736197|FG001|Overall Study|Adverse Event|25|||
143053791|NCT00787605|515736196|FG000|Overall Study|Lost to Follow-up|3|||
143053792|NCT00787605|515736197|FG001|Overall Study|Lost to Follow-up|6|||
143053793|NCT00787605|515736196|FG000|Overall Study|Protocol Violation|7|||
143053794|NCT00787605|515736197|FG001|Overall Study|Protocol Violation|3|||
143053795|NCT00787605|515736196|FG000|Overall Study|Withdrawal by Subject|6|||
143053796|NCT00787605|515736197|FG001|Overall Study|Withdrawal by Subject|13|||
143053797|NCT00787605|515736196|FG000|Overall Study|Lack of Efficacy|13|||
143053798|NCT00787605|515736197|FG001|Overall Study|Lack of Efficacy|9|||
143053799|NCT00688844|515736198|FG000|Overall Study|Lost to Follow-up|10|||
143053800|NCT01374451|515736200|FG000|Overall Study|Administrative problems|1|||
143053801|NCT01374451|515736201|FG001|Overall Study|Administrative problems|0|||
143053802|NCT01223027|515736202|FG000|Overall Study|Adverse Event|20|||
143053803|NCT01223027|515736203|FG001|Overall Study|Adverse Event|10|||
143169407|NCT00928668|516169877|FG002|Overall Study|Withdrawal by Subject|1|||
143169408|NCT00928668|516169878|FG003|Overall Study|Withdrawal by Subject|0|||
143169409|NCT00928668|516169879|FG004|Overall Study|Withdrawal by Subject|0|||
143169410|NCT00928668|516169875|FG000|Overall Study|Other reasons not listed above|0|||
143169411|NCT00928668|516169876|FG001|Overall Study|Other reasons not listed above|0|||
143169412|NCT00928668|516169877|FG002|Overall Study|Other reasons not listed above|0|||
143169413|NCT00928668|516169878|FG003|Overall Study|Other reasons not listed above|1|||
143169414|NCT00928668|516169879|FG004|Overall Study|Other reasons not listed above|0|||
143169415|NCT01559935|516169880|FG000|Car Phase|Toxicity|4|||
143169416|NCT01559935|516169880|FG000|Car Phase|Death|1|||
143169417|NCT01559935|516169880|FG000|Car Phase|Lack of Efficacy|2|||
143169418|NCT01559935|516169880|FG000|Car Phase|Lost to Follow-up|1|||
143169419|NCT01559935|516169880|FG000|Car Phase|Physician Decision|1|||
143169420|NCT01559935|516169880|FG000|Car Phase|Withdrawal by Subject|2|||
143169421|NCT01559935|516169880|FG000|Car Phase|Per protocol|1|||
143169422|NCT01559935|516169880|FG000|Car Phase|Insurance|1|||
143169423|NCT01559935|516169880|FG000|Car Phase|non-compliance|1|||
143169424|NCT01559935|516169880|FG000|BiRD Phase|Toxicity|1|||
143169425|NCT01559935|516169880|FG000|BiRD Phase|Lack of Efficacy|1|||
143169426|NCT01559935|516169880|FG000|BiRD Phase|Withdrawal by Subject|2|||
143169427|NCT01559935|516169880|FG000|Maintenance Phase|Remains on study|28|||
143169428|NCT01559935|516169880|FG000|Maintenance Phase|Toxicity|1|||
143169429|NCT01559935|516169880|FG000|Maintenance Phase|Lack of Efficacy|18|||
143169430|NCT01559935|516169880|FG000|Maintenance Phase|Withdrawal by Subject|5|||
143169431|NCT01559935|516169880|FG000|Maintenance Phase|Non-compliance|2|||
143169432|NCT02958865|516169882|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
143169433|NCT02958865|516169883|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
143169434|NCT02958865|516169884|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
143169435|NCT02958865|516169885|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
143169436|NCT02958865|516169886|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
143169437|NCT02958865|516169887|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
143169438|NCT02958865|516169888|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
143169439|NCT02958865|516169889|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
143169440|NCT02958865|516169890|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
143169441|NCT02958865|516169891|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
143169442|NCT02958865|516169892|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
143169443|NCT02958865|516169893|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
143169444|NCT02958865|516169894|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
143169445|NCT02958865|516169895|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
143169446|NCT02958865|516169896|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
143169447|NCT02958865|516169897|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
143169448|NCT02958865|516169882|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
143169449|NCT02958865|516169883|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
143169450|NCT02958865|516169884|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
143169451|NCT02958865|516169885|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
143169452|NCT02958865|516169886|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
143053804|NCT01223027|515736202|FG000|Overall Study|Death|42|||
143053805|NCT01223027|515736203|FG001|Overall Study|Death|42|||
143169453|NCT02958865|516169887|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
143169454|NCT02958865|516169888|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
143169455|NCT02958865|516169889|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
143169456|NCT02958865|516169890|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
143169457|NCT02958865|516169891|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
143169458|NCT02958865|516169892|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
143169459|NCT02958865|516169893|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
143169460|NCT02958865|516169894|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
143169461|NCT02958865|516169895|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
143053806|NCT01223027|515736202|FG000|Overall Study|Lost to Follow-up|2|||
143245012|NCT01349049|516449576|FG001|Overall Study|Physician Decision|1|||
143245013|NCT01349049|516449577|FG002|Overall Study|Physician Decision|0|||
143245014|NCT01349049|516449578|FG003|Overall Study|Physician Decision|0|||
143245015|NCT01349049|516449579|FG004|Overall Study|Physician Decision|0|||
143245016|NCT01349049|516449580|FG005|Overall Study|Physician Decision|0|||
143245017|NCT01349049|516449581|FG006|Overall Study|Physician Decision|0|||
143053807|NCT01223027|515736203|FG001|Overall Study|Lost to Follow-up|1|||
143053808|NCT01223027|515736202|FG000|Overall Study|Physician Decision|4|||
143245018|NCT01349049|516449582|FG007|Overall Study|Physician Decision|0|||
143245019|NCT01349049|516449583|FG008|Overall Study|Physician Decision|2|||
143245020|NCT01349049|516449575|FG000|Overall Study|Protocol Violation|0|||
143245021|NCT01349049|516449576|FG001|Overall Study|Protocol Violation|0|||
143245022|NCT01349049|516449577|FG002|Overall Study|Protocol Violation|0|||
143053809|NCT01223027|515736203|FG001|Overall Study|Physician Decision|8|||
143053810|NCT01223027|515736202|FG000|Overall Study|Progressive Disease|167|||
143053811|NCT01223027|515736203|FG001|Overall Study|Progressive Disease|183|||
143053812|NCT01223027|515736202|FG000|Overall Study|Protocol Violation|2|||
143053813|NCT01223027|515736203|FG001|Overall Study|Protocol Violation|1|||
143053814|NCT01223027|515736202|FG000|Overall Study|Subject/guardian decicion|18|||
143053815|NCT01223027|515736203|FG001|Overall Study|Subject/guardian decicion|16|||
143053816|NCT01223027|515736202|FG000|Overall Study|New therapy for study indication|17|||
143053817|NCT01223027|515736203|FG001|Overall Study|New therapy for study indication|8|||
143053818|NCT01223027|515736202|FG000|Overall Study|Study terminated by sponsor|2|||
143053819|NCT01223027|515736203|FG001|Overall Study|Study terminated by sponsor|8|||
143053820|NCT03493919|515736204|FG000|Overall Study|Other|2|||
143053821|NCT03493919|515736205|FG001|Overall Study|Other|0|||
143053822|NCT03493919|515736206|FG002|Overall Study|Other|1|||
143053823|NCT03493919|515736207|FG003|Overall Study|Other|0|||
143053824|NCT03493919|515736204|FG000|Overall Study|Withdrawal by Subject|9|||
143053825|NCT03493919|515736205|FG001|Overall Study|Withdrawal by Subject|3|||
143053826|NCT03493919|515736206|FG002|Overall Study|Withdrawal by Subject|1|||
143053827|NCT03493919|515736207|FG003|Overall Study|Withdrawal by Subject|1|||
143053828|NCT03493919|515736204|FG000|Overall Study|Lost to Follow-up|5|||
143053829|NCT03493919|515736205|FG001|Overall Study|Lost to Follow-up|0|||
143053830|NCT03493919|515736206|FG002|Overall Study|Lost to Follow-up|0|||
143053831|NCT03493919|515736207|FG003|Overall Study|Lost to Follow-up|3|||
143053832|NCT03493919|515736204|FG000|Overall Study|Adverse Event|0|||
143053833|NCT03493919|515736205|FG001|Overall Study|Adverse Event|1|||
143053834|NCT03493919|515736206|FG002|Overall Study|Adverse Event|0|||
143053835|NCT03493919|515736207|FG003|Overall Study|Adverse Event|0|||
143053836|NCT01337596|515736209|FG000|Overall Study|Withdrawal by Subject|0|||
143053837|NCT01337596|515736210|FG001|Overall Study|Withdrawal by Subject|0|||
143053838|NCT01337596|515736211|FG002|Overall Study|Withdrawal by Subject|0|||
143053839|NCT01337596|515736212|FG003|Overall Study|Withdrawal by Subject|0|||
143053840|NCT01337596|515736213|FG004|Overall Study|Withdrawal by Subject|2|||
143053841|NCT01337596|515736214|FG005|Overall Study|Withdrawal by Subject|0|||
143053842|NCT01337596|515736215|FG006|Overall Study|Withdrawal by Subject|0|||
143053843|NCT01337596|515736216|FG007|Overall Study|Withdrawal by Subject|0|||
143053844|NCT01337596|515736217|FG008|Overall Study|Withdrawal by Subject|0|||
143053845|NCT04640194|515736218|FG000|Overall Study|Adverse Event|3|||
143053846|NCT04640194|515736219|FG001|Overall Study|Adverse Event|7|||
143053847|NCT04640194|515736220|FG002|Overall Study|Adverse Event|0|||
143053848|NCT04640194|515736221|FG003|Overall Study|Adverse Event|5|||
143053849|NCT04640194|515736222|FG004|Overall Study|Adverse Event|0|||
143053850|NCT04640194|515736223|FG005|Overall Study|Adverse Event|4|||
143053851|NCT04640194|515736224|FG006|Overall Study|Adverse Event|0|||
143053852|NCT04640194|515736218|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
143053853|NCT04640194|515736219|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
143053854|NCT04640194|515736220|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
143053855|NCT04640194|515736221|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
143245023|NCT01349049|516449578|FG003|Overall Study|Protocol Violation|0|||
143364696|NCT02072226|516878681|FG001|Overall Study|Patient Non-compliance|3|||
143364697|NCT02072226|516878680|FG000|Overall Study|Death|1|||
143364698|NCT02072226|516878681|FG001|Overall Study|Death|0|||
143364699|NCT02072226|516878680|FG000|Overall Study|Patient Withdrawal of Consent|1|||
143499627|NCT00944034|517370455|FG005|Overall Study|Inappropriate enrollment|1|||
143364700|NCT02072226|516878681|FG001|Overall Study|Patient Withdrawal of Consent|0|||
143499628|NCT00944034|517370456|FG006|Overall Study|Inappropriate enrollment|0|||
143499629|NCT00944034|517370457|FG007|Overall Study|Inappropriate enrollment|0|||
143053856|NCT04640194|515736222|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
143053857|NCT04640194|515736223|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
143053858|NCT04640194|515736224|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
143053859|NCT04640194|515736218|FG000|Overall Study|fibrinogen level too low|0|||
143053860|NCT04640194|515736219|FG001|Overall Study|fibrinogen level too low|0|||
143053861|NCT04640194|515736220|FG002|Overall Study|fibrinogen level too low|0|||
143053862|NCT04640194|515736221|FG003|Overall Study|fibrinogen level too low|1|||
143053863|NCT04640194|515736222|FG004|Overall Study|fibrinogen level too low|0|||
143499630|NCT00944034|517370458|FG008|Overall Study|Inappropriate enrollment|1|||
143053864|NCT04640194|515736223|FG005|Overall Study|fibrinogen level too low|0|||
143053865|NCT04640194|515736224|FG006|Overall Study|fibrinogen level too low|0|||
143053866|NCT04640194|515736218|FG000|Overall Study|mild bleeding|0|||
143053867|NCT04640194|515736219|FG001|Overall Study|mild bleeding|0|||
143053868|NCT04640194|515736220|FG002|Overall Study|mild bleeding|0|||
143053869|NCT04640194|515736221|FG003|Overall Study|mild bleeding|1|||
143053870|NCT04640194|515736222|FG004|Overall Study|mild bleeding|0|||
143053871|NCT04640194|515736223|FG005|Overall Study|mild bleeding|0|||
143053872|NCT04640194|515736224|FG006|Overall Study|mild bleeding|0|||
143053873|NCT04640194|515736218|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
143053874|NCT04640194|515736219|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
143053875|NCT04640194|515736220|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
143053876|NCT04640194|515736221|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
143053877|NCT04640194|515736222|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
143053878|NCT04640194|515736223|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
143053879|NCT04640194|515736224|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
143053880|NCT01709903|515736228|FG000|Overall Study|administrative problems|2|||
143053881|NCT01709903|515736229|FG001|Overall Study|administrative problems|6|||
143053882|NCT01709903|515736228|FG000|Overall Study|Abnormal test procedure results|1|||
143053883|NCT01709903|515736229|FG001|Overall Study|Abnormal test procedure results|0|||
143053884|NCT01709903|515736228|FG000|Overall Study|In ability to use device|1|||
143053885|NCT01709903|515736229|FG001|Overall Study|In ability to use device|1|||
143053886|NCT01709903|515736228|FG000|Overall Study|no longer needed study drug|0|||
143053887|NCT01709903|515736229|FG001|Overall Study|no longer needed study drug|1|||
143245024|NCT01349049|516449579|FG004|Overall Study|Protocol Violation|0|||
143245025|NCT01349049|516449580|FG005|Overall Study|Protocol Violation|0|||
143245026|NCT01349049|516449581|FG006|Overall Study|Protocol Violation|0|||
143245027|NCT01349049|516449582|FG007|Overall Study|Protocol Violation|0|||
143245028|NCT01349049|516449583|FG008|Overall Study|Protocol Violation|1|||
143245029|NCT01349049|516449575|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
143245030|NCT01349049|516449576|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
143245031|NCT01349049|516449577|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
143245032|NCT01349049|516449578|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
143245033|NCT01349049|516449579|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
143245034|NCT01349049|516449580|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
143245035|NCT01349049|516449581|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
143053888|NCT01709903|515736228|FG000|Overall Study|Lost to Follow-up|0|||
143053889|NCT01709903|515736229|FG001|Overall Study|Lost to Follow-up|2|||
143053890|NCT01709903|515736228|FG000|Overall Study|Death|2|||
143053891|NCT01709903|515736229|FG001|Overall Study|Death|0|||
143053892|NCT01709903|515736228|FG000|Overall Study|Protocol Violation|3|||
143053893|NCT01709903|515736229|FG001|Overall Study|Protocol Violation|2|||
143053894|NCT01709903|515736228|FG000|Overall Study|Lack of Efficacy|3|||
143053895|NCT01709903|515736229|FG001|Overall Study|Lack of Efficacy|3|||
143053896|NCT01709903|515736228|FG000|Overall Study|Withdrawal by Subject|6|||
143053897|NCT01709903|515736229|FG001|Overall Study|Withdrawal by Subject|6|||
143053898|NCT01709903|515736228|FG000|Overall Study|Adverse Event|11|||
143053899|NCT01709903|515736229|FG001|Overall Study|Adverse Event|18|||
143053900|NCT02061280|515736230|FG000|Overall Study|Protocol Violation|12|||
143245036|NCT01349049|516449582|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
143245037|NCT01349049|516449583|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
143245038|NCT01349049|516449575|FG000|Overall Study|Other|0|||
143245039|NCT01349049|516449576|FG001|Overall Study|Other|0|||
143245040|NCT01349049|516449577|FG002|Overall Study|Other|0|||
143245041|NCT01349049|516449578|FG003|Overall Study|Other|0|||
143245042|NCT01349049|516449579|FG004|Overall Study|Other|0|||
143245043|NCT01349049|516449580|FG005|Overall Study|Other|1|||
143245044|NCT01349049|516449581|FG006|Overall Study|Other|0|||
143245045|NCT01349049|516449582|FG007|Overall Study|Other|0|||
143245046|NCT01349049|516449583|FG008|Overall Study|Other|4|||
143053901|NCT02061280|515736231|FG001|Overall Study|Protocol Violation|8|||
143053902|NCT02061280|515736230|FG000|Overall Study|moved out of state|0|||
143053903|NCT02061280|515736231|FG001|Overall Study|moved out of state|1|||
143053904|NCT02061280|515736230|FG000|Overall Study|Withdrawal by Subject|1|||
143053905|NCT02061280|515736231|FG001|Overall Study|Withdrawal by Subject|2|||
143053906|NCT02061280|515736230|FG000|Overall Study|Lost to Follow-up|5|||
143245047|NCT01349049|516449575|FG000|Overall Study|Death|0|||
143053907|NCT02061280|515736231|FG001|Overall Study|Lost to Follow-up|1|||
143053908|NCT00965731|515736234|FG000|Overall Study|Death|0|||
143245048|NCT01349049|516449576|FG001|Overall Study|Death|0|||
143053909|NCT00965731|515736235|FG001|Overall Study|Death|4|||
143053910|NCT00965731|515736234|FG000|Overall Study|Withdrawal by Subject|0|||
143053911|NCT00965731|515736235|FG001|Overall Study|Withdrawal by Subject|1|||
143053912|NCT00965731|515736234|FG000|Overall Study|Other|7|||
143245049|NCT01349049|516449577|FG002|Overall Study|Death|0|||
143245050|NCT01349049|516449578|FG003|Overall Study|Death|0|||
143245051|NCT01349049|516449579|FG004|Overall Study|Death|0|||
143053913|NCT00965731|515736235|FG001|Overall Study|Other|15|||
143053914|NCT00063258|515738590|FG000|Overall Study|Physician Decision|2|||
143053915|NCT00063258|515738591|FG001|Overall Study|Physician Decision|0|||
143053916|NCT00063258|515738590|FG000|Overall Study|Lack of Efficacy|2|||
143053917|NCT00063258|515738591|FG001|Overall Study|Lack of Efficacy|0|||
143053918|NCT00965757|515738593|FG000|Double-blind Phase|Progression of concomitant disease|1|||
143053919|NCT00965757|515738594|FG001|Double-blind Phase|Progression of concomitant disease|2|||
143053920|NCT00965757|515738595|FG002|Double-blind Phase|Progression of concomitant disease|0|||
143053921|NCT00965757|515738596|FG003|Double-blind Phase|Progression of concomitant disease|0|||
143053922|NCT00965757|515738593|FG000|Double-blind Phase|Adverse drug reaction|2|||
143053923|NCT00965757|515738594|FG001|Double-blind Phase|Adverse drug reaction|1|||
143053924|NCT00965757|515738595|FG002|Double-blind Phase|Adverse drug reaction|0|||
143053925|NCT00965757|515738596|FG003|Double-blind Phase|Adverse drug reaction|0|||
143053926|NCT00965757|515738593|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
143245052|NCT01349049|516449580|FG005|Overall Study|Death|0|||
143053927|NCT00965757|515738594|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
143053928|NCT00965757|515738595|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
143053929|NCT00965757|515738596|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
143245053|NCT01349049|516449581|FG006|Overall Study|Death|0|||
143245054|NCT01349049|516449582|FG007|Overall Study|Death|1|||
143245055|NCT01349049|516449583|FG008|Overall Study|Death|5|||
143245056|NCT01349049|516449575|FG000|Overall Study|Non-compliance|0|||
143499631|NCT00944034|517370459|FG009|Overall Study|Inappropriate enrollment|1|||
143499632|NCT00944034|517370460|FG010|Overall Study|Inappropriate enrollment|0|||
143499633|NCT00944034|517370461|FG011|Overall Study|Inappropriate enrollment|0|||
143499634|NCT00944034|517370450|FG000|Overall Study|Withdrawal by Subject|3|||
143499635|NCT00944034|517370451|FG001|Overall Study|Withdrawal by Subject|2|||
143499636|NCT00944034|517370452|FG002|Overall Study|Withdrawal by Subject|6|||
143499637|NCT00944034|517370453|FG003|Overall Study|Withdrawal by Subject|2|||
143499638|NCT00944034|517370454|FG004|Overall Study|Withdrawal by Subject|5|||
143499639|NCT00944034|517370455|FG005|Overall Study|Withdrawal by Subject|8|||
143499640|NCT00944034|517370456|FG006|Overall Study|Withdrawal by Subject|2|||
143053930|NCT00965757|515738593|FG000|Double-blind Phase|Lack of Efficacy|7|||
143053931|NCT00965757|515738594|FG001|Double-blind Phase|Lack of Efficacy|11|||
143053932|NCT00965757|515738595|FG002|Double-blind Phase|Lack of Efficacy|0|||
143053933|NCT00965757|515738596|FG003|Double-blind Phase|Lack of Efficacy|0|||
143053934|NCT00965757|515738593|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
143053935|NCT00965757|515738594|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
143053936|NCT00965757|515738595|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
143053937|NCT00965757|515738596|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
143053938|NCT00965757|515738593|FG000|Double-blind Phase|Lost to Follow-up|0|||
143053939|NCT00965757|515738594|FG001|Double-blind Phase|Lost to Follow-up|1|||
143053940|NCT00965757|515738595|FG002|Double-blind Phase|Lost to Follow-up|0|||
143053941|NCT00965757|515738596|FG003|Double-blind Phase|Lost to Follow-up|0|||
143053942|NCT00965757|515738593|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
143053943|NCT00965757|515738594|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
143053944|NCT00965757|515738595|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
143053945|NCT00965757|515738596|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
143053946|NCT00965757|515738593|FG000|Double-blind Phase|Other|1|||
143053947|NCT00965757|515738594|FG001|Double-blind Phase|Other|0|||
143053948|NCT00965757|515738595|FG002|Double-blind Phase|Other|0|||
143053949|NCT00965757|515738596|FG003|Double-blind Phase|Other|0|||
143053950|NCT00965757|515738593|FG000|Extension Phase|Progression of concomitant disease|0|||
143053951|NCT00965757|515738594|FG001|Extension Phase|Progression of concomitant disease|0|||
143053952|NCT00965757|515738595|FG002|Extension Phase|Progression of concomitant disease|4|||
143053953|NCT00965757|515738596|FG003|Extension Phase|Progression of concomitant disease|2|||
143053954|NCT00965757|515738593|FG000|Extension Phase|Adverse drug reaction|0|||
143053955|NCT00965757|515738594|FG001|Extension Phase|Adverse drug reaction|0|||
143053956|NCT00965757|515738595|FG002|Extension Phase|Adverse drug reaction|6|||
143053957|NCT00965757|515738596|FG003|Extension Phase|Adverse drug reaction|3|||
143053958|NCT00965757|515738593|FG000|Extension Phase|Abnormal Laboratory Value|0|||
143053959|NCT00965757|515738594|FG001|Extension Phase|Abnormal Laboratory Value|0|||
143053960|NCT00965757|515738595|FG002|Extension Phase|Abnormal Laboratory Value|6|||
143053961|NCT00965757|515738596|FG003|Extension Phase|Abnormal Laboratory Value|1|||
143053962|NCT00965757|515738593|FG000|Extension Phase|Lack of Efficacy|0|||
143053963|NCT00965757|515738594|FG001|Extension Phase|Lack of Efficacy|0|||
143053964|NCT00965757|515738595|FG002|Extension Phase|Lack of Efficacy|8|||
143053965|NCT00965757|515738596|FG003|Extension Phase|Lack of Efficacy|12|||
143053966|NCT00965757|515738593|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
143053967|NCT00965757|515738594|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
143053968|NCT00965757|515738595|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
143245057|NCT01349049|516449576|FG001|Overall Study|Non-compliance|0|||
143499641|NCT00944034|517370457|FG007|Overall Study|Withdrawal by Subject|2|||
143499642|NCT00944034|517370458|FG008|Overall Study|Withdrawal by Subject|3|||
143053969|NCT00965757|515738596|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
143053970|NCT00965757|515738593|FG000|Extension Phase|Lost to Follow-up|0|||
143053971|NCT00965757|515738594|FG001|Extension Phase|Lost to Follow-up|0|||
143053972|NCT00965757|515738595|FG002|Extension Phase|Lost to Follow-up|0|||
143053973|NCT00965757|515738596|FG003|Extension Phase|Lost to Follow-up|1|||
143053974|NCT00965757|515738593|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
143053975|NCT00965757|515738594|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
143053976|NCT00965757|515738595|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
143053977|NCT00965757|515738596|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
143053978|NCT00965757|515738593|FG000|Extension Phase|Protocol Violation|0|||
143053979|NCT00965757|515738594|FG001|Extension Phase|Protocol Violation|0|||
143053980|NCT00965757|515738595|FG002|Extension Phase|Protocol Violation|0|||
143053981|NCT00965757|515738596|FG003|Extension Phase|Protocol Violation|1|||
143053982|NCT00965757|515738593|FG000|Extension Phase|Other|0|||
143053983|NCT00965757|515738594|FG001|Extension Phase|Other|0|||
143053984|NCT00965757|515738595|FG002|Extension Phase|Other|2|||
143053985|NCT00965757|515738596|FG003|Extension Phase|Other|1|||
143053986|NCT03807440|515738597|FG000|Overall Study|No documentation of index date 2|320|||
143053987|NCT03807440|515738597|FG000|Overall Study|No informed consent for index date 2|117|||
143053988|NCT02451358|515738598|FG000|Overall Study|Withdrawal by Subject|1|||
143053989|NCT02451358|515738599|FG001|Overall Study|Withdrawal by Subject|1|||
143053990|NCT02451358|515738600|FG002|Overall Study|Withdrawal by Subject|0|||
143053991|NCT02451358|515738601|FG003|Overall Study|Withdrawal by Subject|0|||
143053992|NCT02451358|515738598|FG000|Overall Study|Protocol Violation|0|||
143053993|NCT02451358|515738599|FG001|Overall Study|Protocol Violation|1|||
143053994|NCT02451358|515738600|FG002|Overall Study|Protocol Violation|1|||
143053995|NCT02451358|515738601|FG003|Overall Study|Protocol Violation|0|||
143053996|NCT01698554|515738602|FG000|Overall Study|Adverse Event|2|||
143053997|NCT01698554|515738603|FG001|Overall Study|Adverse Event|5|||
143053998|NCT01698554|515738604|FG002|Overall Study|Adverse Event|0|||
143053999|NCT01698554|515738605|FG003|Overall Study|Adverse Event|1|||
143054000|NCT01698554|515738602|FG000|Overall Study|Lost to Follow-up|1|||
143054001|NCT01698554|515738603|FG001|Overall Study|Lost to Follow-up|0|||
143054002|NCT01698554|515738604|FG002|Overall Study|Lost to Follow-up|0|||
143054003|NCT01698554|515738605|FG003|Overall Study|Lost to Follow-up|0|||
143054004|NCT01698554|515738602|FG000|Overall Study|Personal Reasons|0|||
143054005|NCT01698554|515738603|FG001|Overall Study|Personal Reasons|5|||
143054006|NCT01698554|515738604|FG002|Overall Study|Personal Reasons|1|||
143054007|NCT01698554|515738605|FG003|Overall Study|Personal Reasons|1|||
143054008|NCT01698554|515738602|FG000|Overall Study|Protocol Violation|2|||
143054009|NCT01698554|515738603|FG001|Overall Study|Protocol Violation|0|||
143054010|NCT01698554|515738604|FG002|Overall Study|Protocol Violation|1|||
143054011|NCT01698554|515738605|FG003|Overall Study|Protocol Violation|0|||
143054012|NCT01698554|515738602|FG000|Overall Study|Other Miscellaneous Reasons|1|||
143054013|NCT01698554|515738603|FG001|Overall Study|Other Miscellaneous Reasons|0|||
143054014|NCT01698554|515738604|FG002|Overall Study|Other Miscellaneous Reasons|0|||
143054015|NCT01698554|515738605|FG003|Overall Study|Other Miscellaneous Reasons|0|||
143054016|NCT00252564|515738608|FG000|Overall Study|Adverse Event|17|||
143054017|NCT00252564|515738609|FG001|Overall Study|Adverse Event|13|||
143054018|NCT00252564|515738608|FG000|Overall Study|Unrelated Complication|2|||
143054019|NCT00252564|515738609|FG001|Overall Study|Unrelated Complication|1|||
143054020|NCT00252564|515738608|FG000|Overall Study|Disease Progression|14|||
143054021|NCT00252564|515738609|FG001|Overall Study|Disease Progression|20|||
143054022|NCT00252564|515738608|FG000|Overall Study|Death|0|||
143054023|NCT00252564|515738609|FG001|Overall Study|Death|3|||
143054024|NCT00252564|515738608|FG000|Overall Study|Physician Decision|1|||
143054025|NCT00252564|515738609|FG001|Overall Study|Physician Decision|0|||
143054026|NCT00252564|515738608|FG000|Overall Study|Lost to Follow-up|1|||
143054027|NCT00252564|515738609|FG001|Overall Study|Lost to Follow-up|0|||
143054028|NCT00252564|515738608|FG000|Overall Study|Patient Request|4|||
143054029|NCT00252564|515738609|FG001|Overall Study|Patient Request|5|||
143054030|NCT00252564|515738608|FG000|Overall Study|Withdrawal by Subject|0|||
143054031|NCT00252564|515738609|FG001|Overall Study|Withdrawal by Subject|2|||
143169462|NCT02958865|516169896|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
143054032|NCT01583530|515738610|FG000|Overall Study|Adverse Event|0|||
143054033|NCT01583530|515738611|FG001|Overall Study|Adverse Event|0|||
143054034|NCT01583530|515738612|FG002|Overall Study|Adverse Event|0|||
143054035|NCT01583530|515738613|FG003|Overall Study|Adverse Event|0|||
143054036|NCT01583530|515738614|FG004|Overall Study|Adverse Event|0|||
143054037|NCT01583530|515738615|FG005|Overall Study|Adverse Event|1|||
143054038|NCT01583530|515738610|FG000|Overall Study|Withdrawal by Subject|0|||
143054039|NCT01583530|515738611|FG001|Overall Study|Withdrawal by Subject|3|||
143054040|NCT01583530|515738612|FG002|Overall Study|Withdrawal by Subject|0|||
143054041|NCT01583530|515738613|FG003|Overall Study|Withdrawal by Subject|1|||
143054042|NCT01583530|515738614|FG004|Overall Study|Withdrawal by Subject|1|||
143054043|NCT01583530|515738615|FG005|Overall Study|Withdrawal by Subject|2|||
143054044|NCT01583530|515738610|FG000|Overall Study|Lost to Follow-up|0|||
143054045|NCT01583530|515738611|FG001|Overall Study|Lost to Follow-up|0|||
143054046|NCT01583530|515738612|FG002|Overall Study|Lost to Follow-up|0|||
143054047|NCT01583530|515738613|FG003|Overall Study|Lost to Follow-up|0|||
143054048|NCT01583530|515738614|FG004|Overall Study|Lost to Follow-up|3|||
143054049|NCT01583530|515738615|FG005|Overall Study|Lost to Follow-up|0|||
143054050|NCT01583530|515738610|FG000|Overall Study|Lack of compliance|0|||
143054051|NCT01583530|515738611|FG001|Overall Study|Lack of compliance|0|||
143054052|NCT01583530|515738612|FG002|Overall Study|Lack of compliance|0|||
143054053|NCT01583530|515738613|FG003|Overall Study|Lack of compliance|0|||
143054054|NCT01583530|515738614|FG004|Overall Study|Lack of compliance|1|||
143054055|NCT01583530|515738615|FG005|Overall Study|Lack of compliance|0|||
143054056|NCT02416180|515738616|FG000|Overall Study|Withdrawal by Subject|1|||
143054057|NCT03414034|515738617|FG000|Overall Study|Adverse Event|6|||
143054058|NCT03414034|515738618|FG001|Overall Study|Adverse Event|1|||
143054059|NCT03414034|515738619|FG002|Overall Study|Adverse Event|1|||
143054060|NCT03414034|515738617|FG000|Overall Study|Death|0|||
143054061|NCT03414034|515738618|FG001|Overall Study|Death|0|||
143054062|NCT03414034|515738619|FG002|Overall Study|Death|1|||
143054063|NCT03414034|515738617|FG000|Overall Study|Non-compliance With Study Drug|0|||
143054064|NCT03414034|515738618|FG001|Overall Study|Non-compliance With Study Drug|0|||
143054065|NCT03414034|515738619|FG002|Overall Study|Non-compliance With Study Drug|1|||
143054066|NCT03414034|515738617|FG000|Overall Study|Physician Decision|1|||
143054067|NCT03414034|515738618|FG001|Overall Study|Physician Decision|3|||
143054068|NCT03414034|515738619|FG002|Overall Study|Physician Decision|2|||
143054069|NCT03414034|515738617|FG000|Overall Study|Withdrawal of Informed Consent|2|||
143054070|NCT03414034|515738618|FG001|Overall Study|Withdrawal of Informed Consent|1|||
143054071|NCT03414034|515738619|FG002|Overall Study|Withdrawal of Informed Consent|4|||
143054072|NCT03414034|515738617|FG000|Overall Study|Progressive Disease|15|||
143054073|NCT03414034|515738618|FG001|Overall Study|Progressive Disease|15|||
143054074|NCT03414034|515738619|FG002|Overall Study|Progressive Disease|17|||
143054075|NCT03414034|515738617|FG000|Overall Study|Miscellaneous|0|||
143054076|NCT03414034|515738618|FG001|Overall Study|Miscellaneous|0|||
143054077|NCT03414034|515738619|FG002|Overall Study|Miscellaneous|2|||
143054078|NCT04010227|515738621|FG000|Overall Study|Death|1|||
143054079|NCT04010227|515738622|FG001|Overall Study|Death|2|||
143054080|NCT04010227|515738621|FG000|Overall Study|Medical Reasons|4|||
143054081|NCT04010227|515738622|FG001|Overall Study|Medical Reasons|3|||
143054082|NCT04010227|515738621|FG000|Overall Study|Withdrawal by Subject|2|||
143054083|NCT04010227|515738622|FG001|Overall Study|Withdrawal by Subject|0|||
143054084|NCT04010227|515738621|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
143054085|NCT04010227|515738622|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
143054086|NCT01332968|515738623|FG000|Induction Period|Adverse Event|23|||
143054087|NCT01332968|515738624|FG001|Induction Period|Adverse Event|26|||
143054088|NCT01332968|515738625|FG002|Induction Period|Adverse Event|0|||
143054089|NCT01332968|515738626|FG003|Induction Period|Adverse Event|0|||
143054090|NCT01332968|515738627|FG004|Induction Period|Adverse Event|0|||
143054091|NCT01332968|515738628|FG005|Induction Period|Adverse Event|0|||
143054092|NCT01332968|515738629|FG006|Induction Period|Adverse Event|0|||
143054093|NCT01332968|515738630|FG007|Induction Period|Adverse Event|0|||
143054094|NCT01332968|515738623|FG000|Induction Period|Death|1|||
143054095|NCT01332968|515738624|FG001|Induction Period|Death|4|||
143054096|NCT01332968|515738625|FG002|Induction Period|Death|0|||
143054097|NCT01332968|515738626|FG003|Induction Period|Death|0|||
143054098|NCT01332968|515738627|FG004|Induction Period|Death|0|||
143054099|NCT01332968|515738628|FG005|Induction Period|Death|0|||
143054100|NCT01332968|515738629|FG006|Induction Period|Death|0|||
143054101|NCT01332968|515738630|FG007|Induction Period|Death|0|||
143054102|NCT01332968|515738623|FG000|Induction Period|Non-compliance|1|||
143054103|NCT01332968|515738624|FG001|Induction Period|Non-compliance|0|||
143054104|NCT01332968|515738625|FG002|Induction Period|Non-compliance|0|||
143054105|NCT01332968|515738626|FG003|Induction Period|Non-compliance|0|||
143054106|NCT01332968|515738627|FG004|Induction Period|Non-compliance|0|||
143054107|NCT01332968|515738628|FG005|Induction Period|Non-compliance|0|||
143054108|NCT01332968|515738629|FG006|Induction Period|Non-compliance|0|||
143054109|NCT01332968|515738630|FG007|Induction Period|Non-compliance|0|||
143054110|NCT01332968|515738623|FG000|Induction Period|Other|2|||
143054111|NCT01332968|515738624|FG001|Induction Period|Other|2|||
143054112|NCT01332968|515738625|FG002|Induction Period|Other|0|||
143054113|NCT01332968|515738626|FG003|Induction Period|Other|0|||
143054114|NCT01332968|515738627|FG004|Induction Period|Other|0|||
143054115|NCT01332968|515738628|FG005|Induction Period|Other|0|||
143054116|NCT01332968|515738629|FG006|Induction Period|Other|0|||
143054117|NCT01332968|515738630|FG007|Induction Period|Other|0|||
143054118|NCT01332968|515738623|FG000|Induction Period|Physician Decision|6|||
143054119|NCT01332968|515738624|FG001|Induction Period|Physician Decision|1|||
143054120|NCT01332968|515738625|FG002|Induction Period|Physician Decision|0|||
143054121|NCT01332968|515738626|FG003|Induction Period|Physician Decision|0|||
143054122|NCT01332968|515738627|FG004|Induction Period|Physician Decision|0|||
143054123|NCT01332968|515738628|FG005|Induction Period|Physician Decision|0|||
143054124|NCT01332968|515738629|FG006|Induction Period|Physician Decision|0|||
143054125|NCT01332968|515738630|FG007|Induction Period|Physician Decision|0|||
143054126|NCT01332968|515738623|FG000|Induction Period|Progressive Disease|15|||
143054127|NCT01332968|515738624|FG001|Induction Period|Progressive Disease|7|||
143054128|NCT01332968|515738625|FG002|Induction Period|Progressive Disease|0|||
143054129|NCT01332968|515738626|FG003|Induction Period|Progressive Disease|0|||
143054130|NCT01332968|515738627|FG004|Induction Period|Progressive Disease|0|||
143054131|NCT01332968|515738628|FG005|Induction Period|Progressive Disease|0|||
143054132|NCT01332968|515738629|FG006|Induction Period|Progressive Disease|0|||
143054133|NCT01332968|515738630|FG007|Induction Period|Progressive Disease|0|||
143054134|NCT01332968|515738623|FG000|Induction Period|Protocol Violation|3|||
143054135|NCT01332968|515738624|FG001|Induction Period|Protocol Violation|4|||
143054136|NCT01332968|515738625|FG002|Induction Period|Protocol Violation|0|||
143054137|NCT01332968|515738626|FG003|Induction Period|Protocol Violation|0|||
143054138|NCT01332968|515738627|FG004|Induction Period|Protocol Violation|0|||
143054139|NCT01332968|515738628|FG005|Induction Period|Protocol Violation|0|||
143054140|NCT01332968|515738629|FG006|Induction Period|Protocol Violation|0|||
143054141|NCT01332968|515738630|FG007|Induction Period|Protocol Violation|0|||
143054142|NCT01332968|515738623|FG000|Induction Period|Withdrawal by Subject|3|||
143054143|NCT01332968|515738624|FG001|Induction Period|Withdrawal by Subject|5|||
143054144|NCT01332968|515738625|FG002|Induction Period|Withdrawal by Subject|0|||
143054145|NCT01332968|515738626|FG003|Induction Period|Withdrawal by Subject|0|||
143054146|NCT01332968|515738627|FG004|Induction Period|Withdrawal by Subject|0|||
143054147|NCT01332968|515738628|FG005|Induction Period|Withdrawal by Subject|0|||
143054148|NCT01332968|515738629|FG006|Induction Period|Withdrawal by Subject|0|||
143054149|NCT01332968|515738630|FG007|Induction Period|Withdrawal by Subject|0|||
143054150|NCT01332968|515738623|FG000|Induction Period|Randomised but not treated|4|||
143054151|NCT01332968|515738624|FG001|Induction Period|Randomised but not treated|7|||
143054152|NCT01332968|515738625|FG002|Induction Period|Randomised but not treated|0|||
143054153|NCT01332968|515738626|FG003|Induction Period|Randomised but not treated|0|||
143054154|NCT01332968|515738627|FG004|Induction Period|Randomised but not treated|0|||
143054155|NCT01332968|515738628|FG005|Induction Period|Randomised but not treated|0|||
143054156|NCT01332968|515738629|FG006|Induction Period|Randomised but not treated|0|||
143054157|NCT01332968|515738630|FG007|Induction Period|Randomised but not treated|0|||
143054158|NCT01332968|515738623|FG000|Maintenance/Observation Period|Adverse Event|0|||
143054159|NCT01332968|515738624|FG001|Maintenance/Observation Period|Adverse Event|0|||
143054160|NCT01332968|515738625|FG002|Maintenance/Observation Period|Adverse Event|53|||
143054161|NCT01332968|515738626|FG003|Maintenance/Observation Period|Adverse Event|66|||
143054162|NCT01332968|515738627|FG004|Maintenance/Observation Period|Adverse Event|0|||
143054163|NCT01332968|515738628|FG005|Maintenance/Observation Period|Adverse Event|0|||
143054164|NCT01332968|515738629|FG006|Maintenance/Observation Period|Adverse Event|0|||
143054165|NCT01332968|515738630|FG007|Maintenance/Observation Period|Adverse Event|0|||
143054166|NCT01332968|515738623|FG000|Maintenance/Observation Period|Death|0|||
143054167|NCT01332968|515738624|FG001|Maintenance/Observation Period|Death|0|||
143054168|NCT01332968|515738625|FG002|Maintenance/Observation Period|Death|5|||
143054169|NCT01332968|515738626|FG003|Maintenance/Observation Period|Death|6|||
143054170|NCT01332968|515738627|FG004|Maintenance/Observation Period|Death|0|||
143054171|NCT01332968|515738628|FG005|Maintenance/Observation Period|Death|0|||
143054172|NCT01332968|515738629|FG006|Maintenance/Observation Period|Death|0|||
143054173|NCT01332968|515738630|FG007|Maintenance/Observation Period|Death|0|||
143054174|NCT01332968|515738623|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
143054175|NCT01332968|515738624|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
143054176|NCT01332968|515738625|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
143054177|NCT01332968|515738626|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
143054178|NCT01332968|515738627|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
143054179|NCT01332968|515738628|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
143054180|NCT01332968|515738629|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
143054181|NCT01332968|515738630|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
143054182|NCT01332968|515738623|FG000|Maintenance/Observation Period|Non-compliance|0|||
143054183|NCT01332968|515738624|FG001|Maintenance/Observation Period|Non-compliance|0|||
143054184|NCT01332968|515738625|FG002|Maintenance/Observation Period|Non-compliance|4|||
143054185|NCT01332968|515738626|FG003|Maintenance/Observation Period|Non-compliance|3|||
143054186|NCT01332968|515738627|FG004|Maintenance/Observation Period|Non-compliance|0|||
143054187|NCT01332968|515738628|FG005|Maintenance/Observation Period|Non-compliance|0|||
143054188|NCT01332968|515738629|FG006|Maintenance/Observation Period|Non-compliance|0|||
143054189|NCT01332968|515738630|FG007|Maintenance/Observation Period|Non-compliance|0|||
143054190|NCT01332968|515738623|FG000|Maintenance/Observation Period|Other|0|||
143054191|NCT01332968|515738624|FG001|Maintenance/Observation Period|Other|0|||
143054192|NCT01332968|515738625|FG002|Maintenance/Observation Period|Other|4|||
143054193|NCT01332968|515738626|FG003|Maintenance/Observation Period|Other|7|||
143054194|NCT01332968|515738627|FG004|Maintenance/Observation Period|Other|0|||
143054195|NCT01332968|515738628|FG005|Maintenance/Observation Period|Other|0|||
143054196|NCT01332968|515738629|FG006|Maintenance/Observation Period|Other|0|||
143054197|NCT01332968|515738630|FG007|Maintenance/Observation Period|Other|0|||
143054198|NCT01332968|515738623|FG000|Maintenance/Observation Period|Physician Decision|0|||
143054199|NCT01332968|515738624|FG001|Maintenance/Observation Period|Physician Decision|0|||
143054200|NCT01332968|515738625|FG002|Maintenance/Observation Period|Physician Decision|14|||
143054201|NCT01332968|515738626|FG003|Maintenance/Observation Period|Physician Decision|19|||
143054202|NCT01332968|515738627|FG004|Maintenance/Observation Period|Physician Decision|0|||
143054203|NCT01332968|515738628|FG005|Maintenance/Observation Period|Physician Decision|1|||
143054204|NCT01332968|515738629|FG006|Maintenance/Observation Period|Physician Decision|0|||
143054205|NCT01332968|515738630|FG007|Maintenance/Observation Period|Physician Decision|0|||
143054206|NCT01332968|515738623|FG000|Maintenance/Observation Period|Progressive Disease|0|||
143054207|NCT01332968|515738624|FG001|Maintenance/Observation Period|Progressive Disease|0|||
143054208|NCT01332968|515738625|FG002|Maintenance/Observation Period|Progressive Disease|72|||
143054209|NCT01332968|515738626|FG003|Maintenance/Observation Period|Progressive Disease|40|||
143054210|NCT01332968|515738627|FG004|Maintenance/Observation Period|Progressive Disease|0|||
143054211|NCT01332968|515738628|FG005|Maintenance/Observation Period|Progressive Disease|0|||
143054212|NCT01332968|515738629|FG006|Maintenance/Observation Period|Progressive Disease|0|||
143054213|NCT01332968|515738630|FG007|Maintenance/Observation Period|Progressive Disease|0|||
143054214|NCT01332968|515738623|FG000|Maintenance/Observation Period|Protocol Violation|0|||
143054215|NCT01332968|515738624|FG001|Maintenance/Observation Period|Protocol Violation|0|||
143054216|NCT01332968|515738625|FG002|Maintenance/Observation Period|Protocol Violation|1|||
143054217|NCT01332968|515738626|FG003|Maintenance/Observation Period|Protocol Violation|1|||
143054218|NCT01332968|515738627|FG004|Maintenance/Observation Period|Protocol Violation|0|||
143054219|NCT01332968|515738628|FG005|Maintenance/Observation Period|Protocol Violation|0|||
143054220|NCT01332968|515738629|FG006|Maintenance/Observation Period|Protocol Violation|0|||
143054221|NCT01332968|515738630|FG007|Maintenance/Observation Period|Protocol Violation|0|||
143054222|NCT01332968|515738623|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
143054223|NCT01332968|515738624|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
143054224|NCT01332968|515738625|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
143054225|NCT01332968|515738626|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
143054226|NCT01332968|515738627|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
143054227|NCT01332968|515738628|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
143054228|NCT01332968|515738629|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
143054229|NCT01332968|515738630|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
143054230|NCT01332968|515738623|FG000|Follow-Up Period|Adverse Event|0|||
143054231|NCT01332968|515738624|FG001|Follow-Up Period|Adverse Event|0|||
143054232|NCT01332968|515738625|FG002|Follow-Up Period|Adverse Event|0|||
143169463|NCT02958865|516169897|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
143169464|NCT02958865|516169882|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
143169465|NCT02958865|516169883|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
143169466|NCT02958865|516169884|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
143169467|NCT02958865|516169885|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
143169468|NCT02958865|516169886|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
143169469|NCT02958865|516169887|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
143169470|NCT02958865|516169888|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
143169471|NCT02958865|516169889|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
143169472|NCT02958865|516169890|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
143169473|NCT02958865|516169891|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
143169474|NCT02958865|516169892|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
143169475|NCT02958865|516169893|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
143169476|NCT02958865|516169894|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
143169477|NCT02958865|516169895|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
143169478|NCT02958865|516169896|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
143169479|NCT02958865|516169897|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
143169480|NCT02958865|516169882|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
143169481|NCT02958865|516169883|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
143169482|NCT02958865|516169884|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
143169483|NCT02958865|516169885|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
143169484|NCT02958865|516169886|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
143169485|NCT02958865|516169887|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
143169486|NCT02958865|516169888|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
143169487|NCT02958865|516169889|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
143499643|NCT00944034|517370459|FG009|Overall Study|Withdrawal by Subject|4|||
143054233|NCT01332968|515738626|FG003|Follow-Up Period|Adverse Event|0|||
143054234|NCT01332968|515738627|FG004|Follow-Up Period|Adverse Event|0|||
143499644|NCT00944034|517370460|FG010|Overall Study|Withdrawal by Subject|0|||
143054235|NCT01332968|515738628|FG005|Follow-Up Period|Adverse Event|0|||
143054236|NCT01332968|515738629|FG006|Follow-Up Period|Adverse Event|0|||
143054237|NCT01332968|515738630|FG007|Follow-Up Period|Adverse Event|4|||
143054238|NCT01332968|515738623|FG000|Follow-Up Period|Death|0|||
143054239|NCT01332968|515738624|FG001|Follow-Up Period|Death|0|||
143054240|NCT01332968|515738625|FG002|Follow-Up Period|Death|0|||
143054241|NCT01332968|515738626|FG003|Follow-Up Period|Death|0|||
143054242|NCT01332968|515738627|FG004|Follow-Up Period|Death|0|||
143054243|NCT01332968|515738628|FG005|Follow-Up Period|Death|0|||
143054244|NCT01332968|515738629|FG006|Follow-Up Period|Death|27|||
143054245|NCT01332968|515738630|FG007|Follow-Up Period|Death|30|||
143054246|NCT01332968|515738623|FG000|Follow-Up Period|Lost to Follow-up|0|||
143054247|NCT01332968|515738624|FG001|Follow-Up Period|Lost to Follow-up|0|||
143054248|NCT01332968|515738625|FG002|Follow-Up Period|Lost to Follow-up|0|||
143054249|NCT01332968|515738626|FG003|Follow-Up Period|Lost to Follow-up|0|||
143054250|NCT01332968|515738627|FG004|Follow-Up Period|Lost to Follow-up|0|||
143054251|NCT01332968|515738628|FG005|Follow-Up Period|Lost to Follow-up|0|||
143054252|NCT01332968|515738629|FG006|Follow-Up Period|Lost to Follow-up|11|||
143054253|NCT01332968|515738630|FG007|Follow-Up Period|Lost to Follow-up|15|||
143054254|NCT01332968|515738623|FG000|Follow-Up Period|Non-compliance|0|||
143054255|NCT01332968|515738624|FG001|Follow-Up Period|Non-compliance|0|||
143054256|NCT01332968|515738625|FG002|Follow-Up Period|Non-compliance|0|||
143054257|NCT01332968|515738626|FG003|Follow-Up Period|Non-compliance|0|||
143054258|NCT01332968|515738627|FG004|Follow-Up Period|Non-compliance|0|||
143054259|NCT01332968|515738628|FG005|Follow-Up Period|Non-compliance|0|||
143054260|NCT01332968|515738629|FG006|Follow-Up Period|Non-compliance|4|||
143054261|NCT01332968|515738630|FG007|Follow-Up Period|Non-compliance|9|||
143054262|NCT01332968|515738623|FG000|Follow-Up Period|Other|0|||
143054263|NCT01332968|515738624|FG001|Follow-Up Period|Other|0|||
143054264|NCT01332968|515738625|FG002|Follow-Up Period|Other|0|||
143054265|NCT01332968|515738626|FG003|Follow-Up Period|Other|0|||
143054266|NCT01332968|515738627|FG004|Follow-Up Period|Other|0|||
143054267|NCT01332968|515738628|FG005|Follow-Up Period|Other|0|||
143054268|NCT01332968|515738629|FG006|Follow-Up Period|Other|18|||
143054269|NCT01332968|515738630|FG007|Follow-Up Period|Other|21|||
143054270|NCT01332968|515738623|FG000|Follow-Up Period|Physician Decision|0|||
143054271|NCT01332968|515738624|FG001|Follow-Up Period|Physician Decision|0|||
143054272|NCT01332968|515738625|FG002|Follow-Up Period|Physician Decision|0|||
143054273|NCT01332968|515738626|FG003|Follow-Up Period|Physician Decision|0|||
143054274|NCT01332968|515738627|FG004|Follow-Up Period|Physician Decision|0|||
143054275|NCT01332968|515738628|FG005|Follow-Up Period|Physician Decision|0|||
143054276|NCT01332968|515738629|FG006|Follow-Up Period|Physician Decision|12|||
143169488|NCT02958865|516169890|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
143169489|NCT02958865|516169891|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
143169490|NCT02958865|516169892|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
143169491|NCT02958865|516169893|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
143169492|NCT02958865|516169894|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
143169493|NCT02958865|516169895|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
143169494|NCT02958865|516169896|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
143169495|NCT02958865|516169897|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
143169496|NCT02958865|516169882|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
143169497|NCT02958865|516169883|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
143169498|NCT02958865|516169884|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
143169499|NCT02958865|516169885|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
143169500|NCT02958865|516169886|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
143169501|NCT02958865|516169887|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
143169502|NCT02958865|516169888|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
143169503|NCT02958865|516169889|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
143169504|NCT02958865|516169890|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
143169505|NCT02958865|516169891|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
143169506|NCT02958865|516169892|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
143169507|NCT02958865|516169893|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
143169508|NCT02958865|516169894|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
143245058|NCT01349049|516449577|FG002|Overall Study|Non-compliance|0|||
143054277|NCT01332968|515738630|FG007|Follow-Up Period|Physician Decision|15|||
143054278|NCT01332968|515738623|FG000|Follow-Up Period|Progressive Disease|0|||
143054279|NCT01332968|515738624|FG001|Follow-Up Period|Progressive Disease|0|||
143054280|NCT01332968|515738625|FG002|Follow-Up Period|Progressive Disease|0|||
143054281|NCT01332968|515738626|FG003|Follow-Up Period|Progressive Disease|0|||
143054282|NCT01332968|515738627|FG004|Follow-Up Period|Progressive Disease|0|||
143054283|NCT01332968|515738628|FG005|Follow-Up Period|Progressive Disease|0|||
143054284|NCT01332968|515738629|FG006|Follow-Up Period|Progressive Disease|126|||
143054285|NCT01332968|515738630|FG007|Follow-Up Period|Progressive Disease|106|||
143054286|NCT01332968|515738623|FG000|Follow-Up Period|Protocol Violation|0|||
143054287|NCT01332968|515738624|FG001|Follow-Up Period|Protocol Violation|0|||
143054288|NCT01332968|515738625|FG002|Follow-Up Period|Protocol Violation|0|||
143054289|NCT01332968|515738626|FG003|Follow-Up Period|Protocol Violation|0|||
143054290|NCT01332968|515738627|FG004|Follow-Up Period|Protocol Violation|0|||
143054291|NCT01332968|515738628|FG005|Follow-Up Period|Protocol Violation|0|||
143054292|NCT01332968|515738629|FG006|Follow-Up Period|Protocol Violation|1|||
143054293|NCT01332968|515738630|FG007|Follow-Up Period|Protocol Violation|0|||
143054294|NCT01332968|515738623|FG000|Follow-Up Period|Withdrawal by Subject|0|||
143054295|NCT01332968|515738624|FG001|Follow-Up Period|Withdrawal by Subject|0|||
143054296|NCT01332968|515738625|FG002|Follow-Up Period|Withdrawal by Subject|0|||
143054297|NCT01332968|515738626|FG003|Follow-Up Period|Withdrawal by Subject|0|||
143054298|NCT01332968|515738627|FG004|Follow-Up Period|Withdrawal by Subject|0|||
143054299|NCT01332968|515738628|FG005|Follow-Up Period|Withdrawal by Subject|0|||
143054300|NCT01332968|515738629|FG006|Follow-Up Period|Withdrawal by Subject|29|||
143054301|NCT01332968|515738630|FG007|Follow-Up Period|Withdrawal by Subject|32|||
143054302|NCT01332968|515738623|FG000|Follow-Up Period|No reason provided|0|||
143054303|NCT01332968|515738624|FG001|Follow-Up Period|No reason provided|0|||
143054304|NCT01332968|515738625|FG002|Follow-Up Period|No reason provided|0|||
143054305|NCT01332968|515738626|FG003|Follow-Up Period|No reason provided|0|||
143054306|NCT01332968|515738627|FG004|Follow-Up Period|No reason provided|0|||
143054307|NCT01332968|515738628|FG005|Follow-Up Period|No reason provided|0|||
143054308|NCT01332968|515738629|FG006|Follow-Up Period|No reason provided|2|||
143054309|NCT01332968|515738630|FG007|Follow-Up Period|No reason provided|3|||
143054310|NCT00640926|515738631|FG000|Overall Study|Adverse Event|2|||
143054311|NCT00640926|515738632|FG001|Overall Study|Adverse Event|3|||
143054312|NCT00640926|515738633|FG002|Overall Study|Adverse Event|2|||
143054313|NCT00640926|515738631|FG000|Overall Study|Lack of Efficacy|0|||
143054314|NCT00640926|515738632|FG001|Overall Study|Lack of Efficacy|2|||
143054315|NCT00640926|515738633|FG002|Overall Study|Lack of Efficacy|1|||
143054316|NCT00640926|515738631|FG000|Overall Study|Protocol Violation|2|||
143054317|NCT00640926|515738632|FG001|Overall Study|Protocol Violation|0|||
143054318|NCT00640926|515738633|FG002|Overall Study|Protocol Violation|2|||
143054319|NCT00640926|515738631|FG000|Overall Study|Lost to Follow-up|3|||
143054320|NCT00640926|515738632|FG001|Overall Study|Lost to Follow-up|1|||
143054321|NCT00640926|515738633|FG002|Overall Study|Lost to Follow-up|2|||
143054322|NCT00640926|515738631|FG000|Overall Study|Withdrawal by Subject|1|||
143054323|NCT00640926|515738632|FG001|Overall Study|Withdrawal by Subject|0|||
143054324|NCT00640926|515738633|FG002|Overall Study|Withdrawal by Subject|1|||
143054325|NCT01841073|515738634|FG000|Overall Study|Adverse Event|1|||
143054326|NCT01841073|515738635|FG001|Overall Study|Adverse Event|1|||
143054327|NCT01841073|515738634|FG000|Overall Study|Physician Decision|1|||
143054328|NCT01841073|515738635|FG001|Overall Study|Physician Decision|0|||
143054329|NCT01841073|515738634|FG000|Overall Study|Lost to Follow-up|0|||
143054330|NCT01841073|515738635|FG001|Overall Study|Lost to Follow-up|2|||
143054331|NCT02858037|515738640|FG000|Overall Study|Death|1|||
143054332|NCT02858037|515738640|FG000|Overall Study|Withdrawal by Subject|18|||
143054333|NCT02858037|515738640|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
143054334|NCT02858037|515738640|FG000|Overall Study|Lost to Follow-up|3|||
143054335|NCT02858037|515738640|FG000|Overall Study|Other|4|||
143054336|NCT04320745|515738643|FG000|Overall Study|Adverse Event|26|||
143054337|NCT04320745|515738643|FG000|Overall Study|Withdrawal by Subject|4|||
143054338|NCT04320745|515738643|FG000|Overall Study|Lost to Follow-up|12|||
143054339|NCT04320745|515738643|FG000|Overall Study|Protocol Deviation|2|||
143054340|NCT04320745|515738643|FG000|Overall Study|Non-compliance With Study Drug|2|||
143054341|NCT04320745|515738643|FG000|Overall Study|Reason Not Specified|1|||
143054342|NCT02050321|515738647|FG000|Overall Study|Withdrawal by Subject|1|||
143054343|NCT02050321|515738647|FG000|Overall Study|Adverse Event|1|||
143054344|NCT02308696|515738648|FG000|Overall Study|Lost to Follow-up|28|||
143054345|NCT02308696|515738649|FG001|Overall Study|Lost to Follow-up|21|||
143169509|NCT02958865|516169895|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
143054346|NCT02308696|515738648|FG000|Overall Study|Death|8|||
143054347|NCT02308696|515738649|FG001|Overall Study|Death|4|||
143054348|NCT02308696|515738648|FG000|Overall Study|Moved to a Higher Level of Care|17|||
143054349|NCT02308696|515738649|FG001|Overall Study|Moved to a Higher Level of Care|6|||
143054350|NCT04768114|515738651|FG000|Overall Study|Lost to Follow-up|5|||
143054351|NCT04768114|515738652|FG001|Overall Study|Lost to Follow-up|10|||
143054352|NCT04768114|515738651|FG000|Overall Study|Withdrawal by Subject|0|||
143054353|NCT04768114|515738652|FG001|Overall Study|Withdrawal by Subject|1|||
143054354|NCT00715676|515738658|FG000|Overall Study|Adverse Event|3|||
143054355|NCT00715676|515738659|FG001|Overall Study|Adverse Event|5|||
143054356|NCT00715676|515738660|FG002|Overall Study|Adverse Event|21|||
143054357|NCT00715676|515738658|FG000|Overall Study|Withdrawal by Subject|1|||
143054358|NCT00715676|515738659|FG001|Overall Study|Withdrawal by Subject|3|||
143054359|NCT00715676|515738660|FG002|Overall Study|Withdrawal by Subject|8|||
143054360|NCT00715676|515738658|FG000|Overall Study|Lost to Follow-up|1|||
143054361|NCT00715676|515738659|FG001|Overall Study|Lost to Follow-up|2|||
143054362|NCT00715676|515738660|FG002|Overall Study|Lost to Follow-up|1|||
143054363|NCT00715676|515738658|FG000|Overall Study|Terminated by Sponsor|1|||
143054364|NCT00715676|515738659|FG001|Overall Study|Terminated by Sponsor|0|||
143054365|NCT00715676|515738660|FG002|Overall Study|Terminated by Sponsor|0|||
143054366|NCT00715676|515738658|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
143054367|NCT00715676|515738659|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
143054368|NCT00715676|515738660|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
143054369|NCT00715676|515738658|FG000|Overall Study|Use of Exclusionary Medication|0|||
143054370|NCT00715676|515738659|FG001|Overall Study|Use of Exclusionary Medication|0|||
143054371|NCT00715676|515738660|FG002|Overall Study|Use of Exclusionary Medication|1|||
143054372|NCT00715676|515738658|FG000|Overall Study|Elevated Blood Glucose|0|||
143054373|NCT00715676|515738659|FG001|Overall Study|Elevated Blood Glucose|1|||
143054374|NCT00715676|515738660|FG002|Overall Study|Elevated Blood Glucose|0|||
143054375|NCT03419962|515738663|FG000|Overall Study|Change to other medication|1|||
143054376|NCT03419962|515738663|FG000|Overall Study|Refusal of continuing with trial drug|1|||
143054377|NCT03419962|515738663|FG000|Overall Study|Lost to Follow-up|3|||
143054378|NCT03419962|515738663|FG000|Overall Study|Difficulty in inhaling the doses|1|||
143054379|NCT03419962|515738663|FG000|Overall Study|Missing completion data|31|||
143054380|NCT04142658|515738666|FG000|Overall Study|Death|2|||
143054381|NCT04142658|515738667|FG001|Overall Study|Death|1|||
143054382|NCT04142658|515738666|FG000|Overall Study|Lost to Follow-up|4|||
143054383|NCT04142658|515738667|FG001|Overall Study|Lost to Follow-up|13|||
143054384|NCT04142658|515738666|FG000|Overall Study|Withdrawal by Subject|9|||
143054385|NCT04142658|515738667|FG001|Overall Study|Withdrawal by Subject|16|||
143054386|NCT01849458|515738668|FG000|Overall Study|Lost to Follow-up|4|||
143054387|NCT01781234|515738669|FG000|Overall Study|Adverse Event|2|||
143054388|NCT01781234|515738670|FG001|Overall Study|Adverse Event|0|||
143054389|NCT01781234|515738669|FG000|Overall Study|Protocol Violation|3|||
143054390|NCT01781234|515738670|FG001|Overall Study|Protocol Violation|0|||
143054391|NCT01781234|515738669|FG000|Overall Study|Withdrawal by Subject|4|||
143054392|NCT01781234|515738670|FG001|Overall Study|Withdrawal by Subject|3|||
143054393|NCT00830167|515738671|FG000|Overall Study|Lack of Efficacy|26|||
143054394|NCT00830167|515738672|FG001|Overall Study|Lack of Efficacy|10|||
143054395|NCT00830167|515738671|FG000|Overall Study|Adverse Event|8|||
143054396|NCT00830167|515738672|FG001|Overall Study|Adverse Event|24|||
143054397|NCT00830167|515738671|FG000|Overall Study|Not meeting entrance criteria|2|||
143054398|NCT00830167|515738672|FG001|Overall Study|Not meeting entrance criteria|5|||
143054399|NCT00830167|515738671|FG000|Overall Study|Withdrawal by Subject|2|||
143054400|NCT00830167|515738672|FG001|Overall Study|Withdrawal by Subject|0|||
143054401|NCT00830167|515738671|FG000|Overall Study|Lost to Follow-up|0|||
143054402|NCT00830167|515738672|FG001|Overall Study|Lost to Follow-up|1|||
143054403|NCT00830167|515738671|FG000|Overall Study|Protocol Violation|0|||
143054404|NCT00830167|515738672|FG001|Overall Study|Protocol Violation|1|||
143054405|NCT00830167|515738671|FG000|Overall Study|Other|2|||
143054406|NCT00830167|515738672|FG001|Overall Study|Other|2|||
143054407|NCT00609154|515738673|FG000|Overall Study|Protocol Violation|1|||
143054408|NCT00609154|515738674|FG001|Overall Study|Protocol Violation|2|||
143054409|NCT00609154|515738673|FG000|Overall Study|Unable to establish IV access|0|||
143054410|NCT00609154|515738674|FG001|Overall Study|Unable to establish IV access|4|||
143054411|NCT00609154|515738673|FG000|Overall Study|Adverse Event|0|||
143054412|NCT00609154|515738674|FG001|Overall Study|Adverse Event|2|||
143054413|NCT04194008|515738678|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
143054414|NCT04194008|515738678|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
143054415|NCT04194008|515738678|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
143054416|NCT04194008|515738678|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
143054417|NCT04194008|515738678|FG000|Treatment Phase With Nerivio|Missing data|4|||
143054418|NCT04194008|515738678|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
143054419|NCT04106817|515738682|FG000|Overall Study|Lost to Follow-up|1|||
143054420|NCT04106817|515738683|FG001|Overall Study|Lost to Follow-up|0|||
143054421|NCT04106817|515738684|FG002|Overall Study|Lost to Follow-up|0|||
143054422|NCT02260635|515738685|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
143054423|NCT02260635|515738686|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
143054424|NCT02260635|515738685|FG000|Open-Label Extension|Study Termination|25|||
143054425|NCT02260635|515738686|FG001|Open-Label Extension|Study Termination|25|||
143054426|NCT02260635|515738685|FG000|Open-Label Extension|Withdrawal by Subject|1|||
143054427|NCT02260635|515738686|FG001|Open-Label Extension|Withdrawal by Subject|0|||
143054428|NCT00152516|515738687|FG000|Overall Study|Adverse Event|18|||
143054429|NCT00152516|515738687|FG000|Overall Study|Lack and Loss of Efficacy|30|||
143054430|NCT00152516|515738687|FG000|Overall Study|Lost to Follow-up|5|||
143169510|NCT02958865|516169896|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
143054431|NCT00152516|515738687|FG000|Overall Study|Withdrawal by Subject|8|||
143054432|NCT00152516|515738687|FG000|Overall Study|Protocol Violation|3|||
143245059|NCT01349049|516449578|FG003|Overall Study|Non-compliance|1|||
143499645|NCT00944034|517370461|FG011|Overall Study|Withdrawal by Subject|4|||
143054433|NCT00152516|515738687|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
143054434|NCT00152516|515738687|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
143054435|NCT00152516|515738687|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
143054436|NCT00152516|515738687|FG000|Overall Study|Other: Non-Compliance|2|||
143054437|NCT00152516|515738687|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
143054438|NCT00152516|515738687|FG000|Overall Study|Other: Moved Out Of State|1|||
143054439|NCT00152516|515738687|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
143054440|NCT00152516|515738687|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
143054441|NCT00926367|515738689|FG000|Overall Study|Withdrawal by Subject|0|||
143054442|NCT00926367|515738690|FG001|Overall Study|Withdrawal by Subject|1|||
143054443|NCT00926367|515738689|FG000|Overall Study|Lost to Follow-up|1|||
143054444|NCT00926367|515738690|FG001|Overall Study|Lost to Follow-up|0|||
143054445|NCT00926367|515738689|FG000|Overall Study|Skin Irritation|1|||
143054446|NCT00926367|515738690|FG001|Overall Study|Skin Irritation|2|||
143054447|NCT02725411|515738692|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
143054448|NCT02725411|515738693|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
143054449|NCT02725411|515738694|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
143054450|NCT02725411|515738692|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
143054451|NCT02725411|515738693|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
143054452|NCT02725411|515738694|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
143054453|NCT02725411|515738692|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
143054454|NCT02725411|515738693|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
143054455|NCT02725411|515738694|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
143054456|NCT02725411|515738692|FG000|Treatment Period (56 Weeks)|Other|1|||
143054457|NCT02725411|515738693|FG001|Treatment Period (56 Weeks)|Other|4|||
143054458|NCT02725411|515738694|FG002|Treatment Period (56 Weeks)|Other|5|||
143054459|NCT02725411|515738692|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
143054460|NCT02725411|515738693|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
143054461|NCT02725411|515738694|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
143054462|NCT02725411|515738692|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
143054463|NCT02725411|515738693|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
143054464|NCT02725411|515738694|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
143054465|NCT02725411|515738692|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
143054466|NCT02725411|515738693|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
143054467|NCT02725411|515738694|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
143054468|NCT02725411|515738692|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
143054469|NCT02725411|515738693|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
143054470|NCT02725411|515738694|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
143054471|NCT02725411|515738692|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
143054472|NCT02725411|515738693|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
143054473|NCT02725411|515738694|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
143054474|NCT02725411|515738692|FG000|Follow-up Period (24 Weeks)|Other|1|||
143054475|NCT02725411|515738693|FG001|Follow-up Period (24 Weeks)|Other|4|||
143054476|NCT02725411|515738694|FG002|Follow-up Period (24 Weeks)|Other|2|||
143054477|NCT02725411|515738692|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
143054478|NCT02725411|515738693|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
143054479|NCT02725411|515738694|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
143054480|NCT03847974|515738695|FG000|Overall Study|relocated out of region|3|||
143054481|NCT03847974|515738695|FG000|Overall Study|Withdrawal by Subject|2|||
143054482|NCT03847974|515738695|FG000|Overall Study|Adverse Event|1|||
143054483|NCT04307849|515738696|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
143054484|NCT04307849|515738697|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
143054485|NCT04307849|515738698|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
143054486|NCT04307849|515738699|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
143054487|NCT04307849|515738700|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
143054488|NCT04307849|515738701|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
143054489|NCT04307849|515738696|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
143054490|NCT04307849|515738697|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
143499646|NCT00944034|517370450|FG000|Overall Study|Lost to Follow-up|0|||
143499647|NCT00944034|517370451|FG001|Overall Study|Lost to Follow-up|4|||
143499648|NCT00944034|517370452|FG002|Overall Study|Lost to Follow-up|2|||
143499649|NCT00944034|517370453|FG003|Overall Study|Lost to Follow-up|0|||
143499650|NCT00944034|517370454|FG004|Overall Study|Lost to Follow-up|5|||
143054491|NCT04307849|515738698|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
143054492|NCT04307849|515738699|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
143499651|NCT00944034|517370455|FG005|Overall Study|Lost to Follow-up|7|||
143054493|NCT04307849|515738700|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
143499652|NCT00944034|517370456|FG006|Overall Study|Lost to Follow-up|0|||
143499653|NCT00944034|517370457|FG007|Overall Study|Lost to Follow-up|1|||
143364701|NCT03255018|516878687|FG000|Overall Study|Death on study|0|||
143364702|NCT03255018|516878688|FG001|Overall Study|Death on study|5|||
143054494|NCT04307849|515738701|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
143054495|NCT04307849|515738696|FG000|Overall Study|Family member did not want them to continue|0|||
143054496|NCT04307849|515738697|FG001|Overall Study|Family member did not want them to continue|0|||
143054497|NCT04307849|515738698|FG002|Overall Study|Family member did not want them to continue|1|||
143054498|NCT04307849|515738699|FG003|Overall Study|Family member did not want them to continue|0|||
143054499|NCT04307849|515738700|FG004|Overall Study|Family member did not want them to continue|0|||
143054500|NCT04307849|515738701|FG005|Overall Study|Family member did not want them to continue|0|||
143054501|NCT04307849|515738696|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
143054502|NCT04307849|515738697|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
143054503|NCT04307849|515738698|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
143054504|NCT04307849|515738699|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
143054505|NCT04307849|515738700|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
143054506|NCT04307849|515738701|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
143054507|NCT01685216|515738702|FG000|Overall Study|Did not receive study drug|1|||
143054508|NCT01294449|515738703|FG000|Overall Study|Death|11|||
143054509|NCT01294449|515738704|FG001|Overall Study|Death|12|||
143054510|NCT01294449|515738703|FG000|Overall Study|Withdrawal by Subject|1|||
143054511|NCT01294449|515738704|FG001|Overall Study|Withdrawal by Subject|3|||
143054512|NCT02911935|515738705|FG000|Overall Study|Lost to Follow-up|5|||
143054513|NCT02911935|515738706|FG001|Overall Study|Lost to Follow-up|7|||
143054514|NCT00603512|515738709|FG000|Overall Study|Adverse Event|0|||
143054515|NCT00603512|515738710|FG001|Overall Study|Adverse Event|2|||
143054516|NCT00603512|515738711|FG002|Overall Study|Adverse Event|4|||
143054517|NCT00603512|515738712|FG003|Overall Study|Adverse Event|4|||
143054518|NCT00603512|515738713|FG004|Overall Study|Adverse Event|2|||
143054519|NCT00603512|515738709|FG000|Overall Study|Lack of Efficacy|0|||
143054520|NCT00603512|515738710|FG001|Overall Study|Lack of Efficacy|1|||
143054521|NCT00603512|515738711|FG002|Overall Study|Lack of Efficacy|0|||
143054522|NCT00603512|515738712|FG003|Overall Study|Lack of Efficacy|0|||
143054523|NCT00603512|515738713|FG004|Overall Study|Lack of Efficacy|1|||
143054524|NCT00603512|515738709|FG000|Overall Study|Other|2|||
143054525|NCT00603512|515738710|FG001|Overall Study|Other|1|||
143054526|NCT00603512|515738711|FG002|Overall Study|Other|0|||
143054527|NCT00603512|515738712|FG003|Overall Study|Other|1|||
143054528|NCT00603512|515738713|FG004|Overall Study|Other|1|||
143054529|NCT00603512|515738709|FG000|Overall Study|Withdrawal by Subject|0|||
143054530|NCT00603512|515738710|FG001|Overall Study|Withdrawal by Subject|0|||
143054531|NCT00603512|515738711|FG002|Overall Study|Withdrawal by Subject|0|||
143054532|NCT00603512|515738712|FG003|Overall Study|Withdrawal by Subject|0|||
143054533|NCT00603512|515738713|FG004|Overall Study|Withdrawal by Subject|1|||
143054534|NCT00603512|515738709|FG000|Overall Study|Randomized but not treated|0|||
143054535|NCT00603512|515738710|FG001|Overall Study|Randomized but not treated|1|||
143054536|NCT00603512|515738711|FG002|Overall Study|Randomized but not treated|1|||
143054537|NCT00603512|515738712|FG003|Overall Study|Randomized but not treated|2|||
143054538|NCT00603512|515738713|FG004|Overall Study|Randomized but not treated|0|||
143054539|NCT00756717|515738714|FG000|Overall Study|Withdrawal by Subject|2|||
143054540|NCT04979858|515738715|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
143054541|NCT04979858|515738716|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
143054542|NCT04253236|515738717|FG000|Overall Study|Adverse Event|1|||
143054543|NCT04253236|515738718|FG001|Overall Study|Adverse Event|0|||
143054544|NCT04253236|515738717|FG000|Overall Study|Safety Concerns|1|||
143054545|NCT04253236|515738718|FG001|Overall Study|Safety Concerns|0|||
143054546|NCT04253236|515738717|FG000|Overall Study|Study Terminated by Sponsor|1|||
143054547|NCT04253236|515738718|FG001|Overall Study|Study Terminated by Sponsor|0|||
143054548|NCT02654015|515738719|FG000|Overall Study|Death|12|||
143054549|NCT02654015|515738719|FG000|Overall Study|Lost to Follow-up|3|||
143054550|NCT01896505|515738722|FG000|Overall Study|Adverse Event|1|||
143054551|NCT01896505|515738723|FG001|Overall Study|Adverse Event|0|||
143054552|NCT01896505|515738724|FG002|Overall Study|Adverse Event|2|||
143054553|NCT01896505|515738725|FG003|Overall Study|Adverse Event|1|||
143054554|NCT01896505|515738726|FG004|Overall Study|Adverse Event|1|||
143364703|NCT03255018|516878687|FG000|Overall Study|Withdrawal by Subject|0|||
143364704|NCT03255018|516878688|FG001|Overall Study|Withdrawal by Subject|2|||
143499654|NCT00944034|517370458|FG008|Overall Study|Lost to Follow-up|5|||
143054555|NCT01896505|515738727|FG005|Overall Study|Adverse Event|0|||
143054556|NCT01896505|515738722|FG000|Overall Study|Physician Decision|1|||
143364705|NCT02680756|516878691|FG000|Overall Study|Adverse Event|10|||
143054557|NCT01896505|515738723|FG001|Overall Study|Physician Decision|3|||
143054558|NCT01896505|515738724|FG002|Overall Study|Physician Decision|2|||
143054559|NCT01896505|515738725|FG003|Overall Study|Physician Decision|0|||
143054560|NCT01896505|515738726|FG004|Overall Study|Physician Decision|0|||
143054561|NCT01896505|515738727|FG005|Overall Study|Physician Decision|1|||
143364706|NCT02680756|516878692|FG001|Overall Study|Adverse Event|2|||
143364707|NCT02680756|516878691|FG000|Overall Study|Lost to Follow-up|7|||
143054562|NCT01896505|515738722|FG000|Overall Study|Withdrawal by Subject|1|||
143054563|NCT01896505|515738723|FG001|Overall Study|Withdrawal by Subject|0|||
143054564|NCT01896505|515738724|FG002|Overall Study|Withdrawal by Subject|3|||
143054565|NCT01896505|515738725|FG003|Overall Study|Withdrawal by Subject|1|||
143054566|NCT01896505|515738726|FG004|Overall Study|Withdrawal by Subject|0|||
143054567|NCT01896505|515738727|FG005|Overall Study|Withdrawal by Subject|0|||
143054568|NCT01896505|515738722|FG000|Overall Study|Disease Progression|7|||
143054569|NCT01896505|515738723|FG001|Overall Study|Disease Progression|5|||
143054570|NCT01896505|515738724|FG002|Overall Study|Disease Progression|8|||
143054571|NCT01896505|515738725|FG003|Overall Study|Disease Progression|4|||
143054572|NCT01896505|515738726|FG004|Overall Study|Disease Progression|4|||
143054573|NCT01896505|515738727|FG005|Overall Study|Disease Progression|4|||
143054574|NCT01896505|515738722|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
143054575|NCT01896505|515738723|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
143054576|NCT01896505|515738724|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
143054577|NCT01896505|515738725|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
143054578|NCT01896505|515738726|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
143054579|NCT01896505|515738727|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
143054580|NCT01896505|515738722|FG000|Overall Study|Intercurrent illness|0|||
143054581|NCT01896505|515738723|FG001|Overall Study|Intercurrent illness|1|||
143054582|NCT01896505|515738724|FG002|Overall Study|Intercurrent illness|0|||
143054583|NCT01896505|515738725|FG003|Overall Study|Intercurrent illness|0|||
143054584|NCT01896505|515738726|FG004|Overall Study|Intercurrent illness|0|||
143054585|NCT01896505|515738727|FG005|Overall Study|Intercurrent illness|0|||
143054586|NCT01896505|515738722|FG000|Overall Study|Death|0|||
143054587|NCT01896505|515738723|FG001|Overall Study|Death|0|||
143054588|NCT01896505|515738724|FG002|Overall Study|Death|1|||
143054589|NCT01896505|515738725|FG003|Overall Study|Death|1|||
143054590|NCT01896505|515738726|FG004|Overall Study|Death|0|||
143054591|NCT01896505|515738727|FG005|Overall Study|Death|1|||
143054592|NCT02466386|515738728|FG000|Overall Study|Adverse Event|5|||
143054593|NCT02466386|515738728|FG000|Overall Study|Protocol Violation|2|||
143054594|NCT02466386|515738728|FG000|Overall Study|Withdrawal by Subject|14|||
143054595|NCT02466386|515738728|FG000|Overall Study|Lost to Follow-up|5|||
143054596|NCT02466386|515738728|FG000|Overall Study|Lack of Efficacy|8|||
143054597|NCT02466386|515738728|FG000|Overall Study|Other|10|||
143054598|NCT05317195|515738729|FG000|Randomization|Withdrawal by Subject|1|||
143364708|NCT02680756|516878692|FG001|Overall Study|Lost to Follow-up|6|||
143364709|NCT02680756|516878691|FG000|Overall Study|Withdrawal by Subject|5|||
143364710|NCT02680756|516878692|FG001|Overall Study|Withdrawal by Subject|5|||
143364711|NCT02680756|516878691|FG000|Overall Study|Physician Decision|4|||
143364712|NCT02680756|516878692|FG001|Overall Study|Physician Decision|1|||
143364713|NCT02680756|516878691|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
143499655|NCT00944034|517370459|FG009|Overall Study|Lost to Follow-up|1|||
143499656|NCT00944034|517370460|FG010|Overall Study|Lost to Follow-up|1|||
143499657|NCT00944034|517370461|FG011|Overall Study|Lost to Follow-up|0|||
143054599|NCT05317195|515738729|FG000|Randomization|Discontinued|6|||
143054600|NCT05317195|515738729|FG000|Admission|Withdrawal by Subject|2|||
143054601|NCT03259789|515738730|FG000|Overall Study|Adverse Event|3|||
143054602|NCT03259789|515738731|FG001|Overall Study|Adverse Event|2|||
143054603|NCT03259789|515738732|FG002|Overall Study|Adverse Event|1|||
143054604|NCT03259789|515738730|FG000|Overall Study|Withdrawal by Subject|9|||
143054605|NCT03259789|515738731|FG001|Overall Study|Withdrawal by Subject|5|||
143054606|NCT03259789|515738732|FG002|Overall Study|Withdrawal by Subject|1|||
143054607|NCT03259789|515738730|FG000|Overall Study|Lost to Follow-up|5|||
143054608|NCT03259789|515738731|FG001|Overall Study|Lost to Follow-up|9|||
143054609|NCT03259789|515738732|FG002|Overall Study|Lost to Follow-up|4|||
143054610|NCT03259789|515738730|FG000|Overall Study|Physician Decision|0|||
143054611|NCT03259789|515738731|FG001|Overall Study|Physician Decision|1|||
143054612|NCT03259789|515738732|FG002|Overall Study|Physician Decision|0|||
143054613|NCT02063217|515738733|FG000|Overall Study|Withdrawal by Subject|1|||
143054614|NCT02063217|515738734|FG001|Overall Study|Withdrawal by Subject|0|||
143054615|NCT02063217|515738735|FG002|Overall Study|Withdrawal by Subject|0|||
143054616|NCT00889252|515738736|FG000|Overall Study|Adverse Event|2|||
143054617|NCT00889252|515738737|FG001|Overall Study|Adverse Event|4|||
143054618|NCT00889252|515738736|FG000|Overall Study|Withdrawal by Subject|3|||
143364714|NCT02680756|516878692|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
143364715|NCT02680756|516878691|FG000|Overall Study|Blood transfusion for any reason|0|||
143499658|NCT00944034|517370450|FG000|Overall Study|Death|0|||
143054619|NCT00889252|515738737|FG001|Overall Study|Withdrawal by Subject|0|||
143054620|NCT00889252|515738736|FG000|Overall Study|Protocol Violation|2|||
143054621|NCT00889252|515738737|FG001|Overall Study|Protocol Violation|0|||
143054622|NCT04291508|515738738|FG000|Overall Study|Withdrawal by Subject|1|||
143054623|NCT04291508|515738739|FG001|Overall Study|Withdrawal by Subject|0|||
143054624|NCT04291508|515738740|FG002|Overall Study|Withdrawal by Subject|1|||
143054625|NCT04291508|515738741|FG003|Overall Study|Withdrawal by Subject|0|||
143054626|NCT04291508|515738738|FG000|Overall Study|lost to follow up|4|||
143054627|NCT04291508|515738739|FG001|Overall Study|lost to follow up|0|||
143054628|NCT04291508|515738740|FG002|Overall Study|lost to follow up|1|||
143054629|NCT04291508|515738741|FG003|Overall Study|lost to follow up|0|||
143054630|NCT02212457|515738742|FG000|Overall Study|Adverse Event|1|||
143054631|NCT02212457|515738743|FG001|Overall Study|Adverse Event|2|||
143054632|NCT02212457|515738744|FG002|Overall Study|Adverse Event|2|||
143054633|NCT02212457|515738745|FG003|Overall Study|Adverse Event|2|||
143054634|NCT02212457|515738746|FG004|Overall Study|Adverse Event|0|||
143054635|NCT02212457|515738747|FG005|Overall Study|Adverse Event|1|||
143054636|NCT02212457|515738742|FG000|Overall Study|Withdrawal by Subject|8|||
143054637|NCT02212457|515738743|FG001|Overall Study|Withdrawal by Subject|10|||
143054638|NCT02212457|515738744|FG002|Overall Study|Withdrawal by Subject|8|||
143054639|NCT02212457|515738745|FG003|Overall Study|Withdrawal by Subject|6|||
143054640|NCT02212457|515738746|FG004|Overall Study|Withdrawal by Subject|5|||
143054641|NCT02212457|515738747|FG005|Overall Study|Withdrawal by Subject|4|||
143054642|NCT02212457|515738742|FG000|Overall Study|Lost to Follow-up|6|||
143054643|NCT02212457|515738743|FG001|Overall Study|Lost to Follow-up|7|||
143054644|NCT02212457|515738744|FG002|Overall Study|Lost to Follow-up|4|||
143054645|NCT02212457|515738745|FG003|Overall Study|Lost to Follow-up|1|||
143054646|NCT02212457|515738746|FG004|Overall Study|Lost to Follow-up|8|||
143054647|NCT02212457|515738747|FG005|Overall Study|Lost to Follow-up|4|||
143054648|NCT02212457|515738742|FG000|Overall Study|Protocol Violation|2|||
143054649|NCT02212457|515738743|FG001|Overall Study|Protocol Violation|1|||
143054650|NCT02212457|515738744|FG002|Overall Study|Protocol Violation|0|||
143054651|NCT02212457|515738745|FG003|Overall Study|Protocol Violation|1|||
143054652|NCT02212457|515738746|FG004|Overall Study|Protocol Violation|2|||
143054653|NCT02212457|515738747|FG005|Overall Study|Protocol Violation|3|||
143054654|NCT02212457|515738742|FG000|Overall Study|Other|2|||
143054655|NCT02212457|515738743|FG001|Overall Study|Other|1|||
143054656|NCT02212457|515738744|FG002|Overall Study|Other|2|||
143054657|NCT02212457|515738745|FG003|Overall Study|Other|1|||
143054658|NCT02212457|515738746|FG004|Overall Study|Other|0|||
143054659|NCT02212457|515738747|FG005|Overall Study|Other|1|||
143054660|NCT00420095|515738749|FG000|Overall Study|Adverse Event|1|||
143054661|NCT00420095|515738750|FG001|Overall Study|Adverse Event|0|||
143054662|NCT00420095|515738749|FG000|Overall Study|Protocol Violation|1|||
143054663|NCT00420095|515738750|FG001|Overall Study|Protocol Violation|1|||
143054664|NCT00420095|515738749|FG000|Overall Study|Lost to Follow-up|1|||
143054665|NCT00420095|515738750|FG001|Overall Study|Lost to Follow-up|0|||
143054666|NCT00393705|515738751|FG000|Overall Study|Adverse Event|0|||
143054667|NCT00393705|515738752|FG001|Overall Study|Adverse Event|2|||
143054668|NCT00393705|515738751|FG000|Overall Study|Death|0|||
143054669|NCT00393705|515738752|FG001|Overall Study|Death|1|||
143054670|NCT00393705|515738751|FG000|Overall Study|Lost to Follow-up|2|||
143054671|NCT00393705|515738752|FG001|Overall Study|Lost to Follow-up|2|||
143054672|NCT00393705|515738751|FG000|Overall Study|Entry Criteria Not Met|10|||
143054673|NCT00393705|515738752|FG001|Overall Study|Entry Criteria Not Met|10|||
143054674|NCT00393705|515738751|FG000|Overall Study|Protocol Violation|4|||
143054675|NCT00393705|515738752|FG001|Overall Study|Protocol Violation|3|||
143054676|NCT00393705|515738751|FG000|Overall Study|Withdrawal by Subject|5|||
143054677|NCT00393705|515738752|FG001|Overall Study|Withdrawal by Subject|3|||
143054678|NCT00393705|515738751|FG000|Overall Study|Physician Decision|2|||
143054679|NCT00393705|515738752|FG001|Overall Study|Physician Decision|2|||
143054680|NCT03108820|515738753|FG000|Overall Study|Lost to Follow-up|30|||
143054681|NCT03108820|515738754|FG001|Overall Study|Lost to Follow-up|28|||
143054682|NCT03108820|515738753|FG000|Overall Study|Withdrawal by Subject|32|||
143054683|NCT03108820|515738754|FG001|Overall Study|Withdrawal by Subject|24|||
143054684|NCT03108820|515738753|FG000|Overall Study|Death|6|||
143054685|NCT03108820|515738754|FG001|Overall Study|Death|11|||
143054686|NCT00089973|515738761|FG000|Overall Study|Adverse Event|3|||
143054687|NCT00089973|515738761|FG000|Overall Study|Withdrawal by Subject|1|||
143499659|NCT00944034|517370451|FG001|Overall Study|Death|0|||
143499660|NCT00944034|517370452|FG002|Overall Study|Death|1|||
143499661|NCT00944034|517370453|FG003|Overall Study|Death|0|||
143499662|NCT00944034|517370454|FG004|Overall Study|Death|0|||
143499663|NCT00944034|517370455|FG005|Overall Study|Death|0|||
143054688|NCT00089973|515738761|FG000|Overall Study|Disease progression|45|||
143499664|NCT00944034|517370456|FG006|Overall Study|Death|0|||
143499665|NCT00944034|517370457|FG007|Overall Study|Death|0|||
143054689|NCT00089973|515738761|FG000|Overall Study|Death|1|||
143054690|NCT01475487|515738762|FG000|Overall Study|had to leave early for personal reasons|2|||
143054691|NCT01475487|515738763|FG001|Overall Study|had to leave early for personal reasons|1|||
143054692|NCT00559637|515740118|FG000|Overall Study|Adverse Event|22|||
143054693|NCT00559637|515740118|FG000|Overall Study|Withdrawal by Subject|4|||
143054694|NCT00559637|515740118|FG000|Overall Study|Protocol Violation|6|||
143054695|NCT00559637|515740118|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
143054696|NCT00559637|515740118|FG000|Overall Study|Failure to return|6|||
143054697|NCT00559637|515740118|FG000|Overall Study|Insufficient response|3|||
143054698|NCT00559637|515740118|FG000|Overall Study|Started requiring dialysis after month 7|2|||
143054699|NCT00559637|515740118|FG000|Overall Study|Suspected lung cancer|1|||
143054700|NCT00559637|515740118|FG000|Overall Study|Participation in another study|1|||
143054701|NCT00559637|515740118|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
143054702|NCT00559637|515740118|FG000|Overall Study|Change of center|1|||
143054703|NCT00559637|515740118|FG000|Overall Study|Change of home|1|||
143054704|NCT00559637|515740118|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
143054705|NCT02722616|515740119|FG000|Overall Study|Sponsor closed study after one month|2|||
143054706|NCT02722616|515740120|FG001|Overall Study|Sponsor closed study after one month|0|||
143054707|NCT02722616|515740121|FG002|Overall Study|Sponsor closed study after one month|0|||
143054708|NCT02031237|515740122|FG000|Overall Study|Death|1|||
143054709|NCT02031237|515740123|FG001|Overall Study|Death|5|||
143054710|NCT02031237|515740124|FG002|Overall Study|Death|0|||
143054711|NCT02031237|515740122|FG000|Overall Study|Physician Decision|0|||
143054712|NCT02031237|515740123|FG001|Overall Study|Physician Decision|1|||
143054713|NCT02031237|515740124|FG002|Overall Study|Physician Decision|0|||
143054714|NCT02031237|515740122|FG000|Overall Study|Withdrawal by Subject|2|||
143054715|NCT02031237|515740123|FG001|Overall Study|Withdrawal by Subject|2|||
143054716|NCT02031237|515740124|FG002|Overall Study|Withdrawal by Subject|0|||
143054717|NCT02031237|515740122|FG000|Overall Study|Protocol Violation|2|||
143054718|NCT02031237|515740123|FG001|Overall Study|Protocol Violation|6|||
143054719|NCT02031237|515740124|FG002|Overall Study|Protocol Violation|0|||
143054720|NCT02031237|515740122|FG000|Overall Study|Alternate Treatment Given|0|||
143054721|NCT02031237|515740123|FG001|Overall Study|Alternate Treatment Given|0|||
143054722|NCT02031237|515740124|FG002|Overall Study|Alternate Treatment Given|3|||
143054723|NCT00676650|515740130|FG000|Overall Study|Death|45|||
143054724|NCT00676650|515740131|FG001|Overall Study|Death|14|||
143054725|NCT00676650|515740130|FG000|Overall Study|Adverse Event|159|||
143054726|NCT00676650|515740131|FG001|Overall Study|Adverse Event|21|||
143054727|NCT00676650|515740130|FG000|Overall Study|Global deterioration of health status|66|||
143054728|NCT00676650|515740131|FG001|Overall Study|Global deterioration of health status|31|||
143054729|NCT00676650|515740130|FG000|Overall Study|Lost to Follow-up|0|||
143054730|NCT00676650|515740131|FG001|Overall Study|Lost to Follow-up|1|||
143054731|NCT00676650|515740130|FG000|Overall Study|Objective progression or relapse|189|||
143054732|NCT00676650|515740131|FG001|Overall Study|Objective progression or relapse|140|||
143054733|NCT00676650|515740130|FG000|Overall Study|Other|14|||
143054734|NCT00676650|515740131|FG001|Overall Study|Other|10|||
143054735|NCT00676650|515740130|FG000|Overall Study|Protocol Violation|3|||
143054736|NCT00676650|515740131|FG001|Overall Study|Protocol Violation|1|||
143054737|NCT00676650|515740130|FG000|Overall Study|Study terminated by sponsor|57|||
143054738|NCT00676650|515740131|FG001|Overall Study|Study terminated by sponsor|43|||
143054739|NCT00676650|515740130|FG000|Overall Study|Withdrawal by Subject|48|||
143054740|NCT00676650|515740131|FG001|Overall Study|Withdrawal by Subject|24|||
143054741|NCT00676650|515740130|FG000|Overall Study|Randomized but not treated|3|||
143054742|NCT00676650|515740131|FG001|Overall Study|Randomized but not treated|4|||
143054743|NCT02297841|515740135|FG000|Overall Study|Withdrawal by Subject|1|||
143054744|NCT02297841|515740135|FG000|Overall Study|Protocol Violation|7|||
143054745|NCT03429049|515740136|FG000|Overall Study|Adverse Event|2|||
143054746|NCT03429049|515740137|FG001|Overall Study|Adverse Event|3|||
143054747|NCT03429049|515740136|FG000|Overall Study|Death|0|||
143054748|NCT03429049|515740137|FG001|Overall Study|Death|1|||
143054749|NCT03429049|515740136|FG000|Overall Study|Lack of Efficacy|4|||
143054750|NCT03429049|515740137|FG001|Overall Study|Lack of Efficacy|2|||
143054751|NCT03429049|515740136|FG000|Overall Study|Lost to Follow-up|9|||
143054752|NCT03429049|515740137|FG001|Overall Study|Lost to Follow-up|8|||
143054753|NCT03429049|515740136|FG000|Overall Study|Physician Decision|1|||
143054754|NCT03429049|515740137|FG001|Overall Study|Physician Decision|0|||
143054755|NCT03429049|515740136|FG000|Overall Study|Protocol Violation|3|||
143054756|NCT03429049|515740137|FG001|Overall Study|Protocol Violation|0|||
143054757|NCT03429049|515740136|FG000|Overall Study|Sponsor Decision|2|||
143054758|NCT03429049|515740137|FG001|Overall Study|Sponsor Decision|0|||
143054759|NCT03429049|515740136|FG000|Overall Study|Withdrawal by Subject|4|||
143054760|NCT03429049|515740137|FG001|Overall Study|Withdrawal by Subject|20|||
143054761|NCT03429049|515740136|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
143054762|NCT03429049|515740137|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
143054763|NCT01841060|515740141|FG000|Overall Study|Protocol Violation|10|||
143054764|NCT02459418|515740145|FG000|Overall Study|Exclusion Criteria|4|||
143054765|NCT02459418|515740146|FG001|Overall Study|Exclusion Criteria|0|||
143054766|NCT02459418|515740145|FG000|Overall Study|Protocol Violation|0|||
143054767|NCT02459418|515740146|FG001|Overall Study|Protocol Violation|2|||
143054768|NCT02459418|515740145|FG000|Overall Study|Physician Decision|0|||
143054769|NCT02459418|515740146|FG001|Overall Study|Physician Decision|2|||
143054770|NCT02459418|515740145|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
143054771|NCT02459418|515740146|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
143054772|NCT02459418|515740145|FG000|Overall Study|Adverse Event|0|||
143364716|NCT02680756|516878692|FG001|Overall Study|Blood transfusion for any reason|1|||
143054773|NCT02459418|515740146|FG001|Overall Study|Adverse Event|1|||
143054774|NCT02459418|515740145|FG000|Overall Study|Withdrawal by Subject|1|||
143054775|NCT02459418|515740146|FG001|Overall Study|Withdrawal by Subject|1|||
143054776|NCT02459418|515740145|FG000|Overall Study|Elevated Creatine Kinase|1|||
143054777|NCT02459418|515740146|FG001|Overall Study|Elevated Creatine Kinase|0|||
143054778|NCT02459418|515740145|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
143054779|NCT02459418|515740146|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
143054780|NCT00653159|515740147|FG000|Overall Study|Adverse Event|4|||
143054781|NCT00653159|515740148|FG001|Overall Study|Adverse Event|1|||
143054782|NCT00653159|515740147|FG000|Overall Study|Lost to Follow-up|1|||
143054783|NCT00653159|515740148|FG001|Overall Study|Lost to Follow-up|2|||
143054784|NCT01872715|515740149|FG000|Overall Study|Adverse Event|1|||
143054785|NCT01872715|515740149|FG000|Overall Study|Protocol Violation|1|||
143054786|NCT01872715|515740149|FG000|Overall Study|Withdrawal by Subject|2|||
143054787|NCT00683592|515740150|FG000|Overall Study|Adverse Event|12|||
143054788|NCT00683592|515740151|FG001|Overall Study|Adverse Event|4|||
143054789|NCT00683592|515740150|FG000|Overall Study|Withdrawal by Subject|11|||
143054790|NCT00683592|515740151|FG001|Overall Study|Withdrawal by Subject|11|||
143054791|NCT00683592|515740150|FG000|Overall Study|Lost to Follow-up|17|||
143054792|NCT00683592|515740151|FG001|Overall Study|Lost to Follow-up|17|||
143054793|NCT00683592|515740150|FG000|Overall Study|Lack of Efficacy|3|||
143054794|NCT00683592|515740151|FG001|Overall Study|Lack of Efficacy|7|||
143054795|NCT00683592|515740150|FG000|Overall Study|Physician Decision|0|||
143054796|NCT00683592|515740151|FG001|Overall Study|Physician Decision|1|||
143054797|NCT00683592|515740150|FG000|Overall Study|Non-compliance|3|||
143054798|NCT00683592|515740151|FG001|Overall Study|Non-compliance|5|||
143054799|NCT00683592|515740150|FG000|Overall Study|Other|1|||
143054800|NCT00683592|515740151|FG001|Overall Study|Other|1|||
143054801|NCT03303417|515740159|FG000|Overall Study|Withdrawal by Subject|1|||
143054802|NCT03303417|515740160|FG001|Overall Study|Withdrawal by Subject|1|||
143054803|NCT01848210|515740163|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
143054804|NCT01848210|515740164|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
143054805|NCT01848210|515740163|FG000|Overall Study|Lost to Follow-up|24|||
143054806|NCT01848210|515740164|FG001|Overall Study|Lost to Follow-up|12|||
143054807|NCT01848210|515740163|FG000|Overall Study|Protocol Violation|3|||
143054808|NCT01848210|515740164|FG001|Overall Study|Protocol Violation|5|||
143054809|NCT01848210|515740163|FG000|Overall Study|Use of Forbidden Drugs|9|||
143054810|NCT01848210|515740164|FG001|Overall Study|Use of Forbidden Drugs|10|||
143054811|NCT01848210|515740163|FG000|Overall Study|Impedition Condition|5|||
143054812|NCT01848210|515740164|FG001|Overall Study|Impedition Condition|9|||
143054813|NCT01848210|515740163|FG000|Overall Study|Adverse Event|7|||
143054814|NCT01848210|515740164|FG001|Overall Study|Adverse Event|9|||
143054815|NCT01848210|515740163|FG000|Overall Study|Discontinuation Criterion|5|||
143054816|NCT01848210|515740164|FG001|Overall Study|Discontinuation Criterion|7|||
143054817|NCT01848210|515740163|FG000|Overall Study|Hypesensitivity|1|||
143054818|NCT01848210|515740164|FG001|Overall Study|Hypesensitivity|0|||
143054819|NCT01848210|515740163|FG000|Overall Study|Hepatic Function Alteration|4|||
143054820|NCT01848210|515740164|FG001|Overall Study|Hepatic Function Alteration|0|||
143054821|NCT01848210|515740163|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
143054822|NCT01848210|515740164|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
143054823|NCT01848210|515740163|FG000|Overall Study|Administrative|1|||
143054824|NCT01848210|515740164|FG001|Overall Study|Administrative|0|||
143054825|NCT04592419|515740165|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
143054826|NCT04592419|515740166|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
143054827|NCT04592419|515740165|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
143054828|NCT04592419|515740166|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
143054829|NCT04592419|515740165|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
143054830|NCT04592419|515740166|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
143054831|NCT04592419|515740165|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
143054832|NCT04592419|515740166|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
143054833|NCT04592419|515740165|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
143054834|NCT04592419|515740166|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
143054835|NCT04592419|515740165|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
143054836|NCT04592419|515740166|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
143054837|NCT04592419|515740165|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
143054838|NCT04592419|515740166|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
143169511|NCT02958865|516169897|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
143169512|NCT02958865|516169882|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
143499666|NCT00944034|517370458|FG008|Overall Study|Death|0|||
143499667|NCT00944034|517370459|FG009|Overall Study|Death|0|||
143054839|NCT04592419|515740165|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
143054840|NCT04592419|515740166|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
143054841|NCT04592419|515740165|FG000|Open-Label Extension Period|Adverse Event|1|||
143054842|NCT04592419|515740166|FG001|Open-Label Extension Period|Adverse Event|2|||
143054843|NCT04592419|515740165|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
143054844|NCT04592419|515740166|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
143499668|NCT00944034|517370460|FG010|Overall Study|Death|0|||
143499669|NCT00944034|517370461|FG011|Overall Study|Death|0|||
143499670|NCT00944034|517370450|FG000|Overall Study|Protocol Violation|2|||
143499671|NCT00944034|517370451|FG001|Overall Study|Protocol Violation|0|||
143499672|NCT00944034|517370452|FG002|Overall Study|Protocol Violation|0|||
143499673|NCT00944034|517370453|FG003|Overall Study|Protocol Violation|1|||
143499674|NCT00944034|517370454|FG004|Overall Study|Protocol Violation|2|||
143499675|NCT00944034|517370455|FG005|Overall Study|Protocol Violation|3|||
143499676|NCT00944034|517370456|FG006|Overall Study|Protocol Violation|0|||
143499677|NCT00944034|517370457|FG007|Overall Study|Protocol Violation|1|||
143499678|NCT00944034|517370458|FG008|Overall Study|Protocol Violation|1|||
143499679|NCT00944034|517370459|FG009|Overall Study|Protocol Violation|4|||
143499680|NCT00944034|517370460|FG010|Overall Study|Protocol Violation|0|||
143499681|NCT00944034|517370461|FG011|Overall Study|Protocol Violation|0|||
143499682|NCT00944034|517370450|FG000|Overall Study|Unable to classify|0|||
143499683|NCT00944034|517370451|FG001|Overall Study|Unable to classify|0|||
143499684|NCT00944034|517370452|FG002|Overall Study|Unable to classify|0|||
143499685|NCT00944034|517370453|FG003|Overall Study|Unable to classify|0|||
143499686|NCT00944034|517370454|FG004|Overall Study|Unable to classify|0|||
143499687|NCT00944034|517370455|FG005|Overall Study|Unable to classify|1|||
143499688|NCT00944034|517370456|FG006|Overall Study|Unable to classify|1|||
143499689|NCT00944034|517370457|FG007|Overall Study|Unable to classify|1|||
143499690|NCT00944034|517370458|FG008|Overall Study|Unable to classify|0|||
143499691|NCT00944034|517370459|FG009|Overall Study|Unable to classify|0|||
143499692|NCT00944034|517370460|FG010|Overall Study|Unable to classify|0|||
143499693|NCT00944034|517370461|FG011|Overall Study|Unable to classify|0|||
143499694|NCT00944034|517370450|FG000|Overall Study|Administrative reason|0|||
143499695|NCT00944034|517370451|FG001|Overall Study|Administrative reason|0|||
143499696|NCT00944034|517370452|FG002|Overall Study|Administrative reason|0|||
143499697|NCT00944034|517370453|FG003|Overall Study|Administrative reason|0|||
143499698|NCT00944034|517370454|FG004|Overall Study|Administrative reason|0|||
143499699|NCT00944034|517370455|FG005|Overall Study|Administrative reason|0|||
143499700|NCT00944034|517370456|FG006|Overall Study|Administrative reason|1|||
143499701|NCT00944034|517370457|FG007|Overall Study|Administrative reason|0|||
143499702|NCT00944034|517370458|FG008|Overall Study|Administrative reason|0|||
143499703|NCT00944034|517370459|FG009|Overall Study|Administrative reason|0|||
143499704|NCT00944034|517370460|FG010|Overall Study|Administrative reason|0|||
143499705|NCT00944034|517370461|FG011|Overall Study|Administrative reason|0|||
143499706|NCT01596257|517370462|FG000|Overall Study|Inadequate Collection|23|||
143499707|NCT01596257|517370463|FG001|Overall Study|Inadequate Collection|19|||
143499708|NCT01570244|517370464|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
143499709|NCT00531960|517370475|FG000|Overall Study|Adverse Event|5|||
143499710|NCT00531960|517370476|FG001|Overall Study|Adverse Event|4|||
143499711|NCT00531960|517370475|FG000|Overall Study|Death|3|||
143499712|NCT00531960|517370476|FG001|Overall Study|Death|2|||
143499713|NCT00531960|517370475|FG000|Overall Study|Lack of Efficacy|42|||
143499714|NCT00531960|517370476|FG001|Overall Study|Lack of Efficacy|41|||
143499715|NCT00531960|517370475|FG000|Overall Study|Violation of Selection Criteria|2|||
143499716|NCT00531960|517370476|FG001|Overall Study|Violation of Selection Criteria|0|||
143499717|NCT00531960|517370475|FG000|Overall Study|Refused Treatment|5|||
143499718|NCT00531960|517370476|FG001|Overall Study|Refused Treatment|6|||
143499719|NCT00531960|517370475|FG000|Overall Study|Other|4|||
143499720|NCT00531960|517370476|FG001|Overall Study|Other|10|||
143499721|NCT03157531|517370478|FG000|Overall Study|Death|2|||
143054845|NCT04592419|515740165|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
143054846|NCT04592419|515740166|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
143054847|NCT04592419|515740165|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
143054848|NCT04592419|515740166|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
143054849|NCT04592419|515740165|FG000|Open-Label Extension Period|Sponsor Request|73|||
143054850|NCT04592419|515740166|FG001|Open-Label Extension Period|Sponsor Request|84|||
143054851|NCT00381849|515740167|FG000|Wash Out|Withdrawal by Subject|0|||
143054852|NCT00381849|515740168|FG001|Wash Out|Withdrawal by Subject|1|||
143054853|NCT00329160|515740172|FG000|Overall Study|Adverse Event|27|||
143054854|NCT00329160|515740172|FG000|Overall Study|Withdrawal by Subject|13|||
143245060|NCT01349049|516449579|FG004|Overall Study|Non-compliance|0|||
143245061|NCT01349049|516449580|FG005|Overall Study|Non-compliance|0|||
143245062|NCT01349049|516449581|FG006|Overall Study|Non-compliance|0|||
143499722|NCT03157531|517370478|FG000|Overall Study|Lost to Follow-up|4|||
143499723|NCT00331006|517370479|FG000|Screening Phase|Withdrawal by Subject|1|||
143499724|NCT00331006|517370479|FG000|Screening Phase|enrollment halted|1|||
143499725|NCT00331006|517370479|FG000|Screening Phase|Lost to Follow-up|1|||
143499726|NCT00331006|517370479|FG000|Screening Phase|Ineligible for treatment phase|4|||
143499727|NCT00331006|517370479|FG000|Treatment Phase|Withdrawal by Subject|1|||
143054855|NCT00329160|515740172|FG000|Overall Study|Protocol Violation|2|||
143245063|NCT01349049|516449582|FG007|Overall Study|Non-compliance|0|||
143499728|NCT00331006|517370479|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
143499729|NCT00331006|517370479|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
143499730|NCT01879410|517370485|FG000|Overall Study|Adverse Event|9|||
143499731|NCT01879410|517370486|FG001|Overall Study|Adverse Event|14|||
143499732|NCT01879410|517370485|FG000|Overall Study|Lack of Efficacy|4|||
143499733|NCT01879410|517370486|FG001|Overall Study|Lack of Efficacy|6|||
143054856|NCT00329160|515740172|FG000|Overall Study|Did not Receive Study Drug|1|||
143054857|NCT00329160|515740172|FG000|Overall Study|Incomplete IVUS|45|||
143054858|NCT00685035|515740174|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
143054859|NCT00685035|515740175|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
143054860|NCT04167618|515740179|FG000|Overall Study|Trial terminated by sponsor|1|||
143054861|NCT04167618|515740180|FG001|Overall Study|Trial terminated by sponsor|1|||
143054862|NCT02943993|515740183|FG000|Overall Study|Withdrawal by Subject|52|||
143054863|NCT02943993|515740183|FG000|Overall Study|Transfer to another institution|6|||
143054864|NCT02943993|515740183|FG000|Overall Study|Lost to Follow-up|135|||
143054865|NCT02943993|515740183|FG000|Overall Study|Death|98|||
143054866|NCT02943993|515740183|FG000|Overall Study|Other reason for premature termination|32|||
143054867|NCT02943993|515740183|FG000|Overall Study|Missing reason for termination|7|||
143054868|NCT04968925|515740187|FG000|Phase I- Period 1|COVID-19 related|0|||
143054869|NCT04968925|515740188|FG001|Phase I- Period 1|COVID-19 related|1|||
143054870|NCT04968925|515740189|FG002|Phase I- Period 1|COVID-19 related|0|||
143054871|NCT04968925|515740190|FG003|Phase I- Period 1|COVID-19 related|0|||
143054872|NCT04968925|515740187|FG000|Phase I- Period 1|Subject enrolled in error|1|||
143054873|NCT04968925|515740188|FG001|Phase I- Period 1|Subject enrolled in error|1|||
143054874|NCT04968925|515740189|FG002|Phase I- Period 1|Subject enrolled in error|0|||
143054875|NCT04968925|515740190|FG003|Phase I- Period 1|Subject enrolled in error|0|||
143054876|NCT04968925|515740187|FG000|Phase II- Period 1|COVID-19 Related|0|||
143054877|NCT04968925|515740188|FG001|Phase II- Period 1|COVID-19 Related|0|||
143054878|NCT04968925|515740189|FG002|Phase II- Period 1|COVID-19 Related|6|||
143054879|NCT04968925|515740190|FG003|Phase II- Period 1|COVID-19 Related|6|||
143054880|NCT04968925|515740187|FG000|Phase II- Period 1|Subject enrolled in error|0|||
143054881|NCT04968925|515740188|FG001|Phase II- Period 1|Subject enrolled in error|0|||
143054882|NCT04968925|515740189|FG002|Phase II- Period 1|Subject enrolled in error|1|||
143054883|NCT04968925|515740190|FG003|Phase II- Period 1|Subject enrolled in error|0|||
143054884|NCT04968925|515740187|FG000|Phase II -Period 2|COVID-19 related|0|||
143054885|NCT04968925|515740188|FG001|Phase II -Period 2|COVID-19 related|0|||
143054886|NCT04968925|515740189|FG002|Phase II -Period 2|COVID-19 related|4|||
143054887|NCT04968925|515740190|FG003|Phase II -Period 2|COVID-19 related|3|||
143054888|NCT04968925|515740187|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
143054889|NCT04968925|515740188|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
143054890|NCT04968925|515740189|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
143054891|NCT04968925|515740190|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
143054892|NCT00876265|515740191|FG000|Overall Study|Miscellaneous reasons|4|||
143054893|NCT00876265|515740191|FG000|Overall Study|Lost to Follow-up|6|||
143054894|NCT00876265|515740191|FG000|Overall Study|Withdrawal by Subject|2|||
143054895|NCT01755975|515740192|FG000|Overall Study|Adverse Event|0|||
143054896|NCT01755975|515740193|FG001|Overall Study|Adverse Event|0|||
143054897|NCT01755975|515740194|FG002|Overall Study|Adverse Event|1|||
143054898|NCT01755975|515740195|FG003|Overall Study|Adverse Event|0|||
143054899|NCT01755975|515740196|FG004|Overall Study|Adverse Event|2|||
143054900|NCT03653026|515740197|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
143054901|NCT03653026|515740198|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
143054902|NCT03653026|515740199|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
143054903|NCT03653026|515740200|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
143054904|NCT03653026|515740197|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
143054905|NCT03653026|515740198|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
143054906|NCT03653026|515740199|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
143054907|NCT03653026|515740200|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
143054908|NCT03653026|515740197|FG000|Part 1: Placebo-controlled Period|Other|0|||
143054909|NCT03653026|515740198|FG001|Part 1: Placebo-controlled Period|Other|3|||
143054910|NCT03653026|515740199|FG002|Part 1: Placebo-controlled Period|Other|0|||
143054911|NCT03653026|515740200|FG003|Part 1: Placebo-controlled Period|Other|0|||
143054912|NCT03653026|515740197|FG000|Part 2: Open-label Extension|Adverse Event|0|||
143054913|NCT03653026|515740198|FG001|Part 2: Open-label Extension|Adverse Event|0|||
143054914|NCT03653026|515740199|FG002|Part 2: Open-label Extension|Adverse Event|1|||
143054915|NCT03653026|515740200|FG003|Part 2: Open-label Extension|Adverse Event|1|||
143054916|NCT03653026|515740197|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
143169513|NCT02958865|516169883|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
143169514|NCT02958865|516169884|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
143169515|NCT02958865|516169885|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
143169516|NCT02958865|516169886|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
143169517|NCT02958865|516169887|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
143054917|NCT03653026|515740198|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
143054918|NCT03653026|515740199|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
143054919|NCT03653026|515740200|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
143054920|NCT03653026|515740197|FG000|Part 2: Open-label Extension|Other|0|||
143169518|NCT02958865|516169888|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
143364717|NCT02680756|516878691|FG000|Overall Study|Death|1|||
143054921|NCT03653026|515740198|FG001|Part 2: Open-label Extension|Other|0|||
143054922|NCT03653026|515740199|FG002|Part 2: Open-label Extension|Other|1|||
143054923|NCT03653026|515740200|FG003|Part 2: Open-label Extension|Other|2|||
143054924|NCT02457819|515740206|FG000|Overall Study|reason not given|8|||
143054925|NCT02457819|515740206|FG000|Overall Study|Withdrawal by Subject|24|||
143054926|NCT02457819|515740206|FG000|Overall Study|Protocol Violation|1|||
143054927|NCT02457819|515740206|FG000|Overall Study|non compliance with study drug|4|||
143054928|NCT02457819|515740206|FG000|Overall Study|Lost to Follow-up|10|||
143054929|NCT02457819|515740206|FG000|Overall Study|Lack of Efficacy|19|||
143054930|NCT02457819|515740206|FG000|Overall Study|Adverse Event|33|||
143054931|NCT00763555|515740210|FG000|Overall Study|Adverse Event|2|||
143054932|NCT00763555|515740211|FG001|Overall Study|Adverse Event|1|||
143054933|NCT00763555|515740210|FG000|Overall Study|Withdrawal by Subject|2|||
143054934|NCT00763555|515740211|FG001|Overall Study|Withdrawal by Subject|6|||
143054935|NCT00763555|515740210|FG000|Overall Study|Lost to Follow-up|0|||
143054936|NCT00763555|515740211|FG001|Overall Study|Lost to Follow-up|3|||
143054937|NCT03710590|515740212|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
143054938|NCT03710590|515740213|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
143054939|NCT00852917|515740214|FG000|Overall Study|Adverse Event|13|||
143054940|NCT00852917|515740215|FG001|Overall Study|Adverse Event|20|||
143054941|NCT00852917|515740216|FG002|Overall Study|Adverse Event|35|||
143054942|NCT00852917|515740217|FG003|Overall Study|Adverse Event|17|||
143054943|NCT00852917|515740214|FG000|Overall Study|Lack of Efficacy|21|||
143054944|NCT00852917|515740215|FG001|Overall Study|Lack of Efficacy|11|||
143054945|NCT00852917|515740216|FG002|Overall Study|Lack of Efficacy|11|||
143054946|NCT00852917|515740217|FG003|Overall Study|Lack of Efficacy|47|||
143054947|NCT00852917|515740214|FG000|Overall Study|Withdrawal by Subject|4|||
143054948|NCT00852917|515740215|FG001|Overall Study|Withdrawal by Subject|8|||
143054949|NCT00852917|515740216|FG002|Overall Study|Withdrawal by Subject|10|||
143054950|NCT00852917|515740217|FG003|Overall Study|Withdrawal by Subject|9|||
143054951|NCT00852917|515740214|FG000|Overall Study|Physician Decision|6|||
143054952|NCT00852917|515740215|FG001|Overall Study|Physician Decision|7|||
143054953|NCT00852917|515740216|FG002|Overall Study|Physician Decision|2|||
143054954|NCT00852917|515740217|FG003|Overall Study|Physician Decision|19|||
143245064|NCT01349049|516449583|FG008|Overall Study|Non-compliance|0|||
143054955|NCT00852917|515740214|FG000|Overall Study|Death|0|||
143054956|NCT00852917|515740215|FG001|Overall Study|Death|0|||
143054957|NCT00852917|515740216|FG002|Overall Study|Death|0|||
143054958|NCT00852917|515740217|FG003|Overall Study|Death|1|||
143054959|NCT02510261|515740218|FG000|Overall Study|Adverse Event|5|||
143245065|NCT01349049|516449575|FG000|Overall Study|Withdrawal by Subject|0|||
143245066|NCT01349049|516449576|FG001|Overall Study|Withdrawal by Subject|0|||
143245067|NCT01349049|516449577|FG002|Overall Study|Withdrawal by Subject|0|||
143245068|NCT01349049|516449578|FG003|Overall Study|Withdrawal by Subject|0|||
143245069|NCT01349049|516449579|FG004|Overall Study|Withdrawal by Subject|0|||
143245070|NCT01349049|516449580|FG005|Overall Study|Withdrawal by Subject|0|||
143245071|NCT01349049|516449581|FG006|Overall Study|Withdrawal by Subject|0|||
143245072|NCT01349049|516449582|FG007|Overall Study|Withdrawal by Subject|0|||
143245073|NCT01349049|516449583|FG008|Overall Study|Withdrawal by Subject|6|||
143245074|NCT00552188|516449586|FG000|Overall Study|Adverse Event|0|||
143245075|NCT00552188|516449587|FG001|Overall Study|Adverse Event|2|||
143245076|NCT00552188|516449586|FG000|Overall Study|Lost to Follow-up|2|||
143245077|NCT00552188|516449587|FG001|Overall Study|Lost to Follow-up|1|||
143245078|NCT00552188|516449586|FG000|Overall Study|Withdrawal of consent|0|||
143245079|NCT00552188|516449587|FG001|Overall Study|Withdrawal of consent|1|||
143245080|NCT00552188|516449586|FG000|Overall Study|Subject returned to home country|0|||
143245081|NCT00552188|516449587|FG001|Overall Study|Subject returned to home country|1|||
143245082|NCT01193257|516449590|FG000|Overall Study|Death|202|||
143245083|NCT01193257|516449591|FG001|Overall Study|Death|391|||
143245084|NCT01193257|516449590|FG000|Overall Study|Study termination by sponsor|0|||
143245085|NCT01193257|516449591|FG001|Overall Study|Study termination by sponsor|3|||
143245086|NCT01193257|516449590|FG000|Overall Study|Withdrawal by Subject|26|||
143245087|NCT01193257|516449591|FG001|Overall Study|Withdrawal by Subject|86|||
143245088|NCT01193257|516449590|FG000|Overall Study|Lost to Follow-up|2|||
143245089|NCT01193257|516449591|FG001|Overall Study|Lost to Follow-up|3|||
143245090|NCT01193257|516449590|FG000|Overall Study|Unblinded due to futility|135|||
143245091|NCT01193257|516449591|FG001|Overall Study|Unblinded due to futility|251|||
143245092|NCT01168219|516449602|FG000|Overall Study|off study before starting treatment|2|||
143245093|NCT01168219|516449602|FG000|Overall Study|withdrew before transplant|1|||
143245094|NCT01168219|516449602|FG000|Overall Study|ineligible due to CML|2|||
143245095|NCT01027273|516449603|FG000|Overall Study|Lost to Follow-up|57|||
143245096|NCT01027273|516449604|FG001|Overall Study|Lost to Follow-up|31|||
143245097|NCT01027273|516449603|FG000|Overall Study|Death|2|||
143245098|NCT01027273|516449604|FG001|Overall Study|Death|2|||
143245099|NCT03790696|516449607|FG000|Overall Study|Cognitive training task was too difficult for child to complete.|0|||
143245100|NCT03790696|516449608|FG001|Overall Study|Cognitive training task was too difficult for child to complete.|1|||
143245101|NCT02563067|516449611|FG000|Overall Study|Subject/guardian decision|14|||
143245102|NCT02563067|516449612|FG001|Overall Study|Subject/guardian decision|20|||
143245103|NCT02563067|516449613|FG002|Overall Study|Subject/guardian decision|16|||
143245104|NCT02563067|516449611|FG000|Overall Study|Physician Decision|0|||
143245105|NCT02563067|516449612|FG001|Overall Study|Physician Decision|1|||
143245106|NCT02563067|516449613|FG002|Overall Study|Physician Decision|3|||
143245107|NCT02563067|516449611|FG000|Overall Study|Lost to Follow-up|1|||
143245108|NCT02563067|516449612|FG001|Overall Study|Lost to Follow-up|2|||
143054960|NCT02510261|515740219|FG001|Overall Study|Adverse Event|8|||
143054961|NCT02510261|515740220|FG002|Overall Study|Adverse Event|0|||
143054962|NCT02510261|515740218|FG000|Overall Study|Physician Decision|1|||
143054963|NCT02510261|515740219|FG001|Overall Study|Physician Decision|5|||
143054964|NCT02510261|515740220|FG002|Overall Study|Physician Decision|0|||
143245109|NCT02563067|516449613|FG002|Overall Study|Lost to Follow-up|0|||
143245110|NCT02563067|516449611|FG000|Overall Study|Technical problems|0|||
143245111|NCT02563067|516449612|FG001|Overall Study|Technical problems|1|||
143245112|NCT02563067|516449613|FG002|Overall Study|Technical problems|0|||
143245113|NCT02563067|516449611|FG000|Overall Study|Lack of Efficacy|1|||
143245114|NCT02563067|516449612|FG001|Overall Study|Lack of Efficacy|0|||
143245115|NCT02563067|516449613|FG002|Overall Study|Lack of Efficacy|0|||
143245116|NCT02563067|516449611|FG000|Overall Study|Death|0|||
143245117|NCT02563067|516449612|FG001|Overall Study|Death|1|||
143245118|NCT02563067|516449613|FG002|Overall Study|Death|1|||
143245119|NCT02563067|516449611|FG000|Overall Study|Adverse Event|2|||
143245120|NCT02563067|516449612|FG001|Overall Study|Adverse Event|1|||
143245121|NCT02563067|516449613|FG002|Overall Study|Adverse Event|0|||
143245122|NCT02563067|516449611|FG000|Overall Study|Death post Treatment/safety period|1|||
143245123|NCT02563067|516449612|FG001|Overall Study|Death post Treatment/safety period|0|||
143245124|NCT02563067|516449613|FG002|Overall Study|Death post Treatment/safety period|0|||
143245125|NCT03544333|516449619|FG000|Overall Study|Withdrawal by Subject|1|||
143245126|NCT03544333|516449620|FG001|Overall Study|Withdrawal by Subject|0|||
143245127|NCT01330108|516449623|FG000|Overall Study|Withdrawal by Subject|4|||
143245128|NCT00423917|516449624|FG000|Overall Study|Cancel|2|||
143245129|NCT00423917|516449624|FG000|Overall Study|Ineligible|1|||
143245130|NCT00243269|516449625|FG000|Overall Study|Protocol Violation|2|||
143245131|NCT00243269|516449626|FG001|Overall Study|Protocol Violation|1|||
143245132|NCT00243269|516449627|FG002|Overall Study|Protocol Violation|0|||
143245133|NCT00243269|516449628|FG003|Overall Study|Protocol Violation|1|||
143245134|NCT00243269|516449625|FG000|Overall Study|Lost to Follow-up|1|||
143245135|NCT00243269|516449626|FG001|Overall Study|Lost to Follow-up|0|||
143364718|NCT02680756|516878692|FG001|Overall Study|Death|0|||
143054965|NCT02510261|515740218|FG000|Overall Study|Death|19|||
143054966|NCT02510261|515740219|FG001|Overall Study|Death|19|||
143054967|NCT02510261|515740220|FG002|Overall Study|Death|0|||
143054968|NCT02510261|515740218|FG000|Overall Study|Withdrawal by Subject|3|||
143054969|NCT02510261|515740219|FG001|Overall Study|Withdrawal by Subject|10|||
143054970|NCT02510261|515740220|FG002|Overall Study|Withdrawal by Subject|3|||
143054971|NCT02161549|515740224|FG000|Overall Study|Physician Decision|6|||
143054972|NCT02161549|515740225|FG001|Overall Study|Physician Decision|2|||
143054973|NCT01344018|515740236|FG000|Overall Study|Death|22|||
143054974|NCT01344018|515740237|FG001|Overall Study|Death|25|||
143054975|NCT01344018|515740236|FG000|Overall Study|Lost to Follow-up|4|||
143054976|NCT01344018|515740237|FG001|Overall Study|Lost to Follow-up|7|||
143054977|NCT00702507|515740239|FG000|Initial Treatment Phase|Adverse Event|2|||
143054978|NCT00702507|515740239|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
143054979|NCT00702507|515740239|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
143054980|NCT00702507|515740239|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
143054981|NCT00702507|515740239|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
143054982|NCT00702507|515740239|FG000|Follow-up Phase|Protocol Violation|2|||
143054983|NCT00702507|515740239|FG000|Follow-up Phase|Lost to Follow-up|23|||
143054984|NCT00702507|515740239|FG000|Follow-up Phase|Late Enrollment|1|||
143054985|NCT04994431|515740240|FG000|Overall Study|Adverse Event|1|||
143054986|NCT04994431|515740241|FG001|Overall Study|Adverse Event|0|||
143054987|NCT02522780|515740248|FG000|Overall Study|Consent withdrawn by subject|5|||
143054988|NCT02522780|515740249|FG001|Overall Study|Consent withdrawn by subject|7|||
143054989|NCT02522780|515740248|FG000|Overall Study|Protocol deviation|1|||
143054990|NCT02522780|515740249|FG001|Overall Study|Protocol deviation|3|||
143054991|NCT02522780|515740248|FG000|Overall Study|Subject refused endoscopic procedure|0|||
143054992|NCT02522780|515740249|FG001|Overall Study|Subject refused endoscopic procedure|1|||
143054993|NCT02522780|515740248|FG000|Overall Study|Adverse event, non-fatal|11|||
143054994|NCT02522780|515740249|FG001|Overall Study|Adverse event, non-fatal|16|||
143054995|NCT03310619|515740250|FG000|Pre-Treatment Period|Death|1|||
143054996|NCT03310619|515740251|FG001|Pre-Treatment Period|Death|0|||
143054997|NCT03310619|515740252|FG002|Pre-Treatment Period|Death|0|||
143054998|NCT03310619|515740253|FG003|Pre-Treatment Period|Death|0|||
143054999|NCT03310619|515740254|FG004|Pre-Treatment Period|Death|1|||
143055000|NCT03310619|515740255|FG005|Pre-Treatment Period|Death|0|||
143055001|NCT03310619|515740256|FG006|Pre-Treatment Period|Death|0|||
143055002|NCT03310619|515740257|FG007|Pre-Treatment Period|Death|0|||
143055003|NCT03310619|515740250|FG000|Pre-Treatment Period|Other reasons|2|||
143055004|NCT03310619|515740251|FG001|Pre-Treatment Period|Other reasons|1|||
143055005|NCT03310619|515740252|FG002|Pre-Treatment Period|Other reasons|2|||
143055006|NCT03310619|515740253|FG003|Pre-Treatment Period|Other reasons|0|||
143055007|NCT03310619|515740254|FG004|Pre-Treatment Period|Other reasons|0|||
143055008|NCT03310619|515740255|FG005|Pre-Treatment Period|Other reasons|0|||
143055009|NCT03310619|515740256|FG006|Pre-Treatment Period|Other reasons|2|||
143055010|NCT03310619|515740257|FG007|Pre-Treatment Period|Other reasons|0|||
143055011|NCT03310619|515740250|FG000|Treatment Period|Death|1|||
143055012|NCT03310619|515740251|FG001|Treatment Period|Death|2|||
143055013|NCT03310619|515740252|FG002|Treatment Period|Death|0|||
143055014|NCT03310619|515740253|FG003|Treatment Period|Death|0|||
143055015|NCT03310619|515740254|FG004|Treatment Period|Death|1|||
143055016|NCT03310619|515740255|FG005|Treatment Period|Death|0|||
143055017|NCT03310619|515740256|FG006|Treatment Period|Death|2|||
143055018|NCT03310619|515740257|FG007|Treatment Period|Death|0|||
143055019|NCT03310619|515740250|FG000|Treatment Period|Adverse Event|0|||
143055020|NCT03310619|515740251|FG001|Treatment Period|Adverse Event|1|||
143055021|NCT03310619|515740252|FG002|Treatment Period|Adverse Event|4|||
143055022|NCT03310619|515740253|FG003|Treatment Period|Adverse Event|1|||
143055023|NCT03310619|515740254|FG004|Treatment Period|Adverse Event|0|||
143055024|NCT03310619|515740255|FG005|Treatment Period|Adverse Event|0|||
143055025|NCT03310619|515740256|FG006|Treatment Period|Adverse Event|0|||
143055026|NCT03310619|515740257|FG007|Treatment Period|Adverse Event|0|||
143055027|NCT03310619|515740250|FG000|Treatment Period|Withdrawal by participant|0|||
143055028|NCT03310619|515740251|FG001|Treatment Period|Withdrawal by participant|0|||
143055029|NCT03310619|515740252|FG002|Treatment Period|Withdrawal by participant|1|||
143055030|NCT03310619|515740253|FG003|Treatment Period|Withdrawal by participant|0|||
143055031|NCT03310619|515740254|FG004|Treatment Period|Withdrawal by participant|0|||
143055032|NCT03310619|515740255|FG005|Treatment Period|Withdrawal by participant|0|||
143055033|NCT03310619|515740256|FG006|Treatment Period|Withdrawal by participant|0|||
143055034|NCT03310619|515740257|FG007|Treatment Period|Withdrawal by participant|0|||
143055035|NCT03310619|515740250|FG000|Treatment Period|Lost to Follow-up|0|||
143055036|NCT03310619|515740251|FG001|Treatment Period|Lost to Follow-up|0|||
143055037|NCT03310619|515740252|FG002|Treatment Period|Lost to Follow-up|0|||
143055038|NCT03310619|515740253|FG003|Treatment Period|Lost to Follow-up|0|||
143055039|NCT03310619|515740254|FG004|Treatment Period|Lost to Follow-up|0|||
143055040|NCT03310619|515740255|FG005|Treatment Period|Lost to Follow-up|0|||
143055041|NCT03310619|515740256|FG006|Treatment Period|Lost to Follow-up|0|||
143055042|NCT03310619|515740257|FG007|Treatment Period|Lost to Follow-up|1|||
143055043|NCT03310619|515740250|FG000|Treatment Period|Study terminated by sponsor|0|||
143055044|NCT03310619|515740251|FG001|Treatment Period|Study terminated by sponsor|0|||
143055045|NCT03310619|515740252|FG002|Treatment Period|Study terminated by sponsor|0|||
143055046|NCT03310619|515740253|FG003|Treatment Period|Study terminated by sponsor|0|||
143055047|NCT03310619|515740254|FG004|Treatment Period|Study terminated by sponsor|0|||
143055048|NCT03310619|515740255|FG005|Treatment Period|Study terminated by sponsor|0|||
143055049|NCT03310619|515740256|FG006|Treatment Period|Study terminated by sponsor|0|||
143055050|NCT03310619|515740257|FG007|Treatment Period|Study terminated by sponsor|1|||
143055051|NCT03310619|515740250|FG000|Treatment Period|Physician Decision|0|||
143055052|NCT03310619|515740251|FG001|Treatment Period|Physician Decision|0|||
143055053|NCT03310619|515740252|FG002|Treatment Period|Physician Decision|0|||
143055054|NCT03310619|515740253|FG003|Treatment Period|Physician Decision|0|||
143055055|NCT03310619|515740254|FG004|Treatment Period|Physician Decision|3|||
143055056|NCT03310619|515740255|FG005|Treatment Period|Physician Decision|0|||
143055057|NCT03310619|515740256|FG006|Treatment Period|Physician Decision|0|||
143055058|NCT03310619|515740257|FG007|Treatment Period|Physician Decision|0|||
143055059|NCT03310619|515740250|FG000|Treatment Period|Other reasons|1|||
143055060|NCT03310619|515740251|FG001|Treatment Period|Other reasons|0|||
143055061|NCT03310619|515740252|FG002|Treatment Period|Other reasons|2|||
143055062|NCT03310619|515740253|FG003|Treatment Period|Other reasons|0|||
143055063|NCT03310619|515740254|FG004|Treatment Period|Other reasons|0|||
143055064|NCT03310619|515740255|FG005|Treatment Period|Other reasons|0|||
143055065|NCT03310619|515740256|FG006|Treatment Period|Other reasons|0|||
143055066|NCT03310619|515740257|FG007|Treatment Period|Other reasons|0|||
143245136|NCT00243269|516449627|FG002|Overall Study|Lost to Follow-up|1|||
143245137|NCT00243269|516449628|FG003|Overall Study|Lost to Follow-up|3|||
143245138|NCT00485134|516449634|FG000|Overall Study|Lost to Follow-up|1|||
143245139|NCT00485134|516449635|FG001|Overall Study|Lost to Follow-up|0|||
143245140|NCT00485134|516449636|FG002|Overall Study|Lost to Follow-up|0|||
143245141|NCT00485134|516449637|FG003|Overall Study|Lost to Follow-up|0|||
143245142|NCT00485134|516449638|FG004|Overall Study|Lost to Follow-up|0|||
143245143|NCT00485134|516449639|FG005|Overall Study|Lost to Follow-up|0|||
143245144|NCT00485134|516449640|FG006|Overall Study|Lost to Follow-up|0|||
143245145|NCT00485134|516449641|FG007|Overall Study|Lost to Follow-up|0|||
143245146|NCT00485134|516449634|FG000|Overall Study|Withdrawal by Subject|0|||
143245147|NCT00485134|516449635|FG001|Overall Study|Withdrawal by Subject|1|||
143245148|NCT00485134|516449636|FG002|Overall Study|Withdrawal by Subject|0|||
143245149|NCT00485134|516449637|FG003|Overall Study|Withdrawal by Subject|0|||
143245150|NCT00485134|516449638|FG004|Overall Study|Withdrawal by Subject|0|||
143245151|NCT00485134|516449639|FG005|Overall Study|Withdrawal by Subject|0|||
143245152|NCT00485134|516449640|FG006|Overall Study|Withdrawal by Subject|0|||
143245153|NCT00485134|516449641|FG007|Overall Study|Withdrawal by Subject|0|||
143245154|NCT00485134|516449634|FG000|Overall Study|Change in health status|0|||
143245155|NCT00485134|516449635|FG001|Overall Study|Change in health status|1|||
143245156|NCT00485134|516449636|FG002|Overall Study|Change in health status|2|||
143245157|NCT00485134|516449637|FG003|Overall Study|Change in health status|1|||
143245158|NCT00485134|516449638|FG004|Overall Study|Change in health status|0|||
143245159|NCT00485134|516449639|FG005|Overall Study|Change in health status|1|||
143245160|NCT00485134|516449640|FG006|Overall Study|Change in health status|0|||
143245161|NCT00485134|516449641|FG007|Overall Study|Change in health status|0|||
143055067|NCT01517867|515740258|FG000|Overall Study|never started treatment|29|||
143055068|NCT01517867|515740259|FG001|Overall Study|never started treatment|32|||
143055069|NCT01517867|515740258|FG000|Overall Study|Withdrawal by Subject|34|||
143055070|NCT01517867|515740259|FG001|Overall Study|Withdrawal by Subject|30|||
143055071|NCT01517867|515740258|FG000|Overall Study|Still in treatment at study end|0|||
143245162|NCT00485134|516449634|FG000|Overall Study|Withdrew for adverse event|0|||
143245163|NCT00485134|516449635|FG001|Overall Study|Withdrew for adverse event|0|||
143245164|NCT00485134|516449636|FG002|Overall Study|Withdrew for adverse event|1|||
143245165|NCT00485134|516449637|FG003|Overall Study|Withdrew for adverse event|0|||
143245166|NCT00485134|516449638|FG004|Overall Study|Withdrew for adverse event|0|||
143245167|NCT00485134|516449639|FG005|Overall Study|Withdrew for adverse event|0|||
143245168|NCT00485134|516449640|FG006|Overall Study|Withdrew for adverse event|0|||
143245169|NCT00485134|516449641|FG007|Overall Study|Withdrew for adverse event|0|||
143245170|NCT00485134|516449634|FG000|Overall Study|Positive drug test|0|||
143245171|NCT00485134|516449635|FG001|Overall Study|Positive drug test|0|||
143245172|NCT00485134|516449636|FG002|Overall Study|Positive drug test|0|||
143245173|NCT00485134|516449637|FG003|Overall Study|Positive drug test|0|||
143245174|NCT00485134|516449638|FG004|Overall Study|Positive drug test|2|||
143055072|NCT01517867|515740259|FG001|Overall Study|Still in treatment at study end|3|||
143055073|NCT03294317|515740260|FG000|Overall Study|Physician Decision|1|||
143055074|NCT03294317|515740260|FG000|Overall Study|Withdrawal by Subject|6|||
143055075|NCT03294317|515740260|FG000|Overall Study|Lost to Follow-up|1|||
143055076|NCT03294317|515740260|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
143055077|NCT03294317|515740260|FG000|Overall Study|Failed HB lead implant|8|||
143055078|NCT03294317|515740260|FG000|Overall Study|Received CRT instead|1|||
143055079|NCT03294317|515740260|FG000|Overall Study|Exited after lead revision|2|||
143055080|NCT04428645|515740261|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
143055081|NCT01977456|515740266|FG000|Overall Study|Death|5|||
143055082|NCT01765270|515741851|FG000|Overall Study|Physician Decision|1|||
143055083|NCT01765270|515741852|FG001|Overall Study|Physician Decision|0|||
143055084|NCT01765270|515741851|FG000|Overall Study|Withdrawal by Subject|0|||
143055085|NCT01765270|515741852|FG001|Overall Study|Withdrawal by Subject|1|||
143055086|NCT04129944|515741853|FG000|Overall Study|Death|0|||
143055087|NCT04129944|515741854|FG001|Overall Study|Death|0|||
143055088|NCT04129944|515741855|FG002|Overall Study|Death|0|||
143055089|NCT04129944|515741856|FG003|Overall Study|Death|1|||
143055090|NCT04129944|515741853|FG000|Overall Study|Lost to Follow-up|1|||
143055091|NCT04129944|515741854|FG001|Overall Study|Lost to Follow-up|0|||
143055092|NCT04129944|515741855|FG002|Overall Study|Lost to Follow-up|0|||
143055093|NCT04129944|515741856|FG003|Overall Study|Lost to Follow-up|0|||
143055094|NCT04129944|515741853|FG000|Overall Study|Withdrawal by Subject|1|||
143055095|NCT04129944|515741854|FG001|Overall Study|Withdrawal by Subject|0|||
143055096|NCT04129944|515741855|FG002|Overall Study|Withdrawal by Subject|1|||
143055097|NCT04129944|515741856|FG003|Overall Study|Withdrawal by Subject|2|||
143055098|NCT00493792|515741859|FG000|Overall Study|Death|55|||
143055099|NCT00493792|515741860|FG001|Overall Study|Death|50|||
143055100|NCT00493792|515741859|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
143055101|NCT00493792|515741860|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
143055102|NCT04501094|515741861|FG000|Overall Study|Death (unrelated to research)|1|||
143055103|NCT04501094|515741862|FG001|Overall Study|Death (unrelated to research)|0|||
143055104|NCT00784979|515741869|FG000|Overall Study|incomplete data|6|||
143055105|NCT00894933|515741873|FG000|Overall Study|Lost to Follow-up|2|||
143055106|NCT00894933|515741873|FG000|Overall Study|Cancelled Procedure|1|||
143055107|NCT00894933|515741873|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
143055108|NCT04241133|515741876|FG000|Overall Study|COVID19 Precautions|14|||
143055109|NCT04241133|515741877|FG001|Overall Study|COVID19 Precautions|34|||
143055110|NCT02674633|515741879|FG000|Overall Study|Lost to Follow-up|3|||
143055111|NCT02674633|515741880|FG001|Overall Study|Lost to Follow-up|2|||
143055112|NCT02674633|515741879|FG000|Overall Study|Physician Decision|1|||
143055113|NCT02674633|515741880|FG001|Overall Study|Physician Decision|0|||
143055114|NCT02674633|515741879|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
143055115|NCT02674633|515741880|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
143055116|NCT00683787|515741881|FG000|Overall Study|Progression|3|||
143245175|NCT00485134|516449639|FG005|Overall Study|Positive drug test|1|||
143245176|NCT00485134|516449640|FG006|Overall Study|Positive drug test|0|||
143055117|NCT00683787|515741882|FG001|Overall Study|Progression|3|||
143055118|NCT00683787|515741883|FG002|Overall Study|Progression|0|||
143055119|NCT00683787|515741881|FG000|Overall Study|Adverse Event|0|||
143055120|NCT00683787|515741882|FG001|Overall Study|Adverse Event|0|||
143245177|NCT00485134|516449641|FG007|Overall Study|Positive drug test|0|||
143055121|NCT00683787|515741883|FG002|Overall Study|Adverse Event|2|||
143055122|NCT01235715|515741884|FG000|Overall Study|Physician Decision|0|||
143055123|NCT01235715|515741885|FG001|Overall Study|Physician Decision|2|||
143055124|NCT02994394|515741886|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
143055125|NCT02994394|515741887|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
143055126|NCT02994394|515741888|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
143055127|NCT02994394|515741889|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
143055128|NCT02994394|515741890|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
143055129|NCT02994394|515741891|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
143055130|NCT02994394|515741886|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
143055131|NCT02994394|515741887|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
143055132|NCT02994394|515741888|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
143055133|NCT02994394|515741889|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
143055134|NCT02994394|515741890|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
143055135|NCT02994394|515741891|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
143055136|NCT03619876|515741892|FG000|Overall Study|Withdrawal by Subject|1|||
143055137|NCT03619876|515741893|FG001|Overall Study|Withdrawal by Subject|2|||
143055138|NCT03619876|515741892|FG000|Overall Study|Withdrawal due to incidental finding|0|||
143055139|NCT03619876|515741893|FG001|Overall Study|Withdrawal due to incidental finding|2|||
143055140|NCT02344745|515741894|FG000|Overall Study|Data collection sheets were lost|2|||
143055141|NCT02344745|515741895|FG001|Overall Study|Data collection sheets were lost|0|||
143055142|NCT02788513|515741896|FG000|Overall Study|Withdrawal by Subject|3|||
143055143|NCT02788513|515741897|FG001|Overall Study|Withdrawal by Subject|0|||
143055144|NCT02788513|515741898|FG002|Overall Study|Withdrawal by Subject|2|||
143055145|NCT02788513|515741899|FG003|Overall Study|Withdrawal by Subject|3|||
143055146|NCT02788513|515741900|FG004|Overall Study|Withdrawal by Subject|1|||
143055147|NCT02788513|515741896|FG000|Overall Study|Lost to Follow-up|1|||
143055148|NCT02788513|515741897|FG001|Overall Study|Lost to Follow-up|0|||
143055149|NCT02788513|515741898|FG002|Overall Study|Lost to Follow-up|0|||
143055150|NCT02788513|515741899|FG003|Overall Study|Lost to Follow-up|0|||
143055151|NCT02788513|515741900|FG004|Overall Study|Lost to Follow-up|1|||
143055152|NCT02788513|515741896|FG000|Overall Study|Adverse Event|5|||
143055153|NCT02788513|515741897|FG001|Overall Study|Adverse Event|8|||
143055154|NCT02788513|515741898|FG002|Overall Study|Adverse Event|4|||
143055155|NCT02788513|515741899|FG003|Overall Study|Adverse Event|2|||
143055156|NCT02788513|515741900|FG004|Overall Study|Adverse Event|2|||
143055157|NCT02788513|515741896|FG000|Overall Study|Protocol Violation|0|||
143055158|NCT02788513|515741897|FG001|Overall Study|Protocol Violation|0|||
143055159|NCT02788513|515741898|FG002|Overall Study|Protocol Violation|1|||
143055160|NCT02788513|515741899|FG003|Overall Study|Protocol Violation|1|||
143055161|NCT02788513|515741900|FG004|Overall Study|Protocol Violation|0|||
143055162|NCT02788513|515741896|FG000|Overall Study|Subject decided to stop taking treatment|0|||
143055163|NCT02788513|515741897|FG001|Overall Study|Subject decided to stop taking treatment|0|||
143055164|NCT02788513|515741898|FG002|Overall Study|Subject decided to stop taking treatment|1|||
143499734|NCT01879410|517370485|FG000|Overall Study|Protocol Violation|1|||
143499735|NCT01879410|517370486|FG001|Overall Study|Protocol Violation|7|||
143499736|NCT01879410|517370485|FG000|Overall Study|Lost to Follow-up|2|||
143499737|NCT01879410|517370486|FG001|Overall Study|Lost to Follow-up|1|||
143499738|NCT01879410|517370485|FG000|Overall Study|Withdrawal by Subject|7|||
143499739|NCT01879410|517370486|FG001|Overall Study|Withdrawal by Subject|8|||
143499740|NCT01879410|517370485|FG000|Overall Study|Randomised in Error|1|||
143499741|NCT01879410|517370486|FG001|Overall Study|Randomised in Error|2|||
143499742|NCT01360645|517370493|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
143499743|NCT01360645|517370494|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
143499744|NCT01360645|517370495|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
143499745|NCT01360645|517370496|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
143499746|NCT01360645|517370493|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
143499747|NCT01360645|517370494|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
143499748|NCT01360645|517370495|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
143499749|NCT01360645|517370496|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
143055165|NCT02788513|515741899|FG003|Overall Study|Subject decided to stop taking treatment|0|||
143055166|NCT02788513|515741900|FG004|Overall Study|Subject decided to stop taking treatment|0|||
143055167|NCT02788513|515741896|FG000|Overall Study|Decision by the study team|0|||
143055168|NCT02788513|515741897|FG001|Overall Study|Decision by the study team|0|||
143055169|NCT02788513|515741898|FG002|Overall Study|Decision by the study team|0|||
143499750|NCT01360645|517370493|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
143499751|NCT01360645|517370494|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
143055170|NCT02788513|515741899|FG003|Overall Study|Decision by the study team|0|||
143055171|NCT02788513|515741900|FG004|Overall Study|Decision by the study team|1|||
143055172|NCT04982445|515741901|FG000|Overall Study|Protocol Violation|1|||
143055173|NCT04982445|515741901|FG000|Overall Study|Withdrawal by Subject|4|||
143055174|NCT04982445|515741901|FG000|Overall Study|Lost to Follow-up|1|||
143055175|NCT05996198|515741904|FG000|Overall Study|Withdrawal by Subject|1|||
143055176|NCT05996198|515741905|FG001|Overall Study|Withdrawal by Subject|0|||
143055177|NCT00835796|515741907|FG000|First Intervention|Withdrawal by Subject|0|||
143055178|NCT00835796|515741908|FG001|First Intervention|Withdrawal by Subject|1|||
143055179|NCT00396630|515741909|FG000|Overall Study|Lost to Follow-up|1|||
143055180|NCT00396630|515741910|FG001|Overall Study|Lost to Follow-up|1|||
143055181|NCT00396630|515741909|FG000|Overall Study|Withdrawal by Subject|1|||
143055182|NCT00396630|515741910|FG001|Overall Study|Withdrawal by Subject|1|||
143055183|NCT00396630|515741909|FG000|Overall Study|Not vaccinated at Visit 3|3|||
143055184|NCT00396630|515741910|FG001|Overall Study|Not vaccinated at Visit 3|3|||
143055185|NCT02327325|515741911|FG000|Overall Study|Withdrawal by Subject|1|||
143055186|NCT02327325|515741912|FG001|Overall Study|Withdrawal by Subject|4|||
143055187|NCT02327325|515741913|FG002|Overall Study|Withdrawal by Subject|4|||
143055188|NCT02327325|515741911|FG000|Overall Study|Excluded by Study Team|0|||
143055189|NCT02327325|515741912|FG001|Overall Study|Excluded by Study Team|0|||
143055190|NCT02327325|515741913|FG002|Overall Study|Excluded by Study Team|1|||
143055191|NCT00651183|515741918|FG000|Overall Study|Lack of Efficacy|1|||
143055192|NCT00651183|515741919|FG001|Overall Study|Lack of Efficacy|0|||
143055193|NCT00651183|515741918|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
143055194|NCT00651183|515741919|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
143055195|NCT00651183|515741918|FG000|Overall Study|Tolerability insufficient|5|||
143055196|NCT00651183|515741919|FG001|Overall Study|Tolerability insufficient|2|||
143055197|NCT00651183|515741918|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
143055198|NCT00651183|515741919|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
143055199|NCT00651183|515741918|FG000|Overall Study|Withdrawal by Subject|6|||
143055200|NCT00651183|515741919|FG001|Overall Study|Withdrawal by Subject|3|||
143055201|NCT00651183|515741918|FG000|Overall Study|Lost to Follow-up|3|||
143055202|NCT00651183|515741919|FG001|Overall Study|Lost to Follow-up|1|||
143055203|NCT00651183|515741918|FG000|Overall Study|Other reasons|4|||
143055204|NCT00651183|515741919|FG001|Overall Study|Other reasons|2|||
143055205|NCT00651183|515741918|FG000|Overall Study|missing|1|||
143055206|NCT00651183|515741919|FG001|Overall Study|missing|0|||
143055207|NCT01933919|515741920|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
143055208|NCT01933919|515741921|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
143055209|NCT01933919|515741920|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
143055210|NCT01933919|515741921|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
143055211|NCT01933919|515741920|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
143055212|NCT01933919|515741921|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
143055213|NCT01933919|515741920|FG000|Open-label Long-term Phase|Adverse Event|2|||
143055214|NCT01933919|515741921|FG001|Open-label Long-term Phase|Adverse Event|0|||
143055215|NCT01933919|515741920|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
143055216|NCT01933919|515741921|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
143055217|NCT01933919|515741920|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
143055218|NCT01933919|515741921|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
143245178|NCT00485134|516449634|FG000|Overall Study|Non-compliance|0|||
143245179|NCT00485134|516449635|FG001|Overall Study|Non-compliance|0|||
143245180|NCT00485134|516449636|FG002|Overall Study|Non-compliance|0|||
143245181|NCT00485134|516449637|FG003|Overall Study|Non-compliance|0|||
143245182|NCT00485134|516449638|FG004|Overall Study|Non-compliance|1|||
143245183|NCT00485134|516449639|FG005|Overall Study|Non-compliance|2|||
143055219|NCT01933919|515741920|FG000|Open-label Long-term Phase|Other|1|||
143055220|NCT01933919|515741921|FG001|Open-label Long-term Phase|Other|2|||
143055221|NCT03330236|515741922|FG000|Overall Study|Death|2|||
143055222|NCT03330236|515741923|FG001|Overall Study|Death|1|||
143055223|NCT03330236|515741922|FG000|Overall Study|Withdrawal by Subject|2|||
143055224|NCT03330236|515741923|FG001|Overall Study|Withdrawal by Subject|4|||
143055225|NCT03330236|515741922|FG000|Overall Study|Lost to Follow-up|0|||
143055226|NCT03330236|515741923|FG001|Overall Study|Lost to Follow-up|2|||
143055227|NCT03330236|515741922|FG000|Overall Study|Physician Decision|2|||
143055228|NCT03330236|515741923|FG001|Overall Study|Physician Decision|0|||
143055229|NCT03330236|515741922|FG000|Overall Study|Protocol Violation|4|||
143055230|NCT03330236|515741923|FG001|Overall Study|Protocol Violation|3|||
143055231|NCT03330236|515741922|FG000|Overall Study|SedLine malfunction/blinding|19|||
143055232|NCT03330236|515741923|FG001|Overall Study|SedLine malfunction/blinding|14|||
143055233|NCT03330236|515741922|FG000|Overall Study|Volatile anesthetics used|11|||
143055234|NCT03330236|515741923|FG001|Overall Study|Volatile anesthetics used|8|||
143055235|NCT03330236|515741922|FG000|Overall Study|Surgery aborted/converted to open|60|||
143055236|NCT03330236|515741923|FG001|Overall Study|Surgery aborted/converted to open|52|||
143055237|NCT00407745|515741925|FG000|Overall Study|Lack of Efficacy|1|||
143055238|NCT00407745|515741926|FG001|Overall Study|Lack of Efficacy|2|||
143055239|NCT00407745|515741925|FG000|Overall Study|Withdrawal by Subject|3|||
143055240|NCT00407745|515741926|FG001|Overall Study|Withdrawal by Subject|3|||
143055241|NCT00407745|515741925|FG000|Overall Study|Protocol Violation|5|||
143055242|NCT00407745|515741926|FG001|Overall Study|Protocol Violation|3|||
143055243|NCT00407745|515741925|FG000|Overall Study|Adverse Event|8|||
143055244|NCT00407745|515741926|FG001|Overall Study|Adverse Event|8|||
143245184|NCT00485134|516449640|FG006|Overall Study|Non-compliance|2|||
143245185|NCT00485134|516449641|FG007|Overall Study|Non-compliance|0|||
143055245|NCT00407745|515741925|FG000|Overall Study|Other|2|||
143055246|NCT00407745|515741926|FG001|Overall Study|Other|0|||
143055247|NCT00407745|515741925|FG000|Overall Study|Randomized, unknown if treated|0|||
143055248|NCT00407745|515741926|FG001|Overall Study|Randomized, unknown if treated|1|||
143055249|NCT00108082|515741927|FG000|Overall Study|Adverse Event|14|||
143055250|NCT00108082|515741928|FG001|Overall Study|Adverse Event|12|||
143055251|NCT00108082|515741929|FG002|Overall Study|Adverse Event|17|||
143055252|NCT00108082|515741927|FG000|Overall Study|Lost to Follow-up|6|||
143055253|NCT00108082|515741928|FG001|Overall Study|Lost to Follow-up|3|||
143055254|NCT00108082|515741929|FG002|Overall Study|Lost to Follow-up|7|||
143055255|NCT00108082|515741927|FG000|Overall Study|Consent Withdrawn|3|||
143055256|NCT00108082|515741928|FG001|Overall Study|Consent Withdrawn|3|||
143055257|NCT00108082|515741929|FG002|Overall Study|Consent Withdrawn|5|||
143055258|NCT00108082|515741927|FG000|Overall Study|Protocol Violation|1|||
143055259|NCT00108082|515741928|FG001|Overall Study|Protocol Violation|2|||
143055260|NCT00108082|515741929|FG002|Overall Study|Protocol Violation|0|||
143055261|NCT00108082|515741927|FG000|Overall Study|Lack of Efficacy|3|||
143055262|NCT00108082|515741928|FG001|Overall Study|Lack of Efficacy|1|||
143055263|NCT00108082|515741929|FG002|Overall Study|Lack of Efficacy|2|||
143055264|NCT00108082|515741927|FG000|Overall Study|Amendment 4: > Month 12|5|||
143055265|NCT00108082|515741928|FG001|Overall Study|Amendment 4: > Month 12|7|||
143055266|NCT00108082|515741929|FG002|Overall Study|Amendment 4: > Month 12|5|||
143055267|NCT00108082|515741927|FG000|Overall Study|Woman of Child-bearing Potential|2|||
143055268|NCT00108082|515741928|FG001|Overall Study|Woman of Child-bearing Potential|0|||
143055269|NCT00108082|515741929|FG002|Overall Study|Woman of Child-bearing Potential|2|||
143364719|NCT02680756|516878691|FG000|Overall Study|Protocol Violation|1|||
143245186|NCT00485134|516449634|FG000|Overall Study|Unable to comply with study schedule|0|||
143245187|NCT00485134|516449635|FG001|Overall Study|Unable to comply with study schedule|0|||
143245188|NCT00485134|516449636|FG002|Overall Study|Unable to comply with study schedule|0|||
143245189|NCT00485134|516449637|FG003|Overall Study|Unable to comply with study schedule|0|||
143245190|NCT00485134|516449638|FG004|Overall Study|Unable to comply with study schedule|0|||
143245191|NCT00485134|516449639|FG005|Overall Study|Unable to comply with study schedule|0|||
143245192|NCT00485134|516449640|FG006|Overall Study|Unable to comply with study schedule|0|||
143245193|NCT00485134|516449641|FG007|Overall Study|Unable to comply with study schedule|1|||
143245194|NCT00485134|516449634|FG000|Overall Study|Pregnancy|0|||
143245195|NCT00485134|516449635|FG001|Overall Study|Pregnancy|0|||
143245196|NCT00485134|516449636|FG002|Overall Study|Pregnancy|0|||
143499752|NCT01360645|517370495|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
143499753|NCT01360645|517370496|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
143499754|NCT01360645|517370493|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
143499755|NCT01360645|517370494|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
143245197|NCT00485134|516449637|FG003|Overall Study|Pregnancy|0|||
143245198|NCT00485134|516449638|FG004|Overall Study|Pregnancy|0|||
143245199|NCT00485134|516449639|FG005|Overall Study|Pregnancy|0|||
143245200|NCT00485134|516449640|FG006|Overall Study|Pregnancy|1|||
143245201|NCT00485134|516449641|FG007|Overall Study|Pregnancy|0|||
143245202|NCT00970684|516449642|FG000|Overall Study|Lack of Efficacy|5|||
143245203|NCT00970684|516449642|FG000|Overall Study|Adverse Event|4|||
143245204|NCT00970684|516449642|FG000|Overall Study|Withdrawal by Subject|1|||
143245205|NCT04294680|516449643|FG000|Overall Study|Withdrawal by Subject|2|||
143245206|NCT04294680|516449644|FG001|Overall Study|Withdrawal by Subject|1|||
143245207|NCT04294680|516449643|FG000|Overall Study|Follow-up visits completed outside of window|1|||
143245208|NCT04294680|516449644|FG001|Overall Study|Follow-up visits completed outside of window|0|||
143245209|NCT04661579|516449646|FG000|Overall Study|Lost to Follow-up|19|||
143245210|NCT04661579|516449647|FG001|Overall Study|Lost to Follow-up|10|||
143245211|NCT04661579|516449648|FG002|Overall Study|Lost to Follow-up|2|||
143245212|NCT04661579|516449649|FG003|Overall Study|Lost to Follow-up|7|||
143499756|NCT01360645|517370495|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
143499757|NCT01360645|517370496|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
143055270|NCT00108082|515741927|FG000|Overall Study|Incorrectly Randomized|0|||
143055271|NCT00108082|515741928|FG001|Overall Study|Incorrectly Randomized|0|||
143055272|NCT00108082|515741929|FG002|Overall Study|Incorrectly Randomized|2|||
143055273|NCT00108082|515741927|FG000|Overall Study|Non-compliance|1|||
143055274|NCT00108082|515741928|FG001|Overall Study|Non-compliance|0|||
143055275|NCT00108082|515741929|FG002|Overall Study|Non-compliance|2|||
143364720|NCT02680756|516878692|FG001|Overall Study|Protocol Violation|0|||
143499758|NCT01360645|517370493|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
143055276|NCT00108082|515741927|FG000|Overall Study|Stopped Study Medication|0|||
143055277|NCT00108082|515741928|FG001|Overall Study|Stopped Study Medication|0|||
143055278|NCT00108082|515741929|FG002|Overall Study|Stopped Study Medication|1|||
143055279|NCT00108082|515741927|FG000|Overall Study|Site Closed Study|0|||
143055280|NCT00108082|515741928|FG001|Overall Study|Site Closed Study|2|||
143245213|NCT04661579|516449650|FG004|Overall Study|Lost to Follow-up|11|||
143245214|NCT04661579|516449646|FG000|Overall Study|Physician Decision|2|||
143055281|NCT00108082|515741929|FG002|Overall Study|Site Closed Study|0|||
143055282|NCT00108082|515741927|FG000|Overall Study|Protocol Amendment|0|||
143055283|NCT00108082|515741928|FG001|Overall Study|Protocol Amendment|1|||
143055284|NCT00108082|515741929|FG002|Overall Study|Protocol Amendment|0|||
143055285|NCT00108082|515741927|FG000|Overall Study|Study Medication Not Tapered|0|||
143055286|NCT00108082|515741928|FG001|Overall Study|Study Medication Not Tapered|1|||
143055287|NCT00108082|515741929|FG002|Overall Study|Study Medication Not Tapered|0|||
143055288|NCT00108082|515741927|FG000|Overall Study|Subject Left Site Location|1|||
143055289|NCT00108082|515741928|FG001|Overall Study|Subject Left Site Location|0|||
143055290|NCT00108082|515741929|FG002|Overall Study|Subject Left Site Location|0|||
143055291|NCT00108082|515741927|FG000|Overall Study|Investigator Not at Site|1|||
143055292|NCT00108082|515741928|FG001|Overall Study|Investigator Not at Site|0|||
143055293|NCT00108082|515741929|FG002|Overall Study|Investigator Not at Site|0|||
143055294|NCT00108082|515741927|FG000|Overall Study|Blood Pressure Not Controlled|1|||
143055295|NCT00108082|515741928|FG001|Overall Study|Blood Pressure Not Controlled|0|||
143055296|NCT00108082|515741929|FG002|Overall Study|Blood Pressure Not Controlled|0|||
143055297|NCT01045707|515741935|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
143055298|NCT01045707|515741936|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
143055299|NCT01045707|515741935|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
143055300|NCT01045707|515741936|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
143055301|NCT01045707|515741935|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
143055302|NCT01045707|515741936|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
143055303|NCT01045707|515741935|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
143499759|NCT01360645|517370494|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
143055304|NCT01045707|515741936|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
143055305|NCT01045707|515741935|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
143055306|NCT01045707|515741936|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
143055307|NCT01045707|515741935|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
143055308|NCT01045707|515741936|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
143055309|NCT01045707|515741935|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
143055310|NCT01045707|515741936|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
143055311|NCT01045707|515741935|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
143055312|NCT01045707|515741936|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
143055313|NCT01045707|515741935|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
143055314|NCT01045707|515741936|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
143499760|NCT01360645|517370495|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
143499761|NCT01360645|517370496|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
143245215|NCT04661579|516449647|FG001|Overall Study|Physician Decision|0|||
143245216|NCT04661579|516449648|FG002|Overall Study|Physician Decision|0|||
143499762|NCT01360645|517370493|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
143055315|NCT00348816|515741937|FG000|Overall Study|Noncompliance with radiation treatment|1|||
143055316|NCT00848042|515741938|FG000|Overall Study|Death|1|||
143055317|NCT00848042|515741939|FG001|Overall Study|Death|2|||
143055318|NCT00848042|515741940|FG002|Overall Study|Death|0|||
143055319|NCT00848042|515741938|FG000|Overall Study|Other Therapy|3|||
143055320|NCT00848042|515741939|FG001|Overall Study|Other Therapy|0|||
143055321|NCT00848042|515741940|FG002|Overall Study|Other Therapy|0|||
143055322|NCT01190930|515741941|FG000|Induction|Adverse Event|17|||
143499763|NCT01360645|517370494|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
143499764|NCT01360645|517370495|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
143499765|NCT01360645|517370496|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
143499766|NCT01360645|517370493|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
143499767|NCT01360645|517370494|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
143499768|NCT01360645|517370495|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
143499769|NCT01360645|517370496|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
143499770|NCT01360645|517370493|FG000|Phase B (6 Weeks)|Adverse Event|0|||
143499771|NCT01360645|517370494|FG001|Phase B (6 Weeks)|Adverse Event|6|||
143499772|NCT01360645|517370495|FG002|Phase B (6 Weeks)|Adverse Event|0|||
143499773|NCT01360645|517370496|FG003|Phase B (6 Weeks)|Adverse Event|0|||
143499774|NCT01360645|517370493|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
143499775|NCT01360645|517370494|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
143499776|NCT01360645|517370495|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
143499777|NCT01360645|517370496|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
143499778|NCT01360645|517370493|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
143499779|NCT01360645|517370494|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
143055323|NCT01190930|515741942|FG001|Induction|Adverse Event|0|||
143055324|NCT01190930|515741943|FG002|Induction|Adverse Event|0|||
143055325|NCT01190930|515741944|FG003|Induction|Adverse Event|0|||
143245217|NCT04661579|516449649|FG003|Overall Study|Physician Decision|1|||
143499780|NCT01360645|517370495|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
143499781|NCT01360645|517370496|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
143245218|NCT04661579|516449650|FG004|Overall Study|Physician Decision|0|||
143245219|NCT04661579|516449646|FG000|Overall Study|Withdrawal by Subject|1|||
143055326|NCT01190930|515741945|FG004|Induction|Adverse Event|0|||
143055327|NCT01190930|515741946|FG005|Induction|Adverse Event|0|||
143055328|NCT01190930|515741947|FG006|Induction|Adverse Event|0|||
143055329|NCT01190930|515741948|FG007|Induction|Adverse Event|0|||
143055330|NCT01190930|515741949|FG008|Induction|Adverse Event|0|||
143245220|NCT04661579|516449647|FG001|Overall Study|Withdrawal by Subject|4|||
143245221|NCT04661579|516449648|FG002|Overall Study|Withdrawal by Subject|0|||
143055331|NCT01190930|515741950|FG009|Induction|Adverse Event|0|||
143055332|NCT01190930|515741941|FG000|Induction|Death|34|||
143055333|NCT01190930|515741942|FG001|Induction|Death|0|||
143055334|NCT01190930|515741943|FG002|Induction|Death|0|||
143055335|NCT01190930|515741944|FG003|Induction|Death|0|||
143055336|NCT01190930|515741945|FG004|Induction|Death|0|||
143055337|NCT01190930|515741946|FG005|Induction|Death|0|||
143055338|NCT01190930|515741947|FG006|Induction|Death|0|||
143055339|NCT01190930|515741948|FG007|Induction|Death|0|||
143055340|NCT01190930|515741949|FG008|Induction|Death|0|||
143055341|NCT01190930|515741950|FG009|Induction|Death|0|||
143055342|NCT01190930|515741941|FG000|Induction|Lost to Follow-up|1|||
143055343|NCT01190930|515741942|FG001|Induction|Lost to Follow-up|0|||
143055344|NCT01190930|515741943|FG002|Induction|Lost to Follow-up|0|||
143055345|NCT01190930|515741944|FG003|Induction|Lost to Follow-up|0|||
143055346|NCT01190930|515741945|FG004|Induction|Lost to Follow-up|0|||
143055347|NCT01190930|515741946|FG005|Induction|Lost to Follow-up|0|||
143055348|NCT01190930|515741947|FG006|Induction|Lost to Follow-up|0|||
143055349|NCT01190930|515741948|FG007|Induction|Lost to Follow-up|0|||
143055350|NCT01190930|515741949|FG008|Induction|Lost to Follow-up|0|||
143055351|NCT01190930|515741950|FG009|Induction|Lost to Follow-up|0|||
143055352|NCT01190930|515741941|FG000|Induction|Physician Decision|125|||
143055353|NCT01190930|515741942|FG001|Induction|Physician Decision|3|||
143055354|NCT01190930|515741943|FG002|Induction|Physician Decision|0|||
143055355|NCT01190930|515741944|FG003|Induction|Physician Decision|0|||
143055356|NCT01190930|515741945|FG004|Induction|Physician Decision|0|||
143055357|NCT01190930|515741946|FG005|Induction|Physician Decision|0|||
143055358|NCT01190930|515741947|FG006|Induction|Physician Decision|0|||
143055359|NCT01190930|515741948|FG007|Induction|Physician Decision|0|||
143055360|NCT01190930|515741949|FG008|Induction|Physician Decision|0|||
143055361|NCT01190930|515741950|FG009|Induction|Physician Decision|0|||
143055362|NCT01190930|515741941|FG000|Induction|Withdrawal by Subject|9|||
143055363|NCT01190930|515741942|FG001|Induction|Withdrawal by Subject|0|||
143055364|NCT01190930|515741943|FG002|Induction|Withdrawal by Subject|0|||
143055365|NCT01190930|515741944|FG003|Induction|Withdrawal by Subject|0|||
143055366|NCT01190930|515741945|FG004|Induction|Withdrawal by Subject|0|||
143055367|NCT01190930|515741946|FG005|Induction|Withdrawal by Subject|0|||
143055368|NCT01190930|515741947|FG006|Induction|Withdrawal by Subject|0|||
143055369|NCT01190930|515741948|FG007|Induction|Withdrawal by Subject|0|||
143055370|NCT01190930|515741949|FG008|Induction|Withdrawal by Subject|0|||
143055371|NCT01190930|515741950|FG009|Induction|Withdrawal by Subject|0|||
143055372|NCT01190930|515741941|FG000|Induction|Refusal|235|||
143055373|NCT01190930|515741942|FG001|Induction|Refusal|0|||
143055374|NCT01190930|515741943|FG002|Induction|Refusal|0|||
143055375|NCT01190930|515741944|FG003|Induction|Refusal|0|||
143055376|NCT01190930|515741945|FG004|Induction|Refusal|0|||
143055377|NCT01190930|515741946|FG005|Induction|Refusal|0|||
143055378|NCT01190930|515741947|FG006|Induction|Refusal|0|||
143055379|NCT01190930|515741948|FG007|Induction|Refusal|0|||
143055380|NCT01190930|515741949|FG008|Induction|Refusal|0|||
143055381|NCT01190930|515741950|FG009|Induction|Refusal|0|||
143055382|NCT01190930|515741941|FG000|Induction|Inevaluable|23|||
143055383|NCT01190930|515741942|FG001|Induction|Inevaluable|1|||
143055384|NCT01190930|515741943|FG002|Induction|Inevaluable|0|||
143055385|NCT01190930|515741944|FG003|Induction|Inevaluable|0|||
143055386|NCT01190930|515741945|FG004|Induction|Inevaluable|0|||
143055387|NCT01190930|515741946|FG005|Induction|Inevaluable|0|||
143055388|NCT01190930|515741947|FG006|Induction|Inevaluable|0|||
143055389|NCT01190930|515741948|FG007|Induction|Inevaluable|0|||
143055390|NCT01190930|515741949|FG008|Induction|Inevaluable|0|||
143055391|NCT01190930|515741950|FG009|Induction|Inevaluable|0|||
143055392|NCT01190930|515741941|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
143055393|NCT01190930|515741942|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
143055394|NCT01190930|515741943|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
143055395|NCT01190930|515741944|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
143055396|NCT01190930|515741945|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
143055397|NCT01190930|515741946|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
143055398|NCT01190930|515741947|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
143055399|NCT01190930|515741948|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
143055400|NCT01190930|515741949|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
143055401|NCT01190930|515741950|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
143055402|NCT01190930|515741941|FG000|Induction|High Risk Downs|80|||
143055403|NCT01190930|515741942|FG001|Induction|High Risk Downs|0|||
143055404|NCT01190930|515741943|FG002|Induction|High Risk Downs|0|||
143055405|NCT01190930|515741944|FG003|Induction|High Risk Downs|0|||
143055406|NCT01190930|515741945|FG004|Induction|High Risk Downs|0|||
143055407|NCT01190930|515741946|FG005|Induction|High Risk Downs|0|||
143055408|NCT01190930|515741947|FG006|Induction|High Risk Downs|0|||
143055409|NCT01190930|515741948|FG007|Induction|High Risk Downs|0|||
143055410|NCT01190930|515741949|FG008|Induction|High Risk Downs|0|||
143055411|NCT01190930|515741950|FG009|Induction|High Risk Downs|0|||
143055412|NCT01190930|515741941|FG000|Induction|Enrollment onto another COG Protocol|1|||
143055413|NCT01190930|515741942|FG001|Induction|Enrollment onto another COG Protocol|0|||
143055414|NCT01190930|515741943|FG002|Induction|Enrollment onto another COG Protocol|0|||
143055415|NCT01190930|515741944|FG003|Induction|Enrollment onto another COG Protocol|0|||
143055416|NCT01190930|515741945|FG004|Induction|Enrollment onto another COG Protocol|0|||
143055417|NCT01190930|515741946|FG005|Induction|Enrollment onto another COG Protocol|0|||
143055418|NCT01190930|515741947|FG006|Induction|Enrollment onto another COG Protocol|0|||
143055419|NCT01190930|515741948|FG007|Induction|Enrollment onto another COG Protocol|0|||
143055420|NCT01190930|515741949|FG008|Induction|Enrollment onto another COG Protocol|0|||
143055421|NCT01190930|515741950|FG009|Induction|Enrollment onto another COG Protocol|0|||
143055422|NCT01190930|515741941|FG000|Induction|Average Risk|1847|||
143055423|NCT01190930|515741942|FG001|Induction|Average Risk|0|||
143055424|NCT01190930|515741943|FG002|Induction|Average Risk|0|||
143055425|NCT01190930|515741944|FG003|Induction|Average Risk|0|||
143055426|NCT01190930|515741945|FG004|Induction|Average Risk|0|||
143055427|NCT01190930|515741946|FG005|Induction|Average Risk|0|||
143055428|NCT01190930|515741947|FG006|Induction|Average Risk|0|||
143055429|NCT01190930|515741948|FG007|Induction|Average Risk|0|||
143055430|NCT01190930|515741949|FG008|Induction|Average Risk|0|||
143055431|NCT01190930|515741950|FG009|Induction|Average Risk|0|||
143055432|NCT01190930|515741941|FG000|Induction|High Risk|1227|||
143055433|NCT01190930|515741942|FG001|Induction|High Risk|0|||
143055434|NCT01190930|515741943|FG002|Induction|High Risk|0|||
143055435|NCT01190930|515741944|FG003|Induction|High Risk|0|||
143055436|NCT01190930|515741945|FG004|Induction|High Risk|0|||
143055437|NCT01190930|515741946|FG005|Induction|High Risk|0|||
143055438|NCT01190930|515741947|FG006|Induction|High Risk|0|||
143055439|NCT01190930|515741948|FG007|Induction|High Risk|0|||
143055440|NCT01190930|515741949|FG008|Induction|High Risk|0|||
143055441|NCT01190930|515741950|FG009|Induction|High Risk|0|||
143055442|NCT01190930|515741941|FG000|Induction|Low Risk|443|||
143055443|NCT01190930|515741942|FG001|Induction|Low Risk|0|||
143055444|NCT01190930|515741943|FG002|Induction|Low Risk|0|||
143055445|NCT01190930|515741944|FG003|Induction|Low Risk|0|||
143055446|NCT01190930|515741945|FG004|Induction|Low Risk|0|||
143055447|NCT01190930|515741946|FG005|Induction|Low Risk|0|||
143055448|NCT01190930|515741947|FG006|Induction|Low Risk|0|||
143055449|NCT01190930|515741948|FG007|Induction|Low Risk|0|||
143055450|NCT01190930|515741949|FG008|Induction|Low Risk|0|||
143055451|NCT01190930|515741950|FG009|Induction|Low Risk|0|||
143055452|NCT01190930|515741941|FG000|Induction|Very High Risk|1012|||
143055453|NCT01190930|515741942|FG001|Induction|Very High Risk|0|||
143055454|NCT01190930|515741943|FG002|Induction|Very High Risk|0|||
143055455|NCT01190930|515741944|FG003|Induction|Very High Risk|0|||
143055456|NCT01190930|515741945|FG004|Induction|Very High Risk|0|||
143055457|NCT01190930|515741946|FG005|Induction|Very High Risk|0|||
143055458|NCT01190930|515741947|FG006|Induction|Very High Risk|0|||
143055459|NCT01190930|515741948|FG007|Induction|Very High Risk|0|||
143055460|NCT01190930|515741949|FG008|Induction|Very High Risk|0|||
143055461|NCT01190930|515741950|FG009|Induction|Very High Risk|0|||
143055462|NCT01190930|515741941|FG000|Induction|Philadelphia chromosome-positive|99|||
143055463|NCT01190930|515741942|FG001|Induction|Philadelphia chromosome-positive|0|||
143055464|NCT01190930|515741943|FG002|Induction|Philadelphia chromosome-positive|0|||
143055465|NCT01190930|515741944|FG003|Induction|Philadelphia chromosome-positive|0|||
143055466|NCT01190930|515741945|FG004|Induction|Philadelphia chromosome-positive|0|||
143055467|NCT01190930|515741946|FG005|Induction|Philadelphia chromosome-positive|0|||
143055468|NCT01190930|515741947|FG006|Induction|Philadelphia chromosome-positive|0|||
143055469|NCT01190930|515741948|FG007|Induction|Philadelphia chromosome-positive|0|||
143055470|NCT01190930|515741949|FG008|Induction|Philadelphia chromosome-positive|0|||
143055471|NCT01190930|515741950|FG009|Induction|Philadelphia chromosome-positive|0|||
143055472|NCT01190930|515741941|FG000|Induction|Incomplete Induction data|63|||
143055473|NCT01190930|515741942|FG001|Induction|Incomplete Induction data|0|||
143055474|NCT01190930|515741943|FG002|Induction|Incomplete Induction data|0|||
143055475|NCT01190930|515741944|FG003|Induction|Incomplete Induction data|0|||
143055476|NCT01190930|515741945|FG004|Induction|Incomplete Induction data|0|||
143364721|NCT02680756|516878691|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
143055477|NCT01190930|515741946|FG005|Induction|Incomplete Induction data|0|||
143055478|NCT01190930|515741947|FG006|Induction|Incomplete Induction data|0|||
143055479|NCT01190930|515741948|FG007|Induction|Incomplete Induction data|0|||
143055480|NCT01190930|515741949|FG008|Induction|Incomplete Induction data|0|||
143055481|NCT01190930|515741950|FG009|Induction|Incomplete Induction data|0|||
143055482|NCT01190930|515741941|FG000|Induction|Progressive disease|0|||
143055483|NCT01190930|515741942|FG001|Induction|Progressive disease|1|||
143055484|NCT01190930|515741943|FG002|Induction|Progressive disease|0|||
143055485|NCT01190930|515741944|FG003|Induction|Progressive disease|0|||
143055486|NCT01190930|515741945|FG004|Induction|Progressive disease|0|||
143055487|NCT01190930|515741946|FG005|Induction|Progressive disease|0|||
143055488|NCT01190930|515741947|FG006|Induction|Progressive disease|0|||
143055489|NCT01190930|515741948|FG007|Induction|Progressive disease|0|||
143055490|NCT01190930|515741949|FG008|Induction|Progressive disease|0|||
143055491|NCT01190930|515741950|FG009|Induction|Progressive disease|0|||
143055492|NCT01190930|515741941|FG000|Induction|No treatment|3|||
143055493|NCT01190930|515741942|FG001|Induction|No treatment|0|||
143055494|NCT01190930|515741943|FG002|Induction|No treatment|0|||
143055495|NCT01190930|515741944|FG003|Induction|No treatment|0|||
143055496|NCT01190930|515741945|FG004|Induction|No treatment|0|||
143055497|NCT01190930|515741946|FG005|Induction|No treatment|0|||
143055498|NCT01190930|515741947|FG006|Induction|No treatment|0|||
143055499|NCT01190930|515741948|FG007|Induction|No treatment|0|||
143055500|NCT01190930|515741949|FG008|Induction|No treatment|0|||
143055501|NCT01190930|515741950|FG009|Induction|No treatment|0|||
143055502|NCT01190930|515741941|FG000|Induction|Ineligible|69|||
143055503|NCT01190930|515741942|FG001|Induction|Ineligible|4|||
143055504|NCT01190930|515741943|FG002|Induction|Ineligible|0|||
143055505|NCT01190930|515741944|FG003|Induction|Ineligible|0|||
143055506|NCT01190930|515741945|FG004|Induction|Ineligible|0|||
143055507|NCT01190930|515741946|FG005|Induction|Ineligible|0|||
143055508|NCT01190930|515741947|FG006|Induction|Ineligible|0|||
143055509|NCT01190930|515741948|FG007|Induction|Ineligible|0|||
143055510|NCT01190930|515741949|FG008|Induction|Ineligible|0|||
143055511|NCT01190930|515741950|FG009|Induction|Ineligible|0|||
143055512|NCT01190930|515741941|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
143055513|NCT01190930|515741942|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
143055514|NCT01190930|515741943|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
143055515|NCT01190930|515741944|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
143055516|NCT01190930|515741945|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
143055517|NCT01190930|515741946|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
143055518|NCT01190930|515741947|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
143055519|NCT01190930|515741948|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
143055520|NCT01190930|515741949|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
143055521|NCT01190930|515741950|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
143055522|NCT01190930|515741941|FG000|Post Induction Pre-Maintenance|Death|0|||
143055523|NCT01190930|515741942|FG001|Post Induction Pre-Maintenance|Death|0|||
143055524|NCT01190930|515741943|FG002|Post Induction Pre-Maintenance|Death|8|||
143055525|NCT01190930|515741944|FG003|Post Induction Pre-Maintenance|Death|4|||
143055526|NCT01190930|515741945|FG004|Post Induction Pre-Maintenance|Death|0|||
143055527|NCT01190930|515741946|FG005|Post Induction Pre-Maintenance|Death|0|||
143055528|NCT01190930|515741947|FG006|Post Induction Pre-Maintenance|Death|0|||
143055529|NCT01190930|515741948|FG007|Post Induction Pre-Maintenance|Death|0|||
143055530|NCT01190930|515741949|FG008|Post Induction Pre-Maintenance|Death|0|||
143055531|NCT01190930|515741950|FG009|Post Induction Pre-Maintenance|Death|0|||
143055532|NCT01190930|515741941|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
143055533|NCT01190930|515741942|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
143055534|NCT01190930|515741943|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
143055535|NCT01190930|515741944|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
143055536|NCT01190930|515741945|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
143055537|NCT01190930|515741946|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
143055538|NCT01190930|515741947|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
143055539|NCT01190930|515741948|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
143055540|NCT01190930|515741949|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
143055541|NCT01190930|515741950|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
143055542|NCT01190930|515741941|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
143055543|NCT01190930|515741942|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
143055544|NCT01190930|515741943|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
143055545|NCT01190930|515741944|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
143055546|NCT01190930|515741945|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
143055547|NCT01190930|515741946|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
143055548|NCT01190930|515741947|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
143055549|NCT01190930|515741948|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
143055550|NCT01190930|515741949|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
143055551|NCT01190930|515741950|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
143055552|NCT01190930|515741941|FG000|Post Induction Pre-Maintenance|Refusal|0|||
143055553|NCT01190930|515741942|FG001|Post Induction Pre-Maintenance|Refusal|2|||
143055554|NCT01190930|515741943|FG002|Post Induction Pre-Maintenance|Refusal|694|||
143055555|NCT01190930|515741944|FG003|Post Induction Pre-Maintenance|Refusal|4|||
143055556|NCT01190930|515741945|FG004|Post Induction Pre-Maintenance|Refusal|0|||
143055557|NCT01190930|515741946|FG005|Post Induction Pre-Maintenance|Refusal|3|||
143055558|NCT01190930|515741947|FG006|Post Induction Pre-Maintenance|Refusal|0|||
143055559|NCT01190930|515741948|FG007|Post Induction Pre-Maintenance|Refusal|0|||
143364722|NCT02680756|516878692|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
143364723|NCT02680756|516878691|FG000|Overall Study|None of above or not recorded|3|||
143364724|NCT02680756|516878692|FG001|Overall Study|None of above or not recorded|2|||
143364725|NCT00480441|516878693|FG000|Screening|Not Eligible|37|||
143055560|NCT01190930|515741949|FG008|Post Induction Pre-Maintenance|Refusal|0|||
143364726|NCT00480441|516878694|FG001|Screening|Not Eligible|0|||
143055561|NCT01190930|515741950|FG009|Post Induction Pre-Maintenance|Refusal|0|||
143055562|NCT01190930|515741941|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
143055563|NCT01190930|515741942|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
143055564|NCT01190930|515741943|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
143055565|NCT01190930|515741944|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
143055566|NCT01190930|515741945|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
143055567|NCT01190930|515741946|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
143055568|NCT01190930|515741947|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
143055569|NCT01190930|515741948|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
143055570|NCT01190930|515741949|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
143364727|NCT00480441|516878695|FG002|Screening|Not Eligible|0|||
143364728|NCT00480441|516878693|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
143364729|NCT00480441|516878694|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
143364730|NCT00480441|516878695|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
143364731|NCT00480441|516878693|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
143364732|NCT00480441|516878694|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
143364733|NCT00480441|516878695|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
143364734|NCT00480441|516878693|FG000|Baseline Functional MRI|physical contraindication|4|||
143364735|NCT00480441|516878694|FG001|Baseline Functional MRI|physical contraindication|0|||
143364736|NCT00480441|516878695|FG002|Baseline Functional MRI|physical contraindication|0|||
143364737|NCT00480441|516878693|FG000|Randomization|Lost to Follow-up|0|||
143364738|NCT00480441|516878694|FG001|Randomization|Lost to Follow-up|7|||
143364739|NCT00480441|516878695|FG002|Randomization|Lost to Follow-up|2|||
143364740|NCT02095158|516878703|FG000|Overall Study|Adverse Event|14|||
143364741|NCT02095158|516878703|FG000|Overall Study|Lack of Efficacy|3|||
143364742|NCT02095158|516878703|FG000|Overall Study|Pregnancy|1|||
143364743|NCT02095158|516878703|FG000|Overall Study|Lost to Follow-up|20|||
143364744|NCT02095158|516878703|FG000|Overall Study|Personal Reasons|35|||
143499782|NCT01360645|517370493|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
143499783|NCT01360645|517370494|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
143499784|NCT01360645|517370495|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
143499785|NCT01360645|517370496|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
143499786|NCT01360645|517370493|FG000|Phase A+|Lost to Follow-up|0|||
143055571|NCT01190930|515741950|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
143055572|NCT01190930|515741941|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
143055573|NCT01190930|515741942|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
143055574|NCT01190930|515741943|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
143055575|NCT01190930|515741944|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
143055576|NCT01190930|515741945|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
143055577|NCT01190930|515741946|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
143055578|NCT01190930|515741947|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
143055579|NCT01190930|515741948|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
143364745|NCT02095158|516878703|FG000|Overall Study|Protocol Violation|1|||
143364746|NCT02095158|516878703|FG000|Overall Study|Other Miscellaneous Reasons|1|||
143364747|NCT02282527|516878704|FG000|Overall Study|Lost to Follow-up|0|||
143364748|NCT02282527|516878705|FG001|Overall Study|Lost to Follow-up|1|||
143055580|NCT01190930|515741949|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
143055581|NCT01190930|515741950|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
143364749|NCT02282527|516878704|FG000|Overall Study|Lack of home health aid|1|||
143364750|NCT02282527|516878705|FG001|Overall Study|Lack of home health aid|0|||
143364751|NCT00941031|516878706|FG000|Induction Period|Lack of Efficacy|2|||
143364752|NCT00941031|516878707|FG001|Induction Period|Lack of Efficacy|1|||
143364753|NCT00941031|516878708|FG002|Induction Period|Lack of Efficacy|0|||
143364754|NCT00941031|516878709|FG003|Induction Period|Lack of Efficacy|5|||
143364755|NCT00941031|516878710|FG004|Induction Period|Lack of Efficacy|0|||
143364756|NCT00941031|516878711|FG005|Induction Period|Lack of Efficacy|0|||
143364757|NCT00941031|516878712|FG006|Induction Period|Lack of Efficacy|0|||
143055582|NCT01190930|515741941|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
143169519|NCT02958865|516169889|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
143169520|NCT02958865|516169890|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
143499787|NCT01360645|517370494|FG001|Phase A+|Lost to Follow-up|0|||
143499788|NCT01360645|517370495|FG002|Phase A+|Lost to Follow-up|0|||
143364758|NCT00941031|516878706|FG000|Induction Period|Withdrawal by Subject|1|||
143364759|NCT00941031|516878707|FG001|Induction Period|Withdrawal by Subject|2|||
143364760|NCT00941031|516878708|FG002|Induction Period|Withdrawal by Subject|2|||
143364761|NCT00941031|516878709|FG003|Induction Period|Withdrawal by Subject|2|||
143055583|NCT01190930|515741942|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
143055584|NCT01190930|515741943|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
143055585|NCT01190930|515741944|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
143055586|NCT01190930|515741945|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
143055587|NCT01190930|515741946|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
143055588|NCT01190930|515741947|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
143055589|NCT01190930|515741948|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
143055590|NCT01190930|515741949|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
143055591|NCT01190930|515741950|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
143055592|NCT01190930|515741941|FG000|Post Induction Pre-Maintenance|Relapse|0|||
143055593|NCT01190930|515741942|FG001|Post Induction Pre-Maintenance|Relapse|0|||
143055594|NCT01190930|515741943|FG002|Post Induction Pre-Maintenance|Relapse|1|||
143055595|NCT01190930|515741944|FG003|Post Induction Pre-Maintenance|Relapse|0|||
143055596|NCT01190930|515741945|FG004|Post Induction Pre-Maintenance|Relapse|0|||
143055597|NCT01190930|515741946|FG005|Post Induction Pre-Maintenance|Relapse|0|||
143055598|NCT01190930|515741947|FG006|Post Induction Pre-Maintenance|Relapse|0|||
143055599|NCT01190930|515741948|FG007|Post Induction Pre-Maintenance|Relapse|0|||
143055600|NCT01190930|515741949|FG008|Post Induction Pre-Maintenance|Relapse|0|||
143055601|NCT01190930|515741950|FG009|Post Induction Pre-Maintenance|Relapse|0|||
143055602|NCT01190930|515741941|FG000|Maintenance|Adverse Event|0|||
143055603|NCT01190930|515741942|FG001|Maintenance|Adverse Event|0|||
143055604|NCT01190930|515741943|FG002|Maintenance|Adverse Event|0|||
143055605|NCT01190930|515741944|FG003|Maintenance|Adverse Event|0|||
143055606|NCT01190930|515741945|FG004|Maintenance|Adverse Event|0|||
143055607|NCT01190930|515741946|FG005|Maintenance|Adverse Event|1|||
143055608|NCT01190930|515741947|FG006|Maintenance|Adverse Event|1|||
143055609|NCT01190930|515741948|FG007|Maintenance|Adverse Event|3|||
143055610|NCT01190930|515741949|FG008|Maintenance|Adverse Event|3|||
143055611|NCT01190930|515741950|FG009|Maintenance|Adverse Event|0|||
143055612|NCT01190930|515741941|FG000|Maintenance|Death|0|||
143055613|NCT01190930|515741942|FG001|Maintenance|Death|0|||
143055614|NCT01190930|515741943|FG002|Maintenance|Death|0|||
143055615|NCT01190930|515741944|FG003|Maintenance|Death|1|||
143055616|NCT01190930|515741945|FG004|Maintenance|Death|0|||
143055617|NCT01190930|515741946|FG005|Maintenance|Death|0|||
143055618|NCT01190930|515741947|FG006|Maintenance|Death|2|||
143055619|NCT01190930|515741948|FG007|Maintenance|Death|2|||
143055620|NCT01190930|515741949|FG008|Maintenance|Death|2|||
143055621|NCT01190930|515741950|FG009|Maintenance|Death|2|||
143055622|NCT01190930|515741941|FG000|Maintenance|Lost to Follow-up|0|||
143055623|NCT01190930|515741942|FG001|Maintenance|Lost to Follow-up|0|||
143055624|NCT01190930|515741943|FG002|Maintenance|Lost to Follow-up|0|||
143055625|NCT01190930|515741944|FG003|Maintenance|Lost to Follow-up|0|||
143055626|NCT01190930|515741945|FG004|Maintenance|Lost to Follow-up|0|||
143055627|NCT01190930|515741946|FG005|Maintenance|Lost to Follow-up|0|||
143055628|NCT01190930|515741947|FG006|Maintenance|Lost to Follow-up|1|||
143055629|NCT01190930|515741948|FG007|Maintenance|Lost to Follow-up|1|||
143055630|NCT01190930|515741949|FG008|Maintenance|Lost to Follow-up|1|||
143055631|NCT01190930|515741950|FG009|Maintenance|Lost to Follow-up|0|||
143055632|NCT01190930|515741941|FG000|Maintenance|Physician Decision|0|||
143055633|NCT01190930|515741942|FG001|Maintenance|Physician Decision|1|||
143055634|NCT01190930|515741943|FG002|Maintenance|Physician Decision|0|||
143055635|NCT01190930|515741944|FG003|Maintenance|Physician Decision|5|||
143055636|NCT01190930|515741945|FG004|Maintenance|Physician Decision|9|||
143055637|NCT01190930|515741946|FG005|Maintenance|Physician Decision|4|||
143055638|NCT01190930|515741947|FG006|Maintenance|Physician Decision|8|||
143055639|NCT01190930|515741948|FG007|Maintenance|Physician Decision|8|||
143055640|NCT01190930|515741949|FG008|Maintenance|Physician Decision|10|||
143055641|NCT01190930|515741950|FG009|Maintenance|Physician Decision|17|||
143055642|NCT01190930|515741941|FG000|Maintenance|Withdrawal by Subject|0|||
143055643|NCT01190930|515741942|FG001|Maintenance|Withdrawal by Subject|0|||
143055644|NCT01190930|515741943|FG002|Maintenance|Withdrawal by Subject|0|||
143055645|NCT01190930|515741944|FG003|Maintenance|Withdrawal by Subject|0|||
143055646|NCT01190930|515741945|FG004|Maintenance|Withdrawal by Subject|0|||
143055647|NCT01190930|515741946|FG005|Maintenance|Withdrawal by Subject|0|||
143055648|NCT01190930|515741947|FG006|Maintenance|Withdrawal by Subject|2|||
143055649|NCT01190930|515741948|FG007|Maintenance|Withdrawal by Subject|1|||
143055650|NCT01190930|515741949|FG008|Maintenance|Withdrawal by Subject|4|||
143055651|NCT01190930|515741950|FG009|Maintenance|Withdrawal by Subject|1|||
143055652|NCT01190930|515741941|FG000|Maintenance|Refusal|0|||
143055653|NCT01190930|515741942|FG001|Maintenance|Refusal|1|||
143055654|NCT01190930|515741943|FG002|Maintenance|Refusal|0|||
143055655|NCT01190930|515741944|FG003|Maintenance|Refusal|2|||
143055656|NCT01190930|515741945|FG004|Maintenance|Refusal|0|||
143055657|NCT01190930|515741946|FG005|Maintenance|Refusal|4|||
143169521|NCT02958865|516169891|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
143055658|NCT01190930|515741947|FG006|Maintenance|Refusal|5|||
143055659|NCT01190930|515741948|FG007|Maintenance|Refusal|17|||
143055660|NCT01190930|515741949|FG008|Maintenance|Refusal|13|||
143055661|NCT01190930|515741950|FG009|Maintenance|Refusal|6|||
143055662|NCT01190930|515741941|FG000|Maintenance|second malignant neoplasm|0|||
143055663|NCT01190930|515741942|FG001|Maintenance|second malignant neoplasm|0|||
143055664|NCT01190930|515741943|FG002|Maintenance|second malignant neoplasm|0|||
143055665|NCT01190930|515741944|FG003|Maintenance|second malignant neoplasm|1|||
143055666|NCT01190930|515741945|FG004|Maintenance|second malignant neoplasm|0|||
143055667|NCT01190930|515741946|FG005|Maintenance|second malignant neoplasm|1|||
143055668|NCT01190930|515741947|FG006|Maintenance|second malignant neoplasm|0|||
143055669|NCT01190930|515741948|FG007|Maintenance|second malignant neoplasm|0|||
143055670|NCT01190930|515741949|FG008|Maintenance|second malignant neoplasm|1|||
143055671|NCT01190930|515741950|FG009|Maintenance|second malignant neoplasm|0|||
143055672|NCT01190930|515741941|FG000|Maintenance|Inevaluable|0|||
143055673|NCT01190930|515741942|FG001|Maintenance|Inevaluable|0|||
143055674|NCT01190930|515741943|FG002|Maintenance|Inevaluable|0|||
143055675|NCT01190930|515741944|FG003|Maintenance|Inevaluable|0|||
143055676|NCT01190930|515741945|FG004|Maintenance|Inevaluable|0|||
143055677|NCT01190930|515741946|FG005|Maintenance|Inevaluable|1|||
143055678|NCT01190930|515741947|FG006|Maintenance|Inevaluable|1|||
143055679|NCT01190930|515741948|FG007|Maintenance|Inevaluable|1|||
143055680|NCT01190930|515741949|FG008|Maintenance|Inevaluable|0|||
143055681|NCT01190930|515741950|FG009|Maintenance|Inevaluable|0|||
143055682|NCT01190930|515741941|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
143055683|NCT01190930|515741942|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
143055684|NCT01190930|515741943|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
143055685|NCT01190930|515741944|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
143055686|NCT01190930|515741945|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
143055687|NCT01190930|515741946|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
143055688|NCT01190930|515741947|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
143055689|NCT01190930|515741948|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
143055690|NCT01190930|515741949|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
143055691|NCT01190930|515741950|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
143055692|NCT01190930|515741941|FG000|Maintenance|Relapse|0|||
143055693|NCT01190930|515741942|FG001|Maintenance|Relapse|0|||
143055694|NCT01190930|515741943|FG002|Maintenance|Relapse|0|||
143055695|NCT01190930|515741944|FG003|Maintenance|Relapse|2|||
143055696|NCT01190930|515741945|FG004|Maintenance|Relapse|0|||
143055697|NCT01190930|515741946|FG005|Maintenance|Relapse|1|||
143055698|NCT01190930|515741947|FG006|Maintenance|Relapse|6|||
143055699|NCT01190930|515741948|FG007|Maintenance|Relapse|13|||
143055700|NCT01190930|515741949|FG008|Maintenance|Relapse|11|||
143055701|NCT01190930|515741950|FG009|Maintenance|Relapse|11|||
143055702|NCT01190930|515741941|FG000|Maintenance|Still on therapy|0|||
143055703|NCT01190930|515741942|FG001|Maintenance|Still on therapy|8|||
143055704|NCT01190930|515741943|FG002|Maintenance|Still on therapy|0|||
143055705|NCT01190930|515741944|FG003|Maintenance|Still on therapy|29|||
143055706|NCT01190930|515741945|FG004|Maintenance|Still on therapy|0|||
143055707|NCT01190930|515741946|FG005|Maintenance|Still on therapy|0|||
143055708|NCT01190930|515741947|FG006|Maintenance|Still on therapy|0|||
143055709|NCT01190930|515741948|FG007|Maintenance|Still on therapy|0|||
143055710|NCT01190930|515741949|FG008|Maintenance|Still on therapy|0|||
143055711|NCT01190930|515741950|FG009|Maintenance|Still on therapy|0|||
143055712|NCT00979212|515741953|FG000|Overall Study|Protocol Violation|1|||
143055713|NCT00979212|515741954|FG001|Overall Study|Protocol Violation|8|||
143055714|NCT00979212|515741953|FG000|Overall Study|No protocol therapy received|1|||
143055715|NCT00979212|515741954|FG001|Overall Study|No protocol therapy received|0|||
143055716|NCT04886063|515741957|FG000|Overall Study|Adverse Event|50|||
143055717|NCT04886063|515741957|FG000|Overall Study|Lack of Efficacy|31|||
143055718|NCT04886063|515741957|FG000|Overall Study|Withdrawal by Subject|45|||
143055719|NCT04886063|515741957|FG000|Overall Study|Physician Decision|3|||
143055720|NCT04886063|515741957|FG000|Overall Study|Protocol Violation|3|||
143055721|NCT04886063|515741957|FG000|Overall Study|Site closure|4|||
143055722|NCT04886063|515741957|FG000|Overall Study|Nursing home replacement|3|||
143055723|NCT04886063|515741957|FG000|Overall Study|Lost to Follow-up|5|||
143055724|NCT04886063|515741957|FG000|Overall Study|Early study termination or other undetermined reasons|224|||
143055725|NCT04886063|515741957|FG000|Overall Study|>1 reason|20|||
143055726|NCT00177164|515741960|FG000|Overall Study|Protocol Violation|0|||
143055727|NCT00177164|515741961|FG001|Overall Study|Protocol Violation|7|||
143055728|NCT00177164|515741960|FG000|Overall Study|Lost to Follow-up|4|||
143055729|NCT00177164|515741961|FG001|Overall Study|Lost to Follow-up|5|||
143055730|NCT00177164|515741960|FG000|Overall Study|increase in alcohol and drug use|1|||
143055731|NCT00177164|515741961|FG001|Overall Study|increase in alcohol and drug use|2|||
143055732|NCT00177164|515741960|FG000|Overall Study|Adverse Event|1|||
143055733|NCT00177164|515741961|FG001|Overall Study|Adverse Event|0|||
143055734|NCT00177164|515741960|FG000|Overall Study|discharge from hospital|1|||
143055735|NCT00177164|515741961|FG001|Overall Study|discharge from hospital|0|||
143055736|NCT00177164|515741960|FG000|Overall Study|Lack of Efficacy|2|||
143055737|NCT00177164|515741961|FG001|Overall Study|Lack of Efficacy|1|||
143055738|NCT00177164|515741960|FG000|Overall Study|Pregnancy|0|||
143055739|NCT00177164|515741961|FG001|Overall Study|Pregnancy|1|||
143055740|NCT05070754|515741965|FG000|Overall Study|Withdrawal by Subject|0|||
143055741|NCT05070754|515741966|FG001|Overall Study|Withdrawal by Subject|0|||
143055742|NCT05070754|515741967|FG002|Overall Study|Withdrawal by Subject|0|||
143055743|NCT05070754|515741968|FG003|Overall Study|Withdrawal by Subject|1|||
143055744|NCT05070754|515741965|FG000|Overall Study|Protocol Violation|0|||
143055745|NCT05070754|515741966|FG001|Overall Study|Protocol Violation|0|||
143055746|NCT05070754|515741967|FG002|Overall Study|Protocol Violation|0|||
143055747|NCT05070754|515741968|FG003|Overall Study|Protocol Violation|1|||
143055748|NCT01398787|515741969|FG000|Overall Study|Adverse Event|1|||
143055749|NCT02351167|515741970|FG000|Overall Study|Withdrawal by Subject|19|||
143055750|NCT02351167|515741971|FG001|Overall Study|Withdrawal by Subject|18|||
143055751|NCT02351167|515741972|FG002|Overall Study|Withdrawal by Subject|21|||
143055752|NCT02448563|515741975|FG000|Overall Study|Lost to Follow-up|16|||
143055753|NCT02448563|515741976|FG001|Overall Study|Lost to Follow-up|10|||
143055754|NCT02448563|515741975|FG000|Overall Study|Withdrawal by Subject|0|||
143055755|NCT02448563|515741976|FG001|Overall Study|Withdrawal by Subject|1|||
143055756|NCT00113919|515741978|FG000|Overall Study|Physician Decision|8|||
143055757|NCT00113919|515741978|FG000|Overall Study|Death|6|||
143055758|NCT02914457|515741979|FG000|Overall Study|Withdrawal by Subject|1|||
143055759|NCT02914457|515741979|FG000|Overall Study|Physician Decision|1|||
143055760|NCT02914457|515741979|FG000|Overall Study|No veins available for lead placement|1|||
143055761|NCT02914457|515741979|FG000|Overall Study|Electrical instability of patient|1|||
143055762|NCT02914457|515741979|FG000|Overall Study|ECG acquisition error due to sweating|1|||
143055763|NCT02914457|515741979|FG000|Overall Study|Protocol Violation|1|||
143055764|NCT02661022|515741983|FG000|Overall Study|Withdrawal by Subject|3|||
143055765|NCT02661022|515741984|FG001|Overall Study|Withdrawal by Subject|0|||
143055766|NCT02661022|515741983|FG000|Overall Study|Adverse Event|1|||
143055767|NCT02661022|515741984|FG001|Overall Study|Adverse Event|1|||
143055768|NCT02661022|515741983|FG000|Overall Study|Physician Decision|1|||
143055769|NCT02661022|515741984|FG001|Overall Study|Physician Decision|0|||
143055770|NCT02661022|515741983|FG000|Overall Study|Progressive Disease|2|||
143055771|NCT02661022|515741984|FG001|Overall Study|Progressive Disease|1|||
143055772|NCT01055886|515741985|FG000|Overall Study|Withdrawal by Subject|4|||
143055773|NCT01055886|515741986|FG001|Overall Study|Withdrawal by Subject|9|||
143055774|NCT01055886|515741985|FG000|Overall Study|Lost to Follow-up|1|||
143055775|NCT01055886|515741986|FG001|Overall Study|Lost to Follow-up|1|||
143055776|NCT01055886|515741985|FG000|Overall Study|Withdrawal by PI|0|||
143055777|NCT01055886|515741986|FG001|Overall Study|Withdrawal by PI|1|||
143055778|NCT04531527|515741987|FG000|Overall Study|Found to be Ineligible|3|||
143055779|NCT00434837|515741992|FG000|Overall Study|Lost to Follow-up|20|||
143055780|NCT00434837|515741993|FG001|Overall Study|Lost to Follow-up|23|||
143055781|NCT00434837|515741994|FG002|Overall Study|Lost to Follow-up|30|||
143055782|NCT01785615|515741995|FG000|Dietary Phase|Lost to Follow-up|0|||
143169522|NCT02958865|516169892|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
143169523|NCT02958865|516169893|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
143169524|NCT02958865|516169894|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
143499789|NCT01360645|517370496|FG003|Phase A+|Lost to Follow-up|7|||
143499790|NCT01360645|517370493|FG000|Phase A+|Adverse Event|0|||
143499791|NCT01360645|517370494|FG001|Phase A+|Adverse Event|0|||
143499792|NCT01360645|517370495|FG002|Phase A+|Adverse Event|0|||
143499793|NCT01360645|517370496|FG003|Phase A+|Adverse Event|2|||
143499794|NCT01360645|517370493|FG000|Phase A+|Met Withdrawal Criteria|0|||
143499795|NCT01360645|517370494|FG001|Phase A+|Met Withdrawal Criteria|0|||
143499796|NCT01360645|517370495|FG002|Phase A+|Met Withdrawal Criteria|0|||
143499797|NCT01360645|517370496|FG003|Phase A+|Met Withdrawal Criteria|4|||
143499798|NCT01360645|517370493|FG000|Phase A+|Physician Decision|0|||
143499799|NCT01360645|517370494|FG001|Phase A+|Physician Decision|0|||
143499800|NCT01360645|517370495|FG002|Phase A+|Physician Decision|0|||
143499801|NCT01360645|517370496|FG003|Phase A+|Physician Decision|2|||
143499802|NCT01360645|517370493|FG000|Phase A+|Withdrawal by Subject|0|||
143499803|NCT01360645|517370494|FG001|Phase A+|Withdrawal by Subject|0|||
143499804|NCT01360645|517370495|FG002|Phase A+|Withdrawal by Subject|0|||
143499805|NCT01360645|517370496|FG003|Phase A+|Withdrawal by Subject|5|||
143055783|NCT01785615|515741996|FG001|Dietary Phase|Lost to Follow-up|0|||
143055784|NCT01785615|515741997|FG002|Dietary Phase|Lost to Follow-up|0|||
143055785|NCT01785615|515741998|FG003|Dietary Phase|Lost to Follow-up|24|||
143055786|NCT01881737|515741999|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
143055787|NCT01881737|515741999|FG000|Overall Study|Withdrawal by Subject|1|||
143055788|NCT01881737|515741999|FG000|Overall Study|Worsening of baseline behavior|1|||
143055789|NCT02058160|515742004|FG000|Overall Study|Randomized but not treated|2|||
143055790|NCT02058160|515742005|FG001|Overall Study|Randomized but not treated|4|||
143055791|NCT02058160|515742004|FG000|Overall Study|Poor compliance to protocol|4|||
143055792|NCT02058160|515742005|FG001|Overall Study|Poor compliance to protocol|1|||
143055793|NCT02058160|515742004|FG000|Overall Study|Adverse Event|12|||
143055794|NCT02058160|515742005|FG001|Overall Study|Adverse Event|3|||
143499806|NCT01360645|517370493|FG000|Phase A+|Protocol Deviation|0|||
143055795|NCT02058160|515742004|FG000|Overall Study|Lost to Follow-up|1|||
143055796|NCT02058160|515742005|FG001|Overall Study|Lost to Follow-up|0|||
143055797|NCT02058160|515742004|FG000|Overall Study|Other than specified above|12|||
143499807|NCT01360645|517370494|FG001|Phase A+|Protocol Deviation|0|||
143055798|NCT02058160|515742005|FG001|Overall Study|Other than specified above|6|||
143055799|NCT01266603|515742011|FG000|Overall Study|Adverse Event|1|||
143055800|NCT01266603|515742011|FG000|Overall Study|Lack of Efficacy|14|||
143055801|NCT01266603|515742011|FG000|Overall Study|Withdrawal by Subject|1|||
143055802|NCT01266603|515742011|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
143055803|NCT00398073|515742014|FG000|Overall Study|Withdrawal by Subject|1|||
143055804|NCT00398073|515742015|FG001|Overall Study|Withdrawal by Subject|0|||
143055805|NCT01833169|515742019|FG000|Overall Study|Disease Progression|99|||
143055806|NCT01833169|515742019|FG000|Overall Study|Adverse Event|33|||
143055807|NCT01833169|515742019|FG000|Overall Study|Withdrawal by Subject|9|||
143055808|NCT01833169|515742019|FG000|Overall Study|Death|3|||
143055809|NCT01833169|515742019|FG000|Overall Study|Physician Decision|2|||
143055810|NCT01183884|515742020|FG000|Overall Study|Progressive Disease|26|||
143055811|NCT01183884|515742020|FG000|Overall Study|Adverse Event|3|||
143055812|NCT01183884|515742020|FG000|Overall Study|Withdrawal by Subject|1|||
143055813|NCT01183884|515742020|FG000|Overall Study|Other Complicating Disease|3|||
143055814|NCT01183884|515742020|FG000|Overall Study|Not Treated|1|||
143055815|NCT01183884|515742020|FG000|Overall Study|Other|4|||
143055816|NCT03168906|515742021|FG000|Overall Study|Lack of Efficacy|6|||
143055817|NCT03168906|515742022|FG001|Overall Study|Lack of Efficacy|6|||
143055818|NCT01214239|515742023|FG000|Overall Study|Adverse Event|3|||
143055819|NCT01214239|515742024|FG001|Overall Study|Adverse Event|4|||
143055820|NCT01214239|515742023|FG000|Overall Study|Protocol Violation|2|||
143055821|NCT01214239|515742024|FG001|Overall Study|Protocol Violation|1|||
143055822|NCT01214239|515742023|FG000|Overall Study|Lost to Follow-up|1|||
143055823|NCT01214239|515742024|FG001|Overall Study|Lost to Follow-up|1|||
143055824|NCT01214239|515742023|FG000|Overall Study|Withdrawal by Subject|4|||
143055825|NCT01214239|515742024|FG001|Overall Study|Withdrawal by Subject|9|||
143055826|NCT01214239|515742023|FG000|Overall Study|Lack of Efficacy|1|||
143055827|NCT01214239|515742024|FG001|Overall Study|Lack of Efficacy|2|||
143055828|NCT01214239|515742023|FG000|Overall Study|patient's private reason|1|||
143055829|NCT01214239|515742024|FG001|Overall Study|patient's private reason|1|||
143055830|NCT00857818|515742025|FG000|Overall Study|Lack of Efficacy|1|||
143055831|NCT00857818|515742026|FG001|Overall Study|Lack of Efficacy|0|||
143055832|NCT00857818|515742025|FG000|Overall Study|Adverse Event|3|||
143055833|NCT00857818|515742026|FG001|Overall Study|Adverse Event|0|||
143055834|NCT00857818|515742025|FG000|Overall Study|Withdrawal by Subject|0|||
143055835|NCT00857818|515742026|FG001|Overall Study|Withdrawal by Subject|4|||
143055836|NCT00857818|515742025|FG000|Overall Study|Sponsor terminated study|6|||
143055837|NCT00857818|515742026|FG001|Overall Study|Sponsor terminated study|4|||
143055838|NCT00857818|515742025|FG000|Overall Study|Investigator decision|1|||
143055839|NCT00857818|515742026|FG001|Overall Study|Investigator decision|0|||
143055840|NCT02129062|515743585|FG000|Overall Study|Death|1|||
143055841|NCT02129062|515743585|FG000|Overall Study|Disease Progression|2|||
143055842|NCT01923311|515743586|FG000|Overall Study|Pregnancy|1|||
143055843|NCT01923311|515743587|FG001|Overall Study|Pregnancy|0|||
143055844|NCT01923311|515743586|FG000|Overall Study|Investigator's Discretion|1|||
143055845|NCT01923311|515743587|FG001|Overall Study|Investigator's Discretion|0|||
143055846|NCT01923311|515743586|FG000|Overall Study|Non-Compliance with Study Drug|2|||
143055847|NCT01923311|515743587|FG001|Overall Study|Non-Compliance with Study Drug|1|||
143055848|NCT01923311|515743586|FG000|Overall Study|Withdrew Consent|1|||
143055849|NCT01923311|515743587|FG001|Overall Study|Withdrew Consent|0|||
143055850|NCT01923311|515743586|FG000|Overall Study|Study Terminated by Sponsor|12|||
143055851|NCT01923311|515743587|FG001|Overall Study|Study Terminated by Sponsor|0|||
143055852|NCT05258630|515743589|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
143055853|NCT05258630|515743590|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
143055854|NCT05258630|515743589|FG000|Overall Study|Lost to Follow-up|0|||
143055855|NCT05258630|515743590|FG001|Overall Study|Lost to Follow-up|2|||
143055856|NCT03431337|515743592|FG000|Overall Study|Lost to Follow-up|21|||
143055857|NCT03431337|515743593|FG001|Overall Study|Lost to Follow-up|19|||
143055858|NCT03431337|515743592|FG000|Overall Study|Withdrawal by Subject|8|||
143055859|NCT03431337|515743593|FG001|Overall Study|Withdrawal by Subject|3|||
143055860|NCT02419573|515743594|FG000|Overall Study|Lost to Follow-up|3|||
143055861|NCT02419573|515743595|FG001|Overall Study|Lost to Follow-up|0|||
143055862|NCT02419573|515743594|FG000|Overall Study|Withdrawal by Subject|1|||
143055863|NCT02419573|515743595|FG001|Overall Study|Withdrawal by Subject|0|||
143055864|NCT00401245|515743596|FG000|Double Blind Titration Phase|Adverse Event|3|||
143055865|NCT00401245|515743597|FG001|Double Blind Titration Phase|Adverse Event|2|||
143055866|NCT00401245|515743598|FG002|Double Blind Titration Phase|Adverse Event|5|||
143055867|NCT00401245|515743599|FG003|Double Blind Titration Phase|Adverse Event|12|||
143055868|NCT00401245|515743600|FG004|Double Blind Titration Phase|Adverse Event|0|||
143055869|NCT00401245|515743601|FG005|Double Blind Titration Phase|Adverse Event|0|||
143055870|NCT00401245|515743602|FG006|Double Blind Titration Phase|Adverse Event|0|||
143055871|NCT00401245|515743603|FG007|Double Blind Titration Phase|Adverse Event|0|||
143055872|NCT00401245|515743596|FG000|Double Blind Titration Phase|Other|0|||
143055873|NCT00401245|515743597|FG001|Double Blind Titration Phase|Other|0|||
143055874|NCT00401245|515743598|FG002|Double Blind Titration Phase|Other|1|||
143055875|NCT00401245|515743599|FG003|Double Blind Titration Phase|Other|0|||
143055876|NCT00401245|515743600|FG004|Double Blind Titration Phase|Other|0|||
143055877|NCT00401245|515743601|FG005|Double Blind Titration Phase|Other|0|||
143055878|NCT00401245|515743602|FG006|Double Blind Titration Phase|Other|0|||
143055879|NCT00401245|515743603|FG007|Double Blind Titration Phase|Other|0|||
143055880|NCT00401245|515743596|FG000|Double Blind Titration Phase|Protocol Violation|0|||
143055881|NCT00401245|515743597|FG001|Double Blind Titration Phase|Protocol Violation|0|||
143055882|NCT00401245|515743598|FG002|Double Blind Titration Phase|Protocol Violation|0|||
143055883|NCT00401245|515743599|FG003|Double Blind Titration Phase|Protocol Violation|1|||
143055884|NCT00401245|515743600|FG004|Double Blind Titration Phase|Protocol Violation|0|||
143055885|NCT00401245|515743601|FG005|Double Blind Titration Phase|Protocol Violation|0|||
143055886|NCT00401245|515743602|FG006|Double Blind Titration Phase|Protocol Violation|0|||
143055887|NCT00401245|515743603|FG007|Double Blind Titration Phase|Protocol Violation|0|||
143055888|NCT00401245|515743596|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
143055889|NCT00401245|515743597|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
143055890|NCT00401245|515743598|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
143055891|NCT00401245|515743599|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
143055892|NCT00401245|515743600|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
143055893|NCT00401245|515743601|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
143055894|NCT00401245|515743602|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
143055895|NCT00401245|515743603|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
143055896|NCT00401245|515743596|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
143055897|NCT00401245|515743597|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
143055898|NCT00401245|515743598|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
143055899|NCT00401245|515743599|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
143055900|NCT00401245|515743600|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
143055901|NCT00401245|515743601|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
143055902|NCT00401245|515743602|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
143055903|NCT00401245|515743603|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
143055904|NCT00401245|515743596|FG000|Open Label Phase|Adverse Event|5|||
143055905|NCT00401245|515743597|FG001|Open Label Phase|Adverse Event|14|||
143055906|NCT00401245|515743598|FG002|Open Label Phase|Adverse Event|6|||
143055907|NCT00401245|515743599|FG003|Open Label Phase|Adverse Event|7|||
143055908|NCT00401245|515743600|FG004|Open Label Phase|Adverse Event|0|||
143055909|NCT00401245|515743601|FG005|Open Label Phase|Adverse Event|0|||
143055910|NCT00401245|515743602|FG006|Open Label Phase|Adverse Event|0|||
143055911|NCT00401245|515743603|FG007|Open Label Phase|Adverse Event|0|||
143055912|NCT00401245|515743596|FG000|Open Label Phase|Lost to Follow-up|5|||
143055913|NCT00401245|515743597|FG001|Open Label Phase|Lost to Follow-up|7|||
143055914|NCT00401245|515743598|FG002|Open Label Phase|Lost to Follow-up|5|||
143055915|NCT00401245|515743599|FG003|Open Label Phase|Lost to Follow-up|4|||
143055916|NCT00401245|515743600|FG004|Open Label Phase|Lost to Follow-up|0|||
143055917|NCT00401245|515743601|FG005|Open Label Phase|Lost to Follow-up|0|||
143055918|NCT00401245|515743602|FG006|Open Label Phase|Lost to Follow-up|0|||
143169525|NCT02958865|516169895|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
143055919|NCT00401245|515743603|FG007|Open Label Phase|Lost to Follow-up|0|||
143055920|NCT00401245|515743596|FG000|Open Label Phase|Other|4|||
143055921|NCT00401245|515743597|FG001|Open Label Phase|Other|8|||
143055922|NCT00401245|515743598|FG002|Open Label Phase|Other|7|||
143055923|NCT00401245|515743599|FG003|Open Label Phase|Other|8|||
143055924|NCT00401245|515743600|FG004|Open Label Phase|Other|0|||
143055925|NCT00401245|515743601|FG005|Open Label Phase|Other|0|||
143055926|NCT00401245|515743602|FG006|Open Label Phase|Other|0|||
143055927|NCT00401245|515743603|FG007|Open Label Phase|Other|0|||
143055928|NCT00401245|515743596|FG000|Open Label Phase|Protocol Violation|0|||
143055929|NCT00401245|515743597|FG001|Open Label Phase|Protocol Violation|1|||
143055930|NCT00401245|515743598|FG002|Open Label Phase|Protocol Violation|0|||
143055931|NCT00401245|515743599|FG003|Open Label Phase|Protocol Violation|1|||
143055932|NCT00401245|515743600|FG004|Open Label Phase|Protocol Violation|0|||
143055933|NCT00401245|515743601|FG005|Open Label Phase|Protocol Violation|0|||
143055934|NCT00401245|515743602|FG006|Open Label Phase|Protocol Violation|0|||
143055935|NCT00401245|515743603|FG007|Open Label Phase|Protocol Violation|0|||
143055936|NCT00401245|515743596|FG000|Open Label Phase|Withdrawal by Subject|3|||
143055937|NCT00401245|515743597|FG001|Open Label Phase|Withdrawal by Subject|3|||
143055938|NCT00401245|515743598|FG002|Open Label Phase|Withdrawal by Subject|2|||
143055939|NCT00401245|515743599|FG003|Open Label Phase|Withdrawal by Subject|1|||
143055940|NCT00401245|515743600|FG004|Open Label Phase|Withdrawal by Subject|0|||
143055941|NCT00401245|515743601|FG005|Open Label Phase|Withdrawal by Subject|0|||
143055942|NCT00401245|515743602|FG006|Open Label Phase|Withdrawal by Subject|0|||
143055943|NCT00401245|515743603|FG007|Open Label Phase|Withdrawal by Subject|0|||
143055944|NCT00401245|515743596|FG000|Open Label Phase|Lack of Efficacy|4|||
143055945|NCT00401245|515743597|FG001|Open Label Phase|Lack of Efficacy|2|||
143055946|NCT00401245|515743598|FG002|Open Label Phase|Lack of Efficacy|3|||
143055947|NCT00401245|515743599|FG003|Open Label Phase|Lack of Efficacy|0|||
143055948|NCT00401245|515743600|FG004|Open Label Phase|Lack of Efficacy|0|||
143055949|NCT00401245|515743601|FG005|Open Label Phase|Lack of Efficacy|0|||
143055950|NCT00401245|515743602|FG006|Open Label Phase|Lack of Efficacy|0|||
143055951|NCT00401245|515743603|FG007|Open Label Phase|Lack of Efficacy|0|||
143055952|NCT00401245|515743596|FG000|Double Blind Tapering Phase|Adverse Event|0|||
143055953|NCT00401245|515743597|FG001|Double Blind Tapering Phase|Adverse Event|0|||
143055954|NCT00401245|515743598|FG002|Double Blind Tapering Phase|Adverse Event|0|||
143055955|NCT00401245|515743599|FG003|Double Blind Tapering Phase|Adverse Event|0|||
143055956|NCT00401245|515743600|FG004|Double Blind Tapering Phase|Adverse Event|1|||
143055957|NCT00401245|515743601|FG005|Double Blind Tapering Phase|Adverse Event|1|||
143055958|NCT00401245|515743602|FG006|Double Blind Tapering Phase|Adverse Event|2|||
143055959|NCT00401245|515743603|FG007|Double Blind Tapering Phase|Adverse Event|4|||
143055960|NCT00401245|515743596|FG000|Double Blind Tapering Phase|Investigator request|0|||
143055961|NCT00401245|515743597|FG001|Double Blind Tapering Phase|Investigator request|0|||
143055962|NCT00401245|515743598|FG002|Double Blind Tapering Phase|Investigator request|0|||
143055963|NCT00401245|515743599|FG003|Double Blind Tapering Phase|Investigator request|0|||
143055964|NCT00401245|515743600|FG004|Double Blind Tapering Phase|Investigator request|0|||
143055965|NCT00401245|515743601|FG005|Double Blind Tapering Phase|Investigator request|0|||
143055966|NCT00401245|515743602|FG006|Double Blind Tapering Phase|Investigator request|0|||
143055967|NCT00401245|515743603|FG007|Double Blind Tapering Phase|Investigator request|1|||
143055968|NCT00401245|515743596|FG000|Double Blind Tapering Phase|Other|0|||
143055969|NCT00401245|515743597|FG001|Double Blind Tapering Phase|Other|0|||
143055970|NCT00401245|515743598|FG002|Double Blind Tapering Phase|Other|0|||
143055971|NCT00401245|515743599|FG003|Double Blind Tapering Phase|Other|0|||
143055972|NCT00401245|515743600|FG004|Double Blind Tapering Phase|Other|1|||
143055973|NCT00401245|515743601|FG005|Double Blind Tapering Phase|Other|0|||
143055974|NCT00401245|515743602|FG006|Double Blind Tapering Phase|Other|2|||
143055975|NCT00401245|515743603|FG007|Double Blind Tapering Phase|Other|2|||
143055976|NCT00401245|515743596|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
143055977|NCT00401245|515743597|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
143055978|NCT00401245|515743598|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
143055979|NCT00401245|515743599|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
143055980|NCT00401245|515743600|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
143055981|NCT00401245|515743601|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
143055982|NCT00401245|515743602|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
143055983|NCT00401245|515743603|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
143055984|NCT00401245|515743596|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
143055985|NCT00401245|515743597|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
143055986|NCT00401245|515743598|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
143055987|NCT00401245|515743599|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
143055988|NCT00401245|515743600|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
143055989|NCT00401245|515743601|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
143055990|NCT00401245|515743602|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
143055991|NCT00401245|515743603|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
143055992|NCT02426541|515743607|FG000|Overall Study|Protocol Violation|1|||
143055993|NCT02426541|515743608|FG001|Overall Study|Protocol Violation|0|||
143055994|NCT00631007|515743609|FG000|Overall Study|Adverse Event|0|||
143055995|NCT00631007|515743610|FG001|Overall Study|Adverse Event|2|||
143055996|NCT00631007|515743611|FG002|Overall Study|Adverse Event|0|||
143055997|NCT00631007|515743612|FG003|Overall Study|Adverse Event|2|||
143055998|NCT00631007|515743613|FG004|Overall Study|Adverse Event|3|||
143055999|NCT00631007|515743614|FG005|Overall Study|Adverse Event|2|||
143056000|NCT00631007|515743609|FG000|Overall Study|Lost to Follow-up|2|||
143056001|NCT00631007|515743610|FG001|Overall Study|Lost to Follow-up|1|||
143056002|NCT00631007|515743611|FG002|Overall Study|Lost to Follow-up|2|||
143056003|NCT00631007|515743612|FG003|Overall Study|Lost to Follow-up|4|||
143056004|NCT00631007|515743613|FG004|Overall Study|Lost to Follow-up|5|||
143056005|NCT00631007|515743614|FG005|Overall Study|Lost to Follow-up|3|||
143056006|NCT00631007|515743609|FG000|Overall Study|Physician Decision|1|||
143056007|NCT00631007|515743610|FG001|Overall Study|Physician Decision|0|||
143056008|NCT00631007|515743611|FG002|Overall Study|Physician Decision|1|||
143056009|NCT00631007|515743612|FG003|Overall Study|Physician Decision|0|||
143056010|NCT00631007|515743613|FG004|Overall Study|Physician Decision|0|||
143056011|NCT00631007|515743614|FG005|Overall Study|Physician Decision|2|||
143056012|NCT00631007|515743609|FG000|Overall Study|Persistent Hyperglycemia|2|||
143056013|NCT00631007|515743610|FG001|Overall Study|Persistent Hyperglycemia|2|||
143056014|NCT00631007|515743611|FG002|Overall Study|Persistent Hyperglycemia|5|||
143056015|NCT00631007|515743612|FG003|Overall Study|Persistent Hyperglycemia|1|||
143056016|NCT00631007|515743613|FG004|Overall Study|Persistent Hyperglycemia|2|||
143056017|NCT00631007|515743614|FG005|Overall Study|Persistent Hyperglycemia|5|||
143056018|NCT00631007|515743609|FG000|Overall Study|Withdrawal by Subject|4|||
143056019|NCT00631007|515743610|FG001|Overall Study|Withdrawal by Subject|5|||
143056020|NCT00631007|515743611|FG002|Overall Study|Withdrawal by Subject|2|||
143056021|NCT00631007|515743612|FG003|Overall Study|Withdrawal by Subject|2|||
143056022|NCT00631007|515743613|FG004|Overall Study|Withdrawal by Subject|1|||
143056023|NCT00631007|515743614|FG005|Overall Study|Withdrawal by Subject|3|||
143056024|NCT00631007|515743609|FG000|Overall Study|Other|2|||
143056025|NCT00631007|515743610|FG001|Overall Study|Other|1|||
143056026|NCT00631007|515743611|FG002|Overall Study|Other|0|||
143056027|NCT00631007|515743612|FG003|Overall Study|Other|0|||
143056028|NCT00631007|515743613|FG004|Overall Study|Other|1|||
143056029|NCT00631007|515743614|FG005|Overall Study|Other|0|||
143056030|NCT00460109|515743615|FG000|Overall Study|Death|1|||
143169526|NCT02958865|516169896|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
143169527|NCT02958865|516169897|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
143499808|NCT01360645|517370495|FG002|Phase A+|Protocol Deviation|0|||
143056031|NCT02014441|515743619|FG000|Overall Study|Withdrawal by Subject|12|||
143056032|NCT00996437|515743623|FG000|Overall Study|Death|1|||
143169528|NCT02958865|516169882|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
143056033|NCT00996437|515743624|FG001|Overall Study|Death|0|||
143056034|NCT00996437|515743623|FG000|Overall Study|Dropped|2|||
143056035|NCT00996437|515743624|FG001|Overall Study|Dropped|2|||
143056036|NCT00996437|515743623|FG000|Overall Study|Missed|2|||
143056037|NCT00996437|515743624|FG001|Overall Study|Missed|5|||
143056038|NCT01901848|515743627|FG000|Randomized and Treated|Lost to Follow-up|3|||
143056039|NCT01901848|515743628|FG001|Randomized and Treated|Lost to Follow-up|6|||
143169529|NCT02958865|516169883|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
143056040|NCT01901848|515743627|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
143056041|NCT01901848|515743628|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
143056042|NCT02940730|515743630|FG000|Intervention 2|Physician Decision|7|||
143056043|NCT02940730|515743631|FG001|Intervention 2|Physician Decision|0|||
143056044|NCT03036839|515743632|FG000|Overall Study|Adverse Event|0|||
143056045|NCT03036839|515743633|FG001|Overall Study|Adverse Event|0|||
143056046|NCT03036839|515743634|FG002|Overall Study|Adverse Event|1|||
143056047|NCT03036839|515743632|FG000|Overall Study|Death|3|||
143056048|NCT03036839|515743633|FG001|Overall Study|Death|0|||
143056049|NCT03036839|515743634|FG002|Overall Study|Death|3|||
143056050|NCT03036839|515743632|FG000|Overall Study|Withdrew Consent|0|||
143056051|NCT03036839|515743633|FG001|Overall Study|Withdrew Consent|0|||
143056052|NCT03036839|515743634|FG002|Overall Study|Withdrew Consent|1|||
143056053|NCT01628549|515743635|FG000|Overall Study|Adverse Event|1|||
143056054|NCT01628549|515743636|FG001|Overall Study|Adverse Event|1|||
143056055|NCT01628549|515743637|FG002|Overall Study|Adverse Event|0|||
143056056|NCT01628549|515743638|FG003|Overall Study|Adverse Event|4|||
143056057|NCT01628549|515743635|FG000|Overall Study|Lost to Follow-up|3|||
143056058|NCT01628549|515743636|FG001|Overall Study|Lost to Follow-up|4|||
143056059|NCT01628549|515743637|FG002|Overall Study|Lost to Follow-up|3|||
143056060|NCT01628549|515743638|FG003|Overall Study|Lost to Follow-up|3|||
143056061|NCT01628549|515743635|FG000|Overall Study|Withdrawal by Subject|3|||
143056062|NCT01628549|515743636|FG001|Overall Study|Withdrawal by Subject|4|||
143056063|NCT01628549|515743637|FG002|Overall Study|Withdrawal by Subject|4|||
143056064|NCT01628549|515743638|FG003|Overall Study|Withdrawal by Subject|1|||
143056065|NCT01628549|515743635|FG000|Overall Study|Protocol Violation|2|||
143056066|NCT01628549|515743636|FG001|Overall Study|Protocol Violation|1|||
143056067|NCT01628549|515743637|FG002|Overall Study|Protocol Violation|1|||
143056068|NCT01628549|515743638|FG003|Overall Study|Protocol Violation|0|||
143056069|NCT01628549|515743635|FG000|Overall Study|withdrawn for noncompliance|0|||
143056070|NCT01628549|515743636|FG001|Overall Study|withdrawn for noncompliance|2|||
143056071|NCT01628549|515743637|FG002|Overall Study|withdrawn for noncompliance|1|||
143056072|NCT01628549|515743638|FG003|Overall Study|withdrawn for noncompliance|0|||
143056073|NCT01628549|515743635|FG000|Overall Study|abnormal laboratory test results|0|||
143056074|NCT01628549|515743636|FG001|Overall Study|abnormal laboratory test results|0|||
143056075|NCT01628549|515743637|FG002|Overall Study|abnormal laboratory test results|1|||
143056076|NCT01628549|515743638|FG003|Overall Study|abnormal laboratory test results|0|||
143056077|NCT01628549|515743635|FG000|Overall Study|positive pregnancy test|0|||
143056078|NCT01628549|515743636|FG001|Overall Study|positive pregnancy test|0|||
143056079|NCT01628549|515743637|FG002|Overall Study|positive pregnancy test|0|||
143056080|NCT01628549|515743638|FG003|Overall Study|positive pregnancy test|1|||
143056081|NCT02340962|515743639|FG000|Overall Study|Lost to Follow-up|1|||
143056082|NCT02340962|515743640|FG001|Overall Study|Lost to Follow-up|0|||
143056083|NCT00372996|515743641|FG000|Overall Study|Death|11|||
143056084|NCT00372996|515743642|FG001|Overall Study|Death|4|||
143056085|NCT00372996|515743643|FG002|Overall Study|Death|8|||
143056086|NCT00372996|515743644|FG003|Overall Study|Death|7|||
143056087|NCT00372996|515743641|FG000|Overall Study|Lost to Follow-up|0|||
143056088|NCT00372996|515743642|FG001|Overall Study|Lost to Follow-up|2|||
143056089|NCT00372996|515743643|FG002|Overall Study|Lost to Follow-up|0|||
143056090|NCT00372996|515743644|FG003|Overall Study|Lost to Follow-up|1|||
143056091|NCT00372996|515743641|FG000|Overall Study|Withdrawal by Subject|12|||
143056092|NCT00372996|515743642|FG001|Overall Study|Withdrawal by Subject|6|||
143056093|NCT00372996|515743643|FG002|Overall Study|Withdrawal by Subject|9|||
143056094|NCT00372996|515743644|FG003|Overall Study|Withdrawal by Subject|5|||
143169530|NCT02958865|516169884|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
143169531|NCT02958865|516169885|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
143169532|NCT02958865|516169886|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
143169533|NCT02958865|516169887|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
143169534|NCT02958865|516169888|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
143169535|NCT02958865|516169889|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
143169536|NCT02958865|516169890|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
143056095|NCT00372996|515743641|FG000|Overall Study|Study Terminated by Sponsor|4|||
143056096|NCT00372996|515743642|FG001|Overall Study|Study Terminated by Sponsor|0|||
143056097|NCT00372996|515743643|FG002|Overall Study|Study Terminated by Sponsor|4|||
143169537|NCT02958865|516169891|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
143056098|NCT00372996|515743644|FG003|Overall Study|Study Terminated by Sponsor|0|||
143056099|NCT00372996|515743641|FG000|Overall Study|Other|10|||
143056100|NCT00372996|515743642|FG001|Overall Study|Other|2|||
143056101|NCT00372996|515743643|FG002|Overall Study|Other|7|||
143056102|NCT00372996|515743644|FG003|Overall Study|Other|7|||
143056103|NCT01186016|515743645|FG000|Overall Study|Withdrawal by Subject|46|||
143056104|NCT01186016|515743646|FG001|Overall Study|Withdrawal by Subject|29|||
143056105|NCT00721955|515743650|FG000|Overall Study|Adverse Event|0|||
143056106|NCT00721955|515743651|FG001|Overall Study|Adverse Event|0|||
143056107|NCT00721955|515743652|FG002|Overall Study|Adverse Event|2|||
143056108|NCT01292837|515743653|FG000|Overall Study|Adverse Event|1|||
143056109|NCT01292837|515743653|FG000|Overall Study|Further treatment determined|1|||
143056110|NCT02174276|515743656|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
143056111|NCT02174276|515743657|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
143056112|NCT02174276|515743658|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
143056113|NCT02174276|515743659|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
143056114|NCT02174276|515743656|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
143056115|NCT02174276|515743657|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
143056116|NCT02174276|515743658|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
143056117|NCT02174276|515743659|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
143056118|NCT02174276|515743656|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
143056119|NCT02174276|515743657|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
143056120|NCT02174276|515743658|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
143056121|NCT02174276|515743659|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
143056122|NCT02174276|515743656|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
143056123|NCT02174276|515743657|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
143056124|NCT02174276|515743658|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
143056125|NCT02174276|515743659|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
143056126|NCT02174276|515743656|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
143056127|NCT02174276|515743657|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
143056128|NCT02174276|515743658|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
143056129|NCT02174276|515743659|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
143056130|NCT02174276|515743656|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
143056131|NCT02174276|515743657|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
143056132|NCT02174276|515743658|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
143056133|NCT02174276|515743659|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
143056134|NCT01206439|515743660|FG000|Overall Study|subject did not meet inclusion criteria|1|||
143056135|NCT05889039|515743661|FG000|Overall Study|error in completing survey|0|||
143056136|NCT05889039|515743662|FG001|Overall Study|error in completing survey|2|||
143056137|NCT05889039|515743663|FG002|Overall Study|error in completing survey|0|||
143056138|NCT05889039|515743664|FG003|Overall Study|error in completing survey|0|||
143056139|NCT05889039|515743661|FG000|Overall Study|Lost to Follow-up|4|||
143056140|NCT05889039|515743662|FG001|Overall Study|Lost to Follow-up|0|||
143056141|NCT05889039|515743663|FG002|Overall Study|Lost to Follow-up|0|||
143056142|NCT05889039|515743664|FG003|Overall Study|Lost to Follow-up|0|||
143056143|NCT02972515|515743668|FG000|Overall Study|Lost to Follow-up|78|||
143056144|NCT03496298|515743683|FG000|Overall Study|Adverse Event|49|||
143056145|NCT03496298|515743684|FG001|Overall Study|Adverse Event|68|||
143056146|NCT03496298|515743685|FG002|Overall Study|Adverse Event|79|||
143056147|NCT03496298|515743683|FG000|Overall Study|Study terminated by Sponsor|1050|||
143056148|NCT03496298|515743684|FG001|Overall Study|Study terminated by Sponsor|1063|||
143056149|NCT03496298|515743685|FG002|Overall Study|Study terminated by Sponsor|1071|||
143056150|NCT03496298|515743683|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
143056151|NCT03496298|515743684|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
143056152|NCT03496298|515743685|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
143056153|NCT03496298|515743683|FG000|Overall Study|Withdrawal by Subject|176|||
143056154|NCT03496298|515743684|FG001|Overall Study|Withdrawal by Subject|154|||
143056155|NCT03496298|515743685|FG002|Overall Study|Withdrawal by Subject|151|||
143056156|NCT03496298|515743683|FG000|Overall Study|Other|29|||
143056157|NCT03496298|515743684|FG001|Overall Study|Other|20|||
143056158|NCT03496298|515743685|FG002|Overall Study|Other|23|||
143056159|NCT03496298|515743683|FG000|Overall Study|Randomized and not treated|1|||
143056160|NCT03496298|515743684|FG001|Overall Study|Randomized and not treated|1|||
143056161|NCT03496298|515743685|FG002|Overall Study|Randomized and not treated|1|||
143056162|NCT02427399|515743688|FG000|Overall Study|Protocol Violation|14|||
143056163|NCT02427399|515743689|FG001|Overall Study|Protocol Violation|16|||
143056164|NCT02427399|515743690|FG002|Overall Study|Protocol Violation|12|||
143056165|NCT02427399|515743691|FG003|Overall Study|Protocol Violation|18|||
143056166|NCT02427399|515743692|FG004|Overall Study|Protocol Violation|15|||
143056167|NCT00685750|515743697|FG000|Overall Study|Tumor sampling failure|0|||
143056168|NCT00685750|515743698|FG001|Overall Study|Tumor sampling failure|0|||
143056169|NCT00685750|515743699|FG002|Overall Study|Tumor sampling failure|1|||
143245222|NCT04661579|516449649|FG003|Overall Study|Withdrawal by Subject|2|||
143245223|NCT04661579|516449650|FG004|Overall Study|Withdrawal by Subject|0|||
143245224|NCT04661579|516449646|FG000|Overall Study|Death|1|||
143245225|NCT04661579|516449647|FG001|Overall Study|Death|0|||
143245226|NCT04661579|516449648|FG002|Overall Study|Death|0|||
143056170|NCT00685750|515743700|FG003|Overall Study|Tumor sampling failure|0|||
143056171|NCT00685750|515743701|FG004|Overall Study|Tumor sampling failure|0|||
143245227|NCT04661579|516449649|FG003|Overall Study|Death|0|||
143245228|NCT04661579|516449650|FG004|Overall Study|Death|0|||
143056172|NCT00685750|515743702|FG005|Overall Study|Tumor sampling failure|0|||
143056173|NCT00685750|515743703|FG006|Overall Study|Tumor sampling failure|0|||
143245229|NCT04661579|516449646|FG000|Overall Study|Other|1|||
143245230|NCT04661579|516449647|FG001|Overall Study|Other|2|||
143245231|NCT04661579|516449648|FG002|Overall Study|Other|1|||
143245232|NCT04661579|516449649|FG003|Overall Study|Other|1|||
143245233|NCT04661579|516449650|FG004|Overall Study|Other|1|||
143056174|NCT00685750|515743697|FG000|Overall Study|Patient didn't receive the treatment|0|||
143056175|NCT00685750|515743698|FG001|Overall Study|Patient didn't receive the treatment|0|||
143056176|NCT00685750|515743699|FG002|Overall Study|Patient didn't receive the treatment|0|||
143056177|NCT00685750|515743700|FG003|Overall Study|Patient didn't receive the treatment|0|||
143056178|NCT00685750|515743701|FG004|Overall Study|Patient didn't receive the treatment|0|||
143056179|NCT00685750|515743702|FG005|Overall Study|Patient didn't receive the treatment|0|||
143056180|NCT00685750|515743703|FG006|Overall Study|Patient didn't receive the treatment|1|||
143056181|NCT00685750|515743697|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
143056182|NCT00685750|515743698|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
143056183|NCT00685750|515743699|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
143056184|NCT00685750|515743700|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
143056185|NCT00685750|515743701|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
143056186|NCT00685750|515743702|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
143056187|NCT00685750|515743703|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
143056188|NCT01263561|515743710|FG000|Overall Study|Death|1|||
143056189|NCT01263561|515743711|FG001|Overall Study|Death|2|||
143056190|NCT04203667|515743712|FG000|Overall Study|Withdrawal by Subject|1|||
143056191|NCT04203667|515743712|FG000|Overall Study|Lost to Follow-up|1|||
143056192|NCT04203667|515743712|FG000|Overall Study|Death|1|||
143056193|NCT04203667|515743712|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
143056194|NCT04718129|515743717|FG000|Overall Study|Lost to Follow-up|6|||
143056195|NCT04718129|515743718|FG001|Overall Study|Lost to Follow-up|7|||
143056196|NCT03185741|515743719|FG000|Baseline|Withdrawal by Subject|1|||
143056197|NCT03185741|515743720|FG001|Baseline|Withdrawal by Subject|3|||
143056198|NCT03185741|515743721|FG002|Baseline|Withdrawal by Subject|2|||
143056199|NCT03185741|515743719|FG000|Baseline|Lost to Follow-up|1|||
143056200|NCT03185741|515743720|FG001|Baseline|Lost to Follow-up|2|||
143056201|NCT03185741|515743721|FG002|Baseline|Lost to Follow-up|3|||
143056202|NCT03185741|515743719|FG000|3Month|Death|1|||
143056203|NCT03185741|515743720|FG001|3Month|Death|1|||
143056204|NCT03185741|515743721|FG002|3Month|Death|2|||
143056205|NCT03185741|515743719|FG000|3Month|Withdrawal by Subject|1|||
143056206|NCT03185741|515743720|FG001|3Month|Withdrawal by Subject|5|||
143056207|NCT03185741|515743721|FG002|3Month|Withdrawal by Subject|1|||
143056208|NCT03185741|515743719|FG000|3Month|Lost to Follow-up|7|||
143056209|NCT03185741|515743720|FG001|3Month|Lost to Follow-up|9|||
143056210|NCT03185741|515743721|FG002|3Month|Lost to Follow-up|8|||
143056211|NCT03185741|515743719|FG000|3Month|Unavailable for 3Month|11|||
143056212|NCT03185741|515743720|FG001|3Month|Unavailable for 3Month|10|||
143056213|NCT03185741|515743721|FG002|3Month|Unavailable for 3Month|11|||
143056214|NCT03185741|515743719|FG000|3Month|Protocol Violation|0|||
143056215|NCT03185741|515743720|FG001|3Month|Protocol Violation|0|||
143056216|NCT03185741|515743721|FG002|3Month|Protocol Violation|3|||
143056217|NCT03185741|515743719|FG000|6Month|Death|1|||
143056218|NCT03185741|515743720|FG001|6Month|Death|1|||
143056219|NCT03185741|515743721|FG002|6Month|Death|2|||
143056220|NCT03185741|515743719|FG000|6Month|Withdrawal by Subject|2|||
143056221|NCT03185741|515743720|FG001|6Month|Withdrawal by Subject|3|||
143056222|NCT03185741|515743721|FG002|6Month|Withdrawal by Subject|1|||
143056223|NCT03185741|515743719|FG000|6Month|Lost to Follow-up|16|||
143056224|NCT03185741|515743720|FG001|6Month|Lost to Follow-up|15|||
143056225|NCT03185741|515743721|FG002|6Month|Lost to Follow-up|16|||
143056226|NCT01992094|515743722|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
143056227|NCT01992094|515743723|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
143056228|NCT01992094|515743724|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
143056229|NCT01992094|515743722|FG000|Overall Study|Adverse Event|1|||
143056230|NCT01992094|515743723|FG001|Overall Study|Adverse Event|0|||
143056231|NCT01992094|515743724|FG002|Overall Study|Adverse Event|0|||
143056232|NCT01992094|515743722|FG000|Overall Study|Death|5|||
143056233|NCT01992094|515743723|FG001|Overall Study|Death|5|||
143056234|NCT01992094|515743724|FG002|Overall Study|Death|2|||
143056235|NCT01992094|515743722|FG000|Overall Study|Lost to Follow-up|26|||
143056236|NCT01992094|515743723|FG001|Overall Study|Lost to Follow-up|9|||
143056237|NCT01992094|515743724|FG002|Overall Study|Lost to Follow-up|13|||
143056238|NCT01992094|515743722|FG000|Overall Study|OTHER|4|||
143056239|NCT01992094|515743723|FG001|Overall Study|OTHER|0|||
143056240|NCT01992094|515743724|FG002|Overall Study|OTHER|0|||
143056241|NCT01992094|515743722|FG000|Overall Study|Protocol Violation|1|||
143056242|NCT01992094|515743723|FG001|Overall Study|Protocol Violation|0|||
143056243|NCT01992094|515743724|FG002|Overall Study|Protocol Violation|1|||
143056244|NCT01992094|515743722|FG000|Overall Study|Withdrawal by Subject|7|||
143056245|NCT01992094|515743723|FG001|Overall Study|Withdrawal by Subject|3|||
143056246|NCT01992094|515743724|FG002|Overall Study|Withdrawal by Subject|4|||
143056247|NCT01321697|515743725|FG000|Overall Study|Study Terminated|7|||
143056248|NCT01049581|515743728|FG000|Overall Study|Lost to Follow-up|2|||
143056249|NCT01049581|515743729|FG001|Overall Study|Lost to Follow-up|1|||
143056250|NCT02625974|515743730|FG000|Part 1|Lost to Follow-up|9|||
143056251|NCT02625974|515743731|FG001|Part 1|Lost to Follow-up|3|||
143056252|NCT02625974|515743730|FG000|Part 2|Lost to Follow-up|4|||
143056253|NCT02625974|515743731|FG001|Part 2|Lost to Follow-up|6|||
143056254|NCT02625974|515743730|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
143056255|NCT02625974|515743731|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
143056256|NCT01142661|515743732|FG000|Overall Study|Adverse Event|2|||
143056257|NCT01142661|515743732|FG000|Overall Study|Withdrawal by Subject|1|||
143056258|NCT01142661|515743732|FG000|Overall Study|Physician Decision|1|||
143056259|NCT02839798|515745608|FG000|Overall Study|Withdrawal by Subject|2|||
143056260|NCT04703855|515745609|FG000|Overall Study|Heart Transplant|1|||
143056261|NCT01560819|515745611|FG000|Overall Study|Physician Decision|1|||
143056262|NCT01560819|515745612|FG001|Overall Study|Physician Decision|0|||
143056263|NCT02576717|515745613|FG000|Overall Study|Other Reasons|16|||
143056264|NCT02576717|515745614|FG001|Overall Study|Other Reasons|18|||
143056265|NCT02576717|515745615|FG002|Overall Study|Other Reasons|15|||
143056266|NCT02576717|515745613|FG000|Overall Study|Covid-19 Pandemic|0|||
143056267|NCT02576717|515745614|FG001|Overall Study|Covid-19 Pandemic|1|||
143364762|NCT00941031|516878710|FG004|Induction Period|Withdrawal by Subject|0|||
143364763|NCT00941031|516878711|FG005|Induction Period|Withdrawal by Subject|0|||
143364764|NCT00941031|516878712|FG006|Induction Period|Withdrawal by Subject|0|||
143364765|NCT00941031|516878706|FG000|Induction Period|Adminstative Problems|1|||
143056268|NCT02576717|515745615|FG002|Overall Study|Covid-19 Pandemic|1|||
143056269|NCT02576717|515745613|FG000|Overall Study|Sponsor Decision|0|||
143056270|NCT02576717|515745614|FG001|Overall Study|Sponsor Decision|0|||
143056271|NCT02576717|515745615|FG002|Overall Study|Sponsor Decision|1|||
143364766|NCT00941031|516878707|FG001|Induction Period|Adminstative Problems|1|||
143364767|NCT00941031|516878708|FG002|Induction Period|Adminstative Problems|1|||
143364768|NCT00941031|516878709|FG003|Induction Period|Adminstative Problems|0|||
143364769|NCT00941031|516878710|FG004|Induction Period|Adminstative Problems|0|||
143364770|NCT00941031|516878711|FG005|Induction Period|Adminstative Problems|0|||
143364771|NCT00941031|516878712|FG006|Induction Period|Adminstative Problems|0|||
143364772|NCT00941031|516878706|FG000|Induction Period|Adverse Event|1|||
143364773|NCT00941031|516878707|FG001|Induction Period|Adverse Event|0|||
143364774|NCT00941031|516878708|FG002|Induction Period|Adverse Event|3|||
143364775|NCT00941031|516878709|FG003|Induction Period|Adverse Event|2|||
143364776|NCT00941031|516878710|FG004|Induction Period|Adverse Event|0|||
143364777|NCT00941031|516878711|FG005|Induction Period|Adverse Event|0|||
143364778|NCT00941031|516878712|FG006|Induction Period|Adverse Event|0|||
143364779|NCT00941031|516878706|FG000|Maintenance Period|Withdrawal by Subject|0|||
143364780|NCT00941031|516878707|FG001|Maintenance Period|Withdrawal by Subject|0|||
143364781|NCT00941031|516878708|FG002|Maintenance Period|Withdrawal by Subject|0|||
143364782|NCT00941031|516878709|FG003|Maintenance Period|Withdrawal by Subject|0|||
143364783|NCT00941031|516878710|FG004|Maintenance Period|Withdrawal by Subject|6|||
143364784|NCT00941031|516878711|FG005|Maintenance Period|Withdrawal by Subject|2|||
143364785|NCT00941031|516878712|FG006|Maintenance Period|Withdrawal by Subject|13|||
143364786|NCT00941031|516878706|FG000|Maintenance Period|Administrative Problems|0|||
143364787|NCT00941031|516878707|FG001|Maintenance Period|Administrative Problems|0|||
143364788|NCT00941031|516878708|FG002|Maintenance Period|Administrative Problems|0|||
143364789|NCT00941031|516878709|FG003|Maintenance Period|Administrative Problems|0|||
143364790|NCT00941031|516878710|FG004|Maintenance Period|Administrative Problems|1|||
143364791|NCT00941031|516878711|FG005|Maintenance Period|Administrative Problems|0|||
143364792|NCT00941031|516878712|FG006|Maintenance Period|Administrative Problems|1|||
143364793|NCT00941031|516878706|FG000|Maintenance Period|Protocol Violation|0|||
143364794|NCT00941031|516878707|FG001|Maintenance Period|Protocol Violation|0|||
143364795|NCT00941031|516878708|FG002|Maintenance Period|Protocol Violation|0|||
143364796|NCT00941031|516878709|FG003|Maintenance Period|Protocol Violation|0|||
143364797|NCT00941031|516878710|FG004|Maintenance Period|Protocol Violation|0|||
143364798|NCT00941031|516878711|FG005|Maintenance Period|Protocol Violation|0|||
143364799|NCT00941031|516878712|FG006|Maintenance Period|Protocol Violation|1|||
143364800|NCT00941031|516878706|FG000|Maintenance Period|Adverse Event|0|||
143364801|NCT00941031|516878707|FG001|Maintenance Period|Adverse Event|0|||
143364802|NCT00941031|516878708|FG002|Maintenance Period|Adverse Event|0|||
143364803|NCT00941031|516878709|FG003|Maintenance Period|Adverse Event|0|||
143056272|NCT02576717|515745613|FG000|Overall Study|Physician Decision|3|||
143056273|NCT02576717|515745614|FG001|Overall Study|Physician Decision|8|||
143056274|NCT02576717|515745615|FG002|Overall Study|Physician Decision|9|||
143056275|NCT02576717|515745613|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
143056276|NCT02576717|515745614|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
143056277|NCT02576717|515745615|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
143056278|NCT02576717|515745613|FG000|Overall Study|Death|3|||
143056279|NCT02576717|515745614|FG001|Overall Study|Death|5|||
143056280|NCT02576717|515745615|FG002|Overall Study|Death|3|||
143056281|NCT02576717|515745613|FG000|Overall Study|Lost to Follow-up|9|||
143364804|NCT00941031|516878710|FG004|Maintenance Period|Adverse Event|0|||
143364805|NCT00941031|516878711|FG005|Maintenance Period|Adverse Event|2|||
143364806|NCT00941031|516878712|FG006|Maintenance Period|Adverse Event|8|||
143364807|NCT00941031|516878706|FG000|Maintenance Period|Lost to Follow-up|0|||
143364808|NCT00941031|516878707|FG001|Maintenance Period|Lost to Follow-up|0|||
143364809|NCT00941031|516878708|FG002|Maintenance Period|Lost to Follow-up|0|||
143364810|NCT00941031|516878709|FG003|Maintenance Period|Lost to Follow-up|0|||
143056282|NCT02576717|515745614|FG001|Overall Study|Lost to Follow-up|10|||
143056283|NCT02576717|515745615|FG002|Overall Study|Lost to Follow-up|19|||
143056284|NCT02576717|515745613|FG000|Overall Study|Protocol Violation|4|||
143056285|NCT02576717|515745614|FG001|Overall Study|Protocol Violation|0|||
143056286|NCT02576717|515745615|FG002|Overall Study|Protocol Violation|5|||
143056287|NCT02576717|515745613|FG000|Overall Study|Lack of Efficacy|24|||
143056288|NCT02576717|515745614|FG001|Overall Study|Lack of Efficacy|28|||
143056289|NCT02576717|515745615|FG002|Overall Study|Lack of Efficacy|20|||
143056290|NCT02576717|515745613|FG000|Overall Study|Adverse Event|26|||
143056291|NCT02576717|515745614|FG001|Overall Study|Adverse Event|32|||
143056292|NCT02576717|515745615|FG002|Overall Study|Adverse Event|26|||
143056293|NCT00399893|515745616|FG000|Overall Study|Withdrawal by Subject|1|||
143056294|NCT00399893|515745617|FG001|Overall Study|Withdrawal by Subject|0|||
143056295|NCT01363011|515745618|FG000|Main Study|Adverse Event|2|||
143056296|NCT01363011|515745619|FG001|Main Study|Adverse Event|3|||
143056297|NCT01363011|515745618|FG000|Main Study|Investigator's Discretion|1|||
143056298|NCT01363011|515745619|FG001|Main Study|Investigator's Discretion|1|||
143056299|NCT01363011|515745618|FG000|Main Study|Withdrew Consent|1|||
143056300|NCT01363011|515745619|FG001|Main Study|Withdrew Consent|4|||
143245234|NCT04661579|516449646|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
143245235|NCT04661579|516449647|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
143245236|NCT04661579|516449648|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
143245237|NCT04661579|516449649|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
143245238|NCT04661579|516449650|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
143056301|NCT01363011|515745618|FG000|Main Study|Protocol Violation|0|||
143056302|NCT01363011|515745619|FG001|Main Study|Protocol Violation|1|||
143056303|NCT01363011|515745618|FG000|Extension Phase|Adverse Event|1|||
143245239|NCT04329806|516449652|FG000|Overall Study|Physician Decision|3|||
143245240|NCT04329806|516449653|FG001|Overall Study|Physician Decision|4|||
143245241|NCT04838626|516449654|FG000|Overall Study|Adverse Event|2|||
143245242|NCT04838626|516449654|FG000|Overall Study|Physician Decision|6|||
143245243|NCT04838626|516449654|FG000|Overall Study|Protocol Violation|3|||
143245244|NCT04838626|516449654|FG000|Overall Study|Withdrawal by Subject|9|||
143245245|NCT04838626|516449654|FG000|Overall Study|Technical Problems|2|||
143245246|NCT00578292|516449655|FG000|Overall Study|Death|1|||
143245247|NCT00578292|516449655|FG000|Overall Study|Graft failure|2|||
143245248|NCT03901469|516449656|FG000|Overall Study|Radiographic Progression|4|||
143245249|NCT03901469|516449657|FG001|Overall Study|Radiographic Progression|6|||
143245250|NCT03901469|516449658|FG002|Overall Study|Radiographic Progression|3|||
143245251|NCT03901469|516449659|FG003|Overall Study|Radiographic Progression|30|||
143245252|NCT03901469|516449660|FG004|Overall Study|Radiographic Progression|7|||
143245253|NCT03901469|516449661|FG005|Overall Study|Radiographic Progression|2|||
143245254|NCT03901469|516449662|FG006|Overall Study|Radiographic Progression|11|||
143245255|NCT03901469|516449656|FG000|Overall Study|Clinical Progression|0|||
143245256|NCT03901469|516449657|FG001|Overall Study|Clinical Progression|2|||
143245257|NCT03901469|516449658|FG002|Overall Study|Clinical Progression|0|||
143245258|NCT03901469|516449659|FG003|Overall Study|Clinical Progression|7|||
143245259|NCT03901469|516449660|FG004|Overall Study|Clinical Progression|6|||
143499809|NCT01360645|517370496|FG003|Phase A+|Protocol Deviation|4|||
143499810|NCT00713219|517370500|FG000|Overall Study|Death|1|||
143056304|NCT01363011|515745619|FG001|Extension Phase|Adverse Event|1|||
143056305|NCT01363011|515745618|FG000|Extension Phase|Lack of Efficacy|0|||
143245260|NCT03901469|516449661|FG005|Overall Study|Clinical Progression|0|||
143245261|NCT03901469|516449662|FG006|Overall Study|Clinical Progression|2|||
143245262|NCT03901469|516449656|FG000|Overall Study|Adverse Event|1|||
143245263|NCT03901469|516449657|FG001|Overall Study|Adverse Event|0|||
143245264|NCT03901469|516449658|FG002|Overall Study|Adverse Event|0|||
143245265|NCT03901469|516449659|FG003|Overall Study|Adverse Event|0|||
143245266|NCT03901469|516449660|FG004|Overall Study|Adverse Event|0|||
143245267|NCT03901469|516449661|FG005|Overall Study|Adverse Event|0|||
143245268|NCT03901469|516449662|FG006|Overall Study|Adverse Event|9|||
143245269|NCT03901469|516449656|FG000|Overall Study|Physician Decision|0|||
143245270|NCT03901469|516449657|FG001|Overall Study|Physician Decision|0|||
143245271|NCT03901469|516449658|FG002|Overall Study|Physician Decision|0|||
143245272|NCT03901469|516449659|FG003|Overall Study|Physician Decision|1|||
143245273|NCT03901469|516449660|FG004|Overall Study|Physician Decision|0|||
143245274|NCT03901469|516449661|FG005|Overall Study|Physician Decision|0|||
143245275|NCT03901469|516449662|FG006|Overall Study|Physician Decision|0|||
143499811|NCT00713219|517370500|FG000|Overall Study|Protocol Violation|1|||
143056306|NCT01363011|515745619|FG001|Extension Phase|Lack of Efficacy|1|||
143056307|NCT01363011|515745618|FG000|Extension Phase|Investigator's Discretion|2|||
143056308|NCT01363011|515745619|FG001|Extension Phase|Investigator's Discretion|2|||
143499812|NCT04897867|517370501|FG000|Overall Study|Withdrawal of Consent|1|||
143499813|NCT04897867|517370501|FG000|Overall Study|Pregnancy|1|||
143056309|NCT01363011|515745618|FG000|Extension Phase|Withdrew Consent|0|||
143056310|NCT01363011|515745619|FG001|Extension Phase|Withdrew Consent|1|||
143056311|NCT01363011|515745618|FG000|Extension Phase|Lost to Follow-up|0|||
143056312|NCT01363011|515745619|FG001|Extension Phase|Lost to Follow-up|2|||
143364811|NCT00941031|516878710|FG004|Maintenance Period|Lost to Follow-up|2|||
143364812|NCT00941031|516878711|FG005|Maintenance Period|Lost to Follow-up|2|||
143364813|NCT00941031|516878712|FG006|Maintenance Period|Lost to Follow-up|7|||
143364814|NCT00941031|516878706|FG000|Maintenance Period|Lack of Efficacy|0|||
143364815|NCT00941031|516878707|FG001|Maintenance Period|Lack of Efficacy|0|||
143364816|NCT00941031|516878708|FG002|Maintenance Period|Lack of Efficacy|0|||
143364817|NCT00941031|516878709|FG003|Maintenance Period|Lack of Efficacy|0|||
143364818|NCT00941031|516878710|FG004|Maintenance Period|Lack of Efficacy|0|||
143364819|NCT00941031|516878711|FG005|Maintenance Period|Lack of Efficacy|0|||
143364820|NCT00941031|516878712|FG006|Maintenance Period|Lack of Efficacy|13|||
143364821|NCT01872611|516878713|FG000|Overall Study|Adverse Event|3|||
143364822|NCT01872611|516878714|FG001|Overall Study|Adverse Event|1|||
143056313|NCT01363011|515745618|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
143056314|NCT01363011|515745619|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
143056315|NCT04412057|515745620|FG000|Overall Study|Death|3|||
143056316|NCT04412057|515745621|FG001|Overall Study|Death|7|||
143056317|NCT04412057|515745620|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
143056318|NCT04412057|515745621|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
143056319|NCT00114231|515745622|FG000|Overall Study|No consent|2|||
143056320|NCT00114231|515745623|FG001|Overall Study|No consent|0|||
143056321|NCT00114231|515745622|FG000|Overall Study|QARC requirement not met|1|||
143056322|NCT00114231|515745623|FG001|Overall Study|QARC requirement not met|0|||
143056323|NCT00114231|515745622|FG000|Overall Study|Suspected metastatic disease|1|||
143056324|NCT00114231|515745623|FG001|Overall Study|Suspected metastatic disease|0|||
143056325|NCT00114231|515745622|FG000|Overall Study|No adenocarcinoma|1|||
143056326|NCT00114231|515745623|FG001|Overall Study|No adenocarcinoma|0|||
143056327|NCT00114231|515745622|FG000|Overall Study|Low creatinine clearance|0|||
143056328|NCT00114231|515745623|FG001|Overall Study|Low creatinine clearance|1|||
143056329|NCT00114231|515745622|FG000|Overall Study|Tumor size > 4cm|1|||
143056330|NCT00114231|515745623|FG001|Overall Study|Tumor size > 4cm|0|||
143056331|NCT00114231|515745622|FG000|Overall Study|Tumor fixed on digital exam|0|||
143056332|NCT00114231|515745623|FG001|Overall Study|Tumor fixed on digital exam|1|||
143056333|NCT00114231|515745622|FG000|Overall Study|No Absolute Neutrophil Count|2|||
143056334|NCT00114231|515745623|FG001|Overall Study|No Absolute Neutrophil Count|0|||
143056335|NCT00114231|515745622|FG000|Overall Study|Biopsy done after registration|1|||
143056336|NCT00114231|515745623|FG001|Overall Study|Biopsy done after registration|0|||
143056337|NCT01961882|515745627|FG000|Overall Study|Adverse Event|3|||
143056338|NCT01961882|515745628|FG001|Overall Study|Adverse Event|2|||
143056339|NCT01961882|515745627|FG000|Overall Study|Physician Decision|1|||
143056340|NCT01961882|515745628|FG001|Overall Study|Physician Decision|0|||
143056341|NCT01961882|515745627|FG000|Overall Study|Withdrawal by Subject|4|||
143056342|NCT01961882|515745628|FG001|Overall Study|Withdrawal by Subject|1|||
143056343|NCT01961882|515745627|FG000|Overall Study|Relapse of AML|39|||
143056344|NCT01961882|515745628|FG001|Overall Study|Relapse of AML|37|||
143056345|NCT01961882|515745627|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
143056346|NCT01961882|515745628|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
143056347|NCT01961882|515745627|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
143056348|NCT01961882|515745628|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
143056349|NCT01729026|515745631|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
143056350|NCT01729026|515745632|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
143056351|NCT01729026|515745631|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
143056352|NCT01729026|515745632|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
143056353|NCT02488824|515745637|FG000|Overall Study|Adverse Event|1|||
143056354|NCT02488824|515745638|FG001|Overall Study|Adverse Event|1|||
143056355|NCT02668822|515745639|FG000|Overall Study|Protocol Violation|2|||
143056356|NCT02668822|515745640|FG001|Overall Study|Protocol Violation|0|||
143056357|NCT02668822|515745639|FG000|Overall Study|Study Terminated by Sponsor|7|||
143056358|NCT02668822|515745640|FG001|Overall Study|Study Terminated by Sponsor|9|||
143056359|NCT01522950|515745641|FG000|Overall Study|Withdrawal by Subject|3|||
143056360|NCT01522950|515745642|FG001|Overall Study|Withdrawal by Subject|2|||
143056361|NCT01522950|515745643|FG002|Overall Study|Withdrawal by Subject|1|||
143056362|NCT01522950|515745641|FG000|Overall Study|Adverse Event|3|||
143056363|NCT01522950|515745642|FG001|Overall Study|Adverse Event|1|||
143056364|NCT01522950|515745643|FG002|Overall Study|Adverse Event|1|||
143056365|NCT01522950|515745641|FG000|Overall Study|Protocol Violation|0|||
143056366|NCT01522950|515745642|FG001|Overall Study|Protocol Violation|0|||
143499814|NCT04897867|517370501|FG000|Overall Study|Lost to Follow-up|7|||
143499815|NCT04897867|517370501|FG000|Overall Study|Reason not Specified|2|||
143499816|NCT03183128|517370502|FG000|Overall Study|Adverse Event|1|||
143056367|NCT01522950|515745643|FG002|Overall Study|Protocol Violation|2|||
143499817|NCT03183128|517370503|FG001|Overall Study|Adverse Event|2|||
143499818|NCT03183128|517370502|FG000|Overall Study|Withdrawal by Subject|1|||
143056368|NCT01522950|515745641|FG000|Overall Study|Death|0|||
143056369|NCT01522950|515745642|FG001|Overall Study|Death|1|||
143364823|NCT01872611|516878713|FG000|Overall Study|Adverse Event, prior to treatment|0|||
143056370|NCT01522950|515745643|FG002|Overall Study|Death|1|||
143056371|NCT01522950|515745641|FG000|Overall Study|Study Medication Sensitivity|0|||
143056372|NCT01522950|515745642|FG001|Overall Study|Study Medication Sensitivity|1|||
143056373|NCT01522950|515745643|FG002|Overall Study|Study Medication Sensitivity|0|||
143056374|NCT00412737|515745647|FG000|Overall Study|Death|1|||
143056375|NCT00412737|515745648|FG001|Overall Study|Death|0|||
143056376|NCT00412737|515745647|FG000|Overall Study|Adverse Event|3|||
143056377|NCT00412737|515745648|FG001|Overall Study|Adverse Event|2|||
143056378|NCT00412737|515745647|FG000|Overall Study|Refused Treatment|6|||
143056379|NCT00412737|515745648|FG001|Overall Study|Refused Treatment|2|||
143056380|NCT00412737|515745647|FG000|Overall Study|Failure to Return|6|||
143056381|NCT00412737|515745648|FG001|Overall Study|Failure to Return|2|||
143056382|NCT01064531|515745649|FG000|Overall Study|Lost to Follow-up|0|||
143056383|NCT01064531|515745650|FG001|Overall Study|Lost to Follow-up|2|||
143056384|NCT01064531|515745649|FG000|Overall Study|Physician Decision|0|||
143056385|NCT01064531|515745650|FG001|Overall Study|Physician Decision|1|||
143056386|NCT01064531|515745649|FG000|Overall Study|Withdrawal by Subject|2|||
143056387|NCT01064531|515745650|FG001|Overall Study|Withdrawal by Subject|2|||
143056388|NCT01064531|515745649|FG000|Overall Study|Revision due to femoral stem loosening|1|||
143056389|NCT01064531|515745650|FG001|Overall Study|Revision due to femoral stem loosening|0|||
143056390|NCT01064531|515745649|FG000|Overall Study|Revision due to dislocation|0|||
143056391|NCT01064531|515745650|FG001|Overall Study|Revision due to dislocation|1|||
143056392|NCT01064531|515745649|FG000|Overall Study|Death|0|||
143056393|NCT01064531|515745650|FG001|Overall Study|Death|1|||
143056394|NCT00298740|515745651|FG000|Overall Study|Lack of Efficacy|6|||
143056395|NCT00298740|515745651|FG000|Overall Study|Withdrawal by Subject|3|||
143056396|NCT03449199|515745655|FG000|Overall Study|Lost to Follow-up|1|||
143056397|NCT03449199|515745656|FG001|Overall Study|Lost to Follow-up|1|||
143056398|NCT03449199|515745657|FG002|Overall Study|Lost to Follow-up|0|||
143056399|NCT03449199|515745655|FG000|Overall Study|Protocol Deviation|0|||
143056400|NCT03449199|515745656|FG001|Overall Study|Protocol Deviation|0|||
143056401|NCT03449199|515745657|FG002|Overall Study|Protocol Deviation|1|||
143056402|NCT03449199|515745655|FG000|Overall Study|Withdrawal by Subject|0|||
143056403|NCT03449199|515745656|FG001|Overall Study|Withdrawal by Subject|0|||
143056404|NCT03449199|515745657|FG002|Overall Study|Withdrawal by Subject|1|||
143056405|NCT01091103|515745658|FG000|Overall Study|Adverse Event|1|||
143056406|NCT01091103|515745658|FG000|Overall Study|Progressive Disease|3|||
143056407|NCT01270620|515745659|FG000|Overall Study|Withdrawal by Subject|1|||
143056408|NCT01270620|515745660|FG001|Overall Study|Withdrawal by Subject|3|||
143056409|NCT00684567|515745661|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
143056410|NCT00684567|515745661|FG000|Monotherapy Period|Adverse Event|2|||
143056411|NCT00684567|515745661|FG000|Monotherapy Period|Death|1|||
143056412|NCT00684567|515745661|FG000|Monotherapy Period|Progression of primary disease|11|||
143056413|NCT03136406|515745662|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
143056414|NCT01086969|515745673|FG000|Overall Study|Withdrawal by Subject|1|||
143056415|NCT01086969|515745674|FG001|Overall Study|Withdrawal by Subject|2|||
143056416|NCT01086969|515745675|FG002|Overall Study|Withdrawal by Subject|0|||
143056417|NCT00819767|515745678|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
143056418|NCT00819767|515745679|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
143056419|NCT02418754|515745682|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
143056420|NCT02418754|515745683|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
143056421|NCT02418754|515745684|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
143056422|NCT02418754|515745685|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
143499819|NCT03183128|517370503|FG001|Overall Study|Withdrawal by Subject|8|||
143056423|NCT02418754|515745686|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
143056424|NCT02418754|515745682|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
143056425|NCT02418754|515745683|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
143056426|NCT02418754|515745684|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
143056427|NCT02418754|515745685|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
143056428|NCT02418754|515745686|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
143056429|NCT02418754|515745682|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
143499820|NCT03183128|517370502|FG000|Overall Study|Protocol Violation|2|||
143499821|NCT03183128|517370503|FG001|Overall Study|Protocol Violation|0|||
143499822|NCT03183128|517370502|FG000|Overall Study|Lack of Efficacy|4|||
143499823|NCT03183128|517370503|FG001|Overall Study|Lack of Efficacy|27|||
143499824|NCT03183128|517370502|FG000|Overall Study|Lost to Follow-up|1|||
143499825|NCT03183128|517370503|FG001|Overall Study|Lost to Follow-up|0|||
143499826|NCT03183128|517370502|FG000|Overall Study|Death|2|||
143499827|NCT03183128|517370503|FG001|Overall Study|Death|0|||
143499828|NCT03183128|517370502|FG000|Overall Study|Physician Decision|1|||
143499829|NCT03183128|517370503|FG001|Overall Study|Physician Decision|0|||
143056430|NCT02418754|515745683|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
143056431|NCT02418754|515745684|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
143056432|NCT02418754|515745685|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
143056433|NCT02418754|515745686|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
143056434|NCT02418754|515745682|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
143499830|NCT00330187|517370506|FG000|Overall Study|Lost to Follow-up|12|||
143056435|NCT02418754|515745683|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
143056436|NCT02418754|515745684|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
143056437|NCT02418754|515745685|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
143056438|NCT02418754|515745686|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
143056439|NCT02418754|515745682|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
143056440|NCT02418754|515745683|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
143056441|NCT02418754|515745684|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
143056442|NCT02418754|515745685|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
143056443|NCT02418754|515745686|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
143056444|NCT02418754|515745682|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
143056445|NCT02418754|515745683|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
143056446|NCT02418754|515745684|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
143056447|NCT02418754|515745685|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
143056448|NCT02418754|515745686|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
143056449|NCT02418754|515745682|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
143056450|NCT02418754|515745683|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
143056451|NCT02418754|515745684|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
143056452|NCT02418754|515745685|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
143056453|NCT02418754|515745686|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
143056454|NCT02418754|515745682|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
143056455|NCT02418754|515745683|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
143056456|NCT02418754|515745684|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
143245276|NCT03901469|516449656|FG000|Overall Study|Withdrawal by Subject|0|||
143499831|NCT00330187|517370507|FG001|Overall Study|Lost to Follow-up|13|||
143499832|NCT00330187|517370508|FG002|Overall Study|Lost to Follow-up|14|||
143499833|NCT00330187|517370509|FG003|Overall Study|Lost to Follow-up|10|||
143499834|NCT00330187|517370506|FG000|Overall Study|Withdrawal by Subject|8|||
143499835|NCT00330187|517370507|FG001|Overall Study|Withdrawal by Subject|5|||
143499836|NCT00330187|517370508|FG002|Overall Study|Withdrawal by Subject|4|||
143499837|NCT00330187|517370509|FG003|Overall Study|Withdrawal by Subject|4|||
143499838|NCT03258814|517370510|FG000|Overall Study|Early Termination|4|||
143499839|NCT03258814|517370511|FG001|Overall Study|Early Termination|3|||
143499840|NCT03258814|517370512|FG002|Overall Study|Early Termination|10|||
143499841|NCT01900002|517370513|FG000|Overall Study|Withdrawal by Subject|2|||
143499842|NCT01900002|517370513|FG000|Overall Study|ineligible for Y-90|4|||
143499843|NCT01573910|517370520|FG000|Overall Study|Adverse Event|4|||
143499844|NCT01573910|517370521|FG001|Overall Study|Adverse Event|4|||
143056457|NCT02418754|515745685|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
143245277|NCT03901469|516449657|FG001|Overall Study|Withdrawal by Subject|0|||
143245278|NCT03901469|516449658|FG002|Overall Study|Withdrawal by Subject|0|||
143245279|NCT03901469|516449659|FG003|Overall Study|Withdrawal by Subject|0|||
143245280|NCT03901469|516449660|FG004|Overall Study|Withdrawal by Subject|2|||
143245281|NCT03901469|516449661|FG005|Overall Study|Withdrawal by Subject|0|||
143245282|NCT03901469|516449662|FG006|Overall Study|Withdrawal by Subject|8|||
143245283|NCT03901469|516449656|FG000|Overall Study|Death|0|||
143245284|NCT03901469|516449657|FG001|Overall Study|Death|0|||
143245285|NCT03901469|516449658|FG002|Overall Study|Death|0|||
143245286|NCT03901469|516449659|FG003|Overall Study|Death|3|||
143245287|NCT03901469|516449660|FG004|Overall Study|Death|5|||
143245288|NCT03901469|516449661|FG005|Overall Study|Death|0|||
143245289|NCT03901469|516449662|FG006|Overall Study|Death|1|||
143245290|NCT03901469|516449656|FG000|Overall Study|Termination of study by sponsor|0|||
143245291|NCT03901469|516449657|FG001|Overall Study|Termination of study by sponsor|0|||
143245292|NCT03901469|516449658|FG002|Overall Study|Termination of study by sponsor|0|||
143245293|NCT03901469|516449659|FG003|Overall Study|Termination of study by sponsor|0|||
143245294|NCT03901469|516449660|FG004|Overall Study|Termination of study by sponsor|1|||
143245295|NCT03901469|516449661|FG005|Overall Study|Termination of study by sponsor|1|||
143245296|NCT03901469|516449662|FG006|Overall Study|Termination of study by sponsor|0|||
143245297|NCT03901469|516449656|FG000|Overall Study|Not Reported|1|||
143245298|NCT03901469|516449657|FG001|Overall Study|Not Reported|0|||
143245299|NCT03901469|516449658|FG002|Overall Study|Not Reported|0|||
143245300|NCT03901469|516449659|FG003|Overall Study|Not Reported|1|||
143245301|NCT03901469|516449660|FG004|Overall Study|Not Reported|0|||
143245302|NCT03901469|516449661|FG005|Overall Study|Not Reported|0|||
143245303|NCT03901469|516449662|FG006|Overall Study|Not Reported|1|||
143245304|NCT00459186|516449663|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
143245305|NCT00459186|516449663|FG000|PET Imaging and Assessment|Adverse Event|3|||
143245306|NCT03710083|516449664|FG000|Overall Study|Withdrawal by Subject|2|||
143245307|NCT03710083|516449664|FG000|Overall Study|Unsuccessful Procedure|1|||
143245308|NCT02920242|516449665|FG000|Overall Study|Withdrawal by Subject|1|||
143245309|NCT02920242|516449666|FG001|Overall Study|Withdrawal by Subject|0|||
143499845|NCT01573910|517370520|FG000|Overall Study|Lost to Follow-up|2|||
143499846|NCT01573910|517370521|FG001|Overall Study|Lost to Follow-up|1|||
143499847|NCT01573910|517370520|FG000|Overall Study|Withdrawal by Subject|0|||
143169538|NCT02958865|516169892|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
143169539|NCT02958865|516169893|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
143169540|NCT02958865|516169894|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
143169541|NCT02958865|516169895|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
143169542|NCT02958865|516169896|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
143169543|NCT02958865|516169897|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
143169544|NCT02958865|516169882|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
143169545|NCT02958865|516169883|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
143169546|NCT02958865|516169884|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
143169547|NCT02958865|516169885|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
143169548|NCT02958865|516169886|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
143169549|NCT02958865|516169887|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
143169550|NCT02958865|516169888|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
143169551|NCT02958865|516169889|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
143169552|NCT02958865|516169890|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
143169553|NCT02958865|516169891|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
143499848|NCT01573910|517370521|FG001|Overall Study|Withdrawal by Subject|1|||
143499849|NCT01573910|517370520|FG000|Overall Study|Protocol Violation|3|||
143499850|NCT01573910|517370521|FG001|Overall Study|Protocol Violation|0|||
143499851|NCT01573910|517370520|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
143499852|NCT01573910|517370521|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
143499853|NCT00364182|517370522|FG000|First Intervention|Secondary prophylaxis|1|||
143499854|NCT00364182|517370523|FG001|First Intervention|Secondary prophylaxis|0|||
143499855|NCT00364182|517370524|FG002|First Intervention|Secondary prophylaxis|0|||
143499856|NCT00364182|517370522|FG000|First Intervention|Withdrawal by Subject|2|||
143499857|NCT00364182|517370523|FG001|First Intervention|Withdrawal by Subject|0|||
143499858|NCT00364182|517370524|FG002|First Intervention|Withdrawal by Subject|0|||
143499859|NCT00364182|517370522|FG000|Second Intervention|non-compliance|0|||
143499860|NCT00364182|517370523|FG001|Second Intervention|non-compliance|1|||
143499861|NCT00364182|517370524|FG002|Second Intervention|non-compliance|1|||
143499862|NCT00364182|517370522|FG000|Second Intervention|Protocol Violation|0|||
143499863|NCT00364182|517370523|FG001|Second Intervention|Protocol Violation|1|||
143499864|NCT00364182|517370524|FG002|Second Intervention|Protocol Violation|0|||
143499865|NCT00364182|517370522|FG000|Second Intervention|Adverse Event|0|||
143499866|NCT00364182|517370523|FG001|Second Intervention|Adverse Event|0|||
143499867|NCT00364182|517370524|FG002|Second Intervention|Adverse Event|1|||
143499868|NCT00364182|517370522|FG000|Third Intervention|non-compliance|0|||
143499869|NCT00364182|517370523|FG001|Third Intervention|non-compliance|1|||
143499870|NCT00364182|517370524|FG002|Third Intervention|non-compliance|0|||
143499871|NCT00364182|517370522|FG000|Third Intervention|Lost to Follow-up|0|||
143499872|NCT00364182|517370523|FG001|Third Intervention|Lost to Follow-up|0|||
143499873|NCT00364182|517370524|FG002|Third Intervention|Lost to Follow-up|1|||
143499874|NCT00974220|517370527|FG000|Treatment Period 1|Adverse Event|2|||
143499875|NCT00974220|517370528|FG001|Treatment Period 1|Adverse Event|1|||
143499876|NCT00974220|517370527|FG000|Treatment Period 1|noncompliant subjects|0|||
143499877|NCT00974220|517370528|FG001|Treatment Period 1|noncompliant subjects|1|||
143499878|NCT03403400|517370529|FG000|Overall Study|Lost to Follow-up|1|||
143499879|NCT03403400|517370530|FG001|Overall Study|Lost to Follow-up|0|||
143499880|NCT03403400|517370531|FG002|Overall Study|Lost to Follow-up|1|||
143499881|NCT03403400|517370529|FG000|Overall Study|Hospitalization|1|||
143499882|NCT03403400|517370530|FG001|Overall Study|Hospitalization|0|||
143499883|NCT03403400|517370531|FG002|Overall Study|Hospitalization|0|||
143499884|NCT03403400|517370529|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
143499885|NCT03403400|517370530|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
143499886|NCT03403400|517370531|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
143499887|NCT00565617|517370532|FG000|Overall Study|Withdrawal by Subject|1|||
143499888|NCT01273064|517370533|FG000|Overall Study|Adverse Event|5|||
143499889|NCT01273064|517370534|FG001|Overall Study|Adverse Event|1|||
143499890|NCT01273064|517370535|FG002|Overall Study|Adverse Event|3|||
143499891|NCT01273064|517370536|FG003|Overall Study|Adverse Event|2|||
143169554|NCT02958865|516169892|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
143169555|NCT02958865|516169893|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
143499892|NCT01273064|517370537|FG004|Overall Study|Adverse Event|1|||
143499893|NCT01273064|517370533|FG000|Overall Study|Withdrawal by Subject|4|||
143169556|NCT02958865|516169894|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
143169557|NCT02958865|516169895|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
143169558|NCT02958865|516169896|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
143169559|NCT02958865|516169897|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
143169560|NCT02958865|516169882|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
143169561|NCT02958865|516169883|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
143169562|NCT02958865|516169884|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
143169563|NCT02958865|516169885|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
143056458|NCT02418754|515745686|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
143056459|NCT02418754|515745682|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
143056460|NCT02418754|515745683|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
143056461|NCT02418754|515745684|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
143056462|NCT02418754|515745685|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
143056463|NCT02418754|515745686|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
143056464|NCT02418754|515745682|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
143056465|NCT02418754|515745683|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
143056466|NCT02418754|515745684|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
143056467|NCT02418754|515745685|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
143499894|NCT01273064|517370534|FG001|Overall Study|Withdrawal by Subject|2|||
143499895|NCT01273064|517370535|FG002|Overall Study|Withdrawal by Subject|2|||
143499896|NCT01273064|517370536|FG003|Overall Study|Withdrawal by Subject|2|||
143499897|NCT01273064|517370537|FG004|Overall Study|Withdrawal by Subject|0|||
143499898|NCT01273064|517370533|FG000|Overall Study|Study Termination|13|||
143499899|NCT01273064|517370534|FG001|Overall Study|Study Termination|27|||
143245310|NCT02920242|516449667|FG002|Overall Study|Withdrawal by Subject|1|||
143245311|NCT02920242|516449665|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
143245312|NCT02920242|516449666|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
143245313|NCT02920242|516449667|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
143245314|NCT00573144|516449670|FG000|Overall Study|Withdrawal by Subject|2|||
143245315|NCT00573144|516449671|FG001|Overall Study|Withdrawal by Subject|3|||
143245316|NCT00441064|516449672|FG000|Overall Study|Adverse Event|1|||
143245317|NCT00441064|516449673|FG001|Overall Study|Adverse Event|0|||
143245318|NCT00441064|516449672|FG000|Overall Study|Abnormal laboratory values|0|||
143245319|NCT00441064|516449673|FG001|Overall Study|Abnormal laboratory values|2|||
143245320|NCT00441064|516449672|FG000|Overall Study|Abnormal test procedure results|0|||
143364824|NCT01872611|516878714|FG001|Overall Study|Adverse Event, prior to treatment|1|||
143364825|NCT01872611|516878713|FG000|Overall Study|Death|0|||
143364826|NCT01872611|516878714|FG001|Overall Study|Death|1|||
143245321|NCT00441064|516449673|FG001|Overall Study|Abnormal test procedure results|1|||
143245322|NCT00441064|516449672|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
143245323|NCT00441064|516449673|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
143499900|NCT01273064|517370535|FG002|Overall Study|Study Termination|26|||
143499901|NCT01273064|517370536|FG003|Overall Study|Study Termination|16|||
143499902|NCT01273064|517370537|FG004|Overall Study|Study Termination|8|||
143499903|NCT01273064|517370533|FG000|Overall Study|Lost to Follow-up|1|||
143499904|NCT01273064|517370534|FG001|Overall Study|Lost to Follow-up|0|||
143499905|NCT01273064|517370535|FG002|Overall Study|Lost to Follow-up|0|||
143499906|NCT01273064|517370536|FG003|Overall Study|Lost to Follow-up|0|||
143499907|NCT01273064|517370537|FG004|Overall Study|Lost to Follow-up|0|||
143499908|NCT01273064|517370533|FG000|Overall Study|Physician Decision|0|||
143499909|NCT01273064|517370534|FG001|Overall Study|Physician Decision|0|||
143499910|NCT01273064|517370535|FG002|Overall Study|Physician Decision|0|||
143499911|NCT01273064|517370536|FG003|Overall Study|Physician Decision|0|||
143499912|NCT01273064|517370537|FG004|Overall Study|Physician Decision|1|||
143499913|NCT02867761|517370540|FG000|Overall Study|Participant withdrawn by investigator|0|||
143499914|NCT02867761|517370541|FG001|Overall Study|Participant withdrawn by investigator|1|||
143499915|NCT02867761|517370540|FG000|Overall Study|Lost to Follow-up|25|||
143499916|NCT02867761|517370541|FG001|Overall Study|Lost to Follow-up|18|||
143499917|NCT02867761|517370540|FG000|Overall Study|Unable to complete protocol|3|||
143499918|NCT02867761|517370541|FG001|Overall Study|Unable to complete protocol|7|||
143499919|NCT01512264|517370542|FG000|Overall Study|Lost to Follow-up|0|||
143499920|NCT01512264|517370543|FG001|Overall Study|Lost to Follow-up|0|||
143056468|NCT02418754|515745686|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
143056469|NCT02418754|515745682|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
143056470|NCT02418754|515745683|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
143245324|NCT00441064|516449672|FG000|Overall Study|Protocol Deviation|3|||
143245325|NCT00441064|516449673|FG001|Overall Study|Protocol Deviation|2|||
143245326|NCT00441064|516449672|FG000|Overall Study|Patient withdrew consent|5|||
143499921|NCT01512264|517370544|FG002|Overall Study|Lost to Follow-up|0|||
143499922|NCT01512264|517370545|FG003|Overall Study|Lost to Follow-up|1|||
143499923|NCT01931059|517370546|FG000|Day 1|Pregnancy|0|||
143499924|NCT01931059|517370547|FG001|Day 1|Pregnancy|1|||
143499925|NCT01931059|517370546|FG000|Day3|Lost to Follow-up|1|||
143499926|NCT01931059|517370547|FG001|Day3|Lost to Follow-up|0|||
143499927|NCT03158220|517370548|FG000|Overall Study|Screen Failure|0|||
143499928|NCT03158220|517370549|FG001|Overall Study|Screen Failure|1|||
143499929|NCT03158220|517370548|FG000|Overall Study|Withdrawal by Subject|8|||
143364827|NCT01872611|516878713|FG000|Overall Study|Death, prior to treatment|0|||
143499930|NCT03158220|517370549|FG001|Overall Study|Withdrawal by Subject|9|||
143499931|NCT03158220|517370548|FG000|Overall Study|Status unknown|0|||
143499932|NCT03158220|517370549|FG001|Overall Study|Status unknown|1|||
143499933|NCT03158220|517370548|FG000|Overall Study|Lost to Follow-up|8|||
143499934|NCT03158220|517370549|FG001|Overall Study|Lost to Follow-up|5|||
143499935|NCT03158220|517370548|FG000|Overall Study|Physician Decision|1|||
143499936|NCT03158220|517370549|FG001|Overall Study|Physician Decision|0|||
143499937|NCT00560755|517370552|FG000|Overall Study|Protocol Violation|15|||
143499938|NCT00560755|517370552|FG000|Overall Study|Withdrawal by Subject|26|||
143499939|NCT00560755|517370552|FG000|Overall Study|Lost to Follow-up|9|||
143499940|NCT00560755|517370552|FG000|Overall Study|Adverse Event|8|||
143499941|NCT00560755|517370552|FG000|Overall Study|Physician Decision|2|||
143499942|NCT00848120|517370553|FG000|Overall Study|Adverse Event|1|||
143499943|NCT01961115|517370557|FG000|Overall Study|Disease Progression|1|||
143499944|NCT01961115|517370558|FG001|Overall Study|Disease Progression|0|||
143499945|NCT01961115|517370559|FG002|Overall Study|Disease Progression|3|||
143499946|NCT01961115|517370557|FG000|Overall Study|Adverse Event|1|||
143499947|NCT01961115|517370558|FG001|Overall Study|Adverse Event|0|||
143499948|NCT01961115|517370559|FG002|Overall Study|Adverse Event|1|||
143499949|NCT05501119|517370560|FG000|Overall Study|Withdrawal by Subject|2|||
143499950|NCT05501119|517370560|FG000|Overall Study|Lost to Follow-up|5|||
143499951|NCT01078805|517370569|FG000|Overall Study|Clinically significant abnormal lab|5|||
143499952|NCT01078805|517370569|FG000|Overall Study|Death|134|||
143499953|NCT01078805|517370569|FG000|Overall Study|Lost to Follow-up|676|||
143499954|NCT01078805|517370569|FG000|Overall Study|Physician Decision|169|||
143499955|NCT01078805|517370569|FG000|Overall Study|Serious adverse event|26|||
143499956|NCT01078805|517370569|FG000|Overall Study|Sponsor decision|46|||
143499957|NCT01078805|517370569|FG000|Overall Study|Withdrawal by Subject|739|||
143499958|NCT01078805|517370569|FG000|Overall Study|Other|173|||
143499959|NCT01078805|517370569|FG000|Overall Study|Didn't take study drug|82|||
143499960|NCT02246621|517370577|FG000|Overall Study|Withdrawal by Subject|28|||
143499961|NCT02246621|517370578|FG001|Overall Study|Withdrawal by Subject|16|||
143499962|NCT02246621|517370577|FG000|Overall Study|Lost to Follow-up|1|||
143499963|NCT02246621|517370578|FG001|Overall Study|Lost to Follow-up|0|||
143499964|NCT02246621|517370577|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
143499965|NCT02246621|517370578|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
143499966|NCT01292057|517370579|FG000|Overall Study|Protocol Violation|1|||
143499967|NCT01292057|517370580|FG001|Overall Study|Protocol Violation|1|||
143499968|NCT01292057|517370579|FG000|Overall Study|Lost to Follow-up|1|||
143499969|NCT01292057|517370580|FG001|Overall Study|Lost to Follow-up|1|||
143499970|NCT04025632|517372278|FG000|Overall Study|Adverse Event|1|||
143499971|NCT04025632|517372279|FG001|Overall Study|Adverse Event|1|||
143499972|NCT04025632|517372278|FG000|Overall Study|Withdrawal by Subject|1|||
143499973|NCT04025632|517372279|FG001|Overall Study|Withdrawal by Subject|1|||
143499974|NCT04025632|517372278|FG000|Overall Study|Study Terminated by Sponsor|10|||
143499975|NCT04025632|517372279|FG001|Overall Study|Study Terminated by Sponsor|9|||
143499976|NCT04025632|517372278|FG000|Overall Study|Physician Decision|3|||
143499977|NCT04025632|517372279|FG001|Overall Study|Physician Decision|1|||
143499978|NCT00376961|517372280|FG000|Initial Registration|Adverse Event|1|||
143499979|NCT00376961|517372281|FG001|Initial Registration|Adverse Event|0|||
143499980|NCT00376961|517372280|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
143499981|NCT00376961|517372281|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
143499982|NCT00376961|517372280|FG000|Initial Registration|Progression/relapse|1|||
143499983|NCT00376961|517372281|FG001|Initial Registration|Progression/relapse|0|||
143499984|NCT00376961|517372280|FG000|Initial Registration|Ineligible|3|||
143499985|NCT00376961|517372281|FG001|Initial Registration|Ineligible|0|||
143499986|NCT00376961|517372280|FG000|Maintenance|Adverse Event|0|||
143499987|NCT00376961|517372281|FG001|Maintenance|Adverse Event|1|||
143499988|NCT00376961|517372280|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
143499989|NCT00376961|517372281|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
143499990|NCT00376961|517372280|FG000|Maintenance|Progression/relapse|0|||
143499991|NCT00376961|517372281|FG001|Maintenance|Progression/relapse|18|||
143499992|NCT00376961|517372280|FG000|Maintenance|Ineligible|0|||
143499993|NCT00376961|517372281|FG001|Maintenance|Ineligible|3|||
143499994|NCT01974817|517372283|FG000|Overall Study|Death|4|||
143499995|NCT01974817|517372283|FG000|Overall Study|Lost to Follow-up|2|||
143499996|NCT01974817|517372283|FG000|Overall Study|Protocol Violation|2|||
143499997|NCT04047797|517372286|FG000|Overall Study|Progressive Disease|1|||
143499998|NCT00947531|517372288|FG000|Overall Study|Withdrawal by Subject|10|||
143499999|NCT00947531|517372289|FG001|Overall Study|Withdrawal by Subject|7|||
143500000|NCT00947531|517372288|FG000|Overall Study|Administrative Reason|0|||
143500001|NCT00947531|517372289|FG001|Overall Study|Administrative Reason|1|||
143500002|NCT00947531|517372288|FG000|Overall Study|Adverse Event|2|||
143500003|NCT00947531|517372289|FG001|Overall Study|Adverse Event|2|||
143500004|NCT00947531|517372288|FG000|Overall Study|Lack of Efficacy|1|||
143500005|NCT00947531|517372289|FG001|Overall Study|Lack of Efficacy|0|||
143500006|NCT00947531|517372288|FG000|Overall Study|Other|1|||
143500007|NCT00947531|517372289|FG001|Overall Study|Other|1|||
143500008|NCT00988247|517372294|FG000|Overall Study|Adverse Event|17|||
143500009|NCT00988247|517372295|FG001|Overall Study|Adverse Event|3|||
143500010|NCT00988247|517372294|FG000|Overall Study|Withdrawal by Subject|44|||
143500011|NCT00988247|517372295|FG001|Overall Study|Withdrawal by Subject|13|||
143056471|NCT02418754|515745684|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
143056472|NCT02418754|515745685|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
143056473|NCT02418754|515745686|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
143056474|NCT04974580|515745687|FG000|Overall Study|Lost to Follow-up|33|||
143056475|NCT04974580|515745688|FG001|Overall Study|Lost to Follow-up|39|||
143056476|NCT04974580|515745689|FG002|Overall Study|Lost to Follow-up|30|||
143169564|NCT02958865|516169886|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
143169565|NCT02958865|516169887|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
143169566|NCT02958865|516169888|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
143169567|NCT02958865|516169889|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
143169568|NCT02958865|516169890|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
143169569|NCT02958865|516169891|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
143169570|NCT02958865|516169892|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
143169571|NCT02958865|516169893|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
143169572|NCT02958865|516169894|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
143169573|NCT02958865|516169895|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
143169574|NCT02958865|516169896|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
143169575|NCT02958865|516169897|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
143169576|NCT02958865|516169882|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
143169577|NCT02958865|516169883|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
143169578|NCT02958865|516169884|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
143169579|NCT02958865|516169885|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
143169580|NCT02958865|516169886|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
143169581|NCT02958865|516169887|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
143169582|NCT02958865|516169888|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
143169583|NCT02958865|516169889|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
143169584|NCT02958865|516169890|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
143169585|NCT02958865|516169891|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
143169586|NCT02958865|516169892|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
143169587|NCT02958865|516169893|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
143169588|NCT02958865|516169894|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
143169589|NCT02958865|516169895|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
143169590|NCT02958865|516169896|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
143169591|NCT02958865|516169897|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
143169592|NCT02958865|516169882|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
143169593|NCT02958865|516169883|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
143169594|NCT02958865|516169884|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
143169595|NCT02958865|516169885|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
143169596|NCT02958865|516169886|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
143169597|NCT02958865|516169887|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
143169598|NCT02958865|516169888|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
143169599|NCT02958865|516169889|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
143169600|NCT02958865|516169890|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
143169601|NCT02958865|516169891|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
143169602|NCT02958865|516169892|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
143169603|NCT02958865|516169893|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
143169604|NCT02958865|516169894|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
143169605|NCT02958865|516169895|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
143169606|NCT02958865|516169896|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
143169607|NCT02958865|516169897|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
143169608|NCT02958865|516169882|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
143169609|NCT02958865|516169883|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
143169610|NCT02958865|516169884|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
143169611|NCT02958865|516169885|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
143169612|NCT02958865|516169886|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
143169613|NCT02958865|516169887|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
143169614|NCT02958865|516169888|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
143169615|NCT02958865|516169889|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
143169616|NCT02958865|516169890|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
143169617|NCT02958865|516169891|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
143169618|NCT02958865|516169892|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
143169619|NCT02958865|516169893|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
143169620|NCT02958865|516169894|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
143169621|NCT02958865|516169895|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
143056477|NCT04974580|515745690|FG003|Overall Study|Lost to Follow-up|29|||
143056478|NCT00250705|515745691|FG000|Overall Study|Lack of Efficacy|2|||
143056479|NCT05467982|515745692|FG000|Overall Study|Death|0|||
143500012|NCT00988247|517372294|FG000|Overall Study|Pregnancy|1|||
143056480|NCT05467982|515745693|FG001|Overall Study|Death|1|||
143056481|NCT05467982|515745692|FG000|Overall Study|Lost to Follow-up|3|||
143056482|NCT05467982|515745693|FG001|Overall Study|Lost to Follow-up|1|||
143056483|NCT00761176|515745720|FG000|Overall Study|Death|1|||
143056484|NCT00761176|515745721|FG001|Overall Study|Death|0|||
143056485|NCT00761176|515745720|FG000|Overall Study|Withdrawal by Subject|1|||
143056486|NCT00761176|515745721|FG001|Overall Study|Withdrawal by Subject|1|||
143056487|NCT02762994|515745722|FG000|Overall Study|Withdrawal by Subject|0|||
143056488|NCT02762994|515745723|FG001|Overall Study|Withdrawal by Subject|1|||
143056489|NCT02762994|515745724|FG002|Overall Study|Withdrawal by Subject|2|||
143056490|NCT02762994|515745725|FG003|Overall Study|Withdrawal by Subject|0|||
143056491|NCT02762994|515745722|FG000|Overall Study|Protocol Violation|1|||
143169622|NCT02958865|516169896|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
143056492|NCT02762994|515745723|FG001|Overall Study|Protocol Violation|0|||
143056493|NCT02762994|515745724|FG002|Overall Study|Protocol Violation|0|||
143056494|NCT02762994|515745725|FG003|Overall Study|Protocol Violation|2|||
143056495|NCT02020967|515745734|FG000|Overall Study|Withdrawal by Subject|51|||
143056496|NCT00585312|515745737|FG000|Overall Study|Adverse Event|3|||
143056497|NCT00585312|515745738|FG001|Overall Study|Adverse Event|0|||
143056498|NCT00585312|515745737|FG000|Overall Study|Lack of Efficacy|6|||
143056499|NCT00585312|515745738|FG001|Overall Study|Lack of Efficacy|11|||
143056500|NCT00585312|515745737|FG000|Overall Study|Lost to Follow-up|1|||
143056501|NCT00585312|515745738|FG001|Overall Study|Lost to Follow-up|1|||
143056502|NCT00585312|515745737|FG000|Overall Study|Reason not specified|2|||
143056503|NCT00585312|515745738|FG001|Overall Study|Reason not specified|0|||
143056504|NCT00585312|515745737|FG000|Overall Study|Withdrawal by Subject|5|||
143056505|NCT00585312|515745738|FG001|Overall Study|Withdrawal by Subject|1|||
143056506|NCT00585312|515745737|FG000|Overall Study|Study terminated by the sponsor|34|||
143056507|NCT00585312|515745738|FG001|Overall Study|Study terminated by the sponsor|31|||
143056508|NCT04234464|515745739|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
143056509|NCT04234464|515745740|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
143056510|NCT00983528|515745741|FG000|Overall Study|Death|4|||
143056511|NCT00983528|515745741|FG000|Overall Study|Lost to Follow-up|1|||
143056512|NCT00983528|515745741|FG000|Overall Study|Study Terminated|1|||
143056513|NCT00476593|515745742|FG000|Overall Study|Lost to Follow-up|10|||
143056514|NCT00476593|515745743|FG001|Overall Study|Lost to Follow-up|2|||
143056515|NCT00476593|515745744|FG002|Overall Study|Lost to Follow-up|8|||
143056516|NCT00476593|515745745|FG003|Overall Study|Lost to Follow-up|22|||
143056517|NCT03712124|515745749|FG000|Overall Study|Protocol Violation|1|||
143500013|NCT00988247|517372295|FG001|Overall Study|Pregnancy|2|||
143056518|NCT03712124|515745750|FG001|Overall Study|Protocol Violation|0|||
143056519|NCT00129116|515745751|FG000|Primary Phase|Lost to Follow-up|1|||
143056520|NCT00129116|515745752|FG001|Primary Phase|Lost to Follow-up|1|||
143056521|NCT00129116|515745753|FG002|Primary Phase|Lost to Follow-up|0|||
143056522|NCT00129116|515745754|FG003|Primary Phase|Lost to Follow-up|1|||
143056523|NCT00129116|515745755|FG004|Primary Phase|Lost to Follow-up|1|||
143056524|NCT00129116|515745751|FG000|Primary Phase|Protocol Violation|0|||
143056525|NCT00129116|515745752|FG001|Primary Phase|Protocol Violation|1|||
143056526|NCT00129116|515745753|FG002|Primary Phase|Protocol Violation|0|||
143056527|NCT00129116|515745754|FG003|Primary Phase|Protocol Violation|0|||
143056528|NCT00129116|515745755|FG004|Primary Phase|Protocol Violation|0|||
143056529|NCT00129116|515745751|FG000|Primary Phase|Adverse Event|1|||
143056530|NCT00129116|515745752|FG001|Primary Phase|Adverse Event|1|||
143056531|NCT00129116|515745753|FG002|Primary Phase|Adverse Event|0|||
143500014|NCT00988247|517372294|FG000|Overall Study|Lost to Follow-up|11|||
143500015|NCT00988247|517372295|FG001|Overall Study|Lost to Follow-up|2|||
143056532|NCT00129116|515745754|FG003|Primary Phase|Adverse Event|0|||
143056533|NCT00129116|515745755|FG004|Primary Phase|Adverse Event|0|||
143056534|NCT00129116|515745751|FG000|Primary Phase|Withdrawal by Subject|0|||
143056535|NCT00129116|515745752|FG001|Primary Phase|Withdrawal by Subject|1|||
143056536|NCT00129116|515745753|FG002|Primary Phase|Withdrawal by Subject|0|||
143056537|NCT00129116|515745754|FG003|Primary Phase|Withdrawal by Subject|0|||
143056538|NCT00129116|515745755|FG004|Primary Phase|Withdrawal by Subject|0|||
143056539|NCT00129116|515745751|FG000|Primary Phase|Other|0|||
143056540|NCT00129116|515745752|FG001|Primary Phase|Other|0|||
143056541|NCT00129116|515745753|FG002|Primary Phase|Other|1|||
143056542|NCT00129116|515745754|FG003|Primary Phase|Other|0|||
143056543|NCT00129116|515745755|FG004|Primary Phase|Other|0|||
143056544|NCT00129116|515745751|FG000|Booster Phase|Lost to Follow-up|2|||
143056545|NCT00129116|515745752|FG001|Booster Phase|Lost to Follow-up|0|||
143056546|NCT00129116|515745753|FG002|Booster Phase|Lost to Follow-up|0|||
143056547|NCT00129116|515745754|FG003|Booster Phase|Lost to Follow-up|0|||
143056548|NCT00129116|515745755|FG004|Booster Phase|Lost to Follow-up|1|||
143056549|NCT01020526|515745756|FG000|Overall Study|Withdrawal by Subject|5|||
143056550|NCT01020526|515745756|FG000|Overall Study|Other reasons|3|||
143500016|NCT00988247|517372294|FG000|Overall Study|Protocol Violation|4|||
143500017|NCT00988247|517372295|FG001|Overall Study|Protocol Violation|5|||
143500018|NCT00988247|517372294|FG000|Overall Study|Sponsor requested withdrawal|3|||
143056551|NCT01020526|515745756|FG000|Overall Study|Insufficient clinical response|3|||
143056552|NCT01020526|515745756|FG000|Overall Study|Lost to Follow-up|1|||
143056553|NCT01020526|515745756|FG000|Overall Study|Adverse Event|2|||
143056554|NCT00879684|515745757|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
143056555|NCT00879684|515745758|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
143056556|NCT00879684|515745759|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
143056557|NCT00879684|515745760|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
143056558|NCT00879684|515745761|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
143056559|NCT00879684|515745762|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
143056560|NCT00879684|515745763|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
143056561|NCT00879684|515745757|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
143056562|NCT00879684|515745758|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
143056563|NCT00879684|515745759|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
143056564|NCT00879684|515745760|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
143056565|NCT00879684|515745761|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
143056566|NCT00879684|515745762|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
143056567|NCT00879684|515745763|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
143056568|NCT00879684|515745757|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
143056569|NCT00879684|515745758|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
143500019|NCT00988247|517372295|FG001|Overall Study|Sponsor requested withdrawal|1|||
143500020|NCT00988247|517372294|FG000|Overall Study|Other|3|||
143500021|NCT00988247|517372295|FG001|Overall Study|Other|0|||
143500022|NCT03822884|517372296|FG000|Overall Study|Withdrawal by Subject|0|||
143500023|NCT03822884|517372297|FG001|Overall Study|Withdrawal by Subject|0|||
143500024|NCT03822884|517372298|FG002|Overall Study|Withdrawal by Subject|0|||
143500025|NCT03822884|517372299|FG003|Overall Study|Withdrawal by Subject|0|||
143500026|NCT03822884|517372300|FG004|Overall Study|Withdrawal by Subject|1|||
143500027|NCT03822884|517372301|FG005|Overall Study|Withdrawal by Subject|0|||
143500028|NCT03617705|517372306|FG000|Overall Study|Withdrawal by Subject|2|||
143500029|NCT03617705|517372306|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
143500030|NCT03617705|517372306|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
143500031|NCT00214461|517372307|FG000|Overall Study|Adverse Event|0|||
143500032|NCT00214461|517372308|FG001|Overall Study|Adverse Event|0|||
143500033|NCT00214461|517372309|FG002|Overall Study|Adverse Event|1|||
143500034|NCT00214461|517372310|FG003|Overall Study|Adverse Event|1|||
143500035|NCT00214461|517372307|FG000|Overall Study|Withdrawal by Subject|0|||
143500036|NCT00214461|517372308|FG001|Overall Study|Withdrawal by Subject|0|||
143500037|NCT00214461|517372309|FG002|Overall Study|Withdrawal by Subject|1|||
143500038|NCT00214461|517372310|FG003|Overall Study|Withdrawal by Subject|0|||
143500039|NCT02913313|517372311|FG000|Overall Study|DISEASE PROGRESSION|1|||
143500040|NCT02913313|517372312|FG001|Overall Study|DISEASE PROGRESSION|2|||
143500041|NCT02913313|517372313|FG002|Overall Study|DISEASE PROGRESSION|2|||
143500042|NCT02913313|517372314|FG003|Overall Study|DISEASE PROGRESSION|4|||
143500043|NCT02913313|517372315|FG004|Overall Study|DISEASE PROGRESSION|6|||
143500044|NCT02913313|517372316|FG005|Overall Study|DISEASE PROGRESSION|4|||
143500045|NCT02913313|517372317|FG006|Overall Study|DISEASE PROGRESSION|19|||
143500046|NCT02913313|517372318|FG007|Overall Study|DISEASE PROGRESSION|3|||
143500047|NCT02913313|517372319|FG008|Overall Study|DISEASE PROGRESSION|4|||
143500048|NCT02913313|517372320|FG009|Overall Study|DISEASE PROGRESSION|4|||
143500049|NCT02913313|517372321|FG010|Overall Study|DISEASE PROGRESSION|11|||
143500050|NCT02913313|517372322|FG011|Overall Study|DISEASE PROGRESSION|5|||
143500051|NCT02913313|517372323|FG012|Overall Study|DISEASE PROGRESSION|14|||
143500052|NCT02913313|517372324|FG013|Overall Study|DISEASE PROGRESSION|3|||
143500053|NCT02913313|517372311|FG000|Overall Study|Not Reported|0|||
143500054|NCT02913313|517372312|FG001|Overall Study|Not Reported|0|||
143500055|NCT02913313|517372313|FG002|Overall Study|Not Reported|0|||
143500056|NCT02913313|517372314|FG003|Overall Study|Not Reported|0|||
143500057|NCT02913313|517372315|FG004|Overall Study|Not Reported|1|||
143500058|NCT02913313|517372316|FG005|Overall Study|Not Reported|0|||
143500059|NCT02913313|517372317|FG006|Overall Study|Not Reported|0|||
143500060|NCT02913313|517372318|FG007|Overall Study|Not Reported|0|||
143500061|NCT02913313|517372319|FG008|Overall Study|Not Reported|0|||
143500062|NCT02913313|517372320|FG009|Overall Study|Not Reported|0|||
143500063|NCT02913313|517372321|FG010|Overall Study|Not Reported|4|||
143500064|NCT02913313|517372322|FG011|Overall Study|Not Reported|0|||
143500065|NCT02913313|517372323|FG012|Overall Study|Not Reported|0|||
143500066|NCT02913313|517372324|FG013|Overall Study|Not Reported|0|||
143500067|NCT02913313|517372311|FG000|Overall Study|Other reasons|0|||
143500068|NCT02913313|517372312|FG001|Overall Study|Other reasons|0|||
143500069|NCT02913313|517372313|FG002|Overall Study|Other reasons|0|||
143500070|NCT02913313|517372314|FG003|Overall Study|Other reasons|0|||
143500071|NCT02913313|517372315|FG004|Overall Study|Other reasons|1|||
143500072|NCT02913313|517372316|FG005|Overall Study|Other reasons|0|||
143500073|NCT02913313|517372317|FG006|Overall Study|Other reasons|0|||
143056570|NCT00879684|515745759|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
143056571|NCT00879684|515745760|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
143056572|NCT00879684|515745761|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
143500074|NCT02913313|517372318|FG007|Overall Study|Other reasons|0|||
143500075|NCT02913313|517372319|FG008|Overall Study|Other reasons|0|||
143500076|NCT02913313|517372320|FG009|Overall Study|Other reasons|0|||
143500077|NCT02913313|517372321|FG010|Overall Study|Other reasons|1|||
143500078|NCT02913313|517372322|FG011|Overall Study|Other reasons|0|||
143500079|NCT02913313|517372323|FG012|Overall Study|Other reasons|0|||
143500080|NCT02913313|517372324|FG013|Overall Study|Other reasons|0|||
143245327|NCT00441064|516449673|FG001|Overall Study|Patient withdrew consent|2|||
143245328|NCT03051178|516449674|FG000|Overall Study|Withdrawal by Subject|5|||
143245329|NCT00953056|516449675|FG000|Overall Study|Withdrew Consent|0|||
143245330|NCT00953056|516449676|FG001|Overall Study|Withdrew Consent|0|||
143245331|NCT00953056|516449677|FG002|Overall Study|Withdrew Consent|0|||
143245332|NCT00953056|516449678|FG003|Overall Study|Withdrew Consent|0|||
143245333|NCT00953056|516449679|FG004|Overall Study|Withdrew Consent|2|||
143245334|NCT00953056|516449680|FG005|Overall Study|Withdrew Consent|3|||
143245335|NCT00953056|516449675|FG000|Overall Study|Serious Adverse Event|0|||
143245336|NCT00953056|516449676|FG001|Overall Study|Serious Adverse Event|0|||
143245337|NCT00953056|516449677|FG002|Overall Study|Serious Adverse Event|0|||
143245338|NCT00953056|516449678|FG003|Overall Study|Serious Adverse Event|0|||
143245339|NCT00953056|516449679|FG004|Overall Study|Serious Adverse Event|0|||
143245340|NCT00953056|516449680|FG005|Overall Study|Serious Adverse Event|1|||
143245341|NCT03962504|516449681|FG000|Overall Study|Other|11|||
143245342|NCT03962504|516449682|FG001|Overall Study|Other|32|||
143245343|NCT02813577|516449683|FG000|Overall Study|Study terminated|4|||
143245344|NCT01388335|516449684|FG000|Period 1|Progressive Disease|1|||
143245345|NCT01388335|516449684|FG000|Period 2|Progressive Disease|2|||
143245346|NCT01388335|516449684|FG000|Period 2|Sponsor Decision|1|||
143245347|NCT01388335|516449684|FG000|Safety Extension|Progressive Disease|7|||
143245348|NCT01415882|516449685|FG000|Overall Study|Ineligible|1|||
143245349|NCT01415882|516449686|FG001|Overall Study|Ineligible|0|||
143245350|NCT01415882|516449687|FG002|Overall Study|Ineligible|0|||
143245351|NCT01415882|516449688|FG003|Overall Study|Ineligible|3|||
143245352|NCT01415882|516449689|FG004|Overall Study|Ineligible|0|||
143245353|NCT01415882|516449685|FG000|Overall Study|Withdrawal by Subject|0|||
143245354|NCT01415882|516449686|FG001|Overall Study|Withdrawal by Subject|1|||
143245355|NCT01415882|516449687|FG002|Overall Study|Withdrawal by Subject|0|||
143245356|NCT01415882|516449688|FG003|Overall Study|Withdrawal by Subject|1|||
143245357|NCT01415882|516449689|FG004|Overall Study|Withdrawal by Subject|0|||
143245358|NCT03339219|516449690|FG000|Overall Study|Death|12|||
143245359|NCT03339219|516449690|FG000|Overall Study|Site Terminated by Sponsor|22|||
143245360|NCT03339219|516449690|FG000|Overall Study|Withdrawal by Subject|1|||
143245361|NCT00845897|516449693|FG000|Overall Study|Lost to Follow-up|1|||
143245362|NCT00845897|516449694|FG001|Overall Study|Lost to Follow-up|1|||
143245363|NCT00845897|516449695|FG002|Overall Study|Lost to Follow-up|0|||
143245364|NCT00845897|516449693|FG000|Overall Study|Withdrawal by Subject|0|||
143245365|NCT00845897|516449694|FG001|Overall Study|Withdrawal by Subject|3|||
143245366|NCT00845897|516449695|FG002|Overall Study|Withdrawal by Subject|2|||
143245367|NCT00845897|516449693|FG000|Overall Study|Ulcer did not heal|1|||
143245368|NCT00845897|516449694|FG001|Overall Study|Ulcer did not heal|0|||
143245369|NCT00845897|516449695|FG002|Overall Study|Ulcer did not heal|1|||
143245370|NCT00845897|516449693|FG000|Overall Study|Too ill to participate|0|||
143245371|NCT00845897|516449694|FG001|Overall Study|Too ill to participate|1|||
143245372|NCT00845897|516449695|FG002|Overall Study|Too ill to participate|0|||
143245373|NCT02722499|516449696|FG000|Overall Study|Lost to Follow-up|2|||
143245374|NCT02722499|516449697|FG001|Overall Study|Lost to Follow-up|0|||
143245375|NCT02722499|516449698|FG002|Overall Study|Lost to Follow-up|1|||
143245376|NCT00369265|516449700|FG000|Overall Study|Study terminated|4|||
143245377|NCT00369265|516449701|FG001|Overall Study|Study terminated|7|||
143245378|NCT00467753|516449702|FG000|Overall Study|Lost to Follow-up|1|||
143245379|NCT00467753|516449703|FG001|Overall Study|Lost to Follow-up|2|||
143245380|NCT00467753|516449702|FG000|Overall Study|Adverse Event|2|||
143500081|NCT02913313|517372311|FG000|Overall Study|Withdrawal by Subject|0|||
143500082|NCT02913313|517372312|FG001|Overall Study|Withdrawal by Subject|0|||
143169623|NCT02958865|516169897|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
143169624|NCT02958865|516169882|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
143169625|NCT02958865|516169883|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
143169626|NCT02958865|516169884|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
143169627|NCT02958865|516169885|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
143169628|NCT02958865|516169886|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
143169629|NCT02958865|516169887|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
143169630|NCT02958865|516169888|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
143169631|NCT02958865|516169889|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
143169632|NCT02958865|516169890|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
143169633|NCT02958865|516169891|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
143245381|NCT00467753|516449703|FG001|Overall Study|Adverse Event|0|||
143500083|NCT02913313|517372313|FG002|Overall Study|Withdrawal by Subject|1|||
143245382|NCT02817464|516449705|FG000|Overall Study|Lost to Follow-up|1|||
143245383|NCT02817464|516449706|FG001|Overall Study|Lost to Follow-up|0|||
143245384|NCT02817464|516449705|FG000|Overall Study|Discontinued early due to personal decision|1|||
143245385|NCT02817464|516449706|FG001|Overall Study|Discontinued early due to personal decision|1|||
143245386|NCT02541604|516449708|FG000|Overall Study|Death|6|||
143245387|NCT02541604|516449709|FG001|Overall Study|Death|5|||
143245388|NCT02541604|516449710|FG002|Overall Study|Death|7|||
143056573|NCT00879684|515745762|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
143056574|NCT00879684|515745763|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
143056575|NCT00879684|515745757|FG000|Stage 1: Dose Escalation|Death|0|||
143056576|NCT00879684|515745758|FG001|Stage 1: Dose Escalation|Death|0|||
143056577|NCT00879684|515745759|FG002|Stage 1: Dose Escalation|Death|1|||
143056578|NCT00879684|515745760|FG003|Stage 1: Dose Escalation|Death|0|||
143056579|NCT00879684|515745761|FG004|Stage 1: Dose Escalation|Death|0|||
143056580|NCT00879684|515745762|FG005|Stage 1: Dose Escalation|Death|0|||
143056581|NCT00879684|515745763|FG006|Stage 1: Dose Escalation|Death|0|||
143056582|NCT00879684|515745757|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
143056583|NCT00879684|515745758|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
143056584|NCT00879684|515745759|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
143056585|NCT00879684|515745760|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
143056586|NCT00879684|515745761|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
143056587|NCT00879684|515745762|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
143056588|NCT00879684|515745763|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
143056589|NCT00879684|515745757|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
143056590|NCT00879684|515745758|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
143056591|NCT00879684|515745759|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
143056592|NCT00879684|515745760|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
143056593|NCT00879684|515745761|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
143056594|NCT00879684|515745762|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
143056595|NCT00879684|515745763|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
143056596|NCT00879684|515745757|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
143056597|NCT00879684|515745758|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
143056598|NCT00879684|515745759|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
143056599|NCT00879684|515745760|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
143056600|NCT00879684|515745761|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
143056601|NCT00879684|515745762|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
143056602|NCT00879684|515745763|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
143056603|NCT00105157|515745764|FG000|Double-Blind (DB)|Never Treated|1|||
143056604|NCT00105157|515745765|FG001|Double-Blind (DB)|Never Treated|0|||
143056605|NCT00105157|515745766|FG002|Double-Blind (DB)|Never Treated|0|||
143056606|NCT00105157|515745767|FG003|Double-Blind (DB)|Never Treated|0|||
143056607|NCT00105157|515745764|FG000|Double-Blind (DB)|Adverse Event|2|||
143056608|NCT00105157|515745765|FG001|Double-Blind (DB)|Adverse Event|0|||
143056609|NCT00105157|515745766|FG002|Double-Blind (DB)|Adverse Event|1|||
143056610|NCT00105157|515745767|FG003|Double-Blind (DB)|Adverse Event|1|||
143056611|NCT00105157|515745764|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
143056612|NCT00105157|515745765|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
143056613|NCT00105157|515745766|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
143056614|NCT00105157|515745767|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
143056615|NCT00105157|515745764|FG000|Open-Label Continuation of DB|Adverse Event|3|||
143056616|NCT00105157|515745765|FG001|Open-Label Continuation of DB|Adverse Event|1|||
143056617|NCT00105157|515745766|FG002|Open-Label Continuation of DB|Adverse Event|0|||
143056618|NCT00105157|515745767|FG003|Open-Label Continuation of DB|Adverse Event|0|||
143056619|NCT00105157|515745764|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
143056620|NCT00105157|515745765|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
143056621|NCT00105157|515745766|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
143056622|NCT00105157|515745767|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
143056623|NCT00105157|515745764|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
143056624|NCT00105157|515745765|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
143056625|NCT00105157|515745766|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
143056626|NCT00105157|515745767|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
143056627|NCT00105157|515745764|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
143056628|NCT00105157|515745765|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
143056629|NCT00105157|515745766|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
143056630|NCT00105157|515745767|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
143056631|NCT00105157|515745764|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
143056632|NCT00105157|515745765|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
143056633|NCT00105157|515745766|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
143056634|NCT00105157|515745767|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
143056635|NCT00105157|515745764|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
143056636|NCT00105157|515745765|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
143056637|NCT00105157|515745766|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
143056638|NCT00105157|515745767|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
143056639|NCT00105157|515745764|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
143056640|NCT00105157|515745765|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
143245389|NCT02541604|516449711|FG003|Overall Study|Death|2|||
143500084|NCT02913313|517372314|FG003|Overall Study|Withdrawal by Subject|0|||
143500085|NCT02913313|517372315|FG004|Overall Study|Withdrawal by Subject|0|||
143500086|NCT02913313|517372316|FG005|Overall Study|Withdrawal by Subject|0|||
143500087|NCT02913313|517372317|FG006|Overall Study|Withdrawal by Subject|1|||
143500088|NCT02913313|517372318|FG007|Overall Study|Withdrawal by Subject|1|||
143500089|NCT02913313|517372319|FG008|Overall Study|Withdrawal by Subject|0|||
143500090|NCT02913313|517372320|FG009|Overall Study|Withdrawal by Subject|0|||
143500091|NCT02913313|517372321|FG010|Overall Study|Withdrawal by Subject|1|||
143500092|NCT02913313|517372322|FG011|Overall Study|Withdrawal by Subject|0|||
143500093|NCT02913313|517372323|FG012|Overall Study|Withdrawal by Subject|0|||
143500094|NCT02913313|517372324|FG013|Overall Study|Withdrawal by Subject|0|||
143500095|NCT02913313|517372311|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
143500096|NCT02913313|517372312|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
143056641|NCT00105157|515745766|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
143056642|NCT00105157|515745767|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
143056643|NCT00105157|515745764|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
143056644|NCT00105157|515745765|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
143056645|NCT00105157|515745766|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
143056646|NCT00105157|515745767|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
143056647|NCT00105157|515745764|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
143056648|NCT00105157|515745765|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
143056649|NCT00105157|515745766|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
143056650|NCT00105157|515745767|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
143056651|NCT00105157|515745764|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
143056652|NCT00105157|515745765|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
143056653|NCT00105157|515745766|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
143056654|NCT00105157|515745767|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
143056655|NCT00105157|515745764|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
143056656|NCT00105157|515745765|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
143056657|NCT00105157|515745766|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
143056658|NCT00105157|515745767|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
143056659|NCT00127166|515745768|FG000|Period I|Protocol Violation|0|||
143056660|NCT00127166|515745769|FG001|Period I|Protocol Violation|2|||
143056661|NCT00127166|515745768|FG000|Period I|Withdrawal by Subject|2|||
143056662|NCT00127166|515745769|FG001|Period I|Withdrawal by Subject|0|||
143056663|NCT00127166|515745768|FG000|Period I|Patient did not meet inclusion criteria|1|||
143056664|NCT00127166|515745769|FG001|Period I|Patient did not meet inclusion criteria|0|||
143056665|NCT00127166|515745768|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
143056666|NCT00127166|515745769|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
143056667|NCT00127166|515745768|FG000|Period II|Withdrawal by Subject|2|||
143056668|NCT00127166|515745769|FG001|Period II|Withdrawal by Subject|0|||
143056669|NCT00127166|515745768|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
143056670|NCT00127166|515745769|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
143056671|NCT00708682|515745770|FG000|Infant Series|Adverse Event|1|||
143056672|NCT00708682|515745770|FG000|Infant Series|Lost to Follow-up|4|||
143056673|NCT00708682|515745770|FG000|Infant Series|Protocol Violation|1|||
143056674|NCT00708682|515745770|FG000|Infant Series|Parent/legal guardian request|6|||
143056675|NCT00708682|515745770|FG000|Infant Series|Failed to return|2|||
143056676|NCT00708682|515745770|FG000|Infant Series|Other|19|||
143056677|NCT00708682|515745770|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
143169634|NCT02958865|516169892|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
143169635|NCT02958865|516169893|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
143169636|NCT02958865|516169894|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
143169637|NCT02958865|516169895|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
143169638|NCT02958865|516169896|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
143169639|NCT02958865|516169897|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
143169640|NCT02958865|516169882|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
143169641|NCT02958865|516169883|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
143169642|NCT02958865|516169884|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
143169643|NCT02958865|516169885|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
143169644|NCT02958865|516169886|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
143169645|NCT02958865|516169887|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
143169646|NCT02958865|516169888|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
143169647|NCT02958865|516169889|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
143169648|NCT02958865|516169890|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
143245390|NCT02541604|516449712|FG004|Overall Study|Death|9|||
143500097|NCT02913313|517372313|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
143500098|NCT02913313|517372314|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
143245391|NCT02541604|516449713|FG005|Overall Study|Death|8|||
143245392|NCT02541604|516449714|FG006|Overall Study|Death|9|||
143364828|NCT01872611|516878714|FG001|Overall Study|Death, prior to treatment|1|||
143364829|NCT01872611|516878713|FG000|Overall Study|Lost to Follow-up|8|||
143364830|NCT01872611|516878714|FG001|Overall Study|Lost to Follow-up|1|||
143364831|NCT01872611|516878713|FG000|Overall Study|Physician Decision|1|||
143364832|NCT01872611|516878714|FG001|Overall Study|Physician Decision|0|||
143364833|NCT01872611|516878713|FG000|Overall Study|Withdrawal by Subject|6|||
143364834|NCT01872611|516878714|FG001|Overall Study|Withdrawal by Subject|1|||
143364835|NCT01872611|516878713|FG000|Overall Study|Reason not provided|6|||
143364836|NCT01872611|516878714|FG001|Overall Study|Reason not provided|6|||
143364837|NCT03124108|516878715|FG000|Overall Study|Adverse Event|0|||
143364838|NCT03124108|516878716|FG001|Overall Study|Adverse Event|1|||
143364839|NCT03124108|516878717|FG002|Overall Study|Adverse Event|0|||
143364840|NCT00631917|516878718|FG000|Overall Study|Adverse Event|34|||
143364841|NCT00631917|516878719|FG001|Overall Study|Adverse Event|45|||
143245393|NCT02541604|516449715|FG007|Overall Study|Death|9|||
143245394|NCT02541604|516449716|FG008|Overall Study|Death|3|||
143245395|NCT02541604|516449717|FG009|Overall Study|Death|4|||
143245396|NCT02541604|516449718|FG010|Overall Study|Death|2|||
143245397|NCT02541604|516449719|FG011|Overall Study|Death|3|||
143245398|NCT02541604|516449708|FG000|Overall Study|Lost to Follow-up|2|||
143245399|NCT02541604|516449709|FG001|Overall Study|Lost to Follow-up|0|||
143245400|NCT02541604|516449710|FG002|Overall Study|Lost to Follow-up|1|||
143245401|NCT02541604|516449711|FG003|Overall Study|Lost to Follow-up|0|||
143245402|NCT02541604|516449712|FG004|Overall Study|Lost to Follow-up|0|||
143245403|NCT02541604|516449713|FG005|Overall Study|Lost to Follow-up|1|||
143245404|NCT02541604|516449714|FG006|Overall Study|Lost to Follow-up|1|||
143245405|NCT02541604|516449715|FG007|Overall Study|Lost to Follow-up|0|||
143245406|NCT02541604|516449716|FG008|Overall Study|Lost to Follow-up|0|||
143245407|NCT02541604|516449717|FG009|Overall Study|Lost to Follow-up|0|||
143245408|NCT02541604|516449718|FG010|Overall Study|Lost to Follow-up|0|||
143245409|NCT02541604|516449719|FG011|Overall Study|Lost to Follow-up|0|||
143245410|NCT02541604|516449708|FG000|Overall Study|Withdrawal by Subject|2|||
143245411|NCT02541604|516449709|FG001|Overall Study|Withdrawal by Subject|0|||
143245412|NCT02541604|516449710|FG002|Overall Study|Withdrawal by Subject|1|||
143245413|NCT02541604|516449711|FG003|Overall Study|Withdrawal by Subject|0|||
143245414|NCT02541604|516449712|FG004|Overall Study|Withdrawal by Subject|1|||
143245415|NCT02541604|516449713|FG005|Overall Study|Withdrawal by Subject|1|||
143245416|NCT02541604|516449714|FG006|Overall Study|Withdrawal by Subject|0|||
143245417|NCT02541604|516449715|FG007|Overall Study|Withdrawal by Subject|0|||
143245418|NCT02541604|516449716|FG008|Overall Study|Withdrawal by Subject|1|||
143245419|NCT02541604|516449717|FG009|Overall Study|Withdrawal by Subject|0|||
143245420|NCT02541604|516449718|FG010|Overall Study|Withdrawal by Subject|0|||
143245421|NCT02541604|516449719|FG011|Overall Study|Withdrawal by Subject|0|||
143245422|NCT02541604|516449708|FG000|Overall Study|Study Terminated by Sponsor|1|||
143364842|NCT00631917|516878718|FG000|Overall Study|Abnormal laboratory value(s)|2|||
143364843|NCT00631917|516878719|FG001|Overall Study|Abnormal laboratory value(s)|1|||
143056678|NCT00708682|515745770|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
143056679|NCT00708682|515745770|FG000|Toddler Dose|Lost to Follow-up|3|||
143056680|NCT00708682|515745770|FG000|Toddler Dose|Failed to Return|4|||
143056681|NCT00434590|515745773|FG000|Overall Study|Administrative problems|5|||
143056682|NCT00434590|515745774|FG001|Overall Study|Administrative problems|5|||
143056683|NCT04149535|515745780|FG000|Overall Study|Death|11|||
143056684|NCT04149535|515745781|FG001|Overall Study|Death|7|||
143056685|NCT04149535|515745780|FG000|Overall Study|Physician Decision|10|||
143056686|NCT04149535|515745781|FG001|Overall Study|Physician Decision|4|||
143056687|NCT04149535|515745780|FG000|Overall Study|Withdrawal by Subject|6|||
143056688|NCT04149535|515745781|FG001|Overall Study|Withdrawal by Subject|7|||
143056689|NCT04149535|515745780|FG000|Overall Study|Not described|2|||
143056690|NCT04149535|515745781|FG001|Overall Study|Not described|0|||
143056691|NCT02175368|515745782|FG000|Overall Study|Lost to Follow-up|1|||
143056692|NCT05068284|515745783|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
143364844|NCT00631917|516878718|FG000|Overall Study|Abnormal test procedure result(s)|3|||
143056693|NCT05068284|515745784|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
143056694|NCT05068284|515745785|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
143364845|NCT00631917|516878719|FG001|Overall Study|Abnormal test procedure result(s)|2|||
143364846|NCT00631917|516878718|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
143056695|NCT05068284|515745786|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
143056696|NCT05068284|515745787|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
143245423|NCT02541604|516449709|FG001|Overall Study|Study Terminated by Sponsor|4|||
143245424|NCT02541604|516449710|FG002|Overall Study|Study Terminated by Sponsor|2|||
143245425|NCT02541604|516449711|FG003|Overall Study|Study Terminated by Sponsor|1|||
143245426|NCT02541604|516449712|FG004|Overall Study|Study Terminated by Sponsor|0|||
143245427|NCT02541604|516449713|FG005|Overall Study|Study Terminated by Sponsor|0|||
143245428|NCT02541604|516449714|FG006|Overall Study|Study Terminated by Sponsor|0|||
143245429|NCT02541604|516449715|FG007|Overall Study|Study Terminated by Sponsor|0|||
143245430|NCT02541604|516449716|FG008|Overall Study|Study Terminated by Sponsor|0|||
143245431|NCT02541604|516449717|FG009|Overall Study|Study Terminated by Sponsor|0|||
143245432|NCT02541604|516449718|FG010|Overall Study|Study Terminated by Sponsor|0|||
143245433|NCT02541604|516449719|FG011|Overall Study|Study Terminated by Sponsor|0|||
143245434|NCT02541604|516449708|FG000|Overall Study|Medical condition may jeopardize safety|0|||
143245435|NCT02541604|516449709|FG001|Overall Study|Medical condition may jeopardize safety|0|||
143245436|NCT02541604|516449710|FG002|Overall Study|Medical condition may jeopardize safety|0|||
143245437|NCT02541604|516449711|FG003|Overall Study|Medical condition may jeopardize safety|0|||
143245438|NCT02541604|516449712|FG004|Overall Study|Medical condition may jeopardize safety|0|||
143245439|NCT02541604|516449713|FG005|Overall Study|Medical condition may jeopardize safety|0|||
143056697|NCT05068284|515745788|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
143245440|NCT02541604|516449714|FG006|Overall Study|Medical condition may jeopardize safety|0|||
143245441|NCT02541604|516449715|FG007|Overall Study|Medical condition may jeopardize safety|1|||
143245442|NCT02541604|516449716|FG008|Overall Study|Medical condition may jeopardize safety|0|||
143245443|NCT02541604|516449717|FG009|Overall Study|Medical condition may jeopardize safety|0|||
143245444|NCT02541604|516449718|FG010|Overall Study|Medical condition may jeopardize safety|0|||
143245445|NCT02541604|516449719|FG011|Overall Study|Medical condition may jeopardize safety|0|||
143245446|NCT01704599|516449720|FG000|Overall Study|Adverse Event|1|||
143245447|NCT05064358|516449721|FG000|Overall Study|Death|23|||
143245448|NCT05064358|516449722|FG001|Overall Study|Death|23|||
143245449|NCT05064358|516449723|FG002|Overall Study|Death|25|||
143245450|NCT05064358|516449724|FG003|Overall Study|Death|21|||
143245451|NCT05064358|516449725|FG004|Overall Study|Death|5|||
143245452|NCT05064358|516449721|FG000|Overall Study|Lost to Follow-up|1|||
143245453|NCT05064358|516449722|FG001|Overall Study|Lost to Follow-up|2|||
143245454|NCT05064358|516449723|FG002|Overall Study|Lost to Follow-up|0|||
143245455|NCT05064358|516449724|FG003|Overall Study|Lost to Follow-up|2|||
143245456|NCT05064358|516449725|FG004|Overall Study|Lost to Follow-up|0|||
143245457|NCT05064358|516449721|FG000|Overall Study|Physician Decision|1|||
143245458|NCT05064358|516449722|FG001|Overall Study|Physician Decision|1|||
143245459|NCT05064358|516449723|FG002|Overall Study|Physician Decision|2|||
143245460|NCT05064358|516449724|FG003|Overall Study|Physician Decision|0|||
143245461|NCT05064358|516449725|FG004|Overall Study|Physician Decision|0|||
143245462|NCT05064358|516449721|FG000|Overall Study|Withdrawal by Subject|4|||
143245463|NCT05064358|516449722|FG001|Overall Study|Withdrawal by Subject|5|||
143245464|NCT05064358|516449723|FG002|Overall Study|Withdrawal by Subject|3|||
143245465|NCT05064358|516449724|FG003|Overall Study|Withdrawal by Subject|6|||
143245466|NCT05064358|516449725|FG004|Overall Study|Withdrawal by Subject|3|||
143245467|NCT05064358|516449721|FG000|Overall Study|Ongoing at the time of analysis|1|||
143245468|NCT05064358|516449722|FG001|Overall Study|Ongoing at the time of analysis|2|||
143245469|NCT05064358|516449723|FG002|Overall Study|Ongoing at the time of analysis|2|||
143245470|NCT05064358|516449724|FG003|Overall Study|Ongoing at the time of analysis|2|||
143245471|NCT05064358|516449725|FG004|Overall Study|Ongoing at the time of analysis|2|||
143245472|NCT02003924|516449735|FG000|Double-blind Phase|Lost to Follow-up|2|||
143245473|NCT02003924|516449736|FG001|Double-blind Phase|Lost to Follow-up|1|||
143245474|NCT02003924|516449737|FG002|Double-blind Phase|Lost to Follow-up|0|||
143245475|NCT02003924|516449735|FG000|Double-blind Phase|Protocol Violation|1|||
143056698|NCT05068284|515745789|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
143056699|NCT05068284|515745790|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
143056700|NCT05068284|515745783|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
143056701|NCT05068284|515745784|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
143056702|NCT05068284|515745785|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
143056703|NCT05068284|515745786|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
143056704|NCT05068284|515745787|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
143056705|NCT05068284|515745788|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
143056706|NCT05068284|515745789|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
143056707|NCT05068284|515745790|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
143245476|NCT02003924|516449736|FG001|Double-blind Phase|Protocol Violation|2|||
143056708|NCT05068284|515745783|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
143056709|NCT05068284|515745784|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
143245477|NCT02003924|516449737|FG002|Double-blind Phase|Protocol Violation|0|||
143245478|NCT02003924|516449735|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
143245479|NCT02003924|516449736|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
143245480|NCT02003924|516449737|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
143245481|NCT02003924|516449735|FG000|Double-blind Phase|Disease Progression|229|||
143245482|NCT02003924|516449736|FG001|Double-blind Phase|Disease Progression|247|||
143245483|NCT02003924|516449737|FG002|Double-blind Phase|Disease Progression|0|||
143245484|NCT02003924|516449735|FG000|Double-blind Phase|Adverse Event|120|||
143245485|NCT02003924|516449736|FG001|Double-blind Phase|Adverse Event|31|||
143245486|NCT02003924|516449737|FG002|Double-blind Phase|Adverse Event|0|||
143245487|NCT02003924|516449735|FG000|Double-blind Phase|Randomized But not Treated|3|||
143245488|NCT02003924|516449736|FG001|Double-blind Phase|Randomized But not Treated|3|||
143245489|NCT02003924|516449737|FG002|Double-blind Phase|Randomized But not Treated|0|||
143245490|NCT02003924|516449735|FG000|Double-blind Phase|Other|29|||
143245491|NCT02003924|516449736|FG001|Double-blind Phase|Other|50|||
143245492|NCT02003924|516449737|FG002|Double-blind Phase|Other|0|||
143245493|NCT02003924|516449735|FG000|Open-label Phase|Lost to Follow-up|0|||
143245494|NCT02003924|516449736|FG001|Open-label Phase|Lost to Follow-up|0|||
143245495|NCT02003924|516449737|FG002|Open-label Phase|Lost to Follow-up|1|||
143245496|NCT02003924|516449735|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
143245497|NCT02003924|516449736|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
143245498|NCT02003924|516449737|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
143245499|NCT02003924|516449735|FG000|Open-label Phase|Disease Progression|59|||
143245500|NCT02003924|516449736|FG001|Open-label Phase|Disease Progression|0|||
143245501|NCT02003924|516449737|FG002|Open-label Phase|Disease Progression|5|||
143245502|NCT02003924|516449735|FG000|Open-label Phase|Adverse Event|25|||
143245503|NCT02003924|516449736|FG001|Open-label Phase|Adverse Event|0|||
143245504|NCT02003924|516449737|FG002|Open-label Phase|Adverse Event|10|||
143245505|NCT02003924|516449735|FG000|Open-label Phase|Other|7|||
143245506|NCT02003924|516449736|FG001|Open-label Phase|Other|0|||
143245507|NCT02003924|516449737|FG002|Open-label Phase|Other|0|||
143245508|NCT02003924|516449735|FG000|Long-term Follow-up Phase|Death|288|||
143245509|NCT02003924|516449736|FG001|Long-term Follow-up Phase|Death|174|||
143245510|NCT02003924|516449737|FG002|Long-term Follow-up Phase|Death|4|||
143245511|NCT02003924|516449735|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
143245512|NCT02003924|516449736|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
143245513|NCT02003924|516449737|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
143245514|NCT02003924|516449735|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
143245515|NCT02003924|516449736|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
143245516|NCT02003924|516449737|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
143245517|NCT02003924|516449735|FG000|Long-term Follow-up Phase|Other|5|||
143056710|NCT05068284|515745785|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
143056711|NCT05068284|515745786|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
143056712|NCT05068284|515745787|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
143056713|NCT05068284|515745788|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
143056714|NCT05068284|515745789|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
143056715|NCT05068284|515745790|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
143056716|NCT05068284|515745783|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
143056717|NCT05068284|515745784|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
143056718|NCT05068284|515745785|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
143056719|NCT05068284|515745786|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
143056720|NCT05068284|515745787|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
143056721|NCT05068284|515745788|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
143056722|NCT05068284|515745789|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
143056723|NCT05068284|515745790|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
143056724|NCT05068284|515745783|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
143056725|NCT05068284|515745784|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
143056726|NCT05068284|515745785|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
143245518|NCT02003924|516449736|FG001|Long-term Follow-up Phase|Other|2|||
143245519|NCT02003924|516449737|FG002|Long-term Follow-up Phase|Other|1|||
143245520|NCT01006291|516451729|FG000|Overall Study|Adverse Event|2|||
143245521|NCT01006291|516451730|FG001|Overall Study|Adverse Event|1|||
143245522|NCT01006291|516451731|FG002|Overall Study|Adverse Event|2|||
143245523|NCT01006291|516451729|FG000|Overall Study|Lack of Efficacy|2|||
143245524|NCT01006291|516451730|FG001|Overall Study|Lack of Efficacy|2|||
143245525|NCT01006291|516451731|FG002|Overall Study|Lack of Efficacy|1|||
143500099|NCT02913313|517372315|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
143500100|NCT02913313|517372316|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
143500101|NCT02913313|517372317|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
143500102|NCT02913313|517372318|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
143500103|NCT02913313|517372319|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
143500104|NCT02913313|517372320|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
143056727|NCT05068284|515745786|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
143056728|NCT05068284|515745787|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
143056729|NCT05068284|515745788|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
143056730|NCT05068284|515745789|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
143245526|NCT01006291|516451729|FG000|Overall Study|Protocol Violation|3|||
143245527|NCT01006291|516451730|FG001|Overall Study|Protocol Violation|3|||
143245528|NCT01006291|516451731|FG002|Overall Study|Protocol Violation|3|||
143245529|NCT01006291|516451729|FG000|Overall Study|Withdrawal criteria|5|||
143245530|NCT01006291|516451730|FG001|Overall Study|Withdrawal criteria|4|||
143245531|NCT01006291|516451731|FG002|Overall Study|Withdrawal criteria|4|||
143245532|NCT01006291|516451729|FG000|Overall Study|Other|14|||
143245533|NCT01006291|516451730|FG001|Overall Study|Other|14|||
143056731|NCT05068284|515745790|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
143056732|NCT05068284|515745783|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
143056733|NCT05068284|515745784|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
143056734|NCT05068284|515745785|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
143056735|NCT05068284|515745786|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
143056736|NCT05068284|515745787|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
143056737|NCT05068284|515745788|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
143056738|NCT05068284|515745789|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
143056739|NCT05068284|515745790|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
143056740|NCT05068284|515745783|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
143056741|NCT05068284|515745784|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
143056742|NCT05068284|515745785|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
143056743|NCT05068284|515745786|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
143056744|NCT05068284|515745787|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
143056745|NCT05068284|515745788|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
143056746|NCT05068284|515745789|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
143056747|NCT05068284|515745790|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
143056748|NCT05068284|515745783|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
143056749|NCT05068284|515745784|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
143056750|NCT05068284|515745785|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
143056751|NCT05068284|515745786|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
143056752|NCT05068284|515745787|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
143056753|NCT05068284|515745788|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
143056754|NCT05068284|515745789|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
143056755|NCT05068284|515745790|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
143056756|NCT05068284|515745783|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
143056757|NCT05068284|515745784|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
143056758|NCT05068284|515745785|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
143056759|NCT05068284|515745786|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
143056760|NCT05068284|515745787|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
143056761|NCT05068284|515745788|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
143056762|NCT05068284|515745789|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
143056763|NCT05068284|515745790|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
143056764|NCT05068284|515745783|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
143056765|NCT05068284|515745784|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
143056766|NCT05068284|515745785|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
143056767|NCT05068284|515745786|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
143056768|NCT05068284|515745787|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
143056769|NCT05068284|515745788|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
143056770|NCT05068284|515745789|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
143056771|NCT05068284|515745790|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
143056772|NCT05068284|515745783|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
143056773|NCT05068284|515745784|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
143056774|NCT05068284|515745785|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
143056775|NCT05068284|515745786|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
143056776|NCT05068284|515745787|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
143056777|NCT05068284|515745788|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
143056778|NCT05068284|515745789|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
143056779|NCT05068284|515745790|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
143056780|NCT05068284|515745783|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
143056781|NCT05068284|515745784|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
143056782|NCT05068284|515745785|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
143245534|NCT01006291|516451731|FG002|Overall Study|Other|17|||
143500105|NCT02913313|517372321|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
143500106|NCT02913313|517372322|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
143500107|NCT02913313|517372323|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
143500108|NCT02913313|517372324|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
143500109|NCT02913313|517372311|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
143500110|NCT02913313|517372312|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
143500111|NCT02913313|517372313|FG002|Overall Study|STUDY DRUG TOXICITY|0|||
143500112|NCT02913313|517372314|FG003|Overall Study|STUDY DRUG TOXICITY|0|||
143500113|NCT02913313|517372315|FG004|Overall Study|STUDY DRUG TOXICITY|0|||
143500114|NCT02913313|517372316|FG005|Overall Study|STUDY DRUG TOXICITY|0|||
143500115|NCT02913313|517372317|FG006|Overall Study|STUDY DRUG TOXICITY|0|||
143500116|NCT02913313|517372318|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
143500117|NCT02913313|517372319|FG008|Overall Study|STUDY DRUG TOXICITY|0|||
143500118|NCT02913313|517372320|FG009|Overall Study|STUDY DRUG TOXICITY|0|||
143500119|NCT02913313|517372321|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
143056783|NCT05068284|515745786|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
143056784|NCT05068284|515745787|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
143056785|NCT05068284|515745788|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
143056786|NCT05068284|515745789|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
143056787|NCT05068284|515745790|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
143056788|NCT05068284|515745783|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
143056789|NCT05068284|515745784|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
143056790|NCT05068284|515745785|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
143056791|NCT05068284|515745786|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
143056792|NCT05068284|515745787|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
143056793|NCT05068284|515745788|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
143056794|NCT05068284|515745789|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
143056795|NCT05068284|515745790|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
143056796|NCT05068284|515745783|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
143056797|NCT05068284|515745784|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
143056798|NCT05068284|515745785|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
143056799|NCT05068284|515745786|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
143056800|NCT05068284|515745787|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
143056801|NCT05068284|515745788|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
143056802|NCT05068284|515745789|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
143056803|NCT05068284|515745790|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
143056804|NCT02447887|515747595|FG000|Overall Study|Study was terminated|3|||
143056805|NCT03180528|515747596|FG000|Overall Study|Adverse Event|1|||
143056806|NCT03180528|515747596|FG000|Overall Study|Withdrawal by Subject|1|||
143056807|NCT03180528|515747596|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
143056808|NCT00109837|515747597|FG000|Overall Study|Adverse Event|2|||
143056809|NCT00109837|515747597|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
143056810|NCT00109837|515747597|FG000|Overall Study|Death|1|||
143056811|NCT00109837|515747597|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
143056812|NCT00109837|515747597|FG000|Overall Study|Not treated|1|||
143056813|NCT00109837|515747597|FG000|Overall Study|Ineligible|1|||
143056814|NCT01563237|515747606|FG000|Overall Study|Lost to Follow-up|6|||
143056815|NCT01563237|515747607|FG001|Overall Study|Lost to Follow-up|0|||
143056816|NCT01563237|515747606|FG000|Overall Study|Withdrawal by Subject|1|||
143056817|NCT01563237|515747607|FG001|Overall Study|Withdrawal by Subject|0|||
143056818|NCT01563237|515747606|FG000|Overall Study|Adverse Event|1|||
143056819|NCT01563237|515747607|FG001|Overall Study|Adverse Event|0|||
143056820|NCT01563237|515747606|FG000|Overall Study|Medical Reasons|1|||
143056821|NCT01563237|515747607|FG001|Overall Study|Medical Reasons|0|||
143056822|NCT01563237|515747606|FG000|Overall Study|Death|1|||
143169649|NCT02958865|516169891|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
143169650|NCT02958865|516169892|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
143169651|NCT02958865|516169893|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
143169652|NCT02958865|516169894|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
143169653|NCT02958865|516169895|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
143169654|NCT02958865|516169896|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
143169655|NCT02958865|516169897|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
143169656|NCT02958865|516169882|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
143169657|NCT02958865|516169883|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
143169658|NCT02958865|516169884|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
143169659|NCT02958865|516169885|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
143169660|NCT02958865|516169886|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
143169661|NCT02958865|516169887|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
143169662|NCT02958865|516169888|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
143245535|NCT01865552|516451732|FG000|Period 1|Adverse Event|1|||
143500120|NCT02913313|517372322|FG011|Overall Study|STUDY DRUG TOXICITY|1|||
143245536|NCT01865552|516451733|FG001|Period 1|Adverse Event|0|||
143245537|NCT01865552|516451734|FG002|Period 1|Adverse Event|0|||
143245538|NCT01865552|516451735|FG003|Period 1|Adverse Event|1|||
143364847|NCT00631917|516878719|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
143364848|NCT00631917|516878718|FG000|Overall Study|No longer required study drug|0|||
143364849|NCT00631917|516878719|FG001|Overall Study|No longer required study drug|1|||
143364850|NCT00631917|516878718|FG000|Overall Study|Protocol deviation|6|||
143364851|NCT00631917|516878719|FG001|Overall Study|Protocol deviation|5|||
143364852|NCT00631917|516878718|FG000|Overall Study|Subject withdrew consent|25|||
143364853|NCT00631917|516878719|FG001|Overall Study|Subject withdrew consent|33|||
143364854|NCT00631917|516878718|FG000|Overall Study|Lost to Follow-up|7|||
143364855|NCT00631917|516878719|FG001|Overall Study|Lost to Follow-up|7|||
143364856|NCT00631917|516878718|FG000|Overall Study|Administrative problems|2|||
143364857|NCT00631917|516878719|FG001|Overall Study|Administrative problems|0|||
143364858|NCT00631917|516878718|FG000|Overall Study|Death|1|||
143364859|NCT00631917|516878719|FG001|Overall Study|Death|0|||
143364860|NCT05650333|516878722|FG000|Treatment Period (7 Days)|Adverse Event|1|||
143364861|NCT03537651|516878723|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
143364862|NCT03537651|516878723|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
143364863|NCT03537651|516878723|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
143364864|NCT03537651|516878723|FG000|Part A (Up to 96 Weeks)|Other|1|||
143364865|NCT03537651|516878723|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
143364866|NCT03537651|516878723|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
143364867|NCT03537651|516878723|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
143364868|NCT03537651|516878723|FG000|Part B (Up to 192 Weeks)|Other|1|||
143364869|NCT05487703|516878724|FG000|Overall Study|Other|19|||
143364870|NCT05487703|516878724|FG000|Overall Study|Participant not well|5|||
143500121|NCT02913313|517372323|FG012|Overall Study|STUDY DRUG TOXICITY|2|||
143245539|NCT01865552|516451736|FG004|Period 1|Adverse Event|1|||
143245540|NCT01865552|516451737|FG005|Period 1|Adverse Event|1|||
143245541|NCT01865552|516451732|FG000|Period 1|Pathological lab|0|||
143245542|NCT01865552|516451733|FG001|Period 1|Pathological lab|0|||
143245543|NCT01865552|516451734|FG002|Period 1|Pathological lab|0|||
143245544|NCT01865552|516451735|FG003|Period 1|Pathological lab|0|||
143245545|NCT01865552|516451736|FG004|Period 1|Pathological lab|1|||
143245546|NCT01865552|516451737|FG005|Period 1|Pathological lab|0|||
143245547|NCT01865552|516451732|FG000|Period 1|Other|0|||
143245548|NCT01865552|516451733|FG001|Period 1|Other|0|||
143245549|NCT01865552|516451734|FG002|Period 1|Other|0|||
143245550|NCT01865552|516451735|FG003|Period 1|Other|0|||
143245551|NCT01865552|516451736|FG004|Period 1|Other|1|||
143245552|NCT01865552|516451737|FG005|Period 1|Other|0|||
143245553|NCT03079102|516451740|FG000|Overall Study|Physician Decision|0|||
143245554|NCT03079102|516451741|FG001|Overall Study|Physician Decision|1|||
143245555|NCT03083873|516451742|FG000|Overall Study|Death|6|||
143245556|NCT03083873|516451743|FG001|Overall Study|Death|15|||
143245557|NCT03083873|516451744|FG002|Overall Study|Death|13|||
143245558|NCT03083873|516451745|FG003|Overall Study|Death|9|||
143245559|NCT03083873|516451746|FG004|Overall Study|Death|0|||
143245560|NCT03083873|516451742|FG000|Overall Study|Sponsor Terminated Study|0|||
143245561|NCT03083873|516451743|FG001|Overall Study|Sponsor Terminated Study|1|||
143245562|NCT03083873|516451744|FG002|Overall Study|Sponsor Terminated Study|2|||
143245563|NCT03083873|516451745|FG003|Overall Study|Sponsor Terminated Study|3|||
143245564|NCT03083873|516451746|FG004|Overall Study|Sponsor Terminated Study|0|||
143245565|NCT03083873|516451742|FG000|Overall Study|Lost to Follow-up|0|||
143245566|NCT03083873|516451743|FG001|Overall Study|Lost to Follow-up|1|||
143245567|NCT03083873|516451744|FG002|Overall Study|Lost to Follow-up|1|||
143245568|NCT03083873|516451745|FG003|Overall Study|Lost to Follow-up|0|||
143245569|NCT03083873|516451746|FG004|Overall Study|Lost to Follow-up|0|||
143245570|NCT03083873|516451742|FG000|Overall Study|Withdrawal by Subject|2|||
143245571|NCT03083873|516451743|FG001|Overall Study|Withdrawal by Subject|0|||
143245572|NCT03083873|516451744|FG002|Overall Study|Withdrawal by Subject|0|||
143364871|NCT05487703|516878724|FG000|Overall Study|Insurance Reasons|6|||
143364872|NCT05487703|516878724|FG000|Overall Study|Physician Decision|19|||
143364873|NCT05487703|516878724|FG000|Overall Study|Lack of Efficacy|60|||
143364874|NCT02403323|516878725|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
143500122|NCT02913313|517372324|FG013|Overall Study|STUDY DRUG TOXICITY|1|||
143500123|NCT06118385|517372325|FG000|Overall Study|Protocol Violation|0|||
143500124|NCT06118385|517372326|FG001|Overall Study|Protocol Violation|0|||
143500125|NCT06118385|517372327|FG002|Overall Study|Protocol Violation|0|||
143500126|NCT06118385|517372328|FG003|Overall Study|Protocol Violation|0|||
143245573|NCT03083873|516451745|FG003|Overall Study|Withdrawal by Subject|0|||
143245574|NCT03083873|516451746|FG004|Overall Study|Withdrawal by Subject|0|||
143245575|NCT03083873|516451742|FG000|Overall Study|Did Not Receive TIL|2|||
143245576|NCT03083873|516451743|FG001|Overall Study|Did Not Receive TIL|5|||
143245577|NCT03083873|516451744|FG002|Overall Study|Did Not Receive TIL|3|||
143245578|NCT03083873|516451745|FG003|Overall Study|Did Not Receive TIL|1|||
143245579|NCT03083873|516451746|FG004|Overall Study|Did Not Receive TIL|0|||
143245580|NCT01677377|516451747|FG000|Overall Study|Protocol Violation|1|||
143245581|NCT01677377|516451748|FG001|Overall Study|Protocol Violation|0|||
143245582|NCT01677377|516451749|FG002|Overall Study|Protocol Violation|0|||
143245583|NCT01677377|516451747|FG000|Overall Study|Lost to Follow-up|0|||
143245584|NCT01677377|516451748|FG001|Overall Study|Lost to Follow-up|1|||
143245585|NCT01677377|516451749|FG002|Overall Study|Lost to Follow-up|1|||
143245586|NCT01677377|516451747|FG000|Overall Study|Withdrawal by Subject|0|||
143245587|NCT01677377|516451748|FG001|Overall Study|Withdrawal by Subject|0|||
143245588|NCT01677377|516451749|FG002|Overall Study|Withdrawal by Subject|3|||
143245589|NCT01677377|516451747|FG000|Overall Study|Lack of Efficacy|0|||
143245590|NCT01677377|516451748|FG001|Overall Study|Lack of Efficacy|0|||
143245591|NCT01677377|516451749|FG002|Overall Study|Lack of Efficacy|1|||
143245592|NCT01677377|516451747|FG000|Overall Study|Pregnancy|0|||
143245593|NCT01677377|516451748|FG001|Overall Study|Pregnancy|0|||
143245594|NCT01677377|516451749|FG002|Overall Study|Pregnancy|1|||
143056823|NCT01563237|515747607|FG001|Overall Study|Death|0|||
143056824|NCT00988208|515747615|FG000|Overall Study|Adverse Event|71|||
143056825|NCT00988208|515747616|FG001|Overall Study|Adverse Event|122|||
143056826|NCT00988208|515747615|FG000|Overall Study|Disease Progression|103|||
143056827|NCT00988208|515747616|FG001|Overall Study|Disease Progression|89|||
143056828|NCT00988208|515747615|FG000|Overall Study|Withdrawal by Subject|50|||
143056829|NCT00988208|515747616|FG001|Overall Study|Withdrawal by Subject|57|||
143056830|NCT00988208|515747615|FG000|Overall Study|Death|9|||
143056831|NCT00988208|515747616|FG001|Overall Study|Death|15|||
143056832|NCT00988208|515747615|FG000|Overall Study|Lost to Follow-up|2|||
143056833|NCT00988208|515747616|FG001|Overall Study|Lost to Follow-up|3|||
143056834|NCT00988208|515747615|FG000|Overall Study|Protocol Violation|9|||
143056835|NCT00988208|515747616|FG001|Overall Study|Protocol Violation|2|||
143056836|NCT00988208|515747615|FG000|Overall Study|Sponsor Decision|102|||
143056837|NCT00988208|515747616|FG001|Overall Study|Sponsor Decision|78|||
143056838|NCT00988208|515747615|FG000|Overall Study|Clinical Progression|17|||
143056839|NCT00988208|515747616|FG001|Overall Study|Clinical Progression|16|||
143056840|NCT00988208|515747615|FG000|Overall Study|Biochemical Progression|21|||
143056841|NCT00988208|515747616|FG001|Overall Study|Biochemical Progression|7|||
143056842|NCT00988208|515747615|FG000|Overall Study|Clinical Deterioration|7|||
143056843|NCT00988208|515747616|FG001|Overall Study|Clinical Deterioration|14|||
143056844|NCT00988208|515747615|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
143056845|NCT00988208|515747616|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
143056846|NCT00988208|515747615|FG000|Overall Study|Other|8|||
143056847|NCT00988208|515747616|FG001|Overall Study|Other|3|||
143056848|NCT01201759|515747619|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
143056849|NCT01201759|515747620|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
143056850|NCT01201759|515747619|FG000|Visit 3 - Washout|Adverse Event|0|||
143056851|NCT01201759|515747620|FG001|Visit 3 - Washout|Adverse Event|3|||
143056852|NCT01201759|515747619|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
143056853|NCT01201759|515747620|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
143056854|NCT01201759|515747619|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
143056855|NCT01201759|515747620|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
143056856|NCT00906373|515747623|FG000|Overall Study|Withdrawal by Subject|0|||
143056857|NCT00906373|515747624|FG001|Overall Study|Withdrawal by Subject|5|||
143056858|NCT00906373|515747623|FG000|Overall Study|Other|0|||
143056859|NCT00906373|515747624|FG001|Overall Study|Other|1|||
143056860|NCT00906373|515747623|FG000|Overall Study|Still on treatment at cutoff date|0|||
143056861|NCT00906373|515747624|FG001|Overall Study|Still on treatment at cutoff date|2|||
143056862|NCT01597479|515747625|FG000|Overall Study|Protocol Violation|1|||
143056863|NCT01597479|515747626|FG001|Overall Study|Protocol Violation|0|||
143056864|NCT01597479|515747625|FG000|Overall Study|Lost to Follow-up|1|||
143056865|NCT01597479|515747626|FG001|Overall Study|Lost to Follow-up|0|||
143056866|NCT04317599|515747634|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
143056867|NCT04317599|515747634|FG000|Overall Study|treatment outside standard of care|4|||
143056868|NCT00809965|515747635|FG000|Overall Study|Death|194|||
143056869|NCT00809965|515747636|FG001|Overall Study|Death|147|||
143245595|NCT00479687|516451750|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
143245596|NCT00479687|516451751|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
143245597|NCT00479687|516451752|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
143245598|NCT00479687|516451750|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
143245599|NCT00479687|516451751|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
143245600|NCT00479687|516451752|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
143245601|NCT00479687|516451750|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
143245602|NCT00479687|516451751|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
143245603|NCT00479687|516451752|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
143245604|NCT00479687|516451750|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
143056870|NCT00809965|515747637|FG002|Overall Study|Death|196|||
143056871|NCT00809965|515747635|FG000|Overall Study|Lost to Follow-up|17|||
143245605|NCT00479687|516451751|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
143245606|NCT00479687|516451752|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
143500127|NCT06118385|517372329|FG004|Overall Study|Protocol Violation|0|||
143500128|NCT06118385|517372330|FG005|Overall Study|Protocol Violation|0|||
143500129|NCT06118385|517372331|FG006|Overall Study|Protocol Violation|0|||
143056872|NCT00809965|515747636|FG001|Overall Study|Lost to Follow-up|10|||
143056873|NCT00809965|515747637|FG002|Overall Study|Lost to Follow-up|18|||
143056874|NCT00809965|515747635|FG000|Overall Study|Withdrawal by Subject|405|||
143056875|NCT00809965|515747636|FG001|Overall Study|Withdrawal by Subject|448|||
143056876|NCT00809965|515747637|FG002|Overall Study|Withdrawal by Subject|441|||
143056877|NCT00809965|515747635|FG000|Overall Study|Other Reason|167|||
143056878|NCT00809965|515747636|FG001|Overall Study|Other Reason|170|||
143056879|NCT00809965|515747637|FG002|Overall Study|Other Reason|189|||
143056880|NCT02780167|515747638|FG000|Overall Study|Adverse Event|9|||
143056881|NCT02780167|515747639|FG001|Overall Study|Adverse Event|8|||
143056882|NCT02780167|515747640|FG002|Overall Study|Adverse Event|8|||
143169663|NCT02958865|516169889|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
143500130|NCT06118385|517372332|FG007|Overall Study|Protocol Violation|0|||
143500131|NCT06118385|517372333|FG008|Overall Study|Protocol Violation|1|||
143500132|NCT06118385|517372334|FG009|Overall Study|Protocol Violation|0|||
143500133|NCT06118385|517372335|FG010|Overall Study|Protocol Violation|0|||
143500134|NCT06118385|517372336|FG011|Overall Study|Protocol Violation|0|||
143500135|NCT06118385|517372325|FG000|Overall Study|Out-of-range blood tests|0|||
143500136|NCT06118385|517372326|FG001|Overall Study|Out-of-range blood tests|0|||
143500137|NCT06118385|517372327|FG002|Overall Study|Out-of-range blood tests|0|||
143500138|NCT06118385|517372328|FG003|Overall Study|Out-of-range blood tests|0|||
143500139|NCT06118385|517372329|FG004|Overall Study|Out-of-range blood tests|0|||
143500140|NCT06118385|517372330|FG005|Overall Study|Out-of-range blood tests|0|||
143500141|NCT06118385|517372331|FG006|Overall Study|Out-of-range blood tests|0|||
143500142|NCT06118385|517372332|FG007|Overall Study|Out-of-range blood tests|0|||
143500143|NCT06118385|517372333|FG008|Overall Study|Out-of-range blood tests|1|||
143500144|NCT06118385|517372334|FG009|Overall Study|Out-of-range blood tests|0|||
143500145|NCT06118385|517372335|FG010|Overall Study|Out-of-range blood tests|0|||
143500146|NCT06118385|517372336|FG011|Overall Study|Out-of-range blood tests|0|||
143500147|NCT00440726|517372337|FG000|Phase 1|Dose-Limiting Toxicity|0|||
143500148|NCT00440726|517372338|FG001|Phase 1|Dose-Limiting Toxicity|1|||
143500149|NCT00440726|517372339|FG002|Phase 1|Dose-Limiting Toxicity|0|||
143500150|NCT00440726|517372337|FG000|Phase 1|Physician Decision|1|||
143500151|NCT00440726|517372338|FG001|Phase 1|Physician Decision|0|||
143500152|NCT00440726|517372339|FG002|Phase 1|Physician Decision|0|||
143500153|NCT00440726|517372337|FG000|Phase 2|Death|0|||
143500154|NCT00440726|517372338|FG001|Phase 2|Death|0|||
143500155|NCT00440726|517372339|FG002|Phase 2|Death|1|||
143500156|NCT00440726|517372337|FG000|Phase 2|Adverse Event|0|||
143500157|NCT00440726|517372338|FG001|Phase 2|Adverse Event|0|||
143500158|NCT00440726|517372339|FG002|Phase 2|Adverse Event|1|||
143500159|NCT03683394|517372340|FG000|Overall Study|Withdrawal by Subject|4|||
143500160|NCT03683394|517372341|FG001|Overall Study|Withdrawal by Subject|8|||
143500161|NCT03683394|517372340|FG000|Overall Study|Lost to Follow-up|7|||
143500162|NCT03683394|517372341|FG001|Overall Study|Lost to Follow-up|0|||
143500163|NCT03683394|517372340|FG000|Overall Study|Death|3|||
143500164|NCT03683394|517372341|FG001|Overall Study|Death|1|||
143500165|NCT03624946|517372344|FG000|Overall Study|Lost to Follow-up|0|||
143500166|NCT03624946|517372345|FG001|Overall Study|Lost to Follow-up|1|||
143500167|NCT01925209|517372346|FG000|Treatment Epoch|Physician Decision|1|||
143500168|NCT01925209|517372347|FG001|Treatment Epoch|Physician Decision|0|||
143500169|NCT01925209|517372348|FG002|Treatment Epoch|Physician Decision|0|||
143500170|NCT01925209|517372349|FG003|Treatment Epoch|Physician Decision|0|||
143500171|NCT01925209|517372346|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
143500172|NCT01925209|517372347|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
143500173|NCT01925209|517372348|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
143500174|NCT01925209|517372349|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
143500175|NCT01925209|517372346|FG000|Treatment Epoch|Death|1|||
143500176|NCT01925209|517372347|FG001|Treatment Epoch|Death|0|||
143500177|NCT01925209|517372348|FG002|Treatment Epoch|Death|0|||
143500178|NCT01925209|517372349|FG003|Treatment Epoch|Death|0|||
143500179|NCT01925209|517372346|FG000|Treatment Epoch|Protocol deviation|0|||
143500180|NCT01925209|517372347|FG001|Treatment Epoch|Protocol deviation|0|||
143500181|NCT01925209|517372348|FG002|Treatment Epoch|Protocol deviation|1|||
143500182|NCT01925209|517372349|FG003|Treatment Epoch|Protocol deviation|1|||
143500183|NCT01925209|517372346|FG000|Treatment Epoch|Withdrawal by Subject|4|||
143500184|NCT01925209|517372347|FG001|Treatment Epoch|Withdrawal by Subject|3|||
143500185|NCT01925209|517372348|FG002|Treatment Epoch|Withdrawal by Subject|3|||
143500186|NCT01925209|517372349|FG003|Treatment Epoch|Withdrawal by Subject|2|||
143500187|NCT01925209|517372346|FG000|Treatment Epoch|Adverse Event|3|||
143500188|NCT01925209|517372347|FG001|Treatment Epoch|Adverse Event|5|||
143500189|NCT01925209|517372348|FG002|Treatment Epoch|Adverse Event|3|||
143500190|NCT01925209|517372349|FG003|Treatment Epoch|Adverse Event|1|||
143500191|NCT01925209|517372346|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
143500192|NCT01925209|517372347|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
143500193|NCT01925209|517372348|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
143500194|NCT01925209|517372349|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
143500195|NCT01925209|517372346|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
143245607|NCT00479687|516451750|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
143245608|NCT00479687|516451751|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
143245609|NCT00479687|516451752|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
143245610|NCT00479687|516451750|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
143245611|NCT00479687|516451751|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
143245612|NCT00479687|516451752|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
143245613|NCT00479687|516451750|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
143245614|NCT00479687|516451751|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
143245615|NCT00479687|516451752|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
143245616|NCT00479687|516451750|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
143245617|NCT00479687|516451751|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
143245618|NCT00479687|516451752|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
143245619|NCT00479687|516451750|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
143245620|NCT00479687|516451751|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
143245621|NCT00479687|516451752|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
143245622|NCT00295880|516451753|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
143245623|NCT00295880|516451753|FG000|Overall Study|Unit randomization did not occur|1|||
143245624|NCT01474239|516451754|FG000|Overall Study|Disease Progression|37|||
143245625|NCT01474239|516451755|FG001|Overall Study|Disease Progression|25|||
143245626|NCT01474239|516451754|FG000|Overall Study|Adverse Event|12|||
143245627|NCT01474239|516451755|FG001|Overall Study|Adverse Event|3|||
143245628|NCT01474239|516451754|FG000|Overall Study|Withdrawal by Subject|1|||
143500196|NCT01925209|517372347|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
143500197|NCT01925209|517372348|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
143500198|NCT01925209|517372349|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
143500199|NCT01925209|517372346|FG000|Follow-up|Adverse Event|1|||
143500200|NCT01925209|517372347|FG001|Follow-up|Adverse Event|4|||
143500201|NCT01925209|517372348|FG002|Follow-up|Adverse Event|0|||
143500202|NCT01925209|517372349|FG003|Follow-up|Adverse Event|1|||
143500203|NCT01925209|517372346|FG000|Follow-up|Physician Decision|0|||
143056883|NCT02780167|515747641|FG003|Overall Study|Adverse Event|12|||
143056884|NCT02780167|515747642|FG004|Overall Study|Adverse Event|8|||
143056885|NCT02780167|515747638|FG000|Overall Study|Lack of Efficacy|6|||
143056886|NCT02780167|515747639|FG001|Overall Study|Lack of Efficacy|5|||
143056887|NCT02780167|515747640|FG002|Overall Study|Lack of Efficacy|6|||
143056888|NCT02780167|515747641|FG003|Overall Study|Lack of Efficacy|1|||
143056889|NCT02780167|515747642|FG004|Overall Study|Lack of Efficacy|0|||
143056890|NCT02780167|515747638|FG000|Overall Study|Lost to Follow-up|2|||
143056891|NCT02780167|515747639|FG001|Overall Study|Lost to Follow-up|0|||
143056892|NCT02780167|515747640|FG002|Overall Study|Lost to Follow-up|1|||
143056893|NCT02780167|515747641|FG003|Overall Study|Lost to Follow-up|0|||
143056894|NCT02780167|515747642|FG004|Overall Study|Lost to Follow-up|0|||
143056895|NCT02780167|515747638|FG000|Overall Study|Does not meet entrance criteria|0|||
143056896|NCT02780167|515747639|FG001|Overall Study|Does not meet entrance criteria|0|||
143056897|NCT02780167|515747640|FG002|Overall Study|Does not meet entrance criteria|1|||
143056898|NCT02780167|515747641|FG003|Overall Study|Does not meet entrance criteria|0|||
143500204|NCT01925209|517372347|FG001|Follow-up|Physician Decision|0|||
143056899|NCT02780167|515747642|FG004|Overall Study|Does not meet entrance criteria|0|||
143056900|NCT02780167|515747638|FG000|Overall Study|No longer meets eligibility criteria|0|||
143056901|NCT02780167|515747639|FG001|Overall Study|No longer meets eligibility criteria|0|||
143056902|NCT02780167|515747640|FG002|Overall Study|No longer meets eligibility criteria|0|||
143056903|NCT02780167|515747641|FG003|Overall Study|No longer meets eligibility criteria|1|||
143056904|NCT02780167|515747642|FG004|Overall Study|No longer meets eligibility criteria|1|||
143056905|NCT02780167|515747638|FG000|Overall Study|Protocol Violation|5|||
143245629|NCT01474239|516451755|FG001|Overall Study|Withdrawal by Subject|2|||
143245630|NCT01474239|516451754|FG000|Overall Study|Death|1|||
143245631|NCT01474239|516451755|FG001|Overall Study|Death|1|||
143245632|NCT01474239|516451754|FG000|Overall Study|Clinical Disease Progression|7|||
143245633|NCT01474239|516451755|FG001|Overall Study|Clinical Disease Progression|1|||
143245634|NCT01474239|516451754|FG000|Overall Study|Withdrawal for Economic Reason|1|||
143245635|NCT01474239|516451755|FG001|Overall Study|Withdrawal for Economic Reason|0|||
143245636|NCT02260180|516451759|FG000|Overall Study|Adverse Event|2|||
143056906|NCT02780167|515747639|FG001|Overall Study|Protocol Violation|5|||
143056907|NCT02780167|515747640|FG002|Overall Study|Protocol Violation|1|||
143056908|NCT02780167|515747641|FG003|Overall Study|Protocol Violation|1|||
143056909|NCT02780167|515747642|FG004|Overall Study|Protocol Violation|2|||
143245637|NCT02260180|516451760|FG001|Overall Study|Adverse Event|0|||
143245638|NCT02260180|516451761|FG002|Overall Study|Adverse Event|1|||
143245639|NCT00539864|516451764|FG000|Overall Study|Lost to Follow-up|0|||
143245640|NCT00539864|516451765|FG001|Overall Study|Lost to Follow-up|1|||
143245641|NCT00539864|516451764|FG000|Overall Study|Withdrawal by Subject|1|||
143245642|NCT00539864|516451765|FG001|Overall Study|Withdrawal by Subject|1|||
143245643|NCT00943072|516451771|FG000|Overall Study|Adverse Event|0|||
143500205|NCT01925209|517372348|FG002|Follow-up|Physician Decision|1|||
143056910|NCT02780167|515747638|FG000|Overall Study|Withdrawal by Subject|6|||
143056911|NCT02780167|515747639|FG001|Overall Study|Withdrawal by Subject|4|||
143056912|NCT02780167|515747640|FG002|Overall Study|Withdrawal by Subject|4|||
143056913|NCT02780167|515747641|FG003|Overall Study|Withdrawal by Subject|3|||
143056914|NCT02780167|515747642|FG004|Overall Study|Withdrawal by Subject|4|||
143056915|NCT02780167|515747638|FG000|Overall Study|Other|0|||
143169664|NCT02958865|516169890|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
143169665|NCT02958865|516169891|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
143169666|NCT02958865|516169892|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
143169667|NCT02958865|516169893|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
143056916|NCT02780167|515747639|FG001|Overall Study|Other|0|||
143169668|NCT02958865|516169894|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
143169669|NCT02958865|516169895|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
143169670|NCT02958865|516169896|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
143056917|NCT02780167|515747640|FG002|Overall Study|Other|3|||
143056918|NCT02780167|515747641|FG003|Overall Study|Other|1|||
143056919|NCT02780167|515747642|FG004|Overall Study|Other|2|||
143056920|NCT02315066|515747643|FG000|Overall Study|Lost to Follow-up|0|||
143056921|NCT02315066|515747644|FG001|Overall Study|Lost to Follow-up|1|||
143056922|NCT02315066|515747645|FG002|Overall Study|Lost to Follow-up|1|||
143056923|NCT02315066|515747646|FG003|Overall Study|Lost to Follow-up|0|||
143056924|NCT02315066|515747647|FG004|Overall Study|Lost to Follow-up|1|||
143056925|NCT02315066|515747648|FG005|Overall Study|Lost to Follow-up|0|||
143056926|NCT02315066|515747649|FG006|Overall Study|Lost to Follow-up|2|||
143056927|NCT02315066|515747650|FG007|Overall Study|Lost to Follow-up|1|||
143056928|NCT02315066|515747651|FG008|Overall Study|Lost to Follow-up|0|||
143056929|NCT02315066|515747652|FG009|Overall Study|Lost to Follow-up|0|||
143056930|NCT02315066|515747653|FG010|Overall Study|Lost to Follow-up|1|||
143056931|NCT02315066|515747654|FG011|Overall Study|Lost to Follow-up|2|||
143056932|NCT02315066|515747655|FG012|Overall Study|Lost to Follow-up|0|||
143056933|NCT02315066|515747656|FG013|Overall Study|Lost to Follow-up|4|||
143245644|NCT00943072|516451772|FG001|Overall Study|Adverse Event|3|||
143245645|NCT00943072|516451771|FG000|Overall Study|Death|0|||
143245646|NCT00943072|516451772|FG001|Overall Study|Death|2|||
143245647|NCT00943072|516451771|FG000|Overall Study|Withdrawal by Subject|3|||
143245648|NCT00943072|516451772|FG001|Overall Study|Withdrawal by Subject|1|||
143245649|NCT00943072|516451771|FG000|Overall Study|Protocol Violation|0|||
143245650|NCT00943072|516451772|FG001|Overall Study|Protocol Violation|1|||
143245651|NCT00943072|516451771|FG000|Overall Study|Lost to Follow-up|1|||
143245652|NCT00943072|516451772|FG001|Overall Study|Lost to Follow-up|2|||
143245653|NCT00943072|516451771|FG000|Overall Study|Lack of Efficacy|0|||
143245654|NCT00943072|516451772|FG001|Overall Study|Lack of Efficacy|4|||
143245655|NCT00943072|516451771|FG000|Overall Study|Other|1|||
143245656|NCT00943072|516451772|FG001|Overall Study|Other|1|||
143245657|NCT03126344|516451781|FG000|Overall Study|Lost to Follow-up|0|||
143245658|NCT03126344|516451782|FG001|Overall Study|Lost to Follow-up|0|||
143245659|NCT03126344|516451783|FG002|Overall Study|Lost to Follow-up|5|||
143245660|NCT00481091|516451784|FG000|Overall Study|Withdrawal by Subject|0|||
143245661|NCT00481091|516451785|FG001|Overall Study|Withdrawal by Subject|1|||
143245662|NCT00481091|516451786|FG002|Overall Study|Withdrawal by Subject|1|||
143245663|NCT00481091|516451787|FG003|Overall Study|Withdrawal by Subject|0|||
143245664|NCT00481091|516451788|FG004|Overall Study|Withdrawal by Subject|0|||
143245665|NCT00481091|516451789|FG005|Overall Study|Withdrawal by Subject|0|||
143245666|NCT00481091|516451790|FG006|Overall Study|Withdrawal by Subject|0|||
143245667|NCT00481091|516451791|FG007|Overall Study|Withdrawal by Subject|0|||
143245668|NCT00481091|516451792|FG008|Overall Study|Withdrawal by Subject|1|||
143245669|NCT00481091|516451793|FG009|Overall Study|Withdrawal by Subject|6|||
143245670|NCT00481091|516451784|FG000|Overall Study|Other, Not Specified|0|||
143245671|NCT00481091|516451785|FG001|Overall Study|Other, Not Specified|1|||
143245672|NCT00481091|516451786|FG002|Overall Study|Other, Not Specified|1|||
143169671|NCT02958865|516169897|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
143169672|NCT02958865|516169882|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
143169673|NCT02958865|516169883|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
143245673|NCT00481091|516451787|FG003|Overall Study|Other, Not Specified|0|||
143056934|NCT02315066|515747643|FG000|Overall Study|Death|2|||
143056935|NCT02315066|515747644|FG001|Overall Study|Death|7|||
143056936|NCT02315066|515747645|FG002|Overall Study|Death|6|||
143056937|NCT02315066|515747646|FG003|Overall Study|Death|11|||
143056938|NCT02315066|515747647|FG004|Overall Study|Death|10|||
143056939|NCT02315066|515747648|FG005|Overall Study|Death|3|||
143245674|NCT00481091|516451788|FG004|Overall Study|Other, Not Specified|0|||
143245675|NCT00481091|516451789|FG005|Overall Study|Other, Not Specified|1|||
143245676|NCT00481091|516451790|FG006|Overall Study|Other, Not Specified|0|||
143245677|NCT00481091|516451791|FG007|Overall Study|Other, Not Specified|0|||
143245678|NCT00481091|516451792|FG008|Overall Study|Other, Not Specified|0|||
143245679|NCT00481091|516451793|FG009|Overall Study|Other, Not Specified|4|||
143056940|NCT02315066|515747649|FG006|Overall Study|Death|9|||
143056941|NCT02315066|515747650|FG007|Overall Study|Death|9|||
143056942|NCT02315066|515747651|FG008|Overall Study|Death|10|||
143056943|NCT02315066|515747652|FG009|Overall Study|Death|8|||
143056944|NCT02315066|515747653|FG010|Overall Study|Death|10|||
143056945|NCT02315066|515747654|FG011|Overall Study|Death|7|||
143056946|NCT02315066|515747655|FG012|Overall Study|Death|8|||
143056947|NCT02315066|515747656|FG013|Overall Study|Death|21|||
143056948|NCT02315066|515747643|FG000|Overall Study|Other|0|||
143056949|NCT02315066|515747644|FG001|Overall Study|Other|0|||
143056950|NCT02315066|515747645|FG002|Overall Study|Other|0|||
143056951|NCT02315066|515747646|FG003|Overall Study|Other|0|||
143056952|NCT02315066|515747647|FG004|Overall Study|Other|0|||
143056953|NCT02315066|515747648|FG005|Overall Study|Other|0|||
143056954|NCT02315066|515747649|FG006|Overall Study|Other|0|||
143056955|NCT02315066|515747650|FG007|Overall Study|Other|1|||
143056956|NCT02315066|515747651|FG008|Overall Study|Other|1|||
143056957|NCT02315066|515747652|FG009|Overall Study|Other|2|||
143056958|NCT02315066|515747653|FG010|Overall Study|Other|0|||
143056959|NCT02315066|515747654|FG011|Overall Study|Other|0|||
143056960|NCT02315066|515747655|FG012|Overall Study|Other|0|||
143056961|NCT02315066|515747656|FG013|Overall Study|Other|0|||
143056962|NCT02315066|515747643|FG000|Overall Study|Subject refused further follow-up|0|||
143056963|NCT02315066|515747644|FG001|Overall Study|Subject refused further follow-up|2|||
143056964|NCT02315066|515747645|FG002|Overall Study|Subject refused further follow-up|2|||
143056965|NCT02315066|515747646|FG003|Overall Study|Subject refused further follow-up|0|||
143056966|NCT02315066|515747647|FG004|Overall Study|Subject refused further follow-up|0|||
143056967|NCT02315066|515747648|FG005|Overall Study|Subject refused further follow-up|0|||
143056968|NCT02315066|515747649|FG006|Overall Study|Subject refused further follow-up|2|||
143056969|NCT02315066|515747650|FG007|Overall Study|Subject refused further follow-up|3|||
143056970|NCT02315066|515747651|FG008|Overall Study|Subject refused further follow-up|0|||
143056971|NCT02315066|515747652|FG009|Overall Study|Subject refused further follow-up|1|||
143056972|NCT02315066|515747653|FG010|Overall Study|Subject refused further follow-up|1|||
143056973|NCT02315066|515747654|FG011|Overall Study|Subject refused further follow-up|2|||
143056974|NCT02315066|515747655|FG012|Overall Study|Subject refused further follow-up|2|||
143056975|NCT02315066|515747656|FG013|Overall Study|Subject refused further follow-up|4|||
143056976|NCT02315066|515747643|FG000|Overall Study|Study ongoing at date of cut-off|0|||
143056977|NCT02315066|515747644|FG001|Overall Study|Study ongoing at date of cut-off|0|||
143056978|NCT02315066|515747645|FG002|Overall Study|Study ongoing at date of cut-off|0|||
143056979|NCT02315066|515747646|FG003|Overall Study|Study ongoing at date of cut-off|0|||
143056980|NCT02315066|515747647|FG004|Overall Study|Study ongoing at date of cut-off|0|||
143056981|NCT02315066|515747648|FG005|Overall Study|Study ongoing at date of cut-off|0|||
143056982|NCT02315066|515747649|FG006|Overall Study|Study ongoing at date of cut-off|0|||
143056983|NCT02315066|515747650|FG007|Overall Study|Study ongoing at date of cut-off|0|||
143056984|NCT02315066|515747651|FG008|Overall Study|Study ongoing at date of cut-off|0|||
143056985|NCT02315066|515747652|FG009|Overall Study|Study ongoing at date of cut-off|0|||
143056986|NCT02315066|515747653|FG010|Overall Study|Study ongoing at date of cut-off|0|||
143056987|NCT02315066|515747654|FG011|Overall Study|Study ongoing at date of cut-off|0|||
143056988|NCT02315066|515747655|FG012|Overall Study|Study ongoing at date of cut-off|0|||
143056989|NCT02315066|515747656|FG013|Overall Study|Study ongoing at date of cut-off|1|||
143056990|NCT02916693|515747657|FG000|Overall Study|Lost to Follow-up|7|||
143056991|NCT01142908|515747658|FG000|Overall Study|Lost to Follow-up|19|||
143056992|NCT01142908|515747659|FG001|Overall Study|Lost to Follow-up|13|||
143056993|NCT01142908|515747658|FG000|Overall Study|Death|1|||
143056994|NCT01142908|515747659|FG001|Overall Study|Death|4|||
143056995|NCT01142908|515747658|FG000|Overall Study|Excluded - did not meet criteria|9|||
143056996|NCT01142908|515747659|FG001|Overall Study|Excluded - did not meet criteria|5|||
143056997|NCT01142908|515747658|FG000|Overall Study|Withdrawal by Subject|3|||
143056998|NCT01142908|515747659|FG001|Overall Study|Withdrawal by Subject|0|||
143056999|NCT00337428|515747661|FG000|Overall Study|Withdrawal by Subject|1|||
143057000|NCT00337428|515747662|FG001|Overall Study|Withdrawal by Subject|2|||
143057001|NCT00337428|515747661|FG000|Overall Study|Lack of Time|1|||
143057002|NCT00337428|515747662|FG001|Overall Study|Lack of Time|1|||
143057003|NCT00337428|515747661|FG000|Overall Study|Unwilling to Continue|1|||
143057004|NCT00337428|515747662|FG001|Overall Study|Unwilling to Continue|0|||
143057005|NCT00337428|515747661|FG000|Overall Study|Anorexia|1|||
143057006|NCT00337428|515747662|FG001|Overall Study|Anorexia|0|||
143057007|NCT00779402|515747663|FG000|Treatment Phase 1|Disease Progression|1|||
143057008|NCT00779402|515747664|FG001|Treatment Phase 1|Disease Progression|0|||
143057009|NCT00779402|515747663|FG000|Treatment Phase 1|Adverse Event|2|||
143057010|NCT00779402|515747664|FG001|Treatment Phase 1|Adverse Event|0|||
143057011|NCT00779402|515747663|FG000|Treatment Phase 1|Protocol Violation|1|||
143057012|NCT00779402|515747664|FG001|Treatment Phase 1|Protocol Violation|0|||
143057013|NCT00779402|515747663|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
143057014|NCT00779402|515747664|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
143057015|NCT00779402|515747663|FG000|Treatment Phase 1|Lost to Follow-up|0|||
143057016|NCT00779402|515747664|FG001|Treatment Phase 1|Lost to Follow-up|1|||
143057017|NCT00779402|515747663|FG000|Treatment Phase 1|Death|0|||
143057018|NCT00779402|515747664|FG001|Treatment Phase 1|Death|1|||
143057019|NCT00779402|515747663|FG000|Treatment Phase 1|Intercurrent Illness|1|||
143057020|NCT00779402|515747664|FG001|Treatment Phase 1|Intercurrent Illness|1|||
143057021|NCT00779402|515747663|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
143057022|NCT00779402|515747664|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
143057023|NCT00779402|515747663|FG000|Treatment Phase 1|Other|4|||
143057024|NCT00779402|515747664|FG001|Treatment Phase 1|Other|2|||
143057025|NCT00779402|515747663|FG000|Treatment Phase 1|Closure of Study|3|||
143057026|NCT00779402|515747664|FG001|Treatment Phase 1|Closure of Study|2|||
143057027|NCT00779402|515747663|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
143057028|NCT00779402|515747664|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
143057029|NCT00779402|515747663|FG000|Surveillance Phase|Protocol Violation|0|||
143057030|NCT00779402|515747664|FG001|Surveillance Phase|Protocol Violation|1|||
143057031|NCT00779402|515747663|FG000|Surveillance Phase|Patient refused to continue|22|||
143057032|NCT00779402|515747664|FG001|Surveillance Phase|Patient refused to continue|14|||
143057033|NCT00779402|515747663|FG000|Surveillance Phase|Lost to Follow-up|2|||
143057034|NCT00779402|515747664|FG001|Surveillance Phase|Lost to Follow-up|1|||
143057035|NCT00779402|515747663|FG000|Surveillance Phase|Death|0|||
143057036|NCT00779402|515747664|FG001|Surveillance Phase|Death|1|||
143057037|NCT00779402|515747663|FG000|Surveillance Phase|Intercurrent Illness|2|||
143057038|NCT00779402|515747664|FG001|Surveillance Phase|Intercurrent Illness|0|||
143057039|NCT00779402|515747663|FG000|Surveillance Phase|Other|5|||
143057040|NCT00779402|515747664|FG001|Surveillance Phase|Other|5|||
143057041|NCT00779402|515747663|FG000|Surveillance Phase|Withdrawal by Subject|4|||
143057042|NCT00779402|515747664|FG001|Surveillance Phase|Withdrawal by Subject|1|||
143057043|NCT00779402|515747663|FG000|Surveillance Phase|Closure of study|5|||
143057044|NCT00779402|515747664|FG001|Surveillance Phase|Closure of study|6|||
143057045|NCT00779402|515747663|FG000|Surveillance Phase|Completed Protocol Visits|3|||
143057046|NCT00779402|515747664|FG001|Surveillance Phase|Completed Protocol Visits|2|||
143057047|NCT00779402|515747663|FG000|Long-term Follow-up|Patient refused to continue|2|||
143057048|NCT00779402|515747664|FG001|Long-term Follow-up|Patient refused to continue|0|||
143057049|NCT00779402|515747663|FG000|Long-term Follow-up|Other|5|||
143057050|NCT00779402|515747664|FG001|Long-term Follow-up|Other|0|||
143057051|NCT00779402|515747663|FG000|Long-term Follow-up|Closure of Study|8|||
143057052|NCT00779402|515747664|FG001|Long-term Follow-up|Closure of Study|4|||
143057053|NCT00779402|515747663|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
143057054|NCT00779402|515747664|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
143057055|NCT04254809|515747667|FG000|Overall Study|Lost to Follow-up|5|||
143057056|NCT04254809|515747668|FG001|Overall Study|Lost to Follow-up|10|||
143057057|NCT01928615|515747669|FG000|Overall Study|Study Terminated by Sponsor|2|||
143057058|NCT01077258|515747672|FG000|Overall Study|Lost to Follow-up|1390|||
143057059|NCT01077258|515747672|FG000|Overall Study|Adverse drug reaction|218|||
143057060|NCT01077258|515747672|FG000|Overall Study|Lack of Efficacy|663|||
143057061|NCT01077258|515747672|FG000|Overall Study|Clinical remission|37|||
143057062|NCT01077258|515747672|FG000|Overall Study|Other reasons|260|||
143057063|NCT00515216|515747673|FG000|Overall Study|Withdrawal by Subject|1|||
143057064|NCT00726895|515747675|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
143057065|NCT00726895|515747676|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
143057066|NCT01450800|515747678|FG000|Overall Study|Protocol Violation|1|||
143057067|NCT01450800|515747679|FG001|Overall Study|Protocol Violation|3|||
143057068|NCT02250651|515747680|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
143057069|NCT02250651|515747681|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
143057070|NCT02250651|515747682|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
143057071|NCT02250651|515747680|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
143057072|NCT02250651|515747681|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
143057073|NCT02250651|515747682|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
143057074|NCT02250651|515747680|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
143057075|NCT02250651|515747681|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
143057076|NCT02250651|515747682|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
143169674|NCT02958865|516169884|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
143169675|NCT02958865|516169885|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
143057077|NCT02250651|515747680|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
143057078|NCT02250651|515747681|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
143057079|NCT02250651|515747682|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
143057080|NCT02250651|515747680|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
143057081|NCT02250651|515747681|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
143057082|NCT02250651|515747682|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
143057083|NCT02250651|515747680|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
143057084|NCT02250651|515747681|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
143169676|NCT02958865|516169886|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
143057085|NCT02250651|515747682|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
143057086|NCT02250651|515747680|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
143057087|NCT02250651|515747681|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
143057088|NCT02250651|515747682|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
143057089|NCT02250651|515747680|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
143057090|NCT02250651|515747681|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
143245680|NCT00481091|516451784|FG000|Overall Study|Adverse Event|1|||
143245681|NCT00481091|516451785|FG001|Overall Study|Adverse Event|2|||
143245682|NCT00481091|516451786|FG002|Overall Study|Adverse Event|0|||
143245683|NCT00481091|516451787|FG003|Overall Study|Adverse Event|1|||
143245684|NCT00481091|516451788|FG004|Overall Study|Adverse Event|1|||
143245685|NCT00481091|516451789|FG005|Overall Study|Adverse Event|1|||
143057091|NCT02250651|515747682|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
143057092|NCT02250651|515747680|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
143057093|NCT02250651|515747681|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
143057094|NCT02250651|515747682|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
143057095|NCT02250651|515747680|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
143057096|NCT02250651|515747681|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
143057097|NCT02250651|515747682|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
143169677|NCT02958865|516169887|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
143169678|NCT02958865|516169888|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
143169679|NCT02958865|516169889|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
143169680|NCT02958865|516169890|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
143169681|NCT02958865|516169891|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
143169682|NCT02958865|516169892|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
143169683|NCT02958865|516169893|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
143169684|NCT02958865|516169894|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
143169685|NCT02958865|516169895|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
143169686|NCT02958865|516169896|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
143169687|NCT02958865|516169897|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
143169688|NCT02958865|516169882|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
143169689|NCT02958865|516169883|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
143169690|NCT02958865|516169884|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
143169691|NCT02958865|516169885|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
143169692|NCT02958865|516169886|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
143169693|NCT02958865|516169887|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
143169694|NCT02958865|516169888|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
143169695|NCT02958865|516169889|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
143169696|NCT02958865|516169890|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
143169697|NCT02958865|516169891|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
143169698|NCT02958865|516169892|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
143169699|NCT02958865|516169893|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
143169700|NCT02958865|516169894|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
143169701|NCT02958865|516169895|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
143169702|NCT02958865|516169896|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
143169703|NCT02958865|516169897|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
143169704|NCT01767987|516169898|FG000|Overall Study|Physician Decision|4|||
143169705|NCT01767987|516169899|FG001|Overall Study|Physician Decision|1|||
143169706|NCT03232567|516169900|FG000|Overall Study|Withdrawal by Subject|0|||
143169707|NCT03232567|516169901|FG001|Overall Study|Withdrawal by Subject|1|||
143169708|NCT03232567|516169902|FG002|Overall Study|Withdrawal by Subject|0|||
143245686|NCT00481091|516451790|FG006|Overall Study|Adverse Event|2|||
143245687|NCT00481091|516451791|FG007|Overall Study|Adverse Event|1|||
143057098|NCT02250651|515747680|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
143057099|NCT02250651|515747681|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
143057100|NCT02250651|515747682|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
143057101|NCT02250651|515747680|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
143057102|NCT02250651|515747681|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
143057103|NCT02250651|515747682|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
143057104|NCT02250651|515747680|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
143057105|NCT02250651|515747681|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
143057106|NCT02250651|515747682|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
143057107|NCT02250651|515747680|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
143057108|NCT02250651|515747681|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
143057109|NCT02250651|515747682|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
143057110|NCT02250651|515747680|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
143057111|NCT02250651|515747681|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
143057112|NCT02250651|515747682|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
143057113|NCT02608476|515747683|FG000|Overall Study|Withdrawal by Subject|30|||
143057114|NCT02608476|515747684|FG001|Overall Study|Withdrawal by Subject|37|||
143057115|NCT02608476|515747683|FG000|Overall Study|Lost to Follow-up|24|||
143057116|NCT02608476|515747684|FG001|Overall Study|Lost to Follow-up|24|||
143057117|NCT02608476|515747683|FG000|Overall Study|Adverse Event|2|||
143057118|NCT02608476|515747684|FG001|Overall Study|Adverse Event|8|||
143057119|NCT02608476|515747683|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
143057120|NCT02608476|515747684|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
143057121|NCT02608476|515747683|FG000|Overall Study|Noncompliance with treatment|1|||
143057122|NCT02608476|515747684|FG001|Overall Study|Noncompliance with treatment|5|||
143057123|NCT02608476|515747683|FG000|Overall Study|Lack of Efficacy|3|||
143057124|NCT02608476|515747684|FG001|Overall Study|Lack of Efficacy|1|||
143057125|NCT02608476|515747683|FG000|Overall Study|Other|0|||
143057126|NCT02608476|515747684|FG001|Overall Study|Other|1|||
143057127|NCT02608476|515747683|FG000|Overall Study|Physician Decision|1|||
143057128|NCT02608476|515747684|FG001|Overall Study|Physician Decision|0|||
143057129|NCT02608476|515747683|FG000|Overall Study|Pregnancy|0|||
143057130|NCT02608476|515747684|FG001|Overall Study|Pregnancy|1|||
143057131|NCT02608476|515747683|FG000|Overall Study|Progressive disease|1|||
143057132|NCT02608476|515747684|FG001|Overall Study|Progressive disease|0|||
143057133|NCT00676494|515747685|FG000|Overall Study|Missed Visit|8|||
143057134|NCT00676494|515747685|FG000|Overall Study|Withdrawal by Subject|6|||
143057135|NCT01115933|515747686|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
143057136|NCT04660032|515747687|FG000|Overall Study|Protocol Violation|1|||
143057137|NCT04660032|515747688|FG001|Overall Study|Protocol Violation|1|||
143057138|NCT00090753|515747689|FG000|First Treatment Period|Adverse Event|20|||
143057139|NCT00090753|515747690|FG001|First Treatment Period|Adverse Event|8|||
143057140|NCT00090753|515747689|FG000|First Treatment Period|Death|88|||
143057141|NCT00090753|515747690|FG001|First Treatment Period|Death|62|||
143245688|NCT00481091|516451792|FG008|Overall Study|Adverse Event|1|||
143057142|NCT00090753|515747689|FG000|First Treatment Period|Lack of Efficacy|2|||
143057143|NCT00090753|515747690|FG001|First Treatment Period|Lack of Efficacy|1|||
143057144|NCT00090753|515747689|FG000|First Treatment Period|Refused Treatment|32|||
143057145|NCT00090753|515747690|FG001|First Treatment Period|Refused Treatment|25|||
143057146|NCT00090753|515747689|FG000|First Treatment Period|Lost to Follow-up|4|||
143057147|NCT00090753|515747690|FG001|First Treatment Period|Lost to Follow-up|4|||
143057148|NCT00090753|515747689|FG000|First Treatment Period|Renal Transplant|70|||
143057149|NCT00090753|515747690|FG001|First Treatment Period|Renal Transplant|50|||
143364875|NCT02403323|516878726|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
143057150|NCT00090753|515747689|FG000|First Treatment Period|Mircera Commercialization|1|||
143057151|NCT00090753|515747690|FG001|First Treatment Period|Mircera Commercialization|0|||
143057152|NCT00090753|515747689|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
143057153|NCT00090753|515747690|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
143057154|NCT00090753|515747689|FG000|Extended Treatment Period|Adverse Event|11|||
143057155|NCT00090753|515747690|FG001|Extended Treatment Period|Adverse Event|0|||
143057156|NCT00090753|515747689|FG000|Extended Treatment Period|Death|58|||
143057157|NCT00090753|515747690|FG001|Extended Treatment Period|Death|30|||
143057158|NCT00090753|515747689|FG000|Extended Treatment Period|Lack of Efficacy|1|||
143057159|NCT00090753|515747690|FG001|Extended Treatment Period|Lack of Efficacy|0|||
143057160|NCT00090753|515747689|FG000|Extended Treatment Period|Refused Treatment|18|||
143057161|NCT00090753|515747690|FG001|Extended Treatment Period|Refused Treatment|12|||
143057162|NCT00090753|515747689|FG000|Extended Treatment Period|Lost to Follow-up|3|||
143057163|NCT00090753|515747690|FG001|Extended Treatment Period|Lost to Follow-up|1|||
143057164|NCT00090753|515747689|FG000|Extended Treatment Period|Renal Transplant|15|||
143057165|NCT00090753|515747690|FG001|Extended Treatment Period|Renal Transplant|12|||
143057166|NCT00090753|515747689|FG000|Extended Treatment Period|Mircera Commercialization|188|||
143057167|NCT00090753|515747690|FG001|Extended Treatment Period|Mircera Commercialization|93|||
143057168|NCT00090753|515747689|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
143057169|NCT00090753|515747690|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
143057170|NCT01609582|515747693|FG000|Overall Study|Adverse Event|20|||
143057171|NCT01609582|515747694|FG001|Overall Study|Adverse Event|18|||
143057172|NCT01609582|515747693|FG000|Overall Study|Lost to Follow-up|10|||
143057173|NCT01609582|515747694|FG001|Overall Study|Lost to Follow-up|10|||
143057174|NCT01609582|515747693|FG000|Overall Study|Withdrawal by Subject|21|||
143057175|NCT01609582|515747694|FG001|Overall Study|Withdrawal by Subject|15|||
143057176|NCT01609582|515747693|FG000|Overall Study|Study Terminated by Sponsor|1543|||
143057177|NCT01609582|515747694|FG001|Overall Study|Study Terminated by Sponsor|1548|||
143057178|NCT01609582|515747693|FG000|Overall Study|Other|9|||
143057179|NCT01609582|515747694|FG001|Overall Study|Other|10|||
143057180|NCT01609582|515747693|FG000|Overall Study|Randomized, but not treated|0|||
143057181|NCT01609582|515747694|FG001|Overall Study|Randomized, but not treated|3|||
143057182|NCT00587431|515747697|FG000|Overall Study|Adverse Event|1|||
143057183|NCT00587431|515747698|FG001|Overall Study|Adverse Event|0|||
143057184|NCT00587431|515747697|FG000|Overall Study|Withdrawal by Subject|0|||
143057185|NCT00587431|515747698|FG001|Overall Study|Withdrawal by Subject|1|||
143057186|NCT03430011|515747700|FG000|Pre-Treatment|Death|1|||
143057187|NCT03430011|515747701|FG001|Pre-Treatment|Death|0|||
143057188|NCT03430011|515747702|FG002|Pre-Treatment|Death|0|||
143057189|NCT03430011|515747703|FG003|Pre-Treatment|Death|0|||
143057190|NCT03430011|515747704|FG004|Pre-Treatment|Death|1|||
143057191|NCT03430011|515747705|FG005|Pre-Treatment|Death|0|||
143057192|NCT03430011|515747706|FG006|Pre-Treatment|Death|1|||
143245689|NCT00481091|516451793|FG009|Overall Study|Adverse Event|6|||
143057193|NCT03430011|515747707|FG007|Pre-Treatment|Death|0|||
143057194|NCT03430011|515747700|FG000|Pre-Treatment|Screen Fail|0|||
143057195|NCT03430011|515747701|FG001|Pre-Treatment|Screen Fail|0|||
143057196|NCT03430011|515747702|FG002|Pre-Treatment|Screen Fail|0|||
143057197|NCT03430011|515747703|FG003|Pre-Treatment|Screen Fail|0|||
143057198|NCT03430011|515747704|FG004|Pre-Treatment|Screen Fail|1|||
143057199|NCT03430011|515747705|FG005|Pre-Treatment|Screen Fail|0|||
143057200|NCT03430011|515747706|FG006|Pre-Treatment|Screen Fail|0|||
143057201|NCT03430011|515747707|FG007|Pre-Treatment|Screen Fail|0|||
143057202|NCT03430011|515747700|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
143057203|NCT03430011|515747701|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
143057204|NCT03430011|515747702|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
143057205|NCT03430011|515747703|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
143057206|NCT03430011|515747704|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
143057207|NCT03430011|515747705|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
143057208|NCT03430011|515747706|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
143057209|NCT03430011|515747707|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
143057210|NCT03430011|515747700|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
143057211|NCT03430011|515747701|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
143057212|NCT03430011|515747702|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
143057213|NCT03430011|515747703|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
143057214|NCT03430011|515747704|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
143057215|NCT03430011|515747705|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
143057216|NCT03430011|515747706|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
143057217|NCT03430011|515747707|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
143057218|NCT03430011|515747700|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
143057219|NCT03430011|515747701|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
143057220|NCT03430011|515747702|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
143057221|NCT03430011|515747703|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
143057222|NCT03430011|515747704|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
143057223|NCT03430011|515747705|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
143057224|NCT03430011|515747706|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
143057225|NCT03430011|515747707|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
143057226|NCT03430011|515747700|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
143057227|NCT03430011|515747701|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
143057228|NCT03430011|515747702|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
143057229|NCT03430011|515747703|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
143057230|NCT03430011|515747704|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
143057231|NCT03430011|515747705|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
143057232|NCT03430011|515747706|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
143057233|NCT03430011|515747707|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
143169709|NCT03232567|516169903|FG003|Overall Study|Withdrawal by Subject|0|||
143169710|NCT01153516|516169904|FG000|Overall Study|Both subjects refused surgery|2|||
143169711|NCT01153516|516169905|FG001|Overall Study|Both subjects refused surgery|0|||
143169712|NCT04581395|516169906|FG000|Overall Study|Protocol Violation|4|||
143169713|NCT04581395|516169907|FG001|Overall Study|Protocol Violation|3|||
143169714|NCT04581395|516169908|FG002|Overall Study|Protocol Violation|2|||
143169715|NCT04581395|516169906|FG000|Overall Study|Physician Decision|0|||
143169716|NCT04581395|516169907|FG001|Overall Study|Physician Decision|1|||
143169717|NCT04581395|516169908|FG002|Overall Study|Physician Decision|0|||
143169718|NCT01983111|516169909|FG000|Overall Study|Withdrawal by Subject|8|||
143169719|NCT01983111|516169910|FG001|Overall Study|Withdrawal by Subject|6|||
143169720|NCT01983111|516169909|FG000|Overall Study|Adverse Event|4|||
143169721|NCT01983111|516169910|FG001|Overall Study|Adverse Event|0|||
143169722|NCT01983111|516169909|FG000|Overall Study|Protocol Violation|0|||
143169723|NCT01983111|516169910|FG001|Overall Study|Protocol Violation|1|||
143169724|NCT00855335|516169911|FG000|Overall Study|Lost to Follow-up|0|||
143169725|NCT00855335|516169912|FG001|Overall Study|Lost to Follow-up|0|||
143169726|NCT00855335|516169913|FG002|Overall Study|Lost to Follow-up|3|||
143169727|NCT00855335|516169914|FG003|Overall Study|Lost to Follow-up|1|||
143169728|NCT00855335|516169915|FG004|Overall Study|Lost to Follow-up|0|||
143169729|NCT00855335|516169911|FG000|Overall Study|Withdrawal by Subject|0|||
143169730|NCT00855335|516169912|FG001|Overall Study|Withdrawal by Subject|0|||
143169731|NCT00855335|516169913|FG002|Overall Study|Withdrawal by Subject|0|||
143169732|NCT00855335|516169914|FG003|Overall Study|Withdrawal by Subject|1|||
143169733|NCT00855335|516169915|FG004|Overall Study|Withdrawal by Subject|0|||
143169734|NCT00855335|516169911|FG000|Overall Study|Adverse Event|2|||
143169735|NCT00855335|516169912|FG001|Overall Study|Adverse Event|0|||
143169736|NCT00855335|516169913|FG002|Overall Study|Adverse Event|0|||
143169737|NCT00855335|516169914|FG003|Overall Study|Adverse Event|0|||
143169738|NCT00855335|516169915|FG004|Overall Study|Adverse Event|0|||
143169739|NCT00855335|516169911|FG000|Overall Study|Physician Decision|1|||
143169740|NCT00855335|516169912|FG001|Overall Study|Physician Decision|1|||
143169741|NCT00855335|516169913|FG002|Overall Study|Physician Decision|0|||
143169742|NCT00855335|516169914|FG003|Overall Study|Physician Decision|0|||
143169743|NCT00855335|516169915|FG004|Overall Study|Physician Decision|0|||
143169744|NCT00855335|516169911|FG000|Overall Study|Other|2|||
143169745|NCT00855335|516169912|FG001|Overall Study|Other|1|||
143169746|NCT00855335|516169913|FG002|Overall Study|Other|2|||
143169747|NCT00855335|516169914|FG003|Overall Study|Other|5|||
143169748|NCT00855335|516169915|FG004|Overall Study|Other|1|||
143169749|NCT00787150|516169920|FG000|Overall Study|Adverse Event|4|||
143057234|NCT03430011|515747700|FG000|JCARH125 Treatment|Death|4|||
143057235|NCT03430011|515747701|FG001|JCARH125 Treatment|Death|19|||
143057236|NCT03430011|515747702|FG002|JCARH125 Treatment|Death|10|||
143057237|NCT03430011|515747703|FG003|JCARH125 Treatment|Death|8|||
143057238|NCT03430011|515747704|FG004|JCARH125 Treatment|Death|5|||
143057239|NCT03430011|515747705|FG005|JCARH125 Treatment|Death|3|||
143057240|NCT03430011|515747706|FG006|JCARH125 Treatment|Death|4|||
143057241|NCT03430011|515747707|FG007|JCARH125 Treatment|Death|2|||
143057242|NCT03430011|515747700|FG000|JCARH125 Treatment|Other reasons|1|||
143169750|NCT00787150|516169921|FG001|Overall Study|Adverse Event|4|||
143364876|NCT02403323|516878727|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
143169751|NCT00787150|516169922|FG002|Overall Study|Adverse Event|4|||
143169752|NCT00787150|516169920|FG000|Overall Study|Physician Decision|1|||
143169753|NCT00787150|516169921|FG001|Overall Study|Physician Decision|2|||
143169754|NCT00787150|516169922|FG002|Overall Study|Physician Decision|1|||
143169755|NCT00787150|516169920|FG000|Overall Study|Withdrawal by Subject|2|||
143169756|NCT00787150|516169921|FG001|Overall Study|Withdrawal by Subject|1|||
143169757|NCT00787150|516169922|FG002|Overall Study|Withdrawal by Subject|0|||
143169758|NCT00787150|516169920|FG000|Overall Study|Dosing incorrect study durg|2|||
143169759|NCT00787150|516169921|FG001|Overall Study|Dosing incorrect study durg|0|||
143169760|NCT00787150|516169922|FG002|Overall Study|Dosing incorrect study durg|0|||
143169761|NCT04562090|516169925|FG000|Overall Study|Withdrawal by Subject|3|||
143169762|NCT04562090|516169926|FG001|Overall Study|Withdrawal by Subject|4|||
143169763|NCT04562090|516169925|FG000|Overall Study|Protocol Violation|2|||
143169764|NCT04562090|516169926|FG001|Overall Study|Protocol Violation|0|||
143169765|NCT04562090|516169925|FG000|Overall Study|Lack of Efficacy|0|||
143169766|NCT04562090|516169926|FG001|Overall Study|Lack of Efficacy|1|||
143169767|NCT04562090|516169925|FG000|Overall Study|Adverse Event|1|||
143169768|NCT04562090|516169926|FG001|Overall Study|Adverse Event|4|||
143169769|NCT04562090|516169925|FG000|Overall Study|Miscellaneous|0|||
143169770|NCT04562090|516169926|FG001|Overall Study|Miscellaneous|3|||
143169771|NCT03636022|516169927|FG000|Overall Study|Withdrawal by Subject|1|||
143169772|NCT03636022|516169928|FG001|Overall Study|Withdrawal by Subject|3|||
143169773|NCT03448393|516169932|FG000|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
143169774|NCT03448393|516169933|FG001|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
143169775|NCT03448393|516169934|FG002|Dose Escalation|Not Treated - participant did not receive cell infusion.|1|||
143169776|NCT03448393|516169935|FG003|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
143169777|NCT03448393|516169936|FG004|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
143169778|NCT03448393|516169937|FG005|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
143169779|NCT03448393|516169938|FG006|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
143169780|NCT03448393|516169939|FG007|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
143169781|NCT03448393|516169940|FG008|Dose Escalation|Not Treated - participant did not receive cell infusion.|8|||
143169782|NCT03448393|516169932|FG000|Dose Expansion|Not treated - screen failure|0|||
143169783|NCT03448393|516169933|FG001|Dose Expansion|Not treated - screen failure|0|||
143169784|NCT03448393|516169934|FG002|Dose Expansion|Not treated - screen failure|0|||
143169785|NCT03448393|516169935|FG003|Dose Expansion|Not treated - screen failure|0|||
143169786|NCT03448393|516169936|FG004|Dose Expansion|Not treated - screen failure|0|||
143169787|NCT03448393|516169937|FG005|Dose Expansion|Not treated - screen failure|0|||
143169788|NCT03448393|516169938|FG006|Dose Expansion|Not treated - screen failure|0|||
143169789|NCT03448393|516169939|FG007|Dose Expansion|Not treated - screen failure|0|||
143169790|NCT03448393|516169940|FG008|Dose Expansion|Not treated - screen failure|7|||
143169791|NCT01587196|516169941|FG000|Overall Study|Lost to Follow-up|50|||
143169792|NCT01587196|516169941|FG000|Overall Study|Withdrawal by Subject|4|||
143169793|NCT00642759|516169942|FG000|Overall Study|Protocol Violation|1|||
143169794|NCT00643279|516169945|FG000|Overall Study|Death|13|||
143169795|NCT00643279|516169946|FG001|Overall Study|Death|11|||
143169796|NCT00643279|516169945|FG000|Overall Study|Withdrawal by Subject|3|||
143169797|NCT00643279|516169946|FG001|Overall Study|Withdrawal by Subject|0|||
143169798|NCT00643279|516169945|FG000|Overall Study|Lost to Follow-up|0|||
143169799|NCT00643279|516169946|FG001|Overall Study|Lost to Follow-up|1|||
143169800|NCT00643279|516169945|FG000|Overall Study|Physician Decision|0|||
143057243|NCT03430011|515747701|FG001|JCARH125 Treatment|Other reasons|0|||
143057244|NCT03430011|515747702|FG002|JCARH125 Treatment|Other reasons|4|||
143169801|NCT00643279|516169946|FG001|Overall Study|Physician Decision|1|||
143169802|NCT03612570|516169947|FG000|Overall Study|Lost to Follow-up|1|||
143169803|NCT02457793|516169950|FG000|Overall Study|Reason not specified|0|||
143169804|NCT02457793|516169951|FG001|Overall Study|Reason not specified|0|||
143057245|NCT03430011|515747703|FG003|JCARH125 Treatment|Other reasons|2|||
143057246|NCT03430011|515747704|FG004|JCARH125 Treatment|Other reasons|2|||
143169805|NCT02457793|516169952|FG002|Overall Study|Reason not specified|0|||
143169806|NCT02457793|516169953|FG003|Overall Study|Reason not specified|1|||
143169807|NCT02457793|516169954|FG004|Overall Study|Reason not specified|1|||
143169808|NCT02457793|516169955|FG005|Overall Study|Reason not specified|1|||
143169809|NCT02457793|516169950|FG000|Overall Study|Withdrawal by Subject|0|||
143057247|NCT03430011|515747705|FG005|JCARH125 Treatment|Other reasons|1|||
143057248|NCT03430011|515747706|FG006|JCARH125 Treatment|Other reasons|3|||
143057249|NCT03430011|515747707|FG007|JCARH125 Treatment|Other reasons|2|||
143057250|NCT04126343|515747708|FG000|Overall Study|Adverse Event|0|||
143057251|NCT04126343|515747709|FG001|Overall Study|Adverse Event|0|||
143057252|NCT04126343|515747710|FG002|Overall Study|Adverse Event|0|||
143057253|NCT04126343|515747711|FG003|Overall Study|Adverse Event|0|||
143057254|NCT04126343|515747712|FG004|Overall Study|Adverse Event|0|||
143057255|NCT04126343|515747713|FG005|Overall Study|Adverse Event|1|||
143057256|NCT04126343|515747708|FG000|Overall Study|Withdrawal by Subject|0|||
143057257|NCT04126343|515747709|FG001|Overall Study|Withdrawal by Subject|0|||
143057258|NCT04126343|515747710|FG002|Overall Study|Withdrawal by Subject|0|||
143057259|NCT04126343|515747711|FG003|Overall Study|Withdrawal by Subject|1|||
143057260|NCT04126343|515747712|FG004|Overall Study|Withdrawal by Subject|0|||
143057261|NCT04126343|515747713|FG005|Overall Study|Withdrawal by Subject|0|||
143057262|NCT04126343|515747708|FG000|Overall Study|Related to COVID-19 pandemic|3|||
143057263|NCT04126343|515747709|FG001|Overall Study|Related to COVID-19 pandemic|4|||
143057264|NCT04126343|515747710|FG002|Overall Study|Related to COVID-19 pandemic|3|||
143057265|NCT04126343|515747711|FG003|Overall Study|Related to COVID-19 pandemic|3|||
143057266|NCT04126343|515747712|FG004|Overall Study|Related to COVID-19 pandemic|3|||
143364877|NCT02403323|516878725|FG000|Part 1: Open Label Extension Period|Death|3|||
143364878|NCT02403323|516878726|FG001|Part 1: Open Label Extension Period|Death|0|||
143364879|NCT02403323|516878727|FG002|Part 1: Open Label Extension Period|Death|0|||
143364880|NCT02403323|516878725|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
143364881|NCT02403323|516878726|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
143364882|NCT02403323|516878727|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
143364883|NCT02403323|516878725|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
143364884|NCT02403323|516878726|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
143364885|NCT02403323|516878727|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
143364886|NCT02403323|516878725|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
143364887|NCT02403323|516878726|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
143364888|NCT02403323|516878727|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
143364889|NCT02403323|516878725|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
143364890|NCT02403323|516878726|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
143364891|NCT02403323|516878727|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
143364892|NCT02403323|516878725|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
143364893|NCT02403323|516878726|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
143057267|NCT04126343|515747713|FG005|Overall Study|Related to COVID-19 pandemic|3|||
143057268|NCT00330460|515747716|FG000|Overall Study|Physician Decision|1|||
143057269|NCT00330460|515747717|FG001|Overall Study|Physician Decision|0|||
143364894|NCT02403323|516878727|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
143057270|NCT00330460|515747716|FG000|Overall Study|Adverse Event|10|||
143057271|NCT00330460|515747717|FG001|Overall Study|Adverse Event|8|||
143057272|NCT00330460|515747716|FG000|Overall Study|Withdrawal by Subject|18|||
143057273|NCT00330460|515747717|FG001|Overall Study|Withdrawal by Subject|17|||
143364895|NCT02403323|516878725|FG000|Part 1: Open Label Extension Period|Other|1|||
143364896|NCT02403323|516878726|FG001|Part 1: Open Label Extension Period|Other|0|||
143364897|NCT02403323|516878727|FG002|Part 1: Open Label Extension Period|Other|0|||
143364898|NCT02403323|516878725|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
143057274|NCT00330460|515747716|FG000|Overall Study|Death|1|||
143057275|NCT00330460|515747717|FG001|Overall Study|Death|1|||
143057276|NCT00330460|515747716|FG000|Overall Study|Ineligibility determined|1|||
143057277|NCT00330460|515747717|FG001|Overall Study|Ineligibility determined|3|||
143057278|NCT00330460|515747716|FG000|Overall Study|Lost to Follow-up|8|||
143057279|NCT00330460|515747717|FG001|Overall Study|Lost to Follow-up|3|||
143057280|NCT00330460|515747716|FG000|Overall Study|Noncompliance|2|||
143057281|NCT00330460|515747717|FG001|Overall Study|Noncompliance|1|||
143057282|NCT00330460|515747716|FG000|Overall Study|Other|1|||
143057283|NCT00330460|515747717|FG001|Overall Study|Other|0|||
143057284|NCT01148225|515747722|FG000|Overall Study|Other|185|||
143057285|NCT01169038|515747724|FG000|Overall Study|Death|1|||
143057286|NCT01169038|515747724|FG000|Overall Study|Adverse Event|5|||
143057287|NCT01169038|515747724|FG000|Overall Study|Required antibiotic administration|1|||
143057288|NCT01488448|515747725|FG000|Overall Study|Withdrawal by Subject|3|||
143057289|NCT01488448|515747726|FG001|Overall Study|Withdrawal by Subject|1|||
143057290|NCT01488448|515747725|FG000|Overall Study|Adverse Event|9|||
143057291|NCT01488448|515747726|FG001|Overall Study|Adverse Event|4|||
143057292|NCT01488448|515747725|FG000|Overall Study|Physician Decision|4|||
143057293|NCT01488448|515747726|FG001|Overall Study|Physician Decision|9|||
143057294|NCT01488448|515747725|FG000|Overall Study|Protocol Violation|4|||
143057295|NCT01488448|515747726|FG001|Overall Study|Protocol Violation|3|||
143057296|NCT03257254|515747727|FG000|Overall Study|Withdrawal by Subject|7|||
143057297|NCT03257254|515747727|FG000|Overall Study|Lost to Follow-up|9|||
143057298|NCT03257254|515747727|FG000|Overall Study|Study discontinued by sponsor|5|||
143057299|NCT00654641|515747728|FG000|Overall Study|Lost to Follow-up|2|||
143057300|NCT00654641|515747729|FG001|Overall Study|Lost to Follow-up|3|||
143057301|NCT02329431|515747730|FG000|Overall Study|Lost to Follow-up|20|||
143057302|NCT02329431|515747731|FG001|Overall Study|Lost to Follow-up|13|||
143057303|NCT00810602|515747732|FG000|Overall Study|Withdrawal by Subject|8|||
143057304|NCT00810602|515747733|FG001|Overall Study|Withdrawal by Subject|3|||
143057305|NCT01557582|515747737|FG000|Overall Study|Protocol Violation|4|||
143057306|NCT01557582|515747737|FG000|Overall Study|Operator error|2|||
143057307|NCT03840382|515747738|FG000|Overall Study|Lost to Follow-up|11|||
143057308|NCT02843659|515747739|FG000|Overall Study|Subject Withdrew Consent|0|||
143057309|NCT02843659|515747740|FG001|Overall Study|Subject Withdrew Consent|0|||
143057310|NCT02843659|515747741|FG002|Overall Study|Subject Withdrew Consent|1|||
143057311|NCT02843659|515747739|FG000|Overall Study|Administrative Reason by Sponsor|4|||
143057312|NCT02843659|515747740|FG001|Overall Study|Administrative Reason by Sponsor|5|||
143057313|NCT02843659|515747741|FG002|Overall Study|Administrative Reason by Sponsor|4|||
143057314|NCT02843659|515747739|FG000|Overall Study|Adverse Event|0|||
143057315|NCT02843659|515747740|FG001|Overall Study|Adverse Event|1|||
143057316|NCT02843659|515747741|FG002|Overall Study|Adverse Event|0|||
143245690|NCT00481091|516451784|FG000|Overall Study|Progressive disease clinical|0|||
143245691|NCT00481091|516451785|FG001|Overall Study|Progressive disease clinical|0|||
143245692|NCT00481091|516451786|FG002|Overall Study|Progressive disease clinical|0|||
143245693|NCT00481091|516451787|FG003|Overall Study|Progressive disease clinical|0|||
143245694|NCT00481091|516451788|FG004|Overall Study|Progressive disease clinical|0|||
143245695|NCT00481091|516451789|FG005|Overall Study|Progressive disease clinical|0|||
143245696|NCT00481091|516451790|FG006|Overall Study|Progressive disease clinical|0|||
143245697|NCT00481091|516451791|FG007|Overall Study|Progressive disease clinical|0|||
143057317|NCT03203642|515747742|FG000|Overall Study|Adverse Event|3|||
143057318|NCT03203642|515747743|FG001|Overall Study|Adverse Event|1|||
143057319|NCT03203642|515747742|FG000|Overall Study|Withdrawal by Subject|6|||
143057320|NCT03203642|515747743|FG001|Overall Study|Withdrawal by Subject|6|||
143057321|NCT03203642|515747742|FG000|Overall Study|Lost to Follow-up|2|||
143057322|NCT03203642|515747743|FG001|Overall Study|Lost to Follow-up|1|||
143057323|NCT03203642|515747742|FG000|Overall Study|Termination of the study by sponsor|1|||
143057324|NCT03203642|515747743|FG001|Overall Study|Termination of the study by sponsor|1|||
143057325|NCT03203642|515747742|FG000|Overall Study|Participant moved|0|||
143057326|NCT03203642|515747743|FG001|Overall Study|Participant moved|1|||
143057327|NCT03203642|515747742|FG000|Overall Study|Investigator's decision|3|||
143057328|NCT03203642|515747743|FG001|Overall Study|Investigator's decision|0|||
143057329|NCT03203642|515747742|FG000|Overall Study|Other than above specified|0|||
143057330|NCT03203642|515747743|FG001|Overall Study|Other than above specified|1|||
143057331|NCT02413294|515747744|FG000|Overall Study|Withdrawal by Subject|1|||
143245698|NCT00481091|516451792|FG008|Overall Study|Progressive disease clinical|1|||
143057332|NCT02875028|515747745|FG000|Washout Period|Withdrawal by Subject|0|||
143057333|NCT02875028|515747746|FG001|Washout Period|Withdrawal by Subject|1|||
143057334|NCT04100096|515749656|FG000|Overall Study|Adverse Event|19|||
143057335|NCT04100096|515749657|FG001|Overall Study|Adverse Event|7|||
143057336|NCT04100096|515749656|FG000|Overall Study|Lack of Efficacy|0|||
143057337|NCT04100096|515749657|FG001|Overall Study|Lack of Efficacy|1|||
143057338|NCT04100096|515749656|FG000|Overall Study|Lost to Follow-up|13|||
143057339|NCT04100096|515749657|FG001|Overall Study|Lost to Follow-up|11|||
143057340|NCT04100096|515749656|FG000|Overall Study|Non-Compliance With Study Drug|1|||
143057341|NCT04100096|515749657|FG001|Overall Study|Non-Compliance With Study Drug|3|||
143057342|NCT04100096|515749656|FG000|Overall Study|Protocol Deviation|1|||
143245699|NCT00481091|516451793|FG009|Overall Study|Progressive disease clinical|7|||
143500206|NCT01925209|517372349|FG003|Follow-up|Physician Decision|0|||
143500207|NCT01925209|517372346|FG000|Follow-up|Non-compliance with study treatment|0|||
143500208|NCT01925209|517372347|FG001|Follow-up|Non-compliance with study treatment|0|||
143500209|NCT01925209|517372348|FG002|Follow-up|Non-compliance with study treatment|0|||
143500210|NCT01925209|517372349|FG003|Follow-up|Non-compliance with study treatment|1|||
143057343|NCT04100096|515749657|FG001|Overall Study|Protocol Deviation|1|||
143057344|NCT04100096|515749656|FG000|Overall Study|Withdrawal by Participant|13|||
143057345|NCT04100096|515749657|FG001|Overall Study|Withdrawal by Participant|15|||
143057346|NCT00991510|515749660|FG000|Period I (Days 1-14)|Adverse Event|1|||
143057347|NCT00991510|515749661|FG001|Period I (Days 1-14)|Adverse Event|0|||
143057348|NCT00991510|515749660|FG000|Period III (Days 29-112)|Adverse Event|1|||
143057349|NCT00991510|515749661|FG001|Period III (Days 29-112)|Adverse Event|1|||
143057350|NCT02744755|515749662|FG000|Study Period 1|Protocol Violation|2|||
143057351|NCT02744755|515749663|FG001|Study Period 1|Protocol Violation|1|||
143057352|NCT02744755|515749662|FG000|Study Period 1|not defined|0|||
143057353|NCT02744755|515749663|FG001|Study Period 1|not defined|1|||
143500211|NCT01925209|517372346|FG000|Follow-up|Withdrawal by Subject|0|||
143500212|NCT01925209|517372347|FG001|Follow-up|Withdrawal by Subject|2|||
143500213|NCT01925209|517372348|FG002|Follow-up|Withdrawal by Subject|0|||
143057354|NCT02744755|515749662|FG000|Study Period 1|Pregnancy|1|||
143057355|NCT02744755|515749663|FG001|Study Period 1|Pregnancy|0|||
143057356|NCT02744755|515749662|FG000|Study Period 1|Adverse Event|1|||
143057357|NCT02744755|515749663|FG001|Study Period 1|Adverse Event|1|||
143057358|NCT02744755|515749662|FG000|Study Period 1|Lost to Follow-up|1|||
143057359|NCT02744755|515749663|FG001|Study Period 1|Lost to Follow-up|1|||
143057360|NCT02744755|515749662|FG000|Study Period 1|Lack of Efficacy|1|||
143057361|NCT02744755|515749663|FG001|Study Period 1|Lack of Efficacy|0|||
143057362|NCT02744755|515749662|FG000|Study Period 1|Withdrawal by Subject|8|||
143057363|NCT02744755|515749663|FG001|Study Period 1|Withdrawal by Subject|4|||
143057364|NCT02744755|515749662|FG000|Study Period 2|Adverse Event|5|||
143057365|NCT02744755|515749663|FG001|Study Period 2|Adverse Event|0|||
143057366|NCT02744755|515749662|FG000|Study Period 2|Protocol Violation|1|||
143057367|NCT02744755|515749663|FG001|Study Period 2|Protocol Violation|0|||
143057368|NCT02744755|515749662|FG000|Study Period 2|not defined|3|||
143057369|NCT02744755|515749663|FG001|Study Period 2|not defined|2|||
143057370|NCT02744755|515749662|FG000|Study Period 2|Lost to Follow-up|0|||
143057371|NCT02744755|515749663|FG001|Study Period 2|Lost to Follow-up|2|||
143057372|NCT02744755|515749662|FG000|Study Period 2|Withdrawal by Subject|2|||
143057373|NCT02744755|515749663|FG001|Study Period 2|Withdrawal by Subject|2|||
143057374|NCT02744755|515749662|FG000|Study Period 2|Lack of Efficacy|3|||
143057375|NCT02744755|515749663|FG001|Study Period 2|Lack of Efficacy|2|||
143057376|NCT03180801|515749664|FG000|Overall Study|Physician Decision|3|||
143057377|NCT03180801|515749665|FG001|Overall Study|Physician Decision|3|||
143057378|NCT03180801|515749666|FG002|Overall Study|Physician Decision|1|||
143057379|NCT03180801|515749664|FG000|Overall Study|Non-compliance|1|||
143057380|NCT03180801|515749665|FG001|Overall Study|Non-compliance|4|||
143057381|NCT03180801|515749666|FG002|Overall Study|Non-compliance|0|||
143057382|NCT03180801|515749664|FG000|Overall Study|Inoculation Target Reached|1|||
143057383|NCT03180801|515749665|FG001|Overall Study|Inoculation Target Reached|1|||
143169810|NCT02457793|516169951|FG001|Overall Study|Withdrawal by Subject|4|||
143169811|NCT02457793|516169952|FG002|Overall Study|Withdrawal by Subject|2|||
143169812|NCT02457793|516169953|FG003|Overall Study|Withdrawal by Subject|2|||
143169813|NCT02457793|516169954|FG004|Overall Study|Withdrawal by Subject|2|||
143169814|NCT02457793|516169955|FG005|Overall Study|Withdrawal by Subject|2|||
143169815|NCT02457793|516169950|FG000|Overall Study|Adverse Event|0|||
143169816|NCT02457793|516169951|FG001|Overall Study|Adverse Event|0|||
143169817|NCT02457793|516169952|FG002|Overall Study|Adverse Event|0|||
143169818|NCT02457793|516169953|FG003|Overall Study|Adverse Event|1|||
143364899|NCT02403323|516878726|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
143364900|NCT02403323|516878727|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
143057384|NCT03180801|515749666|FG002|Overall Study|Inoculation Target Reached|3|||
143057385|NCT03180801|515749664|FG000|Overall Study|Adverse Event|1|||
143057386|NCT03180801|515749665|FG001|Overall Study|Adverse Event|0|||
143057387|NCT03180801|515749666|FG002|Overall Study|Adverse Event|2|||
143057388|NCT03180801|515749664|FG000|Overall Study|Withdrawal by Subject|2|||
143057389|NCT03180801|515749665|FG001|Overall Study|Withdrawal by Subject|2|||
143500214|NCT01925209|517372349|FG003|Follow-up|Withdrawal by Subject|2|||
143057390|NCT03180801|515749666|FG002|Overall Study|Withdrawal by Subject|1|||
143057391|NCT03180801|515749664|FG000|Overall Study|Lost to Follow-up|0|||
143057392|NCT03180801|515749665|FG001|Overall Study|Lost to Follow-up|2|||
143169819|NCT02457793|516169954|FG004|Overall Study|Adverse Event|0|||
143169820|NCT02457793|516169955|FG005|Overall Study|Adverse Event|0|||
143364901|NCT02403323|516878725|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
143057393|NCT03180801|515749666|FG002|Overall Study|Lost to Follow-up|3|||
143057394|NCT00868296|515749669|FG000|Overall Study|Adverse Event|0|||
143057395|NCT00868296|515749670|FG001|Overall Study|Adverse Event|2|||
143057396|NCT00868296|515749669|FG000|Overall Study|Withdrawal by Subject|0|||
143057397|NCT00868296|515749670|FG001|Overall Study|Withdrawal by Subject|1|||
143057398|NCT00035555|515749671|FG000|Overall Study|Adverse Event|5|||
143057399|NCT00035555|515749672|FG001|Overall Study|Adverse Event|8|||
143057400|NCT00035555|515749673|FG002|Overall Study|Adverse Event|9|||
143057401|NCT00035555|515749671|FG000|Overall Study|Allograft loss|1|||
143057402|NCT00035555|515749672|FG001|Overall Study|Allograft loss|1|||
143057403|NCT00035555|515749673|FG002|Overall Study|Allograft loss|2|||
143057404|NCT00035555|515749671|FG000|Overall Study|Death|0|||
143057405|NCT00035555|515749672|FG001|Overall Study|Death|0|||
143057406|NCT00035555|515749673|FG002|Overall Study|Death|2|||
143057407|NCT00035555|515749671|FG000|Overall Study|Lost to Follow-up|0|||
143057408|NCT00035555|515749672|FG001|Overall Study|Lost to Follow-up|0|||
143057409|NCT00035555|515749673|FG002|Overall Study|Lost to Follow-up|1|||
143057410|NCT00035555|515749671|FG000|Overall Study|Noncompliance|0|||
143057411|NCT00035555|515749672|FG001|Overall Study|Noncompliance|1|||
143057412|NCT00035555|515749673|FG002|Overall Study|Noncompliance|1|||
143057413|NCT00035555|515749671|FG000|Overall Study|Prohibited medication|1|||
143057414|NCT00035555|515749672|FG001|Overall Study|Prohibited medication|1|||
143057415|NCT00035555|515749673|FG002|Overall Study|Prohibited medication|0|||
143057416|NCT00035555|515749671|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
143057417|NCT00035555|515749672|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
143057418|NCT00035555|515749673|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
143057419|NCT00035555|515749671|FG000|Overall Study|Withdrawal by Subject|2|||
143057420|NCT00035555|515749672|FG001|Overall Study|Withdrawal by Subject|0|||
143500215|NCT00675025|517372350|FG000|Overall Study|Study Terminated by Sponsor|38|||
143057421|NCT00035555|515749673|FG002|Overall Study|Withdrawal by Subject|2|||
143057422|NCT00035555|515749671|FG000|Overall Study|Investigator deemed not a good candidate|0|||
143057423|NCT00035555|515749672|FG001|Overall Study|Investigator deemed not a good candidate|0|||
143057424|NCT00035555|515749673|FG002|Overall Study|Investigator deemed not a good candidate|1|||
143057425|NCT00035555|515749671|FG000|Overall Study|Received cyclosporin in error|0|||
143057426|NCT00035555|515749672|FG001|Overall Study|Received cyclosporin in error|0|||
143057427|NCT00035555|515749673|FG002|Overall Study|Received cyclosporin in error|1|||
143057428|NCT02618382|515749674|FG000|Overall Study|Physician Decision|1|||
143057429|NCT02618382|515749674|FG000|Overall Study|Withdrawal by Subject|1|||
143057430|NCT02618382|515749674|FG000|Overall Study|Protocol Violation|1|||
143364902|NCT02403323|516878726|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
143364903|NCT02403323|516878727|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
143364904|NCT02403323|516878725|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
143364905|NCT02403323|516878726|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
143364906|NCT02403323|516878727|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
143057431|NCT03235479|515749677|FG000|Overall Study|Lost to Follow-up|8|||
143057432|NCT03235479|515749678|FG001|Overall Study|Lost to Follow-up|11|||
143057433|NCT03235479|515749677|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
143057434|NCT03235479|515749678|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
143057435|NCT03235479|515749677|FG000|Overall Study|Pregnancy|1|||
143057436|NCT03235479|515749678|FG001|Overall Study|Pregnancy|0|||
143057437|NCT03235479|515749677|FG000|Overall Study|Protocol Deviation|1|||
143057438|NCT03235479|515749678|FG001|Overall Study|Protocol Deviation|3|||
143057439|NCT03235479|515749677|FG000|Overall Study|Technical Problems|3|||
143057440|NCT03235479|515749678|FG001|Overall Study|Technical Problems|2|||
143057441|NCT03235479|515749677|FG000|Overall Study|Withdrawal by Subject|2|||
143057442|NCT03235479|515749678|FG001|Overall Study|Withdrawal by Subject|2|||
143057443|NCT03235479|515749677|FG000|Overall Study|Other Reasons|3|||
143057444|NCT03235479|515749678|FG001|Overall Study|Other Reasons|5|||
143057445|NCT00529217|515749685|FG000|Overall Study|Lack of Efficacy|2|||
143057446|NCT00529217|515749685|FG000|Overall Study|Unable to adhere to study schedule|2|||
143057447|NCT01999894|515749686|FG000|Overall Study|Adverse Event|9|||
143057448|NCT01999894|515749686|FG000|Overall Study|Lack of Efficacy|5|||
143057449|NCT01999894|515749686|FG000|Overall Study|Protocol Violation|1|||
143057450|NCT01999894|515749686|FG000|Overall Study|Withdrawal by Subject|7|||
143057451|NCT01999894|515749686|FG000|Overall Study|Lost to Follow-up|10|||
143057452|NCT01999894|515749686|FG000|Overall Study|Other Reason|3|||
143057453|NCT01999894|515749686|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
143057454|NCT01519947|515749689|FG000|Overall Study|Death|0|||
143364907|NCT02403323|516878725|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
143364908|NCT02403323|516878726|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
143364909|NCT02403323|516878727|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
143500216|NCT00675025|517372351|FG001|Overall Study|Study Terminated by Sponsor|42|||
143057455|NCT01519947|515749690|FG001|Overall Study|Death|0|||
143057456|NCT01519947|515749691|FG002|Overall Study|Death|0|||
143057457|NCT01519947|515749692|FG003|Overall Study|Death|1|||
143057458|NCT01519947|515749689|FG000|Overall Study|Protocol Violation|0|||
143500217|NCT00675025|517372350|FG000|Overall Study|Adverse Event|6|||
143057459|NCT01519947|515749690|FG001|Overall Study|Protocol Violation|0|||
143057460|NCT01519947|515749691|FG002|Overall Study|Protocol Violation|2|||
143057461|NCT01519947|515749692|FG003|Overall Study|Protocol Violation|1|||
143057462|NCT01519947|515749689|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
143057463|NCT01519947|515749690|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
143057464|NCT01519947|515749691|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
143057465|NCT01519947|515749692|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
143057466|NCT01519947|515749689|FG000|Overall Study|Development of Anemia|0|||
143057467|NCT01519947|515749690|FG001|Overall Study|Development of Anemia|1|||
143057468|NCT01519947|515749691|FG002|Overall Study|Development of Anemia|0|||
143057469|NCT01519947|515749692|FG003|Overall Study|Development of Anemia|1|||
143057470|NCT01519947|515749689|FG000|Overall Study|Blood Transfusion|0|||
143057471|NCT01519947|515749690|FG001|Overall Study|Blood Transfusion|1|||
143057472|NCT01519947|515749691|FG002|Overall Study|Blood Transfusion|1|||
143057473|NCT01519947|515749692|FG003|Overall Study|Blood Transfusion|0|||
143057474|NCT01519947|515749689|FG000|Overall Study|Withdrawal by Subject|0|||
143057475|NCT01519947|515749690|FG001|Overall Study|Withdrawal by Subject|1|||
143057476|NCT01519947|515749691|FG002|Overall Study|Withdrawal by Subject|0|||
143057477|NCT01519947|515749692|FG003|Overall Study|Withdrawal by Subject|1|||
143057478|NCT01519947|515749689|FG000|Overall Study|Lost to Follow-up|0|||
143057479|NCT01519947|515749690|FG001|Overall Study|Lost to Follow-up|0|||
143057480|NCT01519947|515749691|FG002|Overall Study|Lost to Follow-up|3|||
143057481|NCT01519947|515749692|FG003|Overall Study|Lost to Follow-up|2|||
143057482|NCT01519947|515749689|FG000|Overall Study|Poor Response|1|||
143057483|NCT01519947|515749690|FG001|Overall Study|Poor Response|0|||
143057484|NCT01519947|515749691|FG002|Overall Study|Poor Response|0|||
143057485|NCT01519947|515749692|FG003|Overall Study|Poor Response|1|||
143057486|NCT01519947|515749689|FG000|Overall Study|Adverse Event|1|||
143057487|NCT01519947|515749690|FG001|Overall Study|Adverse Event|0|||
143057488|NCT01519947|515749691|FG002|Overall Study|Adverse Event|1|||
143057489|NCT01519947|515749692|FG003|Overall Study|Adverse Event|1|||
143057490|NCT00194792|515749693|FG000|Overall Study|Withdrawal by Subject|1|||
143057491|NCT02531594|515749694|FG000|Overall Study|Withdrawal by Subject|7|||
143057492|NCT02531594|515749695|FG001|Overall Study|Withdrawal by Subject|8|||
143057493|NCT00614822|515749696|FG000|Overall Study|Adverse Event|3|||
143057494|NCT03750695|515749697|FG000|Overall Study|Lost to Follow-up|0|||
143057495|NCT03750695|515749698|FG001|Overall Study|Lost to Follow-up|1|||
143057496|NCT01098539|515749699|FG000|Overall Study|Adverse Event|26|||
143057497|NCT01098539|515749700|FG001|Overall Study|Adverse Event|26|||
143057498|NCT01098539|515749699|FG000|Overall Study|Protocol Violation|1|||
143057499|NCT01098539|515749700|FG001|Overall Study|Protocol Violation|4|||
143057500|NCT01098539|515749699|FG000|Overall Study|Noncompliance|3|||
143057501|NCT01098539|515749700|FG001|Overall Study|Noncompliance|5|||
143500218|NCT00675025|517372351|FG001|Overall Study|Adverse Event|11|||
143500219|NCT00675025|517372350|FG000|Overall Study|Lost to Follow-up|6|||
143500220|NCT00675025|517372351|FG001|Overall Study|Lost to Follow-up|4|||
143500221|NCT00675025|517372350|FG000|Overall Study|Withdrawal by Subject|4|||
143500222|NCT00675025|517372351|FG001|Overall Study|Withdrawal by Subject|6|||
143500223|NCT00110994|517372352|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
143500224|NCT00110994|517372353|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
143500225|NCT00110994|517372352|FG000|Double-blind (DB) Treatment|Death|1|||
143500226|NCT00110994|517372353|FG001|Double-blind (DB) Treatment|Death|0|||
143057502|NCT01098539|515749699|FG000|Overall Study|Lost to Follow-up|4|||
143057503|NCT01098539|515749700|FG001|Overall Study|Lost to Follow-up|4|||
143057504|NCT01098539|515749699|FG000|Overall Study|Withdrawal by Subject|12|||
143057505|NCT01098539|515749700|FG001|Overall Study|Withdrawal by Subject|26|||
143057506|NCT01098539|515749699|FG000|Overall Study|Physician Decision|5|||
143057507|NCT01098539|515749700|FG001|Overall Study|Physician Decision|3|||
143057508|NCT03843125|515749701|FG000|Overall Study|Adverse Event|17|||
143057509|NCT03843125|515749702|FG001|Overall Study|Adverse Event|13|||
143057510|NCT03843125|515749703|FG002|Overall Study|Adverse Event|5|||
143057511|NCT03843125|515749704|FG003|Overall Study|Adverse Event|9|||
143057512|NCT03843125|515749701|FG000|Overall Study|Death|0|||
143057513|NCT03843125|515749702|FG001|Overall Study|Death|6|||
143057514|NCT03843125|515749703|FG002|Overall Study|Death|2|||
143057515|NCT03843125|515749704|FG003|Overall Study|Death|0|||
143057516|NCT03843125|515749701|FG000|Overall Study|Lack of Efficacy|14|||
143057517|NCT03843125|515749702|FG001|Overall Study|Lack of Efficacy|11|||
143057518|NCT03843125|515749703|FG002|Overall Study|Lack of Efficacy|9|||
143500227|NCT00110994|517372352|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
143057519|NCT03843125|515749704|FG003|Overall Study|Lack of Efficacy|4|||
143057520|NCT03843125|515749701|FG000|Overall Study|Lost to Follow-up|3|||
143500228|NCT00110994|517372353|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
143057521|NCT03843125|515749702|FG001|Overall Study|Lost to Follow-up|4|||
143057522|NCT03843125|515749703|FG002|Overall Study|Lost to Follow-up|0|||
143057523|NCT03843125|515749704|FG003|Overall Study|Lost to Follow-up|2|||
143057524|NCT03843125|515749701|FG000|Overall Study|Other|12|||
143057525|NCT03843125|515749702|FG001|Overall Study|Other|14|||
143057526|NCT03843125|515749703|FG002|Overall Study|Other|3|||
143364910|NCT02403323|516878725|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
143364911|NCT02403323|516878726|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
143364912|NCT02403323|516878727|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
143364913|NCT02403323|516878725|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
143057527|NCT03843125|515749704|FG003|Overall Study|Other|4|||
143057528|NCT03843125|515749701|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
143057529|NCT03843125|515749702|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
143364914|NCT02403323|516878726|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
143364915|NCT02403323|516878727|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
143364916|NCT02403323|516878725|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
143364917|NCT02403323|516878726|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
143364918|NCT02403323|516878727|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
143364919|NCT02403323|516878725|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
143364920|NCT02403323|516878726|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
143364921|NCT02403323|516878727|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
143364922|NCT02403323|516878725|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
143364923|NCT02403323|516878726|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
143364924|NCT02403323|516878727|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
143364925|NCT02403323|516878725|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
143364926|NCT02403323|516878726|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
143364927|NCT02403323|516878727|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
143364928|NCT00197236|516878728|FG000|Overall Study|Adverse Event|1|||
143364929|NCT00197236|516878729|FG001|Overall Study|Adverse Event|0|||
143364930|NCT00197236|516878730|FG002|Overall Study|Adverse Event|1|||
143500229|NCT00110994|517372352|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
143500230|NCT00110994|517372353|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
143500231|NCT00110994|517372352|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
143500232|NCT00110994|517372353|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
143500233|NCT00110994|517372352|FG000|Double-blind (DB) Treatment|other reasons|2|||
143500234|NCT00110994|517372353|FG001|Double-blind (DB) Treatment|other reasons|3|||
143500235|NCT00110994|517372352|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
143500236|NCT00110994|517372353|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
143500237|NCT00110994|517372352|FG000|Active Follow-up|Other reasons|0|||
143500238|NCT00110994|517372353|FG001|Active Follow-up|Other reasons|2|||
143500239|NCT00110994|517372352|FG000|Long Term Follow-up|Death|19|||
143500240|NCT00110994|517372353|FG001|Long Term Follow-up|Death|17|||
143500241|NCT01551693|517372355|FG000|Overall Study|Disease Progression|1|||
143500242|NCT01551693|517372356|FG001|Overall Study|Disease Progression|0|||
143500243|NCT01551693|517372355|FG000|Overall Study|Adverse Event|0|||
143500244|NCT01551693|517372356|FG001|Overall Study|Adverse Event|1|||
143500245|NCT01551693|517372355|FG000|Overall Study|Withdrawal by Subject|0|||
143500246|NCT01551693|517372356|FG001|Overall Study|Withdrawal by Subject|1|||
143500247|NCT04134494|517372360|FG000|Overall Study|Lost to Follow-up|2|||
143500248|NCT01950819|517372361|FG000|Overall Study|Graft Loss|35|||
143500249|NCT01950819|517372362|FG001|Overall Study|Graft Loss|30|||
143500250|NCT01950819|517372361|FG000|Overall Study|Death|29|||
143500251|NCT01950819|517372362|FG001|Overall Study|Death|34|||
143500252|NCT01950819|517372361|FG000|Overall Study|Subject / Gardian decision|54|||
143500253|NCT01950819|517372362|FG001|Overall Study|Subject / Gardian decision|51|||
143500254|NCT01950819|517372361|FG000|Overall Study|technical problems|2|||
143500255|NCT01950819|517372362|FG001|Overall Study|technical problems|0|||
143500256|NCT01950819|517372361|FG000|Overall Study|Pregnancy|0|||
143500257|NCT01950819|517372362|FG001|Overall Study|Pregnancy|2|||
143500258|NCT01950819|517372361|FG000|Overall Study|Lost to Follow-up|9|||
143500259|NCT01950819|517372362|FG001|Overall Study|Lost to Follow-up|17|||
143500260|NCT01686568|517372372|FG000|Main Study|Withdrawal by Subject|1|||
143500261|NCT01686568|517372373|FG001|Main Study|Withdrawal by Subject|3|||
143500262|NCT01686568|517372372|FG000|Main Study|Noncompliance with protocol|0|||
143500263|NCT01686568|517372373|FG001|Main Study|Noncompliance with protocol|1|||
143057530|NCT03843125|515749703|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
143057531|NCT03843125|515749704|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
143500264|NCT01686568|517372372|FG000|Main Study|Liver enzymes above range of exclusion|1|||
143500265|NCT01686568|517372373|FG001|Main Study|Liver enzymes above range of exclusion|0|||
143500266|NCT01686568|517372372|FG000|Sub-Study|Not consented for sub-study|2|||
143500267|NCT01686568|517372373|FG001|Sub-Study|Not consented for sub-study|2|||
143500268|NCT02978222|517372374|FG000|Overall Study|Withdrawal by Subject|2|||
143500269|NCT02978222|517372375|FG001|Overall Study|Withdrawal by Subject|2|||
143500270|NCT02978222|517372374|FG000|Overall Study|Physician Decision|2|||
143057532|NCT03843125|515749701|FG000|Overall Study|Study Terminated by Sponsor|318|||
143500271|NCT02978222|517372375|FG001|Overall Study|Physician Decision|0|||
143500272|NCT02978222|517372374|FG000|Overall Study|Adverse Event|0|||
143057533|NCT03843125|515749702|FG001|Overall Study|Study Terminated by Sponsor|318|||
143057534|NCT03843125|515749703|FG002|Overall Study|Study Terminated by Sponsor|163|||
143057535|NCT03843125|515749704|FG003|Overall Study|Study Terminated by Sponsor|163|||
143057536|NCT03843125|515749701|FG000|Overall Study|Withdrawal by Subject|23|||
143057537|NCT03843125|515749702|FG001|Overall Study|Withdrawal by Subject|12|||
143057538|NCT03843125|515749703|FG002|Overall Study|Withdrawal by Subject|6|||
143057539|NCT03843125|515749704|FG003|Overall Study|Withdrawal by Subject|9|||
143500273|NCT02978222|517372375|FG001|Overall Study|Adverse Event|1|||
143500274|NCT02978222|517372374|FG000|Overall Study|Death|1|||
143500275|NCT02978222|517372375|FG001|Overall Study|Death|0|||
143500276|NCT02978222|517372374|FG000|Overall Study|Disease Progression|32|||
143500277|NCT02978222|517372375|FG001|Overall Study|Disease Progression|32|||
143500278|NCT02978222|517372374|FG000|Overall Study|Early Study Termination|24|||
143500279|NCT02978222|517372375|FG001|Overall Study|Early Study Termination|21|||
143500280|NCT01413958|517372376|FG000|Overall Study|Lost to Follow-up|0|||
143500281|NCT01413958|517372377|FG001|Overall Study|Lost to Follow-up|1|||
143500282|NCT02928952|517372379|FG000|Overall Study|Lost to Follow-up|5|||
143500283|NCT02928952|517372380|FG001|Overall Study|Lost to Follow-up|5|||
143500284|NCT02928952|517372379|FG000|Overall Study|Withdrawal by Subject|5|||
143500285|NCT02928952|517372380|FG001|Overall Study|Withdrawal by Subject|1|||
143500286|NCT02928952|517372379|FG000|Overall Study|Physician Decision|0|||
143500287|NCT02928952|517372380|FG001|Overall Study|Physician Decision|1|||
143500288|NCT01850615|517372381|FG000|Overall Study|Protocol Violation|4|||
143500289|NCT01850615|517372382|FG001|Overall Study|Protocol Violation|1|||
143500290|NCT01850615|517372381|FG000|Overall Study|Adverse Event|2|||
143500291|NCT01850615|517372382|FG001|Overall Study|Adverse Event|1|||
143500292|NCT01850615|517372381|FG000|Overall Study|Withdrawal by Subject|3|||
143500293|NCT01850615|517372382|FG001|Overall Study|Withdrawal by Subject|1|||
143500294|NCT01850615|517372381|FG000|Overall Study|Lost to Follow-up|0|||
143500295|NCT01850615|517372382|FG001|Overall Study|Lost to Follow-up|1|||
143500296|NCT01850615|517372381|FG000|Overall Study|Unclassified|0|||
143500297|NCT01850615|517372382|FG001|Overall Study|Unclassified|1|||
143500298|NCT01227967|517372383|FG000|Overall Study|Protocol Violation|3|||
143500299|NCT01227967|517372384|FG001|Overall Study|Protocol Violation|1|||
143500300|NCT01227967|517372383|FG000|Overall Study|Death|0|||
143500301|NCT01227967|517372384|FG001|Overall Study|Death|1|||
143500302|NCT01227967|517372383|FG000|Overall Study|Lost to Follow-up|8|||
143500303|NCT01227967|517372384|FG001|Overall Study|Lost to Follow-up|3|||
143500304|NCT01227967|517372383|FG000|Overall Study|Withdrawal by Subject|4|||
143500305|NCT01227967|517372384|FG001|Overall Study|Withdrawal by Subject|3|||
143500306|NCT01227967|517372383|FG000|Overall Study|Physician Decision|0|||
143500307|NCT01227967|517372384|FG001|Overall Study|Physician Decision|1|||
143500308|NCT01227967|517372383|FG000|Overall Study|Never Started Treatment|0|||
143500309|NCT01227967|517372384|FG001|Overall Study|Never Started Treatment|4|||
143500310|NCT01227967|517372383|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
143500311|NCT01227967|517372384|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
143500312|NCT01439945|517372408|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
143500313|NCT01439945|517372409|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
143500314|NCT01439945|517372410|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
143500315|NCT01439945|517372411|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
143500316|NCT01439945|517372408|FG000|Double-Blind Treatment Phase|Ineligible|1|||
143500317|NCT01439945|517372409|FG001|Double-Blind Treatment Phase|Ineligible|2|||
143500318|NCT01439945|517372410|FG002|Double-Blind Treatment Phase|Ineligible|0|||
143500319|NCT01439945|517372411|FG003|Double-Blind Treatment Phase|Ineligible|1|||
143500320|NCT04082663|517372412|FG000|Overall Study|Adverse Event|6|||
143500321|NCT04082663|517372412|FG000|Overall Study|Lost to Follow-up|1|||
143500322|NCT00705263|517372415|FG000|Overall Study|Withdrawal by Subject|2|||
143500323|NCT01752023|517372416|FG000|Overall Study|Physician Decision|2|||
143500324|NCT01752023|517372417|FG001|Overall Study|Physician Decision|1|||
143500325|NCT02440581|517372420|FG000|Overall Study|Death|0|||
143500326|NCT02440581|517372421|FG001|Overall Study|Death|0|||
143057540|NCT03843125|515749701|FG000|Overall Study|Missing data|0|||
143245700|NCT00481091|516451784|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
143364931|NCT00197236|516878728|FG000|Overall Study|Lost to Follow-up|5|||
143500327|NCT02440581|517372422|FG002|Overall Study|Death|7|||
143057541|NCT03843125|515749702|FG001|Overall Study|Missing data|1|||
143500328|NCT02440581|517372423|FG003|Overall Study|Death|5|||
143500329|NCT02440581|517372420|FG000|Overall Study|Transplanted|1|||
143500330|NCT02440581|517372421|FG001|Overall Study|Transplanted|0|||
143500331|NCT02440581|517372422|FG002|Overall Study|Transplanted|3|||
143500332|NCT02440581|517372423|FG003|Overall Study|Transplanted|2|||
143500333|NCT02440581|517372420|FG000|Overall Study|Withdrawal by Subject|4|||
143500334|NCT02440581|517372421|FG001|Overall Study|Withdrawal by Subject|11|||
143500335|NCT02440581|517372422|FG002|Overall Study|Withdrawal by Subject|3|||
143500336|NCT02440581|517372423|FG003|Overall Study|Withdrawal by Subject|7|||
143057542|NCT03843125|515749703|FG002|Overall Study|Missing data|1|||
143057543|NCT03843125|515749704|FG003|Overall Study|Missing data|0|||
143057544|NCT03173560|515749705|FG000|Overall Study|Death|70|||
143057545|NCT03173560|515749706|FG001|Overall Study|Death|60|||
143057546|NCT03173560|515749705|FG000|Overall Study|Lost to Follow-up|1|||
143057547|NCT03173560|515749706|FG001|Overall Study|Lost to Follow-up|4|||
143057548|NCT03173560|515749705|FG000|Overall Study|Withdrawal by Subject|10|||
143057549|NCT03173560|515749706|FG001|Overall Study|Withdrawal by Subject|5|||
143057550|NCT03173560|515749705|FG000|Overall Study|Other|0|||
143364932|NCT00197236|516878729|FG001|Overall Study|Lost to Follow-up|14|||
143364933|NCT00197236|516878730|FG002|Overall Study|Lost to Follow-up|6|||
143364934|NCT00197236|516878728|FG000|Overall Study|Protocol Violation|0|||
143364935|NCT00197236|516878729|FG001|Overall Study|Protocol Violation|0|||
143057551|NCT03173560|515749706|FG001|Overall Study|Other|1|||
143057552|NCT00725764|515749708|FG000|Overall Study|Withdrawal by Subject|2|||
143057553|NCT00725764|515749708|FG000|Overall Study|Physician Decision|1|||
143057554|NCT00725764|515749708|FG000|Overall Study|Progressive Disease|7|||
143057555|NCT00725764|515749708|FG000|Overall Study|Lost to Follow-up|1|||
143057556|NCT00725764|515749708|FG000|Overall Study|Death|1|||
143057557|NCT00725764|515749708|FG000|Overall Study|Participant non compliant with protocol|1|||
143057558|NCT00725764|515749708|FG000|Overall Study|Decline in performance status|1|||
143364936|NCT00197236|516878730|FG002|Overall Study|Protocol Violation|1|||
143364937|NCT00197236|516878728|FG000|Overall Study|Withdrawal by Subject|7|||
143364938|NCT00197236|516878729|FG001|Overall Study|Withdrawal by Subject|3|||
143364939|NCT00197236|516878730|FG002|Overall Study|Withdrawal by Subject|11|||
143057559|NCT04480307|515749712|FG000|Overall Study|Withdrawal by Subject|0|||
143057560|NCT04480307|515749713|FG001|Overall Study|Withdrawal by Subject|1|||
143057561|NCT04480307|515749714|FG002|Overall Study|Withdrawal by Subject|0|||
143057562|NCT04480307|515749715|FG003|Overall Study|Withdrawal by Subject|0|||
143057563|NCT04480307|515749712|FG000|Overall Study|Adverse Event|0|||
143057564|NCT04480307|515749713|FG001|Overall Study|Adverse Event|0|||
143057565|NCT04480307|515749714|FG002|Overall Study|Adverse Event|0|||
143057566|NCT04480307|515749715|FG003|Overall Study|Adverse Event|1|||
143057567|NCT03023137|515749718|FG000|Overall Study|Multiple pregnancy|2|||
143057568|NCT03023137|515749719|FG001|Overall Study|Multiple pregnancy|4|||
143057569|NCT03023137|515749718|FG000|Overall Study|Lost to Follow-up|1|||
143057570|NCT03023137|515749719|FG001|Overall Study|Lost to Follow-up|1|||
143057571|NCT03023137|515749718|FG000|Overall Study|Protocol Violation|0|||
143057572|NCT03023137|515749719|FG001|Overall Study|Protocol Violation|4|||
143057573|NCT03023137|515749718|FG000|Overall Study|Lost the baby in a car accident|1|||
143500337|NCT01468987|517372424|FG000|Overall Study|Adverse Event|12|||
143500338|NCT01468987|517372425|FG001|Overall Study|Adverse Event|9|||
143500339|NCT01468987|517372424|FG000|Overall Study|Death|4|||
143500340|NCT01468987|517372425|FG001|Overall Study|Death|1|||
143500341|NCT01468987|517372424|FG000|Overall Study|Lost to Follow-up|10|||
143057574|NCT03023137|515749719|FG001|Overall Study|Lost the baby in a car accident|0|||
143057575|NCT00732160|515749723|FG000|Overall Study|Adverse Event|1|||
143057576|NCT00732160|515749724|FG001|Overall Study|Adverse Event|0|||
143057577|NCT00732160|515749725|FG002|Overall Study|Adverse Event|1|||
143057578|NCT00732160|515749726|FG003|Overall Study|Adverse Event|1|||
143057579|NCT00732160|515749723|FG000|Overall Study|scheduling|4|||
143057580|NCT00732160|515749724|FG001|Overall Study|scheduling|4|||
143057581|NCT00732160|515749725|FG002|Overall Study|scheduling|2|||
143057582|NCT00732160|515749726|FG003|Overall Study|scheduling|1|||
143057583|NCT01203917|515749727|FG000|Overall Study|Death|29|||
143500342|NCT01468987|517372425|FG001|Overall Study|Lost to Follow-up|5|||
143500343|NCT01468987|517372424|FG000|Overall Study|Protocol Violation|8|||
143500344|NCT01468987|517372425|FG001|Overall Study|Protocol Violation|2|||
143500345|NCT01468987|517372424|FG000|Overall Study|Withdrawal by Subject|28|||
143500346|NCT01468987|517372425|FG001|Overall Study|Withdrawal by Subject|28|||
143500347|NCT01468987|517372424|FG000|Overall Study|Physician Decision|8|||
143057584|NCT01203917|515749727|FG000|Overall Study|Lost to Follow-up|2|||
143364940|NCT00197236|516878728|FG000|Overall Study|Study drug/medication expiration|1|||
143500348|NCT01468987|517372425|FG001|Overall Study|Physician Decision|15|||
143364941|NCT00197236|516878729|FG001|Overall Study|Study drug/medication expiration|0|||
143057585|NCT01203917|515749727|FG000|Overall Study|Withdrawal by Subject|3|||
143364942|NCT00197236|516878730|FG002|Overall Study|Study drug/medication expiration|3|||
143057586|NCT01203917|515749727|FG000|Overall Study|Due to objective disease progression|1|||
143057587|NCT01203917|515749727|FG000|Overall Study|Due to EGFR M+I patient|1|||
143057588|NCT01264835|515749728|FG000|Overall Study|Lost to Follow-up|1|||
143057589|NCT05103657|515749741|FG000|Overall Study|Other reasons than listed|9|||
143057590|NCT05103657|515749742|FG001|Overall Study|Other reasons than listed|8|||
143057591|NCT05103657|515749741|FG000|Overall Study|Protocol deviation|2|||
143057592|NCT05103657|515749742|FG001|Overall Study|Protocol deviation|2|||
143364943|NCT00197236|516878728|FG000|Overall Study|Returned out of specified time window|0|||
143500349|NCT01468987|517372424|FG000|Overall Study|Sponsor Decision|1|||
143500350|NCT01468987|517372425|FG001|Overall Study|Sponsor Decision|0|||
143500351|NCT00787787|517372426|FG000|Overall Study|Lack of Efficacy|4|||
143057593|NCT05103657|515749741|FG000|Overall Study|No reason available|5|||
143057594|NCT05103657|515749742|FG001|Overall Study|No reason available|4|||
143057595|NCT05103657|515749741|FG000|Overall Study|Burden of study procedures|3|||
143057596|NCT05103657|515749742|FG001|Overall Study|Burden of study procedures|1|||
143057597|NCT05103657|515749741|FG000|Overall Study|Perceived lack of efficacy|1|||
143500352|NCT00787787|517372426|FG000|Overall Study|Adverse Event|3|||
143500353|NCT05032950|517372429|FG000|Overall Study|Adverse Event|0|||
143500354|NCT05032950|517372430|FG001|Overall Study|Adverse Event|0|||
143500355|NCT05032950|517372431|FG002|Overall Study|Adverse Event|1|||
143500356|NCT05032950|517372432|FG003|Overall Study|Adverse Event|1|||
143500357|NCT05032950|517372433|FG004|Overall Study|Adverse Event|0|||
143500358|NCT05032950|517372434|FG005|Overall Study|Adverse Event|0|||
143500359|NCT03430986|517372435|FG000|24-week Control Period|Adverse Event|1|||
143500360|NCT03430986|517372436|FG001|24-week Control Period|Adverse Event|0|||
143500361|NCT03430986|517372435|FG000|24-week Control Period|Lost to Follow-up|2|||
143500362|NCT03430986|517372436|FG001|24-week Control Period|Lost to Follow-up|2|||
143500363|NCT03430986|517372435|FG000|24-week Control Period|Withdrawal by Participant|5|||
143500364|NCT03430986|517372436|FG001|24-week Control Period|Withdrawal by Participant|0|||
143500365|NCT03430986|517372435|FG000|24-week Control Period|Protocol Deviation|0|||
143500366|NCT03430986|517372436|FG001|24-week Control Period|Protocol Deviation|2|||
143500367|NCT03430986|517372435|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
143500368|NCT03430986|517372436|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
143500369|NCT03430986|517372435|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
143500370|NCT03430986|517372436|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
143500371|NCT02959814|517372438|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
143500372|NCT02959814|517372438|FG000|Overall Study|Excluded based on anatomical criteria|2|||
143500373|NCT02959814|517372438|FG000|Overall Study|Protocol Violation|7|||
143500374|NCT02959814|517372438|FG000|Overall Study|FFR not measured|2|||
143500375|NCT02959814|517372438|FG000|Overall Study|In-procedure QFR not computed|6|||
143500376|NCT02959814|517372438|FG000|Overall Study|Excluded by FFR core-lab|24|||
143500377|NCT04722991|517372442|FG000|Overall Study|Adverse Event|12|||
143500378|NCT04722991|517372443|FG001|Overall Study|Adverse Event|4|||
143500379|NCT04722991|517372442|FG000|Overall Study|Death|2|||
143500380|NCT04722991|517372443|FG001|Overall Study|Death|0|||
143500381|NCT04722991|517372442|FG000|Overall Study|Lost to Follow-up|1|||
143500382|NCT04722991|517372443|FG001|Overall Study|Lost to Follow-up|1|||
143500383|NCT04722991|517372442|FG000|Overall Study|Withdrawal cirterion met|2|||
143500384|NCT04722991|517372443|FG001|Overall Study|Withdrawal cirterion met|2|||
143500385|NCT04722991|517372442|FG000|Overall Study|Other|1|||
143500386|NCT04722991|517372443|FG001|Overall Study|Other|0|||
143500387|NCT04722991|517372442|FG000|Overall Study|Non-compliance|0|||
143500388|NCT04722991|517372443|FG001|Overall Study|Non-compliance|1|||
143500389|NCT04722991|517372442|FG000|Overall Study|Withdrawal by Subject|0|||
143500390|NCT04722991|517372443|FG001|Overall Study|Withdrawal by Subject|1|||
143500391|NCT01459614|517372444|FG000|Overall Study|Adverse Event|1|||
143500392|NCT01459614|517372445|FG001|Overall Study|Adverse Event|0|||
143500393|NCT03641560|517372451|FG000|Overall Study|Withdrawal by Subject|6|||
143500394|NCT03641560|517372451|FG000|Overall Study|Progressive disease|40|||
143500395|NCT03641560|517372451|FG000|Overall Study|Death|6|||
143500396|NCT01793792|517374118|FG000|Overall Study|Death|5|||
143500397|NCT01793792|517374118|FG000|Overall Study|Lost to Follow-up|5|||
143500398|NCT01793792|517374118|FG000|Overall Study|Withdrawal by Subject|1|||
143500399|NCT01793792|517374118|FG000|Overall Study|Device Not Implanted|1|||
143500400|NCT05211336|517374124|FG000|Overall Study|Unacceptable adverse event - autoimmune hepatitis|1|||
143500401|NCT05211336|517374125|FG001|Overall Study|Unacceptable adverse event - autoimmune hepatitis|0|||
143500402|NCT05211336|517374124|FG000|Overall Study|Progressive disease|0|||
143500403|NCT05211336|517374125|FG001|Overall Study|Progressive disease|4|||
143500404|NCT05211336|517374124|FG000|Overall Study|Death due to myocardial infarction|0|||
143500405|NCT05211336|517374125|FG001|Overall Study|Death due to myocardial infarction|1|||
143500406|NCT05211336|517374124|FG000|Overall Study|Death due to unknown cause|0|||
143500407|NCT05211336|517374125|FG001|Overall Study|Death due to unknown cause|1|||
143500408|NCT05211336|517374124|FG000|Overall Study|Worsening kidney function and quality of response|0|||
143057598|NCT05103657|515749742|FG001|Overall Study|Perceived lack of efficacy|1|||
143500409|NCT05211336|517374125|FG001|Overall Study|Worsening kidney function and quality of response|1|||
143500410|NCT01084551|517374126|FG000|Overall Study|Adverse Event|2|||
143500411|NCT01084551|517374127|FG001|Overall Study|Adverse Event|9|||
143500412|NCT01084551|517374128|FG002|Overall Study|Adverse Event|4|||
143057599|NCT05103657|515749741|FG000|Overall Study|Adverse Event|6|||
143057600|NCT05103657|515749742|FG001|Overall Study|Adverse Event|14|||
143057601|NCT05103657|515749741|FG000|Overall Study|Not Treated|1|||
143500413|NCT01084551|517374126|FG000|Overall Study|Lack of Efficacy|2|||
143500414|NCT01084551|517374127|FG001|Overall Study|Lack of Efficacy|0|||
143500415|NCT01084551|517374128|FG002|Overall Study|Lack of Efficacy|1|||
143500416|NCT01084551|517374126|FG000|Overall Study|Withdrawal by Subject|2|||
143500417|NCT01084551|517374127|FG001|Overall Study|Withdrawal by Subject|1|||
143500418|NCT01084551|517374128|FG002|Overall Study|Withdrawal by Subject|0|||
143500419|NCT01084551|517374126|FG000|Overall Study|Protocol Violation|2|||
143500420|NCT01084551|517374127|FG001|Overall Study|Protocol Violation|4|||
143057602|NCT05103657|515749742|FG001|Overall Study|Not Treated|1|||
143057603|NCT03507686|515749743|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
143057604|NCT03507686|515749744|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
143057605|NCT03507686|515749743|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
143057606|NCT03507686|515749744|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
143057607|NCT03507686|515749743|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
143057608|NCT03507686|515749744|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
143057609|NCT03507686|515749743|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
143057610|NCT03507686|515749744|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
143057611|NCT03507686|515749743|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
143057612|NCT03507686|515749744|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
143057613|NCT03507686|515749743|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
143057614|NCT03507686|515749744|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
143169821|NCT02457793|516169950|FG000|Overall Study|Physician Decision|1|||
143169822|NCT02457793|516169951|FG001|Overall Study|Physician Decision|0|||
143169823|NCT02457793|516169952|FG002|Overall Study|Physician Decision|1|||
143169824|NCT02457793|516169953|FG003|Overall Study|Physician Decision|1|||
143169825|NCT02457793|516169954|FG004|Overall Study|Physician Decision|1|||
143169826|NCT02457793|516169955|FG005|Overall Study|Physician Decision|3|||
143169827|NCT02445391|516169956|FG000|Overall Study|No active protocol treatment|3|||
143169828|NCT02445391|516169957|FG001|Overall Study|No active protocol treatment|0|||
143169829|NCT02445391|516169958|FG002|Overall Study|No active protocol treatment|0|||
143169830|NCT02445391|516169956|FG000|Overall Study|Adverse Event|0|||
143169831|NCT02445391|516169957|FG001|Overall Study|Adverse Event|21|||
143169832|NCT02445391|516169958|FG002|Overall Study|Adverse Event|12|||
143169833|NCT02445391|516169956|FG000|Overall Study|Alternative therapy|0|||
143169834|NCT02445391|516169957|FG001|Overall Study|Alternative therapy|0|||
143169835|NCT02445391|516169958|FG002|Overall Study|Alternative therapy|1|||
143169836|NCT02445391|516169956|FG000|Overall Study|Disease progression|0|||
143169837|NCT02445391|516169957|FG001|Overall Study|Disease progression|7|||
143169838|NCT02445391|516169958|FG002|Overall Study|Disease progression|22|||
143500421|NCT01084551|517374128|FG002|Overall Study|Protocol Violation|0|||
143500422|NCT01084551|517374126|FG000|Overall Study|Lost to Follow-up|0|||
143169839|NCT02445391|516169956|FG000|Overall Study|Complicating disease|0|||
143169840|NCT02445391|516169957|FG001|Overall Study|Complicating disease|2|||
143169841|NCT02445391|516169958|FG002|Overall Study|Complicating disease|1|||
143169842|NCT02445391|516169956|FG000|Overall Study|Withdrawal by Subject|0|||
143169843|NCT02445391|516169957|FG001|Overall Study|Withdrawal by Subject|4|||
143169844|NCT02445391|516169958|FG002|Overall Study|Withdrawal by Subject|9|||
143169845|NCT02445391|516169956|FG000|Overall Study|Financial issue|0|||
143500423|NCT01084551|517374127|FG001|Overall Study|Lost to Follow-up|0|||
143500424|NCT01084551|517374128|FG002|Overall Study|Lost to Follow-up|3|||
143500425|NCT01084551|517374126|FG000|Overall Study|Physician Decision|1|||
143500426|NCT01084551|517374127|FG001|Overall Study|Physician Decision|0|||
143500427|NCT01084551|517374128|FG002|Overall Study|Physician Decision|0|||
143500428|NCT00463476|517374129|FG000|Overall Study|Withdrawal by Subject|1|||
143500429|NCT00463476|517374130|FG001|Overall Study|Withdrawal by Subject|2|||
143500430|NCT00463476|517374129|FG000|Overall Study|Lost to Follow-up|1|||
143500431|NCT00463476|517374130|FG001|Overall Study|Lost to Follow-up|1|||
143500432|NCT03502187|517374135|FG000|Overall Study|Withdrawal by Subject|4|||
143500433|NCT03502187|517374136|FG001|Overall Study|Withdrawal by Subject|3|||
143500434|NCT03502187|517374137|FG002|Overall Study|Withdrawal by Subject|3|||
143500435|NCT03502187|517374135|FG000|Overall Study|Lost to Follow-up|5|||
143500436|NCT03502187|517374136|FG001|Overall Study|Lost to Follow-up|4|||
143500437|NCT03502187|517374137|FG002|Overall Study|Lost to Follow-up|5|||
143500438|NCT01848145|517374138|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
143500439|NCT01848145|517374138|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
143500440|NCT01848145|517374138|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
143500441|NCT01848145|517374138|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
143500442|NCT01848145|517374138|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
143500443|NCT01848145|517374138|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
143500444|NCT01848145|517374138|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
143500445|NCT00556426|517374139|FG000|Overall Study|Withdrawal by Subject|3|||
143500446|NCT00556426|517374139|FG000|Overall Study|Death|6|||
143500447|NCT00781365|517374144|FG000|Overall Study|Withdrawal by Subject|13|||
143500448|NCT00781365|517374145|FG001|Overall Study|Withdrawal by Subject|8|||
143500449|NCT00781365|517374144|FG000|Overall Study|Did Not Attend Visit|20|||
143169846|NCT02445391|516169957|FG001|Overall Study|Financial issue|0|||
143169847|NCT02445391|516169958|FG002|Overall Study|Financial issue|2|||
143500450|NCT00781365|517374145|FG001|Overall Study|Did Not Attend Visit|28|||
143169848|NCT02445391|516169956|FG000|Overall Study|Still on treatment|0|||
143169849|NCT02445391|516169957|FG001|Overall Study|Still on treatment|7|||
143169850|NCT02445391|516169958|FG002|Overall Study|Still on treatment|16|||
143500451|NCT00781365|517374144|FG000|Overall Study|Language barrier|1|||
143500452|NCT00781365|517374145|FG001|Overall Study|Language barrier|0|||
143500453|NCT02649634|517374146|FG000|Overall Study|Withdrawal by Subject|3|||
143500454|NCT02649634|517374147|FG001|Overall Study|Withdrawal by Subject|5|||
143500455|NCT02649634|517374146|FG000|Overall Study|Lost to Follow-up|0|||
143500456|NCT02649634|517374147|FG001|Overall Study|Lost to Follow-up|1|||
143500457|NCT00238264|517374148|FG000|Overall Study|Death|7|||
143500458|NCT00238264|517374148|FG000|Overall Study|Lost to Follow-up|18|||
143500459|NCT00238264|517374148|FG000|Overall Study|Withdrawal by Subject|4|||
143500460|NCT00238264|517374148|FG000|Overall Study|Ineligible|7|||
143500461|NCT01756456|517374149|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
143500462|NCT01756456|517374150|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
143500463|NCT01756456|517374151|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
143245701|NCT00481091|516451785|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
143245702|NCT00481091|516451786|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
143245703|NCT00481091|516451787|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
143245704|NCT00481091|516451788|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
143245705|NCT00481091|516451789|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
143245706|NCT00481091|516451790|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
143245707|NCT00481091|516451791|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
143245708|NCT00481091|516451792|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
143245709|NCT00481091|516451793|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
143500464|NCT01756456|517374152|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
143500465|NCT01756456|517374153|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
143500466|NCT01756456|517374154|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
143057615|NCT00559364|515749745|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
143057616|NCT00559364|515749746|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
143057617|NCT00084799|515749747|FG000|Overall Study|Disease Progression|1|||
143057618|NCT00084799|515749748|FG001|Overall Study|Disease Progression|0|||
143057619|NCT03566238|515749753|FG000|Overall Study|Adverse Event|0|||
143057620|NCT03566238|515749754|FG001|Overall Study|Adverse Event|1|||
143057621|NCT03566238|515749755|FG002|Overall Study|Adverse Event|0|||
143057622|NCT03566238|515749753|FG000|Overall Study|Lack of Efficacy|4|||
143057623|NCT03566238|515749754|FG001|Overall Study|Lack of Efficacy|2|||
143057624|NCT03566238|515749755|FG002|Overall Study|Lack of Efficacy|5|||
143057625|NCT03566238|515749753|FG000|Overall Study|Other|1|||
143057626|NCT03566238|515749754|FG001|Overall Study|Other|0|||
143057627|NCT03566238|515749755|FG002|Overall Study|Other|0|||
143057628|NCT00602537|515749757|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
143057629|NCT00602537|515749758|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
143057630|NCT00602537|515749757|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
143057631|NCT00602537|515749758|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
143057632|NCT00602537|515749757|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
143057633|NCT00602537|515749758|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
143057634|NCT00602537|515749757|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
143057635|NCT00602537|515749758|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
143057636|NCT00602537|515749757|FG000|Follow Up Study Comparison|Adverse Event|1|||
143057637|NCT00602537|515749758|FG001|Follow Up Study Comparison|Adverse Event|0|||
143057638|NCT00602537|515749757|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
143057639|NCT00602537|515749758|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
143057640|NCT00602537|515749757|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
143057641|NCT00602537|515749758|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
143057642|NCT00388037|515749761|FG000|Overall Study|Protocol Violation|1|||
143500467|NCT01756456|517374149|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
143500468|NCT01756456|517374150|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
143500469|NCT01756456|517374151|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
143500470|NCT01756456|517374152|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
143500471|NCT01756456|517374153|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
143500472|NCT01756456|517374154|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
143500473|NCT01756456|517374149|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
143500474|NCT01756456|517374150|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
143500475|NCT01756456|517374151|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
143500476|NCT01756456|517374152|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
143500477|NCT01756456|517374153|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
143500478|NCT01756456|517374154|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
143500479|NCT01756456|517374149|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
143500480|NCT01756456|517374150|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
143500481|NCT01756456|517374151|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
143500482|NCT01756456|517374152|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
143057643|NCT02412722|515749766|FG000|Overall Study|Adverse Event|0|||
143057644|NCT02412722|515749767|FG001|Overall Study|Adverse Event|2|||
143169851|NCT02445391|516169956|FG000|Overall Study|Not start protocol therapy|0|||
143169852|NCT02445391|516169957|FG001|Overall Study|Not start protocol therapy|12|||
143169853|NCT02445391|516169958|FG002|Overall Study|Not start protocol therapy|9|||
143169854|NCT03814044|516169959|FG000|Overall Study|Protocol deviation|1|||
143169855|NCT05929326|516169960|FG000|Overall Study|unqualified sample|2|||
143169856|NCT05929326|516169961|FG001|Overall Study|unqualified sample|3|||
143500483|NCT01756456|517374153|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
143500484|NCT01756456|517374154|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
143500485|NCT01756456|517374149|FG000|Treatment Period: Phase I/II|Other causes|0|||
143500486|NCT01756456|517374150|FG001|Treatment Period: Phase I/II|Other causes|0|||
143500487|NCT01756456|517374151|FG002|Treatment Period: Phase I/II|Other causes|0|||
143500488|NCT01756456|517374152|FG003|Treatment Period: Phase I/II|Other causes|1|||
143500489|NCT01756456|517374153|FG004|Treatment Period: Phase I/II|Other causes|2|||
143500490|NCT01756456|517374154|FG005|Treatment Period: Phase I/II|Other causes|2|||
143500491|NCT01756456|517374149|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
143500492|NCT01756456|517374150|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
143500493|NCT01756456|517374151|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
143500494|NCT01756456|517374152|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
143500495|NCT01756456|517374153|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
143500496|NCT01756456|517374154|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
143500497|NCT01756456|517374149|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
143500498|NCT01756456|517374150|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
143500499|NCT01756456|517374151|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
143500500|NCT01756456|517374152|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
143500501|NCT01756456|517374153|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
143500502|NCT01756456|517374154|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
143500503|NCT01756456|517374149|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
143500504|NCT01756456|517374150|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
143500505|NCT01756456|517374151|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
143500506|NCT01756456|517374152|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
143500507|NCT01756456|517374153|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
143500508|NCT01756456|517374154|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
143500509|NCT01756456|517374149|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
143500510|NCT01756456|517374150|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
143500511|NCT01756456|517374151|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
143500512|NCT01756456|517374152|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
143500513|NCT01756456|517374153|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
143500514|NCT01756456|517374154|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
143500515|NCT01756456|517374149|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
143500516|NCT01756456|517374150|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
143500517|NCT01756456|517374151|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
143500518|NCT01756456|517374152|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
143500519|NCT01756456|517374153|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
143500520|NCT01756456|517374154|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
143500521|NCT01756456|517374149|FG000|Follow Up Period Phase I/II|Other causes|0|||
143500522|NCT01756456|517374150|FG001|Follow Up Period Phase I/II|Other causes|0|||
143500523|NCT01756456|517374151|FG002|Follow Up Period Phase I/II|Other causes|0|||
143500524|NCT01756456|517374152|FG003|Follow Up Period Phase I/II|Other causes|1|||
143500525|NCT01756456|517374153|FG004|Follow Up Period Phase I/II|Other causes|3|||
143500526|NCT01756456|517374154|FG005|Follow Up Period Phase I/II|Other causes|5|||
143500527|NCT01838044|517374155|FG000|Overall Study|Adverse Event|4|||
143500528|NCT01838044|517374156|FG001|Overall Study|Adverse Event|6|||
143500529|NCT01838044|517374155|FG000|Overall Study|Protocol Violation|3|||
143500530|NCT01838044|517374156|FG001|Overall Study|Protocol Violation|3|||
143500531|NCT01838044|517374155|FG000|Overall Study|Withdrawal by Subject|0|||
143500532|NCT01838044|517374156|FG001|Overall Study|Withdrawal by Subject|2|||
143500533|NCT01838044|517374155|FG000|Overall Study|Insufficient clinical response|1|||
143500534|NCT01838044|517374156|FG001|Overall Study|Insufficient clinical response|2|||
143500535|NCT01838044|517374155|FG000|Overall Study|Medication error without associated AE|0|||
143500536|NCT01838044|517374156|FG001|Overall Study|Medication error without associated AE|1|||
143500537|NCT01838044|517374155|FG000|Overall Study|Lost to Follow-up|0|||
143500538|NCT01838044|517374156|FG001|Overall Study|Lost to Follow-up|2|||
143500539|NCT00348140|517374157|FG000|Overall Study|Adverse Event|46|||
143500540|NCT00348140|517374158|FG001|Overall Study|Adverse Event|49|||
143500541|NCT00348140|517374159|FG002|Overall Study|Adverse Event|78|||
143500542|NCT00348140|517374157|FG000|Overall Study|Lost to Follow-up|4|||
143169857|NCT05929326|516169962|FG002|Overall Study|unqualified sample|7|||
143169858|NCT05212168|516169965|FG000|Overall Study|Lost to Follow-up|0|||
143169859|NCT05212168|516169966|FG001|Overall Study|Lost to Follow-up|3|||
143169860|NCT05212168|516169965|FG000|Overall Study|Study terminated by sponsor|30|||
143057645|NCT02412722|515749768|FG002|Overall Study|Adverse Event|0|||
143057646|NCT02412722|515749769|FG003|Overall Study|Adverse Event|3|||
143057647|NCT02412722|515749770|FG004|Overall Study|Adverse Event|0|||
143057648|NCT02412722|515749771|FG005|Overall Study|Adverse Event|3|||
143057649|NCT02412722|515749766|FG000|Overall Study|Progressive Disease|6|||
143057650|NCT02412722|515749767|FG001|Overall Study|Progressive Disease|4|||
143500543|NCT00348140|517374158|FG001|Overall Study|Lost to Follow-up|4|||
143500544|NCT00348140|517374159|FG002|Overall Study|Lost to Follow-up|4|||
143500545|NCT00348140|517374157|FG000|Overall Study|Protocol Violation|12|||
143500546|NCT00348140|517374158|FG001|Overall Study|Protocol Violation|13|||
143500547|NCT00348140|517374159|FG002|Overall Study|Protocol Violation|14|||
143500548|NCT00348140|517374157|FG000|Overall Study|Withdrawal by Subject|32|||
143500549|NCT00348140|517374158|FG001|Overall Study|Withdrawal by Subject|40|||
143500550|NCT00348140|517374159|FG002|Overall Study|Withdrawal by Subject|40|||
143500551|NCT00348140|517374157|FG000|Overall Study|Non-compliance|8|||
143500552|NCT00348140|517374158|FG001|Overall Study|Non-compliance|13|||
143500553|NCT00348140|517374159|FG002|Overall Study|Non-compliance|5|||
143500554|NCT00348140|517374157|FG000|Overall Study|Participant at risk due to study drug|2|||
143500555|NCT00348140|517374158|FG001|Overall Study|Participant at risk due to study drug|0|||
143500556|NCT00348140|517374159|FG002|Overall Study|Participant at risk due to study drug|0|||
143500557|NCT00348140|517374157|FG000|Overall Study|Conditional medication increased dose|1|||
143500558|NCT00348140|517374158|FG001|Overall Study|Conditional medication increased dose|0|||
143500559|NCT00348140|517374159|FG002|Overall Study|Conditional medication increased dose|0|||
143500560|NCT00348140|517374157|FG000|Overall Study|Caregiver related|4|||
143500561|NCT00348140|517374158|FG001|Overall Study|Caregiver related|7|||
143500562|NCT00348140|517374159|FG002|Overall Study|Caregiver related|3|||
143500563|NCT00348140|517374157|FG000|Overall Study|Participant hospitalised|3|||
143500564|NCT00348140|517374158|FG001|Overall Study|Participant hospitalised|0|||
143500565|NCT00348140|517374159|FG002|Overall Study|Participant hospitalised|0|||
143500566|NCT00348140|517374157|FG000|Overall Study|Efficacy related|1|||
143500567|NCT00348140|517374158|FG001|Overall Study|Efficacy related|1|||
143500568|NCT00348140|517374159|FG002|Overall Study|Efficacy related|0|||
143500569|NCT00348140|517374157|FG000|Overall Study|Administration related|3|||
143500570|NCT00348140|517374158|FG001|Overall Study|Administration related|1|||
143500571|NCT00348140|517374159|FG002|Overall Study|Administration related|1|||
143500572|NCT00348140|517374157|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
143500573|NCT00348140|517374158|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
143500574|NCT00348140|517374159|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
143500575|NCT00348140|517374157|FG000|Overall Study|Participant unwell|1|||
143500576|NCT00348140|517374158|FG001|Overall Study|Participant unwell|0|||
143500577|NCT00348140|517374159|FG002|Overall Study|Participant unwell|0|||
143500578|NCT00348140|517374157|FG000|Overall Study|Screen failure|1|||
143500579|NCT00348140|517374158|FG001|Overall Study|Screen failure|0|||
143500580|NCT00348140|517374159|FG002|Overall Study|Screen failure|0|||
143500581|NCT00348140|517374157|FG000|Overall Study|Investigator decided to discontinue|4|||
143500582|NCT00348140|517374158|FG001|Overall Study|Investigator decided to discontinue|1|||
143500583|NCT00348140|517374159|FG002|Overall Study|Investigator decided to discontinue|4|||
143500584|NCT00348140|517374157|FG000|Overall Study|Decided to discontinue on their own|1|||
143500585|NCT00348140|517374158|FG001|Overall Study|Decided to discontinue on their own|4|||
143500586|NCT00348140|517374159|FG002|Overall Study|Decided to discontinue on their own|1|||
143500587|NCT00348140|517374157|FG000|Overall Study|Use of prohibited drug|1|||
143500588|NCT00348140|517374158|FG001|Overall Study|Use of prohibited drug|0|||
143057651|NCT02412722|515749768|FG002|Overall Study|Progressive Disease|4|||
143057652|NCT02412722|515749769|FG003|Overall Study|Progressive Disease|9|||
143057653|NCT02412722|515749770|FG004|Overall Study|Progressive Disease|3|||
143057654|NCT02412722|515749771|FG005|Overall Study|Progressive Disease|3|||
143057655|NCT02412722|515749766|FG000|Overall Study|Withdrawal by Subject|2|||
143500589|NCT00348140|517374159|FG002|Overall Study|Use of prohibited drug|2|||
143500590|NCT00348140|517374157|FG000|Overall Study|Disease progression|1|||
143500591|NCT00348140|517374158|FG001|Overall Study|Disease progression|2|||
143500592|NCT00348140|517374159|FG002|Overall Study|Disease progression|5|||
143500593|NCT00348140|517374157|FG000|Overall Study|Increased risk of cardiac infarction|0|||
143500594|NCT00348140|517374158|FG001|Overall Study|Increased risk of cardiac infarction|1|||
143500595|NCT00348140|517374159|FG002|Overall Study|Increased risk of cardiac infarction|0|||
143500596|NCT00348140|517374157|FG000|Overall Study|Serious adverse event|0|||
143500597|NCT00348140|517374158|FG001|Overall Study|Serious adverse event|1|||
143500598|NCT00348140|517374159|FG002|Overall Study|Serious adverse event|0|||
143500599|NCT00348140|517374157|FG000|Overall Study|Abnormal ECG|0|||
143500600|NCT00348140|517374158|FG001|Overall Study|Abnormal ECG|1|||
143500601|NCT00348140|517374159|FG002|Overall Study|Abnormal ECG|3|||
143500602|NCT00348140|517374157|FG000|Overall Study|Participant died|0|||
143500603|NCT00348140|517374158|FG001|Overall Study|Participant died|1|||
143057656|NCT02412722|515749767|FG001|Overall Study|Withdrawal by Subject|0|||
143057657|NCT02412722|515749768|FG002|Overall Study|Withdrawal by Subject|1|||
143500604|NCT00348140|517374159|FG002|Overall Study|Participant died|0|||
143057658|NCT02412722|515749769|FG003|Overall Study|Withdrawal by Subject|2|||
143057659|NCT02412722|515749770|FG004|Overall Study|Withdrawal by Subject|1|||
143057660|NCT02412722|515749771|FG005|Overall Study|Withdrawal by Subject|1|||
143057661|NCT02412722|515749766|FG000|Overall Study|Lost to Follow-up|0|||
143057662|NCT02412722|515749767|FG001|Overall Study|Lost to Follow-up|0|||
143057663|NCT02412722|515749768|FG002|Overall Study|Lost to Follow-up|0|||
143057664|NCT02412722|515749769|FG003|Overall Study|Lost to Follow-up|0|||
143057665|NCT02412722|515749770|FG004|Overall Study|Lost to Follow-up|1|||
143057666|NCT02412722|515749771|FG005|Overall Study|Lost to Follow-up|0|||
143057667|NCT02412722|515749766|FG000|Overall Study|Received drug in run-in and discontinued|0|||
143057668|NCT02412722|515749767|FG001|Overall Study|Received drug in run-in and discontinued|2|||
143057669|NCT02412722|515749768|FG002|Overall Study|Received drug in run-in and discontinued|0|||
143500605|NCT00348140|517374157|FG000|Overall Study|Exclusion criteria met|0|||
143500606|NCT00348140|517374158|FG001|Overall Study|Exclusion criteria met|0|||
143500607|NCT00348140|517374159|FG002|Overall Study|Exclusion criteria met|1|||
143500608|NCT00348140|517374157|FG000|Overall Study|Memory declined|0|||
143500609|NCT00348140|517374158|FG001|Overall Study|Memory declined|0|||
143500610|NCT00348140|517374159|FG002|Overall Study|Memory declined|1|||
143500611|NCT00706628|517374160|FG000|Overall Study|Other Adverse Event|16|||
143500612|NCT00706628|517374161|FG001|Overall Study|Other Adverse Event|5|||
143500613|NCT00706628|517374162|FG002|Overall Study|Other Adverse Event|5|||
143500614|NCT00706628|517374163|FG003|Overall Study|Other Adverse Event|2|||
143500615|NCT00706628|517374160|FG000|Overall Study|Non compliant with protocol|0|||
143500616|NCT00706628|517374161|FG001|Overall Study|Non compliant with protocol|1|||
143500617|NCT00706628|517374162|FG002|Overall Study|Non compliant with protocol|0|||
143500618|NCT00706628|517374163|FG003|Overall Study|Non compliant with protocol|0|||
143500619|NCT00706628|517374160|FG000|Overall Study|Consent withdrawn|6|||
143500620|NCT00706628|517374161|FG001|Overall Study|Consent withdrawn|1|||
143500621|NCT00706628|517374162|FG002|Overall Study|Consent withdrawn|3|||
143057670|NCT02412722|515749769|FG003|Overall Study|Received drug in run-in and discontinued|0|||
143057671|NCT02412722|515749770|FG004|Overall Study|Received drug in run-in and discontinued|0|||
143057672|NCT02412722|515749771|FG005|Overall Study|Received drug in run-in and discontinued|0|||
143057673|NCT02412722|515749766|FG000|Overall Study|Reason not Specified|3|||
143057674|NCT02412722|515749767|FG001|Overall Study|Reason not Specified|0|||
143057675|NCT02412722|515749768|FG002|Overall Study|Reason not Specified|2|||
143057676|NCT02412722|515749769|FG003|Overall Study|Reason not Specified|1|||
143057677|NCT02412722|515749770|FG004|Overall Study|Reason not Specified|2|||
143057678|NCT02412722|515749771|FG005|Overall Study|Reason not Specified|6|||
143057679|NCT02941523|515749772|FG000|Monotherapy|Withdrawal by Subject|0|||
143057680|NCT02941523|515749773|FG001|Monotherapy|Withdrawal by Subject|1|||
143057681|NCT02941523|515749772|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
143057682|NCT02941523|515749773|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
143057683|NCT02941523|515749772|FG000|Carboplatin Combination Therapy|Death|1|||
143057684|NCT02941523|515749773|FG001|Carboplatin Combination Therapy|Death|2|||
143057685|NCT02941523|515749772|FG000|Carboplatin Combination Therapy|Disease progression|2|||
143057686|NCT02941523|515749773|FG001|Carboplatin Combination Therapy|Disease progression|0|||
143057687|NCT02941523|515749772|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
143057688|NCT02941523|515749773|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
143057689|NCT04330157|515749774|FG000|Overall Study|Protocol Violation|4|||
143057690|NCT04330157|515749774|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
143057691|NCT02539368|515749775|FG000|Overall Study|Death|4|||
143057692|NCT02539368|515749776|FG001|Overall Study|Death|2|||
143057693|NCT02539368|515749777|FG002|Overall Study|Death|1|||
143057694|NCT02539368|515749778|FG003|Overall Study|Death|0|||
143057695|NCT02539368|515749779|FG004|Overall Study|Death|0|||
143057696|NCT02539368|515749775|FG000|Overall Study|Withdrawal by Subject|44|||
143057697|NCT02539368|515749776|FG001|Overall Study|Withdrawal by Subject|35|||
143057698|NCT02539368|515749777|FG002|Overall Study|Withdrawal by Subject|9|||
143057699|NCT02539368|515749778|FG003|Overall Study|Withdrawal by Subject|1|||
143057700|NCT02539368|515749779|FG004|Overall Study|Withdrawal by Subject|3|||
143057701|NCT02539368|515749775|FG000|Overall Study|Physician Decision|49|||
143057702|NCT02539368|515749776|FG001|Overall Study|Physician Decision|15|||
143245710|NCT00481091|516451784|FG000|Overall Study|Progressive disease other|1|||
143500622|NCT00706628|517374163|FG003|Overall Study|Consent withdrawn|0|||
143500623|NCT00706628|517374160|FG000|Overall Study|Progressive disease|20|||
143500624|NCT00706628|517374161|FG001|Overall Study|Progressive disease|13|||
143500625|NCT00706628|517374162|FG002|Overall Study|Progressive disease|8|||
143500626|NCT00706628|517374163|FG003|Overall Study|Progressive disease|1|||
143500627|NCT00706628|517374160|FG000|Overall Study|Other than those stated above|4|||
143057703|NCT02539368|515749777|FG002|Overall Study|Physician Decision|7|||
143057704|NCT02539368|515749778|FG003|Overall Study|Physician Decision|0|||
143057705|NCT02539368|515749779|FG004|Overall Study|Physician Decision|2|||
143057706|NCT02539368|515749775|FG000|Overall Study|Lost to Follow-up|96|||
143057707|NCT02539368|515749776|FG001|Overall Study|Lost to Follow-up|21|||
143057708|NCT02539368|515749777|FG002|Overall Study|Lost to Follow-up|16|||
143057709|NCT02539368|515749778|FG003|Overall Study|Lost to Follow-up|4|||
143500628|NCT00706628|517374161|FG001|Overall Study|Other than those stated above|0|||
143057710|NCT02539368|515749779|FG004|Overall Study|Lost to Follow-up|3|||
143057711|NCT02539368|515749775|FG000|Overall Study|Adverse Event|44|||
143057712|NCT02539368|515749776|FG001|Overall Study|Adverse Event|5|||
143057713|NCT02539368|515749777|FG002|Overall Study|Adverse Event|9|||
143057714|NCT02539368|515749778|FG003|Overall Study|Adverse Event|0|||
143057715|NCT02539368|515749779|FG004|Overall Study|Adverse Event|3|||
143057716|NCT02539368|515749775|FG000|Overall Study|Participant Non-compliant|13|||
143057717|NCT02539368|515749776|FG001|Overall Study|Participant Non-compliant|2|||
143057718|NCT02539368|515749777|FG002|Overall Study|Participant Non-compliant|1|||
143057719|NCT02539368|515749778|FG003|Overall Study|Participant Non-compliant|1|||
143057720|NCT02539368|515749779|FG004|Overall Study|Participant Non-compliant|0|||
143057721|NCT02539368|515749775|FG000|Overall Study|Other|145|||
143057722|NCT02539368|515749776|FG001|Overall Study|Other|18|||
143057723|NCT02539368|515749777|FG002|Overall Study|Other|24|||
143057724|NCT02539368|515749778|FG003|Overall Study|Other|1|||
143057725|NCT02539368|515749779|FG004|Overall Study|Other|3|||
143057726|NCT02539368|515749775|FG000|Overall Study|Missing|10|||
143057727|NCT02539368|515749776|FG001|Overall Study|Missing|3|||
143057728|NCT02539368|515749777|FG002|Overall Study|Missing|0|||
143057729|NCT02539368|515749778|FG003|Overall Study|Missing|0|||
143057730|NCT02539368|515749779|FG004|Overall Study|Missing|0|||
143057731|NCT04314843|515749781|FG000|Overall Study|Death|2|||
143057732|NCT04314843|515749782|FG001|Overall Study|Death|2|||
143057733|NCT04314843|515749781|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
143057734|NCT04314843|515749782|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
143057735|NCT00373425|515749783|FG000|Overall Study|Relapse of NSCLC|116|||
143057736|NCT00373425|515749784|FG001|Overall Study|Relapse of NSCLC|104|||
143057737|NCT00373425|515749785|FG002|Overall Study|Relapse of NSCLC|19|||
143057738|NCT00373425|515749786|FG003|Overall Study|Relapse of NSCLC|2|||
143057739|NCT00373425|515749787|FG004|Overall Study|Relapse of NSCLC|26|||
143057740|NCT00373425|515749783|FG000|Overall Study|Adverse Event|191|||
143057741|NCT00373425|515749784|FG001|Overall Study|Adverse Event|22|||
143057742|NCT00373425|515749785|FG002|Overall Study|Adverse Event|59|||
143057743|NCT00373425|515749786|FG003|Overall Study|Adverse Event|0|||
143057744|NCT00373425|515749787|FG004|Overall Study|Adverse Event|34|||
143057745|NCT00373425|515749783|FG000|Overall Study|Patient request|35|||
143057746|NCT00373425|515749784|FG001|Overall Study|Patient request|18|||
143057747|NCT00373425|515749785|FG002|Overall Study|Patient request|43|||
143057748|NCT00373425|515749786|FG003|Overall Study|Patient request|6|||
143057749|NCT00373425|515749787|FG004|Overall Study|Patient request|7|||
143057750|NCT00373425|515749783|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
143057751|NCT00373425|515749784|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
143057752|NCT00373425|515749785|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
143057753|NCT00373425|515749786|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
143057754|NCT00373425|515749787|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
143057755|NCT00373425|515749783|FG000|Overall Study|Death|7|||
143057756|NCT00373425|515749784|FG001|Overall Study|Death|0|||
143057757|NCT00373425|515749785|FG002|Overall Study|Death|3|||
143057758|NCT00373425|515749786|FG003|Overall Study|Death|1|||
143057759|NCT00373425|515749787|FG004|Overall Study|Death|0|||
143057760|NCT02752802|515749788|FG000|Overall Study|Contrast Volume Not Collected|1|||
143057761|NCT02752802|515749789|FG001|Overall Study|Contrast Volume Not Collected|0|||
143057762|NCT01396421|515749798|FG000|Overall Study|Lost to Follow-up|0|||
143057763|NCT01396421|515749799|FG001|Overall Study|Lost to Follow-up|0|||
143057764|NCT01396421|515749800|FG002|Overall Study|Lost to Follow-up|0|||
143057765|NCT01396421|515749801|FG003|Overall Study|Lost to Follow-up|1|||
143057766|NCT01396421|515749798|FG000|Overall Study|Adverse Event|17|||
143057767|NCT01396421|515749799|FG001|Overall Study|Adverse Event|15|||
143057768|NCT01396421|515749800|FG002|Overall Study|Adverse Event|12|||
143057769|NCT01396421|515749801|FG003|Overall Study|Adverse Event|32|||
143057770|NCT01396421|515749798|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
143057771|NCT01396421|515749799|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
143057772|NCT01396421|515749800|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
143057773|NCT01396421|515749801|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
143057774|NCT01396421|515749798|FG000|Overall Study|Physician Decision|1|||
143057775|NCT01396421|515749799|FG001|Overall Study|Physician Decision|1|||
143057776|NCT01396421|515749800|FG002|Overall Study|Physician Decision|0|||
143057777|NCT01396421|515749801|FG003|Overall Study|Physician Decision|3|||
143057778|NCT01396421|515749798|FG000|Overall Study|Withdrawal by Subject|31|||
143057779|NCT01396421|515749799|FG001|Overall Study|Withdrawal by Subject|24|||
143057780|NCT01396421|515749800|FG002|Overall Study|Withdrawal by Subject|13|||
143057781|NCT01396421|515749801|FG003|Overall Study|Withdrawal by Subject|21|||
143057782|NCT01396421|515749798|FG000|Overall Study|Protocol Deviation|2|||
143057783|NCT01396421|515749799|FG001|Overall Study|Protocol Deviation|1|||
143057784|NCT01396421|515749800|FG002|Overall Study|Protocol Deviation|1|||
143057785|NCT01396421|515749801|FG003|Overall Study|Protocol Deviation|0|||
143057786|NCT01396421|515749798|FG000|Overall Study|Lack of Efficacy|7|||
143057787|NCT01396421|515749799|FG001|Overall Study|Lack of Efficacy|17|||
143057788|NCT01396421|515749800|FG002|Overall Study|Lack of Efficacy|7|||
143500629|NCT00706628|517374162|FG002|Overall Study|Other than those stated above|0|||
143500630|NCT00706628|517374163|FG003|Overall Study|Other than those stated above|0|||
143500631|NCT00706628|517374160|FG000|Overall Study|Not treated|1|||
143500632|NCT00706628|517374161|FG001|Overall Study|Not treated|1|||
143500633|NCT00706628|517374162|FG002|Overall Study|Not treated|0|||
143500634|NCT00706628|517374163|FG003|Overall Study|Not treated|0|||
143500635|NCT02266433|517374164|FG000|Overall Study|Lost to Follow-up|54|||
143500636|NCT02266433|517374165|FG001|Overall Study|Lost to Follow-up|46|||
143500637|NCT02266433|517374164|FG000|Overall Study|Withdrawal by Subject|5|||
143500638|NCT02266433|517374165|FG001|Overall Study|Withdrawal by Subject|7|||
143500639|NCT01145560|517374166|FG000|Overall Study|Withdrawal by Subject|2|||
143500640|NCT01145560|517374167|FG001|Overall Study|Withdrawal by Subject|1|||
143500641|NCT01145560|517374168|FG002|Overall Study|Withdrawal by Subject|0|||
143500642|NCT01145560|517374166|FG000|Overall Study|Lost to Follow-up|1|||
143500643|NCT01145560|517374167|FG001|Overall Study|Lost to Follow-up|1|||
143500644|NCT01145560|517374168|FG002|Overall Study|Lost to Follow-up|1|||
143500645|NCT01145560|517374166|FG000|Overall Study|No study drug by 24h after organ failure|1|||
143500646|NCT01145560|517374167|FG001|Overall Study|No study drug by 24h after organ failure|0|||
143500647|NCT01145560|517374168|FG002|Overall Study|No study drug by 24h after organ failure|0|||
143500648|NCT01145560|517374166|FG000|Overall Study|Accidental unblinding of study treatment|0|||
143500649|NCT01145560|517374167|FG001|Overall Study|Accidental unblinding of study treatment|1|||
143500650|NCT01145560|517374168|FG002|Overall Study|Accidental unblinding of study treatment|0|||
143500651|NCT01145560|517374166|FG000|Overall Study|False insurance information|0|||
143057789|NCT01396421|515749801|FG003|Overall Study|Lack of Efficacy|18|||
143057790|NCT03689894|515749803|FG000|Overall Study|Adverse Event|1|||
143057791|NCT00569777|515749804|FG000|Overall Study|Withdrawal by Subject|4|||
143057792|NCT00569777|515749805|FG001|Overall Study|Withdrawal by Subject|0|||
143057793|NCT00569777|515749804|FG000|Overall Study|Adverse Event|3|||
143057794|NCT00569777|515749805|FG001|Overall Study|Adverse Event|0|||
143057795|NCT00569777|515749804|FG000|Overall Study|Lost to Follow-up|1|||
143057796|NCT00569777|515749805|FG001|Overall Study|Lost to Follow-up|0|||
143057797|NCT00569777|515749804|FG000|Overall Study|scheduled eye surgery|0|||
143057798|NCT00569777|515749805|FG001|Overall Study|scheduled eye surgery|1|||
143057799|NCT00569777|515749804|FG000|Overall Study|did not meet exclusion criteria|1|||
143057800|NCT00569777|515749805|FG001|Overall Study|did not meet exclusion criteria|2|||
143057801|NCT00569777|515749804|FG000|Overall Study|pregnant|1|||
143057802|NCT00569777|515749805|FG001|Overall Study|pregnant|0|||
143057803|NCT02030535|515749810|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
143057804|NCT01835548|515749811|FG000|Dose Optimization Period|Adverse Event|0|||
143057805|NCT01835548|515749812|FG001|Dose Optimization Period|Adverse Event|0|||
143057806|NCT01835548|515749813|FG002|Dose Optimization Period|Adverse Event|1|||
143057807|NCT01835548|515749811|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
143057808|NCT01835548|515749812|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
143057809|NCT01835548|515749813|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
143057810|NCT01835548|515749811|FG000|Double-Blind Treatment Period|Adverse Event|0|||
143057811|NCT01835548|515749812|FG001|Double-Blind Treatment Period|Adverse Event|1|||
143057812|NCT01835548|515749813|FG002|Double-Blind Treatment Period|Adverse Event|0|||
143057813|NCT01835548|515749811|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
143057814|NCT01835548|515749812|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
143245711|NCT00481091|516451785|FG001|Overall Study|Progressive disease other|1|||
143245712|NCT00481091|516451786|FG002|Overall Study|Progressive disease other|0|||
143245713|NCT00481091|516451787|FG003|Overall Study|Progressive disease other|1|||
143245714|NCT00481091|516451788|FG004|Overall Study|Progressive disease other|1|||
143245715|NCT00481091|516451789|FG005|Overall Study|Progressive disease other|1|||
143245716|NCT00481091|516451790|FG006|Overall Study|Progressive disease other|0|||
143245717|NCT00481091|516451791|FG007|Overall Study|Progressive disease other|2|||
143245718|NCT00481091|516451792|FG008|Overall Study|Progressive disease other|0|||
143245719|NCT00481091|516451793|FG009|Overall Study|Progressive disease other|0|||
143245720|NCT00481091|516451784|FG000|Overall Study|No reason given|0|||
143500652|NCT01145560|517374167|FG001|Overall Study|False insurance information|1|||
143500653|NCT01145560|517374168|FG002|Overall Study|False insurance information|0|||
143057815|NCT01835548|515749813|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
143057816|NCT02490800|515749814|FG000|Overall Study|Adverse Event|0|||
143057817|NCT02490800|515749815|FG001|Overall Study|Adverse Event|0|||
143057818|NCT02490800|515749816|FG002|Overall Study|Adverse Event|0|||
143057819|NCT02490800|515749817|FG003|Overall Study|Adverse Event|2|||
143245721|NCT00481091|516451785|FG001|Overall Study|No reason given|0|||
143245722|NCT00481091|516451786|FG002|Overall Study|No reason given|1|||
143245723|NCT00481091|516451787|FG003|Overall Study|No reason given|1|||
143500654|NCT01145560|517374166|FG000|Overall Study|Withdrawal of therapy|0|||
143500655|NCT01145560|517374167|FG001|Overall Study|Withdrawal of therapy|0|||
143500656|NCT01145560|517374168|FG002|Overall Study|Withdrawal of therapy|1|||
143057820|NCT02490800|515749818|FG004|Overall Study|Adverse Event|3|||
143057821|NCT02490800|515749819|FG005|Overall Study|Adverse Event|2|||
143057822|NCT02490800|515749820|FG006|Overall Study|Adverse Event|0|||
143057823|NCT02490800|515749821|FG007|Overall Study|Adverse Event|0|||
143057824|NCT02490800|515749822|FG008|Overall Study|Adverse Event|0|||
143057825|NCT02490800|515749823|FG009|Overall Study|Adverse Event|0|||
143057826|NCT02490800|515749824|FG010|Overall Study|Adverse Event|0|||
143057827|NCT02490800|515749825|FG011|Overall Study|Adverse Event|2|||
143057828|NCT02490800|515749826|FG012|Overall Study|Adverse Event|2|||
143057829|NCT02490800|515749814|FG000|Overall Study|Withdrawal by Subject|0|||
143057830|NCT02490800|515749815|FG001|Overall Study|Withdrawal by Subject|0|||
143057831|NCT02490800|515749816|FG002|Overall Study|Withdrawal by Subject|0|||
143057832|NCT02490800|515749817|FG003|Overall Study|Withdrawal by Subject|1|||
143057833|NCT02490800|515749818|FG004|Overall Study|Withdrawal by Subject|0|||
143057834|NCT02490800|515749819|FG005|Overall Study|Withdrawal by Subject|0|||
143500657|NCT00712348|517374169|FG000|Overall Study|Withdrawal by Subject|1|||
143057835|NCT02490800|515749820|FG006|Overall Study|Withdrawal by Subject|0|||
143057836|NCT02490800|515749821|FG007|Overall Study|Withdrawal by Subject|0|||
143057837|NCT02490800|515749822|FG008|Overall Study|Withdrawal by Subject|1|||
143057838|NCT02490800|515749823|FG009|Overall Study|Withdrawal by Subject|0|||
143057839|NCT02490800|515749824|FG010|Overall Study|Withdrawal by Subject|0|||
143057840|NCT02490800|515749825|FG011|Overall Study|Withdrawal by Subject|0|||
143057841|NCT02490800|515749826|FG012|Overall Study|Withdrawal by Subject|0|||
143057842|NCT02490800|515749814|FG000|Overall Study|Progressive disease|3|||
143057843|NCT02490800|515749815|FG001|Overall Study|Progressive disease|3|||
143057844|NCT02490800|515749816|FG002|Overall Study|Progressive disease|3|||
143057845|NCT02490800|515749817|FG003|Overall Study|Progressive disease|4|||
143057846|NCT02490800|515749818|FG004|Overall Study|Progressive disease|4|||
143057847|NCT02490800|515749819|FG005|Overall Study|Progressive disease|1|||
143057848|NCT02490800|515749820|FG006|Overall Study|Progressive disease|4|||
143057849|NCT02490800|515749821|FG007|Overall Study|Progressive disease|3|||
143057850|NCT02490800|515749822|FG008|Overall Study|Progressive disease|6|||
143057851|NCT02490800|515749823|FG009|Overall Study|Progressive disease|2|||
143057852|NCT02490800|515749824|FG010|Overall Study|Progressive disease|7|||
143057853|NCT02490800|515749825|FG011|Overall Study|Progressive disease|1|||
143057854|NCT02490800|515749826|FG012|Overall Study|Progressive disease|10|||
143057855|NCT02490800|515749814|FG000|Overall Study|Patient enrolled in post-trial access|0|||
143057856|NCT02490800|515749815|FG001|Overall Study|Patient enrolled in post-trial access|0|||
143057857|NCT02490800|515749816|FG002|Overall Study|Patient enrolled in post-trial access|0|||
143500658|NCT04666038|517374172|FG000|Overall Study|Progressive Disease|2|||
143500659|NCT04666038|517374173|FG001|Overall Study|Progressive Disease|0|||
143500660|NCT04666038|517374172|FG000|Overall Study|Death|38|||
143500661|NCT04666038|517374173|FG001|Overall Study|Death|32|||
143500662|NCT04666038|517374172|FG000|Overall Study|Withdrawal by Subject|10|||
143500663|NCT04666038|517374173|FG001|Overall Study|Withdrawal by Subject|19|||
143500664|NCT04666038|517374172|FG000|Overall Study|Lost to Follow-up|0|||
143500665|NCT04666038|517374173|FG001|Overall Study|Lost to Follow-up|2|||
143500666|NCT04666038|517374172|FG000|Overall Study|On Study Treatment|46|||
143500667|NCT04666038|517374173|FG001|Overall Study|On Study Treatment|5|||
143500668|NCT04666038|517374172|FG000|Overall Study|Off treatment on post-treatment-discontinuation follow-up|23|||
143500669|NCT04666038|517374173|FG001|Overall Study|Off treatment on post-treatment-discontinuation follow-up|61|||
143500670|NCT01375764|517374175|FG000|Overall Study|Lost to Follow-up|0|||
143500671|NCT01375764|517374176|FG001|Overall Study|Lost to Follow-up|1|||
143500672|NCT01375764|517374177|FG002|Overall Study|Lost to Follow-up|0|||
143057858|NCT02490800|515749817|FG003|Overall Study|Patient enrolled in post-trial access|0|||
143057859|NCT02490800|515749818|FG004|Overall Study|Patient enrolled in post-trial access|0|||
143057860|NCT02490800|515749819|FG005|Overall Study|Patient enrolled in post-trial access|0|||
143057861|NCT02490800|515749820|FG006|Overall Study|Patient enrolled in post-trial access|0|||
143057862|NCT02490800|515749821|FG007|Overall Study|Patient enrolled in post-trial access|0|||
143500673|NCT01375764|517374178|FG003|Overall Study|Lost to Follow-up|0|||
143500674|NCT01375764|517374179|FG004|Overall Study|Lost to Follow-up|0|||
143500675|NCT01375764|517374175|FG000|Overall Study|Withdrawal by Subject|2|||
143500676|NCT01375764|517374176|FG001|Overall Study|Withdrawal by Subject|0|||
143500677|NCT01375764|517374177|FG002|Overall Study|Withdrawal by Subject|0|||
143057863|NCT02490800|515749822|FG008|Overall Study|Patient enrolled in post-trial access|0|||
143057864|NCT02490800|515749823|FG009|Overall Study|Patient enrolled in post-trial access|1|||
143057865|NCT02490800|515749824|FG010|Overall Study|Patient enrolled in post-trial access|1|||
143057866|NCT02490800|515749825|FG011|Overall Study|Patient enrolled in post-trial access|0|||
143057867|NCT02490800|515749826|FG012|Overall Study|Patient enrolled in post-trial access|6|||
143057868|NCT00537017|515749827|FG000|Treatment Phase|Adverse Event|19|||
143500678|NCT01375764|517374178|FG003|Overall Study|Withdrawal by Subject|0|||
143500679|NCT01375764|517374179|FG004|Overall Study|Withdrawal by Subject|1|||
143500680|NCT01375764|517374175|FG000|Overall Study|Other|0|||
143500681|NCT01375764|517374176|FG001|Overall Study|Other|0|||
143500682|NCT01375764|517374177|FG002|Overall Study|Other|0|||
143500683|NCT01375764|517374178|FG003|Overall Study|Other|1|||
143500684|NCT01375764|517374179|FG004|Overall Study|Other|0|||
143500685|NCT03595280|517374180|FG000|Overall Study|Lost to Follow-up|6|||
143500686|NCT03595280|517374181|FG001|Overall Study|Lost to Follow-up|9|||
143500687|NCT03595280|517374182|FG002|Overall Study|Lost to Follow-up|15|||
143500688|NCT02658812|517374183|FG000|Overall Study|Disease Progression|7|||
143500689|NCT02658812|517374183|FG000|Overall Study|Unrelated to study treatment|1|||
143500690|NCT02658812|517374183|FG000|Overall Study|Adverse Event|1|||
143057869|NCT00537017|515749827|FG000|Treatment Phase|Withdrawal by Subject|13|||
143057870|NCT00537017|515749827|FG000|Treatment Phase|Protocol Violation|2|||
143057871|NCT00537017|515749827|FG000|Follow-up Phase|Withdrawal by Subject|9|||
143057872|NCT03365791|515749828|FG000|Overall Study|Adverse Event|5|||
143057873|NCT03365791|515749828|FG000|Overall Study|Death|1|||
143057874|NCT03365791|515749828|FG000|Overall Study|Lost to Follow-up|1|||
143057875|NCT03365791|515749828|FG000|Overall Study|Physician Decision|9|||
143057876|NCT03365791|515749828|FG000|Overall Study|Progressive disease|51|||
143057877|NCT03365791|515749828|FG000|Overall Study|Subject/guardian decision|5|||
143057878|NCT00987831|515749829|FG000|Overall Study|Never flared in 12 months|1|||
143057879|NCT00987831|515749830|FG001|Overall Study|Never flared in 12 months|0|||
143057880|NCT00987831|515749831|FG002|Overall Study|Never flared in 12 months|0|||
143057881|NCT00987831|515749829|FG000|Overall Study|Lost to Follow-up|0|||
143057882|NCT00987831|515749830|FG001|Overall Study|Lost to Follow-up|3|||
143057883|NCT00987831|515749831|FG002|Overall Study|Lost to Follow-up|0|||
143057884|NCT00794417|515751340|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
143057885|NCT00794417|515751341|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
143057886|NCT00794417|515751342|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
143057887|NCT00794417|515751343|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
143057888|NCT00794417|515751340|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
143057889|NCT00794417|515751341|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
143057890|NCT00794417|515751342|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
143057891|NCT00794417|515751343|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
143057892|NCT00794417|515751340|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
143057893|NCT00794417|515751341|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
143057894|NCT00794417|515751342|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
143057895|NCT00794417|515751343|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
143057896|NCT00794417|515751340|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
143057897|NCT00794417|515751341|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
143057898|NCT00794417|515751342|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
143057899|NCT00794417|515751343|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
143057900|NCT00794417|515751340|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
143057901|NCT00794417|515751341|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
143057902|NCT00794417|515751342|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
143057903|NCT00794417|515751343|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
143500691|NCT01194440|517374186|FG000|Baseline (First Dose)|Reason not specified|4|||
143500692|NCT01194440|517374186|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
143057904|NCT00794417|515751340|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
143057905|NCT00794417|515751341|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
143057906|NCT00794417|515751342|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
143057907|NCT00794417|515751343|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
143057908|NCT01239472|515751345|FG000|Overall Study|Withdrawal by Subject|5|||
143057909|NCT01239472|515751346|FG001|Overall Study|Withdrawal by Subject|1|||
143057910|NCT01239472|515751345|FG000|Overall Study|Adverse Event|0|||
143057911|NCT01239472|515751346|FG001|Overall Study|Adverse Event|1|||
143057912|NCT01239472|515751345|FG000|Overall Study|Lack of Efficacy|0|||
143057913|NCT01239472|515751346|FG001|Overall Study|Lack of Efficacy|1|||
143057914|NCT01534078|515751349|FG000|Overall Study|Death|1|||
143057915|NCT01534078|515751349|FG000|Overall Study|Withdrawal by Subject|1|||
143057916|NCT01049412|515751350|FG000|Period I|Withdrawal by Subject|4|||
143057917|NCT01049412|515751351|FG001|Period I|Withdrawal by Subject|6|||
143057918|NCT01049412|515751350|FG000|Period I|Lost to Follow-up|2|||
143057919|NCT01049412|515751351|FG001|Period I|Lost to Follow-up|2|||
143364944|NCT00197236|516878729|FG001|Overall Study|Returned out of specified time window|0|||
143500693|NCT01194440|517374186|FG000|Baseline (First Dose)|Change in therapy|1|||
143500694|NCT01194440|517374186|FG000|Baseline (First Dose)|Adverse Event|1|||
143057920|NCT01049412|515751350|FG000|Period I|Physician Decision|0|||
143057921|NCT01049412|515751351|FG001|Period I|Physician Decision|3|||
143057922|NCT01049412|515751350|FG000|Period I|Protocol Violation|1|||
143057923|NCT01049412|515751351|FG001|Period I|Protocol Violation|2|||
143500695|NCT01194440|517374186|FG000|6-months (2nd Dose)|Change in therapy|4|||
143500696|NCT00854828|517374187|FG000|Overall Study|Death|1|||
143057924|NCT01049412|515751350|FG000|Period I|Adverse Event|1|||
143057925|NCT01049412|515751351|FG001|Period I|Adverse Event|0|||
143057926|NCT01049412|515751350|FG000|Period II|Withdrawal by Subject|2|||
143057927|NCT01049412|515751351|FG001|Period II|Withdrawal by Subject|3|||
143057928|NCT01049412|515751350|FG000|Period II|Adverse Event|1|||
143057929|NCT01049412|515751351|FG001|Period II|Adverse Event|0|||
143057930|NCT01049412|515751350|FG000|Period II|Lost to Follow-up|1|||
143057931|NCT01049412|515751351|FG001|Period II|Lost to Follow-up|0|||
143057932|NCT04364737|515751353|FG000|Overall Study|Withdrawal by Subject|4|||
143057933|NCT04364737|515751354|FG001|Overall Study|Withdrawal by Subject|9|||
143057934|NCT04364737|515751353|FG000|Overall Study|Lost to Follow-up|1|||
143057935|NCT04364737|515751354|FG001|Overall Study|Lost to Follow-up|1|||
143057936|NCT01220609|515751355|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
143057937|NCT01220609|515751355|FG000|Overall Study|Ineligible- Wrong cell type|1|||
143057938|NCT01220609|515751355|FG000|Overall Study|Ineligible-Never treated|1|||
143057939|NCT00112294|515751356|FG000|Overall Study|Still on study|5|||
143057940|NCT00112294|515751357|FG001|Overall Study|Still on study|0|||
143057941|NCT03110380|515751358|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
143057942|NCT03110380|515751359|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
143057943|NCT03110380|515751360|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
143057944|NCT03110380|515751361|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
143057945|NCT03110380|515751358|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
143057946|NCT03110380|515751359|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
143057947|NCT03110380|515751360|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
143057948|NCT03110380|515751361|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
143057949|NCT03110380|515751358|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
143057950|NCT03110380|515751359|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
143057951|NCT03110380|515751360|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
143057952|NCT03110380|515751361|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
143057953|NCT03110380|515751358|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
143057954|NCT03110380|515751359|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
143057955|NCT03110380|515751360|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
143057956|NCT03110380|515751361|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
143057957|NCT03110380|515751358|FG000|Double-Blind Treatment Phase|Death|2|||
143057958|NCT03110380|515751359|FG001|Double-Blind Treatment Phase|Death|1|||
143057959|NCT03110380|515751360|FG002|Double-Blind Treatment Phase|Death|0|||
143057960|NCT03110380|515751361|FG003|Double-Blind Treatment Phase|Death|0|||
143057961|NCT03110380|515751358|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
143057962|NCT03110380|515751359|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
143057963|NCT03110380|515751360|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
143057964|NCT03110380|515751361|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
143057965|NCT03110380|515751358|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
143057966|NCT03110380|515751359|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
143057967|NCT03110380|515751360|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
143057968|NCT03110380|515751361|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
143057969|NCT03110380|515751358|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
143057970|NCT03110380|515751359|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
143057971|NCT03110380|515751360|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
143057972|NCT03110380|515751361|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
143057973|NCT03110380|515751358|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
143057974|NCT03110380|515751359|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
143057975|NCT03110380|515751360|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
143057976|NCT03110380|515751361|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
143500697|NCT00854828|517374188|FG001|Overall Study|Death|0|||
143500698|NCT00854828|517374189|FG002|Overall Study|Death|0|||
143500699|NCT00854828|517374190|FG003|Overall Study|Death|0|||
143500700|NCT00854828|517374187|FG000|Overall Study|Withdrawal by Subject|1|||
143500701|NCT00854828|517374188|FG001|Overall Study|Withdrawal by Subject|1|||
143057977|NCT03110380|515751358|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
143500702|NCT00854828|517374189|FG002|Overall Study|Withdrawal by Subject|0|||
143057978|NCT03110380|515751359|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
143500703|NCT00854828|517374190|FG003|Overall Study|Withdrawal by Subject|9|||
143057979|NCT03110380|515751360|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
143500704|NCT00854828|517374187|FG000|Overall Study|Missed 24mo visit|1|||
143057980|NCT03110380|515751361|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
143057981|NCT03110380|515751358|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
143057982|NCT03110380|515751359|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
143057983|NCT03110380|515751360|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
143364945|NCT00197236|516878730|FG002|Overall Study|Returned out of specified time window|1|||
143500705|NCT00854828|517374188|FG001|Overall Study|Missed 24mo visit|1|||
143500706|NCT00854828|517374189|FG002|Overall Study|Missed 24mo visit|8|||
143500707|NCT00854828|517374190|FG003|Overall Study|Missed 24mo visit|8|||
143500708|NCT02292212|517374192|FG000|ViE Phase|Withdrawal by Subject|1|||
143500709|NCT02292212|517374192|FG000|ViE Phase|Protocol Violation|2|||
143500710|NCT04957290|517374201|FG000|Overall Study|Progressive disease|3|||
143500711|NCT04957290|517374202|FG001|Overall Study|Progressive disease|3|||
143500712|NCT04957290|517374203|FG002|Overall Study|Progressive disease|2|||
143500713|NCT04957290|517374204|FG003|Overall Study|Progressive disease|0|||
143500714|NCT04957290|517374205|FG004|Overall Study|Progressive disease|0|||
143500715|NCT04957290|517374206|FG005|Overall Study|Progressive disease|0|||
143500716|NCT04957290|517374201|FG000|Overall Study|Withdrawal by Subject|1|||
143500717|NCT04957290|517374202|FG001|Overall Study|Withdrawal by Subject|0|||
143500718|NCT04957290|517374203|FG002|Overall Study|Withdrawal by Subject|1|||
143500719|NCT04957290|517374204|FG003|Overall Study|Withdrawal by Subject|0|||
143500720|NCT04957290|517374205|FG004|Overall Study|Withdrawal by Subject|0|||
143500721|NCT04957290|517374206|FG005|Overall Study|Withdrawal by Subject|0|||
143500722|NCT04957290|517374201|FG000|Overall Study|Death|0|||
143500723|NCT04957290|517374202|FG001|Overall Study|Death|2|||
143500724|NCT04957290|517374203|FG002|Overall Study|Death|1|||
143057984|NCT03110380|515751361|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
143057985|NCT00693225|515751367|FG000|Overall Study|Lost to Follow-up|1|||
143057986|NCT00693225|515751368|FG001|Overall Study|Lost to Follow-up|2|||
143057987|NCT00693225|515751367|FG000|Overall Study|Adverse Event|1|||
143057988|NCT00693225|515751368|FG001|Overall Study|Adverse Event|3|||
143057989|NCT01315028|515751369|FG000|Overall Study|Lost to Follow-up|1|||
143057990|NCT01315028|515751370|FG001|Overall Study|Lost to Follow-up|0|||
143057991|NCT01315028|515751369|FG000|Overall Study|Death|0|||
143057992|NCT01315028|515751370|FG001|Overall Study|Death|1|||
143057993|NCT01714739|515751371|FG000|Overall Study|Disease progression|3|||
143057994|NCT01714739|515751372|FG001|Overall Study|Disease progression|5|||
143057995|NCT01714739|515751373|FG002|Overall Study|Disease progression|5|||
143057996|NCT01714739|515751374|FG003|Overall Study|Disease progression|204|||
143057997|NCT01714739|515751375|FG004|Overall Study|Disease progression|1|||
143057998|NCT01714739|515751376|FG005|Overall Study|Disease progression|3|||
143057999|NCT01714739|515751377|FG006|Overall Study|Disease progression|5|||
143058000|NCT01714739|515751371|FG000|Overall Study|Study drug toxicity|1|||
143058001|NCT01714739|515751372|FG001|Overall Study|Study drug toxicity|1|||
143058002|NCT01714739|515751373|FG002|Overall Study|Study drug toxicity|1|||
143058003|NCT01714739|515751374|FG003|Overall Study|Study drug toxicity|15|||
143058004|NCT01714739|515751375|FG004|Overall Study|Study drug toxicity|0|||
143058005|NCT01714739|515751376|FG005|Overall Study|Study drug toxicity|0|||
143058006|NCT01714739|515751377|FG006|Overall Study|Study drug toxicity|5|||
143058007|NCT01714739|515751371|FG000|Overall Study|Death|0|||
143058008|NCT01714739|515751372|FG001|Overall Study|Death|0|||
143058009|NCT01714739|515751373|FG002|Overall Study|Death|0|||
143058010|NCT01714739|515751374|FG003|Overall Study|Death|1|||
143058011|NCT01714739|515751375|FG004|Overall Study|Death|0|||
143058012|NCT01714739|515751376|FG005|Overall Study|Death|0|||
143058013|NCT01714739|515751377|FG006|Overall Study|Death|0|||
143058014|NCT01714739|515751371|FG000|Overall Study|Adverse Event unrelated to drug|0|||
143058015|NCT01714739|515751372|FG001|Overall Study|Adverse Event unrelated to drug|0|||
143500725|NCT04957290|517374204|FG003|Overall Study|Death|0|||
143500726|NCT04957290|517374205|FG004|Overall Study|Death|0|||
143500727|NCT04957290|517374206|FG005|Overall Study|Death|0|||
143500728|NCT04957290|517374201|FG000|Overall Study|non compliance with study drug|0|||
143058016|NCT01714739|515751373|FG002|Overall Study|Adverse Event unrelated to drug|3|||
143058017|NCT01714739|515751374|FG003|Overall Study|Adverse Event unrelated to drug|21|||
143058018|NCT01714739|515751375|FG004|Overall Study|Adverse Event unrelated to drug|0|||
143058019|NCT01714739|515751376|FG005|Overall Study|Adverse Event unrelated to drug|0|||
143058020|NCT01714739|515751377|FG006|Overall Study|Adverse Event unrelated to drug|0|||
143058021|NCT01714739|515751371|FG000|Overall Study|Participant request to stop therapy|0|||
143500729|NCT04957290|517374202|FG001|Overall Study|non compliance with study drug|1|||
143058022|NCT01714739|515751372|FG001|Overall Study|Participant request to stop therapy|1|||
143058023|NCT01714739|515751373|FG002|Overall Study|Participant request to stop therapy|0|||
143058024|NCT01714739|515751374|FG003|Overall Study|Participant request to stop therapy|6|||
143058025|NCT01714739|515751375|FG004|Overall Study|Participant request to stop therapy|0|||
143500730|NCT04957290|517374203|FG002|Overall Study|non compliance with study drug|0|||
143500731|NCT04957290|517374204|FG003|Overall Study|non compliance with study drug|0|||
143500732|NCT04957290|517374205|FG004|Overall Study|non compliance with study drug|0|||
143500733|NCT04957290|517374206|FG005|Overall Study|non compliance with study drug|0|||
143500734|NCT04957290|517374201|FG000|Overall Study|none specified.|0|||
143500735|NCT04957290|517374202|FG001|Overall Study|none specified.|1|||
143500736|NCT04957290|517374203|FG002|Overall Study|none specified.|2|||
143058026|NCT01714739|515751376|FG005|Overall Study|Participant request to stop therapy|0|||
143058027|NCT01714739|515751377|FG006|Overall Study|Participant request to stop therapy|0|||
143500737|NCT04957290|517374204|FG003|Overall Study|none specified.|0|||
143058028|NCT01714739|515751371|FG000|Overall Study|Participant withdrew consent|0|||
143058029|NCT01714739|515751372|FG001|Overall Study|Participant withdrew consent|1|||
143058030|NCT01714739|515751373|FG002|Overall Study|Participant withdrew consent|0|||
143058031|NCT01714739|515751374|FG003|Overall Study|Participant withdrew consent|8|||
143058032|NCT01714739|515751375|FG004|Overall Study|Participant withdrew consent|0|||
143058033|NCT01714739|515751376|FG005|Overall Study|Participant withdrew consent|0|||
143058034|NCT01714739|515751377|FG006|Overall Study|Participant withdrew consent|0|||
143058035|NCT01714739|515751371|FG000|Overall Study|Lost to Follow-up|0|||
143058036|NCT01714739|515751372|FG001|Overall Study|Lost to Follow-up|0|||
143058037|NCT01714739|515751373|FG002|Overall Study|Lost to Follow-up|0|||
143058038|NCT01714739|515751374|FG003|Overall Study|Lost to Follow-up|1|||
143058039|NCT01714739|515751375|FG004|Overall Study|Lost to Follow-up|0|||
143058040|NCT01714739|515751376|FG005|Overall Study|Lost to Follow-up|0|||
143058041|NCT01714739|515751377|FG006|Overall Study|Lost to Follow-up|0|||
143058042|NCT01714739|515751371|FG000|Overall Study|Maximum clinical benefit|0|||
143058043|NCT01714739|515751372|FG001|Overall Study|Maximum clinical benefit|1|||
143058044|NCT01714739|515751373|FG002|Overall Study|Maximum clinical benefit|1|||
143058045|NCT01714739|515751374|FG003|Overall Study|Maximum clinical benefit|3|||
143058046|NCT01714739|515751375|FG004|Overall Study|Maximum clinical benefit|0|||
143058047|NCT01714739|515751376|FG005|Overall Study|Maximum clinical benefit|0|||
143058048|NCT01714739|515751377|FG006|Overall Study|Maximum clinical benefit|0|||
143058049|NCT01714739|515751371|FG000|Overall Study|Poor/non-comliance|0|||
143058050|NCT01714739|515751372|FG001|Overall Study|Poor/non-comliance|1|||
143058051|NCT01714739|515751373|FG002|Overall Study|Poor/non-comliance|0|||
143058052|NCT01714739|515751374|FG003|Overall Study|Poor/non-comliance|1|||
143058053|NCT01714739|515751375|FG004|Overall Study|Poor/non-comliance|0|||
143058054|NCT01714739|515751376|FG005|Overall Study|Poor/non-comliance|0|||
143058055|NCT01714739|515751377|FG006|Overall Study|Poor/non-comliance|0|||
143058056|NCT01714739|515751371|FG000|Overall Study|No longer meets study criteria|0|||
143058057|NCT01714739|515751372|FG001|Overall Study|No longer meets study criteria|0|||
143058058|NCT01714739|515751373|FG002|Overall Study|No longer meets study criteria|0|||
143058059|NCT01714739|515751374|FG003|Overall Study|No longer meets study criteria|1|||
143058060|NCT01714739|515751375|FG004|Overall Study|No longer meets study criteria|0|||
143058061|NCT01714739|515751376|FG005|Overall Study|No longer meets study criteria|0|||
143058062|NCT01714739|515751377|FG006|Overall Study|No longer meets study criteria|0|||
143058063|NCT01714739|515751371|FG000|Overall Study|Other reason|0|||
143058064|NCT01714739|515751372|FG001|Overall Study|Other reason|0|||
143058065|NCT01714739|515751373|FG002|Overall Study|Other reason|0|||
143058066|NCT01714739|515751374|FG003|Overall Study|Other reason|3|||
143058067|NCT01714739|515751375|FG004|Overall Study|Other reason|1|||
143058068|NCT01714739|515751376|FG005|Overall Study|Other reason|0|||
143058069|NCT01714739|515751377|FG006|Overall Study|Other reason|0|||
143058070|NCT02274948|515751384|FG000|Overall Study|Lost to Follow-up|28|||
143169861|NCT05212168|516169966|FG001|Overall Study|Study terminated by sponsor|27|||
143169862|NCT05212168|516169965|FG000|Overall Study|Other|4|||
143169863|NCT05212168|516169966|FG001|Overall Study|Other|7|||
143169864|NCT03274466|516169967|FG000|Overall Study|Withdrawal by Subject|7|||
143169865|NCT03274466|516169968|FG001|Overall Study|Withdrawal by Subject|3|||
143169866|NCT03274466|516169967|FG000|Overall Study|Protocol Specified Withdrawal|5|||
143169867|NCT03274466|516169968|FG001|Overall Study|Protocol Specified Withdrawal|11|||
143169868|NCT03274466|516169967|FG000|Overall Study|Lost to Follow-up|5|||
143169869|NCT03274466|516169968|FG001|Overall Study|Lost to Follow-up|7|||
143169870|NCT03274466|516169967|FG000|Overall Study|Subject Non-compliance|0|||
143169871|NCT03274466|516169968|FG001|Overall Study|Subject Non-compliance|1|||
143169872|NCT03274466|516169967|FG000|Overall Study|Adverse Event|3|||
143169873|NCT03274466|516169968|FG001|Overall Study|Adverse Event|3|||
143169874|NCT03274466|516169967|FG000|Overall Study|Physician Decision|0|||
143169875|NCT03274466|516169968|FG001|Overall Study|Physician Decision|1|||
143169876|NCT03274466|516169967|FG000|Overall Study|Protocol Violation|3|||
143169877|NCT03274466|516169968|FG001|Overall Study|Protocol Violation|3|||
143169878|NCT01994876|516169969|FG000|Test Period 1|Withdrawal by Subject|0|||
143169879|NCT01994876|516169970|FG001|Test Period 1|Withdrawal by Subject|1|||
143169880|NCT01994876|516169969|FG000|Test Period 1|Adverse Event|0|||
143169881|NCT01994876|516169970|FG001|Test Period 1|Adverse Event|1|||
143169882|NCT01994876|516169969|FG000|Test Period 2|Adverse Event|1|||
143169883|NCT01994876|516169970|FG001|Test Period 2|Adverse Event|0|||
143169884|NCT01994876|516169969|FG000|Test Period 2|Protocol Violation|0|||
143169885|NCT01994876|516169970|FG001|Test Period 2|Protocol Violation|1|||
143364946|NCT03885596|516878731|FG000|Overall Study|Withdrawal by Subject|2|||
143058071|NCT02274948|515751385|FG001|Overall Study|Lost to Follow-up|25|||
143058072|NCT02274948|515751384|FG000|Overall Study|Withdrawal by Subject|64|||
143364947|NCT03885596|516878732|FG001|Overall Study|Withdrawal by Subject|1|||
143500738|NCT04957290|517374205|FG004|Overall Study|none specified.|0|||
143500739|NCT04957290|517374206|FG005|Overall Study|none specified.|0|||
143058073|NCT02274948|515751385|FG001|Overall Study|Withdrawal by Subject|58|||
143058074|NCT02274948|515751384|FG000|Overall Study|Stopped on family Practitioner advice|2|||
143058075|NCT02274948|515751385|FG001|Overall Study|Stopped on family Practitioner advice|5|||
143058076|NCT02274948|515751384|FG000|Overall Study|Left the area|4|||
143169886|NCT06022107|516169971|FG000|Overall Study|Did not complete baseline questionnaire / did not begin using intervention|4|||
143058077|NCT02274948|515751385|FG001|Overall Study|Left the area|3|||
143058078|NCT00707434|515751386|FG000|Overall Study|Adverse Event|1|||
143058079|NCT03585959|515751387|FG000|Overall Study|Physician Decision|1|||
143058080|NCT03585959|515751387|FG000|Overall Study|Unsuccessful Procedure|2|||
143058081|NCT04364763|515751388|FG000|Overall Study|Death|1|||
143058082|NCT04364763|515751389|FG001|Overall Study|Death|2|||
143058083|NCT04364763|515751388|FG000|Overall Study|Lost to Follow-up|1|||
143058084|NCT04364763|515751389|FG001|Overall Study|Lost to Follow-up|0|||
143058085|NCT01386125|515751390|FG000|Overall Study|Lost to Follow-up|3|||
143058086|NCT01386125|515751391|FG001|Overall Study|Lost to Follow-up|9|||
143058087|NCT01386125|515751390|FG000|Overall Study|Physician Decision|0|||
143058088|NCT01386125|515751391|FG001|Overall Study|Physician Decision|1|||
143058089|NCT01386125|515751390|FG000|Overall Study|Protocol Violation|5|||
143058090|NCT01386125|515751391|FG001|Overall Study|Protocol Violation|7|||
143058091|NCT01386125|515751390|FG000|Overall Study|Disease Progress|1|||
143058092|NCT01386125|515751391|FG001|Overall Study|Disease Progress|2|||
143058093|NCT01386125|515751390|FG000|Overall Study|Withdrawal by Subject|13|||
143058094|NCT01386125|515751391|FG001|Overall Study|Withdrawal by Subject|12|||
143058095|NCT01386125|515751390|FG000|Overall Study|Adverse Event|2|||
143058096|NCT01386125|515751391|FG001|Overall Study|Adverse Event|5|||
143058097|NCT01386125|515751390|FG000|Overall Study|Lack of Efficacy|0|||
143058098|NCT01386125|515751391|FG001|Overall Study|Lack of Efficacy|1|||
143058099|NCT01386125|515751390|FG000|Overall Study|Participant Leaving Country|1|||
143058100|NCT01386125|515751391|FG001|Overall Study|Participant Leaving Country|0|||
143058101|NCT02359864|515751392|FG000|Overall Study|Withdrawal by Subject|1|||
143058102|NCT02359864|515751393|FG001|Overall Study|Withdrawal by Subject|0|||
143058103|NCT02795676|515751394|FG000|Overall Study|Adverse Event|2|||
143058104|NCT02795676|515751395|FG001|Overall Study|Adverse Event|0|||
143169887|NCT06022107|516169971|FG000|Overall Study|Dropped out of study for higher level of care|1|||
143058105|NCT02795676|515751394|FG000|Overall Study|Withdrawal by Subject|3|||
143058106|NCT02795676|515751395|FG001|Overall Study|Withdrawal by Subject|1|||
143169888|NCT06022107|516169971|FG000|Overall Study|Lost to Follow-up|2|||
143169889|NCT01649869|516169972|FG000|Overall Study|Family member illness|1|||
143169890|NCT01649869|516169973|FG001|Overall Study|Family member illness|0|||
143169891|NCT01649869|516169972|FG000|Overall Study|Required treatment outside protocol|1|||
143169892|NCT01649869|516169973|FG001|Overall Study|Required treatment outside protocol|0|||
143169893|NCT01649869|516169972|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
143169894|NCT01649869|516169973|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
143169895|NCT05847686|516171819|FG000|Overall Study|Withdrawal by Subject|3|||
143169896|NCT03716830|516171820|FG000|Overall Study|Withdrawal by Subject|2|||
143169897|NCT03716830|516171821|FG001|Overall Study|Withdrawal by Subject|2|||
143169898|NCT03716830|516171822|FG002|Overall Study|Withdrawal by Subject|6|||
143169899|NCT03716830|516171823|FG003|Overall Study|Withdrawal by Subject|5|||
143169900|NCT03716830|516171820|FG000|Overall Study|Adverse Event|1|||
143169901|NCT03716830|516171821|FG001|Overall Study|Adverse Event|2|||
143169902|NCT03716830|516171822|FG002|Overall Study|Adverse Event|0|||
143169903|NCT03716830|516171823|FG003|Overall Study|Adverse Event|1|||
143169904|NCT03716830|516171820|FG000|Overall Study|Lost to Follow-up|1|||
143169905|NCT03716830|516171821|FG001|Overall Study|Lost to Follow-up|1|||
143169906|NCT03716830|516171822|FG002|Overall Study|Lost to Follow-up|0|||
143169907|NCT03716830|516171823|FG003|Overall Study|Lost to Follow-up|0|||
143169908|NCT04795531|516171824|FG000|Overall Study|Withdrawal by Subject|4|||
143169909|NCT04795531|516171825|FG001|Overall Study|Withdrawal by Subject|4|||
143169910|NCT04795531|516171824|FG000|Overall Study|Lost to Follow-up|0|||
143169911|NCT04795531|516171825|FG001|Overall Study|Lost to Follow-up|1|||
143169912|NCT04795531|516171824|FG000|Overall Study|Physician Decision|0|||
143169913|NCT04795531|516171825|FG001|Overall Study|Physician Decision|2|||
143169914|NCT04795531|516171824|FG000|Overall Study|Death|2|||
143169915|NCT04795531|516171825|FG001|Overall Study|Death|1|||
143500740|NCT04957290|517374201|FG000|Overall Study|unacceptable toxicity|0|||
143058107|NCT00605176|515751396|FG000|Overall Study|Adverse Event|2|||
143169916|NCT04887831|516171826|FG000|Overall Study|Death|26|||
143169917|NCT04887831|516171827|FG001|Overall Study|Death|26|||
143169918|NCT04887831|516171826|FG000|Overall Study|Lost to Follow-up|0|||
143058108|NCT00605176|515751397|FG001|Overall Study|Adverse Event|1|||
143058109|NCT00605176|515751398|FG002|Overall Study|Adverse Event|3|||
143058110|NCT00605176|515751396|FG000|Overall Study|Withdrawal by Subject|4|||
143058111|NCT00605176|515751397|FG001|Overall Study|Withdrawal by Subject|2|||
143058112|NCT00605176|515751398|FG002|Overall Study|Withdrawal by Subject|4|||
143058113|NCT00605176|515751396|FG000|Overall Study|Lost to Follow-up|2|||
143058114|NCT00605176|515751397|FG001|Overall Study|Lost to Follow-up|2|||
143058115|NCT00605176|515751398|FG002|Overall Study|Lost to Follow-up|1|||
143058116|NCT00605176|515751396|FG000|Overall Study|Non-complicance with study procedures|1|||
143169919|NCT04887831|516171827|FG001|Overall Study|Lost to Follow-up|1|||
143169920|NCT04887831|516171826|FG000|Overall Study|Withdrawal by Subject|2|||
143169921|NCT04887831|516171827|FG001|Overall Study|Withdrawal by Subject|1|||
143169922|NCT04887831|516171826|FG000|Overall Study|Study Terminated by Sponsor|18|||
143169923|NCT04887831|516171827|FG001|Overall Study|Study Terminated by Sponsor|17|||
143058117|NCT00605176|515751397|FG001|Overall Study|Non-complicance with study procedures|0|||
143058118|NCT00605176|515751398|FG002|Overall Study|Non-complicance with study procedures|0|||
143058119|NCT00605176|515751396|FG000|Overall Study|Use of concomitant therapy|1|||
143058120|NCT00605176|515751397|FG001|Overall Study|Use of concomitant therapy|0|||
143058121|NCT00605176|515751398|FG002|Overall Study|Use of concomitant therapy|1|||
143058122|NCT00605176|515751396|FG000|Overall Study|Other (not due to AE)|1|||
143058123|NCT00605176|515751397|FG001|Overall Study|Other (not due to AE)|1|||
143058124|NCT00605176|515751398|FG002|Overall Study|Other (not due to AE)|0|||
143058125|NCT01466036|515751403|FG000|Overall Study|Death|1|||
143058126|NCT01466036|515751404|FG001|Overall Study|Death|1|||
143058127|NCT01466036|515751403|FG000|Overall Study|Physician Decision|0|||
143058128|NCT01466036|515751404|FG001|Overall Study|Physician Decision|4|||
143058129|NCT01466036|515751403|FG000|Overall Study|Adverse Event|2|||
143058130|NCT01466036|515751404|FG001|Overall Study|Adverse Event|6|||
143058131|NCT01466036|515751403|FG000|Overall Study|Withdrawal by Subject|2|||
143058132|NCT01466036|515751404|FG001|Overall Study|Withdrawal by Subject|8|||
143058133|NCT01466036|515751403|FG000|Overall Study|progression/relapse|14|||
143058134|NCT01466036|515751404|FG001|Overall Study|progression/relapse|21|||
143058135|NCT01466036|515751403|FG000|Overall Study|prolonged treatment delay|1|||
143058136|NCT01466036|515751404|FG001|Overall Study|prolonged treatment delay|1|||
143058137|NCT00220727|515751405|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
143058138|NCT00220727|515751406|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
143058139|NCT00983476|515751407|FG000|Overall Study|Did not receive intervention|17|||
143058140|NCT00983476|515751408|FG001|Overall Study|Did not receive intervention|22|||
143058141|NCT00983476|515751409|FG002|Overall Study|Did not receive intervention|0|||
143058142|NCT02508116|515751410|FG000|Overall Study|Lost to Follow-up|2|||
143058143|NCT02508116|515751411|FG001|Overall Study|Lost to Follow-up|3|||
143058144|NCT02508116|515751410|FG000|Overall Study|Withdrawal by Subject|3|||
143058145|NCT02508116|515751411|FG001|Overall Study|Withdrawal by Subject|2|||
143058146|NCT02508116|515751410|FG000|Overall Study|Protocol Violation|1|||
143058147|NCT02508116|515751411|FG001|Overall Study|Protocol Violation|2|||
143058148|NCT02508116|515751410|FG000|Overall Study|Physician Decision|2|||
143058149|NCT02508116|515751411|FG001|Overall Study|Physician Decision|0|||
143058150|NCT00109850|515751412|FG000|Overall Study|Adverse Event|1|||
143058151|NCT00109850|515751412|FG000|Overall Study|Death|2|||
143058152|NCT00109850|515751412|FG000|Overall Study|Ineligible|1|||
143058153|NCT03635983|515751413|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
143058154|NCT03635983|515751414|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
143058155|NCT03635983|515751413|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
143058156|NCT03635983|515751414|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
143058157|NCT03635983|515751413|FG000|Pre-Treatment Period|Other reasons|0|||
143058158|NCT03635983|515751414|FG001|Pre-Treatment Period|Other reasons|1|||
143058159|NCT03635983|515751413|FG000|Pre-Treatment Period|Disease Progression|0|||
143058160|NCT03635983|515751414|FG001|Pre-Treatment Period|Disease Progression|1|||
143058161|NCT03635983|515751413|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|2|||
143058162|NCT03635983|515751414|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
143058163|NCT03635983|515751413|FG000|Treatment Period|Participant request to discontinue Study treatment|6|||
143058164|NCT03635983|515751414|FG001|Treatment Period|Participant request to discontinue Study treatment|7|||
143058165|NCT03635983|515751413|FG000|Treatment Period|Withdrawal by Subject|3|||
143058166|NCT03635983|515751414|FG001|Treatment Period|Withdrawal by Subject|5|||
143058167|NCT03635983|515751413|FG000|Treatment Period|Death|3|||
143058168|NCT03635983|515751414|FG001|Treatment Period|Death|5|||
143058169|NCT03635983|515751413|FG000|Treatment Period|Poor/Non-compliance|2|||
143058170|NCT03635983|515751414|FG001|Treatment Period|Poor/Non-compliance|1|||
143058171|NCT03635983|515751413|FG000|Treatment Period|Participant no longer meets Study criteria|1|||
143058172|NCT03635983|515751414|FG001|Treatment Period|Participant no longer meets Study criteria|4|||
143058173|NCT03635983|515751413|FG000|Treatment Period|Other reasons|7|||
143364948|NCT03885596|516878733|FG002|Overall Study|Withdrawal by Subject|0|||
143500741|NCT04957290|517374202|FG001|Overall Study|unacceptable toxicity|0|||
143500742|NCT04957290|517374203|FG002|Overall Study|unacceptable toxicity|1|||
143500743|NCT04957290|517374204|FG003|Overall Study|unacceptable toxicity|0|||
143058174|NCT03635983|515751414|FG001|Treatment Period|Other reasons|4|||
143058175|NCT03635983|515751413|FG000|Treatment Period|Disease progression|230|||
143500744|NCT04957290|517374205|FG004|Overall Study|unacceptable toxicity|0|||
143500745|NCT04957290|517374206|FG005|Overall Study|unacceptable toxicity|0|||
143058176|NCT03635983|515751414|FG001|Treatment Period|Disease progression|201|||
143058177|NCT03635983|515751413|FG000|Treatment Period|Study drug toxicity|35|||
143058178|NCT03635983|515751414|FG001|Treatment Period|Study drug toxicity|36|||
143058179|NCT03635983|515751413|FG000|Treatment Period|Adverse event unrelated to Study drug|15|||
143058180|NCT03635983|515751414|FG001|Treatment Period|Adverse event unrelated to Study drug|15|||
143058181|NCT03635983|515751413|FG000|Treatment Period|Maximum clinical benefit|3|||
143058182|NCT03635983|515751414|FG001|Treatment Period|Maximum clinical benefit|5|||
143058183|NCT03635983|515751413|FG000|Treatment Period|Administrative reason by the sponsor|1|||
143364949|NCT03885596|516878734|FG003|Overall Study|Withdrawal by Subject|0|||
143500746|NCT04957290|517374201|FG000|Overall Study|Adverse Event|0|||
143500747|NCT04957290|517374202|FG001|Overall Study|Adverse Event|0|||
143500748|NCT04957290|517374203|FG002|Overall Study|Adverse Event|1|||
143500749|NCT04957290|517374204|FG003|Overall Study|Adverse Event|0|||
143500750|NCT04957290|517374205|FG004|Overall Study|Adverse Event|0|||
143500751|NCT04957290|517374206|FG005|Overall Study|Adverse Event|0|||
143500752|NCT04957290|517374201|FG000|Overall Study|study terminated by sponsor|0|||
143500753|NCT04957290|517374202|FG001|Overall Study|study terminated by sponsor|0|||
143500754|NCT04957290|517374203|FG002|Overall Study|study terminated by sponsor|2|||
143500755|NCT04957290|517374204|FG003|Overall Study|study terminated by sponsor|0|||
143500756|NCT04957290|517374205|FG004|Overall Study|study terminated by sponsor|0|||
143500757|NCT04957290|517374206|FG005|Overall Study|study terminated by sponsor|0|||
143500758|NCT01282229|517374207|FG000|Overall Study|Protocol Violation|2|||
143500759|NCT02411747|517374208|FG000|Overall Study|Withdrawal by Subject|1|||
143500760|NCT02411747|517374209|FG001|Overall Study|Withdrawal by Subject|0|||
143500761|NCT02411747|517374208|FG000|Overall Study|Protocol Violation|2|||
143500762|NCT02411747|517374209|FG001|Overall Study|Protocol Violation|4|||
143500763|NCT02149810|517374210|FG000|Overall Study|Physician Decision|1|||
143500764|NCT02149810|517374211|FG001|Overall Study|Physician Decision|2|||
143500765|NCT02149810|517374210|FG000|Overall Study|Lost to Follow-up|2|||
143500766|NCT02149810|517374211|FG001|Overall Study|Lost to Follow-up|1|||
143500767|NCT02149810|517374210|FG000|Overall Study|Withdrawal by Subject|5|||
143500768|NCT02149810|517374211|FG001|Overall Study|Withdrawal by Subject|1|||
143500769|NCT01671280|517374212|FG000|Overall Study|Withdrawal by Subject|2|||
143500770|NCT01959165|517374213|FG000|Overall Study|Adverse Event|0|||
143500771|NCT01959165|517374214|FG001|Overall Study|Adverse Event|0|||
143500772|NCT01959165|517374215|FG002|Overall Study|Adverse Event|0|||
143500773|NCT01959165|517374216|FG003|Overall Study|Adverse Event|1|||
143500774|NCT01959165|517374213|FG000|Overall Study|Lack of Efficacy|1|||
143500775|NCT01959165|517374214|FG001|Overall Study|Lack of Efficacy|0|||
143058184|NCT03635983|515751414|FG001|Treatment Period|Administrative reason by the sponsor|2|||
143058185|NCT03635983|515751413|FG000|Treatment Period|Lost to Follow-up|0|||
143058186|NCT03635983|515751414|FG001|Treatment Period|Lost to Follow-up|1|||
143058187|NCT01235442|515751416|FG000|Overall Study|Lost to Follow-up|12|||
143058188|NCT01235442|515751417|FG001|Overall Study|Lost to Follow-up|10|||
143058189|NCT01235442|515751416|FG000|Overall Study|Death|0|||
143058190|NCT01235442|515751417|FG001|Overall Study|Death|2|||
143058191|NCT01235442|515751416|FG000|Overall Study|Pregnancy|1|||
143058192|NCT01235442|515751417|FG001|Overall Study|Pregnancy|1|||
143058193|NCT01235442|515751416|FG000|Overall Study|Ineligibility determined|5|||
143058194|NCT01235442|515751417|FG001|Overall Study|Ineligibility determined|4|||
143058195|NCT01235442|515751416|FG000|Overall Study|Protocol Violation|3|||
143058196|NCT01235442|515751417|FG001|Overall Study|Protocol Violation|3|||
143058197|NCT01235442|515751416|FG000|Overall Study|Adverse Event|4|||
143058198|NCT01235442|515751417|FG001|Overall Study|Adverse Event|6|||
143058199|NCT01235442|515751416|FG000|Overall Study|Withdrawal by Subject|15|||
143058200|NCT01235442|515751417|FG001|Overall Study|Withdrawal by Subject|9|||
143058201|NCT01235442|515751416|FG000|Overall Study|Lack of Efficacy|1|||
143058202|NCT01235442|515751417|FG001|Overall Study|Lack of Efficacy|3|||
143058203|NCT01235442|515751416|FG000|Overall Study|Noncompliance|1|||
143058204|NCT01235442|515751417|FG001|Overall Study|Noncompliance|2|||
143058205|NCT01235442|515751416|FG000|Overall Study|Administrative decision|1|||
143058206|NCT01235442|515751417|FG001|Overall Study|Administrative decision|2|||
143058207|NCT01235442|515751416|FG000|Overall Study|Other unspecified|1|||
143058208|NCT01235442|515751417|FG001|Overall Study|Other unspecified|2|||
143058209|NCT01857973|515751418|FG000|Overall Study|Subject did not meet required BG range|3|||
143058210|NCT01857973|515751418|FG000|Overall Study|drop out after 3 failed attempts|1|||
143500776|NCT01959165|517374215|FG002|Overall Study|Lack of Efficacy|0|||
143500777|NCT01959165|517374216|FG003|Overall Study|Lack of Efficacy|0|||
143058211|NCT01857973|515751418|FG000|Overall Study|Physician Decision|1|||
143058212|NCT01701973|515751419|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
143058213|NCT01701973|515751420|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
143500778|NCT01959165|517374213|FG000|Overall Study|overdose|0|||
143500779|NCT01959165|517374214|FG001|Overall Study|overdose|0|||
143500780|NCT01959165|517374215|FG002|Overall Study|overdose|0|||
143500781|NCT01959165|517374216|FG003|Overall Study|overdose|1|||
143500782|NCT01959165|517374213|FG000|Overall Study|Welfare recipient|0|||
143500783|NCT01959165|517374214|FG001|Overall Study|Welfare recipient|1|||
143500784|NCT01959165|517374215|FG002|Overall Study|Welfare recipient|0|||
143500785|NCT01959165|517374216|FG003|Overall Study|Welfare recipient|0|||
143500786|NCT03686969|517374217|FG000|Overall Study|Study terminated|1|||
143500787|NCT03686969|517374218|FG001|Overall Study|Study terminated|0|||
143058214|NCT01701973|515751421|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
143058215|NCT01701973|515751422|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
143058216|NCT01701973|515751423|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
143058217|NCT01701973|515751424|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
143058218|NCT01701973|515751425|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
143500788|NCT00927563|517374220|FG000|Overall Study|Lost to Follow-up|1|||
143364950|NCT01076335|516878735|FG000|Overall Study|Withdrawal by Subject|3|||
143364951|NCT01076335|516878735|FG000|Overall Study|Withdrawal without treatment|1|||
143364952|NCT01835899|516878736|FG000|Overall Study|Adverse Event|0|||
143364953|NCT01835899|516878737|FG001|Overall Study|Adverse Event|0|||
143364954|NCT01835899|516878738|FG002|Overall Study|Adverse Event|1|||
143364955|NCT01835899|516878736|FG000|Overall Study|Other than stated above|0|||
143364956|NCT01835899|516878737|FG001|Overall Study|Other than stated above|1|||
143364957|NCT01835899|516878738|FG002|Overall Study|Other than stated above|0|||
143364958|NCT02616263|516878739|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
143364959|NCT02616263|516878740|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
143364960|NCT02616263|516878739|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
143364961|NCT02616263|516878740|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
143364962|NCT02616263|516878739|FG000|6 Month to 1.5 Year|Death|1|||
143364963|NCT02616263|516878740|FG001|6 Month to 1.5 Year|Death|0|||
143364964|NCT02616263|516878739|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
143364965|NCT02616263|516878740|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
143364966|NCT02616263|516878739|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
143364967|NCT02616263|516878740|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
143364968|NCT02616263|516878739|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
143364969|NCT02616263|516878740|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
143364970|NCT04939428|516878743|FG000|Overall Study|Death|0|||
143364971|NCT04939428|516878744|FG001|Overall Study|Death|1|||
143364972|NCT04939428|516878745|FG002|Overall Study|Death|0|||
143364973|NCT04939428|516878743|FG000|Overall Study|Lost to Follow-up|0|||
143364974|NCT04939428|516878744|FG001|Overall Study|Lost to Follow-up|5|||
143364975|NCT04939428|516878745|FG002|Overall Study|Lost to Follow-up|0|||
143364976|NCT04939428|516878743|FG000|Overall Study|Physician Decision|1|||
143364977|NCT04939428|516878744|FG001|Overall Study|Physician Decision|0|||
143364978|NCT04939428|516878745|FG002|Overall Study|Physician Decision|0|||
143364979|NCT04939428|516878743|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
143364980|NCT04939428|516878744|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
143364981|NCT04939428|516878745|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
143364982|NCT04939428|516878743|FG000|Overall Study|Withdrawal by Subject|10|||
143364983|NCT04939428|516878744|FG001|Overall Study|Withdrawal by Subject|11|||
143364984|NCT04939428|516878745|FG002|Overall Study|Withdrawal by Subject|0|||
143364985|NCT04939428|516878743|FG000|Overall Study|Unkown|6|||
143364986|NCT04939428|516878744|FG001|Overall Study|Unkown|3|||
143364987|NCT04939428|516878745|FG002|Overall Study|Unkown|0|||
143364988|NCT04939428|516878743|FG000|Overall Study|Discotinued per protocol|0|||
143364989|NCT04939428|516878744|FG001|Overall Study|Discotinued per protocol|0|||
143364990|NCT04939428|516878745|FG002|Overall Study|Discotinued per protocol|902|||
143364991|NCT04319094|516878748|FG000|Baseline|Lost to Follow-up|4|||
143364992|NCT04319094|516878749|FG001|Baseline|Lost to Follow-up|5|||
143364993|NCT04319094|516878748|FG000|Baseline|Protocol Violation|0|||
143364994|NCT04319094|516878749|FG001|Baseline|Protocol Violation|3|||
143364995|NCT04319094|516878748|FG000|Baseline|Withdrawal by Subject|2|||
143364996|NCT04319094|516878749|FG001|Baseline|Withdrawal by Subject|1|||
143364997|NCT04319094|516878748|FG000|Post-Intervention|Death|0|||
143364998|NCT04319094|516878749|FG001|Post-Intervention|Death|1|||
143364999|NCT04319094|516878748|FG000|Post-Intervention|Lost to Follow-up|4|||
143365000|NCT04319094|516878749|FG001|Post-Intervention|Lost to Follow-up|4|||
143365001|NCT04319094|516878748|FG000|Post-Intervention|Withdrawal by Subject|8|||
143365002|NCT04319094|516878749|FG001|Post-Intervention|Withdrawal by Subject|5|||
143365003|NCT04319094|516878748|FG000|Post-Intervention|Incomplete Data Collection|1|||
143500789|NCT00927563|517374220|FG000|Overall Study|Withdrawal by Subject|1|||
143500790|NCT00961961|517374221|FG000|Phase I|Withdrawal by Subject|7|||
143169924|NCT04887831|516171826|FG000|Overall Study|Other|1|||
143169925|NCT04887831|516171827|FG001|Overall Study|Other|0|||
143169926|NCT03396445|516171828|FG000|Treatment Period|Death|2|||
143169927|NCT03396445|516171829|FG001|Treatment Period|Death|2|||
143169928|NCT03396445|516171830|FG002|Treatment Period|Death|1|||
143169929|NCT03396445|516171831|FG003|Treatment Period|Death|1|||
143169930|NCT03396445|516171832|FG004|Treatment Period|Death|3|||
143169931|NCT03396445|516171833|FG005|Treatment Period|Death|2|||
143169932|NCT03396445|516171834|FG006|Treatment Period|Death|5|||
143169933|NCT03396445|516171835|FG007|Treatment Period|Death|3|||
143365004|NCT04319094|516878749|FG001|Post-Intervention|Incomplete Data Collection|3|||
143365005|NCT04319094|516878748|FG000|3-month|Death|1|||
143365006|NCT04319094|516878749|FG001|3-month|Death|0|||
143365007|NCT04319094|516878748|FG000|3-month|Lost to Follow-up|2|||
143365008|NCT04319094|516878749|FG001|3-month|Lost to Follow-up|2|||
143169934|NCT03396445|516171836|FG008|Treatment Period|Death|3|||
143169935|NCT03396445|516171837|FG009|Treatment Period|Death|3|||
143365009|NCT04319094|516878748|FG000|3-month|Withdrawal by Subject|0|||
143365010|NCT04319094|516878749|FG001|3-month|Withdrawal by Subject|3|||
143365011|NCT04319094|516878748|FG000|3-month|Incomplete data collection|9|||
143365012|NCT04319094|516878749|FG001|3-month|Incomplete data collection|7|||
143365013|NCT04319094|516878748|FG000|6-month|Lost to Follow-up|1|||
143500791|NCT00961961|517374222|FG001|Phase I|Withdrawal by Subject|0|||
143058219|NCT01701973|515751426|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
143058220|NCT02663882|515751429|FG000|Overall Study|Lost to Follow-up|4|||
143058221|NCT02663882|515751430|FG001|Overall Study|Lost to Follow-up|2|||
143058222|NCT04449341|515751433|FG000|Overall Study|Protocol Violation|1|||
143058223|NCT04449341|515751434|FG001|Overall Study|Protocol Violation|0|||
143058224|NCT04499482|515751435|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
143058225|NCT01899326|515751436|FG000|Overall Study|Withdrawal by Subject|1|||
143058226|NCT01899326|515751436|FG000|Overall Study|Adverse Event|2|||
143058227|NCT01899326|515751436|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
143058228|NCT03558139|515751438|FG000|Overall Study|Consent Withdrawn|1|||
143058229|NCT03558139|515751439|FG001|Overall Study|Consent Withdrawn|1|||
143058230|NCT03558139|515751440|FG002|Overall Study|Consent Withdrawn|4|||
143058231|NCT03558139|515751438|FG000|Overall Study|Death|5|||
143058232|NCT03558139|515751439|FG001|Overall Study|Death|3|||
143058233|NCT03558139|515751440|FG002|Overall Study|Death|8|||
143058234|NCT03558139|515751438|FG000|Overall Study|Lost to Follow-up|0|||
143058235|NCT03558139|515751439|FG001|Overall Study|Lost to Follow-up|0|||
143058236|NCT03558139|515751440|FG002|Overall Study|Lost to Follow-up|3|||
143058237|NCT03558139|515751438|FG000|Overall Study|Study Ended Per Protocol|0|||
143058238|NCT03558139|515751439|FG001|Overall Study|Study Ended Per Protocol|3|||
143058239|NCT03558139|515751440|FG002|Overall Study|Study Ended Per Protocol|6|||
143058240|NCT00551616|515751443|FG000|Overall Study|Lost to Follow-up|48|||
143058241|NCT00551616|515751444|FG001|Overall Study|Lost to Follow-up|40|||
143058242|NCT02808819|515751445|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
143058243|NCT02808819|515751446|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
143058244|NCT02808819|515751445|FG000|Overall Study|Withdrawal by Subject|10|||
143058245|NCT02808819|515751446|FG001|Overall Study|Withdrawal by Subject|13|||
143058246|NCT02808819|515751445|FG000|Overall Study|Site terminated by sponsor|2|||
143058247|NCT02808819|515751446|FG001|Overall Study|Site terminated by sponsor|0|||
143058248|NCT02808819|515751445|FG000|Overall Study|Pregnancy|1|||
143058249|NCT02808819|515751446|FG001|Overall Study|Pregnancy|0|||
143058250|NCT02808819|515751445|FG000|Overall Study|Lost to Follow-up|1|||
143058251|NCT02808819|515751446|FG001|Overall Study|Lost to Follow-up|6|||
143058252|NCT02808819|515751445|FG000|Overall Study|Protocol Violation|0|||
143058253|NCT02808819|515751446|FG001|Overall Study|Protocol Violation|1|||
143058254|NCT02808819|515751445|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
143058255|NCT02808819|515751446|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
143058256|NCT02808819|515751445|FG000|Overall Study|Death|1|||
143058257|NCT02808819|515751446|FG001|Overall Study|Death|0|||
143058258|NCT02808819|515751445|FG000|Overall Study|Adverse Event|3|||
143058259|NCT02808819|515751446|FG001|Overall Study|Adverse Event|4|||
143058260|NCT01083680|515751447|FG000|Overall Study|Lost to Follow-up|2758|||
143058261|NCT01083680|515751447|FG000|Overall Study|Withdrawal by Subject|1086|||
143058262|NCT02692482|515751448|FG000|Overall Study|Death|2|||
143058263|NCT02692482|515751449|FG001|Overall Study|Death|2|||
143058264|NCT02692482|515751448|FG000|Overall Study|Withdrawal by Subject|1|||
143058265|NCT02692482|515751449|FG001|Overall Study|Withdrawal by Subject|2|||
143058266|NCT01588548|515751455|FG000|Overall Study|Withdrawal by Subject|0|||
143058267|NCT01588548|515751456|FG001|Overall Study|Withdrawal by Subject|1|||
143058268|NCT01588548|515751457|FG002|Overall Study|Withdrawal by Subject|1|||
143058269|NCT01588548|515751458|FG003|Overall Study|Withdrawal by Subject|1|||
143058270|NCT01588548|515751459|FG004|Overall Study|Withdrawal by Subject|2|||
143058271|NCT01588548|515751460|FG005|Overall Study|Withdrawal by Subject|3|||
143058272|NCT01588548|515751455|FG000|Overall Study|Adverse Event|0|||
143058273|NCT01588548|515751456|FG001|Overall Study|Adverse Event|0|||
143058274|NCT01588548|515751457|FG002|Overall Study|Adverse Event|1|||
143500792|NCT00961961|517374223|FG002|Phase I|Withdrawal by Subject|0|||
143500793|NCT00961961|517374224|FG003|Phase I|Withdrawal by Subject|0|||
143500794|NCT00961961|517374221|FG000|Phase I|Lost to Follow-up|10|||
143500795|NCT00961961|517374222|FG001|Phase I|Lost to Follow-up|0|||
143500796|NCT00961961|517374223|FG002|Phase I|Lost to Follow-up|0|||
143500797|NCT00961961|517374224|FG003|Phase I|Lost to Follow-up|0|||
143500798|NCT00961961|517374221|FG000|Phase I|Lack of Efficacy|94|||
143058275|NCT01588548|515751458|FG003|Overall Study|Adverse Event|2|||
143058276|NCT01588548|515751459|FG004|Overall Study|Adverse Event|1|||
143058277|NCT01588548|515751460|FG005|Overall Study|Adverse Event|0|||
143058278|NCT01588548|515751455|FG000|Overall Study|Condition Under Investigation Worsened|3|||
143058279|NCT01588548|515751456|FG001|Overall Study|Condition Under Investigation Worsened|6|||
143058280|NCT01588548|515751457|FG002|Overall Study|Condition Under Investigation Worsened|4|||
143058281|NCT01588548|515751458|FG003|Overall Study|Condition Under Investigation Worsened|4|||
143058282|NCT01588548|515751459|FG004|Overall Study|Condition Under Investigation Worsened|3|||
143058283|NCT01588548|515751460|FG005|Overall Study|Condition Under Investigation Worsened|3|||
143058284|NCT00292227|515751461|FG000|Patch Period|Adverse Event|1|||
143058285|NCT00292227|515751462|FG001|Patch Period|Adverse Event|0|||
143058286|NCT00292227|515751463|FG002|Patch Period|Adverse Event|2|||
143500799|NCT00961961|517374222|FG001|Phase I|Lack of Efficacy|0|||
143500800|NCT00961961|517374223|FG002|Phase I|Lack of Efficacy|0|||
143500801|NCT00961961|517374224|FG003|Phase I|Lack of Efficacy|0|||
143500802|NCT00961961|517374221|FG000|Phase I|Adverse Event|7|||
143500803|NCT00961961|517374222|FG001|Phase I|Adverse Event|0|||
143500804|NCT00961961|517374223|FG002|Phase I|Adverse Event|0|||
143500805|NCT00961961|517374224|FG003|Phase I|Adverse Event|0|||
143500806|NCT00961961|517374221|FG000|Phase I|Physician Decision|8|||
143500807|NCT00961961|517374222|FG001|Phase I|Physician Decision|0|||
143500808|NCT00961961|517374223|FG002|Phase I|Physician Decision|0|||
143500809|NCT00961961|517374224|FG003|Phase I|Physician Decision|0|||
143500810|NCT00961961|517374221|FG000|Phase II|Lost to Follow-up|0|||
143058287|NCT00292227|515751461|FG000|Patch Period|Withdrawal by Subject|0|||
143058288|NCT00292227|515751462|FG001|Patch Period|Withdrawal by Subject|0|||
143500811|NCT00961961|517374222|FG001|Phase II|Lost to Follow-up|0|||
143500812|NCT00961961|517374223|FG002|Phase II|Lost to Follow-up|10|||
143500813|NCT00961961|517374224|FG003|Phase II|Lost to Follow-up|7|||
143058289|NCT00292227|515751463|FG002|Patch Period|Withdrawal by Subject|1|||
143058290|NCT01634854|515751466|FG000|Overall Study|Cesarean delivery|2|||
143058291|NCT01634854|515751467|FG001|Overall Study|Cesarean delivery|7|||
143058292|NCT03693950|515751469|FG000|Overall Study|Withdrawal by Subject|1|||
143058293|NCT03693950|515751470|FG001|Overall Study|Withdrawal by Subject|0|||
143058294|NCT01362296|515751471|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
143058295|NCT01362296|515751472|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
143058296|NCT01362296|515751473|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
143058297|NCT01362296|515751474|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
143365014|NCT04319094|516878749|FG001|6-month|Lost to Follow-up|1|||
143365015|NCT04319094|516878748|FG000|6-month|Withdrawal by Subject|0|||
143365016|NCT04319094|516878749|FG001|6-month|Withdrawal by Subject|3|||
143365017|NCT04319094|516878748|FG000|6-month|Incomplete data collection|14|||
143365018|NCT04319094|516878749|FG001|6-month|Incomplete data collection|9|||
143365019|NCT04319094|516878748|FG000|9-month|Lost to Follow-up|8|||
143365020|NCT04319094|516878749|FG001|9-month|Lost to Follow-up|4|||
143365021|NCT04319094|516878748|FG000|9-month|Withdrawal by Subject|0|||
143365022|NCT04319094|516878749|FG001|9-month|Withdrawal by Subject|1|||
143365023|NCT04319094|516878748|FG000|9-month|Incomplete data collection|8|||
143365024|NCT04319094|516878749|FG001|9-month|Incomplete data collection|5|||
143365025|NCT04319094|516878748|FG000|12-month|Lost to Follow-up|11|||
143365026|NCT04319094|516878749|FG001|12-month|Lost to Follow-up|8|||
143365027|NCT00654238|516878752|FG000|Overall Study|Screen Failures|4|||
143365028|NCT00614744|516878753|FG000|Overall Study|Lost to Follow-up|5|||
143365029|NCT00614744|516878754|FG001|Overall Study|Lost to Follow-up|4|||
143365030|NCT00614744|516878753|FG000|Overall Study|Incomplete for Behavior Issues|0|||
143365031|NCT00614744|516878754|FG001|Overall Study|Incomplete for Behavior Issues|2|||
143365032|NCT00877851|516878755|FG000|Overall Study|Lost to Follow-up|5|||
143365033|NCT00877851|516878756|FG001|Overall Study|Lost to Follow-up|5|||
143365034|NCT00877851|516878755|FG000|Overall Study|computer problem|3|||
143365035|NCT00877851|516878756|FG001|Overall Study|computer problem|0|||
143365036|NCT00877851|516878755|FG000|Overall Study|no longer interested in participating|1|||
143365037|NCT00877851|516878756|FG001|Overall Study|no longer interested in participating|0|||
143365038|NCT03424239|516878757|FG000|Overall Study|Withdrawal by Subject|2|||
143365039|NCT00318656|516878758|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
143365040|NCT00318656|516878759|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
143365041|NCT00318656|516878758|FG000|Overall Study|Did not receive any treatment|0|||
143365042|NCT00318656|516878759|FG001|Overall Study|Did not receive any treatment|1|||
143500814|NCT00961961|517374221|FG000|Phase II|Adverse Event|0|||
143500815|NCT00961961|517374222|FG001|Phase II|Adverse Event|0|||
143058298|NCT01362296|515751471|FG000|Randomized Phase (RP)|Physician Decision|1|||
143058299|NCT01362296|515751472|FG001|Randomized Phase (RP)|Physician Decision|9|||
143058300|NCT01362296|515751473|FG002|Randomized Phase (RP)|Physician Decision|0|||
143058301|NCT01362296|515751474|FG003|Randomized Phase (RP)|Physician Decision|0|||
143365043|NCT01446003|516878761|FG000|Period 1|Protocol Violation|2|||
143365044|NCT01446003|516878762|FG001|Period 1|Protocol Violation|0|||
143365045|NCT01446003|516878761|FG000|Period 2|Adverse Event|1|||
143500816|NCT00961961|517374223|FG002|Phase II|Adverse Event|0|||
143500817|NCT00961961|517374224|FG003|Phase II|Adverse Event|1|||
143500818|NCT00961961|517374221|FG000|Phase II|Physician Decision|0|||
143500819|NCT00961961|517374222|FG001|Phase II|Physician Decision|0|||
143500820|NCT00961961|517374223|FG002|Phase II|Physician Decision|1|||
143500821|NCT00961961|517374224|FG003|Phase II|Physician Decision|0|||
143058302|NCT01362296|515751471|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
143058303|NCT01362296|515751472|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
143058304|NCT01362296|515751473|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
143365046|NCT01446003|516878762|FG001|Period 2|Adverse Event|0|||
143365047|NCT03905135|516878763|FG000|Dose Escalation|Adverse Event|1|||
143365048|NCT03905135|516878764|FG001|Dose Escalation|Adverse Event|1|||
143365049|NCT03905135|516878763|FG000|Dose Escalation|Progressive disease|3|||
143365050|NCT03905135|516878764|FG001|Dose Escalation|Progressive disease|1|||
143500822|NCT00961961|517374221|FG000|Phase II|Withdrawal by Subject|0|||
143500823|NCT00961961|517374222|FG001|Phase II|Withdrawal by Subject|0|||
143058305|NCT01362296|515751474|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
143058306|NCT01362296|515751471|FG000|Randomized Phase (RP)|Adverse Event|20|||
143058307|NCT01362296|515751472|FG001|Randomized Phase (RP)|Adverse Event|4|||
143058308|NCT01362296|515751473|FG002|Randomized Phase (RP)|Adverse Event|0|||
143058309|NCT01362296|515751474|FG003|Randomized Phase (RP)|Adverse Event|0|||
143058310|NCT01362296|515751471|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
143058311|NCT01362296|515751472|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
143058312|NCT01362296|515751473|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
143058313|NCT01362296|515751474|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
143058314|NCT01362296|515751471|FG000|Crossover Phase|PD including Death due to PD|0|||
143058315|NCT01362296|515751472|FG001|Crossover Phase|PD including Death due to PD|0|||
143058316|NCT01362296|515751473|FG002|Crossover Phase|PD including Death due to PD|16|||
143058317|NCT01362296|515751474|FG003|Crossover Phase|PD including Death due to PD|1|||
143058318|NCT01362296|515751471|FG000|Crossover Phase|Withdrawal by Subject|0|||
143058319|NCT01362296|515751472|FG001|Crossover Phase|Withdrawal by Subject|0|||
143058320|NCT01362296|515751473|FG002|Crossover Phase|Withdrawal by Subject|2|||
143058321|NCT01362296|515751474|FG003|Crossover Phase|Withdrawal by Subject|1|||
143058322|NCT01362296|515751471|FG000|Crossover Phase|Adverse Event|0|||
143058323|NCT01362296|515751472|FG001|Crossover Phase|Adverse Event|0|||
143058324|NCT01362296|515751473|FG002|Crossover Phase|Adverse Event|4|||
143058325|NCT01362296|515751474|FG003|Crossover Phase|Adverse Event|0|||
143058326|NCT01362296|515751471|FG000|Crossover Phase|Study Closed/Terminated|0|||
143058327|NCT01362296|515751472|FG001|Crossover Phase|Study Closed/Terminated|0|||
143058328|NCT01362296|515751473|FG002|Crossover Phase|Study Closed/Terminated|1|||
143058329|NCT01362296|515751474|FG003|Crossover Phase|Study Closed/Terminated|0|||
143058330|NCT00739973|515751475|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
143058331|NCT00739973|515751476|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
143058332|NCT00739973|515751477|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
143058333|NCT00739973|515751478|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
143058334|NCT00739973|515751479|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
143058335|NCT00739973|515751480|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
143058336|NCT00739973|515751481|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
143058337|NCT00739973|515751482|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
143058338|NCT00739973|515751483|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
143058339|NCT00739973|515751475|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
143058340|NCT00739973|515751476|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
143058341|NCT00739973|515751477|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
143058342|NCT00739973|515751478|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
143058343|NCT00739973|515751479|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
143058344|NCT00739973|515751480|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
143058345|NCT00739973|515751481|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
143058346|NCT00739973|515751482|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
143058347|NCT00739973|515751483|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
143058348|NCT00739973|515751475|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
143058349|NCT00739973|515751476|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
143058350|NCT00739973|515751477|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
143058351|NCT00739973|515751478|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
143058352|NCT00739973|515751479|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
143058353|NCT00739973|515751480|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
143058354|NCT00739973|515751481|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
143058355|NCT00739973|515751482|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
143058356|NCT00739973|515751483|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
143058357|NCT00739973|515751475|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
143058358|NCT00739973|515751476|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
143058359|NCT00739973|515751477|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
143058360|NCT00739973|515751478|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
143058361|NCT00739973|515751479|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
143058362|NCT00739973|515751480|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
143058363|NCT00739973|515751481|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
143058364|NCT00739973|515751482|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
143365051|NCT03905135|516878763|FG000|Dose Escalation|Intercurrent illness|1|||
143058365|NCT00739973|515751483|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
143169936|NCT03396445|516171838|FG010|Treatment Period|Death|7|||
143058366|NCT00739973|515751475|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
143058367|NCT00739973|515751476|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
143058368|NCT00739973|515751477|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
143058369|NCT00739973|515751478|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
143500824|NCT00961961|517374223|FG002|Phase II|Withdrawal by Subject|1|||
143500825|NCT00961961|517374224|FG003|Phase II|Withdrawal by Subject|0|||
143058370|NCT00739973|515751479|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
143058371|NCT00739973|515751480|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
143058372|NCT00739973|515751481|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
143058373|NCT00739973|515751482|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
143058374|NCT00739973|515751483|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
143058375|NCT00739973|515751475|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
143058376|NCT00739973|515751476|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
143058377|NCT00739973|515751477|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
143058378|NCT00739973|515751478|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
143058379|NCT00739973|515751479|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
143058380|NCT00739973|515751480|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
143058381|NCT00739973|515751481|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
143058382|NCT00739973|515751482|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
143058383|NCT00739973|515751483|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
143058384|NCT00739973|515751475|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
143058385|NCT00739973|515751476|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
143058386|NCT00739973|515751477|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
143058387|NCT00739973|515751478|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
143058388|NCT00739973|515751479|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
143058389|NCT00739973|515751480|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
143058390|NCT00739973|515751481|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
143058391|NCT00739973|515751482|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
143058392|NCT00739973|515751483|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
143058393|NCT00739973|515751475|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
143058394|NCT00739973|515751476|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
143058395|NCT00739973|515751477|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
143058396|NCT00739973|515751478|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
143058397|NCT00739973|515751479|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
143058398|NCT00739973|515751480|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
143058399|NCT00739973|515751481|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
143058400|NCT00739973|515751482|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
143058401|NCT00739973|515751483|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
143058402|NCT00739973|515751475|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
143058403|NCT00739973|515751476|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
143058404|NCT00739973|515751477|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
143058405|NCT00739973|515751478|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
143058406|NCT00739973|515751479|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
143058407|NCT00739973|515751480|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
143058408|NCT00739973|515751481|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
143058409|NCT00739973|515751482|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
143058410|NCT00739973|515751483|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
143058411|NCT00739973|515751475|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
143058412|NCT00739973|515751476|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
143058413|NCT00739973|515751477|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
143058414|NCT00739973|515751478|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
143058415|NCT00739973|515751479|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
143058416|NCT00739973|515751480|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
143058417|NCT00739973|515751481|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
143058418|NCT00739973|515751482|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
143058419|NCT00739973|515751483|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
143058420|NCT00739973|515751475|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
143058421|NCT00739973|515751476|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
143058422|NCT00739973|515751477|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
143058423|NCT00739973|515751478|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
143058424|NCT00739973|515751479|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
143058425|NCT00739973|515751480|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
143058426|NCT00739973|515751481|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
143365052|NCT03905135|516878764|FG001|Dose Escalation|Intercurrent illness|0|||
143365053|NCT00490555|516878765|FG000|Overall Study|noncompliant with drug administration|0|||
143500826|NCT01412957|517374225|FG000|Overall Study|Withdrawal by Subject|6|||
143500827|NCT01412957|517374226|FG001|Overall Study|Withdrawal by Subject|22|||
143500828|NCT01412957|517374225|FG000|Overall Study|Lost to Follow-up|7|||
143500829|NCT01412957|517374226|FG001|Overall Study|Lost to Follow-up|2|||
143500830|NCT01412957|517374225|FG000|Overall Study|Death|136|||
143500831|NCT01412957|517374226|FG001|Overall Study|Death|133|||
143500832|NCT01245673|517374227|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
143500833|NCT03186989|517374228|FG000|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
143500834|NCT03186989|517374229|FG001|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
143500835|NCT03186989|517374230|FG002|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
143500836|NCT03186989|517374231|FG003|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
143500837|NCT03186989|517374232|FG004|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
143500838|NCT03186989|517374233|FG005|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
143500839|NCT03186989|517374234|FG006|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
143500840|NCT03186989|517374235|FG007|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
143058427|NCT00739973|515751482|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
143058428|NCT00739973|515751483|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
143058429|NCT00739973|515751475|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
143058430|NCT00739973|515751476|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
143058431|NCT00739973|515751477|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
143058432|NCT00739973|515751478|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
143058433|NCT00739973|515751479|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
143058434|NCT00739973|515751480|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
143058435|NCT00739973|515751481|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
143058436|NCT00739973|515751482|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
143058437|NCT00739973|515751483|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
143058438|NCT00739973|515751475|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
143058439|NCT00739973|515751476|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
143058440|NCT00739973|515751477|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
143058441|NCT00739973|515751478|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
143058442|NCT00739973|515751479|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
143058443|NCT00739973|515751480|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
143058444|NCT00739973|515751481|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
143058445|NCT00739973|515751482|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
143058446|NCT00739973|515751483|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
143058447|NCT00739973|515751475|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
143058448|NCT00739973|515751476|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
143058449|NCT00739973|515751477|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
143058450|NCT00739973|515751478|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
143058451|NCT00739973|515751479|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
143058452|NCT00739973|515751480|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
143058453|NCT00739973|515751481|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
143058454|NCT00739973|515751482|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
143058455|NCT00739973|515751483|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
143058456|NCT00739973|515751475|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
143058457|NCT00739973|515751476|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
143058458|NCT00739973|515751477|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
143058459|NCT00739973|515751478|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
143058460|NCT00739973|515751479|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
143058461|NCT00739973|515751480|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
143058462|NCT00739973|515751481|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
143058463|NCT00739973|515751482|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
143058464|NCT00739973|515751483|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
143058465|NCT00739973|515751475|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
143058466|NCT00739973|515751476|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
143058467|NCT00739973|515751477|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
143058468|NCT00739973|515751478|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
143058469|NCT00739973|515751479|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
143058470|NCT00739973|515751480|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
143058471|NCT00739973|515751481|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
143058472|NCT00739973|515751482|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
143058473|NCT00739973|515751483|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
143169937|NCT03396445|516171839|FG011|Treatment Period|Death|12|||
143058474|NCT00739973|515751475|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
143058475|NCT00739973|515751476|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
143500841|NCT03186989|517374236|FG008|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
143500842|NCT03186989|517374237|FG009|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
143500843|NCT03186989|517374238|FG010|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
143500844|NCT03186989|517374228|FG000|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
143500845|NCT03186989|517374229|FG001|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
143500846|NCT03186989|517374230|FG002|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
143500847|NCT03186989|517374231|FG003|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
143058476|NCT00739973|515751477|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
143058477|NCT00739973|515751478|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
143058478|NCT00739973|515751479|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
143058479|NCT00739973|515751480|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
143058480|NCT00739973|515751481|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
143058481|NCT00739973|515751482|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
143058482|NCT00739973|515751483|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
143058483|NCT02219308|515751484|FG000|Overall Study|Withdrawal by Subject|1|||
143058484|NCT02219308|515751485|FG001|Overall Study|Withdrawal by Subject|2|||
143058485|NCT02688387|515753180|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
143058486|NCT02688387|515753181|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
143058487|NCT02688387|515753182|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
143058488|NCT02688387|515753183|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
143058489|NCT02688387|515753184|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
143058490|NCT02688387|515753185|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
143058491|NCT02688387|515753186|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
143058492|NCT02688387|515753187|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
143058493|NCT02688387|515753188|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
143058494|NCT02688387|515753189|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
143058495|NCT02688387|515753190|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
143058496|NCT02688387|515753191|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
143058497|NCT02688387|515753192|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
143058498|NCT02688387|515753193|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
143058499|NCT02688387|515753194|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
143058500|NCT02688387|515753195|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
143058501|NCT02688387|515753196|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
143058502|NCT02688387|515753197|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
143058503|NCT02688387|515753198|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
143058504|NCT02688387|515753199|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
143058505|NCT02688387|515753200|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
143058506|NCT02688387|515753201|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
143058507|NCT02688387|515753180|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058508|NCT02688387|515753181|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058509|NCT02688387|515753182|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058510|NCT02688387|515753183|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
143058511|NCT02688387|515753184|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143500848|NCT03186989|517374232|FG004|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
143500849|NCT03186989|517374233|FG005|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|1|||
143500850|NCT03186989|517374234|FG006|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
143500851|NCT03186989|517374235|FG007|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
143058512|NCT02688387|515753185|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058513|NCT02688387|515753186|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058514|NCT02688387|515753187|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058515|NCT02688387|515753188|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058516|NCT02688387|515753189|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058517|NCT02688387|515753190|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058518|NCT02688387|515753191|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058519|NCT02688387|515753192|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058520|NCT02688387|515753193|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058521|NCT02688387|515753194|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058522|NCT02688387|515753195|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058523|NCT02688387|515753196|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058524|NCT02688387|515753197|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058525|NCT02688387|515753198|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058526|NCT02688387|515753199|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143365054|NCT00490555|516878766|FG001|Overall Study|noncompliant with drug administration|0|||
143058527|NCT02688387|515753200|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058528|NCT02688387|515753201|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058529|NCT02688387|515753180|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
143058530|NCT02688387|515753181|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
143058531|NCT02688387|515753182|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
143058532|NCT02688387|515753183|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
143058533|NCT02688387|515753184|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
143500852|NCT03186989|517374236|FG008|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
143500853|NCT03186989|517374237|FG009|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
143500854|NCT03186989|517374238|FG010|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
143500855|NCT03186989|517374228|FG000|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
143500856|NCT03186989|517374229|FG001|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
143500857|NCT03186989|517374230|FG002|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
143500858|NCT03186989|517374231|FG003|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
143500859|NCT03186989|517374232|FG004|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
143500860|NCT03186989|517374233|FG005|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
143500861|NCT03186989|517374234|FG006|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|1|||
143500862|NCT03186989|517374235|FG007|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
143500863|NCT03186989|517374236|FG008|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
143500864|NCT03186989|517374237|FG009|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
143500865|NCT03186989|517374238|FG010|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
143500866|NCT03186989|517374228|FG000|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
143500867|NCT03186989|517374229|FG001|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
143500868|NCT03186989|517374230|FG002|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
143500869|NCT03186989|517374231|FG003|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
143500870|NCT03186989|517374232|FG004|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
143500871|NCT03186989|517374233|FG005|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
143500872|NCT03186989|517374234|FG006|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
143500873|NCT03186989|517374235|FG007|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
143500874|NCT03186989|517374236|FG008|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
143500875|NCT03186989|517374237|FG009|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
143500876|NCT03186989|517374238|FG010|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
143500877|NCT00413959|517374239|FG000|Overall Study|Pt had only one cycle.|1|||
143058534|NCT02688387|515753185|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
143058535|NCT02688387|515753186|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
143058536|NCT02688387|515753187|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
143058537|NCT02688387|515753188|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
143058538|NCT02688387|515753189|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
143058539|NCT02688387|515753190|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
143058540|NCT02688387|515753191|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
143058541|NCT02688387|515753192|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
143058542|NCT02688387|515753193|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
143058543|NCT02688387|515753194|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
143058544|NCT02688387|515753195|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
143058545|NCT02688387|515753196|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
143058546|NCT02688387|515753197|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
143058547|NCT02688387|515753198|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
143058548|NCT02688387|515753199|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
143058549|NCT02688387|515753200|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
143058550|NCT02688387|515753201|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
143058551|NCT02688387|515753180|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
143058552|NCT02688387|515753181|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
143058553|NCT02688387|515753182|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
143058554|NCT02688387|515753183|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
143058555|NCT02688387|515753184|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
143500878|NCT02078219|517374245|FG000|Overall Study|Other|2|||
143500879|NCT02078219|517374246|FG001|Overall Study|Other|2|||
143500880|NCT02078219|517374247|FG002|Overall Study|Other|3|||
143500881|NCT02078219|517374248|FG003|Overall Study|Other|0|||
143500882|NCT02078219|517374249|FG004|Overall Study|Other|1|||
143500883|NCT02078219|517374245|FG000|Overall Study|Withdrawal by Subject|0|||
143500884|NCT02078219|517374246|FG001|Overall Study|Withdrawal by Subject|1|||
143500885|NCT02078219|517374247|FG002|Overall Study|Withdrawal by Subject|0|||
143500886|NCT02078219|517374248|FG003|Overall Study|Withdrawal by Subject|1|||
143500887|NCT02078219|517374249|FG004|Overall Study|Withdrawal by Subject|1|||
143500888|NCT02078219|517374245|FG000|Overall Study|Protocol Violation|0|||
143058556|NCT02688387|515753185|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
143058557|NCT02688387|515753186|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
143058558|NCT02688387|515753187|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
143058559|NCT02688387|515753188|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
143058560|NCT02688387|515753189|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
143058561|NCT02688387|515753190|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
143058562|NCT02688387|515753191|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
143058563|NCT02688387|515753192|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
143058564|NCT02688387|515753193|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
143058565|NCT02688387|515753194|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
143058566|NCT02688387|515753195|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
143058567|NCT02688387|515753196|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
143058568|NCT02688387|515753197|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
143058569|NCT02688387|515753198|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
143058570|NCT02688387|515753199|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
143058571|NCT02688387|515753200|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
143058572|NCT02688387|515753201|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
143365055|NCT00490555|516878767|FG002|Overall Study|noncompliant with drug administration|2|||
143365056|NCT00490555|516878768|FG003|Overall Study|noncompliant with drug administration|0|||
143365057|NCT02042443|516878771|FG000|Overall Study|Adverse Event|2|||
143058573|NCT02688387|515753180|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
143058574|NCT02688387|515753181|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
143058575|NCT02688387|515753182|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
143058576|NCT02688387|515753183|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
143058577|NCT02688387|515753184|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
143058578|NCT02688387|515753185|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
143058579|NCT02688387|515753186|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
143058580|NCT02688387|515753187|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
143058581|NCT02688387|515753188|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
143058582|NCT02688387|515753189|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
143058583|NCT02688387|515753190|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
143058584|NCT02688387|515753191|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
143058585|NCT02688387|515753192|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
143058586|NCT02688387|515753193|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
143058587|NCT02688387|515753194|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
143058588|NCT02688387|515753195|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
143058589|NCT02688387|515753196|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
143058590|NCT02688387|515753197|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
143058591|NCT02688387|515753198|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
143058592|NCT02688387|515753199|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
143058593|NCT02688387|515753200|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
143058594|NCT02688387|515753201|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
143058595|NCT02688387|515753180|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
143058596|NCT02688387|515753181|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
143058597|NCT02688387|515753182|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
143058598|NCT02688387|515753183|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
143058599|NCT02688387|515753184|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
143058600|NCT02688387|515753185|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
143058601|NCT02688387|515753186|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
143058602|NCT02688387|515753187|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
143058603|NCT02688387|515753188|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
143058604|NCT02688387|515753189|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
143058605|NCT02688387|515753190|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
143058606|NCT02688387|515753191|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
143058607|NCT02688387|515753192|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
143058608|NCT02688387|515753193|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
143169938|NCT03396445|516171840|FG012|Treatment Period|Death|28|||
143365058|NCT02042443|516878772|FG001|Overall Study|Adverse Event|1|||
143500889|NCT02078219|517374246|FG001|Overall Study|Protocol Violation|0|||
143500890|NCT02078219|517374247|FG002|Overall Study|Protocol Violation|0|||
143500891|NCT02078219|517374248|FG003|Overall Study|Protocol Violation|1|||
143500892|NCT02078219|517374249|FG004|Overall Study|Protocol Violation|0|||
143500893|NCT02078219|517374245|FG000|Overall Study|Death|0|||
143058609|NCT02688387|515753194|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
143058610|NCT02688387|515753195|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
143058611|NCT02688387|515753196|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
143058612|NCT02688387|515753197|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
143058613|NCT02688387|515753198|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
143058614|NCT02688387|515753199|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
143058615|NCT02688387|515753200|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
143058616|NCT02688387|515753201|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
143058617|NCT02688387|515753180|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058618|NCT02688387|515753181|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058619|NCT02688387|515753182|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058620|NCT02688387|515753183|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058621|NCT02688387|515753184|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058622|NCT02688387|515753185|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058623|NCT02688387|515753186|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058624|NCT02688387|515753187|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058625|NCT02688387|515753188|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058626|NCT02688387|515753189|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058627|NCT02688387|515753190|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058628|NCT02688387|515753191|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058629|NCT02688387|515753192|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058630|NCT02688387|515753193|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058631|NCT02688387|515753194|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
143058632|NCT02688387|515753195|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058633|NCT02688387|515753196|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058634|NCT02688387|515753197|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058635|NCT02688387|515753198|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058636|NCT02688387|515753199|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058637|NCT02688387|515753200|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143500894|NCT02078219|517374246|FG001|Overall Study|Death|0|||
143500895|NCT02078219|517374247|FG002|Overall Study|Death|0|||
143500896|NCT02078219|517374248|FG003|Overall Study|Death|1|||
143500897|NCT02078219|517374249|FG004|Overall Study|Death|0|||
143500898|NCT02078219|517374245|FG000|Overall Study|Adverse Event|1|||
143500899|NCT02078219|517374246|FG001|Overall Study|Adverse Event|1|||
143500900|NCT02078219|517374247|FG002|Overall Study|Adverse Event|3|||
143500901|NCT02078219|517374248|FG003|Overall Study|Adverse Event|1|||
143500902|NCT02078219|517374249|FG004|Overall Study|Adverse Event|0|||
143500903|NCT03136107|517374256|FG000|Overall Study|Other (Not specified)|1|||
143500904|NCT03283085|517374257|FG000|Overall Study|Adverse Event|18|||
143500905|NCT03283085|517374258|FG001|Overall Study|Adverse Event|3|||
143500906|NCT03283085|517374259|FG002|Overall Study|Adverse Event|13|||
143500907|NCT03283085|517374260|FG003|Overall Study|Adverse Event|0|||
143500908|NCT03283085|517374261|FG004|Overall Study|Adverse Event|0|||
143500909|NCT03283085|517374262|FG005|Overall Study|Adverse Event|5|||
143500910|NCT03283085|517374257|FG000|Overall Study|Death|0|||
143500911|NCT03283085|517374258|FG001|Overall Study|Death|0|||
143500912|NCT03283085|517374259|FG002|Overall Study|Death|3|||
143058638|NCT02688387|515753201|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
143058639|NCT02688387|515753180|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
143058640|NCT02688387|515753181|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
143058641|NCT02688387|515753182|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
143058642|NCT02688387|515753183|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
143058643|NCT02688387|515753184|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
143058644|NCT02688387|515753185|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
143058645|NCT02688387|515753186|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
143058646|NCT02688387|515753187|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
143058647|NCT02688387|515753188|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
143058648|NCT02688387|515753189|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
143058649|NCT02688387|515753190|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
143058650|NCT02688387|515753191|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
143058651|NCT02688387|515753192|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
143169939|NCT03396445|516171841|FG013|Treatment Period|Death|14|||
143500913|NCT03283085|517374260|FG003|Overall Study|Death|1|||
143500914|NCT03283085|517374261|FG004|Overall Study|Death|0|||
143500915|NCT03283085|517374262|FG005|Overall Study|Death|0|||
143500916|NCT03283085|517374257|FG000|Overall Study|Withdrawal by Subject|42|||
143500917|NCT03283085|517374258|FG001|Overall Study|Withdrawal by Subject|21|||
143500918|NCT03283085|517374259|FG002|Overall Study|Withdrawal by Subject|66|||
143500919|NCT03283085|517374260|FG003|Overall Study|Withdrawal by Subject|3|||
143058652|NCT02688387|515753193|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
143058653|NCT02688387|515753194|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
143058654|NCT02688387|515753195|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
143058655|NCT02688387|515753196|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
143058656|NCT02688387|515753197|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
143058657|NCT02688387|515753198|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
143058658|NCT02688387|515753199|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
143058659|NCT02688387|515753200|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
143058660|NCT02688387|515753201|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
143058661|NCT02688387|515753180|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
143058662|NCT02688387|515753181|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
143058663|NCT02688387|515753182|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
143058664|NCT02688387|515753183|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
143058665|NCT02688387|515753184|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
143058666|NCT02688387|515753185|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
143058667|NCT02688387|515753186|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
143058668|NCT02688387|515753187|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
143058669|NCT02688387|515753188|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
143058670|NCT02688387|515753189|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
143058671|NCT02688387|515753190|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
143058672|NCT02688387|515753191|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
143058673|NCT02688387|515753192|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
143058674|NCT02688387|515753193|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
143058675|NCT02688387|515753194|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
143058676|NCT02688387|515753195|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
143058677|NCT02688387|515753196|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
143058678|NCT02688387|515753197|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
143058679|NCT02688387|515753198|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
143058680|NCT02688387|515753199|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
143058681|NCT02688387|515753200|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
143058682|NCT02688387|515753201|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
143058683|NCT02688387|515753180|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
143058684|NCT02688387|515753181|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
143058685|NCT02688387|515753182|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
143058686|NCT02688387|515753183|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
143058687|NCT02688387|515753184|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
143058688|NCT02688387|515753185|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
143058689|NCT02688387|515753186|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
143058690|NCT02688387|515753187|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
143058691|NCT02688387|515753188|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
143058692|NCT02688387|515753189|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
143058693|NCT02688387|515753190|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
143058694|NCT02688387|515753191|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
143058695|NCT02688387|515753192|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
143058696|NCT02688387|515753193|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
143058697|NCT02688387|515753194|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
143058698|NCT02688387|515753195|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
143058699|NCT02688387|515753196|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
143058700|NCT02688387|515753197|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
143058701|NCT02688387|515753198|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
143058702|NCT02688387|515753199|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
143058703|NCT02688387|515753200|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
143058704|NCT02688387|515753201|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
143058705|NCT00802178|515753202|FG000|Overall Study|Lack of Efficacy|36|||
143058706|NCT00802178|515753202|FG000|Overall Study|Insufficient tolerability (IT)|17|||
143058707|NCT00802178|515753202|FG000|Overall Study|Withdrawal by Subject|18|||
143058708|NCT00802178|515753202|FG000|Overall Study|Other|32|||
143058709|NCT00802178|515753202|FG000|Overall Study|Lack of efficacy and patient wish|1|||
143058710|NCT00802178|515753202|FG000|Overall Study|IT and patient wish|8|||
143058711|NCT00802178|515753202|FG000|Overall Study|Patients wish and other reason|1|||
143058712|NCT00831233|515753203|FG000|Overall Study|Adverse Event|0|||
143058713|NCT00831233|515753204|FG001|Overall Study|Adverse Event|1|||
143058714|NCT00831233|515753203|FG000|Overall Study|Protocol Violation|1|||
143058715|NCT00831233|515753204|FG001|Overall Study|Protocol Violation|0|||
143058716|NCT00831233|515753203|FG000|Overall Study|Selection Criteria Not Met|2|||
143058717|NCT00831233|515753204|FG001|Overall Study|Selection Criteria Not Met|0|||
143058718|NCT01976728|515753205|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
143058719|NCT01976728|515753206|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
143058720|NCT01976728|515753207|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
143058721|NCT01976728|515753208|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
143058722|NCT02356211|515753209|FG000|Overall Study|Withdrawal by Subject|2|||
143058723|NCT02356211|515753210|FG001|Overall Study|Withdrawal by Subject|2|||
143058724|NCT02356211|515753209|FG000|Overall Study|ineligible|1|||
143058725|NCT02356211|515753210|FG001|Overall Study|ineligible|8|||
143058726|NCT02211014|515753211|FG000|Overall Study|Adverse Event|0|||
143058727|NCT02211014|515753212|FG001|Overall Study|Adverse Event|2|||
143058728|NCT02211014|515753211|FG000|Overall Study|Physician Decision|1|||
143365059|NCT02042443|516878771|FG000|Overall Study|Withdrawal by Subject|0|||
143365060|NCT02042443|516878772|FG001|Overall Study|Withdrawal by Subject|1|||
143500920|NCT03283085|517374261|FG004|Overall Study|Withdrawal by Subject|3|||
143500921|NCT03283085|517374262|FG005|Overall Study|Withdrawal by Subject|5|||
143500922|NCT03283085|517374257|FG000|Overall Study|Physician Decision|14|||
143500923|NCT03283085|517374258|FG001|Overall Study|Physician Decision|8|||
143500924|NCT03283085|517374259|FG002|Overall Study|Physician Decision|19|||
143500925|NCT03283085|517374260|FG003|Overall Study|Physician Decision|0|||
143500926|NCT03283085|517374261|FG004|Overall Study|Physician Decision|0|||
143500927|NCT03283085|517374262|FG005|Overall Study|Physician Decision|2|||
143500928|NCT03283085|517374257|FG000|Overall Study|Site Terminated by Sponsor|1|||
143500929|NCT03283085|517374258|FG001|Overall Study|Site Terminated by Sponsor|0|||
143500930|NCT03283085|517374259|FG002|Overall Study|Site Terminated by Sponsor|3|||
143500931|NCT03283085|517374260|FG003|Overall Study|Site Terminated by Sponsor|0|||
143500932|NCT03283085|517374261|FG004|Overall Study|Site Terminated by Sponsor|0|||
143500933|NCT03283085|517374262|FG005|Overall Study|Site Terminated by Sponsor|0|||
143500934|NCT03283085|517374257|FG000|Overall Study|Lost to Follow-up|2|||
143500935|NCT03283085|517374258|FG001|Overall Study|Lost to Follow-up|0|||
143500936|NCT03283085|517374259|FG002|Overall Study|Lost to Follow-up|2|||
143500937|NCT03283085|517374260|FG003|Overall Study|Lost to Follow-up|0|||
143500938|NCT03283085|517374261|FG004|Overall Study|Lost to Follow-up|0|||
143500939|NCT03283085|517374262|FG005|Overall Study|Lost to Follow-up|1|||
143500940|NCT03283085|517374257|FG000|Overall Study|Pregnancy|0|||
143500941|NCT03283085|517374258|FG001|Overall Study|Pregnancy|0|||
143500942|NCT03283085|517374259|FG002|Overall Study|Pregnancy|1|||
143500943|NCT03283085|517374260|FG003|Overall Study|Pregnancy|0|||
143500944|NCT03283085|517374261|FG004|Overall Study|Pregnancy|0|||
143500945|NCT03283085|517374262|FG005|Overall Study|Pregnancy|0|||
143500946|NCT03283085|517374257|FG000|Overall Study|Lack of Efficacy|12|||
143500947|NCT03283085|517374258|FG001|Overall Study|Lack of Efficacy|6|||
143500948|NCT03283085|517374259|FG002|Overall Study|Lack of Efficacy|24|||
143500949|NCT03283085|517374260|FG003|Overall Study|Lack of Efficacy|1|||
143500950|NCT03283085|517374261|FG004|Overall Study|Lack of Efficacy|1|||
143500951|NCT03283085|517374262|FG005|Overall Study|Lack of Efficacy|0|||
143500952|NCT03283085|517374257|FG000|Overall Study|Reason not Specified|0|||
143500953|NCT03283085|517374258|FG001|Overall Study|Reason not Specified|4|||
143500954|NCT03283085|517374259|FG002|Overall Study|Reason not Specified|8|||
143500955|NCT03283085|517374260|FG003|Overall Study|Reason not Specified|0|||
143500956|NCT03283085|517374261|FG004|Overall Study|Reason not Specified|0|||
143500957|NCT03283085|517374262|FG005|Overall Study|Reason not Specified|1|||
143500958|NCT02292771|517374266|FG000|Overall Study|Withdrawal by Subject|2|||
143500959|NCT02292771|517374267|FG001|Overall Study|Withdrawal by Subject|1|||
143500960|NCT02292771|517374266|FG000|Overall Study|Lost to Follow-up|2|||
143500961|NCT02292771|517374267|FG001|Overall Study|Lost to Follow-up|1|||
143500962|NCT01468311|517374268|FG000|Overall Study|mobilization failure|1|||
143500963|NCT01468311|517374268|FG000|Overall Study|Withdrawal by Subject|1|||
143500964|NCT00224016|517376083|FG000|Titration Period|Withdrawal by Subject|0|||
143500965|NCT00224016|517376084|FG001|Titration Period|Withdrawal by Subject|1|||
143500966|NCT00224016|517376083|FG000|Titration Period|Lost to Follow-up|1|||
143500967|NCT00224016|517376084|FG001|Titration Period|Lost to Follow-up|0|||
143500968|NCT00224016|517376083|FG000|Maintenance Period|Withdrawal by Subject|2|||
143500969|NCT00224016|517376084|FG001|Maintenance Period|Withdrawal by Subject|0|||
143500970|NCT00224016|517376083|FG000|Maintenance Period|Lost to Follow-up|0|||
143500971|NCT00224016|517376084|FG001|Maintenance Period|Lost to Follow-up|1|||
143500972|NCT01524991|517376085|FG000|Overall Study|Adverse Event|12|||
143500973|NCT01524991|517376085|FG000|Overall Study|Death|1|||
143500974|NCT01524991|517376085|FG000|Overall Study|Disease ProgressionDu|17|||
143500975|NCT01524991|517376085|FG000|Overall Study|Other complicating disease|1|||
143365061|NCT02042443|516878771|FG000|Overall Study|Progression|21|||
143500976|NCT01524991|517376085|FG000|Overall Study|Withdrawal by Subject|2|||
143058729|NCT02211014|515753212|FG001|Overall Study|Physician Decision|2|||
143500977|NCT01524991|517376085|FG000|Overall Study|Symptomatic Deterioration|1|||
143058730|NCT02211014|515753211|FG000|Overall Study|Started another cancer therapy|1|||
143058731|NCT02211014|515753212|FG001|Overall Study|Started another cancer therapy|0|||
143058732|NCT02211014|515753211|FG000|Overall Study|Withdrawal by Subject|0|||
143500978|NCT01805180|517376086|FG000|Lead-in Donor Phase|screen failure|1|||
143500979|NCT01805180|517376087|FG001|Lead-in Donor Phase|screen failure|0|||
143500980|NCT01805180|517376088|FG002|Lead-in Donor Phase|screen failure|0|||
143500981|NCT04574999|517376091|FG000|Overall Study|Adverse Event|1|||
143500982|NCT04574999|517376092|FG001|Overall Study|Adverse Event|0|||
143500983|NCT04574999|517376091|FG000|Overall Study|Lack of Efficacy|2|||
143500984|NCT04574999|517376092|FG001|Overall Study|Lack of Efficacy|3|||
143500985|NCT04574999|517376091|FG000|Overall Study|Protocol Violation|1|||
143500986|NCT04574999|517376092|FG001|Overall Study|Protocol Violation|0|||
143500987|NCT04574999|517376091|FG000|Overall Study|Withdrawal by Subject|2|||
143058733|NCT02211014|515753212|FG001|Overall Study|Withdrawal by Subject|1|||
143058734|NCT02211014|515753211|FG000|Overall Study|In agreement with patient, no benefit|0|||
143058735|NCT02211014|515753212|FG001|Overall Study|In agreement with patient, no benefit|1|||
143058736|NCT00966381|515753213|FG000|Overall Study|Withdrawal by Subject|2|||
143058737|NCT00966381|515753214|FG001|Overall Study|Withdrawal by Subject|2|||
143058738|NCT01124695|515753215|FG000|Overall Study|Disease progression|77|||
143058739|NCT01124695|515753215|FG000|Overall Study|Adverse Event|11|||
143058740|NCT01124695|515753215|FG000|Overall Study|Death|1|||
143058741|NCT01124695|515753215|FG000|Overall Study|Withdrawal by Subject|7|||
143058742|NCT01124695|515753215|FG000|Overall Study|Physician Decision|3|||
143058743|NCT01124695|515753215|FG000|Overall Study|Alternative therapy|9|||
143058744|NCT01124695|515753215|FG000|Overall Study|No documentation that patient went off treatment|4|||
143058745|NCT01124695|515753215|FG000|Overall Study|Ineligible|9|||
143058746|NCT01124695|515753215|FG000|Overall Study|Ineligible and never start treatment|2|||
143058747|NCT01796964|515753220|FG000|Overall Study|Adverse Event|1|||
143058748|NCT01796964|515753221|FG001|Overall Study|Adverse Event|1|||
143058749|NCT01796964|515753220|FG000|Overall Study|Death|1|||
143058750|NCT01796964|515753221|FG001|Overall Study|Death|0|||
143058751|NCT01796964|515753220|FG000|Overall Study|Protocol Violation|0|||
143058752|NCT01796964|515753221|FG001|Overall Study|Protocol Violation|1|||
143058753|NCT01796964|515753220|FG000|Overall Study|Withdrawal by Subject|1|||
143058754|NCT01796964|515753221|FG001|Overall Study|Withdrawal by Subject|1|||
143058755|NCT04025684|515753222|FG000|Overall Study|Withdrawal by Subject|1|||
143058756|NCT04025684|515753223|FG001|Overall Study|Withdrawal by Subject|1|||
143058757|NCT04025684|515753224|FG002|Overall Study|Withdrawal by Subject|0|||
143058758|NCT04025684|515753225|FG003|Overall Study|Withdrawal by Subject|0|||
143058759|NCT04025684|515753222|FG000|Overall Study|Multiple reasons|1|||
143058760|NCT04025684|515753223|FG001|Overall Study|Multiple reasons|3|||
143058761|NCT04025684|515753224|FG002|Overall Study|Multiple reasons|0|||
143058762|NCT04025684|515753225|FG003|Overall Study|Multiple reasons|1|||
143058763|NCT02000531|515753232|FG000|Overall Study|Lost to Follow-up|1|||
143058764|NCT02000531|515753233|FG001|Overall Study|Lost to Follow-up|0|||
143058765|NCT02000531|515753232|FG000|Overall Study|Discontinued due to data cut-off|3|||
143058766|NCT02000531|515753233|FG001|Overall Study|Discontinued due to data cut-off|8|||
143058767|NCT01345318|515753240|FG000|Overall Study|Adverse Event|16|||
143058768|NCT01345318|515753240|FG000|Overall Study|Lack of Efficacy|17|||
143058769|NCT01345318|515753240|FG000|Overall Study|Lost to Follow-up|2|||
143058770|NCT01345318|515753240|FG000|Overall Study|Protocol Violation|1|||
143058771|NCT01345318|515753240|FG000|Overall Study|Withdrawal by Subject|41|||
143058772|NCT01345318|515753240|FG000|Overall Study|Other|3|||
143058773|NCT00317642|515753241|FG000|Overall Study|Not Received Either Study Drug|1|||
143169940|NCT03396445|516171842|FG014|Treatment Period|Death|10|||
143169941|NCT03396445|516171843|FG015|Treatment Period|Death|8|||
143169942|NCT03396445|516171844|FG016|Treatment Period|Death|18|||
143169943|NCT03396445|516171845|FG017|Treatment Period|Death|0|||
143500988|NCT04574999|517376092|FG001|Overall Study|Withdrawal by Subject|2|||
143500989|NCT04574999|517376091|FG000|Overall Study|Lost to Follow-up|1|||
143500990|NCT04574999|517376092|FG001|Overall Study|Lost to Follow-up|0|||
143500991|NCT04574999|517376091|FG000|Overall Study|Personal problems|1|||
143500992|NCT04574999|517376092|FG001|Overall Study|Personal problems|0|||
143500993|NCT04574999|517376091|FG000|Overall Study|Previous planned surgery|1|||
143500994|NCT04574999|517376092|FG001|Overall Study|Previous planned surgery|0|||
143500995|NCT00008385|517376112|FG000|Overall Study|Off treatment reasons not reported|79|||
143500996|NCT00008385|517376113|FG001|Overall Study|Off treatment reasons not reported|70|||
143058774|NCT00317642|515753242|FG001|Overall Study|Not Received Either Study Drug|3|||
143058775|NCT00317642|515753241|FG000|Overall Study|Physician Decision|15|||
143058776|NCT00317642|515753242|FG001|Overall Study|Physician Decision|7|||
143058777|NCT00317642|515753241|FG000|Overall Study|Participant declined treatment|14|||
143058778|NCT00317642|515753242|FG001|Overall Study|Participant declined treatment|3|||
143058779|NCT00317642|515753241|FG000|Overall Study|Adverse Event|17|||
143058780|NCT00317642|515753242|FG001|Overall Study|Adverse Event|5|||
143058781|NCT00317642|515753241|FG000|Overall Study|Treatment Failure|56|||
143058782|NCT00317642|515753242|FG001|Overall Study|Treatment Failure|102|||
143058783|NCT00317642|515753241|FG000|Overall Study|Disease Recurrence|1|||
143169944|NCT03396445|516171846|FG018|Treatment Period|Death|0|||
143169945|NCT03396445|516171847|FG019|Treatment Period|Death|0|||
143169946|NCT03396445|516171848|FG020|Treatment Period|Death|0|||
143058784|NCT00317642|515753242|FG001|Overall Study|Disease Recurrence|2|||
143058785|NCT00317642|515753241|FG000|Overall Study|Death|14|||
143058786|NCT00317642|515753242|FG001|Overall Study|Death|7|||
143169947|NCT03396445|516171849|FG021|Treatment Period|Death|0|||
143500997|NCT00008385|517376112|FG000|Overall Study|Progressive disease|52|||
143500998|NCT00008385|517376113|FG001|Overall Study|Progressive disease|117|||
143500999|NCT00008385|517376112|FG000|Overall Study|Adverse Event|8|||
143501000|NCT00008385|517376113|FG001|Overall Study|Adverse Event|20|||
143501001|NCT00008385|517376112|FG000|Overall Study|Death|12|||
143501002|NCT00008385|517376113|FG001|Overall Study|Death|18|||
143501003|NCT00008385|517376112|FG000|Overall Study|Withdrawal by Subject|67|||
143501004|NCT00008385|517376113|FG001|Overall Study|Withdrawal by Subject|157|||
143501005|NCT00008385|517376112|FG000|Overall Study|Start non-protocol therapy|3|||
143501006|NCT00008385|517376113|FG001|Overall Study|Start non-protocol therapy|1|||
143501007|NCT00008385|517376112|FG000|Overall Study|Other complicating disease|17|||
143501008|NCT00008385|517376113|FG001|Overall Study|Other complicating disease|30|||
143501009|NCT00008385|517376112|FG000|Overall Study|Maximum dose reached|0|||
143501010|NCT00008385|517376113|FG001|Overall Study|Maximum dose reached|2|||
143058787|NCT00317642|515753241|FG000|Overall Study|Not Continue to Consolidation|2|||
143058788|NCT00317642|515753242|FG001|Overall Study|Not Continue to Consolidation|0|||
143058789|NCT00317642|515753241|FG000|Overall Study|Withdrawal by Subject|0|||
143058790|NCT00317642|515753242|FG001|Overall Study|Withdrawal by Subject|1|||
143058791|NCT00317642|515753241|FG000|Overall Study|Referred For Transplantation|1|||
143058792|NCT00317642|515753242|FG001|Overall Study|Referred For Transplantation|0|||
143058793|NCT00317642|515753241|FG000|Overall Study|AML Not Centrally Confirmed|1|||
143058794|NCT00317642|515753242|FG001|Overall Study|AML Not Centrally Confirmed|5|||
143058795|NCT02695719|515753245|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
143058796|NCT02695719|515753246|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
143058797|NCT02695719|515753245|FG000|Overall Study|Significant Protocol Deviation|0|||
143058798|NCT02695719|515753246|FG001|Overall Study|Significant Protocol Deviation|1|||
143058799|NCT02695719|515753245|FG000|Overall Study|Voluntary Withdrawal|1|||
143058800|NCT02695719|515753246|FG001|Overall Study|Voluntary Withdrawal|0|||
143058801|NCT00573170|515753247|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
143058802|NCT00573170|515753248|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
143058803|NCT00573170|515753249|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
143058804|NCT00573170|515753250|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
143058805|NCT00573170|515753251|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
143058806|NCT00573170|515753252|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
143058807|NCT00573170|515753247|FG000|First Washout Period|Adverse Event|1|||
143058808|NCT00573170|515753248|FG001|First Washout Period|Adverse Event|1|||
143058809|NCT00573170|515753249|FG002|First Washout Period|Adverse Event|0|||
143058810|NCT00573170|515753250|FG003|First Washout Period|Adverse Event|0|||
143058811|NCT00573170|515753251|FG004|First Washout Period|Adverse Event|0|||
143058812|NCT00573170|515753252|FG005|First Washout Period|Adverse Event|1|||
143058813|NCT00573170|515753247|FG000|First Washout Period|Lack of Efficacy|0|||
143058814|NCT00573170|515753248|FG001|First Washout Period|Lack of Efficacy|0|||
143058815|NCT00573170|515753249|FG002|First Washout Period|Lack of Efficacy|0|||
143058816|NCT00573170|515753250|FG003|First Washout Period|Lack of Efficacy|0|||
143058817|NCT00573170|515753251|FG004|First Washout Period|Lack of Efficacy|0|||
143058818|NCT00573170|515753252|FG005|First Washout Period|Lack of Efficacy|1|||
143058819|NCT00573170|515753247|FG000|First Washout Period|Lost to Follow-up|1|||
143058820|NCT00573170|515753248|FG001|First Washout Period|Lost to Follow-up|1|||
143058821|NCT00573170|515753249|FG002|First Washout Period|Lost to Follow-up|0|||
143058822|NCT00573170|515753250|FG003|First Washout Period|Lost to Follow-up|2|||
143058823|NCT00573170|515753251|FG004|First Washout Period|Lost to Follow-up|0|||
143058824|NCT00573170|515753252|FG005|First Washout Period|Lost to Follow-up|2|||
143058825|NCT00573170|515753247|FG000|First Washout Period|Withdrawal by Subject|2|||
143058826|NCT00573170|515753248|FG001|First Washout Period|Withdrawal by Subject|0|||
143058827|NCT00573170|515753249|FG002|First Washout Period|Withdrawal by Subject|0|||
143058828|NCT00573170|515753250|FG003|First Washout Period|Withdrawal by Subject|2|||
143058829|NCT00573170|515753251|FG004|First Washout Period|Withdrawal by Subject|3|||
143058830|NCT00573170|515753252|FG005|First Washout Period|Withdrawal by Subject|3|||
143058831|NCT00573170|515753247|FG000|First Washout Period|Other|4|||
143365062|NCT02042443|516878772|FG001|Overall Study|Progression|17|||
143501011|NCT00008385|517376112|FG000|Overall Study|Other|105|||
143501012|NCT00008385|517376113|FG001|Overall Study|Other|212|||
143501013|NCT00008385|517376112|FG000|Overall Study|Not start protocol therapy|44|||
143501014|NCT00008385|517376113|FG001|Overall Study|Not start protocol therapy|175|||
143058832|NCT00573170|515753248|FG001|First Washout Period|Other|0|||
143058833|NCT00573170|515753249|FG002|First Washout Period|Other|1|||
143501015|NCT05148884|517376114|FG000|Overall Study|Withdrawal by Subject|3|||
143501016|NCT05148884|517376115|FG001|Overall Study|Withdrawal by Subject|0|||
143501017|NCT05148884|517376114|FG000|Overall Study|Deep brain stimulation operation|0|||
143501018|NCT05148884|517376115|FG001|Overall Study|Deep brain stimulation operation|1|||
143501019|NCT00582556|517376116|FG000|Overall Study|Withdrawal by Subject|0|||
143501020|NCT00582556|517376117|FG001|Overall Study|Withdrawal by Subject|1|||
143501021|NCT00582556|517376118|FG002|Overall Study|Withdrawal by Subject|1|||
143501022|NCT00582556|517376116|FG000|Overall Study|Physician Decision|0|||
143501023|NCT00582556|517376117|FG001|Overall Study|Physician Decision|0|||
143058834|NCT00573170|515753250|FG003|First Washout Period|Other|1|||
143058835|NCT00573170|515753251|FG004|First Washout Period|Other|0|||
143058836|NCT00573170|515753252|FG005|First Washout Period|Other|0|||
143058837|NCT00573170|515753247|FG000|Second Washout Period|Adverse Event|1|||
143501024|NCT00582556|517376118|FG002|Overall Study|Physician Decision|1|||
143501025|NCT01341457|517376121|FG000|Overall Study|Adverse Event|2|||
143501026|NCT01341457|517376122|FG001|Overall Study|Adverse Event|0|||
143501027|NCT00365989|517376123|FG000|Overall Study|Withdrawal by Subject|1|||
143058838|NCT00573170|515753248|FG001|Second Washout Period|Adverse Event|0|||
143058839|NCT00573170|515753249|FG002|Second Washout Period|Adverse Event|0|||
143058840|NCT00573170|515753250|FG003|Second Washout Period|Adverse Event|0|||
143058841|NCT00573170|515753251|FG004|Second Washout Period|Adverse Event|1|||
143058842|NCT00573170|515753252|FG005|Second Washout Period|Adverse Event|0|||
143058843|NCT00573170|515753247|FG000|Second Washout Period|Protocol Violation|2|||
143058844|NCT00573170|515753248|FG001|Second Washout Period|Protocol Violation|1|||
143058845|NCT00573170|515753249|FG002|Second Washout Period|Protocol Violation|1|||
143058846|NCT00573170|515753250|FG003|Second Washout Period|Protocol Violation|0|||
143058847|NCT00573170|515753251|FG004|Second Washout Period|Protocol Violation|0|||
143058848|NCT00573170|515753252|FG005|Second Washout Period|Protocol Violation|0|||
143058849|NCT00573170|515753247|FG000|Second Washout Period|Withdrawal by Subject|1|||
143058850|NCT00573170|515753248|FG001|Second Washout Period|Withdrawal by Subject|1|||
143058851|NCT00573170|515753249|FG002|Second Washout Period|Withdrawal by Subject|2|||
143058852|NCT00573170|515753250|FG003|Second Washout Period|Withdrawal by Subject|0|||
143058853|NCT00573170|515753251|FG004|Second Washout Period|Withdrawal by Subject|1|||
143058854|NCT00573170|515753252|FG005|Second Washout Period|Withdrawal by Subject|0|||
143501028|NCT00365989|517376123|FG000|Overall Study|Non-compliance|1|||
143501029|NCT00832819|517376128|FG000|Overall Study|Adverse Event|0|||
143501030|NCT00832819|517376129|FG001|Overall Study|Adverse Event|1|||
143058855|NCT00573170|515753247|FG000|Second Washout Period|Lost to Follow-up|0|||
143058856|NCT00573170|515753248|FG001|Second Washout Period|Lost to Follow-up|0|||
143058857|NCT00573170|515753249|FG002|Second Washout Period|Lost to Follow-up|0|||
143058858|NCT00573170|515753250|FG003|Second Washout Period|Lost to Follow-up|1|||
143058859|NCT00573170|515753251|FG004|Second Washout Period|Lost to Follow-up|0|||
143058860|NCT00573170|515753252|FG005|Second Washout Period|Lost to Follow-up|0|||
143058861|NCT00573170|515753247|FG000|Second Washout Period|Other|1|||
143058862|NCT00573170|515753248|FG001|Second Washout Period|Other|2|||
143058863|NCT00573170|515753249|FG002|Second Washout Period|Other|1|||
143058864|NCT00573170|515753250|FG003|Second Washout Period|Other|4|||
143058865|NCT00573170|515753251|FG004|Second Washout Period|Other|6|||
143058866|NCT00573170|515753252|FG005|Second Washout Period|Other|2|||
143058867|NCT00573170|515753247|FG000|Third Treatment Period|Withdrawal by Subject|1|||
143058868|NCT00573170|515753248|FG001|Third Treatment Period|Withdrawal by Subject|0|||
143058869|NCT00573170|515753249|FG002|Third Treatment Period|Withdrawal by Subject|0|||
143058870|NCT00573170|515753250|FG003|Third Treatment Period|Withdrawal by Subject|0|||
143058871|NCT00573170|515753251|FG004|Third Treatment Period|Withdrawal by Subject|0|||
143058872|NCT00573170|515753252|FG005|Third Treatment Period|Withdrawal by Subject|0|||
143058873|NCT00573170|515753247|FG000|Third Treatment Period|Lost to Follow-up|0|||
143058874|NCT00573170|515753248|FG001|Third Treatment Period|Lost to Follow-up|0|||
143058875|NCT00573170|515753249|FG002|Third Treatment Period|Lost to Follow-up|0|||
143058876|NCT00573170|515753250|FG003|Third Treatment Period|Lost to Follow-up|0|||
143058877|NCT00573170|515753251|FG004|Third Treatment Period|Lost to Follow-up|0|||
143058878|NCT00573170|515753252|FG005|Third Treatment Period|Lost to Follow-up|2|||
143058879|NCT05966090|515753253|FG000|Overall Study|Lost to Follow-up|6|||
143058880|NCT05966090|515753254|FG001|Overall Study|Lost to Follow-up|6|||
143058881|NCT05966090|515753253|FG000|Overall Study|Adverse Event|1|||
143058882|NCT05966090|515753254|FG001|Overall Study|Adverse Event|1|||
143058883|NCT05966090|515753253|FG000|Overall Study|Withdrawal by Subject|1|||
143058884|NCT05966090|515753254|FG001|Overall Study|Withdrawal by Subject|1|||
143058885|NCT05966090|515753253|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
143058886|NCT05966090|515753254|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
143365063|NCT02042443|516878771|FG000|Overall Study|not protocol specified|1|||
143365064|NCT02042443|516878772|FG001|Overall Study|not protocol specified|1|||
143365065|NCT02042443|516878771|FG000|Overall Study|Not eligible/not analyzable|3|||
143501031|NCT00832819|517376130|FG002|Overall Study|Adverse Event|0|||
143501032|NCT00832819|517376128|FG000|Overall Study|Protocol Violation|0|||
143058887|NCT05966090|515753253|FG000|Overall Study|Other|1|||
143058888|NCT05966090|515753254|FG001|Overall Study|Other|1|||
143365066|NCT02042443|516878772|FG001|Overall Study|Not eligible/not analyzable|6|||
143058889|NCT02001051|515753255|FG000|Overall Study|Deemed not eligible following enrollment|0|||
143058890|NCT02001051|515753256|FG001|Overall Study|Deemed not eligible following enrollment|1|||
143058891|NCT00309985|515753263|FG000|Overall Study|Disease progression|12|||
143058892|NCT00309985|515753264|FG001|Overall Study|Disease progression|0|||
143058893|NCT00309985|515753263|FG000|Overall Study|Adverse Event|30|||
143365067|NCT01007149|516878775|FG000|Overall Study|Administrative problems|0|||
143501033|NCT00832819|517376129|FG001|Overall Study|Protocol Violation|0|||
143501034|NCT00832819|517376130|FG002|Overall Study|Protocol Violation|1|||
143058894|NCT00309985|515753264|FG001|Overall Study|Adverse Event|0|||
143058895|NCT00309985|515753263|FG000|Overall Study|Death|2|||
143058896|NCT00309985|515753264|FG001|Overall Study|Death|0|||
143058897|NCT00309985|515753263|FG000|Overall Study|Withdrawal by Subject|5|||
143058898|NCT00309985|515753264|FG001|Overall Study|Withdrawal by Subject|1|||
143058899|NCT00309985|515753263|FG000|Overall Study|Physician Decision|3|||
143058900|NCT00309985|515753264|FG001|Overall Study|Physician Decision|0|||
143058901|NCT00309985|515753263|FG000|Overall Study|Never started treatment|7|||
143058902|NCT00309985|515753264|FG001|Overall Study|Never started treatment|0|||
143501035|NCT02318095|517376131|FG000|Overall Study|Adverse Event|1|||
143058903|NCT00309985|515753263|FG000|Overall Study|Complicating disease|1|||
143058904|NCT00309985|515753264|FG001|Overall Study|Complicating disease|0|||
143058905|NCT00309985|515753263|FG000|Overall Study|Non-compliance|1|||
143058906|NCT00309985|515753264|FG001|Overall Study|Non-compliance|0|||
143058907|NCT00309985|515753263|FG000|Overall Study|Chemotherapy discontinued only|1|||
143058908|NCT00309985|515753264|FG001|Overall Study|Chemotherapy discontinued only|0|||
143058909|NCT04205162|515753275|FG000|Overall Study|Lost to Follow-up|1|||
143058910|NCT04205162|515753276|FG001|Overall Study|Lost to Follow-up|0|||
143058911|NCT04205162|515753275|FG000|Overall Study|Withdrawal by Subject|2|||
143058912|NCT04205162|515753276|FG001|Overall Study|Withdrawal by Subject|0|||
143058913|NCT04205162|515753275|FG000|Overall Study|University closure due to COVID-19|1|||
143058914|NCT04205162|515753276|FG001|Overall Study|University closure due to COVID-19|0|||
143169948|NCT03396445|516171850|FG022|Treatment Period|Death|0|||
143501036|NCT01717638|517376132|FG000|Overall Study|Lost to Follow-up|0|||
143501037|NCT01717638|517376133|FG001|Overall Study|Lost to Follow-up|0|||
143169949|NCT03396445|516171851|FG023|Treatment Period|Death|0|||
143501038|NCT01717638|517376134|FG002|Overall Study|Lost to Follow-up|0|||
143501039|NCT01717638|517376135|FG003|Overall Study|Lost to Follow-up|0|||
143501040|NCT01717638|517376136|FG004|Overall Study|Lost to Follow-up|0|||
143501041|NCT01717638|517376137|FG005|Overall Study|Lost to Follow-up|1|||
143501042|NCT01717638|517376138|FG006|Overall Study|Lost to Follow-up|0|||
143501043|NCT01717638|517376139|FG007|Overall Study|Lost to Follow-up|0|||
143501044|NCT01717638|517376140|FG008|Overall Study|Lost to Follow-up|0|||
143501045|NCT01717638|517376141|FG009|Overall Study|Lost to Follow-up|0|||
143501046|NCT01717638|517376142|FG010|Overall Study|Lost to Follow-up|0|||
143501047|NCT01717638|517376143|FG011|Overall Study|Lost to Follow-up|0|||
143501048|NCT01717638|517376144|FG012|Overall Study|Lost to Follow-up|0|||
143501049|NCT01717638|517376132|FG000|Overall Study|Father in hospital|0|||
143501050|NCT01717638|517376133|FG001|Overall Study|Father in hospital|0|||
143501051|NCT01717638|517376134|FG002|Overall Study|Father in hospital|0|||
143501052|NCT01717638|517376135|FG003|Overall Study|Father in hospital|0|||
143501053|NCT01717638|517376136|FG004|Overall Study|Father in hospital|0|||
143501054|NCT01717638|517376137|FG005|Overall Study|Father in hospital|0|||
143501055|NCT01717638|517376138|FG006|Overall Study|Father in hospital|0|||
143501056|NCT01717638|517376139|FG007|Overall Study|Father in hospital|0|||
143501057|NCT01717638|517376140|FG008|Overall Study|Father in hospital|0|||
143501058|NCT01717638|517376141|FG009|Overall Study|Father in hospital|0|||
143501059|NCT01717638|517376142|FG010|Overall Study|Father in hospital|0|||
143501060|NCT01717638|517376143|FG011|Overall Study|Father in hospital|0|||
143501061|NCT01717638|517376144|FG012|Overall Study|Father in hospital|1|||
143058915|NCT01355302|515753283|FG000|Phase 1b|Death|4|||
143501062|NCT01717638|517376132|FG000|Overall Study|Withdrawal by Subject|0|||
143501063|NCT01717638|517376133|FG001|Overall Study|Withdrawal by Subject|1|||
143501064|NCT01717638|517376134|FG002|Overall Study|Withdrawal by Subject|1|||
143058916|NCT01355302|515753284|FG001|Phase 1b|Death|0|||
143058917|NCT01355302|515753285|FG002|Phase 1b|Death|0|||
143058918|NCT01355302|515753283|FG000|Phase 1b|Study terminated by sponsor|2|||
143169950|NCT03396445|516171852|FG024|Treatment Period|Death|0|||
143501065|NCT01717638|517376135|FG003|Overall Study|Withdrawal by Subject|0|||
143501066|NCT01717638|517376136|FG004|Overall Study|Withdrawal by Subject|1|||
143245724|NCT00481091|516451788|FG004|Overall Study|No reason given|1|||
143169951|NCT03396445|516171853|FG025|Treatment Period|Death|0|||
143169952|NCT03396445|516171828|FG000|Treatment Period|Lost to Follow-up|0|||
143169953|NCT03396445|516171829|FG001|Treatment Period|Lost to Follow-up|0|||
143501067|NCT01717638|517376137|FG005|Overall Study|Withdrawal by Subject|0|||
143501068|NCT01717638|517376138|FG006|Overall Study|Withdrawal by Subject|2|||
143501069|NCT01717638|517376139|FG007|Overall Study|Withdrawal by Subject|1|||
143501070|NCT01717638|517376140|FG008|Overall Study|Withdrawal by Subject|2|||
143501071|NCT01717638|517376141|FG009|Overall Study|Withdrawal by Subject|1|||
143501072|NCT01717638|517376142|FG010|Overall Study|Withdrawal by Subject|0|||
143501073|NCT01717638|517376143|FG011|Overall Study|Withdrawal by Subject|0|||
143501074|NCT01717638|517376144|FG012|Overall Study|Withdrawal by Subject|18|||
143501075|NCT01901224|517376145|FG000|Overall Study|study was not funded and terminated|2|||
143501076|NCT02300129|517376146|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
143501077|NCT02300129|517376147|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
143501078|NCT02300129|517376148|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
143501079|NCT02300129|517376149|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
143501080|NCT02300129|517376146|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
143501081|NCT02300129|517376147|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
143501082|NCT02300129|517376148|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
143501083|NCT02300129|517376149|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
143501084|NCT02300129|517376146|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
143501085|NCT02300129|517376147|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
143501086|NCT02300129|517376148|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
143501087|NCT02300129|517376149|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
143501088|NCT05742984|517376150|FG000|Overall Study|Adverse Event|0|||
143501089|NCT05742984|517376151|FG001|Overall Study|Adverse Event|0|||
143501090|NCT05742984|517376152|FG002|Overall Study|Adverse Event|1|||
143501091|NCT05742984|517376153|FG003|Overall Study|Adverse Event|0|||
143501092|NCT05742984|517376154|FG004|Overall Study|Adverse Event|1|||
143501093|NCT05742984|517376155|FG005|Overall Study|Adverse Event|1|||
143501094|NCT05742984|517376150|FG000|Overall Study|Withdrawal by Subject|0|||
143501095|NCT05742984|517376151|FG001|Overall Study|Withdrawal by Subject|1|||
143501096|NCT05742984|517376152|FG002|Overall Study|Withdrawal by Subject|0|||
143501097|NCT05742984|517376153|FG003|Overall Study|Withdrawal by Subject|0|||
143501098|NCT05742984|517376154|FG004|Overall Study|Withdrawal by Subject|0|||
143501099|NCT05742984|517376155|FG005|Overall Study|Withdrawal by Subject|2|||
143501100|NCT02162862|517376159|FG000|Overall Study|Lost to Follow-up|0|||
143501101|NCT02162862|517376160|FG001|Overall Study|Lost to Follow-up|11|||
143501102|NCT02162862|517376161|FG002|Overall Study|Lost to Follow-up|0|||
143501103|NCT02162862|517376159|FG000|Overall Study|Subject did not feel the med was needed|0|||
143501104|NCT02162862|517376160|FG001|Overall Study|Subject did not feel the med was needed|0|||
143501105|NCT02162862|517376161|FG002|Overall Study|Subject did not feel the med was needed|4|||
143501106|NCT00430755|517376166|FG000|Overall Study|Withdrawal by Subject|53|||
143501107|NCT00103012|517376169|FG000|Overall Study|Withdrawal by Subject|2|||
143501108|NCT00103012|517376170|FG001|Overall Study|Withdrawal by Subject|1|||
143501109|NCT00103012|517376171|FG002|Overall Study|Withdrawal by Subject|2|||
143501110|NCT00103012|517376169|FG000|Overall Study|Pregnancy|1|||
143501111|NCT00103012|517376170|FG001|Overall Study|Pregnancy|0|||
143501112|NCT00103012|517376171|FG002|Overall Study|Pregnancy|0|||
143501113|NCT00103012|517376169|FG000|Overall Study|Adverse Event|0|||
143501114|NCT00103012|517376170|FG001|Overall Study|Adverse Event|0|||
143501115|NCT00103012|517376171|FG002|Overall Study|Adverse Event|1|||
143501116|NCT00103012|517376169|FG000|Overall Study|Subject non-compliant with medications|0|||
143501117|NCT00103012|517376170|FG001|Overall Study|Subject non-compliant with medications|0|||
143501118|NCT00103012|517376171|FG002|Overall Study|Subject non-compliant with medications|1|||
143501119|NCT02661594|517376177|FG000|Overall Study|Protocol Violation|1|||
143501120|NCT02661594|517376178|FG001|Overall Study|Protocol Violation|0|||
143501121|NCT02661594|517376179|FG002|Overall Study|Protocol Violation|1|||
143501122|NCT02661594|517376180|FG003|Overall Study|Protocol Violation|0|||
143501123|NCT01169779|517376183|FG000|Overall Study|Adverse Event|3|||
143501124|NCT01169779|517376184|FG001|Overall Study|Adverse Event|11|||
143501125|NCT01169779|517376183|FG000|Overall Study|Lack of Efficacy|1|||
143501126|NCT01169779|517376184|FG001|Overall Study|Lack of Efficacy|0|||
143501127|NCT01169779|517376183|FG000|Overall Study|Protocol Violation|1|||
143501128|NCT01169779|517376184|FG001|Overall Study|Protocol Violation|1|||
143058919|NCT01355302|515753284|FG001|Phase 1b|Study terminated by sponsor|0|||
143058920|NCT01355302|515753285|FG002|Phase 1b|Study terminated by sponsor|0|||
143058921|NCT01546519|515753286|FG000|Overall Study|Adverse Event|0|||
143501129|NCT01169779|517376183|FG000|Overall Study|Withdrawal by Subject|3|||
143501130|NCT01169779|517376184|FG001|Overall Study|Withdrawal by Subject|2|||
143501131|NCT01169779|517376183|FG000|Overall Study|Familial and personal reasons|3|||
143501132|NCT01169779|517376184|FG001|Overall Study|Familial and personal reasons|3|||
143501133|NCT00432237|517376185|FG000|Overall Study|Adverse Event|0|||
143501134|NCT00432237|517376186|FG001|Overall Study|Adverse Event|0|||
143501135|NCT00432237|517376187|FG002|Overall Study|Adverse Event|0|||
143501136|NCT00432237|517376188|FG003|Overall Study|Adverse Event|1|||
143501137|NCT00432237|517376185|FG000|Overall Study|Lack of Efficacy|0|||
143501138|NCT00432237|517376186|FG001|Overall Study|Lack of Efficacy|0|||
143501139|NCT00432237|517376187|FG002|Overall Study|Lack of Efficacy|0|||
143501140|NCT00432237|517376188|FG003|Overall Study|Lack of Efficacy|1|||
143058922|NCT01546519|515753287|FG001|Overall Study|Adverse Event|0|||
143058923|NCT01546519|515753288|FG002|Overall Study|Adverse Event|1|||
143058924|NCT01546519|515753289|FG003|Overall Study|Adverse Event|1|||
143058925|NCT01546519|515753286|FG000|Overall Study|Death|0|||
143058926|NCT01546519|515753287|FG001|Overall Study|Death|1|||
143058927|NCT01546519|515753288|FG002|Overall Study|Death|3|||
143058928|NCT01546519|515753289|FG003|Overall Study|Death|1|||
143058929|NCT01546519|515753286|FG000|Overall Study|related to disease progression|2|||
143058930|NCT01546519|515753287|FG001|Overall Study|related to disease progression|2|||
143058931|NCT01546519|515753288|FG002|Overall Study|related to disease progression|2|||
143058932|NCT01546519|515753289|FG003|Overall Study|related to disease progression|1|||
143058933|NCT01546519|515753286|FG000|Overall Study|Physician Decision|6|||
143058934|NCT01546519|515753287|FG001|Overall Study|Physician Decision|5|||
143058935|NCT01546519|515753288|FG002|Overall Study|Physician Decision|2|||
143058936|NCT01546519|515753289|FG003|Overall Study|Physician Decision|3|||
143058937|NCT01546519|515753286|FG000|Overall Study|Withdrawal by Subject|1|||
143058938|NCT01546519|515753287|FG001|Overall Study|Withdrawal by Subject|0|||
143058939|NCT01546519|515753288|FG002|Overall Study|Withdrawal by Subject|0|||
143058940|NCT01546519|515753289|FG003|Overall Study|Withdrawal by Subject|0|||
143058941|NCT01256060|515753290|FG000|Overall Study|Lost to Follow-up|0|||
143058942|NCT01256060|515753291|FG001|Overall Study|Lost to Follow-up|1|||
143058943|NCT01256060|515753292|FG002|Overall Study|Lost to Follow-up|0|||
143058944|NCT01256060|515753293|FG003|Overall Study|Lost to Follow-up|0|||
143058945|NCT00985231|515753300|FG000|Overall Study|ineligible|1|||
143058946|NCT00985231|515753301|FG001|Overall Study|ineligible|0|||
143058947|NCT00985231|515753300|FG000|Overall Study|Protocol Violation|1|||
143058948|NCT00985231|515753301|FG001|Overall Study|Protocol Violation|0|||
143058949|NCT00985231|515753300|FG000|Overall Study|Withdrawal by Subject|1|||
143058950|NCT00985231|515753301|FG001|Overall Study|Withdrawal by Subject|0|||
143058951|NCT00985231|515753300|FG000|Overall Study|Lost to Follow-up|0|||
143058952|NCT00985231|515753301|FG001|Overall Study|Lost to Follow-up|1|||
143058953|NCT00985231|515753300|FG000|Overall Study|Study related symptoms & complaints|0|||
143058954|NCT00985231|515753301|FG001|Overall Study|Study related symptoms & complaints|2|||
143058955|NCT01808248|515753302|FG000|Overall Study|Lack of Efficacy|3|||
143058956|NCT01808248|515753302|FG000|Overall Study|Withdrawal by Subject|1|||
143058957|NCT01808248|515753302|FG000|Overall Study|Lost to Follow-up|1|||
143058958|NCT00089076|515753303|FG000|Overall Study|Alternate Therapy|1|||
143058959|NCT00089076|515753303|FG000|Overall Study|Withdrawal by Subject|2|||
143058960|NCT00089076|515753303|FG000|Overall Study|Progression|7|||
143365068|NCT01007149|516878776|FG001|Overall Study|Administrative problems|1|||
143501141|NCT00432237|517376185|FG000|Overall Study|Lost to Follow-up|10|||
143501142|NCT00432237|517376186|FG001|Overall Study|Lost to Follow-up|10|||
143501143|NCT00432237|517376187|FG002|Overall Study|Lost to Follow-up|18|||
143501144|NCT00432237|517376188|FG003|Overall Study|Lost to Follow-up|18|||
143501145|NCT00432237|517376185|FG000|Overall Study|Physician Decision|1|||
143501146|NCT00432237|517376186|FG001|Overall Study|Physician Decision|3|||
143501147|NCT00432237|517376187|FG002|Overall Study|Physician Decision|2|||
143501148|NCT00432237|517376188|FG003|Overall Study|Physician Decision|1|||
143501149|NCT00432237|517376185|FG000|Overall Study|Pregnancy|0|||
143501150|NCT00432237|517376186|FG001|Overall Study|Pregnancy|1|||
143501151|NCT00432237|517376187|FG002|Overall Study|Pregnancy|0|||
143501152|NCT00432237|517376188|FG003|Overall Study|Pregnancy|0|||
143501153|NCT00432237|517376185|FG000|Overall Study|Protocol Violation|13|||
143501154|NCT00432237|517376186|FG001|Overall Study|Protocol Violation|10|||
143501155|NCT00432237|517376187|FG002|Overall Study|Protocol Violation|11|||
143058961|NCT01009515|515753305|FG000|Overall Study|Withdrawal by Subject|3|||
143058962|NCT01175473|515753311|FG000|Overall Study|Adverse Event|2|||
143058963|NCT01175473|515753312|FG001|Overall Study|Adverse Event|2|||
143058964|NCT00869440|515753326|FG000|Overall Study|Withdrawal by Subject|1|||
143058965|NCT00869440|515753327|FG001|Overall Study|Withdrawal by Subject|0|||
143058966|NCT00869440|515753328|FG002|Overall Study|Withdrawal by Subject|0|||
143058967|NCT00869440|515753329|FG003|Overall Study|Withdrawal by Subject|0|||
143058968|NCT00869440|515753326|FG000|Overall Study|Physician Decision|1|||
143058969|NCT00869440|515753327|FG001|Overall Study|Physician Decision|1|||
143058970|NCT00869440|515753328|FG002|Overall Study|Physician Decision|0|||
143169954|NCT03396445|516171830|FG002|Treatment Period|Lost to Follow-up|0|||
143169955|NCT03396445|516171831|FG003|Treatment Period|Lost to Follow-up|0|||
143169956|NCT03396445|516171832|FG004|Treatment Period|Lost to Follow-up|0|||
143169957|NCT03396445|516171833|FG005|Treatment Period|Lost to Follow-up|0|||
143501156|NCT00432237|517376188|FG003|Overall Study|Protocol Violation|8|||
143501157|NCT00432237|517376185|FG000|Overall Study|Withdrawal by Subject|5|||
143501158|NCT00432237|517376186|FG001|Overall Study|Withdrawal by Subject|6|||
143501159|NCT00432237|517376187|FG002|Overall Study|Withdrawal by Subject|9|||
143501160|NCT00432237|517376188|FG003|Overall Study|Withdrawal by Subject|11|||
143501161|NCT00432237|517376185|FG000|Overall Study|Lack of Qualifying Event|38|||
143501162|NCT00432237|517376186|FG001|Overall Study|Lack of Qualifying Event|71|||
143501163|NCT00432237|517376187|FG002|Overall Study|Lack of Qualifying Event|69|||
143501164|NCT00432237|517376188|FG003|Overall Study|Lack of Qualifying Event|84|||
143501165|NCT01279057|517376189|FG000|Overall Study|Adverse Event|1|||
143501166|NCT01279057|517376190|FG001|Overall Study|Adverse Event|0|||
143501167|NCT01279057|517376191|FG002|Overall Study|Adverse Event|1|||
143501168|NCT01279057|517376189|FG000|Overall Study|Insufficient therapeutic response|0|||
143501169|NCT01279057|517376190|FG001|Overall Study|Insufficient therapeutic response|0|||
143501170|NCT01279057|517376191|FG002|Overall Study|Insufficient therapeutic response|1|||
143501171|NCT01279057|517376189|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
143501172|NCT01279057|517376190|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
143501173|NCT01279057|517376191|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
143501174|NCT01279057|517376189|FG000|Overall Study|Withdrew consent|2|||
143501175|NCT01279057|517376190|FG001|Overall Study|Withdrew consent|0|||
143501176|NCT01279057|517376191|FG002|Overall Study|Withdrew consent|1|||
143501177|NCT01279057|517376189|FG000|Overall Study|Pregnancy|0|||
143501178|NCT01279057|517376190|FG001|Overall Study|Pregnancy|1|||
143501179|NCT01279057|517376191|FG002|Overall Study|Pregnancy|0|||
143501180|NCT01279057|517376189|FG000|Overall Study|Other|3|||
143501181|NCT01279057|517376190|FG001|Overall Study|Other|3|||
143501182|NCT01279057|517376191|FG002|Overall Study|Other|0|||
143501183|NCT01427309|517376193|FG000|Overall Study|Lost to Follow-up|130|||
143501184|NCT01427309|517376194|FG001|Overall Study|Lost to Follow-up|145|||
143501185|NCT01427309|517376195|FG002|Overall Study|Lost to Follow-up|122|||
143501186|NCT01427309|517376196|FG003|Overall Study|Lost to Follow-up|135|||
143501187|NCT01427309|517376193|FG000|Overall Study|Protocol Violation|42|||
143501188|NCT01427309|517376194|FG001|Overall Study|Protocol Violation|69|||
143501189|NCT01427309|517376195|FG002|Overall Study|Protocol Violation|125|||
143501190|NCT01427309|517376196|FG003|Overall Study|Protocol Violation|124|||
143501191|NCT01427309|517376193|FG000|Overall Study|Adverse Event|0|||
143501192|NCT01427309|517376194|FG001|Overall Study|Adverse Event|0|||
143501193|NCT01427309|517376195|FG002|Overall Study|Adverse Event|3|||
143501194|NCT01427309|517376196|FG003|Overall Study|Adverse Event|1|||
143058971|NCT00869440|515753329|FG003|Overall Study|Physician Decision|0|||
143058972|NCT03546647|515753331|FG000|Overall Study|Adverse Event|1|||
143058973|NCT03546647|515753332|FG001|Overall Study|Adverse Event|0|||
143058974|NCT02400476|515753333|FG000|Overall Study|Adverse Event|57|||
143058975|NCT02400476|515753334|FG001|Overall Study|Adverse Event|10|||
143058976|NCT02400476|515753335|FG002|Overall Study|Adverse Event|22|||
143058977|NCT02400476|515753336|FG003|Overall Study|Adverse Event|19|||
143058978|NCT02400476|515753337|FG004|Overall Study|Adverse Event|5|||
143058979|NCT02400476|515753338|FG005|Overall Study|Adverse Event|8|||
143058980|NCT02400476|515753333|FG000|Overall Study|Withdrawal by Subject|4|||
143058981|NCT02400476|515753334|FG001|Overall Study|Withdrawal by Subject|1|||
143058982|NCT02400476|515753335|FG002|Overall Study|Withdrawal by Subject|12|||
143058983|NCT02400476|515753336|FG003|Overall Study|Withdrawal by Subject|7|||
143058984|NCT02400476|515753337|FG004|Overall Study|Withdrawal by Subject|5|||
143058985|NCT02400476|515753338|FG005|Overall Study|Withdrawal by Subject|5|||
143058986|NCT02400476|515753333|FG000|Overall Study|Lost to Follow-up|0|||
143058987|NCT02400476|515753334|FG001|Overall Study|Lost to Follow-up|0|||
143058988|NCT02400476|515753335|FG002|Overall Study|Lost to Follow-up|0|||
143058989|NCT02400476|515753336|FG003|Overall Study|Lost to Follow-up|1|||
143058990|NCT02400476|515753337|FG004|Overall Study|Lost to Follow-up|3|||
143058991|NCT02400476|515753338|FG005|Overall Study|Lost to Follow-up|1|||
143501195|NCT01427309|517376193|FG000|Overall Study|Serious adverse event|52|||
143501196|NCT01427309|517376194|FG001|Overall Study|Serious adverse event|45|||
143501197|NCT01427309|517376195|FG002|Overall Study|Serious adverse event|50|||
143501198|NCT01427309|517376196|FG003|Overall Study|Serious adverse event|61|||
143501199|NCT01427309|517376193|FG000|Overall Study|Withdrawal by Subject|148|||
143501200|NCT01427309|517376194|FG001|Overall Study|Withdrawal by Subject|148|||
143501201|NCT01427309|517376195|FG002|Overall Study|Withdrawal by Subject|61|||
143501202|NCT01427309|517376196|FG003|Overall Study|Withdrawal by Subject|55|||
143501203|NCT00191854|517376197|FG000|Overall Study|Death|26|||
143501204|NCT00191854|517376198|FG001|Overall Study|Death|23|||
143501205|NCT00191854|517376199|FG002|Overall Study|Death|29|||
143501206|NCT00191854|517376197|FG000|Overall Study|Lost to Follow-up|7|||
143501207|NCT00191854|517376198|FG001|Overall Study|Lost to Follow-up|5|||
143501208|NCT00191854|517376199|FG002|Overall Study|Lost to Follow-up|5|||
143501209|NCT00191854|517376197|FG000|Overall Study|Withdrawal by Subject|4|||
143501210|NCT00191854|517376198|FG001|Overall Study|Withdrawal by Subject|2|||
143501211|NCT00191854|517376199|FG002|Overall Study|Withdrawal by Subject|3|||
143501212|NCT00191854|517376197|FG000|Overall Study|Sponsor Decision|0|||
143501213|NCT00191854|517376198|FG001|Overall Study|Sponsor Decision|0|||
143501214|NCT00191854|517376199|FG002|Overall Study|Sponsor Decision|1|||
143501215|NCT00191854|517376197|FG000|Overall Study|Screen Failure|0|||
143501216|NCT00191854|517376198|FG001|Overall Study|Screen Failure|0|||
143058992|NCT02400476|515753333|FG000|Overall Study|Physician Decision|0|||
143058993|NCT02400476|515753334|FG001|Overall Study|Physician Decision|0|||
143058994|NCT02400476|515753335|FG002|Overall Study|Physician Decision|1|||
143058995|NCT02400476|515753336|FG003|Overall Study|Physician Decision|1|||
143058996|NCT02400476|515753337|FG004|Overall Study|Physician Decision|0|||
143058997|NCT02400476|515753338|FG005|Overall Study|Physician Decision|1|||
143058998|NCT02400476|515753333|FG000|Overall Study|Other, Disease Progression|0|||
143058999|NCT02400476|515753334|FG001|Overall Study|Other, Disease Progression|1|||
143059000|NCT02400476|515753335|FG002|Overall Study|Other, Disease Progression|2|||
143059001|NCT02400476|515753336|FG003|Overall Study|Other, Disease Progression|1|||
143059002|NCT02400476|515753337|FG004|Overall Study|Other, Disease Progression|2|||
143059003|NCT02400476|515753338|FG005|Overall Study|Other, Disease Progression|1|||
143059004|NCT02400476|515753333|FG000|Overall Study|Other, Decreased Quality of Life|0|||
143059005|NCT02400476|515753334|FG001|Overall Study|Other, Decreased Quality of Life|0|||
143059006|NCT02400476|515753335|FG002|Overall Study|Other, Decreased Quality of Life|2|||
143059007|NCT02400476|515753336|FG003|Overall Study|Other, Decreased Quality of Life|0|||
143059008|NCT02400476|515753337|FG004|Overall Study|Other, Decreased Quality of Life|0|||
143059009|NCT02400476|515753338|FG005|Overall Study|Other, Decreased Quality of Life|0|||
143059010|NCT02400476|515753333|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
143059011|NCT02400476|515753334|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
143059012|NCT02400476|515753335|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
143059013|NCT02400476|515753336|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
143059014|NCT02400476|515753337|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
143059015|NCT02400476|515753338|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
143059016|NCT00588731|515753339|FG000|Overall Study|Withdrawal by Subject|3|||
143059017|NCT00588731|515753340|FG001|Overall Study|Withdrawal by Subject|2|||
143059018|NCT00346164|515753341|FG000|Overall Study|Adverse Event|0|||
143059019|NCT00346164|515753342|FG001|Overall Study|Adverse Event|0|||
143059020|NCT00346164|515753343|FG002|Overall Study|Adverse Event|0|||
143059021|NCT00346164|515753344|FG003|Overall Study|Adverse Event|1|||
143059022|NCT00346164|515753341|FG000|Overall Study|Lack of Efficacy|0|||
143059023|NCT00346164|515753342|FG001|Overall Study|Lack of Efficacy|1|||
143059024|NCT00346164|515753343|FG002|Overall Study|Lack of Efficacy|7|||
143059025|NCT00346164|515753344|FG003|Overall Study|Lack of Efficacy|25|||
143059026|NCT00346164|515753341|FG000|Overall Study|Physician Decision|0|||
143059027|NCT00346164|515753342|FG001|Overall Study|Physician Decision|1|||
143059028|NCT00346164|515753343|FG002|Overall Study|Physician Decision|2|||
143059029|NCT00346164|515753344|FG003|Overall Study|Physician Decision|27|||
143059030|NCT00346164|515753341|FG000|Overall Study|Protocol Violation|6|||
143059031|NCT00346164|515753342|FG001|Overall Study|Protocol Violation|2|||
143059032|NCT00346164|515753343|FG002|Overall Study|Protocol Violation|10|||
143059033|NCT00346164|515753344|FG003|Overall Study|Protocol Violation|4|||
143059034|NCT00346164|515753341|FG000|Overall Study|Withdrawal by Subject|0|||
143059035|NCT00346164|515753342|FG001|Overall Study|Withdrawal by Subject|0|||
143059036|NCT00346164|515753343|FG002|Overall Study|Withdrawal by Subject|2|||
143059037|NCT00346164|515753344|FG003|Overall Study|Withdrawal by Subject|0|||
143059038|NCT00346164|515753341|FG000|Overall Study|Ineligible|11|||
143059039|NCT00346164|515753342|FG001|Overall Study|Ineligible|2|||
143059040|NCT00346164|515753343|FG002|Overall Study|Ineligible|2|||
143059041|NCT00346164|515753344|FG003|Overall Study|Ineligible|23|||
143059042|NCT00346164|515753341|FG000|Overall Study|Refusal of further protocol therapy|0|||
143059043|NCT00346164|515753342|FG001|Overall Study|Refusal of further protocol therapy|1|||
143059044|NCT00346164|515753343|FG002|Overall Study|Refusal of further protocol therapy|3|||
143059045|NCT00346164|515753344|FG003|Overall Study|Refusal of further protocol therapy|15|||
143059046|NCT00346164|515753341|FG000|Overall Study|Inability to start week 16 tx on time|0|||
143059047|NCT00346164|515753342|FG001|Overall Study|Inability to start week 16 tx on time|0|||
143059048|NCT00346164|515753343|FG002|Overall Study|Inability to start week 16 tx on time|0|||
143059049|NCT00346164|515753344|FG003|Overall Study|Inability to start week 16 tx on time|11|||
143059050|NCT03297294|515753345|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
143059051|NCT03297294|515753346|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
143059052|NCT03297294|515753347|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
143059053|NCT03297294|515753348|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
143059054|NCT03297294|515753349|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
143365069|NCT02784704|516878777|FG000|Overall Study|Adverse Event|4|||
143365070|NCT02784704|516878778|FG001|Overall Study|Adverse Event|2|||
143365071|NCT02784704|516878777|FG000|Overall Study|Lost to Follow-up|6|||
143059055|NCT03297294|515753345|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
143059056|NCT03297294|515753346|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
143059057|NCT03297294|515753347|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
143059058|NCT03297294|515753348|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
143059059|NCT03297294|515753349|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
143059060|NCT03297294|515753345|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
143245725|NCT00481091|516451789|FG005|Overall Study|No reason given|0|||
143059061|NCT03297294|515753346|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
143059062|NCT03297294|515753347|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
143059063|NCT03297294|515753348|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
143059064|NCT03297294|515753349|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
143059065|NCT03297294|515753345|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
143059066|NCT03297294|515753346|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
143059067|NCT03297294|515753347|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
143059068|NCT03297294|515753348|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
143059069|NCT03297294|515753349|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
143059070|NCT03297294|515753345|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
143059071|NCT03297294|515753346|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
143059072|NCT03297294|515753347|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
143059073|NCT03297294|515753348|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
143059074|NCT03297294|515753349|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
143059075|NCT03942211|515753350|FG000|Overall Study|Death|1|||
143059076|NCT03942211|515753351|FG001|Overall Study|Death|0|||
143059077|NCT03942211|515753350|FG000|Overall Study|Study terminated by sponsor|5|||
143059078|NCT03942211|515753351|FG001|Overall Study|Study terminated by sponsor|3|||
143059079|NCT03942211|515753350|FG000|Overall Study|Adverse Event|0|||
143059080|NCT03942211|515753351|FG001|Overall Study|Adverse Event|1|||
143059081|NCT04405739|515753359|FG000|Overall Study|Adverse Event|0|||
143059082|NCT04405739|515753360|FG001|Overall Study|Adverse Event|1|||
143059083|NCT04405739|515753361|FG002|Overall Study|Adverse Event|0|||
143059084|NCT04405739|515753362|FG003|Overall Study|Adverse Event|0|||
143059085|NCT04405739|515753359|FG000|Overall Study|Lost to Follow-up|0|||
143059086|NCT04405739|515753360|FG001|Overall Study|Lost to Follow-up|2|||
143059087|NCT04405739|515753361|FG002|Overall Study|Lost to Follow-up|1|||
143059088|NCT04405739|515753362|FG003|Overall Study|Lost to Follow-up|3|||
143059089|NCT04405739|515753359|FG000|Overall Study|Withdrawal by Subject|0|||
143059090|NCT04405739|515753360|FG001|Overall Study|Withdrawal by Subject|2|||
143059091|NCT04405739|515753361|FG002|Overall Study|Withdrawal by Subject|1|||
143059092|NCT04405739|515753362|FG003|Overall Study|Withdrawal by Subject|1|||
143059093|NCT04405739|515753359|FG000|Overall Study|Death|0|||
143059094|NCT04405739|515753360|FG001|Overall Study|Death|0|||
143059095|NCT04405739|515753361|FG002|Overall Study|Death|1|||
143059096|NCT04405739|515753362|FG003|Overall Study|Death|0|||
143169958|NCT03396445|516171834|FG006|Treatment Period|Lost to Follow-up|0|||
143169959|NCT03396445|516171835|FG007|Treatment Period|Lost to Follow-up|0|||
143169960|NCT03396445|516171836|FG008|Treatment Period|Lost to Follow-up|0|||
143169961|NCT03396445|516171837|FG009|Treatment Period|Lost to Follow-up|0|||
143169962|NCT03396445|516171838|FG010|Treatment Period|Lost to Follow-up|0|||
143169963|NCT03396445|516171839|FG011|Treatment Period|Lost to Follow-up|0|||
143169964|NCT03396445|516171840|FG012|Treatment Period|Lost to Follow-up|1|||
143169965|NCT03396445|516171841|FG013|Treatment Period|Lost to Follow-up|0|||
143169966|NCT03396445|516171842|FG014|Treatment Period|Lost to Follow-up|1|||
143169967|NCT03396445|516171843|FG015|Treatment Period|Lost to Follow-up|0|||
143169968|NCT03396445|516171844|FG016|Treatment Period|Lost to Follow-up|0|||
143169969|NCT03396445|516171845|FG017|Treatment Period|Lost to Follow-up|0|||
143169970|NCT03396445|516171846|FG018|Treatment Period|Lost to Follow-up|0|||
143169971|NCT03396445|516171847|FG019|Treatment Period|Lost to Follow-up|0|||
143169972|NCT03396445|516171848|FG020|Treatment Period|Lost to Follow-up|0|||
143169973|NCT03396445|516171849|FG021|Treatment Period|Lost to Follow-up|0|||
143169974|NCT03396445|516171850|FG022|Treatment Period|Lost to Follow-up|0|||
143169975|NCT03396445|516171851|FG023|Treatment Period|Lost to Follow-up|0|||
143169976|NCT03396445|516171852|FG024|Treatment Period|Lost to Follow-up|0|||
143169977|NCT03396445|516171853|FG025|Treatment Period|Lost to Follow-up|0|||
143169978|NCT03396445|516171828|FG000|Treatment Period|Physician Decision|0|||
143169979|NCT03396445|516171829|FG001|Treatment Period|Physician Decision|0|||
143169980|NCT03396445|516171830|FG002|Treatment Period|Physician Decision|0|||
143169981|NCT03396445|516171831|FG003|Treatment Period|Physician Decision|0|||
143169982|NCT03396445|516171832|FG004|Treatment Period|Physician Decision|1|||
143059097|NCT04405739|515753359|FG000|Overall Study|Transferred to rehab|0|||
143059098|NCT04405739|515753360|FG001|Overall Study|Transferred to rehab|0|||
143059099|NCT04405739|515753361|FG002|Overall Study|Transferred to rehab|0|||
143059100|NCT04405739|515753362|FG003|Overall Study|Transferred to rehab|1|||
143059101|NCT04405739|515753359|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
143059102|NCT04405739|515753360|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
143059103|NCT04405739|515753361|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
143059104|NCT04405739|515753362|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
143169983|NCT03396445|516171833|FG005|Treatment Period|Physician Decision|0|||
143059105|NCT05766787|515753363|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
143169984|NCT03396445|516171834|FG006|Treatment Period|Physician Decision|0|||
143169985|NCT03396445|516171835|FG007|Treatment Period|Physician Decision|0|||
143501217|NCT00191854|517376199|FG002|Overall Study|Screen Failure|1|||
143501218|NCT00849017|517376200|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
143501219|NCT00849017|517376201|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
143501220|NCT00849017|517376202|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
143501221|NCT00849017|517376200|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
143501222|NCT00849017|517376201|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
143501223|NCT00849017|517376202|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
143501224|NCT00849017|517376200|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
143501225|NCT00849017|517376201|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
143501226|NCT00849017|517376202|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
143501227|NCT00849017|517376200|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
143501228|NCT00849017|517376201|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
143501229|NCT00849017|517376202|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
143501230|NCT00849017|517376200|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
143501231|NCT00849017|517376201|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
143501232|NCT00849017|517376202|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
143501233|NCT00849017|517376200|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
143501234|NCT00849017|517376201|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
143501235|NCT00849017|517376202|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
143501236|NCT00849017|517376200|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
143501237|NCT00849017|517376201|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
143501238|NCT00849017|517376202|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
143501239|NCT00849017|517376200|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
143501240|NCT00849017|517376201|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
143501241|NCT00849017|517376202|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
143501242|NCT00849017|517376200|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
143501243|NCT00849017|517376201|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
143501244|NCT00849017|517376202|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
143501245|NCT00849017|517376200|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
143501246|NCT00849017|517376201|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
143501247|NCT00849017|517376202|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
143501248|NCT00849017|517376200|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
143501249|NCT00849017|517376201|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
143501250|NCT00849017|517376202|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
143501251|NCT00849017|517376200|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
143501252|NCT00849017|517376201|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
143501253|NCT00849017|517376202|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
143501254|NCT00849017|517376200|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
143501255|NCT00849017|517376201|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
143501256|NCT00849017|517376202|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
143501257|NCT00849017|517376200|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
143501258|NCT00849017|517376201|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
143501259|NCT00849017|517376202|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
143365072|NCT02784704|516878778|FG001|Overall Study|Lost to Follow-up|4|||
143365073|NCT02784704|516878777|FG000|Overall Study|Withdrawal by Subject|1|||
143501260|NCT00849017|517376200|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
143501261|NCT00849017|517376201|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
143501262|NCT00849017|517376202|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
143501263|NCT00849017|517376200|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
143501264|NCT00849017|517376201|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
143501265|NCT00849017|517376202|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
143501266|NCT00849017|517376200|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
143501267|NCT00849017|517376201|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
143501268|NCT00849017|517376202|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
143501269|NCT00849017|517376200|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
143501270|NCT00849017|517376201|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
143501271|NCT00849017|517376202|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
143501272|NCT00849017|517376200|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
143501273|NCT00849017|517376201|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
143501274|NCT00849017|517376202|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
143501275|NCT01323478|517376204|FG000|Overall Study|Adverse Event|7|||
143501276|NCT01323478|517376204|FG000|Overall Study|Lack of Efficacy|4|||
143365074|NCT02784704|516878778|FG001|Overall Study|Withdrawal by Subject|3|||
143501277|NCT01323478|517376204|FG000|Overall Study|Non-compliance With Study Product|3|||
143501278|NCT01323478|517376204|FG000|Overall Study|Protocol Violation|1|||
143245726|NCT00481091|516451790|FG006|Overall Study|No reason given|1|||
143365075|NCT02784704|516878777|FG000|Overall Study|Subject Non Compliance|2|||
143245727|NCT00481091|516451791|FG007|Overall Study|No reason given|1|||
143501279|NCT01323478|517376204|FG000|Overall Study|Withdrawal of Consent|1|||
143501280|NCT01323478|517376204|FG000|Overall Study|Administrative or Other Reasons|8|||
143501281|NCT02411448|517376205|FG000|Overall Study|Withdrawal by Subject|1|||
143059106|NCT05766787|515753364|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
143059107|NCT05766787|515753363|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
143059108|NCT05766787|515753364|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
143059109|NCT05766787|515753363|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
143059110|NCT05766787|515753364|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
143059111|NCT01917968|515753365|FG000|Overall Study|Death|3|||
143059112|NCT01917968|515753366|FG001|Overall Study|Death|2|||
143059113|NCT01917968|515753365|FG000|Overall Study|Lost to Follow-up|21|||
143059114|NCT01917968|515753366|FG001|Overall Study|Lost to Follow-up|39|||
143059115|NCT01917968|515753365|FG000|Overall Study|Physician Decision|1|||
143059116|NCT01917968|515753366|FG001|Overall Study|Physician Decision|2|||
143059117|NCT01917968|515753365|FG000|Overall Study|Withdrawal by Subject|20|||
143059118|NCT01917968|515753366|FG001|Overall Study|Withdrawal by Subject|35|||
143059119|NCT01917968|515753365|FG000|Overall Study|Subject Relocation|5|||
143059120|NCT01917968|515753366|FG001|Overall Study|Subject Relocation|1|||
143059121|NCT01917968|515753365|FG000|Overall Study|36M Missed Visit|3|||
143059122|NCT01917968|515753366|FG001|Overall Study|36M Missed Visit|2|||
143059123|NCT01917968|515753365|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
143059124|NCT01917968|515753366|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
143059125|NCT01917968|515753365|FG000|Overall Study|Change in Family Circumstances|0|||
143059126|NCT01917968|515753366|FG001|Overall Study|Change in Family Circumstances|1|||
143059127|NCT01917968|515753365|FG000|Overall Study|No Data Available|0|||
143059128|NCT01917968|515753366|FG001|Overall Study|No Data Available|2|||
143059129|NCT03234608|515753369|FG000|Overall Study|Lost to Follow-up|23|||
143059130|NCT03234608|515753370|FG001|Overall Study|Lost to Follow-up|21|||
143059131|NCT03253094|515753371|FG000|Overall Study|Adverse Event|2|||
143059132|NCT03253094|515753372|FG001|Overall Study|Adverse Event|0|||
143059133|NCT03253094|515753373|FG002|Overall Study|Adverse Event|0|||
143059134|NCT03253094|515753374|FG003|Overall Study|Adverse Event|0|||
143059135|NCT03253094|515753375|FG004|Overall Study|Adverse Event|0|||
143059136|NCT03253094|515753376|FG005|Overall Study|Adverse Event|0|||
143059137|NCT03253094|515753371|FG000|Overall Study|Lack of Efficacy|0|||
143059138|NCT03253094|515753372|FG001|Overall Study|Lack of Efficacy|0|||
143059139|NCT03253094|515753373|FG002|Overall Study|Lack of Efficacy|2|||
143059140|NCT03253094|515753374|FG003|Overall Study|Lack of Efficacy|1|||
143059141|NCT03253094|515753375|FG004|Overall Study|Lack of Efficacy|2|||
143059142|NCT03253094|515753376|FG005|Overall Study|Lack of Efficacy|1|||
143059143|NCT03253094|515753371|FG000|Overall Study|Lost to Follow-up|0|||
143059144|NCT03253094|515753372|FG001|Overall Study|Lost to Follow-up|0|||
143059145|NCT03253094|515753373|FG002|Overall Study|Lost to Follow-up|1|||
143059146|NCT03253094|515753374|FG003|Overall Study|Lost to Follow-up|1|||
143059147|NCT03253094|515753375|FG004|Overall Study|Lost to Follow-up|0|||
143059148|NCT03253094|515753376|FG005|Overall Study|Lost to Follow-up|1|||
143059149|NCT03253094|515753371|FG000|Overall Study|Physician Decision|1|||
143059150|NCT03253094|515753372|FG001|Overall Study|Physician Decision|0|||
143059151|NCT03253094|515753373|FG002|Overall Study|Physician Decision|0|||
143501282|NCT02411448|517376206|FG001|Overall Study|Withdrawal by Subject|14|||
143501283|NCT02411448|517376207|FG002|Overall Study|Withdrawal by Subject|9|||
143501284|NCT02411448|517376205|FG000|Overall Study|Other|0|||
143501285|NCT02411448|517376206|FG001|Overall Study|Other|2|||
143501286|NCT02411448|517376207|FG002|Overall Study|Other|0|||
143501287|NCT02411448|517376205|FG000|Overall Study|Did not receive study treatment|0|||
143501288|NCT02411448|517376206|FG001|Overall Study|Did not receive study treatment|3|||
143501289|NCT02411448|517376207|FG002|Overall Study|Did not receive study treatment|0|||
143501290|NCT02411448|517376205|FG000|Overall Study|Alive on study treatment|3|||
143365076|NCT02784704|516878778|FG001|Overall Study|Subject Non Compliance|0|||
143501291|NCT02411448|517376206|FG001|Overall Study|Alive on study treatment|64|||
143501292|NCT02411448|517376207|FG002|Overall Study|Alive on study treatment|43|||
143059152|NCT03253094|515753374|FG003|Overall Study|Physician Decision|1|||
143059153|NCT03253094|515753375|FG004|Overall Study|Physician Decision|0|||
143059154|NCT03253094|515753376|FG005|Overall Study|Physician Decision|2|||
143059155|NCT03253094|515753371|FG000|Overall Study|Withdrawal by Subject|1|||
143059156|NCT03253094|515753372|FG001|Overall Study|Withdrawal by Subject|2|||
143059157|NCT03253094|515753373|FG002|Overall Study|Withdrawal by Subject|1|||
143059158|NCT03253094|515753374|FG003|Overall Study|Withdrawal by Subject|0|||
143059159|NCT03253094|515753375|FG004|Overall Study|Withdrawal by Subject|3|||
143059160|NCT03253094|515753376|FG005|Overall Study|Withdrawal by Subject|0|||
143059161|NCT03253094|515753371|FG000|Overall Study|Other|0|||
143059162|NCT03253094|515753372|FG001|Overall Study|Other|1|||
143059163|NCT03253094|515753373|FG002|Overall Study|Other|2|||
143059164|NCT03253094|515753374|FG003|Overall Study|Other|1|||
143059165|NCT03253094|515753375|FG004|Overall Study|Other|0|||
143059166|NCT03253094|515753376|FG005|Overall Study|Other|0|||
143059167|NCT00824369|515753377|FG000|Overall Study|Nolonger willing to participate in study|1|||
143059168|NCT00824369|515753378|FG001|Overall Study|Nolonger willing to participate in study|0|||
143059169|NCT00824369|515753379|FG002|Overall Study|Nolonger willing to participate in study|1|||
143059170|NCT00824369|515753380|FG003|Overall Study|Nolonger willing to participate in study|2|||
143059171|NCT00824369|515753381|FG004|Overall Study|Nolonger willing to participate in study|0|||
143059172|NCT00824369|515753382|FG005|Overall Study|Nolonger willing to participate in study|1|||
143059173|NCT00824369|515753377|FG000|Overall Study|Lost to Follow-up|0|||
143059174|NCT00824369|515753378|FG001|Overall Study|Lost to Follow-up|0|||
143059175|NCT00824369|515753379|FG002|Overall Study|Lost to Follow-up|0|||
143059176|NCT00824369|515753380|FG003|Overall Study|Lost to Follow-up|0|||
143059177|NCT00824369|515753381|FG004|Overall Study|Lost to Follow-up|1|||
143059178|NCT00824369|515753382|FG005|Overall Study|Lost to Follow-up|0|||
143059179|NCT01844531|515754955|FG000|Overall Study|Withdrawal by Subject|0|||
143059180|NCT01844531|515754956|FG001|Overall Study|Withdrawal by Subject|1|||
143059181|NCT01844531|515754957|FG002|Overall Study|Withdrawal by Subject|0|||
143059182|NCT01844531|515754958|FG003|Overall Study|Withdrawal by Subject|0|||
143059183|NCT01613378|515754959|FG000|Overall Study|Lack of Efficacy|13|||
143059184|NCT01613378|515754959|FG000|Overall Study|Adverse Event|11|||
143059185|NCT01613378|515754959|FG000|Overall Study|Withdrawal by Subject|8|||
143059186|NCT01613378|515754959|FG000|Overall Study|Death|2|||
143059187|NCT01613378|515754959|FG000|Overall Study|Lost to Follow-up|1|||
143059188|NCT01613378|515754959|FG000|Overall Study|Other Reason|4|||
143059189|NCT00418522|515754961|FG000|Overall Study|Adverse Event|7|||
143059190|NCT00418522|515754962|FG001|Overall Study|Adverse Event|1|||
143059191|NCT00418522|515754961|FG000|Overall Study|Lack of Efficacy|1|||
143059192|NCT00418522|515754962|FG001|Overall Study|Lack of Efficacy|3|||
143059193|NCT00418522|515754961|FG000|Overall Study|Lost to Follow-up|10|||
143059194|NCT00418522|515754962|FG001|Overall Study|Lost to Follow-up|4|||
143059195|NCT00418522|515754961|FG000|Overall Study|Withdrawal by Subject|31|||
143059196|NCT00418522|515754962|FG001|Overall Study|Withdrawal by Subject|7|||
143059197|NCT00418522|515754961|FG000|Overall Study|Other|27|||
143059198|NCT00418522|515754962|FG001|Overall Study|Other|23|||
143059199|NCT00418522|515754961|FG000|Overall Study|Randomized but did not receive treatment|7|||
143059200|NCT00418522|515754962|FG001|Overall Study|Randomized but did not receive treatment|4|||
143059201|NCT01652729|515754963|FG000|Overall Study|Withdrawal by Subject|14|||
143059202|NCT01652729|515754964|FG001|Overall Study|Withdrawal by Subject|7|||
143059203|NCT01652729|515754965|FG002|Overall Study|Withdrawal by Subject|7|||
143059204|NCT01652729|515754963|FG000|Overall Study|Adverse Event|4|||
143059205|NCT01652729|515754964|FG001|Overall Study|Adverse Event|0|||
143059206|NCT01652729|515754965|FG002|Overall Study|Adverse Event|3|||
143059207|NCT01652729|515754963|FG000|Overall Study|Physician Decision|1|||
143059208|NCT01652729|515754964|FG001|Overall Study|Physician Decision|0|||
143059209|NCT01652729|515754965|FG002|Overall Study|Physician Decision|1|||
143501293|NCT02771522|517376210|FG000|Overall Study|Lost to Follow-up|3|||
143059210|NCT01652729|515754963|FG000|Overall Study|Protocol Violation|1|||
143059211|NCT01652729|515754964|FG001|Overall Study|Protocol Violation|0|||
143059212|NCT01652729|515754965|FG002|Overall Study|Protocol Violation|0|||
143059213|NCT01652729|515754963|FG000|Overall Study|Lost to Follow-up|6|||
143059214|NCT01652729|515754964|FG001|Overall Study|Lost to Follow-up|6|||
143059215|NCT01652729|515754965|FG002|Overall Study|Lost to Follow-up|3|||
143059216|NCT01652729|515754963|FG000|Overall Study|Administrative|1|||
143059217|NCT01652729|515754964|FG001|Overall Study|Administrative|0|||
143059218|NCT01652729|515754965|FG002|Overall Study|Administrative|0|||
143059219|NCT01280617|515754968|FG000|Overall Study|Adverse Event|0|||
143059220|NCT01280617|515754969|FG001|Overall Study|Adverse Event|1|||
143059221|NCT00804141|515754970|FG000|Overall Study|Adverse Event|157|||
143059222|NCT00804141|515754970|FG000|Overall Study|Death|4|||
143059223|NCT00804141|515754970|FG000|Overall Study|Failed to return|96|||
143501294|NCT02771522|517376210|FG000|Overall Study|Withdrawal by Subject|2|||
143501295|NCT02771522|517376210|FG000|Overall Study|No white spot lesions|3|||
143059224|NCT00804141|515754970|FG000|Overall Study|Investigator request|8|||
143059225|NCT00804141|515754970|FG000|Overall Study|Protocol Violation|85|||
143059226|NCT00804141|515754970|FG000|Overall Study|Withdrawal by Subject|131|||
143059227|NCT00804141|515754970|FG000|Overall Study|Lack of Efficacy|46|||
143059228|NCT00804141|515754970|FG000|Overall Study|Other than specified|30|||
143059229|NCT00804141|515754970|FG000|Overall Study|Enrolled but not treated|6|||
143059230|NCT00572039|515754971|FG000|Overall Study|Withdrawal by Subject|9|||
143059231|NCT00572039|515754972|FG001|Overall Study|Withdrawal by Subject|6|||
143059232|NCT00572039|515754971|FG000|Overall Study|Death|2|||
143059233|NCT00572039|515754972|FG001|Overall Study|Death|3|||
143059234|NCT00572039|515754971|FG000|Overall Study|Ill|5|||
143059235|NCT00572039|515754972|FG001|Overall Study|Ill|1|||
143059236|NCT03756883|515754975|FG000|Overall Study|Adverse Event|2|||
143059237|NCT03756883|515754976|FG001|Overall Study|Adverse Event|2|||
143059238|NCT03756883|515754977|FG002|Overall Study|Adverse Event|2|||
143059239|NCT03756883|515754975|FG000|Overall Study|Lack of Efficacy|0|||
143059240|NCT03756883|515754976|FG001|Overall Study|Lack of Efficacy|1|||
143059241|NCT03756883|515754977|FG002|Overall Study|Lack of Efficacy|2|||
143059242|NCT03756883|515754975|FG000|Overall Study|Lost to Follow-up|3|||
143059243|NCT03756883|515754976|FG001|Overall Study|Lost to Follow-up|3|||
143059244|NCT03756883|515754977|FG002|Overall Study|Lost to Follow-up|0|||
143059245|NCT03756883|515754975|FG000|Overall Study|Protocol Violation|2|||
143059246|NCT03756883|515754976|FG001|Overall Study|Protocol Violation|0|||
143059247|NCT03756883|515754977|FG002|Overall Study|Protocol Violation|1|||
143059248|NCT03756883|515754975|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
143059249|NCT03756883|515754976|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
143059250|NCT03756883|515754977|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
143059251|NCT03756883|515754975|FG000|Overall Study|Withdrawal by Subject|4|||
143059252|NCT03756883|515754976|FG001|Overall Study|Withdrawal by Subject|1|||
143245728|NCT00481091|516451792|FG008|Overall Study|No reason given|1|||
143245729|NCT00481091|516451793|FG009|Overall Study|No reason given|4|||
143245730|NCT00475306|516451794|FG000|Overall Study|Protocol Violation|1|||
143245731|NCT00475306|516451795|FG001|Overall Study|Protocol Violation|1|||
143245732|NCT00475306|516451796|FG002|Overall Study|Protocol Violation|0|||
143245733|NCT00475306|516451797|FG003|Overall Study|Protocol Violation|1|||
143245734|NCT02405442|516451798|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
143245735|NCT02405442|516451799|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
143501296|NCT00624520|517376211|FG000|Overall Study|Withdrawal by Subject|12|||
143501297|NCT00624520|517376212|FG001|Overall Study|Withdrawal by Subject|7|||
143059253|NCT03756883|515754977|FG002|Overall Study|Withdrawal by Subject|0|||
143059254|NCT03756883|515754975|FG000|Overall Study|Other Reasons|2|||
143059255|NCT03756883|515754976|FG001|Overall Study|Other Reasons|4|||
143059256|NCT03756883|515754977|FG002|Overall Study|Other Reasons|0|||
143059257|NCT01011556|515754980|FG000|Overall Study|Adverse Event|1|||
143059258|NCT01011556|515754981|FG001|Overall Study|Adverse Event|3|||
143059259|NCT01011556|515754982|FG002|Overall Study|Adverse Event|2|||
143059260|NCT01011556|515754983|FG003|Overall Study|Adverse Event|1|||
143059261|NCT01011556|515754980|FG000|Overall Study|Lost to Follow-up|1|||
143059262|NCT01011556|515754981|FG001|Overall Study|Lost to Follow-up|0|||
143059263|NCT01011556|515754982|FG002|Overall Study|Lost to Follow-up|0|||
143059264|NCT01011556|515754983|FG003|Overall Study|Lost to Follow-up|0|||
143059265|NCT01011556|515754980|FG000|Overall Study|Physician Decision|1|||
143059266|NCT01011556|515754981|FG001|Overall Study|Physician Decision|0|||
143059267|NCT01011556|515754982|FG002|Overall Study|Physician Decision|0|||
143059268|NCT01011556|515754983|FG003|Overall Study|Physician Decision|1|||
143059269|NCT01011556|515754980|FG000|Overall Study|Protocol Violation|0|||
143059270|NCT01011556|515754981|FG001|Overall Study|Protocol Violation|1|||
143059271|NCT01011556|515754982|FG002|Overall Study|Protocol Violation|0|||
143059272|NCT01011556|515754983|FG003|Overall Study|Protocol Violation|0|||
143059273|NCT01011556|515754980|FG000|Overall Study|Withdrawal by Subject|1|||
143059274|NCT01011556|515754981|FG001|Overall Study|Withdrawal by Subject|2|||
143059275|NCT01011556|515754982|FG002|Overall Study|Withdrawal by Subject|4|||
143059276|NCT01011556|515754983|FG003|Overall Study|Withdrawal by Subject|4|||
143059277|NCT01011556|515754980|FG000|Overall Study|Sponsor decision|0|||
143059278|NCT01011556|515754981|FG001|Overall Study|Sponsor decision|1|||
143059279|NCT01011556|515754982|FG002|Overall Study|Sponsor decision|1|||
143059280|NCT01011556|515754983|FG003|Overall Study|Sponsor decision|2|||
143059281|NCT01011556|515754980|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
143059282|NCT01011556|515754981|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
143059283|NCT01011556|515754982|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
143059284|NCT01011556|515754983|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
143059285|NCT02147587|515754985|FG000|Overall Study|Adverse Event|9|||
143501298|NCT00624520|517376211|FG000|Overall Study|Death|0|||
143501299|NCT00624520|517376212|FG001|Overall Study|Death|1|||
143501300|NCT00934102|517376220|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
143501301|NCT00934102|517376221|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
143501302|NCT00934102|517376222|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
143501303|NCT02318784|517376223|FG000|Overall Study|Adverse Event|13|||
143501304|NCT02318784|517376223|FG000|Overall Study|Death|2|||
143501305|NCT02318784|517376223|FG000|Overall Study|Progressive Disease|37|||
143059286|NCT02147587|515754986|FG001|Overall Study|Adverse Event|4|||
143059287|NCT02147587|515754985|FG000|Overall Study|Lack of Efficacy|2|||
143059288|NCT02147587|515754986|FG001|Overall Study|Lack of Efficacy|1|||
143059289|NCT00865514|515754987|FG000|Overall Study|Infusion cost exceeded funding|2|||
143059290|NCT00530348|515754988|FG000|Overall Study|Adverse Event|5|||
143059291|NCT00530348|515754989|FG001|Overall Study|Adverse Event|1|||
143059292|NCT00530348|515754988|FG000|Overall Study|Death|0|||
143059293|NCT00530348|515754989|FG001|Overall Study|Death|1|||
143059294|NCT00530348|515754988|FG000|Overall Study|Lack of Efficacy|2|||
143245736|NCT02405442|516451800|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
143501306|NCT02318784|517376223|FG000|Overall Study|Withdrawal by Subject|10|||
143059295|NCT00530348|515754989|FG001|Overall Study|Lack of Efficacy|0|||
143059296|NCT00530348|515754988|FG000|Overall Study|Lost to Follow-up|0|||
143059297|NCT00530348|515754989|FG001|Overall Study|Lost to Follow-up|2|||
143059298|NCT00530348|515754988|FG000|Overall Study|Physician Decision|1|||
143059299|NCT00530348|515754989|FG001|Overall Study|Physician Decision|2|||
143059300|NCT00530348|515754988|FG000|Overall Study|Pregnancy|1|||
143059301|NCT00530348|515754989|FG001|Overall Study|Pregnancy|0|||
143059302|NCT00530348|515754988|FG000|Overall Study|Withdrawal by Subject|12|||
143059303|NCT00530348|515754989|FG001|Overall Study|Withdrawal by Subject|12|||
143059304|NCT00530348|515754988|FG000|Overall Study|Randomised in error|1|||
143059305|NCT00530348|515754989|FG001|Overall Study|Randomised in error|0|||
143059306|NCT00530348|515754988|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
143059307|NCT00530348|515754989|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
143059308|NCT00808509|515755005|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
143059309|NCT00808509|515755006|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
143059310|NCT00808509|515755005|FG000|Randomized Phase|Reduced methotrexate dose|1|||
143059311|NCT00808509|515755006|FG001|Randomized Phase|Reduced methotrexate dose|2|||
143059312|NCT00808509|515755005|FG000|Randomized Phase|Patient refused rescue therapy|0|||
143245737|NCT02405442|516451801|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
143245738|NCT02405442|516451798|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
143245739|NCT02405442|516451799|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
143245740|NCT02405442|516451800|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
143245741|NCT02405442|516451801|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
143245742|NCT02405442|516451798|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
143245743|NCT02405442|516451799|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
143245744|NCT02405442|516451800|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
143245745|NCT02405442|516451801|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
143245746|NCT02405442|516451798|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
143245747|NCT02405442|516451799|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
143245748|NCT02405442|516451800|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
143245749|NCT02405442|516451801|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
143245750|NCT02405442|516451798|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
143245751|NCT02405442|516451799|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
143245752|NCT02405442|516451800|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
143245753|NCT02405442|516451801|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
143245754|NCT02405442|516451798|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
143245755|NCT02405442|516451799|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
143245756|NCT02405442|516451800|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
143245757|NCT02405442|516451801|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
143245758|NCT02405442|516451798|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
143245759|NCT02405442|516451799|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
143245760|NCT02405442|516451800|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
143245761|NCT02405442|516451801|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
143245762|NCT02405442|516451798|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
143245763|NCT02405442|516451799|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
143245764|NCT02405442|516451800|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
143245765|NCT02405442|516451801|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
143245766|NCT02405442|516451798|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
143245767|NCT02405442|516451799|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
143245768|NCT02405442|516451800|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
143245769|NCT02405442|516451801|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
143245770|NCT02405442|516451798|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
143245771|NCT02405442|516451799|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
143245772|NCT02405442|516451800|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
143245773|NCT02405442|516451801|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
143245774|NCT02405442|516451798|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
143245775|NCT02405442|516451799|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
143245776|NCT02405442|516451800|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
143245777|NCT02405442|516451801|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
143245778|NCT02405442|516451798|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
143245779|NCT02405442|516451799|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
143245780|NCT02405442|516451800|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
143245781|NCT02405442|516451801|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
143501307|NCT02304926|517376224|FG000|Overall Study|Lost to Follow-up|2|||
143501308|NCT02304926|517376225|FG001|Overall Study|Lost to Follow-up|1|||
143501309|NCT04258579|517376232|FG000|Overall Study|Withdrawal by Subject|7|||
143501310|NCT04258579|517376232|FG000|Overall Study|Lost to Follow-up|3|||
143245782|NCT02405442|516451798|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
143245783|NCT02405442|516451799|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
143245784|NCT02405442|516451800|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
143245785|NCT02405442|516451801|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
143245786|NCT02405442|516451798|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
143245787|NCT02405442|516451799|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
143245788|NCT02405442|516451800|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
143245789|NCT02405442|516451801|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
143245790|NCT02078960|516451802|FG000|Treatment Period|Other|0|||
143501311|NCT04258579|517376232|FG000|Overall Study|Protocol Violation|2|||
143501312|NCT04258579|517376232|FG000|Overall Study|Adverse Event|1|||
143245791|NCT02078960|516451803|FG001|Treatment Period|Other|0|||
143245792|NCT02078960|516451804|FG002|Treatment Period|Other|1|||
143245793|NCT02078960|516451802|FG000|Treatment Period|Lack of Efficacy|0|||
143245794|NCT02078960|516451803|FG001|Treatment Period|Lack of Efficacy|1|||
143245795|NCT02078960|516451804|FG002|Treatment Period|Lack of Efficacy|0|||
143245796|NCT02078960|516451802|FG000|Treatment Period|Disease progression - accelerated phase|0|||
143245797|NCT02078960|516451803|FG001|Treatment Period|Disease progression - accelerated phase|1|||
143245798|NCT02078960|516451804|FG002|Treatment Period|Disease progression - accelerated phase|0|||
143245799|NCT02078960|516451802|FG000|Treatment Period|Disease progression - blast phase|1|||
143245800|NCT02078960|516451803|FG001|Treatment Period|Disease progression - blast phase|0|||
143245801|NCT02078960|516451804|FG002|Treatment Period|Disease progression - blast phase|0|||
143245802|NCT02078960|516451802|FG000|Treatment Period|Withdrawal by Subject|0|||
143245803|NCT02078960|516451803|FG001|Treatment Period|Withdrawal by Subject|1|||
143245804|NCT02078960|516451804|FG002|Treatment Period|Withdrawal by Subject|1|||
143245805|NCT02078960|516451802|FG000|Treatment Period|Adverse Event|1|||
143245806|NCT02078960|516451803|FG001|Treatment Period|Adverse Event|0|||
143245807|NCT02078960|516451804|FG002|Treatment Period|Adverse Event|0|||
143245808|NCT02078960|516451802|FG000|Treatment Period|Death|0|||
143245809|NCT02078960|516451803|FG001|Treatment Period|Death|0|||
143245810|NCT02078960|516451804|FG002|Treatment Period|Death|1|||
143245811|NCT02078960|516451802|FG000|Follow-up Period|Death|2|||
143245812|NCT02078960|516451803|FG001|Follow-up Period|Death|0|||
143245813|NCT02078960|516451804|FG002|Follow-up Period|Death|0|||
143245814|NCT02078960|516451802|FG000|Follow-up Period|Lost to Follow-up|0|||
143245815|NCT02078960|516451803|FG001|Follow-up Period|Lost to Follow-up|1|||
143245816|NCT02078960|516451804|FG002|Follow-up Period|Lost to Follow-up|0|||
143245817|NCT03275350|516451805|FG000|Overall Study|Lost to Follow-up|4|||
143245818|NCT03275350|516451806|FG001|Overall Study|Lost to Follow-up|6|||
143245819|NCT03275350|516451805|FG000|Overall Study|Death|2|||
143245820|NCT03275350|516451806|FG001|Overall Study|Death|1|||
143245821|NCT03275350|516451805|FG000|Overall Study|Physician Decision|1|||
143245822|NCT03275350|516451806|FG001|Overall Study|Physician Decision|0|||
143245823|NCT03275350|516451805|FG000|Overall Study|Incarcerated|1|||
143245824|NCT03275350|516451806|FG001|Overall Study|Incarcerated|1|||
143245825|NCT00905645|516451808|FG000|Overall Study|Death (not device related)|10|||
143245826|NCT00905645|516451809|FG001|Overall Study|Death (not device related)|4|||
143245827|NCT00905645|516451810|FG002|Overall Study|Death (not device related)|15|||
143245828|NCT00905645|516451811|FG003|Overall Study|Death (not device related)|8|||
143245829|NCT00905645|516451808|FG000|Overall Study|Explantation of study device(s)|78|||
143245830|NCT00905645|516451809|FG001|Overall Study|Explantation of study device(s)|47|||
143245831|NCT00905645|516451810|FG002|Overall Study|Explantation of study device(s)|28|||
143501313|NCT02388295|517376233|FG000|Dose Escalation Week 1|Adverse Event|1|||
143501314|NCT02388295|517376234|FG001|Dose Escalation Week 1|Adverse Event|2|||
143501315|NCT02388295|517376235|FG002|Dose Escalation Week 1|Adverse Event|1|||
143501316|NCT02388295|517376233|FG000|Dose Escalation Week 1|Determined not eligible|1|||
143501317|NCT02388295|517376234|FG001|Dose Escalation Week 1|Determined not eligible|1|||
143245832|NCT00905645|516451811|FG003|Overall Study|Explantation of study device(s)|21|||
143245833|NCT00905645|516451808|FG000|Overall Study|Subject Request|41|||
143245834|NCT00905645|516451809|FG001|Overall Study|Subject Request|17|||
143245835|NCT00905645|516451810|FG002|Overall Study|Subject Request|13|||
143501318|NCT02388295|517376235|FG002|Dose Escalation Week 1|Determined not eligible|1|||
143501319|NCT02388295|517376233|FG000|Dose Escalation Week 2|Protocol Violation|0|||
143501320|NCT02388295|517376234|FG001|Dose Escalation Week 2|Protocol Violation|1|||
143245836|NCT00905645|516451811|FG003|Overall Study|Subject Request|11|||
143245837|NCT00905645|516451808|FG000|Overall Study|Lost to Follow-up|299|||
143245838|NCT00905645|516451809|FG001|Overall Study|Lost to Follow-up|103|||
143245839|NCT00905645|516451810|FG002|Overall Study|Lost to Follow-up|51|||
143245840|NCT00905645|516451811|FG003|Overall Study|Lost to Follow-up|12|||
143245841|NCT01386970|516451812|FG000|Overall Study|Withdrawal by Subject|0|||
143245842|NCT01386970|516451813|FG001|Overall Study|Withdrawal by Subject|1|||
143501321|NCT02388295|517376235|FG002|Dose Escalation Week 2|Protocol Violation|0|||
143501322|NCT02388295|517376233|FG000|Dose Escalation Week 2|Determined not eligible|1|||
143501323|NCT02388295|517376234|FG001|Dose Escalation Week 2|Determined not eligible|1|||
143245843|NCT01386970|516451812|FG000|Overall Study|Adverse Event|4|||
143245844|NCT01386970|516451813|FG001|Overall Study|Adverse Event|1|||
143245845|NCT04881942|516451815|FG000|Overall Study|Adverse Event|0|||
143245846|NCT04881942|516451816|FG001|Overall Study|Adverse Event|0|||
143245847|NCT04881942|516451817|FG002|Overall Study|Adverse Event|0|||
143245848|NCT04881942|516451818|FG003|Overall Study|Adverse Event|0|||
143245849|NCT04881942|516451819|FG004|Overall Study|Adverse Event|1|||
143245850|NCT04881942|516451815|FG000|Overall Study|Alternates|0|||
143245851|NCT04881942|516451816|FG001|Overall Study|Alternates|0|||
143245852|NCT04881942|516451817|FG002|Overall Study|Alternates|0|||
143245853|NCT04881942|516451818|FG003|Overall Study|Alternates|0|||
143245854|NCT04881942|516451819|FG004|Overall Study|Alternates|2|||
143245855|NCT02423902|516451820|FG000|Overall Study|Disease progression|1|||
143245856|NCT02423902|516451821|FG001|Overall Study|Disease progression|4|||
143245857|NCT02136069|516451822|FG000|Overall Study|UC flare-up|1|||
143245858|NCT02136069|516451823|FG001|Overall Study|UC flare-up|0|||
143245859|NCT02136069|516451822|FG000|Overall Study|Adverse Event|6|||
143245860|NCT02136069|516451823|FG001|Overall Study|Adverse Event|8|||
143245861|NCT02136069|516451822|FG000|Overall Study|Death|0|||
143245862|NCT02136069|516451823|FG001|Overall Study|Death|1|||
143245863|NCT02136069|516451822|FG000|Overall Study|Lack of Efficacy|10|||
143245864|NCT02136069|516451823|FG001|Overall Study|Lack of Efficacy|4|||
143245865|NCT02136069|516451822|FG000|Overall Study|Lost to Follow-up|1|||
143245866|NCT02136069|516451823|FG001|Overall Study|Lost to Follow-up|0|||
143245867|NCT02136069|516451822|FG000|Overall Study|Non-Compliance|1|||
143245868|NCT02136069|516451823|FG001|Overall Study|Non-Compliance|0|||
143245869|NCT02136069|516451822|FG000|Overall Study|Physician Decision|5|||
143245870|NCT02136069|516451823|FG001|Overall Study|Physician Decision|4|||
143245871|NCT02136069|516451822|FG000|Overall Study|Withdrawal by Subject|10|||
143245872|NCT02136069|516451823|FG001|Overall Study|Withdrawal by Subject|11|||
143245873|NCT04693234|516451824|FG000|Overall Study|Death|79|||
143245874|NCT04693234|516451825|FG001|Overall Study|Death|19|||
143245875|NCT04693234|516451824|FG000|Overall Study|Sponsor Ended Study|47|||
143245876|NCT04693234|516451825|FG001|Overall Study|Sponsor Ended Study|18|||
143245877|NCT04693234|516451824|FG000|Overall Study|Withdrawal by Subject|10|||
143245878|NCT04693234|516451825|FG001|Overall Study|Withdrawal by Subject|2|||
143245879|NCT04693234|516451824|FG000|Overall Study|Lost to Follow-up|2|||
143501324|NCT02388295|517376235|FG002|Dose Escalation Week 2|Determined not eligible|1|||
143245880|NCT04693234|516451825|FG001|Overall Study|Lost to Follow-up|1|||
143245881|NCT02867384|516451826|FG000|Overall Study|GVHD requiring change in Treatment Medication|14|||
143245882|NCT02867384|516451827|FG001|Overall Study|GVHD requiring change in Treatment Medication|30|||
143245883|NCT02867384|516451828|FG002|Overall Study|GVHD requiring change in Treatment Medication|0|||
143501325|NCT02388295|517376233|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
143501326|NCT02388295|517376234|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
143245884|NCT02867384|516451826|FG000|Overall Study|Progression/ Relapse|15|||
143245885|NCT02867384|516451827|FG001|Overall Study|Progression/ Relapse|19|||
143245886|NCT02867384|516451828|FG002|Overall Study|Progression/ Relapse|0|||
143245887|NCT02867384|516451826|FG000|Overall Study|Adverse Event|13|||
143245888|NCT02867384|516451827|FG001|Overall Study|Adverse Event|1|||
143245889|NCT02867384|516451828|FG002|Overall Study|Adverse Event|0|||
143245890|NCT02867384|516451826|FG000|Overall Study|Withdrawal by Subject|6|||
143245891|NCT02867384|516451827|FG001|Overall Study|Withdrawal by Subject|5|||
143245892|NCT02867384|516451828|FG002|Overall Study|Withdrawal by Subject|0|||
143245893|NCT02867384|516451826|FG000|Overall Study|Physician Decision|1|||
143245894|NCT02867384|516451827|FG001|Overall Study|Physician Decision|2|||
143245895|NCT02867384|516451828|FG002|Overall Study|Physician Decision|0|||
143245896|NCT02867384|516451826|FG000|Overall Study|Patient compliance|1|||
143501327|NCT02388295|517376235|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
143501328|NCT04007159|517376236|FG000|Induction Phase|(missed study visits)|16|||
143245897|NCT02867384|516451827|FG001|Overall Study|Patient compliance|0|||
143245898|NCT02867384|516451828|FG002|Overall Study|Patient compliance|0|||
143245899|NCT02867384|516451826|FG000|Overall Study|Intercurrent illness or uncontrolled infection|1|||
143245900|NCT02867384|516451827|FG001|Overall Study|Intercurrent illness or uncontrolled infection|1|||
143245901|NCT02867384|516451828|FG002|Overall Study|Intercurrent illness or uncontrolled infection|0|||
143245902|NCT02867384|516451826|FG000|Overall Study|Never start treatment|3|||
143245903|NCT02867384|516451827|FG001|Overall Study|Never start treatment|0|||
143245904|NCT02867384|516451828|FG002|Overall Study|Never start treatment|0|||
143245905|NCT01727024|516451829|FG000|Period 1|Lost to Follow-up|1|||
143501329|NCT04007159|517376236|FG000|Induction Phase|Withdrawal by Subject|4|||
143245906|NCT01727024|516451830|FG001|Period 1|Lost to Follow-up|1|||
143245907|NCT01727024|516451829|FG000|Period 1|Withdrawal by Subject|2|||
143245908|NCT01727024|516451830|FG001|Period 1|Withdrawal by Subject|3|||
143245909|NCT01485172|516451831|FG000|Overall Study|Adverse Event|2|||
143245910|NCT01485172|516451832|FG001|Overall Study|Adverse Event|1|||
143245911|NCT01485172|516451833|FG002|Overall Study|Adverse Event|2|||
143059313|NCT00808509|515755006|FG001|Randomized Phase|Patient refused rescue therapy|3|||
143059314|NCT00931463|515755007|FG000|Overall Study|Death|8|||
143059315|NCT00931463|515755008|FG001|Overall Study|Death|4|||
143059316|NCT00931463|515755007|FG000|Overall Study|Withdrawal by Subject|5|||
143059317|NCT00931463|515755008|FG001|Overall Study|Withdrawal by Subject|0|||
143059318|NCT00931463|515755007|FG000|Overall Study|Lost to Follow-up|4|||
143059319|NCT00931463|515755008|FG001|Overall Study|Lost to Follow-up|1|||
143059320|NCT00436917|515755009|FG000|Overall Study|Withdrawal by Subject|13|||
143059321|NCT00436917|515755009|FG000|Overall Study|Adverse Event|2|||
143059322|NCT00436917|515755009|FG000|Overall Study|Physician Decision|1|||
143059323|NCT00436917|515755009|FG000|Overall Study|Death|1|||
143059324|NCT00436917|515755009|FG000|Overall Study|Lost to Follow-up|1|||
143059325|NCT00436917|515755009|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
143059326|NCT00436917|515755009|FG000|Overall Study|Increased creatinine|1|||
143059327|NCT00436917|515755009|FG000|Overall Study|Personal conflicts of patient|1|||
143059328|NCT02169791|515755010|FG000|Overall Study|Death|6|||
143059329|NCT02169791|515755010|FG000|Overall Study|patient withdrew consent|1|||
143059330|NCT01857206|515755018|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
143059331|NCT01857206|515755019|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
143059332|NCT01857206|515755018|FG000|Overall Study|Lost to Follow-up|9|||
143059333|NCT01857206|515755019|FG001|Overall Study|Lost to Follow-up|6|||
143059334|NCT01857206|515755018|FG000|Overall Study|Unclassified|3|||
143059335|NCT01857206|515755019|FG001|Overall Study|Unclassified|3|||
143059336|NCT01857206|515755018|FG000|Overall Study|Withdrawal by Subject|1|||
143059337|NCT01857206|515755019|FG001|Overall Study|Withdrawal by Subject|0|||
143059338|NCT00575380|515755020|FG000|Overall Study|Withdrawal by Subject|1|||
143059339|NCT00575380|515755021|FG001|Overall Study|Withdrawal by Subject|0|||
143059340|NCT00575380|515755020|FG000|Overall Study|Adverse Event|0|||
143059341|NCT00575380|515755021|FG001|Overall Study|Adverse Event|1|||
143059342|NCT00575380|515755020|FG000|Overall Study|Various|0|||
143059343|NCT00575380|515755021|FG001|Overall Study|Various|2|||
143059344|NCT03554317|515755022|FG000|Overall Study|Withdrawal by Subject|1|||
143059345|NCT03554317|515755022|FG000|Overall Study|PSA Progression|3|||
143059346|NCT03554317|515755022|FG000|Overall Study|Radiographic Progression|4|||
143059347|NCT00124462|515755025|FG000|Overall Study|Lost to Follow-up|3|||
143059348|NCT00124462|515755026|FG001|Overall Study|Lost to Follow-up|3|||
143059349|NCT00124462|515755025|FG000|Overall Study|Physician Decision|3|||
143059350|NCT00124462|515755026|FG001|Overall Study|Physician Decision|4|||
143059351|NCT00124462|515755025|FG000|Overall Study|Withdrawal by Subject|4|||
143059352|NCT00124462|515755026|FG001|Overall Study|Withdrawal by Subject|5|||
143059353|NCT00124462|515755025|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
143059354|NCT00124462|515755026|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
143059355|NCT00003531|515755027|FG000|Overall Study|Not evaluable|10|||
143059356|NCT02487082|515755028|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
143059357|NCT02487082|515755029|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
143059358|NCT02487082|515755028|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
143059359|NCT02487082|515755029|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
143169986|NCT03396445|516171836|FG008|Treatment Period|Physician Decision|0|||
143169987|NCT03396445|516171837|FG009|Treatment Period|Physician Decision|1|||
143169988|NCT03396445|516171838|FG010|Treatment Period|Physician Decision|0|||
143169989|NCT03396445|516171839|FG011|Treatment Period|Physician Decision|0|||
143169990|NCT03396445|516171840|FG012|Treatment Period|Physician Decision|0|||
143169991|NCT03396445|516171841|FG013|Treatment Period|Physician Decision|0|||
143169992|NCT03396445|516171842|FG014|Treatment Period|Physician Decision|0|||
143169993|NCT03396445|516171843|FG015|Treatment Period|Physician Decision|0|||
143169994|NCT03396445|516171844|FG016|Treatment Period|Physician Decision|0|||
143169995|NCT03396445|516171845|FG017|Treatment Period|Physician Decision|0|||
143169996|NCT03396445|516171846|FG018|Treatment Period|Physician Decision|0|||
143169997|NCT03396445|516171847|FG019|Treatment Period|Physician Decision|0|||
143169998|NCT03396445|516171848|FG020|Treatment Period|Physician Decision|0|||
143169999|NCT03396445|516171849|FG021|Treatment Period|Physician Decision|0|||
143170000|NCT03396445|516171850|FG022|Treatment Period|Physician Decision|0|||
143170001|NCT03396445|516171851|FG023|Treatment Period|Physician Decision|0|||
143170002|NCT03396445|516171852|FG024|Treatment Period|Physician Decision|0|||
143170003|NCT03396445|516171853|FG025|Treatment Period|Physician Decision|0|||
143170004|NCT03396445|516171828|FG000|Treatment Period|Randomized by Mistake without Study Treatment|0|||
143170005|NCT03396445|516171829|FG001|Treatment Period|Randomized by Mistake without Study Treatment|0|||
143170006|NCT03396445|516171830|FG002|Treatment Period|Randomized by Mistake without Study Treatment|0|||
143170007|NCT03396445|516171831|FG003|Treatment Period|Randomized by Mistake without Study Treatment|0|||
143170008|NCT03396445|516171832|FG004|Treatment Period|Randomized by Mistake without Study Treatment|0|||
143170009|NCT03396445|516171833|FG005|Treatment Period|Randomized by Mistake without Study Treatment|0|||
143170010|NCT03396445|516171834|FG006|Treatment Period|Randomized by Mistake without Study Treatment|0|||
143170011|NCT03396445|516171835|FG007|Treatment Period|Randomized by Mistake without Study Treatment|0|||
143170012|NCT03396445|516171836|FG008|Treatment Period|Randomized by Mistake without Study Treatment|0|||
143245912|NCT01485172|516451834|FG003|Overall Study|Adverse Event|2|||
143059360|NCT00251316|515755030|FG000|Overall Study|Physician Decision|2|||
143059361|NCT00251316|515755031|FG001|Overall Study|Physician Decision|3|||
143059362|NCT01198873|515755032|FG000|Overall Study|Adverse Event|4|||
143059363|NCT01198873|515755033|FG001|Overall Study|Adverse Event|7|||
143059364|NCT01198873|515755032|FG000|Overall Study|Study closure|29|||
143059365|NCT01198873|515755033|FG001|Overall Study|Study closure|23|||
143059366|NCT01198873|515755032|FG000|Overall Study|Other than above|4|||
143059367|NCT01198873|515755033|FG001|Overall Study|Other than above|2|||
143059368|NCT03139240|515755034|FG000|Overall Study|Lost to Follow-up|0|||
143059369|NCT03139240|515755035|FG001|Overall Study|Lost to Follow-up|1|||
143059370|NCT03139240|515755036|FG002|Overall Study|Lost to Follow-up|1|||
143059371|NCT03139240|515755037|FG003|Overall Study|Lost to Follow-up|0|||
143059372|NCT04569786|515755038|FG000|Overall Study|Lost to Follow-up|1|||
143059373|NCT04569786|515755039|FG001|Overall Study|Lost to Follow-up|0|||
143059374|NCT04569786|515755040|FG002|Overall Study|Lost to Follow-up|4|||
143059375|NCT04569786|515755041|FG003|Overall Study|Lost to Follow-up|1|||
143059376|NCT04569786|515755042|FG004|Overall Study|Lost to Follow-up|0|||
143059377|NCT04569786|515755038|FG000|Overall Study|Withdrawal by Subject|0|||
143059378|NCT04569786|515755039|FG001|Overall Study|Withdrawal by Subject|0|||
143059379|NCT04569786|515755040|FG002|Overall Study|Withdrawal by Subject|0|||
143059380|NCT04569786|515755041|FG003|Overall Study|Withdrawal by Subject|5|||
143059381|NCT04569786|515755042|FG004|Overall Study|Withdrawal by Subject|1|||
143059382|NCT04569786|515755038|FG000|Overall Study|Physician Decision|0|||
143059383|NCT04569786|515755039|FG001|Overall Study|Physician Decision|0|||
143059384|NCT04569786|515755040|FG002|Overall Study|Physician Decision|0|||
143059385|NCT04569786|515755041|FG003|Overall Study|Physician Decision|1|||
143059386|NCT04569786|515755042|FG004|Overall Study|Physician Decision|0|||
143059387|NCT01640184|515755043|FG000|Overall Study|Death|1|||
143059388|NCT01640184|515755044|FG001|Overall Study|Death|0|||
143059389|NCT01640184|515755045|FG002|Overall Study|Death|0|||
143059390|NCT01640184|515755043|FG000|Overall Study|Lost to Follow-up|4|||
143059391|NCT01640184|515755044|FG001|Overall Study|Lost to Follow-up|1|||
143059392|NCT01640184|515755045|FG002|Overall Study|Lost to Follow-up|0|||
143059393|NCT01640184|515755043|FG000|Overall Study|Physician Decision|3|||
143059394|NCT01640184|515755044|FG001|Overall Study|Physician Decision|0|||
143059395|NCT01640184|515755045|FG002|Overall Study|Physician Decision|0|||
143059396|NCT01640184|515755043|FG000|Overall Study|Withdrawal by Subject|0|||
143059397|NCT01640184|515755044|FG001|Overall Study|Withdrawal by Subject|1|||
143059398|NCT01640184|515755045|FG002|Overall Study|Withdrawal by Subject|1|||
143059399|NCT01640184|515755043|FG000|Overall Study|Protocol Violation|0|||
143059400|NCT01640184|515755044|FG001|Overall Study|Protocol Violation|0|||
143059401|NCT01640184|515755045|FG002|Overall Study|Protocol Violation|1|||
143501330|NCT04007159|517376236|FG000|Induction Phase|Adverse Event|2|||
143059402|NCT00613730|515755049|FG000|Overall Study|Disease progression|2|||
143059403|NCT00613730|515755049|FG000|Overall Study|Administrative decision|1|||
143059404|NCT00479388|515755050|FG000|Overall Study|Adverse Event|90|||
143059405|NCT00479388|515755051|FG001|Overall Study|Adverse Event|45|||
143059406|NCT00479388|515755050|FG000|Overall Study|Lost to Follow-up|0|||
143059407|NCT00479388|515755051|FG001|Overall Study|Lost to Follow-up|2|||
143059408|NCT00479388|515755050|FG000|Overall Study|Protocol Violation|10|||
143059409|NCT00479388|515755051|FG001|Overall Study|Protocol Violation|9|||
143059410|NCT00479388|515755050|FG000|Overall Study|Withdrawal by Subject|32|||
143059411|NCT00479388|515755051|FG001|Overall Study|Withdrawal by Subject|17|||
143059412|NCT01955044|515755052|FG000|Overall Study|Death|1|||
143059413|NCT01955044|515755053|FG001|Overall Study|Death|1|||
143059414|NCT01955044|515755054|FG002|Overall Study|Death|0|||
143059415|NCT02260258|515755055|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
143059416|NCT02260258|515755056|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
143501331|NCT04007159|517376236|FG000|Challenge Phase|missed study visits|3|||
143501332|NCT02076165|517376238|FG000|Overall Study|Lost to Follow-up|7|||
143501333|NCT02076165|517376239|FG001|Overall Study|Lost to Follow-up|5|||
143501334|NCT02076165|517376238|FG000|Overall Study|Refused follow-up assessment|1|||
143501335|NCT02076165|517376239|FG001|Overall Study|Refused follow-up assessment|1|||
143059417|NCT01610063|515755057|FG000|Overall Study|Lost to Follow-up|42|||
143059418|NCT01610063|515755058|FG001|Overall Study|Lost to Follow-up|20|||
143059419|NCT03314662|515755059|FG000|Overall Study|Withdrawal by Subject|1|||
143059420|NCT03314662|515755060|FG001|Overall Study|Withdrawal by Subject|1|||
143059421|NCT03314662|515755061|FG002|Overall Study|Withdrawal by Subject|1|||
143059422|NCT03314662|515755059|FG000|Overall Study|Lost to Follow-up|5|||
143059423|NCT03314662|515755060|FG001|Overall Study|Lost to Follow-up|4|||
143501336|NCT03804684|517376240|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
143059424|NCT03314662|515755061|FG002|Overall Study|Lost to Follow-up|4|||
143059425|NCT03314662|515755059|FG000|Overall Study|Death|2|||
143059426|NCT03314662|515755060|FG001|Overall Study|Death|0|||
143059427|NCT03314662|515755061|FG002|Overall Study|Death|0|||
143059428|NCT00925301|515755064|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
143059429|NCT00925301|515755065|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
143059430|NCT00925301|515755066|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
143059431|NCT00925301|515755067|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
143059432|NCT00925301|515755064|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
143059433|NCT00925301|515755065|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
143059434|NCT00925301|515755066|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
143059435|NCT00925301|515755067|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
143059436|NCT00925301|515755064|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
143059437|NCT00925301|515755065|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
143059438|NCT00925301|515755066|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
143059439|NCT00925301|515755067|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
143059440|NCT00925301|515755064|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
143059441|NCT00925301|515755065|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
143059442|NCT00925301|515755066|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
143059443|NCT00925301|515755067|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
143059444|NCT00925301|515755064|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
143059445|NCT00925301|515755065|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
143059446|NCT00925301|515755066|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
143059447|NCT00925301|515755067|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
143059448|NCT00925301|515755064|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
143059449|NCT00925301|515755065|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
143059450|NCT00925301|515755066|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
143059451|NCT00925301|515755067|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
143059452|NCT00925301|515755064|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
143059453|NCT00925301|515755065|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
143059454|NCT00925301|515755066|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
143059455|NCT00925301|515755067|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
143059456|NCT03043560|515755068|FG000|Overall Study|Discontinued Intervention|1|||
143059457|NCT03043560|515755069|FG001|Overall Study|Discontinued Intervention|2|||
143059458|NCT03043560|515755068|FG000|Overall Study|Lost to Follow-up|0|||
143059459|NCT03043560|515755069|FG001|Overall Study|Lost to Follow-up|1|||
143059460|NCT01117766|515755070|FG000|First Intervention|Adverse Event|0|||
143059461|NCT01117766|515755071|FG001|First Intervention|Adverse Event|1|||
143059462|NCT01117766|515755070|FG000|First Intervention|Protocol Violation|1|||
143059463|NCT01117766|515755071|FG001|First Intervention|Protocol Violation|0|||
143059464|NCT01117766|515755070|FG000|Washout Period|Protocol Violation|0|||
143059465|NCT01117766|515755071|FG001|Washout Period|Protocol Violation|2|||
143059466|NCT01117766|515755070|FG000|Second Intervention|Lost to Follow-up|1|||
143059467|NCT01117766|515755071|FG001|Second Intervention|Lost to Follow-up|0|||
143059468|NCT01117766|515755070|FG000|Second Intervention|Other|1|||
143059469|NCT01117766|515755071|FG001|Second Intervention|Other|2|||
143059470|NCT01117766|515755070|FG000|Second Intervention|Adverse Event|0|||
143059471|NCT01117766|515755071|FG001|Second Intervention|Adverse Event|2|||
143059472|NCT01117766|515755070|FG000|Second Intervention|Withdrawal by Subject|0|||
143059473|NCT01117766|515755071|FG001|Second Intervention|Withdrawal by Subject|1|||
143059474|NCT01436643|515755072|FG000|2-week Pre-treatment|Abnormal test result|0|||
143059475|NCT01436643|515755073|FG001|2-week Pre-treatment|Abnormal test result|0|||
143059476|NCT01436643|515755074|FG002|2-week Pre-treatment|Abnormal test result|0|||
143059477|NCT01436643|515755075|FG003|2-week Pre-treatment|Abnormal test result|1|||
143059478|NCT01436643|515755072|FG000|2-week Pre-treatment|Adverse Event|0|||
143059479|NCT01436643|515755073|FG001|2-week Pre-treatment|Adverse Event|0|||
143059480|NCT01436643|515755074|FG002|2-week Pre-treatment|Adverse Event|0|||
143059481|NCT01436643|515755075|FG003|2-week Pre-treatment|Adverse Event|5|||
143059482|NCT01436643|515755072|FG000|2-week Pre-treatment|Protocol Violation|0|||
143059483|NCT01436643|515755073|FG001|2-week Pre-treatment|Protocol Violation|0|||
143059484|NCT01436643|515755074|FG002|2-week Pre-treatment|Protocol Violation|0|||
143059485|NCT01436643|515755075|FG003|2-week Pre-treatment|Protocol Violation|4|||
143059486|NCT01436643|515755072|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
143059487|NCT01436643|515755073|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
143059488|NCT01436643|515755074|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
143059489|NCT01436643|515755075|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
143059490|NCT01436643|515755072|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
143059491|NCT01436643|515755073|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
143059492|NCT01436643|515755074|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
143059493|NCT01436643|515755075|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
143059494|NCT01436643|515755072|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
143059495|NCT01436643|515755073|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
143059496|NCT01436643|515755074|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
143501337|NCT03804684|517376241|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
143501338|NCT02429856|517376242|FG000|Overall Study|Death|12|||
143501339|NCT02429856|517376243|FG001|Overall Study|Death|13|||
143501340|NCT02429856|517376242|FG000|Overall Study|Lost to Follow-up|6|||
143059497|NCT01436643|515755075|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
143059498|NCT00438659|515755076|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
143059499|NCT00438659|515755077|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
143059500|NCT00438659|515755076|FG000|Overall Study|Cancel|5|||
143059501|NCT00438659|515755077|FG001|Overall Study|Cancel|2|||
143059502|NCT01867606|515755078|FG000|Overall Study|Withdrawal by Subject|10|||
143059503|NCT01867606|515755079|FG001|Overall Study|Withdrawal by Subject|14|||
143059504|NCT01867606|515755078|FG000|Overall Study|Protocol Violation|0|||
143059505|NCT01867606|515755079|FG001|Overall Study|Protocol Violation|1|||
143059506|NCT01378962|515755080|FG000|Overall Study|Death|14|||
143059507|NCT01378962|515755080|FG000|Overall Study|Lost to Follow-up|1|||
143059508|NCT01378962|515755080|FG000|Overall Study|Other|2|||
143059509|NCT02056652|515755081|FG000|Overall Study|Withdrawal by Subject|1|||
143059510|NCT02056652|515755082|FG001|Overall Study|Withdrawal by Subject|0|||
143059511|NCT02056652|515755081|FG000|Overall Study|Lost to Follow-up|0|||
143059512|NCT02056652|515755082|FG001|Overall Study|Lost to Follow-up|3|||
143059513|NCT01435928|515755083|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
143059514|NCT01435928|515755084|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
143059515|NCT01435928|515755085|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
143059516|NCT01435928|515755083|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
143059517|NCT01435928|515755084|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
143059518|NCT01435928|515755085|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
143059519|NCT01435928|515755083|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
143059520|NCT01435928|515755084|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
143059521|NCT01435928|515755085|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
143059522|NCT01435928|515755083|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
143059523|NCT01435928|515755084|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
143059524|NCT01435928|515755085|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
143059525|NCT01435928|515755083|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
143059526|NCT01435928|515755084|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
143059527|NCT01435928|515755085|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
143059528|NCT01435928|515755083|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
143059529|NCT01435928|515755084|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
143059530|NCT01435928|515755085|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
143059531|NCT01435928|515755083|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
143059532|NCT01435928|515755084|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
143059533|NCT01435928|515755085|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
143059534|NCT01435928|515755083|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
143059535|NCT01435928|515755084|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
143059536|NCT01435928|515755085|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
143059537|NCT01435928|515755083|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
143059538|NCT01435928|515755084|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
143059539|NCT01435928|515755085|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
143059540|NCT01435928|515755083|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
143059541|NCT01435928|515755084|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
143059542|NCT01435928|515755085|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
143059543|NCT01435928|515755083|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
143059544|NCT01435928|515755084|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
143059545|NCT01435928|515755085|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
143059546|NCT01435928|515755083|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
143059547|NCT01435928|515755084|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
143059548|NCT01435928|515755085|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
143059549|NCT01435928|515755083|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
143059550|NCT01435928|515755084|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
143059551|NCT01435928|515755085|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
143059552|NCT01435928|515755083|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
143059553|NCT01435928|515755084|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
143059554|NCT01435928|515755085|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
143059555|NCT01435928|515755083|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
143059556|NCT01435928|515755084|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
143059557|NCT01435928|515755085|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
143059558|NCT01435928|515755083|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
143059559|NCT01435928|515755084|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
143059560|NCT01435928|515755085|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
143059561|NCT04232540|515755089|FG000|Overall Study|Lost to Follow-up|1|||
143059562|NCT04232540|515755090|FG001|Overall Study|Lost to Follow-up|0|||
143059563|NCT02105701|515755091|FG000|Overall Study|Lost to Follow-up|1|||
143059564|NCT02105701|515755092|FG001|Overall Study|Lost to Follow-up|0|||
143170013|NCT03396445|516171837|FG009|Treatment Period|Randomized by Mistake without Study Treatment|0|||
143170014|NCT03396445|516171838|FG010|Treatment Period|Randomized by Mistake without Study Treatment|0|||
143245913|NCT01485172|516451835|FG004|Overall Study|Adverse Event|1|||
143059565|NCT02105701|515755093|FG002|Overall Study|Lost to Follow-up|2|||
143059566|NCT02105701|515755094|FG003|Overall Study|Lost to Follow-up|1|||
143059567|NCT02105701|515755091|FG000|Overall Study|Protocol Violation|0|||
143059568|NCT02105701|515755092|FG001|Overall Study|Protocol Violation|0|||
143059569|NCT02105701|515755093|FG002|Overall Study|Protocol Violation|1|||
143059570|NCT02105701|515755094|FG003|Overall Study|Protocol Violation|0|||
143059571|NCT02105701|515755091|FG000|Overall Study|Withdrawal by Subject|2|||
143059572|NCT02105701|515755092|FG001|Overall Study|Withdrawal by Subject|1|||
143059573|NCT02105701|515755093|FG002|Overall Study|Withdrawal by Subject|0|||
143059574|NCT02105701|515755094|FG003|Overall Study|Withdrawal by Subject|1|||
143059575|NCT02105701|515755091|FG000|Overall Study|Death|1|||
143059576|NCT02105701|515755092|FG001|Overall Study|Death|0|||
143059577|NCT02105701|515755093|FG002|Overall Study|Death|0|||
143059578|NCT02105701|515755094|FG003|Overall Study|Death|0|||
143059579|NCT00442546|515755099|FG000|Overall Study|Adverse Event|11|||
143059580|NCT00442546|515755100|FG001|Overall Study|Adverse Event|17|||
143059581|NCT00442546|515755101|FG002|Overall Study|Adverse Event|13|||
143059582|NCT00442546|515755099|FG000|Overall Study|Lost to Follow-up|1|||
143059583|NCT00442546|515755100|FG001|Overall Study|Lost to Follow-up|2|||
143059584|NCT00442546|515755101|FG002|Overall Study|Lost to Follow-up|1|||
143059585|NCT00442546|515755099|FG000|Overall Study|Other|4|||
143059586|NCT00442546|515755100|FG001|Overall Study|Other|9|||
143059587|NCT00442546|515755101|FG002|Overall Study|Other|6|||
143059588|NCT00442546|515755099|FG000|Overall Study|Withdrawal by Subject|5|||
143059589|NCT00442546|515755100|FG001|Overall Study|Withdrawal by Subject|5|||
143059590|NCT00442546|515755101|FG002|Overall Study|Withdrawal by Subject|7|||
143059591|NCT00442546|515755099|FG000|Overall Study|Randomized But Not Treated|5|||
143059592|NCT00442546|515755100|FG001|Overall Study|Randomized But Not Treated|4|||
143059593|NCT00442546|515755101|FG002|Overall Study|Randomized But Not Treated|6|||
143059594|NCT00248170|515755102|FG000|Overall Study|Withdrawal by Subject|71|||
143059595|NCT00248170|515755103|FG001|Overall Study|Withdrawal by Subject|79|||
143059596|NCT00248170|515755102|FG000|Overall Study|Protocol Violation|35|||
143059597|NCT00248170|515755103|FG001|Overall Study|Protocol Violation|30|||
143059598|NCT00248170|515755102|FG000|Overall Study|Lost to Follow-up|28|||
143059599|NCT00248170|515755103|FG001|Overall Study|Lost to Follow-up|35|||
143059600|NCT00248170|515755102|FG000|Overall Study|Disease progression|196|||
143059601|NCT00248170|515755103|FG001|Overall Study|Disease progression|216|||
143059602|NCT00248170|515755102|FG000|Overall Study|Death|28|||
143059603|NCT00248170|515755103|FG001|Overall Study|Death|47|||
143059604|NCT00248170|515755102|FG000|Overall Study|Adverse Event|311|||
143059605|NCT00248170|515755103|FG001|Overall Study|Adverse Event|296|||
143059606|NCT00248170|515755102|FG000|Overall Study|Administrative problems|22|||
143059607|NCT00248170|515755103|FG001|Overall Study|Administrative problems|25|||
143059608|NCT00248170|515755102|FG000|Overall Study|Abnormal test procedure(s) result|49|||
143059609|NCT00248170|515755103|FG001|Overall Study|Abnormal test procedure(s) result|61|||
143059610|NCT00248170|515755102|FG000|Overall Study|Abnormal laboratory values|4|||
143059611|NCT00248170|515755103|FG001|Overall Study|Abnormal laboratory values|0|||
143059612|NCT00248170|515755102|FG000|Overall Study|Protocol deviation|17|||
143059613|NCT00248170|515755103|FG001|Overall Study|Protocol deviation|19|||
143059614|NCT00749411|515755112|FG000|Overall Study|Adverse Event|0|||
143059615|NCT00749411|515755113|FG001|Overall Study|Adverse Event|2|||
143059616|NCT00749411|515755112|FG000|Overall Study|Lack of Efficacy|0|||
143059617|NCT00749411|515755113|FG001|Overall Study|Lack of Efficacy|1|||
143059618|NCT00749411|515755112|FG000|Overall Study|Protocol Violation|1|||
143059619|NCT00749411|515755113|FG001|Overall Study|Protocol Violation|1|||
143059620|NCT00749411|515755112|FG000|Overall Study|Protocol-defined stopping criteria|0|||
143059621|NCT00749411|515755113|FG001|Overall Study|Protocol-defined stopping criteria|1|||
143059622|NCT03183141|515755114|FG000|Overall Study|Withdrawal by Subject|2|||
143059623|NCT03183141|515755115|FG001|Overall Study|Withdrawal by Subject|4|||
143059624|NCT03183141|515755114|FG000|Overall Study|Death|0|||
143059625|NCT03183141|515755115|FG001|Overall Study|Death|8|||
143059626|NCT01507090|515755119|FG000|Overall Study|incomplete dataset|18|||
143059627|NCT03581188|515757046|FG000|Overall Study|Inclusion criteria not met|3|||
143059628|NCT03581188|515757047|FG001|Overall Study|Inclusion criteria not met|2|||
143059629|NCT03581188|515757046|FG000|Overall Study|Lost to Follow-up|5|||
143059630|NCT03581188|515757047|FG001|Overall Study|Lost to Follow-up|5|||
143059631|NCT03581188|515757046|FG000|Overall Study|Discontinued intervention|11|||
143059632|NCT03581188|515757047|FG001|Overall Study|Discontinued intervention|8|||
143059633|NCT01989676|515757048|FG000|Overall Study|Death|52|||
143059634|NCT01989676|515757049|FG001|Overall Study|Death|60|||
143059635|NCT01989676|515757048|FG000|Overall Study|Protocol Violation|2|||
143170015|NCT03396445|516171839|FG011|Treatment Period|Randomized by Mistake without Study Treatment|0|||
143059636|NCT01989676|515757049|FG001|Overall Study|Protocol Violation|1|||
143059637|NCT01989676|515757048|FG000|Overall Study|Lost to Follow-up|8|||
143365077|NCT00603538|516878779|FG000|Overall Study|Adverse Event|0|||
143365078|NCT00603538|516878780|FG001|Overall Study|Adverse Event|4|||
143059638|NCT01989676|515757049|FG001|Overall Study|Lost to Follow-up|18|||
143059639|NCT01989676|515757048|FG000|Overall Study|No longer willing to participate in study|26|||
143059640|NCT01989676|515757049|FG001|Overall Study|No longer willing to participate in study|26|||
143059641|NCT01989676|515757048|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
143059642|NCT01989676|515757049|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
143059643|NCT01989676|515757048|FG000|Overall Study|Other|4|||
143059644|NCT01989676|515757049|FG001|Overall Study|Other|3|||
143059645|NCT03941834|515757050|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
143059646|NCT03941834|515757051|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
143059647|NCT03941834|515757052|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
143059648|NCT03941834|515757050|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
143059649|NCT03941834|515757051|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
143059650|NCT03941834|515757052|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
143059651|NCT03941834|515757050|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
143059652|NCT03941834|515757051|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
143059653|NCT03941834|515757052|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
143059654|NCT03941834|515757050|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
143059655|NCT03941834|515757051|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
143059656|NCT03941834|515757052|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
143059657|NCT03941834|515757050|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
143059658|NCT03941834|515757051|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
143059659|NCT03941834|515757052|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
143059660|NCT03941834|515757050|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
143059661|NCT03941834|515757051|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
143059662|NCT03941834|515757052|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
143059663|NCT01606228|515757053|FG000|Overall Study|Lost to Follow-up|20|||
143059664|NCT01606228|515757053|FG000|Overall Study|Withdrawal by Subject|3|||
143059665|NCT01606228|515757053|FG000|Overall Study|Non-compliant|3|||
143059666|NCT01606228|515757053|FG000|Overall Study|Lack of Efficacy|2|||
143059667|NCT01606228|515757053|FG000|Overall Study|Adverse Event|1|||
143059668|NCT01115855|515757054|FG000|Overall Study|Adverse Event|16|||
143059669|NCT01115855|515757055|FG001|Overall Study|Adverse Event|18|||
143059670|NCT01115855|515757054|FG000|Overall Study|Death|6|||
143059671|NCT01115855|515757055|FG001|Overall Study|Death|5|||
143059672|NCT01115855|515757054|FG000|Overall Study|Lab Abnormality|1|||
143059673|NCT01115855|515757055|FG001|Overall Study|Lab Abnormality|1|||
143059674|NCT01115855|515757054|FG000|Overall Study|Protocol Violation|0|||
143059675|NCT01115855|515757055|FG001|Overall Study|Protocol Violation|1|||
143059676|NCT01115855|515757054|FG000|Overall Study|Withdrawal by Subject|5|||
143059677|NCT01115855|515757055|FG001|Overall Study|Withdrawal by Subject|5|||
143059678|NCT01115855|515757054|FG000|Overall Study|Other|8|||
143059679|NCT01115855|515757055|FG001|Overall Study|Other|6|||
143059680|NCT00480324|515757056|FG000|Overall Study|Adverse Event|1|||
143059681|NCT00480324|515757057|FG001|Overall Study|Adverse Event|1|||
143059682|NCT00480324|515757056|FG000|Overall Study|Protocol Violation|0|||
143059683|NCT00480324|515757057|FG001|Overall Study|Protocol Violation|1|||
143059684|NCT00480324|515757056|FG000|Overall Study|Withdrawal by Subject|14|||
143059685|NCT00480324|515757057|FG001|Overall Study|Withdrawal by Subject|5|||
143059686|NCT00480324|515757056|FG000|Overall Study|Lost to Follow-up|17|||
143059687|NCT00480324|515757057|FG001|Overall Study|Lost to Follow-up|8|||
143059688|NCT00480324|515757056|FG000|Overall Study|Subject's mother pregnant|0|||
143059689|NCT00480324|515757057|FG001|Overall Study|Subject's mother pregnant|1|||
143059690|NCT00784134|515757058|FG000|Overall Study|Lost to Follow-up|3|||
143059691|NCT00784134|515757059|FG001|Overall Study|Lost to Follow-up|6|||
143059692|NCT03785145|515757060|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
143059693|NCT03785145|515757061|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
143059694|NCT03785145|515757060|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
143059695|NCT03785145|515757061|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
143059696|NCT03785145|515757060|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
143059697|NCT03785145|515757061|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
143059698|NCT03785145|515757060|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
143059699|NCT03785145|515757061|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
143059700|NCT03785145|515757060|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
143059701|NCT03785145|515757061|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
143059702|NCT03785145|515757060|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
143059703|NCT03785145|515757061|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
143059704|NCT03785145|515757060|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
143059705|NCT03785145|515757061|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
143059706|NCT03785145|515757060|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
143059707|NCT03785145|515757061|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
143059708|NCT03785145|515757060|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
143059709|NCT03785145|515757061|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
143059710|NCT03785145|515757060|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
143059711|NCT03785145|515757061|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
143059712|NCT03785145|515757060|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
143059713|NCT03785145|515757061|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
143059714|NCT00097786|515757062|FG000|Overall Study|lost to follow-up for all-cause death|296|||
143059715|NCT00097786|515757063|FG001|Overall Study|lost to follow-up for all-cause death|292|||
143059716|NCT00097786|515757064|FG002|Overall Study|lost to follow-up for all-cause death|313|||
143059717|NCT00097786|515757065|FG003|Overall Study|lost to follow-up for all-cause death|310|||
143059718|NCT02960438|515757066|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
143059719|NCT02960438|515757067|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
143059720|NCT02960438|515757068|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
143059721|NCT02960438|515757069|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
143059722|NCT02960438|515757066|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
143059723|NCT02960438|515757067|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
143059724|NCT02960438|515757068|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
143059725|NCT02960438|515757069|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
143059726|NCT02960438|515757066|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
143059727|NCT02960438|515757067|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
143059728|NCT02960438|515757068|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
143059729|NCT02960438|515757069|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
143059730|NCT02960438|515757066|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
143059731|NCT02960438|515757067|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
143059732|NCT02960438|515757068|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
143059733|NCT02960438|515757069|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
143059734|NCT02960438|515757066|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
143059735|NCT02960438|515757067|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
143059736|NCT02960438|515757068|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
143059737|NCT02960438|515757069|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
143059738|NCT02960438|515757066|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
143059739|NCT02960438|515757067|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
143059740|NCT02960438|515757068|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
143059741|NCT02960438|515757069|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
143059742|NCT02960438|515757066|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
143059743|NCT02960438|515757067|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
143059744|NCT02960438|515757068|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
143059745|NCT02960438|515757069|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
143059746|NCT02960438|515757066|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
143059747|NCT02960438|515757067|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
143059748|NCT02960438|515757068|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
143501341|NCT02429856|517376243|FG001|Overall Study|Lost to Follow-up|5|||
143059749|NCT02960438|515757069|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
143059750|NCT02960438|515757066|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
143059751|NCT02960438|515757067|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
143059752|NCT02960438|515757068|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
143059753|NCT02960438|515757069|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
143059754|NCT02960438|515757066|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
143059755|NCT02960438|515757067|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
143059756|NCT02960438|515757068|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
143059757|NCT02960438|515757069|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
143059758|NCT02960438|515757066|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
143059759|NCT02960438|515757067|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
143059760|NCT02960438|515757068|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
143059761|NCT02960438|515757069|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
143059762|NCT02960438|515757066|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
143059763|NCT02960438|515757067|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
143059764|NCT02960438|515757068|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
143059765|NCT02960438|515757069|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
143059766|NCT03686150|515757070|FG000|Overall Study|Withdrawal by Subject|1|||
143059767|NCT03686150|515757071|FG001|Overall Study|Withdrawal by Subject|1|||
143059768|NCT03686150|515757072|FG002|Overall Study|Withdrawal by Subject|1|||
143059769|NCT03686150|515757073|FG003|Overall Study|Withdrawal by Subject|0|||
143501342|NCT02429856|517376242|FG000|Overall Study|Withdrawal by Subject|1|||
143059770|NCT03686150|515757074|FG004|Overall Study|Withdrawal by Subject|1|||
143170016|NCT03396445|516171840|FG012|Treatment Period|Randomized by Mistake without Study Treatment|1|||
143170017|NCT03396445|516171841|FG013|Treatment Period|Randomized by Mistake without Study Treatment|0|||
143501343|NCT02429856|517376243|FG001|Overall Study|Withdrawal by Subject|1|||
143501344|NCT00486603|517376245|FG000|Overall Study|Withdrawal by Subject|1|||
143059771|NCT03686150|515757075|FG005|Overall Study|Withdrawal by Subject|2|||
143059772|NCT03686150|515757070|FG000|Overall Study|Physician Decision|1|||
143059773|NCT03686150|515757071|FG001|Overall Study|Physician Decision|0|||
143059774|NCT03686150|515757072|FG002|Overall Study|Physician Decision|0|||
143059775|NCT03686150|515757073|FG003|Overall Study|Physician Decision|0|||
143059776|NCT03686150|515757074|FG004|Overall Study|Physician Decision|0|||
143059777|NCT03686150|515757075|FG005|Overall Study|Physician Decision|1|||
143059778|NCT03686150|515757070|FG000|Overall Study|Lost to Follow-up|0|||
143059779|NCT03686150|515757071|FG001|Overall Study|Lost to Follow-up|1|||
143059780|NCT03686150|515757072|FG002|Overall Study|Lost to Follow-up|0|||
143059781|NCT03686150|515757073|FG003|Overall Study|Lost to Follow-up|0|||
143059782|NCT03686150|515757074|FG004|Overall Study|Lost to Follow-up|0|||
143059783|NCT03686150|515757075|FG005|Overall Study|Lost to Follow-up|0|||
143059784|NCT02443324|515757077|FG000|Overall Study|Death|4|||
143059785|NCT02443324|515757078|FG001|Overall Study|Death|1|||
143059786|NCT02443324|515757079|FG002|Overall Study|Death|0|||
143059787|NCT02443324|515757080|FG003|Overall Study|Death|3|||
143059788|NCT02443324|515757081|FG004|Overall Study|Death|1|||
143059789|NCT02443324|515757082|FG005|Overall Study|Death|3|||
143059790|NCT02443324|515757083|FG006|Overall Study|Death|2|||
143059791|NCT02443324|515757077|FG000|Overall Study|Lost to Follow-up|0|||
143059792|NCT02443324|515757078|FG001|Overall Study|Lost to Follow-up|0|||
143059793|NCT02443324|515757079|FG002|Overall Study|Lost to Follow-up|0|||
143059794|NCT02443324|515757080|FG003|Overall Study|Lost to Follow-up|1|||
143059795|NCT02443324|515757081|FG004|Overall Study|Lost to Follow-up|0|||
143059796|NCT02443324|515757082|FG005|Overall Study|Lost to Follow-up|1|||
143059797|NCT02443324|515757083|FG006|Overall Study|Lost to Follow-up|0|||
143059798|NCT02443324|515757077|FG000|Overall Study|Physician Decision|0|||
143059799|NCT02443324|515757078|FG001|Overall Study|Physician Decision|3|||
143059800|NCT02443324|515757079|FG002|Overall Study|Physician Decision|5|||
143059801|NCT02443324|515757080|FG003|Overall Study|Physician Decision|1|||
143059802|NCT02443324|515757081|FG004|Overall Study|Physician Decision|1|||
143059803|NCT02443324|515757082|FG005|Overall Study|Physician Decision|0|||
143059804|NCT02443324|515757083|FG006|Overall Study|Physician Decision|2|||
143059805|NCT02443324|515757077|FG000|Overall Study|Progressive Disease|20|||
143059806|NCT02443324|515757078|FG001|Overall Study|Progressive Disease|20|||
143059807|NCT02443324|515757079|FG002|Overall Study|Progressive Disease|13|||
143059808|NCT02443324|515757080|FG003|Overall Study|Progressive Disease|10|||
143059809|NCT02443324|515757081|FG004|Overall Study|Progressive Disease|13|||
143059810|NCT02443324|515757082|FG005|Overall Study|Progressive Disease|17|||
143059811|NCT02443324|515757083|FG006|Overall Study|Progressive Disease|10|||
143059812|NCT02443324|515757077|FG000|Overall Study|Withdrawal by Subject|0|||
143059813|NCT02443324|515757078|FG001|Overall Study|Withdrawal by Subject|0|||
143059814|NCT02443324|515757079|FG002|Overall Study|Withdrawal by Subject|3|||
143059815|NCT02443324|515757080|FG003|Overall Study|Withdrawal by Subject|1|||
143059816|NCT02443324|515757081|FG004|Overall Study|Withdrawal by Subject|1|||
143059817|NCT02443324|515757082|FG005|Overall Study|Withdrawal by Subject|0|||
143059818|NCT02443324|515757083|FG006|Overall Study|Withdrawal by Subject|1|||
143059819|NCT02443324|515757077|FG000|Overall Study|Adverse Event|0|||
143059820|NCT02443324|515757078|FG001|Overall Study|Adverse Event|1|||
143059821|NCT02443324|515757079|FG002|Overall Study|Adverse Event|3|||
143059822|NCT02443324|515757080|FG003|Overall Study|Adverse Event|0|||
143245914|NCT01485172|516451836|FG005|Overall Study|Adverse Event|2|||
143501345|NCT00486603|517376246|FG001|Overall Study|Withdrawal by Subject|0|||
143501346|NCT00486603|517376247|FG002|Overall Study|Withdrawal by Subject|0|||
143501347|NCT00486603|517376248|FG003|Overall Study|Withdrawal by Subject|0|||
143245915|NCT01485172|516451831|FG000|Overall Study|Lack of Efficacy|2|||
143245916|NCT01485172|516451832|FG001|Overall Study|Lack of Efficacy|0|||
143245917|NCT01485172|516451833|FG002|Overall Study|Lack of Efficacy|0|||
143245918|NCT01485172|516451834|FG003|Overall Study|Lack of Efficacy|0|||
143245919|NCT01485172|516451835|FG004|Overall Study|Lack of Efficacy|0|||
143501348|NCT00486603|517376249|FG004|Overall Study|Withdrawal by Subject|0|||
143501349|NCT00486603|517376245|FG000|Overall Study|Physician Decision|0|||
143501350|NCT00486603|517376246|FG001|Overall Study|Physician Decision|1|||
143059823|NCT02443324|515757081|FG004|Overall Study|Adverse Event|4|||
143059824|NCT02443324|515757082|FG005|Overall Study|Adverse Event|3|||
143059825|NCT02443324|515757083|FG006|Overall Study|Adverse Event|3|||
143059826|NCT02443324|515757077|FG000|Overall Study|Enrolled but Never Treated|0|||
143059827|NCT02443324|515757078|FG001|Overall Study|Enrolled but Never Treated|0|||
143059828|NCT02443324|515757079|FG002|Overall Study|Enrolled but Never Treated|1|||
143059829|NCT02443324|515757080|FG003|Overall Study|Enrolled but Never Treated|0|||
143501351|NCT00486603|517376247|FG002|Overall Study|Physician Decision|0|||
143059830|NCT02443324|515757081|FG004|Overall Study|Enrolled but Never Treated|1|||
143059831|NCT02443324|515757082|FG005|Overall Study|Enrolled but Never Treated|0|||
143059832|NCT02443324|515757083|FG006|Overall Study|Enrolled but Never Treated|1|||
143245920|NCT01485172|516451836|FG005|Overall Study|Lack of Efficacy|0|||
143245921|NCT01485172|516451831|FG000|Overall Study|Protocol Violation|0|||
143501352|NCT00486603|517376248|FG003|Overall Study|Physician Decision|0|||
143059833|NCT01647711|515757084|FG000|Overall Study|Progressive disease|6|||
143059834|NCT01647711|515757085|FG001|Overall Study|Progressive disease|2|||
143501353|NCT00486603|517376249|FG004|Overall Study|Physician Decision|0|||
143501354|NCT00763009|517376250|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
143501355|NCT02706938|517376253|FG000|First Period, 6 Weeks|Adverse Event|8|||
143501356|NCT02706938|517376254|FG001|First Period, 6 Weeks|Adverse Event|0|||
143501357|NCT02706938|517376253|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
143501358|NCT02706938|517376254|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
143501359|NCT02706938|517376253|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
143501360|NCT02706938|517376254|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
143501361|NCT02706938|517376253|FG000|Second Period, 6 Weeks|Adverse Event|0|||
143501362|NCT02706938|517376254|FG001|Second Period, 6 Weeks|Adverse Event|7|||
143501363|NCT02706938|517376253|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
143501364|NCT02706938|517376254|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
143501365|NCT01662648|517376257|FG000|Overall Study|Death|1|||
143501366|NCT01662648|517376258|FG001|Overall Study|Death|3|||
143501367|NCT01662648|517376257|FG000|Overall Study|Adverse Event|40|||
143501368|NCT01662648|517376258|FG001|Overall Study|Adverse Event|37|||
143501369|NCT01662648|517376257|FG000|Overall Study|Lack of Efficacy|17|||
143501370|NCT01662648|517376258|FG001|Overall Study|Lack of Efficacy|16|||
143501371|NCT01662648|517376257|FG000|Overall Study|Participant ineligible to continue trial|1|||
143501372|NCT01662648|517376258|FG001|Overall Study|Participant ineligible to continue trial|1|||
143501373|NCT01662648|517376257|FG000|Overall Study|Lost to Follow-up|24|||
143501374|NCT01662648|517376258|FG001|Overall Study|Lost to Follow-up|36|||
143501375|NCT01662648|517376257|FG000|Overall Study|Withdrawal by Subject|36|||
143501376|NCT01662648|517376258|FG001|Overall Study|Withdrawal by Subject|53|||
143501377|NCT01662648|517376257|FG000|Overall Study|Participant non-compliant|16|||
143501378|NCT01662648|517376258|FG001|Overall Study|Participant non-compliant|20|||
143501379|NCT01662648|517376257|FG000|Overall Study|Other|8|||
143501380|NCT01662648|517376258|FG001|Overall Study|Other|11|||
143501381|NCT01662648|517376257|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
143501382|NCT01662648|517376258|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
143501383|NCT01662648|517376257|FG000|Overall Study|LOE and other reason unspecified|1|||
143501384|NCT01662648|517376258|FG001|Overall Study|LOE and other reason unspecified|0|||
143501385|NCT01662648|517376257|FG000|Overall Study|LOE and Participant non-compliant|0|||
143501386|NCT01662648|517376258|FG001|Overall Study|LOE and Participant non-compliant|1|||
143501387|NCT02868892|517376259|FG000|Overall Study|Investigator left site and no follow-up|6|||
143501388|NCT02675075|517376272|FG000|Overall Study|Lost to Follow-up|3|||
143501389|NCT02675075|517376273|FG001|Overall Study|Lost to Follow-up|0|||
143501390|NCT00896532|517376274|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
143501391|NCT00896532|517376275|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
143501392|NCT00896532|517376276|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
143501393|NCT00896532|517376277|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
143501394|NCT00896532|517376278|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
143501395|NCT00896532|517376279|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
143501396|NCT00896532|517376280|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
143501397|NCT00896532|517376281|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
143501398|NCT00896532|517376282|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
143059835|NCT01647711|515757086|FG002|Overall Study|Progressive disease|6|||
143059836|NCT01647711|515757087|FG003|Overall Study|Progressive disease|8|||
143059837|NCT01647711|515757088|FG004|Overall Study|Progressive disease|2|||
143059838|NCT01647711|515757084|FG000|Overall Study|Other adverse event|0|||
143059839|NCT01647711|515757085|FG001|Overall Study|Other adverse event|0|||
143059840|NCT01647711|515757086|FG002|Overall Study|Other adverse event|2|||
143059841|NCT01647711|515757087|FG003|Overall Study|Other adverse event|0|||
143059842|NCT01647711|515757088|FG004|Overall Study|Other adverse event|2|||
143059843|NCT01647711|515757084|FG000|Overall Study|Protocol Violation|0|||
143059844|NCT01647711|515757085|FG001|Overall Study|Protocol Violation|0|||
143059845|NCT01647711|515757086|FG002|Overall Study|Protocol Violation|0|||
143059846|NCT01647711|515757087|FG003|Overall Study|Protocol Violation|0|||
143059847|NCT01647711|515757088|FG004|Overall Study|Protocol Violation|1|||
143501399|NCT00896532|517376283|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
143501400|NCT00896532|517376284|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
143501401|NCT00896532|517376285|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
143059848|NCT01647711|515757084|FG000|Overall Study|Refused to continue taking medication|0|||
143501402|NCT00896532|517376286|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
143501403|NCT00896532|517376287|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
143501404|NCT00896532|517376288|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
143501405|NCT00896532|517376289|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
143059849|NCT01647711|515757085|FG001|Overall Study|Refused to continue taking medication|0|||
143059850|NCT01647711|515757086|FG002|Overall Study|Refused to continue taking medication|0|||
143059851|NCT01647711|515757087|FG003|Overall Study|Refused to continue taking medication|2|||
143059852|NCT01647711|515757088|FG004|Overall Study|Refused to continue taking medication|1|||
143059853|NCT01647711|515757084|FG000|Overall Study|Other reason not defined|0|||
143059854|NCT01647711|515757085|FG001|Overall Study|Other reason not defined|1|||
143501406|NCT00896532|517376290|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
143059855|NCT01647711|515757086|FG002|Overall Study|Other reason not defined|1|||
143059856|NCT01647711|515757087|FG003|Overall Study|Other reason not defined|1|||
143059857|NCT01647711|515757088|FG004|Overall Study|Other reason not defined|0|||
143059858|NCT02070757|515757092|FG000|Overall Study|Adverse Event|107|||
143059859|NCT02070757|515757093|FG001|Overall Study|Adverse Event|99|||
143059860|NCT02070757|515757092|FG000|Overall Study|Lost to Follow-up|7|||
143059861|NCT02070757|515757093|FG001|Overall Study|Lost to Follow-up|4|||
143059862|NCT02070757|515757092|FG000|Overall Study|Protocol Violation|0|||
143059863|NCT02070757|515757093|FG001|Overall Study|Protocol Violation|4|||
143059864|NCT02070757|515757092|FG000|Overall Study|Withdrawal by Subject|1|||
143059865|NCT02070757|515757093|FG001|Overall Study|Withdrawal by Subject|3|||
143059866|NCT02070757|515757092|FG000|Overall Study|Investigator Decision|0|||
143059867|NCT02070757|515757093|FG001|Overall Study|Investigator Decision|2|||
143059868|NCT02070757|515757092|FG000|Overall Study|Discharged from Study Hospital|2|||
143059869|NCT02070757|515757093|FG001|Overall Study|Discharged from Study Hospital|2|||
143059870|NCT01546922|515757094|FG000|First Period of 10 Weeks|Protocol Violation|3|||
143059871|NCT01546922|515757095|FG001|First Period of 10 Weeks|Protocol Violation|1|||
143059872|NCT01546922|515757094|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
143059873|NCT01546922|515757095|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
143059874|NCT01546922|515757094|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
143059875|NCT01546922|515757095|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
143059876|NCT01546922|515757094|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
143501407|NCT00896532|517376291|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
143501408|NCT00896532|517376292|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
143501409|NCT00896532|517376293|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
143059877|NCT01546922|515757095|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
143059878|NCT01546922|515757094|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
143059879|NCT01546922|515757095|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
143059880|NCT04086641|515757098|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
143059881|NCT04086641|515757099|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
143059882|NCT00792623|515757100|FG000|Overall Study|Adverse Event|2|||
143059883|NCT00792623|515757100|FG000|Overall Study|Withdrawal by Subject|5|||
143059884|NCT00880087|515757101|FG000|Overall Study|Lost to Follow-up|0|||
143059885|NCT00880087|515757102|FG001|Overall Study|Lost to Follow-up|2|||
143059886|NCT00743509|515757103|FG000|Overall Study|Withdrawal by Subject|2|||
143059887|NCT00483548|515757104|FG000|Overall Study|Randomized; not treated with study drug|1|||
143059888|NCT00483548|515757105|FG001|Overall Study|Randomized; not treated with study drug|3|||
143059889|NCT00483548|515757104|FG000|Overall Study|Adverse Event|25|||
143059890|NCT00483548|515757105|FG001|Overall Study|Adverse Event|14|||
143059891|NCT00483548|515757104|FG000|Overall Study|Laboratory abnormality|1|||
143059892|NCT00483548|515757105|FG001|Overall Study|Laboratory abnormality|2|||
143059893|NCT00483548|515757104|FG000|Overall Study|Lack of Efficacy|4|||
143059894|NCT00483548|515757105|FG001|Overall Study|Lack of Efficacy|8|||
143059895|NCT00483548|515757104|FG000|Overall Study|Protocol Violation|11|||
143501410|NCT00896532|517376294|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
143501411|NCT00896532|517376295|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
143501412|NCT00896532|517376296|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
143501413|NCT00896532|517376274|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
143501414|NCT00896532|517376275|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
143501415|NCT00896532|517376276|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
143501416|NCT00896532|517376277|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
143501417|NCT00896532|517376278|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
143501418|NCT00896532|517376279|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
143501419|NCT00896532|517376280|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
143501420|NCT00896532|517376281|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
143501421|NCT00896532|517376282|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
143501422|NCT00896532|517376283|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
143501423|NCT00896532|517376284|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
143059896|NCT00483548|515757105|FG001|Overall Study|Protocol Violation|7|||
143059897|NCT00483548|515757104|FG000|Overall Study|Pregnancy|1|||
143059898|NCT00483548|515757105|FG001|Overall Study|Pregnancy|0|||
143059899|NCT00483548|515757104|FG000|Overall Study|Protocol required discontinuation|6|||
143059900|NCT00483548|515757105|FG001|Overall Study|Protocol required discontinuation|6|||
143059901|NCT00483548|515757104|FG000|Overall Study|Unable to comply with protocol schedule|1|||
143059902|NCT00483548|515757105|FG001|Overall Study|Unable to comply with protocol schedule|0|||
143245922|NCT01485172|516451832|FG001|Overall Study|Protocol Violation|0|||
143501424|NCT00896532|517376285|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
143501425|NCT00896532|517376286|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
143501426|NCT00896532|517376287|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
143501427|NCT00896532|517376288|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
143501428|NCT00896532|517376289|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
143501429|NCT00896532|517376290|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
143501430|NCT00896532|517376291|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
143501431|NCT00896532|517376292|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
143501432|NCT00896532|517376293|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
143501433|NCT00896532|517376294|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
143501434|NCT00896532|517376295|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
143501435|NCT00896532|517376296|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
143501436|NCT00896532|517376274|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
143501437|NCT00896532|517376275|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
143501438|NCT00896532|517376276|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
143501439|NCT00896532|517376277|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
143501440|NCT00896532|517376278|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
143501441|NCT00896532|517376279|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
143501442|NCT00896532|517376280|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
143501443|NCT00896532|517376281|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
143059903|NCT00483548|515757104|FG000|Overall Study|Non-compliance with medication|2|||
143059904|NCT00483548|515757105|FG001|Overall Study|Non-compliance with medication|0|||
143059905|NCT00483548|515757104|FG000|Overall Study|Lost to Follow-up|3|||
143059906|NCT00483548|515757105|FG001|Overall Study|Lost to Follow-up|4|||
143059907|NCT00483548|515757104|FG000|Overall Study|Withdrawal by Subject|5|||
143059908|NCT00483548|515757105|FG001|Overall Study|Withdrawal by Subject|2|||
143059909|NCT00126126|515757106|FG000|Overall Study|Lost to Follow-up|0|||
143059910|NCT00126126|515757107|FG001|Overall Study|Lost to Follow-up|2|||
143059911|NCT01470417|515757111|FG000|Overall Study|Disease progression|0|||
143059912|NCT01470417|515757112|FG001|Overall Study|Disease progression|2|||
143059913|NCT02418455|515757113|FG000|48-Week Treatment Period|Other- Not Specified|1|||
143059914|NCT02418455|515757113|FG000|Continuation Period|Sponsor Decision|7|||
143059915|NCT02973321|515757116|FG000|Overall Study|Other than specified|0|||
143059916|NCT02973321|515757117|FG001|Overall Study|Other than specified|5|||
143059917|NCT02973321|515757118|FG002|Overall Study|Other than specified|3|||
143059918|NCT02973321|515757119|FG003|Overall Study|Other than specified|3|||
143059919|NCT02973321|515757120|FG004|Overall Study|Other than specified|1|||
143059920|NCT02973321|515757116|FG000|Overall Study|Lack of Efficacy|0|||
143059921|NCT02973321|515757117|FG001|Overall Study|Lack of Efficacy|0|||
143059922|NCT02973321|515757118|FG002|Overall Study|Lack of Efficacy|0|||
143059923|NCT02973321|515757119|FG003|Overall Study|Lack of Efficacy|0|||
143059924|NCT02973321|515757120|FG004|Overall Study|Lack of Efficacy|1|||
143059925|NCT02973321|515757116|FG000|Overall Study|Adverse Event|1|||
143059926|NCT02973321|515757117|FG001|Overall Study|Adverse Event|10|||
143059927|NCT02973321|515757118|FG002|Overall Study|Adverse Event|11|||
143059928|NCT02973321|515757119|FG003|Overall Study|Adverse Event|13|||
143059929|NCT02973321|515757120|FG004|Overall Study|Adverse Event|3|||
143059930|NCT01098110|515757121|FG000|Overall Study|Withdrawal by Subject|14|||
143059931|NCT01098110|515757122|FG001|Overall Study|Withdrawal by Subject|24|||
143059932|NCT01098110|515757123|FG002|Overall Study|Withdrawal by Subject|19|||
143059933|NCT01098110|515757121|FG000|Overall Study|Adverse Event|30|||
143501444|NCT00896532|517376282|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
143501445|NCT00896532|517376283|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
143501446|NCT00896532|517376284|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
143501447|NCT00896532|517376285|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
143501448|NCT00896532|517376286|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
143501449|NCT00896532|517376287|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
143501450|NCT00896532|517376288|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
143501451|NCT00896532|517376289|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
143501452|NCT00896532|517376290|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
143501453|NCT00896532|517376291|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
143501454|NCT00896532|517376292|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
143501455|NCT00896532|517376293|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
143501456|NCT00896532|517376294|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
143059934|NCT01098110|515757122|FG001|Overall Study|Adverse Event|32|||
143059935|NCT01098110|515757123|FG002|Overall Study|Adverse Event|43|||
143059936|NCT01098110|515757121|FG000|Overall Study|Lack of Efficacy|13|||
143059937|NCT01098110|515757122|FG001|Overall Study|Lack of Efficacy|9|||
143059938|NCT01098110|515757123|FG002|Overall Study|Lack of Efficacy|27|||
143059939|NCT01098110|515757121|FG000|Overall Study|Other|4|||
143501457|NCT00896532|517376295|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
143501458|NCT00896532|517376296|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
143501459|NCT00896532|517376274|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
143501460|NCT00896532|517376275|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
143501461|NCT00896532|517376276|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
143501462|NCT00896532|517376277|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
143501463|NCT00896532|517376278|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
143501464|NCT00896532|517376279|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
143501465|NCT00896532|517376280|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
143501466|NCT00896532|517376281|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
143501467|NCT00896532|517376282|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
143501468|NCT00896532|517376283|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
143501469|NCT00896532|517376284|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
143501470|NCT00896532|517376285|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
143501471|NCT00896532|517376286|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
143501472|NCT00896532|517376287|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
143501473|NCT00896532|517376288|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
143501474|NCT00896532|517376289|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
143501475|NCT00896532|517376290|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
143501476|NCT00896532|517376291|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
143501477|NCT00896532|517376292|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
143501478|NCT00896532|517376293|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
143501479|NCT00896532|517376294|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
143501480|NCT00896532|517376295|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
143501481|NCT00896532|517376296|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
143501482|NCT00896532|517376274|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
143501483|NCT00896532|517376275|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
143501484|NCT00896532|517376276|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
143501485|NCT00896532|517376277|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
143501486|NCT00896532|517376278|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
143059940|NCT01098110|515757122|FG001|Overall Study|Other|7|||
143059941|NCT01098110|515757123|FG002|Overall Study|Other|5|||
143059942|NCT01098110|515757121|FG000|Overall Study|Untreated|1|||
143059943|NCT01098110|515757122|FG001|Overall Study|Untreated|1|||
143059944|NCT01098110|515757123|FG002|Overall Study|Untreated|0|||
143059945|NCT00263887|515757124|FG000|Overall Study|Withdrawal by Subject|1|||
143059946|NCT00263887|515757125|FG001|Overall Study|Withdrawal by Subject|1|||
143059947|NCT00263887|515757124|FG000|Overall Study|Lung transplantation|1|||
143059948|NCT00263887|515757125|FG001|Overall Study|Lung transplantation|2|||
143059949|NCT00263887|515757124|FG000|Overall Study|Too ill to attend visit|1|||
143170018|NCT03396445|516171842|FG014|Treatment Period|Randomized by Mistake without Study Treatment|1|||
143170019|NCT03396445|516171843|FG015|Treatment Period|Randomized by Mistake without Study Treatment|0|||
143170020|NCT03396445|516171844|FG016|Treatment Period|Randomized by Mistake without Study Treatment|0|||
143170021|NCT03396445|516171845|FG017|Treatment Period|Randomized by Mistake without Study Treatment|0|||
143170022|NCT03396445|516171846|FG018|Treatment Period|Randomized by Mistake without Study Treatment|0|||
143170023|NCT03396445|516171847|FG019|Treatment Period|Randomized by Mistake without Study Treatment|0|||
143170024|NCT03396445|516171848|FG020|Treatment Period|Randomized by Mistake without Study Treatment|0|||
143170025|NCT03396445|516171849|FG021|Treatment Period|Randomized by Mistake without Study Treatment|0|||
143170026|NCT03396445|516171850|FG022|Treatment Period|Randomized by Mistake without Study Treatment|0|||
143170027|NCT03396445|516171851|FG023|Treatment Period|Randomized by Mistake without Study Treatment|0|||
143170028|NCT03396445|516171852|FG024|Treatment Period|Randomized by Mistake without Study Treatment|0|||
143170029|NCT03396445|516171853|FG025|Treatment Period|Randomized by Mistake without Study Treatment|0|||
143170030|NCT03396445|516171828|FG000|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
143170031|NCT03396445|516171829|FG001|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
143170032|NCT03396445|516171830|FG002|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
143170033|NCT03396445|516171831|FG003|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|2|||
143170034|NCT03396445|516171832|FG004|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
143501487|NCT00896532|517376279|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
143059950|NCT00263887|515757125|FG001|Overall Study|Too ill to attend visit|0|||
143059951|NCT00263887|515757124|FG000|Overall Study|Adverse Event|0|||
143059952|NCT00263887|515757125|FG001|Overall Study|Adverse Event|2|||
143059953|NCT00263887|515757124|FG000|Overall Study|Disease progression|0|||
143059954|NCT00263887|515757125|FG001|Overall Study|Disease progression|1|||
143059955|NCT00263887|515757124|FG000|Overall Study|Lack of Efficacy|0|||
143059956|NCT00263887|515757125|FG001|Overall Study|Lack of Efficacy|1|||
143059957|NCT02865395|515757126|FG000|Overall Study|Physician Decision|6|||
143059958|NCT02865395|515757127|FG001|Overall Study|Physician Decision|10|||
143059959|NCT02865395|515757128|FG002|Overall Study|Physician Decision|7|||
143059960|NCT04220775|515757129|FG000|Overall Study|Adverse Event|1|||
143059961|NCT04220775|515757130|FG001|Overall Study|Adverse Event|0|||
143059962|NCT04220775|515757129|FG000|Overall Study|Disease Progression|1|||
143059963|NCT04220775|515757130|FG001|Overall Study|Disease Progression|0|||
143059964|NCT01040793|515757135|FG000|Overall Study|Adverse Event|5|||
143501488|NCT00896532|517376280|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
143501489|NCT00896532|517376281|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
143501490|NCT00896532|517376282|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
143501491|NCT00896532|517376283|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
143501492|NCT00896532|517376284|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
143501493|NCT00896532|517376285|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
143059965|NCT01040793|515757136|FG001|Overall Study|Adverse Event|3|||
143170035|NCT03396445|516171833|FG005|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
143170036|NCT03396445|516171834|FG006|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|9|||
143170037|NCT03396445|516171835|FG007|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
143170038|NCT03396445|516171836|FG008|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
143170039|NCT03396445|516171837|FG009|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
143170040|NCT03396445|516171838|FG010|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
143170041|NCT03396445|516171839|FG011|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
143170042|NCT03396445|516171840|FG012|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
143170043|NCT03396445|516171841|FG013|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
143170044|NCT03396445|516171842|FG014|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
143170045|NCT03396445|516171843|FG015|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
143170046|NCT03396445|516171844|FG016|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
143170047|NCT03396445|516171845|FG017|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
143170048|NCT03396445|516171846|FG018|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
143170049|NCT03396445|516171847|FG019|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
143170050|NCT03396445|516171848|FG020|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
143170051|NCT03396445|516171849|FG021|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
143170052|NCT03396445|516171850|FG022|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
143170053|NCT03396445|516171851|FG023|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
143170054|NCT03396445|516171852|FG024|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
143170055|NCT03396445|516171853|FG025|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
143170056|NCT03396445|516171828|FG000|Treatment Period|Withdrawal by Subject|0|||
143170057|NCT03396445|516171829|FG001|Treatment Period|Withdrawal by Subject|0|||
143170058|NCT03396445|516171830|FG002|Treatment Period|Withdrawal by Subject|0|||
143170059|NCT03396445|516171831|FG003|Treatment Period|Withdrawal by Subject|0|||
143170060|NCT03396445|516171832|FG004|Treatment Period|Withdrawal by Subject|0|||
143170061|NCT03396445|516171833|FG005|Treatment Period|Withdrawal by Subject|0|||
143170062|NCT03396445|516171834|FG006|Treatment Period|Withdrawal by Subject|0|||
143170063|NCT03396445|516171835|FG007|Treatment Period|Withdrawal by Subject|0|||
143170064|NCT03396445|516171836|FG008|Treatment Period|Withdrawal by Subject|0|||
143170065|NCT03396445|516171837|FG009|Treatment Period|Withdrawal by Subject|0|||
143170066|NCT03396445|516171838|FG010|Treatment Period|Withdrawal by Subject|0|||
143170067|NCT03396445|516171839|FG011|Treatment Period|Withdrawal by Subject|0|||
143170068|NCT03396445|516171840|FG012|Treatment Period|Withdrawal by Subject|0|||
143365079|NCT00603538|516878781|FG002|Overall Study|Adverse Event|2|||
143365080|NCT00603538|516878779|FG000|Overall Study|Objective progression or relapse|3|||
143365081|NCT00603538|516878780|FG001|Overall Study|Objective progression or relapse|0|||
143501494|NCT00896532|517376286|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
143501495|NCT00896532|517376287|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
143501496|NCT00896532|517376288|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
143059966|NCT01040793|515757137|FG002|Overall Study|Adverse Event|0|||
143059967|NCT01040793|515757138|FG003|Overall Study|Adverse Event|2|||
143059968|NCT01040793|515757139|FG004|Overall Study|Adverse Event|2|||
143059969|NCT01040793|515757140|FG005|Overall Study|Adverse Event|1|||
143059970|NCT01040793|515757135|FG000|Overall Study|Protocol Violation|1|||
143059971|NCT01040793|515757136|FG001|Overall Study|Protocol Violation|1|||
143059972|NCT01040793|515757137|FG002|Overall Study|Protocol Violation|1|||
143059973|NCT01040793|515757138|FG003|Overall Study|Protocol Violation|0|||
143059974|NCT01040793|515757139|FG004|Overall Study|Protocol Violation|1|||
143059975|NCT01040793|515757140|FG005|Overall Study|Protocol Violation|0|||
143059976|NCT01040793|515757135|FG000|Overall Study|Lost to Follow-up|0|||
143059977|NCT01040793|515757136|FG001|Overall Study|Lost to Follow-up|1|||
143059978|NCT01040793|515757137|FG002|Overall Study|Lost to Follow-up|1|||
143059979|NCT01040793|515757138|FG003|Overall Study|Lost to Follow-up|0|||
143059980|NCT01040793|515757139|FG004|Overall Study|Lost to Follow-up|0|||
143059981|NCT01040793|515757140|FG005|Overall Study|Lost to Follow-up|0|||
143059982|NCT01040793|515757135|FG000|Overall Study|Withdrawal by Subject|0|||
143059983|NCT01040793|515757136|FG001|Overall Study|Withdrawal by Subject|0|||
143059984|NCT01040793|515757137|FG002|Overall Study|Withdrawal by Subject|0|||
143059985|NCT01040793|515757138|FG003|Overall Study|Withdrawal by Subject|2|||
143059986|NCT01040793|515757139|FG004|Overall Study|Withdrawal by Subject|0|||
143059987|NCT01040793|515757140|FG005|Overall Study|Withdrawal by Subject|0|||
143059988|NCT01040793|515757135|FG000|Overall Study|Other reasons not listed above|0|||
143059989|NCT01040793|515757136|FG001|Overall Study|Other reasons not listed above|0|||
143059990|NCT01040793|515757137|FG002|Overall Study|Other reasons not listed above|1|||
143059991|NCT01040793|515757138|FG003|Overall Study|Other reasons not listed above|0|||
143059992|NCT01040793|515757139|FG004|Overall Study|Other reasons not listed above|1|||
143059993|NCT01040793|515757140|FG005|Overall Study|Other reasons not listed above|0|||
143059994|NCT03573817|515757145|FG000|Overall Study|Adverse Event|0|||
143059995|NCT03573817|515757146|FG001|Overall Study|Adverse Event|2|||
143059996|NCT03573817|515757145|FG000|Overall Study|Protocol Violation|0|||
143059997|NCT03573817|515757146|FG001|Overall Study|Protocol Violation|1|||
143059998|NCT03573817|515757145|FG000|Overall Study|Withdrawal by Subject|1|||
143059999|NCT03573817|515757146|FG001|Overall Study|Withdrawal by Subject|1|||
143060000|NCT00939627|515757147|FG000|Overall Study|Disease Progression|16|||
143060001|NCT00939627|515757148|FG001|Overall Study|Disease Progression|12|||
143060002|NCT00939627|515757149|FG002|Overall Study|Disease Progression|0|||
143060003|NCT00939627|515757147|FG000|Overall Study|Adverse Event|6|||
143060004|NCT00939627|515757148|FG001|Overall Study|Adverse Event|7|||
143060005|NCT00939627|515757149|FG002|Overall Study|Adverse Event|0|||
143060006|NCT00939627|515757147|FG000|Overall Study|Death|0|||
143060007|NCT00939627|515757148|FG001|Overall Study|Death|2|||
143060008|NCT00939627|515757149|FG002|Overall Study|Death|0|||
143060009|NCT00939627|515757147|FG000|Overall Study|Withdrawal by Subject|2|||
143060010|NCT00939627|515757148|FG001|Overall Study|Withdrawal by Subject|4|||
143060011|NCT00939627|515757149|FG002|Overall Study|Withdrawal by Subject|0|||
143060012|NCT00939627|515757147|FG000|Overall Study|Other complicating disease|1|||
143060013|NCT00939627|515757148|FG001|Overall Study|Other complicating disease|1|||
143060014|NCT00939627|515757149|FG002|Overall Study|Other complicating disease|0|||
143060015|NCT00939627|515757147|FG000|Overall Study|Not compliant|2|||
143060016|NCT00939627|515757148|FG001|Overall Study|Not compliant|0|||
143060017|NCT00939627|515757149|FG002|Overall Study|Not compliant|0|||
143060018|NCT00939627|515757147|FG000|Overall Study|No off-tx reason given|0|||
143060019|NCT00939627|515757148|FG001|Overall Study|No off-tx reason given|2|||
143060020|NCT00939627|515757149|FG002|Overall Study|No off-tx reason given|0|||
143060021|NCT00612677|515757152|FG000|Overall Study|study closed before treatment started|1|||
143060022|NCT00860743|515757153|FG000|Overall Study|Withdrawal by Subject|3|||
143060023|NCT00860743|515757154|FG001|Overall Study|Withdrawal by Subject|0|||
143060024|NCT00823199|515757155|FG000|Overall Study|Withdrawal by Subject|2|||
143060025|NCT02776553|515757156|FG000|Overall Study|Lost to Follow-up|1|||
143060026|NCT02776553|515757157|FG001|Overall Study|Lost to Follow-up|0|||
143060027|NCT02776553|515757156|FG000|Overall Study|got liver transplant|1|||
143060028|NCT02776553|515757157|FG001|Overall Study|got liver transplant|2|||
143060029|NCT02776553|515757156|FG000|Overall Study|had other surgery|1|||
143060030|NCT02776553|515757157|FG001|Overall Study|had other surgery|0|||
143060031|NCT02776553|515757156|FG000|Overall Study|Protocol Violation|0|||
143060032|NCT02776553|515757157|FG001|Overall Study|Protocol Violation|1|||
143060033|NCT01998243|515757158|FG000|Overall Study|Pregnancy|0|||
143060034|NCT01998243|515757159|FG001|Overall Study|Pregnancy|1|||
143060035|NCT01998243|515757158|FG000|Overall Study|Protocol Violation|5|||
143060036|NCT01998243|515757159|FG001|Overall Study|Protocol Violation|2|||
143060037|NCT01998243|515757158|FG000|Overall Study|Withdrawal by Subject|3|||
143060038|NCT01998243|515757159|FG001|Overall Study|Withdrawal by Subject|4|||
143060039|NCT00104247|515757166|FG000|Overall Study|Withdrawal by Subject|1|||
143060040|NCT00104247|515757167|FG001|Overall Study|Withdrawal by Subject|0|||
143060041|NCT00104247|515757166|FG000|Overall Study|Noncompliant with dosing|0|||
143060042|NCT00104247|515757167|FG001|Overall Study|Noncompliant with dosing|1|||
143060043|NCT01644149|515757168|FG000|Overall Study|Withdrawal by Subject|1|||
143060044|NCT01644149|515757169|FG001|Overall Study|Withdrawal by Subject|0|||
143060045|NCT01644149|515757168|FG000|Overall Study|Lost to Follow-up|3|||
143060046|NCT01644149|515757169|FG001|Overall Study|Lost to Follow-up|1|||
143060047|NCT00690482|515757170|FG000|Overall Study|Adverse Event|2|||
143060048|NCT00690482|515757171|FG001|Overall Study|Adverse Event|1|||
143060049|NCT00690482|515757170|FG000|Overall Study|Incorrect enrolment|0|||
143060050|NCT00690482|515757171|FG001|Overall Study|Incorrect enrolment|1|||
143060051|NCT00690482|515757170|FG000|Overall Study|Study-specific discontinuation criteria|1|||
143060052|NCT00690482|515757171|FG001|Overall Study|Study-specific discontinuation criteria|0|||
143060053|NCT00690482|515757170|FG000|Overall Study|Intake of prohibited medicine|1|||
143060054|NCT00690482|515757171|FG001|Overall Study|Intake of prohibited medicine|0|||
143060055|NCT00690482|515757170|FG000|Overall Study|withdrew consent at rand.day|0|||
143060056|NCT00690482|515757171|FG001|Overall Study|withdrew consent at rand.day|1|||
143060057|NCT01930175|515757174|FG000|Core Study|Lost to Follow-up|0|||
143060058|NCT01930175|515757175|FG001|Core Study|Lost to Follow-up|1|||
143060059|NCT01930175|515757176|FG002|Core Study|Lost to Follow-up|0|||
143060060|NCT01930175|515757174|FG000|Core Study|Adverse Event|0|||
143060061|NCT01930175|515757175|FG001|Core Study|Adverse Event|0|||
143060062|NCT01930175|515757176|FG002|Core Study|Adverse Event|1|||
143060063|NCT01506908|515757177|FG000|Overall Study|Adverse Event|1|||
143060064|NCT01506908|515757178|FG001|Overall Study|Adverse Event|0|||
143060065|NCT03450629|515757183|FG000|Overall Study|Adverse Event|15|||
143060066|NCT03450629|515757184|FG001|Overall Study|Adverse Event|14|||
143060067|NCT03450629|515757183|FG000|Overall Study|Physician Decision|2|||
143060068|NCT03450629|515757184|FG001|Overall Study|Physician Decision|2|||
143060069|NCT03450629|515757183|FG000|Overall Study|Lack of Efficacy|2|||
143060070|NCT03450629|515757184|FG001|Overall Study|Lack of Efficacy|0|||
143060071|NCT03450629|515757183|FG000|Overall Study|Lost to Follow-up|4|||
143060072|NCT03450629|515757184|FG001|Overall Study|Lost to Follow-up|2|||
143060073|NCT03450629|515757183|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
143060074|NCT03450629|515757184|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
143060075|NCT03450629|515757183|FG000|Overall Study|Non-Compliance With Study Drug|2|||
143060076|NCT03450629|515757184|FG001|Overall Study|Non-Compliance With Study Drug|1|||
143060077|NCT03450629|515757183|FG000|Overall Study|Protocol Violation|11|||
143060078|NCT03450629|515757184|FG001|Overall Study|Protocol Violation|8|||
143060079|NCT03450629|515757183|FG000|Overall Study|Withdrawal by Subject|12|||
143060080|NCT03450629|515757184|FG001|Overall Study|Withdrawal by Subject|6|||
143060081|NCT03438006|515757185|FG000|Overall Study|Adverse Event|1|||
143060082|NCT03438006|515757185|FG000|Overall Study|Lost to Follow-up|67|||
143060083|NCT03438006|515757185|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
143060084|NCT03438006|515757185|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
143060085|NCT01662362|515757200|FG000|Overall Study|Lost to Follow-up|38|||
143060086|NCT03078478|515757201|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
143060087|NCT03078478|515757202|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
143060088|NCT03078478|515757201|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
143060089|NCT03078478|515757202|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
143060090|NCT03078478|515757201|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
143060091|NCT03078478|515757202|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
143060092|NCT03078478|515757201|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
143060093|NCT03078478|515757202|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
143060094|NCT03078478|515757201|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
143060095|NCT03078478|515757202|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
143060096|NCT03078478|515757201|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
143060097|NCT03078478|515757202|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
143060098|NCT03078478|515757201|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
143060099|NCT03078478|515757202|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
143060100|NCT03078478|515757201|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
143060101|NCT03078478|515757202|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
143060102|NCT01181531|515757204|FG000|Overall Study|Other|17|||
143060103|NCT01181531|515757205|FG001|Overall Study|Other|12|||
143060104|NCT01181531|515757204|FG000|Overall Study|Partial consent by subject withdrawn|0|||
143060105|NCT01181531|515757205|FG001|Overall Study|Partial consent by subject withdrawn|1|||
143060106|NCT01181531|515757204|FG000|Overall Study|Physician Decision|3|||
143060107|NCT01181531|515757205|FG001|Overall Study|Physician Decision|1|||
143060108|NCT01181531|515757204|FG000|Overall Study|Noncompliance|2|||
143060109|NCT01181531|515757205|FG001|Overall Study|Noncompliance|2|||
143060110|NCT01181531|515757204|FG000|Overall Study|Ineligibility determined|1|||
143060111|NCT01181531|515757205|FG001|Overall Study|Ineligibility determined|2|||
143060112|NCT01181531|515757204|FG000|Overall Study|Protocol Specified Criteria|15|||
143060113|NCT01181531|515757205|FG001|Overall Study|Protocol Specified Criteria|8|||
143060114|NCT01181531|515757204|FG000|Overall Study|Pregnancy|0|||
143060115|NCT01181531|515757205|FG001|Overall Study|Pregnancy|1|||
143060116|NCT01181531|515757204|FG000|Overall Study|Withdrawal by Subject|8|||
143060117|NCT01181531|515757205|FG001|Overall Study|Withdrawal by Subject|7|||
143365082|NCT00603538|516878781|FG002|Overall Study|Objective progression or relapse|0|||
143060118|NCT01181531|515757204|FG000|Overall Study|Protocol Violation|6|||
143060119|NCT01181531|515757205|FG001|Overall Study|Protocol Violation|6|||
143060120|NCT01181531|515757204|FG000|Overall Study|Death|9|||
143060121|NCT01181531|515757205|FG001|Overall Study|Death|12|||
143060122|NCT01181531|515757204|FG000|Overall Study|Adverse Event|0|||
143060123|NCT01181531|515757205|FG001|Overall Study|Adverse Event|1|||
143060124|NCT02339090|515757206|FG000|Overall Study|Adverse Event|1|||
143060125|NCT02339090|515757207|FG001|Overall Study|Adverse Event|0|||
143060126|NCT02339090|515757206|FG000|Overall Study|Lost to Follow-up|0|||
143060127|NCT02339090|515757207|FG001|Overall Study|Lost to Follow-up|1|||
143060128|NCT02339090|515757206|FG000|Overall Study|Non-compliance With Study Drug|0|||
143060129|NCT02339090|515757207|FG001|Overall Study|Non-compliance With Study Drug|1|||
143060130|NCT02339090|515757206|FG000|Overall Study|Withdrawal by Subject|2|||
143060131|NCT02339090|515757207|FG001|Overall Study|Withdrawal by Subject|1|||
143060132|NCT02339090|515757206|FG000|Overall Study|Poor Growth|3|||
143060133|NCT02339090|515757207|FG001|Overall Study|Poor Growth|0|||
143060134|NCT02339090|515757206|FG000|Overall Study|Randomized but not treated|0|||
143060135|NCT02339090|515757207|FG001|Overall Study|Randomized but not treated|2|||
143060136|NCT02737592|515757210|FG000|Overall Study|Withdrawal by Subject|1|||
143060137|NCT00576303|515757212|FG000|Dose Titration Period|Early withdrawal|17|||
143060138|NCT00576303|515757212|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
143060139|NCT00576303|515757212|FG000|Long Term Safety Period|Early withdrawal|16|||
143060140|NCT02792218|515757213|FG000|Overall Study|Patient/guardian decision|15|||
143060141|NCT02792218|515757214|FG001|Overall Study|Patient/guardian decision|42|||
143060142|NCT02792218|515757213|FG000|Overall Study|Adverse Event|15|||
143060143|NCT02792218|515757214|FG001|Overall Study|Adverse Event|14|||
143060144|NCT02792218|515757213|FG000|Overall Study|Lost to Follow-up|10|||
143060145|NCT02792218|515757214|FG001|Overall Study|Lost to Follow-up|5|||
143060146|NCT02792218|515757213|FG000|Overall Study|Lack of Efficacy|1|||
143060147|NCT02792218|515757214|FG001|Overall Study|Lack of Efficacy|12|||
143060148|NCT02792218|515757213|FG000|Overall Study|Physician Decision|4|||
143060149|NCT02792218|515757214|FG001|Overall Study|Physician Decision|4|||
143060150|NCT02792218|515757213|FG000|Overall Study|Protocol deviation|3|||
143060151|NCT02792218|515757214|FG001|Overall Study|Protocol deviation|2|||
143060152|NCT02792218|515757213|FG000|Overall Study|New therapy for study indication|0|||
143060153|NCT02792218|515757214|FG001|Overall Study|New therapy for study indication|1|||
143060154|NCT02792218|515757213|FG000|Overall Study|Non-compliance with study treatment|0|||
143060155|NCT02792218|515757214|FG001|Overall Study|Non-compliance with study treatment|1|||
143060156|NCT02792218|515757213|FG000|Overall Study|Pregnancy|1|||
143060157|NCT02792218|515757214|FG001|Overall Study|Pregnancy|0|||
143060158|NCT03123783|515757215|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
143060159|NCT03123783|515757216|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
143060160|NCT03123783|515757217|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
143060161|NCT03123783|515757218|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
143060162|NCT03123783|515757219|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
143060163|NCT03123783|515757220|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
143060164|NCT03123783|515757221|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
143060165|NCT03123783|515757215|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
143060166|NCT03123783|515757216|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
143060167|NCT03123783|515757217|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
143060168|NCT03123783|515757218|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
143060169|NCT03123783|515757219|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
143060170|NCT03123783|515757220|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
143060171|NCT03123783|515757221|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
143060172|NCT03123783|515757215|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
143060173|NCT03123783|515757216|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
143060174|NCT03123783|515757217|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
143060175|NCT03123783|515757218|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
143060176|NCT03123783|515757219|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
143060177|NCT03123783|515757220|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
143060178|NCT03123783|515757221|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
143060179|NCT03123783|515757215|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
143060180|NCT03123783|515757216|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
143060181|NCT03123783|515757217|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
143060182|NCT03123783|515757218|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
143060183|NCT03123783|515757219|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
143060184|NCT03123783|515757220|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
143060185|NCT03123783|515757221|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
143170069|NCT03396445|516171841|FG013|Treatment Period|Withdrawal by Subject|0|||
143365083|NCT04794179|516878783|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
143501497|NCT00896532|517376289|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
143501498|NCT00896532|517376290|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
143501499|NCT00896532|517376291|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
143501500|NCT00896532|517376292|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
143501501|NCT00896532|517376293|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
143501502|NCT00896532|517376294|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
143501503|NCT00896532|517376295|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
143501504|NCT00896532|517376296|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
143501505|NCT00896532|517376274|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
143501506|NCT00896532|517376275|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
143501507|NCT00896532|517376276|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
143501508|NCT00896532|517376277|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
143501509|NCT00896532|517376278|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
143501510|NCT00896532|517376279|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
143501511|NCT00896532|517376280|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
143501512|NCT00896532|517376281|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
143501513|NCT00896532|517376282|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
143501514|NCT00896532|517376283|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
143501515|NCT00896532|517376284|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
143501516|NCT00896532|517376285|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
143501517|NCT00896532|517376286|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
143501518|NCT00896532|517376287|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
143501519|NCT00896532|517376288|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
143501520|NCT00896532|517376289|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
143501521|NCT00896532|517376290|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
143501522|NCT00896532|517376291|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
143501523|NCT00896532|517376292|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
143501524|NCT00896532|517376293|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
143501525|NCT00896532|517376294|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
143501526|NCT00896532|517376295|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
143501527|NCT00896532|517376296|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
143501528|NCT00896532|517376274|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
143501529|NCT00896532|517376275|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
143501530|NCT00896532|517376276|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
143501531|NCT00896532|517376277|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
143501532|NCT00896532|517376278|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
143501533|NCT00896532|517376279|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
143501534|NCT00896532|517376280|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
143501535|NCT00896532|517376281|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
143501536|NCT00896532|517376282|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
143501537|NCT00896532|517376283|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
143501538|NCT00896532|517376284|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
143501539|NCT00896532|517376285|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
143501540|NCT00896532|517376286|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
143501541|NCT00896532|517376287|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
143501542|NCT00896532|517376288|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
143501543|NCT00896532|517376289|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
143501544|NCT00896532|517376290|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
143501545|NCT00896532|517376291|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
143501546|NCT00896532|517376292|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
143501547|NCT00896532|517376293|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
143501548|NCT00896532|517376294|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
143501549|NCT00896532|517376295|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
143501550|NCT00896532|517376296|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
143501551|NCT00896532|517376274|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
143501552|NCT00896532|517376275|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
143501553|NCT00896532|517376276|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
143501554|NCT00896532|517376277|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
143501555|NCT00896532|517376278|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
143501556|NCT00896532|517376279|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
143501557|NCT00896532|517376280|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
143501558|NCT00896532|517376281|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
143501559|NCT00896532|517376282|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
143501560|NCT00896532|517376283|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
143060186|NCT01253317|515757232|FG000|Overall Study|Adverse Event|2|||
143501561|NCT00896532|517376284|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
143501562|NCT00896532|517376285|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
143501563|NCT00896532|517376286|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
143501564|NCT00896532|517376287|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
143501565|NCT00896532|517376288|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
143501566|NCT00896532|517376289|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
143501567|NCT00896532|517376290|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
143501568|NCT00896532|517376291|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
143501569|NCT00896532|517376292|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
143501570|NCT00896532|517376293|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
143501571|NCT00896532|517376294|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
143501572|NCT00896532|517376295|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
143501573|NCT00896532|517376296|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
143501574|NCT00896532|517376274|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
143501575|NCT00896532|517376275|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
143501576|NCT00896532|517376276|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
143501577|NCT00896532|517376277|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
143501578|NCT00896532|517376278|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
143501579|NCT00896532|517376279|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
143501580|NCT00896532|517376280|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
143501581|NCT00896532|517376281|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
143501582|NCT00896532|517376282|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
143501583|NCT00896532|517376283|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
143060187|NCT04678817|515759877|FG000|Overall Study|Lost to Follow-up|28|||
143060188|NCT04678817|515759878|FG001|Overall Study|Lost to Follow-up|0|||
143060189|NCT04678817|515759879|FG002|Overall Study|Lost to Follow-up|0|||
143060190|NCT01619579|515759884|FG000|Overall Study|Withdrawal by Subject|0|||
143060191|NCT01619579|515759885|FG001|Overall Study|Withdrawal by Subject|3|||
143060192|NCT02124902|515759886|FG000|Overall Study|Adverse Event|7|||
143060193|NCT02124902|515759887|FG001|Overall Study|Adverse Event|2|||
143060194|NCT02124902|515759886|FG000|Overall Study|Went to alternative treatment|4|||
143060195|NCT02124902|515759887|FG001|Overall Study|Went to alternative treatment|0|||
143060196|NCT02124902|515759886|FG000|Overall Study|Withdrawal by Subject|2|||
143060197|NCT02124902|515759887|FG001|Overall Study|Withdrawal by Subject|1|||
143365084|NCT04794179|516878784|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
143365085|NCT04831775|516878785|FG000|Overall Study|Lost to Follow-up|11|||
143365086|NCT04831775|516878786|FG001|Overall Study|Lost to Follow-up|13|||
143365087|NCT00337818|516878787|FG000|Overall Study|Lost to Follow-up|289|||
143060198|NCT02124902|515759886|FG000|Overall Study|Physician Decision|2|||
143060199|NCT02124902|515759887|FG001|Overall Study|Physician Decision|0|||
143060200|NCT02124902|515759886|FG000|Overall Study|Not eligible|1|||
143060201|NCT02124902|515759887|FG001|Overall Study|Not eligible|0|||
143060202|NCT02124902|515759886|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
143060203|NCT02124902|515759887|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
143060204|NCT02012452|515759889|FG000|Overall Study|Lost to Follow-up|2|||
143060205|NCT02012452|515759890|FG001|Overall Study|Lost to Follow-up|1|||
143060206|NCT02012452|515759889|FG000|Overall Study|Withdrawal by Subject|4|||
143060207|NCT02012452|515759890|FG001|Overall Study|Withdrawal by Subject|0|||
143365088|NCT00337818|516878788|FG001|Overall Study|Lost to Follow-up|91|||
143365089|NCT00337818|516878789|FG002|Overall Study|Lost to Follow-up|107|||
143365090|NCT04678830|516878790|FG000|Overall Study|Lack of Efficacy|2|||
143365091|NCT04678830|516878791|FG001|Overall Study|Lack of Efficacy|0|||
143365092|NCT04678830|516878790|FG000|Overall Study|Withdrawal by Subject|0|||
143501584|NCT00896532|517376284|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
143501585|NCT00896532|517376285|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
143501586|NCT00896532|517376286|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
143501587|NCT00896532|517376287|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
143501588|NCT00896532|517376288|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
143501589|NCT00896532|517376289|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
143501590|NCT00896532|517376290|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
143501591|NCT00896532|517376291|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
143501592|NCT00896532|517376292|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
143501593|NCT00896532|517376293|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
143501594|NCT00896532|517376294|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
143501595|NCT00896532|517376295|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
143501596|NCT00896532|517376296|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
143501597|NCT00896532|517376274|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
143060208|NCT02190279|515759891|FG000|Overall Study|Withdrawal consent|1|||
143060209|NCT02190279|515759892|FG001|Overall Study|Withdrawal consent|0|||
143060210|NCT02190279|515759893|FG002|Overall Study|Withdrawal consent|1|||
143060211|NCT02190279|515759891|FG000|Overall Study|Lost to Follow-up|2|||
143060212|NCT02190279|515759892|FG001|Overall Study|Lost to Follow-up|0|||
143060213|NCT02190279|515759893|FG002|Overall Study|Lost to Follow-up|0|||
143060214|NCT02190279|515759891|FG000|Overall Study|Refused further treatment|0|||
143060215|NCT02190279|515759892|FG001|Overall Study|Refused further treatment|0|||
143060216|NCT02190279|515759893|FG002|Overall Study|Refused further treatment|1|||
143060217|NCT02190279|515759891|FG000|Overall Study|Screening failure|0|||
143060218|NCT02190279|515759892|FG001|Overall Study|Screening failure|0|||
143060219|NCT02190279|515759893|FG002|Overall Study|Screening failure|1|||
143060220|NCT02938442|515759894|FG000|Overall Study|Death|0|||
143060221|NCT02938442|515759895|FG001|Overall Study|Death|1|||
143060222|NCT02938442|515759894|FG000|Overall Study|Lost to Follow-up|0|||
143060223|NCT02938442|515759895|FG001|Overall Study|Lost to Follow-up|1|||
143060224|NCT02938442|515759894|FG000|Overall Study|Physician Decision|0|||
143060225|NCT02938442|515759895|FG001|Overall Study|Physician Decision|1|||
143060226|NCT02938442|515759894|FG000|Overall Study|Withdrawal by Subject|2|||
143060227|NCT02938442|515759895|FG001|Overall Study|Withdrawal by Subject|0|||
143060228|NCT04403399|515759896|FG000|Period 2|Physician Decision|0|||
143060229|NCT04403399|515759897|FG001|Period 2|Physician Decision|1|||
143060230|NCT02999984|515759906|FG000|Overall Study|Treatment Failure|1|||
143060231|NCT01316419|515759907|FG000|Overall Study|Not treated|103|||
143060232|NCT01316419|515759907|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
143060233|NCT01316419|515759907|FG000|Overall Study|Lost to Follow-up|19|||
143060234|NCT00754013|515759912|FG000|Overall Study|Lost to Follow-up|1|||
143060235|NCT00754013|515759913|FG001|Overall Study|Lost to Follow-up|1|||
143060236|NCT00754013|515759912|FG000|Overall Study|didn't return after study termed|3|||
143060237|NCT00754013|515759913|FG001|Overall Study|didn't return after study termed|4|||
143060238|NCT00983918|515759918|FG000|Overall Study|conversion to open cholecystectomy|0|||
143060239|NCT00983918|515759919|FG001|Overall Study|conversion to open cholecystectomy|2|||
143060240|NCT00983918|515759920|FG002|Overall Study|conversion to open cholecystectomy|2|||
143060241|NCT00983918|515759921|FG003|Overall Study|conversion to open cholecystectomy|2|||
143060242|NCT01005329|515759939|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
143060243|NCT00986570|515759943|FG000|Overall Study|Lost to Follow-up|6|||
143060244|NCT00986570|515759943|FG000|Overall Study|Potential bias for objective assessment|1|||
143060245|NCT01557920|515759944|FG000|Overall Study|Withdrawal by Subject|2|||
143060246|NCT01557920|515759945|FG001|Overall Study|Withdrawal by Subject|3|||
143060247|NCT01557920|515759944|FG000|Overall Study|Lack of Efficacy|1|||
143060248|NCT01557920|515759945|FG001|Overall Study|Lack of Efficacy|0|||
143060249|NCT01439724|515759946|FG000|Overall Study|missing consultation|9|||
143060250|NCT01439724|515759947|FG001|Overall Study|missing consultation|8|||
143060251|NCT00271024|515759954|FG000|Overall Study|Lost Interest|3|||
143060252|NCT00271024|515759955|FG001|Overall Study|Lost Interest|4|||
143060253|NCT00271024|515759956|FG002|Overall Study|Lost Interest|2|||
143060254|NCT00271024|515759957|FG003|Overall Study|Lost Interest|3|||
143060255|NCT00271024|515759954|FG000|Overall Study|Unknown/Unspecified|11|||
143060256|NCT00271024|515759955|FG001|Overall Study|Unknown/Unspecified|11|||
143060257|NCT00271024|515759956|FG002|Overall Study|Unknown/Unspecified|8|||
143060258|NCT00271024|515759957|FG003|Overall Study|Unknown/Unspecified|4|||
143060259|NCT00271024|515759954|FG000|Overall Study|Protocol Violation|1|||
143060260|NCT00271024|515759955|FG001|Overall Study|Protocol Violation|6|||
143060261|NCT00271024|515759956|FG002|Overall Study|Protocol Violation|5|||
143060262|NCT00271024|515759957|FG003|Overall Study|Protocol Violation|11|||
143060263|NCT00271024|515759954|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
143060264|NCT00271024|515759955|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
143060265|NCT00271024|515759956|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
143060266|NCT00271024|515759957|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
143060267|NCT00271024|515759954|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
143060268|NCT00271024|515759955|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
143060269|NCT00271024|515759956|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
143060270|NCT00271024|515759957|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
143060271|NCT00537199|515759960|FG000|Overall Study|Study Terminated|1|||
143060272|NCT02039063|515759962|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
143060273|NCT02039063|515759963|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
143060274|NCT02039063|515759964|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
143060275|NCT02039063|515759965|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
143060276|NCT02039063|515759962|FG000|Treatment Phase|Progression of disease|0|||
143060277|NCT02039063|515759963|FG001|Treatment Phase|Progression of disease|0|||
143060278|NCT02039063|515759964|FG002|Treatment Phase|Progression of disease|1|||
143060279|NCT02039063|515759965|FG003|Treatment Phase|Progression of disease|1|||
143060280|NCT02039063|515759962|FG000|Extension Phase|Inadequate therapeutic effect|0|||
143245923|NCT01485172|516451833|FG002|Overall Study|Protocol Violation|4|||
143060281|NCT02039063|515759963|FG001|Extension Phase|Inadequate therapeutic effect|1|||
143060282|NCT02039063|515759964|FG002|Extension Phase|Inadequate therapeutic effect|2|||
143060283|NCT02039063|515759965|FG003|Extension Phase|Inadequate therapeutic effect|0|||
143245924|NCT01485172|516451834|FG003|Overall Study|Protocol Violation|5|||
143060284|NCT02039063|515759962|FG000|Extension Phase|Progression of disease|0|||
143060285|NCT02039063|515759963|FG001|Extension Phase|Progression of disease|0|||
143060286|NCT02039063|515759964|FG002|Extension Phase|Progression of disease|0|||
143060287|NCT02039063|515759965|FG003|Extension Phase|Progression of disease|1|||
143060288|NCT02039063|515759962|FG000|Extension Phase|Adverse Event|0|||
143060289|NCT02039063|515759963|FG001|Extension Phase|Adverse Event|0|||
143060290|NCT02039063|515759964|FG002|Extension Phase|Adverse Event|1|||
143060291|NCT02039063|515759965|FG003|Extension Phase|Adverse Event|0|||
143060292|NCT00268892|515759971|FG000|Overall Study|Adverse Event|14|||
143060293|NCT00268892|515759972|FG001|Overall Study|Adverse Event|17|||
143060294|NCT00268892|515759973|FG002|Overall Study|Adverse Event|20|||
143060295|NCT00268892|515759971|FG000|Overall Study|Lack of Efficacy|1|||
143060296|NCT00268892|515759972|FG001|Overall Study|Lack of Efficacy|3|||
143060297|NCT00268892|515759973|FG002|Overall Study|Lack of Efficacy|0|||
143060298|NCT00268892|515759971|FG000|Overall Study|Withdrawal by Subject|14|||
143060299|NCT00268892|515759972|FG001|Overall Study|Withdrawal by Subject|15|||
143060300|NCT00268892|515759973|FG002|Overall Study|Withdrawal by Subject|13|||
143060301|NCT00268892|515759971|FG000|Overall Study|Physician Decision|0|||
143060302|NCT00268892|515759972|FG001|Overall Study|Physician Decision|1|||
143060303|NCT00268892|515759973|FG002|Overall Study|Physician Decision|0|||
143060304|NCT00268892|515759971|FG000|Overall Study|Lost to Follow-up|5|||
143060305|NCT00268892|515759972|FG001|Overall Study|Lost to Follow-up|2|||
143060306|NCT00268892|515759973|FG002|Overall Study|Lost to Follow-up|4|||
143060307|NCT00268892|515759971|FG000|Overall Study|Protocol Violation|0|||
143060308|NCT00268892|515759972|FG001|Overall Study|Protocol Violation|1|||
143060309|NCT00268892|515759973|FG002|Overall Study|Protocol Violation|0|||
143060310|NCT00268892|515759971|FG000|Overall Study|Disease Progression|1|||
143060311|NCT00268892|515759972|FG001|Overall Study|Disease Progression|1|||
143060312|NCT00268892|515759973|FG002|Overall Study|Disease Progression|0|||
143060313|NCT00268892|515759971|FG000|Overall Study|Trial Site Closed|4|||
143060314|NCT00268892|515759972|FG001|Overall Study|Trial Site Closed|2|||
143060315|NCT00268892|515759973|FG002|Overall Study|Trial Site Closed|2|||
143060316|NCT01684878|515759974|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
143060317|NCT01684878|515759975|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
143060318|NCT01684878|515759976|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
143060319|NCT01684878|515759977|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
143060320|NCT01684878|515759974|FG000|Part 1: Safety Run in Phase|Death|15|||
143060321|NCT01684878|515759975|FG001|Part 1: Safety Run in Phase|Death|20|||
143060322|NCT01684878|515759976|FG002|Part 1: Safety Run in Phase|Death|0|||
143060323|NCT01684878|515759977|FG003|Part 1: Safety Run in Phase|Death|0|||
143060324|NCT01684878|515759974|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
143060325|NCT01684878|515759975|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
143060326|NCT01684878|515759976|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
143060327|NCT01684878|515759977|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
143060328|NCT01684878|515759974|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
143060329|NCT01684878|515759975|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
143060330|NCT01684878|515759976|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
143060331|NCT01684878|515759977|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
143060332|NCT01684878|515759974|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
143060333|NCT01684878|515759975|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
143060334|NCT01684878|515759976|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
143060335|NCT01684878|515759977|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
143060336|NCT01684878|515759974|FG000|Part 2: Randomized Phase|Death|0|||
143060337|NCT01684878|515759975|FG001|Part 2: Randomized Phase|Death|0|||
143060338|NCT01684878|515759976|FG002|Part 2: Randomized Phase|Death|62|||
143060339|NCT01684878|515759977|FG003|Part 2: Randomized Phase|Death|68|||
143060340|NCT01684878|515759974|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
143060341|NCT01684878|515759975|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
143060342|NCT01684878|515759976|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
143060343|NCT01684878|515759977|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
143060344|NCT01684878|515759974|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
143060345|NCT01684878|515759975|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
143060346|NCT01684878|515759976|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
143060347|NCT01684878|515759977|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
143245925|NCT01485172|516451835|FG004|Overall Study|Protocol Violation|1|||
143060348|NCT01435031|515759981|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
143060349|NCT01435031|515759981|FG000|ITT at 1 Month|Death|1|||
143060350|NCT01435031|515759981|FG000|ITT at 1 Month|Lost to Follow-up|4|||
143060351|NCT01435031|515759981|FG000|ITT at 6 Months|Death|2|||
143060352|NCT01435031|515759981|FG000|ITT at 6 Months|Lost to Follow-up|3|||
143060353|NCT01435031|515759981|FG000|ITT at 1 Year|Death|1|||
143060354|NCT01435031|515759981|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
143060355|NCT01435031|515759981|FG000|ITT at 1 Year|Lost to Follow-up|6|||
143060356|NCT01435031|515759981|FG000|ITT at 2 Years|Death|7|||
143365093|NCT04678830|516878791|FG001|Overall Study|Withdrawal by Subject|1|||
143060357|NCT01435031|515759981|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
143060358|NCT01435031|515759981|FG000|ITT at 2 Years|Lost to Follow-up|4|||
143060359|NCT01435031|515759981|FG000|ITT at 3 Years|Death|5|||
143060360|NCT01435031|515759981|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
143060361|NCT01435031|515759981|FG000|ITT at 3 Years|Lost to Follow-up|4|||
143060362|NCT01435031|515759981|FG000|ITT at 4 Years|Death|4|||
143060363|NCT01435031|515759981|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
143060364|NCT01435031|515759981|FG000|ITT at 4 Years|Lost to Follow-up|1|||
143060365|NCT02927834|515759982|FG000|Overall Study|Lost to Follow-up|1|||
143060366|NCT02927834|515759983|FG001|Overall Study|Lost to Follow-up|2|||
143060367|NCT02927834|515759984|FG002|Overall Study|Lost to Follow-up|2|||
143060368|NCT01876368|515759987|FG000|Overall Study|Adverse Event|2|||
143060369|NCT01876368|515759988|FG001|Overall Study|Adverse Event|5|||
143060370|NCT01876368|515759987|FG000|Overall Study|Lack of Efficacy|1|||
143060371|NCT01876368|515759988|FG001|Overall Study|Lack of Efficacy|0|||
143060372|NCT01876368|515759987|FG000|Overall Study|Lost to Follow-up|0|||
143060373|NCT01876368|515759988|FG001|Overall Study|Lost to Follow-up|1|||
143060374|NCT01876368|515759987|FG000|Overall Study|Non-compliance with study treatment|0|||
143060375|NCT01876368|515759988|FG001|Overall Study|Non-compliance with study treatment|1|||
143060376|NCT01876368|515759987|FG000|Overall Study|Physician Decision|0|||
143060377|NCT01876368|515759988|FG001|Overall Study|Physician Decision|2|||
143060378|NCT01876368|515759987|FG000|Overall Study|Protocol deviation|3|||
143060379|NCT01876368|515759988|FG001|Overall Study|Protocol deviation|3|||
143060380|NCT01876368|515759987|FG000|Overall Study|Subject/guardian decision|3|||
143060381|NCT01876368|515759988|FG001|Overall Study|Subject/guardian decision|1|||
143060382|NCT02563769|515759989|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
143060383|NCT02563769|515759990|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
143060384|NCT02563769|515759991|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
143060385|NCT02820740|515759998|FG000|Overall Study|Did not have procedure|2|||
143060386|NCT00605917|515759999|FG000|Overall Study|Protocol Violation|79|||
143060387|NCT00890552|515760000|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
143060388|NCT00890552|515760000|FG000|On-treatment|Early prog disease/ death|10|||
143060389|NCT04965389|515760002|FG000|Overall Study|Other reasons|1|||
143060390|NCT04965389|515760003|FG001|Overall Study|Other reasons|0|||
143060391|NCT04965389|515760004|FG002|Overall Study|Other reasons|0|||
143060392|NCT04965389|515760005|FG003|Overall Study|Other reasons|0|||
143060393|NCT04965389|515760002|FG000|Overall Study|Participant withdrew consent|0|||
143060394|NCT04965389|515760003|FG001|Overall Study|Participant withdrew consent|1|||
143060395|NCT04965389|515760004|FG002|Overall Study|Participant withdrew consent|0|||
143060396|NCT04965389|515760005|FG003|Overall Study|Participant withdrew consent|0|||
143060397|NCT04965389|515760002|FG000|Overall Study|Poor/Non-compliance|0|||
143060398|NCT04965389|515760003|FG001|Overall Study|Poor/Non-compliance|1|||
143060399|NCT04965389|515760004|FG002|Overall Study|Poor/Non-compliance|0|||
143060400|NCT04965389|515760005|FG003|Overall Study|Poor/Non-compliance|0|||
143060401|NCT03903159|515760006|FG000|Overall Study|Discharged with Staff Approval|2|||
143060402|NCT03903159|515760006|FG000|Overall Study|Discharged at Staff Request|2|||
143060403|NCT03903159|515760006|FG000|Overall Study|Discharged Against Staff Advice|1|||
143060404|NCT00724373|515760009|FG000|Overall Study|Adverse Event|41|||
143060405|NCT00724373|515760009|FG000|Overall Study|Lack of Efficacy|82|||
143060406|NCT00724373|515760009|FG000|Overall Study|Lost to Follow-up|7|||
143060407|NCT00724373|515760009|FG000|Overall Study|Non-compliance|2|||
143060408|NCT00724373|515760009|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
143060409|NCT00724373|515760009|FG000|Overall Study|Participant moved away|1|||
143060410|NCT00724373|515760009|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
143060411|NCT00724373|515760009|FG000|Overall Study|Only to have 24 week regimen|1|||
143060412|NCT00724373|515760009|FG000|Overall Study|Viral Relapse|1|||
143060413|NCT00724373|515760009|FG000|Overall Study|Acute HCV infection|1|||
143060414|NCT00724373|515760009|FG000|Overall Study|Drug Relapse|1|||
143060415|NCT00724373|515760009|FG000|Overall Study|Tolerability|23|||
143060416|NCT03718117|515760016|FG000|Overall Study|Death|12|||
143060417|NCT03718117|515760017|FG001|Overall Study|Death|11|||
143060418|NCT03718117|515760018|FG002|Overall Study|Death|0|||
143060419|NCT03718117|515760016|FG000|Overall Study|Other|0|||
143060420|NCT03718117|515760017|FG001|Overall Study|Other|1|||
143060421|NCT03718117|515760018|FG002|Overall Study|Other|0|||
143060422|NCT03718117|515760016|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
143060423|NCT03718117|515760017|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
143060424|NCT03718117|515760018|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
143060425|NCT03718117|515760016|FG000|Overall Study|Participant not met eligibility criteria|0|||
143060426|NCT03718117|515760017|FG001|Overall Study|Participant not met eligibility criteria|0|||
143060427|NCT03718117|515760018|FG002|Overall Study|Participant not met eligibility criteria|2|||
143060428|NCT01382251|515760019|FG000|Overall Study|Surgeries cancelled or delayed|16|||
143060429|NCT01382251|515760020|FG001|Overall Study|Surgeries cancelled or delayed|16|||
143060430|NCT01382251|515760019|FG000|Overall Study|Lost to Follow-up|4|||
143060431|NCT01382251|515760020|FG001|Overall Study|Lost to Follow-up|4|||
143060432|NCT01382251|515760019|FG000|Overall Study|Contacted after study closed|1|||
143060433|NCT01382251|515760020|FG001|Overall Study|Contacted after study closed|1|||
143060434|NCT01117987|515760021|FG000|Overall Study|Protocol deviation|0|||
143060435|NCT01117987|515760022|FG001|Overall Study|Protocol deviation|1|||
143060436|NCT01117987|515760021|FG000|Overall Study|Subject no longer requires study drug|1|||
143060437|NCT01117987|515760022|FG001|Overall Study|Subject no longer requires study drug|0|||
143060438|NCT01117987|515760021|FG000|Overall Study|Lost to Follow-up|1|||
143060439|NCT01117987|515760022|FG001|Overall Study|Lost to Follow-up|1|||
143060440|NCT01117987|515760021|FG000|Overall Study|Abnormal test procedure result|2|||
143060441|NCT01117987|515760022|FG001|Overall Study|Abnormal test procedure result|0|||
143060442|NCT01117987|515760021|FG000|Overall Study|Lack of Efficacy|3|||
143060443|NCT01117987|515760022|FG001|Overall Study|Lack of Efficacy|4|||
143060444|NCT01117987|515760021|FG000|Overall Study|Death|5|||
143060445|NCT01117987|515760022|FG001|Overall Study|Death|10|||
143060446|NCT01117987|515760021|FG000|Overall Study|Withdrawal by Subject|5|||
143060447|NCT01117987|515760022|FG001|Overall Study|Withdrawal by Subject|10|||
143060448|NCT01117987|515760021|FG000|Overall Study|Adverse Event|19|||
143060449|NCT01117987|515760022|FG001|Overall Study|Adverse Event|26|||
143060450|NCT01117987|515760021|FG000|Overall Study|Administrative problems|25|||
143060451|NCT01117987|515760022|FG001|Overall Study|Administrative problems|22|||
143060452|NCT00206102|515760026|FG000|Overall Study|Adverse Event|119|||
143060453|NCT00206102|515760027|FG001|Overall Study|Adverse Event|82|||
143060454|NCT00206102|515760026|FG000|Overall Study|Protocol Violation|0|||
143060455|NCT00206102|515760027|FG001|Overall Study|Protocol Violation|2|||
143060456|NCT00206102|515760026|FG000|Overall Study|Lack of therapeutic response|16|||
143060457|NCT00206102|515760027|FG001|Overall Study|Lack of therapeutic response|11|||
143170070|NCT03396445|516171842|FG014|Treatment Period|Withdrawal by Subject|1|||
143170071|NCT03396445|516171843|FG015|Treatment Period|Withdrawal by Subject|0|||
143501598|NCT00896532|517376275|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
143501599|NCT00896532|517376276|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
143501600|NCT00896532|517376277|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
143501601|NCT00896532|517376278|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
143501602|NCT00896532|517376279|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
143501603|NCT00896532|517376280|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
143501604|NCT00896532|517376281|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
143060458|NCT00206102|515760026|FG000|Overall Study|Lost to Follow-up|95|||
143060459|NCT00206102|515760027|FG001|Overall Study|Lost to Follow-up|66|||
143060460|NCT00206102|515760026|FG000|Overall Study|Withdrawal by Subject|118|||
143060461|NCT00206102|515760027|FG001|Overall Study|Withdrawal by Subject|101|||
143170072|NCT03396445|516171844|FG016|Treatment Period|Withdrawal by Subject|1|||
143060462|NCT00206102|515760026|FG000|Overall Study|Study-specific discontinuation criteria|18|||
143060463|NCT00206102|515760027|FG001|Overall Study|Study-specific discontinuation criteria|17|||
143060464|NCT00206102|515760026|FG000|Overall Study|None of those categories|42|||
143060465|NCT00206102|515760027|FG001|Overall Study|None of those categories|36|||
143060466|NCT04117945|515760028|FG000|Overall Study|Death|1|||
143060467|NCT04117945|515760029|FG001|Overall Study|Death|0|||
143060468|NCT04117945|515760028|FG000|Overall Study|Withdrawal by Subject|3|||
143060469|NCT04117945|515760029|FG001|Overall Study|Withdrawal by Subject|1|||
143060470|NCT04117945|515760028|FG000|Overall Study|Disease Progression|0|||
143060471|NCT04117945|515760029|FG001|Overall Study|Disease Progression|2|||
143060472|NCT04117945|515760028|FG000|Overall Study|Ineligible|8|||
143060473|NCT04117945|515760029|FG001|Overall Study|Ineligible|7|||
143060474|NCT02148445|515760033|FG000|Overall Study|Death|1|||
143060475|NCT02148445|515760034|FG001|Overall Study|Death|3|||
143060476|NCT04230876|515760035|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
143060477|NCT04230876|515760036|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
143060478|NCT02093923|515760038|FG000|Overall Study|Lost to Follow-up|0|||
143060479|NCT02093923|515760039|FG001|Overall Study|Lost to Follow-up|0|||
143060480|NCT02093923|515760040|FG002|Overall Study|Lost to Follow-up|0|||
143060481|NCT02093923|515760041|FG003|Overall Study|Lost to Follow-up|1|||
143060482|NCT02093923|515760042|FG004|Overall Study|Lost to Follow-up|0|||
143060483|NCT02093923|515760038|FG000|Overall Study|Screen failure after randomization|0|||
143060484|NCT02093923|515760039|FG001|Overall Study|Screen failure after randomization|0|||
143060485|NCT02093923|515760040|FG002|Overall Study|Screen failure after randomization|0|||
143060486|NCT02093923|515760041|FG003|Overall Study|Screen failure after randomization|1|||
143060487|NCT02093923|515760042|FG004|Overall Study|Screen failure after randomization|0|||
143060488|NCT00955721|515760044|FG000|Overall Study|Physician Decision|1|||
143060489|NCT00955721|515760045|FG001|Overall Study|Physician Decision|0|||
143060490|NCT00955721|515760044|FG000|Overall Study|Death|1|||
143060491|NCT00955721|515760045|FG001|Overall Study|Death|0|||
143060492|NCT00955721|515760044|FG000|Overall Study|Withdrawal by Subject|1|||
143060493|NCT00955721|515760045|FG001|Overall Study|Withdrawal by Subject|0|||
143060494|NCT02756637|515760046|FG000|Overall Study|Not eligible for initial SWOG study|10|||
143060495|NCT02756637|515760047|FG001|Overall Study|Not eligible for initial SWOG study|10|||
143060496|NCT02756637|515760046|FG000|Overall Study|No available NLR value|44|||
143060497|NCT02756637|515760047|FG001|Overall Study|No available NLR value|44|||
143060498|NCT02756637|515760046|FG000|Overall Study|Did not complete curative therapy|33|||
143060499|NCT02756637|515760047|FG001|Overall Study|Did not complete curative therapy|0|||
143060500|NCT04034355|515760064|FG000|Overall Study|Study terminated by Sponsor|10|||
143060501|NCT04034355|515760065|FG001|Overall Study|Study terminated by Sponsor|17|||
143060502|NCT04034355|515760064|FG000|Overall Study|Withdrawal by Subject|12|||
143060503|NCT04034355|515760065|FG001|Overall Study|Withdrawal by Subject|11|||
143060504|NCT04034355|515760064|FG000|Overall Study|Site terminated by Sponsor|4|||
143501605|NCT00896532|517376282|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
143501606|NCT00896532|517376283|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
143501607|NCT00896532|517376284|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
143501608|NCT00896532|517376285|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
143501609|NCT00896532|517376286|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
143501610|NCT00896532|517376287|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
143501611|NCT00896532|517376288|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
143501612|NCT00896532|517376289|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
143501613|NCT00896532|517376290|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
143501614|NCT00896532|517376291|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
143501615|NCT00896532|517376292|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
143501616|NCT00896532|517376293|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
143501617|NCT00896532|517376294|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
143501618|NCT00896532|517376295|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
143501619|NCT00896532|517376296|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
143501620|NCT00896532|517376274|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
143060505|NCT04034355|515760065|FG001|Overall Study|Site terminated by Sponsor|5|||
143060506|NCT04034355|515760064|FG000|Overall Study|Adverse Event|2|||
143060507|NCT04034355|515760065|FG001|Overall Study|Adverse Event|0|||
143060508|NCT04034355|515760064|FG000|Overall Study|Death|1|||
143060509|NCT04034355|515760065|FG001|Overall Study|Death|1|||
143060510|NCT04034355|515760064|FG000|Overall Study|Not reported|2|||
143060511|NCT04034355|515760065|FG001|Overall Study|Not reported|0|||
143060512|NCT04034355|515760064|FG000|Overall Study|Lost to Follow-up|1|||
143060513|NCT04034355|515760065|FG001|Overall Study|Lost to Follow-up|0|||
143060514|NCT04034355|515760064|FG000|Overall Study|Physician Decision|1|||
143060515|NCT04034355|515760065|FG001|Overall Study|Physician Decision|0|||
143060516|NCT04034355|515760064|FG000|Overall Study|Protocol Violation|0|||
143060517|NCT04034355|515760065|FG001|Overall Study|Protocol Violation|1|||
143060518|NCT04034355|515760064|FG000|Overall Study|Progressive disease|1|||
143060519|NCT04034355|515760065|FG001|Overall Study|Progressive disease|0|||
143060520|NCT00546910|515761757|FG000|Overall Study|Adverse Event|2|||
143060521|NCT00546910|515761758|FG001|Overall Study|Adverse Event|3|||
143060522|NCT00546910|515761757|FG000|Overall Study|Lack of Efficacy|5|||
143060523|NCT00546910|515761758|FG001|Overall Study|Lack of Efficacy|7|||
143060524|NCT00546910|515761757|FG000|Overall Study|Physician Decision|0|||
143060525|NCT00546910|515761758|FG001|Overall Study|Physician Decision|1|||
143060526|NCT00546910|515761757|FG000|Overall Study|Withdrawal by Subject|2|||
143060527|NCT00546910|515761758|FG001|Overall Study|Withdrawal by Subject|0|||
143060528|NCT02284347|515761759|FG000|Overall Study|Lost to Follow-up|2|||
143060529|NCT02284347|515761759|FG000|Overall Study|Withdrawn prior to treatment|1|||
143501621|NCT00896532|517376275|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
143501622|NCT00896532|517376276|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
143501623|NCT00896532|517376277|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
143501624|NCT00896532|517376278|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
143501625|NCT00896532|517376279|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
143501626|NCT00896532|517376280|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
143501627|NCT00896532|517376281|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
143501628|NCT00896532|517376282|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
143501629|NCT00896532|517376283|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
143501630|NCT00896532|517376284|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
143501631|NCT00896532|517376285|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
143501632|NCT00896532|517376286|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
143501633|NCT00896532|517376287|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
143501634|NCT00896532|517376288|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
143501635|NCT00896532|517376289|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
143501636|NCT00896532|517376290|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
143501637|NCT00896532|517376291|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
143501638|NCT00896532|517376292|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
143501639|NCT00896532|517376293|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
143060530|NCT01915940|515761760|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
143060531|NCT01915940|515761761|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
143060532|NCT01915940|515761762|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
143060533|NCT01915940|515761760|FG000|Treatment Period|Decision of Participant|0|||
143060534|NCT01915940|515761761|FG001|Treatment Period|Decision of Participant|1|||
143060535|NCT01915940|515761762|FG002|Treatment Period|Decision of Participant|3|||
143060536|NCT01915940|515761760|FG000|Treatment Period|Adverse Event|0|||
143060537|NCT01915940|515761761|FG001|Treatment Period|Adverse Event|9|||
143060538|NCT01915940|515761762|FG002|Treatment Period|Adverse Event|1|||
143060539|NCT01915940|515761760|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
143060540|NCT01915940|515761761|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
143060541|NCT01915940|515761762|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
143060542|NCT02310789|515761763|FG000|Overall Study|Adverse Event|1|||
143060543|NCT03346070|515761771|FG000|Overall Study|Death|0|||
143060544|NCT03346070|515761772|FG001|Overall Study|Death|0|||
143060545|NCT03346070|515761773|FG002|Overall Study|Death|0|||
143060546|NCT03346070|515761774|FG003|Overall Study|Death|0|||
143060547|NCT03346070|515761775|FG004|Overall Study|Death|1|||
143060548|NCT03346070|515761771|FG000|Overall Study|Lost to Follow-up|0|||
143060549|NCT03346070|515761772|FG001|Overall Study|Lost to Follow-up|1|||
143060550|NCT03346070|515761773|FG002|Overall Study|Lost to Follow-up|2|||
143060551|NCT03346070|515761774|FG003|Overall Study|Lost to Follow-up|0|||
143060552|NCT03346070|515761775|FG004|Overall Study|Lost to Follow-up|0|||
143060553|NCT03346070|515761771|FG000|Overall Study|Physician Decision|0|||
143501640|NCT00896532|517376294|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
143501641|NCT00896532|517376295|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
143501642|NCT00896532|517376296|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
143501643|NCT00896532|517376274|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
143501644|NCT00896532|517376275|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
143060554|NCT03346070|515761772|FG001|Overall Study|Physician Decision|0|||
143060555|NCT03346070|515761773|FG002|Overall Study|Physician Decision|0|||
143060556|NCT03346070|515761774|FG003|Overall Study|Physician Decision|1|||
143060557|NCT03346070|515761775|FG004|Overall Study|Physician Decision|1|||
143060558|NCT03346070|515761771|FG000|Overall Study|Withdrawal by Subject|1|||
143060559|NCT03346070|515761772|FG001|Overall Study|Withdrawal by Subject|0|||
143060560|NCT03346070|515761773|FG002|Overall Study|Withdrawal by Subject|0|||
143060561|NCT03346070|515761774|FG003|Overall Study|Withdrawal by Subject|1|||
143501645|NCT00896532|517376276|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
143060562|NCT03346070|515761775|FG004|Overall Study|Withdrawal by Subject|0|||
143060563|NCT03346070|515761771|FG000|Overall Study|Study medication not received as planned|2|||
143060564|NCT03346070|515761772|FG001|Overall Study|Study medication not received as planned|3|||
143060565|NCT03346070|515761773|FG002|Overall Study|Study medication not received as planned|2|||
143060566|NCT03346070|515761774|FG003|Overall Study|Study medication not received as planned|3|||
143060567|NCT03346070|515761775|FG004|Overall Study|Study medication not received as planned|2|||
143060568|NCT03346070|515761771|FG000|Overall Study|Screen Failure|0|||
143060569|NCT03346070|515761772|FG001|Overall Study|Screen Failure|0|||
143060570|NCT03346070|515761773|FG002|Overall Study|Screen Failure|0|||
143501646|NCT00896532|517376277|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
143501647|NCT00896532|517376278|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
143060571|NCT03346070|515761774|FG003|Overall Study|Screen Failure|1|||
143501648|NCT00896532|517376279|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
143501649|NCT00896532|517376280|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
143501650|NCT00896532|517376281|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
143501651|NCT00896532|517376282|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
143501652|NCT00896532|517376283|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
143501653|NCT00896532|517376284|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
143501654|NCT00896532|517376285|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
143501655|NCT00896532|517376286|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
143501656|NCT00896532|517376287|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
143501657|NCT00896532|517376288|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
143060572|NCT03346070|515761775|FG004|Overall Study|Screen Failure|1|||
143060573|NCT00977548|515761776|FG000|Overall Study|Ineligible|4|||
143060574|NCT00977548|515761776|FG000|Overall Study|Adverse Event|8|||
143060575|NCT00977548|515761776|FG000|Overall Study|Withdrawal by Subject|1|||
143060576|NCT00107042|515761779|FG000|Overall Study|Lost to Follow-up|9|||
143060577|NCT00107042|515761780|FG001|Overall Study|Lost to Follow-up|7|||
143060578|NCT00107042|515761779|FG000|Overall Study|Withdrawal by Subject|6|||
143060579|NCT00107042|515761780|FG001|Overall Study|Withdrawal by Subject|1|||
143060580|NCT00107042|515761779|FG000|Overall Study|Moved out of area|5|||
143060581|NCT00107042|515761780|FG001|Overall Study|Moved out of area|3|||
143060582|NCT00107042|515761779|FG000|Overall Study|Pregnancy|1|||
143060583|NCT00107042|515761780|FG001|Overall Study|Pregnancy|1|||
143060584|NCT00107042|515761779|FG000|Overall Study|Inadvertent enrollment|0|||
143060585|NCT00107042|515761780|FG001|Overall Study|Inadvertent enrollment|1|||
143060586|NCT00107042|515761779|FG000|Overall Study|vaccinated outside window|1|||
143060587|NCT00107042|515761780|FG001|Overall Study|vaccinated outside window|1|||
143501658|NCT00896532|517376289|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
143501659|NCT00896532|517376290|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
143060588|NCT00107042|515761779|FG000|Overall Study|Disallowed medications|0|||
143060589|NCT00107042|515761780|FG001|Overall Study|Disallowed medications|2|||
143060590|NCT03919448|515761781|FG000|Overall Study|Withdrawal by Subject|1|||
143501660|NCT00896532|517376291|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
143501661|NCT00896532|517376292|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
143501662|NCT00896532|517376293|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
143501663|NCT00896532|517376294|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
143501664|NCT00896532|517376295|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
143501665|NCT00896532|517376296|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
143501666|NCT00896532|517376274|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
143501667|NCT00896532|517376275|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
143501668|NCT00896532|517376276|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
143501669|NCT00896532|517376277|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
143501670|NCT00896532|517376278|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
143501671|NCT00896532|517376279|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
143501672|NCT00896532|517376280|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
143501673|NCT00896532|517376281|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
143501674|NCT00896532|517376282|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
143501675|NCT00896532|517376283|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
143501676|NCT00896532|517376284|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
143501677|NCT00896532|517376285|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
143501678|NCT00896532|517376286|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
143501679|NCT00896532|517376287|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
143501680|NCT00896532|517376288|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
143501681|NCT00896532|517376289|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
143060591|NCT03919448|515761782|FG001|Overall Study|Withdrawal by Subject|0|||
143060592|NCT03919448|515761783|FG002|Overall Study|Withdrawal by Subject|0|||
143060593|NCT04213209|515761784|FG000|Overall Study|Protocol Violation|1|||
143365094|NCT05550337|516878792|FG000|Overall Study|Lack of Efficacy|0|||
143365095|NCT05550337|516878793|FG001|Overall Study|Lack of Efficacy|0|||
143060594|NCT04213209|515761785|FG001|Overall Study|Protocol Violation|0|||
143365096|NCT05550337|516878794|FG002|Overall Study|Lack of Efficacy|1|||
143060595|NCT04213209|515761786|FG002|Overall Study|Protocol Violation|0|||
143060596|NCT04213209|515761787|FG003|Overall Study|Protocol Violation|0|||
143060597|NCT04213209|515761788|FG004|Overall Study|Protocol Violation|0|||
143060598|NCT04213209|515761789|FG005|Overall Study|Protocol Violation|0|||
143060599|NCT02065713|515761793|FG000|Overall Study|Adverse Event|0|||
143060600|NCT02065713|515761794|FG001|Overall Study|Adverse Event|1|||
143060601|NCT02065713|515761793|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
143060602|NCT02065713|515761794|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
143060603|NCT00655850|515761803|FG000|Overall Study|Death|2|||
143060604|NCT00655850|515761803|FG000|Overall Study|Withdrawal by Subject|1|||
143060605|NCT02129647|515761804|FG000|Overall Study|Adverse Event|2|||
143060606|NCT02129647|515761804|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
143060607|NCT02225665|515761805|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
143060608|NCT02225665|515761806|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
143060609|NCT02225665|515761805|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
143060610|NCT02225665|515761806|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
143060611|NCT01311557|515761807|FG000|Overall Study|Serious adverse event|0|||
143060612|NCT01311557|515761808|FG001|Overall Study|Serious adverse event|1|||
143060613|NCT01311557|515761807|FG000|Overall Study|Protocol Violation|4|||
143060614|NCT01311557|515761808|FG001|Overall Study|Protocol Violation|2|||
143060615|NCT01311557|515761807|FG000|Overall Study|Lost to Follow-up|0|||
143060616|NCT01311557|515761808|FG001|Overall Study|Lost to Follow-up|1|||
143060617|NCT01311557|515761807|FG000|Overall Study|Withdrawal by Subject|1|||
143060618|NCT01311557|515761808|FG001|Overall Study|Withdrawal by Subject|2|||
143060619|NCT00608517|515761809|FG000|Overall Study|Death|1|||
143060620|NCT00608517|515761810|FG001|Overall Study|Death|0|||
143060621|NCT00608517|515761811|FG002|Overall Study|Death|0|||
143060622|NCT01833533|515761812|FG000|Overall Study|Adverse Event|0|||
143060623|NCT01833533|515761813|FG001|Overall Study|Adverse Event|1|||
143060624|NCT01833533|515761812|FG000|Overall Study|Lost to Follow-up|4|||
143060625|NCT01833533|515761813|FG001|Overall Study|Lost to Follow-up|9|||
143060626|NCT01833533|515761812|FG000|Overall Study|To Enter an Extension Study|0|||
143060627|NCT01833533|515761813|FG001|Overall Study|To Enter an Extension Study|4|||
143060628|NCT01833533|515761812|FG000|Overall Study|Other|2|||
143060629|NCT01833533|515761813|FG001|Overall Study|Other|7|||
143060630|NCT05212883|515761817|FG000|Overall Study|Invalid test result|125|||
143060631|NCT02502734|515761818|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
143060632|NCT02502734|515761819|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
143060633|NCT02502734|515761818|FG000|Washout Period|Adverse Event|1|||
143060634|NCT02502734|515761819|FG001|Washout Period|Adverse Event|0|||
143060635|NCT03649412|515761823|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
143060636|NCT03649412|515761824|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
143060637|NCT03649412|515761823|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
143060638|NCT03649412|515761824|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
143060639|NCT03649412|515761823|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
143060640|NCT03649412|515761824|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
143501682|NCT00896532|517376290|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
143501683|NCT00896532|517376291|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
143501684|NCT00896532|517376292|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
143501685|NCT00896532|517376293|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
143501686|NCT00896532|517376294|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
143501687|NCT00896532|517376295|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
143501688|NCT00896532|517376296|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
143501689|NCT00896532|517376274|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
143501690|NCT00896532|517376275|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
143501691|NCT00896532|517376276|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
143501692|NCT00896532|517376277|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
143501693|NCT00896532|517376278|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
143501694|NCT00896532|517376279|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
143501695|NCT00896532|517376280|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
143501696|NCT00896532|517376281|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
143501697|NCT00896532|517376282|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
143501698|NCT00896532|517376283|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
143501699|NCT00896532|517376284|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
143501700|NCT00896532|517376285|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
143501701|NCT00896532|517376286|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
143501702|NCT00896532|517376287|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
143501703|NCT00896532|517376288|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
143501704|NCT00896532|517376289|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
143501705|NCT00896532|517376290|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
143501706|NCT00896532|517376291|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
143501707|NCT00896532|517376292|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
143501708|NCT00896532|517376293|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
143501709|NCT00896532|517376294|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
143501710|NCT00896532|517376295|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
143501711|NCT00896532|517376296|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
143501712|NCT00896532|517376274|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
143501713|NCT00896532|517376275|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
143501714|NCT00896532|517376276|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
143060641|NCT03649412|515761823|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
143060642|NCT03649412|515761824|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
143060643|NCT03649412|515761823|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
143060644|NCT03649412|515761824|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
143060645|NCT03649412|515761823|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
143060646|NCT03649412|515761824|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
143060647|NCT03920280|515761825|FG000|Overall Study|Adverse Event|2|||
143060648|NCT03920280|515761826|FG001|Overall Study|Adverse Event|3|||
143060649|NCT03920280|515761825|FG000|Overall Study|Lost to Follow-up|0|||
143060650|NCT03920280|515761826|FG001|Overall Study|Lost to Follow-up|1|||
143060651|NCT03920280|515761825|FG000|Overall Study|Withdrawal by Subject|1|||
143060652|NCT03920280|515761826|FG001|Overall Study|Withdrawal by Subject|1|||
143060653|NCT03920280|515761825|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
143060654|NCT03920280|515761826|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
143060655|NCT01740791|515761827|FG000|Overall Study|Randomized but never treated|5|||
143060656|NCT01740791|515761828|FG001|Overall Study|Randomized but never treated|3|||
143060657|NCT01740791|515761829|FG002|Overall Study|Randomized but never treated|2|||
143060658|NCT01740791|515761830|FG003|Overall Study|Randomized but never treated|2|||
143060659|NCT01740791|515761831|FG004|Overall Study|Randomized but never treated|1|||
143060660|NCT01740791|515761832|FG005|Overall Study|Randomized but never treated|3|||
143060661|NCT01740791|515761827|FG000|Overall Study|Lost to Follow-up|2|||
143060662|NCT01740791|515761828|FG001|Overall Study|Lost to Follow-up|0|||
143060663|NCT01740791|515761829|FG002|Overall Study|Lost to Follow-up|2|||
143060664|NCT01740791|515761830|FG003|Overall Study|Lost to Follow-up|3|||
143060665|NCT01740791|515761831|FG004|Overall Study|Lost to Follow-up|2|||
143060666|NCT01740791|515761832|FG005|Overall Study|Lost to Follow-up|3|||
143060667|NCT01740791|515761827|FG000|Overall Study|Withdrew Consent|4|||
143060668|NCT01740791|515761828|FG001|Overall Study|Withdrew Consent|0|||
143365097|NCT05550337|516878792|FG000|Overall Study|Adverse Event|1|||
143501715|NCT00896532|517376277|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
143501716|NCT00896532|517376278|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
143501717|NCT00896532|517376279|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
143060669|NCT01740791|515761829|FG002|Overall Study|Withdrew Consent|1|||
143060670|NCT01740791|515761830|FG003|Overall Study|Withdrew Consent|2|||
143060671|NCT01740791|515761831|FG004|Overall Study|Withdrew Consent|0|||
143501718|NCT00896532|517376280|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
143501719|NCT00896532|517376281|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
143501720|NCT00896532|517376282|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
143060672|NCT01740791|515761832|FG005|Overall Study|Withdrew Consent|3|||
143060673|NCT01740791|515761827|FG000|Overall Study|Investigator's discretion|1|||
143060674|NCT01740791|515761828|FG001|Overall Study|Investigator's discretion|0|||
143060675|NCT01740791|515761829|FG002|Overall Study|Investigator's discretion|1|||
143060676|NCT01740791|515761830|FG003|Overall Study|Investigator's discretion|0|||
143060677|NCT01740791|515761831|FG004|Overall Study|Investigator's discretion|0|||
143060678|NCT01740791|515761832|FG005|Overall Study|Investigator's discretion|1|||
143060679|NCT01740791|515761827|FG000|Overall Study|Adverse Event|0|||
143501721|NCT00896532|517376283|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
143501722|NCT00896532|517376284|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
143501723|NCT00896532|517376285|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
143501724|NCT00896532|517376286|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
143501725|NCT00896532|517376287|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
143501726|NCT00896532|517376288|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
143501727|NCT00896532|517376289|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
143501728|NCT00896532|517376290|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
143501729|NCT00896532|517376291|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
143501730|NCT00896532|517376292|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
143501731|NCT00896532|517376293|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
143501732|NCT00896532|517376294|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
143501733|NCT00896532|517376295|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
143501734|NCT00896532|517376296|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
143501735|NCT00896532|517376274|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
143501736|NCT00896532|517376275|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
143501737|NCT00896532|517376276|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
143501738|NCT00896532|517376277|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
143501739|NCT00896532|517376278|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
143501740|NCT00896532|517376279|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
143501741|NCT00896532|517376280|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
143501742|NCT00896532|517376281|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
143501743|NCT00896532|517376282|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
143501744|NCT00896532|517376283|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
143060680|NCT01740791|515761828|FG001|Overall Study|Adverse Event|0|||
143060681|NCT01740791|515761829|FG002|Overall Study|Adverse Event|0|||
143060682|NCT01740791|515761830|FG003|Overall Study|Adverse Event|0|||
143060683|NCT01740791|515761831|FG004|Overall Study|Adverse Event|0|||
143060684|NCT01740791|515761832|FG005|Overall Study|Adverse Event|1|||
143060685|NCT01463982|515761833|FG000|Overall Study|Withdrawal by Subject|0|||
143060686|NCT01463982|515761834|FG001|Overall Study|Withdrawal by Subject|1|||
143060687|NCT01463982|515761835|FG002|Overall Study|Withdrawal by Subject|1|||
143060688|NCT01463982|515761836|FG003|Overall Study|Withdrawal by Subject|0|||
143060689|NCT01463982|515761833|FG000|Overall Study|Treatment delay over 5 week|0|||
143060690|NCT01463982|515761834|FG001|Overall Study|Treatment delay over 5 week|0|||
143060691|NCT01463982|515761835|FG002|Overall Study|Treatment delay over 5 week|1|||
143060692|NCT01463982|515761836|FG003|Overall Study|Treatment delay over 5 week|0|||
143060693|NCT03170869|515761841|FG000|Overall Study|Protocol Violation|5|||
143060694|NCT03170869|515761841|FG000|Overall Study|Early study termination|3|||
143060695|NCT01501110|515761842|FG000|Overall Study|Death|0|||
143060696|NCT01501110|515761843|FG001|Overall Study|Death|1|||
143060697|NCT02075606|515761844|FG000|Overall Study|Adverse Event|5|||
143060698|NCT02075606|515761844|FG000|Overall Study|Withdrawal by Subject|1|||
143060699|NCT02075606|515761844|FG000|Overall Study|Death|1|||
143060700|NCT02075606|515761844|FG000|Overall Study|Investigator's decision|1|||
143060701|NCT02075606|515761844|FG000|Overall Study|Symptom management|1|||
143060702|NCT02075606|515761844|FG000|Overall Study|Increasing Symptoms|1|||
143060703|NCT04019054|515761847|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
143060704|NCT04019054|515761848|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
143060705|NCT04019054|515761847|FG000|Overall Study|Withdrawal by Subject|3|||
143060706|NCT04019054|515761848|FG001|Overall Study|Withdrawal by Subject|1|||
143060707|NCT01261624|515761849|FG000|Week 0 to Week 12|Disease Progression|1|||
143060708|NCT01261624|515761850|FG001|Week 0 to Week 12|Disease Progression|1|||
143060709|NCT01261624|515761849|FG000|Week 0 to Week 12|Insufficient Response|0|||
143170073|NCT03396445|516171845|FG017|Treatment Period|Withdrawal by Subject|0|||
143501745|NCT00896532|517376284|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
143501746|NCT00896532|517376285|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
143501747|NCT00896532|517376286|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
143060710|NCT01261624|515761850|FG001|Week 0 to Week 12|Insufficient Response|2|||
143060711|NCT01261624|515761849|FG000|Week 13 to Week 24|Insufficient Response|0|||
143060712|NCT01261624|515761850|FG001|Week 13 to Week 24|Insufficient Response|1|||
143245926|NCT01485172|516451836|FG005|Overall Study|Protocol Violation|0|||
143060713|NCT01719562|515761861|FG000|Overall Study|Lost to Follow-up|1|||
143060714|NCT01719562|515761862|FG001|Overall Study|Lost to Follow-up|0|||
143060715|NCT01719562|515761861|FG000|Overall Study|Death|1|||
143060716|NCT01719562|515761862|FG001|Overall Study|Death|0|||
143060717|NCT01719562|515761861|FG000|Overall Study|New cancer diagnosis|1|||
143060718|NCT01719562|515761862|FG001|Overall Study|New cancer diagnosis|0|||
143060719|NCT00508027|515761863|FG000|Dose Level 1|Lost to Follow-up|4|||
143060720|NCT00508027|515761863|FG000|Dose Level 1|Withdrawal by Subject|2|||
143060721|NCT00508027|515761863|FG000|Dose Level 1|Physician Decision|2|||
143060722|NCT00508027|515761863|FG000|Dose Level 2|Lost to Follow-up|2|||
143060723|NCT00508027|515761863|FG000|Dose Level 2|Withdrawal by Subject|2|||
143060724|NCT02013531|515761864|FG000|Overall Study|Lost to Follow-up|3|||
143060725|NCT02013531|515761864|FG000|Overall Study|Met Withdrawal Criteria|1|||
143060726|NCT02013531|515761864|FG000|Overall Study|Withdrawal by Subject|1|||
143060727|NCT03877926|515761867|FG000|Overall Study|Adverse Event|1|||
143060728|NCT03877926|515761868|FG001|Overall Study|Adverse Event|0|||
143060729|NCT03877926|515761869|FG002|Overall Study|Adverse Event|0|||
143060730|NCT03877926|515761870|FG003|Overall Study|Adverse Event|0|||
143060731|NCT03877926|515761867|FG000|Overall Study|Death|2|||
143060732|NCT03877926|515761868|FG001|Overall Study|Death|2|||
143060733|NCT03877926|515761869|FG002|Overall Study|Death|2|||
143060734|NCT03877926|515761870|FG003|Overall Study|Death|0|||
143060735|NCT03877926|515761867|FG000|Overall Study|Lost to Follow-up|41|||
143060736|NCT03877926|515761868|FG001|Overall Study|Lost to Follow-up|52|||
143060737|NCT03877926|515761869|FG002|Overall Study|Lost to Follow-up|45|||
143060738|NCT03877926|515761870|FG003|Overall Study|Lost to Follow-up|17|||
143060739|NCT03877926|515761867|FG000|Overall Study|Physician Decision|2|||
143060740|NCT03877926|515761868|FG001|Overall Study|Physician Decision|0|||
143060741|NCT03877926|515761869|FG002|Overall Study|Physician Decision|2|||
143060742|NCT03877926|515761870|FG003|Overall Study|Physician Decision|0|||
143060743|NCT03877926|515761867|FG000|Overall Study|Withdrawal by Subject|18|||
143060744|NCT03877926|515761868|FG001|Overall Study|Withdrawal by Subject|21|||
143060745|NCT03877926|515761869|FG002|Overall Study|Withdrawal by Subject|12|||
143060746|NCT03877926|515761870|FG003|Overall Study|Withdrawal by Subject|4|||
143060747|NCT03877926|515761867|FG000|Overall Study|Other - Various|4|||
143060748|NCT03877926|515761868|FG001|Overall Study|Other - Various|1|||
143060749|NCT03877926|515761869|FG002|Overall Study|Other - Various|1|||
143060750|NCT03877926|515761870|FG003|Overall Study|Other - Various|0|||
143060751|NCT03877926|515761867|FG000|Overall Study|Not Treated|3|||
143060752|NCT03877926|515761868|FG001|Overall Study|Not Treated|1|||
143060753|NCT03877926|515761869|FG002|Overall Study|Not Treated|1|||
143060754|NCT03877926|515761870|FG003|Overall Study|Not Treated|0|||
143060755|NCT00467831|515761872|FG000|Overall Study|Death|2|||
143060756|NCT00467831|515761872|FG000|Overall Study|Withdrawal by Subject|1|||
143060757|NCT01832402|515761875|FG000|Overall Study|Lost to Follow-up|2|||
143060758|NCT01832402|515761876|FG001|Overall Study|Lost to Follow-up|0|||
143060759|NCT01832402|515761875|FG000|Overall Study|Withdrawal by Subject|3|||
143060760|NCT01832402|515761876|FG001|Overall Study|Withdrawal by Subject|3|||
143060761|NCT01832402|515761875|FG000|Overall Study|Declining Performance status|2|||
143060762|NCT01832402|515761876|FG001|Overall Study|Declining Performance status|1|||
143060763|NCT03417830|515761878|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
143060764|NCT03417830|515761879|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
143060765|NCT03827018|515761882|FG000|Overall Study|Adverse Event|1|||
143060766|NCT03827018|515761883|FG001|Overall Study|Adverse Event|0|||
143060767|NCT03827018|515761882|FG000|Overall Study|Withdrawal by Subject|2|||
143060768|NCT03827018|515761883|FG001|Overall Study|Withdrawal by Subject|2|||
143060769|NCT03827018|515761882|FG000|Overall Study|Lack of Efficacy|0|||
143060770|NCT03827018|515761883|FG001|Overall Study|Lack of Efficacy|1|||
143365098|NCT05550337|516878793|FG001|Overall Study|Adverse Event|5|||
143365099|NCT05550337|516878794|FG002|Overall Study|Adverse Event|0|||
143365100|NCT05550337|516878792|FG000|Overall Study|Withdrawal by Subject|8|||
143365101|NCT05550337|516878793|FG001|Overall Study|Withdrawal by Subject|14|||
143060771|NCT02492841|515761884|FG000|Overall Study|Lost to Follow-up|34|||
143060772|NCT02492841|515761885|FG001|Overall Study|Lost to Follow-up|31|||
143060773|NCT02492841|515761886|FG002|Overall Study|Lost to Follow-up|35|||
143060774|NCT04798482|515761891|FG000|Overall Study|Physician Decision|1|||
143060775|NCT04798482|515761891|FG000|Overall Study|Lost eligibility|1|||
143060776|NCT00562120|515761895|FG000|First Intervention Period|Adverse Event|1|||
143060777|NCT00562120|515761896|FG001|First Intervention Period|Adverse Event|0|||
143060778|NCT00562120|515761897|FG002|First Intervention Period|Adverse Event|0|||
143060779|NCT00562120|515761898|FG003|First Intervention Period|Adverse Event|0|||
143060780|NCT00562120|515761895|FG000|First Intervention Period|Randomized but not Treated|1|||
143365102|NCT05550337|516878794|FG002|Overall Study|Withdrawal by Subject|10|||
143060781|NCT00562120|515761896|FG001|First Intervention Period|Randomized but not Treated|0|||
143060782|NCT00562120|515761897|FG002|First Intervention Period|Randomized but not Treated|0|||
143060783|NCT00562120|515761898|FG003|First Intervention Period|Randomized but not Treated|0|||
143060784|NCT00545688|515761902|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
143365103|NCT05550337|516878792|FG000|Overall Study|Pregnancy|0|||
143501748|NCT00896532|517376287|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
143501749|NCT00896532|517376288|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
143501750|NCT00896532|517376289|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
143501751|NCT00896532|517376290|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
143060785|NCT00545688|515761903|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
143060786|NCT00545688|515761904|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
143060787|NCT00545688|515761905|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
143060788|NCT00545688|515761902|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
143060789|NCT00545688|515761903|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
143060790|NCT00545688|515761904|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
143060791|NCT00545688|515761905|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
143060792|NCT00545688|515761902|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
143060793|NCT00545688|515761903|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
143060794|NCT00545688|515761904|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
143060795|NCT00545688|515761905|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
143060796|NCT00545688|515761902|FG000|Neo-Adjuvant Treatment Period|Death|0|||
143060797|NCT00545688|515761903|FG001|Neo-Adjuvant Treatment Period|Death|1|||
143060798|NCT00545688|515761904|FG002|Neo-Adjuvant Treatment Period|Death|0|||
143060799|NCT00545688|515761905|FG003|Neo-Adjuvant Treatment Period|Death|0|||
143060800|NCT00545688|515761902|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
143060801|NCT00545688|515761903|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
143060802|NCT00545688|515761904|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
143060803|NCT00545688|515761905|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
143060804|NCT00545688|515761902|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
143060805|NCT00545688|515761903|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
143060806|NCT00545688|515761904|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
143060807|NCT00545688|515761905|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
143060808|NCT00545688|515761902|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
143501752|NCT00896532|517376291|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
143501753|NCT00896532|517376292|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
143060809|NCT00545688|515761903|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
143060810|NCT00545688|515761904|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
143501754|NCT00896532|517376293|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
143501755|NCT00896532|517376294|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
143501756|NCT00896532|517376295|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
143501757|NCT00896532|517376296|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
143501758|NCT00896532|517376274|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
143501759|NCT00896532|517376275|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
143501760|NCT00896532|517376276|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
143501761|NCT00896532|517376277|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
143501762|NCT00896532|517376278|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
143501763|NCT00896532|517376279|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
143501764|NCT00896532|517376280|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
143060811|NCT00545688|515761905|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
143060812|NCT00545688|515761902|FG000|Adjuvant Treatment Period|Disease Progression|3|||
143060813|NCT00545688|515761903|FG001|Adjuvant Treatment Period|Disease Progression|3|||
143060814|NCT00545688|515761904|FG002|Adjuvant Treatment Period|Disease Progression|0|||
143060815|NCT00545688|515761905|FG003|Adjuvant Treatment Period|Disease Progression|7|||
143245927|NCT01485172|516451831|FG000|Overall Study|Protocol defined stopping criteria|1|||
143245928|NCT01485172|516451832|FG001|Overall Study|Protocol defined stopping criteria|0|||
143245929|NCT01485172|516451833|FG002|Overall Study|Protocol defined stopping criteria|0|||
143245930|NCT01485172|516451834|FG003|Overall Study|Protocol defined stopping criteria|0|||
143245931|NCT01485172|516451835|FG004|Overall Study|Protocol defined stopping criteria|1|||
143245932|NCT01485172|516451836|FG005|Overall Study|Protocol defined stopping criteria|0|||
143245933|NCT01485172|516451831|FG000|Overall Study|Lost to Follow-up|0|||
143245934|NCT01485172|516451832|FG001|Overall Study|Lost to Follow-up|0|||
143365104|NCT05550337|516878793|FG001|Overall Study|Pregnancy|0|||
143501765|NCT00896532|517376281|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
143060816|NCT00545688|515761902|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
143060817|NCT00545688|515761903|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
143060818|NCT00545688|515761904|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
143060819|NCT00545688|515761905|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
143245935|NCT01485172|516451833|FG002|Overall Study|Lost to Follow-up|1|||
143245936|NCT01485172|516451834|FG003|Overall Study|Lost to Follow-up|0|||
143365105|NCT05550337|516878794|FG002|Overall Study|Pregnancy|1|||
143501766|NCT00896532|517376282|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
143501767|NCT00896532|517376283|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
143501768|NCT00896532|517376284|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
143060820|NCT00545688|515761902|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
143060821|NCT00545688|515761903|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
143060822|NCT00545688|515761904|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
143060823|NCT00545688|515761905|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
143060824|NCT00545688|515761902|FG000|Adjuvant Treatment Period|Adverse Event|0|||
143060825|NCT00545688|515761903|FG001|Adjuvant Treatment Period|Adverse Event|3|||
143060826|NCT00545688|515761904|FG002|Adjuvant Treatment Period|Adverse Event|2|||
143245937|NCT01485172|516451835|FG004|Overall Study|Lost to Follow-up|0|||
143060827|NCT00545688|515761905|FG003|Adjuvant Treatment Period|Adverse Event|2|||
143060828|NCT00545688|515761902|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
143060829|NCT00545688|515761903|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
143245938|NCT01485172|516451836|FG005|Overall Study|Lost to Follow-up|1|||
143060830|NCT00545688|515761904|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
143060831|NCT00545688|515761905|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
143060832|NCT00545688|515761902|FG000|Follow-Up Period|Death|4|||
143060833|NCT00545688|515761903|FG001|Follow-Up Period|Death|2|||
143060834|NCT00545688|515761904|FG002|Follow-Up Period|Death|2|||
143060835|NCT00545688|515761905|FG003|Follow-Up Period|Death|6|||
143060836|NCT00545688|515761902|FG000|Follow-Up Period|Disease Progression|6|||
143501769|NCT00896532|517376285|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
143501770|NCT00896532|517376286|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
143501771|NCT00896532|517376287|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
143501772|NCT00896532|517376288|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
143501773|NCT00896532|517376289|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
143501774|NCT00896532|517376290|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
143501775|NCT00896532|517376291|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
143501776|NCT00896532|517376292|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
143501777|NCT00896532|517376293|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
143501778|NCT00896532|517376294|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
143501779|NCT00896532|517376295|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
143501780|NCT00896532|517376296|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
143501781|NCT00896532|517376274|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
143501782|NCT00896532|517376275|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
143501783|NCT00896532|517376276|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
143501784|NCT00896532|517376277|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
143501785|NCT00896532|517376278|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
143501786|NCT00896532|517376279|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
143501787|NCT00896532|517376280|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
143501788|NCT00896532|517376281|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
143501789|NCT00896532|517376282|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
143501790|NCT00896532|517376283|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
143060837|NCT00545688|515761903|FG001|Follow-Up Period|Disease Progression|5|||
143060838|NCT00545688|515761904|FG002|Follow-Up Period|Disease Progression|9|||
143501791|NCT00896532|517376284|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
143501792|NCT00896532|517376285|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
143501793|NCT00896532|517376286|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
143501794|NCT00896532|517376287|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
143501795|NCT00896532|517376288|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
143501796|NCT00896532|517376289|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
143501797|NCT00896532|517376290|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
143501798|NCT00896532|517376291|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
143501799|NCT00896532|517376292|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
143501800|NCT00896532|517376293|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
143060839|NCT00545688|515761905|FG003|Follow-Up Period|Disease Progression|9|||
143060840|NCT00545688|515761902|FG000|Follow-Up Period|Refused Treatment|6|||
143060841|NCT00545688|515761903|FG001|Follow-Up Period|Refused Treatment|2|||
143060842|NCT00545688|515761904|FG002|Follow-Up Period|Refused Treatment|0|||
143060843|NCT00545688|515761905|FG003|Follow-Up Period|Refused Treatment|2|||
143060844|NCT00545688|515761902|FG000|Follow-Up Period|Lost to Follow-up|3|||
143060845|NCT00545688|515761903|FG001|Follow-Up Period|Lost to Follow-up|3|||
143060846|NCT00545688|515761904|FG002|Follow-Up Period|Lost to Follow-up|3|||
143060847|NCT00545688|515761905|FG003|Follow-Up Period|Lost to Follow-up|1|||
143060848|NCT00545688|515761902|FG000|Follow-Up Period|Unspecified Reason|2|||
143060849|NCT00545688|515761903|FG001|Follow-Up Period|Unspecified Reason|5|||
143060850|NCT00545688|515761904|FG002|Follow-Up Period|Unspecified Reason|6|||
143060851|NCT00545688|515761905|FG003|Follow-Up Period|Unspecified Reason|8|||
143060852|NCT00545688|515761902|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
143060853|NCT00545688|515761903|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
143060854|NCT00545688|515761904|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
143060855|NCT00545688|515761905|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
143060856|NCT01467479|515763223|FG000|Overall Study|No Study Medication|1|||
143060857|NCT01467479|515763224|FG001|Overall Study|No Study Medication|0|||
143060858|NCT01467479|515763225|FG002|Overall Study|No Study Medication|2|||
143060859|NCT01467479|515763223|FG000|Overall Study|Adverse Event|1|||
143060860|NCT01467479|515763224|FG001|Overall Study|Adverse Event|2|||
143060861|NCT01467479|515763225|FG002|Overall Study|Adverse Event|0|||
143060862|NCT01467479|515763223|FG000|Overall Study|Death|0|||
143060863|NCT01467479|515763224|FG001|Overall Study|Death|0|||
143060864|NCT01467479|515763225|FG002|Overall Study|Death|1|||
143060865|NCT01467479|515763223|FG000|Overall Study|Lost to Follow-up|2|||
143060866|NCT01467479|515763224|FG001|Overall Study|Lost to Follow-up|5|||
143060867|NCT01467479|515763225|FG002|Overall Study|Lost to Follow-up|3|||
143060868|NCT01467479|515763223|FG000|Overall Study|Withdrawal of Consent|3|||
143060869|NCT01467479|515763224|FG001|Overall Study|Withdrawal of Consent|7|||
143060870|NCT01467479|515763225|FG002|Overall Study|Withdrawal of Consent|7|||
143501801|NCT00896532|517376294|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
143501802|NCT00896532|517376295|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
143501803|NCT00896532|517376296|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
143501804|NCT00896532|517376274|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
143501805|NCT00896532|517376275|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
143501806|NCT00896532|517376276|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
143501807|NCT00896532|517376277|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
143501808|NCT00896532|517376278|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
143501809|NCT00896532|517376279|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
143501810|NCT00896532|517376280|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
143501811|NCT00896532|517376281|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
143501812|NCT00896532|517376282|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
143060871|NCT01467479|515763223|FG000|Overall Study|Study Terminated by Sponsor|1|||
143060872|NCT01467479|515763224|FG001|Overall Study|Study Terminated by Sponsor|3|||
143060873|NCT01467479|515763225|FG002|Overall Study|Study Terminated by Sponsor|3|||
143060874|NCT01467479|515763223|FG000|Overall Study|Other|1|||
143060875|NCT01467479|515763224|FG001|Overall Study|Other|0|||
143060876|NCT01467479|515763225|FG002|Overall Study|Other|0|||
143060877|NCT01684215|515763238|FG000|Phase 1, Part 1|Adverse Event|1|||
143060878|NCT01684215|515763239|FG001|Phase 1, Part 1|Adverse Event|0|||
143060879|NCT01684215|515763240|FG002|Phase 1, Part 1|Adverse Event|0|||
143060880|NCT01684215|515763241|FG003|Phase 1, Part 1|Adverse Event|0|||
143060881|NCT01684215|515763238|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
143060882|NCT01684215|515763239|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
143060883|NCT01684215|515763240|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
143060884|NCT01684215|515763241|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
143060885|NCT01684215|515763238|FG000|Phase 1, Part 2|Adverse Event|0|||
143060886|NCT01684215|515763239|FG001|Phase 1, Part 2|Adverse Event|0|||
143060887|NCT01684215|515763240|FG002|Phase 1, Part 2|Adverse Event|1|||
143060888|NCT01684215|515763241|FG003|Phase 1, Part 2|Adverse Event|0|||
143060889|NCT01684215|515763238|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
143060890|NCT01684215|515763239|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
143060891|NCT01684215|515763240|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
143060892|NCT01684215|515763241|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
143060893|NCT01684215|515763238|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
143060894|NCT01684215|515763239|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
143060895|NCT01684215|515763240|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
143060896|NCT01684215|515763241|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
143060897|NCT01684215|515763238|FG000|Phase 2|Death|0|||
143060898|NCT01684215|515763239|FG001|Phase 2|Death|0|||
143060899|NCT01684215|515763240|FG002|Phase 2|Death|0|||
143060900|NCT01684215|515763241|FG003|Phase 2|Death|8|||
143060901|NCT01684215|515763238|FG000|Phase 2|Study terminated by sponsor|0|||
143060902|NCT01684215|515763239|FG001|Phase 2|Study terminated by sponsor|0|||
143060903|NCT01684215|515763240|FG002|Phase 2|Study terminated by sponsor|0|||
143060904|NCT01684215|515763241|FG003|Phase 2|Study terminated by sponsor|30|||
143060905|NCT01684215|515763238|FG000|Phase 2|Enrolled but not treated|0|||
143060906|NCT01684215|515763239|FG001|Phase 2|Enrolled but not treated|0|||
143060907|NCT01684215|515763240|FG002|Phase 2|Enrolled but not treated|0|||
143060908|NCT01684215|515763241|FG003|Phase 2|Enrolled but not treated|1|||
143060909|NCT01684215|515763238|FG000|Phase 2|Lost to Follow-up|0|||
143501813|NCT00896532|517376283|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
143501814|NCT00896532|517376284|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
143501815|NCT00896532|517376285|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
143501816|NCT00896532|517376286|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
143501817|NCT00896532|517376287|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
143060910|NCT01684215|515763239|FG001|Phase 2|Lost to Follow-up|0|||
143060911|NCT01684215|515763240|FG002|Phase 2|Lost to Follow-up|0|||
143060912|NCT01684215|515763241|FG003|Phase 2|Lost to Follow-up|4|||
143060913|NCT01301482|515763242|FG000|Overall Study|Withdrawal by Subject|1|||
143060914|NCT00614926|515763248|FG000|Overall Study|Burden of travel|1|||
143060915|NCT00614926|515763249|FG001|Overall Study|Burden of travel|0|||
143060916|NCT00614926|515763248|FG000|Overall Study|Adverse Event|3|||
143060917|NCT00614926|515763249|FG001|Overall Study|Adverse Event|0|||
143060918|NCT04039919|515763252|FG000|Treatment Period 1|Withdrawal by Subject|1|||
143060919|NCT04039919|515763253|FG001|Treatment Period 1|Withdrawal by Subject|0|||
143060920|NCT04039919|515763254|FG002|Treatment Period 1|Withdrawal by Subject|0|||
143060921|NCT04039919|515763255|FG003|Treatment Period 1|Withdrawal by Subject|0|||
143060922|NCT04039919|515763256|FG004|Treatment Period 1|Withdrawal by Subject|0|||
143060923|NCT04039919|515763252|FG000|Treatment Period 1|Sponsor's decision|0|||
143060924|NCT04039919|515763253|FG001|Treatment Period 1|Sponsor's decision|0|||
143060925|NCT04039919|515763254|FG002|Treatment Period 1|Sponsor's decision|0|||
143060926|NCT04039919|515763255|FG003|Treatment Period 1|Sponsor's decision|0|||
143060927|NCT04039919|515763256|FG004|Treatment Period 1|Sponsor's decision|16|||
143060928|NCT04039919|515763252|FG000|Treatment Period 5|Withdrawal by Subject|1|||
143501818|NCT00896532|517376288|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
143060929|NCT04039919|515763253|FG001|Treatment Period 5|Withdrawal by Subject|0|||
143060930|NCT04039919|515763254|FG002|Treatment Period 5|Withdrawal by Subject|0|||
143060931|NCT04039919|515763255|FG003|Treatment Period 5|Withdrawal by Subject|0|||
143060932|NCT04039919|515763256|FG004|Treatment Period 5|Withdrawal by Subject|0|||
143060933|NCT01197417|515763257|FG000|Overall Study|Physician Decision|3|||
143060934|NCT01197417|515763258|FG001|Overall Study|Physician Decision|2|||
143060935|NCT01197417|515763257|FG000|Overall Study|Withdrawal by Subject|2|||
143060936|NCT01197417|515763258|FG001|Overall Study|Withdrawal by Subject|4|||
143060937|NCT01197417|515763257|FG000|Overall Study|Site miscommunication|0|||
143060938|NCT01197417|515763258|FG001|Overall Study|Site miscommunication|1|||
143060939|NCT01197417|515763257|FG000|Overall Study|Subject transferred to intensive care|0|||
143060940|NCT01197417|515763258|FG001|Overall Study|Subject transferred to intensive care|1|||
143170074|NCT03396445|516171846|FG018|Treatment Period|Withdrawal by Subject|0|||
143501819|NCT00896532|517376289|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
143501820|NCT00896532|517376290|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
143501821|NCT00896532|517376291|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
143501822|NCT00896532|517376292|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
143501823|NCT00896532|517376293|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
143501824|NCT00896532|517376294|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
143501825|NCT00896532|517376295|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
143501826|NCT00896532|517376296|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
143501827|NCT00896532|517376274|FG000|Months 48-72: Follow-on Phase|Death|0|||
143501828|NCT00896532|517376275|FG001|Months 48-72: Follow-on Phase|Death|0|||
143501829|NCT00896532|517376276|FG002|Months 48-72: Follow-on Phase|Death|0|||
143501830|NCT00896532|517376277|FG003|Months 48-72: Follow-on Phase|Death|0|||
143501831|NCT00896532|517376278|FG004|Months 48-72: Follow-on Phase|Death|0|||
143501832|NCT00896532|517376279|FG005|Months 48-72: Follow-on Phase|Death|0|||
143501833|NCT00896532|517376280|FG006|Months 48-72: Follow-on Phase|Death|0|||
143501834|NCT00896532|517376281|FG007|Months 48-72: Follow-on Phase|Death|0|||
143501835|NCT00896532|517376282|FG008|Months 48-72: Follow-on Phase|Death|0|||
143501836|NCT00896532|517376283|FG009|Months 48-72: Follow-on Phase|Death|0|||
143501837|NCT00896532|517376284|FG010|Months 48-72: Follow-on Phase|Death|0|||
143501838|NCT00896532|517376285|FG011|Months 48-72: Follow-on Phase|Death|0|||
143501839|NCT00896532|517376286|FG012|Months 48-72: Follow-on Phase|Death|0|||
143501840|NCT00896532|517376287|FG013|Months 48-72: Follow-on Phase|Death|0|||
143501841|NCT00896532|517376288|FG014|Months 48-72: Follow-on Phase|Death|0|||
143501842|NCT00896532|517376289|FG015|Months 48-72: Follow-on Phase|Death|0|||
143501843|NCT00896532|517376290|FG016|Months 48-72: Follow-on Phase|Death|0|||
143501844|NCT00896532|517376291|FG017|Months 48-72: Follow-on Phase|Death|0|||
143501845|NCT00896532|517376292|FG018|Months 48-72: Follow-on Phase|Death|1|||
143501846|NCT00896532|517376293|FG019|Months 48-72: Follow-on Phase|Death|0|||
143501847|NCT00896532|517376294|FG020|Months 48-72: Follow-on Phase|Death|0|||
143501848|NCT00896532|517376295|FG021|Months 48-72: Follow-on Phase|Death|0|||
143501849|NCT00896532|517376296|FG022|Months 48-72: Follow-on Phase|Death|0|||
143501850|NCT00896532|517376274|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
143501851|NCT00896532|517376275|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
143501852|NCT00896532|517376276|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
143501853|NCT00896532|517376277|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
143501854|NCT00896532|517376278|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
143170075|NCT03396445|516171847|FG019|Treatment Period|Withdrawal by Subject|0|||
143170076|NCT03396445|516171848|FG020|Treatment Period|Withdrawal by Subject|0|||
143170077|NCT03396445|516171849|FG021|Treatment Period|Withdrawal by Subject|0|||
143170078|NCT03396445|516171850|FG022|Treatment Period|Withdrawal by Subject|0|||
143170079|NCT03396445|516171851|FG023|Treatment Period|Withdrawal by Subject|0|||
143170080|NCT03396445|516171852|FG024|Treatment Period|Withdrawal by Subject|0|||
143170081|NCT03396445|516171853|FG025|Treatment Period|Withdrawal by Subject|0|||
143170082|NCT03396445|516171828|FG000|Switch-over Period|Death|0|||
143170083|NCT03396445|516171829|FG001|Switch-over Period|Death|0|||
143501855|NCT00896532|517376279|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
143060941|NCT01197417|515763257|FG000|Overall Study|Not consented in time to receive drug|0|||
143060942|NCT01197417|515763258|FG001|Overall Study|Not consented in time to receive drug|1|||
143060943|NCT01197417|515763257|FG000|Overall Study|Hypotension|1|||
143170084|NCT03396445|516171830|FG002|Switch-over Period|Death|0|||
143170085|NCT03396445|516171831|FG003|Switch-over Period|Death|0|||
143060944|NCT01197417|515763258|FG001|Overall Study|Hypotension|2|||
143060945|NCT01197417|515763257|FG000|Overall Study|Found to be ineligible|2|||
143060946|NCT01197417|515763258|FG001|Overall Study|Found to be ineligible|5|||
143060947|NCT01197417|515763257|FG000|Overall Study|No 25-hour magnesium level|0|||
143060948|NCT01197417|515763258|FG001|Overall Study|No 25-hour magnesium level|2|||
143060949|NCT03250299|515763259|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
143060950|NCT03250299|515763260|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
143060951|NCT03250299|515763261|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
143060952|NCT03250299|515763262|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
143060953|NCT03250299|515763263|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
143060954|NCT03250299|515763259|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
143060955|NCT03250299|515763260|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
143060956|NCT03250299|515763261|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
143060957|NCT03250299|515763262|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
143060958|NCT03250299|515763263|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
143060959|NCT03250299|515763259|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
143060960|NCT03250299|515763260|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
143060961|NCT03250299|515763261|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
143060962|NCT03250299|515763262|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
143060963|NCT03250299|515763263|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
143060964|NCT03250299|515763259|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
143060965|NCT03250299|515763260|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
143060966|NCT03250299|515763261|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
143060967|NCT03250299|515763262|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
143060968|NCT03250299|515763263|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
143060969|NCT01042535|515763268|FG000|Overall Study|disease progression prior to treatment|3|||
143060970|NCT01042535|515763268|FG000|Overall Study|disease progression during treatment|3|||
143060971|NCT01042535|515763268|FG000|Overall Study|complications from other disease|2|||
143060972|NCT01546142|515763271|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
143060973|NCT01546142|515763272|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
143501856|NCT00896532|517376280|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
143501857|NCT00896532|517376281|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
143501858|NCT00896532|517376282|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
143501859|NCT00896532|517376283|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
143501860|NCT00896532|517376284|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
143501861|NCT00896532|517376285|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
143501862|NCT00896532|517376286|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
143501863|NCT00896532|517376287|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
143501864|NCT00896532|517376288|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
143501865|NCT00896532|517376289|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
143501866|NCT00896532|517376290|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
143501867|NCT00896532|517376291|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
143501868|NCT00896532|517376292|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
143501869|NCT00896532|517376293|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
143501870|NCT00896532|517376294|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
143501871|NCT00896532|517376295|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
143501872|NCT00896532|517376296|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
143501873|NCT00896532|517376274|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
143501874|NCT00896532|517376275|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
143501875|NCT00896532|517376276|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
143501876|NCT00896532|517376277|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
143501877|NCT00896532|517376278|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
143060974|NCT01546142|515763271|FG000|Overall Study|Subject Noncompliance|1|||
143060975|NCT01546142|515763272|FG001|Overall Study|Subject Noncompliance|1|||
143060976|NCT01546142|515763271|FG000|Overall Study|Adverse Event|6|||
143060977|NCT01546142|515763272|FG001|Overall Study|Adverse Event|3|||
143060978|NCT01546142|515763271|FG000|Overall Study|Lost to Follow-up|20|||
143060979|NCT01546142|515763272|FG001|Overall Study|Lost to Follow-up|15|||
143060980|NCT01546142|515763271|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
143060981|NCT01546142|515763272|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
143060982|NCT01546142|515763271|FG000|Overall Study|Subject Randomized but Not Treated|1|||
143501878|NCT00896532|517376279|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
143501879|NCT00896532|517376280|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
143060983|NCT01546142|515763272|FG001|Overall Study|Subject Randomized but Not Treated|0|||
143060984|NCT01213836|515763279|FG000|Period 1, First Intervention|Adverse Event|2|||
143170086|NCT03396445|516171832|FG004|Switch-over Period|Death|0|||
143170087|NCT03396445|516171833|FG005|Switch-over Period|Death|0|||
143060985|NCT01213836|515763280|FG001|Period 1, First Intervention|Adverse Event|1|||
143060986|NCT01213836|515763279|FG000|Period 1, First Intervention|Protocol Violation|0|||
143060987|NCT01213836|515763280|FG001|Period 1, First Intervention|Protocol Violation|1|||
143170088|NCT03396445|516171834|FG006|Switch-over Period|Death|0|||
143060988|NCT01213836|515763279|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
143060989|NCT01213836|515763280|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
143060990|NCT00255151|515763282|FG000|Overall Study|Adverse Event|10|||
143060991|NCT00255151|515763283|FG001|Overall Study|Adverse Event|6|||
143060992|NCT00255151|515763284|FG002|Overall Study|Adverse Event|9|||
143060993|NCT00255151|515763282|FG000|Overall Study|Lost to Follow-up|4|||
143060994|NCT00255151|515763283|FG001|Overall Study|Lost to Follow-up|3|||
143060995|NCT00255151|515763284|FG002|Overall Study|Lost to Follow-up|4|||
143060996|NCT00255151|515763282|FG000|Overall Study|Withdrawal by Subject|18|||
143060997|NCT00255151|515763283|FG001|Overall Study|Withdrawal by Subject|17|||
143060998|NCT00255151|515763284|FG002|Overall Study|Withdrawal by Subject|8|||
143060999|NCT00255151|515763282|FG000|Overall Study|Noncompliance|0|||
143061000|NCT00255151|515763283|FG001|Overall Study|Noncompliance|1|||
143061001|NCT00255151|515763284|FG002|Overall Study|Noncompliance|2|||
143061002|NCT00255151|515763282|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
143061003|NCT00255151|515763283|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
143061004|NCT00255151|515763284|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
143061005|NCT00255151|515763282|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
143061006|NCT00255151|515763283|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
143061007|NCT00255151|515763284|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
143061008|NCT00255151|515763282|FG000|Overall Study|Possible Barrett's Esophagus|1|||
143061009|NCT00255151|515763283|FG001|Overall Study|Possible Barrett's Esophagus|3|||
143061010|NCT00255151|515763284|FG002|Overall Study|Possible Barrett's Esophagus|8|||
143061011|NCT00255151|515763282|FG000|Overall Study|Esophageal Stricture|0|||
143061012|NCT00255151|515763283|FG001|Overall Study|Esophageal Stricture|0|||
143061013|NCT00255151|515763284|FG002|Overall Study|Esophageal Stricture|1|||
143061014|NCT00255151|515763282|FG000|Overall Study|Therapeutic Failure|11|||
143061015|NCT00255151|515763283|FG001|Overall Study|Therapeutic Failure|2|||
143061016|NCT00255151|515763284|FG002|Overall Study|Therapeutic Failure|3|||
143061017|NCT00706095|515763290|FG000|Overall Study|Progressive Disease|4|||
143061018|NCT00706095|515763291|FG001|Overall Study|Progressive Disease|5|||
143061019|NCT00706095|515763292|FG002|Overall Study|Progressive Disease|3|||
143061020|NCT00706095|515763290|FG000|Overall Study|Clinical Progression|1|||
143061021|NCT00706095|515763291|FG001|Overall Study|Clinical Progression|2|||
143061022|NCT00706095|515763292|FG002|Overall Study|Clinical Progression|2|||
143061023|NCT00706095|515763290|FG000|Overall Study|Withdrawal by Subject|1|||
143061024|NCT00706095|515763291|FG001|Overall Study|Withdrawal by Subject|0|||
143061025|NCT00706095|515763292|FG002|Overall Study|Withdrawal by Subject|0|||
143061026|NCT01685073|515763293|FG000|Overall Study|Lost to Follow-up|6|||
143061027|NCT01685073|515763294|FG001|Overall Study|Lost to Follow-up|8|||
143061028|NCT01685073|515763293|FG000|Overall Study|Withdrawal by Subject|24|||
143061029|NCT01685073|515763294|FG001|Overall Study|Withdrawal by Subject|24|||
143061030|NCT01221090|515763298|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
143061031|NCT01221090|515763299|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
143061032|NCT01221090|515763300|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
143061033|NCT01221090|515763301|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
143061034|NCT01221090|515763298|FG000|Overall Study|Withdrawal by Subject|0|||
143061035|NCT01221090|515763299|FG001|Overall Study|Withdrawal by Subject|22|||
143061036|NCT01221090|515763300|FG002|Overall Study|Withdrawal by Subject|27|||
143061037|NCT01221090|515763301|FG003|Overall Study|Withdrawal by Subject|2|||
143061038|NCT03438539|515763302|FG000|Overall Study|Lost to Follow-up|8|||
143061039|NCT03438539|515763303|FG001|Overall Study|Lost to Follow-up|4|||
143061040|NCT03438539|515763304|FG002|Overall Study|Lost to Follow-up|10|||
143061041|NCT03438539|515763305|FG003|Overall Study|Lost to Follow-up|9|||
143061042|NCT03438539|515763306|FG004|Overall Study|Lost to Follow-up|3|||
143061043|NCT03438539|515763307|FG005|Overall Study|Lost to Follow-up|8|||
143061044|NCT02459665|515763315|FG000|Overall Study|Withdrawal by Subject|0|||
143061045|NCT02459665|515763316|FG001|Overall Study|Withdrawal by Subject|1|||
143061046|NCT02459665|515763317|FG002|Overall Study|Withdrawal by Subject|1|||
143061047|NCT02459665|515763318|FG003|Overall Study|Withdrawal by Subject|2|||
143061048|NCT01360866|515763319|FG000|Overall Study|Lost to Follow-up|11|||
143061049|NCT01360866|515763320|FG001|Overall Study|Lost to Follow-up|28|||
143061050|NCT01360866|515763321|FG002|Overall Study|Lost to Follow-up|41|||
143061051|NCT01360866|515763322|FG003|Overall Study|Lost to Follow-up|0|||
143061052|NCT01360866|515763319|FG000|Overall Study|Adverse Event|56|||
143061053|NCT01360866|515763320|FG001|Overall Study|Adverse Event|61|||
143061054|NCT01360866|515763321|FG002|Overall Study|Adverse Event|134|||
143061055|NCT01360866|515763322|FG003|Overall Study|Adverse Event|6|||
143061056|NCT01360866|515763319|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
143061057|NCT01360866|515763320|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
143061058|NCT01360866|515763321|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
143061059|NCT01360866|515763322|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
143061060|NCT01360866|515763319|FG000|Overall Study|Withdrawn by Investigator|9|||
143061061|NCT01360866|515763320|FG001|Overall Study|Withdrawn by Investigator|8|||
143365106|NCT05550337|516878792|FG000|Overall Study|Protocol Violation|1|||
143061062|NCT01360866|515763321|FG002|Overall Study|Withdrawn by Investigator|31|||
143061063|NCT01360866|515763322|FG003|Overall Study|Withdrawn by Investigator|2|||
143061064|NCT01360866|515763319|FG000|Overall Study|Withdrawal by participant|79|||
143061065|NCT01360866|515763320|FG001|Overall Study|Withdrawal by participant|89|||
143061066|NCT01360866|515763321|FG002|Overall Study|Withdrawal by participant|168|||
143061067|NCT01360866|515763322|FG003|Overall Study|Withdrawal by participant|8|||
143061068|NCT01360866|515763319|FG000|Overall Study|Protocol Deviation|25|||
143061069|NCT01360866|515763320|FG001|Overall Study|Protocol Deviation|33|||
143061070|NCT01360866|515763321|FG002|Overall Study|Protocol Deviation|61|||
143061071|NCT01360866|515763322|FG003|Overall Study|Protocol Deviation|2|||
143061072|NCT01360866|515763319|FG000|Overall Study|Lack of Efficacy|30|||
143061073|NCT01360866|515763320|FG001|Overall Study|Lack of Efficacy|40|||
143061074|NCT01360866|515763321|FG002|Overall Study|Lack of Efficacy|30|||
143061075|NCT01360866|515763322|FG003|Overall Study|Lack of Efficacy|4|||
143061076|NCT00493454|515763328|FG000|Overall Study|Withdrawal by Subject|1|||
143501880|NCT00896532|517376281|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
143501881|NCT00896532|517376282|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
143501882|NCT00896532|517376283|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
143501883|NCT00896532|517376284|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
143501884|NCT00896532|517376285|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
143501885|NCT00896532|517376286|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
143501886|NCT00896532|517376287|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
143501887|NCT00896532|517376288|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
143501888|NCT00896532|517376289|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
143501889|NCT00896532|517376290|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
143501890|NCT00896532|517376291|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
143501891|NCT00896532|517376292|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
143501892|NCT00896532|517376293|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
143501893|NCT00896532|517376294|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
143501894|NCT00896532|517376295|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
143501895|NCT00896532|517376296|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
143501896|NCT01176916|517376297|FG000|Overall Study|Adverse Event|61|||
143501897|NCT01176916|517376297|FG000|Overall Study|Death|1|||
143501898|NCT01176916|517376297|FG000|Overall Study|Lost to Follow-up|15|||
143501899|NCT01176916|517376297|FG000|Overall Study|Objective progression or relapse|17|||
143501900|NCT01176916|517376297|FG000|Overall Study|Protocol Violation|24|||
143501901|NCT01176916|517376297|FG000|Overall Study|Withdrawal by Subject|37|||
143501902|NCT01176916|517376297|FG000|Overall Study|Other|6|||
143501903|NCT01176916|517376297|FG000|Overall Study|Withdrawal prior to Treatment|6|||
143061077|NCT00103038|515763329|FG000|Overall Study|Withdrawal by Subject|8|||
143061078|NCT00103038|515763329|FG000|Overall Study|Screen failure|3|||
143061079|NCT00103038|515763329|FG000|Overall Study|Death|1|||
143061080|NCT00103038|515763329|FG000|Overall Study|Physician Decision|1|||
143061081|NCT02310763|515763334|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
143061082|NCT02310763|515763335|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
143061083|NCT02310763|515763336|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
143061084|NCT02310763|515763334|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
143061085|NCT02310763|515763335|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
143061086|NCT02310763|515763336|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
143061087|NCT02310763|515763334|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
143061088|NCT02310763|515763335|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
143061089|NCT02310763|515763336|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
143061090|NCT02310763|515763334|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
143061091|NCT02310763|515763335|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
143061092|NCT02310763|515763336|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
143061093|NCT02310763|515763334|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
143061094|NCT02310763|515763335|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
143061095|NCT02310763|515763336|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
143061096|NCT00941720|515763343|FG000|Overall Study|Withdrawal by Subject|1|||
143061097|NCT00941720|515763343|FG000|Overall Study|Insurance denied participation|11|||
143061098|NCT00941720|515763343|FG000|Overall Study|ineligible|2|||
143061099|NCT00171340|515763344|FG000|Overall Study|Adverse Event|46|||
143061100|NCT00171340|515763345|FG001|Overall Study|Adverse Event|42|||
143061101|NCT00171340|515763344|FG000|Overall Study|Lack of Efficacy|29|||
143061102|NCT00171340|515763345|FG001|Overall Study|Lack of Efficacy|41|||
143061103|NCT00171340|515763344|FG000|Overall Study|Protocol Violation|7|||
143061104|NCT00171340|515763345|FG001|Overall Study|Protocol Violation|8|||
143061105|NCT00171340|515763344|FG000|Overall Study|Withdrawal by Subject|22|||
143061106|NCT00171340|515763345|FG001|Overall Study|Withdrawal by Subject|19|||
143501904|NCT00675597|517376298|FG000|Overall Study|Withdrawal by Subject|3|||
143501905|NCT03094195|517376303|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
143501906|NCT03094195|517376304|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
143061107|NCT00171340|515763344|FG000|Overall Study|Lost to Follow-up|0|||
143061108|NCT00171340|515763345|FG001|Overall Study|Lost to Follow-up|5|||
143061109|NCT00171340|515763344|FG000|Overall Study|Abnormal Laboratory Results|2|||
143061110|NCT00171340|515763345|FG001|Overall Study|Abnormal Laboratory Results|0|||
143245939|NCT01485172|516451831|FG000|Overall Study|Physician Decision|0|||
143245940|NCT01485172|516451832|FG001|Overall Study|Physician Decision|0|||
143245941|NCT01485172|516451833|FG002|Overall Study|Physician Decision|0|||
143245942|NCT01485172|516451834|FG003|Overall Study|Physician Decision|0|||
143501907|NCT03094195|517376305|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
143501908|NCT03094195|517376306|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
143501909|NCT03094195|517376307|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
143501910|NCT03094195|517376308|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
143501911|NCT03094195|517376309|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
143501912|NCT03094195|517376310|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
143501913|NCT03094195|517376303|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
143501914|NCT03094195|517376304|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
143501915|NCT03094195|517376305|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
143501916|NCT03094195|517376306|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
143501917|NCT03094195|517376307|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
143501918|NCT03094195|517376308|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
143501919|NCT03094195|517376309|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
143501920|NCT03094195|517376310|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
143501921|NCT03094195|517376303|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
143501922|NCT03094195|517376304|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
143501923|NCT03094195|517376305|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
143501924|NCT03094195|517376306|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
143501925|NCT03094195|517376307|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
143501926|NCT03094195|517376308|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
143501927|NCT03094195|517376309|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
143501928|NCT03094195|517376310|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
143501929|NCT03094195|517376303|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
143501930|NCT03094195|517376304|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
143501931|NCT03094195|517376305|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
143501932|NCT03094195|517376306|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
143061111|NCT00171340|515763344|FG000|Overall Study|Abnormal Test Procedure Results|6|||
143061112|NCT00171340|515763345|FG001|Overall Study|Abnormal Test Procedure Results|11|||
143245943|NCT01485172|516451835|FG004|Overall Study|Physician Decision|1|||
143245944|NCT01485172|516451836|FG005|Overall Study|Physician Decision|0|||
143245945|NCT01485172|516451831|FG000|Overall Study|Withdrawal by Subject|2|||
143245946|NCT01485172|516451832|FG001|Overall Study|Withdrawal by Subject|0|||
143245947|NCT01485172|516451833|FG002|Overall Study|Withdrawal by Subject|0|||
143245948|NCT01485172|516451834|FG003|Overall Study|Withdrawal by Subject|1|||
143245949|NCT01485172|516451835|FG004|Overall Study|Withdrawal by Subject|1|||
143245950|NCT01485172|516451836|FG005|Overall Study|Withdrawal by Subject|1|||
143245951|NCT01077076|516451840|FG000|First Intervention|Withdrawal by Subject|1|||
143245952|NCT01077076|516451841|FG001|First Intervention|Withdrawal by Subject|0|||
143245953|NCT01077076|516451842|FG002|First Intervention|Withdrawal by Subject|0|||
143245954|NCT01077076|516451843|FG003|First Intervention|Withdrawal by Subject|0|||
143245955|NCT01077076|516451844|FG004|First Intervention|Withdrawal by Subject|0|||
143245956|NCT01077076|516451845|FG005|First Intervention|Withdrawal by Subject|0|||
143245957|NCT01077076|516451840|FG000|Third Intervention|Death in the participant's family|0|||
143245958|NCT01077076|516451841|FG001|Third Intervention|Death in the participant's family|0|||
143245959|NCT01077076|516451842|FG002|Third Intervention|Death in the participant's family|0|||
143245960|NCT01077076|516451843|FG003|Third Intervention|Death in the participant's family|0|||
143061113|NCT00171340|515763344|FG000|Overall Study|No Longer Required Study Drug|1|||
143061114|NCT00171340|515763345|FG001|Overall Study|No Longer Required Study Drug|1|||
143061115|NCT00171340|515763344|FG000|Overall Study|Administrative Problems|5|||
143245961|NCT01077076|516451844|FG004|Third Intervention|Death in the participant's family|0|||
143245962|NCT01077076|516451845|FG005|Third Intervention|Death in the participant's family|1|||
143245963|NCT01301027|516451846|FG000|Overall Study|Physician Decision|2|||
143245964|NCT01301027|516451847|FG001|Overall Study|Physician Decision|0|||
143245965|NCT01301027|516451846|FG000|Overall Study|Withdrawal by Subject|2|||
143245966|NCT01301027|516451847|FG001|Overall Study|Withdrawal by Subject|3|||
143245967|NCT01301027|516451846|FG000|Overall Study|Adverse Event|0|||
143245968|NCT01301027|516451847|FG001|Overall Study|Adverse Event|2|||
143245969|NCT01301027|516451846|FG000|Overall Study|Fracture|1|||
143501933|NCT03094195|517376307|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
143501934|NCT03094195|517376308|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
143501935|NCT03094195|517376309|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
143501936|NCT03094195|517376310|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
143501937|NCT01988090|517376311|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
143061116|NCT00171340|515763345|FG001|Overall Study|Administrative Problems|2|||
143061117|NCT00171340|515763344|FG000|Overall Study|Death|6|||
143061118|NCT00171340|515763345|FG001|Overall Study|Death|6|||
143061119|NCT01682148|515763346|FG000|Overall Study|Withdrawal by Subject|2|||
143061120|NCT01682148|515763347|FG001|Overall Study|Withdrawal by Subject|0|||
143061121|NCT01682148|515763346|FG000|Overall Study|Lost to Follow-up|1|||
143501938|NCT01988090|517376312|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
143501939|NCT01988090|517376311|FG000|Start Treament After Randomization|Protocol Violation|0|||
143061122|NCT01682148|515763347|FG001|Overall Study|Lost to Follow-up|2|||
143061123|NCT01682148|515763346|FG000|Overall Study|Protocol Violation|1|||
143061124|NCT01682148|515763347|FG001|Overall Study|Protocol Violation|1|||
143061125|NCT04099641|515763349|FG000|Overall Study|Death|46|||
143061126|NCT04099641|515763350|FG001|Overall Study|Death|12|||
143061127|NCT04099641|515763349|FG000|Overall Study|Lost to Follow-up|1|||
143061128|NCT04099641|515763350|FG001|Overall Study|Lost to Follow-up|0|||
143061129|NCT04099641|515763349|FG000|Overall Study|Withdrawal by Subject|2|||
143061130|NCT04099641|515763350|FG001|Overall Study|Withdrawal by Subject|0|||
143061131|NCT00895037|515763351|FG000|Overall Study|Death|0|||
143061132|NCT00895037|515763352|FG001|Overall Study|Death|2|||
143061133|NCT00895037|515763353|FG002|Overall Study|Death|1|||
143061134|NCT00536484|515763362|FG000|Overall Study|Adverse Event|21|||
143061135|NCT00536484|515763363|FG001|Overall Study|Adverse Event|34|||
143061136|NCT00536484|515763362|FG000|Overall Study|Withdrawal by Subject|11|||
143365107|NCT05550337|516878793|FG001|Overall Study|Protocol Violation|3|||
143365108|NCT05550337|516878794|FG002|Overall Study|Protocol Violation|4|||
143365109|NCT05550337|516878792|FG000|Overall Study|Physician Decision|2|||
143365110|NCT05550337|516878793|FG001|Overall Study|Physician Decision|1|||
143365111|NCT05550337|516878794|FG002|Overall Study|Physician Decision|1|||
143365112|NCT05550337|516878792|FG000|Overall Study|Lost to Follow-up|16|||
143365113|NCT05550337|516878793|FG001|Overall Study|Lost to Follow-up|11|||
143365114|NCT05550337|516878794|FG002|Overall Study|Lost to Follow-up|11|||
143365115|NCT03115346|516878795|FG000|Overall Study|Did not have AAA surgery|28|||
143365116|NCT03115346|516878796|FG001|Overall Study|Did not have AAA surgery|15|||
143365117|NCT03115346|516878795|FG000|Overall Study|Death|3|||
143365118|NCT03115346|516878796|FG001|Overall Study|Death|1|||
143365119|NCT03115346|516878795|FG000|Overall Study|Withdrawal by Subject|0|||
143365120|NCT03115346|516878796|FG001|Overall Study|Withdrawal by Subject|3|||
143365121|NCT03115346|516878795|FG000|Overall Study|Lost to Follow-up|0|||
143365122|NCT03115346|516878796|FG001|Overall Study|Lost to Follow-up|3|||
143365123|NCT01737268|516878798|FG000|Overall Study|Adverse Event|6|||
143365124|NCT01737268|516878798|FG000|Overall Study|Worsening of Target Disease|2|||
143365125|NCT01737268|516878798|FG000|Overall Study|In consideration of the patient's safety|1|||
143365126|NCT01190176|516878799|FG000|Overall Study|Withdrawal by Subject|1|||
143501940|NCT01988090|517376312|FG001|Start Treament After Randomization|Protocol Violation|1|||
143501941|NCT01988090|517376311|FG000|Complete Study After Start|Withdrawal by Subject|2|||
143501942|NCT01988090|517376312|FG001|Complete Study After Start|Withdrawal by Subject|0|||
143501943|NCT01988090|517376311|FG000|Complete Study After Start|Protocol Violation|1|||
143061137|NCT00536484|515763363|FG001|Overall Study|Withdrawal by Subject|11|||
143061138|NCT00536484|515763362|FG000|Overall Study|Lost to Follow-up|8|||
143061139|NCT00536484|515763363|FG001|Overall Study|Lost to Follow-up|6|||
143061140|NCT00536484|515763362|FG000|Overall Study|Lack of Efficacy|16|||
143061141|NCT00536484|515763363|FG001|Overall Study|Lack of Efficacy|5|||
143061142|NCT00536484|515763362|FG000|Overall Study|Other|4|||
143061143|NCT00536484|515763363|FG001|Overall Study|Other|0|||
143061144|NCT02244424|515763364|FG000|Overall Study|Lost to Follow-up|20|||
143061145|NCT02244424|515763365|FG001|Overall Study|Lost to Follow-up|10|||
143061146|NCT01937351|515764870|FG000|Overall Study|Withdrawal by Subject|4|||
143061147|NCT01937351|515764871|FG001|Overall Study|Withdrawal by Subject|2|||
143061148|NCT01937351|515764870|FG000|Overall Study|Death|1|||
143061149|NCT01937351|515764871|FG001|Overall Study|Death|0|||
143061150|NCT01937351|515764870|FG000|Overall Study|Not treated w device, per protocol fail|4|||
143501944|NCT01988090|517376312|FG001|Complete Study After Start|Protocol Violation|1|||
143501945|NCT03887130|517376317|FG000|Overall Study|Progressive disease|23|||
143061151|NCT01937351|515764871|FG001|Overall Study|Not treated w device, per protocol fail|0|||
143061152|NCT01961687|515764872|FG000|Overall Study|Lost to Follow-up|19|||
143061153|NCT01961687|515764872|FG000|Overall Study|Re-operation|17|||
143245970|NCT01301027|516451847|FG001|Overall Study|Fracture|3|||
143061154|NCT01961687|515764872|FG000|Overall Study|Death|7|||
143061155|NCT01961687|515764872|FG000|Overall Study|Withdrawal by Subject|6|||
143061156|NCT01961687|515764872|FG000|Overall Study|Adverse Event|6|||
143061157|NCT01961687|515764872|FG000|Overall Study|Moved to area without study site|2|||
143061158|NCT01961687|515764872|FG000|Overall Study|Sponsor decision|2|||
143245971|NCT01301027|516451846|FG000|Overall Study|Transplant|0|||
143365127|NCT01190176|516878799|FG000|Overall Study|Lost to Follow-up|1|||
143365128|NCT02189863|516878800|FG000|First 2 Weeks|Motion Sickness|4|||
143365129|NCT02189863|516878801|FG001|First 2 Weeks|Motion Sickness|2|||
143365130|NCT03697460|516878802|FG000|Overall Study|Withdrawal by Subject|3|||
143365131|NCT03369951|516878803|FG000|Overall Study|Withdrawal by Subject|3|||
143501946|NCT03887130|517376318|FG001|Overall Study|Progressive disease|14|||
143061159|NCT01961687|515764872|FG000|Overall Study|Physician Decision|1|||
143061160|NCT01961687|515764872|FG000|Overall Study|Unable to meet follow-up requirements|1|||
143061161|NCT01730040|515764873|FG000|Overall Study|Randomized but not treated|0|||
143061162|NCT01730040|515764874|FG001|Overall Study|Randomized but not treated|0|||
143061163|NCT01730040|515764875|FG002|Overall Study|Randomized but not treated|0|||
143061164|NCT01730040|515764876|FG003|Overall Study|Randomized but not treated|0|||
143061165|NCT01730040|515764877|FG004|Overall Study|Randomized but not treated|0|||
143061166|NCT01730040|515764878|FG005|Overall Study|Randomized but not treated|1|||
143061167|NCT01730040|515764879|FG006|Overall Study|Randomized but not treated|0|||
143061168|NCT01730040|515764873|FG000|Overall Study|Subject moved|0|||
143061169|NCT01730040|515764874|FG001|Overall Study|Subject moved|0|||
143061170|NCT01730040|515764875|FG002|Overall Study|Subject moved|1|||
143061171|NCT01730040|515764876|FG003|Overall Study|Subject moved|0|||
143061172|NCT01730040|515764877|FG004|Overall Study|Subject moved|0|||
143061173|NCT01730040|515764878|FG005|Overall Study|Subject moved|0|||
143061174|NCT01730040|515764879|FG006|Overall Study|Subject moved|1|||
143061175|NCT01730040|515764873|FG000|Overall Study|Physician Decision|0|||
143061176|NCT01730040|515764874|FG001|Overall Study|Physician Decision|0|||
143061177|NCT01730040|515764875|FG002|Overall Study|Physician Decision|0|||
143061178|NCT01730040|515764876|FG003|Overall Study|Physician Decision|0|||
143061179|NCT01730040|515764877|FG004|Overall Study|Physician Decision|0|||
143061180|NCT01730040|515764878|FG005|Overall Study|Physician Decision|1|||
143061181|NCT01730040|515764879|FG006|Overall Study|Physician Decision|1|||
143061182|NCT01730040|515764873|FG000|Overall Study|Other than specified|7|||
143061183|NCT01730040|515764874|FG001|Overall Study|Other than specified|8|||
143061184|NCT01730040|515764875|FG002|Overall Study|Other than specified|5|||
143061185|NCT01730040|515764876|FG003|Overall Study|Other than specified|5|||
143061186|NCT01730040|515764877|FG004|Overall Study|Other than specified|5|||
143061187|NCT01730040|515764878|FG005|Overall Study|Other than specified|4|||
143061188|NCT01730040|515764879|FG006|Overall Study|Other than specified|4|||
143061189|NCT01730040|515764873|FG000|Overall Study|Adverse Event|4|||
143061190|NCT01730040|515764874|FG001|Overall Study|Adverse Event|3|||
143061191|NCT01730040|515764875|FG002|Overall Study|Adverse Event|5|||
143061192|NCT01730040|515764876|FG003|Overall Study|Adverse Event|3|||
143061193|NCT01730040|515764877|FG004|Overall Study|Adverse Event|1|||
143061194|NCT01730040|515764878|FG005|Overall Study|Adverse Event|1|||
143061195|NCT01730040|515764879|FG006|Overall Study|Adverse Event|2|||
143061196|NCT01730040|515764873|FG000|Overall Study|Poor compliance to protocol|2|||
143061197|NCT01730040|515764874|FG001|Overall Study|Poor compliance to protocol|4|||
143061198|NCT01730040|515764875|FG002|Overall Study|Poor compliance to protocol|0|||
143061199|NCT01730040|515764876|FG003|Overall Study|Poor compliance to protocol|0|||
143061200|NCT01730040|515764877|FG004|Overall Study|Poor compliance to protocol|0|||
143061201|NCT01730040|515764878|FG005|Overall Study|Poor compliance to protocol|0|||
143061202|NCT01730040|515764879|FG006|Overall Study|Poor compliance to protocol|1|||
143061203|NCT00544817|515764880|FG000|Combined Modality|Lack of Efficacy|2|||
143061204|NCT00544817|515764880|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
143061205|NCT00544817|515764880|FG000|Combined Modality|Adverse Event|2|||
143061206|NCT00544817|515764880|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
143061207|NCT00544817|515764880|FG000|No Treatment Interval|Lack of Efficacy|8|||
143061208|NCT00544817|515764880|FG000|No Treatment Interval|Physician Decision|3|||
143061209|NCT00544817|515764880|FG000|No Treatment Interval|Adverse Event|1|||
143061210|NCT00544817|515764880|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
143061211|NCT00544817|515764880|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
143061212|NCT00544817|515764880|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
143061213|NCT01552369|515764881|FG000|Overall Study|Did not consent to extended follow up|8|||
143061214|NCT01552369|515764882|FG001|Overall Study|Did not consent to extended follow up|9|||
143061215|NCT02813421|515764883|FG000|Overall Study|Withdrawal by Subject|1|||
143061216|NCT02813421|515764884|FG001|Overall Study|Withdrawal by Subject|2|||
143061217|NCT02813421|515764883|FG000|Overall Study|Lost to Follow-up|1|||
143061218|NCT02813421|515764884|FG001|Overall Study|Lost to Follow-up|1|||
143061219|NCT04776746|515764885|FG000|Overall Study|Study terminated by sponsor|61|||
143061220|NCT04776746|515764885|FG000|Overall Study|Adverse Event|5|||
143501947|NCT03887130|517376319|FG002|Overall Study|Progressive disease|7|||
143501948|NCT03887130|517376317|FG000|Overall Study|Protocol Violation|3|||
143501949|NCT03887130|517376318|FG001|Overall Study|Protocol Violation|1|||
143501950|NCT03887130|517376319|FG002|Overall Study|Protocol Violation|2|||
143501951|NCT03887130|517376317|FG000|Overall Study|Drug related toxicity|7|||
143501952|NCT03887130|517376318|FG001|Overall Study|Drug related toxicity|7|||
143501953|NCT03887130|517376319|FG002|Overall Study|Drug related toxicity|13|||
143061221|NCT04776746|515764885|FG000|Overall Study|Death|4|||
143061222|NCT04776746|515764885|FG000|Overall Study|Lack of Efficacy|3|||
143245972|NCT01301027|516451847|FG001|Overall Study|Transplant|2|||
143245973|NCT01301027|516451846|FG000|Overall Study|Volume Overload|3|||
143501954|NCT03887130|517376317|FG000|Overall Study|Non drug related toxicity|3|||
143061223|NCT04776746|515764885|FG000|Overall Study|Noncompliance with study drug|2|||
143061224|NCT04776746|515764885|FG000|Overall Study|Not related to COVID-19|2|||
143245974|NCT01301027|516451847|FG001|Overall Study|Volume Overload|0|||
143501955|NCT03887130|517376318|FG001|Overall Study|Non drug related toxicity|0|||
143501956|NCT03887130|517376319|FG002|Overall Study|Non drug related toxicity|0|||
143501957|NCT03887130|517376317|FG000|Overall Study|Death|2|||
143501958|NCT03887130|517376318|FG001|Overall Study|Death|2|||
143501959|NCT03887130|517376319|FG002|Overall Study|Death|1|||
143501960|NCT03887130|517376317|FG000|Overall Study|Withdrawal by Subject|7|||
143501961|NCT03887130|517376318|FG001|Overall Study|Withdrawal by Subject|6|||
143501962|NCT03887130|517376319|FG002|Overall Study|Withdrawal by Subject|11|||
143501963|NCT03887130|517376317|FG000|Overall Study|other reason|6|||
143501964|NCT03887130|517376318|FG001|Overall Study|other reason|20|||
143501965|NCT03887130|517376319|FG002|Overall Study|other reason|17|||
143501966|NCT02899156|517376320|FG000|Overall Study|Death|1|||
143501967|NCT02899156|517376321|FG001|Overall Study|Death|0|||
143501968|NCT02899156|517376320|FG000|Overall Study|Physician Decision|0|||
143501969|NCT02899156|517376321|FG001|Overall Study|Physician Decision|1|||
143501970|NCT02116621|517376325|FG000|Baseline|Withdrawal by Subject|0|||
143501971|NCT02116621|517376326|FG001|Baseline|Withdrawal by Subject|4|||
143501972|NCT02116621|517376325|FG000|Three Month Follow-up|Death|1|||
143501973|NCT02116621|517376326|FG001|Three Month Follow-up|Death|1|||
143501974|NCT02116621|517376325|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
143501975|NCT02116621|517376326|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
143501976|NCT02116621|517376325|FG000|Three Month Follow-up|Lost to Follow-up|0|||
143501977|NCT02116621|517376326|FG001|Three Month Follow-up|Lost to Follow-up|1|||
143501978|NCT02116621|517376325|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
143501979|NCT02116621|517376326|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
143501980|NCT02116621|517376325|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
143501981|NCT02116621|517376326|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
143501982|NCT02116621|517376325|FG000|Six Month Follow-up|Lost to Follow-up|2|||
143501983|NCT02116621|517376326|FG001|Six Month Follow-up|Lost to Follow-up|1|||
143501984|NCT02116621|517376325|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
143501985|NCT02116621|517376326|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
143501986|NCT02116621|517376325|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
143501987|NCT02116621|517376326|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
143501988|NCT02116621|517376325|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
143501989|NCT02116621|517376326|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
143061225|NCT00440466|515764886|FG000|Overall Study|Death|3|||
143061226|NCT00440466|515764887|FG001|Overall Study|Death|2|||
143061227|NCT00440466|515764888|FG002|Overall Study|Death|9|||
143061228|NCT00440466|515764886|FG000|Overall Study|Adverse Event|3|||
143061229|NCT00440466|515764887|FG001|Overall Study|Adverse Event|4|||
143061230|NCT00440466|515764888|FG002|Overall Study|Adverse Event|11|||
143061231|NCT00440466|515764886|FG000|Overall Study|Lost to Follow-up|1|||
143061232|NCT00440466|515764887|FG001|Overall Study|Lost to Follow-up|0|||
143061233|NCT00440466|515764888|FG002|Overall Study|Lost to Follow-up|2|||
143061234|NCT00440466|515764886|FG000|Overall Study|Physician Decision|2|||
143061235|NCT00440466|515764887|FG001|Overall Study|Physician Decision|0|||
143061236|NCT00440466|515764888|FG002|Overall Study|Physician Decision|1|||
143061237|NCT00440466|515764886|FG000|Overall Study|Protocol Violation|2|||
143061238|NCT00440466|515764887|FG001|Overall Study|Protocol Violation|0|||
143061239|NCT00440466|515764888|FG002|Overall Study|Protocol Violation|4|||
143061240|NCT00440466|515764886|FG000|Overall Study|Withdrawal by Subject|2|||
143061241|NCT00440466|515764887|FG001|Overall Study|Withdrawal by Subject|5|||
143061242|NCT00440466|515764888|FG002|Overall Study|Withdrawal by Subject|9|||
143061243|NCT00440466|515764886|FG000|Overall Study|Began Dialysis|0|||
143061244|NCT00440466|515764887|FG001|Overall Study|Began Dialysis|0|||
143061245|NCT00440466|515764888|FG002|Overall Study|Began Dialysis|1|||
143061246|NCT00440466|515764886|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
143061247|NCT00440466|515764887|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
143061248|NCT00440466|515764888|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
143061249|NCT00892281|515764893|FG000|Overall Study|Adverse Event|65|||
143061250|NCT00892281|515764894|FG001|Overall Study|Adverse Event|8|||
143501990|NCT02116621|517376325|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
143061251|NCT00892281|515764893|FG000|Overall Study|Lost to Follow-up|81|||
143061252|NCT00892281|515764894|FG001|Overall Study|Lost to Follow-up|8|||
143061253|NCT00892281|515764893|FG000|Overall Study|Pregnancy|1|||
143245975|NCT03566485|516451857|FG000|Overall Study|Disease progression|5|||
143245976|NCT03566485|516451858|FG001|Overall Study|Disease progression|4|||
143245977|NCT03566485|516451857|FG000|Overall Study|Clinical progression|0|||
143245978|NCT03566485|516451858|FG001|Overall Study|Clinical progression|1|||
143061254|NCT00892281|515764894|FG001|Overall Study|Pregnancy|0|||
143061255|NCT00892281|515764893|FG000|Overall Study|Protocol Violation|7|||
143501991|NCT02116621|517376326|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
143501992|NCT02116621|517376325|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
143501993|NCT02116621|517376326|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
143061256|NCT00892281|515764894|FG001|Overall Study|Protocol Violation|2|||
143061257|NCT00892281|515764893|FG000|Overall Study|Withdrawal by Subject|86|||
143061258|NCT00892281|515764894|FG001|Overall Study|Withdrawal by Subject|14|||
143061259|NCT00892281|515764893|FG000|Overall Study|Subject failed to return for final visit|2|||
143061260|NCT00892281|515764894|FG001|Overall Study|Subject failed to return for final visit|0|||
143061261|NCT00892281|515764893|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
143061262|NCT00892281|515764894|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
143061263|NCT00892281|515764893|FG000|Overall Study|Final visit completed 4 weeks late|0|||
143061264|NCT00892281|515764894|FG001|Overall Study|Final visit completed 4 weeks late|1|||
143061265|NCT00892281|515764893|FG000|Overall Study|Subject completed day after study closed|1|||
143061266|NCT00892281|515764894|FG001|Overall Study|Subject completed day after study closed|0|||
143061267|NCT00892281|515764893|FG000|Overall Study|Family emergency|1|||
143061268|NCT00892281|515764894|FG001|Overall Study|Family emergency|0|||
143061269|NCT00892281|515764893|FG000|Overall Study|Last visit not done - death in family|1|||
143061270|NCT00892281|515764894|FG001|Overall Study|Last visit not done - death in family|0|||
143061271|NCT00892281|515764893|FG000|Overall Study|Did not meet incl/excl criteria|1|||
143061272|NCT00892281|515764894|FG001|Overall Study|Did not meet incl/excl criteria|0|||
143061273|NCT00892281|515764893|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
143061274|NCT00892281|515764894|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
143061275|NCT00892281|515764893|FG000|Overall Study|Unable to redeem the drug voucher|1|||
143061276|NCT00892281|515764894|FG001|Overall Study|Unable to redeem the drug voucher|0|||
143061277|NCT00892281|515764893|FG000|Overall Study|Subject not good candidate for study|1|||
143061278|NCT00892281|515764894|FG001|Overall Study|Subject not good candidate for study|0|||
143061279|NCT00892281|515764893|FG000|Overall Study|Subject did not return for any visits|1|||
143061280|NCT00892281|515764894|FG001|Overall Study|Subject did not return for any visits|0|||
143061281|NCT00892281|515764893|FG000|Overall Study|Subject missed several visits/lost meds|1|||
143061282|NCT00892281|515764894|FG001|Overall Study|Subject missed several visits/lost meds|0|||
143061283|NCT00892281|515764893|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
143061284|NCT00892281|515764894|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
143061285|NCT00892281|515764893|FG000|Overall Study|Scheduled for knee replacement|0|||
143061286|NCT00892281|515764894|FG001|Overall Study|Scheduled for knee replacement|1|||
143061287|NCT00892281|515764893|FG000|Overall Study|PI complained of inadequate compensation|3|||
143061288|NCT00892281|515764894|FG001|Overall Study|PI complained of inadequate compensation|0|||
143061289|NCT00892281|515764893|FG000|Overall Study|Subject lost interest in program|0|||
143061290|NCT00892281|515764894|FG001|Overall Study|Subject lost interest in program|1|||
143061291|NCT00892281|515764893|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
143061292|NCT00892281|515764894|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
143061293|NCT00892281|515764893|FG000|Overall Study|Death in family|1|||
143061294|NCT00892281|515764894|FG001|Overall Study|Death in family|0|||
143061295|NCT00892281|515764893|FG000|Overall Study|Lack of efficacy of study product|2|||
143061296|NCT00892281|515764894|FG001|Overall Study|Lack of efficacy of study product|0|||
143061297|NCT00892281|515764893|FG000|Overall Study|Subject not seen by PI at final visit|1|||
143061298|NCT00892281|515764894|FG001|Overall Study|Subject not seen by PI at final visit|0|||
143061299|NCT00892281|515764893|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
143061300|NCT00892281|515764894|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
143061301|NCT00892281|515764893|FG000|Overall Study|Missed multiple visits|1|||
143061302|NCT00892281|515764894|FG001|Overall Study|Missed multiple visits|0|||
143061303|NCT00892281|515764893|FG000|Overall Study|Missed visits rescheduled out of window|1|||
143061304|NCT00892281|515764894|FG001|Overall Study|Missed visits rescheduled out of window|0|||
143061305|NCT00892281|515764893|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
143061306|NCT00892281|515764894|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
143061307|NCT00892281|515764893|FG000|Overall Study|Subject had history of drug abuse|1|||
143061308|NCT00892281|515764894|FG001|Overall Study|Subject had history of drug abuse|0|||
143061309|NCT00892281|515764893|FG000|Overall Study|Rash on hand|1|||
143170089|NCT03396445|516171835|FG007|Switch-over Period|Death|0|||
143170090|NCT03396445|516171836|FG008|Switch-over Period|Death|0|||
143170091|NCT03396445|516171837|FG009|Switch-over Period|Death|0|||
143170092|NCT03396445|516171838|FG010|Switch-over Period|Death|0|||
143170093|NCT03396445|516171839|FG011|Switch-over Period|Death|0|||
143170094|NCT03396445|516171840|FG012|Switch-over Period|Death|0|||
143170095|NCT03396445|516171841|FG013|Switch-over Period|Death|0|||
143170096|NCT03396445|516171842|FG014|Switch-over Period|Death|0|||
143170097|NCT03396445|516171843|FG015|Switch-over Period|Death|0|||
143170098|NCT03396445|516171844|FG016|Switch-over Period|Death|0|||
143170099|NCT03396445|516171845|FG017|Switch-over Period|Death|0|||
143170100|NCT03396445|516171846|FG018|Switch-over Period|Death|1|||
143170101|NCT03396445|516171847|FG019|Switch-over Period|Death|2|||
143170102|NCT03396445|516171848|FG020|Switch-over Period|Death|2|||
143061310|NCT00892281|515764894|FG001|Overall Study|Rash on hand|0|||
143061311|NCT00892281|515764893|FG000|Overall Study|Visit 4 date out of window|1|||
143170103|NCT03396445|516171849|FG021|Switch-over Period|Death|1|||
143170104|NCT03396445|516171850|FG022|Switch-over Period|Death|2|||
143170105|NCT03396445|516171851|FG023|Switch-over Period|Death|0|||
143170106|NCT03396445|516171852|FG024|Switch-over Period|Death|1|||
143170107|NCT03396445|516171853|FG025|Switch-over Period|Death|6|||
143170108|NCT03396445|516171828|FG000|Switch-over Period|Lost to Follow-up|0|||
143061312|NCT00892281|515764894|FG001|Overall Study|Visit 4 date out of window|0|||
143061313|NCT01223235|515764895|FG000|Overall Study|Withdrawal by Subject|1|||
143061314|NCT03702049|515764896|FG000|Overall Study|Lost to Follow-up|4|||
143061315|NCT03702049|515764896|FG000|Overall Study|Physician Decision|1|||
143061316|NCT01117337|515764899|FG000|Overall Study|Lost to Follow-up|4|||
143061317|NCT01117337|515764900|FG001|Overall Study|Lost to Follow-up|0|||
143061318|NCT02791893|515764905|FG000|Blinded Phase|Lost to Follow-up|2|||
143061319|NCT02791893|515764906|FG001|Blinded Phase|Lost to Follow-up|2|||
143061320|NCT02791893|515764905|FG000|Blinded Phase|Withdrawal by Subject|1|||
143061321|NCT02791893|515764906|FG001|Blinded Phase|Withdrawal by Subject|2|||
143061322|NCT02791893|515764905|FG000|Open Label Phase|Lost to Follow-up|3|||
143061323|NCT02791893|515764906|FG001|Open Label Phase|Lost to Follow-up|0|||
143061324|NCT02791893|515764905|FG000|Open Label Phase|Withdrawal by Subject|0|||
143061325|NCT02791893|515764906|FG001|Open Label Phase|Withdrawal by Subject|2|||
143061326|NCT00685802|515764909|FG000|Washout Period of 7 Days|Protocol Violation|2|||
143061327|NCT00685802|515764910|FG001|Washout Period of 7 Days|Protocol Violation|0|||
143061328|NCT00685802|515764909|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
143061329|NCT00685802|515764910|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
143061330|NCT01048502|515764911|FG000|Overall Study|Lost to Follow-up|2|||
143245979|NCT03566485|516451857|FG000|Overall Study|Toxicity|0|||
143245980|NCT03566485|516451858|FG001|Overall Study|Toxicity|2|||
143245981|NCT02116205|516451859|FG000|Overall Study|Withdrawal by Subject|2|||
143245982|NCT02116205|516451860|FG001|Overall Study|Withdrawal by Subject|4|||
143245983|NCT02116205|516451861|FG002|Overall Study|Withdrawal by Subject|1|||
143245984|NCT02116205|516451862|FG003|Overall Study|Withdrawal by Subject|3|||
143245985|NCT02116205|516451859|FG000|Overall Study|Lost to Follow-up|0|||
143245986|NCT02116205|516451860|FG001|Overall Study|Lost to Follow-up|2|||
143245987|NCT02116205|516451861|FG002|Overall Study|Lost to Follow-up|1|||
143245988|NCT02116205|516451862|FG003|Overall Study|Lost to Follow-up|2|||
143245989|NCT02116205|516451859|FG000|Overall Study|Physician Decision|0|||
143245990|NCT02116205|516451860|FG001|Overall Study|Physician Decision|1|||
143245991|NCT02116205|516451861|FG002|Overall Study|Physician Decision|1|||
143245992|NCT02116205|516451862|FG003|Overall Study|Physician Decision|1|||
143245993|NCT02116205|516451859|FG000|Overall Study|Exclusion criteria|0|||
143245994|NCT02116205|516451860|FG001|Overall Study|Exclusion criteria|0|||
143245995|NCT02116205|516451861|FG002|Overall Study|Exclusion criteria|1|||
143245996|NCT02116205|516451862|FG003|Overall Study|Exclusion criteria|0|||
143245997|NCT02752165|516451869|FG000|Overall Study|Withdrawal by Subject|6|||
143245998|NCT02752165|516451870|FG001|Overall Study|Withdrawal by Subject|6|||
143245999|NCT02752165|516451869|FG000|Overall Study|Protocol Violation|6|||
143246000|NCT02752165|516451870|FG001|Overall Study|Protocol Violation|5|||
143246001|NCT02752165|516451869|FG000|Overall Study|Lost to Follow-up|33|||
143246002|NCT02752165|516451870|FG001|Overall Study|Lost to Follow-up|38|||
143246003|NCT02840461|516451872|FG000|Overall Study|Adverse Event|1|||
143246004|NCT02840461|516451873|FG001|Overall Study|Adverse Event|5|||
143246005|NCT02840461|516451874|FG002|Overall Study|Adverse Event|3|||
143246006|NCT02840461|516451872|FG000|Overall Study|Lost to Follow-up|10|||
143246007|NCT02840461|516451873|FG001|Overall Study|Lost to Follow-up|7|||
143246008|NCT02840461|516451874|FG002|Overall Study|Lost to Follow-up|6|||
143246009|NCT02840461|516451872|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
143246010|NCT02840461|516451873|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
143246011|NCT02840461|516451874|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
143246012|NCT02840461|516451872|FG000|Overall Study|Protocol Violation|2|||
143246013|NCT02840461|516451873|FG001|Overall Study|Protocol Violation|3|||
143246014|NCT02840461|516451874|FG002|Overall Study|Protocol Violation|1|||
143246015|NCT02840461|516451872|FG000|Overall Study|Withdrawal by Subject|10|||
143246016|NCT02840461|516451873|FG001|Overall Study|Withdrawal by Subject|6|||
143246017|NCT02840461|516451874|FG002|Overall Study|Withdrawal by Subject|2|||
143246018|NCT02840461|516451872|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
143246019|NCT02840461|516451873|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
143501994|NCT00484315|517376327|FG000|12-Month Clinical Follow-up|Death|6|||
143246020|NCT02840461|516451874|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
143501995|NCT00484315|517376328|FG001|12-Month Clinical Follow-up|Death|2|||
143246021|NCT00912197|516451875|FG000|Overall Study|Withdrawal by Subject|3|||
143246022|NCT00912197|516451876|FG001|Overall Study|Withdrawal by Subject|3|||
143246023|NCT01287741|516451882|FG000|Overall Study|Withdrawal by Subject|35|||
143246024|NCT01287741|516451883|FG001|Overall Study|Withdrawal by Subject|38|||
143246025|NCT01287741|516451882|FG000|Overall Study|Protocol Violation|2|||
143246026|NCT01287741|516451883|FG001|Overall Study|Protocol Violation|0|||
143246027|NCT01287741|516451882|FG000|Overall Study|Physician Decision|15|||
143365132|NCT03369951|516878803|FG000|Overall Study|Death|1|||
143365133|NCT03369951|516878803|FG000|Overall Study|Lost to Follow-up|1|||
143501996|NCT00484315|517376327|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
143061331|NCT01048502|515764912|FG001|Overall Study|Lost to Follow-up|0|||
143061332|NCT01048502|515764913|FG002|Overall Study|Lost to Follow-up|0|||
143061333|NCT01048502|515764914|FG003|Overall Study|Lost to Follow-up|0|||
143061334|NCT01048502|515764911|FG000|Overall Study|Adverse Event|1|||
143246028|NCT01287741|516451883|FG001|Overall Study|Physician Decision|23|||
143061335|NCT01048502|515764912|FG001|Overall Study|Adverse Event|0|||
143061336|NCT01048502|515764913|FG002|Overall Study|Adverse Event|0|||
143061337|NCT01048502|515764914|FG003|Overall Study|Adverse Event|0|||
143061338|NCT01048502|515764911|FG000|Overall Study|Withdrawal by Subject|1|||
143061339|NCT01048502|515764912|FG001|Overall Study|Withdrawal by Subject|4|||
143061340|NCT01048502|515764913|FG002|Overall Study|Withdrawal by Subject|5|||
143061341|NCT01048502|515764914|FG003|Overall Study|Withdrawal by Subject|3|||
143061342|NCT01048502|515764911|FG000|Overall Study|Physician Decision|0|||
143061343|NCT01048502|515764912|FG001|Overall Study|Physician Decision|3|||
143061344|NCT01048502|515764913|FG002|Overall Study|Physician Decision|0|||
143061345|NCT01048502|515764914|FG003|Overall Study|Physician Decision|1|||
143061346|NCT01333072|515764915|FG000|Overall Study|Lost to Follow-up|3|||
143061347|NCT01333072|515764916|FG001|Overall Study|Lost to Follow-up|0|||
143501997|NCT00484315|517376328|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
143501998|NCT00484315|517376327|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
143501999|NCT00484315|517376328|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
143502000|NCT00484315|517376327|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
143061348|NCT01333072|515764915|FG000|Overall Study|Adverse Event|2|||
143061349|NCT01333072|515764916|FG001|Overall Study|Adverse Event|4|||
143061350|NCT01333072|515764915|FG000|Overall Study|Physician Decision|1|||
143061351|NCT01333072|515764916|FG001|Overall Study|Physician Decision|0|||
143061352|NCT00619359|515764919|FG000|Overall Study|Adverse Event|32|||
143061353|NCT00619359|515764920|FG001|Overall Study|Adverse Event|36|||
143061354|NCT00619359|515764919|FG000|Overall Study|Lost to Follow-up|12|||
143061355|NCT00619359|515764920|FG001|Overall Study|Lost to Follow-up|16|||
143061356|NCT00619359|515764919|FG000|Overall Study|Physician Decision|0|||
143061357|NCT00619359|515764920|FG001|Overall Study|Physician Decision|7|||
143502001|NCT00484315|517376328|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
143502002|NCT00484315|517376327|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
143502003|NCT00484315|517376328|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
143502004|NCT00484315|517376327|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
143502005|NCT00484315|517376328|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
143502006|NCT00484315|517376327|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
143061358|NCT00619359|515764919|FG000|Overall Study|Protocol Violation|1|||
143061359|NCT00619359|515764920|FG001|Overall Study|Protocol Violation|1|||
143502007|NCT00484315|517376328|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
143502008|NCT00943683|517376329|FG000|Overall Study|Adverse Event|3|||
143502009|NCT00943683|517376330|FG001|Overall Study|Adverse Event|3|||
143502010|NCT00943683|517376329|FG000|Overall Study|Lost to Follow-up|1|||
143502011|NCT00943683|517376330|FG001|Overall Study|Lost to Follow-up|1|||
143502012|NCT00943683|517376329|FG000|Overall Study|Protocol Violation|1|||
143502013|NCT00943683|517376330|FG001|Overall Study|Protocol Violation|2|||
143502014|NCT00943683|517376329|FG000|Overall Study|Withdrawal by Subject|1|||
143502015|NCT00943683|517376330|FG001|Overall Study|Withdrawal by Subject|0|||
143502016|NCT00943683|517376329|FG000|Overall Study|Patient Moved|1|||
143502017|NCT00943683|517376330|FG001|Overall Study|Patient Moved|0|||
143502018|NCT00630331|517376331|FG000|Overall Study|Death|2|||
143502019|NCT00630331|517376332|FG001|Overall Study|Death|1|||
143502020|NCT00630331|517376333|FG002|Overall Study|Death|1|||
143502021|NCT00630331|517376331|FG000|Overall Study|Adverse Event|1|||
143502022|NCT00630331|517376332|FG001|Overall Study|Adverse Event|0|||
143502023|NCT00630331|517376333|FG002|Overall Study|Adverse Event|0|||
143502024|NCT00630331|517376331|FG000|Overall Study|Withdrawal by Subject|12|||
143502025|NCT00630331|517376332|FG001|Overall Study|Withdrawal by Subject|7|||
143502026|NCT00630331|517376333|FG002|Overall Study|Withdrawal by Subject|5|||
143502027|NCT00630331|517376331|FG000|Overall Study|Lost to Follow-up|175|||
143502028|NCT00630331|517376332|FG001|Overall Study|Lost to Follow-up|143|||
143061360|NCT00619359|515764919|FG000|Overall Study|Withdrawal by Subject|19|||
143061361|NCT00619359|515764920|FG001|Overall Study|Withdrawal by Subject|20|||
143502029|NCT00630331|517376333|FG002|Overall Study|Lost to Follow-up|170|||
143061362|NCT00619359|515764919|FG000|Overall Study|Progressive Disease|3|||
143061363|NCT00619359|515764920|FG001|Overall Study|Progressive Disease|1|||
143246029|NCT01287741|516451882|FG000|Overall Study|Non-compliance|8|||
143502030|NCT00630331|517376331|FG000|Overall Study|Inappropriate enrollment|3|||
143502031|NCT00630331|517376332|FG001|Overall Study|Inappropriate enrollment|6|||
143502032|NCT00630331|517376333|FG002|Overall Study|Inappropriate enrollment|3|||
143502033|NCT00630331|517376331|FG000|Overall Study|Unable to classify|9|||
143061364|NCT03095118|515764928|FG000|Overall Study|Adverse Event|1|||
143061365|NCT03095118|515764928|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
143061366|NCT04668274|515764929|FG000|Part 1 Study Period 1|Adverse Event|3|||
143061367|NCT04668274|515764930|FG001|Part 1 Study Period 1|Adverse Event|0|||
143061368|NCT04668274|515764931|FG002|Part 1 Study Period 1|Adverse Event|0|||
143061369|NCT04668274|515764932|FG003|Part 1 Study Period 1|Adverse Event|0|||
143061370|NCT04668274|515764929|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
143061371|NCT04668274|515764930|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
143061372|NCT04668274|515764931|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
143061373|NCT04668274|515764932|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
143061374|NCT04668274|515764929|FG000|Part 1 Study Period 2|Other|0|||
143061375|NCT04668274|515764930|FG001|Part 1 Study Period 2|Other|1|||
143061376|NCT04668274|515764931|FG002|Part 1 Study Period 2|Other|0|||
143061377|NCT04668274|515764932|FG003|Part 1 Study Period 2|Other|0|||
143061378|NCT04668274|515764929|FG000|Part 1 Study Period 3|Adverse Event|0|||
143061379|NCT04668274|515764930|FG001|Part 1 Study Period 3|Adverse Event|0|||
143061380|NCT04668274|515764931|FG002|Part 1 Study Period 3|Adverse Event|1|||
143061381|NCT04668274|515764932|FG003|Part 1 Study Period 3|Adverse Event|0|||
143061382|NCT04668274|515764929|FG000|Part 1 Study Period 3|Other|0|||
143061383|NCT04668274|515764930|FG001|Part 1 Study Period 3|Other|0|||
143061384|NCT04668274|515764931|FG002|Part 1 Study Period 3|Other|2|||
143061385|NCT04668274|515764932|FG003|Part 1 Study Period 3|Other|0|||
143061386|NCT04668274|515764929|FG000|Part 2 Study Period 4|Other|0|||
143061387|NCT04668274|515764930|FG001|Part 2 Study Period 4|Other|0|||
143061388|NCT04668274|515764931|FG002|Part 2 Study Period 4|Other|0|||
143061389|NCT04668274|515764932|FG003|Part 2 Study Period 4|Other|1|||
143061390|NCT02363439|515764935|FG000|Overall Study|Lack of Efficacy|4|||
143061391|NCT01056640|515764937|FG000|Overall Study|Withdrawal by Subject|11|||
143061392|NCT01056640|515764938|FG001|Overall Study|Withdrawal by Subject|8|||
143061393|NCT01056640|515764937|FG000|Overall Study|Death|15|||
143061394|NCT01056640|515764938|FG001|Overall Study|Death|4|||
143061395|NCT01202877|515764941|FG000|Overall Study|Disease Progression|0|||
143061396|NCT01202877|515764942|FG001|Overall Study|Disease Progression|1|||
143061397|NCT01202877|515764943|FG002|Overall Study|Disease Progression|2|||
143061398|NCT01202877|515764941|FG000|Overall Study|Adverse Event|0|||
143061399|NCT01202877|515764942|FG001|Overall Study|Adverse Event|0|||
143061400|NCT01202877|515764943|FG002|Overall Study|Adverse Event|2|||
143061401|NCT01202877|515764941|FG000|Overall Study|Withdrawal by Subject|0|||
143061402|NCT01202877|515764942|FG001|Overall Study|Withdrawal by Subject|0|||
143061403|NCT01202877|515764943|FG002|Overall Study|Withdrawal by Subject|1|||
143061404|NCT01202877|515764941|FG000|Overall Study|Death|0|||
143061405|NCT01202877|515764942|FG001|Overall Study|Death|0|||
143061406|NCT01202877|515764943|FG002|Overall Study|Death|1|||
143061407|NCT00396331|515764944|FG000|Overall Study|Failed to mobilize - no transplant|8|||
143061408|NCT00396331|515764944|FG000|Overall Study|Did not go on to transplant|5|||
143061409|NCT00396331|515764944|FG000|Overall Study|Lost to Follow-up|3|||
143061410|NCT00396331|515764944|FG000|Overall Study|Death|16|||
143061411|NCT00680186|515764945|FG000|Overall Study|Adverse Event|47|||
143061412|NCT00680186|515764946|FG001|Overall Study|Adverse Event|44|||
143061413|NCT00680186|515764945|FG000|Overall Study|Protocol Violation|31|||
143061414|NCT00680186|515764946|FG001|Overall Study|Protocol Violation|26|||
143061415|NCT00680186|515764945|FG000|Overall Study|Lost to Follow-up|11|||
143061416|NCT00680186|515764946|FG001|Overall Study|Lost to Follow-up|6|||
143061417|NCT00680186|515764945|FG000|Overall Study|Withdrawal by Subject|32|||
143061418|NCT00680186|515764946|FG001|Overall Study|Withdrawal by Subject|39|||
143061419|NCT00680186|515764945|FG000|Overall Study|Other|4|||
143061420|NCT00680186|515764946|FG001|Overall Study|Other|1|||
143061421|NCT01351350|515764947|FG000|Overall Study|Disease Progression|5|||
143061422|NCT01351350|515764948|FG001|Overall Study|Disease Progression|13|||
143061423|NCT01351350|515764949|FG002|Overall Study|Disease Progression|6|||
143061424|NCT01351350|515764950|FG003|Overall Study|Disease Progression|8|||
143061425|NCT01351350|515764951|FG004|Overall Study|Disease Progression|5|||
143061426|NCT01351350|515764947|FG000|Overall Study|Adverse Event|1|||
143061427|NCT01351350|515764948|FG001|Overall Study|Adverse Event|10|||
143061428|NCT01351350|515764949|FG002|Overall Study|Adverse Event|1|||
143061429|NCT01351350|515764950|FG003|Overall Study|Adverse Event|2|||
143061430|NCT01351350|515764951|FG004|Overall Study|Adverse Event|0|||
143061431|NCT01351350|515764947|FG000|Overall Study|Participant Decision|2|||
143061432|NCT01351350|515764948|FG001|Overall Study|Participant Decision|6|||
143061433|NCT01351350|515764949|FG002|Overall Study|Participant Decision|3|||
143061434|NCT01351350|515764950|FG003|Overall Study|Participant Decision|3|||
143061435|NCT01351350|515764951|FG004|Overall Study|Participant Decision|2|||
143061436|NCT01351350|515764947|FG000|Overall Study|Enrolled but not Treated|0|||
143061437|NCT01351350|515764948|FG001|Overall Study|Enrolled but not Treated|0|||
143061438|NCT01351350|515764949|FG002|Overall Study|Enrolled but not Treated|1|||
143061439|NCT01351350|515764950|FG003|Overall Study|Enrolled but not Treated|0|||
143061440|NCT01351350|515764951|FG004|Overall Study|Enrolled but not Treated|0|||
143061441|NCT00775528|515764956|FG000|Overall Study|Protocol Violation|1|||
143061442|NCT00285584|515764957|FG000|Month 3|Lost to Follow-up|3|||
143061443|NCT00285584|515764958|FG001|Month 3|Lost to Follow-up|3|||
143061444|NCT00285584|515764957|FG000|Month 3|Withdrawal by Subject|1|||
143061445|NCT00285584|515764958|FG001|Month 3|Withdrawal by Subject|0|||
143061446|NCT00285584|515764957|FG000|Month 6|Lost to Follow-up|0|||
143061447|NCT00285584|515764958|FG001|Month 6|Lost to Follow-up|1|||
143061448|NCT02470091|515764971|FG000|Overall Study|Withdrawal by Subject|1|||
143061449|NCT02470091|515764972|FG001|Overall Study|Withdrawal by Subject|0|||
143061450|NCT02470091|515764971|FG000|Overall Study|Ineligible|0|||
143061451|NCT02470091|515764972|FG001|Overall Study|Ineligible|2|||
143061452|NCT00303667|515764974|FG000|Overall Study|Death|0|||
143061453|NCT00303667|515764975|FG001|Overall Study|Death|4|||
143061454|NCT01192399|515764976|FG000|Overall Study|Lack of Efficacy|2|||
143061455|NCT01029392|515764978|FG000|Overall Study|Withdrawal by Subject|18|||
143061456|NCT01029392|515764979|FG001|Overall Study|Withdrawal by Subject|11|||
143061457|NCT01029392|515764978|FG000|Overall Study|Physician Decision|2|||
143061458|NCT01029392|515764979|FG001|Overall Study|Physician Decision|0|||
143061459|NCT01103479|515764980|FG000|Overall Study|Up to date with CRC screening|1|||
143061460|NCT01103479|515764981|FG001|Overall Study|Up to date with CRC screening|9|||
143061461|NCT01103479|515764982|FG002|Overall Study|Up to date with CRC screening|12|||
143061462|NCT01103479|515764980|FG000|Overall Study|Family history of CRC|1|||
143061463|NCT01103479|515764981|FG001|Overall Study|Family history of CRC|0|||
143061464|NCT01103479|515764982|FG002|Overall Study|Family history of CRC|2|||
143061465|NCT01103479|515764980|FG000|Overall Study|Active cancer|1|||
143061466|NCT01103479|515764981|FG001|Overall Study|Active cancer|0|||
143061467|NCT01103479|515764982|FG002|Overall Study|Active cancer|0|||
143061468|NCT01103479|515764980|FG000|Overall Study|Saw non-study physician|2|||
143061469|NCT01103479|515764981|FG001|Overall Study|Saw non-study physician|0|||
143061470|NCT01103479|515764982|FG002|Overall Study|Saw non-study physician|0|||
143061471|NCT01298778|515764983|FG000|Overall Study|Lost to Follow-up|2|||
143061472|NCT01298778|515764984|FG001|Overall Study|Lost to Follow-up|3|||
143061473|NCT01298778|515764983|FG000|Overall Study|Incorrect use of VAS|1|||
143061474|NCT01298778|515764984|FG001|Overall Study|Incorrect use of VAS|0|||
143061475|NCT01298778|515764983|FG000|Overall Study|Withdrawal by Subject|0|||
143061476|NCT01298778|515764984|FG001|Overall Study|Withdrawal by Subject|1|||
143061477|NCT01298778|515764983|FG000|Overall Study|Protocol Violation|0|||
143061478|NCT01298778|515764984|FG001|Overall Study|Protocol Violation|1|||
143061479|NCT01298778|515764983|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
143061480|NCT01298778|515764984|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
143061481|NCT02709486|515764990|FG000|Overall Study|Adverse Event|2|||
143061482|NCT02709486|515764991|FG001|Overall Study|Adverse Event|5|||
143061483|NCT02709486|515764992|FG002|Overall Study|Adverse Event|3|||
143061484|NCT02709486|515764990|FG000|Overall Study|Death|0|||
143061485|NCT02709486|515764991|FG001|Overall Study|Death|0|||
143061486|NCT02709486|515764992|FG002|Overall Study|Death|2|||
143061487|NCT02709486|515764990|FG000|Overall Study|Insufficient clinical response|7|||
143061488|NCT02709486|515764991|FG001|Overall Study|Insufficient clinical response|3|||
143061489|NCT02709486|515764992|FG002|Overall Study|Insufficient clinical response|3|||
143061490|NCT02709486|515764990|FG000|Overall Study|Lost to Follow-up|3|||
143061491|NCT02709486|515764991|FG001|Overall Study|Lost to Follow-up|2|||
143061492|NCT02709486|515764992|FG002|Overall Study|Lost to Follow-up|2|||
143061493|NCT02709486|515764990|FG000|Overall Study|Other|0|||
143061494|NCT02709486|515764991|FG001|Overall Study|Other|2|||
143061495|NCT02709486|515764992|FG002|Overall Study|Other|3|||
143061496|NCT02709486|515764990|FG000|Overall Study|Withdrawal by Subject|32|||
143061497|NCT02709486|515764991|FG001|Overall Study|Withdrawal by Subject|22|||
143061498|NCT02709486|515764992|FG002|Overall Study|Withdrawal by Subject|32|||
143061499|NCT02443545|515764993|FG000|Overall Study|Adverse Event|1|||
143061500|NCT02443545|515764994|FG001|Overall Study|Adverse Event|1|||
143061501|NCT02443545|515764993|FG000|Overall Study|Lost to Follow-up|0|||
143061502|NCT02443545|515764994|FG001|Overall Study|Lost to Follow-up|2|||
143061503|NCT02443545|515764993|FG000|Overall Study|Physician Decision|3|||
143061504|NCT02443545|515764994|FG001|Overall Study|Physician Decision|0|||
143061505|NCT02443545|515764993|FG000|Overall Study|Protocol Violation|8|||
143061506|NCT02443545|515764994|FG001|Overall Study|Protocol Violation|1|||
143061507|NCT02443545|515764993|FG000|Overall Study|Pregnancy|1|||
143061508|NCT02443545|515764994|FG001|Overall Study|Pregnancy|1|||
143061509|NCT02443545|515764993|FG000|Overall Study|Withdrawal by Subject|6|||
143061510|NCT02443545|515764994|FG001|Overall Study|Withdrawal by Subject|3|||
143061511|NCT02443545|515764993|FG000|Overall Study|Termination of study|20|||
143061512|NCT02443545|515764994|FG001|Overall Study|Termination of study|11|||
143061513|NCT01855048|515764998|FG000|Overall Study|Withdrawal by Subject|0|||
143061514|NCT01855048|515764999|FG001|Overall Study|Withdrawal by Subject|1|||
143061515|NCT01855048|515765000|FG002|Overall Study|Withdrawal by Subject|0|||
143061516|NCT01855048|515765001|FG003|Overall Study|Withdrawal by Subject|0|||
143061517|NCT01855048|515765002|FG004|Overall Study|Withdrawal by Subject|1|||
143061518|NCT01855048|515765003|FG005|Overall Study|Withdrawal by Subject|0|||
143061519|NCT02691741|515765004|FG000|Overall Study|Adverse Event|0|||
143061520|NCT02691741|515765005|FG001|Overall Study|Adverse Event|2|||
143061521|NCT02691741|515765004|FG000|Overall Study|Lost to Follow-up|1|||
143061522|NCT02691741|515765005|FG001|Overall Study|Lost to Follow-up|0|||
143061523|NCT02691741|515765004|FG000|Overall Study|Physician Decision|0|||
143061524|NCT02691741|515765005|FG001|Overall Study|Physician Decision|1|||
143061525|NCT02691741|515765004|FG000|Overall Study|Withdrawal by Subject|0|||
143061526|NCT02691741|515765005|FG001|Overall Study|Withdrawal by Subject|4|||
143061527|NCT02139124|515765006|FG000|Overall Study|Adverse Event|2|||
143061528|NCT02139124|515765007|FG001|Overall Study|Adverse Event|0|||
143061529|NCT02139124|515765008|FG002|Overall Study|Adverse Event|1|||
143061530|NCT02139124|515765009|FG003|Overall Study|Adverse Event|2|||
143061531|NCT02139124|515765010|FG004|Overall Study|Adverse Event|5|||
143061532|NCT02139124|515765006|FG000|Overall Study|Withdrawal by Subject|2|||
143061533|NCT02139124|515765007|FG001|Overall Study|Withdrawal by Subject|2|||
143061534|NCT02139124|515765008|FG002|Overall Study|Withdrawal by Subject|2|||
143061535|NCT02139124|515765009|FG003|Overall Study|Withdrawal by Subject|2|||
143061536|NCT02139124|515765010|FG004|Overall Study|Withdrawal by Subject|3|||
143061537|NCT02139124|515765006|FG000|Overall Study|Protocol Violation|0|||
143061538|NCT02139124|515765007|FG001|Overall Study|Protocol Violation|0|||
143061539|NCT02139124|515765008|FG002|Overall Study|Protocol Violation|0|||
143061540|NCT02139124|515765009|FG003|Overall Study|Protocol Violation|1|||
143061541|NCT02139124|515765010|FG004|Overall Study|Protocol Violation|1|||
143061542|NCT02139124|515765006|FG000|Overall Study|non-compliant|1|||
143061543|NCT02139124|515765007|FG001|Overall Study|non-compliant|0|||
143061544|NCT02139124|515765008|FG002|Overall Study|non-compliant|0|||
143061545|NCT02139124|515765009|FG003|Overall Study|non-compliant|2|||
143061546|NCT02139124|515765010|FG004|Overall Study|non-compliant|0|||
143061547|NCT02139124|515765006|FG000|Overall Study|incarceration|0|||
143061548|NCT02139124|515765007|FG001|Overall Study|incarceration|0|||
143061549|NCT02139124|515765008|FG002|Overall Study|incarceration|1|||
143061550|NCT02139124|515765009|FG003|Overall Study|incarceration|0|||
143061551|NCT02139124|515765010|FG004|Overall Study|incarceration|0|||
143061552|NCT02139124|515765006|FG000|Overall Study|subject moved|1|||
143061553|NCT02139124|515765007|FG001|Overall Study|subject moved|0|||
143061554|NCT02139124|515765008|FG002|Overall Study|subject moved|0|||
143061555|NCT02139124|515765009|FG003|Overall Study|subject moved|0|||
143061556|NCT02139124|515765010|FG004|Overall Study|subject moved|0|||
143061557|NCT02139124|515765006|FG000|Overall Study|Lost to Follow-up|3|||
143061558|NCT02139124|515765007|FG001|Overall Study|Lost to Follow-up|2|||
143061559|NCT02139124|515765008|FG002|Overall Study|Lost to Follow-up|0|||
143061560|NCT02139124|515765009|FG003|Overall Study|Lost to Follow-up|5|||
143061561|NCT02139124|515765010|FG004|Overall Study|Lost to Follow-up|4|||
143061562|NCT03069417|515765011|FG000|Overall Study|Lost to Follow-up|2|||
143061563|NCT03069417|515765012|FG001|Overall Study|Lost to Follow-up|0|||
143061564|NCT03069417|515765011|FG000|Overall Study|Reason Unknown|4|||
143061565|NCT03069417|515765012|FG001|Overall Study|Reason Unknown|7|||
143061566|NCT00402025|515765013|FG000|Overall Study|Adverse Event|0|||
143061567|NCT00402025|515765014|FG001|Overall Study|Adverse Event|0|||
143061568|NCT00402025|515765015|FG002|Overall Study|Adverse Event|2|||
143061569|NCT00402025|515765013|FG000|Overall Study|Death|0|||
143061570|NCT00402025|515765014|FG001|Overall Study|Death|1|||
143061571|NCT00402025|515765015|FG002|Overall Study|Death|5|||
143061572|NCT00402025|515765013|FG000|Overall Study|Disease Progression|1|||
143061573|NCT00402025|515765014|FG001|Overall Study|Disease Progression|1|||
143061574|NCT00402025|515765015|FG002|Overall Study|Disease Progression|2|||
143061575|NCT00402025|515765013|FG000|Overall Study|Physician Decision|1|||
143061576|NCT00402025|515765014|FG001|Overall Study|Physician Decision|1|||
143061577|NCT00402025|515765015|FG002|Overall Study|Physician Decision|0|||
143061578|NCT00402025|515765013|FG000|Overall Study|Participant Decision|0|||
143061579|NCT00402025|515765014|FG001|Overall Study|Participant Decision|0|||
143061580|NCT00402025|515765015|FG002|Overall Study|Participant Decision|1|||
143061581|NCT03064438|515767122|FG000|Overall Study|Lost to Follow-up|1|||
143061582|NCT03064438|515767123|FG001|Overall Study|Lost to Follow-up|0|||
143061583|NCT03064438|515767122|FG000|Overall Study|Withdrawal by Subject|0|||
143061584|NCT03064438|515767123|FG001|Overall Study|Withdrawal by Subject|1|||
143061585|NCT02658487|515767128|FG000|Overall Study|Death|2|||
143061586|NCT02658487|515767128|FG000|Overall Study|Disease progression|10|||
143061587|NCT02658487|515767128|FG000|Overall Study|Alternative therapy|1|||
143061588|NCT02658487|515767128|FG000|Overall Study|Adverse Event|1|||
143061589|NCT02658487|515767128|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
143061590|NCT02658487|515767128|FG000|Overall Study|Refractory acute myeloid leukemia (AML)|1|||
143061591|NCT01647958|515767129|FG000|Initial Study|Lost to Follow-up|2|||
143061592|NCT01647958|515767130|FG001|Initial Study|Lost to Follow-up|3|||
143061593|NCT01647958|515767129|FG000|Continuation Phase|treatment received during Overall Study|39|||
143061594|NCT01647958|515767130|FG001|Continuation Phase|treatment received during Overall Study|0|||
143061595|NCT01647958|515767129|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
143061596|NCT01647958|515767130|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
143061597|NCT02676284|515767131|FG000|Overall Study|Withdrawal by Subject|1|||
143061598|NCT00708708|515767133|FG000|Overall Study|Another therapy instead of Enbrel|141|||
143061599|NCT00708708|515767133|FG000|Overall Study|Lost to Follow-up|52|||
143061600|NCT00708708|515767133|FG000|Overall Study|Withdrawal by Subject|51|||
143061601|NCT00708708|515767133|FG000|Overall Study|Intolerance|42|||
143061602|NCT00708708|515767133|FG000|Overall Study|Another therapy along with Enbrel|15|||
143061603|NCT00708708|515767133|FG000|Overall Study|Other unspecified|11|||
143061604|NCT00708708|515767133|FG000|Overall Study|Good effectiveness|9|||
143061605|NCT00708708|515767133|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
143061606|NCT00708708|515767133|FG000|Overall Study|Administrative reasons|7|||
143061607|NCT00708708|515767133|FG000|Overall Study|Lack of effectiveness|4|||
143061608|NCT00708708|515767133|FG000|Overall Study|Lack of compliance|3|||
143061609|NCT00708708|515767133|FG000|Overall Study|Pregnancy|3|||
143061610|NCT00708708|515767133|FG000|Overall Study|Adverse Event|3|||
143061611|NCT00708708|515767133|FG000|Overall Study|Missing values|392|||
143061612|NCT01567826|515767137|FG000|Overall Study|Lost to Follow-up|3|||
143061613|NCT01567826|515767138|FG001|Overall Study|Lost to Follow-up|2|||
143061614|NCT00865098|515767144|FG000|Overall Study|Progressive disease|1|||
143061615|NCT01014624|515767152|FG000|Overall Study|Adverse Event|0|||
143061616|NCT01014624|515767153|FG001|Overall Study|Adverse Event|1|||
143061617|NCT01014624|515767152|FG000|Overall Study|Protocol Violation|1|||
143061618|NCT01014624|515767153|FG001|Overall Study|Protocol Violation|0|||
143061619|NCT01014624|515767152|FG000|Overall Study|Withdrawal by Subject|1|||
143061620|NCT01014624|515767153|FG001|Overall Study|Withdrawal by Subject|0|||
143061621|NCT01715896|515767154|FG000|Overall Study|Lost to Follow-up|0|||
143061622|NCT01715896|515767155|FG001|Overall Study|Lost to Follow-up|2|||
143061623|NCT01715896|515767154|FG000|Overall Study|Withdrawal by Subject|1|||
143061624|NCT01715896|515767155|FG001|Overall Study|Withdrawal by Subject|4|||
143061625|NCT01715896|515767154|FG000|Overall Study|Other|2|||
143061626|NCT01715896|515767155|FG001|Overall Study|Other|5|||
143061627|NCT03336242|515767163|FG000|Overall Study|Adverse Event|0|||
143061628|NCT03336242|515767164|FG001|Overall Study|Adverse Event|1|||
143061629|NCT00252174|515767168|FG000|Overall Study|Withdrawal by Subject|0|||
143061630|NCT00252174|515767169|FG001|Overall Study|Withdrawal by Subject|1|||
143061631|NCT00252174|515767170|FG002|Overall Study|Withdrawal by Subject|0|||
143061632|NCT02224573|515767171|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
143061633|NCT02224573|515767172|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
143061634|NCT02224573|515767171|FG000|Treatment Phase|Started on Other IMP|1|||
143061635|NCT02224573|515767172|FG001|Treatment Phase|Started on Other IMP|0|||
143061636|NCT02224573|515767171|FG000|Treatment Phase|Participant Discontinued IMP|0|||
143061637|NCT02224573|515767172|FG001|Treatment Phase|Participant Discontinued IMP|1|||
143061638|NCT02224573|515767171|FG000|Treatment Phase|Lack of Efficacy|15|||
143061639|NCT02224573|515767172|FG001|Treatment Phase|Lack of Efficacy|8|||
143061640|NCT02224573|515767171|FG000|Treatment Phase|Began Commercial Product|1|||
143061641|NCT02224573|515767172|FG001|Treatment Phase|Began Commercial Product|0|||
143061642|NCT02224573|515767171|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
143061643|NCT02224573|515767172|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
143061644|NCT02224573|515767171|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
143061645|NCT02224573|515767172|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
143061646|NCT02224573|515767171|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
143061647|NCT02224573|515767172|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
143061648|NCT02224573|515767171|FG000|Treatment Phase|Continued Compassionate Use|1|||
143502034|NCT00630331|517376332|FG001|Overall Study|Unable to classify|4|||
143502035|NCT00630331|517376333|FG002|Overall Study|Unable to classify|3|||
143502036|NCT00630331|517376331|FG000|Overall Study|Protocol Violation|4|||
143502037|NCT00630331|517376332|FG001|Overall Study|Protocol Violation|5|||
143502038|NCT00630331|517376333|FG002|Overall Study|Protocol Violation|6|||
143502039|NCT02425098|517376334|FG000|Overall Study|Lost to Follow-up|7|||
143502040|NCT02425098|517376335|FG001|Overall Study|Lost to Follow-up|7|||
143502041|NCT02425098|517376334|FG000|Overall Study|Withdrawal by Subject|4|||
143502042|NCT02425098|517376335|FG001|Overall Study|Withdrawal by Subject|8|||
143502043|NCT02425098|517376334|FG000|Overall Study|Pregnancy|2|||
143502044|NCT02425098|517376335|FG001|Overall Study|Pregnancy|0|||
143502045|NCT02425098|517376334|FG000|Overall Study|Reason not Specified|0|||
143502046|NCT02425098|517376335|FG001|Overall Study|Reason not Specified|1|||
143502047|NCT02689492|517378448|FG000|Overall Study|Lost to Follow-up|61|||
143502048|NCT02689492|517378448|FG000|Overall Study|Withdrawal by Subject|11|||
143502049|NCT02689492|517378448|FG000|Overall Study|Death|9|||
143502050|NCT02689492|517378448|FG000|Overall Study|Physician Decision|2|||
143502051|NCT02689492|517378448|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
143502052|NCT02689492|517378448|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
143502053|NCT02689492|517378448|FG000|Overall Study|Other than listed|1|||
143502054|NCT00110305|517378449|FG000|Overall Study|Adverse Event|46|||
143502055|NCT00110305|517378450|FG001|Overall Study|Adverse Event|13|||
143502056|NCT00110305|517378449|FG000|Overall Study|Sponsors Decision|1|||
143061649|NCT02224573|515767172|FG001|Treatment Phase|Continued Compassionate Use|0|||
143502057|NCT00110305|517378450|FG001|Overall Study|Sponsors Decision|0|||
143061650|NCT02224573|515767171|FG000|Treatment Phase|Lack of Efficiency|2|||
143061651|NCT02224573|515767172|FG001|Treatment Phase|Lack of Efficiency|1|||
143061652|NCT02224573|515767171|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
143061653|NCT02224573|515767172|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
143061654|NCT02224573|515767171|FG000|Treatment Phase|Participant Moved|2|||
143061655|NCT02224573|515767172|FG001|Treatment Phase|Participant Moved|0|||
143061656|NCT02224573|515767171|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
143502058|NCT00110305|517378449|FG000|Overall Study|Subject Non-Compliant|9|||
143502059|NCT00110305|517378450|FG001|Overall Study|Subject Non-Compliant|2|||
143061657|NCT02224573|515767172|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
143502060|NCT00110305|517378449|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
143502061|NCT00110305|517378450|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
143061658|NCT02224573|515767171|FG000|Treatment Phase|Refused Medication|1|||
143061659|NCT02224573|515767172|FG001|Treatment Phase|Refused Medication|1|||
143061660|NCT02224573|515767171|FG000|Treatment Phase|Adverse Event|26|||
143061661|NCT02224573|515767172|FG001|Treatment Phase|Adverse Event|38|||
143061662|NCT02224573|515767171|FG000|Treatment Phase|Placed in Group Home|0|||
143061663|NCT02224573|515767172|FG001|Treatment Phase|Placed in Group Home|1|||
143061664|NCT02224573|515767171|FG000|Treatment Phase|Pursued Other Trials|1|||
143061665|NCT02224573|515767172|FG001|Treatment Phase|Pursued Other Trials|0|||
143061666|NCT02224573|515767171|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
143061667|NCT02224573|515767172|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
143061668|NCT02224573|515767171|FG000|Treatment Phase|Lost to Follow-up|2|||
143502062|NCT00110305|517378449|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
143502063|NCT00110305|517378450|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
143502064|NCT00110305|517378449|FG000|Overall Study|Protocol Violation|0|||
143502065|NCT00110305|517378450|FG001|Overall Study|Protocol Violation|1|||
143502066|NCT00110305|517378449|FG000|Overall Study|Withdrawal by Subject|7|||
143502067|NCT00110305|517378450|FG001|Overall Study|Withdrawal by Subject|7|||
143502068|NCT00110305|517378449|FG000|Overall Study|Lost to Follow-up|20|||
143502069|NCT00110305|517378450|FG001|Overall Study|Lost to Follow-up|3|||
143502070|NCT00110305|517378449|FG000|Overall Study|Other|8|||
143502071|NCT00110305|517378450|FG001|Overall Study|Other|2|||
143502072|NCT05047523|517378453|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
143502073|NCT05047523|517378454|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
143502074|NCT05047523|517378455|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
143502075|NCT05047523|517378456|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
143061669|NCT02224573|515767172|FG001|Treatment Phase|Lost to Follow-up|1|||
143061670|NCT02224573|515767171|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
143502076|NCT05047523|517378457|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
143502077|NCT05047523|517378458|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
143502078|NCT05047523|517378453|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
143502079|NCT05047523|517378454|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
143502080|NCT05047523|517378455|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
143502081|NCT05047523|517378456|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
143502082|NCT05047523|517378457|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
143502083|NCT05047523|517378458|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
143502084|NCT05047523|517378453|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
143502085|NCT05047523|517378454|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
143502086|NCT05047523|517378455|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
143502087|NCT05047523|517378456|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
143502088|NCT05047523|517378457|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
143502089|NCT05047523|517378458|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
143502090|NCT05047523|517378453|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
143502091|NCT05047523|517378454|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
143502092|NCT05047523|517378455|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
143502093|NCT05047523|517378456|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
143502094|NCT05047523|517378457|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
143502095|NCT05047523|517378458|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
143502096|NCT05047523|517378453|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
143502097|NCT05047523|517378454|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
143502098|NCT05047523|517378455|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
143502099|NCT05047523|517378456|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
143502100|NCT05047523|517378457|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
143502101|NCT05047523|517378458|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
143502102|NCT05047523|517378453|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
143502103|NCT05047523|517378454|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
143502104|NCT05047523|517378455|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
143502105|NCT05047523|517378456|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
143502106|NCT05047523|517378457|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
143502107|NCT05047523|517378458|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
143502108|NCT01993888|517378464|FG000|Overall Study|Death|1|||
143502109|NCT01993888|517378465|FG001|Overall Study|Death|1|||
143502110|NCT01993888|517378464|FG000|Overall Study|Lost to Follow-up|1|||
143502111|NCT01993888|517378465|FG001|Overall Study|Lost to Follow-up|1|||
143502112|NCT01993888|517378464|FG000|Overall Study|Withdrawal by Subject|0|||
143502113|NCT01993888|517378465|FG001|Overall Study|Withdrawal by Subject|1|||
143502114|NCT00317044|517378466|FG000|Overall Study|Protocol Violation|28|||
143502115|NCT00317044|517378467|FG001|Overall Study|Protocol Violation|22|||
143502116|NCT00317044|517378468|FG002|Overall Study|Protocol Violation|20|||
143502117|NCT00317044|517378466|FG000|Overall Study|Adverse Event|4|||
143502118|NCT00317044|517378467|FG001|Overall Study|Adverse Event|7|||
143502119|NCT00317044|517378468|FG002|Overall Study|Adverse Event|4|||
143502120|NCT00317044|517378466|FG000|Overall Study|Withdrawal by Subject|10|||
143502121|NCT00317044|517378467|FG001|Overall Study|Withdrawal by Subject|7|||
143502122|NCT00317044|517378468|FG002|Overall Study|Withdrawal by Subject|12|||
143502123|NCT00317044|517378466|FG000|Overall Study|Lost to Follow-up|0|||
143502124|NCT00317044|517378467|FG001|Overall Study|Lost to Follow-up|2|||
143502125|NCT00317044|517378468|FG002|Overall Study|Lost to Follow-up|3|||
143502126|NCT00317044|517378466|FG000|Overall Study|Multiple Reasons|6|||
143502127|NCT00317044|517378467|FG001|Overall Study|Multiple Reasons|2|||
143502128|NCT00317044|517378468|FG002|Overall Study|Multiple Reasons|6|||
143502129|NCT01719757|517378472|FG000|Overall Study|Adverse Event|38|||
143061671|NCT02224573|515767172|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
143061672|NCT02224573|515767171|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
143061673|NCT02224573|515767172|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
143061674|NCT02224573|515767171|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
143061675|NCT02224573|515767172|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
143061676|NCT02224573|515767171|FG000|Taper Phase|Adverse Event|1|||
143365134|NCT03369951|516878803|FG000|Overall Study|Protocol Violation|1|||
143365135|NCT00725010|516878810|FG000|Overall Study|Toxicity|9|||
143502130|NCT01719757|517378472|FG000|Overall Study|Withdrawal by Subject|15|||
143502131|NCT01719757|517378472|FG000|Overall Study|Lost to Follow-up|20|||
143502132|NCT01719757|517378472|FG000|Overall Study|Protocol Violation|1|||
143502133|NCT01719757|517378472|FG000|Overall Study|well controlled pain|27|||
143502134|NCT02626338|517378473|FG000|Overall Study|Lack of Efficacy|3|||
143061677|NCT02224573|515767172|FG001|Taper Phase|Adverse Event|1|||
143061678|NCT02546362|515767173|FG000|4-week Treatment Period|Lost to Follow-up|1|||
143365136|NCT00725010|516878810|FG000|Overall Study|Tumor Progression|7|||
143502135|NCT02626338|517378474|FG001|Overall Study|Lack of Efficacy|2|||
143502136|NCT02626338|517378475|FG002|Overall Study|Lack of Efficacy|0|||
143061679|NCT02546362|515767173|FG000|4-week Treatment Period|Change in medication|2|||
143061680|NCT02546362|515767173|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
143061681|NCT02546362|515767173|FG000|12-week Treatment Period|Lost to Follow-up|2|||
143061682|NCT02546362|515767173|FG000|12-week Treatment Period|Change in medication|1|||
143061683|NCT01138826|515767174|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
143061684|NCT01138826|515767175|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
143061685|NCT01138826|515767176|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
143061686|NCT01138826|515767177|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
143061687|NCT01138826|515767178|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
143061688|NCT01138826|515767179|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
143061689|NCT05206448|515767180|FG000|Overall Study|Lost to Follow-up|2|||
143502137|NCT00522392|517378476|FG000|Overall Study|Disease progression|0|||
143502138|NCT00522392|517378477|FG001|Overall Study|Disease progression|3|||
143502139|NCT00522392|517378476|FG000|Overall Study|Adverse Event|7|||
143502140|NCT00522392|517378477|FG001|Overall Study|Adverse Event|7|||
143061690|NCT05206448|515767181|FG001|Overall Study|Lost to Follow-up|2|||
143061691|NCT05206448|515767180|FG000|Overall Study|Withdrawal by Subject|2|||
143061692|NCT05206448|515767181|FG001|Overall Study|Withdrawal by Subject|0|||
143061693|NCT05206448|515767180|FG000|Overall Study|found ineligible after randomization|1|||
143061694|NCT05206448|515767181|FG001|Overall Study|found ineligible after randomization|1|||
143061695|NCT05206448|515767180|FG000|Overall Study|unable to complete study due to personal constraints|1|||
143061696|NCT05206448|515767181|FG001|Overall Study|unable to complete study due to personal constraints|0|||
143061697|NCT05206448|515767180|FG000|Overall Study|Became pregnant during gap in treatment after pregnancy loss|0|||
143061698|NCT05206448|515767181|FG001|Overall Study|Became pregnant during gap in treatment after pregnancy loss|1|||
143061699|NCT01557842|515767182|FG000|Overall Study|Lost to Follow-up|0|||
143061700|NCT01557842|515767183|FG001|Overall Study|Lost to Follow-up|1|||
143061701|NCT01557842|515767182|FG000|Overall Study|Death|1|||
143061702|NCT01557842|515767183|FG001|Overall Study|Death|0|||
143061703|NCT01557842|515767182|FG000|Overall Study|Lack of Efficacy|0|||
143061704|NCT01557842|515767183|FG001|Overall Study|Lack of Efficacy|1|||
143061705|NCT01557842|515767182|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
143061706|NCT01557842|515767183|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
143061707|NCT01557842|515767182|FG000|Overall Study|Study Terminated by Sponsor|3|||
143061708|NCT01557842|515767183|FG001|Overall Study|Study Terminated by Sponsor|4|||
143061709|NCT01557842|515767182|FG000|Overall Study|Not Ablated|2|||
143061710|NCT01557842|515767183|FG001|Overall Study|Not Ablated|0|||
143061711|NCT02457611|515767187|FG000|Overall Study|Lost to Follow-up|3|||
143061712|NCT00384293|515767188|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
143061713|NCT00384293|515767189|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
143061714|NCT00384293|515767190|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
143061715|NCT00384293|515767188|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
143061716|NCT00384293|515767189|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
143061717|NCT00384293|515767190|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
143061718|NCT00384293|515767188|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
143061719|NCT00384293|515767189|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
143061720|NCT00384293|515767190|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
143502141|NCT00522392|517378476|FG000|Overall Study|Withdrawal by Subject|1|||
143502142|NCT00522392|517378477|FG001|Overall Study|Withdrawal by Subject|1|||
143061721|NCT00384293|515767188|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
143061722|NCT00384293|515767189|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
143061723|NCT00384293|515767190|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
143061724|NCT00384293|515767188|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
143061725|NCT00384293|515767189|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
143061726|NCT00384293|515767190|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
143061727|NCT00384293|515767188|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
143061728|NCT00384293|515767189|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
143061729|NCT00384293|515767190|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
143061730|NCT00384293|515767188|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
143061731|NCT00384293|515767189|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
143061732|NCT00384293|515767190|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
143061733|NCT00384293|515767188|FG000|Post-randomization Period|Adverse Event|0|||
143061734|NCT00384293|515767189|FG001|Post-randomization Period|Adverse Event|23|||
143061735|NCT00384293|515767190|FG002|Post-randomization Period|Adverse Event|7|||
143502143|NCT00522392|517378476|FG000|Overall Study|Physician Decision|0|||
143170109|NCT03396445|516171829|FG001|Switch-over Period|Lost to Follow-up|0|||
143170110|NCT03396445|516171830|FG002|Switch-over Period|Lost to Follow-up|0|||
143170111|NCT03396445|516171831|FG003|Switch-over Period|Lost to Follow-up|0|||
143502144|NCT00522392|517378477|FG001|Overall Study|Physician Decision|1|||
143502145|NCT00522392|517378476|FG000|Overall Study|Non-compliance|0|||
143061736|NCT00384293|515767188|FG000|Post-randomization Period|Lost to Follow-up|0|||
143061737|NCT00384293|515767189|FG001|Post-randomization Period|Lost to Follow-up|2|||
143061738|NCT00384293|515767190|FG002|Post-randomization Period|Lost to Follow-up|1|||
143061739|NCT00384293|515767188|FG000|Post-randomization Period|Protocol Violation|0|||
143061740|NCT00384293|515767189|FG001|Post-randomization Period|Protocol Violation|1|||
143061741|NCT00384293|515767190|FG002|Post-randomization Period|Protocol Violation|0|||
143061742|NCT00384293|515767188|FG000|Post-randomization Period|Withdrawal by Subject|0|||
143061743|NCT00384293|515767189|FG001|Post-randomization Period|Withdrawal by Subject|8|||
143061744|NCT00384293|515767190|FG002|Post-randomization Period|Withdrawal by Subject|6|||
143061745|NCT00384293|515767188|FG000|Post-randomization Period|Trial Termination|0|||
143061746|NCT00384293|515767189|FG001|Post-randomization Period|Trial Termination|180|||
143061747|NCT00384293|515767190|FG002|Post-randomization Period|Trial Termination|204|||
143061748|NCT00384293|515767188|FG000|Post-randomization Period|Patient Randomized in Error|0|||
143061749|NCT00384293|515767189|FG001|Post-randomization Period|Patient Randomized in Error|0|||
143061750|NCT00384293|515767190|FG002|Post-randomization Period|Patient Randomized in Error|1|||
143061751|NCT03005067|515767191|FG000|Overall Study|Withdrawal by Subject|3|||
143061752|NCT03005067|515767192|FG001|Overall Study|Withdrawal by Subject|2|||
143061753|NCT03005067|515767191|FG000|Overall Study|Adverse Event|4|||
143061754|NCT03005067|515767192|FG001|Overall Study|Adverse Event|3|||
143061755|NCT03005067|515767191|FG000|Overall Study|Other (reason not specified)|3|||
143061756|NCT03005067|515767192|FG001|Overall Study|Other (reason not specified)|1|||
143061757|NCT03005067|515767191|FG000|Overall Study|Protocol Violation|0|||
143061758|NCT03005067|515767192|FG001|Overall Study|Protocol Violation|1|||
143061759|NCT01790113|515767196|FG000|Overall Study|Adverse Event|2|||
143061760|NCT01790113|515767197|FG001|Overall Study|Adverse Event|7|||
143061761|NCT01790113|515767196|FG000|Overall Study|Study ended due to FDA clearance|1|||
143061762|NCT01790113|515767197|FG001|Overall Study|Study ended due to FDA clearance|68|||
143061763|NCT02674386|515767198|FG000|Overall Study|Lost to Follow-up|0|||
143061764|NCT02674386|515767199|FG001|Overall Study|Lost to Follow-up|1|||
143061765|NCT02674386|515767200|FG002|Overall Study|Lost to Follow-up|1|||
143061766|NCT02674386|515767198|FG000|Overall Study|Withdrawal by Subject|0|||
143061767|NCT02674386|515767199|FG001|Overall Study|Withdrawal by Subject|4|||
143061768|NCT02674386|515767200|FG002|Overall Study|Withdrawal by Subject|0|||
143061769|NCT02674386|515767198|FG000|Overall Study|Other|0|||
143061770|NCT02674386|515767199|FG001|Overall Study|Other|1|||
143061771|NCT02674386|515767200|FG002|Overall Study|Other|0|||
143061772|NCT02674386|515767198|FG000|Overall Study|Enrolled but not evaluated|0|||
143061773|NCT02674386|515767199|FG001|Overall Study|Enrolled but not evaluated|4|||
143061774|NCT02674386|515767200|FG002|Overall Study|Enrolled but not evaluated|0|||
143061775|NCT02462486|515767201|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
143061776|NCT02462486|515767202|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
143061777|NCT02462486|515767203|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
143061778|NCT02462486|515767201|FG000|Overall Study|Adverse Event|53|||
143061779|NCT02462486|515767202|FG001|Overall Study|Adverse Event|48|||
143061780|NCT02462486|515767203|FG002|Overall Study|Adverse Event|21|||
143061781|NCT02462486|515767201|FG000|Overall Study|Lack of Efficacy|6|||
143061782|NCT02462486|515767202|FG001|Overall Study|Lack of Efficacy|12|||
143061783|NCT02462486|515767203|FG002|Overall Study|Lack of Efficacy|3|||
143246030|NCT01287741|516451883|FG001|Overall Study|Non-compliance|6|||
143061784|NCT02462486|515767201|FG000|Overall Study|Lost to Follow-up|3|||
143061785|NCT02462486|515767202|FG001|Overall Study|Lost to Follow-up|4|||
143502146|NCT00522392|517378477|FG001|Overall Study|Non-compliance|1|||
143502147|NCT01703000|517378483|FG000|Overall Study|Death|1|||
143502148|NCT00434967|517378484|FG000|Overall Study|Adverse Event|2|||
143502149|NCT00434967|517378485|FG001|Overall Study|Adverse Event|4|||
143502150|NCT00434967|517378486|FG002|Overall Study|Adverse Event|3|||
143502151|NCT00434967|517378487|FG003|Overall Study|Adverse Event|3|||
143502152|NCT00434967|517378484|FG000|Overall Study|Lost to Follow-up|0|||
143502153|NCT00434967|517378485|FG001|Overall Study|Lost to Follow-up|0|||
143502154|NCT00434967|517378486|FG002|Overall Study|Lost to Follow-up|1|||
143502155|NCT00434967|517378487|FG003|Overall Study|Lost to Follow-up|0|||
143502156|NCT00434967|517378484|FG000|Overall Study|Withdrawal by Subject|2|||
143502157|NCT00434967|517378485|FG001|Overall Study|Withdrawal by Subject|2|||
143502158|NCT00434967|517378486|FG002|Overall Study|Withdrawal by Subject|4|||
143502159|NCT00434967|517378487|FG003|Overall Study|Withdrawal by Subject|6|||
143502160|NCT00434967|517378484|FG000|Overall Study|Randomized in error|0|||
143502161|NCT00434967|517378485|FG001|Overall Study|Randomized in error|0|||
143502162|NCT00434967|517378486|FG002|Overall Study|Randomized in error|0|||
143502163|NCT00434967|517378487|FG003|Overall Study|Randomized in error|1|||
143502164|NCT00434967|517378484|FG000|Overall Study|Protocol Violation|0|||
143502165|NCT00434967|517378485|FG001|Overall Study|Protocol Violation|1|||
143502166|NCT00434967|517378486|FG002|Overall Study|Protocol Violation|0|||
143502167|NCT00434967|517378487|FG003|Overall Study|Protocol Violation|1|||
143502168|NCT00434967|517378484|FG000|Overall Study|Physician Decision|1|||
143502169|NCT00434967|517378485|FG001|Overall Study|Physician Decision|1|||
143502170|NCT00434967|517378486|FG002|Overall Study|Physician Decision|1|||
143061786|NCT02462486|515767203|FG002|Overall Study|Lost to Follow-up|2|||
143061787|NCT02462486|515767201|FG000|Overall Study|Withdrawal by Subject|25|||
143061788|NCT02462486|515767202|FG001|Overall Study|Withdrawal by Subject|22|||
143061789|NCT02462486|515767203|FG002|Overall Study|Withdrawal by Subject|19|||
143061790|NCT02462486|515767201|FG000|Overall Study|Protocol Violation|3|||
143061791|NCT02462486|515767202|FG001|Overall Study|Protocol Violation|1|||
143061792|NCT02462486|515767203|FG002|Overall Study|Protocol Violation|1|||
143061793|NCT02462486|515767201|FG000|Overall Study|Reason not Specified|3|||
143061794|NCT02462486|515767202|FG001|Overall Study|Reason not Specified|4|||
143061795|NCT02462486|515767203|FG002|Overall Study|Reason not Specified|3|||
143170112|NCT03396445|516171832|FG004|Switch-over Period|Lost to Follow-up|0|||
143061796|NCT01483625|515767204|FG000|Overall Study|Adverse Event|1|||
143061797|NCT01483625|515767205|FG001|Overall Study|Adverse Event|1|||
143061798|NCT01483625|515767204|FG000|Overall Study|Refused to continue medication|2|||
143061799|NCT01483625|515767205|FG001|Overall Study|Refused to continue medication|1|||
143061800|NCT01483625|515767204|FG000|Overall Study|Due to other reason|1|||
143061801|NCT01483625|515767205|FG001|Overall Study|Due to other reason|0|||
143061802|NCT01731886|515767206|FG000|Overall Study|Death|1|||
143061803|NCT01731886|515767207|FG001|Overall Study|Death|0|||
143061804|NCT01731886|515767206|FG000|Overall Study|Never started treatment|0|||
143061805|NCT01731886|515767207|FG001|Overall Study|Never started treatment|1|||
143061806|NCT01731886|515767206|FG000|Overall Study|Non-compliant|1|||
143061807|NCT01731886|515767207|FG001|Overall Study|Non-compliant|0|||
143061808|NCT02280187|515767210|FG000|Overall Study|Lost to Follow-up|218|||
143061809|NCT02094261|515767211|FG000|Overall Study|Death|24|||
143061810|NCT02094261|515767211|FG000|Overall Study|Lost to Follow-up|1|||
143502171|NCT00434967|517378487|FG003|Overall Study|Physician Decision|0|||
143502172|NCT00434967|517378484|FG000|Overall Study|Patient Disposition Challenges|2|||
143502173|NCT00434967|517378485|FG001|Overall Study|Patient Disposition Challenges|0|||
143502174|NCT00434967|517378486|FG002|Overall Study|Patient Disposition Challenges|0|||
143502175|NCT00434967|517378487|FG003|Overall Study|Patient Disposition Challenges|3|||
143502176|NCT00862251|517378493|FG000|Overall Study|Adverse Event|8|||
143502177|NCT00862251|517378494|FG001|Overall Study|Adverse Event|3|||
143502178|NCT00862251|517378495|FG002|Overall Study|Adverse Event|1|||
143502179|NCT00862251|517378493|FG000|Overall Study|Lost to Follow-up|0|||
143502180|NCT00862251|517378494|FG001|Overall Study|Lost to Follow-up|0|||
143502181|NCT00862251|517378495|FG002|Overall Study|Lost to Follow-up|1|||
143502182|NCT00862251|517378493|FG000|Overall Study|Protocol Violation|2|||
143502183|NCT00862251|517378494|FG001|Overall Study|Protocol Violation|0|||
143502184|NCT00862251|517378495|FG002|Overall Study|Protocol Violation|1|||
143502185|NCT00862251|517378493|FG000|Overall Study|Withdrawal by Subject|9|||
143502186|NCT00862251|517378494|FG001|Overall Study|Withdrawal by Subject|2|||
143061811|NCT02094261|515767211|FG000|Overall Study|Withdrawal by Subject|4|||
143061812|NCT02094261|515767211|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
143061813|NCT01803269|515767216|FG000|Overall Study|Withdrawal by Subject|3|||
143502187|NCT00862251|517378495|FG002|Overall Study|Withdrawal by Subject|6|||
143502188|NCT01728779|517378496|FG000|Overall Study|Withdrawal by Subject|1|||
143502189|NCT02054702|517378499|FG000|Overall Study|Lost to Follow-up|3|||
143061814|NCT01803269|515767217|FG001|Overall Study|Withdrawal by Subject|0|||
143061815|NCT01803269|515767218|FG002|Overall Study|Withdrawal by Subject|0|||
143061816|NCT01807117|515767219|FG000|Overall Study|Physician Decision|2|||
143061817|NCT01807117|515767219|FG000|Overall Study|Disease diagnosis not a study disease|1|||
143170113|NCT03396445|516171833|FG005|Switch-over Period|Lost to Follow-up|0|||
143061818|NCT01534637|515767220|FG000|Overall Study|Physician Decision|3|||
143061819|NCT01534637|515767220|FG000|Overall Study|Lack of Efficacy|3|||
143061820|NCT01534637|515767220|FG000|Overall Study|Withdrawal by Subject|1|||
143502190|NCT02054702|517378500|FG001|Overall Study|Lost to Follow-up|5|||
143502191|NCT02054702|517378499|FG000|Overall Study|Adverse Event|3|||
143502192|NCT02054702|517378500|FG001|Overall Study|Adverse Event|1|||
143061821|NCT01534637|515767220|FG000|Overall Study|Adverse Event|1|||
143061822|NCT01534637|515767220|FG000|Overall Study|Liver Mets before treatment|1|||
143061823|NCT00834899|515767221|FG000|Overall Study|Withdrawal by Subject|1|||
143061824|NCT00834899|515767222|FG001|Overall Study|Withdrawal by Subject|1|||
143061825|NCT01523587|515767223|FG000|Overall Study|Other than listed|5|||
143061826|NCT01523587|515767224|FG001|Overall Study|Other than listed|5|||
143061827|NCT01523587|515767223|FG000|Overall Study|Worsening of underlying cancer disease|19|||
143502193|NCT02054702|517378499|FG000|Overall Study|Met Withdrawal Criteria|4|||
143502194|NCT02054702|517378500|FG001|Overall Study|Met Withdrawal Criteria|1|||
143502195|NCT02054702|517378499|FG000|Overall Study|Physician Decision|0|||
143502196|NCT02054702|517378500|FG001|Overall Study|Physician Decision|1|||
143502197|NCT02054702|517378499|FG000|Overall Study|Withdrawal by Subject|14|||
143061828|NCT01523587|515767224|FG001|Overall Study|Worsening of underlying cancer disease|34|||
143502198|NCT02054702|517378500|FG001|Overall Study|Withdrawal by Subject|4|||
143502199|NCT02347631|517378501|FG000|First Intervention (2 Months)|Adverse Event|1|||
143502200|NCT02347631|517378502|FG001|First Intervention (2 Months)|Adverse Event|1|||
143061829|NCT01523587|515767223|FG000|Overall Study|Adverse Event|68|||
143061830|NCT01523587|515767224|FG001|Overall Study|Adverse Event|52|||
143061831|NCT01523587|515767223|FG000|Overall Study|Protocol Violation|5|||
143061832|NCT01523587|515767224|FG001|Overall Study|Protocol Violation|3|||
143061833|NCT01523587|515767223|FG000|Overall Study|Lost to Follow-up|2|||
143061834|NCT01523587|515767224|FG001|Overall Study|Lost to Follow-up|2|||
143061835|NCT01523587|515767223|FG000|Overall Study|Withdrawal by Subject|28|||
143061836|NCT01523587|515767224|FG001|Overall Study|Withdrawal by Subject|20|||
143061837|NCT01523587|515767223|FG000|Overall Study|Withdrew due to Progressive disease|265|||
143061838|NCT01523587|515767224|FG001|Overall Study|Withdrew due to Progressive disease|279|||
143061839|NCT01523587|515767223|FG000|Overall Study|Randomised but bot treated|6|||
143061840|NCT01523587|515767224|FG001|Overall Study|Randomised but bot treated|2|||
143061841|NCT00606502|515767230|FG000|Randomization|Randomized but not treated|3|||
143061842|NCT00606502|515767231|FG001|Randomization|Randomized but not treated|0|||
143061843|NCT00606502|515767230|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
143061844|NCT00606502|515767231|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
143061845|NCT02377921|515767232|FG000|Overall Study|Subject non-compliance|1|||
143061846|NCT02377921|515767233|FG001|Overall Study|Subject non-compliance|1|||
143170114|NCT03396445|516171834|FG006|Switch-over Period|Lost to Follow-up|0|||
143170115|NCT03396445|516171835|FG007|Switch-over Period|Lost to Follow-up|0|||
143170116|NCT03396445|516171836|FG008|Switch-over Period|Lost to Follow-up|0|||
143170117|NCT03396445|516171837|FG009|Switch-over Period|Lost to Follow-up|0|||
143170118|NCT03396445|516171838|FG010|Switch-over Period|Lost to Follow-up|0|||
143170119|NCT03396445|516171839|FG011|Switch-over Period|Lost to Follow-up|0|||
143170120|NCT03396445|516171840|FG012|Switch-over Period|Lost to Follow-up|0|||
143170121|NCT03396445|516171841|FG013|Switch-over Period|Lost to Follow-up|0|||
143170122|NCT03396445|516171842|FG014|Switch-over Period|Lost to Follow-up|0|||
143170123|NCT03396445|516171843|FG015|Switch-over Period|Lost to Follow-up|0|||
143246031|NCT01287741|516451882|FG000|Overall Study|Lost to Follow-up|10|||
143246032|NCT01287741|516451883|FG001|Overall Study|Lost to Follow-up|8|||
143502201|NCT02347631|517378501|FG000|First Intervention (2 Months)|Pregnancy|1|||
143502202|NCT02347631|517378502|FG001|First Intervention (2 Months)|Pregnancy|0|||
143502203|NCT02347631|517378501|FG000|First Intervention (2 Months)|Moved out of area|0|||
143502204|NCT02347631|517378502|FG001|First Intervention (2 Months)|Moved out of area|2|||
143502205|NCT02347631|517378501|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
143502206|NCT02347631|517378502|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
143502207|NCT02347631|517378501|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
143502208|NCT02347631|517378502|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
143502209|NCT02347631|517378501|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
143502210|NCT02347631|517378502|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
143502211|NCT02347631|517378501|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
143502212|NCT02347631|517378502|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
143502213|NCT02347631|517378501|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
143061847|NCT00706355|515767245|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
143061848|NCT00706355|515767246|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
143061849|NCT00706355|515767247|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
143061850|NCT00706355|515767248|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
143061851|NCT00706355|515767245|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
143061852|NCT00706355|515767246|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
143061853|NCT00706355|515767247|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
143170124|NCT03396445|516171844|FG016|Switch-over Period|Lost to Follow-up|0|||
143246033|NCT01287741|516451882|FG000|Overall Study|Death|32|||
143170125|NCT03396445|516171845|FG017|Switch-over Period|Lost to Follow-up|0|||
143170126|NCT03396445|516171846|FG018|Switch-over Period|Lost to Follow-up|0|||
143170127|NCT03396445|516171847|FG019|Switch-over Period|Lost to Follow-up|0|||
143170128|NCT03396445|516171848|FG020|Switch-over Period|Lost to Follow-up|0|||
143170129|NCT03396445|516171849|FG021|Switch-over Period|Lost to Follow-up|0|||
143170130|NCT03396445|516171850|FG022|Switch-over Period|Lost to Follow-up|0|||
143170131|NCT03396445|516171851|FG023|Switch-over Period|Lost to Follow-up|1|||
143170132|NCT03396445|516171852|FG024|Switch-over Period|Lost to Follow-up|0|||
143170133|NCT03396445|516171853|FG025|Switch-over Period|Lost to Follow-up|0|||
143170134|NCT03309202|516171859|FG000|Overall Study|Lost to Follow-up|1|||
143170135|NCT03309202|516171860|FG001|Overall Study|Lost to Follow-up|0|||
143170136|NCT03309202|516171861|FG002|Overall Study|Lost to Follow-up|0|||
143170137|NCT03309202|516171862|FG003|Overall Study|Lost to Follow-up|0|||
143170138|NCT01209767|516171863|FG000|Overall Study|Withdrawal by Subject|1|||
143502214|NCT02347631|517378502|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
143502215|NCT01111604|517378511|FG000|Overall Study|Lost to Follow-up|0|||
143502216|NCT01111604|517378512|FG001|Overall Study|Lost to Follow-up|0|||
143502217|NCT01111604|517378513|FG002|Overall Study|Lost to Follow-up|1|||
143502218|NCT01111604|517378511|FG000|Overall Study|Withdrew Consent|3|||
143502219|NCT01111604|517378512|FG001|Overall Study|Withdrew Consent|0|||
143502220|NCT01111604|517378513|FG002|Overall Study|Withdrew Consent|2|||
143502221|NCT01111604|517378511|FG000|Overall Study|Withdrawal by Subject|2|||
143502222|NCT01111604|517378512|FG001|Overall Study|Withdrawal by Subject|0|||
143502223|NCT01111604|517378513|FG002|Overall Study|Withdrawal by Subject|0|||
143502224|NCT01111604|517378511|FG000|Overall Study|Death|1|||
143502225|NCT01111604|517378512|FG001|Overall Study|Death|0|||
143502226|NCT01111604|517378513|FG002|Overall Study|Death|0|||
143502227|NCT01111604|517378511|FG000|Overall Study|Met Exclusion Criteria|2|||
143502228|NCT01111604|517378512|FG001|Overall Study|Met Exclusion Criteria|0|||
143502229|NCT01111604|517378513|FG002|Overall Study|Met Exclusion Criteria|0|||
143502230|NCT01295125|517378515|FG000|Overall Study|Study stopped prematurely|9|||
143502231|NCT01355289|517378516|FG000|Core Study|Adverse Event, Non-Fatal|1|||
143502232|NCT01355289|517378517|FG001|Core Study|Adverse Event, Non-Fatal|0|||
143502233|NCT01355289|517378518|FG002|Core Study|Adverse Event, Non-Fatal|0|||
143502234|NCT01355289|517378519|FG003|Core Study|Adverse Event, Non-Fatal|0|||
143502235|NCT01355289|517378520|FG004|Core Study|Adverse Event, Non-Fatal|0|||
143502236|NCT01355289|517378516|FG000|Core Study|Inadequate Therapeutic Effect|0|||
143502237|NCT01355289|517378517|FG001|Core Study|Inadequate Therapeutic Effect|0|||
143502238|NCT01355289|517378518|FG002|Core Study|Inadequate Therapeutic Effect|0|||
143502239|NCT01355289|517378519|FG003|Core Study|Inadequate Therapeutic Effect|1|||
143502240|NCT01355289|517378520|FG004|Core Study|Inadequate Therapeutic Effect|0|||
143502241|NCT01355289|517378516|FG000|Core Study|Other|0|||
143502242|NCT01355289|517378517|FG001|Core Study|Other|0|||
143502243|NCT01355289|517378518|FG002|Core Study|Other|0|||
143502244|NCT01355289|517378519|FG003|Core Study|Other|1|||
143502245|NCT01355289|517378520|FG004|Core Study|Other|0|||
143502246|NCT01355289|517378516|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
143502247|NCT01355289|517378517|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
143502248|NCT01355289|517378518|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
143502249|NCT01355289|517378519|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
143502250|NCT01355289|517378520|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
143502251|NCT01355289|517378516|FG000|Open Label Extension|Lost to Follow-up|0|||
143502252|NCT01355289|517378517|FG001|Open Label Extension|Lost to Follow-up|0|||
143502253|NCT01355289|517378518|FG002|Open Label Extension|Lost to Follow-up|0|||
143502254|NCT01355289|517378519|FG003|Open Label Extension|Lost to Follow-up|0|||
143502255|NCT01355289|517378520|FG004|Open Label Extension|Lost to Follow-up|1|||
143502256|NCT01355289|517378516|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
143502257|NCT01355289|517378517|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
143502258|NCT01355289|517378518|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
143502259|NCT01355289|517378519|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
143502260|NCT01355289|517378520|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
143502261|NCT01355289|517378516|FG000|Open Label Extension|Other|0|||
143502262|NCT01355289|517378517|FG001|Open Label Extension|Other|0|||
143502263|NCT01355289|517378518|FG002|Open Label Extension|Other|0|||
143502264|NCT01355289|517378519|FG003|Open Label Extension|Other|0|||
143502265|NCT01355289|517378520|FG004|Open Label Extension|Other|3|||
143502266|NCT03838484|517378531|FG000|Overall Study|Lost to Follow-up|0|||
143502267|NCT03838484|517378532|FG001|Overall Study|Lost to Follow-up|1|||
143502268|NCT03838484|517378533|FG002|Overall Study|Lost to Follow-up|0|||
143502269|NCT03838484|517378534|FG003|Overall Study|Lost to Follow-up|0|||
143170139|NCT01209767|516171863|FG000|Overall Study|Lost to Follow-up|3|||
143502270|NCT02507349|517378535|FG000|Overall Study|Death|12|||
143502271|NCT02507349|517378536|FG001|Overall Study|Death|16|||
143502272|NCT02507349|517378535|FG000|Overall Study|Withdrawal by Subject|1|||
143502273|NCT02507349|517378536|FG001|Overall Study|Withdrawal by Subject|1|||
143502274|NCT02507349|517378535|FG000|Overall Study|Lost to Follow-up|174|||
143502275|NCT02507349|517378536|FG001|Overall Study|Lost to Follow-up|144|||
143502276|NCT00813995|517378537|FG000|Overall Study|Clinical adverse event|9|||
143502277|NCT00813995|517378538|FG001|Overall Study|Clinical adverse event|3|||
143502278|NCT00813995|517378537|FG000|Overall Study|Laboratory adverse event|0|||
143502279|NCT00813995|517378538|FG001|Overall Study|Laboratory adverse event|2|||
143502280|NCT00813995|517378537|FG000|Overall Study|Lack of Efficacy|1|||
143502281|NCT00813995|517378538|FG001|Overall Study|Lack of Efficacy|0|||
143502282|NCT00813995|517378537|FG000|Overall Study|Lost to Follow-up|4|||
143502283|NCT00813995|517378538|FG001|Overall Study|Lost to Follow-up|2|||
143502284|NCT00813995|517378537|FG000|Overall Study|Other reason|2|||
143502285|NCT00813995|517378538|FG001|Overall Study|Other reason|2|||
143502286|NCT00813995|517378537|FG000|Overall Study|Protocol Violation|3|||
143502287|NCT00813995|517378538|FG001|Overall Study|Protocol Violation|2|||
143502288|NCT00813995|517378537|FG000|Overall Study|Subject moved|4|||
143502289|NCT00813995|517378538|FG001|Overall Study|Subject moved|0|||
143502290|NCT00813995|517378537|FG000|Overall Study|Withdrawal by Subject|0|||
143502291|NCT00813995|517378538|FG001|Overall Study|Withdrawal by Subject|5|||
143061854|NCT00706355|515767248|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
143061855|NCT00706355|515767245|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
143061856|NCT00706355|515767246|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
143061857|NCT00706355|515767247|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
143061858|NCT00706355|515767248|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
143061859|NCT00706355|515767245|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
143061860|NCT00706355|515767246|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
143061861|NCT00706355|515767247|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
143061862|NCT00706355|515767248|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
143061863|NCT00706355|515767245|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
143061864|NCT00706355|515767246|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
143061865|NCT00706355|515767247|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
143061866|NCT00706355|515767248|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
143061867|NCT00706355|515767245|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
143061868|NCT00706355|515767246|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
143061869|NCT00706355|515767247|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
143061870|NCT00706355|515767248|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
143061871|NCT00706355|515767245|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
143061872|NCT00706355|515767246|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
143061873|NCT00706355|515767247|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
143061874|NCT00706355|515767248|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
143061875|NCT00706355|515767245|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
143061876|NCT00706355|515767246|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
143061877|NCT00706355|515767247|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
143061878|NCT00706355|515767248|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
143061879|NCT00706355|515767245|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
143061880|NCT00706355|515767246|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
143061881|NCT00706355|515767247|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
143061882|NCT00706355|515767248|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
143061883|NCT01020799|515767249|FG000|Overall Study|Adverse Event|4|||
143061884|NCT01020799|515767250|FG001|Overall Study|Adverse Event|3|||
143061885|NCT01020799|515767251|FG002|Overall Study|Adverse Event|2|||
143061886|NCT01020799|515767249|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
143061887|NCT01020799|515767250|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
143061888|NCT01020799|515767251|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
143061889|NCT01020799|515767249|FG000|Overall Study|Protocol Violation|3|||
143061890|NCT01020799|515767250|FG001|Overall Study|Protocol Violation|2|||
143061891|NCT01020799|515767251|FG002|Overall Study|Protocol Violation|0|||
143061892|NCT01020799|515767249|FG000|Overall Study|Withdrawal by Subject|2|||
143170140|NCT01702298|516171864|FG000|Overall Study|Withdrawal by Subject|1|||
143502292|NCT01614964|517378539|FG000|Overall Study|Withdrawal by Subject|2|||
143502293|NCT01614964|517378540|FG001|Overall Study|Withdrawal by Subject|0|||
143061893|NCT01020799|515767250|FG001|Overall Study|Withdrawal by Subject|2|||
143502294|NCT01614964|517378539|FG000|Overall Study|Lost to Follow-up|3|||
143502295|NCT01614964|517378540|FG001|Overall Study|Lost to Follow-up|0|||
143502296|NCT00860470|517378551|FG000|Overall Study|Death|6|||
143061894|NCT01020799|515767251|FG002|Overall Study|Withdrawal by Subject|3|||
143170141|NCT01664624|516171868|FG000|Overall Study|Adverse Event|0|||
143170142|NCT01664624|516171869|FG001|Overall Study|Adverse Event|1|||
143502297|NCT00860470|517378552|FG001|Overall Study|Death|10|||
143502298|NCT00860470|517378551|FG000|Overall Study|Moved away|8|||
143061895|NCT01020799|515767249|FG000|Overall Study|Lost to Follow-up|6|||
143061896|NCT01020799|515767250|FG001|Overall Study|Lost to Follow-up|4|||
143061897|NCT01020799|515767251|FG002|Overall Study|Lost to Follow-up|2|||
143061898|NCT04179019|515767252|FG000|Overall Study|Lost to Follow-up|2|||
143061899|NCT04179019|515767252|FG000|Overall Study|Physician Decision|2|||
143061900|NCT04179019|515767252|FG000|Overall Study|Withdrawal by Subject|5|||
143061901|NCT04179019|515767252|FG000|Overall Study|Adverse Event|4|||
143061902|NCT02549573|515767255|FG000|Overall Study|Withdrawal by Subject|0|||
143061903|NCT02549573|515767256|FG001|Overall Study|Withdrawal by Subject|2|||
143061904|NCT02549573|515767255|FG000|Overall Study|Protocol Violation|0|||
143061905|NCT02549573|515767256|FG001|Overall Study|Protocol Violation|1|||
143061906|NCT03465436|515767259|FG000|Period 1|Protocol Violation|0|||
143061907|NCT03465436|515767260|FG001|Period 1|Protocol Violation|0|||
143061908|NCT03465436|515767261|FG002|Period 1|Protocol Violation|1|||
143061909|NCT03465436|515767262|FG003|Period 1|Protocol Violation|0|||
143061910|NCT03465436|515767259|FG000|Period 2|Protocol Violation|0|||
143061911|NCT03465436|515767260|FG001|Period 2|Protocol Violation|1|||
143061912|NCT03465436|515767261|FG002|Period 2|Protocol Violation|0|||
143061913|NCT03465436|515767262|FG003|Period 2|Protocol Violation|0|||
143061914|NCT03465436|515767259|FG000|Period 3|Protocol Violation|1|||
143061915|NCT03465436|515767260|FG001|Period 3|Protocol Violation|1|||
143061916|NCT03465436|515767261|FG002|Period 3|Protocol Violation|0|||
143061917|NCT03465436|515767262|FG003|Period 3|Protocol Violation|0|||
143061918|NCT03465436|515767259|FG000|Period 4|Protocol Violation|0|||
143061919|NCT03465436|515767260|FG001|Period 4|Protocol Violation|0|||
143061920|NCT03465436|515767261|FG002|Period 4|Protocol Violation|1|||
143061921|NCT03465436|515767262|FG003|Period 4|Protocol Violation|0|||
143061922|NCT01813071|515767263|FG000|Overall Study|Protocol Violation|0|||
143061923|NCT01813071|515767264|FG001|Overall Study|Protocol Violation|0|||
143061924|NCT01813071|515767265|FG002|Overall Study|Protocol Violation|0|||
143061925|NCT01813071|515767266|FG003|Overall Study|Protocol Violation|0|||
143061926|NCT01813071|515767267|FG004|Overall Study|Protocol Violation|1|||
143061927|NCT01813071|515767268|FG005|Overall Study|Protocol Violation|4|||
143061928|NCT01813071|515767269|FG006|Overall Study|Protocol Violation|2|||
143061929|NCT01813071|515767270|FG007|Overall Study|Protocol Violation|4|||
143061930|NCT01813071|515767271|FG008|Overall Study|Protocol Violation|2|||
143061931|NCT01813071|515767263|FG000|Overall Study|Withdrawal by Subject|0|||
143061932|NCT01813071|515767264|FG001|Overall Study|Withdrawal by Subject|0|||
143061933|NCT01813071|515767265|FG002|Overall Study|Withdrawal by Subject|0|||
143061934|NCT01813071|515767266|FG003|Overall Study|Withdrawal by Subject|0|||
143061935|NCT01813071|515767267|FG004|Overall Study|Withdrawal by Subject|0|||
143061936|NCT01813071|515767268|FG005|Overall Study|Withdrawal by Subject|1|||
143061937|NCT01813071|515767269|FG006|Overall Study|Withdrawal by Subject|0|||
143061938|NCT01813071|515767270|FG007|Overall Study|Withdrawal by Subject|0|||
143061939|NCT01813071|515767271|FG008|Overall Study|Withdrawal by Subject|0|||
143061940|NCT01813071|515767263|FG000|Overall Study|Adverse Event|0|||
143061941|NCT01813071|515767264|FG001|Overall Study|Adverse Event|0|||
143061942|NCT01813071|515767265|FG002|Overall Study|Adverse Event|0|||
143061943|NCT01813071|515767266|FG003|Overall Study|Adverse Event|0|||
143061944|NCT01813071|515767267|FG004|Overall Study|Adverse Event|0|||
143170143|NCT01664624|516171870|FG002|Overall Study|Adverse Event|0|||
143061945|NCT01813071|515767268|FG005|Overall Study|Adverse Event|1|||
143061946|NCT01813071|515767269|FG006|Overall Study|Adverse Event|0|||
143061947|NCT01813071|515767270|FG007|Overall Study|Adverse Event|0|||
143061948|NCT01813071|515767271|FG008|Overall Study|Adverse Event|0|||
143061949|NCT01813071|515767263|FG000|Overall Study|Physician Decision|0|||
143061950|NCT01813071|515767264|FG001|Overall Study|Physician Decision|0|||
143061951|NCT01813071|515767265|FG002|Overall Study|Physician Decision|0|||
143170144|NCT01664624|516171871|FG003|Overall Study|Adverse Event|0|||
143061952|NCT01813071|515767266|FG003|Overall Study|Physician Decision|0|||
143061953|NCT01813071|515767267|FG004|Overall Study|Physician Decision|0|||
143061954|NCT01813071|515767268|FG005|Overall Study|Physician Decision|0|||
143061955|NCT01813071|515767269|FG006|Overall Study|Physician Decision|1|||
143061956|NCT01813071|515767270|FG007|Overall Study|Physician Decision|0|||
143061957|NCT01813071|515767271|FG008|Overall Study|Physician Decision|0|||
143061958|NCT01813071|515767263|FG000|Overall Study|Met inc/exc criteria|0|||
143061959|NCT01813071|515767264|FG001|Overall Study|Met inc/exc criteria|0|||
143502299|NCT00860470|517378552|FG001|Overall Study|Moved away|10|||
143502300|NCT00860470|517378551|FG000|Overall Study|Lost to Follow-up|34|||
143061960|NCT01813071|515767265|FG002|Overall Study|Met inc/exc criteria|0|||
143061961|NCT01813071|515767266|FG003|Overall Study|Met inc/exc criteria|0|||
143061962|NCT01813071|515767267|FG004|Overall Study|Met inc/exc criteria|0|||
143061963|NCT01813071|515767268|FG005|Overall Study|Met inc/exc criteria|1|||
143061964|NCT01813071|515767269|FG006|Overall Study|Met inc/exc criteria|0|||
143061965|NCT01813071|515767270|FG007|Overall Study|Met inc/exc criteria|1|||
143061966|NCT01813071|515767271|FG008|Overall Study|Met inc/exc criteria|1|||
143061967|NCT00613834|515767272|FG000|Overall Study|Withdrawal by Subject|0|||
143061968|NCT00613834|515767273|FG001|Overall Study|Withdrawal by Subject|3|||
143061969|NCT00440115|515767274|FG000|Overall Study|Death|7|||
143061970|NCT00440115|515767275|FG001|Overall Study|Death|9|||
143061971|NCT00440115|515767276|FG002|Overall Study|Death|5|||
143061972|NCT00440115|515767274|FG000|Overall Study|Incarceration|0|||
143061973|NCT00440115|515767275|FG001|Overall Study|Incarceration|2|||
143061974|NCT00440115|515767276|FG002|Overall Study|Incarceration|1|||
143061975|NCT03366194|515767280|FG000|Overall Study|Lost to Follow-up|2|||
143061976|NCT01481324|515767283|FG000|Overall Study|Missing Data|0|||
143061977|NCT01481324|515767284|FG001|Overall Study|Missing Data|2|||
143061978|NCT01481324|515767285|FG002|Overall Study|Missing Data|2|||
143061979|NCT01172821|515767286|FG000|Overall Study|Adverse Event|5|||
143061980|NCT01172821|515767287|FG001|Overall Study|Adverse Event|2|||
143061981|NCT01172821|515767288|FG002|Overall Study|Adverse Event|2|||
143061982|NCT01172821|515767289|FG003|Overall Study|Adverse Event|7|||
143061983|NCT01172821|515767286|FG000|Overall Study|Protocol Violation|0|||
143061984|NCT01172821|515767287|FG001|Overall Study|Protocol Violation|2|||
143061985|NCT01172821|515767288|FG002|Overall Study|Protocol Violation|1|||
143061986|NCT01172821|515767289|FG003|Overall Study|Protocol Violation|2|||
143061987|NCT01172821|515767286|FG000|Overall Study|Lost to Follow-up|4|||
143061988|NCT01172821|515767287|FG001|Overall Study|Lost to Follow-up|1|||
143061989|NCT01172821|515767288|FG002|Overall Study|Lost to Follow-up|2|||
143061990|NCT01172821|515767289|FG003|Overall Study|Lost to Follow-up|2|||
143061991|NCT01172821|515767286|FG000|Overall Study|Withdrawal by Subject|2|||
143061992|NCT01172821|515767287|FG001|Overall Study|Withdrawal by Subject|3|||
143061993|NCT01172821|515767288|FG002|Overall Study|Withdrawal by Subject|3|||
143061994|NCT01172821|515767289|FG003|Overall Study|Withdrawal by Subject|3|||
143061995|NCT01172821|515767286|FG000|Overall Study|Other|3|||
143061996|NCT01172821|515767287|FG001|Overall Study|Other|4|||
143061997|NCT01172821|515767288|FG002|Overall Study|Other|5|||
143061998|NCT01172821|515767289|FG003|Overall Study|Other|3|||
143061999|NCT00710749|515767290|FG000|First Intervention|Withdrawal by Subject|1|||
143062000|NCT00710749|515767291|FG001|First Intervention|Withdrawal by Subject|0|||
143062001|NCT02953678|515767293|FG000|Overall Study|Adverse Event|20|||
143062002|NCT02953678|515767293|FG000|Overall Study|Death|7|||
143062003|NCT02953678|515767293|FG000|Overall Study|Physician Decision|23|||
143062004|NCT02953678|515767293|FG000|Overall Study|Progressive Disease of GVHD|7|||
143062005|NCT02953678|515767293|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
143062006|NCT02953678|515767293|FG000|Overall Study|Withdrawal by participant|3|||
143062007|NCT02953678|515767293|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
143062008|NCT02953678|515767293|FG000|Overall Study|Participants were transferred to commercial product.|3|||
143062009|NCT00952276|515767294|FG000|Overall Study|Withdrawal by Subject|1|||
143062010|NCT00952276|515767295|FG001|Overall Study|Withdrawal by Subject|0|||
143246034|NCT01287741|516451883|FG001|Overall Study|Death|44|||
143246035|NCT01287741|516451882|FG000|Overall Study|Adverse Event|4|||
143062011|NCT00952276|515767296|FG002|Overall Study|Withdrawal by Subject|0|||
143062012|NCT00952276|515767297|FG003|Overall Study|Withdrawal by Subject|1|||
143062013|NCT00952276|515767298|FG004|Overall Study|Withdrawal by Subject|0|||
143114948|NCT02326298|515962469|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
143114949|NCT02326298|515962470|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
143114950|NCT02326298|515962471|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
143114951|NCT02326298|515962458|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
143114952|NCT02326298|515962459|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
143114953|NCT02326298|515962460|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
143114954|NCT02326298|515962461|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
143114955|NCT02326298|515962462|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
143114956|NCT02326298|515962463|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
143114957|NCT02326298|515962464|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
143114958|NCT02326298|515962465|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
143114959|NCT02326298|515962466|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
143114960|NCT02326298|515962467|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
143114961|NCT02326298|515962468|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
143114962|NCT02326298|515962469|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
143170145|NCT01517984|516171874|FG000|Overall Study|Lost to Follow-up|0|||
143170146|NCT01517984|516171875|FG001|Overall Study|Lost to Follow-up|1|||
143170147|NCT01517984|516171876|FG002|Overall Study|Lost to Follow-up|0|||
143170148|NCT01517984|516171877|FG003|Overall Study|Lost to Follow-up|0|||
143170149|NCT01517984|516171874|FG000|Overall Study|Withdrawal by Subject|1|||
143170150|NCT01517984|516171875|FG001|Overall Study|Withdrawal by Subject|8|||
143170151|NCT01517984|516171876|FG002|Overall Study|Withdrawal by Subject|4|||
143170152|NCT01517984|516171877|FG003|Overall Study|Withdrawal by Subject|1|||
143170153|NCT01517984|516171874|FG000|Overall Study|Screen Failure|4|||
143170154|NCT01517984|516171875|FG001|Overall Study|Screen Failure|0|||
143170155|NCT01517984|516171876|FG002|Overall Study|Screen Failure|0|||
143170156|NCT01517984|516171877|FG003|Overall Study|Screen Failure|0|||
143170157|NCT01517984|516171874|FG000|Overall Study|Ineligible for randomization|0|||
143170158|NCT01517984|516171875|FG001|Overall Study|Ineligible for randomization|14|||
143170159|NCT01517984|516171876|FG002|Overall Study|Ineligible for randomization|0|||
143170160|NCT01517984|516171877|FG003|Overall Study|Ineligible for randomization|0|||
143170161|NCT00583219|516171878|FG000|Phase 2|Withdrawal by Subject|1|||
143170162|NCT03898180|516171879|FG000|Overall Study|Death|178|||
143170163|NCT03898180|516171880|FG001|Overall Study|Death|173|||
143170164|NCT03898180|516171879|FG000|Overall Study|Physician Decision|1|||
143170165|NCT03898180|516171880|FG001|Overall Study|Physician Decision|0|||
143170166|NCT03898180|516171879|FG000|Overall Study|Sponsor Decision|3|||
143170167|NCT03898180|516171880|FG001|Overall Study|Sponsor Decision|0|||
143246036|NCT01287741|516451883|FG001|Overall Study|Adverse Event|6|||
143246037|NCT01287741|516451882|FG000|Overall Study|Study terminated by Sponsor|307|||
143246038|NCT01287741|516451883|FG001|Overall Study|Study terminated by Sponsor|315|||
143246039|NCT01287741|516451882|FG000|Overall Study|Progressive disease|190|||
143170168|NCT03898180|516171879|FG000|Overall Study|Lost to Follow-up|1|||
143170169|NCT03898180|516171880|FG001|Overall Study|Lost to Follow-up|0|||
143246040|NCT01287741|516451883|FG001|Overall Study|Progressive disease|166|||
143170170|NCT03898180|516171879|FG000|Overall Study|Withdrawal by Subject|5|||
143170171|NCT03898180|516171880|FG001|Overall Study|Withdrawal by Subject|4|||
143170172|NCT04392154|516171883|FG000|Primary Treatment Period (100 Weeks)|Adverse Event|3|||
143170173|NCT04392154|516171884|FG001|Primary Treatment Period (100 Weeks)|Adverse Event|46|||
143170174|NCT04392154|516171885|FG002|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
143502301|NCT00860470|517378552|FG001|Overall Study|Lost to Follow-up|39|||
143502302|NCT00888238|517378554|FG000|Washout Period After Period 2|Adverse Event|0|||
143502303|NCT00888238|517378555|FG001|Washout Period After Period 2|Adverse Event|0|||
143502304|NCT00888238|517378556|FG002|Washout Period After Period 2|Adverse Event|1|||
143502305|NCT02700984|517378557|FG000|Overall Study|Death|2|||
143502306|NCT02700984|517378558|FG001|Overall Study|Death|1|||
143502307|NCT02700984|517378557|FG000|Overall Study|Lost to Follow-up|2|||
143502308|NCT02700984|517378558|FG001|Overall Study|Lost to Follow-up|1|||
143502309|NCT02700984|517378557|FG000|Overall Study|Physician Decision|0|||
143502310|NCT02700984|517378558|FG001|Overall Study|Physician Decision|1|||
143502311|NCT02700984|517378557|FG000|Overall Study|Withdrawal by Subject|8|||
143502312|NCT02700984|517378558|FG001|Overall Study|Withdrawal by Subject|9|||
143502313|NCT02700984|517378557|FG000|Overall Study|Reason not specified|3|||
143502314|NCT02700984|517378558|FG001|Overall Study|Reason not specified|2|||
143502315|NCT01032629|517378560|FG000|Overall Study|Closed Site|21|||
143502316|NCT01032629|517378561|FG001|Overall Study|Closed Site|18|||
143502317|NCT01032629|517378562|FG002|Overall Study|Closed Site|16|||
143502318|NCT01032629|517378560|FG000|Overall Study|Withdrawal by Subject|50|||
143502319|NCT01032629|517378561|FG001|Overall Study|Withdrawal by Subject|36|||
143502320|NCT01032629|517378562|FG002|Overall Study|Withdrawal by Subject|35|||
143502321|NCT01032629|517378560|FG000|Overall Study|Lost to Follow-up|74|||
143502322|NCT01032629|517378561|FG001|Overall Study|Lost to Follow-up|47|||
143502323|NCT01032629|517378562|FG002|Overall Study|Lost to Follow-up|37|||
143502324|NCT03371355|517378563|FG000|Overall Study|Investigator judgment|0|||
143502325|NCT03371355|517378564|FG001|Overall Study|Investigator judgment|0|||
143502326|NCT03371355|517378565|FG002|Overall Study|Investigator judgment|1|||
143502327|NCT03371355|517378566|FG003|Overall Study|Investigator judgment|1|||
143502328|NCT03371355|517378563|FG000|Overall Study|Voluntary withdrawal|1|||
143502329|NCT03371355|517378564|FG001|Overall Study|Voluntary withdrawal|0|||
143502330|NCT03371355|517378565|FG002|Overall Study|Voluntary withdrawal|1|||
143502331|NCT03371355|517378566|FG003|Overall Study|Voluntary withdrawal|2|||
143502332|NCT03371355|517378563|FG000|Overall Study|Adverse Event|0|||
143502333|NCT03371355|517378564|FG001|Overall Study|Adverse Event|1|||
143502334|NCT03371355|517378565|FG002|Overall Study|Adverse Event|2|||
143502335|NCT03371355|517378566|FG003|Overall Study|Adverse Event|3|||
143062014|NCT04974619|515769343|FG000|Overall Study|Lost to Follow-up|0|||
143062015|NCT04974619|515769344|FG001|Overall Study|Lost to Follow-up|0|||
143062016|NCT04974619|515769345|FG002|Overall Study|Lost to Follow-up|1|||
143502336|NCT03371355|517378563|FG000|Overall Study|Reason not Specified|0|||
143502337|NCT03371355|517378564|FG001|Overall Study|Reason not Specified|1|||
143502338|NCT03371355|517378565|FG002|Overall Study|Reason not Specified|0|||
143502339|NCT03371355|517378566|FG003|Overall Study|Reason not Specified|1|||
143502340|NCT00619957|517378567|FG000|Month 24 Double-Blind|Adverse Event|9|||
143502341|NCT00619957|517378568|FG001|Month 24 Double-Blind|Adverse Event|7|||
143502342|NCT00619957|517378567|FG000|Month 24 Double-Blind|Protocol Violation|1|||
143502343|NCT00619957|517378568|FG001|Month 24 Double-Blind|Protocol Violation|0|||
143062017|NCT04974619|515769343|FG000|Overall Study|Withdrawal by Subject|0|||
143062018|NCT04974619|515769344|FG001|Overall Study|Withdrawal by Subject|0|||
143062019|NCT04974619|515769345|FG002|Overall Study|Withdrawal by Subject|1|||
143062020|NCT04974619|515769343|FG000|Overall Study|Protocol Violation|0|||
143062021|NCT04974619|515769344|FG001|Overall Study|Protocol Violation|1|||
143062022|NCT04974619|515769345|FG002|Overall Study|Protocol Violation|0|||
143062023|NCT00595335|515769356|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
143062024|NCT00595335|515769357|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
143062025|NCT00595335|515769356|FG000|Baseline to Six Months|Disease Progression|1|||
143062026|NCT00595335|515769357|FG001|Baseline to Six Months|Disease Progression|1|||
143062027|NCT00595335|515769356|FG000|Baseline to Six Months|Adverse Event|1|||
143062028|NCT00595335|515769357|FG001|Baseline to Six Months|Adverse Event|0|||
143062029|NCT00595335|515769356|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
143062030|NCT00595335|515769357|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
143062031|NCT00595335|515769356|FG000|Six Months to Twelve Months|Disease Progression|1|||
143062032|NCT00595335|515769357|FG001|Six Months to Twelve Months|Disease Progression|0|||
143062033|NCT01131299|515769361|FG000|Overall Study|Withdrawal by Subject|4|||
143062034|NCT01131299|515769362|FG001|Overall Study|Withdrawal by Subject|7|||
143062035|NCT01207440|515769376|FG000|Overall Study|Adverse Event|46|||
143062036|NCT01207440|515769377|FG001|Overall Study|Adverse Event|11|||
143062037|NCT01207440|515769378|FG002|Overall Study|Adverse Event|7|||
143062038|NCT01207440|515769379|FG003|Overall Study|Adverse Event|2|||
143062039|NCT01207440|515769380|FG004|Overall Study|Adverse Event|6|||
143062040|NCT01207440|515769381|FG005|Overall Study|Adverse Event|6|||
143062041|NCT01207440|515769382|FG006|Overall Study|Adverse Event|2|||
143062042|NCT01207440|515769376|FG000|Overall Study|Death|6|||
143062043|NCT01207440|515769377|FG001|Overall Study|Death|3|||
143062044|NCT01207440|515769378|FG002|Overall Study|Death|2|||
143062045|NCT01207440|515769379|FG003|Overall Study|Death|2|||
143062046|NCT01207440|515769380|FG004|Overall Study|Death|7|||
143062047|NCT01207440|515769381|FG005|Overall Study|Death|5|||
143062048|NCT01207440|515769382|FG006|Overall Study|Death|1|||
143062049|NCT01207440|515769376|FG000|Overall Study|Lack of Efficacy|13|||
143062050|NCT01207440|515769377|FG001|Overall Study|Lack of Efficacy|2|||
143062051|NCT01207440|515769378|FG002|Overall Study|Lack of Efficacy|5|||
143062052|NCT01207440|515769379|FG003|Overall Study|Lack of Efficacy|1|||
143062053|NCT01207440|515769380|FG004|Overall Study|Lack of Efficacy|2|||
143062054|NCT01207440|515769381|FG005|Overall Study|Lack of Efficacy|3|||
143062055|NCT01207440|515769382|FG006|Overall Study|Lack of Efficacy|0|||
143062056|NCT01207440|515769376|FG000|Overall Study|Lost to Follow-up|0|||
143062057|NCT01207440|515769377|FG001|Overall Study|Lost to Follow-up|0|||
143062058|NCT01207440|515769378|FG002|Overall Study|Lost to Follow-up|2|||
143062059|NCT01207440|515769379|FG003|Overall Study|Lost to Follow-up|1|||
143062060|NCT01207440|515769380|FG004|Overall Study|Lost to Follow-up|0|||
143062061|NCT01207440|515769381|FG005|Overall Study|Lost to Follow-up|0|||
143062062|NCT01207440|515769382|FG006|Overall Study|Lost to Follow-up|0|||
143062063|NCT01207440|515769376|FG000|Overall Study|Non-compliance with Study Drug|3|||
143062064|NCT01207440|515769377|FG001|Overall Study|Non-compliance with Study Drug|0|||
143062065|NCT01207440|515769378|FG002|Overall Study|Non-compliance with Study Drug|1|||
143062066|NCT01207440|515769379|FG003|Overall Study|Non-compliance with Study Drug|0|||
143062067|NCT01207440|515769380|FG004|Overall Study|Non-compliance with Study Drug|0|||
143062068|NCT01207440|515769381|FG005|Overall Study|Non-compliance with Study Drug|0|||
143062069|NCT01207440|515769382|FG006|Overall Study|Non-compliance with Study Drug|0|||
143062070|NCT01207440|515769376|FG000|Overall Study|Physician Decision|6|||
143062071|NCT01207440|515769377|FG001|Overall Study|Physician Decision|5|||
143062072|NCT01207440|515769378|FG002|Overall Study|Physician Decision|5|||
143062073|NCT01207440|515769379|FG003|Overall Study|Physician Decision|0|||
143062074|NCT01207440|515769380|FG004|Overall Study|Physician Decision|1|||
143062075|NCT01207440|515769381|FG005|Overall Study|Physician Decision|0|||
143062076|NCT01207440|515769382|FG006|Overall Study|Physician Decision|0|||
143062077|NCT01207440|515769376|FG000|Overall Study|Progressive Disease|19|||
143062078|NCT01207440|515769377|FG001|Overall Study|Progressive Disease|10|||
143062079|NCT01207440|515769378|FG002|Overall Study|Progressive Disease|19|||
143062080|NCT01207440|515769379|FG003|Overall Study|Progressive Disease|7|||
143062081|NCT01207440|515769380|FG004|Overall Study|Progressive Disease|23|||
143062082|NCT01207440|515769381|FG005|Overall Study|Progressive Disease|27|||
143062083|NCT01207440|515769382|FG006|Overall Study|Progressive Disease|0|||
143062084|NCT01207440|515769376|FG000|Overall Study|Protocol Violation|2|||
143062085|NCT01207440|515769377|FG001|Overall Study|Protocol Violation|0|||
143062086|NCT01207440|515769378|FG002|Overall Study|Protocol Violation|0|||
143062087|NCT01207440|515769379|FG003|Overall Study|Protocol Violation|0|||
143062088|NCT01207440|515769380|FG004|Overall Study|Protocol Violation|0|||
143062089|NCT01207440|515769381|FG005|Overall Study|Protocol Violation|0|||
143062090|NCT01207440|515769382|FG006|Overall Study|Protocol Violation|0|||
143062091|NCT01207440|515769376|FG000|Overall Study|Site Terminated by Sponsor|69|||
143062092|NCT01207440|515769377|FG001|Overall Study|Site Terminated by Sponsor|19|||
143062093|NCT01207440|515769378|FG002|Overall Study|Site Terminated by Sponsor|12|||
143062094|NCT01207440|515769379|FG003|Overall Study|Site Terminated by Sponsor|2|||
143062095|NCT01207440|515769380|FG004|Overall Study|Site Terminated by Sponsor|3|||
143062096|NCT01207440|515769381|FG005|Overall Study|Site Terminated by Sponsor|0|||
143062097|NCT01207440|515769382|FG006|Overall Study|Site Terminated by Sponsor|2|||
143062098|NCT01207440|515769376|FG000|Overall Study|Withdrawal by Subject|29|||
143062099|NCT01207440|515769377|FG001|Overall Study|Withdrawal by Subject|4|||
143062100|NCT01207440|515769378|FG002|Overall Study|Withdrawal by Subject|5|||
143062101|NCT01207440|515769379|FG003|Overall Study|Withdrawal by Subject|3|||
143062102|NCT01207440|515769380|FG004|Overall Study|Withdrawal by Subject|2|||
143062103|NCT01207440|515769381|FG005|Overall Study|Withdrawal by Subject|2|||
143062104|NCT01207440|515769382|FG006|Overall Study|Withdrawal by Subject|0|||
143062105|NCT01207440|515769376|FG000|Overall Study|Reason Not Specified|10|||
143062106|NCT01207440|515769377|FG001|Overall Study|Reason Not Specified|10|||
143502344|NCT00619957|517378567|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
143502345|NCT00619957|517378568|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
143502346|NCT00619957|517378567|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
143502347|NCT00619957|517378568|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
143502348|NCT00619957|517378567|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
143502349|NCT00619957|517378568|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
143502350|NCT00619957|517378567|FG000|Month 48 Open-Label|Adverse Event|4|||
143502351|NCT00619957|517378568|FG001|Month 48 Open-Label|Adverse Event|4|||
143502352|NCT00619957|517378567|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
143502353|NCT00619957|517378568|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
143502354|NCT00619957|517378567|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
143062107|NCT01207440|515769378|FG002|Overall Study|Reason Not Specified|7|||
143062108|NCT01207440|515769379|FG003|Overall Study|Reason Not Specified|0|||
143062109|NCT01207440|515769380|FG004|Overall Study|Reason Not Specified|4|||
143062110|NCT01207440|515769381|FG005|Overall Study|Reason Not Specified|3|||
143062111|NCT01207440|515769382|FG006|Overall Study|Reason Not Specified|0|||
143062112|NCT01432574|515769385|FG000|Overall Study|Moved|2|||
143062113|NCT01432574|515769385|FG000|Overall Study|Not interested|1|||
143062114|NCT04146363|515769386|FG000|Induction Period|Adverse Event|1|||
143062115|NCT04146363|515769387|FG001|Induction Period|Adverse Event|2|||
143062116|NCT04146363|515769388|FG002|Induction Period|Adverse Event|0|||
143062117|NCT04146363|515769389|FG003|Induction Period|Adverse Event|0|||
143062118|NCT04146363|515769390|FG004|Induction Period|Adverse Event|0|||
143062119|NCT04146363|515769391|FG005|Induction Period|Adverse Event|0|||
143502355|NCT00619957|517378568|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
143502356|NCT00723957|517378569|FG000|Overall Study|Adverse event unrelated to study drug|1|||
143062120|NCT04146363|515769392|FG006|Induction Period|Adverse Event|0|||
143062121|NCT04146363|515769393|FG007|Induction Period|Adverse Event|0|||
143062122|NCT04146363|515769394|FG008|Induction Period|Adverse Event|0|||
143062123|NCT04146363|515769395|FG009|Induction Period|Adverse Event|0|||
143062124|NCT04146363|515769396|FG010|Induction Period|Adverse Event|0|||
143062125|NCT04146363|515769386|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
143062126|NCT04146363|515769387|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
143062127|NCT04146363|515769388|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
143062128|NCT04146363|515769389|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
143062129|NCT04146363|515769390|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
143062130|NCT04146363|515769391|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
143062131|NCT04146363|515769392|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
143062132|NCT04146363|515769393|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
143062133|NCT04146363|515769394|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
143062134|NCT04146363|515769395|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
143062135|NCT04146363|515769396|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
143062136|NCT04146363|515769386|FG000|Induction Period|Lack of Efficacy|7|||
143062137|NCT04146363|515769387|FG001|Induction Period|Lack of Efficacy|2|||
143062138|NCT04146363|515769388|FG002|Induction Period|Lack of Efficacy|0|||
143062139|NCT04146363|515769389|FG003|Induction Period|Lack of Efficacy|0|||
143062140|NCT04146363|515769390|FG004|Induction Period|Lack of Efficacy|0|||
143062141|NCT04146363|515769391|FG005|Induction Period|Lack of Efficacy|0|||
143062142|NCT04146363|515769392|FG006|Induction Period|Lack of Efficacy|0|||
143062143|NCT04146363|515769393|FG007|Induction Period|Lack of Efficacy|0|||
143062144|NCT04146363|515769394|FG008|Induction Period|Lack of Efficacy|0|||
143062145|NCT04146363|515769395|FG009|Induction Period|Lack of Efficacy|0|||
143062146|NCT04146363|515769396|FG010|Induction Period|Lack of Efficacy|0|||
143062147|NCT04146363|515769386|FG000|Induction Period|Lost to Follow-up|1|||
143062148|NCT04146363|515769387|FG001|Induction Period|Lost to Follow-up|4|||
143062149|NCT04146363|515769388|FG002|Induction Period|Lost to Follow-up|0|||
143062150|NCT04146363|515769389|FG003|Induction Period|Lost to Follow-up|0|||
143062151|NCT04146363|515769390|FG004|Induction Period|Lost to Follow-up|0|||
143062152|NCT04146363|515769391|FG005|Induction Period|Lost to Follow-up|0|||
143062153|NCT04146363|515769392|FG006|Induction Period|Lost to Follow-up|0|||
143062154|NCT04146363|515769393|FG007|Induction Period|Lost to Follow-up|0|||
143062155|NCT04146363|515769394|FG008|Induction Period|Lost to Follow-up|0|||
143062156|NCT04146363|515769395|FG009|Induction Period|Lost to Follow-up|0|||
143502357|NCT00723957|517378570|FG001|Overall Study|Adverse event unrelated to study drug|4|||
143062157|NCT04146363|515769396|FG010|Induction Period|Lost to Follow-up|0|||
143062158|NCT04146363|515769386|FG000|Induction Period|Positive quantiferon test|0|||
143062159|NCT04146363|515769387|FG001|Induction Period|Positive quantiferon test|1|||
143062160|NCT04146363|515769388|FG002|Induction Period|Positive quantiferon test|0|||
143062161|NCT04146363|515769389|FG003|Induction Period|Positive quantiferon test|0|||
143062162|NCT04146363|515769390|FG004|Induction Period|Positive quantiferon test|0|||
143062163|NCT04146363|515769391|FG005|Induction Period|Positive quantiferon test|0|||
143062164|NCT04146363|515769392|FG006|Induction Period|Positive quantiferon test|0|||
143062165|NCT04146363|515769393|FG007|Induction Period|Positive quantiferon test|0|||
143062166|NCT04146363|515769394|FG008|Induction Period|Positive quantiferon test|0|||
143062167|NCT04146363|515769395|FG009|Induction Period|Positive quantiferon test|0|||
143062168|NCT04146363|515769396|FG010|Induction Period|Positive quantiferon test|0|||
143062169|NCT04146363|515769386|FG000|Induction Period|Protocol Deviation|5|||
143062170|NCT04146363|515769387|FG001|Induction Period|Protocol Deviation|6|||
143062171|NCT04146363|515769388|FG002|Induction Period|Protocol Deviation|0|||
143062172|NCT04146363|515769389|FG003|Induction Period|Protocol Deviation|0|||
143062173|NCT04146363|515769390|FG004|Induction Period|Protocol Deviation|0|||
143062174|NCT04146363|515769391|FG005|Induction Period|Protocol Deviation|0|||
143062175|NCT04146363|515769392|FG006|Induction Period|Protocol Deviation|0|||
143062176|NCT04146363|515769393|FG007|Induction Period|Protocol Deviation|0|||
143062177|NCT04146363|515769394|FG008|Induction Period|Protocol Deviation|0|||
143062178|NCT04146363|515769395|FG009|Induction Period|Protocol Deviation|0|||
143062179|NCT04146363|515769396|FG010|Induction Period|Protocol Deviation|0|||
143062180|NCT04146363|515769386|FG000|Induction Period|Withdrawal by Subject|6|||
143062181|NCT04146363|515769387|FG001|Induction Period|Withdrawal by Subject|3|||
143062182|NCT04146363|515769388|FG002|Induction Period|Withdrawal by Subject|0|||
143062183|NCT04146363|515769389|FG003|Induction Period|Withdrawal by Subject|0|||
143062184|NCT04146363|515769390|FG004|Induction Period|Withdrawal by Subject|0|||
143062185|NCT04146363|515769391|FG005|Induction Period|Withdrawal by Subject|0|||
143062186|NCT04146363|515769392|FG006|Induction Period|Withdrawal by Subject|0|||
143062187|NCT04146363|515769393|FG007|Induction Period|Withdrawal by Subject|0|||
143062188|NCT04146363|515769394|FG008|Induction Period|Withdrawal by Subject|0|||
143062189|NCT04146363|515769395|FG009|Induction Period|Withdrawal by Subject|0|||
143062190|NCT04146363|515769396|FG010|Induction Period|Withdrawal by Subject|0|||
143062191|NCT04146363|515769386|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
143062192|NCT04146363|515769387|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
143062193|NCT04146363|515769388|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
143062194|NCT04146363|515769389|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
143062195|NCT04146363|515769390|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
143062196|NCT04146363|515769391|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
143062197|NCT04146363|515769392|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
143062198|NCT04146363|515769393|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
143062199|NCT04146363|515769394|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
143062200|NCT04146363|515769395|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
143062201|NCT04146363|515769396|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
143062202|NCT04146363|515769386|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
143062203|NCT04146363|515769387|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
143062204|NCT04146363|515769388|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
143062205|NCT04146363|515769389|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
143062206|NCT04146363|515769390|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
143062207|NCT04146363|515769391|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
143062208|NCT04146363|515769392|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
143062209|NCT04146363|515769393|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
143062210|NCT04146363|515769394|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
143062211|NCT04146363|515769395|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
143062212|NCT04146363|515769396|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
143062213|NCT04146363|515769386|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
143062214|NCT04146363|515769387|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
143062215|NCT04146363|515769388|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
143062216|NCT04146363|515769389|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
143170175|NCT04392154|516171886|FG003|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
143502358|NCT00723957|517378569|FG000|Overall Study|Death|3|||
143502359|NCT00723957|517378570|FG001|Overall Study|Death|4|||
143502360|NCT00723957|517378569|FG000|Overall Study|Disease progression|27|||
143502361|NCT00723957|517378570|FG001|Overall Study|Disease progression|25|||
143502362|NCT00723957|517378569|FG000|Overall Study|Maximum clinical benefit|4|||
143502363|NCT00723957|517378570|FG001|Overall Study|Maximum clinical benefit|5|||
143502364|NCT00723957|517378569|FG000|Overall Study|Investigator decision|1|||
143502365|NCT00723957|517378570|FG001|Overall Study|Investigator decision|1|||
143062217|NCT04146363|515769390|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
143170176|NCT04392154|516171883|FG000|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
143062218|NCT04146363|515769391|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
143170177|NCT04392154|516171884|FG001|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|1|||
143502366|NCT00723957|517378569|FG000|Overall Study|Study drug toxicity|4|||
143502367|NCT00723957|517378570|FG001|Overall Study|Study drug toxicity|6|||
143502368|NCT00723957|517378569|FG000|Overall Study|Withdrawal by Subject|7|||
143502369|NCT00723957|517378570|FG001|Overall Study|Withdrawal by Subject|5|||
143502370|NCT00723957|517378569|FG000|Overall Study|Reason not analyzed|1|||
143502371|NCT00723957|517378570|FG001|Overall Study|Reason not analyzed|0|||
143502372|NCT00723957|517378569|FG000|Overall Study|Never received treatment|3|||
143502373|NCT00723957|517378570|FG001|Overall Study|Never received treatment|3|||
143502374|NCT00868790|517378573|FG000|Period 1|Adverse Event|1|||
143502375|NCT00868790|517378574|FG001|Period 1|Adverse Event|0|||
143502376|NCT00868790|517378575|FG002|Period 1|Adverse Event|0|||
143502377|NCT00868790|517378576|FG003|Period 1|Adverse Event|0|||
143502378|NCT00868790|517378577|FG004|Period 1|Adverse Event|0|||
143502379|NCT00868790|517378578|FG005|Period 1|Adverse Event|0|||
143502380|NCT00868790|517378579|FG006|Period 1|Adverse Event|0|||
143502381|NCT00868790|517378580|FG007|Period 1|Adverse Event|3|||
143502382|NCT00868790|517378581|FG008|Period 1|Adverse Event|1|||
143502383|NCT00868790|517378582|FG009|Period 1|Adverse Event|0|||
143502384|NCT00868790|517378583|FG010|Period 1|Adverse Event|0|||
143502385|NCT00868790|517378584|FG011|Period 1|Adverse Event|0|||
143502386|NCT00868790|517378585|FG012|Period 1|Adverse Event|0|||
143502387|NCT00868790|517378586|FG013|Period 1|Adverse Event|1|||
143502388|NCT00868790|517378573|FG000|Period 1|Protocol Violation|1|||
143502389|NCT00868790|517378574|FG001|Period 1|Protocol Violation|0|||
143502390|NCT00868790|517378575|FG002|Period 1|Protocol Violation|0|||
143502391|NCT00868790|517378576|FG003|Period 1|Protocol Violation|0|||
143502392|NCT00868790|517378577|FG004|Period 1|Protocol Violation|0|||
143502393|NCT00868790|517378578|FG005|Period 1|Protocol Violation|0|||
143502394|NCT00868790|517378579|FG006|Period 1|Protocol Violation|0|||
143502395|NCT00868790|517378580|FG007|Period 1|Protocol Violation|0|||
143502396|NCT00868790|517378581|FG008|Period 1|Protocol Violation|0|||
143502397|NCT00868790|517378582|FG009|Period 1|Protocol Violation|0|||
143502398|NCT00868790|517378583|FG010|Period 1|Protocol Violation|0|||
143502399|NCT00868790|517378584|FG011|Period 1|Protocol Violation|0|||
143502400|NCT00868790|517378585|FG012|Period 1|Protocol Violation|0|||
143502401|NCT00868790|517378586|FG013|Period 1|Protocol Violation|0|||
143502402|NCT00868790|517378573|FG000|Period 1|Withdrawal by Subject|0|||
143502403|NCT00868790|517378574|FG001|Period 1|Withdrawal by Subject|1|||
143502404|NCT00868790|517378575|FG002|Period 1|Withdrawal by Subject|0|||
143502405|NCT00868790|517378576|FG003|Period 1|Withdrawal by Subject|0|||
143502406|NCT00868790|517378577|FG004|Period 1|Withdrawal by Subject|0|||
143502407|NCT00868790|517378578|FG005|Period 1|Withdrawal by Subject|0|||
143502408|NCT00868790|517378579|FG006|Period 1|Withdrawal by Subject|0|||
143502409|NCT00868790|517378580|FG007|Period 1|Withdrawal by Subject|0|||
143062219|NCT04146363|515769392|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
143062220|NCT04146363|515769393|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
143062221|NCT04146363|515769394|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
143062222|NCT04146363|515769395|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
143062223|NCT04146363|515769396|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
143062224|NCT04146363|515769386|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
143062225|NCT04146363|515769387|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
143062226|NCT04146363|515769388|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
143062227|NCT04146363|515769389|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
143062228|NCT04146363|515769390|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
143062229|NCT04146363|515769391|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
143062230|NCT04146363|515769392|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
143062231|NCT04146363|515769393|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
143062232|NCT04146363|515769394|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
143062233|NCT04146363|515769395|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
143062234|NCT04146363|515769396|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
143062235|NCT04146363|515769386|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
143062236|NCT04146363|515769387|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
143062237|NCT04146363|515769388|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
143062238|NCT04146363|515769389|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
143246041|NCT01287741|516451882|FG000|Overall Study|Reason not specified|23|||
143246042|NCT01287741|516451883|FG001|Overall Study|Reason not specified|9|||
143246043|NCT04421027|516451884|FG000|Treatment Period|Adverse Event|5|||
143502410|NCT00868790|517378581|FG008|Period 1|Withdrawal by Subject|0|||
143502411|NCT00868790|517378582|FG009|Period 1|Withdrawal by Subject|0|||
143502412|NCT00868790|517378583|FG010|Period 1|Withdrawal by Subject|0|||
143502413|NCT00868790|517378584|FG011|Period 1|Withdrawal by Subject|0|||
143502414|NCT00868790|517378585|FG012|Period 1|Withdrawal by Subject|0|||
143502415|NCT00868790|517378586|FG013|Period 1|Withdrawal by Subject|1|||
143502416|NCT00868790|517378573|FG000|Period 1|Abnormal Triglycerides|0|||
143502417|NCT00868790|517378574|FG001|Period 1|Abnormal Triglycerides|0|||
143502418|NCT00868790|517378575|FG002|Period 1|Abnormal Triglycerides|0|||
143502419|NCT00868790|517378576|FG003|Period 1|Abnormal Triglycerides|0|||
143502420|NCT00868790|517378577|FG004|Period 1|Abnormal Triglycerides|1|||
143502421|NCT00868790|517378578|FG005|Period 1|Abnormal Triglycerides|0|||
143502422|NCT00868790|517378579|FG006|Period 1|Abnormal Triglycerides|0|||
143062239|NCT04146363|515769390|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
143062240|NCT04146363|515769391|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
143062241|NCT04146363|515769392|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
143062242|NCT04146363|515769393|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
143062243|NCT04146363|515769394|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
143062244|NCT04146363|515769395|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
143062245|NCT04146363|515769396|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
143062246|NCT04146363|515769386|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
143062247|NCT04146363|515769387|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
143062248|NCT04146363|515769388|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
143062249|NCT04146363|515769389|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
143062250|NCT04146363|515769390|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
143062251|NCT04146363|515769391|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
143062252|NCT04146363|515769392|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
143062253|NCT04146363|515769393|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
143062254|NCT04146363|515769394|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
143062255|NCT04146363|515769395|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
143062256|NCT04146363|515769396|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
143062257|NCT04146363|515769386|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
143062258|NCT04146363|515769387|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
143062259|NCT04146363|515769388|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
143062260|NCT04146363|515769389|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
143062261|NCT04146363|515769390|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
143062262|NCT04146363|515769391|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
143062263|NCT04146363|515769392|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
143062264|NCT04146363|515769393|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
143062265|NCT04146363|515769394|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
143062266|NCT04146363|515769395|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
143062267|NCT04146363|515769396|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
143062268|NCT04146363|515769386|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
143062269|NCT04146363|515769387|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
143062270|NCT04146363|515769388|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
143062271|NCT04146363|515769389|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
143062272|NCT04146363|515769390|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
143062273|NCT04146363|515769391|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
143062274|NCT04146363|515769392|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
143062275|NCT04146363|515769393|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
143062276|NCT04146363|515769394|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
143062277|NCT04146363|515769395|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
143062278|NCT04146363|515769396|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
143062279|NCT04146363|515769386|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
143062280|NCT04146363|515769387|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
143062281|NCT04146363|515769388|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
143062282|NCT04146363|515769389|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
143062283|NCT04146363|515769390|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
143062284|NCT04146363|515769391|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
143062285|NCT04146363|515769392|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
143062286|NCT04146363|515769393|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
143062287|NCT04146363|515769394|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
143062288|NCT04146363|515769395|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
143062289|NCT04146363|515769396|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
143062290|NCT04146363|515769386|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
143062291|NCT04146363|515769387|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
143062292|NCT04146363|515769388|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
143062293|NCT04146363|515769389|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
143062294|NCT04146363|515769390|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
143062295|NCT04146363|515769391|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
143062296|NCT04146363|515769392|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
143062297|NCT04146363|515769393|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
143062298|NCT04146363|515769394|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
143062299|NCT04146363|515769395|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
143062300|NCT04146363|515769396|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
143170178|NCT04392154|516171885|FG002|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
143170179|NCT04392154|516171886|FG003|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
143170180|NCT04392154|516171883|FG000|Primary Treatment Period (100 Weeks)|Lack of Efficacy|1|||
143170181|NCT04392154|516171884|FG001|Primary Treatment Period (100 Weeks)|Lack of Efficacy|47|||
143062301|NCT04146363|515769386|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
143062302|NCT04146363|515769387|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
143062303|NCT04146363|515769388|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
143062304|NCT04146363|515769389|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
143062305|NCT04146363|515769390|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
143062306|NCT04146363|515769391|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
143062307|NCT04146363|515769392|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
143062308|NCT04146363|515769393|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
143062309|NCT04146363|515769394|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
143062310|NCT04146363|515769395|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
143062311|NCT04146363|515769396|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
143062312|NCT04146363|515769386|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
143062313|NCT04146363|515769387|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
143062314|NCT04146363|515769388|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
143062315|NCT04146363|515769389|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
143062316|NCT04146363|515769390|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
143062317|NCT04146363|515769391|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
143062318|NCT04146363|515769392|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
143062319|NCT04146363|515769393|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
143062320|NCT04146363|515769394|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
143062321|NCT04146363|515769395|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
143062322|NCT04146363|515769396|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
143062323|NCT04146363|515769386|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
143062324|NCT04146363|515769387|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
143062325|NCT04146363|515769388|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
143062326|NCT04146363|515769389|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
143062327|NCT04146363|515769390|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
143062328|NCT04146363|515769391|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
143062329|NCT04146363|515769392|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
143062330|NCT04146363|515769393|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
143062331|NCT04146363|515769394|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
143062332|NCT04146363|515769395|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
143062333|NCT04146363|515769396|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
143062334|NCT00856830|515769397|FG000|Irinotecan & Bendamustine|Death|0|||
143062335|NCT00856830|515769398|FG001|Irinotecan & Bendamustine|Death|0|||
143062336|NCT00856830|515769399|FG002|Irinotecan & Bendamustine|Death|0|||
143062337|NCT00856830|515769400|FG003|Irinotecan & Bendamustine|Death|2|||
143062338|NCT00856830|515769397|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
143062339|NCT00856830|515769398|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
143062340|NCT00856830|515769399|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
143062341|NCT00856830|515769400|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
143062342|NCT03768726|515769401|FG000|Treatment Phase|Adverse Event|2|||
143062343|NCT03768726|515769402|FG001|Treatment Phase|Adverse Event|2|||
143062344|NCT03768726|515769401|FG000|Treatment Phase|Lost to Follow-up|1|||
143062345|NCT03768726|515769402|FG001|Treatment Phase|Lost to Follow-up|0|||
143062346|NCT03768726|515769401|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
143062347|NCT03768726|515769402|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
143062348|NCT03768726|515769401|FG000|Treatment Phase|Withdrawal by Subject|3|||
143062349|NCT03768726|515769402|FG001|Treatment Phase|Withdrawal by Subject|1|||
143062350|NCT03768726|515769401|FG000|Follow-Up|Adverse Event|2|||
143062351|NCT03768726|515769402|FG001|Follow-Up|Adverse Event|2|||
143062352|NCT03768726|515769401|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
143062353|NCT03768726|515769402|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
143062354|NCT03768726|515769401|FG000|Follow-Up|Withdrawal by Subject|2|||
143062355|NCT03768726|515769402|FG001|Follow-Up|Withdrawal by Subject|0|||
143062356|NCT03768726|515769401|FG000|Follow-Up|Other|1|||
143062357|NCT03768726|515769402|FG001|Follow-Up|Other|0|||
143062358|NCT01286558|515769403|FG000|Overall Study|Adverse Event|1|||
143062359|NCT01286558|515769404|FG001|Overall Study|Adverse Event|1|||
143062360|NCT01286558|515769403|FG000|Overall Study|Withdrawal by Subject|0|||
143062361|NCT01286558|515769404|FG001|Overall Study|Withdrawal by Subject|1|||
143062362|NCT01787279|515769406|FG000|Overall Study|Lost to Follow-up|2|||
143062363|NCT01787279|515769406|FG000|Overall Study|Lack of Efficacy|1|||
143062364|NCT04109313|515769407|FG000|Overall Study|Pregnancy|1|||
143062365|NCT04109313|515769407|FG000|Overall Study|Adverse Event|11|||
143062366|NCT04109313|515769407|FG000|Overall Study|Lack of Efficacy|11|||
143246044|NCT04421027|516451885|FG001|Treatment Period|Adverse Event|3|||
143246045|NCT04421027|516451886|FG002|Treatment Period|Adverse Event|0|||
143246046|NCT04421027|516451887|FG003|Treatment Period|Adverse Event|0|||
143062367|NCT04109313|515769407|FG000|Overall Study|Lost to Follow-up|1|||
143062368|NCT04109313|515769407|FG000|Overall Study|Physician Decision|2|||
143062369|NCT04109313|515769407|FG000|Overall Study|Subject Decision|13|||
143062370|NCT04109313|515769407|FG000|Overall Study|Covid-19 situation|2|||
143062371|NCT01272921|515769408|FG000|Overall Study|Protocol Violation|2|||
143062372|NCT01272921|515769409|FG001|Overall Study|Protocol Violation|1|||
143062373|NCT01132664|515769410|FG000|Phase lb|Adverse Event|0|||
143062374|NCT01132664|515769411|FG001|Phase lb|Adverse Event|1|||
143062375|NCT01132664|515769412|FG002|Phase lb|Adverse Event|0|||
143062376|NCT01132664|515769413|FG003|Phase lb|Adverse Event|0|||
143062377|NCT01132664|515769414|FG004|Phase lb|Adverse Event|0|||
143062378|NCT01132664|515769410|FG000|Phase lb|Withdrawal by Subject|1|||
143062379|NCT01132664|515769411|FG001|Phase lb|Withdrawal by Subject|2|||
143062380|NCT01132664|515769412|FG002|Phase lb|Withdrawal by Subject|0|||
143062381|NCT01132664|515769413|FG003|Phase lb|Withdrawal by Subject|0|||
143062382|NCT01132664|515769414|FG004|Phase lb|Withdrawal by Subject|0|||
143062383|NCT01132664|515769410|FG000|Phase lb|Disease Progression|4|||
143062384|NCT01132664|515769411|FG001|Phase lb|Disease Progression|9|||
143062385|NCT01132664|515769412|FG002|Phase lb|Disease Progression|0|||
143062386|NCT01132664|515769413|FG003|Phase lb|Disease Progression|0|||
143062387|NCT01132664|515769414|FG004|Phase lb|Disease Progression|0|||
143062388|NCT01132664|515769410|FG000|Phase ll|Death|0|||
143062389|NCT01132664|515769411|FG001|Phase ll|Death|0|||
143062390|NCT01132664|515769412|FG002|Phase ll|Death|2|||
143062391|NCT01132664|515769413|FG003|Phase ll|Death|0|||
143062392|NCT01132664|515769414|FG004|Phase ll|Death|0|||
143062393|NCT01132664|515769410|FG000|Phase ll|Adverse Event|0|||
143062394|NCT01132664|515769411|FG001|Phase ll|Adverse Event|0|||
143062395|NCT01132664|515769412|FG002|Phase ll|Adverse Event|10|||
143062396|NCT01132664|515769413|FG003|Phase ll|Adverse Event|0|||
143062397|NCT01132664|515769414|FG004|Phase ll|Adverse Event|0|||
143062398|NCT01132664|515769410|FG000|Phase ll|Withdrawal by Subject|0|||
143062399|NCT01132664|515769411|FG001|Phase ll|Withdrawal by Subject|0|||
143062400|NCT01132664|515769412|FG002|Phase ll|Withdrawal by Subject|3|||
143062401|NCT01132664|515769413|FG003|Phase ll|Withdrawal by Subject|0|||
143062402|NCT01132664|515769414|FG004|Phase ll|Withdrawal by Subject|0|||
143062403|NCT01132664|515769410|FG000|Phase ll|Disease progression|0|||
143062404|NCT01132664|515769411|FG001|Phase ll|Disease progression|0|||
143062405|NCT01132664|515769412|FG002|Phase ll|Disease progression|35|||
143062406|NCT01132664|515769413|FG003|Phase ll|Disease progression|0|||
143062407|NCT01132664|515769414|FG004|Phase ll|Disease progression|0|||
143062408|NCT01132664|515769410|FG000|BM Cohort|Disease progression|0|||
143062409|NCT01132664|515769411|FG001|BM Cohort|Disease progression|0|||
143062410|NCT01132664|515769412|FG002|BM Cohort|Disease progression|0|||
143062411|NCT01132664|515769413|FG003|BM Cohort|Disease progression|3|||
143062412|NCT01132664|515769414|FG004|BM Cohort|Disease progression|4|||
143062413|NCT01132664|515769410|FG000|BM Cohort|Adverse Event|0|||
143062414|NCT01132664|515769411|FG001|BM Cohort|Adverse Event|0|||
143062415|NCT01132664|515769412|FG002|BM Cohort|Adverse Event|0|||
143062416|NCT01132664|515769413|FG003|BM Cohort|Adverse Event|0|||
143062417|NCT01132664|515769414|FG004|BM Cohort|Adverse Event|1|||
143062418|NCT01132664|515769410|FG000|BM Cohort|Withdrawal by Subject|0|||
143062419|NCT01132664|515769411|FG001|BM Cohort|Withdrawal by Subject|0|||
143062420|NCT01132664|515769412|FG002|BM Cohort|Withdrawal by Subject|0|||
143062421|NCT01132664|515769413|FG003|BM Cohort|Withdrawal by Subject|0|||
143062422|NCT01132664|515769414|FG004|BM Cohort|Withdrawal by Subject|1|||
143062423|NCT00140413|515769416|FG000|Overall Study|Lost to Follow-up|1|||
143062424|NCT00140413|515769417|FG001|Overall Study|Lost to Follow-up|0|||
143062425|NCT00140413|515769416|FG000|Overall Study|Withdrawal by Subject|2|||
143502423|NCT00868790|517378580|FG007|Period 1|Abnormal Triglycerides|0|||
143502424|NCT00868790|517378581|FG008|Period 1|Abnormal Triglycerides|0|||
143502425|NCT00868790|517378582|FG009|Period 1|Abnormal Triglycerides|0|||
143502426|NCT00868790|517378583|FG010|Period 1|Abnormal Triglycerides|0|||
143502427|NCT00868790|517378584|FG011|Period 1|Abnormal Triglycerides|0|||
143502428|NCT00868790|517378585|FG012|Period 1|Abnormal Triglycerides|0|||
143062426|NCT00140413|515769417|FG001|Overall Study|Withdrawal by Subject|0|||
143062427|NCT02694549|515769418|FG000|Overall Study|screen failures|2|||
143062428|NCT00099268|515769426|FG000|Overall Study|Withdrawal by Subject|46|||
143062429|NCT00099268|515769427|FG001|Overall Study|Withdrawal by Subject|28|||
143062430|NCT00099268|515769426|FG000|Overall Study|Adverse Event|19|||
143062431|NCT00099268|515769427|FG001|Overall Study|Adverse Event|19|||
143062432|NCT00099268|515769426|FG000|Overall Study|Protocol Violation|9|||
143062433|NCT00099268|515769427|FG001|Overall Study|Protocol Violation|8|||
143062434|NCT00099268|515769426|FG000|Overall Study|Lost to Follow-up|6|||
143062435|NCT00099268|515769427|FG001|Overall Study|Lost to Follow-up|4|||
143502429|NCT00868790|517378586|FG013|Period 1|Abnormal Triglycerides|0|||
143062436|NCT00099268|515769426|FG000|Overall Study|Lack of Efficacy|5|||
143062437|NCT00099268|515769427|FG001|Overall Study|Lack of Efficacy|18|||
143062438|NCT00099268|515769426|FG000|Overall Study|Administrative problems|4|||
143062439|NCT00099268|515769427|FG001|Overall Study|Administrative problems|4|||
143062440|NCT00099268|515769426|FG000|Overall Study|Death|3|||
143062441|NCT00099268|515769427|FG001|Overall Study|Death|1|||
143062442|NCT02954159|515769430|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
143062443|NCT02954159|515769431|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
143062444|NCT02954159|515769430|FG000|Overall Study|Withdrawal by Subject|0|||
143502430|NCT00868790|517378573|FG000|Period 1|Lost to Follow-up|0|||
143062445|NCT02954159|515769431|FG001|Overall Study|Withdrawal by Subject|1|||
143062446|NCT01570283|515769434|FG000|Cohort 1: Dose Level 1|Death|0|||
143062447|NCT01570283|515769435|FG001|Cohort 1: Dose Level 1|Death|1|||
143062448|NCT01570283|515769436|FG002|Cohort 1: Dose Level 1|Death|0|||
143062449|NCT01570283|515769437|FG003|Cohort 1: Dose Level 1|Death|0|||
143062450|NCT01570283|515769438|FG004|Cohort 1: Dose Level 1|Death|0|||
143062451|NCT01570283|515769439|FG005|Cohort 1: Dose Level 1|Death|0|||
143062452|NCT01570283|515769434|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
143062453|NCT01570283|515769435|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
143062454|NCT01570283|515769436|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
143062455|NCT01570283|515769437|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
143062456|NCT01570283|515769438|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
143062457|NCT01570283|515769439|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
143062458|NCT01570283|515769434|FG000|Cohort 2: Dose Level 2|Death|0|||
143062459|NCT01570283|515769435|FG001|Cohort 2: Dose Level 2|Death|0|||
143062460|NCT01570283|515769436|FG002|Cohort 2: Dose Level 2|Death|1|||
143062461|NCT01570283|515769437|FG003|Cohort 2: Dose Level 2|Death|0|||
143062462|NCT01570283|515769438|FG004|Cohort 2: Dose Level 2|Death|0|||
143062463|NCT01570283|515769439|FG005|Cohort 2: Dose Level 2|Death|0|||
143062464|NCT01570283|515769434|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
143062465|NCT01570283|515769435|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
143062466|NCT01570283|515769436|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
143062467|NCT01570283|515769437|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
143062468|NCT01570283|515769438|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
143062469|NCT01570283|515769439|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
143062470|NCT01570283|515769434|FG000|Cohort 3: Dose Level 3|Death|0|||
143062471|NCT01570283|515769435|FG001|Cohort 3: Dose Level 3|Death|0|||
143062472|NCT01570283|515769436|FG002|Cohort 3: Dose Level 3|Death|0|||
143062473|NCT01570283|515769437|FG003|Cohort 3: Dose Level 3|Death|0|||
143062474|NCT01570283|515769438|FG004|Cohort 3: Dose Level 3|Death|0|||
143062475|NCT01570283|515769439|FG005|Cohort 3: Dose Level 3|Death|1|||
143062476|NCT01570283|515769434|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
143062477|NCT01570283|515769435|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
143062478|NCT01570283|515769436|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
143062479|NCT01570283|515769437|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
143062480|NCT01570283|515769438|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
143062481|NCT01570283|515769439|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
143062482|NCT00262041|515769442|FG000|Overall Study|Withdrawal by Subject|0|||
143062483|NCT00262041|515769443|FG001|Overall Study|Withdrawal by Subject|3|||
143062484|NCT00262041|515769444|FG002|Overall Study|Withdrawal by Subject|1|||
143062485|NCT00262041|515769442|FG000|Overall Study|Lost to Follow-up|1|||
143062486|NCT00262041|515769443|FG001|Overall Study|Lost to Follow-up|1|||
143062487|NCT00262041|515769444|FG002|Overall Study|Lost to Follow-up|5|||
143062488|NCT00262041|515769442|FG000|Overall Study|Unable to classify|1|||
143062489|NCT00262041|515769443|FG001|Overall Study|Unable to classify|0|||
143062490|NCT00262041|515769444|FG002|Overall Study|Unable to classify|0|||
143062491|NCT02017860|515769445|FG000|Overall Study|Adverse Event|1|||
143062492|NCT02017860|515769445|FG000|Overall Study|Withdrawal by Subject|1|||
143062493|NCT00584844|515769446|FG000|Overall Study|Withdrawal by Subject|59|||
143062494|NCT00584844|515769446|FG000|Overall Study|Screen Failure|20|||
143062495|NCT02488330|515769447|FG000|Overall Study|Adverse Event|1|||
143062496|NCT02488330|515769447|FG000|Overall Study|Physician Decision|2|||
143062497|NCT02488330|515769447|FG000|Overall Study|Death|2|||
143062498|NCT02488330|515769447|FG000|Overall Study|Disease Progression|3|||
143062499|NCT02488330|515769447|FG000|Overall Study|Study Termination by Sponsor|4|||
143062500|NCT02010255|515769460|FG000|Overall Study|Death|0|||
143170182|NCT04392154|516171885|FG002|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
143170183|NCT04392154|516171886|FG003|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
143170184|NCT04392154|516171883|FG000|Primary Treatment Period (100 Weeks)|Lost to Follow-up|11|||
143170185|NCT04392154|516171884|FG001|Primary Treatment Period (100 Weeks)|Lost to Follow-up|61|||
143170186|NCT04392154|516171885|FG002|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
143170187|NCT04392154|516171886|FG003|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
143365137|NCT00725010|516878810|FG000|Overall Study|Withdrawal by Subject|2|||
143062501|NCT02010255|515769461|FG001|Overall Study|Death|1|||
143062502|NCT02010255|515769462|FG002|Overall Study|Death|4|||
143062503|NCT02010255|515769463|FG003|Overall Study|Death|4|||
143365138|NCT00725010|516878810|FG000|Overall Study|Death|1|||
143062504|NCT02010255|515769464|FG004|Overall Study|Death|2|||
143062505|NCT02010255|515769465|FG005|Overall Study|Death|0|||
143062506|NCT02010255|515769466|FG006|Overall Study|Death|1|||
143062507|NCT02010255|515769467|FG007|Overall Study|Death|1|||
143062508|NCT02010255|515769468|FG008|Overall Study|Death|1|||
143365139|NCT00725010|516878810|FG000|Overall Study|Lost to Follow-up|1|||
143502431|NCT00868790|517378574|FG001|Period 1|Lost to Follow-up|0|||
143062509|NCT02010255|515769469|FG009|Overall Study|Death|0|||
143062510|NCT02010255|515769470|FG010|Overall Study|Death|1|||
143062511|NCT02010255|515769471|FG011|Overall Study|Death|1|||
143062512|NCT02010255|515769472|FG012|Overall Study|Death|0|||
143062513|NCT02010255|515769473|FG013|Overall Study|Death|0|||
143062514|NCT02010255|515769460|FG000|Overall Study|Lack of Efficacy|4|||
143062515|NCT02010255|515769461|FG001|Overall Study|Lack of Efficacy|1|||
143062516|NCT02010255|515769462|FG002|Overall Study|Lack of Efficacy|2|||
143502432|NCT00868790|517378575|FG002|Period 1|Lost to Follow-up|0|||
143502433|NCT00868790|517378576|FG003|Period 1|Lost to Follow-up|0|||
143062517|NCT02010255|515769463|FG003|Overall Study|Lack of Efficacy|1|||
143062518|NCT02010255|515769464|FG004|Overall Study|Lack of Efficacy|1|||
143062519|NCT02010255|515769465|FG005|Overall Study|Lack of Efficacy|0|||
143062520|NCT02010255|515769466|FG006|Overall Study|Lack of Efficacy|0|||
143062521|NCT02010255|515769467|FG007|Overall Study|Lack of Efficacy|0|||
143062522|NCT02010255|515769468|FG008|Overall Study|Lack of Efficacy|0|||
143062523|NCT02010255|515769469|FG009|Overall Study|Lack of Efficacy|0|||
143062524|NCT02010255|515769470|FG010|Overall Study|Lack of Efficacy|1|||
143502434|NCT00868790|517378577|FG004|Period 1|Lost to Follow-up|0|||
143502435|NCT00868790|517378578|FG005|Period 1|Lost to Follow-up|1|||
143502436|NCT00868790|517378579|FG006|Period 1|Lost to Follow-up|0|||
143502437|NCT00868790|517378580|FG007|Period 1|Lost to Follow-up|0|||
143062525|NCT02010255|515769471|FG011|Overall Study|Lack of Efficacy|0|||
143062526|NCT02010255|515769472|FG012|Overall Study|Lack of Efficacy|0|||
143062527|NCT02010255|515769473|FG013|Overall Study|Lack of Efficacy|0|||
143062528|NCT02010255|515769460|FG000|Overall Study|Withdrew Consent|1|||
143062529|NCT02010255|515769461|FG001|Overall Study|Withdrew Consent|0|||
143062530|NCT02010255|515769462|FG002|Overall Study|Withdrew Consent|0|||
143062531|NCT02010255|515769463|FG003|Overall Study|Withdrew Consent|1|||
143062532|NCT02010255|515769464|FG004|Overall Study|Withdrew Consent|0|||
143062533|NCT02010255|515769465|FG005|Overall Study|Withdrew Consent|0|||
143062534|NCT02010255|515769466|FG006|Overall Study|Withdrew Consent|0|||
143062535|NCT02010255|515769467|FG007|Overall Study|Withdrew Consent|0|||
143062536|NCT02010255|515769468|FG008|Overall Study|Withdrew Consent|0|||
143062537|NCT02010255|515769469|FG009|Overall Study|Withdrew Consent|0|||
143062538|NCT02010255|515769470|FG010|Overall Study|Withdrew Consent|0|||
143062539|NCT02010255|515769471|FG011|Overall Study|Withdrew Consent|0|||
143062540|NCT02010255|515769472|FG012|Overall Study|Withdrew Consent|0|||
143062541|NCT02010255|515769473|FG013|Overall Study|Withdrew Consent|0|||
143062542|NCT02010255|515769460|FG000|Overall Study|Adverse Event|1|||
143062543|NCT02010255|515769461|FG001|Overall Study|Adverse Event|0|||
143062544|NCT02010255|515769462|FG002|Overall Study|Adverse Event|0|||
143062545|NCT02010255|515769463|FG003|Overall Study|Adverse Event|0|||
143062546|NCT02010255|515769464|FG004|Overall Study|Adverse Event|0|||
143062547|NCT02010255|515769465|FG005|Overall Study|Adverse Event|0|||
143062548|NCT02010255|515769466|FG006|Overall Study|Adverse Event|0|||
143062549|NCT02010255|515769467|FG007|Overall Study|Adverse Event|0|||
143062550|NCT02010255|515769468|FG008|Overall Study|Adverse Event|0|||
143062551|NCT02010255|515769469|FG009|Overall Study|Adverse Event|0|||
143502438|NCT00868790|517378581|FG008|Period 1|Lost to Follow-up|0|||
143502439|NCT00868790|517378582|FG009|Period 1|Lost to Follow-up|0|||
143502440|NCT00868790|517378583|FG010|Period 1|Lost to Follow-up|0|||
143062552|NCT02010255|515769470|FG010|Overall Study|Adverse Event|0|||
143062553|NCT02010255|515769471|FG011|Overall Study|Adverse Event|0|||
143062554|NCT02010255|515769472|FG012|Overall Study|Adverse Event|0|||
143062555|NCT02010255|515769473|FG013|Overall Study|Adverse Event|0|||
143062556|NCT02010255|515769460|FG000|Overall Study|Lost to Follow-up|0|||
143062557|NCT02010255|515769461|FG001|Overall Study|Lost to Follow-up|0|||
143170188|NCT04392154|516171883|FG000|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
143502441|NCT00868790|517378584|FG011|Period 1|Lost to Follow-up|0|||
143502442|NCT00868790|517378585|FG012|Period 1|Lost to Follow-up|0|||
143502443|NCT00868790|517378586|FG013|Period 1|Lost to Follow-up|0|||
143502444|NCT00868790|517378573|FG000|Period 2|Adverse Event|0|||
143062558|NCT02010255|515769462|FG002|Overall Study|Lost to Follow-up|1|||
143062559|NCT02010255|515769463|FG003|Overall Study|Lost to Follow-up|0|||
143062560|NCT02010255|515769464|FG004|Overall Study|Lost to Follow-up|1|||
143062561|NCT02010255|515769465|FG005|Overall Study|Lost to Follow-up|0|||
143062562|NCT02010255|515769466|FG006|Overall Study|Lost to Follow-up|0|||
143170189|NCT04392154|516171884|FG001|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
143170190|NCT04392154|516171885|FG002|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
143502445|NCT00868790|517378574|FG001|Period 2|Adverse Event|0|||
143502446|NCT00868790|517378575|FG002|Period 2|Adverse Event|0|||
143502447|NCT00868790|517378576|FG003|Period 2|Adverse Event|0|||
143502448|NCT00868790|517378577|FG004|Period 2|Adverse Event|0|||
143062563|NCT02010255|515769467|FG007|Overall Study|Lost to Follow-up|0|||
143062564|NCT02010255|515769468|FG008|Overall Study|Lost to Follow-up|0|||
143062565|NCT02010255|515769469|FG009|Overall Study|Lost to Follow-up|0|||
143502449|NCT00868790|517378578|FG005|Period 2|Adverse Event|0|||
143502450|NCT00868790|517378579|FG006|Period 2|Adverse Event|0|||
143062566|NCT02010255|515769470|FG010|Overall Study|Lost to Follow-up|0|||
143062567|NCT02010255|515769471|FG011|Overall Study|Lost to Follow-up|0|||
143062568|NCT02010255|515769472|FG012|Overall Study|Lost to Follow-up|0|||
143062569|NCT02010255|515769473|FG013|Overall Study|Lost to Follow-up|0|||
143062570|NCT02010255|515769460|FG000|Overall Study|Randomized but Not Treated|0|||
143062571|NCT02010255|515769461|FG001|Overall Study|Randomized but Not Treated|0|||
143062572|NCT02010255|515769462|FG002|Overall Study|Randomized but Not Treated|0|||
143062573|NCT02010255|515769463|FG003|Overall Study|Randomized but Not Treated|0|||
143062574|NCT02010255|515769464|FG004|Overall Study|Randomized but Not Treated|0|||
143062575|NCT02010255|515769465|FG005|Overall Study|Randomized but Not Treated|0|||
143062576|NCT02010255|515769466|FG006|Overall Study|Randomized but Not Treated|0|||
143062577|NCT02010255|515769467|FG007|Overall Study|Randomized but Not Treated|0|||
143062578|NCT02010255|515769468|FG008|Overall Study|Randomized but Not Treated|0|||
143062579|NCT02010255|515769469|FG009|Overall Study|Randomized but Not Treated|0|||
143062580|NCT02010255|515769470|FG010|Overall Study|Randomized but Not Treated|0|||
143062581|NCT02010255|515769471|FG011|Overall Study|Randomized but Not Treated|0|||
143062582|NCT02010255|515769472|FG012|Overall Study|Randomized but Not Treated|0|||
143062583|NCT02010255|515769473|FG013|Overall Study|Randomized but Not Treated|1|||
143062584|NCT01341587|515769474|FG000|Overall Study|Lost to Follow-up|2|||
143062585|NCT01341587|515769475|FG001|Overall Study|Lost to Follow-up|0|||
143062586|NCT01341587|515769474|FG000|Overall Study|stopped using the meters|2|||
143062587|NCT01341587|515769475|FG001|Overall Study|stopped using the meters|10|||
143062588|NCT00351351|515769476|FG000|Overall Study|surgical access pbs; device issues|9|||
143062589|NCT00351351|515769477|FG001|Overall Study|surgical access pbs; device issues|4|||
143062590|NCT03176784|515769478|FG000|Overall Study|Lost to Follow-up|77|||
143062591|NCT03176784|515769479|FG001|Overall Study|Lost to Follow-up|79|||
143062592|NCT03176784|515769480|FG002|Overall Study|Lost to Follow-up|79|||
143062593|NCT03176784|515769481|FG003|Overall Study|Lost to Follow-up|49|||
143062594|NCT03176784|515769478|FG000|Overall Study|Withdrawal by Subject|28|||
143062595|NCT03176784|515769479|FG001|Overall Study|Withdrawal by Subject|34|||
143062596|NCT03176784|515769480|FG002|Overall Study|Withdrawal by Subject|34|||
143062597|NCT03176784|515769481|FG003|Overall Study|Withdrawal by Subject|21|||
143062598|NCT00904748|515769482|FG000|Overall Study|Withdrawal by Subject|1|||
143062599|NCT00904748|515769483|FG001|Overall Study|Withdrawal by Subject|1|||
143062600|NCT00904748|515769484|FG002|Overall Study|Withdrawal by Subject|1|||
143062601|NCT00904748|515769485|FG003|Overall Study|Withdrawal by Subject|2|||
143062602|NCT00904748|515769486|FG004|Overall Study|Withdrawal by Subject|0|||
143062603|NCT00904748|515769487|FG005|Overall Study|Withdrawal by Subject|0|||
143062604|NCT00904748|515769482|FG000|Overall Study|Adverse Event|0|||
143062605|NCT00904748|515769483|FG001|Overall Study|Adverse Event|0|||
143062606|NCT00904748|515769484|FG002|Overall Study|Adverse Event|0|||
143062607|NCT00904748|515769485|FG003|Overall Study|Adverse Event|0|||
143062608|NCT00904748|515769486|FG004|Overall Study|Adverse Event|1|||
143062609|NCT00904748|515769487|FG005|Overall Study|Adverse Event|0|||
143062610|NCT04647383|515769488|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
143062611|NCT04647383|515769489|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
143062612|NCT04647383|515769490|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
143062613|NCT04647383|515769491|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
143062614|NCT02087176|515769492|FG000|Overall Study|Withdrawal by Subject|1|||
143062615|NCT02087176|515769492|FG000|Overall Study|Death|10|||
143062616|NCT02087176|515769492|FG000|Overall Study|Censored|19|||
143062617|NCT02087176|515769492|FG000|Overall Study|Study Terminated by Sponsor|2|||
143062618|NCT00873119|515769499|FG000|Overall Study|Patient request|4|||
143062619|NCT00873119|515769500|FG001|Overall Study|Patient request|2|||
143062620|NCT00873119|515769499|FG000|Overall Study|Adverse Event|8|||
143062621|NCT00873119|515769500|FG001|Overall Study|Adverse Event|0|||
143062622|NCT00873119|515769499|FG000|Overall Study|Progressive disease|26|||
143062623|NCT00873119|515769500|FG001|Overall Study|Progressive disease|18|||
143062624|NCT00873119|515769499|FG000|Overall Study|Death|2|||
143502451|NCT00868790|517378580|FG007|Period 2|Adverse Event|0|||
143502452|NCT00868790|517378581|FG008|Period 2|Adverse Event|1|||
143502453|NCT00868790|517378582|FG009|Period 2|Adverse Event|0|||
143502454|NCT00868790|517378583|FG010|Period 2|Adverse Event|0|||
143502455|NCT00868790|517378584|FG011|Period 2|Adverse Event|0|||
143502456|NCT00868790|517378585|FG012|Period 2|Adverse Event|0|||
143502457|NCT00868790|517378586|FG013|Period 2|Adverse Event|0|||
143062625|NCT00873119|515769500|FG001|Overall Study|Death|1|||
143062626|NCT00873119|515769499|FG000|Overall Study|Other|2|||
143062627|NCT00873119|515769500|FG001|Overall Study|Other|5|||
143062628|NCT00873119|515769499|FG000|Overall Study|Not treated|2|||
143062629|NCT00873119|515769500|FG001|Overall Study|Not treated|0|||
143502458|NCT00868790|517378573|FG000|Period 2|Lost to Follow-up|0|||
143502459|NCT00868790|517378574|FG001|Period 2|Lost to Follow-up|1|||
143062630|NCT03812991|515769501|FG000|Overall Study|Lost to Follow-up|3|||
143062631|NCT03812991|515769502|FG001|Overall Study|Lost to Follow-up|1|||
143062632|NCT00466726|515769503|FG000|Overall Study|Not evaluable for response|14|||
143062633|NCT04740931|515769504|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
143062634|NCT04740931|515769505|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
143062635|NCT04740931|515769504|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
143062636|NCT04740931|515769505|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
143062637|NCT04740931|515769504|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
143502460|NCT00868790|517378575|FG002|Period 2|Lost to Follow-up|0|||
143062638|NCT04740931|515769505|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
143062639|NCT04740931|515769504|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
143062640|NCT04740931|515769505|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
143062641|NCT04740931|515769504|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
143062642|NCT04740931|515769505|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
143062643|NCT04740931|515769504|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
143062644|NCT04740931|515769505|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
143062645|NCT04740931|515769504|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
143062646|NCT04740931|515769505|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
143062647|NCT04740931|515769504|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
143062648|NCT04740931|515769505|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
143062649|NCT04740931|515769504|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
143062650|NCT04740931|515769505|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
143062651|NCT04740931|515769504|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
143062652|NCT04740931|515769505|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
143062653|NCT04740931|515769504|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
143062654|NCT04740931|515769505|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
143062655|NCT04740931|515769504|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
143062656|NCT04740931|515769505|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
143062657|NCT04740931|515769504|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
143062658|NCT04740931|515769505|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
143062659|NCT04740931|515769504|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
143062660|NCT04740931|515769505|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
143062661|NCT04740931|515769504|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
143062662|NCT04740931|515769505|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
143062663|NCT04403763|515769506|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
143062664|NCT04403763|515769507|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
143062665|NCT04403763|515769508|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
143062666|NCT04403763|515769509|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
143062667|NCT04403763|515769510|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
143062668|NCT04403763|515769511|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
143062669|NCT04403763|515769512|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
143062670|NCT04403763|515769506|FG000|Stage 1|Early termination due to PK tube failure|0|||
143062671|NCT04403763|515769507|FG001|Stage 1|Early termination due to PK tube failure|0|||
143062672|NCT04403763|515769508|FG002|Stage 1|Early termination due to PK tube failure|1|||
143062673|NCT04403763|515769509|FG003|Stage 1|Early termination due to PK tube failure|0|||
143062674|NCT04403763|515769510|FG004|Stage 1|Early termination due to PK tube failure|0|||
143062675|NCT04403763|515769511|FG005|Stage 1|Early termination due to PK tube failure|0|||
143062676|NCT04403763|515769512|FG006|Stage 1|Early termination due to PK tube failure|0|||
143062677|NCT04403763|515769506|FG000|Stage 2A|Adverse Event|0|||
143062678|NCT04403763|515769507|FG001|Stage 2A|Adverse Event|0|||
143062679|NCT04403763|515769508|FG002|Stage 2A|Adverse Event|0|||
143062680|NCT04403763|515769509|FG003|Stage 2A|Adverse Event|0|||
143062681|NCT04403763|515769510|FG004|Stage 2A|Adverse Event|0|||
143062682|NCT04403763|515769511|FG005|Stage 2A|Adverse Event|0|||
143062683|NCT04403763|515769512|FG006|Stage 2A|Adverse Event|1|||
143062684|NCT00350402|515769513|FG000|Overall Study|Lost to Follow-up|1|||
143062685|NCT00350402|515769514|FG001|Overall Study|Lost to Follow-up|1|||
143062686|NCT01376310|515769515|FG000|Overall Study|Study closed/terminated|1|||
143062687|NCT01376310|515769516|FG001|Overall Study|Study closed/terminated|2|||
143062688|NCT01376310|515769515|FG000|Overall Study|Withdrawal by Subject|8|||
143062689|NCT01376310|515769516|FG001|Overall Study|Withdrawal by Subject|2|||
143062690|NCT01376310|515769515|FG000|Overall Study|Physician Decision|26|||
143062691|NCT01376310|515769516|FG001|Overall Study|Physician Decision|7|||
143062692|NCT01376310|515769515|FG000|Overall Study|Lost to Follow-up|1|||
143062693|NCT01376310|515769516|FG001|Overall Study|Lost to Follow-up|0|||
143062694|NCT01884688|515769519|FG000|Overall Study|Screen Failure|2|||
143062695|NCT02510014|515769523|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
143062696|NCT02510014|515769524|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
143062697|NCT02510014|515769523|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
143062698|NCT02510014|515769524|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
143062699|NCT02510014|515769523|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
143062700|NCT02510014|515769524|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
143062701|NCT02510014|515769523|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
143246047|NCT04421027|516451884|FG000|Treatment Period|Death|98|||
143062702|NCT02510014|515769524|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
143062703|NCT02510014|515769523|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
143062704|NCT02510014|515769524|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
143062705|NCT02510014|515769523|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
143062706|NCT02510014|515769524|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
143246048|NCT04421027|516451885|FG001|Treatment Period|Death|61|||
143246049|NCT04421027|516451886|FG002|Treatment Period|Death|0|||
143062707|NCT02510014|515769523|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
143062708|NCT02510014|515769524|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
143062709|NCT02510014|515769523|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
143062710|NCT02510014|515769524|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
143062711|NCT02510014|515769523|FG000|Treatment Period|Adverse Event|11|||
143062712|NCT02510014|515769524|FG001|Treatment Period|Adverse Event|4|||
143062713|NCT02510014|515769523|FG000|Treatment Period|Withdrawal symptoms|3|||
143062714|NCT02510014|515769524|FG001|Treatment Period|Withdrawal symptoms|0|||
143062715|NCT02510014|515769523|FG000|Treatment Period|Lost to Follow-up|80|||
143062716|NCT02510014|515769524|FG001|Treatment Period|Lost to Follow-up|19|||
143062717|NCT02510014|515769523|FG000|Treatment Period|Physician Decision|5|||
143062718|NCT02510014|515769524|FG001|Treatment Period|Physician Decision|0|||
143062719|NCT02510014|515769523|FG000|Treatment Period|Withdrawal by Subject|67|||
143062720|NCT02510014|515769524|FG001|Treatment Period|Withdrawal by Subject|24|||
143062721|NCT02510014|515769523|FG000|Treatment Period|Withdrawn by the investigator|7|||
143062722|NCT02510014|515769524|FG001|Treatment Period|Withdrawn by the investigator|1|||
143062723|NCT02510014|515769523|FG000|Treatment Period|Protocol Violation|4|||
143062724|NCT02510014|515769524|FG001|Treatment Period|Protocol Violation|4|||
143062725|NCT02510014|515769523|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
143062726|NCT02510014|515769524|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
143062727|NCT02083926|515769527|FG000|Overall Study|Withdrawal by Subject|1|||
143062728|NCT02083926|515769528|FG001|Overall Study|Withdrawal by Subject|0|||
143062729|NCT02610816|515769529|FG000|Phase 1|Withdrawal by Subject|2|||
143062730|NCT02610816|515769530|FG001|Phase 1|Withdrawal by Subject|6|||
143062731|NCT02610816|515769531|FG002|Phase 1|Withdrawal by Subject|0|||
143062732|NCT02610816|515769532|FG003|Phase 1|Withdrawal by Subject|0|||
143062733|NCT02610816|515769529|FG000|Phase 1|Lost to Follow-up|2|||
143062734|NCT02610816|515769530|FG001|Phase 1|Lost to Follow-up|1|||
143062735|NCT02610816|515769531|FG002|Phase 1|Lost to Follow-up|0|||
143062736|NCT02610816|515769532|FG003|Phase 1|Lost to Follow-up|0|||
143062737|NCT02610816|515769529|FG000|Phase 1|Physician Decision|0|||
143062738|NCT02610816|515769530|FG001|Phase 1|Physician Decision|1|||
143062739|NCT02610816|515769531|FG002|Phase 1|Physician Decision|0|||
143062740|NCT02610816|515769532|FG003|Phase 1|Physician Decision|0|||
143062741|NCT02610816|515769529|FG000|Phase 2|Withdrawal by Subject|0|||
143062742|NCT02610816|515769530|FG001|Phase 2|Withdrawal by Subject|0|||
143062743|NCT02610816|515769531|FG002|Phase 2|Withdrawal by Subject|9|||
143062744|NCT02610816|515769532|FG003|Phase 2|Withdrawal by Subject|3|||
143062745|NCT02610816|515769529|FG000|Phase 2|Lost to Follow-up|0|||
143062746|NCT02610816|515769530|FG001|Phase 2|Lost to Follow-up|0|||
143062747|NCT02610816|515769531|FG002|Phase 2|Lost to Follow-up|2|||
143062748|NCT02610816|515769532|FG003|Phase 2|Lost to Follow-up|0|||
143062749|NCT02610816|515769529|FG000|Phase 2|Physician Decision|0|||
143062750|NCT02610816|515769530|FG001|Phase 2|Physician Decision|0|||
143062751|NCT02610816|515769531|FG002|Phase 2|Physician Decision|0|||
143062752|NCT02610816|515769532|FG003|Phase 2|Physician Decision|2|||
143062753|NCT02610816|515769529|FG000|Phase 2|Pregnancy|0|||
143062754|NCT02610816|515769530|FG001|Phase 2|Pregnancy|0|||
143062755|NCT02610816|515769531|FG002|Phase 2|Pregnancy|0|||
143062756|NCT02610816|515769532|FG003|Phase 2|Pregnancy|1|||
143062757|NCT00384176|515769533|FG000|Overall Study|Death|239|||
143062758|NCT00384176|515769534|FG001|Overall Study|Death|247|||
143062759|NCT00384176|515769535|FG002|Overall Study|Death|105|||
143062760|NCT00384176|515769533|FG000|Overall Study|Withdrawal by Subject|52|||
143062761|NCT00384176|515769534|FG001|Overall Study|Withdrawal by Subject|48|||
143062762|NCT00384176|515769535|FG002|Overall Study|Withdrawal by Subject|22|||
143062763|NCT00384176|515769533|FG000|Overall Study|Lost to Follow-up|16|||
143062764|NCT00384176|515769534|FG001|Overall Study|Lost to Follow-up|18|||
143062765|NCT00384176|515769535|FG002|Overall Study|Lost to Follow-up|4|||
143062766|NCT00384176|515769533|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
143062767|NCT00384176|515769534|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
143062768|NCT00384176|515769535|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
143062769|NCT00384176|515769533|FG000|Overall Study|Longer QTC as Visit 1|1|||
143246050|NCT04421027|516451887|FG003|Treatment Period|Death|0|||
143062770|NCT00384176|515769534|FG001|Overall Study|Longer QTC as Visit 1|0|||
143062771|NCT00384176|515769535|FG002|Overall Study|Longer QTC as Visit 1|0|||
143062772|NCT00384176|515769533|FG000|Overall Study|Toxicity of treatment|1|||
143062773|NCT00384176|515769534|FG001|Overall Study|Toxicity of treatment|0|||
143062774|NCT00384176|515769535|FG002|Overall Study|Toxicity of treatment|0|||
143062775|NCT00384176|515769533|FG000|Overall Study|Did not receive study treatment|0|||
143062776|NCT00384176|515769534|FG001|Overall Study|Did not receive study treatment|1|||
143062777|NCT00384176|515769535|FG002|Overall Study|Did not receive study treatment|1|||
143062778|NCT00384176|515769533|FG000|Overall Study|Physician Decision|0|||
143062779|NCT00384176|515769534|FG001|Overall Study|Physician Decision|2|||
143062780|NCT00384176|515769535|FG002|Overall Study|Physician Decision|0|||
143062781|NCT00384176|515769533|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
143062782|NCT00384176|515769534|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
143062783|NCT00384176|515769535|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
143062784|NCT01425528|515769536|FG000|Overall Study|Withdrawal by Subject|1|||
143062785|NCT01425528|515769537|FG001|Overall Study|Withdrawal by Subject|1|||
143062786|NCT00854373|515769538|FG000|Overall Study|Withdrawal by Subject|1|||
143062787|NCT00854373|515769539|FG001|Overall Study|Withdrawal by Subject|3|||
143062788|NCT00854373|515769538|FG000|Overall Study|Forgot to take study drug|1|||
143062789|NCT00854373|515769539|FG001|Overall Study|Forgot to take study drug|1|||
143062790|NCT00307931|515769540|FG000|Overall Study|Adverse Event|1|||
143062791|NCT02697773|515769541|FG000|Overall Study|Adverse Event|2|||
143502461|NCT00868790|517378576|FG003|Period 2|Lost to Follow-up|0|||
143062792|NCT02697773|515769542|FG001|Overall Study|Adverse Event|1|||
143062793|NCT02697773|515769543|FG002|Overall Study|Adverse Event|2|||
143062794|NCT02697773|515769541|FG000|Overall Study|Death|0|||
143062795|NCT02697773|515769542|FG001|Overall Study|Death|0|||
143062796|NCT02697773|515769543|FG002|Overall Study|Death|2|||
143502462|NCT00868790|517378577|FG004|Period 2|Lost to Follow-up|0|||
143502463|NCT00868790|517378578|FG005|Period 2|Lost to Follow-up|1|||
143502464|NCT00868790|517378579|FG006|Period 2|Lost to Follow-up|0|||
143502465|NCT00868790|517378580|FG007|Period 2|Lost to Follow-up|0|||
143502466|NCT00868790|517378581|FG008|Period 2|Lost to Follow-up|0|||
143502467|NCT00868790|517378582|FG009|Period 2|Lost to Follow-up|0|||
143502468|NCT00868790|517378583|FG010|Period 2|Lost to Follow-up|0|||
143502469|NCT00868790|517378584|FG011|Period 2|Lost to Follow-up|0|||
143502470|NCT00868790|517378585|FG012|Period 2|Lost to Follow-up|0|||
143502471|NCT00868790|517378586|FG013|Period 2|Lost to Follow-up|0|||
143502472|NCT00868790|517378573|FG000|Period 2|Withdrawal by Subject|0|||
143502473|NCT00868790|517378574|FG001|Period 2|Withdrawal by Subject|0|||
143502474|NCT00868790|517378575|FG002|Period 2|Withdrawal by Subject|0|||
143502475|NCT00868790|517378576|FG003|Period 2|Withdrawal by Subject|0|||
143502476|NCT00868790|517378577|FG004|Period 2|Withdrawal by Subject|0|||
143502477|NCT00868790|517378578|FG005|Period 2|Withdrawal by Subject|0|||
143502478|NCT00868790|517378579|FG006|Period 2|Withdrawal by Subject|0|||
143502479|NCT00868790|517378580|FG007|Period 2|Withdrawal by Subject|0|||
143502480|NCT00868790|517378581|FG008|Period 2|Withdrawal by Subject|1|||
143502481|NCT00868790|517378582|FG009|Period 2|Withdrawal by Subject|0|||
143502482|NCT00868790|517378583|FG010|Period 2|Withdrawal by Subject|0|||
143502483|NCT00868790|517378584|FG011|Period 2|Withdrawal by Subject|0|||
143062797|NCT02697773|515769541|FG000|Overall Study|Lack of Efficacy|4|||
143062798|NCT02697773|515769542|FG001|Overall Study|Lack of Efficacy|6|||
143062799|NCT02697773|515769543|FG002|Overall Study|Lack of Efficacy|6|||
143062800|NCT02697773|515769541|FG000|Overall Study|Lost to Follow-up|5|||
143062801|NCT02697773|515769542|FG001|Overall Study|Lost to Follow-up|5|||
143062802|NCT02697773|515769543|FG002|Overall Study|Lost to Follow-up|7|||
143062803|NCT02697773|515769541|FG000|Overall Study|Other|15|||
143062804|NCT02697773|515769542|FG001|Overall Study|Other|11|||
143062805|NCT02697773|515769543|FG002|Overall Study|Other|10|||
143062806|NCT02697773|515769541|FG000|Overall Study|Protocol Violation|1|||
143062807|NCT02697773|515769542|FG001|Overall Study|Protocol Violation|1|||
143062808|NCT02697773|515769543|FG002|Overall Study|Protocol Violation|0|||
143062809|NCT02697773|515769541|FG000|Overall Study|Withdrawal by Subject|10|||
143062810|NCT02697773|515769542|FG001|Overall Study|Withdrawal by Subject|13|||
143062811|NCT02697773|515769543|FG002|Overall Study|Withdrawal by Subject|13|||
143062812|NCT02697773|515769541|FG000|Overall Study|Randomized but not treated|1|||
143062813|NCT02697773|515769542|FG001|Overall Study|Randomized but not treated|1|||
143062814|NCT02697773|515769543|FG002|Overall Study|Randomized but not treated|0|||
143062815|NCT00842530|515769544|FG000|Overall Study|Serious adverse event|0|||
143062816|NCT00842530|515769545|FG001|Overall Study|Serious adverse event|6|||
143062817|NCT00842530|515769544|FG000|Overall Study|Other adverse event|6|||
143062818|NCT00842530|515769545|FG001|Overall Study|Other adverse event|1|||
143062819|NCT00842530|515769544|FG000|Overall Study|Protocol Violation|32|||
143062820|NCT00842530|515769545|FG001|Overall Study|Protocol Violation|14|||
143062821|NCT00842530|515769544|FG000|Overall Study|Lost to Follow-up|6|||
143365140|NCT00725010|516878810|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
143502484|NCT00868790|517378585|FG012|Period 2|Withdrawal by Subject|0|||
143502485|NCT00868790|517378586|FG013|Period 2|Withdrawal by Subject|1|||
143502486|NCT00868790|517378573|FG000|Period 3|Adverse Event|0|||
143062822|NCT00842530|515769545|FG001|Overall Study|Lost to Follow-up|8|||
143062823|NCT00842530|515769544|FG000|Overall Study|Withdrawal by Subject|73|||
143062824|NCT00842530|515769545|FG001|Overall Study|Withdrawal by Subject|28|||
143502487|NCT00868790|517378574|FG001|Period 3|Adverse Event|0|||
143502488|NCT00868790|517378575|FG002|Period 3|Adverse Event|0|||
143502489|NCT00868790|517378576|FG003|Period 3|Adverse Event|0|||
143502490|NCT00868790|517378577|FG004|Period 3|Adverse Event|0|||
143062825|NCT02939950|515769546|FG000|Overall Study|Lost to Follow-up|13|||
143062826|NCT02939950|515769547|FG001|Overall Study|Lost to Follow-up|16|||
143062827|NCT02939950|515769546|FG000|Overall Study|Positive slit lamp findings|0|||
143502491|NCT00868790|517378578|FG005|Period 3|Adverse Event|0|||
143502492|NCT00868790|517378579|FG006|Period 3|Adverse Event|0|||
143502493|NCT00868790|517378580|FG007|Period 3|Adverse Event|0|||
143502494|NCT00868790|517378581|FG008|Period 3|Adverse Event|0|||
143502495|NCT00868790|517378582|FG009|Period 3|Adverse Event|1|||
143502496|NCT00868790|517378583|FG010|Period 3|Adverse Event|0|||
143502497|NCT00868790|517378584|FG011|Period 3|Adverse Event|0|||
143502498|NCT00868790|517378585|FG012|Period 3|Adverse Event|0|||
143502499|NCT00868790|517378586|FG013|Period 3|Adverse Event|0|||
143502500|NCT00868790|517378573|FG000|Period 3|Protocol Violation|0|||
143502501|NCT00868790|517378574|FG001|Period 3|Protocol Violation|0|||
143502502|NCT00868790|517378575|FG002|Period 3|Protocol Violation|0|||
143502503|NCT00868790|517378576|FG003|Period 3|Protocol Violation|0|||
143502504|NCT00868790|517378577|FG004|Period 3|Protocol Violation|0|||
143502505|NCT00868790|517378578|FG005|Period 3|Protocol Violation|0|||
143502506|NCT00868790|517378579|FG006|Period 3|Protocol Violation|0|||
143502507|NCT00868790|517378580|FG007|Period 3|Protocol Violation|0|||
143502508|NCT00868790|517378581|FG008|Period 3|Protocol Violation|0|||
143502509|NCT00868790|517378582|FG009|Period 3|Protocol Violation|0|||
143502510|NCT00868790|517378583|FG010|Period 3|Protocol Violation|1|||
143502511|NCT00868790|517378584|FG011|Period 3|Protocol Violation|0|||
143502512|NCT00868790|517378585|FG012|Period 3|Protocol Violation|0|||
143502513|NCT00868790|517378586|FG013|Period 3|Protocol Violation|0|||
143502514|NCT00868790|517378573|FG000|Period 3|Study Terminated by Sponsor|0|||
143502515|NCT00868790|517378574|FG001|Period 3|Study Terminated by Sponsor|0|||
143502516|NCT00868790|517378575|FG002|Period 3|Study Terminated by Sponsor|0|||
143502517|NCT00868790|517378576|FG003|Period 3|Study Terminated by Sponsor|1|||
143502518|NCT00868790|517378577|FG004|Period 3|Study Terminated by Sponsor|0|||
143502519|NCT00868790|517378578|FG005|Period 3|Study Terminated by Sponsor|0|||
143502520|NCT00868790|517378579|FG006|Period 3|Study Terminated by Sponsor|0|||
143502521|NCT00868790|517378580|FG007|Period 3|Study Terminated by Sponsor|0|||
143502522|NCT00868790|517378581|FG008|Period 3|Study Terminated by Sponsor|0|||
143502523|NCT00868790|517378582|FG009|Period 3|Study Terminated by Sponsor|0|||
143502524|NCT00868790|517378583|FG010|Period 3|Study Terminated by Sponsor|0|||
143502525|NCT00868790|517378584|FG011|Period 3|Study Terminated by Sponsor|0|||
143502526|NCT00868790|517378585|FG012|Period 3|Study Terminated by Sponsor|0|||
143502527|NCT00868790|517378586|FG013|Period 3|Study Terminated by Sponsor|0|||
143502528|NCT00868790|517378573|FG000|Period 4|Adverse Event|0|||
143502529|NCT00868790|517378574|FG001|Period 4|Adverse Event|0|||
143502530|NCT00868790|517378575|FG002|Period 4|Adverse Event|0|||
143502531|NCT00868790|517378576|FG003|Period 4|Adverse Event|0|||
143502532|NCT00868790|517378577|FG004|Period 4|Adverse Event|0|||
143502533|NCT00868790|517378578|FG005|Period 4|Adverse Event|0|||
143502534|NCT00868790|517378579|FG006|Period 4|Adverse Event|0|||
143502535|NCT00868790|517378580|FG007|Period 4|Adverse Event|1|||
143062828|NCT02939950|515769547|FG001|Overall Study|Positive slit lamp findings|1|||
143062829|NCT02939950|515769546|FG000|Overall Study|Chalazion upper lid|0|||
143062830|NCT02939950|515769547|FG001|Overall Study|Chalazion upper lid|1|||
143062831|NCT02939950|515769546|FG000|Overall Study|Lack of motivation|0|||
143502536|NCT00868790|517378581|FG008|Period 4|Adverse Event|0|||
143502537|NCT00868790|517378582|FG009|Period 4|Adverse Event|0|||
143062832|NCT02939950|515769547|FG001|Overall Study|Lack of motivation|2|||
143502538|NCT00868790|517378583|FG010|Period 4|Adverse Event|1|||
143502539|NCT00868790|517378584|FG011|Period 4|Adverse Event|0|||
143502540|NCT00868790|517378585|FG012|Period 4|Adverse Event|1|||
143502541|NCT00868790|517378586|FG013|Period 4|Adverse Event|0|||
143502542|NCT00868790|517378573|FG000|Period 4|Lost to Follow-up|0|||
143062833|NCT02939950|515769546|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
143062834|NCT02939950|515769547|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
143062835|NCT02939950|515769546|FG000|Overall Study|Military orders|1|||
143062836|NCT02939950|515769547|FG001|Overall Study|Military orders|0|||
143062837|NCT02939950|515769546|FG000|Overall Study|Participant Relocated|5|||
143062838|NCT02939950|515769547|FG001|Overall Study|Participant Relocated|3|||
143062839|NCT02939950|515769546|FG000|Overall Study|Study related symptoms|8|||
143062840|NCT02939950|515769547|FG001|Overall Study|Study related symptoms|8|||
143062841|NCT02939950|515769546|FG000|Overall Study|Unacceptable lens movement|2|||
143062842|NCT02939950|515769547|FG001|Overall Study|Unacceptable lens movement|0|||
143062843|NCT02939950|515769546|FG000|Overall Study|Protocol Violation|6|||
143062844|NCT02939950|515769547|FG001|Overall Study|Protocol Violation|3|||
143062845|NCT02939950|515769546|FG000|Overall Study|Physician Decision|2|||
143062846|NCT02939950|515769547|FG001|Overall Study|Physician Decision|0|||
143062847|NCT02939950|515769546|FG000|Overall Study|Pregnancy|6|||
143062848|NCT02939950|515769547|FG001|Overall Study|Pregnancy|7|||
143062849|NCT02939950|515769546|FG000|Overall Study|Withdrawal by Subject|12|||
143062850|NCT02939950|515769547|FG001|Overall Study|Withdrawal by Subject|28|||
143062851|NCT02939950|515769546|FG000|Overall Study|Adverse Event|7|||
143062852|NCT02939950|515769547|FG001|Overall Study|Adverse Event|3|||
143502543|NCT00868790|517378574|FG001|Period 4|Lost to Follow-up|0|||
143502544|NCT00868790|517378575|FG002|Period 4|Lost to Follow-up|0|||
143502545|NCT00868790|517378576|FG003|Period 4|Lost to Follow-up|0|||
143502546|NCT00868790|517378577|FG004|Period 4|Lost to Follow-up|0|||
143502547|NCT00868790|517378578|FG005|Period 4|Lost to Follow-up|0|||
143062853|NCT02939950|515769546|FG000|Overall Study|Randomized, not dispensed|1|||
143502548|NCT00868790|517378579|FG006|Period 4|Lost to Follow-up|0|||
143502549|NCT00868790|517378580|FG007|Period 4|Lost to Follow-up|1|||
143502550|NCT00868790|517378581|FG008|Period 4|Lost to Follow-up|0|||
143502551|NCT00868790|517378582|FG009|Period 4|Lost to Follow-up|0|||
143502552|NCT00868790|517378583|FG010|Period 4|Lost to Follow-up|0|||
143502553|NCT00868790|517378584|FG011|Period 4|Lost to Follow-up|0|||
143502554|NCT00868790|517378585|FG012|Period 4|Lost to Follow-up|0|||
143502555|NCT00868790|517378586|FG013|Period 4|Lost to Follow-up|0|||
143502556|NCT00868790|517378573|FG000|Period 4|Study Terminated by Sponsor|2|||
143502557|NCT00868790|517378574|FG001|Period 4|Study Terminated by Sponsor|0|||
143502558|NCT00868790|517378575|FG002|Period 4|Study Terminated by Sponsor|0|||
143502559|NCT00868790|517378576|FG003|Period 4|Study Terminated by Sponsor|0|||
143502560|NCT00868790|517378577|FG004|Period 4|Study Terminated by Sponsor|0|||
143502561|NCT00868790|517378578|FG005|Period 4|Study Terminated by Sponsor|0|||
143502562|NCT00868790|517378579|FG006|Period 4|Study Terminated by Sponsor|0|||
143502563|NCT00868790|517378580|FG007|Period 4|Study Terminated by Sponsor|1|||
143502564|NCT00868790|517378581|FG008|Period 4|Study Terminated by Sponsor|2|||
143502565|NCT00868790|517378582|FG009|Period 4|Study Terminated by Sponsor|0|||
143502566|NCT00868790|517378583|FG010|Period 4|Study Terminated by Sponsor|2|||
143502567|NCT00868790|517378584|FG011|Period 4|Study Terminated by Sponsor|1|||
143502568|NCT00868790|517378585|FG012|Period 4|Study Terminated by Sponsor|0|||
143502569|NCT00868790|517378586|FG013|Period 4|Study Terminated by Sponsor|1|||
143502570|NCT00868790|517378573|FG000|Period 4|Abnormal ALT/AST|0|||
143502571|NCT00868790|517378574|FG001|Period 4|Abnormal ALT/AST|0|||
143502572|NCT00868790|517378575|FG002|Period 4|Abnormal ALT/AST|1|||
143502573|NCT00868790|517378576|FG003|Period 4|Abnormal ALT/AST|0|||
143502574|NCT00868790|517378577|FG004|Period 4|Abnormal ALT/AST|0|||
143502575|NCT00868790|517378578|FG005|Period 4|Abnormal ALT/AST|0|||
143502576|NCT00868790|517378579|FG006|Period 4|Abnormal ALT/AST|0|||
143502577|NCT00868790|517378580|FG007|Period 4|Abnormal ALT/AST|0|||
143062854|NCT02939950|515769547|FG001|Overall Study|Randomized, not dispensed|0|||
143062855|NCT02939950|515769546|FG000|Overall Study|Ineligible at Baseline|2|||
143062856|NCT02939950|515769547|FG001|Overall Study|Ineligible at Baseline|8|||
143502578|NCT00868790|517378581|FG008|Period 4|Abnormal ALT/AST|0|||
143502579|NCT00868790|517378582|FG009|Period 4|Abnormal ALT/AST|0|||
143502580|NCT00868790|517378583|FG010|Period 4|Abnormal ALT/AST|0|||
143502581|NCT00868790|517378584|FG011|Period 4|Abnormal ALT/AST|0|||
143502582|NCT00868790|517378585|FG012|Period 4|Abnormal ALT/AST|0|||
143502583|NCT00868790|517378586|FG013|Period 4|Abnormal ALT/AST|0|||
143502584|NCT00868790|517378573|FG000|Post-study|Withdrawal by Subject|0|||
143062857|NCT02243293|515769548|FG000|Overall Study|Adverse Event|1|||
143062858|NCT02243293|515769549|FG001|Overall Study|Adverse Event|0|||
143502585|NCT00868790|517378574|FG001|Post-study|Withdrawal by Subject|0|||
143502586|NCT00868790|517378575|FG002|Post-study|Withdrawal by Subject|0|||
143502587|NCT00868790|517378576|FG003|Post-study|Withdrawal by Subject|0|||
143502588|NCT00868790|517378577|FG004|Post-study|Withdrawal by Subject|1|||
143062859|NCT02243293|515769550|FG002|Overall Study|Adverse Event|0|||
143062860|NCT02243293|515769551|FG003|Overall Study|Adverse Event|0|||
143502589|NCT00868790|517378578|FG005|Post-study|Withdrawal by Subject|0|||
143502590|NCT00868790|517378579|FG006|Post-study|Withdrawal by Subject|0|||
143502591|NCT00868790|517378580|FG007|Post-study|Withdrawal by Subject|0|||
143502592|NCT00868790|517378581|FG008|Post-study|Withdrawal by Subject|0|||
143502593|NCT00868790|517378582|FG009|Post-study|Withdrawal by Subject|0|||
143502594|NCT00868790|517378583|FG010|Post-study|Withdrawal by Subject|0|||
143502595|NCT00868790|517378584|FG011|Post-study|Withdrawal by Subject|0|||
143062861|NCT02243293|515769552|FG004|Overall Study|Adverse Event|0|||
143062862|NCT02243293|515769553|FG005|Overall Study|Adverse Event|0|||
143062863|NCT02243293|515769554|FG006|Overall Study|Adverse Event|0|||
143062864|NCT02243293|515769555|FG007|Overall Study|Adverse Event|0|||
143062865|NCT02243293|515769556|FG008|Overall Study|Adverse Event|0|||
143062866|NCT02243293|515769557|FG009|Overall Study|Adverse Event|0|||
143062867|NCT02243293|515769558|FG010|Overall Study|Adverse Event|0|||
143062868|NCT02243293|515769559|FG011|Overall Study|Adverse Event|0|||
143062869|NCT02243293|515769560|FG012|Overall Study|Adverse Event|0|||
143062870|NCT02243293|515769561|FG013|Overall Study|Adverse Event|0|||
143062871|NCT02243293|515769562|FG014|Overall Study|Adverse Event|0|||
143062872|NCT02243293|515769563|FG015|Overall Study|Adverse Event|1|||
143062873|NCT02243293|515769564|FG016|Overall Study|Adverse Event|0|||
143062874|NCT02243293|515769565|FG017|Overall Study|Adverse Event|0|||
143062875|NCT02243293|515769566|FG018|Overall Study|Adverse Event|0|||
143062876|NCT02243293|515769567|FG019|Overall Study|Adverse Event|0|||
143062877|NCT02243293|515769568|FG020|Overall Study|Adverse Event|1|||
143062878|NCT02243293|515769569|FG021|Overall Study|Adverse Event|0|||
143062879|NCT02243293|515769548|FG000|Overall Study|Withdrawal by Subject|1|||
143062880|NCT02243293|515769549|FG001|Overall Study|Withdrawal by Subject|0|||
143062881|NCT02243293|515769550|FG002|Overall Study|Withdrawal by Subject|0|||
143062882|NCT02243293|515769551|FG003|Overall Study|Withdrawal by Subject|0|||
143062883|NCT02243293|515769552|FG004|Overall Study|Withdrawal by Subject|0|||
143062884|NCT02243293|515769553|FG005|Overall Study|Withdrawal by Subject|0|||
143062885|NCT02243293|515769554|FG006|Overall Study|Withdrawal by Subject|0|||
143062886|NCT02243293|515769555|FG007|Overall Study|Withdrawal by Subject|0|||
143062887|NCT02243293|515769556|FG008|Overall Study|Withdrawal by Subject|0|||
143062888|NCT02243293|515769557|FG009|Overall Study|Withdrawal by Subject|1|||
143062889|NCT02243293|515769558|FG010|Overall Study|Withdrawal by Subject|0|||
143062890|NCT02243293|515769559|FG011|Overall Study|Withdrawal by Subject|1|||
143062891|NCT02243293|515769560|FG012|Overall Study|Withdrawal by Subject|0|||
143062892|NCT02243293|515769561|FG013|Overall Study|Withdrawal by Subject|0|||
143062893|NCT02243293|515769562|FG014|Overall Study|Withdrawal by Subject|0|||
143062894|NCT02243293|515769563|FG015|Overall Study|Withdrawal by Subject|0|||
143062895|NCT02243293|515769564|FG016|Overall Study|Withdrawal by Subject|0|||
143062896|NCT02243293|515769565|FG017|Overall Study|Withdrawal by Subject|0|||
143062897|NCT02243293|515769566|FG018|Overall Study|Withdrawal by Subject|0|||
143062898|NCT02243293|515769567|FG019|Overall Study|Withdrawal by Subject|0|||
143062899|NCT02243293|515769568|FG020|Overall Study|Withdrawal by Subject|0|||
143062900|NCT02243293|515769569|FG021|Overall Study|Withdrawal by Subject|1|||
143062901|NCT02243293|515769548|FG000|Overall Study|Lost to Follow-up|0|||
143062902|NCT02243293|515769549|FG001|Overall Study|Lost to Follow-up|1|||
143062903|NCT02243293|515769550|FG002|Overall Study|Lost to Follow-up|1|||
143062904|NCT02243293|515769551|FG003|Overall Study|Lost to Follow-up|1|||
143062905|NCT02243293|515769552|FG004|Overall Study|Lost to Follow-up|0|||
143062906|NCT02243293|515769553|FG005|Overall Study|Lost to Follow-up|0|||
143062907|NCT02243293|515769554|FG006|Overall Study|Lost to Follow-up|3|||
143062908|NCT02243293|515769555|FG007|Overall Study|Lost to Follow-up|0|||
143062909|NCT02243293|515769556|FG008|Overall Study|Lost to Follow-up|0|||
143062910|NCT02243293|515769557|FG009|Overall Study|Lost to Follow-up|0|||
143062911|NCT02243293|515769558|FG010|Overall Study|Lost to Follow-up|0|||
143062912|NCT02243293|515769559|FG011|Overall Study|Lost to Follow-up|2|||
143062913|NCT02243293|515769560|FG012|Overall Study|Lost to Follow-up|0|||
143062914|NCT02243293|515769561|FG013|Overall Study|Lost to Follow-up|0|||
143062915|NCT02243293|515769562|FG014|Overall Study|Lost to Follow-up|0|||
143062916|NCT02243293|515769563|FG015|Overall Study|Lost to Follow-up|0|||
143062917|NCT02243293|515769564|FG016|Overall Study|Lost to Follow-up|3|||
143062918|NCT02243293|515769565|FG017|Overall Study|Lost to Follow-up|1|||
143062919|NCT02243293|515769566|FG018|Overall Study|Lost to Follow-up|0|||
143062920|NCT02243293|515769567|FG019|Overall Study|Lost to Follow-up|0|||
143502596|NCT00868790|517378585|FG012|Post-study|Withdrawal by Subject|0|||
143502597|NCT00868790|517378586|FG013|Post-study|Withdrawal by Subject|0|||
143502598|NCT00868790|517378573|FG000|Post-study|Excluded Medication|0|||
143062921|NCT02243293|515769568|FG020|Overall Study|Lost to Follow-up|1|||
143062922|NCT02243293|515769569|FG021|Overall Study|Lost to Follow-up|2|||
143062923|NCT02243293|515769548|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
143062924|NCT02243293|515769549|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
143502599|NCT00868790|517378574|FG001|Post-study|Excluded Medication|0|||
143502600|NCT00868790|517378575|FG002|Post-study|Excluded Medication|0|||
143062925|NCT02243293|515769550|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
143062926|NCT02243293|515769551|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
143365141|NCT00725010|516878810|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
143062927|NCT02243293|515769552|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
143062928|NCT02243293|515769553|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
143502601|NCT00868790|517378576|FG003|Post-study|Excluded Medication|0|||
143502602|NCT00868790|517378577|FG004|Post-study|Excluded Medication|0|||
143062929|NCT02243293|515769554|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
143062930|NCT02243293|515769555|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
143062931|NCT02243293|515769556|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
143062932|NCT02243293|515769557|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
143062933|NCT02243293|515769558|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
143062934|NCT02243293|515769559|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
143062935|NCT02243293|515769560|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
143062936|NCT02243293|515769561|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
143062937|NCT02243293|515769562|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
143062938|NCT02243293|515769563|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
143062939|NCT02243293|515769564|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
143062940|NCT02243293|515769565|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
143062941|NCT02243293|515769566|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
143062942|NCT02243293|515769567|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
143062943|NCT02243293|515769568|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
143062944|NCT02243293|515769569|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
143062945|NCT02243293|515769548|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
143062946|NCT02243293|515769549|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
143062947|NCT02243293|515769550|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
143062948|NCT02243293|515769551|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
143062949|NCT02243293|515769552|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
143062950|NCT02243293|515769553|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
143062951|NCT02243293|515769554|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
143062952|NCT02243293|515769555|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
143062953|NCT02243293|515769556|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
143062954|NCT02243293|515769557|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
143062955|NCT02243293|515769558|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
143062956|NCT02243293|515769559|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
143062957|NCT02243293|515769560|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
143062958|NCT02243293|515769561|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
143062959|NCT02243293|515769562|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
143062960|NCT02243293|515769563|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
143062961|NCT02243293|515769564|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
143062962|NCT02243293|515769565|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
143062963|NCT02243293|515769566|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
143062964|NCT02243293|515769567|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
143062965|NCT02243293|515769568|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
143062966|NCT02243293|515769569|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
143062967|NCT04553913|515769573|FG000|Overall Study|patient's block resolved prior to PACU|1|||
143062968|NCT04553913|515769573|FG000|Overall Study|did not use the device properly|5|||
143062969|NCT02985879|515769576|FG000|Overall Study|Adverse Event|7|||
143062970|NCT02985879|515769577|FG001|Overall Study|Adverse Event|9|||
143062971|NCT02985879|515769578|FG002|Overall Study|Adverse Event|7|||
143062972|NCT02985879|515769576|FG000|Overall Study|Withdrew consent|6|||
143062973|NCT02985879|515769577|FG001|Overall Study|Withdrew consent|8|||
143062974|NCT02985879|515769578|FG002|Overall Study|Withdrew consent|10|||
143502603|NCT00868790|517378578|FG005|Post-study|Excluded Medication|0|||
143502604|NCT00868790|517378579|FG006|Post-study|Excluded Medication|0|||
143502605|NCT00868790|517378580|FG007|Post-study|Excluded Medication|2|||
143502606|NCT00868790|517378581|FG008|Post-study|Excluded Medication|0|||
143502607|NCT00868790|517378582|FG009|Post-study|Excluded Medication|1|||
143502608|NCT00868790|517378583|FG010|Post-study|Excluded Medication|0|||
143502609|NCT00868790|517378584|FG011|Post-study|Excluded Medication|0|||
143502610|NCT00868790|517378585|FG012|Post-study|Excluded Medication|0|||
143502611|NCT00868790|517378586|FG013|Post-study|Excluded Medication|0|||
143502612|NCT01763164|517378590|FG000|Treatment Phase|Participant/Guardian decision|26|||
143502613|NCT01763164|517378591|FG001|Treatment Phase|Participant/Guardian decision|14|||
143502614|NCT01763164|517378590|FG000|Treatment Phase|Protocol Violation|1|||
143502615|NCT01763164|517378591|FG001|Treatment Phase|Protocol Violation|1|||
143502616|NCT01763164|517378590|FG000|Treatment Phase|Progressive Disease|142|||
143502617|NCT01763164|517378591|FG001|Treatment Phase|Progressive Disease|76|||
143062975|NCT02985879|515769576|FG000|Overall Study|Lost to Follow-up|1|||
143062976|NCT02985879|515769577|FG001|Overall Study|Lost to Follow-up|0|||
143062977|NCT02985879|515769578|FG002|Overall Study|Lost to Follow-up|2|||
143062978|NCT02985879|515769576|FG000|Overall Study|Other, not specified|62|||
143062979|NCT02985879|515769577|FG001|Overall Study|Other, not specified|58|||
143062980|NCT02985879|515769578|FG002|Overall Study|Other, not specified|58|||
143062981|NCT03959527|515770900|FG000|Overall Study|Withdrawal by Subject|8|||
143062982|NCT03959527|515770901|FG001|Overall Study|Withdrawal by Subject|3|||
143502618|NCT01763164|517378590|FG000|Treatment Phase|Physician Decision|24|||
143502619|NCT01763164|517378591|FG001|Treatment Phase|Physician Decision|13|||
143502620|NCT01763164|517378590|FG000|Treatment Phase|Death|10|||
143062983|NCT03959527|515770900|FG000|Overall Study|Lost to Follow-up|31|||
143062984|NCT03959527|515770901|FG001|Overall Study|Lost to Follow-up|15|||
143062985|NCT03959527|515770900|FG000|Overall Study|Did not meet eligibility criteria|1|||
143062986|NCT03959527|515770901|FG001|Overall Study|Did not meet eligibility criteria|1|||
143062987|NCT03959527|515770900|FG000|Overall Study|Protocol Violation|10|||
143062988|NCT03959527|515770901|FG001|Overall Study|Protocol Violation|5|||
143062989|NCT01688466|515770902|FG000|Overall Study|Withdrawal by Subject|2|||
143062990|NCT01688466|515770903|FG001|Overall Study|Withdrawal by Subject|1|||
143062991|NCT01688466|515770902|FG000|Overall Study|Death|0|||
143062992|NCT01688466|515770903|FG001|Overall Study|Death|1|||
143062993|NCT01688466|515770902|FG000|Overall Study|Adverse Event|0|||
143062994|NCT01688466|515770903|FG001|Overall Study|Adverse Event|4|||
143062995|NCT01688466|515770902|FG000|Overall Study|Not evaluable|0|||
143062996|NCT01688466|515770903|FG001|Overall Study|Not evaluable|1|||
143062997|NCT01000610|515770908|FG000|Overall Study|Adverse Event|1|||
143062998|NCT01000610|515770908|FG000|Overall Study|Lost to Follow-up|4|||
143062999|NCT01000610|515770908|FG000|Overall Study|Treatment failure|1|||
143063000|NCT00493779|515770917|FG000|Overall Study|Logistical issue at site|1|||
143063001|NCT01885182|515770918|FG000|Overall Study|Adverse Event|11|||
143063002|NCT01885182|515770919|FG001|Overall Study|Adverse Event|13|||
143063003|NCT01885182|515770918|FG000|Overall Study|Withdrawal by Subject|13|||
143063004|NCT01885182|515770919|FG001|Overall Study|Withdrawal by Subject|6|||
143063005|NCT01885182|515770918|FG000|Overall Study|Lost to Follow-up|2|||
143063006|NCT01885182|515770919|FG001|Overall Study|Lost to Follow-up|2|||
143063007|NCT01885182|515770918|FG000|Overall Study|Lack of Efficacy|8|||
143063008|NCT01885182|515770919|FG001|Overall Study|Lack of Efficacy|1|||
143063009|NCT03341000|515770920|FG000|Overall Study|Adverse Event|1|||
143063010|NCT01592721|515770921|FG000|Long-term Follow-up|Death|1|||
143063011|NCT02516410|515770923|FG000|Overall Study|Adverse Event|0|||
143063012|NCT02516410|515770924|FG001|Overall Study|Adverse Event|1|||
143063013|NCT02516410|515770923|FG000|Overall Study|Withdrawal by Subject|0|||
143063014|NCT02516410|515770924|FG001|Overall Study|Withdrawal by Subject|1|||
143063015|NCT01475253|515770929|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
143063016|NCT01475253|515770930|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
143063017|NCT01475253|515770931|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
143063018|NCT01475253|515770932|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
143063019|NCT01475253|515770929|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
143063020|NCT01475253|515770930|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
143063021|NCT01475253|515770931|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
143063022|NCT01475253|515770932|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
143063023|NCT03135899|515770933|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
143063024|NCT03135899|515770934|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
143063025|NCT03135899|515770935|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
143063026|NCT03135899|515770936|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
143063027|NCT03135899|515770937|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
143063028|NCT03135899|515770938|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
143063029|NCT03135899|515770939|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
143063030|NCT03135899|515770940|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
143063031|NCT03135899|515770933|FG000|Overall Study|Withdrawal by Subject|0|||
143063032|NCT03135899|515770934|FG001|Overall Study|Withdrawal by Subject|0|||
143063033|NCT03135899|515770935|FG002|Overall Study|Withdrawal by Subject|0|||
143063034|NCT03135899|515770936|FG003|Overall Study|Withdrawal by Subject|0|||
143063035|NCT03135899|515770937|FG004|Overall Study|Withdrawal by Subject|0|||
143063036|NCT03135899|515770938|FG005|Overall Study|Withdrawal by Subject|2|||
143063037|NCT03135899|515770939|FG006|Overall Study|Withdrawal by Subject|0|||
143063038|NCT03135899|515770940|FG007|Overall Study|Withdrawal by Subject|0|||
143063039|NCT02914236|515770945|FG000|Overall Study|Lost to Follow-up|1|||
143063040|NCT03265288|515770949|FG000|Overall Study|Adverse Event|0|||
143063041|NCT03265288|515770950|FG001|Overall Study|Adverse Event|1|||
143063042|NCT03265288|515770949|FG000|Overall Study|Withdrawal by Subject|13|||
143063043|NCT03265288|515770950|FG001|Overall Study|Withdrawal by Subject|5|||
143063044|NCT03265288|515770949|FG000|Overall Study|Drug Withdrawn|3|||
143063045|NCT03265288|515770950|FG001|Overall Study|Drug Withdrawn|3|||
143063046|NCT03265288|515770949|FG000|Overall Study|Any Other Reason|7|||
143063047|NCT03265288|515770950|FG001|Overall Study|Any Other Reason|3|||
143063048|NCT00918463|515770953|FG000|Overall Study|Death|1|||
143063049|NCT00918463|515770953|FG000|Overall Study|Lack of Efficacy|1|||
143063050|NCT05506358|515770956|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
143063051|NCT05506358|515770957|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
143063052|NCT05506358|515770958|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
143063053|NCT05506358|515770959|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
143063054|NCT05506358|515770960|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
143063055|NCT05506358|515770956|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
143063056|NCT05506358|515770957|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
143063057|NCT05506358|515770958|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
143063058|NCT05506358|515770959|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
143063059|NCT05506358|515770960|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
143063060|NCT05506358|515770956|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
143063061|NCT05506358|515770957|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
143063062|NCT05506358|515770958|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
143063063|NCT05506358|515770959|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
143063064|NCT05506358|515770960|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
143063065|NCT05506358|515770956|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
143063066|NCT05506358|515770957|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
143063067|NCT05506358|515770958|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
143063068|NCT05506358|515770959|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
143063069|NCT05506358|515770960|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
143063070|NCT05506358|515770956|FG000|Overall Study|HbE trait|0|||
143063071|NCT05506358|515770957|FG001|Overall Study|HbE trait|0|||
143063072|NCT05506358|515770958|FG002|Overall Study|HbE trait|0|||
143063073|NCT05506358|515770959|FG003|Overall Study|HbE trait|1|||
143063074|NCT05506358|515770960|FG004|Overall Study|HbE trait|0|||
143063075|NCT01659736|515770961|FG000|Treatment Period|Adverse Event|1|||
143063076|NCT01659736|515770962|FG001|Treatment Period|Adverse Event|1|||
143063077|NCT01659736|515770961|FG000|Treatment Period|Protocol Violation|3|||
143063078|NCT01659736|515770962|FG001|Treatment Period|Protocol Violation|1|||
143063079|NCT01659736|515770961|FG000|Treatment Period|Withdrawal by Subject|1|||
143063080|NCT01659736|515770962|FG001|Treatment Period|Withdrawal by Subject|0|||
143063081|NCT01659736|515770961|FG000|3-month Follow-up|Lost to Follow-up|0|||
143063082|NCT01659736|515770962|FG001|3-month Follow-up|Lost to Follow-up|1|||
143063083|NCT03578237|515770967|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
143063084|NCT03578237|515770968|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
143063085|NCT01173471|515770969|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
143063086|NCT01173471|515770970|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
143063087|NCT01173471|515770971|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
143063088|NCT01173471|515770972|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
143063089|NCT01173471|515770969|FG000|Overall Study|Condition under investigation worsened|2|||
143063090|NCT01173471|515770970|FG001|Overall Study|Condition under investigation worsened|0|||
143063091|NCT01173471|515770971|FG002|Overall Study|Condition under investigation worsened|0|||
143063092|NCT01173471|515770972|FG003|Overall Study|Condition under investigation worsened|0|||
143063093|NCT01173471|515770969|FG000|Overall Study|Lost to Follow-up|0|||
143063094|NCT01173471|515770970|FG001|Overall Study|Lost to Follow-up|0|||
143063095|NCT01173471|515770971|FG002|Overall Study|Lost to Follow-up|1|||
143063096|NCT01173471|515770972|FG003|Overall Study|Lost to Follow-up|0|||
143063097|NCT01173471|515770969|FG000|Overall Study|Reason given as Other|0|||
143063098|NCT01173471|515770970|FG001|Overall Study|Reason given as Other|0|||
143063099|NCT01173471|515770971|FG002|Overall Study|Reason given as Other|1|||
143063100|NCT01173471|515770972|FG003|Overall Study|Reason given as Other|0|||
143063101|NCT04132336|515770973|FG000|Overall Study|Investigator Decision|0|||
143063102|NCT04132336|515770974|FG001|Overall Study|Investigator Decision|1|||
143063103|NCT04132336|515770975|FG002|Overall Study|Investigator Decision|0|||
143063104|NCT04132336|515770976|FG003|Overall Study|Investigator Decision|0|||
143063105|NCT04132336|515770977|FG004|Overall Study|Investigator Decision|0|||
143063106|NCT04132336|515770978|FG005|Overall Study|Investigator Decision|0|||
143063107|NCT04132336|515770979|FG006|Overall Study|Investigator Decision|0|||
143063108|NCT01206816|515770982|FG000|Overall Study|Protocol Violation|0|||
143063109|NCT01206816|515770983|FG001|Overall Study|Protocol Violation|0|||
143063110|NCT01206816|515770984|FG002|Overall Study|Protocol Violation|1|||
143063111|NCT01206816|515770985|FG003|Overall Study|Protocol Violation|0|||
143063112|NCT01206816|515770986|FG004|Overall Study|Protocol Violation|0|||
143063113|NCT01206816|515770987|FG005|Overall Study|Protocol Violation|0|||
143063114|NCT01206816|515770988|FG006|Overall Study|Protocol Violation|0|||
143063115|NCT01206816|515770982|FG000|Overall Study|Withdrawal by Subject|0|||
143063116|NCT01206816|515770983|FG001|Overall Study|Withdrawal by Subject|0|||
143063117|NCT01206816|515770984|FG002|Overall Study|Withdrawal by Subject|1|||
143063118|NCT01206816|515770985|FG003|Overall Study|Withdrawal by Subject|0|||
143063119|NCT01206816|515770986|FG004|Overall Study|Withdrawal by Subject|0|||
143365142|NCT00725010|516878810|FG000|Overall Study|No further documentation|1|||
143365143|NCT00725010|516878810|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
143063120|NCT01206816|515770987|FG005|Overall Study|Withdrawal by Subject|0|||
143063121|NCT01206816|515770988|FG006|Overall Study|Withdrawal by Subject|0|||
143063122|NCT01206816|515770982|FG000|Overall Study|Progressive disease|3|||
143063123|NCT01206816|515770983|FG001|Overall Study|Progressive disease|3|||
143063124|NCT01206816|515770984|FG002|Overall Study|Progressive disease|13|||
143063125|NCT01206816|515770985|FG003|Overall Study|Progressive disease|3|||
143063126|NCT01206816|515770986|FG004|Overall Study|Progressive disease|3|||
143063127|NCT01206816|515770987|FG005|Overall Study|Progressive disease|16|||
143063128|NCT01206816|515770988|FG006|Overall Study|Progressive disease|3|||
143063129|NCT01206816|515770982|FG000|Overall Study|Other AE|0|||
143063130|NCT01206816|515770983|FG001|Overall Study|Other AE|0|||
143063131|NCT01206816|515770984|FG002|Overall Study|Other AE|4|||
143063132|NCT01206816|515770985|FG003|Overall Study|Other AE|0|||
143063133|NCT01206816|515770986|FG004|Overall Study|Other AE|0|||
143063134|NCT01206816|515770987|FG005|Overall Study|Other AE|3|||
143063135|NCT01206816|515770988|FG006|Overall Study|Other AE|2|||
143063136|NCT01206816|515770982|FG000|Overall Study|other than stated above|0|||
143063137|NCT01206816|515770983|FG001|Overall Study|other than stated above|0|||
143063138|NCT01206816|515770984|FG002|Overall Study|other than stated above|1|||
143063139|NCT01206816|515770985|FG003|Overall Study|other than stated above|0|||
143063140|NCT01206816|515770986|FG004|Overall Study|other than stated above|0|||
143063141|NCT01206816|515770987|FG005|Overall Study|other than stated above|0|||
143063142|NCT01206816|515770988|FG006|Overall Study|other than stated above|1|||
143063143|NCT01939496|515770989|FG000|Overall Study|Adverse Event|2|||
143063144|NCT01939496|515770990|FG001|Overall Study|Adverse Event|0|||
143063145|NCT01939496|515770991|FG002|Overall Study|Adverse Event|0|||
143063146|NCT01939496|515770989|FG000|Overall Study|Lost to Follow-up|1|||
143063147|NCT01939496|515770990|FG001|Overall Study|Lost to Follow-up|1|||
143063148|NCT01939496|515770991|FG002|Overall Study|Lost to Follow-up|0|||
143063149|NCT01939496|515770989|FG000|Overall Study|Physician Decision|1|||
143063150|NCT01939496|515770990|FG001|Overall Study|Physician Decision|0|||
143063151|NCT01939496|515770991|FG002|Overall Study|Physician Decision|0|||
143063152|NCT01939496|515770989|FG000|Overall Study|Protocol Violation|3|||
143063153|NCT01939496|515770990|FG001|Overall Study|Protocol Violation|0|||
143063154|NCT01939496|515770991|FG002|Overall Study|Protocol Violation|0|||
143063155|NCT01939496|515770989|FG000|Overall Study|Withdrawal by Subject|0|||
143063156|NCT01939496|515770990|FG001|Overall Study|Withdrawal by Subject|1|||
143063157|NCT01939496|515770991|FG002|Overall Study|Withdrawal by Subject|1|||
143502621|NCT01763164|517378591|FG001|Treatment Phase|Death|1|||
143502622|NCT01763164|517378590|FG000|Treatment Phase|Adverse Event|66|||
143502623|NCT01763164|517378591|FG001|Treatment Phase|Adverse Event|8|||
143502624|NCT01763164|517378590|FG000|Treatment Phase|Randomized but not Treated|0|||
143502625|NCT01763164|517378591|FG001|Treatment Phase|Randomized but not Treated|19|||
143502626|NCT01763164|517378590|FG000|Treatment Phase|Other|0|||
143502627|NCT01763164|517378591|FG001|Treatment Phase|Other|1|||
143502628|NCT01763164|517378590|FG000|Follow up Phase|New therapy for study indication|12|||
143502629|NCT01763164|517378591|FG001|Follow up Phase|New therapy for study indication|3|||
143502630|NCT01763164|517378590|FG000|Follow up Phase|Death|21|||
143502631|NCT01763164|517378591|FG001|Follow up Phase|Death|4|||
143502632|NCT01763164|517378590|FG000|Follow up Phase|Subject/guardian decision|9|||
143502633|NCT01763164|517378591|FG001|Follow up Phase|Subject/guardian decision|2|||
143502634|NCT01763164|517378590|FG000|Follow up Phase|Progressive disease|127|||
143502635|NCT01763164|517378591|FG001|Follow up Phase|Progressive disease|62|||
143502636|NCT01763164|517378590|FG000|Follow up Phase|Physician Decision|10|||
143502637|NCT01763164|517378591|FG001|Follow up Phase|Physician Decision|3|||
143502638|NCT01763164|517378590|FG000|Follow up Phase|Lost to Follow-up|1|||
143063158|NCT01939496|515770989|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
143063159|NCT01939496|515770990|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
143063160|NCT01939496|515770991|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
143063161|NCT01939496|515770989|FG000|Overall Study|Other|2|||
143063162|NCT01939496|515770990|FG001|Overall Study|Other|0|||
143170191|NCT04392154|516171886|FG003|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
143170192|NCT04392154|516171883|FG000|Primary Treatment Period (100 Weeks)|Physician Decision|1|||
143170193|NCT04392154|516171884|FG001|Primary Treatment Period (100 Weeks)|Physician Decision|5|||
143170194|NCT04392154|516171885|FG002|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
143170195|NCT04392154|516171886|FG003|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
143170196|NCT04392154|516171883|FG000|Primary Treatment Period (100 Weeks)|Pregnancy|1|||
143170197|NCT04392154|516171884|FG001|Primary Treatment Period (100 Weeks)|Pregnancy|8|||
143170198|NCT04392154|516171885|FG002|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
143170199|NCT04392154|516171886|FG003|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
143170200|NCT04392154|516171883|FG000|Primary Treatment Period (100 Weeks)|Protocol deviation|1|||
143170201|NCT04392154|516171884|FG001|Primary Treatment Period (100 Weeks)|Protocol deviation|12|||
143170202|NCT04392154|516171885|FG002|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
143170203|NCT04392154|516171886|FG003|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
143170204|NCT04392154|516171883|FG000|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|18|||
143170205|NCT04392154|516171884|FG001|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|138|||
143170206|NCT04392154|516171885|FG002|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
143170207|NCT04392154|516171886|FG003|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
143170208|NCT04392154|516171883|FG000|Primary Treatment Period (100 Weeks)|Sponsor Decision|1|||
143170209|NCT04392154|516171884|FG001|Primary Treatment Period (100 Weeks)|Sponsor Decision|14|||
143502639|NCT01763164|517378591|FG001|Follow up Phase|Lost to Follow-up|0|||
143246051|NCT04421027|516451884|FG000|Treatment Period|Lost to Follow-up|22|||
143246052|NCT04421027|516451885|FG001|Treatment Period|Lost to Follow-up|20|||
143246053|NCT04421027|516451886|FG002|Treatment Period|Lost to Follow-up|0|||
143246054|NCT04421027|516451887|FG003|Treatment Period|Lost to Follow-up|0|||
143246055|NCT04421027|516451884|FG000|Treatment Period|Other-Unknown|15|||
143246056|NCT04421027|516451885|FG001|Treatment Period|Other-Unknown|9|||
143246057|NCT04421027|516451886|FG002|Treatment Period|Other-Unknown|0|||
143246058|NCT04421027|516451887|FG003|Treatment Period|Other-Unknown|0|||
143246059|NCT04421027|516451884|FG000|Treatment Period|Physician Decision|1|||
143246060|NCT04421027|516451885|FG001|Treatment Period|Physician Decision|1|||
143246061|NCT04421027|516451886|FG002|Treatment Period|Physician Decision|0|||
143063163|NCT01939496|515770991|FG002|Overall Study|Other|1|||
143063164|NCT03451006|515770995|FG000|Overall Study|Withdrawal by Subject|2|||
143063165|NCT03451006|515770996|FG001|Overall Study|Withdrawal by Subject|2|||
143063166|NCT01829113|515770998|FG000|Overall Study|Disease Progression|37|||
143063167|NCT01829113|515770999|FG001|Overall Study|Disease Progression|48|||
143063168|NCT01829113|515770998|FG000|Overall Study|Adverse Event|14|||
143063169|NCT01829113|515770999|FG001|Overall Study|Adverse Event|10|||
143063170|NCT01829113|515770998|FG000|Overall Study|Withdrawal by Subject|17|||
143063171|NCT01829113|515770999|FG001|Overall Study|Withdrawal by Subject|10|||
143063172|NCT01829113|515770998|FG000|Overall Study|Death|4|||
143063173|NCT01829113|515770999|FG001|Overall Study|Death|6|||
143063174|NCT01829113|515770998|FG000|Overall Study|Sponsor Decision|1|||
143063175|NCT01829113|515770999|FG001|Overall Study|Sponsor Decision|1|||
143063176|NCT01829113|515770998|FG000|Overall Study|No Study Treatment Received|3|||
143063177|NCT01829113|515770999|FG001|Overall Study|No Study Treatment Received|2|||
143063178|NCT01829113|515770998|FG000|Overall Study|Physician Decision|1|||
143063179|NCT01829113|515770999|FG001|Overall Study|Physician Decision|1|||
143063180|NCT05444543|515771000|FG000|Overall Study|Withdrawal by Subject|1|||
143063181|NCT05444543|515771001|FG001|Overall Study|Withdrawal by Subject|0|||
143063182|NCT05444543|515771000|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
143063183|NCT05444543|515771001|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
143063184|NCT05444543|515771000|FG000|Overall Study|Adverse Event|0|||
143063185|NCT05444543|515771001|FG001|Overall Study|Adverse Event|1|||
143063186|NCT05444543|515771000|FG000|Overall Study|Family relocating at a distance from study site|0|||
143063187|NCT05444543|515771001|FG001|Overall Study|Family relocating at a distance from study site|1|||
143063188|NCT01144403|515771002|FG000|Overall Study|Lost to Follow-up|3|||
143063189|NCT01144403|515771002|FG000|Overall Study|Death|1|||
143063190|NCT01144403|515771002|FG000|Overall Study|Adverse Event|1|||
143063191|NCT03891329|515771003|FG000|Overall Study|Death|5|||
143063192|NCT03891329|515771003|FG000|Overall Study|Lost to Follow-up|4|||
143063193|NCT03891329|515771003|FG000|Overall Study|Physician Decision|4|||
143063194|NCT03891329|515771003|FG000|Overall Study|Device explanted|3|||
143063195|NCT03891329|515771003|FG000|Overall Study|No study device implanted|3|||
143063196|NCT02442271|515771006|FG000|Overall Study|Adverse Event|1|||
143063197|NCT02442271|515771006|FG000|Overall Study|Withdrew Consent|1|||
143063198|NCT02442271|515771006|FG000|Overall Study|Lost to Follow-up|1|||
143063199|NCT02442271|515771006|FG000|Overall Study|Other|1|||
143063200|NCT01560507|515771010|FG000|Overall Study|Lost to Follow-up|3|||
143063201|NCT01560507|515771011|FG001|Overall Study|Lost to Follow-up|1|||
143063202|NCT01560507|515771012|FG002|Overall Study|Lost to Follow-up|2|||
143063203|NCT01560507|515771010|FG000|Overall Study|Withdrawal by Subject|1|||
143063204|NCT01560507|515771011|FG001|Overall Study|Withdrawal by Subject|1|||
143063205|NCT01560507|515771012|FG002|Overall Study|Withdrawal by Subject|0|||
143063206|NCT01660022|515771013|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
143063207|NCT01660022|515771014|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
143063208|NCT01660022|515771015|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
143063209|NCT01660022|515771016|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
143063210|NCT01660022|515771017|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
143063211|NCT01660022|515771018|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
143063212|NCT01660022|515771013|FG000|First Sequence (7 Days)|Adverse Event|0|||
143063213|NCT01660022|515771014|FG001|First Sequence (7 Days)|Adverse Event|0|||
143063214|NCT01660022|515771015|FG002|First Sequence (7 Days)|Adverse Event|0|||
143063215|NCT01660022|515771016|FG003|First Sequence (7 Days)|Adverse Event|0|||
143063216|NCT01660022|515771017|FG004|First Sequence (7 Days)|Adverse Event|1|||
143063217|NCT01660022|515771018|FG005|First Sequence (7 Days)|Adverse Event|3|||
143063218|NCT01660022|515771013|FG000|First Sequence (7 Days)|Protocol Violation|0|||
143063219|NCT01660022|515771014|FG001|First Sequence (7 Days)|Protocol Violation|0|||
143063220|NCT01660022|515771015|FG002|First Sequence (7 Days)|Protocol Violation|0|||
143063221|NCT01660022|515771016|FG003|First Sequence (7 Days)|Protocol Violation|0|||
143063222|NCT01660022|515771017|FG004|First Sequence (7 Days)|Protocol Violation|0|||
143063223|NCT01660022|515771018|FG005|First Sequence (7 Days)|Protocol Violation|1|||
143063224|NCT02149121|515771021|FG000|Main Study Period|Lack of Efficacy|2|||
143063225|NCT02149121|515771022|FG001|Main Study Period|Lack of Efficacy|2|||
143246062|NCT04421027|516451887|FG003|Treatment Period|Physician Decision|0|||
143246063|NCT04421027|516451884|FG000|Treatment Period|Withdrawal by Subject|7|||
143063226|NCT02149121|515771023|FG002|Main Study Period|Lack of Efficacy|1|||
143063227|NCT02149121|515771024|FG003|Main Study Period|Lack of Efficacy|0|||
143063228|NCT02149121|515771025|FG004|Main Study Period|Lack of Efficacy|0|||
143063229|NCT02149121|515771026|FG005|Main Study Period|Lack of Efficacy|0|||
143063230|NCT02149121|515771027|FG006|Main Study Period|Lack of Efficacy|0|||
143063231|NCT02149121|515771021|FG000|Main Study Period|Withdrawal by Subject|9|||
143063232|NCT02149121|515771022|FG001|Main Study Period|Withdrawal by Subject|5|||
143063233|NCT02149121|515771023|FG002|Main Study Period|Withdrawal by Subject|1|||
143063234|NCT02149121|515771024|FG003|Main Study Period|Withdrawal by Subject|0|||
143063235|NCT02149121|515771025|FG004|Main Study Period|Withdrawal by Subject|0|||
143063236|NCT02149121|515771026|FG005|Main Study Period|Withdrawal by Subject|0|||
143063237|NCT02149121|515771027|FG006|Main Study Period|Withdrawal by Subject|0|||
143063238|NCT02149121|515771021|FG000|Main Study Period|Adverse Event|2|||
143063239|NCT02149121|515771022|FG001|Main Study Period|Adverse Event|5|||
143063240|NCT02149121|515771023|FG002|Main Study Period|Adverse Event|1|||
143063241|NCT02149121|515771024|FG003|Main Study Period|Adverse Event|0|||
143063242|NCT02149121|515771025|FG004|Main Study Period|Adverse Event|0|||
143063243|NCT02149121|515771026|FG005|Main Study Period|Adverse Event|0|||
143063244|NCT02149121|515771027|FG006|Main Study Period|Adverse Event|0|||
143063245|NCT02149121|515771021|FG000|Main Study Period|Protocol Violation|2|||
143063246|NCT02149121|515771022|FG001|Main Study Period|Protocol Violation|0|||
143063247|NCT02149121|515771023|FG002|Main Study Period|Protocol Violation|0|||
143063248|NCT02149121|515771024|FG003|Main Study Period|Protocol Violation|0|||
143063249|NCT02149121|515771025|FG004|Main Study Period|Protocol Violation|0|||
143063250|NCT02149121|515771026|FG005|Main Study Period|Protocol Violation|0|||
143063251|NCT02149121|515771027|FG006|Main Study Period|Protocol Violation|0|||
143063252|NCT02149121|515771021|FG000|Main Study Period|Lost to Follow-up|2|||
143063253|NCT02149121|515771022|FG001|Main Study Period|Lost to Follow-up|1|||
143063254|NCT02149121|515771023|FG002|Main Study Period|Lost to Follow-up|0|||
143063255|NCT02149121|515771024|FG003|Main Study Period|Lost to Follow-up|0|||
143063256|NCT02149121|515771025|FG004|Main Study Period|Lost to Follow-up|0|||
143063257|NCT02149121|515771026|FG005|Main Study Period|Lost to Follow-up|0|||
143063258|NCT02149121|515771027|FG006|Main Study Period|Lost to Follow-up|0|||
143063259|NCT02149121|515771021|FG000|Main Study Period|Death|1|||
143063260|NCT02149121|515771022|FG001|Main Study Period|Death|0|||
143063261|NCT02149121|515771023|FG002|Main Study Period|Death|0|||
143063262|NCT02149121|515771024|FG003|Main Study Period|Death|0|||
143063263|NCT02149121|515771025|FG004|Main Study Period|Death|0|||
143063264|NCT02149121|515771026|FG005|Main Study Period|Death|0|||
143063265|NCT02149121|515771027|FG006|Main Study Period|Death|0|||
143063266|NCT02149121|515771021|FG000|Main Study Period|Physician Decision|1|||
143063267|NCT02149121|515771022|FG001|Main Study Period|Physician Decision|0|||
143063268|NCT02149121|515771023|FG002|Main Study Period|Physician Decision|0|||
143063269|NCT02149121|515771024|FG003|Main Study Period|Physician Decision|0|||
143063270|NCT02149121|515771025|FG004|Main Study Period|Physician Decision|0|||
143063271|NCT02149121|515771026|FG005|Main Study Period|Physician Decision|0|||
143063272|NCT02149121|515771027|FG006|Main Study Period|Physician Decision|0|||
143063273|NCT02149121|515771021|FG000|Main Study Period|Developed any malignancy|0|||
143063274|NCT02149121|515771022|FG001|Main Study Period|Developed any malignancy|1|||
143063275|NCT02149121|515771023|FG002|Main Study Period|Developed any malignancy|1|||
143063276|NCT02149121|515771024|FG003|Main Study Period|Developed any malignancy|0|||
143063277|NCT02149121|515771025|FG004|Main Study Period|Developed any malignancy|0|||
143063278|NCT02149121|515771026|FG005|Main Study Period|Developed any malignancy|0|||
143063279|NCT02149121|515771027|FG006|Main Study Period|Developed any malignancy|0|||
143063280|NCT02149121|515771021|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
143063281|NCT02149121|515771022|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
143063282|NCT02149121|515771023|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
143063283|NCT02149121|515771024|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
143502640|NCT01763164|517378590|FG000|Follow up Phase|Adverse Event|17|||
143246064|NCT04421027|516451885|FG001|Treatment Period|Withdrawal by Subject|12|||
143246065|NCT04421027|516451886|FG002|Treatment Period|Withdrawal by Subject|0|||
143502641|NCT01763164|517378591|FG001|Follow up Phase|Adverse Event|1|||
143246066|NCT04421027|516451887|FG003|Treatment Period|Withdrawal by Subject|0|||
143246067|NCT04421027|516451884|FG000|Treatment Period|Randomized Not Dosed|9|||
143502642|NCT03377634|517378592|FG000|Study Period|Adverse Event|1|||
143063284|NCT02149121|515771025|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
143063285|NCT02149121|515771026|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
143063286|NCT02149121|515771027|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
143246068|NCT04421027|516451885|FG001|Treatment Period|Randomized Not Dosed|14|||
143502643|NCT03377634|517378593|FG001|Study Period|Adverse Event|0|||
143502644|NCT03377634|517378592|FG000|Study Period|Withdrawal by Subject|1|||
143063287|NCT02149121|515771021|FG000|Main Study Period|Disease progression|0|||
143063288|NCT02149121|515771022|FG001|Main Study Period|Disease progression|1|||
143063289|NCT02149121|515771023|FG002|Main Study Period|Disease progression|0|||
143246069|NCT04421027|516451886|FG002|Treatment Period|Randomized Not Dosed|0|||
143063290|NCT02149121|515771024|FG003|Main Study Period|Disease progression|0|||
143063291|NCT02149121|515771025|FG004|Main Study Period|Disease progression|0|||
143063292|NCT02149121|515771026|FG005|Main Study Period|Disease progression|0|||
143063293|NCT02149121|515771027|FG006|Main Study Period|Disease progression|0|||
143063294|NCT02149121|515771021|FG000|Extension Study Period|Withdrawal by Subject|0|||
143063295|NCT02149121|515771022|FG001|Extension Study Period|Withdrawal by Subject|0|||
143063296|NCT02149121|515771023|FG002|Extension Study Period|Withdrawal by Subject|0|||
143063297|NCT02149121|515771024|FG003|Extension Study Period|Withdrawal by Subject|1|||
143063298|NCT02149121|515771025|FG004|Extension Study Period|Withdrawal by Subject|0|||
143063299|NCT02149121|515771026|FG005|Extension Study Period|Withdrawal by Subject|2|||
143063300|NCT02149121|515771027|FG006|Extension Study Period|Withdrawal by Subject|0|||
143063301|NCT00766831|515771028|FG000|Overall Study|Withdrawal by Subject|4|||
143063302|NCT00766831|515771028|FG000|Overall Study|Lost to Follow-up|3|||
143063303|NCT00766831|515771028|FG000|Overall Study|Adverse Event|20|||
143063304|NCT00766831|515771028|FG000|Overall Study|Protocol Violation|15|||
143063305|NCT00766831|515771028|FG000|Overall Study|Physician Decision|5|||
143063306|NCT00766831|515771028|FG000|Overall Study|Withdrawal of consent|26|||
143063307|NCT00766831|515771028|FG000|Overall Study|Non cooperation by participants|14|||
143063308|NCT00766831|515771028|FG000|Overall Study|Other|28|||
143063309|NCT03166124|515771029|FG000|Treatment Period 1|Adverse Event|0|||
143063310|NCT03166124|515771030|FG001|Treatment Period 1|Adverse Event|0|||
143063311|NCT03166124|515771031|FG002|Treatment Period 1|Adverse Event|1|||
143502645|NCT03377634|517378593|FG001|Study Period|Withdrawal by Subject|0|||
143502646|NCT01264939|517378594|FG000|Overall Study|Adverse Event|1|||
143502647|NCT01264939|517378595|FG001|Overall Study|Adverse Event|3|||
143502648|NCT01264939|517378594|FG000|Overall Study|Lost to Follow-up|0|||
143502649|NCT01264939|517378595|FG001|Overall Study|Lost to Follow-up|3|||
143502650|NCT01264939|517378594|FG000|Overall Study|Physician Decision|1|||
143502651|NCT01264939|517378595|FG001|Overall Study|Physician Decision|1|||
143502652|NCT01264939|517378594|FG000|Overall Study|Patient/Guardian Decision|8|||
143502653|NCT01264939|517378595|FG001|Overall Study|Patient/Guardian Decision|10|||
143502654|NCT01264939|517378594|FG000|Overall Study|Disease Progression|8|||
143502655|NCT01264939|517378595|FG001|Overall Study|Disease Progression|11|||
143502656|NCT01384292|517378599|FG000|Part B|Severe non-compliance to protocol|1|||
143502657|NCT01384292|517378600|FG001|Part B|Severe non-compliance to protocol|0|||
143502658|NCT01384292|517378601|FG002|Part B|Severe non-compliance to protocol|0|||
143502659|NCT01171612|517378603|FG000|Overall Study|Lost to Follow-up|51|||
143502660|NCT00737529|517378604|FG000|Overall Study|Disease Progression|95|||
143502661|NCT00737529|517378604|FG000|Overall Study|Adverse Event|24|||
143502662|NCT00737529|517378604|FG000|Overall Study|Withdrawal by Subject|5|||
143502663|NCT00737529|517378604|FG000|Overall Study|Death|4|||
143502664|NCT00737529|517378604|FG000|Overall Study|Protocol Violation|1|||
143502665|NCT00737529|517378604|FG000|Overall Study|Other|4|||
143502666|NCT04525703|517378605|FG000|Overall Study|Lost to Follow-up|6|||
143502667|NCT04525703|517378606|FG001|Overall Study|Lost to Follow-up|15|||
143502668|NCT04525703|517378607|FG002|Overall Study|Lost to Follow-up|8|||
143502669|NCT00291551|517378608|FG000|Overall Study|Death|7|||
143502670|NCT00291551|517378608|FG000|Overall Study|Withdrawal by Subject|6|||
143502671|NCT03682120|517378609|FG000|Overall Study|Lost to Follow-up|11|||
143502672|NCT03682120|517378610|FG001|Overall Study|Lost to Follow-up|4|||
143502673|NCT03682120|517378611|FG002|Overall Study|Lost to Follow-up|5|||
143502674|NCT03682120|517378612|FG003|Overall Study|Lost to Follow-up|2|||
143502675|NCT03682120|517378609|FG000|Overall Study|Physician Decision|1|||
143502676|NCT03682120|517378610|FG001|Overall Study|Physician Decision|0|||
143502677|NCT03682120|517378611|FG002|Overall Study|Physician Decision|0|||
143502678|NCT03682120|517378612|FG003|Overall Study|Physician Decision|0|||
143502679|NCT03682120|517378609|FG000|Overall Study|Withdrawal by Subject|1|||
143502680|NCT03682120|517378610|FG001|Overall Study|Withdrawal by Subject|2|||
143063312|NCT03166124|515771032|FG003|Treatment Period 1|Adverse Event|0|||
143063313|NCT03166124|515771029|FG000|Wash-out Period|Withdrawal by Subject|0|||
143063314|NCT03166124|515771030|FG001|Wash-out Period|Withdrawal by Subject|1|||
143063315|NCT03166124|515771031|FG002|Wash-out Period|Withdrawal by Subject|0|||
143502681|NCT03682120|517378611|FG002|Overall Study|Withdrawal by Subject|3|||
143502682|NCT03682120|517378612|FG003|Overall Study|Withdrawal by Subject|0|||
143502683|NCT03682120|517378609|FG000|Overall Study|Death|0|||
143502684|NCT03682120|517378610|FG001|Overall Study|Death|1|||
143502685|NCT03682120|517378611|FG002|Overall Study|Death|0|||
143502686|NCT03682120|517378612|FG003|Overall Study|Death|0|||
143502687|NCT03682120|517378609|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
143063316|NCT03166124|515771032|FG003|Wash-out Period|Withdrawal by Subject|1|||
143063317|NCT03166124|515771029|FG000|Wash-out Period|Adverse Event|0|||
143063318|NCT03166124|515771030|FG001|Wash-out Period|Adverse Event|1|||
143063319|NCT03166124|515771031|FG002|Wash-out Period|Adverse Event|1|||
143170210|NCT04392154|516171885|FG002|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
143502688|NCT03682120|517378610|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
143502689|NCT03682120|517378611|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
143502690|NCT03682120|517378612|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
143502691|NCT01015833|517378613|FG000|Overall Study|Death|1|||
143063320|NCT03166124|515771032|FG003|Wash-out Period|Adverse Event|0|||
143063321|NCT00788593|515771035|FG000|Placebo Run-in Phase|Adverse Event|2|||
143063322|NCT00788593|515771036|FG001|Placebo Run-in Phase|Adverse Event|0|||
143063323|NCT00788593|515771037|FG002|Placebo Run-in Phase|Adverse Event|0|||
143063324|NCT00788593|515771035|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
143063325|NCT00788593|515771036|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
143063326|NCT00788593|515771037|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
143063327|NCT00788593|515771035|FG000|Placebo Run-in Phase|Protocol Violation|2|||
143063328|NCT00788593|515771036|FG001|Placebo Run-in Phase|Protocol Violation|0|||
143063329|NCT00788593|515771037|FG002|Placebo Run-in Phase|Protocol Violation|0|||
143063330|NCT00788593|515771035|FG000|First Intervention Period|Adverse Event|0|||
143063331|NCT00788593|515771036|FG001|First Intervention Period|Adverse Event|1|||
143170211|NCT04392154|516171886|FG003|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
143170212|NCT04392154|516171883|FG000|Primary Treatment Period (100 Weeks)|Site Closure|0|||
143170213|NCT04392154|516171884|FG001|Primary Treatment Period (100 Weeks)|Site Closure|4|||
143502692|NCT01015833|517378614|FG001|Overall Study|Death|0|||
143502693|NCT01015833|517378613|FG000|Overall Study|Withdrawal by Subject|3|||
143063332|NCT00788593|515771037|FG002|First Intervention Period|Adverse Event|0|||
143502694|NCT01015833|517378614|FG001|Overall Study|Withdrawal by Subject|2|||
143502695|NCT01015833|517378613|FG000|Overall Study|Adverse Event|0|||
143063333|NCT00788593|515771035|FG000|Second Intervention Period|Lost to Follow-up|0|||
143063334|NCT00788593|515771036|FG001|Second Intervention Period|Lost to Follow-up|1|||
143063335|NCT00788593|515771037|FG002|Second Intervention Period|Lost to Follow-up|0|||
143063336|NCT00788593|515771035|FG000|Second Intervention Period|Other|0|||
143063337|NCT00788593|515771036|FG001|Second Intervention Period|Other|0|||
143063338|NCT00788593|515771037|FG002|Second Intervention Period|Other|1|||
143063339|NCT00515034|515771038|FG000|Overall Study|Adverse Event|2|||
143063340|NCT00515034|515771039|FG001|Overall Study|Adverse Event|0|||
143063341|NCT00515034|515771040|FG002|Overall Study|Adverse Event|1|||
143063342|NCT00515034|515771041|FG003|Overall Study|Adverse Event|0|||
143063343|NCT00515034|515771038|FG000|Overall Study|Death|4|||
143063344|NCT00515034|515771039|FG001|Overall Study|Death|2|||
143063345|NCT00515034|515771040|FG002|Overall Study|Death|1|||
143063346|NCT00515034|515771041|FG003|Overall Study|Death|3|||
143063347|NCT00515034|515771038|FG000|Overall Study|Withdrawal by Subject|1|||
143063348|NCT00515034|515771039|FG001|Overall Study|Withdrawal by Subject|0|||
143063349|NCT00515034|515771040|FG002|Overall Study|Withdrawal by Subject|3|||
143502696|NCT01015833|517378614|FG001|Overall Study|Adverse Event|1|||
143502697|NCT01015833|517378613|FG000|Overall Study|Physician Decision|2|||
143502698|NCT01015833|517378614|FG001|Overall Study|Physician Decision|0|||
143502699|NCT01015833|517378613|FG000|Overall Study|Symptomatic deterioration|0|||
143502700|NCT01015833|517378614|FG001|Overall Study|Symptomatic deterioration|1|||
143502701|NCT01015833|517378613|FG000|Overall Study|Other|5|||
143063350|NCT00515034|515771041|FG003|Overall Study|Withdrawal by Subject|0|||
143170214|NCT04392154|516171885|FG002|Primary Treatment Period (100 Weeks)|Site Closure|0|||
143170215|NCT04392154|516171886|FG003|Primary Treatment Period (100 Weeks)|Site Closure|0|||
143170216|NCT04392154|516171883|FG000|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
143170217|NCT04392154|516171884|FG001|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
143170218|NCT04392154|516171885|FG002|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
143170219|NCT04392154|516171886|FG003|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|1|||
143170220|NCT04392154|516171883|FG000|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
143170221|NCT04392154|516171884|FG001|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
143170222|NCT04392154|516171885|FG002|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|1|||
143170223|NCT04392154|516171886|FG003|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
143170224|NCT04392154|516171883|FG000|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
143170225|NCT04392154|516171884|FG001|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
143170226|NCT04392154|516171885|FG002|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
143170227|NCT04392154|516171886|FG003|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|1|||
143170228|NCT02661815|516171889|FG000|Overall Study|Withdrawal by Subject|1|||
143170229|NCT02661815|516171890|FG001|Overall Study|Withdrawal by Subject|0|||
143170230|NCT02661815|516171891|FG002|Overall Study|Withdrawal by Subject|0|||
143365144|NCT03499600|516878811|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
143502702|NCT01015833|517378614|FG001|Overall Study|Other|1|||
143502703|NCT01015833|517378613|FG000|Overall Study|Motor Vehicle Accidents|1|||
143502704|NCT01015833|517378614|FG001|Overall Study|Motor Vehicle Accidents|0|||
143502705|NCT01015833|517378613|FG000|Overall Study|Did not start treatment|1|||
143502706|NCT01015833|517378614|FG001|Overall Study|Did not start treatment|0|||
143063351|NCT00515034|515771038|FG000|Overall Study|Physician Decision|0|||
143063352|NCT00515034|515771039|FG001|Overall Study|Physician Decision|0|||
143063353|NCT00515034|515771040|FG002|Overall Study|Physician Decision|1|||
143063354|NCT00515034|515771041|FG003|Overall Study|Physician Decision|1|||
143502707|NCT00996203|517378615|FG000|Overall Study|Adverse Event|3|||
143063355|NCT00515034|515771038|FG000|Overall Study|Other|1|||
143063356|NCT00515034|515771039|FG001|Overall Study|Other|0|||
143063357|NCT00515034|515771040|FG002|Overall Study|Other|2|||
143063358|NCT00515034|515771041|FG003|Overall Study|Other|1|||
143063359|NCT05626803|515773244|FG000|Overall Study|Lost to Follow-up|0|||
143063360|NCT05626803|515773245|FG001|Overall Study|Lost to Follow-up|1|||
143063361|NCT05626803|515773246|FG002|Overall Study|Lost to Follow-up|0|||
143063362|NCT05626803|515773247|FG003|Overall Study|Lost to Follow-up|0|||
143063363|NCT01010126|515773248|FG000|Overall Study|Withdrawal by Subject|1|||
143063364|NCT01010126|515773249|FG001|Overall Study|Withdrawal by Subject|0|||
143063365|NCT01010126|515773250|FG002|Overall Study|Withdrawal by Subject|1|||
143063366|NCT01010126|515773251|FG003|Overall Study|Withdrawal by Subject|0|||
143063367|NCT01010126|515773252|FG004|Overall Study|Withdrawal by Subject|3|||
143063368|NCT01010126|515773253|FG005|Overall Study|Withdrawal by Subject|0|||
143063369|NCT00493246|515773256|FG000|Overall Study|Withdrawal by Subject|0|||
143063370|NCT00493246|515773257|FG001|Overall Study|Withdrawal by Subject|0|||
143063371|NCT00493246|515773258|FG002|Overall Study|Withdrawal by Subject|0|||
143063372|NCT00493246|515773259|FG003|Overall Study|Withdrawal by Subject|0|||
143063373|NCT00493246|515773260|FG004|Overall Study|Withdrawal by Subject|1|||
143063374|NCT00493246|515773261|FG005|Overall Study|Withdrawal by Subject|0|||
143063375|NCT00493246|515773262|FG006|Overall Study|Withdrawal by Subject|0|||
143063376|NCT00493246|515773263|FG007|Overall Study|Withdrawal by Subject|0|||
143063377|NCT00493246|515773256|FG000|Overall Study|No access to draw blood|0|||
143063378|NCT00493246|515773257|FG001|Overall Study|No access to draw blood|0|||
143063379|NCT00493246|515773258|FG002|Overall Study|No access to draw blood|0|||
143063380|NCT00493246|515773259|FG003|Overall Study|No access to draw blood|0|||
143063381|NCT00493246|515773260|FG004|Overall Study|No access to draw blood|0|||
143063382|NCT00493246|515773261|FG005|Overall Study|No access to draw blood|1|||
143063383|NCT00493246|515773262|FG006|Overall Study|No access to draw blood|0|||
143063384|NCT00493246|515773263|FG007|Overall Study|No access to draw blood|0|||
143063385|NCT00493246|515773256|FG000|Overall Study|Lost to Follow-up|0|||
143063386|NCT00493246|515773257|FG001|Overall Study|Lost to Follow-up|0|||
143063387|NCT00493246|515773258|FG002|Overall Study|Lost to Follow-up|0|||
143063388|NCT00493246|515773259|FG003|Overall Study|Lost to Follow-up|0|||
143063389|NCT00493246|515773260|FG004|Overall Study|Lost to Follow-up|0|||
143063390|NCT00493246|515773261|FG005|Overall Study|Lost to Follow-up|0|||
143063391|NCT00493246|515773262|FG006|Overall Study|Lost to Follow-up|1|||
143063392|NCT00493246|515773263|FG007|Overall Study|Lost to Follow-up|0|||
143063393|NCT02698865|515773264|FG000|Overall Study|Other|11|||
143063394|NCT02698865|515773265|FG001|Overall Study|Other|11|||
143063395|NCT02698865|515773264|FG000|Overall Study|Withdrawal by Subject|20|||
143063396|NCT02698865|515773265|FG001|Overall Study|Withdrawal by Subject|16|||
143063397|NCT02698865|515773264|FG000|Overall Study|Physician Decision|0|||
143063398|NCT02698865|515773265|FG001|Overall Study|Physician Decision|4|||
143063399|NCT02698865|515773264|FG000|Overall Study|Lost to Follow-up|4|||
143063400|NCT02698865|515773265|FG001|Overall Study|Lost to Follow-up|2|||
143063401|NCT03861481|515773268|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
143063402|NCT03861481|515773269|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
143063403|NCT03861481|515773268|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
143063404|NCT03861481|515773269|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
143063405|NCT03861481|515773268|FG000|Overall Study|Relapse|1|||
143063406|NCT03861481|515773269|FG001|Overall Study|Relapse|0|||
143063407|NCT03861481|515773268|FG000|Overall Study|Withdrawal by Subject|0|||
143063408|NCT03861481|515773269|FG001|Overall Study|Withdrawal by Subject|1|||
143063409|NCT03861481|515773268|FG000|Overall Study|Lack of Efficacy|4|||
143063410|NCT03861481|515773269|FG001|Overall Study|Lack of Efficacy|5|||
143063411|NCT00773734|515773270|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
143063412|NCT00773734|515773271|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
143063413|NCT00773734|515773272|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
143063414|NCT00773734|515773273|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
143063415|NCT00773734|515773274|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
143063416|NCT00773734|515773275|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
143063417|NCT00773734|515773270|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
143063418|NCT00773734|515773271|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
143063419|NCT00773734|515773272|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
143063420|NCT00773734|515773273|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
143063421|NCT00773734|515773274|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
143063422|NCT00773734|515773275|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
143063423|NCT00773734|515773270|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
143063424|NCT00773734|515773271|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
143063425|NCT00773734|515773272|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
143063426|NCT00773734|515773273|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
143063427|NCT00773734|515773274|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
143063428|NCT00773734|515773275|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
143063429|NCT00773734|515773270|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
143502708|NCT00996203|517378615|FG000|Overall Study|Lost to Follow-up|1|||
143063430|NCT00773734|515773271|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
143063431|NCT00773734|515773272|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
143063432|NCT00773734|515773273|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
143063433|NCT00773734|515773274|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
143063434|NCT00773734|515773275|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
143063435|NCT00773734|515773270|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
143063436|NCT00773734|515773271|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
143063437|NCT00773734|515773272|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
143063438|NCT00773734|515773273|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
143063439|NCT00773734|515773274|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
143063440|NCT00773734|515773275|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
143063441|NCT00773734|515773270|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
143063442|NCT00773734|515773271|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
143063443|NCT00773734|515773272|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
143063444|NCT00773734|515773273|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
143063445|NCT00773734|515773274|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
143063446|NCT00773734|515773275|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
143063447|NCT00773734|515773270|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
143063448|NCT00773734|515773271|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
143063449|NCT00773734|515773272|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
143063450|NCT00773734|515773273|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
143063451|NCT00773734|515773274|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
143063452|NCT00773734|515773275|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
143063453|NCT00773734|515773270|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
143063454|NCT00773734|515773271|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
143063455|NCT00773734|515773272|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
143063456|NCT00773734|515773273|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
143063457|NCT00773734|515773274|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
143170231|NCT02661815|516171892|FG003|Overall Study|Withdrawal by Subject|0|||
143502709|NCT00996203|517378615|FG000|Overall Study|Lack of Efficacy|1|||
143502710|NCT00996203|517378615|FG000|Overall Study|Protocol Violation|2|||
143502711|NCT01929135|517378617|FG000|Overall Study|Lost to Follow-up|1|||
143502712|NCT01929135|517378618|FG001|Overall Study|Lost to Follow-up|1|||
143502713|NCT04280081|517378630|FG000|Overall Study|Adverse Event|4|||
143502714|NCT04280081|517378630|FG000|Overall Study|Death|2|||
143170232|NCT00654355|516171902|FG000|Overall Study|Lost to Follow-up|2|||
143502715|NCT04280081|517378630|FG000|Overall Study|Progressive Disease|6|||
143502716|NCT03219164|517380881|FG000|Overall Study|Study Terminated by Sponsor|16|||
143502717|NCT03219164|517380882|FG001|Overall Study|Study Terminated by Sponsor|12|||
143502718|NCT03219164|517380881|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
143502719|NCT03219164|517380882|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
143502720|NCT03219164|517380881|FG000|Overall Study|Lost to Follow-up|1|||
143502721|NCT03219164|517380882|FG001|Overall Study|Lost to Follow-up|1|||
143502722|NCT03219164|517380881|FG000|Overall Study|Adverse Event|1|||
143502723|NCT03219164|517380882|FG001|Overall Study|Adverse Event|0|||
143502724|NCT03219164|517380881|FG000|Overall Study|Non-Compliance with Study Drug|1|||
143502725|NCT03219164|517380882|FG001|Overall Study|Non-Compliance with Study Drug|0|||
143502726|NCT03219164|517380881|FG000|Overall Study|Protocol Violation|0|||
143502727|NCT03219164|517380882|FG001|Overall Study|Protocol Violation|1|||
143502728|NCT03219164|517380881|FG000|Overall Study|Withdrew Assent|1|||
143502729|NCT03219164|517380882|FG001|Overall Study|Withdrew Assent|0|||
143502730|NCT02732951|517380883|FG000|Overall Study|Other than listed|1|||
143502731|NCT02732951|517380884|FG001|Overall Study|Other than listed|0|||
143502732|NCT02732951|517380883|FG000|Overall Study|Lost to Follow-up|0|||
143502733|NCT02732951|517380884|FG001|Overall Study|Lost to Follow-up|1|||
143502734|NCT02732951|517380883|FG000|Overall Study|Adverse Event|4|||
143502735|NCT02732951|517380884|FG001|Overall Study|Adverse Event|4|||
143502736|NCT02732951|517380883|FG000|Overall Study|Protocol Violation|0|||
143502737|NCT02732951|517380884|FG001|Overall Study|Protocol Violation|1|||
143502738|NCT01750918|517380885|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
143502739|NCT01750918|517380886|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
143063458|NCT00773734|515773275|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
143063459|NCT00773734|515773270|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
143063460|NCT00773734|515773271|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
143170233|NCT00654355|516171903|FG001|Overall Study|Lost to Follow-up|2|||
143170234|NCT05805150|516171908|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
143502740|NCT01750918|517380887|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
143502741|NCT01750918|517380888|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
143502742|NCT01750918|517380889|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
143502743|NCT01750918|517380890|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
143063461|NCT00773734|515773272|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
143063462|NCT00773734|515773273|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
143063463|NCT00773734|515773274|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
143063464|NCT00773734|515773275|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
143063465|NCT00773734|515773270|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
143063466|NCT00773734|515773271|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
143063467|NCT00773734|515773272|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
143063468|NCT00773734|515773273|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
143063469|NCT00773734|515773274|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
143063470|NCT00773734|515773275|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
143063471|NCT00773734|515773270|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
143063472|NCT00773734|515773271|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
143063473|NCT00773734|515773272|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
143063474|NCT00773734|515773273|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
143063475|NCT00773734|515773274|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
143063476|NCT00773734|515773275|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
143063477|NCT00773734|515773270|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
143063478|NCT00773734|515773271|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
143063479|NCT00773734|515773272|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
143063480|NCT00773734|515773273|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
143063481|NCT00773734|515773274|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
143063482|NCT00773734|515773275|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
143063483|NCT00773734|515773270|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
143063484|NCT00773734|515773271|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
143063485|NCT00773734|515773272|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
143063486|NCT00773734|515773273|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
143063487|NCT00773734|515773274|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
143063488|NCT00773734|515773275|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
143063489|NCT00773734|515773270|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
143063490|NCT00773734|515773271|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
143063491|NCT00773734|515773272|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
143063492|NCT00773734|515773273|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
143063493|NCT00773734|515773274|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
143063494|NCT00773734|515773275|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
143063495|NCT00773734|515773270|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
143063496|NCT00773734|515773271|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
143063497|NCT00773734|515773272|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
143063498|NCT00773734|515773273|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
143063499|NCT00773734|515773274|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
143063500|NCT00773734|515773275|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
143063501|NCT00773734|515773270|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
143063502|NCT00773734|515773271|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
143063503|NCT00773734|515773272|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
143063504|NCT00773734|515773273|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
143063505|NCT00773734|515773274|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
143063506|NCT00773734|515773275|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
143063507|NCT00773734|515773270|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
143063508|NCT00773734|515773271|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
143063509|NCT00773734|515773272|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
143063510|NCT00773734|515773273|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
143063511|NCT00773734|515773274|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
143063512|NCT00773734|515773275|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
143063513|NCT00773734|515773270|FG000|Extension: Active Treatment Week 24-52|Other|0|||
143063514|NCT00773734|515773271|FG001|Extension: Active Treatment Week 24-52|Other|0|||
143063515|NCT00773734|515773272|FG002|Extension: Active Treatment Week 24-52|Other|1|||
143063516|NCT00773734|515773273|FG003|Extension: Active Treatment Week 24-52|Other|2|||
143063517|NCT00773734|515773274|FG004|Extension: Active Treatment Week 24-52|Other|0|||
143063518|NCT00773734|515773275|FG005|Extension: Active Treatment Week 24-52|Other|1|||
143063519|NCT00773734|515773270|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
143063520|NCT00773734|515773271|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
143063521|NCT00773734|515773272|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
143063522|NCT00773734|515773273|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
143063523|NCT00773734|515773274|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
143063524|NCT00773734|515773275|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
143063525|NCT00773734|515773270|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
143063526|NCT00773734|515773271|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
143063527|NCT00773734|515773272|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
143063528|NCT00773734|515773273|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
143063529|NCT00773734|515773274|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
143063530|NCT00773734|515773275|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
143063531|NCT00773734|515773270|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
143063532|NCT00773734|515773271|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
143063533|NCT00773734|515773272|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
143063534|NCT00773734|515773273|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
143063535|NCT00773734|515773274|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
143063536|NCT00773734|515773275|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
143063537|NCT00773734|515773270|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
143063538|NCT00773734|515773271|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
143063539|NCT00773734|515773272|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
143063540|NCT00773734|515773273|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
143063541|NCT00773734|515773274|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
143063542|NCT00773734|515773275|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
143063543|NCT02148913|515773276|FG000|Overall Study|Death|0|||
143063544|NCT02148913|515773277|FG001|Overall Study|Death|1|||
143063545|NCT02148913|515773278|FG002|Overall Study|Death|0|||
143063546|NCT02148913|515773279|FG003|Overall Study|Death|0|||
143063547|NCT01287039|515773280|FG000|Overall Study|Noncompliance with study procedures|0|||
143063548|NCT01287039|515773281|FG001|Overall Study|Noncompliance with study procedures|1|||
143063549|NCT01287039|515773280|FG000|Overall Study|Change of location/residence|0|||
143063550|NCT01287039|515773281|FG001|Overall Study|Change of location/residence|3|||
143063551|NCT01287039|515773280|FG000|Overall Study|Elective surgery|0|||
143063552|NCT01287039|515773281|FG001|Overall Study|Elective surgery|1|||
143063553|NCT01287039|515773280|FG000|Overall Study|Protocol Violation|2|||
143063554|NCT01287039|515773281|FG001|Overall Study|Protocol Violation|3|||
143063555|NCT01287039|515773280|FG000|Overall Study|Excluded medication taken|1|||
143063556|NCT01287039|515773281|FG001|Overall Study|Excluded medication taken|0|||
143063557|NCT01287039|515773280|FG000|Overall Study|Noncompliance with study medication|0|||
143063558|NCT01287039|515773281|FG001|Overall Study|Noncompliance with study medication|1|||
143063559|NCT01287039|515773280|FG000|Overall Study|Problem with travel|0|||
143063560|NCT01287039|515773281|FG001|Overall Study|Problem with travel|1|||
143063561|NCT01287039|515773280|FG000|Overall Study|Death|1|||
143063562|NCT01287039|515773281|FG001|Overall Study|Death|0|||
143063563|NCT01287039|515773280|FG000|Overall Study|Change of residence|1|||
143063564|NCT01287039|515773281|FG001|Overall Study|Change of residence|0|||
143063565|NCT01287039|515773280|FG000|Overall Study|Adverse Event|7|||
143063566|NCT01287039|515773281|FG001|Overall Study|Adverse Event|4|||
143063567|NCT01287039|515773280|FG000|Overall Study|Withdrawal by Subject|14|||
143063568|NCT01287039|515773281|FG001|Overall Study|Withdrawal by Subject|11|||
143063569|NCT01287039|515773280|FG000|Overall Study|Lost to Follow-up|3|||
143063570|NCT01287039|515773281|FG001|Overall Study|Lost to Follow-up|2|||
143063571|NCT05016622|515773282|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
143063572|NCT05016622|515773282|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
143063573|NCT01304693|515773283|FG000|Overall Study|Adverse Event|0|||
143063574|NCT01304693|515773284|FG001|Overall Study|Adverse Event|0|||
143063575|NCT01304693|515773285|FG002|Overall Study|Adverse Event|0|||
143063576|NCT01304693|515773286|FG003|Overall Study|Adverse Event|0|||
143063577|NCT01304693|515773287|FG004|Overall Study|Adverse Event|1|||
143063578|NCT01304693|515773283|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
143063579|NCT01304693|515773284|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
143063580|NCT01304693|515773285|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
143063581|NCT01304693|515773286|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
143063582|NCT01304693|515773287|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
143063583|NCT03575871|515773288|FG000|Overall Study|Adverse Event|5|||
143063584|NCT03575871|515773289|FG001|Overall Study|Adverse Event|5|||
143063585|NCT03575871|515773290|FG002|Overall Study|Adverse Event|8|||
143063586|NCT03575871|515773288|FG000|Overall Study|Death|1|||
143063587|NCT03575871|515773289|FG001|Overall Study|Death|0|||
143063588|NCT03575871|515773290|FG002|Overall Study|Death|0|||
143063589|NCT03575871|515773288|FG000|Overall Study|Lack of Efficacy|5|||
143063590|NCT03575871|515773289|FG001|Overall Study|Lack of Efficacy|4|||
143502744|NCT01750918|517380891|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
143502745|NCT01750918|517380892|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
143502746|NCT01750918|517380885|FG000|Overall Study|Lost to Follow-up|0|||
143502747|NCT01750918|517380886|FG001|Overall Study|Lost to Follow-up|0|||
143502748|NCT01750918|517380887|FG002|Overall Study|Lost to Follow-up|2|||
143502749|NCT01750918|517380888|FG003|Overall Study|Lost to Follow-up|2|||
143502750|NCT01750918|517380889|FG004|Overall Study|Lost to Follow-up|0|||
143063591|NCT03575871|515773290|FG002|Overall Study|Lack of Efficacy|7|||
143063592|NCT03575871|515773288|FG000|Overall Study|Lost to Follow-up|1|||
143063593|NCT03575871|515773289|FG001|Overall Study|Lost to Follow-up|1|||
143063594|NCT03575871|515773290|FG002|Overall Study|Lost to Follow-up|1|||
143063595|NCT03575871|515773288|FG000|Overall Study|Protocol Deviation|1|||
143063596|NCT03575871|515773289|FG001|Overall Study|Protocol Deviation|1|||
143063597|NCT03575871|515773290|FG002|Overall Study|Protocol Deviation|1|||
143063598|NCT03575871|515773288|FG000|Overall Study|Withdrawal by Subject|6|||
143063599|NCT03575871|515773289|FG001|Overall Study|Withdrawal by Subject|1|||
143063600|NCT03575871|515773290|FG002|Overall Study|Withdrawal by Subject|9|||
143063601|NCT03575871|515773288|FG000|Overall Study|Other than specified|2|||
143063602|NCT03575871|515773289|FG001|Overall Study|Other than specified|2|||
143063603|NCT03575871|515773290|FG002|Overall Study|Other than specified|0|||
143063604|NCT01045993|515773291|FG000|Overall Study|Treated-later found eligibility not met|0|||
143063605|NCT01045993|515773292|FG001|Overall Study|Treated-later found eligibility not met|1|||
143063606|NCT01045993|515773293|FG002|Overall Study|Treated-later found eligibility not met|0|||
143063607|NCT01045993|515773294|FG003|Overall Study|Treated-later found eligibility not met|0|||
143063608|NCT02581163|515773299|FG000|Overall Study|Failure to return|15|||
143063609|NCT02581163|515773299|FG000|Overall Study|Insufficient virological response|3|||
143063610|NCT02581163|515773299|FG000|Overall Study|Withdrew consent|1|||
143063611|NCT02581163|515773299|FG000|Overall Study|Death|1|||
143063612|NCT02581163|515773299|FG000|Overall Study|Other, not specified|9|||
143063613|NCT03438396|515773300|FG000|Overall Study|Reason Not Specified|9|||
143063614|NCT03438396|515773300|FG000|Overall Study|Withdrawal by Subject|5|||
143063615|NCT03438396|515773300|FG000|Overall Study|Lost to Follow-up|2|||
143063616|NCT03438396|515773300|FG000|Overall Study|Death|85|||
143063617|NCT03438396|515773300|FG000|Overall Study|Not treated|1|||
143063618|NCT01744093|515773304|FG000|Overall Study|Withdrawal by Subject|6|||
143063619|NCT01744093|515773305|FG001|Overall Study|Withdrawal by Subject|1|||
143063620|NCT02006628|515773306|FG000|Overall Study|Adverse Event|1|||
143063621|NCT02006628|515773307|FG001|Overall Study|Adverse Event|1|||
143063622|NCT02006628|515773306|FG000|Overall Study|Withdrawal by Subject|2|||
143063623|NCT02006628|515773307|FG001|Overall Study|Withdrawal by Subject|1|||
143063624|NCT02384941|515773308|FG000|Overall Study|Adverse Event|11|||
143063625|NCT02384941|515773309|FG001|Overall Study|Adverse Event|13|||
143063626|NCT02384941|515773310|FG002|Overall Study|Adverse Event|17|||
143063627|NCT02384941|515773308|FG000|Overall Study|Lost to Follow-up|3|||
143063628|NCT02384941|515773309|FG001|Overall Study|Lost to Follow-up|2|||
143063629|NCT02384941|515773310|FG002|Overall Study|Lost to Follow-up|1|||
143063630|NCT02384941|515773308|FG000|Overall Study|Non-Compliance With Study Drug|2|||
143063631|NCT02384941|515773309|FG001|Overall Study|Non-Compliance With Study Drug|0|||
143063632|NCT02384941|515773310|FG002|Overall Study|Non-Compliance With Study Drug|1|||
143063633|NCT02384941|515773308|FG000|Overall Study|Physician Decision|1|||
143063634|NCT02384941|515773309|FG001|Overall Study|Physician Decision|1|||
143063635|NCT02384941|515773310|FG002|Overall Study|Physician Decision|0|||
143063636|NCT02384941|515773308|FG000|Overall Study|Protocol Violation|3|||
143063637|NCT02384941|515773309|FG001|Overall Study|Protocol Violation|0|||
143063638|NCT02384941|515773310|FG002|Overall Study|Protocol Violation|0|||
143063639|NCT02384941|515773308|FG000|Overall Study|Withdrawal by Subject|26|||
143063640|NCT02384941|515773309|FG001|Overall Study|Withdrawal by Subject|19|||
143063641|NCT02384941|515773310|FG002|Overall Study|Withdrawal by Subject|20|||
143063642|NCT02384941|515773308|FG000|Overall Study|Pregnancy|0|||
143063643|NCT02384941|515773309|FG001|Overall Study|Pregnancy|0|||
143063644|NCT02384941|515773310|FG002|Overall Study|Pregnancy|1|||
143063645|NCT02384941|515773308|FG000|Overall Study|Other than specified above|4|||
143063646|NCT02384941|515773309|FG001|Overall Study|Other than specified above|0|||
143246070|NCT04421027|516451887|FG003|Treatment Period|Randomized Not Dosed|0|||
143246071|NCT04421027|516451884|FG000|Follow-Up Period|Adverse Event|0|||
143246072|NCT04421027|516451885|FG001|Follow-Up Period|Adverse Event|0|||
143246073|NCT04421027|516451886|FG002|Follow-Up Period|Adverse Event|0|||
143246074|NCT04421027|516451887|FG003|Follow-Up Period|Adverse Event|3|||
143246075|NCT04421027|516451884|FG000|Follow-Up Period|Death|0|||
143246076|NCT04421027|516451885|FG001|Follow-Up Period|Death|0|||
143246077|NCT04421027|516451886|FG002|Follow-Up Period|Death|16|||
143063647|NCT02384941|515773310|FG002|Overall Study|Other than specified above|1|||
143063648|NCT02493777|515773311|FG000|Overall Study|Lost to Follow-up|0|||
143063649|NCT02493777|515773312|FG001|Overall Study|Lost to Follow-up|1|||
143063650|NCT05611996|515773313|FG000|Overall Study|Ineligible|1|||
143063651|NCT05611996|515773313|FG000|Overall Study|Withdrawal by Subject|9|||
143063652|NCT04479475|515773314|FG000|Overall Study|Withdrawal by Subject|7|||
143063653|NCT02025010|515773315|FG000|Overall Study|Symptomatic or radiographic progression|36|||
143063654|NCT02025010|515773315|FG000|Overall Study|Adverse Event|6|||
143246078|NCT04421027|516451887|FG003|Follow-Up Period|Death|17|||
143246079|NCT04421027|516451884|FG000|Follow-Up Period|Lost to Follow-up|0|||
143063655|NCT02025010|515773315|FG000|Overall Study|Physician Decision|7|||
143063656|NCT02025010|515773315|FG000|Overall Study|Withdrawal by Subject|3|||
143502751|NCT01750918|517380890|FG005|Overall Study|Lost to Follow-up|0|||
143063657|NCT02025010|515773315|FG000|Overall Study|Intercurrent illness|3|||
143063658|NCT02025010|515773315|FG000|Overall Study|Patients still on treatment|3|||
143063659|NCT02025010|515773315|FG000|Overall Study|Never initiate the treatment|2|||
143063660|NCT05560763|515773316|FG000|Overall Study|Withdrawal by Subject|4|||
143246080|NCT04421027|516451885|FG001|Follow-Up Period|Lost to Follow-up|0|||
143063661|NCT00296491|515773318|FG000|Overall Study|Low Pollen Counts|18|||
143063662|NCT00296491|515773319|FG001|Overall Study|Low Pollen Counts|26|||
143063663|NCT00296491|515773320|FG002|Overall Study|Low Pollen Counts|25|||
143063664|NCT00296491|515773321|FG003|Overall Study|Low Pollen Counts|16|||
143063665|NCT00296491|515773318|FG000|Overall Study|Protocol Violation|4|||
143063666|NCT00296491|515773319|FG001|Overall Study|Protocol Violation|6|||
143063667|NCT00296491|515773320|FG002|Overall Study|Protocol Violation|2|||
143063668|NCT00296491|515773321|FG003|Overall Study|Protocol Violation|3|||
143063669|NCT00296491|515773318|FG000|Overall Study|Adverse Event|1|||
143063670|NCT00296491|515773319|FG001|Overall Study|Adverse Event|3|||
143246081|NCT04421027|516451886|FG002|Follow-Up Period|Lost to Follow-up|7|||
143246082|NCT04421027|516451887|FG003|Follow-Up Period|Lost to Follow-up|7|||
143063671|NCT00296491|515773320|FG002|Overall Study|Adverse Event|1|||
143063672|NCT00296491|515773321|FG003|Overall Study|Adverse Event|4|||
143063673|NCT00296491|515773318|FG000|Overall Study|Withdrawn due to Asthma|0|||
143063674|NCT00296491|515773319|FG001|Overall Study|Withdrawn due to Asthma|0|||
143063675|NCT00296491|515773320|FG002|Overall Study|Withdrawn due to Asthma|0|||
143063676|NCT00296491|515773321|FG003|Overall Study|Withdrawn due to Asthma|4|||
143063677|NCT00296491|515773318|FG000|Overall Study|Withdrawal by Subject|7|||
143063678|NCT00296491|515773319|FG001|Overall Study|Withdrawal by Subject|3|||
143063679|NCT00296491|515773320|FG002|Overall Study|Withdrawal by Subject|3|||
143063680|NCT00296491|515773321|FG003|Overall Study|Withdrawal by Subject|2|||
143063681|NCT00296491|515773318|FG000|Overall Study|Non-Compliance|12|||
143063682|NCT00296491|515773319|FG001|Overall Study|Non-Compliance|13|||
143063683|NCT00296491|515773320|FG002|Overall Study|Non-Compliance|10|||
143063684|NCT00296491|515773321|FG003|Overall Study|Non-Compliance|14|||
143063685|NCT00296491|515773318|FG000|Overall Study|Lost to Follow-up|0|||
143063686|NCT00296491|515773319|FG001|Overall Study|Lost to Follow-up|2|||
143063687|NCT00296491|515773320|FG002|Overall Study|Lost to Follow-up|2|||
143063688|NCT00296491|515773321|FG003|Overall Study|Lost to Follow-up|0|||
143063689|NCT01300052|515773324|FG000|Overall Study|Adverse Event|3|||
143063690|NCT01300052|515773325|FG001|Overall Study|Adverse Event|0|||
143063691|NCT01300052|515773324|FG000|Overall Study|Withdrawal by Subject|2|||
143063692|NCT01300052|515773325|FG001|Overall Study|Withdrawal by Subject|2|||
143063693|NCT01300052|515773324|FG000|Overall Study|Protocol Violation|1|||
143063694|NCT01300052|515773325|FG001|Overall Study|Protocol Violation|1|||
143063695|NCT06972251|515773326|FG000|Overall Study|Withdrawal by Subject|1|||
143063696|NCT06972251|515773327|FG001|Overall Study|Withdrawal by Subject|0|||
143063697|NCT06972251|515773326|FG000|Overall Study|Lost to Follow-up|10|||
143063698|NCT06972251|515773327|FG001|Overall Study|Lost to Follow-up|2|||
143063699|NCT01661881|515773328|FG000|Overall Study|Disease Progression|1|||
143063700|NCT01231373|515773329|FG000|Overall Study|Withdrew consent prior to randomization|2|||
143063701|NCT01231373|515773330|FG001|Overall Study|Withdrew consent prior to randomization|1|||
143063702|NCT01231373|515773331|FG002|Overall Study|Withdrew consent prior to randomization|0|||
143063703|NCT01231373|515773332|FG003|Overall Study|Withdrew consent prior to randomization|0|||
143063704|NCT01231373|515773329|FG000|Overall Study|Lost to Follow-up|0|||
143063705|NCT01231373|515773330|FG001|Overall Study|Lost to Follow-up|0|||
143063706|NCT01231373|515773331|FG002|Overall Study|Lost to Follow-up|0|||
143063707|NCT01231373|515773332|FG003|Overall Study|Lost to Follow-up|1|||
143063708|NCT01231373|515773329|FG000|Overall Study|Withdrew Consent|1|||
143063709|NCT01231373|515773330|FG001|Overall Study|Withdrew Consent|0|||
143063710|NCT01231373|515773331|FG002|Overall Study|Withdrew Consent|0|||
143063711|NCT01231373|515773332|FG003|Overall Study|Withdrew Consent|0|||
143063712|NCT00949988|515773333|FG000|Overall Study|Withdrawal by Subject|3|||
143063713|NCT02547766|515773334|FG000|Overall Study|Withdrawal by Subject|1|||
143063714|NCT01929395|515773336|FG000|Overall Study|Did not complete - non-related toxicity|1|||
143063715|NCT01929395|515773337|FG001|Overall Study|Did not complete - non-related toxicity|0|||
143063716|NCT01929395|515773338|FG002|Overall Study|Did not complete - non-related toxicity|0|||
143063717|NCT01929395|515773336|FG000|Overall Study|Withdrawal by Subject|0|||
143063718|NCT01929395|515773337|FG001|Overall Study|Withdrawal by Subject|1|||
143063719|NCT01929395|515773338|FG002|Overall Study|Withdrawal by Subject|0|||
143063720|NCT01929395|515773336|FG000|Overall Study|Screen Fail|0|||
143063721|NCT01929395|515773337|FG001|Overall Study|Screen Fail|0|||
143063722|NCT01929395|515773338|FG002|Overall Study|Screen Fail|1|||
143063723|NCT03604341|515773341|FG000|Overall Study|Withdrawal by Subject|1|||
143063724|NCT03604341|515773342|FG001|Overall Study|Withdrawal by Subject|1|||
143063725|NCT03604341|515773341|FG000|Overall Study|Adverse Event|1|||
143063726|NCT03604341|515773342|FG001|Overall Study|Adverse Event|0|||
143063727|NCT03604341|515773341|FG000|Overall Study|Protocol Violation|0|||
143063728|NCT03604341|515773342|FG001|Overall Study|Protocol Violation|1|||
143063729|NCT00484419|515773343|FG000|Overall Study|Adverse Event|3|||
143063730|NCT00484419|515773344|FG001|Overall Study|Adverse Event|0|||
143063731|NCT00484419|515773345|FG002|Overall Study|Adverse Event|0|||
143063732|NCT00484419|515773343|FG000|Overall Study|Lost to Follow-up|1|||
143063733|NCT00484419|515773344|FG001|Overall Study|Lost to Follow-up|0|||
143063734|NCT00484419|515773345|FG002|Overall Study|Lost to Follow-up|2|||
143063735|NCT00484419|515773343|FG000|Overall Study|Withdrawal by Subject|3|||
143063736|NCT00484419|515773344|FG001|Overall Study|Withdrawal by Subject|1|||
143063737|NCT00484419|515773345|FG002|Overall Study|Withdrawal by Subject|1|||
143063738|NCT00484419|515773343|FG000|Overall Study|subject met discontinuation criteria|2|||
143063739|NCT00484419|515773344|FG001|Overall Study|subject met discontinuation criteria|2|||
143063740|NCT00484419|515773345|FG002|Overall Study|subject met discontinuation criteria|4|||
143502752|NCT01750918|517380891|FG006|Overall Study|Lost to Follow-up|0|||
143502753|NCT01750918|517380892|FG007|Overall Study|Lost to Follow-up|1|||
143502754|NCT01750918|517380885|FG000|Overall Study|Withdrawal by Subject|0|||
143502755|NCT01750918|517380886|FG001|Overall Study|Withdrawal by Subject|0|||
143063741|NCT00484419|515773343|FG000|Overall Study|required restricted medication|1|||
143063742|NCT00484419|515773344|FG001|Overall Study|required restricted medication|0|||
143063743|NCT00484419|515773345|FG002|Overall Study|required restricted medication|1|||
143063744|NCT00484419|515773343|FG000|Overall Study|Physician Decision|1|||
143063745|NCT00484419|515773344|FG001|Overall Study|Physician Decision|1|||
143063746|NCT00484419|515773345|FG002|Overall Study|Physician Decision|1|||
143063747|NCT00484419|515773343|FG000|Overall Study|subject unable to receive medication|1|||
143063748|NCT00484419|515773344|FG001|Overall Study|subject unable to receive medication|0|||
143063749|NCT00484419|515773345|FG002|Overall Study|subject unable to receive medication|0|||
143063750|NCT00484419|515773343|FG000|Overall Study|subject relocated|0|||
143063751|NCT00484419|515773344|FG001|Overall Study|subject relocated|1|||
143063752|NCT00484419|515773345|FG002|Overall Study|subject relocated|0|||
143063753|NCT00484419|515773343|FG000|Overall Study|sponsor decision, randomized in error|0|||
143063754|NCT00484419|515773344|FG001|Overall Study|sponsor decision, randomized in error|0|||
143063755|NCT00484419|515773345|FG002|Overall Study|sponsor decision, randomized in error|2|||
143063756|NCT00355472|515773346|FG000|Overall Study|Physician Decision|1|||
143063757|NCT03847194|515773353|FG000|Overall Study|Lost to Follow-up|2|||
143063758|NCT03847194|515773354|FG001|Overall Study|Lost to Follow-up|5|||
143063759|NCT03847194|515773353|FG000|Overall Study|Withdrawal by Subject|1|||
143063760|NCT03847194|515773354|FG001|Overall Study|Withdrawal by Subject|2|||
143063761|NCT03847194|515773353|FG000|Overall Study|Death|0|||
143063762|NCT03847194|515773354|FG001|Overall Study|Death|1|||
143063763|NCT02408120|515773355|FG000|Overall Study|Withdrawal by Subject|0|||
143063764|NCT02408120|515773356|FG001|Overall Study|Withdrawal by Subject|1|||
143063765|NCT02408120|515773355|FG000|Overall Study|Treatment Refusal|1|||
143063766|NCT02408120|515773356|FG001|Overall Study|Treatment Refusal|0|||
143063767|NCT02408120|515773355|FG000|Overall Study|Received Steroids|1|||
143063768|NCT02408120|515773356|FG001|Overall Study|Received Steroids|1|||
143063769|NCT02408120|515773355|FG000|Overall Study|Discharged same day|1|||
143063770|NCT02408120|515773356|FG001|Overall Study|Discharged same day|1|||
143063771|NCT02408120|515773355|FG000|Overall Study|Did not receive insulin|1|||
143063772|NCT02408120|515773356|FG001|Overall Study|Did not receive insulin|2|||
143063773|NCT02990806|515773358|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
143063774|NCT02990806|515773359|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
143063775|NCT02990806|515773360|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
143063776|NCT02990806|515773361|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
143063777|NCT02990806|515773358|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
143063778|NCT02990806|515773359|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
143063779|NCT02990806|515773360|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
143063780|NCT02990806|515773361|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
143063781|NCT02990806|515773358|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
143063782|NCT02990806|515773359|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
143063783|NCT02990806|515773360|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
143063784|NCT02990806|515773361|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
143063785|NCT02990806|515773358|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
143063786|NCT02990806|515773359|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
143063787|NCT02990806|515773360|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
143063788|NCT02990806|515773361|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
143063789|NCT02990806|515773358|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
143063790|NCT02990806|515773359|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
143063791|NCT02990806|515773360|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
143063792|NCT02990806|515773361|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
143170235|NCT05805150|516171909|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
143170236|NCT02284893|516171912|FG000|26 Week (Short Term)|Adverse Event|1|||
143170237|NCT02284893|516171913|FG001|26 Week (Short Term)|Adverse Event|9|||
143502756|NCT01750918|517380887|FG002|Overall Study|Withdrawal by Subject|1|||
143063793|NCT02990806|515773358|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
143063794|NCT02990806|515773359|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
143063795|NCT02990806|515773360|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
143063796|NCT02990806|515773361|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
143063797|NCT02990806|515773358|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
143063798|NCT02990806|515773359|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
143063799|NCT02990806|515773360|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
143063800|NCT02990806|515773361|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
143502757|NCT01750918|517380888|FG003|Overall Study|Withdrawal by Subject|2|||
143063801|NCT02990806|515773358|FG000|Stage 1 (22 Weeks)|Death|0|||
143063802|NCT02990806|515773359|FG001|Stage 1 (22 Weeks)|Death|1|||
143063803|NCT02990806|515773360|FG002|Stage 1 (22 Weeks)|Death|0|||
143063804|NCT02990806|515773361|FG003|Stage 1 (22 Weeks)|Death|0|||
143063805|NCT02990806|515773358|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
143063806|NCT02990806|515773359|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
143063807|NCT02990806|515773360|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
143063808|NCT02990806|515773361|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
143063809|NCT02990806|515773358|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
143063810|NCT02990806|515773359|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
143063811|NCT02990806|515773360|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
143063812|NCT02990806|515773361|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
143063813|NCT02990806|515773358|FG000|Stage 1 (22 Weeks)|Other|1|||
143063814|NCT02990806|515773359|FG001|Stage 1 (22 Weeks)|Other|3|||
143063815|NCT02990806|515773360|FG002|Stage 1 (22 Weeks)|Other|0|||
143063816|NCT02990806|515773361|FG003|Stage 1 (22 Weeks)|Other|0|||
143063817|NCT02990806|515773358|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
143063818|NCT02990806|515773359|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
143063819|NCT02990806|515773360|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
143063820|NCT02990806|515773361|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
143063821|NCT02990806|515773358|FG000|Stage 2 (32 Weeks)|Death|1|||
143063822|NCT02990806|515773359|FG001|Stage 2 (32 Weeks)|Death|0|||
143063823|NCT02990806|515773360|FG002|Stage 2 (32 Weeks)|Death|0|||
143063824|NCT02990806|515773361|FG003|Stage 2 (32 Weeks)|Death|0|||
143063825|NCT02990806|515773358|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
143063826|NCT02990806|515773359|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
143502758|NCT01750918|517380889|FG004|Overall Study|Withdrawal by Subject|1|||
143063827|NCT02990806|515773360|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
143063828|NCT02990806|515773361|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
143063829|NCT02990806|515773358|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
143063830|NCT02990806|515773359|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
143063831|NCT02990806|515773360|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
143063832|NCT02990806|515773361|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
143063833|NCT02990806|515773358|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
143063834|NCT02990806|515773359|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
143063835|NCT02990806|515773360|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
143502759|NCT01750918|517380890|FG005|Overall Study|Withdrawal by Subject|1|||
143502760|NCT01750918|517380891|FG006|Overall Study|Withdrawal by Subject|2|||
143502761|NCT01750918|517380892|FG007|Overall Study|Withdrawal by Subject|2|||
143502762|NCT04840667|517380900|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
143502763|NCT00023322|517380902|FG000|Overall Study|Lost to Follow-up|1|||
143502764|NCT03658889|517380917|FG000|Overall Study|Protocol Violation|2|||
143502765|NCT03658889|517380918|FG001|Overall Study|Protocol Violation|0|||
143502766|NCT00206726|517380920|FG000|Overall Study|Delayed recovery of blood counts|1|||
143502767|NCT00206726|517380920|FG000|Overall Study|Progressive disease or relapsed disease|18|||
143502768|NCT00206726|517380920|FG000|Overall Study|Placed on new protocol|1|||
143502769|NCT00206726|517380920|FG000|Overall Study|Bone marrow transplant|1|||
143502770|NCT00206726|517380920|FG000|Overall Study|Adverse Event|17|||
143502771|NCT00206726|517380920|FG000|Overall Study|Death|4|||
143502772|NCT00206726|517380920|FG000|Overall Study|Protocol Violation|1|||
143502773|NCT00206726|517380920|FG000|Overall Study|Withdrawal by Subject|8|||
143502774|NCT04317690|517380921|FG000|Overall Study|did not have complete information for primary outcome|0|||
143063836|NCT02990806|515773361|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
143063837|NCT02990806|515773358|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
143502775|NCT04317690|517380922|FG001|Overall Study|did not have complete information for primary outcome|4|||
143063838|NCT02990806|515773359|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
143063839|NCT02990806|515773360|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
143170238|NCT02284893|516171912|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
143170239|NCT02284893|516171913|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
143170240|NCT02284893|516171912|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
143170241|NCT02284893|516171913|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
143170242|NCT02284893|516171912|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
143170243|NCT02284893|516171913|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
143170244|NCT02284893|516171912|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
143063840|NCT02990806|515773361|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
143063841|NCT02990806|515773358|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
143170245|NCT02284893|516171913|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
143063842|NCT02990806|515773359|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
143502776|NCT04317690|517380923|FG002|Overall Study|did not have complete information for primary outcome|0|||
143502777|NCT04317690|517380924|FG003|Overall Study|did not have complete information for primary outcome|2|||
143502778|NCT04317690|517380925|FG004|Overall Study|did not have complete information for primary outcome|0|||
143502779|NCT03312218|517380931|FG000|Overall Study|Never signed in to access the app|54|||
143502780|NCT03312218|517380932|FG001|Overall Study|Never signed in to access the app|58|||
143502781|NCT01154101|517380933|FG000|Overall Study|Adverse Event|0|||
143502782|NCT01154101|517380934|FG001|Overall Study|Adverse Event|2|||
143063843|NCT02990806|515773360|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
143063844|NCT02990806|515773361|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
143502783|NCT01154101|517380935|FG002|Overall Study|Adverse Event|1|||
143502784|NCT01154101|517380936|FG003|Overall Study|Adverse Event|1|||
143502785|NCT01154101|517380937|FG004|Overall Study|Adverse Event|0|||
143502786|NCT01154101|517380933|FG000|Overall Study|Lost to Follow-up|0|||
143502787|NCT01154101|517380934|FG001|Overall Study|Lost to Follow-up|1|||
143502788|NCT01154101|517380935|FG002|Overall Study|Lost to Follow-up|0|||
143502789|NCT01154101|517380936|FG003|Overall Study|Lost to Follow-up|1|||
143502790|NCT01154101|517380937|FG004|Overall Study|Lost to Follow-up|0|||
143502791|NCT01154101|517380933|FG000|Overall Study|Withdrawal by Subject|0|||
143502792|NCT01154101|517380934|FG001|Overall Study|Withdrawal by Subject|1|||
143063845|NCT02990806|515773358|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
143063846|NCT02990806|515773359|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
143063847|NCT02990806|515773360|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
143063848|NCT02990806|515773361|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
143063849|NCT02990806|515773358|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
143063850|NCT02990806|515773359|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
143063851|NCT02990806|515773360|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
143063852|NCT02990806|515773361|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
143063853|NCT02990806|515773358|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
143063854|NCT02990806|515773359|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
143063855|NCT02990806|515773360|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
143063856|NCT02990806|515773361|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
143063857|NCT02990806|515773358|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
143063858|NCT02990806|515773359|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
143063859|NCT02990806|515773360|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
143063860|NCT02990806|515773361|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
143063861|NCT02990806|515773358|FG000|Stage 2 (32 Weeks)|Other|3|||
143063862|NCT02990806|515773359|FG001|Stage 2 (32 Weeks)|Other|0|||
143063863|NCT02990806|515773360|FG002|Stage 2 (32 Weeks)|Other|4|||
143063864|NCT02990806|515773361|FG003|Stage 2 (32 Weeks)|Other|1|||
143063865|NCT02990806|515773358|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
143063866|NCT02990806|515773359|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
143063867|NCT02990806|515773360|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
143063868|NCT02990806|515773361|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
143063869|NCT02990806|515773358|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
143063870|NCT02990806|515773359|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
143063871|NCT02990806|515773360|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
143063872|NCT02990806|515773361|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
143063873|NCT02990806|515773358|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
143063874|NCT02990806|515773359|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
143063875|NCT02990806|515773360|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
143063876|NCT02990806|515773361|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
143063877|NCT02990806|515773358|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
143063878|NCT02990806|515773359|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
143063879|NCT02990806|515773360|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
143063880|NCT02990806|515773361|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
143063881|NCT02990806|515773358|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
143063882|NCT02990806|515773359|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
143063883|NCT02990806|515773360|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
143063884|NCT02990806|515773361|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
143063885|NCT02990806|515773358|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
143502793|NCT01154101|517380935|FG002|Overall Study|Withdrawal by Subject|2|||
143502794|NCT01154101|517380936|FG003|Overall Study|Withdrawal by Subject|0|||
143246083|NCT04421027|516451884|FG000|Follow-Up Period|Protocol Deviation|0|||
143502795|NCT01154101|517380937|FG004|Overall Study|Withdrawal by Subject|1|||
143502796|NCT00393718|517380938|FG000|Overall Study|Adverse Event|20|||
143502797|NCT00393718|517380939|FG001|Overall Study|Adverse Event|8|||
143063886|NCT02990806|515773359|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
143502798|NCT00393718|517380938|FG000|Overall Study|Protocol Violation|1|||
143063887|NCT02990806|515773360|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
143063888|NCT02990806|515773361|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
143063889|NCT02990806|515773358|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
143063890|NCT02990806|515773359|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
143063891|NCT02990806|515773360|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
143063892|NCT02990806|515773361|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
143063893|NCT02990806|515773358|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
143063894|NCT02990806|515773359|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
143063895|NCT02990806|515773360|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
143063896|NCT02990806|515773361|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
143063897|NCT02990806|515773358|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
143063898|NCT02990806|515773359|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
143063899|NCT02990806|515773360|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
143063900|NCT02990806|515773361|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
143063901|NCT01010750|515773362|FG000|Second Intervention|Adverse Event|0|||
143063902|NCT01010750|515773363|FG001|Second Intervention|Adverse Event|1|||
143063903|NCT01010750|515773364|FG002|Second Intervention|Adverse Event|0|||
143063904|NCT01010750|515773365|FG003|Second Intervention|Adverse Event|0|||
143063905|NCT01010750|515773366|FG004|Second Intervention|Adverse Event|0|||
143063906|NCT01010750|515773367|FG005|Second Intervention|Adverse Event|0|||
143063907|NCT02654587|515773368|FG000|Overall Study|patient alive at end of study|22|||
143063908|NCT02654587|515773369|FG001|Overall Study|patient alive at end of study|8|||
143063909|NCT02654587|515773368|FG000|Overall Study|Withdrawal by Subject|1|||
143063910|NCT02654587|515773369|FG001|Overall Study|Withdrawal by Subject|7|||
143502799|NCT00393718|517380939|FG001|Overall Study|Protocol Violation|2|||
143502800|NCT00393718|517380938|FG000|Overall Study|Lack of Efficacy|10|||
143502801|NCT00393718|517380939|FG001|Overall Study|Lack of Efficacy|9|||
143063911|NCT01825837|515773370|FG000|PART I|Withdrawal by Subject|0|||
143063912|NCT01825837|515773371|FG001|PART I|Withdrawal by Subject|0|||
143063913|NCT01825837|515773372|FG002|PART I|Withdrawal by Subject|0|||
143063914|NCT01825837|515773373|FG003|PART I|Withdrawal by Subject|6|||
143063915|NCT01825837|515773370|FG000|PART I|Patient non-compliance|0|||
143063916|NCT01825837|515773371|FG001|PART I|Patient non-compliance|0|||
143063917|NCT01825837|515773372|FG002|PART I|Patient non-compliance|0|||
143063918|NCT01825837|515773373|FG003|PART I|Patient non-compliance|1|||
143063919|NCT01825837|515773370|FG000|PART I|Treatment failure|0|||
143063920|NCT01825837|515773371|FG001|PART I|Treatment failure|0|||
143063921|NCT01825837|515773372|FG002|PART I|Treatment failure|0|||
143063922|NCT01825837|515773373|FG003|PART I|Treatment failure|7|||
143063923|NCT01825837|515773370|FG000|PART I|reason unspecified|0|||
143063924|NCT01825837|515773371|FG001|PART I|reason unspecified|0|||
143063925|NCT01825837|515773372|FG002|PART I|reason unspecified|0|||
143063926|NCT01825837|515773373|FG003|PART I|reason unspecified|3|||
143063927|NCT01825837|515773370|FG000|PART II|Withdrawal by Subject|3|||
143063928|NCT01825837|515773371|FG001|PART II|Withdrawal by Subject|3|||
143063929|NCT01825837|515773372|FG002|PART II|Withdrawal by Subject|7|||
143063930|NCT01825837|515773373|FG003|PART II|Withdrawal by Subject|0|||
143063931|NCT01825837|515773370|FG000|PART II|Patient non-compliance|5|||
143063932|NCT01825837|515773371|FG001|PART II|Patient non-compliance|2|||
143063933|NCT01825837|515773372|FG002|PART II|Patient non-compliance|4|||
143063934|NCT01825837|515773373|FG003|PART II|Patient non-compliance|0|||
143063935|NCT01825837|515773370|FG000|PART II|Adverse Event|3|||
143063936|NCT01825837|515773371|FG001|PART II|Adverse Event|3|||
143063937|NCT01825837|515773372|FG002|PART II|Adverse Event|1|||
143063938|NCT01825837|515773373|FG003|PART II|Adverse Event|0|||
143063939|NCT01825837|515773370|FG000|PART II|Treatment failure|6|||
143063940|NCT01825837|515773371|FG001|PART II|Treatment failure|4|||
143246084|NCT04421027|516451885|FG001|Follow-Up Period|Protocol Deviation|0|||
143246085|NCT04421027|516451886|FG002|Follow-Up Period|Protocol Deviation|1|||
143246086|NCT04421027|516451887|FG003|Follow-Up Period|Protocol Deviation|0|||
143502802|NCT00393718|517380938|FG000|Overall Study|Hypoglycaemia|3|||
143502803|NCT00393718|517380939|FG001|Overall Study|Hypoglycaemia|2|||
143063941|NCT01825837|515773372|FG002|PART II|Treatment failure|5|||
143063942|NCT01825837|515773373|FG003|PART II|Treatment failure|0|||
143063943|NCT01825837|515773370|FG000|PART II|reason unspecified|2|||
143063944|NCT01825837|515773371|FG001|PART II|reason unspecified|2|||
143063945|NCT01825837|515773372|FG002|PART II|reason unspecified|2|||
143063946|NCT01825837|515773373|FG003|PART II|reason unspecified|0|||
143063947|NCT03648879|515773378|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
143063948|NCT00645944|515773379|FG000|Randomized|Withdrawal by Subject|1|||
143063949|NCT00645944|515773380|FG001|Randomized|Withdrawal by Subject|2|||
143063950|NCT00645944|515773379|FG000|Received Medication|Adverse Event|2|||
143063951|NCT00645944|515773380|FG001|Received Medication|Adverse Event|1|||
143063952|NCT00645944|515773379|FG000|Received Medication|Withdrawal by Subject|1|||
143502804|NCT00393718|517380938|FG000|Overall Study|Subject decision|5|||
143063953|NCT00645944|515773380|FG001|Received Medication|Withdrawal by Subject|1|||
143063954|NCT00645944|515773379|FG000|Received Medication|Lost to Follow-up|1|||
143063955|NCT00645944|515773380|FG001|Received Medication|Lost to Follow-up|0|||
143063956|NCT00645944|515773379|FG000|Received Medication|Protocol Violation|2|||
143063957|NCT00645944|515773380|FG001|Received Medication|Protocol Violation|1|||
143063958|NCT02339740|515773381|FG000|Overall Study|Death|1|||
143063959|NCT02339740|515773382|FG001|Overall Study|Death|0|||
143063960|NCT02339740|515773381|FG000|Overall Study|Physician Decision|0|||
143063961|NCT02339740|515773382|FG001|Overall Study|Physician Decision|2|||
143063962|NCT02339740|515773381|FG000|Overall Study|Withdrawal by Subject|5|||
143063963|NCT02339740|515773382|FG001|Overall Study|Withdrawal by Subject|1|||
143063964|NCT02339740|515773381|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
143063965|NCT02339740|515773382|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
143063966|NCT02096588|515773383|FG000|Overall Study|Lack of Efficacy|2|||
143063967|NCT02096588|515773384|FG001|Overall Study|Lack of Efficacy|0|||
143063968|NCT02096588|515773383|FG000|Overall Study|Withdrawal by Subject|0|||
143063969|NCT02096588|515773384|FG001|Overall Study|Withdrawal by Subject|1|||
143063970|NCT01258101|515773386|FG000|Overall Study|Adverse Event|5|||
143063971|NCT01258101|515773387|FG001|Overall Study|Adverse Event|6|||
143063972|NCT01258101|515773388|FG002|Overall Study|Adverse Event|0|||
143063973|NCT01258101|515773389|FG003|Overall Study|Adverse Event|0|||
143063974|NCT01258101|515773386|FG000|Overall Study|Extra exclusion criterion amended|2|||
143063975|NCT01258101|515773387|FG001|Overall Study|Extra exclusion criterion amended|1|||
143063976|NCT01258101|515773388|FG002|Overall Study|Extra exclusion criterion amended|1|||
143063977|NCT01258101|515773389|FG003|Overall Study|Extra exclusion criterion amended|1|||
143063978|NCT01258101|515773386|FG000|Overall Study|Informed consent has been withdrawn|2|||
143063979|NCT01258101|515773387|FG001|Overall Study|Informed consent has been withdrawn|2|||
143063980|NCT01258101|515773388|FG002|Overall Study|Informed consent has been withdrawn|1|||
143063981|NCT01258101|515773389|FG003|Overall Study|Informed consent has been withdrawn|1|||
143063982|NCT01258101|515773386|FG000|Overall Study|Patient is not able to attend visits|8|||
143063983|NCT01258101|515773387|FG001|Overall Study|Patient is not able to attend visits|9|||
143063984|NCT01258101|515773388|FG002|Overall Study|Patient is not able to attend visits|7|||
143063985|NCT01258101|515773389|FG003|Overall Study|Patient is not able to attend visits|6|||
143063986|NCT01258101|515773386|FG000|Overall Study|Patient´s compliance|4|||
143063987|NCT01258101|515773387|FG001|Overall Study|Patient´s compliance|3|||
143063988|NCT01258101|515773388|FG002|Overall Study|Patient´s compliance|1|||
143063989|NCT01258101|515773389|FG003|Overall Study|Patient´s compliance|2|||
143063990|NCT01258101|515773386|FG000|Overall Study|Lost to Follow-up|5|||
143063991|NCT01258101|515773387|FG001|Overall Study|Lost to Follow-up|5|||
143063992|NCT01258101|515773388|FG002|Overall Study|Lost to Follow-up|0|||
143063993|NCT01258101|515773389|FG003|Overall Study|Lost to Follow-up|6|||
143063994|NCT01258101|515773386|FG000|Overall Study|PCR positive at week 24|0|||
143063995|NCT01258101|515773387|FG001|Overall Study|PCR positive at week 24|0|||
143063996|NCT01258101|515773388|FG002|Overall Study|PCR positive at week 24|0|||
143063997|NCT01258101|515773389|FG003|Overall Study|PCR positive at week 24|1|||
143063998|NCT01258101|515773386|FG000|Overall Study|Other reason|7|||
143063999|NCT01258101|515773387|FG001|Overall Study|Other reason|8|||
143064000|NCT01258101|515773388|FG002|Overall Study|Other reason|1|||
143064001|NCT01258101|515773389|FG003|Overall Study|Other reason|8|||
143064002|NCT00063882|515773390|FG000|Overall Study|Protocol Violation|3|||
143064003|NCT00063882|515773391|FG001|Overall Study|Protocol Violation|3|||
143064004|NCT00063882|515773390|FG000|Overall Study|Withdrawal by Subject|2|||
143064005|NCT00063882|515773391|FG001|Overall Study|Withdrawal by Subject|1|||
143064006|NCT03438227|515773393|FG000|Overall Study|Withdrawal by Subject|10|||
143064007|NCT03438227|515773394|FG001|Overall Study|Withdrawal by Subject|5|||
143064008|NCT02972502|515773396|FG000|Overall Study|Lost to Follow-up|3|||
143064009|NCT02972502|515773397|FG001|Overall Study|Lost to Follow-up|1|||
143502805|NCT00393718|517380939|FG001|Overall Study|Subject decision|0|||
143502806|NCT00393718|517380938|FG000|Overall Study|Withdrawal of consent|2|||
143502807|NCT00393718|517380939|FG001|Overall Study|Withdrawal of consent|1|||
143502808|NCT00393718|517380938|FG000|Overall Study|Missed measurement|1|||
143502809|NCT00393718|517380939|FG001|Overall Study|Missed measurement|0|||
143502810|NCT00393718|517380938|FG000|Overall Study|Move|1|||
143064010|NCT02972502|515773396|FG000|Overall Study|Withdrawal by Subject|1|||
143064011|NCT02972502|515773397|FG001|Overall Study|Withdrawal by Subject|1|||
143064012|NCT00293202|515773401|FG000|Overall Study|Withdrawal by Subject|1|||
143064013|NCT00293202|515773402|FG001|Overall Study|Withdrawal by Subject|2|||
143064014|NCT00293202|515773401|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
143064015|NCT00293202|515773402|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
143064016|NCT00293202|515773401|FG000|Overall Study|on-hold due to fistula maturation time|1|||
143064017|NCT00293202|515773402|FG001|Overall Study|on-hold due to fistula maturation time|0|||
143064018|NCT02377063|515773407|FG000|Overall Study|Non-compliance|5|||
143064019|NCT01524913|515773411|FG000|Overall Study|Lost to Follow-up|4|||
143064020|NCT01524913|515773412|FG001|Overall Study|Lost to Follow-up|0|||
143064021|NCT01524913|515773413|FG002|Overall Study|Lost to Follow-up|0|||
143064022|NCT00702208|515773414|FG000|Overall Study|Lost to Follow-up|28|||
143064023|NCT00702208|515773414|FG000|Overall Study|Did not self-lavage|1|||
143064024|NCT00702208|515773414|FG000|Overall Study|Unsatisfactory colposcopy|2|||
143064025|NCT02858726|515773415|FG000|Overall Study|Adverse Event|4|||
143064026|NCT02858726|515773416|FG001|Overall Study|Adverse Event|4|||
143064027|NCT02858726|515773417|FG002|Overall Study|Adverse Event|9|||
143064028|NCT02858726|515773418|FG003|Overall Study|Adverse Event|1|||
143064029|NCT02858726|515773415|FG000|Overall Study|Physician Decision|0|||
143064030|NCT02858726|515773416|FG001|Overall Study|Physician Decision|0|||
143064031|NCT02858726|515773417|FG002|Overall Study|Physician Decision|1|||
143064032|NCT02858726|515773418|FG003|Overall Study|Physician Decision|0|||
143064033|NCT02858726|515773415|FG000|Overall Study|Protocol Violation|0|||
143064034|NCT02858726|515773416|FG001|Overall Study|Protocol Violation|0|||
143064035|NCT02858726|515773417|FG002|Overall Study|Protocol Violation|0|||
143064036|NCT02858726|515773418|FG003|Overall Study|Protocol Violation|1|||
143064037|NCT02858726|515773415|FG000|Overall Study|Study Terminated by Sponsor|0|||
143064038|NCT02858726|515773416|FG001|Overall Study|Study Terminated by Sponsor|0|||
143064039|NCT02858726|515773417|FG002|Overall Study|Study Terminated by Sponsor|0|||
143064040|NCT02858726|515773418|FG003|Overall Study|Study Terminated by Sponsor|1|||
143064041|NCT02858726|515773415|FG000|Overall Study|Withdrawal by Subject|1|||
143064042|NCT02858726|515773416|FG001|Overall Study|Withdrawal by Subject|2|||
143064043|NCT02858726|515773417|FG002|Overall Study|Withdrawal by Subject|1|||
143064044|NCT02858726|515773418|FG003|Overall Study|Withdrawal by Subject|0|||
143064045|NCT02858726|515773415|FG000|Overall Study|Noncompliance|0|||
143064046|NCT02858726|515773416|FG001|Overall Study|Noncompliance|1|||
143064047|NCT02858726|515773417|FG002|Overall Study|Noncompliance|0|||
143064048|NCT02858726|515773418|FG003|Overall Study|Noncompliance|0|||
143064049|NCT00233987|515773425|FG000|Overall Study|Withdrawal by Subject|1|||
143064050|NCT00233987|515773425|FG000|Overall Study|Lack of Efficacy|2|||
143064051|NCT00233987|515773425|FG000|Overall Study|Reason Under Review|1|||
143064052|NCT00233987|515773425|FG000|Overall Study|Other - Not Protocol Specified|5|||
143064053|NCT00233987|515773425|FG000|Overall Study|Eligible but No Treatment Received|2|||
143064054|NCT00233987|515773425|FG000|Overall Study|Ineligible|4|||
143064055|NCT01688726|515773428|FG000|Overall Study|Adverse Event|1|||
143064056|NCT01688726|515773429|FG001|Overall Study|Adverse Event|0|||
143064057|NCT01688726|515773428|FG000|Overall Study|Relocated abroad|0|||
143064058|NCT01688726|515773429|FG001|Overall Study|Relocated abroad|1|||
143064059|NCT02427984|515773431|FG000|Overall Study|Lost to Follow-up|13|||
143064060|NCT02427984|515773432|FG001|Overall Study|Lost to Follow-up|5|||
143064061|NCT02427984|515773433|FG002|Overall Study|Lost to Follow-up|18|||
143064062|NCT03821272|515775187|FG000|Overall Study|Death|1|||
143064063|NCT03821272|515775188|FG001|Overall Study|Death|0|||
143064064|NCT03821272|515775187|FG000|Overall Study|Physician Decision|1|||
143064065|NCT03821272|515775188|FG001|Overall Study|Physician Decision|0|||
143064066|NCT03821272|515775187|FG000|Overall Study|Withdrawal by Subject|1|||
143365145|NCT03499600|516878812|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
143365146|NCT02414828|516878813|FG000|Overall Study|Lost to Follow-up|0|||
143502811|NCT00393718|517380939|FG001|Overall Study|Move|0|||
143502812|NCT03902080|517380940|FG000|Overall Study|Adverse Event|17|||
143502813|NCT03902080|517380941|FG001|Overall Study|Adverse Event|15|||
143502814|NCT03902080|517380940|FG000|Overall Study|Withdrawal by Subject|28|||
143502815|NCT03902080|517380941|FG001|Overall Study|Withdrawal by Subject|35|||
143502816|NCT03902080|517380940|FG000|Overall Study|Lost to Follow-up|6|||
143502817|NCT03902080|517380941|FG001|Overall Study|Lost to Follow-up|7|||
143502818|NCT03902080|517380940|FG000|Overall Study|Other|3|||
143502819|NCT03902080|517380941|FG001|Overall Study|Other|5|||
143502820|NCT03902080|517380940|FG000|Overall Study|Non compliance|4|||
143502821|NCT03902080|517380941|FG001|Overall Study|Non compliance|3|||
143502822|NCT03902080|517380940|FG000|Overall Study|Physician Decision|5|||
143502823|NCT03902080|517380941|FG001|Overall Study|Physician Decision|1|||
143502824|NCT03902080|517380940|FG000|Overall Study|Protocol Violation|3|||
143502825|NCT03902080|517380941|FG001|Overall Study|Protocol Violation|3|||
143502826|NCT03902080|517380940|FG000|Overall Study|Lack of Efficacy|1|||
143502827|NCT03902080|517380941|FG001|Overall Study|Lack of Efficacy|3|||
143502828|NCT03902080|517380940|FG000|Overall Study|Withdrawn prior to dosing|0|||
143502829|NCT03902080|517380941|FG001|Overall Study|Withdrawn prior to dosing|1|||
143502830|NCT03575104|517380942|FG000|Overall Study|Adverse Event|4|||
143502831|NCT03575104|517380943|FG001|Overall Study|Adverse Event|3|||
143502832|NCT03575104|517380944|FG002|Overall Study|Adverse Event|4|||
143502833|NCT03575104|517380942|FG000|Overall Study|Withdrawal by Subject|13|||
143502834|NCT03575104|517380943|FG001|Overall Study|Withdrawal by Subject|16|||
143502835|NCT03575104|517380944|FG002|Overall Study|Withdrawal by Subject|11|||
143502836|NCT03575104|517380942|FG000|Overall Study|Other reasons|6|||
143064067|NCT03821272|515775188|FG001|Overall Study|Withdrawal by Subject|0|||
143064068|NCT05904769|515775189|FG000|Overall Study|Physician Decision|0|||
143064069|NCT05904769|515775190|FG001|Overall Study|Physician Decision|6|||
143064070|NCT02119286|515775204|FG000|Overall Study|Adverse Event|9|||
143064071|NCT02119286|515775205|FG001|Overall Study|Adverse Event|7|||
143502837|NCT03575104|517380943|FG001|Overall Study|Other reasons|8|||
143502838|NCT03575104|517380944|FG002|Overall Study|Other reasons|6|||
143064072|NCT02119286|515775206|FG002|Overall Study|Adverse Event|2|||
143064073|NCT02119286|515775204|FG000|Overall Study|Lack of Efficacy|11|||
143064074|NCT02119286|515775205|FG001|Overall Study|Lack of Efficacy|3|||
143064075|NCT02119286|515775206|FG002|Overall Study|Lack of Efficacy|4|||
143064076|NCT02119286|515775204|FG000|Overall Study|Lost to Follow-up|2|||
143064077|NCT02119286|515775205|FG001|Overall Study|Lost to Follow-up|0|||
143064078|NCT02119286|515775206|FG002|Overall Study|Lost to Follow-up|1|||
143064079|NCT02119286|515775204|FG000|Overall Study|Withdrawal by Subject|4|||
143064080|NCT02119286|515775205|FG001|Overall Study|Withdrawal by Subject|1|||
143064081|NCT02119286|515775206|FG002|Overall Study|Withdrawal by Subject|0|||
143064082|NCT00468728|515775209|FG000|Treatment|criteria for mITT population|4|||
143064083|NCT00468728|515775210|FG001|Treatment|criteria for mITT population|11|||
143064084|NCT00468728|515775209|FG000|Follow-up|mITT failure|34|||
143064085|NCT00468728|515775210|FG001|Follow-up|mITT failure|31|||
143064086|NCT01642914|515775211|FG000|Overall Study|Adverse Event|11|||
143064087|NCT01642914|515775212|FG001|Overall Study|Adverse Event|7|||
143064088|NCT01642914|515775213|FG002|Overall Study|Adverse Event|15|||
143064089|NCT01642914|515775211|FG000|Overall Study|Lack of Efficacy|9|||
143064090|NCT01642914|515775212|FG001|Overall Study|Lack of Efficacy|4|||
143064091|NCT01642914|515775213|FG002|Overall Study|Lack of Efficacy|2|||
143064092|NCT01642914|515775211|FG000|Overall Study|Protocol Violation|15|||
143064093|NCT01642914|515775212|FG001|Overall Study|Protocol Violation|13|||
143064094|NCT01642914|515775213|FG002|Overall Study|Protocol Violation|6|||
143064095|NCT01642914|515775211|FG000|Overall Study|Withdrawal by Subject|5|||
143064096|NCT01642914|515775212|FG001|Overall Study|Withdrawal by Subject|5|||
143064097|NCT01642914|515775213|FG002|Overall Study|Withdrawal by Subject|10|||
143064098|NCT01642914|515775211|FG000|Overall Study|Lost to Follow-up|5|||
143064099|NCT01642914|515775212|FG001|Overall Study|Lost to Follow-up|3|||
143064100|NCT01642914|515775213|FG002|Overall Study|Lost to Follow-up|7|||
143064101|NCT01642914|515775211|FG000|Overall Study|Other Reason|1|||
143064102|NCT01642914|515775212|FG001|Overall Study|Other Reason|0|||
143064103|NCT01642914|515775213|FG002|Overall Study|Other Reason|0|||
143064104|NCT01705236|515775214|FG000|Overall Study|Lost to Follow-up|1|||
143064105|NCT01705236|515775214|FG000|Overall Study|Administrative problems|2|||
143064106|NCT01705236|515775214|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
143064107|NCT01705236|515775214|FG000|Overall Study|Protocol Violation|3|||
143064108|NCT01705236|515775214|FG000|Overall Study|Abnormal test procedure result(s)|4|||
143064109|NCT01705236|515775214|FG000|Overall Study|Abnormal laboratory value(s)|4|||
143064110|NCT01705236|515775214|FG000|Overall Study|Withdrawal by Subject|5|||
143064111|NCT01705236|515775214|FG000|Overall Study|Adverse Event|5|||
143064112|NCT03028740|515775215|FG000|Overall Study|Did not Receive Study Drug|4|||
143064113|NCT03028740|515775216|FG001|Overall Study|Did not Receive Study Drug|5|||
143064114|NCT03028740|515775215|FG000|Overall Study|Adverse Event|8|||
143064115|NCT03028740|515775216|FG001|Overall Study|Adverse Event|26|||
143064116|NCT03028740|515775215|FG000|Overall Study|Lack of Efficacy|0|||
143064117|NCT03028740|515775216|FG001|Overall Study|Lack of Efficacy|1|||
143064118|NCT03028740|515775215|FG000|Overall Study|Withdrawal by Subject|48|||
143064119|NCT03028740|515775216|FG001|Overall Study|Withdrawal by Subject|101|||
143502839|NCT03575104|517380942|FG000|Overall Study|Lost to Follow-up|1|||
143064120|NCT03028740|515775215|FG000|Overall Study|Lost to Follow-up|30|||
143064121|NCT03028740|515775216|FG001|Overall Study|Lost to Follow-up|54|||
143064122|NCT03028740|515775215|FG000|Overall Study|Physician Decision|4|||
143064123|NCT03028740|515775216|FG001|Overall Study|Physician Decision|11|||
143064124|NCT03028740|515775215|FG000|Overall Study|Protocol Violation|4|||
143064125|NCT03028740|515775216|FG001|Overall Study|Protocol Violation|8|||
143064126|NCT03028740|515775215|FG000|Overall Study|Non-compliance with Study Drug|0|||
143064127|NCT03028740|515775216|FG001|Overall Study|Non-compliance with Study Drug|2|||
143064128|NCT03028740|515775215|FG000|Overall Study|Study Terminated by Sponsor|467|||
143064129|NCT03028740|515775216|FG001|Overall Study|Study Terminated by Sponsor|917|||
143064130|NCT03028740|515775215|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
143064131|NCT03028740|515775216|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
143064132|NCT03028740|515775215|FG000|Overall Study|Reason not Specified|1|||
143064133|NCT03028740|515775216|FG001|Overall Study|Reason not Specified|5|||
143064134|NCT00171301|515775217|FG000|Overall Study|Death|1|||
143064135|NCT00171301|515775218|FG001|Overall Study|Death|2|||
143064136|NCT00171301|515775217|FG000|Overall Study|Adverse Event|1|||
143064137|NCT00171301|515775218|FG001|Overall Study|Adverse Event|2|||
143064138|NCT00171301|515775217|FG000|Overall Study|Lost to Follow-up|6|||
143064139|NCT00171301|515775218|FG001|Overall Study|Lost to Follow-up|2|||
143064140|NCT00171301|515775217|FG000|Overall Study|Protocol Violation|0|||
143064141|NCT00171301|515775218|FG001|Overall Study|Protocol Violation|2|||
143064142|NCT00171301|515775217|FG000|Overall Study|Withdrawal by Subject|0|||
143064143|NCT00171301|515775218|FG001|Overall Study|Withdrawal by Subject|1|||
143064144|NCT04319159|515775220|FG000|Overall Study|Screening failure|13|||
143064145|NCT04319159|515775220|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
143246087|NCT04421027|516451884|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
143502840|NCT03575104|517380943|FG001|Overall Study|Lost to Follow-up|2|||
143064146|NCT04319159|515775220|FG000|Overall Study|Withdrawal by Subject|1|||
143502841|NCT03575104|517380944|FG002|Overall Study|Lost to Follow-up|1|||
143502842|NCT04684420|517380945|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
143502843|NCT04684420|517380946|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
143502844|NCT04684420|517380947|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
143502845|NCT04684420|517380948|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
143502846|NCT04684420|517380945|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
143502847|NCT04684420|517380946|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
143502848|NCT04684420|517380947|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
143502849|NCT04684420|517380948|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
143502850|NCT01409928|517380949|FG000|Overall Study|Physician Decision|12|||
143502851|NCT01354132|517380950|FG000|Randomization|Physician Decision|1|||
143502852|NCT01354132|517380951|FG001|Randomization|Physician Decision|0|||
143502853|NCT01354132|517380950|FG000|Randomization|Withdrawal by Subject|0|||
143502854|NCT01354132|517380951|FG001|Randomization|Withdrawal by Subject|1|||
143502855|NCT01354132|517380950|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
143502856|NCT01354132|517380951|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
143502857|NCT01354132|517380950|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
143064147|NCT06005597|515775223|FG000|Overall Study|Lost to Follow-up|1|||
143064148|NCT06005597|515775224|FG001|Overall Study|Lost to Follow-up|2|||
143064149|NCT06005597|515775225|FG002|Overall Study|Lost to Follow-up|1|||
143064150|NCT06005597|515775226|FG003|Overall Study|Lost to Follow-up|2|||
143064151|NCT06005597|515775223|FG000|Overall Study|Death|1|||
143064152|NCT06005597|515775224|FG001|Overall Study|Death|1|||
143502858|NCT01354132|517380951|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
143064153|NCT06005597|515775225|FG002|Overall Study|Death|1|||
143064154|NCT06005597|515775226|FG003|Overall Study|Death|0|||
143064155|NCT02100319|515775227|FG000|Overall Study|Case Report Forms Uncollected|11|||
143064156|NCT02100319|515775227|FG000|Overall Study|Protocol Deviation|5|||
143064157|NCT02370914|515775228|FG000|Overall Study|Protocol Violation|2|||
143064158|NCT02589522|515775230|FG000|Overall Study|Physician Decision|1|||
143064159|NCT02589522|515775231|FG001|Overall Study|Physician Decision|2|||
143064160|NCT02589522|515775232|FG002|Overall Study|Physician Decision|0|||
143064161|NCT02589522|515775230|FG000|Overall Study|Did not start treatment|1|||
143064162|NCT02589522|515775231|FG001|Overall Study|Did not start treatment|0|||
143064163|NCT02589522|515775232|FG002|Overall Study|Did not start treatment|0|||
143064164|NCT01478828|515775233|FG000|Overall Study|Adverse Event|1|||
143064165|NCT00754442|515775234|FG000|Overall Study|Withdrawal by Subject|5|||
143064166|NCT00754442|515775235|FG001|Overall Study|Withdrawal by Subject|3|||
143064167|NCT04572243|515775236|FG000|Core Study: 14 Weeks|Adverse Event|1|||
143064168|NCT04572243|515775237|FG001|Core Study: 14 Weeks|Adverse Event|2|||
143064169|NCT04572243|515775238|FG002|Core Study: 14 Weeks|Adverse Event|0|||
143064170|NCT04572243|515775239|FG003|Core Study: 14 Weeks|Adverse Event|0|||
143064171|NCT04572243|515775236|FG000|Core Study: 14 Weeks|Subject choice|0|||
143064172|NCT04572243|515775237|FG001|Core Study: 14 Weeks|Subject choice|2|||
143064173|NCT04572243|515775238|FG002|Core Study: 14 Weeks|Subject choice|0|||
143064174|NCT04572243|515775239|FG003|Core Study: 14 Weeks|Subject choice|0|||
143064175|NCT04572243|515775236|FG000|Core Study: 14 Weeks|Withdrawal of consent|1|||
143064176|NCT04572243|515775237|FG001|Core Study: 14 Weeks|Withdrawal of consent|0|||
143064177|NCT04572243|515775238|FG002|Core Study: 14 Weeks|Withdrawal of consent|0|||
143064178|NCT04572243|515775239|FG003|Core Study: 14 Weeks|Withdrawal of consent|0|||
143064179|NCT04572243|515775236|FG000|Core Study: 14 Weeks|Randomized but not treated|1|||
143064180|NCT04572243|515775237|FG001|Core Study: 14 Weeks|Randomized but not treated|0|||
143064181|NCT04572243|515775238|FG002|Core Study: 14 Weeks|Randomized but not treated|0|||
143064182|NCT04572243|515775239|FG003|Core Study: 14 Weeks|Randomized but not treated|0|||
143064183|NCT00775606|515775244|FG000|Overall Study|Study sponsor terminated funding|3|||
143064184|NCT00775606|515775245|FG001|Overall Study|Study sponsor terminated funding|0|||
143064185|NCT02278718|515775246|FG000|Overall Study|Adverse Event|1|||
143064186|NCT02278718|515775247|FG001|Overall Study|Adverse Event|0|||
143502859|NCT01354132|517380950|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
143502860|NCT01354132|517380951|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
143064187|NCT02278718|515775246|FG000|Overall Study|Lost to Follow-up|2|||
143064188|NCT02278718|515775247|FG001|Overall Study|Lost to Follow-up|4|||
143064189|NCT02278718|515775246|FG000|Overall Study|Withdrawal by Subject|1|||
143246088|NCT04421027|516451885|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
143502861|NCT00928070|517380954|FG000|Overall Study|Lost to Follow-up|1|||
143502862|NCT00928070|517380955|FG001|Overall Study|Lost to Follow-up|2|||
143064190|NCT02278718|515775247|FG001|Overall Study|Withdrawal by Subject|4|||
143064191|NCT02278718|515775246|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
143365147|NCT02414828|516878814|FG001|Overall Study|Lost to Follow-up|1|||
143064192|NCT02278718|515775247|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
143064193|NCT02278718|515775246|FG000|Overall Study|Missing|0|||
143064194|NCT02278718|515775247|FG001|Overall Study|Missing|1|||
143064195|NCT00700817|515775256|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
143064196|NCT00700817|515775257|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
143064197|NCT00700817|515775258|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
143064198|NCT00700817|515775259|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
143064199|NCT00700817|515775260|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
143064200|NCT00700817|515775256|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
143064201|NCT00700817|515775257|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
143064202|NCT00700817|515775258|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
143064203|NCT00700817|515775259|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
143064204|NCT00700817|515775260|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
143064205|NCT00700817|515775256|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
143064206|NCT00700817|515775257|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
143064207|NCT00700817|515775258|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
143064208|NCT00700817|515775259|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
143064209|NCT00700817|515775260|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
143064210|NCT00700817|515775256|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
143064211|NCT00700817|515775257|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
143064212|NCT00700817|515775258|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
143064213|NCT00700817|515775259|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
143064214|NCT00700817|515775260|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
143064215|NCT00700817|515775256|FG000|Week 0-26 (Main Period)|Unclassified|14|||
143064216|NCT00700817|515775257|FG001|Week 0-26 (Main Period)|Unclassified|4|||
143064217|NCT00700817|515775258|FG002|Week 0-26 (Main Period)|Unclassified|8|||
143064218|NCT00700817|515775259|FG003|Week 0-26 (Main Period)|Unclassified|0|||
143064219|NCT00700817|515775260|FG004|Week 0-26 (Main Period)|Unclassified|0|||
143064220|NCT00700817|515775256|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
143064221|NCT00700817|515775257|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
143064222|NCT00700817|515775258|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
143064223|NCT00700817|515775259|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
143064224|NCT00700817|515775260|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
143064225|NCT00700817|515775256|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
143064226|NCT00700817|515775257|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
143064227|NCT00700817|515775258|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
143064228|NCT00700817|515775259|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
143064229|NCT00700817|515775260|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
143064230|NCT00700817|515775256|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
143064231|NCT00700817|515775257|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
143064232|NCT00700817|515775258|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
143064233|NCT00700817|515775259|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
143064234|NCT00700817|515775260|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
143064235|NCT00700817|515775256|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
143064236|NCT00700817|515775257|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
143064237|NCT00700817|515775258|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
143064238|NCT00700817|515775259|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
143064239|NCT00700817|515775260|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
143064240|NCT00700817|515775256|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
143064241|NCT00700817|515775257|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
143064242|NCT00700817|515775258|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
143064243|NCT00700817|515775259|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
143064244|NCT00700817|515775260|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
143064245|NCT00700817|515775256|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
143064246|NCT00700817|515775257|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
143064247|NCT00700817|515775258|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
143246089|NCT04421027|516451886|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
143246090|NCT04421027|516451887|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
143246091|NCT04421027|516451884|FG000|Follow-Up Period|Left message, participant did not call back|0|||
143246092|NCT04421027|516451885|FG001|Follow-Up Period|Left message, participant did not call back|0|||
143246093|NCT04421027|516451886|FG002|Follow-Up Period|Left message, participant did not call back|0|||
143064248|NCT00700817|515775259|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
143064249|NCT00700817|515775260|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
143064250|NCT00700817|515775256|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
143064251|NCT00700817|515775257|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
143064252|NCT00700817|515775258|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
143064253|NCT00700817|515775259|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
143064254|NCT00700817|515775260|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
143064255|NCT00700817|515775256|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
143064256|NCT00700817|515775257|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
143064257|NCT00700817|515775258|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
143064258|NCT00700817|515775259|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
143064259|NCT00700817|515775260|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
143064260|NCT00700817|515775256|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
143064261|NCT00700817|515775257|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
143064262|NCT00700817|515775258|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
143064263|NCT00700817|515775259|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
143064264|NCT00700817|515775260|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
143064265|NCT00700817|515775256|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
143064266|NCT00700817|515775257|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
143064267|NCT00700817|515775258|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
143064268|NCT00700817|515775259|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
143064269|NCT00700817|515775260|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
143064270|NCT01338987|515775263|FG000|Overall Study|enrolled on new protocol|0|||
143064271|NCT01338987|515775264|FG001|Overall Study|enrolled on new protocol|0|||
143064272|NCT01338987|515775265|FG002|Overall Study|enrolled on new protocol|1|||
143064273|NCT01338987|515775266|FG003|Overall Study|enrolled on new protocol|0|||
143064274|NCT01338987|515775267|FG004|Overall Study|enrolled on new protocol|0|||
143064275|NCT01338987|515775263|FG000|Overall Study|Disease progression on study|2|||
143064276|NCT01338987|515775264|FG001|Overall Study|Disease progression on study|1|||
143064277|NCT01338987|515775265|FG002|Overall Study|Disease progression on study|1|||
143064278|NCT01338987|515775266|FG003|Overall Study|Disease progression on study|0|||
143064279|NCT01338987|515775267|FG004|Overall Study|Disease progression on study|0|||
143064280|NCT00757848|515775268|FG000|Overall Study|Voluntary discontinuation|1|||
143064281|NCT00757848|515775269|FG001|Overall Study|Voluntary discontinuation|0|||
143064282|NCT00757848|515775268|FG000|Overall Study|Adverse Event|1|||
143064283|NCT00757848|515775269|FG001|Overall Study|Adverse Event|2|||
143064284|NCT00757848|515775268|FG000|Overall Study|Incorrect enrolment|1|||
143064285|NCT00757848|515775269|FG001|Overall Study|Incorrect enrolment|0|||
143064286|NCT00058214|515775272|FG000|Overall Study|Adverse Event|1|||
143064287|NCT00958126|515775280|FG000|Overall Study|Serious Adverse Event|0|||
143064288|NCT00958126|515775281|FG001|Overall Study|Serious Adverse Event|2|||
143064289|NCT00958126|515775282|FG002|Overall Study|Serious Adverse Event|0|||
143064290|NCT00958126|515775283|FG003|Overall Study|Serious Adverse Event|0|||
143064291|NCT00958126|515775284|FG004|Overall Study|Serious Adverse Event|0|||
143064292|NCT00958126|515775285|FG005|Overall Study|Serious Adverse Event|0|||
143064293|NCT00958126|515775286|FG006|Overall Study|Serious Adverse Event|1|||
143064294|NCT00958126|515775287|FG007|Overall Study|Serious Adverse Event|0|||
143064295|NCT00958126|515775280|FG000|Overall Study|Withdrawal by Subject|0|||
143064296|NCT00958126|515775281|FG001|Overall Study|Withdrawal by Subject|2|||
143064297|NCT00958126|515775282|FG002|Overall Study|Withdrawal by Subject|0|||
143064298|NCT00958126|515775283|FG003|Overall Study|Withdrawal by Subject|0|||
143064299|NCT00958126|515775284|FG004|Overall Study|Withdrawal by Subject|0|||
143064300|NCT00958126|515775285|FG005|Overall Study|Withdrawal by Subject|0|||
143064301|NCT00958126|515775286|FG006|Overall Study|Withdrawal by Subject|0|||
143064302|NCT00958126|515775287|FG007|Overall Study|Withdrawal by Subject|0|||
143064303|NCT00958126|515775280|FG000|Overall Study|Moved away from study area|0|||
143064304|NCT00958126|515775281|FG001|Overall Study|Moved away from study area|0|||
143064305|NCT00958126|515775282|FG002|Overall Study|Moved away from study area|1|||
143064306|NCT00958126|515775283|FG003|Overall Study|Moved away from study area|1|||
143064307|NCT00958126|515775284|FG004|Overall Study|Moved away from study area|0|||
143064308|NCT00958126|515775285|FG005|Overall Study|Moved away from study area|0|||
143064309|NCT00958126|515775286|FG006|Overall Study|Moved away from study area|0|||
143064310|NCT00958126|515775287|FG007|Overall Study|Moved away from study area|0|||
143064311|NCT00958126|515775280|FG000|Overall Study|Lost to Follow-up|1|||
143064312|NCT00958126|515775281|FG001|Overall Study|Lost to Follow-up|5|||
143064313|NCT00958126|515775282|FG002|Overall Study|Lost to Follow-up|9|||
143502863|NCT00928070|517380954|FG000|Overall Study|Withdrawal by Subject|10|||
143502864|NCT00928070|517380955|FG001|Overall Study|Withdrawal by Subject|3|||
143064314|NCT00958126|515775283|FG003|Overall Study|Lost to Follow-up|8|||
143170246|NCT02284893|516171912|FG000|26 Week (Short Term)|Other|1|||
143170247|NCT02284893|516171913|FG001|26 Week (Short Term)|Other|1|||
143502865|NCT00928070|517380954|FG000|Overall Study|Adverse Event|14|||
143502866|NCT00928070|517380955|FG001|Overall Study|Adverse Event|26|||
143502867|NCT00928070|517380954|FG000|Overall Study|Lack of Efficacy|9|||
143502868|NCT00928070|517380955|FG001|Overall Study|Lack of Efficacy|5|||
143502869|NCT00928070|517380954|FG000|Overall Study|Did not meet entrance criteria|16|||
143502870|NCT00928070|517380955|FG001|Overall Study|Did not meet entrance criteria|9|||
143502871|NCT00928070|517380954|FG000|Overall Study|Protocol Violation|6|||
143064315|NCT00958126|515775284|FG004|Overall Study|Lost to Follow-up|0|||
143064316|NCT00958126|515775285|FG005|Overall Study|Lost to Follow-up|0|||
143064317|NCT00958126|515775286|FG006|Overall Study|Lost to Follow-up|0|||
143064318|NCT00958126|515775287|FG007|Overall Study|Lost to Follow-up|0|||
143502872|NCT00928070|517380955|FG001|Overall Study|Protocol Violation|5|||
143502873|NCT00928070|517380954|FG000|Overall Study|Randomized but not treated|2|||
143365148|NCT02414828|516878815|FG002|Overall Study|Lost to Follow-up|1|||
143064319|NCT00958126|515775280|FG000|Overall Study|Sponsor/Investigator decision|0|||
143064320|NCT00958126|515775281|FG001|Overall Study|Sponsor/Investigator decision|0|||
143064321|NCT00958126|515775282|FG002|Overall Study|Sponsor/Investigator decision|0|||
143064322|NCT00958126|515775283|FG003|Overall Study|Sponsor/Investigator decision|1|||
143064323|NCT00958126|515775284|FG004|Overall Study|Sponsor/Investigator decision|0|||
143064324|NCT00958126|515775285|FG005|Overall Study|Sponsor/Investigator decision|0|||
143064325|NCT00958126|515775286|FG006|Overall Study|Sponsor/Investigator decision|0|||
143064326|NCT00958126|515775287|FG007|Overall Study|Sponsor/Investigator decision|0|||
143064327|NCT00958126|515775280|FG000|Overall Study|Other Reason|0|||
143064328|NCT00958126|515775281|FG001|Overall Study|Other Reason|0|||
143064329|NCT00958126|515775282|FG002|Overall Study|Other Reason|0|||
143064330|NCT00958126|515775283|FG003|Overall Study|Other Reason|1|||
143064331|NCT00958126|515775284|FG004|Overall Study|Other Reason|0|||
143064332|NCT00958126|515775285|FG005|Overall Study|Other Reason|1|||
143064333|NCT00958126|515775286|FG006|Overall Study|Other Reason|0|||
143064334|NCT00958126|515775287|FG007|Overall Study|Other Reason|0|||
143064335|NCT00720226|515775288|FG000|Overall Study|Withdrawal by Subject|7|||
143064336|NCT00720226|515775289|FG001|Overall Study|Withdrawal by Subject|4|||
143064337|NCT00733369|515775290|FG000|Overall Study|Lost to Follow-up|2|||
143064338|NCT00733369|515775291|FG001|Overall Study|Lost to Follow-up|1|||
143064339|NCT00733369|515775290|FG000|Overall Study|Adverse Event|4|||
143064340|NCT00733369|515775291|FG001|Overall Study|Adverse Event|4|||
143064341|NCT00733369|515775290|FG000|Overall Study|Protocol Violation|4|||
143064342|NCT00733369|515775291|FG001|Overall Study|Protocol Violation|4|||
143064343|NCT01470612|515775292|FG000|Overall Study|Adverse Event|20|||
143064344|NCT01470612|515775293|FG001|Overall Study|Adverse Event|80|||
143064345|NCT01470612|515775292|FG000|Overall Study|Death|0|||
143064346|NCT01470612|515775293|FG001|Overall Study|Death|1|||
143064347|NCT01470612|515775292|FG000|Overall Study|Lack of Efficacy|20|||
143064348|NCT01470612|515775293|FG001|Overall Study|Lack of Efficacy|326|||
143064349|NCT01470612|515775292|FG000|Overall Study|Lost to Follow-up|2|||
143064350|NCT01470612|515775293|FG001|Overall Study|Lost to Follow-up|5|||
143064351|NCT01470612|515775292|FG000|Overall Study|Did not meet entrance criteria|0|||
143064352|NCT01470612|515775293|FG001|Overall Study|Did not meet entrance criteria|1|||
143064353|NCT01470612|515775292|FG000|Overall Study|Pregnancy|2|||
143064354|NCT01470612|515775293|FG001|Overall Study|Pregnancy|10|||
143064355|NCT01470612|515775292|FG000|Overall Study|Protocol Violation|2|||
143064356|NCT01470612|515775293|FG001|Overall Study|Protocol Violation|7|||
143064357|NCT01470612|515775292|FG000|Overall Study|Withdrawal by Subject|24|||
143064358|NCT01470612|515775293|FG001|Overall Study|Withdrawal by Subject|79|||
143064359|NCT01470612|515775292|FG000|Overall Study|Other|14|||
143064360|NCT01470612|515775293|FG001|Overall Study|Other|156|||
143064361|NCT01138111|515775302|FG000|Overall Study|Withdrawal by Subject|5|||
143064362|NCT01138111|515775302|FG000|Overall Study|Adverse Event|1|||
143064363|NCT01138111|515775302|FG000|Overall Study|Death|1|||
143064364|NCT01138111|515775302|FG000|Overall Study|Lost to Follow-up|2|||
143064365|NCT01277718|515775303|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
143064366|NCT01277718|515775304|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
143064367|NCT01277718|515775303|FG000|Period 2 - Second Intervention|Physician Decision|0|||
143064368|NCT01277718|515775304|FG001|Period 2 - Second Intervention|Physician Decision|2|||
143064369|NCT02746627|515775306|FG000|Overall Study|Withdrawal by Subject|1|||
143064370|NCT02746627|515775307|FG001|Overall Study|Withdrawal by Subject|1|||
143064371|NCT02746627|515775308|FG002|Overall Study|Withdrawal by Subject|1|||
143064372|NCT04459715|515775312|FG000|Overall Study|Adverse Event|3|||
143064373|NCT04459715|515775313|FG001|Overall Study|Adverse Event|3|||
143064374|NCT04459715|515775312|FG000|Overall Study|Death|111|||
143064375|NCT04459715|515775313|FG001|Overall Study|Death|93|||
143064376|NCT04459715|515775312|FG000|Overall Study|Lost to Follow-up|10|||
143064377|NCT04459715|515775313|FG001|Overall Study|Lost to Follow-up|9|||
143064378|NCT04459715|515775312|FG000|Overall Study|Other Reasons|4|||
143064379|NCT04459715|515775313|FG001|Overall Study|Other Reasons|5|||
143365149|NCT02414828|516878816|FG003|Overall Study|Lost to Follow-up|2|||
143064380|NCT04459715|515775312|FG000|Overall Study|PROTOCOL DEVIATION|0|||
143064381|NCT04459715|515775313|FG001|Overall Study|PROTOCOL DEVIATION|1|||
143064382|NCT04459715|515775312|FG000|Overall Study|RANDOMIZED BY MISTAKE|0|||
143064383|NCT04459715|515775313|FG001|Overall Study|RANDOMIZED BY MISTAKE|1|||
143064384|NCT04459715|515775312|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|214|||
143064385|NCT04459715|515775313|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|232|||
143064386|NCT04459715|515775312|FG000|Overall Study|Withdrawal by Subject|22|||
143064387|NCT04459715|515775313|FG001|Overall Study|Withdrawal by Subject|22|||
143365150|NCT05025449|516880642|FG000|Overall Study|Withdrawal by Subject|1|||
143064388|NCT01408563|515776786|FG000|Overall Study|Ineligible after consent/ registration|2|||
143064389|NCT00380692|515776788|FG000|Study Period II - Double Blind|Adverse Event|1|||
143064390|NCT00380692|515776789|FG001|Study Period II - Double Blind|Adverse Event|0|||
143064391|NCT00380692|515776788|FG000|Study Period II - Double Blind|Protocol Violation|2|||
143064392|NCT00380692|515776789|FG001|Study Period II - Double Blind|Protocol Violation|2|||
143064393|NCT00380692|515776788|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
143064394|NCT00380692|515776789|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
143064395|NCT00380692|515776788|FG000|Study Period II - Double Blind|Physician Decision|0|||
143064396|NCT00380692|515776789|FG001|Study Period II - Double Blind|Physician Decision|1|||
143064397|NCT00380692|515776788|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
143064398|NCT00380692|515776789|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
143064399|NCT00380692|515776788|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
143064400|NCT00380692|515776789|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
143064401|NCT00380692|515776788|FG000|Study Period III - Open Label|Adverse Event|5|||
143064402|NCT00380692|515776789|FG001|Study Period III - Open Label|Adverse Event|3|||
143064403|NCT00380692|515776788|FG000|Study Period III - Open Label|Protocol Violation|0|||
143064404|NCT00380692|515776789|FG001|Study Period III - Open Label|Protocol Violation|0|||
143064405|NCT00380692|515776788|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
143064406|NCT00380692|515776789|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
143064407|NCT00380692|515776788|FG000|Study Period III - Open Label|Physician Decision|0|||
143064408|NCT00380692|515776789|FG001|Study Period III - Open Label|Physician Decision|3|||
143064409|NCT00380692|515776788|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
143064410|NCT00380692|515776789|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
143064411|NCT00380692|515776788|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
143064412|NCT00380692|515776789|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
143064413|NCT01220297|515776790|FG000|Overall Study|Death|2|||
143064414|NCT01220297|515776790|FG000|Overall Study|Lost to Follow-up|1|||
143064415|NCT01996332|515776791|FG000|Overall Study|Adverse Event|117|||
143064416|NCT01996332|515776791|FG000|Overall Study|Lack of Efficacy|1245|||
143064417|NCT01996332|515776791|FG000|Overall Study|Death|264|||
143064418|NCT01996332|515776791|FG000|Overall Study|Protocol Violation|9|||
143064419|NCT01996332|515776791|FG000|Overall Study|Withdrawal by Subject|71|||
143064420|NCT01996332|515776791|FG000|Overall Study|Other|20|||
143064421|NCT01996332|515776791|FG000|Overall Study|Clinical Deterioration|28|||
143064422|NCT01996332|515776791|FG000|Overall Study|Physician Decision|17|||
143064423|NCT01996332|515776791|FG000|Overall Study|Lost to Follow-up|34|||
143064424|NCT02113189|515776792|FG000|Overall Study|Lost to follow up|2|||
143064425|NCT02113189|515776793|FG001|Overall Study|Lost to follow up|1|||
143064426|NCT02113189|515776794|FG002|Overall Study|Lost to follow up|3|||
143064427|NCT00931268|515776795|FG000|Overall Study|Lost to Follow-up|6|||
143064428|NCT01421342|515776796|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
143064429|NCT01421342|515776797|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
143064430|NCT01421342|515776798|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
143064431|NCT01421342|515776796|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
143064432|NCT01421342|515776797|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
143064433|NCT01421342|515776798|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
143064434|NCT01421342|515776796|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
143064435|NCT01421342|515776797|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
143064436|NCT01421342|515776798|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
143064437|NCT01421342|515776796|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
143064438|NCT01421342|515776797|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
143365151|NCT05025449|516880642|FG000|Overall Study|Patient emergently taken to operating room|1|||
143365152|NCT00256308|516880643|FG000|Overall Study|Death|2|||
143064439|NCT01421342|515776798|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
143064440|NCT01421342|515776796|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
143064441|NCT01421342|515776797|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
143064442|NCT01421342|515776798|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
143064443|NCT01421342|515776796|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
143064444|NCT01421342|515776797|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
143064445|NCT01421342|515776798|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
143064446|NCT01421342|515776796|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
143064447|NCT01421342|515776797|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
143064448|NCT01421342|515776798|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
143064449|NCT01421342|515776796|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
143064450|NCT01421342|515776797|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
143064451|NCT01421342|515776798|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
143064452|NCT01421342|515776796|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
143064453|NCT01421342|515776797|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
143064454|NCT01421342|515776798|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
143064455|NCT01421342|515776796|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
143064456|NCT01421342|515776797|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
143064457|NCT01421342|515776798|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
143064458|NCT01421342|515776796|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
143064459|NCT01421342|515776797|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
143064460|NCT01421342|515776798|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
143064461|NCT01421342|515776796|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
143064462|NCT01421342|515776797|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
143064463|NCT01421342|515776798|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
143064464|NCT01421342|515776796|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
143064465|NCT01421342|515776797|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
143064466|NCT01421342|515776798|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
143064467|NCT01421342|515776796|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
143064468|NCT01421342|515776797|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
143064469|NCT01421342|515776798|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
143064470|NCT01421342|515776796|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
143064471|NCT01421342|515776797|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
143064472|NCT01421342|515776798|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
143064473|NCT01421342|515776796|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
143064474|NCT01421342|515776797|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
143064475|NCT01421342|515776798|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
143064476|NCT01421342|515776796|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
143064477|NCT01421342|515776797|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
143064478|NCT01421342|515776798|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
143064479|NCT01421342|515776796|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
143064480|NCT01421342|515776797|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
143064481|NCT01421342|515776798|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
143064482|NCT01421342|515776796|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
143064483|NCT01421342|515776797|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
143064484|NCT01421342|515776798|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
143064485|NCT01421342|515776796|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
143064486|NCT01421342|515776797|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
143064487|NCT01421342|515776798|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
143064488|NCT01421342|515776796|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
143064489|NCT01421342|515776797|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
143064490|NCT01421342|515776798|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
143064491|NCT01421342|515776796|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
143064492|NCT01421342|515776797|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
143064493|NCT01421342|515776798|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
143064494|NCT01421342|515776796|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
143064495|NCT01421342|515776797|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
143064496|NCT01421342|515776798|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
143064497|NCT01421342|515776796|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
143064498|NCT01421342|515776797|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
143064499|NCT01421342|515776798|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
143064500|NCT01421342|515776796|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
143064501|NCT01421342|515776797|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
143064502|NCT01421342|515776798|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
143064503|NCT01421342|515776796|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
143170248|NCT02284893|516171912|FG000|52 Week (Long Term)|Adverse Event|3|||
143170249|NCT02284893|516171913|FG001|52 Week (Long Term)|Adverse Event|1|||
143170250|NCT02284893|516171912|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
143170251|NCT02284893|516171913|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
143064504|NCT01421342|515776797|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
143064505|NCT01421342|515776798|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
143064506|NCT01421342|515776796|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
143064507|NCT01421342|515776797|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
143170252|NCT02284893|516171912|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
143064508|NCT01421342|515776798|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
143064509|NCT01421342|515776796|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
143064510|NCT01421342|515776797|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
143064511|NCT01421342|515776798|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
143064512|NCT02712333|515776805|FG000|First Period|Withdrawal by Subject|3|||
143064513|NCT02712333|515776806|FG001|First Period|Withdrawal by Subject|2|||
143064514|NCT03463993|515776807|FG000|Overall Study|Lost to Follow-up|7|||
143064515|NCT03463993|515776808|FG001|Overall Study|Lost to Follow-up|8|||
143064516|NCT03463993|515776807|FG000|Overall Study|Withdrawal by Subject|2|||
143064517|NCT03463993|515776808|FG001|Overall Study|Withdrawal by Subject|0|||
143064518|NCT03463993|515776807|FG000|Overall Study|Protocol Violation|4|||
143064519|NCT03463993|515776808|FG001|Overall Study|Protocol Violation|1|||
143064520|NCT03463993|515776807|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
143064521|NCT03463993|515776808|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
143064522|NCT03463993|515776807|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
143064523|NCT03463993|515776808|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
143064524|NCT03212794|515776809|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
143064525|NCT03212794|515776810|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
143064526|NCT03212794|515776809|FG000|Overall Study|Lost to Follow-up|5|||
143064527|NCT03212794|515776810|FG001|Overall Study|Lost to Follow-up|6|||
143064528|NCT03212794|515776809|FG000|Overall Study|Incarcerated; unable to participate|2|||
143064529|NCT03212794|515776810|FG001|Overall Study|Incarcerated; unable to participate|0|||
143064530|NCT03212794|515776809|FG000|Overall Study|Withdrawal by Subject|1|||
143064531|NCT03212794|515776810|FG001|Overall Study|Withdrawal by Subject|0|||
143064532|NCT03212794|515776809|FG000|Overall Study|Death|0|||
143064533|NCT03212794|515776810|FG001|Overall Study|Death|1|||
143064534|NCT03212794|515776809|FG000|Overall Study|Found to be ineligible after allocation|0|||
143064535|NCT03212794|515776810|FG001|Overall Study|Found to be ineligible after allocation|1|||
143064536|NCT03212794|515776809|FG000|Overall Study|Relocated out of area|2|||
143064537|NCT03212794|515776810|FG001|Overall Study|Relocated out of area|0|||
143064538|NCT00897949|515776811|FG000|Overall Study|Adverse Event|1|||
143064539|NCT00897949|515776812|FG001|Overall Study|Adverse Event|1|||
143064540|NCT00897949|515776813|FG002|Overall Study|Adverse Event|0|||
143064541|NCT00897949|515776811|FG000|Overall Study|Lost to Follow-up|0|||
143064542|NCT00897949|515776812|FG001|Overall Study|Lost to Follow-up|2|||
143064543|NCT00897949|515776813|FG002|Overall Study|Lost to Follow-up|1|||
143064544|NCT00897949|515776811|FG000|Overall Study|Protocol Violation|6|||
143064545|NCT00897949|515776812|FG001|Overall Study|Protocol Violation|3|||
143064546|NCT00897949|515776813|FG002|Overall Study|Protocol Violation|1|||
143064547|NCT00897949|515776811|FG000|Overall Study|Withdrawal by Subject|1|||
143064548|NCT00897949|515776812|FG001|Overall Study|Withdrawal by Subject|2|||
143064549|NCT00897949|515776813|FG002|Overall Study|Withdrawal by Subject|0|||
143064550|NCT00897949|515776811|FG000|Overall Study|Patient Uncoorperative|0|||
143064551|NCT00897949|515776812|FG001|Overall Study|Patient Uncoorperative|2|||
143064552|NCT00897949|515776813|FG002|Overall Study|Patient Uncoorperative|1|||
143064553|NCT00897949|515776811|FG000|Overall Study|Lost to Follow-up|30|||
143064554|NCT00897949|515776812|FG001|Overall Study|Lost to Follow-up|23|||
143064555|NCT00897949|515776813|FG002|Overall Study|Lost to Follow-up|17|||
143064556|NCT00897949|515776811|FG000|Overall Study|Withdrawal by Subject|24|||
143064557|NCT00897949|515776812|FG001|Overall Study|Withdrawal by Subject|31|||
143064558|NCT00897949|515776813|FG002|Overall Study|Withdrawal by Subject|17|||
143064559|NCT00897949|515776811|FG000|Overall Study|Abnormal Prestudy Labs|2|||
143064560|NCT00897949|515776812|FG001|Overall Study|Abnormal Prestudy Labs|3|||
143064561|NCT00897949|515776813|FG002|Overall Study|Abnormal Prestudy Labs|4|||
143064562|NCT00897949|515776811|FG000|Overall Study|Abnormal Baseline ECG|2|||
143064563|NCT00897949|515776812|FG001|Overall Study|Abnormal Baseline ECG|2|||
143064564|NCT00897949|515776813|FG002|Overall Study|Abnormal Baseline ECG|4|||
143064565|NCT00897949|515776811|FG000|Overall Study|Need for Concom. Med.|0|||
143064566|NCT00897949|515776812|FG001|Overall Study|Need for Concom. Med.|1|||
143246094|NCT04421027|516451887|FG003|Follow-Up Period|Left message, participant did not call back|1|||
143064567|NCT00897949|515776813|FG002|Overall Study|Need for Concom. Med.|1|||
143064568|NCT00897949|515776811|FG000|Overall Study|Lack of Migraine Attack|29|||
143064569|NCT00897949|515776812|FG001|Overall Study|Lack of Migraine Attack|30|||
143064570|NCT00897949|515776813|FG002|Overall Study|Lack of Migraine Attack|19|||
143064571|NCT00897949|515776811|FG000|Overall Study|Did not take study drug|9|||
143246095|NCT04421027|516451884|FG000|Follow-Up Period|Participant died|0|||
143246096|NCT04421027|516451885|FG001|Follow-Up Period|Participant died|0|||
143064572|NCT00897949|515776812|FG001|Overall Study|Did not take study drug|3|||
143064573|NCT00897949|515776813|FG002|Overall Study|Did not take study drug|4|||
143064574|NCT01763918|515776814|FG000|Overall Study|Withdrawal by Subject|2|||
143064575|NCT01763918|515776815|FG001|Overall Study|Withdrawal by Subject|1|||
143064576|NCT01763918|515776816|FG002|Overall Study|Withdrawal by Subject|1|||
143064577|NCT01763918|515776817|FG003|Overall Study|Withdrawal by Subject|2|||
143064578|NCT01763918|515776814|FG000|Overall Study|Sponsor Decision|4|||
143064579|NCT01763918|515776815|FG001|Overall Study|Sponsor Decision|0|||
143064580|NCT01763918|515776816|FG002|Overall Study|Sponsor Decision|9|||
143064581|NCT01763918|515776817|FG003|Overall Study|Sponsor Decision|0|||
143064582|NCT00102687|515776818|FG000|Initial Period|Withdrawal by Subject|6|||
143064583|NCT00102687|515776819|FG001|Initial Period|Withdrawal by Subject|3|||
143064584|NCT00102687|515776820|FG002|Initial Period|Withdrawal by Subject|5|||
143064585|NCT00102687|515776821|FG003|Initial Period|Withdrawal by Subject|0|||
143064586|NCT00102687|515776822|FG004|Initial Period|Withdrawal by Subject|0|||
143064587|NCT00102687|515776818|FG000|Initial Period|Adverse Event|4|||
143064588|NCT00102687|515776819|FG001|Initial Period|Adverse Event|7|||
143064589|NCT00102687|515776820|FG002|Initial Period|Adverse Event|9|||
143064590|NCT00102687|515776821|FG003|Initial Period|Adverse Event|0|||
143064591|NCT00102687|515776822|FG004|Initial Period|Adverse Event|0|||
143064592|NCT00102687|515776818|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
143064593|NCT00102687|515776819|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
143064594|NCT00102687|515776820|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
143064595|NCT00102687|515776821|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
143064596|NCT00102687|515776822|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
143064597|NCT00102687|515776818|FG000|Initial Period|Protocol Violation|0|||
143064598|NCT00102687|515776819|FG001|Initial Period|Protocol Violation|0|||
143064599|NCT00102687|515776820|FG002|Initial Period|Protocol Violation|2|||
143064600|NCT00102687|515776821|FG003|Initial Period|Protocol Violation|0|||
143064601|NCT00102687|515776822|FG004|Initial Period|Protocol Violation|0|||
143064602|NCT00102687|515776818|FG000|Initial Period|Physician Decision|2|||
143064603|NCT00102687|515776819|FG001|Initial Period|Physician Decision|9|||
143064604|NCT00102687|515776820|FG002|Initial Period|Physician Decision|6|||
143064605|NCT00102687|515776821|FG003|Initial Period|Physician Decision|0|||
143064606|NCT00102687|515776822|FG004|Initial Period|Physician Decision|0|||
143064607|NCT00102687|515776818|FG000|Initial Period|Sponsor's decision|0|||
143064608|NCT00102687|515776819|FG001|Initial Period|Sponsor's decision|1|||
143064609|NCT00102687|515776820|FG002|Initial Period|Sponsor's decision|1|||
143064610|NCT00102687|515776821|FG003|Initial Period|Sponsor's decision|0|||
143064611|NCT00102687|515776822|FG004|Initial Period|Sponsor's decision|0|||
143064612|NCT00102687|515776818|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
143064613|NCT00102687|515776819|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
143064614|NCT00102687|515776820|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
143064615|NCT00102687|515776821|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
143064616|NCT00102687|515776822|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
143064617|NCT00102687|515776818|FG000|Initial Period|Death|1|||
143064618|NCT00102687|515776819|FG001|Initial Period|Death|1|||
143064619|NCT00102687|515776820|FG002|Initial Period|Death|1|||
143064620|NCT00102687|515776821|FG003|Initial Period|Death|0|||
143064621|NCT00102687|515776822|FG004|Initial Period|Death|0|||
143064622|NCT00102687|515776818|FG000|Maintenance Period|Withdrawal by Subject|4|||
143064623|NCT00102687|515776819|FG001|Maintenance Period|Withdrawal by Subject|0|||
143064624|NCT00102687|515776820|FG002|Maintenance Period|Withdrawal by Subject|2|||
143064625|NCT00102687|515776821|FG003|Maintenance Period|Withdrawal by Subject|3|||
143064626|NCT00102687|515776822|FG004|Maintenance Period|Withdrawal by Subject|1|||
143064627|NCT00102687|515776818|FG000|Maintenance Period|Adverse Event|1|||
143064628|NCT00102687|515776819|FG001|Maintenance Period|Adverse Event|0|||
143064629|NCT00102687|515776820|FG002|Maintenance Period|Adverse Event|0|||
143064630|NCT00102687|515776821|FG003|Maintenance Period|Adverse Event|1|||
143064631|NCT00102687|515776822|FG004|Maintenance Period|Adverse Event|3|||
143064632|NCT00102687|515776818|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
143064633|NCT00102687|515776819|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
143064634|NCT00102687|515776820|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
143064635|NCT00102687|515776821|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
143064636|NCT00102687|515776822|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
143064637|NCT00102687|515776818|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
143064638|NCT00102687|515776819|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
143064639|NCT00102687|515776820|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
143064640|NCT00102687|515776821|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
143064641|NCT00102687|515776822|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
143064642|NCT00102687|515776818|FG000|Maintenance Period|Death|0|||
143064643|NCT00102687|515776819|FG001|Maintenance Period|Death|0|||
143064644|NCT00102687|515776820|FG002|Maintenance Period|Death|0|||
143064645|NCT00102687|515776821|FG003|Maintenance Period|Death|1|||
143064646|NCT00102687|515776822|FG004|Maintenance Period|Death|1|||
143064647|NCT00102687|515776818|FG000|Maintenance Period|Physician Decision|1|||
143064648|NCT00102687|515776819|FG001|Maintenance Period|Physician Decision|2|||
143064649|NCT00102687|515776820|FG002|Maintenance Period|Physician Decision|3|||
143170253|NCT02284893|516171913|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
143064650|NCT00102687|515776821|FG003|Maintenance Period|Physician Decision|0|||
143064651|NCT00102687|515776822|FG004|Maintenance Period|Physician Decision|4|||
143064652|NCT03739138|515776831|FG000|Overall Study|Death|0|||
143064653|NCT03739138|515776832|FG001|Overall Study|Death|7|||
143365153|NCT01537133|516880644|FG000|Overall Study|Withdrawal by Subject|2|||
143365154|NCT01537133|516880645|FG001|Overall Study|Withdrawal by Subject|0|||
143064654|NCT03739138|515776833|FG002|Overall Study|Death|4|||
143064655|NCT03739138|515776834|FG003|Overall Study|Death|13|||
143064656|NCT03739138|515776835|FG004|Overall Study|Death|0|||
143064657|NCT03739138|515776831|FG000|Overall Study|Lost to Follow-up|0|||
143064658|NCT03739138|515776832|FG001|Overall Study|Lost to Follow-up|0|||
143064659|NCT03739138|515776833|FG002|Overall Study|Lost to Follow-up|1|||
143064660|NCT03739138|515776834|FG003|Overall Study|Lost to Follow-up|0|||
143064661|NCT03739138|515776835|FG004|Overall Study|Lost to Follow-up|0|||
143064662|NCT03739138|515776831|FG000|Overall Study|Study Terminated By Sponsor|0|||
143064663|NCT03739138|515776832|FG001|Overall Study|Study Terminated By Sponsor|0|||
143064664|NCT03739138|515776833|FG002|Overall Study|Study Terminated By Sponsor|0|||
143064665|NCT03739138|515776834|FG003|Overall Study|Study Terminated By Sponsor|4|||
143064666|NCT03739138|515776835|FG004|Overall Study|Study Terminated By Sponsor|0|||
143064667|NCT03739138|515776831|FG000|Overall Study|Withdrawal by Subject|0|||
143064668|NCT03739138|515776832|FG001|Overall Study|Withdrawal by Subject|0|||
143064669|NCT03739138|515776833|FG002|Overall Study|Withdrawal by Subject|0|||
143064670|NCT03739138|515776834|FG003|Overall Study|Withdrawal by Subject|1|||
143064671|NCT03739138|515776835|FG004|Overall Study|Withdrawal by Subject|0|||
143064672|NCT00597116|515776839|FG000|Overall Study|Adverse Event|2|||
143064673|NCT00597116|515776840|FG001|Overall Study|Adverse Event|1|||
143064674|NCT00597116|515776839|FG000|Overall Study|Withdrawal by Subject|0|||
143064675|NCT00597116|515776840|FG001|Overall Study|Withdrawal by Subject|2|||
143064676|NCT00597116|515776839|FG000|Overall Study|Physician Decision|0|||
143064677|NCT00597116|515776840|FG001|Overall Study|Physician Decision|1|||
143064678|NCT00597116|515776839|FG000|Overall Study|Death|0|||
143064679|NCT00597116|515776840|FG001|Overall Study|Death|1|||
143064680|NCT00597116|515776839|FG000|Overall Study|Lost to Follow-up|1|||
143064681|NCT00597116|515776840|FG001|Overall Study|Lost to Follow-up|0|||
143064682|NCT00597116|515776839|FG000|Overall Study|Progressive disease|11|||
143064683|NCT00597116|515776840|FG001|Overall Study|Progressive disease|6|||
143064684|NCT02903238|515776843|FG000|Overall Study|Lost to Follow-up|4|||
143064685|NCT00767520|515776844|FG000|Overall Study|Participants still on treatment|11|||
143064686|NCT00767520|515776845|FG001|Overall Study|Participants still on treatment|15|||
143064687|NCT00767520|515776844|FG000|Overall Study|Randomized in error and Never treated|0|||
143064688|NCT00767520|515776845|FG001|Overall Study|Randomized in error and Never treated|2|||
143064689|NCT02777918|515776846|FG000|Overall Study|Medical reasons|1|||
143170254|NCT02284893|516171912|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
143064690|NCT02777918|515776847|FG001|Overall Study|Medical reasons|2|||
143064691|NCT02777918|515776846|FG000|Overall Study|Too busy / stressed|1|||
143064692|NCT02777918|515776847|FG001|Overall Study|Too busy / stressed|1|||
143064693|NCT02777918|515776846|FG000|Overall Study|Withdrawal by Subject|1|||
143064694|NCT02777918|515776847|FG001|Overall Study|Withdrawal by Subject|1|||
143064695|NCT03856593|515776848|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
143064696|NCT03856593|515776849|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
143064697|NCT01901874|515776850|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
143064698|NCT01901874|515776850|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
143064699|NCT01901874|515776850|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
143064700|NCT01901874|515776850|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
143064701|NCT01901874|515776850|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
143064702|NCT01901874|515776850|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
143064703|NCT01949116|515776853|FG000|Overall Study|Death|2|||
143064704|NCT01949116|515776854|FG001|Overall Study|Death|0|||
143064705|NCT01949116|515776853|FG000|Overall Study|Lost to Follow-up|1|||
143064706|NCT01949116|515776854|FG001|Overall Study|Lost to Follow-up|3|||
143170255|NCT02284893|516171913|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
143365155|NCT01537133|516880646|FG002|Overall Study|Withdrawal by Subject|0|||
143170256|NCT02284893|516171912|FG000|52 Week (Long Term)|Non-Compliance|2|||
143502874|NCT00928070|517380955|FG001|Overall Study|Randomized but not treated|2|||
143502875|NCT00928070|517380954|FG000|Overall Study|Other|5|||
143502876|NCT00928070|517380955|FG001|Overall Study|Other|5|||
143064707|NCT01949116|515776853|FG000|Overall Study|Withdrawal by Subject|5|||
143064708|NCT01949116|515776854|FG001|Overall Study|Withdrawal by Subject|3|||
143064709|NCT02556307|515776864|FG000|Overall Study|Premature treatment interruption|11|||
143064710|NCT02556307|515776864|FG000|Overall Study|Lost to Follow-up|36|||
143064711|NCT02556307|515776864|FG000|Overall Study|Change to triple therapy|4|||
143170257|NCT02284893|516171913|FG001|52 Week (Long Term)|Non-Compliance|3|||
143170258|NCT02757430|516171914|FG000|Overall Study|Physician Decision|6|||
143502877|NCT06161012|517380956|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
143064712|NCT02556307|515776864|FG000|Overall Study|Enrolled but not treated|2|||
143064713|NCT03078582|515776865|FG000|Overall Study|Adverse Event|0|||
143064714|NCT03078582|515776866|FG001|Overall Study|Adverse Event|8|||
143064715|NCT03832738|515776873|FG000|Overall Study|Withdrawal by Subject|6|||
143064716|NCT03832738|515776874|FG001|Overall Study|Withdrawal by Subject|7|||
143064717|NCT03832738|515776875|FG002|Overall Study|Withdrawal by Subject|16|||
143064718|NCT03832738|515776873|FG000|Overall Study|Physician Decision|0|||
143064719|NCT03832738|515776874|FG001|Overall Study|Physician Decision|1|||
143064720|NCT03832738|515776875|FG002|Overall Study|Physician Decision|2|||
143064721|NCT03832738|515776873|FG000|Overall Study|Adverse Event|2|||
143064722|NCT03832738|515776874|FG001|Overall Study|Adverse Event|3|||
143064723|NCT03832738|515776875|FG002|Overall Study|Adverse Event|1|||
143064724|NCT03832738|515776873|FG000|Overall Study|Pregnancy|0|||
143064725|NCT03832738|515776874|FG001|Overall Study|Pregnancy|1|||
143064726|NCT03832738|515776875|FG002|Overall Study|Pregnancy|0|||
143064727|NCT00049842|515776876|FG000|Treatment Phase|Adverse Event|47|||
143064728|NCT00049842|515776877|FG001|Treatment Phase|Adverse Event|12|||
143064729|NCT00049842|515776876|FG000|Treatment Phase|Withdrawal by Subject|35|||
143064730|NCT00049842|515776877|FG001|Treatment Phase|Withdrawal by Subject|46|||
143064731|NCT00049842|515776876|FG000|Treatment Phase|Non-compliance with protocol|7|||
143064732|NCT00049842|515776877|FG001|Treatment Phase|Non-compliance with protocol|8|||
143064733|NCT00049842|515776876|FG000|Treatment Phase|Lost to Follow-up|4|||
143064734|NCT00049842|515776877|FG001|Treatment Phase|Lost to Follow-up|8|||
143064735|NCT00049842|515776876|FG000|Treatment Phase|Administrative|0|||
143064736|NCT00049842|515776877|FG001|Treatment Phase|Administrative|3|||
143064737|NCT00049842|515776876|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
143064738|NCT00049842|515776877|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
143064739|NCT00049842|515776876|FG000|Follow-up Phase|Adverse Event|6|||
143064740|NCT00049842|515776877|FG001|Follow-up Phase|Adverse Event|1|||
143064741|NCT00049842|515776876|FG000|Follow-up Phase|Other|1|||
143064742|NCT00049842|515776877|FG001|Follow-up Phase|Other|4|||
143064743|NCT03977701|515776878|FG000|Overall Study|COVID-19 pandemic|0|||
143064744|NCT03977701|515776879|FG001|Overall Study|COVID-19 pandemic|0|||
143064745|NCT03977701|515776880|FG002|Overall Study|COVID-19 pandemic|0|||
143064746|NCT03977701|515776881|FG003|Overall Study|COVID-19 pandemic|0|||
143064747|NCT03977701|515776882|FG004|Overall Study|COVID-19 pandemic|0|||
143064748|NCT03977701|515776883|FG005|Overall Study|COVID-19 pandemic|1|||
143064749|NCT03977701|515776884|FG006|Overall Study|COVID-19 pandemic|0|||
143064750|NCT03977701|515776885|FG007|Overall Study|COVID-19 pandemic|1|||
143064751|NCT03977701|515776886|FG008|Overall Study|COVID-19 pandemic|0|||
143064752|NCT03977701|515776887|FG009|Overall Study|COVID-19 pandemic|0|||
143064753|NCT00430950|515776888|FG000|Overall Study|Adverse Event|7|||
143064754|NCT00430950|515776889|FG001|Overall Study|Adverse Event|6|||
143064755|NCT00430950|515776888|FG000|Overall Study|Withdrawal by Subject|1|||
143064756|NCT00430950|515776889|FG001|Overall Study|Withdrawal by Subject|0|||
143064757|NCT00430950|515776888|FG000|Overall Study|concomitant medication,etc.|5|||
143064758|NCT00430950|515776889|FG001|Overall Study|concomitant medication,etc.|7|||
143064759|NCT02429934|515776890|FG000|Overall Study|Withdrawal by Subject|0|||
143064760|NCT02429934|515776891|FG001|Overall Study|Withdrawal by Subject|2|||
143064761|NCT02429934|515776890|FG000|Overall Study|Adverse Event|2|||
143064762|NCT02429934|515776891|FG001|Overall Study|Adverse Event|0|||
143064763|NCT02429934|515776890|FG000|Overall Study|Lost to Follow-up|1|||
143064764|NCT02429934|515776891|FG001|Overall Study|Lost to Follow-up|1|||
143064765|NCT02429934|515776890|FG000|Overall Study|Physician Decision|1|||
143064766|NCT02429934|515776891|FG001|Overall Study|Physician Decision|0|||
143064767|NCT00831623|515776898|FG000|Overall Study|Withdrawal by Subject|9|||
143064768|NCT00831623|515776898|FG000|Overall Study|Lost to Follow-up|1|||
143064769|NCT00831623|515776898|FG000|Overall Study|Not 2 years post-treatment|12|||
143064770|NCT01564459|515776900|FG000|Run-In|Adverse Event|7|||
143064771|NCT01564459|515776901|FG001|Run-In|Adverse Event|0|||
143064772|NCT01564459|515776902|FG002|Run-In|Adverse Event|0|||
143064773|NCT01564459|515776900|FG000|Run-In|Lost to Follow-up|1|||
143064774|NCT01564459|515776901|FG001|Run-In|Lost to Follow-up|0|||
143064775|NCT01564459|515776902|FG002|Run-In|Lost to Follow-up|0|||
143064776|NCT01564459|515776900|FG000|Run-In|Non-compliance with study drug|2|||
143064777|NCT01564459|515776901|FG001|Run-In|Non-compliance with study drug|0|||
143064778|NCT01564459|515776902|FG002|Run-In|Non-compliance with study drug|0|||
143064779|NCT01564459|515776900|FG000|Run-In|Protocol Violation|1|||
143064780|NCT01564459|515776901|FG001|Run-In|Protocol Violation|0|||
143064781|NCT01564459|515776902|FG002|Run-In|Protocol Violation|0|||
143064782|NCT01564459|515776900|FG000|Run-In|Withdrawal by Subject|1|||
143064783|NCT01564459|515776901|FG001|Run-In|Withdrawal by Subject|0|||
143064784|NCT01564459|515776902|FG002|Run-In|Withdrawal by Subject|0|||
143246097|NCT04421027|516451886|FG002|Follow-Up Period|Participant died|0|||
143064785|NCT01564459|515776900|FG000|Double-blind Treatment|Adverse Event|0|||
143064786|NCT01564459|515776901|FG001|Double-blind Treatment|Adverse Event|0|||
143064787|NCT01564459|515776902|FG002|Double-blind Treatment|Adverse Event|1|||
143064788|NCT02080832|515776911|FG000|Overall Study|Excluded from analysis by MRI|9|||
143064789|NCT02080832|515776912|FG001|Overall Study|Excluded from analysis by MRI|10|||
143064790|NCT02080832|515776913|FG002|Overall Study|Excluded from analysis by MRI|14|||
143064791|NCT02080832|515776911|FG000|Overall Study|Lost to Follow-up|0|||
143064792|NCT02080832|515776912|FG001|Overall Study|Lost to Follow-up|2|||
143064793|NCT02080832|515776913|FG002|Overall Study|Lost to Follow-up|2|||
143064794|NCT00560937|515776914|FG000|Overall Study|Withdrawal by Subject|0|||
143064795|NCT00560937|515776915|FG001|Overall Study|Withdrawal by Subject|1|||
143064796|NCT00560937|515776914|FG000|Overall Study|Physician Decision|1|||
143064797|NCT00560937|515776915|FG001|Overall Study|Physician Decision|1|||
143064798|NCT01118117|515776916|FG000|Overall Study|Death|8|||
143064799|NCT01118117|515776917|FG001|Overall Study|Death|0|||
143170259|NCT02757430|516171914|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
143170260|NCT02757430|516171914|FG000|Overall Study|No informed consent|1|||
143170261|NCT02757430|516171914|FG000|Overall Study|No procedure performed|2|||
143064800|NCT01118117|515776916|FG000|Overall Study|Lost to Follow-up|6|||
143064801|NCT01118117|515776917|FG001|Overall Study|Lost to Follow-up|0|||
143064802|NCT01118117|515776916|FG000|Overall Study|Missed 12 Month Visit|7|||
143064803|NCT01118117|515776917|FG001|Overall Study|Missed 12 Month Visit|0|||
143170262|NCT03502200|516171917|FG000|Overall Study|Adverse Event|1|||
143064804|NCT00706992|515776918|FG000|Overall Study|Study termination|5|||
143064805|NCT00706992|515776919|FG001|Overall Study|Study termination|5|||
143064806|NCT00706992|515776920|FG002|Overall Study|Study termination|6|||
143064807|NCT00706992|515776921|FG003|Overall Study|Study termination|2|||
143064808|NCT00706992|515776922|FG004|Overall Study|Study termination|3|||
143064809|NCT00706992|515776923|FG005|Overall Study|Study termination|2|||
143064810|NCT00706992|515776924|FG006|Overall Study|Study termination|3|||
143064811|NCT00706992|515776918|FG000|Overall Study|Disease progression before treatment|0|||
143064812|NCT00706992|515776919|FG001|Overall Study|Disease progression before treatment|0|||
143064813|NCT00706992|515776920|FG002|Overall Study|Disease progression before treatment|0|||
143064814|NCT00706992|515776921|FG003|Overall Study|Disease progression before treatment|0|||
143064815|NCT00706992|515776922|FG004|Overall Study|Disease progression before treatment|1|||
143170263|NCT03502200|516171918|FG001|Overall Study|Adverse Event|0|||
143170264|NCT03502200|516171917|FG000|Overall Study|Lost to Follow-up|36|||
143170265|NCT03502200|516171918|FG001|Overall Study|Lost to Follow-up|38|||
143170266|NCT03502200|516171917|FG000|Overall Study|Study Team Decision|1|||
143170267|NCT03502200|516171918|FG001|Overall Study|Study Team Decision|1|||
143170268|NCT03502200|516171917|FG000|Overall Study|Withdrawal by Subject|5|||
143170269|NCT03502200|516171918|FG001|Overall Study|Withdrawal by Subject|7|||
143170270|NCT03502200|516171917|FG000|Overall Study|Death|0|||
143170271|NCT03502200|516171918|FG001|Overall Study|Death|2|||
143170272|NCT02526290|516171922|FG000|Overall Study|Adverse Event|3|||
143170273|NCT02526290|516171922|FG000|Overall Study|Withdrawal by Subject|4|||
143170274|NCT02526290|516171922|FG000|Overall Study|Physician Decision|1|||
143170275|NCT04138056|516171923|FG000|Primary Study|Lost to Follow-up|3|||
143170276|NCT04138056|516171924|FG001|Primary Study|Lost to Follow-up|4|||
143170277|NCT04138056|516171925|FG002|Primary Study|Lost to Follow-up|1|||
143246098|NCT04421027|516451887|FG003|Follow-Up Period|Participant died|1|||
143246099|NCT04421027|516451884|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
143246100|NCT04421027|516451885|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
143246101|NCT04421027|516451886|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
143246102|NCT04421027|516451887|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
143246103|NCT00124306|516451896|FG000|Overall Study|Adverse Event|7|||
143246104|NCT00124306|516451897|FG001|Overall Study|Adverse Event|2|||
143246105|NCT00124306|516451896|FG000|Overall Study|Lost to Follow-up|10|||
143246106|NCT00124306|516451897|FG001|Overall Study|Lost to Follow-up|6|||
143246107|NCT00124306|516451896|FG000|Overall Study|Lack of Efficacy|3|||
143246108|NCT00124306|516451897|FG001|Overall Study|Lack of Efficacy|6|||
143246109|NCT00124306|516451896|FG000|Overall Study|Personal constraints|0|||
143064816|NCT00706992|515776923|FG005|Overall Study|Disease progression before treatment|0|||
143064817|NCT00706992|515776924|FG006|Overall Study|Disease progression before treatment|0|||
143064818|NCT02181296|515776928|FG000|Overall Study|Lost to Follow-up|7|||
143064819|NCT02181296|515776929|FG001|Overall Study|Lost to Follow-up|6|||
143064820|NCT01392326|515776932|FG000|Overall Study|Death|2|||
143064821|NCT01392326|515776933|FG001|Overall Study|Death|0|||
143064822|NCT01392326|515776934|FG002|Overall Study|Death|0|||
143064823|NCT01392326|515776932|FG000|Overall Study|Withdrawal by Subject|12|||
143064824|NCT01392326|515776933|FG001|Overall Study|Withdrawal by Subject|11|||
143064825|NCT01392326|515776934|FG002|Overall Study|Withdrawal by Subject|15|||
143064826|NCT01392326|515776932|FG000|Overall Study|Protocol Violation|2|||
143064827|NCT01392326|515776933|FG001|Overall Study|Protocol Violation|0|||
143064828|NCT01392326|515776934|FG002|Overall Study|Protocol Violation|0|||
143064829|NCT01392326|515776932|FG000|Overall Study|Pregnancy|0|||
143064830|NCT01392326|515776933|FG001|Overall Study|Pregnancy|0|||
143064831|NCT01392326|515776934|FG002|Overall Study|Pregnancy|1|||
143064832|NCT01392326|515776932|FG000|Overall Study|Physician Decision|7|||
143064833|NCT01392326|515776933|FG001|Overall Study|Physician Decision|5|||
143064834|NCT01392326|515776934|FG002|Overall Study|Physician Decision|2|||
143064835|NCT01392326|515776932|FG000|Overall Study|Lost to Follow-up|1|||
143064836|NCT01392326|515776933|FG001|Overall Study|Lost to Follow-up|3|||
143064837|NCT01392326|515776934|FG002|Overall Study|Lost to Follow-up|4|||
143064838|NCT01392326|515776932|FG000|Overall Study|Lack of Efficacy|14|||
143064839|NCT01392326|515776933|FG001|Overall Study|Lack of Efficacy|10|||
143064840|NCT01392326|515776934|FG002|Overall Study|Lack of Efficacy|15|||
143064841|NCT01392326|515776932|FG000|Overall Study|Adverse Event|9|||
143064842|NCT01392326|515776933|FG001|Overall Study|Adverse Event|6|||
143064843|NCT01392326|515776934|FG002|Overall Study|Adverse Event|11|||
143064844|NCT00518622|515776937|FG000|Overall Study|Lost to Follow-up|0|||
143064845|NCT00518622|515776938|FG001|Overall Study|Lost to Follow-up|0|||
143170278|NCT04138056|516171926|FG003|Primary Study|Lost to Follow-up|1|||
143170279|NCT04138056|516171927|FG004|Primary Study|Lost to Follow-up|4|||
143170280|NCT04138056|516171923|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
143170281|NCT04138056|516171924|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
143064846|NCT00518622|515776939|FG002|Overall Study|Lost to Follow-up|1|||
143064847|NCT00518622|515776940|FG003|Overall Study|Lost to Follow-up|0|||
143064848|NCT00518622|515776941|FG004|Overall Study|Lost to Follow-up|0|||
143064849|NCT00518622|515776942|FG005|Overall Study|Lost to Follow-up|0|||
143246110|NCT00124306|516451897|FG001|Overall Study|Personal constraints|2|||
143064850|NCT00518622|515776943|FG006|Overall Study|Lost to Follow-up|0|||
143064851|NCT00518622|515776944|FG007|Overall Study|Lost to Follow-up|0|||
143064852|NCT00518622|515776937|FG000|Overall Study|Study medication taken incorrectly|0|||
143064853|NCT00518622|515776938|FG001|Overall Study|Study medication taken incorrectly|1|||
143064854|NCT00518622|515776939|FG002|Overall Study|Study medication taken incorrectly|0|||
143064855|NCT00518622|515776940|FG003|Overall Study|Study medication taken incorrectly|0|||
143064856|NCT00518622|515776941|FG004|Overall Study|Study medication taken incorrectly|0|||
143064857|NCT00518622|515776942|FG005|Overall Study|Study medication taken incorrectly|0|||
143064858|NCT00518622|515776943|FG006|Overall Study|Study medication taken incorrectly|0|||
143064859|NCT00518622|515776944|FG007|Overall Study|Study medication taken incorrectly|0|||
143064860|NCT02333487|515776945|FG000|Overall Study|Adverse Event|0|||
143064861|NCT02333487|515776946|FG001|Overall Study|Adverse Event|2|||
143064862|NCT02333487|515776947|FG002|Overall Study|Adverse Event|0|||
143064863|NCT00094094|515776948|FG000|Overall Study|Death|2|||
143064864|NCT00094094|515776948|FG000|Overall Study|Lack of Efficacy|23|||
143064865|NCT00094094|515776948|FG000|Overall Study|Adverse Event|7|||
143064866|NCT02091141|515778561|FG000|Overall Study|Death|280|||
143064867|NCT02091141|515778562|FG001|Overall Study|Death|118|||
143064868|NCT02091141|515778563|FG002|Overall Study|Death|46|||
143064869|NCT02091141|515778564|FG003|Overall Study|Death|13|||
143064870|NCT02091141|515778565|FG004|Overall Study|Death|31|||
143064871|NCT02091141|515778566|FG005|Overall Study|Death|16|||
143064872|NCT02091141|515778567|FG006|Overall Study|Death|12|||
143064873|NCT02091141|515778561|FG000|Overall Study|Withdrawal by Subject|21|||
143064874|NCT02091141|515778562|FG001|Overall Study|Withdrawal by Subject|13|||
143064875|NCT02091141|515778563|FG002|Overall Study|Withdrawal by Subject|3|||
143064876|NCT02091141|515778564|FG003|Overall Study|Withdrawal by Subject|2|||
143064877|NCT02091141|515778565|FG004|Overall Study|Withdrawal by Subject|2|||
143064878|NCT02091141|515778566|FG005|Overall Study|Withdrawal by Subject|3|||
143064879|NCT02091141|515778567|FG006|Overall Study|Withdrawal by Subject|0|||
143064880|NCT02091141|515778561|FG000|Overall Study|Lost to Follow-up|21|||
143064881|NCT02091141|515778562|FG001|Overall Study|Lost to Follow-up|5|||
143064882|NCT02091141|515778563|FG002|Overall Study|Lost to Follow-up|1|||
143064883|NCT02091141|515778564|FG003|Overall Study|Lost to Follow-up|0|||
143064884|NCT02091141|515778565|FG004|Overall Study|Lost to Follow-up|1|||
143064885|NCT02091141|515778566|FG005|Overall Study|Lost to Follow-up|2|||
143064886|NCT02091141|515778567|FG006|Overall Study|Lost to Follow-up|0|||
143064887|NCT02091141|515778561|FG000|Overall Study|Reason Not Specified|6|||
143064888|NCT02091141|515778562|FG001|Overall Study|Reason Not Specified|5|||
143064889|NCT02091141|515778563|FG002|Overall Study|Reason Not Specified|2|||
143064890|NCT02091141|515778564|FG003|Overall Study|Reason Not Specified|0|||
143064891|NCT02091141|515778565|FG004|Overall Study|Reason Not Specified|0|||
143064892|NCT02091141|515778566|FG005|Overall Study|Reason Not Specified|0|||
143064893|NCT02091141|515778567|FG006|Overall Study|Reason Not Specified|1|||
143064894|NCT02091141|515778561|FG000|Overall Study|Study Ended by Sponsor|1|||
143064895|NCT02091141|515778562|FG001|Overall Study|Study Ended by Sponsor|9|||
143064896|NCT02091141|515778563|FG002|Overall Study|Study Ended by Sponsor|0|||
143064897|NCT02091141|515778564|FG003|Overall Study|Study Ended by Sponsor|0|||
143064898|NCT02091141|515778565|FG004|Overall Study|Study Ended by Sponsor|0|||
143064899|NCT02091141|515778566|FG005|Overall Study|Study Ended by Sponsor|0|||
143064900|NCT02091141|515778567|FG006|Overall Study|Study Ended by Sponsor|0|||
143064901|NCT02091141|515778561|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
143064902|NCT02091141|515778562|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
143064903|NCT02091141|515778563|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
143064904|NCT02091141|515778564|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
143064905|NCT02091141|515778565|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
143170282|NCT04138056|516171925|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
143170283|NCT04138056|516171926|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
143170284|NCT04138056|516171927|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
143170285|NCT04138056|516171923|FG000|Extension Study|Lost to Follow-up|1|||
143170286|NCT04138056|516171924|FG001|Extension Study|Lost to Follow-up|2|||
143170287|NCT04138056|516171925|FG002|Extension Study|Lost to Follow-up|1|||
143170288|NCT04138056|516171926|FG003|Extension Study|Lost to Follow-up|0|||
143170289|NCT04138056|516171927|FG004|Extension Study|Lost to Follow-up|1|||
143170290|NCT02706392|516171930|FG000|Overall Study|Death|1|||
143170291|NCT02706392|516171931|FG001|Overall Study|Death|0|||
143170292|NCT02706392|516171932|FG002|Overall Study|Death|2|||
143064906|NCT02091141|515778566|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
143064907|NCT02091141|515778567|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
143064908|NCT02246439|515778568|FG000|Overall Study|Adverse Event|3|||
143064909|NCT02246439|515778569|FG001|Overall Study|Adverse Event|0|||
143064910|NCT02246439|515778568|FG000|Overall Study|Lost to Follow-up|7|||
143064911|NCT02246439|515778569|FG001|Overall Study|Lost to Follow-up|5|||
143064912|NCT02246439|515778568|FG000|Overall Study|Protocol Violation|0|||
143170293|NCT02706392|516171933|FG003|Overall Study|Death|2|||
143064913|NCT02246439|515778569|FG001|Overall Study|Protocol Violation|2|||
143064914|NCT02246439|515778568|FG000|Overall Study|Physician Decision|0|||
143064915|NCT02246439|515778569|FG001|Overall Study|Physician Decision|1|||
143064916|NCT02246439|515778568|FG000|Overall Study|Unkonwn|1|||
143064917|NCT02246439|515778569|FG001|Overall Study|Unkonwn|3|||
143064918|NCT02246439|515778568|FG000|Overall Study|Withdrawal by Subject|1|||
143064919|NCT02246439|515778569|FG001|Overall Study|Withdrawal by Subject|0|||
143064920|NCT03439852|515778570|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
143064921|NCT03439852|515778571|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
143064922|NCT03439852|515778570|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
143064923|NCT03439852|515778571|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
143064924|NCT03439852|515778570|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
143064925|NCT03439852|515778571|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
143064926|NCT02054130|515778580|FG000|Overall Study|Withdrawal by Subject|4|||
143064927|NCT02054130|515778581|FG001|Overall Study|Withdrawal by Subject|4|||
143064928|NCT02054130|515778582|FG002|Overall Study|Withdrawal by Subject|7|||
143064929|NCT02054130|515778583|FG003|Overall Study|Withdrawal by Subject|10|||
143064930|NCT02054130|515778580|FG000|Overall Study|Death|0|||
143064931|NCT02054130|515778581|FG001|Overall Study|Death|1|||
143064932|NCT02054130|515778582|FG002|Overall Study|Death|0|||
143064933|NCT02054130|515778583|FG003|Overall Study|Death|0|||
143064934|NCT02054130|515778580|FG000|Overall Study|Lost to Follow-up|0|||
143064935|NCT02054130|515778581|FG001|Overall Study|Lost to Follow-up|0|||
143064936|NCT02054130|515778582|FG002|Overall Study|Lost to Follow-up|1|||
143064937|NCT02054130|515778583|FG003|Overall Study|Lost to Follow-up|2|||
143064938|NCT02054130|515778580|FG000|Overall Study|Missed dose|4|||
143064939|NCT02054130|515778581|FG001|Overall Study|Missed dose|6|||
143064940|NCT02054130|515778582|FG002|Overall Study|Missed dose|7|||
143064941|NCT02054130|515778583|FG003|Overall Study|Missed dose|10|||
143064942|NCT03247517|515778584|FG000|Overall Study|Adverse Event|0|||
143064943|NCT03247517|515778585|FG001|Overall Study|Adverse Event|4|||
143064944|NCT03247517|515778586|FG002|Overall Study|Adverse Event|2|||
143064945|NCT03247517|515778584|FG000|Overall Study|Lost to Follow-up|2|||
143064946|NCT03247517|515778585|FG001|Overall Study|Lost to Follow-up|6|||
143064947|NCT03247517|515778586|FG002|Overall Study|Lost to Follow-up|4|||
143170294|NCT02706392|516171934|FG004|Overall Study|Death|5|||
143170295|NCT02706392|516171935|FG005|Overall Study|Death|2|||
143170296|NCT01467466|516171947|FG000|Overall Study|Withdrawal by Subject|15|||
143365156|NCT01537133|516880647|FG003|Overall Study|Withdrawal by Subject|0|||
143064948|NCT03247517|515778584|FG000|Overall Study|Consent withdrawn by caregiver|1|||
143064949|NCT03247517|515778585|FG001|Overall Study|Consent withdrawn by caregiver|4|||
143064950|NCT03247517|515778586|FG002|Overall Study|Consent withdrawn by caregiver|7|||
143064951|NCT03247517|515778584|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
143064952|NCT03247517|515778585|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
143064953|NCT03247517|515778586|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
143064954|NCT03247517|515778584|FG000|Overall Study|Protocol Violation|0|||
143064955|NCT03247517|515778585|FG001|Overall Study|Protocol Violation|2|||
143064956|NCT03247517|515778586|FG002|Overall Study|Protocol Violation|0|||
143064957|NCT03247517|515778584|FG000|Overall Study|Multiple reasons|3|||
143064958|NCT03247517|515778585|FG001|Overall Study|Multiple reasons|1|||
143064959|NCT03247517|515778586|FG002|Overall Study|Multiple reasons|0|||
143064960|NCT03197558|515778587|FG000|Overall Study|Tubes not placed|1|||
143064961|NCT01892657|515778588|FG000|Overall Study|Withdrawal by Subject|6|||
143064962|NCT01892657|515778588|FG000|Overall Study|Protocol Violation|12|||
143064963|NCT01546649|515778591|FG000|Overall Study|Adverse Event|4|||
143064964|NCT01546649|515778592|FG001|Overall Study|Adverse Event|5|||
143170297|NCT01467466|516171948|FG001|Overall Study|Withdrawal by Subject|18|||
143365157|NCT01537133|516880644|FG000|Overall Study|Lost to Follow-up|1|||
143064965|NCT01546649|515778591|FG000|Overall Study|Protocol Violation|1|||
143064966|NCT01546649|515778592|FG001|Overall Study|Protocol Violation|0|||
143064967|NCT01546649|515778591|FG000|Overall Study|Lack of Efficacy|1|||
143064968|NCT01546649|515778592|FG001|Overall Study|Lack of Efficacy|0|||
143064969|NCT01546649|515778591|FG000|Overall Study|Recurrence|1|||
143064970|NCT01546649|515778592|FG001|Overall Study|Recurrence|1|||
143064971|NCT01546649|515778591|FG000|Overall Study|Discovery of secondary cancer|0|||
143064972|NCT01546649|515778592|FG001|Overall Study|Discovery of secondary cancer|1|||
143064973|NCT01546649|515778591|FG000|Overall Study|Withdrawal by Subject|1|||
143064974|NCT01546649|515778592|FG001|Overall Study|Withdrawal by Subject|2|||
143064975|NCT04440449|515778593|FG000|Overall Study|Lost to Follow-up|2|||
143064976|NCT04440449|515778594|FG001|Overall Study|Lost to Follow-up|0|||
143064977|NCT01553747|515778598|FG000|Overall Study|Protocol Violation|0|||
143064978|NCT01553747|515778599|FG001|Overall Study|Protocol Violation|2|||
143064979|NCT01553747|515778600|FG002|Overall Study|Protocol Violation|0|||
143064980|NCT01553747|515778598|FG000|Overall Study|Voluntarily withdrew|70|||
143064981|NCT01553747|515778599|FG001|Overall Study|Voluntarily withdrew|66|||
143064982|NCT01553747|515778600|FG002|Overall Study|Voluntarily withdrew|74|||
143064983|NCT01553747|515778598|FG000|Overall Study|Adverse event or SAE|32|||
143064984|NCT01553747|515778599|FG001|Overall Study|Adverse event or SAE|28|||
143064985|NCT01553747|515778600|FG002|Overall Study|Adverse event or SAE|19|||
143064986|NCT01553747|515778598|FG000|Overall Study|Physician decision: other|10|||
143064987|NCT01553747|515778599|FG001|Overall Study|Physician decision: other|8|||
143064988|NCT01553747|515778600|FG002|Overall Study|Physician decision: other|7|||
143064989|NCT01553747|515778598|FG000|Overall Study|Lost to Follow-up|11|||
143064990|NCT01553747|515778599|FG001|Overall Study|Lost to Follow-up|5|||
143064991|NCT01553747|515778600|FG002|Overall Study|Lost to Follow-up|6|||
143064992|NCT01553747|515778598|FG000|Overall Study|Sponsor decision, specify|7|||
143064993|NCT01553747|515778599|FG001|Overall Study|Sponsor decision, specify|5|||
143064994|NCT01553747|515778600|FG002|Overall Study|Sponsor decision, specify|0|||
143064995|NCT01553747|515778598|FG000|Overall Study|Physician decision: lack of efficacy|1|||
143064996|NCT01553747|515778599|FG001|Overall Study|Physician decision: lack of efficacy|5|||
143064997|NCT01553747|515778600|FG002|Overall Study|Physician decision: lack of efficacy|3|||
143064998|NCT05420012|515778604|FG000|Overall Study|Lost to Follow-up|0|||
143064999|NCT05420012|515778605|FG001|Overall Study|Lost to Follow-up|1|||
143065000|NCT03253744|515778607|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
143065001|NCT03253744|515778608|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
143065002|NCT03253744|515778609|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
143065003|NCT03253744|515778610|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
143065004|NCT00977431|515778611|FG000|Overall Study|Other than listed|1|||
143065005|NCT00977431|515778612|FG001|Overall Study|Other than listed|0|||
143065006|NCT00977431|515778613|FG002|Overall Study|Other than listed|0|||
143065007|NCT00977431|515778614|FG003|Overall Study|Other than listed|0|||
143065008|NCT00977431|515778615|FG004|Overall Study|Other than listed|2|||
143065009|NCT00977431|515778611|FG000|Overall Study|Protocol Violation|0|||
143065010|NCT00977431|515778612|FG001|Overall Study|Protocol Violation|0|||
143065011|NCT00977431|515778613|FG002|Overall Study|Protocol Violation|1|||
143065012|NCT00977431|515778614|FG003|Overall Study|Protocol Violation|0|||
143065013|NCT00977431|515778615|FG004|Overall Study|Protocol Violation|0|||
143065014|NCT00977431|515778611|FG000|Overall Study|Adverse Event|3|||
143065015|NCT00977431|515778612|FG001|Overall Study|Adverse Event|0|||
143065016|NCT00977431|515778613|FG002|Overall Study|Adverse Event|4|||
143065017|NCT00977431|515778614|FG003|Overall Study|Adverse Event|0|||
143065018|NCT00977431|515778615|FG004|Overall Study|Adverse Event|6|||
143065019|NCT00977431|515778611|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
143065020|NCT00977431|515778612|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
143065021|NCT00977431|515778613|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
143065022|NCT00977431|515778614|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
143065023|NCT00977431|515778615|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
143065024|NCT00977431|515778611|FG000|Overall Study|Progressive disease|2|||
143065025|NCT00977431|515778612|FG001|Overall Study|Progressive disease|6|||
143065026|NCT00977431|515778613|FG002|Overall Study|Progressive disease|1|||
143065027|NCT00977431|515778614|FG003|Overall Study|Progressive disease|3|||
143065028|NCT00977431|515778615|FG004|Overall Study|Progressive disease|5|||
143065029|NCT02039414|515778622|FG000|Overall Study|Delivered|1|||
143065030|NCT02039414|515778623|FG001|Overall Study|Delivered|1|||
143065031|NCT02039414|515778622|FG000|Overall Study|Lost to Follow-up|2|||
143065032|NCT02039414|515778623|FG001|Overall Study|Lost to Follow-up|0|||
143502878|NCT06161012|517380957|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
143065033|NCT02039414|515778622|FG000|Overall Study|Protocol Violation|3|||
143065034|NCT02039414|515778623|FG001|Overall Study|Protocol Violation|1|||
143065035|NCT03852459|515778626|FG000|Overall Study|Adverse Event|2|||
143065036|NCT03852459|515778627|FG001|Overall Study|Adverse Event|2|||
143065037|NCT03852459|515778626|FG000|Overall Study|Withdrawal by Subject|1|||
143065038|NCT03852459|515778627|FG001|Overall Study|Withdrawal by Subject|1|||
143065039|NCT01347866|515778628|FG000|Overall Study|Death|0|||
143065040|NCT01347866|515778629|FG001|Overall Study|Death|0|||
143065041|NCT01347866|515778630|FG002|Overall Study|Death|0|||
143065042|NCT01347866|515778631|FG003|Overall Study|Death|1|||
143065043|NCT01347866|515778632|FG004|Overall Study|Death|2|||
143065044|NCT01347866|515778633|FG005|Overall Study|Death|2|||
143065045|NCT01347866|515778634|FG006|Overall Study|Death|1|||
143065046|NCT01347866|515778635|FG007|Overall Study|Death|0|||
143065047|NCT01347866|515778636|FG008|Overall Study|Death|4|||
143065048|NCT01347866|515778637|FG009|Overall Study|Death|1|||
143065049|NCT01347866|515778638|FG010|Overall Study|Death|3|||
143065050|NCT01347866|515778639|FG011|Overall Study|Death|1|||
143065051|NCT01347866|515778640|FG012|Overall Study|Death|2|||
143065052|NCT01347866|515778641|FG013|Overall Study|Death|0|||
143065053|NCT01347866|515778642|FG014|Overall Study|Death|0|||
143065054|NCT01347866|515778643|FG015|Overall Study|Death|1|||
143065055|NCT01347866|515778644|FG016|Overall Study|Death|0|||
143065056|NCT01347866|515778628|FG000|Overall Study|Lost to Follow-up|0|||
143065057|NCT01347866|515778629|FG001|Overall Study|Lost to Follow-up|0|||
143065058|NCT01347866|515778630|FG002|Overall Study|Lost to Follow-up|0|||
143065059|NCT01347866|515778631|FG003|Overall Study|Lost to Follow-up|0|||
143065060|NCT01347866|515778632|FG004|Overall Study|Lost to Follow-up|0|||
143065061|NCT01347866|515778633|FG005|Overall Study|Lost to Follow-up|0|||
143065062|NCT01347866|515778634|FG006|Overall Study|Lost to Follow-up|0|||
143065063|NCT01347866|515778635|FG007|Overall Study|Lost to Follow-up|1|||
143065064|NCT01347866|515778636|FG008|Overall Study|Lost to Follow-up|1|||
143065065|NCT01347866|515778637|FG009|Overall Study|Lost to Follow-up|0|||
143065066|NCT01347866|515778638|FG010|Overall Study|Lost to Follow-up|0|||
143065067|NCT01347866|515778639|FG011|Overall Study|Lost to Follow-up|0|||
143065068|NCT01347866|515778640|FG012|Overall Study|Lost to Follow-up|0|||
143065069|NCT01347866|515778641|FG013|Overall Study|Lost to Follow-up|0|||
143065070|NCT01347866|515778642|FG014|Overall Study|Lost to Follow-up|0|||
143065071|NCT01347866|515778643|FG015|Overall Study|Lost to Follow-up|0|||
143065072|NCT01347866|515778644|FG016|Overall Study|Lost to Follow-up|0|||
143065073|NCT01347866|515778628|FG000|Overall Study|Other|3|||
143065074|NCT01347866|515778629|FG001|Overall Study|Other|1|||
143065075|NCT01347866|515778630|FG002|Overall Study|Other|1|||
143065076|NCT01347866|515778631|FG003|Overall Study|Other|4|||
143065077|NCT01347866|515778632|FG004|Overall Study|Other|5|||
143065078|NCT01347866|515778633|FG005|Overall Study|Other|0|||
143065079|NCT01347866|515778634|FG006|Overall Study|Other|5|||
143065080|NCT01347866|515778635|FG007|Overall Study|Other|3|||
143065081|NCT01347866|515778636|FG008|Overall Study|Other|22|||
143065082|NCT01347866|515778637|FG009|Overall Study|Other|5|||
143065083|NCT01347866|515778638|FG010|Overall Study|Other|0|||
143246111|NCT00124306|516451896|FG000|Overall Study|Use of unacceptable medication|1|||
143246112|NCT00124306|516451897|FG001|Overall Study|Use of unacceptable medication|0|||
143246113|NCT00124306|516451896|FG000|Overall Study|Abnormal lab result|0|||
143246114|NCT00124306|516451897|FG001|Overall Study|Abnormal lab result|1|||
143246115|NCT00124306|516451896|FG000|Overall Study|Other|2|||
143246116|NCT00124306|516451897|FG001|Overall Study|Other|0|||
143246117|NCT02948088|516453407|FG000|Overall Study|Lost to Follow-up|8|||
143246118|NCT02948088|516453407|FG000|Overall Study|Death|1|||
143246119|NCT02948088|516453407|FG000|Overall Study|Withdrawal by Subject|4|||
143246120|NCT02948088|516453407|FG000|Overall Study|Other|2|||
143246121|NCT01409811|516453408|FG000|Overall Study|Insurance denial|1|||
143365158|NCT01537133|516880645|FG001|Overall Study|Lost to Follow-up|0|||
143065084|NCT01347866|515778639|FG011|Overall Study|Other|3|||
143065085|NCT01347866|515778640|FG012|Overall Study|Other|4|||
143065086|NCT01347866|515778641|FG013|Overall Study|Other|4|||
143246122|NCT00634101|516453409|FG000|Overall Study|Study Terminated|3|||
143365159|NCT01537133|516880646|FG002|Overall Study|Lost to Follow-up|0|||
143065087|NCT01347866|515778642|FG014|Overall Study|Other|2|||
143065088|NCT01347866|515778643|FG015|Overall Study|Other|3|||
143065089|NCT01347866|515778644|FG016|Overall Study|Other|0|||
143065090|NCT01347866|515778628|FG000|Overall Study|Subject refused further follow-up|2|||
143065091|NCT01347866|515778629|FG001|Overall Study|Subject refused further follow-up|0|||
143065092|NCT01347866|515778630|FG002|Overall Study|Subject refused further follow-up|0|||
143065093|NCT01347866|515778631|FG003|Overall Study|Subject refused further follow-up|2|||
143065094|NCT01347866|515778632|FG004|Overall Study|Subject refused further follow-up|0|||
143246123|NCT00634101|516453410|FG001|Overall Study|Study Terminated|3|||
143065095|NCT01347866|515778633|FG005|Overall Study|Subject refused further follow-up|1|||
143246124|NCT00634101|516453409|FG000|Overall Study|Lost to Follow-up|2|||
143065096|NCT01347866|515778634|FG006|Overall Study|Subject refused further follow-up|0|||
143065097|NCT01347866|515778635|FG007|Overall Study|Subject refused further follow-up|0|||
143065098|NCT01347866|515778636|FG008|Overall Study|Subject refused further follow-up|4|||
143065099|NCT01347866|515778637|FG009|Overall Study|Subject refused further follow-up|1|||
143065100|NCT01347866|515778638|FG010|Overall Study|Subject refused further follow-up|0|||
143246125|NCT00634101|516453410|FG001|Overall Study|Lost to Follow-up|0|||
143065101|NCT01347866|515778639|FG011|Overall Study|Subject refused further follow-up|0|||
143065102|NCT01347866|515778640|FG012|Overall Study|Subject refused further follow-up|1|||
143065103|NCT01347866|515778641|FG013|Overall Study|Subject refused further follow-up|3|||
143065104|NCT01347866|515778642|FG014|Overall Study|Subject refused further follow-up|1|||
143065105|NCT01347866|515778643|FG015|Overall Study|Subject refused further follow-up|0|||
143065106|NCT01347866|515778644|FG016|Overall Study|Subject refused further follow-up|2|||
143065107|NCT00869024|515778645|FG000|Overall Study|Death|2|||
143065108|NCT00869024|515778646|FG001|Overall Study|Death|3|||
143065109|NCT00869024|515778645|FG000|Overall Study|Lost to Follow-up|0|||
143065110|NCT00869024|515778646|FG001|Overall Study|Lost to Follow-up|1|||
143065111|NCT00869024|515778645|FG000|Overall Study|Protocol Violation|0|||
143065112|NCT00869024|515778646|FG001|Overall Study|Protocol Violation|1|||
143065113|NCT03545191|515778652|FG000|Overall Study|Death|1|||
143065114|NCT03545191|515778653|FG001|Overall Study|Death|0|||
143065115|NCT03545191|515778654|FG002|Overall Study|Death|0|||
143065116|NCT03545191|515778652|FG000|Overall Study|Adverse Event|4|||
143065117|NCT03545191|515778653|FG001|Overall Study|Adverse Event|2|||
143065118|NCT03545191|515778654|FG002|Overall Study|Adverse Event|7|||
143065119|NCT03545191|515778652|FG000|Overall Study|Other reasons|3|||
143065120|NCT03545191|515778653|FG001|Overall Study|Other reasons|11|||
143065121|NCT03545191|515778654|FG002|Overall Study|Other reasons|8|||
143065122|NCT03545191|515778652|FG000|Overall Study|Withdrawal by Subject|13|||
143065123|NCT03545191|515778653|FG001|Overall Study|Withdrawal by Subject|10|||
143065124|NCT03545191|515778654|FG002|Overall Study|Withdrawal by Subject|12|||
143065125|NCT03545191|515778652|FG000|Overall Study|Lost to Follow-up|1|||
143065126|NCT03545191|515778653|FG001|Overall Study|Lost to Follow-up|2|||
143065127|NCT03545191|515778654|FG002|Overall Study|Lost to Follow-up|3|||
143065128|NCT02025751|515778655|FG000|Overall Study|Lost to Follow-up|1|||
143065129|NCT02025751|515778656|FG001|Overall Study|Lost to Follow-up|0|||
143065130|NCT02025751|515778655|FG000|Overall Study|Adverse Event|0|||
143065131|NCT02025751|515778656|FG001|Overall Study|Adverse Event|1|||
143065132|NCT02025751|515778655|FG000|Overall Study|Physician Decision|0|||
143065133|NCT02025751|515778656|FG001|Overall Study|Physician Decision|1|||
143065134|NCT02025751|515778655|FG000|Overall Study|Withdrawal by Subject|0|||
143065135|NCT02025751|515778656|FG001|Overall Study|Withdrawal by Subject|1|||
143065136|NCT00653991|515778657|FG000|3 Month Follow-up|Participant would not respond|150|||
143065137|NCT00653991|515778658|FG001|3 Month Follow-up|Participant would not respond|157|||
143065138|NCT00653991|515778657|FG000|6 Month Follow-up|Participant would not respond|133|||
143065139|NCT00653991|515778658|FG001|6 Month Follow-up|Participant would not respond|141|||
143065140|NCT02939014|515778659|FG000|Overall Study|Lost to Follow-up|1|||
143065141|NCT02939014|515778660|FG001|Overall Study|Lost to Follow-up|0|||
143065142|NCT02939014|515778659|FG000|Overall Study|Death|4|||
143065143|NCT02939014|515778660|FG001|Overall Study|Death|3|||
143065144|NCT03351231|515778669|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
143065145|NCT03351231|515778669|FG000|Combination Therapy Period|Disease progression|2|||
143065146|NCT03351231|515778669|FG000|Combination Therapy Period|Study drug toxicity|1|||
143065147|NCT03351231|515778669|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
143065148|NCT03351231|515778669|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
143065149|NCT03351231|515778669|FG000|Safety Follow-Up Period|Other reason|2|||
143065150|NCT02340221|515778674|FG000|Overall Study|Death|100|||
143065151|NCT02340221|515778675|FG001|Overall Study|Death|197|||
143065152|NCT02340221|515778674|FG000|Overall Study|Withdrawal by Participant|24|||
143065153|NCT02340221|515778675|FG001|Overall Study|Withdrawal by Participant|37|||
143065154|NCT02340221|515778674|FG000|Overall Study|Lost to Follow-up|4|||
143065155|NCT02340221|515778675|FG001|Overall Study|Lost to Follow-up|15|||
143065156|NCT02340221|515778674|FG000|Overall Study|Reason Not Specified|85|||
143065157|NCT02340221|515778675|FG001|Overall Study|Reason Not Specified|165|||
143065158|NCT02340221|515778674|FG000|Overall Study|Study Terminated by Sponsor|1|||
143065159|NCT02340221|515778675|FG001|Overall Study|Study Terminated by Sponsor|3|||
143065160|NCT03487848|515778676|FG000|Overall Study|Lost to Follow-up|1|||
143065161|NCT03499119|515778677|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
143065162|NCT03499119|515778678|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
143246126|NCT00838513|516453412|FG000|Screening Period|Screen Failure|3|||
143065163|NCT03499119|515778679|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
143065164|NCT03499119|515778680|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
143065165|NCT03499119|515778677|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
143065166|NCT03499119|515778678|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
143065167|NCT03499119|515778679|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
143065168|NCT03499119|515778680|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
143065169|NCT03499119|515778677|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
143065170|NCT03499119|515778678|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
143065171|NCT03499119|515778679|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
143065172|NCT03499119|515778680|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
143065173|NCT03499119|515778677|FG000|Optional Extension Phase|Lost to Follow-up|0|||
143065174|NCT03499119|515778678|FG001|Optional Extension Phase|Lost to Follow-up|0|||
143246127|NCT00838513|516453412|FG000|Extension Treatment Period|Death|1|||
143065175|NCT03499119|515778679|FG002|Optional Extension Phase|Lost to Follow-up|0|||
143065176|NCT03499119|515778680|FG003|Optional Extension Phase|Lost to Follow-up|1|||
143065177|NCT03499119|515778677|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
143065178|NCT03499119|515778678|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
143065179|NCT03499119|515778679|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
143065180|NCT03499119|515778680|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
143065181|NCT03499119|515778677|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
143065182|NCT03499119|515778678|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
143065183|NCT03499119|515778679|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
143065184|NCT03499119|515778680|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
143065185|NCT01393730|515778681|FG000|Overall Study|Withdrawal by Subject|3|||
143065186|NCT01393730|515778681|FG000|Overall Study|Other|2|||
143065187|NCT01393730|515778681|FG000|Overall Study|Adverse Event|1|||
143065188|NCT00103402|515778682|FG000|Overall Study|Adverse Event|3|||
143065189|NCT00103402|515778683|FG001|Overall Study|Adverse Event|4|||
143065190|NCT00103402|515778682|FG000|Overall Study|Lost to Follow-up|8|||
143065191|NCT00103402|515778683|FG001|Overall Study|Lost to Follow-up|7|||
143065192|NCT00103402|515778682|FG000|Overall Study|Dissatisfied/No longer interested|6|||
143065193|NCT00103402|515778683|FG001|Overall Study|Dissatisfied/No longer interested|6|||
143065194|NCT00103402|515778682|FG000|Overall Study|Personal constraints/Other|5|||
143065195|NCT00103402|515778683|FG001|Overall Study|Personal constraints/Other|0|||
143065196|NCT02655016|515778686|FG000|Overall Study|Disease progression|6|||
143065197|NCT02655016|515778687|FG001|Overall Study|Disease progression|4|||
143065198|NCT02655016|515778686|FG000|Overall Study|Site closed|0|||
143065199|NCT02655016|515778687|FG001|Overall Study|Site closed|1|||
143065200|NCT02655016|515778686|FG000|Overall Study|Death|30|||
143065201|NCT02655016|515778687|FG001|Overall Study|Death|48|||
143065202|NCT02655016|515778686|FG000|Overall Study|Lost to Follow-up|1|||
143065203|NCT02655016|515778687|FG001|Overall Study|Lost to Follow-up|1|||
143065204|NCT02655016|515778686|FG000|Overall Study|Withdrawal by Subject|18|||
143065205|NCT02655016|515778687|FG001|Overall Study|Withdrawal by Subject|36|||
143065206|NCT06029959|515780531|FG000|Overall Study|Physician Decision|6|||
143065207|NCT00003138|515780532|FG000|Step 1|Reasons off treatment not documented|60|||
143065208|NCT00003138|515780533|FG001|Step 1|Reasons off treatment not documented|57|||
143065209|NCT00003138|515780532|FG000|Step 1|Never started treatment|1|||
143065210|NCT00003138|515780533|FG001|Step 1|Never started treatment|0|||
143065211|NCT00003138|515780532|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
143065212|NCT00003138|515780533|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
143065213|NCT00003138|515780532|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
143065214|NCT00003138|515780533|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
143065215|NCT00003138|515780532|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
143065216|NCT00003138|515780533|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
143065217|NCT00003138|515780532|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
143065218|NCT00003138|515780533|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
143065219|NCT04495283|515780534|FG000|Overall Study|Physician Decision|0|||
143065220|NCT04495283|515780535|FG001|Overall Study|Physician Decision|0|||
143065221|NCT04495283|515780536|FG002|Overall Study|Physician Decision|1|||
143065222|NCT04495283|515780534|FG000|Overall Study|Withdrawal by Subject|0|||
143065223|NCT04495283|515780535|FG001|Overall Study|Withdrawal by Subject|1|||
143065224|NCT04495283|515780536|FG002|Overall Study|Withdrawal by Subject|1|||
143065225|NCT04495283|515780534|FG000|Overall Study|Other|1|||
143065226|NCT04495283|515780535|FG001|Overall Study|Other|0|||
143065227|NCT04495283|515780536|FG002|Overall Study|Other|1|||
143065228|NCT02960893|515780537|FG000|Randomization Phase (8 Weeks)|Adverse Event|5|||
143065229|NCT02960893|515780538|FG001|Randomization Phase (8 Weeks)|Adverse Event|0|||
143065230|NCT02960893|515780539|FG002|Randomization Phase (8 Weeks)|Adverse Event|0|||
143065231|NCT02960893|515780540|FG003|Randomization Phase (8 Weeks)|Adverse Event|0|||
143065232|NCT02960893|515780537|FG000|Randomization Phase (8 Weeks)|Withdrawal by Participant|2|||
143065233|NCT02960893|515780538|FG001|Randomization Phase (8 Weeks)|Withdrawal by Participant|1|||
143170298|NCT01467466|516171949|FG002|Overall Study|Withdrawal by Subject|13|||
143170299|NCT01467466|516171950|FG003|Overall Study|Withdrawal by Subject|11|||
143365160|NCT01537133|516880647|FG003|Overall Study|Lost to Follow-up|0|||
143365161|NCT03837028|516880649|FG000|Overall Study|Lost to Follow-up|4|||
143365162|NCT03837028|516880650|FG001|Overall Study|Lost to Follow-up|0|||
143065234|NCT02960893|515780539|FG002|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
143065235|NCT02960893|515780540|FG003|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
143065236|NCT02960893|515780537|FG000|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
143065237|NCT02960893|515780538|FG001|Randomization Phase (8 Weeks)|Reason Not Specified|1|||
143065238|NCT02960893|515780539|FG002|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
143065239|NCT02960893|515780540|FG003|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
143065240|NCT02960893|515780537|FG000|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
143170300|NCT01467466|516171947|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
143365163|NCT03837028|516880651|FG002|Overall Study|Lost to Follow-up|2|||
143065241|NCT02960893|515780538|FG001|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
143065242|NCT02960893|515780539|FG002|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
143065243|NCT02960893|515780540|FG003|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
143065244|NCT02960893|515780537|FG000|Open Label Extension Phase (336 Weeks)|Death|0|||
143065245|NCT02960893|515780538|FG001|Open Label Extension Phase (336 Weeks)|Death|0|||
143065246|NCT02960893|515780539|FG002|Open Label Extension Phase (336 Weeks)|Death|0|||
143065247|NCT02960893|515780540|FG003|Open Label Extension Phase (336 Weeks)|Death|1|||
143065248|NCT02960893|515780537|FG000|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
143065249|NCT02960893|515780538|FG001|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
143065250|NCT02960893|515780539|FG002|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
143065251|NCT02960893|515780540|FG003|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
143065252|NCT02960893|515780537|FG000|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
143065253|NCT02960893|515780538|FG001|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
143065254|NCT02960893|515780539|FG002|Open Label Extension Phase (336 Weeks)|Physician Decision|3|||
143065255|NCT02960893|515780540|FG003|Open Label Extension Phase (336 Weeks)|Physician Decision|2|||
143065256|NCT02960893|515780537|FG000|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
143065257|NCT02960893|515780538|FG001|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
143065258|NCT02960893|515780539|FG002|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|19|||
143065259|NCT02960893|515780540|FG003|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|18|||
143065260|NCT02960893|515780537|FG000|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
143065261|NCT02960893|515780538|FG001|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
143065262|NCT02960893|515780539|FG002|Open Label Extension Phase (336 Weeks)|Sponsor Request|4|||
143065263|NCT02960893|515780540|FG003|Open Label Extension Phase (336 Weeks)|Sponsor Request|2|||
143065264|NCT02960893|515780537|FG000|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
143065265|NCT02960893|515780538|FG001|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
143065266|NCT02960893|515780539|FG002|Open Label Extension Phase (336 Weeks)|Miscellaneous|3|||
143065267|NCT02960893|515780540|FG003|Open Label Extension Phase (336 Weeks)|Miscellaneous|1|||
143065268|NCT02631876|515780543|FG000|Overall Study|Death|96|||
143065269|NCT02631876|515780544|FG001|Overall Study|Death|50|||
143065270|NCT02631876|515780543|FG000|Overall Study|Investigator's discretion|1|||
143065271|NCT02631876|515780544|FG001|Overall Study|Investigator's discretion|0|||
143065272|NCT02631876|515780543|FG000|Overall Study|Lost to Follow-up|2|||
143065273|NCT02631876|515780544|FG001|Overall Study|Lost to Follow-up|0|||
143065274|NCT02631876|515780543|FG000|Overall Study|Withdrawal by Subject|16|||
143065275|NCT02631876|515780544|FG001|Overall Study|Withdrawal by Subject|9|||
143065276|NCT02631876|515780543|FG000|Overall Study|Other than specified|4|||
143065277|NCT02631876|515780544|FG001|Overall Study|Other than specified|4|||
143065278|NCT04285567|515780547|FG000|Overall Study|Death|3|||
143065279|NCT04285567|515780548|FG001|Overall Study|Death|3|||
143065280|NCT04285567|515780547|FG000|Overall Study|Lost to Follow-up|1|||
143065281|NCT04285567|515780548|FG001|Overall Study|Lost to Follow-up|1|||
143065282|NCT04285567|515780547|FG000|Overall Study|Reason Not Specified|1|||
143065283|NCT04285567|515780548|FG001|Overall Study|Reason Not Specified|1|||
143065284|NCT04285567|515780547|FG000|Overall Study|Physician Decision|2|||
143065285|NCT04285567|515780548|FG001|Overall Study|Physician Decision|1|||
143065286|NCT04285567|515780547|FG000|Overall Study|Withdrawal by Subject|2|||
143065287|NCT04285567|515780548|FG001|Overall Study|Withdrawal by Subject|6|||
143065288|NCT04285567|515780547|FG000|Overall Study|Adverse Event|1|||
143065289|NCT04285567|515780548|FG001|Overall Study|Adverse Event|0|||
143065290|NCT04285567|515780547|FG000|Overall Study|Participants Ongoing in Follow-up|70|||
143065291|NCT04285567|515780548|FG001|Overall Study|Participants Ongoing in Follow-up|74|||
143065292|NCT01386684|515780550|FG000|Overall Study|Lost to Follow-up|51|||
143065293|NCT01386684|515780550|FG000|Overall Study|Other|51|||
143065294|NCT01386684|515780550|FG000|Overall Study|Death|47|||
143065295|NCT01386684|515780550|FG000|Overall Study|Withdrawal of Consent|44|||
143065296|NCT01386684|515780550|FG000|Overall Study|Alternative Therapy Required|37|||
143065297|NCT01386684|515780550|FG000|Overall Study|Disease Progression|28|||
143065298|NCT01386684|515780550|FG000|Overall Study|Adverse Event|20|||
143065299|NCT01386684|515780550|FG000|Overall Study|Noncompliance|8|||
143065300|NCT01386684|515780550|FG000|Overall Study|Protocol Violation|4|||
143065301|NCT01386684|515780550|FG000|Overall Study|Missing|3|||
143065302|NCT03623386|515780551|FG000|Overall Study|Protocol Violation|3|||
143065303|NCT03623386|515780552|FG001|Overall Study|Protocol Violation|2|||
143170301|NCT01467466|516171948|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
143170302|NCT01467466|516171949|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
143170303|NCT01467466|516171950|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
143065304|NCT03623386|515780553|FG002|Overall Study|Protocol Violation|0|||
143065305|NCT03623386|515780551|FG000|Overall Study|Physician Decision|1|||
143065306|NCT03623386|515780552|FG001|Overall Study|Physician Decision|1|||
143065307|NCT03623386|515780553|FG002|Overall Study|Physician Decision|0|||
143065308|NCT03623386|515780551|FG000|Overall Study|Lost to Follow-up|0|||
143065309|NCT03623386|515780552|FG001|Overall Study|Lost to Follow-up|2|||
143065310|NCT03623386|515780553|FG002|Overall Study|Lost to Follow-up|0|||
143065311|NCT03623386|515780551|FG000|Overall Study|COVID-19|0|||
143065312|NCT03623386|515780552|FG001|Overall Study|COVID-19|1|||
143065313|NCT03623386|515780553|FG002|Overall Study|COVID-19|0|||
143065314|NCT04271735|515780554|FG000|Overall Study|Physician Decision|2|||
143065315|NCT04271735|515780555|FG001|Overall Study|Physician Decision|0|||
143065316|NCT02072148|515780564|FG000|Overall Study|withdrew prior to surgery|23|||
143065317|NCT02072148|515780565|FG001|Overall Study|withdrew prior to surgery|0|||
143065318|NCT02072148|515780566|FG002|Overall Study|withdrew prior to surgery|0|||
143065319|NCT02072148|515780564|FG000|Overall Study|Death|0|||
143065320|NCT02072148|515780565|FG001|Overall Study|Death|0|||
143065321|NCT02072148|515780566|FG002|Overall Study|Death|1|||
143065322|NCT02072148|515780564|FG000|Overall Study|Withdrawal by Subject|0|||
143065323|NCT02072148|515780565|FG001|Overall Study|Withdrawal by Subject|13|||
143065324|NCT02072148|515780566|FG002|Overall Study|Withdrawal by Subject|12|||
143065325|NCT00430495|515780567|FG000|Overall Study|Adverse Event|2|||
143065326|NCT00430495|515780568|FG001|Overall Study|Adverse Event|3|||
143065327|NCT00430495|515780569|FG002|Overall Study|Adverse Event|2|||
143065328|NCT00430495|515780570|FG003|Overall Study|Adverse Event|0|||
143065329|NCT00430495|515780567|FG000|Overall Study|Death|0|||
143065330|NCT00430495|515780568|FG001|Overall Study|Death|0|||
143065331|NCT00430495|515780569|FG002|Overall Study|Death|1|||
143065332|NCT00430495|515780570|FG003|Overall Study|Death|0|||
143065333|NCT00430495|515780567|FG000|Overall Study|Lost to Follow-up|0|||
143065334|NCT00430495|515780568|FG001|Overall Study|Lost to Follow-up|1|||
143065335|NCT00430495|515780569|FG002|Overall Study|Lost to Follow-up|4|||
143065336|NCT00430495|515780570|FG003|Overall Study|Lost to Follow-up|0|||
143170304|NCT01467466|516171947|FG000|Overall Study|Procedure Cancelled|46|||
143170305|NCT01467466|516171948|FG001|Overall Study|Procedure Cancelled|45|||
143170306|NCT01467466|516171949|FG002|Overall Study|Procedure Cancelled|25|||
143170307|NCT01467466|516171950|FG003|Overall Study|Procedure Cancelled|29|||
143170308|NCT01467466|516171947|FG000|Overall Study|No Endpoint Blood Draw|38|||
143170309|NCT01467466|516171948|FG001|Overall Study|No Endpoint Blood Draw|32|||
143170310|NCT01467466|516171949|FG002|Overall Study|No Endpoint Blood Draw|51|||
143170311|NCT01467466|516171950|FG003|Overall Study|No Endpoint Blood Draw|43|||
143170312|NCT03261505|516171951|FG000|Overall Study|Withdrawal by Subject|2|||
143365164|NCT03837028|516880652|FG003|Overall Study|Lost to Follow-up|0|||
143502879|NCT00408005|517380958|FG000|Induction|Adverse Event|19|||
143502880|NCT00408005|517380959|FG001|Induction|Adverse Event|3|||
143502881|NCT00408005|517380960|FG002|Induction|Adverse Event|0|||
143502882|NCT00408005|517380961|FG003|Induction|Adverse Event|0|||
143502883|NCT00408005|517380962|FG004|Induction|Adverse Event|0|||
143502884|NCT00408005|517380963|FG005|Induction|Adverse Event|0|||
143502885|NCT00408005|517380964|FG006|Induction|Adverse Event|0|||
143502886|NCT00408005|517380965|FG007|Induction|Adverse Event|0|||
143502887|NCT00408005|517380958|FG000|Induction|Death|6|||
143502888|NCT00408005|517380959|FG001|Induction|Death|0|||
143502889|NCT00408005|517380960|FG002|Induction|Death|0|||
143502890|NCT00408005|517380961|FG003|Induction|Death|0|||
143502891|NCT00408005|517380962|FG004|Induction|Death|0|||
143502892|NCT00408005|517380963|FG005|Induction|Death|0|||
143502893|NCT00408005|517380964|FG006|Induction|Death|0|||
143502894|NCT00408005|517380965|FG007|Induction|Death|0|||
143502895|NCT00408005|517380958|FG000|Induction|Physician Decision|83|||
143502896|NCT00408005|517380959|FG001|Induction|Physician Decision|9|||
143502897|NCT00408005|517380960|FG002|Induction|Physician Decision|0|||
143502898|NCT00408005|517380961|FG003|Induction|Physician Decision|0|||
143502899|NCT00408005|517380962|FG004|Induction|Physician Decision|0|||
143502900|NCT00408005|517380963|FG005|Induction|Physician Decision|0|||
143502901|NCT00408005|517380964|FG006|Induction|Physician Decision|0|||
143502902|NCT00408005|517380965|FG007|Induction|Physician Decision|0|||
143502903|NCT00408005|517380958|FG000|Induction|Withdrawal by Subject|2|||
143502904|NCT00408005|517380959|FG001|Induction|Withdrawal by Subject|4|||
143502905|NCT00408005|517380960|FG002|Induction|Withdrawal by Subject|0|||
143502906|NCT00408005|517380961|FG003|Induction|Withdrawal by Subject|0|||
143502907|NCT00408005|517380962|FG004|Induction|Withdrawal by Subject|0|||
143502908|NCT00408005|517380963|FG005|Induction|Withdrawal by Subject|0|||
143065337|NCT00430495|515780567|FG000|Overall Study|Protocol Violation|1|||
143170313|NCT03261505|516171952|FG001|Overall Study|Withdrawal by Subject|3|||
143170314|NCT03261505|516171953|FG002|Overall Study|Withdrawal by Subject|4|||
143502909|NCT00408005|517380964|FG006|Induction|Withdrawal by Subject|0|||
143065338|NCT00430495|515780568|FG001|Overall Study|Protocol Violation|0|||
143065339|NCT00430495|515780569|FG002|Overall Study|Protocol Violation|1|||
143065340|NCT00430495|515780570|FG003|Overall Study|Protocol Violation|0|||
143065341|NCT00430495|515780567|FG000|Overall Study|Disease Progression|1|||
143065342|NCT00430495|515780568|FG001|Overall Study|Disease Progression|1|||
143065343|NCT00430495|515780569|FG002|Overall Study|Disease Progression|0|||
143502910|NCT00408005|517380965|FG007|Induction|Withdrawal by Subject|0|||
143502911|NCT00408005|517380958|FG000|Induction|Ineligible|33|||
143502912|NCT00408005|517380959|FG001|Induction|Ineligible|14|||
143502913|NCT00408005|517380960|FG002|Induction|Ineligible|0|||
143502914|NCT00408005|517380961|FG003|Induction|Ineligible|0|||
143502915|NCT00408005|517380962|FG004|Induction|Ineligible|0|||
143502916|NCT00408005|517380963|FG005|Induction|Ineligible|0|||
143065344|NCT00430495|515780570|FG003|Overall Study|Disease Progression|0|||
143065345|NCT00430495|515780567|FG000|Overall Study|Other|8|||
143065346|NCT00430495|515780568|FG001|Overall Study|Other|2|||
143065347|NCT00430495|515780569|FG002|Overall Study|Other|5|||
143065348|NCT00430495|515780570|FG003|Overall Study|Other|4|||
143065349|NCT00430495|515780567|FG000|Overall Study|Randomized but not Treated|2|||
143065350|NCT00430495|515780568|FG001|Overall Study|Randomized but not Treated|0|||
143065351|NCT00430495|515780569|FG002|Overall Study|Randomized but not Treated|0|||
143065352|NCT00430495|515780570|FG003|Overall Study|Randomized but not Treated|0|||
143065353|NCT00158756|515780571|FG000|Overall Study|Withdrawal by Subject|5|||
143065354|NCT00158756|515780572|FG001|Overall Study|Withdrawal by Subject|0|||
143065355|NCT00158756|515780573|FG002|Overall Study|Withdrawal by Subject|6|||
143065356|NCT00158756|515780574|FG003|Overall Study|Withdrawal by Subject|1|||
143065357|NCT00158756|515780575|FG004|Overall Study|Withdrawal by Subject|3|||
143065358|NCT00158756|515780571|FG000|Overall Study|Adverse Event|0|||
143065359|NCT00158756|515780572|FG001|Overall Study|Adverse Event|0|||
143065360|NCT00158756|515780573|FG002|Overall Study|Adverse Event|1|||
143065361|NCT00158756|515780574|FG003|Overall Study|Adverse Event|0|||
143065362|NCT00158756|515780575|FG004|Overall Study|Adverse Event|0|||
143065363|NCT00158756|515780571|FG000|Overall Study|Serious adverse event|0|||
143065364|NCT00158756|515780572|FG001|Overall Study|Serious adverse event|0|||
143065365|NCT00158756|515780573|FG002|Overall Study|Serious adverse event|1|||
143065366|NCT00158756|515780574|FG003|Overall Study|Serious adverse event|0|||
143065367|NCT00158756|515780575|FG004|Overall Study|Serious adverse event|0|||
143065368|NCT03052322|515780576|FG000|Overall Study|Other un-specified|1|||
143065369|NCT03052322|515780577|FG001|Overall Study|Other un-specified|2|||
143065370|NCT03052322|515780576|FG000|Overall Study|Withdrawal by Subject|10|||
143065371|NCT03052322|515780577|FG001|Overall Study|Withdrawal by Subject|9|||
143065372|NCT03052322|515780576|FG000|Overall Study|Death|0|||
143065373|NCT03052322|515780577|FG001|Overall Study|Death|2|||
143065374|NCT03052322|515780576|FG000|Overall Study|Lack of Efficacy|1|||
143065375|NCT03052322|515780577|FG001|Overall Study|Lack of Efficacy|2|||
143065376|NCT03052322|515780576|FG000|Overall Study|Protocol Violation|1|||
143065377|NCT03052322|515780577|FG001|Overall Study|Protocol Violation|0|||
143065378|NCT03052322|515780576|FG000|Overall Study|Lost to Follow-up|2|||
143065379|NCT03052322|515780577|FG001|Overall Study|Lost to Follow-up|4|||
143065380|NCT03052322|515780576|FG000|Overall Study|Adverse Event|6|||
143065381|NCT03052322|515780577|FG001|Overall Study|Adverse Event|13|||
143065382|NCT04920916|515780578|FG000|Phase IIa 60 Day Study|Death|2|||
143065383|NCT04920916|515780579|FG001|Phase IIa 60 Day Study|Death|5|||
143065384|NCT04920916|515780578|FG000|1 Year Follow up (Phone Call)|Death|1|||
143065385|NCT04920916|515780579|FG001|1 Year Follow up (Phone Call)|Death|3|||
143065386|NCT04920916|515780578|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
143065387|NCT04920916|515780579|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
143065388|NCT00973765|515780580|FG000|Overall Study|Lost to Follow-up|8|||
143065389|NCT00973765|515780581|FG001|Overall Study|Lost to Follow-up|14|||
143065390|NCT02011113|515780582|FG000|Overall Study|Adverse Event|4|||
143065391|NCT02011113|515780582|FG000|Overall Study|Disease Progression (DP)|16|||
143065392|NCT02011113|515780582|FG000|Overall Study|Death|1|||
143065393|NCT02011113|515780582|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
143065394|NCT02011113|515780582|FG000|Overall Study|Investigator's judgement- DP|3|||
143065395|NCT02011113|515780582|FG000|Overall Study|Study terminated by sponsor|11|||
143065396|NCT00354341|515780583|FG000|Overall Study|Adverse Event|1|||
143065397|NCT00354341|515780584|FG001|Overall Study|Adverse Event|0|||
143065398|NCT00354341|515780583|FG000|Overall Study|Death|0|||
143065399|NCT00354341|515780584|FG001|Overall Study|Death|2|||
143065400|NCT00354341|515780583|FG000|Overall Study|Refused treatment|1|||
143065401|NCT00354341|515780584|FG001|Overall Study|Refused treatment|2|||
143065402|NCT00354341|515780583|FG000|Overall Study|Failure to return|0|||
143065403|NCT00354341|515780584|FG001|Overall Study|Failure to return|1|||
143065404|NCT00354341|515780583|FG000|Overall Study|Other|1|||
143065405|NCT00354341|515780584|FG001|Overall Study|Other|2|||
143065406|NCT02566993|515780586|FG000|Overall Study|Randomized but not treated|5|||
143170315|NCT03261505|516171954|FG003|Overall Study|Withdrawal by Subject|3|||
143181471|NCT00642707|516211755|FG003|Overall Study|Withdrawal by Subject|0|||
143065407|NCT02566993|515780587|FG001|Overall Study|Randomized but not treated|16|||
143065408|NCT02566993|515780586|FG000|Overall Study|Progressive disease|213|||
143065409|NCT02566993|515780587|FG001|Overall Study|Progressive disease|152|||
143065410|NCT02566993|515780586|FG000|Overall Study|Withdrawal by Subject|12|||
143065411|NCT02566993|515780587|FG001|Overall Study|Withdrawal by Subject|28|||
143065412|NCT02566993|515780586|FG000|Overall Study|Death|17|||
143065413|NCT02566993|515780587|FG001|Overall Study|Death|23|||
143065414|NCT02566993|515780586|FG000|Overall Study|Physician Decision|10|||
143065415|NCT02566993|515780587|FG001|Overall Study|Physician Decision|17|||
143065416|NCT02566993|515780586|FG000|Overall Study|Study drug-related adverse event|20|||
143065417|NCT02566993|515780587|FG001|Overall Study|Study drug-related adverse event|41|||
143065418|NCT02566993|515780586|FG000|Overall Study|Non study drug-related adverse event|9|||
143065419|NCT02566993|515780587|FG001|Overall Study|Non study drug-related adverse event|9|||
143065420|NCT02566993|515780586|FG000|Overall Study|Symptomatic deterioration|9|||
143065421|NCT02566993|515780587|FG001|Overall Study|Symptomatic deterioration|16|||
143065422|NCT02566993|515780586|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
143065423|NCT02566993|515780587|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
143065424|NCT02566993|515780586|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
143065425|NCT02566993|515780587|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
143065426|NCT02566993|515780586|FG000|Overall Study|Screening failure|2|||
143065427|NCT02566993|515780587|FG001|Overall Study|Screening failure|0|||
143065428|NCT02566993|515780586|FG000|Overall Study|Lost to Follow-up|0|||
143065429|NCT02566993|515780587|FG001|Overall Study|Lost to Follow-up|1|||
143065430|NCT02566993|515780586|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
143065431|NCT02566993|515780587|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
143065432|NCT00136318|515780588|FG000|Overall Study|Adverse Event|5|||
143065433|NCT00136318|515780589|FG001|Overall Study|Adverse Event|5|||
143065434|NCT00136318|515780588|FG000|Overall Study|Withdrawal by Subject|2|||
143065435|NCT00136318|515780589|FG001|Overall Study|Withdrawal by Subject|2|||
143065436|NCT01621191|515780590|FG000|Overall Study|Adverse Event|9|||
143065437|NCT01621191|515780590|FG000|Overall Study|Withdrawal by Subject|8|||
143065438|NCT01621191|515780590|FG000|Overall Study|Lack of Efficacy|6|||
143065439|NCT01621191|515780590|FG000|Overall Study|Lost to Follow-up|1|||
143065440|NCT01621191|515780590|FG000|Overall Study|Site Removed From Study|1|||
143065441|NCT01134627|515780593|FG000|Overall Study|Adverse Event|47|||
143065442|NCT01134627|515780594|FG001|Overall Study|Adverse Event|31|||
143065443|NCT01134627|515780593|FG000|Overall Study|Lost to Follow-up|1|||
143065444|NCT01134627|515780594|FG001|Overall Study|Lost to Follow-up|2|||
143065445|NCT01134627|515780593|FG000|Overall Study|Protocol Violation|3|||
143065446|NCT01134627|515780594|FG001|Overall Study|Protocol Violation|5|||
143065447|NCT01134627|515780593|FG000|Overall Study|Lack of Efficacy|2|||
143065448|NCT01134627|515780594|FG001|Overall Study|Lack of Efficacy|12|||
143065449|NCT01134627|515780593|FG000|Overall Study|Withdrawal by Subject|4|||
143065450|NCT01134627|515780594|FG001|Overall Study|Withdrawal by Subject|3|||
143065451|NCT01134627|515780593|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
143065452|NCT01134627|515780594|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
143065453|NCT01134627|515780593|FG000|Overall Study|Other|11|||
143065454|NCT01134627|515780594|FG001|Overall Study|Other|14|||
143065455|NCT00518882|515780600|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
143065456|NCT00518882|515780601|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
143065457|NCT00518882|515780600|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
143065458|NCT00518882|515780601|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
143065459|NCT00518882|515780600|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
143065460|NCT00518882|515780601|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
143065461|NCT00518882|515780600|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
143065462|NCT00518882|515780601|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
143065463|NCT00518882|515780600|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
143065464|NCT00518882|515780601|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
143065465|NCT00518882|515780600|FG000|Double-Blind, Week 0-26|Subject decision|1|||
143065466|NCT00518882|515780601|FG001|Double-Blind, Week 0-26|Subject decision|1|||
143065467|NCT00518882|515780600|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
143065468|NCT00518882|515780601|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
143065469|NCT00518882|515780600|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
143065470|NCT00518882|515780601|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
143065471|NCT00518882|515780600|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
143065472|NCT00518882|515780601|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
143065473|NCT00518882|515780600|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
143065474|NCT00518882|515780601|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
143065475|NCT00518882|515780600|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
143065476|NCT00518882|515780601|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
143065477|NCT00518882|515780600|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
143065478|NCT00518882|515780601|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
143065479|NCT00518882|515780600|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
143065480|NCT00518882|515780601|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
143365165|NCT03837028|516880649|FG000|Overall Study|Withdrawal by Subject|12|||
143365166|NCT03837028|516880650|FG001|Overall Study|Withdrawal by Subject|11|||
143065481|NCT00518882|515780600|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
143065482|NCT00518882|515780601|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
143065483|NCT00518882|515780600|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
143065484|NCT00518882|515780601|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
143065485|NCT00518882|515780600|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
143065486|NCT00518882|515780601|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
143065487|NCT00518882|515780600|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
143170316|NCT03261505|516171951|FG000|Overall Study|unrelated surgery preventing the subject participating the study|0|||
143170317|NCT03261505|516171952|FG001|Overall Study|unrelated surgery preventing the subject participating the study|0|||
143170318|NCT03261505|516171953|FG002|Overall Study|unrelated surgery preventing the subject participating the study|1|||
143065488|NCT00518882|515780601|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
143065489|NCT00518882|515780600|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
143065490|NCT00518882|515780601|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
143065491|NCT00518882|515780600|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
143065492|NCT00518882|515780601|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
143065493|NCT00518882|515780600|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
143065494|NCT00518882|515780601|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
143065495|NCT00518882|515780600|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
143065496|NCT00518882|515780601|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
143065497|NCT00518882|515780600|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
143065498|NCT00518882|515780601|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
143065499|NCT00518882|515780600|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
143065500|NCT00518882|515780601|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
143065501|NCT00518882|515780600|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
143065502|NCT00518882|515780601|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
143065503|NCT00942331|515780602|FG000|Overall Study|Did not start treatment|15|||
143065504|NCT00942331|515780603|FG001|Overall Study|Did not start treatment|22|||
143065505|NCT00567476|515780605|FG000|Overall Study|Adverse Event|2|||
143065506|NCT00567476|515780606|FG001|Overall Study|Adverse Event|0|||
143065507|NCT00567476|515780605|FG000|Overall Study|Pregnancy|1|||
143065508|NCT00567476|515780606|FG001|Overall Study|Pregnancy|0|||
143065509|NCT00567476|515780605|FG000|Overall Study|Protocol Violation|4|||
143065510|NCT00567476|515780606|FG001|Overall Study|Protocol Violation|1|||
143065511|NCT00567476|515780605|FG000|Overall Study|Lost to Follow-up|0|||
143065512|NCT00567476|515780606|FG001|Overall Study|Lost to Follow-up|1|||
143065513|NCT00567476|515780605|FG000|Overall Study|Administrative issues|1|||
143065514|NCT00567476|515780606|FG001|Overall Study|Administrative issues|0|||
143065515|NCT00567476|515780605|FG000|Overall Study|Medical Decision|0|||
143065516|NCT00567476|515780606|FG001|Overall Study|Medical Decision|1|||
143065517|NCT00567476|515780605|FG000|Overall Study|Non-adherence to protocol|0|||
143065518|NCT00567476|515780606|FG001|Overall Study|Non-adherence to protocol|1|||
143065519|NCT02696031|515780607|FG000|Up to Week 24|Adverse Event|2|||
143065520|NCT02696031|515780608|FG001|Up to Week 24|Adverse Event|4|||
143065521|NCT02696031|515780609|FG002|Up to Week 24|Adverse Event|2|||
143065522|NCT02696031|515780610|FG003|Up to Week 24|Adverse Event|0|||
143065523|NCT02696031|515780611|FG004|Up to Week 24|Adverse Event|0|||
143065524|NCT02696031|515780612|FG005|Up to Week 24|Adverse Event|0|||
143065525|NCT02696031|515780607|FG000|Up to Week 24|Lack of Efficacy|2|||
143170319|NCT03261505|516171954|FG003|Overall Study|unrelated surgery preventing the subject participating the study|0|||
143170320|NCT03261505|516171951|FG000|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
143181472|NCT03706430|516211756|FG000|Overall Study|No A-Line placed|5|||
143065526|NCT02696031|515780608|FG001|Up to Week 24|Lack of Efficacy|1|||
143065527|NCT02696031|515780609|FG002|Up to Week 24|Lack of Efficacy|2|||
143065528|NCT02696031|515780610|FG003|Up to Week 24|Lack of Efficacy|0|||
143065529|NCT02696031|515780611|FG004|Up to Week 24|Lack of Efficacy|0|||
143065530|NCT02696031|515780612|FG005|Up to Week 24|Lack of Efficacy|0|||
143065531|NCT02696031|515780607|FG000|Up to Week 24|Lost to Follow-up|0|||
143065532|NCT02696031|515780608|FG001|Up to Week 24|Lost to Follow-up|1|||
143065533|NCT02696031|515780609|FG002|Up to Week 24|Lost to Follow-up|1|||
143065534|NCT02696031|515780610|FG003|Up to Week 24|Lost to Follow-up|0|||
143065535|NCT02696031|515780611|FG004|Up to Week 24|Lost to Follow-up|0|||
143065536|NCT02696031|515780612|FG005|Up to Week 24|Lost to Follow-up|0|||
143065537|NCT02696031|515780607|FG000|Up to Week 24|Physician Decision|1|||
143065538|NCT02696031|515780608|FG001|Up to Week 24|Physician Decision|0|||
143065539|NCT02696031|515780609|FG002|Up to Week 24|Physician Decision|1|||
143065540|NCT02696031|515780610|FG003|Up to Week 24|Physician Decision|0|||
143065541|NCT02696031|515780611|FG004|Up to Week 24|Physician Decision|0|||
143065542|NCT02696031|515780612|FG005|Up to Week 24|Physician Decision|0|||
143065543|NCT02696031|515780607|FG000|Up to Week 24|Protocol Violation|1|||
143065544|NCT02696031|515780608|FG001|Up to Week 24|Protocol Violation|0|||
143065545|NCT02696031|515780609|FG002|Up to Week 24|Protocol Violation|0|||
143065546|NCT02696031|515780610|FG003|Up to Week 24|Protocol Violation|0|||
143065547|NCT02696031|515780611|FG004|Up to Week 24|Protocol Violation|0|||
143065548|NCT02696031|515780612|FG005|Up to Week 24|Protocol Violation|0|||
143065549|NCT02696031|515780607|FG000|Up to Week 24|Withdrawal by Subject|4|||
143065550|NCT02696031|515780608|FG001|Up to Week 24|Withdrawal by Subject|1|||
143065551|NCT02696031|515780609|FG002|Up to Week 24|Withdrawal by Subject|5|||
143065552|NCT02696031|515780610|FG003|Up to Week 24|Withdrawal by Subject|0|||
143065553|NCT02696031|515780611|FG004|Up to Week 24|Withdrawal by Subject|0|||
143065554|NCT02696031|515780612|FG005|Up to Week 24|Withdrawal by Subject|0|||
143065555|NCT02696031|515780607|FG000|Up to Week 52|Adverse Event|4|||
143065556|NCT02696031|515780608|FG001|Up to Week 52|Adverse Event|5|||
143065557|NCT02696031|515780609|FG002|Up to Week 52|Adverse Event|3|||
143065558|NCT02696031|515780610|FG003|Up to Week 52|Adverse Event|0|||
143065559|NCT02696031|515780611|FG004|Up to Week 52|Adverse Event|0|||
143065560|NCT02696031|515780612|FG005|Up to Week 52|Adverse Event|0|||
143065561|NCT02696031|515780607|FG000|Up to Week 52|Lack of Efficacy|10|||
143065562|NCT02696031|515780608|FG001|Up to Week 52|Lack of Efficacy|7|||
143065563|NCT02696031|515780609|FG002|Up to Week 52|Lack of Efficacy|11|||
143065564|NCT02696031|515780610|FG003|Up to Week 52|Lack of Efficacy|0|||
143065565|NCT02696031|515780611|FG004|Up to Week 52|Lack of Efficacy|0|||
143065566|NCT02696031|515780612|FG005|Up to Week 52|Lack of Efficacy|0|||
143065567|NCT02696031|515780607|FG000|Up to Week 52|Lost to Follow-up|1|||
143246128|NCT00838513|516453412|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
143246129|NCT00139477|516453416|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
143246130|NCT00139477|516453417|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
143246131|NCT00139477|516453416|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
143065568|NCT02696031|515780608|FG001|Up to Week 52|Lost to Follow-up|1|||
143502917|NCT00408005|517380964|FG006|Induction|Ineligible|0|||
143065569|NCT02696031|515780609|FG002|Up to Week 52|Lost to Follow-up|1|||
143502918|NCT00408005|517380965|FG007|Induction|Ineligible|0|||
143502919|NCT00408005|517380958|FG000|Induction|Refusal of Further Protocol Therapy|225|||
143502920|NCT00408005|517380959|FG001|Induction|Refusal of Further Protocol Therapy|44|||
143502921|NCT00408005|517380960|FG002|Induction|Refusal of Further Protocol Therapy|0|||
143502922|NCT00408005|517380961|FG003|Induction|Refusal of Further Protocol Therapy|0|||
143502923|NCT00408005|517380962|FG004|Induction|Refusal of Further Protocol Therapy|0|||
143502924|NCT00408005|517380963|FG005|Induction|Refusal of Further Protocol Therapy|0|||
143502925|NCT00408005|517380964|FG006|Induction|Refusal of Further Protocol Therapy|0|||
143502926|NCT00408005|517380965|FG007|Induction|Refusal of Further Protocol Therapy|0|||
143065570|NCT02696031|515780610|FG003|Up to Week 52|Lost to Follow-up|0|||
143502927|NCT00408005|517380958|FG000|Induction|Entered another COG therapeutic protocol|4|||
143502928|NCT00408005|517380959|FG001|Induction|Entered another COG therapeutic protocol|0|||
143502929|NCT00408005|517380960|FG002|Induction|Entered another COG therapeutic protocol|0|||
143502930|NCT00408005|517380961|FG003|Induction|Entered another COG therapeutic protocol|0|||
143502931|NCT00408005|517380962|FG004|Induction|Entered another COG therapeutic protocol|0|||
143502932|NCT00408005|517380963|FG005|Induction|Entered another COG therapeutic protocol|0|||
143502933|NCT00408005|517380964|FG006|Induction|Entered another COG therapeutic protocol|0|||
143502934|NCT00408005|517380965|FG007|Induction|Entered another COG therapeutic protocol|0|||
143502935|NCT00408005|517380958|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
143502936|NCT00408005|517380959|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
143502937|NCT00408005|517380960|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
143502938|NCT00408005|517380961|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
143502939|NCT00408005|517380962|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
143502940|NCT00408005|517380963|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
143502941|NCT00408005|517380964|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
143502942|NCT00408005|517380965|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
143502943|NCT00408005|517380958|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
143502944|NCT00408005|517380959|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
143502945|NCT00408005|517380960|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
143502946|NCT00408005|517380961|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
143502947|NCT00408005|517380962|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
143502948|NCT00408005|517380963|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
143502949|NCT00408005|517380964|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
143502950|NCT00408005|517380965|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
143502951|NCT00408005|517380958|FG000|Induction|Progressive Disease|0|||
143502952|NCT00408005|517380959|FG001|Induction|Progressive Disease|1|||
143502953|NCT00408005|517380960|FG002|Induction|Progressive Disease|0|||
143502954|NCT00408005|517380961|FG003|Induction|Progressive Disease|0|||
143502955|NCT00408005|517380962|FG004|Induction|Progressive Disease|0|||
143502956|NCT00408005|517380963|FG005|Induction|Progressive Disease|0|||
143502957|NCT00408005|517380964|FG006|Induction|Progressive Disease|0|||
143502958|NCT00408005|517380965|FG007|Induction|Progressive Disease|0|||
143502959|NCT00408005|517380958|FG000|Induction|Inevaluable|18|||
143502960|NCT00408005|517380959|FG001|Induction|Inevaluable|14|||
143502961|NCT00408005|517380960|FG002|Induction|Inevaluable|0|||
143502962|NCT00408005|517380961|FG003|Induction|Inevaluable|0|||
143502963|NCT00408005|517380962|FG004|Induction|Inevaluable|0|||
143502964|NCT00408005|517380963|FG005|Induction|Inevaluable|0|||
143502965|NCT00408005|517380964|FG006|Induction|Inevaluable|0|||
143502966|NCT00408005|517380965|FG007|Induction|Inevaluable|0|||
143502967|NCT00408005|517380958|FG000|Induction|Failed to Complete Randomization|3|||
143502968|NCT00408005|517380959|FG001|Induction|Failed to Complete Randomization|2|||
143502969|NCT00408005|517380960|FG002|Induction|Failed to Complete Randomization|0|||
143502970|NCT00408005|517380961|FG003|Induction|Failed to Complete Randomization|0|||
143502971|NCT00408005|517380962|FG004|Induction|Failed to Complete Randomization|0|||
143502972|NCT00408005|517380963|FG005|Induction|Failed to Complete Randomization|0|||
143502973|NCT00408005|517380964|FG006|Induction|Failed to Complete Randomization|0|||
143502974|NCT00408005|517380965|FG007|Induction|Failed to Complete Randomization|0|||
143502975|NCT00408005|517380958|FG000|Induction|Protocol Deviation|3|||
143502976|NCT00408005|517380959|FG001|Induction|Protocol Deviation|1|||
143502977|NCT00408005|517380960|FG002|Induction|Protocol Deviation|0|||
143502978|NCT00408005|517380961|FG003|Induction|Protocol Deviation|0|||
143502979|NCT00408005|517380962|FG004|Induction|Protocol Deviation|0|||
143502980|NCT00408005|517380963|FG005|Induction|Protocol Deviation|0|||
143502981|NCT00408005|517380964|FG006|Induction|Protocol Deviation|0|||
143502982|NCT00408005|517380965|FG007|Induction|Protocol Deviation|0|||
143502983|NCT00408005|517380958|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
143502984|NCT00408005|517380959|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
143502985|NCT00408005|517380960|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
143502986|NCT00408005|517380961|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
143502987|NCT00408005|517380962|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
143502988|NCT00408005|517380963|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
143502989|NCT00408005|517380964|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
143502990|NCT00408005|517380965|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
143502991|NCT00408005|517380958|FG000|Induction|Recurrent leukemia|1|||
143065571|NCT02696031|515780611|FG004|Up to Week 52|Lost to Follow-up|0|||
143502992|NCT00408005|517380959|FG001|Induction|Recurrent leukemia|0|||
143502993|NCT00408005|517380960|FG002|Induction|Recurrent leukemia|0|||
143502994|NCT00408005|517380961|FG003|Induction|Recurrent leukemia|0|||
143502995|NCT00408005|517380962|FG004|Induction|Recurrent leukemia|0|||
143502996|NCT00408005|517380963|FG005|Induction|Recurrent leukemia|0|||
143502997|NCT00408005|517380964|FG006|Induction|Recurrent leukemia|0|||
143502998|NCT00408005|517380965|FG007|Induction|Recurrent leukemia|0|||
143065572|NCT02696031|515780612|FG005|Up to Week 52|Lost to Follow-up|0|||
143065573|NCT02696031|515780607|FG000|Up to Week 52|Physician Decision|1|||
143065574|NCT02696031|515780608|FG001|Up to Week 52|Physician Decision|1|||
143065575|NCT02696031|515780609|FG002|Up to Week 52|Physician Decision|2|||
143065576|NCT02696031|515780610|FG003|Up to Week 52|Physician Decision|0|||
143065577|NCT02696031|515780611|FG004|Up to Week 52|Physician Decision|0|||
143065578|NCT02696031|515780612|FG005|Up to Week 52|Physician Decision|0|||
143065579|NCT02696031|515780607|FG000|Up to Week 52|Pregnancy|0|||
143065580|NCT02696031|515780608|FG001|Up to Week 52|Pregnancy|2|||
143065581|NCT02696031|515780609|FG002|Up to Week 52|Pregnancy|0|||
143065582|NCT02696031|515780610|FG003|Up to Week 52|Pregnancy|0|||
143065583|NCT02696031|515780611|FG004|Up to Week 52|Pregnancy|0|||
143065584|NCT02696031|515780612|FG005|Up to Week 52|Pregnancy|0|||
143065585|NCT02696031|515780607|FG000|Up to Week 52|Protocol Violation|1|||
143065586|NCT02696031|515780608|FG001|Up to Week 52|Protocol Violation|0|||
143065587|NCT02696031|515780609|FG002|Up to Week 52|Protocol Violation|0|||
143065588|NCT02696031|515780610|FG003|Up to Week 52|Protocol Violation|0|||
143065589|NCT02696031|515780611|FG004|Up to Week 52|Protocol Violation|0|||
143065590|NCT02696031|515780612|FG005|Up to Week 52|Protocol Violation|0|||
143065591|NCT02696031|515780607|FG000|Up to Week 52|Withdrawal by Subject|12|||
143065592|NCT02696031|515780608|FG001|Up to Week 52|Withdrawal by Subject|3|||
143065593|NCT02696031|515780609|FG002|Up to Week 52|Withdrawal by Subject|9|||
143065594|NCT02696031|515780610|FG003|Up to Week 52|Withdrawal by Subject|0|||
143065595|NCT02696031|515780611|FG004|Up to Week 52|Withdrawal by Subject|0|||
143065596|NCT02696031|515780612|FG005|Up to Week 52|Withdrawal by Subject|0|||
143065597|NCT02696031|515780607|FG000|Up to Week 104|Pregnancy|0|||
143065598|NCT02696031|515780608|FG001|Up to Week 104|Pregnancy|2|||
143065599|NCT02696031|515780609|FG002|Up to Week 104|Pregnancy|1|||
143065600|NCT02696031|515780610|FG003|Up to Week 104|Pregnancy|0|||
143065601|NCT02696031|515780611|FG004|Up to Week 104|Pregnancy|0|||
143065602|NCT02696031|515780612|FG005|Up to Week 104|Pregnancy|0|||
143065603|NCT02696031|515780607|FG000|Up to Week 104|Withdrawal by Subject|15|||
143065604|NCT02696031|515780608|FG001|Up to Week 104|Withdrawal by Subject|10|||
143065605|NCT02696031|515780609|FG002|Up to Week 104|Withdrawal by Subject|16|||
143065606|NCT02696031|515780610|FG003|Up to Week 104|Withdrawal by Subject|0|||
143065607|NCT02696031|515780611|FG004|Up to Week 104|Withdrawal by Subject|0|||
143065608|NCT02696031|515780612|FG005|Up to Week 104|Withdrawal by Subject|0|||
143065609|NCT02696031|515780607|FG000|Up to Week 104|Protocol Violation|1|||
143065610|NCT02696031|515780608|FG001|Up to Week 104|Protocol Violation|0|||
143065611|NCT02696031|515780609|FG002|Up to Week 104|Protocol Violation|0|||
143065612|NCT02696031|515780610|FG003|Up to Week 104|Protocol Violation|0|||
143065613|NCT02696031|515780611|FG004|Up to Week 104|Protocol Violation|0|||
143065614|NCT02696031|515780612|FG005|Up to Week 104|Protocol Violation|0|||
143065615|NCT02696031|515780607|FG000|Up to Week 104|Physician Decision|1|||
143065616|NCT02696031|515780608|FG001|Up to Week 104|Physician Decision|2|||
143065617|NCT02696031|515780609|FG002|Up to Week 104|Physician Decision|3|||
143065618|NCT02696031|515780610|FG003|Up to Week 104|Physician Decision|0|||
143065619|NCT02696031|515780611|FG004|Up to Week 104|Physician Decision|0|||
143065620|NCT02696031|515780612|FG005|Up to Week 104|Physician Decision|0|||
143065621|NCT02696031|515780607|FG000|Up to Week 104|Lost to Follow-up|2|||
143065622|NCT02696031|515780608|FG001|Up to Week 104|Lost to Follow-up|3|||
143065623|NCT02696031|515780609|FG002|Up to Week 104|Lost to Follow-up|1|||
143065624|NCT02696031|515780610|FG003|Up to Week 104|Lost to Follow-up|0|||
143065625|NCT02696031|515780611|FG004|Up to Week 104|Lost to Follow-up|0|||
143065626|NCT02696031|515780612|FG005|Up to Week 104|Lost to Follow-up|0|||
143170321|NCT03261505|516171952|FG001|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
143170322|NCT03261505|516171953|FG002|Overall Study|Claustrophobic or can not provide proof of diagnosis|2|||
143170323|NCT03261505|516171954|FG003|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
143170324|NCT03261505|516171951|FG000|Overall Study|the subject can not concentrate to complete the questionnaire|1|||
143170325|NCT03261505|516171952|FG001|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
143170326|NCT03261505|516171953|FG002|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
143170327|NCT03261505|516171954|FG003|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
143170328|NCT03773484|516171955|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
143170329|NCT04079738|516171956|FG000|Study Treatment|Death|1|||
143065627|NCT02696031|515780607|FG000|Up to Week 104|Lack of Efficacy|13|||
143065628|NCT02696031|515780608|FG001|Up to Week 104|Lack of Efficacy|12|||
143065629|NCT02696031|515780609|FG002|Up to Week 104|Lack of Efficacy|11|||
143065630|NCT02696031|515780610|FG003|Up to Week 104|Lack of Efficacy|0|||
143065631|NCT02696031|515780611|FG004|Up to Week 104|Lack of Efficacy|0|||
143065632|NCT02696031|515780612|FG005|Up to Week 104|Lack of Efficacy|0|||
143065633|NCT02696031|515780607|FG000|Up to Week 104|Adverse Event|7|||
143065634|NCT02696031|515780608|FG001|Up to Week 104|Adverse Event|11|||
143065635|NCT02696031|515780609|FG002|Up to Week 104|Adverse Event|5|||
143065636|NCT02696031|515780610|FG003|Up to Week 104|Adverse Event|0|||
143065637|NCT02696031|515780611|FG004|Up to Week 104|Adverse Event|0|||
143065638|NCT02696031|515780612|FG005|Up to Week 104|Adverse Event|0|||
143502999|NCT00408005|517380958|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
143503000|NCT00408005|517380959|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
143503001|NCT00408005|517380960|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
143503002|NCT00408005|517380961|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
143503003|NCT00408005|517380962|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
143065639|NCT02696031|515780607|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
143065640|NCT02696031|515780608|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
143065641|NCT02696031|515780609|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
143065642|NCT02696031|515780610|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
143065643|NCT02696031|515780611|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
143065644|NCT02696031|515780612|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
143065645|NCT02696031|515780607|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
143065646|NCT02696031|515780608|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
143065647|NCT02696031|515780609|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
143065648|NCT02696031|515780610|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
143065649|NCT02696031|515780611|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
143065650|NCT02696031|515780612|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
143065651|NCT02696031|515780607|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
143065652|NCT02696031|515780608|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
143065653|NCT02696031|515780609|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
143065654|NCT02696031|515780610|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
143065655|NCT02696031|515780611|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
143065656|NCT02696031|515780612|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
143065657|NCT02696031|515780607|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
143065658|NCT02696031|515780608|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
143065659|NCT02696031|515780609|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
143065660|NCT02696031|515780610|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
143065661|NCT02696031|515780611|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
143065662|NCT02696031|515780612|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
143065663|NCT02696031|515780607|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
143065664|NCT02696031|515780608|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
143065665|NCT02696031|515780609|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
143065666|NCT02696031|515780610|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
143065667|NCT02696031|515780611|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
143065668|NCT02696031|515780612|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
143065669|NCT02696031|515780607|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
143065670|NCT02696031|515780608|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
143065671|NCT02696031|515780609|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
143065672|NCT02696031|515780610|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
143065673|NCT02696031|515780611|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
143065674|NCT02696031|515780612|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
143065675|NCT02696031|515780607|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
143065676|NCT02696031|515780608|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
143065677|NCT02696031|515780609|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
143065678|NCT02696031|515780610|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
143065679|NCT02696031|515780611|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
143065680|NCT02696031|515780612|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
143065681|NCT03401073|515780613|FG000|Overall Study|Lost to Follow-up|1|||
143065682|NCT03401073|515780614|FG001|Overall Study|Lost to Follow-up|2|||
143065683|NCT01491035|515780619|FG000|Overall Study|Lost to Follow-up|0|||
143065684|NCT01491035|515780620|FG001|Overall Study|Lost to Follow-up|0|||
143065685|NCT01491035|515780621|FG002|Overall Study|Lost to Follow-up|0|||
143065686|NCT01491035|515780622|FG003|Overall Study|Lost to Follow-up|0|||
143065687|NCT01491035|515780623|FG004|Overall Study|Lost to Follow-up|1|||
143065688|NCT01491035|515780624|FG005|Overall Study|Lost to Follow-up|0|||
143065689|NCT01491035|515780625|FG006|Overall Study|Lost to Follow-up|0|||
143065690|NCT01491035|515780626|FG007|Overall Study|Lost to Follow-up|0|||
143065691|NCT02999477|515780630|FG000|Overall Study|found ineligible after first dose|0|||
143065692|NCT02999477|515780631|FG001|Overall Study|found ineligible after first dose|1|||
143503004|NCT00408005|517380963|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
143065693|NCT02999477|515780630|FG000|Overall Study|Withdrawal by Subject|1|||
143065694|NCT02999477|515780631|FG001|Overall Study|Withdrawal by Subject|1|||
143065695|NCT01846273|515780632|FG000|Overall Study|Adverse Event|9|||
143065696|NCT01846273|515780633|FG001|Overall Study|Adverse Event|7|||
143065697|NCT01846273|515780634|FG002|Overall Study|Adverse Event|0|||
143065698|NCT01846273|515780632|FG000|Overall Study|Subject withdrew consent|5|||
143065699|NCT01846273|515780633|FG001|Overall Study|Subject withdrew consent|8|||
143065700|NCT01846273|515780634|FG002|Overall Study|Subject withdrew consent|0|||
143065701|NCT01846273|515780632|FG000|Overall Study|Lost to Follow-up|2|||
143065702|NCT01846273|515780633|FG001|Overall Study|Lost to Follow-up|1|||
143065703|NCT01846273|515780634|FG002|Overall Study|Lost to Follow-up|0|||
143065704|NCT01846273|515780632|FG000|Overall Study|Administrative problems|1|||
143065705|NCT01846273|515780633|FG001|Overall Study|Administrative problems|0|||
143065706|NCT01846273|515780634|FG002|Overall Study|Administrative problems|0|||
143065707|NCT01846273|515780632|FG000|Overall Study|Death|2|||
143065708|NCT01846273|515780633|FG001|Overall Study|Death|1|||
143065709|NCT01846273|515780634|FG002|Overall Study|Death|0|||
143065710|NCT01846273|515780632|FG000|Overall Study|Disease Progression|0|||
143065711|NCT01846273|515780633|FG001|Overall Study|Disease Progression|4|||
143065712|NCT01846273|515780634|FG002|Overall Study|Disease Progression|0|||
143065713|NCT01846273|515780632|FG000|Overall Study|Protocol Deviation|2|||
143065714|NCT01846273|515780633|FG001|Overall Study|Protocol Deviation|3|||
143065715|NCT01846273|515780634|FG002|Overall Study|Protocol Deviation|0|||
143065716|NCT01846273|515780632|FG000|Overall Study|Physician Decision|1|||
143065717|NCT01846273|515780633|FG001|Overall Study|Physician Decision|2|||
143065718|NCT01846273|515780634|FG002|Overall Study|Physician Decision|0|||
143065719|NCT00891839|515780635|FG000|Overall Study|Adverse Event|2|||
143065720|NCT00891839|515780635|FG000|Overall Study|Withdrawal by Subject|2|||
143065721|NCT00891839|515780635|FG000|Overall Study|Disease progression|3|||
143065722|NCT01568866|515780641|FG000|Overall Study|Disease Progression|208|||
143065723|NCT01568866|515780642|FG001|Overall Study|Disease Progression|183|||
143065724|NCT01568866|515780641|FG000|Overall Study|Adverse Event|94|||
143065725|NCT01568866|515780642|FG001|Overall Study|Adverse Event|96|||
143065726|NCT01568866|515780641|FG000|Overall Study|Patient Request|55|||
143065727|NCT01568866|515780642|FG001|Overall Study|Patient Request|71|||
143065728|NCT01568866|515780641|FG000|Overall Study|Physician Decision|40|||
143065729|NCT01568866|515780642|FG001|Overall Study|Physician Decision|32|||
143065730|NCT01568866|515780641|FG000|Overall Study|Withdrawal by Subject|19|||
143065731|NCT01568866|515780642|FG001|Overall Study|Withdrawal by Subject|11|||
143065732|NCT01568866|515780641|FG000|Overall Study|Death|10|||
143065733|NCT01568866|515780642|FG001|Overall Study|Death|18|||
143065734|NCT01568866|515780641|FG000|Overall Study|Protocol Non-compliance|2|||
143065735|NCT01568866|515780642|FG001|Overall Study|Protocol Non-compliance|4|||
143065736|NCT01568866|515780641|FG000|Overall Study|Lost to Follow-up|1|||
143065737|NCT01568866|515780642|FG001|Overall Study|Lost to Follow-up|0|||
143065738|NCT01568866|515780641|FG000|Overall Study|Randomized but Not Dosed|9|||
143065739|NCT01568866|515780642|FG001|Overall Study|Randomized but Not Dosed|1|||
143065740|NCT00851643|515780643|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
143065741|NCT00851643|515780644|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
143065742|NCT00851643|515780645|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
143065743|NCT00851643|515780646|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
143065744|NCT00851643|515780647|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
143170330|NCT04079738|516171957|FG001|Study Treatment|Death|0|||
143170331|NCT04079738|516171958|FG002|Study Treatment|Death|0|||
143065745|NCT00851643|515780648|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
143065746|NCT00851643|515780643|FG000|Base Study (Up to 12 Months)|Other|0|||
143065747|NCT00851643|515780644|FG001|Base Study (Up to 12 Months)|Other|0|||
143065748|NCT00851643|515780645|FG002|Base Study (Up to 12 Months)|Other|0|||
143065749|NCT00851643|515780646|FG003|Base Study (Up to 12 Months)|Other|0|||
143065750|NCT00851643|515780647|FG004|Base Study (Up to 12 Months)|Other|0|||
143065751|NCT00851643|515780648|FG005|Base Study (Up to 12 Months)|Other|1|||
143065752|NCT00851643|515780643|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
143065753|NCT00851643|515780644|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
143065754|NCT00851643|515780645|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
143065755|NCT00851643|515780646|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
143065756|NCT00851643|515780647|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
143065757|NCT00851643|515780648|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
143065758|NCT00851643|515780643|FG000|Extension Study (Up to 36 Months)|Moved|0|||
143065759|NCT00851643|515780644|FG001|Extension Study (Up to 36 Months)|Moved|2|||
143065760|NCT00851643|515780645|FG002|Extension Study (Up to 36 Months)|Moved|1|||
143065761|NCT00851643|515780646|FG003|Extension Study (Up to 36 Months)|Moved|1|||
143065762|NCT00851643|515780647|FG004|Extension Study (Up to 36 Months)|Moved|0|||
143065763|NCT00851643|515780648|FG005|Extension Study (Up to 36 Months)|Moved|1|||
143065764|NCT03864042|515780649|FG000|DDI Phase|Adverse Event|2|||
143065765|NCT03864042|515780650|FG001|DDI Phase|Adverse Event|0|||
143065766|NCT03864042|515780651|FG002|DDI Phase|Adverse Event|0|||
143170332|NCT04079738|516171959|FG003|Study Treatment|Death|0|||
143503005|NCT00408005|517380964|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
143065767|NCT03864042|515780649|FG000|DDI Phase|Physician Decision|1|||
143065768|NCT03864042|515780650|FG001|DDI Phase|Physician Decision|0|||
143065769|NCT03864042|515780651|FG002|DDI Phase|Physician Decision|0|||
143065770|NCT03864042|515780649|FG000|DDI Phase|Progressive Disease|1|||
143065771|NCT03864042|515780650|FG001|DDI Phase|Progressive Disease|0|||
143065772|NCT03864042|515780651|FG002|DDI Phase|Progressive Disease|0|||
143065773|NCT03864042|515780649|FG000|Post-DDI Phase|Adverse Event|5|||
143065774|NCT03864042|515780650|FG001|Post-DDI Phase|Adverse Event|3|||
143065775|NCT03864042|515780651|FG002|Post-DDI Phase|Adverse Event|2|||
143065776|NCT03864042|515780649|FG000|Post-DDI Phase|Progressive Disease|11|||
143065777|NCT03864042|515780650|FG001|Post-DDI Phase|Progressive Disease|6|||
143065778|NCT03864042|515780651|FG002|Post-DDI Phase|Progressive Disease|13|||
143065779|NCT03864042|515780649|FG000|Post-DDI Phase|Discretion of investigator|1|||
143065780|NCT03864042|515780650|FG001|Post-DDI Phase|Discretion of investigator|1|||
143065781|NCT03864042|515780651|FG002|Post-DDI Phase|Discretion of investigator|0|||
143065782|NCT03864042|515780649|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
143065783|NCT03864042|515780650|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
143065784|NCT03864042|515780651|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
143065785|NCT03864042|515780649|FG000|Post-DDI Phase|Withdrawal of consent|1|||
143065786|NCT03864042|515780650|FG001|Post-DDI Phase|Withdrawal of consent|2|||
143065787|NCT03864042|515780651|FG002|Post-DDI Phase|Withdrawal of consent|0|||
143065788|NCT01698775|515780652|FG000|Phase A|Adverse Event|2|||
143065789|NCT01698775|515780653|FG001|Phase A|Adverse Event|1|||
143065790|NCT01698775|515780652|FG000|Phase A|Death|1|||
143065791|NCT01698775|515780653|FG001|Phase A|Death|1|||
143065792|NCT01698775|515780652|FG000|Phase A|Lack of Efficacy|1|||
143065793|NCT01698775|515780653|FG001|Phase A|Lack of Efficacy|0|||
143065794|NCT01698775|515780652|FG000|Phase A|Lost to Follow-up|1|||
143065795|NCT01698775|515780653|FG001|Phase A|Lost to Follow-up|2|||
143065796|NCT01698775|515780652|FG000|Phase A|Protocol Violation|1|||
143065797|NCT01698775|515780653|FG001|Phase A|Protocol Violation|0|||
143065798|NCT01698775|515780652|FG000|Phase A|Withdrawal by Subject|3|||
143065799|NCT01698775|515780653|FG001|Phase A|Withdrawal by Subject|4|||
143065800|NCT01698775|515780652|FG000|Phase A|Kidney [transplant]|0|||
143065801|NCT01698775|515780653|FG001|Phase A|Kidney [transplant]|1|||
143065802|NCT01698775|515780652|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
143065803|NCT01698775|515780653|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
143065804|NCT01698775|515780652|FG000|Phase B|Adverse Event|6|||
143065805|NCT01698775|515780653|FG001|Phase B|Adverse Event|3|||
143065806|NCT01698775|515780652|FG000|Phase B|Death|0|||
143065807|NCT01698775|515780653|FG001|Phase B|Death|1|||
143065808|NCT01698775|515780652|FG000|Phase B|Lack of Efficacy|0|||
143065809|NCT01698775|515780653|FG001|Phase B|Lack of Efficacy|1|||
143065810|NCT01698775|515780652|FG000|Phase B|Lost to Follow-up|0|||
143065811|NCT01698775|515780653|FG001|Phase B|Lost to Follow-up|1|||
143065812|NCT01698775|515780652|FG000|Phase B|Physician Decision|1|||
143065813|NCT01698775|515780653|FG001|Phase B|Physician Decision|1|||
143065814|NCT01698775|515780652|FG000|Phase B|Protocol Violation|1|||
143065815|NCT01698775|515780653|FG001|Phase B|Protocol Violation|1|||
143065816|NCT01698775|515780652|FG000|Phase B|Withdrawal by Subject|6|||
143065817|NCT01698775|515780653|FG001|Phase B|Withdrawal by Subject|2|||
143065818|NCT00359788|515780654|FG000|Overall Study|Adverse Event|11|||
143065819|NCT00359788|515780655|FG001|Overall Study|Adverse Event|10|||
143065820|NCT00359788|515780654|FG000|Overall Study|Lack of Efficacy|1|||
143065821|NCT00359788|515780655|FG001|Overall Study|Lack of Efficacy|2|||
143065822|NCT00359788|515780654|FG000|Overall Study|Lost to Follow-up|3|||
143065823|NCT00359788|515780655|FG001|Overall Study|Lost to Follow-up|2|||
143065824|NCT00359788|515780654|FG000|Overall Study|Withdrawal by Subject|4|||
143065825|NCT00359788|515780655|FG001|Overall Study|Withdrawal by Subject|1|||
143065826|NCT00359788|515780654|FG000|Overall Study|Protocol Violation|4|||
143065827|NCT00359788|515780655|FG001|Overall Study|Protocol Violation|2|||
143503006|NCT00408005|517380965|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
143065828|NCT04189445|515781984|FG000|Overall Study|Withdrawal of consent|8|||
143065829|NCT04189445|515781985|FG001|Overall Study|Withdrawal of consent|1|||
143170333|NCT04079738|516171956|FG000|Study Treatment|Adverse Event|2|||
143170334|NCT04079738|516171957|FG001|Study Treatment|Adverse Event|0|||
143170335|NCT04079738|516171958|FG002|Study Treatment|Adverse Event|0|||
143503007|NCT00408005|517380958|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
143503008|NCT00408005|517380959|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
143065830|NCT04189445|515781986|FG002|Overall Study|Withdrawal of consent|0|||
143065831|NCT04189445|515781984|FG000|Overall Study|Study Terminated by Sponsor|25|||
143065832|NCT04189445|515781985|FG001|Overall Study|Study Terminated by Sponsor|3|||
143170336|NCT04079738|516171959|FG003|Study Treatment|Adverse Event|0|||
143170337|NCT04079738|516171956|FG000|Study Treatment|withdrawal before treatment|1|||
143065833|NCT04189445|515781986|FG002|Overall Study|Study Terminated by Sponsor|0|||
143065834|NCT04189445|515781984|FG000|Overall Study|Death|54|||
143065835|NCT04189445|515781985|FG001|Overall Study|Death|24|||
143170338|NCT04079738|516171957|FG001|Study Treatment|withdrawal before treatment|0|||
143065836|NCT04189445|515781986|FG002|Overall Study|Death|0|||
143065837|NCT01013649|515781988|FG000|First Step|Withdrawal by Subject|36|||
143065838|NCT01013649|515781989|FG001|First Step|Withdrawal by Subject|19|||
143065839|NCT01013649|515781990|FG002|First Step|Withdrawal by Subject|0|||
143065840|NCT01013649|515781991|FG003|First Step|Withdrawal by Subject|0|||
143065841|NCT01013649|515781988|FG000|First Step|Progression|58|||
143503009|NCT00408005|517380960|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
143065842|NCT01013649|515781989|FG001|First Step|Progression|23|||
143065843|NCT01013649|515781990|FG002|First Step|Progression|0|||
143065844|NCT01013649|515781991|FG003|First Step|Progression|0|||
143065845|NCT01013649|515781988|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
143065846|NCT01013649|515781989|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
143065847|NCT01013649|515781990|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
143065848|NCT01013649|515781991|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
143065849|NCT01013649|515781988|FG000|First Step|Death|3|||
143065850|NCT01013649|515781989|FG001|First Step|Death|4|||
143065851|NCT01013649|515781990|FG002|First Step|Death|0|||
143065852|NCT01013649|515781991|FG003|First Step|Death|0|||
143065853|NCT01013649|515781988|FG000|First Step|Adverse Event|9|||
143065854|NCT01013649|515781989|FG001|First Step|Adverse Event|5|||
143065855|NCT01013649|515781990|FG002|First Step|Adverse Event|0|||
143065856|NCT01013649|515781991|FG003|First Step|Adverse Event|0|||
143065857|NCT01013649|515781988|FG000|First Step|Other|4|||
143065858|NCT01013649|515781989|FG001|First Step|Other|6|||
143065859|NCT01013649|515781990|FG002|First Step|Other|0|||
143065860|NCT01013649|515781991|FG003|First Step|Other|0|||
143065861|NCT02177136|515781996|FG000|DB Phase|Withdrawal by Subject|2|||
143065862|NCT02177136|515781997|FG001|DB Phase|Withdrawal by Subject|0|||
143065863|NCT02177136|515781998|FG002|DB Phase|Withdrawal by Subject|0|||
143065864|NCT02177136|515781999|FG003|DB Phase|Withdrawal by Subject|0|||
143065865|NCT02177136|515781996|FG000|DB Phase|Discontinued Due to Pruritus|1|||
143065866|NCT02177136|515781997|FG001|DB Phase|Discontinued Due to Pruritus|3|||
143065867|NCT02177136|515781998|FG002|DB Phase|Discontinued Due to Pruritus|0|||
143065868|NCT02177136|515781999|FG003|DB Phase|Discontinued Due to Pruritus|0|||
143065869|NCT02177136|515781996|FG000|DB Phase|Adverse Event|3|||
143065870|NCT02177136|515781997|FG001|DB Phase|Adverse Event|2|||
143065871|NCT02177136|515781998|FG002|DB Phase|Adverse Event|3|||
143065872|NCT02177136|515781999|FG003|DB Phase|Adverse Event|0|||
143065873|NCT02177136|515781996|FG000|DB Phase|Protocol Violation|0|||
143065874|NCT02177136|515781997|FG001|DB Phase|Protocol Violation|0|||
143065875|NCT02177136|515781998|FG002|DB Phase|Protocol Violation|1|||
143065876|NCT02177136|515781999|FG003|DB Phase|Protocol Violation|0|||
143065877|NCT02177136|515781996|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
143065878|NCT02177136|515781997|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
143065879|NCT02177136|515781998|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
143065880|NCT02177136|515781999|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
143065881|NCT02177136|515781996|FG000|LTSE Phase|Withdrawal by Subject|0|||
143065882|NCT02177136|515781997|FG001|LTSE Phase|Withdrawal by Subject|0|||
143065883|NCT02177136|515781998|FG002|LTSE Phase|Withdrawal by Subject|0|||
143065884|NCT02177136|515781999|FG003|LTSE Phase|Withdrawal by Subject|6|||
143065885|NCT02177136|515781996|FG000|LTSE Phase|Adverse Event|0|||
143503010|NCT00408005|517380961|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
143503011|NCT00408005|517380962|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
143503012|NCT00408005|517380963|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
143503013|NCT00408005|517380964|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
143503014|NCT00408005|517380965|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
143503015|NCT00408005|517380958|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
143503016|NCT00408005|517380959|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
143503017|NCT00408005|517380960|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
143503018|NCT00408005|517380961|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
143503019|NCT00408005|517380962|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
143065886|NCT02177136|515781997|FG001|LTSE Phase|Adverse Event|0|||
143065887|NCT02177136|515781998|FG002|LTSE Phase|Adverse Event|0|||
143065888|NCT02177136|515781999|FG003|LTSE Phase|Adverse Event|10|||
143065889|NCT02177136|515781996|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
143065890|NCT02177136|515781997|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
143065891|NCT02177136|515781998|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
143065892|NCT02177136|515781999|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
143065893|NCT02177136|515781996|FG000|LTSE Phase|Physician Decision|0|||
143065894|NCT02177136|515781997|FG001|LTSE Phase|Physician Decision|0|||
143065895|NCT02177136|515781998|FG002|LTSE Phase|Physician Decision|0|||
143065896|NCT02177136|515781999|FG003|LTSE Phase|Physician Decision|2|||
143065897|NCT02177136|515781996|FG000|LTSE Phase|Lost to Follow-up|0|||
143065898|NCT02177136|515781997|FG001|LTSE Phase|Lost to Follow-up|0|||
143365167|NCT03837028|516880651|FG002|Overall Study|Withdrawal by Subject|11|||
143065899|NCT02177136|515781998|FG002|LTSE Phase|Lost to Follow-up|0|||
143065900|NCT02177136|515781999|FG003|LTSE Phase|Lost to Follow-up|1|||
143065901|NCT02177136|515781996|FG000|LTSE Phase|Participant Moved|0|||
143065902|NCT02177136|515781997|FG001|LTSE Phase|Participant Moved|0|||
143065903|NCT02177136|515781998|FG002|LTSE Phase|Participant Moved|0|||
143065904|NCT02177136|515781999|FG003|LTSE Phase|Participant Moved|1|||
143065905|NCT00094458|515782000|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
143065906|NCT00094458|515782001|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
143065907|NCT00094458|515782002|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
143503020|NCT00408005|517380963|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
143503021|NCT00408005|517380964|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
143503022|NCT00408005|517380965|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
143503023|NCT00408005|517380958|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
143503024|NCT00408005|517380959|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
143503025|NCT00408005|517380960|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
143503026|NCT00408005|517380961|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
143503027|NCT00408005|517380962|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
143503028|NCT00408005|517380963|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
143503029|NCT00408005|517380964|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
143503030|NCT00408005|517380965|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
143503031|NCT00408005|517380958|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
143503032|NCT00408005|517380959|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
143503033|NCT00408005|517380960|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
143503034|NCT00408005|517380961|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
143503035|NCT00408005|517380962|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
143503036|NCT00408005|517380963|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
143503037|NCT00408005|517380964|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
143503038|NCT00408005|517380965|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
143503039|NCT00408005|517380958|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
143503040|NCT00408005|517380959|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
143503041|NCT00408005|517380960|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
143503042|NCT00408005|517380961|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
143503043|NCT00408005|517380962|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
143503044|NCT00408005|517380963|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
143503045|NCT00408005|517380964|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
143065908|NCT00094458|515782003|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
143065909|NCT00094458|515782004|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
143065910|NCT00094458|515782005|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
143065911|NCT00094458|515782000|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
143065912|NCT00094458|515782001|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
143065913|NCT00094458|515782002|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
143065914|NCT00094458|515782003|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
143065915|NCT00094458|515782004|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
143065916|NCT00094458|515782005|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
143065917|NCT00094458|515782000|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
143065918|NCT00094458|515782001|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
143065919|NCT00094458|515782002|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
143065920|NCT00094458|515782003|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
143065921|NCT00094458|515782004|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
143065922|NCT00094458|515782005|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
143065923|NCT00094458|515782000|FG000|Main Study: Through Week 30|Adverse Event|38|||
143065924|NCT00094458|515782001|FG001|Main Study: Through Week 30|Adverse Event|20|||
143065925|NCT00094458|515782002|FG002|Main Study: Through Week 30|Adverse Event|28|||
143065926|NCT00094458|515782003|FG003|Main Study: Through Week 30|Adverse Event|0|||
143065927|NCT00094458|515782004|FG004|Main Study: Through Week 30|Adverse Event|0|||
143065928|NCT00094458|515782005|FG005|Main Study: Through Week 30|Adverse Event|0|||
143065929|NCT00094458|515782000|FG000|Main Study: Through Week 30|Death|1|||
143065930|NCT00094458|515782001|FG001|Main Study: Through Week 30|Death|0|||
143065931|NCT00094458|515782002|FG002|Main Study: Through Week 30|Death|0|||
143065932|NCT00094458|515782003|FG003|Main Study: Through Week 30|Death|0|||
143065933|NCT00094458|515782004|FG004|Main Study: Through Week 30|Death|0|||
143065934|NCT00094458|515782005|FG005|Main Study: Through Week 30|Death|0|||
143065935|NCT00094458|515782000|FG000|Main Study: Through Week 30|Other|19|||
143065936|NCT00094458|515782001|FG001|Main Study: Through Week 30|Other|16|||
143065937|NCT00094458|515782002|FG002|Main Study: Through Week 30|Other|9|||
143065938|NCT00094458|515782003|FG003|Main Study: Through Week 30|Other|0|||
143065939|NCT00094458|515782004|FG004|Main Study: Through Week 30|Other|0|||
143503046|NCT00408005|517380965|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
143065940|NCT00094458|515782005|FG005|Main Study: Through Week 30|Other|0|||
143065941|NCT00094458|515782000|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
143065942|NCT00094458|515782001|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
143065943|NCT00094458|515782002|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
143065944|NCT00094458|515782003|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
143065945|NCT00094458|515782004|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
143170339|NCT04079738|516171958|FG002|Study Treatment|withdrawal before treatment|0|||
143170340|NCT04079738|516171959|FG003|Study Treatment|withdrawal before treatment|0|||
143170341|NCT04079738|516171956|FG000|Study Treatment|symptomatic deterioration|2|||
143065946|NCT00094458|515782005|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
143065947|NCT00094458|515782000|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
143065948|NCT00094458|515782001|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
143065949|NCT00094458|515782002|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
143065950|NCT00094458|515782003|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
143065951|NCT00094458|515782004|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
143065952|NCT00094458|515782005|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
143065953|NCT00094458|515782000|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
143065954|NCT00094458|515782001|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
143065955|NCT00094458|515782002|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
143065956|NCT00094458|515782003|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
143065957|NCT00094458|515782004|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
143065958|NCT00094458|515782005|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
143065959|NCT00094458|515782000|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
143065960|NCT00094458|515782001|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
143065961|NCT00094458|515782002|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
143065962|NCT00094458|515782003|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
143065963|NCT00094458|515782004|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
143065964|NCT00094458|515782005|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
143065965|NCT00094458|515782000|FG000|OLE: Open-Label Extension|Adverse Event|0|||
143065966|NCT00094458|515782001|FG001|OLE: Open-Label Extension|Adverse Event|0|||
143065967|NCT00094458|515782002|FG002|OLE: Open-Label Extension|Adverse Event|0|||
143065968|NCT00094458|515782003|FG003|OLE: Open-Label Extension|Adverse Event|0|||
143065969|NCT00094458|515782004|FG004|OLE: Open-Label Extension|Adverse Event|3|||
143065970|NCT00094458|515782005|FG005|OLE: Open-Label Extension|Adverse Event|4|||
143065971|NCT00094458|515782000|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
143065972|NCT00094458|515782001|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
143065973|NCT00094458|515782002|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
143065974|NCT00094458|515782003|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
143065975|NCT00094458|515782004|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
143065976|NCT00094458|515782005|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
143065977|NCT00094458|515782000|FG000|OLE: Open-Label Extension|Patient decision|0|||
143065978|NCT00094458|515782001|FG001|OLE: Open-Label Extension|Patient decision|0|||
143065979|NCT00094458|515782002|FG002|OLE: Open-Label Extension|Patient decision|0|||
143065980|NCT00094458|515782003|FG003|OLE: Open-Label Extension|Patient decision|0|||
143065981|NCT00094458|515782004|FG004|OLE: Open-Label Extension|Patient decision|1|||
143065982|NCT00094458|515782005|FG005|OLE: Open-Label Extension|Patient decision|0|||
143065983|NCT03310411|515782008|FG000|Period 1|Adverse Event|0|||
143065984|NCT03310411|515782009|FG001|Period 1|Adverse Event|0|||
143065985|NCT03310411|515782010|FG002|Period 1|Adverse Event|0|||
143065986|NCT03310411|515782011|FG003|Period 1|Adverse Event|1|||
143065987|NCT00515541|515782014|FG000|Overall Study|Physician Decision|0|||
143065988|NCT00515541|515782015|FG001|Overall Study|Physician Decision|2|||
143065989|NCT00515541|515782016|FG002|Overall Study|Physician Decision|0|||
143065990|NCT00515541|515782017|FG003|Overall Study|Physician Decision|1|||
143065991|NCT00515541|515782014|FG000|Overall Study|No show for appointments|0|||
143065992|NCT00515541|515782015|FG001|Overall Study|No show for appointments|1|||
143065993|NCT00515541|515782016|FG002|Overall Study|No show for appointments|0|||
143065994|NCT00515541|515782017|FG003|Overall Study|No show for appointments|2|||
143065995|NCT00515541|515782014|FG000|Overall Study|Withdrawal by Subject|0|||
143065996|NCT00515541|515782015|FG001|Overall Study|Withdrawal by Subject|2|||
143065997|NCT00515541|515782016|FG002|Overall Study|Withdrawal by Subject|0|||
143065998|NCT00515541|515782017|FG003|Overall Study|Withdrawal by Subject|2|||
143065999|NCT02072824|515782022|FG000|Overall Study|Insufficient clinical response|1|||
143066000|NCT02072824|515782023|FG001|Overall Study|Insufficient clinical response|0|||
143066001|NCT02072824|515782024|FG002|Overall Study|Insufficient clinical response|1|||
143066002|NCT02072824|515782022|FG000|Overall Study|No longer willing to participate|1|||
143503047|NCT00408005|517380958|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
143066003|NCT02072824|515782023|FG001|Overall Study|No longer willing to participate|0|||
143066004|NCT02072824|515782024|FG002|Overall Study|No longer willing to participate|1|||
143066005|NCT02072824|515782022|FG000|Overall Study|Medication error|0|||
143066006|NCT02072824|515782023|FG001|Overall Study|Medication error|1|||
143066007|NCT02072824|515782024|FG002|Overall Study|Medication error|0|||
143066008|NCT02072824|515782022|FG000|Overall Study|Adverse Event|0|||
143066009|NCT02072824|515782023|FG001|Overall Study|Adverse Event|0|||
143066010|NCT02072824|515782024|FG002|Overall Study|Adverse Event|1|||
143503048|NCT00408005|517380959|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
143503049|NCT00408005|517380960|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
143503050|NCT00408005|517380961|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
143503051|NCT00408005|517380962|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
143066011|NCT02400671|515782026|FG000|Overall Study|Death|5|||
143066012|NCT02400671|515782027|FG001|Overall Study|Death|3|||
143066013|NCT02400671|515782028|FG002|Overall Study|Death|4|||
143066014|NCT02400671|515782026|FG000|Overall Study|Lost to Follow-up|20|||
143066015|NCT02400671|515782027|FG001|Overall Study|Lost to Follow-up|27|||
143066016|NCT02400671|515782028|FG002|Overall Study|Lost to Follow-up|24|||
143066017|NCT02400671|515782026|FG000|Overall Study|Withdrawal by Subject|2|||
143066018|NCT02400671|515782027|FG001|Overall Study|Withdrawal by Subject|2|||
143066019|NCT02400671|515782028|FG002|Overall Study|Withdrawal by Subject|0|||
143066020|NCT02145026|515782032|FG000|Overall Study|Adverse Event|2|||
143066021|NCT02145026|515782032|FG000|Overall Study|Death|4|||
143066022|NCT02145026|515782032|FG000|Overall Study|Withdrawal by Subject|2|||
143066023|NCT02145026|515782032|FG000|Overall Study|Physician Decision|4|||
143066024|NCT05065983|515782040|FG000|Overall Study|Lost to Follow-up|2|||
143066025|NCT00616941|515782041|FG000|Overall Study|Progressive Disease|1|||
143066026|NCT00616941|515782042|FG001|Overall Study|Progressive Disease|2|||
143066027|NCT00616941|515782043|FG002|Overall Study|Progressive Disease|1|||
143066028|NCT00616941|515782041|FG000|Overall Study|Adverse Event|0|||
143066029|NCT00616941|515782042|FG001|Overall Study|Adverse Event|1|||
143066030|NCT00616941|515782043|FG002|Overall Study|Adverse Event|1|||
143066031|NCT00616941|515782041|FG000|Overall Study|Subject Non-compliance|0|||
143066032|NCT00616941|515782042|FG001|Overall Study|Subject Non-compliance|0|||
143066033|NCT00616941|515782043|FG002|Overall Study|Subject Non-compliance|1|||
143066034|NCT00616941|515782041|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
143066035|NCT00616941|515782042|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
143066036|NCT00616941|515782043|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
143066037|NCT00616941|515782041|FG000|Overall Study|Vaccination Suspended|0|||
143066038|NCT00616941|515782042|FG001|Overall Study|Vaccination Suspended|0|||
143066039|NCT00616941|515782043|FG002|Overall Study|Vaccination Suspended|3|||
143066040|NCT00289874|515782045|FG000|Overall Study|Adverse Event|1|||
143066041|NCT00289874|515782046|FG001|Overall Study|Adverse Event|5|||
143066042|NCT00289874|515782045|FG000|Overall Study|Lost to Follow-up|1|||
143066043|NCT00289874|515782046|FG001|Overall Study|Lost to Follow-up|1|||
143066044|NCT00289874|515782045|FG000|Overall Study|Protocol Violation|3|||
143066045|NCT00289874|515782046|FG001|Overall Study|Protocol Violation|2|||
143066046|NCT00289874|515782045|FG000|Overall Study|Did not meet eligibility|1|||
143066047|NCT00289874|515782046|FG001|Overall Study|Did not meet eligibility|0|||
143066048|NCT03835325|515782047|FG000|Overall Study|Lack of adherence to protocol procedures|1|||
143066049|NCT03835325|515782047|FG000|Overall Study|Selection failure|1|||
143066050|NCT04355663|515782048|FG000|Overall Study|Physician Decision|2|||
143066051|NCT04355663|515782049|FG001|Overall Study|Physician Decision|7|||
143066052|NCT04355663|515782050|FG002|Overall Study|Physician Decision|0|||
143066053|NCT04355663|515782048|FG000|Overall Study|Adverse Event|0|||
143066054|NCT04355663|515782049|FG001|Overall Study|Adverse Event|0|||
143066055|NCT04355663|515782050|FG002|Overall Study|Adverse Event|1|||
143066056|NCT04355663|515782048|FG000|Overall Study|Withdrawal by Subject|0|||
143066057|NCT04355663|515782049|FG001|Overall Study|Withdrawal by Subject|8|||
143066058|NCT04355663|515782050|FG002|Overall Study|Withdrawal by Subject|3|||
143066059|NCT03395639|515782053|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
143066060|NCT03395639|515782054|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
143066061|NCT03395639|515782055|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
143066062|NCT03395639|515782053|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
143066063|NCT03395639|515782054|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
143066064|NCT03395639|515782055|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
143066065|NCT03395639|515782053|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
143503052|NCT00408005|517380963|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
143503053|NCT00408005|517380964|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
143066066|NCT03395639|515782054|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
143066067|NCT03395639|515782055|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
143170342|NCT04079738|516171957|FG001|Study Treatment|symptomatic deterioration|0|||
143170343|NCT04079738|516171958|FG002|Study Treatment|symptomatic deterioration|0|||
143170344|NCT04079738|516171959|FG003|Study Treatment|symptomatic deterioration|0|||
143170345|NCT04079738|516171956|FG000|Study Treatment|Disease Progression|1|||
143170346|NCT04079738|516171957|FG001|Study Treatment|Disease Progression|0|||
143170347|NCT04079738|516171958|FG002|Study Treatment|Disease Progression|0|||
143170348|NCT04079738|516171959|FG003|Study Treatment|Disease Progression|0|||
143170349|NCT04079738|516171956|FG000|Study Treatment|withdrawal after treatment|1|||
143170350|NCT04079738|516171957|FG001|Study Treatment|withdrawal after treatment|0|||
143170351|NCT04079738|516171958|FG002|Study Treatment|withdrawal after treatment|0|||
143170352|NCT04079738|516171959|FG003|Study Treatment|withdrawal after treatment|0|||
143066068|NCT03395639|515782053|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
143066069|NCT03395639|515782054|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
143066070|NCT03395639|515782055|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
143066071|NCT03395639|515782053|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
143066072|NCT03395639|515782054|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
143066073|NCT03395639|515782055|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
143066074|NCT00995085|515782059|FG000|Overall Study|Withdrawal by Subject|5|||
143066075|NCT00257920|515782063|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
143066076|NCT00257920|515782064|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
143066077|NCT00257920|515782063|FG000|Period: Second Intervention|Other|2|||
143066078|NCT00257920|515782064|FG001|Period: Second Intervention|Other|1|||
143066079|NCT00770692|515782067|FG000|Overall Study|Withdrawal by Subject|7|||
143066080|NCT00770692|515782068|FG001|Overall Study|Withdrawal by Subject|9|||
143066081|NCT00770692|515782069|FG002|Overall Study|Withdrawal by Subject|9|||
143066082|NCT00770692|515782070|FG003|Overall Study|Withdrawal by Subject|6|||
143066083|NCT00770692|515782067|FG000|Overall Study|Adverse Event|3|||
143066084|NCT00770692|515782068|FG001|Overall Study|Adverse Event|0|||
143066085|NCT00770692|515782069|FG002|Overall Study|Adverse Event|4|||
143066086|NCT00770692|515782070|FG003|Overall Study|Adverse Event|4|||
143066087|NCT00770692|515782067|FG000|Overall Study|Investigator judgment|2|||
143066088|NCT00770692|515782068|FG001|Overall Study|Investigator judgment|0|||
143066089|NCT00770692|515782069|FG002|Overall Study|Investigator judgment|1|||
143066090|NCT00770692|515782070|FG003|Overall Study|Investigator judgment|1|||
143066091|NCT02037165|515782072|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
143066092|NCT02037165|515782073|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
143066093|NCT02037165|515782074|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
143066094|NCT02037165|515782075|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
143066095|NCT02037165|515782076|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
143066096|NCT02143583|515782079|FG000|Overall Study|Withdrawal by Subject|1|||
143066097|NCT02143583|515782080|FG001|Overall Study|Withdrawal by Subject|0|||
143066098|NCT02143583|515782081|FG002|Overall Study|Withdrawal by Subject|1|||
143066099|NCT02143583|515782079|FG000|Overall Study|husband illness|0|||
143066100|NCT02143583|515782080|FG001|Overall Study|husband illness|0|||
143066101|NCT02143583|515782081|FG002|Overall Study|husband illness|1|||
143066102|NCT01244061|515782082|FG000|Overall Study|Death|1|||
143066103|NCT01244061|515782083|FG001|Overall Study|Death|0|||
143066104|NCT01244061|515782082|FG000|Overall Study|Did not meet entrance criteria|1|||
143066105|NCT01244061|515782083|FG001|Overall Study|Did not meet entrance criteria|0|||
143066106|NCT01244061|515782082|FG000|Overall Study|Lack of Efficacy|1|||
143066107|NCT01244061|515782083|FG001|Overall Study|Lack of Efficacy|3|||
143066108|NCT01244061|515782082|FG000|Overall Study|Lost to Follow-up|34|||
143066109|NCT01244061|515782083|FG001|Overall Study|Lost to Follow-up|30|||
143066110|NCT01244061|515782082|FG000|Overall Study|Withdrawal by Subject|29|||
143066111|NCT01244061|515782083|FG001|Overall Study|Withdrawal by Subject|46|||
143066112|NCT01244061|515782082|FG000|Overall Study|Other|8|||
143066113|NCT01244061|515782083|FG001|Overall Study|Other|19|||
143066114|NCT01244061|515782082|FG000|Overall Study|Protocol Violation|1|||
143066115|NCT01244061|515782083|FG001|Overall Study|Protocol Violation|1|||
143066116|NCT01244061|515782082|FG000|Overall Study|Adverse Event|5|||
143066117|NCT01244061|515782083|FG001|Overall Study|Adverse Event|2|||
143066118|NCT01244061|515782082|FG000|Overall Study|Randomized but not treated|2|||
143066119|NCT01244061|515782083|FG001|Overall Study|Randomized but not treated|2|||
143066120|NCT01641133|515782084|FG000|Overall Study|Protocol Violation|0|||
143066121|NCT01641133|515782085|FG001|Overall Study|Protocol Violation|1|||
143066122|NCT01641133|515782086|FG002|Overall Study|Protocol Violation|1|||
143066123|NCT01641133|515782084|FG000|Overall Study|Migrated/moved from study area|5|||
143066124|NCT01641133|515782085|FG001|Overall Study|Migrated/moved from study area|3|||
143066125|NCT01641133|515782086|FG002|Overall Study|Migrated/moved from study area|1|||
143066126|NCT01641133|515782084|FG000|Overall Study|Adverse Event|0|||
143066127|NCT01641133|515782085|FG001|Overall Study|Adverse Event|0|||
143066128|NCT01641133|515782086|FG002|Overall Study|Adverse Event|1|||
143066129|NCT01641133|515782084|FG000|Overall Study|Withdrawal by Subject|5|||
143066130|NCT01641133|515782085|FG001|Overall Study|Withdrawal by Subject|3|||
143066131|NCT01641133|515782086|FG002|Overall Study|Withdrawal by Subject|3|||
143066132|NCT01641133|515782084|FG000|Overall Study|Lost to Follow-up|0|||
143066133|NCT01641133|515782085|FG001|Overall Study|Lost to Follow-up|2|||
143170353|NCT04079738|516171956|FG000|Follow up|Withdrawal by Subject|3|||
143170354|NCT04079738|516171957|FG001|Follow up|Withdrawal by Subject|0|||
143066134|NCT01641133|515782086|FG002|Overall Study|Lost to Follow-up|2|||
143066135|NCT02220725|515782087|FG000|Overall Study|Lost to Follow-up|0|||
143066136|NCT02220725|515782088|FG001|Overall Study|Lost to Follow-up|0|||
143066137|NCT02220725|515782089|FG002|Overall Study|Lost to Follow-up|0|||
143066138|NCT02220725|515782090|FG003|Overall Study|Lost to Follow-up|1|||
143066139|NCT02220725|515782087|FG000|Overall Study|Withdrawal by Subject|0|||
143066140|NCT02220725|515782088|FG001|Overall Study|Withdrawal by Subject|0|||
143170355|NCT04079738|516171958|FG002|Follow up|Withdrawal by Subject|0|||
143066141|NCT02220725|515782089|FG002|Overall Study|Withdrawal by Subject|0|||
143066142|NCT02220725|515782090|FG003|Overall Study|Withdrawal by Subject|1|||
143066143|NCT04932941|515782091|FG000|Overall Study|Lost to Follow-up|3|||
143066144|NCT04932941|515782092|FG001|Overall Study|Lost to Follow-up|1|||
143066145|NCT04932941|515782091|FG000|Overall Study|Withdrawal by Subject|7|||
143066146|NCT04932941|515782092|FG001|Overall Study|Withdrawal by Subject|4|||
143066147|NCT04932941|515782091|FG000|Overall Study|Other|4|||
143066148|NCT04932941|515782092|FG001|Overall Study|Other|2|||
143066149|NCT05069155|515782093|FG000|Overall Study|Withdrawal by Subject|1|||
143066150|NCT05069155|515782094|FG001|Overall Study|Withdrawal by Subject|3|||
143066151|NCT01366443|515782095|FG000|Overall Study|Lost to Follow-up|2|||
143066152|NCT01366443|515782095|FG000|Overall Study|Under 18 yo|1|||
143066153|NCT00588640|515782096|FG000|Overall Study|Physician Decision|1|||
143066154|NCT00588640|515782096|FG000|Overall Study|Ineligible Patient|1|||
143066155|NCT01673698|515782097|FG000|Overall Study|Lost to Follow-up|51|||
143066156|NCT01673698|515782098|FG001|Overall Study|Lost to Follow-up|13|||
143066157|NCT01297322|515782099|FG000|Overall Study|Lost to Follow-up|1|||
143066158|NCT01297322|515782100|FG001|Overall Study|Lost to Follow-up|0|||
143066159|NCT01297322|515782099|FG000|Overall Study|Withdrawal by Subject|0|||
143066160|NCT01297322|515782100|FG001|Overall Study|Withdrawal by Subject|1|||
143066161|NCT01297322|515782099|FG000|Overall Study|Protocol Violation|0|||
143066162|NCT01297322|515782100|FG001|Overall Study|Protocol Violation|3|||
143066163|NCT01111019|515782101|FG000|Overall Study|Withdrew Prematurely|2|||
143066164|NCT01111019|515782101|FG000|Overall Study|Other|1|||
143066165|NCT01583218|515782102|FG000|Overall Study|Withdrawal by Subject|43|||
143066166|NCT01583218|515782103|FG001|Overall Study|Withdrawal by Subject|29|||
143066167|NCT01583218|515782102|FG000|Overall Study|Death|206|||
143066168|NCT01583218|515782103|FG001|Overall Study|Death|211|||
143066169|NCT01583218|515782102|FG000|Overall Study|Lost to Follow-up|11|||
143066170|NCT01583218|515782103|FG001|Overall Study|Lost to Follow-up|17|||
143066171|NCT01583218|515782102|FG000|Overall Study|Adverse event or serious adverse event|3|||
143066172|NCT01583218|515782103|FG001|Overall Study|Adverse event or serious adverse event|3|||
143066173|NCT01583218|515782102|FG000|Overall Study|Patient /Family decision|3|||
143066174|NCT01583218|515782103|FG001|Overall Study|Patient /Family decision|0|||
143066175|NCT01583218|515782102|FG000|Overall Study|Cannot contact patient directly|1|||
143066176|NCT01583218|515782103|FG001|Overall Study|Cannot contact patient directly|2|||
143066177|NCT01583218|515782102|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
143066178|NCT01583218|515782103|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
143066179|NCT01583218|515782102|FG000|Overall Study|Patient did not wish to attend visits|0|||
143066180|NCT01583218|515782103|FG001|Overall Study|Patient did not wish to attend visits|1|||
143066181|NCT01583218|515782102|FG000|Overall Study|Patient randomized but not dosed|17|||
143066182|NCT01583218|515782103|FG001|Overall Study|Patient randomized but not dosed|16|||
143066183|NCT01583218|515782102|FG000|Overall Study|Patient was assessed via phone in person|1|||
143066184|NCT01583218|515782103|FG001|Overall Study|Patient was assessed via phone in person|0|||
143066185|NCT01583218|515782102|FG000|Overall Study|Patient deemed ineligible after random|2|||
143066186|NCT01583218|515782103|FG001|Overall Study|Patient deemed ineligible after random|0|||
143066187|NCT01583218|515782102|FG000|Overall Study|Patient was early terminated from study|0|||
143066188|NCT01583218|515782103|FG001|Overall Study|Patient was early terminated from study|1|||
143066189|NCT01583218|515782102|FG000|Overall Study|Patient was randomized due to mistake|1|||
143066190|NCT01583218|515782103|FG001|Overall Study|Patient was randomized due to mistake|0|||
143066191|NCT01583218|515782102|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
143066192|NCT01583218|515782103|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
143066193|NCT01583218|515782102|FG000|Overall Study|Withdraw of consent on day of random|1|||
143066194|NCT01583218|515782103|FG001|Overall Study|Withdraw of consent on day of random|0|||
143066195|NCT02674061|515782106|FG000|Overall Study|Death|229|||
143066196|NCT02674061|515782107|FG001|Overall Study|Death|77|||
143066197|NCT02674061|515782106|FG000|Overall Study|Lost to Follow-up|3|||
143066198|NCT02674061|515782107|FG001|Overall Study|Lost to Follow-up|3|||
143066199|NCT02674061|515782106|FG000|Overall Study|Withdrawal by Subject|9|||
143170356|NCT04079738|516171959|FG003|Follow up|Withdrawal by Subject|0|||
143170357|NCT04079738|516171956|FG000|Follow up|Death|5|||
143066200|NCT02674061|515782107|FG001|Overall Study|Withdrawal by Subject|1|||
143066201|NCT02674061|515782106|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
143066202|NCT02674061|515782107|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
143066203|NCT00123955|515782110|FG000|Overall Study|Adverse Event|1|||
143170358|NCT04079738|516171957|FG001|Follow up|Death|0|||
143170359|NCT04079738|516171958|FG002|Follow up|Death|0|||
143365168|NCT03837028|516880652|FG003|Overall Study|Withdrawal by Subject|7|||
143365169|NCT01456780|516880653|FG000|Overall Study|Lost to Follow-up|3|||
143503054|NCT00408005|517380965|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
143503055|NCT00408005|517380958|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
143066204|NCT00123955|515782111|FG001|Overall Study|Adverse Event|0|||
143066205|NCT00123955|515782110|FG000|Overall Study|Withdrawal by Subject|4|||
143066206|NCT00123955|515782111|FG001|Overall Study|Withdrawal by Subject|3|||
143066207|NCT00123955|515782110|FG000|Overall Study|Death|0|||
143066208|NCT00123955|515782111|FG001|Overall Study|Death|1|||
143066209|NCT03334721|515782112|FG000|Overall Study|Withdrawal by Subject|1|||
143066210|NCT03334721|515782113|FG001|Overall Study|Withdrawal by Subject|0|||
143066211|NCT03334721|515782112|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
143066212|NCT03334721|515782113|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
143066213|NCT01558297|515782115|FG000|Overall Study|Withdrawal by Subject|2|||
143066214|NCT01558297|515782116|FG001|Overall Study|Withdrawal by Subject|2|||
143066215|NCT01558297|515782117|FG002|Overall Study|Withdrawal by Subject|1|||
143066216|NCT01232491|515782118|FG000|Overall Study|Adverse Event|13|||
143066217|NCT01232491|515782119|FG001|Overall Study|Adverse Event|8|||
143066218|NCT01232491|515782118|FG000|Overall Study|Lack of Efficacy|1|||
143066219|NCT01232491|515782119|FG001|Overall Study|Lack of Efficacy|5|||
143066220|NCT01232491|515782118|FG000|Overall Study|Protocol Violation|13|||
143066221|NCT01232491|515782119|FG001|Overall Study|Protocol Violation|11|||
143066222|NCT01232491|515782118|FG000|Overall Study|Withdrawal Criteria|12|||
143066223|NCT01232491|515782119|FG001|Overall Study|Withdrawal Criteria|21|||
143066224|NCT01232491|515782118|FG000|Overall Study|Other|21|||
143066225|NCT01232491|515782119|FG001|Overall Study|Other|18|||
143066226|NCT05142566|515783706|FG000|Overall Study|Protocol Violation|1|||
143066227|NCT04556552|515783708|FG000|Overall Study|Lost to Follow-up|1|||
143066228|NCT04556552|515783709|FG001|Overall Study|Lost to Follow-up|0|||
143066229|NCT04556552|515783708|FG000|Overall Study|Claustrophobia|0|||
143066230|NCT04556552|515783709|FG001|Overall Study|Claustrophobia|1|||
143066231|NCT04556552|515783708|FG000|Overall Study|Inability to continue|0|||
143066232|NCT04556552|515783709|FG001|Overall Study|Inability to continue|1|||
143066233|NCT04551911|515783710|FG000|Overall Study|Lost to Follow-up|2|||
143066234|NCT04551911|515783711|FG001|Overall Study|Lost to Follow-up|1|||
143066235|NCT04551911|515783710|FG000|Overall Study|Withdrawal by Subject|10|||
143066236|NCT04551911|515783711|FG001|Overall Study|Withdrawal by Subject|10|||
143066237|NCT04551911|515783710|FG000|Overall Study|Did not receive the study drug|3|||
143066238|NCT04551911|515783711|FG001|Overall Study|Did not receive the study drug|4|||
143066239|NCT01553279|515783712|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
143066240|NCT01553279|515783713|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
143066241|NCT01553279|515783712|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
143066242|NCT01553279|515783713|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
143066243|NCT01553279|515783712|FG000|Interim Period|Withdrawal by Subject|2|||
143066244|NCT01553279|515783713|FG001|Interim Period|Withdrawal by Subject|2|||
143066245|NCT01553279|515783712|FG000|Interim Period|Lost to Follow-up|1|||
143066246|NCT01553279|515783713|FG001|Interim Period|Lost to Follow-up|0|||
143066247|NCT01553279|515783712|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
143066248|NCT01553279|515783713|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
143066249|NCT01553279|515783712|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
143066250|NCT01553279|515783713|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
143066251|NCT00605865|515783714|FG000|Overall Study|Protocol Violation|115|||
143066252|NCT02858492|515783717|FG000|Overall Study|Withdrawal by Subject|0|||
143066253|NCT02858492|515783718|FG001|Overall Study|Withdrawal by Subject|1|||
143066254|NCT02858492|515783719|FG002|Overall Study|Withdrawal by Subject|0|||
143066255|NCT02858492|515783720|FG003|Overall Study|Withdrawal by Subject|1|||
143066256|NCT02858492|515783717|FG000|Overall Study|Adverse Event|0|||
143066257|NCT02858492|515783718|FG001|Overall Study|Adverse Event|0|||
143066258|NCT02858492|515783719|FG002|Overall Study|Adverse Event|0|||
143066259|NCT02858492|515783720|FG003|Overall Study|Adverse Event|3|||
143066260|NCT02858492|515783717|FG000|Overall Study|Lack of Efficacy|0|||
143066261|NCT02858492|515783718|FG001|Overall Study|Lack of Efficacy|0|||
143066262|NCT02858492|515783719|FG002|Overall Study|Lack of Efficacy|0|||
143066263|NCT02858492|515783720|FG003|Overall Study|Lack of Efficacy|1|||
143066264|NCT02858492|515783717|FG000|Overall Study|Protocol defined stopping criteria|0|||
143066265|NCT02858492|515783718|FG001|Overall Study|Protocol defined stopping criteria|0|||
143066266|NCT02858492|515783719|FG002|Overall Study|Protocol defined stopping criteria|0|||
143066267|NCT02858492|515783720|FG003|Overall Study|Protocol defined stopping criteria|1|||
143066268|NCT04268316|515783725|FG000|Overall Study|Withdrawal by Subject|2|||
143066269|NCT04268316|515783726|FG001|Overall Study|Withdrawal by Subject|1|||
143066270|NCT04268316|515783727|FG002|Overall Study|Withdrawal by Subject|0|||
143066271|NCT02132637|515783728|FG000|Study Period 1|Withdrawal by Subject|0|||
143066272|NCT02132637|515783729|FG001|Study Period 1|Withdrawal by Subject|4|||
143066273|NCT02132637|515783728|FG000|Study Period 1|Physician Decision|1|||
143365170|NCT01456780|516880654|FG001|Overall Study|Lost to Follow-up|3|||
143066274|NCT02132637|515783729|FG001|Study Period 1|Physician Decision|0|||
143066275|NCT02132637|515783728|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
143066276|NCT02132637|515783729|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
143066277|NCT02132637|515783728|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
143066278|NCT02132637|515783729|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
143066279|NCT00652028|515783732|FG000|Overall Study|Adverse Event|1|||
143066280|NCT00652028|515783733|FG001|Overall Study|Adverse Event|0|||
143066281|NCT00652028|515783734|FG002|Overall Study|Adverse Event|0|||
143066282|NCT00652028|515783735|FG003|Overall Study|Adverse Event|0|||
143066283|NCT00652028|515783732|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
143066284|NCT00652028|515783733|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
143066285|NCT00652028|515783734|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
143066286|NCT00652028|515783735|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
143066287|NCT00652028|515783732|FG000|Overall Study|Physician Decision|0|||
143066288|NCT00652028|515783733|FG001|Overall Study|Physician Decision|0|||
143066289|NCT00652028|515783734|FG002|Overall Study|Physician Decision|1|||
143066290|NCT00652028|515783735|FG003|Overall Study|Physician Decision|0|||
143066291|NCT00841906|515783736|FG000|Overall Study|Withdrawal by Subject|2|||
143066292|NCT00841906|515783737|FG001|Overall Study|Withdrawal by Subject|0|||
143066293|NCT02751359|515783742|FG000|Overall Study|Lost to Follow-up|1|||
143066294|NCT02667288|515783743|FG000|Overall Study|Protocol Violation|5|||
143066295|NCT02667288|515783743|FG000|Overall Study|Lost to Follow-up|3|||
143066296|NCT02667288|515783743|FG000|Overall Study|Withdrawal by Subject|5|||
143066297|NCT01196078|515783744|FG000|Overall Study|Withdrawal by Subject|3|||
143066298|NCT01196078|515783745|FG001|Overall Study|Withdrawal by Subject|5|||
143066299|NCT01196078|515783744|FG000|Overall Study|Adverse Event|4|||
143066300|NCT01196078|515783745|FG001|Overall Study|Adverse Event|4|||
143066301|NCT01196078|515783744|FG000|Overall Study|Protocol Violation|2|||
143066302|NCT01196078|515783745|FG001|Overall Study|Protocol Violation|1|||
143066303|NCT01196078|515783744|FG000|Overall Study|Lack of Efficacy|17|||
143066304|NCT01196078|515783745|FG001|Overall Study|Lack of Efficacy|23|||
143066305|NCT01196078|515783744|FG000|Overall Study|Lost to Follow-up|1|||
143066306|NCT01196078|515783745|FG001|Overall Study|Lost to Follow-up|0|||
143066307|NCT01196078|515783744|FG000|Overall Study|Death|6|||
143066308|NCT01196078|515783745|FG001|Overall Study|Death|4|||
143066309|NCT00127036|515783746|FG000|Overall Study|Insufficient Data for Analysis|6|||
143066310|NCT00127036|515783747|FG001|Overall Study|Insufficient Data for Analysis|11|||
143066311|NCT00127036|515783746|FG000|Overall Study|Screen Failure|2|||
143066312|NCT00127036|515783747|FG001|Overall Study|Screen Failure|0|||
143066313|NCT03656874|515783748|FG000|Overall Study|Lost to Follow-up|3|||
143066314|NCT03656874|515783749|FG001|Overall Study|Lost to Follow-up|17|||
143066315|NCT03001219|515783755|FG000|Proof of Concept|Study Termination by Sponsor|0|||
143066316|NCT03001219|515783756|FG001|Proof of Concept|Study Termination by Sponsor|1|||
143066317|NCT03001219|515783755|FG000|Proof of Concept|Withdrawal by Subject|0|||
143066318|NCT03001219|515783756|FG001|Proof of Concept|Withdrawal by Subject|4|||
143066319|NCT03001219|515783755|FG000|Proof of Concept|Protocol Deviation|0|||
143066320|NCT03001219|515783756|FG001|Proof of Concept|Protocol Deviation|1|||
143066321|NCT03001219|515783755|FG000|Proof of Concept|Adverse Event|1|||
143066322|NCT03001219|515783756|FG001|Proof of Concept|Adverse Event|1|||
143066323|NCT03001219|515783755|FG000|Proof of Concept|Physician Decision|1|||
143066324|NCT03001219|515783756|FG001|Proof of Concept|Physician Decision|0|||
143066325|NCT03001219|515783755|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
143066326|NCT03001219|515783756|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
143066327|NCT03001219|515783755|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
143066328|NCT03001219|515783756|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
143066329|NCT03001219|515783755|FG000|Extension Period Analysis|Physician Decision|0|||
143066330|NCT03001219|515783756|FG001|Extension Period Analysis|Physician Decision|1|||
143066331|NCT03001219|515783755|FG000|Extension Period Analysis|Adverse Event|1|||
143503056|NCT00408005|517380959|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
143503057|NCT00408005|517380960|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
143503058|NCT00408005|517380961|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
143503059|NCT00408005|517380962|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
143066332|NCT03001219|515783756|FG001|Extension Period Analysis|Adverse Event|1|||
143066333|NCT03001219|515783755|FG000|Extension Period Analysis|Protocol Deviation|0|||
143066334|NCT03001219|515783756|FG001|Extension Period Analysis|Protocol Deviation|1|||
143066335|NCT03001219|515783755|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
143066336|NCT03001219|515783756|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
143066337|NCT01797835|515783757|FG000|Overall Study|Lost to Follow-up|31|||
143066338|NCT01797835|515783758|FG001|Overall Study|Lost to Follow-up|27|||
143066339|NCT01403064|515783759|FG000|Overall Study|Death|0|||
143066340|NCT01403064|515783760|FG001|Overall Study|Death|0|||
143066341|NCT01403064|515783761|FG002|Overall Study|Death|1|||
143066342|NCT01403064|515783762|FG003|Overall Study|Death|1|||
143066343|NCT01403064|515783759|FG000|Overall Study|Withdrawal by Subject|0|||
143066344|NCT01403064|515783760|FG001|Overall Study|Withdrawal by Subject|0|||
143066345|NCT01403064|515783761|FG002|Overall Study|Withdrawal by Subject|1|||
143066346|NCT01403064|515783762|FG003|Overall Study|Withdrawal by Subject|1|||
143066347|NCT01403064|515783759|FG000|Overall Study|Other|1|||
143066348|NCT01403064|515783760|FG001|Overall Study|Other|0|||
143066349|NCT01403064|515783761|FG002|Overall Study|Other|2|||
143066350|NCT01403064|515783762|FG003|Overall Study|Other|1|||
143066351|NCT03733210|515783763|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
143066352|NCT03733210|515783764|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
143066353|NCT03760250|515783765|FG000|Overall Study|Withdrawal by Subject|1|||
143066354|NCT03760250|515783765|FG000|Overall Study|Physician Decision|1|||
143066355|NCT04421586|515783773|FG000|Overall Study|Death|0|||
143066356|NCT04421586|515783774|FG001|Overall Study|Death|1|||
143066357|NCT04421586|515783773|FG000|Overall Study|Lost to Follow-up|2|||
143066358|NCT04421586|515783774|FG001|Overall Study|Lost to Follow-up|2|||
143066359|NCT04421586|515783773|FG000|Overall Study|Withdrawn by PI|1|||
143066360|NCT04421586|515783774|FG001|Overall Study|Withdrawn by PI|0|||
143066361|NCT04421586|515783773|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
143066362|NCT04421586|515783774|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
143066363|NCT02669940|515783777|FG000|Overall Study|Failure to return|0|||
143066364|NCT02669940|515783778|FG001|Overall Study|Failure to return|3|||
143066365|NCT02669940|515783777|FG000|Overall Study|Insufficient follow-up data|1|||
143066366|NCT02669940|515783778|FG001|Overall Study|Insufficient follow-up data|0|||
143066367|NCT00986180|515783781|FG000|Overall Study|Adverse Event|21|||
143066368|NCT00986180|515783782|FG001|Overall Study|Adverse Event|23|||
143066369|NCT00986180|515783781|FG000|Overall Study|Lack of Efficacy|4|||
143066370|NCT00986180|515783782|FG001|Overall Study|Lack of Efficacy|3|||
143066371|NCT00986180|515783781|FG000|Overall Study|Lost to Follow-up|5|||
143066372|NCT00986180|515783782|FG001|Overall Study|Lost to Follow-up|7|||
143066373|NCT00986180|515783781|FG000|Overall Study|Physician Decision|1|||
143066374|NCT00986180|515783782|FG001|Overall Study|Physician Decision|3|||
143066375|NCT00986180|515783781|FG000|Overall Study|Protocol Violation|2|||
143066376|NCT00986180|515783782|FG001|Overall Study|Protocol Violation|0|||
143066377|NCT00986180|515783781|FG000|Overall Study|Withdrawal by Subject|1|||
143066378|NCT00986180|515783782|FG001|Overall Study|Withdrawal by Subject|9|||
143066379|NCT00986180|515783781|FG000|Overall Study|Miscellanies|10|||
143066380|NCT00986180|515783782|FG001|Overall Study|Miscellanies|11|||
143066381|NCT01765582|515783783|FG000|Overall Study|Other|3|||
143066382|NCT01765582|515783784|FG001|Overall Study|Other|6|||
143066383|NCT01765582|515783785|FG002|Overall Study|Other|9|||
143066384|NCT01765582|515783783|FG000|Overall Study|Lost to Follow-up|2|||
143066385|NCT01765582|515783784|FG001|Overall Study|Lost to Follow-up|2|||
143066386|NCT01765582|515783785|FG002|Overall Study|Lost to Follow-up|1|||
143066387|NCT01765582|515783783|FG000|Overall Study|Death|31|||
143066388|NCT01765582|515783784|FG001|Overall Study|Death|36|||
143066389|NCT01765582|515783785|FG002|Overall Study|Death|33|||
143066390|NCT01765582|515783783|FG000|Overall Study|Sponsor Decision|46|||
143066391|NCT01765582|515783784|FG001|Overall Study|Sponsor Decision|42|||
143066392|NCT01765582|515783785|FG002|Overall Study|Sponsor Decision|42|||
143066393|NCT01765582|515783783|FG000|Overall Study|Withdrawal of Consent|11|||
143066394|NCT01765582|515783784|FG001|Overall Study|Withdrawal of Consent|6|||
143066395|NCT01765582|515783785|FG002|Overall Study|Withdrawal of Consent|10|||
143066396|NCT03251963|515783790|FG000|Overall Study|inappropriate Xa level timing|6|||
143066397|NCT03251963|515783791|FG001|Overall Study|inappropriate Xa level timing|3|||
143066398|NCT03251963|515783790|FG000|Overall Study|no peak Xa level drawn|2|||
143066399|NCT03251963|515783791|FG001|Overall Study|no peak Xa level drawn|0|||
143066400|NCT03251963|515783790|FG000|Overall Study|bled prior to Xa level|1|||
143066401|NCT03251963|515783791|FG001|Overall Study|bled prior to Xa level|2|||
143066402|NCT00714493|515783799|FG000|Overall Study|Adverse Event|11|||
143066403|NCT00714493|515783799|FG000|Overall Study|Death|3|||
143066404|NCT00714493|515783799|FG000|Overall Study|Lack of Efficacy|10|||
143066405|NCT00714493|515783799|FG000|Overall Study|Lost to Follow-up|3|||
143066406|NCT00714493|515783799|FG000|Overall Study|Protocol Violation|12|||
143066407|NCT00714493|515783799|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
143066408|NCT00714493|515783799|FG000|Overall Study|OTHER|2|||
143066409|NCT00076804|515783800|FG000|Overall Study|Death|9|||
143066410|NCT00076804|515783801|FG001|Overall Study|Death|20|||
143066411|NCT00076804|515783800|FG000|Overall Study|Lost to Follow-up|9|||
143066412|NCT00076804|515783801|FG001|Overall Study|Lost to Follow-up|9|||
143066413|NCT00076804|515783800|FG000|Overall Study|Withdrawal by Subject|10|||
143066414|NCT00076804|515783801|FG001|Overall Study|Withdrawal by Subject|8|||
143066415|NCT00076804|515783800|FG000|Overall Study|Early study Closure|32|||
143066416|NCT00076804|515783801|FG001|Overall Study|Early study Closure|32|||
143066417|NCT04295135|515783802|FG000|Overall Study|Withdrawal by Subject|2|||
143066418|NCT04295135|515783803|FG001|Overall Study|Withdrawal by Subject|1|||
143066419|NCT04295135|515783802|FG000|Overall Study|Subject left organization|8|||
143066420|NCT04295135|515783803|FG001|Overall Study|Subject left organization|4|||
143066421|NCT01732874|515783805|FG000|Overall Study|Withdrawal by Subject|5|||
143066422|NCT01732874|515783806|FG001|Overall Study|Withdrawal by Subject|1|||
143066423|NCT01732874|515783805|FG000|Overall Study|Death of Infant|3|||
143066424|NCT01732874|515783806|FG001|Overall Study|Death of Infant|2|||
143066425|NCT00557076|515783807|FG000|Overall Study|Unblinding|0|||
143066426|NCT00557076|515783808|FG001|Overall Study|Unblinding|1|||
143170360|NCT04079738|516171959|FG003|Follow up|Death|0|||
143170361|NCT05552859|516171960|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
143170362|NCT05552859|516171961|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
143170363|NCT04251533|516171962|FG000|Overall Study|Progressive disease|33|||
143170364|NCT04251533|516171963|FG001|Overall Study|Progressive disease|29|||
143170365|NCT04251533|516171964|FG002|Overall Study|Progressive disease|22|||
143170366|NCT04251533|516171962|FG000|Overall Study|Death|5|||
143170367|NCT04251533|516171963|FG001|Overall Study|Death|1|||
143170368|NCT04251533|516171964|FG002|Overall Study|Death|3|||
143170369|NCT04251533|516171962|FG000|Overall Study|Physician Decision|3|||
143170370|NCT04251533|516171963|FG001|Overall Study|Physician Decision|2|||
143503060|NCT00408005|517380963|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
143503061|NCT00408005|517380964|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
143066427|NCT04392583|515783809|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
143066428|NCT03484117|515783810|FG000|Overall Study|Lost to Follow-up|1|||
143066429|NCT03484117|515783811|FG001|Overall Study|Lost to Follow-up|3|||
143066430|NCT03484117|515783810|FG000|Overall Study|Declined participation in exit assess|1|||
143066431|NCT03484117|515783811|FG001|Overall Study|Declined participation in exit assess|1|||
143066432|NCT02303041|515783812|FG000|Overall Study|Adverse Event|1|||
143066433|NCT02303041|515783813|FG001|Overall Study|Adverse Event|2|||
143066434|NCT01070771|515783814|FG000|Overall Study|Adverse Event|2|||
143066435|NCT01070771|515783814|FG000|Overall Study|Protocol Violation|1|||
143066436|NCT01370213|515783815|FG000|Overall Study|Early Death|1|||
143066437|NCT01370213|515783816|FG001|Overall Study|Early Death|0|||
143066438|NCT01370213|515783817|FG002|Overall Study|Early Death|0|||
143066439|NCT01370213|515783815|FG000|Overall Study|Not evaluable|0|||
143066440|NCT01370213|515783816|FG001|Overall Study|Not evaluable|2|||
143066441|NCT01370213|515783817|FG002|Overall Study|Not evaluable|0|||
143066442|NCT01550744|515783820|FG000|Open-Label|Lost to Follow-up|7|||
143066443|NCT01550744|515783821|FG001|Open-Label|Lost to Follow-up|0|||
143066444|NCT01550744|515783822|FG002|Open-Label|Lost to Follow-up|0|||
143066445|NCT01550744|515783820|FG000|Open-Label|Withdrawal by Subject|13|||
143066446|NCT01550744|515783821|FG001|Open-Label|Withdrawal by Subject|0|||
143066447|NCT01550744|515783822|FG002|Open-Label|Withdrawal by Subject|0|||
143066448|NCT01550744|515783820|FG000|Open-Label|Adverse Event|11|||
143066449|NCT01550744|515783821|FG001|Open-Label|Adverse Event|0|||
143066450|NCT01550744|515783822|FG002|Open-Label|Adverse Event|0|||
143066451|NCT01550744|515783820|FG000|Open-Label|Lack of Efficacy|4|||
143066452|NCT01550744|515783821|FG001|Open-Label|Lack of Efficacy|0|||
143066453|NCT01550744|515783822|FG002|Open-Label|Lack of Efficacy|0|||
143066454|NCT01550744|515783820|FG000|Open-Label|Protocol Violation|4|||
143066455|NCT01550744|515783821|FG001|Open-Label|Protocol Violation|0|||
143066456|NCT01550744|515783822|FG002|Open-Label|Protocol Violation|0|||
143066457|NCT01550744|515783820|FG000|Open-Label|Not all 3 study drug injections received|2|||
143066458|NCT01550744|515783821|FG001|Open-Label|Not all 3 study drug injections received|0|||
143066459|NCT01550744|515783822|FG002|Open-Label|Not all 3 study drug injections received|0|||
143066460|NCT01550744|515783820|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
143066461|NCT01550744|515783821|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
143066462|NCT01550744|515783822|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
143066463|NCT01550744|515783820|FG000|Open-Label|Other|1|||
143066464|NCT01550744|515783821|FG001|Open-Label|Other|0|||
143066465|NCT01550744|515783822|FG002|Open-Label|Other|0|||
143066466|NCT01550744|515783820|FG000|Double-Blind|Lost to Follow-up|0|||
143066467|NCT01550744|515783821|FG001|Double-Blind|Lost to Follow-up|6|||
143066468|NCT01550744|515783822|FG002|Double-Blind|Lost to Follow-up|12|||
143066469|NCT01550744|515783820|FG000|Double-Blind|Withdrawal by Subject|0|||
143066470|NCT01550744|515783821|FG001|Double-Blind|Withdrawal by Subject|2|||
143066471|NCT01550744|515783822|FG002|Double-Blind|Withdrawal by Subject|15|||
143066472|NCT01550744|515783820|FG000|Double-Blind|Adverse Event|0|||
143066473|NCT01550744|515783821|FG001|Double-Blind|Adverse Event|4|||
143066474|NCT01550744|515783822|FG002|Double-Blind|Adverse Event|15|||
143066475|NCT01550744|515783820|FG000|Double-Blind|Death|0|||
143066476|NCT01550744|515783821|FG001|Double-Blind|Death|1|||
143066477|NCT01550744|515783822|FG002|Double-Blind|Death|0|||
143066478|NCT01550744|515783820|FG000|Double-Blind|Lack of Efficacy|0|||
143170371|NCT04251533|516171964|FG002|Overall Study|Physician Decision|4|||
143066479|NCT01550744|515783821|FG001|Double-Blind|Lack of Efficacy|2|||
143066480|NCT01550744|515783822|FG002|Double-Blind|Lack of Efficacy|8|||
143066481|NCT01550744|515783820|FG000|Double-Blind|Protocol Violation|0|||
143066482|NCT01550744|515783821|FG001|Double-Blind|Protocol Violation|0|||
143066483|NCT01550744|515783822|FG002|Double-Blind|Protocol Violation|4|||
143170372|NCT04251533|516171962|FG000|Overall Study|Participant decision|1|||
143066484|NCT01550744|515783820|FG000|Double-Blind|Pregnancy|0|||
143066485|NCT01550744|515783821|FG001|Double-Blind|Pregnancy|0|||
143066486|NCT01550744|515783822|FG002|Double-Blind|Pregnancy|3|||
143066487|NCT01550744|515783820|FG000|Double-Blind|Other|0|||
143066488|NCT01550744|515783821|FG001|Double-Blind|Other|2|||
143066489|NCT01550744|515783822|FG002|Double-Blind|Other|10|||
143066490|NCT00706381|515783825|FG000|Overall Study|Lost to Follow-up|0|||
143066491|NCT00706381|515783826|FG001|Overall Study|Lost to Follow-up|1|||
143066492|NCT00706381|515783827|FG002|Overall Study|Lost to Follow-up|1|||
143066493|NCT00706381|515783828|FG003|Overall Study|Lost to Follow-up|0|||
143066494|NCT00038649|515783834|FG000|Overall Study|Adverse Event|9|||
143066495|NCT01640873|515783840|FG000|Overall Study|Protocol Violation|2|||
143066496|NCT01640873|515783841|FG001|Overall Study|Protocol Violation|1|||
143066497|NCT01875471|515783842|FG000|Overall Study|Adverse Event|0|||
143066498|NCT01875471|515783843|FG001|Overall Study|Adverse Event|1|||
143066499|NCT01875471|515783842|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
143066500|NCT01875471|515783843|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
143066501|NCT02687360|515783844|FG000|Overall Study|Withdrawal by Subject|3|||
143066502|NCT02687360|515783845|FG001|Overall Study|Withdrawal by Subject|0|||
143066503|NCT00731549|515783851|FG000|Overall Study|Lost to Follow-up|19|||
143066504|NCT00731549|515783851|FG000|Overall Study|Met withdrawal criteria|24|||
143066505|NCT00731549|515783851|FG000|Overall Study|Physician Decision|16|||
143066506|NCT00731549|515783851|FG000|Overall Study|Withdrawal by Subject|89|||
143066507|NCT00731549|515783851|FG000|Overall Study|Protocol deviation|1|||
143066508|NCT00731549|515783851|FG000|Overall Study|Adverse Event|31|||
143066509|NCT00731549|515783851|FG000|Overall Study|Lack of efficacy with AE|37|||
143066510|NCT00731549|515783851|FG000|Overall Study|Lack of efficacy without AE|6|||
143066511|NCT02013375|515783857|FG000|Overall Study|Did not engraft|1|||
143066512|NCT02013375|515783857|FG000|Overall Study|Did not engraft|1|||
143066513|NCT00712985|515783858|FG000|Overall Study|1 withdrew prior to start of drug|1|||
143066514|NCT00712985|515783858|FG000|Overall Study|1 patient moved out of state|1|||
143066515|NCT00712985|515783858|FG000|Overall Study|Lack of Efficacy|3|||
143066516|NCT01663727|515783859|FG000|Overall Study|Death|161|||
143066517|NCT01663727|515783860|FG001|Overall Study|Death|155|||
143066518|NCT01663727|515783859|FG000|Overall Study|Lost to Follow-up|10|||
143066519|NCT01663727|515783860|FG001|Overall Study|Lost to Follow-up|8|||
143066520|NCT01663727|515783859|FG000|Overall Study|Withdrawal by Subject|18|||
143066521|NCT01663727|515783860|FG001|Overall Study|Withdrawal by Subject|25|||
143066522|NCT01663727|515783859|FG000|Overall Study|Study Terminated|51|||
143066523|NCT01663727|515783860|FG001|Overall Study|Study Terminated|50|||
143066524|NCT01663727|515783859|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
143066525|NCT01663727|515783860|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
143066526|NCT01663727|515783859|FG000|Overall Study|Withdrawal prior to dosing.|1|||
143066527|NCT01663727|515783860|FG001|Overall Study|Withdrawal prior to dosing.|0|||
143066528|NCT01902628|515783861|FG000|Overall Study|Withdrawal of participant's consent|7|||
143066529|NCT01902628|515783861|FG000|Overall Study|Adverse Event|41|||
143066530|NCT01902628|515783861|FG000|Overall Study|Lost to Follow-up|35|||
143066531|NCT02932228|515783864|FG000|Overall Study|Death|8|||
143066532|NCT02932228|515783865|FG001|Overall Study|Death|23|||
143066533|NCT02932228|515783864|FG000|Overall Study|not eligible upon chart review|2|||
143066534|NCT02932228|515783865|FG001|Overall Study|not eligible upon chart review|5|||
143066535|NCT06204887|515785204|FG000|Overall Study|Lost to Follow-up|3|||
143066536|NCT06204887|515785205|FG001|Overall Study|Lost to Follow-up|4|||
143066537|NCT06204887|515785206|FG002|Overall Study|Lost to Follow-up|1|||
143066538|NCT06204887|515785207|FG003|Overall Study|Lost to Follow-up|6|||
143066539|NCT02522403|515785208|FG000|Overall Study|Lost to Follow-up|2|||
143066540|NCT02522403|515785209|FG001|Overall Study|Lost to Follow-up|2|||
143066541|NCT02522403|515785208|FG000|Overall Study|Withdrawal by Subject|2|||
143066542|NCT02522403|515785209|FG001|Overall Study|Withdrawal by Subject|4|||
143066543|NCT01215513|515785212|FG000|Overall Study|Not completed CS42|9|||
143066544|NCT01215513|515785212|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
143066545|NCT01215513|515785212|FG000|Overall Study|Adverse event (CS42A)|2|||
143066546|NCT01215513|515785212|FG000|Overall Study|Physician decision (CS42A)|6|||
143066547|NCT01215513|515785212|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
143066548|NCT01215513|515785212|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
143170373|NCT04251533|516171963|FG001|Overall Study|Participant decision|3|||
143066549|NCT03955471|515785213|FG000|Overall Study|Death|22|||
143066550|NCT03955471|515785213|FG000|Overall Study|Lost to Follow-up|1|||
143066551|NCT03955471|515785213|FG000|Overall Study|Withdrawal by Subject|6|||
143066552|NCT03955471|515785213|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
143066553|NCT01030341|515785214|FG000|Overall Study|Withdrawal by Subject|1|||
143066554|NCT01030341|515785214|FG000|Overall Study|Lost to Follow-up|2|||
143066555|NCT01884311|515785215|FG000|Overall Study|Withdrawal by Subject|3|||
143066556|NCT01884311|515785215|FG000|Overall Study|withdrew consent due to AEs|1|||
143066557|NCT01884311|515785215|FG000|Overall Study|Precautionary measure|1|||
143066558|NCT02307266|515785216|FG000|Overall Study|Adverse Event|3|||
143170374|NCT04251533|516171964|FG002|Overall Study|Participant decision|1|||
143170375|NCT04251533|516171962|FG000|Overall Study|Adverse Event|2|||
143066559|NCT02307266|515785217|FG001|Overall Study|Adverse Event|1|||
143503062|NCT00408005|517380965|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
143503063|NCT00408005|517380958|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
143066560|NCT02307266|515785218|FG002|Overall Study|Adverse Event|5|||
143066561|NCT02307266|515785216|FG000|Overall Study|Withdrawal by Subject|2|||
143066562|NCT02307266|515785217|FG001|Overall Study|Withdrawal by Subject|0|||
143066563|NCT02307266|515785218|FG002|Overall Study|Withdrawal by Subject|1|||
143066564|NCT02307266|515785216|FG000|Overall Study|Lost to Follow-up|3|||
143066565|NCT02307266|515785217|FG001|Overall Study|Lost to Follow-up|0|||
143066566|NCT02307266|515785218|FG002|Overall Study|Lost to Follow-up|0|||
143066567|NCT00573157|515785221|FG000|Overall Study|Adverse Event|3|||
143066568|NCT00573157|515785222|FG001|Overall Study|Adverse Event|1|||
143066569|NCT00573157|515785221|FG000|Overall Study|Other|1|||
143066570|NCT00573157|515785222|FG001|Overall Study|Other|1|||
143066571|NCT01032018|515785225|FG000|Overall Study|Lost to Follow-up|6|||
143066572|NCT01032018|515785226|FG001|Overall Study|Lost to Follow-up|5|||
143066573|NCT01032018|515785225|FG000|Overall Study|Death|0|||
143066574|NCT01032018|515785226|FG001|Overall Study|Death|1|||
143066575|NCT01995266|515785232|FG000|Overall Study|Death|1|||
143066576|NCT01995266|515785232|FG000|Overall Study|Lack of Efficacy|6|||
143066577|NCT01995266|515785232|FG000|Overall Study|Adverse Event|2|||
143066578|NCT00619112|515785233|FG000|Overall Study|Adverse Event|1|||
143066579|NCT00619112|515785234|FG001|Overall Study|Adverse Event|2|||
143066580|NCT02040779|515785239|FG000|Overall Study|Adverse Event|1|||
143066581|NCT02040779|515785240|FG001|Overall Study|Adverse Event|0|||
143066582|NCT02040779|515785241|FG002|Overall Study|Adverse Event|0|||
143066583|NCT02040779|515785239|FG000|Overall Study|Withdrawal by Subject|4|||
143066584|NCT02040779|515785240|FG001|Overall Study|Withdrawal by Subject|1|||
143066585|NCT02040779|515785241|FG002|Overall Study|Withdrawal by Subject|3|||
143066586|NCT02040779|515785239|FG000|Overall Study|Non-compliance|0|||
143066587|NCT02040779|515785240|FG001|Overall Study|Non-compliance|1|||
143066588|NCT02040779|515785241|FG002|Overall Study|Non-compliance|0|||
143066589|NCT02040779|515785239|FG000|Overall Study|Protocol Violation|2|||
143066590|NCT02040779|515785240|FG001|Overall Study|Protocol Violation|1|||
143066591|NCT02040779|515785241|FG002|Overall Study|Protocol Violation|0|||
143066592|NCT02040779|515785239|FG000|Overall Study|Lost to Follow-up|1|||
143066593|NCT02040779|515785240|FG001|Overall Study|Lost to Follow-up|2|||
143066594|NCT02040779|515785241|FG002|Overall Study|Lost to Follow-up|1|||
143066595|NCT02040779|515785239|FG000|Overall Study|Lack of Efficacy|4|||
143066596|NCT02040779|515785240|FG001|Overall Study|Lack of Efficacy|2|||
143066597|NCT02040779|515785241|FG002|Overall Study|Lack of Efficacy|0|||
143066598|NCT00922272|515785242|FG000|Open-label Phase|Adverse Event|5|||
143066599|NCT00922272|515785243|FG001|Open-label Phase|Adverse Event|0|||
143066600|NCT00922272|515785242|FG000|Open-label Phase|Protocol Violation|1|||
143066601|NCT00922272|515785243|FG001|Open-label Phase|Protocol Violation|0|||
143066602|NCT00922272|515785242|FG000|Open-label Phase|Withdrawal by Subject|11|||
143066603|NCT00922272|515785243|FG001|Open-label Phase|Withdrawal by Subject|0|||
143066604|NCT00922272|515785242|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
143066605|NCT00922272|515785243|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
143066606|NCT00922272|515785242|FG000|Open-label Phase|Withdrawal criteria met|5|||
143066607|NCT00922272|515785243|FG001|Open-label Phase|Withdrawal criteria met|0|||
143066608|NCT00922272|515785242|FG000|Double-blind Phase|Adverse Event|1|||
143066609|NCT00922272|515785243|FG001|Double-blind Phase|Adverse Event|1|||
143066610|NCT00922272|515785242|FG000|Double-blind Phase|Withdrawal by Subject|1|||
143066611|NCT00922272|515785243|FG001|Double-blind Phase|Withdrawal by Subject|1|||
143066612|NCT00922272|515785242|FG000|Double-blind Phase|Lost to Follow-up|2|||
143066613|NCT00922272|515785243|FG001|Double-blind Phase|Lost to Follow-up|1|||
143066614|NCT00922272|515785242|FG000|Double-blind Phase|Withdrawal criteria met|1|||
143066615|NCT00922272|515785243|FG001|Double-blind Phase|Withdrawal criteria met|1|||
143066616|NCT00922272|515785242|FG000|Double-blind Phase|Noncompliance|1|||
143066617|NCT00922272|515785243|FG001|Double-blind Phase|Noncompliance|1|||
143066618|NCT00922272|515785242|FG000|Double-blind Phase|Positive urine drug screen|1|||
143066619|NCT00922272|515785243|FG001|Double-blind Phase|Positive urine drug screen|1|||
143066620|NCT02588950|515785244|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
143503064|NCT00408005|517380959|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
143066621|NCT02588950|515785245|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
143066622|NCT02588950|515785246|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
143066623|NCT02588950|515785247|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
143066624|NCT02588950|515785244|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
143066625|NCT02588950|515785245|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
143066626|NCT02588950|515785246|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
143066627|NCT02588950|515785247|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
143066628|NCT01248013|515785250|FG000|Overall Study|Withdrawal by Subject|14|||
143066629|NCT01388166|515785253|FG000|Overall Study|Adverse Event|16|||
143066630|NCT01388166|515785253|FG000|Overall Study|Lost to Follow-up|30|||
143066631|NCT01388166|515785253|FG000|Overall Study|Others than specified above|13|||
143066632|NCT02528123|515785257|FG000|Overall Study|Lost to Follow-up|1|||
143066633|NCT02963441|515785260|FG000|Overall Study|Protocol violation or withdrawn|8|||
143066634|NCT02963441|515785260|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
143066635|NCT02963441|515785260|FG000|Overall Study|IDx-DR insufficient quality|33|||
143066636|NCT04688931|515785261|FG000|Overall Study|Adverse Event|4|||
143066637|NCT04688931|515785262|FG001|Overall Study|Adverse Event|1|||
143066638|NCT04688931|515785261|FG000|Overall Study|Withdrawal by Subject|5|||
143066639|NCT04688931|515785262|FG001|Overall Study|Withdrawal by Subject|16|||
143066640|NCT04688931|515785261|FG000|Overall Study|Physician Decision|3|||
143066641|NCT04688931|515785262|FG001|Overall Study|Physician Decision|5|||
143066642|NCT04688931|515785261|FG000|Overall Study|Noncompliance|0|||
143066643|NCT04688931|515785262|FG001|Overall Study|Noncompliance|1|||
143066644|NCT04688931|515785261|FG000|Overall Study|Lost to Follow-up|1|||
143066645|NCT04688931|515785262|FG001|Overall Study|Lost to Follow-up|3|||
143066646|NCT04688931|515785261|FG000|Overall Study|Randomization Error|3|||
143066647|NCT04688931|515785262|FG001|Overall Study|Randomization Error|0|||
143066648|NCT04688931|515785261|FG000|Overall Study|Not Eligible|1|||
143066649|NCT04688931|515785262|FG001|Overall Study|Not Eligible|3|||
143066650|NCT04688931|515785261|FG000|Overall Study|Disease Progression|0|||
143066651|NCT04688931|515785262|FG001|Overall Study|Disease Progression|2|||
143066652|NCT04688931|515785261|FG000|Overall Study|Sponsor Requirement|1|||
143066653|NCT04688931|515785262|FG001|Overall Study|Sponsor Requirement|1|||
143066654|NCT04688931|515785261|FG000|Overall Study|Other Reason|1|||
143066655|NCT04688931|515785262|FG001|Overall Study|Other Reason|2|||
143066656|NCT00361335|515785263|FG000|IV Period: Baseline to E0|Adverse Event|9|||
143066657|NCT00361335|515785264|FG001|IV Period: Baseline to E0|Adverse Event|4|||
143066658|NCT00361335|515785265|FG002|IV Period: Baseline to E0|Adverse Event|5|||
143066659|NCT00361335|515785266|FG003|IV Period: Baseline to E0|Adverse Event|9|||
143066660|NCT00361335|515785267|FG004|IV Period: Baseline to E0|Adverse Event|8|||
143066661|NCT00361335|515785268|FG005|IV Period: Baseline to E0|Adverse Event|0|||
143066662|NCT00361335|515785269|FG006|IV Period: Baseline to E0|Adverse Event|0|||
143066663|NCT00361335|515785263|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
143066664|NCT00361335|515785264|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
143066665|NCT00361335|515785265|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
143066666|NCT00361335|515785266|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
143066667|NCT00361335|515785267|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
143066668|NCT00361335|515785268|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
143066669|NCT00361335|515785269|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
143066670|NCT00361335|515785263|FG000|IV Period: Baseline to E0|Death|1|||
143066671|NCT00361335|515785264|FG001|IV Period: Baseline to E0|Death|1|||
143066672|NCT00361335|515785265|FG002|IV Period: Baseline to E0|Death|1|||
143066673|NCT00361335|515785266|FG003|IV Period: Baseline to E0|Death|1|||
143066674|NCT00361335|515785267|FG004|IV Period: Baseline to E0|Death|0|||
143066675|NCT00361335|515785268|FG005|IV Period: Baseline to E0|Death|0|||
143066676|NCT00361335|515785269|FG006|IV Period: Baseline to E0|Death|0|||
143066677|NCT00361335|515785263|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
143066678|NCT00361335|515785264|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
143066679|NCT00361335|515785265|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
143066680|NCT00361335|515785266|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
143066681|NCT00361335|515785267|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
143066682|NCT00361335|515785268|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
143066683|NCT00361335|515785269|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
143066684|NCT00361335|515785263|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
143066685|NCT00361335|515785264|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
143066686|NCT00361335|515785265|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
143066687|NCT00361335|515785266|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
143066688|NCT00361335|515785267|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
143066689|NCT00361335|515785268|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
143066690|NCT00361335|515785269|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
143066691|NCT00361335|515785263|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
143066692|NCT00361335|515785264|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
143066693|NCT00361335|515785265|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
143365171|NCT01456780|516880655|FG002|Overall Study|Lost to Follow-up|0|||
143365172|NCT05349864|516880666|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
143365173|NCT05349864|516880667|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
143066694|NCT00361335|515785266|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
143066695|NCT00361335|515785267|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
143066696|NCT00361335|515785268|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
143066697|NCT00361335|515785269|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
143066698|NCT00361335|515785263|FG000|IV Period: Baseline to E0|Other|2|||
143066699|NCT00361335|515785264|FG001|IV Period: Baseline to E0|Other|9|||
143066700|NCT00361335|515785265|FG002|IV Period: Baseline to E0|Other|9|||
143066701|NCT00361335|515785266|FG003|IV Period: Baseline to E0|Other|3|||
143066702|NCT00361335|515785267|FG004|IV Period: Baseline to E0|Other|2|||
143066703|NCT00361335|515785268|FG005|IV Period: Baseline to E0|Other|0|||
143066704|NCT00361335|515785269|FG006|IV Period: Baseline to E0|Other|0|||
143066705|NCT00361335|515785263|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
143066706|NCT00361335|515785264|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
143066707|NCT00361335|515785265|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
143066708|NCT00361335|515785266|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
143066709|NCT00361335|515785267|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
143066710|NCT00361335|515785268|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
143066711|NCT00361335|515785269|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
143066712|NCT00361335|515785263|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
143066713|NCT00361335|515785264|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
143066714|NCT00361335|515785265|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
143066715|NCT00361335|515785266|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
143066716|NCT00361335|515785267|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
143066717|NCT00361335|515785268|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
143066718|NCT00361335|515785269|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
143066719|NCT00361335|515785263|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
143066720|NCT00361335|515785264|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
143066721|NCT00361335|515785265|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
143066722|NCT00361335|515785266|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
143066723|NCT00361335|515785267|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
143066724|NCT00361335|515785268|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
143066725|NCT00361335|515785269|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
143066726|NCT00361335|515785263|FG000|SC Period: Week E0 to Week E24|Death|0|||
143066727|NCT00361335|515785264|FG001|SC Period: Week E0 to Week E24|Death|0|||
143066728|NCT00361335|515785265|FG002|SC Period: Week E0 to Week E24|Death|0|||
143066729|NCT00361335|515785266|FG003|SC Period: Week E0 to Week E24|Death|0|||
143066730|NCT00361335|515785267|FG004|SC Period: Week E0 to Week E24|Death|0|||
143066731|NCT00361335|515785268|FG005|SC Period: Week E0 to Week E24|Death|0|||
143066732|NCT00361335|515785269|FG006|SC Period: Week E0 to Week E24|Death|1|||
143066733|NCT00361335|515785263|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
143066734|NCT00361335|515785264|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
143066735|NCT00361335|515785265|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
143066736|NCT00361335|515785266|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
143066737|NCT00361335|515785267|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
143066738|NCT00361335|515785268|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
143066739|NCT00361335|515785269|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
143066740|NCT00361335|515785263|FG000|SC Period: Week E0 to Week E24|Other|1|||
143066741|NCT00361335|515785264|FG001|SC Period: Week E0 to Week E24|Other|0|||
143066742|NCT00361335|515785265|FG002|SC Period: Week E0 to Week E24|Other|0|||
143066743|NCT00361335|515785266|FG003|SC Period: Week E0 to Week E24|Other|1|||
143066744|NCT00361335|515785267|FG004|SC Period: Week E0 to Week E24|Other|0|||
143066745|NCT00361335|515785268|FG005|SC Period: Week E0 to Week E24|Other|1|||
143066746|NCT00361335|515785269|FG006|SC Period: Week E0 to Week E24|Other|2|||
143066747|NCT00361335|515785263|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
143066748|NCT00361335|515785264|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
143066749|NCT00361335|515785265|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
143066750|NCT00361335|515785266|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
143066751|NCT00361335|515785267|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
143066752|NCT00361335|515785268|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
143066753|NCT00361335|515785269|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
143066754|NCT04505293|515785270|FG000|Overall Study|Lost to Follow-up|2|||
143066755|NCT04505293|515785270|FG000|Overall Study|Withdrawal by Subject|6|||
143066756|NCT04505293|515785270|FG000|Overall Study|CT scan unreadable|277|||
143066757|NCT01968694|515785271|FG000|Washout (1 Month)|Lost to Follow-up|0|||
143066758|NCT01968694|515785272|FG001|Washout (1 Month)|Lost to Follow-up|1|||
143066759|NCT01400919|515785276|FG000|Overall Study|Withdrawal by Subject|4|||
143066760|NCT01400919|515785276|FG000|Overall Study|Lost to Follow-up|2|||
143066761|NCT01400919|515785276|FG000|Overall Study|Missed visit|2|||
143066762|NCT00251719|515785277|FG000|Overall Study|Adverse Event|14|||
143066763|NCT00251719|515785278|FG001|Overall Study|Adverse Event|8|||
143066764|NCT00251719|515785279|FG002|Overall Study|Adverse Event|7|||
143066765|NCT00251719|515785277|FG000|Overall Study|Protocol Violation|1|||
143066766|NCT00251719|515785278|FG001|Overall Study|Protocol Violation|1|||
143066767|NCT00251719|515785279|FG002|Overall Study|Protocol Violation|1|||
143066768|NCT00251719|515785277|FG000|Overall Study|Lost to Follow-up|5|||
143066769|NCT00251719|515785278|FG001|Overall Study|Lost to Follow-up|11|||
143066770|NCT00251719|515785279|FG002|Overall Study|Lost to Follow-up|8|||
143066771|NCT00251719|515785277|FG000|Overall Study|Withdrawal by Subject|14|||
143066772|NCT00251719|515785278|FG001|Overall Study|Withdrawal by Subject|12|||
143066773|NCT00251719|515785279|FG002|Overall Study|Withdrawal by Subject|11|||
143066774|NCT00251719|515785277|FG000|Overall Study|Lack of Efficacy|2|||
143066775|NCT00251719|515785278|FG001|Overall Study|Lack of Efficacy|1|||
143066776|NCT00251719|515785279|FG002|Overall Study|Lack of Efficacy|0|||
143246132|NCT00139477|516453417|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
143246133|NCT00139477|516453416|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
143246134|NCT00139477|516453417|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
143246135|NCT00139477|516453416|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
143246136|NCT00139477|516453417|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
143246137|NCT00139477|516453416|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
143246138|NCT00139477|516453417|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
143246139|NCT00139477|516453416|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
143246140|NCT00139477|516453417|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
143246141|NCT00139477|516453416|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
143246142|NCT00139477|516453417|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
143246143|NCT00975780|516453418|FG000|Follow Up|Death|88|||
143246144|NCT00975780|516453419|FG001|Follow Up|Death|122|||
143246145|NCT00975780|516453418|FG000|Follow Up|Facility Withdrawal|7|||
143503065|NCT00408005|517380960|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
143503066|NCT00408005|517380961|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
143503067|NCT00408005|517380962|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
143066777|NCT00251719|515785277|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
143066778|NCT00251719|515785278|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
143066779|NCT00251719|515785279|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
143066780|NCT00251719|515785277|FG000|Overall Study|Investigator decision|1|||
143066781|NCT00251719|515785278|FG001|Overall Study|Investigator decision|1|||
143066782|NCT00251719|515785279|FG002|Overall Study|Investigator decision|0|||
143066783|NCT00251719|515785277|FG000|Overall Study|Noncompliance|2|||
143066784|NCT00251719|515785278|FG001|Overall Study|Noncompliance|3|||
143066785|NCT00251719|515785279|FG002|Overall Study|Noncompliance|1|||
143066786|NCT00251719|515785277|FG000|Overall Study|Barrett's esophagus|2|||
143066787|NCT00251719|515785278|FG001|Overall Study|Barrett's esophagus|2|||
143066788|NCT00251719|515785279|FG002|Overall Study|Barrett's esophagus|0|||
143066789|NCT02923674|515785282|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
143066790|NCT02923674|515785283|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
143066791|NCT02923674|515785284|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
143066792|NCT02923674|515785282|FG000|Overall Study|Lost to Follow-up|7|||
143066793|NCT02923674|515785283|FG001|Overall Study|Lost to Follow-up|12|||
143066794|NCT02923674|515785284|FG002|Overall Study|Lost to Follow-up|7|||
143066795|NCT02923674|515785282|FG000|Overall Study|Problem with intervention|2|||
143066796|NCT02923674|515785283|FG001|Overall Study|Problem with intervention|2|||
143066797|NCT02923674|515785284|FG002|Overall Study|Problem with intervention|1|||
143066798|NCT02923674|515785282|FG000|Overall Study|Adverse Event|3|||
143066799|NCT02923674|515785283|FG001|Overall Study|Adverse Event|1|||
143066800|NCT02923674|515785284|FG002|Overall Study|Adverse Event|1|||
143066801|NCT02923674|515785282|FG000|Overall Study|Withdrawal by Subject|2|||
143066802|NCT02923674|515785283|FG001|Overall Study|Withdrawal by Subject|2|||
143066803|NCT02923674|515785284|FG002|Overall Study|Withdrawal by Subject|2|||
143066804|NCT00688376|515785287|FG000|Double-Blind Phase|Adverse Event|4|||
143066805|NCT00688376|515785288|FG001|Double-Blind Phase|Adverse Event|4|||
143066806|NCT00688376|515785287|FG000|Double-Blind Phase|Protocol Violation|1|||
143066807|NCT00688376|515785288|FG001|Double-Blind Phase|Protocol Violation|2|||
143066808|NCT00688376|515785287|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
143066809|NCT00688376|515785288|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
143066810|NCT00688376|515785287|FG000|Double-Blind Phase|Not treated|0|||
143066811|NCT00688376|515785288|FG001|Double-Blind Phase|Not treated|1|||
143066812|NCT00688376|515785287|FG000|Blinded Extension Phase|Adverse Event|3|||
143066813|NCT00688376|515785288|FG001|Blinded Extension Phase|Adverse Event|4|||
143066814|NCT00688376|515785287|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
143066815|NCT00688376|515785288|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
143066816|NCT00688376|515785287|FG000|Blinded Extension Phase|Physician Decision|1|||
143066817|NCT00688376|515785288|FG001|Blinded Extension Phase|Physician Decision|0|||
143066818|NCT00688376|515785287|FG000|Blinded Extension Phase|Other|1|||
143066819|NCT00688376|515785288|FG001|Blinded Extension Phase|Other|0|||
143066820|NCT00846521|515785289|FG000|Overall Study|Withdrawal by Subject|5|||
143066821|NCT00846521|515785289|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
143066822|NCT00846521|515785289|FG000|Overall Study|Protocol Violation|1|||
143066823|NCT02408068|515785290|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
143066824|NCT02408068|515785291|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
143066825|NCT02408068|515785292|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
143246146|NCT00975780|516453419|FG001|Follow Up|Facility Withdrawal|23|||
143246147|NCT00975780|516453418|FG000|Follow Up|Discharged from Facility|7|||
143246148|NCT00975780|516453419|FG001|Follow Up|Discharged from Facility|12|||
143246149|NCT01976741|516453424|FG000|Overall Study|Withdrawal by Subject|1|||
143246150|NCT01976741|516453425|FG001|Overall Study|Withdrawal by Subject|0|||
143246151|NCT01976741|516453426|FG002|Overall Study|Withdrawal by Subject|1|||
143246152|NCT01976741|516453427|FG003|Overall Study|Withdrawal by Subject|1|||
143066826|NCT02408068|515785293|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
143066827|NCT02408068|515785294|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
143066828|NCT02408068|515785295|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
143066829|NCT00003875|515785296|FG000|Overall Study|Screen Failed|1|||
143066830|NCT00886288|515785297|FG000|Overall Study|no respect of the 12 weeks period|657|||
143066831|NCT00886288|515785298|FG001|Overall Study|no respect of the 12 weeks period|227|||
143066832|NCT00886288|515785297|FG000|Overall Study|Lost to Follow-up|86|||
143066833|NCT00886288|515785298|FG001|Overall Study|Lost to Follow-up|0|||
143066834|NCT01321008|515785304|FG000|Overall Study|Early Study Termination|1|||
143066835|NCT03978091|515785305|FG000|Overall Study|Lost to Follow-up|0|||
143066836|NCT03978091|515785306|FG001|Overall Study|Lost to Follow-up|0|||
143066837|NCT03978091|515785307|FG002|Overall Study|Lost to Follow-up|1|||
143066838|NCT03978091|515785308|FG003|Overall Study|Lost to Follow-up|0|||
143066839|NCT03978091|515785309|FG004|Overall Study|Lost to Follow-up|0|||
143066840|NCT03978091|515785310|FG005|Overall Study|Lost to Follow-up|0|||
143066841|NCT03978091|515785305|FG000|Overall Study|Withdrawal by Subject|0|||
143066842|NCT03978091|515785306|FG001|Overall Study|Withdrawal by Subject|0|||
143066843|NCT03978091|515785307|FG002|Overall Study|Withdrawal by Subject|0|||
143066844|NCT03978091|515785308|FG003|Overall Study|Withdrawal by Subject|1|||
143066845|NCT03978091|515785309|FG004|Overall Study|Withdrawal by Subject|1|||
143066846|NCT03978091|515785310|FG005|Overall Study|Withdrawal by Subject|0|||
143066847|NCT02595008|515785311|FG000|Overall Study|Enrolled In Error|1|||
143066848|NCT02595008|515785312|FG001|Overall Study|Enrolled In Error|0|||
143066849|NCT03407118|515785313|FG000|Period 2|Withdrawal by Subject|1|||
143066850|NCT03407118|515785314|FG001|Period 2|Withdrawal by Subject|0|||
143066851|NCT04700280|515785317|FG000|Overall Study|Adverse Event|4|||
143066852|NCT04700280|515785318|FG001|Overall Study|Adverse Event|0|||
143066853|NCT04700280|515785317|FG000|Overall Study|Lack of Efficacy|1|||
143066854|NCT04700280|515785318|FG001|Overall Study|Lack of Efficacy|0|||
143066855|NCT04700280|515785317|FG000|Overall Study|Study terminated by sponsor|5|||
143066856|NCT04700280|515785318|FG001|Overall Study|Study terminated by sponsor|3|||
143066857|NCT04700280|515785317|FG000|Overall Study|Other than specified|1|||
143066858|NCT04700280|515785318|FG001|Overall Study|Other than specified|0|||
143066859|NCT01843348|515785319|FG000|Overall Study|Withdrawal by Subject|4|||
143066860|NCT01843348|515785320|FG001|Overall Study|Withdrawal by Subject|16|||
143066861|NCT01843348|515785321|FG002|Overall Study|Withdrawal by Subject|18|||
143066862|NCT01843348|515785319|FG000|Overall Study|Lost to Follow-up|5|||
143066863|NCT01843348|515785320|FG001|Overall Study|Lost to Follow-up|4|||
143066864|NCT01843348|515785321|FG002|Overall Study|Lost to Follow-up|2|||
143066865|NCT01843348|515785319|FG000|Overall Study|Death|5|||
143066866|NCT01843348|515785320|FG001|Overall Study|Death|3|||
143066867|NCT01843348|515785321|FG002|Overall Study|Death|4|||
143066868|NCT01843348|515785319|FG000|Overall Study|Graft loss/retransplantation|5|||
143066869|NCT01843348|515785320|FG001|Overall Study|Graft loss/retransplantation|8|||
143066870|NCT01843348|515785321|FG002|Overall Study|Graft loss/retransplantation|11|||
143066871|NCT01843348|515785319|FG000|Overall Study|Various reasons|4|||
143066872|NCT01843348|515785320|FG001|Overall Study|Various reasons|9|||
143066873|NCT01843348|515785321|FG002|Overall Study|Various reasons|6|||
143066874|NCT02093221|515785324|FG000|Overall Study|Adverse Event|1|||
143066875|NCT02093221|515785325|FG001|Overall Study|Adverse Event|0|||
143066876|NCT02093221|515785326|FG002|Overall Study|Adverse Event|0|||
143066877|NCT02093221|515785327|FG003|Overall Study|Adverse Event|0|||
143066878|NCT02093221|515785328|FG004|Overall Study|Adverse Event|0|||
143066879|NCT02093221|515785324|FG000|Overall Study|Withdrawal by Subject|1|||
143066880|NCT02093221|515785325|FG001|Overall Study|Withdrawal by Subject|1|||
143066881|NCT02093221|515785326|FG002|Overall Study|Withdrawal by Subject|4|||
143066882|NCT02093221|515785327|FG003|Overall Study|Withdrawal by Subject|1|||
143066883|NCT02093221|515785328|FG004|Overall Study|Withdrawal by Subject|1|||
143066884|NCT02093221|515785324|FG000|Overall Study|Lost to Follow-up|2|||
143066885|NCT02093221|515785325|FG001|Overall Study|Lost to Follow-up|0|||
143066886|NCT02093221|515785326|FG002|Overall Study|Lost to Follow-up|1|||
143066887|NCT02093221|515785327|FG003|Overall Study|Lost to Follow-up|1|||
143170376|NCT04251533|516171963|FG001|Overall Study|Adverse Event|1|||
143170377|NCT04251533|516171964|FG002|Overall Study|Adverse Event|1|||
143170378|NCT01889251|516171967|FG000|Overall Study|Adverse Event|1|||
143170379|NCT01889251|516171968|FG001|Overall Study|Adverse Event|0|||
143170380|NCT01344226|516171971|FG000|Overall Study|Protocol Violation|2|||
143170381|NCT01344226|516171971|FG000|Overall Study|Withdrawal by Subject|3|||
143170382|NCT01344226|516171971|FG000|Overall Study|Lack of Efficacy|3|||
143066888|NCT02093221|515785328|FG004|Overall Study|Lost to Follow-up|0|||
143066889|NCT02093221|515785324|FG000|Overall Study|Death|0|||
143066890|NCT02093221|515785325|FG001|Overall Study|Death|1|||
143066891|NCT02093221|515785326|FG002|Overall Study|Death|0|||
143170383|NCT04846868|516171974|FG000|Overall Study|Adverse Event|12|||
143066892|NCT02093221|515785327|FG003|Overall Study|Death|0|||
143066893|NCT02093221|515785328|FG004|Overall Study|Death|0|||
143066894|NCT02093221|515785324|FG000|Overall Study|Protocol Violation|0|||
143066895|NCT02093221|515785325|FG001|Overall Study|Protocol Violation|1|||
143066896|NCT02093221|515785326|FG002|Overall Study|Protocol Violation|0|||
143066897|NCT02093221|515785327|FG003|Overall Study|Protocol Violation|0|||
143066898|NCT02093221|515785328|FG004|Overall Study|Protocol Violation|0|||
143066899|NCT02093221|515785324|FG000|Overall Study|Study termination|6|||
143066900|NCT02093221|515785325|FG001|Overall Study|Study termination|5|||
143066901|NCT02093221|515785326|FG002|Overall Study|Study termination|4|||
143066902|NCT02093221|515785327|FG003|Overall Study|Study termination|6|||
143066903|NCT02093221|515785328|FG004|Overall Study|Study termination|7|||
143066904|NCT00679913|515785329|FG000|Overall Study|Protocol Violation|18|||
143066905|NCT00679913|515785330|FG001|Overall Study|Protocol Violation|13|||
143066906|NCT01000493|515785331|FG000|Overall Study|Adverse Event|3|||
143066907|NCT01000493|515785332|FG001|Overall Study|Adverse Event|6|||
143066908|NCT01000493|515785331|FG000|Overall Study|Lack of Efficacy|1|||
143066909|NCT01000493|515785332|FG001|Overall Study|Lack of Efficacy|1|||
143066910|NCT01000493|515785331|FG000|Overall Study|Protocol Violation|1|||
143066911|NCT01000493|515785332|FG001|Overall Study|Protocol Violation|8|||
143066912|NCT01000493|515785331|FG000|Overall Study|Study closed/terminated|25|||
143066913|NCT01000493|515785332|FG001|Overall Study|Study closed/terminated|23|||
143066914|NCT01000493|515785331|FG000|Overall Study|Lost to Follow-up|5|||
143066915|NCT01000493|515785332|FG001|Overall Study|Lost to Follow-up|9|||
143066916|NCT01000493|515785331|FG000|Overall Study|Physician Decision|1|||
143066917|NCT01000493|515785332|FG001|Overall Study|Physician Decision|1|||
143066918|NCT01000493|515785331|FG000|Overall Study|Withdrawal by Subject|3|||
143066919|NCT01000493|515785332|FG001|Overall Study|Withdrawal by Subject|7|||
143066920|NCT00062751|515785333|FG000|Overall Study|Disease progression|24|||
143066921|NCT00062751|515785334|FG001|Overall Study|Disease progression|17|||
143066922|NCT00062751|515785335|FG002|Overall Study|Disease progression|24|||
143066923|NCT00062751|515785336|FG003|Overall Study|Disease progression|2|||
143066924|NCT00062751|515785337|FG004|Overall Study|Disease progression|2|||
143066925|NCT00062751|515785333|FG000|Overall Study|Adverse Event|4|||
143066926|NCT00062751|515785334|FG001|Overall Study|Adverse Event|7|||
143066927|NCT00062751|515785335|FG002|Overall Study|Adverse Event|2|||
143066928|NCT00062751|515785336|FG003|Overall Study|Adverse Event|2|||
143066929|NCT00062751|515785337|FG004|Overall Study|Adverse Event|2|||
143066930|NCT00062751|515785333|FG000|Overall Study|Other|2|||
143066931|NCT00062751|515785334|FG001|Overall Study|Other|3|||
143066932|NCT00062751|515785335|FG002|Overall Study|Other|1|||
143066933|NCT00062751|515785336|FG003|Overall Study|Other|0|||
143066934|NCT00062751|515785337|FG004|Overall Study|Other|1|||
143066935|NCT00062751|515785333|FG000|Overall Study|Withdrawal by Subject|1|||
143066936|NCT00062751|515785334|FG001|Overall Study|Withdrawal by Subject|2|||
143066937|NCT00062751|515785335|FG002|Overall Study|Withdrawal by Subject|2|||
143066938|NCT00062751|515785336|FG003|Overall Study|Withdrawal by Subject|1|||
143066939|NCT00062751|515785337|FG004|Overall Study|Withdrawal by Subject|0|||
143066940|NCT00062751|515785333|FG000|Overall Study|Symptomatic deterioration|1|||
143066941|NCT00062751|515785334|FG001|Overall Study|Symptomatic deterioration|1|||
143066942|NCT00062751|515785335|FG002|Overall Study|Symptomatic deterioration|0|||
143066943|NCT00062751|515785336|FG003|Overall Study|Symptomatic deterioration|0|||
143066944|NCT00062751|515785337|FG004|Overall Study|Symptomatic deterioration|1|||
143066945|NCT00062751|515785333|FG000|Overall Study|Death|1|||
143066946|NCT00062751|515785334|FG001|Overall Study|Death|0|||
143066947|NCT00062751|515785335|FG002|Overall Study|Death|1|||
143066948|NCT00062751|515785336|FG003|Overall Study|Death|0|||
143066949|NCT00062751|515785337|FG004|Overall Study|Death|0|||
143066950|NCT03629028|515785338|FG000|Overall Study|Lost to Follow-up|26|||
143066951|NCT03629028|515785339|FG001|Overall Study|Lost to Follow-up|23|||
143066952|NCT03629028|515785338|FG000|Overall Study|Pregnancy|4|||
143066953|NCT03629028|515785339|FG001|Overall Study|Pregnancy|2|||
143066954|NCT03629028|515785338|FG000|Overall Study|intolerance to examination|2|||
143066955|NCT03629028|515785339|FG001|Overall Study|intolerance to examination|0|||
143066956|NCT04969861|515785345|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
143066957|NCT04969861|515785346|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
143066958|NCT04718194|515786904|FG000|Overall Study|Withdrawal by Subject|3|||
143066959|NCT04718194|515786905|FG001|Overall Study|Withdrawal by Subject|0|||
143066960|NCT04718194|515786904|FG000|Overall Study|Lost to Follow-up|3|||
143066961|NCT04718194|515786905|FG001|Overall Study|Lost to Follow-up|0|||
143066962|NCT00856973|515786906|FG000|Overall Study|Adverse Event|5|||
143066963|NCT00856973|515786907|FG001|Overall Study|Adverse Event|5|||
143066964|NCT00856973|515786908|FG002|Overall Study|Adverse Event|3|||
143066965|NCT00856973|515786906|FG000|Overall Study|Lost to Follow-up|6|||
143066966|NCT00856973|515786907|FG001|Overall Study|Lost to Follow-up|3|||
143066967|NCT00856973|515786908|FG002|Overall Study|Lost to Follow-up|5|||
143066968|NCT00856973|515786906|FG000|Overall Study|Physician Decision|0|||
143066969|NCT00856973|515786907|FG001|Overall Study|Physician Decision|3|||
143066970|NCT00856973|515786908|FG002|Overall Study|Physician Decision|1|||
143066971|NCT00856973|515786906|FG000|Overall Study|Protocol Violation|1|||
143066972|NCT00856973|515786907|FG001|Overall Study|Protocol Violation|2|||
143066973|NCT00856973|515786908|FG002|Overall Study|Protocol Violation|1|||
143066974|NCT00856973|515786906|FG000|Overall Study|Withdrawal by Subject|13|||
143066975|NCT00856973|515786907|FG001|Overall Study|Withdrawal by Subject|16|||
143066976|NCT00856973|515786908|FG002|Overall Study|Withdrawal by Subject|15|||
143066977|NCT00856973|515786906|FG000|Overall Study|Other|11|||
143066978|NCT00856973|515786907|FG001|Overall Study|Other|12|||
143066979|NCT00856973|515786908|FG002|Overall Study|Other|13|||
143066980|NCT00821873|515786914|FG000|Overall Study|Lost to Follow-up|4|||
143066981|NCT00321828|515786917|FG000|Overall Study|Ineligible|3|||
143066982|NCT00321828|515786917|FG000|Overall Study|No follow up data|1|||
143066983|NCT02856880|515786919|FG000|Overall Study|Withdrawal of consent|1|||
143066984|NCT00793780|515786920|FG000|Overall Study|Withdrawal by Subject|2|||
143066985|NCT00793780|515786921|FG001|Overall Study|Withdrawal by Subject|1|||
143066986|NCT00858143|515786924|FG000|Overall Study|Adverse Event|16|||
143066987|NCT00858143|515786924|FG000|Overall Study|Lack of Efficacy|4|||
143066988|NCT00858143|515786924|FG000|Overall Study|Death|7|||
143066989|NCT00858143|515786924|FG000|Overall Study|Other|23|||
143066990|NCT03853148|515786925|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
143066991|NCT03853148|515786926|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
143066992|NCT03853148|515786927|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
143066993|NCT03853148|515786928|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
143066994|NCT00729248|515786929|FG000|Overall Study|Physician Decision|2|||
143066995|NCT03573505|515786930|FG000|Overall Study|Adverse Event|1|||
143066996|NCT03573505|515786931|FG001|Overall Study|Adverse Event|1|||
143066997|NCT03573505|515786930|FG000|Overall Study|Consent withdrawn|0|||
143066998|NCT03573505|515786931|FG001|Overall Study|Consent withdrawn|1|||
143066999|NCT03573505|515786930|FG000|Overall Study|Disease progression|0|||
143067000|NCT03573505|515786931|FG001|Overall Study|Disease progression|1|||
143067001|NCT03573505|515786930|FG000|Overall Study|Site Terminated by Sponsor|1|||
143067002|NCT03573505|515786931|FG001|Overall Study|Site Terminated by Sponsor|1|||
143067003|NCT03573505|515786930|FG000|Overall Study|Study terminated by sponsor|50|||
143067004|NCT03573505|515786931|FG001|Overall Study|Study terminated by sponsor|45|||
143067005|NCT03573505|515786930|FG000|Overall Study|Reason not specified|0|||
143067006|NCT03573505|515786931|FG001|Overall Study|Reason not specified|1|||
143067007|NCT03573505|515786930|FG000|Overall Study|Death|0|||
143067008|NCT03573505|515786931|FG001|Overall Study|Death|4|||
143067009|NCT00866658|515786938|FG000|Overall Study|Adverse Event|5|||
143067010|NCT00866658|515786939|FG001|Overall Study|Adverse Event|14|||
143067011|NCT00866658|515786938|FG000|Overall Study|Lack of Efficacy|2|||
143067012|NCT00866658|515786939|FG001|Overall Study|Lack of Efficacy|1|||
143067013|NCT00866658|515786938|FG000|Overall Study|Withdrawal by Subject|1|||
143067014|NCT00866658|515786939|FG001|Overall Study|Withdrawal by Subject|0|||
143067015|NCT00866658|515786938|FG000|Overall Study|Protocol Violation|1|||
143067016|NCT00866658|515786939|FG001|Overall Study|Protocol Violation|1|||
143067017|NCT00866658|515786938|FG000|Overall Study|Familial and Personal Reasons|4|||
143067018|NCT00866658|515786939|FG001|Overall Study|Familial and Personal Reasons|5|||
143067019|NCT00059787|515786940|FG000|Overall Study|Adverse Event|13|||
143067020|NCT00059787|515786940|FG000|Overall Study|disease progression|2|||
143067021|NCT00059787|515786940|FG000|Overall Study|ineligible|1|||
143067022|NCT00059787|515786940|FG000|Overall Study|Other|4|||
143067023|NCT03084367|515786945|FG000|Overall Study|Lost to Follow-up|32|||
143067024|NCT03084367|515786945|FG000|Overall Study|Withdrawal by Subject|4|||
143503068|NCT00408005|517380963|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
143503069|NCT00408005|517380964|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
143067025|NCT03084367|515786945|FG000|Overall Study|Other|1|||
143067026|NCT01206101|515786946|FG000|Overall Study|Adverse Event|1|||
143067027|NCT01206101|515786947|FG001|Overall Study|Adverse Event|0|||
143067028|NCT01206101|515786946|FG000|Overall Study|Physician Decision|0|||
143067029|NCT01206101|515786947|FG001|Overall Study|Physician Decision|1|||
143067030|NCT01206101|515786946|FG000|Overall Study|Unclassified|1|||
143067031|NCT01206101|515786947|FG001|Overall Study|Unclassified|0|||
143067032|NCT04709835|515786950|FG000|Overall Study|Withdrawal by Subject|0|||
143170384|NCT04846868|516171975|FG001|Overall Study|Adverse Event|11|||
143170385|NCT04846868|516171974|FG000|Overall Study|Protocol deviation|6|||
143170386|NCT04846868|516171975|FG001|Overall Study|Protocol deviation|2|||
143170387|NCT04846868|516171974|FG000|Overall Study|Perceived lack of efficacy|3|||
143170388|NCT04846868|516171975|FG001|Overall Study|Perceived lack of efficacy|2|||
143170389|NCT04846868|516171974|FG000|Overall Study|Change of residence|2|||
143170390|NCT04846868|516171975|FG001|Overall Study|Change of residence|3|||
143170391|NCT04846868|516171974|FG000|Overall Study|Burden of study procedures|1|||
143170392|NCT04846868|516171975|FG001|Overall Study|Burden of study procedures|1|||
143170393|NCT04846868|516171974|FG000|Overall Study|No reason available|2|||
143170394|NCT04846868|516171975|FG001|Overall Study|No reason available|5|||
143170395|NCT04846868|516171974|FG000|Overall Study|Other reason listed|20|||
143170396|NCT04846868|516171975|FG001|Overall Study|Other reason listed|10|||
143170397|NCT04846868|516171974|FG000|Overall Study|Not treated|0|||
143170398|NCT04846868|516171975|FG001|Overall Study|Not treated|1|||
143170399|NCT04116853|516171976|FG000|Overall Study|Adverse Event|1|||
143170400|NCT04116853|516171977|FG001|Overall Study|Adverse Event|3|||
143503070|NCT00408005|517380965|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
143503071|NCT00408005|517380958|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
143503072|NCT00408005|517380959|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
143503073|NCT00408005|517380960|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
143067033|NCT04709835|515786951|FG001|Overall Study|Withdrawal by Subject|1|||
143067034|NCT04709835|515786952|FG002|Overall Study|Withdrawal by Subject|0|||
143067035|NCT01859130|515786953|FG000|Overall Study|Death|4|||
143067036|NCT01859130|515786953|FG000|Overall Study|Lost to Follow-up|16|||
143067037|NCT01859130|515786953|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
143067038|NCT01859130|515786953|FG000|Overall Study|Physician Decision|6|||
143067039|NCT01859130|515786953|FG000|Overall Study|Withdrawal by Subject|17|||
143067040|NCT01859130|515786953|FG000|Overall Study|Adverse Event|11|||
143067041|NCT00912093|515786954|FG000|The Controlled Phase|Death|0|||
143067042|NCT00912093|515786955|FG001|The Controlled Phase|Death|1|||
143067043|NCT00912093|515786956|FG002|The Controlled Phase|Death|0|||
143067044|NCT00912093|515786957|FG003|The Controlled Phase|Death|0|||
143067045|NCT00912093|515786958|FG004|The Controlled Phase|Death|0|||
143067046|NCT00912093|515786954|FG000|The Controlled Phase|Medical Condition|0|||
143067047|NCT00912093|515786955|FG001|The Controlled Phase|Medical Condition|1|||
143067048|NCT00912093|515786956|FG002|The Controlled Phase|Medical Condition|0|||
143067049|NCT00912093|515786957|FG003|The Controlled Phase|Medical Condition|0|||
143067050|NCT00912093|515786958|FG004|The Controlled Phase|Medical Condition|0|||
143067051|NCT00912093|515786954|FG000|The Controlled Phase|Lost to Follow-up|0|||
143067052|NCT00912093|515786955|FG001|The Controlled Phase|Lost to Follow-up|0|||
143067053|NCT00912093|515786956|FG002|The Controlled Phase|Lost to Follow-up|0|||
143067054|NCT00912093|515786957|FG003|The Controlled Phase|Lost to Follow-up|0|||
143067055|NCT00912093|515786958|FG004|The Controlled Phase|Lost to Follow-up|1|||
143067056|NCT04397445|515786965|FG000|Overall Study|Withdrawal by Subject|1|||
143067057|NCT04397445|515786966|FG001|Overall Study|Withdrawal by Subject|0|||
143067058|NCT04397445|515786967|FG002|Overall Study|Withdrawal by Subject|0|||
143067059|NCT04397445|515786968|FG003|Overall Study|Withdrawal by Subject|0|||
143067060|NCT03921151|515786969|FG000|Overall Study|Withdrawal by Subject|11|||
143067061|NCT03921151|515786970|FG001|Overall Study|Withdrawal by Subject|16|||
143067062|NCT01429051|515786971|FG000|Titration Phase|Death|1|||
143067063|NCT01429051|515786971|FG000|Titration Phase|Withdrawal by Subject|7|||
143067064|NCT01429051|515786971|FG000|Titration Phase|Physician Decision|1|||
143067065|NCT01429051|515786971|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
143067066|NCT01429051|515786971|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
143067067|NCT01429051|515786971|FG000|Efficacy Phase|Adverse Event|1|||
143067068|NCT01429051|515786971|FG000|Efficacy Phase|Death|1|||
143067069|NCT01429051|515786971|FG000|Tolerability Phase|Death|5|||
143067070|NCT01429051|515786971|FG000|Tolerability Phase|Adverse Event|2|||
143067071|NCT01429051|515786971|FG000|Tolerability Phase|Withdrawal by Subject|5|||
143067072|NCT01429051|515786971|FG000|Tolerability Phase|Physician Decision|1|||
143067073|NCT01429051|515786971|FG000|Tolerability Phase|Other|2|||
143067074|NCT00506129|515786973|FG000|Overall Study|Disease Progression/Relapse|15|||
143067075|NCT00506129|515786973|FG000|Overall Study|Death|7|||
143067076|NCT02792959|515786974|FG000|Overall Study|Protocol Violation|1|||
143067077|NCT03127644|515786984|FG000|Overall Study|Study-specific withdrawal criteria|0|||
143067078|NCT03127644|515786985|FG001|Overall Study|Study-specific withdrawal criteria|0|||
143067079|NCT03127644|515786986|FG002|Overall Study|Study-specific withdrawal criteria|2|||
143067080|NCT00160641|515786990|FG000|Overall Study|Adverse Event|102|||
143067081|NCT00160641|515786990|FG000|Overall Study|Withdrawal by Subject|87|||
143067082|NCT00160641|515786990|FG000|Overall Study|Lost to Follow-up|8|||
143067083|NCT00160641|515786990|FG000|Overall Study|Lack of Efficacy|12|||
143067084|NCT00160641|515786990|FG000|Overall Study|Protocol Violation|3|||
143067085|NCT00160641|515786990|FG000|Overall Study|Other|9|||
143067086|NCT02787408|515786991|FG000|Overall Study|Death|16|||
143067087|NCT02787408|515786991|FG000|Overall Study|Withdrawal by Subject|1|||
143503074|NCT00408005|517380961|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
143503075|NCT00408005|517380962|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
143503076|NCT00408005|517380963|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
143067088|NCT02787408|515786991|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
143067089|NCT01782482|515786992|FG000|Overall Study|Adverse Event|2|||
143067090|NCT01782482|515786993|FG001|Overall Study|Adverse Event|1|||
143067091|NCT01782482|515786992|FG000|Overall Study|Lost to Follow-up|2|||
143067092|NCT01782482|515786993|FG001|Overall Study|Lost to Follow-up|3|||
143067093|NCT01782482|515786992|FG000|Overall Study|Physician Decision|1|||
143067094|NCT01782482|515786993|FG001|Overall Study|Physician Decision|0|||
143067095|NCT01782482|515786992|FG000|Overall Study|Protocol Violation|1|||
143067096|NCT01782482|515786993|FG001|Overall Study|Protocol Violation|0|||
143170401|NCT04116853|516171976|FG000|Overall Study|Lost to Follow-up|2|||
143067097|NCT01782482|515786992|FG000|Overall Study|Withdrawal by Subject|2|||
143067098|NCT01782482|515786993|FG001|Overall Study|Withdrawal by Subject|3|||
143067099|NCT01782482|515786992|FG000|Overall Study|Randomized in Error|2|||
143067100|NCT01782482|515786993|FG001|Overall Study|Randomized in Error|2|||
143067101|NCT01782482|515786992|FG000|Overall Study|Habitually wearing toric lens OS|0|||
143067102|NCT01782482|515786993|FG001|Overall Study|Habitually wearing toric lens OS|1|||
143067103|NCT00985712|515786995|FG000|Overall Study|Adverse Event|0|||
143067104|NCT00985712|515786996|FG001|Overall Study|Adverse Event|1|||
143067105|NCT00985712|515786995|FG000|Overall Study|Lost to Follow-up|2|||
143067106|NCT00985712|515786996|FG001|Overall Study|Lost to Follow-up|2|||
143067107|NCT00985712|515786995|FG000|Overall Study|Protocol Violation|0|||
143067108|NCT00985712|515786996|FG001|Overall Study|Protocol Violation|1|||
143067109|NCT00985712|515786995|FG000|Overall Study|Withdrawal by Subject|4|||
143067110|NCT00985712|515786996|FG001|Overall Study|Withdrawal by Subject|1|||
143067111|NCT00985712|515786995|FG000|Overall Study|Sponsor decision|0|||
143067112|NCT00985712|515786996|FG001|Overall Study|Sponsor decision|2|||
143067113|NCT01194973|515786997|FG000|Screening Period|Screen Failure|3|||
143067114|NCT01194973|515786997|FG000|26 Week Treatment Period|Adverse Event|1|||
143067115|NCT01194973|515786997|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
143067116|NCT01194973|515786997|FG000|26 Week Treatment Period|Pregnancy|1|||
143067117|NCT03096847|515786998|FG000|Overall Study|Other|2|||
143067118|NCT03096847|515786999|FG001|Overall Study|Other|1|||
143067119|NCT03096847|515787000|FG002|Overall Study|Other|2|||
143067120|NCT03096847|515786998|FG000|Overall Study|Lost to Follow-up|1|||
143067121|NCT03096847|515786999|FG001|Overall Study|Lost to Follow-up|0|||
143067122|NCT03096847|515787000|FG002|Overall Study|Lost to Follow-up|1|||
143067123|NCT03096847|515786998|FG000|Overall Study|Death|6|||
143067124|NCT03096847|515786999|FG001|Overall Study|Death|0|||
143067125|NCT03096847|515787000|FG002|Overall Study|Death|2|||
143067126|NCT03096847|515786998|FG000|Overall Study|Protocol Violation|3|||
143067127|NCT03096847|515786999|FG001|Overall Study|Protocol Violation|0|||
143067128|NCT03096847|515787000|FG002|Overall Study|Protocol Violation|6|||
143067129|NCT03096847|515786998|FG000|Overall Study|Physician Decision|12|||
143067130|NCT03096847|515786999|FG001|Overall Study|Physician Decision|2|||
143067131|NCT03096847|515787000|FG002|Overall Study|Physician Decision|8|||
143067132|NCT03096847|515786998|FG000|Overall Study|Withdrawal by Subject|24|||
143067133|NCT03096847|515786999|FG001|Overall Study|Withdrawal by Subject|1|||
143067134|NCT03096847|515787000|FG002|Overall Study|Withdrawal by Subject|12|||
143170402|NCT04116853|516171977|FG001|Overall Study|Lost to Follow-up|0|||
143170403|NCT04116853|516171976|FG000|Overall Study|Incarceration|0|||
143170404|NCT04116853|516171977|FG001|Overall Study|Incarceration|1|||
143067135|NCT03096847|515786998|FG000|Overall Study|Adverse Event|72|||
143067136|NCT03096847|515786999|FG001|Overall Study|Adverse Event|6|||
143067137|NCT03096847|515787000|FG002|Overall Study|Adverse Event|28|||
143067138|NCT03096847|515786998|FG000|Overall Study|Progressive disease|97|||
143067139|NCT03096847|515786999|FG001|Overall Study|Progressive disease|10|||
143067140|NCT03096847|515787000|FG002|Overall Study|Progressive disease|78|||
143067141|NCT03096847|515786998|FG000|Overall Study|Non-compliance with study medication|1|||
143067142|NCT03096847|515786999|FG001|Overall Study|Non-compliance with study medication|0|||
143067143|NCT03096847|515787000|FG002|Overall Study|Non-compliance with study medication|0|||
143067144|NCT03096847|515786998|FG000|Overall Study|New therapy for study indication|1|||
143067145|NCT03096847|515786999|FG001|Overall Study|New therapy for study indication|0|||
143067146|NCT03096847|515787000|FG002|Overall Study|New therapy for study indication|1|||
143067147|NCT00359632|515787001|FG000|Overall Study|Death|2|||
143067148|NCT00359632|515787002|FG001|Overall Study|Death|0|||
143067149|NCT00359632|515787001|FG000|Overall Study|Adverse Event|1|||
143067150|NCT00359632|515787002|FG001|Overall Study|Adverse Event|0|||
143067151|NCT00359632|515787001|FG000|Overall Study|Non-compliance with visit schedule|1|||
143067152|NCT00359632|515787002|FG001|Overall Study|Non-compliance with visit schedule|0|||
143067153|NCT02749292|515787007|FG000|Overall Study|Physician Decision|1|||
143067154|NCT02749292|515787008|FG001|Overall Study|Physician Decision|0|||
143067155|NCT02749292|515787007|FG000|Overall Study|Withdrawal by Subject|5|||
143067156|NCT02749292|515787008|FG001|Overall Study|Withdrawal by Subject|7|||
143170405|NCT04116853|516171976|FG000|Overall Study|Pregnancy|1|||
143170406|NCT04116853|516171977|FG001|Overall Study|Pregnancy|1|||
143170407|NCT04116853|516171976|FG000|Overall Study|Began Other Weight Loss program|4|||
143170408|NCT04116853|516171977|FG001|Overall Study|Began Other Weight Loss program|8|||
143170409|NCT04116853|516171976|FG000|Overall Study|Began Anti-Obesity Medication|3|||
143067157|NCT02749292|515787007|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
143067158|NCT02749292|515787008|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
143067159|NCT02749292|515787007|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
143067160|NCT02749292|515787008|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
143067161|NCT02749292|515787007|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
143067162|NCT02749292|515787008|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
143067163|NCT02749292|515787007|FG000|Overall Study|Adverse Event|4|||
143067164|NCT02749292|515787008|FG001|Overall Study|Adverse Event|1|||
143067165|NCT02749292|515787007|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
143170410|NCT04116853|516171977|FG001|Overall Study|Began Anti-Obesity Medication|3|||
143067166|NCT02749292|515787008|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
143365174|NCT02223793|516880668|FG000|Overall Study|Lost to Follow-up|10|||
143170411|NCT04116853|516171976|FG000|Overall Study|Protocol Violation|0|||
143503077|NCT00408005|517380964|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
143503078|NCT00408005|517380965|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
143503079|NCT00408005|517380958|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
143503080|NCT00408005|517380959|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
143503081|NCT00408005|517380960|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
143503082|NCT00408005|517380961|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
143067167|NCT02749292|515787007|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
143067168|NCT02749292|515787008|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
143067169|NCT02749292|515787007|FG000|Overall Study|Requiring glucocorticoids|0|||
143067170|NCT02749292|515787008|FG001|Overall Study|Requiring glucocorticoids|3|||
143067171|NCT02749292|515787007|FG000|Overall Study|Cancer|1|||
143067172|NCT02749292|515787008|FG001|Overall Study|Cancer|0|||
143067173|NCT01230892|515787009|FG000|Overall Study|Withdrawal by Subject|1|||
143067174|NCT01230892|515787010|FG001|Overall Study|Withdrawal by Subject|1|||
143067175|NCT01230892|515787009|FG000|Overall Study|Lost to Follow-up|2|||
143067176|NCT01230892|515787010|FG001|Overall Study|Lost to Follow-up|0|||
143067177|NCT00725621|515787013|FG000|Overall Study|Adverse Event|25|||
143067178|NCT00725621|515787013|FG000|Overall Study|Lack of Efficacy|46|||
143067179|NCT00725621|515787013|FG000|Overall Study|Withdrawal by Subject|57|||
143067180|NCT00725621|515787013|FG000|Overall Study|Physician Decision|19|||
143067181|NCT00725621|515787013|FG000|Overall Study|Lost to Follow-up|52|||
143067182|NCT00725621|515787013|FG000|Overall Study|Non-compliance|8|||
143067183|NCT00725621|515787013|FG000|Overall Study|Continued treatment by other physician|6|||
143067184|NCT00725621|515787013|FG000|Overall Study|Switched to other study|1|||
143067185|NCT00725621|515787013|FG000|Overall Study|Switched to other drug|1|||
143067186|NCT00725621|515787013|FG000|Overall Study|Prepared for elective surgery|1|||
143067187|NCT00725621|515787013|FG000|Overall Study|Reason not specified|55|||
143067188|NCT03097588|515787022|FG000|Overall Study|Adverse Event|1|||
143067189|NCT01144364|515787023|FG000|Induction Phase|Disease progression|14|||
143067190|NCT01144364|515787024|FG001|Induction Phase|Disease progression|0|||
143067191|NCT01144364|515787025|FG002|Induction Phase|Disease progression|0|||
143067192|NCT01144364|515787023|FG000|Induction Phase|Adverse Event|9|||
143067193|NCT01144364|515787024|FG001|Induction Phase|Adverse Event|0|||
143067194|NCT01144364|515787025|FG002|Induction Phase|Adverse Event|0|||
143067195|NCT01144364|515787023|FG000|Induction Phase|Death|1|||
143067196|NCT01144364|515787024|FG001|Induction Phase|Death|0|||
143067197|NCT01144364|515787025|FG002|Induction Phase|Death|0|||
143067198|NCT01144364|515787023|FG000|Induction Phase|Withdrawal by Subject|1|||
143067199|NCT01144364|515787024|FG001|Induction Phase|Withdrawal by Subject|0|||
143067200|NCT01144364|515787025|FG002|Induction Phase|Withdrawal by Subject|0|||
143067201|NCT01144364|515787023|FG000|Induction Phase|Lost to Follow-up|2|||
143067202|NCT01144364|515787024|FG001|Induction Phase|Lost to Follow-up|0|||
143067203|NCT01144364|515787025|FG002|Induction Phase|Lost to Follow-up|0|||
143067204|NCT01144364|515787023|FG000|Induction Phase|Physician Decision|1|||
143067205|NCT01144364|515787024|FG001|Induction Phase|Physician Decision|0|||
143067206|NCT01144364|515787025|FG002|Induction Phase|Physician Decision|0|||
143067207|NCT01144364|515787023|FG000|Induction Phase|Stable disease|2|||
143067208|NCT01144364|515787024|FG001|Induction Phase|Stable disease|0|||
143067209|NCT01144364|515787025|FG002|Induction Phase|Stable disease|0|||
143067210|NCT01144364|515787023|FG000|Induction Phase|Secondary neoplasia|1|||
143067211|NCT01144364|515787024|FG001|Induction Phase|Secondary neoplasia|0|||
143067212|NCT01144364|515787025|FG002|Induction Phase|Secondary neoplasia|0|||
143067213|NCT01144364|515787023|FG000|Induction Phase|Protocol Violation|1|||
143067214|NCT01144364|515787024|FG001|Induction Phase|Protocol Violation|0|||
143067215|NCT01144364|515787025|FG002|Induction Phase|Protocol Violation|0|||
143067216|NCT01144364|515787023|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
143067217|NCT01144364|515787024|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
143067218|NCT01144364|515787025|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
143067219|NCT01144364|515787023|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
143067220|NCT01144364|515787024|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
143067221|NCT01144364|515787025|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
143067222|NCT01144364|515787023|FG000|Follow-Up/Maintenance Phase|Death|0|||
143067223|NCT01144364|515787024|FG001|Follow-Up/Maintenance Phase|Death|2|||
143365175|NCT02223793|516880669|FG001|Overall Study|Lost to Follow-up|1|||
143365176|NCT02223793|516880670|FG002|Overall Study|Lost to Follow-up|2|||
143067224|NCT01144364|515787025|FG002|Follow-Up/Maintenance Phase|Death|0|||
143067225|NCT01144364|515787023|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
143067226|NCT01144364|515787024|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
143067227|NCT01144364|515787025|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
143067228|NCT01144364|515787023|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
143067229|NCT01144364|515787024|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
143067230|NCT01144364|515787025|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
143067231|NCT01144364|515787023|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
143067232|NCT01144364|515787024|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
143067233|NCT01144364|515787025|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
143067234|NCT01144364|515787023|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
143067235|NCT01144364|515787024|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
143067236|NCT01144364|515787025|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
143067237|NCT02989168|515787026|FG000|Overall Study|Withdrawal by Subject|2|||
143067238|NCT02989168|515787027|FG001|Overall Study|Withdrawal by Subject|0|||
143067239|NCT02989168|515787026|FG000|Overall Study|Physician Decision|0|||
143067240|NCT02989168|515787027|FG001|Overall Study|Physician Decision|1|||
143067241|NCT02989168|515787026|FG000|Overall Study|Adverse Event|1|||
143067242|NCT02989168|515787027|FG001|Overall Study|Adverse Event|2|||
143067243|NCT02989168|515787026|FG000|Overall Study|Sponsor stopped study.|1|||
143067244|NCT02989168|515787027|FG001|Overall Study|Sponsor stopped study.|0|||
143067245|NCT03456960|515787028|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
143067246|NCT03456960|515787029|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
143067247|NCT03456960|515787030|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
143067248|NCT03456960|515787031|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
143067249|NCT03456960|515787032|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
143067250|NCT03456960|515787033|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
143067251|NCT03456960|515787028|FG000|Period 2 (1 Day)|Adverse Event|1|||
143067252|NCT03456960|515787029|FG001|Period 2 (1 Day)|Adverse Event|0|||
143067253|NCT03456960|515787030|FG002|Period 2 (1 Day)|Adverse Event|0|||
143067254|NCT03456960|515787031|FG003|Period 2 (1 Day)|Adverse Event|1|||
143067255|NCT03456960|515787032|FG004|Period 2 (1 Day)|Adverse Event|0|||
143067256|NCT03456960|515787033|FG005|Period 2 (1 Day)|Adverse Event|0|||
143067257|NCT03828448|515787034|FG000|Overall Study|Sponsor's Discretion|34|||
143067258|NCT05816200|515787035|FG000|Overall Study|Lost to Follow-up|2|||
143067259|NCT05816200|515787036|FG001|Overall Study|Lost to Follow-up|1|||
143067260|NCT02384850|515787037|FG000|Overall Study|Withdrawal by Subject|2|||
143067261|NCT02384850|515787038|FG001|Overall Study|Withdrawal by Subject|2|||
143067262|NCT00507546|515787039|FG000|Overall Study|Withdrawal by Subject|1|||
143067263|NCT00507546|515787040|FG001|Overall Study|Withdrawal by Subject|0|||
143067264|NCT00507546|515787039|FG000|Overall Study|Protocol Violation|1|||
143067265|NCT00507546|515787040|FG001|Overall Study|Protocol Violation|0|||
143067266|NCT00507546|515787039|FG000|Overall Study|Physician Decision|0|||
143067267|NCT00507546|515787040|FG001|Overall Study|Physician Decision|1|||
143067268|NCT01334710|515787042|FG000|Overall Study|Trial was terminated|3|||
143067269|NCT00375492|515787043|FG000|Overall Study|Adverse Event|4|||
143067270|NCT00375492|515787044|FG001|Overall Study|Adverse Event|5|||
143067271|NCT00375492|515787043|FG000|Overall Study|Entry Criteria Not Met|0|||
143067272|NCT00375492|515787044|FG001|Overall Study|Entry Criteria Not Met|1|||
143067273|NCT00375492|515787043|FG000|Overall Study|Loss of Glucose Control|0|||
143067274|NCT00375492|515787044|FG001|Overall Study|Loss of Glucose Control|1|||
143067275|NCT00375492|515787043|FG000|Overall Study|Lost to Follow-up|10|||
143067276|NCT00375492|515787044|FG001|Overall Study|Lost to Follow-up|5|||
143067277|NCT00375492|515787043|FG000|Overall Study|Physician Decision|0|||
143067278|NCT00375492|515787044|FG001|Overall Study|Physician Decision|4|||
143067279|NCT00375492|515787043|FG000|Overall Study|Protocol Violation|6|||
143067280|NCT00375492|515787044|FG001|Overall Study|Protocol Violation|3|||
143067281|NCT00375492|515787043|FG000|Overall Study|Sponsor Decision|0|||
143067282|NCT00375492|515787044|FG001|Overall Study|Sponsor Decision|1|||
143067283|NCT00375492|515787043|FG000|Overall Study|Withdrawal by Subject|6|||
143067284|NCT00375492|515787044|FG001|Overall Study|Withdrawal by Subject|6|||
143067285|NCT00290251|515787045|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
143067286|NCT00290251|515787046|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
143067287|NCT00290251|515787047|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
143067288|NCT00290251|515787048|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
143067289|NCT00290251|515787049|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
143067290|NCT00290251|515787050|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
143067291|NCT00290251|515787045|FG000|Treatment 1 (Months 2-4)|headache|0|||
143067292|NCT00290251|515787046|FG001|Treatment 1 (Months 2-4)|headache|0|||
143067293|NCT00290251|515787047|FG002|Treatment 1 (Months 2-4)|headache|0|||
143067294|NCT00290251|515787048|FG003|Treatment 1 (Months 2-4)|headache|0|||
143067295|NCT00290251|515787049|FG004|Treatment 1 (Months 2-4)|headache|1|||
143067296|NCT00290251|515787050|FG005|Treatment 1 (Months 2-4)|headache|0|||
143067297|NCT00290251|515787045|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
143067298|NCT00290251|515787046|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
143067299|NCT00290251|515787047|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
143067300|NCT00290251|515787048|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
143067301|NCT00290251|515787049|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
143067302|NCT00290251|515787050|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
143067303|NCT04062448|515788688|FG000|Overall Study|Lost to Follow-up|1|||
143067304|NCT04062448|515788688|FG000|Overall Study|Withdrawal by Subject|2|||
143067305|NCT06077487|515788689|FG000|Overall Study|Withdrawal by Subject|0|||
143067306|NCT06077487|515788690|FG001|Overall Study|Withdrawal by Subject|1|||
143067307|NCT04905290|515788691|FG000|Overall Study|Adverse Event|4|||
143067308|NCT04905290|515788691|FG000|Overall Study|Death|2|||
143067309|NCT04905290|515788691|FG000|Overall Study|Withdrawal by Subject|4|||
143067310|NCT04905290|515788691|FG000|Overall Study|Physician Decision|2|||
143067311|NCT04905290|515788691|FG000|Overall Study|Lost to Follow-up|2|||
143067312|NCT04905290|515788691|FG000|Overall Study|Screen Failure|2|||
143067313|NCT04905290|515788691|FG000|Overall Study|Unsuccessful Procedure|2|||
143067314|NCT05101486|515788692|FG000|Overall Study|Death|1|||
143067315|NCT05101486|515788693|FG001|Overall Study|Death|0|||
143067316|NCT05101486|515788694|FG002|Overall Study|Death|1|||
143067317|NCT05101486|515788692|FG000|Overall Study|Lost to Follow-up|12|||
143067318|NCT05101486|515788693|FG001|Overall Study|Lost to Follow-up|8|||
143067319|NCT05101486|515788694|FG002|Overall Study|Lost to Follow-up|17|||
143067320|NCT05101486|515788692|FG000|Overall Study|Physician Decision|1|||
143067321|NCT05101486|515788693|FG001|Overall Study|Physician Decision|0|||
143067322|NCT05101486|515788694|FG002|Overall Study|Physician Decision|0|||
143067323|NCT05101486|515788692|FG000|Overall Study|Protocol Violation|0|||
143067324|NCT05101486|515788693|FG001|Overall Study|Protocol Violation|0|||
143067325|NCT05101486|515788694|FG002|Overall Study|Protocol Violation|1|||
143067326|NCT05101486|515788692|FG000|Overall Study|Withdrawal by Subject|5|||
143067327|NCT05101486|515788693|FG001|Overall Study|Withdrawal by Subject|2|||
143067328|NCT05101486|515788694|FG002|Overall Study|Withdrawal by Subject|4|||
143067329|NCT05101486|515788692|FG000|Overall Study|Randomized but not vaccinated|1|||
143067330|NCT05101486|515788693|FG001|Overall Study|Randomized but not vaccinated|1|||
143067331|NCT05101486|515788694|FG002|Overall Study|Randomized but not vaccinated|1|||
143067332|NCT03295318|515788695|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
143067333|NCT03295318|515788696|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
143067334|NCT03295318|515788697|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
143067335|NCT03295318|515788695|FG000|Overall Study|Death|1|||
143067336|NCT03295318|515788696|FG001|Overall Study|Death|1|||
143067337|NCT03295318|515788697|FG002|Overall Study|Death|1|||
143067338|NCT03295318|515788695|FG000|Overall Study|Protocol Violation|4|||
143067339|NCT03295318|515788696|FG001|Overall Study|Protocol Violation|3|||
143067340|NCT03295318|515788697|FG002|Overall Study|Protocol Violation|3|||
143067341|NCT03295318|515788695|FG000|Overall Study|Withdrawal by Subject|0|||
143067342|NCT03295318|515788696|FG001|Overall Study|Withdrawal by Subject|0|||
143067343|NCT03295318|515788697|FG002|Overall Study|Withdrawal by Subject|1|||
143067344|NCT03295318|515788695|FG000|Overall Study|Subject discontinued due to travel|0|||
143067345|NCT03295318|515788696|FG001|Overall Study|Subject discontinued due to travel|1|||
143067346|NCT03295318|515788697|FG002|Overall Study|Subject discontinued due to travel|0|||
143067347|NCT03747601|515788698|FG000|Overall Study|COVID halt to visits|4|||
143067348|NCT02788045|515788699|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
143067349|NCT02788045|515788700|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
143067350|NCT02788045|515788701|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
143067351|NCT02788045|515788699|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
143067352|NCT02788045|515788700|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
143067353|NCT02788045|515788701|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
143067354|NCT02788045|515788699|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
143067355|NCT02788045|515788700|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
143067356|NCT02788045|515788701|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
143067357|NCT02788045|515788699|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
143067358|NCT02788045|515788700|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
143067359|NCT02788045|515788701|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
143067360|NCT02788045|515788699|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
143067361|NCT02788045|515788700|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
143067362|NCT02788045|515788701|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
143067363|NCT02788045|515788699|FG000|Main Study (Up to Week 72)|Other|3|||
143067364|NCT02788045|515788700|FG001|Main Study (Up to Week 72)|Other|0|||
143067365|NCT02788045|515788701|FG002|Main Study (Up to Week 72)|Other|0|||
143067366|NCT02788045|515788699|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
143067367|NCT02788045|515788700|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
143067368|NCT02788045|515788701|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
143067369|NCT02788045|515788699|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
143067370|NCT02788045|515788700|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
143067371|NCT02788045|515788701|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
143067372|NCT02788045|515788699|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
143067373|NCT02788045|515788700|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
143067374|NCT02788045|515788701|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
143067375|NCT03303625|515788702|FG000|Overall Study|Withdrawal by Subject|2|||
143067376|NCT03303625|515788703|FG001|Overall Study|Withdrawal by Subject|0|||
143067377|NCT03303625|515788704|FG002|Overall Study|Withdrawal by Subject|0|||
143067378|NCT03303625|515788705|FG003|Overall Study|Withdrawal by Subject|0|||
143503083|NCT00408005|517380962|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
143503084|NCT00408005|517380963|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
143067379|NCT04319718|515788706|FG000|Overall Study|Adverse Event|0|||
143503085|NCT00408005|517380964|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
143067380|NCT04319718|515788707|FG001|Overall Study|Adverse Event|2|||
143067381|NCT04319718|515788706|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
143067382|NCT04319718|515788707|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
143067383|NCT01288053|515788708|FG000|Overall Study|Death|1|||
143067384|NCT03188666|515788709|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
143067385|NCT03188666|515788710|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
143067386|NCT03188666|515788711|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
143067387|NCT03188666|515788712|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
143067388|NCT03188666|515788709|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
143067389|NCT03188666|515788710|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
143067390|NCT03188666|515788711|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
143067391|NCT03188666|515788712|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
143067392|NCT03188666|515788709|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
143067393|NCT03188666|515788710|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
143503086|NCT00408005|517380965|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
143503087|NCT00408005|517380958|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
143170412|NCT04116853|516171977|FG001|Overall Study|Protocol Violation|1|||
143170413|NCT05819398|516171980|FG000|Overall Study|Withdrawal by Subject|11|||
143170414|NCT05819398|516171981|FG001|Overall Study|Withdrawal by Subject|7|||
143170415|NCT05819398|516171982|FG002|Overall Study|Withdrawal by Subject|6|||
143170416|NCT05819398|516171983|FG003|Overall Study|Withdrawal by Subject|6|||
143170417|NCT05819398|516171980|FG000|Overall Study|Lost to Follow-up|0|||
143170418|NCT05819398|516171981|FG001|Overall Study|Lost to Follow-up|2|||
143170419|NCT05819398|516171982|FG002|Overall Study|Lost to Follow-up|0|||
143170420|NCT05819398|516171983|FG003|Overall Study|Lost to Follow-up|1|||
143246153|NCT01976741|516453428|FG004|Overall Study|Withdrawal by Subject|0|||
143246154|NCT01976741|516453429|FG005|Overall Study|Withdrawal by Subject|0|||
143246155|NCT01976741|516453430|FG006|Overall Study|Withdrawal by Subject|1|||
143246156|NCT01976741|516453431|FG007|Overall Study|Withdrawal by Subject|4|||
143170421|NCT05819398|516171980|FG000|Overall Study|Adverse Event|1|||
143170422|NCT05819398|516171981|FG001|Overall Study|Adverse Event|3|||
143170423|NCT05819398|516171982|FG002|Overall Study|Adverse Event|4|||
143170424|NCT05819398|516171983|FG003|Overall Study|Adverse Event|5|||
143170425|NCT05819398|516171980|FG000|Overall Study|Other than listed|0|||
143170426|NCT05819398|516171981|FG001|Overall Study|Other than listed|2|||
143170427|NCT05819398|516171982|FG002|Overall Study|Other than listed|2|||
143170428|NCT05819398|516171983|FG003|Overall Study|Other than listed|0|||
143170429|NCT05819398|516171980|FG000|Overall Study|Lack of Efficacy|0|||
143170430|NCT05819398|516171981|FG001|Overall Study|Lack of Efficacy|1|||
143170431|NCT05819398|516171982|FG002|Overall Study|Lack of Efficacy|0|||
143170432|NCT05819398|516171983|FG003|Overall Study|Lack of Efficacy|0|||
143170433|NCT05819398|516171980|FG000|Overall Study|Study terminated by sponsor|20|||
143170434|NCT05819398|516171981|FG001|Overall Study|Study terminated by sponsor|18|||
143170435|NCT05819398|516171982|FG002|Overall Study|Study terminated by sponsor|20|||
143170436|NCT05819398|516171983|FG003|Overall Study|Study terminated by sponsor|22|||
143170437|NCT04522973|516171984|FG000|Overall Study|Lost to Follow-up|4|||
143170438|NCT04522973|516171984|FG000|Overall Study|Could not adhere to study schedule|1|||
143170439|NCT04043286|516173520|FG000|Overall Study|Withdrawal by Subject|2|||
143170440|NCT04043286|516173521|FG001|Overall Study|Withdrawal by Subject|2|||
143170441|NCT00573768|516173527|FG000|Overall Study|Adverse Event|1|||
143170442|NCT00573768|516173528|FG001|Overall Study|Adverse Event|1|||
143170443|NCT00573768|516173529|FG002|Overall Study|Adverse Event|2|||
143170444|NCT00573768|516173527|FG000|Overall Study|Protocol Violation|1|||
143170445|NCT00573768|516173528|FG001|Overall Study|Protocol Violation|0|||
143170446|NCT00573768|516173529|FG002|Overall Study|Protocol Violation|1|||
143170447|NCT00573768|516173527|FG000|Overall Study|Withdrawal by Subject|0|||
143170448|NCT00573768|516173528|FG001|Overall Study|Withdrawal by Subject|1|||
143170449|NCT00573768|516173529|FG002|Overall Study|Withdrawal by Subject|0|||
143170450|NCT00573768|516173527|FG000|Overall Study|Lost to Follow-up|0|||
143170451|NCT00573768|516173528|FG001|Overall Study|Lost to Follow-up|0|||
143170452|NCT00573768|516173529|FG002|Overall Study|Lost to Follow-up|1|||
143170453|NCT01143402|516173536|FG000|Overall Study|Rapid clinical decline|1|||
143170454|NCT01143402|516173537|FG001|Overall Study|Rapid clinical decline|1|||
143170455|NCT01143402|516173538|FG002|Overall Study|Rapid clinical decline|0|||
143170456|NCT01143402|516173536|FG000|Overall Study|Not Treated|0|||
143170457|NCT01143402|516173537|FG001|Overall Study|Not Treated|0|||
143170458|NCT01143402|516173538|FG002|Overall Study|Not Treated|1|||
143170459|NCT04462471|516173539|FG000|Overall Study|Adverse Event|0|||
143170460|NCT04462471|516173540|FG001|Overall Study|Adverse Event|1|||
143170461|NCT04462471|516173541|FG002|Overall Study|Adverse Event|0|||
143170462|NCT04462471|516173542|FG003|Overall Study|Adverse Event|0|||
143170463|NCT04462471|516173539|FG000|Overall Study|Disease progression|1|||
143170464|NCT04462471|516173540|FG001|Overall Study|Disease progression|0|||
143170465|NCT04462471|516173541|FG002|Overall Study|Disease progression|0|||
143170466|NCT04462471|516173542|FG003|Overall Study|Disease progression|0|||
143246157|NCT01976741|516453432|FG008|Overall Study|Withdrawal by Subject|0|||
143067394|NCT03188666|515788711|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
143067395|NCT03188666|515788712|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
143067396|NCT03188666|515788709|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
143067397|NCT03188666|515788710|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
143067398|NCT03188666|515788711|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
143067399|NCT03188666|515788712|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
143067400|NCT00144781|515788713|FG000|Overall Study|Adverse Event|0|||
143067401|NCT00144781|515788714|FG001|Overall Study|Adverse Event|1|||
143067402|NCT00144781|515788715|FG002|Overall Study|Adverse Event|0|||
143067403|NCT00144781|515788716|FG003|Overall Study|Adverse Event|0|||
143067404|NCT00144781|515788713|FG000|Overall Study|Non-compliant|0|||
143067405|NCT00144781|515788714|FG001|Overall Study|Non-compliant|1|||
143067406|NCT00144781|515788715|FG002|Overall Study|Non-compliant|0|||
143067407|NCT00144781|515788716|FG003|Overall Study|Non-compliant|0|||
143067408|NCT02068092|515788717|FG000|Overall Study|Physician Decision|2|||
143067409|NCT02068092|515788717|FG000|Overall Study|Adverse Event|2|||
143067410|NCT02068092|515788717|FG000|Overall Study|Lost to Follow-up|4|||
143067411|NCT02068092|515788717|FG000|Overall Study|Withdrawal by Subject|2|||
143067412|NCT00062010|515788718|FG000|Overall Study|Ineligible|3|||
143067413|NCT00292188|515788719|FG000|Single-Blind|Adverse Event|14|||
143067414|NCT00292188|515788720|FG001|Single-Blind|Adverse Event|0|||
143067415|NCT00292188|515788721|FG002|Single-Blind|Adverse Event|0|||
143067416|NCT00292188|515788719|FG000|Single-Blind|Lack of Efficacy|2|||
143067417|NCT00292188|515788720|FG001|Single-Blind|Lack of Efficacy|0|||
143067418|NCT00292188|515788721|FG002|Single-Blind|Lack of Efficacy|0|||
143067419|NCT00292188|515788719|FG000|Single-Blind|Laboratory Abnormality|5|||
143170467|NCT00619866|516173548|FG000|Weeks 1 - 12|Adverse Event|0|||
143170468|NCT00619866|516173549|FG001|Weeks 1 - 12|Adverse Event|1|||
143170469|NCT00619866|516173550|FG002|Weeks 1 - 12|Adverse Event|2|||
143170470|NCT00619866|516173551|FG003|Weeks 1 - 12|Adverse Event|0|||
143170471|NCT00619866|516173552|FG004|Weeks 1 - 12|Adverse Event|0|||
143170472|NCT00619866|516173548|FG000|Weeks 1 - 12|Non-compliance|0|||
143170473|NCT00619866|516173549|FG001|Weeks 1 - 12|Non-compliance|0|||
143170474|NCT00619866|516173550|FG002|Weeks 1 - 12|Non-compliance|1|||
143170475|NCT00619866|516173551|FG003|Weeks 1 - 12|Non-compliance|0|||
143170476|NCT00619866|516173552|FG004|Weeks 1 - 12|Non-compliance|0|||
143170477|NCT00619866|516173548|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
143170478|NCT00619866|516173549|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
143170479|NCT00619866|516173550|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
143365177|NCT02223793|516880668|FG000|Overall Study|Withdrawal by Subject|3|||
143365178|NCT02223793|516880669|FG001|Overall Study|Withdrawal by Subject|2|||
143365179|NCT02223793|516880670|FG002|Overall Study|Withdrawal by Subject|3|||
143067420|NCT00292188|515788720|FG001|Single-Blind|Laboratory Abnormality|0|||
143067421|NCT00292188|515788721|FG002|Single-Blind|Laboratory Abnormality|0|||
143067422|NCT00292188|515788719|FG000|Single-Blind|Lost to Follow-up|3|||
143170480|NCT00619866|516173551|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
143170481|NCT00619866|516173552|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
143170482|NCT00619866|516173548|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
143170483|NCT00619866|516173549|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
143170484|NCT00619866|516173550|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
143170485|NCT00619866|516173551|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
143170486|NCT00619866|516173552|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
143170487|NCT00619866|516173548|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
143170488|NCT00619866|516173549|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
143170489|NCT00619866|516173550|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
143170490|NCT00619866|516173551|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
143170491|NCT00619866|516173552|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
143170492|NCT00619866|516173548|FG000|Weeks 1 - 12|Sponsor Decision|0|||
143170493|NCT00619866|516173549|FG001|Weeks 1 - 12|Sponsor Decision|1|||
143170494|NCT00619866|516173550|FG002|Weeks 1 - 12|Sponsor Decision|0|||
143170495|NCT00619866|516173551|FG003|Weeks 1 - 12|Sponsor Decision|0|||
143170496|NCT00619866|516173552|FG004|Weeks 1 - 12|Sponsor Decision|0|||
143170497|NCT00619866|516173548|FG000|Weeks 13 - 24|Adverse Event|0|||
143170498|NCT00619866|516173549|FG001|Weeks 13 - 24|Adverse Event|0|||
143170499|NCT00619866|516173550|FG002|Weeks 13 - 24|Adverse Event|2|||
143067423|NCT00292188|515788720|FG001|Single-Blind|Lost to Follow-up|0|||
143170500|NCT00619866|516173551|FG003|Weeks 13 - 24|Adverse Event|1|||
143067424|NCT00292188|515788721|FG002|Single-Blind|Lost to Follow-up|0|||
143067425|NCT00292188|515788719|FG000|Single-Blind|Other|77|||
143067426|NCT00292188|515788720|FG001|Single-Blind|Other|0|||
143067427|NCT00292188|515788721|FG002|Single-Blind|Other|0|||
143067428|NCT00292188|515788719|FG000|Single-Blind|Withdrawal by Subject|12|||
143170501|NCT00619866|516173552|FG004|Weeks 13 - 24|Adverse Event|0|||
143170502|NCT00619866|516173548|FG000|Weeks 13 - 24|Protocol Deviation|0|||
143503088|NCT00408005|517380959|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
143067429|NCT00292188|515788720|FG001|Single-Blind|Withdrawal by Subject|0|||
143170503|NCT00619866|516173549|FG001|Weeks 13 - 24|Protocol Deviation|0|||
143170504|NCT00619866|516173550|FG002|Weeks 13 - 24|Protocol Deviation|0|||
143170505|NCT00619866|516173551|FG003|Weeks 13 - 24|Protocol Deviation|1|||
143503089|NCT00408005|517380960|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
143503090|NCT00408005|517380961|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
143503091|NCT00408005|517380962|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
143503092|NCT00408005|517380963|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
143067430|NCT00292188|515788721|FG002|Single-Blind|Withdrawal by Subject|0|||
143067431|NCT00292188|515788719|FG000|Single-Blind|Did not receive treatment|1|||
143067432|NCT00292188|515788720|FG001|Single-Blind|Did not receive treatment|0|||
143067433|NCT00292188|515788721|FG002|Single-Blind|Did not receive treatment|0|||
143067434|NCT00292188|515788719|FG000|Double-Blind|Adverse Event|0|||
143067435|NCT00292188|515788720|FG001|Double-Blind|Adverse Event|25|||
143067436|NCT00292188|515788721|FG002|Double-Blind|Adverse Event|9|||
143067437|NCT00292188|515788719|FG000|Double-Blind|Lack of Efficacy|0|||
143067438|NCT00292188|515788720|FG001|Double-Blind|Lack of Efficacy|2|||
143067439|NCT00292188|515788721|FG002|Double-Blind|Lack of Efficacy|12|||
143067440|NCT00292188|515788719|FG000|Double-Blind|Lost to Follow-up|0|||
143170506|NCT00619866|516173552|FG004|Weeks 13 - 24|Protocol Deviation|0|||
143170507|NCT00619866|516173548|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
143170508|NCT00619866|516173549|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
143170509|NCT00619866|516173550|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
143170510|NCT00619866|516173551|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
143170511|NCT00619866|516173552|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
143170512|NCT00619866|516173548|FG000|Weeks 13 - 24|Non-compliance|0|||
143170513|NCT00619866|516173549|FG001|Weeks 13 - 24|Non-compliance|1|||
143170514|NCT00619866|516173550|FG002|Weeks 13 - 24|Non-compliance|1|||
143170515|NCT00619866|516173551|FG003|Weeks 13 - 24|Non-compliance|0|||
143170516|NCT00619866|516173552|FG004|Weeks 13 - 24|Non-compliance|0|||
143170517|NCT00619866|516173548|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
143170518|NCT00619866|516173549|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
143170519|NCT00619866|516173550|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
143170520|NCT00619866|516173551|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
143170521|NCT00619866|516173552|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
143170522|NCT03510273|516173554|FG000|Overall Study|Withdrawal by Subject|2|||
143170523|NCT03510273|516173554|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
143170524|NCT03510273|516173554|FG000|Overall Study|Moved away from study area|4|||
143170525|NCT01121757|516173555|FG000|First Drug|Death|1|||
143170526|NCT01121757|516173556|FG001|First Drug|Death|0|||
143170527|NCT01121757|516173555|FG000|First Drug|Disease Progression|0|||
143170528|NCT01121757|516173556|FG001|First Drug|Disease Progression|2|||
143170529|NCT01121757|516173555|FG000|Combination|Physician Decision|0|||
143170530|NCT01121757|516173556|FG001|Combination|Physician Decision|1|||
143170531|NCT01121757|516173555|FG000|Combination|Disease Progression|2|||
143170532|NCT01121757|516173556|FG001|Combination|Disease Progression|0|||
143170533|NCT05901636|516173575|FG000|Overall Study|Lost to Follow-up|0|||
143170534|NCT05901636|516173576|FG001|Overall Study|Lost to Follow-up|1|||
143170535|NCT05901636|516173577|FG002|Overall Study|Lost to Follow-up|0|||
143170536|NCT05901636|516173578|FG003|Overall Study|Lost to Follow-up|1|||
143170537|NCT05901636|516173579|FG004|Overall Study|Lost to Follow-up|1|||
143170538|NCT05901636|516173580|FG005|Overall Study|Lost to Follow-up|3|||
143170539|NCT05901636|516173581|FG006|Overall Study|Lost to Follow-up|1|||
143170540|NCT05901636|516173575|FG000|Overall Study|Non- Compliance With Study Schedule|0|||
143170541|NCT05901636|516173576|FG001|Overall Study|Non- Compliance With Study Schedule|0|||
143170542|NCT05901636|516173577|FG002|Overall Study|Non- Compliance With Study Schedule|2|||
143170543|NCT05901636|516173578|FG003|Overall Study|Non- Compliance With Study Schedule|1|||
143170544|NCT05901636|516173579|FG004|Overall Study|Non- Compliance With Study Schedule|0|||
143170545|NCT05901636|516173580|FG005|Overall Study|Non- Compliance With Study Schedule|0|||
143170546|NCT05901636|516173581|FG006|Overall Study|Non- Compliance With Study Schedule|2|||
143170547|NCT05901636|516173575|FG000|Overall Study|Withdrawal by Subject|1|||
143170548|NCT05901636|516173576|FG001|Overall Study|Withdrawal by Subject|1|||
143170549|NCT05901636|516173577|FG002|Overall Study|Withdrawal by Subject|0|||
143170550|NCT05901636|516173578|FG003|Overall Study|Withdrawal by Subject|0|||
143170551|NCT05901636|516173579|FG004|Overall Study|Withdrawal by Subject|1|||
143170552|NCT05901636|516173580|FG005|Overall Study|Withdrawal by Subject|1|||
143170553|NCT05901636|516173581|FG006|Overall Study|Withdrawal by Subject|0|||
143170554|NCT05901636|516173575|FG000|Overall Study|Other|0|||
143067441|NCT00292188|515788720|FG001|Double-Blind|Lost to Follow-up|1|||
143067442|NCT00292188|515788721|FG002|Double-Blind|Lost to Follow-up|0|||
143067443|NCT00292188|515788719|FG000|Double-Blind|Other|0|||
143170555|NCT05901636|516173576|FG001|Overall Study|Other|0|||
143067444|NCT00292188|515788720|FG001|Double-Blind|Other|3|||
143170556|NCT05901636|516173577|FG002|Overall Study|Other|1|||
143170557|NCT05901636|516173578|FG003|Overall Study|Other|1|||
143170558|NCT05901636|516173579|FG004|Overall Study|Other|0|||
143170559|NCT05901636|516173580|FG005|Overall Study|Other|0|||
143170560|NCT05901636|516173581|FG006|Overall Study|Other|0|||
143170561|NCT02303821|516173582|FG000|Overall Study|Withdrawal by Subject|0|||
143170562|NCT02303821|516173583|FG001|Overall Study|Withdrawal by Subject|0|||
143170563|NCT02303821|516173584|FG002|Overall Study|Withdrawal by Subject|0|||
143246158|NCT01976741|516453433|FG009|Overall Study|Withdrawal by Subject|0|||
143246159|NCT01976741|516453424|FG000|Overall Study|Adverse Event|0|||
143246160|NCT01976741|516453425|FG001|Overall Study|Adverse Event|0|||
143246161|NCT01976741|516453426|FG002|Overall Study|Adverse Event|2|||
143246162|NCT01976741|516453427|FG003|Overall Study|Adverse Event|0|||
143503093|NCT00408005|517380964|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
143503094|NCT00408005|517380965|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
143503095|NCT00408005|517380958|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
143503096|NCT00408005|517380959|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
143503097|NCT00408005|517380960|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
143503098|NCT00408005|517380961|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
143503099|NCT00408005|517380962|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
143503100|NCT00408005|517380963|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
143503101|NCT00408005|517380964|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
143503102|NCT00408005|517380965|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
143503103|NCT00408005|517380958|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
143503104|NCT00408005|517380959|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
143067445|NCT00292188|515788721|FG002|Double-Blind|Other|4|||
143067446|NCT00292188|515788719|FG000|Double-Blind|Withdrawal by Subject|0|||
143067447|NCT00292188|515788720|FG001|Double-Blind|Withdrawal by Subject|0|||
143067448|NCT00292188|515788721|FG002|Double-Blind|Withdrawal by Subject|3|||
143067449|NCT00292188|515788719|FG000|Double-Blind|Laboratory Abnormality|0|||
143067450|NCT00292188|515788720|FG001|Double-Blind|Laboratory Abnormality|0|||
143067451|NCT00292188|515788721|FG002|Double-Blind|Laboratory Abnormality|1|||
143067452|NCT04322149|515788722|FG000|Overall Study|Adverse Event|1|||
143067453|NCT04322149|515788723|FG001|Overall Study|Adverse Event|1|||
143067454|NCT04322149|515788724|FG002|Overall Study|Adverse Event|0|||
143503105|NCT00408005|517380960|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
143503106|NCT00408005|517380961|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
143503107|NCT00408005|517380962|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
143503108|NCT00408005|517380963|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
143067455|NCT04322149|515788725|FG003|Overall Study|Adverse Event|0|||
143067456|NCT04322149|515788722|FG000|Overall Study|Withdrawal by Subject|0|||
143067457|NCT04322149|515788723|FG001|Overall Study|Withdrawal by Subject|0|||
143067458|NCT04322149|515788724|FG002|Overall Study|Withdrawal by Subject|0|||
143067459|NCT04322149|515788725|FG003|Overall Study|Withdrawal by Subject|2|||
143067460|NCT04322149|515788722|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
143067461|NCT04322149|515788723|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
143067462|NCT04322149|515788724|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
143067463|NCT04322149|515788725|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
143067464|NCT00103311|515788728|FG000|Overall Study|Lost to Follow-up|1|||
143067465|NCT00103311|515788729|FG001|Overall Study|Lost to Follow-up|0|||
143067466|NCT00103311|515788728|FG000|Overall Study|Withdrawal by Subject|2|||
143067467|NCT00103311|515788729|FG001|Overall Study|Withdrawal by Subject|1|||
143067468|NCT00103311|515788728|FG000|Overall Study|Adverse Event|1|||
143067469|NCT00103311|515788729|FG001|Overall Study|Adverse Event|0|||
143067470|NCT00891371|515788730|FG000|Pre-assignment|Inclusion/exclusion|5|||
143067471|NCT00891371|515788730|FG000|Pre-assignment|Consent withdrawal|1|||
143067472|NCT00891371|515788730|FG000|Treatment|Lack of Efficacy|5|||
143067473|NCT00891371|515788730|FG000|Treatment|Adverse Event|2|||
143503109|NCT00408005|517380964|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
143503110|NCT00408005|517380965|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
143503111|NCT03155997|517380966|FG000|Overall Study|Withdrawal by Subject|119|||
143503112|NCT03155997|517380967|FG001|Overall Study|Withdrawal by Subject|134|||
143503113|NCT03155997|517380966|FG000|Overall Study|Lost to Follow-up|12|||
143503114|NCT03155997|517380967|FG001|Overall Study|Lost to Follow-up|13|||
143503115|NCT03155997|517380966|FG000|Overall Study|Missing disposition data|0|||
143503116|NCT03155997|517380967|FG001|Overall Study|Missing disposition data|1|||
143503117|NCT03155997|517380966|FG000|Overall Study|On study treatment|2027|||
143503118|NCT03155997|517380967|FG001|Overall Study|On study treatment|2074|||
143067474|NCT00891371|515788730|FG000|Treatment|Death|1|||
143067475|NCT00891371|515788730|FG000|Treatment|Lost to Follow-up|1|||
143246163|NCT01976741|516453428|FG004|Overall Study|Adverse Event|0|||
143246164|NCT01976741|516453429|FG005|Overall Study|Adverse Event|0|||
143246165|NCT01976741|516453430|FG006|Overall Study|Adverse Event|3|||
143067476|NCT00857792|515788731|FG000|Overall Study|inadequate image quality for analysis|12|||
143067477|NCT00270257|515788732|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
143246166|NCT01976741|516453431|FG007|Overall Study|Adverse Event|8|||
143246167|NCT01976741|516453432|FG008|Overall Study|Adverse Event|1|||
143067478|NCT00270257|515788733|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
143067479|NCT01195103|515788734|FG000|Overall Study|Withdrawal by Subject|1|||
143067480|NCT01195103|515788735|FG001|Overall Study|Withdrawal by Subject|0|||
143067481|NCT01195103|515788736|FG002|Overall Study|Withdrawal by Subject|0|||
143067482|NCT00307034|515788737|FG000|Overall Study|Adverse Event|1|||
143067483|NCT00307034|515788738|FG001|Overall Study|Adverse Event|2|||
143067484|NCT00307034|515788737|FG000|Overall Study|Withdrawal by Subject|1|||
143067485|NCT00307034|515788738|FG001|Overall Study|Withdrawal by Subject|2|||
143067486|NCT00307034|515788737|FG000|Overall Study|Lost to Follow-up|0|||
143067487|NCT00307034|515788738|FG001|Overall Study|Lost to Follow-up|3|||
143067488|NCT02621034|515788739|FG000|Overall Study|Lost to Follow-up|3|||
143067489|NCT02621034|515788740|FG001|Overall Study|Lost to Follow-up|2|||
143067490|NCT02621034|515788741|FG002|Overall Study|Lost to Follow-up|5|||
143067491|NCT01691820|515788755|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
143067492|NCT01691820|515788756|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
143067493|NCT01691820|515788755|FG000|Overall Study|Migrated/moved from study area|7|||
143067494|NCT01691820|515788756|FG001|Overall Study|Migrated/moved from study area|4|||
143067495|NCT01691820|515788755|FG000|Overall Study|Lost to Follow-up|6|||
143067496|NCT01691820|515788756|FG001|Overall Study|Lost to Follow-up|17|||
143067497|NCT01691820|515788755|FG000|Overall Study|Other (unspecified)|4|||
143067498|NCT01691820|515788756|FG001|Overall Study|Other (unspecified)|1|||
143067499|NCT01780987|515788769|FG000|Overall Study|Adverse Event|0|||
143067500|NCT01780987|515788770|FG001|Overall Study|Adverse Event|4|||
143503119|NCT04067518|517380968|FG000|Overall Study|Adverse Event|1|||
143503120|NCT04067518|517380969|FG001|Overall Study|Adverse Event|3|||
143503121|NCT04067518|517380968|FG000|Overall Study|Screen failures|0|||
143503122|NCT04067518|517380969|FG001|Overall Study|Screen failures|1|||
143503123|NCT04067518|517380968|FG000|Overall Study|Enrolled but not treated|0|||
143503124|NCT04067518|517380969|FG001|Overall Study|Enrolled but not treated|1|||
143503125|NCT00792298|517380975|FG000|Treatment Period 1|Adverse Event|0|||
143503126|NCT00792298|517380976|FG001|Treatment Period 1|Adverse Event|1|||
143503127|NCT00792298|517380977|FG002|Treatment Period 1|Adverse Event|0|||
143503128|NCT00792298|517380978|FG003|Treatment Period 1|Adverse Event|1|||
143503129|NCT00792298|517380979|FG004|Treatment Period 1|Adverse Event|0|||
143067501|NCT01780987|515788769|FG000|Overall Study|Withdrawal by Subject|2|||
143503130|NCT00792298|517380980|FG005|Treatment Period 1|Adverse Event|1|||
143503131|NCT00792298|517380981|FG006|Treatment Period 1|Adverse Event|1|||
143503132|NCT00792298|517380982|FG007|Treatment Period 1|Adverse Event|0|||
143503133|NCT00792298|517380975|FG000|Treatment Period 1|Lack of Efficacy|0|||
143503134|NCT00792298|517380976|FG001|Treatment Period 1|Lack of Efficacy|0|||
143503135|NCT00792298|517380977|FG002|Treatment Period 1|Lack of Efficacy|1|||
143503136|NCT00792298|517380978|FG003|Treatment Period 1|Lack of Efficacy|0|||
143503137|NCT00792298|517380979|FG004|Treatment Period 1|Lack of Efficacy|0|||
143503138|NCT00792298|517380980|FG005|Treatment Period 1|Lack of Efficacy|0|||
143503139|NCT00792298|517380981|FG006|Treatment Period 1|Lack of Efficacy|0|||
143503140|NCT00792298|517380982|FG007|Treatment Period 1|Lack of Efficacy|0|||
143503141|NCT00792298|517380975|FG000|Treatment Period 1|Withdrawal by Subject|1|||
143503142|NCT00792298|517380976|FG001|Treatment Period 1|Withdrawal by Subject|0|||
143503143|NCT00792298|517380977|FG002|Treatment Period 1|Withdrawal by Subject|1|||
143503144|NCT00792298|517380978|FG003|Treatment Period 1|Withdrawal by Subject|2|||
143503145|NCT00792298|517380979|FG004|Treatment Period 1|Withdrawal by Subject|0|||
143067502|NCT01780987|515788770|FG001|Overall Study|Withdrawal by Subject|0|||
143067503|NCT01780987|515788769|FG000|Overall Study|Request of Changing Hospital|0|||
143067504|NCT01780987|515788770|FG001|Overall Study|Request of Changing Hospital|1|||
143067505|NCT01780987|515788769|FG000|Overall Study|Changing Residence|1|||
143067506|NCT01780987|515788770|FG001|Overall Study|Changing Residence|0|||
143067507|NCT01780987|515788769|FG000|Overall Study|Not Receiving any Study Medication|0|||
143067508|NCT01780987|515788770|FG001|Overall Study|Not Receiving any Study Medication|1|||
143067509|NCT04168190|515788771|FG000|Overall Study|Lost to Follow-up|0|||
143067510|NCT04168190|515788772|FG001|Overall Study|Lost to Follow-up|1|||
143067511|NCT04168190|515788773|FG002|Overall Study|Lost to Follow-up|0|||
143503146|NCT00792298|517380980|FG005|Treatment Period 1|Withdrawal by Subject|2|||
143067512|NCT04168190|515788774|FG003|Overall Study|Lost to Follow-up|7|||
143067513|NCT04168190|515788775|FG004|Overall Study|Lost to Follow-up|5|||
143067514|NCT04168190|515788771|FG000|Overall Study|Withdrawal by Subject|1|||
143067515|NCT04168190|515788772|FG001|Overall Study|Withdrawal by Subject|0|||
143067516|NCT04168190|515788773|FG002|Overall Study|Withdrawal by Subject|0|||
143067517|NCT04168190|515788774|FG003|Overall Study|Withdrawal by Subject|2|||
143067518|NCT04168190|515788775|FG004|Overall Study|Withdrawal by Subject|4|||
143067519|NCT04168190|515788771|FG000|Overall Study|Death|0|||
143503147|NCT00792298|517380981|FG006|Treatment Period 1|Withdrawal by Subject|1|||
143503148|NCT00792298|517380982|FG007|Treatment Period 1|Withdrawal by Subject|0|||
143503149|NCT00792298|517380975|FG000|Treatment Period 1|Lost to Follow-up|0|||
143503150|NCT00792298|517380976|FG001|Treatment Period 1|Lost to Follow-up|0|||
143503151|NCT00792298|517380977|FG002|Treatment Period 1|Lost to Follow-up|0|||
143503152|NCT00792298|517380978|FG003|Treatment Period 1|Lost to Follow-up|0|||
143503153|NCT00792298|517380979|FG004|Treatment Period 1|Lost to Follow-up|0|||
143503154|NCT00792298|517380980|FG005|Treatment Period 1|Lost to Follow-up|0|||
143067520|NCT04168190|515788772|FG001|Overall Study|Death|0|||
143067521|NCT04168190|515788773|FG002|Overall Study|Death|0|||
143067522|NCT04168190|515788774|FG003|Overall Study|Death|1|||
143067523|NCT04168190|515788775|FG004|Overall Study|Death|0|||
143067524|NCT02335983|515788776|FG000|Overall Study|Sponsor Decision|0|||
143067525|NCT02335983|515788777|FG001|Overall Study|Sponsor Decision|0|||
143067526|NCT02335983|515788778|FG002|Overall Study|Sponsor Decision|1|||
143067527|NCT02335983|515788779|FG003|Overall Study|Sponsor Decision|1|||
143067528|NCT02335983|515788780|FG004|Overall Study|Sponsor Decision|0|||
143067529|NCT02335983|515788781|FG005|Overall Study|Sponsor Decision|1|||
143067530|NCT02335983|515788776|FG000|Overall Study|Withdrawal by Subject|3|||
143067531|NCT02335983|515788777|FG001|Overall Study|Withdrawal by Subject|2|||
143067532|NCT02335983|515788778|FG002|Overall Study|Withdrawal by Subject|2|||
143067533|NCT02335983|515788779|FG003|Overall Study|Withdrawal by Subject|1|||
143067534|NCT02335983|515788780|FG004|Overall Study|Withdrawal by Subject|3|||
143067535|NCT02335983|515788781|FG005|Overall Study|Withdrawal by Subject|9|||
143067536|NCT02335983|515788776|FG000|Overall Study|Death|0|||
143067537|NCT02335983|515788777|FG001|Overall Study|Death|0|||
143067538|NCT02335983|515788778|FG002|Overall Study|Death|2|||
143067539|NCT02335983|515788779|FG003|Overall Study|Death|0|||
143067540|NCT02335983|515788780|FG004|Overall Study|Death|0|||
143067541|NCT02335983|515788781|FG005|Overall Study|Death|0|||
143067542|NCT02335983|515788776|FG000|Overall Study|Lost to Follow-up|0|||
143067543|NCT02335983|515788777|FG001|Overall Study|Lost to Follow-up|0|||
143067544|NCT02335983|515788778|FG002|Overall Study|Lost to Follow-up|0|||
143067545|NCT02335983|515788779|FG003|Overall Study|Lost to Follow-up|0|||
143067546|NCT02335983|515788780|FG004|Overall Study|Lost to Follow-up|0|||
143067547|NCT02335983|515788781|FG005|Overall Study|Lost to Follow-up|1|||
143067548|NCT02335983|515788776|FG000|Overall Study|Protocol Specified Criteria|5|||
143067549|NCT02335983|515788777|FG001|Overall Study|Protocol Specified Criteria|7|||
143067550|NCT02335983|515788778|FG002|Overall Study|Protocol Specified Criteria|27|||
143067551|NCT02335983|515788779|FG003|Overall Study|Protocol Specified Criteria|7|||
143067552|NCT02335983|515788780|FG004|Overall Study|Protocol Specified Criteria|5|||
143246168|NCT01976741|516453433|FG009|Overall Study|Adverse Event|4|||
143246169|NCT00670306|516453434|FG000|Overall Study|Adverse Event|8|||
143246170|NCT00670306|516453434|FG000|Overall Study|Lack of Efficacy|10|||
143246171|NCT00670306|516453434|FG000|Overall Study|Withdrawal by Subject|9|||
143246172|NCT00670306|516453434|FG000|Overall Study|Physician Decision|1|||
143246173|NCT00670306|516453434|FG000|Overall Study|Lost to Follow-up|8|||
143246174|NCT00670306|516453434|FG000|Overall Study|incl/excl criterias did not meet|19|||
143246175|NCT02067676|516453435|FG000|Overall Study|Withdrawal by Subject|1|||
143246176|NCT02067676|516453436|FG001|Overall Study|Withdrawal by Subject|0|||
143246177|NCT02067676|516453437|FG002|Overall Study|Withdrawal by Subject|0|||
143246178|NCT02067676|516453438|FG003|Overall Study|Withdrawal by Subject|0|||
143246179|NCT02067676|516453439|FG004|Overall Study|Withdrawal by Subject|0|||
143246180|NCT02067676|516453440|FG005|Overall Study|Withdrawal by Subject|0|||
143246181|NCT00996333|516453441|FG000|Overall Study|Screen failure|1|||
143246182|NCT00996333|516453441|FG000|Overall Study|Withdrawal by Subject|1|||
143246183|NCT00996333|516453441|FG000|Overall Study|Death|4|||
143246184|NCT00996333|516453441|FG000|Overall Study|Adverse Event|1|||
143246185|NCT00996333|516453441|FG000|Overall Study|Physician Decision|1|||
143246186|NCT00996333|516453441|FG000|Overall Study|Other|5|||
143246187|NCT03865381|516453444|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
143246188|NCT03865381|516453444|FG000|Overall Study|Withdrawal by Subject|2|||
143246189|NCT04999852|516453445|FG000|Overall Study|Withdrawal by Subject|11|||
143246190|NCT04999852|516453446|FG001|Overall Study|Withdrawal by Subject|1|||
143246191|NCT04999852|516453445|FG000|Overall Study|Switched to different psychotherapy that was ineligible for study|2|||
143503155|NCT00792298|517380981|FG006|Treatment Period 1|Lost to Follow-up|1|||
143067553|NCT02335983|515788781|FG005|Overall Study|Protocol Specified Criteria|21|||
143246192|NCT04999852|516453446|FG001|Overall Study|Switched to different psychotherapy that was ineligible for study|0|||
143246193|NCT05626322|516453447|FG000|Overall Study|Death|2|||
143246194|NCT05626322|516453448|FG001|Overall Study|Death|0|||
143246195|NCT05626322|516453449|FG002|Overall Study|Death|0|||
143067554|NCT00629265|515788782|FG000|Overall Study|Lost to Follow-up|4|||
143067555|NCT00629265|515788783|FG001|Overall Study|Lost to Follow-up|5|||
143067556|NCT00629265|515788782|FG000|Overall Study|Withdrawal by Subject|11|||
143067557|NCT00629265|515788783|FG001|Overall Study|Withdrawal by Subject|8|||
143067558|NCT00629265|515788782|FG000|Overall Study|Death|1|||
143067559|NCT00629265|515788783|FG001|Overall Study|Death|0|||
143067560|NCT00629265|515788782|FG000|Overall Study|Adverse Event|2|||
143067561|NCT00629265|515788783|FG001|Overall Study|Adverse Event|0|||
143067562|NCT00629265|515788782|FG000|Overall Study|HNC Recurrence|4|||
143246196|NCT05626322|516453447|FG000|Overall Study|Physician Decision|1|||
143246197|NCT05626322|516453448|FG001|Overall Study|Physician Decision|0|||
143246198|NCT05626322|516453449|FG002|Overall Study|Physician Decision|0|||
143246199|NCT05626322|516453447|FG000|Overall Study|Progressive Disease|0|||
143246200|NCT05626322|516453448|FG001|Overall Study|Progressive Disease|1|||
143067563|NCT00629265|515788783|FG001|Overall Study|HNC Recurrence|0|||
143067564|NCT00629265|515788782|FG000|Overall Study|Other CA Requiring Treatment|1|||
143067565|NCT00629265|515788783|FG001|Overall Study|Other CA Requiring Treatment|3|||
143067566|NCT00629265|515788782|FG000|Overall Study|Needed Esophageal Dilation|4|||
143067567|NCT00629265|515788783|FG001|Overall Study|Needed Esophageal Dilation|1|||
143067568|NCT00629265|515788782|FG000|Overall Study|Unrelated Medical Complications|3|||
143067569|NCT00629265|515788783|FG001|Overall Study|Unrelated Medical Complications|1|||
143067570|NCT00629265|515788782|FG000|Overall Study|Unknown Reason|2|||
143067571|NCT00629265|515788783|FG001|Overall Study|Unknown Reason|2|||
143067572|NCT02458092|515788789|FG000|Overall Study|Withdrawal by Subject|1|||
143067573|NCT02458092|515788790|FG001|Overall Study|Withdrawal by Subject|0|||
143067574|NCT00251641|515788791|FG000|Overall Study|Adverse Event|80|||
143067575|NCT00251641|515788792|FG001|Overall Study|Adverse Event|8|||
143067576|NCT00251641|515788791|FG000|Overall Study|Lack of Efficacy|2|||
143067577|NCT00251641|515788792|FG001|Overall Study|Lack of Efficacy|1|||
143067578|NCT00251641|515788791|FG000|Overall Study|Progression of Disease|0|||
143067579|NCT00251641|515788792|FG001|Overall Study|Progression of Disease|2|||
143067580|NCT00251641|515788791|FG000|Overall Study|Lost to Follow-up|3|||
143067581|NCT00251641|515788792|FG001|Overall Study|Lost to Follow-up|3|||
143067582|NCT00251641|515788791|FG000|Overall Study|Withdrawal by Subject|6|||
143067583|NCT00251641|515788792|FG001|Overall Study|Withdrawal by Subject|8|||
143067584|NCT00251641|515788791|FG000|Overall Study|Protocol Violation|10|||
143067585|NCT00251641|515788792|FG001|Overall Study|Protocol Violation|2|||
143067586|NCT00251641|515788791|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
143067587|NCT00251641|515788792|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
143067588|NCT00251641|515788791|FG000|Overall Study|Switched Treatment|9|||
143067589|NCT00251641|515788792|FG001|Overall Study|Switched Treatment|63|||
143067590|NCT00876018|515788793|FG000|Overall Study|Lost to Follow-up|0|||
143067591|NCT00876018|515788794|FG001|Overall Study|Lost to Follow-up|1|||
143067592|NCT00876018|515788795|FG002|Overall Study|Lost to Follow-up|1|||
143067593|NCT00876018|515788793|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
143067594|NCT00876018|515788794|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
143067595|NCT00876018|515788795|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
143067596|NCT01189500|515788796|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
143067597|NCT01189500|515788796|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
143067598|NCT00532935|515788800|FG000|Overall Study|Adverse Event|11|||
143067599|NCT00532935|515788801|FG001|Overall Study|Adverse Event|12|||
143067600|NCT00532935|515788800|FG000|Overall Study|Lack of Efficacy|0|||
143067601|NCT00532935|515788801|FG001|Overall Study|Lack of Efficacy|3|||
143067602|NCT00532935|515788800|FG000|Overall Study|Lost to Follow-up|10|||
143067603|NCT00532935|515788801|FG001|Overall Study|Lost to Follow-up|6|||
143067604|NCT00532935|515788800|FG000|Overall Study|Physician Decision|4|||
143067605|NCT00532935|515788801|FG001|Overall Study|Physician Decision|5|||
143067606|NCT00532935|515788800|FG000|Overall Study|Pregnancy|1|||
143067607|NCT00532935|515788801|FG001|Overall Study|Pregnancy|0|||
143067608|NCT00532935|515788800|FG000|Overall Study|Protocol Violation|4|||
143067609|NCT00532935|515788801|FG001|Overall Study|Protocol Violation|2|||
143067610|NCT00532935|515788800|FG000|Overall Study|Withdrawal by Subject|10|||
143067611|NCT00532935|515788801|FG001|Overall Study|Withdrawal by Subject|9|||
143067612|NCT00532935|515788800|FG000|Overall Study|Protocol Specific Criteria|11|||
143067613|NCT00532935|515788801|FG001|Overall Study|Protocol Specific Criteria|15|||
143067614|NCT00456495|515788802|FG000|Overall Study|Physician Decision|2|||
143067615|NCT01301508|515788803|FG000|Overall Study|Withdrawal by Subject|1|||
143067616|NCT01301508|515788804|FG001|Overall Study|Withdrawal by Subject|2|||
143067617|NCT01301508|515788803|FG000|Overall Study|Lost to Follow-up|0|||
143067618|NCT01301508|515788804|FG001|Overall Study|Lost to Follow-up|1|||
143067619|NCT02192164|515788805|FG000|Overall Study|Other|8|||
143067620|NCT02192164|515788805|FG000|Overall Study|Withdrawal by Subject|1|||
143067621|NCT02192164|515788805|FG000|Overall Study|Physician Decision|4|||
143067622|NCT02192164|515788805|FG000|Overall Study|Did not meet the exclusion criteria|1|||
143067623|NCT01300923|515788806|FG000|Overall Study|Physician Decision|0|||
143067624|NCT01300923|515788807|FG001|Overall Study|Physician Decision|2|||
143067625|NCT01940497|515788810|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
143067626|NCT01940497|515788811|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
143067627|NCT01940497|515788810|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
143067628|NCT01940497|515788811|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
143067629|NCT01940497|515788810|FG000|Overall Study|Violation of Entry Criteria|1|||
143067630|NCT01940497|515788811|FG001|Overall Study|Violation of Entry Criteria|1|||
143067631|NCT01940497|515788810|FG000|Overall Study|Refused Treatment|1|||
143067632|NCT01940497|515788811|FG001|Overall Study|Refused Treatment|3|||
143067633|NCT01940497|515788810|FG000|Overall Study|Withdrew Consent|6|||
143067634|NCT01940497|515788811|FG001|Overall Study|Withdrew Consent|2|||
143067635|NCT01940497|515788810|FG000|Overall Study|Administrative/Other|1|||
143067636|NCT01940497|515788811|FG001|Overall Study|Administrative/Other|1|||
143067637|NCT02707861|515788812|FG000|Overall Study|Went onto commercial drug|30|||
143067638|NCT02707861|515788813|FG001|Overall Study|Went onto commercial drug|23|||
143067639|NCT02707861|515788812|FG000|Overall Study|Adverse Event|2|||
143067640|NCT02707861|515788813|FG001|Overall Study|Adverse Event|3|||
143067641|NCT02707861|515788812|FG000|Overall Study|Death|5|||
143067642|NCT02707861|515788813|FG001|Overall Study|Death|2|||
143067643|NCT02707861|515788812|FG000|Overall Study|Lack of Efficacy|0|||
143067644|NCT02707861|515788813|FG001|Overall Study|Lack of Efficacy|2|||
143067645|NCT02707861|515788812|FG000|Overall Study|Physician Decision|1|||
143067646|NCT02707861|515788813|FG001|Overall Study|Physician Decision|4|||
143067647|NCT02707861|515788812|FG000|Overall Study|Withdrawal by Subject|2|||
143067648|NCT02707861|515788813|FG001|Overall Study|Withdrawal by Subject|1|||
143067649|NCT02707861|515788812|FG000|Overall Study|Lost to Follow-up|1|||
143067650|NCT02707861|515788813|FG001|Overall Study|Lost to Follow-up|3|||
143067651|NCT03123861|515788814|FG000|Overall Study|Protocol Violation|1|||
143067652|NCT03123861|515788815|FG001|Overall Study|Protocol Violation|1|||
143067653|NCT03123861|515788814|FG000|Overall Study|Withdrawal by Subject|2|||
143067654|NCT03123861|515788815|FG001|Overall Study|Withdrawal by Subject|2|||
143067655|NCT00673933|515788816|FG000|Overall Study|Withdrawal by Subject|2|||
143503156|NCT00792298|517380982|FG007|Treatment Period 1|Lost to Follow-up|0|||
143067656|NCT00673933|515788816|FG000|Overall Study|Lost to Follow-up|1|||
143067657|NCT02206620|515788819|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
143067658|NCT02206620|515788820|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
143067659|NCT02206620|515788819|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
143067660|NCT02206620|515788820|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
143067661|NCT01346774|515788821|FG000|Overall Study|Did not take a single dose|6|||
143067662|NCT01346774|515788822|FG001|Overall Study|Did not take a single dose|4|||
143067663|NCT01346774|515788821|FG000|Overall Study|Lost to Follow-up|3|||
143067664|NCT01346774|515788822|FG001|Overall Study|Lost to Follow-up|4|||
143067665|NCT01346774|515788821|FG000|Overall Study|Withdrawal by Subject|1|||
143067666|NCT01346774|515788822|FG001|Overall Study|Withdrawal by Subject|4|||
143067667|NCT01346774|515788821|FG000|Overall Study|Protocol Violation|2|||
143067668|NCT01346774|515788822|FG001|Overall Study|Protocol Violation|3|||
143067669|NCT01346774|515788821|FG000|Overall Study|Adverse Event|1|||
143067670|NCT01346774|515788822|FG001|Overall Study|Adverse Event|2|||
143067671|NCT01929031|515788823|FG000|Overall Study|Adverse Event|3|||
143067672|NCT01929031|515788824|FG001|Overall Study|Adverse Event|1|||
143067673|NCT01929031|515788825|FG002|Overall Study|Adverse Event|1|||
143067674|NCT01929031|515788826|FG003|Overall Study|Adverse Event|0|||
143067675|NCT01929031|515788827|FG004|Overall Study|Adverse Event|0|||
143067676|NCT01929031|515788828|FG005|Overall Study|Adverse Event|0|||
143067677|NCT01929031|515788823|FG000|Overall Study|Protocol Violation|1|||
143067678|NCT01929031|515788824|FG001|Overall Study|Protocol Violation|0|||
143067679|NCT01929031|515788825|FG002|Overall Study|Protocol Violation|0|||
143067680|NCT01929031|515788826|FG003|Overall Study|Protocol Violation|0|||
143067681|NCT01929031|515788827|FG004|Overall Study|Protocol Violation|0|||
143067682|NCT01929031|515788828|FG005|Overall Study|Protocol Violation|1|||
143067683|NCT01929031|515788823|FG000|Overall Study|Reason other than specified above|0|||
143067684|NCT01929031|515788824|FG001|Overall Study|Reason other than specified above|1|||
143067685|NCT01929031|515788825|FG002|Overall Study|Reason other than specified above|0|||
143067686|NCT01929031|515788826|FG003|Overall Study|Reason other than specified above|0|||
143067687|NCT01929031|515788827|FG004|Overall Study|Reason other than specified above|1|||
143067688|NCT01929031|515788828|FG005|Overall Study|Reason other than specified above|0|||
143067689|NCT02394730|515788831|FG000|Overall Study|Lost to Follow-up|1|||
143067690|NCT02394730|515788832|FG001|Overall Study|Lost to Follow-up|0|||
143067691|NCT02394730|515788831|FG000|Overall Study|Withdrawal by Subject|0|||
143067692|NCT02394730|515788832|FG001|Overall Study|Withdrawal by Subject|1|||
143067693|NCT00448136|515788835|FG000|Overall Study|Death|3|||
143067694|NCT00448136|515788836|FG001|Overall Study|Death|8|||
143067695|NCT00448136|515788835|FG000|Overall Study|Investigator's decision (progression)|1|||
143067696|NCT00448136|515788836|FG001|Overall Study|Investigator's decision (progression)|0|||
143067697|NCT00609466|515788837|FG000|Overall Study|Withdrawal by Subject|0|||
143503157|NCT00792298|517380975|FG000|Treatment Period 1|Physician Decision|0|||
143503158|NCT00792298|517380976|FG001|Treatment Period 1|Physician Decision|0|||
143503159|NCT00792298|517380977|FG002|Treatment Period 1|Physician Decision|0|||
143067698|NCT00609466|515788838|FG001|Overall Study|Withdrawal by Subject|1|||
143067699|NCT00609466|515788839|FG002|Overall Study|Withdrawal by Subject|1|||
143067700|NCT00609466|515788837|FG000|Overall Study|Adverse Event|2|||
143067701|NCT00609466|515788838|FG001|Overall Study|Adverse Event|3|||
143246201|NCT05626322|516453449|FG002|Overall Study|Progressive Disease|1|||
143067702|NCT00609466|515788839|FG002|Overall Study|Adverse Event|1|||
143067703|NCT00609466|515788837|FG000|Overall Study|Lack of Efficacy|0|||
143067704|NCT00609466|515788838|FG001|Overall Study|Lack of Efficacy|2|||
143246202|NCT05626322|516453447|FG000|Overall Study|Study terminated by sponsor|0|||
143067705|NCT00609466|515788839|FG002|Overall Study|Lack of Efficacy|2|||
143067706|NCT03512262|515788840|FG000|Overall Study|Adverse Event|8|||
143067707|NCT03512262|515788841|FG001|Overall Study|Adverse Event|3|||
143067708|NCT03512262|515788840|FG000|Overall Study|Death (non-treatment emergent)|1|||
143067709|NCT03512262|515788841|FG001|Overall Study|Death (non-treatment emergent)|0|||
143067710|NCT03512262|515788840|FG000|Overall Study|Withdrawal by Subject|17|||
143503160|NCT00792298|517380978|FG003|Treatment Period 1|Physician Decision|1|||
143067711|NCT03512262|515788841|FG001|Overall Study|Withdrawal by Subject|9|||
143067712|NCT03512262|515788840|FG000|Overall Study|Lost to Follow-up|7|||
143067713|NCT03512262|515788841|FG001|Overall Study|Lost to Follow-up|1|||
143067714|NCT03512262|515788840|FG000|Overall Study|Other than Specified|2|||
143067715|NCT03512262|515788841|FG001|Overall Study|Other than Specified|2|||
143067716|NCT01299805|515788844|FG000|Overall Study|Adverse Event|2|||
143067717|NCT01299805|515788845|FG001|Overall Study|Adverse Event|0|||
143067718|NCT03407430|515788846|FG000|Washout|Protocol Violation|1|||
143067719|NCT03407430|515788847|FG001|Washout|Protocol Violation|0|||
143067720|NCT00922987|515788849|FG000|Overall Study|Insufficient clinical response|1|||
143067721|NCT00922987|515788849|FG000|Overall Study|Protocol Violation|2|||
143067722|NCT00922987|515788849|FG000|Overall Study|Adverse Event|1|||
143067723|NCT03510182|515788850|FG000|Overall Study|Withdrawal by Subject|2|||
143067724|NCT03502707|515790999|FG000|Overall Study|Adverse Event|0|||
143067725|NCT03502707|515791000|FG001|Overall Study|Adverse Event|0|||
143067726|NCT03502707|515791001|FG002|Overall Study|Adverse Event|0|||
143067727|NCT03502707|515791002|FG003|Overall Study|Adverse Event|0|||
143067728|NCT03502707|515791003|FG004|Overall Study|Adverse Event|0|||
143067729|NCT03502707|515791004|FG005|Overall Study|Adverse Event|0|||
143067730|NCT03502707|515791005|FG006|Overall Study|Adverse Event|0|||
143067731|NCT03502707|515791006|FG007|Overall Study|Adverse Event|0|||
143067732|NCT03502707|515791007|FG008|Overall Study|Adverse Event|0|||
143067733|NCT03502707|515791008|FG009|Overall Study|Adverse Event|0|||
143067734|NCT03502707|515791009|FG010|Overall Study|Adverse Event|0|||
143067735|NCT03502707|515791010|FG011|Overall Study|Adverse Event|0|||
143067736|NCT03502707|515791011|FG012|Overall Study|Adverse Event|0|||
143067737|NCT03502707|515791012|FG013|Overall Study|Adverse Event|0|||
143067738|NCT03502707|515791013|FG014|Overall Study|Adverse Event|0|||
143067739|NCT03502707|515791014|FG015|Overall Study|Adverse Event|1|||
143067740|NCT03502707|515791015|FG016|Overall Study|Adverse Event|5|||
143067741|NCT03502707|515791016|FG017|Overall Study|Adverse Event|0|||
143067742|NCT03502707|515790999|FG000|Overall Study|Death|0|||
143067743|NCT03502707|515791000|FG001|Overall Study|Death|0|||
143067744|NCT03502707|515791001|FG002|Overall Study|Death|0|||
143067745|NCT03502707|515791002|FG003|Overall Study|Death|1|||
143067746|NCT03502707|515791003|FG004|Overall Study|Death|0|||
143067747|NCT03502707|515791004|FG005|Overall Study|Death|0|||
143067748|NCT03502707|515791005|FG006|Overall Study|Death|0|||
143067749|NCT03502707|515791006|FG007|Overall Study|Death|0|||
143067750|NCT03502707|515791007|FG008|Overall Study|Death|1|||
143067751|NCT03502707|515791008|FG009|Overall Study|Death|1|||
143067752|NCT03502707|515791009|FG010|Overall Study|Death|0|||
143067753|NCT03502707|515791010|FG011|Overall Study|Death|0|||
143067754|NCT03502707|515791011|FG012|Overall Study|Death|1|||
143067755|NCT03502707|515791012|FG013|Overall Study|Death|0|||
143067756|NCT03502707|515791013|FG014|Overall Study|Death|0|||
143067757|NCT03502707|515791014|FG015|Overall Study|Death|1|||
143067758|NCT03502707|515791015|FG016|Overall Study|Death|0|||
143067759|NCT03502707|515791016|FG017|Overall Study|Death|0|||
143067760|NCT03502707|515790999|FG000|Overall Study|Lost to Follow-up|0|||
143067761|NCT03502707|515791000|FG001|Overall Study|Lost to Follow-up|0|||
143067762|NCT03502707|515791001|FG002|Overall Study|Lost to Follow-up|0|||
143067763|NCT03502707|515791002|FG003|Overall Study|Lost to Follow-up|0|||
143067764|NCT03502707|515791003|FG004|Overall Study|Lost to Follow-up|0|||
143067765|NCT03502707|515791004|FG005|Overall Study|Lost to Follow-up|0|||
143067766|NCT03502707|515791005|FG006|Overall Study|Lost to Follow-up|0|||
143067767|NCT03502707|515791006|FG007|Overall Study|Lost to Follow-up|5|||
143067768|NCT03502707|515791007|FG008|Overall Study|Lost to Follow-up|0|||
143067769|NCT03502707|515791008|FG009|Overall Study|Lost to Follow-up|2|||
143067770|NCT03502707|515791009|FG010|Overall Study|Lost to Follow-up|1|||
143067771|NCT03502707|515791010|FG011|Overall Study|Lost to Follow-up|2|||
143067772|NCT03502707|515791011|FG012|Overall Study|Lost to Follow-up|1|||
143067773|NCT03502707|515791012|FG013|Overall Study|Lost to Follow-up|1|||
143067774|NCT03502707|515791013|FG014|Overall Study|Lost to Follow-up|0|||
143067775|NCT03502707|515791014|FG015|Overall Study|Lost to Follow-up|4|||
143067776|NCT03502707|515791015|FG016|Overall Study|Lost to Follow-up|9|||
143067777|NCT03502707|515791016|FG017|Overall Study|Lost to Follow-up|2|||
143067778|NCT03502707|515790999|FG000|Overall Study|Physician Decision|0|||
143067779|NCT03502707|515791000|FG001|Overall Study|Physician Decision|0|||
143067780|NCT03502707|515791001|FG002|Overall Study|Physician Decision|0|||
143067781|NCT03502707|515791002|FG003|Overall Study|Physician Decision|0|||
143067782|NCT03502707|515791003|FG004|Overall Study|Physician Decision|0|||
143067783|NCT03502707|515791004|FG005|Overall Study|Physician Decision|0|||
143067784|NCT03502707|515791005|FG006|Overall Study|Physician Decision|0|||
143067785|NCT03502707|515791006|FG007|Overall Study|Physician Decision|0|||
143067786|NCT03502707|515791007|FG008|Overall Study|Physician Decision|2|||
143067787|NCT03502707|515791008|FG009|Overall Study|Physician Decision|1|||
143067788|NCT03502707|515791009|FG010|Overall Study|Physician Decision|0|||
143067789|NCT03502707|515791010|FG011|Overall Study|Physician Decision|0|||
143067790|NCT03502707|515791011|FG012|Overall Study|Physician Decision|0|||
143067791|NCT03502707|515791012|FG013|Overall Study|Physician Decision|0|||
143067792|NCT03502707|515791013|FG014|Overall Study|Physician Decision|1|||
143170564|NCT02303821|516173585|FG003|Overall Study|Withdrawal by Subject|0|||
143170565|NCT02303821|516173586|FG004|Overall Study|Withdrawal by Subject|0|||
143170566|NCT02303821|516173587|FG005|Overall Study|Withdrawal by Subject|0|||
143170567|NCT02303821|516173588|FG006|Overall Study|Withdrawal by Subject|0|||
143170568|NCT02303821|516173589|FG007|Overall Study|Withdrawal by Subject|2|||
143170569|NCT02303821|516173582|FG000|Overall Study|Death|0|||
143170570|NCT02303821|516173583|FG001|Overall Study|Death|2|||
143170571|NCT02303821|516173584|FG002|Overall Study|Death|0|||
143170572|NCT02303821|516173585|FG003|Overall Study|Death|0|||
143170573|NCT02303821|516173586|FG004|Overall Study|Death|0|||
143170574|NCT02303821|516173587|FG005|Overall Study|Death|3|||
143170575|NCT02303821|516173588|FG006|Overall Study|Death|41|||
143170576|NCT02303821|516173589|FG007|Overall Study|Death|29|||
143170577|NCT02303821|516173582|FG000|Overall Study|Lost to Follow-up|0|||
143170578|NCT02303821|516173583|FG001|Overall Study|Lost to Follow-up|0|||
143170579|NCT02303821|516173584|FG002|Overall Study|Lost to Follow-up|0|||
143170580|NCT02303821|516173585|FG003|Overall Study|Lost to Follow-up|0|||
143170581|NCT02303821|516173586|FG004|Overall Study|Lost to Follow-up|0|||
143246203|NCT05626322|516453448|FG001|Overall Study|Study terminated by sponsor|1|||
143246204|NCT05626322|516453449|FG002|Overall Study|Study terminated by sponsor|0|||
143246205|NCT03776812|516453450|FG000|Overall Study|Death|53|||
143246206|NCT03776812|516453451|FG001|Overall Study|Death|49|||
143246207|NCT03776812|516453452|FG002|Overall Study|Death|56|||
143246208|NCT03776812|516453450|FG000|Overall Study|Withdrawal by Subject|1|||
143246209|NCT03776812|516453451|FG001|Overall Study|Withdrawal by Subject|7|||
143246210|NCT03776812|516453452|FG002|Overall Study|Withdrawal by Subject|2|||
143246211|NCT03776812|516453450|FG000|Overall Study|Lost to Follow-up|1|||
143246212|NCT03776812|516453451|FG001|Overall Study|Lost to Follow-up|1|||
143246213|NCT03776812|516453452|FG002|Overall Study|Lost to Follow-up|0|||
143246214|NCT03776812|516453450|FG000|Overall Study|Did not enter long-term follow-up|3|||
143246215|NCT03776812|516453451|FG001|Overall Study|Did not enter long-term follow-up|3|||
143246216|NCT03776812|516453452|FG002|Overall Study|Did not enter long-term follow-up|2|||
143246217|NCT04758637|516453453|FG000|Overall Study|Lost to Follow-up|0|||
143246218|NCT04758637|516453454|FG001|Overall Study|Lost to Follow-up|1|||
143246219|NCT04758637|516453455|FG002|Overall Study|Lost to Follow-up|0|||
143246220|NCT04758637|516453456|FG003|Overall Study|Lost to Follow-up|0|||
143246221|NCT00048074|516453464|FG000|Overall Study|Adverse Event|46|||
143246222|NCT00048074|516453465|FG001|Overall Study|Adverse Event|41|||
143246223|NCT00048074|516453466|FG002|Overall Study|Adverse Event|53|||
143246224|NCT00048074|516453464|FG000|Overall Study|Death|3|||
143246225|NCT00048074|516453465|FG001|Overall Study|Death|3|||
143067793|NCT03502707|515791014|FG015|Overall Study|Physician Decision|3|||
143067794|NCT03502707|515791015|FG016|Overall Study|Physician Decision|0|||
143067795|NCT03502707|515791016|FG017|Overall Study|Physician Decision|0|||
143067796|NCT03502707|515790999|FG000|Overall Study|Protocol Violation|0|||
143067797|NCT03502707|515791000|FG001|Overall Study|Protocol Violation|0|||
143067798|NCT03502707|515791001|FG002|Overall Study|Protocol Violation|0|||
143067799|NCT03502707|515791002|FG003|Overall Study|Protocol Violation|0|||
143067800|NCT03502707|515791003|FG004|Overall Study|Protocol Violation|0|||
143067801|NCT03502707|515791004|FG005|Overall Study|Protocol Violation|0|||
143067802|NCT03502707|515791005|FG006|Overall Study|Protocol Violation|0|||
143067803|NCT03502707|515791006|FG007|Overall Study|Protocol Violation|0|||
143067804|NCT03502707|515791007|FG008|Overall Study|Protocol Violation|0|||
143067805|NCT03502707|515791008|FG009|Overall Study|Protocol Violation|0|||
143067806|NCT03502707|515791009|FG010|Overall Study|Protocol Violation|0|||
143067807|NCT03502707|515791010|FG011|Overall Study|Protocol Violation|0|||
143067808|NCT03502707|515791011|FG012|Overall Study|Protocol Violation|0|||
143067809|NCT03502707|515791012|FG013|Overall Study|Protocol Violation|0|||
143067810|NCT03502707|515791013|FG014|Overall Study|Protocol Violation|0|||
143067811|NCT03502707|515791014|FG015|Overall Study|Protocol Violation|1|||
143067812|NCT03502707|515791015|FG016|Overall Study|Protocol Violation|0|||
143170582|NCT02303821|516173587|FG005|Overall Study|Lost to Follow-up|0|||
143170583|NCT02303821|516173588|FG006|Overall Study|Lost to Follow-up|1|||
143246226|NCT00048074|516453466|FG002|Overall Study|Death|2|||
143246227|NCT00048074|516453464|FG000|Overall Study|Lost to Follow-up|2|||
143246228|NCT00048074|516453465|FG001|Overall Study|Lost to Follow-up|6|||
143246229|NCT00048074|516453466|FG002|Overall Study|Lost to Follow-up|6|||
143067813|NCT03502707|515791016|FG017|Overall Study|Protocol Violation|0|||
143067814|NCT03502707|515790999|FG000|Overall Study|Withdrawal by Subject|1|||
143246230|NCT00048074|516453464|FG000|Overall Study|Withdrawal by Subject|28|||
143246231|NCT00048074|516453465|FG001|Overall Study|Withdrawal by Subject|30|||
143246232|NCT00048074|516453466|FG002|Overall Study|Withdrawal by Subject|35|||
143246233|NCT00048074|516453464|FG000|Overall Study|Protocol Violation|1|||
143067815|NCT03502707|515791000|FG001|Overall Study|Withdrawal by Subject|1|||
143067816|NCT03502707|515791001|FG002|Overall Study|Withdrawal by Subject|0|||
143067817|NCT03502707|515791002|FG003|Overall Study|Withdrawal by Subject|0|||
143246234|NCT00048074|516453465|FG001|Overall Study|Protocol Violation|3|||
143067818|NCT03502707|515791003|FG004|Overall Study|Withdrawal by Subject|0|||
143246235|NCT00048074|516453466|FG002|Overall Study|Protocol Violation|0|||
143246236|NCT00048074|516453464|FG000|Overall Study|Study participation was terminated|0|||
143067819|NCT03502707|515791004|FG005|Overall Study|Withdrawal by Subject|2|||
143067820|NCT03502707|515791005|FG006|Overall Study|Withdrawal by Subject|0|||
143067821|NCT03502707|515791006|FG007|Overall Study|Withdrawal by Subject|3|||
143067822|NCT03502707|515791007|FG008|Overall Study|Withdrawal by Subject|1|||
143067823|NCT03502707|515791008|FG009|Overall Study|Withdrawal by Subject|2|||
143067824|NCT03502707|515791009|FG010|Overall Study|Withdrawal by Subject|12|||
143067825|NCT03502707|515791010|FG011|Overall Study|Withdrawal by Subject|23|||
143067826|NCT03502707|515791011|FG012|Overall Study|Withdrawal by Subject|5|||
143067827|NCT03502707|515791012|FG013|Overall Study|Withdrawal by Subject|3|||
143067828|NCT03502707|515791013|FG014|Overall Study|Withdrawal by Subject|3|||
143067829|NCT03502707|515791014|FG015|Overall Study|Withdrawal by Subject|43|||
143067830|NCT03502707|515791015|FG016|Overall Study|Withdrawal by Subject|44|||
143067831|NCT03502707|515791016|FG017|Overall Study|Withdrawal by Subject|18|||
143067832|NCT03502707|515790999|FG000|Overall Study|Sponsor's Decision|1|||
143067833|NCT03502707|515791000|FG001|Overall Study|Sponsor's Decision|0|||
143067834|NCT03502707|515791001|FG002|Overall Study|Sponsor's Decision|0|||
143067835|NCT03502707|515791002|FG003|Overall Study|Sponsor's Decision|0|||
143067836|NCT03502707|515791003|FG004|Overall Study|Sponsor's Decision|0|||
143067837|NCT03502707|515791004|FG005|Overall Study|Sponsor's Decision|0|||
143067838|NCT03502707|515791005|FG006|Overall Study|Sponsor's Decision|0|||
143067839|NCT03502707|515791006|FG007|Overall Study|Sponsor's Decision|0|||
143067840|NCT03502707|515791007|FG008|Overall Study|Sponsor's Decision|0|||
143067841|NCT03502707|515791008|FG009|Overall Study|Sponsor's Decision|1|||
143067842|NCT03502707|515791009|FG010|Overall Study|Sponsor's Decision|0|||
143067843|NCT03502707|515791010|FG011|Overall Study|Sponsor's Decision|0|||
143067844|NCT03502707|515791011|FG012|Overall Study|Sponsor's Decision|0|||
143067845|NCT03502707|515791012|FG013|Overall Study|Sponsor's Decision|0|||
143067846|NCT03502707|515791013|FG014|Overall Study|Sponsor's Decision|0|||
143067847|NCT03502707|515791014|FG015|Overall Study|Sponsor's Decision|2|||
143067848|NCT03502707|515791015|FG016|Overall Study|Sponsor's Decision|1|||
143067849|NCT03502707|515791016|FG017|Overall Study|Sponsor's Decision|0|||
143067850|NCT03502707|515790999|FG000|Overall Study|Initiated Prohibited Medication|0|||
143067851|NCT03502707|515791000|FG001|Overall Study|Initiated Prohibited Medication|0|||
143067852|NCT03502707|515791001|FG002|Overall Study|Initiated Prohibited Medication|0|||
143067853|NCT03502707|515791002|FG003|Overall Study|Initiated Prohibited Medication|0|||
143067854|NCT03502707|515791003|FG004|Overall Study|Initiated Prohibited Medication|0|||
143067855|NCT03502707|515791004|FG005|Overall Study|Initiated Prohibited Medication|0|||
143067856|NCT03502707|515791005|FG006|Overall Study|Initiated Prohibited Medication|0|||
143067857|NCT03502707|515791006|FG007|Overall Study|Initiated Prohibited Medication|0|||
143067858|NCT03502707|515791007|FG008|Overall Study|Initiated Prohibited Medication|0|||
143067859|NCT03502707|515791008|FG009|Overall Study|Initiated Prohibited Medication|0|||
143067860|NCT03502707|515791009|FG010|Overall Study|Initiated Prohibited Medication|0|||
143067861|NCT03502707|515791010|FG011|Overall Study|Initiated Prohibited Medication|0|||
143170584|NCT02303821|516173589|FG007|Overall Study|Lost to Follow-up|0|||
143170585|NCT02303821|516173582|FG000|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
143170586|NCT02303821|516173583|FG001|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
143170587|NCT02303821|516173584|FG002|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
143170588|NCT02303821|516173585|FG003|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
143170589|NCT02303821|516173586|FG004|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
143170590|NCT02303821|516173587|FG005|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
143170591|NCT02303821|516173588|FG006|Overall Study|Withdrawal prior to Carfilzomib dosing|1|||
143170592|NCT02303821|516173589|FG007|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
143170593|NCT02303821|516173582|FG000|Overall Study|Decision by sponsor|0|||
143170594|NCT02303821|516173583|FG001|Overall Study|Decision by sponsor|0|||
143170595|NCT02303821|516173584|FG002|Overall Study|Decision by sponsor|0|||
143170596|NCT02303821|516173585|FG003|Overall Study|Decision by sponsor|0|||
143170597|NCT02303821|516173586|FG004|Overall Study|Decision by sponsor|0|||
143170598|NCT02303821|516173587|FG005|Overall Study|Decision by sponsor|1|||
143170599|NCT02303821|516173588|FG006|Overall Study|Decision by sponsor|0|||
143170600|NCT02303821|516173589|FG007|Overall Study|Decision by sponsor|0|||
143170601|NCT02303821|516173582|FG000|Overall Study|Protocol-specified criteria|0|||
143170602|NCT02303821|516173583|FG001|Overall Study|Protocol-specified criteria|1|||
143170603|NCT02303821|516173584|FG002|Overall Study|Protocol-specified criteria|0|||
143503161|NCT00792298|517380979|FG004|Treatment Period 1|Physician Decision|0|||
143503162|NCT00792298|517380980|FG005|Treatment Period 1|Physician Decision|0|||
143067862|NCT03502707|515791011|FG012|Overall Study|Initiated Prohibited Medication|0|||
143067863|NCT03502707|515791012|FG013|Overall Study|Initiated Prohibited Medication|0|||
143170604|NCT02303821|516173585|FG003|Overall Study|Protocol-specified criteria|0|||
143170605|NCT02303821|516173586|FG004|Overall Study|Protocol-specified criteria|0|||
143067864|NCT03502707|515791013|FG014|Overall Study|Initiated Prohibited Medication|0|||
143067865|NCT03502707|515791014|FG015|Overall Study|Initiated Prohibited Medication|0|||
143067866|NCT03502707|515791015|FG016|Overall Study|Initiated Prohibited Medication|1|||
143170606|NCT02303821|516173587|FG005|Overall Study|Protocol-specified criteria|1|||
143067867|NCT03502707|515791016|FG017|Overall Study|Initiated Prohibited Medication|0|||
143067868|NCT03502707|515790999|FG000|Overall Study|Other|0|||
143067869|NCT03502707|515791000|FG001|Overall Study|Other|0|||
143067870|NCT03502707|515791001|FG002|Overall Study|Other|0|||
143067871|NCT03502707|515791002|FG003|Overall Study|Other|0|||
143067872|NCT03502707|515791003|FG004|Overall Study|Other|0|||
143067873|NCT03502707|515791004|FG005|Overall Study|Other|0|||
143067874|NCT03502707|515791005|FG006|Overall Study|Other|0|||
143067875|NCT03502707|515791006|FG007|Overall Study|Other|0|||
143067876|NCT03502707|515791007|FG008|Overall Study|Other|1|||
143067877|NCT03502707|515791008|FG009|Overall Study|Other|1|||
143067878|NCT03502707|515791009|FG010|Overall Study|Other|2|||
143067879|NCT03502707|515791010|FG011|Overall Study|Other|0|||
143067880|NCT03502707|515791011|FG012|Overall Study|Other|0|||
143067881|NCT03502707|515791012|FG013|Overall Study|Other|0|||
143067882|NCT03502707|515791013|FG014|Overall Study|Other|0|||
143067883|NCT03502707|515791014|FG015|Overall Study|Other|4|||
143067884|NCT03502707|515791015|FG016|Overall Study|Other|1|||
143067885|NCT03502707|515791016|FG017|Overall Study|Other|0|||
143067886|NCT03502707|515790999|FG000|Overall Study|Randomized but not vaccinated|0|||
143067887|NCT03502707|515791000|FG001|Overall Study|Randomized but not vaccinated|0|||
143067888|NCT03502707|515791001|FG002|Overall Study|Randomized but not vaccinated|0|||
143067889|NCT03502707|515791002|FG003|Overall Study|Randomized but not vaccinated|0|||
143067890|NCT03502707|515791003|FG004|Overall Study|Randomized but not vaccinated|0|||
143067891|NCT03502707|515791004|FG005|Overall Study|Randomized but not vaccinated|0|||
143067892|NCT03502707|515791005|FG006|Overall Study|Randomized but not vaccinated|0|||
143067893|NCT03502707|515791006|FG007|Overall Study|Randomized but not vaccinated|0|||
143067894|NCT03502707|515791007|FG008|Overall Study|Randomized but not vaccinated|0|||
143067895|NCT03502707|515791008|FG009|Overall Study|Randomized but not vaccinated|0|||
143067896|NCT03502707|515791009|FG010|Overall Study|Randomized but not vaccinated|0|||
143067897|NCT03502707|515791010|FG011|Overall Study|Randomized but not vaccinated|1|||
143067898|NCT03502707|515791011|FG012|Overall Study|Randomized but not vaccinated|0|||
143067899|NCT03502707|515791012|FG013|Overall Study|Randomized but not vaccinated|0|||
143067900|NCT03502707|515791013|FG014|Overall Study|Randomized but not vaccinated|0|||
143067901|NCT03502707|515791014|FG015|Overall Study|Randomized but not vaccinated|0|||
143067902|NCT03502707|515791015|FG016|Overall Study|Randomized but not vaccinated|0|||
143067903|NCT03502707|515791016|FG017|Overall Study|Randomized but not vaccinated|1|||
143067904|NCT03340064|515791018|FG000|First Period|Adverse Event, non-fatal|2|||
143067905|NCT03340064|515791019|FG001|First Period|Adverse Event, non-fatal|0|||
143067906|NCT03340064|515791018|FG000|First Period|Lack of Efficacy|3|||
143067907|NCT03340064|515791019|FG001|First Period|Lack of Efficacy|0|||
143067908|NCT03340064|515791018|FG000|Second Period|Adverse Event, non-fatal|1|||
143067909|NCT03340064|515791019|FG001|Second Period|Adverse Event, non-fatal|1|||
143067910|NCT03340064|515791018|FG000|Second Period|Lack of Efficacy|11|||
143067911|NCT03340064|515791019|FG001|Second Period|Lack of Efficacy|0|||
143067912|NCT03340064|515791018|FG000|Second Period|Physician Decision|3|||
143067913|NCT03340064|515791019|FG001|Second Period|Physician Decision|0|||
143067914|NCT03340064|515791018|FG000|Second Period|Withdrawal by Subject|2|||
143067915|NCT03340064|515791019|FG001|Second Period|Withdrawal by Subject|1|||
143067916|NCT03340064|515791018|FG000|Second Period|Approved Drug Available For Indication|1|||
143067917|NCT03340064|515791019|FG001|Second Period|Approved Drug Available For Indication|0|||
143067918|NCT03340064|515791018|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
143067919|NCT03340064|515791019|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
143067920|NCT01045421|515791020|FG000|Phase 1|Progressive Disease|0|||
143067921|NCT01045421|515791021|FG001|Phase 1|Progressive Disease|0|||
143067922|NCT01045421|515791022|FG002|Phase 1|Progressive Disease|0|||
143067923|NCT01045421|515791023|FG003|Phase 1|Progressive Disease|0|||
143067924|NCT01045421|515791024|FG004|Phase 1|Progressive Disease|1|||
143067925|NCT01045421|515791025|FG005|Phase 1|Progressive Disease|0|||
143067926|NCT01045421|515791026|FG006|Phase 1|Progressive Disease|0|||
143067927|NCT01045421|515791027|FG007|Phase 1|Progressive Disease|0|||
143067928|NCT01045421|515791028|FG008|Phase 1|Progressive Disease|0|||
143067929|NCT01045421|515791029|FG009|Phase 1|Progressive Disease|0|||
143067930|NCT01045421|515791030|FG010|Phase 1|Progressive Disease|0|||
143067931|NCT01045421|515791020|FG000|Phase 1|Withdrawal by Subject|0|||
143067932|NCT01045421|515791021|FG001|Phase 1|Withdrawal by Subject|0|||
143067933|NCT01045421|515791022|FG002|Phase 1|Withdrawal by Subject|0|||
143067934|NCT01045421|515791023|FG003|Phase 1|Withdrawal by Subject|1|||
143067935|NCT01045421|515791024|FG004|Phase 1|Withdrawal by Subject|0|||
143067936|NCT01045421|515791025|FG005|Phase 1|Withdrawal by Subject|0|||
143067937|NCT01045421|515791026|FG006|Phase 1|Withdrawal by Subject|0|||
143067938|NCT01045421|515791027|FG007|Phase 1|Withdrawal by Subject|0|||
143067939|NCT01045421|515791028|FG008|Phase 1|Withdrawal by Subject|0|||
143067940|NCT01045421|515791029|FG009|Phase 1|Withdrawal by Subject|0|||
143067941|NCT01045421|515791030|FG010|Phase 1|Withdrawal by Subject|0|||
143067942|NCT01045421|515791020|FG000|Phase 2|Progressive Disease|0|||
143067943|NCT01045421|515791021|FG001|Phase 2|Progressive Disease|0|||
143067944|NCT01045421|515791022|FG002|Phase 2|Progressive Disease|0|||
143067945|NCT01045421|515791023|FG003|Phase 2|Progressive Disease|0|||
143503163|NCT00792298|517380981|FG006|Treatment Period 1|Physician Decision|1|||
143503164|NCT00792298|517380982|FG007|Treatment Period 1|Physician Decision|0|||
143503165|NCT00792298|517380975|FG000|Treatment Period 1|Protocol Violation|0|||
143503166|NCT00792298|517380976|FG001|Treatment Period 1|Protocol Violation|0|||
143503167|NCT00792298|517380977|FG002|Treatment Period 1|Protocol Violation|0|||
143503168|NCT00792298|517380978|FG003|Treatment Period 1|Protocol Violation|0|||
143503169|NCT00792298|517380979|FG004|Treatment Period 1|Protocol Violation|0|||
143503170|NCT00792298|517380980|FG005|Treatment Period 1|Protocol Violation|0|||
143503171|NCT00792298|517380981|FG006|Treatment Period 1|Protocol Violation|0|||
143503172|NCT00792298|517380982|FG007|Treatment Period 1|Protocol Violation|1|||
143503173|NCT00792298|517380975|FG000|Washout|Adverse Event|0|||
143503174|NCT00792298|517380976|FG001|Washout|Adverse Event|0|||
143503175|NCT00792298|517380977|FG002|Washout|Adverse Event|0|||
143503176|NCT00792298|517380978|FG003|Washout|Adverse Event|0|||
143503177|NCT00792298|517380979|FG004|Washout|Adverse Event|0|||
143503178|NCT00792298|517380980|FG005|Washout|Adverse Event|1|||
143503179|NCT00792298|517380981|FG006|Washout|Adverse Event|0|||
143503180|NCT00792298|517380982|FG007|Washout|Adverse Event|0|||
143503181|NCT00792298|517380975|FG000|Washout|Withdrawal by Subject|0|||
143503182|NCT00792298|517380976|FG001|Washout|Withdrawal by Subject|0|||
143503183|NCT00792298|517380977|FG002|Washout|Withdrawal by Subject|1|||
143503184|NCT00792298|517380978|FG003|Washout|Withdrawal by Subject|0|||
143503185|NCT00792298|517380979|FG004|Washout|Withdrawal by Subject|0|||
143503186|NCT00792298|517380980|FG005|Washout|Withdrawal by Subject|1|||
143503187|NCT00792298|517380981|FG006|Washout|Withdrawal by Subject|0|||
143503188|NCT00792298|517380982|FG007|Washout|Withdrawal by Subject|0|||
143503189|NCT00792298|517380975|FG000|Treatment Period 2|Lack of Efficacy|0|||
143503190|NCT00792298|517380976|FG001|Treatment Period 2|Lack of Efficacy|0|||
143503191|NCT00792298|517380977|FG002|Treatment Period 2|Lack of Efficacy|0|||
143503192|NCT00792298|517380978|FG003|Treatment Period 2|Lack of Efficacy|0|||
143503193|NCT00792298|517380979|FG004|Treatment Period 2|Lack of Efficacy|1|||
143503194|NCT00792298|517380980|FG005|Treatment Period 2|Lack of Efficacy|0|||
143503195|NCT00792298|517380981|FG006|Treatment Period 2|Lack of Efficacy|0|||
143503196|NCT00792298|517380982|FG007|Treatment Period 2|Lack of Efficacy|0|||
143503197|NCT00792298|517380975|FG000|Treatment Period 2|Physician Decision|0|||
143503198|NCT00792298|517380976|FG001|Treatment Period 2|Physician Decision|0|||
143503199|NCT00792298|517380977|FG002|Treatment Period 2|Physician Decision|0|||
143503200|NCT00792298|517380978|FG003|Treatment Period 2|Physician Decision|0|||
143503201|NCT00792298|517380979|FG004|Treatment Period 2|Physician Decision|0|||
143503202|NCT00792298|517380980|FG005|Treatment Period 2|Physician Decision|0|||
143503203|NCT00792298|517380981|FG006|Treatment Period 2|Physician Decision|1|||
143503204|NCT00792298|517380982|FG007|Treatment Period 2|Physician Decision|0|||
143503205|NCT00792298|517380975|FG000|Treatment Period 2|Pregnancy|0|||
143503206|NCT00792298|517380976|FG001|Treatment Period 2|Pregnancy|0|||
143503207|NCT00792298|517380977|FG002|Treatment Period 2|Pregnancy|1|||
143503208|NCT00792298|517380978|FG003|Treatment Period 2|Pregnancy|0|||
143503209|NCT00792298|517380979|FG004|Treatment Period 2|Pregnancy|0|||
143067946|NCT01045421|515791024|FG004|Phase 2|Progressive Disease|0|||
143067947|NCT01045421|515791025|FG005|Phase 2|Progressive Disease|0|||
143067948|NCT01045421|515791026|FG006|Phase 2|Progressive Disease|0|||
143067949|NCT01045421|515791027|FG007|Phase 2|Progressive Disease|1|||
143067950|NCT01045421|515791028|FG008|Phase 2|Progressive Disease|1|||
143067951|NCT01045421|515791029|FG009|Phase 2|Progressive Disease|1|||
143067952|NCT01045421|515791030|FG010|Phase 2|Progressive Disease|1|||
143246237|NCT00048074|516453465|FG001|Overall Study|Study participation was terminated|1|||
143503210|NCT00792298|517380980|FG005|Treatment Period 2|Pregnancy|0|||
143503211|NCT00792298|517380981|FG006|Treatment Period 2|Pregnancy|0|||
143503212|NCT00792298|517380982|FG007|Treatment Period 2|Pregnancy|0|||
143503213|NCT00792298|517380975|FG000|Treatment Period 2|Withdrawal by Subject|1|||
143503214|NCT00792298|517380976|FG001|Treatment Period 2|Withdrawal by Subject|1|||
143503215|NCT00792298|517380977|FG002|Treatment Period 2|Withdrawal by Subject|0|||
143246238|NCT00048074|516453466|FG002|Overall Study|Study participation was terminated|0|||
143246239|NCT00048074|516453464|FG000|Overall Study|Husband ill|0|||
143067953|NCT01045421|515791020|FG000|Phase 2|Death|0|||
143067954|NCT01045421|515791021|FG001|Phase 2|Death|0|||
143246240|NCT00048074|516453465|FG001|Overall Study|Husband ill|1|||
143503216|NCT00792298|517380978|FG003|Treatment Period 2|Withdrawal by Subject|2|||
143503217|NCT00792298|517380979|FG004|Treatment Period 2|Withdrawal by Subject|1|||
143503218|NCT00792298|517380980|FG005|Treatment Period 2|Withdrawal by Subject|0|||
143503219|NCT00792298|517380981|FG006|Treatment Period 2|Withdrawal by Subject|0|||
143503220|NCT00792298|517380982|FG007|Treatment Period 2|Withdrawal by Subject|2|||
143503221|NCT03304522|517380983|FG000|Overall Study|Adverse Event|0|||
143503222|NCT03304522|517380984|FG001|Overall Study|Adverse Event|4|||
143503223|NCT03304522|517380983|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
143503224|NCT03304522|517380984|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
143503225|NCT03304522|517380983|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
143503226|NCT03304522|517380984|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
143503227|NCT03304522|517380983|FG000|Overall Study|Other|0|||
143246241|NCT00048074|516453466|FG002|Overall Study|Husband ill|0|||
143246242|NCT00048074|516453464|FG000|Overall Study|Poor compliance|0|||
143246243|NCT00048074|516453465|FG001|Overall Study|Poor compliance|1|||
143246244|NCT00048074|516453466|FG002|Overall Study|Poor compliance|0|||
143246245|NCT00048074|516453464|FG000|Overall Study|Out of station|0|||
143246246|NCT00048074|516453465|FG001|Overall Study|Out of station|1|||
143246247|NCT00048074|516453466|FG002|Overall Study|Out of station|1|||
143246248|NCT00048074|516453464|FG000|Overall Study|Social reasons|1|||
143246249|NCT00048074|516453465|FG001|Overall Study|Social reasons|0|||
143246250|NCT00048074|516453466|FG002|Overall Study|Social reasons|0|||
143246251|NCT02873377|516453467|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
143246252|NCT02873377|516453468|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
143246253|NCT02873377|516453467|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
143246254|NCT02873377|516453468|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
143246255|NCT01192191|516453469|FG000|Overall Study|Adverse Event|7|||
143246256|NCT01192191|516453470|FG001|Overall Study|Adverse Event|12|||
143246257|NCT01192191|516453469|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
143246258|NCT01192191|516453470|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
143246259|NCT01192191|516453469|FG000|Overall Study|Lost to Follow-up|0|||
143246260|NCT01192191|516453470|FG001|Overall Study|Lost to Follow-up|1|||
143246261|NCT01192191|516453469|FG000|Overall Study|Withdrawal by Subject|1|||
143246262|NCT01192191|516453470|FG001|Overall Study|Withdrawal by Subject|6|||
143246263|NCT01047553|516453473|FG000|Overall Study|Adverse Event|10|||
143246264|NCT01047553|516453474|FG001|Overall Study|Adverse Event|5|||
143246265|NCT01047553|516453473|FG000|Overall Study|Withdrawal by Subject|4|||
143246266|NCT01047553|516453474|FG001|Overall Study|Withdrawal by Subject|2|||
143246267|NCT01047553|516453473|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
143246268|NCT01047553|516453474|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
143246269|NCT01047553|516453473|FG000|Overall Study|Lost to Follow-up|1|||
143246270|NCT01047553|516453474|FG001|Overall Study|Lost to Follow-up|0|||
143246271|NCT01047553|516453473|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
143246272|NCT01047553|516453474|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
143246273|NCT01047553|516453473|FG000|Overall Study|PI's decision|0|||
143246274|NCT01047553|516453474|FG001|Overall Study|PI's decision|1|||
143246275|NCT01583296|516453475|FG000|Overall Study|Withdrawal by Subject|11|||
143246276|NCT01583296|516453476|FG001|Overall Study|Withdrawal by Subject|10|||
143246277|NCT01063283|516453477|FG000|Cycle 1|Adverse Event|2|||
143246278|NCT01063283|516453478|FG001|Cycle 1|Adverse Event|0|||
143246279|NCT01063283|516453479|FG002|Cycle 1|Adverse Event|0|||
143246280|NCT01063283|516453477|FG000|Cycle 1|Technical failure in data collection|1|||
143246281|NCT01063283|516453478|FG001|Cycle 1|Technical failure in data collection|0|||
143246282|NCT01063283|516453479|FG002|Cycle 1|Technical failure in data collection|0|||
143246283|NCT02624986|516453481|FG000|Overall Study|Death|0|||
143246284|NCT02624986|516453482|FG001|Overall Study|Death|1|||
143246285|NCT02624986|516453483|FG002|Overall Study|Death|2|||
143246286|NCT02624986|516453484|FG003|Overall Study|Death|2|||
143246287|NCT02624986|516453485|FG004|Overall Study|Death|2|||
143246288|NCT02624986|516453486|FG005|Overall Study|Death|0|||
143246289|NCT02624986|516453487|FG006|Overall Study|Death|0|||
143246290|NCT02624986|516453488|FG007|Overall Study|Death|1|||
143246291|NCT02624986|516453481|FG000|Overall Study|Study Terminated by Sponsor|1|||
143246292|NCT02624986|516453482|FG001|Overall Study|Study Terminated by Sponsor|1|||
143067955|NCT01045421|515791022|FG002|Phase 2|Death|0|||
143067956|NCT01045421|515791023|FG003|Phase 2|Death|0|||
143067957|NCT01045421|515791024|FG004|Phase 2|Death|0|||
143067958|NCT01045421|515791025|FG005|Phase 2|Death|0|||
143067959|NCT01045421|515791026|FG006|Phase 2|Death|0|||
143067960|NCT01045421|515791027|FG007|Phase 2|Death|1|||
143067961|NCT01045421|515791028|FG008|Phase 2|Death|1|||
143067962|NCT01045421|515791029|FG009|Phase 2|Death|2|||
143246293|NCT02624986|516453483|FG002|Overall Study|Study Terminated by Sponsor|0|||
143067963|NCT01045421|515791030|FG010|Phase 2|Death|0|||
143067964|NCT01045421|515791020|FG000|Phase 2|Other|0|||
143246294|NCT02624986|516453484|FG003|Overall Study|Study Terminated by Sponsor|1|||
143246295|NCT02624986|516453485|FG004|Overall Study|Study Terminated by Sponsor|2|||
143503228|NCT03304522|517380984|FG001|Overall Study|Other|1|||
143503229|NCT01526148|517380990|FG000|Overall Study|Adverse Event|6|||
143067965|NCT01045421|515791021|FG001|Phase 2|Other|0|||
143067966|NCT01045421|515791022|FG002|Phase 2|Other|0|||
143067967|NCT01045421|515791023|FG003|Phase 2|Other|0|||
143067968|NCT01045421|515791024|FG004|Phase 2|Other|0|||
143067969|NCT01045421|515791025|FG005|Phase 2|Other|0|||
143067970|NCT01045421|515791026|FG006|Phase 2|Other|0|||
143246296|NCT02624986|516453486|FG005|Overall Study|Study Terminated by Sponsor|2|||
143246297|NCT02624986|516453487|FG006|Overall Study|Study Terminated by Sponsor|4|||
143246298|NCT02624986|516453488|FG007|Overall Study|Study Terminated by Sponsor|3|||
143246299|NCT02624986|516453481|FG000|Overall Study|Progressive Disease|0|||
143246300|NCT02624986|516453482|FG001|Overall Study|Progressive Disease|1|||
143246301|NCT02624986|516453483|FG002|Overall Study|Progressive Disease|0|||
143503230|NCT01526148|517380991|FG001|Overall Study|Adverse Event|5|||
143503231|NCT01526148|517380990|FG000|Overall Study|Lost to Follow-up|3|||
143503232|NCT01526148|517380991|FG001|Overall Study|Lost to Follow-up|6|||
143067971|NCT01045421|515791027|FG007|Phase 2|Other|3|||
143067972|NCT01045421|515791028|FG008|Phase 2|Other|0|||
143067973|NCT01045421|515791029|FG009|Phase 2|Other|0|||
143067974|NCT01045421|515791030|FG010|Phase 2|Other|1|||
143067975|NCT02221037|515791031|FG000|Overall Study|Physician Decision|0|||
143067976|NCT02221037|515791032|FG001|Overall Study|Physician Decision|0|||
143067977|NCT02221037|515791033|FG002|Overall Study|Physician Decision|1|||
143067978|NCT02221037|515791034|FG003|Overall Study|Physician Decision|0|||
143067979|NCT02944383|515791037|FG000|Overall Study|Lost to Follow-up|0|||
143067980|NCT02944383|515791038|FG001|Overall Study|Lost to Follow-up|0|||
143067981|NCT02944383|515791039|FG002|Overall Study|Lost to Follow-up|1|||
143067982|NCT02944383|515791037|FG000|Overall Study|Withdrawal by Subject|1|||
143067983|NCT02944383|515791038|FG001|Overall Study|Withdrawal by Subject|0|||
143067984|NCT02944383|515791039|FG002|Overall Study|Withdrawal by Subject|0|||
143067985|NCT00678041|515791047|FG000|Overall Study|Physician Decision|5|||
143067986|NCT00678041|515791048|FG001|Overall Study|Physician Decision|5|||
143067987|NCT00807248|515791051|FG000|Overall Study|Adverse Event|1|||
143067988|NCT00807248|515791052|FG001|Overall Study|Adverse Event|2|||
143067989|NCT00807248|515791053|FG002|Overall Study|Adverse Event|2|||
143067990|NCT00807248|515791054|FG003|Overall Study|Adverse Event|6|||
143067991|NCT00807248|515791051|FG000|Overall Study|Lack of Efficacy|14|||
143067992|NCT00807248|515791052|FG001|Overall Study|Lack of Efficacy|4|||
143067993|NCT00807248|515791053|FG002|Overall Study|Lack of Efficacy|8|||
143067994|NCT00807248|515791054|FG003|Overall Study|Lack of Efficacy|3|||
143503233|NCT01526148|517380990|FG000|Overall Study|Withdrawal by Subject|2|||
143067995|NCT00807248|515791051|FG000|Overall Study|Protocol Violation|0|||
143067996|NCT00807248|515791052|FG001|Overall Study|Protocol Violation|1|||
143067997|NCT00807248|515791053|FG002|Overall Study|Protocol Violation|1|||
143067998|NCT00807248|515791054|FG003|Overall Study|Protocol Violation|0|||
143067999|NCT00807248|515791051|FG000|Overall Study|Withdrawal of Consent|5|||
143068000|NCT00807248|515791052|FG001|Overall Study|Withdrawal of Consent|5|||
143068001|NCT00807248|515791053|FG002|Overall Study|Withdrawal of Consent|5|||
143068002|NCT00807248|515791054|FG003|Overall Study|Withdrawal of Consent|5|||
143068003|NCT00807248|515791051|FG000|Overall Study|Lost to Follow-up|1|||
143068004|NCT00807248|515791052|FG001|Overall Study|Lost to Follow-up|0|||
143068005|NCT00807248|515791053|FG002|Overall Study|Lost to Follow-up|0|||
143068006|NCT00807248|515791054|FG003|Overall Study|Lost to Follow-up|0|||
143068007|NCT00807248|515791051|FG000|Overall Study|Other Reason|0|||
143068008|NCT00807248|515791052|FG001|Overall Study|Other Reason|0|||
143068009|NCT00807248|515791053|FG002|Overall Study|Other Reason|2|||
143068010|NCT00807248|515791054|FG003|Overall Study|Other Reason|0|||
143068011|NCT02444793|515791055|FG000|Overall Study|Lost to Follow-up|2|||
143068012|NCT02444793|515791056|FG001|Overall Study|Lost to Follow-up|2|||
143068013|NCT02444793|515791057|FG002|Overall Study|Lost to Follow-up|0|||
143068014|NCT02444793|515791058|FG003|Overall Study|Lost to Follow-up|0|||
143068015|NCT02444793|515791055|FG000|Overall Study|Death|0|||
143068016|NCT02444793|515791056|FG001|Overall Study|Death|3|||
143068017|NCT02444793|515791057|FG002|Overall Study|Death|0|||
143068018|NCT02444793|515791058|FG003|Overall Study|Death|0|||
143068019|NCT02444793|515791055|FG000|Overall Study|Other|0|||
143068020|NCT02444793|515791056|FG001|Overall Study|Other|0|||
143068021|NCT02444793|515791057|FG002|Overall Study|Other|2|||
143068022|NCT02444793|515791058|FG003|Overall Study|Other|0|||
143068023|NCT02444793|515791055|FG000|Overall Study|Objective progression or relapse|9|||
143068024|NCT02444793|515791056|FG001|Overall Study|Objective progression or relapse|1|||
143068025|NCT02444793|515791057|FG002|Overall Study|Objective progression or relapse|2|||
143068026|NCT02444793|515791058|FG003|Overall Study|Objective progression or relapse|3|||
143068027|NCT00210249|515791062|FG000|Overall Study|Lost to Follow-up|5|||
143068028|NCT00210249|515791062|FG000|Overall Study|Protocol Violation|11|||
143068029|NCT04280705|515791063|FG000|Overall Study|Enrolled but not treated|4|||
143068030|NCT04280705|515791064|FG001|Overall Study|Enrolled but not treated|10|||
143068031|NCT04280705|515791063|FG000|Overall Study|Physician Decision|1|||
143068032|NCT04280705|515791064|FG001|Overall Study|Physician Decision|0|||
143068033|NCT04280705|515791063|FG000|Overall Study|Withdrawal by Subject|7|||
143068034|NCT04280705|515791064|FG001|Overall Study|Withdrawal by Subject|9|||
143068035|NCT04280705|515791063|FG000|Overall Study|Adverse Event|0|||
143068036|NCT04280705|515791064|FG001|Overall Study|Adverse Event|4|||
143068037|NCT04280705|515791063|FG000|Overall Study|Transferred to another hospital|1|||
143503234|NCT01526148|517380991|FG001|Overall Study|Withdrawal by Subject|0|||
143068038|NCT04280705|515791064|FG001|Overall Study|Transferred to another hospital|1|||
143068039|NCT02518919|515791067|FG000|Overall Study|Protocol Violation|1|||
143068040|NCT02518919|515791068|FG001|Overall Study|Protocol Violation|1|||
143068041|NCT02518919|515791069|FG002|Overall Study|Protocol Violation|2|||
143068042|NCT00599521|515791070|FG000|Overall Study|Lack of Efficacy|4|||
143068043|NCT00599521|515791071|FG001|Overall Study|Lack of Efficacy|8|||
143068044|NCT00599521|515791070|FG000|Overall Study|Adverse Event|4|||
143068045|NCT00599521|515791071|FG001|Overall Study|Adverse Event|1|||
143068046|NCT00599521|515791070|FG000|Overall Study|Withdrawal by Subject|28|||
143503235|NCT01526148|517380990|FG000|Overall Study|Unstable Medical Condition|1|||
143503236|NCT01526148|517380991|FG001|Overall Study|Unstable Medical Condition|0|||
143068047|NCT00599521|515791071|FG001|Overall Study|Withdrawal by Subject|34|||
143246302|NCT02624986|516453484|FG003|Overall Study|Progressive Disease|0|||
143246303|NCT02624986|516453485|FG004|Overall Study|Progressive Disease|0|||
143246304|NCT02624986|516453486|FG005|Overall Study|Progressive Disease|0|||
143246305|NCT02624986|516453487|FG006|Overall Study|Progressive Disease|0|||
143246306|NCT02624986|516453488|FG007|Overall Study|Progressive Disease|0|||
143246307|NCT02624986|516453481|FG000|Overall Study|Protocol Violation|1|||
143246308|NCT02624986|516453482|FG001|Overall Study|Protocol Violation|0|||
143246309|NCT02624986|516453483|FG002|Overall Study|Protocol Violation|0|||
143246310|NCT02624986|516453484|FG003|Overall Study|Protocol Violation|0|||
143246311|NCT02624986|516453485|FG004|Overall Study|Protocol Violation|0|||
143246312|NCT02624986|516453486|FG005|Overall Study|Protocol Violation|0|||
143246313|NCT02624986|516453487|FG006|Overall Study|Protocol Violation|0|||
143246314|NCT02624986|516453488|FG007|Overall Study|Protocol Violation|0|||
143246315|NCT02624986|516453481|FG000|Overall Study|Withdrawal by Subject|0|||
143246316|NCT02624986|516453482|FG001|Overall Study|Withdrawal by Subject|0|||
143246317|NCT02624986|516453483|FG002|Overall Study|Withdrawal by Subject|0|||
143246318|NCT02624986|516453484|FG003|Overall Study|Withdrawal by Subject|0|||
143246319|NCT02624986|516453485|FG004|Overall Study|Withdrawal by Subject|0|||
143246320|NCT02624986|516453486|FG005|Overall Study|Withdrawal by Subject|0|||
143246321|NCT02624986|516453487|FG006|Overall Study|Withdrawal by Subject|0|||
143246322|NCT02624986|516453488|FG007|Overall Study|Withdrawal by Subject|1|||
143246323|NCT04200352|516453494|FG000|Overall Study|Death|1|||
143246324|NCT04200352|516453494|FG000|Overall Study|Adverse Event|6|||
143246325|NCT04200352|516453494|FG000|Overall Study|Withdrawal by parent/guardian|6|||
143246326|NCT04200352|516453494|FG000|Overall Study|Lack of Efficacy|1|||
143246327|NCT04200352|516453494|FG000|Overall Study|Other than specified|6|||
143246328|NCT00806819|516453495|FG000|Overall Study|progressive disease (modified RECIST )|217|||
143246329|NCT00806819|516453496|FG001|Overall Study|progressive disease (modified RECIST )|216|||
143246330|NCT00806819|516453495|FG000|Overall Study|Worsening or AE of underlying disease|18|||
143246331|NCT00806819|516453496|FG001|Overall Study|Worsening or AE of underlying disease|25|||
143246332|NCT00806819|516453495|FG000|Overall Study|Other AE|38|||
143246333|NCT00806819|516453496|FG001|Overall Study|Other AE|40|||
143246334|NCT00806819|516453495|FG000|Overall Study|Protocol Violation|9|||
143246335|NCT00806819|516453496|FG001|Overall Study|Protocol Violation|4|||
143246336|NCT00806819|516453495|FG000|Overall Study|Lost to Follow-up|1|||
143246337|NCT00806819|516453496|FG001|Overall Study|Lost to Follow-up|0|||
143246338|NCT00806819|516453495|FG000|Overall Study|Withdrawal by Subject|32|||
143246339|NCT00806819|516453496|FG001|Overall Study|Withdrawal by Subject|29|||
143246340|NCT00806819|516453495|FG000|Overall Study|Not treated|6|||
143246341|NCT00806819|516453496|FG001|Overall Study|Not treated|3|||
143365180|NCT02223793|516880668|FG000|Overall Study|Moved/studycenter unable to participate|4|||
143365181|NCT02223793|516880669|FG001|Overall Study|Moved/studycenter unable to participate|6|||
143503237|NCT01526148|517380990|FG000|Overall Study|Unable to discontinue concomitant med|1|||
143503238|NCT01526148|517380991|FG001|Overall Study|Unable to discontinue concomitant med|0|||
143503239|NCT01526148|517380990|FG000|Overall Study|Moved out of state|1|||
143503240|NCT01526148|517380991|FG001|Overall Study|Moved out of state|0|||
143503241|NCT01526148|517380990|FG000|Overall Study|Incarcerated|0|||
143503242|NCT01526148|517380991|FG001|Overall Study|Incarcerated|2|||
143503243|NCT01173653|517380992|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
143068048|NCT00599521|515791070|FG000|Overall Study|Protocol Violation|1|||
143068049|NCT00599521|515791071|FG001|Overall Study|Protocol Violation|1|||
143068050|NCT00599521|515791070|FG000|Overall Study|Lost to Follow-up|23|||
143068051|NCT00599521|515791071|FG001|Overall Study|Lost to Follow-up|23|||
143068052|NCT00599521|515791070|FG000|Overall Study|Pregnancy|0|||
143068053|NCT00599521|515791071|FG001|Overall Study|Pregnancy|2|||
143068054|NCT01293539|515791073|FG000|Overall Study|Physician Decision|1|||
143503244|NCT01173653|517380993|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
143503245|NCT02452762|517380994|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
143503246|NCT02452762|517380995|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
143503247|NCT02452762|517380994|FG000|Overall Study|Withdrawal by Subject|1|||
143068055|NCT01700049|515791074|FG000|Overall Study|Withdrawal by Subject|1|||
143068056|NCT04325204|515791077|FG000|Overall Study|Death|0|||
143246342|NCT00806819|516453495|FG000|Overall Study|Reasons other than stated above|25|||
143246343|NCT00806819|516453496|FG001|Overall Study|Reasons other than stated above|41|||
143246344|NCT02302339|516453499|FG000|Overall Study|Lost to Follow-up|1|||
143246345|NCT02302339|516453500|FG001|Overall Study|Lost to Follow-up|0|||
143246346|NCT02302339|516453501|FG002|Overall Study|Lost to Follow-up|0|||
143246347|NCT02302339|516453502|FG003|Overall Study|Lost to Follow-up|0|||
143246348|NCT02302339|516453499|FG000|Overall Study|Withdrawal by Subject|0|||
143246349|NCT02302339|516453500|FG001|Overall Study|Withdrawal by Subject|2|||
143246350|NCT02302339|516453501|FG002|Overall Study|Withdrawal by Subject|1|||
143503248|NCT02452762|517380995|FG001|Overall Study|Withdrawal by Subject|0|||
143170607|NCT02303821|516173588|FG006|Overall Study|Protocol-specified criteria|0|||
143170608|NCT02303821|516173589|FG007|Overall Study|Protocol-specified criteria|0|||
143170609|NCT04583618|516173595|FG000|Overall Study|Adverse Event|0|||
143170610|NCT04583618|516173596|FG001|Overall Study|Adverse Event|0|||
143170611|NCT04583618|516173597|FG002|Overall Study|Adverse Event|1|||
143170612|NCT04583618|516173598|FG003|Overall Study|Adverse Event|0|||
143170613|NCT04583618|516173599|FG004|Overall Study|Adverse Event|0|||
143170614|NCT04583618|516173595|FG000|Overall Study|Protocol deviation|1|||
143170615|NCT04583618|516173596|FG001|Overall Study|Protocol deviation|1|||
143170616|NCT04583618|516173597|FG002|Overall Study|Protocol deviation|1|||
143170617|NCT04583618|516173598|FG003|Overall Study|Protocol deviation|0|||
143170618|NCT04583618|516173599|FG004|Overall Study|Protocol deviation|0|||
143170619|NCT04583618|516173595|FG000|Overall Study|Withdrawal by Subject|2|||
143170620|NCT04583618|516173596|FG001|Overall Study|Withdrawal by Subject|1|||
143170621|NCT04583618|516173597|FG002|Overall Study|Withdrawal by Subject|3|||
143170622|NCT04583618|516173598|FG003|Overall Study|Withdrawal by Subject|1|||
143170623|NCT04583618|516173599|FG004|Overall Study|Withdrawal by Subject|1|||
143170624|NCT04583618|516173595|FG000|Overall Study|Lost to Follow-up|0|||
143170625|NCT04583618|516173596|FG001|Overall Study|Lost to Follow-up|1|||
143170626|NCT04583618|516173597|FG002|Overall Study|Lost to Follow-up|3|||
143170627|NCT04583618|516173598|FG003|Overall Study|Lost to Follow-up|1|||
143170628|NCT04583618|516173599|FG004|Overall Study|Lost to Follow-up|1|||
143170629|NCT00210132|516173600|FG000|Overall Study|Protocol Violation|1|||
143170630|NCT00210132|516173601|FG001|Overall Study|Protocol Violation|4|||
143170631|NCT02711202|516173602|FG000|Overall Study|Adverse Event|3|||
143170632|NCT02711202|516173603|FG001|Overall Study|Adverse Event|0|||
143170633|NCT02711202|516173602|FG000|Overall Study|graft loss|1|||
143170634|NCT02711202|516173603|FG001|Overall Study|graft loss|0|||
143170635|NCT00432965|516173604|FG000|Overall Study|Lost to Follow-up|22|||
143170636|NCT00432965|516173605|FG001|Overall Study|Lost to Follow-up|19|||
143170637|NCT00432965|516173604|FG000|Overall Study|Withdrawal by Subject|13|||
143170638|NCT00432965|516173605|FG001|Overall Study|Withdrawal by Subject|13|||
143170639|NCT00432965|516173604|FG000|Overall Study|Physician Decision|14|||
143170640|NCT00432965|516173605|FG001|Overall Study|Physician Decision|13|||
143170641|NCT00432965|516173604|FG000|Overall Study|Lack of Efficacy|8|||
143170642|NCT00432965|516173605|FG001|Overall Study|Lack of Efficacy|13|||
143170643|NCT00432965|516173604|FG000|Overall Study|Non-compliance|7|||
143170644|NCT00432965|516173605|FG001|Overall Study|Non-compliance|0|||
143170645|NCT00432965|516173604|FG000|Overall Study|Adverse Event|22|||
143170646|NCT00432965|516173605|FG001|Overall Study|Adverse Event|19|||
143170647|NCT00432965|516173604|FG000|Overall Study|Death|3|||
143170648|NCT00432965|516173605|FG001|Overall Study|Death|4|||
143170649|NCT00432965|516173604|FG000|Overall Study|Exclusionary Methods|1|||
143246351|NCT02302339|516453502|FG003|Overall Study|Withdrawal by Subject|0|||
143246352|NCT01326104|516453507|FG000|Overall Study|progressed prior to vaccine|0|||
143246353|NCT01326104|516453508|FG001|Overall Study|progressed prior to vaccine|2|||
143246354|NCT01326104|516453507|FG000|Overall Study|unable to make vaccine|0|||
143246355|NCT01326104|516453508|FG001|Overall Study|unable to make vaccine|2|||
143246356|NCT00494676|516453511|FG000|Allocation|Withdrawal by Subject|2|||
143246357|NCT00494676|516453512|FG001|Allocation|Withdrawal by Subject|4|||
143246358|NCT00494676|516453511|FG000|First Intervention|Withdrawal by Subject|1|||
143246359|NCT00494676|516453512|FG001|First Intervention|Withdrawal by Subject|3|||
143246360|NCT00494676|516453511|FG000|Second Intervention|Withdrawal by Subject|1|||
143246361|NCT00494676|516453512|FG001|Second Intervention|Withdrawal by Subject|1|||
143246362|NCT04073225|516453514|FG000|Overall Study|Lost to Follow-up|4|||
143246363|NCT04073225|516453515|FG001|Overall Study|Lost to Follow-up|3|||
143246364|NCT03568461|516453520|FG000|Overall Study|Death|7|||
143246365|NCT03568461|516453520|FG000|Overall Study|Physician Decision|5|||
143503249|NCT00584870|517380996|FG000|Overall Study|Adverse Event|4|||
143503250|NCT00584870|517380997|FG001|Overall Study|Adverse Event|3|||
143503251|NCT00584870|517380998|FG002|Overall Study|Adverse Event|2|||
143246366|NCT03568461|516453520|FG000|Overall Study|Subject decision|5|||
143246367|NCT03568461|516453520|FG000|Overall Study|Lost to Follow-up|1|||
143246368|NCT04695977|516453521|FG000|Overall Study|Sponsor Decision|9|||
143170650|NCT00432965|516173605|FG001|Overall Study|Exclusionary Methods|2|||
143170651|NCT00432965|516173604|FG000|Overall Study|Incomplete Data|4|||
143170652|NCT00432965|516173605|FG001|Overall Study|Incomplete Data|3|||
143170653|NCT02302222|516173612|FG000|Overall Study|Physician Decision|0|||
143170654|NCT02302222|516173613|FG001|Overall Study|Physician Decision|4|||
143246369|NCT04695977|516453522|FG001|Overall Study|Sponsor Decision|4|||
143246370|NCT04695977|516453521|FG000|Overall Study|Death|2|||
143246371|NCT04695977|516453522|FG001|Overall Study|Death|5|||
143170655|NCT02302222|516173612|FG000|Overall Study|Lost to Follow-up|1|||
143170656|NCT02302222|516173613|FG001|Overall Study|Lost to Follow-up|0|||
143170657|NCT02302222|516173612|FG000|Overall Study|Treatment discontinued before day 5|0|||
143170658|NCT02302222|516173613|FG001|Overall Study|Treatment discontinued before day 5|1|||
143170659|NCT02302222|516173612|FG000|Overall Study|Withdrawn prior to any treatment|0|||
143170660|NCT02302222|516173613|FG001|Overall Study|Withdrawn prior to any treatment|1|||
143246372|NCT02175199|516454604|FG000|Overall Study|Withdrawal by Subject|1|||
143246373|NCT02175199|516454605|FG001|Overall Study|Withdrawal by Subject|5|||
143246374|NCT02175199|516454604|FG000|Overall Study|Randomized in Error|1|||
143246375|NCT02175199|516454605|FG001|Overall Study|Randomized in Error|0|||
143246376|NCT02175199|516454604|FG000|Overall Study|Sponsor Decision|1|||
143246377|NCT02175199|516454605|FG001|Overall Study|Sponsor Decision|0|||
143246378|NCT03983317|516454612|FG000|Overall Study|Physician Decision|5|||
143246379|NCT01761162|516454613|FG000|Overall Study|Withdrawal by Subject|3|||
143246380|NCT04681352|516454614|FG000|Overall Study|Lost to Follow-up|2|||
143246381|NCT04681352|516454614|FG000|Overall Study|Withdrawal by Subject|22|||
143246382|NCT01643772|516454615|FG000|Overall Study|Protocol Violation|0|||
143246383|NCT01643772|516454616|FG001|Overall Study|Protocol Violation|0|||
143246384|NCT01643772|516454617|FG002|Overall Study|Protocol Violation|0|||
143246385|NCT01643772|516454618|FG003|Overall Study|Protocol Violation|1|||
143246386|NCT01643772|516454615|FG000|Overall Study|Adverse Event|0|||
143246387|NCT01643772|516454616|FG001|Overall Study|Adverse Event|0|||
143246388|NCT01643772|516454617|FG002|Overall Study|Adverse Event|0|||
143246389|NCT01643772|516454618|FG003|Overall Study|Adverse Event|1|||
143246390|NCT03860818|516454619|FG000|Overall Study|Death|144|||
143246391|NCT03860818|516454620|FG001|Overall Study|Death|195|||
143246392|NCT03860818|516454619|FG000|Overall Study|Graft Loss|32|||
143246393|NCT03860818|516454620|FG001|Overall Study|Graft Loss|45|||
143246394|NCT00792571|516454621|FG000|Overall Study|Death|1|||
143246395|NCT00792571|516454621|FG000|Overall Study|Adverse Event|4|||
143246396|NCT00792571|516454621|FG000|Overall Study|Withdrawal by Subject|1|||
143246397|NCT00792571|516454621|FG000|Overall Study|Other|4|||
143246398|NCT02600819|516454622|FG000|GEN Phase|Adverse Event|2|||
143246399|NCT02600819|516454623|FG001|GEN Phase|Adverse Event|0|||
143246400|NCT02600819|516454622|FG000|GEN Phase|Death|2|||
143246401|NCT02600819|516454623|FG001|GEN Phase|Death|0|||
143246402|NCT02600819|516454622|FG000|GEN Phase|Investigator's Discretion|4|||
143246403|NCT02600819|516454623|FG001|GEN Phase|Investigator's Discretion|0|||
143246404|NCT02600819|516454622|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
143246405|NCT02600819|516454623|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
143246406|NCT02600819|516454622|FG000|GEN Phase|Withdrew Consent|5|||
143246407|NCT02600819|516454623|FG001|GEN Phase|Withdrew Consent|0|||
143246408|NCT02600819|516454622|FG000|GEN Phase|Lost to Follow-up|2|||
143246409|NCT02600819|516454623|FG001|GEN Phase|Lost to Follow-up|0|||
143246410|NCT01715857|516454624|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
143246411|NCT00505778|516454625|FG000|Overall Study|Adverse Event|2|||
143246412|NCT00505778|516454626|FG001|Overall Study|Adverse Event|7|||
143246413|NCT00505778|516454625|FG000|Overall Study|Physician Decision|8|||
143246414|NCT00505778|516454626|FG001|Overall Study|Physician Decision|14|||
143246415|NCT00505778|516454625|FG000|Overall Study|Lost to Follow-up|17|||
143246416|NCT00505778|516454626|FG001|Overall Study|Lost to Follow-up|23|||
143246417|NCT00505778|516454625|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
143246418|NCT00505778|516454626|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
143246419|NCT00505778|516454625|FG000|Overall Study|Protocol Violation|7|||
143246420|NCT00505778|516454626|FG001|Overall Study|Protocol Violation|9|||
143246421|NCT00505778|516454625|FG000|Overall Study|Withdrawal by Subject|29|||
143246422|NCT00505778|516454626|FG001|Overall Study|Withdrawal by Subject|14|||
143170661|NCT03193801|516173614|FG000|Overall Study|Physician Decision|2|||
143170662|NCT03193801|516173614|FG000|Overall Study|Withdrawal by Subject|1|||
143170663|NCT03138564|516173615|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
143170664|NCT03138564|516173616|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
143170665|NCT03138564|516173615|FG000|Overall Study|Lost to Follow-up|16|||
143170666|NCT03138564|516173616|FG001|Overall Study|Lost to Follow-up|2|||
143170667|NCT03138564|516173615|FG000|Overall Study|Withdrawal by Subject|48|||
143170668|NCT03138564|516173616|FG001|Overall Study|Withdrawal by Subject|4|||
143246423|NCT00505778|516454625|FG000|Overall Study|Relapse|65|||
143246424|NCT00505778|516454626|FG001|Overall Study|Relapse|65|||
143170669|NCT03138564|516173615|FG000|Overall Study|No longer met eligibility criteria|2|||
143170670|NCT03138564|516173616|FG001|Overall Study|No longer met eligibility criteria|0|||
143246425|NCT00505778|516454625|FG000|Overall Study|Took No Study Drug|2|||
143246426|NCT00505778|516454626|FG001|Overall Study|Took No Study Drug|2|||
143246427|NCT02881567|516454628|FG000|Overall Study|Adverse Event|1|||
143246428|NCT02881567|516454628|FG000|Overall Study|Lost to Follow-up|3|||
143246429|NCT02881567|516454628|FG000|Overall Study|Consent withdrawn|1|||
143246430|NCT02881567|516454628|FG000|Overall Study|Investigator decision|1|||
143365182|NCT02223793|516880670|FG002|Overall Study|Moved/studycenter unable to participate|8|||
143365183|NCT00315055|516880671|FG000|Overall Study|Protocol Violation|2|||
143365184|NCT00315055|516880672|FG001|Overall Study|Protocol Violation|4|||
143365185|NCT00315055|516880671|FG000|Overall Study|Lost to Follow-up|1|||
143365186|NCT00315055|516880672|FG001|Overall Study|Lost to Follow-up|1|||
143365187|NCT01289119|516880674|FG000|Overall Study|Adverse Event|2|||
143365188|NCT01289119|516880675|FG001|Overall Study|Adverse Event|1|||
143365189|NCT01289119|516880676|FG002|Overall Study|Adverse Event|0|||
143365190|NCT01289119|516880677|FG003|Overall Study|Adverse Event|2|||
143365191|NCT01289119|516880678|FG004|Overall Study|Adverse Event|1|||
143365192|NCT01289119|516880679|FG005|Overall Study|Adverse Event|0|||
143365193|NCT01289119|516880674|FG000|Overall Study|Major Protocol Deviation|2|||
143365194|NCT01289119|516880675|FG001|Overall Study|Major Protocol Deviation|1|||
143365195|NCT01289119|516880676|FG002|Overall Study|Major Protocol Deviation|3|||
143365196|NCT01289119|516880677|FG003|Overall Study|Major Protocol Deviation|0|||
143365197|NCT01289119|516880678|FG004|Overall Study|Major Protocol Deviation|2|||
143365198|NCT01289119|516880679|FG005|Overall Study|Major Protocol Deviation|1|||
143365199|NCT01289119|516880674|FG000|Overall Study|Lost to Follow-up|0|||
143365200|NCT01289119|516880675|FG001|Overall Study|Lost to Follow-up|3|||
143365201|NCT01289119|516880676|FG002|Overall Study|Lost to Follow-up|0|||
143365202|NCT01289119|516880677|FG003|Overall Study|Lost to Follow-up|0|||
143365203|NCT01289119|516880678|FG004|Overall Study|Lost to Follow-up|0|||
143365204|NCT01289119|516880679|FG005|Overall Study|Lost to Follow-up|1|||
143365205|NCT01289119|516880674|FG000|Overall Study|Withdrawal by Subject|4|||
143365206|NCT01289119|516880675|FG001|Overall Study|Withdrawal by Subject|2|||
143365207|NCT01289119|516880676|FG002|Overall Study|Withdrawal by Subject|4|||
143365208|NCT01289119|516880677|FG003|Overall Study|Withdrawal by Subject|3|||
143365209|NCT01289119|516880678|FG004|Overall Study|Withdrawal by Subject|1|||
143365210|NCT01289119|516880679|FG005|Overall Study|Withdrawal by Subject|1|||
143365211|NCT01289119|516880674|FG000|Overall Study|Pregnancy|0|||
143365212|NCT01289119|516880675|FG001|Overall Study|Pregnancy|1|||
143365213|NCT01289119|516880676|FG002|Overall Study|Pregnancy|0|||
143365214|NCT01289119|516880677|FG003|Overall Study|Pregnancy|0|||
143365215|NCT01289119|516880678|FG004|Overall Study|Pregnancy|0|||
143365216|NCT01289119|516880679|FG005|Overall Study|Pregnancy|0|||
143365217|NCT01289119|516880674|FG000|Overall Study|Lack of Efficacy|0|||
143365218|NCT01289119|516880675|FG001|Overall Study|Lack of Efficacy|1|||
143365219|NCT01289119|516880676|FG002|Overall Study|Lack of Efficacy|1|||
143365220|NCT01289119|516880677|FG003|Overall Study|Lack of Efficacy|1|||
143365221|NCT01289119|516880678|FG004|Overall Study|Lack of Efficacy|1|||
143365222|NCT01289119|516880679|FG005|Overall Study|Lack of Efficacy|1|||
143365223|NCT01289119|516880674|FG000|Overall Study|Other|1|||
143365224|NCT01289119|516880675|FG001|Overall Study|Other|0|||
143365225|NCT01289119|516880676|FG002|Overall Study|Other|1|||
143068057|NCT04325204|515791078|FG001|Overall Study|Death|1|||
143068058|NCT04325204|515791077|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
143068059|NCT04325204|515791078|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
143068060|NCT04325204|515791077|FG000|Overall Study|Lost to Follow-up|8|||
143068061|NCT04325204|515791078|FG001|Overall Study|Lost to Follow-up|8|||
143068062|NCT04325204|515791077|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
143068063|NCT04325204|515791078|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
143068064|NCT03827564|515791085|FG000|Overall Study|Discontinued due to Study Termination|1|||
143068065|NCT03827564|515791086|FG001|Overall Study|Discontinued due to Study Termination|0|||
143068066|NCT00974974|515791090|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
143365226|NCT01289119|516880677|FG003|Overall Study|Other|0|||
143365227|NCT01289119|516880678|FG004|Overall Study|Other|0|||
143365228|NCT01289119|516880679|FG005|Overall Study|Other|0|||
143365229|NCT01704846|516880680|FG000|Treatment Period 2|Withdrawal by Subject|0|||
143365230|NCT01704846|516880681|FG001|Treatment Period 2|Withdrawal by Subject|1|||
143365231|NCT00530335|516880682|FG000|Overall Study|Adverse Event|3|||
143365232|NCT00530335|516880682|FG000|Overall Study|Protocol Violation|1|||
143365233|NCT00530335|516880682|FG000|Overall Study|Withdrawal by Subject|1|||
143365234|NCT00530335|516880682|FG000|Overall Study|Physician Decision|1|||
143365235|NCT01244984|516880683|FG000|Overall Study|Adverse Event|2|||
143365236|NCT01244984|516880684|FG001|Overall Study|Adverse Event|11|||
143503252|NCT00584870|517380996|FG000|Overall Study|Lost to Follow-up|4|||
143503253|NCT00584870|517380997|FG001|Overall Study|Lost to Follow-up|1|||
143503254|NCT00584870|517380998|FG002|Overall Study|Lost to Follow-up|1|||
143503255|NCT00584870|517380996|FG000|Overall Study|Lack of Efficacy|7|||
143503256|NCT00584870|517380997|FG001|Overall Study|Lack of Efficacy|14|||
143503257|NCT00584870|517380998|FG002|Overall Study|Lack of Efficacy|8|||
143503258|NCT00584870|517380996|FG000|Overall Study|Withdrawal by Subject|10|||
143503259|NCT00584870|517380997|FG001|Overall Study|Withdrawal by Subject|5|||
143503260|NCT00584870|517380998|FG002|Overall Study|Withdrawal by Subject|3|||
143503261|NCT00584870|517380996|FG000|Overall Study|Protocol Violation|1|||
143503262|NCT00584870|517380997|FG001|Overall Study|Protocol Violation|1|||
143503263|NCT00584870|517380998|FG002|Overall Study|Protocol Violation|2|||
143503264|NCT00584870|517380996|FG000|Overall Study|Did not met entrance criteria|1|||
143503265|NCT00584870|517380997|FG001|Overall Study|Did not met entrance criteria|0|||
143503266|NCT00584870|517380998|FG002|Overall Study|Did not met entrance criteria|0|||
143503267|NCT00584870|517380996|FG000|Overall Study|Other|2|||
143068067|NCT00974974|515791091|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
143068068|NCT00974974|515791090|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
143068069|NCT00974974|515791091|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
143068070|NCT00974974|515791090|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
143068071|NCT00974974|515791091|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
143068072|NCT00974974|515791090|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
143068073|NCT00974974|515791091|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
143068074|NCT00974974|515791090|FG000|IR CD-LD Dose Adjustment|Various|0|||
143068075|NCT00974974|515791091|FG001|IR CD-LD Dose Adjustment|Various|9|||
143068076|NCT00974974|515791090|FG000|IPX066 Dose Conversion|Adverse Event|23|||
143068077|NCT00974974|515791091|FG001|IPX066 Dose Conversion|Adverse Event|0|||
143068078|NCT00974974|515791090|FG000|IPX066 Dose Conversion|Death|2|||
143068079|NCT00974974|515791091|FG001|IPX066 Dose Conversion|Death|0|||
143068080|NCT00974974|515791090|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
143068081|NCT00974974|515791091|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
143068082|NCT00974974|515791090|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
143068083|NCT00974974|515791091|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
143068084|NCT00974974|515791090|FG000|IPX066 Dose Conversion|Various|3|||
143068085|NCT00974974|515791091|FG001|IPX066 Dose Conversion|Various|0|||
143068086|NCT00974974|515791090|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
143068087|NCT00974974|515791091|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
143068088|NCT00974974|515791090|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
143068089|NCT00974974|515791091|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
143068090|NCT00974974|515791090|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
143068091|NCT00974974|515791091|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
143068092|NCT00974974|515791090|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
143068093|NCT00974974|515791091|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
143068094|NCT00974974|515791090|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
143068095|NCT00974974|515791091|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
143068096|NCT00974974|515791090|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
143068097|NCT00974974|515791091|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
143068098|NCT00974974|515791090|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
143068099|NCT00974974|515791091|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
143068100|NCT00974974|515791090|FG000|Maintenance - Double Blind Treatment|Various|4|||
143068101|NCT00974974|515791091|FG001|Maintenance - Double Blind Treatment|Various|0|||
143068102|NCT01959035|515791092|FG000|Overall Study|Adverse Event|5|||
143068103|NCT01959035|515791092|FG000|Overall Study|Withdrawal by Subject|4|||
143068104|NCT01959035|515791092|FG000|Overall Study|Lost to Follow-up|1|||
143068105|NCT01959035|515791092|FG000|Overall Study|Other (no primary reason given)|1|||
143068106|NCT00450619|515791093|FG000|Overall Study|refused treatment after randomization|2|||
143068107|NCT00450619|515791094|FG001|Overall Study|refused treatment after randomization|0|||
143068108|NCT00450619|515791093|FG000|Overall Study|did not progress; refused further trmt|1|||
143068109|NCT00450619|515791094|FG001|Overall Study|did not progress; refused further trmt|1|||
143068110|NCT00450619|515791093|FG000|Overall Study|Adverse Event|1|||
143068111|NCT00450619|515791094|FG001|Overall Study|Adverse Event|0|||
143068112|NCT02034058|515791095|FG000|Overall Study|Death|3|||
143068113|NCT03254602|515791096|FG000|Overall Study|Lost to Follow-up|4|||
143068114|NCT02372071|515791099|FG000|Overall Study|Protocol Violation|18|||
143068115|NCT02836496|515791100|FG000|Overall Study|Adverse Event|2|||
143068116|NCT02836496|515791101|FG001|Overall Study|Adverse Event|1|||
143068117|NCT02836496|515791100|FG000|Overall Study|Withdrawal by Subject|0|||
143068118|NCT02836496|515791101|FG001|Overall Study|Withdrawal by Subject|1|||
143068119|NCT02618408|515791103|FG000|Overall Study|Withdrawal by Subject|1|||
143068120|NCT02618408|515791104|FG001|Overall Study|Withdrawal by Subject|0|||
143068121|NCT02618408|515791105|FG002|Overall Study|Withdrawal by Subject|4|||
143068122|NCT02618408|515791103|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
143068123|NCT02618408|515791104|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
143068124|NCT02618408|515791105|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
143068125|NCT02618408|515791103|FG000|Overall Study|Lost to Follow-up|4|||
143068126|NCT02618408|515791104|FG001|Overall Study|Lost to Follow-up|2|||
143068127|NCT02618408|515791105|FG002|Overall Study|Lost to Follow-up|6|||
143068128|NCT02618408|515791103|FG000|Overall Study|Adverse Event|4|||
143068129|NCT02618408|515791104|FG001|Overall Study|Adverse Event|0|||
143068130|NCT02618408|515791105|FG002|Overall Study|Adverse Event|10|||
143068131|NCT02618408|515791103|FG000|Overall Study|Physician Decision|1|||
143068132|NCT02618408|515791104|FG001|Overall Study|Physician Decision|1|||
143068133|NCT02618408|515791105|FG002|Overall Study|Physician Decision|2|||
143068134|NCT02618408|515791103|FG000|Overall Study|Protocol Violation|1|||
143503268|NCT00584870|517380997|FG001|Overall Study|Other|0|||
143068135|NCT02618408|515791104|FG001|Overall Study|Protocol Violation|1|||
143068136|NCT02618408|515791105|FG002|Overall Study|Protocol Violation|2|||
143068137|NCT02618408|515791103|FG000|Overall Study|Other, Multiple Categories|0|||
143068138|NCT02618408|515791104|FG001|Overall Study|Other, Multiple Categories|0|||
143068139|NCT02618408|515791105|FG002|Overall Study|Other, Multiple Categories|4|||
143068140|NCT03914950|515791113|FG000|Overall Study|Physician Decision|54|||
143068141|NCT03201250|515791114|FG000|Overall Study|screen failures|3|||
143068142|NCT03201250|515791115|FG001|Overall Study|screen failures|0|||
143068143|NCT03201250|515791116|FG002|Overall Study|screen failures|0|||
143068144|NCT01936623|515791117|FG000|Overall Study|Lost to Follow-up|0|||
143068145|NCT01936623|515791118|FG001|Overall Study|Lost to Follow-up|5|||
143068146|NCT02575911|515791121|FG000|Overall Study|Lost to Follow-up|1|||
143068147|NCT03052959|515791126|FG000|Overall Study|Lost to Follow-up|4|||
143068148|NCT03052959|515791127|FG001|Overall Study|Lost to Follow-up|5|||
143068149|NCT03551496|515791128|FG000|Overall Study|Death|11|||
143068150|NCT03551496|515791129|FG001|Overall Study|Death|7|||
143068151|NCT03551496|515791128|FG000|Overall Study|Withdrawal by Subject|4|||
143068152|NCT03551496|515791129|FG001|Overall Study|Withdrawal by Subject|3|||
143068153|NCT03551496|515791128|FG000|Overall Study|Other Reasons|1|||
143068154|NCT03551496|515791129|FG001|Overall Study|Other Reasons|0|||
143246431|NCT02881567|516454628|FG000|Overall Study|Study terminated by sponsor|9|||
143246432|NCT02881567|516454628|FG000|Overall Study|Reason not Specified|3|||
143246433|NCT00373113|516454629|FG000|Overall Study|Death|1|||
143246434|NCT00373113|516454630|FG001|Overall Study|Death|7|||
143246435|NCT00373113|516454629|FG000|Overall Study|Adverse Event|38|||
143246436|NCT00373113|516454630|FG001|Overall Study|Adverse Event|24|||
143246437|NCT00373113|516454629|FG000|Overall Study|Study terminated by sponsor|9|||
143246438|NCT00373113|516454630|FG001|Overall Study|Study terminated by sponsor|1|||
143246439|NCT00373113|516454629|FG000|Overall Study|Global deterioration of health status|10|||
143246440|NCT00373113|516454630|FG001|Overall Study|Global deterioration of health status|7|||
143246441|NCT00373113|516454629|FG000|Overall Study|Lost to Follow-up|1|||
143246442|NCT00373113|516454630|FG001|Overall Study|Lost to Follow-up|3|||
143246443|NCT00373113|516454629|FG000|Overall Study|Objective progression or relapse|150|||
143246444|NCT00373113|516454630|FG001|Overall Study|Objective progression or relapse|169|||
143246445|NCT00373113|516454629|FG000|Overall Study|Other|14|||
143246446|NCT00373113|516454630|FG001|Overall Study|Other|17|||
143246447|NCT00373113|516454629|FG000|Overall Study|Protocol Violation|5|||
143246448|NCT00373113|516454630|FG001|Overall Study|Protocol Violation|1|||
143246449|NCT00373113|516454629|FG000|Overall Study|Withdrawal by Subject|10|||
143246450|NCT00373113|516454630|FG001|Overall Study|Withdrawal by Subject|15|||
143246451|NCT01396447|516454633|FG000|Overall Study|Did Not Receive Treatment|3|||
143246452|NCT01396447|516454634|FG001|Overall Study|Did Not Receive Treatment|2|||
143246453|NCT01396447|516454635|FG002|Overall Study|Did Not Receive Treatment|1|||
143246454|NCT01396447|516454636|FG003|Overall Study|Did Not Receive Treatment|0|||
143246455|NCT01396447|516454633|FG000|Overall Study|Adverse Event|15|||
143246456|NCT01396447|516454634|FG001|Overall Study|Adverse Event|12|||
143246457|NCT01396447|516454635|FG002|Overall Study|Adverse Event|12|||
143246458|NCT01396447|516454636|FG003|Overall Study|Adverse Event|17|||
143246459|NCT01396447|516454633|FG000|Overall Study|Insufficient Therapeutic Response|5|||
143246460|NCT01396447|516454634|FG001|Overall Study|Insufficient Therapeutic Response|5|||
143068155|NCT01524679|515791130|FG000|Overall Study|Lost to Follow-up|1|||
143068156|NCT01524679|515791131|FG001|Overall Study|Lost to Follow-up|4|||
143068157|NCT01524679|515791130|FG000|Overall Study|Withdrawal by Subject|4|||
143068158|NCT01524679|515791131|FG001|Overall Study|Withdrawal by Subject|4|||
143068159|NCT01524679|515791130|FG000|Overall Study|Adverse Event|9|||
143068160|NCT01524679|515791131|FG001|Overall Study|Adverse Event|0|||
143068161|NCT01524679|515791130|FG000|Overall Study|Protocol Violation|1|||
143068162|NCT01524679|515791131|FG001|Overall Study|Protocol Violation|0|||
143068163|NCT01524679|515791130|FG000|Overall Study|Lack of Efficacy|2|||
143068164|NCT01524679|515791131|FG001|Overall Study|Lack of Efficacy|0|||
143068165|NCT01524679|515791130|FG000|Overall Study|e.g.wish for children, relocation|6|||
143068166|NCT01524679|515791131|FG001|Overall Study|e.g.wish for children, relocation|1|||
143068167|NCT00140426|515791134|FG000|Overall Study|Withdrawal by Subject|0|||
143170671|NCT03138564|516173615|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
143170672|NCT03138564|516173616|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
143170673|NCT03138564|516173615|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
143170674|NCT03138564|516173616|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
143170675|NCT03138564|516173615|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
143170676|NCT03138564|516173616|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
143170677|NCT03138564|516173615|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
143170678|NCT03138564|516173616|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
143170679|NCT03909971|516173618|FG000|Overall Study|Participant transition to rollover study|26|||
143246461|NCT01396447|516454635|FG002|Overall Study|Insufficient Therapeutic Response|2|||
143068168|NCT00140426|515791135|FG001|Overall Study|Withdrawal by Subject|3|||
143068169|NCT04765384|515791136|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
143068170|NCT04765384|515791137|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
143068171|NCT04765384|515791138|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
143068172|NCT04765384|515791139|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
143068173|NCT04765384|515791140|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
143068174|NCT04765384|515791141|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
143068175|NCT04765384|515791136|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
143068176|NCT04765384|515791137|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
143068177|NCT04765384|515791138|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
143068178|NCT04765384|515791139|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
143068179|NCT04765384|515791140|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
143068180|NCT04765384|515791141|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
143068181|NCT04765384|515791136|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
143068182|NCT04765384|515791137|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
143068183|NCT04765384|515791138|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
143068184|NCT04765384|515791139|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
143068185|NCT04765384|515791140|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
143068186|NCT04765384|515791141|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
143068187|NCT04765384|515791136|FG000|Post-natal: Neonates and Infants|Death|0|||
143068188|NCT04765384|515791137|FG001|Post-natal: Neonates and Infants|Death|0|||
143068189|NCT04765384|515791138|FG002|Post-natal: Neonates and Infants|Death|0|||
143068190|NCT04765384|515791139|FG003|Post-natal: Neonates and Infants|Death|1|||
143068191|NCT04765384|515791140|FG004|Post-natal: Neonates and Infants|Death|0|||
143068192|NCT04765384|515791141|FG005|Post-natal: Neonates and Infants|Death|0|||
143068193|NCT04765384|515791136|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
143068194|NCT04765384|515791137|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
143068195|NCT04765384|515791138|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
143068196|NCT04765384|515791139|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
143068197|NCT04765384|515791140|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
143068198|NCT04765384|515791141|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
143068199|NCT00987389|515791142|FG000|Overall Study|Ineligible|0|||
143068200|NCT00987389|515791143|FG001|Overall Study|Ineligible|3|||
143068201|NCT00987389|515791144|FG002|Overall Study|Ineligible|0|||
143068202|NCT00987389|515791145|FG003|Overall Study|Ineligible|0|||
143068203|NCT00987389|515791142|FG000|Overall Study|Lost to Follow-up|4|||
143068204|NCT00987389|515791143|FG001|Overall Study|Lost to Follow-up|1|||
143068205|NCT00987389|515791144|FG002|Overall Study|Lost to Follow-up|3|||
143068206|NCT00987389|515791145|FG003|Overall Study|Lost to Follow-up|1|||
143068207|NCT00987389|515791142|FG000|Overall Study|Withdrawal by Subject|4|||
143068208|NCT00987389|515791143|FG001|Overall Study|Withdrawal by Subject|3|||
143068209|NCT00987389|515791144|FG002|Overall Study|Withdrawal by Subject|2|||
143246462|NCT01396447|516454636|FG003|Overall Study|Insufficient Therapeutic Response|4|||
143246463|NCT01396447|516454633|FG000|Overall Study|Protocol Violation|5|||
143246464|NCT01396447|516454634|FG001|Overall Study|Protocol Violation|2|||
143246465|NCT01396447|516454635|FG002|Overall Study|Protocol Violation|3|||
143246466|NCT01396447|516454636|FG003|Overall Study|Protocol Violation|7|||
143246467|NCT01396447|516454633|FG000|Overall Study|Withdrawal of Consent|11|||
143246468|NCT01396447|516454634|FG001|Overall Study|Withdrawal of Consent|9|||
143246469|NCT01396447|516454635|FG002|Overall Study|Withdrawal of Consent|4|||
143246470|NCT01396447|516454636|FG003|Overall Study|Withdrawal of Consent|15|||
143246471|NCT01396447|516454633|FG000|Overall Study|Lost to Follow-up|4|||
143246472|NCT01396447|516454634|FG001|Overall Study|Lost to Follow-up|8|||
143246473|NCT01396447|516454635|FG002|Overall Study|Lost to Follow-up|7|||
143246474|NCT01396447|516454636|FG003|Overall Study|Lost to Follow-up|9|||
143246475|NCT01396447|516454633|FG000|Overall Study|Other Miscellaneous Reasons|0|||
143246476|NCT01396447|516454634|FG001|Overall Study|Other Miscellaneous Reasons|2|||
143246477|NCT01396447|516454635|FG002|Overall Study|Other Miscellaneous Reasons|1|||
143246478|NCT01396447|516454636|FG003|Overall Study|Other Miscellaneous Reasons|0|||
143246479|NCT01402102|516454637|FG000|Overall Study|Protocol Violation|1|||
143246480|NCT01402102|516454638|FG001|Overall Study|Protocol Violation|0|||
143246481|NCT01402102|516454637|FG000|Overall Study|Insufficiency of compliance|1|||
143246482|NCT01402102|516454638|FG001|Overall Study|Insufficiency of compliance|1|||
143068210|NCT00987389|515791145|FG003|Overall Study|Withdrawal by Subject|1|||
143246483|NCT01402102|516454637|FG000|Overall Study|Withdrawal by Subject|0|||
143246484|NCT01402102|516454638|FG001|Overall Study|Withdrawal by Subject|2|||
143246485|NCT01305577|516454639|FG000|Overall Study|Adverse Event|2|||
143246486|NCT01305577|516454640|FG001|Overall Study|Adverse Event|2|||
143068211|NCT00987389|515791142|FG000|Overall Study|Withdrawn from Treatment|0|||
143068212|NCT00987389|515791143|FG001|Overall Study|Withdrawn from Treatment|1|||
143068213|NCT00987389|515791144|FG002|Overall Study|Withdrawn from Treatment|0|||
143246487|NCT01305577|516454641|FG002|Overall Study|Adverse Event|1|||
143246488|NCT01305577|516454639|FG000|Overall Study|Withdrawal by Subject|7|||
143246489|NCT01305577|516454640|FG001|Overall Study|Withdrawal by Subject|5|||
143246490|NCT01305577|516454641|FG002|Overall Study|Withdrawal by Subject|6|||
143170680|NCT03909971|516173619|FG001|Overall Study|Participant transition to rollover study|9|||
143170681|NCT03909971|516173618|FG000|Overall Study|Global Deterioration of Health Status|2|||
143170682|NCT03909971|516173619|FG001|Overall Study|Global Deterioration of Health Status|2|||
143170683|NCT03909971|516173618|FG000|Overall Study|Progressive Disease|28|||
143170684|NCT03909971|516173619|FG001|Overall Study|Progressive Disease|21|||
143170685|NCT03909971|516173618|FG000|Overall Study|Death|6|||
143170686|NCT03909971|516173619|FG001|Overall Study|Death|6|||
143170687|NCT03909971|516173618|FG000|Overall Study|Adverse Event|1|||
143170688|NCT03909971|516173619|FG001|Overall Study|Adverse Event|2|||
143170689|NCT03909971|516173618|FG000|Overall Study|Withdrawal by Subject|2|||
143170690|NCT03909971|516173619|FG001|Overall Study|Withdrawal by Subject|1|||
143170691|NCT03909971|516173618|FG000|Overall Study|Participant was unwilling to come to site visit|0|||
143170692|NCT03909971|516173619|FG001|Overall Study|Participant was unwilling to come to site visit|1|||
143170693|NCT03909971|516173618|FG000|Overall Study|No longer benefit from Lorlatinib|2|||
143170694|NCT03909971|516173619|FG001|Overall Study|No longer benefit from Lorlatinib|0|||
143170695|NCT05177354|516173620|FG000|Implant to 30-day Visit|Physician Decision|1|||
143170696|NCT05177354|516173620|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
143170697|NCT05177354|516173620|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
143170698|NCT05177354|516173620|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
143170699|NCT03734536|516173621|FG000|Overall Study|Withdrew Consent|1|||
143170700|NCT03734536|516173622|FG001|Overall Study|Withdrew Consent|5|||
143170701|NCT03734536|516173621|FG000|Overall Study|Lost to Follow-up|10|||
143170702|NCT03734536|516173622|FG001|Overall Study|Lost to Follow-up|7|||
143170703|NCT06028464|516173626|FG000|Washout|Positive drug test.|1|||
143170704|NCT03189719|516173627|FG000|Overall Study|Death|325|||
143170705|NCT03189719|516173628|FG001|Overall Study|Death|361|||
143170706|NCT03189719|516173627|FG000|Overall Study|Physician Decision|1|||
143246491|NCT01305577|516454639|FG000|Overall Study|Lost to Follow-up|4|||
143246492|NCT01305577|516454640|FG001|Overall Study|Lost to Follow-up|3|||
143246493|NCT01305577|516454641|FG002|Overall Study|Lost to Follow-up|2|||
143246494|NCT01305577|516454639|FG000|Overall Study|Protocol Deviation|0|||
143246495|NCT01305577|516454640|FG001|Overall Study|Protocol Deviation|1|||
143246496|NCT01305577|516454641|FG002|Overall Study|Protocol Deviation|1|||
143246497|NCT00796978|516454642|FG000|Overall Study|Cardiac adverse event|5|||
143246498|NCT00796978|516454642|FG000|Overall Study|Adverse Event|4|||
143246499|NCT00796978|516454642|FG000|Overall Study|Withdrawal by Subject|3|||
143246500|NCT02675634|516454643|FG000|Test Period 1|Adverse Event|0|||
143246501|NCT02675634|516454644|FG001|Test Period 1|Adverse Event|1|||
143246502|NCT02675634|516454645|FG002|Test Period 1|Adverse Event|0|||
143246503|NCT02675634|516454646|FG003|Test Period 1|Adverse Event|1|||
143246504|NCT02675634|516454647|FG004|Test Period 1|Adverse Event|0|||
143246505|NCT02675634|516454648|FG005|Test Period 1|Adverse Event|0|||
143246506|NCT02675634|516454643|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
143246507|NCT02675634|516454644|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
143246508|NCT02675634|516454645|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
143246509|NCT02675634|516454646|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
143246510|NCT02675634|516454647|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
143246511|NCT02675634|516454648|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
143246512|NCT02675634|516454643|FG000|Test Period 2|Lack of Efficacy|1|||
143246513|NCT02675634|516454644|FG001|Test Period 2|Lack of Efficacy|0|||
143246514|NCT02675634|516454645|FG002|Test Period 2|Lack of Efficacy|0|||
143246515|NCT02675634|516454646|FG003|Test Period 2|Lack of Efficacy|0|||
143246516|NCT02675634|516454647|FG004|Test Period 2|Lack of Efficacy|0|||
143246517|NCT02675634|516454648|FG005|Test Period 2|Lack of Efficacy|0|||
143246518|NCT02675634|516454643|FG000|Test Period 2|Adverse Event|0|||
143246519|NCT02675634|516454644|FG001|Test Period 2|Adverse Event|0|||
143246520|NCT02675634|516454645|FG002|Test Period 2|Adverse Event|0|||
143246521|NCT02675634|516454646|FG003|Test Period 2|Adverse Event|0|||
143246522|NCT02675634|516454647|FG004|Test Period 2|Adverse Event|0|||
143246523|NCT02675634|516454648|FG005|Test Period 2|Adverse Event|1|||
143246524|NCT04380519|516454651|FG000|Overall Study|Withdrawal by Subject|4|||
143246525|NCT04380519|516454652|FG001|Overall Study|Withdrawal by Subject|0|||
143246526|NCT04380519|516454653|FG002|Overall Study|Withdrawal by Subject|1|||
143246527|NCT04380519|516454651|FG000|Overall Study|Death|14|||
143246528|NCT04380519|516454652|FG001|Overall Study|Death|9|||
143246529|NCT04380519|516454653|FG002|Overall Study|Death|6|||
143246530|NCT04380519|516454651|FG000|Overall Study|Adverse Event|0|||
143170707|NCT03189719|516173628|FG001|Overall Study|Physician Decision|0|||
143246531|NCT04380519|516454652|FG001|Overall Study|Adverse Event|1|||
143170708|NCT03189719|516173627|FG000|Overall Study|Sponsor Decision|40|||
143170709|NCT03189719|516173628|FG001|Overall Study|Sponsor Decision|12|||
143246532|NCT04380519|516454653|FG002|Overall Study|Adverse Event|0|||
143246533|NCT04380519|516454651|FG000|Overall Study|relatives' decision|0|||
143246534|NCT04380519|516454652|FG001|Overall Study|relatives' decision|1|||
143246535|NCT04380519|516454653|FG002|Overall Study|relatives' decision|0|||
143246536|NCT00393861|516454656|FG000|Overall Study|Adverse Event|2|||
143503269|NCT00584870|517380998|FG002|Overall Study|Other|0|||
143246537|NCT00393861|516454656|FG000|Overall Study|Disease Progression|24|||
143246538|NCT02283762|516454657|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
143246539|NCT02283762|516454658|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
143246540|NCT02283762|516454657|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
143246541|NCT02283762|516454658|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
143365237|NCT01244984|516880685|FG002|Overall Study|Adverse Event|2|||
143365238|NCT01244984|516880683|FG000|Overall Study|Protocol Violation|1|||
143365239|NCT01244984|516880684|FG001|Overall Study|Protocol Violation|0|||
143365240|NCT01244984|516880685|FG002|Overall Study|Protocol Violation|0|||
143365241|NCT01244984|516880683|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
143365242|NCT01244984|516880684|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
143365243|NCT01244984|516880685|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
143365244|NCT01244984|516880683|FG000|Overall Study|Withdrawal by Subject|1|||
143365245|NCT01244984|516880684|FG001|Overall Study|Withdrawal by Subject|2|||
143365246|NCT01244984|516880685|FG002|Overall Study|Withdrawal by Subject|2|||
143365247|NCT01168401|516880686|FG000|Overall Study|Lost to Follow-up|1|||
143365248|NCT01168401|516880687|FG001|Overall Study|Lost to Follow-up|1|||
143365249|NCT01168401|516880688|FG002|Overall Study|Lost to Follow-up|2|||
143365250|NCT01168401|516880689|FG003|Overall Study|Lost to Follow-up|1|||
143365251|NCT01168401|516880690|FG004|Overall Study|Lost to Follow-up|0|||
143365252|NCT01168401|516880691|FG005|Overall Study|Lost to Follow-up|0|||
143365253|NCT01168401|516880692|FG006|Overall Study|Lost to Follow-up|0|||
143365254|NCT01168401|516880693|FG007|Overall Study|Lost to Follow-up|0|||
143365255|NCT01168401|516880694|FG008|Overall Study|Lost to Follow-up|0|||
143365256|NCT01168401|516880695|FG009|Overall Study|Lost to Follow-up|0|||
143365257|NCT01168401|516880696|FG010|Overall Study|Lost to Follow-up|0|||
143365258|NCT01168401|516880686|FG000|Overall Study|Withdrawal by Subject|0|||
143365259|NCT01168401|516880687|FG001|Overall Study|Withdrawal by Subject|0|||
143365260|NCT01168401|516880688|FG002|Overall Study|Withdrawal by Subject|0|||
143365261|NCT01168401|516880689|FG003|Overall Study|Withdrawal by Subject|1|||
143365262|NCT01168401|516880690|FG004|Overall Study|Withdrawal by Subject|0|||
143365263|NCT01168401|516880691|FG005|Overall Study|Withdrawal by Subject|0|||
143365264|NCT01168401|516880692|FG006|Overall Study|Withdrawal by Subject|0|||
143365265|NCT01168401|516880693|FG007|Overall Study|Withdrawal by Subject|0|||
143365266|NCT01168401|516880694|FG008|Overall Study|Withdrawal by Subject|0|||
143365267|NCT01168401|516880695|FG009|Overall Study|Withdrawal by Subject|0|||
143365268|NCT01168401|516880696|FG010|Overall Study|Withdrawal by Subject|0|||
143365269|NCT01801930|516880698|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
143365270|NCT01801930|516880699|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
143068214|NCT00987389|515791145|FG003|Overall Study|Withdrawn from Treatment|0|||
143068215|NCT00987389|515791142|FG000|Overall Study|Multiple different reasons|1|||
143068216|NCT00987389|515791143|FG001|Overall Study|Multiple different reasons|0|||
143068217|NCT00987389|515791144|FG002|Overall Study|Multiple different reasons|3|||
143246542|NCT02283762|516454657|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
143246543|NCT02283762|516454658|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
143246544|NCT02283762|516454657|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
143246545|NCT02283762|516454658|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
143246546|NCT02283762|516454657|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
143246547|NCT02283762|516454658|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
143246548|NCT02283762|516454657|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
143246549|NCT02283762|516454658|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
143246550|NCT02283762|516454657|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
143246551|NCT02283762|516454658|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
143246552|NCT02283762|516454657|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
143246553|NCT02283762|516454658|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
143246554|NCT02283762|516454657|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
143246555|NCT02283762|516454658|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
143246556|NCT02283762|516454657|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
143068218|NCT00987389|515791145|FG003|Overall Study|Multiple different reasons|1|||
143068219|NCT02992418|515791146|FG000|Overall Study|Withdrawal by Subject|11|||
143246557|NCT02283762|516454658|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
143365271|NCT01801930|516880700|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
143365272|NCT01801930|516880701|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
143365273|NCT01801930|516880698|FG000|Overall Study|DLT occurs|0|||
143365274|NCT01801930|516880699|FG001|Overall Study|DLT occurs|1|||
143365275|NCT01801930|516880700|FG002|Overall Study|DLT occurs|0|||
143365276|NCT01801930|516880701|FG003|Overall Study|DLT occurs|0|||
143365277|NCT01720043|516880713|FG000|Overall Study|Withdrawal by Subject|1|||
143068220|NCT02992418|515791147|FG001|Overall Study|Withdrawal by Subject|12|||
143068221|NCT02992418|515791146|FG000|Overall Study|Non-compliance with the protocol|308|||
143246558|NCT02283762|516454657|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
143365278|NCT01516892|516880715|FG000|Overall Study|Adverse Event|25|||
143365279|NCT01516892|516880715|FG000|Overall Study|Lack of Efficacy|35|||
143365280|NCT01516892|516880715|FG000|Overall Study|Pregnancy|5|||
143503270|NCT00584870|517380996|FG000|Overall Study|Randomized but not treated|0|||
143503271|NCT00584870|517380997|FG001|Overall Study|Randomized but not treated|1|||
143503272|NCT00584870|517380998|FG002|Overall Study|Randomized but not treated|2|||
143503273|NCT03308188|517380999|FG000|Overall Study|Withdrawal by Subject|0|||
143503274|NCT03308188|517381000|FG001|Overall Study|Withdrawal by Subject|3|||
143503275|NCT03308188|517380999|FG000|Overall Study|Death|0|||
143503276|NCT03308188|517381000|FG001|Overall Study|Death|1|||
143503277|NCT01791855|517381001|FG000|Overall Study|Adverse Event|0|||
143503278|NCT01791855|517381002|FG001|Overall Study|Adverse Event|0|||
143068222|NCT02992418|515791147|FG001|Overall Study|Non-compliance with the protocol|308|||
143068223|NCT02992418|515791146|FG000|Overall Study|Lost to Follow-up|27|||
143068224|NCT02992418|515791147|FG001|Overall Study|Lost to Follow-up|22|||
143068225|NCT04465630|515791150|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
143068226|NCT04465630|515791150|FG000|Overall Study|Screen failure|8|||
143246559|NCT02283762|516454658|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
143246560|NCT02283762|516454657|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
143246561|NCT02283762|516454658|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
143246562|NCT01587014|516454662|FG000|Overall Study|Death|2|||
143246563|NCT02367833|516454663|FG000|Overall Study|Withdrawal by Subject|1|||
143246564|NCT02367833|516454664|FG001|Overall Study|Withdrawal by Subject|1|||
143246565|NCT02367833|516454665|FG002|Overall Study|Withdrawal by Subject|0|||
143246566|NCT00889720|516454668|FG000|Overall Study|Withdrawal by Subject|4|||
143246567|NCT00889720|516454668|FG000|Overall Study|Other|4|||
143246568|NCT00775593|516454669|FG000|Overall Study|Unmet eligibility criteria|6|||
143246569|NCT00775593|516454669|FG000|Overall Study|Death|1|||
143246570|NCT01327482|516454670|FG000|Overall Study|Adverse Event|1|||
143246571|NCT00476229|516454671|FG000|Overall Study|Progressive shortness of breath|1|||
143246572|NCT02164461|516454672|FG000|Overall Study|Adverse Event|0|||
143246573|NCT02164461|516454673|FG001|Overall Study|Adverse Event|0|||
143246574|NCT02164461|516454674|FG002|Overall Study|Adverse Event|1|||
143246575|NCT02164461|516454672|FG000|Overall Study|Disease Progression|1|||
143246576|NCT02164461|516454673|FG001|Overall Study|Disease Progression|3|||
143246577|NCT02164461|516454674|FG002|Overall Study|Disease Progression|4|||
143246578|NCT02164461|516454672|FG000|Overall Study|Withdrawal by Subject|0|||
143246579|NCT02164461|516454673|FG001|Overall Study|Withdrawal by Subject|3|||
143246580|NCT02164461|516454674|FG002|Overall Study|Withdrawal by Subject|0|||
143246581|NCT02100696|516454676|FG000|Induction Phase|Adverse Event|0|||
143246582|NCT02100696|516454677|FG001|Induction Phase|Adverse Event|0|||
143246583|NCT02100696|516454678|FG002|Induction Phase|Adverse Event|1|||
143246584|NCT02100696|516454679|FG003|Induction Phase|Adverse Event|0|||
143246585|NCT02100696|516454680|FG004|Induction Phase|Adverse Event|0|||
143246586|NCT02100696|516454681|FG005|Induction Phase|Adverse Event|0|||
143246587|NCT02100696|516454676|FG000|Induction Phase|Lost to Follow-up|1|||
143246588|NCT02100696|516454677|FG001|Induction Phase|Lost to Follow-up|0|||
143246589|NCT02100696|516454678|FG002|Induction Phase|Lost to Follow-up|1|||
143246590|NCT02100696|516454679|FG003|Induction Phase|Lost to Follow-up|0|||
143246591|NCT02100696|516454680|FG004|Induction Phase|Lost to Follow-up|0|||
143246592|NCT02100696|516454681|FG005|Induction Phase|Lost to Follow-up|0|||
143246593|NCT02100696|516454676|FG000|Induction Phase|Protocol Violation|0|||
143246594|NCT02100696|516454677|FG001|Induction Phase|Protocol Violation|1|||
143246595|NCT02100696|516454678|FG002|Induction Phase|Protocol Violation|1|||
143246596|NCT02100696|516454679|FG003|Induction Phase|Protocol Violation|0|||
143246597|NCT02100696|516454680|FG004|Induction Phase|Protocol Violation|0|||
143246598|NCT02100696|516454681|FG005|Induction Phase|Protocol Violation|0|||
143246599|NCT02100696|516454676|FG000|Induction Phase|Withdrawal by Subject|8|||
143246600|NCT02100696|516454677|FG001|Induction Phase|Withdrawal by Subject|2|||
143246601|NCT02100696|516454678|FG002|Induction Phase|Withdrawal by Subject|13|||
143246602|NCT02100696|516454679|FG003|Induction Phase|Withdrawal by Subject|0|||
143246603|NCT02100696|516454680|FG004|Induction Phase|Withdrawal by Subject|0|||
143246604|NCT02100696|516454681|FG005|Induction Phase|Withdrawal by Subject|0|||
143246605|NCT02100696|516454676|FG000|Induction Phase|Physician Decision|1|||
143246606|NCT02100696|516454677|FG001|Induction Phase|Physician Decision|0|||
143365281|NCT01516892|516880715|FG000|Overall Study|Lost to Follow-up|82|||
143068227|NCT04465630|515791150|FG000|Overall Study|Baseline failure|16|||
143068228|NCT01732484|515791153|FG000|Overall Study|Death|7|||
143246607|NCT02100696|516454678|FG002|Induction Phase|Physician Decision|2|||
143246608|NCT02100696|516454679|FG003|Induction Phase|Physician Decision|0|||
143246609|NCT02100696|516454680|FG004|Induction Phase|Physician Decision|0|||
143246610|NCT02100696|516454681|FG005|Induction Phase|Physician Decision|0|||
143246611|NCT02100696|516454676|FG000|Induction Phase|Multiple Reasons|5|||
143246612|NCT02100696|516454677|FG001|Induction Phase|Multiple Reasons|2|||
143246613|NCT02100696|516454678|FG002|Induction Phase|Multiple Reasons|8|||
143246614|NCT02100696|516454679|FG003|Induction Phase|Multiple Reasons|0|||
143246615|NCT02100696|516454680|FG004|Induction Phase|Multiple Reasons|0|||
143246616|NCT02100696|516454681|FG005|Induction Phase|Multiple Reasons|0|||
143246617|NCT02100696|516454676|FG000|Maintenance Phase|Adverse Event|0|||
143503279|NCT01791855|517381003|FG002|Overall Study|Adverse Event|0|||
143503280|NCT01791855|517381004|FG003|Overall Study|Adverse Event|1|||
143170710|NCT03189719|516173627|FG000|Overall Study|Withdrawal by Subject|7|||
143170711|NCT03189719|516173628|FG001|Overall Study|Withdrawal by Subject|3|||
143170712|NCT03330847|516173631|FG000|Overall Study|Patients ongoing study|62|||
143170713|NCT03330847|516173632|FG001|Overall Study|Patients ongoing study|65|||
143170714|NCT03330847|516173633|FG002|Overall Study|Patients ongoing study|15|||
143170715|NCT05211596|516173636|FG000|Baseline to 6 Months|Lost to Follow-up|11|||
143170716|NCT05211596|516173636|FG000|Baseline to 6 Months|Death|1|||
143170717|NCT05211596|516173636|FG000|Baseline to 6 Months|Withdrawal by Subject|1|||
143170718|NCT05211596|516173636|FG000|6 Months to 18 Months|Lost to Follow-up|9|||
143170719|NCT02769481|516173637|FG000|Overall Study|Protocol Violation|1|||
143170720|NCT02769481|516173638|FG001|Overall Study|Protocol Violation|0|||
143170721|NCT02769481|516173637|FG000|Overall Study|Adverse Event|3|||
143170722|NCT02769481|516173638|FG001|Overall Study|Adverse Event|6|||
143170723|NCT02769481|516173637|FG000|Overall Study|Entry Criteria Not Met|1|||
143170724|NCT02769481|516173638|FG001|Overall Study|Entry Criteria Not Met|2|||
143170725|NCT02769481|516173637|FG000|Overall Study|Withdrawal by Subject|14|||
143170726|NCT02769481|516173638|FG001|Overall Study|Withdrawal by Subject|16|||
143170727|NCT02769481|516173637|FG000|Overall Study|Lost to Follow-up|9|||
143170728|NCT02769481|516173638|FG001|Overall Study|Lost to Follow-up|9|||
143170729|NCT02769481|516173637|FG000|Overall Study|Physician Decision|0|||
143170730|NCT02769481|516173638|FG001|Overall Study|Physician Decision|1|||
143170731|NCT02769481|516173637|FG000|Overall Study|Terminated by Sponsor|1|||
143170732|NCT02769481|516173638|FG001|Overall Study|Terminated by Sponsor|0|||
143170733|NCT02769481|516173637|FG000|Overall Study|Death|0|||
143170734|NCT02769481|516173638|FG001|Overall Study|Death|1|||
143170735|NCT02769481|516173637|FG000|Overall Study|Undefined|4|||
143170736|NCT02769481|516173638|FG001|Overall Study|Undefined|1|||
143170737|NCT06272383|516173641|FG000|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|6|||
143170738|NCT06272383|516173642|FG001|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|4|||
143170739|NCT04398706|516173643|FG000|Overall Study|Adverse Event|0|||
143170740|NCT04398706|516173644|FG001|Overall Study|Adverse Event|0|||
143170741|NCT04398706|516173645|FG002|Overall Study|Adverse Event|0|||
143170742|NCT04398706|516173646|FG003|Overall Study|Adverse Event|0|||
143170743|NCT04398706|516173647|FG004|Overall Study|Adverse Event|0|||
143170744|NCT04398706|516173648|FG005|Overall Study|Adverse Event|1|||
143170745|NCT04398706|516173649|FG006|Overall Study|Adverse Event|1|||
143170746|NCT04398706|516173650|FG007|Overall Study|Adverse Event|0|||
143170747|NCT04398706|516173643|FG000|Overall Study|Lost to Follow-up|0|||
143170748|NCT04398706|516173644|FG001|Overall Study|Lost to Follow-up|1|||
143170749|NCT04398706|516173645|FG002|Overall Study|Lost to Follow-up|2|||
143170750|NCT04398706|516173646|FG003|Overall Study|Lost to Follow-up|1|||
143170751|NCT04398706|516173647|FG004|Overall Study|Lost to Follow-up|6|||
143170752|NCT04398706|516173648|FG005|Overall Study|Lost to Follow-up|3|||
143170753|NCT04398706|516173649|FG006|Overall Study|Lost to Follow-up|8|||
143170754|NCT04398706|516173650|FG007|Overall Study|Lost to Follow-up|2|||
143170755|NCT04398706|516173643|FG000|Overall Study|Withdrawal by parent/guardian|0|||
143170756|NCT04398706|516173644|FG001|Overall Study|Withdrawal by parent/guardian|2|||
143170757|NCT04398706|516173645|FG002|Overall Study|Withdrawal by parent/guardian|1|||
143170758|NCT04398706|516173646|FG003|Overall Study|Withdrawal by parent/guardian|2|||
143170759|NCT04398706|516173647|FG004|Overall Study|Withdrawal by parent/guardian|19|||
143170760|NCT04398706|516173648|FG005|Overall Study|Withdrawal by parent/guardian|23|||
143503281|NCT01791855|517381001|FG000|Overall Study|Randomized, not treated|0|||
143503282|NCT01791855|517381002|FG001|Overall Study|Randomized, not treated|1|||
143503283|NCT01791855|517381003|FG002|Overall Study|Randomized, not treated|0|||
143503284|NCT01791855|517381004|FG003|Overall Study|Randomized, not treated|0|||
143503285|NCT00772447|517381005|FG000|Overall Study|Withdrawal by Subject|9|||
143503286|NCT00772447|517381006|FG001|Overall Study|Withdrawal by Subject|5|||
143503287|NCT00772447|517381005|FG000|Overall Study|Physician Decision|4|||
143503288|NCT00772447|517381006|FG001|Overall Study|Physician Decision|8|||
143503289|NCT00772447|517381005|FG000|Overall Study|Lost to Follow-up|2|||
143503290|NCT00772447|517381006|FG001|Overall Study|Lost to Follow-up|4|||
143503291|NCT00772447|517381005|FG000|Overall Study|incorrect enrolment|3|||
143503292|NCT00772447|517381006|FG001|Overall Study|incorrect enrolment|4|||
143503293|NCT00772447|517381005|FG000|Overall Study|Protocol Violation|0|||
143503294|NCT00772447|517381006|FG001|Overall Study|Protocol Violation|1|||
143170761|NCT04398706|516173649|FG006|Overall Study|Withdrawal by parent/guardian|13|||
143170762|NCT04398706|516173650|FG007|Overall Study|Withdrawal by parent/guardian|11|||
143246618|NCT02100696|516454677|FG001|Maintenance Phase|Adverse Event|0|||
143503295|NCT00772447|517381005|FG000|Overall Study|all others|2|||
143503296|NCT00772447|517381006|FG001|Overall Study|all others|2|||
143503297|NCT01957137|517381018|FG000|Randomized Portion|Adverse Event|1|||
143503298|NCT01957137|517381018|FG000|Randomized Portion|Withdrawal by Subject|1|||
143503299|NCT03529409|517381021|FG000|Randomized|Lost to Follow-up|0|||
143170763|NCT04398706|516173643|FG000|Overall Study|Protocol deviation|0|||
143170764|NCT04398706|516173644|FG001|Overall Study|Protocol deviation|1|||
143503300|NCT03529409|517381022|FG001|Randomized|Lost to Follow-up|0|||
143068229|NCT01732484|515791153|FG000|Overall Study|Lost to Follow-up|14|||
143068230|NCT01732484|515791153|FG000|Overall Study|chronical illness|5|||
143068231|NCT01169532|515791157|FG000|Overall Study|Withdrawal by Subject|1|||
143068232|NCT01087489|515791158|FG000|Overall Study|enrolled in another VA study|0|||
143068233|NCT01087489|515791159|FG001|Overall Study|enrolled in another VA study|1|||
143068234|NCT01087489|515791158|FG000|Overall Study|Death|0|||
143068235|NCT01087489|515791159|FG001|Overall Study|Death|1|||
143068236|NCT01087489|515791158|FG000|Overall Study|unable to survey by telephone|0|||
143068237|NCT01087489|515791159|FG001|Overall Study|unable to survey by telephone|1|||
143068238|NCT02032706|515791167|FG000|Overall Study|Did not qualify|5|||
143068239|NCT02032706|515791167|FG000|Overall Study|Protocol Violation|1|||
143068240|NCT00928707|515791168|FG000|Overall Study|Protocol Violation|1|||
143068241|NCT00928707|515791169|FG001|Overall Study|Protocol Violation|0|||
143068242|NCT00132028|515791170|FG000|Overall Study|Adverse Event|7|||
143068243|NCT00132028|515791170|FG000|Overall Study|Death|2|||
143068244|NCT00132028|515791170|FG000|Overall Study|Lack of Efficacy|11|||
143068245|NCT00132028|515791170|FG000|Overall Study|Withdrawal by Subject|2|||
143068246|NCT00132028|515791170|FG000|Overall Study|not eligible|2|||
143068247|NCT00132028|515791170|FG000|Overall Study|Physician Decision|3|||
143068248|NCT02140411|515791171|FG000|Overall Study|Adverse Event|1|||
143068249|NCT05070546|515791178|FG000|Overall Study|Death|0|||
143068250|NCT05070546|515791179|FG001|Overall Study|Death|0|||
143068251|NCT05070546|515791180|FG002|Overall Study|Death|0|||
143068252|NCT05070546|515791181|FG003|Overall Study|Death|0|||
143068253|NCT05070546|515791182|FG004|Overall Study|Death|0|||
143068254|NCT05070546|515791183|FG005|Overall Study|Death|1|||
143068255|NCT05070546|515791178|FG000|Overall Study|Lost to Follow-up|8|||
143068256|NCT05070546|515791179|FG001|Overall Study|Lost to Follow-up|2|||
143068257|NCT05070546|515791180|FG002|Overall Study|Lost to Follow-up|7|||
143068258|NCT05070546|515791181|FG003|Overall Study|Lost to Follow-up|1|||
143068259|NCT05070546|515791182|FG004|Overall Study|Lost to Follow-up|2|||
143068260|NCT05070546|515791183|FG005|Overall Study|Lost to Follow-up|0|||
143068261|NCT05070546|515791178|FG000|Overall Study|Withdrawal by Subject|1|||
143068262|NCT05070546|515791179|FG001|Overall Study|Withdrawal by Subject|1|||
143068263|NCT05070546|515791180|FG002|Overall Study|Withdrawal by Subject|3|||
143068264|NCT05070546|515791181|FG003|Overall Study|Withdrawal by Subject|0|||
143068265|NCT05070546|515791182|FG004|Overall Study|Withdrawal by Subject|0|||
143068266|NCT05070546|515791183|FG005|Overall Study|Withdrawal by Subject|0|||
143068267|NCT05070546|515791178|FG000|Overall Study|Other|0|||
143068268|NCT05070546|515791179|FG001|Overall Study|Other|0|||
143068269|NCT05070546|515791180|FG002|Overall Study|Other|0|||
143068270|NCT05070546|515791181|FG003|Overall Study|Other|0|||
143068271|NCT05070546|515791182|FG004|Overall Study|Other|3|||
143068272|NCT05070546|515791183|FG005|Overall Study|Other|0|||
143068273|NCT05070546|515791178|FG000|Overall Study|Randomized but not vaccinated|1|||
143068274|NCT05070546|515791179|FG001|Overall Study|Randomized but not vaccinated|0|||
143068275|NCT05070546|515791180|FG002|Overall Study|Randomized but not vaccinated|1|||
143068276|NCT05070546|515791181|FG003|Overall Study|Randomized but not vaccinated|1|||
143068277|NCT05070546|515791182|FG004|Overall Study|Randomized but not vaccinated|3|||
143068278|NCT05070546|515791183|FG005|Overall Study|Randomized but not vaccinated|0|||
143068279|NCT02005887|515791195|FG000|Overall Study|Protocol Violation|0|||
143068280|NCT02005887|515791196|FG001|Overall Study|Protocol Violation|2|||
143068281|NCT00446199|515791199|FG000|Overall Study|Adverse Event|7|||
143068282|NCT00446199|515791200|FG001|Overall Study|Adverse Event|4|||
143068283|NCT00446199|515791201|FG002|Overall Study|Adverse Event|6|||
143068284|NCT00446199|515791202|FG003|Overall Study|Adverse Event|4|||
143068285|NCT00446199|515791199|FG000|Overall Study|Lost to Follow-up|4|||
143068286|NCT00446199|515791200|FG001|Overall Study|Lost to Follow-up|5|||
143068287|NCT00446199|515791201|FG002|Overall Study|Lost to Follow-up|2|||
143068288|NCT00446199|515791202|FG003|Overall Study|Lost to Follow-up|6|||
143068289|NCT00446199|515791199|FG000|Overall Study|Protocol Violation|1|||
143068290|NCT00446199|515791200|FG001|Overall Study|Protocol Violation|2|||
143503301|NCT03529409|517381023|FG002|Randomized|Lost to Follow-up|4|||
143503302|NCT03529409|517381021|FG000|Randomized|Excluded|0|||
143068291|NCT00446199|515791201|FG002|Overall Study|Protocol Violation|1|||
143068292|NCT00446199|515791202|FG003|Overall Study|Protocol Violation|3|||
143068293|NCT00446199|515791199|FG000|Overall Study|Withdrawal by Subject|2|||
143068294|NCT00446199|515791200|FG001|Overall Study|Withdrawal by Subject|5|||
143068295|NCT00446199|515791201|FG002|Overall Study|Withdrawal by Subject|9|||
143068296|NCT00446199|515791202|FG003|Overall Study|Withdrawal by Subject|10|||
143068297|NCT00446199|515791199|FG000|Overall Study|Site termination|2|||
143068298|NCT00446199|515791200|FG001|Overall Study|Site termination|0|||
143068299|NCT00446199|515791201|FG002|Overall Study|Site termination|0|||
143068300|NCT00446199|515791202|FG003|Overall Study|Site termination|1|||
143068301|NCT00446199|515791199|FG000|Overall Study|Randomization in Error|2|||
143068302|NCT00446199|515791200|FG001|Overall Study|Randomization in Error|0|||
143068303|NCT00446199|515791201|FG002|Overall Study|Randomization in Error|1|||
143068304|NCT00446199|515791202|FG003|Overall Study|Randomization in Error|1|||
143068305|NCT00446199|515791199|FG000|Overall Study|Lack of Efficacy|1|||
143068306|NCT00446199|515791200|FG001|Overall Study|Lack of Efficacy|0|||
143503303|NCT03529409|517381022|FG001|Randomized|Excluded|0|||
143503304|NCT03529409|517381023|FG002|Randomized|Excluded|1|||
143246619|NCT02100696|516454678|FG002|Maintenance Phase|Adverse Event|0|||
143246620|NCT02100696|516454679|FG003|Maintenance Phase|Adverse Event|0|||
143246621|NCT02100696|516454680|FG004|Maintenance Phase|Adverse Event|0|||
143246622|NCT02100696|516454681|FG005|Maintenance Phase|Adverse Event|2|||
143246623|NCT02100696|516454676|FG000|Maintenance Phase|Lost to Follow-up|0|||
143246624|NCT02100696|516454677|FG001|Maintenance Phase|Lost to Follow-up|0|||
143246625|NCT02100696|516454678|FG002|Maintenance Phase|Lost to Follow-up|0|||
143246626|NCT02100696|516454679|FG003|Maintenance Phase|Lost to Follow-up|0|||
143246627|NCT02100696|516454680|FG004|Maintenance Phase|Lost to Follow-up|1|||
143246628|NCT02100696|516454681|FG005|Maintenance Phase|Lost to Follow-up|0|||
143246629|NCT02100696|516454676|FG000|Maintenance Phase|Protocol Violation|0|||
143246630|NCT02100696|516454677|FG001|Maintenance Phase|Protocol Violation|0|||
143246631|NCT02100696|516454678|FG002|Maintenance Phase|Protocol Violation|0|||
143246632|NCT02100696|516454679|FG003|Maintenance Phase|Protocol Violation|0|||
143246633|NCT02100696|516454680|FG004|Maintenance Phase|Protocol Violation|1|||
143246634|NCT02100696|516454681|FG005|Maintenance Phase|Protocol Violation|0|||
143246635|NCT02100696|516454676|FG000|Maintenance Phase|Withdrawal by Subject|0|||
143246636|NCT02100696|516454677|FG001|Maintenance Phase|Withdrawal by Subject|0|||
143246637|NCT02100696|516454678|FG002|Maintenance Phase|Withdrawal by Subject|0|||
143246638|NCT02100696|516454679|FG003|Maintenance Phase|Withdrawal by Subject|1|||
143246639|NCT02100696|516454680|FG004|Maintenance Phase|Withdrawal by Subject|4|||
143246640|NCT02100696|516454681|FG005|Maintenance Phase|Withdrawal by Subject|2|||
143246641|NCT02100696|516454676|FG000|Maintenance Phase|Physician Decision|0|||
143246642|NCT02100696|516454677|FG001|Maintenance Phase|Physician Decision|0|||
143246643|NCT02100696|516454678|FG002|Maintenance Phase|Physician Decision|0|||
143246644|NCT02100696|516454679|FG003|Maintenance Phase|Physician Decision|0|||
143246645|NCT02100696|516454680|FG004|Maintenance Phase|Physician Decision|1|||
143246646|NCT02100696|516454681|FG005|Maintenance Phase|Physician Decision|0|||
143246647|NCT02100696|516454676|FG000|Maintenance Phase|Multiple Reasons|0|||
143246648|NCT02100696|516454677|FG001|Maintenance Phase|Multiple Reasons|0|||
143246649|NCT02100696|516454678|FG002|Maintenance Phase|Multiple Reasons|0|||
143246650|NCT02100696|516454679|FG003|Maintenance Phase|Multiple Reasons|0|||
143246651|NCT02100696|516454680|FG004|Maintenance Phase|Multiple Reasons|2|||
143246652|NCT02100696|516454681|FG005|Maintenance Phase|Multiple Reasons|1|||
143246653|NCT03350672|516454685|FG000|Overall Study|Withdrawal by Subject|7|||
143246654|NCT03350672|516454686|FG001|Overall Study|Withdrawal by Subject|0|||
143246655|NCT03350672|516454687|FG002|Overall Study|Withdrawal by Subject|0|||
143246656|NCT03237286|516454694|FG000|Overall Study|Withdrawal by Subject|1|||
143246657|NCT03237286|516454695|FG001|Overall Study|Withdrawal by Subject|0|||
143246658|NCT03237286|516454696|FG002|Overall Study|Withdrawal by Subject|2|||
143246659|NCT03237286|516454694|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
143246660|NCT03237286|516454695|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
143246661|NCT03237286|516454696|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
143246662|NCT01668589|516454699|FG000|Overall Study|Lost to Follow-up|29|||
143246663|NCT01668589|516454700|FG001|Overall Study|Lost to Follow-up|37|||
143246664|NCT01668589|516454701|FG002|Overall Study|Lost to Follow-up|15|||
143246665|NCT01668589|516454702|FG003|Overall Study|Lost to Follow-up|5|||
143246666|NCT01668589|516454699|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
143246667|NCT01668589|516454700|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
143246668|NCT01668589|516454701|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
143246669|NCT01668589|516454702|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
143246670|NCT01668589|516454699|FG000|Overall Study|Death|12|||
143246671|NCT01668589|516454700|FG001|Overall Study|Death|3|||
143246672|NCT01668589|516454701|FG002|Overall Study|Death|2|||
143246673|NCT01668589|516454702|FG003|Overall Study|Death|11|||
143246674|NCT01668589|516454699|FG000|Overall Study|Other|44|||
143246675|NCT01668589|516454700|FG001|Overall Study|Other|10|||
143246676|NCT01668589|516454701|FG002|Overall Study|Other|7|||
143246677|NCT01668589|516454702|FG003|Overall Study|Other|15|||
143246678|NCT02355184|516454704|FG000|Overall Study|Lost to Follow-up|2|||
143246679|NCT02355184|516454704|FG000|Overall Study|Study Terminated|10|||
143246680|NCT01088048|516456597|FG000|Overall Study|Adverse Event|7|||
143246681|NCT01088048|516456598|FG001|Overall Study|Adverse Event|9|||
143246682|NCT01088048|516456599|FG002|Overall Study|Adverse Event|7|||
143503305|NCT03529409|517381021|FG000|Post-treatment Assessment|Death|1|||
143246683|NCT01088048|516456600|FG003|Overall Study|Adverse Event|5|||
143246684|NCT01088048|516456601|FG004|Overall Study|Adverse Event|6|||
143503306|NCT03529409|517381022|FG001|Post-treatment Assessment|Death|0|||
143246685|NCT01088048|516456602|FG005|Overall Study|Adverse Event|3|||
143246686|NCT01088048|516456603|FG006|Overall Study|Adverse Event|3|||
143503307|NCT03529409|517381023|FG002|Post-treatment Assessment|Death|0|||
143503308|NCT03529409|517381021|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
143246687|NCT01088048|516456604|FG007|Overall Study|Adverse Event|0|||
143246688|NCT01088048|516456605|FG008|Overall Study|Adverse Event|2|||
143503309|NCT03529409|517381022|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
143503310|NCT03529409|517381023|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
143503311|NCT03529409|517381021|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
143503312|NCT03529409|517381022|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
143503313|NCT03529409|517381023|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
143503314|NCT03529409|517381021|FG000|Follow-up Assessment|Death|1|||
143503315|NCT03529409|517381022|FG001|Follow-up Assessment|Death|0|||
143503316|NCT03529409|517381023|FG002|Follow-up Assessment|Death|0|||
143503317|NCT03529409|517381021|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
143503318|NCT03529409|517381022|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
143503319|NCT03529409|517381023|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
143503320|NCT01497262|517381024|FG000|Overall Study|Abnormal Lab Values|4|||
143503321|NCT01497262|517381024|FG000|Overall Study|Abnormal Test Procedure Result|1|||
143503322|NCT01497262|517381024|FG000|Overall Study|Physician Decision|1|||
143503323|NCT01497262|517381024|FG000|Overall Study|Withdrawal by Subject|2|||
143503324|NCT01497262|517381024|FG000|Overall Study|Adverse Event|2|||
143503325|NCT01497262|517381024|FG000|Overall Study|Protocol Violation|1|||
143503326|NCT02497001|517381025|FG000|Overall Study|Lost to Follow-up|10|||
143503327|NCT02497001|517381026|FG001|Overall Study|Lost to Follow-up|2|||
143503328|NCT02497001|517381027|FG002|Overall Study|Lost to Follow-up|0|||
143503329|NCT02497001|517381028|FG003|Overall Study|Lost to Follow-up|2|||
143503330|NCT02497001|517381025|FG000|Overall Study|Adverse Event|28|||
143503331|NCT02497001|517381026|FG001|Overall Study|Adverse Event|30|||
143503332|NCT02497001|517381027|FG002|Overall Study|Adverse Event|11|||
143503333|NCT02497001|517381028|FG003|Overall Study|Adverse Event|11|||
143503334|NCT02497001|517381025|FG000|Overall Study|Withdrawal by Subject|14|||
143503335|NCT02497001|517381026|FG001|Overall Study|Withdrawal by Subject|37|||
143503336|NCT02497001|517381027|FG002|Overall Study|Withdrawal by Subject|19|||
143503337|NCT02497001|517381028|FG003|Overall Study|Withdrawal by Subject|15|||
143503338|NCT02497001|517381025|FG000|Overall Study|Physician Decision|5|||
143503339|NCT02497001|517381026|FG001|Overall Study|Physician Decision|11|||
143503340|NCT02497001|517381027|FG002|Overall Study|Physician Decision|5|||
143503341|NCT02497001|517381028|FG003|Overall Study|Physician Decision|1|||
143503342|NCT02497001|517381025|FG000|Overall Study|subjects that were not treated|1|||
143503343|NCT02497001|517381026|FG001|Overall Study|subjects that were not treated|2|||
143503344|NCT02497001|517381027|FG002|Overall Study|subjects that were not treated|2|||
143503345|NCT02497001|517381028|FG003|Overall Study|subjects that were not treated|1|||
143503346|NCT02497001|517381025|FG000|Overall Study|Major Protocol Deviation|3|||
143503347|NCT02497001|517381026|FG001|Overall Study|Major Protocol Deviation|4|||
143503348|NCT02497001|517381027|FG002|Overall Study|Major Protocol Deviation|4|||
143503349|NCT02497001|517381028|FG003|Overall Study|Major Protocol Deviation|4|||
143503350|NCT02497001|517381025|FG000|Overall Study|Lack of Efficacy|10|||
143503351|NCT02497001|517381026|FG001|Overall Study|Lack of Efficacy|16|||
143503352|NCT02497001|517381027|FG002|Overall Study|Lack of Efficacy|6|||
143503353|NCT02497001|517381028|FG003|Overall Study|Lack of Efficacy|6|||
143503354|NCT02497001|517381025|FG000|Overall Study|Protocol Violation|3|||
143503355|NCT02497001|517381026|FG001|Overall Study|Protocol Violation|1|||
143503356|NCT02497001|517381027|FG002|Overall Study|Protocol Violation|3|||
143503357|NCT02497001|517381028|FG003|Overall Study|Protocol Violation|1|||
143068307|NCT00446199|515791201|FG002|Overall Study|Lack of Efficacy|0|||
143068308|NCT00446199|515791202|FG003|Overall Study|Lack of Efficacy|1|||
143068309|NCT00446199|515791199|FG000|Overall Study|Non-compliant with study drug|1|||
143068310|NCT00446199|515791200|FG001|Overall Study|Non-compliant with study drug|0|||
143068311|NCT00446199|515791201|FG002|Overall Study|Non-compliant with study drug|5|||
143068312|NCT00446199|515791202|FG003|Overall Study|Non-compliant with study drug|0|||
143068313|NCT00446199|515791199|FG000|Overall Study|Non-compliant with visit schedule|1|||
143068314|NCT00446199|515791200|FG001|Overall Study|Non-compliant with visit schedule|1|||
143068315|NCT00446199|515791201|FG002|Overall Study|Non-compliant with visit schedule|1|||
143068316|NCT00446199|515791202|FG003|Overall Study|Non-compliant with visit schedule|2|||
143068317|NCT00446199|515791199|FG000|Overall Study|Hormone fear|0|||
143068318|NCT00446199|515791200|FG001|Overall Study|Hormone fear|0|||
143068319|NCT00446199|515791201|FG002|Overall Study|Hormone fear|0|||
143068320|NCT00446199|515791202|FG003|Overall Study|Hormone fear|1|||
143068321|NCT00446199|515791199|FG000|Overall Study|Lost interest in study participation|0|||
143068322|NCT00446199|515791200|FG001|Overall Study|Lost interest in study participation|1|||
143503358|NCT01651780|517381031|FG000|Overall Study|Physician decision: No 30-day visit|2|||
143503359|NCT01651780|517381032|FG001|Overall Study|Physician decision: No 30-day visit|1|||
143503360|NCT01651780|517381031|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
143503361|NCT01651780|517381032|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
143068323|NCT00446199|515791201|FG002|Overall Study|Lost interest in study participation|0|||
143068324|NCT00446199|515791202|FG003|Overall Study|Lost interest in study participation|0|||
143068325|NCT00446199|515791199|FG000|Overall Study|In-/Exclusion criterion violated|2|||
143503362|NCT01651780|517381031|FG000|Overall Study|Withdrawal by Subject|2|||
143503363|NCT01651780|517381032|FG001|Overall Study|Withdrawal by Subject|0|||
143503364|NCT01651780|517381031|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
143503365|NCT01651780|517381032|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
143503366|NCT01651780|517381031|FG000|Overall Study|Lost to Follow-up|1|||
143503367|NCT01651780|517381032|FG001|Overall Study|Lost to Follow-up|2|||
143503368|NCT01651780|517381031|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
143503369|NCT01651780|517381032|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
143503370|NCT03898063|517381033|FG000|Overall Study|Withdrawal by Subject|10|||
143503371|NCT03898063|517381034|FG001|Overall Study|Withdrawal by Subject|8|||
143503372|NCT02949830|517381035|FG000|Overall Study|Adverse Event|1|||
143503373|NCT02949830|517381035|FG000|Overall Study|Withdrawal by Subject|1|||
143503374|NCT00054132|517381036|FG000|Overall Study|Not Treated|1|||
143503375|NCT01290887|517381037|FG000|Overall Study|Adverse Event|6|||
143503376|NCT01290887|517381038|FG001|Overall Study|Adverse Event|11|||
143503377|NCT01290887|517381037|FG000|Overall Study|Lack of Efficacy|4|||
143503378|NCT01290887|517381038|FG001|Overall Study|Lack of Efficacy|5|||
143503379|NCT01290887|517381037|FG000|Overall Study|Withdrawal by Subject|26|||
143503380|NCT01290887|517381038|FG001|Overall Study|Withdrawal by Subject|32|||
143503381|NCT01290887|517381037|FG000|Overall Study|Protocol Violation|2|||
143503382|NCT01290887|517381038|FG001|Overall Study|Protocol Violation|1|||
143503383|NCT01290887|517381037|FG000|Overall Study|Lost to Follow-up|4|||
143503384|NCT01290887|517381038|FG001|Overall Study|Lost to Follow-up|4|||
143503385|NCT01290887|517381037|FG000|Overall Study|Non-compliance to study procedures|0|||
143503386|NCT01290887|517381038|FG001|Overall Study|Non-compliance to study procedures|1|||
143503387|NCT01290887|517381037|FG000|Overall Study|Non-compliance to study medications|1|||
143503388|NCT01290887|517381038|FG001|Overall Study|Non-compliance to study medications|0|||
143503389|NCT01290887|517381037|FG000|Overall Study|Sponsor closure of study|420|||
143503390|NCT01290887|517381038|FG001|Overall Study|Sponsor closure of study|476|||
143503391|NCT01290887|517381037|FG000|Overall Study|Other|3|||
143503392|NCT01290887|517381038|FG001|Overall Study|Other|6|||
143503393|NCT01628926|517381039|FG000|Overall Study|Adverse Event|13|||
143503394|NCT01628926|517381040|FG001|Overall Study|Adverse Event|11|||
143503395|NCT01628926|517381041|FG002|Overall Study|Adverse Event|9|||
143503396|NCT01628926|517381039|FG000|Overall Study|Lack of Efficacy|2|||
143503397|NCT01628926|517381040|FG001|Overall Study|Lack of Efficacy|1|||
143503398|NCT01628926|517381041|FG002|Overall Study|Lack of Efficacy|5|||
143503399|NCT01628926|517381039|FG000|Overall Study|Withdrawal by Subject|6|||
143503400|NCT01628926|517381040|FG001|Overall Study|Withdrawal by Subject|4|||
143503401|NCT01628926|517381041|FG002|Overall Study|Withdrawal by Subject|2|||
143503402|NCT01628926|517381039|FG000|Overall Study|Protocol Violation|0|||
143503403|NCT01628926|517381040|FG001|Overall Study|Protocol Violation|1|||
143503404|NCT01628926|517381041|FG002|Overall Study|Protocol Violation|0|||
143503405|NCT01628926|517381039|FG000|Overall Study|Discontinuation criteria|3|||
143503406|NCT01628926|517381040|FG001|Overall Study|Discontinuation criteria|4|||
143503407|NCT01628926|517381041|FG002|Overall Study|Discontinuation criteria|0|||
143503408|NCT01628926|517381039|FG000|Overall Study|Physician Decision|2|||
143503409|NCT01628926|517381040|FG001|Overall Study|Physician Decision|2|||
143503410|NCT01628926|517381041|FG002|Overall Study|Physician Decision|1|||
143503411|NCT01551745|517381044|FG000|Overall Study|Withdrawal by Subject|1|||
143503412|NCT01551745|517381044|FG000|Overall Study|Disease Progression|2|||
143503413|NCT02764541|517381045|FG000|Overall Study|Withdrawal by Subject|0|||
143503414|NCT02764541|517381046|FG001|Overall Study|Withdrawal by Subject|0|||
143503415|NCT02764541|517381047|FG002|Overall Study|Withdrawal by Subject|0|||
143503416|NCT02764541|517381048|FG003|Overall Study|Withdrawal by Subject|0|||
143503417|NCT02764541|517381049|FG004|Overall Study|Withdrawal by Subject|1|||
143503418|NCT02764541|517381050|FG005|Overall Study|Withdrawal by Subject|1|||
143503419|NCT02764541|517381051|FG006|Overall Study|Withdrawal by Subject|0|||
143503420|NCT02764541|517381052|FG007|Overall Study|Withdrawal by Subject|1|||
143503421|NCT02764541|517381045|FG000|Overall Study|Adverse Event|1|||
143503422|NCT02764541|517381046|FG001|Overall Study|Adverse Event|0|||
143503423|NCT02764541|517381047|FG002|Overall Study|Adverse Event|0|||
143503424|NCT02764541|517381048|FG003|Overall Study|Adverse Event|0|||
143503425|NCT02764541|517381049|FG004|Overall Study|Adverse Event|0|||
143503426|NCT02764541|517381050|FG005|Overall Study|Adverse Event|0|||
143246689|NCT01088048|516456606|FG009|Overall Study|Adverse Event|2|||
143503427|NCT02764541|517381051|FG006|Overall Study|Adverse Event|1|||
143503428|NCT02764541|517381052|FG007|Overall Study|Adverse Event|0|||
143503429|NCT02764541|517381045|FG000|Overall Study|Metastasis|1|||
143503430|NCT02764541|517381046|FG001|Overall Study|Metastasis|0|||
143503431|NCT02764541|517381047|FG002|Overall Study|Metastasis|0|||
143503432|NCT02764541|517381048|FG003|Overall Study|Metastasis|0|||
143503433|NCT02764541|517381049|FG004|Overall Study|Metastasis|0|||
143503434|NCT02764541|517381050|FG005|Overall Study|Metastasis|0|||
143503435|NCT02764541|517381051|FG006|Overall Study|Metastasis|0|||
143503436|NCT02764541|517381052|FG007|Overall Study|Metastasis|0|||
143503437|NCT02764541|517381045|FG000|Overall Study|Disease progression|1|||
143503438|NCT02764541|517381046|FG001|Overall Study|Disease progression|1|||
143503439|NCT02764541|517381047|FG002|Overall Study|Disease progression|0|||
143503440|NCT02764541|517381048|FG003|Overall Study|Disease progression|0|||
143246690|NCT01088048|516456597|FG000|Overall Study|Withdrew Consent|1|||
143246691|NCT01088048|516456598|FG001|Overall Study|Withdrew Consent|1|||
143246692|NCT01088048|516456599|FG002|Overall Study|Withdrew Consent|1|||
143246693|NCT01088048|516456600|FG003|Overall Study|Withdrew Consent|1|||
143246694|NCT01088048|516456601|FG004|Overall Study|Withdrew Consent|2|||
143246695|NCT01088048|516456602|FG005|Overall Study|Withdrew Consent|1|||
143246696|NCT01088048|516456603|FG006|Overall Study|Withdrew Consent|0|||
143246697|NCT01088048|516456604|FG007|Overall Study|Withdrew Consent|2|||
143246698|NCT01088048|516456605|FG008|Overall Study|Withdrew Consent|2|||
143246699|NCT01088048|516456606|FG009|Overall Study|Withdrew Consent|1|||
143246700|NCT01088048|516456597|FG000|Overall Study|Concomitant Medication Prohibited|1|||
143246701|NCT01088048|516456598|FG001|Overall Study|Concomitant Medication Prohibited|0|||
143246702|NCT01088048|516456599|FG002|Overall Study|Concomitant Medication Prohibited|0|||
143246703|NCT01088048|516456600|FG003|Overall Study|Concomitant Medication Prohibited|0|||
143246704|NCT01088048|516456601|FG004|Overall Study|Concomitant Medication Prohibited|0|||
143246705|NCT01088048|516456602|FG005|Overall Study|Concomitant Medication Prohibited|0|||
143246706|NCT01088048|516456603|FG006|Overall Study|Concomitant Medication Prohibited|0|||
143246707|NCT01088048|516456604|FG007|Overall Study|Concomitant Medication Prohibited|0|||
143246708|NCT01088048|516456605|FG008|Overall Study|Concomitant Medication Prohibited|0|||
143246709|NCT01088048|516456606|FG009|Overall Study|Concomitant Medication Prohibited|0|||
143246710|NCT01088048|516456597|FG000|Overall Study|Investigator Request|2|||
143246711|NCT01088048|516456598|FG001|Overall Study|Investigator Request|2|||
143246712|NCT01088048|516456599|FG002|Overall Study|Investigator Request|0|||
143246713|NCT01088048|516456600|FG003|Overall Study|Investigator Request|0|||
143246714|NCT01088048|516456601|FG004|Overall Study|Investigator Request|3|||
143246715|NCT01088048|516456602|FG005|Overall Study|Investigator Request|1|||
143246716|NCT01088048|516456603|FG006|Overall Study|Investigator Request|1|||
143246717|NCT01088048|516456604|FG007|Overall Study|Investigator Request|0|||
143246718|NCT01088048|516456605|FG008|Overall Study|Investigator Request|0|||
143246719|NCT01088048|516456606|FG009|Overall Study|Investigator Request|0|||
143246720|NCT01088048|516456597|FG000|Overall Study|Patient Non-compliance|0|||
143246721|NCT01088048|516456598|FG001|Overall Study|Patient Non-compliance|1|||
143246722|NCT01088048|516456599|FG002|Overall Study|Patient Non-compliance|0|||
143246723|NCT01088048|516456600|FG003|Overall Study|Patient Non-compliance|0|||
143246724|NCT01088048|516456601|FG004|Overall Study|Patient Non-compliance|0|||
143246725|NCT01088048|516456602|FG005|Overall Study|Patient Non-compliance|0|||
143246726|NCT01088048|516456603|FG006|Overall Study|Patient Non-compliance|0|||
143246727|NCT01088048|516456604|FG007|Overall Study|Patient Non-compliance|0|||
143246728|NCT01088048|516456605|FG008|Overall Study|Patient Non-compliance|0|||
143246729|NCT01088048|516456606|FG009|Overall Study|Patient Non-compliance|0|||
143246730|NCT01088048|516456597|FG000|Overall Study|Disease Progression|7|||
143246731|NCT01088048|516456598|FG001|Overall Study|Disease Progression|4|||
143246732|NCT01088048|516456599|FG002|Overall Study|Disease Progression|3|||
143246733|NCT01088048|516456600|FG003|Overall Study|Disease Progression|5|||
143246734|NCT01088048|516456601|FG004|Overall Study|Disease Progression|3|||
143246735|NCT01088048|516456602|FG005|Overall Study|Disease Progression|3|||
143246736|NCT01088048|516456603|FG006|Overall Study|Disease Progression|2|||
143246737|NCT01088048|516456604|FG007|Overall Study|Disease Progression|1|||
143246738|NCT01088048|516456605|FG008|Overall Study|Disease Progression|0|||
143246739|NCT01088048|516456606|FG009|Overall Study|Disease Progression|0|||
143246740|NCT01088048|516456597|FG000|Overall Study|Death|1|||
143246741|NCT01088048|516456598|FG001|Overall Study|Death|5|||
143246742|NCT01088048|516456599|FG002|Overall Study|Death|3|||
143246743|NCT01088048|516456600|FG003|Overall Study|Death|3|||
143246744|NCT01088048|516456601|FG004|Overall Study|Death|1|||
143246745|NCT01088048|516456602|FG005|Overall Study|Death|3|||
143246746|NCT01088048|516456603|FG006|Overall Study|Death|0|||
143246747|NCT01088048|516456604|FG007|Overall Study|Death|0|||
143246748|NCT01088048|516456605|FG008|Overall Study|Death|3|||
143246749|NCT01088048|516456606|FG009|Overall Study|Death|1|||
143246750|NCT01088048|516456597|FG000|Overall Study|Other|3|||
143246751|NCT01088048|516456598|FG001|Overall Study|Other|5|||
143246752|NCT01088048|516456599|FG002|Overall Study|Other|0|||
143246753|NCT01088048|516456600|FG003|Overall Study|Other|0|||
143246754|NCT01088048|516456601|FG004|Overall Study|Other|2|||
143365282|NCT01516892|516880715|FG000|Overall Study|Subject Withdrew Consent|92|||
143246755|NCT01088048|516456602|FG005|Overall Study|Other|0|||
143246756|NCT01088048|516456603|FG006|Overall Study|Other|0|||
143246757|NCT01088048|516456604|FG007|Overall Study|Other|2|||
143246758|NCT01088048|516456605|FG008|Overall Study|Other|0|||
143246759|NCT01088048|516456606|FG009|Overall Study|Other|0|||
143246760|NCT01621802|516456607|FG000|Overall Study|Protocol Violation|0|||
143246761|NCT01621802|516456608|FG001|Overall Study|Protocol Violation|0|||
143246762|NCT01621802|516456609|FG002|Overall Study|Protocol Violation|0|||
143246763|NCT01621802|516456610|FG003|Overall Study|Protocol Violation|0|||
143246764|NCT01621802|516456611|FG004|Overall Study|Protocol Violation|0|||
143246765|NCT01621802|516456612|FG005|Overall Study|Protocol Violation|1|||
143246766|NCT01621802|516456607|FG000|Overall Study|Withdrawal by Subject|8|||
143246767|NCT01621802|516456608|FG001|Overall Study|Withdrawal by Subject|4|||
143068326|NCT00446199|515791200|FG001|Overall Study|In-/Exclusion criterion violated|1|||
143068327|NCT00446199|515791201|FG002|Overall Study|In-/Exclusion criterion violated|2|||
143068328|NCT00446199|515791202|FG003|Overall Study|In-/Exclusion criterion violated|1|||
143068329|NCT00446199|515791199|FG000|Overall Study|Move|0|||
143068330|NCT00446199|515791200|FG001|Overall Study|Move|1|||
143068331|NCT00446199|515791201|FG002|Overall Study|Move|0|||
143503441|NCT02764541|517381049|FG004|Overall Study|Disease progression|0|||
143503442|NCT02764541|517381050|FG005|Overall Study|Disease progression|0|||
143503443|NCT02764541|517381051|FG006|Overall Study|Disease progression|0|||
143068332|NCT00446199|515791202|FG003|Overall Study|Move|0|||
143068333|NCT03696953|515793205|FG000|Overall Study|Withdrawal by Subject|6|||
143068334|NCT03696953|515793206|FG001|Overall Study|Withdrawal by Subject|1|||
143068335|NCT03696953|515793205|FG000|Overall Study|missed GBS swabs|2|||
143068336|NCT03696953|515793206|FG001|Overall Study|missed GBS swabs|2|||
143068337|NCT03696953|515793205|FG000|Overall Study|lost study bottle containing capsules|2|||
143068338|NCT03696953|515793206|FG001|Overall Study|lost study bottle containing capsules|0|||
143068339|NCT03696953|515793205|FG000|Overall Study|Premature birth|1|||
143068340|NCT03696953|515793206|FG001|Overall Study|Premature birth|4|||
143068341|NCT03696953|515793205|FG000|Overall Study|Gestational hypertension|1|||
143068342|NCT03696953|515793206|FG001|Overall Study|Gestational hypertension|1|||
143068343|NCT03696953|515793205|FG000|Overall Study|Gestational diabetes|2|||
143068344|NCT03696953|515793206|FG001|Overall Study|Gestational diabetes|1|||
143068345|NCT03696953|515793205|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
143068346|NCT03696953|515793206|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
143068347|NCT03696953|515793205|FG000|Overall Study|Changed prenatal provider|1|||
143170765|NCT04398706|516173645|FG002|Overall Study|Protocol deviation|0|||
143170766|NCT04398706|516173646|FG003|Overall Study|Protocol deviation|0|||
143170767|NCT04398706|516173647|FG004|Overall Study|Protocol deviation|6|||
143170768|NCT04398706|516173648|FG005|Overall Study|Protocol deviation|4|||
143170769|NCT04398706|516173649|FG006|Overall Study|Protocol deviation|6|||
143170770|NCT04398706|516173650|FG007|Overall Study|Protocol deviation|3|||
143170771|NCT01346176|516173652|FG000|Recruited|Protocol Violation|1|||
143170772|NCT01346176|516173653|FG001|Recruited|Protocol Violation|0|||
143170773|NCT01346176|516173654|FG002|Recruited|Protocol Violation|0|||
143170774|NCT01346176|516173652|FG000|Completed Advance Directive|Death|3|||
143170775|NCT01346176|516173653|FG001|Completed Advance Directive|Death|2|||
143170776|NCT01346176|516173654|FG002|Completed Advance Directive|Death|2|||
143170777|NCT01346176|516173652|FG000|Completed Advance Directive|Became Ineligible|3|||
143170778|NCT01346176|516173653|FG001|Completed Advance Directive|Became Ineligible|0|||
143170779|NCT01346176|516173654|FG002|Completed Advance Directive|Became Ineligible|1|||
143170780|NCT01346176|516173652|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
143170781|NCT01346176|516173653|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
143170782|NCT01346176|516173654|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
143170783|NCT01346176|516173652|FG000|Completed Satisfaction Survey|Death|3|||
143170784|NCT01346176|516173653|FG001|Completed Satisfaction Survey|Death|0|||
143170785|NCT01346176|516173654|FG002|Completed Satisfaction Survey|Death|2|||
143170786|NCT01346176|516173652|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
143170787|NCT01346176|516173653|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
143170788|NCT01346176|516173654|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
143170789|NCT05489328|516174764|FG000|Overall Study|Lost to Follow-up|0|||
143170790|NCT05489328|516174765|FG001|Overall Study|Lost to Follow-up|0|||
143170791|NCT05489328|516174766|FG002|Overall Study|Lost to Follow-up|1|||
143170792|NCT05489328|516174767|FG003|Overall Study|Lost to Follow-up|0|||
143170793|NCT05489328|516174768|FG004|Overall Study|Lost to Follow-up|2|||
143170794|NCT05489328|516174769|FG005|Overall Study|Lost to Follow-up|0|||
143170795|NCT05489328|516174770|FG006|Overall Study|Lost to Follow-up|0|||
143170796|NCT05489328|516174771|FG007|Overall Study|Lost to Follow-up|1|||
143170797|NCT05489328|516174772|FG008|Overall Study|Lost to Follow-up|0|||
143170798|NCT05489328|516174764|FG000|Overall Study|Withdrawal by Subject|0|||
143170799|NCT05489328|516174765|FG001|Overall Study|Withdrawal by Subject|0|||
143170800|NCT05489328|516174766|FG002|Overall Study|Withdrawal by Subject|0|||
143170801|NCT05489328|516174767|FG003|Overall Study|Withdrawal by Subject|0|||
143170802|NCT05489328|516174768|FG004|Overall Study|Withdrawal by Subject|0|||
143170803|NCT05489328|516174769|FG005|Overall Study|Withdrawal by Subject|0|||
143170804|NCT05489328|516174770|FG006|Overall Study|Withdrawal by Subject|1|||
143365283|NCT01516892|516880715|FG000|Overall Study|Protocol Violation|60|||
143068348|NCT03696953|515793206|FG001|Overall Study|Changed prenatal provider|1|||
143068349|NCT00759902|515793208|FG000|Overall Study|Adverse Event|0|||
143068350|NCT00759902|515793209|FG001|Overall Study|Adverse Event|1|||
143068351|NCT02128217|515793210|FG000|Overall Study|Lost to Follow-up|0|||
143068352|NCT02128217|515793211|FG001|Overall Study|Lost to Follow-up|1|||
143170805|NCT05489328|516174771|FG007|Overall Study|Withdrawal by Subject|1|||
143170806|NCT05489328|516174772|FG008|Overall Study|Withdrawal by Subject|0|||
143170807|NCT05489328|516174764|FG000|Overall Study|Other|0|||
143170808|NCT05489328|516174765|FG001|Overall Study|Other|0|||
143170809|NCT05489328|516174766|FG002|Overall Study|Other|0|||
143170810|NCT05489328|516174767|FG003|Overall Study|Other|0|||
143246768|NCT01621802|516456609|FG002|Overall Study|Withdrawal by Subject|4|||
143246769|NCT01621802|516456610|FG003|Overall Study|Withdrawal by Subject|2|||
143246770|NCT01621802|516456611|FG004|Overall Study|Withdrawal by Subject|2|||
143246771|NCT01621802|516456612|FG005|Overall Study|Withdrawal by Subject|0|||
143246772|NCT01621802|516456607|FG000|Overall Study|Migrated/moved from study area|0|||
143246773|NCT01621802|516456608|FG001|Overall Study|Migrated/moved from study area|0|||
143246774|NCT01621802|516456609|FG002|Overall Study|Migrated/moved from study area|2|||
143246775|NCT01621802|516456610|FG003|Overall Study|Migrated/moved from study area|0|||
143246776|NCT01621802|516456611|FG004|Overall Study|Migrated/moved from study area|1|||
143503444|NCT02764541|517381052|FG007|Overall Study|Disease progression|1|||
143503445|NCT02764541|517381045|FG000|Overall Study|Protocol Violation|0|||
143503446|NCT02764541|517381046|FG001|Overall Study|Protocol Violation|0|||
143503447|NCT02764541|517381047|FG002|Overall Study|Protocol Violation|0|||
143503448|NCT02764541|517381048|FG003|Overall Study|Protocol Violation|1|||
143503449|NCT02764541|517381049|FG004|Overall Study|Protocol Violation|0|||
143503450|NCT02764541|517381050|FG005|Overall Study|Protocol Violation|1|||
143503451|NCT02764541|517381051|FG006|Overall Study|Protocol Violation|0|||
143503452|NCT02764541|517381052|FG007|Overall Study|Protocol Violation|0|||
143503453|NCT02764541|517381045|FG000|Overall Study|Physician Decision|0|||
143503454|NCT02764541|517381046|FG001|Overall Study|Physician Decision|0|||
143503455|NCT02764541|517381047|FG002|Overall Study|Physician Decision|0|||
143503456|NCT02764541|517381048|FG003|Overall Study|Physician Decision|1|||
143503457|NCT02764541|517381049|FG004|Overall Study|Physician Decision|0|||
143503458|NCT02764541|517381050|FG005|Overall Study|Physician Decision|0|||
143503459|NCT02764541|517381051|FG006|Overall Study|Physician Decision|0|||
143503460|NCT02764541|517381052|FG007|Overall Study|Physician Decision|1|||
143503461|NCT02764541|517381045|FG000|Overall Study|Three Cycles completed before surgery|0|||
143503462|NCT02764541|517381046|FG001|Overall Study|Three Cycles completed before surgery|0|||
143503463|NCT02764541|517381047|FG002|Overall Study|Three Cycles completed before surgery|0|||
143503464|NCT02764541|517381048|FG003|Overall Study|Three Cycles completed before surgery|1|||
143503465|NCT02764541|517381049|FG004|Overall Study|Three Cycles completed before surgery|0|||
143503466|NCT02764541|517381050|FG005|Overall Study|Three Cycles completed before surgery|0|||
143503467|NCT02764541|517381051|FG006|Overall Study|Three Cycles completed before surgery|0|||
143503468|NCT02764541|517381052|FG007|Overall Study|Three Cycles completed before surgery|0|||
143503469|NCT02764541|517381045|FG000|Overall Study|Patient Compliance|0|||
143503470|NCT02764541|517381046|FG001|Overall Study|Patient Compliance|0|||
143503471|NCT02764541|517381047|FG002|Overall Study|Patient Compliance|1|||
143503472|NCT02764541|517381048|FG003|Overall Study|Patient Compliance|0|||
143503473|NCT02764541|517381049|FG004|Overall Study|Patient Compliance|0|||
143503474|NCT02764541|517381050|FG005|Overall Study|Patient Compliance|0|||
143503475|NCT02764541|517381051|FG006|Overall Study|Patient Compliance|0|||
143503476|NCT02764541|517381052|FG007|Overall Study|Patient Compliance|0|||
143503477|NCT02764541|517381045|FG000|Overall Study|Death|0|||
143503478|NCT02764541|517381046|FG001|Overall Study|Death|0|||
143503479|NCT02764541|517381047|FG002|Overall Study|Death|0|||
143503480|NCT02764541|517381048|FG003|Overall Study|Death|0|||
143503481|NCT02764541|517381049|FG004|Overall Study|Death|0|||
143503482|NCT02764541|517381050|FG005|Overall Study|Death|0|||
143503483|NCT02764541|517381051|FG006|Overall Study|Death|1|||
143503484|NCT02764541|517381052|FG007|Overall Study|Death|0|||
143503485|NCT02764541|517381045|FG000|Overall Study|Insurance reasons|0|||
143503486|NCT02764541|517381046|FG001|Overall Study|Insurance reasons|0|||
143503487|NCT02764541|517381047|FG002|Overall Study|Insurance reasons|0|||
143503488|NCT02764541|517381048|FG003|Overall Study|Insurance reasons|0|||
143503489|NCT02764541|517381049|FG004|Overall Study|Insurance reasons|0|||
143503490|NCT02764541|517381050|FG005|Overall Study|Insurance reasons|0|||
143503491|NCT02764541|517381051|FG006|Overall Study|Insurance reasons|1|||
143503492|NCT02764541|517381052|FG007|Overall Study|Insurance reasons|0|||
143503493|NCT00749190|517381055|FG000|Overall Study|Adverse Event|0|||
143068353|NCT05071313|515793214|FG000|Overall Study|Lost to Follow-up|17|||
143068354|NCT05071313|515793215|FG001|Overall Study|Lost to Follow-up|10|||
143246777|NCT01621802|516456612|FG005|Overall Study|Migrated/moved from study area|0|||
143365284|NCT01516892|516880715|FG000|Overall Study|Other Miscellaneous Reasons|43|||
143365285|NCT01516892|516880715|FG000|Overall Study|Missing|1|||
143503494|NCT00749190|517381056|FG001|Overall Study|Adverse Event|2|||
143246778|NCT01621802|516456607|FG000|Overall Study|Others|3|||
143246779|NCT01621802|516456608|FG001|Overall Study|Others|3|||
143503495|NCT00749190|517381057|FG002|Overall Study|Adverse Event|0|||
143503496|NCT00749190|517381058|FG003|Overall Study|Adverse Event|4|||
143503497|NCT00749190|517381059|FG004|Overall Study|Adverse Event|0|||
143503498|NCT00749190|517381060|FG005|Overall Study|Adverse Event|3|||
143503499|NCT00749190|517381061|FG006|Overall Study|Adverse Event|0|||
143503500|NCT00749190|517381055|FG000|Overall Study|Lack of Efficacy|3|||
143246780|NCT01621802|516456609|FG002|Overall Study|Others|3|||
143503501|NCT00749190|517381056|FG001|Overall Study|Lack of Efficacy|1|||
143503502|NCT00749190|517381057|FG002|Overall Study|Lack of Efficacy|1|||
143503503|NCT00749190|517381058|FG003|Overall Study|Lack of Efficacy|0|||
143503504|NCT00749190|517381059|FG004|Overall Study|Lack of Efficacy|0|||
143503505|NCT00749190|517381060|FG005|Overall Study|Lack of Efficacy|1|||
143503506|NCT00749190|517381061|FG006|Overall Study|Lack of Efficacy|0|||
143503507|NCT00749190|517381055|FG000|Overall Study|Withdrawal by Subject|2|||
143503508|NCT00749190|517381056|FG001|Overall Study|Withdrawal by Subject|1|||
143503509|NCT00749190|517381057|FG002|Overall Study|Withdrawal by Subject|0|||
143503510|NCT00749190|517381058|FG003|Overall Study|Withdrawal by Subject|0|||
143503511|NCT00749190|517381059|FG004|Overall Study|Withdrawal by Subject|0|||
143503512|NCT00749190|517381060|FG005|Overall Study|Withdrawal by Subject|1|||
143503513|NCT00749190|517381061|FG006|Overall Study|Withdrawal by Subject|0|||
143503514|NCT00749190|517381055|FG000|Overall Study|Protocol Violation|0|||
143503515|NCT00749190|517381056|FG001|Overall Study|Protocol Violation|1|||
143503516|NCT00749190|517381057|FG002|Overall Study|Protocol Violation|0|||
143068355|NCT05071313|515793214|FG000|Overall Study|Physician Decision|1|||
143068356|NCT05071313|515793215|FG001|Overall Study|Physician Decision|6|||
143068357|NCT05071313|515793214|FG000|Overall Study|Death|1|||
143068358|NCT05071313|515793215|FG001|Overall Study|Death|0|||
143068359|NCT05071313|515793214|FG000|Overall Study|Withdrawal by Subject|10|||
143068360|NCT05071313|515793215|FG001|Overall Study|Withdrawal by Subject|15|||
143068361|NCT05071313|515793214|FG000|Overall Study|Other|1|||
143068362|NCT05071313|515793215|FG001|Overall Study|Other|0|||
143068363|NCT05071313|515793214|FG000|Overall Study|Randomized but not vaccinated|4|||
143068364|NCT05071313|515793215|FG001|Overall Study|Randomized but not vaccinated|2|||
143068365|NCT01183221|515793216|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
143068366|NCT01183221|515793217|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
143068367|NCT00852969|515793218|FG000|Overall Study|Adverse Event|0|||
143068368|NCT00852969|515793219|FG001|Overall Study|Adverse Event|1|||
143068369|NCT00852969|515793218|FG000|Overall Study|Lost to Follow-up|0|||
143068370|NCT00852969|515793219|FG001|Overall Study|Lost to Follow-up|1|||
143068371|NCT02358343|515793222|FG000|Screening Intervention|Death|0|||
143068372|NCT02358343|515793223|FG001|Screening Intervention|Death|2|||
143068373|NCT02358343|515793224|FG002|Screening Intervention|Death|0|||
143068374|NCT02358343|515793225|FG003|Screening Intervention|Death|0|||
143068375|NCT02358343|515793226|FG004|Screening Intervention|Death|0|||
143068376|NCT02358343|515793222|FG000|Screening Intervention|Withdrawal by Subject|1|||
143068377|NCT02358343|515793223|FG001|Screening Intervention|Withdrawal by Subject|0|||
143068378|NCT02358343|515793224|FG002|Screening Intervention|Withdrawal by Subject|0|||
143068379|NCT02358343|515793225|FG003|Screening Intervention|Withdrawal by Subject|0|||
143068380|NCT02358343|515793226|FG004|Screening Intervention|Withdrawal by Subject|0|||
143068381|NCT02358343|515793222|FG000|Screening Intervention|Determined Ineligible|5|||
143068382|NCT02358343|515793223|FG001|Screening Intervention|Determined Ineligible|6|||
143068383|NCT02358343|515793224|FG002|Screening Intervention|Determined Ineligible|0|||
143068384|NCT02358343|515793225|FG003|Screening Intervention|Determined Ineligible|0|||
143068385|NCT02358343|515793226|FG004|Screening Intervention|Determined Ineligible|0|||
143246781|NCT01621802|516456610|FG003|Overall Study|Others|2|||
143246782|NCT01621802|516456611|FG004|Overall Study|Others|1|||
143246783|NCT01621802|516456612|FG005|Overall Study|Others|0|||
143246784|NCT01621802|516456607|FG000|Overall Study|Lost to Follow-up|36|||
143246785|NCT01621802|516456608|FG001|Overall Study|Lost to Follow-up|16|||
143246786|NCT01621802|516456609|FG002|Overall Study|Lost to Follow-up|24|||
143246787|NCT01621802|516456610|FG003|Overall Study|Lost to Follow-up|7|||
143246788|NCT01621802|516456611|FG004|Overall Study|Lost to Follow-up|31|||
143246789|NCT01621802|516456612|FG005|Overall Study|Lost to Follow-up|11|||
143246790|NCT01149148|516456613|FG000|Overall Study|Lost to Follow-up|1|||
143246791|NCT01149148|516456614|FG001|Overall Study|Lost to Follow-up|2|||
143246792|NCT01149148|516456613|FG000|Overall Study|Death|1|||
143246793|NCT01149148|516456614|FG001|Overall Study|Death|0|||
143246794|NCT03436082|516456615|FG000|Overall Study|Did not undergo procedure|1|||
143246795|NCT03436082|516456616|FG001|Overall Study|Did not undergo procedure|0|||
143246796|NCT02249832|516456617|FG000|Overall Study|Withdrawal by Subject|3|||
143246797|NCT02249832|516456617|FG000|Overall Study|Lost to Follow-up|10|||
143246798|NCT00545272|516456627|FG000|Overall Study|Protocol deviation|0|||
143246799|NCT00545272|516456628|FG001|Overall Study|Protocol deviation|1|||
143246800|NCT00545272|516456629|FG002|Overall Study|Protocol deviation|0|||
143503517|NCT00749190|517381058|FG003|Overall Study|Protocol Violation|0|||
143246801|NCT00545272|516456630|FG003|Overall Study|Protocol deviation|1|||
143503518|NCT00749190|517381059|FG004|Overall Study|Protocol Violation|0|||
143503519|NCT00749190|517381060|FG005|Overall Study|Protocol Violation|0|||
143068386|NCT02358343|515793222|FG000|Comparative Efficacy Trial / Observation|Death|0|||
143068387|NCT02358343|515793223|FG001|Comparative Efficacy Trial / Observation|Death|0|||
143068388|NCT02358343|515793224|FG002|Comparative Efficacy Trial / Observation|Death|2|||
143068389|NCT02358343|515793225|FG003|Comparative Efficacy Trial / Observation|Death|0|||
143246802|NCT00545272|516456631|FG004|Overall Study|Protocol deviation|0|||
143246803|NCT00545272|516456632|FG005|Overall Study|Protocol deviation|1|||
143246804|NCT00545272|516456627|FG000|Overall Study|Adverse Event|0|||
143246805|NCT00545272|516456628|FG001|Overall Study|Adverse Event|0|||
143068390|NCT02358343|515793226|FG004|Comparative Efficacy Trial / Observation|Death|0|||
143068391|NCT02358343|515793222|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
143068392|NCT02358343|515793223|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
143068393|NCT02358343|515793224|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
143068394|NCT02358343|515793225|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
143068395|NCT02358343|515793226|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
143068396|NCT02358343|515793222|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
143068397|NCT02358343|515793223|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
143068398|NCT02358343|515793224|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
143068399|NCT02358343|515793225|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
143068400|NCT02358343|515793226|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
143068401|NCT03596151|515793227|FG000|Overall Study|Withdrawal by Subject|1|||
143068402|NCT00090610|515793228|FG000|Overall Study|Withdrawal by Subject|1|||
143068403|NCT00090610|515793229|FG001|Overall Study|Withdrawal by Subject|1|||
143068404|NCT02504671|515793233|FG000|Overall Study|Withdrawal by Subject|1|||
143068405|NCT02504671|515793234|FG001|Overall Study|Withdrawal by Subject|5|||
143068406|NCT02504671|515793235|FG002|Overall Study|Withdrawal by Subject|4|||
143068407|NCT02504671|515793236|FG003|Overall Study|Withdrawal by Subject|4|||
143068408|NCT02504671|515793237|FG004|Overall Study|Withdrawal by Subject|5|||
143068409|NCT02504671|515793238|FG005|Overall Study|Withdrawal by Subject|3|||
143068410|NCT02504671|515793233|FG000|Overall Study|Lack of Efficacy|1|||
143068411|NCT02504671|515793234|FG001|Overall Study|Lack of Efficacy|3|||
143068412|NCT02504671|515793235|FG002|Overall Study|Lack of Efficacy|1|||
143068413|NCT02504671|515793236|FG003|Overall Study|Lack of Efficacy|0|||
143068414|NCT02504671|515793237|FG004|Overall Study|Lack of Efficacy|4|||
143068415|NCT02504671|515793238|FG005|Overall Study|Lack of Efficacy|4|||
143068416|NCT02504671|515793233|FG000|Overall Study|Adverse Event|1|||
143068417|NCT02504671|515793234|FG001|Overall Study|Adverse Event|1|||
143068418|NCT02504671|515793235|FG002|Overall Study|Adverse Event|0|||
143068419|NCT02504671|515793236|FG003|Overall Study|Adverse Event|1|||
143068420|NCT02504671|515793237|FG004|Overall Study|Adverse Event|0|||
143068421|NCT02504671|515793238|FG005|Overall Study|Adverse Event|2|||
143068422|NCT02504671|515793233|FG000|Overall Study|Protocol Violation|2|||
143068423|NCT02504671|515793234|FG001|Overall Study|Protocol Violation|1|||
143068424|NCT02504671|515793235|FG002|Overall Study|Protocol Violation|0|||
143068425|NCT02504671|515793236|FG003|Overall Study|Protocol Violation|0|||
143068426|NCT02504671|515793237|FG004|Overall Study|Protocol Violation|0|||
143068427|NCT02504671|515793238|FG005|Overall Study|Protocol Violation|1|||
143068428|NCT02504671|515793233|FG000|Overall Study|Lost to Follow-up|0|||
143068429|NCT02504671|515793234|FG001|Overall Study|Lost to Follow-up|0|||
143170811|NCT05489328|516174768|FG004|Overall Study|Other|0|||
143170812|NCT05489328|516174769|FG005|Overall Study|Other|0|||
143170813|NCT05489328|516174770|FG006|Overall Study|Other|0|||
143170814|NCT05489328|516174771|FG007|Overall Study|Other|1|||
143170815|NCT05489328|516174772|FG008|Overall Study|Other|1|||
143170816|NCT01083602|516174773|FG000|Overall Study|Adverse Event|11|||
143170817|NCT01083602|516174773|FG000|Overall Study|New Cancer Therapy|2|||
143170818|NCT01083602|516174773|FG000|Overall Study|Death|1|||
143170819|NCT01083602|516174773|FG000|Overall Study|Withdrawal by Subject|5|||
143170820|NCT01083602|516174773|FG000|Overall Study|Lack of Efficacy|36|||
143170821|NCT01657370|516174774|FG000|Overall Study|Withdrawal by Subject|0|||
143170822|NCT01657370|516174775|FG001|Overall Study|Withdrawal by Subject|0|||
143170823|NCT01657370|516174776|FG002|Overall Study|Withdrawal by Subject|1|||
143170824|NCT01657370|516174777|FG003|Overall Study|Withdrawal by Subject|0|||
143170825|NCT01657370|516174778|FG004|Overall Study|Withdrawal by Subject|0|||
143170826|NCT01657370|516174779|FG005|Overall Study|Withdrawal by Subject|1|||
143170827|NCT01657370|516174774|FG000|Overall Study|Physician Decision|2|||
143170828|NCT01657370|516174775|FG001|Overall Study|Physician Decision|3|||
143170829|NCT01657370|516174776|FG002|Overall Study|Physician Decision|1|||
143170830|NCT01657370|516174777|FG003|Overall Study|Physician Decision|2|||
143170831|NCT01657370|516174778|FG004|Overall Study|Physician Decision|5|||
143170832|NCT01657370|516174779|FG005|Overall Study|Physician Decision|0|||
143170833|NCT01657370|516174774|FG000|Overall Study|Lack of Qualifying Event|1|||
143170834|NCT01657370|516174775|FG001|Overall Study|Lack of Qualifying Event|0|||
143170835|NCT01657370|516174776|FG002|Overall Study|Lack of Qualifying Event|3|||
143170836|NCT01657370|516174777|FG003|Overall Study|Lack of Qualifying Event|2|||
143170837|NCT01657370|516174778|FG004|Overall Study|Lack of Qualifying Event|1|||
143170838|NCT01657370|516174779|FG005|Overall Study|Lack of Qualifying Event|2|||
143170839|NCT01657370|516174774|FG000|Overall Study|Adverse Event|0|||
143170840|NCT01657370|516174775|FG001|Overall Study|Adverse Event|0|||
143068430|NCT02504671|515793235|FG002|Overall Study|Lost to Follow-up|2|||
143068431|NCT02504671|515793236|FG003|Overall Study|Lost to Follow-up|0|||
143068432|NCT02504671|515793237|FG004|Overall Study|Lost to Follow-up|0|||
143068433|NCT02504671|515793238|FG005|Overall Study|Lost to Follow-up|1|||
143170841|NCT01657370|516174776|FG002|Overall Study|Adverse Event|0|||
143170842|NCT01657370|516174777|FG003|Overall Study|Adverse Event|0|||
143365286|NCT04381494|516880716|FG000|Overall Study|Early termination of trial|19|||
143365287|NCT04381494|516880716|FG000|Overall Study|Investigator's discretion|1|||
143365288|NCT04381494|516880716|FG000|Overall Study|Withdrawal by Subject|9|||
143365289|NCT04381494|516880716|FG000|Overall Study|NSCLC disease progression|4|||
143365290|NCT04381494|516880716|FG000|Overall Study|Device-Related Adverse Event|2|||
143365291|NCT01451814|516880717|FG000|Overall Study|Withdrawal by Subject|1|||
143365292|NCT01451814|516880718|FG001|Overall Study|Withdrawal by Subject|1|||
143365293|NCT01451814|516880717|FG000|Overall Study|Lost to Follow-up|5|||
143365294|NCT01451814|516880718|FG001|Overall Study|Lost to Follow-up|4|||
143365295|NCT03006341|516880721|FG000|Overall Study|Not linked in the EMR|25069|||
143365296|NCT03006341|516880722|FG001|Overall Study|Not linked in the EMR|67505|||
143365297|NCT03006341|516880723|FG002|Overall Study|Not linked in the EMR|30993|||
143365298|NCT03006341|516880724|FG003|Overall Study|Not linked in the EMR|10685|||
143365299|NCT03101592|516880727|FG000|Overall Study|participant files could not be located|111|||
143365300|NCT03101592|516880728|FG001|Overall Study|participant files could not be located|170|||
143365301|NCT03101592|516880729|FG002|Overall Study|participant files could not be located|118|||
143365302|NCT00742274|516880730|FG000|Overall Study|Death|1|||
143365303|NCT00742274|516880731|FG001|Overall Study|Death|0|||
143365304|NCT00742274|516880730|FG000|Overall Study|Withdrawal by Subject|1|||
143365305|NCT00742274|516880731|FG001|Overall Study|Withdrawal by Subject|2|||
143365306|NCT00742274|516880730|FG000|Overall Study|Removed for medical reasons|1|||
143365307|NCT00742274|516880731|FG001|Overall Study|Removed for medical reasons|1|||
143365308|NCT02939183|516880737|FG000|Overall Study|Death|0|||
143365309|NCT02939183|516880738|FG001|Overall Study|Death|0|||
143365310|NCT02939183|516880739|FG002|Overall Study|Death|1|||
143503520|NCT00749190|517381061|FG006|Overall Study|Protocol Violation|1|||
143503521|NCT00749190|517381055|FG000|Overall Study|Other reason not defined above|0|||
143068434|NCT02504671|515793233|FG000|Overall Study|Protocol defined stopping criteria|7|||
143068435|NCT02504671|515793234|FG001|Overall Study|Protocol defined stopping criteria|4|||
143068436|NCT02504671|515793235|FG002|Overall Study|Protocol defined stopping criteria|3|||
143068437|NCT02504671|515793236|FG003|Overall Study|Protocol defined stopping criteria|5|||
143068438|NCT02504671|515793237|FG004|Overall Study|Protocol defined stopping criteria|3|||
143068439|NCT02504671|515793238|FG005|Overall Study|Protocol defined stopping criteria|3|||
143068440|NCT03222583|515793241|FG000|Overall Study|Withdrawal by Subject|3|||
143068441|NCT03222583|515793242|FG001|Overall Study|Withdrawal by Subject|3|||
143503522|NCT00749190|517381056|FG001|Overall Study|Other reason not defined above|0|||
143068442|NCT03222583|515793241|FG000|Overall Study|Lost to Follow-up|1|||
143068443|NCT03222583|515793242|FG001|Overall Study|Lost to Follow-up|0|||
143068444|NCT03222583|515793241|FG000|Overall Study|Other|1|||
143068445|NCT03222583|515793242|FG001|Overall Study|Other|3|||
143068446|NCT04498403|515793243|FG000|Overall Study|Adverse Event|1|||
143068447|NCT04498403|515793244|FG001|Overall Study|Adverse Event|0|||
143068448|NCT04498403|515793243|FG000|Overall Study|Study Terminated By Sponsor|29|||
143068449|NCT04498403|515793244|FG001|Overall Study|Study Terminated By Sponsor|10|||
143068450|NCT02031458|515793245|FG000|May 8, 2015 to January 11, 2019|Death|89|||
143068451|NCT02031458|515793246|FG001|May 8, 2015 to January 11, 2019|Death|193|||
143068452|NCT02031458|515793247|FG002|May 8, 2015 to January 11, 2019|Death|198|||
143068453|NCT02031458|515793245|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
143068454|NCT02031458|515793246|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
143068455|NCT02031458|515793247|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
143068456|NCT02031458|515793245|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
143068457|NCT02031458|515793246|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
143068458|NCT02031458|515793247|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
143068459|NCT02031458|515793245|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
143068460|NCT02031458|515793246|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
143068461|NCT02031458|515793247|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
143068462|NCT02031458|515793245|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
143068463|NCT02031458|515793246|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
143068464|NCT02031458|515793247|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
143068465|NCT02031458|515793245|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
143068466|NCT02031458|515793246|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
143068467|NCT02031458|515793247|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
143068468|NCT02031458|515793245|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
143068469|NCT02031458|515793246|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
143068470|NCT02031458|515793247|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
143068471|NCT02031458|515793245|FG000|Baseline to May 8, 2015|Death|36|||
143068472|NCT02031458|515793246|FG001|Baseline to May 8, 2015|Death|87|||
143365311|NCT02939183|516880740|FG003|Overall Study|Death|0|||
143365312|NCT02939183|516880741|FG004|Overall Study|Death|0|||
143365313|NCT02939183|516880742|FG005|Overall Study|Death|2|||
143365314|NCT02939183|516880743|FG006|Overall Study|Death|1|||
143503523|NCT00749190|517381057|FG002|Overall Study|Other reason not defined above|0|||
143365315|NCT02939183|516880744|FG007|Overall Study|Death|0|||
143170843|NCT01657370|516174778|FG004|Overall Study|Adverse Event|1|||
143170844|NCT01657370|516174779|FG005|Overall Study|Adverse Event|0|||
143170845|NCT01657370|516174774|FG000|Overall Study|Protocol Violation|1|||
143170846|NCT01657370|516174775|FG001|Overall Study|Protocol Violation|1|||
143170847|NCT01657370|516174776|FG002|Overall Study|Protocol Violation|1|||
143170848|NCT01657370|516174777|FG003|Overall Study|Protocol Violation|1|||
143170849|NCT01657370|516174778|FG004|Overall Study|Protocol Violation|0|||
143170850|NCT01657370|516174779|FG005|Overall Study|Protocol Violation|0|||
143170851|NCT01657370|516174774|FG000|Overall Study|Lost to Follow-up|2|||
143170852|NCT01657370|516174775|FG001|Overall Study|Lost to Follow-up|0|||
143170853|NCT01657370|516174776|FG002|Overall Study|Lost to Follow-up|1|||
143170854|NCT01657370|516174777|FG003|Overall Study|Lost to Follow-up|0|||
143170855|NCT01657370|516174778|FG004|Overall Study|Lost to Follow-up|0|||
143170856|NCT01657370|516174779|FG005|Overall Study|Lost to Follow-up|1|||
143170857|NCT03021486|516174780|FG000|Overall Study|Withdrawal by Subject|1|||
143170858|NCT03021486|516174781|FG001|Overall Study|Withdrawal by Subject|1|||
143170859|NCT03021486|516174782|FG002|Overall Study|Withdrawal by Subject|3|||
143170860|NCT03021486|516174780|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
143170861|NCT03021486|516174781|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
143170862|NCT03021486|516174782|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
143170863|NCT03698279|516174783|FG000|Overall Study|Withdrawal by parent/guardian|1|||
143170864|NCT03698279|516174784|FG001|Overall Study|Withdrawal by parent/guardian|1|||
143170865|NCT03698279|516174785|FG002|Overall Study|Withdrawal by parent/guardian|1|||
143170866|NCT03698279|516174786|FG003|Overall Study|Withdrawal by parent/guardian|1|||
143170867|NCT03698279|516174787|FG004|Overall Study|Withdrawal by parent/guardian|0|||
143170868|NCT03698279|516174788|FG005|Overall Study|Withdrawal by parent/guardian|0|||
143170869|NCT03698279|516174783|FG000|Overall Study|Protocol deviation|1|||
143170870|NCT03698279|516174784|FG001|Overall Study|Protocol deviation|0|||
143170871|NCT03698279|516174785|FG002|Overall Study|Protocol deviation|1|||
143170872|NCT03698279|516174786|FG003|Overall Study|Protocol deviation|0|||
143170873|NCT03698279|516174787|FG004|Overall Study|Protocol deviation|0|||
143170874|NCT03698279|516174788|FG005|Overall Study|Protocol deviation|0|||
143170875|NCT03698279|516174783|FG000|Overall Study|Withdrawal by Subject|0|||
143170876|NCT03698279|516174784|FG001|Overall Study|Withdrawal by Subject|0|||
143170877|NCT03698279|516174785|FG002|Overall Study|Withdrawal by Subject|1|||
143170878|NCT03698279|516174786|FG003|Overall Study|Withdrawal by Subject|0|||
143170879|NCT03698279|516174787|FG004|Overall Study|Withdrawal by Subject|0|||
143170880|NCT03698279|516174788|FG005|Overall Study|Withdrawal by Subject|0|||
143170881|NCT03698279|516174783|FG000|Overall Study|Lost to Follow-up|3|||
143170882|NCT03698279|516174784|FG001|Overall Study|Lost to Follow-up|1|||
143170883|NCT03698279|516174785|FG002|Overall Study|Lost to Follow-up|4|||
143170884|NCT03698279|516174786|FG003|Overall Study|Lost to Follow-up|5|||
143170885|NCT03698279|516174787|FG004|Overall Study|Lost to Follow-up|0|||
143170886|NCT03698279|516174788|FG005|Overall Study|Lost to Follow-up|0|||
143170887|NCT00582907|516174789|FG000|1st Course|Withdrawal by Subject|1|||
143170888|NCT00582907|516174790|FG001|1st Course|Withdrawal by Subject|0|||
143170889|NCT00582907|516174791|FG002|1st Course|Withdrawal by Subject|0|||
143170890|NCT00582907|516174792|FG003|1st Course|Withdrawal by Subject|0|||
143170891|NCT00582907|516174789|FG000|1st Course|Lost to Follow-up|0|||
143170892|NCT00582907|516174790|FG001|1st Course|Lost to Follow-up|0|||
143170893|NCT00582907|516174791|FG002|1st Course|Lost to Follow-up|0|||
143170894|NCT00582907|516174792|FG003|1st Course|Lost to Follow-up|1|||
143170895|NCT00582907|516174789|FG000|2nd Course|Lack of Efficacy|1|||
143170896|NCT00582907|516174790|FG001|2nd Course|Lack of Efficacy|0|||
143170897|NCT00582907|516174791|FG002|2nd Course|Lack of Efficacy|0|||
143170898|NCT00582907|516174792|FG003|2nd Course|Lack of Efficacy|0|||
143246806|NCT00545272|516456629|FG002|Overall Study|Adverse Event|1|||
143246807|NCT00545272|516456630|FG003|Overall Study|Adverse Event|0|||
143246808|NCT00545272|516456631|FG004|Overall Study|Adverse Event|0|||
143246809|NCT00545272|516456632|FG005|Overall Study|Adverse Event|1|||
143246810|NCT00545272|516456627|FG000|Overall Study|Abnormal laboratory value(s)|0|||
143246811|NCT00545272|516456628|FG001|Overall Study|Abnormal laboratory value(s)|0|||
143170899|NCT01441960|516174793|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
143246812|NCT00545272|516456629|FG002|Overall Study|Abnormal laboratory value(s)|0|||
143170900|NCT01441960|516174794|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
143170901|NCT01441960|516174793|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
143170902|NCT01441960|516174794|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
143170903|NCT01441960|516174793|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
143170904|NCT01441960|516174794|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
143170905|NCT00415636|516174796|FG000|Overall Study|Symptomatic deterioration|1|||
143170906|NCT00415636|516174797|FG001|Overall Study|Symptomatic deterioration|0|||
143170907|NCT00415636|516174798|FG002|Overall Study|Symptomatic deterioration|1|||
143170908|NCT00415636|516174799|FG003|Overall Study|Symptomatic deterioration|2|||
143170909|NCT00415636|516174800|FG004|Overall Study|Symptomatic deterioration|0|||
143246813|NCT00545272|516456630|FG003|Overall Study|Abnormal laboratory value(s)|0|||
143246814|NCT00545272|516456631|FG004|Overall Study|Abnormal laboratory value(s)|0|||
143246815|NCT00545272|516456632|FG005|Overall Study|Abnormal laboratory value(s)|1|||
143365316|NCT02939183|516880745|FG008|Overall Study|Death|0|||
143068473|NCT02031458|515793247|FG002|Baseline to May 8, 2015|Death|100|||
143068474|NCT02031458|515793245|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
143068475|NCT02031458|515793246|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
143068476|NCT02031458|515793247|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
143068477|NCT02031458|515793245|FG000|Baseline to May 8, 2015|Physician Decision|0|||
143068478|NCT02031458|515793246|FG001|Baseline to May 8, 2015|Physician Decision|1|||
143068479|NCT02031458|515793247|FG002|Baseline to May 8, 2015|Physician Decision|0|||
143068480|NCT02031458|515793245|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
143068481|NCT02031458|515793246|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
143068482|NCT02031458|515793247|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
143068483|NCT02031458|515793245|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
143068484|NCT02031458|515793246|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
143068485|NCT02031458|515793247|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
143068486|NCT02031458|515793245|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
143068487|NCT02031458|515793246|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
143068488|NCT02031458|515793247|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
143068489|NCT02031458|515793245|FG000|Baseline to May 8, 2015|On Treatment|43|||
143068490|NCT02031458|515793246|FG001|Baseline to May 8, 2015|On Treatment|81|||
143068491|NCT02031458|515793247|FG002|Baseline to May 8, 2015|On Treatment|73|||
143068492|NCT02031458|515793245|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
143068493|NCT02031458|515793246|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
143068494|NCT02031458|515793247|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
143068495|NCT00609518|515793251|FG000|Overall Study|Death from Study Disease|32|||
143068496|NCT00609518|515793252|FG001|Overall Study|Death from Study Disease|32|||
143068497|NCT00609518|515793251|FG000|Overall Study|Withdrawal by Subject|5|||
143068498|NCT00609518|515793252|FG001|Overall Study|Withdrawal by Subject|3|||
143068499|NCT00609518|515793251|FG000|Overall Study|Lost to Follow-up|3|||
143068500|NCT00609518|515793252|FG001|Overall Study|Lost to Follow-up|0|||
143068501|NCT00609518|515793251|FG000|Overall Study|Physician Decision|1|||
143068502|NCT00609518|515793252|FG001|Overall Study|Physician Decision|3|||
143068503|NCT00609518|515793251|FG000|Overall Study|Death from Adverse Event|2|||
143068504|NCT00609518|515793252|FG001|Overall Study|Death from Adverse Event|2|||
143068505|NCT01687478|515793253|FG000|Overall Study|Adverse Event|3|||
143068506|NCT01687478|515793254|FG001|Overall Study|Adverse Event|10|||
143068507|NCT01687478|515793253|FG000|Overall Study|Lost to Follow-up|1|||
143503524|NCT00749190|517381058|FG003|Overall Study|Other reason not defined above|1|||
143503525|NCT00749190|517381059|FG004|Overall Study|Other reason not defined above|0|||
143503526|NCT00749190|517381060|FG005|Overall Study|Other reason not defined above|0|||
143503527|NCT00749190|517381061|FG006|Overall Study|Other reason not defined above|0|||
143068508|NCT01687478|515793254|FG001|Overall Study|Lost to Follow-up|3|||
143068509|NCT01687478|515793253|FG000|Overall Study|Protocol Violation|0|||
143068510|NCT01687478|515793254|FG001|Overall Study|Protocol Violation|2|||
143068511|NCT01687478|515793253|FG000|Overall Study|Withdrawal by Subject|21|||
143068512|NCT01687478|515793254|FG001|Overall Study|Withdrawal by Subject|19|||
143068513|NCT01687478|515793253|FG000|Overall Study|Physician Decision|1|||
143068514|NCT01687478|515793254|FG001|Overall Study|Physician Decision|3|||
143068515|NCT01687478|515793253|FG000|Overall Study|Entry Criteria Not Met|6|||
143068516|NCT01687478|515793254|FG001|Overall Study|Entry Criteria Not Met|2|||
143068517|NCT03188718|515793255|FG000|Overall Study|Participant noncompliance|4|||
143068518|NCT03188718|515793255|FG000|Overall Study|Withdrawal by Subject|1|||
143068519|NCT03188718|515793255|FG000|Overall Study|Device failure|3|||
143068520|NCT05855616|515793259|FG000|Overall Study|Lost to Follow-up|1|||
143068521|NCT05855616|515793260|FG001|Overall Study|Lost to Follow-up|2|||
143068522|NCT04032158|515793261|FG000|Overall Study|Study Termination|2|||
143068523|NCT04032158|515793262|FG001|Overall Study|Study Termination|1|||
143068524|NCT00824616|515793263|FG000|Overall Study|Adverse Event|2|||
143068525|NCT00824616|515793264|FG001|Overall Study|Adverse Event|1|||
143068526|NCT00824616|515793263|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
143068527|NCT00824616|515793264|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
143068528|NCT00824616|515793263|FG000|Overall Study|Hyperglycemia|1|||
143068529|NCT00824616|515793264|FG001|Overall Study|Hyperglycemia|1|||
143068530|NCT00824616|515793263|FG000|Overall Study|Lack of Efficacy|2|||
143068531|NCT00824616|515793264|FG001|Overall Study|Lack of Efficacy|1|||
143068532|NCT00824616|515793263|FG000|Overall Study|Lost to Follow-up|0|||
143068533|NCT00824616|515793264|FG001|Overall Study|Lost to Follow-up|1|||
143068534|NCT00824616|515793263|FG000|Overall Study|Withdrawal by Subject|1|||
143068535|NCT00824616|515793264|FG001|Overall Study|Withdrawal by Subject|1|||
143068536|NCT00577395|515793265|FG000|Overall Study|Study was terminated early by Sponsor|7|||
143068537|NCT00577395|515793266|FG001|Overall Study|Study was terminated early by Sponsor|6|||
143068538|NCT02963311|515793267|FG000|Overall Study|Withdrawal by Subject|1|||
143068539|NCT02963311|515793267|FG000|Overall Study|Screen Failure|4|||
143068540|NCT04442490|515793268|FG000|Overall Study|Withdrawal by Subject|18|||
143068541|NCT04442490|515793269|FG001|Overall Study|Withdrawal by Subject|10|||
143068542|NCT04442490|515793268|FG000|Overall Study|Lost to Follow-up|7|||
143068543|NCT04442490|515793269|FG001|Overall Study|Lost to Follow-up|7|||
143068544|NCT04442490|515793268|FG000|Overall Study|Adverse Event|2|||
143246816|NCT00545272|516456627|FG000|Overall Study|Abnormal test procedure result(s)|0|||
143246817|NCT00545272|516456628|FG001|Overall Study|Abnormal test procedure result(s)|0|||
143246818|NCT00545272|516456629|FG002|Overall Study|Abnormal test procedure result(s)|0|||
143246819|NCT00545272|516456630|FG003|Overall Study|Abnormal test procedure result(s)|0|||
143246820|NCT00545272|516456631|FG004|Overall Study|Abnormal test procedure result(s)|1|||
143246821|NCT00545272|516456632|FG005|Overall Study|Abnormal test procedure result(s)|0|||
143246822|NCT00545272|516456627|FG000|Overall Study|Lost to Follow-up|0|||
143246823|NCT00545272|516456628|FG001|Overall Study|Lost to Follow-up|0|||
143068545|NCT04442490|515793269|FG001|Overall Study|Adverse Event|6|||
143068546|NCT04442490|515793268|FG000|Overall Study|Noncompliance|3|||
143503528|NCT00784758|517381070|FG000|Overall Study|Withdrawal by Subject|3|||
143503529|NCT00784758|517381071|FG001|Overall Study|Withdrawal by Subject|0|||
143068547|NCT04442490|515793269|FG001|Overall Study|Noncompliance|1|||
143068548|NCT04442490|515793268|FG000|Overall Study|Physician Decision|2|||
143068549|NCT04442490|515793269|FG001|Overall Study|Physician Decision|1|||
143068550|NCT04442490|515793268|FG000|Overall Study|Reason not Specified|2|||
143068551|NCT04442490|515793269|FG001|Overall Study|Reason not Specified|1|||
143068552|NCT04442490|515793268|FG000|Overall Study|Randomized but not Treated|3|||
143246824|NCT00545272|516456629|FG002|Overall Study|Lost to Follow-up|0|||
143246825|NCT00545272|516456630|FG003|Overall Study|Lost to Follow-up|0|||
143503530|NCT00784758|517381070|FG000|Overall Study|Adverse Event|1|||
143503531|NCT00784758|517381071|FG001|Overall Study|Adverse Event|0|||
143068553|NCT04442490|515793269|FG001|Overall Study|Randomized but not Treated|3|||
143068554|NCT01449279|515793270|FG000|Overall Study|Lack of Efficacy|5|||
143068555|NCT01449279|515793270|FG000|Overall Study|Toxicity|2|||
143068556|NCT00158600|515793273|FG000|Overall Study|unable to commit time to study|0|||
143068557|NCT00158600|515793274|FG001|Overall Study|unable to commit time to study|1|||
143068558|NCT00158600|515793273|FG000|Overall Study|Adverse Event|2|||
143068559|NCT00158600|515793274|FG001|Overall Study|Adverse Event|1|||
143068560|NCT00158600|515793273|FG000|Overall Study|Death|1|||
143068561|NCT00158600|515793274|FG001|Overall Study|Death|0|||
143068562|NCT00158600|515793273|FG000|Overall Study|Withdrawal by Subject|2|||
143068563|NCT00158600|515793274|FG001|Overall Study|Withdrawal by Subject|2|||
143068564|NCT02038907|515793275|FG000|Overall Study|Protocol Violation|0|||
143246826|NCT00545272|516456631|FG004|Overall Study|Lost to Follow-up|1|||
143246827|NCT00545272|516456632|FG005|Overall Study|Lost to Follow-up|0|||
143068565|NCT02038907|515793276|FG001|Overall Study|Protocol Violation|0|||
143068566|NCT02038907|515793277|FG002|Overall Study|Protocol Violation|0|||
143068567|NCT02038907|515793278|FG003|Overall Study|Protocol Violation|0|||
143068568|NCT02038907|515793279|FG004|Overall Study|Protocol Violation|0|||
143068569|NCT02038907|515793280|FG005|Overall Study|Protocol Violation|0|||
143068570|NCT02038907|515793281|FG006|Overall Study|Protocol Violation|0|||
143068571|NCT02038907|515793282|FG007|Overall Study|Protocol Violation|0|||
143068572|NCT02038907|515793283|FG008|Overall Study|Protocol Violation|0|||
143068573|NCT02038907|515793284|FG009|Overall Study|Protocol Violation|0|||
143068574|NCT02038907|515793285|FG010|Overall Study|Protocol Violation|1|||
143068575|NCT02038907|515793286|FG011|Overall Study|Protocol Violation|0|||
143068576|NCT02038907|515793287|FG012|Overall Study|Protocol Violation|0|||
143068577|NCT02038907|515793288|FG013|Overall Study|Protocol Violation|0|||
143068578|NCT02038907|515793275|FG000|Overall Study|Withdrawal by Subject|0|||
143068579|NCT02038907|515793276|FG001|Overall Study|Withdrawal by Subject|0|||
143068580|NCT02038907|515793277|FG002|Overall Study|Withdrawal by Subject|0|||
143068581|NCT02038907|515793278|FG003|Overall Study|Withdrawal by Subject|0|||
143068582|NCT02038907|515793279|FG004|Overall Study|Withdrawal by Subject|0|||
143068583|NCT02038907|515793280|FG005|Overall Study|Withdrawal by Subject|0|||
143068584|NCT02038907|515793281|FG006|Overall Study|Withdrawal by Subject|0|||
143068585|NCT02038907|515793282|FG007|Overall Study|Withdrawal by Subject|0|||
143068586|NCT02038907|515793283|FG008|Overall Study|Withdrawal by Subject|0|||
143068587|NCT02038907|515793284|FG009|Overall Study|Withdrawal by Subject|0|||
143068588|NCT02038907|515793285|FG010|Overall Study|Withdrawal by Subject|1|||
143068589|NCT02038907|515793286|FG011|Overall Study|Withdrawal by Subject|0|||
143068590|NCT02038907|515793287|FG012|Overall Study|Withdrawal by Subject|0|||
143068591|NCT02038907|515793288|FG013|Overall Study|Withdrawal by Subject|0|||
143068592|NCT03579966|515793291|FG000|Overall Study|Adverse Event|6|||
143068593|NCT03579966|515793291|FG000|Overall Study|Lost to Follow-up|4|||
143068594|NCT03579966|515793291|FG000|Overall Study|Physician Decision|10|||
143068595|NCT03579966|515793291|FG000|Overall Study|Pregnancy|1|||
143068596|NCT03579966|515793291|FG000|Overall Study|Withdrawal by Subject|16|||
143068597|NCT03579966|515793291|FG000|Overall Study|Study terminated by Sponsor|22|||
143068598|NCT03579966|515793291|FG000|Overall Study|Protocol Violation|1|||
143068599|NCT01249365|515793292|FG000|Overall Study|Lost to Follow-up|1|||
143068600|NCT01340768|515793293|FG000|Overall Study|Lost to Follow-up|10|||
143068601|NCT01340768|515793294|FG001|Overall Study|Lost to Follow-up|4|||
143068602|NCT01340768|515793293|FG000|Overall Study|Withdrawal by Subject|5|||
143068603|NCT01340768|515793294|FG001|Overall Study|Withdrawal by Subject|1|||
143068604|NCT01340768|515793293|FG000|Overall Study|Other|2|||
143068605|NCT01340768|515793294|FG001|Overall Study|Other|0|||
143068606|NCT00801099|515793295|FG000|Overall Study|Lost to Follow-up|101|||
143068607|NCT03321630|515793296|FG000|Overall Study|Adverse Event|1|||
143068608|NCT03321630|515793296|FG000|Overall Study|Investigator Discretion|2|||
143068609|NCT03321630|515793296|FG000|Overall Study|Withdrawal by Subject|1|||
143068610|NCT00950963|515793297|FG000|Overall Study|Lost to Follow-up|29|||
143068611|NCT00950963|515793298|FG001|Overall Study|Lost to Follow-up|24|||
143068612|NCT01675661|515793299|FG000|Overall Study|Lost to Follow-up|22|||
143068613|NCT01675661|515793300|FG001|Overall Study|Lost to Follow-up|23|||
143068614|NCT01675661|515793299|FG000|Overall Study|Practical problems|9|||
143068615|NCT01675661|515793300|FG001|Overall Study|Practical problems|5|||
143068616|NCT01675661|515793299|FG000|Overall Study|Moved away|5|||
143068617|NCT01675661|515793300|FG001|Overall Study|Moved away|6|||
143068618|NCT01675661|515793299|FG000|Overall Study|Withdrawal by Subject|3|||
143068619|NCT01675661|515793300|FG001|Overall Study|Withdrawal by Subject|7|||
143068620|NCT01675661|515793299|FG000|Overall Study|Physician Decision|0|||
143068621|NCT01675661|515793300|FG001|Overall Study|Physician Decision|2|||
143068622|NCT01675661|515793299|FG000|Overall Study|Death|0|||
143068623|NCT01675661|515793300|FG001|Overall Study|Death|1|||
143068624|NCT01675661|515793299|FG000|Overall Study|Other reason|1|||
143068625|NCT01675661|515793300|FG001|Overall Study|Other reason|2|||
143068626|NCT01006135|515793303|FG000|Overall Study|Adverse Event|22|||
143068627|NCT01006135|515793303|FG000|Overall Study|Protocol Violation|14|||
143068628|NCT01006135|515793303|FG000|Overall Study|Lost to Follow-up|32|||
143068629|NCT01006135|515793303|FG000|Overall Study|Other|72|||
143246828|NCT02934503|516456633|FG000|Overall Study|progression of disease|3|||
143246829|NCT02934503|516456633|FG000|Overall Study|Withdrawal by Subject|1|||
143068630|NCT01330459|515793305|FG000|Overall Study|Physician Decision|0|||
143068631|NCT01330459|515793306|FG001|Overall Study|Physician Decision|2|||
143068632|NCT00895947|515793307|FG000|Overall Study|Adverse Event|3|||
143068633|NCT00895947|515793308|FG001|Overall Study|Adverse Event|4|||
143068634|NCT00895947|515793307|FG000|Overall Study|Lost to Follow-up|3|||
143068635|NCT00895947|515793308|FG001|Overall Study|Lost to Follow-up|4|||
143068636|NCT00895947|515793307|FG000|Overall Study|Protocol Violation|4|||
143068637|NCT00895947|515793308|FG001|Overall Study|Protocol Violation|2|||
143068638|NCT00895947|515793307|FG000|Overall Study|Withdrawal by Subject|2|||
143068639|NCT00895947|515793308|FG001|Overall Study|Withdrawal by Subject|0|||
143068640|NCT04620135|515793312|FG000|Study Completion|Adverse Event|2|||
143068641|NCT04620135|515793313|FG001|Study Completion|Adverse Event|3|||
143068642|NCT04620135|515793312|FG000|Study Completion|Withdrawal by Subject|2|||
143068643|NCT04620135|515793313|FG001|Study Completion|Withdrawal by Subject|0|||
143068644|NCT04771403|515793314|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
143068645|NCT04771403|515793315|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
143068646|NCT04771403|515793314|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
143068647|NCT04771403|515793315|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
143068648|NCT04771403|515793314|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
143068649|NCT04771403|515793315|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
143068650|NCT04771403|515793314|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
143068651|NCT04771403|515793315|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
143246830|NCT00724867|516456634|FG000|Overall Study|Adverse Event|25|||
143246831|NCT00724867|516456634|FG000|Overall Study|Lack of Efficacy|14|||
143246832|NCT00724867|516456634|FG000|Overall Study|Lost to Follow-up|12|||
143246833|NCT00724867|516456634|FG000|Overall Study|Non-compliance with study drug|6|||
143246834|NCT00724867|516456634|FG000|Overall Study|Physician Decision|17|||
143246835|NCT00724867|516456634|FG000|Overall Study|Protocol Violation|1|||
143246836|NCT00724867|516456634|FG000|Overall Study|Withdrawal by Subject|31|||
143246837|NCT00724867|516456634|FG000|Overall Study|Sponsor decision to end study|14|||
143246838|NCT00724867|516456634|FG000|Overall Study|Subject incarcerated|1|||
143246839|NCT00724867|516456634|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
143246840|NCT00724867|516456634|FG000|Overall Study|Subject moved out of state|1|||
143246841|NCT00724867|516456634|FG000|Overall Study|Elected to exit due to site closure|2|||
143246842|NCT00436345|516456635|FG000|Overall Study|ICU resident beyond follow-up period|3|||
143246843|NCT00436345|516456636|FG001|Overall Study|ICU resident beyond follow-up period|0|||
143246844|NCT01175083|516456637|FG000|Primary Epoch|Withdrawal by Subject|0|||
143246845|NCT01175083|516456638|FG001|Primary Epoch|Withdrawal by Subject|0|||
143246846|NCT01175083|516456639|FG002|Primary Epoch|Withdrawal by Subject|0|||
143246847|NCT01175083|516456640|FG003|Primary Epoch|Withdrawal by Subject|0|||
143246848|NCT01175083|516456641|FG004|Primary Epoch|Withdrawal by Subject|0|||
143246849|NCT01175083|516456642|FG005|Primary Epoch|Withdrawal by Subject|2|||
143246850|NCT01175083|516456637|FG000|Primary Epoch|Lost to Follow-up|0|||
143246851|NCT01175083|516456638|FG001|Primary Epoch|Lost to Follow-up|0|||
143246852|NCT01175083|516456639|FG002|Primary Epoch|Lost to Follow-up|0|||
143246853|NCT01175083|516456640|FG003|Primary Epoch|Lost to Follow-up|0|||
143246854|NCT01175083|516456641|FG004|Primary Epoch|Lost to Follow-up|0|||
143246855|NCT01175083|516456642|FG005|Primary Epoch|Lost to Follow-up|1|||
143246856|NCT01175083|516456637|FG000|Booster Epoch|Death|0|||
143246857|NCT01175083|516456638|FG001|Booster Epoch|Death|0|||
143246858|NCT01175083|516456639|FG002|Booster Epoch|Death|1|||
143246859|NCT01175083|516456640|FG003|Booster Epoch|Death|0|||
143246860|NCT01175083|516456641|FG004|Booster Epoch|Death|0|||
143246861|NCT01175083|516456642|FG005|Booster Epoch|Death|0|||
143246862|NCT01175083|516456637|FG000|Booster Epoch|Withdrawal by Subject|0|||
143246863|NCT01175083|516456638|FG001|Booster Epoch|Withdrawal by Subject|0|||
143246864|NCT01175083|516456639|FG002|Booster Epoch|Withdrawal by Subject|0|||
143246865|NCT01175083|516456640|FG003|Booster Epoch|Withdrawal by Subject|1|||
143246866|NCT01175083|516456641|FG004|Booster Epoch|Withdrawal by Subject|0|||
143365317|NCT02939183|516880737|FG000|Overall Study|Sponsor decision|0|||
143068652|NCT04771403|515793314|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
143068653|NCT04771403|515793315|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
143068654|NCT04771403|515793314|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
143068655|NCT04771403|515793315|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
143068656|NCT04771403|515793314|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
143068657|NCT04771403|515793315|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
143068658|NCT04771403|515793314|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
143068659|NCT04771403|515793315|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
143068660|NCT01615263|515793316|FG000|Overall Study|Post-randomization exclusion|0|||
143068661|NCT01615263|515793317|FG001|Overall Study|Post-randomization exclusion|2|||
143068662|NCT00857259|515793318|FG000|Overall Study|Protocol Violation|1|||
143068663|NCT00857259|515793319|FG001|Overall Study|Protocol Violation|0|||
143068664|NCT00857259|515793320|FG002|Overall Study|Protocol Violation|1|||
143068665|NCT02701413|515793321|FG000|Overall Study|Withdrawal by Subject|7|||
143246867|NCT01175083|516456642|FG005|Booster Epoch|Withdrawal by Subject|0|||
143246868|NCT01296672|516456643|FG000|Overall Study|Lost to Follow-up|73|||
143246869|NCT01296672|516456644|FG001|Overall Study|Lost to Follow-up|18|||
143068666|NCT02701413|515793322|FG001|Overall Study|Withdrawal by Subject|11|||
143246870|NCT01716052|516456645|FG000|Overall Study|Withdrawal of funding|1|||
143246871|NCT01716052|516456646|FG001|Overall Study|Withdrawal of funding|1|||
143246872|NCT04027608|516456649|FG000|Overall Study|Withdrawal by Subject|13|||
143246873|NCT04027608|516456650|FG001|Overall Study|Withdrawal by Subject|2|||
143246874|NCT04027608|516456649|FG000|Overall Study|Protocol Violation|2|||
143246875|NCT04027608|516456650|FG001|Overall Study|Protocol Violation|1|||
143246876|NCT04027608|516456649|FG000|Overall Study|Physician Decision|1|||
143246877|NCT04027608|516456650|FG001|Overall Study|Physician Decision|0|||
143246878|NCT04027608|516456649|FG000|Overall Study|Lost to Follow-up|20|||
143246879|NCT04027608|516456650|FG001|Overall Study|Lost to Follow-up|4|||
143246880|NCT01652534|516456667|FG000|Overall Study|Lack of Efficacy|1|||
143246881|NCT01652534|516456668|FG001|Overall Study|Lack of Efficacy|0|||
143246882|NCT02105961|516456669|FG000|Overall Study|Adverse Event|18|||
143246883|NCT02105961|516456670|FG001|Overall Study|Adverse Event|7|||
143246884|NCT02105961|516456671|FG002|Overall Study|Adverse Event|13|||
143246885|NCT02105961|516456669|FG000|Overall Study|Lack of Efficacy|3|||
143246886|NCT02105961|516456670|FG001|Overall Study|Lack of Efficacy|0|||
143246887|NCT02105961|516456671|FG002|Overall Study|Lack of Efficacy|3|||
143246888|NCT02105961|516456669|FG000|Overall Study|Lost to Follow-up|2|||
143246889|NCT02105961|516456670|FG001|Overall Study|Lost to Follow-up|0|||
143246890|NCT02105961|516456671|FG002|Overall Study|Lost to Follow-up|1|||
143246891|NCT02105961|516456669|FG000|Overall Study|Physician Decision|3|||
143246892|NCT02105961|516456670|FG001|Overall Study|Physician Decision|3|||
143246893|NCT02105961|516456671|FG002|Overall Study|Physician Decision|2|||
143246894|NCT02105961|516456669|FG000|Overall Study|Withdrawal by Subject|15|||
143246895|NCT02105961|516456670|FG001|Overall Study|Withdrawal by Subject|7|||
143246896|NCT02105961|516456671|FG002|Overall Study|Withdrawal by Subject|11|||
143246897|NCT03860259|516456672|FG000|Overall Study|Lost to Follow-up|5|||
143246898|NCT03860259|516456673|FG001|Overall Study|Lost to Follow-up|5|||
143246899|NCT03860259|516456672|FG000|Overall Study|Protocol Violation|1|||
143503532|NCT04752384|517381072|FG000|Overall Study|Withdrawal by Subject|1|||
143068667|NCT02138136|515793323|FG000|Overall Study|Protocol Violation|4|||
143503533|NCT04752384|517381072|FG000|Overall Study|Death|1|||
143503534|NCT02330419|517381073|FG000|Overall Study|Lost to Follow-up|3|||
143503535|NCT02330419|517381074|FG001|Overall Study|Lost to Follow-up|7|||
143503536|NCT03952559|517381075|FG000|Double Blind Treatment Period|Adverse Event|0|||
143503537|NCT03952559|517381076|FG001|Double Blind Treatment Period|Adverse Event|2|||
143503538|NCT03952559|517381077|FG002|Double Blind Treatment Period|Adverse Event|1|||
143068668|NCT02138136|515793323|FG000|Overall Study|Physician Decision|7|||
143068669|NCT02138136|515793323|FG000|Overall Study|Lack of Efficacy|35|||
143068670|NCT02138136|515793323|FG000|Overall Study|Pregnancy|2|||
143068671|NCT02138136|515793323|FG000|Overall Study|Adverse Event|18|||
143068672|NCT02138136|515793323|FG000|Overall Study|Withdrawal by Subject|36|||
143068673|NCT02138136|515793323|FG000|Overall Study|Lost to Follow-up|32|||
143068674|NCT02138136|515793323|FG000|Overall Study|Withdrawn by Sponsor|5|||
143068675|NCT01359644|515793328|FG000|Treatment Period|Lack of Efficacy|0|||
143068676|NCT01359644|515793329|FG001|Treatment Period|Lack of Efficacy|1|||
143068677|NCT01359644|515793330|FG002|Treatment Period|Lack of Efficacy|0|||
143068678|NCT01359644|515793331|FG003|Treatment Period|Lack of Efficacy|0|||
143068679|NCT01359644|515793332|FG004|Treatment Period|Lack of Efficacy|0|||
143068680|NCT01359644|515793333|FG005|Treatment Period|Lack of Efficacy|0|||
143068681|NCT01359644|515793334|FG006|Treatment Period|Lack of Efficacy|0|||
143068682|NCT01359644|515793335|FG007|Treatment Period|Lack of Efficacy|0|||
143068683|NCT01359644|515793336|FG008|Treatment Period|Lack of Efficacy|0|||
143068684|NCT01359644|515793337|FG009|Treatment Period|Lack of Efficacy|0|||
143068685|NCT01359644|515793328|FG000|Treatment Period|Adverse Event|0|||
143068686|NCT01359644|515793329|FG001|Treatment Period|Adverse Event|0|||
143068687|NCT01359644|515793330|FG002|Treatment Period|Adverse Event|1|||
143068688|NCT01359644|515793331|FG003|Treatment Period|Adverse Event|0|||
143068689|NCT01359644|515793332|FG004|Treatment Period|Adverse Event|0|||
143068690|NCT01359644|515793333|FG005|Treatment Period|Adverse Event|1|||
143068691|NCT01359644|515793334|FG006|Treatment Period|Adverse Event|0|||
143068692|NCT01359644|515793335|FG007|Treatment Period|Adverse Event|0|||
143068693|NCT01359644|515793336|FG008|Treatment Period|Adverse Event|0|||
143246900|NCT03860259|516456673|FG001|Overall Study|Protocol Violation|0|||
143246901|NCT00811018|516456674|FG000|Overall Study|Additional Chronic Treatment|31|||
143246902|NCT00811018|516456674|FG000|Overall Study|Adverse Event|79|||
143246903|NCT00811018|516456674|FG000|Overall Study|Death|147|||
143246904|NCT00811018|516456674|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
143246905|NCT00811018|516456674|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
143246906|NCT00811018|516456674|FG000|Overall Study|Investigator Decision|57|||
143503539|NCT03952559|517381078|FG003|Double Blind Treatment Period|Adverse Event|0|||
143068694|NCT01359644|515793337|FG009|Treatment Period|Adverse Event|0|||
143068695|NCT01359644|515793328|FG000|Treatment Period|Lost to Follow-up|0|||
143068696|NCT01359644|515793329|FG001|Treatment Period|Lost to Follow-up|0|||
143068697|NCT01359644|515793330|FG002|Treatment Period|Lost to Follow-up|0|||
143068698|NCT01359644|515793331|FG003|Treatment Period|Lost to Follow-up|0|||
143068699|NCT01359644|515793332|FG004|Treatment Period|Lost to Follow-up|0|||
143068700|NCT01359644|515793333|FG005|Treatment Period|Lost to Follow-up|1|||
143068701|NCT01359644|515793334|FG006|Treatment Period|Lost to Follow-up|0|||
143068702|NCT01359644|515793335|FG007|Treatment Period|Lost to Follow-up|0|||
143068703|NCT01359644|515793336|FG008|Treatment Period|Lost to Follow-up|0|||
143246907|NCT00811018|516456674|FG000|Overall Study|Lost to Follow-up|19|||
143246908|NCT00811018|516456674|FG000|Overall Study|Pregnancy|6|||
143246909|NCT00811018|516456674|FG000|Overall Study|Sponsor Decision|450|||
143246910|NCT00811018|516456674|FG000|Overall Study|Withdrawal by Subject|70|||
143246911|NCT00811018|516456674|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
143246912|NCT00811018|516456674|FG000|Overall Study|Other|26|||
143246913|NCT02722304|516456678|FG000|Overall Study|Study Terminated by Sponsor|1|||
143246914|NCT02722304|516456679|FG001|Overall Study|Study Terminated by Sponsor|0|||
143246915|NCT02722304|516456680|FG002|Overall Study|Study Terminated by Sponsor|2|||
143246916|NCT02722304|516456681|FG003|Overall Study|Study Terminated by Sponsor|1|||
143246917|NCT02722304|516456682|FG004|Overall Study|Study Terminated by Sponsor|1|||
143246918|NCT02722304|516456678|FG000|Overall Study|Other|0|||
143246919|NCT02722304|516456679|FG001|Overall Study|Other|0|||
143246920|NCT02722304|516456680|FG002|Overall Study|Other|0|||
143246921|NCT02722304|516456681|FG003|Overall Study|Other|1|||
143246922|NCT02722304|516456682|FG004|Overall Study|Other|1|||
143246923|NCT00934362|516456683|FG000|Overall Study|Adverse Event|1|||
143246924|NCT00934362|516456684|FG001|Overall Study|Adverse Event|0|||
143246925|NCT04154189|516456685|FG000|Overall Study|Withdrawal by Subject|4|||
143246926|NCT04154189|516456686|FG001|Overall Study|Withdrawal by Subject|6|||
143246927|NCT04154189|516456685|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
143246928|NCT04154189|516456686|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
143246929|NCT04154189|516456685|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
143246930|NCT04154189|516456686|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
143246931|NCT04154189|516456685|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
143246932|NCT04154189|516456686|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
143246933|NCT04154189|516456685|FG000|Overall Study|Death|25|||
143246934|NCT04154189|516456686|FG001|Overall Study|Death|25|||
143246935|NCT02280408|516456687|FG000|Overall Study|Lost to Follow-up|0|||
143246936|NCT02280408|516456688|FG001|Overall Study|Lost to Follow-up|2|||
143246937|NCT02280408|516456689|FG002|Overall Study|Lost to Follow-up|0|||
143246938|NCT02280408|516456690|FG003|Overall Study|Lost to Follow-up|0|||
143246939|NCT04173494|516456691|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
143246940|NCT04173494|516456692|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
143246941|NCT04173494|516456691|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
143246942|NCT04173494|516456692|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
143246943|NCT04173494|516456691|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
143246944|NCT04173494|516456692|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
143246945|NCT04173494|516456691|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
143246946|NCT04173494|516456692|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
143246947|NCT04173494|516456691|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
143246948|NCT04173494|516456692|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
143246949|NCT04173494|516456691|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
143246950|NCT04173494|516456692|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
143246951|NCT04173494|516456691|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
143246952|NCT04173494|516456692|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
143246953|NCT04173494|516456691|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
143246954|NCT04173494|516456692|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
143246955|NCT04173494|516456691|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
143246956|NCT04173494|516456692|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
143246957|NCT04173494|516456691|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
143246958|NCT04173494|516456692|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
143365318|NCT02939183|516880738|FG001|Overall Study|Sponsor decision|1|||
143503540|NCT03952559|517381079|FG004|Double Blind Treatment Period|Adverse Event|1|||
143503541|NCT03952559|517381075|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
143503542|NCT03952559|517381076|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
143503543|NCT03952559|517381077|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
143503544|NCT03952559|517381078|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
143503545|NCT03952559|517381079|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
143503546|NCT03952559|517381075|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
143246959|NCT04173494|516456691|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
143246960|NCT04173494|516456692|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
143365319|NCT02939183|516880739|FG002|Overall Study|Sponsor decision|0|||
143068704|NCT01359644|515793337|FG009|Treatment Period|Lost to Follow-up|0|||
143246961|NCT04173494|516456691|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
143246962|NCT04173494|516456692|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
143246963|NCT04173494|516456691|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
143246964|NCT04173494|516456692|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
143246965|NCT04173494|516456691|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
143246966|NCT04173494|516456692|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
143246967|NCT04173494|516456691|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
143246968|NCT04173494|516456692|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
143246969|NCT04173494|516456691|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
143246970|NCT04173494|516456692|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
143246971|NCT02474069|516456693|FG000|Selection Phase (SP)|Adverse Event|8|||
143246972|NCT02474069|516456694|FG001|Selection Phase (SP)|Adverse Event|0|||
143246973|NCT02474069|516456695|FG002|Selection Phase (SP)|Adverse Event|0|||
143246974|NCT02474069|516456693|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
143246975|NCT02474069|516456694|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
143246976|NCT02474069|516456695|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
143246977|NCT02474069|516456693|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
143246978|NCT02474069|516456694|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
143246979|NCT02474069|516456695|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
143246980|NCT02474069|516456693|FG000|Selection Phase (SP)|Physician Decision|1|||
143246981|NCT02474069|516456694|FG001|Selection Phase (SP)|Physician Decision|0|||
143246982|NCT02474069|516456695|FG002|Selection Phase (SP)|Physician Decision|0|||
143246983|NCT02474069|516456693|FG000|Selection Phase (SP)|Protocol Violation|1|||
143246984|NCT02474069|516456694|FG001|Selection Phase (SP)|Protocol Violation|0|||
143246985|NCT02474069|516456695|FG002|Selection Phase (SP)|Protocol Violation|0|||
143246986|NCT02474069|516456693|FG000|Selection Phase (SP)|No longer requires treatment|1|||
143246987|NCT02474069|516456694|FG001|Selection Phase (SP)|No longer requires treatment|0|||
143246988|NCT02474069|516456695|FG002|Selection Phase (SP)|No longer requires treatment|0|||
143246989|NCT02474069|516456693|FG000|Selection Phase (SP)|Technical Problem|1|||
143246990|NCT02474069|516456694|FG001|Selection Phase (SP)|Technical Problem|0|||
143246991|NCT02474069|516456695|FG002|Selection Phase (SP)|Technical Problem|0|||
143246992|NCT02474069|516456693|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
143246993|NCT02474069|516456694|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
143246994|NCT02474069|516456695|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
143246995|NCT02474069|516456693|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
143246996|NCT02474069|516456694|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
143246997|NCT02474069|516456695|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
143246998|NCT02474069|516456693|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
143365320|NCT02939183|516880740|FG003|Overall Study|Sponsor decision|1|||
143503547|NCT03952559|517381076|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
143503548|NCT03952559|517381077|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
143503549|NCT03952559|517381078|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
143503550|NCT03952559|517381079|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
143503551|NCT03952559|517381075|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
143503552|NCT03952559|517381076|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
143503553|NCT03952559|517381077|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
143503554|NCT03952559|517381078|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
143503555|NCT03952559|517381079|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
143503556|NCT01870739|517381080|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
143503557|NCT01870739|517381081|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
143503558|NCT01870739|517381080|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
143503559|NCT01870739|517381081|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
143503560|NCT01870739|517381080|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
143503561|NCT01870739|517381081|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
143503562|NCT01870739|517381080|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
143503563|NCT01870739|517381081|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
143503564|NCT01870739|517381080|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
143503565|NCT01870739|517381081|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
143503566|NCT01870739|517381080|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
143246999|NCT02474069|516456694|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
143068705|NCT01359644|515793328|FG000|Follow-up Period|Withdrawal by Subject|0|||
143068706|NCT01359644|515793329|FG001|Follow-up Period|Withdrawal by Subject|0|||
143068707|NCT01359644|515793330|FG002|Follow-up Period|Withdrawal by Subject|0|||
143068708|NCT01359644|515793331|FG003|Follow-up Period|Withdrawal by Subject|0|||
143068709|NCT01359644|515793332|FG004|Follow-up Period|Withdrawal by Subject|0|||
143068710|NCT01359644|515793333|FG005|Follow-up Period|Withdrawal by Subject|1|||
143068711|NCT01359644|515793334|FG006|Follow-up Period|Withdrawal by Subject|0|||
143068712|NCT01359644|515793335|FG007|Follow-up Period|Withdrawal by Subject|0|||
143068713|NCT01359644|515793336|FG008|Follow-up Period|Withdrawal by Subject|0|||
143068714|NCT01359644|515793337|FG009|Follow-up Period|Withdrawal by Subject|0|||
143170910|NCT00415636|516174801|FG005|Overall Study|Symptomatic deterioration|1|||
143170911|NCT00415636|516174796|FG000|Overall Study|Adverse Event|0|||
143170912|NCT00415636|516174797|FG001|Overall Study|Adverse Event|0|||
143170913|NCT00415636|516174798|FG002|Overall Study|Adverse Event|0|||
143170914|NCT00415636|516174799|FG003|Overall Study|Adverse Event|1|||
143170915|NCT00415636|516174800|FG004|Overall Study|Adverse Event|1|||
143170916|NCT00415636|516174801|FG005|Overall Study|Adverse Event|0|||
143170917|NCT00415636|516174796|FG000|Overall Study|Withdrawal by Subject|0|||
143170918|NCT00415636|516174797|FG001|Overall Study|Withdrawal by Subject|0|||
143170919|NCT00415636|516174798|FG002|Overall Study|Withdrawal by Subject|0|||
143247000|NCT02474069|516456695|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
143247001|NCT02474069|516456693|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
143503567|NCT01870739|517381081|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
143503568|NCT01870739|517381080|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
143503569|NCT01870739|517381081|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
143503570|NCT01986062|517381082|FG000|Overall Study|Lost to Follow-up|1|||
143503571|NCT01986062|517381083|FG001|Overall Study|Lost to Follow-up|0|||
143503572|NCT01986062|517381082|FG000|Overall Study|Withdrawal by Subject|0|||
143503573|NCT01986062|517381083|FG001|Overall Study|Withdrawal by Subject|1|||
143503574|NCT01565980|517381085|FG000|Overall Study|Death|1|||
143503575|NCT01565980|517381086|FG001|Overall Study|Death|0|||
143503576|NCT01565980|517381085|FG000|Overall Study|Lost to Follow-up|1|||
143503577|NCT01565980|517381086|FG001|Overall Study|Lost to Follow-up|0|||
143503578|NCT01565980|517381085|FG000|Overall Study|health complications|1|||
143503579|NCT01565980|517381086|FG001|Overall Study|health complications|1|||
143503580|NCT01565980|517381085|FG000|Overall Study|stopped medical treatment|1|||
143503581|NCT01565980|517381086|FG001|Overall Study|stopped medical treatment|0|||
143503582|NCT01565980|517381085|FG000|Overall Study|Withdrawal by Subject|0|||
143503583|NCT01565980|517381086|FG001|Overall Study|Withdrawal by Subject|3|||
143503584|NCT01955707|517381087|FG000|Overall Study|Adverse Event|1|||
143503585|NCT01955707|517381088|FG001|Overall Study|Adverse Event|2|||
143503586|NCT01955707|517381087|FG000|Overall Study|Lost to Follow-up|2|||
143503587|NCT01955707|517381088|FG001|Overall Study|Lost to Follow-up|1|||
143503588|NCT01955707|517381087|FG000|Overall Study|Withdrawal by Subject|0|||
143503589|NCT01955707|517381088|FG001|Overall Study|Withdrawal by Subject|3|||
143503590|NCT01955707|517381087|FG000|Overall Study|Death|13|||
143503591|NCT01955707|517381088|FG001|Overall Study|Death|14|||
143503592|NCT01955707|517381087|FG000|Overall Study|Other|4|||
143503593|NCT01955707|517381088|FG001|Overall Study|Other|2|||
143503594|NCT01817790|517381091|FG000|Overall Study|Adverse Event|0|||
143503595|NCT01817790|517381092|FG001|Overall Study|Adverse Event|2|||
143503596|NCT01817790|517381091|FG000|Overall Study|Lost to Follow-up|0|||
143503597|NCT01817790|517381092|FG001|Overall Study|Lost to Follow-up|1|||
143503598|NCT01817790|517381091|FG000|Overall Study|Protocol Violation|2|||
143503599|NCT01817790|517381092|FG001|Overall Study|Protocol Violation|1|||
143503600|NCT01817790|517381091|FG000|Overall Study|Withdrawal by Subject|1|||
143503601|NCT01817790|517381092|FG001|Overall Study|Withdrawal by Subject|3|||
143503602|NCT01817790|517381091|FG000|Overall Study|Other: Could not attend appointment|1|||
143503603|NCT01817790|517381092|FG001|Overall Study|Other: Could not attend appointment|1|||
143503604|NCT01671345|517381093|FG000|Overall Study|Lost to Follow-up|10|||
143503605|NCT01671345|517381094|FG001|Overall Study|Lost to Follow-up|6|||
143503606|NCT01671345|517381093|FG000|Overall Study|visit with non-participating physician|3|||
143503607|NCT01671345|517381094|FG001|Overall Study|visit with non-participating physician|3|||
143503608|NCT03636906|517381095|FG000|Overall Study|Adverse Event|0|||
143503609|NCT03636906|517381096|FG001|Overall Study|Adverse Event|0|||
143503610|NCT03636906|517381097|FG002|Overall Study|Adverse Event|1|||
143503611|NCT03636906|517381095|FG000|Overall Study|Lost to Follow-up|1|||
143503612|NCT03636906|517381096|FG001|Overall Study|Lost to Follow-up|0|||
143503613|NCT03636906|517381097|FG002|Overall Study|Lost to Follow-up|0|||
143503614|NCT03636906|517381095|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
143503615|NCT03636906|517381096|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
143503616|NCT03636906|517381097|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
143503617|NCT03636906|517381095|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
143170920|NCT00415636|516174799|FG003|Overall Study|Withdrawal by Subject|0|||
143170921|NCT00415636|516174800|FG004|Overall Study|Withdrawal by Subject|1|||
143170922|NCT00415636|516174801|FG005|Overall Study|Withdrawal by Subject|0|||
143503618|NCT03636906|517381096|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
143503619|NCT03636906|517381097|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
143503620|NCT03636906|517381095|FG000|Overall Study|Other|0|||
143503621|NCT03636906|517381096|FG001|Overall Study|Other|0|||
143503622|NCT03636906|517381097|FG002|Overall Study|Other|1|||
143503623|NCT00891202|517381098|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
143503624|NCT00891202|517381099|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
143503625|NCT00891202|517381100|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
143503626|NCT00891202|517381101|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
143503627|NCT00891202|517381098|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
143068715|NCT01359644|515793328|FG000|Follow-up Period|Lost to Follow-up|0|||
143068716|NCT01359644|515793329|FG001|Follow-up Period|Lost to Follow-up|0|||
143068717|NCT01359644|515793330|FG002|Follow-up Period|Lost to Follow-up|0|||
143068718|NCT01359644|515793331|FG003|Follow-up Period|Lost to Follow-up|0|||
143068719|NCT01359644|515793332|FG004|Follow-up Period|Lost to Follow-up|0|||
143068720|NCT01359644|515793333|FG005|Follow-up Period|Lost to Follow-up|0|||
143068721|NCT01359644|515793334|FG006|Follow-up Period|Lost to Follow-up|1|||
143247002|NCT02474069|516456694|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
143247003|NCT02474069|516456695|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
143247004|NCT02474069|516456693|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
143247005|NCT02474069|516456694|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
143247006|NCT02474069|516456695|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
143247007|NCT02474069|516456693|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
143247008|NCT02474069|516456694|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
143247009|NCT02474069|516456695|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
143247010|NCT01623050|516456696|FG000|Overall Study|Lost to Follow-up|9|||
143247011|NCT02147561|516456699|FG000|Overall Study|Lost to Follow-up|3|||
143247012|NCT02147561|516456699|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
143247013|NCT05300763|516456700|FG000|Overall Study|Adverse Event|0|||
143247014|NCT05300763|516456701|FG001|Overall Study|Adverse Event|1|||
143247015|NCT05300763|516456700|FG000|Overall Study|Major Protocol Deviation|1|||
143068722|NCT01359644|515793335|FG007|Follow-up Period|Lost to Follow-up|2|||
143068723|NCT01359644|515793336|FG008|Follow-up Period|Lost to Follow-up|0|||
143068724|NCT01359644|515793337|FG009|Follow-up Period|Lost to Follow-up|0|||
143068725|NCT01660334|515793339|FG000|Overall Study|Lost to Follow-up|1|||
143068726|NCT00311311|515793340|FG000|Overall Study|Adverse Event|3|||
143068727|NCT00311311|515793341|FG001|Overall Study|Adverse Event|2|||
143068728|NCT00311311|515793340|FG000|Overall Study|Withdrawal by Subject|1|||
143068729|NCT00311311|515793341|FG001|Overall Study|Withdrawal by Subject|1|||
143068730|NCT00311311|515793340|FG000|Overall Study|Noncompliance|0|||
143365321|NCT02939183|516880741|FG004|Overall Study|Sponsor decision|2|||
143503628|NCT00891202|517381099|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
143503629|NCT00891202|517381100|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
143068731|NCT00311311|515793341|FG001|Overall Study|Noncompliance|1|||
143068732|NCT00311311|515793340|FG000|Overall Study|Study Termination by Sponsor|3|||
143068733|NCT00311311|515793341|FG001|Overall Study|Study Termination by Sponsor|4|||
143068734|NCT00311311|515793340|FG000|Overall Study|Death|1|||
143068735|NCT00311311|515793341|FG001|Overall Study|Death|0|||
143068736|NCT00311311|515793340|FG000|Overall Study|Lack of ancillary assistance|0|||
143068737|NCT00311311|515793341|FG001|Overall Study|Lack of ancillary assistance|1|||
143068738|NCT03979820|515793342|FG000|Overall Study|Protocol Violation|1|||
143068739|NCT03979820|515793343|FG001|Overall Study|Protocol Violation|0|||
143068740|NCT03979820|515793344|FG002|Overall Study|Protocol Violation|0|||
143068741|NCT03979820|515793345|FG003|Overall Study|Protocol Violation|0|||
143068742|NCT03979820|515793342|FG000|Overall Study|Withdrawal by Subject|0|||
143068743|NCT03979820|515793343|FG001|Overall Study|Withdrawal by Subject|0|||
143068744|NCT03979820|515793344|FG002|Overall Study|Withdrawal by Subject|1|||
143068745|NCT03979820|515793345|FG003|Overall Study|Withdrawal by Subject|0|||
143068746|NCT03979820|515793342|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
143068747|NCT03979820|515793343|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
143068748|NCT03979820|515793344|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
143068749|NCT03979820|515793345|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
143068750|NCT01229735|515793346|FG000|Overall Study|Lack of Efficacy|8|||
143068751|NCT01229735|515793347|FG001|Overall Study|Lack of Efficacy|8|||
143068752|NCT01229735|515793346|FG000|Overall Study|Protocol Violation|13|||
143068753|NCT01229735|515793347|FG001|Overall Study|Protocol Violation|8|||
143068754|NCT01229735|515793346|FG000|Overall Study|Lost to Follow-up|0|||
143068755|NCT01229735|515793347|FG001|Overall Study|Lost to Follow-up|2|||
143503630|NCT00891202|517381101|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
143503631|NCT00891202|517381098|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
143503632|NCT00891202|517381099|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
143503633|NCT00891202|517381100|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
143503634|NCT00891202|517381101|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
143503635|NCT00891202|517381098|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
143503636|NCT00891202|517381099|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
143503637|NCT00891202|517381100|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
143503638|NCT00891202|517381101|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
143503639|NCT02031679|517382728|FG000|Overall Study|Protocol Violation|0|||
143503640|NCT02031679|517382729|FG001|Overall Study|Protocol Violation|1|||
143503641|NCT02031679|517382728|FG000|Overall Study|Lack of Efficacy|0|||
143503642|NCT02031679|517382729|FG001|Overall Study|Lack of Efficacy|1|||
143503643|NCT03263806|517382730|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
143503644|NCT03263806|517382731|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
143503645|NCT03263806|517382730|FG000|Overall Study|Withdrawal by Subject|0|||
143503646|NCT03263806|517382731|FG001|Overall Study|Withdrawal by Subject|1|||
143503647|NCT03263806|517382730|FG000|Overall Study|Study Termination|5|||
143503648|NCT03263806|517382731|FG001|Overall Study|Study Termination|6|||
143503649|NCT02338843|517382738|FG000|Overall Study|Adverse Event|2|||
143503650|NCT02338843|517382739|FG001|Overall Study|Adverse Event|1|||
143503651|NCT02338843|517382738|FG000|Overall Study|Death|40|||
143503652|NCT02338843|517382739|FG001|Overall Study|Death|53|||
143503653|NCT02338843|517382738|FG000|Overall Study|Physician Decision|1|||
143503654|NCT02338843|517382739|FG001|Overall Study|Physician Decision|0|||
143503655|NCT02338843|517382738|FG000|Overall Study|Withdrawal by Subject|0|||
143503656|NCT02338843|517382739|FG001|Overall Study|Withdrawal by Subject|2|||
143503657|NCT02338843|517382738|FG000|Overall Study|Subject Recovered|0|||
143068756|NCT01229735|515793346|FG000|Overall Study|Withdrawal by Subject|18|||
143170923|NCT00415636|516174796|FG000|Overall Study|Disease progression|0|||
143503658|NCT02338843|517382739|FG001|Overall Study|Subject Recovered|2|||
143503659|NCT02338843|517382738|FG000|Overall Study|Discontinued prior to randomizat|1|||
143503660|NCT02338843|517382739|FG001|Overall Study|Discontinued prior to randomizat|0|||
143503661|NCT01609933|517382744|FG000|Overall Study|Adverse Event|1|||
143068757|NCT01229735|515793347|FG001|Overall Study|Withdrawal by Subject|17|||
143503662|NCT01609933|517382744|FG000|Overall Study|Withdrawal by Subject|3|||
143503663|NCT01252966|517382745|FG000|Overall Study|Lost to Follow-up|16|||
143503664|NCT01252966|517382746|FG001|Overall Study|Lost to Follow-up|10|||
143503665|NCT01252966|517382745|FG000|Overall Study|Withdrawal by Subject|7|||
143503666|NCT01252966|517382746|FG001|Overall Study|Withdrawal by Subject|3|||
143503667|NCT05019131|517382751|FG000|Overall Study|Lost to Follow-up|0|||
143503668|NCT05019131|517382752|FG001|Overall Study|Lost to Follow-up|3|||
143503669|NCT00332709|517382753|FG000|Overall Study|Adverse Event|11|||
143503670|NCT00332709|517382754|FG001|Overall Study|Adverse Event|14|||
143503671|NCT00332709|517382753|FG000|Overall Study|Withdrawal by Subject|2|||
143503672|NCT00332709|517382754|FG001|Overall Study|Withdrawal by Subject|3|||
143503673|NCT00332709|517382753|FG000|Overall Study|Lost to Follow-up|2|||
143503674|NCT00332709|517382754|FG001|Overall Study|Lost to Follow-up|0|||
143503675|NCT00332709|517382753|FG000|Overall Study|Administrative Problems|0|||
143503676|NCT00332709|517382754|FG001|Overall Study|Administrative Problems|3|||
143503677|NCT00332709|517382753|FG000|Overall Study|Abnormal test procedure result|1|||
143503678|NCT00332709|517382754|FG001|Overall Study|Abnormal test procedure result|0|||
143503679|NCT03480802|517382755|FG000|Overall Study|Lost to Follow-up|5|||
143503680|NCT03480802|517382756|FG001|Overall Study|Lost to Follow-up|1|||
143503681|NCT03480802|517382755|FG000|Overall Study|Withdrawal by Subject|2|||
143503682|NCT03480802|517382756|FG001|Overall Study|Withdrawal by Subject|1|||
143503683|NCT03480802|517382755|FG000|Overall Study|Relocated|0|||
143503684|NCT03480802|517382756|FG001|Overall Study|Relocated|1|||
143503685|NCT02360098|517382761|FG000|Overall Study|Physician Decision|7|||
143503686|NCT03293654|517382767|FG000|Overall Study|Lost to Follow-up|0|||
143503687|NCT03293654|517382768|FG001|Overall Study|Lost to Follow-up|1|||
143503688|NCT03293654|517382769|FG002|Overall Study|Lost to Follow-up|0|||
143503689|NCT01919307|517382770|FG000|Overall Study|Withdrawal by Subject|9|||
143247016|NCT05300763|516456701|FG001|Overall Study|Major Protocol Deviation|0|||
143170924|NCT00415636|516174797|FG001|Overall Study|Disease progression|0|||
143170925|NCT00415636|516174798|FG002|Overall Study|Disease progression|0|||
143170926|NCT00415636|516174799|FG003|Overall Study|Disease progression|3|||
143170927|NCT00415636|516174800|FG004|Overall Study|Disease progression|0|||
143170928|NCT00415636|516174801|FG005|Overall Study|Disease progression|1|||
143170929|NCT02138825|516174802|FG000|Main Study Treatment|Adverse Event|11|||
143170930|NCT02138825|516174803|FG001|Main Study Treatment|Adverse Event|3|||
143170931|NCT02138825|516174802|FG000|Main Study Treatment|Death|1|||
143170932|NCT02138825|516174803|FG001|Main Study Treatment|Death|2|||
143170933|NCT02138825|516174802|FG000|Main Study Treatment|Protocol Violation|2|||
143170934|NCT02138825|516174803|FG001|Main Study Treatment|Protocol Violation|2|||
143170935|NCT02138825|516174802|FG000|Main Study Treatment|Sponsor decision|12|||
143170936|NCT02138825|516174803|FG001|Main Study Treatment|Sponsor decision|18|||
143170937|NCT02138825|516174802|FG000|Main Study Treatment|Study terminated by sponsor|10|||
143170938|NCT02138825|516174803|FG001|Main Study Treatment|Study terminated by sponsor|9|||
143170939|NCT02138825|516174802|FG000|Main Study Treatment|Withdrawal by Subject|3|||
143170940|NCT02138825|516174803|FG001|Main Study Treatment|Withdrawal by Subject|1|||
143170941|NCT02138825|516174802|FG000|Main Study Treatment|Medical decision|1|||
143170942|NCT02138825|516174803|FG001|Main Study Treatment|Medical decision|0|||
143170943|NCT02138825|516174802|FG000|Long-term Extension|Study termination by sponsor|32|||
143170944|NCT02138825|516174803|FG001|Long-term Extension|Study termination by sponsor|38|||
143247017|NCT05300763|516456700|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
143247018|NCT05300763|516456701|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
143170945|NCT02138825|516174802|FG000|Safety Follow-up|Adverse Event|4|||
143503690|NCT02796755|517382776|FG000|Overall Study|Adverse Event|2|||
143503691|NCT02796755|517382777|FG001|Overall Study|Adverse Event|0|||
143503692|NCT00501228|517382778|FG000|Overall Study|Withdrawal by Subject|1|||
143503693|NCT01262898|517382779|FG000|Overall Study|Protocol Violation|1|||
143503694|NCT01262898|517382780|FG001|Overall Study|Protocol Violation|1|||
143503695|NCT01262898|517382781|FG002|Overall Study|Protocol Violation|0|||
143068758|NCT01229735|515793346|FG000|Overall Study|Other Reason|13|||
143068759|NCT01229735|515793347|FG001|Overall Study|Other Reason|10|||
143068760|NCT01229735|515793346|FG000|Overall Study|SAE, non-fatal|0|||
143068761|NCT01229735|515793347|FG001|Overall Study|SAE, non-fatal|4|||
143068762|NCT01229735|515793346|FG000|Overall Study|AE, non-serious non-fatal|13|||
143068763|NCT01229735|515793347|FG001|Overall Study|AE, non-serious non-fatal|17|||
143068764|NCT01229735|515793346|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
143068765|NCT01229735|515793347|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
143068766|NCT02685202|515793348|FG000|Overall Study|Lost to Follow-up|9|||
143068767|NCT02130882|515793349|FG000|Overall Study|Withdrawal by Subject|0|||
143068768|NCT02130882|515793350|FG001|Overall Study|Withdrawal by Subject|1|||
143068769|NCT00741936|515793365|FG000|Overall Study|Lost to Follow-up|1|||
143068770|NCT00741936|515793366|FG001|Overall Study|Lost to Follow-up|1|||
143068771|NCT00741936|515793365|FG000|Overall Study|Adverse Event|3|||
143068772|NCT00741936|515793366|FG001|Overall Study|Adverse Event|4|||
143503696|NCT01262898|517382782|FG003|Overall Study|Protocol Violation|0|||
143503697|NCT01262898|517382779|FG000|Overall Study|Lost to Follow-up|1|||
143503698|NCT01262898|517382780|FG001|Overall Study|Lost to Follow-up|0|||
143503699|NCT01262898|517382781|FG002|Overall Study|Lost to Follow-up|0|||
143503700|NCT01262898|517382782|FG003|Overall Study|Lost to Follow-up|0|||
143503701|NCT01262898|517382779|FG000|Overall Study|Withdrawal by Subject|1|||
143503702|NCT01262898|517382780|FG001|Overall Study|Withdrawal by Subject|1|||
143503703|NCT01262898|517382781|FG002|Overall Study|Withdrawal by Subject|0|||
143503704|NCT01262898|517382782|FG003|Overall Study|Withdrawal by Subject|0|||
143503705|NCT01756274|517382785|FG000|Overall Study|Protocol Violation|2|||
143503706|NCT01756274|517382785|FG000|Overall Study|Laboratory error|1|||
143503707|NCT00885365|517382792|FG000|4 Weeks ON Treatment|Adverse Event|2|||
143503708|NCT00885365|517382793|FG001|4 Weeks ON Treatment|Adverse Event|4|||
143503709|NCT00885365|517382792|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
143503710|NCT00885365|517382793|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
143503711|NCT00885365|517382792|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
143503712|NCT00885365|517382793|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
143503713|NCT01824979|517382794|FG000|Overall Study|Withdrawal by Subject|5|||
143503714|NCT01824979|517382795|FG001|Overall Study|Withdrawal by Subject|0|||
143503715|NCT01824979|517382794|FG000|Overall Study|Physician Decision|2|||
143503716|NCT01824979|517382795|FG001|Overall Study|Physician Decision|0|||
143503717|NCT01824979|517382794|FG000|Overall Study|Protocol Violation|6|||
143503718|NCT01824979|517382795|FG001|Overall Study|Protocol Violation|13|||
143503719|NCT00473876|517382799|FG000|Overall Study|Lost to Follow-up|3|||
143503720|NCT00473876|517382800|FG001|Overall Study|Lost to Follow-up|1|||
143503721|NCT00755079|517382805|FG000|Overall Study|Lost to Follow-up|1|||
143503722|NCT00755079|517382806|FG001|Overall Study|Lost to Follow-up|3|||
143503723|NCT00755079|517382805|FG000|Overall Study|Adverse Event|0|||
143503724|NCT00755079|517382806|FG001|Overall Study|Adverse Event|1|||
143503725|NCT00755079|517382805|FG000|Overall Study|Withdrawal by Subject|0|||
143503726|NCT00755079|517382806|FG001|Overall Study|Withdrawal by Subject|2|||
143503727|NCT03751111|517382807|FG000|Overall Study|Lack of Efficacy|9|||
143503728|NCT03751111|517382808|FG001|Overall Study|Lack of Efficacy|30|||
143503729|NCT03751111|517382807|FG000|Overall Study|Adverse Event|3|||
143503730|NCT03751111|517382808|FG001|Overall Study|Adverse Event|2|||
143503731|NCT01360996|517382809|FG000|Overall Study|Withdrawal by Subject|4|||
143503732|NCT01360996|517382810|FG001|Overall Study|Withdrawal by Subject|3|||
143503733|NCT01360996|517382811|FG002|Overall Study|Withdrawal by Subject|2|||
143503734|NCT01360996|517382809|FG000|Overall Study|Noncompliant|2|||
143503735|NCT01360996|517382810|FG001|Overall Study|Noncompliant|0|||
143503736|NCT01360996|517382811|FG002|Overall Study|Noncompliant|0|||
143503737|NCT01454076|517382813|FG000|Overall Study|Other|2|||
143503738|NCT01454076|517382814|FG001|Overall Study|Other|0|||
143503739|NCT01454076|517382815|FG002|Overall Study|Other|0|||
143503740|NCT01454076|517382816|FG003|Overall Study|Other|1|||
143503741|NCT01454076|517382817|FG004|Overall Study|Other|2|||
143503742|NCT01454076|517382813|FG000|Overall Study|Withdrawal by Subject|3|||
143503743|NCT01454076|517382814|FG001|Overall Study|Withdrawal by Subject|4|||
143503744|NCT01454076|517382815|FG002|Overall Study|Withdrawal by Subject|2|||
143068773|NCT00741936|515793365|FG000|Overall Study|Pregnancy|0|||
143068774|NCT00741936|515793366|FG001|Overall Study|Pregnancy|1|||
143503745|NCT01454076|517382816|FG003|Overall Study|Withdrawal by Subject|1|||
143503746|NCT01454076|517382817|FG004|Overall Study|Withdrawal by Subject|2|||
143503747|NCT01454076|517382813|FG000|Overall Study|Adverse Event|8|||
143503748|NCT01454076|517382814|FG001|Overall Study|Adverse Event|2|||
143503749|NCT01454076|517382815|FG002|Overall Study|Adverse Event|7|||
143503750|NCT01454076|517382816|FG003|Overall Study|Adverse Event|0|||
143503751|NCT01454076|517382817|FG004|Overall Study|Adverse Event|2|||
143503752|NCT02965378|517382818|FG000|Overall Study|Progression|16|||
143503753|NCT02965378|517382819|FG001|Overall Study|Progression|4|||
143503754|NCT02965378|517382818|FG000|Overall Study|Adverse Event|5|||
143503755|NCT02965378|517382819|FG001|Overall Study|Adverse Event|2|||
143503756|NCT02965378|517382818|FG000|Overall Study|Death|2|||
143503757|NCT02965378|517382819|FG001|Overall Study|Death|0|||
143503758|NCT02965378|517382818|FG000|Overall Study|Refusal|2|||
143503759|NCT02965378|517382819|FG001|Overall Study|Refusal|1|||
143503760|NCT02965378|517382818|FG000|Overall Study|Not protocol specified|0|||
143503761|NCT02965378|517382819|FG001|Overall Study|Not protocol specified|2|||
143503762|NCT04964258|517382820|FG000|Overall Study|Lost to Follow-up|1|||
143503763|NCT04964258|517382821|FG001|Overall Study|Lost to Follow-up|0|||
143503764|NCT04964258|517382822|FG002|Overall Study|Lost to Follow-up|0|||
143503765|NCT04964258|517382823|FG003|Overall Study|Lost to Follow-up|0|||
143503766|NCT04964258|517382824|FG004|Overall Study|Lost to Follow-up|0|||
143503767|NCT04964258|517382825|FG005|Overall Study|Lost to Follow-up|1|||
143503768|NCT04964258|517382826|FG006|Overall Study|Lost to Follow-up|0|||
143503769|NCT04964258|517382827|FG007|Overall Study|Lost to Follow-up|0|||
143503770|NCT04964258|517382828|FG008|Overall Study|Lost to Follow-up|0|||
143503771|NCT04964258|517382829|FG009|Overall Study|Lost to Follow-up|0|||
143503772|NCT04964258|517382830|FG010|Overall Study|Lost to Follow-up|0|||
143503773|NCT01285349|517382832|FG000|Overall Study|Lost to Follow-up|27|||
143503774|NCT01285349|517382833|FG001|Overall Study|Lost to Follow-up|20|||
143503775|NCT01285349|517382834|FG002|Overall Study|Lost to Follow-up|27|||
143503776|NCT02909153|517382835|FG000|Overall Study|Withdrawal by Subject|0|||
143503777|NCT02909153|517382836|FG001|Overall Study|Withdrawal by Subject|1|||
143503778|NCT02909153|517382837|FG002|Overall Study|Withdrawal by Subject|0|||
143503779|NCT02909153|517382838|FG003|Overall Study|Withdrawal by Subject|0|||
143503780|NCT02909153|517382839|FG004|Overall Study|Withdrawal by Subject|0|||
143503781|NCT03040024|517382840|FG000|Overall Study|Adverse Event|0|||
143503782|NCT03040024|517382841|FG001|Overall Study|Adverse Event|1|||
143503783|NCT03040024|517382842|FG002|Overall Study|Adverse Event|0|||
143503784|NCT03040024|517382840|FG000|Overall Study|Death|0|||
143503785|NCT03040024|517382841|FG001|Overall Study|Death|1|||
143503786|NCT03040024|517382842|FG002|Overall Study|Death|0|||
143503787|NCT03040024|517382840|FG000|Overall Study|Physician Decision|0|||
143503788|NCT03040024|517382841|FG001|Overall Study|Physician Decision|0|||
143503789|NCT03040024|517382842|FG002|Overall Study|Physician Decision|1|||
143503790|NCT01818297|517382846|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
143503791|NCT01818297|517382847|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
143503792|NCT01818297|517382846|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
143503793|NCT01818297|517382847|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
143503794|NCT01818297|517382846|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
143503795|NCT01818297|517382847|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
143503796|NCT00631137|517382848|FG000|Overall Study|Withdrawal by Subject|1|||
143503797|NCT00631137|517382849|FG001|Overall Study|Withdrawal by Subject|0|||
143503798|NCT01795547|517382850|FG000|Overall Study|Adverse Event|16|||
143503799|NCT01795547|517382851|FG001|Overall Study|Adverse Event|27|||
143170946|NCT02138825|516174803|FG001|Safety Follow-up|Adverse Event|3|||
143503800|NCT01795547|517382850|FG000|Overall Study|Lack of Efficacy|8|||
143503801|NCT01795547|517382851|FG001|Overall Study|Lack of Efficacy|3|||
143503802|NCT01795547|517382850|FG000|Overall Study|Protocol Violation|6|||
143503803|NCT01795547|517382851|FG001|Overall Study|Protocol Violation|4|||
143503804|NCT01795547|517382850|FG000|Overall Study|Lost to Follow-up|2|||
143503805|NCT01795547|517382851|FG001|Overall Study|Lost to Follow-up|5|||
143503806|NCT01795547|517382850|FG000|Overall Study|Withdrawal of consent|7|||
143503807|NCT01795547|517382851|FG001|Overall Study|Withdrawal of consent|12|||
143503808|NCT01795547|517382850|FG000|Overall Study|Not Treated|4|||
143503809|NCT01795547|517382851|FG001|Overall Study|Not Treated|10|||
143503810|NCT01795547|517382850|FG000|Overall Study|Non-compliance with IMP|1|||
143503811|NCT01795547|517382851|FG001|Overall Study|Non-compliance with IMP|1|||
143503812|NCT01795547|517382850|FG000|Overall Study|Others|4|||
143170947|NCT02138825|516174802|FG000|Safety Follow-up|Death|11|||
143170948|NCT02138825|516174803|FG001|Safety Follow-up|Death|5|||
143503813|NCT01795547|517382851|FG001|Overall Study|Others|1|||
143503814|NCT01795547|517382850|FG000|Overall Study|Not stated|0|||
143503815|NCT01795547|517382851|FG001|Overall Study|Not stated|1|||
143503816|NCT01889602|517382852|FG000|First Intervention|Adverse Event|1|||
143503817|NCT01889602|517382853|FG001|First Intervention|Adverse Event|1|||
143503818|NCT01889602|517382854|FG002|First Intervention|Adverse Event|1|||
143503819|NCT01889602|517382852|FG000|First Intervention|Protocol Violation|0|||
143503820|NCT01889602|517382853|FG001|First Intervention|Protocol Violation|1|||
143503821|NCT01889602|517382854|FG002|First Intervention|Protocol Violation|1|||
143503822|NCT01889602|517382852|FG000|First Intervention|Study ending|0|||
143503823|NCT01889602|517382853|FG001|First Intervention|Study ending|1|||
143503824|NCT01889602|517382854|FG002|First Intervention|Study ending|0|||
143503825|NCT01889602|517382852|FG000|Second Intervention|Adverse Event|0|||
143503826|NCT01889602|517382853|FG001|Second Intervention|Adverse Event|0|||
143503827|NCT01889602|517382854|FG002|Second Intervention|Adverse Event|1|||
143503828|NCT01889602|517382852|FG000|Second Intervention|Study ending|1|||
143503829|NCT01889602|517382853|FG001|Second Intervention|Study ending|0|||
143503830|NCT01889602|517382854|FG002|Second Intervention|Study ending|0|||
143170949|NCT02138825|516174802|FG000|Safety Follow-up|Withdrawal by Subject|5|||
143170950|NCT02138825|516174803|FG001|Safety Follow-up|Withdrawal by Subject|3|||
143170951|NCT02138825|516174802|FG000|Safety Follow-up|clinic worsening|1|||
143170952|NCT02138825|516174803|FG001|Safety Follow-up|clinic worsening|0|||
143170953|NCT02138825|516174802|FG000|Safety Follow-up|withdrawal by PI|1|||
143170954|NCT02138825|516174803|FG001|Safety Follow-up|withdrawal by PI|0|||
143170955|NCT02138825|516174802|FG000|Safety Follow-up|logistical difficulties|0|||
143170956|NCT02138825|516174803|FG001|Safety Follow-up|logistical difficulties|1|||
143170957|NCT02138825|516174802|FG000|Safety Follow-up|progressive disease|0|||
143170958|NCT02138825|516174803|FG001|Safety Follow-up|progressive disease|2|||
143170959|NCT02138825|516174802|FG000|Safety Follow-up|too unwell to attend the visit|0|||
143170960|NCT02138825|516174803|FG001|Safety Follow-up|too unwell to attend the visit|1|||
143170961|NCT02138825|516174802|FG000|Safety Follow-up|treatment unblinded|0|||
143170962|NCT02138825|516174803|FG001|Safety Follow-up|treatment unblinded|1|||
143170963|NCT02138825|516174802|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
143170964|NCT02138825|516174803|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
143170965|NCT05201807|516174804|FG000|Overall Study|Adverse Event|1|||
143170966|NCT05201807|516174804|FG000|Overall Study|COVID-19 Related|1|||
143170967|NCT02367456|516174807|FG000|Overall Study|Death|8|||
143170968|NCT02367456|516174808|FG001|Overall Study|Death|24|||
143170969|NCT02367456|516174809|FG002|Overall Study|Death|17|||
143170970|NCT02367456|516174807|FG000|Overall Study|Lost to Follow-up|1|||
143170971|NCT02367456|516174808|FG001|Overall Study|Lost to Follow-up|3|||
143170972|NCT02367456|516174809|FG002|Overall Study|Lost to Follow-up|1|||
143170973|NCT02367456|516174807|FG000|Overall Study|Other reason|3|||
143170974|NCT02367456|516174808|FG001|Overall Study|Other reason|3|||
143170975|NCT02367456|516174809|FG002|Overall Study|Other reason|9|||
143170976|NCT02367456|516174807|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
143170977|NCT02367456|516174808|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
143170978|NCT02367456|516174809|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
143170979|NCT04573972|516174812|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
143170980|NCT04573972|516174813|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
143170981|NCT00976456|516174814|FG000|Overall Study|Adverse Event|17|||
143170982|NCT00976456|516174815|FG001|Overall Study|Adverse Event|22|||
143170983|NCT00976456|516174814|FG000|Overall Study|Death|7|||
143170984|NCT00976456|516174815|FG001|Overall Study|Death|9|||
143170985|NCT00976456|516174814|FG000|Overall Study|Lack of Efficacy|5|||
143170986|NCT00976456|516174815|FG001|Overall Study|Lack of Efficacy|2|||
143170987|NCT00976456|516174814|FG000|Overall Study|Withdrawal by Subject|3|||
143170988|NCT00976456|516174815|FG001|Overall Study|Withdrawal by Subject|1|||
143170989|NCT00976456|516174814|FG000|Overall Study|screening failure, unknown|11|||
143170990|NCT00976456|516174815|FG001|Overall Study|screening failure, unknown|4|||
143170991|NCT02037529|516174816|FG000|Overall Study|Withdrawal by Subject|1|||
143170992|NCT02037529|516174817|FG001|Overall Study|Withdrawal by Subject|3|||
143170993|NCT02037529|516174816|FG000|Overall Study|Adverse Event|0|||
143170994|NCT02037529|516174817|FG001|Overall Study|Adverse Event|1|||
143170995|NCT00833690|516174823|FG000|Overall Study|Withdrawal by Subject|1|||
143170996|NCT00833690|516174824|FG001|Overall Study|Withdrawal by Subject|0|||
143170997|NCT00833690|516174825|FG002|Overall Study|Withdrawal by Subject|0|||
143170998|NCT00833690|516174823|FG000|Overall Study|Discontinued study drug|3|||
143170999|NCT00833690|516174824|FG001|Overall Study|Discontinued study drug|2|||
143171000|NCT00833690|516174825|FG002|Overall Study|Discontinued study drug|0|||
143171001|NCT03097289|516174826|FG000|Overall Study|Adverse Event|1|||
143171002|NCT03097289|516174826|FG000|Overall Study|Equipment failure|2|||
143171003|NCT03097289|516174826|FG000|Overall Study|Collected platelet product unusable|3|||
143171004|NCT00397540|516174827|FG000|Overall Study|short follow-up duration < 12 months|1|||
143171005|NCT00397540|516174828|FG001|Overall Study|short follow-up duration < 12 months|0|||
143171006|NCT01656161|516174829|FG000|Overall Study|Death|3|||
143171007|NCT01656161|516174829|FG000|Overall Study|Adverse Event|2|||
143503831|NCT01889602|517382852|FG000|Second Intervention|Withdrawal by Subject|0|||
143503832|NCT01889602|517382853|FG001|Second Intervention|Withdrawal by Subject|0|||
143503833|NCT01889602|517382854|FG002|Second Intervention|Withdrawal by Subject|1|||
143503834|NCT01889602|517382852|FG000|Third Intervention|Protocol Violation|1|||
143503835|NCT01889602|517382853|FG001|Third Intervention|Protocol Violation|0|||
143503836|NCT01889602|517382854|FG002|Third Intervention|Protocol Violation|0|||
143247019|NCT00948441|516456702|FG000|Overall Study|no longer meet inclusion criteria|1|||
143247020|NCT00948441|516456703|FG001|Overall Study|no longer meet inclusion criteria|4|||
143247021|NCT02792829|516456704|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
143247022|NCT02792829|516456705|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
143247023|NCT02792829|516456706|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
143247024|NCT02792829|516456707|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
143247025|NCT02792829|516456708|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
143247026|NCT02792829|516456709|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
143247027|NCT02792829|516456710|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
143247028|NCT02792829|516456711|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
143247029|NCT02792829|516456704|FG000|Treatment Period 2|Adverse Event|0|||
143247030|NCT02792829|516456705|FG001|Treatment Period 2|Adverse Event|0|||
143247031|NCT02792829|516456706|FG002|Treatment Period 2|Adverse Event|0|||
143247032|NCT02792829|516456707|FG003|Treatment Period 2|Adverse Event|0|||
143247033|NCT02792829|516456708|FG004|Treatment Period 2|Adverse Event|1|||
143247034|NCT02792829|516456709|FG005|Treatment Period 2|Adverse Event|0|||
143247035|NCT02792829|516456710|FG006|Treatment Period 2|Adverse Event|1|||
143247036|NCT02792829|516456711|FG007|Treatment Period 2|Adverse Event|1|||
143247037|NCT02792829|516456704|FG000|Treatment Period 2|Use of proscribed medications|0|||
143247038|NCT02792829|516456705|FG001|Treatment Period 2|Use of proscribed medications|0|||
143247039|NCT02792829|516456706|FG002|Treatment Period 2|Use of proscribed medications|0|||
143247040|NCT02792829|516456707|FG003|Treatment Period 2|Use of proscribed medications|0|||
143247041|NCT02792829|516456708|FG004|Treatment Period 2|Use of proscribed medications|0|||
143247042|NCT02792829|516456709|FG005|Treatment Period 2|Use of proscribed medications|0|||
143247043|NCT02792829|516456710|FG006|Treatment Period 2|Use of proscribed medications|0|||
143247044|NCT02792829|516456711|FG007|Treatment Period 2|Use of proscribed medications|1|||
143247045|NCT01262820|516456712|FG000|Overall Study|Adverse Event|5|||
143247046|NCT01262820|516456712|FG000|Overall Study|Lack of Efficacy|9|||
143247047|NCT01262820|516456712|FG000|Overall Study|Drug held for 21+ days|1|||
143247048|NCT00104520|516456713|FG000|Overall Study|Unrelated adverse event|34|||
143247049|NCT00104520|516456714|FG001|Overall Study|Unrelated adverse event|47|||
143247050|NCT00104520|516456713|FG000|Overall Study|Study drug intolerance|0|||
143247051|NCT00104520|516456714|FG001|Overall Study|Study drug intolerance|1|||
143247052|NCT00104520|516456713|FG000|Overall Study|Related adverse event|13|||
143247053|NCT00104520|516456714|FG001|Overall Study|Related adverse event|15|||
143247054|NCT00104520|516456713|FG000|Overall Study|Lost to Follow-up|1|||
143247055|NCT00104520|516456714|FG001|Overall Study|Lost to Follow-up|0|||
143247056|NCT00104520|516456713|FG000|Overall Study|Noncompliance|0|||
143247057|NCT00104520|516456714|FG001|Overall Study|Noncompliance|2|||
143247058|NCT00104520|516456713|FG000|Overall Study|Personal/administrative|1|||
143247059|NCT00104520|516456714|FG001|Overall Study|Personal/administrative|1|||
143247060|NCT00104520|516456713|FG000|Overall Study|Other|1|||
143247061|NCT00104520|516456714|FG001|Overall Study|Other|5|||
143247062|NCT01026324|516456716|FG000|Follow up/Survival|Withdrawal by Subject|1|||
143247063|NCT01026324|516456717|FG001|Follow up/Survival|Withdrawal by Subject|0|||
143247064|NCT01026324|516456718|FG002|Follow up/Survival|Withdrawal by Subject|0|||
143247065|NCT02442804|516456720|FG000|Overall Study|Withdrawal by Subject|0|||
143247066|NCT02442804|516456721|FG001|Overall Study|Withdrawal by Subject|1|||
143247067|NCT02442804|516456720|FG000|Overall Study|Adverse Event|1|||
143247068|NCT02442804|516456721|FG001|Overall Study|Adverse Event|0|||
143247069|NCT01309282|516456725|FG000|Overall Study|Lost to Follow-up|1|||
143503837|NCT01889602|517382852|FG000|Third Intervention|Withdrawal by Subject|2|||
143503838|NCT01889602|517382853|FG001|Third Intervention|Withdrawal by Subject|2|||
143503839|NCT01889602|517382854|FG002|Third Intervention|Withdrawal by Subject|0|||
143247070|NCT02087423|516456726|FG000|Overall Study|Withdrawal by Subject|20|||
143247071|NCT02087423|516456727|FG001|Overall Study|Withdrawal by Subject|20|||
143247072|NCT02087423|516456728|FG002|Overall Study|Withdrawal by Subject|3|||
143247073|NCT02087423|516456726|FG000|Overall Study|Death|68|||
143247074|NCT02087423|516456727|FG001|Overall Study|Death|207|||
143247075|NCT02087423|516456728|FG002|Overall Study|Death|40|||
143365322|NCT02939183|516880742|FG005|Overall Study|Sponsor decision|0|||
143247076|NCT02087423|516456726|FG000|Overall Study|Lost to Follow-up|0|||
143247077|NCT02087423|516456727|FG001|Overall Study|Lost to Follow-up|2|||
143247078|NCT02087423|516456728|FG002|Overall Study|Lost to Follow-up|0|||
143247079|NCT02087423|516456726|FG000|Overall Study|Terminated from study at final DCO|23|||
143503840|NCT03437447|517382857|FG000|Treatment Period 1|Withdrawal by Subject|0|||
143503841|NCT03437447|517382858|FG001|Treatment Period 1|Withdrawal by Subject|0|||
143503842|NCT03437447|517382859|FG002|Treatment Period 1|Withdrawal by Subject|1|||
143247080|NCT02087423|516456727|FG001|Overall Study|Terminated from study at final DCO|36|||
143247081|NCT02087423|516456728|FG002|Overall Study|Terminated from study at final DCO|25|||
143247082|NCT01010867|516456729|FG000|Overall Study|< 50% adherence to probiotic|1|||
143247083|NCT02762370|516456732|FG000|Overall Study|Protocol Violation|1|||
143247084|NCT02762370|516456733|FG001|Overall Study|Protocol Violation|0|||
143247085|NCT02445794|516456735|FG000|Overall Study|Adverse Event|0|||
143247086|NCT02445794|516456736|FG001|Overall Study|Adverse Event|0|||
143247087|NCT02445794|516456737|FG002|Overall Study|Adverse Event|2|||
143247088|NCT02445794|516456738|FG003|Overall Study|Adverse Event|0|||
143247089|NCT01136785|516456739|FG000|Overall Study|Protocol Violation|2|||
143247090|NCT01136785|516456740|FG001|Overall Study|Protocol Violation|1|||
143247091|NCT00993148|516456746|FG000|Overall Study|Lost to Follow-up|2|||
143365323|NCT02939183|516880743|FG006|Overall Study|Sponsor decision|3|||
143365324|NCT02939183|516880744|FG007|Overall Study|Sponsor decision|1|||
143365325|NCT02939183|516880745|FG008|Overall Study|Sponsor decision|4|||
143365326|NCT02939183|516880737|FG000|Overall Study|Withdrawal by Subject|0|||
143365327|NCT02939183|516880738|FG001|Overall Study|Withdrawal by Subject|2|||
143365328|NCT02939183|516880739|FG002|Overall Study|Withdrawal by Subject|0|||
143365329|NCT02939183|516880740|FG003|Overall Study|Withdrawal by Subject|1|||
143365330|NCT02939183|516880741|FG004|Overall Study|Withdrawal by Subject|0|||
143365331|NCT02939183|516880742|FG005|Overall Study|Withdrawal by Subject|0|||
143365332|NCT02939183|516880743|FG006|Overall Study|Withdrawal by Subject|2|||
143365333|NCT02939183|516880744|FG007|Overall Study|Withdrawal by Subject|2|||
143365334|NCT02939183|516880745|FG008|Overall Study|Withdrawal by Subject|2|||
143365335|NCT02939183|516880737|FG000|Overall Study|Not treated due to adverse event|0|||
143365336|NCT02939183|516880738|FG001|Overall Study|Not treated due to adverse event|0|||
143365337|NCT02939183|516880739|FG002|Overall Study|Not treated due to adverse event|0|||
143365338|NCT02939183|516880740|FG003|Overall Study|Not treated due to adverse event|1|||
143503843|NCT02040142|517382860|FG000|Overall Study|Lost to Follow-up|5|||
143503844|NCT02040142|517382860|FG000|Overall Study|Death|17|||
143503845|NCT02040142|517382860|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
143503846|NCT02875223|517382865|FG000|Overall Study|Other reasons|0|||
143503847|NCT02875223|517382866|FG001|Overall Study|Other reasons|0|||
143503848|NCT02875223|517382867|FG002|Overall Study|Other reasons|1|||
143503849|NCT02875223|517382868|FG003|Overall Study|Other reasons|0|||
143503850|NCT02875223|517382869|FG004|Overall Study|Other reasons|1|||
143503851|NCT02875223|517382870|FG005|Overall Study|Other reasons|2|||
143503852|NCT02875223|517382871|FG006|Overall Study|Other reasons|0|||
143503853|NCT02875223|517382872|FG007|Overall Study|Other reasons|2|||
143503854|NCT02875223|517382873|FG008|Overall Study|Other reasons|0|||
143503855|NCT02875223|517382874|FG009|Overall Study|Other reasons|0|||
143503856|NCT02875223|517382875|FG010|Overall Study|Other reasons|0|||
143503857|NCT02875223|517382876|FG011|Overall Study|Other reasons|0|||
143503858|NCT02875223|517382877|FG012|Overall Study|Other reasons|0|||
143503859|NCT02875223|517382865|FG000|Overall Study|Withdrawal by Subject|0|||
143503860|NCT02875223|517382866|FG001|Overall Study|Withdrawal by Subject|0|||
143503861|NCT02875223|517382867|FG002|Overall Study|Withdrawal by Subject|0|||
143503862|NCT02875223|517382868|FG003|Overall Study|Withdrawal by Subject|0|||
143503863|NCT02875223|517382869|FG004|Overall Study|Withdrawal by Subject|1|||
143503864|NCT02875223|517382870|FG005|Overall Study|Withdrawal by Subject|1|||
143503865|NCT02875223|517382871|FG006|Overall Study|Withdrawal by Subject|0|||
143503866|NCT02875223|517382872|FG007|Overall Study|Withdrawal by Subject|0|||
143503867|NCT02875223|517382873|FG008|Overall Study|Withdrawal by Subject|1|||
143503868|NCT02875223|517382874|FG009|Overall Study|Withdrawal by Subject|0|||
143503869|NCT02875223|517382875|FG010|Overall Study|Withdrawal by Subject|0|||
143503870|NCT02875223|517382876|FG011|Overall Study|Withdrawal by Subject|0|||
143503871|NCT02875223|517382877|FG012|Overall Study|Withdrawal by Subject|0|||
143503872|NCT02875223|517382865|FG000|Overall Study|Progressive disease|0|||
143503873|NCT02875223|517382866|FG001|Overall Study|Progressive disease|0|||
143503874|NCT02875223|517382867|FG002|Overall Study|Progressive disease|1|||
143503875|NCT02875223|517382868|FG003|Overall Study|Progressive disease|0|||
143503876|NCT02875223|517382869|FG004|Overall Study|Progressive disease|0|||
143503877|NCT02875223|517382870|FG005|Overall Study|Progressive disease|0|||
143503878|NCT02875223|517382871|FG006|Overall Study|Progressive disease|0|||
143503879|NCT02875223|517382872|FG007|Overall Study|Progressive disease|0|||
143503880|NCT02875223|517382873|FG008|Overall Study|Progressive disease|0|||
143503881|NCT02875223|517382874|FG009|Overall Study|Progressive disease|12|||
143503882|NCT02875223|517382875|FG010|Overall Study|Progressive disease|2|||
143503883|NCT02875223|517382876|FG011|Overall Study|Progressive disease|3|||
143503884|NCT02875223|517382877|FG012|Overall Study|Progressive disease|6|||
143503885|NCT02875223|517382865|FG000|Overall Study|Death|4|||
143503886|NCT02875223|517382866|FG001|Overall Study|Death|4|||
143503887|NCT02875223|517382867|FG002|Overall Study|Death|3|||
143503888|NCT02875223|517382868|FG003|Overall Study|Death|4|||
143365339|NCT02939183|516880741|FG004|Overall Study|Not treated due to adverse event|0|||
143365340|NCT02939183|516880742|FG005|Overall Study|Not treated due to adverse event|0|||
143503889|NCT02875223|517382869|FG004|Overall Study|Death|2|||
143503890|NCT02875223|517382870|FG005|Overall Study|Death|3|||
143365341|NCT02939183|516880743|FG006|Overall Study|Not treated due to adverse event|1|||
143503891|NCT02875223|517382871|FG006|Overall Study|Death|5|||
143503892|NCT02875223|517382872|FG007|Overall Study|Death|7|||
143503893|NCT02875223|517382873|FG008|Overall Study|Death|3|||
143503894|NCT02875223|517382874|FG009|Overall Study|Death|2|||
143503895|NCT02875223|517382875|FG010|Overall Study|Death|0|||
143503896|NCT02875223|517382876|FG011|Overall Study|Death|0|||
143503897|NCT02875223|517382877|FG012|Overall Study|Death|0|||
143503898|NCT02875223|517382865|FG000|Overall Study|Lost to Follow-up|0|||
143503899|NCT02875223|517382866|FG001|Overall Study|Lost to Follow-up|1|||
143503900|NCT02875223|517382867|FG002|Overall Study|Lost to Follow-up|1|||
143503901|NCT02875223|517382868|FG003|Overall Study|Lost to Follow-up|0|||
143503902|NCT02875223|517382869|FG004|Overall Study|Lost to Follow-up|1|||
143171008|NCT01656161|516174829|FG000|Overall Study|Protocol Violation|1|||
143171009|NCT01656161|516174829|FG000|Overall Study|Withdrawal by Subject|1|||
143171010|NCT01215851|516174832|FG000|Treatment Period|Adverse Event|1|||
143171011|NCT01215851|516174833|FG001|Treatment Period|Adverse Event|1|||
143171012|NCT01215851|516174834|FG002|Treatment Period|Adverse Event|1|||
143171013|NCT01215851|516174835|FG003|Treatment Period|Adverse Event|3|||
143171014|NCT01215851|516174836|FG004|Treatment Period|Adverse Event|0|||
143171015|NCT01215851|516174837|FG005|Treatment Period|Adverse Event|1|||
143171016|NCT01215851|516174832|FG000|Follow up Period|Lost to Follow-up|0|||
143171017|NCT01215851|516174833|FG001|Follow up Period|Lost to Follow-up|0|||
143171018|NCT01215851|516174834|FG002|Follow up Period|Lost to Follow-up|0|||
143171019|NCT01215851|516174835|FG003|Follow up Period|Lost to Follow-up|0|||
143171020|NCT01215851|516174836|FG004|Follow up Period|Lost to Follow-up|0|||
143171021|NCT01215851|516174837|FG005|Follow up Period|Lost to Follow-up|1|||
143171022|NCT02589938|516174838|FG000|Overall Study|Withdrawal by Subject|11|||
143171023|NCT02589938|516174839|FG001|Overall Study|Withdrawal by Subject|5|||
143171024|NCT02589938|516174840|FG002|Overall Study|Withdrawal by Subject|6|||
143171025|NCT02589938|516174838|FG000|Overall Study|Lost to Follow-up|3|||
143171026|NCT02589938|516174839|FG001|Overall Study|Lost to Follow-up|3|||
143171027|NCT02589938|516174840|FG002|Overall Study|Lost to Follow-up|3|||
143171028|NCT02589938|516174838|FG000|Overall Study|Death|1|||
143171029|NCT02589938|516174839|FG001|Overall Study|Death|0|||
143503903|NCT02875223|517382870|FG005|Overall Study|Lost to Follow-up|0|||
143247092|NCT00993148|516456746|FG000|Overall Study|never initiated treatment|1|||
143247093|NCT00233064|516456747|FG000|Overall Study|Lost to Follow-up|7|||
143247094|NCT00233064|516456748|FG001|Overall Study|Lost to Follow-up|7|||
143247095|NCT00233064|516456747|FG000|Overall Study|Withdrawal by Subject|5|||
143247096|NCT00233064|516456748|FG001|Overall Study|Withdrawal by Subject|3|||
143247097|NCT00233064|516456747|FG000|Overall Study|Death|0|||
143247098|NCT00233064|516456748|FG001|Overall Study|Death|1|||
143247099|NCT00233064|516456747|FG000|Overall Study|Relocation|0|||
143247100|NCT00233064|516456748|FG001|Overall Study|Relocation|1|||
143247101|NCT00233064|516456747|FG000|Overall Study|Protocol Violation|1|||
143247102|NCT00233064|516456748|FG001|Overall Study|Protocol Violation|0|||
143247103|NCT00233064|516456747|FG000|Overall Study|Moved to Dom. Republic|1|||
143247104|NCT00233064|516456748|FG001|Overall Study|Moved to Dom. Republic|0|||
143247105|NCT04393454|516456751|FG000|Overall Study|Death|1|||
143247106|NCT04393454|516456751|FG000|Overall Study|Lost to Follow-up|1|||
143247107|NCT01120964|516456752|FG000|Overall Study|Did not receive full treatment|1|||
143247108|NCT01120964|516456753|FG001|Overall Study|Did not receive full treatment|0|||
143247109|NCT03304249|516456757|FG000|Overall Study|Lost to Follow-up|8|||
143247110|NCT03304249|516456758|FG001|Overall Study|Lost to Follow-up|10|||
143247111|NCT03304249|516456757|FG000|Overall Study|Withdrawal by Subject|12|||
143247112|NCT03304249|516456758|FG001|Overall Study|Withdrawal by Subject|2|||
143247113|NCT03304249|516456757|FG000|Overall Study|Moved Out of District|4|||
143247114|NCT03304249|516456758|FG001|Overall Study|Moved Out of District|2|||
143247115|NCT04976192|516456759|FG000|Main Treatment Period (12 Weeks)|Adverse Event|0|||
143247116|NCT04976192|516456760|FG001|Main Treatment Period (12 Weeks)|Adverse Event|1|||
143247117|NCT04976192|516456761|FG002|Main Treatment Period (12 Weeks)|Adverse Event|0|||
143247118|NCT04976192|516456762|FG003|Main Treatment Period (12 Weeks)|Adverse Event|0|||
143247119|NCT04976192|516456763|FG004|Main Treatment Period (12 Weeks)|Adverse Event|0|||
143247120|NCT04976192|516456764|FG005|Main Treatment Period (12 Weeks)|Adverse Event|0|||
143247121|NCT04976192|516456765|FG006|Main Treatment Period (12 Weeks)|Adverse Event|0|||
143247122|NCT04976192|516456766|FG007|Main Treatment Period (12 Weeks)|Adverse Event|0|||
143247123|NCT04976192|516456767|FG008|Main Treatment Period (12 Weeks)|Adverse Event|0|||
143247124|NCT04976192|516456768|FG009|Main Treatment Period (12 Weeks)|Adverse Event|0|||
143247125|NCT04976192|516456759|FG000|Main Treatment Period (12 Weeks)|Withdrawal by Subject|12|||
143247126|NCT04976192|516456760|FG001|Main Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
143247127|NCT04976192|516456761|FG002|Main Treatment Period (12 Weeks)|Withdrawal by Subject|8|||
143247128|NCT04976192|516456762|FG003|Main Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
143247129|NCT04976192|516456763|FG004|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
143247130|NCT04976192|516456764|FG005|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
143247131|NCT04976192|516456765|FG006|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
143247132|NCT04976192|516456766|FG007|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
143247133|NCT04976192|516456767|FG008|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
143247134|NCT04976192|516456768|FG009|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
143247135|NCT04976192|516456759|FG000|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
143247136|NCT04976192|516456760|FG001|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
143247137|NCT04976192|516456761|FG002|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
143247138|NCT04976192|516456762|FG003|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
143247139|NCT04976192|516456763|FG004|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
143247140|NCT04976192|516456764|FG005|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
143247141|NCT04976192|516456765|FG006|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
143247142|NCT04976192|516456766|FG007|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
143247143|NCT04976192|516456767|FG008|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
143247144|NCT04976192|516456768|FG009|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
143247145|NCT04976192|516456759|FG000|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
143247146|NCT04976192|516456760|FG001|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
143247147|NCT04976192|516456761|FG002|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
143247148|NCT04976192|516456762|FG003|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
143247149|NCT04976192|516456763|FG004|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
143247150|NCT04976192|516456764|FG005|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
143247151|NCT04976192|516456765|FG006|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
143247152|NCT04976192|516456766|FG007|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
143247153|NCT04976192|516456767|FG008|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
143247154|NCT04976192|516456768|FG009|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
143503904|NCT02875223|517382871|FG006|Overall Study|Lost to Follow-up|1|||
143503905|NCT02875223|517382872|FG007|Overall Study|Lost to Follow-up|1|||
143503906|NCT02875223|517382873|FG008|Overall Study|Lost to Follow-up|0|||
143503907|NCT02875223|517382874|FG009|Overall Study|Lost to Follow-up|0|||
143503908|NCT02875223|517382875|FG010|Overall Study|Lost to Follow-up|0|||
143503909|NCT02875223|517382876|FG011|Overall Study|Lost to Follow-up|0|||
143503910|NCT02875223|517382877|FG012|Overall Study|Lost to Follow-up|0|||
143068775|NCT00741936|515793365|FG000|Overall Study|Protocol Violation|2|||
143503911|NCT03538743|517382880|FG000|Overall Study|Adverse Event|0|||
143503912|NCT03538743|517382881|FG001|Overall Study|Adverse Event|0|||
143503913|NCT03538743|517382882|FG002|Overall Study|Adverse Event|1|||
143503914|NCT03538743|517382883|FG003|Overall Study|Adverse Event|1|||
143503915|NCT03538743|517382884|FG004|Overall Study|Adverse Event|0|||
143503916|NCT03538743|517382885|FG005|Overall Study|Adverse Event|0|||
143503917|NCT03538743|517382886|FG006|Overall Study|Adverse Event|0|||
143503918|NCT03538743|517382887|FG007|Overall Study|Adverse Event|0|||
143503919|NCT03538743|517382888|FG008|Overall Study|Adverse Event|0|||
143503920|NCT03538743|517382880|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
143503921|NCT03538743|517382881|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
143503922|NCT03538743|517382882|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
143503923|NCT03538743|517382883|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
143503924|NCT03538743|517382884|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
143503925|NCT03538743|517382885|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
143503926|NCT03538743|517382886|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
143503927|NCT03538743|517382887|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
143503928|NCT03538743|517382888|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
143503929|NCT03538743|517382880|FG000|Overall Study|Withdrawal by Subject|0|||
143503930|NCT03538743|517382881|FG001|Overall Study|Withdrawal by Subject|0|||
143503931|NCT03538743|517382882|FG002|Overall Study|Withdrawal by Subject|0|||
143503932|NCT03538743|517382883|FG003|Overall Study|Withdrawal by Subject|1|||
143503933|NCT03538743|517382884|FG004|Overall Study|Withdrawal by Subject|0|||
143503934|NCT03538743|517382885|FG005|Overall Study|Withdrawal by Subject|0|||
143503935|NCT03538743|517382886|FG006|Overall Study|Withdrawal by Subject|0|||
143503936|NCT03538743|517382887|FG007|Overall Study|Withdrawal by Subject|0|||
143503937|NCT03538743|517382888|FG008|Overall Study|Withdrawal by Subject|0|||
143171030|NCT02589938|516174840|FG002|Overall Study|Death|1|||
143171031|NCT02589938|516174838|FG000|Overall Study|Protocol Violation|6|||
143171032|NCT02589938|516174839|FG001|Overall Study|Protocol Violation|2|||
143171033|NCT02589938|516174840|FG002|Overall Study|Protocol Violation|3|||
143171034|NCT02589938|516174838|FG000|Overall Study|Physician Decision|1|||
143171035|NCT02589938|516174839|FG001|Overall Study|Physician Decision|0|||
143171036|NCT02589938|516174840|FG002|Overall Study|Physician Decision|0|||
143171037|NCT02589938|516174838|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
143171038|NCT02589938|516174839|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
143171039|NCT02589938|516174840|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
143171040|NCT01276106|516174841|FG000|Overall Study|Adverse Event|3|||
143171041|NCT01276106|516174842|FG001|Overall Study|Adverse Event|3|||
143171042|NCT01276106|516174843|FG002|Overall Study|Adverse Event|11|||
143171043|NCT01276106|516174844|FG003|Overall Study|Adverse Event|3|||
143171044|NCT01276106|516174841|FG000|Overall Study|Withdrawal by Subject|6|||
143171045|NCT01276106|516174842|FG001|Overall Study|Withdrawal by Subject|3|||
143171046|NCT01276106|516174843|FG002|Overall Study|Withdrawal by Subject|1|||
143171047|NCT01276106|516174844|FG003|Overall Study|Withdrawal by Subject|6|||
143171048|NCT01276106|516174841|FG000|Overall Study|Lack of Efficacy|0|||
143171049|NCT01276106|516174842|FG001|Overall Study|Lack of Efficacy|1|||
143171050|NCT01276106|516174843|FG002|Overall Study|Lack of Efficacy|0|||
143171051|NCT01276106|516174844|FG003|Overall Study|Lack of Efficacy|1|||
143171052|NCT01276106|516174841|FG000|Overall Study|Lost to Follow-up|2|||
143171053|NCT01276106|516174842|FG001|Overall Study|Lost to Follow-up|1|||
143503938|NCT01926626|517382891|FG000|Overall Study|Withdrawal by Subject|15|||
143503939|NCT01926626|517382891|FG000|Overall Study|Lost to Follow-up|7|||
143503940|NCT03690869|517382892|FG000|Overall Study|Adverse Event|0|||
143503941|NCT03690869|517382893|FG001|Overall Study|Adverse Event|0|||
143503942|NCT03690869|517382894|FG002|Overall Study|Adverse Event|0|||
143171054|NCT01276106|516174843|FG002|Overall Study|Lost to Follow-up|1|||
143171055|NCT01276106|516174844|FG003|Overall Study|Lost to Follow-up|0|||
143171056|NCT01276106|516174841|FG000|Overall Study|Physician Decision|0|||
143171057|NCT01276106|516174842|FG001|Overall Study|Physician Decision|0|||
143171058|NCT01276106|516174843|FG002|Overall Study|Physician Decision|1|||
143503943|NCT03690869|517382895|FG003|Overall Study|Adverse Event|1|||
143503944|NCT03690869|517382896|FG004|Overall Study|Adverse Event|0|||
143503945|NCT03690869|517382897|FG005|Overall Study|Adverse Event|0|||
143503946|NCT03690869|517382898|FG006|Overall Study|Adverse Event|0|||
143503947|NCT03690869|517382899|FG007|Overall Study|Adverse Event|1|||
143171059|NCT01276106|516174844|FG003|Overall Study|Physician Decision|1|||
143171060|NCT01276106|516174841|FG000|Overall Study|Protocol Violation|1|||
143171061|NCT01276106|516174842|FG001|Overall Study|Protocol Violation|1|||
143171062|NCT01276106|516174843|FG002|Overall Study|Protocol Violation|0|||
143171063|NCT01276106|516174844|FG003|Overall Study|Protocol Violation|2|||
143503948|NCT03690869|517382900|FG008|Overall Study|Adverse Event|0|||
143503949|NCT03690869|517382901|FG009|Overall Study|Adverse Event|1|||
143503950|NCT03690869|517382892|FG000|Overall Study|Death|1|||
143503951|NCT03690869|517382893|FG001|Overall Study|Death|1|||
143503952|NCT03690869|517382894|FG002|Overall Study|Death|1|||
143503953|NCT03690869|517382895|FG003|Overall Study|Death|4|||
143503954|NCT03690869|517382896|FG004|Overall Study|Death|2|||
143503955|NCT03690869|517382897|FG005|Overall Study|Death|5|||
143503956|NCT03690869|517382898|FG006|Overall Study|Death|3|||
143503957|NCT03690869|517382899|FG007|Overall Study|Death|2|||
143503958|NCT03690869|517382900|FG008|Overall Study|Death|0|||
143503959|NCT03690869|517382901|FG009|Overall Study|Death|3|||
143503960|NCT03690869|517382892|FG000|Overall Study|Lost to Follow-up|0|||
143503961|NCT03690869|517382893|FG001|Overall Study|Lost to Follow-up|0|||
143503962|NCT03690869|517382894|FG002|Overall Study|Lost to Follow-up|1|||
143503963|NCT03690869|517382895|FG003|Overall Study|Lost to Follow-up|0|||
143503964|NCT03690869|517382896|FG004|Overall Study|Lost to Follow-up|0|||
143503965|NCT03690869|517382897|FG005|Overall Study|Lost to Follow-up|0|||
143503966|NCT03690869|517382898|FG006|Overall Study|Lost to Follow-up|0|||
143503967|NCT03690869|517382899|FG007|Overall Study|Lost to Follow-up|0|||
143503968|NCT03690869|517382900|FG008|Overall Study|Lost to Follow-up|0|||
143503969|NCT03690869|517382901|FG009|Overall Study|Lost to Follow-up|0|||
143503970|NCT03690869|517382892|FG000|Overall Study|Other Treatment|1|||
143503971|NCT03690869|517382893|FG001|Overall Study|Other Treatment|1|||
143503972|NCT03690869|517382894|FG002|Overall Study|Other Treatment|1|||
143503973|NCT03690869|517382895|FG003|Overall Study|Other Treatment|2|||
143503974|NCT03690869|517382896|FG004|Overall Study|Other Treatment|3|||
143503975|NCT03690869|517382897|FG005|Overall Study|Other Treatment|1|||
143503976|NCT03690869|517382898|FG006|Overall Study|Other Treatment|2|||
143503977|NCT03690869|517382899|FG007|Overall Study|Other Treatment|7|||
143503978|NCT03690869|517382900|FG008|Overall Study|Other Treatment|0|||
143503979|NCT03690869|517382901|FG009|Overall Study|Other Treatment|3|||
143503980|NCT03690869|517382892|FG000|Overall Study|Physician Decision|0|||
143503981|NCT03690869|517382893|FG001|Overall Study|Physician Decision|1|||
143503982|NCT03690869|517382894|FG002|Overall Study|Physician Decision|0|||
143503983|NCT03690869|517382895|FG003|Overall Study|Physician Decision|0|||
143503984|NCT03690869|517382896|FG004|Overall Study|Physician Decision|0|||
143503985|NCT03690869|517382897|FG005|Overall Study|Physician Decision|0|||
143503986|NCT03690869|517382898|FG006|Overall Study|Physician Decision|0|||
143503987|NCT03690869|517382899|FG007|Overall Study|Physician Decision|0|||
143503988|NCT03690869|517382900|FG008|Overall Study|Physician Decision|0|||
143503989|NCT03690869|517382901|FG009|Overall Study|Physician Decision|0|||
143503990|NCT03690869|517382892|FG000|Overall Study|Progressive Disease|1|||
143503991|NCT03690869|517382893|FG001|Overall Study|Progressive Disease|2|||
143503992|NCT03690869|517382894|FG002|Overall Study|Progressive Disease|0|||
143503993|NCT03690869|517382895|FG003|Overall Study|Progressive Disease|1|||
143503994|NCT03690869|517382896|FG004|Overall Study|Progressive Disease|0|||
143503995|NCT03690869|517382897|FG005|Overall Study|Progressive Disease|0|||
143503996|NCT03690869|517382898|FG006|Overall Study|Progressive Disease|0|||
143503997|NCT03690869|517382899|FG007|Overall Study|Progressive Disease|0|||
143503998|NCT03690869|517382900|FG008|Overall Study|Progressive Disease|1|||
143503999|NCT03690869|517382901|FG009|Overall Study|Progressive Disease|1|||
143504000|NCT03690869|517382892|FG000|Overall Study|Subject Decision|0|||
143504001|NCT03690869|517382893|FG001|Overall Study|Subject Decision|0|||
143504002|NCT03690869|517382894|FG002|Overall Study|Subject Decision|0|||
143504003|NCT03690869|517382895|FG003|Overall Study|Subject Decision|1|||
143504004|NCT03690869|517382896|FG004|Overall Study|Subject Decision|0|||
143504005|NCT03690869|517382897|FG005|Overall Study|Subject Decision|0|||
143504006|NCT03690869|517382898|FG006|Overall Study|Subject Decision|0|||
143504007|NCT03690869|517382899|FG007|Overall Study|Subject Decision|1|||
143504008|NCT03690869|517382900|FG008|Overall Study|Subject Decision|0|||
143504009|NCT03690869|517382901|FG009|Overall Study|Subject Decision|0|||
143504010|NCT04167345|517382902|FG000|Overall Study|Other|1|||
143504011|NCT04167345|517382903|FG001|Overall Study|Other|1|||
143171064|NCT01276106|516174841|FG000|Overall Study|Insufficient therapeutic effects|0|||
143504012|NCT04167345|517382904|FG002|Overall Study|Other|0|||
143504013|NCT04167345|517382905|FG003|Overall Study|Other|0|||
143504014|NCT04167345|517382906|FG004|Overall Study|Other|0|||
143504015|NCT03978117|517384223|FG000|Overall Study|self- withdrawal or PI withdrawal|26|||
143504016|NCT03978117|517384224|FG001|Overall Study|self- withdrawal or PI withdrawal|26|||
143504017|NCT03978117|517384223|FG000|Overall Study|Lost to Follow-up|4|||
143504018|NCT03978117|517384224|FG001|Overall Study|Lost to Follow-up|4|||
143504019|NCT06001307|517384225|FG000|Overall Study|Lost to Follow-up|1|||
143504020|NCT06001307|517384226|FG001|Overall Study|Lost to Follow-up|2|||
143504021|NCT03532100|517384227|FG000|Overall Study|Intervention malfunction|1|||
143504022|NCT04063384|517384229|FG000|Overall Study|placebo manipulation issue|1|||
143365342|NCT02939183|516880744|FG007|Overall Study|Not treated due to adverse event|0|||
143365343|NCT02939183|516880745|FG008|Overall Study|Not treated due to adverse event|0|||
143365344|NCT05015478|516880746|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
143504023|NCT04063384|517384230|FG001|Overall Study|placebo manipulation issue|2|||
143068776|NCT00741936|515793366|FG001|Overall Study|Protocol Violation|0|||
143504024|NCT04063384|517384231|FG002|Overall Study|placebo manipulation issue|1|||
143068777|NCT00741936|515793365|FG000|Overall Study|Lack of Efficacy|0|||
143068778|NCT00741936|515793366|FG001|Overall Study|Lack of Efficacy|2|||
143068779|NCT00741936|515793365|FG000|Overall Study|Low compliance|3|||
143068780|NCT00741936|515793366|FG001|Overall Study|Low compliance|0|||
143068781|NCT00369382|515793367|FG000|Overall Study|Death|0|||
143068782|NCT00369382|515793368|FG001|Overall Study|Death|2|||
143068783|NCT00369382|515793367|FG000|Overall Study|Physician Decision|2|||
143068784|NCT00369382|515793368|FG001|Overall Study|Physician Decision|1|||
143068785|NCT00369382|515793367|FG000|Overall Study|Withdrawal by Subject|5|||
143068786|NCT00369382|515793368|FG001|Overall Study|Withdrawal by Subject|0|||
143068787|NCT00369382|515793367|FG000|Overall Study|Randomized, not treated|2|||
143068788|NCT00369382|515793368|FG001|Overall Study|Randomized, not treated|0|||
143068789|NCT00369382|515793367|FG000|Overall Study|Other|1|||
143068790|NCT00369382|515793368|FG001|Overall Study|Other|0|||
143068791|NCT03176459|515793370|FG000|Overall Study|Lost to Follow-up|5|||
143068792|NCT03176459|515793371|FG001|Overall Study|Lost to Follow-up|7|||
143068793|NCT00321737|515793372|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
143068794|NCT00321737|515793373|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
143068795|NCT00321737|515793374|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
143068796|NCT00321737|515793372|FG000|Overall Study|Adverse Event|11|||
143068797|NCT00321737|515793373|FG001|Overall Study|Adverse Event|3|||
143068798|NCT00321737|515793374|FG002|Overall Study|Adverse Event|6|||
143504025|NCT04063384|517384232|FG003|Overall Study|placebo manipulation issue|1|||
143504026|NCT02316548|517384233|FG000|Overall Study|Protocol Violation|0|||
143504027|NCT02316548|517384234|FG001|Overall Study|Protocol Violation|1|||
143504028|NCT04300751|517384238|FG000|Overall Study|Withdrawal by Subject|1|||
143504029|NCT05723835|517384239|FG000|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|4|||
143504030|NCT05723835|517384240|FG001|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
143504031|NCT05723835|517384241|FG002|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|3|||
143504032|NCT05723835|517384242|FG003|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
143504033|NCT05723835|517384243|FG004|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|6|||
143504034|NCT05723835|517384244|FG005|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|7|||
143504035|NCT05723835|517384245|FG006|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|2|||
143504036|NCT05723835|517384246|FG007|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|9|||
143504037|NCT04439279|517384247|FG000|Overall Study|Adverse Event|7|||
143504038|NCT04439279|517384247|FG000|Overall Study|Death|4|||
143504039|NCT04439279|517384247|FG000|Overall Study|Disease progression|17|||
143504040|NCT04439279|517384247|FG000|Overall Study|Complicating disease|3|||
143504041|NCT04439279|517384247|FG000|Overall Study|Withdrawal by Subject|2|||
143504042|NCT04439279|517384247|FG000|Overall Study|Ineligible|1|||
143504043|NCT04439279|517384247|FG000|Overall Study|Treatment still ongoing|1|||
143504044|NCT05226286|517384248|FG000|Overall Study|Screen failures prior to implant|62|||
143504045|NCT05226286|517384248|FG000|Overall Study|Withdrawal by Subject|13|||
143504046|NCT05226286|517384248|FG000|Overall Study|Lost to Follow-up|3|||
143504047|NCT05226286|517384248|FG000|Overall Study|Physician Decision|1|||
143504048|NCT05226286|517384248|FG000|Overall Study|Adverse Event|1|||
143504049|NCT05226286|517384248|FG000|Overall Study|Death|1|||
143504050|NCT05226286|517384248|FG000|Overall Study|Device explant with no planned replacement|1|||
143504051|NCT05226286|517384248|FG000|Overall Study|Planned surgery with an implanted metal material closer than allowed in research protocol|1|||
143504052|NCT05226286|517384248|FG000|Overall Study|Transitioned to urethral catheter/suprapubic tube|1|||
143504053|NCT05194345|517384249|FG000|Overall Study|Withdrawal by Subject|6|||
143504054|NCT05194345|517384250|FG001|Overall Study|Withdrawal by Subject|4|||
143504055|NCT05194345|517384251|FG002|Overall Study|Withdrawal by Subject|0|||
143504056|NCT05194345|517384249|FG000|Overall Study|Moved to another state, becoming ineligible.|0|||
143504057|NCT05194345|517384250|FG001|Overall Study|Moved to another state, becoming ineligible.|2|||
143504058|NCT05194345|517384251|FG002|Overall Study|Moved to another state, becoming ineligible.|0|||
143068799|NCT00321737|515793372|FG000|Overall Study|Lost to Follow-up|5|||
143068800|NCT00321737|515793373|FG001|Overall Study|Lost to Follow-up|5|||
143068801|NCT00321737|515793374|FG002|Overall Study|Lost to Follow-up|6|||
143068802|NCT00321737|515793372|FG000|Overall Study|Withdrawal by Subject|19|||
143068803|NCT00321737|515793373|FG001|Overall Study|Withdrawal by Subject|12|||
143068804|NCT00321737|515793374|FG002|Overall Study|Withdrawal by Subject|17|||
143068805|NCT00321737|515793372|FG000|Overall Study|Protocol Violation|0|||
143068806|NCT00321737|515793373|FG001|Overall Study|Protocol Violation|0|||
143504059|NCT04854499|517384256|FG000|Overall Study|Study Terminated by Sponsor|5|||
143504060|NCT04854499|517384257|FG001|Overall Study|Study Terminated by Sponsor|27|||
143504061|NCT04854499|517384258|FG002|Overall Study|Study Terminated by Sponsor|28|||
143504062|NCT04854499|517384259|FG003|Overall Study|Study Terminated by Sponsor|19|||
143068807|NCT00321737|515793374|FG002|Overall Study|Protocol Violation|1|||
143068808|NCT00321737|515793372|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
143068809|NCT00321737|515793373|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
143068810|NCT00321737|515793374|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
143068811|NCT00321737|515793372|FG000|Overall Study|Possible Barrett's Esophagus|2|||
143068812|NCT00321737|515793373|FG001|Overall Study|Possible Barrett's Esophagus|1|||
143068813|NCT00321737|515793374|FG002|Overall Study|Possible Barrett's Esophagus|1|||
143068814|NCT00321737|515793372|FG000|Overall Study|Therapeutic Failure|6|||
143504063|NCT04854499|517384260|FG004|Overall Study|Study Terminated by Sponsor|1|||
143504064|NCT04854499|517384261|FG005|Overall Study|Study Terminated by Sponsor|10|||
143504065|NCT04854499|517384256|FG000|Overall Study|Death|1|||
143504066|NCT04854499|517384257|FG001|Overall Study|Death|23|||
143504067|NCT04854499|517384258|FG002|Overall Study|Death|21|||
143504068|NCT04854499|517384259|FG003|Overall Study|Death|7|||
143504069|NCT04854499|517384260|FG004|Overall Study|Death|6|||
143504070|NCT04854499|517384261|FG005|Overall Study|Death|24|||
143504071|NCT04854499|517384256|FG000|Overall Study|Investigator's Discretion|0|||
143504072|NCT04854499|517384257|FG001|Overall Study|Investigator's Discretion|1|||
143504073|NCT04854499|517384258|FG002|Overall Study|Investigator's Discretion|3|||
143504074|NCT04854499|517384259|FG003|Overall Study|Investigator's Discretion|4|||
143504075|NCT04854499|517384260|FG004|Overall Study|Investigator's Discretion|1|||
143504076|NCT04854499|517384261|FG005|Overall Study|Investigator's Discretion|5|||
143504077|NCT04854499|517384256|FG000|Overall Study|Withdrew Consent|0|||
143504078|NCT04854499|517384257|FG001|Overall Study|Withdrew Consent|1|||
143504079|NCT04854499|517384258|FG002|Overall Study|Withdrew Consent|2|||
143504080|NCT04854499|517384259|FG003|Overall Study|Withdrew Consent|2|||
143504081|NCT04854499|517384260|FG004|Overall Study|Withdrew Consent|0|||
143504082|NCT04854499|517384261|FG005|Overall Study|Withdrew Consent|1|||
143504083|NCT04854499|517384256|FG000|Overall Study|Lost to Follow-up|0|||
143504084|NCT04854499|517384257|FG001|Overall Study|Lost to Follow-up|0|||
143504085|NCT04854499|517384258|FG002|Overall Study|Lost to Follow-up|0|||
143504086|NCT04854499|517384259|FG003|Overall Study|Lost to Follow-up|0|||
143504087|NCT04854499|517384260|FG004|Overall Study|Lost to Follow-up|0|||
143504088|NCT04854499|517384261|FG005|Overall Study|Lost to Follow-up|1|||
143504089|NCT03395197|517384262|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
143504090|NCT03395197|517384263|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
143504091|NCT03395197|517384264|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
143504092|NCT03395197|517384265|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
143504093|NCT03395197|517384266|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
143504094|NCT03395197|517384267|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
143504095|NCT03395197|517384262|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
143504096|NCT03395197|517384263|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
143504097|NCT03395197|517384264|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
143504098|NCT03395197|517384265|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
143504099|NCT03395197|517384266|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
143504100|NCT03395197|517384267|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
143504101|NCT03395197|517384262|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
143504102|NCT03395197|517384263|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
143504103|NCT03395197|517384264|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
143504104|NCT03395197|517384265|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
143504105|NCT03395197|517384266|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
143504106|NCT03395197|517384267|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
143504107|NCT03395197|517384262|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
143504108|NCT03395197|517384263|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
143068815|NCT00321737|515793373|FG001|Overall Study|Therapeutic Failure|0|||
143068816|NCT00321737|515793374|FG002|Overall Study|Therapeutic Failure|2|||
143068817|NCT00321737|515793372|FG000|Overall Study|Pregnancy|0|||
143068818|NCT00321737|515793373|FG001|Overall Study|Pregnancy|2|||
143365345|NCT05015478|516880747|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
143504109|NCT03395197|517384264|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
143504110|NCT03395197|517384265|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
143504111|NCT03395197|517384266|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
143504112|NCT03395197|517384267|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
143504113|NCT03395197|517384262|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
143504114|NCT03395197|517384263|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
143504115|NCT03395197|517384264|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
143247155|NCT04976192|516456759|FG000|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
143247156|NCT04976192|516456760|FG001|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
143247157|NCT04976192|516456761|FG002|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
143247158|NCT04976192|516456762|FG003|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
143504116|NCT03395197|517384265|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
143504117|NCT03395197|517384266|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
143504118|NCT03395197|517384267|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
143504119|NCT03395197|517384262|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
143504120|NCT03395197|517384263|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
143504121|NCT03395197|517384264|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
143504122|NCT03395197|517384265|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
143504123|NCT03395197|517384266|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
143504124|NCT03395197|517384267|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
143504125|NCT03395197|517384262|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
143504126|NCT03395197|517384263|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
143504127|NCT03395197|517384264|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
143504128|NCT03395197|517384265|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
143504129|NCT03395197|517384266|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
143504130|NCT03395197|517384267|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
143504131|NCT03395197|517384262|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
143504132|NCT03395197|517384263|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
143504133|NCT03395197|517384264|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
143247159|NCT04976192|516456763|FG004|Transition Treatment Period (12 Weeks)|Other Than Specified|1|||
143247160|NCT04976192|516456764|FG005|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
143247161|NCT04976192|516456765|FG006|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
143247162|NCT04976192|516456766|FG007|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
143247163|NCT04976192|516456767|FG008|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
143247164|NCT04976192|516456768|FG009|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
143247165|NCT04976192|516456759|FG000|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
143247166|NCT04976192|516456760|FG001|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
143247167|NCT04976192|516456761|FG002|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
143247168|NCT04976192|516456762|FG003|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
143247169|NCT04976192|516456763|FG004|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
143247170|NCT04976192|516456764|FG005|Transition Treatment Period (12 Weeks)|Lost to Follow-up|1|||
143247171|NCT04976192|516456765|FG006|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
143247172|NCT04976192|516456766|FG007|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
143247173|NCT04976192|516456767|FG008|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
143247174|NCT04976192|516456768|FG009|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
143247175|NCT02621151|516456769|FG000|Overall Study|Not eligible for trial|6|||
143247176|NCT04198714|516456770|FG000|Overall Study|Physician Decision|0|||
143247177|NCT04198714|516456771|FG001|Overall Study|Physician Decision|1|||
143247178|NCT04238819|516456772|FG000|Overall Study|Ongoing Treatment|0|||
143247179|NCT04238819|516456773|FG001|Overall Study|Ongoing Treatment|0|||
143247180|NCT04238819|516456774|FG002|Overall Study|Ongoing Treatment|0|||
143247181|NCT04238819|516456775|FG003|Overall Study|Ongoing Treatment|0|||
143247182|NCT04238819|516456776|FG004|Overall Study|Ongoing Treatment|1|||
143247183|NCT04238819|516456777|FG005|Overall Study|Ongoing Treatment|4|||
143247184|NCT04238819|516456778|FG006|Overall Study|Ongoing Treatment|0|||
143247185|NCT04238819|516456772|FG000|Overall Study|Withdrawal by Parent/Subject|0|||
143247186|NCT04238819|516456773|FG001|Overall Study|Withdrawal by Parent/Subject|0|||
143247187|NCT04238819|516456774|FG002|Overall Study|Withdrawal by Parent/Subject|0|||
143247188|NCT04238819|516456775|FG003|Overall Study|Withdrawal by Parent/Subject|1|||
143247189|NCT04238819|516456776|FG004|Overall Study|Withdrawal by Parent/Subject|0|||
143247190|NCT04238819|516456777|FG005|Overall Study|Withdrawal by Parent/Subject|0|||
143247191|NCT04238819|516456778|FG006|Overall Study|Withdrawal by Parent/Subject|1|||
143247192|NCT02529553|516456779|FG000|Overall Study|Progressive Disease|1|||
143247193|NCT02529553|516456780|FG001|Overall Study|Progressive Disease|0|||
143247194|NCT02529553|516456781|FG002|Overall Study|Progressive Disease|1|||
143247195|NCT02529553|516456782|FG003|Overall Study|Progressive Disease|3|||
143247196|NCT02529553|516456783|FG004|Overall Study|Progressive Disease|2|||
143247197|NCT02529553|516456784|FG005|Overall Study|Progressive Disease|3|||
143247198|NCT02529553|516456785|FG006|Overall Study|Progressive Disease|3|||
143247199|NCT02529553|516456786|FG007|Overall Study|Progressive Disease|5|||
143247200|NCT02529553|516456787|FG008|Overall Study|Progressive Disease|3|||
143247201|NCT02529553|516456779|FG000|Overall Study|Physician Decision|0|||
143247202|NCT02529553|516456780|FG001|Overall Study|Physician Decision|1|||
143247203|NCT02529553|516456781|FG002|Overall Study|Physician Decision|0|||
143247204|NCT02529553|516456782|FG003|Overall Study|Physician Decision|0|||
143247205|NCT02529553|516456783|FG004|Overall Study|Physician Decision|1|||
143247206|NCT02529553|516456784|FG005|Overall Study|Physician Decision|0|||
143247207|NCT02529553|516456785|FG006|Overall Study|Physician Decision|0|||
143247208|NCT02529553|516456786|FG007|Overall Study|Physician Decision|0|||
143247209|NCT02529553|516456787|FG008|Overall Study|Physician Decision|0|||
143247210|NCT02529553|516456779|FG000|Overall Study|Withdrawal by Subject|0|||
143247211|NCT02529553|516456780|FG001|Overall Study|Withdrawal by Subject|0|||
143247212|NCT02529553|516456781|FG002|Overall Study|Withdrawal by Subject|0|||
143247213|NCT02529553|516456782|FG003|Overall Study|Withdrawal by Subject|0|||
143247214|NCT02529553|516456783|FG004|Overall Study|Withdrawal by Subject|0|||
143247215|NCT02529553|516456784|FG005|Overall Study|Withdrawal by Subject|1|||
143247216|NCT02529553|516456785|FG006|Overall Study|Withdrawal by Subject|0|||
143247217|NCT02529553|516456786|FG007|Overall Study|Withdrawal by Subject|1|||
143247218|NCT02529553|516456787|FG008|Overall Study|Withdrawal by Subject|0|||
143247219|NCT00924027|516456788|FG000|Overall Study|Lost to Further Follow-Up|4|||
143247220|NCT00924027|516456789|FG001|Overall Study|Lost to Further Follow-Up|0|||
143247221|NCT00924027|516456790|FG002|Overall Study|Lost to Further Follow-Up|0|||
143247222|NCT00924027|516456791|FG003|Overall Study|Lost to Further Follow-Up|0|||
143247223|NCT00924027|516456788|FG000|Overall Study|Physician Decision|1|||
143247224|NCT00924027|516456789|FG001|Overall Study|Physician Decision|0|||
143247225|NCT00924027|516456790|FG002|Overall Study|Physician Decision|0|||
143247226|NCT00924027|516456791|FG003|Overall Study|Physician Decision|1|||
143247227|NCT00924027|516456788|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
143247228|NCT00924027|516456789|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
143247229|NCT00924027|516456790|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
143247230|NCT00924027|516456791|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
143247231|NCT00924027|516456788|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
143247232|NCT00924027|516456789|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
143247233|NCT00924027|516456790|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
143247234|NCT00924027|516456791|FG003|Overall Study|Withdrawal: Refused to start treatment|0|||
143247235|NCT00924027|516456788|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
143247236|NCT00924027|516456789|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
143247237|NCT00924027|516456790|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
143247238|NCT00924027|516456791|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
143247239|NCT00724711|516458546|FG000|Overall Study|Adverse Event|7|||
143247240|NCT00724711|516458547|FG001|Overall Study|Adverse Event|3|||
143247241|NCT00724711|516458546|FG000|Overall Study|Pregnancy|0|||
143247242|NCT00724711|516458547|FG001|Overall Study|Pregnancy|1|||
143247243|NCT00724711|516458546|FG000|Overall Study|Lack of Efficacy|0|||
143247244|NCT00724711|516458547|FG001|Overall Study|Lack of Efficacy|1|||
143247245|NCT00724711|516458546|FG000|Overall Study|Physician Decision|0|||
143068819|NCT00321737|515793374|FG002|Overall Study|Pregnancy|0|||
143068820|NCT00321737|515793372|FG000|Overall Study|Noncompliance|2|||
143068821|NCT00321737|515793373|FG001|Overall Study|Noncompliance|0|||
143068822|NCT00321737|515793374|FG002|Overall Study|Noncompliance|0|||
143068823|NCT00321737|515793372|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
143171065|NCT01276106|516174842|FG001|Overall Study|Insufficient therapeutic effects|0|||
143171066|NCT01276106|516174843|FG002|Overall Study|Insufficient therapeutic effects|2|||
143171067|NCT01276106|516174844|FG003|Overall Study|Insufficient therapeutic effects|0|||
143171068|NCT01242514|516174847|FG000|Overall Study|e.g., project closure|1042|||
143171069|NCT01242514|516174848|FG001|Overall Study|e.g., project closure|305|||
143171070|NCT01242514|516174849|FG002|Overall Study|e.g., project closure|171|||
143171071|NCT01242514|516174847|FG000|Overall Study|Subject decision|33|||
143171072|NCT01242514|516174848|FG001|Overall Study|Subject decision|8|||
143247246|NCT00724711|516458547|FG001|Overall Study|Physician Decision|3|||
143247247|NCT00724711|516458546|FG000|Overall Study|Withdrawal by Subject|5|||
143247248|NCT00724711|516458547|FG001|Overall Study|Withdrawal by Subject|4|||
143247249|NCT00724711|516458546|FG000|Overall Study|Lost to Follow-up|4|||
143247250|NCT00724711|516458547|FG001|Overall Study|Lost to Follow-up|5|||
143068824|NCT00321737|515793373|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
143068825|NCT00321737|515793374|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
143068826|NCT01079832|515793375|FG000|Overall Study|Withdrawal by Subject|1|||
143068827|NCT02283294|515793376|FG000|Overall Study|Lost to Follow-up|1|||
143068828|NCT02283294|515793377|FG001|Overall Study|Lost to Follow-up|1|||
143068829|NCT02283294|515793376|FG000|Overall Study|Withdrawal by Subject|1|||
143068830|NCT02283294|515793377|FG001|Overall Study|Withdrawal by Subject|6|||
143068831|NCT02283294|515793376|FG000|Overall Study|Protocol Violation|1|||
143068832|NCT02283294|515793377|FG001|Overall Study|Protocol Violation|0|||
143068833|NCT02283294|515793376|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
143068834|NCT02283294|515793377|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
143068835|NCT01769339|515793378|FG000|Overall Study|Lost to Follow-up|42|||
143068836|NCT01769339|515793378|FG000|Overall Study|Adverse Event|1|||
143068837|NCT02049450|515795050|FG000|Overall Study|Adverse Event|2|||
143068838|NCT02049450|515795050|FG000|Overall Study|Withdrawal by Subject|1|||
143068839|NCT02049450|515795050|FG000|Overall Study|Patients/guardian decision|1|||
143068840|NCT04711902|515795051|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
143068841|NCT04711902|515795052|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
143068842|NCT04711902|515795053|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
143171073|NCT01242514|516174849|FG002|Overall Study|Subject decision|2|||
143171074|NCT01242514|516174847|FG000|Overall Study|Severe non-compliance to protocol|5|||
143171075|NCT01242514|516174848|FG001|Overall Study|Severe non-compliance to protocol|2|||
143247251|NCT00724711|516458546|FG000|Overall Study|Protocol Violation|1|||
143068843|NCT04711902|515795054|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
143171076|NCT01242514|516174849|FG002|Overall Study|Severe non-compliance to protocol|1|||
143247252|NCT00724711|516458547|FG001|Overall Study|Protocol Violation|0|||
143504134|NCT03395197|517384265|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
143504135|NCT03395197|517384266|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
143504136|NCT03395197|517384267|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
143504137|NCT03395197|517384262|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
143504138|NCT03395197|517384263|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
143504139|NCT03395197|517384264|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
143504140|NCT03395197|517384265|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
143504141|NCT03395197|517384266|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
143504142|NCT03395197|517384267|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
143504143|NCT03395197|517384262|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
143504144|NCT03395197|517384263|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
143504145|NCT03395197|517384264|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
143504146|NCT03395197|517384265|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
143504147|NCT03395197|517384266|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
143504148|NCT03395197|517384267|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
143504149|NCT03395197|517384262|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
143504150|NCT03395197|517384263|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
143504151|NCT03395197|517384264|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
143504152|NCT03395197|517384265|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
143504153|NCT03395197|517384266|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
143504154|NCT03395197|517384267|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
143504155|NCT03395197|517384262|FG000|Analysis for DDR-Deficient Participants|Death|0|||
143504156|NCT03395197|517384263|FG001|Analysis for DDR-Deficient Participants|Death|0|||
143504157|NCT03395197|517384264|FG002|Analysis for DDR-Deficient Participants|Death|0|||
143504158|NCT03395197|517384265|FG003|Analysis for DDR-Deficient Participants|Death|0|||
143504159|NCT03395197|517384266|FG004|Analysis for DDR-Deficient Participants|Death|1|||
143504160|NCT03395197|517384267|FG005|Analysis for DDR-Deficient Participants|Death|4|||
143504161|NCT03395197|517384262|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
143504162|NCT03395197|517384263|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
143504163|NCT03395197|517384264|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
143504164|NCT03395197|517384265|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
143504165|NCT03395197|517384266|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
143504166|NCT03395197|517384267|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
143504167|NCT03395197|517384262|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
143504168|NCT03395197|517384263|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
143504169|NCT03395197|517384264|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
143504170|NCT03395197|517384265|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
143504171|NCT03395197|517384266|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
143504172|NCT03395197|517384267|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
143504173|NCT03395197|517384262|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
143504174|NCT03395197|517384263|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
143504175|NCT03395197|517384264|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
143504176|NCT03395197|517384265|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
143504177|NCT03395197|517384266|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
143504178|NCT03395197|517384267|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
143504179|NCT03395197|517384262|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
143504180|NCT03395197|517384263|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
143504181|NCT03395197|517384264|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
143504182|NCT03395197|517384265|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
143504183|NCT03395197|517384266|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
143504184|NCT03395197|517384267|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
143504185|NCT03395197|517384262|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
143504186|NCT03395197|517384263|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
143504187|NCT03395197|517384264|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
143504188|NCT03395197|517384265|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
143504189|NCT03395197|517384266|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
143504190|NCT03395197|517384267|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
143504191|NCT03395197|517384262|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
143247253|NCT00950859|516458548|FG000|Overall Study|Adverse Event|3|||
143247254|NCT00950859|516458549|FG001|Overall Study|Adverse Event|3|||
143247255|NCT00950859|516458548|FG000|Overall Study|Insufficient Viral Load Response|12|||
143068844|NCT04711902|515795055|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
143171077|NCT01242514|516174847|FG000|Overall Study|Lack of therapeutic response|99|||
143171078|NCT01242514|516174848|FG001|Overall Study|Lack of therapeutic response|16|||
143171079|NCT01242514|516174849|FG002|Overall Study|Lack of therapeutic response|10|||
143171080|NCT01242514|516174847|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
143171081|NCT01242514|516174848|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
143171082|NCT01242514|516174849|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
143171083|NCT01242514|516174847|FG000|Overall Study|Lost to Follow-up|14|||
143171084|NCT01242514|516174848|FG001|Overall Study|Lost to Follow-up|5|||
143171085|NCT01242514|516174849|FG002|Overall Study|Lost to Follow-up|4|||
143504192|NCT03395197|517384263|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
143504193|NCT03395197|517384264|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
143504194|NCT03395197|517384265|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
143504195|NCT03395197|517384266|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
143504196|NCT03395197|517384267|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
143504197|NCT03395197|517384262|FG000|Analysis for DDR-Deficient Participants|Other|0|||
143504198|NCT03395197|517384263|FG001|Analysis for DDR-Deficient Participants|Other|0|||
143504199|NCT03395197|517384264|FG002|Analysis for DDR-Deficient Participants|Other|0|||
143504200|NCT03395197|517384265|FG003|Analysis for DDR-Deficient Participants|Other|0|||
143504201|NCT03395197|517384266|FG004|Analysis for DDR-Deficient Participants|Other|3|||
143504202|NCT03395197|517384267|FG005|Analysis for DDR-Deficient Participants|Other|3|||
143504203|NCT03395197|517384262|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
143504204|NCT03395197|517384263|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
143504205|NCT03395197|517384264|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
143504206|NCT03395197|517384265|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
143504207|NCT03395197|517384266|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
143504208|NCT03395197|517384267|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
143504209|NCT05415449|517384268|FG000|Overall Study|Lost to Follow-up|2|||
143504210|NCT05415449|517384268|FG000|Overall Study|Withdrawal by Subject|4|||
143504211|NCT04256759|517384269|FG000|Overall Study|Physician Decision|1|||
143504212|NCT04256759|517384269|FG000|Overall Study|Lack of Efficacy|1|||
143504213|NCT05247398|517384270|FG000|Overall Study|Withdrawal by Subject|1|||
143504214|NCT00602641|517384276|FG000|Overall Study|Never started protocol therapy|6|||
143504215|NCT00602641|517384277|FG001|Overall Study|Never started protocol therapy|2|||
143504216|NCT00602641|517384276|FG000|Overall Study|Still on treatment at time of analysis|8|||
143504217|NCT00602641|517384277|FG001|Overall Study|Still on treatment at time of analysis|15|||
143504218|NCT00602641|517384276|FG000|Overall Study|Adverse Event|62|||
143504219|NCT00602641|517384277|FG001|Overall Study|Adverse Event|53|||
143504220|NCT00602641|517384276|FG000|Overall Study|Disease progression|38|||
143504221|NCT00602641|517384277|FG001|Overall Study|Disease progression|55|||
143171086|NCT01242514|516174847|FG000|Overall Study|Adverse Event|129|||
143504222|NCT00602641|517384276|FG000|Overall Study|Death|6|||
143504223|NCT00602641|517384277|FG001|Overall Study|Death|5|||
143504224|NCT00602641|517384276|FG000|Overall Study|Withdrawal by Subject|15|||
143504225|NCT00602641|517384277|FG001|Overall Study|Withdrawal by Subject|12|||
143504226|NCT00602641|517384276|FG000|Overall Study|Alternative therapy|5|||
143504227|NCT00602641|517384277|FG001|Overall Study|Alternative therapy|2|||
143504228|NCT00602641|517384276|FG000|Overall Study|Other Complicating Disease|5|||
143068845|NCT04711902|515795056|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
143068846|NCT04710979|515795057|FG000|Overall Study|Lost to Follow-up|2|||
143068847|NCT04710979|515795058|FG001|Overall Study|Lost to Follow-up|4|||
143068848|NCT04710979|515795057|FG000|Overall Study|Withdrawal by Subject|1|||
143068849|NCT04710979|515795058|FG001|Overall Study|Withdrawal by Subject|0|||
143068850|NCT00394524|515795061|FG000|Overall Study|Protocol Violation|2|||
143068851|NCT00394524|515795062|FG001|Overall Study|Protocol Violation|3|||
143068852|NCT00394524|515795061|FG000|Overall Study|Death|1|||
143068853|NCT00394524|515795062|FG001|Overall Study|Death|0|||
143068854|NCT00394524|515795061|FG000|Overall Study|Withdrawal by Subject|0|||
143068855|NCT00394524|515795062|FG001|Overall Study|Withdrawal by Subject|1|||
143068856|NCT01462318|515795063|FG000|Main Study / TP-DI Study|Other|2|||
143068857|NCT01462318|515795064|FG001|Main Study / TP-DI Study|Other|0|||
143068858|NCT01462318|515795065|FG002|Main Study / TP-DI Study|Other|0|||
143068859|NCT01462318|515795063|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
143068860|NCT01462318|515795064|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
143068861|NCT01462318|515795065|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
143068862|NCT01462318|515795063|FG000|Main Study / TP-DI Study|Adverse Event|4|||
143068863|NCT01462318|515795064|FG001|Main Study / TP-DI Study|Adverse Event|0|||
143068864|NCT01462318|515795065|FG002|Main Study / TP-DI Study|Adverse Event|0|||
143171087|NCT01242514|516174848|FG001|Overall Study|Adverse Event|18|||
143171088|NCT01242514|516174849|FG002|Overall Study|Adverse Event|19|||
143171089|NCT00862940|516174851|FG000|Overall Study|Adverse Event|15|||
143171090|NCT00862940|516174852|FG001|Overall Study|Adverse Event|12|||
143171091|NCT00862940|516174851|FG000|Overall Study|Lack of Efficacy|1|||
143171092|NCT00862940|516174852|FG001|Overall Study|Lack of Efficacy|3|||
143171093|NCT00862940|516174851|FG000|Overall Study|Protocol Violation|2|||
143171094|NCT00862940|516174852|FG001|Overall Study|Protocol Violation|5|||
143068865|NCT01462318|515795063|FG000|Extension Phase|Lost to Follow-up|0|||
143068866|NCT01462318|515795064|FG001|Extension Phase|Lost to Follow-up|0|||
143068867|NCT01462318|515795065|FG002|Extension Phase|Lost to Follow-up|1|||
143068868|NCT01462318|515795063|FG000|Extension Phase|Other|0|||
143068869|NCT01462318|515795064|FG001|Extension Phase|Other|0|||
143068870|NCT01462318|515795065|FG002|Extension Phase|Other|1|||
143068871|NCT01462318|515795063|FG000|Extension Phase|Disease Progression|0|||
143068872|NCT01462318|515795064|FG001|Extension Phase|Disease Progression|0|||
143068873|NCT01462318|515795065|FG002|Extension Phase|Disease Progression|1|||
143068874|NCT01462318|515795063|FG000|Extension Phase|Withdrawal by Subject|0|||
143068875|NCT01462318|515795064|FG001|Extension Phase|Withdrawal by Subject|0|||
143068876|NCT01462318|515795065|FG002|Extension Phase|Withdrawal by Subject|15|||
143068877|NCT01462318|515795063|FG000|Extension Phase|Investigator Decision|0|||
143068878|NCT01462318|515795064|FG001|Extension Phase|Investigator Decision|0|||
143504229|NCT00602641|517384277|FG001|Overall Study|Other Complicating Disease|2|||
143504230|NCT00602641|517384276|FG000|Overall Study|Physician Decision|5|||
143504231|NCT00602641|517384277|FG001|Overall Study|Physician Decision|4|||
143504232|NCT00602641|517384276|FG000|Overall Study|Administrative Closure|1|||
143504233|NCT00602641|517384277|FG001|Overall Study|Administrative Closure|1|||
143504234|NCT00602641|517384276|FG000|Overall Study|Other|3|||
143504235|NCT00602641|517384277|FG001|Overall Study|Other|1|||
143504236|NCT04075292|517384282|FG000|Overall Study|Withdrawal by Subject|1|||
143504237|NCT04075292|517384283|FG001|Overall Study|Withdrawal by Subject|9|||
143504238|NCT04075292|517384282|FG000|Overall Study|Death|2|||
143504239|NCT04075292|517384283|FG001|Overall Study|Death|5|||
143504240|NCT04075292|517384282|FG000|Overall Study|Remained on study at time of DCO|74|||
143504241|NCT04075292|517384283|FG001|Overall Study|Remained on study at time of DCO|64|||
143504242|NCT05171816|517384285|FG000|Overall Study|Death|18|||
143504243|NCT05171816|517384286|FG001|Overall Study|Death|16|||
143504244|NCT02937571|517384287|FG000|Overall Study|Adverse Event|0|||
143504245|NCT02937571|517384288|FG001|Overall Study|Adverse Event|0|||
143504246|NCT02937571|517384289|FG002|Overall Study|Adverse Event|4|||
143504247|NCT02937571|517384287|FG000|Overall Study|Withdrawal by Subject|0|||
143504248|NCT02937571|517384288|FG001|Overall Study|Withdrawal by Subject|0|||
143504249|NCT02937571|517384289|FG002|Overall Study|Withdrawal by Subject|3|||
143504250|NCT02747927|517384290|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|5|||
143504251|NCT02747927|517384291|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|14|||
143504252|NCT02747927|517384290|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|13|||
143504253|NCT02747927|517384291|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|26|||
143504254|NCT02747927|517384290|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|19|||
143504255|NCT02747927|517384291|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|42|||
143504256|NCT02747927|517384290|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|2|||
143504257|NCT02747927|517384291|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|5|||
143504258|NCT02747927|517384290|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|131|||
143504259|NCT02747927|517384291|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|260|||
143504260|NCT02747927|517384290|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|1|||
143504261|NCT02747927|517384291|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|4|||
143504262|NCT02747927|517384290|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|7|||
143504263|NCT02747927|517384291|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|15|||
143504264|NCT02747927|517384290|FG000|Part 2: Additional VE (Months 16-21)|Adverse Event|0|||
143504265|NCT02747927|517384291|FG001|Part 2: Additional VE (Months 16-21)|Adverse Event|1|||
143504266|NCT02747927|517384290|FG000|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|4|||
143504267|NCT02747927|517384291|FG001|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|8|||
143504268|NCT02747927|517384290|FG000|Part 2: Additional VE (Months 16-21)|Pregnancy|11|||
143504269|NCT02747927|517384291|FG001|Part 2: Additional VE (Months 16-21)|Pregnancy|17|||
143504270|NCT02747927|517384290|FG000|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|13|||
143504271|NCT02747927|517384291|FG001|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|33|||
143504272|NCT02747927|517384290|FG000|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|1|||
143504273|NCT02747927|517384291|FG001|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|7|||
143504274|NCT02747927|517384290|FG000|Part 2: Additional VE (Months 16-21)|Reason Not Specified|3|||
143504275|NCT02747927|517384291|FG001|Part 2: Additional VE (Months 16-21)|Reason Not Specified|6|||
143068879|NCT01462318|515795065|FG002|Extension Phase|Investigator Decision|5|||
143068880|NCT01462318|515795063|FG000|Extension Phase|Adverse Event|0|||
143068881|NCT01462318|515795064|FG001|Extension Phase|Adverse Event|0|||
143068882|NCT01462318|515795065|FG002|Extension Phase|Adverse Event|22|||
143504276|NCT02747927|517384290|FG000|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|6|||
143504277|NCT02747927|517384291|FG001|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|10|||
143068883|NCT03514641|515795066|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
143068884|NCT03514641|515795067|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
143171095|NCT00862940|516174851|FG000|Overall Study|Withdrawal by Subject|4|||
143171096|NCT00862940|516174852|FG001|Overall Study|Withdrawal by Subject|6|||
143068885|NCT03514641|515795068|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
143068886|NCT03514641|515795069|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
143068887|NCT03514641|515795066|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
143068888|NCT03514641|515795067|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
143068889|NCT03514641|515795068|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
143068890|NCT03514641|515795069|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
143068891|NCT03514641|515795066|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
143068892|NCT03514641|515795067|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
143504278|NCT02747927|517384290|FG000|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|67|||
143504279|NCT02747927|517384291|FG001|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|149|||
143504280|NCT02747927|517384290|FG000|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|120|||
143504281|NCT02747927|517384291|FG001|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|228|||
143504282|NCT02747927|517384290|FG000|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|1|||
143504283|NCT02747927|517384291|FG001|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|2|||
143504284|NCT02747927|517384290|FG000|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|119|||
143504285|NCT02747927|517384291|FG001|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|227|||
143504286|NCT02747927|517384290|FG000|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|82|||
143504287|NCT02747927|517384291|FG001|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|150|||
143504288|NCT02747927|517384290|FG000|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|13|||
143504289|NCT02747927|517384291|FG001|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|18|||
143504290|NCT02747927|517384290|FG000|Part 4: Booster VE & Safety (13 Months)|Adverse Event|1|||
143504291|NCT02747927|517384291|FG001|Part 4: Booster VE & Safety (13 Months)|Adverse Event|3|||
143504292|NCT02747927|517384290|FG000|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|4|||
143504293|NCT02747927|517384291|FG001|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|13|||
143504294|NCT02747927|517384290|FG000|Part 4: Booster VE & Safety (13 Months)|Pregnancy|8|||
143504295|NCT02747927|517384291|FG001|Part 4: Booster VE & Safety (13 Months)|Pregnancy|15|||
143504296|NCT02747927|517384290|FG000|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|29|||
143504297|NCT02747927|517384291|FG001|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|60|||
143504298|NCT02747927|517384290|FG000|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|0|||
143504299|NCT02747927|517384291|FG001|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|1|||
143504300|NCT02747927|517384290|FG000|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|4|||
143504301|NCT02747927|517384291|FG001|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|9|||
143504302|NCT02747927|517384290|FG000|Part 5: Booster VE & Safety (1 Year)|Adverse Event|0|||
143504303|NCT02747927|517384291|FG001|Part 5: Booster VE & Safety (1 Year)|Adverse Event|3|||
143504304|NCT02747927|517384290|FG000|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|8|||
143504305|NCT02747927|517384291|FG001|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|30|||
143504306|NCT02747927|517384290|FG000|Part 5: Booster VE & Safety (1 Year)|Pregnancy|18|||
143504307|NCT02747927|517384291|FG001|Part 5: Booster VE & Safety (1 Year)|Pregnancy|27|||
143504308|NCT02747927|517384290|FG000|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|18|||
143504309|NCT02747927|517384291|FG001|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|40|||
143504310|NCT02747927|517384290|FG000|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|14|||
143504311|NCT02747927|517384291|FG001|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|29|||
143504312|NCT02747927|517384290|FG000|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|40|||
143504313|NCT02747927|517384291|FG001|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|89|||
143504314|NCT04214288|517384292|FG000|Overall Study|Ongoing in the study|41|||
143504315|NCT04214288|517384293|FG001|Overall Study|Ongoing in the study|51|||
143504316|NCT04214288|517384294|FG002|Overall Study|Ongoing in the study|12|||
143504317|NCT04214288|517384295|FG003|Overall Study|Ongoing in the study|39|||
143504318|NCT04214288|517384292|FG000|Overall Study|Adverse Event|1|||
143504319|NCT04214288|517384293|FG001|Overall Study|Adverse Event|0|||
143504320|NCT04214288|517384294|FG002|Overall Study|Adverse Event|0|||
143504321|NCT04214288|517384295|FG003|Overall Study|Adverse Event|0|||
143504322|NCT04214288|517384292|FG000|Overall Study|Death|22|||
143504323|NCT04214288|517384293|FG001|Overall Study|Death|13|||
143504324|NCT04214288|517384294|FG002|Overall Study|Death|7|||
143504325|NCT04214288|517384295|FG003|Overall Study|Death|19|||
143504326|NCT04214288|517384292|FG000|Overall Study|Lost to Follow-up|1|||
143504327|NCT04214288|517384293|FG001|Overall Study|Lost to Follow-up|2|||
143504328|NCT04214288|517384294|FG002|Overall Study|Lost to Follow-up|1|||
143504329|NCT04214288|517384295|FG003|Overall Study|Lost to Follow-up|0|||
143068893|NCT03514641|515795068|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
143068894|NCT03514641|515795069|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
143068895|NCT03514641|515795066|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
143068896|NCT03514641|515795067|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
143504330|NCT04214288|517384292|FG000|Overall Study|Other|1|||
143504331|NCT04214288|517384293|FG001|Overall Study|Other|2|||
143504332|NCT04214288|517384294|FG002|Overall Study|Other|0|||
143504333|NCT04214288|517384295|FG003|Overall Study|Other|6|||
143247256|NCT00950859|516458549|FG001|Overall Study|Insufficient Viral Load Response|3|||
143247257|NCT00950859|516458548|FG000|Overall Study|Protocol Violation|1|||
143247258|NCT00950859|516458549|FG001|Overall Study|Protocol Violation|1|||
143247259|NCT00950859|516458548|FG000|Overall Study|Lost to Follow-up|0|||
143247260|NCT00950859|516458549|FG001|Overall Study|Lost to Follow-up|3|||
143247261|NCT04896086|516458550|FG000|Overall Study|Lost to Follow-up|0|||
143247262|NCT04896086|516458551|FG001|Overall Study|Lost to Follow-up|2|||
143247263|NCT04896086|516458552|FG002|Overall Study|Lost to Follow-up|1|||
143247264|NCT04896086|516458553|FG003|Overall Study|Lost to Follow-up|0|||
143247265|NCT04896086|516458554|FG004|Overall Study|Lost to Follow-up|0|||
143247266|NCT04896086|516458550|FG000|Overall Study|Physician Decision|0|||
143247267|NCT04896086|516458551|FG001|Overall Study|Physician Decision|1|||
143247268|NCT04896086|516458552|FG002|Overall Study|Physician Decision|0|||
143247269|NCT04896086|516458553|FG003|Overall Study|Physician Decision|0|||
143247270|NCT04896086|516458554|FG004|Overall Study|Physician Decision|0|||
143247271|NCT04896086|516458550|FG000|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
143247272|NCT04896086|516458551|FG001|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
143247273|NCT04896086|516458552|FG002|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
143247274|NCT04896086|516458553|FG003|Overall Study|Difficulties were experienced with vein access for blood sample collection|1|||
143247275|NCT04896086|516458554|FG004|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
143247276|NCT04896086|516458550|FG000|Overall Study|Participant had a syncopal event during a blood draw|0|||
143247277|NCT04896086|516458551|FG001|Overall Study|Participant had a syncopal event during a blood draw|0|||
143247278|NCT04896086|516458552|FG002|Overall Study|Participant had a syncopal event during a blood draw|0|||
143247279|NCT04896086|516458553|FG003|Overall Study|Participant had a syncopal event during a blood draw|1|||
143247280|NCT04896086|516458554|FG004|Overall Study|Participant had a syncopal event during a blood draw|0|||
143247281|NCT04248491|516458557|FG000|Overall Study|Lost to Follow-up|1|||
143247282|NCT04248491|516458558|FG001|Overall Study|Lost to Follow-up|0|||
143247283|NCT04335136|516458559|FG000|Overall Study|Death|8|||
143247284|NCT04335136|516458560|FG001|Overall Study|Death|4|||
143247285|NCT04335136|516458559|FG000|Overall Study|Lost to Follow-up|2|||
143247286|NCT04335136|516458560|FG001|Overall Study|Lost to Follow-up|0|||
143247287|NCT04335136|516458559|FG000|Overall Study|Protocol Violation|1|||
143247288|NCT04335136|516458560|FG001|Overall Study|Protocol Violation|0|||
143247289|NCT04335136|516458559|FG000|Overall Study|Withdrawal by Subject|1|||
143247290|NCT04335136|516458560|FG001|Overall Study|Withdrawal by Subject|1|||
143247291|NCT04335136|516458559|FG000|Overall Study|Health-threatening condition|0|||
143247292|NCT04335136|516458560|FG001|Overall Study|Health-threatening condition|1|||
143247293|NCT04335136|516458559|FG000|Overall Study|Adverse Event|0|||
143247294|NCT04335136|516458560|FG001|Overall Study|Adverse Event|1|||
143247295|NCT04335136|516458559|FG000|Overall Study|Erroneously randomized|2|||
143247296|NCT04335136|516458560|FG001|Overall Study|Erroneously randomized|0|||
143247297|NCT00975689|516458561|FG000|Overall Study|Adverse Event|0|||
143247298|NCT00975689|516458562|FG001|Overall Study|Adverse Event|3|||
143247299|NCT00975689|516458561|FG000|Overall Study|Withdrawal by Subject|1|||
143247300|NCT00975689|516458562|FG001|Overall Study|Withdrawal by Subject|0|||
143247301|NCT00975689|516458561|FG000|Overall Study|Physician Decision|1|||
143247302|NCT00975689|516458562|FG001|Overall Study|Physician Decision|0|||
143247303|NCT01652469|516458566|FG000|Overall Study|Withdrawal by Subject|1|||
143247304|NCT01652469|516458567|FG001|Overall Study|Withdrawal by Subject|4|||
143247305|NCT01652469|516458566|FG000|Overall Study|Lost to Follow-up|0|||
143247306|NCT01652469|516458567|FG001|Overall Study|Lost to Follow-up|2|||
143247307|NCT02834793|516458568|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
143247308|NCT02834793|516458569|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
143247309|NCT02834793|516458570|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
143247310|NCT02834793|516458571|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
143247311|NCT02834793|516458568|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
143247312|NCT02834793|516458569|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
143247313|NCT02834793|516458570|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
143247314|NCT02834793|516458571|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
143247315|NCT02834793|516458568|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
143247316|NCT02834793|516458569|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
143247317|NCT02834793|516458570|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
143247318|NCT02834793|516458571|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
143247319|NCT02834793|516458568|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
143247320|NCT02834793|516458569|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
143247321|NCT02834793|516458570|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
143247322|NCT02834793|516458571|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
143247323|NCT02834793|516458568|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
143365346|NCT05015478|516880748|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
143504334|NCT04214288|517384292|FG000|Overall Study|Protocol Violation|0|||
143504335|NCT04214288|517384293|FG001|Overall Study|Protocol Violation|1|||
143504336|NCT04214288|517384294|FG002|Overall Study|Protocol Violation|0|||
143504337|NCT04214288|517384295|FG003|Overall Study|Protocol Violation|0|||
143504338|NCT04214288|517384292|FG000|Overall Study|Withdrawal by Subject|8|||
143504339|NCT04214288|517384293|FG001|Overall Study|Withdrawal by Subject|4|||
143504340|NCT04214288|517384294|FG002|Overall Study|Withdrawal by Subject|0|||
143504341|NCT04214288|517384295|FG003|Overall Study|Withdrawal by Subject|9|||
143504342|NCT03675321|517384298|FG000|Overall Study|Lack of Efficacy|2|||
143504343|NCT03675321|517384299|FG001|Overall Study|Lack of Efficacy|2|||
143504344|NCT03675321|517384298|FG000|Overall Study|Withdrawal by Subject|1|||
143504345|NCT03675321|517384299|FG001|Overall Study|Withdrawal by Subject|3|||
143504346|NCT03932812|517384300|FG000|Overall Study|Lost to Follow-up|12|||
143504347|NCT03932812|517384301|FG001|Overall Study|Lost to Follow-up|14|||
143504348|NCT03932812|517384300|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
143504349|NCT03932812|517384301|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
143504350|NCT03997383|517384303|FG000|Double-blind Treatment Period|Adverse Event|4|||
143504351|NCT03997383|517384304|FG001|Double-blind Treatment Period|Adverse Event|3|||
143504352|NCT03997383|517384303|FG000|Double-blind Treatment Period|Death|4|||
143504353|NCT03997383|517384304|FG001|Double-blind Treatment Period|Death|4|||
143504354|NCT03997383|517384303|FG000|Double-blind Treatment Period|Physician Decision|2|||
143504355|NCT03997383|517384304|FG001|Double-blind Treatment Period|Physician Decision|0|||
143504356|NCT03997383|517384303|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
143504357|NCT03997383|517384304|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
143504358|NCT03997383|517384303|FG000|Open-label Extension Period|Ongoing|148|||
143504359|NCT03997383|517384304|FG001|Open-label Extension Period|Ongoing|151|||
143504360|NCT03997383|517384303|FG000|Open-label Extension Period|Adverse Event|4|||
143504361|NCT03997383|517384304|FG001|Open-label Extension Period|Adverse Event|1|||
143504362|NCT03997383|517384303|FG000|Open-label Extension Period|Death|8|||
143504363|NCT03997383|517384304|FG001|Open-label Extension Period|Death|9|||
143504364|NCT03997383|517384303|FG000|Open-label Extension Period|Physician Decision|1|||
143504365|NCT03997383|517384304|FG001|Open-label Extension Period|Physician Decision|1|||
143504366|NCT03997383|517384303|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
143504367|NCT03997383|517384304|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
143504368|NCT03997383|517384303|FG000|Open-label Extension Period|Reason Not Specified|2|||
143504369|NCT03997383|517384304|FG001|Open-label Extension Period|Reason Not Specified|0|||
143504370|NCT04798781|517384305|FG000|Overall Study|Withdrawal by Subject|1|||
143504371|NCT05954143|517384306|FG000|Overall Study|Progressive Disease|1|||
143504372|NCT05954143|517384307|FG001|Overall Study|Progressive Disease|0|||
143504373|NCT05954143|517384306|FG000|Overall Study|Physician Decision|1|||
143504374|NCT05954143|517384307|FG001|Overall Study|Physician Decision|0|||
143504375|NCT05954143|517384306|FG000|Overall Study|Study Terminated by Sponsor|2|||
143504376|NCT05954143|517384307|FG001|Overall Study|Study Terminated by Sponsor|4|||
143504377|NCT05954143|517384306|FG000|Overall Study|Death|1|||
143504378|NCT05954143|517384307|FG001|Overall Study|Death|0|||
143504379|NCT05954143|517384306|FG000|Overall Study|Withdrawal by Subject|0|||
143504380|NCT05954143|517384307|FG001|Overall Study|Withdrawal by Subject|1|||
143504381|NCT05954143|517384306|FG000|Overall Study|Other|1|||
143504382|NCT05954143|517384307|FG001|Overall Study|Other|0|||
143504383|NCT05511428|517384308|FG000|Overall Study|Withdrawal by Subject|1|||
143504384|NCT05511428|517384308|FG000|Overall Study|Adverse Event|1|||
143504385|NCT03829462|517384311|FG000|Overall Study|No tumoral evaluation due to progression disease|6|||
143504386|NCT03829462|517384312|FG001|Overall Study|No tumoral evaluation due to progression disease|3|||
143504387|NCT03829462|517384311|FG000|Overall Study|No treatment due to progression disease|0|||
143504388|NCT03829462|517384312|FG001|Overall Study|No treatment due to progression disease|1|||
143504389|NCT04572633|517384313|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
143504390|NCT05318183|517384318|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
143504391|NCT05318183|517384319|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|3|||
143504392|NCT05318183|517384318|FG000|First Intervention (2 Weeks)|Lost to Follow-up|2|||
143504393|NCT05318183|517384319|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
143504394|NCT05318183|517384318|FG000|Second Intervention (2 Weeks)|Protocol Violation|0|||
143504395|NCT05318183|517384319|FG001|Second Intervention (2 Weeks)|Protocol Violation|2|||
143504396|NCT05318183|517384318|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
143504397|NCT05318183|517384319|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
143504398|NCT01046825|517384320|FG000|Overall Study|Failed to achieve CR to Induction Therapy|0|||
143504399|NCT01046825|517384321|FG001|Overall Study|Failed to achieve CR to Induction Therapy|1|||
143504400|NCT01046825|517384322|FG002|Overall Study|Failed to achieve CR to Induction Therapy|0|||
143504401|NCT01046825|517384323|FG003|Overall Study|Failed to achieve CR to Induction Therapy|0|||
143504402|NCT01046825|517384324|FG004|Overall Study|Failed to achieve CR to Induction Therapy|0|||
143504403|NCT01046825|517384320|FG000|Overall Study|Physician Decision|0|||
143171097|NCT00862940|516174851|FG000|Overall Study|Non-compliance|4|||
143504404|NCT01046825|517384321|FG001|Overall Study|Physician Decision|1|||
143504405|NCT01046825|517384322|FG002|Overall Study|Physician Decision|2|||
143504406|NCT01046825|517384323|FG003|Overall Study|Physician Decision|0|||
143504407|NCT01046825|517384324|FG004|Overall Study|Physician Decision|0|||
143504408|NCT01046825|517384320|FG000|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
143504409|NCT01046825|517384321|FG001|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
143504410|NCT01046825|517384322|FG002|Overall Study|Participant or family decision to withdraw from protocol treatment|1|||
143504411|NCT01046825|517384323|FG003|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
143504412|NCT01046825|517384324|FG004|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
143504413|NCT01046825|517384320|FG000|Overall Study|Found to be ineligible|0|||
143504414|NCT01046825|517384321|FG001|Overall Study|Found to be ineligible|1|||
143504415|NCT01046825|517384322|FG002|Overall Study|Found to be ineligible|0|||
143504416|NCT01046825|517384323|FG003|Overall Study|Found to be ineligible|0|||
143504417|NCT01046825|517384324|FG004|Overall Study|Found to be ineligible|0|||
143504418|NCT01046825|517384320|FG000|Overall Study|Death|0|||
143504419|NCT01046825|517384321|FG001|Overall Study|Death|0|||
143504420|NCT01046825|517384322|FG002|Overall Study|Death|0|||
143504421|NCT01046825|517384323|FG003|Overall Study|Death|1|||
143504422|NCT01046825|517384324|FG004|Overall Study|Death|0|||
143504423|NCT01046825|517384320|FG000|Overall Study|Did not submit biology samples|0|||
143504424|NCT01046825|517384321|FG001|Overall Study|Did not submit biology samples|0|||
143504425|NCT01046825|517384322|FG002|Overall Study|Did not submit biology samples|0|||
143504426|NCT01046825|517384323|FG003|Overall Study|Did not submit biology samples|0|||
143504427|NCT01046825|517384324|FG004|Overall Study|Did not submit biology samples|13|||
143504428|NCT04439266|517384325|FG000|Overall Study|Ineligible|1|||
143504429|NCT04439266|517384325|FG000|Overall Study|Adverse Event|1|||
143504430|NCT04439266|517384325|FG000|Overall Study|Death|1|||
143504431|NCT04439266|517384325|FG000|Overall Study|Disease progression|1|||
143504432|NCT04439266|517384325|FG000|Overall Study|Still on treatment|1|||
143504433|NCT04971226|517384326|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
143504434|NCT04971226|517384327|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
143504435|NCT04971226|517384328|FG002|Overall Study|Unsatisfactory therapeutic effect|21|||
143504436|NCT04971226|517384329|FG003|Overall Study|Unsatisfactory therapeutic effect|10|||
143504437|NCT04971226|517384326|FG000|Overall Study|Adverse Event|6|||
143504438|NCT04971226|517384327|FG001|Overall Study|Adverse Event|5|||
143504439|NCT04971226|517384328|FG002|Overall Study|Adverse Event|11|||
143504440|NCT04971226|517384329|FG003|Overall Study|Adverse Event|10|||
143504441|NCT04971226|517384326|FG000|Overall Study|Progressive disease|2|||
143504442|NCT04971226|517384327|FG001|Overall Study|Progressive disease|0|||
143504443|NCT04971226|517384328|FG002|Overall Study|Progressive disease|3|||
143504444|NCT04971226|517384329|FG003|Overall Study|Progressive disease|1|||
143504445|NCT04971226|517384326|FG000|Overall Study|Protocol Deviation|1|||
143171098|NCT00862940|516174852|FG001|Overall Study|Non-compliance|0|||
143171099|NCT00862940|516174851|FG000|Overall Study|Lost to Follow-up|0|||
143171100|NCT00862940|516174852|FG001|Overall Study|Lost to Follow-up|1|||
143171101|NCT00862940|516174851|FG000|Overall Study|Administrative or other reason(s)|4|||
143171102|NCT00862940|516174852|FG001|Overall Study|Administrative or other reason(s)|3|||
143171103|NCT00879398|516174853|FG000|Overall Study|Visit Stop|399|||
143171104|NCT00879398|516174853|FG000|Overall Study|Lack of Efficacy|64|||
143171105|NCT00879398|516174853|FG000|Overall Study|Adverse Event|41|||
143171106|NCT00879398|516174853|FG000|Overall Study|Other Reasons|171|||
143171107|NCT04222673|516174857|FG000|Overall Study|Lost to Follow-up|5|||
143171108|NCT01380080|516174861|FG000|Overall Study|Death|36|||
143171109|NCT01380080|516174862|FG001|Overall Study|Death|44|||
143171110|NCT01380080|516174861|FG000|Overall Study|Site is closing|28|||
143171111|NCT01380080|516174862|FG001|Overall Study|Site is closing|31|||
143171112|NCT01380080|516174861|FG000|Overall Study|Not able to get to clinic|7|||
143171113|NCT01380080|516174862|FG001|Overall Study|Not able to get to clinic|1|||
143171114|NCT01380080|516174861|FG000|Overall Study|Not willing to adhere to requirements|6|||
143171115|NCT01380080|516174862|FG001|Overall Study|Not willing to adhere to requirements|2|||
143171116|NCT01380080|516174861|FG000|Overall Study|Withdrawal by Subject|5|||
143171117|NCT01380080|516174862|FG001|Overall Study|Withdrawal by Subject|2|||
143171118|NCT01380080|516174861|FG000|Overall Study|Lost to Follow-up|3|||
143171119|NCT01380080|516174862|FG001|Overall Study|Lost to Follow-up|3|||
143171120|NCT01355627|516174869|FG000|Overall Study|Request By the Patient to Discontinue|5|||
143171121|NCT01355627|516174870|FG001|Overall Study|Request By the Patient to Discontinue|7|||
143171122|NCT01355627|516174869|FG000|Overall Study|Lost to Follow-up|8|||
143171123|NCT01355627|516174870|FG001|Overall Study|Lost to Follow-up|7|||
143171124|NCT01355627|516174869|FG000|Overall Study|Fatal Adverse Event|19|||
143171125|NCT01355627|516174870|FG001|Overall Study|Fatal Adverse Event|23|||
143171126|NCT01355627|516174869|FG000|Overall Study|Other|1|||
143171127|NCT01355627|516174870|FG001|Overall Study|Other|1|||
143171128|NCT04532749|516174871|FG000|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|1|||
143171129|NCT04532749|516174872|FG001|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|6|||
143504446|NCT04971226|517384327|FG001|Overall Study|Protocol Deviation|0|||
143504447|NCT04971226|517384328|FG002|Overall Study|Protocol Deviation|1|||
143504448|NCT04971226|517384329|FG003|Overall Study|Protocol Deviation|1|||
143504449|NCT04971226|517384326|FG000|Overall Study|Subject Decision|0|||
143504450|NCT04971226|517384327|FG001|Overall Study|Subject Decision|1|||
143504451|NCT04971226|517384328|FG002|Overall Study|Subject Decision|1|||
143504452|NCT04971226|517384329|FG003|Overall Study|Subject Decision|1|||
143504453|NCT04971226|517384326|FG000|Overall Study|Pregnancy|0|||
143504454|NCT04971226|517384327|FG001|Overall Study|Pregnancy|0|||
143504455|NCT04971226|517384328|FG002|Overall Study|Pregnancy|0|||
143504456|NCT04971226|517384329|FG003|Overall Study|Pregnancy|1|||
143504457|NCT04971226|517384326|FG000|Overall Study|Participants not treated|1|||
143504458|NCT04971226|517384327|FG001|Overall Study|Participants not treated|0|||
143504459|NCT04971226|517384328|FG002|Overall Study|Participants not treated|2|||
143504460|NCT04971226|517384329|FG003|Overall Study|Participants not treated|1|||
143504461|NCT05052723|517384330|FG000|Overall Study|Death|19|||
143504462|NCT04439149|517384331|FG000|Overall Study|Ineligible|1|||
143504463|NCT04439149|517384331|FG000|Overall Study|Never start protocol therapy|1|||
143068897|NCT03514641|515795068|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
143068898|NCT03514641|515795069|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
143068899|NCT03514641|515795066|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
143068900|NCT03514641|515795067|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
143068901|NCT03514641|515795068|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
143068902|NCT03514641|515795069|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
143068903|NCT03514641|515795066|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
143068904|NCT03514641|515795067|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
143068905|NCT03514641|515795068|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
143068906|NCT03514641|515795069|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
143068907|NCT03514641|515795066|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
143068908|NCT03514641|515795067|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
143068909|NCT03514641|515795068|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
143247324|NCT02834793|516458569|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
143504464|NCT04439149|517384331|FG000|Overall Study|Adverse Event|4|||
143504465|NCT04439149|517384331|FG000|Overall Study|Disease Progression|14|||
143504466|NCT04439149|517384331|FG000|Overall Study|Complicating disease|1|||
143504467|NCT04439149|517384331|FG000|Overall Study|Withdrawal by Subject|3|||
143504468|NCT06400251|517384332|FG000|Overall Study|Never Start Protocol Therapy|1|||
143504469|NCT06400251|517384332|FG000|Overall Study|Ineligible|2|||
143504470|NCT06400251|517384332|FG000|Overall Study|Mutation Status Not Confirmed|3|||
143504471|NCT06400251|517384332|FG000|Overall Study|Disease Progression|25|||
143504472|NCT06400251|517384332|FG000|Overall Study|Adverse Event|1|||
143504473|NCT06400251|517384332|FG000|Overall Study|Complicating Disease|1|||
143504474|NCT06400251|517384332|FG000|Overall Study|Physician Decision|2|||
143504475|NCT01933932|517384333|FG000|Overall Study|Death|173|||
143504476|NCT01933932|517384334|FG001|Overall Study|Death|163|||
143504477|NCT01933932|517384333|FG000|Overall Study|Withdrawal by Subject|11|||
143504478|NCT01933932|517384334|FG001|Overall Study|Withdrawal by Subject|14|||
143504479|NCT01933932|517384333|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
143504480|NCT01933932|517384334|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
143504481|NCT05264506|517384337|FG000|Overall Study|Adverse Event|59|||
143504482|NCT05264506|517384337|FG000|Overall Study|Lost to Follow-up|204|||
143504483|NCT05264506|517384337|FG000|Overall Study|Protocol Violation|185|||
143504484|NCT05264506|517384337|FG000|Overall Study|Pregnancy|60|||
143504485|NCT05264506|517384337|FG000|Overall Study|Physician Decision|6|||
143504486|NCT05264506|517384337|FG000|Overall Study|Non-compliance with Study Drug|29|||
143504487|NCT05264506|517384337|FG000|Overall Study|Study termination|677|||
143504488|NCT05264506|517384337|FG000|Overall Study|Withdrawal by Subject|208|||
143504489|NCT05264506|517384337|FG000|Overall Study|Discontinued prior treatment|89|||
143504490|NCT05540652|517384338|FG000|Overall Study|Withdrawal by Subject|1|||
143504491|NCT06390839|517384339|FG000|Overall Study|Ineligible|2|||
143504492|NCT06390839|517384339|FG000|Overall Study|Never start protocol therapy|3|||
143504493|NCT06390839|517384339|FG000|Overall Study|Adverse Event|1|||
143504494|NCT06390839|517384339|FG000|Overall Study|Alternative therapy|2|||
143504495|NCT06390839|517384339|FG000|Overall Study|Death|3|||
143504496|NCT06390839|517384339|FG000|Overall Study|Disease progression|28|||
143504497|NCT06390839|517384339|FG000|Overall Study|Withdrawal by Subject|2|||
143504498|NCT06390839|517384339|FG000|Overall Study|Complicating disease|1|||
143504499|NCT06390839|517384339|FG000|Overall Study|Noncompliance|1|||
143068910|NCT03514641|515795069|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
143068911|NCT03514641|515795066|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
143068912|NCT03514641|515795067|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
143068913|NCT03514641|515795068|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
143068914|NCT03514641|515795069|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
143068915|NCT03514641|515795066|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
143504500|NCT02275533|517385665|FG000|Overall Study|Protocol Violation|2|||
143504501|NCT02275533|517385666|FG001|Overall Study|Protocol Violation|0|||
143504502|NCT02275533|517385665|FG000|Overall Study|Never received study treatment|1|||
143504503|NCT02275533|517385666|FG001|Overall Study|Never received study treatment|0|||
143504504|NCT05424276|517385667|FG000|Overall Study|Adverse Event|1|||
143504505|NCT05424276|517385668|FG001|Overall Study|Adverse Event|0|||
143504506|NCT05424276|517385669|FG002|Overall Study|Adverse Event|0|||
143504507|NCT05424276|517385670|FG003|Overall Study|Adverse Event|2|||
143504508|NCT05424276|517385667|FG000|Overall Study|Withdrawal by Subject|0|||
143504509|NCT05424276|517385668|FG001|Overall Study|Withdrawal by Subject|0|||
143504510|NCT05424276|517385669|FG002|Overall Study|Withdrawal by Subject|2|||
143504511|NCT05424276|517385670|FG003|Overall Study|Withdrawal by Subject|0|||
143504512|NCT05424276|517385667|FG000|Overall Study|Protocol Violation|0|||
143504513|NCT05424276|517385668|FG001|Overall Study|Protocol Violation|1|||
143504514|NCT05424276|517385669|FG002|Overall Study|Protocol Violation|0|||
143504515|NCT05424276|517385670|FG003|Overall Study|Protocol Violation|0|||
143247325|NCT02834793|516458570|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
143504516|NCT05424276|517385667|FG000|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
143504517|NCT05424276|517385668|FG001|Overall Study|Subjects Withdrawn due to regulatory hold|2|||
143504518|NCT05424276|517385669|FG002|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
143247326|NCT02834793|516458571|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
143247327|NCT02834793|516458568|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
143247328|NCT02834793|516458569|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
143247329|NCT02834793|516458570|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
143247330|NCT02834793|516458571|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
143504519|NCT05424276|517385670|FG003|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
143504520|NCT02157883|517385689|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
143504521|NCT02157883|517385689|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
143504522|NCT02157883|517385689|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
143504523|NCT02157883|517385689|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
143504524|NCT02157883|517385689|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
143504525|NCT05919823|517385690|FG000|Pre-Treatment Period|Screen failure|1|||
143504526|NCT05919823|517385691|FG001|Pre-Treatment Period|Screen failure|0|||
143504527|NCT05919823|517385692|FG002|Pre-Treatment Period|Screen failure|0|||
143504528|NCT05919823|517385693|FG003|Pre-Treatment Period|Screen failure|0|||
143504529|NCT05919823|517385690|FG000|Pre-Treatment Period|Protocol Violation|0|||
143504530|NCT05919823|517385691|FG001|Pre-Treatment Period|Protocol Violation|1|||
143068916|NCT03514641|515795067|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
143247331|NCT02834793|516458568|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
143247332|NCT02834793|516458569|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
143247333|NCT02834793|516458570|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
143247334|NCT02834793|516458571|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
143247335|NCT02834793|516458568|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
143247336|NCT02834793|516458569|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
143247337|NCT02834793|516458570|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
143247338|NCT02834793|516458571|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
143247339|NCT02834793|516458568|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
143247340|NCT02834793|516458569|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
143247341|NCT02834793|516458570|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
143247342|NCT02834793|516458571|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
143247343|NCT02834793|516458568|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
143247344|NCT02834793|516458569|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
143247345|NCT02834793|516458570|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
143247346|NCT02834793|516458571|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
143247347|NCT02834793|516458568|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
143247348|NCT02834793|516458569|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
143247349|NCT02834793|516458570|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
143247350|NCT02834793|516458571|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
143247351|NCT02834793|516458568|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
143247352|NCT02834793|516458569|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
143247353|NCT02834793|516458570|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
143247354|NCT02834793|516458571|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
143247355|NCT02834793|516458568|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
143247356|NCT02834793|516458569|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
143247357|NCT02834793|516458570|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
143247358|NCT02834793|516458571|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
143247359|NCT02834793|516458568|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
143247360|NCT02834793|516458569|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
143247361|NCT02834793|516458570|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
143247362|NCT02834793|516458571|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
143247363|NCT02834793|516458568|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
143247364|NCT02834793|516458569|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
143247365|NCT02834793|516458570|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
143247366|NCT02834793|516458571|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
143247367|NCT01731938|516458572|FG000|Preliminary Part I|Withdrawal by Subject|2|||
143247368|NCT01731938|516458573|FG001|Preliminary Part I|Withdrawal by Subject|2|||
143247369|NCT01731938|516458572|FG000|Preliminary Part I|Physician Decision|1|||
143247370|NCT01731938|516458573|FG001|Preliminary Part I|Physician Decision|0|||
143247371|NCT01731938|516458572|FG000|Preliminary Part I|Lost to Follow-up|0|||
143247372|NCT01731938|516458573|FG001|Preliminary Part I|Lost to Follow-up|3|||
143247373|NCT01731938|516458572|FG000|Preliminary Part I|Missed Week 6 visit|0|||
143247374|NCT01731938|516458573|FG001|Preliminary Part I|Missed Week 6 visit|3|||
143247375|NCT01731938|516458572|FG000|Primary Part II|Withdrawal by Subject|5|||
143247376|NCT01731938|516458573|FG001|Primary Part II|Withdrawal by Subject|4|||
143247377|NCT01731938|516458572|FG000|Primary Part II|Lost to Follow-up|4|||
143247378|NCT01731938|516458573|FG001|Primary Part II|Lost to Follow-up|5|||
143247379|NCT01731938|516458572|FG000|Primary Part II|Death|2|||
143247380|NCT01731938|516458573|FG001|Primary Part II|Death|1|||
143247381|NCT01731938|516458572|FG000|Primary Part II|Missed Week 6 visit|2|||
143247382|NCT01731938|516458573|FG001|Primary Part II|Missed Week 6 visit|3|||
143247383|NCT04931888|516458574|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
143247384|NCT04931888|516458575|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
143247385|NCT04931888|516458576|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
143247386|NCT04931888|516458577|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
143247387|NCT01049009|516458578|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
143247388|NCT01049009|516458579|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
143247389|NCT01049009|516458578|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
143247390|NCT01049009|516458579|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
143247391|NCT01049009|516458578|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
143247392|NCT01049009|516458579|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
143247393|NCT01049009|516458578|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
143365347|NCT05015478|516880749|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
143504531|NCT05919823|517385692|FG002|Pre-Treatment Period|Protocol Violation|0|||
143504532|NCT05919823|517385693|FG003|Pre-Treatment Period|Protocol Violation|0|||
143247394|NCT01049009|516458579|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
143247395|NCT00622440|516458580|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
143365348|NCT00770211|516880750|FG000|Overall Study|Lost to Follow-up|1|||
143068917|NCT03514641|515795068|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
143068918|NCT03514641|515795069|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
143247396|NCT00622440|516458581|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
143247397|NCT00622440|516458580|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
143247398|NCT00622440|516458581|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
143247399|NCT00622440|516458580|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
143247400|NCT00622440|516458581|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
143247401|NCT00622440|516458580|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
143247402|NCT00622440|516458581|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
143247403|NCT00771953|516458582|FG000|Overall Study|Adverse Event|5|||
143247404|NCT00771953|516458583|FG001|Overall Study|Adverse Event|3|||
143247405|NCT00771953|516458582|FG000|Overall Study|Death|2|||
143247406|NCT00771953|516458583|FG001|Overall Study|Death|2|||
143247407|NCT00771953|516458582|FG000|Overall Study|Progression before active Tx|1|||
143247408|NCT00771953|516458583|FG001|Overall Study|Progression before active Tx|2|||
143247409|NCT00771953|516458582|FG000|Overall Study|Sponsor decision|1|||
143247410|NCT00771953|516458583|FG001|Overall Study|Sponsor decision|0|||
143247411|NCT00771953|516458582|FG000|Overall Study|Other complicating disease|1|||
143247412|NCT00771953|516458583|FG001|Overall Study|Other complicating disease|0|||
143247413|NCT00771953|516458582|FG000|Overall Study|Withdrawal by Subject|0|||
143247414|NCT00771953|516458583|FG001|Overall Study|Withdrawal by Subject|3|||
143247415|NCT00947193|516458586|FG000|Overall Study|Lost to Follow-up|1|||
143247416|NCT00947193|516458587|FG001|Overall Study|Lost to Follow-up|0|||
143247417|NCT00947193|516458586|FG000|Overall Study|Withdrawal by Subject|1|||
143247418|NCT00947193|516458587|FG001|Overall Study|Withdrawal by Subject|0|||
143247419|NCT00947193|516458586|FG000|Overall Study|Factor VIII >1%|1|||
143247420|NCT00947193|516458587|FG001|Overall Study|Factor VIII >1%|0|||
143247421|NCT04364984|516458588|FG000|Overall Study|Death|2|||
143247422|NCT04364984|516458589|FG001|Overall Study|Death|2|||
143247423|NCT04364984|516458590|FG002|Overall Study|Death|0|||
143247424|NCT01349959|516458591|FG000|Overall Study|Adverse Event|7|||
143247425|NCT01941186|516458592|FG000|Follow-up|Lost to Follow-up|1|||
143247426|NCT01941186|516458593|FG001|Follow-up|Lost to Follow-up|0|||
143247427|NCT01092117|516458594|FG000|Index Procedure to 1 Month|Death|1|||
143247428|NCT01092117|516458594|FG000|1 Month|Death|1|||
143247429|NCT01092117|516458594|FG000|1 Month|Withdrawal by Subject|1|||
143247430|NCT01092117|516458594|FG000|1 Month|Lost to Follow-up|1|||
143365349|NCT00770211|516880751|FG001|Overall Study|Lost to Follow-up|0|||
143365350|NCT00770211|516880750|FG000|Overall Study|Withdrawal by Subject|0|||
143068919|NCT03514641|515795066|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
143247431|NCT01092117|516458594|FG000|6 Months|Death|2|||
143247432|NCT01092117|516458594|FG000|6 Months|Withdrawal by Subject|3|||
143247433|NCT01092117|516458594|FG000|12 Month|Death|11|||
143247434|NCT01092117|516458594|FG000|12 Month|Withdrawal by Subject|2|||
143247435|NCT01092117|516458594|FG000|12 Month|Lost to Follow-up|1|||
143247436|NCT01092117|516458594|FG000|Year 2|Death|5|||
143068920|NCT03514641|515795067|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
143068921|NCT03514641|515795068|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
143068922|NCT03514641|515795069|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
143068923|NCT03514641|515795066|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
143068924|NCT03514641|515795067|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
143068925|NCT03514641|515795068|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
143068926|NCT03514641|515795069|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
143171130|NCT04532749|516174871|FG000|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|2|||
143171131|NCT04532749|516174872|FG001|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|5|||
143504533|NCT05919823|517385690|FG000|Double-Blind Period|Adverse Event|8|||
143504534|NCT05919823|517385691|FG001|Double-Blind Period|Adverse Event|9|||
143504535|NCT05919823|517385692|FG002|Double-Blind Period|Adverse Event|0|||
143504536|NCT05919823|517385693|FG003|Double-Blind Period|Adverse Event|0|||
143504537|NCT05919823|517385690|FG000|Double-Blind Period|Protocol Violation|2|||
143504538|NCT05919823|517385691|FG001|Double-Blind Period|Protocol Violation|1|||
143504539|NCT05919823|517385692|FG002|Double-Blind Period|Protocol Violation|0|||
143504540|NCT05919823|517385693|FG003|Double-Blind Period|Protocol Violation|0|||
143504541|NCT05919823|517385690|FG000|Double-Blind Period|Participant withdrew consent|11|||
143504542|NCT05919823|517385691|FG001|Double-Blind Period|Participant withdrew consent|7|||
143171132|NCT04532749|516174871|FG000|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|2|||
143171133|NCT04532749|516174872|FG001|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|0|||
143171134|NCT04532749|516174871|FG000|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|0|||
143171135|NCT04532749|516174872|FG001|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|1|||
143171136|NCT04532749|516174871|FG000|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|0|||
143171137|NCT04532749|516174872|FG001|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|1|||
143171138|NCT04532749|516174871|FG000|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|0|||
143171139|NCT04532749|516174872|FG001|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|1|||
143171140|NCT04532749|516174871|FG000|DB Treatment Phase (Day 1 to Day 43)|Other|1|||
143171141|NCT04532749|516174872|FG001|DB Treatment Phase (Day 1 to Day 43)|Other|2|||
143171142|NCT04532749|516174871|FG000|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|0|||
143247437|NCT01092117|516458594|FG000|Year 2|Withdrawal by Subject|4|||
143504543|NCT05919823|517385692|FG002|Double-Blind Period|Participant withdrew consent|0|||
143504544|NCT05919823|517385693|FG003|Double-Blind Period|Participant withdrew consent|0|||
143504545|NCT05919823|517385690|FG000|Double-Blind Period|Other reasons|2|||
143504546|NCT05919823|517385691|FG001|Double-Blind Period|Other reasons|3|||
143504547|NCT05919823|517385692|FG002|Double-Blind Period|Other reasons|0|||
143171143|NCT04532749|516174872|FG001|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|3|||
143247438|NCT01092117|516458594|FG000|Year 2|Lost to Follow-up|1|||
143504548|NCT05919823|517385693|FG003|Double-Blind Period|Other reasons|0|||
143504549|NCT05919823|517385690|FG000|Open Label Period|Adverse Event|0|||
143504550|NCT05919823|517385691|FG001|Open Label Period|Adverse Event|0|||
143504551|NCT05919823|517385692|FG002|Open Label Period|Adverse Event|2|||
143504552|NCT05919823|517385693|FG003|Open Label Period|Adverse Event|4|||
143504553|NCT05919823|517385690|FG000|Open Label Period|Lost to Follow-up|0|||
143504554|NCT05919823|517385691|FG001|Open Label Period|Lost to Follow-up|0|||
143504555|NCT05919823|517385692|FG002|Open Label Period|Lost to Follow-up|1|||
143504556|NCT05919823|517385693|FG003|Open Label Period|Lost to Follow-up|0|||
143504557|NCT05919823|517385690|FG000|Open Label Period|Protocol Violation|0|||
143504558|NCT05919823|517385691|FG001|Open Label Period|Protocol Violation|0|||
143504559|NCT05919823|517385692|FG002|Open Label Period|Protocol Violation|0|||
143504560|NCT05919823|517385693|FG003|Open Label Period|Protocol Violation|1|||
143504561|NCT05919823|517385690|FG000|Open Label Period|Participant withdrew consent|0|||
143504562|NCT05919823|517385691|FG001|Open Label Period|Participant withdrew consent|0|||
143504563|NCT05919823|517385692|FG002|Open Label Period|Participant withdrew consent|8|||
143504564|NCT05919823|517385693|FG003|Open Label Period|Participant withdrew consent|6|||
143504565|NCT05919823|517385690|FG000|Open Label Period|Death|0|||
143247439|NCT01092117|516458594|FG000|Year 3|Death|7|||
143247440|NCT01092117|516458594|FG000|Year 3|Withdrawal by Subject|9|||
143247441|NCT01092117|516458594|FG000|Year 3|Lost to Follow-up|3|||
143247442|NCT01092117|516458594|FG000|Year 4|Death|8|||
143247443|NCT01092117|516458594|FG000|Year 4|Withdrawal by Subject|4|||
143247444|NCT01092117|516458594|FG000|Year 4|Lost to Follow-up|4|||
143247445|NCT01068600|516458595|FG000|Overall Study|Withdrawal by Subject|5|||
143247446|NCT01068600|516458596|FG001|Overall Study|Withdrawal by Subject|6|||
143247447|NCT01068600|516458595|FG000|Overall Study|Adverse Event|3|||
143247448|NCT01068600|516458596|FG001|Overall Study|Adverse Event|3|||
143247449|NCT01068600|516458595|FG000|Overall Study|Abnormal laboratory value(s)|1|||
143504566|NCT05919823|517385691|FG001|Open Label Period|Death|0|||
143504567|NCT05919823|517385692|FG002|Open Label Period|Death|0|||
143504568|NCT05919823|517385693|FG003|Open Label Period|Death|1|||
143068927|NCT03514641|515795066|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
143068928|NCT03514641|515795067|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
143247450|NCT01068600|516458596|FG001|Overall Study|Abnormal laboratory value(s)|0|||
143247451|NCT01068600|516458595|FG000|Overall Study|Lost to Follow-up|1|||
143247452|NCT01068600|516458596|FG001|Overall Study|Lost to Follow-up|2|||
143247453|NCT01068600|516458595|FG000|Overall Study|Protocol deviation|1|||
143247454|NCT01068600|516458596|FG001|Overall Study|Protocol deviation|1|||
143247455|NCT01068600|516458595|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
143247456|NCT01068600|516458596|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
143247457|NCT01068600|516458595|FG000|Overall Study|Administrative problems|0|||
143247458|NCT01068600|516458596|FG001|Overall Study|Administrative problems|1|||
143247459|NCT01191762|516458597|FG000|Overall Study|Adverse Event|1|||
143247460|NCT01191762|516458598|FG001|Overall Study|Adverse Event|0|||
143247461|NCT01519869|516458601|FG000|Overall Study|Lost to Follow-up|1|||
143247462|NCT03023813|516458602|FG000|Overall Study|Lost to Follow-up|1|||
143247463|NCT03023813|516458603|FG001|Overall Study|Lost to Follow-up|2|||
143247464|NCT03023813|516458604|FG002|Overall Study|Lost to Follow-up|0|||
143247465|NCT00202878|516458606|FG000|Overall Study|Death|964|||
143247466|NCT00202878|516458607|FG001|Overall Study|Death|968|||
143247467|NCT00202878|516458606|FG000|Overall Study|Only Vital Status Known|357|||
143247468|NCT00202878|516458607|FG001|Overall Study|Only Vital Status Known|356|||
143247469|NCT00202878|516458606|FG000|Overall Study|Lost to Follow-up|44|||
143247470|NCT00202878|516458607|FG001|Overall Study|Lost to Follow-up|49|||
143247471|NCT00202878|516458606|FG000|Overall Study|Site Closure|39|||
143247472|NCT00202878|516458607|FG001|Overall Study|Site Closure|36|||
143247473|NCT00202878|516458606|FG000|Overall Study|Withdrawal by Subject|795|||
143247474|NCT00202878|516458607|FG001|Overall Study|Withdrawal by Subject|808|||
143247475|NCT02123472|516458608|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
143247476|NCT02123472|516458609|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
143247477|NCT02433080|516458611|FG000|Overall Study|Lost to Follow-up|1|||
143247478|NCT02433080|516458612|FG001|Overall Study|Lost to Follow-up|2|||
143247479|NCT02433080|516458611|FG000|Overall Study|Withdrawal by Subject|0|||
143247480|NCT02433080|516458612|FG001|Overall Study|Withdrawal by Subject|2|||
143247481|NCT03801031|516458613|FG000|Overall Study|Lost to Follow-up|1|||
143247482|NCT03801031|516458614|FG001|Overall Study|Lost to Follow-up|0|||
143247483|NCT03801031|516458613|FG000|Overall Study|Unable to comply|1|||
143247484|NCT03801031|516458614|FG001|Overall Study|Unable to comply|0|||
143247485|NCT03801031|516458613|FG000|Overall Study|Withdrawal by Subject|0|||
143247486|NCT03801031|516458614|FG001|Overall Study|Withdrawal by Subject|1|||
143247487|NCT01598506|516458617|FG000|Overall Study|Withdrawal by Subject|2|||
143247488|NCT00035932|516458624|FG000|Overall Study|Adverse Event|10|||
143247489|NCT00035932|516458625|FG001|Overall Study|Adverse Event|9|||
143247490|NCT00035932|516458626|FG002|Overall Study|Adverse Event|9|||
143247491|NCT00035932|516458624|FG000|Overall Study|Death|0|||
143247492|NCT00035932|516458625|FG001|Overall Study|Death|0|||
143247493|NCT00035932|516458626|FG002|Overall Study|Death|1|||
143247494|NCT00035932|516458624|FG000|Overall Study|Disease Progression / Relapse|1|||
143247495|NCT00035932|516458625|FG001|Overall Study|Disease Progression / Relapse|1|||
143247496|NCT00035932|516458626|FG002|Overall Study|Disease Progression / Relapse|0|||
143247497|NCT00035932|516458624|FG000|Overall Study|Lost to Follow-up|4|||
143247498|NCT00035932|516458625|FG001|Overall Study|Lost to Follow-up|4|||
143247499|NCT00035932|516458626|FG002|Overall Study|Lost to Follow-up|3|||
143247500|NCT00035932|516458624|FG000|Overall Study|Noncompliance|6|||
143247501|NCT00035932|516458625|FG001|Overall Study|Noncompliance|7|||
143247502|NCT00035932|516458626|FG002|Overall Study|Noncompliance|6|||
143247503|NCT00035932|516458624|FG000|Overall Study|Protocol Violation While on Study|0|||
143247504|NCT00035932|516458625|FG001|Overall Study|Protocol Violation While on Study|1|||
143068929|NCT03514641|515795068|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
143068930|NCT03514641|515795069|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
143068931|NCT03709823|515795070|FG000|Overall Study|Adverse Event|0|||
143068932|NCT03709823|515795071|FG001|Overall Study|Adverse Event|0|||
143068933|NCT03709823|515795072|FG002|Overall Study|Adverse Event|1|||
143068934|NCT03709823|515795073|FG003|Overall Study|Adverse Event|0|||
143068935|NCT03709823|515795074|FG004|Overall Study|Adverse Event|0|||
143068936|NCT03709823|515795075|FG005|Overall Study|Adverse Event|0|||
143068937|NCT03709823|515795070|FG000|Overall Study|Lost to Follow-up|2|||
143068938|NCT03709823|515795071|FG001|Overall Study|Lost to Follow-up|2|||
143247505|NCT00035932|516458626|FG002|Overall Study|Protocol Violation While on Study|2|||
143247506|NCT00035932|516458624|FG000|Overall Study|Withdrawal by Subject|1|||
143247507|NCT00035932|516458625|FG001|Overall Study|Withdrawal by Subject|5|||
143247508|NCT00035932|516458626|FG002|Overall Study|Withdrawal by Subject|0|||
143068939|NCT03709823|515795072|FG002|Overall Study|Lost to Follow-up|2|||
143068940|NCT03709823|515795073|FG003|Overall Study|Lost to Follow-up|1|||
143068941|NCT03709823|515795074|FG004|Overall Study|Lost to Follow-up|1|||
143247509|NCT00035932|516458624|FG000|Overall Study|Study Termination by Sponsor|1|||
143247510|NCT00035932|516458625|FG001|Overall Study|Study Termination by Sponsor|0|||
143247511|NCT00035932|516458626|FG002|Overall Study|Study Termination by Sponsor|0|||
143247512|NCT00035932|516458624|FG000|Overall Study|Lack of Efficacy|33|||
143247513|NCT00035932|516458625|FG001|Overall Study|Lack of Efficacy|33|||
143247514|NCT00035932|516458626|FG002|Overall Study|Lack of Efficacy|28|||
143247515|NCT04413617|516458627|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
143504569|NCT05919823|517385690|FG000|Open Label Period|Other reasons|0|||
143504570|NCT05919823|517385691|FG001|Open Label Period|Other reasons|0|||
143068942|NCT03709823|515795075|FG005|Overall Study|Lost to Follow-up|0|||
143068943|NCT03709823|515795070|FG000|Overall Study|Withdrawal by Subject|1|||
143068944|NCT03709823|515795071|FG001|Overall Study|Withdrawal by Subject|3|||
143068945|NCT03709823|515795072|FG002|Overall Study|Withdrawal by Subject|0|||
143068946|NCT03709823|515795073|FG003|Overall Study|Withdrawal by Subject|0|||
143068947|NCT03709823|515795074|FG004|Overall Study|Withdrawal by Subject|0|||
143068948|NCT03709823|515795075|FG005|Overall Study|Withdrawal by Subject|0|||
143068949|NCT03709823|515795070|FG000|Overall Study|Other, Not Specified|0|||
143068950|NCT03709823|515795071|FG001|Overall Study|Other, Not Specified|0|||
143068951|NCT03709823|515795072|FG002|Overall Study|Other, Not Specified|0|||
143068952|NCT03709823|515795073|FG003|Overall Study|Other, Not Specified|1|||
143068953|NCT03709823|515795074|FG004|Overall Study|Other, Not Specified|0|||
143068954|NCT03709823|515795075|FG005|Overall Study|Other, Not Specified|0|||
143068955|NCT01246011|515795079|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
143068956|NCT01246011|515795080|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
143068957|NCT01246011|515795081|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
143068958|NCT01246011|515795079|FG000|Overall Study|Withdrawal by Subject|0|||
143068959|NCT01246011|515795080|FG001|Overall Study|Withdrawal by Subject|0|||
143068960|NCT01246011|515795081|FG002|Overall Study|Withdrawal by Subject|1|||
143068961|NCT01155024|515795082|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
143068962|NCT01155024|515795083|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
143068963|NCT01155024|515795082|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
143068964|NCT01155024|515795083|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
143068965|NCT01155024|515795082|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
143068966|NCT01155024|515795083|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
143068967|NCT03412396|515795087|FG000|Overall Study|Withdrawal by Subject|2|||
143068968|NCT03412396|515795087|FG000|Overall Study|"stopped apalutamide at <9 weeks after initiation"|1|||
143068969|NCT03412396|515795087|FG000|Overall Study|Did not undergo RP|2|||
143068970|NCT01593696|515795088|FG000|Dose Escalation|Progressive Disease|2|||
143068971|NCT01593696|515795089|FG001|Dose Escalation|Progressive Disease|0|||
143068972|NCT01593696|515795090|FG002|Dose Escalation|Progressive Disease|0|||
143068973|NCT01593696|515795091|FG003|Dose Escalation|Progressive Disease|0|||
143068974|NCT01593696|515795088|FG000|Dose Expansion|Fungal infection|0|||
143171144|NCT04532749|516174871|FG000|Follow-up Phase (Day 44 to Day 57)|Adverse Event|0|||
143171145|NCT04532749|516174872|FG001|Follow-up Phase (Day 44 to Day 57)|Adverse Event|1|||
143171146|NCT04532749|516174871|FG000|Follow-up Phase (Day 44 to Day 57)|Other|1|||
143171147|NCT04532749|516174872|FG001|Follow-up Phase (Day 44 to Day 57)|Other|2|||
143171148|NCT01323192|516175996|FG000|Overall Study|Adverse Event|6|||
143171149|NCT01323192|516175997|FG001|Overall Study|Adverse Event|1|||
143171150|NCT01323192|516175996|FG000|Overall Study|Withdrawal by Subject|3|||
143171151|NCT01323192|516175997|FG001|Overall Study|Withdrawal by Subject|1|||
143171152|NCT01323192|516175996|FG000|Overall Study|Noncompliance with study medication|0|||
143171153|NCT01323192|516175997|FG001|Overall Study|Noncompliance with study medication|3|||
143171154|NCT01323192|516175996|FG000|Overall Study|Nonmedical reasons|0|||
143171155|NCT01323192|516175997|FG001|Overall Study|Nonmedical reasons|1|||
143171156|NCT02276040|516176000|FG000|Overall Study|Physician Decision|15|||
143171157|NCT02835690|516176001|FG000|Overall Study|Death|12|||
143171158|NCT02835690|516176002|FG001|Overall Study|Death|11|||
143171159|NCT02835690|516176003|FG002|Overall Study|Death|13|||
143171160|NCT02835690|516176001|FG000|Overall Study|Transferred to Extension Study|2|||
143171161|NCT02835690|516176002|FG001|Overall Study|Transferred to Extension Study|2|||
143171162|NCT02835690|516176003|FG002|Overall Study|Transferred to Extension Study|1|||
143171163|NCT02835690|516176001|FG000|Overall Study|Did Not Continue on Extension Study|0|||
143171164|NCT02835690|516176002|FG001|Overall Study|Did Not Continue on Extension Study|0|||
143171165|NCT02835690|516176003|FG002|Overall Study|Did Not Continue on Extension Study|1|||
143171166|NCT02835690|516176001|FG000|Overall Study|Not Treated|0|||
143504571|NCT05919823|517385692|FG002|Open Label Period|Other reasons|9|||
143504572|NCT05919823|517385693|FG003|Open Label Period|Other reasons|5|||
143504573|NCT06065176|517385694|FG000|Overall Study|Lost to Follow-up|11|||
143504574|NCT06065176|517385695|FG001|Overall Study|Lost to Follow-up|11|||
143504575|NCT06065176|517385696|FG002|Overall Study|Lost to Follow-up|10|||
143504576|NCT06065176|517385694|FG000|Overall Study|Withdrawal by Subject|1|||
143504577|NCT06065176|517385695|FG001|Overall Study|Withdrawal by Subject|1|||
143504578|NCT06065176|517385696|FG002|Overall Study|Withdrawal by Subject|2|||
143504579|NCT06065176|517385694|FG000|Overall Study|No longer met eligibility requirements to continue participation.|3|||
143504580|NCT06065176|517385695|FG001|Overall Study|No longer met eligibility requirements to continue participation.|5|||
143504581|NCT06065176|517385696|FG002|Overall Study|No longer met eligibility requirements to continue participation.|1|||
143504582|NCT04521608|517385697|FG000|Overall Study|Death|8|||
143504583|NCT04521608|517385698|FG001|Overall Study|Death|9|||
143504584|NCT04521608|517385697|FG000|Overall Study|Withdrawal by Subject|25|||
143171167|NCT02835690|516176002|FG001|Overall Study|Not Treated|2|||
143171168|NCT02835690|516176003|FG002|Overall Study|Not Treated|0|||
143247516|NCT04413617|516458628|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
143247517|NCT04413617|516458629|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
143247518|NCT04413617|516458630|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
143247519|NCT04413617|516458631|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
143247520|NCT04413617|516458627|FG000|Overall Study|Protocol Violation|0|||
143247521|NCT04413617|516458628|FG001|Overall Study|Protocol Violation|1|||
143247522|NCT04413617|516458629|FG002|Overall Study|Protocol Violation|0|||
143247523|NCT04413617|516458630|FG003|Overall Study|Protocol Violation|0|||
143247524|NCT04413617|516458631|FG004|Overall Study|Protocol Violation|1|||
143247525|NCT04413617|516458627|FG000|Overall Study|Lack of Efficacy|2|||
143247526|NCT04413617|516458628|FG001|Overall Study|Lack of Efficacy|0|||
143247527|NCT04413617|516458629|FG002|Overall Study|Lack of Efficacy|2|||
143247528|NCT04413617|516458630|FG003|Overall Study|Lack of Efficacy|1|||
143247529|NCT04413617|516458631|FG004|Overall Study|Lack of Efficacy|0|||
143247530|NCT04413617|516458627|FG000|Overall Study|Withdrawal by Subject|3|||
143247531|NCT04413617|516458628|FG001|Overall Study|Withdrawal by Subject|4|||
143247532|NCT04413617|516458629|FG002|Overall Study|Withdrawal by Subject|2|||
143247533|NCT04413617|516458630|FG003|Overall Study|Withdrawal by Subject|5|||
143247534|NCT04413617|516458631|FG004|Overall Study|Withdrawal by Subject|3|||
143247535|NCT04413617|516458627|FG000|Overall Study|Death|1|||
143247536|NCT04413617|516458628|FG001|Overall Study|Death|0|||
143247537|NCT04413617|516458629|FG002|Overall Study|Death|0|||
143247538|NCT04413617|516458630|FG003|Overall Study|Death|0|||
143247539|NCT04413617|516458631|FG004|Overall Study|Death|0|||
143247540|NCT04413617|516458627|FG000|Overall Study|Adverse Event|1|||
143247541|NCT04413617|516458628|FG001|Overall Study|Adverse Event|0|||
143068975|NCT01593696|515795089|FG001|Dose Expansion|Fungal infection|0|||
143068976|NCT01593696|515795090|FG002|Dose Expansion|Fungal infection|1|||
143068977|NCT01593696|515795091|FG003|Dose Expansion|Fungal infection|0|||
143068978|NCT01683838|515795101|FG000|Overall Study|Adverse Event|12|||
143068979|NCT01683838|515795102|FG001|Overall Study|Adverse Event|2|||
143068980|NCT01683838|515795101|FG000|Overall Study|Protocol Violation|3|||
143068981|NCT01683838|515795102|FG001|Overall Study|Protocol Violation|1|||
143068982|NCT01683838|515795101|FG000|Overall Study|Withdrawal by Subject|6|||
143068983|NCT01683838|515795102|FG001|Overall Study|Withdrawal by Subject|5|||
143068984|NCT01683838|515795101|FG000|Overall Study|Lost to Follow-up|1|||
143068985|NCT01683838|515795102|FG001|Overall Study|Lost to Follow-up|1|||
143068986|NCT01683838|515795101|FG000|Overall Study|Other|4|||
143068987|NCT01683838|515795102|FG001|Overall Study|Other|3|||
143068988|NCT03397771|515795105|FG000|Overall Study|2 erroneously randomized, never treated|3|||
143068989|NCT03397771|515795106|FG001|Overall Study|2 erroneously randomized, never treated|1|||
143068990|NCT03397771|515795105|FG000|Overall Study|Withdrawal by Subject|1|||
143068991|NCT03397771|515795106|FG001|Overall Study|Withdrawal by Subject|3|||
143068992|NCT03397771|515795105|FG000|Overall Study|Protocol Violation|2|||
143068993|NCT03397771|515795106|FG001|Overall Study|Protocol Violation|2|||
143068994|NCT03397771|515795105|FG000|Overall Study|Adverse Event|2|||
143068995|NCT03397771|515795106|FG001|Overall Study|Adverse Event|1|||
143068996|NCT01831765|515795107|FG000|Overall Study|Lack of Efficacy|1|||
143068997|NCT01831765|515795108|FG001|Overall Study|Lack of Efficacy|0|||
143068998|NCT01831765|515795109|FG002|Overall Study|Lack of Efficacy|0|||
143068999|NCT01831765|515795107|FG000|Overall Study|Other, sponsor withdrew subject|0|||
143069000|NCT01831765|515795108|FG001|Overall Study|Other, sponsor withdrew subject|1|||
143069001|NCT01831765|515795109|FG002|Overall Study|Other, sponsor withdrew subject|0|||
143069002|NCT01831765|515795107|FG000|Overall Study|Pregnancy|1|||
143069003|NCT01831765|515795108|FG001|Overall Study|Pregnancy|1|||
143069004|NCT01831765|515795109|FG002|Overall Study|Pregnancy|2|||
143069005|NCT01831765|515795107|FG000|Overall Study|Death|0|||
143069006|NCT01831765|515795108|FG001|Overall Study|Death|1|||
143069007|NCT01831765|515795109|FG002|Overall Study|Death|1|||
143069008|NCT01831765|515795107|FG000|Overall Study|Other, site closed|1|||
143069009|NCT01831765|515795108|FG001|Overall Study|Other, site closed|1|||
143069010|NCT01831765|515795109|FG002|Overall Study|Other, site closed|0|||
143069011|NCT01831765|515795107|FG000|Overall Study|Adverse Event|5|||
143069012|NCT01831765|515795108|FG001|Overall Study|Adverse Event|3|||
143247542|NCT04413617|516458629|FG002|Overall Study|Adverse Event|0|||
143247543|NCT04413617|516458630|FG003|Overall Study|Adverse Event|1|||
143247544|NCT04413617|516458631|FG004|Overall Study|Adverse Event|1|||
143247545|NCT04413617|516458627|FG000|Overall Study|COVID-19|0|||
143069013|NCT01831765|515795109|FG002|Overall Study|Adverse Event|3|||
143069014|NCT01831765|515795107|FG000|Overall Study|Withdrawal by Subject|22|||
143069015|NCT01831765|515795108|FG001|Overall Study|Withdrawal by Subject|7|||
143247546|NCT04413617|516458628|FG001|Overall Study|COVID-19|1|||
143247547|NCT04413617|516458629|FG002|Overall Study|COVID-19|0|||
143247548|NCT04413617|516458630|FG003|Overall Study|COVID-19|0|||
143069016|NCT01831765|515795109|FG002|Overall Study|Withdrawal by Subject|17|||
143247549|NCT04413617|516458631|FG004|Overall Study|COVID-19|0|||
143247550|NCT01703754|516458634|FG000|Overall Study|Clinically significant disease progression|2|||
143247551|NCT01703754|516458635|FG001|Overall Study|Clinically significant disease progression|2|||
143069017|NCT01831765|515795107|FG000|Overall Study|Withdrawal criteria|12|||
143069018|NCT01831765|515795108|FG001|Overall Study|Withdrawal criteria|10|||
143069019|NCT01831765|515795109|FG002|Overall Study|Withdrawal criteria|16|||
143069020|NCT01831765|515795107|FG000|Overall Study|Lost to Follow-up|2|||
143069021|NCT01831765|515795108|FG001|Overall Study|Lost to Follow-up|3|||
143069022|NCT01831765|515795109|FG002|Overall Study|Lost to Follow-up|3|||
143069023|NCT02524730|515795110|FG000|Overall Study|Lost to Follow-up|5|||
143069024|NCT02524730|515795110|FG000|Overall Study|Withdrawal by Subject|18|||
143069025|NCT02524730|515795110|FG000|Overall Study|Death|10|||
143069026|NCT02524730|515795110|FG000|Overall Study|Adverse Event|8|||
143069027|NCT02524730|515795110|FG000|Overall Study|Protocol Violation|1|||
143069028|NCT02524730|515795110|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
143069029|NCT00507130|515795111|FG000|Overall Study|Lost to Follow-up|0|||
143069030|NCT00507130|515795112|FG001|Overall Study|Lost to Follow-up|0|||
143069031|NCT00507130|515795113|FG002|Overall Study|Lost to Follow-up|1|||
143069032|NCT00507130|515795114|FG003|Overall Study|Lost to Follow-up|1|||
143069033|NCT00507130|515795111|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
143069034|NCT00507130|515795112|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
143069035|NCT00507130|515795113|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
143069036|NCT00507130|515795114|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
143069037|NCT01460901|515795119|FG000|Overall Study|Withdrawal by Subject|2|||
143069038|NCT01156142|515795120|FG000|Overall Study|Withdrawal by Subject|8|||
143069039|NCT01156142|515795121|FG001|Overall Study|Withdrawal by Subject|6|||
143069040|NCT01156142|515795120|FG000|Overall Study|Ineligible|0|||
143069041|NCT01156142|515795121|FG001|Overall Study|Ineligible|1|||
143069042|NCT02272634|515795124|FG000|Overall Study|Adverse Event|1|||
143069043|NCT02272634|515795125|FG001|Overall Study|Adverse Event|0|||
143069044|NCT02272634|515795126|FG002|Overall Study|Adverse Event|0|||
143069045|NCT02272634|515795124|FG000|Overall Study|Protocol Violation|0|||
143069046|NCT02272634|515795125|FG001|Overall Study|Protocol Violation|0|||
143069047|NCT02272634|515795126|FG002|Overall Study|Protocol Violation|1|||
143069048|NCT02272634|515795124|FG000|Overall Study|Withdrawal by Subject|0|||
143069049|NCT02272634|515795125|FG001|Overall Study|Withdrawal by Subject|1|||
143069050|NCT02272634|515795126|FG002|Overall Study|Withdrawal by Subject|0|||
143069051|NCT00546572|515795128|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
143069052|NCT00546572|515795129|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
143069053|NCT00546572|515795128|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
143069054|NCT00546572|515795129|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
143069055|NCT00546572|515795128|FG000|Vax 1 / Year 0|Protocol Violation|3|||
143069056|NCT00546572|515795129|FG001|Vax 1 / Year 0|Protocol Violation|4|||
143069057|NCT00546572|515795128|FG000|Vax 1 / Year 0|Death|2|||
143069058|NCT00546572|515795129|FG001|Vax 1 / Year 0|Death|2|||
143069059|NCT00546572|515795128|FG000|Vax 1 / Year 0|Adverse Event|0|||
143069060|NCT00546572|515795129|FG001|Vax 1 / Year 0|Adverse Event|1|||
143069061|NCT00546572|515795128|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
143069062|NCT00546572|515795129|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
143069063|NCT00546572|515795128|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
143069064|NCT00546572|515795129|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
143069065|NCT00546572|515795128|FG000|Vax 2 / Year 1|Other|1|||
143069066|NCT00546572|515795129|FG001|Vax 2 / Year 1|Other|1|||
143069067|NCT00546572|515795128|FG000|Vax 2 / Year 1|Adverse Event|1|||
143069068|NCT00546572|515795129|FG001|Vax 2 / Year 1|Adverse Event|0|||
143069069|NCT00546572|515795128|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
143069070|NCT00546572|515795129|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
143069071|NCT00988065|515795130|FG000|Overall Study|Adverse Event|4|||
143069072|NCT00988065|515795131|FG001|Overall Study|Adverse Event|10|||
143069073|NCT00988065|515795132|FG002|Overall Study|Adverse Event|2|||
143069074|NCT00988065|515795130|FG000|Overall Study|Lost to Follow-up|1|||
143069075|NCT00988065|515795131|FG001|Overall Study|Lost to Follow-up|2|||
143069076|NCT00988065|515795132|FG002|Overall Study|Lost to Follow-up|2|||
143069077|NCT00988065|515795130|FG000|Overall Study|Subject withdrew consent|3|||
143069078|NCT00988065|515795131|FG001|Overall Study|Subject withdrew consent|5|||
143069079|NCT00988065|515795132|FG002|Overall Study|Subject withdrew consent|2|||
143069080|NCT00988065|515795130|FG000|Overall Study|Noncompliance with protocol|5|||
143171169|NCT03674281|516176004|FG000|Overall Study|screen failure|2|||
143069081|NCT00988065|515795131|FG001|Overall Study|Noncompliance with protocol|6|||
143069082|NCT00988065|515795132|FG002|Overall Study|Noncompliance with protocol|9|||
143069083|NCT01355159|515795142|FG000|Overall Study|Withdrew consent|39|||
143069084|NCT01355159|515795143|FG001|Overall Study|Withdrew consent|47|||
143069085|NCT01355159|515795142|FG000|Overall Study|No primary outcome data|17|||
143069086|NCT01355159|515795143|FG001|Overall Study|No primary outcome data|11|||
143069087|NCT01355159|515795142|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
143069088|NCT01355159|515795143|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
143069089|NCT01355159|515795142|FG000|Overall Study|Early intrauterine fetal death|6|||
143171170|NCT03674281|516176005|FG001|Overall Study|screen failure|0|||
143069090|NCT01355159|515795143|FG001|Overall Study|Early intrauterine fetal death|6|||
143171171|NCT03674281|516176006|FG002|Overall Study|screen failure|0|||
143069091|NCT02615171|515795144|FG000|Overall Study|Lost to Follow-up|2|||
143069092|NCT02615171|515795145|FG001|Overall Study|Lost to Follow-up|1|||
143069093|NCT00502801|515795152|FG000|Treatment Period|Withdrawal by Subject|3|||
143069094|NCT00502801|515795152|FG000|Treatment Period|Adverse Event|7|||
143069095|NCT00502801|515795152|FG000|Treatment Period|Death|14|||
143069096|NCT00502801|515795152|FG000|Treatment Period|OTHER|30|||
143069097|NCT00502801|515795152|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
143069098|NCT00502801|515795152|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
143069099|NCT00502801|515795152|FG000|End of Therapy to Test of Cure|Death|3|||
143069100|NCT00502801|515795152|FG000|End of Therapy to Test of Cure|OTHER|2|||
143069101|NCT03212521|515795156|FG000|Overall Study|Adverse Event|1|||
143069102|NCT03212521|515795156|FG000|Overall Study|Lost to Follow-up|4|||
143069103|NCT03212521|515795156|FG000|Overall Study|Withdrawal by Subject|1|||
143069104|NCT03212521|515795156|FG000|Overall Study|Other|1|||
143069105|NCT00914459|515795157|FG000|Overall Study|Protocol Violation|0|||
143069106|NCT00914459|515795158|FG001|Overall Study|Protocol Violation|1|||
143069107|NCT00914459|515795157|FG000|Overall Study|Parent/Legal guardian request|1|||
143069108|NCT00914459|515795158|FG001|Overall Study|Parent/Legal guardian request|0|||
143069109|NCT01970865|515795159|FG000|Overall Study|Death|3|||
143069110|NCT01970865|515795160|FG001|Overall Study|Death|2|||
143069111|NCT01970865|515795161|FG002|Overall Study|Death|3|||
143069112|NCT01970865|515795162|FG003|Overall Study|Death|6|||
143069113|NCT01970865|515795163|FG004|Overall Study|Death|9|||
143069114|NCT01970865|515795164|FG005|Overall Study|Death|3|||
143069115|NCT01970865|515795165|FG006|Overall Study|Death|2|||
143069116|NCT01970865|515795166|FG007|Overall Study|Death|3|||
143069117|NCT01970865|515795167|FG008|Overall Study|Death|2|||
143069118|NCT01970865|515795168|FG009|Overall Study|Death|2|||
143069119|NCT01970865|515795169|FG010|Overall Study|Death|8|||
143069120|NCT01970865|515795170|FG011|Overall Study|Death|13|||
143069121|NCT01970865|515795171|FG012|Overall Study|Death|25|||
143069122|NCT01970865|515795172|FG013|Overall Study|Death|46|||
143069123|NCT01970865|515795173|FG014|Overall Study|Death|37|||
143069124|NCT01970865|515795174|FG015|Overall Study|Death|22|||
143069125|NCT01970865|515795175|FG016|Overall Study|Death|1|||
143069126|NCT01970865|515795176|FG017|Overall Study|Death|17|||
143069127|NCT01970865|515795159|FG000|Overall Study|Lost to Follow-up|0|||
143069128|NCT01970865|515795160|FG001|Overall Study|Lost to Follow-up|0|||
143069129|NCT01970865|515795161|FG002|Overall Study|Lost to Follow-up|0|||
143069130|NCT01970865|515795162|FG003|Overall Study|Lost to Follow-up|1|||
143069131|NCT01970865|515795163|FG004|Overall Study|Lost to Follow-up|1|||
143069132|NCT01970865|515795164|FG005|Overall Study|Lost to Follow-up|0|||
143069133|NCT01970865|515795165|FG006|Overall Study|Lost to Follow-up|0|||
143069134|NCT01970865|515795166|FG007|Overall Study|Lost to Follow-up|0|||
143069135|NCT01970865|515795167|FG008|Overall Study|Lost to Follow-up|0|||
143069136|NCT01970865|515795168|FG009|Overall Study|Lost to Follow-up|0|||
143069137|NCT01970865|515795169|FG010|Overall Study|Lost to Follow-up|1|||
143069138|NCT01970865|515795170|FG011|Overall Study|Lost to Follow-up|0|||
143069139|NCT01970865|515795171|FG012|Overall Study|Lost to Follow-up|2|||
143069140|NCT01970865|515795172|FG013|Overall Study|Lost to Follow-up|0|||
143069141|NCT01970865|515795173|FG014|Overall Study|Lost to Follow-up|1|||
143069142|NCT01970865|515795174|FG015|Overall Study|Lost to Follow-up|4|||
143069143|NCT01970865|515795175|FG016|Overall Study|Lost to Follow-up|0|||
143069144|NCT01970865|515795176|FG017|Overall Study|Lost to Follow-up|1|||
143069145|NCT01970865|515795159|FG000|Overall Study|Other|0|||
143069146|NCT01970865|515795160|FG001|Overall Study|Other|1|||
143069147|NCT01970865|515795161|FG002|Overall Study|Other|0|||
143069148|NCT01970865|515795162|FG003|Overall Study|Other|1|||
143069149|NCT01970865|515795163|FG004|Overall Study|Other|1|||
143069150|NCT01970865|515795164|FG005|Overall Study|Other|0|||
143069151|NCT01970865|515795165|FG006|Overall Study|Other|1|||
143069152|NCT01970865|515795166|FG007|Overall Study|Other|0|||
143069153|NCT01970865|515795167|FG008|Overall Study|Other|0|||
143069154|NCT01970865|515795168|FG009|Overall Study|Other|0|||
143069155|NCT01970865|515795169|FG010|Overall Study|Other|2|||
143069156|NCT01970865|515795170|FG011|Overall Study|Other|3|||
143069157|NCT01970865|515795171|FG012|Overall Study|Other|8|||
143069158|NCT01970865|515795172|FG013|Overall Study|Other|3|||
143247552|NCT01703754|516458636|FG002|Overall Study|Clinically significant disease progression|1|||
143069159|NCT01970865|515795173|FG014|Overall Study|Other|2|||
143069160|NCT01970865|515795174|FG015|Overall Study|Other|3|||
143069161|NCT01970865|515795175|FG016|Overall Study|Other|0|||
143069162|NCT01970865|515795176|FG017|Overall Study|Other|2|||
143069163|NCT01970865|515795159|FG000|Overall Study|Participant refused further follow-up|0|||
143069164|NCT01970865|515795160|FG001|Overall Study|Participant refused further follow-up|0|||
143069165|NCT01970865|515795161|FG002|Overall Study|Participant refused further follow-up|0|||
143069166|NCT01970865|515795162|FG003|Overall Study|Participant refused further follow-up|2|||
143069167|NCT01970865|515795163|FG004|Overall Study|Participant refused further follow-up|3|||
143069168|NCT01970865|515795164|FG005|Overall Study|Participant refused further follow-up|0|||
143069169|NCT01970865|515795165|FG006|Overall Study|Participant refused further follow-up|0|||
143069170|NCT01970865|515795166|FG007|Overall Study|Participant refused further follow-up|0|||
143069171|NCT01970865|515795167|FG008|Overall Study|Participant refused further follow-up|0|||
143069172|NCT01970865|515795168|FG009|Overall Study|Participant refused further follow-up|0|||
143069173|NCT01970865|515795169|FG010|Overall Study|Participant refused further follow-up|1|||
143069174|NCT01970865|515795170|FG011|Overall Study|Participant refused further follow-up|4|||
143069175|NCT01970865|515795171|FG012|Overall Study|Participant refused further follow-up|7|||
143069176|NCT01970865|515795172|FG013|Overall Study|Participant refused further follow-up|8|||
143069177|NCT01970865|515795173|FG014|Overall Study|Participant refused further follow-up|3|||
143069178|NCT01970865|515795174|FG015|Overall Study|Participant refused further follow-up|11|||
143069179|NCT01970865|515795175|FG016|Overall Study|Participant refused further follow-up|0|||
143069180|NCT01970865|515795176|FG017|Overall Study|Participant refused further follow-up|6|||
143069181|NCT01661179|515795177|FG000|Overall Study|Death|1|||
143069182|NCT01661179|515795177|FG000|Overall Study|Withdrawal by Subject|1|||
143069183|NCT01661179|515795177|FG000|Overall Study|Other Eligibility criteria|4|||
143069184|NCT01946191|515795178|FG000|Allocation|Did not complete orientation|1|||
143069185|NCT01946191|515795179|FG001|Allocation|Did not complete orientation|1|||
143069186|NCT01946191|515795178|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
143069187|NCT01946191|515795179|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
143069188|NCT01946191|515795178|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
143069189|NCT01946191|515795179|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
143069190|NCT01946191|515795178|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
143069191|NCT01946191|515795179|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
143069192|NCT02041091|515795180|FG000|Treatment|Adverse Event|3|||
143069193|NCT02041091|515795181|FG001|Treatment|Adverse Event|3|||
143069194|NCT02041091|515795180|FG000|Treatment|Withdrawal by Subject|2|||
143069195|NCT02041091|515795181|FG001|Treatment|Withdrawal by Subject|4|||
143069196|NCT02041091|515795180|FG000|Treatment|Physician Decision|1|||
143171172|NCT03674281|516176004|FG000|Overall Study|Withdrawal by Subject|1|||
143171173|NCT03674281|516176005|FG001|Overall Study|Withdrawal by Subject|3|||
143171174|NCT03674281|516176006|FG002|Overall Study|Withdrawal by Subject|3|||
143171175|NCT00069641|516176011|FG000|Overall Study|Death|1|||
143171176|NCT00069641|516176012|FG001|Overall Study|Death|0|||
143171177|NCT00069641|516176013|FG002|Overall Study|Death|1|||
143171178|NCT03186638|516176014|FG000|Overall Study|Withdrawal by Subject|4|||
143171179|NCT03186638|516176015|FG001|Overall Study|Withdrawal by Subject|4|||
143171180|NCT03186638|516176014|FG000|Overall Study|Withdrawn due to medical problem|3|||
143171181|NCT03186638|516176015|FG001|Overall Study|Withdrawn due to medical problem|2|||
143171182|NCT03186638|516176014|FG000|Overall Study|Lost to Follow-up|1|||
143171183|NCT03186638|516176015|FG001|Overall Study|Lost to Follow-up|0|||
143171184|NCT02239926|516176016|FG000|Overall Study|Withdrawal by Subject|0|||
143171185|NCT02239926|516176017|FG001|Overall Study|Withdrawal by Subject|1|||
143171186|NCT01263119|516176018|FG000|Period 1|Protocol Violation|2|||
143171187|NCT01263119|516176018|FG000|Period 2|Adverse Event|2|||
143171188|NCT02862574|516176019|FG000|Double-Blind Treatment Period|Adverse Event|0|||
143171189|NCT02862574|516176020|FG001|Double-Blind Treatment Period|Adverse Event|1|||
143171190|NCT02862574|516176021|FG002|Double-Blind Treatment Period|Adverse Event|0|||
143171191|NCT02862574|516176019|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
143171192|NCT02862574|516176020|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
143171193|NCT02862574|516176021|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
143171194|NCT02862574|516176019|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
143171195|NCT02862574|516176020|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
143171196|NCT02862574|516176021|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
143171197|NCT03639610|516176023|FG000|Overall Study|Adverse Event|7|||
143171198|NCT03639610|516176024|FG001|Overall Study|Adverse Event|1|||
143171199|NCT03639610|516176025|FG002|Overall Study|Adverse Event|0|||
143171200|NCT03639610|516176023|FG000|Overall Study|Physician Decision|3|||
143171201|NCT03639610|516176024|FG001|Overall Study|Physician Decision|1|||
143171202|NCT03639610|516176025|FG002|Overall Study|Physician Decision|0|||
143171203|NCT03639610|516176023|FG000|Overall Study|Disease progression|8|||
143171204|NCT03639610|516176024|FG001|Overall Study|Disease progression|5|||
143171205|NCT03639610|516176025|FG002|Overall Study|Disease progression|3|||
143171206|NCT03639610|516176023|FG000|Overall Study|Study terminated by sponsor|2|||
143171207|NCT03639610|516176024|FG001|Overall Study|Study terminated by sponsor|1|||
143171208|NCT03639610|516176025|FG002|Overall Study|Study terminated by sponsor|1|||
143171209|NCT03639610|516176023|FG000|Overall Study|Patient request to stop treatment|1|||
143247553|NCT01703754|516458634|FG000|Overall Study|Adverse Event|1|||
143171210|NCT03639610|516176024|FG001|Overall Study|Patient request to stop treatment|2|||
143171211|NCT03639610|516176025|FG002|Overall Study|Patient request to stop treatment|0|||
143171212|NCT00949533|516176030|FG000|Overall Study|Lost to Follow-up|0|||
143171213|NCT00949533|516176031|FG001|Overall Study|Lost to Follow-up|1|||
143171214|NCT02234362|516176032|FG000|Overall Study|Not eligible after first screening visit|17|||
143171215|NCT02234362|516176032|FG000|Overall Study|Lost to Follow-up|6|||
143171216|NCT02234362|516176032|FG000|Overall Study|Withdrawal by Subject|3|||
143247554|NCT01703754|516458635|FG001|Overall Study|Adverse Event|1|||
143247555|NCT01703754|516458636|FG002|Overall Study|Adverse Event|0|||
143247556|NCT01703754|516458634|FG000|Overall Study|Withdrawal by Subject|2|||
143247557|NCT01703754|516458635|FG001|Overall Study|Withdrawal by Subject|0|||
143247558|NCT01703754|516458636|FG002|Overall Study|Withdrawal by Subject|0|||
143247559|NCT01459497|516458640|FG000|Overall Study|Inability to meet trial constraints.|1|||
143247560|NCT01459497|516458641|FG001|Overall Study|Inability to meet trial constraints.|0|||
143247561|NCT01459497|516458640|FG000|Overall Study|Physician Decision|1|||
143247562|NCT01459497|516458641|FG001|Overall Study|Physician Decision|1|||
143247563|NCT01459497|516458640|FG000|Overall Study|Hospitalization.|0|||
143247564|NCT01459497|516458641|FG001|Overall Study|Hospitalization.|3|||
143247565|NCT01459497|516458640|FG000|Overall Study|Disease progression.|0|||
143247566|NCT01459497|516458641|FG001|Overall Study|Disease progression.|1|||
143247567|NCT03530124|516458642|FG000|Overall Study|Withdrawal by Subject|0|||
143247568|NCT03530124|516458643|FG001|Overall Study|Withdrawal by Subject|1|||
143247569|NCT03530124|516458642|FG000|Overall Study|Protocol Violation|1|||
143247570|NCT03530124|516458643|FG001|Overall Study|Protocol Violation|0|||
143247571|NCT03530124|516458642|FG000|Overall Study|Discharged prior to study completion|1|||
143247572|NCT03530124|516458643|FG001|Overall Study|Discharged prior to study completion|0|||
143247573|NCT03179319|516458644|FG000|Overall Study|Lost to Follow-up|6|||
143247574|NCT03179319|516458645|FG001|Overall Study|Lost to Follow-up|0|||
143247575|NCT01120717|516458646|FG000|Overall Study|Withdrawal by Subject|11|||
143247576|NCT01120717|516458647|FG001|Overall Study|Withdrawal by Subject|6|||
143247577|NCT01120717|516458646|FG000|Overall Study|Adverse Event|10|||
143247578|NCT01120717|516458647|FG001|Overall Study|Adverse Event|6|||
143247579|NCT01120717|516458646|FG000|Overall Study|Protocol Deviation|2|||
143247580|NCT01120717|516458647|FG001|Overall Study|Protocol Deviation|5|||
143247581|NCT01120717|516458646|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
143247582|NCT01120717|516458647|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
143247583|NCT01120717|516458646|FG000|Overall Study|Lost to Follow-up|2|||
143247584|NCT01120717|516458647|FG001|Overall Study|Lost to Follow-up|3|||
143247585|NCT01120717|516458646|FG000|Overall Study|Death|3|||
143247586|NCT01120717|516458647|FG001|Overall Study|Death|1|||
143247587|NCT01120717|516458646|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
143247588|NCT01120717|516458647|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
143247589|NCT02504216|516458652|FG000|Overall Study|Lost to Follow-up|3|||
143247590|NCT02504216|516458653|FG001|Overall Study|Lost to Follow-up|3|||
143247591|NCT02504216|516458652|FG000|Overall Study|Withdrawal by Subject|8|||
143247592|NCT02504216|516458653|FG001|Overall Study|Withdrawal by Subject|12|||
143247593|NCT00223080|516458654|FG000|Overall Study|Withdrawal by Subject|253|||
143247594|NCT00223080|516458655|FG001|Overall Study|Withdrawal by Subject|232|||
143247595|NCT00223080|516458654|FG000|Overall Study|Required contraindicated med|0|||
143247596|NCT00223080|516458655|FG001|Overall Study|Required contraindicated med|1|||
143247597|NCT00223080|516458654|FG000|Overall Study|Non-compliant|7|||
143504585|NCT04521608|517385698|FG001|Overall Study|Withdrawal by Subject|18|||
143504586|NCT04521608|517385697|FG000|Overall Study|Disease Progression|3|||
143504587|NCT04521608|517385698|FG001|Overall Study|Disease Progression|10|||
143504588|NCT04521608|517385697|FG000|Overall Study|Complicating Disease|6|||
143504589|NCT04521608|517385698|FG001|Overall Study|Complicating Disease|3|||
143504590|NCT04521608|517385697|FG000|Overall Study|Lost Contact|25|||
143504591|NCT04521608|517385698|FG001|Overall Study|Lost Contact|27|||
143069197|NCT02041091|515795181|FG001|Treatment|Physician Decision|0|||
143069198|NCT02041091|515795180|FG000|Treatment|Sponsor Decision|15|||
143069199|NCT02041091|515795181|FG001|Treatment|Sponsor Decision|16|||
143069200|NCT02041091|515795180|FG000|Treatment|Lost to Follow-up|1|||
143069201|NCT02041091|515795181|FG001|Treatment|Lost to Follow-up|0|||
143069202|NCT02041091|515795180|FG000|Optional Safety Extension Period|Adverse Event|4|||
143069203|NCT02041091|515795181|FG001|Optional Safety Extension Period|Adverse Event|2|||
143069204|NCT02041091|515795180|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
143069205|NCT02041091|515795181|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
143069206|NCT02041091|515795180|FG000|Optional Safety Extension Period|Protocol Violation|2|||
143069207|NCT02041091|515795181|FG001|Optional Safety Extension Period|Protocol Violation|0|||
143069208|NCT02041091|515795180|FG000|Optional Safety Extension Period|Physician Decision|2|||
143069209|NCT02041091|515795181|FG001|Optional Safety Extension Period|Physician Decision|1|||
143069210|NCT02041091|515795180|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
143069211|NCT02041091|515795181|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
143069212|NCT02041091|515795180|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
143069213|NCT02041091|515795181|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
143069214|NCT01855074|515795182|FG000|Overall Study|Adverse Event|1|||
143069215|NCT01855074|515795182|FG000|Overall Study|Lost to Follow-up|4|||
143069216|NCT01855074|515795182|FG000|Overall Study|Withdrawal by Subject|8|||
143069217|NCT01855074|515795182|FG000|Overall Study|Started but not treated|1|||
143247598|NCT00223080|516458655|FG001|Overall Study|Non-compliant|7|||
143247599|NCT00223080|516458654|FG000|Overall Study|Moved from study area|37|||
143504592|NCT04521608|517385697|FG000|Overall Study|Ineligible|1|||
143504593|NCT04521608|517385698|FG001|Overall Study|Ineligible|0|||
143069218|NCT01602965|515795183|FG000|Overall Study|Lost to Follow-up|4|||
143069219|NCT01602965|515795184|FG001|Overall Study|Lost to Follow-up|2|||
143069220|NCT01150890|515795185|FG000|Overall Study|Other|0|||
143069221|NCT01150890|515795186|FG001|Overall Study|Other|1|||
143069222|NCT01150890|515795187|FG002|Overall Study|Other|0|||
143069223|NCT01150890|515795188|FG003|Overall Study|Other|2|||
143069224|NCT01150890|515795185|FG000|Overall Study|Pregnancy|0|||
143069225|NCT01150890|515795186|FG001|Overall Study|Pregnancy|0|||
143069226|NCT01150890|515795187|FG002|Overall Study|Pregnancy|0|||
143069227|NCT01150890|515795188|FG003|Overall Study|Pregnancy|1|||
143069228|NCT01150890|515795185|FG000|Overall Study|Administrative Decision|4|||
143069229|NCT01150890|515795186|FG001|Overall Study|Administrative Decision|4|||
143069230|NCT01150890|515795187|FG002|Overall Study|Administrative Decision|5|||
143069231|NCT01150890|515795188|FG003|Overall Study|Administrative Decision|6|||
143069232|NCT01150890|515795185|FG000|Overall Study|Ineligibility determined|0|||
143069233|NCT01150890|515795186|FG001|Overall Study|Ineligibility determined|1|||
143069234|NCT01150890|515795187|FG002|Overall Study|Ineligibility determined|0|||
143069235|NCT01150890|515795188|FG003|Overall Study|Ineligibility determined|0|||
143069236|NCT01150890|515795185|FG000|Overall Study|Adverse Event|0|||
143069237|NCT01150890|515795186|FG001|Overall Study|Adverse Event|0|||
143069238|NCT01150890|515795187|FG002|Overall Study|Adverse Event|2|||
143069239|NCT01150890|515795188|FG003|Overall Study|Adverse Event|0|||
143069240|NCT01150890|515795185|FG000|Overall Study|Withdrawal by Subject|0|||
143069241|NCT01150890|515795186|FG001|Overall Study|Withdrawal by Subject|0|||
143069242|NCT01150890|515795187|FG002|Overall Study|Withdrawal by Subject|2|||
143069243|NCT01150890|515795188|FG003|Overall Study|Withdrawal by Subject|1|||
143069244|NCT01150890|515795185|FG000|Overall Study|Disease progression|0|||
143069245|NCT01150890|515795186|FG001|Overall Study|Disease progression|7|||
143069246|NCT01150890|515795187|FG002|Overall Study|Disease progression|3|||
143069247|NCT01150890|515795188|FG003|Overall Study|Disease progression|7|||
143069248|NCT03118570|515795189|FG000|Overall Study|Adverse Event|2|||
143069249|NCT03118570|515795190|FG001|Overall Study|Adverse Event|0|||
143069250|NCT03118570|515795191|FG002|Overall Study|Adverse Event|0|||
143069251|NCT03118570|515795192|FG003|Overall Study|Adverse Event|0|||
143069252|NCT03118570|515795193|FG004|Overall Study|Adverse Event|3|||
143069253|NCT03118570|515795189|FG000|Overall Study|Withdrawal by Subject|0|||
143069254|NCT03118570|515795190|FG001|Overall Study|Withdrawal by Subject|1|||
143069255|NCT03118570|515795191|FG002|Overall Study|Withdrawal by Subject|4|||
143069256|NCT03118570|515795192|FG003|Overall Study|Withdrawal by Subject|0|||
143069257|NCT03118570|515795193|FG004|Overall Study|Withdrawal by Subject|1|||
143069258|NCT03118570|515795189|FG000|Overall Study|Lost to Follow-up|2|||
143069259|NCT03118570|515795190|FG001|Overall Study|Lost to Follow-up|3|||
143069260|NCT03118570|515795191|FG002|Overall Study|Lost to Follow-up|1|||
143069261|NCT03118570|515795192|FG003|Overall Study|Lost to Follow-up|0|||
143069262|NCT03118570|515795193|FG004|Overall Study|Lost to Follow-up|1|||
143069263|NCT03118570|515795189|FG000|Overall Study|Other, Not Specified|1|||
143069264|NCT03118570|515795190|FG001|Overall Study|Other, Not Specified|3|||
143069265|NCT03118570|515795191|FG002|Overall Study|Other, Not Specified|0|||
143069266|NCT03118570|515795192|FG003|Overall Study|Other, Not Specified|0|||
143069267|NCT03118570|515795193|FG004|Overall Study|Other, Not Specified|0|||
143069268|NCT01195272|515795199|FG000|Overall Study|Adverse Event|1|||
143069269|NCT01195272|515795199|FG000|Overall Study|Lack of Efficacy|3|||
143069270|NCT04221789|515797099|FG000|Overall Study|deviation from protoco|22|||
143069271|NCT04221789|515797100|FG001|Overall Study|deviation from protoco|8|||
143069272|NCT02935686|515797101|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
143069273|NCT02935686|515797102|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
143069274|NCT02935686|515797103|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
143069275|NCT02935686|515797104|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
143069276|NCT02935686|515797105|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
143365351|NCT00770211|516880751|FG001|Overall Study|Withdrawal by Subject|2|||
143365352|NCT01740557|516880752|FG000|Overall Study|Ineligible|1|||
143069277|NCT02935686|515797101|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
143069278|NCT02935686|515797102|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
143069279|NCT02935686|515797103|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
143069280|NCT02935686|515797104|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
143069281|NCT02935686|515797105|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
143069282|NCT02935686|515797101|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
143069283|NCT02935686|515797102|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
143365353|NCT01740557|516880752|FG000|Overall Study|Screen failure|1|||
143365354|NCT01913340|516880753|FG000|Overall Study|Death|2|||
143504594|NCT04521608|517385697|FG000|Overall Study|Refused Further Study Participation|13|||
143069284|NCT02935686|515797103|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
143069285|NCT02935686|515797104|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
143069286|NCT02935686|515797105|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
143069287|NCT02935686|515797101|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
143365355|NCT01913340|516880754|FG001|Overall Study|Death|5|||
143365356|NCT01913340|516880753|FG000|Overall Study|Lost to Follow-up|1|||
143069288|NCT02935686|515797102|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
143069289|NCT02935686|515797103|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
143069290|NCT02935686|515797104|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
143069291|NCT02935686|515797105|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
143069292|NCT02935686|515797101|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
143069293|NCT02935686|515797102|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
143069294|NCT02935686|515797103|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
143069295|NCT02935686|515797104|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
143069296|NCT02935686|515797105|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
143069297|NCT02935686|515797101|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
143069298|NCT02935686|515797102|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
143069299|NCT02935686|515797103|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
143171217|NCT01959529|516176033|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
143171218|NCT01959529|516176034|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
143171219|NCT01959529|516176033|FG000|Overall Study|Lost to Follow-up|4|||
143171220|NCT01959529|516176034|FG001|Overall Study|Lost to Follow-up|1|||
143171221|NCT01959529|516176033|FG000|Overall Study|Other|70|||
143171222|NCT01959529|516176034|FG001|Overall Study|Other|68|||
143171223|NCT01959529|516176033|FG000|Overall Study|Hypoglycaemia|1|||
143171224|NCT01959529|516176034|FG001|Overall Study|Hypoglycaemia|1|||
143171225|NCT01959529|516176033|FG000|Overall Study|Lack of glycaemic control|1|||
143171226|NCT01959529|516176034|FG001|Overall Study|Lack of glycaemic control|1|||
143171227|NCT00261833|516176042|FG000|Overall Study|Death|1|||
143171228|NCT00261833|516176043|FG001|Overall Study|Death|3|||
143171229|NCT00261833|516176042|FG000|Overall Study|Adverse Event|1|||
143171230|NCT00261833|516176043|FG001|Overall Study|Adverse Event|4|||
143171231|NCT00261833|516176042|FG000|Overall Study|Withdrawal by Subject|5|||
143171232|NCT00261833|516176043|FG001|Overall Study|Withdrawal by Subject|7|||
143171233|NCT00261833|516176042|FG000|Overall Study|Protocol Violation|0|||
143171234|NCT00261833|516176043|FG001|Overall Study|Protocol Violation|1|||
143171235|NCT00261833|516176042|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
143171236|NCT00261833|516176043|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
143171237|NCT00261833|516176042|FG000|Overall Study|Lung transplantation|1|||
143171238|NCT00261833|516176043|FG001|Overall Study|Lung transplantation|1|||
143171239|NCT00261833|516176042|FG000|Overall Study|Missing reason|1|||
143171240|NCT00261833|516176043|FG001|Overall Study|Missing reason|0|||
143171241|NCT00261833|516176042|FG000|Overall Study|Not interested in being participant|0|||
143171242|NCT00261833|516176043|FG001|Overall Study|Not interested in being participant|1|||
143171243|NCT02434081|516176046|FG000|Overall Study|Death (never started treatment)|2|||
143171244|NCT02434081|516176046|FG000|Overall Study|Death|2|||
143171245|NCT02434081|516176046|FG000|Overall Study|Progression|20|||
143171246|NCT02434081|516176046|FG000|Overall Study|Adverse Event|20|||
143171247|NCT02434081|516176046|FG000|Overall Study|Physician Decision|2|||
143171248|NCT02434081|516176046|FG000|Overall Study|Withdrawal by Subject|1|||
143171249|NCT02434081|516176046|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
143171250|NCT01500317|516176048|FG000|Overall Study|Withdrawal by Subject|3|||
143171251|NCT01500317|516176049|FG001|Overall Study|Withdrawal by Subject|2|||
143171252|NCT01500317|516176050|FG002|Overall Study|Withdrawal by Subject|0|||
143171253|NCT02090764|516176051|FG000|Overall Study|Adverse Event|1|||
143171254|NCT02090764|516176052|FG001|Overall Study|Adverse Event|3|||
143171255|NCT02090764|516176051|FG000|Overall Study|Lack of Efficacy|0|||
143171256|NCT02090764|516176052|FG001|Overall Study|Lack of Efficacy|13|||
143171257|NCT02090764|516176051|FG000|Overall Study|Withdrawal by Subject|2|||
143171258|NCT02090764|516176052|FG001|Overall Study|Withdrawal by Subject|1|||
143171259|NCT02090764|516176051|FG000|Overall Study|Intercurrent illness and other|1|||
143171260|NCT02090764|516176052|FG001|Overall Study|Intercurrent illness and other|1|||
143171261|NCT02090764|516176051|FG000|Overall Study|Lost to Follow-up|2|||
143171262|NCT02090764|516176052|FG001|Overall Study|Lost to Follow-up|2|||
143171263|NCT02131766|516176053|FG000|Overall Study|Withdrawal by Subject|4|||
143504595|NCT04521608|517385698|FG001|Overall Study|Refused Further Study Participation|7|||
143504596|NCT04454489|517385699|FG000|Overall Study|Disease progression|12|||
143504597|NCT04454489|517385699|FG000|Overall Study|Death|4|||
143504598|NCT04454489|517385699|FG000|Overall Study|Adverse Event|1|||
143171264|NCT00754572|516176054|FG000|Overall Study|Adverse Event|19|||
143171265|NCT00754572|516176054|FG000|Overall Study|Other|39|||
143171266|NCT00754572|516176054|FG000|Overall Study|Protocol Violation|3|||
143171267|NCT00754572|516176054|FG000|Overall Study|Withdrawal by Subject|3|||
143171268|NCT00754572|516176054|FG000|Overall Study|Lack of Efficacy|2|||
143171269|NCT00754572|516176054|FG000|Overall Study|Death|1|||
143171270|NCT00754572|516176054|FG000|Overall Study|Administrative Reason|3|||
143171271|NCT00754572|516176054|FG000|Overall Study|Lost to Follow-up|1|||
143171272|NCT00718315|516176056|FG000|Overall Study|Adverse Event|1|||
143171273|NCT00718315|516176057|FG001|Overall Study|Adverse Event|2|||
143069300|NCT02935686|515797104|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
143171274|NCT00718315|516176058|FG002|Overall Study|Adverse Event|3|||
143171275|NCT00718315|516176056|FG000|Overall Study|Death|6|||
143069301|NCT02935686|515797105|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
143069302|NCT02935686|515797101|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
143069303|NCT02935686|515797102|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
143069304|NCT02935686|515797103|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
143069305|NCT02935686|515797104|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
143069306|NCT02935686|515797105|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
143247600|NCT00223080|516458655|FG001|Overall Study|Moved from study area|47|||
143247601|NCT00223080|516458654|FG000|Overall Study|Lost to Follow-up|259|||
143247602|NCT00223080|516458655|FG001|Overall Study|Lost to Follow-up|284|||
143247603|NCT00223080|516458654|FG000|Overall Study|Death|85|||
143247604|NCT00223080|516458655|FG001|Overall Study|Death|74|||
143247605|NCT00223080|516458654|FG000|Overall Study|Other|14|||
143247606|NCT00223080|516458655|FG001|Overall Study|Other|11|||
143247607|NCT00223080|516458654|FG000|Overall Study|Reason not provided|141|||
143247608|NCT00223080|516458655|FG001|Overall Study|Reason not provided|140|||
143247609|NCT00223080|516458654|FG000|Overall Study|Adverse Event|0|||
143247610|NCT00223080|516458655|FG001|Overall Study|Adverse Event|1|||
143247611|NCT02598583|516458656|FG000|Extension Period|Withdrawal by Subject|1|||
143247612|NCT02598583|516458657|FG001|Extension Period|Withdrawal by Subject|0|||
143069307|NCT02935686|515797101|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
143069308|NCT02935686|515797102|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
143069309|NCT02935686|515797103|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
143069310|NCT02935686|515797104|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
143069311|NCT02935686|515797105|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
143069312|NCT02935686|515797101|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
143069313|NCT02935686|515797102|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
143069314|NCT02935686|515797103|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
143069315|NCT02935686|515797104|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
143069316|NCT02935686|515797105|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
143069317|NCT02935686|515797101|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
143069318|NCT02935686|515797102|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
143069319|NCT02935686|515797103|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
143069320|NCT02935686|515797104|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
143069321|NCT02935686|515797105|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
143069322|NCT02935686|515797101|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
143069323|NCT02935686|515797102|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
143069324|NCT02935686|515797103|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
143069325|NCT02935686|515797104|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
143069326|NCT02935686|515797105|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
143069327|NCT00541970|515797108|FG000|Month 7|Protocol Violation|9|||
143069328|NCT00541970|515797109|FG001|Month 7|Protocol Violation|13|||
143069329|NCT00541970|515797110|FG002|Month 7|Protocol Violation|11|||
143069330|NCT00541970|515797111|FG003|Month 7|Protocol Violation|5|||
143069331|NCT00541970|515797108|FG000|Month 12|Adverse Event|0|||
143069332|NCT00541970|515797109|FG001|Month 12|Adverse Event|1|||
143069333|NCT00541970|515797110|FG002|Month 12|Adverse Event|1|||
143069334|NCT00541970|515797111|FG003|Month 12|Adverse Event|1|||
143069335|NCT00541970|515797108|FG000|Month 12|Protocol Violation|12|||
143069336|NCT00541970|515797109|FG001|Month 12|Protocol Violation|21|||
143069337|NCT00541970|515797110|FG002|Month 12|Protocol Violation|20|||
143069338|NCT00541970|515797111|FG003|Month 12|Protocol Violation|15|||
143069339|NCT00541970|515797108|FG000|Month 18|Adverse Event|0|||
143069340|NCT00541970|515797109|FG001|Month 18|Adverse Event|1|||
143069341|NCT00541970|515797110|FG002|Month 18|Adverse Event|1|||
143069342|NCT00541970|515797111|FG003|Month 18|Adverse Event|1|||
143069343|NCT00541970|515797108|FG000|Month 18|Protocol Violation|14|||
143069344|NCT00541970|515797109|FG001|Month 18|Protocol Violation|23|||
143069345|NCT00541970|515797110|FG002|Month 18|Protocol Violation|24|||
143069346|NCT00541970|515797111|FG003|Month 18|Protocol Violation|16|||
143069347|NCT00541970|515797108|FG000|Month 24|Adverse Event|0|||
143069348|NCT00541970|515797109|FG001|Month 24|Adverse Event|1|||
143069349|NCT00541970|515797110|FG002|Month 24|Adverse Event|1|||
143069350|NCT00541970|515797111|FG003|Month 24|Adverse Event|1|||
143069351|NCT00541970|515797108|FG000|Month 24|Protocol Violation|29|||
143069352|NCT00541970|515797109|FG001|Month 24|Protocol Violation|31|||
143069353|NCT00541970|515797110|FG002|Month 24|Protocol Violation|31|||
143069354|NCT00541970|515797111|FG003|Month 24|Protocol Violation|21|||
143069355|NCT00541970|515797108|FG000|Month 36|Protocol Violation|61|||
143069356|NCT00541970|515797109|FG001|Month 36|Protocol Violation|66|||
143069357|NCT00541970|515797110|FG002|Month 36|Protocol Violation|66|||
143247613|NCT00947882|516458665|FG000|Overall Study|Adverse Event|0|||
143247614|NCT00947882|516458666|FG001|Overall Study|Adverse Event|1|||
143069358|NCT00541970|515797111|FG003|Month 36|Protocol Violation|60|||
143069359|NCT00541970|515797108|FG000|Month 48|Withdrawal by Subject|2|||
143069360|NCT00541970|515797109|FG001|Month 48|Withdrawal by Subject|4|||
143247615|NCT00947882|516458667|FG002|Overall Study|Adverse Event|4|||
143069361|NCT00541970|515797110|FG002|Month 48|Withdrawal by Subject|4|||
143069362|NCT00541970|515797111|FG003|Month 48|Withdrawal by Subject|2|||
143069363|NCT00541970|515797108|FG000|Month 48|Other|3|||
143069364|NCT00541970|515797109|FG001|Month 48|Other|1|||
143069365|NCT00541970|515797110|FG002|Month 48|Other|1|||
143069366|NCT00541970|515797111|FG003|Month 48|Other|0|||
143069367|NCT00541970|515797108|FG000|Month 48|Lost to Follow-up|66|||
143069368|NCT00541970|515797109|FG001|Month 48|Lost to Follow-up|68|||
143069369|NCT00541970|515797110|FG002|Month 48|Lost to Follow-up|68|||
143069370|NCT00541970|515797111|FG003|Month 48|Lost to Follow-up|73|||
143069371|NCT00541970|515797108|FG000|Month 60|Protocol Violation|78|||
143069372|NCT00541970|515797109|FG001|Month 60|Protocol Violation|77|||
143069373|NCT00541970|515797110|FG002|Month 60|Protocol Violation|82|||
143069374|NCT00541970|515797111|FG003|Month 60|Protocol Violation|72|||
143069375|NCT03107026|515797112|FG000|Overall Study|Adverse Event|2|||
143069376|NCT03107026|515797113|FG001|Overall Study|Adverse Event|14|||
143069377|NCT03107026|515797114|FG002|Overall Study|Adverse Event|23|||
143069378|NCT03107026|515797112|FG000|Overall Study|Lost to Follow-up|12|||
143069379|NCT03107026|515797113|FG001|Overall Study|Lost to Follow-up|12|||
143069380|NCT03107026|515797114|FG002|Overall Study|Lost to Follow-up|13|||
143069381|NCT03107026|515797112|FG000|Overall Study|Protocol Violation|1|||
143069382|NCT03107026|515797113|FG001|Overall Study|Protocol Violation|2|||
143069383|NCT03107026|515797114|FG002|Overall Study|Protocol Violation|0|||
143069384|NCT03107026|515797112|FG000|Overall Study|Pregnancy|1|||
143069385|NCT03107026|515797113|FG001|Overall Study|Pregnancy|0|||
143069386|NCT03107026|515797114|FG002|Overall Study|Pregnancy|0|||
143069387|NCT03107026|515797112|FG000|Overall Study|Withdrawal by Subject|13|||
143069388|NCT03107026|515797113|FG001|Overall Study|Withdrawal by Subject|5|||
143069389|NCT03107026|515797114|FG002|Overall Study|Withdrawal by Subject|17|||
143069390|NCT03107026|515797112|FG000|Overall Study|non compliance with study visits|1|||
143069391|NCT03107026|515797113|FG001|Overall Study|non compliance with study visits|2|||
143069392|NCT03107026|515797114|FG002|Overall Study|non compliance with study visits|0|||
143069393|NCT03107026|515797112|FG000|Overall Study|non-compliance with study drug|2|||
143069394|NCT03107026|515797113|FG001|Overall Study|non-compliance with study drug|2|||
143069395|NCT03107026|515797114|FG002|Overall Study|non-compliance with study drug|3|||
143069396|NCT03107026|515797112|FG000|Overall Study|Physician Decision|0|||
143069397|NCT03107026|515797113|FG001|Overall Study|Physician Decision|1|||
143069398|NCT03107026|515797114|FG002|Overall Study|Physician Decision|0|||
143069399|NCT01951885|515797117|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
143069400|NCT01951885|515797118|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
143069401|NCT01951885|515797117|FG000|Overall Study|Adverse Event|1|||
143069402|NCT01951885|515797118|FG001|Overall Study|Adverse Event|0|||
143069403|NCT01951885|515797117|FG000|Overall Study|Withdrawal by Subject|0|||
143069404|NCT01951885|515797118|FG001|Overall Study|Withdrawal by Subject|1|||
143069405|NCT01951885|515797117|FG000|Overall Study|ineligible due to a change in donor|0|||
143069406|NCT01951885|515797118|FG001|Overall Study|ineligible due to a change in donor|1|||
143069407|NCT01951885|515797117|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
143069408|NCT01951885|515797118|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
143069409|NCT02238626|515797119|FG000|Overall Study|Adverse Event|3|||
143069410|NCT02238626|515797120|FG001|Overall Study|Adverse Event|5|||
143069411|NCT02238626|515797121|FG002|Overall Study|Adverse Event|0|||
143069412|NCT02238626|515797122|FG003|Overall Study|Adverse Event|3|||
143069413|NCT02238626|515797119|FG000|Overall Study|Lost to Follow-up|2|||
143069414|NCT02238626|515797120|FG001|Overall Study|Lost to Follow-up|4|||
143069415|NCT02238626|515797121|FG002|Overall Study|Lost to Follow-up|2|||
143069416|NCT02238626|515797122|FG003|Overall Study|Lost to Follow-up|2|||
143069417|NCT02238626|515797119|FG000|Overall Study|Withdrawal by Subject|0|||
143069418|NCT02238626|515797120|FG001|Overall Study|Withdrawal by Subject|3|||
143069419|NCT02238626|515797121|FG002|Overall Study|Withdrawal by Subject|0|||
143069420|NCT02238626|515797122|FG003|Overall Study|Withdrawal by Subject|1|||
143069421|NCT02238626|515797119|FG000|Overall Study|Death|0|||
143069422|NCT02238626|515797120|FG001|Overall Study|Death|0|||
143069423|NCT02238626|515797121|FG002|Overall Study|Death|1|||
143069424|NCT02238626|515797122|FG003|Overall Study|Death|1|||
143069425|NCT02238626|515797119|FG000|Overall Study|Other|0|||
143069426|NCT02238626|515797120|FG001|Overall Study|Other|2|||
143069427|NCT02238626|515797121|FG002|Overall Study|Other|0|||
143069428|NCT02238626|515797122|FG003|Overall Study|Other|0|||
143069429|NCT02622113|515797125|FG000|Overall Study|Adverse Event|4|||
143069430|NCT02622113|515797126|FG001|Overall Study|Adverse Event|4|||
143069431|NCT02622113|515797125|FG000|Overall Study|Physician Decision|0|||
143069432|NCT02622113|515797126|FG001|Overall Study|Physician Decision|1|||
143069433|NCT02622113|515797125|FG000|Overall Study|Withdrawal by Subject|0|||
143171276|NCT00718315|516176057|FG001|Overall Study|Death|6|||
143069434|NCT02622113|515797126|FG001|Overall Study|Withdrawal by Subject|2|||
143069435|NCT02622113|515797125|FG000|Overall Study|Stopping Criteria|1|||
143069436|NCT02622113|515797126|FG001|Overall Study|Stopping Criteria|3|||
143171277|NCT00718315|516176058|FG002|Overall Study|Death|5|||
143069437|NCT00667810|515797127|FG000|Overall Study|Adverse Event|13|||
143504599|NCT04454489|517385699|FG000|Overall Study|Physician Decision|1|||
143504600|NCT02588651|517385700|FG000|Overall Study|Adverse Event|1|||
143504601|NCT02588651|517385700|FG000|Overall Study|Withdrawal by Subject|2|||
143504602|NCT02588651|517385700|FG000|Overall Study|Death|1|||
143504603|NCT02588651|517385700|FG000|Overall Study|Lack of Efficacy|13|||
143504604|NCT02588651|517385700|FG000|Overall Study|Lost to Follow-up|1|||
143504605|NCT02588651|517385700|FG000|Overall Study|Physician Decision|1|||
143504606|NCT02588651|517385700|FG000|Overall Study|Disease progression|2|||
143504607|NCT00569127|517385705|FG000|Overall Study|Adverse Event|57|||
143504608|NCT00569127|517385706|FG001|Overall Study|Adverse Event|47|||
143504609|NCT00569127|517385705|FG000|Overall Study|Withdrawal by Subject|13|||
143069438|NCT00667810|515797128|FG001|Overall Study|Adverse Event|14|||
143069439|NCT00667810|515797129|FG002|Overall Study|Adverse Event|19|||
143069440|NCT00667810|515797130|FG003|Overall Study|Adverse Event|1|||
143069441|NCT00667810|515797127|FG000|Overall Study|Death|1|||
143069442|NCT00667810|515797128|FG001|Overall Study|Death|1|||
143069443|NCT00667810|515797129|FG002|Overall Study|Death|3|||
143069444|NCT00667810|515797130|FG003|Overall Study|Death|0|||
143069445|NCT00667810|515797127|FG000|Overall Study|Lack of Efficacy|1|||
143069446|NCT00667810|515797128|FG001|Overall Study|Lack of Efficacy|0|||
143069447|NCT00667810|515797129|FG002|Overall Study|Lack of Efficacy|2|||
143069448|NCT00667810|515797130|FG003|Overall Study|Lack of Efficacy|0|||
143069449|NCT00667810|515797127|FG000|Overall Study|Lost to Follow-up|1|||
143069450|NCT00667810|515797128|FG001|Overall Study|Lost to Follow-up|4|||
143069451|NCT00667810|515797129|FG002|Overall Study|Lost to Follow-up|2|||
143069452|NCT00667810|515797130|FG003|Overall Study|Lost to Follow-up|0|||
143069453|NCT00667810|515797127|FG000|Overall Study|Physician Decision|1|||
143069454|NCT00667810|515797128|FG001|Overall Study|Physician Decision|1|||
143069455|NCT00667810|515797129|FG002|Overall Study|Physician Decision|2|||
143069456|NCT00667810|515797130|FG003|Overall Study|Physician Decision|0|||
143069457|NCT00667810|515797127|FG000|Overall Study|Protocol Violation|0|||
143069458|NCT00667810|515797128|FG001|Overall Study|Protocol Violation|2|||
143069459|NCT00667810|515797129|FG002|Overall Study|Protocol Violation|0|||
143069460|NCT00667810|515797130|FG003|Overall Study|Protocol Violation|0|||
143069461|NCT00667810|515797127|FG000|Overall Study|Withdrawal by Subject|14|||
143069462|NCT00667810|515797128|FG001|Overall Study|Withdrawal by Subject|20|||
143069463|NCT00667810|515797129|FG002|Overall Study|Withdrawal by Subject|29|||
143069464|NCT00667810|515797130|FG003|Overall Study|Withdrawal by Subject|1|||
143069465|NCT00667810|515797127|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
143069466|NCT00667810|515797128|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
143069467|NCT00667810|515797129|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
143069468|NCT00667810|515797130|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
143069469|NCT00667810|515797127|FG000|Overall Study|Failed to Return|0|||
143069470|NCT00667810|515797128|FG001|Overall Study|Failed to Return|0|||
143069471|NCT00667810|515797129|FG002|Overall Study|Failed to Return|2|||
143069472|NCT00667810|515797130|FG003|Overall Study|Failed to Return|0|||
143069473|NCT00667810|515797127|FG000|Overall Study|Loss of Caregiver|0|||
143069474|NCT00667810|515797128|FG001|Overall Study|Loss of Caregiver|1|||
143069475|NCT00667810|515797129|FG002|Overall Study|Loss of Caregiver|3|||
143069476|NCT00667810|515797130|FG003|Overall Study|Loss of Caregiver|0|||
143069477|NCT00667810|515797127|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
143069478|NCT00667810|515797128|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
143069479|NCT00667810|515797129|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
143069480|NCT00667810|515797130|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
143069481|NCT00667810|515797127|FG000|Overall Study|Other|6|||
143069482|NCT00667810|515797128|FG001|Overall Study|Other|6|||
143069483|NCT00667810|515797129|FG002|Overall Study|Other|5|||
143069484|NCT00667810|515797130|FG003|Overall Study|Other|0|||
143069485|NCT02227147|515797140|FG000|Controlled Treatment Period|Adverse Event|4|||
143069486|NCT02227147|515797141|FG001|Controlled Treatment Period|Adverse Event|3|||
143069487|NCT02227147|515797140|FG000|Controlled Treatment Period|Other|2|||
143069488|NCT02227147|515797141|FG001|Controlled Treatment Period|Other|0|||
143069489|NCT02227147|515797140|FG000|Follow-up Period|Other|3|||
143069490|NCT02227147|515797141|FG001|Follow-up Period|Other|5|||
143247616|NCT00947882|516458668|FG003|Overall Study|Adverse Event|4|||
143247617|NCT00947882|516458665|FG000|Overall Study|Withdrawal by Subject|2|||
143247618|NCT00947882|516458666|FG001|Overall Study|Withdrawal by Subject|0|||
143247619|NCT00947882|516458667|FG002|Overall Study|Withdrawal by Subject|8|||
143247620|NCT00947882|516458668|FG003|Overall Study|Withdrawal by Subject|2|||
143247621|NCT00947882|516458665|FG000|Overall Study|Protocol Violation|0|||
143504610|NCT00569127|517385706|FG001|Overall Study|Withdrawal by Subject|27|||
143069491|NCT00505375|515797144|FG000|Overall Study|Death|1|||
143069492|NCT00505375|515797145|FG001|Overall Study|Death|0|||
143069493|NCT00505375|515797144|FG000|Overall Study|Withdrawal by Subject|2|||
143069494|NCT00505375|515797145|FG001|Overall Study|Withdrawal by Subject|2|||
143069495|NCT00505375|515797144|FG000|Overall Study|Lost to Follow-up|0|||
143069496|NCT00505375|515797145|FG001|Overall Study|Lost to Follow-up|2|||
143069497|NCT00505375|515797144|FG000|Overall Study|Pregnancy|1|||
143247622|NCT00947882|516458666|FG001|Overall Study|Protocol Violation|0|||
143069498|NCT00505375|515797145|FG001|Overall Study|Pregnancy|0|||
143504611|NCT00569127|517385705|FG000|Overall Study|Progression|99|||
143504612|NCT00569127|517385706|FG001|Overall Study|Progression|100|||
143504613|NCT00569127|517385705|FG000|Overall Study|Death|4|||
143504614|NCT00569127|517385706|FG001|Overall Study|Death|3|||
143504615|NCT00569127|517385705|FG000|Overall Study|Other|20|||
143504616|NCT00569127|517385706|FG001|Overall Study|Other|19|||
143504617|NCT00569127|517385705|FG000|Overall Study|Lost to Follow-up|0|||
143504618|NCT00569127|517385706|FG001|Overall Study|Lost to Follow-up|3|||
143504619|NCT00569127|517385705|FG000|Overall Study|Not Eligible|14|||
143504620|NCT00569127|517385706|FG001|Overall Study|Not Eligible|11|||
143504621|NCT00569127|517385705|FG000|Overall Study|Still on Treatment|7|||
143504622|NCT00569127|517385706|FG001|Overall Study|Still on Treatment|3|||
143504623|NCT02197234|517385709|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
143504624|NCT02197234|517385709|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
143504625|NCT02197234|517385709|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
143504626|NCT02197234|517385709|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
143504627|NCT02197234|517385709|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
143504628|NCT02197234|517385709|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
143504629|NCT04439344|517385710|FG000|Overall Study|Never started threapy|3|||
143504630|NCT04439344|517385710|FG000|Overall Study|Ineligible|3|||
143504631|NCT04439344|517385710|FG000|Overall Study|Adverse Event|13|||
143504632|NCT04439344|517385710|FG000|Overall Study|Death|2|||
143504633|NCT04439344|517385710|FG000|Overall Study|Disease progression|29|||
143504634|NCT04439344|517385710|FG000|Overall Study|Withdrawal by Subject|2|||
143504635|NCT04439344|517385710|FG000|Overall Study|Alternative therapy|1|||
143504636|NCT04083378|517385716|FG000|Overall Study|Death|18|||
143504637|NCT04083378|517385717|FG001|Overall Study|Death|4|||
143504638|NCT04083378|517385716|FG000|Overall Study|Lost to Follow-up|4|||
143504639|NCT04083378|517385717|FG001|Overall Study|Lost to Follow-up|0|||
143504640|NCT04803214|517385718|FG000|Overall Study|Adverse Event|1|||
143504641|NCT04803214|517385719|FG001|Overall Study|Adverse Event|0|||
143504642|NCT04803214|517385718|FG000|Overall Study|Withdrawal by Subject|1|||
143504643|NCT04803214|517385719|FG001|Overall Study|Withdrawal by Subject|2|||
143504644|NCT04803214|517385718|FG000|Overall Study|Lost to Follow-up|2|||
143504645|NCT04803214|517385719|FG001|Overall Study|Lost to Follow-up|4|||
143504646|NCT04803214|517385718|FG000|Overall Study|Physician Decision|1|||
143504647|NCT04803214|517385719|FG001|Overall Study|Physician Decision|1|||
143504648|NCT04803214|517385718|FG000|Overall Study|Missed 12 month visit|0|||
143504649|NCT04803214|517385719|FG001|Overall Study|Missed 12 month visit|3|||
143504650|NCT00644228|517385725|FG000|Randomization & Eligibility|Ineligible|31|||
143504651|NCT00644228|517385726|FG001|Randomization & Eligibility|Ineligible|21|||
143504652|NCT00644228|517385725|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
143504653|NCT00644228|517385726|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
143504654|NCT00644228|517385725|FG000|Randomization & Eligibility|Invalid Consent|0|||
143504655|NCT00644228|517385726|FG001|Randomization & Eligibility|Invalid Consent|1|||
143069499|NCT00505375|515797144|FG000|Overall Study|Travel issues|0|||
143069500|NCT00505375|515797145|FG001|Overall Study|Travel issues|1|||
143069501|NCT01561430|515797146|FG000|Overall Study|Adverse Event|0|||
143069502|NCT01561430|515797147|FG001|Overall Study|Adverse Event|0|||
143069503|NCT01561430|515797148|FG002|Overall Study|Adverse Event|3|||
143069504|NCT01561430|515797149|FG003|Overall Study|Adverse Event|1|||
143069505|NCT01561430|515797146|FG000|Overall Study|Withdrawal by Subject|0|||
143069506|NCT01561430|515797147|FG001|Overall Study|Withdrawal by Subject|0|||
143069507|NCT01561430|515797148|FG002|Overall Study|Withdrawal by Subject|1|||
143069508|NCT01561430|515797149|FG003|Overall Study|Withdrawal by Subject|0|||
143069509|NCT01561430|515797146|FG000|Overall Study|Physician Decision|0|||
143069510|NCT01561430|515797147|FG001|Overall Study|Physician Decision|1|||
143069511|NCT01561430|515797148|FG002|Overall Study|Physician Decision|0|||
143069512|NCT01561430|515797149|FG003|Overall Study|Physician Decision|0|||
143247623|NCT00947882|516458667|FG002|Overall Study|Protocol Violation|1|||
143247624|NCT00947882|516458668|FG003|Overall Study|Protocol Violation|0|||
143247625|NCT00947882|516458665|FG000|Overall Study|Lost to Follow-up|0|||
143247626|NCT00947882|516458666|FG001|Overall Study|Lost to Follow-up|2|||
143247627|NCT00947882|516458667|FG002|Overall Study|Lost to Follow-up|1|||
143247628|NCT00947882|516458668|FG003|Overall Study|Lost to Follow-up|0|||
143504656|NCT00644228|517385725|FG000|Induction Therapy|Adverse Event|22|||
143504657|NCT00644228|517385726|FG001|Induction Therapy|Adverse Event|55|||
143504658|NCT00644228|517385725|FG000|Induction Therapy|Withdrawal by Subject|10|||
143504659|NCT00644228|517385726|FG001|Induction Therapy|Withdrawal by Subject|3|||
143504660|NCT00644228|517385725|FG000|Induction Therapy|Progression/Relapse|24|||
143504661|NCT00644228|517385726|FG001|Induction Therapy|Progression/Relapse|12|||
143504662|NCT00644228|517385725|FG000|Induction Therapy|Death|3|||
143069513|NCT01561430|515797146|FG000|Overall Study|Sponsor Decision|1|||
143069514|NCT01561430|515797147|FG001|Overall Study|Sponsor Decision|14|||
143504663|NCT00644228|517385726|FG001|Induction Therapy|Death|7|||
143504664|NCT00644228|517385725|FG000|Induction Therapy|Not Protocol-Specified|24|||
143504665|NCT00644228|517385726|FG001|Induction Therapy|Not Protocol-Specified|28|||
143504666|NCT00644228|517385725|FG000|Maintenance|Adverse Event|27|||
143069515|NCT01561430|515797148|FG002|Overall Study|Sponsor Decision|13|||
143069516|NCT01561430|515797149|FG003|Overall Study|Sponsor Decision|12|||
143069517|NCT03347422|515797150|FG000|Part A (26 Weeks)|Adverse Event|3|||
143069518|NCT03347422|515797151|FG001|Part A (26 Weeks)|Adverse Event|0|||
143069519|NCT03347422|515797150|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
143069520|NCT03347422|515797151|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
143069521|NCT03347422|515797150|FG000|Part B (149 Weeks)|Adverse Event|0|||
143069522|NCT03347422|515797151|FG001|Part B (149 Weeks)|Adverse Event|1|||
143069523|NCT03347422|515797150|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
143069524|NCT03347422|515797151|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
143069525|NCT03347422|515797150|FG000|Part B (149 Weeks)|Other|1|||
143069526|NCT03347422|515797151|FG001|Part B (149 Weeks)|Other|0|||
143069527|NCT02564211|515797152|FG000|Overall Study|Adverse Event|4|||
143069528|NCT05183217|515797163|FG000|Overall Study|Withdrawal by Subject|1|||
143069529|NCT05183217|515797164|FG001|Overall Study|Withdrawal by Subject|1|||
143069530|NCT04594707|515797165|FG000|Overall Study|Adverse Event|0|||
143069531|NCT04594707|515797166|FG001|Overall Study|Adverse Event|0|||
143069532|NCT04594707|515797167|FG002|Overall Study|Adverse Event|1|||
143069533|NCT04594707|515797165|FG000|Overall Study|Death|0|||
143069534|NCT04594707|515797166|FG001|Overall Study|Death|2|||
143069535|NCT04594707|515797167|FG002|Overall Study|Death|2|||
143069536|NCT04594707|515797165|FG000|Overall Study|Lung Transplant|0|||
143069537|NCT04594707|515797166|FG001|Overall Study|Lung Transplant|0|||
143504667|NCT00644228|517385726|FG001|Maintenance|Adverse Event|31|||
143504668|NCT00644228|517385725|FG000|Maintenance|Withdrawal by Subject|6|||
143504669|NCT00644228|517385726|FG001|Maintenance|Withdrawal by Subject|4|||
143504670|NCT00644228|517385725|FG000|Maintenance|Progression/Relapse|67|||
143504671|NCT00644228|517385726|FG001|Maintenance|Progression/Relapse|42|||
143504672|NCT00644228|517385725|FG000|Maintenance|Death|3|||
143504673|NCT00644228|517385726|FG001|Maintenance|Death|3|||
143504674|NCT00644228|517385725|FG000|Maintenance|Not Protocol-Specified|14|||
143504675|NCT00644228|517385726|FG001|Maintenance|Not Protocol-Specified|15|||
143504676|NCT00644228|517385725|FG000|Maintenance|On Treatment|26|||
143504677|NCT00644228|517385726|FG001|Maintenance|On Treatment|40|||
143504678|NCT06078124|517385727|FG000|Overall Study|Lost to Follow-up|14|||
143504679|NCT06078124|517385728|FG001|Overall Study|Lost to Follow-up|14|||
143504680|NCT05775289|517385729|FG000|Overall Study|Study Ongoing|20|||
143504681|NCT05775289|517385730|FG001|Overall Study|Study Ongoing|53|||
143504682|NCT05775289|517385731|FG002|Overall Study|Study Ongoing|15|||
143504683|NCT05775289|517385732|FG003|Overall Study|Study Ongoing|55|||
143504684|NCT05775289|517385729|FG000|Overall Study|Death|4|||
143504685|NCT05775289|517385730|FG001|Overall Study|Death|11|||
143504686|NCT05775289|517385731|FG002|Overall Study|Death|8|||
143504687|NCT05775289|517385732|FG003|Overall Study|Death|12|||
143504688|NCT05775289|517385729|FG000|Overall Study|Lost to Follow-up|0|||
143504689|NCT05775289|517385730|FG001|Overall Study|Lost to Follow-up|1|||
143504690|NCT05775289|517385731|FG002|Overall Study|Lost to Follow-up|0|||
143504691|NCT05775289|517385732|FG003|Overall Study|Lost to Follow-up|0|||
143504692|NCT05775289|517385729|FG000|Overall Study|Progressive Disease|0|||
143504693|NCT05775289|517385730|FG001|Overall Study|Progressive Disease|0|||
143504694|NCT05775289|517385731|FG002|Overall Study|Progressive Disease|1|||
143504695|NCT05775289|517385732|FG003|Overall Study|Progressive Disease|0|||
143504696|NCT05775289|517385729|FG000|Overall Study|Withdrawal by Subject|1|||
143504697|NCT05775289|517385730|FG001|Overall Study|Withdrawal by Subject|1|||
143504698|NCT05775289|517385731|FG002|Overall Study|Withdrawal by Subject|0|||
143504699|NCT05775289|517385732|FG003|Overall Study|Withdrawal by Subject|0|||
143504700|NCT05824273|517385733|FG000|Overall Study|Lost to Follow-up|16|||
143504701|NCT05824273|517385734|FG001|Overall Study|Lost to Follow-up|13|||
143504702|NCT04439331|517385735|FG000|Overall Study|Never Start Protocol Therapy|2|||
143504703|NCT04439331|517385735|FG000|Overall Study|Ineligible|2|||
143504704|NCT04439331|517385735|FG000|Overall Study|Mutation Status Not Confirmed|1|||
143069538|NCT04594707|515797167|FG002|Overall Study|Lung Transplant|1|||
143069539|NCT04594707|515797165|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
143069540|NCT04594707|515797166|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
143069541|NCT04594707|515797167|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
143069542|NCT04594707|515797165|FG000|Overall Study|Study Terminated By Sponsor|19|||
143247629|NCT00947882|516458665|FG000|Overall Study|Other/Unknown|10|||
143247630|NCT00947882|516458666|FG001|Overall Study|Other/Unknown|13|||
143247631|NCT00947882|516458667|FG002|Overall Study|Other/Unknown|3|||
143504705|NCT04439331|517385735|FG000|Overall Study|Adverse Event|1|||
143504706|NCT04439331|517385735|FG000|Overall Study|Death|1|||
143504707|NCT04439331|517385735|FG000|Overall Study|Disease Progression|20|||
143069543|NCT04594707|515797166|FG001|Overall Study|Study Terminated By Sponsor|47|||
143069544|NCT04594707|515797167|FG002|Overall Study|Study Terminated By Sponsor|41|||
143069545|NCT04594707|515797165|FG000|Overall Study|Withdrawal by Subject|1|||
143247632|NCT00947882|516458668|FG003|Overall Study|Other/Unknown|6|||
143504708|NCT04439331|517385735|FG000|Overall Study|Withdrawal by Subject|6|||
143504709|NCT04439331|517385735|FG000|Overall Study|Physician Decision|1|||
143504710|NCT04439331|517385735|FG000|Overall Study|Other Complicating Disease|1|||
143504711|NCT02736695|517385736|FG000|Overall Study|Ineligible|6|||
143504712|NCT02736695|517385737|FG001|Overall Study|Ineligible|0|||
143504713|NCT03726268|517385738|FG000|Overall Study|Physician Decision|2|||
143504714|NCT03726268|517385739|FG001|Overall Study|Physician Decision|8|||
143504715|NCT03726268|517385740|FG002|Overall Study|Physician Decision|6|||
143504716|NCT03726268|517385741|FG003|Overall Study|Physician Decision|3|||
143504717|NCT03726268|517385738|FG000|Overall Study|Withdrawal by Subject|11|||
143504718|NCT03726268|517385739|FG001|Overall Study|Withdrawal by Subject|5|||
143504719|NCT03726268|517385740|FG002|Overall Study|Withdrawal by Subject|9|||
143504720|NCT03726268|517385741|FG003|Overall Study|Withdrawal by Subject|8|||
143504721|NCT03764033|517385743|FG000|Treatment Phase|Withdrawal by Subject|8|||
143504722|NCT03764033|517385744|FG001|Treatment Phase|Withdrawal by Subject|3|||
143504723|NCT03764033|517385743|FG000|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|0|||
143504724|NCT03764033|517385744|FG001|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|1|||
143504725|NCT03764033|517385743|FG000|Six Month Follow-Up|Lost to Follow-up|0|||
143504726|NCT03764033|517385744|FG001|Six Month Follow-Up|Lost to Follow-up|5|||
143504727|NCT04050293|517385747|FG000|Overall Study|Lost to Follow-up|1|||
143504728|NCT04050293|517385748|FG001|Overall Study|Lost to Follow-up|2|||
143504729|NCT04050293|517385747|FG000|Overall Study|Withdrawal by Subject|2|||
143504730|NCT04050293|517385748|FG001|Overall Study|Withdrawal by Subject|0|||
143504731|NCT05631093|517385751|FG000|Overall Study|Death|0|||
143504732|NCT05631093|517385752|FG001|Overall Study|Death|1|||
143504733|NCT05631093|517385751|FG000|Overall Study|Lost to Follow-up|1|||
143504734|NCT05631093|517385752|FG001|Overall Study|Lost to Follow-up|2|||
143504735|NCT05631093|517385751|FG000|Overall Study|Physician Decision|1|||
143504736|NCT05631093|517385752|FG001|Overall Study|Physician Decision|0|||
143504737|NCT05631093|517385751|FG000|Overall Study|Withdrawal by Subject|4|||
143504738|NCT05631093|517385752|FG001|Overall Study|Withdrawal by Subject|1|||
143504739|NCT05631093|517385751|FG000|Overall Study|Ongoing|353|||
143504740|NCT05631093|517385752|FG001|Overall Study|Ongoing|177|||
143504741|NCT05631093|517385751|FG000|Overall Study|Adverse Event|0|||
143504742|NCT05631093|517385752|FG001|Overall Study|Adverse Event|1|||
143504743|NCT01602666|517385756|FG000|Induction Chemotherapy|Death|2|||
143504744|NCT01602666|517385757|FG001|Induction Chemotherapy|Death|1|||
143504745|NCT01602666|517385756|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
143504746|NCT01602666|517385757|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
143504747|NCT01602666|517385756|FG000|Induction Chemotherapy|Physician Decision|12|||
143504748|NCT01602666|517385757|FG001|Induction Chemotherapy|Physician Decision|5|||
143504749|NCT01602666|517385756|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
143504750|NCT01602666|517385757|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
143504751|NCT01602666|517385756|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
143504752|NCT01602666|517385757|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
143504753|NCT01602666|517385756|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
143504754|NCT01602666|517385757|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
143504755|NCT01602666|517385756|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
143504756|NCT01602666|517385757|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
143504757|NCT01602666|517385756|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
143504758|NCT01602666|517385757|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
143504759|NCT01602666|517385756|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
143504760|NCT01602666|517385757|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
143504761|NCT01602666|517385756|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
143504762|NCT01602666|517385757|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
143504763|NCT01602666|517385756|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
143504764|NCT01602666|517385757|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
143504765|NCT04223193|517385758|FG000|Overall Study|Adverse Event|6|||
143504766|NCT04223193|517385759|FG001|Overall Study|Adverse Event|36|||
143504767|NCT04223193|517385758|FG000|Overall Study|Lack of Efficacy|2|||
143504768|NCT04223193|517385759|FG001|Overall Study|Lack of Efficacy|2|||
143069546|NCT04594707|515797166|FG001|Overall Study|Withdrawal by Subject|0|||
143069547|NCT04594707|515797167|FG002|Overall Study|Withdrawal by Subject|2|||
143069548|NCT00969540|515797169|FG000|Overall Study|Lost to Follow-up|1|||
143069549|NCT00969540|515797170|FG001|Overall Study|Lost to Follow-up|1|||
143069550|NCT02397408|515797171|FG000|Overall Study|Physician Decision|4|||
143069551|NCT02397408|515797171|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
143504769|NCT04223193|517385758|FG000|Overall Study|Lost to Follow-up|1|||
143504770|NCT04223193|517385759|FG001|Overall Study|Lost to Follow-up|1|||
143504771|NCT04223193|517385758|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
143069552|NCT01646138|515797172|FG000|Overall Study|Lost to Follow-up|0|||
143069553|NCT01646138|515797173|FG001|Overall Study|Lost to Follow-up|0|||
143504772|NCT04223193|517385759|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
143504773|NCT04223193|517385758|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|3|||
143504774|NCT04223193|517385759|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
143504775|NCT04223193|517385758|FG000|Overall Study|Non-Compliance with Study Drug|0|||
143504776|NCT04223193|517385759|FG001|Overall Study|Non-Compliance with Study Drug|1|||
143504777|NCT04223193|517385758|FG000|Overall Study|Physician Decision|0|||
143504778|NCT04223193|517385759|FG001|Overall Study|Physician Decision|1|||
143504779|NCT04223193|517385758|FG000|Overall Study|Protocol Violation|1|||
143504780|NCT04223193|517385759|FG001|Overall Study|Protocol Violation|1|||
143504781|NCT04223193|517385758|FG000|Overall Study|Site Terminated by Sponsor|1|||
143504782|NCT04223193|517385759|FG001|Overall Study|Site Terminated by Sponsor|3|||
143504783|NCT04223193|517385758|FG000|Overall Study|Withdrawal by Subject|5|||
143504784|NCT04223193|517385759|FG001|Overall Study|Withdrawal by Subject|6|||
143504785|NCT04223193|517385758|FG000|Overall Study|Other|3|||
143504786|NCT04223193|517385759|FG001|Overall Study|Other|6|||
143504787|NCT04370509|517385760|FG000|Overall Study|Adverse Event|1|||
143504788|NCT04370509|517385761|FG001|Overall Study|Adverse Event|0|||
143504789|NCT04370509|517385760|FG000|Overall Study|Did not receive post-op Pembrolizumab|1|||
143504790|NCT04370509|517385761|FG001|Overall Study|Did not receive post-op Pembrolizumab|0|||
143504791|NCT04743856|517385764|FG000|Overall Study|Lost to Follow-up|6|||
143504792|NCT04743856|517385765|FG001|Overall Study|Lost to Follow-up|7|||
143504793|NCT04743856|517385764|FG000|Overall Study|Withdrawal by Subject|1|||
143504794|NCT04743856|517385765|FG001|Overall Study|Withdrawal by Subject|0|||
143504795|NCT05856760|517385766|FG000|Overall Study|Adverse Event|2|||
143504796|NCT05856760|517385766|FG000|Overall Study|Physician Decision|1|||
143504797|NCT05856760|517385766|FG000|Overall Study|Protocol Violation|1|||
143504798|NCT05856760|517385766|FG000|Overall Study|Withdrawal by Subject|3|||
143504799|NCT04439188|517385767|FG000|Overall Study|Ineligible|3|||
143504800|NCT04439188|517385767|FG000|Overall Study|Adverse Event|4|||
143504801|NCT04439188|517385767|FG000|Overall Study|Death|1|||
143504802|NCT04439188|517385767|FG000|Overall Study|Disease Progression|25|||
143504803|NCT04439188|517385767|FG000|Overall Study|Withdrawal by Subject|2|||
143504804|NCT03193190|517385768|FG000|Stage 1|Arm Terminated by Sponsor|0|||
143504805|NCT03193190|517385769|FG001|Stage 1|Arm Terminated by Sponsor|0|||
143504806|NCT03193190|517385770|FG002|Stage 1|Arm Terminated by Sponsor|0|||
143504807|NCT03193190|517385771|FG003|Stage 1|Arm Terminated by Sponsor|1|||
143504808|NCT03193190|517385772|FG004|Stage 1|Arm Terminated by Sponsor|0|||
143504809|NCT03193190|517385773|FG005|Stage 1|Arm Terminated by Sponsor|2|||
143365357|NCT01913340|516880754|FG001|Overall Study|Lost to Follow-up|1|||
143365358|NCT05096884|516880755|FG000|Overall Study|Excluded based on negative tilt table test|4|||
143069554|NCT01646138|515797174|FG002|Overall Study|Lost to Follow-up|0|||
143069555|NCT01646138|515797175|FG003|Overall Study|Lost to Follow-up|0|||
143365359|NCT01096056|516880756|FG000|Overall Study|Lost to Follow-up|0|||
143365360|NCT01096056|516880757|FG001|Overall Study|Lost to Follow-up|1|||
143365361|NCT03568162|516880758|FG000|Overall Study|Adverse Event|0|||
143069556|NCT01646138|515797176|FG004|Overall Study|Lost to Follow-up|2|||
143069557|NCT04049617|515797177|FG000|Overall Study|Adverse Event|0|||
143069558|NCT04049617|515797178|FG001|Overall Study|Adverse Event|0|||
143069559|NCT04049617|515797179|FG002|Overall Study|Adverse Event|0|||
143069560|NCT04049617|515797180|FG003|Overall Study|Adverse Event|1|||
143069561|NCT04049617|515797181|FG004|Overall Study|Adverse Event|0|||
143069562|NCT04049617|515797182|FG005|Overall Study|Adverse Event|0|||
143069563|NCT04049617|515797177|FG000|Overall Study|Death|0|||
143069564|NCT04049617|515797178|FG001|Overall Study|Death|0|||
143069565|NCT04049617|515797179|FG002|Overall Study|Death|0|||
143069566|NCT04049617|515797180|FG003|Overall Study|Death|0|||
143069567|NCT04049617|515797181|FG004|Overall Study|Death|0|||
143069568|NCT04049617|515797182|FG005|Overall Study|Death|1|||
143069569|NCT04049617|515797177|FG000|Overall Study|Lost to Follow-up|0|||
143069570|NCT04049617|515797178|FG001|Overall Study|Lost to Follow-up|0|||
143069571|NCT04049617|515797179|FG002|Overall Study|Lost to Follow-up|0|||
143069572|NCT04049617|515797180|FG003|Overall Study|Lost to Follow-up|1|||
143069573|NCT04049617|515797181|FG004|Overall Study|Lost to Follow-up|0|||
143069574|NCT04049617|515797182|FG005|Overall Study|Lost to Follow-up|0|||
143069575|NCT04049617|515797177|FG000|Overall Study|Withdrew consent|0|||
143069576|NCT04049617|515797178|FG001|Overall Study|Withdrew consent|0|||
143069577|NCT04049617|515797179|FG002|Overall Study|Withdrew consent|1|||
143069578|NCT04049617|515797180|FG003|Overall Study|Withdrew consent|0|||
143069579|NCT04049617|515797181|FG004|Overall Study|Withdrew consent|0|||
143069580|NCT04049617|515797182|FG005|Overall Study|Withdrew consent|0|||
143069581|NCT04078126|515797183|FG000|Washout|Study put on hold due to COVID-19|0|||
143069582|NCT04078126|515797184|FG001|Washout|Study put on hold due to COVID-19|2|||
143069583|NCT04078126|515797183|FG000|Period 2|Study put on hold due to COVID-19|1|||
143069584|NCT04078126|515797184|FG001|Period 2|Study put on hold due to COVID-19|1|||
143365362|NCT03568162|516880759|FG001|Overall Study|Adverse Event|1|||
143504810|NCT03193190|517385774|FG006|Stage 1|Arm Terminated by Sponsor|0|||
143504811|NCT03193190|517385775|FG007|Stage 1|Arm Terminated by Sponsor|0|||
143504812|NCT03193190|517385776|FG008|Stage 1|Arm Terminated by Sponsor|0|||
143504813|NCT03193190|517385777|FG009|Stage 1|Arm Terminated by Sponsor|0|||
143504814|NCT03193190|517385778|FG010|Stage 1|Arm Terminated by Sponsor|0|||
143504815|NCT03193190|517385779|FG011|Stage 1|Arm Terminated by Sponsor|0|||
143504816|NCT03193190|517385780|FG012|Stage 1|Arm Terminated by Sponsor|0|||
143069585|NCT02669758|515797187|FG000|Overall Study|Withdrawal by Subject|43|||
143504817|NCT03193190|517385781|FG013|Stage 1|Arm Terminated by Sponsor|0|||
143504818|NCT03193190|517385782|FG014|Stage 1|Arm Terminated by Sponsor|0|||
143504819|NCT03193190|517385783|FG015|Stage 1|Arm Terminated by Sponsor|0|||
143504820|NCT03193190|517385768|FG000|Stage 1|Death|22|||
143504821|NCT03193190|517385769|FG001|Stage 1|Death|8|||
143504822|NCT03193190|517385770|FG002|Stage 1|Death|23|||
143504823|NCT03193190|517385771|FG003|Stage 1|Death|14|||
143504824|NCT03193190|517385772|FG004|Stage 1|Death|34|||
143504825|NCT03193190|517385773|FG005|Stage 1|Death|28|||
143504826|NCT03193190|517385774|FG006|Stage 1|Death|19|||
143504827|NCT03193190|517385775|FG007|Stage 1|Death|21|||
143504828|NCT03193190|517385776|FG008|Stage 1|Death|14|||
143504829|NCT03193190|517385777|FG009|Stage 1|Death|10|||
143504830|NCT03193190|517385778|FG010|Stage 1|Death|59|||
143504831|NCT03193190|517385779|FG011|Stage 1|Death|14|||
143504832|NCT03193190|517385780|FG012|Stage 1|Death|14|||
143504833|NCT03193190|517385781|FG013|Stage 1|Death|0|||
143504834|NCT03193190|517385782|FG014|Stage 1|Death|0|||
143504835|NCT03193190|517385783|FG015|Stage 1|Death|0|||
143504836|NCT03193190|517385768|FG000|Stage 1|Lost to Follow-up|2|||
143504837|NCT03193190|517385769|FG001|Stage 1|Lost to Follow-up|1|||
143504838|NCT03193190|517385770|FG002|Stage 1|Lost to Follow-up|1|||
143504839|NCT03193190|517385771|FG003|Stage 1|Lost to Follow-up|0|||
143504840|NCT03193190|517385772|FG004|Stage 1|Lost to Follow-up|0|||
143504841|NCT03193190|517385773|FG005|Stage 1|Lost to Follow-up|0|||
143069586|NCT02669758|515797187|FG000|Overall Study|Lost to Follow-up|19|||
143069587|NCT02669758|515797187|FG000|Overall Study|Adverse Event|16|||
143069588|NCT02669758|515797187|FG000|Overall Study|Non-Compliance with Study Drug|8|||
143504842|NCT03193190|517385774|FG006|Stage 1|Lost to Follow-up|1|||
143504843|NCT03193190|517385775|FG007|Stage 1|Lost to Follow-up|0|||
143504844|NCT03193190|517385776|FG008|Stage 1|Lost to Follow-up|0|||
143504845|NCT03193190|517385777|FG009|Stage 1|Lost to Follow-up|0|||
143504846|NCT03193190|517385778|FG010|Stage 1|Lost to Follow-up|0|||
143504847|NCT03193190|517385779|FG011|Stage 1|Lost to Follow-up|0|||
143069589|NCT02669758|515797187|FG000|Overall Study|Lack of Efficacy|5|||
143069590|NCT02669758|515797187|FG000|Overall Study|Pregnancy|1|||
143069591|NCT02669758|515797187|FG000|Overall Study|Study noncompliance|1|||
143504848|NCT03193190|517385780|FG012|Stage 1|Lost to Follow-up|0|||
143504849|NCT03193190|517385781|FG013|Stage 1|Lost to Follow-up|0|||
143504850|NCT03193190|517385782|FG014|Stage 1|Lost to Follow-up|0|||
143504851|NCT03193190|517385783|FG015|Stage 1|Lost to Follow-up|0|||
143504852|NCT03193190|517385768|FG000|Stage 1|Reason not Specified|1|||
143504853|NCT03193190|517385769|FG001|Stage 1|Reason not Specified|0|||
143504854|NCT03193190|517385770|FG002|Stage 1|Reason not Specified|0|||
143504855|NCT03193190|517385771|FG003|Stage 1|Reason not Specified|1|||
143504856|NCT03193190|517385772|FG004|Stage 1|Reason not Specified|0|||
143504857|NCT03193190|517385773|FG005|Stage 1|Reason not Specified|1|||
143504858|NCT03193190|517385774|FG006|Stage 1|Reason not Specified|2|||
143504859|NCT03193190|517385775|FG007|Stage 1|Reason not Specified|2|||
143504860|NCT03193190|517385776|FG008|Stage 1|Reason not Specified|0|||
143504861|NCT03193190|517385777|FG009|Stage 1|Reason not Specified|1|||
143504862|NCT03193190|517385778|FG010|Stage 1|Reason not Specified|3|||
143504863|NCT03193190|517385779|FG011|Stage 1|Reason not Specified|0|||
143504864|NCT03193190|517385780|FG012|Stage 1|Reason not Specified|1|||
143504865|NCT03193190|517385781|FG013|Stage 1|Reason not Specified|0|||
143504866|NCT03193190|517385782|FG014|Stage 1|Reason not Specified|0|||
143504867|NCT03193190|517385783|FG015|Stage 1|Reason not Specified|0|||
143504868|NCT03193190|517385768|FG000|Stage 1|Physician Decision|0|||
143069592|NCT02669758|515797187|FG000|Overall Study|Protocol Violation|1|||
143069593|NCT02149108|515797188|FG000|Overall Study|Not treated|1|||
143069594|NCT02149108|515797189|FG001|Overall Study|Not treated|2|||
143069595|NCT02149108|515797188|FG000|Overall Study|Progressive Disease (PD)|324|||
143069596|NCT02149108|515797189|FG001|Overall Study|Progressive Disease (PD)|318|||
143069597|NCT02149108|515797188|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
143069598|NCT02149108|515797189|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
143365363|NCT03568162|516880760|FG002|Overall Study|Adverse Event|2|||
143504869|NCT03193190|517385769|FG001|Stage 1|Physician Decision|0|||
143504870|NCT03193190|517385770|FG002|Stage 1|Physician Decision|0|||
143504871|NCT03193190|517385771|FG003|Stage 1|Physician Decision|0|||
143504872|NCT03193190|517385772|FG004|Stage 1|Physician Decision|0|||
143504873|NCT03193190|517385773|FG005|Stage 1|Physician Decision|0|||
143069599|NCT02149108|515797188|FG000|Overall Study|Other Adverse Event (AE)|8|||
143069600|NCT02149108|515797189|FG001|Overall Study|Other Adverse Event (AE)|18|||
143069601|NCT02149108|515797188|FG000|Overall Study|Other not defined above|0|||
143365364|NCT03568162|516880761|FG003|Overall Study|Adverse Event|0|||
143504874|NCT03193190|517385774|FG006|Stage 1|Physician Decision|0|||
143504875|NCT03193190|517385775|FG007|Stage 1|Physician Decision|0|||
143504876|NCT03193190|517385776|FG008|Stage 1|Physician Decision|0|||
143504877|NCT03193190|517385777|FG009|Stage 1|Physician Decision|0|||
143504878|NCT03193190|517385778|FG010|Stage 1|Physician Decision|0|||
143504879|NCT03193190|517385779|FG011|Stage 1|Physician Decision|1|||
143504880|NCT03193190|517385780|FG012|Stage 1|Physician Decision|0|||
143504881|NCT03193190|517385781|FG013|Stage 1|Physician Decision|0|||
143504882|NCT03193190|517385782|FG014|Stage 1|Physician Decision|0|||
143504883|NCT03193190|517385783|FG015|Stage 1|Physician Decision|0|||
143365365|NCT03568162|516880762|FG004|Overall Study|Adverse Event|0|||
143069602|NCT02149108|515797189|FG001|Overall Study|Other not defined above|2|||
143069603|NCT02149108|515797188|FG000|Overall Study|Refusal to continue trial medication|15|||
143069604|NCT02149108|515797189|FG001|Overall Study|Refusal to continue trial medication|11|||
143069605|NCT02149108|515797188|FG000|Overall Study|Lost to Follow-up|1|||
143069606|NCT02149108|515797189|FG001|Overall Study|Lost to Follow-up|0|||
143069607|NCT02455050|515797190|FG000|Treatment Period 1|Lost to Follow-up|1|||
143069608|NCT02455050|515797191|FG001|Treatment Period 1|Lost to Follow-up|1|||
143069609|NCT02455050|515797192|FG002|Treatment Period 1|Lost to Follow-up|1|||
143069610|NCT02455050|515797193|FG003|Treatment Period 1|Lost to Follow-up|2|||
143069611|NCT02455050|515797190|FG000|Treatment Period 2|Lost to Follow-up|1|||
143069612|NCT02455050|515797191|FG001|Treatment Period 2|Lost to Follow-up|0|||
143069613|NCT02455050|515797192|FG002|Treatment Period 2|Lost to Follow-up|2|||
143069614|NCT02455050|515797193|FG003|Treatment Period 2|Lost to Follow-up|1|||
143069615|NCT03402750|515797194|FG000|Overall Study|Lost to Follow-up|2|||
143069616|NCT03402750|515797195|FG001|Overall Study|Lost to Follow-up|1|||
143069617|NCT02981303|515797196|FG000|Overall Study|Progressive Disease|17|||
143069618|NCT02981303|515797197|FG001|Overall Study|Progressive Disease|37|||
143069619|NCT02981303|515797196|FG000|Overall Study|Adverse Event|1|||
143069620|NCT02981303|515797197|FG001|Overall Study|Adverse Event|4|||
143069621|NCT02981303|515797196|FG000|Overall Study|Withdrawal by Subject|0|||
143069622|NCT02981303|515797197|FG001|Overall Study|Withdrawal by Subject|1|||
143069623|NCT02325518|515797198|FG000|Overall Study|Adverse Event|4|||
143069624|NCT02325518|515797199|FG001|Overall Study|Adverse Event|1|||
143069625|NCT02325518|515797198|FG000|Overall Study|Physician Decision|0|||
143069626|NCT02325518|515797199|FG001|Overall Study|Physician Decision|1|||
143069627|NCT02325518|515797198|FG000|Overall Study|Withdrawal by Subject|0|||
143069628|NCT02325518|515797199|FG001|Overall Study|Withdrawal by Subject|1|||
143069629|NCT03393806|515797202|FG000|Overall Study|Physician Decision|1|||
143069630|NCT03393806|515797203|FG001|Overall Study|Physician Decision|0|||
143069631|NCT01259115|515797204|FG000|Period 1|Adverse Event|1|||
143069632|NCT01259115|515797205|FG001|Period 1|Adverse Event|0|||
143069633|NCT01259115|515797204|FG000|Period 1|Protocol Violation|2|||
143069634|NCT01259115|515797205|FG001|Period 1|Protocol Violation|0|||
143069635|NCT01259115|515797204|FG000|Period 1|Lost to Follow-up|0|||
143069636|NCT01259115|515797205|FG001|Period 1|Lost to Follow-up|1|||
143069637|NCT01259115|515797204|FG000|Period 2|Adverse Event|1|||
143069638|NCT01259115|515797205|FG001|Period 2|Adverse Event|0|||
143069639|NCT01971970|515797206|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
143069640|NCT01971970|515797207|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
143069641|NCT01971970|515797206|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
143069642|NCT01971970|515797207|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
143069643|NCT01971970|515797206|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
143069644|NCT01971970|515797207|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
143069645|NCT01971970|515797206|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
143069646|NCT01971970|515797207|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
143069647|NCT01971970|515797206|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
143069648|NCT01971970|515797207|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
143069649|NCT01971970|515797206|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
143069650|NCT01971970|515797207|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
143069651|NCT01971970|515797206|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
143069652|NCT01971970|515797207|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
143069653|NCT00848107|515797208|FG000|Overall Study|Lost to Follow-up|2|||
143069654|NCT00848107|515797208|FG000|Overall Study|Withdrawal by Subject|8|||
143069655|NCT00848107|515797208|FG000|Overall Study|Adverse Event|9|||
143069656|NCT00848107|515797208|FG000|Overall Study|Death|1|||
143069657|NCT00848107|515797208|FG000|Overall Study|Pregnancy|1|||
143069658|NCT00859586|515797209|FG000|Overall Study|Donors|4|||
143069659|NCT00080938|515797210|FG000|Overall Study|Adverse Event|3|||
143069660|NCT00080938|515797210|FG000|Overall Study|Withdrawal by Subject|6|||
143069661|NCT00080938|515797210|FG000|Overall Study|Death|2|||
143069662|NCT00080938|515797210|FG000|Overall Study|Lack of Efficacy|7|||
143069663|NCT00080938|515797210|FG000|Overall Study|other disease|1|||
143069664|NCT00080938|515797210|FG000|Overall Study|Not started protocol therapy|1|||
143069665|NCT00080938|515797210|FG000|Overall Study|Ineligible|4|||
143069666|NCT00706511|515797213|FG000|Overall Study|Withdrawal by Subject|1|||
143069667|NCT00706511|515797214|FG001|Overall Study|Withdrawal by Subject|0|||
143069668|NCT00706511|515797215|FG002|Overall Study|Withdrawal by Subject|0|||
143069669|NCT00706511|515797216|FG003|Overall Study|Withdrawal by Subject|0|||
143069670|NCT02605993|515797217|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
143365366|NCT03568162|516880763|FG005|Overall Study|Adverse Event|1|||
143069671|NCT02605993|515797218|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
143069672|NCT02605993|515797219|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
143171278|NCT00718315|516176056|FG000|Overall Study|Lost to Follow-up|2|||
143504884|NCT03193190|517385768|FG000|Stage 1|Progressive Disease|1|||
143504885|NCT03193190|517385769|FG001|Stage 1|Progressive Disease|0|||
143504886|NCT03193190|517385770|FG002|Stage 1|Progressive Disease|0|||
143504887|NCT03193190|517385771|FG003|Stage 1|Progressive Disease|0|||
143504888|NCT03193190|517385772|FG004|Stage 1|Progressive Disease|0|||
143504889|NCT03193190|517385773|FG005|Stage 1|Progressive Disease|0|||
143504890|NCT03193190|517385774|FG006|Stage 1|Progressive Disease|0|||
143504891|NCT03193190|517385775|FG007|Stage 1|Progressive Disease|0|||
143504892|NCT03193190|517385776|FG008|Stage 1|Progressive Disease|0|||
143504893|NCT03193190|517385777|FG009|Stage 1|Progressive Disease|0|||
143504894|NCT03193190|517385778|FG010|Stage 1|Progressive Disease|0|||
143504895|NCT03193190|517385779|FG011|Stage 1|Progressive Disease|0|||
143504896|NCT03193190|517385780|FG012|Stage 1|Progressive Disease|0|||
143504897|NCT03193190|517385781|FG013|Stage 1|Progressive Disease|0|||
143504898|NCT03193190|517385782|FG014|Stage 1|Progressive Disease|0|||
143504899|NCT03193190|517385783|FG015|Stage 1|Progressive Disease|0|||
143504900|NCT03193190|517385768|FG000|Stage 1|Study Terminated By Sponsor|3|||
143504901|NCT03193190|517385769|FG001|Stage 1|Study Terminated By Sponsor|0|||
143504902|NCT03193190|517385770|FG002|Stage 1|Study Terminated By Sponsor|0|||
143504903|NCT03193190|517385771|FG003|Stage 1|Study Terminated By Sponsor|0|||
143504904|NCT03193190|517385772|FG004|Stage 1|Study Terminated By Sponsor|6|||
143504905|NCT03193190|517385773|FG005|Stage 1|Study Terminated By Sponsor|0|||
143504906|NCT03193190|517385774|FG006|Stage 1|Study Terminated By Sponsor|0|||
143504907|NCT03193190|517385775|FG007|Stage 1|Study Terminated By Sponsor|0|||
143504908|NCT03193190|517385776|FG008|Stage 1|Study Terminated By Sponsor|0|||
143504909|NCT03193190|517385777|FG009|Stage 1|Study Terminated By Sponsor|0|||
143504910|NCT03193190|517385778|FG010|Stage 1|Study Terminated By Sponsor|0|||
143504911|NCT03193190|517385779|FG011|Stage 1|Study Terminated By Sponsor|0|||
143504912|NCT03193190|517385780|FG012|Stage 1|Study Terminated By Sponsor|0|||
143504913|NCT03193190|517385781|FG013|Stage 1|Study Terminated By Sponsor|0|||
143504914|NCT03193190|517385782|FG014|Stage 1|Study Terminated By Sponsor|0|||
143504915|NCT03193190|517385783|FG015|Stage 1|Study Terminated By Sponsor|0|||
143504916|NCT03193190|517385768|FG000|Stage 1|Withdrawal by Subject|6|||
143504917|NCT03193190|517385769|FG001|Stage 1|Withdrawal by Subject|0|||
143504918|NCT03193190|517385770|FG002|Stage 1|Withdrawal by Subject|1|||
143504919|NCT03193190|517385771|FG003|Stage 1|Withdrawal by Subject|0|||
143504920|NCT03193190|517385772|FG004|Stage 1|Withdrawal by Subject|2|||
143504921|NCT03193190|517385773|FG005|Stage 1|Withdrawal by Subject|0|||
143504922|NCT03193190|517385774|FG006|Stage 1|Withdrawal by Subject|3|||
143504923|NCT03193190|517385775|FG007|Stage 1|Withdrawal by Subject|2|||
143504924|NCT03193190|517385776|FG008|Stage 1|Withdrawal by Subject|2|||
143504925|NCT03193190|517385777|FG009|Stage 1|Withdrawal by Subject|4|||
143069673|NCT02605993|515797220|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
143069674|NCT03246126|515797223|FG000|Overall Study|Withdrawal by Subject|0|||
143069675|NCT03246126|515797224|FG001|Overall Study|Withdrawal by Subject|1|||
143069676|NCT00893737|515797230|FG000|Overall Study|Adverse Event|4|||
143365367|NCT03568162|516880758|FG000|Overall Study|Death|0|||
143365368|NCT03568162|516880759|FG001|Overall Study|Death|0|||
143365369|NCT03568162|516880760|FG002|Overall Study|Death|0|||
143365370|NCT03568162|516880761|FG003|Overall Study|Death|0|||
143365371|NCT03568162|516880762|FG004|Overall Study|Death|1|||
143069677|NCT00893737|515797230|FG000|Overall Study|Withdrawal by Subject|2|||
143069678|NCT00893737|515797230|FG000|Overall Study|Lost to Follow-up|6|||
143069679|NCT03981419|515797231|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
143069680|NCT03981419|515797232|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
143069681|NCT01437943|515797233|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
143504926|NCT03193190|517385778|FG010|Stage 1|Withdrawal by Subject|9|||
143504927|NCT03193190|517385779|FG011|Stage 1|Withdrawal by Subject|1|||
143504928|NCT03193190|517385780|FG012|Stage 1|Withdrawal by Subject|0|||
143365372|NCT03568162|516880763|FG005|Overall Study|Death|0|||
143365373|NCT03568162|516880758|FG000|Overall Study|Lost to Follow-up|3|||
143365374|NCT03568162|516880759|FG001|Overall Study|Lost to Follow-up|2|||
143365375|NCT03568162|516880760|FG002|Overall Study|Lost to Follow-up|4|||
143365376|NCT03568162|516880761|FG003|Overall Study|Lost to Follow-up|2|||
143504929|NCT03193190|517385781|FG013|Stage 1|Withdrawal by Subject|0|||
143504930|NCT03193190|517385782|FG014|Stage 1|Withdrawal by Subject|0|||
143504931|NCT03193190|517385783|FG015|Stage 1|Withdrawal by Subject|0|||
143504932|NCT03193190|517385768|FG000|Stage 2|Death|0|||
143504933|NCT03193190|517385769|FG001|Stage 2|Death|0|||
143504934|NCT03193190|517385770|FG002|Stage 2|Death|0|||
143504935|NCT03193190|517385771|FG003|Stage 2|Death|0|||
143069682|NCT01437943|515797234|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
143365377|NCT03568162|516880762|FG004|Overall Study|Lost to Follow-up|3|||
143365378|NCT03568162|516880763|FG005|Overall Study|Lost to Follow-up|2|||
143504936|NCT03193190|517385772|FG004|Stage 2|Death|0|||
143504937|NCT03193190|517385773|FG005|Stage 2|Death|0|||
143504938|NCT03193190|517385774|FG006|Stage 2|Death|0|||
143504939|NCT03193190|517385775|FG007|Stage 2|Death|0|||
143504940|NCT03193190|517385776|FG008|Stage 2|Death|0|||
143504941|NCT03193190|517385777|FG009|Stage 2|Death|0|||
143504942|NCT03193190|517385778|FG010|Stage 2|Death|0|||
143504943|NCT03193190|517385779|FG011|Stage 2|Death|0|||
143504944|NCT03193190|517385780|FG012|Stage 2|Death|0|||
143069683|NCT01437943|515797233|FG000|Overall Study|Subject expressed pregnancy plans|1|||
143069684|NCT01437943|515797234|FG001|Overall Study|Subject expressed pregnancy plans|0|||
143069685|NCT01437943|515797233|FG000|Overall Study|Adverse Event|2|||
143069686|NCT01437943|515797234|FG001|Overall Study|Adverse Event|0|||
143069687|NCT01941940|515797249|FG000|Overall Study|Adverse Event|11|||
143069688|NCT01941940|515797249|FG000|Overall Study|Lost to Follow-up|2|||
143069689|NCT01941940|515797249|FG000|Overall Study|Physician Decision|2|||
143069690|NCT01941940|515797249|FG000|Overall Study|Withdrawal by Subject|15|||
143069691|NCT01941940|515797249|FG000|Overall Study|Death|1|||
143069692|NCT01941940|515797249|FG000|Overall Study|Other|1|||
143069693|NCT01941940|515797249|FG000|Overall Study|Other|1|||
143069694|NCT00444457|515797252|FG000|Infant Series|Other|0|||
143069695|NCT00444457|515797253|FG001|Infant Series|Other|1|||
143069696|NCT00444457|515797254|FG002|Infant Series|Other|0|||
143069697|NCT00444457|515797255|FG003|Infant Series|Other|0|||
143069698|NCT00444457|515797252|FG000|Infant Series|Parent or legal guardian request|18|||
143069699|NCT00444457|515797253|FG001|Infant Series|Parent or legal guardian request|29|||
143069700|NCT00444457|515797254|FG002|Infant Series|Parent or legal guardian request|34|||
143069701|NCT00444457|515797255|FG003|Infant Series|Parent or legal guardian request|14|||
143069702|NCT00444457|515797252|FG000|Infant Series|Lost to Follow-up|10|||
143171279|NCT00718315|516176057|FG001|Overall Study|Lost to Follow-up|3|||
143171280|NCT00718315|516176058|FG002|Overall Study|Lost to Follow-up|4|||
143171281|NCT00718315|516176056|FG000|Overall Study|Protocol Violation|5|||
143171282|NCT00718315|516176057|FG001|Overall Study|Protocol Violation|5|||
143171283|NCT00718315|516176058|FG002|Overall Study|Protocol Violation|3|||
143171284|NCT00718315|516176056|FG000|Overall Study|Erlotinib dose decreased|4|||
143171285|NCT00718315|516176057|FG001|Overall Study|Erlotinib dose decreased|3|||
143171286|NCT00718315|516176058|FG002|Overall Study|Erlotinib dose decreased|1|||
143171287|NCT00718315|516176056|FG000|Overall Study|Use of Minocyclin|1|||
143171288|NCT00718315|516176057|FG001|Overall Study|Use of Minocyclin|1|||
143171289|NCT00718315|516176058|FG002|Overall Study|Use of Minocyclin|1|||
143171290|NCT00718315|516176056|FG000|Overall Study|Disease progression|0|||
143171291|NCT00718315|516176057|FG001|Overall Study|Disease progression|1|||
143171292|NCT00718315|516176058|FG002|Overall Study|Disease progression|1|||
143171293|NCT00718315|516176056|FG000|Overall Study|Other|0|||
143171294|NCT00718315|516176057|FG001|Overall Study|Other|0|||
143171295|NCT00718315|516176058|FG002|Overall Study|Other|1|||
143171296|NCT00718315|516176056|FG000|Overall Study|Use of ATB and Corticoids|0|||
143171297|NCT00718315|516176057|FG001|Overall Study|Use of ATB and Corticoids|1|||
143171298|NCT00718315|516176058|FG002|Overall Study|Use of ATB and Corticoids|2|||
143171299|NCT00806585|516176060|FG000|Overall Study|Study terminated by Sponsor|0|||
143171300|NCT00806585|516176061|FG001|Overall Study|Study terminated by Sponsor|0|||
143171301|NCT00806585|516176062|FG002|Overall Study|Study terminated by Sponsor|1|||
143171302|NCT00806585|516176063|FG003|Overall Study|Study terminated by Sponsor|2|||
143171303|NCT00806585|516176064|FG004|Overall Study|Study terminated by Sponsor|0|||
143171304|NCT00806585|516176060|FG000|Overall Study|Protocol Violation|3|||
143171305|NCT00806585|516176061|FG001|Overall Study|Protocol Violation|1|||
143171306|NCT00806585|516176062|FG002|Overall Study|Protocol Violation|2|||
143171307|NCT00806585|516176063|FG003|Overall Study|Protocol Violation|0|||
143171308|NCT00806585|516176064|FG004|Overall Study|Protocol Violation|0|||
143171309|NCT00806585|516176060|FG000|Overall Study|Physician Decision|0|||
143171310|NCT00806585|516176061|FG001|Overall Study|Physician Decision|2|||
143171311|NCT00806585|516176062|FG002|Overall Study|Physician Decision|3|||
143171312|NCT00806585|516176063|FG003|Overall Study|Physician Decision|0|||
143171313|NCT00806585|516176064|FG004|Overall Study|Physician Decision|1|||
143171314|NCT00806585|516176060|FG000|Overall Study|Lost to Follow-up|2|||
143171315|NCT00806585|516176061|FG001|Overall Study|Lost to Follow-up|1|||
143365379|NCT03568162|516880758|FG000|Overall Study|Physician Decision|0|||
143069703|NCT00444457|515797253|FG001|Infant Series|Lost to Follow-up|11|||
143069704|NCT00444457|515797254|FG002|Infant Series|Lost to Follow-up|7|||
143069705|NCT00444457|515797255|FG003|Infant Series|Lost to Follow-up|6|||
143171316|NCT00806585|516176062|FG002|Overall Study|Lost to Follow-up|2|||
143171317|NCT00806585|516176063|FG003|Overall Study|Lost to Follow-up|2|||
143171318|NCT00806585|516176064|FG004|Overall Study|Lost to Follow-up|5|||
143171319|NCT00806585|516176060|FG000|Overall Study|Lack of Efficacy|1|||
143365380|NCT03568162|516880759|FG001|Overall Study|Physician Decision|1|||
143171320|NCT00806585|516176061|FG001|Overall Study|Lack of Efficacy|0|||
143171321|NCT00806585|516176062|FG002|Overall Study|Lack of Efficacy|0|||
143504945|NCT03193190|517385781|FG013|Stage 2|Death|14|||
143504946|NCT03193190|517385782|FG014|Stage 2|Death|4|||
143171322|NCT00806585|516176063|FG003|Overall Study|Lack of Efficacy|0|||
143171323|NCT00806585|516176064|FG004|Overall Study|Lack of Efficacy|0|||
143171324|NCT00806585|516176060|FG000|Overall Study|Adverse Event|1|||
143171325|NCT00806585|516176061|FG001|Overall Study|Adverse Event|5|||
143504947|NCT03193190|517385783|FG015|Stage 2|Death|1|||
143069706|NCT00444457|515797252|FG000|Infant Series|Protocol Violation|16|||
143069707|NCT00444457|515797253|FG001|Infant Series|Protocol Violation|8|||
143504948|NCT03193190|517385768|FG000|Stage 2|Lost to Follow-up|0|||
143504949|NCT03193190|517385769|FG001|Stage 2|Lost to Follow-up|0|||
143504950|NCT03193190|517385770|FG002|Stage 2|Lost to Follow-up|0|||
143504951|NCT03193190|517385771|FG003|Stage 2|Lost to Follow-up|0|||
143504952|NCT03193190|517385772|FG004|Stage 2|Lost to Follow-up|0|||
143504953|NCT03193190|517385773|FG005|Stage 2|Lost to Follow-up|0|||
143504954|NCT03193190|517385774|FG006|Stage 2|Lost to Follow-up|0|||
143504955|NCT03193190|517385775|FG007|Stage 2|Lost to Follow-up|0|||
143504956|NCT03193190|517385776|FG008|Stage 2|Lost to Follow-up|0|||
143504957|NCT03193190|517385777|FG009|Stage 2|Lost to Follow-up|0|||
143504958|NCT03193190|517385778|FG010|Stage 2|Lost to Follow-up|0|||
143504959|NCT03193190|517385779|FG011|Stage 2|Lost to Follow-up|0|||
143504960|NCT03193190|517385780|FG012|Stage 2|Lost to Follow-up|0|||
143504961|NCT03193190|517385781|FG013|Stage 2|Lost to Follow-up|0|||
143504962|NCT03193190|517385782|FG014|Stage 2|Lost to Follow-up|1|||
143504963|NCT03193190|517385783|FG015|Stage 2|Lost to Follow-up|0|||
143504964|NCT03193190|517385768|FG000|Stage 2|Withdrawal by Subject|0|||
143504965|NCT03193190|517385769|FG001|Stage 2|Withdrawal by Subject|0|||
143504966|NCT03193190|517385770|FG002|Stage 2|Withdrawal by Subject|0|||
143504967|NCT03193190|517385771|FG003|Stage 2|Withdrawal by Subject|0|||
143504968|NCT03193190|517385772|FG004|Stage 2|Withdrawal by Subject|0|||
143504969|NCT03193190|517385773|FG005|Stage 2|Withdrawal by Subject|0|||
143504970|NCT03193190|517385774|FG006|Stage 2|Withdrawal by Subject|0|||
143504971|NCT03193190|517385775|FG007|Stage 2|Withdrawal by Subject|0|||
143504972|NCT03193190|517385776|FG008|Stage 2|Withdrawal by Subject|0|||
143504973|NCT03193190|517385777|FG009|Stage 2|Withdrawal by Subject|0|||
143504974|NCT03193190|517385778|FG010|Stage 2|Withdrawal by Subject|0|||
143504975|NCT03193190|517385779|FG011|Stage 2|Withdrawal by Subject|0|||
143504976|NCT03193190|517385780|FG012|Stage 2|Withdrawal by Subject|0|||
143504977|NCT03193190|517385781|FG013|Stage 2|Withdrawal by Subject|1|||
143504978|NCT03193190|517385782|FG014|Stage 2|Withdrawal by Subject|1|||
143504979|NCT03193190|517385783|FG015|Stage 2|Withdrawal by Subject|0|||
143504980|NCT03532295|517385784|FG000|Overall Study|Did not start treatment|0|||
143504981|NCT03532295|517385785|FG001|Overall Study|Did not start treatment|2|||
143504982|NCT05526521|517385786|FG000|Overall Study|Withdrawal by Subject|0|||
143504983|NCT05526521|517385787|FG001|Overall Study|Withdrawal by Subject|1|||
143504984|NCT05526521|517385788|FG002|Overall Study|Withdrawal by Subject|0|||
143504985|NCT05526521|517385789|FG003|Overall Study|Withdrawal by Subject|0|||
143504986|NCT04482647|517385790|FG000|Overall Study|Time constraints|2|||
143504987|NCT04482647|517385790|FG000|Overall Study|Health issues|1|||
143504988|NCT04482647|517385790|FG000|Overall Study|Death in the family|1|||
143504989|NCT04482647|517385790|FG000|Overall Study|Disliked the intervention|1|||
143504990|NCT04482647|517385790|FG000|Overall Study|No reasons specified|7|||
143504991|NCT03732677|517385794|FG000|Overall Study|Terminated the study|154|||
143504992|NCT03732677|517385795|FG001|Overall Study|Terminated the study|197|||
143504993|NCT03732677|517385794|FG000|Overall Study|Continuing study off treatment|379|||
143504994|NCT03732677|517385795|FG001|Overall Study|Continuing study off treatment|333|||
143504995|NCT04644237|517385796|FG000|Overall Study|Death|4|||
143504996|NCT04644237|517385797|FG001|Overall Study|Death|2|||
143504997|NCT04644237|517385796|FG000|Overall Study|Adverse Event|18|||
143504998|NCT04644237|517385797|FG001|Overall Study|Adverse Event|19|||
143504999|NCT04644237|517385796|FG000|Overall Study|Progressive Disease|61|||
143505000|NCT04644237|517385797|FG001|Overall Study|Progressive Disease|23|||
143505001|NCT04644237|517385796|FG000|Overall Study|Clinical Progression|4|||
143505002|NCT04644237|517385797|FG001|Overall Study|Clinical Progression|1|||
143069708|NCT00444457|515797254|FG002|Infant Series|Protocol Violation|6|||
143069709|NCT00444457|515797255|FG003|Infant Series|Protocol Violation|3|||
143069710|NCT00444457|515797252|FG000|Infant Series|Failed to return|5|||
143505003|NCT04644237|517385796|FG000|Overall Study|Withdrawal by Subject|4|||
143505004|NCT04644237|517385797|FG001|Overall Study|Withdrawal by Subject|2|||
143505005|NCT04644237|517385796|FG000|Overall Study|Physician Decision|4|||
143505006|NCT04644237|517385797|FG001|Overall Study|Physician Decision|0|||
143505007|NCT04644237|517385796|FG000|Overall Study|Other|6|||
143505008|NCT04644237|517385797|FG001|Overall Study|Other|3|||
143505009|NCT04644237|517385796|FG000|Overall Study|Randomized but not Treated|1|||
143505010|NCT04644237|517385797|FG001|Overall Study|Randomized but not Treated|0|||
143505011|NCT03131817|517385798|FG000|Overall Study|Participant developed cognitive decline and was unable to provide regular symptom assessments|1|||
143505012|NCT01892722|517385801|FG000|Overall Study|Protocol deviation|0|||
143069711|NCT00444457|515797253|FG001|Infant Series|Failed to return|4|||
143505013|NCT01892722|517385802|FG001|Overall Study|Protocol deviation|1|||
143505014|NCT01892722|517385801|FG000|Overall Study|Administrative problems|0|||
143505015|NCT01892722|517385802|FG001|Overall Study|Administrative problems|1|||
143505016|NCT01892722|517385801|FG000|Overall Study|Patient/guardian decision|0|||
143505017|NCT01892722|517385802|FG001|Overall Study|Patient/guardian decision|2|||
143505018|NCT01892722|517385801|FG000|Overall Study|Physician Decision|1|||
143505019|NCT01892722|517385802|FG001|Overall Study|Physician Decision|2|||
143505020|NCT01892722|517385801|FG000|Overall Study|Adverse Event|3|||
143505021|NCT01892722|517385802|FG001|Overall Study|Adverse Event|2|||
143505022|NCT01892722|517385801|FG000|Overall Study|Lack of Efficacy|0|||
143069712|NCT00444457|515797254|FG002|Infant Series|Failed to return|4|||
143505023|NCT01892722|517385802|FG001|Overall Study|Lack of Efficacy|7|||
143069713|NCT00444457|515797255|FG003|Infant Series|Failed to return|2|||
143069714|NCT00444457|515797252|FG000|Infant Series|Investigator request|4|||
143069715|NCT00444457|515797253|FG001|Infant Series|Investigator request|3|||
143069716|NCT00444457|515797254|FG002|Infant Series|Investigator request|3|||
143069717|NCT00444457|515797255|FG003|Infant Series|Investigator request|2|||
143069718|NCT00444457|515797252|FG000|Infant Series|Other|0|||
143069719|NCT00444457|515797253|FG001|Infant Series|Other|2|||
143069720|NCT00444457|515797254|FG002|Infant Series|Other|4|||
143069721|NCT00444457|515797255|FG003|Infant Series|Other|0|||
143069722|NCT00444457|515797252|FG000|Infant Series|Adverse Event|1|||
143069723|NCT00444457|515797253|FG001|Infant Series|Adverse Event|2|||
143069724|NCT00444457|515797254|FG002|Infant Series|Adverse Event|2|||
143069725|NCT00444457|515797255|FG003|Infant Series|Adverse Event|0|||
143069726|NCT00444457|515797252|FG000|Infant Series|Death|0|||
143069727|NCT00444457|515797253|FG001|Infant Series|Death|1|||
143069728|NCT00444457|515797254|FG002|Infant Series|Death|1|||
143069729|NCT00444457|515797255|FG003|Infant Series|Death|1|||
143069730|NCT00444457|515797252|FG000|After Infant Series|Other|0|||
143069731|NCT00444457|515797253|FG001|After Infant Series|Other|1|||
143069732|NCT00444457|515797254|FG002|After Infant Series|Other|1|||
143069733|NCT00444457|515797255|FG003|After Infant Series|Other|1|||
143069734|NCT00444457|515797252|FG000|After Infant Series|Parent or legal guardian request|4|||
143069735|NCT00444457|515797253|FG001|After Infant Series|Parent or legal guardian request|11|||
143069736|NCT00444457|515797254|FG002|After Infant Series|Parent or legal guardian request|6|||
143069737|NCT00444457|515797255|FG003|After Infant Series|Parent or legal guardian request|3|||
143069738|NCT00444457|515797252|FG000|After Infant Series|Failed to return|7|||
143069739|NCT00444457|515797253|FG001|After Infant Series|Failed to return|6|||
143069740|NCT00444457|515797254|FG002|After Infant Series|Failed to return|5|||
143069741|NCT00444457|515797255|FG003|After Infant Series|Failed to return|1|||
143069742|NCT00444457|515797252|FG000|After Infant Series|Lost to Follow-up|5|||
143069743|NCT00444457|515797253|FG001|After Infant Series|Lost to Follow-up|5|||
143069744|NCT00444457|515797254|FG002|After Infant Series|Lost to Follow-up|5|||
143069745|NCT00444457|515797255|FG003|After Infant Series|Lost to Follow-up|2|||
143069746|NCT00444457|515797252|FG000|After Infant Series|Protocol Violation|2|||
143069747|NCT00444457|515797253|FG001|After Infant Series|Protocol Violation|4|||
143069748|NCT00444457|515797254|FG002|After Infant Series|Protocol Violation|2|||
143069749|NCT00444457|515797255|FG003|After Infant Series|Protocol Violation|2|||
143069750|NCT00444457|515797252|FG000|After Infant Series|Adverse Event|2|||
143069751|NCT00444457|515797253|FG001|After Infant Series|Adverse Event|2|||
143069752|NCT00444457|515797254|FG002|After Infant Series|Adverse Event|0|||
143069753|NCT00444457|515797255|FG003|After Infant Series|Adverse Event|0|||
143069754|NCT00444457|515797252|FG000|After Infant Series|Investigator request|0|||
143069755|NCT00444457|515797253|FG001|After Infant Series|Investigator request|0|||
143069756|NCT00444457|515797254|FG002|After Infant Series|Investigator request|0|||
143069757|NCT00444457|515797255|FG003|After Infant Series|Investigator request|1|||
143069758|NCT00444457|515797252|FG000|After Infant Series|Other|0|||
143069759|NCT00444457|515797253|FG001|After Infant Series|Other|1|||
143069760|NCT00444457|515797254|FG002|After Infant Series|Other|0|||
143069761|NCT00444457|515797255|FG003|After Infant Series|Other|0|||
143069762|NCT00444457|515797252|FG000|Toddler Dose|Lost to Follow-up|4|||
143069763|NCT00444457|515797253|FG001|Toddler Dose|Lost to Follow-up|1|||
143069764|NCT00444457|515797254|FG002|Toddler Dose|Lost to Follow-up|1|||
143069765|NCT00444457|515797255|FG003|Toddler Dose|Lost to Follow-up|3|||
143069766|NCT00444457|515797252|FG000|Toddler Dose|Failed to return|2|||
143069767|NCT00444457|515797253|FG001|Toddler Dose|Failed to return|2|||
143069768|NCT00444457|515797254|FG002|Toddler Dose|Failed to return|1|||
143069769|NCT00444457|515797255|FG003|Toddler Dose|Failed to return|3|||
143069770|NCT00444457|515797252|FG000|Toddler Dose|Parent or legal guardian request|0|||
143069771|NCT00444457|515797253|FG001|Toddler Dose|Parent or legal guardian request|3|||
143069772|NCT00444457|515797254|FG002|Toddler Dose|Parent or legal guardian request|2|||
143069773|NCT00444457|515797255|FG003|Toddler Dose|Parent or legal guardian request|1|||
143069774|NCT00444457|515797252|FG000|Toddler Dose|Protocol Violation|1|||
143069775|NCT00444457|515797253|FG001|Toddler Dose|Protocol Violation|0|||
143069776|NCT00444457|515797254|FG002|Toddler Dose|Protocol Violation|0|||
143069777|NCT00444457|515797255|FG003|Toddler Dose|Protocol Violation|1|||
143069778|NCT03201211|515797258|FG000|Overall Study|Adverse Event|1|||
143069779|NCT03201211|515797259|FG001|Overall Study|Adverse Event|0|||
143069780|NCT03201211|515797260|FG002|Overall Study|Adverse Event|0|||
143069781|NCT03201211|515797258|FG000|Overall Study|Protocol Violation|1|||
143069782|NCT03201211|515797259|FG001|Overall Study|Protocol Violation|0|||
143069783|NCT03201211|515797260|FG002|Overall Study|Protocol Violation|0|||
143365381|NCT03568162|516880760|FG002|Overall Study|Physician Decision|1|||
143069784|NCT03201211|515797258|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
143069785|NCT03201211|515797259|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
143069786|NCT03201211|515797260|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
143069787|NCT03201211|515797258|FG000|Overall Study|OTHER unknown reasons|0|||
143069788|NCT03201211|515797259|FG001|Overall Study|OTHER unknown reasons|1|||
143069789|NCT03201211|515797260|FG002|Overall Study|OTHER unknown reasons|0|||
143505024|NCT01892722|517385801|FG000|Overall Study|Withdrawal by Subject|3|||
143505025|NCT01892722|517385802|FG001|Overall Study|Withdrawal by Subject|5|||
143069790|NCT03071094|515797264|FG000|Overall Study|Death|1|||
143069791|NCT03071094|515797265|FG001|Overall Study|Death|1|||
143505026|NCT05568888|517385805|FG000|Overall Study|Physician Decision|1|||
143505027|NCT05568888|517385806|FG001|Overall Study|Physician Decision|0|||
143505028|NCT05568888|517385805|FG000|Overall Study|Protocol Deviation|2|||
143505029|NCT05568888|517385806|FG001|Overall Study|Protocol Deviation|1|||
143505030|NCT05568888|517385805|FG000|Overall Study|Withdrawal by Subject/Legally Authorized Representative|47|||
143505031|NCT05568888|517385806|FG001|Overall Study|Withdrawal by Subject/Legally Authorized Representative|53|||
143505032|NCT05568888|517385805|FG000|Overall Study|Withdrawal by Parent/Guardian|10|||
143505033|NCT05568888|517385806|FG001|Overall Study|Withdrawal by Parent/Guardian|14|||
143505034|NCT05568888|517385805|FG000|Overall Study|No IP Administered/Subject Excluded|1|||
143505035|NCT05568888|517385806|FG001|Overall Study|No IP Administered/Subject Excluded|4|||
143505036|NCT03498521|517385813|FG000|Overall Study|Death|227|||
143505037|NCT03498521|517385814|FG001|Overall Study|Death|79|||
143505038|NCT03498521|517385815|FG002|Overall Study|Death|84|||
143505039|NCT03498521|517385813|FG000|Overall Study|Exclusion criteria|1|||
143505040|NCT03498521|517385814|FG001|Overall Study|Exclusion criteria|0|||
143069792|NCT03071094|515797264|FG000|Overall Study|Adverse Event|1|||
143069793|NCT03071094|515797265|FG001|Overall Study|Adverse Event|0|||
143069794|NCT02312063|515797266|FG000|Overall Study|Withdrawal by Subject|0|||
143069795|NCT02312063|515797267|FG001|Overall Study|Withdrawal by Subject|1|||
143069796|NCT00594646|515797270|FG000|Overall Study|Withdrawal by Subject|1|||
143069797|NCT00594646|515797270|FG000|Overall Study|Lost to Follow-up|15|||
143069798|NCT00658658|515799553|FG000|Overall Study|Withdrawal by Subject|0|||
143069799|NCT00658658|515799554|FG001|Overall Study|Withdrawal by Subject|1|||
143069800|NCT00658658|515799555|FG002|Overall Study|Withdrawal by Subject|0|||
143069801|NCT00658658|515799556|FG003|Overall Study|Withdrawal by Subject|0|||
143069802|NCT00658658|515799557|FG004|Overall Study|Withdrawal by Subject|0|||
143069803|NCT00658658|515799553|FG000|Overall Study|Death|4|||
143069804|NCT00658658|515799554|FG001|Overall Study|Death|0|||
143069805|NCT00658658|515799555|FG002|Overall Study|Death|0|||
143069806|NCT00658658|515799556|FG003|Overall Study|Death|1|||
143069807|NCT00658658|515799557|FG004|Overall Study|Death|1|||
143069808|NCT00658658|515799553|FG000|Overall Study|Disease Progression|0|||
143069809|NCT00658658|515799554|FG001|Overall Study|Disease Progression|1|||
143069810|NCT00658658|515799555|FG002|Overall Study|Disease Progression|0|||
143069811|NCT00658658|515799556|FG003|Overall Study|Disease Progression|1|||
143069812|NCT00658658|515799557|FG004|Overall Study|Disease Progression|3|||
143069813|NCT00658658|515799553|FG000|Overall Study|Protocol-specified Criteria|1|||
143069814|NCT00658658|515799554|FG001|Overall Study|Protocol-specified Criteria|0|||
143069815|NCT00658658|515799555|FG002|Overall Study|Protocol-specified Criteria|0|||
143069816|NCT00658658|515799556|FG003|Overall Study|Protocol-specified Criteria|0|||
143069817|NCT00658658|515799557|FG004|Overall Study|Protocol-specified Criteria|0|||
143069818|NCT00658658|515799553|FG000|Overall Study|Other|0|||
143069819|NCT00658658|515799554|FG001|Overall Study|Other|0|||
143069820|NCT00658658|515799555|FG002|Overall Study|Other|0|||
143069821|NCT00658658|515799556|FG003|Overall Study|Other|0|||
143505041|NCT03498521|517385815|FG002|Overall Study|Exclusion criteria|0|||
143505042|NCT03498521|517385813|FG000|Overall Study|Lost to Follow-up|4|||
143505043|NCT03498521|517385814|FG001|Overall Study|Lost to Follow-up|3|||
143505044|NCT03498521|517385815|FG002|Overall Study|Lost to Follow-up|3|||
143505045|NCT03498521|517385813|FG000|Overall Study|No profile due to technical failure|1|||
143069822|NCT00658658|515799557|FG004|Overall Study|Other|1|||
143069823|NCT04234984|515799565|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
143247633|NCT00947882|516458665|FG000|Overall Study|Trial Terminated by Sponsor|62|||
143247634|NCT00947882|516458666|FG001|Overall Study|Trial Terminated by Sponsor|61|||
143247635|NCT00947882|516458667|FG002|Overall Study|Trial Terminated by Sponsor|62|||
143247636|NCT00947882|516458668|FG003|Overall Study|Trial Terminated by Sponsor|70|||
143247637|NCT00452361|516458669|FG000|Overall Study|Adverse Event|8|||
143247638|NCT00452361|516458670|FG001|Overall Study|Adverse Event|0|||
143069824|NCT04234984|515799565|FG000|Follow-up at the Second Time Point|Death|1|||
143069825|NCT04234984|515799565|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
143069826|NCT01055132|515799566|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
143069827|NCT01055132|515799567|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
143069828|NCT01055132|515799566|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
143247639|NCT00452361|516458669|FG000|Overall Study|Withdrawal by Subject|0|||
143505046|NCT03498521|517385814|FG001|Overall Study|No profile due to technical failure|0|||
143069829|NCT01055132|515799567|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
143069830|NCT02570113|515799568|FG000|Overall Study|Withdrawal by Subject|3|||
143069831|NCT02746471|515799569|FG000|Overall Study|Death|43|||
143069832|NCT02746471|515799569|FG000|Overall Study|Exited before 36 months|1119|||
143505047|NCT03498521|517385815|FG002|Overall Study|No profile due to technical failure|0|||
143505048|NCT03498521|517385813|FG000|Overall Study|Physician Decision|3|||
143505049|NCT03498521|517385814|FG001|Overall Study|Physician Decision|1|||
143505050|NCT03498521|517385815|FG002|Overall Study|Physician Decision|0|||
143365382|NCT03568162|516880761|FG003|Overall Study|Physician Decision|0|||
143365383|NCT03568162|516880762|FG004|Overall Study|Physician Decision|1|||
143365384|NCT03568162|516880763|FG005|Overall Study|Physician Decision|0|||
143365385|NCT03568162|516880758|FG000|Overall Study|Pregnancy|0|||
143365386|NCT03568162|516880759|FG001|Overall Study|Pregnancy|0|||
143365387|NCT03568162|516880760|FG002|Overall Study|Pregnancy|0|||
143365388|NCT03568162|516880761|FG003|Overall Study|Pregnancy|1|||
143365389|NCT03568162|516880762|FG004|Overall Study|Pregnancy|0|||
143365390|NCT03568162|516880763|FG005|Overall Study|Pregnancy|0|||
143365391|NCT03568162|516880758|FG000|Overall Study|Protocol Violation|1|||
143365392|NCT03568162|516880759|FG001|Overall Study|Protocol Violation|0|||
143365393|NCT03568162|516880760|FG002|Overall Study|Protocol Violation|1|||
143365394|NCT03568162|516880761|FG003|Overall Study|Protocol Violation|1|||
143365395|NCT03568162|516880762|FG004|Overall Study|Protocol Violation|1|||
143365396|NCT03568162|516880763|FG005|Overall Study|Protocol Violation|1|||
143365397|NCT03568162|516880758|FG000|Overall Study|Withdrawal by Subject|15|||
143365398|NCT03568162|516880759|FG001|Overall Study|Withdrawal by Subject|15|||
143365399|NCT03568162|516880760|FG002|Overall Study|Withdrawal by Subject|26|||
143365400|NCT03568162|516880761|FG003|Overall Study|Withdrawal by Subject|22|||
143365401|NCT03568162|516880762|FG004|Overall Study|Withdrawal by Subject|6|||
143365402|NCT03568162|516880763|FG005|Overall Study|Withdrawal by Subject|9|||
143365403|NCT03568162|516880758|FG000|Overall Study|Others|3|||
143365404|NCT03568162|516880759|FG001|Overall Study|Others|4|||
143505051|NCT03498521|517385813|FG000|Overall Study|Withdrawal by Subject|11|||
143505052|NCT03498521|517385814|FG001|Overall Study|Withdrawal by Subject|6|||
143505053|NCT03498521|517385815|FG002|Overall Study|Withdrawal by Subject|2|||
143505054|NCT03498521|517385813|FG000|Overall Study|Study terminated by sponsor|79|||
143505055|NCT03498521|517385814|FG001|Overall Study|Study terminated by sponsor|21|||
143505056|NCT03498521|517385815|FG002|Overall Study|Study terminated by sponsor|4|||
143505057|NCT05838755|517385823|FG000|Overall Study|Adverse Event|1|||
143505058|NCT05838755|517385824|FG001|Overall Study|Adverse Event|0|||
143505059|NCT05838755|517385825|FG002|Overall Study|Adverse Event|0|||
143505060|NCT05838755|517385823|FG000|Overall Study|Lack of Efficacy|1|||
143505061|NCT05838755|517385824|FG001|Overall Study|Lack of Efficacy|0|||
143505062|NCT05838755|517385825|FG002|Overall Study|Lack of Efficacy|1|||
143505063|NCT05838755|517385823|FG000|Overall Study|Lost to Follow-up|0|||
143505064|NCT05838755|517385824|FG001|Overall Study|Lost to Follow-up|1|||
143505065|NCT05838755|517385825|FG002|Overall Study|Lost to Follow-up|4|||
143505066|NCT05838755|517385823|FG000|Overall Study|Withdrawal by Subject|0|||
143505067|NCT05838755|517385824|FG001|Overall Study|Withdrawal by Subject|2|||
143505068|NCT05838755|517385825|FG002|Overall Study|Withdrawal by Subject|0|||
143505069|NCT05838755|517385823|FG000|Overall Study|Study terminated by sponsor|26|||
143505070|NCT05838755|517385824|FG001|Overall Study|Study terminated by sponsor|27|||
143505071|NCT05838755|517385825|FG002|Overall Study|Study terminated by sponsor|26|||
143505072|NCT05838755|517385823|FG000|Overall Study|Randomized, not treated|2|||
143505073|NCT05838755|517385824|FG001|Overall Study|Randomized, not treated|0|||
143505074|NCT05838755|517385825|FG002|Overall Study|Randomized, not treated|1|||
143505075|NCT05838755|517385823|FG000|Overall Study|Pregnancy|0|||
143505076|NCT05838755|517385824|FG001|Overall Study|Pregnancy|1|||
143505077|NCT05838755|517385825|FG002|Overall Study|Pregnancy|0|||
143505078|NCT04439110|517385828|FG000|Overall Study|Ineligible|2|||
143505079|NCT04439110|517385828|FG000|Overall Study|Adverse Event|4|||
143505080|NCT04439110|517385828|FG000|Overall Study|Death|2|||
143505081|NCT04439110|517385828|FG000|Overall Study|Disease proression|25|||
143505082|NCT04439110|517385828|FG000|Overall Study|Withdrawal by Subject|1|||
143365405|NCT03568162|516880760|FG002|Overall Study|Others|1|||
143365406|NCT03568162|516880761|FG003|Overall Study|Others|4|||
143365407|NCT03568162|516880762|FG004|Overall Study|Others|2|||
143365408|NCT03568162|516880763|FG005|Overall Study|Others|1|||
143365409|NCT03781804|516880765|FG000|Overall Study|Adverse Event|2|||
143365410|NCT03781804|516880766|FG001|Overall Study|Adverse Event|2|||
143365411|NCT03781804|516880767|FG002|Overall Study|Adverse Event|3|||
143365412|NCT03781804|516880765|FG000|Overall Study|Lost to Follow-up|1|||
143365413|NCT03781804|516880766|FG001|Overall Study|Lost to Follow-up|1|||
143365414|NCT03781804|516880767|FG002|Overall Study|Lost to Follow-up|2|||
143365415|NCT03781804|516880765|FG000|Overall Study|Lack of Efficacy|4|||
143365416|NCT03781804|516880766|FG001|Overall Study|Lack of Efficacy|2|||
143365417|NCT03781804|516880767|FG002|Overall Study|Lack of Efficacy|9|||
143365418|NCT03781804|516880765|FG000|Overall Study|Protocol Violation|0|||
143365419|NCT03781804|516880766|FG001|Overall Study|Protocol Violation|0|||
143505083|NCT04439110|517385828|FG000|Overall Study|Alternative therapy|1|||
143505084|NCT04439110|517385828|FG000|Overall Study|Other complicating disease|1|||
143505085|NCT04439110|517385828|FG000|Overall Study|Personal reasons|1|||
143505086|NCT04439110|517385828|FG000|Overall Study|Still on treatment|1|||
143505087|NCT02477696|517385829|FG000|Overall Study|Death|89|||
143365420|NCT03781804|516880767|FG002|Overall Study|Protocol Violation|1|||
143365421|NCT03781804|516880765|FG000|Overall Study|Withdrawal by Subject|0|||
143365422|NCT03781804|516880766|FG001|Overall Study|Withdrawal by Subject|1|||
143505088|NCT02477696|517385830|FG001|Overall Study|Death|106|||
143505089|NCT02477696|517385829|FG000|Overall Study|Lost to Follow-up|7|||
143505090|NCT02477696|517385830|FG001|Overall Study|Lost to Follow-up|5|||
143365423|NCT03781804|516880767|FG002|Overall Study|Withdrawal by Subject|1|||
143365424|NCT03781804|516880765|FG000|Overall Study|Reason not provided|2|||
143069833|NCT04492020|515799570|FG000|Overall Study|Adverse Event|1|||
143069834|NCT04492020|515799571|FG001|Overall Study|Adverse Event|3|||
143069835|NCT04492020|515799570|FG000|Overall Study|Withdrawal by Subject|4|||
143069836|NCT04492020|515799571|FG001|Overall Study|Withdrawal by Subject|3|||
143069837|NCT04492020|515799570|FG000|Overall Study|Lost to Follow-up|4|||
143069838|NCT04492020|515799571|FG001|Overall Study|Lost to Follow-up|3|||
143069839|NCT04492020|515799570|FG000|Overall Study|Protocol Violation|5|||
143069840|NCT04492020|515799571|FG001|Overall Study|Protocol Violation|2|||
143069841|NCT04492020|515799570|FG000|Overall Study|Lack of Qualifying Event|25|||
143069842|NCT04492020|515799571|FG001|Overall Study|Lack of Qualifying Event|27|||
143069843|NCT04492020|515799570|FG000|Overall Study|Non-compliance with Study Drug|2|||
143069844|NCT04492020|515799571|FG001|Overall Study|Non-compliance with Study Drug|1|||
143069845|NCT01383135|515799572|FG000|Overall Study|Not Scanned / Imaged|1|||
143069846|NCT01383135|515799573|FG001|Overall Study|Not Scanned / Imaged|0|||
143069847|NCT01383135|515799574|FG002|Overall Study|Not Scanned / Imaged|1|||
143069848|NCT01383135|515799575|FG003|Overall Study|Not Scanned / Imaged|0|||
143069849|NCT03167723|515799576|FG000|Overall Study|Protocol Violation|4|||
143069850|NCT03167723|515799577|FG001|Overall Study|Protocol Violation|6|||
143069851|NCT01175811|515799579|FG000|Overall Study|Adverse Event|1|||
143069852|NCT01175811|515799580|FG001|Overall Study|Adverse Event|1|||
143069853|NCT01175811|515799579|FG000|Overall Study|Entry criteria not met|3|||
143069854|NCT01175811|515799580|FG001|Overall Study|Entry criteria not met|1|||
143069855|NCT01175811|515799579|FG000|Overall Study|Lack of Efficacy|1|||
143069856|NCT01175811|515799580|FG001|Overall Study|Lack of Efficacy|0|||
143069857|NCT01175811|515799579|FG000|Overall Study|Lost to Follow-up|3|||
143069858|NCT01175811|515799580|FG001|Overall Study|Lost to Follow-up|2|||
143069859|NCT01175811|515799579|FG000|Overall Study|Physician Decision|1|||
143069860|NCT01175811|515799580|FG001|Overall Study|Physician Decision|1|||
143069861|NCT01175811|515799579|FG000|Overall Study|Protocol Violation|1|||
143069862|NCT01175811|515799580|FG001|Overall Study|Protocol Violation|2|||
143069863|NCT01175811|515799579|FG000|Overall Study|Withdrawal by Subject|6|||
143069864|NCT01175811|515799580|FG001|Overall Study|Withdrawal by Subject|7|||
143069865|NCT00415194|515799581|FG000|Overall Study|Adverse Event|37|||
143069866|NCT00415194|515799582|FG001|Overall Study|Adverse Event|32|||
143069867|NCT00415194|515799581|FG000|Overall Study|Entry Criteria Not Met|4|||
143069868|NCT00415194|515799582|FG001|Overall Study|Entry Criteria Not Met|8|||
143365425|NCT03781804|516880766|FG001|Overall Study|Reason not provided|2|||
143069869|NCT00415194|515799581|FG000|Overall Study|Lost to Follow-up|1|||
143069870|NCT00415194|515799582|FG001|Overall Study|Lost to Follow-up|0|||
143069871|NCT00415194|515799581|FG000|Overall Study|Physician Decision|10|||
143171326|NCT00806585|516176062|FG002|Overall Study|Adverse Event|3|||
143171327|NCT00806585|516176063|FG003|Overall Study|Adverse Event|4|||
143171328|NCT00806585|516176064|FG004|Overall Study|Adverse Event|2|||
143171329|NCT00806585|516176060|FG000|Overall Study|Withdrawal by Subject|10|||
143171330|NCT00806585|516176061|FG001|Overall Study|Withdrawal by Subject|8|||
143171331|NCT00806585|516176062|FG002|Overall Study|Withdrawal by Subject|9|||
143171332|NCT00806585|516176063|FG003|Overall Study|Withdrawal by Subject|3|||
143171333|NCT00806585|516176064|FG004|Overall Study|Withdrawal by Subject|11|||
143171334|NCT00806585|516176060|FG000|Overall Study|Completion status unknown|15|||
143171335|NCT00806585|516176061|FG001|Overall Study|Completion status unknown|14|||
143365426|NCT03781804|516880767|FG002|Overall Study|Reason not provided|0|||
143069872|NCT00415194|515799582|FG001|Overall Study|Physician Decision|16|||
143069873|NCT00415194|515799581|FG000|Overall Study|Progressive Disease|180|||
143069874|NCT00415194|515799582|FG001|Overall Study|Progressive Disease|217|||
143069875|NCT00415194|515799581|FG000|Overall Study|Protocol Violation|4|||
143069876|NCT00415194|515799582|FG001|Overall Study|Protocol Violation|2|||
143069877|NCT00415194|515799581|FG000|Overall Study|Withdrawal by Subject|28|||
143069878|NCT00415194|515799582|FG001|Overall Study|Withdrawal by Subject|21|||
143069879|NCT00415194|515799581|FG000|Overall Study|Death Due to Study Disease|26|||
143069880|NCT00415194|515799582|FG001|Overall Study|Death Due to Study Disease|29|||
143069881|NCT00415194|515799581|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
143171336|NCT00806585|516176062|FG002|Overall Study|Completion status unknown|12|||
143171337|NCT00806585|516176063|FG003|Overall Study|Completion status unknown|4|||
143171338|NCT00806585|516176064|FG004|Overall Study|Completion status unknown|12|||
143069882|NCT00415194|515799582|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
143069883|NCT00415194|515799581|FG000|Overall Study|Death Due to Procedural Related AE|0|||
143069884|NCT00415194|515799582|FG001|Overall Study|Death Due to Procedural Related AE|1|||
143069885|NCT00415194|515799581|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
143069886|NCT00415194|515799582|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
143069887|NCT01297465|515799583|FG000|Overall Study|Lack of Ovarian Response|1|||
143069888|NCT01297465|515799584|FG001|Overall Study|Lack of Ovarian Response|1|||
143069889|NCT01297465|515799583|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
143069890|NCT01297465|515799584|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
143069891|NCT01297465|515799583|FG000|Overall Study|No Oocytes Retrieved|1|||
143069892|NCT01297465|515799584|FG001|Overall Study|No Oocytes Retrieved|1|||
143069893|NCT01297465|515799583|FG000|Overall Study|Poor oocyte quality|0|||
143069894|NCT01297465|515799584|FG001|Overall Study|Poor oocyte quality|1|||
143069895|NCT01297465|515799583|FG000|Overall Study|No Fertilization|6|||
143069896|NCT01297465|515799584|FG001|Overall Study|No Fertilization|4|||
143069897|NCT01297465|515799583|FG000|Overall Study|All Embryos Discarded|0|||
143069898|NCT01297465|515799584|FG001|Overall Study|All Embryos Discarded|1|||
143069899|NCT01297465|515799583|FG000|Overall Study|Intention to Freeze all Embryos|0|||
143069900|NCT01297465|515799584|FG001|Overall Study|Intention to Freeze all Embryos|1|||
143069901|NCT00369655|515799585|FG000|Overall Study|Refusal of further treatment|2|||
143069902|NCT03493386|515799595|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
143069903|NCT03493386|515799596|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
143069904|NCT03493386|515799597|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
143069905|NCT03493386|515799598|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
143069906|NCT04645966|515799599|FG000|Vaccination Phase|Adverse Event|1|||
143069907|NCT04645966|515799600|FG001|Vaccination Phase|Adverse Event|0|||
143069908|NCT04645966|515799601|FG002|Vaccination Phase|Adverse Event|0|||
143505091|NCT02477696|517385829|FG000|Overall Study|Withdrawal by Subject|37|||
143505092|NCT02477696|517385830|FG001|Overall Study|Withdrawal by Subject|34|||
143505093|NCT02477696|517385829|FG000|Overall Study|Physician Decision|7|||
143505094|NCT02477696|517385830|FG001|Overall Study|Physician Decision|9|||
143505095|NCT02477696|517385829|FG000|Overall Study|Study terminated by sponsor|103|||
143505096|NCT02477696|517385830|FG001|Overall Study|Study terminated by sponsor|99|||
143505097|NCT02477696|517385829|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
143505098|NCT02477696|517385830|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
143505099|NCT02477696|517385829|FG000|Overall Study|Missing/Unknown|2|||
143505100|NCT02477696|517385830|FG001|Overall Study|Missing/Unknown|0|||
143505101|NCT04647253|517386263|FG000|Overall Study|Death ≤ 365 Days|16|||
143505102|NCT04647253|517386264|FG001|Overall Study|Death ≤ 365 Days|7|||
143505103|NCT04647253|517386263|FG000|Overall Study|Physician Decision|0|||
143505104|NCT04647253|517386264|FG001|Overall Study|Physician Decision|1|||
143505105|NCT04647253|517386263|FG000|Overall Study|Withdrawal by Subject|7|||
143505106|NCT04647253|517386264|FG001|Overall Study|Withdrawal by Subject|2|||
143505107|NCT04647253|517386263|FG000|Overall Study|Missed 12-Month Visit|9|||
143505108|NCT04647253|517386264|FG001|Overall Study|Missed 12-Month Visit|7|||
143505109|NCT04647253|517386263|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
143505110|NCT04647253|517386264|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
143505111|NCT04153149|517386271|FG000|Double Blind Period|Death|63|||
143505112|NCT04153149|517386272|FG001|Double Blind Period|Death|49|||
143505113|NCT04153149|517386273|FG002|Double Blind Period|Death|0|||
143505114|NCT04153149|517386274|FG003|Double Blind Period|Death|0|||
143505115|NCT04153149|517386271|FG000|Double Blind Period|Withdrawal by Subject|16|||
143505116|NCT04153149|517386272|FG001|Double Blind Period|Withdrawal by Subject|11|||
143505117|NCT04153149|517386273|FG002|Double Blind Period|Withdrawal by Subject|0|||
143505118|NCT04153149|517386274|FG003|Double Blind Period|Withdrawal by Subject|0|||
143505119|NCT04153149|517386271|FG000|Double Blind Period|Adverse Event|6|||
143505120|NCT04153149|517386272|FG001|Double Blind Period|Adverse Event|2|||
143505121|NCT04153149|517386273|FG002|Double Blind Period|Adverse Event|0|||
143505122|NCT04153149|517386274|FG003|Double Blind Period|Adverse Event|0|||
143505123|NCT04153149|517386271|FG000|Double Blind Period|Lost to Follow-up|2|||
143505124|NCT04153149|517386272|FG001|Double Blind Period|Lost to Follow-up|1|||
143505125|NCT04153149|517386273|FG002|Double Blind Period|Lost to Follow-up|0|||
143505126|NCT04153149|517386274|FG003|Double Blind Period|Lost to Follow-up|0|||
143505127|NCT04153149|517386271|FG000|Double Blind Period|Withdrawal by guardian|0|||
143505128|NCT04153149|517386272|FG001|Double Blind Period|Withdrawal by guardian|2|||
143505129|NCT04153149|517386273|FG002|Double Blind Period|Withdrawal by guardian|0|||
143505130|NCT04153149|517386274|FG003|Double Blind Period|Withdrawal by guardian|0|||
143505131|NCT04153149|517386271|FG000|Double Blind Period|Reason Not Specified|5|||
143505132|NCT04153149|517386272|FG001|Double Blind Period|Reason Not Specified|4|||
143505133|NCT04153149|517386273|FG002|Double Blind Period|Reason Not Specified|0|||
143505134|NCT04153149|517386274|FG003|Double Blind Period|Reason Not Specified|0|||
143505135|NCT04153149|517386271|FG000|Double Blind Period|Physician Decision|2|||
143505136|NCT04153149|517386272|FG001|Double Blind Period|Physician Decision|0|||
143247640|NCT00452361|516458670|FG001|Overall Study|Withdrawal by Subject|1|||
143247641|NCT00452361|516458669|FG000|Overall Study|Premature termination|13|||
143247642|NCT00452361|516458670|FG001|Overall Study|Premature termination|9|||
143247643|NCT05188053|516458671|FG000|Overall Study|Lost to Follow-up|23|||
143247644|NCT05188053|516458672|FG001|Overall Study|Lost to Follow-up|30|||
143247645|NCT05188053|516458671|FG000|Overall Study|Protocol Violation|16|||
143247646|NCT05188053|516458672|FG001|Overall Study|Protocol Violation|16|||
143247647|NCT05188053|516458671|FG000|Overall Study|Physician Decision|3|||
143247648|NCT05188053|516458672|FG001|Overall Study|Physician Decision|0|||
143247649|NCT05188053|516458671|FG000|Overall Study|Withdrawal by Subject|0|||
143247650|NCT05188053|516458672|FG001|Overall Study|Withdrawal by Subject|1|||
143247651|NCT02379637|516458676|FG000|Overall Study|Protocol Violation|0|||
143247652|NCT02379637|516458677|FG001|Overall Study|Protocol Violation|1|||
143247653|NCT02379637|516458676|FG000|Overall Study|Adverse Event|1|||
143247654|NCT02379637|516458677|FG001|Overall Study|Adverse Event|0|||
143247655|NCT02379637|516458676|FG000|Overall Study|Withdrawal by Subject|1|||
143247656|NCT02379637|516458677|FG001|Overall Study|Withdrawal by Subject|0|||
143247657|NCT02791763|516458678|FG000|Overall Study|Protocol Violation|0|||
143247658|NCT02791763|516458679|FG001|Overall Study|Protocol Violation|0|||
143069909|NCT04645966|515799602|FG003|Vaccination Phase|Adverse Event|0|||
143069910|NCT04645966|515799603|FG004|Vaccination Phase|Adverse Event|0|||
143069911|NCT04645966|515799604|FG005|Vaccination Phase|Adverse Event|0|||
143069912|NCT04645966|515799605|FG006|Vaccination Phase|Adverse Event|1|||
143069913|NCT04645966|515799606|FG007|Vaccination Phase|Adverse Event|0|||
143069914|NCT04645966|515799607|FG008|Vaccination Phase|Adverse Event|0|||
143069915|NCT04645966|515799599|FG000|Vaccination Phase|Death|0|||
143069916|NCT04645966|515799600|FG001|Vaccination Phase|Death|0|||
143069917|NCT04645966|515799601|FG002|Vaccination Phase|Death|0|||
143069918|NCT04645966|515799602|FG003|Vaccination Phase|Death|0|||
143069919|NCT04645966|515799603|FG004|Vaccination Phase|Death|0|||
143069920|NCT04645966|515799604|FG005|Vaccination Phase|Death|1|||
143069921|NCT04645966|515799605|FG006|Vaccination Phase|Death|0|||
143069922|NCT04645966|515799606|FG007|Vaccination Phase|Death|0|||
143069923|NCT04645966|515799607|FG008|Vaccination Phase|Death|0|||
143069924|NCT04645966|515799599|FG000|Vaccination Phase|Protocol Violation|0|||
143069925|NCT04645966|515799600|FG001|Vaccination Phase|Protocol Violation|0|||
143069926|NCT04645966|515799601|FG002|Vaccination Phase|Protocol Violation|0|||
143069927|NCT04645966|515799602|FG003|Vaccination Phase|Protocol Violation|0|||
143069928|NCT04645966|515799603|FG004|Vaccination Phase|Protocol Violation|1|||
143069929|NCT04645966|515799604|FG005|Vaccination Phase|Protocol Violation|0|||
143069930|NCT04645966|515799605|FG006|Vaccination Phase|Protocol Violation|0|||
143069931|NCT04645966|515799606|FG007|Vaccination Phase|Protocol Violation|0|||
143069932|NCT04645966|515799607|FG008|Vaccination Phase|Protocol Violation|0|||
143069933|NCT04645966|515799599|FG000|Vaccination Phase|Study terminated by sponsor|0|||
143069934|NCT04645966|515799600|FG001|Vaccination Phase|Study terminated by sponsor|0|||
143069935|NCT04645966|515799601|FG002|Vaccination Phase|Study terminated by sponsor|14|||
143069936|NCT04645966|515799602|FG003|Vaccination Phase|Study terminated by sponsor|15|||
143069937|NCT04645966|515799603|FG004|Vaccination Phase|Study terminated by sponsor|47|||
143069938|NCT04645966|515799604|FG005|Vaccination Phase|Study terminated by sponsor|43|||
143069939|NCT04645966|515799605|FG006|Vaccination Phase|Study terminated by sponsor|29|||
143069940|NCT04645966|515799606|FG007|Vaccination Phase|Study terminated by sponsor|29|||
143069941|NCT04645966|515799607|FG008|Vaccination Phase|Study terminated by sponsor|12|||
143069942|NCT04645966|515799599|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
143069943|NCT04645966|515799600|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
143069944|NCT04645966|515799601|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
143069945|NCT04645966|515799602|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
143069946|NCT04645966|515799603|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
143069947|NCT04645966|515799604|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
143247659|NCT02791763|516458680|FG002|Overall Study|Protocol Violation|1|||
143247660|NCT02791763|516458678|FG000|Overall Study|Withdrawal by Subject|5|||
143247661|NCT02791763|516458679|FG001|Overall Study|Withdrawal by Subject|1|||
143247662|NCT02791763|516458680|FG002|Overall Study|Withdrawal by Subject|0|||
143247663|NCT02791763|516458678|FG000|Overall Study|Physician Decision|0|||
143247664|NCT02791763|516458679|FG001|Overall Study|Physician Decision|1|||
143247665|NCT02791763|516458680|FG002|Overall Study|Physician Decision|0|||
143247666|NCT02791763|516458678|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
143247667|NCT02791763|516458679|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
143247668|NCT02791763|516458680|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
143505137|NCT04153149|517386273|FG002|Double Blind Period|Physician Decision|0|||
143069948|NCT04645966|515799605|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
143069949|NCT04645966|515799606|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
143069950|NCT04645966|515799607|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
143069951|NCT04645966|515799599|FG000|Vaccination Phase|Other|0|||
143069952|NCT04645966|515799600|FG001|Vaccination Phase|Other|0|||
143069953|NCT04645966|515799601|FG002|Vaccination Phase|Other|0|||
143069954|NCT04645966|515799602|FG003|Vaccination Phase|Other|0|||
143505138|NCT04153149|517386274|FG003|Double Blind Period|Physician Decision|0|||
143247669|NCT02791763|516458678|FG000|Overall Study|Cancer event|1|||
143247670|NCT02791763|516458679|FG001|Overall Study|Cancer event|3|||
143247671|NCT02791763|516458680|FG002|Overall Study|Cancer event|0|||
143247672|NCT02791763|516458678|FG000|Overall Study|Participant had renal transplant|3|||
143247673|NCT02791763|516458679|FG001|Overall Study|Participant had renal transplant|0|||
143247674|NCT02791763|516458680|FG002|Overall Study|Participant had renal transplant|0|||
143247675|NCT02791763|516458678|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
143247676|NCT02791763|516458679|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
143247677|NCT02791763|516458680|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
143247678|NCT02791763|516458678|FG000|Overall Study|Adverse Event|12|||
143247679|NCT02791763|516458679|FG001|Overall Study|Adverse Event|13|||
143247680|NCT02791763|516458680|FG002|Overall Study|Adverse Event|7|||
143247681|NCT01387542|516458681|FG000|Overall Study|Adverse Event|3|||
143247682|NCT01387542|516458681|FG000|Overall Study|Withdrawal by Subject|1|||
143247683|NCT01387542|516458681|FG000|Overall Study|Changed diagnosis|1|||
143247684|NCT01387542|516458681|FG000|Overall Study|Insufficient response|1|||
143247685|NCT01387542|516458681|FG000|Overall Study|Non-compliant|1|||
143247686|NCT01387542|516458681|FG000|Overall Study|Lost to Follow-up|1|||
143247687|NCT01519167|516458685|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
143069955|NCT04645966|515799603|FG004|Vaccination Phase|Other|0|||
143069956|NCT04645966|515799604|FG005|Vaccination Phase|Other|2|||
143069957|NCT04645966|515799605|FG006|Vaccination Phase|Other|0|||
143069958|NCT04645966|515799606|FG007|Vaccination Phase|Other|0|||
143069959|NCT04645966|515799607|FG008|Vaccination Phase|Other|0|||
143069960|NCT04645966|515799599|FG000|Vaccination Phase|Lost to Follow-up|0|||
143069961|NCT04645966|515799600|FG001|Vaccination Phase|Lost to Follow-up|0|||
143069962|NCT04645966|515799601|FG002|Vaccination Phase|Lost to Follow-up|0|||
143069963|NCT04645966|515799602|FG003|Vaccination Phase|Lost to Follow-up|0|||
143247688|NCT01519167|516458686|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
143247689|NCT01519167|516458685|FG000|Overall Study|Adverse Event|0|||
143247690|NCT01519167|516458686|FG001|Overall Study|Adverse Event|1|||
143247691|NCT01519167|516458685|FG000|Overall Study|Lack of Efficacy|0|||
143247692|NCT01519167|516458686|FG001|Overall Study|Lack of Efficacy|1|||
143247693|NCT01519167|516458685|FG000|Overall Study|Medical condition changes&deep sedation|0|||
143247694|NCT01519167|516458686|FG001|Overall Study|Medical condition changes&deep sedation|2|||
143247695|NCT01519167|516458685|FG000|Overall Study|Physician Decision|0|||
143247696|NCT01519167|516458686|FG001|Overall Study|Physician Decision|1|||
143247697|NCT04189224|516458687|FG000|Period 2|Adverse Event|0|||
143247698|NCT04189224|516458688|FG001|Period 2|Adverse Event|1|||
143247699|NCT04549545|516460395|FG000|Initial Period|Withdrawal by Subject|4|||
143247700|NCT04549545|516460396|FG001|Initial Period|Withdrawal by Subject|0|||
143247701|NCT04549545|516460395|FG000|Initial Period|Additional ENT Procedure|3|||
143247702|NCT04549545|516460396|FG001|Initial Period|Additional ENT Procedure|0|||
143247703|NCT04549545|516460395|FG000|Initial Period|Lost to Follow-up|3|||
143247704|NCT04549545|516460396|FG001|Initial Period|Lost to Follow-up|1|||
143247705|NCT04549545|516460395|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
143247706|NCT04549545|516460396|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
143247707|NCT04549545|516460395|FG000|Crossover Period|Additional ENT Procedure|0|||
143247708|NCT04549545|516460396|FG001|Crossover Period|Additional ENT Procedure|6|||
143247709|NCT04549545|516460395|FG000|Crossover Period|Lost to Follow-up|0|||
143069964|NCT04645966|515799603|FG004|Vaccination Phase|Lost to Follow-up|0|||
143069965|NCT04645966|515799604|FG005|Vaccination Phase|Lost to Follow-up|0|||
143069966|NCT04645966|515799605|FG006|Vaccination Phase|Lost to Follow-up|0|||
143247710|NCT04549545|516460396|FG001|Crossover Period|Lost to Follow-up|1|||
143069967|NCT04645966|515799606|FG007|Vaccination Phase|Lost to Follow-up|1|||
143069968|NCT04645966|515799607|FG008|Vaccination Phase|Lost to Follow-up|0|||
143069969|NCT04645966|515799599|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
143069970|NCT04645966|515799600|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
143069971|NCT04645966|515799601|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
143069972|NCT04645966|515799602|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
143069973|NCT04645966|515799603|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
143069974|NCT04645966|515799604|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
143247711|NCT04549545|516460395|FG000|Crossover Period|Withdrawal by Subject|0|||
143247712|NCT04549545|516460396|FG001|Crossover Period|Withdrawal by Subject|4|||
143247713|NCT01395524|516460399|FG000|Overall Study|Non-compliance with study schedule|1|||
143247714|NCT01395524|516460400|FG001|Overall Study|Non-compliance with study schedule|0|||
143069975|NCT04645966|515799605|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
143247715|NCT01395524|516460401|FG002|Overall Study|Non-compliance with study schedule|1|||
143247716|NCT01395524|516460399|FG000|Overall Study|Lost to Follow-up|3|||
143247717|NCT01395524|516460400|FG001|Overall Study|Lost to Follow-up|1|||
143247718|NCT01395524|516460401|FG002|Overall Study|Lost to Follow-up|1|||
143247719|NCT01395524|516460399|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
143069976|NCT04645966|515799606|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
143069977|NCT04645966|515799607|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
143247720|NCT01395524|516460400|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
143247721|NCT01395524|516460401|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
143247722|NCT01395524|516460399|FG000|Overall Study|Severe noncompliance with protocol|1|||
143247723|NCT01395524|516460400|FG001|Overall Study|Severe noncompliance with protocol|0|||
143247724|NCT01395524|516460401|FG002|Overall Study|Severe noncompliance with protocol|0|||
143247725|NCT01395524|516460399|FG000|Overall Study|Adverse Event|4|||
143247726|NCT01395524|516460400|FG001|Overall Study|Adverse Event|4|||
143247727|NCT01395524|516460401|FG002|Overall Study|Adverse Event|3|||
143247728|NCT01395524|516460399|FG000|Overall Study|Death|1|||
143247729|NCT01395524|516460400|FG001|Overall Study|Death|0|||
143247730|NCT01395524|516460401|FG002|Overall Study|Death|0|||
143247731|NCT01395524|516460399|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
143247732|NCT01395524|516460400|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
143247733|NCT01395524|516460401|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
143247734|NCT01395524|516460399|FG000|Overall Study|Withdrawal by Subject|4|||
143247735|NCT01395524|516460400|FG001|Overall Study|Withdrawal by Subject|8|||
143247736|NCT01395524|516460401|FG002|Overall Study|Withdrawal by Subject|8|||
143247737|NCT01395524|516460399|FG000|Overall Study|Did not receive treatment|1|||
143247738|NCT01395524|516460400|FG001|Overall Study|Did not receive treatment|1|||
143247739|NCT01395524|516460401|FG002|Overall Study|Did not receive treatment|3|||
143247740|NCT01395524|516460399|FG000|Overall Study|Subject had spinal surgery|0|||
143247741|NCT01395524|516460400|FG001|Overall Study|Subject had spinal surgery|0|||
143247742|NCT01395524|516460401|FG002|Overall Study|Subject had spinal surgery|1|||
143247743|NCT01657461|516460402|FG000|Overall Study|Death|9|||
143247744|NCT01657461|516460403|FG001|Overall Study|Death|12|||
143247745|NCT01657461|516460402|FG000|Overall Study|Lost to Follow-up|0|||
143247746|NCT01657461|516460403|FG001|Overall Study|Lost to Follow-up|3|||
143247747|NCT01657461|516460402|FG000|Overall Study|Physician Decision|0|||
143247748|NCT01657461|516460403|FG001|Overall Study|Physician Decision|2|||
143247749|NCT01657461|516460402|FG000|Overall Study|Withdrawal by Subject|1|||
143247750|NCT01657461|516460403|FG001|Overall Study|Withdrawal by Subject|3|||
143247751|NCT01868542|516460404|FG000|Overall Study|Protocol Violation|0|||
143247752|NCT01868542|516460405|FG001|Overall Study|Protocol Violation|1|||
143247753|NCT01868542|516460404|FG000|Overall Study|Unclassified|0|||
143247754|NCT01868542|516460405|FG001|Overall Study|Unclassified|1|||
143247755|NCT00843284|516460408|FG000|Overall Study|Adverse Event|39|||
143247756|NCT00843284|516460408|FG000|Overall Study|Lack of Efficacy|5|||
143247757|NCT00843284|516460408|FG000|Overall Study|Lost to Follow-up|11|||
143247758|NCT00843284|516460408|FG000|Overall Study|Other|10|||
143247759|NCT00843284|516460408|FG000|Overall Study|Withdrawal by Subject|4|||
143247760|NCT00843284|516460408|FG000|Overall Study|Death|3|||
143247761|NCT02160899|516460413|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
143247762|NCT02160899|516460414|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
143247763|NCT02160899|516460415|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
143247764|NCT02160899|516460416|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
143247765|NCT02160899|516460417|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
143247766|NCT02160899|516460418|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
143247767|NCT01256294|516460419|FG000|Overall Study|Adverse Event|1|||
143247768|NCT01256294|516460420|FG001|Overall Study|Adverse Event|0|||
143247769|NCT01256294|516460419|FG000|Overall Study|Withdrawal by Subject|1|||
143247770|NCT01256294|516460420|FG001|Overall Study|Withdrawal by Subject|1|||
143069978|NCT04645966|515799599|FG000|Follow-up Phase|Lost to Follow-up|0|||
143069979|NCT04645966|515799600|FG001|Follow-up Phase|Lost to Follow-up|0|||
143069980|NCT04645966|515799601|FG002|Follow-up Phase|Lost to Follow-up|0|||
143069981|NCT04645966|515799602|FG003|Follow-up Phase|Lost to Follow-up|0|||
143069982|NCT04645966|515799603|FG004|Follow-up Phase|Lost to Follow-up|0|||
143069983|NCT04645966|515799604|FG005|Follow-up Phase|Lost to Follow-up|0|||
143069984|NCT04645966|515799605|FG006|Follow-up Phase|Lost to Follow-up|0|||
143069985|NCT04645966|515799606|FG007|Follow-up Phase|Lost to Follow-up|1|||
143069986|NCT04645966|515799607|FG008|Follow-up Phase|Lost to Follow-up|0|||
143069987|NCT00289536|515799609|FG000|Period 3|Lost to Follow-up|0|||
143069988|NCT00289536|515799610|FG001|Period 3|Lost to Follow-up|0|||
143247771|NCT01256294|516460419|FG000|Overall Study|Protocol deviation|2|||
143247772|NCT01256294|516460420|FG001|Overall Study|Protocol deviation|1|||
143247773|NCT04129151|516460421|FG000|Overall Study|Adverse Event|1|||
143247774|NCT04129151|516460421|FG000|Overall Study|Disease Progression|7|||
143247775|NCT04129151|516460421|FG000|Overall Study|Study closure|1|||
143247776|NCT01139008|516460423|FG000|Overall Study|Withdrawal by Subject|5|||
143247777|NCT01139008|516460423|FG000|Overall Study|Non-compliant, lost product|1|||
143247778|NCT04838977|516460424|FG000|Overall Study|Lost to Follow-up|2|||
143365427|NCT00768066|516880768|FG000|Overall Study|Did not receive study product injection.|3|||
143069989|NCT00289536|515799611|FG002|Period 3|Lost to Follow-up|1|||
143247779|NCT04838977|516460425|FG001|Overall Study|Lost to Follow-up|3|||
143247780|NCT04838977|516460424|FG000|Overall Study|Withdrawal by Subject|1|||
143069990|NCT02116608|515799616|FG000|Overall Study|Lost to Follow-up|0|||
143247781|NCT04838977|516460425|FG001|Overall Study|Withdrawal by Subject|1|||
143247782|NCT00265148|516460426|FG000|Overall Study|Adverse Event|2|||
143069991|NCT02116608|515799617|FG001|Overall Study|Lost to Follow-up|0|||
143069992|NCT02116608|515799618|FG002|Overall Study|Lost to Follow-up|1|||
143069993|NCT02116608|515799616|FG000|Overall Study|Physician Decision|0|||
143069994|NCT02116608|515799617|FG001|Overall Study|Physician Decision|1|||
143069995|NCT02116608|515799618|FG002|Overall Study|Physician Decision|0|||
143069996|NCT02116608|515799616|FG000|Overall Study|Death|0|||
143069997|NCT02116608|515799617|FG001|Overall Study|Death|1|||
143069998|NCT02116608|515799618|FG002|Overall Study|Death|0|||
143069999|NCT00988442|515799620|FG000|Overall Study|Death|1|||
143070000|NCT00988442|515799621|FG001|Overall Study|Death|2|||
143070001|NCT00988442|515799620|FG000|Overall Study|Lost to Follow-up|0|||
143070002|NCT00988442|515799621|FG001|Overall Study|Lost to Follow-up|1|||
143070003|NCT00988442|515799620|FG000|Overall Study|Early Study Closure|29|||
143070004|NCT00988442|515799621|FG001|Overall Study|Early Study Closure|25|||
143070005|NCT05297578|515799630|FG000|Overall Study|Lost to Follow-up|1|||
143070006|NCT05297578|515799631|FG001|Overall Study|Lost to Follow-up|1|||
143070007|NCT05297578|515799632|FG002|Overall Study|Lost to Follow-up|2|||
143070008|NCT05297578|515799633|FG003|Overall Study|Lost to Follow-up|1|||
143070009|NCT05297578|515799630|FG000|Overall Study|Death|0|||
143070010|NCT05297578|515799631|FG001|Overall Study|Death|1|||
143070011|NCT05297578|515799632|FG002|Overall Study|Death|0|||
143070012|NCT05297578|515799633|FG003|Overall Study|Death|0|||
143070013|NCT05297578|515799630|FG000|Overall Study|Withdrawal by Subject|0|||
143070014|NCT05297578|515799631|FG001|Overall Study|Withdrawal by Subject|0|||
143070015|NCT05297578|515799632|FG002|Overall Study|Withdrawal by Subject|1|||
143070016|NCT05297578|515799633|FG003|Overall Study|Withdrawal by Subject|0|||
143070017|NCT00117325|515799634|FG000|Overall Study|Adverse Event|3|||
143070018|NCT00117325|515799635|FG001|Overall Study|Adverse Event|3|||
143070019|NCT00117325|515799634|FG000|Overall Study|Lost to Follow-up|1|||
143070020|NCT00117325|515799635|FG001|Overall Study|Lost to Follow-up|1|||
143070021|NCT00117325|515799634|FG000|Overall Study|Protocol Violation|2|||
143070022|NCT00117325|515799635|FG001|Overall Study|Protocol Violation|3|||
143070023|NCT00117325|515799634|FG000|Overall Study|Withdrawal by Subject|3|||
143070024|NCT00117325|515799635|FG001|Overall Study|Withdrawal by Subject|2|||
143070025|NCT00117325|515799634|FG000|Overall Study|Lack of Efficacy|1|||
143070026|NCT00117325|515799635|FG001|Overall Study|Lack of Efficacy|0|||
143070027|NCT00117325|515799634|FG000|Overall Study|Use of prohibited medicine|1|||
143070028|NCT00117325|515799635|FG001|Overall Study|Use of prohibited medicine|2|||
143070029|NCT00117325|515799634|FG000|Overall Study|Early termination|1|||
143070030|NCT00117325|515799635|FG001|Overall Study|Early termination|1|||
143070031|NCT00117325|515799634|FG000|Overall Study|Admisnitrative|1|||
143070032|NCT00117325|515799635|FG001|Overall Study|Admisnitrative|0|||
143070033|NCT02731326|515799640|FG000|Overall Study|Withdrawal by Subject|4|||
143070034|NCT02731326|515799641|FG001|Overall Study|Withdrawal by Subject|1|||
143070035|NCT02731326|515799640|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
143070036|NCT02731326|515799641|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
143070037|NCT02731326|515799640|FG000|Overall Study|Discharged without AliveCor|10|||
143070038|NCT02731326|515799641|FG001|Overall Study|Discharged without AliveCor|0|||
143070039|NCT02731326|515799640|FG000|Overall Study|Duplicate Participant|1|||
143070040|NCT02731326|515799641|FG001|Overall Study|Duplicate Participant|1|||
143070041|NCT04647721|515799643|FG000|Overall Study|Withdrawal by Subject|0|||
143070042|NCT04647721|515799644|FG001|Overall Study|Withdrawal by Subject|2|||
143070043|NCT04647721|515799643|FG000|Overall Study|Lost to Follow-up|2|||
143505139|NCT04153149|517386271|FG000|Open Label Extension Period|Death|0|||
143505140|NCT04153149|517386272|FG001|Open Label Extension Period|Death|0|||
143505141|NCT04153149|517386273|FG002|Open Label Extension Period|Death|7|||
143070044|NCT04647721|515799644|FG001|Overall Study|Lost to Follow-up|0|||
143070045|NCT01974440|515799648|FG000|Overall Study|Lost to Follow-up|7|||
143070046|NCT01974440|515799649|FG001|Overall Study|Lost to Follow-up|7|||
143505142|NCT04153149|517386274|FG003|Open Label Extension Period|Death|3|||
143505143|NCT04153149|517386271|FG000|Open Label Extension Period|Withdrawal by guardian|0|||
143070047|NCT01974440|515799648|FG000|Overall Study|Withdrawal by Subject|24|||
143070048|NCT01974440|515799649|FG001|Overall Study|Withdrawal by Subject|20|||
143070049|NCT01974440|515799648|FG000|Overall Study|Sponsor decision|109|||
143070050|NCT01974440|515799649|FG001|Overall Study|Sponsor decision|110|||
143070051|NCT00762437|515799650|FG000|Overall Study|Lost to Follow-up|7|||
143070052|NCT00762437|515799650|FG000|Overall Study|Missed final study visit|11|||
143070053|NCT00762437|515799650|FG000|Overall Study|No treatment (unable to attach sleeve to participant)|1|||
143070054|NCT00302081|515799651|FG000|Overall Study|Adverse Event|6|||
143070055|NCT00302081|515799652|FG001|Overall Study|Adverse Event|5|||
143070056|NCT00302081|515799653|FG002|Overall Study|Adverse Event|4|||
143070057|NCT00302081|515799651|FG000|Overall Study|Lost to Follow-up|21|||
143070058|NCT00302081|515799652|FG001|Overall Study|Lost to Follow-up|18|||
143070059|NCT00302081|515799653|FG002|Overall Study|Lost to Follow-up|28|||
143070060|NCT00302081|515799651|FG000|Overall Study|Withdrawal by Subject|8|||
143070061|NCT00302081|515799652|FG001|Overall Study|Withdrawal by Subject|12|||
143070062|NCT00302081|515799653|FG002|Overall Study|Withdrawal by Subject|8|||
143070063|NCT00302081|515799651|FG000|Overall Study|Protocol Violation|5|||
143505144|NCT04153149|517386272|FG001|Open Label Extension Period|Withdrawal by guardian|0|||
143505145|NCT04153149|517386273|FG002|Open Label Extension Period|Withdrawal by guardian|1|||
143505146|NCT04153149|517386274|FG003|Open Label Extension Period|Withdrawal by guardian|0|||
143505147|NCT04153149|517386271|FG000|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
143505148|NCT04153149|517386272|FG001|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
143070064|NCT00302081|515799652|FG001|Overall Study|Protocol Violation|1|||
143070065|NCT00302081|515799653|FG002|Overall Study|Protocol Violation|2|||
143070066|NCT00302081|515799651|FG000|Overall Study|Lack of Efficacy|1|||
143070067|NCT00302081|515799652|FG001|Overall Study|Lack of Efficacy|0|||
143070068|NCT00302081|515799653|FG002|Overall Study|Lack of Efficacy|5|||
143070069|NCT00302081|515799651|FG000|Overall Study|Death|2|||
143070070|NCT00302081|515799652|FG001|Overall Study|Death|1|||
143070071|NCT00302081|515799653|FG002|Overall Study|Death|0|||
143070072|NCT00302081|515799651|FG000|Overall Study|Other|13|||
143070073|NCT00302081|515799652|FG001|Overall Study|Other|6|||
143070074|NCT00302081|515799653|FG002|Overall Study|Other|5|||
143070075|NCT04480710|515799654|FG000|Overall Study|Adverse Event|0|||
143070076|NCT04480710|515799655|FG001|Overall Study|Adverse Event|2|||
143070077|NCT04480710|515799656|FG002|Overall Study|Adverse Event|0|||
143070078|NCT04480710|515799657|FG003|Overall Study|Adverse Event|0|||
143070079|NCT04480710|515799654|FG000|Overall Study|Withdrawal by Subject|0|||
143070080|NCT04480710|515799655|FG001|Overall Study|Withdrawal by Subject|1|||
143070081|NCT04480710|515799656|FG002|Overall Study|Withdrawal by Subject|0|||
143070082|NCT04480710|515799657|FG003|Overall Study|Withdrawal by Subject|0|||
143070083|NCT04480710|515799654|FG000|Overall Study|Physician Decision|0|||
143070084|NCT04480710|515799655|FG001|Overall Study|Physician Decision|0|||
143070085|NCT04480710|515799656|FG002|Overall Study|Physician Decision|1|||
143070086|NCT04480710|515799657|FG003|Overall Study|Physician Decision|0|||
143070087|NCT05084963|515799659|FG000|Overall Study|Withdrawal by Subject|0|||
143070088|NCT05084963|515799660|FG001|Overall Study|Withdrawal by Subject|0|||
143070089|NCT05084963|515799661|FG002|Overall Study|Withdrawal by Subject|1|||
143070090|NCT03569228|515799662|FG000|Overall Study|Withdrawal by PI|0|||
143070091|NCT03569228|515799663|FG001|Overall Study|Withdrawal by PI|0|||
143070092|NCT03569228|515799664|FG002|Overall Study|Withdrawal by PI|2|||
143070093|NCT03569228|515799665|FG003|Overall Study|Withdrawal by PI|2|||
143070094|NCT03569228|515799666|FG004|Overall Study|Withdrawal by PI|1|||
143070095|NCT03569228|515799667|FG005|Overall Study|Withdrawal by PI|0|||
143070096|NCT03569228|515799668|FG006|Overall Study|Withdrawal by PI|0|||
143070097|NCT03569228|515799669|FG007|Overall Study|Withdrawal by PI|0|||
143070098|NCT03569228|515799670|FG008|Overall Study|Withdrawal by PI|0|||
143070099|NCT03569228|515799662|FG000|Overall Study|Lost to Follow-up|0|||
143070100|NCT03569228|515799663|FG001|Overall Study|Lost to Follow-up|0|||
143070101|NCT03569228|515799664|FG002|Overall Study|Lost to Follow-up|0|||
143070102|NCT03569228|515799665|FG003|Overall Study|Lost to Follow-up|0|||
143070103|NCT03569228|515799666|FG004|Overall Study|Lost to Follow-up|0|||
143070104|NCT03569228|515799667|FG005|Overall Study|Lost to Follow-up|0|||
143365428|NCT00768066|516880769|FG001|Overall Study|Did not receive study product injection.|3|||
143365429|NCT00768066|516880770|FG002|Overall Study|Did not receive study product injection.|0|||
143365430|NCT01836458|516880776|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
143365431|NCT01836458|516880777|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
143365432|NCT01836458|516880778|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
143365433|NCT01836458|516880779|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
143365434|NCT00389519|516880787|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
143365435|NCT00389519|516880788|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
143365436|NCT00389519|516880789|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
143505149|NCT04153149|517386273|FG002|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
143070105|NCT03569228|515799668|FG006|Overall Study|Lost to Follow-up|0|||
143070106|NCT03569228|515799669|FG007|Overall Study|Lost to Follow-up|0|||
143070107|NCT03569228|515799670|FG008|Overall Study|Lost to Follow-up|1|||
143070108|NCT03569228|515799662|FG000|Overall Study|Screen Fail|2|||
143070109|NCT03569228|515799663|FG001|Overall Study|Screen Fail|2|||
143070110|NCT03569228|515799664|FG002|Overall Study|Screen Fail|1|||
143505150|NCT04153149|517386274|FG003|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|1|||
143505151|NCT04153149|517386271|FG000|Open Label Extension Period|Study Treatment Ongoing|0|||
143070111|NCT03569228|515799665|FG003|Overall Study|Screen Fail|1|||
143070112|NCT03569228|515799666|FG004|Overall Study|Screen Fail|1|||
143070113|NCT03569228|515799667|FG005|Overall Study|Screen Fail|3|||
143070114|NCT03569228|515799668|FG006|Overall Study|Screen Fail|1|||
143070115|NCT03569228|515799669|FG007|Overall Study|Screen Fail|5|||
143070116|NCT03569228|515799670|FG008|Overall Study|Screen Fail|2|||
143070117|NCT05442866|515799671|FG000|Overall Study|Death|1|||
143070118|NCT05442866|515799671|FG000|Overall Study|Lost to Follow-up|9|||
143070119|NCT05442866|515799671|FG000|Overall Study|Protocol Violation|1|||
143070120|NCT03819049|515799672|FG000|Overall Study|Lost to Follow-up|1|||
143070121|NCT03819049|515799673|FG001|Overall Study|Lost to Follow-up|2|||
143070122|NCT03819049|515799674|FG002|Overall Study|Lost to Follow-up|9|||
143070123|NCT03819049|515799675|FG003|Overall Study|Lost to Follow-up|0|||
143505152|NCT04153149|517386272|FG001|Open Label Extension Period|Study Treatment Ongoing|0|||
143070124|NCT03819049|515799676|FG004|Overall Study|Lost to Follow-up|3|||
143070125|NCT03819049|515799677|FG005|Overall Study|Lost to Follow-up|1|||
143070126|NCT03819049|515799678|FG006|Overall Study|Lost to Follow-up|0|||
143070127|NCT03819049|515799672|FG000|Overall Study|Withdrawal by Subject|0|||
143070128|NCT03819049|515799673|FG001|Overall Study|Withdrawal by Subject|0|||
143070129|NCT03819049|515799674|FG002|Overall Study|Withdrawal by Subject|18|||
143070130|NCT03819049|515799675|FG003|Overall Study|Withdrawal by Subject|0|||
143070131|NCT03819049|515799676|FG004|Overall Study|Withdrawal by Subject|10|||
143070132|NCT03819049|515799677|FG005|Overall Study|Withdrawal by Subject|9|||
143070133|NCT03819049|515799678|FG006|Overall Study|Withdrawal by Subject|1|||
143070134|NCT03819049|515799672|FG000|Overall Study|Ongoing|0|||
143070135|NCT03819049|515799673|FG001|Overall Study|Ongoing|0|||
143070136|NCT03819049|515799674|FG002|Overall Study|Ongoing|75|||
143070137|NCT03819049|515799675|FG003|Overall Study|Ongoing|0|||
143070138|NCT03819049|515799676|FG004|Overall Study|Ongoing|41|||
143070139|NCT03819049|515799677|FG005|Overall Study|Ongoing|0|||
143070140|NCT03819049|515799678|FG006|Overall Study|Ongoing|0|||
143070141|NCT03819049|515799672|FG000|Overall Study|Other|0|||
143070142|NCT03819049|515799673|FG001|Overall Study|Other|0|||
143070143|NCT03819049|515799674|FG002|Overall Study|Other|2|||
143070144|NCT03819049|515799675|FG003|Overall Study|Other|0|||
143070145|NCT03819049|515799676|FG004|Overall Study|Other|0|||
143070146|NCT03819049|515799677|FG005|Overall Study|Other|0|||
143070147|NCT03819049|515799678|FG006|Overall Study|Other|0|||
143070148|NCT03819049|515799672|FG000|Overall Study|Randomized but not vaccinated|0|||
143070149|NCT03819049|515799673|FG001|Overall Study|Randomized but not vaccinated|0|||
143070150|NCT03819049|515799674|FG002|Overall Study|Randomized but not vaccinated|0|||
143070151|NCT03819049|515799675|FG003|Overall Study|Randomized but not vaccinated|1|||
143070152|NCT03819049|515799676|FG004|Overall Study|Randomized but not vaccinated|0|||
143070153|NCT03819049|515799677|FG005|Overall Study|Randomized but not vaccinated|2|||
143070154|NCT03819049|515799678|FG006|Overall Study|Randomized but not vaccinated|1|||
143070155|NCT03819049|515799672|FG000|Overall Study|Physician Decision|0|||
143070156|NCT03819049|515799673|FG001|Overall Study|Physician Decision|0|||
143070157|NCT03819049|515799674|FG002|Overall Study|Physician Decision|0|||
143070158|NCT03819049|515799675|FG003|Overall Study|Physician Decision|0|||
143070159|NCT03819049|515799676|FG004|Overall Study|Physician Decision|0|||
143070160|NCT03819049|515799677|FG005|Overall Study|Physician Decision|0|||
143070161|NCT03819049|515799678|FG006|Overall Study|Physician Decision|1|||
143070162|NCT01616953|515799679|FG000|Overall Study|Lost to Follow-up|1|||
143070163|NCT01616953|515799680|FG001|Overall Study|Lost to Follow-up|0|||
143070164|NCT01616953|515799679|FG000|Overall Study|lack of bone and soft tissue|1|||
143070165|NCT01616953|515799680|FG001|Overall Study|lack of bone and soft tissue|0|||
143070166|NCT01568320|515799681|FG000|Overall Study|Death|20|||
143070167|NCT01568320|515799681|FG000|Overall Study|Lost to Follow-up|9|||
143070168|NCT01568320|515799681|FG000|Overall Study|Withdrawal by Subject|10|||
143070169|NCT01568320|515799681|FG000|Overall Study|Conversion to open repair|1|||
143070170|NCT01568320|515799681|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
143070171|NCT00816361|515799683|FG000|Overall Study|Withdrawal by Subject|0|||
143070172|NCT00816361|515799684|FG001|Overall Study|Withdrawal by Subject|0|||
143070173|NCT00816361|515799685|FG002|Overall Study|Withdrawal by Subject|0|||
143070174|NCT00816361|515799686|FG003|Overall Study|Withdrawal by Subject|0|||
143070175|NCT00816361|515799687|FG004|Overall Study|Withdrawal by Subject|1|||
143070176|NCT00816361|515799688|FG005|Overall Study|Withdrawal by Subject|2|||
143070177|NCT00816361|515799689|FG006|Overall Study|Withdrawal by Subject|0|||
143070178|NCT00816361|515799690|FG007|Overall Study|Withdrawal by Subject|2|||
143070179|NCT00816361|515799691|FG008|Overall Study|Withdrawal by Subject|1|||
143070180|NCT00816361|515799683|FG000|Overall Study|Death|4|||
143070181|NCT00816361|515799684|FG001|Overall Study|Death|3|||
143505153|NCT04153149|517386273|FG002|Open Label Extension Period|Study Treatment Ongoing|213|||
143505154|NCT04153149|517386274|FG003|Open Label Extension Period|Study Treatment Ongoing|237|||
143505155|NCT02706353|517386281|FG000|Dose Level 1|Disease Progression|1|||
143070182|NCT00816361|515799685|FG002|Overall Study|Death|3|||
143070183|NCT00816361|515799686|FG003|Overall Study|Death|3|||
143070184|NCT00816361|515799687|FG004|Overall Study|Death|1|||
143070185|NCT00816361|515799688|FG005|Overall Study|Death|1|||
143070186|NCT00816361|515799689|FG006|Overall Study|Death|3|||
143070187|NCT00816361|515799690|FG007|Overall Study|Death|7|||
143070188|NCT00816361|515799691|FG008|Overall Study|Death|8|||
143070189|NCT00816361|515799683|FG000|Overall Study|Other|0|||
143070190|NCT00816361|515799684|FG001|Overall Study|Other|0|||
143247783|NCT00265148|516460427|FG001|Overall Study|Adverse Event|2|||
143505156|NCT02706353|517386282|FG001|Dose Level 1|Disease Progression|0|||
143070191|NCT00816361|515799685|FG002|Overall Study|Other|0|||
143070192|NCT00816361|515799686|FG003|Overall Study|Other|0|||
143070193|NCT00816361|515799687|FG004|Overall Study|Other|0|||
143070194|NCT00816361|515799688|FG005|Overall Study|Other|0|||
143070195|NCT00816361|515799689|FG006|Overall Study|Other|0|||
143247784|NCT00265148|516460426|FG000|Overall Study|Lack of Efficacy|0|||
143505157|NCT02706353|517386283|FG002|Dose Level 1|Disease Progression|0|||
143505158|NCT02706353|517386284|FG003|Dose Level 1|Disease Progression|0|||
143505159|NCT02706353|517386285|FG004|Dose Level 1|Disease Progression|0|||
143505160|NCT02706353|517386286|FG005|Dose Level 1|Disease Progression|0|||
143505161|NCT02706353|517386281|FG000|Dose Level 3|Disease Progression|0|||
143505162|NCT02706353|517386282|FG001|Dose Level 3|Disease Progression|0|||
143505163|NCT02706353|517386283|FG002|Dose Level 3|Disease Progression|2|||
143505164|NCT02706353|517386284|FG003|Dose Level 3|Disease Progression|0|||
143505165|NCT02706353|517386285|FG004|Dose Level 3|Disease Progression|0|||
143505166|NCT02706353|517386286|FG005|Dose Level 3|Disease Progression|0|||
143505167|NCT02706353|517386281|FG000|Dose Level 4|Disease Progression|0|||
143505168|NCT02706353|517386282|FG001|Dose Level 4|Disease Progression|0|||
143505169|NCT02706353|517386283|FG002|Dose Level 4|Disease Progression|0|||
143505170|NCT02706353|517386284|FG003|Dose Level 4|Disease Progression|1|||
143505171|NCT02706353|517386285|FG004|Dose Level 4|Disease Progression|0|||
143505172|NCT02706353|517386286|FG005|Dose Level 4|Disease Progression|0|||
143505173|NCT02706353|517386281|FG000|Dose Level 4|Toxicity|0|||
143505174|NCT02706353|517386282|FG001|Dose Level 4|Toxicity|0|||
143505175|NCT02706353|517386283|FG002|Dose Level 4|Toxicity|0|||
143505176|NCT02706353|517386284|FG003|Dose Level 4|Toxicity|1|||
143505177|NCT02706353|517386285|FG004|Dose Level 4|Toxicity|0|||
143505178|NCT02706353|517386286|FG005|Dose Level 4|Toxicity|0|||
143505179|NCT02706353|517386281|FG000|Dose Level 4|Death|0|||
143505180|NCT02706353|517386282|FG001|Dose Level 4|Death|0|||
143505181|NCT02706353|517386283|FG002|Dose Level 4|Death|0|||
143505182|NCT02706353|517386284|FG003|Dose Level 4|Death|1|||
143505183|NCT02706353|517386285|FG004|Dose Level 4|Death|0|||
143505184|NCT02706353|517386286|FG005|Dose Level 4|Death|0|||
143505185|NCT02706353|517386281|FG000|Dose Level 5|Toxicity|0|||
143505186|NCT02706353|517386282|FG001|Dose Level 5|Toxicity|0|||
143505187|NCT02706353|517386283|FG002|Dose Level 5|Toxicity|0|||
143070196|NCT00816361|515799690|FG007|Overall Study|Other|0|||
143070197|NCT00816361|515799691|FG008|Overall Study|Other|1|||
143070198|NCT01986010|515799692|FG000|Overall Study|Adverse Event|0|||
143070199|NCT01986010|515799693|FG001|Overall Study|Adverse Event|1|||
143070200|NCT01986010|515799694|FG002|Overall Study|Adverse Event|0|||
143070201|NCT01986010|515799695|FG003|Overall Study|Adverse Event|0|||
143070202|NCT01986010|515799696|FG004|Overall Study|Adverse Event|0|||
143070203|NCT01986010|515799697|FG005|Overall Study|Adverse Event|0|||
143070204|NCT01986010|515799698|FG006|Overall Study|Adverse Event|0|||
143070205|NCT01986010|515799699|FG007|Overall Study|Adverse Event|0|||
143070206|NCT01986010|515799700|FG008|Overall Study|Adverse Event|0|||
143070207|NCT01986010|515799701|FG009|Overall Study|Adverse Event|0|||
143070208|NCT01986010|515799702|FG010|Overall Study|Adverse Event|0|||
143070209|NCT01986010|515799703|FG011|Overall Study|Adverse Event|0|||
143070210|NCT01986010|515799704|FG012|Overall Study|Adverse Event|0|||
143070211|NCT01986010|515799705|FG013|Overall Study|Adverse Event|0|||
143070212|NCT01986010|515799706|FG014|Overall Study|Adverse Event|0|||
143070213|NCT01986010|515799707|FG015|Overall Study|Adverse Event|1|||
143070214|NCT01986010|515799708|FG016|Overall Study|Adverse Event|0|||
143070215|NCT01986010|515799692|FG000|Overall Study|Lost to Follow-up|2|||
143070216|NCT01986010|515799693|FG001|Overall Study|Lost to Follow-up|1|||
143070217|NCT01986010|515799694|FG002|Overall Study|Lost to Follow-up|2|||
143070218|NCT01986010|515799695|FG003|Overall Study|Lost to Follow-up|2|||
143070219|NCT01986010|515799696|FG004|Overall Study|Lost to Follow-up|2|||
143070220|NCT01986010|515799697|FG005|Overall Study|Lost to Follow-up|2|||
143505188|NCT02706353|517386284|FG003|Dose Level 5|Toxicity|0|||
143505189|NCT02706353|517386285|FG004|Dose Level 5|Toxicity|1|||
143505190|NCT02706353|517386286|FG005|Dose Level 5|Toxicity|0|||
143505191|NCT02706353|517386281|FG000|Dose Level 5|Disease Progression|0|||
143505192|NCT02706353|517386282|FG001|Dose Level 5|Disease Progression|0|||
143505193|NCT02706353|517386283|FG002|Dose Level 5|Disease Progression|0|||
143505194|NCT02706353|517386284|FG003|Dose Level 5|Disease Progression|0|||
143505195|NCT02706353|517386285|FG004|Dose Level 5|Disease Progression|3|||
143505196|NCT02706353|517386286|FG005|Dose Level 5|Disease Progression|2|||
143505197|NCT02706353|517386281|FG000|Dose Level 5|Death|0|||
143505198|NCT02706353|517386282|FG001|Dose Level 5|Death|0|||
143505199|NCT02706353|517386283|FG002|Dose Level 5|Death|0|||
143505200|NCT02706353|517386284|FG003|Dose Level 5|Death|0|||
143505201|NCT02706353|517386285|FG004|Dose Level 5|Death|1|||
143070221|NCT01986010|515799698|FG006|Overall Study|Lost to Follow-up|0|||
143070222|NCT01986010|515799699|FG007|Overall Study|Lost to Follow-up|0|||
143070223|NCT01986010|515799700|FG008|Overall Study|Lost to Follow-up|4|||
143070224|NCT01986010|515799701|FG009|Overall Study|Lost to Follow-up|2|||
143070225|NCT01986010|515799702|FG010|Overall Study|Lost to Follow-up|0|||
143070226|NCT01986010|515799703|FG011|Overall Study|Lost to Follow-up|1|||
143070227|NCT01986010|515799704|FG012|Overall Study|Lost to Follow-up|1|||
143505202|NCT02706353|517386286|FG005|Dose Level 5|Death|6|||
143505203|NCT02706353|517386281|FG000|Dose Level 5|Withdrawal by Subject|0|||
143070228|NCT01986010|515799705|FG013|Overall Study|Lost to Follow-up|1|||
143505204|NCT02706353|517386282|FG001|Dose Level 5|Withdrawal by Subject|0|||
143505205|NCT02706353|517386283|FG002|Dose Level 5|Withdrawal by Subject|0|||
143505206|NCT02706353|517386284|FG003|Dose Level 5|Withdrawal by Subject|0|||
143070229|NCT01986010|515799706|FG014|Overall Study|Lost to Follow-up|2|||
143070230|NCT01986010|515799707|FG015|Overall Study|Lost to Follow-up|0|||
143070231|NCT01986010|515799708|FG016|Overall Study|Lost to Follow-up|0|||
143247785|NCT00265148|516460427|FG001|Overall Study|Lack of Efficacy|2|||
143247786|NCT00265148|516460426|FG000|Overall Study|Protocol Violation|3|||
143247787|NCT00265148|516460427|FG001|Overall Study|Protocol Violation|2|||
143070232|NCT01986010|515799692|FG000|Overall Study|Physician Decision|0|||
143070233|NCT01986010|515799693|FG001|Overall Study|Physician Decision|0|||
143070234|NCT01986010|515799694|FG002|Overall Study|Physician Decision|0|||
143070235|NCT01986010|515799695|FG003|Overall Study|Physician Decision|0|||
143070236|NCT01986010|515799696|FG004|Overall Study|Physician Decision|0|||
143070237|NCT01986010|515799697|FG005|Overall Study|Physician Decision|0|||
143070238|NCT01986010|515799698|FG006|Overall Study|Physician Decision|0|||
143070239|NCT01986010|515799699|FG007|Overall Study|Physician Decision|0|||
143070240|NCT01986010|515799700|FG008|Overall Study|Physician Decision|0|||
143070241|NCT01986010|515799701|FG009|Overall Study|Physician Decision|0|||
143070242|NCT01986010|515799702|FG010|Overall Study|Physician Decision|0|||
143070243|NCT01986010|515799703|FG011|Overall Study|Physician Decision|0|||
143070244|NCT01986010|515799704|FG012|Overall Study|Physician Decision|0|||
143070245|NCT01986010|515799705|FG013|Overall Study|Physician Decision|0|||
143070246|NCT01986010|515799706|FG014|Overall Study|Physician Decision|1|||
143070247|NCT01986010|515799707|FG015|Overall Study|Physician Decision|0|||
143070248|NCT01986010|515799708|FG016|Overall Study|Physician Decision|0|||
143070249|NCT01986010|515799692|FG000|Overall Study|Withdrawal by Subject|2|||
143070250|NCT01986010|515799693|FG001|Overall Study|Withdrawal by Subject|2|||
143247788|NCT00265148|516460426|FG000|Overall Study|Lost to Follow-up|0|||
143247789|NCT00265148|516460427|FG001|Overall Study|Lost to Follow-up|1|||
143247790|NCT00265148|516460426|FG000|Overall Study|Withdrawal by Subject|2|||
143247791|NCT00265148|516460427|FG001|Overall Study|Withdrawal by Subject|1|||
143247792|NCT00265148|516460426|FG000|Overall Study|Physician Decision|1|||
143247793|NCT00265148|516460427|FG001|Overall Study|Physician Decision|0|||
143247794|NCT00265148|516460426|FG000|Overall Study|Increasing frailty|0|||
143247795|NCT00265148|516460427|FG001|Overall Study|Increasing frailty|1|||
143247796|NCT00265148|516460426|FG000|Overall Study|Subject chose to change of the dose|1|||
143247797|NCT00265148|516460427|FG001|Overall Study|Subject chose to change of the dose|0|||
143247798|NCT01463007|516460428|FG000|Overall Study|Physician Decision|1|||
143247799|NCT00942994|516460429|FG000|Overall Study|Adverse Event|7|||
143247800|NCT00942994|516460430|FG001|Overall Study|Adverse Event|4|||
143070251|NCT01986010|515799694|FG002|Overall Study|Withdrawal by Subject|3|||
143070252|NCT01986010|515799695|FG003|Overall Study|Withdrawal by Subject|0|||
143070253|NCT01986010|515799696|FG004|Overall Study|Withdrawal by Subject|2|||
143070254|NCT01986010|515799697|FG005|Overall Study|Withdrawal by Subject|4|||
143070255|NCT01986010|515799698|FG006|Overall Study|Withdrawal by Subject|0|||
143070256|NCT01986010|515799699|FG007|Overall Study|Withdrawal by Subject|0|||
143070257|NCT01986010|515799700|FG008|Overall Study|Withdrawal by Subject|0|||
143070258|NCT01986010|515799701|FG009|Overall Study|Withdrawal by Subject|0|||
143070259|NCT01986010|515799702|FG010|Overall Study|Withdrawal by Subject|0|||
143070260|NCT01986010|515799703|FG011|Overall Study|Withdrawal by Subject|2|||
143070261|NCT01986010|515799704|FG012|Overall Study|Withdrawal by Subject|0|||
143070262|NCT01986010|515799705|FG013|Overall Study|Withdrawal by Subject|1|||
143070263|NCT01986010|515799706|FG014|Overall Study|Withdrawal by Subject|2|||
143070264|NCT01986010|515799707|FG015|Overall Study|Withdrawal by Subject|0|||
143070265|NCT01986010|515799708|FG016|Overall Study|Withdrawal by Subject|0|||
143070266|NCT01986010|515799692|FG000|Overall Study|Status Not Recorded|2|||
143070267|NCT01986010|515799693|FG001|Overall Study|Status Not Recorded|4|||
143070268|NCT01986010|515799694|FG002|Overall Study|Status Not Recorded|2|||
143070269|NCT01986010|515799695|FG003|Overall Study|Status Not Recorded|0|||
143070270|NCT01986010|515799696|FG004|Overall Study|Status Not Recorded|1|||
143070271|NCT01986010|515799697|FG005|Overall Study|Status Not Recorded|2|||
143070272|NCT01986010|515799698|FG006|Overall Study|Status Not Recorded|0|||
143070273|NCT01986010|515799699|FG007|Overall Study|Status Not Recorded|0|||
143247801|NCT00942994|516460429|FG000|Overall Study|Abnormal laboratory value(s)|1|||
143247802|NCT00942994|516460430|FG001|Overall Study|Abnormal laboratory value(s)|0|||
143247803|NCT00942994|516460429|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
143247804|NCT00942994|516460430|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
143070274|NCT01986010|515799700|FG008|Overall Study|Status Not Recorded|2|||
143070275|NCT01986010|515799701|FG009|Overall Study|Status Not Recorded|1|||
143070276|NCT01986010|515799702|FG010|Overall Study|Status Not Recorded|7|||
143070277|NCT01986010|515799703|FG011|Overall Study|Status Not Recorded|7|||
143070278|NCT01986010|515799704|FG012|Overall Study|Status Not Recorded|9|||
143070279|NCT01986010|515799705|FG013|Overall Study|Status Not Recorded|9|||
143247805|NCT00942994|516460429|FG000|Overall Study|Patient withdrew consent|5|||
143247806|NCT00942994|516460430|FG001|Overall Study|Patient withdrew consent|8|||
143247807|NCT00942994|516460429|FG000|Overall Study|Lost to Follow-up|1|||
143070280|NCT01986010|515799706|FG014|Overall Study|Status Not Recorded|5|||
143070281|NCT01986010|515799707|FG015|Overall Study|Status Not Recorded|10|||
143070282|NCT01986010|515799708|FG016|Overall Study|Status Not Recorded|4|||
143070283|NCT01394952|515799709|FG000|Overall Study|Lost to Follow-up|0|||
143247808|NCT00942994|516460430|FG001|Overall Study|Lost to Follow-up|4|||
143247809|NCT00942994|516460429|FG000|Overall Study|Protocol deviation|1|||
143247810|NCT00942994|516460430|FG001|Overall Study|Protocol deviation|2|||
143070284|NCT01394952|515799710|FG001|Overall Study|Lost to Follow-up|5|||
143070285|NCT01394952|515799709|FG000|Overall Study|Withdrawal by Subject|10|||
143070286|NCT01394952|515799710|FG001|Overall Study|Withdrawal by Subject|5|||
143070287|NCT01394952|515799709|FG000|Overall Study|Physician Decision|2|||
143070288|NCT01394952|515799710|FG001|Overall Study|Physician Decision|0|||
143070289|NCT01394952|515799709|FG000|Overall Study|Sponsor Decision|5|||
143070290|NCT01394952|515799710|FG001|Overall Study|Sponsor Decision|7|||
143070291|NCT01335997|515799713|FG000|Period I and II|Adverse Event|63|||
143070292|NCT01335997|515799714|FG001|Period I and II|Adverse Event|43|||
143070293|NCT01335997|515799713|FG000|Period I and II|Noncompliance with Study Drug|1|||
143247811|NCT03583385|516460431|FG000|Treatment Period 1|Withdrawal by Subject|1|||
143247812|NCT03583385|516460432|FG001|Treatment Period 1|Withdrawal by Subject|1|||
143247813|NCT03583385|516460431|FG000|Treatment Period 2|Adverse Event|1|||
143247814|NCT03583385|516460432|FG001|Treatment Period 2|Adverse Event|0|||
143247815|NCT00095940|516460435|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
143247816|NCT00095940|516460436|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
143247817|NCT00095940|516460437|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
143247818|NCT00095940|516460438|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
143247819|NCT00095940|516460439|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
143247820|NCT00095940|516460440|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
143070294|NCT01335997|515799714|FG001|Period I and II|Noncompliance with Study Drug|1|||
143070295|NCT01335997|515799713|FG000|Period I and II|Lost to Follow-up|3|||
143070296|NCT01335997|515799714|FG001|Period I and II|Lost to Follow-up|5|||
143070297|NCT01335997|515799713|FG000|Period I and II|Withdrawal by Subject|9|||
143070298|NCT01335997|515799714|FG001|Period I and II|Withdrawal by Subject|4|||
143070299|NCT01335997|515799713|FG000|Period I and II|Study Terminated by Sponsor|406|||
143070300|NCT01335997|515799714|FG001|Period I and II|Study Terminated by Sponsor|415|||
143070301|NCT01335997|515799713|FG000|Period I and II|Protocol Violation|9|||
143070302|NCT01335997|515799714|FG001|Period I and II|Protocol Violation|10|||
143070303|NCT01335997|515799713|FG000|Period I and II|Physician Decision|2|||
143070304|NCT01335997|515799714|FG001|Period I and II|Physician Decision|1|||
143070305|NCT01335997|515799713|FG000|Period III|Adverse Event|0|||
143070306|NCT01335997|515799714|FG001|Period III|Adverse Event|2|||
143070307|NCT01335997|515799713|FG000|Period III|Study Terminated by Sponsor|77|||
143070308|NCT01335997|515799714|FG001|Period III|Study Terminated by Sponsor|76|||
143070309|NCT01335997|515799713|FG000|Period III|Protocol Violation|0|||
143070310|NCT01335997|515799714|FG001|Period III|Protocol Violation|1|||
143070311|NCT01335997|515799713|FG000|Period III|Lost to Follow-up|1|||
143070312|NCT01335997|515799714|FG001|Period III|Lost to Follow-up|0|||
143070313|NCT02440568|515799715|FG000|Overall Study|Death|1|||
143070314|NCT02440568|515799716|FG001|Overall Study|Death|3|||
143070315|NCT02440568|515799717|FG002|Overall Study|Death|4|||
143070316|NCT02440568|515799718|FG003|Overall Study|Death|2|||
143247821|NCT00095940|516460441|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
143247822|NCT00095940|516460442|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
143247823|NCT00095940|516460443|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
143247824|NCT00095940|516460435|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
143247825|NCT00095940|516460436|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
143247826|NCT00095940|516460437|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
143247827|NCT00095940|516460438|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
143247828|NCT00095940|516460439|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
143247829|NCT00095940|516460440|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
143247830|NCT00095940|516460441|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
143247831|NCT00095940|516460442|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
143247832|NCT00095940|516460443|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
143247833|NCT00095940|516460435|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
143247834|NCT00095940|516460436|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
143247835|NCT00095940|516460437|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
143247836|NCT00095940|516460438|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
143247837|NCT00095940|516460439|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
143247838|NCT00095940|516460440|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
143070317|NCT02440568|515799715|FG000|Overall Study|Lack of Efficacy|2|||
143070318|NCT02440568|515799716|FG001|Overall Study|Lack of Efficacy|0|||
143070319|NCT02440568|515799717|FG002|Overall Study|Lack of Efficacy|1|||
143070320|NCT02440568|515799718|FG003|Overall Study|Lack of Efficacy|0|||
143070321|NCT02440568|515799715|FG000|Overall Study|Lost to Follow-up|1|||
143070322|NCT02440568|515799716|FG001|Overall Study|Lost to Follow-up|0|||
143070323|NCT02440568|515799717|FG002|Overall Study|Lost to Follow-up|0|||
143070324|NCT02440568|515799718|FG003|Overall Study|Lost to Follow-up|0|||
143070325|NCT01103466|515799721|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
143070326|NCT01103466|515799722|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
143070327|NCT01103466|515799723|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
143070328|NCT01103466|515799721|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
143070329|NCT01103466|515799722|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
143070330|NCT01103466|515799723|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
143070331|NCT01103466|515799721|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
143070332|NCT01103466|515799722|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
143070333|NCT01103466|515799723|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
143070334|NCT01103466|515799721|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
143070335|NCT01103466|515799722|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
143070336|NCT01103466|515799723|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
143070337|NCT01103466|515799721|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
143070338|NCT01103466|515799722|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
143070339|NCT01103466|515799723|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
143070340|NCT01103466|515799721|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
143070341|NCT01103466|515799722|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
143070342|NCT01103466|515799723|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
143070343|NCT04453202|515799730|FG000|Overall Study|Adverse Event|0|||
143070344|NCT04453202|515799731|FG001|Overall Study|Adverse Event|0|||
143070345|NCT04453202|515799732|FG002|Overall Study|Adverse Event|0|||
143070346|NCT04453202|515799733|FG003|Overall Study|Adverse Event|0|||
143070347|NCT04453202|515799734|FG004|Overall Study|Adverse Event|0|||
143070348|NCT04453202|515799735|FG005|Overall Study|Adverse Event|0|||
143070349|NCT04453202|515799736|FG006|Overall Study|Adverse Event|1|||
143070350|NCT04453202|515799737|FG007|Overall Study|Adverse Event|0|||
143070351|NCT04453202|515799738|FG008|Overall Study|Adverse Event|0|||
143070352|NCT04453202|515799739|FG009|Overall Study|Adverse Event|0|||
143070353|NCT04453202|515799740|FG010|Overall Study|Adverse Event|0|||
143070354|NCT04453202|515799730|FG000|Overall Study|Death|0|||
143070355|NCT04453202|515799731|FG001|Overall Study|Death|0|||
143070356|NCT04453202|515799732|FG002|Overall Study|Death|0|||
143070357|NCT04453202|515799733|FG003|Overall Study|Death|0|||
143070358|NCT04453202|515799734|FG004|Overall Study|Death|0|||
143070359|NCT04453202|515799735|FG005|Overall Study|Death|0|||
143070360|NCT04453202|515799736|FG006|Overall Study|Death|0|||
143070361|NCT04453202|515799737|FG007|Overall Study|Death|0|||
143070362|NCT04453202|515799738|FG008|Overall Study|Death|0|||
143070363|NCT04453202|515799739|FG009|Overall Study|Death|1|||
143070364|NCT04453202|515799740|FG010|Overall Study|Death|0|||
143070365|NCT04453202|515799730|FG000|Overall Study|Lost to Follow-up|0|||
143070366|NCT04453202|515799731|FG001|Overall Study|Lost to Follow-up|1|||
143070367|NCT04453202|515799732|FG002|Overall Study|Lost to Follow-up|0|||
143070368|NCT04453202|515799733|FG003|Overall Study|Lost to Follow-up|1|||
143070369|NCT04453202|515799734|FG004|Overall Study|Lost to Follow-up|0|||
143070370|NCT04453202|515799735|FG005|Overall Study|Lost to Follow-up|0|||
143070371|NCT04453202|515799736|FG006|Overall Study|Lost to Follow-up|0|||
143070372|NCT04453202|515799737|FG007|Overall Study|Lost to Follow-up|0|||
143070373|NCT04453202|515799738|FG008|Overall Study|Lost to Follow-up|0|||
143070374|NCT04453202|515799739|FG009|Overall Study|Lost to Follow-up|1|||
143070375|NCT04453202|515799740|FG010|Overall Study|Lost to Follow-up|1|||
143070376|NCT04453202|515799730|FG000|Overall Study|Withdrawal by Subject|1|||
143070377|NCT04453202|515799731|FG001|Overall Study|Withdrawal by Subject|2|||
143070378|NCT04453202|515799732|FG002|Overall Study|Withdrawal by Subject|1|||
143070379|NCT04453202|515799733|FG003|Overall Study|Withdrawal by Subject|2|||
143070380|NCT04453202|515799734|FG004|Overall Study|Withdrawal by Subject|1|||
143070381|NCT04453202|515799735|FG005|Overall Study|Withdrawal by Subject|1|||
143070382|NCT04453202|515799736|FG006|Overall Study|Withdrawal by Subject|0|||
143070383|NCT04453202|515799737|FG007|Overall Study|Withdrawal by Subject|0|||
143070384|NCT04453202|515799738|FG008|Overall Study|Withdrawal by Subject|0|||
143070385|NCT04453202|515799739|FG009|Overall Study|Withdrawal by Subject|1|||
143070386|NCT04453202|515799740|FG010|Overall Study|Withdrawal by Subject|0|||
143505207|NCT02706353|517386285|FG004|Dose Level 5|Withdrawal by Subject|0|||
143505208|NCT02706353|517386286|FG005|Dose Level 5|Withdrawal by Subject|2|||
143505209|NCT03560466|517386287|FG000|Overall Study|Adverse Event|1|||
143505210|NCT03560466|517386288|FG001|Overall Study|Adverse Event|2|||
143070387|NCT04453202|515799730|FG000|Overall Study|Adverse Event|0|||
143070388|NCT04453202|515799731|FG001|Overall Study|Adverse Event|0|||
143070389|NCT04453202|515799732|FG002|Overall Study|Adverse Event|0|||
143070390|NCT04453202|515799733|FG003|Overall Study|Adverse Event|0|||
143070391|NCT04453202|515799734|FG004|Overall Study|Adverse Event|0|||
143070392|NCT04453202|515799735|FG005|Overall Study|Adverse Event|1|||
143070393|NCT04453202|515799736|FG006|Overall Study|Adverse Event|0|||
143070394|NCT04453202|515799737|FG007|Overall Study|Adverse Event|0|||
143070395|NCT04453202|515799738|FG008|Overall Study|Adverse Event|0|||
143070396|NCT04453202|515799739|FG009|Overall Study|Adverse Event|0|||
143070397|NCT04453202|515799740|FG010|Overall Study|Adverse Event|0|||
143070398|NCT00669071|515799741|FG000|Overall Study|Lost to Follow-up|3|||
143070399|NCT00669071|515799741|FG000|Overall Study|Final visit 40 days out of window|1|||
143070400|NCT01157897|515799744|FG000|Overall Study|Lost to Follow-up|2|||
143070401|NCT01157897|515799745|FG001|Overall Study|Lost to Follow-up|0|||
143505211|NCT03560466|517386289|FG002|Overall Study|Adverse Event|0|||
143505212|NCT03560466|517386287|FG000|Overall Study|Poor Compliance to Protocol|0|||
143505213|NCT03560466|517386288|FG001|Overall Study|Poor Compliance to Protocol|2|||
143505214|NCT03560466|517386289|FG002|Overall Study|Poor Compliance to Protocol|0|||
143505215|NCT03560466|517386287|FG000|Overall Study|Other|6|||
143070402|NCT01157897|515799746|FG002|Overall Study|Lost to Follow-up|0|||
143505216|NCT03560466|517386288|FG001|Overall Study|Other|8|||
143505217|NCT03560466|517386289|FG002|Overall Study|Other|1|||
143505218|NCT03703297|517386360|FG000|Overall Study|Death|115|||
143505219|NCT03703297|517386361|FG001|Overall Study|Death|0|||
143505220|NCT03703297|517386362|FG002|Overall Study|Death|144|||
143505221|NCT03703297|517386360|FG000|Overall Study|Withdrawal by Subject|9|||
143505222|NCT03703297|517386361|FG001|Overall Study|Withdrawal by Subject|0|||
143505223|NCT03703297|517386362|FG002|Overall Study|Withdrawal by Subject|11|||
143505224|NCT03703297|517386360|FG000|Overall Study|Ongoing at the time of DCO|140|||
143505225|NCT03703297|517386361|FG001|Overall Study|Ongoing at the time of DCO|200|||
143505226|NCT03703297|517386362|FG002|Overall Study|Ongoing at the time of DCO|111|||
143070403|NCT01157897|515799747|FG003|Overall Study|Lost to Follow-up|1|||
143070404|NCT01157897|515799744|FG000|Overall Study|Relocated|0|||
143070405|NCT01157897|515799745|FG001|Overall Study|Relocated|2|||
143070406|NCT01157897|515799746|FG002|Overall Study|Relocated|0|||
143070407|NCT01157897|515799747|FG003|Overall Study|Relocated|0|||
143070408|NCT02912650|515799748|FG000|Overall Study|Withdrawal by Subject|1|||
143070409|NCT02912650|515799749|FG001|Overall Study|Withdrawal by Subject|0|||
143171339|NCT01170663|516176066|FG000|Overall Study|Lost to Follow-up|3|||
143070410|NCT02912650|515799750|FG002|Overall Study|Withdrawal by Subject|1|||
143070411|NCT02912650|515799751|FG003|Overall Study|Withdrawal by Subject|5|||
143070412|NCT02912650|515799748|FG000|Overall Study|Adverse Event|0|||
143070413|NCT02912650|515799749|FG001|Overall Study|Adverse Event|0|||
143070414|NCT02912650|515799750|FG002|Overall Study|Adverse Event|1|||
143070415|NCT02912650|515799751|FG003|Overall Study|Adverse Event|0|||
143070416|NCT01791153|515799753|FG000|Part 1: Blinded Period|Adverse Event|7|||
143070417|NCT01791153|515799754|FG001|Part 1: Blinded Period|Adverse Event|3|||
143070418|NCT01791153|515799755|FG002|Part 1: Blinded Period|Adverse Event|2|||
143070419|NCT01791153|515799756|FG003|Part 1: Blinded Period|Adverse Event|0|||
143070420|NCT01791153|515799757|FG004|Part 1: Blinded Period|Adverse Event|0|||
143070421|NCT01791153|515799758|FG005|Part 1: Blinded Period|Adverse Event|0|||
143070422|NCT01791153|515799759|FG006|Part 1: Blinded Period|Adverse Event|0|||
143070423|NCT01791153|515799760|FG007|Part 1: Blinded Period|Adverse Event|0|||
143070424|NCT01791153|515799753|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
143070425|NCT01791153|515799754|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
143070426|NCT01791153|515799755|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
143070427|NCT01791153|515799756|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
143070428|NCT01791153|515799757|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
143070429|NCT01791153|515799758|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
143070430|NCT01791153|515799759|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
143070431|NCT01791153|515799760|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
143070432|NCT01791153|515799753|FG000|Part 1: Blinded Period|Non-Compliance|1|||
143070433|NCT01791153|515799754|FG001|Part 1: Blinded Period|Non-Compliance|0|||
143070434|NCT01791153|515799755|FG002|Part 1: Blinded Period|Non-Compliance|0|||
143070435|NCT01791153|515799756|FG003|Part 1: Blinded Period|Non-Compliance|0|||
143070436|NCT01791153|515799757|FG004|Part 1: Blinded Period|Non-Compliance|0|||
143070437|NCT01791153|515799758|FG005|Part 1: Blinded Period|Non-Compliance|0|||
143070438|NCT01791153|515799759|FG006|Part 1: Blinded Period|Non-Compliance|0|||
143070439|NCT01791153|515799760|FG007|Part 1: Blinded Period|Non-Compliance|0|||
143070440|NCT01791153|515799753|FG000|Part 1: Blinded Period|Physician Decision|0|||
143070441|NCT01791153|515799754|FG001|Part 1: Blinded Period|Physician Decision|0|||
143070442|NCT01791153|515799755|FG002|Part 1: Blinded Period|Physician Decision|0|||
143070443|NCT01791153|515799756|FG003|Part 1: Blinded Period|Physician Decision|1|||
143070444|NCT01791153|515799757|FG004|Part 1: Blinded Period|Physician Decision|0|||
143070445|NCT01791153|515799758|FG005|Part 1: Blinded Period|Physician Decision|0|||
143070446|NCT01791153|515799759|FG006|Part 1: Blinded Period|Physician Decision|0|||
143070447|NCT01791153|515799760|FG007|Part 1: Blinded Period|Physician Decision|0|||
143070448|NCT01791153|515799753|FG000|Part 1: Blinded Period|Protocol Violation|0|||
143070449|NCT01791153|515799754|FG001|Part 1: Blinded Period|Protocol Violation|0|||
143070450|NCT01791153|515799755|FG002|Part 1: Blinded Period|Protocol Violation|0|||
143070451|NCT01791153|515799756|FG003|Part 1: Blinded Period|Protocol Violation|1|||
143070452|NCT01791153|515799757|FG004|Part 1: Blinded Period|Protocol Violation|0|||
143070453|NCT01791153|515799758|FG005|Part 1: Blinded Period|Protocol Violation|0|||
143070454|NCT01791153|515799759|FG006|Part 1: Blinded Period|Protocol Violation|0|||
143070455|NCT01791153|515799760|FG007|Part 1: Blinded Period|Protocol Violation|0|||
143070456|NCT01791153|515799753|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
143070457|NCT01791153|515799754|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
143070458|NCT01791153|515799755|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
143070459|NCT01791153|515799756|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
143070460|NCT01791153|515799757|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
143070461|NCT01791153|515799758|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
143070462|NCT01791153|515799759|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
143070463|NCT01791153|515799760|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
143070464|NCT01791153|515799753|FG000|Part 2: Open-label Period|Adverse Event|0|||
143070465|NCT01791153|515799754|FG001|Part 2: Open-label Period|Adverse Event|0|||
143070466|NCT01791153|515799755|FG002|Part 2: Open-label Period|Adverse Event|0|||
143070467|NCT01791153|515799756|FG003|Part 2: Open-label Period|Adverse Event|0|||
143070468|NCT01791153|515799757|FG004|Part 2: Open-label Period|Adverse Event|0|||
143070469|NCT01791153|515799758|FG005|Part 2: Open-label Period|Adverse Event|1|||
143070470|NCT01791153|515799759|FG006|Part 2: Open-label Period|Adverse Event|1|||
143070471|NCT01791153|515799760|FG007|Part 2: Open-label Period|Adverse Event|2|||
143070472|NCT01791153|515799753|FG000|Part 2: Open-label Period|Death|0|||
143070473|NCT01791153|515799754|FG001|Part 2: Open-label Period|Death|0|||
143070474|NCT01791153|515799755|FG002|Part 2: Open-label Period|Death|0|||
143070475|NCT01791153|515799756|FG003|Part 2: Open-label Period|Death|0|||
143070476|NCT01791153|515799757|FG004|Part 2: Open-label Period|Death|0|||
143070477|NCT01791153|515799758|FG005|Part 2: Open-label Period|Death|1|||
143070478|NCT01791153|515799759|FG006|Part 2: Open-label Period|Death|1|||
143070479|NCT01791153|515799760|FG007|Part 2: Open-label Period|Death|1|||
143070480|NCT01791153|515799753|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
143171340|NCT01170663|516176067|FG001|Overall Study|Lost to Follow-up|9|||
143070481|NCT01791153|515799754|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
143070482|NCT01791153|515799755|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
143070483|NCT01791153|515799756|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
143070484|NCT01791153|515799757|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
143070485|NCT01791153|515799758|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
143070486|NCT01791153|515799759|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
143070487|NCT01791153|515799760|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
143070488|NCT01791153|515799753|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
143070489|NCT01791153|515799754|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
143070490|NCT01791153|515799755|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
143070491|NCT01791153|515799756|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
143070492|NCT01791153|515799757|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
143070493|NCT01791153|515799758|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
143070494|NCT01791153|515799759|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
143070495|NCT01791153|515799760|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
143070496|NCT01791153|515799753|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
143070497|NCT01791153|515799754|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
143070498|NCT01791153|515799755|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
143070499|NCT01791153|515799756|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
143070500|NCT01791153|515799757|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
143070501|NCT01791153|515799758|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
143070502|NCT01791153|515799759|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
143070503|NCT01791153|515799760|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
143070504|NCT01791153|515799753|FG000|Part 2: Open-label Period|Physician Decision|0|||
143070505|NCT01791153|515799754|FG001|Part 2: Open-label Period|Physician Decision|0|||
143070506|NCT01791153|515799755|FG002|Part 2: Open-label Period|Physician Decision|0|||
143070507|NCT01791153|515799756|FG003|Part 2: Open-label Period|Physician Decision|0|||
143070508|NCT01791153|515799757|FG004|Part 2: Open-label Period|Physician Decision|1|||
143070509|NCT01791153|515799758|FG005|Part 2: Open-label Period|Physician Decision|1|||
143070510|NCT01791153|515799759|FG006|Part 2: Open-label Period|Physician Decision|0|||
143247839|NCT00095940|516460441|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
143247840|NCT00095940|516460442|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
143070511|NCT01791153|515799760|FG007|Part 2: Open-label Period|Physician Decision|0|||
143070512|NCT02562482|515799761|FG000|Overall Study|Enrolled, but did not receive product|4|||
143070513|NCT02562482|515799762|FG001|Overall Study|Enrolled, but did not receive product|0|||
143070514|NCT02562482|515799761|FG000|Overall Study|Lost to Follow-up|9|||
143247841|NCT00095940|516460443|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
143247842|NCT02314637|516460444|FG000|Overall Study|Adverse Event|4|||
143247843|NCT02314637|516460445|FG001|Overall Study|Adverse Event|8|||
143247844|NCT02314637|516460444|FG000|Overall Study|Lack of Efficacy|1|||
143247845|NCT02314637|516460445|FG001|Overall Study|Lack of Efficacy|0|||
143247846|NCT02314637|516460444|FG000|Overall Study|Physician Decision|5|||
143070515|NCT02562482|515799762|FG001|Overall Study|Lost to Follow-up|6|||
143070516|NCT02562482|515799761|FG000|Overall Study|Moved from area|2|||
143070517|NCT02562482|515799762|FG001|Overall Study|Moved from area|3|||
143070518|NCT02562482|515799761|FG000|Overall Study|Withdrawal by Subject|5|||
143070519|NCT02562482|515799762|FG001|Overall Study|Withdrawal by Subject|3|||
143070520|NCT02562482|515799761|FG000|Overall Study|Physician Decision|1|||
143070521|NCT02562482|515799762|FG001|Overall Study|Physician Decision|3|||
143070522|NCT02562482|515799761|FG000|Overall Study|Illness/Injury unrelated to product|0|||
143070523|NCT02562482|515799762|FG001|Overall Study|Illness/Injury unrelated to product|1|||
143070524|NCT01490866|515799766|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
143070525|NCT01490866|515799766|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
143070526|NCT01490866|515799766|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
143070527|NCT01490866|515799766|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
143070528|NCT01490866|515799766|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
143070529|NCT01490866|515799766|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
143070530|NCT01490866|515799766|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
143070531|NCT01490866|515799766|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
143070532|NCT01490866|515799766|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
143070533|NCT01490866|515799766|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
143070534|NCT01490866|515799766|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
143070535|NCT01408628|515799767|FG000|Consented|Withdrawal by Subject|12|||
143070536|NCT01408628|515799767|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
143070537|NCT01408628|515799767|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
143070538|NCT01408628|515799767|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
143070539|NCT01181271|515799768|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
143070540|NCT01181271|515799768|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
143070541|NCT01181271|515799768|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
143070542|NCT01181271|515799768|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
143070543|NCT00750308|515799769|FG000|First Treatment|Adverse Event|0|||
143070544|NCT00750308|515799770|FG001|First Treatment|Adverse Event|1|||
143070545|NCT00750308|515799771|FG002|First Treatment|Adverse Event|0|||
143070546|NCT00750308|515799772|FG003|First Treatment|Adverse Event|0|||
143070547|NCT00750308|515799773|FG004|First Treatment|Adverse Event|0|||
143070548|NCT00750308|515799774|FG005|First Treatment|Adverse Event|0|||
143070549|NCT00750308|515799775|FG006|First Treatment|Adverse Event|0|||
143070550|NCT00750308|515799776|FG007|First Treatment|Adverse Event|0|||
143070551|NCT00750308|515799777|FG008|First Treatment|Adverse Event|0|||
143070552|NCT00750308|515799778|FG009|First Treatment|Adverse Event|0|||
143070553|NCT00750308|515799779|FG010|First Treatment|Adverse Event|1|||
143070554|NCT00750308|515799780|FG011|First Treatment|Adverse Event|1|||
143070555|NCT00750308|515799769|FG000|First Treatment|Withdrawal by Subject|0|||
143070556|NCT00750308|515799770|FG001|First Treatment|Withdrawal by Subject|0|||
143247847|NCT02314637|516460445|FG001|Overall Study|Physician Decision|2|||
143247848|NCT02314637|516460444|FG000|Overall Study|Withdrawal by Subject|5|||
143247849|NCT02314637|516460445|FG001|Overall Study|Withdrawal by Subject|4|||
143247850|NCT02314637|516460444|FG000|Overall Study|Other Reason|1|||
143247851|NCT02314637|516460445|FG001|Overall Study|Other Reason|0|||
143247852|NCT02597478|516460451|FG000|Overall Study|Withdrawal by Subject|2|||
143247853|NCT02597478|516460452|FG001|Overall Study|Withdrawal by Subject|0|||
143247854|NCT02597478|516460451|FG000|Overall Study|Change of opioid dose|1|||
143247855|NCT02597478|516460452|FG001|Overall Study|Change of opioid dose|0|||
143247856|NCT02597478|516460451|FG000|Overall Study|Insufficient exertional dyspnea|0|||
143247857|NCT02597478|516460452|FG001|Overall Study|Insufficient exertional dyspnea|1|||
143247858|NCT01256190|516460454|FG000|Overall Study|Lost to Follow-up|2|||
143247859|NCT01256190|516460455|FG001|Overall Study|Lost to Follow-up|0|||
143247860|NCT02364336|516460456|FG000|Overall Study|Adverse Event|0|||
143247861|NCT02364336|516460457|FG001|Overall Study|Adverse Event|1|||
143070557|NCT00750308|515799771|FG002|First Treatment|Withdrawal by Subject|0|||
143070558|NCT00750308|515799772|FG003|First Treatment|Withdrawal by Subject|1|||
143070559|NCT00750308|515799773|FG004|First Treatment|Withdrawal by Subject|0|||
143247862|NCT03179202|516460458|FG000|Overall Study|Screen Failure|67|||
143247863|NCT03179202|516460458|FG000|Overall Study|Subject Lost to Follow Up|12|||
143247864|NCT03179202|516460458|FG000|Overall Study|Withdrawal by Subject|7|||
143365437|NCT00389519|516880790|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
143070560|NCT00750308|515799774|FG005|First Treatment|Withdrawal by Subject|0|||
143070561|NCT00750308|515799775|FG006|First Treatment|Withdrawal by Subject|0|||
143247865|NCT03179202|516460458|FG000|Overall Study|Adverse Event|3|||
143247866|NCT03179202|516460458|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
143247867|NCT03179202|516460458|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
143247868|NCT00859638|516460459|FG000|Overall Study|Lost to Follow-up|6|||
143070562|NCT00750308|515799776|FG007|First Treatment|Withdrawal by Subject|1|||
143070563|NCT00750308|515799777|FG008|First Treatment|Withdrawal by Subject|0|||
143070564|NCT00750308|515799778|FG009|First Treatment|Withdrawal by Subject|0|||
143070565|NCT00750308|515799779|FG010|First Treatment|Withdrawal by Subject|0|||
143070566|NCT00750308|515799780|FG011|First Treatment|Withdrawal by Subject|0|||
143070567|NCT00750308|515799769|FG000|Second Treatment|Adverse Event|0|||
143070568|NCT00750308|515799770|FG001|Second Treatment|Adverse Event|0|||
143070569|NCT00750308|515799771|FG002|Second Treatment|Adverse Event|0|||
143070570|NCT00750308|515799772|FG003|Second Treatment|Adverse Event|0|||
143070571|NCT00750308|515799773|FG004|Second Treatment|Adverse Event|0|||
143070572|NCT00750308|515799774|FG005|Second Treatment|Adverse Event|1|||
143070573|NCT00750308|515799775|FG006|Second Treatment|Adverse Event|0|||
143070574|NCT00750308|515799776|FG007|Second Treatment|Adverse Event|0|||
143070575|NCT00750308|515799777|FG008|Second Treatment|Adverse Event|1|||
143070576|NCT00750308|515799778|FG009|Second Treatment|Adverse Event|0|||
143070577|NCT00750308|515799779|FG010|Second Treatment|Adverse Event|0|||
143070578|NCT00750308|515799780|FG011|Second Treatment|Adverse Event|0|||
143070579|NCT00750308|515799769|FG000|Second Treatment|Withdrawal by Subject|0|||
143070580|NCT00750308|515799770|FG001|Second Treatment|Withdrawal by Subject|0|||
143070581|NCT00750308|515799771|FG002|Second Treatment|Withdrawal by Subject|0|||
143070582|NCT00750308|515799772|FG003|Second Treatment|Withdrawal by Subject|0|||
143070583|NCT00750308|515799773|FG004|Second Treatment|Withdrawal by Subject|1|||
143070584|NCT00750308|515799774|FG005|Second Treatment|Withdrawal by Subject|0|||
143070585|NCT00750308|515799775|FG006|Second Treatment|Withdrawal by Subject|0|||
143070586|NCT00750308|515799776|FG007|Second Treatment|Withdrawal by Subject|0|||
143070587|NCT00750308|515799777|FG008|Second Treatment|Withdrawal by Subject|0|||
143070588|NCT00750308|515799778|FG009|Second Treatment|Withdrawal by Subject|0|||
143070589|NCT00750308|515799779|FG010|Second Treatment|Withdrawal by Subject|0|||
143070590|NCT00750308|515799780|FG011|Second Treatment|Withdrawal by Subject|0|||
143070591|NCT00750308|515799769|FG000|Third Treatment|Withdrawal by Subject|0|||
143070592|NCT00750308|515799770|FG001|Third Treatment|Withdrawal by Subject|1|||
143070593|NCT00750308|515799771|FG002|Third Treatment|Withdrawal by Subject|0|||
143171341|NCT01170663|516176066|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
143171342|NCT01170663|516176067|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
143171343|NCT00673920|516176074|FG000|Baseline up to Week 48|Withdrew consent|1|||
143171344|NCT00673920|516176075|FG001|Baseline up to Week 48|Withdrew consent|0|||
143171345|NCT00673920|516176076|FG002|Baseline up to Week 48|Withdrew consent|2|||
143171346|NCT00673920|516176077|FG003|Baseline up to Week 48|Withdrew consent|0|||
143171347|NCT00673920|516176078|FG004|Baseline up to Week 48|Withdrew consent|0|||
143171348|NCT00673920|516176079|FG005|Baseline up to Week 48|Withdrew consent|0|||
143171349|NCT00673920|516176080|FG006|Baseline up to Week 48|Withdrew consent|0|||
143171350|NCT00673920|516176081|FG007|Baseline up to Week 48|Withdrew consent|0|||
143171351|NCT00673920|516176074|FG000|Baseline up to Week 48|Refused treatment|1|||
143171352|NCT00673920|516176075|FG001|Baseline up to Week 48|Refused treatment|0|||
143171353|NCT00673920|516176076|FG002|Baseline up to Week 48|Refused treatment|0|||
143171354|NCT00673920|516176077|FG003|Baseline up to Week 48|Refused treatment|0|||
143171355|NCT00673920|516176078|FG004|Baseline up to Week 48|Refused treatment|0|||
143171356|NCT00673920|516176079|FG005|Baseline up to Week 48|Refused treatment|0|||
143171357|NCT00673920|516176080|FG006|Baseline up to Week 48|Refused treatment|0|||
143171358|NCT00673920|516176081|FG007|Baseline up to Week 48|Refused treatment|0|||
143171359|NCT00673920|516176074|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
143171360|NCT00673920|516176075|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
143171361|NCT00673920|516176076|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
143171362|NCT00673920|516176077|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
143171363|NCT00673920|516176078|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
143171364|NCT00673920|516176079|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
143171365|NCT00673920|516176080|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
143070594|NCT00750308|515799772|FG003|Third Treatment|Withdrawal by Subject|0|||
143070595|NCT00750308|515799773|FG004|Third Treatment|Withdrawal by Subject|0|||
143070596|NCT00750308|515799774|FG005|Third Treatment|Withdrawal by Subject|0|||
143070597|NCT00750308|515799775|FG006|Third Treatment|Withdrawal by Subject|0|||
143070598|NCT00750308|515799776|FG007|Third Treatment|Withdrawal by Subject|0|||
143070599|NCT00750308|515799777|FG008|Third Treatment|Withdrawal by Subject|0|||
143070600|NCT00750308|515799778|FG009|Third Treatment|Withdrawal by Subject|0|||
143070601|NCT00750308|515799779|FG010|Third Treatment|Withdrawal by Subject|0|||
143070602|NCT00750308|515799780|FG011|Third Treatment|Withdrawal by Subject|0|||
143171366|NCT00673920|516176081|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
143171367|NCT00673920|516176074|FG000|Baseline up to Week 48|Protocol Violation|0|||
143070603|NCT01121666|515799781|FG000|Overall Study|Protocol Violation|29|||
143070604|NCT01121666|515799782|FG001|Overall Study|Protocol Violation|10|||
143070605|NCT01083810|515799785|FG000|Overall Study|Lost to Follow-up|23|||
143247869|NCT00859638|516460460|FG001|Overall Study|Lost to Follow-up|1|||
143070606|NCT01083810|515799786|FG001|Overall Study|Lost to Follow-up|11|||
143070607|NCT01083810|515799787|FG002|Overall Study|Lost to Follow-up|4|||
143070608|NCT01083810|515799785|FG000|Overall Study|Adverse Event|15|||
143070609|NCT01083810|515799786|FG001|Overall Study|Adverse Event|11|||
143070610|NCT01083810|515799787|FG002|Overall Study|Adverse Event|4|||
143070611|NCT01083810|515799785|FG000|Overall Study|Withdrawal by Subject|7|||
143070612|NCT01083810|515799786|FG001|Overall Study|Withdrawal by Subject|2|||
143070613|NCT01083810|515799787|FG002|Overall Study|Withdrawal by Subject|4|||
143070614|NCT01083810|515799785|FG000|Overall Study|Reason not reported|6|||
143070615|NCT01083810|515799786|FG001|Overall Study|Reason not reported|1|||
143070616|NCT01083810|515799787|FG002|Overall Study|Reason not reported|1|||
143070617|NCT01083810|515799785|FG000|Overall Study|Non-compliance|4|||
143070618|NCT01083810|515799786|FG001|Overall Study|Non-compliance|7|||
143070619|NCT01083810|515799787|FG002|Overall Study|Non-compliance|2|||
143070620|NCT01083810|515799785|FG000|Overall Study|Simplification|4|||
143070621|NCT01083810|515799786|FG001|Overall Study|Simplification|1|||
143070622|NCT01083810|515799787|FG002|Overall Study|Simplification|0|||
143070623|NCT01083810|515799785|FG000|Overall Study|Death|2|||
143070624|NCT01083810|515799786|FG001|Overall Study|Death|2|||
143070625|NCT01083810|515799787|FG002|Overall Study|Death|3|||
143070626|NCT01083810|515799785|FG000|Overall Study|Co-morbidities|1|||
143070627|NCT01083810|515799786|FG001|Overall Study|Co-morbidities|0|||
143070628|NCT01083810|515799787|FG002|Overall Study|Co-morbidities|0|||
143070629|NCT01083810|515799785|FG000|Overall Study|Participation in study|1|||
143070630|NCT01083810|515799786|FG001|Overall Study|Participation in study|0|||
143070631|NCT01083810|515799787|FG002|Overall Study|Participation in study|0|||
143070632|NCT01083810|515799785|FG000|Overall Study|Therapy break|1|||
143070633|NCT01083810|515799786|FG001|Overall Study|Therapy break|2|||
143070634|NCT01083810|515799787|FG002|Overall Study|Therapy break|2|||
143070635|NCT01083810|515799785|FG000|Overall Study|Virologic failure|1|||
143070636|NCT01083810|515799786|FG001|Overall Study|Virologic failure|8|||
143070637|NCT01083810|515799787|FG002|Overall Study|Virologic failure|0|||
143070638|NCT05011123|515803071|FG000|Overall Study|Withdrawal by Subject|4|||
143070639|NCT05011123|515803072|FG001|Overall Study|Withdrawal by Subject|2|||
143070640|NCT05011123|515803071|FG000|Overall Study|Lost to Follow-up|7|||
143070641|NCT05011123|515803072|FG001|Overall Study|Lost to Follow-up|6|||
143070642|NCT05011123|515803071|FG000|Overall Study|Ongoing at the time of DBL date|36|||
143070643|NCT05011123|515803072|FG001|Overall Study|Ongoing at the time of DBL date|10|||
143070644|NCT05011123|515803071|FG000|Overall Study|Randomized but did not receive vaccination|1|||
143070645|NCT05011123|515803072|FG001|Overall Study|Randomized but did not receive vaccination|0|||
143070646|NCT03845296|515803075|FG000|Overall Study|On Treatment|2|||
143247870|NCT00859638|516460459|FG000|Overall Study|Withdrawal by Subject|3|||
143247871|NCT00859638|516460460|FG001|Overall Study|Withdrawal by Subject|2|||
143247872|NCT00859638|516460459|FG000|Overall Study|Ill health|1|||
143247873|NCT00859638|516460460|FG001|Overall Study|Ill health|1|||
143247874|NCT02969408|516460462|FG000|Overall Study|Adverse Event|2|||
143247875|NCT02969408|516460462|FG000|Overall Study|Withdrawal by Subject|8|||
143247876|NCT02969408|516460462|FG000|Overall Study|Lost to Follow-up|4|||
143247877|NCT02969408|516460462|FG000|Overall Study|Protocol Violation|1|||
143247878|NCT02969408|516460462|FG000|Overall Study|Other than specified|1|||
143247879|NCT01092546|516460466|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
143247880|NCT01667419|516460469|FG000|Overall Study|Reason Not Specified|1|||
143247881|NCT01667419|516460470|FG001|Overall Study|Reason Not Specified|0|||
143247882|NCT01667419|516460471|FG002|Overall Study|Reason Not Specified|0|||
143247883|NCT01667419|516460472|FG003|Overall Study|Reason Not Specified|0|||
143247884|NCT01667419|516460469|FG000|Overall Study|Withdrawal by Subject|16|||
143247885|NCT01667419|516460470|FG001|Overall Study|Withdrawal by Subject|8|||
143247886|NCT01667419|516460471|FG002|Overall Study|Withdrawal by Subject|9|||
143247887|NCT01667419|516460472|FG003|Overall Study|Withdrawal by Subject|8|||
143247888|NCT01667419|516460469|FG000|Overall Study|Non-compliance|0|||
143247889|NCT01667419|516460470|FG001|Overall Study|Non-compliance|0|||
143247890|NCT01667419|516460471|FG002|Overall Study|Non-compliance|0|||
143247891|NCT01667419|516460472|FG003|Overall Study|Non-compliance|1|||
143247892|NCT01667419|516460469|FG000|Overall Study|Protocol Violation|1|||
143247893|NCT01667419|516460470|FG001|Overall Study|Protocol Violation|0|||
143247894|NCT01667419|516460471|FG002|Overall Study|Protocol Violation|0|||
143247895|NCT01667419|516460472|FG003|Overall Study|Protocol Violation|0|||
143247896|NCT01667419|516460469|FG000|Overall Study|Lost to Follow-up|7|||
143247897|NCT01667419|516460470|FG001|Overall Study|Lost to Follow-up|6|||
143247898|NCT01667419|516460471|FG002|Overall Study|Lost to Follow-up|2|||
143070647|NCT03845296|515803076|FG001|Overall Study|On Treatment|1|||
143070648|NCT03845296|515803075|FG000|Overall Study|Adverse Event|4|||
143070649|NCT03845296|515803076|FG001|Overall Study|Adverse Event|11|||
143070650|NCT03845296|515803075|FG000|Overall Study|Refusal unrelated to adverse event|0|||
143070651|NCT03845296|515803076|FG001|Overall Study|Refusal unrelated to adverse event|1|||
143070652|NCT03845296|515803075|FG000|Overall Study|Progression/relapse|14|||
143070653|NCT03845296|515803076|FG001|Overall Study|Progression/relapse|18|||
143070654|NCT03845296|515803075|FG000|Overall Study|Death|4|||
143070655|NCT03845296|515803076|FG001|Overall Study|Death|0|||
143070656|NCT03845296|515803075|FG000|Overall Study|Other - not protocol specified|1|||
143070657|NCT03845296|515803076|FG001|Overall Study|Other - not protocol specified|3|||
143070658|NCT06218823|515803079|FG000|Overall Study|Death|3|||
143070659|NCT06218823|515803080|FG001|Overall Study|Death|0|||
143070660|NCT06218823|515803079|FG000|Overall Study|Lost to Follow-up|0|||
143070661|NCT06218823|515803080|FG001|Overall Study|Lost to Follow-up|2|||
143070662|NCT04732221|515803081|FG000|Base Period|Death|2|||
143070663|NCT04732221|515803082|FG001|Base Period|Death|0|||
143070664|NCT04732221|515803083|FG002|Base Period|Death|0|||
143070665|NCT04732221|515803084|FG003|Base Period|Death|0|||
143070666|NCT04732221|515803085|FG004|Base Period|Death|0|||
143070667|NCT04732221|515803086|FG005|Base Period|Death|0|||
143070668|NCT04732221|515803087|FG006|Base Period|Death|0|||
143070669|NCT04732221|515803081|FG000|Base Period|Withdrawal by Subject|0|||
143070670|NCT04732221|515803082|FG001|Base Period|Withdrawal by Subject|1|||
143070671|NCT04732221|515803083|FG002|Base Period|Withdrawal by Subject|1|||
143070672|NCT04732221|515803084|FG003|Base Period|Withdrawal by Subject|0|||
143070673|NCT04732221|515803085|FG004|Base Period|Withdrawal by Subject|0|||
143070674|NCT04732221|515803086|FG005|Base Period|Withdrawal by Subject|0|||
143070675|NCT04732221|515803087|FG006|Base Period|Withdrawal by Subject|0|||
143070676|NCT04732221|515803081|FG000|Extension Period|Adverse Event|0|||
143070677|NCT04732221|515803082|FG001|Extension Period|Adverse Event|0|||
143070678|NCT04732221|515803083|FG002|Extension Period|Adverse Event|0|||
143070679|NCT04732221|515803084|FG003|Extension Period|Adverse Event|0|||
143070680|NCT04732221|515803085|FG004|Extension Period|Adverse Event|0|||
143070681|NCT04732221|515803086|FG005|Extension Period|Adverse Event|1|||
143070682|NCT04732221|515803087|FG006|Extension Period|Adverse Event|0|||
143070683|NCT04732221|515803081|FG000|Extension Period|Death|0|||
143070684|NCT04732221|515803082|FG001|Extension Period|Death|0|||
143070685|NCT04732221|515803083|FG002|Extension Period|Death|0|||
143070686|NCT04732221|515803084|FG003|Extension Period|Death|0|||
143070687|NCT04732221|515803085|FG004|Extension Period|Death|1|||
143070688|NCT04732221|515803086|FG005|Extension Period|Death|0|||
143070689|NCT04732221|515803087|FG006|Extension Period|Death|2|||
143070690|NCT04732221|515803081|FG000|Extension Period|Pregnancy|0|||
143247899|NCT01667419|516460472|FG003|Overall Study|Lost to Follow-up|4|||
143070691|NCT04732221|515803082|FG001|Extension Period|Pregnancy|0|||
143070692|NCT04732221|515803083|FG002|Extension Period|Pregnancy|0|||
143247900|NCT01667419|516460469|FG000|Overall Study|Death|18|||
143070693|NCT04732221|515803084|FG003|Extension Period|Pregnancy|0|||
143070694|NCT04732221|515803085|FG004|Extension Period|Pregnancy|1|||
143247901|NCT01667419|516460470|FG001|Overall Study|Death|33|||
143070695|NCT04732221|515803086|FG005|Extension Period|Pregnancy|0|||
143070696|NCT04732221|515803087|FG006|Extension Period|Pregnancy|0|||
143070697|NCT04732221|515803081|FG000|Extension Period|Sponsors Decision|0|||
143070698|NCT04732221|515803082|FG001|Extension Period|Sponsors Decision|0|||
143070699|NCT04732221|515803083|FG002|Extension Period|Sponsors Decision|0|||
143070700|NCT04732221|515803084|FG003|Extension Period|Sponsors Decision|0|||
143070701|NCT04732221|515803085|FG004|Extension Period|Sponsors Decision|41|||
143365438|NCT00389519|516880787|FG000|Placebo Run-In|Withdrawal by Subject|19|||
143365439|NCT00389519|516880788|FG001|Placebo Run-In|Withdrawal by Subject|0|||
143070702|NCT04732221|515803086|FG005|Extension Period|Sponsors Decision|40|||
143070703|NCT04732221|515803087|FG006|Extension Period|Sponsors Decision|40|||
143070704|NCT04732221|515803081|FG000|Extension Period|Withdrawal by Subject|0|||
143070705|NCT04732221|515803082|FG001|Extension Period|Withdrawal by Subject|0|||
143070706|NCT04732221|515803083|FG002|Extension Period|Withdrawal by Subject|0|||
143070707|NCT04732221|515803084|FG003|Extension Period|Withdrawal by Subject|0|||
143070708|NCT04732221|515803085|FG004|Extension Period|Withdrawal by Subject|1|||
143070709|NCT04732221|515803086|FG005|Extension Period|Withdrawal by Subject|5|||
143070710|NCT04732221|515803087|FG006|Extension Period|Withdrawal by Subject|2|||
143070711|NCT04385277|515803088|FG000|Overall Study|Physician Decision|2|||
143070712|NCT04385277|515803088|FG000|Overall Study|Ineligible|1|||
143070713|NCT04385277|515803088|FG000|Overall Study|Patient/Parent Refusal|2|||
143070714|NCT00461253|515803092|FG000|Overall Study|Death|985|||
143070715|NCT00461253|515803093|FG001|Overall Study|Death|0|||
143070716|NCT00461253|515803092|FG000|Overall Study|Protocol Violation|613|||
143070717|NCT00461253|515803093|FG001|Overall Study|Protocol Violation|236|||
143070718|NCT00461253|515803092|FG000|Overall Study|no response|2609|||
143070719|NCT00461253|515803093|FG001|Overall Study|no response|11789|||
143070720|NCT00461253|515803092|FG000|Overall Study|administrative|773|||
143070721|NCT00461253|515803093|FG001|Overall Study|administrative|7773|||
143070722|NCT02799095|515803094|FG000|Part A|Adverse Event|1|||
143070723|NCT02799095|515803095|FG001|Part A|Adverse Event|0|||
143070724|NCT02799095|515803096|FG002|Part A|Adverse Event|1|||
143070725|NCT02799095|515803097|FG003|Part A|Adverse Event|4|||
143070726|NCT02799095|515803098|FG004|Part A|Adverse Event|1|||
143070727|NCT02799095|515803099|FG005|Part A|Adverse Event|0|||
143070728|NCT02799095|515803100|FG006|Part A|Adverse Event|0|||
143070729|NCT02799095|515803101|FG007|Part A|Adverse Event|0|||
143070730|NCT02799095|515803102|FG008|Part A|Adverse Event|0|||
143070731|NCT02799095|515803103|FG009|Part A|Adverse Event|0|||
143070732|NCT02799095|515803104|FG010|Part A|Adverse Event|0|||
143070733|NCT02799095|515803105|FG011|Part A|Adverse Event|0|||
143070734|NCT02799095|515803106|FG012|Part A|Adverse Event|0|||
143070735|NCT02799095|515803107|FG013|Part A|Adverse Event|0|||
143070736|NCT02799095|515803108|FG014|Part A|Adverse Event|0|||
143070737|NCT02799095|515803109|FG015|Part A|Adverse Event|0|||
143070738|NCT02799095|515803110|FG016|Part A|Adverse Event|0|||
143070739|NCT02799095|515803094|FG000|Part A|Death|0|||
143070740|NCT02799095|515803095|FG001|Part A|Death|0|||
143070741|NCT02799095|515803096|FG002|Part A|Death|0|||
143070742|NCT02799095|515803097|FG003|Part A|Death|0|||
143070743|NCT02799095|515803098|FG004|Part A|Death|0|||
143070744|NCT02799095|515803099|FG005|Part A|Death|0|||
143070745|NCT02799095|515803100|FG006|Part A|Death|3|||
143070746|NCT02799095|515803101|FG007|Part A|Death|0|||
143070747|NCT02799095|515803102|FG008|Part A|Death|0|||
143070748|NCT02799095|515803103|FG009|Part A|Death|0|||
143070749|NCT02799095|515803104|FG010|Part A|Death|0|||
143070750|NCT02799095|515803105|FG011|Part A|Death|0|||
143070751|NCT02799095|515803106|FG012|Part A|Death|0|||
143070752|NCT02799095|515803107|FG013|Part A|Death|0|||
143070753|NCT02799095|515803108|FG014|Part A|Death|0|||
143070754|NCT02799095|515803109|FG015|Part A|Death|0|||
143070755|NCT02799095|515803110|FG016|Part A|Death|0|||
143070756|NCT02799095|515803094|FG000|Part A|Lost to Follow-up|0|||
143070757|NCT02799095|515803095|FG001|Part A|Lost to Follow-up|1|||
143070758|NCT02799095|515803096|FG002|Part A|Lost to Follow-up|0|||
143070759|NCT02799095|515803097|FG003|Part A|Lost to Follow-up|0|||
143070760|NCT02799095|515803098|FG004|Part A|Lost to Follow-up|0|||
143070761|NCT02799095|515803099|FG005|Part A|Lost to Follow-up|0|||
143070762|NCT02799095|515803100|FG006|Part A|Lost to Follow-up|1|||
143070763|NCT02799095|515803101|FG007|Part A|Lost to Follow-up|0|||
143070764|NCT02799095|515803102|FG008|Part A|Lost to Follow-up|0|||
143070765|NCT02799095|515803103|FG009|Part A|Lost to Follow-up|0|||
143365440|NCT00389519|516880789|FG002|Placebo Run-In|Withdrawal by Subject|0|||
143070766|NCT02799095|515803104|FG010|Part A|Lost to Follow-up|0|||
143070767|NCT02799095|515803105|FG011|Part A|Lost to Follow-up|0|||
143070768|NCT02799095|515803106|FG012|Part A|Lost to Follow-up|0|||
143070769|NCT02799095|515803107|FG013|Part A|Lost to Follow-up|0|||
143070770|NCT02799095|515803108|FG014|Part A|Lost to Follow-up|0|||
143070771|NCT02799095|515803109|FG015|Part A|Lost to Follow-up|0|||
143070772|NCT02799095|515803110|FG016|Part A|Lost to Follow-up|0|||
143070773|NCT02799095|515803094|FG000|Part A|Progressive Disease|3|||
143070774|NCT02799095|515803095|FG001|Part A|Progressive Disease|3|||
143070775|NCT02799095|515803096|FG002|Part A|Progressive Disease|3|||
143070776|NCT02799095|515803097|FG003|Part A|Progressive Disease|2|||
143070777|NCT02799095|515803098|FG004|Part A|Progressive Disease|2|||
143070778|NCT02799095|515803099|FG005|Part A|Progressive Disease|0|||
143070779|NCT02799095|515803100|FG006|Part A|Progressive Disease|0|||
143070780|NCT02799095|515803101|FG007|Part A|Progressive Disease|0|||
143070781|NCT02799095|515803102|FG008|Part A|Progressive Disease|0|||
143070782|NCT02799095|515803103|FG009|Part A|Progressive Disease|0|||
143070783|NCT02799095|515803104|FG010|Part A|Progressive Disease|0|||
143070784|NCT02799095|515803105|FG011|Part A|Progressive Disease|0|||
143070785|NCT02799095|515803106|FG012|Part A|Progressive Disease|0|||
143070786|NCT02799095|515803107|FG013|Part A|Progressive Disease|0|||
143070787|NCT02799095|515803108|FG014|Part A|Progressive Disease|0|||
143070788|NCT02799095|515803109|FG015|Part A|Progressive Disease|0|||
143070789|NCT02799095|515803110|FG016|Part A|Progressive Disease|0|||
143070790|NCT02799095|515803094|FG000|Part A|Clinical Progression|1|||
143070791|NCT02799095|515803095|FG001|Part A|Clinical Progression|0|||
143070792|NCT02799095|515803096|FG002|Part A|Clinical Progression|2|||
143070793|NCT02799095|515803097|FG003|Part A|Clinical Progression|1|||
143070794|NCT02799095|515803098|FG004|Part A|Clinical Progression|5|||
143070795|NCT02799095|515803099|FG005|Part A|Clinical Progression|0|||
143070796|NCT02799095|515803100|FG006|Part A|Clinical Progression|0|||
143070797|NCT02799095|515803101|FG007|Part A|Clinical Progression|0|||
143070798|NCT02799095|515803102|FG008|Part A|Clinical Progression|0|||
143070799|NCT02799095|515803103|FG009|Part A|Clinical Progression|0|||
143070800|NCT02799095|515803104|FG010|Part A|Clinical Progression|0|||
143070801|NCT02799095|515803105|FG011|Part A|Clinical Progression|0|||
143070802|NCT02799095|515803106|FG012|Part A|Clinical Progression|0|||
143070803|NCT02799095|515803107|FG013|Part A|Clinical Progression|0|||
143070804|NCT02799095|515803108|FG014|Part A|Clinical Progression|0|||
143070805|NCT02799095|515803109|FG015|Part A|Clinical Progression|0|||
143070806|NCT02799095|515803110|FG016|Part A|Clinical Progression|0|||
143070807|NCT02799095|515803094|FG000|Part A|Protocol Deviation|0|||
143070808|NCT02799095|515803095|FG001|Part A|Protocol Deviation|0|||
143070809|NCT02799095|515803096|FG002|Part A|Protocol Deviation|1|||
143070810|NCT02799095|515803097|FG003|Part A|Protocol Deviation|0|||
143070811|NCT02799095|515803098|FG004|Part A|Protocol Deviation|0|||
143070812|NCT02799095|515803099|FG005|Part A|Protocol Deviation|0|||
143070813|NCT02799095|515803100|FG006|Part A|Protocol Deviation|0|||
143070814|NCT02799095|515803101|FG007|Part A|Protocol Deviation|0|||
143070815|NCT02799095|515803102|FG008|Part A|Protocol Deviation|0|||
143070816|NCT02799095|515803103|FG009|Part A|Protocol Deviation|0|||
143070817|NCT02799095|515803104|FG010|Part A|Protocol Deviation|0|||
143070818|NCT02799095|515803105|FG011|Part A|Protocol Deviation|0|||
143070819|NCT02799095|515803106|FG012|Part A|Protocol Deviation|0|||
143070820|NCT02799095|515803107|FG013|Part A|Protocol Deviation|0|||
143070821|NCT02799095|515803108|FG014|Part A|Protocol Deviation|0|||
143070822|NCT02799095|515803109|FG015|Part A|Protocol Deviation|0|||
143070823|NCT02799095|515803110|FG016|Part A|Protocol Deviation|0|||
143070824|NCT02799095|515803094|FG000|Part A|Withdrawal by Subject|0|||
143070825|NCT02799095|515803095|FG001|Part A|Withdrawal by Subject|0|||
143070826|NCT02799095|515803096|FG002|Part A|Withdrawal by Subject|0|||
143070827|NCT02799095|515803097|FG003|Part A|Withdrawal by Subject|1|||
143070828|NCT02799095|515803098|FG004|Part A|Withdrawal by Subject|3|||
143070829|NCT02799095|515803099|FG005|Part A|Withdrawal by Subject|1|||
143070830|NCT02799095|515803100|FG006|Part A|Withdrawal by Subject|1|||
143070831|NCT02799095|515803101|FG007|Part A|Withdrawal by Subject|0|||
143070832|NCT02799095|515803102|FG008|Part A|Withdrawal by Subject|0|||
143070833|NCT02799095|515803103|FG009|Part A|Withdrawal by Subject|0|||
143070834|NCT02799095|515803104|FG010|Part A|Withdrawal by Subject|0|||
143070835|NCT02799095|515803105|FG011|Part A|Withdrawal by Subject|0|||
143070836|NCT02799095|515803106|FG012|Part A|Withdrawal by Subject|0|||
143070837|NCT02799095|515803107|FG013|Part A|Withdrawal by Subject|0|||
143070838|NCT02799095|515803108|FG014|Part A|Withdrawal by Subject|0|||
143070839|NCT02799095|515803109|FG015|Part A|Withdrawal by Subject|0|||
143070840|NCT02799095|515803110|FG016|Part A|Withdrawal by Subject|0|||
143070841|NCT02799095|515803094|FG000|Part A|Rolled Over to Part C, Cohort 4|0|||
143070842|NCT02799095|515803095|FG001|Part A|Rolled Over to Part C, Cohort 4|0|||
143070843|NCT02799095|515803096|FG002|Part A|Rolled Over to Part C, Cohort 4|0|||
143070844|NCT02799095|515803097|FG003|Part A|Rolled Over to Part C, Cohort 4|0|||
143070845|NCT02799095|515803098|FG004|Part A|Rolled Over to Part C, Cohort 4|1|||
143070846|NCT02799095|515803099|FG005|Part A|Rolled Over to Part C, Cohort 4|2|||
143070847|NCT02799095|515803100|FG006|Part A|Rolled Over to Part C, Cohort 4|2|||
143070848|NCT02799095|515803101|FG007|Part A|Rolled Over to Part C, Cohort 4|0|||
143070849|NCT02799095|515803102|FG008|Part A|Rolled Over to Part C, Cohort 4|0|||
143070850|NCT02799095|515803103|FG009|Part A|Rolled Over to Part C, Cohort 4|0|||
143070851|NCT02799095|515803104|FG010|Part A|Rolled Over to Part C, Cohort 4|0|||
143070852|NCT02799095|515803105|FG011|Part A|Rolled Over to Part C, Cohort 4|0|||
143070853|NCT02799095|515803106|FG012|Part A|Rolled Over to Part C, Cohort 4|0|||
143070854|NCT02799095|515803107|FG013|Part A|Rolled Over to Part C, Cohort 4|0|||
143070855|NCT02799095|515803108|FG014|Part A|Rolled Over to Part C, Cohort 4|0|||
143070856|NCT02799095|515803109|FG015|Part A|Rolled Over to Part C, Cohort 4|0|||
143070857|NCT02799095|515803110|FG016|Part A|Rolled Over to Part C, Cohort 4|0|||
143365441|NCT00389519|516880790|FG003|Placebo Run-In|Withdrawal by Subject|0|||
143070858|NCT02799095|515803094|FG000|Part B|Death|0|||
143070859|NCT02799095|515803095|FG001|Part B|Death|0|||
143070860|NCT02799095|515803096|FG002|Part B|Death|0|||
143070861|NCT02799095|515803097|FG003|Part B|Death|0|||
143070862|NCT02799095|515803098|FG004|Part B|Death|0|||
143070863|NCT02799095|515803099|FG005|Part B|Death|0|||
143070864|NCT02799095|515803100|FG006|Part B|Death|0|||
143070865|NCT02799095|515803101|FG007|Part B|Death|7|||
143070866|NCT02799095|515803102|FG008|Part B|Death|7|||
143070867|NCT02799095|515803103|FG009|Part B|Death|0|||
143070868|NCT02799095|515803104|FG010|Part B|Death|0|||
143070869|NCT02799095|515803105|FG011|Part B|Death|0|||
143070870|NCT02799095|515803106|FG012|Part B|Death|0|||
143070871|NCT02799095|515803107|FG013|Part B|Death|0|||
143070872|NCT02799095|515803108|FG014|Part B|Death|0|||
143070873|NCT02799095|515803109|FG015|Part B|Death|0|||
143070874|NCT02799095|515803110|FG016|Part B|Death|0|||
143070875|NCT02799095|515803094|FG000|Part B|Progressive Disease|0|||
143070876|NCT02799095|515803095|FG001|Part B|Progressive Disease|0|||
143070877|NCT02799095|515803096|FG002|Part B|Progressive Disease|0|||
143070878|NCT02799095|515803097|FG003|Part B|Progressive Disease|0|||
143070879|NCT02799095|515803098|FG004|Part B|Progressive Disease|0|||
143070880|NCT02799095|515803099|FG005|Part B|Progressive Disease|0|||
143070881|NCT02799095|515803100|FG006|Part B|Progressive Disease|0|||
143070882|NCT02799095|515803101|FG007|Part B|Progressive Disease|1|||
143070883|NCT02799095|515803102|FG008|Part B|Progressive Disease|0|||
143070884|NCT02799095|515803103|FG009|Part B|Progressive Disease|0|||
143070885|NCT02799095|515803104|FG010|Part B|Progressive Disease|0|||
143070886|NCT02799095|515803105|FG011|Part B|Progressive Disease|0|||
143070887|NCT02799095|515803106|FG012|Part B|Progressive Disease|0|||
143070888|NCT02799095|515803107|FG013|Part B|Progressive Disease|0|||
143070889|NCT02799095|515803108|FG014|Part B|Progressive Disease|0|||
143070890|NCT02799095|515803109|FG015|Part B|Progressive Disease|0|||
143070891|NCT02799095|515803110|FG016|Part B|Progressive Disease|0|||
143070892|NCT02799095|515803094|FG000|Part B|Withdrawal by Subject|0|||
143070893|NCT02799095|515803095|FG001|Part B|Withdrawal by Subject|0|||
143070894|NCT02799095|515803096|FG002|Part B|Withdrawal by Subject|0|||
143070895|NCT02799095|515803097|FG003|Part B|Withdrawal by Subject|0|||
143070896|NCT02799095|515803098|FG004|Part B|Withdrawal by Subject|0|||
143070897|NCT02799095|515803099|FG005|Part B|Withdrawal by Subject|0|||
143070898|NCT02799095|515803100|FG006|Part B|Withdrawal by Subject|0|||
143070899|NCT02799095|515803101|FG007|Part B|Withdrawal by Subject|10|||
143070900|NCT02799095|515803102|FG008|Part B|Withdrawal by Subject|7|||
143070901|NCT02799095|515803103|FG009|Part B|Withdrawal by Subject|0|||
143070902|NCT02799095|515803104|FG010|Part B|Withdrawal by Subject|0|||
143070903|NCT02799095|515803105|FG011|Part B|Withdrawal by Subject|0|||
143070904|NCT02799095|515803106|FG012|Part B|Withdrawal by Subject|0|||
143070905|NCT02799095|515803107|FG013|Part B|Withdrawal by Subject|0|||
143070906|NCT02799095|515803108|FG014|Part B|Withdrawal by Subject|0|||
143070907|NCT02799095|515803109|FG015|Part B|Withdrawal by Subject|0|||
143070908|NCT02799095|515803110|FG016|Part B|Withdrawal by Subject|0|||
143070909|NCT02799095|515803094|FG000|Part B|Rolled Over to Part C, Cohort 4|0|||
143070910|NCT02799095|515803095|FG001|Part B|Rolled Over to Part C, Cohort 4|0|||
143070911|NCT02799095|515803096|FG002|Part B|Rolled Over to Part C, Cohort 4|0|||
143070912|NCT02799095|515803097|FG003|Part B|Rolled Over to Part C, Cohort 4|0|||
143070913|NCT02799095|515803098|FG004|Part B|Rolled Over to Part C, Cohort 4|0|||
143070914|NCT02799095|515803099|FG005|Part B|Rolled Over to Part C, Cohort 4|0|||
143070915|NCT02799095|515803100|FG006|Part B|Rolled Over to Part C, Cohort 4|0|||
143070916|NCT02799095|515803101|FG007|Part B|Rolled Over to Part C, Cohort 4|26|||
143070917|NCT02799095|515803102|FG008|Part B|Rolled Over to Part C, Cohort 4|12|||
143070918|NCT02799095|515803103|FG009|Part B|Rolled Over to Part C, Cohort 4|0|||
143070919|NCT02799095|515803104|FG010|Part B|Rolled Over to Part C, Cohort 4|0|||
143070920|NCT02799095|515803105|FG011|Part B|Rolled Over to Part C, Cohort 4|0|||
143070921|NCT02799095|515803106|FG012|Part B|Rolled Over to Part C, Cohort 4|0|||
143070922|NCT02799095|515803107|FG013|Part B|Rolled Over to Part C, Cohort 4|0|||
143070923|NCT02799095|515803108|FG014|Part B|Rolled Over to Part C, Cohort 4|0|||
143070924|NCT02799095|515803109|FG015|Part B|Rolled Over to Part C, Cohort 4|0|||
143070925|NCT02799095|515803110|FG016|Part B|Rolled Over to Part C, Cohort 4|0|||
143070926|NCT02799095|515803094|FG000|Part C|Adverse Event|0|||
143070927|NCT02799095|515803095|FG001|Part C|Adverse Event|0|||
143070928|NCT02799095|515803096|FG002|Part C|Adverse Event|0|||
143070929|NCT02799095|515803097|FG003|Part C|Adverse Event|0|||
143070930|NCT02799095|515803098|FG004|Part C|Adverse Event|0|||
143070931|NCT02799095|515803099|FG005|Part C|Adverse Event|0|||
143070932|NCT02799095|515803100|FG006|Part C|Adverse Event|0|||
143070933|NCT02799095|515803101|FG007|Part C|Adverse Event|0|||
143070934|NCT02799095|515803102|FG008|Part C|Adverse Event|0|||
143070935|NCT02799095|515803103|FG009|Part C|Adverse Event|0|||
143070936|NCT02799095|515803104|FG010|Part C|Adverse Event|3|||
143070937|NCT02799095|515803105|FG011|Part C|Adverse Event|1|||
143070938|NCT02799095|515803106|FG012|Part C|Adverse Event|0|||
143070939|NCT02799095|515803107|FG013|Part C|Adverse Event|1|||
143070940|NCT02799095|515803108|FG014|Part C|Adverse Event|0|||
143070941|NCT02799095|515803109|FG015|Part C|Adverse Event|0|||
143070942|NCT02799095|515803110|FG016|Part C|Adverse Event|0|||
143070943|NCT02799095|515803094|FG000|Part C|Death|0|||
143070944|NCT02799095|515803095|FG001|Part C|Death|0|||
143070945|NCT02799095|515803096|FG002|Part C|Death|0|||
143070946|NCT02799095|515803097|FG003|Part C|Death|0|||
143070947|NCT02799095|515803098|FG004|Part C|Death|0|||
143070948|NCT02799095|515803099|FG005|Part C|Death|0|||
143070949|NCT02799095|515803100|FG006|Part C|Death|0|||
143070950|NCT02799095|515803101|FG007|Part C|Death|0|||
143070951|NCT02799095|515803102|FG008|Part C|Death|0|||
143070952|NCT02799095|515803103|FG009|Part C|Death|0|||
143070953|NCT02799095|515803104|FG010|Part C|Death|7|||
143070954|NCT02799095|515803105|FG011|Part C|Death|5|||
143070955|NCT02799095|515803106|FG012|Part C|Death|6|||
143070956|NCT02799095|515803107|FG013|Part C|Death|8|||
143070957|NCT02799095|515803108|FG014|Part C|Death|1|||
143070958|NCT02799095|515803109|FG015|Part C|Death|8|||
143070959|NCT02799095|515803110|FG016|Part C|Death|1|||
143070960|NCT02799095|515803094|FG000|Part C|Lost to Follow-up|0|||
143070961|NCT02799095|515803095|FG001|Part C|Lost to Follow-up|0|||
143070962|NCT02799095|515803096|FG002|Part C|Lost to Follow-up|0|||
143070963|NCT02799095|515803097|FG003|Part C|Lost to Follow-up|0|||
143070964|NCT02799095|515803098|FG004|Part C|Lost to Follow-up|0|||
143070965|NCT02799095|515803099|FG005|Part C|Lost to Follow-up|0|||
143070966|NCT02799095|515803100|FG006|Part C|Lost to Follow-up|0|||
143070967|NCT02799095|515803101|FG007|Part C|Lost to Follow-up|0|||
143070968|NCT02799095|515803102|FG008|Part C|Lost to Follow-up|0|||
143070969|NCT02799095|515803103|FG009|Part C|Lost to Follow-up|0|||
143070970|NCT02799095|515803104|FG010|Part C|Lost to Follow-up|1|||
143070971|NCT02799095|515803105|FG011|Part C|Lost to Follow-up|1|||
143070972|NCT02799095|515803106|FG012|Part C|Lost to Follow-up|1|||
143070973|NCT02799095|515803107|FG013|Part C|Lost to Follow-up|3|||
143171368|NCT00673920|516176075|FG001|Baseline up to Week 48|Protocol Violation|0|||
143171369|NCT00673920|516176076|FG002|Baseline up to Week 48|Protocol Violation|1|||
143070974|NCT02799095|515803108|FG014|Part C|Lost to Follow-up|0|||
143070975|NCT02799095|515803109|FG015|Part C|Lost to Follow-up|0|||
143171370|NCT00673920|516176077|FG003|Baseline up to Week 48|Protocol Violation|0|||
143070976|NCT02799095|515803110|FG016|Part C|Lost to Follow-up|0|||
143070977|NCT02799095|515803094|FG000|Part C|Progressive Disease|0|||
143070978|NCT02799095|515803095|FG001|Part C|Progressive Disease|0|||
143070979|NCT02799095|515803096|FG002|Part C|Progressive Disease|0|||
143070980|NCT02799095|515803097|FG003|Part C|Progressive Disease|0|||
143070981|NCT02799095|515803098|FG004|Part C|Progressive Disease|0|||
143070982|NCT02799095|515803099|FG005|Part C|Progressive Disease|0|||
143070983|NCT02799095|515803100|FG006|Part C|Progressive Disease|0|||
143070984|NCT02799095|515803101|FG007|Part C|Progressive Disease|0|||
143070985|NCT02799095|515803102|FG008|Part C|Progressive Disease|0|||
143070986|NCT02799095|515803103|FG009|Part C|Progressive Disease|2|||
143070987|NCT02799095|515803104|FG010|Part C|Progressive Disease|13|||
143070988|NCT02799095|515803105|FG011|Part C|Progressive Disease|2|||
143070989|NCT02799095|515803106|FG012|Part C|Progressive Disease|0|||
143070990|NCT02799095|515803107|FG013|Part C|Progressive Disease|1|||
143070991|NCT02799095|515803108|FG014|Part C|Progressive Disease|0|||
143070992|NCT02799095|515803109|FG015|Part C|Progressive Disease|0|||
143070993|NCT02799095|515803110|FG016|Part C|Progressive Disease|0|||
143070994|NCT02799095|515803094|FG000|Part C|Clinical Progression|0|||
143070995|NCT02799095|515803095|FG001|Part C|Clinical Progression|0|||
143070996|NCT02799095|515803096|FG002|Part C|Clinical Progression|0|||
143070997|NCT02799095|515803097|FG003|Part C|Clinical Progression|0|||
143070998|NCT02799095|515803098|FG004|Part C|Clinical Progression|0|||
143070999|NCT02799095|515803099|FG005|Part C|Clinical Progression|0|||
143071000|NCT02799095|515803100|FG006|Part C|Clinical Progression|0|||
143071001|NCT02799095|515803101|FG007|Part C|Clinical Progression|0|||
143071002|NCT02799095|515803102|FG008|Part C|Clinical Progression|0|||
143071003|NCT02799095|515803103|FG009|Part C|Clinical Progression|1|||
143071004|NCT02799095|515803104|FG010|Part C|Clinical Progression|3|||
143071005|NCT02799095|515803105|FG011|Part C|Clinical Progression|0|||
143071006|NCT02799095|515803106|FG012|Part C|Clinical Progression|0|||
143071007|NCT02799095|515803107|FG013|Part C|Clinical Progression|1|||
143071008|NCT02799095|515803108|FG014|Part C|Clinical Progression|0|||
143071009|NCT02799095|515803109|FG015|Part C|Clinical Progression|0|||
143071010|NCT02799095|515803110|FG016|Part C|Clinical Progression|0|||
143071011|NCT02799095|515803094|FG000|Part C|Withdrawal by Subject|0|||
143071012|NCT02799095|515803095|FG001|Part C|Withdrawal by Subject|0|||
143071013|NCT02799095|515803096|FG002|Part C|Withdrawal by Subject|0|||
143071014|NCT02799095|515803097|FG003|Part C|Withdrawal by Subject|0|||
143071015|NCT02799095|515803098|FG004|Part C|Withdrawal by Subject|0|||
143071016|NCT02799095|515803099|FG005|Part C|Withdrawal by Subject|0|||
143071017|NCT02799095|515803100|FG006|Part C|Withdrawal by Subject|0|||
143071018|NCT02799095|515803101|FG007|Part C|Withdrawal by Subject|0|||
143071019|NCT02799095|515803102|FG008|Part C|Withdrawal by Subject|0|||
143071020|NCT02799095|515803103|FG009|Part C|Withdrawal by Subject|0|||
143071021|NCT02799095|515803104|FG010|Part C|Withdrawal by Subject|13|||
143071022|NCT02799095|515803105|FG011|Part C|Withdrawal by Subject|15|||
143071023|NCT02799095|515803106|FG012|Part C|Withdrawal by Subject|13|||
143071024|NCT02799095|515803107|FG013|Part C|Withdrawal by Subject|21|||
143071025|NCT02799095|515803108|FG014|Part C|Withdrawal by Subject|0|||
143071026|NCT02799095|515803109|FG015|Part C|Withdrawal by Subject|12|||
143071027|NCT02799095|515803110|FG016|Part C|Withdrawal by Subject|1|||
143071028|NCT02799095|515803094|FG000|Part C|Physician Decision|0|||
143071029|NCT02799095|515803095|FG001|Part C|Physician Decision|0|||
143071030|NCT02799095|515803096|FG002|Part C|Physician Decision|0|||
143071031|NCT02799095|515803097|FG003|Part C|Physician Decision|0|||
143071032|NCT02799095|515803098|FG004|Part C|Physician Decision|0|||
143071033|NCT02799095|515803099|FG005|Part C|Physician Decision|0|||
143071034|NCT02799095|515803100|FG006|Part C|Physician Decision|0|||
143071035|NCT02799095|515803101|FG007|Part C|Physician Decision|0|||
143071036|NCT02799095|515803102|FG008|Part C|Physician Decision|0|||
143071037|NCT02799095|515803103|FG009|Part C|Physician Decision|0|||
143071038|NCT02799095|515803104|FG010|Part C|Physician Decision|1|||
143071039|NCT02799095|515803105|FG011|Part C|Physician Decision|0|||
143071040|NCT02799095|515803106|FG012|Part C|Physician Decision|0|||
143071041|NCT02799095|515803107|FG013|Part C|Physician Decision|0|||
143071042|NCT02799095|515803108|FG014|Part C|Physician Decision|0|||
143071043|NCT02799095|515803109|FG015|Part C|Physician Decision|0|||
143071044|NCT02799095|515803110|FG016|Part C|Physician Decision|0|||
143071045|NCT02799095|515803094|FG000|Part C|Other|0|||
143071046|NCT02799095|515803095|FG001|Part C|Other|0|||
143071047|NCT02799095|515803096|FG002|Part C|Other|0|||
143071048|NCT02799095|515803097|FG003|Part C|Other|0|||
143071049|NCT02799095|515803098|FG004|Part C|Other|0|||
143071050|NCT02799095|515803099|FG005|Part C|Other|0|||
143071051|NCT02799095|515803100|FG006|Part C|Other|0|||
143071052|NCT02799095|515803101|FG007|Part C|Other|0|||
143071053|NCT02799095|515803102|FG008|Part C|Other|0|||
143071054|NCT02799095|515803103|FG009|Part C|Other|0|||
143071055|NCT02799095|515803104|FG010|Part C|Other|0|||
143071056|NCT02799095|515803105|FG011|Part C|Other|2|||
143071057|NCT02799095|515803106|FG012|Part C|Other|2|||
143071058|NCT02799095|515803107|FG013|Part C|Other|0|||
143071059|NCT02799095|515803108|FG014|Part C|Other|0|||
143071060|NCT02799095|515803109|FG015|Part C|Other|0|||
143071061|NCT02799095|515803110|FG016|Part C|Other|0|||
143071062|NCT01933113|515803111|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
143071063|NCT02297438|515803112|FG000|Overall Study|Death|79|||
143071064|NCT02297438|515803113|FG001|Overall Study|Death|86|||
143071065|NCT02297438|515803112|FG000|Overall Study|Lost to Follow-up|9|||
143071066|NCT02297438|515803113|FG001|Overall Study|Lost to Follow-up|7|||
143071067|NCT02297438|515803112|FG000|Overall Study|Withdrawal by Subject|7|||
143071068|NCT02297438|515803113|FG001|Overall Study|Withdrawal by Subject|0|||
143071069|NCT02297438|515803112|FG000|Overall Study|Other|9|||
143071070|NCT02297438|515803113|FG001|Overall Study|Other|5|||
143071071|NCT02297438|515803112|FG000|Overall Study|Ongoing|65|||
143071072|NCT02297438|515803113|FG001|Overall Study|Ongoing|73|||
143071073|NCT04092894|515803118|FG000|Overall Study|Withdrawal by Subject|2|||
143071074|NCT04092894|515803119|FG001|Overall Study|Withdrawal by Subject|4|||
143071075|NCT04092894|515803118|FG000|Overall Study|Discontinued EEG after randomization|10|||
143071076|NCT04092894|515803119|FG001|Overall Study|Discontinued EEG after randomization|6|||
143071077|NCT01523457|515803120|FG000|Overall Study|Withdrawal by Subject|7|||
143071078|NCT01523457|515803121|FG001|Overall Study|Withdrawal by Subject|2|||
143071079|NCT01367665|515803122|FG000|Overall Study|Death|102|||
143071080|NCT01367665|515803123|FG001|Overall Study|Death|19|||
143071081|NCT01367665|515803122|FG000|Overall Study|Lost to Follow-up|222|||
143071082|NCT01367665|515803123|FG001|Overall Study|Lost to Follow-up|22|||
143071083|NCT01367665|515803122|FG000|Overall Study|Not Done|118|||
143071084|NCT01367665|515803123|FG001|Overall Study|Not Done|14|||
143071085|NCT03182244|515803124|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
143071086|NCT03182244|515803125|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
143071087|NCT03182244|515803124|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
143071088|NCT03182244|515803125|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
143071089|NCT03182244|515803124|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
143071090|NCT03182244|515803125|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
143071091|NCT03182244|515803124|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
143071092|NCT03182244|515803125|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
143071093|NCT03182244|515803124|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
143071094|NCT03182244|515803125|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
143071095|NCT03182244|515803124|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
143071096|NCT03182244|515803125|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
143071097|NCT03182244|515803124|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
143071098|NCT03182244|515803125|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
143071099|NCT03182244|515803124|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
143071100|NCT03182244|515803125|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
143071101|NCT03182244|515803124|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
143071102|NCT03182244|515803125|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
143071103|NCT03182244|515803124|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
143071104|NCT03182244|515803125|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
143071105|NCT03182244|515803124|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
143071106|NCT03182244|515803125|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
143071107|NCT03182244|515803124|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
143071108|NCT03182244|515803125|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
143071109|NCT03182244|515803124|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
143071110|NCT03182244|515803125|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
143365442|NCT00389519|516880787|FG000|Placebo Run-In|Reason not specified|40|||
143071111|NCT01345175|515803127|FG000|Overall Study|Physician Decision|0|||
143071112|NCT01345175|515803128|FG001|Overall Study|Physician Decision|1|||
143071113|NCT01345175|515803127|FG000|Overall Study|Withdrawal by Subject|1|||
143071114|NCT01345175|515803128|FG001|Overall Study|Withdrawal by Subject|1|||
143071115|NCT01345175|515803127|FG000|Overall Study|Failed to complete BFI|3|||
143071116|NCT01345175|515803128|FG001|Overall Study|Failed to complete BFI|2|||
143071117|NCT01345175|515803127|FG000|Overall Study|Stopped taking medication|2|||
143071118|NCT01345175|515803128|FG001|Overall Study|Stopped taking medication|2|||
143171371|NCT00673920|516176078|FG004|Baseline up to Week 48|Protocol Violation|0|||
143171372|NCT00673920|516176079|FG005|Baseline up to Week 48|Protocol Violation|0|||
143171373|NCT00673920|516176080|FG006|Baseline up to Week 48|Protocol Violation|0|||
143171374|NCT00673920|516176081|FG007|Baseline up to Week 48|Protocol Violation|0|||
143171375|NCT00673920|516176074|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
143171376|NCT00673920|516176075|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
143171377|NCT00673920|516176076|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
143171378|NCT00673920|516176077|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
143171379|NCT00673920|516176078|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
143171380|NCT00673920|516176079|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
143171381|NCT00673920|516176080|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
143171382|NCT00673920|516176081|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
143365443|NCT00389519|516880788|FG001|Placebo Run-In|Reason not specified|0|||
143365444|NCT00389519|516880789|FG002|Placebo Run-In|Reason not specified|0|||
143071119|NCT04585789|515803129|FG000|FU Phase: Week 48 to Week 96|Lost to Follow-up|1|||
143071120|NCT04585789|515803130|FG001|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
143365445|NCT00389519|516880790|FG003|Placebo Run-In|Reason not specified|0|||
143071121|NCT04585789|515803131|FG002|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
143071122|NCT04585789|515803129|FG000|FU Phase: Week 48 to Week 96|Withdrawal by Subject|1|||
143071123|NCT04585789|515803130|FG001|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
143071124|NCT04585789|515803131|FG002|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
143071125|NCT02628743|515803133|FG000|Overall Study|Other|3|||
143071126|NCT02628743|515803133|FG000|Overall Study|Withdrawal by Subject|50|||
143071127|NCT02628743|515803133|FG000|Overall Study|Study Terminated by Sponsor|76|||
143071128|NCT02628743|515803133|FG000|Overall Study|Physician Decision|2|||
143071129|NCT02534844|515803134|FG000|Part B|Withdrawal by Subject|0|||
143071130|NCT02534844|515803135|FG001|Part B|Withdrawal by Subject|0|||
143071131|NCT02534844|515803136|FG002|Part B|Withdrawal by Subject|0|||
143071132|NCT02534844|515803137|FG003|Part B|Withdrawal by Subject|0|||
143071133|NCT02534844|515803138|FG004|Part B|Withdrawal by Subject|2|||
143071134|NCT02534844|515803139|FG005|Part B|Withdrawal by Subject|1|||
143071135|NCT00655876|515803140|FG000|Overall Study|Protocol Violation|9|||
143071136|NCT00655876|515803141|FG001|Overall Study|Protocol Violation|7|||
143071137|NCT00326963|515803142|FG000|Overall Study|Adverse Event|2|||
143071138|NCT00326963|515803142|FG000|Overall Study|Injection site reaction|1|||
143071139|NCT00326963|515803142|FG000|Overall Study|Death|1|||
143071140|NCT00326963|515803142|FG000|Overall Study|Failure to return|10|||
143071141|NCT00326963|515803142|FG000|Overall Study|Withdrawal by Subject|10|||
143071142|NCT00326963|515803142|FG000|Overall Study|Refused treatment / did not cooperate|5|||
143071143|NCT00326963|515803142|FG000|Overall Study|Violation of selection criteria at entry|2|||
143071144|NCT00326963|515803142|FG000|Overall Study|Other protocol violation|1|||
143071145|NCT00326963|515803142|FG000|Overall Study|Administrative / other|1|||
143071146|NCT01783548|515803143|FG000|Overall Study|Adverse Event|8|||
143071147|NCT01783548|515803144|FG001|Overall Study|Adverse Event|4|||
143071148|NCT01783548|515803143|FG000|Overall Study|Withdrawal by Subject|11|||
143071149|NCT01783548|515803144|FG001|Overall Study|Withdrawal by Subject|8|||
143071150|NCT01783548|515803143|FG000|Overall Study|Non-compliance|4|||
143071151|NCT01783548|515803144|FG001|Overall Study|Non-compliance|0|||
143071152|NCT01783548|515803143|FG000|Overall Study|Protocol Violation|2|||
143071153|NCT01783548|515803144|FG001|Overall Study|Protocol Violation|2|||
143071154|NCT01783548|515803143|FG000|Overall Study|Lost to Follow-up|8|||
143171383|NCT00673920|516176074|FG000|Baseline up to Week 48|Administrative/Other|0|||
143171384|NCT00673920|516176075|FG001|Baseline up to Week 48|Administrative/Other|1|||
143171385|NCT00673920|516176076|FG002|Baseline up to Week 48|Administrative/Other|2|||
143171386|NCT00673920|516176077|FG003|Baseline up to Week 48|Administrative/Other|0|||
143171387|NCT00673920|516176078|FG004|Baseline up to Week 48|Administrative/Other|0|||
143171388|NCT00673920|516176079|FG005|Baseline up to Week 48|Administrative/Other|0|||
143171389|NCT00673920|516176080|FG006|Baseline up to Week 48|Administrative/Other|0|||
143171390|NCT00673920|516176081|FG007|Baseline up to Week 48|Administrative/Other|0|||
143171391|NCT00673920|516176074|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
143071155|NCT01783548|515803144|FG001|Overall Study|Lost to Follow-up|3|||
143071156|NCT01783548|515803143|FG000|Overall Study|Lack of Efficacy|1|||
143071157|NCT01783548|515803144|FG001|Overall Study|Lack of Efficacy|1|||
143071158|NCT02643355|515803149|FG000|Overall Study|Withdrawal by Subject|1|||
143071159|NCT02643355|515803150|FG001|Overall Study|Withdrawal by Subject|3|||
143071160|NCT02643355|515803149|FG000|Overall Study|Protocol Violation|0|||
143071161|NCT02643355|515803150|FG001|Overall Study|Protocol Violation|2|||
143171392|NCT00673920|516176075|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
143171393|NCT00673920|516176076|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
143171394|NCT00673920|516176077|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
143171395|NCT00673920|516176078|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
143171396|NCT00673920|516176079|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
143071162|NCT05788289|515803153|FG000|Overall Study|Death|3|||
143071163|NCT02387983|515803154|FG000|Overall Study|Adverse Event|4|||
143071164|NCT02387983|515803154|FG000|Overall Study|Protocol Violation|1|||
143071165|NCT02387983|515803154|FG000|Overall Study|Withdrawal by Subject|2|||
143071166|NCT06187909|515803157|FG000|Overall Study|Withdrawal by Subject|2|||
143071167|NCT06187909|515803158|FG001|Overall Study|Withdrawal by Subject|2|||
143071168|NCT00085423|515803160|FG000|Overall Study|Withdrawal by Subject|1|||
143071169|NCT00085423|515803160|FG000|Overall Study|screen failure|1|||
143071170|NCT04740814|515803161|FG000|Overall Study|Adverse Event|3|||
143071171|NCT04740814|515803161|FG000|Overall Study|Protocol Violation|2|||
143071172|NCT04740814|515803161|FG000|Overall Study|Lost to Follow-up|2|||
143071173|NCT04740814|515803161|FG000|Overall Study|Withdrawal by Subject|3|||
143071174|NCT02500641|515803164|FG000|Overall Study|Adverse Event|0|||
143071175|NCT02500641|515803165|FG001|Overall Study|Adverse Event|2|||
143071176|NCT02500641|515803164|FG000|Overall Study|Withdrawal by Subject|4|||
143071177|NCT02500641|515803165|FG001|Overall Study|Withdrawal by Subject|5|||
143071178|NCT02500641|515803164|FG000|Overall Study|Unable to follow study procedures|3|||
143071179|NCT02500641|515803165|FG001|Overall Study|Unable to follow study procedures|2|||
143071180|NCT02500641|515803164|FG000|Overall Study|Protocol Violation|1|||
143071181|NCT02500641|515803165|FG001|Overall Study|Protocol Violation|2|||
143071182|NCT02500641|515803164|FG000|Overall Study|Lost to Follow-up|1|||
143071183|NCT02500641|515803165|FG001|Overall Study|Lost to Follow-up|0|||
143071184|NCT02500641|515803164|FG000|Overall Study|Sponsor decision|1|||
143071185|NCT02500641|515803165|FG001|Overall Study|Sponsor decision|0|||
143071186|NCT02500641|515803164|FG000|Overall Study|Non compliance to study drug|0|||
143071187|NCT02500641|515803165|FG001|Overall Study|Non compliance to study drug|1|||
143071188|NCT00536263|515803171|FG000|Overall Study|Adverse Event|5|||
143071189|NCT00536263|515803172|FG001|Overall Study|Adverse Event|5|||
143071190|NCT00536263|515803173|FG002|Overall Study|Adverse Event|7|||
143071191|NCT00536263|515803171|FG000|Overall Study|Lost to Follow-up|3|||
143071192|NCT00536263|515803172|FG001|Overall Study|Lost to Follow-up|4|||
143071193|NCT00536263|515803173|FG002|Overall Study|Lost to Follow-up|4|||
143071194|NCT00536263|515803171|FG000|Overall Study|Subject withdrew - not treatment related|2|||
143071195|NCT00536263|515803172|FG001|Overall Study|Subject withdrew - not treatment related|0|||
143071196|NCT00536263|515803173|FG002|Overall Study|Subject withdrew - not treatment related|5|||
143071197|NCT00536263|515803171|FG000|Overall Study|Subject withdrew - treatment related|0|||
143071198|NCT00536263|515803172|FG001|Overall Study|Subject withdrew - treatment related|3|||
143071199|NCT00536263|515803173|FG002|Overall Study|Subject withdrew - treatment related|2|||
143071200|NCT00536263|515803171|FG000|Overall Study|Noncompliance with protocol|0|||
143071201|NCT00536263|515803172|FG001|Overall Study|Noncompliance with protocol|0|||
143071202|NCT00536263|515803173|FG002|Overall Study|Noncompliance with protocol|1|||
143071203|NCT00536263|515803171|FG000|Overall Study|Did not meet protocol eligibility|1|||
143071204|NCT00536263|515803172|FG001|Overall Study|Did not meet protocol eligibility|2|||
143071205|NCT00536263|515803173|FG002|Overall Study|Did not meet protocol eligibility|2|||
143071206|NCT00826449|515803174|FG000|Overall Study|Disease Progression|4|||
143071207|NCT00826449|515803174|FG000|Overall Study|Withdrawal by Subject|1|||
143071208|NCT02994940|515803175|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
143071209|NCT02994940|515803176|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
143071210|NCT02994940|515803175|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
143071211|NCT02994940|515803176|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
143071212|NCT02994940|515803175|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
143071213|NCT02994940|515803176|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
143071214|NCT02331368|515803177|FG000|Overall Study|Withdrawal by Subject|3|||
143071215|NCT01763684|515803178|FG000|Overall Study|Study terminated early due to low enrollment|126|||
143071216|NCT01763684|515803179|FG001|Overall Study|Study terminated early due to low enrollment|127|||
143071217|NCT01763684|515803178|FG000|Overall Study|Study surgery not performed|7|||
143071218|NCT01763684|515803179|FG001|Overall Study|Study surgery not performed|6|||
143071219|NCT02987959|515803180|FG000|Overall Study|Grantor stopped supply of drugs|6|||
143071220|NCT02302859|515803181|FG000|Overall Study|Lost Phone|1|||
143071221|NCT02302859|515803182|FG001|Overall Study|Lost Phone|1|||
143071222|NCT02302859|515803181|FG000|Overall Study|Withdrawal by Subject|0|||
143071223|NCT02302859|515803182|FG001|Overall Study|Withdrawal by Subject|1|||
143071224|NCT00643565|515803185|FG000|Overall Study|Death|12|||
143071225|NCT00643565|515803186|FG001|Overall Study|Death|11|||
143071226|NCT00643565|515803185|FG000|Overall Study|Withdrawal by Subject|4|||
143071227|NCT00643565|515803186|FG001|Overall Study|Withdrawal by Subject|1|||
143071228|NCT00643565|515803185|FG000|Overall Study|Lost to Follow-up|0|||
143071229|NCT00643565|515803186|FG001|Overall Study|Lost to Follow-up|6|||
143071230|NCT00643565|515803185|FG000|Overall Study|Other|7|||
143071231|NCT00643565|515803186|FG001|Overall Study|Other|8|||
143071232|NCT00643565|515803185|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
143071233|NCT00643565|515803186|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
143071234|NCT00643565|515803185|FG000|Overall Study|Recurrence of Disease|2|||
143071235|NCT00643565|515803186|FG001|Overall Study|Recurrence of Disease|1|||
143071236|NCT00643565|515803185|FG000|Overall Study|Progression of Disease|18|||
143071237|NCT00643565|515803186|FG001|Overall Study|Progression of Disease|14|||
143071238|NCT00643565|515803185|FG000|Overall Study|Protocol Violation|3|||
143071239|NCT00643565|515803186|FG001|Overall Study|Protocol Violation|0|||
143071240|NCT00643565|515803185|FG000|Overall Study|Did Not Cooperate|0|||
143071241|NCT00643565|515803186|FG001|Overall Study|Did Not Cooperate|1|||
143071242|NCT00643565|515803185|FG000|Overall Study|Administrative|22|||
143071243|NCT00643565|515803186|FG001|Overall Study|Administrative|16|||
143071244|NCT00643565|515803185|FG000|Overall Study|Adverse Event|5|||
143071245|NCT00643565|515803186|FG001|Overall Study|Adverse Event|8|||
143071246|NCT02283983|515803189|FG000|Overall Study|Inclusion criteria not met|0|||
143071247|NCT02283983|515803190|FG001|Overall Study|Inclusion criteria not met|1|||
143071248|NCT02283983|515803189|FG000|Overall Study|Withdrawal by Subject|4|||
143071249|NCT02283983|515803190|FG001|Overall Study|Withdrawal by Subject|2|||
143071250|NCT02283983|515803189|FG000|Overall Study|Protocol Violation|0|||
143071251|NCT02283983|515803190|FG001|Overall Study|Protocol Violation|4|||
143071252|NCT02283983|515803189|FG000|Overall Study|Physician Decision|2|||
143071253|NCT02283983|515803190|FG001|Overall Study|Physician Decision|4|||
143071254|NCT02283983|515803189|FG000|Overall Study|Death|1|||
143071255|NCT02283983|515803190|FG001|Overall Study|Death|0|||
143071256|NCT02283983|515803189|FG000|Overall Study|Adverse Event|1|||
143071257|NCT02283983|515803190|FG001|Overall Study|Adverse Event|0|||
143071258|NCT02283983|515803189|FG000|Overall Study|Lost to Follow-up|9|||
143071259|NCT02283983|515803190|FG001|Overall Study|Lost to Follow-up|8|||
143071260|NCT02283983|515803189|FG000|Overall Study|Relapse|1|||
143071261|NCT02283983|515803190|FG001|Overall Study|Relapse|0|||
143071262|NCT04305496|515803191|FG000|Global Cohort|Withdrawal by Subject|13|||
143071263|NCT04305496|515803192|FG001|Global Cohort|Withdrawal by Subject|6|||
143071264|NCT04305496|515803191|FG000|Global Cohort|Physician Decision|1|||
143071265|NCT04305496|515803192|FG001|Global Cohort|Physician Decision|1|||
143071266|NCT04305496|515803191|FG000|Global Cohort|Subjective disease progression|16|||
143071267|NCT04305496|515803192|FG001|Global Cohort|Subjective disease progression|17|||
143071268|NCT04305496|515803191|FG000|Global Cohort|Condition under investigation worsened|209|||
143071269|NCT04305496|515803192|FG001|Global Cohort|Condition under investigation worsened|273|||
143071270|NCT04305496|515803191|FG000|Global Cohort|Protocol Violation|2|||
143071271|NCT04305496|515803192|FG001|Global Cohort|Protocol Violation|0|||
143071272|NCT04305496|515803191|FG000|Global Cohort|Adverse Event|44|||
143071273|NCT04305496|515803192|FG001|Global Cohort|Adverse Event|6|||
143071274|NCT04305496|515803191|FG000|Global Cohort|Death|3|||
143071275|NCT04305496|515803192|FG001|Global Cohort|Death|2|||
143071276|NCT04305496|515803191|FG000|Global Cohort|Any reason not specifically recorded|4|||
143071277|NCT04305496|515803192|FG001|Global Cohort|Any reason not specifically recorded|5|||
143071278|NCT04305496|515803191|FG000|China Cohort|Any reason not specifically recorded|1|||
143071279|NCT04305496|515803192|FG001|China Cohort|Any reason not specifically recorded|1|||
143071280|NCT04305496|515803191|FG000|China Cohort|Adverse Event|8|||
143071281|NCT04305496|515803192|FG001|China Cohort|Adverse Event|2|||
143071282|NCT04305496|515803191|FG000|China Cohort|Condition under investigation worsened|40|||
143071283|NCT04305496|515803192|FG001|China Cohort|Condition under investigation worsened|47|||
143071284|NCT04305496|515803191|FG000|China Cohort|Subjective disease progression|2|||
143071285|NCT04305496|515803192|FG001|China Cohort|Subjective disease progression|2|||
143071286|NCT04305496|515803191|FG000|China Cohort|Withdrawal by Subject|2|||
143071287|NCT04305496|515803192|FG001|China Cohort|Withdrawal by Subject|1|||
143071288|NCT00681590|515803193|FG000|Overall Study|Withdrawal by Subject|2|||
143071289|NCT00681590|515803194|FG001|Overall Study|Withdrawal by Subject|12|||
143071290|NCT00975286|515803200|FG000|Overall Study|Adverse Event|9|||
143071291|NCT00975286|515803201|FG001|Overall Study|Adverse Event|19|||
143071292|NCT00975286|515803200|FG000|Overall Study|Protocol Violation|1|||
143071293|NCT00975286|515803201|FG001|Overall Study|Protocol Violation|2|||
143071294|NCT00975286|515803200|FG000|Overall Study|Withdrawal by Subject|0|||
143071295|NCT00975286|515803201|FG001|Overall Study|Withdrawal by Subject|2|||
143071296|NCT00975286|515803200|FG000|Overall Study|Familial and Personal Reasons|2|||
143171397|NCT00673920|516176080|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
143071297|NCT00975286|515803201|FG001|Overall Study|Familial and Personal Reasons|2|||
143071298|NCT00975286|515803200|FG000|Overall Study|Poor Compliance to Protocol|0|||
143071299|NCT00975286|515803201|FG001|Overall Study|Poor Compliance to Protocol|2|||
143071300|NCT00975286|515803200|FG000|Overall Study|Sponsor Decision|0|||
143071301|NCT00975286|515803201|FG001|Overall Study|Sponsor Decision|2|||
143071302|NCT02357342|515803202|FG000|First 6 Months|Death|2|||
143071303|NCT02357342|515803203|FG001|First 6 Months|Death|0|||
143071304|NCT01674647|515803204|FG000|Treatment Period|Death|4|||
143071305|NCT01674647|515803205|FG001|Treatment Period|Death|1|||
143071306|NCT01674647|515803204|FG000|Treatment Period|Efficacy outcome reached|0|||
143071307|NCT01674647|515803205|FG001|Treatment Period|Efficacy outcome reached|1|||
143071308|NCT01674647|515803204|FG000|Treatment Period|Physician Decision|3|||
143071309|NCT01674647|515803205|FG001|Treatment Period|Physician Decision|1|||
143071310|NCT01674647|515803204|FG000|Treatment Period|Adverse Event|60|||
143071311|NCT01674647|515803205|FG001|Treatment Period|Adverse Event|22|||
143071312|NCT01674647|515803204|FG000|Treatment Period|Non-compliance with study drug|3|||
143071313|NCT01674647|515803205|FG001|Treatment Period|Non-compliance with study drug|0|||
143071314|NCT01674647|515803204|FG000|Treatment Period|Lost to Follow-up|1|||
143071315|NCT01674647|515803205|FG001|Treatment Period|Lost to Follow-up|1|||
143071316|NCT01674647|515803204|FG000|Treatment Period|Withdrawal by Subject|19|||
143071317|NCT01674647|515803205|FG001|Treatment Period|Withdrawal by Subject|16|||
143071318|NCT01674647|515803204|FG000|Treatment Period|Switching to other therapy|5|||
143071319|NCT01674647|515803205|FG001|Treatment Period|Switching to other therapy|2|||
143071320|NCT01674647|515803204|FG000|Treatment Period|Logistical difficulties|5|||
143071321|NCT01674647|515803205|FG001|Treatment Period|Logistical difficulties|8|||
143071322|NCT01674647|515803204|FG000|Treatment Period|Treatment failure|0|||
143071323|NCT01674647|515803205|FG001|Treatment Period|Treatment failure|14|||
143071324|NCT01674647|515803204|FG000|Treatment Period|Protocol Violation|56|||
143071325|NCT01674647|515803205|FG001|Treatment Period|Protocol Violation|36|||
143071326|NCT01674647|515803204|FG000|30-day Safety Follow-up Period|Death|3|||
143071327|NCT01674647|515803205|FG001|30-day Safety Follow-up Period|Death|2|||
143071328|NCT01674647|515803204|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
143071329|NCT01674647|515803205|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
143071330|NCT01674647|515803204|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
143071331|NCT01674647|515803205|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
143071332|NCT01674647|515803204|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
143071333|NCT01674647|515803205|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
143071334|NCT01674647|515803204|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
143071335|NCT01674647|515803205|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
143071336|NCT01674647|515803204|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
143071337|NCT01674647|515803205|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
143071338|NCT04156620|515803206|FG000|Overall Study|Adverse event - TP 1|5|||
143071339|NCT04156620|515803207|FG001|Overall Study|Adverse event - TP 1|2|||
143071340|NCT04156620|515803206|FG000|Overall Study|Lost to follow-up TP 1|1|||
143071341|NCT04156620|515803207|FG001|Overall Study|Lost to follow-up TP 1|1|||
143071342|NCT04156620|515803206|FG000|Overall Study|Progressive disease - TP 1|0|||
143071343|NCT04156620|515803207|FG001|Overall Study|Progressive disease - TP 1|1|||
143071344|NCT04156620|515803206|FG000|Overall Study|Subject decision - TP 1|3|||
143071345|NCT04156620|515803207|FG001|Overall Study|Subject decision - TP 1|5|||
143071346|NCT04156620|515803206|FG000|Overall Study|Adverse event - TP 2|5|||
143071347|NCT04156620|515803207|FG001|Overall Study|Adverse event - TP 2|6|||
143071348|NCT04156620|515803206|FG000|Overall Study|Death - TP 2|1|||
143071349|NCT04156620|515803207|FG001|Overall Study|Death - TP 2|0|||
143071350|NCT04156620|515803206|FG000|Overall Study|Lost to follow-up - TP 2|5|||
143071351|NCT04156620|515803207|FG001|Overall Study|Lost to follow-up - TP 2|2|||
143071352|NCT04156620|515803206|FG000|Overall Study|Physician decision - TP 2|4|||
143071353|NCT04156620|515803207|FG001|Overall Study|Physician decision - TP 2|2|||
143071354|NCT04156620|515803206|FG000|Overall Study|Pregnancy - TP 2|1|||
143071355|NCT04156620|515803207|FG001|Overall Study|Pregnancy - TP 2|1|||
143071356|NCT04156620|515803206|FG000|Overall Study|Subject decision - TP 2|11|||
143071357|NCT04156620|515803207|FG001|Overall Study|Subject decision - TP 2|9|||
143071358|NCT04156620|515803206|FG000|Overall Study|New therapy for study indication - TP 2|1|||
143071359|NCT04156620|515803207|FG001|Overall Study|New therapy for study indication - TP 2|0|||
143071360|NCT02980874|515803208|FG000|Overall Study|Adverse Event|2|||
143071361|NCT02980874|515803209|FG001|Overall Study|Adverse Event|7|||
143071362|NCT02980874|515803208|FG000|Overall Study|Withdrawal by Subject|7|||
143071363|NCT02980874|515803209|FG001|Overall Study|Withdrawal by Subject|2|||
143071364|NCT02980874|515803208|FG000|Overall Study|Lost to Follow-up|5|||
143071365|NCT02980874|515803209|FG001|Overall Study|Lost to Follow-up|5|||
143071366|NCT02980874|515803208|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
143071367|NCT02980874|515803209|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
143071368|NCT02980874|515803208|FG000|Overall Study|Unknown study completion status|1|||
143071369|NCT02980874|515803209|FG001|Overall Study|Unknown study completion status|0|||
143071370|NCT00513682|515803210|FG000|Washout Phase|Adverse Event|2|||
143071371|NCT02450526|515803211|FG000|DB Period (Cycle 1)|Adverse Event|0|||
143071372|NCT02450526|515803212|FG001|DB Period (Cycle 1)|Adverse Event|0|||
143071373|NCT02450526|515803213|FG002|DB Period (Cycle 1)|Adverse Event|2|||
143071374|NCT02450526|515803214|FG003|DB Period (Cycle 1)|Adverse Event|0|||
143071375|NCT02450526|515803215|FG004|DB Period (Cycle 1)|Adverse Event|0|||
143071376|NCT02450526|515803211|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
143071377|NCT02450526|515803212|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
143071378|NCT02450526|515803213|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
143071379|NCT02450526|515803214|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
143071380|NCT02450526|515803215|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
143071381|NCT02450526|515803211|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
143247902|NCT01667419|516460471|FG002|Overall Study|Death|25|||
143071382|NCT02450526|515803212|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
143071383|NCT02450526|515803213|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
143071384|NCT02450526|515803214|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
143071385|NCT02450526|515803215|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
143071386|NCT02450526|515803211|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
143071387|NCT02450526|515803212|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
143071388|NCT02450526|515803213|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
143071389|NCT02450526|515803214|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
143071390|NCT02450526|515803215|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
143071391|NCT02450526|515803211|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
143071392|NCT02450526|515803212|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
143071393|NCT02450526|515803213|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
143071394|NCT02450526|515803214|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
143071395|NCT02450526|515803215|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
143071396|NCT02450526|515803211|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
143071397|NCT02450526|515803212|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
143071398|NCT02450526|515803213|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
143071399|NCT02450526|515803214|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
143071400|NCT02450526|515803215|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
143071401|NCT02450526|515803211|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
143071402|NCT02450526|515803212|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
143071403|NCT02450526|515803213|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
143071404|NCT02450526|515803214|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
143071405|NCT02450526|515803215|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
143071406|NCT02450526|515803211|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
143071407|NCT02450526|515803212|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
143071408|NCT02450526|515803213|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
143071409|NCT02450526|515803214|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
143071410|NCT02450526|515803215|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
143071411|NCT04135196|515803216|FG000|Overall Study|Lost to Follow-up|8|||
143071412|NCT04135196|515803217|FG001|Overall Study|Lost to Follow-up|7|||
143071413|NCT04135196|515803218|FG002|Overall Study|Lost to Follow-up|8|||
143071414|NCT04135196|515803219|FG003|Overall Study|Lost to Follow-up|9|||
143071415|NCT04135196|515803220|FG004|Overall Study|Lost to Follow-up|1|||
143071416|NCT04135196|515803216|FG000|Overall Study|Pregnancy|0|||
143071417|NCT04135196|515803217|FG001|Overall Study|Pregnancy|0|||
143071418|NCT04135196|515803218|FG002|Overall Study|Pregnancy|1|||
143071419|NCT04135196|515803219|FG003|Overall Study|Pregnancy|0|||
143071420|NCT04135196|515803220|FG004|Overall Study|Pregnancy|0|||
143071421|NCT04135196|515803216|FG000|Overall Study|Withdrawal by Subject|0|||
143071422|NCT04135196|515803217|FG001|Overall Study|Withdrawal by Subject|0|||
143071423|NCT04135196|515803218|FG002|Overall Study|Withdrawal by Subject|0|||
143071424|NCT04135196|515803219|FG003|Overall Study|Withdrawal by Subject|0|||
143071425|NCT04135196|515803220|FG004|Overall Study|Withdrawal by Subject|1|||
143071426|NCT02435836|515803221|FG000|Overall Study|Lost to Follow-up|21|||
143071427|NCT02435836|515803221|FG000|Overall Study|Lack of Efficacy|1|||
143071428|NCT02435836|515803221|FG000|Overall Study|Withdrawal by Subject|236|||
143071429|NCT02435836|515803221|FG000|Overall Study|Insufficient Clinical Response|26|||
143071430|NCT02435836|515803221|FG000|Overall Study|Adverse Event|44|||
143071431|NCT02435836|515803221|FG000|Overall Study|Sponsor discontinued trial|167|||
143071432|NCT02435836|515803221|FG000|Overall Study|Noncompliance|27|||
143071433|NCT02435836|515803221|FG000|Overall Study|Protocol Violation|6|||
143071434|NCT02435836|515803221|FG000|Overall Study|Met Withdrawal Criteria|7|||
143071435|NCT02435836|515803221|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
143071436|NCT03970837|515803222|FG000|Overall Study|Adverse Event|23|||
143071437|NCT03970837|515803223|FG001|Overall Study|Adverse Event|20|||
143071438|NCT03970837|515803224|FG002|Overall Study|Adverse Event|16|||
143071439|NCT03970837|515803225|FG003|Overall Study|Adverse Event|6|||
143071440|NCT03970837|515803226|FG004|Overall Study|Adverse Event|4|||
143071441|NCT03970837|515803227|FG005|Overall Study|Adverse Event|5|||
143071442|NCT03970837|515803228|FG006|Overall Study|Adverse Event|1|||
143071443|NCT03970837|515803229|FG007|Overall Study|Adverse Event|5|||
143071444|NCT03970837|515803230|FG008|Overall Study|Adverse Event|0|||
143071445|NCT03970837|515803231|FG009|Overall Study|Adverse Event|0|||
143071446|NCT03970837|515803232|FG010|Overall Study|Adverse Event|1|||
143171398|NCT00673920|516176081|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
143171399|NCT00673920|516176074|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
143171400|NCT00673920|516176075|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
143071447|NCT03970837|515803233|FG011|Overall Study|Adverse Event|1|||
143071448|NCT03970837|515803222|FG000|Overall Study|Lack of Efficacy|14|||
143071449|NCT03970837|515803223|FG001|Overall Study|Lack of Efficacy|12|||
143071450|NCT03970837|515803224|FG002|Overall Study|Lack of Efficacy|1|||
143071451|NCT03970837|515803225|FG003|Overall Study|Lack of Efficacy|2|||
143071452|NCT03970837|515803226|FG004|Overall Study|Lack of Efficacy|3|||
143171401|NCT00673920|516176076|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
143071453|NCT03970837|515803227|FG005|Overall Study|Lack of Efficacy|4|||
143071454|NCT03970837|515803228|FG006|Overall Study|Lack of Efficacy|6|||
143071455|NCT03970837|515803229|FG007|Overall Study|Lack of Efficacy|1|||
143071456|NCT03970837|515803230|FG008|Overall Study|Lack of Efficacy|1|||
143071457|NCT03970837|515803231|FG009|Overall Study|Lack of Efficacy|0|||
143071458|NCT03970837|515803232|FG010|Overall Study|Lack of Efficacy|0|||
143071459|NCT03970837|515803233|FG011|Overall Study|Lack of Efficacy|0|||
143071460|NCT03970837|515803222|FG000|Overall Study|Lost to Follow-up|6|||
143071461|NCT03970837|515803223|FG001|Overall Study|Lost to Follow-up|5|||
143071462|NCT03970837|515803224|FG002|Overall Study|Lost to Follow-up|5|||
143071463|NCT03970837|515803225|FG003|Overall Study|Lost to Follow-up|1|||
143071464|NCT03970837|515803226|FG004|Overall Study|Lost to Follow-up|0|||
143071465|NCT03970837|515803227|FG005|Overall Study|Lost to Follow-up|2|||
143071466|NCT03970837|515803228|FG006|Overall Study|Lost to Follow-up|0|||
143071467|NCT03970837|515803229|FG007|Overall Study|Lost to Follow-up|0|||
143071468|NCT03970837|515803230|FG008|Overall Study|Lost to Follow-up|0|||
143071469|NCT03970837|515803231|FG009|Overall Study|Lost to Follow-up|0|||
143071470|NCT03970837|515803232|FG010|Overall Study|Lost to Follow-up|0|||
143071471|NCT03970837|515803233|FG011|Overall Study|Lost to Follow-up|0|||
143071472|NCT03970837|515803222|FG000|Overall Study|Protocol Violation|1|||
143071473|NCT03970837|515803223|FG001|Overall Study|Protocol Violation|0|||
143071474|NCT03970837|515803224|FG002|Overall Study|Protocol Violation|0|||
143071475|NCT03970837|515803225|FG003|Overall Study|Protocol Violation|0|||
143071476|NCT03970837|515803226|FG004|Overall Study|Protocol Violation|0|||
143247903|NCT01667419|516460472|FG003|Overall Study|Death|26|||
143247904|NCT00856518|516460473|FG000|Overall Study|Lost to Follow-up|4|||
143071477|NCT03970837|515803227|FG005|Overall Study|Protocol Violation|0|||
143071478|NCT03970837|515803228|FG006|Overall Study|Protocol Violation|0|||
143071479|NCT03970837|515803229|FG007|Overall Study|Protocol Violation|0|||
143071480|NCT03970837|515803230|FG008|Overall Study|Protocol Violation|0|||
143071481|NCT03970837|515803231|FG009|Overall Study|Protocol Violation|0|||
143071482|NCT03970837|515803232|FG010|Overall Study|Protocol Violation|0|||
143071483|NCT03970837|515803233|FG011|Overall Study|Protocol Violation|0|||
143071484|NCT03970837|515803222|FG000|Overall Study|Physician Decision|5|||
143071485|NCT03970837|515803223|FG001|Overall Study|Physician Decision|8|||
143071486|NCT03970837|515803224|FG002|Overall Study|Physician Decision|4|||
143071487|NCT03970837|515803225|FG003|Overall Study|Physician Decision|1|||
143071488|NCT03970837|515803226|FG004|Overall Study|Physician Decision|5|||
143071489|NCT03970837|515803227|FG005|Overall Study|Physician Decision|2|||
143247905|NCT00856518|516460474|FG001|Overall Study|Lost to Follow-up|2|||
143071490|NCT03970837|515803228|FG006|Overall Study|Physician Decision|4|||
143071491|NCT03970837|515803229|FG007|Overall Study|Physician Decision|5|||
143071492|NCT03970837|515803230|FG008|Overall Study|Physician Decision|0|||
143071493|NCT03970837|515803231|FG009|Overall Study|Physician Decision|1|||
143071494|NCT03970837|515803232|FG010|Overall Study|Physician Decision|0|||
143071495|NCT03970837|515803233|FG011|Overall Study|Physician Decision|0|||
143071496|NCT03970837|515803222|FG000|Overall Study|Withdrawal by Subject|32|||
143071497|NCT03970837|515803223|FG001|Overall Study|Withdrawal by Subject|35|||
143071498|NCT03970837|515803224|FG002|Overall Study|Withdrawal by Subject|12|||
143071499|NCT03970837|515803225|FG003|Overall Study|Withdrawal by Subject|8|||
143071500|NCT03970837|515803226|FG004|Overall Study|Withdrawal by Subject|6|||
143071501|NCT03970837|515803227|FG005|Overall Study|Withdrawal by Subject|8|||
143071502|NCT03970837|515803228|FG006|Overall Study|Withdrawal by Subject|2|||
143071503|NCT03970837|515803229|FG007|Overall Study|Withdrawal by Subject|3|||
143071504|NCT03970837|515803230|FG008|Overall Study|Withdrawal by Subject|0|||
143071505|NCT03970837|515803231|FG009|Overall Study|Withdrawal by Subject|0|||
143071506|NCT03970837|515803232|FG010|Overall Study|Withdrawal by Subject|0|||
143071507|NCT03970837|515803233|FG011|Overall Study|Withdrawal by Subject|1|||
143071508|NCT03970837|515803222|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
143071509|NCT03970837|515803223|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
143071510|NCT03970837|515803224|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
143071511|NCT03970837|515803225|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
143071512|NCT03970837|515803226|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
143071513|NCT03970837|515803227|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
143071514|NCT03970837|515803228|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
143071515|NCT03970837|515803229|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
143071516|NCT03970837|515803230|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
143071517|NCT03970837|515803231|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
143071518|NCT03970837|515803232|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
143071519|NCT03970837|515803233|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
143071520|NCT03970837|515803222|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
143071521|NCT03970837|515803223|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
143071522|NCT03970837|515803224|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
143071523|NCT03970837|515803225|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
143071524|NCT03970837|515803226|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
143071525|NCT03970837|515803227|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
143071526|NCT03970837|515803228|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
143071527|NCT03970837|515803229|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
143071528|NCT03970837|515803230|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
143071529|NCT03970837|515803231|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
143071530|NCT03970837|515803232|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
143071531|NCT03970837|515803233|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
143071532|NCT02132754|515803234|FG000|Overall Study|Adverse Event|0|||
143071533|NCT02132754|515803235|FG001|Overall Study|Adverse Event|0|||
143071534|NCT02132754|515803236|FG002|Overall Study|Adverse Event|0|||
143071535|NCT02132754|515803237|FG003|Overall Study|Adverse Event|0|||
143071536|NCT02132754|515803238|FG004|Overall Study|Adverse Event|0|||
143071537|NCT02132754|515803239|FG005|Overall Study|Adverse Event|0|||
143171402|NCT00673920|516176077|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
143171403|NCT00673920|516176078|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
143171404|NCT00673920|516176079|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
143171405|NCT00673920|516176080|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
143171406|NCT00673920|516176081|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
143171407|NCT00673920|516176074|FG000|Week 24 to Week 48|Failure to return|0|||
143071538|NCT02132754|515803240|FG006|Overall Study|Adverse Event|0|||
143071539|NCT02132754|515803241|FG007|Overall Study|Adverse Event|0|||
143071540|NCT02132754|515803242|FG008|Overall Study|Adverse Event|0|||
143071541|NCT02132754|515803243|FG009|Overall Study|Adverse Event|0|||
143071542|NCT02132754|515803244|FG010|Overall Study|Adverse Event|0|||
143071543|NCT02132754|515803245|FG011|Overall Study|Adverse Event|0|||
143071544|NCT02132754|515803246|FG012|Overall Study|Adverse Event|0|||
143071545|NCT02132754|515803247|FG013|Overall Study|Adverse Event|0|||
143071546|NCT02132754|515803248|FG014|Overall Study|Adverse Event|0|||
143071547|NCT02132754|515803249|FG015|Overall Study|Adverse Event|0|||
143071548|NCT02132754|515803250|FG016|Overall Study|Adverse Event|0|||
143071549|NCT02132754|515803251|FG017|Overall Study|Adverse Event|1|||
143071550|NCT02132754|515803252|FG018|Overall Study|Adverse Event|0|||
143071551|NCT02132754|515803253|FG019|Overall Study|Adverse Event|0|||
143071552|NCT02132754|515803254|FG020|Overall Study|Adverse Event|0|||
143071553|NCT02132754|515803255|FG021|Overall Study|Adverse Event|0|||
143071554|NCT02132754|515803256|FG022|Overall Study|Adverse Event|0|||
143071555|NCT02132754|515803257|FG023|Overall Study|Adverse Event|0|||
143071556|NCT02132754|515803258|FG024|Overall Study|Adverse Event|0|||
143071557|NCT02132754|515803259|FG025|Overall Study|Adverse Event|1|||
143071558|NCT02132754|515803260|FG026|Overall Study|Adverse Event|1|||
143071559|NCT02132754|515803261|FG027|Overall Study|Adverse Event|0|||
143071560|NCT02132754|515803262|FG028|Overall Study|Adverse Event|0|||
143071561|NCT02132754|515803263|FG029|Overall Study|Adverse Event|0|||
143071562|NCT02132754|515803264|FG030|Overall Study|Adverse Event|1|||
143071563|NCT02132754|515803265|FG031|Overall Study|Adverse Event|0|||
143071564|NCT02132754|515803266|FG032|Overall Study|Adverse Event|1|||
143071565|NCT02132754|515803267|FG033|Overall Study|Adverse Event|1|||
143071566|NCT02132754|515803234|FG000|Overall Study|Clinical Progression|0|||
143071567|NCT02132754|515803235|FG001|Overall Study|Clinical Progression|0|||
143071568|NCT02132754|515803236|FG002|Overall Study|Clinical Progression|0|||
143071569|NCT02132754|515803237|FG003|Overall Study|Clinical Progression|0|||
143071570|NCT02132754|515803238|FG004|Overall Study|Clinical Progression|0|||
143071571|NCT02132754|515803239|FG005|Overall Study|Clinical Progression|0|||
143071572|NCT02132754|515803240|FG006|Overall Study|Clinical Progression|0|||
143071573|NCT02132754|515803241|FG007|Overall Study|Clinical Progression|0|||
143071574|NCT02132754|515803242|FG008|Overall Study|Clinical Progression|0|||
143071575|NCT02132754|515803243|FG009|Overall Study|Clinical Progression|1|||
143071576|NCT02132754|515803244|FG010|Overall Study|Clinical Progression|0|||
143071577|NCT02132754|515803245|FG011|Overall Study|Clinical Progression|0|||
143071578|NCT02132754|515803246|FG012|Overall Study|Clinical Progression|0|||
143071579|NCT02132754|515803247|FG013|Overall Study|Clinical Progression|0|||
143071580|NCT02132754|515803248|FG014|Overall Study|Clinical Progression|0|||
143071581|NCT02132754|515803249|FG015|Overall Study|Clinical Progression|0|||
143071582|NCT02132754|515803250|FG016|Overall Study|Clinical Progression|1|||
143071583|NCT02132754|515803251|FG017|Overall Study|Clinical Progression|1|||
143071584|NCT02132754|515803252|FG018|Overall Study|Clinical Progression|0|||
143071585|NCT02132754|515803253|FG019|Overall Study|Clinical Progression|1|||
143071586|NCT02132754|515803254|FG020|Overall Study|Clinical Progression|0|||
143071587|NCT02132754|515803255|FG021|Overall Study|Clinical Progression|0|||
143071588|NCT02132754|515803256|FG022|Overall Study|Clinical Progression|1|||
143071589|NCT02132754|515803257|FG023|Overall Study|Clinical Progression|0|||
143071590|NCT02132754|515803258|FG024|Overall Study|Clinical Progression|1|||
143071591|NCT02132754|515803259|FG025|Overall Study|Clinical Progression|1|||
143071592|NCT02132754|515803260|FG026|Overall Study|Clinical Progression|0|||
143071593|NCT02132754|515803261|FG027|Overall Study|Clinical Progression|1|||
143071594|NCT02132754|515803262|FG028|Overall Study|Clinical Progression|1|||
143071595|NCT02132754|515803263|FG029|Overall Study|Clinical Progression|0|||
143071596|NCT02132754|515803264|FG030|Overall Study|Clinical Progression|1|||
143071597|NCT02132754|515803265|FG031|Overall Study|Clinical Progression|0|||
143071598|NCT02132754|515803266|FG032|Overall Study|Clinical Progression|0|||
143071599|NCT02132754|515803267|FG033|Overall Study|Clinical Progression|2|||
143071600|NCT02132754|515803234|FG000|Overall Study|Death|0|||
143071601|NCT02132754|515803235|FG001|Overall Study|Death|0|||
143071602|NCT02132754|515803236|FG002|Overall Study|Death|0|||
143071603|NCT02132754|515803237|FG003|Overall Study|Death|0|||
143071604|NCT02132754|515803238|FG004|Overall Study|Death|0|||
143171408|NCT00673920|516176075|FG001|Week 24 to Week 48|Failure to return|0|||
143171409|NCT00673920|516176076|FG002|Week 24 to Week 48|Failure to return|0|||
143071605|NCT02132754|515803239|FG005|Overall Study|Death|0|||
143071606|NCT02132754|515803240|FG006|Overall Study|Death|0|||
143071607|NCT02132754|515803241|FG007|Overall Study|Death|0|||
143071608|NCT02132754|515803242|FG008|Overall Study|Death|0|||
143071609|NCT02132754|515803243|FG009|Overall Study|Death|0|||
143071610|NCT02132754|515803244|FG010|Overall Study|Death|0|||
143071611|NCT02132754|515803245|FG011|Overall Study|Death|0|||
143071612|NCT02132754|515803246|FG012|Overall Study|Death|0|||
143071613|NCT02132754|515803247|FG013|Overall Study|Death|0|||
143071614|NCT02132754|515803248|FG014|Overall Study|Death|0|||
143247906|NCT02644109|516460481|FG000|Overall Study|Adverse Event|0|||
143071615|NCT02132754|515803249|FG015|Overall Study|Death|1|||
143071616|NCT02132754|515803250|FG016|Overall Study|Death|0|||
143071617|NCT02132754|515803251|FG017|Overall Study|Death|0|||
143071618|NCT02132754|515803252|FG018|Overall Study|Death|0|||
143071619|NCT02132754|515803253|FG019|Overall Study|Death|1|||
143071620|NCT02132754|515803254|FG020|Overall Study|Death|0|||
143071621|NCT02132754|515803255|FG021|Overall Study|Death|1|||
143071622|NCT02132754|515803256|FG022|Overall Study|Death|0|||
143071623|NCT02132754|515803257|FG023|Overall Study|Death|0|||
143071624|NCT02132754|515803258|FG024|Overall Study|Death|0|||
143071625|NCT02132754|515803259|FG025|Overall Study|Death|0|||
143071626|NCT02132754|515803260|FG026|Overall Study|Death|1|||
143071627|NCT02132754|515803261|FG027|Overall Study|Death|0|||
143071628|NCT02132754|515803262|FG028|Overall Study|Death|0|||
143071629|NCT02132754|515803263|FG029|Overall Study|Death|0|||
143071630|NCT02132754|515803264|FG030|Overall Study|Death|0|||
143071631|NCT02132754|515803265|FG031|Overall Study|Death|0|||
143071632|NCT02132754|515803266|FG032|Overall Study|Death|0|||
143071633|NCT02132754|515803267|FG033|Overall Study|Death|2|||
143071634|NCT02132754|515803234|FG000|Overall Study|Excluded Medication|0|||
143071635|NCT02132754|515803235|FG001|Overall Study|Excluded Medication|0|||
143071636|NCT02132754|515803236|FG002|Overall Study|Excluded Medication|0|||
143071637|NCT02132754|515803237|FG003|Overall Study|Excluded Medication|0|||
143071638|NCT02132754|515803238|FG004|Overall Study|Excluded Medication|0|||
143071639|NCT02132754|515803239|FG005|Overall Study|Excluded Medication|0|||
143071640|NCT02132754|515803240|FG006|Overall Study|Excluded Medication|0|||
143071641|NCT02132754|515803241|FG007|Overall Study|Excluded Medication|0|||
143071642|NCT02132754|515803242|FG008|Overall Study|Excluded Medication|0|||
143071643|NCT02132754|515803243|FG009|Overall Study|Excluded Medication|0|||
143071644|NCT02132754|515803244|FG010|Overall Study|Excluded Medication|0|||
143071645|NCT02132754|515803245|FG011|Overall Study|Excluded Medication|0|||
143071646|NCT02132754|515803246|FG012|Overall Study|Excluded Medication|0|||
143071647|NCT02132754|515803247|FG013|Overall Study|Excluded Medication|0|||
143071648|NCT02132754|515803248|FG014|Overall Study|Excluded Medication|0|||
143071649|NCT02132754|515803249|FG015|Overall Study|Excluded Medication|0|||
143071650|NCT02132754|515803250|FG016|Overall Study|Excluded Medication|0|||
143071651|NCT02132754|515803251|FG017|Overall Study|Excluded Medication|0|||
143071652|NCT02132754|515803252|FG018|Overall Study|Excluded Medication|0|||
143071653|NCT02132754|515803253|FG019|Overall Study|Excluded Medication|0|||
143071654|NCT02132754|515803254|FG020|Overall Study|Excluded Medication|1|||
143071655|NCT02132754|515803255|FG021|Overall Study|Excluded Medication|0|||
143071656|NCT02132754|515803256|FG022|Overall Study|Excluded Medication|0|||
143071657|NCT02132754|515803257|FG023|Overall Study|Excluded Medication|0|||
143071658|NCT02132754|515803258|FG024|Overall Study|Excluded Medication|0|||
143071659|NCT02132754|515803259|FG025|Overall Study|Excluded Medication|0|||
143071660|NCT02132754|515803260|FG026|Overall Study|Excluded Medication|0|||
143071661|NCT02132754|515803261|FG027|Overall Study|Excluded Medication|0|||
143071662|NCT02132754|515803262|FG028|Overall Study|Excluded Medication|0|||
143071663|NCT02132754|515803263|FG029|Overall Study|Excluded Medication|0|||
143071664|NCT02132754|515803264|FG030|Overall Study|Excluded Medication|0|||
143071665|NCT02132754|515803265|FG031|Overall Study|Excluded Medication|0|||
143071666|NCT02132754|515803266|FG032|Overall Study|Excluded Medication|0|||
143171410|NCT00673920|516176077|FG003|Week 24 to Week 48|Failure to return|0|||
143171411|NCT00673920|516176078|FG004|Week 24 to Week 48|Failure to return|0|||
143171412|NCT00673920|516176079|FG005|Week 24 to Week 48|Failure to return|1|||
143171413|NCT00673920|516176080|FG006|Week 24 to Week 48|Failure to return|0|||
143171414|NCT00673920|516176081|FG007|Week 24 to Week 48|Failure to return|0|||
143171415|NCT00673920|516176074|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
143171416|NCT00673920|516176075|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
143171417|NCT00673920|516176076|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
143071667|NCT02132754|515803267|FG033|Overall Study|Excluded Medication|1|||
143071668|NCT02132754|515803234|FG000|Overall Study|Physician Decision|0|||
143071669|NCT02132754|515803235|FG001|Overall Study|Physician Decision|0|||
143071670|NCT02132754|515803236|FG002|Overall Study|Physician Decision|0|||
143071671|NCT02132754|515803237|FG003|Overall Study|Physician Decision|0|||
143071672|NCT02132754|515803238|FG004|Overall Study|Physician Decision|0|||
143071673|NCT02132754|515803239|FG005|Overall Study|Physician Decision|0|||
143071674|NCT02132754|515803240|FG006|Overall Study|Physician Decision|0|||
143071675|NCT02132754|515803241|FG007|Overall Study|Physician Decision|0|||
143071676|NCT02132754|515803242|FG008|Overall Study|Physician Decision|0|||
143071677|NCT02132754|515803243|FG009|Overall Study|Physician Decision|1|||
143071678|NCT02132754|515803244|FG010|Overall Study|Physician Decision|0|||
143071679|NCT02132754|515803245|FG011|Overall Study|Physician Decision|1|||
143071680|NCT02132754|515803246|FG012|Overall Study|Physician Decision|1|||
143071681|NCT02132754|515803247|FG013|Overall Study|Physician Decision|0|||
143071682|NCT02132754|515803248|FG014|Overall Study|Physician Decision|0|||
143071683|NCT02132754|515803249|FG015|Overall Study|Physician Decision|1|||
143071684|NCT02132754|515803250|FG016|Overall Study|Physician Decision|0|||
143071685|NCT02132754|515803251|FG017|Overall Study|Physician Decision|0|||
143071686|NCT02132754|515803252|FG018|Overall Study|Physician Decision|0|||
143071687|NCT02132754|515803253|FG019|Overall Study|Physician Decision|0|||
143071688|NCT02132754|515803254|FG020|Overall Study|Physician Decision|0|||
143071689|NCT02132754|515803255|FG021|Overall Study|Physician Decision|0|||
143071690|NCT02132754|515803256|FG022|Overall Study|Physician Decision|0|||
143071691|NCT02132754|515803257|FG023|Overall Study|Physician Decision|0|||
143071692|NCT02132754|515803258|FG024|Overall Study|Physician Decision|1|||
143071693|NCT02132754|515803259|FG025|Overall Study|Physician Decision|0|||
143071694|NCT02132754|515803260|FG026|Overall Study|Physician Decision|0|||
143071695|NCT02132754|515803261|FG027|Overall Study|Physician Decision|0|||
143071696|NCT02132754|515803262|FG028|Overall Study|Physician Decision|0|||
143071697|NCT02132754|515803263|FG029|Overall Study|Physician Decision|0|||
143071698|NCT02132754|515803264|FG030|Overall Study|Physician Decision|0|||
143071699|NCT02132754|515803265|FG031|Overall Study|Physician Decision|1|||
143071700|NCT02132754|515803266|FG032|Overall Study|Physician Decision|0|||
143071701|NCT02132754|515803267|FG033|Overall Study|Physician Decision|3|||
143071702|NCT02132754|515803234|FG000|Overall Study|Progressive Disease|1|||
143071703|NCT02132754|515803235|FG001|Overall Study|Progressive Disease|1|||
143071704|NCT02132754|515803236|FG002|Overall Study|Progressive Disease|1|||
143071705|NCT02132754|515803237|FG003|Overall Study|Progressive Disease|1|||
143071706|NCT02132754|515803238|FG004|Overall Study|Progressive Disease|1|||
143071707|NCT02132754|515803239|FG005|Overall Study|Progressive Disease|1|||
143071708|NCT02132754|515803240|FG006|Overall Study|Progressive Disease|1|||
143071709|NCT02132754|515803241|FG007|Overall Study|Progressive Disease|1|||
143071710|NCT02132754|515803242|FG008|Overall Study|Progressive Disease|1|||
143071711|NCT02132754|515803243|FG009|Overall Study|Progressive Disease|3|||
143071712|NCT02132754|515803244|FG010|Overall Study|Progressive Disease|3|||
143071713|NCT02132754|515803245|FG011|Overall Study|Progressive Disease|2|||
143071714|NCT02132754|515803246|FG012|Overall Study|Progressive Disease|2|||
143071715|NCT02132754|515803247|FG013|Overall Study|Progressive Disease|3|||
143071716|NCT02132754|515803248|FG014|Overall Study|Progressive Disease|2|||
143071717|NCT02132754|515803249|FG015|Overall Study|Progressive Disease|1|||
143071718|NCT02132754|515803250|FG016|Overall Study|Progressive Disease|2|||
143071719|NCT02132754|515803251|FG017|Overall Study|Progressive Disease|1|||
143071720|NCT02132754|515803252|FG018|Overall Study|Progressive Disease|3|||
143071721|NCT02132754|515803253|FG019|Overall Study|Progressive Disease|1|||
143071722|NCT02132754|515803254|FG020|Overall Study|Progressive Disease|1|||
143071723|NCT02132754|515803255|FG021|Overall Study|Progressive Disease|3|||
143071724|NCT02132754|515803256|FG022|Overall Study|Progressive Disease|2|||
143071725|NCT02132754|515803257|FG023|Overall Study|Progressive Disease|3|||
143071726|NCT02132754|515803258|FG024|Overall Study|Progressive Disease|0|||
143071727|NCT02132754|515803259|FG025|Overall Study|Progressive Disease|1|||
143071728|NCT02132754|515803260|FG026|Overall Study|Progressive Disease|2|||
143071729|NCT02132754|515803261|FG027|Overall Study|Progressive Disease|1|||
143071730|NCT02132754|515803262|FG028|Overall Study|Progressive Disease|2|||
143071731|NCT02132754|515803263|FG029|Overall Study|Progressive Disease|3|||
143071732|NCT02132754|515803264|FG030|Overall Study|Progressive Disease|1|||
143071733|NCT02132754|515803265|FG031|Overall Study|Progressive Disease|1|||
143071734|NCT02132754|515803266|FG032|Overall Study|Progressive Disease|3|||
143071735|NCT02132754|515803267|FG033|Overall Study|Progressive Disease|6|||
143071736|NCT02132754|515803234|FG000|Overall Study|Screen Failure|0|||
143071737|NCT02132754|515803235|FG001|Overall Study|Screen Failure|0|||
143071738|NCT02132754|515803236|FG002|Overall Study|Screen Failure|0|||
143071739|NCT02132754|515803237|FG003|Overall Study|Screen Failure|0|||
143071740|NCT02132754|515803238|FG004|Overall Study|Screen Failure|0|||
143071741|NCT02132754|515803239|FG005|Overall Study|Screen Failure|0|||
143071742|NCT02132754|515803240|FG006|Overall Study|Screen Failure|0|||
143071743|NCT02132754|515803241|FG007|Overall Study|Screen Failure|0|||
143071744|NCT02132754|515803242|FG008|Overall Study|Screen Failure|0|||
143071745|NCT02132754|515803243|FG009|Overall Study|Screen Failure|0|||
143071746|NCT02132754|515803244|FG010|Overall Study|Screen Failure|0|||
143071747|NCT02132754|515803245|FG011|Overall Study|Screen Failure|0|||
143071748|NCT02132754|515803246|FG012|Overall Study|Screen Failure|0|||
143071749|NCT02132754|515803247|FG013|Overall Study|Screen Failure|0|||
143071750|NCT02132754|515803248|FG014|Overall Study|Screen Failure|0|||
143071751|NCT02132754|515803249|FG015|Overall Study|Screen Failure|0|||
143071752|NCT02132754|515803250|FG016|Overall Study|Screen Failure|0|||
143071753|NCT02132754|515803251|FG017|Overall Study|Screen Failure|0|||
143071754|NCT02132754|515803252|FG018|Overall Study|Screen Failure|0|||
143071755|NCT02132754|515803253|FG019|Overall Study|Screen Failure|1|||
143071756|NCT02132754|515803254|FG020|Overall Study|Screen Failure|0|||
143071757|NCT02132754|515803255|FG021|Overall Study|Screen Failure|1|||
143071758|NCT02132754|515803256|FG022|Overall Study|Screen Failure|0|||
143071759|NCT02132754|515803257|FG023|Overall Study|Screen Failure|0|||
143071760|NCT02132754|515803258|FG024|Overall Study|Screen Failure|0|||
143071761|NCT02132754|515803259|FG025|Overall Study|Screen Failure|0|||
143071762|NCT02132754|515803260|FG026|Overall Study|Screen Failure|0|||
143071763|NCT02132754|515803261|FG027|Overall Study|Screen Failure|0|||
143071764|NCT02132754|515803262|FG028|Overall Study|Screen Failure|0|||
143071765|NCT02132754|515803263|FG029|Overall Study|Screen Failure|0|||
143071766|NCT02132754|515803264|FG030|Overall Study|Screen Failure|0|||
143071767|NCT02132754|515803265|FG031|Overall Study|Screen Failure|0|||
143071768|NCT02132754|515803266|FG032|Overall Study|Screen Failure|0|||
143071769|NCT02132754|515803267|FG033|Overall Study|Screen Failure|0|||
143071770|NCT02132754|515803234|FG000|Overall Study|Transferred to Extension Study|0|||
143071771|NCT02132754|515803235|FG001|Overall Study|Transferred to Extension Study|0|||
143071772|NCT02132754|515803236|FG002|Overall Study|Transferred to Extension Study|0|||
143071773|NCT02132754|515803237|FG003|Overall Study|Transferred to Extension Study|0|||
143071774|NCT02132754|515803238|FG004|Overall Study|Transferred to Extension Study|0|||
143071775|NCT02132754|515803239|FG005|Overall Study|Transferred to Extension Study|0|||
143071776|NCT02132754|515803240|FG006|Overall Study|Transferred to Extension Study|0|||
143071777|NCT02132754|515803241|FG007|Overall Study|Transferred to Extension Study|0|||
143071778|NCT02132754|515803242|FG008|Overall Study|Transferred to Extension Study|0|||
143071779|NCT02132754|515803243|FG009|Overall Study|Transferred to Extension Study|0|||
143071780|NCT02132754|515803244|FG010|Overall Study|Transferred to Extension Study|0|||
143071781|NCT02132754|515803245|FG011|Overall Study|Transferred to Extension Study|0|||
143071782|NCT02132754|515803246|FG012|Overall Study|Transferred to Extension Study|0|||
143071783|NCT02132754|515803247|FG013|Overall Study|Transferred to Extension Study|0|||
143071784|NCT02132754|515803248|FG014|Overall Study|Transferred to Extension Study|0|||
143071785|NCT02132754|515803249|FG015|Overall Study|Transferred to Extension Study|0|||
143171418|NCT00673920|516176077|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
143171419|NCT00673920|516176078|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
143171420|NCT00673920|516176079|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
143171421|NCT00673920|516176080|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
143171422|NCT00673920|516176081|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
143171423|NCT00673920|516176074|FG000|Week 24 to Week 48|Death|0|||
143171424|NCT00673920|516176075|FG001|Week 24 to Week 48|Death|0|||
143171425|NCT00673920|516176076|FG002|Week 24 to Week 48|Death|0|||
143171426|NCT00673920|516176077|FG003|Week 24 to Week 48|Death|0|||
143171427|NCT00673920|516176078|FG004|Week 24 to Week 48|Death|0|||
143171428|NCT00673920|516176079|FG005|Week 24 to Week 48|Death|1|||
143171429|NCT00673920|516176080|FG006|Week 24 to Week 48|Death|0|||
143171430|NCT00673920|516176081|FG007|Week 24 to Week 48|Death|0|||
143171431|NCT00673920|516176074|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
143071786|NCT02132754|515803250|FG016|Overall Study|Transferred to Extension Study|0|||
143071787|NCT02132754|515803251|FG017|Overall Study|Transferred to Extension Study|0|||
143071788|NCT02132754|515803252|FG018|Overall Study|Transferred to Extension Study|0|||
143071789|NCT02132754|515803253|FG019|Overall Study|Transferred to Extension Study|0|||
143071790|NCT02132754|515803254|FG020|Overall Study|Transferred to Extension Study|0|||
143071791|NCT02132754|515803255|FG021|Overall Study|Transferred to Extension Study|0|||
143071792|NCT02132754|515803256|FG022|Overall Study|Transferred to Extension Study|0|||
143071793|NCT02132754|515803257|FG023|Overall Study|Transferred to Extension Study|0|||
143071794|NCT02132754|515803258|FG024|Overall Study|Transferred to Extension Study|0|||
143071795|NCT02132754|515803259|FG025|Overall Study|Transferred to Extension Study|0|||
143071796|NCT02132754|515803260|FG026|Overall Study|Transferred to Extension Study|0|||
143071797|NCT02132754|515803261|FG027|Overall Study|Transferred to Extension Study|0|||
143071798|NCT02132754|515803262|FG028|Overall Study|Transferred to Extension Study|0|||
143071799|NCT02132754|515803263|FG029|Overall Study|Transferred to Extension Study|0|||
143071800|NCT02132754|515803264|FG030|Overall Study|Transferred to Extension Study|0|||
143071801|NCT02132754|515803265|FG031|Overall Study|Transferred to Extension Study|0|||
143071802|NCT02132754|515803266|FG032|Overall Study|Transferred to Extension Study|0|||
143071803|NCT02132754|515803267|FG033|Overall Study|Transferred to Extension Study|6|||
143071804|NCT02132754|515803234|FG000|Overall Study|Withdrawal by Subject|0|||
143071805|NCT02132754|515803235|FG001|Overall Study|Withdrawal by Subject|0|||
143071806|NCT02132754|515803236|FG002|Overall Study|Withdrawal by Subject|0|||
143071807|NCT02132754|515803237|FG003|Overall Study|Withdrawal by Subject|0|||
143071808|NCT02132754|515803238|FG004|Overall Study|Withdrawal by Subject|0|||
143071809|NCT02132754|515803239|FG005|Overall Study|Withdrawal by Subject|0|||
143071810|NCT02132754|515803240|FG006|Overall Study|Withdrawal by Subject|0|||
143071811|NCT02132754|515803241|FG007|Overall Study|Withdrawal by Subject|0|||
143071812|NCT02132754|515803242|FG008|Overall Study|Withdrawal by Subject|0|||
143071813|NCT02132754|515803243|FG009|Overall Study|Withdrawal by Subject|1|||
143071814|NCT02132754|515803244|FG010|Overall Study|Withdrawal by Subject|0|||
143071815|NCT02132754|515803245|FG011|Overall Study|Withdrawal by Subject|0|||
143071816|NCT02132754|515803246|FG012|Overall Study|Withdrawal by Subject|1|||
143071817|NCT02132754|515803247|FG013|Overall Study|Withdrawal by Subject|0|||
143071818|NCT02132754|515803248|FG014|Overall Study|Withdrawal by Subject|1|||
143071819|NCT02132754|515803249|FG015|Overall Study|Withdrawal by Subject|2|||
143071820|NCT02132754|515803250|FG016|Overall Study|Withdrawal by Subject|1|||
143071821|NCT02132754|515803251|FG017|Overall Study|Withdrawal by Subject|0|||
143071822|NCT02132754|515803252|FG018|Overall Study|Withdrawal by Subject|0|||
143071823|NCT02132754|515803253|FG019|Overall Study|Withdrawal by Subject|0|||
143071824|NCT02132754|515803254|FG020|Overall Study|Withdrawal by Subject|1|||
143071825|NCT02132754|515803255|FG021|Overall Study|Withdrawal by Subject|0|||
143071826|NCT02132754|515803256|FG022|Overall Study|Withdrawal by Subject|0|||
143071827|NCT02132754|515803257|FG023|Overall Study|Withdrawal by Subject|0|||
143071828|NCT02132754|515803258|FG024|Overall Study|Withdrawal by Subject|1|||
143071829|NCT02132754|515803259|FG025|Overall Study|Withdrawal by Subject|0|||
143071830|NCT02132754|515803260|FG026|Overall Study|Withdrawal by Subject|0|||
143071831|NCT02132754|515803261|FG027|Overall Study|Withdrawal by Subject|1|||
143071832|NCT02132754|515803262|FG028|Overall Study|Withdrawal by Subject|0|||
143071833|NCT02132754|515803263|FG029|Overall Study|Withdrawal by Subject|0|||
143071834|NCT02132754|515803264|FG030|Overall Study|Withdrawal by Subject|0|||
143247907|NCT02644109|516460482|FG001|Overall Study|Adverse Event|4|||
143247908|NCT01942733|516460486|FG000|Overall Study|Lost to Follow-up|1|||
143071835|NCT02132754|515803265|FG031|Overall Study|Withdrawal by Subject|1|||
143071836|NCT02132754|515803266|FG032|Overall Study|Withdrawal by Subject|0|||
143071837|NCT02132754|515803267|FG033|Overall Study|Withdrawal by Subject|2|||
143171432|NCT00673920|516176075|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
143171433|NCT00673920|516176076|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
143171434|NCT00673920|516176077|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
143171435|NCT00673920|516176078|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
143071838|NCT03907462|515803278|FG000|Overall Study|Physician Decision|1|||
143171436|NCT00673920|516176079|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
143247909|NCT01942733|516460486|FG000|Overall Study|Non-compliance with IMP|1|||
143071839|NCT03907462|515803279|FG001|Overall Study|Physician Decision|3|||
143071840|NCT03907462|515803280|FG002|Overall Study|Physician Decision|1|||
143071841|NCT03907462|515803278|FG000|Overall Study|Withdrawal by Subject|6|||
143071842|NCT03907462|515803279|FG001|Overall Study|Withdrawal by Subject|3|||
143071843|NCT03907462|515803280|FG002|Overall Study|Withdrawal by Subject|3|||
143071844|NCT03907462|515803278|FG000|Overall Study|Pregnancy|4|||
143247910|NCT01942733|516460486|FG000|Overall Study|Administrative|1|||
143247911|NCT00126490|516460494|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
143247912|NCT02625909|516460495|FG000|Overall Study|Death|2|||
143247913|NCT02625909|516460496|FG001|Overall Study|Death|0|||
143247914|NCT02625909|516460495|FG000|Overall Study|Lost to Follow-up|3|||
143247915|NCT02625909|516460496|FG001|Overall Study|Lost to Follow-up|5|||
143247916|NCT02625909|516460495|FG000|Overall Study|Lack of Efficacy|9|||
143071845|NCT03907462|515803279|FG001|Overall Study|Pregnancy|2|||
143071846|NCT03907462|515803280|FG002|Overall Study|Pregnancy|6|||
143071847|NCT03907462|515803278|FG000|Overall Study|Lost to Follow-up|16|||
143071848|NCT03907462|515803279|FG001|Overall Study|Lost to Follow-up|18|||
143071849|NCT03907462|515803280|FG002|Overall Study|Lost to Follow-up|22|||
143071850|NCT03548064|515805897|FG000|Overall Study|Withdrawal by Subject|0|||
143071851|NCT03548064|515805898|FG001|Overall Study|Withdrawal by Subject|0|||
143071852|NCT03548064|515805899|FG002|Overall Study|Withdrawal by Subject|0|||
143071853|NCT03548064|515805900|FG003|Overall Study|Withdrawal by Subject|1|||
143071854|NCT03548064|515805901|FG004|Overall Study|Withdrawal by Subject|0|||
143071855|NCT03548064|515805902|FG005|Overall Study|Withdrawal by Subject|0|||
143071856|NCT03548064|515805903|FG006|Overall Study|Withdrawal by Subject|0|||
143071857|NCT03548064|515805904|FG007|Overall Study|Withdrawal by Subject|0|||
143071858|NCT03548064|515805897|FG000|Overall Study|Lost to Follow-up|0|||
143071859|NCT03548064|515805898|FG001|Overall Study|Lost to Follow-up|0|||
143071860|NCT03548064|515805899|FG002|Overall Study|Lost to Follow-up|0|||
143071861|NCT03548064|515805900|FG003|Overall Study|Lost to Follow-up|0|||
143071862|NCT03548064|515805901|FG004|Overall Study|Lost to Follow-up|2|||
143071863|NCT03548064|515805902|FG005|Overall Study|Lost to Follow-up|0|||
143171437|NCT00673920|516176080|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
143171438|NCT00673920|516176081|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
143171439|NCT05448950|516176087|FG000|Overall Study|Death|2|||
143171440|NCT05448950|516176087|FG000|Overall Study|Withdrawal by Subject|1|||
143171441|NCT05448950|516176087|FG000|Overall Study|AVG abandoned|4|||
143171442|NCT04562116|516176088|FG000|Overall Study|Lost to Follow-up|1|||
143171443|NCT04562116|516176088|FG000|Overall Study|Withdrawal by Subject|3|||
143171444|NCT02303262|516176089|FG000|Overall Study|Withdrawal by Subject|2|||
143171445|NCT02921256|516176090|FG000|Arm 1a v. Arm II|Adverse Event|6|||
143171446|NCT02921256|516176091|FG001|Arm 1a v. Arm II|Adverse Event|15|||
143171447|NCT02921256|516176092|FG002|Arm 1a v. Arm II|Adverse Event|0|||
143171448|NCT02921256|516176090|FG000|Arm 1a v. Arm II|Death|0|||
143171449|NCT02921256|516176091|FG001|Arm 1a v. Arm II|Death|2|||
143171450|NCT02921256|516176092|FG002|Arm 1a v. Arm II|Death|0|||
143171451|NCT02921256|516176090|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
143171452|NCT02921256|516176091|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
143171453|NCT02921256|516176092|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
143171454|NCT02921256|516176090|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
143171455|NCT02921256|516176091|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
143171456|NCT02921256|516176092|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
143171457|NCT02921256|516176090|FG000|Arm 1a v. Arm II|Physician Decision|1|||
143171458|NCT02921256|516176091|FG001|Arm 1a v. Arm II|Physician Decision|1|||
143171459|NCT02921256|516176092|FG002|Arm 1a v. Arm II|Physician Decision|0|||
143171460|NCT02921256|516176090|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
143171461|NCT02921256|516176091|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
143171462|NCT02921256|516176092|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
143171463|NCT02921256|516176090|FG000|Arm Ib v Arm III|Adverse Event|9|||
143247917|NCT02625909|516460496|FG001|Overall Study|Lack of Efficacy|2|||
143247918|NCT02625909|516460495|FG000|Overall Study|Reinfection|3|||
143247919|NCT02625909|516460496|FG001|Overall Study|Reinfection|2|||
143247920|NCT02167139|516460500|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
143171464|NCT02921256|516176091|FG001|Arm Ib v Arm III|Adverse Event|0|||
143171465|NCT02921256|516176092|FG002|Arm Ib v Arm III|Adverse Event|4|||
143171466|NCT02921256|516176090|FG000|Arm Ib v Arm III|Death|1|||
143171467|NCT02921256|516176091|FG001|Arm Ib v Arm III|Death|0|||
143247921|NCT02167139|516460501|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
143071864|NCT03548064|515805903|FG006|Overall Study|Lost to Follow-up|0|||
143071865|NCT03548064|515805904|FG007|Overall Study|Lost to Follow-up|0|||
143071866|NCT03548064|515805897|FG000|Overall Study|Covid-19 Pandemic|0|||
143171468|NCT02921256|516176092|FG002|Arm Ib v Arm III|Death|1|||
143071867|NCT03548064|515805898|FG001|Overall Study|Covid-19 Pandemic|0|||
143071868|NCT03548064|515805899|FG002|Overall Study|Covid-19 Pandemic|0|||
143071869|NCT03548064|515805900|FG003|Overall Study|Covid-19 Pandemic|0|||
143071870|NCT03548064|515805901|FG004|Overall Study|Covid-19 Pandemic|10|||
143071871|NCT03548064|515805902|FG005|Overall Study|Covid-19 Pandemic|3|||
143071872|NCT03548064|515805903|FG006|Overall Study|Covid-19 Pandemic|0|||
143071873|NCT03548064|515805904|FG007|Overall Study|Covid-19 Pandemic|0|||
143071874|NCT04941729|515805905|FG000|Overall Study|Death|0|||
143071875|NCT04941729|515805906|FG001|Overall Study|Death|1|||
143071876|NCT04941729|515805905|FG000|Overall Study|Study terminated by sponsor|11|||
143071877|NCT04941729|515805906|FG001|Overall Study|Study terminated by sponsor|10|||
143071878|NCT00006721|515805916|FG000|Overall Study|Adverse Event|0|||
143071879|NCT00006721|515805917|FG001|Overall Study|Adverse Event|4|||
143071880|NCT00006721|515805918|FG002|Overall Study|Adverse Event|4|||
143071881|NCT00006721|515805916|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
143071882|NCT00006721|515805917|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
143071883|NCT00006721|515805918|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
143071884|NCT00006721|515805916|FG000|Overall Study|Progression/Relapse|0|||
143071885|NCT00006721|515805917|FG001|Overall Study|Progression/Relapse|1|||
143071886|NCT00006721|515805918|FG002|Overall Study|Progression/Relapse|2|||
143071887|NCT00006721|515805916|FG000|Overall Study|Death|0|||
143071888|NCT00006721|515805917|FG001|Overall Study|Death|1|||
143071889|NCT00006721|515805918|FG002|Overall Study|Death|2|||
143071890|NCT00006721|515805916|FG000|Overall Study|Other - Not Protocol Specified|0|||
143071891|NCT00006721|515805917|FG001|Overall Study|Other - Not Protocol Specified|7|||
143071892|NCT00006721|515805918|FG002|Overall Study|Other - Not Protocol Specified|7|||
143071893|NCT00006721|515805916|FG000|Overall Study|Ineligible|2|||
143071894|NCT00006721|515805917|FG001|Overall Study|Ineligible|12|||
143071895|NCT00006721|515805918|FG002|Overall Study|Ineligible|10|||
143071896|NCT00006721|515805916|FG000|Overall Study|Eligible but no Treatment Received|1|||
143071897|NCT00006721|515805917|FG001|Overall Study|Eligible but no Treatment Received|0|||
143071898|NCT00006721|515805918|FG002|Overall Study|Eligible but no Treatment Received|0|||
143071899|NCT05424042|515805919|FG000|Overall Study|Withdrawal by Subject|2|||
143071900|NCT05424042|515805920|FG001|Overall Study|Withdrawal by Subject|0|||
143071901|NCT05424042|515805921|FG002|Overall Study|Withdrawal by Subject|4|||
143071902|NCT05424042|515805919|FG000|Overall Study|Lost to Follow-up|0|||
143071903|NCT05424042|515805920|FG001|Overall Study|Lost to Follow-up|0|||
143071904|NCT05424042|515805921|FG002|Overall Study|Lost to Follow-up|1|||
143071905|NCT05091307|515805922|FG000|Overall Study|Death|0|||
143071906|NCT05091307|515805923|FG001|Overall Study|Death|0|||
143071907|NCT05091307|515805924|FG002|Overall Study|Death|1|||
143071908|NCT05091307|515805925|FG003|Overall Study|Death|0|||
143071909|NCT05091307|515805922|FG000|Overall Study|Lost to Follow-up|33|||
143071910|NCT05091307|515805923|FG001|Overall Study|Lost to Follow-up|33|||
143071911|NCT05091307|515805924|FG002|Overall Study|Lost to Follow-up|2|||
143071912|NCT05091307|515805925|FG003|Overall Study|Lost to Follow-up|0|||
143071913|NCT05091307|515805922|FG000|Overall Study|Physician Decision|1|||
143071914|NCT05091307|515805923|FG001|Overall Study|Physician Decision|0|||
143247922|NCT02167139|516460502|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
143247923|NCT02167139|516460503|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
143247924|NCT02167139|516460500|FG000|Randomised, Double-blind|Adverse Event|2|||
143247925|NCT02167139|516460501|FG001|Randomised, Double-blind|Adverse Event|9|||
143247926|NCT02167139|516460502|FG002|Randomised, Double-blind|Adverse Event|0|||
143247927|NCT02167139|516460503|FG003|Randomised, Double-blind|Adverse Event|0|||
143247928|NCT02167139|516460500|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
143247929|NCT02167139|516460501|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
143247930|NCT02167139|516460502|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
143247931|NCT02167139|516460503|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
143247932|NCT02167139|516460500|FG000|Randomised, Double-blind|Other|3|||
143071915|NCT05091307|515805924|FG002|Overall Study|Physician Decision|0|||
143071916|NCT05091307|515805925|FG003|Overall Study|Physician Decision|0|||
143071917|NCT05091307|515805922|FG000|Overall Study|Protocol Violation|1|||
143071918|NCT05091307|515805923|FG001|Overall Study|Protocol Violation|0|||
143071919|NCT05091307|515805924|FG002|Overall Study|Protocol Violation|0|||
143071920|NCT05091307|515805925|FG003|Overall Study|Protocol Violation|0|||
143071921|NCT05091307|515805922|FG000|Overall Study|Withdrawal by Subject|16|||
143071922|NCT05091307|515805923|FG001|Overall Study|Withdrawal by Subject|16|||
143071923|NCT05091307|515805924|FG002|Overall Study|Withdrawal by Subject|0|||
143071924|NCT05091307|515805925|FG003|Overall Study|Withdrawal by Subject|1|||
143071925|NCT05091307|515805922|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
143071926|NCT05091307|515805923|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
143071927|NCT05091307|515805924|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
143071928|NCT05091307|515805925|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
143071929|NCT05091307|515805922|FG000|Overall Study|Initiated Prohibited Medication|1|||
143071930|NCT05091307|515805923|FG001|Overall Study|Initiated Prohibited Medication|0|||
143071931|NCT05091307|515805924|FG002|Overall Study|Initiated Prohibited Medication|0|||
143071932|NCT05091307|515805925|FG003|Overall Study|Initiated Prohibited Medication|0|||
143071933|NCT05091307|515805922|FG000|Overall Study|Other|4|||
143071934|NCT05091307|515805923|FG001|Overall Study|Other|4|||
143071935|NCT05091307|515805924|FG002|Overall Study|Other|0|||
143071936|NCT05091307|515805925|FG003|Overall Study|Other|0|||
143071937|NCT05091307|515805922|FG000|Overall Study|Randomized but not vaccinated|0|||
143071938|NCT05091307|515805923|FG001|Overall Study|Randomized but not vaccinated|2|||
143071939|NCT05091307|515805924|FG002|Overall Study|Randomized but not vaccinated|0|||
143071940|NCT05091307|515805925|FG003|Overall Study|Randomized but not vaccinated|0|||
143071941|NCT03611543|515805926|FG000|Overall Study|Withdrawal by Subject|4|||
143071942|NCT03611543|515805927|FG001|Overall Study|Withdrawal by Subject|4|||
143071943|NCT03611543|515805926|FG000|Overall Study|Physician Decision|1|||
143071944|NCT03611543|515805927|FG001|Overall Study|Physician Decision|1|||
143071945|NCT03611543|515805926|FG000|Overall Study|Protocol Violation|2|||
143071946|NCT03611543|515805927|FG001|Overall Study|Protocol Violation|2|||
143071947|NCT03611543|515805926|FG000|Overall Study|Device failure|2|||
143071948|NCT03611543|515805927|FG001|Overall Study|Device failure|2|||
143071949|NCT03611543|515805926|FG000|Overall Study|Missing information|5|||
143071950|NCT03611543|515805927|FG001|Overall Study|Missing information|5|||
143071951|NCT04394351|515805928|FG000|Part A (16 Weeks)|Adverse Event|1|||
143071952|NCT04394351|515805929|FG001|Part A (16 Weeks)|Adverse Event|0|||
143071953|NCT04394351|515805930|FG002|Part A (16 Weeks)|Adverse Event|0|||
143071954|NCT04394351|515805931|FG003|Part A (16 Weeks)|Adverse Event|0|||
143071955|NCT04394351|515805932|FG004|Part A (16 Weeks)|Adverse Event|0|||
143071956|NCT04394351|515805933|FG005|Part A (16 Weeks)|Adverse Event|0|||
143071957|NCT04394351|515805934|FG006|Part A (16 Weeks)|Adverse Event|0|||
143071958|NCT04394351|515805935|FG007|Part A (16 Weeks)|Adverse Event|0|||
143247933|NCT02167139|516460501|FG001|Randomised, Double-blind|Other|0|||
143247934|NCT02167139|516460502|FG002|Randomised, Double-blind|Other|0|||
143247935|NCT02167139|516460503|FG003|Randomised, Double-blind|Other|0|||
143247936|NCT02167139|516460500|FG000|Transition-extension|Adverse Event|2|||
143247937|NCT02167139|516460501|FG001|Transition-extension|Adverse Event|0|||
143247938|NCT02167139|516460502|FG002|Transition-extension|Adverse Event|2|||
143247939|NCT02167139|516460503|FG003|Transition-extension|Adverse Event|3|||
143247940|NCT02167139|516460500|FG000|Transition-extension|Withdrawal by Subject|2|||
143247941|NCT02167139|516460501|FG001|Transition-extension|Withdrawal by Subject|0|||
143247942|NCT02167139|516460502|FG002|Transition-extension|Withdrawal by Subject|4|||
143071959|NCT04394351|515805928|FG000|Part A (16 Weeks)|Physician Decision|0|||
143071960|NCT04394351|515805929|FG001|Part A (16 Weeks)|Physician Decision|1|||
143071961|NCT04394351|515805930|FG002|Part A (16 Weeks)|Physician Decision|0|||
143071962|NCT04394351|515805931|FG003|Part A (16 Weeks)|Physician Decision|0|||
143071963|NCT04394351|515805932|FG004|Part A (16 Weeks)|Physician Decision|0|||
143071964|NCT04394351|515805933|FG005|Part A (16 Weeks)|Physician Decision|0|||
143071965|NCT04394351|515805934|FG006|Part A (16 Weeks)|Physician Decision|0|||
143071966|NCT04394351|515805935|FG007|Part A (16 Weeks)|Physician Decision|0|||
143071967|NCT04394351|515805928|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
143071968|NCT04394351|515805929|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
143247943|NCT02167139|516460503|FG003|Transition-extension|Withdrawal by Subject|1|||
143071969|NCT04394351|515805930|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
143071970|NCT04394351|515805931|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
143071971|NCT04394351|515805932|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
143071972|NCT04394351|515805933|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
143171469|NCT02921256|516176090|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
143171470|NCT02921256|516176091|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
143171471|NCT02921256|516176092|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
143171472|NCT02921256|516176090|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
143171473|NCT02921256|516176091|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
143171474|NCT02921256|516176092|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
143171475|NCT02921256|516176090|FG000|Arm Ib v Arm III|Physician Decision|4|||
143171476|NCT02921256|516176091|FG001|Arm Ib v Arm III|Physician Decision|0|||
143171477|NCT02921256|516176092|FG002|Arm Ib v Arm III|Physician Decision|1|||
143171478|NCT02921256|516176090|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
143171479|NCT02921256|516176091|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
143171480|NCT02921256|516176092|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
143171481|NCT01728246|516176093|FG000|Overall Study|Participant needed rescue medication|1|||
143171482|NCT01728246|516176094|FG001|Overall Study|Participant needed rescue medication|5|||
143171483|NCT01728246|516176093|FG000|Overall Study|Protocol Violation|1|||
143171484|NCT01728246|516176094|FG001|Overall Study|Protocol Violation|0|||
143171485|NCT01728246|516176093|FG000|Overall Study|Withdrawal by Subject|2|||
143171486|NCT01728246|516176094|FG001|Overall Study|Withdrawal by Subject|3|||
143171487|NCT01728246|516176093|FG000|Overall Study|Lost to Follow-up|23|||
143171488|NCT01728246|516176094|FG001|Overall Study|Lost to Follow-up|22|||
143171489|NCT01728246|516176093|FG000|Overall Study|Lack of Efficacy|1|||
143171490|NCT01728246|516176094|FG001|Overall Study|Lack of Efficacy|1|||
143171491|NCT01728246|516176093|FG000|Overall Study|Adverse Event|8|||
143171492|NCT01728246|516176094|FG001|Overall Study|Adverse Event|5|||
143171493|NCT01038323|516176095|FG000|Overall Study|Withdrawal by Subject|3|||
143171494|NCT01038323|516176096|FG001|Overall Study|Withdrawal by Subject|2|||
143171495|NCT01038323|516176097|FG002|Overall Study|Withdrawal by Subject|4|||
143171496|NCT01959932|516176101|FG000|Overall Study|Withdrawal by Subject|1|||
143171497|NCT01959932|516176102|FG001|Overall Study|Withdrawal by Subject|0|||
143171498|NCT01959932|516176103|FG002|Overall Study|Withdrawal by Subject|0|||
143171499|NCT00776230|516176104|FG000|Overall Study|Lost to Follow-up|2|||
143171500|NCT00776230|516176105|FG001|Overall Study|Lost to Follow-up|1|||
143171501|NCT00776230|516176106|FG002|Overall Study|Lost to Follow-up|5|||
143171502|NCT00776230|516176104|FG000|Overall Study|Not vaccinated at Day 0|1|||
143171503|NCT00776230|516176105|FG001|Overall Study|Not vaccinated at Day 0|0|||
143171504|NCT00776230|516176106|FG002|Overall Study|Not vaccinated at Day 0|0|||
143171505|NCT00776230|516176104|FG000|Overall Study|Withdrawal by Subject|0|||
143171506|NCT00776230|516176105|FG001|Overall Study|Withdrawal by Subject|1|||
143171507|NCT00776230|516176106|FG002|Overall Study|Withdrawal by Subject|0|||
143171508|NCT00776230|516176104|FG000|Overall Study|Subject missed Visit 4|0|||
143171509|NCT00776230|516176105|FG001|Overall Study|Subject missed Visit 4|1|||
143171510|NCT00776230|516176106|FG002|Overall Study|Subject missed Visit 4|0|||
143171511|NCT00485173|516176109|FG000|Overall Study|Death|4|||
143171512|NCT00485173|516176110|FG001|Overall Study|Death|3|||
143171513|NCT00485173|516176109|FG000|Overall Study|Lost to Follow-up|32|||
143171514|NCT00485173|516176110|FG001|Overall Study|Lost to Follow-up|61|||
143171515|NCT02297412|516176111|FG000|Overall Study|Canceled|1|||
143171516|NCT02297412|516176112|FG001|Overall Study|Canceled|1|||
143171517|NCT03110562|516176117|FG000|Initial Treatment Period|Disease Progression|1|||
143171518|NCT03110562|516176118|FG001|Initial Treatment Period|Disease Progression|1|||
143171519|NCT03110562|516176119|FG002|Initial Treatment Period|Disease Progression|0|||
143171520|NCT03110562|516176120|FG003|Initial Treatment Period|Disease Progression|0|||
143171521|NCT03110562|516176117|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
143171522|NCT03110562|516176118|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
143171523|NCT03110562|516176119|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
143171524|NCT03110562|516176120|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
143171525|NCT03110562|516176117|FG000|Initial Treatment Period|Adverse Event|1|||
143171526|NCT03110562|516176118|FG001|Initial Treatment Period|Adverse Event|0|||
143171527|NCT03110562|516176119|FG002|Initial Treatment Period|Adverse Event|0|||
143171528|NCT03110562|516176120|FG003|Initial Treatment Period|Adverse Event|0|||
143171529|NCT03110562|516176117|FG000|Initial Treatment Period|Death|74|||
143171530|NCT03110562|516176118|FG001|Initial Treatment Period|Death|82|||
143171531|NCT03110562|516176119|FG002|Initial Treatment Period|Death|0|||
143171532|NCT03110562|516176120|FG003|Initial Treatment Period|Death|0|||
143171533|NCT03110562|516176117|FG000|Initial Treatment Period|Lost to Follow-up|13|||
143171534|NCT03110562|516176118|FG001|Initial Treatment Period|Lost to Follow-up|8|||
143171535|NCT03110562|516176119|FG002|Initial Treatment Period|Lost to Follow-up|0|||
143171536|NCT03110562|516176120|FG003|Initial Treatment Period|Lost to Follow-up|0|||
143171537|NCT03110562|516176117|FG000|Initial Treatment Period|Protocol Deviation|1|||
143171538|NCT03110562|516176118|FG001|Initial Treatment Period|Protocol Deviation|0|||
143171539|NCT03110562|516176119|FG002|Initial Treatment Period|Protocol Deviation|0|||
143071973|NCT04394351|515805934|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
143071974|NCT04394351|515805935|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
143071975|NCT04394351|515805928|FG000|Part B (36 Weeks)|Adverse Event|0|||
143071976|NCT04394351|515805929|FG001|Part B (36 Weeks)|Adverse Event|0|||
143071977|NCT04394351|515805930|FG002|Part B (36 Weeks)|Adverse Event|0|||
143071978|NCT04394351|515805931|FG003|Part B (36 Weeks)|Adverse Event|0|||
143071979|NCT04394351|515805932|FG004|Part B (36 Weeks)|Adverse Event|0|||
143071980|NCT04394351|515805933|FG005|Part B (36 Weeks)|Adverse Event|0|||
143071981|NCT04394351|515805934|FG006|Part B (36 Weeks)|Adverse Event|1|||
143071982|NCT04394351|515805935|FG007|Part B (36 Weeks)|Adverse Event|0|||
143071983|NCT04394351|515805928|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
143071984|NCT04394351|515805929|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
143071985|NCT04394351|515805930|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
143071986|NCT04394351|515805931|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
143071987|NCT04394351|515805932|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
143071988|NCT04394351|515805933|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
143071989|NCT04394351|515805934|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
143071990|NCT04394351|515805935|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|3|||
143071991|NCT04394351|515805928|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
143071992|NCT04394351|515805929|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
143071993|NCT04394351|515805930|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
143071994|NCT04394351|515805931|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
143071995|NCT04394351|515805932|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
143071996|NCT04394351|515805933|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
143071997|NCT04394351|515805934|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
143071998|NCT04394351|515805935|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|16|||
143071999|NCT04394351|515805928|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
143072000|NCT04394351|515805929|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
143072001|NCT04394351|515805930|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
143072002|NCT04394351|515805931|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
143072003|NCT04394351|515805932|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
143072004|NCT04394351|515805933|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
143072005|NCT04394351|515805934|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
143072006|NCT04394351|515805935|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|2|||
143072007|NCT04394351|515805928|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
143072008|NCT04394351|515805929|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
143072009|NCT04394351|515805930|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
143072010|NCT04394351|515805931|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
143072011|NCT04394351|515805932|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
143072012|NCT04394351|515805933|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
143072013|NCT04394351|515805934|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
143072014|NCT04394351|515805935|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Other|32|||
143072015|NCT03653507|515805936|FG000|Overall Study|Miscellaneous|28|||
143072016|NCT03653507|515805937|FG001|Overall Study|Miscellaneous|19|||
143072017|NCT03653507|515805936|FG000|Overall Study|Withdrawal by Subject|37|||
143072018|NCT03653507|515805937|FG001|Overall Study|Withdrawal by Subject|22|||
143072019|NCT03653507|515805936|FG000|Overall Study|Protocol Deviation|2|||
143072020|NCT03653507|515805937|FG001|Overall Study|Protocol Deviation|1|||
143072021|NCT03653507|515805936|FG000|Overall Study|Progressive disease|117|||
143072022|NCT03653507|515805937|FG001|Overall Study|Progressive disease|168|||
143072023|NCT03653507|515805936|FG000|Overall Study|Lost to Follow-up|1|||
143072024|NCT03653507|515805937|FG001|Overall Study|Lost to Follow-up|1|||
143072025|NCT03653507|515805936|FG000|Overall Study|Death|25|||
143072026|NCT03653507|515805937|FG001|Overall Study|Death|22|||
143072027|NCT03653507|515805936|FG000|Overall Study|Adverse Event|35|||
143072028|NCT03653507|515805937|FG001|Overall Study|Adverse Event|14|||
143072029|NCT03047473|515805944|FG000|Overall Study|Lost to Follow-up|2|||
143072030|NCT05327816|515805945|FG000|Overall Study|Lost to Follow-up|1|||
143072031|NCT05327816|515805946|FG001|Overall Study|Lost to Follow-up|0|||
143072032|NCT05327816|515805947|FG002|Overall Study|Lost to Follow-up|0|||
143072033|NCT05327816|515805948|FG003|Overall Study|Lost to Follow-up|0|||
143072034|NCT05327816|515805949|FG004|Overall Study|Lost to Follow-up|0|||
143072035|NCT05327816|515805950|FG005|Overall Study|Lost to Follow-up|0|||
143072036|NCT05327816|515805951|FG006|Overall Study|Lost to Follow-up|0|||
143171540|NCT03110562|516176120|FG003|Initial Treatment Period|Protocol Deviation|0|||
143072037|NCT05327816|515805952|FG007|Overall Study|Lost to Follow-up|0|||
143072038|NCT05327816|515805953|FG008|Overall Study|Lost to Follow-up|0|||
143072039|NCT05327816|515805954|FG009|Overall Study|Lost to Follow-up|1|||
143072040|NCT05327816|515805955|FG010|Overall Study|Lost to Follow-up|0|||
143072041|NCT05327816|515805945|FG000|Overall Study|Withdrawal by Subject|0|||
143072042|NCT05327816|515805946|FG001|Overall Study|Withdrawal by Subject|0|||
143072043|NCT05327816|515805947|FG002|Overall Study|Withdrawal by Subject|0|||
143072044|NCT05327816|515805948|FG003|Overall Study|Withdrawal by Subject|0|||
143072045|NCT05327816|515805949|FG004|Overall Study|Withdrawal by Subject|1|||
143072046|NCT05327816|515805950|FG005|Overall Study|Withdrawal by Subject|1|||
143072047|NCT05327816|515805951|FG006|Overall Study|Withdrawal by Subject|0|||
143072048|NCT05327816|515805952|FG007|Overall Study|Withdrawal by Subject|0|||
143072049|NCT05327816|515805953|FG008|Overall Study|Withdrawal by Subject|0|||
143072050|NCT05327816|515805954|FG009|Overall Study|Withdrawal by Subject|0|||
143072051|NCT05327816|515805955|FG010|Overall Study|Withdrawal by Subject|0|||
143072052|NCT05327816|515805945|FG000|Overall Study|Study Terminated by Sponsor|11|||
143072053|NCT05327816|515805946|FG001|Overall Study|Study Terminated by Sponsor|12|||
143072054|NCT05327816|515805947|FG002|Overall Study|Study Terminated by Sponsor|12|||
143072055|NCT05327816|515805948|FG003|Overall Study|Study Terminated by Sponsor|12|||
143072056|NCT05327816|515805949|FG004|Overall Study|Study Terminated by Sponsor|11|||
143072057|NCT05327816|515805950|FG005|Overall Study|Study Terminated by Sponsor|11|||
143072058|NCT05327816|515805951|FG006|Overall Study|Study Terminated by Sponsor|11|||
143072059|NCT05327816|515805952|FG007|Overall Study|Study Terminated by Sponsor|11|||
143072060|NCT05327816|515805953|FG008|Overall Study|Study Terminated by Sponsor|11|||
143072061|NCT05327816|515805954|FG009|Overall Study|Study Terminated by Sponsor|11|||
143072062|NCT05327816|515805955|FG010|Overall Study|Study Terminated by Sponsor|12|||
143072063|NCT05327816|515805945|FG000|Overall Study|Randomized but not treated|0|||
143072064|NCT05327816|515805946|FG001|Overall Study|Randomized but not treated|0|||
143072065|NCT05327816|515805947|FG002|Overall Study|Randomized but not treated|0|||
143072066|NCT05327816|515805948|FG003|Overall Study|Randomized but not treated|0|||
143072067|NCT05327816|515805949|FG004|Overall Study|Randomized but not treated|0|||
143072068|NCT05327816|515805950|FG005|Overall Study|Randomized but not treated|0|||
143072069|NCT05327816|515805951|FG006|Overall Study|Randomized but not treated|1|||
143247944|NCT02167139|516460500|FG000|Transition-extension|Lack of Efficacy|0|||
143247945|NCT02167139|516460501|FG001|Transition-extension|Lack of Efficacy|0|||
143247946|NCT02167139|516460502|FG002|Transition-extension|Lack of Efficacy|1|||
143247947|NCT02167139|516460503|FG003|Transition-extension|Lack of Efficacy|1|||
143247948|NCT02167139|516460500|FG000|Transition-extension|Other|1|||
143072070|NCT05327816|515805952|FG007|Overall Study|Randomized but not treated|1|||
143072071|NCT05327816|515805953|FG008|Overall Study|Randomized but not treated|1|||
143072072|NCT05327816|515805954|FG009|Overall Study|Randomized but not treated|0|||
143072073|NCT05327816|515805955|FG010|Overall Study|Randomized but not treated|0|||
143072074|NCT01106014|515805956|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
143072075|NCT01106014|515805957|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
143072076|NCT01106014|515805956|FG000|Overall Study|Adverse Event|78|||
143072077|NCT01106014|515805957|FG001|Overall Study|Adverse Event|42|||
143072078|NCT01106014|515805956|FG000|Overall Study|Withdrawal by Subject|43|||
143072079|NCT01106014|515805957|FG001|Overall Study|Withdrawal by Subject|37|||
143072080|NCT01106014|515805956|FG000|Overall Study|Administrative reason|7|||
143072081|NCT01106014|515805957|FG001|Overall Study|Administrative reason|6|||
143072082|NCT01106014|515805956|FG000|Overall Study|Lost to Follow-up|2|||
143072083|NCT01106014|515805957|FG001|Overall Study|Lost to Follow-up|3|||
143072084|NCT03986138|515805959|FG000|First MRI Examination|Physician Decision|0|||
143072085|NCT03986138|515805960|FG001|First MRI Examination|Physician Decision|1|||
143072086|NCT03986138|515805959|FG000|First MRI Examination|Other reason (mainly technical issues with MRI machine)|1|||
143072087|NCT03986138|515805960|FG001|First MRI Examination|Other reason (mainly technical issues with MRI machine)|2|||
143072088|NCT03986138|515805959|FG000|Washout|Withdrawal by Subject|4|||
143072089|NCT03986138|515805960|FG001|Washout|Withdrawal by Subject|5|||
143072090|NCT03986138|515805959|FG000|Washout|Lost to Follow-up|0|||
143072091|NCT03986138|515805960|FG001|Washout|Lost to Follow-up|2|||
143072092|NCT03986138|515805959|FG000|Washout|Adverse Event|1|||
143072093|NCT03986138|515805960|FG001|Washout|Adverse Event|1|||
143072094|NCT03986138|515805959|FG000|Washout|Other reason|5|||
143072095|NCT03986138|515805960|FG001|Washout|Other reason|5|||
143072096|NCT03986138|515805959|FG000|Second MRI Examination|Withdrawal by Subject|0|||
143072097|NCT03986138|515805960|FG001|Second MRI Examination|Withdrawal by Subject|2|||
143072098|NCT04305587|515805962|FG000|Overall Study|Withdrawal by Subject|0|||
143072099|NCT04305587|515805963|FG001|Overall Study|Withdrawal by Subject|0|||
143247949|NCT02167139|516460501|FG001|Transition-extension|Other|0|||
143247950|NCT02167139|516460502|FG002|Transition-extension|Other|1|||
143247951|NCT02167139|516460503|FG003|Transition-extension|Other|0|||
143247952|NCT02167139|516460500|FG000|Transition-extension|Lost to Follow-up|1|||
143247953|NCT02167139|516460501|FG001|Transition-extension|Lost to Follow-up|0|||
143072100|NCT04305587|515805964|FG002|Overall Study|Withdrawal by Subject|0|||
143072101|NCT04305587|515805965|FG003|Overall Study|Withdrawal by Subject|1|||
143072102|NCT04305587|515805966|FG004|Overall Study|Withdrawal by Subject|0|||
143072103|NCT04305587|515805967|FG005|Overall Study|Withdrawal by Subject|0|||
143072104|NCT04305587|515805968|FG006|Overall Study|Withdrawal by Subject|0|||
143072105|NCT04305587|515805969|FG007|Overall Study|Withdrawal by Subject|0|||
143072106|NCT04305587|515805970|FG008|Overall Study|Withdrawal by Subject|0|||
143072107|NCT01200992|515805971|FG000|Overall Study|Study terminated early|35|||
143072108|NCT01200992|515805972|FG001|Overall Study|Study terminated early|41|||
143072109|NCT01200992|515805971|FG000|Overall Study|Randomized but not treated|2|||
143072110|NCT01200992|515805972|FG001|Overall Study|Randomized but not treated|0|||
143072111|NCT00792935|515805973|FG000|Overall Study|Adverse Event|2|||
143072112|NCT00792935|515805974|FG001|Overall Study|Adverse Event|1|||
143072113|NCT00792935|515805973|FG000|Overall Study|Lost to Follow-up|0|||
143072114|NCT00792935|515805974|FG001|Overall Study|Lost to Follow-up|1|||
143072115|NCT00792935|515805973|FG000|Overall Study|Protocol Violation|2|||
143072116|NCT00792935|515805974|FG001|Overall Study|Protocol Violation|0|||
143072117|NCT00792935|515805973|FG000|Overall Study|Withdrawal by Subject|0|||
143072118|NCT00792935|515805974|FG001|Overall Study|Withdrawal by Subject|1|||
143072119|NCT00368979|515805980|FG000|Overall Study|Adverse Event|9|||
143072120|NCT00368979|515805981|FG001|Overall Study|Adverse Event|16|||
143072121|NCT00368979|515805980|FG000|Overall Study|Lack of Efficacy|5|||
143072122|NCT00368979|515805981|FG001|Overall Study|Lack of Efficacy|3|||
143072123|NCT00368979|515805980|FG000|Overall Study|Other|3|||
143072124|NCT00368979|515805981|FG001|Overall Study|Other|1|||
143072125|NCT00368979|515805980|FG000|Overall Study|Lost to Follow-up|1|||
143072126|NCT00368979|515805981|FG001|Overall Study|Lost to Follow-up|0|||
143072127|NCT00368979|515805980|FG000|Overall Study|Protocol Violation|2|||
143072128|NCT00368979|515805981|FG001|Overall Study|Protocol Violation|1|||
143072129|NCT00368979|515805980|FG000|Overall Study|Withdrawal by Subject|5|||
143072130|NCT00368979|515805981|FG001|Overall Study|Withdrawal by Subject|9|||
143072131|NCT04112173|515805984|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
143072132|NCT02906930|515805985|FG000|Overall Study|Withdrawal by Subject|0|||
143072133|NCT02906930|515805986|FG001|Overall Study|Withdrawal by Subject|5|||
143072134|NCT02906930|515805987|FG002|Overall Study|Withdrawal by Subject|5|||
143072135|NCT02906930|515805988|FG003|Overall Study|Withdrawal by Subject|4|||
143072136|NCT02906930|515805985|FG000|Overall Study|Lost to Follow-up|5|||
143072137|NCT02906930|515805986|FG001|Overall Study|Lost to Follow-up|7|||
143072138|NCT02906930|515805987|FG002|Overall Study|Lost to Follow-up|5|||
143072139|NCT02906930|515805988|FG003|Overall Study|Lost to Follow-up|2|||
143072140|NCT02906930|515805985|FG000|Overall Study|Death|0|||
143072141|NCT02906930|515805986|FG001|Overall Study|Death|0|||
143072142|NCT02906930|515805987|FG002|Overall Study|Death|1|||
143072143|NCT02906930|515805988|FG003|Overall Study|Death|0|||
143072144|NCT02906930|515805985|FG000|Overall Study|Other|1|||
143072145|NCT02906930|515805986|FG001|Overall Study|Other|2|||
143072146|NCT02906930|515805987|FG002|Overall Study|Other|1|||
143072147|NCT02906930|515805988|FG003|Overall Study|Other|2|||
143072148|NCT00910091|515805989|FG000|Pre-assignment|Withdrawal by Subject|0|||
143072149|NCT00910091|515805990|FG001|Pre-assignment|Withdrawal by Subject|2|||
143072150|NCT00910091|515805989|FG000|Treatment and Survival|Withdrawal by Subject|3|||
143072151|NCT00910091|515805990|FG001|Treatment and Survival|Withdrawal by Subject|4|||
143072152|NCT00910091|515805989|FG000|Treatment and Survival|Adverse Event|1|||
143072153|NCT00910091|515805990|FG001|Treatment and Survival|Adverse Event|0|||
143072154|NCT01908816|515805991|FG000|Overall Study|Subject's no longer requires study drug|0|||
143072155|NCT01908816|515805992|FG001|Overall Study|Subject's no longer requires study drug|0|||
143072156|NCT01908816|515805993|FG002|Overall Study|Subject's no longer requires study drug|0|||
143072157|NCT01908816|515805994|FG003|Overall Study|Subject's no longer requires study drug|1|||
143072158|NCT01908816|515805991|FG000|Overall Study|Protocol deviation|1|||
143072159|NCT01908816|515805992|FG001|Overall Study|Protocol deviation|2|||
143072160|NCT01908816|515805993|FG002|Overall Study|Protocol deviation|1|||
143072161|NCT01908816|515805994|FG003|Overall Study|Protocol deviation|1|||
143072162|NCT01908816|515805991|FG000|Overall Study|Withdrawal by Subject|0|||
143072163|NCT01908816|515805992|FG001|Overall Study|Withdrawal by Subject|4|||
143072164|NCT01908816|515805993|FG002|Overall Study|Withdrawal by Subject|2|||
143072165|NCT01908816|515805994|FG003|Overall Study|Withdrawal by Subject|2|||
143072166|NCT01908816|515805991|FG000|Overall Study|Lost to Follow-up|3|||
143072167|NCT01908816|515805992|FG001|Overall Study|Lost to Follow-up|5|||
143072168|NCT01908816|515805993|FG002|Overall Study|Lost to Follow-up|4|||
143072169|NCT01908816|515805994|FG003|Overall Study|Lost to Follow-up|2|||
143072170|NCT01908816|515805991|FG000|Overall Study|Death|1|||
143072171|NCT01908816|515805992|FG001|Overall Study|Death|0|||
143072172|NCT01908816|515805993|FG002|Overall Study|Death|7|||
143072173|NCT01908816|515805994|FG003|Overall Study|Death|1|||
143072174|NCT01908816|515805991|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
143072175|NCT01908816|515805992|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
143072176|NCT01908816|515805993|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
143072177|NCT01908816|515805994|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
143072178|NCT01908816|515805991|FG000|Overall Study|Early termination|87|||
143072179|NCT01908816|515805992|FG001|Overall Study|Early termination|60|||
143072180|NCT01908816|515805993|FG002|Overall Study|Early termination|43|||
143072181|NCT01908816|515805994|FG003|Overall Study|Early termination|28|||
143072182|NCT00114166|515805995|FG000|Overall Study|Wrong primary|0|||
143072183|NCT00114166|515805996|FG001|Overall Study|Wrong primary|1|||
143072184|NCT01154816|515805997|FG000|Overall Study|Withdrawal by Subject|1|||
143072185|NCT01154816|515805998|FG001|Overall Study|Withdrawal by Subject|0|||
143072186|NCT01154816|515805999|FG002|Overall Study|Withdrawal by Subject|0|||
143072187|NCT01154816|515806000|FG003|Overall Study|Withdrawal by Subject|1|||
143365446|NCT00389519|516880787|FG000|Randomized|Did not receive study drug|2|||
143365447|NCT00389519|516880788|FG001|Randomized|Did not receive study drug|0|||
143171541|NCT03110562|516176117|FG000|Initial Treatment Period|Physician Decision|2|||
143171542|NCT03110562|516176118|FG001|Initial Treatment Period|Physician Decision|1|||
143171543|NCT03110562|516176119|FG002|Initial Treatment Period|Physician Decision|0|||
143171544|NCT03110562|516176120|FG003|Initial Treatment Period|Physician Decision|0|||
143171545|NCT03110562|516176117|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
143171546|NCT03110562|516176118|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
143171547|NCT03110562|516176119|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
143171548|NCT03110562|516176120|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
143171549|NCT03110562|516176117|FG000|Initial Treatment Period|Other|5|||
143171550|NCT03110562|516176118|FG001|Initial Treatment Period|Other|4|||
143171551|NCT03110562|516176119|FG002|Initial Treatment Period|Other|0|||
143171552|NCT03110562|516176120|FG003|Initial Treatment Period|Other|0|||
143171553|NCT03110562|516176117|FG000|Initial Treatment Period|Randomized but never treated|0|||
143171554|NCT03110562|516176118|FG001|Initial Treatment Period|Randomized but never treated|3|||
143171555|NCT03110562|516176119|FG002|Initial Treatment Period|Randomized but never treated|0|||
143247954|NCT02167139|516460502|FG002|Transition-extension|Lost to Follow-up|0|||
143247955|NCT02167139|516460503|FG003|Transition-extension|Lost to Follow-up|0|||
143247956|NCT00312195|516460504|FG000|Overall Study|Adverse Event|4|||
143247957|NCT00312195|516460505|FG001|Overall Study|Adverse Event|6|||
143247958|NCT00312195|516460504|FG000|Overall Study|Lost to Follow-up|1|||
143247959|NCT00312195|516460505|FG001|Overall Study|Lost to Follow-up|0|||
143247960|NCT00312195|516460504|FG000|Overall Study|Protocol Violation|1|||
143247961|NCT00312195|516460505|FG001|Overall Study|Protocol Violation|0|||
143247962|NCT02511106|516460508|FG000|Overall Study|Lost to Follow-up|6|||
143247963|NCT02511106|516460509|FG001|Overall Study|Lost to Follow-up|4|||
143247964|NCT02511106|516460508|FG000|Overall Study|Withdrawal by Subject|24|||
143365448|NCT00389519|516880789|FG002|Randomized|Did not receive study drug|0|||
143365449|NCT00389519|516880790|FG003|Randomized|Did not receive study drug|0|||
143365450|NCT00389519|516880787|FG000|Treated|Adverse Event|1|||
143247965|NCT02511106|516460509|FG001|Overall Study|Withdrawal by Subject|21|||
143365451|NCT00389519|516880788|FG001|Treated|Adverse Event|0|||
143365452|NCT00389519|516880789|FG002|Treated|Adverse Event|0|||
143247966|NCT02511106|516460508|FG000|Overall Study|Death|42|||
143072188|NCT01154816|515806001|FG004|Overall Study|Withdrawal by Subject|0|||
143072189|NCT01154816|515806002|FG005|Overall Study|Withdrawal by Subject|0|||
143072190|NCT01154816|515806003|FG006|Overall Study|Withdrawal by Subject|0|||
143072191|NCT01154816|515806004|FG007|Overall Study|Withdrawal by Subject|0|||
143072192|NCT01154816|515806005|FG008|Overall Study|Withdrawal by Subject|1|||
143072193|NCT01154816|515806006|FG009|Overall Study|Withdrawal by Subject|3|||
143072194|NCT01154816|515806007|FG010|Overall Study|Withdrawal by Subject|0|||
143072195|NCT01154816|515806008|FG011|Overall Study|Withdrawal by Subject|0|||
143072196|NCT01154816|515805997|FG000|Overall Study|Progressive Disease|13|||
143072197|NCT01154816|515805998|FG001|Overall Study|Progressive Disease|8|||
143072198|NCT01154816|515805999|FG002|Overall Study|Progressive Disease|9|||
143072199|NCT01154816|515806000|FG003|Overall Study|Progressive Disease|9|||
143072200|NCT01154816|515806001|FG004|Overall Study|Progressive Disease|8|||
143072201|NCT01154816|515806002|FG005|Overall Study|Progressive Disease|8|||
143072202|NCT01154816|515806003|FG006|Overall Study|Progressive Disease|5|||
143072203|NCT01154816|515806004|FG007|Overall Study|Progressive Disease|6|||
143072204|NCT01154816|515806005|FG008|Overall Study|Progressive Disease|8|||
143072205|NCT01154816|515806006|FG009|Overall Study|Progressive Disease|6|||
143072206|NCT01154816|515806007|FG010|Overall Study|Progressive Disease|10|||
143072207|NCT01154816|515806008|FG011|Overall Study|Progressive Disease|3|||
143072208|NCT01154816|515805997|FG000|Overall Study|Physician Decision|1|||
143072209|NCT01154816|515805998|FG001|Overall Study|Physician Decision|0|||
143072210|NCT01154816|515805999|FG002|Overall Study|Physician Decision|1|||
143072211|NCT01154816|515806000|FG003|Overall Study|Physician Decision|0|||
143072212|NCT01154816|515806001|FG004|Overall Study|Physician Decision|2|||
143072213|NCT01154816|515806002|FG005|Overall Study|Physician Decision|0|||
143072214|NCT01154816|515806003|FG006|Overall Study|Physician Decision|0|||
143072215|NCT01154816|515806004|FG007|Overall Study|Physician Decision|0|||
143072216|NCT01154816|515806005|FG008|Overall Study|Physician Decision|0|||
143072217|NCT01154816|515806006|FG009|Overall Study|Physician Decision|1|||
143072218|NCT01154816|515806007|FG010|Overall Study|Physician Decision|1|||
143072219|NCT01154816|515806008|FG011|Overall Study|Physician Decision|1|||
143072220|NCT01154816|515805997|FG000|Overall Study|Adverse Event|5|||
143072221|NCT01154816|515805998|FG001|Overall Study|Adverse Event|2|||
143072222|NCT01154816|515805999|FG002|Overall Study|Adverse Event|0|||
143072223|NCT01154816|515806000|FG003|Overall Study|Adverse Event|0|||
143072224|NCT01154816|515806001|FG004|Overall Study|Adverse Event|0|||
143072225|NCT01154816|515806002|FG005|Overall Study|Adverse Event|0|||
143072226|NCT01154816|515806003|FG006|Overall Study|Adverse Event|1|||
143072227|NCT01154816|515806004|FG007|Overall Study|Adverse Event|1|||
143072228|NCT01154816|515806005|FG008|Overall Study|Adverse Event|0|||
143072229|NCT01154816|515806006|FG009|Overall Study|Adverse Event|0|||
143072230|NCT01154816|515806007|FG010|Overall Study|Adverse Event|0|||
143072231|NCT01154816|515806008|FG011|Overall Study|Adverse Event|0|||
143072232|NCT03560986|515806009|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
143072233|NCT03560986|515806010|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
143171556|NCT03110562|516176120|FG003|Initial Treatment Period|Randomized but never treated|0|||
143171557|NCT03110562|516176117|FG000|Crossover Period|Disease Progression|0|||
143171558|NCT03110562|516176118|FG001|Crossover Period|Disease Progression|0|||
143171559|NCT03110562|516176119|FG002|Crossover Period|Disease Progression|1|||
143171560|NCT03110562|516176120|FG003|Crossover Period|Disease Progression|0|||
143171561|NCT03110562|516176117|FG000|Crossover Period|Withdrawal by Subject|0|||
143171562|NCT03110562|516176118|FG001|Crossover Period|Withdrawal by Subject|0|||
143365453|NCT00389519|516880790|FG003|Treated|Adverse Event|2|||
143072234|NCT03560986|515806009|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
143072235|NCT03560986|515806010|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
143072236|NCT03560986|515806009|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
143072237|NCT03560986|515806010|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
143072238|NCT03560986|515806009|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
143072239|NCT03560986|515806010|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
143072240|NCT03560986|515806009|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
143072241|NCT03560986|515806010|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
143247967|NCT02511106|516460509|FG001|Overall Study|Death|82|||
143072242|NCT03560986|515806009|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
143072243|NCT03560986|515806010|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
143072244|NCT03560986|515806009|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
143072245|NCT03560986|515806010|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
143072246|NCT00977379|515806022|FG000|Overall Study|Withdrawal by Subject|1|||
143072247|NCT00977379|515806023|FG001|Overall Study|Withdrawal by Subject|1|||
143072248|NCT00977379|515806022|FG000|Overall Study|Death|7|||
143072249|NCT00977379|515806023|FG001|Overall Study|Death|9|||
143072250|NCT00977379|515806022|FG000|Overall Study|Premature Study Termination|4|||
143072251|NCT00977379|515806023|FG001|Overall Study|Premature Study Termination|0|||
143072252|NCT00977379|515806022|FG000|Overall Study|Participant Moving House|0|||
143072253|NCT00977379|515806023|FG001|Overall Study|Participant Moving House|1|||
143072254|NCT00977379|515806022|FG000|Overall Study|Randomization Error|0|||
143072255|NCT00977379|515806023|FG001|Overall Study|Randomization Error|1|||
143072256|NCT02603393|515806024|FG000|Overall Study|Patient/guardian decision|32|||
143072257|NCT02603393|515806025|FG001|Overall Study|Patient/guardian decision|18|||
143072258|NCT02603393|515806024|FG000|Overall Study|Adverse Event|17|||
143072259|NCT02603393|515806025|FG001|Overall Study|Adverse Event|15|||
143072260|NCT02603393|515806024|FG000|Overall Study|Technical problems|4|||
143072261|NCT02603393|515806025|FG001|Overall Study|Technical problems|7|||
143072262|NCT02603393|515806024|FG000|Overall Study|Lack of Efficacy|7|||
143072263|NCT02603393|515806025|FG001|Overall Study|Lack of Efficacy|2|||
143072264|NCT02603393|515806024|FG000|Overall Study|Death|3|||
143072265|NCT02603393|515806025|FG001|Overall Study|Death|4|||
143072266|NCT02603393|515806024|FG000|Overall Study|Physician Decision|3|||
143072267|NCT02603393|515806025|FG001|Overall Study|Physician Decision|3|||
143072268|NCT02603393|515806024|FG000|Overall Study|Protocol deviation|2|||
143072269|NCT02603393|515806025|FG001|Overall Study|Protocol deviation|3|||
143072270|NCT02603393|515806024|FG000|Overall Study|Lost to Follow-up|1|||
143072271|NCT02603393|515806025|FG001|Overall Study|Lost to Follow-up|2|||
143072272|NCT02603393|515806024|FG000|Overall Study|Non-compliance with study treatment|1|||
143072273|NCT02603393|515806025|FG001|Overall Study|Non-compliance with study treatment|0|||
143072274|NCT02603393|515806024|FG000|Overall Study|Sponsor decision|1|||
143072275|NCT02603393|515806025|FG001|Overall Study|Sponsor decision|0|||
143072276|NCT00593736|515806026|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
143072277|NCT00593736|515806027|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
143072278|NCT00593736|515806028|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
143072279|NCT00593736|515806029|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
143072280|NCT00593736|515806026|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
143072281|NCT00593736|515806027|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
143072282|NCT00593736|515806028|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
143072283|NCT00593736|515806029|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
143072284|NCT00593736|515806026|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
143072285|NCT00593736|515806027|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
143072286|NCT00593736|515806028|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
143072287|NCT00593736|515806029|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
143072288|NCT00593736|515806026|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
143072289|NCT00593736|515806027|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
143072290|NCT00593736|515806028|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
143072291|NCT00593736|515806029|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
143072292|NCT00593736|515806026|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
143072293|NCT00593736|515806027|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
143072294|NCT00593736|515806028|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
143072295|NCT00593736|515806029|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
143072296|NCT00593736|515806026|FG000|Screening Period and Placebo Run-in|Various|0|||
143072297|NCT00593736|515806027|FG001|Screening Period and Placebo Run-in|Various|0|||
143072298|NCT00593736|515806028|FG002|Screening Period and Placebo Run-in|Various|0|||
143072299|NCT00593736|515806029|FG003|Screening Period and Placebo Run-in|Various|25|||
143072300|NCT00593736|515806026|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
143072301|NCT00593736|515806027|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
143072302|NCT00593736|515806028|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
143072303|NCT00593736|515806029|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
143072304|NCT00593736|515806026|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
143072305|NCT00593736|515806027|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
143072306|NCT00593736|515806028|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
143072307|NCT00593736|515806029|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
143072308|NCT00593736|515806026|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
143072309|NCT00593736|515806027|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
143072310|NCT00593736|515806028|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
143072311|NCT00593736|515806029|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
143072312|NCT00593736|515806026|FG000|Treatment Period and Placebo Run-out|Various|1|||
143072313|NCT00593736|515806027|FG001|Treatment Period and Placebo Run-out|Various|1|||
143072314|NCT00593736|515806028|FG002|Treatment Period and Placebo Run-out|Various|1|||
143072315|NCT00593736|515806029|FG003|Treatment Period and Placebo Run-out|Various|0|||
143072316|NCT01868893|515806030|FG000|Overall Study|Adverse Event|2|||
143072317|NCT01868893|515806030|FG000|Overall Study|Commercial availability of study drug|17|||
143072318|NCT01868893|515806030|FG000|Overall Study|Neutropenia|1|||
143072319|NCT01857271|515806031|FG000|Overall Study|Lost to Follow-up|1|||
143072320|NCT03825341|515806032|FG000|Overall Study|Withdrawal by Subject|0|||
143072321|NCT03825341|515806033|FG001|Overall Study|Withdrawal by Subject|1|||
143365454|NCT00389519|516880787|FG000|Treated|Reason not specified|1|||
143365455|NCT00389519|516880788|FG001|Treated|Reason not specified|1|||
143365456|NCT00389519|516880789|FG002|Treated|Reason not specified|0|||
143072322|NCT04283500|515806034|FG000|Overall Study|Lost to Follow-up|8|||
143114963|NCT02326298|515962470|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
143365457|NCT00389519|516880790|FG003|Treated|Reason not specified|2|||
143365458|NCT00946192|516880791|FG000|Overall Study|Lost to Follow-up|6|||
143171563|NCT03110562|516176119|FG002|Crossover Period|Withdrawal by Subject|8|||
143171564|NCT03110562|516176120|FG003|Crossover Period|Withdrawal by Subject|6|||
143171565|NCT03110562|516176117|FG000|Crossover Period|Death|0|||
143171566|NCT03110562|516176118|FG001|Crossover Period|Death|0|||
143171567|NCT03110562|516176119|FG002|Crossover Period|Death|37|||
143171568|NCT03110562|516176120|FG003|Crossover Period|Death|3|||
143171569|NCT03110562|516176117|FG000|Crossover Period|Lost to Follow-up|0|||
143171570|NCT03110562|516176118|FG001|Crossover Period|Lost to Follow-up|0|||
143171571|NCT03110562|516176119|FG002|Crossover Period|Lost to Follow-up|0|||
143171572|NCT03110562|516176120|FG003|Crossover Period|Lost to Follow-up|1|||
143171573|NCT03110562|516176117|FG000|Crossover Period|Other|0|||
143171574|NCT03110562|516176118|FG001|Crossover Period|Other|0|||
143171575|NCT03110562|516176119|FG002|Crossover Period|Other|1|||
143171576|NCT03110562|516176120|FG003|Crossover Period|Other|1|||
143171577|NCT03110562|516176117|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
143171578|NCT03110562|516176118|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
143171579|NCT03110562|516176119|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
143171580|NCT03110562|516176120|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
143171581|NCT03012880|516176126|FG000|Overall Study|Withdrawal by Subject|1|||
143171582|NCT03012880|516176127|FG001|Overall Study|Withdrawal by Subject|0|||
143171583|NCT03012880|516176126|FG000|Overall Study|Ineligible|1|||
143171584|NCT03012880|516176127|FG001|Overall Study|Ineligible|0|||
143171585|NCT01897493|516178404|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
143171586|NCT00805389|516178407|FG000|Overall Study|Adverse Event|0|||
143171587|NCT00805389|516178408|FG001|Overall Study|Adverse Event|0|||
143171588|NCT00805389|516178409|FG002|Overall Study|Adverse Event|1|||
143171589|NCT00805389|516178410|FG003|Overall Study|Adverse Event|2|||
143171590|NCT00805389|516178411|FG004|Overall Study|Adverse Event|0|||
143171591|NCT00805389|516178407|FG000|Overall Study|Lost to Follow-up|4|||
143171592|NCT00805389|516178408|FG001|Overall Study|Lost to Follow-up|3|||
143247968|NCT02511106|516460508|FG000|Overall Study|Ongoing study at data cut-off|3|||
143171593|NCT00805389|516178409|FG002|Overall Study|Lost to Follow-up|6|||
143171594|NCT00805389|516178410|FG003|Overall Study|Lost to Follow-up|10|||
143171595|NCT00805389|516178411|FG004|Overall Study|Lost to Follow-up|9|||
143365459|NCT00946192|516880792|FG001|Overall Study|Lost to Follow-up|11|||
143365460|NCT00946192|516880793|FG002|Overall Study|Lost to Follow-up|9|||
143365461|NCT00946192|516880791|FG000|Overall Study|Withdrawal by Subject|10|||
143365462|NCT00946192|516880792|FG001|Overall Study|Withdrawal by Subject|7|||
143365463|NCT00946192|516880793|FG002|Overall Study|Withdrawal by Subject|3|||
143365464|NCT00946192|516880791|FG000|Overall Study|Did not start medication|2|||
143365465|NCT00946192|516880792|FG001|Overall Study|Did not start medication|0|||
143365466|NCT00946192|516880793|FG002|Overall Study|Did not start medication|0|||
143365467|NCT01560949|516880794|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
143365468|NCT01560949|516880794|FG000|Surgery Phase|Physician Decision|3|||
143365469|NCT01562743|516880797|FG000|Overall Study|Adverse Event|29|||
143365470|NCT01562743|516880797|FG000|Overall Study|Lack of Efficacy|3|||
143365471|NCT01562743|516880797|FG000|Overall Study|Withdrawal by Subject|13|||
143365472|NCT01562743|516880797|FG000|Overall Study|Protocol Violation|1|||
143365473|NCT01562743|516880797|FG000|Overall Study|Discontinuation criteria|2|||
143365474|NCT01562743|516880797|FG000|Overall Study|Lost to Follow-up|2|||
143365475|NCT01562743|516880797|FG000|Overall Study|Physician Decision|2|||
143365476|NCT04155424|516880798|FG000|Overall Study|Other than specified|3|||
143365477|NCT04155424|516880798|FG000|Overall Study|Withdrawal by Subject|1|||
143365478|NCT04155424|516880798|FG000|Overall Study|Adverse Event|1|||
143365479|NCT04159506|516880799|FG000|Overall Study|Lost to Follow-up|2|||
143365480|NCT04159506|516880800|FG001|Overall Study|Lost to Follow-up|5|||
143365481|NCT02449044|516880801|FG000|Overall Study|Lost to Follow-up|2|||
143365482|NCT02449044|516880801|FG000|Overall Study|Withdrawal by Subject|13|||
143365483|NCT02449044|516880801|FG000|Overall Study|Adverse Event|30|||
143365484|NCT02449044|516880801|FG000|Overall Study|Met Withdrawal Criteria|7|||
143365485|NCT02449044|516880801|FG000|Overall Study|Physician Decision|9|||
143365486|NCT02449044|516880801|FG000|Overall Study|Sponsor Discontinued Trial|3|||
143365487|NCT00662909|516880803|FG000|Overall Study|Adverse Event|17|||
143365488|NCT00662909|516880804|FG001|Overall Study|Adverse Event|18|||
143365489|NCT00662909|516880805|FG002|Overall Study|Adverse Event|19|||
143365490|NCT00662909|516880803|FG000|Overall Study|Lack of Efficacy|9|||
143365491|NCT00662909|516880804|FG001|Overall Study|Lack of Efficacy|1|||
143365492|NCT00662909|516880805|FG002|Overall Study|Lack of Efficacy|5|||
143365493|NCT00662909|516880803|FG000|Overall Study|Withdrawal by Subject|29|||
143365494|NCT00662909|516880804|FG001|Overall Study|Withdrawal by Subject|22|||
143365495|NCT00662909|516880805|FG002|Overall Study|Withdrawal by Subject|16|||
143365496|NCT00662909|516880803|FG000|Overall Study|Lost to Follow-up|2|||
143072323|NCT04283500|515806034|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
143072324|NCT04053465|515806040|FG000|Overall Study|Withdrawal by Subject|4|||
143072325|NCT04053465|515806041|FG001|Overall Study|Withdrawal by Subject|4|||
143072326|NCT01468818|515806044|FG000|Overall Study|Death during treatment|2|||
143072327|NCT01059344|515806046|FG000|Overall Study|Adverse Event|12|||
143072328|NCT01059344|515806047|FG001|Overall Study|Adverse Event|30|||
143072329|NCT01059344|515806046|FG000|Overall Study|Withdrawal by Subject|6|||
143072330|NCT01059344|515806047|FG001|Overall Study|Withdrawal by Subject|9|||
143072331|NCT01059344|515806046|FG000|Overall Study|Lost to Follow-up|1|||
143072332|NCT01059344|515806047|FG001|Overall Study|Lost to Follow-up|1|||
143072333|NCT01059344|515806046|FG000|Overall Study|Other|3|||
143072334|NCT01059344|515806047|FG001|Overall Study|Other|6|||
143072335|NCT01739348|515806048|FG000|Part I (Base Study)|Adverse Event|41|||
143072336|NCT01739348|515806049|FG001|Part I (Base Study)|Adverse Event|52|||
143072337|NCT01739348|515806050|FG002|Part I (Base Study)|Adverse Event|8|||
143072338|NCT01739348|515806051|FG003|Part I (Base Study)|Adverse Event|33|||
143365497|NCT00662909|516880804|FG001|Overall Study|Lost to Follow-up|9|||
143365498|NCT00662909|516880805|FG002|Overall Study|Lost to Follow-up|3|||
143365499|NCT00662909|516880803|FG000|Overall Study|Protocol Violation|7|||
143072339|NCT01739348|515806048|FG000|Part I (Base Study)|Death|10|||
143072340|NCT01739348|515806049|FG001|Part I (Base Study)|Death|7|||
143365500|NCT00662909|516880804|FG001|Overall Study|Protocol Violation|4|||
143072341|NCT01739348|515806050|FG002|Part I (Base Study)|Death|2|||
143365501|NCT00662909|516880805|FG002|Overall Study|Protocol Violation|5|||
143365502|NCT00662909|516880803|FG000|Overall Study|Randomized- never received study drug|1|||
143365503|NCT00662909|516880804|FG001|Overall Study|Randomized- never received study drug|0|||
143365504|NCT00662909|516880805|FG002|Overall Study|Randomized- never received study drug|0|||
143365505|NCT00662909|516880803|FG000|Overall Study|Non-compliance with study procedures|3|||
143072342|NCT01739348|515806051|FG003|Part I (Base Study)|Death|8|||
143072343|NCT01739348|515806048|FG000|Part I (Base Study)|Lack of Efficacy|3|||
143072344|NCT01739348|515806049|FG001|Part I (Base Study)|Lack of Efficacy|8|||
143072345|NCT01739348|515806050|FG002|Part I (Base Study)|Lack of Efficacy|0|||
143072346|NCT01739348|515806051|FG003|Part I (Base Study)|Lack of Efficacy|7|||
143072347|NCT01739348|515806048|FG000|Part I (Base Study)|Lost to Follow-up|4|||
143072348|NCT01739348|515806049|FG001|Part I (Base Study)|Lost to Follow-up|2|||
143072349|NCT01739348|515806050|FG002|Part I (Base Study)|Lost to Follow-up|4|||
143072350|NCT01739348|515806051|FG003|Part I (Base Study)|Lost to Follow-up|4|||
143072351|NCT01739348|515806048|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
143072352|NCT01739348|515806049|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
143072353|NCT01739348|515806050|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
143072354|NCT01739348|515806051|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
143072355|NCT01739348|515806048|FG000|Part I (Base Study)|Physician Decision|10|||
143072356|NCT01739348|515806049|FG001|Part I (Base Study)|Physician Decision|7|||
143072357|NCT01739348|515806050|FG002|Part I (Base Study)|Physician Decision|1|||
143072358|NCT01739348|515806051|FG003|Part I (Base Study)|Physician Decision|4|||
143072359|NCT01739348|515806048|FG000|Part I (Base Study)|Protocol Violation|2|||
143072360|NCT01739348|515806049|FG001|Part I (Base Study)|Protocol Violation|0|||
143072361|NCT01739348|515806050|FG002|Part I (Base Study)|Protocol Violation|1|||
143072362|NCT01739348|515806051|FG003|Part I (Base Study)|Protocol Violation|2|||
143072363|NCT01739348|515806048|FG000|Part I (Base Study)|Screen Failure|2|||
143072364|NCT01739348|515806049|FG001|Part I (Base Study)|Screen Failure|0|||
143072365|NCT01739348|515806050|FG002|Part I (Base Study)|Screen Failure|0|||
143072366|NCT01739348|515806051|FG003|Part I (Base Study)|Screen Failure|0|||
143072367|NCT01739348|515806048|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
143072368|NCT01739348|515806049|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
143072369|NCT01739348|515806050|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
143072370|NCT01739348|515806051|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
143072371|NCT01739348|515806048|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
143072372|NCT01739348|515806049|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
143072373|NCT01739348|515806050|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
143171596|NCT00805389|516178407|FG000|Overall Study|Protocol Violation|0|||
143171597|NCT00805389|516178408|FG001|Overall Study|Protocol Violation|0|||
143171598|NCT00805389|516178409|FG002|Overall Study|Protocol Violation|1|||
143171599|NCT00805389|516178410|FG003|Overall Study|Protocol Violation|0|||
143171600|NCT00805389|516178411|FG004|Overall Study|Protocol Violation|0|||
143171601|NCT00805389|516178407|FG000|Overall Study|Withdrawal by Subject|3|||
143171602|NCT00805389|516178408|FG001|Overall Study|Withdrawal by Subject|2|||
143171603|NCT00805389|516178409|FG002|Overall Study|Withdrawal by Subject|4|||
143171604|NCT00805389|516178410|FG003|Overall Study|Withdrawal by Subject|5|||
143171605|NCT00805389|516178411|FG004|Overall Study|Withdrawal by Subject|4|||
143171606|NCT01276704|516178415|FG000|Overall Study|Lost to Follow-up|2|||
143171607|NCT01276704|516178416|FG001|Overall Study|Lost to Follow-up|3|||
143072374|NCT01739348|515806051|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
143072375|NCT01739348|515806048|FG000|Part I (Base Study)|Participant Moved|4|||
143072376|NCT01739348|515806049|FG001|Part I (Base Study)|Participant Moved|3|||
143072377|NCT01739348|515806050|FG002|Part I (Base Study)|Participant Moved|1|||
143072378|NCT01739348|515806051|FG003|Part I (Base Study)|Participant Moved|7|||
143072379|NCT01739348|515806048|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
143072380|NCT01739348|515806049|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
143072381|NCT01739348|515806050|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
143072382|NCT01739348|515806051|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
143072383|NCT01739348|515806048|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
143072384|NCT01739348|515806049|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
143072385|NCT01739348|515806050|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
143072386|NCT01739348|515806051|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
143072387|NCT01739348|515806048|FG000|Part II (Extension Study)|Adverse Event|10|||
143072388|NCT01739348|515806049|FG001|Part II (Extension Study)|Adverse Event|11|||
143072389|NCT01739348|515806050|FG002|Part II (Extension Study)|Adverse Event|7|||
143072390|NCT01739348|515806051|FG003|Part II (Extension Study)|Adverse Event|26|||
143072391|NCT01739348|515806048|FG000|Part II (Extension Study)|Death|3|||
143072392|NCT01739348|515806049|FG001|Part II (Extension Study)|Death|3|||
143072393|NCT01739348|515806050|FG002|Part II (Extension Study)|Death|2|||
143171608|NCT01276704|516178415|FG000|Overall Study|Non-compliant|2|||
143171609|NCT01276704|516178416|FG001|Overall Study|Non-compliant|2|||
143171610|NCT01276704|516178415|FG000|Overall Study|Withdrawal by Subject|7|||
143171611|NCT01276704|516178416|FG001|Overall Study|Withdrawal by Subject|1|||
143171612|NCT01276704|516178415|FG000|Overall Study|Physician Decision|3|||
143072394|NCT01739348|515806051|FG003|Part II (Extension Study)|Death|6|||
143072395|NCT01739348|515806048|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
143072396|NCT01739348|515806049|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
143072397|NCT01739348|515806050|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
143072398|NCT01739348|515806051|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
143072399|NCT01739348|515806048|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
143072400|NCT01739348|515806049|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
143072401|NCT01739348|515806050|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
143072402|NCT01739348|515806051|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
143072403|NCT01739348|515806048|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
143072404|NCT01739348|515806049|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
143072405|NCT01739348|515806050|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
143072406|NCT01739348|515806051|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
143171613|NCT01276704|516178416|FG001|Overall Study|Physician Decision|5|||
143171614|NCT01359956|516178417|FG000|Overall Study|Death|58|||
143171615|NCT01359956|516178418|FG001|Overall Study|Death|60|||
143171616|NCT01359956|516178419|FG002|Overall Study|Death|66|||
143171617|NCT01359956|516178420|FG003|Overall Study|Death|57|||
143171618|NCT01359956|516178417|FG000|Overall Study|Lost to Follow-up|3|||
143072407|NCT01739348|515806048|FG000|Part II (Extension Study)|Physician Decision|7|||
143072408|NCT01739348|515806049|FG001|Part II (Extension Study)|Physician Decision|11|||
143171619|NCT01359956|516178418|FG001|Overall Study|Lost to Follow-up|4|||
143171620|NCT01359956|516178419|FG002|Overall Study|Lost to Follow-up|1|||
143171621|NCT01359956|516178420|FG003|Overall Study|Lost to Follow-up|1|||
143072409|NCT01739348|515806050|FG002|Part II (Extension Study)|Physician Decision|6|||
143072410|NCT01739348|515806051|FG003|Part II (Extension Study)|Physician Decision|12|||
143072411|NCT01739348|515806048|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
143072412|NCT01739348|515806049|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
143072413|NCT01739348|515806050|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
143072414|NCT01739348|515806051|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
143072415|NCT01739348|515806048|FG000|Part II (Extension Study)|Participant Moved|3|||
143072416|NCT01739348|515806049|FG001|Part II (Extension Study)|Participant Moved|3|||
143072417|NCT01739348|515806050|FG002|Part II (Extension Study)|Participant Moved|0|||
143072418|NCT01739348|515806051|FG003|Part II (Extension Study)|Participant Moved|3|||
143072419|NCT01739348|515806048|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
143072420|NCT01739348|515806049|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
143072421|NCT01739348|515806050|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
143072422|NCT01739348|515806051|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
143072423|NCT01739348|515806048|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
143072424|NCT01739348|515806049|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
143072425|NCT01739348|515806050|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
143072426|NCT01739348|515806051|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
143072427|NCT00660400|515806054|FG000|Overall Study|Lack of insurance approval|1|||
143072428|NCT00660400|515806054|FG000|Overall Study|Suboptimal organ function|1|||
143072429|NCT00660400|515806054|FG000|Overall Study|Intracranial hemorrhage|1|||
143072430|NCT00660400|515806054|FG000|Overall Study|Withdrawal by Subject|1|||
143072431|NCT01085201|515806055|FG000|Overall Study|Scheduling conflict|1|||
143072432|NCT01085201|515806056|FG001|Overall Study|Scheduling conflict|0|||
143072433|NCT01085201|515806057|FG002|Overall Study|Scheduling conflict|1|||
143072434|NCT01085201|515806058|FG003|Overall Study|Scheduling conflict|0|||
143072435|NCT01085201|515806059|FG004|Overall Study|Scheduling conflict|0|||
143072436|NCT01085201|515806055|FG000|Overall Study|Unknown- no study drug|2|||
143072437|NCT01085201|515806056|FG001|Overall Study|Unknown- no study drug|0|||
143072438|NCT01085201|515806057|FG002|Overall Study|Unknown- no study drug|0|||
143072439|NCT01085201|515806058|FG003|Overall Study|Unknown- no study drug|0|||
143072440|NCT01085201|515806059|FG004|Overall Study|Unknown- no study drug|0|||
143072441|NCT01085201|515806055|FG000|Overall Study|Fond ineligible after consent|0|||
143072442|NCT01085201|515806056|FG001|Overall Study|Fond ineligible after consent|1|||
143072443|NCT01085201|515806057|FG002|Overall Study|Fond ineligible after consent|1|||
143072444|NCT01085201|515806058|FG003|Overall Study|Fond ineligible after consent|0|||
143072445|NCT01085201|515806059|FG004|Overall Study|Fond ineligible after consent|0|||
143072446|NCT04658095|515806060|FG000|Overall Study|Study terminated|5|||
143072447|NCT04658095|515806061|FG001|Overall Study|Study terminated|1|||
143072448|NCT04658095|515806062|FG002|Overall Study|Study terminated|4|||
143072449|NCT05961215|515806063|FG000|Overall Study|Withdrawal by Subject|1|||
143072450|NCT05187013|515806064|FG000|Overall Study|Withdrawal by Subject|1|||
143072451|NCT05187013|515806065|FG001|Overall Study|Withdrawal by Subject|1|||
143072452|NCT05187013|515806066|FG002|Overall Study|Withdrawal by Subject|0|||
143072453|NCT05187013|515806064|FG000|Overall Study|Death|0|||
143072454|NCT05187013|515806065|FG001|Overall Study|Death|1|||
143072455|NCT05187013|515806066|FG002|Overall Study|Death|0|||
143072456|NCT05187013|515806064|FG000|Overall Study|Lost to Follow-up|20|||
143072457|NCT05187013|515806065|FG001|Overall Study|Lost to Follow-up|17|||
143072458|NCT05187013|515806066|FG002|Overall Study|Lost to Follow-up|0|||
143072459|NCT05187013|515806064|FG000|Overall Study|Ongoing Participants|3|||
143072460|NCT05187013|515806065|FG001|Overall Study|Ongoing Participants|5|||
143072461|NCT05187013|515806066|FG002|Overall Study|Ongoing Participants|0|||
143072462|NCT00077857|515806069|FG000|Overall Study|Adverse Event|30|||
143072463|NCT00077857|515806070|FG001|Overall Study|Adverse Event|32|||
143072464|NCT00077857|515806069|FG000|Overall Study|Death|7|||
143072465|NCT00077857|515806070|FG001|Overall Study|Death|3|||
143072466|NCT00077857|515806069|FG000|Overall Study|Insufficient therapeutic response|112|||
143072467|NCT00077857|515806070|FG001|Overall Study|Insufficient therapeutic response|128|||
143072468|NCT00077857|515806069|FG000|Overall Study|Violation of selection criteria at entry|3|||
143072469|NCT00077857|515806070|FG001|Overall Study|Violation of selection criteria at entry|1|||
143072470|NCT00077857|515806069|FG000|Overall Study|Other protocol violation|0|||
143072471|NCT00077857|515806070|FG001|Overall Study|Other protocol violation|1|||
143072472|NCT00077857|515806069|FG000|Overall Study|Refused treatment|29|||
143072473|NCT00077857|515806070|FG001|Overall Study|Refused treatment|21|||
143072474|NCT00077857|515806069|FG000|Overall Study|Failure to return|5|||
143072475|NCT00077857|515806070|FG001|Overall Study|Failure to return|5|||
143072476|NCT00077857|515806069|FG000|Overall Study|Other|15|||
143072477|NCT00077857|515806070|FG001|Overall Study|Other|13|||
143072478|NCT04480021|515806071|FG000|Overall Study|Lost to Follow-up|3|||
143072479|NCT04480021|515806072|FG001|Overall Study|Lost to Follow-up|4|||
143072480|NCT02970318|515806073|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
143072481|NCT02970318|515806074|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
143072482|NCT02970318|515806075|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
143072483|NCT02970318|515806076|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
143072484|NCT02970318|515806073|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
143072485|NCT02970318|515806074|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
143072486|NCT02970318|515806075|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
143072487|NCT02970318|515806076|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
143072488|NCT02970318|515806073|FG000|Overall for Arm A & Main for Arm B|Death|41|||
143072489|NCT02970318|515806074|FG001|Overall for Arm A & Main for Arm B|Death|33|||
143072490|NCT02970318|515806075|FG002|Overall for Arm A & Main for Arm B|Death|0|||
143072491|NCT02970318|515806076|FG003|Overall for Arm A & Main for Arm B|Death|0|||
143072492|NCT02970318|515806073|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
143072493|NCT02970318|515806074|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
143072494|NCT02970318|515806075|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
143072495|NCT02970318|515806076|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
143072496|NCT02970318|515806073|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
143072497|NCT02970318|515806074|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
143072498|NCT02970318|515806075|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
143072499|NCT02970318|515806076|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
143072500|NCT02970318|515806073|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
143072501|NCT02970318|515806074|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
143072502|NCT02970318|515806075|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
143171622|NCT00370292|516178421|FG000|Overall Study|Disease Progression|4|||
143171623|NCT00370292|516178421|FG000|Overall Study|Adverse Event|7|||
143171624|NCT00370292|516178421|FG000|Overall Study|Physician Decision|2|||
143171625|NCT02704208|516178422|FG000|Overall Study|Lost to Follow-up|42|||
143171626|NCT02704208|516178423|FG001|Overall Study|Lost to Follow-up|37|||
143171627|NCT03801525|516178424|FG000|Overall Study|Adverse Event|17|||
143171628|NCT03801525|516178425|FG001|Overall Study|Adverse Event|1|||
143171629|NCT03801525|516178426|FG002|Overall Study|Adverse Event|0|||
143171630|NCT03801525|516178424|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
143171631|NCT03801525|516178425|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
143171632|NCT03801525|516178426|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
143171633|NCT03801525|516178424|FG000|Overall Study|Death|29|||
143171634|NCT03801525|516178425|FG001|Overall Study|Death|1|||
143171635|NCT03801525|516178426|FG002|Overall Study|Death|4|||
143171636|NCT03801525|516178424|FG000|Overall Study|Disease Progression|6|||
143171637|NCT03801525|516178425|FG001|Overall Study|Disease Progression|0|||
143171638|NCT03801525|516178426|FG002|Overall Study|Disease Progression|1|||
143171639|NCT03801525|516178424|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
143171640|NCT03801525|516178425|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
143171641|NCT03801525|516178426|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
143072503|NCT02970318|515806076|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
143072504|NCT02970318|515806073|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
143072505|NCT02970318|515806074|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
143072506|NCT02970318|515806075|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
143072507|NCT02970318|515806076|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
143072508|NCT01096368|515806077|FG000|Overall Study|Death|0|||
143072509|NCT01096368|515806078|FG001|Overall Study|Death|1|||
143072510|NCT01096368|515806079|FG002|Overall Study|Death|0|||
143072511|NCT01096368|515806080|FG003|Overall Study|Death|0|||
143072512|NCT01096368|515806081|FG004|Overall Study|Death|0|||
143072513|NCT01096368|515806077|FG000|Overall Study|Physician Decision|0|||
143072514|NCT01096368|515806078|FG001|Overall Study|Physician Decision|13|||
143072515|NCT01096368|515806079|FG002|Overall Study|Physician Decision|2|||
143072516|NCT01096368|515806080|FG003|Overall Study|Physician Decision|4|||
143072517|NCT01096368|515806081|FG004|Overall Study|Physician Decision|6|||
143072518|NCT01096368|515806077|FG000|Overall Study|Withdrawal by Subject|0|||
143072519|NCT01096368|515806078|FG001|Overall Study|Withdrawal by Subject|52|||
143072520|NCT01096368|515806079|FG002|Overall Study|Withdrawal by Subject|0|||
143072521|NCT01096368|515806080|FG003|Overall Study|Withdrawal by Subject|10|||
143072522|NCT01096368|515806081|FG004|Overall Study|Withdrawal by Subject|14|||
143072523|NCT01096368|515806077|FG000|Overall Study|Ineligible|0|||
143072524|NCT01096368|515806078|FG001|Overall Study|Ineligible|3|||
143072525|NCT01096368|515806079|FG002|Overall Study|Ineligible|2|||
143072526|NCT01096368|515806080|FG003|Overall Study|Ineligible|0|||
143072527|NCT01096368|515806081|FG004|Overall Study|Ineligible|25|||
143072528|NCT01096368|515806077|FG000|Overall Study|Did not start treatment|0|||
143072529|NCT01096368|515806078|FG001|Overall Study|Did not start treatment|4|||
143072530|NCT01096368|515806079|FG002|Overall Study|Did not start treatment|4|||
143072531|NCT01096368|515806080|FG003|Overall Study|Did not start treatment|0|||
143072532|NCT01096368|515806081|FG004|Overall Study|Did not start treatment|0|||
143072533|NCT01096368|515806077|FG000|Overall Study|Progressive disease|0|||
143072534|NCT01096368|515806078|FG001|Overall Study|Progressive disease|6|||
143072535|NCT01096368|515806079|FG002|Overall Study|Progressive disease|0|||
143072536|NCT01096368|515806080|FG003|Overall Study|Progressive disease|10|||
143072537|NCT01096368|515806081|FG004|Overall Study|Progressive disease|3|||
143072538|NCT01096368|515806077|FG000|Overall Study|Other|0|||
143072539|NCT01096368|515806078|FG001|Overall Study|Other|0|||
143072540|NCT01096368|515806079|FG002|Overall Study|Other|1|||
143072541|NCT01096368|515806080|FG003|Overall Study|Other|0|||
143072542|NCT01096368|515806081|FG004|Overall Study|Other|0|||
143072543|NCT01096368|515806077|FG000|Overall Study|Treated with institutional review|0|||
143072544|NCT01096368|515806078|FG001|Overall Study|Treated with institutional review|0|||
143072545|NCT01096368|515806079|FG002|Overall Study|Treated with institutional review|0|||
143072546|NCT01096368|515806080|FG003|Overall Study|Treated with institutional review|0|||
143072547|NCT01096368|515806081|FG004|Overall Study|Treated with institutional review|1|||
143072548|NCT06354998|515806082|FG000|Overall Study|Withdrawal by Subject|3|||
143072549|NCT06354998|515806083|FG001|Overall Study|Withdrawal by Subject|0|||
143072550|NCT02317614|515806086|FG000|Overall Study|Lost to Follow-up|1|||
143072551|NCT02317614|515806087|FG001|Overall Study|Lost to Follow-up|1|||
143072552|NCT02317614|515806086|FG000|Overall Study|Withdrawal by Subject|1|||
143072553|NCT02317614|515806087|FG001|Overall Study|Withdrawal by Subject|0|||
143072554|NCT02317614|515806086|FG000|Overall Study|Death|1|||
143072555|NCT02317614|515806087|FG001|Overall Study|Death|1|||
143072556|NCT03285308|515806090|FG000|Overall Study|Adverse Event|3|||
143072557|NCT03285308|515806091|FG001|Overall Study|Adverse Event|7|||
143072558|NCT03285308|515806090|FG000|Overall Study|Withdrawal by Subject|8|||
143072559|NCT03285308|515806091|FG001|Overall Study|Withdrawal by Subject|9|||
143072560|NCT03285308|515806090|FG000|Overall Study|Lost to Follow-up|3|||
143072561|NCT03285308|515806091|FG001|Overall Study|Lost to Follow-up|1|||
143072562|NCT03285308|515806090|FG000|Overall Study|Protocol Deviation|6|||
143072563|NCT03285308|515806091|FG001|Overall Study|Protocol Deviation|5|||
143072564|NCT03285308|515806090|FG000|Overall Study|Reason not Specified|0|||
143072565|NCT03285308|515806091|FG001|Overall Study|Reason not Specified|1|||
143072566|NCT03283761|515806092|FG000|Study Treatment|Patient Non-Compliance|1|||
143072567|NCT03283761|515806092|FG000|Study Treatment|Alternative Cancer Therapy|7|||
143072568|NCT03283761|515806092|FG000|Study Treatment|Disease progression|21|||
143072569|NCT03283761|515806092|FG000|Study Treatment|Adverse Event|3|||
143072570|NCT03283761|515806092|FG000|Study Treatment|Withdrawal by Subject|4|||
143072571|NCT03283761|515806092|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
143072572|NCT03283761|515806092|FG000|Study Treatment|Symptomatic Deterioration|1|||
143072573|NCT03283761|515806092|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
143072574|NCT03283761|515806092|FG000|Follow up|Lost to Follow-up|1|||
143072575|NCT03283761|515806092|FG000|Follow up|Symptomatic Deterioration|1|||
143072576|NCT03283761|515806092|FG000|Follow up|Death|29|||
143072577|NCT03283761|515806092|FG000|Follow up|study terminated|4|||
143072578|NCT03283761|515806092|FG000|Follow up|Primary Investigator Withdrawal|1|||
143072579|NCT03283761|515806092|FG000|Follow up|Switched to alternative therapy|1|||
143072580|NCT03283761|515806092|FG000|Follow up|Subject is now in Hospice|1|||
143247969|NCT02511106|516460509|FG001|Overall Study|Ongoing study at data cut-off|2|||
143247970|NCT02511106|516460508|FG000|Overall Study|Without specified reason|3|||
143247971|NCT02511106|516460509|FG001|Overall Study|Without specified reason|0|||
143247972|NCT00984620|516460510|FG000|Overall Study|Adverse Event|5|||
143247973|NCT00984620|516460511|FG001|Overall Study|Adverse Event|5|||
143247974|NCT00984620|516460510|FG000|Overall Study|Lost to Follow-up|1|||
143247975|NCT00984620|516460511|FG001|Overall Study|Lost to Follow-up|1|||
143247976|NCT00984620|516460510|FG000|Overall Study|Withdrawal by Subject|0|||
143247977|NCT00984620|516460511|FG001|Overall Study|Withdrawal by Subject|2|||
143247978|NCT00984620|516460510|FG000|Overall Study|reason other than listed above|0|||
143247979|NCT00984620|516460511|FG001|Overall Study|reason other than listed above|4|||
143072581|NCT03276221|515806098|FG000|Overall Study|Lost to Follow-up|6|||
143247980|NCT02657408|516460514|FG000|Overall Study|Adverse Event|3|||
143247981|NCT02657408|516460515|FG001|Overall Study|Adverse Event|7|||
143247982|NCT00324961|516460517|FG000|Overall Study|Adverse Event|5|||
143247983|NCT00324961|516460517|FG000|Overall Study|Consent Withdrawn|11|||
143072582|NCT03276221|515806099|FG001|Overall Study|Lost to Follow-up|2|||
143072583|NCT03276221|515806100|FG002|Overall Study|Lost to Follow-up|0|||
143072584|NCT03276221|515806098|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
143072585|NCT03276221|515806099|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
143072586|NCT03276221|515806100|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
143072587|NCT00424775|515806101|FG000|Overall Study|Adverse Event|2|||
143072588|NCT00424775|515806102|FG001|Overall Study|Adverse Event|0|||
143072589|NCT00424775|515806101|FG000|Overall Study|Lack of Efficacy|1|||
143072590|NCT00424775|515806102|FG001|Overall Study|Lack of Efficacy|0|||
143072591|NCT02900976|515806104|FG000|Overall Study|Adverse Event|0|||
143072592|NCT02900976|515806105|FG001|Overall Study|Adverse Event|1|||
143072593|NCT02900976|515806104|FG000|Overall Study|Physician Decision|0|||
143072594|NCT02900976|515806105|FG001|Overall Study|Physician Decision|2|||
143072595|NCT02900976|515806104|FG000|Overall Study|Progressive disease|0|||
143072596|NCT02900976|515806105|FG001|Overall Study|Progressive disease|6|||
143072597|NCT00809159|515806106|FG000|Part 1|Adverse Event|1|||
143072598|NCT00809159|515806107|FG001|Part 1|Adverse Event|1|||
143072599|NCT00809159|515806108|FG002|Part 1|Adverse Event|0|||
143072600|NCT00809159|515806109|FG003|Part 1|Adverse Event|0|||
143072601|NCT00809159|515806110|FG004|Part 1|Adverse Event|0|||
143072602|NCT00809159|515806111|FG005|Part 1|Adverse Event|0|||
143072603|NCT00809159|515806106|FG000|Part 1|Lost to Follow-up|1|||
143072604|NCT00809159|515806107|FG001|Part 1|Lost to Follow-up|0|||
143072605|NCT00809159|515806108|FG002|Part 1|Lost to Follow-up|0|||
143072606|NCT00809159|515806109|FG003|Part 1|Lost to Follow-up|0|||
143072607|NCT00809159|515806110|FG004|Part 1|Lost to Follow-up|0|||
143072608|NCT00809159|515806111|FG005|Part 1|Lost to Follow-up|0|||
143072609|NCT00809159|515806106|FG000|Part 1|Withdrawal by Subject|3|||
143072610|NCT00809159|515806107|FG001|Part 1|Withdrawal by Subject|1|||
143072611|NCT00809159|515806108|FG002|Part 1|Withdrawal by Subject|0|||
143072612|NCT00809159|515806109|FG003|Part 1|Withdrawal by Subject|0|||
143072613|NCT00809159|515806110|FG004|Part 1|Withdrawal by Subject|0|||
143072614|NCT00809159|515806111|FG005|Part 1|Withdrawal by Subject|0|||
143072615|NCT00809159|515806106|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
143072616|NCT00809159|515806107|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
143072617|NCT00809159|515806108|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
143072618|NCT00809159|515806109|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
143072619|NCT00809159|515806110|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
143072620|NCT00809159|515806111|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
143072621|NCT00809159|515806106|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
143072622|NCT00809159|515806107|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
143072623|NCT00809159|515806108|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
143072624|NCT00809159|515806109|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
143072625|NCT00809159|515806110|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
143072626|NCT00809159|515806111|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
143072627|NCT00809159|515806106|FG000|Part 1 and 2|Administrative problems|0|||
143072628|NCT00809159|515806107|FG001|Part 1 and 2|Administrative problems|0|||
143072629|NCT00809159|515806108|FG002|Part 1 and 2|Administrative problems|0|||
143072630|NCT00809159|515806109|FG003|Part 1 and 2|Administrative problems|1|||
143072631|NCT00809159|515806110|FG004|Part 1 and 2|Administrative problems|0|||
143072632|NCT00809159|515806111|FG005|Part 1 and 2|Administrative problems|0|||
143072633|NCT00809159|515806106|FG000|Part 1 and 2|Adverse Event|0|||
143072634|NCT00809159|515806107|FG001|Part 1 and 2|Adverse Event|0|||
143072635|NCT00809159|515806108|FG002|Part 1 and 2|Adverse Event|1|||
143072636|NCT00809159|515806109|FG003|Part 1 and 2|Adverse Event|0|||
143072637|NCT00809159|515806110|FG004|Part 1 and 2|Adverse Event|1|||
143072638|NCT00809159|515806111|FG005|Part 1 and 2|Adverse Event|1|||
143171642|NCT03801525|516178424|FG000|Overall Study|Investigator Decision|18|||
143072639|NCT00809159|515806106|FG000|Part 1 and 2|Lost to Follow-up|0|||
143171643|NCT03801525|516178425|FG001|Overall Study|Investigator Decision|1|||
143171644|NCT03801525|516178426|FG002|Overall Study|Investigator Decision|0|||
143171645|NCT03801525|516178424|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
143171646|NCT03801525|516178425|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
143072640|NCT00809159|515806107|FG001|Part 1 and 2|Lost to Follow-up|0|||
143365506|NCT00662909|516880804|FG001|Overall Study|Non-compliance with study procedures|3|||
143072641|NCT00809159|515806108|FG002|Part 1 and 2|Lost to Follow-up|1|||
143072642|NCT00809159|515806109|FG003|Part 1 and 2|Lost to Follow-up|1|||
143072643|NCT00809159|515806110|FG004|Part 1 and 2|Lost to Follow-up|0|||
143072644|NCT00809159|515806111|FG005|Part 1 and 2|Lost to Follow-up|0|||
143072645|NCT00809159|515806106|FG000|Part 1 and 2|Withdrawal by Subject|0|||
143072646|NCT00809159|515806107|FG001|Part 1 and 2|Withdrawal by Subject|0|||
143072647|NCT00809159|515806108|FG002|Part 1 and 2|Withdrawal by Subject|4|||
143072648|NCT00809159|515806109|FG003|Part 1 and 2|Withdrawal by Subject|0|||
143072649|NCT00809159|515806110|FG004|Part 1 and 2|Withdrawal by Subject|0|||
143072650|NCT00809159|515806111|FG005|Part 1 and 2|Withdrawal by Subject|1|||
143171647|NCT03801525|516178426|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
143072651|NCT01629966|515806117|FG000|Overall Study|Pregnancy|0|||
143072652|NCT01629966|515806118|FG001|Overall Study|Pregnancy|1|||
143072653|NCT01629966|515806119|FG002|Overall Study|Pregnancy|0|||
143072654|NCT01629966|515806117|FG000|Overall Study|Lost to Follow-up|10|||
143072655|NCT01629966|515806118|FG001|Overall Study|Lost to Follow-up|13|||
143072656|NCT01629966|515806119|FG002|Overall Study|Lost to Follow-up|9|||
143072657|NCT01629966|515806117|FG000|Overall Study|Withdrawal by Subject|8|||
143072658|NCT01629966|515806118|FG001|Overall Study|Withdrawal by Subject|9|||
143072659|NCT01629966|515806119|FG002|Overall Study|Withdrawal by Subject|16|||
143072660|NCT01629966|515806117|FG000|Overall Study|Protocol Violation|7|||
143072661|NCT01629966|515806118|FG001|Overall Study|Protocol Violation|9|||
143072662|NCT01629966|515806119|FG002|Overall Study|Protocol Violation|7|||
143072663|NCT01629966|515806117|FG000|Overall Study|Lack of Efficacy|5|||
143072664|NCT01629966|515806118|FG001|Overall Study|Lack of Efficacy|2|||
143072665|NCT01629966|515806119|FG002|Overall Study|Lack of Efficacy|4|||
143072666|NCT01629966|515806117|FG000|Overall Study|Adverse Event|11|||
143072667|NCT01629966|515806118|FG001|Overall Study|Adverse Event|18|||
143072668|NCT01629966|515806119|FG002|Overall Study|Adverse Event|30|||
143072669|NCT02991430|515806122|FG000|Treatment Period 1|Adverse Event|1|||
143072670|NCT02991430|515806123|FG001|Treatment Period 1|Adverse Event|0|||
143072671|NCT02991430|515806124|FG002|Treatment Period 1|Adverse Event|2|||
143072672|NCT02991430|515806122|FG000|Treatment Period 1|Withdrawal by Subject|0|||
143072673|NCT02991430|515806123|FG001|Treatment Period 1|Withdrawal by Subject|4|||
143072674|NCT02991430|515806124|FG002|Treatment Period 1|Withdrawal by Subject|0|||
143072675|NCT02991430|515806122|FG000|Treatment Period 2|Study Termination|6|||
143072676|NCT02991430|515806123|FG001|Treatment Period 2|Study Termination|3|||
143072677|NCT02991430|515806124|FG002|Treatment Period 2|Study Termination|3|||
143072678|NCT02991430|515806122|FG000|Treatment Period 2|Lost to Follow-up|0|||
143072679|NCT02991430|515806123|FG001|Treatment Period 2|Lost to Follow-up|0|||
143072680|NCT02991430|515806124|FG002|Treatment Period 2|Lost to Follow-up|1|||
143072681|NCT02991430|515806122|FG000|Post-treatment Observation Period|Study Termination|3|||
143072682|NCT02991430|515806123|FG001|Post-treatment Observation Period|Study Termination|6|||
143072683|NCT02991430|515806124|FG002|Post-treatment Observation Period|Study Termination|5|||
143072684|NCT04188301|515806125|FG000|Month 3|Lost to Follow-up|0|||
143072685|NCT04188301|515806126|FG001|Month 3|Lost to Follow-up|0|||
143072686|NCT04188301|515806127|FG002|Month 3|Lost to Follow-up|1|||
143072687|NCT04188301|515806125|FG000|Month 12|Lost to Follow-up|0|||
143072688|NCT04188301|515806126|FG001|Month 12|Lost to Follow-up|0|||
143072689|NCT04188301|515806127|FG002|Month 12|Lost to Follow-up|2|||
143072690|NCT04188301|515806125|FG000|Month 12|Death|1|||
143072691|NCT04188301|515806126|FG001|Month 12|Death|1|||
143072692|NCT04188301|515806127|FG002|Month 12|Death|0|||
143072693|NCT04188301|515806125|FG000|Month 18|Lost to Follow-up|6|||
143072694|NCT04188301|515806126|FG001|Month 18|Lost to Follow-up|0|||
143072695|NCT04188301|515806127|FG002|Month 18|Lost to Follow-up|0|||
143072696|NCT01770392|515806128|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
143072697|NCT00228423|515806129|FG000|Overall Study|Adverse Event|2|||
143072698|NCT00228423|515806130|FG001|Overall Study|Adverse Event|5|||
143072699|NCT00228423|515806129|FG000|Overall Study|Withdrawal by Subject|7|||
143072700|NCT00228423|515806130|FG001|Overall Study|Withdrawal by Subject|3|||
143072701|NCT00228423|515806129|FG000|Overall Study|Protocol Violation|1|||
143072702|NCT00228423|515806130|FG001|Overall Study|Protocol Violation|3|||
143072703|NCT00228423|515806129|FG000|Overall Study|Physician Decision|0|||
143072704|NCT00228423|515806130|FG001|Overall Study|Physician Decision|1|||
143072705|NCT03870477|515806134|FG000|Overall Study|Early Study Termination|1|||
143072706|NCT04555720|515806135|FG000|Overall Study|Lost to Follow-up|2|||
143072707|NCT04555720|515806136|FG001|Overall Study|Lost to Follow-up|0|||
143072708|NCT04555720|515806137|FG002|Overall Study|Lost to Follow-up|0|||
143072709|NCT04555720|515806138|FG003|Overall Study|Lost to Follow-up|0|||
143072710|NCT04555720|515806135|FG000|Overall Study|Withdrawal by Subject|4|||
143072711|NCT04555720|515806136|FG001|Overall Study|Withdrawal by Subject|6|||
143072712|NCT04555720|515806137|FG002|Overall Study|Withdrawal by Subject|0|||
143072713|NCT04555720|515806138|FG003|Overall Study|Withdrawal by Subject|0|||
143072714|NCT00968799|515806139|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
143072715|NCT01104779|515806142|FG000|Overall Study|Protocol Violation|1|||
143072716|NCT01104779|515806143|FG001|Overall Study|Protocol Violation|2|||
143247984|NCT00324961|516460517|FG000|Overall Study|Lost to Follow-up|22|||
143247985|NCT00324961|516460517|FG000|Overall Study|Protocol Violation|3|||
143247986|NCT00324961|516460517|FG000|Overall Study|Other|2|||
143247987|NCT00344487|516460518|FG000|Overall Study|immunologic failure|1|||
143247988|NCT01561313|516460527|FG000|Overall Study|Withdrawal by Subject|1|||
143247989|NCT01561313|516460528|FG001|Overall Study|Withdrawal by Subject|0|||
143247990|NCT01561313|516460527|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
143247991|NCT01561313|516460528|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
143247992|NCT04535453|516460529|FG000|Overall Study|Death|0|||
143247993|NCT04535453|516460530|FG001|Overall Study|Death|1|||
143247994|NCT04535453|516460531|FG002|Overall Study|Death|0|||
143247995|NCT04535453|516460532|FG003|Overall Study|Death|0|||
143247996|NCT04535453|516460533|FG004|Overall Study|Death|0|||
143247997|NCT04535453|516460534|FG005|Overall Study|Death|0|||
143247998|NCT04535453|516460535|FG006|Overall Study|Death|0|||
143247999|NCT04535453|516460536|FG007|Overall Study|Death|0|||
143248000|NCT04535453|516460537|FG008|Overall Study|Death|0|||
143248001|NCT04535453|516460538|FG009|Overall Study|Death|0|||
143248002|NCT04535453|516460539|FG010|Overall Study|Death|0|||
143248003|NCT04535453|516460540|FG011|Overall Study|Death|0|||
143248004|NCT04535453|516460529|FG000|Overall Study|Lost to Follow-up|1|||
143248005|NCT04535453|516460530|FG001|Overall Study|Lost to Follow-up|1|||
143248006|NCT04535453|516460531|FG002|Overall Study|Lost to Follow-up|1|||
143248007|NCT04535453|516460532|FG003|Overall Study|Lost to Follow-up|0|||
143248008|NCT04535453|516460533|FG004|Overall Study|Lost to Follow-up|3|||
143248009|NCT04535453|516460534|FG005|Overall Study|Lost to Follow-up|1|||
143248010|NCT04535453|516460535|FG006|Overall Study|Lost to Follow-up|0|||
143248011|NCT04535453|516460536|FG007|Overall Study|Lost to Follow-up|0|||
143248012|NCT04535453|516460537|FG008|Overall Study|Lost to Follow-up|1|||
143248013|NCT04535453|516460538|FG009|Overall Study|Lost to Follow-up|1|||
143248014|NCT04535453|516460539|FG010|Overall Study|Lost to Follow-up|0|||
143248015|NCT04535453|516460540|FG011|Overall Study|Lost to Follow-up|0|||
143248016|NCT04535453|516460529|FG000|Overall Study|Physician Decision|0|||
143248017|NCT04535453|516460530|FG001|Overall Study|Physician Decision|0|||
143248018|NCT04535453|516460531|FG002|Overall Study|Physician Decision|0|||
143248019|NCT04535453|516460532|FG003|Overall Study|Physician Decision|1|||
143072717|NCT01104779|515806144|FG002|Overall Study|Protocol Violation|2|||
143072718|NCT01104779|515806142|FG000|Overall Study|Lack of Efficacy|26|||
143072719|NCT01104779|515806143|FG001|Overall Study|Lack of Efficacy|12|||
143072720|NCT01104779|515806144|FG002|Overall Study|Lack of Efficacy|13|||
143072721|NCT01104779|515806142|FG000|Overall Study|Adverse Event|13|||
143072722|NCT01104779|515806143|FG001|Overall Study|Adverse Event|14|||
143072723|NCT01104779|515806144|FG002|Overall Study|Adverse Event|13|||
143072724|NCT01104779|515806142|FG000|Overall Study|Did not meet inc/exc criteria|1|||
143072725|NCT01104779|515806143|FG001|Overall Study|Did not meet inc/exc criteria|1|||
143072726|NCT01104779|515806144|FG002|Overall Study|Did not meet inc/exc criteria|1|||
143072727|NCT01104779|515806142|FG000|Overall Study|Other reasons|0|||
143072728|NCT01104779|515806143|FG001|Overall Study|Other reasons|1|||
143072729|NCT01104779|515806144|FG002|Overall Study|Other reasons|0|||
143072730|NCT01104779|515806142|FG000|Overall Study|Lost to Follow-up|2|||
143072731|NCT01104779|515806143|FG001|Overall Study|Lost to Follow-up|0|||
143072732|NCT01104779|515806144|FG002|Overall Study|Lost to Follow-up|1|||
143072733|NCT01104779|515806142|FG000|Overall Study|Withdrawal by Subject|16|||
143072734|NCT01104779|515806143|FG001|Overall Study|Withdrawal by Subject|25|||
143072735|NCT01104779|515806144|FG002|Overall Study|Withdrawal by Subject|32|||
143072736|NCT02201290|515806145|FG000|Overall Study|Withdrawal by Subject|2|||
143072737|NCT02201290|515806145|FG000|Overall Study|Lack of Efficacy|2|||
143072738|NCT02201290|515806145|FG000|Overall Study|Adverse Event|1|||
143072739|NCT04639713|515806146|FG000|Overall Study|Protocol Noncompliance|2|||
143072740|NCT04639713|515806146|FG000|Overall Study|Withdrawal by Subject|1|||
143072741|NCT02370329|515808260|FG000|Overall Study|Alternate treatment|1|||
143072742|NCT02370329|515808260|FG000|Overall Study|Adverse Event|1|||
143072743|NCT02370329|515808260|FG000|Overall Study|Disease progression|3|||
143072744|NCT02370329|515808260|FG000|Overall Study|Physician Decision|2|||
143072745|NCT02370329|515808260|FG000|Overall Study|Study closure|4|||
143072746|NCT02752906|515808266|FG000|Overall Study|Protocol Violation|2|||
143072747|NCT02752906|515808267|FG001|Overall Study|Protocol Violation|1|||
143072748|NCT02752906|515808266|FG000|Overall Study|Withdrawal by Subject|2|||
143072749|NCT02752906|515808267|FG001|Overall Study|Withdrawal by Subject|2|||
143072750|NCT02752906|515808266|FG000|Overall Study|Lost to Follow-up|3|||
143072751|NCT02752906|515808267|FG001|Overall Study|Lost to Follow-up|2|||
143072752|NCT03283319|515808271|FG000|Overall Study|Lost to Follow-up|5|||
143072753|NCT03283319|515808272|FG001|Overall Study|Lost to Follow-up|4|||
143072754|NCT03283319|515808273|FG002|Overall Study|Lost to Follow-up|5|||
143072755|NCT03283319|515808274|FG003|Overall Study|Lost to Follow-up|5|||
143072756|NCT03283319|515808275|FG004|Overall Study|Lost to Follow-up|4|||
143072757|NCT03283319|515808276|FG005|Overall Study|Lost to Follow-up|3|||
143072758|NCT03283319|515808271|FG000|Overall Study|Withdrawal by Subject|2|||
143072759|NCT03283319|515808272|FG001|Overall Study|Withdrawal by Subject|2|||
143072760|NCT03283319|515808273|FG002|Overall Study|Withdrawal by Subject|2|||
143072761|NCT03283319|515808274|FG003|Overall Study|Withdrawal by Subject|1|||
143072762|NCT03283319|515808275|FG004|Overall Study|Withdrawal by Subject|0|||
143072763|NCT03283319|515808276|FG005|Overall Study|Withdrawal by Subject|1|||
143072764|NCT03283319|515808271|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
143072765|NCT03283319|515808272|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
143072766|NCT03283319|515808273|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
143072767|NCT03283319|515808274|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
143072768|NCT03283319|515808275|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
143072769|NCT03283319|515808276|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
143072770|NCT02492880|515808277|FG000|Overall Study|Lost to Follow-up|1|||
143072771|NCT02492880|515808277|FG000|Overall Study|Protocol Violation|1|||
143072772|NCT03186781|515808278|FG000|Overall Study|Lost to Follow-up|0|||
143072773|NCT03186781|515808279|FG001|Overall Study|Lost to Follow-up|0|||
143072774|NCT03186781|515808280|FG002|Overall Study|Lost to Follow-up|1|||
143072775|NCT03186781|515808281|FG003|Overall Study|Lost to Follow-up|0|||
143171648|NCT03801525|516178424|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
143171649|NCT03801525|516178425|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
143171650|NCT03801525|516178426|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
143171651|NCT03801525|516178424|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
143171652|NCT03801525|516178425|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
143072776|NCT03186781|515808282|FG004|Overall Study|Lost to Follow-up|1|||
143072777|NCT03186781|515808283|FG005|Overall Study|Lost to Follow-up|0|||
143072778|NCT03186781|515808278|FG000|Overall Study|Moved from Area|0|||
143171653|NCT03801525|516178426|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
143072779|NCT03186781|515808279|FG001|Overall Study|Moved from Area|0|||
143072780|NCT03186781|515808280|FG002|Overall Study|Moved from Area|0|||
143072781|NCT03186781|515808281|FG003|Overall Study|Moved from Area|0|||
143171654|NCT03801525|516178424|FG000|Overall Study|Withdrawal of Subject Consent|38|||
143365507|NCT00662909|516880805|FG002|Overall Study|Non-compliance with study procedures|2|||
143072782|NCT03186781|515808282|FG004|Overall Study|Moved from Area|1|||
143072783|NCT03186781|515808283|FG005|Overall Study|Moved from Area|0|||
143072784|NCT03186781|515808278|FG000|Overall Study|Withdrawal by Subject|0|||
143072785|NCT03186781|515808279|FG001|Overall Study|Withdrawal by Subject|0|||
143072786|NCT03186781|515808280|FG002|Overall Study|Withdrawal by Subject|0|||
143072787|NCT03186781|515808281|FG003|Overall Study|Withdrawal by Subject|0|||
143072788|NCT03186781|515808282|FG004|Overall Study|Withdrawal by Subject|1|||
143072789|NCT03186781|515808283|FG005|Overall Study|Withdrawal by Subject|0|||
143072790|NCT03954834|515808284|FG000|Overall Study|Adverse Event|1|||
143072791|NCT03954834|515808285|FG001|Overall Study|Adverse Event|3|||
143072792|NCT03954834|515808286|FG002|Overall Study|Adverse Event|1|||
143072793|NCT03954834|515808287|FG003|Overall Study|Adverse Event|1|||
143072794|NCT03954834|515808284|FG000|Overall Study|Death|0|||
143072795|NCT03954834|515808285|FG001|Overall Study|Death|0|||
143072796|NCT03954834|515808286|FG002|Overall Study|Death|0|||
143072797|NCT03954834|515808287|FG003|Overall Study|Death|1|||
143072798|NCT03954834|515808284|FG000|Overall Study|Physician Decision|0|||
143072799|NCT03954834|515808285|FG001|Overall Study|Physician Decision|1|||
143072800|NCT03954834|515808286|FG002|Overall Study|Physician Decision|0|||
143072801|NCT03954834|515808287|FG003|Overall Study|Physician Decision|2|||
143072802|NCT03954834|515808284|FG000|Overall Study|Protocol Violation|1|||
143072803|NCT03954834|515808285|FG001|Overall Study|Protocol Violation|0|||
143072804|NCT03954834|515808286|FG002|Overall Study|Protocol Violation|0|||
143072805|NCT03954834|515808287|FG003|Overall Study|Protocol Violation|1|||
143072806|NCT03954834|515808284|FG000|Overall Study|Withdrawal by Subject|2|||
143072807|NCT03954834|515808285|FG001|Overall Study|Withdrawal by Subject|3|||
143072808|NCT03954834|515808286|FG002|Overall Study|Withdrawal by Subject|13|||
143072809|NCT03954834|515808287|FG003|Overall Study|Withdrawal by Subject|6|||
143072810|NCT03954834|515808284|FG000|Overall Study|Participant left the country|0|||
143072811|NCT03954834|515808285|FG001|Overall Study|Participant left the country|0|||
143072812|NCT03954834|515808286|FG002|Overall Study|Participant left the country|1|||
143072813|NCT03954834|515808287|FG003|Overall Study|Participant left the country|0|||
143072814|NCT03954834|515808284|FG000|Overall Study|Lost to Follow-up|3|||
143072815|NCT03954834|515808285|FG001|Overall Study|Lost to Follow-up|2|||
143072816|NCT03954834|515808286|FG002|Overall Study|Lost to Follow-up|3|||
143072817|NCT03954834|515808287|FG003|Overall Study|Lost to Follow-up|5|||
143072818|NCT03786718|515808292|FG000|Overall Study|Lost to Follow-up|3|||
143072819|NCT03786718|515808292|FG000|Overall Study|Withdrawal by Subject|1|||
143072820|NCT03786718|515808292|FG000|Overall Study|Did not use the intervention|2|||
143072821|NCT03786718|515808292|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
143072822|NCT00372411|515808299|FG000|Overall Study|Withdrawal by Subject|3|||
143072823|NCT00372411|515808300|FG001|Overall Study|Withdrawal by Subject|4|||
143171655|NCT03801525|516178425|FG001|Overall Study|Withdrawal of Subject Consent|2|||
143171656|NCT03801525|516178426|FG002|Overall Study|Withdrawal of Subject Consent|1|||
143171657|NCT03801525|516178424|FG000|Overall Study|Reason not Specified|4|||
143171658|NCT03801525|516178425|FG001|Overall Study|Reason not Specified|0|||
143171659|NCT03801525|516178426|FG002|Overall Study|Reason not Specified|4|||
143171660|NCT01628913|516178429|FG000|Overall Study|Adverse Event|12|||
143171661|NCT01628913|516178430|FG001|Overall Study|Adverse Event|5|||
143171662|NCT01628913|516178429|FG000|Overall Study|Disease Progression|11|||
143171663|NCT01628913|516178430|FG001|Overall Study|Disease Progression|14|||
143171664|NCT01628913|516178429|FG000|Overall Study|Protocol Violation|1|||
143365508|NCT00662909|516880803|FG000|Overall Study|Physician Decision|1|||
143365509|NCT00662909|516880804|FG001|Overall Study|Physician Decision|1|||
143072824|NCT00372411|515808301|FG002|Overall Study|Withdrawal by Subject|1|||
143072825|NCT00372411|515808299|FG000|Overall Study|Death|0|||
143072826|NCT00372411|515808300|FG001|Overall Study|Death|2|||
143072827|NCT00372411|515808301|FG002|Overall Study|Death|1|||
143072828|NCT00372411|515808299|FG000|Overall Study|Lost to Follow-up|1|||
143072829|NCT00372411|515808300|FG001|Overall Study|Lost to Follow-up|1|||
143171665|NCT01628913|516178430|FG001|Overall Study|Protocol Violation|0|||
143171666|NCT01628913|516178429|FG000|Overall Study|Death|1|||
143171667|NCT01628913|516178430|FG001|Overall Study|Death|0|||
143171668|NCT01628913|516178429|FG000|Overall Study|study terminated by Sponsor|4|||
143171669|NCT01628913|516178430|FG001|Overall Study|study terminated by Sponsor|9|||
143072830|NCT00372411|515808301|FG002|Overall Study|Lost to Follow-up|1|||
143072831|NCT00372411|515808299|FG000|Overall Study|Adverse Event|1|||
143072832|NCT00372411|515808300|FG001|Overall Study|Adverse Event|1|||
143072833|NCT00372411|515808301|FG002|Overall Study|Adverse Event|0|||
143072834|NCT01398514|515808302|FG000|Overall Study|Adverse Event|1|||
143072835|NCT01398514|515808303|FG001|Overall Study|Adverse Event|0|||
143072836|NCT01398514|515808302|FG000|Overall Study|Non-compliance with study procedures|2|||
143072837|NCT01398514|515808303|FG001|Overall Study|Non-compliance with study procedures|0|||
143072838|NCT01398514|515808302|FG000|Overall Study|Physiologic non-responsiveness|1|||
143072839|NCT01398514|515808303|FG001|Overall Study|Physiologic non-responsiveness|3|||
143072840|NCT01398514|515808302|FG000|Overall Study|Failure to show a conditioned response|4|||
143072841|NCT01398514|515808303|FG001|Overall Study|Failure to show a conditioned response|3|||
143072842|NCT01570686|515808307|FG000|Overall Study|Abnormal test procedure result(s)|1|||
143072843|NCT01570686|515808308|FG001|Overall Study|Abnormal test procedure result(s)|1|||
143072844|NCT01570686|515808307|FG000|Overall Study|Administrative problems|0|||
143072845|NCT01570686|515808308|FG001|Overall Study|Administrative problems|1|||
143072846|NCT01570686|515808307|FG000|Overall Study|Adverse Event|8|||
143072847|NCT01570686|515808308|FG001|Overall Study|Adverse Event|6|||
143072848|NCT01570686|515808307|FG000|Overall Study|Lost to Follow-up|4|||
143072849|NCT01570686|515808308|FG001|Overall Study|Lost to Follow-up|3|||
143072850|NCT01570686|515808307|FG000|Overall Study|Protocol Deviation|3|||
143072851|NCT01570686|515808308|FG001|Overall Study|Protocol Deviation|0|||
143072852|NCT01570686|515808307|FG000|Overall Study|Withdrawal by Subject|4|||
143072853|NCT01570686|515808308|FG001|Overall Study|Withdrawal by Subject|4|||
143072854|NCT01570686|515808307|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
143072855|NCT01570686|515808308|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
143072856|NCT00754650|515808309|FG000|Overall Study|Disease Progression|2|||
143072857|NCT00805675|515808310|FG000|Overall Study|Adverse Event|0|||
143072858|NCT00805675|515808311|FG001|Overall Study|Adverse Event|0|||
143072859|NCT00805675|515808312|FG002|Overall Study|Adverse Event|1|||
143072860|NCT02771795|515808313|FG000|Overall Study|Withdrawal by Subject|47|||
143072861|NCT02771795|515808314|FG001|Overall Study|Withdrawal by Subject|37|||
143072862|NCT02771795|515808313|FG000|Overall Study|Termination by premature discontinuation of study|168|||
143072863|NCT02771795|515808314|FG001|Overall Study|Termination by premature discontinuation of study|185|||
143072864|NCT02393248|515808320|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
143072865|NCT02393248|515808321|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
143072866|NCT02393248|515808322|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
143072867|NCT02393248|515808323|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
143072868|NCT02393248|515808324|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
143072869|NCT02393248|515808325|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
143072870|NCT02393248|515808326|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
143072871|NCT02393248|515808327|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
143072872|NCT02393248|515808328|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
143072873|NCT02393248|515808329|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
143072874|NCT02393248|515808330|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
143072875|NCT02393248|515808331|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
143072876|NCT02393248|515808332|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
143072877|NCT02393248|515808333|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
143072878|NCT02393248|515808334|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
143072879|NCT02393248|515808335|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
143072880|NCT02393248|515808336|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
143072881|NCT02393248|515808337|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
143072882|NCT02393248|515808338|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
143072883|NCT02393248|515808339|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
143072884|NCT02393248|515808340|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
143072885|NCT02393248|515808341|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
143072886|NCT02393248|515808342|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
143072887|NCT02393248|515808343|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
143072888|NCT02393248|515808344|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
143072889|NCT02393248|515808320|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
143072890|NCT02393248|515808321|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
143072891|NCT02393248|515808322|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
143072892|NCT02393248|515808323|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
143072893|NCT02393248|515808324|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
143072894|NCT02393248|515808325|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
143072895|NCT02393248|515808326|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
143072896|NCT02393248|515808327|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
143072897|NCT02393248|515808328|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
143072898|NCT02393248|515808329|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
143072899|NCT02393248|515808330|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
143072900|NCT02393248|515808331|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
143072901|NCT02393248|515808332|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
143072902|NCT02393248|515808333|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
143072903|NCT02393248|515808334|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
143072904|NCT02393248|515808335|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
143072905|NCT02393248|515808336|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
143072906|NCT02393248|515808337|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
143072907|NCT02393248|515808338|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
143072908|NCT02393248|515808339|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
143072909|NCT02393248|515808340|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
143072910|NCT02393248|515808341|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
143072911|NCT02393248|515808342|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
143072912|NCT02393248|515808343|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
143072913|NCT02393248|515808344|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
143072914|NCT02393248|515808320|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
143072915|NCT02393248|515808321|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
143072916|NCT02393248|515808322|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
143072917|NCT02393248|515808323|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
143072918|NCT02393248|515808324|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
143072919|NCT02393248|515808325|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
143072920|NCT02393248|515808326|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
143072921|NCT02393248|515808327|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
143072922|NCT02393248|515808328|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
143072923|NCT02393248|515808329|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
143072924|NCT02393248|515808330|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
143072925|NCT02393248|515808331|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
143072926|NCT02393248|515808332|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
143072927|NCT02393248|515808333|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
143072928|NCT02393248|515808334|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
143072929|NCT02393248|515808335|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
143072930|NCT02393248|515808336|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
143072931|NCT02393248|515808337|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
143072932|NCT02393248|515808338|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
143072933|NCT02393248|515808339|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
143072934|NCT02393248|515808340|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
143072935|NCT02393248|515808341|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
143072936|NCT02393248|515808342|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
143072937|NCT02393248|515808343|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
143072938|NCT02393248|515808344|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
143072939|NCT02393248|515808320|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
143072940|NCT02393248|515808321|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
143072941|NCT02393248|515808322|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
143072942|NCT02393248|515808323|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
143072943|NCT02393248|515808324|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
143072944|NCT02393248|515808325|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
143072945|NCT02393248|515808326|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
143072946|NCT02393248|515808327|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
143072947|NCT02393248|515808328|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
143072948|NCT02393248|515808329|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
143072949|NCT02393248|515808330|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
143072950|NCT02393248|515808331|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
143072951|NCT02393248|515808332|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
143072952|NCT02393248|515808333|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
143072953|NCT02393248|515808334|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
143072954|NCT02393248|515808335|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
143072955|NCT02393248|515808336|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
143072956|NCT02393248|515808337|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
143072957|NCT02393248|515808338|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
143072958|NCT02393248|515808339|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
143072959|NCT02393248|515808340|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
143072960|NCT02393248|515808341|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
143072961|NCT02393248|515808342|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
143248020|NCT04535453|516460533|FG004|Overall Study|Physician Decision|0|||
143248021|NCT04535453|516460534|FG005|Overall Study|Physician Decision|0|||
143248022|NCT04535453|516460535|FG006|Overall Study|Physician Decision|0|||
143248023|NCT04535453|516460536|FG007|Overall Study|Physician Decision|0|||
143248024|NCT04535453|516460537|FG008|Overall Study|Physician Decision|0|||
143248025|NCT04535453|516460538|FG009|Overall Study|Physician Decision|0|||
143248026|NCT04535453|516460539|FG010|Overall Study|Physician Decision|0|||
143248027|NCT04535453|516460540|FG011|Overall Study|Physician Decision|0|||
143072962|NCT02393248|515808343|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
143072963|NCT02393248|515808344|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
143072964|NCT02393248|515808320|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
143072965|NCT02393248|515808321|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
143072966|NCT02393248|515808322|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
143072967|NCT02393248|515808323|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
143072968|NCT02393248|515808324|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
143072969|NCT02393248|515808325|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
143072970|NCT02393248|515808326|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
143072971|NCT02393248|515808327|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
143072972|NCT02393248|515808328|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
143072973|NCT02393248|515808329|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
143072974|NCT02393248|515808330|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
143072975|NCT02393248|515808331|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
143072976|NCT02393248|515808332|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
143072977|NCT02393248|515808333|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
143072978|NCT02393248|515808334|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
143072979|NCT02393248|515808335|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
143072980|NCT02393248|515808336|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
143072981|NCT02393248|515808337|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
143072982|NCT02393248|515808338|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
143072983|NCT02393248|515808339|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
143072984|NCT02393248|515808340|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
143072985|NCT02393248|515808341|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
143072986|NCT02393248|515808342|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
143072987|NCT02393248|515808343|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
143072988|NCT02393248|515808344|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
143072989|NCT02393248|515808320|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
143072990|NCT02393248|515808321|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
143072991|NCT02393248|515808322|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
143072992|NCT02393248|515808323|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
143072993|NCT02393248|515808324|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
143072994|NCT02393248|515808325|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
143072995|NCT02393248|515808326|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
143072996|NCT02393248|515808327|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
143072997|NCT02393248|515808328|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
143072998|NCT02393248|515808329|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
143072999|NCT02393248|515808330|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
143073000|NCT02393248|515808331|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
143073001|NCT02393248|515808332|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
143073002|NCT02393248|515808333|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
143073003|NCT02393248|515808334|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
143073004|NCT02393248|515808335|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
143073005|NCT02393248|515808336|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
143073006|NCT02393248|515808337|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
143073007|NCT02393248|515808338|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
143073008|NCT02393248|515808339|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
143073009|NCT02393248|515808340|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
143073010|NCT02393248|515808341|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
143073011|NCT02393248|515808342|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
143073012|NCT02393248|515808343|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
143073013|NCT02393248|515808344|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
143073014|NCT02393248|515808320|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
143248028|NCT04535453|516460529|FG000|Overall Study|Withdrawal by Subject|3|||
143248029|NCT04535453|516460530|FG001|Overall Study|Withdrawal by Subject|6|||
143248030|NCT04535453|516460531|FG002|Overall Study|Withdrawal by Subject|3|||
143248031|NCT04535453|516460532|FG003|Overall Study|Withdrawal by Subject|3|||
143248032|NCT04535453|516460533|FG004|Overall Study|Withdrawal by Subject|2|||
143248033|NCT04535453|516460534|FG005|Overall Study|Withdrawal by Subject|1|||
143248034|NCT04535453|516460535|FG006|Overall Study|Withdrawal by Subject|1|||
143073015|NCT02393248|515808321|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
143073016|NCT02393248|515808322|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
143073017|NCT02393248|515808323|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
143073018|NCT02393248|515808324|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
143073019|NCT02393248|515808325|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
143073020|NCT02393248|515808326|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
143073021|NCT02393248|515808327|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
143073022|NCT02393248|515808328|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
143073023|NCT02393248|515808329|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
143073024|NCT02393248|515808330|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
143073025|NCT02393248|515808331|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
143073026|NCT02393248|515808332|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
143073027|NCT02393248|515808333|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
143073028|NCT02393248|515808334|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
143073029|NCT02393248|515808335|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
143073030|NCT02393248|515808336|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
143073031|NCT02393248|515808337|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
143073032|NCT02393248|515808338|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
143073033|NCT02393248|515808339|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
143073034|NCT02393248|515808340|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
143073035|NCT02393248|515808341|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
143073036|NCT02393248|515808342|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
143073037|NCT02393248|515808343|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
143073038|NCT02393248|515808344|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
143073039|NCT02393248|515808320|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
143073040|NCT02393248|515808321|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
143073041|NCT02393248|515808322|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
143073042|NCT02393248|515808323|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
143073043|NCT02393248|515808324|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
143073044|NCT02393248|515808325|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
143073045|NCT02393248|515808326|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
143073046|NCT02393248|515808327|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
143073047|NCT02393248|515808328|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
143073048|NCT02393248|515808329|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
143073049|NCT02393248|515808330|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
143073050|NCT02393248|515808331|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
143073051|NCT02393248|515808332|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
143073052|NCT02393248|515808333|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
143073053|NCT02393248|515808334|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
143073054|NCT02393248|515808335|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
143073055|NCT02393248|515808336|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
143073056|NCT02393248|515808337|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
143073057|NCT02393248|515808338|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
143073058|NCT02393248|515808339|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
143073059|NCT02393248|515808340|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
143073060|NCT02393248|515808341|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
143073061|NCT02393248|515808342|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
143073062|NCT02393248|515808343|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
143073063|NCT02393248|515808344|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
143073064|NCT02393248|515808320|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
143073065|NCT02393248|515808321|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
143073066|NCT02393248|515808322|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
143073067|NCT02393248|515808323|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
143073068|NCT02393248|515808324|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
143073069|NCT02393248|515808325|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
143171670|NCT01628913|516178429|FG000|Overall Study|Withdrawal by Subject|1|||
143171671|NCT01628913|516178430|FG001|Overall Study|Withdrawal by Subject|0|||
143171672|NCT01628913|516178429|FG000|Overall Study|Physician Decision|1|||
143365510|NCT00662909|516880805|FG002|Overall Study|Physician Decision|2|||
143365511|NCT00662909|516880803|FG000|Overall Study|Eligibility criterion not met|0|||
143073070|NCT02393248|515808326|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
143073071|NCT02393248|515808327|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
143073072|NCT02393248|515808328|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
143171673|NCT01628913|516178430|FG001|Overall Study|Physician Decision|3|||
143073073|NCT02393248|515808329|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
143073074|NCT02393248|515808330|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
143073075|NCT02393248|515808331|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
143073076|NCT02393248|515808332|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
143073077|NCT02393248|515808333|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
143073078|NCT02393248|515808334|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
143073079|NCT02393248|515808335|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
143073080|NCT02393248|515808336|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
143073081|NCT02393248|515808337|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
143073082|NCT02393248|515808338|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
143073083|NCT02393248|515808339|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
143073084|NCT02393248|515808340|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
143073085|NCT02393248|515808341|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
143073086|NCT02393248|515808342|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
143073087|NCT02393248|515808343|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
143073088|NCT02393248|515808344|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
143073089|NCT02393248|515808320|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
143073090|NCT02393248|515808321|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
143073091|NCT02393248|515808322|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
143073092|NCT02393248|515808323|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
143073093|NCT02393248|515808324|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
143073094|NCT02393248|515808325|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
143073095|NCT02393248|515808326|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
143073096|NCT02393248|515808327|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
143073097|NCT02393248|515808328|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
143073098|NCT02393248|515808329|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
143073099|NCT02393248|515808330|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
143073100|NCT02393248|515808331|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
143073101|NCT02393248|515808332|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
143073102|NCT02393248|515808333|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
143073103|NCT02393248|515808334|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
143073104|NCT02393248|515808335|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
143073105|NCT02393248|515808336|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
143073106|NCT02393248|515808337|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
143073107|NCT02393248|515808338|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
143073108|NCT02393248|515808339|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
143073109|NCT02393248|515808340|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
143073110|NCT02393248|515808341|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
143073111|NCT02393248|515808342|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
143073112|NCT02393248|515808343|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
143073113|NCT02393248|515808344|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
143073114|NCT02393248|515808320|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
143073115|NCT02393248|515808321|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
143073116|NCT02393248|515808322|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
143073117|NCT02393248|515808323|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
143073118|NCT02393248|515808324|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
143073119|NCT02393248|515808325|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
143073120|NCT02393248|515808326|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
143073121|NCT02393248|515808327|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
143073122|NCT02393248|515808328|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
143073123|NCT02393248|515808329|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
143073124|NCT02393248|515808330|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
143073125|NCT02393248|515808331|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
143073126|NCT02393248|515808332|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
143073127|NCT02393248|515808333|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
143073128|NCT02393248|515808334|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
143073129|NCT02393248|515808335|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
143073130|NCT02393248|515808336|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
143073131|NCT02393248|515808337|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
143073132|NCT02393248|515808338|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
143073133|NCT02393248|515808339|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
143073134|NCT02393248|515808340|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
143073135|NCT02393248|515808341|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
143073136|NCT02393248|515808342|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
143073137|NCT02393248|515808343|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
143073138|NCT02393248|515808344|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
143073139|NCT02393248|515808320|FG000|Part 3: Combination Therapy|Death|0|||
143073140|NCT02393248|515808321|FG001|Part 3: Combination Therapy|Death|0|||
143073141|NCT02393248|515808322|FG002|Part 3: Combination Therapy|Death|0|||
143073142|NCT02393248|515808323|FG003|Part 3: Combination Therapy|Death|0|||
143073143|NCT02393248|515808324|FG004|Part 3: Combination Therapy|Death|0|||
143073144|NCT02393248|515808325|FG005|Part 3: Combination Therapy|Death|0|||
143073145|NCT02393248|515808326|FG006|Part 3: Combination Therapy|Death|0|||
143073146|NCT02393248|515808327|FG007|Part 3: Combination Therapy|Death|0|||
143073147|NCT02393248|515808328|FG008|Part 3: Combination Therapy|Death|0|||
143073148|NCT02393248|515808329|FG009|Part 3: Combination Therapy|Death|0|||
143073149|NCT02393248|515808330|FG010|Part 3: Combination Therapy|Death|0|||
143073150|NCT02393248|515808331|FG011|Part 3: Combination Therapy|Death|0|||
143073151|NCT02393248|515808332|FG012|Part 3: Combination Therapy|Death|0|||
143073152|NCT02393248|515808333|FG013|Part 3: Combination Therapy|Death|0|||
143073153|NCT02393248|515808334|FG014|Part 3: Combination Therapy|Death|0|||
143073154|NCT02393248|515808335|FG015|Part 3: Combination Therapy|Death|1|||
143073155|NCT02393248|515808336|FG016|Part 3: Combination Therapy|Death|7|||
143073156|NCT02393248|515808337|FG017|Part 3: Combination Therapy|Death|5|||
143073157|NCT02393248|515808338|FG018|Part 3: Combination Therapy|Death|5|||
143073158|NCT02393248|515808339|FG019|Part 3: Combination Therapy|Death|3|||
143073159|NCT02393248|515808340|FG020|Part 3: Combination Therapy|Death|7|||
143073160|NCT02393248|515808341|FG021|Part 3: Combination Therapy|Death|5|||
143073161|NCT02393248|515808342|FG022|Part 3: Combination Therapy|Death|6|||
143073162|NCT02393248|515808343|FG023|Part 3: Combination Therapy|Death|3|||
143073163|NCT02393248|515808344|FG024|Part 3: Combination Therapy|Death|0|||
143073164|NCT02393248|515808320|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
143073165|NCT02393248|515808321|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
143073166|NCT02393248|515808322|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
143073167|NCT02393248|515808323|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
143073168|NCT02393248|515808324|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
143073169|NCT02393248|515808325|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
143073170|NCT02393248|515808326|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
143073171|NCT02393248|515808327|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
143073172|NCT02393248|515808328|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
143073173|NCT02393248|515808329|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
143073174|NCT02393248|515808330|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
143073175|NCT02393248|515808331|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
143073176|NCT02393248|515808332|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
143073177|NCT02393248|515808333|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
143073178|NCT02393248|515808334|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
143073179|NCT02393248|515808335|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
143073180|NCT02393248|515808336|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
143073181|NCT02393248|515808337|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
143073182|NCT02393248|515808338|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
143073183|NCT02393248|515808339|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
143073184|NCT02393248|515808340|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
143073185|NCT02393248|515808341|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
143073186|NCT02393248|515808342|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
143073187|NCT02393248|515808343|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
143073188|NCT02393248|515808344|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
143073189|NCT02393248|515808320|FG000|Part 3: Combination Therapy|Disease Progression|0|||
143073190|NCT02393248|515808321|FG001|Part 3: Combination Therapy|Disease Progression|0|||
143073191|NCT02393248|515808322|FG002|Part 3: Combination Therapy|Disease Progression|0|||
143073192|NCT02393248|515808323|FG003|Part 3: Combination Therapy|Disease Progression|0|||
143073193|NCT02393248|515808324|FG004|Part 3: Combination Therapy|Disease Progression|0|||
143073194|NCT02393248|515808325|FG005|Part 3: Combination Therapy|Disease Progression|0|||
143073195|NCT02393248|515808326|FG006|Part 3: Combination Therapy|Disease Progression|0|||
143073196|NCT02393248|515808327|FG007|Part 3: Combination Therapy|Disease Progression|0|||
143073197|NCT02393248|515808328|FG008|Part 3: Combination Therapy|Disease Progression|0|||
143073198|NCT02393248|515808329|FG009|Part 3: Combination Therapy|Disease Progression|0|||
143073199|NCT02393248|515808330|FG010|Part 3: Combination Therapy|Disease Progression|0|||
143073200|NCT02393248|515808331|FG011|Part 3: Combination Therapy|Disease Progression|0|||
143073201|NCT02393248|515808332|FG012|Part 3: Combination Therapy|Disease Progression|0|||
143073202|NCT02393248|515808333|FG013|Part 3: Combination Therapy|Disease Progression|0|||
143073203|NCT02393248|515808334|FG014|Part 3: Combination Therapy|Disease Progression|0|||
143073204|NCT02393248|515808335|FG015|Part 3: Combination Therapy|Disease Progression|0|||
143073205|NCT02393248|515808336|FG016|Part 3: Combination Therapy|Disease Progression|0|||
143073206|NCT02393248|515808337|FG017|Part 3: Combination Therapy|Disease Progression|0|||
143073207|NCT02393248|515808338|FG018|Part 3: Combination Therapy|Disease Progression|0|||
143073208|NCT02393248|515808339|FG019|Part 3: Combination Therapy|Disease Progression|0|||
143073209|NCT02393248|515808340|FG020|Part 3: Combination Therapy|Disease Progression|2|||
143073210|NCT02393248|515808341|FG021|Part 3: Combination Therapy|Disease Progression|1|||
143073211|NCT02393248|515808342|FG022|Part 3: Combination Therapy|Disease Progression|0|||
143073212|NCT02393248|515808343|FG023|Part 3: Combination Therapy|Disease Progression|0|||
143073213|NCT02393248|515808344|FG024|Part 3: Combination Therapy|Disease Progression|0|||
143073214|NCT02393248|515808320|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
143073215|NCT02393248|515808321|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
143073216|NCT02393248|515808322|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
143073217|NCT02393248|515808323|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
143073218|NCT02393248|515808324|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
143073219|NCT02393248|515808325|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
143073220|NCT02393248|515808326|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
143073221|NCT02393248|515808327|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
143073222|NCT02393248|515808328|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
143073223|NCT02393248|515808329|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
143073224|NCT02393248|515808330|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
143073225|NCT02393248|515808331|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
143073226|NCT02393248|515808332|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
143073227|NCT02393248|515808333|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
143073228|NCT02393248|515808334|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
143073229|NCT02393248|515808335|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
143073230|NCT02393248|515808336|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
143073231|NCT02393248|515808337|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
143073232|NCT02393248|515808338|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
143073233|NCT02393248|515808339|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
143073234|NCT02393248|515808340|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
143073235|NCT02393248|515808341|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
143073236|NCT02393248|515808342|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
143073237|NCT02393248|515808343|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
143073238|NCT02393248|515808344|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
143073239|NCT02393248|515808320|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
143073240|NCT02393248|515808321|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
143073241|NCT02393248|515808322|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
143073242|NCT02393248|515808323|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
143073243|NCT02393248|515808324|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
143073244|NCT02393248|515808325|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
143073245|NCT02393248|515808326|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
143073246|NCT02393248|515808327|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
143073247|NCT02393248|515808328|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
143073248|NCT02393248|515808329|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
143073249|NCT02393248|515808330|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
143073250|NCT02393248|515808331|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
143073251|NCT02393248|515808332|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
143073252|NCT02393248|515808333|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
143073253|NCT02393248|515808334|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
143073254|NCT02393248|515808335|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
143073255|NCT02393248|515808336|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
143073256|NCT02393248|515808337|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
143073257|NCT02393248|515808338|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
143073258|NCT02393248|515808339|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
143073259|NCT02393248|515808340|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
143073260|NCT02393248|515808341|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
143073261|NCT02393248|515808342|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
143073262|NCT02393248|515808343|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
143073263|NCT02393248|515808344|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
143073264|NCT02393248|515808320|FG000|Part 3: Combination Therapy|Adverse Event|0|||
143073265|NCT02393248|515808321|FG001|Part 3: Combination Therapy|Adverse Event|0|||
143073266|NCT02393248|515808322|FG002|Part 3: Combination Therapy|Adverse Event|0|||
143073267|NCT02393248|515808323|FG003|Part 3: Combination Therapy|Adverse Event|0|||
143073268|NCT02393248|515808324|FG004|Part 3: Combination Therapy|Adverse Event|0|||
143073269|NCT02393248|515808325|FG005|Part 3: Combination Therapy|Adverse Event|0|||
143171674|NCT04388826|516178432|FG000|Overall Study|Lost to Follow-up|3|||
143171675|NCT04388826|516178433|FG001|Overall Study|Lost to Follow-up|2|||
143073270|NCT02393248|515808326|FG006|Part 3: Combination Therapy|Adverse Event|0|||
143073271|NCT02393248|515808327|FG007|Part 3: Combination Therapy|Adverse Event|0|||
143073272|NCT02393248|515808328|FG008|Part 3: Combination Therapy|Adverse Event|0|||
143073273|NCT02393248|515808329|FG009|Part 3: Combination Therapy|Adverse Event|0|||
143073274|NCT02393248|515808330|FG010|Part 3: Combination Therapy|Adverse Event|0|||
143073275|NCT02393248|515808331|FG011|Part 3: Combination Therapy|Adverse Event|0|||
143073276|NCT02393248|515808332|FG012|Part 3: Combination Therapy|Adverse Event|0|||
143073277|NCT02393248|515808333|FG013|Part 3: Combination Therapy|Adverse Event|0|||
143073278|NCT02393248|515808334|FG014|Part 3: Combination Therapy|Adverse Event|0|||
143073279|NCT02393248|515808335|FG015|Part 3: Combination Therapy|Adverse Event|0|||
143073280|NCT02393248|515808336|FG016|Part 3: Combination Therapy|Adverse Event|0|||
143073281|NCT02393248|515808337|FG017|Part 3: Combination Therapy|Adverse Event|0|||
143073282|NCT02393248|515808338|FG018|Part 3: Combination Therapy|Adverse Event|0|||
143073283|NCT02393248|515808339|FG019|Part 3: Combination Therapy|Adverse Event|0|||
143073284|NCT02393248|515808340|FG020|Part 3: Combination Therapy|Adverse Event|0|||
143073285|NCT02393248|515808341|FG021|Part 3: Combination Therapy|Adverse Event|0|||
143073286|NCT02393248|515808342|FG022|Part 3: Combination Therapy|Adverse Event|0|||
143073287|NCT02393248|515808343|FG023|Part 3: Combination Therapy|Adverse Event|1|||
143073288|NCT02393248|515808344|FG024|Part 3: Combination Therapy|Adverse Event|0|||
143073289|NCT02393248|515808320|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
143073290|NCT02393248|515808321|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
143073291|NCT02393248|515808322|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
143073292|NCT02393248|515808323|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
143073293|NCT02393248|515808324|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
143073294|NCT02393248|515808325|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
143073295|NCT02393248|515808326|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
143073296|NCT02393248|515808327|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
143073297|NCT02393248|515808328|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
143073298|NCT02393248|515808329|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
143073299|NCT02393248|515808330|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
143073300|NCT02393248|515808331|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
143073301|NCT02393248|515808332|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
143073302|NCT02393248|515808333|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
143073303|NCT02393248|515808334|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
143073304|NCT02393248|515808335|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
143073305|NCT02393248|515808336|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
143073306|NCT02393248|515808337|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
143073307|NCT02393248|515808338|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
143073308|NCT02393248|515808339|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
143073309|NCT02393248|515808340|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
143248035|NCT04535453|516460536|FG007|Overall Study|Withdrawal by Subject|1|||
143248036|NCT04535453|516460537|FG008|Overall Study|Withdrawal by Subject|1|||
143248037|NCT04535453|516460538|FG009|Overall Study|Withdrawal by Subject|1|||
143248038|NCT04535453|516460539|FG010|Overall Study|Withdrawal by Subject|0|||
143248039|NCT04535453|516460540|FG011|Overall Study|Withdrawal by Subject|1|||
143248040|NCT04535453|516460529|FG000|Overall Study|Other|0|||
143248041|NCT04535453|516460530|FG001|Overall Study|Other|0|||
143248042|NCT04535453|516460531|FG002|Overall Study|Other|1|||
143248043|NCT04535453|516460532|FG003|Overall Study|Other|0|||
143248044|NCT04535453|516460533|FG004|Overall Study|Other|1|||
143248045|NCT04535453|516460534|FG005|Overall Study|Other|0|||
143248046|NCT04535453|516460535|FG006|Overall Study|Other|1|||
143248047|NCT04535453|516460536|FG007|Overall Study|Other|1|||
143248048|NCT04535453|516460537|FG008|Overall Study|Other|1|||
143248049|NCT04535453|516460538|FG009|Overall Study|Other|0|||
143248050|NCT04535453|516460539|FG010|Overall Study|Other|0|||
143248051|NCT04535453|516460540|FG011|Overall Study|Other|0|||
143248052|NCT01742286|516460541|FG000|Escalation Phase|Administrative problems|1|||
143248053|NCT01742286|516460542|FG001|Escalation Phase|Administrative problems|1|||
143248054|NCT01742286|516460543|FG002|Escalation Phase|Administrative problems|0|||
143248055|NCT01742286|516460544|FG003|Escalation Phase|Administrative problems|0|||
143248056|NCT01742286|516460545|FG004|Escalation Phase|Administrative problems|0|||
143248057|NCT01742286|516460546|FG005|Escalation Phase|Administrative problems|0|||
143248058|NCT01742286|516460547|FG006|Escalation Phase|Administrative problems|2|||
143248059|NCT01742286|516460541|FG000|Escalation Phase|Adverse Event|0|||
143248060|NCT01742286|516460542|FG001|Escalation Phase|Adverse Event|1|||
143248061|NCT01742286|516460543|FG002|Escalation Phase|Adverse Event|2|||
143248062|NCT01742286|516460544|FG003|Escalation Phase|Adverse Event|0|||
143248063|NCT01742286|516460545|FG004|Escalation Phase|Adverse Event|0|||
143248064|NCT01742286|516460546|FG005|Escalation Phase|Adverse Event|1|||
143248065|NCT01742286|516460547|FG006|Escalation Phase|Adverse Event|0|||
143248066|NCT01742286|516460541|FG000|Escalation Phase|Disease progression|3|||
143248067|NCT01742286|516460542|FG001|Escalation Phase|Disease progression|7|||
143248068|NCT01742286|516460543|FG002|Escalation Phase|Disease progression|4|||
143248069|NCT01742286|516460544|FG003|Escalation Phase|Disease progression|1|||
143248070|NCT01742286|516460545|FG004|Escalation Phase|Disease progression|4|||
143248071|NCT01742286|516460546|FG005|Escalation Phase|Disease progression|3|||
143248072|NCT01742286|516460547|FG006|Escalation Phase|Disease progression|2|||
143248073|NCT01742286|516460541|FG000|Escalation Phase|Death|0|||
143248074|NCT01742286|516460542|FG001|Escalation Phase|Death|0|||
143248075|NCT01742286|516460543|FG002|Escalation Phase|Death|0|||
143248076|NCT01742286|516460544|FG003|Escalation Phase|Death|0|||
143248077|NCT01742286|516460545|FG004|Escalation Phase|Death|0|||
143248078|NCT01742286|516460546|FG005|Escalation Phase|Death|1|||
143248079|NCT01742286|516460547|FG006|Escalation Phase|Death|0|||
143248080|NCT01742286|516460541|FG000|Escalation Phase|Physician Decision|0|||
143248081|NCT01742286|516460542|FG001|Escalation Phase|Physician Decision|3|||
143248082|NCT01742286|516460543|FG002|Escalation Phase|Physician Decision|0|||
143248083|NCT01742286|516460544|FG003|Escalation Phase|Physician Decision|1|||
143248084|NCT01742286|516460545|FG004|Escalation Phase|Physician Decision|0|||
143248085|NCT01742286|516460546|FG005|Escalation Phase|Physician Decision|0|||
143248086|NCT01742286|516460547|FG006|Escalation Phase|Physician Decision|2|||
143248087|NCT01742286|516460541|FG000|Escalation Phase|Subject/guardian decision|1|||
143248088|NCT01742286|516460542|FG001|Escalation Phase|Subject/guardian decision|0|||
143248089|NCT01742286|516460543|FG002|Escalation Phase|Subject/guardian decision|0|||
143248090|NCT01742286|516460544|FG003|Escalation Phase|Subject/guardian decision|0|||
143248091|NCT01742286|516460545|FG004|Escalation Phase|Subject/guardian decision|0|||
143248092|NCT01742286|516460546|FG005|Escalation Phase|Subject/guardian decision|0|||
143248093|NCT01742286|516460547|FG006|Escalation Phase|Subject/guardian decision|0|||
143248094|NCT01742286|516460541|FG000|Expansion Phase|Administrative problems|0|||
143248095|NCT01742286|516460542|FG001|Expansion Phase|Administrative problems|0|||
143248096|NCT01742286|516460543|FG002|Expansion Phase|Administrative problems|0|||
143248097|NCT01742286|516460544|FG003|Expansion Phase|Administrative problems|0|||
143248098|NCT01742286|516460545|FG004|Expansion Phase|Administrative problems|0|||
143248099|NCT01742286|516460546|FG005|Expansion Phase|Administrative problems|0|||
143248100|NCT01742286|516460547|FG006|Expansion Phase|Administrative problems|5|||
143248101|NCT01742286|516460541|FG000|Expansion Phase|Physician Decision|0|||
143248102|NCT01742286|516460542|FG001|Expansion Phase|Physician Decision|0|||
143365512|NCT00662909|516880804|FG001|Overall Study|Eligibility criterion not met|1|||
143365513|NCT00662909|516880805|FG002|Overall Study|Eligibility criterion not met|1|||
143073310|NCT02393248|515808341|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
143073311|NCT02393248|515808342|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
143073312|NCT02393248|515808343|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
143073313|NCT02393248|515808344|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
143073314|NCT00265395|515808345|FG000|Overall Study|Adverse Event|3|||
143073315|NCT00265395|515808346|FG001|Overall Study|Adverse Event|6|||
143073316|NCT00265395|515808345|FG000|Overall Study|Lost to Follow-up|2|||
143073317|NCT00265395|515808346|FG001|Overall Study|Lost to Follow-up|1|||
143073318|NCT00265395|515808345|FG000|Overall Study|Withdrawal by Subject|1|||
143073319|NCT00265395|515808346|FG001|Overall Study|Withdrawal by Subject|6|||
143073320|NCT00265395|515808345|FG000|Overall Study|Protocol Violation|2|||
143073321|NCT00265395|515808346|FG001|Overall Study|Protocol Violation|2|||
143073322|NCT00265395|515808345|FG000|Overall Study|Lack of Efficacy|0|||
143073323|NCT00265395|515808346|FG001|Overall Study|Lack of Efficacy|1|||
143073324|NCT00265395|515808345|FG000|Overall Study|Administrative|0|||
143073325|NCT00265395|515808346|FG001|Overall Study|Administrative|1|||
143073326|NCT00470067|515808347|FG000|Overall Study|Death|1|||
143073327|NCT00470067|515808347|FG000|Overall Study|Disease Progression|6|||
143073328|NCT02563106|515808348|FG000|Overall Study|Withdrawal by Subject|7|||
143073329|NCT02563106|515808349|FG001|Overall Study|Withdrawal by Subject|8|||
143073330|NCT02563106|515808348|FG000|Overall Study|Adverse Event|17|||
143073331|NCT02563106|515808349|FG001|Overall Study|Adverse Event|15|||
143073332|NCT02563106|515808348|FG000|Overall Study|Protocol Violation|1|||
143073333|NCT02563106|515808349|FG001|Overall Study|Protocol Violation|0|||
143073334|NCT02563106|515808348|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
143073335|NCT02563106|515808349|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
143073336|NCT02563106|515808348|FG000|Overall Study|Lost to Follow-up|3|||
143073337|NCT02563106|515808349|FG001|Overall Study|Lost to Follow-up|2|||
143073338|NCT02563106|515808348|FG000|Overall Study|Physician Decision|3|||
143073339|NCT02563106|515808349|FG001|Overall Study|Physician Decision|1|||
143073340|NCT02563106|515808348|FG000|Overall Study|Other reason - not specified|2|||
143073341|NCT02563106|515808349|FG001|Overall Study|Other reason - not specified|1|||
143073342|NCT02085135|515808350|FG000|Overall Study|Adverse Event|4|||
143073343|NCT02085135|515808351|FG001|Overall Study|Adverse Event|7|||
143073344|NCT02085135|515808350|FG000|Overall Study|Lost to Follow-up|2|||
143073345|NCT02085135|515808351|FG001|Overall Study|Lost to Follow-up|2|||
143073346|NCT02085135|515808350|FG000|Overall Study|Withdrawal by Subject|3|||
143073347|NCT02085135|515808351|FG001|Overall Study|Withdrawal by Subject|0|||
143073348|NCT02085135|515808350|FG000|Overall Study|Lack of Efficacy|2|||
143248103|NCT01742286|516460543|FG002|Expansion Phase|Physician Decision|4|||
143248104|NCT01742286|516460544|FG003|Expansion Phase|Physician Decision|0|||
143248105|NCT01742286|516460545|FG004|Expansion Phase|Physician Decision|0|||
143248106|NCT01742286|516460546|FG005|Expansion Phase|Physician Decision|0|||
143248107|NCT01742286|516460547|FG006|Expansion Phase|Physician Decision|9|||
143248108|NCT01742286|516460541|FG000|Expansion Phase|Adverse Event|0|||
143248109|NCT01742286|516460542|FG001|Expansion Phase|Adverse Event|0|||
143073349|NCT02085135|515808351|FG001|Overall Study|Lack of Efficacy|0|||
143073350|NCT01212588|515808353|FG000|Overall Study|Physician Decision|0|||
143073351|NCT01212588|515808354|FG001|Overall Study|Physician Decision|1|||
143073352|NCT01212588|515808353|FG000|Overall Study|Protocol Violation|1|||
143073353|NCT01212588|515808354|FG001|Overall Study|Protocol Violation|1|||
143073354|NCT02338193|515808355|FG000|Overall Study|Withdrawal by Subject|0|||
143073355|NCT02338193|515808356|FG001|Overall Study|Withdrawal by Subject|0|||
143073356|NCT02338193|515808357|FG002|Overall Study|Withdrawal by Subject|2|||
143073357|NCT02338193|515808355|FG000|Overall Study|Pregnancy|0|||
143073358|NCT02338193|515808356|FG001|Overall Study|Pregnancy|1|||
143073359|NCT02338193|515808357|FG002|Overall Study|Pregnancy|1|||
143073360|NCT02338193|515808355|FG000|Overall Study|Noncompliant with visits|2|||
143073361|NCT02338193|515808356|FG001|Overall Study|Noncompliant with visits|2|||
143073362|NCT02338193|515808357|FG002|Overall Study|Noncompliant with visits|7|||
143073363|NCT02338193|515808355|FG000|Overall Study|moved out of state|0|||
143073364|NCT02338193|515808356|FG001|Overall Study|moved out of state|1|||
143073365|NCT02338193|515808357|FG002|Overall Study|moved out of state|0|||
143073366|NCT02338193|515808355|FG000|Overall Study|intolerant of side effects|1|||
143073367|NCT02338193|515808356|FG001|Overall Study|intolerant of side effects|0|||
143073368|NCT02338193|515808357|FG002|Overall Study|intolerant of side effects|0|||
143073369|NCT02885181|515808362|FG000|Overall Study|Investigator's Discretion|0|||
143073370|NCT02885181|515808363|FG001|Overall Study|Investigator's Discretion|1|||
143073371|NCT02885181|515808364|FG002|Overall Study|Investigator's Discretion|0|||
143073372|NCT02885181|515808365|FG003|Overall Study|Investigator's Discretion|1|||
143073373|NCT02885181|515808362|FG000|Overall Study|Adverse Event|0|||
143073374|NCT02885181|515808363|FG001|Overall Study|Adverse Event|0|||
143073375|NCT02885181|515808364|FG002|Overall Study|Adverse Event|0|||
143073376|NCT02885181|515808365|FG003|Overall Study|Adverse Event|1|||
143073377|NCT02885181|515808362|FG000|Overall Study|Withdrawal by Subject|0|||
143073378|NCT02885181|515808363|FG001|Overall Study|Withdrawal by Subject|0|||
143073379|NCT02885181|515808364|FG002|Overall Study|Withdrawal by Subject|0|||
143073380|NCT02885181|515808365|FG003|Overall Study|Withdrawal by Subject|1|||
143073381|NCT03317834|515808368|FG000|Overall Study|Death|2|||
143073382|NCT03317834|515808368|FG000|Overall Study|Device Revision|5|||
143073383|NCT03317834|515808368|FG000|Overall Study|Withdrawal by Subject|13|||
143073384|NCT03317834|515808368|FG000|Overall Study|Lost to Follow-up|13|||
143073385|NCT04091659|515808372|FG000|Overall Study|Protocol Violation|3|||
143073386|NCT04091659|515808373|FG001|Overall Study|Protocol Violation|0|||
143073387|NCT04091659|515808372|FG000|Overall Study|Lost to Follow-up|0|||
143073388|NCT04091659|515808373|FG001|Overall Study|Lost to Follow-up|1|||
143073389|NCT00338455|515808374|FG000|Overall Study|Death|2|||
143073390|NCT00338455|515808375|FG001|Overall Study|Death|1|||
143073391|NCT00338455|515808374|FG000|Overall Study|Physician Decision|1|||
143073392|NCT00338455|515808375|FG001|Overall Study|Physician Decision|0|||
143073393|NCT02266134|515808378|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
143073394|NCT02266134|515808379|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
143073395|NCT02266134|515808380|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
143073396|NCT02266134|515808381|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
143073397|NCT02266134|515808378|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
143073398|NCT02266134|515808379|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
143073399|NCT02266134|515808380|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
143073400|NCT02266134|515808381|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
143073401|NCT02266134|515808378|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
143073402|NCT02266134|515808379|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
143073403|NCT02266134|515808380|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
143073404|NCT02266134|515808381|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
143073405|NCT02266134|515808378|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
143073406|NCT02266134|515808379|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
143073407|NCT02266134|515808380|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
143073408|NCT02266134|515808381|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
143073409|NCT02266134|515808378|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
143073410|NCT02266134|515808379|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
143073411|NCT02266134|515808380|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
143073412|NCT02266134|515808381|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
143073413|NCT02266134|515808378|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
143073414|NCT02266134|515808379|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
143073415|NCT02266134|515808380|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
143073416|NCT02266134|515808381|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
143073417|NCT00123474|515808382|FG000|Randomized to Treatment|Randomized, never treated|1|||
143073418|NCT00123474|515808383|FG001|Randomized to Treatment|Randomized, never treated|4|||
143073419|NCT00123474|515808384|FG002|Randomized to Treatment|Randomized, never treated|2|||
143073420|NCT00123474|515808385|FG003|Randomized to Treatment|Randomized, never treated|1|||
143073421|NCT00123474|515808382|FG000|As Treated at Study Closure|not reported when site closed|1|||
143073422|NCT00123474|515808383|FG001|As Treated at Study Closure|not reported when site closed|0|||
143073423|NCT00123474|515808384|FG002|As Treated at Study Closure|not reported when site closed|1|||
143073424|NCT00123474|515808385|FG003|As Treated at Study Closure|not reported when site closed|0|||
143073425|NCT00123474|515808382|FG000|As Treated at Study Closure|Adverse Event|10|||
143073426|NCT00123474|515808383|FG001|As Treated at Study Closure|Adverse Event|4|||
143073427|NCT00123474|515808384|FG002|As Treated at Study Closure|Adverse Event|10|||
143073428|NCT00123474|515808385|FG003|As Treated at Study Closure|Adverse Event|8|||
143073429|NCT00123474|515808382|FG000|As Treated at Study Closure|Disease Progression|35|||
143073430|NCT00123474|515808383|FG001|As Treated at Study Closure|Disease Progression|42|||
143073431|NCT00123474|515808384|FG002|As Treated at Study Closure|Disease Progression|29|||
143073432|NCT00123474|515808385|FG003|As Treated at Study Closure|Disease Progression|27|||
143073433|NCT00123474|515808382|FG000|As Treated at Study Closure|Investigator Request|12|||
143073434|NCT00123474|515808383|FG001|As Treated at Study Closure|Investigator Request|6|||
143073435|NCT00123474|515808384|FG002|As Treated at Study Closure|Investigator Request|7|||
143073436|NCT00123474|515808385|FG003|As Treated at Study Closure|Investigator Request|5|||
143073437|NCT00123474|515808382|FG000|As Treated at Study Closure|non-specified|54|||
143073438|NCT00123474|515808383|FG001|As Treated at Study Closure|non-specified|47|||
143073439|NCT00123474|515808384|FG002|As Treated at Study Closure|non-specified|57|||
143073440|NCT00123474|515808385|FG003|As Treated at Study Closure|non-specified|60|||
143073441|NCT00123474|515808382|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
143073442|NCT00123474|515808383|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
143073443|NCT00123474|515808384|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
143073444|NCT00123474|515808385|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
143073445|NCT00123474|515808382|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
143073446|NCT00123474|515808383|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
143073447|NCT00123474|515808384|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
143073448|NCT00123474|515808385|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
143073449|NCT01447420|515808386|FG000|Overall Study|Adverse Event|2|||
143073450|NCT01447420|515808387|FG001|Overall Study|Adverse Event|4|||
143073451|NCT01447420|515808388|FG002|Overall Study|Adverse Event|2|||
143073452|NCT01447420|515808386|FG000|Overall Study|Protocol Violation|3|||
143073453|NCT01447420|515808387|FG001|Overall Study|Protocol Violation|3|||
143073454|NCT01447420|515808388|FG002|Overall Study|Protocol Violation|0|||
143073455|NCT01447420|515808386|FG000|Overall Study|Withdrawal by Subject|4|||
143073456|NCT01447420|515808387|FG001|Overall Study|Withdrawal by Subject|1|||
143073457|NCT01447420|515808388|FG002|Overall Study|Withdrawal by Subject|0|||
143073458|NCT01447420|515808386|FG000|Overall Study|Lack of Efficacy|1|||
143073459|NCT01447420|515808387|FG001|Overall Study|Lack of Efficacy|19|||
143073460|NCT01447420|515808388|FG002|Overall Study|Lack of Efficacy|8|||
143073461|NCT00528411|515808392|FG000|Overall Study|Adverse Event|4|||
143073462|NCT00528411|515808393|FG001|Overall Study|Adverse Event|0|||
143073463|NCT00528411|515808394|FG002|Overall Study|Adverse Event|1|||
143073464|NCT00528411|515808392|FG000|Overall Study|Incorrect Enrolment|1|||
143073465|NCT00528411|515808393|FG001|Overall Study|Incorrect Enrolment|1|||
143073466|NCT00528411|515808394|FG002|Overall Study|Incorrect Enrolment|0|||
143073467|NCT00528411|515808392|FG000|Overall Study|Severe non-compliance to protocol|0|||
143073468|NCT00528411|515808393|FG001|Overall Study|Severe non-compliance to protocol|1|||
143171676|NCT04388826|516178432|FG000|Overall Study|Adverse Event|1|||
143171677|NCT04388826|516178433|FG001|Overall Study|Adverse Event|0|||
143171678|NCT04047446|516178434|FG000|Overall Study|Physician Decision|1|||
143171679|NCT04047446|516178435|FG001|Overall Study|Physician Decision|0|||
143171680|NCT00329420|516178436|FG000|Re-induction Phase|Lack of Efficacy|0|||
143171681|NCT00329420|516178437|FG001|Re-induction Phase|Lack of Efficacy|1|||
143171682|NCT00329420|516178438|FG002|Re-induction Phase|Lack of Efficacy|0|||
143073469|NCT00528411|515808394|FG002|Overall Study|Severe non-compliance to protocol|0|||
143073470|NCT00528411|515808392|FG000|Overall Study|Prior commitment medication|0|||
143073471|NCT00528411|515808393|FG001|Overall Study|Prior commitment medication|1|||
143073472|NCT00528411|515808394|FG002|Overall Study|Prior commitment medication|0|||
143171683|NCT00329420|516178436|FG000|Re-induction Phase|Withdrawal of Consent|0|||
143073473|NCT03893565|515808395|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
143073474|NCT03893565|515808396|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
143171684|NCT00329420|516178437|FG001|Re-induction Phase|Withdrawal of Consent|0|||
143171685|NCT00329420|516178438|FG002|Re-induction Phase|Withdrawal of Consent|1|||
143073475|NCT03893565|515808397|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
143073476|NCT03893565|515808398|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
143073477|NCT03893565|515808399|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
143073478|NCT03893565|515808400|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
143073479|NCT03893565|515808401|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
143073480|NCT03893565|515808402|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
143073481|NCT03893565|515808403|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
143073482|NCT03893565|515808395|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
143073483|NCT03893565|515808396|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
143073484|NCT03893565|515808397|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
143073485|NCT03893565|515808398|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
143073486|NCT03893565|515808399|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
143073487|NCT03893565|515808400|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
143073488|NCT03893565|515808401|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
143073489|NCT03893565|515808402|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
143073490|NCT03893565|515808403|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
143073491|NCT03893565|515808395|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
143073492|NCT03893565|515808396|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
143073493|NCT03893565|515808397|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
143073494|NCT03893565|515808398|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
143073495|NCT03893565|515808399|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
143073496|NCT03893565|515808400|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
143073497|NCT03893565|515808401|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
143073498|NCT03893565|515808402|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
143073499|NCT03893565|515808403|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
143073500|NCT03893565|515808395|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
143073501|NCT03893565|515808396|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
143073502|NCT03893565|515808397|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
143073503|NCT03893565|515808398|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
143073504|NCT03893565|515808399|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
143073505|NCT03893565|515808400|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
143073506|NCT03893565|515808401|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
143073507|NCT03893565|515808402|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
143073508|NCT03893565|515808403|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
143073509|NCT03893565|515808395|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
143073510|NCT03893565|515808396|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
143073511|NCT03893565|515808397|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
143073512|NCT03893565|515808398|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
143073513|NCT03893565|515808399|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
143073514|NCT03893565|515808400|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
143073515|NCT03893565|515808401|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
143073516|NCT03893565|515808402|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
143073517|NCT03893565|515808403|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
143073518|NCT03893565|515808395|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
143073519|NCT03893565|515808396|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
143073520|NCT03893565|515808397|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
143073521|NCT03893565|515808398|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
143073522|NCT03893565|515808399|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
143073523|NCT03893565|515808400|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
143073524|NCT03893565|515808401|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
143073525|NCT03893565|515808402|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
143073526|NCT03893565|515808403|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
143073527|NCT03893565|515808395|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
143073528|NCT03893565|515808396|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
143073529|NCT03893565|515808397|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
143073530|NCT03893565|515808398|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
143073531|NCT03893565|515808399|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
143073532|NCT03893565|515808400|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
143171686|NCT00329420|516178436|FG000|Re-induction Phase|Did not respond to re-induction|6|||
143171687|NCT00329420|516178437|FG001|Re-induction Phase|Did not respond to re-induction|5|||
143171688|NCT00329420|516178438|FG002|Re-induction Phase|Did not respond to re-induction|7|||
143073533|NCT03893565|515808401|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
143073534|NCT03893565|515808402|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
143073535|NCT03893565|515808403|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
143073536|NCT03893565|515808395|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
143073537|NCT03893565|515808396|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
143073538|NCT03893565|515808397|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
143073539|NCT03893565|515808398|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
143073540|NCT03893565|515808399|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
143073541|NCT03893565|515808400|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
143073542|NCT03893565|515808401|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
143073543|NCT03893565|515808402|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
143073544|NCT03893565|515808403|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
143073545|NCT03893565|515808395|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
143073546|NCT03893565|515808396|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
143073547|NCT03893565|515808397|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
143073548|NCT03893565|515808398|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
143073549|NCT03893565|515808399|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
143073550|NCT03893565|515808400|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
143073551|NCT03893565|515808401|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
143073552|NCT03893565|515808402|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
143073553|NCT03893565|515808403|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
143073554|NCT03893565|515808395|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
143073555|NCT03893565|515808396|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
143073556|NCT03893565|515808397|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
143073557|NCT03893565|515808398|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
143073558|NCT03893565|515808399|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
143073559|NCT03893565|515808400|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
143073560|NCT03893565|515808401|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
143073561|NCT03893565|515808402|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
143073562|NCT03893565|515808403|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
143073563|NCT03893565|515808395|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
143073564|NCT03893565|515808396|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
143073565|NCT03893565|515808397|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
143073566|NCT03893565|515808398|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
143073567|NCT03893565|515808399|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
143073568|NCT03893565|515808400|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
143073569|NCT03893565|515808401|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
143073570|NCT03893565|515808402|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
143073571|NCT03893565|515808403|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
143073572|NCT03893565|515808395|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
143073573|NCT03893565|515808396|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
143073574|NCT03893565|515808397|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
143073575|NCT03893565|515808398|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
143073576|NCT03893565|515808399|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
143073577|NCT03893565|515808400|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
143073578|NCT03893565|515808401|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
143073579|NCT03893565|515808402|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
143073580|NCT03893565|515808403|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
143073581|NCT03893565|515808395|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
143073582|NCT03893565|515808396|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
143073583|NCT03893565|515808397|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
143073584|NCT03893565|515808398|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
143073585|NCT03893565|515808399|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
143171689|NCT00329420|516178436|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
143171690|NCT00329420|516178437|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
143171691|NCT00329420|516178438|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
143171692|NCT00329420|516178436|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
143171693|NCT00329420|516178437|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
143171694|NCT00329420|516178438|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
143171695|NCT00329420|516178436|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
143171696|NCT00329420|516178437|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
143171697|NCT00329420|516178438|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
143171698|NCT03386773|516178439|FG000|Overall Study|Lost to Follow-up|24|||
143171699|NCT03386773|516178440|FG001|Overall Study|Lost to Follow-up|33|||
143171700|NCT03386773|516178439|FG000|Overall Study|Withdrawal by Subject|3|||
143073586|NCT03893565|515808400|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
143073587|NCT03893565|515808401|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
143073588|NCT03893565|515808402|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
143073589|NCT03893565|515808403|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
143073590|NCT03893565|515808395|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
143073591|NCT03893565|515808396|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
143073592|NCT03893565|515808397|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
143073593|NCT03893565|515808398|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
143073594|NCT03893565|515808399|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
143073595|NCT03893565|515808400|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
143073596|NCT03893565|515808401|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
143073597|NCT03893565|515808402|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
143073598|NCT03893565|515808403|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
143073599|NCT03893565|515808395|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
143073600|NCT03893565|515808396|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
143073601|NCT03893565|515808397|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
143073602|NCT03893565|515808398|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
143073603|NCT03893565|515808399|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
143073604|NCT03893565|515808400|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
143073605|NCT03893565|515808401|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
143073606|NCT03893565|515808402|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
143073607|NCT03893565|515808403|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
143073608|NCT03893565|515808395|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
143073609|NCT03893565|515808396|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
143073610|NCT03893565|515808397|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
143073611|NCT03893565|515808398|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
143073612|NCT03893565|515808399|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
143073613|NCT03893565|515808400|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
143073614|NCT03893565|515808401|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
143073615|NCT03893565|515808402|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
143073616|NCT03893565|515808403|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
143073617|NCT00851318|515808404|FG000|Overall Study|Withdrawal by Subject|7|||
143073618|NCT00851318|515808405|FG001|Overall Study|Withdrawal by Subject|1|||
143073619|NCT00851318|515808406|FG002|Overall Study|Withdrawal by Subject|5|||
143073620|NCT00851318|515808407|FG003|Overall Study|Withdrawal by Subject|3|||
143073621|NCT00851318|515808404|FG000|Overall Study|Adverse Event|13|||
143073622|NCT00851318|515808405|FG001|Overall Study|Adverse Event|2|||
143073623|NCT00851318|515808406|FG002|Overall Study|Adverse Event|9|||
143073624|NCT00851318|515808407|FG003|Overall Study|Adverse Event|12|||
143073625|NCT00851318|515808404|FG000|Overall Study|Pregnancy|0|||
143073626|NCT00851318|515808405|FG001|Overall Study|Pregnancy|0|||
143073627|NCT00851318|515808406|FG002|Overall Study|Pregnancy|1|||
143073628|NCT00851318|515808407|FG003|Overall Study|Pregnancy|1|||
143073629|NCT00851318|515808404|FG000|Overall Study|Lack of Efficacy|8|||
143073630|NCT00851318|515808405|FG001|Overall Study|Lack of Efficacy|2|||
143073631|NCT00851318|515808406|FG002|Overall Study|Lack of Efficacy|4|||
143073632|NCT00851318|515808407|FG003|Overall Study|Lack of Efficacy|2|||
143073633|NCT00851318|515808404|FG000|Overall Study|Non-compliance with Study Procedures|2|||
143073634|NCT00851318|515808405|FG001|Overall Study|Non-compliance with Study Procedures|0|||
143073635|NCT00851318|515808406|FG002|Overall Study|Non-compliance with Study Procedures|1|||
143073636|NCT00851318|515808407|FG003|Overall Study|Non-compliance with Study Procedures|0|||
143073637|NCT00851318|515808404|FG000|Overall Study|Physician Decision|0|||
143073638|NCT00851318|515808405|FG001|Overall Study|Physician Decision|0|||
143073639|NCT00851318|515808406|FG002|Overall Study|Physician Decision|1|||
143073640|NCT00851318|515808407|FG003|Overall Study|Physician Decision|1|||
143073641|NCT02695537|515808408|FG000|Overall Study|Adverse Event|3|||
143073642|NCT02695537|515808408|FG000|Overall Study|Lack of Efficacy|28|||
143073643|NCT02695537|515808408|FG000|Overall Study|Withdrawal by Subject|4|||
143073644|NCT02695537|515808408|FG000|Overall Study|Protocol Violation|3|||
143073645|NCT01715571|515808409|FG000|Overall Study|Lost to Follow-up|8|||
143073646|NCT01753336|515808420|FG000|Overall Study|Patient decision|12|||
143073647|NCT01753336|515808420|FG000|Overall Study|Lost to Follow-up|3|||
143073648|NCT01753336|515808420|FG000|Overall Study|Physician Decision|2|||
143073649|NCT01753336|515808420|FG000|Overall Study|Sponsor's decision|2|||
143073650|NCT01753336|515808420|FG000|Overall Study|Withdrawal by Subject|1|||
143073651|NCT04568031|515808423|FG000|Overall Study|Lost to Follow-up|1|||
143073652|NCT04568031|515808424|FG001|Overall Study|Lost to Follow-up|0|||
143073653|NCT04568031|515808425|FG002|Overall Study|Lost to Follow-up|0|||
143073654|NCT04568031|515808426|FG003|Overall Study|Lost to Follow-up|0|||
143073655|NCT04568031|515808423|FG000|Overall Study|Physician Decision|1|||
143073656|NCT04568031|515808424|FG001|Overall Study|Physician Decision|0|||
143073657|NCT04568031|515808425|FG002|Overall Study|Physician Decision|1|||
143073658|NCT04568031|515808426|FG003|Overall Study|Physician Decision|0|||
143073659|NCT04568031|515808423|FG000|Overall Study|Withdrawal by Subject|1|||
143073660|NCT04568031|515808424|FG001|Overall Study|Withdrawal by Subject|0|||
143073661|NCT04568031|515808425|FG002|Overall Study|Withdrawal by Subject|4|||
143073662|NCT04568031|515808426|FG003|Overall Study|Withdrawal by Subject|1|||
143073663|NCT01709838|515808433|FG000|Overall Study|Withdrawal by Subject|21|||
143073664|NCT01709838|515808433|FG000|Overall Study|Lost to Follow-up|16|||
143073665|NCT01709838|515808433|FG000|Overall Study|Pregnancy|10|||
143073666|NCT01709838|515808433|FG000|Overall Study|Subject/guardian decision|8|||
143073667|NCT01709838|515808433|FG000|Overall Study|Adverse Event|4|||
143073668|NCT01709838|515808433|FG000|Overall Study|Physician Decision|4|||
143073669|NCT01709838|515808433|FG000|Overall Study|Death|3|||
143073670|NCT01709838|515808433|FG000|Overall Study|Protocol Violation|1|||
143073671|NCT03246646|515808436|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
143073672|NCT03246646|515808437|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
143073673|NCT03246646|515808436|FG000|Overall Study|Withdrawal by Subject|3|||
143073674|NCT03246646|515808437|FG001|Overall Study|Withdrawal by Subject|0|||
143073675|NCT03246646|515808436|FG000|Overall Study|Lost to Follow-up|7|||
143073676|NCT03246646|515808437|FG001|Overall Study|Lost to Follow-up|0|||
143073677|NCT02352779|515808438|FG000|Overall Study|Personal Issues|1|||
143073678|NCT02352779|515808439|FG001|Overall Study|Personal Issues|1|||
143073679|NCT02352779|515808440|FG002|Overall Study|Personal Issues|0|||
143073680|NCT02352779|515808438|FG000|Overall Study|Too Many Forms|2|||
143073681|NCT02352779|515808439|FG001|Overall Study|Too Many Forms|0|||
143073682|NCT02352779|515808440|FG002|Overall Study|Too Many Forms|0|||
143073683|NCT02352779|515808438|FG000|Overall Study|Feeling Overwhelmed|1|||
143073684|NCT02352779|515808439|FG001|Overall Study|Feeling Overwhelmed|0|||
143073685|NCT02352779|515808440|FG002|Overall Study|Feeling Overwhelmed|0|||
143073686|NCT02352779|515808438|FG000|Overall Study|Disliked Intervention|1|||
143073687|NCT02352779|515808439|FG001|Overall Study|Disliked Intervention|0|||
143073688|NCT02352779|515808440|FG002|Overall Study|Disliked Intervention|0|||
143073689|NCT02352779|515808438|FG000|Overall Study|Changed Mind|1|||
143073690|NCT02352779|515808439|FG001|Overall Study|Changed Mind|0|||
143073691|NCT02352779|515808440|FG002|Overall Study|Changed Mind|0|||
143073692|NCT02352779|515808438|FG000|Overall Study|Study Related Symptoms|1|||
143073693|NCT02352779|515808439|FG001|Overall Study|Study Related Symptoms|0|||
143073694|NCT02352779|515808440|FG002|Overall Study|Study Related Symptoms|0|||
143073695|NCT02352779|515808438|FG000|Overall Study|Absence of Symptoms|1|||
143073696|NCT02352779|515808439|FG001|Overall Study|Absence of Symptoms|0|||
143073697|NCT02352779|515808440|FG002|Overall Study|Absence of Symptoms|0|||
143073698|NCT02352779|515808438|FG000|Overall Study|Other Medical Reason|0|||
143073699|NCT02352779|515808439|FG001|Overall Study|Other Medical Reason|0|||
143073700|NCT02352779|515808440|FG002|Overall Study|Other Medical Reason|1|||
143073701|NCT02352779|515808438|FG000|Overall Study|No Reason|0|||
143073702|NCT02352779|515808439|FG001|Overall Study|No Reason|0|||
143073703|NCT02352779|515808440|FG002|Overall Study|No Reason|1|||
143073704|NCT03753763|515808443|FG000|Overall Study|Adverse Event|2|||
143073705|NCT03753763|515808444|FG001|Overall Study|Adverse Event|0|||
143073706|NCT03753763|515808443|FG000|Overall Study|Withdrawal by Subject|3|||
143073707|NCT03753763|515808444|FG001|Overall Study|Withdrawal by Subject|1|||
143073708|NCT03753763|515808443|FG000|Overall Study|clinical deterioration|1|||
143073709|NCT03753763|515808444|FG001|Overall Study|clinical deterioration|0|||
143073710|NCT00719849|515808445|FG000|Overall Study|Death|0|||
143073711|NCT00719849|515808446|FG001|Overall Study|Death|1|||
143073712|NCT01372774|515808450|FG000|Overall Study|Withdrawal prior to treatment|4|||
143073713|NCT01372774|515808451|FG001|Overall Study|Withdrawal prior to treatment|5|||
143073714|NCT00389831|515808452|FG000|Overall Study|Lack of Efficacy|0|||
143073715|NCT00389831|515808453|FG001|Overall Study|Lack of Efficacy|2|||
143073716|NCT00389831|515808452|FG000|Overall Study|Did not receive treatment.|0|||
143073717|NCT00389831|515808453|FG001|Overall Study|Did not receive treatment.|2|||
143073718|NCT00389831|515808452|FG000|Overall Study|Other reasons|0|||
143073719|NCT00389831|515808453|FG001|Overall Study|Other reasons|2|||
143073720|NCT00389831|515808452|FG000|Overall Study|Lost to Follow-up|0|||
143073721|NCT00389831|515808453|FG001|Overall Study|Lost to Follow-up|1|||
143073722|NCT03190330|515810853|FG000|Overall Study|Adverse Event|2|||
143073723|NCT03190330|515810853|FG000|Overall Study|Death|10|||
143073724|NCT03190330|515810853|FG000|Overall Study|Lost to Follow-up|1|||
143073725|NCT03190330|515810853|FG000|Overall Study|Withdrawal by Subject|6|||
143073726|NCT03190330|515810853|FG000|Overall Study|Progressive Disease|1|||
143073727|NCT02081209|515810854|FG000|Overall Study|Withdrawal by Subject|1|||
143073728|NCT01167257|515810855|FG000|Overall Study|Lost to Follow-up|2|||
143073729|NCT01167257|515810856|FG001|Overall Study|Lost to Follow-up|2|||
143073730|NCT01167257|515810855|FG000|Overall Study|Withdrew consent|1|||
143073731|NCT01167257|515810856|FG001|Overall Study|Withdrew consent|1|||
143073732|NCT00721630|515810857|FG000|Overall Study|Participant found to be ineligible|1|||
143073733|NCT01555671|515810859|FG000|Overall Study|Physician Decision|20|||
143073734|NCT01555671|515810860|FG001|Overall Study|Physician Decision|25|||
143073735|NCT00699283|515810861|FG000|Overall Study|Lack of Efficacy|15|||
143073736|NCT00699283|515810862|FG001|Overall Study|Lack of Efficacy|5|||
143073737|NCT00699283|515810861|FG000|Overall Study|Lost to Follow-up|2|||
143073738|NCT00699283|515810862|FG001|Overall Study|Lost to Follow-up|0|||
143073739|NCT00699283|515810861|FG000|Overall Study|Withdrawal by Subject|1|||
143073740|NCT00699283|515810862|FG001|Overall Study|Withdrawal by Subject|0|||
143073741|NCT00699283|515810861|FG000|Overall Study|Other Reason|5|||
143073742|NCT00699283|515810862|FG001|Overall Study|Other Reason|1|||
143073743|NCT00699283|515810861|FG000|Overall Study|SAE, non-fatal|1|||
143073744|NCT00699283|515810862|FG001|Overall Study|SAE, non-fatal|1|||
143073745|NCT00699283|515810861|FG000|Overall Study|AE, non-serious non-fatal|8|||
143073746|NCT00699283|515810862|FG001|Overall Study|AE, non-serious non-fatal|1|||
143073747|NCT00699283|515810861|FG000|Overall Study|AE of unknown type|1|||
143073748|NCT00699283|515810862|FG001|Overall Study|AE of unknown type|0|||
143073749|NCT03537599|515810869|FG000|Overall Study|Disease Progression|2|||
143073750|NCT03537599|515810870|FG001|Overall Study|Disease Progression|1|||
143073751|NCT03537599|515810869|FG000|Overall Study|Death|0|||
143073752|NCT03537599|515810870|FG001|Overall Study|Death|1|||
143073753|NCT00622466|515810871|FG000|Overall Study|Death|1|||
143073754|NCT00622466|515810871|FG000|Overall Study|Adverse Event|1|||
143073755|NCT00622466|515810871|FG000|Overall Study|Withdrawal by Subject|2|||
143073756|NCT01007942|515810872|FG000|Overall Study|Adverse Event|29|||
143073757|NCT01007942|515810873|FG001|Overall Study|Adverse Event|14|||
143073758|NCT01007942|515810872|FG000|Overall Study|Abnormal test procedure|0|||
143073759|NCT01007942|515810873|FG001|Overall Study|Abnormal test procedure|1|||
143073760|NCT01007942|515810872|FG000|Overall Study|Disease progression|217|||
143073761|NCT01007942|515810873|FG001|Overall Study|Disease progression|242|||
143073762|NCT01007942|515810872|FG000|Overall Study|New cancer therapy|5|||
143073763|NCT01007942|515810873|FG001|Overall Study|New cancer therapy|1|||
143073764|NCT01007942|515810872|FG000|Overall Study|Protocol Violation|1|||
143073765|NCT01007942|515810873|FG001|Overall Study|Protocol Violation|1|||
143073766|NCT01007942|515810872|FG000|Overall Study|Withdrawal by Subject|19|||
143073767|NCT01007942|515810873|FG001|Overall Study|Withdrawal by Subject|14|||
143073768|NCT01007942|515810872|FG000|Overall Study|Lost to Follow-up|1|||
143073769|NCT01007942|515810873|FG001|Overall Study|Lost to Follow-up|0|||
143073770|NCT01007942|515810872|FG000|Overall Study|Administrative problems|2|||
143073771|NCT01007942|515810873|FG001|Overall Study|Administrative problems|0|||
143073772|NCT01007942|515810872|FG000|Overall Study|Death|3|||
143073773|NCT01007942|515810873|FG001|Overall Study|Death|2|||
143073774|NCT01007942|515810872|FG000|Overall Study|Patients untreated|4|||
143073775|NCT01007942|515810873|FG001|Overall Study|Patients untreated|3|||
143073776|NCT05083585|515810874|FG000|Overall Study|Death|1|||
143073777|NCT05083585|515810875|FG001|Overall Study|Death|1|||
143073778|NCT05083585|515810874|FG000|Overall Study|Lost to Follow-up|1|||
143073779|NCT05083585|515810875|FG001|Overall Study|Lost to Follow-up|1|||
143073780|NCT05083585|515810874|FG000|Overall Study|Withdrawal by Subject|2|||
143073781|NCT05083585|515810875|FG001|Overall Study|Withdrawal by Subject|0|||
143073782|NCT05083585|515810874|FG000|Overall Study|Randomized but not vaccinated|2|||
143073783|NCT05083585|515810875|FG001|Overall Study|Randomized but not vaccinated|0|||
143073784|NCT03929757|515810876|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
143073785|NCT03929757|515810877|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
143073786|NCT03929757|515810878|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
143073787|NCT03929757|515810876|FG000|Main Study: Up to Day 365|Other|1|||
143073788|NCT03929757|515810877|FG001|Main Study: Up to Day 365|Other|0|||
143073789|NCT03929757|515810878|FG002|Main Study: Up to Day 365|Other|0|||
143073790|NCT03929757|515810876|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
143073791|NCT03929757|515810877|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
143073792|NCT03929757|515810878|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
143073793|NCT00699374|515810879|FG000|Overall Study|Death|93|||
143073794|NCT00699374|515810880|FG001|Overall Study|Death|83|||
143073795|NCT00699374|515810879|FG000|Overall Study|Adverse Event|70|||
143073796|NCT00699374|515810880|FG001|Overall Study|Adverse Event|67|||
143073797|NCT00699374|515810879|FG000|Overall Study|Global deterioration of health status|7|||
143073798|NCT00699374|515810880|FG001|Overall Study|Global deterioration of health status|8|||
143073799|NCT00699374|515810879|FG000|Overall Study|Lost to Follow-up|3|||
143073800|NCT00699374|515810880|FG001|Overall Study|Lost to Follow-up|5|||
143073801|NCT00699374|515810879|FG000|Overall Study|Withdrawal by Subject|34|||
143073802|NCT00699374|515810880|FG001|Overall Study|Withdrawal by Subject|44|||
143073803|NCT00699374|515810879|FG000|Overall Study|Objective progression or relapse|281|||
143073804|NCT00699374|515810880|FG001|Overall Study|Objective progression or relapse|277|||
143073805|NCT00699374|515810879|FG000|Overall Study|Other|18|||
143073806|NCT00699374|515810880|FG001|Overall Study|Other|15|||
143073807|NCT00699374|515810879|FG000|Overall Study|Protocol Violation|2|||
143073808|NCT00699374|515810880|FG001|Overall Study|Protocol Violation|6|||
143073809|NCT00699374|515810879|FG000|Overall Study|Study terminated by sponsor|13|||
143073810|NCT00699374|515810880|FG001|Overall Study|Study terminated by sponsor|28|||
143073811|NCT00699374|515810879|FG000|Overall Study|Randomized but not treated|4|||
143073812|NCT00699374|515810880|FG001|Overall Study|Randomized but not treated|2|||
143073813|NCT00699374|515810879|FG000|Overall Study|Died 28 days after last dose|5|||
143073814|NCT00699374|515810880|FG001|Overall Study|Died 28 days after last dose|9|||
143073815|NCT02006693|515810882|FG000|Overall Study|No Reason Specified|6|||
143073816|NCT02006693|515810883|FG001|Overall Study|No Reason Specified|8|||
143073817|NCT02006693|515810882|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
143073818|NCT02006693|515810883|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
143073819|NCT02006693|515810882|FG000|Overall Study|XEN Implant Explantation|0|||
143073820|NCT02006693|515810883|FG001|Overall Study|XEN Implant Explantation|1|||
143073821|NCT02006693|515810882|FG000|Overall Study|Death|2|||
143073822|NCT02006693|515810883|FG001|Overall Study|Death|2|||
143073823|NCT02006693|515810882|FG000|Overall Study|Lost to Follow-up|4|||
143073824|NCT02006693|515810883|FG001|Overall Study|Lost to Follow-up|1|||
143073825|NCT02006693|515810882|FG000|Overall Study|Patient Decision|4|||
143073826|NCT02006693|515810883|FG001|Overall Study|Patient Decision|0|||
143073827|NCT01119508|515810884|FG000|Overall Study|Adverse Event|56|||
143073828|NCT01119508|515810884|FG000|Overall Study|Withdrawal by Subject|2|||
143073829|NCT01119508|515810884|FG000|Overall Study|Died before tumor response evaluation|1|||
143073830|NCT00552578|515810889|FG000|Overall Study|Lost to Follow-up|1|||
143073831|NCT00552578|515810890|FG001|Overall Study|Lost to Follow-up|1|||
143073832|NCT01136967|515810892|FG000|Overall Study|Adverse Event|9|||
143073833|NCT01136967|515810893|FG001|Overall Study|Adverse Event|12|||
143073834|NCT01136967|515810892|FG000|Overall Study|Participant Choice|8|||
143073835|NCT01136967|515810893|FG001|Overall Study|Participant Choice|3|||
143073836|NCT01136967|515810892|FG000|Overall Study|Lost to Follow-up|0|||
143073837|NCT01136967|515810893|FG001|Overall Study|Lost to Follow-up|1|||
143073838|NCT01136967|515810892|FG000|Overall Study|Withdrawal by Subject|1|||
143073839|NCT01136967|515810893|FG001|Overall Study|Withdrawal by Subject|2|||
143073840|NCT01136967|515810892|FG000|Overall Study|Clinical Progression|3|||
143073841|NCT01136967|515810893|FG001|Overall Study|Clinical Progression|5|||
143073842|NCT01136967|515810892|FG000|Overall Study|Radiation|1|||
143073843|NCT01136967|515810893|FG001|Overall Study|Radiation|0|||
143073844|NCT01136967|515810892|FG000|Overall Study|Non-compliance|1|||
143073845|NCT01136967|515810893|FG001|Overall Study|Non-compliance|0|||
143073846|NCT01136967|515810892|FG000|Overall Study|Investigator's Choice|1|||
143073847|NCT01136967|515810893|FG001|Overall Study|Investigator's Choice|1|||
143073848|NCT01136967|515810892|FG000|Overall Study|Increase in Lesion Size|0|||
143073849|NCT01136967|515810893|FG001|Overall Study|Increase in Lesion Size|2|||
143073850|NCT01136967|515810892|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
143073851|NCT01136967|515810893|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
143073852|NCT01735955|515810894|FG000|Overall Study|Administrative problems|1|||
143073853|NCT01735955|515810894|FG000|Overall Study|Patient/guardian decision|1|||
143073854|NCT01735955|515810894|FG000|Overall Study|Patient withdrew consent|2|||
143073855|NCT01735955|515810894|FG000|Overall Study|Physician Decision|4|||
143073856|NCT01735955|515810894|FG000|Overall Study|Disease progression|24|||
143073857|NCT01735955|515810894|FG000|Overall Study|Adverse Event|5|||
143073858|NCT01517373|515810898|FG000|Run-in Period|Death|1|||
143073859|NCT01517373|515810899|FG001|Run-in Period|Death|0|||
143073860|NCT01517373|515810900|FG002|Run-in Period|Death|0|||
143073861|NCT01517373|515810901|FG003|Run-in Period|Death|0|||
143073862|NCT01517373|515810902|FG004|Run-in Period|Death|0|||
143073863|NCT01517373|515810903|FG005|Run-in Period|Death|0|||
143073864|NCT01517373|515810898|FG000|Run-in Period|Adverse Event|5|||
143073865|NCT01517373|515810899|FG001|Run-in Period|Adverse Event|0|||
143073866|NCT01517373|515810900|FG002|Run-in Period|Adverse Event|0|||
143073867|NCT01517373|515810901|FG003|Run-in Period|Adverse Event|0|||
143248110|NCT01742286|516460543|FG002|Expansion Phase|Adverse Event|0|||
143248111|NCT01742286|516460544|FG003|Expansion Phase|Adverse Event|0|||
143248112|NCT01742286|516460545|FG004|Expansion Phase|Adverse Event|0|||
143248113|NCT01742286|516460546|FG005|Expansion Phase|Adverse Event|0|||
143248114|NCT01742286|516460547|FG006|Expansion Phase|Adverse Event|6|||
143248115|NCT01742286|516460541|FG000|Expansion Phase|Disease progression|0|||
143248116|NCT01742286|516460542|FG001|Expansion Phase|Disease progression|0|||
143073868|NCT01517373|515810902|FG004|Run-in Period|Adverse Event|0|||
143073869|NCT01517373|515810903|FG005|Run-in Period|Adverse Event|0|||
143073870|NCT01517373|515810898|FG000|Run-in Period|Did not meet eligibility criteria|34|||
143073871|NCT01517373|515810899|FG001|Run-in Period|Did not meet eligibility criteria|0|||
143073872|NCT01517373|515810900|FG002|Run-in Period|Did not meet eligibility criteria|0|||
143073873|NCT01517373|515810901|FG003|Run-in Period|Did not meet eligibility criteria|0|||
143073874|NCT01517373|515810902|FG004|Run-in Period|Did not meet eligibility criteria|0|||
143073875|NCT01517373|515810903|FG005|Run-in Period|Did not meet eligibility criteria|0|||
143073876|NCT01517373|515810898|FG000|Run-in Period|Lost to Follow-up|1|||
143073877|NCT01517373|515810899|FG001|Run-in Period|Lost to Follow-up|0|||
143073878|NCT01517373|515810900|FG002|Run-in Period|Lost to Follow-up|0|||
143073879|NCT01517373|515810901|FG003|Run-in Period|Lost to Follow-up|0|||
143073880|NCT01517373|515810902|FG004|Run-in Period|Lost to Follow-up|0|||
143073881|NCT01517373|515810903|FG005|Run-in Period|Lost to Follow-up|0|||
143073882|NCT01517373|515810898|FG000|Run-in Period|Withdrawal by Subject|12|||
143073883|NCT01517373|515810899|FG001|Run-in Period|Withdrawal by Subject|0|||
143073884|NCT01517373|515810900|FG002|Run-in Period|Withdrawal by Subject|0|||
143073885|NCT01517373|515810901|FG003|Run-in Period|Withdrawal by Subject|0|||
143073886|NCT01517373|515810902|FG004|Run-in Period|Withdrawal by Subject|0|||
143073887|NCT01517373|515810903|FG005|Run-in Period|Withdrawal by Subject|0|||
143073888|NCT01517373|515810898|FG000|Run-in Period|Sponsor Decision|3|||
143073889|NCT01517373|515810899|FG001|Run-in Period|Sponsor Decision|0|||
143073890|NCT01517373|515810900|FG002|Run-in Period|Sponsor Decision|0|||
143073891|NCT01517373|515810901|FG003|Run-in Period|Sponsor Decision|0|||
143073892|NCT01517373|515810902|FG004|Run-in Period|Sponsor Decision|0|||
143073893|NCT01517373|515810903|FG005|Run-in Period|Sponsor Decision|0|||
143073894|NCT01517373|515810898|FG000|Run-in Period|Other|1|||
143073895|NCT01517373|515810899|FG001|Run-in Period|Other|0|||
143073896|NCT01517373|515810900|FG002|Run-in Period|Other|0|||
143073897|NCT01517373|515810901|FG003|Run-in Period|Other|0|||
143073898|NCT01517373|515810902|FG004|Run-in Period|Other|0|||
143073899|NCT01517373|515810903|FG005|Run-in Period|Other|0|||
143073900|NCT01517373|515810898|FG000|Treatment Period|Adverse Event|0|||
143073901|NCT01517373|515810899|FG001|Treatment Period|Adverse Event|0|||
143073902|NCT01517373|515810900|FG002|Treatment Period|Adverse Event|0|||
143073903|NCT01517373|515810901|FG003|Treatment Period|Adverse Event|0|||
143073904|NCT01517373|515810902|FG004|Treatment Period|Adverse Event|0|||
143073905|NCT01517373|515810903|FG005|Treatment Period|Adverse Event|2|||
143073906|NCT01517373|515810898|FG000|Treatment Period|Lost to Follow-up|0|||
143073907|NCT01517373|515810899|FG001|Treatment Period|Lost to Follow-up|0|||
143073908|NCT01517373|515810900|FG002|Treatment Period|Lost to Follow-up|1|||
143073909|NCT01517373|515810901|FG003|Treatment Period|Lost to Follow-up|1|||
143073910|NCT01517373|515810902|FG004|Treatment Period|Lost to Follow-up|0|||
143073911|NCT01517373|515810903|FG005|Treatment Period|Lost to Follow-up|0|||
143073912|NCT01517373|515810898|FG000|Treatment Period|Withdrawal by Subject|0|||
143073913|NCT01517373|515810899|FG001|Treatment Period|Withdrawal by Subject|3|||
143073914|NCT01517373|515810900|FG002|Treatment Period|Withdrawal by Subject|2|||
143073915|NCT01517373|515810901|FG003|Treatment Period|Withdrawal by Subject|2|||
143073916|NCT01517373|515810902|FG004|Treatment Period|Withdrawal by Subject|2|||
143073917|NCT01517373|515810903|FG005|Treatment Period|Withdrawal by Subject|3|||
143073918|NCT01517373|515810898|FG000|Treatment Period|Other|0|||
143073919|NCT01517373|515810899|FG001|Treatment Period|Other|0|||
143073920|NCT01517373|515810900|FG002|Treatment Period|Other|0|||
143073921|NCT01517373|515810901|FG003|Treatment Period|Other|0|||
143073922|NCT01517373|515810902|FG004|Treatment Period|Other|1|||
143073923|NCT01517373|515810903|FG005|Treatment Period|Other|0|||
143073924|NCT01517373|515810898|FG000|Treatment Period|Protocol Violation|0|||
143073925|NCT01517373|515810899|FG001|Treatment Period|Protocol Violation|0|||
143073926|NCT01517373|515810900|FG002|Treatment Period|Protocol Violation|0|||
143073927|NCT01517373|515810901|FG003|Treatment Period|Protocol Violation|0|||
143073928|NCT01517373|515810902|FG004|Treatment Period|Protocol Violation|1|||
143073929|NCT01517373|515810903|FG005|Treatment Period|Protocol Violation|0|||
143073930|NCT01517373|515810898|FG000|Treatment Period|Lack of Efficacy|0|||
143073931|NCT01517373|515810899|FG001|Treatment Period|Lack of Efficacy|1|||
143073932|NCT01517373|515810900|FG002|Treatment Period|Lack of Efficacy|1|||
143073933|NCT01517373|515810901|FG003|Treatment Period|Lack of Efficacy|3|||
143073934|NCT01517373|515810902|FG004|Treatment Period|Lack of Efficacy|2|||
143073935|NCT01517373|515810903|FG005|Treatment Period|Lack of Efficacy|0|||
143073936|NCT01517373|515810898|FG000|Treatment Period|Medication error without AEs|0|||
143073937|NCT01517373|515810899|FG001|Treatment Period|Medication error without AEs|0|||
143073938|NCT01517373|515810900|FG002|Treatment Period|Medication error without AEs|2|||
143073939|NCT01517373|515810901|FG003|Treatment Period|Medication error without AEs|1|||
143073940|NCT01517373|515810902|FG004|Treatment Period|Medication error without AEs|0|||
143073941|NCT01517373|515810903|FG005|Treatment Period|Medication error without AEs|2|||
143073942|NCT01085734|515810914|FG000|Overall Study|Adverse Event|0|||
143073943|NCT01085734|515810915|FG001|Overall Study|Adverse Event|2|||
143073944|NCT01085734|515810914|FG000|Overall Study|Death|1|||
143073945|NCT01085734|515810915|FG001|Overall Study|Death|0|||
143073946|NCT01085734|515810914|FG000|Overall Study|Lost to Follow-up|0|||
143073947|NCT01085734|515810915|FG001|Overall Study|Lost to Follow-up|1|||
143073948|NCT01085734|515810914|FG000|Overall Study|Withdrawal by Subject|0|||
143073949|NCT01085734|515810915|FG001|Overall Study|Withdrawal by Subject|1|||
143073950|NCT03678285|515810920|FG000|Overall Study|Adverse Event|2|||
143073951|NCT03678285|515810920|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
143073952|NCT03678285|515810920|FG000|Overall Study|Dehydrated prior to start of workout|1|||
143073953|NCT00616629|515810921|FG000|Overall Study|Protocol Violation|1|||
143073954|NCT00616629|515810922|FG001|Overall Study|Protocol Violation|2|||
143073955|NCT00616629|515810923|FG002|Overall Study|Protocol Violation|1|||
143073956|NCT00616629|515810924|FG003|Overall Study|Protocol Violation|0|||
143073957|NCT00616629|515810925|FG004|Overall Study|Protocol Violation|0|||
143073958|NCT00616629|515810921|FG000|Overall Study|AV-block|1|||
143073959|NCT00616629|515810922|FG001|Overall Study|AV-block|0|||
143073960|NCT00616629|515810923|FG002|Overall Study|AV-block|0|||
143073961|NCT00616629|515810924|FG003|Overall Study|AV-block|0|||
143073962|NCT00616629|515810925|FG004|Overall Study|AV-block|0|||
143073963|NCT00742924|515810929|FG000|Overall Study|Adverse Event|0|||
143073964|NCT00742924|515810930|FG001|Overall Study|Adverse Event|0|||
143073965|NCT00742924|515810931|FG002|Overall Study|Adverse Event|1|||
143073966|NCT00742924|515810932|FG003|Overall Study|Adverse Event|1|||
143073967|NCT00742924|515810929|FG000|Overall Study|Lack of Efficacy|5|||
143073968|NCT00742924|515810930|FG001|Overall Study|Lack of Efficacy|1|||
143073969|NCT00742924|515810931|FG002|Overall Study|Lack of Efficacy|2|||
143073970|NCT00742924|515810932|FG003|Overall Study|Lack of Efficacy|4|||
143073971|NCT00742924|515810929|FG000|Overall Study|Physician Decision|0|||
143073972|NCT00742924|515810930|FG001|Overall Study|Physician Decision|0|||
143171701|NCT03386773|516178440|FG001|Overall Study|Withdrawal by Subject|2|||
143171702|NCT03983421|516178441|FG000|Overall Study|Lost to Follow-up|1|||
143171703|NCT02410772|516178443|FG000|Overall Study|Death|3|||
143171704|NCT02410772|516178444|FG001|Overall Study|Death|4|||
143171705|NCT02410772|516178445|FG002|Overall Study|Death|8|||
143171706|NCT02410772|516178443|FG000|Overall Study|Lost to Follow-up|31|||
143171707|NCT02410772|516178444|FG001|Overall Study|Lost to Follow-up|23|||
143073973|NCT00742924|515810931|FG002|Overall Study|Physician Decision|0|||
143073974|NCT00742924|515810932|FG003|Overall Study|Physician Decision|1|||
143073975|NCT00742924|515810929|FG000|Overall Study|Withdrawal by Subject|0|||
143073976|NCT00742924|515810930|FG001|Overall Study|Withdrawal by Subject|1|||
143073977|NCT00742924|515810931|FG002|Overall Study|Withdrawal by Subject|1|||
143073978|NCT00742924|515810932|FG003|Overall Study|Withdrawal by Subject|0|||
143171708|NCT02410772|516178445|FG002|Overall Study|Lost to Follow-up|22|||
143171709|NCT02410772|516178443|FG000|Overall Study|Pregnancy|8|||
143248117|NCT01742286|516460543|FG002|Expansion Phase|Disease progression|3|||
143248118|NCT01742286|516460544|FG003|Expansion Phase|Disease progression|0|||
143073979|NCT01777620|515810933|FG000|Overall Study|Subject Withdrawal|1|||
143073980|NCT01777620|515810934|FG001|Overall Study|Subject Withdrawal|0|||
143073981|NCT04562155|515810937|FG000|Overall Study|COVID-19 pandemic|0|||
143073982|NCT04562155|515810938|FG001|Overall Study|COVID-19 pandemic|0|||
143073983|NCT04562155|515810939|FG002|Overall Study|COVID-19 pandemic|0|||
143073984|NCT04562155|515810940|FG003|Overall Study|COVID-19 pandemic|1|||
143073985|NCT04562155|515810937|FG000|Overall Study|Adverse Event|7|||
143073986|NCT04562155|515810938|FG001|Overall Study|Adverse Event|3|||
143365514|NCT05526911|516882866|FG000|Overall Study|Adverse Event|2|||
143365515|NCT00569946|516882867|FG000|Overall Study|Adverse Event|16|||
143365516|NCT00569946|516882867|FG000|Overall Study|Objective Progression or Relapse|42|||
143365517|NCT00569946|516882867|FG000|Overall Study|Global Deterioration of Health Status|1|||
143365518|NCT00762463|516882868|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
143365519|NCT00762463|516882869|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
143365520|NCT00762463|516882870|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
143365521|NCT00762463|516882871|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
143365522|NCT00762463|516882868|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
143365523|NCT00762463|516882869|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
143365524|NCT00762463|516882870|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
143365525|NCT00762463|516882871|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
143365526|NCT00762463|516882868|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
143365527|NCT00762463|516882869|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
143365528|NCT00762463|516882870|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
143073987|NCT04562155|515810939|FG002|Overall Study|Adverse Event|8|||
143073988|NCT04562155|515810940|FG003|Overall Study|Adverse Event|1|||
143073989|NCT04562155|515810937|FG000|Overall Study|Withdrawal by Subject|3|||
143073990|NCT04562155|515810938|FG001|Overall Study|Withdrawal by Subject|6|||
143073991|NCT04562155|515810939|FG002|Overall Study|Withdrawal by Subject|3|||
143073992|NCT04562155|515810940|FG003|Overall Study|Withdrawal by Subject|3|||
143248119|NCT01742286|516460545|FG004|Expansion Phase|Disease progression|0|||
143248120|NCT01742286|516460546|FG005|Expansion Phase|Disease progression|0|||
143248121|NCT01742286|516460547|FG006|Expansion Phase|Disease progression|15|||
143248122|NCT01742286|516460541|FG000|Expansion Phase|Withdrawal by Subject|0|||
143248123|NCT01742286|516460542|FG001|Expansion Phase|Withdrawal by Subject|0|||
143248124|NCT01742286|516460543|FG002|Expansion Phase|Withdrawal by Subject|0|||
143248125|NCT01742286|516460544|FG003|Expansion Phase|Withdrawal by Subject|0|||
143248126|NCT01742286|516460545|FG004|Expansion Phase|Withdrawal by Subject|0|||
143248127|NCT01742286|516460546|FG005|Expansion Phase|Withdrawal by Subject|0|||
143248128|NCT01742286|516460547|FG006|Expansion Phase|Withdrawal by Subject|1|||
143248129|NCT04530136|516460548|FG000|Overall Study|Lost to Follow-up|2|||
143248130|NCT04530136|516460549|FG001|Overall Study|Lost to Follow-up|3|||
143248131|NCT04530136|516460548|FG000|Overall Study|Withdrawal by Subject|1|||
143248132|NCT04530136|516460549|FG001|Overall Study|Withdrawal by Subject|0|||
143248133|NCT04530136|516460548|FG000|Overall Study|Death|0|||
143248134|NCT04530136|516460549|FG001|Overall Study|Death|1|||
143248135|NCT01233232|516460550|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
143248136|NCT01233232|516460551|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
143248137|NCT01233232|516460552|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
143248138|NCT02954172|516460555|FG000|Overall Study|Protocol Violation|3|||
143248139|NCT02954172|516460556|FG001|Overall Study|Protocol Violation|0|||
143248140|NCT02954172|516460555|FG000|Overall Study|allergic reaction|2|||
143248141|NCT02954172|516460556|FG001|Overall Study|allergic reaction|1|||
143248142|NCT02954172|516460555|FG000|Overall Study|non-measurable lesions at baseline|1|||
143248143|NCT02954172|516460556|FG001|Overall Study|non-measurable lesions at baseline|2|||
143248144|NCT00870584|516460557|FG000|Overall Study|Adverse Event|3|||
143248145|NCT00870584|516460558|FG001|Overall Study|Adverse Event|3|||
143248146|NCT00870584|516460557|FG000|Overall Study|Withdrawal by Subject|6|||
143248147|NCT00870584|516460558|FG001|Overall Study|Withdrawal by Subject|7|||
143248148|NCT00870584|516460557|FG000|Overall Study|Lost to Follow-up|5|||
143248149|NCT00870584|516460558|FG001|Overall Study|Lost to Follow-up|1|||
143248150|NCT00870584|516460557|FG000|Overall Study|Protocol Deviation|2|||
143248151|NCT00870584|516460558|FG001|Overall Study|Protocol Deviation|2|||
143248152|NCT01497366|516460559|FG000|Overall Study|Virologic failure|2|||
143248153|NCT01497366|516460560|FG001|Overall Study|Virologic failure|50|||
143248154|NCT01497366|516460559|FG000|Overall Study|Lost to Follow-up|11|||
143248155|NCT01497366|516460560|FG001|Overall Study|Lost to Follow-up|10|||
143248156|NCT01497366|516460559|FG000|Overall Study|Withdrawal by Subject|6|||
143248157|NCT01497366|516460560|FG001|Overall Study|Withdrawal by Subject|6|||
143248158|NCT01497366|516460559|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
143248159|NCT01497366|516460560|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
143248160|NCT01497366|516460559|FG000|Overall Study|Other|5|||
143248161|NCT01497366|516460560|FG001|Overall Study|Other|0|||
143248162|NCT01497366|516460559|FG000|Overall Study|Death|1|||
143248163|NCT01497366|516460560|FG001|Overall Study|Death|1|||
143248164|NCT01497366|516460559|FG000|Overall Study|Randomized but not treated|7|||
143248165|NCT01497366|516460560|FG001|Overall Study|Randomized but not treated|21|||
143248166|NCT00472030|516460561|FG000|Overall Study|Physician Decision|1|||
143248167|NCT00472030|516460562|FG001|Overall Study|Physician Decision|0|||
143073993|NCT04562155|515810937|FG000|Overall Study|Participant personal reason|1|||
143073994|NCT04562155|515810938|FG001|Overall Study|Participant personal reason|0|||
143073995|NCT04562155|515810939|FG002|Overall Study|Participant personal reason|2|||
143248168|NCT00829504|516460563|FG000|First Intervention|Adverse Event|1|||
143248169|NCT00829504|516460564|FG001|First Intervention|Adverse Event|0|||
143073996|NCT04562155|515810940|FG003|Overall Study|Participant personal reason|1|||
143248170|NCT00829504|516460563|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
143248171|NCT00829504|516460564|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
143248172|NCT00829504|516460563|FG000|Second Intervention|Physician Decision|1|||
143248173|NCT00829504|516460564|FG001|Second Intervention|Physician Decision|0|||
143248174|NCT00488683|516460565|FG000|Overall Study|Withdrawal by Subject|1|||
143248175|NCT00488683|516460566|FG001|Overall Study|Withdrawal by Subject|2|||
143248176|NCT00488683|516460567|FG002|Overall Study|Withdrawal by Subject|2|||
143248177|NCT00488683|516460565|FG000|Overall Study|Lost to Follow-up|5|||
143073997|NCT04005352|515810941|FG000|Overall Study|Adverse Event|4|||
143248178|NCT00488683|516460566|FG001|Overall Study|Lost to Follow-up|3|||
143248179|NCT00488683|516460567|FG002|Overall Study|Lost to Follow-up|0|||
143248180|NCT00488683|516460565|FG000|Overall Study|Protocol Violation|5|||
143248181|NCT00488683|516460566|FG001|Overall Study|Protocol Violation|1|||
143248182|NCT00488683|516460567|FG002|Overall Study|Protocol Violation|0|||
143248183|NCT00488683|516460565|FG000|Overall Study|Unable to Classify|1|||
143248184|NCT00488683|516460566|FG001|Overall Study|Unable to Classify|0|||
143248185|NCT00488683|516460567|FG002|Overall Study|Unable to Classify|0|||
143073998|NCT04005352|515810942|FG001|Overall Study|Adverse Event|5|||
143073999|NCT04005352|515810941|FG000|Overall Study|Death|4|||
143074000|NCT04005352|515810942|FG001|Overall Study|Death|2|||
143074001|NCT04005352|515810941|FG000|Overall Study|Lost to Follow-up|6|||
143074002|NCT04005352|515810942|FG001|Overall Study|Lost to Follow-up|2|||
143074003|NCT04005352|515810941|FG000|Overall Study|Physician Decision|7|||
143074004|NCT04005352|515810942|FG001|Overall Study|Physician Decision|13|||
143074005|NCT04005352|515810941|FG000|Overall Study|Protocol Violation|0|||
143074006|NCT04005352|515810942|FG001|Overall Study|Protocol Violation|1|||
143074007|NCT04005352|515810941|FG000|Overall Study|Withdrawal by Subject|28|||
143074008|NCT04005352|515810942|FG001|Overall Study|Withdrawal by Subject|38|||
143074009|NCT01442688|515810943|FG000|First Intervention|Withdrawal by Subject|1|||
143074010|NCT01442688|515810944|FG001|First Intervention|Withdrawal by Subject|0|||
143074011|NCT01442688|515810943|FG000|First Intervention|subject incarcerated|1|||
143074012|NCT01442688|515810944|FG001|First Intervention|subject incarcerated|0|||
143074013|NCT01442688|515810943|FG000|Second Intervention|Adverse Event|1|||
143074014|NCT01442688|515810944|FG001|Second Intervention|Adverse Event|0|||
143074015|NCT02792699|515810958|FG000|Overall Study|Adverse Event|1|||
143074016|NCT02792699|515810959|FG001|Overall Study|Adverse Event|2|||
143074017|NCT02792699|515810960|FG002|Overall Study|Adverse Event|4|||
143074018|NCT02792699|515810958|FG000|Overall Study|Withdrawal by Subject|4|||
143074019|NCT02792699|515810959|FG001|Overall Study|Withdrawal by Subject|4|||
143074020|NCT02792699|515810960|FG002|Overall Study|Withdrawal by Subject|3|||
143074021|NCT02792699|515810958|FG000|Overall Study|Lost to Follow-up|0|||
143074022|NCT02792699|515810959|FG001|Overall Study|Lost to Follow-up|1|||
143074023|NCT02792699|515810960|FG002|Overall Study|Lost to Follow-up|2|||
143074024|NCT02792699|515810958|FG000|Overall Study|Physician Decision|2|||
143074025|NCT02792699|515810959|FG001|Overall Study|Physician Decision|0|||
143074026|NCT02792699|515810960|FG002|Overall Study|Physician Decision|0|||
143074027|NCT02792699|515810958|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
143074028|NCT02792699|515810959|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
143074029|NCT02792699|515810960|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
143074030|NCT02792699|515810958|FG000|Overall Study|Other|1|||
143074031|NCT02792699|515810959|FG001|Overall Study|Other|0|||
143074032|NCT02792699|515810960|FG002|Overall Study|Other|0|||
143074033|NCT04524364|515810961|FG000|Overall Study|Physician Decision|3|||
143074034|NCT04524364|515810962|FG001|Overall Study|Physician Decision|6|||
143074035|NCT04524364|515810961|FG000|Overall Study|Adverse Event|0|||
143074036|NCT04524364|515810962|FG001|Overall Study|Adverse Event|1|||
143248186|NCT01925131|516462848|FG000|Overall Study|Death|0|||
143248187|NCT01925131|516462849|FG001|Overall Study|Death|0|||
143248188|NCT01925131|516462850|FG002|Overall Study|Death|1|||
143248189|NCT01925131|516462851|FG003|Overall Study|Death|0|||
143248190|NCT01925131|516462852|FG004|Overall Study|Death|0|||
143248191|NCT01925131|516462853|FG005|Overall Study|Death|0|||
143248192|NCT01925131|516462848|FG000|Overall Study|Progression/Relapse|1|||
143248193|NCT01925131|516462849|FG001|Overall Study|Progression/Relapse|1|||
143248194|NCT01925131|516462850|FG002|Overall Study|Progression/Relapse|4|||
143248195|NCT01925131|516462851|FG003|Overall Study|Progression/Relapse|0|||
143248196|NCT01925131|516462852|FG004|Overall Study|Progression/Relapse|0|||
143248197|NCT01925131|516462853|FG005|Overall Study|Progression/Relapse|1|||
143248198|NCT01925131|516462848|FG000|Overall Study|Patient Refusal|1|||
143248199|NCT01925131|516462849|FG001|Overall Study|Patient Refusal|0|||
143248200|NCT01925131|516462850|FG002|Overall Study|Patient Refusal|0|||
143248201|NCT01925131|516462851|FG003|Overall Study|Patient Refusal|0|||
143248202|NCT01925131|516462852|FG004|Overall Study|Patient Refusal|0|||
143248203|NCT01925131|516462853|FG005|Overall Study|Patient Refusal|0|||
143248204|NCT01925131|516462848|FG000|Overall Study|Adverse Event|0|||
143248205|NCT01925131|516462849|FG001|Overall Study|Adverse Event|0|||
143248206|NCT01925131|516462850|FG002|Overall Study|Adverse Event|2|||
143248207|NCT01925131|516462851|FG003|Overall Study|Adverse Event|0|||
143248208|NCT01925131|516462852|FG004|Overall Study|Adverse Event|1|||
143248209|NCT01925131|516462853|FG005|Overall Study|Adverse Event|3|||
143074037|NCT04524364|515810961|FG000|Overall Study|Investigational device deficiency|0|||
143248210|NCT01925131|516462848|FG000|Overall Study|Other - Not Protocol Specified|3|||
143248211|NCT01925131|516462849|FG001|Overall Study|Other - Not Protocol Specified|1|||
143248212|NCT01925131|516462850|FG002|Overall Study|Other - Not Protocol Specified|2|||
143248213|NCT01925131|516462851|FG003|Overall Study|Other - Not Protocol Specified|5|||
143171710|NCT02410772|516178444|FG001|Overall Study|Pregnancy|4|||
143171711|NCT02410772|516178445|FG002|Overall Study|Pregnancy|5|||
143171712|NCT02410772|516178443|FG000|Overall Study|Protocol Violation|8|||
143171713|NCT02410772|516178444|FG001|Overall Study|Protocol Violation|8|||
143171714|NCT02410772|516178445|FG002|Overall Study|Protocol Violation|4|||
143171715|NCT02410772|516178443|FG000|Overall Study|Baseline Drug Resistance|49|||
143171716|NCT02410772|516178444|FG001|Overall Study|Baseline Drug Resistance|40|||
143171717|NCT02410772|516178445|FG002|Overall Study|Baseline Drug Resistance|51|||
143171718|NCT02410772|516178443|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
143171719|NCT02410772|516178444|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
143171720|NCT02410772|516178445|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
143171721|NCT02410772|516178443|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
143171722|NCT02410772|516178444|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
143171723|NCT02410772|516178445|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
143171724|NCT05067335|516178448|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
143171725|NCT05067335|516178449|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
143171726|NCT05067335|516178450|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
143171727|NCT05067335|516178451|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
143365529|NCT00762463|516882871|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
143365530|NCT00762463|516882868|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
143365531|NCT00762463|516882869|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
143365532|NCT00762463|516882870|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
143365533|NCT00762463|516882871|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
143365534|NCT00762463|516882868|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
143365535|NCT00762463|516882869|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
143365536|NCT00762463|516882870|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
143365537|NCT00762463|516882871|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
143365538|NCT00762463|516882868|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
143365539|NCT00762463|516882869|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
143365540|NCT00762463|516882870|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
143365541|NCT00762463|516882871|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
143365542|NCT00762463|516882868|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
143365543|NCT00762463|516882869|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
143365544|NCT00762463|516882870|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
143365545|NCT00762463|516882871|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
143365546|NCT00762463|516882868|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
143365547|NCT00762463|516882869|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
143365548|NCT00762463|516882870|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
143365549|NCT00762463|516882871|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
143365550|NCT00531479|516882872|FG000|Overall Study|Death|68|||
143365551|NCT00531479|516882873|FG001|Overall Study|Death|71|||
143365552|NCT00531479|516882872|FG000|Overall Study|Lost to Follow-up|0|||
143365553|NCT00531479|516882873|FG001|Overall Study|Lost to Follow-up|2|||
143365554|NCT00531479|516882872|FG000|Overall Study|Other|0|||
143365555|NCT00531479|516882873|FG001|Overall Study|Other|1|||
143365556|NCT00531479|516882872|FG000|Overall Study|Withdrawal by Subject|6|||
143365557|NCT00531479|516882873|FG001|Overall Study|Withdrawal by Subject|6|||
143365558|NCT00531479|516882872|FG000|Overall Study|Did not receive treatment|2|||
143365559|NCT00531479|516882873|FG001|Overall Study|Did not receive treatment|3|||
143365560|NCT00797862|516882874|FG000|Overall Study|Adverse Event|86|||
143365561|NCT00797862|516882875|FG001|Overall Study|Adverse Event|44|||
143365562|NCT00797862|516882876|FG002|Overall Study|Adverse Event|58|||
143365563|NCT00797862|516882874|FG000|Overall Study|Abnormal Test Procedure Result|0|||
143074038|NCT04524364|515810962|FG001|Overall Study|Investigational device deficiency|1|||
143074039|NCT04524364|515810961|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
143074040|NCT04524364|515810962|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
143074041|NCT04524364|515810961|FG000|Overall Study|Device unavailability|0|||
143074042|NCT04524364|515810962|FG001|Overall Study|Device unavailability|2|||
143074043|NCT04524364|515810961|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
143074044|NCT04524364|515810962|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
143074045|NCT04524364|515810961|FG000|Overall Study|Low International normalized ratio (INR)|1|||
143074046|NCT04524364|515810962|FG001|Overall Study|Low International normalized ratio (INR)|0|||
143074047|NCT06077149|515810963|FG000|Overall Study|Death|1|||
143074048|NCT06077149|515810964|FG001|Overall Study|Death|0|||
143074049|NCT06077149|515810963|FG000|Overall Study|Withdrawal by Subject|2|||
143074050|NCT06077149|515810964|FG001|Overall Study|Withdrawal by Subject|0|||
143074051|NCT06077149|515810963|FG000|Overall Study|RSV infection before vaccination|3|||
143074052|NCT06077149|515810964|FG001|Overall Study|RSV infection before vaccination|0|||
143074053|NCT03233230|515810967|FG000|Overall Study|Adverse Event|6|||
143074054|NCT03233230|515810968|FG001|Overall Study|Adverse Event|3|||
143074055|NCT03233230|515810969|FG002|Overall Study|Adverse Event|6|||
143074056|NCT03233230|515810970|FG003|Overall Study|Adverse Event|3|||
143074057|NCT03233230|515810967|FG000|Overall Study|Protocol Violation|1|||
143074058|NCT03233230|515810968|FG001|Overall Study|Protocol Violation|2|||
143074059|NCT03233230|515810969|FG002|Overall Study|Protocol Violation|1|||
143074060|NCT03233230|515810970|FG003|Overall Study|Protocol Violation|1|||
143074061|NCT03233230|515810967|FG000|Overall Study|Lack of Efficacy|1|||
143074062|NCT03233230|515810968|FG001|Overall Study|Lack of Efficacy|0|||
143074063|NCT03233230|515810969|FG002|Overall Study|Lack of Efficacy|0|||
143074064|NCT03233230|515810970|FG003|Overall Study|Lack of Efficacy|0|||
143074065|NCT03233230|515810967|FG000|Overall Study|Other|5|||
143074066|NCT03233230|515810968|FG001|Overall Study|Other|5|||
143074067|NCT03233230|515810969|FG002|Overall Study|Other|5|||
143074068|NCT03233230|515810970|FG003|Overall Study|Other|3|||
143074069|NCT03233230|515810967|FG000|Overall Study|Withdrawal by Subject|2|||
143074070|NCT03233230|515810968|FG001|Overall Study|Withdrawal by Subject|2|||
143074071|NCT03233230|515810969|FG002|Overall Study|Withdrawal by Subject|0|||
143074072|NCT03233230|515810970|FG003|Overall Study|Withdrawal by Subject|1|||
143074073|NCT03233230|515810967|FG000|Overall Study|Lost to Follow-up|0|||
143074074|NCT03233230|515810968|FG001|Overall Study|Lost to Follow-up|3|||
143074075|NCT03233230|515810969|FG002|Overall Study|Lost to Follow-up|0|||
143074076|NCT03233230|515810970|FG003|Overall Study|Lost to Follow-up|0|||
143074077|NCT01584843|515810971|FG000|First Treatment Period|Adverse Event|0|||
143074078|NCT01584843|515810972|FG001|First Treatment Period|Adverse Event|0|||
143074079|NCT01584843|515810973|FG002|First Treatment Period|Adverse Event|1|||
143074080|NCT01584843|515810974|FG003|First Treatment Period|Adverse Event|0|||
143171728|NCT05067335|516178448|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
143074081|NCT01584843|515810975|FG004|First Treatment Period|Adverse Event|0|||
143074082|NCT01584843|515810976|FG005|First Treatment Period|Adverse Event|0|||
143074083|NCT01584843|515810971|FG000|First Treatment Period|Protocol Violation|0|||
143074084|NCT01584843|515810972|FG001|First Treatment Period|Protocol Violation|0|||
143074085|NCT01584843|515810973|FG002|First Treatment Period|Protocol Violation|0|||
143074086|NCT01584843|515810974|FG003|First Treatment Period|Protocol Violation|0|||
143074087|NCT01584843|515810975|FG004|First Treatment Period|Protocol Violation|0|||
143171729|NCT05067335|516178449|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
143248214|NCT01925131|516462852|FG004|Overall Study|Other - Not Protocol Specified|10|||
143248215|NCT01925131|516462853|FG005|Overall Study|Other - Not Protocol Specified|6|||
143074088|NCT01584843|515810976|FG005|First Treatment Period|Protocol Violation|1|||
143074089|NCT01584843|515810971|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
143365564|NCT00797862|516882875|FG001|Overall Study|Abnormal Test Procedure Result|1|||
143171730|NCT05067335|516178450|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
143074090|NCT01584843|515810972|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
143074091|NCT01584843|515810973|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
143074092|NCT01584843|515810974|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
143074093|NCT01584843|515810975|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
143074094|NCT01584843|515810976|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
143074095|NCT01584843|515810971|FG000|Second Treatment Period|Withdrawal by Subject|0|||
143074096|NCT01584843|515810972|FG001|Second Treatment Period|Withdrawal by Subject|0|||
143074097|NCT01584843|515810973|FG002|Second Treatment Period|Withdrawal by Subject|0|||
143074098|NCT01584843|515810974|FG003|Second Treatment Period|Withdrawal by Subject|0|||
143074099|NCT01584843|515810975|FG004|Second Treatment Period|Withdrawal by Subject|0|||
143074100|NCT01584843|515810976|FG005|Second Treatment Period|Withdrawal by Subject|1|||
143074101|NCT04126213|515810979|FG000|Overall Study|Lost to Follow-up|9|||
143074102|NCT04126213|515810980|FG001|Overall Study|Lost to Follow-up|1|||
143074103|NCT04126213|515810981|FG002|Overall Study|Lost to Follow-up|5|||
143248216|NCT01217307|516462857|FG000|Overall Study|Withdrawal by Subject|0|||
143248217|NCT01217307|516462858|FG001|Overall Study|Withdrawal by Subject|1|||
143248218|NCT00130247|516462865|FG000|Overall Study|Pregnancy|1|||
143248219|NCT00130247|516462866|FG001|Overall Study|Pregnancy|0|||
143248220|NCT00130247|516462865|FG000|Overall Study|Post-randomization exclusion|1|||
143248221|NCT00130247|516462866|FG001|Overall Study|Post-randomization exclusion|2|||
143248222|NCT00130247|516462865|FG000|Overall Study|Not compliant with DOT|0|||
143248223|NCT00130247|516462866|FG001|Overall Study|Not compliant with DOT|2|||
143248224|NCT00122980|516462869|FG000|Overall Study|Death|0|||
143248225|NCT00122980|516462870|FG001|Overall Study|Death|1|||
143248226|NCT00122980|516462869|FG000|Overall Study|Physician Decision|2|||
143248227|NCT00122980|516462870|FG001|Overall Study|Physician Decision|0|||
143248228|NCT00122980|516462869|FG000|Overall Study|Protocol Violation|5|||
143248229|NCT00122980|516462870|FG001|Overall Study|Protocol Violation|1|||
143248230|NCT00122980|516462869|FG000|Overall Study|Withdrawal by Subject|2|||
143248231|NCT00122980|516462870|FG001|Overall Study|Withdrawal by Subject|3|||
143365565|NCT00797862|516882876|FG002|Overall Study|Abnormal Test Procedure Result|1|||
143365566|NCT00797862|516882874|FG000|Overall Study|Lack of Efficacy|1|||
143365567|NCT00797862|516882875|FG001|Overall Study|Lack of Efficacy|7|||
143365568|NCT00797862|516882876|FG002|Overall Study|Lack of Efficacy|6|||
143365569|NCT00797862|516882874|FG000|Overall Study|No longer required study medication|1|||
143365570|NCT00797862|516882875|FG001|Overall Study|No longer required study medication|0|||
143365571|NCT00797862|516882876|FG002|Overall Study|No longer required study medication|0|||
143365572|NCT00797862|516882874|FG000|Overall Study|Withdrawal by Subject|14|||
143365573|NCT00797862|516882875|FG001|Overall Study|Withdrawal by Subject|7|||
143365574|NCT00797862|516882876|FG002|Overall Study|Withdrawal by Subject|7|||
143365575|NCT00797862|516882874|FG000|Overall Study|Lost to Follow-up|11|||
143365576|NCT00797862|516882875|FG001|Overall Study|Lost to Follow-up|0|||
143365577|NCT00797862|516882876|FG002|Overall Study|Lost to Follow-up|5|||
143365578|NCT00797862|516882874|FG000|Overall Study|Administrative Problem|4|||
143365579|NCT00797862|516882875|FG001|Overall Study|Administrative Problem|0|||
143365580|NCT00797862|516882876|FG002|Overall Study|Administrative Problem|0|||
143365581|NCT00797862|516882874|FG000|Overall Study|Protocol Violation|4|||
143365582|NCT00797862|516882875|FG001|Overall Study|Protocol Violation|6|||
143365583|NCT00797862|516882876|FG002|Overall Study|Protocol Violation|8|||
143365584|NCT00797862|516882874|FG000|Overall Study|Mis-randomized|3|||
143365585|NCT00797862|516882875|FG001|Overall Study|Mis-randomized|3|||
143365586|NCT00797862|516882876|FG002|Overall Study|Mis-randomized|1|||
143365587|NCT05074498|516882879|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
143365588|NCT05074498|516882880|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
143365589|NCT05074498|516882881|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
143365590|NCT05074498|516882882|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
143365591|NCT05074498|516882883|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
143365592|NCT05074498|516882884|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
143365593|NCT05074498|516882879|FG000|Part 1 (Upto Day 104)|Other|1|||
143365594|NCT05074498|516882880|FG001|Part 1 (Upto Day 104)|Other|0|||
143365595|NCT05074498|516882881|FG002|Part 1 (Upto Day 104)|Other|0|||
143365596|NCT05074498|516882882|FG003|Part 1 (Upto Day 104)|Other|0|||
143365597|NCT05074498|516882883|FG004|Part 1 (Upto Day 104)|Other|0|||
143365598|NCT05074498|516882884|FG005|Part 1 (Upto Day 104)|Other|0|||
143365599|NCT05074498|516882879|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
143365600|NCT05074498|516882880|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
143365601|NCT05074498|516882881|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
143365602|NCT05074498|516882882|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
143365603|NCT05074498|516882883|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
143365604|NCT05074498|516882884|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
143365605|NCT05074498|516882879|FG000|Part 2 (Upto Day 104)|Death|0|||
143365606|NCT05074498|516882880|FG001|Part 2 (Upto Day 104)|Death|0|||
143365607|NCT05074498|516882881|FG002|Part 2 (Upto Day 104)|Death|0|||
143365608|NCT05074498|516882882|FG003|Part 2 (Upto Day 104)|Death|0|||
143365609|NCT05074498|516882883|FG004|Part 2 (Upto Day 104)|Death|1|||
143365610|NCT05074498|516882884|FG005|Part 2 (Upto Day 104)|Death|0|||
143365611|NCT05074498|516882879|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
143365612|NCT05074498|516882880|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
143365613|NCT05074498|516882881|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
143365614|NCT05074498|516882882|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
143365615|NCT05074498|516882883|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
143365616|NCT05074498|516882884|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
143365617|NCT05074498|516882879|FG000|Part 2 (Upto Day 104)|Other|0|||
143365618|NCT05074498|516882880|FG001|Part 2 (Upto Day 104)|Other|0|||
143365619|NCT05074498|516882881|FG002|Part 2 (Upto Day 104)|Other|0|||
143365620|NCT05074498|516882882|FG003|Part 2 (Upto Day 104)|Other|0|||
143365621|NCT05074498|516882883|FG004|Part 2 (Upto Day 104)|Other|1|||
143365622|NCT05074498|516882884|FG005|Part 2 (Upto Day 104)|Other|0|||
143365623|NCT01240356|516882885|FG000|Overall Study|Withdrawal by Subject|2|||
143365624|NCT01240356|516882886|FG001|Overall Study|Withdrawal by Subject|0|||
143365625|NCT01240356|516882885|FG000|Overall Study|MRI contraindication|1|||
143365626|NCT01240356|516882886|FG001|Overall Study|MRI contraindication|0|||
143365627|NCT01306331|516882887|FG000|Overall Study|Adverse Event|28|||
143365628|NCT01306331|516882888|FG001|Overall Study|Adverse Event|25|||
143365629|NCT01306331|516882887|FG000|Overall Study|Lost to Follow-up|321|||
143365630|NCT01306331|516882888|FG001|Overall Study|Lost to Follow-up|323|||
143365631|NCT01306331|516882887|FG000|Overall Study|Physician Decision|26|||
143365632|NCT01306331|516882888|FG001|Overall Study|Physician Decision|22|||
143365633|NCT01306331|516882887|FG000|Overall Study|Pregnancy|136|||
143365634|NCT01306331|516882888|FG001|Overall Study|Pregnancy|151|||
143365635|NCT01306331|516882887|FG000|Overall Study|Protocol Violation|154|||
143365636|NCT01306331|516882888|FG001|Overall Study|Protocol Violation|124|||
143365637|NCT01306331|516882887|FG000|Overall Study|Withdrawal by Subject|163|||
143365638|NCT01306331|516882888|FG001|Overall Study|Withdrawal by Subject|152|||
143365639|NCT01306331|516882887|FG000|Overall Study|Not sexually active|29|||
143365640|NCT01306331|516882888|FG001|Overall Study|Not sexually active|28|||
143365641|NCT01306331|516882887|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
143248232|NCT00122980|516462869|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
143248233|NCT00122980|516462870|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
143248234|NCT00122980|516462869|FG000|Overall Study|Study termination|27|||
143248235|NCT00122980|516462870|FG001|Overall Study|Study termination|35|||
143248236|NCT01124864|516462871|FG000|Overall Study|Follow up phase competed as per protocol|18|||
143248237|NCT01124864|516462872|FG001|Overall Study|Follow up phase competed as per protocol|22|||
143248238|NCT01124864|516462873|FG002|Overall Study|Follow up phase competed as per protocol|24|||
143248239|NCT01124864|516462874|FG003|Overall Study|Follow up phase competed as per protocol|18|||
143248240|NCT01124864|516462875|FG004|Overall Study|Follow up phase competed as per protocol|26|||
143248241|NCT01124864|516462876|FG005|Overall Study|Follow up phase competed as per protocol|2|||
143248242|NCT01124864|516462871|FG000|Overall Study|Death|6|||
143248243|NCT01124864|516462872|FG001|Overall Study|Death|9|||
143248244|NCT01124864|516462873|FG002|Overall Study|Death|6|||
143248245|NCT01124864|516462874|FG003|Overall Study|Death|2|||
143365642|NCT01306331|516882888|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
143365643|NCT01306331|516882887|FG000|Overall Study|Other|34|||
143365644|NCT01306331|516882888|FG001|Overall Study|Other|32|||
143365645|NCT00172185|516882894|FG000|Overall Study|Adverse Event|0|||
143248246|NCT01124864|516462875|FG004|Overall Study|Death|1|||
143248247|NCT01124864|516462876|FG005|Overall Study|Death|0|||
143248248|NCT01124864|516462871|FG000|Overall Study|Withdrawal by Subject|2|||
143074104|NCT04126213|515810982|FG003|Overall Study|Lost to Follow-up|10|||
143074105|NCT04126213|515810983|FG004|Overall Study|Lost to Follow-up|4|||
143074106|NCT04126213|515810984|FG005|Overall Study|Lost to Follow-up|7|||
143074107|NCT04126213|515810979|FG000|Overall Study|Withdrawal by Subject|3|||
143248249|NCT01124864|516462872|FG001|Overall Study|Withdrawal by Subject|3|||
143074108|NCT04126213|515810980|FG001|Overall Study|Withdrawal by Subject|2|||
143074109|NCT04126213|515810981|FG002|Overall Study|Withdrawal by Subject|1|||
143074110|NCT04126213|515810982|FG003|Overall Study|Withdrawal by Subject|1|||
143248250|NCT01124864|516462873|FG002|Overall Study|Withdrawal by Subject|4|||
143248251|NCT01124864|516462874|FG003|Overall Study|Withdrawal by Subject|0|||
143248252|NCT01124864|516462875|FG004|Overall Study|Withdrawal by Subject|2|||
143248253|NCT01124864|516462876|FG005|Overall Study|Withdrawal by Subject|1|||
143248254|NCT01124864|516462871|FG000|Overall Study|Lost to Follow-up|1|||
143248255|NCT01124864|516462872|FG001|Overall Study|Lost to Follow-up|1|||
143248256|NCT01124864|516462873|FG002|Overall Study|Lost to Follow-up|0|||
143248257|NCT01124864|516462874|FG003|Overall Study|Lost to Follow-up|1|||
143248258|NCT01124864|516462875|FG004|Overall Study|Lost to Follow-up|0|||
143248259|NCT01124864|516462876|FG005|Overall Study|Lost to Follow-up|0|||
143248260|NCT01124864|516462871|FG000|Overall Study|Protocol Violation|1|||
143248261|NCT01124864|516462872|FG001|Overall Study|Protocol Violation|0|||
143248262|NCT01124864|516462873|FG002|Overall Study|Protocol Violation|0|||
143248263|NCT01124864|516462874|FG003|Overall Study|Protocol Violation|0|||
143248264|NCT01124864|516462875|FG004|Overall Study|Protocol Violation|1|||
143248265|NCT01124864|516462876|FG005|Overall Study|Protocol Violation|0|||
143248266|NCT01243242|516462877|FG000|Overall Study|Adverse Event|1|||
143248267|NCT01243242|516462878|FG001|Overall Study|Adverse Event|1|||
143248268|NCT01243242|516462877|FG000|Overall Study|Withdrawal by Subject|1|||
143365646|NCT00172185|516882895|FG001|Overall Study|Adverse Event|1|||
143248269|NCT01243242|516462878|FG001|Overall Study|Withdrawal by Subject|1|||
143248270|NCT01243242|516462877|FG000|Overall Study|Physician Decision|0|||
143365647|NCT00172185|516882896|FG002|Overall Study|Adverse Event|3|||
143365648|NCT00172185|516882897|FG003|Overall Study|Adverse Event|4|||
143365649|NCT00172185|516882894|FG000|Overall Study|Physician Decision|0|||
143365650|NCT00172185|516882895|FG001|Overall Study|Physician Decision|0|||
143365651|NCT00172185|516882896|FG002|Overall Study|Physician Decision|1|||
143365652|NCT00172185|516882897|FG003|Overall Study|Physician Decision|0|||
143365653|NCT00172185|516882894|FG000|Overall Study|SPONSOR Decision|0|||
143365654|NCT00172185|516882895|FG001|Overall Study|SPONSOR Decision|1|||
143365655|NCT00172185|516882896|FG002|Overall Study|SPONSOR Decision|0|||
143365656|NCT00172185|516882897|FG003|Overall Study|SPONSOR Decision|0|||
143248271|NCT01243242|516462878|FG001|Overall Study|Physician Decision|1|||
143248272|NCT01243242|516462877|FG000|Overall Study|sponsor decision|0|||
143248273|NCT01243242|516462878|FG001|Overall Study|sponsor decision|1|||
143248274|NCT01243242|516462877|FG000|Overall Study|non compliance|1|||
143248275|NCT01243242|516462878|FG001|Overall Study|non compliance|0|||
143248276|NCT03844945|516462881|FG000|Overall Study|Adverse Event|1|||
143248277|NCT03844945|516462882|FG001|Overall Study|Adverse Event|1|||
143248278|NCT03844945|516462883|FG002|Overall Study|Adverse Event|4|||
143365657|NCT00172185|516882894|FG000|Overall Study|Withdrawal by Subject|0|||
143248279|NCT03844945|516462884|FG003|Overall Study|Adverse Event|0|||
143365658|NCT00172185|516882895|FG001|Overall Study|Withdrawal by Subject|0|||
143248280|NCT03844945|516462881|FG000|Overall Study|Withdrawal by Subject|0|||
143171731|NCT05067335|516178451|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
143171732|NCT05067335|516178448|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
143171733|NCT05067335|516178449|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
143171734|NCT05067335|516178450|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
143365659|NCT00172185|516882896|FG002|Overall Study|Withdrawal by Subject|1|||
143365660|NCT00172185|516882897|FG003|Overall Study|Withdrawal by Subject|0|||
143365661|NCT04048135|516882898|FG000|Overall Study|Withdrawal by Subject|1|||
143365662|NCT04048135|516882899|FG001|Overall Study|Withdrawal by Subject|1|||
143365663|NCT04048135|516882900|FG002|Overall Study|Withdrawal by Subject|1|||
143365664|NCT04048135|516882901|FG003|Overall Study|Withdrawal by Subject|2|||
143365665|NCT04048135|516882902|FG004|Overall Study|Withdrawal by Subject|0|||
143365666|NCT04048135|516882903|FG005|Overall Study|Withdrawal by Subject|0|||
143365667|NCT04048135|516882904|FG006|Overall Study|Withdrawal by Subject|1|||
143365668|NCT04048135|516882905|FG007|Overall Study|Withdrawal by Subject|1|||
143365669|NCT04048135|516882898|FG000|Overall Study|Adverse Event|0|||
143365670|NCT04048135|516882899|FG001|Overall Study|Adverse Event|0|||
143365671|NCT04048135|516882900|FG002|Overall Study|Adverse Event|0|||
143365672|NCT04048135|516882901|FG003|Overall Study|Adverse Event|1|||
143365673|NCT04048135|516882902|FG004|Overall Study|Adverse Event|1|||
143365674|NCT04048135|516882903|FG005|Overall Study|Adverse Event|0|||
143365675|NCT04048135|516882904|FG006|Overall Study|Adverse Event|0|||
143365676|NCT04048135|516882905|FG007|Overall Study|Adverse Event|0|||
143365677|NCT04048135|516882898|FG000|Overall Study|Protocol Violation|0|||
143365678|NCT04048135|516882899|FG001|Overall Study|Protocol Violation|0|||
143365679|NCT04048135|516882900|FG002|Overall Study|Protocol Violation|0|||
143365680|NCT04048135|516882901|FG003|Overall Study|Protocol Violation|0|||
143365681|NCT04048135|516882902|FG004|Overall Study|Protocol Violation|0|||
143365682|NCT04048135|516882903|FG005|Overall Study|Protocol Violation|1|||
143365683|NCT04048135|516882904|FG006|Overall Study|Protocol Violation|0|||
143365684|NCT04048135|516882905|FG007|Overall Study|Protocol Violation|0|||
143365685|NCT01677936|516882906|FG000|Overall Study|Lost to Follow-up|4|||
143365686|NCT01677936|516882907|FG001|Overall Study|Lost to Follow-up|1|||
143365687|NCT01677936|516882906|FG000|Overall Study|Protocol Violation|3|||
143365688|NCT01677936|516882907|FG001|Overall Study|Protocol Violation|0|||
143365689|NCT01677936|516882906|FG000|Overall Study|Adverse Event|1|||
143365690|NCT01677936|516882907|FG001|Overall Study|Adverse Event|0|||
143365691|NCT01677936|516882906|FG000|Overall Study|Lost to Follow-up|1|||
143365692|NCT01677936|516882907|FG001|Overall Study|Lost to Follow-up|0|||
143365693|NCT01677936|516882906|FG000|Overall Study|Protocol Violation|0|||
143365694|NCT01677936|516882907|FG001|Overall Study|Protocol Violation|4|||
143248281|NCT03844945|516462882|FG001|Overall Study|Withdrawal by Subject|0|||
143248282|NCT03844945|516462883|FG002|Overall Study|Withdrawal by Subject|1|||
143248283|NCT03844945|516462884|FG003|Overall Study|Withdrawal by Subject|0|||
143248284|NCT03844945|516462881|FG000|Overall Study|Lack of Efficacy|0|||
143248285|NCT03844945|516462882|FG001|Overall Study|Lack of Efficacy|0|||
143248286|NCT03844945|516462883|FG002|Overall Study|Lack of Efficacy|0|||
143248287|NCT03844945|516462884|FG003|Overall Study|Lack of Efficacy|1|||
143248288|NCT04473235|516462894|FG000|Overall Study|Lost to Follow-up|6|||
143248289|NCT04473235|516462895|FG001|Overall Study|Lost to Follow-up|5|||
143248290|NCT04473235|516462894|FG000|Overall Study|Declined continuation|2|||
143248291|NCT04473235|516462895|FG001|Overall Study|Declined continuation|0|||
143248292|NCT04473235|516462894|FG000|Overall Study|Physician Decision|1|||
143248293|NCT04473235|516462895|FG001|Overall Study|Physician Decision|1|||
143248294|NCT04473235|516462894|FG000|Overall Study|Protocol Violation|10|||
143248295|NCT04473235|516462895|FG001|Overall Study|Protocol Violation|6|||
143248296|NCT00798759|516462896|FG000|Overall Study|Adverse Event|3|||
143248297|NCT00798759|516462897|FG001|Overall Study|Adverse Event|3|||
143248298|NCT00798759|516462896|FG000|Overall Study|Lost to Follow-up|1|||
143248299|NCT00798759|516462897|FG001|Overall Study|Lost to Follow-up|1|||
143365695|NCT04358549|516882910|FG000|Overall Study|Adverse Event|0|||
143248300|NCT00798759|516462896|FG000|Overall Study|Protocol Violation|4|||
143248301|NCT00798759|516462897|FG001|Overall Study|Protocol Violation|8|||
143365696|NCT04358549|516882911|FG001|Overall Study|Adverse Event|1|||
143248302|NCT00798759|516462896|FG000|Overall Study|Other|0|||
143365697|NCT04358549|516882910|FG000|Overall Study|Death|1|||
143248303|NCT00798759|516462897|FG001|Overall Study|Other|1|||
143248304|NCT01945710|516462901|FG000|Overall Study|Progressive Disease|5|||
143248305|NCT01945710|516462902|FG001|Overall Study|Progressive Disease|4|||
143365698|NCT04358549|516882911|FG001|Overall Study|Death|0|||
143365699|NCT04358549|516882910|FG000|Overall Study|Lost to Follow-up|2|||
143365700|NCT04358549|516882911|FG001|Overall Study|Lost to Follow-up|1|||
143365701|NCT04358549|516882910|FG000|Overall Study|Withdrawal by Subject|6|||
143365702|NCT04358549|516882911|FG001|Overall Study|Withdrawal by Subject|6|||
143365703|NCT04358549|516882910|FG000|Overall Study|Start remdesivir|1|||
143248306|NCT01945710|516462903|FG002|Overall Study|Progressive Disease|3|||
143248307|NCT01945710|516462904|FG003|Overall Study|Progressive Disease|2|||
143248308|NCT01945710|516462905|FG004|Overall Study|Progressive Disease|7|||
143248309|NCT01945710|516462906|FG005|Overall Study|Progressive Disease|3|||
143248310|NCT01945710|516462907|FG006|Overall Study|Progressive Disease|19|||
143248311|NCT01945710|516462901|FG000|Overall Study|Adverse Event|0|||
143248312|NCT01945710|516462902|FG001|Overall Study|Adverse Event|1|||
143248313|NCT01945710|516462903|FG002|Overall Study|Adverse Event|0|||
143248314|NCT01945710|516462904|FG003|Overall Study|Adverse Event|0|||
143248315|NCT01945710|516462905|FG004|Overall Study|Adverse Event|0|||
143248316|NCT01945710|516462906|FG005|Overall Study|Adverse Event|0|||
143248317|NCT01945710|516462907|FG006|Overall Study|Adverse Event|0|||
143248318|NCT01945710|516462901|FG000|Overall Study|Other|2|||
143248319|NCT01945710|516462902|FG001|Overall Study|Other|0|||
143248320|NCT01945710|516462903|FG002|Overall Study|Other|3|||
143248321|NCT01945710|516462904|FG003|Overall Study|Other|1|||
143248322|NCT01945710|516462905|FG004|Overall Study|Other|1|||
143248323|NCT01945710|516462906|FG005|Overall Study|Other|0|||
143248324|NCT01945710|516462907|FG006|Overall Study|Other|4|||
143248325|NCT01945710|516462901|FG000|Overall Study|Withdrawal by Subject|0|||
143248326|NCT01945710|516462902|FG001|Overall Study|Withdrawal by Subject|1|||
143248327|NCT01945710|516462903|FG002|Overall Study|Withdrawal by Subject|1|||
143074111|NCT04126213|515810983|FG004|Overall Study|Withdrawal by Subject|1|||
143074112|NCT04126213|515810984|FG005|Overall Study|Withdrawal by Subject|1|||
143248328|NCT01945710|516462904|FG003|Overall Study|Withdrawal by Subject|0|||
143248329|NCT01945710|516462905|FG004|Overall Study|Withdrawal by Subject|1|||
143248330|NCT01945710|516462906|FG005|Overall Study|Withdrawal by Subject|0|||
143248331|NCT01945710|516462907|FG006|Overall Study|Withdrawal by Subject|0|||
143248332|NCT02730195|516462908|FG000|Overall Study|Withdrawal by Subject|1|||
143248333|NCT00375609|516462909|FG000|Overall Study|Did not receive treatment|1|||
143248334|NCT00375609|516462910|FG001|Overall Study|Did not receive treatment|0|||
143248335|NCT00375609|516462911|FG002|Overall Study|Did not receive treatment|0|||
143248336|NCT00375609|516462909|FG000|Overall Study|Adverse Event|0|||
143248337|NCT00375609|516462910|FG001|Overall Study|Adverse Event|3|||
143248338|NCT00375609|516462911|FG002|Overall Study|Adverse Event|0|||
143248339|NCT00375609|516462909|FG000|Overall Study|Lost to Follow-up|1|||
143248340|NCT00375609|516462910|FG001|Overall Study|Lost to Follow-up|0|||
143248341|NCT00375609|516462911|FG002|Overall Study|Lost to Follow-up|0|||
143248342|NCT00375609|516462909|FG000|Overall Study|Physician Decision|0|||
143248343|NCT00375609|516462910|FG001|Overall Study|Physician Decision|0|||
143248344|NCT00375609|516462911|FG002|Overall Study|Physician Decision|1|||
143248345|NCT00375609|516462909|FG000|Overall Study|Withdrawal by Subject|1|||
143248346|NCT00375609|516462910|FG001|Overall Study|Withdrawal by Subject|4|||
143248347|NCT00375609|516462911|FG002|Overall Study|Withdrawal by Subject|0|||
143248348|NCT00375609|516462909|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
143248349|NCT00375609|516462910|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
143248350|NCT00375609|516462911|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
143248351|NCT01368562|516462912|FG000|Overall Study|Adverse Event|1|||
143248352|NCT01368562|516462912|FG000|Overall Study|Disease progression|1|||
143248353|NCT01368562|516462912|FG000|Overall Study|Lost to Follow-up|1|||
143248354|NCT01368562|516462912|FG000|Overall Study|Death|6|||
143248355|NCT01368562|516462912|FG000|Overall Study|Unresponsive to treatment|5|||
143248356|NCT01368562|516462912|FG000|Overall Study|Other|3|||
143248357|NCT01368562|516462912|FG000|Overall Study|Other than specified|2|||
143248358|NCT02810444|516462914|FG000|Overall Study|Screen Failures|14|||
143248359|NCT02810444|516462914|FG000|Overall Study|Withdrawal by Subject|4|||
143248360|NCT02810444|516462914|FG000|Overall Study|Adverse Event|3|||
143248361|NCT02891070|516462929|FG000|Overall Study|Adverse Event|1|||
143248362|NCT02891070|516462930|FG001|Overall Study|Adverse Event|0|||
143248363|NCT02891070|516462929|FG000|Overall Study|Physician Decision|0|||
143248364|NCT02891070|516462930|FG001|Overall Study|Physician Decision|1|||
143248365|NCT02891070|516462929|FG000|Overall Study|Lost to Follow-up|4|||
143248366|NCT02891070|516462930|FG001|Overall Study|Lost to Follow-up|4|||
143248367|NCT02891070|516462929|FG000|Overall Study|Other|1|||
143248368|NCT02891070|516462930|FG001|Overall Study|Other|0|||
143248369|NCT02891070|516462929|FG000|Overall Study|Protocol Violation|0|||
143248370|NCT02891070|516462930|FG001|Overall Study|Protocol Violation|1|||
143248371|NCT02891070|516462929|FG000|Overall Study|Withdrawal by Subject|1|||
143248372|NCT02891070|516462930|FG001|Overall Study|Withdrawal by Subject|2|||
143248373|NCT02891070|516462929|FG000|Overall Study|Death|3|||
143248374|NCT02891070|516462930|FG001|Overall Study|Death|0|||
143248375|NCT01311024|516462946|FG000|Overall Study|Protocol Violation|35|||
143248376|NCT01311024|516462947|FG001|Overall Study|Protocol Violation|22|||
143248377|NCT01474018|516462953|FG000|Overall Study|Lost to Follow-up|0|||
143248378|NCT01474018|516462954|FG001|Overall Study|Lost to Follow-up|1|||
143248379|NCT01474018|516462953|FG000|Overall Study|Withdrawal by Subject|0|||
143248380|NCT01474018|516462954|FG001|Overall Study|Withdrawal by Subject|2|||
143248381|NCT00486291|516462955|FG000|Overall Study|Adverse Event|3|||
143248382|NCT00486291|516462956|FG001|Overall Study|Adverse Event|4|||
143248383|NCT00486291|516462955|FG000|Overall Study|Lost to Follow-up|3|||
143248384|NCT00486291|516462956|FG001|Overall Study|Lost to Follow-up|7|||
143248385|NCT00486291|516462955|FG000|Overall Study|protocol non-compliance|10|||
143248386|NCT00486291|516462956|FG001|Overall Study|protocol non-compliance|15|||
143248387|NCT00486291|516462955|FG000|Overall Study|requirement for restricted medication|0|||
143248388|NCT00486291|516462956|FG001|Overall Study|requirement for restricted medication|3|||
143248389|NCT04080167|516462957|FG000|Overall Study|Lost to Follow-up-Patients|7|||
143248390|NCT04080167|516462958|FG001|Overall Study|Lost to Follow-up-Patients|14|||
143248391|NCT04080167|516462959|FG002|Overall Study|Lost to Follow-up-Patients|0|||
143248392|NCT04080167|516462957|FG000|Overall Study|Lost to Follow-up-Providers|2|||
143074113|NCT04126213|515810979|FG000|Overall Study|Other|0|||
143248393|NCT04080167|516462958|FG001|Overall Study|Lost to Follow-up-Providers|2|||
143248394|NCT04080167|516462959|FG002|Overall Study|Lost to Follow-up-Providers|0|||
143248395|NCT04080167|516462957|FG000|Overall Study|Withdrawal by Subject|1|||
143248396|NCT04080167|516462958|FG001|Overall Study|Withdrawal by Subject|2|||
143248397|NCT04080167|516462959|FG002|Overall Study|Withdrawal by Subject|0|||
143248398|NCT04080167|516462957|FG000|Overall Study|Withdrawal by Provider|0|||
143248399|NCT04080167|516462958|FG001|Overall Study|Withdrawal by Provider|0|||
143248400|NCT04080167|516462959|FG002|Overall Study|Withdrawal by Provider|4|||
143248401|NCT04080167|516462957|FG000|Overall Study|Death-Patient|2|||
143248402|NCT04080167|516462958|FG001|Overall Study|Death-Patient|1|||
143248403|NCT04080167|516462959|FG002|Overall Study|Death-Patient|0|||
143248404|NCT04080167|516462957|FG000|Overall Study|Hydroxyurea New Starts|0|||
143248405|NCT04080167|516462958|FG001|Overall Study|Hydroxyurea New Starts|0|||
143248406|NCT04080167|516462959|FG002|Overall Study|Hydroxyurea New Starts|1|||
143248407|NCT04080167|516462957|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
143248408|NCT04080167|516462958|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
143248409|NCT04080167|516462959|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
143248410|NCT01297491|516462960|FG000|Overall Study|Adverse Event|11|||
143248411|NCT01297491|516462961|FG001|Overall Study|Adverse Event|6|||
143248412|NCT01297491|516462960|FG000|Overall Study|Physician Decision|3|||
143248413|NCT01297491|516462961|FG001|Overall Study|Physician Decision|2|||
143248414|NCT01297491|516462960|FG000|Overall Study|Progressive disease|11|||
143248415|NCT01297491|516462961|FG001|Overall Study|Progressive disease|20|||
143248416|NCT01297491|516462960|FG000|Overall Study|Patient/Guardian decision|3|||
143248417|NCT01297491|516462961|FG001|Overall Study|Patient/Guardian decision|4|||
143248418|NCT01297491|516462960|FG000|Overall Study|Death|2|||
143248419|NCT01297491|516462961|FG001|Overall Study|Death|1|||
143248420|NCT01015638|516462965|FG000|Overall Study|Withdrawal by Subject|1|||
143248421|NCT01015638|516462966|FG001|Overall Study|Withdrawal by Subject|0|||
143248422|NCT02447302|516462967|FG000|Overall Study|Physician Decision|1|||
143248423|NCT02447302|516462968|FG001|Overall Study|Physician Decision|0|||
143248424|NCT02447302|516462969|FG002|Overall Study|Physician Decision|0|||
143248425|NCT02447302|516462967|FG000|Overall Study|Adverse Event|4|||
143248426|NCT02447302|516462968|FG001|Overall Study|Adverse Event|3|||
143248427|NCT02447302|516462969|FG002|Overall Study|Adverse Event|0|||
143248428|NCT02447302|516462967|FG000|Overall Study|Withdrawal by Subject|0|||
143248429|NCT02447302|516462968|FG001|Overall Study|Withdrawal by Subject|1|||
143248430|NCT02447302|516462969|FG002|Overall Study|Withdrawal by Subject|5|||
143248431|NCT02447302|516462967|FG000|Overall Study|Sponsor Decision|0|||
143248432|NCT02447302|516462968|FG001|Overall Study|Sponsor Decision|0|||
143248433|NCT02447302|516462969|FG002|Overall Study|Sponsor Decision|1|||
143248434|NCT05334212|516462972|FG000|Overall Study|Study terminated prematurely|7|||
143248435|NCT00910299|516462973|FG000|Overall Study|Withdrawal by Subject|16|||
143248436|NCT00910299|516462974|FG001|Overall Study|Withdrawal by Subject|13|||
143248437|NCT00910299|516462973|FG000|Overall Study|Sponsor Decision|58|||
143248438|NCT00910299|516462974|FG001|Overall Study|Sponsor Decision|60|||
143248439|NCT00910299|516462973|FG000|Overall Study|Didn't receive any study drug|2|||
143248440|NCT00910299|516462974|FG001|Overall Study|Didn't receive any study drug|1|||
143248441|NCT01456897|516462975|FG000|Overall Study|Adverse Event|19|||
143248442|NCT01456897|516462976|FG001|Overall Study|Adverse Event|22|||
143248443|NCT01456897|516462975|FG000|Overall Study|Protocol Violation|3|||
143248444|NCT01456897|516462976|FG001|Overall Study|Protocol Violation|4|||
143248445|NCT01456897|516462975|FG000|Overall Study|Physician Decision|5|||
143248446|NCT01456897|516462976|FG001|Overall Study|Physician Decision|3|||
143248447|NCT01456897|516462975|FG000|Overall Study|Withdrawal by Subject|44|||
143248448|NCT01456897|516462976|FG001|Overall Study|Withdrawal by Subject|17|||
143248449|NCT01456897|516462975|FG000|Overall Study|Lack of Efficacy|4|||
143248450|NCT01456897|516462976|FG001|Overall Study|Lack of Efficacy|11|||
143248451|NCT01396057|516462978|FG000|Overall Study|Adverse Event|2|||
143248452|NCT01396057|516462979|FG001|Overall Study|Adverse Event|6|||
143248453|NCT01396057|516462978|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
143248454|NCT01396057|516462979|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
143248455|NCT01396057|516462978|FG000|Overall Study|Protocol deviation|4|||
143248456|NCT01396057|516462979|FG001|Overall Study|Protocol deviation|4|||
143248457|NCT01396057|516462978|FG000|Overall Study|Consent withdrawn|3|||
143248458|NCT01396057|516462979|FG001|Overall Study|Consent withdrawn|2|||
143248459|NCT00916929|516462982|FG000|Overall Study|Lost to Follow-up|1|||
143248460|NCT00916929|516462983|FG001|Overall Study|Lost to Follow-up|3|||
143248461|NCT00916929|516462982|FG000|Overall Study|Death|5|||
143365704|NCT04358549|516882911|FG001|Overall Study|Start remdesivir|0|||
143248462|NCT00916929|516462983|FG001|Overall Study|Death|10|||
143248463|NCT00916929|516462982|FG000|Overall Study|Withdrawal by Subject|1|||
143248464|NCT00916929|516462983|FG001|Overall Study|Withdrawal by Subject|5|||
143248465|NCT00916929|516462982|FG000|Overall Study|Left ventricular epicardial lead|1|||
143248466|NCT00916929|516462983|FG001|Overall Study|Left ventricular epicardial lead|2|||
143248467|NCT00916929|516462982|FG000|Overall Study|Transferred to hospice care|1|||
143248468|NCT00916929|516462983|FG001|Overall Study|Transferred to hospice care|1|||
143248469|NCT00916929|516462982|FG000|Overall Study|System explant|1|||
143248470|NCT00916929|516462983|FG001|Overall Study|System explant|0|||
143248471|NCT00916929|516462982|FG000|Overall Study|Moved to another state|0|||
143248472|NCT00916929|516462983|FG001|Overall Study|Moved to another state|1|||
143248473|NCT00916929|516462982|FG000|Overall Study|Device unable to process impedance data|0|||
143248474|NCT00916929|516462983|FG001|Overall Study|Device unable to process impedance data|7|||
143248475|NCT03500224|516462984|FG000|Overall Study|Withdrawal by Subject|2|||
143365705|NCT00157014|516882915|FG000|Overall Study|Death|4|||
143074114|NCT04126213|515810980|FG001|Overall Study|Other|0|||
143074115|NCT04126213|515810981|FG002|Overall Study|Other|2|||
143074116|NCT04126213|515810982|FG003|Overall Study|Other|2|||
143074117|NCT04126213|515810983|FG004|Overall Study|Other|0|||
143074118|NCT04126213|515810984|FG005|Overall Study|Other|1|||
143074119|NCT04126213|515810979|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143074120|NCT04126213|515810980|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
143074121|NCT04126213|515810981|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
143074122|NCT04126213|515810982|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143365706|NCT00157014|516882916|FG001|Overall Study|Death|2|||
143365707|NCT00157014|516882917|FG002|Overall Study|Death|1|||
143365708|NCT00157014|516882918|FG003|Overall Study|Death|1|||
143365709|NCT00157014|516882915|FG000|Overall Study|Physician Decision|0|||
143365710|NCT00157014|516882916|FG001|Overall Study|Physician Decision|1|||
143365711|NCT00157014|516882917|FG002|Overall Study|Physician Decision|0|||
143365712|NCT00157014|516882918|FG003|Overall Study|Physician Decision|0|||
143365713|NCT00157014|516882915|FG000|Overall Study|Medications withdrawn on family request|0|||
143074123|NCT04126213|515810983|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
143074124|NCT04126213|515810984|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
143365714|NCT00157014|516882916|FG001|Overall Study|Medications withdrawn on family request|1|||
143365715|NCT00157014|516882917|FG002|Overall Study|Medications withdrawn on family request|0|||
143365716|NCT00157014|516882918|FG003|Overall Study|Medications withdrawn on family request|0|||
143365717|NCT00157014|516882915|FG000|Overall Study|Patient withdrawn by investigator|1|||
143365718|NCT00157014|516882916|FG001|Overall Study|Patient withdrawn by investigator|0|||
143365719|NCT00157014|516882917|FG002|Overall Study|Patient withdrawn by investigator|0|||
143365720|NCT00157014|516882918|FG003|Overall Study|Patient withdrawn by investigator|0|||
143365721|NCT00157014|516882915|FG000|Overall Study|Patient unable to return in nursing home|1|||
143365722|NCT00157014|516882916|FG001|Overall Study|Patient unable to return in nursing home|0|||
143365723|NCT00157014|516882917|FG002|Overall Study|Patient unable to return in nursing home|0|||
143365724|NCT00157014|516882918|FG003|Overall Study|Patient unable to return in nursing home|0|||
143365725|NCT00157014|516882915|FG000|Overall Study|Patient would not receive transplant|0|||
143365726|NCT00157014|516882916|FG001|Overall Study|Patient would not receive transplant|1|||
143365727|NCT00157014|516882917|FG002|Overall Study|Patient would not receive transplant|0|||
143365728|NCT00157014|516882918|FG003|Overall Study|Patient would not receive transplant|0|||
143365729|NCT00157014|516882915|FG000|Overall Study|Withdrawal by Subject|1|||
143365730|NCT00157014|516882916|FG001|Overall Study|Withdrawal by Subject|0|||
143365731|NCT00157014|516882917|FG002|Overall Study|Withdrawal by Subject|0|||
143365732|NCT00157014|516882918|FG003|Overall Study|Withdrawal by Subject|0|||
143365733|NCT01362491|516882919|FG000|Overall Study|Ineligible|1|||
143074125|NCT02853370|515810985|FG000|Overall Study|Physician Decision|1|||
143074126|NCT02853370|515810985|FG000|Overall Study|Lack of Efficacy|2|||
143074127|NCT02853370|515810985|FG000|Overall Study|Death|1|||
143074128|NCT02853370|515810985|FG000|Overall Study|Adverse Event|4|||
143074129|NCT02853370|515810985|FG000|Overall Study|Withdrawal by Subject|3|||
143074130|NCT02196701|515810986|FG000|Overall Study|Adverse Event|1|||
143074131|NCT02196701|515810986|FG000|Overall Study|Lost to Follow-up|1|||
143074132|NCT02196701|515810986|FG000|Overall Study|Non-adherence to Protocol|1|||
143074133|NCT03275064|515810987|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
143074134|NCT03275064|515810988|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
143074135|NCT03275064|515810989|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
143074136|NCT03275064|515810990|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
143074137|NCT03275064|515810991|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
143074138|NCT03275064|515810987|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
143074139|NCT03275064|515810988|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
143074140|NCT03275064|515810989|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
143074141|NCT03275064|515810990|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
143074142|NCT03275064|515810991|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
143074143|NCT03275064|515810987|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
143074144|NCT03275064|515810988|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
143074145|NCT03275064|515810989|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
143074146|NCT03275064|515810990|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
143171735|NCT05067335|516178451|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
143074147|NCT03275064|515810991|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
143074148|NCT03275064|515810987|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
143074149|NCT03275064|515810988|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
143171736|NCT05067335|516178448|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
143171737|NCT05067335|516178449|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
143171738|NCT05067335|516178450|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
143171739|NCT05067335|516178451|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
143171740|NCT05067335|516178448|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
143074150|NCT03275064|515810989|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
143248476|NCT01708902|516462985|FG000|Overall Study|Adverse Event|3|||
143248477|NCT01708902|516462986|FG001|Overall Study|Adverse Event|4|||
143248478|NCT01708902|516462987|FG002|Overall Study|Adverse Event|9|||
143248479|NCT01708902|516462988|FG003|Overall Study|Adverse Event|2|||
143248480|NCT01708902|516462989|FG004|Overall Study|Adverse Event|7|||
143248481|NCT01708902|516462990|FG005|Overall Study|Adverse Event|3|||
143248482|NCT01708902|516462991|FG006|Overall Study|Adverse Event|5|||
143248483|NCT01708902|516462985|FG000|Overall Study|Lack of Efficacy|3|||
143074151|NCT03275064|515810990|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
143074152|NCT03275064|515810991|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
143074153|NCT03275064|515810987|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
143074154|NCT03275064|515810988|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
143074155|NCT03275064|515810989|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
143074156|NCT03275064|515810990|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
143074157|NCT03275064|515810991|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
143074158|NCT01341782|515810992|FG000|Overall Study|Adverse Event|1|||
143074159|NCT01341782|515810993|FG001|Overall Study|Adverse Event|1|||
143074160|NCT01341782|515810992|FG000|Overall Study|Withdrawal by Subject|6|||
143074161|NCT01341782|515810993|FG001|Overall Study|Withdrawal by Subject|5|||
143074162|NCT01341782|515810992|FG000|Overall Study|Missed 3 consecutive doses|0|||
143074163|NCT01341782|515810993|FG001|Overall Study|Missed 3 consecutive doses|4|||
143074164|NCT01341782|515810992|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
143074165|NCT01341782|515810993|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
143074166|NCT01341782|515810992|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
143074167|NCT01341782|515810993|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
143074168|NCT01341782|515810992|FG000|Overall Study|Other|5|||
143074169|NCT01341782|515810993|FG001|Overall Study|Other|0|||
143074170|NCT00620555|515810994|FG000|Overall Study|Adverse Event|4|||
143074171|NCT00620555|515810994|FG000|Overall Study|Protocol Violation|2|||
143074172|NCT00620555|515810994|FG000|Overall Study|Lack of Efficacy|12|||
143074173|NCT00620555|515810994|FG000|Overall Study|Withdrawal by Subject|1|||
143074174|NCT00620555|515810994|FG000|Overall Study|Choice of other treatment|1|||
143074175|NCT00620555|515810994|FG000|Overall Study|Visit failure against planned|1|||
143074176|NCT02036775|515810995|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
143074177|NCT02036775|515810996|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
143074178|NCT02036775|515810997|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
143074179|NCT02036775|515810998|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
143074180|NCT02036775|515810999|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
143074181|NCT02036775|515811000|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
143074182|NCT00855803|515811002|FG000|Overall Study|Death|2|||
143074183|NCT00855803|515811002|FG000|Overall Study|Lost to Follow-up|2|||
143074184|NCT00855803|515811002|FG000|Overall Study|Technical inability to undergo procedure|2|||
143074185|NCT00855803|515811002|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
143074186|NCT00855803|515811002|FG000|Overall Study|Withdrawal by Subject|3|||
143074187|NCT00855803|515811002|FG000|Overall Study|Physician Decision|3|||
143074188|NCT04430855|515811003|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
143074189|NCT04430855|515811004|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
143074190|NCT04430855|515811003|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
143074191|NCT04430855|515811004|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
143074192|NCT04430855|515811003|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
143074193|NCT04430855|515811004|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
143074194|NCT04430855|515811003|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
143074195|NCT04430855|515811004|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
143074196|NCT04430855|515811003|FG000|Period 1 (Weeks 1-12)|Other|0|||
143074197|NCT04430855|515811004|FG001|Period 1 (Weeks 1-12)|Other|1|||
143248484|NCT01708902|516462986|FG001|Overall Study|Lack of Efficacy|1|||
143248485|NCT01708902|516462987|FG002|Overall Study|Lack of Efficacy|0|||
143074198|NCT04430855|515811003|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
143074199|NCT04430855|515811004|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
143074200|NCT04430855|515811003|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
143074201|NCT04430855|515811004|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
143074202|NCT04430855|515811003|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
143074203|NCT04430855|515811004|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
143248486|NCT01708902|516462988|FG003|Overall Study|Lack of Efficacy|0|||
143248487|NCT01708902|516462989|FG004|Overall Study|Lack of Efficacy|0|||
143074204|NCT01425723|515811005|FG000|Overall Study|Lack of Efficacy|0|||
143074205|NCT01425723|515811006|FG001|Overall Study|Lack of Efficacy|1|||
143074206|NCT01425723|515811005|FG000|Overall Study|Withdrawal by Subject|1|||
143074207|NCT01425723|515811006|FG001|Overall Study|Withdrawal by Subject|4|||
143074208|NCT01425723|515811005|FG000|Overall Study|Lost to Follow-up|0|||
143074209|NCT01425723|515811006|FG001|Overall Study|Lost to Follow-up|3|||
143074210|NCT01425723|515811005|FG000|Overall Study|Physician Decision|2|||
143074211|NCT01425723|515811006|FG001|Overall Study|Physician Decision|0|||
143074212|NCT01425723|515811005|FG000|Overall Study|Other|1|||
143074213|NCT01425723|515811006|FG001|Overall Study|Other|10|||
143074214|NCT03401450|515811007|FG000|Overall Study|Lost to Follow-up|4|||
143074215|NCT03401450|515811008|FG001|Overall Study|Lost to Follow-up|6|||
143074216|NCT03401450|515811007|FG000|Overall Study|Anesthesia plan changed|2|||
143074217|NCT03401450|515811008|FG001|Overall Study|Anesthesia plan changed|2|||
143074218|NCT03401450|515811007|FG000|Overall Study|Did not complete medication diary|4|||
143074219|NCT03401450|515811008|FG001|Overall Study|Did not complete medication diary|2|||
143074220|NCT03401450|515811007|FG000|Overall Study|post surgery medication change|2|||
143074221|NCT03401450|515811008|FG001|Overall Study|post surgery medication change|1|||
143074222|NCT03401450|515811007|FG000|Overall Study|Cancelled surgery|0|||
143074223|NCT03401450|515811008|FG001|Overall Study|Cancelled surgery|2|||
143074224|NCT03567382|515811024|FG000|Overall Study|Lost to Follow-up|1|||
143074225|NCT03567382|515811025|FG001|Overall Study|Lost to Follow-up|21|||
143074226|NCT03567382|515811026|FG002|Overall Study|Lost to Follow-up|1|||
143074227|NCT03567382|515811027|FG003|Overall Study|Lost to Follow-up|21|||
143074228|NCT03567382|515811024|FG000|Overall Study|Withdrawal by Subject|2|||
143074229|NCT03567382|515811025|FG001|Overall Study|Withdrawal by Subject|14|||
143074230|NCT03567382|515811026|FG002|Overall Study|Withdrawal by Subject|1|||
143074231|NCT03567382|515811027|FG003|Overall Study|Withdrawal by Subject|12|||
143074232|NCT00620659|515811028|FG000|Treatment Period 1|Adverse Event|1|||
143074233|NCT00620659|515811029|FG001|Treatment Period 1|Adverse Event|0|||
143074234|NCT00620659|515811030|FG002|Treatment Period 1|Adverse Event|0|||
143074235|NCT00620659|515811031|FG003|Treatment Period 1|Adverse Event|3|||
143074236|NCT00620659|515811032|FG004|Treatment Period 1|Adverse Event|0|||
143074237|NCT00620659|515811033|FG005|Treatment Period 1|Adverse Event|0|||
143074238|NCT00620659|515811028|FG000|Treatment Period 1|Protocol Violation|1|||
143074239|NCT00620659|515811029|FG001|Treatment Period 1|Protocol Violation|0|||
143074240|NCT00620659|515811030|FG002|Treatment Period 1|Protocol Violation|0|||
143074241|NCT00620659|515811031|FG003|Treatment Period 1|Protocol Violation|0|||
143074242|NCT00620659|515811032|FG004|Treatment Period 1|Protocol Violation|0|||
143074243|NCT00620659|515811033|FG005|Treatment Period 1|Protocol Violation|0|||
143074244|NCT00620659|515811028|FG000|Treatment Period 1|Withdrawal by Subject|1|||
143074245|NCT00620659|515811029|FG001|Treatment Period 1|Withdrawal by Subject|0|||
143074246|NCT00620659|515811030|FG002|Treatment Period 1|Withdrawal by Subject|1|||
143074247|NCT00620659|515811031|FG003|Treatment Period 1|Withdrawal by Subject|0|||
143074248|NCT00620659|515811032|FG004|Treatment Period 1|Withdrawal by Subject|1|||
143074249|NCT00620659|515811033|FG005|Treatment Period 1|Withdrawal by Subject|0|||
143074250|NCT00620659|515811028|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
143074251|NCT00620659|515811029|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
143074252|NCT00620659|515811030|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
143074253|NCT00620659|515811031|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
143074254|NCT00620659|515811032|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
143074255|NCT00620659|515811033|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
143074256|NCT00620659|515811028|FG000|Treatment Period 2|Adverse Event|0|||
143074257|NCT00620659|515811029|FG001|Treatment Period 2|Adverse Event|3|||
143074258|NCT00620659|515811030|FG002|Treatment Period 2|Adverse Event|0|||
143248488|NCT01708902|516462990|FG005|Overall Study|Lack of Efficacy|1|||
143248489|NCT01708902|516462991|FG006|Overall Study|Lack of Efficacy|0|||
143248490|NCT01708902|516462985|FG000|Overall Study|Non compliance with protocol|0|||
143248491|NCT01708902|516462986|FG001|Overall Study|Non compliance with protocol|2|||
143248492|NCT01708902|516462987|FG002|Overall Study|Non compliance with protocol|1|||
143248493|NCT01708902|516462988|FG003|Overall Study|Non compliance with protocol|3|||
143074259|NCT00620659|515811031|FG003|Treatment Period 2|Adverse Event|0|||
143074260|NCT00620659|515811032|FG004|Treatment Period 2|Adverse Event|2|||
143074261|NCT00620659|515811033|FG005|Treatment Period 2|Adverse Event|0|||
143074262|NCT00620659|515811028|FG000|Treatment Period 2|Withdrawal by Subject|0|||
143074263|NCT00620659|515811029|FG001|Treatment Period 2|Withdrawal by Subject|0|||
143074264|NCT00620659|515811030|FG002|Treatment Period 2|Withdrawal by Subject|1|||
143074265|NCT00620659|515811031|FG003|Treatment Period 2|Withdrawal by Subject|0|||
143074266|NCT00620659|515811032|FG004|Treatment Period 2|Withdrawal by Subject|3|||
143074267|NCT00620659|515811033|FG005|Treatment Period 2|Withdrawal by Subject|0|||
143074268|NCT00620659|515811028|FG000|Placebo Washout Period 2|Adverse Event|2|||
143074269|NCT00620659|515811029|FG001|Placebo Washout Period 2|Adverse Event|0|||
143074270|NCT00620659|515811030|FG002|Placebo Washout Period 2|Adverse Event|0|||
143074271|NCT00620659|515811031|FG003|Placebo Washout Period 2|Adverse Event|0|||
143074272|NCT00620659|515811032|FG004|Placebo Washout Period 2|Adverse Event|0|||
143248494|NCT01708902|516462989|FG004|Overall Study|Non compliance with protocol|0|||
143074273|NCT00620659|515811033|FG005|Placebo Washout Period 2|Adverse Event|0|||
143074274|NCT00620659|515811028|FG000|Treatment Period 3|Adverse Event|0|||
143074275|NCT00620659|515811029|FG001|Treatment Period 3|Adverse Event|2|||
143074276|NCT00620659|515811030|FG002|Treatment Period 3|Adverse Event|0|||
143074277|NCT00620659|515811031|FG003|Treatment Period 3|Adverse Event|0|||
143074278|NCT00620659|515811032|FG004|Treatment Period 3|Adverse Event|0|||
143074279|NCT00620659|515811033|FG005|Treatment Period 3|Adverse Event|0|||
143074280|NCT00620659|515811028|FG000|Treatment Period 3|Withdrawal by Subject|0|||
143074281|NCT00620659|515811029|FG001|Treatment Period 3|Withdrawal by Subject|0|||
143074282|NCT00620659|515811030|FG002|Treatment Period 3|Withdrawal by Subject|0|||
143074283|NCT00620659|515811031|FG003|Treatment Period 3|Withdrawal by Subject|1|||
143074284|NCT00620659|515811032|FG004|Treatment Period 3|Withdrawal by Subject|0|||
143074285|NCT00620659|515811033|FG005|Treatment Period 3|Withdrawal by Subject|0|||
143074286|NCT01193127|515811034|FG000|Randomized|Surgery Cancelled|0|||
143074287|NCT01193127|515811035|FG001|Randomized|Surgery Cancelled|0|||
143074288|NCT01193127|515811036|FG002|Randomized|Surgery Cancelled|0|||
143074289|NCT01193127|515811037|FG003|Randomized|Surgery Cancelled|1|||
143074290|NCT01193127|515811034|FG000|Treated|Withdrawal by Subject|0|||
143074291|NCT01193127|515811035|FG001|Treated|Withdrawal by Subject|0|||
143074292|NCT01193127|515811036|FG002|Treated|Withdrawal by Subject|0|||
143074293|NCT01193127|515811037|FG003|Treated|Withdrawal by Subject|1|||
143074294|NCT00871741|515811042|FG000|Overall Study|Premature study termination|9|||
143074295|NCT00871741|515811043|FG001|Overall Study|Premature study termination|7|||
143074296|NCT01565850|515811044|FG000|Overall Study|Adverse Event|0|||
143074297|NCT01565850|515811045|FG001|Overall Study|Adverse Event|1|||
143074298|NCT01565850|515811044|FG000|Overall Study|Lost to Follow-up|12|||
143074299|NCT01565850|515811045|FG001|Overall Study|Lost to Follow-up|4|||
143074300|NCT01565850|515811044|FG000|Overall Study|Investigator's Discretion|2|||
143074301|NCT01565850|515811045|FG001|Overall Study|Investigator's Discretion|1|||
143074302|NCT01565850|515811044|FG000|Overall Study|Participant noncompliance|2|||
143074303|NCT01565850|515811045|FG001|Overall Study|Participant noncompliance|0|||
143074304|NCT01565850|515811044|FG000|Overall Study|Withdrew Consent|4|||
143074305|NCT01565850|515811045|FG001|Overall Study|Withdrew Consent|2|||
143074306|NCT05323123|515811046|FG000|Overall Study|Withdrawal by Subject|2|||
143074307|NCT05323123|515811047|FG001|Overall Study|Withdrawal by Subject|1|||
143074308|NCT05323123|515811046|FG000|Overall Study|Lost to Follow-up|4|||
143074309|NCT05323123|515811047|FG001|Overall Study|Lost to Follow-up|2|||
143074310|NCT05323123|515811046|FG000|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|1|||
143074311|NCT05323123|515811047|FG001|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|0|||
143074312|NCT05529472|515811048|FG000|Overall Study|Withdrawal by Subject|1|||
143074313|NCT05529472|515811049|FG001|Overall Study|Withdrawal by Subject|1|||
143074314|NCT02022748|515812622|FG000|Overall Study|Adverse Event|1|||
143074315|NCT02022748|515812623|FG001|Overall Study|Adverse Event|1|||
143074316|NCT02022748|515812624|FG002|Overall Study|Adverse Event|0|||
143074317|NCT02022748|515812622|FG000|Overall Study|Withdrawal by Subject|0|||
143074318|NCT02022748|515812623|FG001|Overall Study|Withdrawal by Subject|1|||
143074319|NCT02022748|515812624|FG002|Overall Study|Withdrawal by Subject|0|||
143074320|NCT00633243|515812625|FG000|Overall Study|Withdrawal by Subject|0|||
143074321|NCT00633243|515812626|FG001|Overall Study|Withdrawal by Subject|1|||
143074322|NCT00633243|515812625|FG000|Overall Study|incarceration|0|||
143074323|NCT00633243|515812626|FG001|Overall Study|incarceration|2|||
143074324|NCT00633243|515812625|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
143074325|NCT00633243|515812626|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
143074326|NCT00633243|515812625|FG000|Overall Study|Not comfortable with self-injecting|0|||
143074327|NCT00633243|515812626|FG001|Overall Study|Not comfortable with self-injecting|1|||
143074328|NCT00633243|515812625|FG000|Overall Study|Mental Health--Depression|0|||
143074329|NCT00633243|515812626|FG001|Overall Study|Mental Health--Depression|1|||
143074330|NCT00633243|515812625|FG000|Overall Study|Couldn't tolerate side-effects|1|||
143074331|NCT00633243|515812626|FG001|Overall Study|Couldn't tolerate side-effects|1|||
143074332|NCT00379340|515812628|FG000|Overall Study|Death|0|||
143074333|NCT00379340|515812629|FG001|Overall Study|Death|0|||
143074334|NCT00379340|515812630|FG002|Overall Study|Death|0|||
143074335|NCT00379340|515812631|FG003|Overall Study|Death|2|||
143074336|NCT00379340|515812632|FG004|Overall Study|Death|0|||
143074337|NCT00379340|515812628|FG000|Overall Study|Lack of Efficacy|6|||
143074338|NCT00379340|515812629|FG001|Overall Study|Lack of Efficacy|1|||
143074339|NCT00379340|515812630|FG002|Overall Study|Lack of Efficacy|0|||
143074340|NCT00379340|515812631|FG003|Overall Study|Lack of Efficacy|4|||
143074341|NCT00379340|515812632|FG004|Overall Study|Lack of Efficacy|3|||
143074342|NCT00379340|515812628|FG000|Overall Study|Physician Decision|6|||
143074343|NCT00379340|515812629|FG001|Overall Study|Physician Decision|2|||
143074344|NCT00379340|515812630|FG002|Overall Study|Physician Decision|1|||
143074345|NCT00379340|515812631|FG003|Overall Study|Physician Decision|2|||
143074346|NCT00379340|515812632|FG004|Overall Study|Physician Decision|3|||
143074347|NCT00379340|515812628|FG000|Overall Study|Withdrawal by Subject|0|||
143074348|NCT00379340|515812629|FG001|Overall Study|Withdrawal by Subject|0|||
143074349|NCT00379340|515812630|FG002|Overall Study|Withdrawal by Subject|0|||
143074350|NCT00379340|515812631|FG003|Overall Study|Withdrawal by Subject|1|||
143074351|NCT00379340|515812632|FG004|Overall Study|Withdrawal by Subject|0|||
143074352|NCT00379340|515812628|FG000|Overall Study|Refusal of further protocol therapy|1|||
143074353|NCT00379340|515812629|FG001|Overall Study|Refusal of further protocol therapy|0|||
143074354|NCT00379340|515812630|FG002|Overall Study|Refusal of further protocol therapy|1|||
143074355|NCT00379340|515812631|FG003|Overall Study|Refusal of further protocol therapy|1|||
143074356|NCT00379340|515812632|FG004|Overall Study|Refusal of further protocol therapy|7|||
143074357|NCT00379340|515812628|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
143074358|NCT00379340|515812629|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
143074359|NCT00379340|515812630|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
143074360|NCT00379340|515812631|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
143074361|NCT00379340|515812632|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
143074362|NCT00379340|515812628|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
143074363|NCT00379340|515812629|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
143074364|NCT00379340|515812630|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
143074365|NCT00379340|515812631|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
143074366|NCT00379340|515812632|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
143074367|NCT04347122|515812633|FG000|Overall Study|Physician Decision|0|||
143074368|NCT04347122|515812634|FG001|Overall Study|Physician Decision|3|||
143074369|NCT04347122|515812635|FG002|Overall Study|Physician Decision|3|||
143074370|NCT04347122|515812636|FG003|Overall Study|Physician Decision|6|||
143074371|NCT02213510|515812640|FG000|Overall Study|Death|0|||
143074372|NCT02213510|515812641|FG001|Overall Study|Death|1|||
143074373|NCT02213510|515812640|FG000|Overall Study|Lost to Follow-up|1|||
143074374|NCT02213510|515812641|FG001|Overall Study|Lost to Follow-up|0|||
143074375|NCT02903030|515812646|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
143171741|NCT05067335|516178449|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
143171742|NCT05067335|516178450|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
143171743|NCT05067335|516178451|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
143171744|NCT05067335|516178448|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
143171745|NCT05067335|516178449|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
143171746|NCT05067335|516178450|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
143171747|NCT05067335|516178451|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
143074376|NCT02903030|515812647|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
143171748|NCT05067335|516178448|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
143074377|NCT01502410|515812648|FG000|Overall Study|Adverse Event|1|||
143074378|NCT01502410|515812649|FG001|Overall Study|Adverse Event|2|||
143074379|NCT01502410|515812650|FG002|Overall Study|Adverse Event|0|||
143074380|NCT01502410|515812651|FG003|Overall Study|Adverse Event|0|||
143074381|NCT01502410|515812648|FG000|Overall Study|Lack of Efficacy|7|||
143074382|NCT01502410|515812649|FG001|Overall Study|Lack of Efficacy|7|||
143074383|NCT01502410|515812650|FG002|Overall Study|Lack of Efficacy|0|||
143074384|NCT01502410|515812651|FG003|Overall Study|Lack of Efficacy|0|||
143074385|NCT01502410|515812648|FG000|Overall Study|Physician Decision|0|||
143074386|NCT01502410|515812649|FG001|Overall Study|Physician Decision|1|||
143074387|NCT01502410|515812650|FG002|Overall Study|Physician Decision|0|||
143074388|NCT01502410|515812651|FG003|Overall Study|Physician Decision|0|||
143074389|NCT01502410|515812648|FG000|Overall Study|Withdrawal by Subject|2|||
143074390|NCT01502410|515812649|FG001|Overall Study|Withdrawal by Subject|0|||
143074391|NCT01502410|515812650|FG002|Overall Study|Withdrawal by Subject|0|||
143074392|NCT01502410|515812651|FG003|Overall Study|Withdrawal by Subject|0|||
143074393|NCT04345601|515812652|FG000|Overall Study|Death|0|||
143074394|NCT04345601|515812653|FG001|Overall Study|Death|3|||
143074395|NCT04345601|515812654|FG002|Overall Study|Death|2|||
143074396|NCT04345601|515812652|FG000|Overall Study|Lost to Follow-up|0|||
143074397|NCT04345601|515812653|FG001|Overall Study|Lost to Follow-up|0|||
143074398|NCT04345601|515812654|FG002|Overall Study|Lost to Follow-up|2|||
143074399|NCT03700385|515812655|FG000|Overall Study|Lost to Follow-up|1|||
143074400|NCT04590040|515812660|FG000|Treatment Period|Lost to Follow-up|2|||
143074401|NCT04590040|515812661|FG001|Treatment Period|Lost to Follow-up|5|||
143074402|NCT04590040|515812662|FG002|Treatment Period|Lost to Follow-up|0|||
143074403|NCT04590040|515812660|FG000|Treatment Period|Physician Decision|0|||
143074404|NCT04590040|515812661|FG001|Treatment Period|Physician Decision|0|||
143074405|NCT04590040|515812662|FG002|Treatment Period|Physician Decision|2|||
143074406|NCT00631657|515812665|FG000|6-Month Treatment Period|Adverse Event|47|||
143074407|NCT00631657|515812666|FG001|6-Month Treatment Period|Adverse Event|0|||
143074408|NCT00631657|515812667|FG002|6-Month Treatment Period|Adverse Event|7|||
143074409|NCT00631657|515812665|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
143074410|NCT00631657|515812666|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
143074411|NCT00631657|515812667|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
143074412|NCT00631657|515812665|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
143074413|NCT00631657|515812666|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
143074414|NCT00631657|515812667|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
143074415|NCT00631657|515812665|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
143074416|NCT00631657|515812666|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
143074417|NCT00631657|515812667|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
143074418|NCT00631657|515812665|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
143074419|NCT00631657|515812666|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
143171749|NCT05067335|516178449|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
143171750|NCT05067335|516178450|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
143171751|NCT05067335|516178451|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
143171752|NCT05067335|516178448|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
143171753|NCT05067335|516178449|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
143074420|NCT00631657|515812667|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
143074421|NCT00631657|515812665|FG000|6-Month Treatment Period|Other|16|||
143074422|NCT00631657|515812666|FG001|6-Month Treatment Period|Other|0|||
143074423|NCT00631657|515812667|FG002|6-Month Treatment Period|Other|4|||
143171754|NCT05067335|516178450|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
143171755|NCT05067335|516178451|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
143171756|NCT05067335|516178448|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
143171757|NCT05067335|516178449|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
143171758|NCT05067335|516178450|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
143171759|NCT05067335|516178451|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
143171760|NCT05067335|516178448|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
143171761|NCT05067335|516178449|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
143171762|NCT05067335|516178450|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
143171763|NCT05067335|516178451|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
143171764|NCT02724839|516178452|FG000|Overall Study|Withdrawal by Subject|1|||
143171765|NCT02724839|516178453|FG001|Overall Study|Withdrawal by Subject|1|||
143171766|NCT02724839|516178454|FG002|Overall Study|Withdrawal by Subject|0|||
143171767|NCT02724839|516178452|FG000|Overall Study|Lost to Follow-up|0|||
143171768|NCT02724839|516178453|FG001|Overall Study|Lost to Follow-up|3|||
143074424|NCT00631657|515812665|FG000|6-Month Treatment Period|Not Treated|2|||
143074425|NCT00631657|515812666|FG001|6-Month Treatment Period|Not Treated|0|||
143074426|NCT00631657|515812667|FG002|6-Month Treatment Period|Not Treated|1|||
143074427|NCT00631657|515812665|FG000|7-Day Discontinuation Period|Not Treated|1|||
143074428|NCT00631657|515812666|FG001|7-Day Discontinuation Period|Not Treated|1|||
143074429|NCT00631657|515812667|FG002|7-Day Discontinuation Period|Not Treated|1|||
143074430|NCT00631657|515812665|FG000|7-Day Discontinuation Period|Other|1|||
143074431|NCT00631657|515812666|FG001|7-Day Discontinuation Period|Other|0|||
143074432|NCT00631657|515812667|FG002|7-Day Discontinuation Period|Other|0|||
143074433|NCT01284361|515812668|FG000|Overall Study|Withdrawal by Subject|1|||
143074434|NCT01284361|515812668|FG000|Overall Study|Protocol Violation|5|||
143074435|NCT01284361|515812668|FG000|Overall Study|Adverse Event|1|||
143074436|NCT01284361|515812668|FG000|Overall Study|Lost to Follow-up|2|||
143074437|NCT04715932|515812669|FG000|Overall Study|Lost to Follow-up|1|||
143074438|NCT04715932|515812670|FG001|Overall Study|Lost to Follow-up|0|||
143074439|NCT01359969|515812675|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
143074440|NCT03400943|515812688|FG000|Treatment Period 1|Adverse Event|0|||
143074441|NCT03400943|515812689|FG001|Treatment Period 1|Adverse Event|0|||
143074442|NCT03400943|515812690|FG002|Treatment Period 1|Adverse Event|0|||
143074443|NCT03400943|515812691|FG003|Treatment Period 1|Adverse Event|1|||
143074444|NCT03400943|515812688|FG000|Treatment Period 1|Lost to Follow-up|1|||
143074445|NCT03400943|515812689|FG001|Treatment Period 1|Lost to Follow-up|0|||
143074446|NCT03400943|515812690|FG002|Treatment Period 1|Lost to Follow-up|0|||
143074447|NCT03400943|515812691|FG003|Treatment Period 1|Lost to Follow-up|0|||
143074448|NCT03400943|515812688|FG000|Treatment Period 1|Protocol Violation|0|||
143074449|NCT03400943|515812689|FG001|Treatment Period 1|Protocol Violation|1|||
143074450|NCT03400943|515812690|FG002|Treatment Period 1|Protocol Violation|1|||
143074451|NCT03400943|515812691|FG003|Treatment Period 1|Protocol Violation|0|||
143074452|NCT03400943|515812688|FG000|Treatment Period 1|Study terminated by sponsor|2|||
143074453|NCT03400943|515812689|FG001|Treatment Period 1|Study terminated by sponsor|0|||
143074454|NCT03400943|515812690|FG002|Treatment Period 1|Study terminated by sponsor|0|||
143074455|NCT03400943|515812691|FG003|Treatment Period 1|Study terminated by sponsor|1|||
143074456|NCT03400943|515812688|FG000|Treatment Period 1|Withdrawal by Subject|0|||
143171769|NCT02724839|516178454|FG002|Overall Study|Lost to Follow-up|2|||
143171770|NCT02724839|516178452|FG000|Overall Study|Physician Decision|0|||
143171771|NCT02724839|516178453|FG001|Overall Study|Physician Decision|0|||
143171772|NCT02724839|516178454|FG002|Overall Study|Physician Decision|3|||
143171773|NCT01645176|516178456|FG000|Overall Study|Lack of Efficacy|4|||
143171774|NCT01645176|516178456|FG000|Overall Study|did not complete final MRI|1|||
143171775|NCT05878067|516178457|FG000|Overall Study|Lost to Follow-up|2|||
143171776|NCT01198587|516178458|FG000|Overall Study|Lost to Follow-up|8|||
143171777|NCT01198587|516178459|FG001|Overall Study|Lost to Follow-up|0|||
143171778|NCT01198587|516178460|FG002|Overall Study|Lost to Follow-up|9|||
143171779|NCT01198587|516178461|FG003|Overall Study|Lost to Follow-up|0|||
143171780|NCT01948427|516178464|FG000|Overall Study|Serious Adverse Event|3|||
143171781|NCT01948427|516178465|FG001|Overall Study|Serious Adverse Event|0|||
143171782|NCT01948427|516178466|FG002|Overall Study|Serious Adverse Event|0|||
143171783|NCT01948427|516178467|FG003|Overall Study|Serious Adverse Event|0|||
143171784|NCT01948427|516178468|FG004|Overall Study|Serious Adverse Event|1|||
143171785|NCT01948427|516178464|FG000|Overall Study|Investigator Request|0|||
143171786|NCT01948427|516178465|FG001|Overall Study|Investigator Request|8|||
143171787|NCT01948427|516178466|FG002|Overall Study|Investigator Request|0|||
143171788|NCT01948427|516178467|FG003|Overall Study|Investigator Request|0|||
143171789|NCT01948427|516178468|FG004|Overall Study|Investigator Request|6|||
143171790|NCT01948427|516178464|FG000|Overall Study|Lost to Follow-up|1|||
143171791|NCT01948427|516178465|FG001|Overall Study|Lost to Follow-up|0|||
143171792|NCT01948427|516178466|FG002|Overall Study|Lost to Follow-up|0|||
143171793|NCT01948427|516178467|FG003|Overall Study|Lost to Follow-up|0|||
143171794|NCT01948427|516178468|FG004|Overall Study|Lost to Follow-up|4|||
143171795|NCT01948427|516178464|FG000|Overall Study|Withdrawal by Subject|2|||
143171796|NCT01948427|516178465|FG001|Overall Study|Withdrawal by Subject|0|||
143171797|NCT01948427|516178466|FG002|Overall Study|Withdrawal by Subject|0|||
143171798|NCT01948427|516178467|FG003|Overall Study|Withdrawal by Subject|0|||
143171799|NCT01948427|516178468|FG004|Overall Study|Withdrawal by Subject|1|||
143171800|NCT01948427|516178464|FG000|Overall Study|Other, Not Specified|1|||
143171801|NCT01948427|516178465|FG001|Overall Study|Other, Not Specified|9|||
143171802|NCT01948427|516178466|FG002|Overall Study|Other, Not Specified|0|||
143171803|NCT01948427|516178467|FG003|Overall Study|Other, Not Specified|0|||
143171804|NCT01948427|516178468|FG004|Overall Study|Other, Not Specified|2|||
143171805|NCT00402987|516178469|FG000|Overall Study|Lack of Efficacy|0|||
143171806|NCT00402987|516178470|FG001|Overall Study|Lack of Efficacy|0|||
143171807|NCT00402987|516178471|FG002|Overall Study|Lack of Efficacy|1|||
143171808|NCT00402987|516178472|FG003|Overall Study|Lack of Efficacy|0|||
143171809|NCT01668004|516178473|FG000|Overall Study|Adverse Event|7|||
143171810|NCT01668004|516178473|FG000|Overall Study|Withdrawal by Subject|2|||
143074457|NCT03400943|515812689|FG001|Treatment Period 1|Withdrawal by Subject|0|||
143074458|NCT03400943|515812690|FG002|Treatment Period 1|Withdrawal by Subject|3|||
143074459|NCT03400943|515812691|FG003|Treatment Period 1|Withdrawal by Subject|1|||
143074460|NCT03400943|515812688|FG000|Treatment Period 1|Other|2|||
143074461|NCT03400943|515812689|FG001|Treatment Period 1|Other|1|||
143074462|NCT03400943|515812690|FG002|Treatment Period 1|Other|2|||
143074463|NCT03400943|515812691|FG003|Treatment Period 1|Other|2|||
143074464|NCT03400943|515812688|FG000|Post-treatment Period 1|Adverse Event|2|||
143074465|NCT03400943|515812689|FG001|Post-treatment Period 1|Adverse Event|0|||
143074466|NCT03400943|515812690|FG002|Post-treatment Period 1|Adverse Event|0|||
143074467|NCT03400943|515812691|FG003|Post-treatment Period 1|Adverse Event|0|||
143074468|NCT03400943|515812688|FG000|Post-treatment Period 1|Protocol Violation|1|||
143074469|NCT03400943|515812689|FG001|Post-treatment Period 1|Protocol Violation|0|||
143074470|NCT03400943|515812690|FG002|Post-treatment Period 1|Protocol Violation|0|||
143074471|NCT03400943|515812691|FG003|Post-treatment Period 1|Protocol Violation|0|||
143074472|NCT03400943|515812688|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
143074473|NCT03400943|515812689|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
143074474|NCT03400943|515812690|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
143074475|NCT03400943|515812691|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
143074476|NCT03400943|515812688|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
143074477|NCT03400943|515812689|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
143074478|NCT03400943|515812690|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
143074479|NCT03400943|515812691|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
143074480|NCT03400943|515812688|FG000|Post-treatment Period 1|Other|2|||
143074481|NCT03400943|515812689|FG001|Post-treatment Period 1|Other|0|||
143074482|NCT03400943|515812690|FG002|Post-treatment Period 1|Other|4|||
143074483|NCT03400943|515812691|FG003|Post-treatment Period 1|Other|5|||
143074484|NCT03400943|515812688|FG000|Treatment Period 2|Study terminated by sponsor|0|||
143074485|NCT03400943|515812689|FG001|Treatment Period 2|Study terminated by sponsor|1|||
143074486|NCT03400943|515812690|FG002|Treatment Period 2|Study terminated by sponsor|0|||
143074487|NCT03400943|515812691|FG003|Treatment Period 2|Study terminated by sponsor|0|||
143074488|NCT03400943|515812688|FG000|Treatment Period 2|Withdrawal by Subject|0|||
143074489|NCT03400943|515812689|FG001|Treatment Period 2|Withdrawal by Subject|1|||
143074490|NCT03400943|515812690|FG002|Treatment Period 2|Withdrawal by Subject|0|||
143074491|NCT03400943|515812691|FG003|Treatment Period 2|Withdrawal by Subject|0|||
143074492|NCT03400943|515812688|FG000|Treatment Period 2|Other|1|||
143074493|NCT03400943|515812689|FG001|Treatment Period 2|Other|6|||
143074494|NCT03400943|515812690|FG002|Treatment Period 2|Other|0|||
143074495|NCT03400943|515812691|FG003|Treatment Period 2|Other|0|||
143074496|NCT03400943|515812688|FG000|Follow-up Period|Withdrawal by Subject|1|||
143074497|NCT03400943|515812689|FG001|Follow-up Period|Withdrawal by Subject|0|||
143074498|NCT03400943|515812690|FG002|Follow-up Period|Withdrawal by Subject|0|||
143074499|NCT03400943|515812691|FG003|Follow-up Period|Withdrawal by Subject|0|||
143074500|NCT04729309|515812692|FG000|Period 1|Subject unable to return for Period 2|3|||
143074501|NCT04729309|515812693|FG001|Period 1|Subject unable to return for Period 2|0|||
143074502|NCT04729309|515812692|FG000|Period 1|Lost to Follow-up|1|||
143074503|NCT04729309|515812693|FG001|Period 1|Lost to Follow-up|0|||
143074504|NCT01059539|515812694|FG000|Overall Study|Adverse Event|66|||
143074505|NCT01059539|515812694|FG000|Overall Study|Insufficient Therapeutic Response|26|||
143074506|NCT01059539|515812694|FG000|Overall Study|Protocol Violation|55|||
143074507|NCT01059539|515812694|FG000|Overall Study|Withdrawal of Consent|80|||
143074508|NCT01059539|515812694|FG000|Overall Study|Lost to Follow-up|42|||
143074509|NCT01059539|515812694|FG000|Overall Study|Reason Not Specified|2|||
143074510|NCT01716715|515812695|FG000|Overall Study|Never Treated|2|||
143074511|NCT01716715|515812696|FG001|Overall Study|Never Treated|4|||
143074512|NCT04228783|515812697|FG000|Overall Study|Adverse Event|1|||
143074513|NCT04228783|515812698|FG001|Overall Study|Adverse Event|0|||
143074514|NCT04228783|515812699|FG002|Overall Study|Adverse Event|2|||
143074515|NCT04228783|515812700|FG003|Overall Study|Adverse Event|0|||
143074516|NCT04228783|515812701|FG004|Overall Study|Adverse Event|0|||
143074517|NCT04228783|515812702|FG005|Overall Study|Adverse Event|1|||
143074518|NCT04228783|515812697|FG000|Overall Study|Death|0|||
143171811|NCT01668004|516178473|FG000|Overall Study|Lost to Follow-up|5|||
143074519|NCT04228783|515812698|FG001|Overall Study|Death|0|||
143074520|NCT04228783|515812699|FG002|Overall Study|Death|0|||
143074521|NCT04228783|515812700|FG003|Overall Study|Death|0|||
143074522|NCT04228783|515812701|FG004|Overall Study|Death|1|||
143074523|NCT04228783|515812702|FG005|Overall Study|Death|0|||
143074524|NCT04228783|515812697|FG000|Overall Study|Lost to Follow-up|36|||
143074525|NCT04228783|515812698|FG001|Overall Study|Lost to Follow-up|36|||
143074526|NCT04228783|515812699|FG002|Overall Study|Lost to Follow-up|28|||
143074527|NCT04228783|515812700|FG003|Overall Study|Lost to Follow-up|6|||
143074528|NCT04228783|515812701|FG004|Overall Study|Lost to Follow-up|14|||
143074529|NCT04228783|515812702|FG005|Overall Study|Lost to Follow-up|3|||
143074530|NCT04228783|515812697|FG000|Overall Study|Physician Decision|1|||
143074531|NCT04228783|515812698|FG001|Overall Study|Physician Decision|2|||
143074532|NCT04228783|515812699|FG002|Overall Study|Physician Decision|0|||
143074533|NCT04228783|515812700|FG003|Overall Study|Physician Decision|0|||
143074534|NCT04228783|515812701|FG004|Overall Study|Physician Decision|0|||
143074535|NCT04228783|515812702|FG005|Overall Study|Physician Decision|0|||
143074536|NCT04228783|515812697|FG000|Overall Study|Protocol Violation|0|||
143074537|NCT04228783|515812698|FG001|Overall Study|Protocol Violation|0|||
143074538|NCT04228783|515812699|FG002|Overall Study|Protocol Violation|0|||
143074539|NCT04228783|515812700|FG003|Overall Study|Protocol Violation|1|||
143074540|NCT04228783|515812701|FG004|Overall Study|Protocol Violation|0|||
143074541|NCT04228783|515812702|FG005|Overall Study|Protocol Violation|0|||
143074542|NCT04228783|515812697|FG000|Overall Study|Withdrawal by Subject|6|||
143074543|NCT04228783|515812698|FG001|Overall Study|Withdrawal by Subject|10|||
143074544|NCT04228783|515812699|FG002|Overall Study|Withdrawal by Subject|19|||
143074545|NCT04228783|515812700|FG003|Overall Study|Withdrawal by Subject|1|||
143074546|NCT04228783|515812701|FG004|Overall Study|Withdrawal by Subject|2|||
143074547|NCT04228783|515812702|FG005|Overall Study|Withdrawal by Subject|0|||
143074548|NCT04228783|515812697|FG000|Overall Study|Other|4|||
143074549|NCT04228783|515812698|FG001|Overall Study|Other|3|||
143074550|NCT04228783|515812699|FG002|Overall Study|Other|2|||
143074551|NCT04228783|515812700|FG003|Overall Study|Other|1|||
143074552|NCT04228783|515812701|FG004|Overall Study|Other|0|||
143074553|NCT04228783|515812702|FG005|Overall Study|Other|0|||
143074554|NCT00626392|515812703|FG000|Run-in Period|Adverse Event|0|||
143074555|NCT00626392|515812704|FG001|Run-in Period|Adverse Event|0|||
143074556|NCT00626392|515812705|FG002|Run-in Period|Adverse Event|1|||
143074557|NCT00626392|515812706|FG003|Run-in Period|Adverse Event|0|||
143074558|NCT00626392|515812707|FG004|Run-in Period|Adverse Event|1|||
143074559|NCT00626392|515812708|FG005|Run-in Period|Adverse Event|0|||
143074560|NCT00626392|515812703|FG000|Run-in Period|Withdrawal by Subject|0|||
143074561|NCT00626392|515812704|FG001|Run-in Period|Withdrawal by Subject|1|||
143074562|NCT00626392|515812705|FG002|Run-in Period|Withdrawal by Subject|1|||
143074563|NCT00626392|515812706|FG003|Run-in Period|Withdrawal by Subject|1|||
143074564|NCT00626392|515812707|FG004|Run-in Period|Withdrawal by Subject|3|||
143074565|NCT00626392|515812708|FG005|Run-in Period|Withdrawal by Subject|1|||
143074566|NCT00626392|515812703|FG000|Run-in Period|Noncompliance|1|||
143074567|NCT00626392|515812704|FG001|Run-in Period|Noncompliance|0|||
143074568|NCT00626392|515812705|FG002|Run-in Period|Noncompliance|1|||
143074569|NCT00626392|515812706|FG003|Run-in Period|Noncompliance|0|||
143248495|NCT01708902|516462990|FG005|Overall Study|Non compliance with protocol|0|||
143248496|NCT01708902|516462991|FG006|Overall Study|Non compliance with protocol|0|||
143248497|NCT01708902|516462985|FG000|Overall Study|Lost to Follow-up|2|||
143248498|NCT01708902|516462986|FG001|Overall Study|Lost to Follow-up|1|||
143248499|NCT01708902|516462987|FG002|Overall Study|Lost to Follow-up|2|||
143248500|NCT01708902|516462988|FG003|Overall Study|Lost to Follow-up|2|||
143248501|NCT01708902|516462989|FG004|Overall Study|Lost to Follow-up|0|||
143248502|NCT01708902|516462990|FG005|Overall Study|Lost to Follow-up|0|||
143248503|NCT01708902|516462991|FG006|Overall Study|Lost to Follow-up|1|||
143248504|NCT01708902|516462985|FG000|Overall Study|Refused to continue trial medication|8|||
143248505|NCT01708902|516462986|FG001|Overall Study|Refused to continue trial medication|0|||
143248506|NCT01708902|516462987|FG002|Overall Study|Refused to continue trial medication|4|||
143248507|NCT01708902|516462988|FG003|Overall Study|Refused to continue trial medication|2|||
143248508|NCT01708902|516462989|FG004|Overall Study|Refused to continue trial medication|8|||
143248509|NCT01708902|516462990|FG005|Overall Study|Refused to continue trial medication|1|||
143248510|NCT01708902|516462991|FG006|Overall Study|Refused to continue trial medication|1|||
143365734|NCT01362491|516882920|FG001|Overall Study|Ineligible|0|||
143074570|NCT00626392|515812707|FG004|Run-in Period|Noncompliance|0|||
143074571|NCT00626392|515812708|FG005|Run-in Period|Noncompliance|0|||
143074572|NCT00626392|515812703|FG000|Coadministration Period|Adverse Event|3|||
143074573|NCT00626392|515812704|FG001|Coadministration Period|Adverse Event|1|||
143074574|NCT00626392|515812705|FG002|Coadministration Period|Adverse Event|7|||
143074575|NCT00626392|515812706|FG003|Coadministration Period|Adverse Event|4|||
143074576|NCT00626392|515812707|FG004|Coadministration Period|Adverse Event|3|||
143074577|NCT00626392|515812708|FG005|Coadministration Period|Adverse Event|4|||
143074578|NCT00626392|515812703|FG000|Coadministration Period|Withdrawal by Subject|1|||
143074579|NCT00626392|515812704|FG001|Coadministration Period|Withdrawal by Subject|1|||
143074580|NCT00626392|515812705|FG002|Coadministration Period|Withdrawal by Subject|0|||
143074581|NCT00626392|515812706|FG003|Coadministration Period|Withdrawal by Subject|1|||
143074582|NCT00626392|515812707|FG004|Coadministration Period|Withdrawal by Subject|0|||
143074583|NCT00626392|515812708|FG005|Coadministration Period|Withdrawal by Subject|1|||
143074584|NCT00626392|515812703|FG000|Coadministration Period|Protocol Violation|0|||
143074585|NCT00626392|515812704|FG001|Coadministration Period|Protocol Violation|1|||
143074586|NCT00626392|515812705|FG002|Coadministration Period|Protocol Violation|0|||
143074587|NCT00626392|515812706|FG003|Coadministration Period|Protocol Violation|1|||
143074588|NCT00626392|515812707|FG004|Coadministration Period|Protocol Violation|1|||
143074589|NCT00626392|515812708|FG005|Coadministration Period|Protocol Violation|0|||
143074590|NCT00626392|515812703|FG000|Coadministration Period|Other|0|||
143074591|NCT00626392|515812704|FG001|Coadministration Period|Other|2|||
143074592|NCT00626392|515812705|FG002|Coadministration Period|Other|3|||
143074593|NCT00626392|515812706|FG003|Coadministration Period|Other|1|||
143074594|NCT00626392|515812707|FG004|Coadministration Period|Other|1|||
143074595|NCT00626392|515812708|FG005|Coadministration Period|Other|1|||
143074596|NCT04154631|515812711|FG000|Overall Study|Patients lost to post or 6-month follow-up|42|||
143074597|NCT04154631|515812712|FG001|Overall Study|Patients lost to post or 6-month follow-up|53|||
143074598|NCT02238795|515812713|FG000|Overall Study|Patient without purpura fulminans|1|||
143074599|NCT03384654|515812717|FG000|Overall Study|Withdrawal by Subject|0|||
143074600|NCT03384654|515812718|FG001|Overall Study|Withdrawal by Subject|0|||
143074601|NCT03384654|515812719|FG002|Overall Study|Withdrawal by Subject|1|||
143074602|NCT03384654|515812720|FG003|Overall Study|Withdrawal by Subject|0|||
143074603|NCT00311402|515812721|FG000|Overall Study|Adverse Event|118|||
143074604|NCT00311402|515812722|FG001|Overall Study|Adverse Event|105|||
143074605|NCT00311402|515812721|FG000|Overall Study|Lost to Follow-up|0|||
143074606|NCT00311402|515812722|FG001|Overall Study|Lost to Follow-up|3|||
143074607|NCT00311402|515812721|FG000|Overall Study|Withdrawal by Subject|17|||
143074608|NCT00311402|515812722|FG001|Overall Study|Withdrawal by Subject|18|||
143074609|NCT00311402|515812721|FG000|Overall Study|Lack of Efficacy|58|||
143074610|NCT00311402|515812722|FG001|Overall Study|Lack of Efficacy|42|||
143074611|NCT00311402|515812721|FG000|Overall Study|Protocol Violation|7|||
143074612|NCT00311402|515812722|FG001|Overall Study|Protocol Violation|6|||
143074613|NCT00311402|515812721|FG000|Overall Study|IRB's rejection etc.|10|||
143074614|NCT00311402|515812722|FG001|Overall Study|IRB's rejection etc.|3|||
143074615|NCT00724048|515812724|FG000|Overall Study|Adverse Event|1|||
143074616|NCT00724048|515812725|FG001|Overall Study|Adverse Event|1|||
143074617|NCT00724048|515812726|FG002|Overall Study|Adverse Event|1|||
143074618|NCT00724048|515812727|FG003|Overall Study|Adverse Event|0|||
143074619|NCT00724048|515812724|FG000|Overall Study|Lost to Follow-up|0|||
143074620|NCT00724048|515812725|FG001|Overall Study|Lost to Follow-up|1|||
143074621|NCT00724048|515812726|FG002|Overall Study|Lost to Follow-up|0|||
143074622|NCT00724048|515812727|FG003|Overall Study|Lost to Follow-up|0|||
143074623|NCT00724048|515812724|FG000|Overall Study|Withdrawal by Subject|1|||
143074624|NCT00724048|515812725|FG001|Overall Study|Withdrawal by Subject|2|||
143074625|NCT00724048|515812726|FG002|Overall Study|Withdrawal by Subject|1|||
143074626|NCT00724048|515812727|FG003|Overall Study|Withdrawal by Subject|2|||
143074627|NCT00724048|515812724|FG000|Overall Study|Investigator decision|0|||
143074628|NCT00724048|515812725|FG001|Overall Study|Investigator decision|0|||
143074629|NCT00724048|515812726|FG002|Overall Study|Investigator decision|1|||
143074630|NCT00724048|515812727|FG003|Overall Study|Investigator decision|0|||
143074631|NCT00724048|515812724|FG000|Overall Study|Did not tolerate study drug|0|||
143074632|NCT00724048|515812725|FG001|Overall Study|Did not tolerate study drug|0|||
143074633|NCT00724048|515812726|FG002|Overall Study|Did not tolerate study drug|0|||
143074634|NCT00724048|515812727|FG003|Overall Study|Did not tolerate study drug|1|||
143074635|NCT00724048|515812724|FG000|Overall Study|Other than specified|1|||
143074636|NCT00724048|515812725|FG001|Overall Study|Other than specified|1|||
143074637|NCT00724048|515812726|FG002|Overall Study|Other than specified|0|||
143171812|NCT01668004|516178473|FG000|Overall Study|Lack of Efficacy|9|||
143171813|NCT01668004|516178473|FG000|Overall Study|Non-compliance with treatment|2|||
143171814|NCT00419744|516178474|FG000|Overall Study|Adverse Event|39|||
143171815|NCT00419744|516178475|FG001|Overall Study|Adverse Event|40|||
143171816|NCT00419744|516178476|FG002|Overall Study|Adverse Event|50|||
143171817|NCT00419744|516178474|FG000|Overall Study|Withdrawal by Subject|45|||
143171818|NCT00419744|516178475|FG001|Overall Study|Withdrawal by Subject|49|||
143171819|NCT00419744|516178476|FG002|Overall Study|Withdrawal by Subject|52|||
143074638|NCT00724048|515812727|FG003|Overall Study|Other than specified|0|||
143074639|NCT03657342|515812730|FG000|Overall Study|Adverse Event, including SAE/Death|6|||
143074640|NCT03657342|515812731|FG001|Overall Study|Adverse Event, including SAE/Death|3|||
143074641|NCT03657342|515812730|FG000|Overall Study|Withdrawal by Subject|4|||
143074642|NCT03657342|515812731|FG001|Overall Study|Withdrawal by Subject|4|||
143074643|NCT03657342|515812730|FG000|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|1|||
143074644|NCT03657342|515812731|FG001|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|0|||
143074645|NCT03657342|515812730|FG000|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|1|||
143074646|NCT03657342|515812731|FG001|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|0|||
143074647|NCT01910389|515812732|FG000|Overall Study|Withdrawal by Subject|2|||
143074648|NCT01910389|515812733|FG001|Overall Study|Withdrawal by Subject|0|||
143074649|NCT01910389|515812732|FG000|Overall Study|Study Closed|13|||
143074650|NCT01910389|515812733|FG001|Overall Study|Study Closed|8|||
143074651|NCT01898650|515812737|FG000|Overall Study|the subject would not lie still for imaging|1|||
143074652|NCT03923530|515812738|FG000|Overall Study|Withdrawal by Subject|1|||
143074653|NCT03923530|515812738|FG000|Overall Study|screen failure|3|||
143074654|NCT01822275|515812742|FG000|Overall Study|Withdrawal by Subject|3|||
143074655|NCT01822275|515812742|FG000|Overall Study|Adverse Event|3|||
143074656|NCT01822275|515812742|FG000|Overall Study|Progression|14|||
143074657|NCT01822275|515812742|FG000|Overall Study|Physician Decision|2|||
143074658|NCT02722148|515812743|FG000|Overall Study|Lost to Follow-up|2|||
143074659|NCT02722148|515812743|FG000|Overall Study|Non compliant with treatment regimen|3|||
143074660|NCT00911807|515812744|FG000|Overall Study|Adverse Event|2|||
143074661|NCT00911807|515812745|FG001|Overall Study|Adverse Event|1|||
143074662|NCT00911807|515812746|FG002|Overall Study|Adverse Event|5|||
143074663|NCT00911807|515812744|FG000|Overall Study|Death|0|||
143074664|NCT00911807|515812745|FG001|Overall Study|Death|0|||
143074665|NCT00911807|515812746|FG002|Overall Study|Death|1|||
143074666|NCT00911807|515812744|FG000|Overall Study|Protocol Violation|6|||
143074667|NCT00911807|515812745|FG001|Overall Study|Protocol Violation|4|||
143074668|NCT00911807|515812746|FG002|Overall Study|Protocol Violation|9|||
143074669|NCT00911807|515812744|FG000|Overall Study|Withdrawal by Subject|8|||
143074670|NCT00911807|515812745|FG001|Overall Study|Withdrawal by Subject|10|||
143074671|NCT00911807|515812746|FG002|Overall Study|Withdrawal by Subject|7|||
143074672|NCT00911807|515812744|FG000|Overall Study|Organizational reasons|1|||
143074673|NCT00911807|515812745|FG001|Overall Study|Organizational reasons|3|||
143074674|NCT00911807|515812746|FG002|Overall Study|Organizational reasons|1|||
143074675|NCT01672970|515812748|FG000|Overall Study|Lack of Efficacy|12|||
143074676|NCT01672970|515812748|FG000|Overall Study|Adverse Event|18|||
143074677|NCT01672970|515812748|FG000|Overall Study|Withdrawal by Subject|2|||
143074678|NCT01672970|515812748|FG000|Overall Study|Lost to Follow-up|5|||
143074679|NCT01672970|515812748|FG000|Overall Study|Other|9|||
143074680|NCT01672970|515812748|FG000|Overall Study|Enrolled but not treated|1|||
143074681|NCT03276780|515812755|FG000|Overall Study|Withdrawal by Subject|5|||
143074682|NCT03276780|515812756|FG001|Overall Study|Withdrawal by Subject|3|||
143074683|NCT03276780|515812755|FG000|Overall Study|Lost to Follow-up|3|||
143074684|NCT03276780|515812756|FG001|Overall Study|Lost to Follow-up|5|||
143074685|NCT03276780|515812755|FG000|Overall Study|Moved out of state|1|||
143074686|NCT03276780|515812756|FG001|Overall Study|Moved out of state|1|||
143074687|NCT03276780|515812755|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
143074688|NCT03276780|515812756|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
143074689|NCT03276780|515812755|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
143074690|NCT03276780|515812756|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
143074691|NCT00186043|515812757|FG000|Overall Study|Lack of Efficacy|1|||
143074692|NCT00186043|515812758|FG001|Overall Study|Lack of Efficacy|3|||
143074693|NCT00186043|515812757|FG000|Overall Study|Lost to Follow-up|4|||
143074694|NCT00186043|515812758|FG001|Overall Study|Lost to Follow-up|6|||
143074695|NCT00186043|515812757|FG000|Overall Study|Withdrawal by Subject|1|||
143074696|NCT00186043|515812758|FG001|Overall Study|Withdrawal by Subject|0|||
143074697|NCT00186043|515812757|FG000|Overall Study|Adverse Event|7|||
143074698|NCT00186043|515812758|FG001|Overall Study|Adverse Event|3|||
143074699|NCT00186043|515812757|FG000|Overall Study|Protocol Violation|2|||
143074700|NCT00186043|515812758|FG001|Overall Study|Protocol Violation|1|||
143074701|NCT04874636|515812759|FG000|Overall Study|Adverse Event|17|||
143074702|NCT04874636|515812760|FG001|Overall Study|Adverse Event|7|||
143074703|NCT04874636|515812759|FG000|Overall Study|Lost to Follow-up|1|||
143074704|NCT04874636|515812760|FG001|Overall Study|Lost to Follow-up|0|||
143074705|NCT04874636|515812759|FG000|Overall Study|Non-Compliance with Study Drug|2|||
143074706|NCT04874636|515812760|FG001|Overall Study|Non-Compliance with Study Drug|0|||
143074707|NCT04874636|515812759|FG000|Overall Study|Physician Decision|1|||
143074708|NCT04874636|515812760|FG001|Overall Study|Physician Decision|0|||
143074709|NCT04874636|515812759|FG000|Overall Study|Withdrawal by Subject|6|||
143074710|NCT04874636|515812760|FG001|Overall Study|Withdrawal by Subject|5|||
143074711|NCT03258853|515812761|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
143074712|NCT03258853|515812762|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
143074713|NCT03982199|515812767|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
143074714|NCT03982199|515812768|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
143171820|NCT00419744|516178474|FG000|Overall Study|Lost to Follow-up|8|||
143171821|NCT00419744|516178475|FG001|Overall Study|Lost to Follow-up|10|||
143171822|NCT00419744|516178476|FG002|Overall Study|Lost to Follow-up|6|||
143171823|NCT00419744|516178474|FG000|Overall Study|Protocol Violation|4|||
143074715|NCT03982199|515812769|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
143074716|NCT03982199|515812770|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
143074717|NCT03982199|515812771|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
143074718|NCT03982199|515812772|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
143074719|NCT03982199|515812773|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
143074720|NCT03982199|515812774|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
143074721|NCT03982199|515812775|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
143074722|NCT03982199|515812776|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
143074723|NCT03982199|515812777|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
143074724|NCT03982199|515812778|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
143074725|NCT03982199|515812779|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
143074726|NCT03982199|515812780|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
143074727|NCT03982199|515812767|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
143074728|NCT03982199|515812768|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
143074729|NCT03982199|515812769|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
143074730|NCT03982199|515812770|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
143074731|NCT03982199|515812771|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
143074732|NCT03982199|515812772|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
143074733|NCT03982199|515812773|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
143074734|NCT03982199|515812774|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
143074735|NCT03982199|515812775|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
143074736|NCT03982199|515812776|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
143074737|NCT03982199|515812777|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
143074738|NCT03982199|515812778|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
143074739|NCT03982199|515812779|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
143074740|NCT03982199|515812780|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
143074741|NCT03982199|515812767|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
143074742|NCT03982199|515812768|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
143074743|NCT03982199|515812769|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
143074744|NCT03982199|515812770|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
143074745|NCT03982199|515812771|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
143074746|NCT03982199|515812772|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
143074747|NCT03982199|515812773|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
143074748|NCT03982199|515812774|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
143074749|NCT03982199|515812775|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
143074750|NCT03982199|515812776|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
143074751|NCT03982199|515812777|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
143074752|NCT03982199|515812778|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
143074753|NCT03982199|515812779|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
143074754|NCT03982199|515812780|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
143074755|NCT03982199|515812767|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
143074756|NCT03982199|515812768|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
143074757|NCT03982199|515812769|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
143074758|NCT03982199|515812770|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
143074759|NCT03982199|515812771|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
143074760|NCT03982199|515812772|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
143074761|NCT03982199|515812773|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
143074762|NCT03982199|515812774|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
143074763|NCT03982199|515812775|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
143074764|NCT03982199|515812776|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
143074765|NCT03982199|515812777|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
143074766|NCT03982199|515812778|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
143074767|NCT03982199|515812779|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
143074768|NCT03982199|515812780|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
143171824|NCT00419744|516178475|FG001|Overall Study|Protocol Violation|7|||
143074769|NCT03982199|515812767|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
143074770|NCT03982199|515812768|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
143074771|NCT03982199|515812769|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
143074772|NCT03982199|515812770|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
143074773|NCT03982199|515812771|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
143074774|NCT03982199|515812772|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
143074775|NCT03982199|515812773|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
143074776|NCT03982199|515812774|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
143074777|NCT03982199|515812775|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
143074778|NCT03982199|515812776|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
143074779|NCT03982199|515812777|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
143074780|NCT03982199|515812778|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
143074781|NCT03982199|515812779|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
143074782|NCT03982199|515812780|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
143074783|NCT03982199|515812767|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
143074784|NCT03982199|515812768|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
143074785|NCT03982199|515812769|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
143074786|NCT03982199|515812770|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
143074787|NCT03982199|515812771|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
143074788|NCT03982199|515812772|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
143074789|NCT03982199|515812773|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
143074790|NCT03982199|515812774|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
143074791|NCT03982199|515812775|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
143074792|NCT03982199|515812776|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
143074793|NCT03982199|515812777|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
143074794|NCT03982199|515812778|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
143074795|NCT03982199|515812779|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
143074796|NCT03982199|515812780|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
143074797|NCT03982199|515812767|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
143074798|NCT03982199|515812768|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
143074799|NCT03982199|515812769|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
143074800|NCT03982199|515812770|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
143074801|NCT03982199|515812771|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
143074802|NCT03982199|515812772|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
143074803|NCT03982199|515812773|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
143074804|NCT03982199|515812774|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
143074805|NCT03982199|515812775|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
143074806|NCT03982199|515812776|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
143074807|NCT03982199|515812777|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
143074808|NCT03982199|515812778|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
143074809|NCT03982199|515812779|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
143074810|NCT03982199|515812780|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
143074811|NCT03982199|515812767|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
143074812|NCT03982199|515812768|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
143074813|NCT03982199|515812769|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
143074814|NCT03982199|515812770|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
143074815|NCT03982199|515812771|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
143074816|NCT03982199|515812772|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
143074817|NCT03982199|515812773|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
143074818|NCT03982199|515812774|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
143074819|NCT03982199|515812775|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
143074820|NCT03982199|515812776|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
143074821|NCT03982199|515812777|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
143074822|NCT03982199|515812778|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
143074823|NCT03982199|515812779|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
143074824|NCT03982199|515812780|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
143171825|NCT00419744|516178476|FG002|Overall Study|Protocol Violation|8|||
143171826|NCT00419744|516178474|FG000|Overall Study|Randomized in error|9|||
143171827|NCT00419744|516178475|FG001|Overall Study|Randomized in error|6|||
143171828|NCT00419744|516178476|FG002|Overall Study|Randomized in error|7|||
143171829|NCT00419744|516178474|FG000|Overall Study|Moving out of state|2|||
143171830|NCT00419744|516178475|FG001|Overall Study|Moving out of state|0|||
143074825|NCT03982199|515812767|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
143074826|NCT03982199|515812768|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
143074827|NCT03982199|515812769|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
143171831|NCT00419744|516178476|FG002|Overall Study|Moving out of state|1|||
143171832|NCT00419744|516178474|FG000|Overall Study|Physician Decision|10|||
143171833|NCT00419744|516178475|FG001|Overall Study|Physician Decision|5|||
143074828|NCT03982199|515812770|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
143074829|NCT03982199|515812771|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
143074830|NCT03982199|515812772|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
143074831|NCT03982199|515812773|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
143074832|NCT03982199|515812774|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
143074833|NCT03982199|515812775|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
143074834|NCT03982199|515812776|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
143074835|NCT03982199|515812777|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
143074836|NCT03982199|515812778|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
143074837|NCT03982199|515812779|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
143074838|NCT03982199|515812780|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
143074839|NCT03982199|515812767|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
143074840|NCT03982199|515812768|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
143074841|NCT03982199|515812769|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
143074842|NCT03982199|515812770|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
143171834|NCT00419744|516178476|FG002|Overall Study|Physician Decision|6|||
143171835|NCT00419744|516178474|FG000|Overall Study|Spirometry mouthpiece issues|0|||
143171836|NCT00419744|516178475|FG001|Overall Study|Spirometry mouthpiece issues|1|||
143171837|NCT00419744|516178476|FG002|Overall Study|Spirometry mouthpiece issues|2|||
143171838|NCT00419744|516178474|FG000|Overall Study|Incorrect medication kit dispensed|0|||
143171839|NCT00419744|516178475|FG001|Overall Study|Incorrect medication kit dispensed|0|||
143171840|NCT00419744|516178476|FG002|Overall Study|Incorrect medication kit dispensed|1|||
143171841|NCT00335829|516178484|FG000|Overall Study|Withdrawal by Subject|1|||
143171842|NCT00335829|516178484|FG000|Overall Study|Lost to Follow-up|1|||
143171843|NCT00335829|516178484|FG000|Overall Study|Adverse Event|1|||
143171844|NCT02006927|516178485|FG000|Overall Study|Adverse Event|2|||
143171845|NCT02006927|516178485|FG000|Overall Study|Withdrawal by Subject|1|||
143171846|NCT02735200|516178488|FG000|Overall Study|Lost to Follow-up|0|||
143171847|NCT02735200|516178489|FG001|Overall Study|Lost to Follow-up|5|||
143171848|NCT02735200|516178488|FG000|Overall Study|Withdrawal by Subject|8|||
143171849|NCT02735200|516178489|FG001|Overall Study|Withdrawal by Subject|0|||
143171850|NCT02746809|516178490|FG000|Enrollment|Inclusion Exclusion not met|9|||
143171851|NCT02746809|516178490|FG000|Enrollment|Withdrawal by Subject|1|||
143171852|NCT02746809|516178490|FG000|Enrollment|Expected Enrollment Met|2|||
143171853|NCT02746809|516178490|FG000|Procedure|Death|1|||
143171854|NCT02746809|516178490|FG000|1-Month|Death|5|||
143171855|NCT02746809|516178490|FG000|6-Month|Death|2|||
143171856|NCT02746809|516178490|FG000|6-Month|Withdrawal by Subject|1|||
143171857|NCT02746809|516178490|FG000|12-Month|Death|3|||
143171858|NCT02746809|516178490|FG000|12-Month|Withdrawal by Subject|2|||
143171859|NCT02746809|516178490|FG000|24-Month|Death|1|||
143171860|NCT02746809|516178490|FG000|24-Month|Withdrawal by Subject|1|||
143171861|NCT02746809|516178490|FG000|36-Month|Death|8|||
143171862|NCT02746809|516178490|FG000|36-Month|Withdrawal by Subject|1|||
143171863|NCT02746809|516178490|FG000|48-Month|Death|7|||
143171864|NCT02746809|516178490|FG000|48-Month|Withdrawal by Subject|1|||
143074843|NCT03982199|515812771|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
143074844|NCT03982199|515812772|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
143074845|NCT03982199|515812773|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
143074846|NCT03982199|515812774|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
143074847|NCT03982199|515812775|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
143074848|NCT03982199|515812776|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
143074849|NCT03982199|515812777|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
143074850|NCT03982199|515812778|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
143074851|NCT03982199|515812779|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
143074852|NCT03982199|515812780|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
143171865|NCT02746809|516178490|FG000|60-Month|Death|1|||
143171866|NCT02746809|516178490|FG000|60-Month|Lost to Follow-up|2|||
143171867|NCT01164007|516178493|FG000|Overall Study|Adverse Event|5|||
143171868|NCT01164007|516178493|FG000|Overall Study|Progression of Disease|30|||
143171869|NCT01164007|516178493|FG000|Overall Study|Protocol Violation|1|||
143171870|NCT01164007|516178493|FG000|Overall Study|Withdrawal by Subject|1|||
143171871|NCT01164007|516178493|FG000|Overall Study|Medical Decision|3|||
143171872|NCT00894387|516178494|FG000|Overall Study|Adverse Event|44|||
143171873|NCT00894387|516178495|FG001|Overall Study|Adverse Event|45|||
143074853|NCT03982199|515812767|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
143074854|NCT03982199|515812768|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
143074855|NCT03982199|515812769|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
143074856|NCT03982199|515812770|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
143074857|NCT03982199|515812771|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
143074858|NCT03982199|515812772|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
143074859|NCT03982199|515812773|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
143074860|NCT03982199|515812774|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
143074861|NCT03982199|515812775|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
143074862|NCT03982199|515812776|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
143074863|NCT03982199|515812777|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
143074864|NCT03982199|515812778|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
143074865|NCT03982199|515812779|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
143074866|NCT03982199|515812780|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
143074867|NCT03982199|515812767|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
143074868|NCT03982199|515812768|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
143074869|NCT03982199|515812769|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
143074870|NCT03982199|515812770|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
143074871|NCT03982199|515812771|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
143074872|NCT03982199|515812772|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
143074873|NCT03982199|515812773|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
143074874|NCT03982199|515812774|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
143074875|NCT03982199|515812775|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
143074876|NCT03982199|515812776|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
143074877|NCT03982199|515812777|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
143074878|NCT03982199|515812778|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
143074879|NCT03982199|515812779|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
143074880|NCT03982199|515812780|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
143074881|NCT03982199|515812767|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
143074882|NCT03982199|515812768|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
143074883|NCT03982199|515812769|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
143074884|NCT03982199|515812770|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
143074885|NCT03982199|515812771|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
143074886|NCT03982199|515812772|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
143074887|NCT03982199|515812773|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
143074888|NCT03982199|515812774|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
143074889|NCT03982199|515812775|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
143074890|NCT03982199|515812776|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
143074891|NCT03982199|515812777|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
143074892|NCT03982199|515812778|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
143074893|NCT03982199|515812779|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
143074894|NCT03982199|515812780|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
143074895|NCT03982199|515812767|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
143074896|NCT03982199|515812768|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
143074897|NCT03982199|515812769|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
143074898|NCT03982199|515812770|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
143074899|NCT03982199|515812771|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
143074900|NCT03982199|515812772|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
143171874|NCT00894387|516178494|FG000|Overall Study|Abnormal Laboratory values|2|||
143074901|NCT03982199|515812773|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
143171875|NCT00894387|516178495|FG001|Overall Study|Abnormal Laboratory values|2|||
143171876|NCT00894387|516178494|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
143171877|NCT00894387|516178495|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
143171878|NCT00894387|516178494|FG000|Overall Study|Lost to Follow-up|3|||
143171879|NCT00894387|516178495|FG001|Overall Study|Lost to Follow-up|5|||
143171880|NCT00894387|516178494|FG000|Overall Study|Administrative problems|2|||
143171881|NCT00894387|516178495|FG001|Overall Study|Administrative problems|2|||
143171882|NCT00894387|516178494|FG000|Overall Study|Death|77|||
143074902|NCT03982199|515812774|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
143074903|NCT03982199|515812775|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
143074904|NCT03982199|515812776|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
143074905|NCT03982199|515812777|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
143074906|NCT03982199|515812778|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
143074907|NCT03982199|515812779|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
143074908|NCT03982199|515812780|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
143074909|NCT03982199|515812767|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
143074910|NCT03982199|515812768|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
143074911|NCT03982199|515812769|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
143074912|NCT03982199|515812770|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
143074913|NCT03982199|515812771|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
143074914|NCT03982199|515812772|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
143074915|NCT03982199|515812773|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
143074916|NCT03982199|515812774|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
143074917|NCT03982199|515812775|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
143074918|NCT03982199|515812776|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
143074919|NCT03982199|515812777|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
143074920|NCT03982199|515812778|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
143074921|NCT03982199|515812779|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
143074922|NCT03982199|515812780|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
143074923|NCT03982199|515812767|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
143074924|NCT03982199|515812768|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
143074925|NCT03982199|515812769|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
143074926|NCT03982199|515812770|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
143074927|NCT03982199|515812771|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
143074928|NCT03982199|515812772|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
143074929|NCT03982199|515812773|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
143074930|NCT03982199|515812774|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
143074931|NCT03982199|515812775|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
143074932|NCT03982199|515812776|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
143074933|NCT03982199|515812777|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
143074934|NCT03982199|515812778|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
143074935|NCT03982199|515812779|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
143074936|NCT03982199|515812780|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
143074937|NCT03982199|515812767|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
143074938|NCT03982199|515812768|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
143074939|NCT03982199|515812769|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
143074940|NCT03982199|515812770|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
143074941|NCT03982199|515812771|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
143074942|NCT03982199|515812772|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
143074943|NCT03982199|515812773|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
143074944|NCT03982199|515812774|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
143074945|NCT03982199|515812775|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
143074946|NCT03982199|515812776|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
143074947|NCT03982199|515812777|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
143074948|NCT03982199|515812778|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
143074949|NCT03982199|515812779|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
143074950|NCT03982199|515812780|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
143074951|NCT03982199|515812767|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
143074952|NCT03982199|515812768|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
143074953|NCT03982199|515812769|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
143074954|NCT03982199|515812770|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
143074955|NCT03982199|515812771|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
143074956|NCT03982199|515812772|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
143074957|NCT03982199|515812773|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
143074958|NCT03982199|515812774|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
143074959|NCT03982199|515812775|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
143074960|NCT03982199|515812776|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
143074961|NCT03982199|515812777|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
143074962|NCT03982199|515812778|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
143074963|NCT03982199|515812779|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
143074964|NCT03982199|515812780|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
143074965|NCT03982199|515812767|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
143074966|NCT03982199|515812768|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
143074967|NCT03982199|515812769|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
143074968|NCT03982199|515812770|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
143074969|NCT03982199|515812771|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
143074970|NCT03982199|515812772|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
143074971|NCT03982199|515812773|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
143074972|NCT03982199|515812774|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
143074973|NCT03982199|515812775|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
143074974|NCT03982199|515812776|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
143074975|NCT03982199|515812777|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
143074976|NCT03982199|515812778|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
143074977|NCT03982199|515812779|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
143074978|NCT03982199|515812780|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
143074979|NCT03982199|515812767|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
143074980|NCT03982199|515812768|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
143171883|NCT00894387|516178495|FG001|Overall Study|Death|76|||
143171884|NCT00894387|516178494|FG000|Overall Study|Protocol Deviation|4|||
143171885|NCT00894387|516178495|FG001|Overall Study|Protocol Deviation|0|||
143171886|NCT00894387|516178494|FG000|Overall Study|Patient's request|25|||
143171887|NCT00894387|516178495|FG001|Overall Study|Patient's request|30|||
143171888|NCT00894387|516178494|FG000|Overall Study|Other (Missing)|5|||
143171889|NCT00894387|516178495|FG001|Overall Study|Other (Missing)|3|||
143171890|NCT00894387|516178494|FG000|Overall Study|Mis-randomized|13|||
143171891|NCT00894387|516178495|FG001|Overall Study|Mis-randomized|9|||
143171892|NCT00894387|516178494|FG000|Overall Study|GCP non-compliance|0|||
143171893|NCT00894387|516178495|FG001|Overall Study|GCP non-compliance|2|||
143171894|NCT04856527|516178496|FG000|Overall Study|Unable to complete experimental task|2|||
143074981|NCT03982199|515812769|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
143074982|NCT03982199|515812770|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
143074983|NCT03982199|515812771|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
143074984|NCT03982199|515812772|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
143074985|NCT03982199|515812773|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
143074986|NCT03982199|515812774|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
143074987|NCT03982199|515812775|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
143074988|NCT03982199|515812776|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
143074989|NCT03982199|515812777|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
143074990|NCT03982199|515812778|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
143074991|NCT03982199|515812779|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
143171895|NCT04856527|516178497|FG001|Overall Study|Unable to complete experimental task|0|||
143171896|NCT05136170|516178500|FG000|Overall Study|Withdrawal by Subject|2|||
143171897|NCT05136170|516178501|FG001|Overall Study|Withdrawal by Subject|2|||
143171898|NCT05136170|516178500|FG000|Overall Study|Can no longer make office visits|1|||
143074992|NCT03982199|515812780|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
143074993|NCT03982199|515812767|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
143074994|NCT03982199|515812768|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
143074995|NCT03982199|515812769|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
143074996|NCT03982199|515812770|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
143074997|NCT03982199|515812771|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
143074998|NCT03982199|515812772|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
143074999|NCT03982199|515812773|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
143075000|NCT03982199|515812774|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
143075001|NCT03982199|515812775|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
143075002|NCT03982199|515812776|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
143075003|NCT03982199|515812777|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
143075004|NCT03982199|515812778|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
143075005|NCT03982199|515812779|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
143075006|NCT03982199|515812780|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
143075007|NCT03982199|515812767|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
143075008|NCT03982199|515812768|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
143075009|NCT03982199|515812769|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
143075010|NCT03982199|515812770|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
143075011|NCT03982199|515812771|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
143075012|NCT03982199|515812772|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
143075013|NCT03982199|515812773|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
143075014|NCT03982199|515812774|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
143075015|NCT03982199|515812775|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
143075016|NCT03982199|515812776|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
143075017|NCT03982199|515812777|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
143075018|NCT03982199|515812778|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
143075019|NCT03982199|515812779|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
143171899|NCT05136170|516178501|FG001|Overall Study|Can no longer make office visits|0|||
143171900|NCT01463527|516178502|FG000|Overall Study|Protocol Violation|1|||
143171901|NCT01463527|516178503|FG001|Overall Study|Protocol Violation|1|||
143171902|NCT01463527|516178502|FG000|Overall Study|Crying >20% of sedation|5|||
143171903|NCT01463527|516178503|FG001|Overall Study|Crying >20% of sedation|6|||
143171904|NCT01493414|516178506|FG000|Overall Study|Adverse Event|405|||
143171905|NCT01493414|516178506|FG000|Overall Study|Disease progression|204|||
143171906|NCT01493414|516178506|FG000|Overall Study|Death|101|||
143171907|NCT01493414|516178506|FG000|Overall Study|Physician Decision|93|||
143171908|NCT01493414|516178506|FG000|Overall Study|Withdrawal by Subject|79|||
143171909|NCT01493414|516178506|FG000|Overall Study|Protocol deviation|27|||
143171910|NCT01493414|516178506|FG000|Overall Study|Administrative problems|25|||
143171911|NCT01493414|516178506|FG000|Overall Study|Lost to Follow-up|16|||
143171912|NCT01977222|516178509|FG000|Overall Study|Withdrawal by Subject|1|||
143171913|NCT04165824|516178510|FG000|Overall Study|Adverse Event|23|||
143171914|NCT04165824|516178510|FG000|Overall Study|Physician Decision|1|||
143171915|NCT04165824|516178510|FG000|Overall Study|Withdrawal by Subject|17|||
143171916|NCT04165824|516178510|FG000|Overall Study|Other|5|||
143171917|NCT04403919|516178511|FG000|Overall Study|Lost to Follow-up|0|||
143171918|NCT04403919|516178512|FG001|Overall Study|Lost to Follow-up|0|||
143171919|NCT04403919|516178513|FG002|Overall Study|Lost to Follow-up|0|||
143171920|NCT04403919|516178514|FG003|Overall Study|Lost to Follow-up|1|||
143171921|NCT03746015|516178516|FG000|Overall Study|Withdrawal of Consent|1|||
143171922|NCT03746015|516178517|FG001|Overall Study|Withdrawal of Consent|0|||
143171923|NCT03746015|516178518|FG002|Overall Study|Withdrawal of Consent|0|||
143171924|NCT00829244|516178520|FG000|Overall Study|Adverse Event|1|||
143171925|NCT00829244|516178521|FG001|Overall Study|Adverse Event|3|||
143075020|NCT03982199|515812780|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
143171926|NCT00829244|516178520|FG000|Overall Study|Protocol Violation|1|||
143171927|NCT00829244|516178521|FG001|Overall Study|Protocol Violation|0|||
143171928|NCT00829244|516178520|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
143171929|NCT00829244|516178521|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
143075021|NCT03982199|515812767|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
143075022|NCT03982199|515812768|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
143075023|NCT03982199|515812769|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
143075024|NCT03982199|515812770|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
143075025|NCT03982199|515812771|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
143075026|NCT03982199|515812772|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
143075027|NCT03982199|515812773|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
143075028|NCT03982199|515812774|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
143075029|NCT03982199|515812775|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
143075030|NCT03982199|515812776|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
143248511|NCT01708902|516462985|FG000|Overall Study|Other Reason|1|||
143248512|NCT01708902|516462986|FG001|Overall Study|Other Reason|0|||
143075031|NCT03982199|515812777|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
143075032|NCT03982199|515812778|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
143075033|NCT03982199|515812779|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
143075034|NCT03982199|515812780|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
143075035|NCT03982199|515812767|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
143075036|NCT03982199|515812768|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
143248513|NCT01708902|516462987|FG002|Overall Study|Other Reason|1|||
143248514|NCT01708902|516462988|FG003|Overall Study|Other Reason|1|||
143075037|NCT03982199|515812769|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
143075038|NCT03982199|515812770|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
143075039|NCT03982199|515812771|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
143075040|NCT03982199|515812772|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
143075041|NCT03982199|515812773|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
143075042|NCT03982199|515812774|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
143075043|NCT03982199|515812775|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
143075044|NCT03982199|515812776|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
143075045|NCT03982199|515812777|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
143075046|NCT03982199|515812778|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
143075047|NCT03982199|515812779|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
143075048|NCT03982199|515812780|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
143075049|NCT03982199|515812767|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
143248515|NCT01708902|516462989|FG004|Overall Study|Other Reason|1|||
143248516|NCT01708902|516462990|FG005|Overall Study|Other Reason|2|||
143248517|NCT01708902|516462991|FG006|Overall Study|Other Reason|0|||
143075050|NCT03982199|515812768|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
143075051|NCT03982199|515812769|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
143248518|NCT00499590|516462992|FG000|Overall Study|Study Terminated|112|||
143365735|NCT01362491|516882921|FG002|Overall Study|Ineligible|0|||
143365736|NCT01257503|516882922|FG000|Overall Study|Lost to Follow-up|7|||
143365737|NCT01257503|516882923|FG001|Overall Study|Lost to Follow-up|10|||
143365738|NCT01257503|516882922|FG000|Overall Study|Over 5 years old at enrollment|0|||
143365739|NCT01257503|516882923|FG001|Overall Study|Over 5 years old at enrollment|1|||
143365740|NCT01257503|516882922|FG000|Overall Study|strep culture positive at enrollment|1|||
143365741|NCT01257503|516882923|FG001|Overall Study|strep culture positive at enrollment|0|||
143365742|NCT04867902|516882924|FG000|Overall Study|Lost to Follow-up|1|||
143365743|NCT04867902|516882924|FG000|Overall Study|Withdrawal by Subject|2|||
143365744|NCT04867902|516882924|FG000|Overall Study|Protocol Violation|1|||
143365745|NCT05355116|516882925|FG000|Overall Study|Withdrawal by Subject|2|||
143075052|NCT03982199|515812770|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
143075053|NCT03982199|515812771|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
143075054|NCT03982199|515812772|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
143075055|NCT03982199|515812773|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
143075056|NCT03982199|515812774|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
143075057|NCT03982199|515812775|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
143075058|NCT03982199|515812776|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
143075059|NCT03982199|515812777|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
143075060|NCT03982199|515812778|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
143075061|NCT03982199|515812779|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
143075062|NCT03982199|515812780|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
143075063|NCT03982199|515812767|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
143075064|NCT03982199|515812768|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
143171930|NCT00829244|516178520|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
143365746|NCT01474538|516882926|FG000|Treatment Period 1|Death|1|||
143365747|NCT01474538|516882927|FG001|Treatment Period 1|Death|0|||
143365748|NCT01474538|516882926|FG000|Treatment Period 1|Physician Decision|1|||
143171931|NCT00829244|516178521|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
143171932|NCT00829244|516178520|FG000|Overall Study|No fertilization|2|||
143171933|NCT00829244|516178521|FG001|Overall Study|No fertilization|2|||
143365749|NCT01474538|516882927|FG001|Treatment Period 1|Physician Decision|0|||
143365750|NCT01474538|516882926|FG000|Treatment Period 1|Withdrawal by Subject|1|||
143365751|NCT01474538|516882927|FG001|Treatment Period 1|Withdrawal by Subject|3|||
143365752|NCT01474538|516882926|FG000|Treatment Period 1|Protocol Violation|0|||
143365753|NCT01474538|516882927|FG001|Treatment Period 1|Protocol Violation|1|||
143171934|NCT00829244|516178520|FG000|Overall Study|All embryos discarded|0|||
143171935|NCT00829244|516178521|FG001|Overall Study|All embryos discarded|3|||
143171936|NCT00829244|516178520|FG000|Overall Study|No embryo cleavage|0|||
143365754|NCT01474538|516882926|FG000|Treatment Period 2|Death|1|||
143365755|NCT01474538|516882927|FG001|Treatment Period 2|Death|0|||
143365756|NCT01474538|516882926|FG000|Treatment Period 2|Adverse Event|1|||
143365757|NCT01474538|516882927|FG001|Treatment Period 2|Adverse Event|1|||
143365758|NCT01474538|516882926|FG000|Treatment Period 2|Withdrawal by Subject|2|||
143365759|NCT01474538|516882927|FG001|Treatment Period 2|Withdrawal by Subject|0|||
143075065|NCT03982199|515812769|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
143075066|NCT03982199|515812770|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
143075067|NCT03982199|515812771|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
143075068|NCT03982199|515812772|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
143075069|NCT03982199|515812773|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
143075070|NCT03982199|515812774|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
143075071|NCT03982199|515812775|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
143075072|NCT03982199|515812776|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
143075073|NCT03982199|515812777|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
143075074|NCT03982199|515812778|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
143075075|NCT03982199|515812779|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
143075076|NCT03982199|515812780|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
143075077|NCT03982199|515812767|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
143075078|NCT03982199|515812768|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
143075079|NCT03982199|515812769|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
143075080|NCT03982199|515812770|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
143075081|NCT03982199|515812771|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
143075082|NCT03982199|515812772|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
143075083|NCT03982199|515812773|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
143075084|NCT03982199|515812774|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
143075085|NCT03982199|515812775|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
143075086|NCT03982199|515812776|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
143075087|NCT03982199|515812777|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
143075088|NCT03982199|515812778|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
143075089|NCT03982199|515812779|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
143075090|NCT03982199|515812780|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
143075091|NCT03982199|515812767|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
143075092|NCT03982199|515812768|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
143075093|NCT03982199|515812769|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
143075094|NCT03982199|515812770|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
143075095|NCT03982199|515812771|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
143075096|NCT03982199|515812772|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
143075097|NCT03982199|515812773|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
143075098|NCT03982199|515812774|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
143075099|NCT03982199|515812775|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
143075100|NCT03982199|515812776|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
143075101|NCT03982199|515812777|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
143248519|NCT00499590|516462993|FG001|Overall Study|Study Terminated|112|||
143248520|NCT00499590|516462994|FG002|Overall Study|Study Terminated|112|||
143248521|NCT00499590|516462992|FG000|Overall Study|Not treated|1|||
143248522|NCT00499590|516462993|FG001|Overall Study|Not treated|0|||
143248523|NCT00499590|516462994|FG002|Overall Study|Not treated|1|||
143248524|NCT02633020|516462996|FG000|Overall Study|Adverse Event|1|||
143248525|NCT02633020|516462997|FG001|Overall Study|Adverse Event|0|||
143248526|NCT02152956|516462998|FG000|Overall Study|Adverse Event|0|||
143171937|NCT00829244|516178521|FG001|Overall Study|No embryo cleavage|2|||
143171938|NCT03213509|516178522|FG000|Overall Study|Did not consent for verbal autopsy|4|||
143171939|NCT03213509|516178523|FG001|Overall Study|Did not consent for verbal autopsy|5|||
143171940|NCT00016354|516178524|FG000|Overall Study|Lack of Efficacy|0|||
143171941|NCT00016354|516178525|FG001|Overall Study|Lack of Efficacy|0|||
143171942|NCT00016354|516178526|FG002|Overall Study|Lack of Efficacy|0|||
143171943|NCT00016354|516178527|FG003|Overall Study|Lack of Efficacy|0|||
143171944|NCT00016354|516178528|FG004|Overall Study|Lack of Efficacy|0|||
143171945|NCT00016354|516178529|FG005|Overall Study|Lack of Efficacy|0|||
143248527|NCT02152956|516462999|FG001|Overall Study|Adverse Event|0|||
143248528|NCT02152956|516463000|FG002|Overall Study|Adverse Event|0|||
143248529|NCT02152956|516463001|FG003|Overall Study|Adverse Event|0|||
143248530|NCT02152956|516463002|FG004|Overall Study|Adverse Event|0|||
143248531|NCT02152956|516463003|FG005|Overall Study|Adverse Event|0|||
143248532|NCT02152956|516463004|FG006|Overall Study|Adverse Event|0|||
143248533|NCT02152956|516463005|FG007|Overall Study|Adverse Event|0|||
143171946|NCT00016354|516178530|FG006|Overall Study|Lack of Efficacy|0|||
143248534|NCT02152956|516463006|FG008|Overall Study|Adverse Event|0|||
143248535|NCT02152956|516463007|FG009|Overall Study|Adverse Event|0|||
143248536|NCT02152956|516463008|FG010|Overall Study|Adverse Event|0|||
143248537|NCT02152956|516463009|FG011|Overall Study|Adverse Event|4|||
143248538|NCT02152956|516463010|FG012|Overall Study|Adverse Event|0|||
143171947|NCT00016354|516178531|FG007|Overall Study|Lack of Efficacy|1|||
143171948|NCT04756531|516178534|FG000|Overall Study|Adverse Event|0|||
143248539|NCT02152956|516462998|FG000|Overall Study|Death|0|||
143248540|NCT02152956|516462999|FG001|Overall Study|Death|3|||
143075102|NCT03982199|515812778|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
143075103|NCT03982199|515812779|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
143075104|NCT03982199|515812780|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
143075105|NCT03982199|515812767|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
143075106|NCT03982199|515812768|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
143075107|NCT03982199|515812769|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
143075108|NCT03982199|515812770|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
143075109|NCT03982199|515812771|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
143075110|NCT03982199|515812772|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
143075111|NCT03982199|515812773|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
143075112|NCT03982199|515812774|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
143075113|NCT03982199|515812775|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
143075114|NCT03982199|515812776|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
143075115|NCT03982199|515812777|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
143075116|NCT03982199|515812778|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
143075117|NCT03982199|515812779|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
143075118|NCT03982199|515812780|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
143075119|NCT03982199|515812767|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
143075120|NCT03982199|515812768|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
143075121|NCT03982199|515812769|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
143075122|NCT03982199|515812770|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
143075123|NCT03982199|515812771|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
143075124|NCT03982199|515812772|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
143075125|NCT03982199|515812773|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
143075126|NCT03982199|515812774|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
143075127|NCT03982199|515812775|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
143075128|NCT03982199|515812776|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
143075129|NCT03982199|515812777|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
143075130|NCT03982199|515812778|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
143075131|NCT03982199|515812779|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
143075132|NCT03982199|515812780|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
143075133|NCT03982199|515812767|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
143075134|NCT03982199|515812768|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
143075135|NCT03982199|515812769|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
143075136|NCT03982199|515812770|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
143075137|NCT03982199|515812771|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
143075138|NCT03982199|515812772|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
143075139|NCT03982199|515812773|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
143075140|NCT03982199|515812774|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
143075141|NCT03982199|515812775|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
143075142|NCT03982199|515812776|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
143171949|NCT04756531|516178535|FG001|Overall Study|Adverse Event|0|||
143171950|NCT04756531|516178536|FG002|Overall Study|Adverse Event|0|||
143171951|NCT04756531|516178537|FG003|Overall Study|Adverse Event|0|||
143171952|NCT04756531|516178538|FG004|Overall Study|Adverse Event|1|||
143171953|NCT04756531|516178539|FG005|Overall Study|Adverse Event|0|||
143171954|NCT04756531|516178540|FG006|Overall Study|Adverse Event|0|||
143171955|NCT04756531|516178541|FG007|Overall Study|Adverse Event|0|||
143171956|NCT04756531|516178542|FG008|Overall Study|Adverse Event|0|||
143171957|NCT04756531|516178543|FG009|Overall Study|Adverse Event|0|||
143171958|NCT04756531|516178544|FG010|Overall Study|Adverse Event|0|||
143171959|NCT04756531|516178545|FG011|Overall Study|Adverse Event|0|||
143171960|NCT04756531|516178546|FG012|Overall Study|Adverse Event|0|||
143171961|NCT04756531|516178547|FG013|Overall Study|Adverse Event|0|||
143171962|NCT04756531|516178548|FG014|Overall Study|Adverse Event|0|||
143171963|NCT04756531|516178549|FG015|Overall Study|Adverse Event|0|||
143171964|NCT04756531|516178550|FG016|Overall Study|Adverse Event|0|||
143171965|NCT04756531|516178551|FG017|Overall Study|Adverse Event|0|||
143171966|NCT04756531|516178534|FG000|Overall Study|Withdrawal by Subject|0|||
143171967|NCT04756531|516178535|FG001|Overall Study|Withdrawal by Subject|0|||
143171968|NCT04756531|516178536|FG002|Overall Study|Withdrawal by Subject|0|||
143171969|NCT04756531|516178537|FG003|Overall Study|Withdrawal by Subject|0|||
143171970|NCT04756531|516178538|FG004|Overall Study|Withdrawal by Subject|0|||
143171971|NCT04756531|516178539|FG005|Overall Study|Withdrawal by Subject|0|||
143171972|NCT04756531|516178540|FG006|Overall Study|Withdrawal by Subject|1|||
143171973|NCT04756531|516178541|FG007|Overall Study|Withdrawal by Subject|0|||
143171974|NCT04756531|516178542|FG008|Overall Study|Withdrawal by Subject|0|||
143171975|NCT04756531|516178543|FG009|Overall Study|Withdrawal by Subject|0|||
143171976|NCT04756531|516178544|FG010|Overall Study|Withdrawal by Subject|0|||
143075143|NCT03982199|515812777|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
143075144|NCT03982199|515812778|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
143075145|NCT03982199|515812779|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
143075146|NCT03982199|515812780|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
143075147|NCT03982199|515812767|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
143075148|NCT03982199|515812768|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
143075149|NCT03982199|515812769|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
143075150|NCT03982199|515812770|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
143075151|NCT03982199|515812771|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
143075152|NCT03982199|515812772|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
143075153|NCT03982199|515812773|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
143075154|NCT03982199|515812774|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
143075155|NCT03982199|515812775|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
143075156|NCT03982199|515812776|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
143075157|NCT03982199|515812777|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
143075158|NCT03982199|515812778|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
143075159|NCT03982199|515812779|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
143075160|NCT03982199|515812780|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
143075161|NCT03982199|515812767|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
143075162|NCT03982199|515812768|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
143075163|NCT03982199|515812769|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
143248541|NCT02152956|516463000|FG002|Overall Study|Death|3|||
143248542|NCT02152956|516463001|FG003|Overall Study|Death|4|||
143248543|NCT02152956|516463002|FG004|Overall Study|Death|1|||
143248544|NCT02152956|516463003|FG005|Overall Study|Death|2|||
143075164|NCT03982199|515812770|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
143248545|NCT02152956|516463004|FG006|Overall Study|Death|6|||
143171977|NCT04756531|516178545|FG011|Overall Study|Withdrawal by Subject|0|||
143171978|NCT04756531|516178546|FG012|Overall Study|Withdrawal by Subject|0|||
143171979|NCT04756531|516178547|FG013|Overall Study|Withdrawal by Subject|0|||
143171980|NCT04756531|516178548|FG014|Overall Study|Withdrawal by Subject|0|||
143171981|NCT04756531|516178549|FG015|Overall Study|Withdrawal by Subject|0|||
143171982|NCT04756531|516178550|FG016|Overall Study|Withdrawal by Subject|0|||
143171983|NCT04756531|516178551|FG017|Overall Study|Withdrawal by Subject|0|||
143171984|NCT05643495|516178552|FG000|Overall Study|Adverse Event|0|||
143171985|NCT05643495|516178553|FG001|Overall Study|Adverse Event|1|||
143171986|NCT05643495|516178552|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
143171987|NCT05643495|516178553|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
143171988|NCT02257528|516178554|FG000|Overall Study|Never received study treatment|1|||
143171989|NCT00789555|516178555|FG000|Overall Study|Protocol Amendment|78|||
143171990|NCT00789555|516178556|FG001|Overall Study|Protocol Amendment|76|||
143171991|NCT00789555|516178557|FG002|Overall Study|Protocol Amendment|80|||
143171992|NCT00789555|516178555|FG000|Overall Study|Adverse Event|17|||
143171993|NCT00789555|516178556|FG001|Overall Study|Adverse Event|7|||
143075165|NCT03982199|515812771|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
143075166|NCT03982199|515812772|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
143075167|NCT03982199|515812773|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
143075168|NCT03982199|515812774|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
143075169|NCT03982199|515812775|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
143075170|NCT03982199|515812776|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
143075171|NCT03982199|515812777|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
143075172|NCT03982199|515812778|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
143075173|NCT03982199|515812779|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
143075174|NCT03982199|515812780|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
143075175|NCT03433755|515812781|FG000|Overall Study|Lost to Follow-up|1|||
143075176|NCT03433755|515812782|FG001|Overall Study|Lost to Follow-up|0|||
143075177|NCT03433755|515812783|FG002|Overall Study|Lost to Follow-up|0|||
143075178|NCT03433755|515812784|FG003|Overall Study|Lost to Follow-up|0|||
143075179|NCT03433755|515812781|FG000|Overall Study|Decision by Sponsor|1|||
143075180|NCT03433755|515812782|FG001|Overall Study|Decision by Sponsor|0|||
143075181|NCT03433755|515812783|FG002|Overall Study|Decision by Sponsor|0|||
143075182|NCT03433755|515812784|FG003|Overall Study|Decision by Sponsor|0|||
143075183|NCT04994483|515814757|FG000|Overall Study|Adverse Event|26|||
143075184|NCT04994483|515814758|FG001|Overall Study|Adverse Event|17|||
143075185|NCT04994483|515814757|FG000|Overall Study|Lost to Follow-up|6|||
143075186|NCT04994483|515814758|FG001|Overall Study|Lost to Follow-up|10|||
143075187|NCT04994483|515814757|FG000|Overall Study|Noncompliance with study drug|8|||
143075188|NCT04994483|515814758|FG001|Overall Study|Noncompliance with study drug|5|||
143075189|NCT04994483|515814757|FG000|Overall Study|Physician Decision|5|||
143075190|NCT04994483|515814758|FG001|Overall Study|Physician Decision|0|||
143075191|NCT04994483|515814757|FG000|Overall Study|Withdrawal by Subject|41|||
143075192|NCT04994483|515814758|FG001|Overall Study|Withdrawal by Subject|38|||
143075193|NCT04994483|515814757|FG000|Overall Study|Sponsor requests subject to be withdrawn|2|||
143075194|NCT04994483|515814758|FG001|Overall Study|Sponsor requests subject to be withdrawn|1|||
143075195|NCT04994483|515814757|FG000|Overall Study|Met stopping criteria|1|||
143075196|NCT04994483|515814758|FG001|Overall Study|Met stopping criteria|0|||
143075197|NCT04994483|515814757|FG000|Overall Study|Randomized in error, not treated|4|||
143075198|NCT04994483|515814758|FG001|Overall Study|Randomized in error, not treated|3|||
143075199|NCT04994483|515814757|FG000|Overall Study|Lack of a reliable study partner|0|||
143075200|NCT04994483|515814758|FG001|Overall Study|Lack of a reliable study partner|1|||
143075201|NCT04994483|515814757|FG000|Overall Study|Met MRI exclusion criteria|0|||
143075202|NCT04994483|515814758|FG001|Overall Study|Met MRI exclusion criteria|1|||
143075203|NCT04240392|515814759|FG000|Overall Study|Withdrawal by Subject|13|||
143075204|NCT04240392|515814760|FG001|Overall Study|Withdrawal by Subject|4|||
143075205|NCT04240392|515814759|FG000|Overall Study|Lost to Follow-up|11|||
143075206|NCT04240392|515814760|FG001|Overall Study|Lost to Follow-up|12|||
143075207|NCT03589768|515814761|FG000|Overall Study|Death|1|||
143075208|NCT03589768|515814762|FG001|Overall Study|Death|0|||
143075209|NCT03589768|515814763|FG002|Overall Study|Death|8|||
143075210|NCT03589768|515814764|FG003|Overall Study|Death|3|||
143075211|NCT03589768|515814761|FG000|Overall Study|Withdrawal by Subject|2|||
143075212|NCT03589768|515814762|FG001|Overall Study|Withdrawal by Subject|0|||
143075213|NCT03589768|515814763|FG002|Overall Study|Withdrawal by Subject|0|||
143075214|NCT03589768|515814764|FG003|Overall Study|Withdrawal by Subject|0|||
143075215|NCT03589768|515814761|FG000|Overall Study|Protocol Violation|1|||
143075216|NCT03589768|515814762|FG001|Overall Study|Protocol Violation|0|||
143075217|NCT03589768|515814763|FG002|Overall Study|Protocol Violation|0|||
143075218|NCT03589768|515814764|FG003|Overall Study|Protocol Violation|0|||
143075219|NCT00112866|515814765|FG000|Overall Study|Protocol Violation|1|||
143075220|NCT00112866|515814766|FG001|Overall Study|Protocol Violation|0|||
143248546|NCT02152956|516463005|FG007|Overall Study|Death|6|||
143075221|NCT00112866|515814765|FG000|Overall Study|did not start treatment post-op|1|||
143075222|NCT00112866|515814766|FG001|Overall Study|did not start treatment post-op|2|||
143075223|NCT04663295|515814767|FG000|Run-in Period|Withdrawal by Subject|3|||
143075224|NCT04663295|515814767|FG000|Overall Study Period|Pregnancy|1|||
143075225|NCT04663295|515814767|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
143075226|NCT03665441|515814775|FG000|Overall Study|survival follow up ongoing|23|||
143075227|NCT03665441|515814776|FG001|Overall Study|survival follow up ongoing|0|||
143248547|NCT02152956|516463006|FG008|Overall Study|Death|4|||
143075228|NCT03665441|515814775|FG000|Overall Study|Patients ongoing on treatment|9|||
143075229|NCT03665441|515814776|FG001|Overall Study|Patients ongoing on treatment|6|||
143075230|NCT03665441|515814775|FG000|Overall Study|Randomized but not treated|7|||
143075231|NCT03665441|515814776|FG001|Overall Study|Randomized but not treated|11|||
143248548|NCT02152956|516463007|FG009|Overall Study|Death|5|||
143171994|NCT00789555|516178557|FG002|Overall Study|Adverse Event|10|||
143171995|NCT00789555|516178555|FG000|Overall Study|Lost to Follow-up|9|||
143171996|NCT00789555|516178556|FG001|Overall Study|Lost to Follow-up|10|||
143171997|NCT00789555|516178557|FG002|Overall Study|Lost to Follow-up|18|||
143171998|NCT00789555|516178555|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
143171999|NCT00789555|516178556|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
143172000|NCT00789555|516178557|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
143172001|NCT00789555|516178555|FG000|Overall Study|Treatment failure|11|||
143172002|NCT00789555|516178556|FG001|Overall Study|Treatment failure|8|||
143172003|NCT00789555|516178557|FG002|Overall Study|Treatment failure|12|||
143172004|NCT00789555|516178555|FG000|Overall Study|Protocol Violation|6|||
143172005|NCT00789555|516178556|FG001|Overall Study|Protocol Violation|9|||
143172006|NCT00789555|516178557|FG002|Overall Study|Protocol Violation|13|||
143172007|NCT04646005|516178561|FG000|Overall Study|Adverse Event|1|||
143172008|NCT04646005|516178561|FG000|Overall Study|Progressive Disease|71|||
143172009|NCT04646005|516178561|FG000|Overall Study|Death|20|||
143172010|NCT04646005|516178561|FG000|Overall Study|Withdrawal by Subject|12|||
143172011|NCT04646005|516178561|FG000|Overall Study|Sponsor Request|9|||
143172012|NCT04237584|516178562|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
143172013|NCT04237584|516178563|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
143172014|NCT04237584|516178564|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
143172015|NCT04237584|516178565|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
143172016|NCT04237584|516178562|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
143172017|NCT04237584|516178563|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
143172018|NCT04237584|516178564|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
143172019|NCT04237584|516178565|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
143172020|NCT04237584|516178562|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
143172021|NCT04237584|516178563|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
143172022|NCT04237584|516178564|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
143172023|NCT04237584|516178565|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
143172024|NCT04237584|516178562|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
143172025|NCT04237584|516178563|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
143172026|NCT04237584|516178564|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
143172027|NCT04237584|516178565|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
143172028|NCT04237584|516178562|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
143172029|NCT04237584|516178563|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
143075232|NCT00554190|515814777|FG000|Overall Study|Termination forms not completed|10|||
143075233|NCT00191113|515814778|FG000|Core Study|Withdrawal by Subject|25|||
143075234|NCT00191113|515814779|FG001|Core Study|Withdrawal by Subject|9|||
143075235|NCT00191113|515814778|FG000|Core Study|Protocol Violation|6|||
143075236|NCT00191113|515814779|FG001|Core Study|Protocol Violation|2|||
143075237|NCT00191113|515814778|FG000|Core Study|Lost to Follow-up|3|||
143075238|NCT00191113|515814779|FG001|Core Study|Lost to Follow-up|0|||
143248549|NCT02152956|516463008|FG010|Overall Study|Death|3|||
143248550|NCT02152956|516463009|FG011|Overall Study|Death|143|||
143075239|NCT00191113|515814778|FG000|Core Study|Adverse Event|0|||
143075240|NCT00191113|515814779|FG001|Core Study|Adverse Event|2|||
143075241|NCT00191113|515814778|FG000|Core Study|Lack of Efficacy|0|||
143075242|NCT00191113|515814779|FG001|Core Study|Lack of Efficacy|2|||
143075243|NCT00191113|515814778|FG000|Core Study|Death|1|||
143075244|NCT00191113|515814779|FG001|Core Study|Death|0|||
143248551|NCT02152956|516463010|FG012|Overall Study|Death|12|||
143172030|NCT04237584|516178564|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
143172031|NCT04237584|516178565|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
143172032|NCT05239221|516178566|FG000|Overall Study|Adverse Event|0|||
143172033|NCT05239221|516178567|FG001|Overall Study|Adverse Event|0|||
143172034|NCT05239221|516178568|FG002|Overall Study|Adverse Event|0|||
143172035|NCT05239221|516178569|FG003|Overall Study|Adverse Event|0|||
143172036|NCT05239221|516178570|FG004|Overall Study|Adverse Event|0|||
143172037|NCT05239221|516178571|FG005|Overall Study|Adverse Event|0|||
143172038|NCT05239221|516178572|FG006|Overall Study|Adverse Event|1|||
143172039|NCT05239221|516178573|FG007|Overall Study|Adverse Event|0|||
143172040|NCT05239221|516178574|FG008|Overall Study|Adverse Event|0|||
143172041|NCT05239221|516178575|FG009|Overall Study|Adverse Event|0|||
143172042|NCT05239221|516178576|FG010|Overall Study|Adverse Event|1|||
143172043|NCT05239221|516178577|FG011|Overall Study|Adverse Event|1|||
143172044|NCT05239221|516178578|FG012|Overall Study|Adverse Event|0|||
143172045|NCT05239221|516178579|FG013|Overall Study|Adverse Event|0|||
143172046|NCT05239221|516178580|FG014|Overall Study|Adverse Event|0|||
143172047|NCT05239221|516178581|FG015|Overall Study|Adverse Event|0|||
143248552|NCT02152956|516462998|FG000|Overall Study|Lost to Follow-up|0|||
143248553|NCT02152956|516462999|FG001|Overall Study|Lost to Follow-up|1|||
143248554|NCT02152956|516463000|FG002|Overall Study|Lost to Follow-up|0|||
143248555|NCT02152956|516463001|FG003|Overall Study|Lost to Follow-up|0|||
143248556|NCT02152956|516463002|FG004|Overall Study|Lost to Follow-up|0|||
143248557|NCT02152956|516463003|FG005|Overall Study|Lost to Follow-up|0|||
143248558|NCT02152956|516463004|FG006|Overall Study|Lost to Follow-up|0|||
143248559|NCT02152956|516463005|FG007|Overall Study|Lost to Follow-up|0|||
143248560|NCT02152956|516463006|FG008|Overall Study|Lost to Follow-up|0|||
143248561|NCT02152956|516463007|FG009|Overall Study|Lost to Follow-up|0|||
143248562|NCT02152956|516463008|FG010|Overall Study|Lost to Follow-up|0|||
143248563|NCT02152956|516463009|FG011|Overall Study|Lost to Follow-up|3|||
143248564|NCT02152956|516463010|FG012|Overall Study|Lost to Follow-up|0|||
143248565|NCT02152956|516462998|FG000|Overall Study|Withdrawal by Subject|1|||
143248566|NCT02152956|516462999|FG001|Overall Study|Withdrawal by Subject|0|||
143248567|NCT02152956|516463000|FG002|Overall Study|Withdrawal by Subject|1|||
143248568|NCT02152956|516463001|FG003|Overall Study|Withdrawal by Subject|0|||
143248569|NCT02152956|516463002|FG004|Overall Study|Withdrawal by Subject|2|||
143248570|NCT02152956|516463003|FG005|Overall Study|Withdrawal by Subject|2|||
143248571|NCT02152956|516463004|FG006|Overall Study|Withdrawal by Subject|0|||
143248572|NCT02152956|516463005|FG007|Overall Study|Withdrawal by Subject|0|||
143248573|NCT02152956|516463006|FG008|Overall Study|Withdrawal by Subject|1|||
143248574|NCT02152956|516463007|FG009|Overall Study|Withdrawal by Subject|0|||
143172048|NCT05239221|516178566|FG000|Overall Study|Withdrawal by Subject|0|||
143172049|NCT05239221|516178567|FG001|Overall Study|Withdrawal by Subject|0|||
143172050|NCT05239221|516178568|FG002|Overall Study|Withdrawal by Subject|0|||
143172051|NCT05239221|516178569|FG003|Overall Study|Withdrawal by Subject|0|||
143172052|NCT05239221|516178570|FG004|Overall Study|Withdrawal by Subject|0|||
143172053|NCT05239221|516178571|FG005|Overall Study|Withdrawal by Subject|0|||
143172054|NCT05239221|516178572|FG006|Overall Study|Withdrawal by Subject|0|||
143172055|NCT05239221|516178573|FG007|Overall Study|Withdrawal by Subject|0|||
143172056|NCT05239221|516178574|FG008|Overall Study|Withdrawal by Subject|0|||
143172057|NCT05239221|516178575|FG009|Overall Study|Withdrawal by Subject|0|||
143172058|NCT05239221|516178576|FG010|Overall Study|Withdrawal by Subject|1|||
143172059|NCT05239221|516178577|FG011|Overall Study|Withdrawal by Subject|0|||
143172060|NCT05239221|516178578|FG012|Overall Study|Withdrawal by Subject|0|||
143172061|NCT05239221|516178579|FG013|Overall Study|Withdrawal by Subject|0|||
143172062|NCT05239221|516178580|FG014|Overall Study|Withdrawal by Subject|0|||
143172063|NCT05239221|516178581|FG015|Overall Study|Withdrawal by Subject|1|||
143172064|NCT04696146|516179640|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
143172065|NCT04696146|516179641|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
143172066|NCT04696146|516179640|FG000|Overall Study|Off hours issue with product|1|||
143172067|NCT04696146|516179641|FG001|Overall Study|Off hours issue with product|0|||
143172068|NCT00529633|516179646|FG000|Overall Study|Withdrawal by Subject|1|||
143172069|NCT00529633|516179647|FG001|Overall Study|Withdrawal by Subject|1|||
143172070|NCT01334918|516179648|FG000|Overall Study|Did not receive study drug|6|||
143172071|NCT01334918|516179649|FG001|Overall Study|Did not receive study drug|0|||
143172072|NCT01334918|516179648|FG000|Overall Study|Adverse Event|2|||
143172073|NCT01334918|516179649|FG001|Overall Study|Adverse Event|0|||
143172074|NCT01334918|516179648|FG000|Overall Study|Withdrawal by Subject|0|||
143172075|NCT01334918|516179649|FG001|Overall Study|Withdrawal by Subject|1|||
143172076|NCT01576783|516179653|FG000|Overall Study|Change in Medical Care|1|||
143172077|NCT01576783|516179654|FG001|Overall Study|Change in Medical Care|0|||
143172078|NCT01576783|516179653|FG000|Overall Study|Lost to Follow-up|14|||
143172079|NCT01576783|516179654|FG001|Overall Study|Lost to Follow-up|16|||
143172080|NCT01576783|516179653|FG000|Overall Study|Withdrawal by Subject|5|||
143075245|NCT04241315|515814781|FG000|Overall Study|Withdrawal by Subject|0|||
143075246|NCT04241315|515814782|FG001|Overall Study|Withdrawal by Subject|1|||
143075247|NCT00000378|515814786|FG000|Overall Study|Lack of Efficacy|16|||
143075248|NCT00000378|515814787|FG001|Overall Study|Lack of Efficacy|14|||
143075249|NCT00663026|515814793|FG000|Overall Study|Lost to Follow-up|1|||
143075250|NCT00663026|515814794|FG001|Overall Study|Lost to Follow-up|0|||
143075251|NCT00663026|515814795|FG002|Overall Study|Lost to Follow-up|0|||
143075252|NCT00663026|515814793|FG000|Overall Study|Other|1|||
143075253|NCT00663026|515814794|FG001|Overall Study|Other|2|||
143075254|NCT00663026|515814795|FG002|Overall Study|Other|0|||
143075255|NCT00663026|515814793|FG000|Overall Study|Adverse Event|0|||
143075256|NCT00663026|515814794|FG001|Overall Study|Adverse Event|2|||
143075257|NCT00663026|515814795|FG002|Overall Study|Adverse Event|3|||
143075258|NCT00663026|515814793|FG000|Overall Study|Caregiver Request|0|||
143075259|NCT00663026|515814794|FG001|Overall Study|Caregiver Request|2|||
143075260|NCT00663026|515814795|FG002|Overall Study|Caregiver Request|0|||
143075261|NCT00663026|515814793|FG000|Overall Study|Withdrawal by Subject|0|||
143075262|NCT00663026|515814794|FG001|Overall Study|Withdrawal by Subject|0|||
143075263|NCT00663026|515814795|FG002|Overall Study|Withdrawal by Subject|1|||
143075264|NCT00325195|515814801|FG000|Randomized|Not dosed|5|||
143075265|NCT00325195|515814802|FG001|Randomized|Not dosed|5|||
143075266|NCT00325195|515814803|FG002|Randomized|Not dosed|3|||
143075267|NCT00325195|515814801|FG000|Received Intervention: ITT Population|Adverse Event|15|||
143075268|NCT00325195|515814802|FG001|Received Intervention: ITT Population|Adverse Event|17|||
143075269|NCT00325195|515814803|FG002|Received Intervention: ITT Population|Adverse Event|1|||
143075270|NCT00325195|515814801|FG000|Received Intervention: ITT Population|Death|3|||
143075271|NCT00325195|515814802|FG001|Received Intervention: ITT Population|Death|1|||
143075272|NCT00325195|515814803|FG002|Received Intervention: ITT Population|Death|0|||
143172081|NCT01576783|516179654|FG001|Overall Study|Withdrawal by Subject|1|||
143172082|NCT01819272|516179656|FG000|Overall Study|Adverse Event|1|||
143172083|NCT01819272|516179657|FG001|Overall Study|Adverse Event|0|||
143172084|NCT01819272|516179658|FG002|Overall Study|Adverse Event|0|||
143172085|NCT01819272|516179659|FG003|Overall Study|Adverse Event|2|||
143172086|NCT01819272|516179660|FG004|Overall Study|Adverse Event|0|||
143172087|NCT01819272|516179661|FG005|Overall Study|Adverse Event|0|||
143248575|NCT02152956|516463008|FG010|Overall Study|Withdrawal by Subject|0|||
143248576|NCT02152956|516463009|FG011|Overall Study|Withdrawal by Subject|4|||
143248577|NCT02152956|516463010|FG012|Overall Study|Withdrawal by Subject|0|||
143248578|NCT02152956|516462998|FG000|Overall Study|Physician Decision|0|||
143172088|NCT01819272|516179656|FG000|Overall Study|Lost to Follow-up|3|||
143172089|NCT01819272|516179657|FG001|Overall Study|Lost to Follow-up|0|||
143172090|NCT01819272|516179658|FG002|Overall Study|Lost to Follow-up|1|||
143172091|NCT01819272|516179659|FG003|Overall Study|Lost to Follow-up|0|||
143248579|NCT02152956|516462999|FG001|Overall Study|Physician Decision|0|||
143172092|NCT01819272|516179660|FG004|Overall Study|Lost to Follow-up|0|||
143075273|NCT00325195|515814801|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
143075274|NCT00325195|515814802|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
143075275|NCT00325195|515814803|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
143075276|NCT00325195|515814801|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
143075277|NCT00325195|515814802|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
143075278|NCT00325195|515814803|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
143075279|NCT00325195|515814801|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
143075280|NCT00325195|515814802|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
143075281|NCT00325195|515814803|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
143075282|NCT03469336|515814804|FG000|Overall Study|Adverse Event|1|||
143075283|NCT02740699|515814805|FG000|Overall Study|Lost to Follow-up|5|||
143365760|NCT01474538|516882926|FG000|Treatment Period 2|Sponsor decision|1|||
143172093|NCT01819272|516179661|FG005|Overall Study|Lost to Follow-up|3|||
143172094|NCT01819272|516179656|FG000|Overall Study|Protocol Violation|0|||
143172095|NCT01819272|516179657|FG001|Overall Study|Protocol Violation|0|||
143172096|NCT01819272|516179658|FG002|Overall Study|Protocol Violation|0|||
143172097|NCT01819272|516179659|FG003|Overall Study|Protocol Violation|1|||
143172098|NCT01819272|516179660|FG004|Overall Study|Protocol Violation|2|||
143172099|NCT01819272|516179661|FG005|Overall Study|Protocol Violation|3|||
143172100|NCT01819272|516179656|FG000|Overall Study|Physician Decision|0|||
143172101|NCT01819272|516179657|FG001|Overall Study|Physician Decision|1|||
143172102|NCT01819272|516179658|FG002|Overall Study|Physician Decision|0|||
143172103|NCT01819272|516179659|FG003|Overall Study|Physician Decision|0|||
143172104|NCT01819272|516179660|FG004|Overall Study|Physician Decision|0|||
143172105|NCT01819272|516179661|FG005|Overall Study|Physician Decision|0|||
143075284|NCT02740699|515814805|FG000|Overall Study|Withdrawal by Subject|14|||
143075285|NCT02740699|515814805|FG000|Overall Study|Physician Decision|5|||
143075286|NCT02585934|515814806|FG000|Overall Study|Lost to Follow-up|2|||
143075287|NCT02585934|515814807|FG001|Overall Study|Lost to Follow-up|2|||
143075288|NCT02585934|515814806|FG000|Overall Study|Protocol Violation|14|||
143075289|NCT02585934|515814807|FG001|Overall Study|Protocol Violation|11|||
143075290|NCT02585934|515814806|FG000|Overall Study|Adverse Event|21|||
143075291|NCT02585934|515814807|FG001|Overall Study|Adverse Event|22|||
143075292|NCT02585934|515814806|FG000|Overall Study|Physician Decision|3|||
143075293|NCT02585934|515814807|FG001|Overall Study|Physician Decision|2|||
143075294|NCT02585934|515814806|FG000|Overall Study|Withdrawal by Subject|7|||
143075295|NCT02585934|515814807|FG001|Overall Study|Withdrawal by Subject|21|||
143075296|NCT02585934|515814806|FG000|Overall Study|Lack of Efficacy|2|||
143075297|NCT02585934|515814807|FG001|Overall Study|Lack of Efficacy|1|||
143075298|NCT02585934|515814806|FG000|Overall Study|Death|2|||
143075299|NCT02585934|515814807|FG001|Overall Study|Death|0|||
143075300|NCT02585934|515814806|FG000|Overall Study|Caregiver Withdrew Consent|7|||
143075301|NCT02585934|515814807|FG001|Overall Study|Caregiver Withdrew Consent|7|||
143075302|NCT02585934|515814806|FG000|Overall Study|Sponsor Termination|1|||
143075303|NCT02585934|515814807|FG001|Overall Study|Sponsor Termination|2|||
143075304|NCT02585934|515814806|FG000|Overall Study|Another Reason|10|||
143075305|NCT02585934|515814807|FG001|Overall Study|Another Reason|5|||
143075306|NCT03783039|515814808|FG000|Overall Study|Death|2|||
143075307|NCT03783039|515814809|FG001|Overall Study|Death|1|||
143075308|NCT00918138|515814810|FG000|Overall Study|Subject withdrew consent|1|||
143172106|NCT01819272|516179656|FG000|Overall Study|Withdrawal of Consent|0|||
143172107|NCT01819272|516179657|FG001|Overall Study|Withdrawal of Consent|1|||
143172108|NCT01819272|516179658|FG002|Overall Study|Withdrawal of Consent|2|||
143172109|NCT01819272|516179659|FG003|Overall Study|Withdrawal of Consent|1|||
143172110|NCT01819272|516179660|FG004|Overall Study|Withdrawal of Consent|0|||
143172111|NCT01819272|516179661|FG005|Overall Study|Withdrawal of Consent|1|||
143172112|NCT01819272|516179656|FG000|Overall Study|Loss of Glucose Control|2|||
143172113|NCT01819272|516179657|FG001|Overall Study|Loss of Glucose Control|1|||
143172114|NCT01819272|516179658|FG002|Overall Study|Loss of Glucose Control|0|||
143172115|NCT01819272|516179659|FG003|Overall Study|Loss of Glucose Control|1|||
143172116|NCT01819272|516179660|FG004|Overall Study|Loss of Glucose Control|2|||
143172117|NCT01819272|516179661|FG005|Overall Study|Loss of Glucose Control|0|||
143172118|NCT01133665|516179662|FG000|Overall Study|Physician Decision|2|||
143172119|NCT03545672|516179663|FG000|Overall Study|Uncertain diagnosis|2|||
143172120|NCT03545672|516179664|FG001|Overall Study|Uncertain diagnosis|1|||
143075309|NCT00918138|515814811|FG001|Overall Study|Subject withdrew consent|1|||
143075310|NCT00918138|515814810|FG000|Overall Study|Death|1|||
143075311|NCT00918138|515814811|FG001|Overall Study|Death|0|||
143075312|NCT02315196|515814812|FG000|Overall Study|Withdrew consent|9|||
143075313|NCT03839823|515814813|FG000|Overall Study|Adverse Event|8|||
143172121|NCT03545672|516179663|FG000|Overall Study|Protocol Violation|2|||
143172122|NCT03545672|516179664|FG001|Overall Study|Protocol Violation|2|||
143172123|NCT00892008|516179667|FG000|Overall Study|Death|5|||
143172124|NCT00892008|516179667|FG000|Overall Study|Lack of Efficacy|3|||
143172125|NCT00892008|516179667|FG000|Overall Study|Lost to Follow-up|142|||
143172126|NCT00892008|516179667|FG000|Overall Study|Other|378|||
143172127|NCT00892008|516179667|FG000|Overall Study|Adverse Event|37|||
143075314|NCT03839823|515814814|FG001|Overall Study|Adverse Event|4|||
143075315|NCT03839823|515814813|FG000|Overall Study|Death|1|||
143248580|NCT02152956|516463000|FG002|Overall Study|Physician Decision|0|||
143248581|NCT02152956|516463001|FG003|Overall Study|Physician Decision|0|||
143248582|NCT02152956|516463002|FG004|Overall Study|Physician Decision|0|||
143248583|NCT02152956|516463003|FG005|Overall Study|Physician Decision|0|||
143248584|NCT02152956|516463004|FG006|Overall Study|Physician Decision|0|||
143248585|NCT02152956|516463005|FG007|Overall Study|Physician Decision|0|||
143248586|NCT02152956|516463006|FG008|Overall Study|Physician Decision|0|||
143248587|NCT02152956|516463007|FG009|Overall Study|Physician Decision|0|||
143248588|NCT02152956|516463008|FG010|Overall Study|Physician Decision|0|||
143248589|NCT02152956|516463009|FG011|Overall Study|Physician Decision|1|||
143248590|NCT02152956|516463010|FG012|Overall Study|Physician Decision|0|||
143248591|NCT02152956|516462998|FG000|Overall Study|Study terminated by sponsor|0|||
143248592|NCT02152956|516462999|FG001|Overall Study|Study terminated by sponsor|0|||
143248593|NCT02152956|516463000|FG002|Overall Study|Study terminated by sponsor|0|||
143248594|NCT02152956|516463001|FG003|Overall Study|Study terminated by sponsor|0|||
143248595|NCT02152956|516463002|FG004|Overall Study|Study terminated by sponsor|0|||
143248596|NCT02152956|516463003|FG005|Overall Study|Study terminated by sponsor|0|||
143248597|NCT02152956|516463004|FG006|Overall Study|Study terminated by sponsor|0|||
143248598|NCT02152956|516463005|FG007|Overall Study|Study terminated by sponsor|0|||
143248599|NCT02152956|516463006|FG008|Overall Study|Study terminated by sponsor|0|||
143075316|NCT03839823|515814814|FG001|Overall Study|Death|0|||
143075317|NCT03839823|515814813|FG000|Overall Study|Physician Decision|1|||
143075318|NCT03839823|515814814|FG001|Overall Study|Physician Decision|5|||
143075319|NCT03839823|515814813|FG000|Overall Study|Progressive Disease (PD)|65|||
143075320|NCT03839823|515814814|FG001|Overall Study|Progressive Disease (PD)|65|||
143075321|NCT03839823|515814813|FG000|Overall Study|Subject Decision|2|||
143075322|NCT03839823|515814814|FG001|Overall Study|Subject Decision|9|||
143075323|NCT03839823|515814813|FG000|Overall Study|Not Treated|0|||
143075324|NCT03839823|515814814|FG001|Overall Study|Not Treated|10|||
143075325|NCT03327792|515814815|FG000|Overall Study|Adverse Event|4|||
143075326|NCT03327792|515814816|FG001|Overall Study|Adverse Event|0|||
143075327|NCT03327792|515814815|FG000|Overall Study|Family/Personal issues|3|||
143075328|NCT03327792|515814816|FG001|Overall Study|Family/Personal issues|2|||
143075329|NCT03327792|515814815|FG000|Overall Study|Lost to Follow-up|0|||
143075330|NCT03327792|515814816|FG001|Overall Study|Lost to Follow-up|1|||
143075331|NCT03151811|515814817|FG000|Overall Study|Randomized But Not Treated|18|||
143075332|NCT03151811|515814818|FG001|Overall Study|Randomized But Not Treated|3|||
143075333|NCT03151811|515814817|FG000|Overall Study|Progressive Disease|130|||
143075334|NCT03151811|515814818|FG001|Overall Study|Progressive Disease|170|||
143075335|NCT03151811|515814817|FG000|Overall Study|Adverse Event|49|||
143075336|NCT03151811|515814818|FG001|Overall Study|Adverse Event|40|||
143075337|NCT03151811|515814817|FG000|Overall Study|Lack of Efficacy|6|||
143075338|NCT03151811|515814818|FG001|Overall Study|Lack of Efficacy|8|||
143075339|NCT03151811|515814817|FG000|Overall Study|Physician Decision|21|||
143075340|NCT03151811|515814818|FG001|Overall Study|Physician Decision|9|||
143075341|NCT03151811|515814817|FG000|Overall Study|Withdrawal by Subject|17|||
143075342|NCT03151811|515814818|FG001|Overall Study|Withdrawal by Subject|7|||
143075343|NCT03151811|515814817|FG000|Overall Study|Lost to Follow-up|0|||
143075344|NCT03151811|515814818|FG001|Overall Study|Lost to Follow-up|1|||
143075345|NCT03151811|515814817|FG000|Overall Study|Study Terminated by Sponsor|5|||
143075346|NCT03151811|515814818|FG001|Overall Study|Study Terminated by Sponsor|11|||
143075347|NCT01081834|515814821|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
143075348|NCT01081834|515814822|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
143075349|NCT01081834|515814823|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
143075350|NCT01081834|515814824|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
143075351|NCT01081834|515814825|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
143075352|NCT01081834|515814821|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
143075353|NCT01081834|515814822|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
143075354|NCT01081834|515814823|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
143075355|NCT01081834|515814824|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
143075356|NCT01081834|515814825|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
143075357|NCT01081834|515814821|FG000|Core Period: Baseline to Week 26|Death|1|||
143365761|NCT01474538|516882927|FG001|Treatment Period 2|Sponsor decision|0|||
143075358|NCT01081834|515814822|FG001|Core Period: Baseline to Week 26|Death|0|||
143075359|NCT01081834|515814823|FG002|Core Period: Baseline to Week 26|Death|0|||
143075360|NCT01081834|515814824|FG003|Core Period: Baseline to Week 26|Death|0|||
143075361|NCT01081834|515814825|FG004|Core Period: Baseline to Week 26|Death|0|||
143075362|NCT01081834|515814821|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
143075363|NCT01081834|515814822|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
143075364|NCT01081834|515814823|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
143075365|NCT01081834|515814824|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
143075366|NCT01081834|515814825|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
143075367|NCT01081834|515814821|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
143075368|NCT01081834|515814822|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
143075369|NCT01081834|515814823|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
143075370|NCT01081834|515814824|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
143075371|NCT01081834|515814825|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
143075372|NCT01081834|515814821|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
143075373|NCT01081834|515814822|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
143075374|NCT01081834|515814823|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
143075375|NCT01081834|515814824|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
143075376|NCT01081834|515814825|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
143075377|NCT01081834|515814821|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
143075378|NCT01081834|515814822|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
143075379|NCT01081834|515814823|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
143075380|NCT01081834|515814824|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
143075381|NCT01081834|515814825|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
143075382|NCT01081834|515814821|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
143075383|NCT01081834|515814822|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
143075384|NCT01081834|515814823|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
143075385|NCT01081834|515814824|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
143075386|NCT01081834|515814825|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
143075387|NCT01081834|515814821|FG000|Core Period: Baseline to Week 26|Other|4|||
143075388|NCT01081834|515814822|FG001|Core Period: Baseline to Week 26|Other|4|||
143075389|NCT01081834|515814823|FG002|Core Period: Baseline to Week 26|Other|3|||
143075390|NCT01081834|515814824|FG003|Core Period: Baseline to Week 26|Other|1|||
143075391|NCT01081834|515814825|FG004|Core Period: Baseline to Week 26|Other|0|||
143075392|NCT01081834|515814821|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
143075393|NCT01081834|515814822|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
143075394|NCT01081834|515814823|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
143075395|NCT01081834|515814824|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
143075396|NCT01081834|515814825|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
143075397|NCT01081834|515814821|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
143075398|NCT01081834|515814822|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
143075399|NCT01081834|515814823|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
143075400|NCT01081834|515814824|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
143075401|NCT01081834|515814825|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
143075402|NCT01081834|515814821|FG000|Extension Period: Week 26 to Week 52|Death|1|||
143075403|NCT01081834|515814822|FG001|Extension Period: Week 26 to Week 52|Death|0|||
143075404|NCT01081834|515814823|FG002|Extension Period: Week 26 to Week 52|Death|0|||
143075405|NCT01081834|515814824|FG003|Extension Period: Week 26 to Week 52|Death|0|||
143172128|NCT01493089|516179670|FG000|Overall Study|Protocol Violation|2|||
143172129|NCT01493089|516179671|FG001|Overall Study|Protocol Violation|2|||
143172130|NCT01493089|516179670|FG000|Overall Study|Withdrawal by Subject|1|||
143172131|NCT01493089|516179671|FG001|Overall Study|Withdrawal by Subject|0|||
143172132|NCT01493089|516179670|FG000|Overall Study|Physician Decision|0|||
143172133|NCT01493089|516179671|FG001|Overall Study|Physician Decision|1|||
143172134|NCT00560417|516179672|FG000|Overall Study|Adverse Event|3|||
143172135|NCT00560417|516179673|FG001|Overall Study|Adverse Event|2|||
143172136|NCT00560417|516179672|FG000|Overall Study|Entry Criteria Not Met|1|||
143172137|NCT00560417|516179673|FG001|Overall Study|Entry Criteria Not Met|0|||
143172138|NCT00560417|516179672|FG000|Overall Study|Lost to Follow-up|0|||
143172139|NCT00560417|516179673|FG001|Overall Study|Lost to Follow-up|1|||
143172140|NCT00560417|516179672|FG000|Overall Study|Physician Decision|2|||
143172141|NCT00560417|516179673|FG001|Overall Study|Physician Decision|6|||
143172142|NCT00560417|516179672|FG000|Overall Study|Protocol Violation|6|||
143172143|NCT00560417|516179673|FG001|Overall Study|Protocol Violation|5|||
143172144|NCT00560417|516179672|FG000|Overall Study|Sponsor Decision|2|||
143172145|NCT00560417|516179673|FG001|Overall Study|Sponsor Decision|0|||
143172146|NCT00560417|516179672|FG000|Overall Study|Withdrawal by Subject|3|||
143075406|NCT01081834|515814825|FG004|Extension Period: Week 26 to Week 52|Death|0|||
143075407|NCT01081834|515814821|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
143075408|NCT01081834|515814822|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
143075409|NCT01081834|515814823|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
143075410|NCT01081834|515814824|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
143075411|NCT01081834|515814825|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
143075412|NCT01081834|515814821|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
143075413|NCT01081834|515814822|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
143075414|NCT01081834|515814823|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
143075415|NCT01081834|515814824|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
143075416|NCT01081834|515814825|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
143075417|NCT01081834|515814821|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
143075418|NCT01081834|515814822|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
143075419|NCT01081834|515814823|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
143075420|NCT01081834|515814824|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
143075421|NCT01081834|515814825|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
143075422|NCT01081834|515814821|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
143075423|NCT01081834|515814822|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
143075424|NCT01081834|515814823|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
143172147|NCT00560417|516179673|FG001|Overall Study|Withdrawal by Subject|3|||
143172148|NCT02164864|516179674|FG000|Overall Study|Trial disease worsening|7|||
143172149|NCT02164864|516179675|FG001|Overall Study|Trial disease worsening|5|||
143172150|NCT02164864|516179676|FG002|Overall Study|Trial disease worsening|1|||
143172151|NCT02164864|516179674|FG000|Overall Study|Other pre-existing disease worsening|6|||
143172152|NCT02164864|516179675|FG001|Overall Study|Other pre-existing disease worsening|4|||
143172153|NCT02164864|516179676|FG002|Overall Study|Other pre-existing disease worsening|9|||
143172154|NCT02164864|516179674|FG000|Overall Study|Other Adverse Event (AE)|52|||
143172155|NCT02164864|516179675|FG001|Overall Study|Other Adverse Event (AE)|32|||
143172156|NCT02164864|516179676|FG002|Overall Study|Other Adverse Event (AE)|49|||
143172157|NCT02164864|516179674|FG000|Overall Study|Protocol Violation|2|||
143172158|NCT02164864|516179675|FG001|Overall Study|Protocol Violation|4|||
143172159|NCT02164864|516179676|FG002|Overall Study|Protocol Violation|1|||
143172160|NCT02164864|516179674|FG000|Overall Study|Lost to Follow-up|4|||
143172161|NCT02164864|516179675|FG001|Overall Study|Lost to Follow-up|3|||
143075425|NCT01081834|515814824|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
143248600|NCT02152956|516463007|FG009|Overall Study|Study terminated by sponsor|0|||
143248601|NCT02152956|516463008|FG010|Overall Study|Study terminated by sponsor|0|||
143248602|NCT02152956|516463009|FG011|Overall Study|Study terminated by sponsor|29|||
143248603|NCT02152956|516463010|FG012|Overall Study|Study terminated by sponsor|0|||
143248604|NCT02152956|516462998|FG000|Overall Study|progressive disease|0|||
143248605|NCT02152956|516462999|FG001|Overall Study|progressive disease|0|||
143248606|NCT02152956|516463000|FG002|Overall Study|progressive disease|0|||
143248607|NCT02152956|516463001|FG003|Overall Study|progressive disease|0|||
143248608|NCT02152956|516463002|FG004|Overall Study|progressive disease|0|||
143248609|NCT02152956|516463003|FG005|Overall Study|progressive disease|0|||
143248610|NCT02152956|516463004|FG006|Overall Study|progressive disease|0|||
143248611|NCT02152956|516463005|FG007|Overall Study|progressive disease|0|||
143248612|NCT02152956|516463006|FG008|Overall Study|progressive disease|1|||
143248613|NCT02152956|516463007|FG009|Overall Study|progressive disease|0|||
143248614|NCT02152956|516463008|FG010|Overall Study|progressive disease|0|||
143248615|NCT02152956|516463009|FG011|Overall Study|progressive disease|1|||
143248616|NCT02152956|516463010|FG012|Overall Study|progressive disease|0|||
143248617|NCT00530816|516463011|FG000|Overall Study|Progressive Disease|16|||
143248618|NCT00530816|516463012|FG001|Overall Study|Progressive Disease|24|||
143248619|NCT00530816|516463013|FG002|Overall Study|Progressive Disease|24|||
143248620|NCT00530816|516463011|FG000|Overall Study|Adverse Event|6|||
143248621|NCT00530816|516463012|FG001|Overall Study|Adverse Event|13|||
143248622|NCT00530816|516463013|FG002|Overall Study|Adverse Event|7|||
143248623|NCT00530816|516463011|FG000|Overall Study|Other|3|||
143248624|NCT00530816|516463012|FG001|Overall Study|Other|3|||
143075426|NCT01081834|515814825|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
143075427|NCT01081834|515814821|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
143075428|NCT01081834|515814822|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
143075429|NCT01081834|515814823|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
143075430|NCT01081834|515814824|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
143075431|NCT01081834|515814825|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
143075432|NCT01081834|515814821|FG000|Extension Period: Week 26 to Week 52|Other|4|||
143075433|NCT01081834|515814822|FG001|Extension Period: Week 26 to Week 52|Other|5|||
143075434|NCT01081834|515814823|FG002|Extension Period: Week 26 to Week 52|Other|4|||
143075435|NCT01081834|515814824|FG003|Extension Period: Week 26 to Week 52|Other|0|||
143248625|NCT00530816|516463013|FG002|Overall Study|Other|4|||
143248626|NCT00530816|516463011|FG000|Overall Study|Withdrawal by Subject|1|||
143248627|NCT00530816|516463012|FG001|Overall Study|Withdrawal by Subject|2|||
143075436|NCT01081834|515814825|FG004|Extension Period: Week 26 to Week 52|Other|0|||
143075437|NCT01081834|515814821|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
143075438|NCT01081834|515814822|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
143075439|NCT01081834|515814823|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
143075440|NCT01081834|515814824|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
143075441|NCT01081834|515814825|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
143075442|NCT01081834|515814821|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
143075443|NCT01081834|515814822|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
143248628|NCT00530816|516463013|FG002|Overall Study|Withdrawal by Subject|6|||
143248629|NCT05661851|516463014|FG000|Overall Study|Protocol Violation|1|||
143248630|NCT05661851|516463015|FG001|Overall Study|Protocol Violation|1|||
143248631|NCT05661851|516463014|FG000|Overall Study|Covid-19 Related|3|||
143248632|NCT05661851|516463015|FG001|Overall Study|Covid-19 Related|4|||
143248633|NCT05661851|516463014|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
143248634|NCT05661851|516463015|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
143248635|NCT05661851|516463014|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
143248636|NCT05661851|516463015|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
143248637|NCT01388985|516463016|FG000|Overall Study|Death|0|||
143248638|NCT01388985|516463017|FG001|Overall Study|Death|1|||
143248639|NCT01388985|516463016|FG000|Overall Study|Lost to Follow-up|30|||
143248640|NCT01388985|516463017|FG001|Overall Study|Lost to Follow-up|30|||
143248641|NCT01388985|516463016|FG000|Overall Study|Withdrawal by Subject|13|||
143248642|NCT01388985|516463017|FG001|Overall Study|Withdrawal by Subject|4|||
143075444|NCT01081834|515814823|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
143075445|NCT01081834|515814824|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
143075446|NCT01081834|515814825|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
143075447|NCT01475097|515814840|FG000|Overall Study|Protocol Violation|1|||
143075448|NCT01475097|515814841|FG001|Overall Study|Protocol Violation|1|||
143075449|NCT00936897|515814850|FG000|Overall Study|Withdrawal by Subject|9|||
143075450|NCT00936897|515814851|FG001|Overall Study|Withdrawal by Subject|19|||
143075451|NCT00936897|515814850|FG000|Overall Study|Adverse Event|4|||
143075452|NCT00936897|515814851|FG001|Overall Study|Adverse Event|13|||
143075453|NCT00936897|515814850|FG000|Overall Study|Other|3|||
143075454|NCT00936897|515814851|FG001|Overall Study|Other|9|||
143075455|NCT00936897|515814850|FG000|Overall Study|Lost to Follow-up|1|||
143075456|NCT00936897|515814851|FG001|Overall Study|Lost to Follow-up|10|||
143075457|NCT00936897|515814850|FG000|Overall Study|Administrative Decision|1|||
143075458|NCT00936897|515814851|FG001|Overall Study|Administrative Decision|2|||
143075459|NCT00936897|515814850|FG000|Overall Study|Protocol Violation|1|||
143075460|NCT00936897|515814851|FG001|Overall Study|Protocol Violation|1|||
143075461|NCT00936897|515814850|FG000|Overall Study|Ineligibility Determined|0|||
143075462|NCT00936897|515814851|FG001|Overall Study|Ineligibility Determined|3|||
143075463|NCT00936897|515814850|FG000|Overall Study|Noncompliance|0|||
143075464|NCT00936897|515814851|FG001|Overall Study|Noncompliance|2|||
143075465|NCT00936897|515814850|FG000|Overall Study|Death|0|||
143075466|NCT00936897|515814851|FG001|Overall Study|Death|1|||
143075467|NCT04058067|515814852|FG000|Overall Study|Adverse Event|2|||
143075468|NCT04058067|515814853|FG001|Overall Study|Adverse Event|0|||
143075469|NCT04058067|515814852|FG000|Overall Study|Death|0|||
143075470|NCT04058067|515814853|FG001|Overall Study|Death|1|||
143075471|NCT04058067|515814852|FG000|Overall Study|Physician Decision|3|||
143075472|NCT04058067|515814853|FG001|Overall Study|Physician Decision|1|||
143075473|NCT04058067|515814852|FG000|Overall Study|Protocol Violation|0|||
143075474|NCT04058067|515814853|FG001|Overall Study|Protocol Violation|1|||
143075475|NCT04058067|515814852|FG000|Overall Study|Withdrawal by Subject|7|||
143075476|NCT04058067|515814853|FG001|Overall Study|Withdrawal by Subject|8|||
143075477|NCT00417170|515814854|FG000|Overall Study|Adverse Event|1|||
143075478|NCT00417170|515814855|FG001|Overall Study|Adverse Event|1|||
143075479|NCT00417170|515814854|FG000|Overall Study|Withdrawal by Subject|1|||
143075480|NCT00417170|515814855|FG001|Overall Study|Withdrawal by Subject|1|||
143075481|NCT00417170|515814854|FG000|Overall Study|Lost to Follow-up|0|||
143075482|NCT00417170|515814855|FG001|Overall Study|Lost to Follow-up|1|||
143075483|NCT05005312|515814856|FG000|Overall Study|Enrolled, but not treated|0|||
143075484|NCT05005312|515814857|FG001|Overall Study|Enrolled, but not treated|1|||
143075485|NCT01283035|515814859|FG000|Overall Study|Subject later found ineligible|1|||
143075486|NCT01844856|515814860|FG000|Overall Study|Lost to Follow-up|15|||
143075487|NCT01844856|515814861|FG001|Overall Study|Lost to Follow-up|3|||
143075488|NCT01844856|515814860|FG000|Overall Study|Adverse Event|3|||
143075489|NCT01844856|515814861|FG001|Overall Study|Adverse Event|6|||
143075490|NCT01844856|515814860|FG000|Overall Study|Withdrawal by Subject|3|||
143075491|NCT01844856|515814861|FG001|Overall Study|Withdrawal by Subject|2|||
143075492|NCT01844856|515814860|FG000|Overall Study|Noncompliance|2|||
143075493|NCT01844856|515814861|FG001|Overall Study|Noncompliance|3|||
143075494|NCT01844856|515814860|FG000|Overall Study|Enterococcus Resistant|0|||
143075495|NCT01844856|515814861|FG001|Overall Study|Enterococcus Resistant|1|||
143075496|NCT01844856|515814860|FG000|Overall Study|Inadvertently Not Scheduled|1|||
143075497|NCT01844856|515814861|FG001|Overall Study|Inadvertently Not Scheduled|0|||
143075498|NCT01844856|515814860|FG000|Overall Study|Randomized but was a Screen Failure|0|||
143172162|NCT02164864|516179676|FG002|Overall Study|Lost to Follow-up|2|||
143172163|NCT02164864|516179674|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
143172164|NCT02164864|516179675|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
143172165|NCT02164864|516179676|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
143172166|NCT02164864|516179674|FG000|Overall Study|Other than stated|3|||
143172167|NCT02164864|516179675|FG001|Overall Study|Other than stated|4|||
143172168|NCT02164864|516179676|FG002|Overall Study|Other than stated|14|||
143172169|NCT01870869|516179677|FG000|Overall Study|Implanted with nonstudy device|1|||
143172170|NCT01870869|516179678|FG001|Overall Study|Implanted with nonstudy device|3|||
143172171|NCT01870869|516179679|FG002|Overall Study|Implanted with nonstudy device|14|||
143172172|NCT01870869|516179680|FG003|Overall Study|Implanted with nonstudy device|4|||
143172173|NCT01870869|516179677|FG000|Overall Study|Death|0|||
143172174|NCT01870869|516179678|FG001|Overall Study|Death|0|||
143172175|NCT01870869|516179679|FG002|Overall Study|Death|7|||
143172176|NCT01870869|516179680|FG003|Overall Study|Death|1|||
143172177|NCT01870869|516179677|FG000|Overall Study|Subject choice|6|||
143172178|NCT01870869|516179678|FG001|Overall Study|Subject choice|2|||
143172179|NCT01870869|516179679|FG002|Overall Study|Subject choice|22|||
143172180|NCT01870869|516179680|FG003|Overall Study|Subject choice|8|||
143172181|NCT01870869|516179677|FG000|Overall Study|Lost to Follow-up|10|||
143172182|NCT01870869|516179678|FG001|Overall Study|Lost to Follow-up|2|||
143172183|NCT01870869|516179679|FG002|Overall Study|Lost to Follow-up|25|||
143172184|NCT01870869|516179680|FG003|Overall Study|Lost to Follow-up|3|||
143172185|NCT01870869|516179677|FG000|Overall Study|Reason not Specified|1|||
143172186|NCT01870869|516179678|FG001|Overall Study|Reason not Specified|2|||
143172187|NCT01870869|516179679|FG002|Overall Study|Reason not Specified|20|||
143172188|NCT01870869|516179680|FG003|Overall Study|Reason not Specified|4|||
143172189|NCT01870869|516179677|FG000|Overall Study|Not evaluable|10|||
143172190|NCT01870869|516179678|FG001|Overall Study|Not evaluable|5|||
143172191|NCT01870869|516179679|FG002|Overall Study|Not evaluable|42|||
143172192|NCT01870869|516179680|FG003|Overall Study|Not evaluable|10|||
143172193|NCT00557193|516179681|FG000|Induction|Adverse Event|2|||
143172194|NCT00557193|516179682|FG001|Induction|Adverse Event|0|||
143172195|NCT00557193|516179683|FG002|Induction|Adverse Event|0|||
143248643|NCT01388985|516463016|FG000|Overall Study|Subject unavailable|1|||
143172196|NCT00557193|516179684|FG003|Induction|Adverse Event|0|||
143172197|NCT00557193|516179685|FG004|Induction|Adverse Event|0|||
143172198|NCT00557193|516179686|FG005|Induction|Adverse Event|0|||
143172199|NCT00557193|516179681|FG000|Induction|Death|6|||
143172200|NCT00557193|516179682|FG001|Induction|Death|0|||
143172201|NCT00557193|516179683|FG002|Induction|Death|0|||
143172202|NCT00557193|516179684|FG003|Induction|Death|0|||
143172203|NCT00557193|516179685|FG004|Induction|Death|0|||
143172204|NCT00557193|516179686|FG005|Induction|Death|0|||
143172205|NCT00557193|516179681|FG000|Induction|Physician Decision|3|||
143172206|NCT00557193|516179682|FG001|Induction|Physician Decision|0|||
143075499|NCT01844856|515814861|FG001|Overall Study|Randomized but was a Screen Failure|1|||
143075500|NCT01001988|515814862|FG000|Overall Study|Protocol Violation|84|||
143075501|NCT01001988|515814862|FG000|Overall Study|Withdrawal by Subject|18|||
143075502|NCT01001988|515814862|FG000|Overall Study|Lost to Follow-up|15|||
143075503|NCT00927394|515814865|FG000|Overall Study|Adverse Event|14|||
143075504|NCT00927394|515814866|FG001|Overall Study|Adverse Event|9|||
143075505|NCT00927394|515814865|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
143075506|NCT00927394|515814866|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
143075507|NCT00927394|515814865|FG000|Overall Study|Withdrawal by Subject|20|||
143075508|NCT00927394|515814866|FG001|Overall Study|Withdrawal by Subject|24|||
143075509|NCT00927394|515814865|FG000|Overall Study|Lost to Follow-up|8|||
143075510|NCT00927394|515814866|FG001|Overall Study|Lost to Follow-up|14|||
143075511|NCT00927394|515814865|FG000|Overall Study|Administrative Problem|1|||
143075512|NCT00927394|515814866|FG001|Overall Study|Administrative Problem|0|||
143075513|NCT00927394|515814865|FG000|Overall Study|Death|1|||
143075514|NCT00927394|515814866|FG001|Overall Study|Death|1|||
143075515|NCT00927394|515814865|FG000|Overall Study|Protocol deviation|16|||
143172207|NCT00557193|516179683|FG002|Induction|Physician Decision|0|||
143075516|NCT00927394|515814866|FG001|Overall Study|Protocol deviation|13|||
143075517|NCT00927394|515814865|FG000|Overall Study|Randomized in error|0|||
143075518|NCT00927394|515814866|FG001|Overall Study|Randomized in error|1|||
143075519|NCT01221363|515814867|FG000|Overall Study|Pregnancy|1|||
143075520|NCT01221363|515814868|FG001|Overall Study|Pregnancy|0|||
143075521|NCT01221363|515814867|FG000|Overall Study|Withdrawal by Subject|11|||
143075522|NCT01221363|515814868|FG001|Overall Study|Withdrawal by Subject|5|||
143365762|NCT01474538|516882926|FG000|Treatment Period 2|Physician Decision|0|||
143365763|NCT01474538|516882927|FG001|Treatment Period 2|Physician Decision|1|||
143075523|NCT01329549|515814871|FG000|Overall Study|Withdrawal by Subject|1|||
143075524|NCT01329549|515814871|FG000|Overall Study|Adverse Event|1|||
143075525|NCT01756079|515814872|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
143075526|NCT01756079|515814872|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
143075527|NCT01756079|515814872|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
143075528|NCT01756079|515814872|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
143075529|NCT01756079|515814872|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
143075530|NCT03597529|515814873|FG000|Overall Study|Lost to Follow-up|10|||
143075531|NCT03597529|515814874|FG001|Overall Study|Lost to Follow-up|12|||
143075532|NCT03597529|515814873|FG000|Overall Study|Physician Decision|3|||
143075533|NCT03597529|515814874|FG001|Overall Study|Physician Decision|1|||
143075534|NCT03597529|515814873|FG000|Overall Study|Withdrawal by Subject|6|||
143075535|NCT03597529|515814874|FG001|Overall Study|Withdrawal by Subject|3|||
143075536|NCT03597529|515814873|FG000|Overall Study|Non-compliant with study activities|1|||
143075537|NCT03597529|515814874|FG001|Overall Study|Non-compliant with study activities|2|||
143365764|NCT01474538|516882926|FG000|Treatment Period 2|Protocol Violation|1|||
143365765|NCT01474538|516882927|FG001|Treatment Period 2|Protocol Violation|0|||
143365766|NCT02501629|516882928|FG000|Overall Study|Death|0|||
143365767|NCT02501629|516882929|FG001|Overall Study|Death|1|||
143365768|NCT02501629|516882928|FG000|Overall Study|Withdrawn from study by sponsor|1|||
143365769|NCT02501629|516882929|FG001|Overall Study|Withdrawn from study by sponsor|0|||
143365770|NCT02501629|516882928|FG000|Overall Study|Early termination by sponsor|1|||
143365771|NCT02501629|516882929|FG001|Overall Study|Early termination by sponsor|0|||
143365772|NCT02501629|516882928|FG000|Overall Study|Withdrawal by Subject|3|||
143365773|NCT02501629|516882929|FG001|Overall Study|Withdrawal by Subject|5|||
143365774|NCT02501629|516882928|FG000|Overall Study|Subject did not return to site|0|||
143365775|NCT02501629|516882929|FG001|Overall Study|Subject did not return to site|1|||
143365776|NCT00868231|516882934|FG000|Treatment Period 1|Adverse Event|0|||
143365777|NCT00868231|516882935|FG001|Treatment Period 1|Adverse Event|0|||
143365778|NCT00868231|516882936|FG002|Treatment Period 1|Adverse Event|0|||
143365779|NCT00868231|516882937|FG003|Treatment Period 1|Adverse Event|0|||
143365780|NCT00868231|516882938|FG004|Treatment Period 1|Adverse Event|1|||
143365781|NCT00868231|516882939|FG005|Treatment Period 1|Adverse Event|0|||
143365782|NCT00868231|516882934|FG000|Treatment Period 2|Adverse Event|1|||
143365783|NCT00868231|516882935|FG001|Treatment Period 2|Adverse Event|0|||
143365784|NCT00868231|516882936|FG002|Treatment Period 2|Adverse Event|0|||
143365785|NCT00868231|516882937|FG003|Treatment Period 2|Adverse Event|0|||
143365786|NCT00868231|516882938|FG004|Treatment Period 2|Adverse Event|0|||
143365787|NCT00868231|516882939|FG005|Treatment Period 2|Adverse Event|0|||
143365788|NCT00868231|516882934|FG000|Treatment Period 3|Adverse Event|0|||
143365789|NCT00868231|516882935|FG001|Treatment Period 3|Adverse Event|0|||
143365790|NCT00868231|516882936|FG002|Treatment Period 3|Adverse Event|1|||
143365791|NCT00868231|516882937|FG003|Treatment Period 3|Adverse Event|0|||
143365792|NCT00868231|516882938|FG004|Treatment Period 3|Adverse Event|0|||
143365793|NCT00868231|516882939|FG005|Treatment Period 3|Adverse Event|0|||
143365794|NCT04565249|516882940|FG000|Overall Study|Death|0|||
143365795|NCT04565249|516882941|FG001|Overall Study|Death|0|||
143365796|NCT04565249|516882942|FG002|Overall Study|Death|0|||
143365797|NCT04565249|516882943|FG003|Overall Study|Death|1|||
143365798|NCT03120676|516882944|FG000|Overall Study|Not treated|1|||
143075538|NCT04623086|515814877|FG000|Overall Study|Withdrawal by Subject|0|||
143365799|NCT00886613|516882945|FG000|Overall Study|Protocol deviation (Part B)|1|||
143365800|NCT00886613|516882946|FG001|Overall Study|Protocol deviation (Part B)|0|||
143365801|NCT00886613|516882947|FG002|Overall Study|Protocol deviation (Part B)|0|||
143365802|NCT00886613|516882945|FG000|Overall Study|Lost to follow-up (Part B)|1|||
143365803|NCT00886613|516882946|FG001|Overall Study|Lost to follow-up (Part B)|0|||
143365804|NCT00886613|516882947|FG002|Overall Study|Lost to follow-up (Part B)|1|||
143075539|NCT04623086|515814878|FG001|Overall Study|Withdrawal by Subject|0|||
143075540|NCT04623086|515814879|FG002|Overall Study|Withdrawal by Subject|10|||
143075541|NCT01755767|515814880|FG000|Overall Study|Progressive Disease|8|||
143075542|NCT01755767|515814881|FG001|Overall Study|Progressive Disease|7|||
143075543|NCT01755767|515814882|FG002|Overall Study|Progressive Disease|91|||
143365805|NCT00886613|516882945|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
143365806|NCT00886613|516882946|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
143365807|NCT00886613|516882947|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
143365808|NCT02333630|516882948|FG000|Overall Study|Lost to Follow-up|5|||
143248644|NCT01388985|516463017|FG001|Overall Study|Subject unavailable|1|||
143248645|NCT01388985|516463016|FG000|Overall Study|Other (no reason)|0|||
143248646|NCT01388985|516463017|FG001|Overall Study|Other (no reason)|1|||
143248647|NCT01388985|516463016|FG000|Overall Study|Error of nurse|5|||
143248648|NCT01388985|516463017|FG001|Overall Study|Error of nurse|1|||
143248649|NCT01057589|516463018|FG000|Overall Study|Disease Progression|35|||
143248650|NCT01057589|516463018|FG000|Overall Study|Adverse Event|10|||
143248651|NCT01057589|516463018|FG000|Overall Study|Physician Decision|8|||
143248652|NCT01057589|516463018|FG000|Overall Study|Withdrawal by Subject|3|||
143248653|NCT01057589|516463018|FG000|Overall Study|Sponsor Decision|1|||
143248654|NCT01057589|516463018|FG000|Overall Study|Death|8|||
143248655|NCT01057589|516463018|FG000|Overall Study|Lost to Follow-up|1|||
143075544|NCT01755767|515814883|FG003|Overall Study|Progressive Disease|43|||
143075545|NCT01755767|515814880|FG000|Overall Study|Clinical Disease Progression|4|||
143075546|NCT01755767|515814881|FG001|Overall Study|Clinical Disease Progression|2|||
143075547|NCT01755767|515814882|FG002|Overall Study|Clinical Disease Progression|29|||
143075548|NCT01755767|515814883|FG003|Overall Study|Clinical Disease Progression|20|||
143075549|NCT01755767|515814880|FG000|Overall Study|Radiographic Disease Progression|9|||
143075550|NCT01755767|515814881|FG001|Overall Study|Radiographic Disease Progression|4|||
143075551|NCT01755767|515814882|FG002|Overall Study|Radiographic Disease Progression|44|||
143075552|NCT01755767|515814883|FG003|Overall Study|Radiographic Disease Progression|27|||
143075553|NCT01755767|515814880|FG000|Overall Study|Adverse Event|6|||
143075554|NCT01755767|515814881|FG001|Overall Study|Adverse Event|0|||
143075555|NCT01755767|515814882|FG002|Overall Study|Adverse Event|28|||
143075556|NCT01755767|515814883|FG003|Overall Study|Adverse Event|11|||
143075557|NCT01755767|515814880|FG000|Overall Study|Death|1|||
143075558|NCT01755767|515814881|FG001|Overall Study|Death|2|||
143075559|NCT01755767|515814882|FG002|Overall Study|Death|15|||
143075560|NCT01755767|515814883|FG003|Overall Study|Death|4|||
143075561|NCT01755767|515814880|FG000|Overall Study|Subject Decision|0|||
143075562|NCT01755767|515814881|FG001|Overall Study|Subject Decision|0|||
143075563|NCT01755767|515814882|FG002|Overall Study|Subject Decision|10|||
143075564|NCT01755767|515814883|FG003|Overall Study|Subject Decision|3|||
143075565|NCT01755767|515814880|FG000|Overall Study|Withdrawal by Subject|0|||
143075566|NCT01755767|515814881|FG001|Overall Study|Withdrawal by Subject|0|||
143075567|NCT01755767|515814882|FG002|Overall Study|Withdrawal by Subject|2|||
143075568|NCT01755767|515814883|FG003|Overall Study|Withdrawal by Subject|1|||
143075569|NCT01755767|515814880|FG000|Overall Study|Other|0|||
143075570|NCT01755767|515814881|FG001|Overall Study|Other|0|||
143075571|NCT01755767|515814882|FG002|Overall Study|Other|2|||
143075572|NCT01755767|515814883|FG003|Overall Study|Other|3|||
143075573|NCT01755767|515814880|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
143075574|NCT01755767|515814881|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
143075575|NCT01755767|515814882|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
143075576|NCT01755767|515814883|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
143075577|NCT03464630|515814884|FG000|Overall Study|Lost to Follow-up|62|||
143075578|NCT03464630|515814885|FG001|Overall Study|Lost to Follow-up|52|||
143248656|NCT01584440|516463032|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
143248657|NCT01584440|516463033|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
143248658|NCT01584440|516463034|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
143248659|NCT01584440|516463035|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
143248660|NCT01584440|516463036|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
143248661|NCT01584440|516463032|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
143248662|NCT01584440|516463033|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
143248663|NCT01584440|516463034|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
143248664|NCT01584440|516463035|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
143248665|NCT01584440|516463036|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
143248666|NCT01584440|516463032|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
143248667|NCT01584440|516463033|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
143248668|NCT01584440|516463034|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
143248669|NCT01584440|516463035|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
143365809|NCT02333630|516882949|FG001|Overall Study|Lost to Follow-up|2|||
143365810|NCT02359435|516882950|FG000|Overall Study|Lost to Follow-up|4|||
143075579|NCT03464630|515814884|FG000|Overall Study|Withdrawal by Subject|16|||
143075580|NCT03464630|515814885|FG001|Overall Study|Withdrawal by Subject|10|||
143075581|NCT03464630|515814884|FG000|Overall Study|Passive Disengagement|8|||
143248670|NCT01584440|516463036|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
143248671|NCT01584440|516463032|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
143248672|NCT01584440|516463033|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
143248673|NCT01584440|516463034|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
143248674|NCT01584440|516463035|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
143248675|NCT01584440|516463036|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
143365811|NCT02359435|516882951|FG001|Overall Study|Lost to Follow-up|4|||
143365812|NCT04577183|516882956|FG000|Overall Study|Death|1|||
143365813|NCT04577183|516882956|FG000|Overall Study|Withdrawal by Subject|3|||
143365814|NCT04577183|516882956|FG000|Overall Study|Early termination|2|||
143365815|NCT00672256|516882957|FG000|Overall Study|PI dropped, bad data|44|||
143365816|NCT01688973|516882958|FG000|Overall Study|Ineligible|2|||
143365817|NCT01688973|516882959|FG001|Overall Study|Ineligible|3|||
143365818|NCT01124162|516882960|FG000|First Intervention|Adverse Event|2|||
143365819|NCT01124162|516882961|FG001|First Intervention|Adverse Event|0|||
143365820|NCT01124162|516882960|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
143365821|NCT01124162|516882961|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
143365822|NCT00938340|516882965|FG000|Overall Study|Withdrawal by Subject|3|||
143365823|NCT00938340|516882965|FG000|Overall Study|Protocol Violation|1|||
143365824|NCT00938340|516882965|FG000|Overall Study|Adverse Event|1|||
143365825|NCT03613129|516882966|FG000|Pre-treatment Assessment|Protocol Violation|2|||
143365826|NCT03613129|516882967|FG001|Pre-treatment Assessment|Protocol Violation|0|||
143365827|NCT03613129|516882968|FG002|Pre-treatment Assessment|Protocol Violation|0|||
143365828|NCT03613129|516882969|FG003|Pre-treatment Assessment|Protocol Violation|0|||
143365829|NCT03613129|516882970|FG004|Pre-treatment Assessment|Protocol Violation|0|||
143365830|NCT03613129|516882966|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
143365831|NCT03613129|516882967|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
143365832|NCT03613129|516882968|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
143365833|NCT03613129|516882969|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
143365834|NCT03613129|516882970|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
143365835|NCT02534896|516882973|FG000|Overall Study|Adverse Event|2|||
143365836|NCT02534896|516882974|FG001|Overall Study|Adverse Event|1|||
143365837|NCT02534896|516882975|FG002|Overall Study|Adverse Event|1|||
143365838|NCT02534896|516882973|FG000|Overall Study|Insufficient therapeutic response|2|||
143365839|NCT02534896|516882974|FG001|Overall Study|Insufficient therapeutic response|0|||
143365840|NCT02534896|516882975|FG002|Overall Study|Insufficient therapeutic response|0|||
143365841|NCT00711646|516882978|FG000|Overall Study|Adverse Event|6|||
143365842|NCT00711646|516882979|FG001|Overall Study|Adverse Event|1|||
143365843|NCT00711646|516882978|FG000|Overall Study|Withdrawal by Subject|4|||
143365844|NCT00711646|516882979|FG001|Overall Study|Withdrawal by Subject|0|||
143365845|NCT00711646|516882978|FG000|Overall Study|Protocol Violation|0|||
143365846|NCT00711646|516882979|FG001|Overall Study|Protocol Violation|1|||
143365847|NCT00711646|516882978|FG000|Overall Study|Lost to Follow-up|1|||
143365848|NCT00711646|516882979|FG001|Overall Study|Lost to Follow-up|0|||
143365849|NCT00711646|516882978|FG000|Overall Study|administrative decision|0|||
143365850|NCT00711646|516882979|FG001|Overall Study|administrative decision|1|||
143365851|NCT00711646|516882978|FG000|Overall Study|patient non-compliance|1|||
143365852|NCT00711646|516882979|FG001|Overall Study|patient non-compliance|0|||
143365853|NCT01107626|516882980|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
143365854|NCT01107626|516882981|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
143365855|NCT01107626|516882982|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
143365856|NCT01107626|516882983|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
143365857|NCT01107626|516882980|FG000|Step 1: Induction Therapy|Adverse Event|198|||
143365858|NCT01107626|516882981|FG001|Step 1: Induction Therapy|Adverse Event|0|||
143365859|NCT01107626|516882982|FG002|Step 1: Induction Therapy|Adverse Event|0|||
143365860|NCT01107626|516882983|FG003|Step 1: Induction Therapy|Adverse Event|0|||
143365861|NCT01107626|516882980|FG000|Step 1: Induction Therapy|Death|62|||
143365862|NCT01107626|516882981|FG001|Step 1: Induction Therapy|Death|0|||
143075582|NCT03464630|515814885|FG001|Overall Study|Passive Disengagement|4|||
143075583|NCT00191165|515814886|FG000|Overall Study|Adverse Event|2|||
143075584|NCT00191165|515814887|FG001|Overall Study|Adverse Event|0|||
143075585|NCT00191165|515814886|FG000|Overall Study|Protocol Violation|0|||
143075586|NCT00191165|515814887|FG001|Overall Study|Protocol Violation|1|||
143075587|NCT00191165|515814886|FG000|Overall Study|Participant Moved Away|0|||
143075588|NCT00191165|515814887|FG001|Overall Study|Participant Moved Away|1|||
143075589|NCT00715624|515814888|FG000|Overall Study|Adverse Event|12|||
143075590|NCT00715624|515814889|FG001|Overall Study|Adverse Event|37|||
143075591|NCT00715624|515814888|FG000|Overall Study|Lack of Efficacy|11|||
143365863|NCT01107626|516882982|FG002|Step 1: Induction Therapy|Death|0|||
143365864|NCT01107626|516882983|FG003|Step 1: Induction Therapy|Death|0|||
143365865|NCT01107626|516882980|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
143365866|NCT01107626|516882981|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
143075592|NCT00715624|515814889|FG001|Overall Study|Lack of Efficacy|11|||
143365867|NCT01107626|516882982|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
143365868|NCT01107626|516882983|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
143075593|NCT00715624|515814888|FG000|Overall Study|Lost to Follow-up|1|||
143075594|NCT00715624|515814889|FG001|Overall Study|Lost to Follow-up|2|||
143365869|NCT01107626|516882980|FG000|Step 1: Induction Therapy|Complicating disease|13|||
143365870|NCT01107626|516882981|FG001|Step 1: Induction Therapy|Complicating disease|0|||
143365871|NCT01107626|516882982|FG002|Step 1: Induction Therapy|Complicating disease|0|||
143365872|NCT01107626|516882983|FG003|Step 1: Induction Therapy|Complicating disease|0|||
143075595|NCT00715624|515814888|FG000|Overall Study|Protocol Violation|1|||
143365873|NCT01107626|516882980|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
143075596|NCT00715624|515814889|FG001|Overall Study|Protocol Violation|0|||
143075597|NCT00715624|515814888|FG000|Overall Study|Withdrawal by Subject|11|||
143075598|NCT00715624|515814889|FG001|Overall Study|Withdrawal by Subject|25|||
143075599|NCT00715624|515814888|FG000|Overall Study|Familial and personal reasons|10|||
143075600|NCT00715624|515814889|FG001|Overall Study|Familial and personal reasons|22|||
143075601|NCT00715624|515814888|FG000|Overall Study|Poor compliance|6|||
143075602|NCT00715624|515814889|FG001|Overall Study|Poor compliance|13|||
143075603|NCT00715624|515814888|FG000|Overall Study|Sponsor decision|0|||
143075604|NCT00715624|515814889|FG001|Overall Study|Sponsor decision|4|||
143075605|NCT00715624|515814888|FG000|Overall Study|Incorrect randomization (not treated)|0|||
143075606|NCT00715624|515814889|FG001|Overall Study|Incorrect randomization (not treated)|1|||
143075607|NCT00715624|515814888|FG000|Overall Study|Other|0|||
143075608|NCT00715624|515814889|FG001|Overall Study|Other|1|||
143075609|NCT03196635|515814891|FG000|Overall Study|Withdrawal by Subject|1|||
143075610|NCT00998309|515814899|FG000|Overall Study|Protocol Violation|4|||
143075611|NCT00735397|515814901|FG000|Overall Study|Adverse Event|194|||
143075612|NCT00735397|515814901|FG000|Overall Study|Lost to Follow-up|33|||
143075613|NCT00735397|515814901|FG000|Overall Study|Participant choice|252|||
143075614|NCT00735397|515814901|FG000|Overall Study|Inadequate therapeutic effect|202|||
143075615|NCT00735397|515814901|FG000|Overall Study|Administrative/Other|502|||
143075616|NCT00380744|515814904|FG000|Overall Study|Death|0|||
143075617|NCT00380744|515814905|FG001|Overall Study|Death|0|||
143075618|NCT00380744|515814906|FG002|Overall Study|Death|0|||
143075619|NCT00380744|515814907|FG003|Overall Study|Death|0|||
143075620|NCT00380744|515814908|FG004|Overall Study|Death|0|||
143075621|NCT00380744|515814909|FG005|Overall Study|Death|0|||
143075622|NCT00380744|515814910|FG006|Overall Study|Death|1|||
143075623|NCT00380744|515814904|FG000|Overall Study|Withdrawal by Subject|1|||
143075624|NCT00380744|515814905|FG001|Overall Study|Withdrawal by Subject|0|||
143075625|NCT00380744|515814906|FG002|Overall Study|Withdrawal by Subject|0|||
143075626|NCT00380744|515814907|FG003|Overall Study|Withdrawal by Subject|0|||
143075627|NCT00380744|515814908|FG004|Overall Study|Withdrawal by Subject|0|||
143075628|NCT00380744|515814909|FG005|Overall Study|Withdrawal by Subject|0|||
143075629|NCT00380744|515814910|FG006|Overall Study|Withdrawal by Subject|0|||
143075630|NCT02865460|515814911|FG000|Overall Study|Adverse Event|1|||
143075631|NCT02865460|515814912|FG001|Overall Study|Adverse Event|0|||
143075632|NCT02865460|515814911|FG000|Overall Study|Withdrawal by Subject|1|||
143075633|NCT02865460|515814912|FG001|Overall Study|Withdrawal by Subject|1|||
143075634|NCT02865460|515814911|FG000|Overall Study|Lost to Follow-up|7|||
143075635|NCT02865460|515814912|FG001|Overall Study|Lost to Follow-up|4|||
143075636|NCT02865460|515814911|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
143075637|NCT02865460|515814912|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
143075638|NCT01140503|515814916|FG000|Overall Study|Withdrawal by Subject|1|||
143075639|NCT00206323|515814917|FG000|Overall Study|Lack of Efficacy|4|||
143075640|NCT00206323|515814918|FG001|Overall Study|Lack of Efficacy|1|||
143075641|NCT00206323|515814917|FG000|Overall Study|Adverse Event|1|||
143075642|NCT00206323|515814918|FG001|Overall Study|Adverse Event|1|||
143075643|NCT00206323|515814917|FG000|Overall Study|Lost to Follow-up|1|||
143075644|NCT00206323|515814918|FG001|Overall Study|Lost to Follow-up|1|||
143075645|NCT03334617|515814919|FG000|Overall Study|Adverse Event|0|||
143075646|NCT03334617|515814920|FG001|Overall Study|Adverse Event|0|||
143365874|NCT01107626|516882981|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
143365875|NCT01107626|516882982|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
143365876|NCT01107626|516882983|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
143365877|NCT01107626|516882980|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
143365878|NCT01107626|516882981|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
143365879|NCT01107626|516882982|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
143365880|NCT01107626|516882983|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
143075647|NCT03334617|515814921|FG002|Overall Study|Adverse Event|0|||
143075648|NCT03334617|515814922|FG003|Overall Study|Adverse Event|0|||
143075649|NCT03334617|515814923|FG004|Overall Study|Adverse Event|0|||
143075650|NCT03334617|515814924|FG005|Overall Study|Adverse Event|0|||
143075651|NCT03334617|515814925|FG006|Overall Study|Adverse Event|0|||
143075652|NCT03334617|515814926|FG007|Overall Study|Adverse Event|0|||
143075653|NCT03334617|515814927|FG008|Overall Study|Adverse Event|1|||
143075654|NCT03334617|515814928|FG009|Overall Study|Adverse Event|0|||
143075655|NCT03334617|515814929|FG010|Overall Study|Adverse Event|0|||
143075656|NCT03334617|515814930|FG011|Overall Study|Adverse Event|0|||
143365881|NCT01107626|516882980|FG000|Step 1: Induction Therapy|Non-compliance|4|||
143075657|NCT03334617|515814931|FG012|Overall Study|Adverse Event|1|||
143075658|NCT03334617|515814932|FG013|Overall Study|Adverse Event|0|||
143075659|NCT03334617|515814933|FG014|Overall Study|Adverse Event|0|||
143365882|NCT01107626|516882981|FG001|Step 1: Induction Therapy|Non-compliance|0|||
143365883|NCT01107626|516882982|FG002|Step 1: Induction Therapy|Non-compliance|0|||
143365884|NCT01107626|516882983|FG003|Step 1: Induction Therapy|Non-compliance|0|||
143365885|NCT01107626|516882980|FG000|Step 1: Induction Therapy|Pain|4|||
143365886|NCT01107626|516882981|FG001|Step 1: Induction Therapy|Pain|0|||
143365887|NCT01107626|516882982|FG002|Step 1: Induction Therapy|Pain|0|||
143365888|NCT01107626|516882983|FG003|Step 1: Induction Therapy|Pain|0|||
143365889|NCT01107626|516882980|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
143365890|NCT01107626|516882981|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
143365891|NCT01107626|516882982|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
143075660|NCT03334617|515814934|FG015|Overall Study|Adverse Event|0|||
143075661|NCT03334617|515814935|FG016|Overall Study|Adverse Event|0|||
143075662|NCT03334617|515814936|FG017|Overall Study|Adverse Event|0|||
143075663|NCT03334617|515814937|FG018|Overall Study|Adverse Event|0|||
143075664|NCT03334617|515814938|FG019|Overall Study|Adverse Event|0|||
143075665|NCT03334617|515814939|FG020|Overall Study|Adverse Event|0|||
143075666|NCT03334617|515814940|FG021|Overall Study|Adverse Event|0|||
143075667|NCT03334617|515814919|FG000|Overall Study|Death|18|||
143075668|NCT03334617|515814920|FG001|Overall Study|Death|18|||
143075669|NCT03334617|515814921|FG002|Overall Study|Death|20|||
143075670|NCT03334617|515814922|FG003|Overall Study|Death|21|||
143075671|NCT03334617|515814923|FG004|Overall Study|Death|20|||
143075672|NCT03334617|515814924|FG005|Overall Study|Death|16|||
143365892|NCT01107626|516882983|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
143075673|NCT03334617|515814925|FG006|Overall Study|Death|28|||
143075674|NCT03334617|515814926|FG007|Overall Study|Death|35|||
143075675|NCT03334617|515814927|FG008|Overall Study|Death|47|||
143365893|NCT01107626|516882980|FG000|Step 1: Induction Therapy|Hospice care|1|||
143365894|NCT01107626|516882981|FG001|Step 1: Induction Therapy|Hospice care|0|||
143365895|NCT01107626|516882982|FG002|Step 1: Induction Therapy|Hospice care|0|||
143365896|NCT01107626|516882983|FG003|Step 1: Induction Therapy|Hospice care|0|||
143365897|NCT01107626|516882980|FG000|Step 1: Induction Therapy|Physician Decision|1|||
143365898|NCT01107626|516882981|FG001|Step 1: Induction Therapy|Physician Decision|0|||
143365899|NCT01107626|516882982|FG002|Step 1: Induction Therapy|Physician Decision|0|||
143365900|NCT01107626|516882983|FG003|Step 1: Induction Therapy|Physician Decision|0|||
143365901|NCT01107626|516882980|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
143365902|NCT01107626|516882981|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
143365903|NCT01107626|516882982|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
143365904|NCT01107626|516882983|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
143365905|NCT01107626|516882980|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
143365906|NCT01107626|516882981|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
143365907|NCT01107626|516882982|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
143365908|NCT01107626|516882983|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
143365909|NCT01107626|516882980|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
143365910|NCT01107626|516882981|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
143365911|NCT01107626|516882982|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
143365912|NCT01107626|516882983|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
143365913|NCT01107626|516882980|FG000|Step 2: Maintenance Therapy|Death|0|||
143365914|NCT01107626|516882981|FG001|Step 2: Maintenance Therapy|Death|8|||
143365915|NCT01107626|516882982|FG002|Step 2: Maintenance Therapy|Death|2|||
143365916|NCT01107626|516882983|FG003|Step 2: Maintenance Therapy|Death|13|||
143365917|NCT01107626|516882980|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
143365918|NCT01107626|516882981|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
143365919|NCT01107626|516882982|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
143365920|NCT01107626|516882983|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
143365921|NCT01107626|516882980|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
143365922|NCT01107626|516882981|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
143365923|NCT01107626|516882982|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
143365924|NCT01107626|516882983|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
143365925|NCT01107626|516882980|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
143365926|NCT01107626|516882981|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
143365927|NCT01107626|516882982|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
143365928|NCT01107626|516882983|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
143365929|NCT01107626|516882980|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
143365930|NCT01107626|516882981|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
143365931|NCT01107626|516882982|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
143365932|NCT01107626|516882983|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
143365933|NCT01107626|516882980|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
143365934|NCT01107626|516882981|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
143365935|NCT01107626|516882982|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
143365936|NCT01107626|516882983|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
143365937|NCT01107626|516882980|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
143365938|NCT01107626|516882981|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
143365939|NCT01107626|516882982|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
143075676|NCT03334617|515814928|FG009|Overall Study|Death|0|||
143075677|NCT03334617|515814929|FG010|Overall Study|Death|19|||
143365940|NCT01107626|516882983|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
143075678|NCT03334617|515814930|FG011|Overall Study|Death|6|||
143075679|NCT03334617|515814931|FG012|Overall Study|Death|20|||
143075680|NCT03334617|515814932|FG013|Overall Study|Death|22|||
143075681|NCT03334617|515814933|FG014|Overall Study|Death|17|||
143075682|NCT03334617|515814934|FG015|Overall Study|Death|18|||
143075683|NCT03334617|515814935|FG016|Overall Study|Death|12|||
143075684|NCT03334617|515814936|FG017|Overall Study|Death|15|||
143075685|NCT03334617|515814937|FG018|Overall Study|Death|16|||
143075686|NCT03334617|515814938|FG019|Overall Study|Death|27|||
143075687|NCT03334617|515814939|FG020|Overall Study|Death|14|||
143075688|NCT03334617|515814940|FG021|Overall Study|Death|27|||
143075689|NCT03334617|515814919|FG000|Overall Study|Lost to Follow-up|0|||
143075690|NCT03334617|515814920|FG001|Overall Study|Lost to Follow-up|0|||
143075691|NCT03334617|515814921|FG002|Overall Study|Lost to Follow-up|0|||
143075692|NCT03334617|515814922|FG003|Overall Study|Lost to Follow-up|1|||
143075693|NCT03334617|515814923|FG004|Overall Study|Lost to Follow-up|0|||
143075694|NCT03334617|515814924|FG005|Overall Study|Lost to Follow-up|1|||
143075695|NCT03334617|515814925|FG006|Overall Study|Lost to Follow-up|0|||
143075696|NCT03334617|515814926|FG007|Overall Study|Lost to Follow-up|0|||
143075697|NCT03334617|515814927|FG008|Overall Study|Lost to Follow-up|1|||
143075698|NCT03334617|515814928|FG009|Overall Study|Lost to Follow-up|0|||
143075699|NCT03334617|515814929|FG010|Overall Study|Lost to Follow-up|0|||
143075700|NCT03334617|515814930|FG011|Overall Study|Lost to Follow-up|0|||
143075701|NCT03334617|515814931|FG012|Overall Study|Lost to Follow-up|0|||
143075702|NCT03334617|515814932|FG013|Overall Study|Lost to Follow-up|0|||
143075703|NCT03334617|515814933|FG014|Overall Study|Lost to Follow-up|0|||
143075704|NCT03334617|515814934|FG015|Overall Study|Lost to Follow-up|0|||
143075705|NCT03334617|515814935|FG016|Overall Study|Lost to Follow-up|0|||
143075706|NCT03334617|515814936|FG017|Overall Study|Lost to Follow-up|0|||
143075707|NCT03334617|515814937|FG018|Overall Study|Lost to Follow-up|0|||
143075708|NCT03334617|515814938|FG019|Overall Study|Lost to Follow-up|0|||
143075709|NCT03334617|515814939|FG020|Overall Study|Lost to Follow-up|0|||
143075710|NCT03334617|515814940|FG021|Overall Study|Lost to Follow-up|0|||
143075711|NCT03334617|515814919|FG000|Overall Study|Withdrawal by Subject|0|||
143075712|NCT03334617|515814920|FG001|Overall Study|Withdrawal by Subject|1|||
143075713|NCT03334617|515814921|FG002|Overall Study|Withdrawal by Subject|0|||
143075714|NCT03334617|515814922|FG003|Overall Study|Withdrawal by Subject|0|||
143075715|NCT03334617|515814923|FG004|Overall Study|Withdrawal by Subject|1|||
143075716|NCT03334617|515814924|FG005|Overall Study|Withdrawal by Subject|1|||
143075717|NCT03334617|515814925|FG006|Overall Study|Withdrawal by Subject|1|||
143075718|NCT03334617|515814926|FG007|Overall Study|Withdrawal by Subject|2|||
143075719|NCT03334617|515814927|FG008|Overall Study|Withdrawal by Subject|0|||
143075720|NCT03334617|515814928|FG009|Overall Study|Withdrawal by Subject|0|||
143075721|NCT03334617|515814929|FG010|Overall Study|Withdrawal by Subject|0|||
143075722|NCT03334617|515814930|FG011|Overall Study|Withdrawal by Subject|1|||
143075723|NCT03334617|515814931|FG012|Overall Study|Withdrawal by Subject|1|||
143075724|NCT03334617|515814932|FG013|Overall Study|Withdrawal by Subject|0|||
143075725|NCT03334617|515814933|FG014|Overall Study|Withdrawal by Subject|2|||
143075726|NCT03334617|515814934|FG015|Overall Study|Withdrawal by Subject|1|||
143075727|NCT03334617|515814935|FG016|Overall Study|Withdrawal by Subject|0|||
143075728|NCT03334617|515814936|FG017|Overall Study|Withdrawal by Subject|1|||
143075729|NCT03334617|515814937|FG018|Overall Study|Withdrawal by Subject|1|||
143075730|NCT03334617|515814938|FG019|Overall Study|Withdrawal by Subject|1|||
143075731|NCT03334617|515814939|FG020|Overall Study|Withdrawal by Subject|0|||
143075732|NCT03334617|515814940|FG021|Overall Study|Withdrawal by Subject|1|||
143075733|NCT03334617|515814919|FG000|Overall Study|Other|1|||
143075734|NCT03334617|515814920|FG001|Overall Study|Other|2|||
143075735|NCT03334617|515814921|FG002|Overall Study|Other|0|||
143075736|NCT03334617|515814922|FG003|Overall Study|Other|1|||
143075737|NCT03334617|515814923|FG004|Overall Study|Other|1|||
143075738|NCT03334617|515814924|FG005|Overall Study|Other|0|||
143075739|NCT03334617|515814925|FG006|Overall Study|Other|2|||
143075740|NCT03334617|515814926|FG007|Overall Study|Other|1|||
143075741|NCT03334617|515814927|FG008|Overall Study|Other|8|||
143075742|NCT03334617|515814928|FG009|Overall Study|Other|0|||
143075743|NCT03334617|515814929|FG010|Overall Study|Other|3|||
143075744|NCT03334617|515814930|FG011|Overall Study|Other|1|||
143075745|NCT03334617|515814931|FG012|Overall Study|Other|3|||
143075746|NCT03334617|515814932|FG013|Overall Study|Other|1|||
143075747|NCT03334617|515814933|FG014|Overall Study|Other|1|||
143075748|NCT03334617|515814934|FG015|Overall Study|Other|3|||
143075749|NCT03334617|515814935|FG016|Overall Study|Other|3|||
143075750|NCT03334617|515814936|FG017|Overall Study|Other|3|||
143075751|NCT03334617|515814937|FG018|Overall Study|Other|7|||
143075752|NCT03334617|515814938|FG019|Overall Study|Other|4|||
143075753|NCT03334617|515814939|FG020|Overall Study|Other|1|||
143075754|NCT03334617|515814940|FG021|Overall Study|Other|4|||
143075755|NCT03334617|515814919|FG000|Overall Study|Continuing study off treatment at data cut-off|0|||
143075756|NCT03334617|515814920|FG001|Overall Study|Continuing study off treatment at data cut-off|0|||
143075757|NCT03334617|515814921|FG002|Overall Study|Continuing study off treatment at data cut-off|0|||
143075758|NCT03334617|515814922|FG003|Overall Study|Continuing study off treatment at data cut-off|0|||
143075759|NCT03334617|515814923|FG004|Overall Study|Continuing study off treatment at data cut-off|0|||
143075760|NCT03334617|515814924|FG005|Overall Study|Continuing study off treatment at data cut-off|2|||
143075761|NCT03334617|515814925|FG006|Overall Study|Continuing study off treatment at data cut-off|0|||
143075762|NCT03334617|515814926|FG007|Overall Study|Continuing study off treatment at data cut-off|0|||
143075763|NCT03334617|515814927|FG008|Overall Study|Continuing study off treatment at data cut-off|0|||
143075764|NCT03334617|515814928|FG009|Overall Study|Continuing study off treatment at data cut-off|0|||
143075765|NCT03334617|515814929|FG010|Overall Study|Continuing study off treatment at data cut-off|1|||
143075766|NCT03334617|515814930|FG011|Overall Study|Continuing study off treatment at data cut-off|0|||
143172208|NCT00557193|516179684|FG003|Induction|Physician Decision|0|||
143172209|NCT00557193|516179685|FG004|Induction|Physician Decision|0|||
143172210|NCT00557193|516179686|FG005|Induction|Physician Decision|0|||
143075767|NCT03334617|515814931|FG012|Overall Study|Continuing study off treatment at data cut-off|0|||
143075768|NCT03334617|515814932|FG013|Overall Study|Continuing study off treatment at data cut-off|0|||
143075769|NCT03334617|515814933|FG014|Overall Study|Continuing study off treatment at data cut-off|0|||
143075770|NCT03334617|515814934|FG015|Overall Study|Continuing study off treatment at data cut-off|0|||
143075771|NCT03334617|515814935|FG016|Overall Study|Continuing study off treatment at data cut-off|0|||
143075772|NCT03334617|515814936|FG017|Overall Study|Continuing study off treatment at data cut-off|0|||
143075773|NCT03334617|515814937|FG018|Overall Study|Continuing study off treatment at data cut-off|0|||
143172211|NCT00557193|516179681|FG000|Induction|Withdrawal by Subject|1|||
143075774|NCT03334617|515814938|FG019|Overall Study|Continuing study off treatment at data cut-off|1|||
143075775|NCT03334617|515814939|FG020|Overall Study|Continuing study off treatment at data cut-off|2|||
143172212|NCT00557193|516179682|FG001|Induction|Withdrawal by Subject|0|||
143172213|NCT00557193|516179683|FG002|Induction|Withdrawal by Subject|0|||
143365941|NCT01107626|516882980|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
143365942|NCT01107626|516882981|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
143365943|NCT01107626|516882982|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
143075776|NCT03334617|515814940|FG021|Overall Study|Continuing study off treatment at data cut-off|4|||
143075777|NCT00827632|515814941|FG000|Overall Study|Lost to Follow-up|8|||
143075778|NCT00827632|515814942|FG001|Overall Study|Lost to Follow-up|12|||
143075779|NCT00827632|515814941|FG000|Overall Study|Early withdrawal|14|||
143075780|NCT00827632|515814942|FG001|Overall Study|Early withdrawal|11|||
143075781|NCT05330468|515814943|FG000|Overall Study|Death|6|||
143075782|NCT05330468|515814943|FG000|Overall Study|Withdrawal by Subject|4|||
143075783|NCT05330468|515814943|FG000|Overall Study|Lost to Follow-up|4|||
143075784|NCT03734666|515814945|FG000|Overall Study|Other|7|||
143075785|NCT03734666|515814946|FG001|Overall Study|Other|4|||
143075786|NCT03734666|515814945|FG000|Overall Study|Lost to Follow-up|12|||
143075787|NCT03734666|515814946|FG001|Overall Study|Lost to Follow-up|12|||
143075788|NCT05896202|515814947|FG000|Overall Study|Lost to Follow-up|2|||
143075789|NCT05896202|515814948|FG001|Overall Study|Lost to Follow-up|2|||
143075790|NCT04669691|515814957|FG000|Overall Study|Death|0|||
143075791|NCT04669691|515814958|FG001|Overall Study|Death|1|||
143075792|NCT04669691|515814959|FG002|Overall Study|Death|0|||
143075793|NCT04669691|515814960|FG003|Overall Study|Death|0|||
143075794|NCT04669691|515814961|FG004|Overall Study|Death|0|||
143075795|NCT04669691|515814962|FG005|Overall Study|Death|0|||
143075796|NCT03918109|515814963|FG000|Overall Study|Withdrawal by Subject|0|||
143075797|NCT03918109|515814964|FG001|Overall Study|Withdrawal by Subject|0|||
143075798|NCT03918109|515814965|FG002|Overall Study|Withdrawal by Subject|2|||
143075799|NCT03918109|515814966|FG003|Overall Study|Withdrawal by Subject|1|||
143075800|NCT03918109|515814963|FG000|Overall Study|Lost to Follow-up|0|||
143075801|NCT03918109|515814964|FG001|Overall Study|Lost to Follow-up|0|||
143075802|NCT03918109|515814965|FG002|Overall Study|Lost to Follow-up|0|||
143075803|NCT03918109|515814966|FG003|Overall Study|Lost to Follow-up|1|||
143075804|NCT00390221|515814967|FG000|Overall Study|Lost to Follow-up|0|||
143075805|NCT00390221|515814968|FG001|Overall Study|Lost to Follow-up|3|||
143075806|NCT00390221|515814969|FG002|Overall Study|Lost to Follow-up|0|||
143365944|NCT01107626|516882983|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
143365945|NCT01107626|516882980|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
143075807|NCT00390221|515814967|FG000|Overall Study|Adverse Event|1|||
143075808|NCT00390221|515814968|FG001|Overall Study|Adverse Event|4|||
143365946|NCT01107626|516882981|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
143075809|NCT00390221|515814969|FG002|Overall Study|Adverse Event|3|||
143075810|NCT00390221|515814967|FG000|Overall Study|Investigator Decision|0|||
143075811|NCT00390221|515814968|FG001|Overall Study|Investigator Decision|0|||
143075812|NCT00390221|515814969|FG002|Overall Study|Investigator Decision|1|||
143075813|NCT00390221|515814967|FG000|Overall Study|Withdrawal by Subject|13|||
143075814|NCT00390221|515814968|FG001|Overall Study|Withdrawal by Subject|9|||
143075815|NCT00390221|515814969|FG002|Overall Study|Withdrawal by Subject|7|||
143075816|NCT00390221|515814967|FG000|Overall Study|Subject Non-compliance|1|||
143075817|NCT00390221|515814968|FG001|Overall Study|Subject Non-compliance|0|||
143075818|NCT00390221|515814969|FG002|Overall Study|Subject Non-compliance|2|||
143075819|NCT00390221|515814967|FG000|Overall Study|Other|3|||
143075820|NCT00390221|515814968|FG001|Overall Study|Other|4|||
143075821|NCT00390221|515814969|FG002|Overall Study|Other|2|||
143075822|NCT02582866|515814970|FG000|Overall Study|Death|1|||
143075823|NCT02582866|515814970|FG000|Overall Study|Lack of Efficacy|2|||
143075824|NCT02582866|515814970|FG000|Overall Study|Lost to Follow-up|2|||
143075825|NCT02582866|515814970|FG000|Overall Study|Withdrawal by Subject|7|||
143075826|NCT02582866|515814970|FG000|Overall Study|Investigator decision|5|||
143075827|NCT02582866|515814970|FG000|Overall Study|Participant wants to get pregnant|1|||
143075828|NCT02582866|515814970|FG000|Overall Study|Pregnancy|2|||
143075829|NCT02582866|515814970|FG000|Overall Study|Sponsor decision|1|||
143075830|NCT02582866|515814970|FG000|Overall Study|Withdrawal due to personal reasons|1|||
143075831|NCT02011386|515814971|FG000|Overall Study|Non-compliance|2|||
143075832|NCT02011386|515814971|FG000|Overall Study|Lack of Efficacy|3|||
143075833|NCT03047330|515817110|FG000|Sleep Block 1|Withdrawal by Subject|3|||
143075834|NCT01957397|515817112|FG000|Test Period 1|sudden leakage/small bag|1|||
143075835|NCT01957397|515817113|FG001|Test Period 1|sudden leakage/small bag|1|||
143075836|NCT01957397|515817112|FG000|Test Period 1|Withdrawal by Subject|1|||
143075837|NCT01957397|515817113|FG001|Test Period 1|Withdrawal by Subject|0|||
143075838|NCT01957397|515817112|FG000|Test Period 2|Adverse Event|0|||
143075839|NCT01957397|515817113|FG001|Test Period 2|Adverse Event|1|||
143075840|NCT01957397|515817112|FG000|Test Period 3|Adverse Event|1|||
143075841|NCT01957397|515817113|FG001|Test Period 3|Adverse Event|2|||
143075842|NCT01957397|515817112|FG000|Test Period 3|the adhesive did not work|1|||
143075843|NCT01957397|515817113|FG001|Test Period 3|the adhesive did not work|0|||
143075844|NCT00540293|515817114|FG000|Overall Study|Adverse event related to study drug|10|||
143075845|NCT00540293|515817114|FG000|Overall Study|Adverse event not related to study drug|7|||
143075846|NCT00540293|515817114|FG000|Overall Study|Withdrawal by Subject|6|||
143075847|NCT00540293|515817114|FG000|Overall Study|Protocol violation, & subject schedule|12|||
143075848|NCT00806286|515817117|FG000|Overall Study|Adverse Event|5|||
143075849|NCT00806286|515817118|FG001|Overall Study|Adverse Event|2|||
143075850|NCT00806286|515817119|FG002|Overall Study|Adverse Event|0|||
143075851|NCT00806286|515817117|FG000|Overall Study|Disease progression|31|||
143075852|NCT00806286|515817118|FG001|Overall Study|Disease progression|38|||
143075853|NCT00806286|515817119|FG002|Overall Study|Disease progression|1|||
143075854|NCT00806286|515817117|FG000|Overall Study|Death|1|||
143075855|NCT00806286|515817118|FG001|Overall Study|Death|6|||
143075856|NCT00806286|515817119|FG002|Overall Study|Death|0|||
143075857|NCT00806286|515817117|FG000|Overall Study|Lost to Follow-up|0|||
143075858|NCT00806286|515817118|FG001|Overall Study|Lost to Follow-up|1|||
143075859|NCT00806286|515817119|FG002|Overall Study|Lost to Follow-up|0|||
143075860|NCT00806286|515817117|FG000|Overall Study|Withdrawal by Subject|8|||
143075861|NCT00806286|515817118|FG001|Overall Study|Withdrawal by Subject|3|||
143075862|NCT00806286|515817119|FG002|Overall Study|Withdrawal by Subject|1|||
143172214|NCT00557193|516179684|FG003|Induction|Withdrawal by Subject|0|||
143172215|NCT00557193|516179685|FG004|Induction|Withdrawal by Subject|0|||
143172216|NCT00557193|516179686|FG005|Induction|Withdrawal by Subject|0|||
143172217|NCT00557193|516179681|FG000|Induction|Refusal of Further Protocol Therapy|2|||
143172218|NCT00557193|516179682|FG001|Induction|Refusal of Further Protocol Therapy|0|||
143172219|NCT00557193|516179683|FG002|Induction|Refusal of Further Protocol Therapy|0|||
143172220|NCT00557193|516179684|FG003|Induction|Refusal of Further Protocol Therapy|0|||
143172221|NCT00557193|516179685|FG004|Induction|Refusal of Further Protocol Therapy|0|||
143248676|NCT01584440|516463032|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
143075863|NCT00806286|515817117|FG000|Overall Study|Physician Decision|2|||
143075864|NCT00806286|515817118|FG001|Overall Study|Physician Decision|2|||
143075865|NCT00806286|515817119|FG002|Overall Study|Physician Decision|0|||
143075866|NCT00806286|515817117|FG000|Overall Study|Due to a variety of reasons|7|||
143075867|NCT00806286|515817118|FG001|Overall Study|Due to a variety of reasons|2|||
143172222|NCT00557193|516179686|FG005|Induction|Refusal of Further Protocol Therapy|0|||
143172223|NCT00557193|516179681|FG000|Induction|Ineligible|8|||
143172224|NCT00557193|516179682|FG001|Induction|Ineligible|0|||
143248677|NCT01584440|516463033|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
143172225|NCT00557193|516179683|FG002|Induction|Ineligible|0|||
143172226|NCT00557193|516179684|FG003|Induction|Ineligible|0|||
143172227|NCT00557193|516179685|FG004|Induction|Ineligible|0|||
143172228|NCT00557193|516179686|FG005|Induction|Ineligible|0|||
143172229|NCT00557193|516179681|FG000|Induction|Inevaluable for post Induction|2|||
143365947|NCT01107626|516882982|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
143365948|NCT01107626|516882983|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
143075868|NCT00806286|515817119|FG002|Overall Study|Due to a variety of reasons|1|||
143075869|NCT00686075|515817121|FG000|Overall Study|Withdrawal by Subject|4|||
143075870|NCT00686075|515817122|FG001|Overall Study|Withdrawal by Subject|3|||
143075871|NCT00686075|515817123|FG002|Overall Study|Withdrawal by Subject|3|||
143075872|NCT00686075|515817124|FG003|Overall Study|Withdrawal by Subject|7|||
143075873|NCT00686075|515817125|FG004|Overall Study|Withdrawal by Subject|1|||
143075874|NCT00686075|515817126|FG005|Overall Study|Withdrawal by Subject|0|||
143075875|NCT00686075|515817127|FG006|Overall Study|Withdrawal by Subject|0|||
143075876|NCT00686075|515817128|FG007|Overall Study|Withdrawal by Subject|2|||
143075877|NCT00686075|515817129|FG008|Overall Study|Withdrawal by Subject|4|||
143075878|NCT00686075|515817130|FG009|Overall Study|Withdrawal by Subject|6|||
143075879|NCT00686075|515817121|FG000|Overall Study|Lost to Follow-up|3|||
143075880|NCT00686075|515817122|FG001|Overall Study|Lost to Follow-up|6|||
143075881|NCT00686075|515817123|FG002|Overall Study|Lost to Follow-up|3|||
143075882|NCT00686075|515817124|FG003|Overall Study|Lost to Follow-up|2|||
143075883|NCT00686075|515817125|FG004|Overall Study|Lost to Follow-up|3|||
143075884|NCT00686075|515817126|FG005|Overall Study|Lost to Follow-up|3|||
143075885|NCT00686075|515817127|FG006|Overall Study|Lost to Follow-up|0|||
143075886|NCT00686075|515817128|FG007|Overall Study|Lost to Follow-up|0|||
143172230|NCT00557193|516179682|FG001|Induction|Inevaluable for post Induction|0|||
143172231|NCT00557193|516179683|FG002|Induction|Inevaluable for post Induction|0|||
143365949|NCT01107626|516882980|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
143075887|NCT00686075|515817129|FG008|Overall Study|Lost to Follow-up|2|||
143075888|NCT00686075|515817130|FG009|Overall Study|Lost to Follow-up|3|||
143075889|NCT00686075|515817121|FG000|Overall Study|Other|1|||
143172232|NCT00557193|516179684|FG003|Induction|Inevaluable for post Induction|0|||
143172233|NCT00557193|516179685|FG004|Induction|Inevaluable for post Induction|0|||
143172234|NCT00557193|516179686|FG005|Induction|Inevaluable for post Induction|0|||
143365950|NCT01107626|516882981|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
143365951|NCT01107626|516882982|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
143365952|NCT01107626|516882983|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
143365953|NCT01107626|516882980|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
143365954|NCT01107626|516882981|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
143365955|NCT01107626|516882982|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
143365956|NCT01107626|516882983|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
143075890|NCT00686075|515817122|FG001|Overall Study|Other|1|||
143075891|NCT00686075|515817123|FG002|Overall Study|Other|0|||
143075892|NCT00686075|515817124|FG003|Overall Study|Other|0|||
143075893|NCT00686075|515817125|FG004|Overall Study|Other|0|||
143075894|NCT00686075|515817126|FG005|Overall Study|Other|0|||
143075895|NCT00686075|515817127|FG006|Overall Study|Other|0|||
143075896|NCT00686075|515817128|FG007|Overall Study|Other|0|||
143075897|NCT00686075|515817129|FG008|Overall Study|Other|0|||
143075898|NCT00686075|515817130|FG009|Overall Study|Other|1|||
143075899|NCT04713553|515817142|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
143075900|NCT04713553|515817143|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
143075901|NCT04713553|515817144|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
143075902|NCT04713553|515817145|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
143075903|NCT04713553|515817146|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
143075904|NCT04713553|515817147|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
143075905|NCT04713553|515817148|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
143075906|NCT04713553|515817142|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
143075907|NCT04713553|515817143|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
143075908|NCT04713553|515817144|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
143365957|NCT01107626|516882980|FG000|Step 2: Maintenance Therapy|Pain|0|||
143365958|NCT01107626|516882981|FG001|Step 2: Maintenance Therapy|Pain|0|||
143365959|NCT01107626|516882982|FG002|Step 2: Maintenance Therapy|Pain|0|||
143365960|NCT01107626|516882983|FG003|Step 2: Maintenance Therapy|Pain|1|||
143365961|NCT01107626|516882980|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
143365962|NCT01107626|516882981|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
143365963|NCT01107626|516882982|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
143365964|NCT01107626|516882983|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
143365965|NCT00269399|516882984|FG000|Overall Study|Lack of Efficacy|27|||
143365966|NCT00269399|516882985|FG001|Overall Study|Lack of Efficacy|10|||
143365967|NCT00269399|516882984|FG000|Overall Study|Adverse Event|10|||
143365968|NCT00269399|516882985|FG001|Overall Study|Adverse Event|4|||
143365969|NCT00269399|516882984|FG000|Overall Study|Withdrawal by Subject|2|||
143365970|NCT00269399|516882985|FG001|Overall Study|Withdrawal by Subject|5|||
143365971|NCT00269399|516882984|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
143365972|NCT00269399|516882985|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
143365973|NCT00269399|516882984|FG000|Overall Study|Other|0|||
143365974|NCT00269399|516882985|FG001|Overall Study|Other|4|||
143365975|NCT00269399|516882984|FG000|Overall Study|Development of exclusion criteria|0|||
143365976|NCT00269399|516882985|FG001|Overall Study|Development of exclusion criteria|1|||
143075909|NCT04713553|515817145|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
143075910|NCT04713553|515817146|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
143075911|NCT04713553|515817147|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
143075912|NCT04713553|515817148|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
143075913|NCT04713553|515817142|FG000|Primary Study (2 Months)|Other|1|||
143075914|NCT04713553|515817143|FG001|Primary Study (2 Months)|Other|2|||
143075915|NCT04713553|515817144|FG002|Primary Study (2 Months)|Other|0|||
143075916|NCT04713553|515817145|FG003|Primary Study (2 Months)|Other|0|||
143075917|NCT04713553|515817146|FG004|Primary Study (2 Months)|Other|1|||
143075918|NCT04713553|515817147|FG005|Primary Study (2 Months)|Other|0|||
143075919|NCT04713553|515817148|FG006|Primary Study (2 Months)|Other|0|||
143075920|NCT04713553|515817142|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
143075921|NCT04713553|515817143|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
143075922|NCT04713553|515817144|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
143075923|NCT04713553|515817145|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
143075924|NCT04713553|515817146|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
143075925|NCT04713553|515817147|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
143075926|NCT04713553|515817148|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
143075927|NCT04713553|515817142|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
143075928|NCT04713553|515817143|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
143075929|NCT04713553|515817144|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
143075930|NCT04713553|515817145|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
143075931|NCT04713553|515817146|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
143075932|NCT04713553|515817147|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
143075933|NCT04713553|515817148|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
143365977|NCT03441360|516882986|FG000|Overall Study|Radiological disease progression|5|||
143365978|NCT03441360|516882987|FG001|Overall Study|Radiological disease progression|6|||
143075934|NCT01682863|515817150|FG000|Overall Study|Subject/guardian decision|19|||
143075935|NCT01682863|515817151|FG001|Overall Study|Subject/guardian decision|12|||
143075936|NCT01682863|515817152|FG002|Overall Study|Subject/guardian decision|10|||
143075937|NCT01682863|515817150|FG000|Overall Study|Lost to Follow-up|5|||
143075938|NCT01682863|515817151|FG001|Overall Study|Lost to Follow-up|1|||
143075939|NCT01682863|515817152|FG002|Overall Study|Lost to Follow-up|6|||
143075940|NCT01682863|515817150|FG000|Overall Study|Death|1|||
143075941|NCT01682863|515817151|FG001|Overall Study|Death|3|||
143075942|NCT01682863|515817152|FG002|Overall Study|Death|4|||
143075943|NCT01682863|515817150|FG000|Overall Study|Protocol deviation|1|||
143075944|NCT01682863|515817151|FG001|Overall Study|Protocol deviation|0|||
143075945|NCT01682863|515817152|FG002|Overall Study|Protocol deviation|1|||
143075946|NCT01682863|515817150|FG000|Overall Study|Technical problems|1|||
143075947|NCT01682863|515817151|FG001|Overall Study|Technical problems|0|||
143075948|NCT01682863|515817152|FG002|Overall Study|Technical problems|0|||
143075949|NCT01682863|515817150|FG000|Overall Study|Adverse Event|0|||
143075950|NCT01682863|515817151|FG001|Overall Study|Adverse Event|1|||
143075951|NCT01682863|515817152|FG002|Overall Study|Adverse Event|2|||
143075952|NCT01682863|515817150|FG000|Overall Study|Physician Decision|0|||
143075953|NCT01682863|515817151|FG001|Overall Study|Physician Decision|0|||
143075954|NCT01682863|515817152|FG002|Overall Study|Physician Decision|1|||
143075955|NCT03972163|515817153|FG000|Overall Study|Death|0|||
143075956|NCT03972163|515817154|FG001|Overall Study|Death|1|||
143075957|NCT01161407|515817155|FG000|Overall Study|Protocol Violation|3|||
143075958|NCT01161407|515817156|FG001|Overall Study|Protocol Violation|1|||
143075959|NCT04516759|515817158|FG000|Overall Study|Withdrawal by Subject|1|||
143075960|NCT04516759|515817159|FG001|Overall Study|Withdrawal by Subject|1|||
143075961|NCT04516759|515817158|FG000|Overall Study|Other|0|||
143075962|NCT04516759|515817159|FG001|Overall Study|Other|1|||
143075963|NCT01352416|515817162|FG000|Overall Study|Physician Decision|1|||
143075964|NCT01352416|515817163|FG001|Overall Study|Physician Decision|2|||
143075965|NCT01352416|515817164|FG002|Overall Study|Physician Decision|2|||
143075966|NCT01352416|515817165|FG003|Overall Study|Physician Decision|1|||
143075967|NCT00229723|515817166|FG000|Concomitant Phase|Adverse Event|4|||
143075968|NCT00229723|515817167|FG001|Concomitant Phase|Adverse Event|2|||
143075969|NCT00229723|515817168|FG002|Concomitant Phase|Adverse Event|5|||
143075970|NCT00229723|515817169|FG003|Concomitant Phase|Adverse Event|2|||
143075971|NCT00229723|515817170|FG004|Concomitant Phase|Adverse Event|0|||
143075972|NCT00229723|515817171|FG005|Concomitant Phase|Adverse Event|1|||
143075973|NCT00229723|515817172|FG006|Concomitant Phase|Adverse Event|2|||
143075974|NCT00229723|515817166|FG000|Concomitant Phase|Objective disease progression|0|||
143075975|NCT00229723|515817167|FG001|Concomitant Phase|Objective disease progression|0|||
143075976|NCT00229723|515817168|FG002|Concomitant Phase|Objective disease progression|0|||
143075977|NCT00229723|515817169|FG003|Concomitant Phase|Objective disease progression|0|||
143075978|NCT00229723|515817170|FG004|Concomitant Phase|Objective disease progression|0|||
143075979|NCT00229723|515817171|FG005|Concomitant Phase|Objective disease progression|0|||
143075980|NCT00229723|515817172|FG006|Concomitant Phase|Objective disease progression|0|||
143075981|NCT00229723|515817166|FG000|Concomitant Phase|Clinical progression|0|||
143075982|NCT00229723|515817167|FG001|Concomitant Phase|Clinical progression|0|||
143075983|NCT00229723|515817168|FG002|Concomitant Phase|Clinical progression|0|||
143075984|NCT00229723|515817169|FG003|Concomitant Phase|Clinical progression|0|||
143075985|NCT00229723|515817170|FG004|Concomitant Phase|Clinical progression|0|||
143075986|NCT00229723|515817171|FG005|Concomitant Phase|Clinical progression|0|||
143075987|NCT00229723|515817172|FG006|Concomitant Phase|Clinical progression|1|||
143075988|NCT00229723|515817166|FG000|Concomitant Phase|Lost to Follow-up|0|||
143075989|NCT00229723|515817167|FG001|Concomitant Phase|Lost to Follow-up|0|||
143075990|NCT00229723|515817168|FG002|Concomitant Phase|Lost to Follow-up|0|||
143075991|NCT00229723|515817169|FG003|Concomitant Phase|Lost to Follow-up|0|||
143075992|NCT00229723|515817170|FG004|Concomitant Phase|Lost to Follow-up|1|||
143075993|NCT00229723|515817171|FG005|Concomitant Phase|Lost to Follow-up|0|||
143075994|NCT00229723|515817172|FG006|Concomitant Phase|Lost to Follow-up|0|||
143075995|NCT00229723|515817166|FG000|Concomitant Phase|Informed consent withdrawn|3|||
143075996|NCT00229723|515817167|FG001|Concomitant Phase|Informed consent withdrawn|2|||
143075997|NCT00229723|515817168|FG002|Concomitant Phase|Informed consent withdrawn|0|||
143075998|NCT00229723|515817169|FG003|Concomitant Phase|Informed consent withdrawn|2|||
143075999|NCT00229723|515817170|FG004|Concomitant Phase|Informed consent withdrawn|0|||
143076000|NCT00229723|515817171|FG005|Concomitant Phase|Informed consent withdrawn|0|||
143076001|NCT00229723|515817172|FG006|Concomitant Phase|Informed consent withdrawn|0|||
143076002|NCT00229723|515817166|FG000|Concomitant Phase|Severe non-compliance|0|||
143076003|NCT00229723|515817167|FG001|Concomitant Phase|Severe non-compliance|1|||
143076004|NCT00229723|515817168|FG002|Concomitant Phase|Severe non-compliance|0|||
143076005|NCT00229723|515817169|FG003|Concomitant Phase|Severe non-compliance|0|||
143365979|NCT03441360|516882988|FG002|Overall Study|Radiological disease progression|4|||
143365980|NCT03441360|516882986|FG000|Overall Study|Clinical disease progression|2|||
143365981|NCT03441360|516882987|FG001|Overall Study|Clinical disease progression|2|||
143365982|NCT03441360|516882988|FG002|Overall Study|Clinical disease progression|0|||
143365983|NCT03441360|516882986|FG000|Overall Study|Adverse Event|1|||
143365984|NCT03441360|516882987|FG001|Overall Study|Adverse Event|0|||
143365985|NCT03441360|516882988|FG002|Overall Study|Adverse Event|1|||
143365986|NCT03396835|516882990|FG000|Overall Study|Withdrawn prior to completion|1|||
143365987|NCT03396835|516882990|FG000|Overall Study|Did not meet criteria for data analysis|1|||
143365988|NCT03439124|516882997|FG000|Overall Study|Adverse Event|2|||
143365989|NCT03439124|516882998|FG001|Overall Study|Adverse Event|0|||
143365990|NCT03439124|516882997|FG000|Overall Study|Lost to Follow-up|1|||
143365991|NCT03439124|516882998|FG001|Overall Study|Lost to Follow-up|0|||
143365992|NCT03439124|516882997|FG000|Overall Study|Other reasons|1|||
143365993|NCT03439124|516882998|FG001|Overall Study|Other reasons|0|||
143365994|NCT02993471|516883004|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
143365995|NCT02993471|516883004|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
143365996|NCT02219490|516883010|FG000|Overall Study|Adverse Event|24|||
143365997|NCT02219490|516883010|FG000|Overall Study|Withdrew consent|96|||
143365998|NCT02219490|516883010|FG000|Overall Study|Lost to Follow-up|126|||
143365999|NCT02219490|516883010|FG000|Overall Study|COVID-19 infection|2|||
143366000|NCT02219490|516883010|FG000|Overall Study|COVID-19 logistical restrictions|33|||
143366001|NCT02219490|516883010|FG000|Overall Study|Other, not specified|57|||
143366002|NCT02775435|516883014|FG000|Overall Study|Adverse Event|32|||
143366003|NCT02775435|516883015|FG001|Overall Study|Adverse Event|27|||
143366004|NCT02775435|516883014|FG000|Overall Study|Lost to Follow-up|2|||
143366005|NCT02775435|516883015|FG001|Overall Study|Lost to Follow-up|2|||
143366006|NCT02775435|516883014|FG000|Overall Study|Sponsor decision|44|||
143366007|NCT02775435|516883015|FG001|Overall Study|Sponsor decision|19|||
143366008|NCT02775435|516883014|FG000|Overall Study|Withdrawal by Subject|4|||
143366009|NCT02775435|516883015|FG001|Overall Study|Withdrawal by Subject|9|||
143366010|NCT02775435|516883014|FG000|Overall Study|Death|196|||
143366011|NCT02775435|516883015|FG001|Overall Study|Death|224|||
143366012|NCT01670019|516883016|FG000|Overall Study|Adverse Event|3|||
143366013|NCT01670019|516883017|FG001|Overall Study|Adverse Event|0|||
143366014|NCT01670019|516883016|FG000|Overall Study|Withdrawal by Subject|6|||
143366015|NCT01670019|516883017|FG001|Overall Study|Withdrawal by Subject|0|||
143366016|NCT03852433|516883023|FG000|Overall Study|Withdrawal of consent|5|||
143366017|NCT03852433|516883024|FG001|Overall Study|Withdrawal of consent|8|||
143366018|NCT03852433|516883025|FG002|Overall Study|Withdrawal of consent|1|||
143366019|NCT03852433|516883026|FG003|Overall Study|Withdrawal of consent|1|||
143366020|NCT03852433|516883023|FG000|Overall Study|Adverse Event|1|||
143366021|NCT03852433|516883024|FG001|Overall Study|Adverse Event|1|||
143366022|NCT03852433|516883025|FG002|Overall Study|Adverse Event|1|||
143366023|NCT03852433|516883026|FG003|Overall Study|Adverse Event|1|||
143366024|NCT03852433|516883023|FG000|Overall Study|Lost to Follow-up|0|||
143366025|NCT03852433|516883024|FG001|Overall Study|Lost to Follow-up|1|||
143366026|NCT03852433|516883025|FG002|Overall Study|Lost to Follow-up|0|||
143366027|NCT03852433|516883026|FG003|Overall Study|Lost to Follow-up|1|||
143366028|NCT03852433|516883023|FG000|Overall Study|Pregnancy|0|||
143366029|NCT03852433|516883024|FG001|Overall Study|Pregnancy|1|||
143366030|NCT03852433|516883025|FG002|Overall Study|Pregnancy|1|||
143366031|NCT03852433|516883026|FG003|Overall Study|Pregnancy|0|||
143366032|NCT03852433|516883023|FG000|Overall Study|Protocol Violation|0|||
143366033|NCT03852433|516883024|FG001|Overall Study|Protocol Violation|0|||
143366034|NCT03852433|516883025|FG002|Overall Study|Protocol Violation|1|||
143366035|NCT03852433|516883026|FG003|Overall Study|Protocol Violation|1|||
143366036|NCT03852433|516883023|FG000|Overall Study|Death|0|||
143366037|NCT03852433|516883024|FG001|Overall Study|Death|0|||
143366038|NCT03852433|516883025|FG002|Overall Study|Death|1|||
143366039|NCT03852433|516883026|FG003|Overall Study|Death|0|||
143076006|NCT00229723|515817170|FG004|Concomitant Phase|Severe non-compliance|1|||
143076007|NCT00229723|515817171|FG005|Concomitant Phase|Severe non-compliance|0|||
143076008|NCT00229723|515817172|FG006|Concomitant Phase|Severe non-compliance|0|||
143366040|NCT03852433|516883023|FG000|Overall Study|Lack of Efficacy|0|||
143366041|NCT03852433|516883024|FG001|Overall Study|Lack of Efficacy|1|||
143366042|NCT03852433|516883025|FG002|Overall Study|Lack of Efficacy|0|||
143366043|NCT03852433|516883026|FG003|Overall Study|Lack of Efficacy|0|||
143366044|NCT03852433|516883023|FG000|Overall Study|Non-compliance with study drug|0|||
143366045|NCT03852433|516883024|FG001|Overall Study|Non-compliance with study drug|0|||
143366046|NCT03852433|516883025|FG002|Overall Study|Non-compliance with study drug|0|||
143366047|NCT03852433|516883026|FG003|Overall Study|Non-compliance with study drug|1|||
143172235|NCT00557193|516179681|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
143172236|NCT00557193|516179682|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
143172237|NCT00557193|516179683|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
143172238|NCT00557193|516179684|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
143172239|NCT00557193|516179685|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
143172240|NCT00557193|516179686|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
143172241|NCT00557193|516179681|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
143172242|NCT00557193|516179682|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
143172243|NCT00557193|516179683|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
143172244|NCT00557193|516179684|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
143076009|NCT00229723|515817166|FG000|Concomitant Phase|Other|3|||
143076010|NCT00229723|515817167|FG001|Concomitant Phase|Other|0|||
143076011|NCT00229723|515817168|FG002|Concomitant Phase|Other|1|||
143172245|NCT00557193|516179685|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
143366048|NCT03852433|516883023|FG000|Overall Study|Physician Decision|1|||
143366049|NCT03852433|516883024|FG001|Overall Study|Physician Decision|0|||
143366050|NCT03852433|516883025|FG002|Overall Study|Physician Decision|0|||
143076012|NCT00229723|515817169|FG003|Concomitant Phase|Other|1|||
143076013|NCT00229723|515817170|FG004|Concomitant Phase|Other|0|||
143076014|NCT00229723|515817171|FG005|Concomitant Phase|Other|2|||
143076015|NCT00229723|515817172|FG006|Concomitant Phase|Other|0|||
143076016|NCT00229723|515817166|FG000|Maintenance Phase|Adverse Event|7|||
143076017|NCT00229723|515817167|FG001|Maintenance Phase|Adverse Event|2|||
143076018|NCT00229723|515817168|FG002|Maintenance Phase|Adverse Event|1|||
143076019|NCT00229723|515817169|FG003|Maintenance Phase|Adverse Event|4|||
143076020|NCT00229723|515817170|FG004|Maintenance Phase|Adverse Event|7|||
143076021|NCT00229723|515817171|FG005|Maintenance Phase|Adverse Event|5|||
143076022|NCT00229723|515817172|FG006|Maintenance Phase|Adverse Event|2|||
143076023|NCT00229723|515817166|FG000|Maintenance Phase|Objective disease progression|5|||
143076024|NCT00229723|515817167|FG001|Maintenance Phase|Objective disease progression|5|||
143076025|NCT00229723|515817168|FG002|Maintenance Phase|Objective disease progression|3|||
143076026|NCT00229723|515817169|FG003|Maintenance Phase|Objective disease progression|6|||
143076027|NCT00229723|515817170|FG004|Maintenance Phase|Objective disease progression|2|||
143076028|NCT00229723|515817171|FG005|Maintenance Phase|Objective disease progression|9|||
143076029|NCT00229723|515817172|FG006|Maintenance Phase|Objective disease progression|5|||
143076030|NCT00229723|515817166|FG000|Maintenance Phase|Clinical progression|4|||
143076031|NCT00229723|515817167|FG001|Maintenance Phase|Clinical progression|1|||
143076032|NCT00229723|515817168|FG002|Maintenance Phase|Clinical progression|2|||
143076033|NCT00229723|515817169|FG003|Maintenance Phase|Clinical progression|2|||
143076034|NCT00229723|515817170|FG004|Maintenance Phase|Clinical progression|1|||
143076035|NCT00229723|515817171|FG005|Maintenance Phase|Clinical progression|1|||
143076036|NCT00229723|515817172|FG006|Maintenance Phase|Clinical progression|1|||
143076037|NCT00229723|515817166|FG000|Maintenance Phase|Lost to Follow-up|0|||
143076038|NCT00229723|515817167|FG001|Maintenance Phase|Lost to Follow-up|1|||
143076039|NCT00229723|515817168|FG002|Maintenance Phase|Lost to Follow-up|2|||
143076040|NCT00229723|515817169|FG003|Maintenance Phase|Lost to Follow-up|2|||
143076041|NCT00229723|515817170|FG004|Maintenance Phase|Lost to Follow-up|0|||
143076042|NCT00229723|515817171|FG005|Maintenance Phase|Lost to Follow-up|0|||
143076043|NCT00229723|515817172|FG006|Maintenance Phase|Lost to Follow-up|1|||
143076044|NCT00229723|515817166|FG000|Maintenance Phase|Informed consent withdrawn|1|||
143076045|NCT00229723|515817167|FG001|Maintenance Phase|Informed consent withdrawn|0|||
143076046|NCT00229723|515817168|FG002|Maintenance Phase|Informed consent withdrawn|0|||
143076047|NCT00229723|515817169|FG003|Maintenance Phase|Informed consent withdrawn|1|||
143076048|NCT00229723|515817170|FG004|Maintenance Phase|Informed consent withdrawn|1|||
143076049|NCT00229723|515817171|FG005|Maintenance Phase|Informed consent withdrawn|1|||
143076050|NCT00229723|515817172|FG006|Maintenance Phase|Informed consent withdrawn|0|||
143076051|NCT00229723|515817166|FG000|Maintenance Phase|Severe non-compliance|3|||
143076052|NCT00229723|515817167|FG001|Maintenance Phase|Severe non-compliance|1|||
143076053|NCT00229723|515817168|FG002|Maintenance Phase|Severe non-compliance|0|||
143366051|NCT03852433|516883026|FG003|Overall Study|Physician Decision|0|||
143366052|NCT03852433|516883023|FG000|Overall Study|Randomized but never treated|1|||
143366053|NCT03852433|516883024|FG001|Overall Study|Randomized but never treated|0|||
143366054|NCT03852433|516883025|FG002|Overall Study|Randomized but never treated|0|||
143366055|NCT03852433|516883026|FG003|Overall Study|Randomized but never treated|0|||
143366056|NCT02014558|516883027|FG000|Overall Study|Never Received Study Drug|0|||
143366057|NCT02014558|516883028|FG001|Overall Study|Never Received Study Drug|0|||
143366058|NCT02014558|516883029|FG002|Overall Study|Never Received Study Drug|0|||
143366059|NCT02014558|516883030|FG003|Overall Study|Never Received Study Drug|0|||
143366060|NCT02014558|516883031|FG004|Overall Study|Never Received Study Drug|1|||
143366061|NCT02014558|516883032|FG005|Overall Study|Never Received Study Drug|0|||
143366062|NCT02014558|516883033|FG006|Overall Study|Never Received Study Drug|1|||
143366063|NCT02014558|516883034|FG007|Overall Study|Never Received Study Drug|0|||
143076054|NCT00229723|515817169|FG003|Maintenance Phase|Severe non-compliance|0|||
143076055|NCT00229723|515817170|FG004|Maintenance Phase|Severe non-compliance|1|||
143076056|NCT00229723|515817171|FG005|Maintenance Phase|Severe non-compliance|0|||
143076057|NCT00229723|515817172|FG006|Maintenance Phase|Severe non-compliance|0|||
143076058|NCT00229723|515817166|FG000|Maintenance Phase|Other|5|||
143366064|NCT02014558|516883035|FG008|Overall Study|Never Received Study Drug|2|||
143366065|NCT02014558|516883036|FG009|Overall Study|Never Received Study Drug|0|||
143366066|NCT02014558|516883037|FG010|Overall Study|Never Received Study Drug|2|||
143076059|NCT00229723|515817167|FG001|Maintenance Phase|Other|4|||
143076060|NCT00229723|515817168|FG002|Maintenance Phase|Other|1|||
143076061|NCT00229723|515817169|FG003|Maintenance Phase|Other|2|||
143076062|NCT00229723|515817170|FG004|Maintenance Phase|Other|3|||
143076063|NCT00229723|515817171|FG005|Maintenance Phase|Other|3|||
143076064|NCT00229723|515817172|FG006|Maintenance Phase|Other|1|||
143366067|NCT02014558|516883038|FG011|Overall Study|Never Received Study Drug|2|||
143076065|NCT02309138|515817173|FG000|Overall Study|Withdrawal by Subject|44|||
143076066|NCT02309138|515817174|FG001|Overall Study|Withdrawal by Subject|15|||
143076067|NCT02309138|515817173|FG000|Overall Study|Protocol Violation|4|||
143076068|NCT02309138|515817174|FG001|Overall Study|Protocol Violation|2|||
143076069|NCT02309138|515817173|FG000|Overall Study|delivered before visit 2|0|||
143076070|NCT02309138|515817174|FG001|Overall Study|delivered before visit 2|1|||
143076071|NCT01441947|515817180|FG000|Overall Study|Withdrawal by Subject|3|||
143076072|NCT01441947|515817181|FG001|Overall Study|Withdrawal by Subject|0|||
143076073|NCT01844505|515817182|FG000|Treatment Period|SUBJECT WITHDREW CONSENT|9|||
143076074|NCT01844505|515817183|FG001|Treatment Period|SUBJECT WITHDREW CONSENT|12|||
143076075|NCT01844505|515817184|FG002|Treatment Period|SUBJECT WITHDREW CONSENT|19|||
143076076|NCT01844505|515817182|FG000|Treatment Period|Other Reasons|120|||
143076077|NCT01844505|515817183|FG001|Treatment Period|Other Reasons|136|||
143076078|NCT01844505|515817184|FG002|Treatment Period|Other Reasons|58|||
143076079|NCT01844505|515817182|FG000|Treatment Period|Lost to Follow-up|9|||
143076080|NCT01844505|515817183|FG001|Treatment Period|Lost to Follow-up|11|||
143076081|NCT01844505|515817184|FG002|Treatment Period|Lost to Follow-up|6|||
143076082|NCT01844505|515817182|FG000|Treatment Period|Death|175|||
143076083|NCT01844505|515817183|FG001|Treatment Period|Death|154|||
143076084|NCT01844505|515817184|FG002|Treatment Period|Death|228|||
143076085|NCT02730351|515817185|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
143076086|NCT02730351|515817186|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
143076087|NCT02730351|515817185|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
143076088|NCT02730351|515817186|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
143076089|NCT02730351|515817185|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
143076090|NCT02730351|515817186|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
143076091|NCT02730351|515817185|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
143172246|NCT00557193|516179686|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
143172247|NCT00557193|516179681|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
143076092|NCT02730351|515817186|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
143076093|NCT02730351|515817185|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
143076094|NCT02730351|515817186|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
143076095|NCT00838435|515817187|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
143076096|NCT00838435|515817187|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
143076097|NCT00838435|515817187|FG000|Part 2 (7 Years)|Adverse Event|2|||
143366068|NCT02014558|516883039|FG012|Overall Study|Never Received Study Drug|0|||
143366069|NCT02014558|516883027|FG000|Overall Study|Adverse Event|0|||
143366070|NCT02014558|516883028|FG001|Overall Study|Adverse Event|0|||
143366071|NCT02014558|516883029|FG002|Overall Study|Adverse Event|0|||
143366072|NCT02014558|516883030|FG003|Overall Study|Adverse Event|0|||
143366073|NCT02014558|516883031|FG004|Overall Study|Adverse Event|1|||
143366074|NCT02014558|516883032|FG005|Overall Study|Adverse Event|0|||
143366075|NCT02014558|516883033|FG006|Overall Study|Adverse Event|0|||
143366076|NCT02014558|516883034|FG007|Overall Study|Adverse Event|0|||
143366077|NCT02014558|516883035|FG008|Overall Study|Adverse Event|2|||
143366078|NCT02014558|516883036|FG009|Overall Study|Adverse Event|2|||
143366079|NCT02014558|516883037|FG010|Overall Study|Adverse Event|5|||
143366080|NCT02014558|516883038|FG011|Overall Study|Adverse Event|21|||
143366081|NCT02014558|516883039|FG012|Overall Study|Adverse Event|3|||
143366082|NCT02014558|516883027|FG000|Overall Study|Death|1|||
143366083|NCT02014558|516883028|FG001|Overall Study|Death|0|||
143366084|NCT02014558|516883029|FG002|Overall Study|Death|0|||
143366085|NCT02014558|516883030|FG003|Overall Study|Death|0|||
143366086|NCT02014558|516883031|FG004|Overall Study|Death|0|||
143366087|NCT02014558|516883032|FG005|Overall Study|Death|0|||
143366088|NCT02014558|516883033|FG006|Overall Study|Death|1|||
143366089|NCT02014558|516883034|FG007|Overall Study|Death|1|||
143366090|NCT02014558|516883035|FG008|Overall Study|Death|2|||
143366091|NCT02014558|516883036|FG009|Overall Study|Death|5|||
143366092|NCT02014558|516883037|FG010|Overall Study|Death|5|||
143366093|NCT02014558|516883038|FG011|Overall Study|Death|19|||
143366094|NCT02014558|516883039|FG012|Overall Study|Death|2|||
143366095|NCT02014558|516883027|FG000|Overall Study|Lack of Efficacy|1|||
143366096|NCT02014558|516883028|FG001|Overall Study|Lack of Efficacy|2|||
143366097|NCT02014558|516883029|FG002|Overall Study|Lack of Efficacy|1|||
143366098|NCT02014558|516883030|FG003|Overall Study|Lack of Efficacy|1|||
143366099|NCT02014558|516883031|FG004|Overall Study|Lack of Efficacy|0|||
143366100|NCT02014558|516883032|FG005|Overall Study|Lack of Efficacy|0|||
143366101|NCT02014558|516883033|FG006|Overall Study|Lack of Efficacy|1|||
143366102|NCT02014558|516883034|FG007|Overall Study|Lack of Efficacy|3|||
143366103|NCT02014558|516883035|FG008|Overall Study|Lack of Efficacy|3|||
143366104|NCT02014558|516883036|FG009|Overall Study|Lack of Efficacy|3|||
143366105|NCT02014558|516883037|FG010|Overall Study|Lack of Efficacy|16|||
143366106|NCT02014558|516883038|FG011|Overall Study|Lack of Efficacy|8|||
143366107|NCT02014558|516883039|FG012|Overall Study|Lack of Efficacy|5|||
143366108|NCT02014558|516883027|FG000|Overall Study|Lost to Follow-up|0|||
143366109|NCT02014558|516883028|FG001|Overall Study|Lost to Follow-up|0|||
143366110|NCT02014558|516883029|FG002|Overall Study|Lost to Follow-up|0|||
143366111|NCT02014558|516883030|FG003|Overall Study|Lost to Follow-up|0|||
143366112|NCT02014558|516883031|FG004|Overall Study|Lost to Follow-up|0|||
143366113|NCT02014558|516883032|FG005|Overall Study|Lost to Follow-up|0|||
143366114|NCT02014558|516883033|FG006|Overall Study|Lost to Follow-up|0|||
143366115|NCT02014558|516883034|FG007|Overall Study|Lost to Follow-up|0|||
143366116|NCT02014558|516883035|FG008|Overall Study|Lost to Follow-up|0|||
143366117|NCT02014558|516883036|FG009|Overall Study|Lost to Follow-up|0|||
143366118|NCT02014558|516883037|FG010|Overall Study|Lost to Follow-up|1|||
143366119|NCT02014558|516883038|FG011|Overall Study|Lost to Follow-up|0|||
143366120|NCT02014558|516883039|FG012|Overall Study|Lost to Follow-up|0|||
143366121|NCT02014558|516883027|FG000|Overall Study|Progressive Disease|1|||
143366122|NCT02014558|516883028|FG001|Overall Study|Progressive Disease|0|||
143366123|NCT02014558|516883029|FG002|Overall Study|Progressive Disease|1|||
143366124|NCT02014558|516883030|FG003|Overall Study|Progressive Disease|1|||
143366125|NCT02014558|516883031|FG004|Overall Study|Progressive Disease|1|||
143076098|NCT00838435|515817187|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
143076099|NCT00838435|515817187|FG000|Part 2 (7 Years)|Physician Decision|1|||
143076100|NCT00838435|515817187|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
143366126|NCT02014558|516883032|FG005|Overall Study|Progressive Disease|2|||
143366127|NCT02014558|516883033|FG006|Overall Study|Progressive Disease|1|||
143366128|NCT02014558|516883034|FG007|Overall Study|Progressive Disease|6|||
143366129|NCT02014558|516883035|FG008|Overall Study|Progressive Disease|5|||
143366130|NCT02014558|516883036|FG009|Overall Study|Progressive Disease|6|||
143366131|NCT02014558|516883037|FG010|Overall Study|Progressive Disease|22|||
143366132|NCT02014558|516883038|FG011|Overall Study|Progressive Disease|31|||
143366133|NCT02014558|516883039|FG012|Overall Study|Progressive Disease|6|||
143366134|NCT02014558|516883027|FG000|Overall Study|Withdrawal by Subject|0|||
143366135|NCT02014558|516883028|FG001|Overall Study|Withdrawal by Subject|0|||
143366136|NCT02014558|516883029|FG002|Overall Study|Withdrawal by Subject|0|||
143366137|NCT02014558|516883030|FG003|Overall Study|Withdrawal by Subject|0|||
143366138|NCT02014558|516883031|FG004|Overall Study|Withdrawal by Subject|1|||
143366139|NCT02014558|516883032|FG005|Overall Study|Withdrawal by Subject|0|||
143076101|NCT00838435|515817187|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
143076102|NCT04159935|515817188|FG000|Overall Study|Study terminated due to COVID-19|1|||
143076103|NCT04159935|515817189|FG001|Overall Study|Study terminated due to COVID-19|3|||
143076104|NCT02348723|515817191|FG000|Overall Study|No ablation|21|||
143076105|NCT02348723|515817192|FG001|Overall Study|No ablation|20|||
143076106|NCT02348723|515817191|FG000|Overall Study|Non-compliant with Protocol|1|||
143076107|NCT02348723|515817192|FG001|Overall Study|Non-compliant with Protocol|0|||
143076108|NCT02348723|515817191|FG000|Overall Study|Lost to Follow-up|1|||
143076109|NCT02348723|515817192|FG001|Overall Study|Lost to Follow-up|1|||
143172248|NCT00557193|516179682|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
143172249|NCT00557193|516179683|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
143076110|NCT02348723|515817191|FG000|Overall Study|Consent withdrawn|1|||
143076111|NCT02348723|515817192|FG001|Overall Study|Consent withdrawn|3|||
143076112|NCT02348723|515817191|FG000|Overall Study|Reason other than specified|1|||
143076113|NCT02348723|515817192|FG001|Overall Study|Reason other than specified|1|||
143076114|NCT02348723|515817191|FG000|Overall Study|Adverse Event|3|||
143076115|NCT02348723|515817192|FG001|Overall Study|Adverse Event|1|||
143076116|NCT01268501|515817193|FG000|Overall Study|Lost to Follow-up|1|||
143076117|NCT01268501|515817193|FG000|Overall Study|Withdrawal by Subject|3|||
143076118|NCT01268501|515817193|FG000|Overall Study|Unacceptable Subjective Vision|3|||
143076119|NCT01268501|515817193|FG000|Overall Study|Handling Difficulties|2|||
143076120|NCT03796039|515817194|FG000|Overall Study|Death|2|||
143076121|NCT03796039|515817195|FG001|Overall Study|Death|1|||
143076122|NCT03796039|515817194|FG000|Overall Study|Withdrawal by Subject|7|||
143076123|NCT03796039|515817195|FG001|Overall Study|Withdrawal by Subject|4|||
143076124|NCT02927366|515817197|FG000|Overall Study|Adverse Event|1|||
143076125|NCT02927366|515817198|FG001|Overall Study|Adverse Event|0|||
143076126|NCT02927366|515817197|FG000|Overall Study|Patient schedule|1|||
143076127|NCT02927366|515817198|FG001|Overall Study|Patient schedule|0|||
143172250|NCT00557193|516179684|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
143172251|NCT00557193|516179685|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
143172252|NCT00557193|516179686|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
143172253|NCT00557193|516179681|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
143172254|NCT00557193|516179682|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
143172255|NCT00557193|516179683|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
143172256|NCT00557193|516179684|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
143172257|NCT00557193|516179685|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
143172258|NCT00557193|516179686|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
143172259|NCT00557193|516179681|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
143172260|NCT00557193|516179682|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
143172261|NCT00557193|516179683|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
143172262|NCT00557193|516179684|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
143172263|NCT00557193|516179685|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
143172264|NCT00557193|516179686|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
143172265|NCT00557193|516179681|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
143172266|NCT00557193|516179682|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
143172267|NCT00557193|516179683|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
143172268|NCT00557193|516179684|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
143172269|NCT00557193|516179685|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
143172270|NCT00557193|516179686|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
143172271|NCT00557193|516179681|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
143172272|NCT00557193|516179682|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
143172273|NCT00557193|516179683|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
143172274|NCT00557193|516179684|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
143172275|NCT00557193|516179685|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
143172276|NCT00557193|516179686|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
143172277|NCT00557193|516179681|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
143172278|NCT00557193|516179682|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
143172279|NCT00557193|516179683|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
143172280|NCT00557193|516179684|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
143172281|NCT00557193|516179685|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
143172282|NCT00557193|516179686|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
143172283|NCT00557193|516179681|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
143172284|NCT00557193|516179682|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
143172285|NCT00557193|516179683|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
143172286|NCT00557193|516179684|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
143172287|NCT00557193|516179685|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
143172288|NCT00557193|516179686|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
143172289|NCT00622726|516179687|FG000|March, 2008 to August, 2010|Death|5|||
143172290|NCT00622726|516179688|FG001|March, 2008 to August, 2010|Death|2|||
143172291|NCT00622726|516179687|FG000|August, 2010 to April, 2013|Death|1|||
143172292|NCT00622726|516179688|FG001|August, 2010 to April, 2013|Death|5|||
143172293|NCT02448381|516179692|FG000|Overall Study|Adverse Event|2|||
143172294|NCT02448381|516179693|FG001|Overall Study|Adverse Event|0|||
143172295|NCT02448381|516179692|FG000|Overall Study|Lost to Follow-up|16|||
143172296|NCT02448381|516179693|FG001|Overall Study|Lost to Follow-up|9|||
143172297|NCT02448381|516179692|FG000|Overall Study|Physician Decision|1|||
143172298|NCT02448381|516179693|FG001|Overall Study|Physician Decision|1|||
143172299|NCT02448381|516179692|FG000|Overall Study|Pregnancy|1|||
143172300|NCT02448381|516179693|FG001|Overall Study|Pregnancy|0|||
143076128|NCT02329847|515817205|FG000|Overall Study|Death|4|||
143076129|NCT02329847|515817206|FG001|Overall Study|Death|4|||
143076130|NCT02329847|515817207|FG002|Overall Study|Death|22|||
143076131|NCT02329847|515817208|FG003|Overall Study|Death|12|||
143076132|NCT02329847|515817209|FG004|Overall Study|Death|20|||
143076133|NCT02329847|515817210|FG005|Overall Study|Death|13|||
143076134|NCT02329847|515817205|FG000|Overall Study|Lost to Follow-up|0|||
143076135|NCT02329847|515817206|FG001|Overall Study|Lost to Follow-up|0|||
143076136|NCT02329847|515817207|FG002|Overall Study|Lost to Follow-up|2|||
143076137|NCT02329847|515817208|FG003|Overall Study|Lost to Follow-up|3|||
143076138|NCT02329847|515817209|FG004|Overall Study|Lost to Follow-up|0|||
143076139|NCT02329847|515817210|FG005|Overall Study|Lost to Follow-up|1|||
143076140|NCT02329847|515817205|FG000|Overall Study|Physician Decision|0|||
143076141|NCT02329847|515817206|FG001|Overall Study|Physician Decision|0|||
143076142|NCT02329847|515817207|FG002|Overall Study|Physician Decision|0|||
143076143|NCT02329847|515817208|FG003|Overall Study|Physician Decision|0|||
143076144|NCT02329847|515817209|FG004|Overall Study|Physician Decision|1|||
143076145|NCT02329847|515817210|FG005|Overall Study|Physician Decision|0|||
143076146|NCT02329847|515817205|FG000|Overall Study|Withdrawal by Subject|2|||
143076147|NCT02329847|515817206|FG001|Overall Study|Withdrawal by Subject|1|||
143076148|NCT02329847|515817207|FG002|Overall Study|Withdrawal by Subject|5|||
143076149|NCT02329847|515817208|FG003|Overall Study|Withdrawal by Subject|7|||
143076150|NCT02329847|515817209|FG004|Overall Study|Withdrawal by Subject|8|||
143076151|NCT02329847|515817210|FG005|Overall Study|Withdrawal by Subject|3|||
143076152|NCT02329847|515817205|FG000|Overall Study|Other|1|||
143076153|NCT02329847|515817206|FG001|Overall Study|Other|2|||
143076154|NCT02329847|515817207|FG002|Overall Study|Other|6|||
143076155|NCT02329847|515817208|FG003|Overall Study|Other|13|||
143076156|NCT02329847|515817209|FG004|Overall Study|Other|10|||
143076157|NCT02329847|515817210|FG005|Overall Study|Other|3|||
143076158|NCT00407758|515817211|FG000|Overall Study|ineligible -improper prior treatment|1|||
143076159|NCT01458106|515817213|FG000|Overall Study|Withdrawal by Subject|2|||
143366140|NCT02014558|516883033|FG006|Overall Study|Withdrawal by Subject|0|||
143366141|NCT02014558|516883034|FG007|Overall Study|Withdrawal by Subject|0|||
143366142|NCT02014558|516883035|FG008|Overall Study|Withdrawal by Subject|0|||
143366143|NCT02014558|516883036|FG009|Overall Study|Withdrawal by Subject|2|||
143366144|NCT02014558|516883037|FG010|Overall Study|Withdrawal by Subject|6|||
143366145|NCT02014558|516883038|FG011|Overall Study|Withdrawal by Subject|10|||
143366146|NCT02014558|516883039|FG012|Overall Study|Withdrawal by Subject|0|||
143366147|NCT02014558|516883027|FG000|Overall Study|Miscellaneous|2|||
143366148|NCT02014558|516883028|FG001|Overall Study|Miscellaneous|1|||
143366149|NCT02014558|516883029|FG002|Overall Study|Miscellaneous|1|||
143366150|NCT02014558|516883030|FG003|Overall Study|Miscellaneous|1|||
143076160|NCT01458106|515817214|FG001|Overall Study|Withdrawal by Subject|0|||
143076161|NCT01458106|515817213|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
143076162|NCT01458106|515817214|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
143076163|NCT01458106|515817213|FG000|Overall Study|Withdrawn Per Protocol|0|||
143076164|NCT01458106|515817214|FG001|Overall Study|Withdrawn Per Protocol|1|||
143076165|NCT00477295|515817215|FG000|Overall Study|Adverse Event|31|||
143076166|NCT00477295|515817216|FG001|Overall Study|Adverse Event|35|||
143366151|NCT02014558|516883031|FG004|Overall Study|Miscellaneous|0|||
143366152|NCT02014558|516883032|FG005|Overall Study|Miscellaneous|1|||
143366153|NCT02014558|516883033|FG006|Overall Study|Miscellaneous|0|||
143366154|NCT02014558|516883034|FG007|Overall Study|Miscellaneous|1|||
143366155|NCT02014558|516883035|FG008|Overall Study|Miscellaneous|1|||
143366156|NCT02014558|516883036|FG009|Overall Study|Miscellaneous|3|||
143366157|NCT02014558|516883037|FG010|Overall Study|Miscellaneous|12|||
143076167|NCT00477295|515817215|FG000|Overall Study|Withdrawal by Subject|35|||
143172301|NCT02448381|516179692|FG000|Overall Study|Withdrawal by Subject|13|||
143172302|NCT02448381|516179693|FG001|Overall Study|Withdrawal by Subject|9|||
143172303|NCT02448381|516179692|FG000|Overall Study|Noncompliance with Study Procedures|2|||
143172304|NCT02448381|516179693|FG001|Overall Study|Noncompliance with Study Procedures|0|||
143076168|NCT00477295|515817216|FG001|Overall Study|Withdrawal by Subject|24|||
143366158|NCT02014558|516883038|FG011|Overall Study|Miscellaneous|11|||
143366159|NCT02014558|516883039|FG012|Overall Study|Miscellaneous|1|||
143366160|NCT04310579|516884585|FG000|Overall Study|Adverse Event|0|||
143366161|NCT04310579|516884586|FG001|Overall Study|Adverse Event|0|||
143366162|NCT04310579|516884587|FG002|Overall Study|Adverse Event|0|||
143076169|NCT00477295|515817215|FG000|Overall Study|Lack of Efficacy|23|||
143076170|NCT00477295|515817216|FG001|Overall Study|Lack of Efficacy|23|||
143076171|NCT00477295|515817215|FG000|Overall Study|Protocol Violation|3|||
143076172|NCT00477295|515817216|FG001|Overall Study|Protocol Violation|8|||
143076173|NCT00477295|515817215|FG000|Overall Study|Physician Decision|4|||
143076174|NCT00477295|515817216|FG001|Overall Study|Physician Decision|5|||
143076175|NCT00477295|515817215|FG000|Overall Study|Lost to Follow-up|21|||
143076176|NCT00477295|515817216|FG001|Overall Study|Lost to Follow-up|11|||
143076177|NCT00477295|515817215|FG000|Overall Study|Other|4|||
143076178|NCT00477295|515817216|FG001|Overall Study|Other|3|||
143076179|NCT03050060|515817217|FG000|Overall Study|Adverse Event|7|||
143172305|NCT00854360|516179694|FG000|Overall Study|Adverse Event|0|||
143076180|NCT03050060|515817217|FG000|Overall Study|Withdrawal by Subject|1|||
143076181|NCT03050060|515817217|FG000|Overall Study|Progression|7|||
143076182|NCT02304458|515817218|FG000|Overall Study|Adverse Event|0|||
143076183|NCT02304458|515817219|FG001|Overall Study|Adverse Event|0|||
143076184|NCT02304458|515817220|FG002|Overall Study|Adverse Event|7|||
143076185|NCT02304458|515817221|FG003|Overall Study|Adverse Event|0|||
143076186|NCT02304458|515817222|FG004|Overall Study|Adverse Event|0|||
143076187|NCT02304458|515817223|FG005|Overall Study|Adverse Event|0|||
143076188|NCT02304458|515817224|FG006|Overall Study|Adverse Event|3|||
143076189|NCT02304458|515817225|FG007|Overall Study|Adverse Event|4|||
143076190|NCT02304458|515817218|FG000|Overall Study|Death|0|||
143076191|NCT02304458|515817219|FG001|Overall Study|Death|0|||
143076192|NCT02304458|515817220|FG002|Overall Study|Death|2|||
143076193|NCT02304458|515817221|FG003|Overall Study|Death|0|||
143076194|NCT02304458|515817222|FG004|Overall Study|Death|0|||
143076195|NCT02304458|515817223|FG005|Overall Study|Death|0|||
143076196|NCT02304458|515817224|FG006|Overall Study|Death|1|||
143076197|NCT02304458|515817225|FG007|Overall Study|Death|0|||
143366163|NCT04310579|516884588|FG003|Overall Study|Adverse Event|0|||
143366164|NCT04310579|516884589|FG004|Overall Study|Adverse Event|0|||
143076198|NCT02304458|515817218|FG000|Overall Study|Lack of Efficacy|4|||
143076199|NCT02304458|515817219|FG001|Overall Study|Lack of Efficacy|6|||
143076200|NCT02304458|515817220|FG002|Overall Study|Lack of Efficacy|38|||
143076201|NCT02304458|515817221|FG003|Overall Study|Lack of Efficacy|5|||
143076202|NCT02304458|515817222|FG004|Overall Study|Lack of Efficacy|6|||
143076203|NCT02304458|515817223|FG005|Overall Study|Lack of Efficacy|6|||
143076204|NCT02304458|515817224|FG006|Overall Study|Lack of Efficacy|21|||
143076205|NCT02304458|515817225|FG007|Overall Study|Lack of Efficacy|4|||
143076206|NCT02304458|515817218|FG000|Overall Study|Physician Decision|2|||
143076207|NCT02304458|515817219|FG001|Overall Study|Physician Decision|0|||
143076208|NCT02304458|515817220|FG002|Overall Study|Physician Decision|16|||
143076209|NCT02304458|515817221|FG003|Overall Study|Physician Decision|1|||
143076210|NCT02304458|515817222|FG004|Overall Study|Physician Decision|0|||
143076211|NCT02304458|515817223|FG005|Overall Study|Physician Decision|0|||
143076212|NCT02304458|515817224|FG006|Overall Study|Physician Decision|3|||
143076213|NCT02304458|515817225|FG007|Overall Study|Physician Decision|0|||
143076214|NCT02304458|515817218|FG000|Overall Study|Protocol Violation|0|||
143076215|NCT02304458|515817219|FG001|Overall Study|Protocol Violation|0|||
143076216|NCT02304458|515817220|FG002|Overall Study|Protocol Violation|1|||
143076217|NCT02304458|515817221|FG003|Overall Study|Protocol Violation|0|||
143076218|NCT02304458|515817222|FG004|Overall Study|Protocol Violation|0|||
143076219|NCT02304458|515817223|FG005|Overall Study|Protocol Violation|0|||
143076220|NCT02304458|515817224|FG006|Overall Study|Protocol Violation|0|||
143076221|NCT02304458|515817225|FG007|Overall Study|Protocol Violation|0|||
143076222|NCT02304458|515817218|FG000|Overall Study|Withdrawal by Subject|1|||
143076223|NCT02304458|515817219|FG001|Overall Study|Withdrawal by Subject|0|||
143076224|NCT02304458|515817220|FG002|Overall Study|Withdrawal by Subject|7|||
143076225|NCT02304458|515817221|FG003|Overall Study|Withdrawal by Subject|0|||
143076226|NCT02304458|515817222|FG004|Overall Study|Withdrawal by Subject|0|||
143076227|NCT02304458|515817223|FG005|Overall Study|Withdrawal by Subject|0|||
143076228|NCT02304458|515817224|FG006|Overall Study|Withdrawal by Subject|1|||
143076229|NCT02304458|515817225|FG007|Overall Study|Withdrawal by Subject|0|||
143076230|NCT02288182|515817231|FG000|Overall Study|Adverse Event|0|||
143076231|NCT02288182|515817232|FG001|Overall Study|Adverse Event|1|||
143076232|NCT02288182|515817231|FG000|Overall Study|Lost to Follow-up|0|||
143076233|NCT02288182|515817232|FG001|Overall Study|Lost to Follow-up|1|||
143076234|NCT01197755|515817233|FG000|Overall Study|Adverse Event|8|||
143076235|NCT01197755|515817234|FG001|Overall Study|Adverse Event|10|||
143076236|NCT01197755|515817235|FG002|Overall Study|Adverse Event|10|||
143076237|NCT01197755|515817233|FG000|Overall Study|Study-specific discontinuation criteria|2|||
143076238|NCT01197755|515817234|FG001|Overall Study|Study-specific discontinuation criteria|1|||
143076239|NCT01197755|515817235|FG002|Overall Study|Study-specific discontinuation criteria|0|||
143076240|NCT01197755|515817233|FG000|Overall Study|Entered the long-term extension study|18|||
143076241|NCT01197755|515817234|FG001|Overall Study|Entered the long-term extension study|21|||
143076242|NCT01197755|515817235|FG002|Overall Study|Entered the long-term extension study|35|||
143076243|NCT01197755|515817233|FG000|Overall Study|Lack of therapeutic response|0|||
143076244|NCT01197755|515817234|FG001|Overall Study|Lack of therapeutic response|7|||
143076245|NCT01197755|515817235|FG002|Overall Study|Lack of therapeutic response|4|||
143076246|NCT01197755|515817233|FG000|Overall Study|Severe non-compliance to the protocol|2|||
143076247|NCT01197755|515817234|FG001|Overall Study|Severe non-compliance to the protocol|1|||
143076248|NCT01197755|515817235|FG002|Overall Study|Severe non-compliance to the protocol|2|||
143076249|NCT01197755|515817233|FG000|Overall Study|Withdrawal by Subject|1|||
143076250|NCT01197755|515817234|FG001|Overall Study|Withdrawal by Subject|0|||
143076251|NCT01197755|515817235|FG002|Overall Study|Withdrawal by Subject|0|||
143172306|NCT00854360|516179695|FG001|Overall Study|Adverse Event|1|||
143172307|NCT00854360|516179696|FG002|Overall Study|Adverse Event|2|||
143172308|NCT00854360|516179697|FG003|Overall Study|Adverse Event|6|||
143172309|NCT00854360|516179694|FG000|Overall Study|Withdrawal by Subject|0|||
143172310|NCT00854360|516179695|FG001|Overall Study|Withdrawal by Subject|0|||
143076252|NCT01197755|515817233|FG000|Overall Study|Lost to Follow-up|0|||
143076253|NCT01197755|515817234|FG001|Overall Study|Lost to Follow-up|0|||
143076254|NCT01197755|515817235|FG002|Overall Study|Lost to Follow-up|1|||
143076255|NCT01197755|515817233|FG000|Overall Study|eg, change in circumstances|7|||
143172311|NCT00854360|516179696|FG002|Overall Study|Withdrawal by Subject|0|||
143172312|NCT00854360|516179697|FG003|Overall Study|Withdrawal by Subject|1|||
143172313|NCT00854360|516179694|FG000|Overall Study|Pregnancy|0|||
143076256|NCT01197755|515817234|FG001|Overall Study|eg, change in circumstances|3|||
143076257|NCT01197755|515817235|FG002|Overall Study|eg, change in circumstances|2|||
143076258|NCT03365011|515817236|FG000|Overall Study|Withdrawal by Subject|1|||
143076259|NCT03365011|515817237|FG001|Overall Study|Withdrawal by Subject|2|||
143076260|NCT00499174|515817238|FG000|Overall Study|Physician Decision|78|||
143076261|NCT00499174|515817239|FG001|Overall Study|Physician Decision|9|||
143076262|NCT01214915|515817241|FG000|Overall Study|Adverse Event|8|||
143172314|NCT00854360|516179695|FG001|Overall Study|Pregnancy|1|||
143172315|NCT00854360|516179696|FG002|Overall Study|Pregnancy|0|||
143172316|NCT00854360|516179697|FG003|Overall Study|Pregnancy|0|||
143172317|NCT00854360|516179694|FG000|Overall Study|Lack of Efficacy|2|||
143172318|NCT00854360|516179695|FG001|Overall Study|Lack of Efficacy|1|||
143172319|NCT00854360|516179696|FG002|Overall Study|Lack of Efficacy|0|||
143172320|NCT00854360|516179697|FG003|Overall Study|Lack of Efficacy|0|||
143172321|NCT00854360|516179694|FG000|Overall Study|Other|0|||
143172322|NCT00854360|516179695|FG001|Overall Study|Other|0|||
143172323|NCT00854360|516179696|FG002|Overall Study|Other|0|||
143172324|NCT00854360|516179697|FG003|Overall Study|Other|3|||
143172325|NCT02271880|516179698|FG000|Overall Study|Premature discontinuation of study|3|||
143172326|NCT02271880|516179699|FG001|Overall Study|Premature discontinuation of study|4|||
143172327|NCT00744861|516179704|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
143172328|NCT00744861|516179705|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
143172329|NCT00744861|516179706|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
143172330|NCT00744861|516179707|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
143172331|NCT00744861|516179704|FG000|Feasibility Stage 1|Pregnancy|0|||
143172332|NCT00744861|516179705|FG001|Feasibility Stage 1|Pregnancy|1|||
143172333|NCT00744861|516179706|FG002|Feasibility Stage 1|Pregnancy|0|||
143172334|NCT00744861|516179707|FG003|Feasibility Stage 1|Pregnancy|0|||
143172335|NCT00744861|516179704|FG000|Pivotal Stage 2|Adverse Event|0|||
143172336|NCT00744861|516179705|FG001|Pivotal Stage 2|Adverse Event|0|||
143172337|NCT00744861|516179706|FG002|Pivotal Stage 2|Adverse Event|6|||
143172338|NCT00744861|516179707|FG003|Pivotal Stage 2|Adverse Event|11|||
143172339|NCT00744861|516179704|FG000|Pivotal Stage 2|Death|0|||
143172340|NCT00744861|516179705|FG001|Pivotal Stage 2|Death|0|||
143172341|NCT00744861|516179706|FG002|Pivotal Stage 2|Death|0|||
143172342|NCT00744861|516179707|FG003|Pivotal Stage 2|Death|1|||
143172343|NCT00744861|516179704|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
143172344|NCT00744861|516179705|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
143172345|NCT00744861|516179706|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
143172346|NCT00744861|516179707|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
143172347|NCT00744861|516179704|FG000|Pivotal Stage 2|Physician Decision|0|||
143172348|NCT00744861|516179705|FG001|Pivotal Stage 2|Physician Decision|0|||
143172349|NCT00744861|516179706|FG002|Pivotal Stage 2|Physician Decision|3|||
143172350|NCT00744861|516179707|FG003|Pivotal Stage 2|Physician Decision|1|||
143172351|NCT00744861|516179704|FG000|Pivotal Stage 2|Protocol Violation|0|||
143172352|NCT00744861|516179705|FG001|Pivotal Stage 2|Protocol Violation|0|||
143172353|NCT00744861|516179706|FG002|Pivotal Stage 2|Protocol Violation|0|||
143172354|NCT00744861|516179707|FG003|Pivotal Stage 2|Protocol Violation|1|||
143172355|NCT00744861|516179704|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
143172356|NCT00744861|516179705|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
143076263|NCT01214915|515817241|FG000|Overall Study|Lack of Efficacy|3|||
143076264|NCT03866902|515817243|FG000|Overall Study|Lost to Follow-up|98|||
143076265|NCT03866902|515817244|FG001|Overall Study|Lost to Follow-up|82|||
143076266|NCT03866902|515817243|FG000|Overall Study|Pregnancy|18|||
143076267|NCT03866902|515817244|FG001|Overall Study|Pregnancy|24|||
143076268|NCT04730349|515817245|FG000|Overall Study|Participant withdrew consent|1|||
143076269|NCT04730349|515817246|FG001|Overall Study|Participant withdrew consent|0|||
143076270|NCT04730349|515817245|FG000|Overall Study|Disease progression|6|||
143076271|NCT04730349|515817246|FG001|Overall Study|Disease progression|4|||
143076272|NCT04730349|515817245|FG000|Overall Study|Study drug toxicity|0|||
143076273|NCT04730349|515817246|FG001|Overall Study|Study drug toxicity|1|||
143076274|NCT03155945|515817247|FG000|Overall Study|Lost to Follow-up|0|||
143076275|NCT03155945|515817248|FG001|Overall Study|Lost to Follow-up|1|||
143076276|NCT03155945|515817247|FG000|Overall Study|Withdrawal by Subject|0|||
143076277|NCT03155945|515817248|FG001|Overall Study|Withdrawal by Subject|1|||
143172357|NCT00744861|516179706|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
143172358|NCT00744861|516179707|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
143172359|NCT00744861|516179704|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
143172360|NCT00744861|516179705|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
143172361|NCT00744861|516179706|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
143172362|NCT00744861|516179707|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
143172363|NCT01561976|516179708|FG000|Period 1|Adverse Event|0|||
143172364|NCT01561976|516179709|FG001|Period 1|Adverse Event|0|||
143076278|NCT03155945|515817247|FG000|Overall Study|Other Reason|0|||
143076279|NCT03155945|515817248|FG001|Overall Study|Other Reason|1|||
143076280|NCT02013674|515817250|FG000|Overall Study|Death|0|||
143172365|NCT01561976|516179710|FG002|Period 1|Adverse Event|1|||
143172366|NCT01561976|516179711|FG003|Period 1|Adverse Event|0|||
143172367|NCT01561976|516179712|FG004|Period 1|Adverse Event|0|||
143172368|NCT01561976|516179713|FG005|Period 1|Adverse Event|0|||
143366165|NCT04310579|516884590|FG005|Overall Study|Adverse Event|0|||
143366166|NCT04310579|516884591|FG006|Overall Study|Adverse Event|2|||
143366167|NCT04310579|516884592|FG007|Overall Study|Adverse Event|0|||
143366168|NCT04310579|516884593|FG008|Overall Study|Adverse Event|1|||
143366169|NCT04310579|516884594|FG009|Overall Study|Adverse Event|1|||
143366170|NCT04310579|516884595|FG010|Overall Study|Adverse Event|0|||
143366171|NCT04310579|516884585|FG000|Overall Study|Withdrawal by Subject|0|||
143366172|NCT04310579|516884586|FG001|Overall Study|Withdrawal by Subject|0|||
143366173|NCT04310579|516884587|FG002|Overall Study|Withdrawal by Subject|0|||
143366174|NCT04310579|516884588|FG003|Overall Study|Withdrawal by Subject|0|||
143366175|NCT04310579|516884589|FG004|Overall Study|Withdrawal by Subject|0|||
143366176|NCT04310579|516884590|FG005|Overall Study|Withdrawal by Subject|1|||
143366177|NCT04310579|516884591|FG006|Overall Study|Withdrawal by Subject|0|||
143366178|NCT04310579|516884592|FG007|Overall Study|Withdrawal by Subject|0|||
143366179|NCT04310579|516884593|FG008|Overall Study|Withdrawal by Subject|0|||
143366180|NCT04310579|516884594|FG009|Overall Study|Withdrawal by Subject|0|||
143366181|NCT04310579|516884595|FG010|Overall Study|Withdrawal by Subject|0|||
143366182|NCT04310579|516884585|FG000|Overall Study|Positive COVID-19 test|0|||
143366183|NCT04310579|516884586|FG001|Overall Study|Positive COVID-19 test|0|||
143366184|NCT04310579|516884587|FG002|Overall Study|Positive COVID-19 test|0|||
143366185|NCT04310579|516884588|FG003|Overall Study|Positive COVID-19 test|0|||
143366186|NCT04310579|516884589|FG004|Overall Study|Positive COVID-19 test|0|||
143366187|NCT04310579|516884590|FG005|Overall Study|Positive COVID-19 test|0|||
143366188|NCT04310579|516884591|FG006|Overall Study|Positive COVID-19 test|0|||
143366189|NCT04310579|516884592|FG007|Overall Study|Positive COVID-19 test|0|||
143366190|NCT04310579|516884593|FG008|Overall Study|Positive COVID-19 test|0|||
143366191|NCT04310579|516884594|FG009|Overall Study|Positive COVID-19 test|0|||
143366192|NCT04310579|516884595|FG010|Overall Study|Positive COVID-19 test|1|||
143366193|NCT03467724|516884596|FG000|Overall Study|Lost to Follow-up|5|||
143366194|NCT03467724|516884596|FG000|Overall Study|Withdrawal by Subject|1|||
143366195|NCT03467724|516884596|FG000|Overall Study|Protocol Violation|1|||
143366196|NCT03467724|516884596|FG000|Overall Study|Adverse Event|1|||
143366197|NCT02236559|516884597|FG000|Overall Study|Met Exclusion|3|||
143366198|NCT02236559|516884598|FG001|Overall Study|Met Exclusion|6|||
143366199|NCT02236559|516884597|FG000|Overall Study|Did not Meet Inclusion|3|||
143366200|NCT02236559|516884598|FG001|Overall Study|Did not Meet Inclusion|3|||
143366201|NCT02236559|516884597|FG000|Overall Study|Subject Did Not Consent|4|||
143366202|NCT02236559|516884598|FG001|Overall Study|Subject Did Not Consent|2|||
143366203|NCT02236559|516884597|FG000|Overall Study|Physician Decision|1|||
143366204|NCT02236559|516884598|FG001|Overall Study|Physician Decision|1|||
143366205|NCT02236559|516884597|FG000|Overall Study|Withdrawal by Subject|1|||
143366206|NCT02236559|516884598|FG001|Overall Study|Withdrawal by Subject|0|||
143366207|NCT03721016|516884599|FG000|Overall Study|Adverse Event|0|||
143366208|NCT03721016|516884600|FG001|Overall Study|Adverse Event|1|||
143366209|NCT03721016|516884601|FG002|Overall Study|Adverse Event|1|||
143366210|NCT03721016|516884599|FG000|Overall Study|Withdrawal by Subject|8|||
143366211|NCT03721016|516884600|FG001|Overall Study|Withdrawal by Subject|16|||
143366212|NCT03721016|516884601|FG002|Overall Study|Withdrawal by Subject|13|||
143366213|NCT03721016|516884599|FG000|Overall Study|Lost to Follow-up|4|||
143366214|NCT03721016|516884600|FG001|Overall Study|Lost to Follow-up|6|||
143366215|NCT03721016|516884601|FG002|Overall Study|Lost to Follow-up|5|||
143366216|NCT03721016|516884599|FG000|Overall Study|Physician Decision|0|||
143366217|NCT03721016|516884600|FG001|Overall Study|Physician Decision|1|||
143366218|NCT03721016|516884601|FG002|Overall Study|Physician Decision|2|||
143366219|NCT03721016|516884599|FG000|Overall Study|Protocol Violation|0|||
143366220|NCT03721016|516884600|FG001|Overall Study|Protocol Violation|1|||
143366221|NCT03721016|516884601|FG002|Overall Study|Protocol Violation|0|||
143366222|NCT03721016|516884599|FG000|Overall Study|Site terminated by sponsor|3|||
143366223|NCT03721016|516884600|FG001|Overall Study|Site terminated by sponsor|7|||
143076281|NCT02013674|515817251|FG001|Overall Study|Death|1|||
143076282|NCT02013674|515817250|FG000|Overall Study|Lost to Follow-up|1|||
143076283|NCT02013674|515817251|FG001|Overall Study|Lost to Follow-up|0|||
143076284|NCT05065567|515817255|FG000|Overall Study|Lost to Follow-up|10|||
143076285|NCT05065567|515817256|FG001|Overall Study|Lost to Follow-up|9|||
143366224|NCT03721016|516884601|FG002|Overall Study|Site terminated by sponsor|6|||
143366225|NCT03721016|516884599|FG000|Overall Study|Subject exited early due to COVID-19|1|||
143366226|NCT03721016|516884600|FG001|Overall Study|Subject exited early due to COVID-19|0|||
143366227|NCT03721016|516884601|FG002|Overall Study|Subject exited early due to COVID-19|0|||
143366228|NCT04353037|516884604|FG000|Overall Study|Lost to Follow-up|0|||
143366229|NCT04353037|516884605|FG001|Overall Study|Lost to Follow-up|1|||
143366230|NCT04353037|516884606|FG002|Overall Study|Lost to Follow-up|2|||
143366231|NCT04353037|516884607|FG003|Overall Study|Lost to Follow-up|3|||
143366232|NCT04353037|516884604|FG000|Overall Study|Withdrawal by Subject|0|||
143366233|NCT04353037|516884605|FG001|Overall Study|Withdrawal by Subject|2|||
143366234|NCT04353037|516884606|FG002|Overall Study|Withdrawal by Subject|3|||
143366235|NCT04353037|516884607|FG003|Overall Study|Withdrawal by Subject|5|||
143076286|NCT05065567|515817257|FG002|Overall Study|Lost to Follow-up|6|||
143076287|NCT03510598|515819152|FG000|Overall Study|Withdrawal by Subject|1|||
143076288|NCT05307510|515819154|FG000|Overall Study|Lost to Follow-up|3|||
143076289|NCT05307510|515819155|FG001|Overall Study|Lost to Follow-up|6|||
143076290|NCT05307510|515819154|FG000|Overall Study|Withdrawal by Subject|0|||
143076291|NCT05307510|515819155|FG001|Overall Study|Withdrawal by Subject|1|||
143076292|NCT03610516|515819156|FG000|Treatment Epoch|Adverse Event|3|||
143076293|NCT03610516|515819157|FG001|Treatment Epoch|Adverse Event|1|||
143076294|NCT03610516|515819156|FG000|Treatment Epoch|Death|1|||
143076295|NCT03610516|515819157|FG001|Treatment Epoch|Death|0|||
143076296|NCT03610516|515819156|FG000|Treatment Epoch|Lack of Efficacy|0|||
143076297|NCT03610516|515819157|FG001|Treatment Epoch|Lack of Efficacy|1|||
143076298|NCT03610516|515819156|FG000|Treatment Epoch|No longer requires treatment|1|||
143076299|NCT03610516|515819157|FG001|Treatment Epoch|No longer requires treatment|0|||
143076300|NCT03610516|515819156|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
143076301|NCT03610516|515819157|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
143076302|NCT03610516|515819156|FG000|Treatment Epoch|Physician Decision|8|||
143076303|NCT03610516|515819157|FG001|Treatment Epoch|Physician Decision|5|||
143076304|NCT03610516|515819156|FG000|Treatment Epoch|Protocol Deviation|1|||
143076305|NCT03610516|515819157|FG001|Treatment Epoch|Protocol Deviation|0|||
143076306|NCT03610516|515819156|FG000|Treatment Epoch|Withdrawal by Subject|3|||
143076307|NCT03610516|515819157|FG001|Treatment Epoch|Withdrawal by Subject|1|||
143076308|NCT03610516|515819156|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
143076309|NCT03610516|515819157|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
143076310|NCT03610516|515819156|FG000|Post-Treatment Follow-up|Death|1|||
143076311|NCT03610516|515819157|FG001|Post-Treatment Follow-up|Death|0|||
143076312|NCT04003896|515819163|FG000|Overall Study|Withdrawal by Subject|3|||
143076313|NCT04003896|515819163|FG000|Overall Study|Physician Decision|1|||
143076314|NCT00537303|515819164|FG000|Overall Study|Adverse Event|1|||
143076315|NCT00537303|515819165|FG001|Overall Study|Adverse Event|4|||
143076316|NCT00537303|515819164|FG000|Overall Study|Lack of Efficacy|6|||
143076317|NCT00537303|515819165|FG001|Overall Study|Lack of Efficacy|7|||
143076318|NCT00537303|515819164|FG000|Overall Study|Protocol Violation|8|||
143076319|NCT00537303|515819165|FG001|Overall Study|Protocol Violation|4|||
143076320|NCT00537303|515819164|FG000|Overall Study|Withdrawal criteria|3|||
143076321|NCT00537303|515819165|FG001|Overall Study|Withdrawal criteria|3|||
143172369|NCT01561976|516179708|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
143172370|NCT01561976|516179709|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
143172371|NCT01561976|516179710|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
143172372|NCT01561976|516179711|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
143172373|NCT01561976|516179712|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
143172374|NCT01561976|516179713|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
143172375|NCT01561976|516179708|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
143172376|NCT01561976|516179709|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
143172377|NCT01561976|516179710|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
143172378|NCT01561976|516179711|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
143172379|NCT01561976|516179712|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
143172380|NCT01561976|516179713|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
143172381|NCT01561976|516179708|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
143172382|NCT01561976|516179709|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
143172383|NCT01561976|516179710|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
143172384|NCT01561976|516179711|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
143172385|NCT01561976|516179712|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
143172386|NCT01561976|516179713|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
143172387|NCT01612676|516179718|FG000|Overall Study|Adverse Event|2|||
143172388|NCT01612676|516179719|FG001|Overall Study|Adverse Event|3|||
143172389|NCT01612676|516179720|FG002|Overall Study|Adverse Event|1|||
143172390|NCT01612676|516179721|FG003|Overall Study|Adverse Event|3|||
143172391|NCT01612676|516179718|FG000|Overall Study|Protocol Violation|0|||
143172392|NCT01612676|516179719|FG001|Overall Study|Protocol Violation|1|||
143172393|NCT01612676|516179720|FG002|Overall Study|Protocol Violation|0|||
143172394|NCT01612676|516179721|FG003|Overall Study|Protocol Violation|0|||
143172395|NCT01156844|516179724|FG000|Overall Study|Adverse Event|0|||
143172396|NCT01156844|516179725|FG001|Overall Study|Adverse Event|0|||
143172397|NCT01156844|516179726|FG002|Overall Study|Adverse Event|1|||
143172398|NCT01156844|516179727|FG003|Overall Study|Adverse Event|1|||
143172399|NCT01156844|516179724|FG000|Overall Study|Abnormal test procedure result(s)|0|||
143172400|NCT01156844|516179725|FG001|Overall Study|Abnormal test procedure result(s)|1|||
143172401|NCT01156844|516179726|FG002|Overall Study|Abnormal test procedure result(s)|2|||
143172402|NCT01156844|516179727|FG003|Overall Study|Abnormal test procedure result(s)|2|||
143172403|NCT01156844|516179724|FG000|Overall Study|Withdrawal by Subject|0|||
143172404|NCT01156844|516179725|FG001|Overall Study|Withdrawal by Subject|0|||
143172405|NCT01156844|516179726|FG002|Overall Study|Withdrawal by Subject|2|||
143172406|NCT01156844|516179727|FG003|Overall Study|Withdrawal by Subject|2|||
143172407|NCT01156844|516179724|FG000|Overall Study|Lost to Follow-up|0|||
143172408|NCT01156844|516179725|FG001|Overall Study|Lost to Follow-up|0|||
143172409|NCT01156844|516179726|FG002|Overall Study|Lost to Follow-up|1|||
143172410|NCT01156844|516179727|FG003|Overall Study|Lost to Follow-up|0|||
143172411|NCT01156844|516179724|FG000|Overall Study|Administrative problems|0|||
143172412|NCT01156844|516179725|FG001|Overall Study|Administrative problems|1|||
143172413|NCT01156844|516179726|FG002|Overall Study|Administrative problems|0|||
143172414|NCT01156844|516179727|FG003|Overall Study|Administrative problems|1|||
143172415|NCT01156844|516179724|FG000|Overall Study|Protocol deviation|2|||
143172416|NCT01156844|516179725|FG001|Overall Study|Protocol deviation|0|||
143172417|NCT01156844|516179726|FG002|Overall Study|Protocol deviation|0|||
143172418|NCT01156844|516179727|FG003|Overall Study|Protocol deviation|0|||
143172419|NCT04067011|516179731|FG000|Overall Study|Not Treated|8|||
143172420|NCT04067011|516179732|FG001|Overall Study|Not Treated|7|||
143172421|NCT04067011|516179733|FG002|Overall Study|Not Treated|5|||
143172422|NCT04067011|516179731|FG000|Overall Study|Adverse Event|2|||
143172423|NCT04067011|516179732|FG001|Overall Study|Adverse Event|1|||
143172424|NCT04067011|516179733|FG002|Overall Study|Adverse Event|0|||
143172425|NCT04067011|516179731|FG000|Overall Study|Withdrawal by Subject|6|||
143172426|NCT04067011|516179732|FG001|Overall Study|Withdrawal by Subject|2|||
143172427|NCT04067011|516179733|FG002|Overall Study|Withdrawal by Subject|1|||
143172428|NCT04067011|516179731|FG000|Overall Study|Lost to Follow-up|0|||
143172429|NCT04067011|516179732|FG001|Overall Study|Lost to Follow-up|0|||
143172430|NCT04067011|516179733|FG002|Overall Study|Lost to Follow-up|1|||
143076322|NCT00537303|515819164|FG000|Overall Study|Unclassified|8|||
143076323|NCT00537303|515819165|FG001|Overall Study|Unclassified|7|||
143076324|NCT00867503|515819169|FG000|Overall Study|Withdrawal by Subject|1|||
143076325|NCT02704403|515819170|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
143076326|NCT02704403|515819171|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
143248678|NCT01584440|516463034|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
143248679|NCT01584440|516463035|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
143248680|NCT01584440|516463036|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
143248681|NCT01584440|516463032|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
143248682|NCT01584440|516463033|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
143248683|NCT01584440|516463034|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
143248684|NCT01584440|516463035|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
143248685|NCT01584440|516463036|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
143248686|NCT01584440|516463032|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
143248687|NCT01584440|516463033|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
143076327|NCT02704403|515819170|FG000|Overall Study|Administrative reasons by sponsor|1251|||
143076328|NCT02704403|515819171|FG001|Overall Study|Administrative reasons by sponsor|616|||
143076329|NCT02704403|515819170|FG000|Overall Study|Death|4|||
143076330|NCT02704403|515819171|FG001|Overall Study|Death|3|||
143076331|NCT02704403|515819170|FG000|Overall Study|Endpoint event|52|||
143076332|NCT02704403|515819171|FG001|Overall Study|Endpoint event|24|||
143076333|NCT02704403|515819170|FG000|Overall Study|Lost to Follow-up|22|||
143076334|NCT02704403|515819171|FG001|Overall Study|Lost to Follow-up|11|||
143248688|NCT01584440|516463034|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
143076335|NCT02704403|515819170|FG000|Overall Study|Protocol Violation|15|||
143076336|NCT02704403|515819171|FG001|Overall Study|Protocol Violation|15|||
143076337|NCT02704403|515819170|FG000|Overall Study|Adverse Event|2|||
143076338|NCT02704403|515819171|FG001|Overall Study|Adverse Event|0|||
143076339|NCT02704403|515819170|FG000|Overall Study|Withdrawal by Subject|85|||
143076340|NCT02704403|515819171|FG001|Overall Study|Withdrawal by Subject|45|||
143248689|NCT01584440|516463035|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
143248690|NCT01584440|516463036|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
143248691|NCT01584440|516463032|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
143248692|NCT01584440|516463033|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
143248693|NCT01584440|516463034|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
143248694|NCT01584440|516463035|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
143248695|NCT01584440|516463036|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
143248696|NCT01584440|516463032|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
143248697|NCT01584440|516463033|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
143248698|NCT01584440|516463034|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
143248699|NCT01584440|516463035|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
143248700|NCT01584440|516463036|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
143248701|NCT04237116|516463037|FG000|Overall Study|Adverse Event|0|||
143248702|NCT04237116|516463038|FG001|Overall Study|Adverse Event|1|||
143248703|NCT04237116|516463037|FG000|Overall Study|Study terminated by Sponsor|4|||
143248704|NCT04237116|516463038|FG001|Overall Study|Study terminated by Sponsor|1|||
143248705|NCT03212144|516463039|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
143248706|NCT03212144|516463040|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
143076341|NCT02704403|515819170|FG000|Overall Study|Investigator decision|1|||
143248707|NCT03212144|516463039|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
143248708|NCT03212144|516463040|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
143248709|NCT00599339|516463041|FG000|Overall Study|Adverse Event|79|||
143248710|NCT00599339|516463041|FG000|Overall Study|Withdrawal by Subject|137|||
143248711|NCT00599339|516463041|FG000|Overall Study|Other Reason|179|||
143172431|NCT04067011|516179731|FG000|Overall Study|Physician Decision|1|||
143172432|NCT04067011|516179732|FG001|Overall Study|Physician Decision|1|||
143172433|NCT04067011|516179733|FG002|Overall Study|Physician Decision|0|||
143172434|NCT04067011|516179731|FG000|Overall Study|Other Reasons|2|||
143172435|NCT04067011|516179732|FG001|Overall Study|Other Reasons|0|||
143172436|NCT04067011|516179733|FG002|Overall Study|Other Reasons|1|||
143172437|NCT04067011|516179731|FG000|Overall Study|Missing|0|||
143172438|NCT04067011|516179732|FG001|Overall Study|Missing|2|||
143172439|NCT04067011|516179733|FG002|Overall Study|Missing|0|||
143172440|NCT05209386|516179734|FG000|Overall Study|Withdrawal by Subject|8|||
143172441|NCT05209386|516179734|FG000|Overall Study|Period of sEEG implant insufficient to collect complete behavioral task|24|||
143172442|NCT05200845|516179735|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
143172443|NCT05200845|516179736|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
143172444|NCT05200845|516179737|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
143172445|NCT05200845|516179738|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
143172446|NCT05200845|516179735|FG000|Overall Study|Withdrawal by Subject|0|||
143172447|NCT05200845|516179736|FG001|Overall Study|Withdrawal by Subject|1|||
143172448|NCT05200845|516179737|FG002|Overall Study|Withdrawal by Subject|1|||
143172449|NCT05200845|516179738|FG003|Overall Study|Withdrawal by Subject|0|||
143172450|NCT02412670|516179739|FG000|Overall Study|Adverse Event|4|||
143172451|NCT02412670|516179740|FG001|Overall Study|Adverse Event|1|||
143172452|NCT02412670|516179739|FG000|Overall Study|Physician Decision|1|||
143172453|NCT02412670|516179740|FG001|Overall Study|Physician Decision|0|||
143172454|NCT02412670|516179739|FG000|Overall Study|Withdrawal by Subject|1|||
143172455|NCT02412670|516179740|FG001|Overall Study|Withdrawal by Subject|0|||
143172456|NCT02412670|516179739|FG000|Overall Study|Ineligible|1|||
143172457|NCT02412670|516179740|FG001|Overall Study|Ineligible|0|||
143172458|NCT01567722|516179746|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
143172459|NCT01567722|516179747|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
143172460|NCT01567722|516179748|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
143172461|NCT01567722|516179746|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
143172462|NCT01567722|516179747|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
143172463|NCT01567722|516179748|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
143172464|NCT01567722|516179746|FG000|Overall Study|Protocol closure by the OCG|2|||
143172465|NCT01567722|516179747|FG001|Overall Study|Protocol closure by the OCG|0|||
143172466|NCT01567722|516179748|FG002|Overall Study|Protocol closure by the OCG|0|||
143172467|NCT01567722|516179746|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
143172468|NCT01567722|516179747|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
143172469|NCT01567722|516179748|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
143172470|NCT02170064|516179749|FG000|Overall Study|Withdrawal by Subject|5|||
143172471|NCT02170064|516179750|FG001|Overall Study|Withdrawal by Subject|1|||
143172472|NCT02170064|516179751|FG002|Overall Study|Withdrawal by Subject|1|||
143172473|NCT02170064|516179749|FG000|Overall Study|Physician Decision|1|||
143172474|NCT02170064|516179750|FG001|Overall Study|Physician Decision|1|||
143172475|NCT02170064|516179751|FG002|Overall Study|Physician Decision|0|||
143172476|NCT00698841|516179752|FG000|Overall Study|Withdrawal by Subject|2|||
143172477|NCT00698841|516179752|FG000|Overall Study|Adverse Event|3|||
143172478|NCT00698841|516179752|FG000|Overall Study|Disease progression|7|||
143172479|NCT00698841|516179752|FG000|Overall Study|Failure to meet eligibility criteria|2|||
143172480|NCT00698841|516179752|FG000|Overall Study|Study drug toxicity|2|||
143172481|NCT00698841|516179752|FG000|Overall Study|Other|2|||
143172482|NCT00404248|516179753|FG000|Overall Study|pts declining status|0|||
143172483|NCT00404248|516179754|FG001|Overall Study|pts declining status|1|||
143172484|NCT00404248|516179755|FG002|Overall Study|pts declining status|0|||
143172485|NCT00404248|516179756|FG003|Overall Study|pts declining status|0|||
143172486|NCT00404248|516179757|FG004|Overall Study|pts declining status|0|||
143172487|NCT00404248|516179758|FG005|Overall Study|pts declining status|0|||
143172488|NCT00404248|516179759|FG006|Overall Study|pts declining status|0|||
143172489|NCT00404248|516179760|FG007|Overall Study|pts declining status|0|||
143172490|NCT00404248|516179761|FG008|Overall Study|pts declining status|0|||
143172491|NCT03802396|516179763|FG000|Overall Study|Withdrawal by Subject|2|||
143172492|NCT03802396|516179764|FG001|Overall Study|Withdrawal by Subject|0|||
143172493|NCT03802396|516179763|FG000|Overall Study|Surgery Cancelled|1|||
143172494|NCT03802396|516179764|FG001|Overall Study|Surgery Cancelled|0|||
143172495|NCT04577404|516179765|FG000|Overall Study|Adverse Event|31|||
143172496|NCT04577404|516179765|FG000|Overall Study|Death|1|||
143172497|NCT04577404|516179765|FG000|Overall Study|Lack of Efficacy|3|||
143172498|NCT04577404|516179765|FG000|Overall Study|Physician Decision|7|||
143172499|NCT04577404|516179765|FG000|Overall Study|Withdrawal by Subject|21|||
143172500|NCT04577404|516179765|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
143172501|NCT03423979|516179766|FG000|Overall Study|Death|1|||
143172502|NCT02581930|516179767|FG000|Overall Study|Withdrawal by Subject|1|||
143248712|NCT00599339|516463041|FG000|Overall Study|Lost to Follow-up|221|||
143248713|NCT00599339|516463041|FG000|Overall Study|No valid data consent|36|||
143248714|NCT00599339|516463041|FG000|Overall Study|Study Termination Status Unknown|12|||
143248715|NCT05564052|516463042|FG000|Overall Study|Withdrawal by Subject|0|||
143248716|NCT05564052|516463043|FG001|Overall Study|Withdrawal by Subject|0|||
143248717|NCT05564052|516463044|FG002|Overall Study|Withdrawal by Subject|0|||
143248718|NCT05564052|516463045|FG003|Overall Study|Withdrawal by Subject|1|||
143248719|NCT01253577|516463047|FG000|Overall Study|Lost to Follow-up|3|||
143248720|NCT01064947|516463048|FG000|Overall Study|negative culture|41|||
143248721|NCT06457204|516463049|FG000|Washout|Adverse Event|0|||
143248722|NCT06457204|516463050|FG001|Washout|Adverse Event|2|||
143248723|NCT01601652|516463052|FG000|Overall Study|Death|1|||
143248724|NCT03818035|516463053|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
143248725|NCT03818035|516463054|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
143248726|NCT03818035|516463055|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
143248727|NCT03818035|516463056|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
143248728|NCT03818035|516463053|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
143248729|NCT03818035|516463054|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
143248730|NCT03818035|516463055|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
143248731|NCT03818035|516463056|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
143248732|NCT03818035|516463053|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
143248733|NCT03818035|516463054|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
143248734|NCT03818035|516463055|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
143248735|NCT03818035|516463056|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
143248736|NCT03818035|516463053|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
143248737|NCT03818035|516463054|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
143248738|NCT03818035|516463055|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
143248739|NCT03818035|516463056|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
143248740|NCT03818035|516463053|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
143248741|NCT03818035|516463054|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
143248742|NCT03818035|516463055|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
143248743|NCT03818035|516463056|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
143248744|NCT03818035|516463053|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
143248745|NCT03818035|516463054|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
143248746|NCT03818035|516463055|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
143248747|NCT03818035|516463056|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
143248748|NCT03818035|516463053|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
143248749|NCT03818035|516463054|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
143248750|NCT03818035|516463055|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
143248751|NCT03818035|516463056|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
143248752|NCT03818035|516463053|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
143248753|NCT03818035|516463054|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
143248754|NCT03818035|516463055|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
143248755|NCT03818035|516463056|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
143248756|NCT03818035|516463053|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
143248757|NCT03818035|516463054|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
143248758|NCT03818035|516463055|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
143248759|NCT03818035|516463056|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
143248760|NCT03818035|516463053|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
143248761|NCT03818035|516463054|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
143248762|NCT03818035|516463055|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
143248763|NCT03818035|516463056|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
143248764|NCT03818035|516463053|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
143248765|NCT03818035|516463054|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
143248766|NCT03818035|516463055|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
143248767|NCT03818035|516463056|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
143248768|NCT03818035|516463053|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
143248769|NCT03818035|516463054|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
143076342|NCT02704403|515819171|FG001|Overall Study|Investigator decision|1|||
143248770|NCT03818035|516463055|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
143248771|NCT03818035|516463056|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
143248772|NCT03818035|516463053|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
143076343|NCT02704403|515819170|FG000|Overall Study|Follow-up not possible|1|||
143076344|NCT02704403|515819171|FG001|Overall Study|Follow-up not possible|2|||
143076345|NCT04040192|515819180|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
143076346|NCT04040192|515819181|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
143076347|NCT04040192|515819182|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
143076348|NCT04040192|515819180|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
143076349|NCT04040192|515819181|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
143076350|NCT04040192|515819182|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
143076351|NCT04040192|515819180|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
143076352|NCT04040192|515819181|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
143076353|NCT04040192|515819182|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
143248773|NCT03818035|516463054|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
143366236|NCT04353037|516884604|FG000|Overall Study|Adverse Event|0|||
143366237|NCT04353037|516884605|FG001|Overall Study|Adverse Event|0|||
143366238|NCT04353037|516884606|FG002|Overall Study|Adverse Event|2|||
143366239|NCT04353037|516884607|FG003|Overall Study|Adverse Event|0|||
143366240|NCT04353037|516884604|FG000|Overall Study|Exposure Change|0|||
143366241|NCT04353037|516884605|FG001|Overall Study|Exposure Change|0|||
143366242|NCT04353037|516884606|FG002|Overall Study|Exposure Change|0|||
143366243|NCT04353037|516884607|FG003|Overall Study|Exposure Change|2|||
143366244|NCT00817635|516884608|FG000|Overall Study|Adverse Event|1|||
143366245|NCT00817635|516884609|FG001|Overall Study|Adverse Event|0|||
143076354|NCT04040192|515819180|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
143366246|NCT00817635|516884610|FG002|Overall Study|Adverse Event|0|||
143076355|NCT04040192|515819181|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
143076356|NCT04040192|515819182|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
143366247|NCT00817635|516884611|FG003|Overall Study|Adverse Event|1|||
143076357|NCT04040192|515819180|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
143076358|NCT04040192|515819181|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
143076359|NCT04040192|515819182|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
143076360|NCT04040192|515819180|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
143076361|NCT04040192|515819181|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
143076362|NCT04040192|515819182|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
143076363|NCT04040192|515819180|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
143076364|NCT04040192|515819181|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
143076365|NCT04040192|515819182|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
143076366|NCT04040192|515819180|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
143076367|NCT04040192|515819181|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
143076368|NCT04040192|515819182|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
143076369|NCT04040192|515819180|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
143076370|NCT04040192|515819181|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
143076371|NCT04040192|515819182|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
143076372|NCT04040192|515819180|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
143076373|NCT04040192|515819181|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
143076374|NCT04040192|515819182|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
143076375|NCT04040192|515819180|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
143076376|NCT04040192|515819181|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
143076377|NCT04040192|515819182|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
143076378|NCT04040192|515819180|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
143076379|NCT04040192|515819181|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
143076380|NCT04040192|515819182|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
143076381|NCT04040192|515819180|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
143076382|NCT04040192|515819181|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
143076383|NCT04040192|515819182|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
143076384|NCT04040192|515819180|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
143076385|NCT04040192|515819181|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
143076386|NCT04040192|515819182|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
143076387|NCT04040192|515819180|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
143076388|NCT04040192|515819181|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
143076389|NCT04040192|515819182|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
143076390|NCT04040192|515819180|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
143076391|NCT04040192|515819181|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
143076392|NCT04040192|515819182|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
143076393|NCT04040192|515819180|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
143076394|NCT04040192|515819181|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
143076395|NCT04040192|515819182|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
143076396|NCT04015908|515819183|FG000|Overall Study|Lost to Follow-up|0|||
143076397|NCT04015908|515819184|FG001|Overall Study|Lost to Follow-up|1|||
143076398|NCT01994291|515819185|FG000|Overall Study|Adverse Event|4|||
143076399|NCT01994291|515819186|FG001|Overall Study|Adverse Event|1|||
143076400|NCT01994291|515819187|FG002|Overall Study|Adverse Event|3|||
143076401|NCT01994291|515819185|FG000|Overall Study|Lost to Follow-up|1|||
143076402|NCT01994291|515819186|FG001|Overall Study|Lost to Follow-up|1|||
143076403|NCT01994291|515819187|FG002|Overall Study|Lost to Follow-up|0|||
143076404|NCT01994291|515819185|FG000|Overall Study|Does not meet entrance criteria|1|||
143076405|NCT01994291|515819186|FG001|Overall Study|Does not meet entrance criteria|0|||
143076406|NCT01994291|515819187|FG002|Overall Study|Does not meet entrance criteria|0|||
143076407|NCT01994291|515819185|FG000|Overall Study|Medication error without associated AE|1|||
143076408|NCT01994291|515819186|FG001|Overall Study|Medication error without associated AE|0|||
143076409|NCT01994291|515819187|FG002|Overall Study|Medication error without associated AE|1|||
143076410|NCT01994291|515819185|FG000|Overall Study|Protocol Violation|1|||
143076411|NCT01994291|515819186|FG001|Overall Study|Protocol Violation|0|||
143076412|NCT01994291|515819187|FG002|Overall Study|Protocol Violation|0|||
143076413|NCT01994291|515819185|FG000|Overall Study|Withdrawal by Subject|6|||
143076414|NCT01994291|515819186|FG001|Overall Study|Withdrawal by Subject|3|||
143076415|NCT01994291|515819187|FG002|Overall Study|Withdrawal by Subject|5|||
143076416|NCT01994291|515819185|FG000|Overall Study|Other|1|||
143076417|NCT01994291|515819186|FG001|Overall Study|Other|2|||
143076418|NCT01994291|515819187|FG002|Overall Study|Other|0|||
143076419|NCT01775189|515819188|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
143076420|NCT01775189|515819189|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
143076421|NCT01775189|515819190|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
143076422|NCT01775189|515819191|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
143076423|NCT01775189|515819192|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
143076424|NCT01775189|515819193|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
143076425|NCT01775189|515819194|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
143076426|NCT01775189|515819188|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
143076427|NCT01775189|515819189|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
143076428|NCT01775189|515819190|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
143076429|NCT01775189|515819191|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
143076430|NCT01775189|515819192|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
143076431|NCT01775189|515819193|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
143076432|NCT01775189|515819194|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
143366248|NCT00817635|516884612|FG004|Overall Study|Adverse Event|1|||
143366249|NCT00817635|516884608|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
143366250|NCT00817635|516884609|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
143366251|NCT00817635|516884610|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
143366252|NCT00817635|516884611|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
143366253|NCT00817635|516884612|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
143366254|NCT00817635|516884608|FG000|Overall Study|Withdrawal by Subject|2|||
143366255|NCT00817635|516884609|FG001|Overall Study|Withdrawal by Subject|1|||
143076433|NCT01775189|515819188|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
143076434|NCT01775189|515819189|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
143248774|NCT03818035|516463055|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
143248775|NCT03818035|516463056|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
143076435|NCT01775189|515819190|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
143076436|NCT01775189|515819191|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
143076437|NCT01775189|515819192|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
143076438|NCT01775189|515819193|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
143076439|NCT01775189|515819194|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
143076440|NCT01775189|515819188|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
143076441|NCT01775189|515819189|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
143076442|NCT01775189|515819190|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
143076443|NCT01775189|515819191|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
143076444|NCT01775189|515819192|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
143076445|NCT01775189|515819193|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
143076446|NCT01775189|515819194|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
143076447|NCT01775189|515819188|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
143076448|NCT01775189|515819189|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
143076449|NCT01775189|515819190|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
143076450|NCT01775189|515819191|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
143076451|NCT01775189|515819192|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
143076452|NCT01775189|515819193|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
143076453|NCT01775189|515819194|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
143076454|NCT01775189|515819188|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
143076455|NCT01775189|515819189|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
143076456|NCT01775189|515819190|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
143076457|NCT01775189|515819191|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
143076458|NCT01775189|515819192|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
143076459|NCT01775189|515819193|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
143076460|NCT01775189|515819194|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
143076461|NCT02227446|515819195|FG000|Overall Study|not eligible post randomization|18|||
143076462|NCT02227446|515819196|FG001|Overall Study|not eligible post randomization|29|||
143076463|NCT02227446|515819195|FG000|Overall Study|Withdrawal by Subject|4|||
143076464|NCT02227446|515819196|FG001|Overall Study|Withdrawal by Subject|5|||
143076465|NCT03200912|515819197|FG000|Overall Study|Adverse Event|3|||
143076466|NCT03200912|515819198|FG001|Overall Study|Adverse Event|0|||
143076467|NCT03200912|515819199|FG002|Overall Study|Adverse Event|0|||
143076468|NCT03200912|515819197|FG000|Overall Study|Withdrawal by Subject|1|||
143076469|NCT03200912|515819198|FG001|Overall Study|Withdrawal by Subject|2|||
143076470|NCT03200912|515819199|FG002|Overall Study|Withdrawal by Subject|4|||
143076471|NCT03200912|515819197|FG000|Overall Study|Non-compliance with study drug|0|||
143076472|NCT03200912|515819198|FG001|Overall Study|Non-compliance with study drug|1|||
143076473|NCT03200912|515819199|FG002|Overall Study|Non-compliance with study drug|0|||
143076474|NCT03421730|515819200|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
143076475|NCT03421730|515819201|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
143076476|NCT03421730|515819202|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
143076477|NCT03421730|515819203|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
143076478|NCT03421730|515819204|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
143076479|NCT03421730|515819205|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
143076480|NCT03421730|515819206|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
143076481|NCT03421730|515819207|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
143076482|NCT03421730|515819208|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
143076483|NCT03421730|515819209|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
143076484|NCT03421730|515819210|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
143076485|NCT03421730|515819211|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
143076486|NCT03421730|515819200|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
143076487|NCT03421730|515819201|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
143076488|NCT03421730|515819202|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
143076489|NCT03421730|515819203|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
143076490|NCT03421730|515819204|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
143076491|NCT03421730|515819205|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
143076492|NCT03421730|515819206|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
143076493|NCT03421730|515819207|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
143076494|NCT03421730|515819208|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
143076495|NCT03421730|515819209|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
143076496|NCT03421730|515819210|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
143076497|NCT03421730|515819211|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
143076498|NCT03016975|515819218|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
143076499|NCT03016975|515819219|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
143076500|NCT03016975|515819220|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
143076501|NCT03016975|515819218|FG000|At 6 Months Follow-up|Death|2|||
143076502|NCT03016975|515819219|FG001|At 6 Months Follow-up|Death|0|||
143076503|NCT03016975|515819220|FG002|At 6 Months Follow-up|Death|0|||
143076504|NCT03016975|515819218|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
143076505|NCT03016975|515819219|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
143076506|NCT03016975|515819220|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
143076507|NCT03016975|515819218|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
143076508|NCT03016975|515819219|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
143076509|NCT03016975|515819220|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
143076510|NCT03016975|515819218|FG000|At 6 Months Follow-up|Aborted implant|1|||
143076511|NCT03016975|515819219|FG001|At 6 Months Follow-up|Aborted implant|0|||
143076512|NCT03016975|515819220|FG002|At 6 Months Follow-up|Aborted implant|0|||
143076513|NCT03016975|515819218|FG000|At 2 Year Follow-up|Death|1|||
143076514|NCT03016975|515819219|FG001|At 2 Year Follow-up|Death|0|||
143076515|NCT03016975|515819220|FG002|At 2 Year Follow-up|Death|0|||
143076516|NCT03016975|515819218|FG000|At 3 Year Follow-up|Death|1|||
143076517|NCT03016975|515819219|FG001|At 3 Year Follow-up|Death|0|||
143076518|NCT03016975|515819220|FG002|At 3 Year Follow-up|Death|0|||
143076519|NCT03016975|515819218|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
143076520|NCT03016975|515819219|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
143076521|NCT03016975|515819220|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
143076522|NCT03016975|515819218|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
143076523|NCT03016975|515819219|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
143076524|NCT03016975|515819220|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
143076525|NCT02901548|515819221|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
143076526|NCT01338870|515819229|FG000|Overall Study|Lost to Follow-up|0|||
143076527|NCT01338870|515819230|FG001|Overall Study|Lost to Follow-up|0|||
143076528|NCT01338870|515819231|FG002|Overall Study|Lost to Follow-up|1|||
143076529|NCT01338870|515819232|FG003|Overall Study|Lost to Follow-up|0|||
143076530|NCT01338870|515819233|FG004|Overall Study|Lost to Follow-up|1|||
143076531|NCT01338870|515819234|FG005|Overall Study|Lost to Follow-up|0|||
143076532|NCT01338870|515819229|FG000|Overall Study|Withdrawal by Subject|2|||
143076533|NCT01338870|515819230|FG001|Overall Study|Withdrawal by Subject|3|||
143076534|NCT01338870|515819231|FG002|Overall Study|Withdrawal by Subject|4|||
143076535|NCT01338870|515819232|FG003|Overall Study|Withdrawal by Subject|0|||
143076536|NCT01338870|515819233|FG004|Overall Study|Withdrawal by Subject|0|||
143076537|NCT01338870|515819234|FG005|Overall Study|Withdrawal by Subject|2|||
143076538|NCT01338870|515819229|FG000|Overall Study|Other|3|||
143076539|NCT01338870|515819230|FG001|Overall Study|Other|3|||
143076540|NCT01338870|515819231|FG002|Overall Study|Other|3|||
143076541|NCT01338870|515819232|FG003|Overall Study|Other|2|||
143076542|NCT01338870|515819233|FG004|Overall Study|Other|0|||
143076543|NCT01338870|515819234|FG005|Overall Study|Other|2|||
143076544|NCT01338870|515819229|FG000|Overall Study|Protocol Violation|0|||
143076545|NCT01338870|515819230|FG001|Overall Study|Protocol Violation|2|||
143076546|NCT01338870|515819231|FG002|Overall Study|Protocol Violation|2|||
143076547|NCT01338870|515819232|FG003|Overall Study|Protocol Violation|2|||
143076548|NCT01338870|515819233|FG004|Overall Study|Protocol Violation|1|||
143076549|NCT01338870|515819234|FG005|Overall Study|Protocol Violation|1|||
143076550|NCT01338870|515819229|FG000|Overall Study|Adverse Event|4|||
143076551|NCT01338870|515819230|FG001|Overall Study|Adverse Event|4|||
143076552|NCT01338870|515819231|FG002|Overall Study|Adverse Event|1|||
143172503|NCT02581930|516179767|FG000|Overall Study|patient declined further treatment|1|||
143172504|NCT01400412|516179768|FG000|Overall Study|Lost to Follow-up|4|||
143172505|NCT01400412|516179769|FG001|Overall Study|Lost to Follow-up|7|||
143172506|NCT01400412|516179768|FG000|Overall Study|Withdrawal by Subject|3|||
143172507|NCT01400412|516179769|FG001|Overall Study|Withdrawal by Subject|4|||
143172508|NCT01400412|516179768|FG000|Overall Study|Unable to complete|3|||
143172509|NCT01400412|516179769|FG001|Overall Study|Unable to complete|3|||
143172510|NCT01400412|516179768|FG000|Overall Study|Never started study treatment|0|||
143172511|NCT01400412|516179769|FG001|Overall Study|Never started study treatment|3|||
143172512|NCT02777086|516181503|FG000|Overall Study|Lost to Follow-up|96|||
143366256|NCT00817635|516884610|FG002|Overall Study|Withdrawal by Subject|0|||
143366257|NCT00817635|516884611|FG003|Overall Study|Withdrawal by Subject|1|||
143076553|NCT01338870|515819232|FG003|Overall Study|Adverse Event|5|||
143076554|NCT01338870|515819233|FG004|Overall Study|Adverse Event|4|||
143076555|NCT01338870|515819234|FG005|Overall Study|Adverse Event|1|||
143076556|NCT01955083|515819235|FG000|Overall Study|Lost to Follow-up|1|||
143076557|NCT01955083|515819236|FG001|Overall Study|Lost to Follow-up|1|||
143076558|NCT00901576|515819249|FG000|Second Intervention|Withdrawal by Subject|0|||
143076559|NCT00901576|515819250|FG001|Second Intervention|Withdrawal by Subject|0|||
143076560|NCT00901576|515819251|FG002|Second Intervention|Withdrawal by Subject|0|||
143076561|NCT00901576|515819252|FG003|Second Intervention|Withdrawal by Subject|1|||
143076562|NCT00901576|515819253|FG004|Second Intervention|Withdrawal by Subject|0|||
143076563|NCT00901576|515819254|FG005|Second Intervention|Withdrawal by Subject|1|||
143076564|NCT00901576|515819249|FG000|Second Intervention|Physician Decision|1|||
143076565|NCT00901576|515819250|FG001|Second Intervention|Physician Decision|0|||
143076566|NCT00901576|515819251|FG002|Second Intervention|Physician Decision|0|||
143076567|NCT00901576|515819252|FG003|Second Intervention|Physician Decision|0|||
143076568|NCT00901576|515819253|FG004|Second Intervention|Physician Decision|0|||
143076569|NCT00901576|515819254|FG005|Second Intervention|Physician Decision|0|||
143076570|NCT01559389|515819255|FG000|Overall Study|Withdrawal by Subject|20|||
143076571|NCT01559389|515819256|FG001|Overall Study|Withdrawal by Subject|20|||
143076572|NCT02871492|515819257|FG000|Overall Study|Lost to Follow-up|6|||
143076573|NCT02871492|515819258|FG001|Overall Study|Lost to Follow-up|3|||
143076574|NCT02871492|515819259|FG002|Overall Study|Lost to Follow-up|5|||
143076575|NCT02871492|515819257|FG000|Overall Study|Withdrawal by Subject|0|||
143076576|NCT02871492|515819258|FG001|Overall Study|Withdrawal by Subject|0|||
143076577|NCT02871492|515819259|FG002|Overall Study|Withdrawal by Subject|1|||
143076578|NCT04546724|515819260|FG000|Overall Study|Withdrawal by Subject|145|||
143076579|NCT04546724|515819261|FG001|Overall Study|Withdrawal by Subject|41|||
143076580|NCT04546724|515819260|FG000|Overall Study|Adverse Event|1|||
143076581|NCT04546724|515819261|FG001|Overall Study|Adverse Event|1|||
143076582|NCT04546724|515819260|FG000|Overall Study|Lost to Follow-up|186|||
143076583|NCT04546724|515819261|FG001|Overall Study|Lost to Follow-up|63|||
143076584|NCT04546724|515819260|FG000|Overall Study|Physician Decision|8|||
143076585|NCT04546724|515819261|FG001|Overall Study|Physician Decision|2|||
143172513|NCT02777086|516181504|FG001|Overall Study|Lost to Follow-up|99|||
143366258|NCT00817635|516884612|FG004|Overall Study|Withdrawal by Subject|2|||
143076586|NCT04546724|515819260|FG000|Overall Study|Death|2|||
143076587|NCT04546724|515819261|FG001|Overall Study|Death|1|||
143076588|NCT04546724|515819260|FG000|Overall Study|subject has been out of town|1|||
143172514|NCT01784029|516181507|FG000|Overall Study|Lost to Follow-up|19|||
143366259|NCT00817635|516884608|FG000|Overall Study|Lost to Follow-up|0|||
143076589|NCT04546724|515819261|FG001|Overall Study|subject has been out of town|0|||
143076590|NCT04546724|515819260|FG000|Overall Study|subject is incarcerated|2|||
143076591|NCT04546724|515819261|FG001|Overall Study|subject is incarcerated|0|||
143076592|NCT04546724|515819260|FG000|Overall Study|subject is relocating|12|||
143076593|NCT04546724|515819261|FG001|Overall Study|subject is relocating|4|||
143076594|NCT04546724|515819260|FG000|Overall Study|Subject in another study|1|||
143076595|NCT04546724|515819261|FG001|Overall Study|Subject in another study|1|||
143076596|NCT02256436|515819264|FG000|Overall Study|Adverse Event|9|||
143076597|NCT02256436|515819265|FG001|Overall Study|Adverse Event|14|||
143076598|NCT02256436|515819264|FG000|Overall Study|Death|216|||
143076599|NCT02256436|515819265|FG001|Overall Study|Death|208|||
143076600|NCT02256436|515819264|FG000|Overall Study|Lost to Follow-up|1|||
143076601|NCT02256436|515819265|FG001|Overall Study|Lost to Follow-up|2|||
143076602|NCT02256436|515819264|FG000|Overall Study|Physician Decision|1|||
143076603|NCT02256436|515819265|FG001|Overall Study|Physician Decision|0|||
143076604|NCT02256436|515819264|FG000|Overall Study|Protocol Violation|0|||
143076605|NCT02256436|515819265|FG001|Overall Study|Protocol Violation|1|||
143076606|NCT02256436|515819264|FG000|Overall Study|Withdrawal by Subject|26|||
143076607|NCT02256436|515819265|FG001|Overall Study|Withdrawal by Subject|10|||
143076608|NCT02256436|515819264|FG000|Overall Study|Transferred to Extension Study|11|||
143076609|NCT02256436|515819265|FG001|Overall Study|Transferred to Extension Study|23|||
143076610|NCT02256436|515819264|FG000|Overall Study|Did Not Continue on Extension Study|8|||
143076611|NCT02256436|515819265|FG001|Overall Study|Did Not Continue on Extension Study|12|||
143076612|NCT03583086|515819266|FG000|Overall Study|Death|2|||
143076613|NCT03583086|515819267|FG001|Overall Study|Death|6|||
143076614|NCT03583086|515819268|FG002|Overall Study|Death|12|||
143076615|NCT03583086|515819269|FG003|Overall Study|Death|10|||
143076616|NCT03583086|515819270|FG004|Overall Study|Death|14|||
143076617|NCT03583086|515819271|FG005|Overall Study|Death|14|||
143076618|NCT03583086|515819272|FG006|Overall Study|Death|4|||
143076619|NCT03583086|515819266|FG000|Overall Study|Withdrawal by Subject|0|||
143076620|NCT03583086|515819267|FG001|Overall Study|Withdrawal by Subject|0|||
143076621|NCT03583086|515819268|FG002|Overall Study|Withdrawal by Subject|1|||
143076622|NCT03583086|515819269|FG003|Overall Study|Withdrawal by Subject|0|||
143076623|NCT03583086|515819270|FG004|Overall Study|Withdrawal by Subject|0|||
143076624|NCT03583086|515819271|FG005|Overall Study|Withdrawal by Subject|0|||
143076625|NCT03583086|515819272|FG006|Overall Study|Withdrawal by Subject|1|||
143076626|NCT03583086|515819266|FG000|Overall Study|Refused follow-up|0|||
143076627|NCT03583086|515819267|FG001|Overall Study|Refused follow-up|0|||
143076628|NCT03583086|515819268|FG002|Overall Study|Refused follow-up|1|||
143076629|NCT03583086|515819269|FG003|Overall Study|Refused follow-up|0|||
143076630|NCT03583086|515819270|FG004|Overall Study|Refused follow-up|1|||
143076631|NCT03583086|515819271|FG005|Overall Study|Refused follow-up|0|||
143076632|NCT03583086|515819272|FG006|Overall Study|Refused follow-up|0|||
143076633|NCT03583086|515819266|FG000|Overall Study|Declining Performance Status|0|||
143076634|NCT03583086|515819267|FG001|Overall Study|Declining Performance Status|0|||
143076635|NCT03583086|515819268|FG002|Overall Study|Declining Performance Status|1|||
143076636|NCT03583086|515819269|FG003|Overall Study|Declining Performance Status|0|||
143076637|NCT03583086|515819270|FG004|Overall Study|Declining Performance Status|0|||
143076638|NCT03583086|515819271|FG005|Overall Study|Declining Performance Status|0|||
143076639|NCT03583086|515819272|FG006|Overall Study|Declining Performance Status|0|||
143076640|NCT03583086|515819266|FG000|Overall Study|Still on study|0|||
143076641|NCT03583086|515819267|FG001|Overall Study|Still on study|0|||
143076642|NCT03583086|515819268|FG002|Overall Study|Still on study|0|||
143076643|NCT03583086|515819269|FG003|Overall Study|Still on study|1|||
143076644|NCT03583086|515819270|FG004|Overall Study|Still on study|0|||
143076645|NCT03583086|515819271|FG005|Overall Study|Still on study|0|||
143076646|NCT03583086|515819272|FG006|Overall Study|Still on study|1|||
143076647|NCT03583086|515819266|FG000|Overall Study|Disease progression|0|||
143076648|NCT03583086|515819267|FG001|Overall Study|Disease progression|0|||
143076649|NCT03583086|515819268|FG002|Overall Study|Disease progression|0|||
143076650|NCT03583086|515819269|FG003|Overall Study|Disease progression|0|||
143076651|NCT03583086|515819270|FG004|Overall Study|Disease progression|0|||
143076652|NCT03583086|515819271|FG005|Overall Study|Disease progression|0|||
143076653|NCT03583086|515819272|FG006|Overall Study|Disease progression|1|||
143076654|NCT03583086|515819266|FG000|Overall Study|Undergoing radiation therapy|0|||
143366260|NCT00817635|516884609|FG001|Overall Study|Lost to Follow-up|1|||
143366261|NCT00817635|516884610|FG002|Overall Study|Lost to Follow-up|0|||
143366262|NCT00817635|516884611|FG003|Overall Study|Lost to Follow-up|1|||
143366263|NCT00817635|516884612|FG004|Overall Study|Lost to Follow-up|0|||
143076655|NCT03583086|515819267|FG001|Overall Study|Undergoing radiation therapy|0|||
143076656|NCT03583086|515819268|FG002|Overall Study|Undergoing radiation therapy|0|||
143076657|NCT03583086|515819269|FG003|Overall Study|Undergoing radiation therapy|0|||
143076658|NCT03583086|515819270|FG004|Overall Study|Undergoing radiation therapy|0|||
143076659|NCT03583086|515819271|FG005|Overall Study|Undergoing radiation therapy|0|||
143076660|NCT03583086|515819272|FG006|Overall Study|Undergoing radiation therapy|1|||
143366264|NCT00817635|516884608|FG000|Overall Study|Administrative Problems|0|||
143076661|NCT03583086|515819266|FG000|Overall Study|Lost to Follow-up|0|||
143076662|NCT03583086|515819267|FG001|Overall Study|Lost to Follow-up|0|||
143248776|NCT03818035|516463053|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
143248777|NCT03818035|516463054|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
143248778|NCT03818035|516463055|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
143248779|NCT03818035|516463056|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
143248780|NCT03818035|516463053|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
143248781|NCT03818035|516463054|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
143076663|NCT03583086|515819268|FG002|Overall Study|Lost to Follow-up|0|||
143076664|NCT03583086|515819269|FG003|Overall Study|Lost to Follow-up|0|||
143076665|NCT03583086|515819270|FG004|Overall Study|Lost to Follow-up|0|||
143076666|NCT03583086|515819271|FG005|Overall Study|Lost to Follow-up|1|||
143076667|NCT03583086|515819272|FG006|Overall Study|Lost to Follow-up|0|||
143076668|NCT03583086|515819266|FG000|Overall Study|Adverse Event|0|||
143076669|NCT03583086|515819267|FG001|Overall Study|Adverse Event|0|||
143076670|NCT03583086|515819268|FG002|Overall Study|Adverse Event|0|||
143076671|NCT03583086|515819269|FG003|Overall Study|Adverse Event|0|||
143076672|NCT03583086|515819270|FG004|Overall Study|Adverse Event|0|||
143076673|NCT03583086|515819271|FG005|Overall Study|Adverse Event|1|||
143076674|NCT03583086|515819272|FG006|Overall Study|Adverse Event|0|||
143076675|NCT01696279|515819273|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
143076676|NCT01696279|515819274|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
143076677|NCT01696279|515819275|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
143076678|NCT01696279|515819276|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
143076679|NCT01696279|515819273|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
143076680|NCT01696279|515819274|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
143076681|NCT01696279|515819275|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
143076682|NCT01696279|515819276|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
143076683|NCT01696279|515819273|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
143076684|NCT01696279|515819274|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
143076685|NCT01696279|515819275|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
143076686|NCT01696279|515819276|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
143076687|NCT01696279|515819273|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
143076688|NCT01696279|515819274|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
143076689|NCT01696279|515819275|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
143076690|NCT01696279|515819276|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
143076691|NCT01696279|515819273|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
143076692|NCT01696279|515819274|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
143076693|NCT01696279|515819275|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
143076694|NCT01696279|515819276|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
143076695|NCT01696279|515819273|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
143076696|NCT01696279|515819274|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
143076697|NCT01696279|515819275|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
143076698|NCT01696279|515819276|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
143076699|NCT01696279|515819273|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
143076700|NCT01696279|515819274|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
143076701|NCT01696279|515819275|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
143076702|NCT01696279|515819276|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
143076703|NCT01696279|515819273|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
143076704|NCT01696279|515819274|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
143076705|NCT01696279|515819275|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
143076706|NCT01696279|515819276|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
143076707|NCT01696279|515819273|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
143076708|NCT01696279|515819274|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
143076709|NCT01696279|515819275|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
143076710|NCT01696279|515819276|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
143076711|NCT01696279|515819273|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
143076712|NCT01696279|515819274|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
143076713|NCT01696279|515819275|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
143248782|NCT03818035|516463055|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
143248783|NCT03818035|516463056|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
143248784|NCT03374202|516463059|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
143248785|NCT03374202|516463060|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
143076714|NCT01696279|515819276|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
143076715|NCT01696279|515819273|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
143076716|NCT01696279|515819274|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
143076717|NCT01696279|515819275|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
143076718|NCT01696279|515819276|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
143076719|NCT00171951|515819278|FG000|Overall Study|Adverse Event|1|||
143076720|NCT00171951|515819278|FG000|Overall Study|Abnormal Laboratory Values|2|||
143076721|NCT00171951|515819278|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
143076722|NCT00171951|515819278|FG000|Overall Study|Participants Withdrew Consent|3|||
143076723|NCT00171951|515819278|FG000|Overall Study|New Cancer Therapy|5|||
143076724|NCT00171951|515819278|FG000|Overall Study|Reason not Specified|2|||
143076725|NCT00396812|515819279|FG000|Overall Study|Physician Decision|1|||
143076726|NCT03201445|515819280|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
143076727|NCT03201445|515819281|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
143076728|NCT03201445|515819280|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
143076729|NCT03201445|515819281|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
143076730|NCT03201445|515819280|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
143076731|NCT03201445|515819281|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
143076732|NCT03201445|515819280|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
143076733|NCT03201445|515819281|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
143076734|NCT03201445|515819280|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
143076735|NCT03201445|515819281|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
143076736|NCT03201445|515819280|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
143076737|NCT03201445|515819281|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
143076738|NCT03201445|515819280|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
143076739|NCT03201445|515819281|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
143076740|NCT03201445|515819280|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
143076741|NCT03201445|515819281|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
143076742|NCT03201445|515819280|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
143076743|NCT03201445|515819281|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
143076744|NCT03201445|515819280|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
143076745|NCT03201445|515819281|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
143076746|NCT03201445|515819280|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
143076747|NCT03201445|515819281|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
143076748|NCT03201445|515819280|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
143076749|NCT03201445|515819281|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
143076750|NCT03201445|515819280|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
143076751|NCT03201445|515819281|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
143076752|NCT03201445|515819280|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
143076753|NCT03201445|515819281|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
143076754|NCT03201445|515819280|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
143076755|NCT03201445|515819281|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
143076756|NCT03201445|515819280|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
143076757|NCT03201445|515819281|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
143076758|NCT03201445|515819280|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
143076759|NCT03201445|515819281|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
143076760|NCT03201445|515819280|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
143076761|NCT03201445|515819281|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
143076762|NCT03201445|515819280|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
143076763|NCT03201445|515819281|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
143076764|NCT03201445|515819280|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
143076765|NCT03201445|515819281|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
143076766|NCT03201445|515819280|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
143076767|NCT03201445|515819281|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
143076768|NCT01346293|515819284|FG000|Overall Study|Protocol Violation|30|||
143076769|NCT01346293|515819285|FG001|Overall Study|Protocol Violation|9|||
143076770|NCT01346293|515819284|FG000|Overall Study|Lost to Follow-up|21|||
143076771|NCT01346293|515819285|FG001|Overall Study|Lost to Follow-up|8|||
143076772|NCT01346293|515819284|FG000|Overall Study|Withdrawal by Subject|15|||
143248786|NCT03374202|516463061|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
143248787|NCT03374202|516463059|FG000|Five Year Long Term Follow Up|Death|0|||
143248788|NCT03374202|516463060|FG001|Five Year Long Term Follow Up|Death|1|||
143248789|NCT03374202|516463061|FG002|Five Year Long Term Follow Up|Death|0|||
143248790|NCT04236141|516465015|FG000|Overall Study|Death|18|||
143248791|NCT04236141|516465016|FG001|Overall Study|Death|10|||
143248792|NCT04236141|516465015|FG000|Overall Study|Withdrawal by Participant|1|||
143248793|NCT04236141|516465016|FG001|Overall Study|Withdrawal by Participant|0|||
143076773|NCT01346293|515819285|FG001|Overall Study|Withdrawal by Subject|4|||
143076774|NCT01346293|515819284|FG000|Overall Study|Other|1|||
143248794|NCT04236141|516465015|FG000|Overall Study|Reason not Specified|1|||
143248795|NCT04236141|516465016|FG001|Overall Study|Reason not Specified|0|||
143248796|NCT04236141|516465015|FG000|Overall Study|Study terminated by Sponsor|8|||
143076775|NCT01346293|515819285|FG001|Overall Study|Other|0|||
143076776|NCT00128830|515819288|FG000|Overall Study|Adverse Event|10|||
143076777|NCT00128830|515819288|FG000|Overall Study|Withdrawal by Subject|14|||
143076778|NCT00128830|515819288|FG000|Overall Study|Lost to Follow-up|4|||
143076779|NCT00128830|515819288|FG000|Overall Study|Reached a virologic endpoint|29|||
143076780|NCT00128830|515819288|FG000|Overall Study|Non-compliant|4|||
143076781|NCT00128830|515819288|FG000|Overall Study|Discontinued or ineligible for study|2|||
143076782|NCT00128830|515819288|FG000|Overall Study|Other|9|||
143076783|NCT02640053|515819289|FG000|Overall Study|Withdrawal by Subject|2|||
143076784|NCT02640053|515819290|FG001|Overall Study|Withdrawal by Subject|1|||
143076785|NCT02640053|515819289|FG000|Overall Study|Adverse Event|1|||
143076786|NCT02640053|515819290|FG001|Overall Study|Adverse Event|1|||
143076787|NCT02640053|515819289|FG000|Overall Study|Alternative Therapy|1|||
143076788|NCT02640053|515819290|FG001|Overall Study|Alternative Therapy|1|||
143076789|NCT02640053|515819289|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
143076790|NCT02640053|515819290|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
143076791|NCT00587990|515819293|FG000|Overall Study|Death|0|||
143076792|NCT00587990|515819294|FG001|Overall Study|Death|0|||
143076793|NCT00587990|515819295|FG002|Overall Study|Death|1|||
143076794|NCT02754856|515819296|FG000|Overall Study|Withdrawal by Subject|1|||
143076795|NCT04874155|515819297|FG000|Overall Study|Lost to Follow-up|1|||
143076796|NCT04874155|515819298|FG001|Overall Study|Lost to Follow-up|1|||
143076797|NCT04874155|515819297|FG000|Overall Study|Withdrawal by Subject|2|||
143076798|NCT04874155|515819298|FG001|Overall Study|Withdrawal by Subject|2|||
143172515|NCT01784029|516181508|FG001|Overall Study|Lost to Follow-up|20|||
143172516|NCT01784029|516181509|FG002|Overall Study|Lost to Follow-up|22|||
143172517|NCT02986074|516181510|FG000|First Trial Period|Adverse Event|1|||
143172518|NCT02986074|516181511|FG001|First Trial Period|Adverse Event|0|||
143076799|NCT00530218|515819299|FG000|Overall Study|CMV Not Detected|13|||
143076800|NCT00530218|515819299|FG000|Overall Study|Death|12|||
143076801|NCT00678886|515819300|FG000|Overall Study|Withdrawal by Subject|0|||
143076802|NCT00678886|515819301|FG001|Overall Study|Withdrawal by Subject|0|||
143076803|NCT00678886|515819302|FG002|Overall Study|Withdrawal by Subject|4|||
143076804|NCT00678886|515819303|FG003|Overall Study|Withdrawal by Subject|6|||
143076805|NCT00678886|515819300|FG000|Overall Study|Physician Decision|0|||
143076806|NCT00678886|515819301|FG001|Overall Study|Physician Decision|0|||
143076807|NCT00678886|515819302|FG002|Overall Study|Physician Decision|1|||
143076808|NCT00678886|515819303|FG003|Overall Study|Physician Decision|1|||
143076809|NCT00678886|515819300|FG000|Overall Study|Lost to Follow-up|0|||
143076810|NCT00678886|515819301|FG001|Overall Study|Lost to Follow-up|0|||
143076811|NCT00678886|515819302|FG002|Overall Study|Lost to Follow-up|3|||
143076812|NCT00678886|515819303|FG003|Overall Study|Lost to Follow-up|2|||
143076813|NCT00678886|515819300|FG000|Overall Study|Other|0|||
143076814|NCT00678886|515819301|FG001|Overall Study|Other|0|||
143076815|NCT00678886|515819302|FG002|Overall Study|Other|1|||
143076816|NCT00678886|515819303|FG003|Overall Study|Other|0|||
143076817|NCT03477903|515819304|FG000|Overall Study|Study Terminated by Sponsor|1|||
143076818|NCT01147107|515819305|FG000|Overall Study|Lack of Efficacy|5|||
143076819|NCT01147107|515819306|FG001|Overall Study|Lack of Efficacy|0|||
143076820|NCT01147107|515819305|FG000|Overall Study|Withdrawal by Subject|1|||
143076821|NCT01147107|515819306|FG001|Overall Study|Withdrawal by Subject|1|||
143076822|NCT03496610|515819307|FG000|Overall Study|Lost to Follow-up|3|||
143172519|NCT02986074|516181512|FG002|First Trial Period|Adverse Event|0|||
143172520|NCT02986074|516181513|FG003|First Trial Period|Adverse Event|0|||
143172521|NCT02986074|516181510|FG000|Follow up Period|system explant|0|||
143172522|NCT02986074|516181511|FG001|Follow up Period|system explant|0|||
143172523|NCT02986074|516181512|FG002|Follow up Period|system explant|1|||
143172524|NCT02986074|516181513|FG003|Follow up Period|system explant|2|||
143172525|NCT02986074|516181510|FG000|Follow up Period|Physician Decision|0|||
143076823|NCT03496610|515819308|FG001|Overall Study|Lost to Follow-up|2|||
143076824|NCT03496610|515819307|FG000|Overall Study|Physician Decision|1|||
143076825|NCT03496610|515819308|FG001|Overall Study|Physician Decision|0|||
143172526|NCT02986074|516181511|FG001|Follow up Period|Physician Decision|0|||
143172527|NCT02986074|516181512|FG002|Follow up Period|Physician Decision|0|||
143172528|NCT02986074|516181513|FG003|Follow up Period|Physician Decision|1|||
143076826|NCT03496610|515819307|FG000|Overall Study|Withdrawal by Subject|1|||
143076827|NCT03496610|515819308|FG001|Overall Study|Withdrawal by Subject|0|||
143076828|NCT03201965|515819312|FG000|Overall Study|Death|5|||
143076829|NCT03201965|515819313|FG001|Overall Study|Death|27|||
143076830|NCT03201965|515819314|FG002|Overall Study|Death|27|||
143076831|NCT03201965|515819312|FG000|Overall Study|Lost to Follow-up|0|||
143076832|NCT03201965|515819313|FG001|Overall Study|Lost to Follow-up|1|||
143076833|NCT03201965|515819314|FG002|Overall Study|Lost to Follow-up|0|||
143076834|NCT03201965|515819312|FG000|Overall Study|Withdrawal by Subject|3|||
143076835|NCT03201965|515819313|FG001|Overall Study|Withdrawal by Subject|13|||
143076836|NCT03201965|515819314|FG002|Overall Study|Withdrawal by Subject|4|||
143076837|NCT03201965|515819312|FG000|Overall Study|Ongoing|20|||
143076838|NCT03201965|515819313|FG001|Overall Study|Ongoing|152|||
143076839|NCT03201965|515819314|FG002|Overall Study|Ongoing|164|||
143076840|NCT02365558|515819318|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
143076841|NCT02365558|515819319|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
143076842|NCT02365558|515819318|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
143076843|NCT02365558|515819319|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
143076844|NCT02828241|515819323|FG000|Overall Study|Adverse Event|7|||
143076845|NCT02828241|515819324|FG001|Overall Study|Adverse Event|2|||
143076846|NCT02828241|515819323|FG000|Overall Study|Protocol Violation|1|||
143076847|NCT02828241|515819324|FG001|Overall Study|Protocol Violation|0|||
143076848|NCT00073021|515819331|FG000|Overall Study|Protocol Violation|2|||
143076849|NCT00073021|515819332|FG001|Overall Study|Protocol Violation|1|||
143076850|NCT00073021|515819331|FG000|Overall Study|Adverse Event|4|||
143076851|NCT00073021|515819332|FG001|Overall Study|Adverse Event|4|||
143076852|NCT00073021|515819331|FG000|Overall Study|Withdrawal by Subject|6|||
143076853|NCT00073021|515819332|FG001|Overall Study|Withdrawal by Subject|5|||
143076854|NCT00073021|515819331|FG000|Overall Study|Physician Decision|3|||
143076855|NCT00073021|515819332|FG001|Overall Study|Physician Decision|1|||
143076856|NCT00073021|515819331|FG000|Overall Study|Lack of Efficacy|11|||
143076857|NCT00073021|515819332|FG001|Overall Study|Lack of Efficacy|5|||
143076858|NCT03835221|515819333|FG000|Methafilcon A|Withdrawal by Subject|1|||
143076859|NCT02823652|515819337|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
143076860|NCT02823652|515819338|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
143076861|NCT02823652|515819339|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
143076862|NCT02823652|515819337|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
143076863|NCT02823652|515819338|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
143076864|NCT02823652|515819339|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
143076865|NCT02823652|515819337|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
143076866|NCT02823652|515819338|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
143076867|NCT02823652|515819339|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
143076868|NCT02823652|515819337|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
143076869|NCT02823652|515819338|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
143076870|NCT02823652|515819339|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
143076871|NCT03582826|515819340|FG000|Overall Study|Lost to Follow-up|39|||
143076872|NCT03582826|515819341|FG001|Overall Study|Lost to Follow-up|0|||
143076873|NCT03582826|515819340|FG000|Overall Study|Withdrawal by Subject|2|||
143076874|NCT03582826|515819341|FG001|Overall Study|Withdrawal by Subject|0|||
143076875|NCT00761865|515819342|FG000|Overall Study|Lost to Follow-up|8|||
143076876|NCT00761865|515819343|FG001|Overall Study|Lost to Follow-up|7|||
143076877|NCT01094886|515819344|FG000|Overall Study|Adverse Event|2|||
143076878|NCT01094886|515819344|FG000|Overall Study|Withdrawal by Subject|5|||
143076879|NCT03395405|515820486|FG000|Overall Study|Death|0|||
143076880|NCT03395405|515820487|FG001|Overall Study|Death|2|||
143076881|NCT03395405|515820486|FG000|Overall Study|Lost to Follow-up|0|||
143076882|NCT03395405|515820487|FG001|Overall Study|Lost to Follow-up|1|||
143076883|NCT03395405|515820486|FG000|Overall Study|Protocol Violation|0|||
143076884|NCT03395405|515820487|FG001|Overall Study|Protocol Violation|1|||
143076885|NCT03395405|515820486|FG000|Overall Study|Withdrawal by Subject|3|||
143076886|NCT03395405|515820487|FG001|Overall Study|Withdrawal by Subject|1|||
143076887|NCT03395405|515820486|FG000|Overall Study|COVID-19 Pandemic|1|||
143076888|NCT03395405|515820487|FG001|Overall Study|COVID-19 Pandemic|0|||
143076889|NCT02886624|515820490|FG000|12-week Post Treatment Follow-up|Death|1|||
143076890|NCT02886624|515820490|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
143076891|NCT01056289|515820492|FG000|Open-label Phase|Adverse Event|29|||
143076892|NCT01056289|515820493|FG001|Open-label Phase|Adverse Event|0|||
143076893|NCT01056289|515820494|FG002|Open-label Phase|Adverse Event|0|||
143076894|NCT01056289|515820495|FG003|Open-label Phase|Adverse Event|0|||
143076895|NCT01056289|515820492|FG000|Open-label Phase|Lost to Follow-up|30|||
143076896|NCT01056289|515820493|FG001|Open-label Phase|Lost to Follow-up|0|||
143076897|NCT01056289|515820494|FG002|Open-label Phase|Lost to Follow-up|0|||
143076898|NCT01056289|515820495|FG003|Open-label Phase|Lost to Follow-up|0|||
143076899|NCT01056289|515820492|FG000|Open-label Phase|Other|9|||
143076900|NCT01056289|515820493|FG001|Open-label Phase|Other|0|||
143076901|NCT01056289|515820494|FG002|Open-label Phase|Other|0|||
143076902|NCT01056289|515820495|FG003|Open-label Phase|Other|0|||
143076903|NCT01056289|515820492|FG000|Open-label Phase|Protocol Violation|6|||
143076904|NCT01056289|515820493|FG001|Open-label Phase|Protocol Violation|0|||
143076905|NCT01056289|515820494|FG002|Open-label Phase|Protocol Violation|0|||
143076906|NCT01056289|515820495|FG003|Open-label Phase|Protocol Violation|0|||
143076907|NCT01056289|515820492|FG000|Open-label Phase|Withdrawal by Subject|26|||
143076908|NCT01056289|515820493|FG001|Open-label Phase|Withdrawal by Subject|0|||
143076909|NCT01056289|515820494|FG002|Open-label Phase|Withdrawal by Subject|0|||
143076910|NCT01056289|515820495|FG003|Open-label Phase|Withdrawal by Subject|0|||
143076911|NCT01056289|515820492|FG000|Open-label Phase|Lack of Efficacy|18|||
143076912|NCT01056289|515820493|FG001|Open-label Phase|Lack of Efficacy|0|||
143076913|NCT01056289|515820494|FG002|Open-label Phase|Lack of Efficacy|0|||
143076914|NCT01056289|515820495|FG003|Open-label Phase|Lack of Efficacy|0|||
143076915|NCT01056289|515820492|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
143076916|NCT01056289|515820493|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
143076917|NCT01056289|515820494|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
143076918|NCT01056289|515820495|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
143076919|NCT01056289|515820492|FG000|Double-blind Phase|Adverse Event|0|||
143076920|NCT01056289|515820493|FG001|Double-blind Phase|Adverse Event|1|||
143076921|NCT01056289|515820494|FG002|Double-blind Phase|Adverse Event|2|||
143076922|NCT01056289|515820495|FG003|Double-blind Phase|Adverse Event|1|||
143076923|NCT01056289|515820492|FG000|Double-blind Phase|Lost to Follow-up|0|||
143076924|NCT01056289|515820493|FG001|Double-blind Phase|Lost to Follow-up|2|||
143076925|NCT01056289|515820494|FG002|Double-blind Phase|Lost to Follow-up|2|||
143076926|NCT01056289|515820495|FG003|Double-blind Phase|Lost to Follow-up|2|||
143076927|NCT01056289|515820492|FG000|Double-blind Phase|Other|0|||
143076928|NCT01056289|515820493|FG001|Double-blind Phase|Other|0|||
143076929|NCT01056289|515820494|FG002|Double-blind Phase|Other|1|||
143076930|NCT01056289|515820495|FG003|Double-blind Phase|Other|2|||
143076931|NCT01056289|515820492|FG000|Double-blind Phase|Protocol Violation|0|||
143076932|NCT01056289|515820493|FG001|Double-blind Phase|Protocol Violation|0|||
143076933|NCT01056289|515820494|FG002|Double-blind Phase|Protocol Violation|1|||
143076934|NCT01056289|515820495|FG003|Double-blind Phase|Protocol Violation|1|||
143076935|NCT01056289|515820492|FG000|Double-blind Phase|Withdrawal by Subject|0|||
143076936|NCT01056289|515820493|FG001|Double-blind Phase|Withdrawal by Subject|0|||
143076937|NCT01056289|515820494|FG002|Double-blind Phase|Withdrawal by Subject|4|||
143076938|NCT01056289|515820495|FG003|Double-blind Phase|Withdrawal by Subject|2|||
143076939|NCT01056289|515820492|FG000|Double-blind Phase|Discontinuation symptom|0|||
143076940|NCT01056289|515820493|FG001|Double-blind Phase|Discontinuation symptom|1|||
143076941|NCT01056289|515820494|FG002|Double-blind Phase|Discontinuation symptom|2|||
143076942|NCT01056289|515820495|FG003|Double-blind Phase|Discontinuation symptom|2|||
143076943|NCT01056289|515820492|FG000|Double-blind Phase|Physician Decision|0|||
143076944|NCT01056289|515820493|FG001|Double-blind Phase|Physician Decision|0|||
143076945|NCT01056289|515820494|FG002|Double-blind Phase|Physician Decision|1|||
143076946|NCT01056289|515820495|FG003|Double-blind Phase|Physician Decision|0|||
143076947|NCT05776862|515820496|FG000|Overall Study|Adverse Event|0|||
143076948|NCT05776862|515820497|FG001|Overall Study|Adverse Event|1|||
143076949|NCT05776862|515820496|FG000|Overall Study|non-compliance|1|||
143076950|NCT05776862|515820497|FG001|Overall Study|non-compliance|0|||
143076951|NCT02448706|515820498|FG000|Overall Study|Withdrawal by Subject|4|||
143076952|NCT02448706|515820499|FG001|Overall Study|Withdrawal by Subject|3|||
143076953|NCT02448706|515820498|FG000|Overall Study|Protocol Violation|1|||
143076954|NCT02448706|515820499|FG001|Overall Study|Protocol Violation|1|||
143076955|NCT00837473|515820500|FG000|Overall Study|Lost to Follow-up|1|||
143076956|NCT00837473|515820500|FG000|Overall Study|Withdrawal by Subject|2|||
143076957|NCT00554606|515820503|FG000|Overall Study|Adverse Event|3|||
143076958|NCT00554606|515820503|FG000|Overall Study|Abnormal laboratory values|1|||
143076959|NCT00554606|515820503|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
143076960|NCT00554606|515820503|FG000|Overall Study|Subject withdrew consent|2|||
143076961|NCT00554606|515820503|FG000|Overall Study|Lost to Follow-up|2|||
143076962|NCT00554606|515820503|FG000|Overall Study|Administrative problems|60|||
143076963|NCT00554606|515820503|FG000|Overall Study|Death|1|||
143076964|NCT00554606|515820503|FG000|Overall Study|Protocol deviation|2|||
143076965|NCT01635283|515820504|FG000|Overall Study|Tumor Progression|3|||
143076966|NCT01635283|515820504|FG000|Overall Study|Lost to Follow-up|1|||
143076967|NCT03511326|515820507|FG000|Overall Study|Withdrawal by Subject|1|||
143076968|NCT01305044|515820510|FG000|Overall Study|Withdrawal by Subject|3|||
143076969|NCT01305044|515820511|FG001|Overall Study|Withdrawal by Subject|6|||
143076970|NCT00849186|515820514|FG000|Overall Study|Adverse Event|2|||
143076971|NCT00849186|515820514|FG000|Overall Study|Withdrawal by Subject|1|||
143172529|NCT00276419|516181514|FG000|First Intervention|Adverse Event|1|||
143172530|NCT00276419|516181515|FG001|First Intervention|Adverse Event|0|||
143076972|NCT00849186|515820514|FG000|Overall Study|not treated|6|||
143076973|NCT00849186|515820514|FG000|Overall Study|Other|1|||
143076974|NCT00492024|515820515|FG000|Treatment|Adverse Event|3|||
143076975|NCT00492024|515820516|FG001|Treatment|Adverse Event|1|||
143076976|NCT00492024|515820515|FG000|Treatment|Lack of Efficacy|21|||
143076977|NCT00492024|515820516|FG001|Treatment|Lack of Efficacy|20|||
143076978|NCT00492024|515820515|FG000|Treatment|Lost to Follow-up|3|||
143076979|NCT00492024|515820516|FG001|Treatment|Lost to Follow-up|1|||
143172531|NCT00276419|516181514|FG000|First Intervention|Withdrawal by Subject|0|||
143172532|NCT00276419|516181515|FG001|First Intervention|Withdrawal by Subject|2|||
143076980|NCT00492024|515820515|FG000|Treatment|Withdrawal by Subject|2|||
143076981|NCT00492024|515820516|FG001|Treatment|Withdrawal by Subject|0|||
143076982|NCT00492024|515820515|FG000|Follow up|Lack of Efficacy|0|||
143076983|NCT00492024|515820516|FG001|Follow up|Lack of Efficacy|1|||
143076984|NCT00492024|515820515|FG000|Follow up|Lost to Follow-up|1|||
143076985|NCT00492024|515820516|FG001|Follow up|Lost to Follow-up|1|||
143076986|NCT02677714|515820519|FG000|Overall Study|Withdrawal by Subject|2|||
143076987|NCT02677714|515820520|FG001|Overall Study|Withdrawal by Subject|0|||
143076988|NCT00469144|515820522|FG000|Overall Study|Death|0|||
143076989|NCT00469144|515820523|FG001|Overall Study|Death|1|||
143076990|NCT00469144|515820522|FG000|Overall Study|No Response|5|||
143076991|NCT00469144|515820523|FG001|Overall Study|No Response|5|||
143076992|NCT00469144|515820522|FG000|Overall Study|Progressive Disease|1|||
143076993|NCT00469144|515820523|FG001|Overall Study|Progressive Disease|0|||
143076994|NCT00856375|515820524|FG000|Overall Study|Other|0|||
143076995|NCT00856375|515820525|FG001|Overall Study|Other|1|||
143076996|NCT00856375|515820524|FG000|Overall Study|Death|32|||
143248797|NCT04236141|516465016|FG001|Overall Study|Study terminated by Sponsor|4|||
143248798|NCT01888432|516465017|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
143248799|NCT01888432|516465018|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
143248800|NCT01888432|516465017|FG000|12-month Analysis (FAS)|Physician Decision|1|||
143248801|NCT01888432|516465018|FG001|12-month Analysis (FAS)|Physician Decision|1|||
143248802|NCT01888432|516465017|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
143248803|NCT01888432|516465018|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
143248804|NCT01888432|516465017|FG000|12-month Analysis (FAS)|Death|4|||
143248805|NCT01888432|516465018|FG001|12-month Analysis (FAS)|Death|3|||
143248806|NCT01888432|516465017|FG000|24-month Analysis (FAS)|Graft loss|0|||
143248807|NCT01888432|516465018|FG001|24-month Analysis (FAS)|Graft loss|1|||
143248808|NCT01888432|516465017|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
143248809|NCT01888432|516465018|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
143248810|NCT01888432|516465017|FG000|24-month Analysis (FAS)|Physician Decision|2|||
143248811|NCT01888432|516465018|FG001|24-month Analysis (FAS)|Physician Decision|4|||
143248812|NCT01888432|516465017|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
143248813|NCT01888432|516465018|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
143248814|NCT01888432|516465017|FG000|24-month Analysis (FAS)|Death|8|||
143248815|NCT01888432|516465018|FG001|24-month Analysis (FAS)|Death|4|||
143248816|NCT01888432|516465017|FG000|36-month Analysis (Extension)|Death|1|||
143248817|NCT01888432|516465018|FG001|36-month Analysis (Extension)|Death|0|||
143248818|NCT01696929|516465019|FG000|Overall Study|Physician Decision|1|||
143248819|NCT02156271|516465024|FG000|Overall Study|Physician Decision|4|||
143248820|NCT02156271|516465025|FG001|Overall Study|Physician Decision|3|||
143248821|NCT00955305|516465026|FG000|Overall Study|Disease progression|39|||
143248822|NCT00955305|516465027|FG001|Overall Study|Disease progression|41|||
143248823|NCT00955305|516465026|FG000|Overall Study|Adverse Event|22|||
143248824|NCT00955305|516465027|FG001|Overall Study|Adverse Event|22|||
143248825|NCT00955305|516465026|FG000|Overall Study|Death|2|||
143248826|NCT00955305|516465027|FG001|Overall Study|Death|1|||
143248827|NCT00955305|516465026|FG000|Overall Study|Withdrawal by Subject|5|||
143248828|NCT00955305|516465027|FG001|Overall Study|Withdrawal by Subject|4|||
143248829|NCT00955305|516465026|FG000|Overall Study|Alternative therapy|4|||
143248830|NCT00955305|516465027|FG001|Overall Study|Alternative therapy|0|||
143248831|NCT00955305|516465026|FG000|Overall Study|Other complicating disease|2|||
143248832|NCT00955305|516465027|FG001|Overall Study|Other complicating disease|4|||
143248833|NCT00955305|516465026|FG000|Overall Study|Physician Decision|1|||
143248834|NCT00955305|516465027|FG001|Overall Study|Physician Decision|0|||
143076997|NCT00856375|515820525|FG001|Overall Study|Death|30|||
143172533|NCT00652834|516181516|FG000|Overall Study|Withdrawal by Subject|3|||
143172534|NCT00652834|516181516|FG000|Overall Study|Lost to Follow-up|2|||
143172535|NCT03984825|516181517|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
143172536|NCT03984825|516181517|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
143172537|NCT03984825|516181517|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
143172538|NCT02569853|516181518|FG000|Overall Study|Adverse Event|2|||
143172539|NCT02569853|516181519|FG001|Overall Study|Adverse Event|0|||
143172540|NCT02569853|516181518|FG000|Overall Study|Withdrawal by Subject|3|||
143172541|NCT02569853|516181519|FG001|Overall Study|Withdrawal by Subject|2|||
143172542|NCT02569853|516181518|FG000|Overall Study|Lost to Follow-up|3|||
143172543|NCT02569853|516181519|FG001|Overall Study|Lost to Follow-up|3|||
143172544|NCT02569853|516181518|FG000|Overall Study|Protocol Violation|1|||
143172545|NCT02569853|516181519|FG001|Overall Study|Protocol Violation|1|||
143172546|NCT02569853|516181518|FG000|Overall Study|Did not experience migraine attack|10|||
143172547|NCT02569853|516181519|FG001|Overall Study|Did not experience migraine attack|7|||
143172548|NCT02569853|516181518|FG000|Overall Study|Physician Decision|1|||
143172549|NCT02569853|516181519|FG001|Overall Study|Physician Decision|1|||
143172550|NCT00474903|516181523|FG000|Overall Study|Protocol Violation|1|||
143172551|NCT00474903|516181524|FG001|Overall Study|Protocol Violation|5|||
143172552|NCT00474903|516181525|FG002|Overall Study|Protocol Violation|2|||
143248835|NCT00955305|516465026|FG000|Overall Study|Continued presence of residual disease|0|||
143248836|NCT00955305|516465027|FG001|Overall Study|Continued presence of residual disease|1|||
143248837|NCT00955305|516465026|FG000|Overall Study|Functional decline|2|||
143076998|NCT00856375|515820524|FG000|Overall Study|Sponsor Terminated Study|7|||
143076999|NCT00856375|515820525|FG001|Overall Study|Sponsor Terminated Study|7|||
143248838|NCT00955305|516465027|FG001|Overall Study|Functional decline|0|||
143077000|NCT00856375|515820524|FG000|Overall Study|Withdrawal by Subject|2|||
143077001|NCT00856375|515820525|FG001|Overall Study|Withdrawal by Subject|1|||
143077002|NCT00856375|515820524|FG000|Overall Study|Lost to Follow-up|1|||
143077003|NCT00856375|515820525|FG001|Overall Study|Lost to Follow-up|2|||
143077004|NCT02121392|515820526|FG000|Prior to Intervention|Protocol Violation|40|||
143077005|NCT02121392|515820527|FG001|Prior to Intervention|Protocol Violation|35|||
143077006|NCT02121392|515820526|FG000|Prior to Intervention|Withdrawal by Subject|8|||
143077007|NCT02121392|515820527|FG001|Prior to Intervention|Withdrawal by Subject|6|||
143077008|NCT02121392|515820526|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
143077009|NCT02121392|515820527|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
143077010|NCT02121392|515820526|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
143077011|NCT02121392|515820527|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
143077012|NCT01228019|515820532|FG000|Overall Study|Dose Violation|70|||
143077013|NCT01228019|515820532|FG000|Overall Study|Duplicate enrollment|1|||
143077014|NCT01228019|515820532|FG000|Overall Study|Missing pre-treatment data|72|||
143077015|NCT01228019|515820532|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
143077016|NCT01228019|515820532|FG000|Overall Study|Violation of Entry Criterion|9|||
143077017|NCT01292226|515820535|FG000|Overall Study|Adverse Event|5|||
143077018|NCT01292226|515820535|FG000|Overall Study|Death|1|||
143248839|NCT00955305|516465026|FG000|Overall Study|Maximum response achieved|0|||
143248840|NCT00955305|516465027|FG001|Overall Study|Maximum response achieved|1|||
143248841|NCT00955305|516465026|FG000|Overall Study|Lost to Follow-up|0|||
143248842|NCT00955305|516465027|FG001|Overall Study|Lost to Follow-up|1|||
143248843|NCT00955305|516465026|FG000|Overall Study|No off-treatment reason submitted|1|||
143248844|NCT00955305|516465027|FG001|Overall Study|No off-treatment reason submitted|0|||
143248845|NCT00955305|516465026|FG000|Overall Study|Never started protocol treatment|5|||
143248846|NCT00955305|516465027|FG001|Overall Study|Never started protocol treatment|5|||
143248847|NCT00955305|516465026|FG000|Overall Study|Ineligible|5|||
143248848|NCT00955305|516465027|FG001|Overall Study|Ineligible|7|||
143248849|NCT03387111|516465028|FG000|Overall Study|Progressive Disease|3|||
143248850|NCT03387111|516465028|FG000|Overall Study|Other|1|||
143248851|NCT01754727|516465029|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
143248852|NCT02785770|516465030|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
143248853|NCT02785770|516465031|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
143248854|NCT02785770|516465032|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
143248855|NCT02785770|516465033|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
143077019|NCT01292226|515820535|FG000|Overall Study|Graft loss|1|||
143077020|NCT01292226|515820535|FG000|Overall Study|Protocol Violation|3|||
143172553|NCT00399529|516181526|FG000|Overall Study|Off Study Prior to Treatment|2|||
143172554|NCT02519842|516181527|FG000|Base Study: Cycle 1|Screening Failure|1|||
143172555|NCT02519842|516181528|FG001|Base Study: Cycle 1|Screening Failure|1|||
143172556|NCT02519842|516181529|FG002|Base Study: Cycle 1|Screening Failure|0|||
143172557|NCT02519842|516181527|FG000|Base Study: Cycle 1|Adverse Event|1|||
143172558|NCT02519842|516181528|FG001|Base Study: Cycle 1|Adverse Event|0|||
143172559|NCT02519842|516181529|FG002|Base Study: Cycle 1|Adverse Event|0|||
143172560|NCT02519842|516181527|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
143172561|NCT02519842|516181528|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
143077021|NCT01292226|515820535|FG000|Overall Study|Withdrawal by Subject|1|||
143077022|NCT01292226|515820535|FG000|Overall Study|Other|2|||
143077023|NCT04106661|515820536|FG000|Overall Study|Protocol Violation|3|||
143077024|NCT04106661|515820537|FG001|Overall Study|Protocol Violation|0|||
143077025|NCT04106661|515820536|FG000|Overall Study|Scheduling difficulties|1|||
143077026|NCT04106661|515820537|FG001|Overall Study|Scheduling difficulties|1|||
143077027|NCT00233402|515820538|FG000|Overall Study|No pathology data|12|||
143248856|NCT02785770|516465030|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
143248857|NCT02785770|516465031|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
143248858|NCT02785770|516465032|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
143172562|NCT02519842|516181529|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
143172563|NCT02519842|516181527|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
143172564|NCT02519842|516181528|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
143172565|NCT02519842|516181529|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
143172566|NCT02519842|516181527|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
143172567|NCT02519842|516181528|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
143172568|NCT02519842|516181529|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
143172569|NCT02519842|516181527|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
143172570|NCT02519842|516181528|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
143172571|NCT02519842|516181529|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
143172572|NCT02519842|516181527|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
143172573|NCT02519842|516181528|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
143172574|NCT02519842|516181529|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
143172575|NCT02519842|516181527|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
143172576|NCT02519842|516181528|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
143172577|NCT02519842|516181529|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
143172578|NCT02519842|516181527|FG000|Optional Extension: Cycles 2-6|Death|0|||
143172579|NCT02519842|516181528|FG001|Optional Extension: Cycles 2-6|Death|0|||
143172580|NCT02519842|516181529|FG002|Optional Extension: Cycles 2-6|Death|1|||
143172581|NCT02519842|516181527|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
143172582|NCT02519842|516181528|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
143172583|NCT02519842|516181529|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
143172584|NCT02519842|516181527|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
143077028|NCT00233402|515820539|FG001|Overall Study|No pathology data|9|||
143077029|NCT00233402|515820538|FG000|Overall Study|No Ta/T1|89|||
143077030|NCT00233402|515820539|FG001|Overall Study|No Ta/T1|94|||
143077031|NCT00233402|515820538|FG000|Overall Study|Lost to follow up etc|3|||
143077032|NCT00233402|515820539|FG001|Overall Study|Lost to follow up etc|21|||
143077033|NCT00468650|515820542|FG000|Overall Study|Lost to Follow-up|4|||
143077034|NCT00468650|515820542|FG000|Overall Study|Withdrawal by Subject|2|||
143077035|NCT00468650|515820542|FG000|Overall Study|Protocol Violation|1|||
143077036|NCT00423319|515820543|FG000|Overall Study|Death|2|||
143077037|NCT00423319|515820544|FG001|Overall Study|Death|0|||
143077038|NCT00423319|515820543|FG000|Overall Study|Adverse Event|93|||
143077039|NCT00423319|515820544|FG001|Overall Study|Adverse Event|112|||
143077040|NCT00423319|515820543|FG000|Overall Study|Withdrawal by Subject|86|||
143077041|NCT00423319|515820544|FG001|Overall Study|Withdrawal by Subject|99|||
143077042|NCT00423319|515820543|FG000|Overall Study|Lost to Follow-up|4|||
143077043|NCT00423319|515820544|FG001|Overall Study|Lost to Follow-up|3|||
143077044|NCT00423319|515820543|FG000|Overall Study|Poor compliance or noncompliance|1|||
143077045|NCT00423319|515820544|FG001|Overall Study|Poor compliance or noncompliance|1|||
143077046|NCT00423319|515820543|FG000|Overall Study|No longer meets study criteria|15|||
143077047|NCT00423319|515820544|FG001|Overall Study|No longer meets study criteria|15|||
143077048|NCT00423319|515820543|FG000|Overall Study|Other|23|||
143077049|NCT00423319|515820544|FG001|Overall Study|Other|22|||
143077050|NCT02639052|515820545|FG000|Overall Study|Lost to Follow-up|1|||
143077051|NCT00510289|515820549|FG000|Overall Study|Withdrawal by Subject|7|||
143077052|NCT00510289|515820549|FG000|Overall Study|Refused bone marrow biopsy|2|||
143077053|NCT00510289|515820549|FG000|Overall Study|Lost to Follow-up|1|||
143077054|NCT00510289|515820549|FG000|Overall Study|Progressed prior to starting drug|2|||
143077055|NCT00861198|515820550|FG000|Overall Study|SpyGlass Failed|5|||
143077056|NCT02269163|515820551|FG000|Overall Study|Lost to Follow-up|1|||
143077057|NCT02269163|515820552|FG001|Overall Study|Lost to Follow-up|0|||
143077058|NCT02269163|515820551|FG000|Overall Study|Major protocol violation|0|||
143077059|NCT02269163|515820552|FG001|Overall Study|Major protocol violation|1|||
143077060|NCT02269163|515820551|FG000|Overall Study|Other|2|||
143077061|NCT02269163|515820552|FG001|Overall Study|Other|2|||
143077062|NCT02269163|515820551|FG000|Overall Study|Withdrawal by Subject|0|||
143077063|NCT02269163|515820552|FG001|Overall Study|Withdrawal by Subject|3|||
143077064|NCT02269163|515820551|FG000|Overall Study|Physician Decision|0|||
143077065|NCT02269163|515820552|FG001|Overall Study|Physician Decision|1|||
143077066|NCT00758680|515820553|FG000|Overall Study|Adverse Event|0|||
143077067|NCT00758680|515820554|FG001|Overall Study|Adverse Event|0|||
143077068|NCT00758680|515820555|FG002|Overall Study|Adverse Event|0|||
143077069|NCT00758680|515820556|FG003|Overall Study|Adverse Event|0|||
143077070|NCT00758680|515820557|FG004|Overall Study|Adverse Event|0|||
143077071|NCT00758680|515820558|FG005|Overall Study|Adverse Event|0|||
143077072|NCT00758680|515820559|FG006|Overall Study|Adverse Event|0|||
143077073|NCT00758680|515820560|FG007|Overall Study|Adverse Event|1|||
143077074|NCT00758680|515820561|FG008|Overall Study|Adverse Event|0|||
143077075|NCT00758680|515820562|FG009|Overall Study|Adverse Event|1|||
143077076|NCT00758680|515820553|FG000|Overall Study|Laboratory Adverse Event|0|||
143077077|NCT00758680|515820554|FG001|Overall Study|Laboratory Adverse Event|0|||
143077078|NCT00758680|515820555|FG002|Overall Study|Laboratory Adverse Event|0|||
143077079|NCT00758680|515820556|FG003|Overall Study|Laboratory Adverse Event|0|||
143077080|NCT00758680|515820557|FG004|Overall Study|Laboratory Adverse Event|0|||
143077081|NCT00758680|515820558|FG005|Overall Study|Laboratory Adverse Event|0|||
143077082|NCT00758680|515820559|FG006|Overall Study|Laboratory Adverse Event|0|||
143077083|NCT00758680|515820560|FG007|Overall Study|Laboratory Adverse Event|0|||
143077084|NCT00758680|515820561|FG008|Overall Study|Laboratory Adverse Event|1|||
143248859|NCT02785770|516465033|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
143077085|NCT00758680|515820562|FG009|Overall Study|Laboratory Adverse Event|0|||
143077086|NCT00758680|515820553|FG000|Overall Study|Withdrawal by Subject|0|||
143077087|NCT00758680|515820554|FG001|Overall Study|Withdrawal by Subject|0|||
143077088|NCT00758680|515820555|FG002|Overall Study|Withdrawal by Subject|0|||
143077089|NCT00758680|515820556|FG003|Overall Study|Withdrawal by Subject|0|||
143077090|NCT00758680|515820557|FG004|Overall Study|Withdrawal by Subject|0|||
143077091|NCT00758680|515820558|FG005|Overall Study|Withdrawal by Subject|0|||
143077092|NCT00758680|515820559|FG006|Overall Study|Withdrawal by Subject|1|||
143077093|NCT00758680|515820560|FG007|Overall Study|Withdrawal by Subject|0|||
143077094|NCT00758680|515820561|FG008|Overall Study|Withdrawal by Subject|1|||
143248860|NCT02785770|516465030|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
143077095|NCT00758680|515820562|FG009|Overall Study|Withdrawal by Subject|0|||
143077096|NCT02351960|515820563|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
143077097|NCT02351960|515820564|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
143077098|NCT02351960|515820563|FG000|Overall Study|Voluntary Withdrawal|5|||
143077099|NCT02351960|515820564|FG001|Overall Study|Voluntary Withdrawal|4|||
143077100|NCT02351960|515820563|FG000|Overall Study|Significant Protocol Deviation|0|||
143248861|NCT02785770|516465031|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
143077101|NCT02351960|515820564|FG001|Overall Study|Significant Protocol Deviation|5|||
143077102|NCT00638027|515820574|FG000|Overall Study|Adverse Event|0|||
143077103|NCT00638027|515820575|FG001|Overall Study|Adverse Event|2|||
143077104|NCT00371397|515820577|FG000|Session 1|Withdrawal by Subject|1|||
143077105|NCT00371397|515820578|FG001|Session 1|Withdrawal by Subject|0|||
143077106|NCT00371397|515820579|FG002|Session 1|Withdrawal by Subject|0|||
143077107|NCT00371397|515820580|FG003|Session 1|Withdrawal by Subject|0|||
143077108|NCT00371397|515820581|FG004|Session 1|Withdrawal by Subject|0|||
143077109|NCT00371397|515820582|FG005|Session 1|Withdrawal by Subject|0|||
143077110|NCT00371397|515820583|FG006|Session 1|Withdrawal by Subject|0|||
143077111|NCT00371397|515820584|FG007|Session 1|Withdrawal by Subject|1|||
143077112|NCT00371397|515820585|FG008|Session 1|Withdrawal by Subject|0|||
143077113|NCT00371397|515820586|FG009|Session 1|Withdrawal by Subject|0|||
143077114|NCT00371397|515820587|FG010|Session 1|Withdrawal by Subject|0|||
143077115|NCT00371397|515820588|FG011|Session 1|Withdrawal by Subject|0|||
143077116|NCT03014180|515820589|FG000|Overall Study|Protocol Violation|2|||
143077117|NCT01284621|515820590|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
143077118|NCT01284621|515820591|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
143077119|NCT01284621|515820592|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
143077120|NCT01284621|515820593|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
143077121|NCT01284621|515820594|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
143077122|NCT01284621|515820595|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
143077123|NCT02099682|515820598|FG000|Overall Study|Data Not Available|51|||
143077124|NCT02099682|515820598|FG000|Overall Study|Lost to Follow-up|31|||
143077125|NCT02099682|515820598|FG000|Overall Study|Other|29|||
143077126|NCT02802631|515820599|FG000|Overall Study|Withdrawal by Subject|1|||
143077127|NCT02802631|515820600|FG001|Overall Study|Withdrawal by Subject|0|||
143077128|NCT02802631|515820601|FG002|Overall Study|Withdrawal by Subject|0|||
143077129|NCT02802631|515820602|FG003|Overall Study|Withdrawal by Subject|0|||
143077130|NCT02802631|515820603|FG004|Overall Study|Withdrawal by Subject|0|||
143077131|NCT02802631|515820604|FG005|Overall Study|Withdrawal by Subject|0|||
143077132|NCT02802631|515820605|FG006|Overall Study|Withdrawal by Subject|0|||
143077133|NCT02802631|515820606|FG007|Overall Study|Withdrawal by Subject|0|||
143077134|NCT02802631|515820599|FG000|Overall Study|Physician Decision|1|||
143077135|NCT02802631|515820600|FG001|Overall Study|Physician Decision|0|||
143077136|NCT02802631|515820601|FG002|Overall Study|Physician Decision|0|||
143077137|NCT02802631|515820602|FG003|Overall Study|Physician Decision|0|||
143077138|NCT02802631|515820603|FG004|Overall Study|Physician Decision|0|||
143077139|NCT02802631|515820604|FG005|Overall Study|Physician Decision|0|||
143077140|NCT02802631|515820605|FG006|Overall Study|Physician Decision|1|||
143077141|NCT02802631|515820606|FG007|Overall Study|Physician Decision|0|||
143077142|NCT02802631|515820599|FG000|Overall Study|Adverse Event|0|||
143077143|NCT02802631|515820600|FG001|Overall Study|Adverse Event|2|||
143077144|NCT02802631|515820601|FG002|Overall Study|Adverse Event|0|||
143077145|NCT02802631|515820602|FG003|Overall Study|Adverse Event|1|||
143077146|NCT02802631|515820603|FG004|Overall Study|Adverse Event|6|||
143077147|NCT02802631|515820604|FG005|Overall Study|Adverse Event|1|||
143077148|NCT02802631|515820605|FG006|Overall Study|Adverse Event|4|||
143077149|NCT02802631|515820606|FG007|Overall Study|Adverse Event|0|||
143077150|NCT02802631|515820599|FG000|Overall Study|Sponsor Decision|0|||
143077151|NCT02802631|515820600|FG001|Overall Study|Sponsor Decision|0|||
143077152|NCT02802631|515820601|FG002|Overall Study|Sponsor Decision|6|||
143077153|NCT02802631|515820602|FG003|Overall Study|Sponsor Decision|0|||
143077154|NCT02802631|515820603|FG004|Overall Study|Sponsor Decision|2|||
143077155|NCT02802631|515820604|FG005|Overall Study|Sponsor Decision|0|||
143077156|NCT02802631|515820605|FG006|Overall Study|Sponsor Decision|0|||
143077157|NCT02802631|515820606|FG007|Overall Study|Sponsor Decision|4|||
143248862|NCT02785770|516465032|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
143248863|NCT02785770|516465033|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
143248864|NCT02338882|516465034|FG000|Overall Study|Death|1|||
143248865|NCT02338882|516465035|FG001|Overall Study|Death|0|||
143248866|NCT02338882|516465034|FG000|Overall Study|Lost to Follow-up|6|||
143248867|NCT02338882|516465035|FG001|Overall Study|Lost to Follow-up|3|||
143077158|NCT02377427|515820607|FG000|Part A (Up to Week 20)|Physician Decision|1|||
143077159|NCT02377427|515820608|FG001|Part A (Up to Week 20)|Physician Decision|0|||
143077160|NCT02377427|515820609|FG002|Part A (Up to Week 20)|Physician Decision|0|||
143077161|NCT02377427|515820610|FG003|Part A (Up to Week 20)|Physician Decision|0|||
143077162|NCT02377427|515820611|FG004|Part A (Up to Week 20)|Physician Decision|0|||
143077163|NCT02377427|515820607|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
143077164|NCT02377427|515820608|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
143077165|NCT02377427|515820609|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
143077166|NCT02377427|515820610|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
143077167|NCT02377427|515820611|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
143077168|NCT02377427|515820607|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
143077169|NCT02377427|515820608|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
143077170|NCT02377427|515820609|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
143077171|NCT02377427|515820610|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
143077172|NCT02377427|515820611|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
143077173|NCT02377427|515820607|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
143077174|NCT02377427|515820608|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
143077175|NCT02377427|515820609|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
143077176|NCT02377427|515820610|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
143077177|NCT02377427|515820611|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
143077178|NCT00704730|515820618|FG000|Overall Study|Adverse Event|35|||
143077179|NCT00704730|515820619|FG001|Overall Study|Adverse Event|9|||
143077180|NCT00704730|515820618|FG000|Overall Study|Death|11|||
143077181|NCT00704730|515820619|FG001|Overall Study|Death|5|||
143077182|NCT00704730|515820618|FG000|Overall Study|Physician Decision|2|||
143077183|NCT00704730|515820619|FG001|Overall Study|Physician Decision|0|||
143077184|NCT00704730|515820618|FG000|Overall Study|Did not receive drug|5|||
143077185|NCT00704730|515820619|FG001|Overall Study|Did not receive drug|2|||
143077186|NCT00704730|515820618|FG000|Overall Study|Disease progression per PI|58|||
143077187|NCT00704730|515820619|FG001|Overall Study|Disease progression per PI|67|||
143077188|NCT00704730|515820618|FG000|Overall Study|data unavailable|1|||
143077189|NCT00704730|515820619|FG001|Overall Study|data unavailable|0|||
143077190|NCT00704730|515820618|FG000|Overall Study|Withdrawal by Subject|9|||
143077191|NCT00704730|515820619|FG001|Overall Study|Withdrawal by Subject|13|||
143077192|NCT00213135|515822456|FG000|Overall Study|Adverse Event|9|||
143077193|NCT00213135|515822457|FG001|Overall Study|Adverse Event|5|||
143077194|NCT00213135|515822458|FG002|Overall Study|Adverse Event|5|||
143077195|NCT00213135|515822456|FG000|Overall Study|Lost to Follow-up|11|||
143077196|NCT00213135|515822457|FG001|Overall Study|Lost to Follow-up|8|||
143077197|NCT00213135|515822458|FG002|Overall Study|Lost to Follow-up|4|||
143077198|NCT00213135|515822456|FG000|Overall Study|Protocol Violation|4|||
143077199|NCT00213135|515822457|FG001|Overall Study|Protocol Violation|4|||
143077200|NCT00213135|515822458|FG002|Overall Study|Protocol Violation|10|||
143077201|NCT00213135|515822456|FG000|Overall Study|Death|1|||
143077202|NCT00213135|515822457|FG001|Overall Study|Death|1|||
143077203|NCT00213135|515822458|FG002|Overall Study|Death|2|||
143077204|NCT00213135|515822456|FG000|Overall Study|Disease progression|4|||
143077205|NCT00213135|515822457|FG001|Overall Study|Disease progression|5|||
143077206|NCT00213135|515822458|FG002|Overall Study|Disease progression|21|||
143077207|NCT00213135|515822456|FG000|Overall Study|Other|21|||
143077208|NCT00213135|515822457|FG001|Overall Study|Other|12|||
143077209|NCT00213135|515822458|FG002|Overall Study|Other|15|||
143077210|NCT00660907|515822462|FG000|Overall Study|Incorrect Enrollment|1|||
143077211|NCT00660907|515822463|FG001|Overall Study|Incorrect Enrollment|1|||
143077212|NCT00660907|515822462|FG000|Overall Study|Adverse Event|33|||
143077213|NCT00660907|515822463|FG001|Overall Study|Adverse Event|19|||
143077214|NCT00660907|515822462|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
143077215|NCT00660907|515822463|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
143077216|NCT00660907|515822462|FG000|Overall Study|Withdrawal by Subject|23|||
143077217|NCT00660907|515822463|FG001|Overall Study|Withdrawal by Subject|32|||
143077218|NCT00660907|515822462|FG000|Overall Study|Lost to Follow-up|3|||
143077219|NCT00660907|515822463|FG001|Overall Study|Lost to Follow-up|3|||
143077220|NCT00660907|515822462|FG000|Overall Study|Poor/Non-Compliance|5|||
143077221|NCT00660907|515822463|FG001|Overall Study|Poor/Non-Compliance|1|||
143077222|NCT00660907|515822462|FG000|Overall Study|Safety|1|||
143077223|NCT00660907|515822463|FG001|Overall Study|Safety|0|||
143248868|NCT01904773|516465036|FG000|Screen|Screen failure|3|||
143248869|NCT01904773|516465037|FG001|Screen|Screen failure|0|||
143248870|NCT01904773|516465038|FG002|Screen|Screen failure|0|||
143077224|NCT00660907|515822462|FG000|Overall Study|Death|1|||
143077225|NCT00660907|515822463|FG001|Overall Study|Death|3|||
143077226|NCT00660907|515822462|FG000|Overall Study|Various|11|||
143077227|NCT00660907|515822463|FG001|Overall Study|Various|8|||
143077228|NCT01908907|515822464|FG000|Overall Study|Physician Decision|1|||
143077229|NCT01908907|515822465|FG001|Overall Study|Physician Decision|0|||
143077230|NCT01908907|515822464|FG000|Overall Study|Protocol Violation|1|||
143077231|NCT01908907|515822465|FG001|Overall Study|Protocol Violation|0|||
143077232|NCT01396512|515822475|FG000|Overall Study|Withdrawal by Subject|0|||
143077233|NCT01396512|515822476|FG001|Overall Study|Withdrawal by Subject|1|||
143077234|NCT02152605|515822477|FG000|Overall Study|Adverse Event|6|||
143077235|NCT02152605|515822478|FG001|Overall Study|Adverse Event|8|||
143077236|NCT02152605|515822477|FG000|Overall Study|Lack of Efficacy|7|||
143248871|NCT01904773|516465039|FG003|Screen|Screen failure|0|||
143077237|NCT02152605|515822478|FG001|Overall Study|Lack of Efficacy|4|||
143077238|NCT02152605|515822477|FG000|Overall Study|Protocol deviation|1|||
143077239|NCT02152605|515822478|FG001|Overall Study|Protocol deviation|4|||
143077240|NCT02152605|515822477|FG000|Overall Study|Lost to Follow-up|1|||
143077241|NCT02152605|515822478|FG001|Overall Study|Lost to Follow-up|0|||
143077242|NCT02152605|515822477|FG000|Overall Study|Withdrew consent|4|||
143077243|NCT02152605|515822478|FG001|Overall Study|Withdrew consent|2|||
143077244|NCT01199471|515822483|FG000|Overall Study|Protocol Violation|4|||
143077245|NCT01199471|515822483|FG000|Overall Study|Withdrawal by Subject|1|||
143077246|NCT01199471|515822483|FG000|Overall Study|Physician Decision|1|||
143077247|NCT03151408|515822484|FG000|Overall Study|Adverse Event|24|||
143077248|NCT03151408|515822485|FG001|Overall Study|Adverse Event|23|||
143077249|NCT03151408|515822484|FG000|Overall Study|Death|46|||
143077250|NCT03151408|515822485|FG001|Overall Study|Death|26|||
143077251|NCT03151408|515822484|FG000|Overall Study|Physician Decision|13|||
143077252|NCT03151408|515822485|FG001|Overall Study|Physician Decision|19|||
143077253|NCT03151408|515822484|FG000|Overall Study|Withdrawal by Subject|16|||
143077254|NCT03151408|515822485|FG001|Overall Study|Withdrawal by Subject|20|||
143077255|NCT03151408|515822484|FG000|Overall Study|Progressive disease|45|||
143077256|NCT03151408|515822485|FG001|Overall Study|Progressive disease|61|||
143077257|NCT03151408|515822484|FG000|Overall Study|non-compliance by patient|1|||
143077258|NCT03151408|515822485|FG001|Overall Study|non-compliance by patient|0|||
143077259|NCT03151408|515822484|FG000|Overall Study|other reasons|56|||
143077260|NCT03151408|515822485|FG001|Overall Study|other reasons|52|||
143077261|NCT03151408|515822484|FG000|Overall Study|randomized and not treated|2|||
143077262|NCT03151408|515822485|FG001|Overall Study|randomized and not treated|2|||
143077263|NCT01635218|515822486|FG000|Overall Study|Lost to Follow-up|3|||
143077264|NCT01635218|515822487|FG001|Overall Study|Lost to Follow-up|7|||
143077265|NCT01635218|515822488|FG002|Overall Study|Lost to Follow-up|6|||
143077266|NCT03262038|515822493|FG000|Overall Study|Withdrawal by Subject|0|||
143248872|NCT01904773|516465040|FG004|Screen|Screen failure|0|||
143248873|NCT01904773|516465041|FG005|Screen|Screen failure|0|||
143248874|NCT01904773|516465042|FG006|Screen|Screen failure|0|||
143248875|NCT01904773|516465043|FG007|Screen|Screen failure|0|||
143248876|NCT01904773|516465044|FG008|Screen|Screen failure|0|||
143248877|NCT01904773|516465036|FG000|Screen|Withdrawal by Subject|1|||
143248878|NCT01904773|516465037|FG001|Screen|Withdrawal by Subject|0|||
143248879|NCT01904773|516465038|FG002|Screen|Withdrawal by Subject|0|||
143248880|NCT01904773|516465039|FG003|Screen|Withdrawal by Subject|0|||
143248881|NCT01904773|516465040|FG004|Screen|Withdrawal by Subject|0|||
143248882|NCT01904773|516465041|FG005|Screen|Withdrawal by Subject|0|||
143248883|NCT01904773|516465042|FG006|Screen|Withdrawal by Subject|0|||
143248884|NCT01904773|516465043|FG007|Screen|Withdrawal by Subject|0|||
143248885|NCT01904773|516465044|FG008|Screen|Withdrawal by Subject|0|||
143248886|NCT01904773|516465036|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
143248887|NCT01904773|516465037|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
143248888|NCT01904773|516465038|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
143248889|NCT01904773|516465039|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
143248890|NCT01904773|516465040|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
143248891|NCT01904773|516465041|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
143248892|NCT01904773|516465042|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
143248893|NCT01904773|516465043|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
143077267|NCT03262038|515822494|FG001|Overall Study|Withdrawal by Subject|1|||
143077268|NCT04933968|515822495|FG000|Overall Study|Adverse Event|0|||
143077269|NCT04933968|515822496|FG001|Overall Study|Adverse Event|0|||
143077270|NCT04933968|515822497|FG002|Overall Study|Adverse Event|1|||
143077271|NCT04933968|515822498|FG003|Overall Study|Adverse Event|1|||
143077272|NCT04933968|515822499|FG004|Overall Study|Adverse Event|0|||
143077273|NCT04933968|515822500|FG005|Overall Study|Adverse Event|0|||
143077274|NCT04933968|515822495|FG000|Overall Study|Lost to Follow-up|1|||
143077275|NCT04933968|515822496|FG001|Overall Study|Lost to Follow-up|0|||
143077276|NCT04933968|515822497|FG002|Overall Study|Lost to Follow-up|1|||
143077277|NCT04933968|515822498|FG003|Overall Study|Lost to Follow-up|0|||
143077278|NCT04933968|515822499|FG004|Overall Study|Lost to Follow-up|0|||
143077279|NCT04933968|515822500|FG005|Overall Study|Lost to Follow-up|0|||
143077280|NCT04933968|515822495|FG000|Overall Study|Randomized not treated|1|||
143077281|NCT04933968|515822496|FG001|Overall Study|Randomized not treated|0|||
143077282|NCT04933968|515822497|FG002|Overall Study|Randomized not treated|0|||
143077283|NCT04933968|515822498|FG003|Overall Study|Randomized not treated|0|||
143077284|NCT04933968|515822499|FG004|Overall Study|Randomized not treated|0|||
143077285|NCT04933968|515822500|FG005|Overall Study|Randomized not treated|0|||
143077286|NCT04933968|515822495|FG000|Overall Study|Sponsor terminated study|0|||
143077287|NCT04933968|515822496|FG001|Overall Study|Sponsor terminated study|0|||
143077288|NCT04933968|515822497|FG002|Overall Study|Sponsor terminated study|0|||
143077289|NCT04933968|515822498|FG003|Overall Study|Sponsor terminated study|1|||
143077290|NCT04933968|515822499|FG004|Overall Study|Sponsor terminated study|2|||
143077291|NCT04933968|515822500|FG005|Overall Study|Sponsor terminated study|0|||
143077292|NCT04933968|515822495|FG000|Overall Study|Other|0|||
143077293|NCT04933968|515822496|FG001|Overall Study|Other|0|||
143077294|NCT04933968|515822497|FG002|Overall Study|Other|0|||
143077295|NCT04933968|515822498|FG003|Overall Study|Other|1|||
143077296|NCT04933968|515822499|FG004|Overall Study|Other|0|||
143077297|NCT04933968|515822500|FG005|Overall Study|Other|0|||
143077298|NCT04933968|515822495|FG000|Overall Study|Missing|1|||
143077299|NCT04933968|515822496|FG001|Overall Study|Missing|3|||
143077300|NCT04933968|515822497|FG002|Overall Study|Missing|2|||
143077301|NCT04933968|515822498|FG003|Overall Study|Missing|1|||
143077302|NCT04933968|515822499|FG004|Overall Study|Missing|1|||
143077303|NCT04933968|515822500|FG005|Overall Study|Missing|0|||
143077304|NCT01724489|515822501|FG000|Overall Study|Adverse Event|8|||
143077305|NCT01724489|515822502|FG001|Overall Study|Adverse Event|3|||
143077306|NCT01724489|515822501|FG000|Overall Study|Surgery, medication|1|||
143077307|NCT01724489|515822502|FG001|Overall Study|Surgery, medication|1|||
143077308|NCT01724489|515822501|FG000|Overall Study|Lost to Follow-up|1|||
143077309|NCT01724489|515822502|FG001|Overall Study|Lost to Follow-up|2|||
143077310|NCT01724489|515822501|FG000|Overall Study|Withdrawal by Subject|6|||
143077311|NCT01724489|515822502|FG001|Overall Study|Withdrawal by Subject|6|||
143077312|NCT04576923|515822503|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
143077313|NCT01664130|515822506|FG000|Overall Study|competing secondary disease|2|||
143077314|NCT03323437|515822508|FG000|Overall Study|Withdrawal by Subject|0|||
143077315|NCT03323437|515822509|FG001|Overall Study|Withdrawal by Subject|4|||
143077316|NCT03247816|515822514|FG000|Overall Study|Adverse Event|12|||
143077317|NCT03247816|515822514|FG000|Overall Study|Physician Decision|3|||
143077318|NCT03247816|515822514|FG000|Overall Study|Lack of Efficacy|1|||
143077319|NCT03247816|515822514|FG000|Overall Study|Lost to Follow-up|10|||
143077320|NCT03247816|515822514|FG000|Overall Study|Missing Feraccru stop date|3|||
143077321|NCT02861014|515822515|FG000|Primary Analysis|Adverse Event|7|||
143077322|NCT02861014|515822515|FG000|Primary Analysis|Death|1|||
143077323|NCT02861014|515822515|FG000|Primary Analysis|Lack of Efficacy|3|||
143077324|NCT02861014|515822515|FG000|Primary Analysis|Physician Decision|2|||
143077325|NCT02861014|515822515|FG000|Primary Analysis|Pregnancy|4|||
143077326|NCT02861014|515822515|FG000|Primary Analysis|Protocol Violation|2|||
143077327|NCT02861014|515822515|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
143077328|NCT02861014|515822515|FG000|Primary Analysis|Withdrawal by Subject|14|||
143077329|NCT02861014|515822515|FG000|Primary Analysis|Commercial ocrelizumab|3|||
143077330|NCT02861014|515822515|FG000|Safety Follow-up|Adverse Event|1|||
143077331|NCT02861014|515822515|FG000|Safety Follow-up|Pregnancy|1|||
143077332|NCT02861014|515822515|FG000|Safety Follow-up|Withdrawal by Subject|9|||
143077333|NCT02861014|515822515|FG000|Safety Follow-up|Study terminated by sponsor|1|||
143077334|NCT02861014|515822515|FG000|Safety Follow-up|Physician Decision|1|||
143077335|NCT02861014|515822515|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
143077336|NCT02861014|515822515|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
143077337|NCT00926783|515822519|FG000|Overall Study|Incomplete CFAE Procedures|3|||
143077338|NCT00926783|515822520|FG001|Overall Study|Incomplete CFAE Procedures|3|||
143077339|NCT01439009|515822521|FG000|Overall Study|Physician Decision|5|||
143077340|NCT01439009|515822522|FG001|Overall Study|Physician Decision|3|||
143077341|NCT01439009|515822521|FG000|Overall Study|Protocol Violation|2|||
143077342|NCT01439009|515822522|FG001|Overall Study|Protocol Violation|0|||
143077343|NCT01439009|515822521|FG000|Overall Study|Deviation of exclusion criteria|1|||
143077344|NCT01439009|515822522|FG001|Overall Study|Deviation of exclusion criteria|0|||
143172585|NCT02519842|516181528|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
143172586|NCT02519842|516181529|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
143172587|NCT02519842|516181527|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
143172588|NCT02519842|516181528|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
143172589|NCT02519842|516181529|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
143077345|NCT04628793|515822523|FG000|Overall Study|Study terminated by sponsor|0|||
143077346|NCT04628793|515822524|FG001|Overall Study|Study terminated by sponsor|0|||
143077347|NCT04628793|515822525|FG002|Overall Study|Study terminated by sponsor|8|||
143077348|NCT04628793|515822523|FG000|Overall Study|Withdrawal by Subject|2|||
143077349|NCT04628793|515822524|FG001|Overall Study|Withdrawal by Subject|3|||
143077350|NCT04628793|515822525|FG002|Overall Study|Withdrawal by Subject|0|||
143077351|NCT04628793|515822523|FG000|Overall Study|Lost to Follow-up|0|||
143077352|NCT04628793|515822524|FG001|Overall Study|Lost to Follow-up|1|||
143077353|NCT04628793|515822525|FG002|Overall Study|Lost to Follow-up|0|||
143077354|NCT02278055|515822527|FG000|Overall Study|Adverse Event|1|||
143077355|NCT02278055|515822527|FG000|Overall Study|Lost to Follow-up|1|||
143077356|NCT02278055|515822527|FG000|Overall Study|Withdrawal by Subject|2|||
143077357|NCT02278055|515822527|FG000|Overall Study|Progressive Disease|4|||
143077358|NCT02087189|515822530|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
143077359|NCT02910063|515822531|FG000|Phase 2|Withdrawal by Subject|3|||
143172590|NCT02519842|516181527|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
143172591|NCT02519842|516181528|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
143172592|NCT02519842|516181529|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
143172593|NCT01627691|516181532|FG000|Overall Study|Death|11|||
143172594|NCT01627691|516181532|FG000|Overall Study|Lost to Follow-up|3|||
143172595|NCT01627691|516181532|FG000|Overall Study|Withdrawal by Subject|1|||
143172596|NCT01627691|516181532|FG000|Overall Study|Missed the visit|3|||
143172597|NCT02493764|516181533|FG000|Overall Study|Adverse Event|2|||
143172598|NCT02493764|516181534|FG001|Overall Study|Adverse Event|2|||
143172599|NCT02493764|516181533|FG000|Overall Study|Death|44|||
143172600|NCT02493764|516181534|FG001|Overall Study|Death|58|||
143172601|NCT02493764|516181533|FG000|Overall Study|Lost to Follow-up|2|||
143172602|NCT02493764|516181534|FG001|Overall Study|Lost to Follow-up|1|||
143172603|NCT02493764|516181533|FG000|Overall Study|Protocol Violation|6|||
143172604|NCT02493764|516181534|FG001|Overall Study|Protocol Violation|7|||
143172605|NCT02493764|516181533|FG000|Overall Study|Physician Decision|1|||
143172606|NCT02493764|516181534|FG001|Overall Study|Physician Decision|1|||
143077360|NCT02910063|515822532|FG001|Phase 2|Withdrawal by Subject|0|||
143077361|NCT02910063|515822533|FG002|Phase 2|Withdrawal by Subject|0|||
143077362|NCT02910063|515822531|FG000|Phase 2|Lost to Follow-up|1|||
143077363|NCT02910063|515822532|FG001|Phase 2|Lost to Follow-up|0|||
143077364|NCT02910063|515822533|FG002|Phase 2|Lost to Follow-up|0|||
143077365|NCT02910063|515822531|FG000|Phase 2|Death|24|||
143077366|NCT02910063|515822532|FG001|Phase 2|Death|0|||
143077367|NCT02910063|515822533|FG002|Phase 2|Death|0|||
143077368|NCT04435184|515822534|FG000|Overall Study|follow-up blood draws missing|3|||
143077369|NCT04435184|515822535|FG001|Overall Study|follow-up blood draws missing|5|||
143077370|NCT04693416|515822536|FG000|Overall Study|Lost to Follow-up|13|||
143077371|NCT04693416|515822537|FG001|Overall Study|Lost to Follow-up|0|||
143077372|NCT00474266|515822538|FG000|Overall Study|Withdrawal by Subject|7|||
143077373|NCT00474266|515822539|FG001|Overall Study|Withdrawal by Subject|20|||
143077374|NCT00474266|515822540|FG002|Overall Study|Withdrawal by Subject|4|||
143077375|NCT00474266|515822541|FG003|Overall Study|Withdrawal by Subject|7|||
143077376|NCT02774642|515822542|FG000|Overall Study|Lost to Follow-up|9|||
143077377|NCT02774642|515822543|FG001|Overall Study|Lost to Follow-up|7|||
143077378|NCT00369317|515822544|FG000|Overall Study|Adverse Event|3|||
143077379|NCT00369317|515822544|FG000|Overall Study|Death|1|||
143077380|NCT00369317|515822544|FG000|Overall Study|Lack of Efficacy|5|||
143077381|NCT00369317|515822544|FG000|Overall Study|Physician Decision|2|||
143077382|NCT00369317|515822544|FG000|Overall Study|Withdrawal by Subject|8|||
143077383|NCT00369317|515822544|FG000|Overall Study|Ineligible|1|||
143077384|NCT00426361|515822550|FG000|Overall Study|Lost to Follow-up|3|||
143077385|NCT00426361|515822551|FG001|Overall Study|Lost to Follow-up|2|||
143077386|NCT00426361|515822552|FG002|Overall Study|Lost to Follow-up|5|||
143077387|NCT00426361|515822550|FG000|Overall Study|Withdrawal by Subject|1|||
143077388|NCT00426361|515822551|FG001|Overall Study|Withdrawal by Subject|3|||
143077389|NCT00426361|515822552|FG002|Overall Study|Withdrawal by Subject|0|||
143077390|NCT06281171|515822564|FG000|Timepoint 2|Lost to Follow-up|6|||
143077391|NCT06281171|515822565|FG001|Timepoint 2|Lost to Follow-up|4|||
143077392|NCT06281171|515822564|FG000|Timepoint 3|Lost to Follow-up|0|||
143077393|NCT06281171|515822565|FG001|Timepoint 3|Lost to Follow-up|5|||
143077394|NCT04572893|515822572|FG000|Part A|Adverse Event|1|||
143077395|NCT04572893|515822573|FG001|Part A|Adverse Event|0|||
143077396|NCT04572893|515822574|FG002|Part A|Adverse Event|0|||
143077397|NCT04572893|515822575|FG003|Part A|Adverse Event|0|||
143077398|NCT04572893|515822576|FG004|Part A|Adverse Event|0|||
143077399|NCT04572893|515822577|FG005|Part A|Adverse Event|0|||
143077400|NCT04572893|515822578|FG006|Part A|Adverse Event|0|||
143077401|NCT04572893|515822572|FG000|Part B|Withdrawal by Subject|0|||
143172607|NCT02493764|516181533|FG000|Overall Study|Participant moved|17|||
143172608|NCT02493764|516181534|FG001|Overall Study|Participant moved|5|||
143172609|NCT02493764|516181533|FG000|Overall Study|Withdrawal parent/guardian|0|||
143172610|NCT02493764|516181534|FG001|Overall Study|Withdrawal parent/guardian|1|||
143172611|NCT02493764|516181533|FG000|Overall Study|Withdrawal by Subject|11|||
143172612|NCT02493764|516181534|FG001|Overall Study|Withdrawal by Subject|7|||
143172613|NCT01816295|516181535|FG000|Double Blind Phase|Adverse Event|11|||
143172614|NCT01816295|516181536|FG001|Double Blind Phase|Adverse Event|8|||
143077402|NCT04572893|515822573|FG001|Part B|Withdrawal by Subject|0|||
143077403|NCT04572893|515822574|FG002|Part B|Withdrawal by Subject|0|||
143077404|NCT04572893|515822575|FG003|Part B|Withdrawal by Subject|0|||
143077405|NCT04572893|515822576|FG004|Part B|Withdrawal by Subject|0|||
143077406|NCT04572893|515822577|FG005|Part B|Withdrawal by Subject|1|||
143077407|NCT04572893|515822578|FG006|Part B|Withdrawal by Subject|0|||
143077408|NCT04572893|515822572|FG000|Part B|Study terminated by sponsor|0|||
143077409|NCT04572893|515822573|FG001|Part B|Study terminated by sponsor|0|||
143172615|NCT01816295|516181535|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
143077410|NCT04572893|515822574|FG002|Part B|Study terminated by sponsor|0|||
143077411|NCT04572893|515822575|FG003|Part B|Study terminated by sponsor|0|||
143077412|NCT04572893|515822576|FG004|Part B|Study terminated by sponsor|7|||
143077413|NCT04572893|515822577|FG005|Part B|Study terminated by sponsor|5|||
143077414|NCT04572893|515822578|FG006|Part B|Study terminated by sponsor|3|||
143077415|NCT04572893|515822572|FG000|Part B|Lost to Follow-up|0|||
143077416|NCT04572893|515822573|FG001|Part B|Lost to Follow-up|0|||
143077417|NCT04572893|515822574|FG002|Part B|Lost to Follow-up|0|||
143077418|NCT04572893|515822575|FG003|Part B|Lost to Follow-up|0|||
143077419|NCT04572893|515822576|FG004|Part B|Lost to Follow-up|0|||
143077420|NCT04572893|515822577|FG005|Part B|Lost to Follow-up|0|||
143077421|NCT04572893|515822578|FG006|Part B|Lost to Follow-up|1|||
143077422|NCT04572893|515822572|FG000|Part B|Adverse Event|0|||
143077423|NCT04572893|515822573|FG001|Part B|Adverse Event|0|||
143077424|NCT04572893|515822574|FG002|Part B|Adverse Event|0|||
143077425|NCT04572893|515822575|FG003|Part B|Adverse Event|0|||
143077426|NCT04572893|515822576|FG004|Part B|Adverse Event|1|||
143077427|NCT04572893|515822577|FG005|Part B|Adverse Event|1|||
143077428|NCT04572893|515822578|FG006|Part B|Adverse Event|0|||
143077429|NCT05038800|515822579|FG000|Overall Study|Death|1|||
143077430|NCT05038800|515822580|FG001|Overall Study|Death|1|||
143077431|NCT05038800|515822581|FG002|Overall Study|Death|5|||
143077432|NCT05038800|515822582|FG003|Overall Study|Death|3|||
143077433|NCT05038800|515822583|FG004|Overall Study|Death|1|||
143077434|NCT05038800|515822579|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
143077435|NCT05038800|515822580|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
143077436|NCT05038800|515822581|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
143077437|NCT05038800|515822582|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
143077438|NCT05038800|515822583|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
143077439|NCT05038800|515822579|FG000|Overall Study|Lack of Efficacy|0|||
143077440|NCT05038800|515822580|FG001|Overall Study|Lack of Efficacy|0|||
143077441|NCT05038800|515822581|FG002|Overall Study|Lack of Efficacy|0|||
143077442|NCT05038800|515822582|FG003|Overall Study|Lack of Efficacy|0|||
143077443|NCT05038800|515822583|FG004|Overall Study|Lack of Efficacy|1|||
143077444|NCT02533375|515822586|FG000|Overall Study|Lack of Efficacy|3|||
143077445|NCT02533375|515822586|FG000|Overall Study|Adverse Event|2|||
143077446|NCT00960115|515822587|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
143077447|NCT00960115|515822588|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
143077448|NCT04428333|515822591|FG000|Overall Study|Physician Decision|5|||
143077449|NCT04428333|515822592|FG001|Overall Study|Physician Decision|6|||
143077450|NCT04428333|515822591|FG000|Overall Study|Withdrawal by Subject|1|||
143077451|NCT04428333|515822592|FG001|Overall Study|Withdrawal by Subject|3|||
143077452|NCT04428333|515822591|FG000|Overall Study|Study Terminated By Sponsor|14|||
143077453|NCT04428333|515822592|FG001|Overall Study|Study Terminated By Sponsor|16|||
143077454|NCT04853992|515822593|FG000|Treatment Period A|Adverse Event|0|||
143077455|NCT04853992|515822594|FG001|Treatment Period A|Adverse Event|1|||
143077456|NCT04853992|515822593|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
143077457|NCT04853992|515822594|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
143077458|NCT00319982|515822595|FG000|Overall Study|Withdrawal by Subject|1|||
143077459|NCT00319982|515822596|FG001|Overall Study|Withdrawal by Subject|0|||
143077460|NCT03480386|515822599|FG000|Overall Study|Did not complete measures at 3-months|17|||
143077461|NCT03480386|515822600|FG001|Overall Study|Did not complete measures at 3-months|14|||
143077462|NCT03480386|515822599|FG000|Overall Study|No baseline measures|11|||
143077463|NCT03480386|515822600|FG001|Overall Study|No baseline measures|14|||
143077464|NCT03480386|515822599|FG000|Overall Study|Death|0|||
143077465|NCT03480386|515822600|FG001|Overall Study|Death|5|||
143077466|NCT03480386|515822599|FG000|Overall Study|Withdrawal by Subject|12|||
143077467|NCT03480386|515822600|FG001|Overall Study|Withdrawal by Subject|8|||
143077468|NCT03480386|515822599|FG000|Overall Study|Lost to Follow-up|2|||
143077469|NCT03480386|515822600|FG001|Overall Study|Lost to Follow-up|1|||
143077470|NCT03480386|515822599|FG000|Overall Study|Complicating disease|0|||
143077471|NCT03480386|515822600|FG001|Overall Study|Complicating disease|1|||
143077472|NCT03480386|515822599|FG000|Overall Study|Disease progression|3|||
143077473|NCT03480386|515822600|FG001|Overall Study|Disease progression|0|||
143077474|NCT03480386|515822599|FG000|Overall Study|Became ineligible|0|||
143077475|NCT03480386|515822600|FG001|Overall Study|Became ineligible|2|||
143077476|NCT00574912|515822601|FG000|Overall Study|Could not place IV lines.|3|||
143077477|NCT00574912|515822601|FG000|Overall Study|scheduling conflicts|3|||
143077478|NCT00574912|515822601|FG000|Overall Study|Physician Decision|2|||
143077479|NCT02293863|515822602|FG000|Overall Study|Death|4|||
143077480|NCT02293863|515822603|FG001|Overall Study|Death|6|||
143077481|NCT02293863|515822604|FG002|Overall Study|Death|4|||
143077482|NCT02293863|515822602|FG000|Overall Study|Lost to Follow-up|2|||
143077483|NCT02293863|515822603|FG001|Overall Study|Lost to Follow-up|2|||
143077484|NCT02293863|515822604|FG002|Overall Study|Lost to Follow-up|2|||
143077485|NCT02293863|515822602|FG000|Overall Study|Withdrawal by Subject|3|||
143077486|NCT02293863|515822603|FG001|Overall Study|Withdrawal by Subject|3|||
143077487|NCT02293863|515822604|FG002|Overall Study|Withdrawal by Subject|1|||
143077488|NCT02293863|515822602|FG000|Overall Study|Reason Not Specified|0|||
143077489|NCT02293863|515822603|FG001|Overall Study|Reason Not Specified|2|||
143077490|NCT02293863|515822604|FG002|Overall Study|Reason Not Specified|2|||
143077491|NCT02342639|515822605|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
143077492|NCT02342639|515822606|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
143077493|NCT02342639|515822605|FG000|Overall Study|Protocol Violation|0|||
143077494|NCT02342639|515822606|FG001|Overall Study|Protocol Violation|2|||
143077495|NCT02212379|515822607|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
143077496|NCT02212379|515822607|FG000|From Baseline to Week 48|Adverse Event|7|||
143077497|NCT02212379|515822607|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
143077498|NCT02212379|515822607|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
143077499|NCT02212379|515822607|FG000|From Week 48 to Week 96|Adverse Event|1|||
143077500|NCT02212379|515822607|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
143077501|NCT00416884|515822610|FG000|Overall Study|Study terminated due to low accrual|1|||
143077502|NCT00805467|515824382|FG000|Overall Study|Lack of Efficacy|0|||
143077503|NCT00805467|515824383|FG001|Overall Study|Lack of Efficacy|8|||
143077504|NCT00805467|515824384|FG002|Overall Study|Lack of Efficacy|13|||
143077505|NCT00805467|515824385|FG003|Overall Study|Lack of Efficacy|86|||
143077506|NCT00805467|515824382|FG000|Overall Study|Lost to Follow-up|0|||
143077507|NCT00805467|515824383|FG001|Overall Study|Lost to Follow-up|1|||
143077508|NCT00805467|515824384|FG002|Overall Study|Lost to Follow-up|7|||
143077509|NCT00805467|515824385|FG003|Overall Study|Lost to Follow-up|21|||
143077510|NCT00805467|515824382|FG000|Overall Study|Withdrawal by Subject|0|||
143077511|NCT00805467|515824383|FG001|Overall Study|Withdrawal by Subject|6|||
143077512|NCT00805467|515824384|FG002|Overall Study|Withdrawal by Subject|45|||
143077513|NCT00805467|515824385|FG003|Overall Study|Withdrawal by Subject|50|||
143077514|NCT00805467|515824382|FG000|Overall Study|Protocol Violation|0|||
143077515|NCT00805467|515824383|FG001|Overall Study|Protocol Violation|3|||
143077516|NCT00805467|515824384|FG002|Overall Study|Protocol Violation|0|||
143077517|NCT00805467|515824385|FG003|Overall Study|Protocol Violation|5|||
143077518|NCT00805467|515824382|FG000|Overall Study|Adverse Event|0|||
143077519|NCT00805467|515824383|FG001|Overall Study|Adverse Event|13|||
143077520|NCT00805467|515824384|FG002|Overall Study|Adverse Event|26|||
143077521|NCT00805467|515824385|FG003|Overall Study|Adverse Event|57|||
143077522|NCT00805467|515824382|FG000|Overall Study|Death|0|||
143077523|NCT00805467|515824383|FG001|Overall Study|Death|2|||
143077524|NCT00805467|515824384|FG002|Overall Study|Death|7|||
143077525|NCT00805467|515824385|FG003|Overall Study|Death|5|||
143077526|NCT00805467|515824382|FG000|Overall Study|Physician Decision|0|||
143077527|NCT00805467|515824383|FG001|Overall Study|Physician Decision|1|||
143077528|NCT00805467|515824384|FG002|Overall Study|Physician Decision|2|||
143077529|NCT00805467|515824385|FG003|Overall Study|Physician Decision|6|||
143077530|NCT00805467|515824382|FG000|Overall Study|Not reported|0|||
143077531|NCT00805467|515824383|FG001|Overall Study|Not reported|0|||
143077532|NCT00805467|515824384|FG002|Overall Study|Not reported|3|||
143077533|NCT00805467|515824385|FG003|Overall Study|Not reported|7|||
143077534|NCT04975191|515824386|FG000|Overall Study|Protocol Violation|1|||
143077535|NCT04975191|515824387|FG001|Overall Study|Protocol Violation|2|||
143077536|NCT04975191|515824388|FG002|Overall Study|Protocol Violation|2|||
143077537|NCT04975191|515824389|FG003|Overall Study|Protocol Violation|2|||
143077538|NCT04975191|515824386|FG000|Overall Study|Lost to Follow-up|13|||
143077539|NCT04975191|515824387|FG001|Overall Study|Lost to Follow-up|3|||
143077540|NCT04975191|515824388|FG002|Overall Study|Lost to Follow-up|8|||
143077541|NCT04975191|515824389|FG003|Overall Study|Lost to Follow-up|8|||
143077542|NCT00761657|515824392|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
143077543|NCT00761657|515824393|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
143077544|NCT00761657|515824394|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
143077545|NCT00761657|515824395|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
143077546|NCT00761657|515824396|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
143077547|NCT00761657|515824397|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
143077548|NCT00761657|515824398|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
143077549|NCT00761657|515824399|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
143077550|NCT00761657|515824400|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
143077551|NCT00761657|515824392|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
143077552|NCT00761657|515824393|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
143077553|NCT00761657|515824394|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
143077554|NCT00761657|515824395|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
143077555|NCT00761657|515824396|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
143077556|NCT00761657|515824397|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
143077557|NCT00761657|515824398|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
143077558|NCT00761657|515824399|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
143077559|NCT00761657|515824400|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
143077560|NCT00761657|515824392|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
143077561|NCT00761657|515824393|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
143077562|NCT00761657|515824394|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
143077563|NCT00761657|515824395|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
143077564|NCT00761657|515824396|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
143077565|NCT00761657|515824397|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
143077566|NCT00761657|515824398|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
143077567|NCT00761657|515824399|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
143077568|NCT00761657|515824400|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
143172616|NCT01816295|516181536|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
143172617|NCT01816295|516181535|FG000|Double Blind Phase|Lost to Follow-up|3|||
143172618|NCT01816295|516181536|FG001|Double Blind Phase|Lost to Follow-up|5|||
143172619|NCT01816295|516181535|FG000|Double Blind Phase|Physician Decision|2|||
143172620|NCT01816295|516181536|FG001|Double Blind Phase|Physician Decision|2|||
143172621|NCT01816295|516181535|FG000|Double Blind Phase|Protocol Violation|17|||
143172622|NCT01816295|516181536|FG001|Double Blind Phase|Protocol Violation|11|||
143172623|NCT01816295|516181535|FG000|Double Blind Phase|Sponsor Decision|8|||
143172624|NCT01816295|516181536|FG001|Double Blind Phase|Sponsor Decision|8|||
143172625|NCT01816295|516181535|FG000|Double Blind Phase|Withdrawal by Subject|22|||
143172626|NCT01816295|516181536|FG001|Double Blind Phase|Withdrawal by Subject|20|||
143172627|NCT01816295|516181535|FG000|OLE Phase|Adverse Event|17|||
143172628|NCT01816295|516181536|FG001|OLE Phase|Adverse Event|15|||
143172629|NCT01816295|516181535|FG000|OLE Phase|Death|1|||
143172630|NCT01816295|516181536|FG001|OLE Phase|Death|0|||
143172631|NCT01816295|516181535|FG000|OLE Phase|Entry Criteria Not Met|3|||
143172632|NCT01816295|516181536|FG001|OLE Phase|Entry Criteria Not Met|5|||
143077569|NCT00761657|515824392|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
143077570|NCT00761657|515824393|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
143077571|NCT00761657|515824394|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
143077572|NCT00761657|515824395|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
143077573|NCT00761657|515824396|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
143077574|NCT00761657|515824397|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
143077575|NCT00761657|515824398|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
143077576|NCT00761657|515824399|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
143077577|NCT00761657|515824400|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
143077578|NCT00359801|515824412|FG000|Overall Study|Lost to Follow-up|72|||
143077579|NCT00359801|515824413|FG001|Overall Study|Lost to Follow-up|58|||
143077580|NCT00359801|515824412|FG000|Overall Study|Withdrawal by Subject|143|||
143077581|NCT00359801|515824413|FG001|Overall Study|Withdrawal by Subject|96|||
143077582|NCT00359801|515824412|FG000|Overall Study|Other|66|||
143077583|NCT00359801|515824413|FG001|Overall Study|Other|46|||
143077584|NCT00359801|515824412|FG000|Overall Study|Final Status Unknown: missing data|7|||
143077585|NCT00359801|515824413|FG001|Overall Study|Final Status Unknown: missing data|4|||
143077586|NCT00359801|515824412|FG000|Overall Study|Sponsor Decision|17|||
143077587|NCT00359801|515824413|FG001|Overall Study|Sponsor Decision|16|||
143077588|NCT02929056|515824414|FG000|Overall Study|Lost to Follow-up|0|||
143077589|NCT02929056|515824415|FG001|Overall Study|Lost to Follow-up|1|||
143077590|NCT00324649|515824422|FG000|Overall Study|Adverse Event|1|||
143077591|NCT00324649|515824423|FG001|Overall Study|Adverse Event|4|||
143077592|NCT00324649|515824422|FG000|Overall Study|Withdrawal by Subject|0|||
143077593|NCT00324649|515824423|FG001|Overall Study|Withdrawal by Subject|1|||
143077594|NCT00324649|515824422|FG000|Overall Study|Noncompliance|1|||
143077595|NCT00324649|515824423|FG001|Overall Study|Noncompliance|0|||
143077596|NCT02618759|515824428|FG000|Overall Study|Lost to Follow-up|0|||
143077597|NCT02618759|515824429|FG001|Overall Study|Lost to Follow-up|1|||
143077598|NCT02618759|515824428|FG000|Overall Study|Withdrawal by Subject|1|||
143077599|NCT02618759|515824429|FG001|Overall Study|Withdrawal by Subject|0|||
143077600|NCT02618759|515824428|FG000|Overall Study|Other Reasons|1|||
143077601|NCT02618759|515824429|FG001|Overall Study|Other Reasons|4|||
143077602|NCT02500043|515824432|FG000|Overall Study|Randomized, but not Treated|2|||
143077603|NCT02500043|515824433|FG001|Overall Study|Randomized, but not Treated|2|||
143077604|NCT02500043|515824432|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
143077605|NCT02500043|515824433|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
143172633|NCT01816295|516181535|FG000|OLE Phase|Lost to Follow-up|5|||
143172634|NCT01816295|516181536|FG001|OLE Phase|Lost to Follow-up|5|||
143172635|NCT01816295|516181535|FG000|OLE Phase|Physician Decision|3|||
143172636|NCT01816295|516181536|FG001|OLE Phase|Physician Decision|1|||
143172637|NCT01816295|516181535|FG000|OLE Phase|Protocol Violation|4|||
143172638|NCT01816295|516181536|FG001|OLE Phase|Protocol Violation|4|||
143077606|NCT02500043|515824432|FG000|Overall Study|Adverse Event|33|||
143077607|NCT02500043|515824433|FG001|Overall Study|Adverse Event|11|||
143077608|NCT02500043|515824432|FG000|Overall Study|Clinical Progression|54|||
143172639|NCT01816295|516181535|FG000|OLE Phase|Sponsor Decision|7|||
143366265|NCT00817635|516884609|FG001|Overall Study|Administrative Problems|0|||
143366266|NCT00817635|516884610|FG002|Overall Study|Administrative Problems|0|||
143077609|NCT02500043|515824433|FG001|Overall Study|Clinical Progression|35|||
143077610|NCT02500043|515824432|FG000|Overall Study|Radiological Progression|192|||
143077611|NCT02500043|515824433|FG001|Overall Study|Radiological Progression|110|||
143077612|NCT02500043|515824432|FG000|Overall Study|Physician's Decision|11|||
143172640|NCT01816295|516181536|FG001|OLE Phase|Sponsor Decision|9|||
143172641|NCT01816295|516181535|FG000|OLE Phase|Withdrawal by Subject|10|||
143172642|NCT01816295|516181536|FG001|OLE Phase|Withdrawal by Subject|10|||
143077613|NCT02500043|515824433|FG001|Overall Study|Physician's Decision|3|||
143077614|NCT02500043|515824432|FG000|Overall Study|Withdrawal by Subject|14|||
143077615|NCT02500043|515824433|FG001|Overall Study|Withdrawal by Subject|4|||
143077616|NCT02500043|515824432|FG000|Overall Study|Death|11|||
143172643|NCT01816295|516181535|FG000|OLE Phase|Lack of Efficacy|3|||
143077617|NCT02500043|515824433|FG001|Overall Study|Death|2|||
143077618|NCT02500043|515824432|FG000|Overall Study|Protocol Deviation|1|||
143077619|NCT02500043|515824433|FG001|Overall Study|Protocol Deviation|0|||
143077620|NCT01371747|515824434|FG000|Overall Study|Adverse Event|4|||
143077621|NCT01371747|515824435|FG001|Overall Study|Adverse Event|2|||
143077622|NCT01371747|515824436|FG002|Overall Study|Adverse Event|7|||
143077623|NCT01371747|515824437|FG003|Overall Study|Adverse Event|2|||
143077624|NCT01371747|515824438|FG004|Overall Study|Adverse Event|2|||
143077625|NCT01371747|515824439|FG005|Overall Study|Adverse Event|2|||
143077626|NCT01371747|515824434|FG000|Overall Study|Death|1|||
143077627|NCT01371747|515824435|FG001|Overall Study|Death|0|||
143077628|NCT01371747|515824436|FG002|Overall Study|Death|4|||
143077629|NCT01371747|515824437|FG003|Overall Study|Death|1|||
143077630|NCT01371747|515824438|FG004|Overall Study|Death|2|||
143077631|NCT01371747|515824439|FG005|Overall Study|Death|0|||
143077632|NCT01371747|515824434|FG000|Overall Study|Abnormal Renal Function|0|||
143077633|NCT01371747|515824435|FG001|Overall Study|Abnormal Renal Function|2|||
143077634|NCT01371747|515824436|FG002|Overall Study|Abnormal Renal Function|0|||
143077635|NCT01371747|515824437|FG003|Overall Study|Abnormal Renal Function|1|||
143077636|NCT01371747|515824438|FG004|Overall Study|Abnormal Renal Function|0|||
143077637|NCT01371747|515824439|FG005|Overall Study|Abnormal Renal Function|1|||
143077638|NCT01371747|515824434|FG000|Overall Study|High Serum Potassium Results|1|||
143077639|NCT01371747|515824435|FG001|Overall Study|High Serum Potassium Results|1|||
143077640|NCT01371747|515824436|FG002|Overall Study|High Serum Potassium Results|1|||
143077641|NCT01371747|515824437|FG003|Overall Study|High Serum Potassium Results|2|||
143077642|NCT01371747|515824438|FG004|Overall Study|High Serum Potassium Results|0|||
143077643|NCT01371747|515824439|FG005|Overall Study|High Serum Potassium Results|2|||
143077644|NCT01371747|515824434|FG000|Overall Study|Low Serum Potassium Results|1|||
143077645|NCT01371747|515824435|FG001|Overall Study|Low Serum Potassium Results|1|||
143077646|NCT01371747|515824436|FG002|Overall Study|Low Serum Potassium Results|1|||
143077647|NCT01371747|515824437|FG003|Overall Study|Low Serum Potassium Results|1|||
143077648|NCT01371747|515824438|FG004|Overall Study|Low Serum Potassium Results|0|||
143077649|NCT01371747|515824439|FG005|Overall Study|Low Serum Potassium Results|3|||
143077650|NCT01371747|515824434|FG000|Overall Study|Protocol Violation|0|||
143077651|NCT01371747|515824435|FG001|Overall Study|Protocol Violation|0|||
143077652|NCT01371747|515824436|FG002|Overall Study|Protocol Violation|1|||
143077653|NCT01371747|515824437|FG003|Overall Study|Protocol Violation|0|||
143077654|NCT01371747|515824438|FG004|Overall Study|Protocol Violation|0|||
143077655|NCT01371747|515824439|FG005|Overall Study|Protocol Violation|0|||
143077656|NCT01371747|515824434|FG000|Overall Study|Non-Compliance|3|||
143077657|NCT01371747|515824435|FG001|Overall Study|Non-Compliance|4|||
143077658|NCT01371747|515824436|FG002|Overall Study|Non-Compliance|3|||
143077659|NCT01371747|515824437|FG003|Overall Study|Non-Compliance|0|||
143077660|NCT01371747|515824438|FG004|Overall Study|Non-Compliance|0|||
143077661|NCT01371747|515824439|FG005|Overall Study|Non-Compliance|1|||
143077662|NCT01371747|515824434|FG000|Overall Study|Physician Decision|0|||
143077663|NCT01371747|515824435|FG001|Overall Study|Physician Decision|0|||
143077664|NCT01371747|515824436|FG002|Overall Study|Physician Decision|0|||
143077665|NCT01371747|515824437|FG003|Overall Study|Physician Decision|0|||
143077666|NCT01371747|515824438|FG004|Overall Study|Physician Decision|1|||
143077667|NCT01371747|515824439|FG005|Overall Study|Physician Decision|0|||
143172644|NCT01816295|516181536|FG001|OLE Phase|Lack of Efficacy|7|||
143172645|NCT00107276|516181537|FG000|Overall Study|Progression|46|||
143172646|NCT00107276|516181537|FG000|Overall Study|Adverse Event|6|||
143172647|NCT00107276|516181537|FG000|Overall Study|M.D. decision|2|||
143172648|NCT00107276|516181537|FG000|Overall Study|Patient refusal|1|||
143172649|NCT00107276|516181537|FG000|Overall Study|Death|1|||
143172650|NCT00107276|516181537|FG000|Overall Study|Ineligible|16|||
143172651|NCT04846231|516181538|FG000|Overall Study|Lost to Follow-up|1|||
143172652|NCT04846231|516181539|FG001|Overall Study|Lost to Follow-up|0|||
143077668|NCT01371747|515824434|FG000|Overall Study|Withdrawal by Subject|6|||
143077669|NCT01371747|515824435|FG001|Overall Study|Withdrawal by Subject|12|||
143077670|NCT01371747|515824436|FG002|Overall Study|Withdrawal by Subject|5|||
143077671|NCT01371747|515824437|FG003|Overall Study|Withdrawal by Subject|2|||
143077672|NCT01371747|515824438|FG004|Overall Study|Withdrawal by Subject|2|||
143077673|NCT01371747|515824439|FG005|Overall Study|Withdrawal by Subject|4|||
143077674|NCT01371747|515824434|FG000|Overall Study|Other Reasons|2|||
143077675|NCT01371747|515824435|FG001|Overall Study|Other Reasons|1|||
143077676|NCT01371747|515824436|FG002|Overall Study|Other Reasons|2|||
143077677|NCT01371747|515824437|FG003|Overall Study|Other Reasons|0|||
143077678|NCT01371747|515824438|FG004|Overall Study|Other Reasons|0|||
143077679|NCT01371747|515824439|FG005|Overall Study|Other Reasons|1|||
143077680|NCT02856555|515824440|FG000|Overall Study|Adverse Event|1|||
143077681|NCT02856555|515824441|FG001|Overall Study|Adverse Event|0|||
143077682|NCT02856555|515824442|FG002|Overall Study|Adverse Event|0|||
143172653|NCT04846231|516181540|FG002|Overall Study|Lost to Follow-up|0|||
143172654|NCT04846231|516181541|FG003|Overall Study|Lost to Follow-up|0|||
143172655|NCT04846231|516181542|FG004|Overall Study|Lost to Follow-up|0|||
143172656|NCT04846231|516181543|FG005|Overall Study|Lost to Follow-up|0|||
143172657|NCT04846231|516181544|FG006|Overall Study|Lost to Follow-up|0|||
143077683|NCT02856555|515824440|FG000|Overall Study|Lost to Follow-up|1|||
143077684|NCT02856555|515824441|FG001|Overall Study|Lost to Follow-up|3|||
143077685|NCT02856555|515824442|FG002|Overall Study|Lost to Follow-up|0|||
143077686|NCT02856555|515824440|FG000|Overall Study|Withdrawal by Subject|3|||
143077687|NCT02856555|515824441|FG001|Overall Study|Withdrawal by Subject|0|||
143077688|NCT02856555|515824442|FG002|Overall Study|Withdrawal by Subject|0|||
143077689|NCT02856555|515824440|FG000|Overall Study|Randomized but Never Treated|0|||
143077690|NCT02856555|515824441|FG001|Overall Study|Randomized but Never Treated|1|||
143077691|NCT02856555|515824442|FG002|Overall Study|Randomized but Never Treated|0|||
143077692|NCT02094417|515824446|FG000|Overall Study|Adverse Event|0|||
143077693|NCT02094417|515824447|FG001|Overall Study|Adverse Event|0|||
143077694|NCT02094417|515824448|FG002|Overall Study|Adverse Event|0|||
143077695|NCT02094417|515824449|FG003|Overall Study|Adverse Event|1|||
143077696|NCT02094417|515824446|FG000|Overall Study|Eligibility criteria|0|||
143077697|NCT02094417|515824447|FG001|Overall Study|Eligibility criteria|1|||
143077698|NCT02094417|515824448|FG002|Overall Study|Eligibility criteria|0|||
143077699|NCT02094417|515824449|FG003|Overall Study|Eligibility criteria|0|||
143077700|NCT02094417|515824446|FG000|Overall Study|No responder|4|||
143077701|NCT02094417|515824447|FG001|Overall Study|No responder|4|||
143077702|NCT02094417|515824448|FG002|Overall Study|No responder|4|||
143077703|NCT02094417|515824449|FG003|Overall Study|No responder|3|||
143077704|NCT02094417|515824446|FG000|Overall Study|Unable to conduct observations or assess|0|||
143077705|NCT02094417|515824447|FG001|Overall Study|Unable to conduct observations or assess|1|||
143077706|NCT02094417|515824448|FG002|Overall Study|Unable to conduct observations or assess|0|||
143077707|NCT02094417|515824449|FG003|Overall Study|Unable to conduct observations or assess|0|||
143077708|NCT02094417|515824446|FG000|Overall Study|Withdrawal by Subject|1|||
143077709|NCT02094417|515824447|FG001|Overall Study|Withdrawal by Subject|2|||
143077710|NCT02094417|515824448|FG002|Overall Study|Withdrawal by Subject|1|||
143077711|NCT02094417|515824449|FG003|Overall Study|Withdrawal by Subject|3|||
143077712|NCT03333941|515824450|FG000|Overall Study|Lost to Follow-up|10|||
143077713|NCT03333941|515824450|FG000|Overall Study|Death|2|||
143077714|NCT03333941|515824450|FG000|Overall Study|Adverse Event|1|||
143077715|NCT01564537|515824451|FG000|Overall Study|Site Terminated by Sponsor|1|||
143077716|NCT01564537|515824452|FG001|Overall Study|Site Terminated by Sponsor|0|||
143077717|NCT01564537|515824451|FG000|Overall Study|Withdrawal by Subject|12|||
143077718|NCT01564537|515824452|FG001|Overall Study|Withdrawal by Subject|14|||
143077719|NCT01564537|515824451|FG000|Overall Study|Lost to Follow-up|7|||
143077720|NCT01564537|515824452|FG001|Overall Study|Lost to Follow-up|3|||
143077721|NCT01564537|515824451|FG000|Overall Study|Reason not specified|81|||
143077722|NCT01564537|515824452|FG001|Overall Study|Reason not specified|82|||
143077723|NCT02065700|515824453|FG000|Overall Study|Adverse Event|165|||
143077724|NCT02065700|515824454|FG001|Overall Study|Adverse Event|101|||
143077725|NCT02065700|515824453|FG000|Overall Study|Withdrawal by Subject|90|||
143077726|NCT02065700|515824454|FG001|Overall Study|Withdrawal by Subject|29|||
143077727|NCT02065700|515824453|FG000|Overall Study|Lost to Follow-up|12|||
143077728|NCT02065700|515824454|FG001|Overall Study|Lost to Follow-up|9|||
143077729|NCT02065700|515824453|FG000|Overall Study|Physician Decision|2|||
143077730|NCT02065700|515824454|FG001|Overall Study|Physician Decision|0|||
143172658|NCT04846231|516181545|FG007|Overall Study|Lost to Follow-up|1|||
143172659|NCT04846231|516181538|FG000|Overall Study|Withdrawal by Subject|0|||
143172660|NCT04846231|516181539|FG001|Overall Study|Withdrawal by Subject|1|||
143172661|NCT04846231|516181540|FG002|Overall Study|Withdrawal by Subject|2|||
143172662|NCT04846231|516181541|FG003|Overall Study|Withdrawal by Subject|1|||
143172663|NCT04846231|516181542|FG004|Overall Study|Withdrawal by Subject|0|||
143172664|NCT04846231|516181543|FG005|Overall Study|Withdrawal by Subject|0|||
143172665|NCT04846231|516181544|FG006|Overall Study|Withdrawal by Subject|0|||
143172666|NCT04846231|516181545|FG007|Overall Study|Withdrawal by Subject|0|||
143172667|NCT04846231|516181538|FG000|Overall Study|Protocol Violation|0|||
143172668|NCT04846231|516181539|FG001|Overall Study|Protocol Violation|1|||
143172669|NCT04846231|516181540|FG002|Overall Study|Protocol Violation|0|||
143172670|NCT04846231|516181541|FG003|Overall Study|Protocol Violation|0|||
143172671|NCT04846231|516181542|FG004|Overall Study|Protocol Violation|0|||
143172672|NCT04846231|516181543|FG005|Overall Study|Protocol Violation|0|||
143077731|NCT02065700|515824453|FG000|Overall Study|Sponsor Request|38|||
143077732|NCT02065700|515824454|FG001|Overall Study|Sponsor Request|15|||
143077733|NCT02065700|515824453|FG000|Overall Study|Treatment Failure|3|||
143077734|NCT02065700|515824454|FG001|Overall Study|Treatment Failure|2|||
143077735|NCT02065700|515824453|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
143077736|NCT02065700|515824454|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
143077737|NCT02065700|515824453|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
143077738|NCT02065700|515824454|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
143077739|NCT02065700|515824453|FG000|Overall Study|Non-compliance with Study Procedures|2|||
143077740|NCT02065700|515824454|FG001|Overall Study|Non-compliance with Study Procedures|0|||
143077741|NCT02065700|515824453|FG000|Overall Study|Not Defined|21|||
143077742|NCT02065700|515824454|FG001|Overall Study|Not Defined|3|||
143077743|NCT03559400|515824459|FG000|Overall Study|Lost to Follow-up|9|||
143077744|NCT03559400|515824460|FG001|Overall Study|Lost to Follow-up|7|||
143077745|NCT03559400|515824459|FG000|Overall Study|Death|0|||
143077746|NCT03559400|515824460|FG001|Overall Study|Death|2|||
143077747|NCT01544179|515824461|FG000|Overall Study|Death|50|||
143077748|NCT01544179|515824462|FG001|Overall Study|Death|37|||
143077749|NCT01544179|515824461|FG000|Overall Study|Lost to Follow-up|0|||
143077750|NCT01544179|515824462|FG001|Overall Study|Lost to Follow-up|1|||
143077751|NCT01544179|515824461|FG000|Overall Study|Adverse Event|0|||
143077752|NCT01544179|515824462|FG001|Overall Study|Adverse Event|1|||
143077753|NCT01544179|515824461|FG000|Overall Study|Withdrawal by Subject|12|||
143077754|NCT01544179|515824462|FG001|Overall Study|Withdrawal by Subject|7|||
143077755|NCT01544179|515824461|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
143077756|NCT01544179|515824462|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
143077757|NCT03146962|515824463|FG000|Overall Study|Lost to Follow-up|1|||
143077758|NCT03146962|515824464|FG001|Overall Study|Lost to Follow-up|1|||
143077759|NCT03146962|515824465|FG002|Overall Study|Lost to Follow-up|0|||
143077760|NCT03146962|515824466|FG003|Overall Study|Lost to Follow-up|0|||
143077761|NCT03146962|515824467|FG004|Overall Study|Lost to Follow-up|0|||
143077762|NCT03146962|515824468|FG005|Overall Study|Lost to Follow-up|0|||
143077763|NCT03146962|515824469|FG006|Overall Study|Lost to Follow-up|0|||
143077764|NCT03146962|515824470|FG007|Overall Study|Lost to Follow-up|0|||
143077765|NCT03146962|515824471|FG008|Overall Study|Lost to Follow-up|0|||
143077766|NCT03146962|515824472|FG009|Overall Study|Lost to Follow-up|0|||
143077767|NCT03146962|515824463|FG000|Overall Study|Adverse Event|0|||
143077768|NCT03146962|515824464|FG001|Overall Study|Adverse Event|3|||
143077769|NCT03146962|515824465|FG002|Overall Study|Adverse Event|0|||
143077770|NCT03146962|515824466|FG003|Overall Study|Adverse Event|0|||
143077771|NCT03146962|515824467|FG004|Overall Study|Adverse Event|0|||
143077772|NCT03146962|515824468|FG005|Overall Study|Adverse Event|0|||
143077773|NCT03146962|515824469|FG006|Overall Study|Adverse Event|0|||
143077774|NCT03146962|515824470|FG007|Overall Study|Adverse Event|1|||
143077775|NCT03146962|515824471|FG008|Overall Study|Adverse Event|0|||
143077776|NCT03146962|515824472|FG009|Overall Study|Adverse Event|0|||
143077777|NCT03146962|515824463|FG000|Overall Study|Withdrawal by Subject|0|||
143077778|NCT03146962|515824464|FG001|Overall Study|Withdrawal by Subject|0|||
143077779|NCT03146962|515824465|FG002|Overall Study|Withdrawal by Subject|0|||
143248894|NCT01904773|516465044|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
143077780|NCT03146962|515824466|FG003|Overall Study|Withdrawal by Subject|0|||
143077781|NCT03146962|515824467|FG004|Overall Study|Withdrawal by Subject|1|||
143077782|NCT03146962|515824468|FG005|Overall Study|Withdrawal by Subject|0|||
143077783|NCT03146962|515824469|FG006|Overall Study|Withdrawal by Subject|0|||
143077784|NCT03146962|515824470|FG007|Overall Study|Withdrawal by Subject|0|||
143077785|NCT03146962|515824471|FG008|Overall Study|Withdrawal by Subject|0|||
143077786|NCT03146962|515824472|FG009|Overall Study|Withdrawal by Subject|0|||
143077787|NCT03146962|515824463|FG000|Overall Study|Death|0|||
143077788|NCT03146962|515824464|FG001|Overall Study|Death|1|||
143077789|NCT03146962|515824465|FG002|Overall Study|Death|0|||
143077790|NCT03146962|515824466|FG003|Overall Study|Death|0|||
143077791|NCT03146962|515824467|FG004|Overall Study|Death|0|||
143077792|NCT03146962|515824468|FG005|Overall Study|Death|0|||
143077793|NCT03146962|515824469|FG006|Overall Study|Death|0|||
143077794|NCT03146962|515824470|FG007|Overall Study|Death|0|||
143077795|NCT03146962|515824471|FG008|Overall Study|Death|0|||
143077796|NCT03146962|515824472|FG009|Overall Study|Death|0|||
143077797|NCT03146962|515824463|FG000|Overall Study|COVID Precautions|1|||
143077798|NCT03146962|515824464|FG001|Overall Study|COVID Precautions|0|||
143077799|NCT03146962|515824465|FG002|Overall Study|COVID Precautions|0|||
143077800|NCT03146962|515824466|FG003|Overall Study|COVID Precautions|0|||
143077801|NCT03146962|515824467|FG004|Overall Study|COVID Precautions|0|||
143077802|NCT03146962|515824468|FG005|Overall Study|COVID Precautions|0|||
143077803|NCT03146962|515824469|FG006|Overall Study|COVID Precautions|0|||
143077804|NCT03146962|515824470|FG007|Overall Study|COVID Precautions|0|||
143077805|NCT03146962|515824471|FG008|Overall Study|COVID Precautions|0|||
143077806|NCT03146962|515824472|FG009|Overall Study|COVID Precautions|0|||
143077807|NCT03146962|515824463|FG000|Overall Study|Physician Decision|0|||
143077808|NCT03146962|515824464|FG001|Overall Study|Physician Decision|0|||
143077809|NCT03146962|515824465|FG002|Overall Study|Physician Decision|0|||
143077810|NCT03146962|515824466|FG003|Overall Study|Physician Decision|0|||
143077811|NCT03146962|515824467|FG004|Overall Study|Physician Decision|0|||
143077812|NCT03146962|515824468|FG005|Overall Study|Physician Decision|0|||
143077813|NCT03146962|515824469|FG006|Overall Study|Physician Decision|0|||
143077814|NCT03146962|515824470|FG007|Overall Study|Physician Decision|0|||
143077815|NCT03146962|515824471|FG008|Overall Study|Physician Decision|0|||
143077816|NCT03146962|515824472|FG009|Overall Study|Physician Decision|1|||
143077817|NCT03146962|515824463|FG000|Overall Study|Started New Treatment|0|||
143077818|NCT03146962|515824464|FG001|Overall Study|Started New Treatment|1|||
143077819|NCT03146962|515824465|FG002|Overall Study|Started New Treatment|0|||
143077820|NCT03146962|515824466|FG003|Overall Study|Started New Treatment|0|||
143077821|NCT03146962|515824467|FG004|Overall Study|Started New Treatment|0|||
143077822|NCT03146962|515824468|FG005|Overall Study|Started New Treatment|0|||
143077823|NCT03146962|515824469|FG006|Overall Study|Started New Treatment|0|||
143077824|NCT03146962|515824470|FG007|Overall Study|Started New Treatment|0|||
143077825|NCT03146962|515824471|FG008|Overall Study|Started New Treatment|0|||
143077826|NCT03146962|515824472|FG009|Overall Study|Started New Treatment|0|||
143077827|NCT03257865|515824474|FG000|Overall Study|Adverse Event|4|||
143077828|NCT03257865|515824475|FG001|Overall Study|Adverse Event|8|||
143077829|NCT03257865|515824474|FG000|Overall Study|Lack of Efficacy|1|||
143077830|NCT03257865|515824475|FG001|Overall Study|Lack of Efficacy|2|||
143077831|NCT03257865|515824474|FG000|Overall Study|Non-compliance with Study Drug|0|||
143077832|NCT03257865|515824475|FG001|Overall Study|Non-compliance with Study Drug|2|||
143077833|NCT03257865|515824474|FG000|Overall Study|Withdrawal by Subject|23|||
143077834|NCT03257865|515824475|FG001|Overall Study|Withdrawal by Subject|17|||
143077835|NCT03257865|515824474|FG000|Overall Study|Physician Decision|3|||
143077836|NCT03257865|515824475|FG001|Overall Study|Physician Decision|1|||
143077837|NCT03257865|515824474|FG000|Overall Study|Other|0|||
143077838|NCT03257865|515824475|FG001|Overall Study|Other|1|||
143077839|NCT03257865|515824474|FG000|Overall Study|Lost to Follow-up|4|||
143077840|NCT03257865|515824475|FG001|Overall Study|Lost to Follow-up|4|||
143077841|NCT01696058|515824478|FG000|Overall Study|Adverse Event|21|||
143077842|NCT01696058|515824479|FG001|Overall Study|Adverse Event|11|||
143077843|NCT01696058|515824478|FG000|Overall Study|Lack of Efficacy|2|||
143077844|NCT01696058|515824479|FG001|Overall Study|Lack of Efficacy|3|||
143077845|NCT01696058|515824478|FG000|Overall Study|Protocol Violation|9|||
143077846|NCT01696058|515824479|FG001|Overall Study|Protocol Violation|3|||
143077847|NCT01696058|515824478|FG000|Overall Study|Lost to Follow-up|2|||
143077848|NCT01696058|515824479|FG001|Overall Study|Lost to Follow-up|5|||
143077849|NCT01696058|515824478|FG000|Overall Study|Withdrawal by Subject|4|||
143077850|NCT01696058|515824479|FG001|Overall Study|Withdrawal by Subject|6|||
143077851|NCT01696058|515824478|FG000|Overall Study|Other reason prematurely discontinued|5|||
143077852|NCT01696058|515824479|FG001|Overall Study|Other reason prematurely discontinued|3|||
143077853|NCT01934335|515824481|FG000|Overall Study|Withdrawal by Subject|1|||
143366267|NCT00817635|516884611|FG003|Overall Study|Administrative Problems|0|||
143077854|NCT01934335|515824482|FG001|Overall Study|Withdrawal by Subject|1|||
143077855|NCT05384171|515824483|FG000|Overall Study|Lost to Follow-up|9|||
143077856|NCT05384171|515824484|FG001|Overall Study|Lost to Follow-up|9|||
143077857|NCT05384171|515824483|FG000|Overall Study|Withdrawal by Subject|3|||
143077858|NCT05384171|515824484|FG001|Overall Study|Withdrawal by Subject|0|||
143077859|NCT01421511|515824485|FG000|Overall Study|Lost to Follow-up|11|||
143077860|NCT01421511|515824486|FG001|Overall Study|Lost to Follow-up|14|||
143077861|NCT01421511|515824485|FG000|Overall Study|Randomized but didn't receive study drug|1|||
143077862|NCT01421511|515824486|FG001|Overall Study|Randomized but didn't receive study drug|7|||
143077863|NCT01421511|515824485|FG000|Overall Study|Physician Decision|0|||
143077864|NCT01421511|515824486|FG001|Overall Study|Physician Decision|1|||
143077865|NCT01421511|515824485|FG000|Overall Study|Withdrawal by Subject|6|||
143077866|NCT01421511|515824486|FG001|Overall Study|Withdrawal by Subject|5|||
143077867|NCT01421511|515824485|FG000|Overall Study|Death|1|||
143077868|NCT01421511|515824486|FG001|Overall Study|Death|1|||
143077869|NCT00749892|515824487|FG000|Overall Study|Withdrawal by Subject|3|||
143077870|NCT04581369|515824488|FG000|Overall Study|Death|7|||
143077871|NCT04581369|515824489|FG001|Overall Study|Death|6|||
143077872|NCT04581369|515824490|FG002|Overall Study|Death|0|||
143077873|NCT04581369|515824488|FG000|Overall Study|Lost to Follow-up|7|||
143077874|NCT04581369|515824489|FG001|Overall Study|Lost to Follow-up|3|||
143077875|NCT04581369|515824490|FG002|Overall Study|Lost to Follow-up|0|||
143077876|NCT04581369|515824488|FG000|Overall Study|liver transplant|2|||
143077877|NCT04581369|515824489|FG001|Overall Study|liver transplant|2|||
143077878|NCT04581369|515824490|FG002|Overall Study|liver transplant|0|||
143077879|NCT04581369|515824488|FG000|Overall Study|transitioned to hospice care|0|||
143077880|NCT04581369|515824489|FG001|Overall Study|transitioned to hospice care|5|||
143077881|NCT04581369|515824490|FG002|Overall Study|transitioned to hospice care|0|||
143077882|NCT00780910|515824491|FG000|Overall Study|Adverse Event|2|||
143077883|NCT01111825|515824492|FG000|Overall Study|Withdrawal by Subject|0|||
143077884|NCT01111825|515824493|FG001|Overall Study|Withdrawal by Subject|0|||
143077885|NCT01111825|515824494|FG002|Overall Study|Withdrawal by Subject|1|||
143077886|NCT01111825|515824495|FG003|Overall Study|Withdrawal by Subject|0|||
143077887|NCT01111825|515824492|FG000|Overall Study|Lost to Follow-up|0|||
143077888|NCT01111825|515824493|FG001|Overall Study|Lost to Follow-up|0|||
143248895|NCT01904773|516465036|FG000|First Intervention|Adverse Event|0|||
143248896|NCT01904773|516465037|FG001|First Intervention|Adverse Event|0|||
143248897|NCT01904773|516465038|FG002|First Intervention|Adverse Event|0|||
143077889|NCT01111825|515824494|FG002|Overall Study|Lost to Follow-up|3|||
143077890|NCT01111825|515824495|FG003|Overall Study|Lost to Follow-up|1|||
143077891|NCT01111825|515824492|FG000|Overall Study|Adverse Event|2|||
143077892|NCT01111825|515824493|FG001|Overall Study|Adverse Event|1|||
143077893|NCT01111825|515824494|FG002|Overall Study|Adverse Event|4|||
143077894|NCT01111825|515824495|FG003|Overall Study|Adverse Event|0|||
143077895|NCT01111825|515824492|FG000|Overall Study|Disease Progression|1|||
143077896|NCT01111825|515824493|FG001|Overall Study|Disease Progression|0|||
143077897|NCT01111825|515824494|FG002|Overall Study|Disease Progression|0|||
143077898|NCT01111825|515824495|FG003|Overall Study|Disease Progression|0|||
143077899|NCT01111825|515824492|FG000|Overall Study|Discontinuation by Sponsor|0|||
143077900|NCT01111825|515824493|FG001|Overall Study|Discontinuation by Sponsor|0|||
143077901|NCT01111825|515824494|FG002|Overall Study|Discontinuation by Sponsor|0|||
143077902|NCT01111825|515824495|FG003|Overall Study|Discontinuation by Sponsor|20|||
143077903|NCT00106964|515824497|FG000|Overall Study|Lost to Follow-up|8|||
143077904|NCT00106964|515824498|FG001|Overall Study|Lost to Follow-up|6|||
143077905|NCT00106964|515824499|FG002|Overall Study|Lost to Follow-up|2|||
143077906|NCT00106964|515824497|FG000|Overall Study|Pregnancy|2|||
143077907|NCT00106964|515824498|FG001|Overall Study|Pregnancy|3|||
143077908|NCT00106964|515824499|FG002|Overall Study|Pregnancy|2|||
143077909|NCT00106964|515824497|FG000|Overall Study|Death|1|||
143077910|NCT00106964|515824498|FG001|Overall Study|Death|1|||
143077911|NCT00106964|515824499|FG002|Overall Study|Death|0|||
143077912|NCT00106964|515824497|FG000|Overall Study|Incarceration|0|||
143077913|NCT00106964|515824498|FG001|Overall Study|Incarceration|1|||
143077914|NCT00106964|515824499|FG002|Overall Study|Incarceration|0|||
143077915|NCT00106964|515824497|FG000|Overall Study|Site Funding Terminated|0|||
143077916|NCT00106964|515824498|FG001|Overall Study|Site Funding Terminated|1|||
143077917|NCT00106964|515824499|FG002|Overall Study|Site Funding Terminated|1|||
143077918|NCT00106964|515824497|FG000|Overall Study|Failure to adhere|2|||
143077919|NCT00106964|515824498|FG001|Overall Study|Failure to adhere|0|||
143077920|NCT00106964|515824499|FG002|Overall Study|Failure to adhere|0|||
143077921|NCT00106964|515824497|FG000|Overall Study|Did not meet eligibility criteria|0|||
143077922|NCT00106964|515824498|FG001|Overall Study|Did not meet eligibility criteria|2|||
143077923|NCT00106964|515824499|FG002|Overall Study|Did not meet eligibility criteria|2|||
143077924|NCT00106964|515824497|FG000|Overall Study|Required disallowed medication|0|||
143077925|NCT00106964|515824498|FG001|Overall Study|Required disallowed medication|1|||
143077926|NCT00106964|515824499|FG002|Overall Study|Required disallowed medication|0|||
143077927|NCT04746794|515824500|FG000|Overall Study|Did not complete any study assessment|50303|||
143077928|NCT04746794|515824501|FG001|Overall Study|Did not complete any study assessment|44997|||
143077929|NCT01422187|515824506|FG000|Overall Study|Personal reason|1|||
143248898|NCT01904773|516465039|FG003|First Intervention|Adverse Event|0|||
143248899|NCT01904773|516465040|FG004|First Intervention|Adverse Event|0|||
143077930|NCT01422187|515824507|FG001|Overall Study|Personal reason|0|||
143077931|NCT01422187|515824508|FG002|Overall Study|Personal reason|0|||
143077932|NCT01422187|515824506|FG000|Overall Study|Lost to Follow-up|0|||
143077933|NCT01422187|515824507|FG001|Overall Study|Lost to Follow-up|1|||
143077934|NCT01422187|515824508|FG002|Overall Study|Lost to Follow-up|0|||
143077935|NCT00168818|515824509|FG000|Overall Study|Adverse Event|23|||
143077936|NCT00168818|515824510|FG001|Overall Study|Adverse Event|29|||
143077937|NCT00168818|515824511|FG002|Overall Study|Adverse Event|31|||
143077938|NCT00168818|515824509|FG000|Overall Study|Protocol Violation|16|||
143077939|NCT00168818|515824510|FG001|Overall Study|Protocol Violation|11|||
143077940|NCT00168818|515824511|FG002|Overall Study|Protocol Violation|11|||
143077941|NCT00168818|515824509|FG000|Overall Study|Lost to Follow-up|13|||
143077942|NCT00168818|515824510|FG001|Overall Study|Lost to Follow-up|4|||
143077943|NCT00168818|515824511|FG002|Overall Study|Lost to Follow-up|15|||
143077944|NCT00168818|515824509|FG000|Overall Study|Withdrawal by Subject|43|||
143077945|NCT00168818|515824510|FG001|Overall Study|Withdrawal by Subject|41|||
143077946|NCT00168818|515824511|FG002|Overall Study|Withdrawal by Subject|37|||
143077947|NCT00168818|515824509|FG000|Overall Study|Other|22|||
143077948|NCT00168818|515824510|FG001|Overall Study|Other|24|||
143077949|NCT00168818|515824511|FG002|Overall Study|Other|30|||
143077950|NCT00168818|515824509|FG000|Treatment|Adverse Event|77|||
143077951|NCT00168818|515824510|FG001|Treatment|Adverse Event|89|||
143077952|NCT00168818|515824511|FG002|Treatment|Adverse Event|68|||
143077953|NCT00168818|515824509|FG000|Treatment|Protocol Violation|8|||
143077954|NCT00168818|515824510|FG001|Treatment|Protocol Violation|11|||
143077955|NCT00168818|515824511|FG002|Treatment|Protocol Violation|11|||
143077956|NCT00168818|515824509|FG000|Treatment|Lost to Follow-up|0|||
143077957|NCT00168818|515824510|FG001|Treatment|Lost to Follow-up|2|||
143077958|NCT00168818|515824511|FG002|Treatment|Lost to Follow-up|1|||
143077959|NCT00168818|515824509|FG000|Treatment|Withdrawal by Subject|25|||
143077960|NCT00168818|515824510|FG001|Treatment|Withdrawal by Subject|20|||
143077961|NCT00168818|515824511|FG002|Treatment|Withdrawal by Subject|22|||
143077962|NCT00168818|515824509|FG000|Treatment|Other|23|||
143077963|NCT00168818|515824510|FG001|Treatment|Other|29|||
143077964|NCT00168818|515824511|FG002|Treatment|Other|31|||
143077965|NCT02538965|515824518|FG000|Treatment Period|Other = Death due to disease progression|1|||
143077966|NCT02538965|515824518|FG000|Treatment Period|Adverse Event|2|||
143077967|NCT02538965|515824518|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
143077968|NCT02538965|515824518|FG000|Treatment Period|Treatment Failure|9|||
143077969|NCT02538965|515824518|FG000|Treatment Period|Disease Progression|1|||
143077970|NCT02538965|515824518|FG000|Treatment Period|Physician Decision|2|||
143077971|NCT02538965|515824518|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
143077972|NCT02538965|515824518|FG000|Follow-Up Period|Withdrawal by Parent|4|||
143077973|NCT00875797|515824519|FG000|Overall Study|Protocol Violation|6|||
143077974|NCT00875797|515824520|FG001|Overall Study|Protocol Violation|3|||
143077975|NCT00811928|515824525|FG000|Overall Study|AEs and SAEs Including Death|7|||
143077976|NCT00811928|515824526|FG001|Overall Study|AEs and SAEs Including Death|11|||
143077977|NCT00811928|515824525|FG000|Overall Study|Withdrawal by Subject|18|||
143077978|NCT00811928|515824526|FG001|Overall Study|Withdrawal by Subject|12|||
143077979|NCT00811928|515824525|FG000|Overall Study|Did Not Take Study Drug|3|||
143077980|NCT00811928|515824526|FG001|Overall Study|Did Not Take Study Drug|0|||
143077981|NCT00811928|515824525|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
143077982|NCT00811928|515824526|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
143077983|NCT00811928|515824525|FG000|Overall Study|Investigator Decision|2|||
143077984|NCT00811928|515824526|FG001|Overall Study|Investigator Decision|1|||
143077985|NCT00811928|515824525|FG000|Overall Study|Poor Compliance|2|||
143077986|NCT00811928|515824526|FG001|Overall Study|Poor Compliance|5|||
143077987|NCT01333397|515824527|FG000|Overall Study|Lost to Follow-up|1|||
143077988|NCT01333397|515824528|FG001|Overall Study|Lost to Follow-up|0|||
143077989|NCT01333397|515824529|FG002|Overall Study|Lost to Follow-up|0|||
143077990|NCT01333397|515824530|FG003|Overall Study|Lost to Follow-up|1|||
143077991|NCT01333397|515824531|FG004|Overall Study|Lost to Follow-up|0|||
143077992|NCT00314951|515824532|FG000|Treatment|Didn't meet criteria for mITT population|16|||
143077993|NCT00314951|515824533|FG001|Treatment|Didn't meet criteria for mITT population|11|||
143077994|NCT00314951|515824532|FG000|Follow-up|mITT failure|44|||
143077995|NCT00314951|515824533|FG001|Follow-up|mITT failure|34|||
143077996|NCT03503864|515824536|FG000|Overall Study|Protocol Violation|6|||
143077997|NCT03503864|515824536|FG000|Overall Study|Withdrawal by Subject|7|||
143077998|NCT00090363|515824539|FG000|Overall Study|Lost to Follow-up|1|||
143077999|NCT00090363|515824540|FG001|Overall Study|Lost to Follow-up|2|||
143078000|NCT00090363|515824541|FG002|Overall Study|Lost to Follow-up|1|||
143078001|NCT00090363|515824539|FG000|Overall Study|Withdrawal by Subject|7|||
143078002|NCT00090363|515824540|FG001|Overall Study|Withdrawal by Subject|7|||
143078003|NCT00090363|515824541|FG002|Overall Study|Withdrawal by Subject|6|||
143078004|NCT00090363|515824539|FG000|Overall Study|Study-specific discontinuation criteria|75|||
143078005|NCT00090363|515824540|FG001|Overall Study|Study-specific discontinuation criteria|74|||
143078006|NCT00090363|515824541|FG002|Overall Study|Study-specific discontinuation criteria|62|||
143078007|NCT00090363|515824539|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
143078008|NCT00090363|515824540|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
143078009|NCT00090363|515824541|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
143078010|NCT00090363|515824539|FG000|Overall Study|Consent expired|7|||
143078011|NCT00090363|515824540|FG001|Overall Study|Consent expired|10|||
143078012|NCT00090363|515824541|FG002|Overall Study|Consent expired|9|||
143078013|NCT00090363|515824539|FG000|Overall Study|Reasons not specified|2|||
143078014|NCT00090363|515824540|FG001|Overall Study|Reasons not specified|1|||
143078015|NCT00090363|515824541|FG002|Overall Study|Reasons not specified|1|||
143078016|NCT00090363|515824539|FG000|Overall Study|Continuing on study off treatment|14|||
143078017|NCT00090363|515824540|FG001|Overall Study|Continuing on study off treatment|13|||
143078018|NCT00090363|515824541|FG002|Overall Study|Continuing on study off treatment|16|||
143078019|NCT04642365|515824545|FG000|Overall Study|Death|3|||
143078020|NCT04642365|515824546|FG001|Overall Study|Death|2|||
143078021|NCT04642365|515824547|FG002|Overall Study|Death|4|||
143078022|NCT04642365|515824548|FG003|Overall Study|Death|5|||
143078023|NCT04642365|515824549|FG004|Overall Study|Death|5|||
143078024|NCT04642365|515824550|FG005|Overall Study|Death|3|||
143078025|NCT04642365|515824551|FG006|Overall Study|Death|2|||
143078026|NCT04642365|515824552|FG007|Overall Study|Death|1|||
143078027|NCT04642365|515824545|FG000|Overall Study|Physician Decision|1|||
143078028|NCT04642365|515824546|FG001|Overall Study|Physician Decision|0|||
143078029|NCT04642365|515824547|FG002|Overall Study|Physician Decision|0|||
143078030|NCT04642365|515824548|FG003|Overall Study|Physician Decision|0|||
143078031|NCT04642365|515824549|FG004|Overall Study|Physician Decision|0|||
143078032|NCT04642365|515824550|FG005|Overall Study|Physician Decision|0|||
143078033|NCT04642365|515824551|FG006|Overall Study|Physician Decision|0|||
143078034|NCT04642365|515824552|FG007|Overall Study|Physician Decision|0|||
143078035|NCT04642365|515824545|FG000|Overall Study|Progressive Disease|1|||
143078036|NCT04642365|515824546|FG001|Overall Study|Progressive Disease|1|||
143078037|NCT04642365|515824547|FG002|Overall Study|Progressive Disease|1|||
143078038|NCT04642365|515824548|FG003|Overall Study|Progressive Disease|0|||
143078039|NCT04642365|515824549|FG004|Overall Study|Progressive Disease|0|||
143078040|NCT04642365|515824550|FG005|Overall Study|Progressive Disease|0|||
143078041|NCT04642365|515824551|FG006|Overall Study|Progressive Disease|1|||
143078042|NCT04642365|515824552|FG007|Overall Study|Progressive Disease|0|||
143078043|NCT04642365|515824545|FG000|Overall Study|Study Terminated By Sponsor|0|||
143078044|NCT04642365|515824546|FG001|Overall Study|Study Terminated By Sponsor|2|||
143078045|NCT04642365|515824547|FG002|Overall Study|Study Terminated By Sponsor|1|||
143078046|NCT04642365|515824548|FG003|Overall Study|Study Terminated By Sponsor|1|||
143078047|NCT04642365|515824549|FG004|Overall Study|Study Terminated By Sponsor|1|||
143078048|NCT04642365|515824550|FG005|Overall Study|Study Terminated By Sponsor|2|||
143078049|NCT04642365|515824551|FG006|Overall Study|Study Terminated By Sponsor|2|||
143078050|NCT04642365|515824552|FG007|Overall Study|Study Terminated By Sponsor|1|||
143078051|NCT04642365|515824545|FG000|Overall Study|Symptomatic Deterioration|1|||
143078052|NCT04642365|515824546|FG001|Overall Study|Symptomatic Deterioration|1|||
143078053|NCT04642365|515824547|FG002|Overall Study|Symptomatic Deterioration|0|||
143078054|NCT04642365|515824548|FG003|Overall Study|Symptomatic Deterioration|0|||
143078055|NCT04642365|515824549|FG004|Overall Study|Symptomatic Deterioration|0|||
143078056|NCT04642365|515824550|FG005|Overall Study|Symptomatic Deterioration|1|||
143078057|NCT04642365|515824551|FG006|Overall Study|Symptomatic Deterioration|0|||
143078058|NCT04642365|515824552|FG007|Overall Study|Symptomatic Deterioration|0|||
143078059|NCT04642365|515824545|FG000|Overall Study|Withdrawal by Subject|0|||
143078060|NCT04642365|515824546|FG001|Overall Study|Withdrawal by Subject|0|||
143078061|NCT04642365|515824547|FG002|Overall Study|Withdrawal by Subject|1|||
143078062|NCT04642365|515824548|FG003|Overall Study|Withdrawal by Subject|1|||
143078063|NCT04642365|515824549|FG004|Overall Study|Withdrawal by Subject|0|||
143078064|NCT04642365|515824550|FG005|Overall Study|Withdrawal by Subject|0|||
143172673|NCT04846231|516181544|FG006|Overall Study|Protocol Violation|0|||
143172674|NCT04846231|516181545|FG007|Overall Study|Protocol Violation|0|||
143078065|NCT04642365|515824551|FG006|Overall Study|Withdrawal by Subject|2|||
143078066|NCT04642365|515824552|FG007|Overall Study|Withdrawal by Subject|0|||
143078067|NCT04642365|515824545|FG000|Overall Study|Adverse Event|0|||
143078068|NCT04642365|515824546|FG001|Overall Study|Adverse Event|0|||
143078069|NCT04642365|515824547|FG002|Overall Study|Adverse Event|0|||
143078070|NCT04642365|515824548|FG003|Overall Study|Adverse Event|0|||
143078071|NCT04642365|515824549|FG004|Overall Study|Adverse Event|0|||
143078072|NCT04642365|515824550|FG005|Overall Study|Adverse Event|0|||
143078073|NCT04642365|515824551|FG006|Overall Study|Adverse Event|0|||
143078074|NCT04642365|515824552|FG007|Overall Study|Adverse Event|1|||
143078075|NCT00121134|515824553|FG000|Overall Study|Progression of Disease|5|||
143078076|NCT00121134|515824554|FG001|Overall Study|Progression of Disease|3|||
143078077|NCT00121134|515824555|FG002|Overall Study|Progression of Disease|4|||
143248900|NCT01904773|516465041|FG005|First Intervention|Adverse Event|0|||
143248901|NCT01904773|516465042|FG006|First Intervention|Adverse Event|1|||
143248902|NCT01904773|516465043|FG007|First Intervention|Adverse Event|0|||
143248903|NCT01904773|516465044|FG008|First Intervention|Adverse Event|0|||
143248904|NCT01904773|516465036|FG000|Placebo Washout First Intervention|Condition worsened|0|||
143248905|NCT01904773|516465037|FG001|Placebo Washout First Intervention|Condition worsened|1|||
143248906|NCT01904773|516465038|FG002|Placebo Washout First Intervention|Condition worsened|0|||
143248907|NCT01904773|516465039|FG003|Placebo Washout First Intervention|Condition worsened|0|||
143248908|NCT01904773|516465040|FG004|Placebo Washout First Intervention|Condition worsened|0|||
143078078|NCT00121134|515824556|FG003|Overall Study|Progression of Disease|2|||
143078079|NCT00121134|515824553|FG000|Overall Study|Toxicity|4|||
143078080|NCT00121134|515824554|FG001|Overall Study|Toxicity|7|||
143078081|NCT00121134|515824555|FG002|Overall Study|Toxicity|13|||
143078082|NCT00121134|515824556|FG003|Overall Study|Toxicity|5|||
143078083|NCT00121134|515824553|FG000|Overall Study|Physician Decision|6|||
143078084|NCT00121134|515824554|FG001|Overall Study|Physician Decision|4|||
143078085|NCT00121134|515824555|FG002|Overall Study|Physician Decision|4|||
143078086|NCT00121134|515824556|FG003|Overall Study|Physician Decision|1|||
143078087|NCT00121134|515824553|FG000|Overall Study|Treatment Delay|1|||
143078088|NCT00121134|515824554|FG001|Overall Study|Treatment Delay|0|||
143078089|NCT00121134|515824555|FG002|Overall Study|Treatment Delay|0|||
143078090|NCT00121134|515824556|FG003|Overall Study|Treatment Delay|0|||
143078091|NCT00121134|515824553|FG000|Overall Study|Intercurrent Illness|0|||
143078092|NCT00121134|515824554|FG001|Overall Study|Intercurrent Illness|0|||
143078093|NCT00121134|515824555|FG002|Overall Study|Intercurrent Illness|0|||
143078094|NCT00121134|515824556|FG003|Overall Study|Intercurrent Illness|1|||
143078095|NCT00121134|515824553|FG000|Overall Study|Patient Personal Reasons|0|||
143078096|NCT00121134|515824554|FG001|Overall Study|Patient Personal Reasons|1|||
143078097|NCT00121134|515824555|FG002|Overall Study|Patient Personal Reasons|0|||
143078098|NCT00121134|515824556|FG003|Overall Study|Patient Personal Reasons|0|||
143078099|NCT02478320|515824557|FG000|Overall Study|Adverse Event|2|||
143172675|NCT04846231|516181538|FG000|Overall Study|Adverse Event|0|||
143172676|NCT04846231|516181539|FG001|Overall Study|Adverse Event|0|||
143172677|NCT04846231|516181540|FG002|Overall Study|Adverse Event|0|||
143172678|NCT04846231|516181541|FG003|Overall Study|Adverse Event|0|||
143172679|NCT04846231|516181542|FG004|Overall Study|Adverse Event|0|||
143172680|NCT04846231|516181543|FG005|Overall Study|Adverse Event|0|||
143172681|NCT04846231|516181544|FG006|Overall Study|Adverse Event|1|||
143172682|NCT04846231|516181545|FG007|Overall Study|Adverse Event|1|||
143172683|NCT02980107|516181546|FG000|Overall Study|Withdrawal by Subject|51|||
143172684|NCT02980107|516181547|FG001|Overall Study|Withdrawal by Subject|62|||
143172685|NCT00945659|516181548|FG000|Overall Study|Lost to Follow-up|7|||
143248909|NCT01904773|516465041|FG005|Placebo Washout First Intervention|Condition worsened|0|||
143248910|NCT01904773|516465042|FG006|Placebo Washout First Intervention|Condition worsened|0|||
143248911|NCT01904773|516465043|FG007|Placebo Washout First Intervention|Condition worsened|0|||
143248912|NCT01904773|516465044|FG008|Placebo Washout First Intervention|Condition worsened|0|||
143248913|NCT01904773|516465036|FG000|Fifth Intervention|Adverse Event|0|||
143248914|NCT01904773|516465037|FG001|Fifth Intervention|Adverse Event|0|||
143248915|NCT01904773|516465038|FG002|Fifth Intervention|Adverse Event|0|||
143248916|NCT01904773|516465039|FG003|Fifth Intervention|Adverse Event|0|||
143248917|NCT01904773|516465040|FG004|Fifth Intervention|Adverse Event|0|||
143248918|NCT01904773|516465041|FG005|Fifth Intervention|Adverse Event|0|||
143248919|NCT01904773|516465042|FG006|Fifth Intervention|Adverse Event|0|||
143248920|NCT01904773|516465043|FG007|Fifth Intervention|Adverse Event|1|||
143248921|NCT01904773|516465044|FG008|Fifth Intervention|Adverse Event|0|||
143078100|NCT02478320|515824558|FG001|Overall Study|Adverse Event|0|||
143078101|NCT02478320|515824557|FG000|Overall Study|Death|1|||
143172686|NCT00945659|516181549|FG001|Overall Study|Lost to Follow-up|20|||
143172687|NCT00945659|516181550|FG002|Overall Study|Lost to Follow-up|17|||
143172688|NCT04064905|516181555|FG000|Overall Study|Lost to Follow-up|0|||
143248922|NCT01904773|516465036|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
143248923|NCT01904773|516465037|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
143078102|NCT02478320|515824558|FG001|Overall Study|Death|0|||
143078103|NCT02478320|515824557|FG000|Overall Study|Lack of Efficacy|4|||
143078104|NCT02478320|515824558|FG001|Overall Study|Lack of Efficacy|0|||
143078105|NCT02478320|515824557|FG000|Overall Study|Withdrawal by Subject|2|||
143078106|NCT02478320|515824558|FG001|Overall Study|Withdrawal by Subject|0|||
143078107|NCT02478320|515824557|FG000|Overall Study|Screen Failure|3|||
143078108|NCT02478320|515824558|FG001|Overall Study|Screen Failure|0|||
143172689|NCT04064905|516181556|FG001|Overall Study|Lost to Follow-up|3|||
143172690|NCT04064905|516181557|FG002|Overall Study|Lost to Follow-up|1|||
143172691|NCT04064905|516181558|FG003|Overall Study|Lost to Follow-up|4|||
143172692|NCT04064905|516181559|FG004|Overall Study|Lost to Follow-up|2|||
143172693|NCT01448616|516181560|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
143172694|NCT01448616|516181561|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
143172695|NCT01448616|516181562|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
143172696|NCT01448616|516181563|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
143172697|NCT01448616|516181560|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
143172698|NCT01448616|516181561|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
143172699|NCT01448616|516181562|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
143172700|NCT01448616|516181563|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
143172701|NCT01448616|516181560|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
143172702|NCT01448616|516181561|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
143172703|NCT01448616|516181562|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
143172704|NCT01448616|516181563|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
143172705|NCT01448616|516181560|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
143172706|NCT01448616|516181561|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
143172707|NCT01448616|516181562|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
143172708|NCT01448616|516181563|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
143172709|NCT01448616|516181560|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
143172710|NCT01448616|516181561|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
143172711|NCT01448616|516181562|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
143172712|NCT01448616|516181563|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
143172713|NCT03323164|516181566|FG000|Overall Study|Poor quality imaging/scans|2|||
143172714|NCT03323164|516181567|FG001|Overall Study|Poor quality imaging/scans|2|||
143172715|NCT04211363|516181568|FG000|Overall Study|Adverse Event|5|||
143172716|NCT04211363|516181569|FG001|Overall Study|Adverse Event|2|||
143172717|NCT04211363|516181568|FG000|Overall Study|Physician Decision|0|||
143172718|NCT04211363|516181569|FG001|Overall Study|Physician Decision|1|||
143172719|NCT04211363|516181568|FG000|Overall Study|Protocol Violation|1|||
143172720|NCT04211363|516181569|FG001|Overall Study|Protocol Violation|0|||
143172721|NCT04211363|516181568|FG000|Overall Study|Pregnancy|1|||
143172722|NCT04211363|516181569|FG001|Overall Study|Pregnancy|0|||
143078109|NCT00673387|515824559|FG000|Overall Study|Withdrawal by Subject|15|||
143078110|NCT00673387|515824560|FG001|Overall Study|Withdrawal by Subject|16|||
143078111|NCT00673387|515824561|FG002|Overall Study|Withdrawal by Subject|20|||
143078112|NCT00673387|515824562|FG003|Overall Study|Withdrawal by Subject|16|||
143078113|NCT00673387|515824563|FG004|Overall Study|Withdrawal by Subject|18|||
143078114|NCT00673387|515824564|FG005|Overall Study|Withdrawal by Subject|21|||
143078115|NCT00673387|515824565|FG006|Overall Study|Withdrawal by Subject|15|||
143078116|NCT00673387|515824566|FG007|Overall Study|Withdrawal by Subject|21|||
143078117|NCT00673387|515824559|FG000|Overall Study|Adverse Event|3|||
143078118|NCT00673387|515824560|FG001|Overall Study|Adverse Event|1|||
143172723|NCT04211363|516181568|FG000|Overall Study|Lost to Follow-up|12|||
143172724|NCT04211363|516181569|FG001|Overall Study|Lost to Follow-up|4|||
143172725|NCT04211363|516181568|FG000|Overall Study|Withdrawal by Subject|11|||
143172726|NCT04211363|516181569|FG001|Overall Study|Withdrawal by Subject|11|||
143172727|NCT04211363|516181568|FG000|Overall Study|Other|1|||
143172728|NCT04211363|516181569|FG001|Overall Study|Other|2|||
143172729|NCT02536664|516181576|FG000|Overall Study|Inadequate completion of documentation|2|||
143172730|NCT02536664|516181577|FG001|Overall Study|Inadequate completion of documentation|4|||
143172731|NCT02536664|516181576|FG000|Overall Study|Progression|13|||
143172732|NCT02536664|516181577|FG001|Overall Study|Progression|18|||
143172733|NCT02536664|516181576|FG000|Overall Study|Death due to lymphoma|2|||
143172734|NCT02536664|516181577|FG001|Overall Study|Death due to lymphoma|1|||
143172735|NCT02536664|516181576|FG000|Overall Study|Death due to other reason|3|||
143172736|NCT02536664|516181577|FG001|Overall Study|Death due to other reason|2|||
143172737|NCT02536664|516181576|FG000|Overall Study|Intolerability|8|||
143172738|NCT02536664|516181577|FG001|Overall Study|Intolerability|6|||
143172739|NCT02536664|516181576|FG000|Overall Study|Withdrawal by Subject|8|||
143172740|NCT02536664|516181577|FG001|Overall Study|Withdrawal by Subject|5|||
143172741|NCT02536664|516181576|FG000|Overall Study|Other|18|||
143172742|NCT02536664|516181577|FG001|Overall Study|Other|24|||
143248924|NCT01904773|516465038|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
143248925|NCT01904773|516465039|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
143248926|NCT01904773|516465040|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
143248927|NCT01904773|516465041|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
143248928|NCT01904773|516465042|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
143248929|NCT01904773|516465043|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
143078119|NCT00673387|515824561|FG002|Overall Study|Adverse Event|5|||
143078120|NCT00673387|515824562|FG003|Overall Study|Adverse Event|2|||
143078121|NCT00673387|515824563|FG004|Overall Study|Adverse Event|6|||
143078122|NCT00673387|515824564|FG005|Overall Study|Adverse Event|2|||
143078123|NCT00673387|515824565|FG006|Overall Study|Adverse Event|5|||
143078124|NCT00673387|515824566|FG007|Overall Study|Adverse Event|5|||
143078125|NCT00673387|515824559|FG000|Overall Study|Physician Decision|0|||
143078126|NCT00673387|515824560|FG001|Overall Study|Physician Decision|0|||
143078127|NCT00673387|515824561|FG002|Overall Study|Physician Decision|0|||
143078128|NCT00673387|515824562|FG003|Overall Study|Physician Decision|0|||
143078129|NCT00673387|515824563|FG004|Overall Study|Physician Decision|0|||
143078130|NCT00673387|515824564|FG005|Overall Study|Physician Decision|5|||
143078131|NCT00673387|515824565|FG006|Overall Study|Physician Decision|1|||
143078132|NCT00673387|515824566|FG007|Overall Study|Physician Decision|1|||
143078133|NCT00673387|515824559|FG000|Overall Study|Protocol Violation|3|||
143078134|NCT00673387|515824560|FG001|Overall Study|Protocol Violation|0|||
143078135|NCT00673387|515824561|FG002|Overall Study|Protocol Violation|1|||
143078136|NCT00673387|515824562|FG003|Overall Study|Protocol Violation|2|||
143078137|NCT00673387|515824563|FG004|Overall Study|Protocol Violation|0|||
143078138|NCT00673387|515824564|FG005|Overall Study|Protocol Violation|1|||
143078139|NCT00673387|515824565|FG006|Overall Study|Protocol Violation|1|||
143078140|NCT00673387|515824566|FG007|Overall Study|Protocol Violation|3|||
143078141|NCT00673387|515824559|FG000|Overall Study|Lost to Follow-up|8|||
143078142|NCT00673387|515824560|FG001|Overall Study|Lost to Follow-up|6|||
143078143|NCT00673387|515824561|FG002|Overall Study|Lost to Follow-up|5|||
143078144|NCT00673387|515824562|FG003|Overall Study|Lost to Follow-up|6|||
143078145|NCT00673387|515824563|FG004|Overall Study|Lost to Follow-up|6|||
143078146|NCT00673387|515824564|FG005|Overall Study|Lost to Follow-up|5|||
143078147|NCT00673387|515824565|FG006|Overall Study|Lost to Follow-up|8|||
143078148|NCT00673387|515824566|FG007|Overall Study|Lost to Follow-up|5|||
143078149|NCT00478244|515826576|FG000|Overall Study|Did not receive transplant|1|||
143078150|NCT02245412|515826579|FG000|Treatment Period|Death|1|||
143078151|NCT02245412|515826580|FG001|Treatment Period|Death|1|||
143078152|NCT02245412|515826581|FG002|Treatment Period|Death|0|||
143078153|NCT02245412|515826579|FG000|Treatment Period|Physician Decision|1|||
143078154|NCT02245412|515826580|FG001|Treatment Period|Physician Decision|1|||
143078155|NCT02245412|515826581|FG002|Treatment Period|Physician Decision|0|||
143078156|NCT02245412|515826579|FG000|Treatment Period|Withdrawal by Subject|2|||
143078157|NCT02245412|515826580|FG001|Treatment Period|Withdrawal by Subject|1|||
143078158|NCT02245412|515826581|FG002|Treatment Period|Withdrawal by Subject|0|||
143078159|NCT02245412|515826579|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
143078160|NCT02245412|515826580|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
143078161|NCT02245412|515826581|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
143078162|NCT02245412|515826579|FG000|Follow-Up Period|Death|4|||
143078163|NCT02245412|515826580|FG001|Follow-Up Period|Death|2|||
143078164|NCT02245412|515826581|FG002|Follow-Up Period|Death|1|||
143078165|NCT02245412|515826579|FG000|Follow-Up Period|Physician Decision|1|||
143078166|NCT02245412|515826580|FG001|Follow-Up Period|Physician Decision|0|||
143078167|NCT02245412|515826581|FG002|Follow-Up Period|Physician Decision|0|||
143078168|NCT02245412|515826579|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
143078169|NCT02245412|515826580|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
143078170|NCT02245412|515826581|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
143078171|NCT01392963|515826582|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
143078172|NCT01392963|515826583|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
143078173|NCT01392963|515826582|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
143078174|NCT01392963|515826583|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
143078175|NCT01392963|515826582|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
143078176|NCT01392963|515826583|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
143078177|NCT00402116|515826584|FG000|Overall Study|Jaw infection after surgery-other|1|||
143078178|NCT00402116|515826585|FG001|Overall Study|Jaw infection after surgery-other|0|||
143078179|NCT00402116|515826586|FG002|Overall Study|Jaw infection after surgery-other|0|||
143078180|NCT00402116|515826584|FG000|Overall Study|Withdrawal by Subject|1|||
143078181|NCT00402116|515826585|FG001|Overall Study|Withdrawal by Subject|0|||
143078182|NCT00402116|515826586|FG002|Overall Study|Withdrawal by Subject|5|||
143078183|NCT00402116|515826584|FG000|Overall Study|Treatment completed per protocol|1|||
143078184|NCT00402116|515826585|FG001|Overall Study|Treatment completed per protocol|1|||
143078185|NCT00402116|515826586|FG002|Overall Study|Treatment completed per protocol|2|||
143078186|NCT00402116|515826584|FG000|Overall Study|other complicating disease|0|||
143078187|NCT00402116|515826585|FG001|Overall Study|other complicating disease|0|||
143078188|NCT00402116|515826586|FG002|Overall Study|other complicating disease|2|||
143078189|NCT00402116|515826584|FG000|Overall Study|Disease Progression|0|||
143078190|NCT00402116|515826585|FG001|Overall Study|Disease Progression|4|||
143078191|NCT00402116|515826586|FG002|Overall Study|Disease Progression|38|||
143078192|NCT00402116|515826584|FG000|Overall Study|mistaken thrombocytopenia|0|||
143078193|NCT00402116|515826585|FG001|Overall Study|mistaken thrombocytopenia|0|||
143078194|NCT00402116|515826586|FG002|Overall Study|mistaken thrombocytopenia|1|||
143078195|NCT00402116|515826584|FG000|Overall Study|decline related hyponatremia/tumor|0|||
143078196|NCT00402116|515826585|FG001|Overall Study|decline related hyponatremia/tumor|0|||
143078197|NCT00402116|515826586|FG002|Overall Study|decline related hyponatremia/tumor|1|||
143078198|NCT00402116|515826584|FG000|Overall Study|Adverse Event|0|||
143078199|NCT00402116|515826585|FG001|Overall Study|Adverse Event|1|||
143078200|NCT00402116|515826586|FG002|Overall Study|Adverse Event|6|||
143078201|NCT00270855|515826587|FG000|Overall Study|Withdrawal by Subject|8|||
143078202|NCT00270855|515826588|FG001|Overall Study|Withdrawal by Subject|8|||
143078203|NCT02899195|515826591|FG000|Concurrent Durvalumab|Adverse Event|4|||
143078204|NCT02899195|515826591|FG000|Concurrent Durvalumab|Physician Decision|1|||
143078205|NCT02899195|515826591|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
143078206|NCT02899195|515826591|FG000|Concurrent Durvalumab|Progressive Disease|5|||
143078207|NCT02899195|515826591|FG000|Maintenance Durvalumab|Adverse Event|1|||
143078208|NCT02899195|515826591|FG000|Maintenance Durvalumab|Physician Decision|1|||
143078209|NCT02899195|515826591|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
143078210|NCT02899195|515826591|FG000|Maintenance Durvalumab|Progressive Disease|31|||
143078211|NCT03156504|515826595|FG000|Overall Study|Withdrawal by Subject|1|||
143078212|NCT04778904|515826596|FG000|Overall Study|Protocol Violation|1|||
143078213|NCT04778904|515826597|FG001|Overall Study|Protocol Violation|0|||
143078214|NCT04778904|515826598|FG002|Overall Study|Protocol Violation|0|||
143078215|NCT04778904|515826599|FG003|Overall Study|Protocol Violation|0|||
143078216|NCT04778904|515826596|FG000|Overall Study|Withdrawal by Subject|0|||
143078217|NCT04778904|515826597|FG001|Overall Study|Withdrawal by Subject|0|||
143078218|NCT04778904|515826598|FG002|Overall Study|Withdrawal by Subject|1|||
143078219|NCT04778904|515826599|FG003|Overall Study|Withdrawal by Subject|0|||
143078220|NCT00450801|515826600|FG000|Overall Study|Death|1|||
143078221|NCT05048329|515826601|FG000|Overall Study|Withdrawal by Subject|1|||
143078222|NCT05048329|515826601|FG000|Overall Study|Screenfail|1|||
143078223|NCT04138043|515826602|FG000|Overall Study|Withdrawal by Subject|0|||
143078224|NCT04138043|515826603|FG001|Overall Study|Withdrawal by Subject|1|||
143078225|NCT00261443|515826604|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
143078226|NCT00261443|515826605|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
143078227|NCT00261443|515826606|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
143078228|NCT00261443|515826604|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
143078229|NCT00261443|515826605|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
143078230|NCT00261443|515826606|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
143078231|NCT00261443|515826604|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
143078232|NCT00261443|515826605|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
143078233|NCT00261443|515826606|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
143078234|NCT00261443|515826604|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
143078235|NCT00261443|515826605|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
143078236|NCT00261443|515826606|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
143078237|NCT00261443|515826604|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
143078238|NCT00261443|515826605|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
143078239|NCT00261443|515826606|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
143078240|NCT00261443|515826604|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
143078241|NCT00261443|515826605|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
143078242|NCT00261443|515826606|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
143078243|NCT00261443|515826604|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
143078244|NCT00261443|515826605|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
143078245|NCT00261443|515826606|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
143078246|NCT00261443|515826604|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
143078247|NCT00261443|515826605|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
143078248|NCT00261443|515826606|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
143078249|NCT00261443|515826604|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
143172743|NCT02536664|516181576|FG000|Overall Study|Missing|53|||
143172744|NCT02536664|516181577|FG001|Overall Study|Missing|20|||
143172745|NCT03507127|516181579|FG000|Overall Study|Withdrawal by Subject|1|||
143172746|NCT03507127|516181580|FG001|Overall Study|Withdrawal by Subject|0|||
143078250|NCT00261443|515826605|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
143078251|NCT00261443|515826606|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
143078252|NCT00261443|515826604|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
143078253|NCT00261443|515826605|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
143078254|NCT00261443|515826606|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
143078255|NCT00261443|515826604|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
143078256|NCT00261443|515826605|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
143078257|NCT00261443|515826606|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
143078258|NCT00261443|515826604|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
143078259|NCT00261443|515826605|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
143078260|NCT00261443|515826606|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
143078261|NCT00261443|515826604|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
143078262|NCT00261443|515826605|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
143078263|NCT00261443|515826606|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
143078264|NCT00261443|515826604|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
143078265|NCT00261443|515826605|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
143078266|NCT00261443|515826606|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
143078267|NCT00261443|515826604|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
143078268|NCT00261443|515826605|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
143078269|NCT00261443|515826606|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
143078270|NCT00261443|515826604|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
143078271|NCT00261443|515826605|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
143078272|NCT00261443|515826606|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
143078273|NCT00261443|515826604|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
143078274|NCT00261443|515826605|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
143078275|NCT00261443|515826606|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
143078276|NCT00261443|515826604|FG000|3: Assessment of Relapse|Adverse Event|0|||
143078277|NCT00261443|515826605|FG001|3: Assessment of Relapse|Adverse Event|15|||
143078278|NCT00261443|515826606|FG002|3: Assessment of Relapse|Adverse Event|19|||
143078279|NCT00261443|515826604|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
143078280|NCT00261443|515826605|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
143078281|NCT00261443|515826606|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
143078282|NCT00261443|515826604|FG000|3: Assessment of Relapse|Death|0|||
143078283|NCT00261443|515826605|FG001|3: Assessment of Relapse|Death|0|||
143078284|NCT00261443|515826606|FG002|3: Assessment of Relapse|Death|1|||
143078285|NCT00261443|515826604|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
143078286|NCT00261443|515826605|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
143078287|NCT00261443|515826606|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
143078288|NCT00261443|515826604|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
143078289|NCT00261443|515826605|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
143078290|NCT00261443|515826606|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
143078291|NCT00261443|515826604|FG000|3: Assessment of Relapse|Pregnancy|0|||
143078292|NCT00261443|515826605|FG001|3: Assessment of Relapse|Pregnancy|2|||
143078293|NCT00261443|515826606|FG002|3: Assessment of Relapse|Pregnancy|1|||
143078294|NCT00261443|515826604|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
143078295|NCT00261443|515826605|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
143078296|NCT00261443|515826606|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
143078297|NCT00261443|515826604|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
143078298|NCT00261443|515826605|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
143078299|NCT00261443|515826606|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
143078300|NCT00261443|515826604|FG000|3: Assessment of Relapse|Other Reasons|0|||
143078301|NCT00261443|515826605|FG001|3: Assessment of Relapse|Other Reasons|4|||
143078302|NCT00261443|515826606|FG002|3: Assessment of Relapse|Other Reasons|3|||
143078303|NCT00261443|515826604|FG000|4: Extension Phase|Adverse Event|0|||
143078304|NCT00261443|515826605|FG001|4: Extension Phase|Adverse Event|1|||
143078305|NCT00261443|515826606|FG002|4: Extension Phase|Adverse Event|0|||
143078306|NCT00261443|515826604|FG000|4: Extension Phase|Withdrawal by Subject|0|||
143078307|NCT00261443|515826605|FG001|4: Extension Phase|Withdrawal by Subject|1|||
143078308|NCT00261443|515826606|FG002|4: Extension Phase|Withdrawal by Subject|2|||
143078309|NCT00261443|515826604|FG000|4: Extension Phase|Lost to Follow-up|0|||
143078310|NCT00261443|515826605|FG001|4: Extension Phase|Lost to Follow-up|1|||
143078311|NCT00261443|515826606|FG002|4: Extension Phase|Lost to Follow-up|0|||
143078312|NCT02755649|515826607|FG000|Overall Study|Transitioned into OLE study|99|||
143078313|NCT02755649|515826608|FG001|Overall Study|Transitioned into OLE study|98|||
143078314|NCT02755649|515826609|FG002|Overall Study|Transitioned into OLE study|100|||
143078315|NCT02755649|515826607|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
143078316|NCT02755649|515826608|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
143078317|NCT02755649|515826609|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
143078318|NCT02755649|515826607|FG000|Overall Study|Physician Decision|0|||
143078319|NCT02755649|515826608|FG001|Overall Study|Physician Decision|0|||
143078320|NCT02755649|515826609|FG002|Overall Study|Physician Decision|2|||
143078321|NCT02755649|515826607|FG000|Overall Study|Withdrawal by Subject|0|||
143078322|NCT02755649|515826608|FG001|Overall Study|Withdrawal by Subject|1|||
143078323|NCT02755649|515826609|FG002|Overall Study|Withdrawal by Subject|0|||
143078324|NCT02755649|515826607|FG000|Overall Study|Undecided|1|||
143078325|NCT02755649|515826608|FG001|Overall Study|Undecided|0|||
143078326|NCT02755649|515826609|FG002|Overall Study|Undecided|0|||
143078327|NCT01286753|515826610|FG000|Overall Study|Adverse Event|7|||
143078328|NCT01286753|515826611|FG001|Overall Study|Adverse Event|6|||
143078329|NCT01286753|515826610|FG000|Overall Study|Progression|11|||
143078330|NCT01286753|515826611|FG001|Overall Study|Progression|13|||
143078331|NCT01286753|515826610|FG000|Overall Study|Refused Treatment|1|||
143078332|NCT01286753|515826611|FG001|Overall Study|Refused Treatment|0|||
143078333|NCT01286753|515826610|FG000|Overall Study|Withdrawal of Consent|0|||
143078334|NCT01286753|515826611|FG001|Overall Study|Withdrawal of Consent|2|||
143078335|NCT01286753|515826610|FG000|Overall Study|Discontinued to Join Extension Study|6|||
143078336|NCT01286753|515826611|FG001|Overall Study|Discontinued to Join Extension Study|4|||
143078337|NCT01286753|515826610|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
143078338|NCT01286753|515826611|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
143078339|NCT00580788|515826615|FG000|Overall Study|Adverse Event|0|||
143078340|NCT00580788|515826616|FG001|Overall Study|Adverse Event|0|||
143078341|NCT00580788|515826617|FG002|Overall Study|Adverse Event|0|||
143078342|NCT00580788|515826618|FG003|Overall Study|Adverse Event|1|||
143078343|NCT03301649|515826621|FG000|Overall Study|Need alternate therapy due to live lice|17|||
143078344|NCT03301649|515826622|FG001|Overall Study|Need alternate therapy due to live lice|25|||
143078345|NCT03301649|515826623|FG002|Overall Study|Need alternate therapy due to live lice|81|||
143078346|NCT03301649|515826621|FG000|Overall Study|Lost to Follow-up|11|||
143078347|NCT03301649|515826622|FG001|Overall Study|Lost to Follow-up|11|||
143078348|NCT03301649|515826623|FG002|Overall Study|Lost to Follow-up|3|||
143078349|NCT03301649|515826621|FG000|Overall Study|Protocol Violation|0|||
143078350|NCT03301649|515826622|FG001|Overall Study|Protocol Violation|1|||
143078351|NCT03301649|515826623|FG002|Overall Study|Protocol Violation|1|||
143078352|NCT03301649|515826621|FG000|Overall Study|Withdrawal by Subject|10|||
143078353|NCT03301649|515826622|FG001|Overall Study|Withdrawal by Subject|4|||
143078354|NCT03301649|515826623|FG002|Overall Study|Withdrawal by Subject|0|||
143078355|NCT03301649|515826621|FG000|Overall Study|Other than specified|5|||
143078356|NCT03301649|515826622|FG001|Overall Study|Other than specified|3|||
143078357|NCT03301649|515826623|FG002|Overall Study|Other than specified|0|||
143078358|NCT01403051|515826624|FG000|Overall Study|Protocol Violation|2|||
143078359|NCT01403051|515826625|FG001|Overall Study|Protocol Violation|0|||
143078360|NCT01403051|515826624|FG000|Overall Study|Death|1|||
143078361|NCT01403051|515826625|FG001|Overall Study|Death|0|||
143078362|NCT01403051|515826624|FG000|Overall Study|Withdrawal by Subject|2|||
143078363|NCT01403051|515826625|FG001|Overall Study|Withdrawal by Subject|1|||
143078364|NCT01403051|515826624|FG000|Overall Study|Lost to Follow-up|5|||
143078365|NCT01403051|515826625|FG001|Overall Study|Lost to Follow-up|5|||
143078366|NCT02045147|515826626|FG000|Overall Study|Withdrawal by Subject|2|||
143078367|NCT02045147|515826627|FG001|Overall Study|Withdrawal by Subject|0|||
143172747|NCT03507127|516181579|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
143172748|NCT03507127|516181580|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
143172749|NCT01240863|516181581|FG000|Open-label Titration Period|Adverse Event|47|||
143172750|NCT01240863|516181582|FG001|Open-label Titration Period|Adverse Event|0|||
143172751|NCT01240863|516181583|FG002|Open-label Titration Period|Adverse Event|0|||
143172752|NCT01240863|516181581|FG000|Open-label Titration Period|Lack of Efficacy|19|||
143172753|NCT01240863|516181582|FG001|Open-label Titration Period|Lack of Efficacy|0|||
143172754|NCT01240863|516181583|FG002|Open-label Titration Period|Lack of Efficacy|0|||
143172755|NCT01240863|516181581|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
143078368|NCT02045147|515826628|FG002|Overall Study|Withdrawal by Subject|0|||
143172756|NCT01240863|516181582|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
143078369|NCT02045147|515826629|FG003|Overall Study|Withdrawal by Subject|0|||
143078370|NCT02045147|515826630|FG004|Overall Study|Withdrawal by Subject|0|||
143172757|NCT01240863|516181583|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
143078371|NCT02045147|515826631|FG005|Overall Study|Withdrawal by Subject|0|||
143078372|NCT02045147|515826632|FG006|Overall Study|Withdrawal by Subject|0|||
143078373|NCT02045147|515826633|FG007|Overall Study|Withdrawal by Subject|1|||
143078374|NCT02045147|515826626|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
143078375|NCT02045147|515826627|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
143078376|NCT02045147|515826628|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
143078377|NCT02045147|515826629|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
143078378|NCT02045147|515826630|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
143078379|NCT02045147|515826631|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
143078380|NCT02045147|515826632|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
143078381|NCT02045147|515826633|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
143078382|NCT00049530|515826634|FG000|Overall Study|Lack of Efficacy|25|||
143078383|NCT00049530|515826634|FG000|Overall Study|Adverse Event|2|||
143078384|NCT00049530|515826634|FG000|Overall Study|Death|1|||
143078385|NCT00049530|515826634|FG000|Overall Study|symptomatic deterioration|1|||
143078386|NCT00049530|515826634|FG000|Overall Study|ineligible|3|||
143078387|NCT02383810|515826635|FG000|Overall Study|Physician Decision|1|||
143078388|NCT02383810|515826636|FG001|Overall Study|Physician Decision|1|||
143078389|NCT02383810|515826637|FG002|Overall Study|Physician Decision|0|||
143078390|NCT02383810|515826638|FG003|Overall Study|Physician Decision|0|||
143078391|NCT02383810|515826639|FG004|Overall Study|Physician Decision|0|||
143078392|NCT02383810|515826640|FG005|Overall Study|Physician Decision|0|||
143078393|NCT02383810|515826641|FG006|Overall Study|Physician Decision|0|||
143078394|NCT02383810|515826642|FG007|Overall Study|Physician Decision|0|||
143078395|NCT02383810|515826635|FG000|Overall Study|Withdrawal by Subject|2|||
143078396|NCT02383810|515826636|FG001|Overall Study|Withdrawal by Subject|3|||
143078397|NCT02383810|515826637|FG002|Overall Study|Withdrawal by Subject|3|||
143078398|NCT02383810|515826638|FG003|Overall Study|Withdrawal by Subject|3|||
143078399|NCT02383810|515826639|FG004|Overall Study|Withdrawal by Subject|0|||
143078400|NCT02383810|515826640|FG005|Overall Study|Withdrawal by Subject|0|||
143078401|NCT02383810|515826641|FG006|Overall Study|Withdrawal by Subject|0|||
143078402|NCT02383810|515826642|FG007|Overall Study|Withdrawal by Subject|0|||
143078403|NCT02383810|515826635|FG000|Overall Study|Adverse Event|0|||
143078404|NCT02383810|515826636|FG001|Overall Study|Adverse Event|2|||
143078405|NCT02383810|515826637|FG002|Overall Study|Adverse Event|4|||
143078406|NCT02383810|515826638|FG003|Overall Study|Adverse Event|5|||
143078407|NCT02383810|515826639|FG004|Overall Study|Adverse Event|0|||
143078408|NCT02383810|515826640|FG005|Overall Study|Adverse Event|1|||
143078409|NCT02383810|515826641|FG006|Overall Study|Adverse Event|1|||
143078410|NCT02383810|515826642|FG007|Overall Study|Adverse Event|0|||
143078411|NCT02383810|515826635|FG000|Overall Study|Lost to Follow-up|0|||
143078412|NCT02383810|515826636|FG001|Overall Study|Lost to Follow-up|1|||
143078413|NCT02383810|515826637|FG002|Overall Study|Lost to Follow-up|0|||
143078414|NCT02383810|515826638|FG003|Overall Study|Lost to Follow-up|1|||
143078415|NCT02383810|515826639|FG004|Overall Study|Lost to Follow-up|0|||
143078416|NCT02383810|515826640|FG005|Overall Study|Lost to Follow-up|0|||
143078417|NCT02383810|515826641|FG006|Overall Study|Lost to Follow-up|0|||
143078418|NCT02383810|515826642|FG007|Overall Study|Lost to Follow-up|0|||
143078419|NCT02383810|515826635|FG000|Overall Study|other|0|||
143078420|NCT02383810|515826636|FG001|Overall Study|other|0|||
143078421|NCT02383810|515826637|FG002|Overall Study|other|0|||
143078422|NCT02383810|515826638|FG003|Overall Study|other|2|||
143078423|NCT02383810|515826639|FG004|Overall Study|other|0|||
143078424|NCT02383810|515826640|FG005|Overall Study|other|0|||
143078425|NCT02383810|515826641|FG006|Overall Study|other|0|||
143078426|NCT02383810|515826642|FG007|Overall Study|other|0|||
143078427|NCT02383810|515826635|FG000|Overall Study|subject did not receive study treatment|0|||
143078428|NCT02383810|515826636|FG001|Overall Study|subject did not receive study treatment|1|||
143078429|NCT02383810|515826637|FG002|Overall Study|subject did not receive study treatment|0|||
143078430|NCT02383810|515826638|FG003|Overall Study|subject did not receive study treatment|0|||
143078431|NCT02383810|515826639|FG004|Overall Study|subject did not receive study treatment|0|||
143078432|NCT02383810|515826640|FG005|Overall Study|subject did not receive study treatment|0|||
143078433|NCT02383810|515826641|FG006|Overall Study|subject did not receive study treatment|0|||
143078434|NCT02383810|515826642|FG007|Overall Study|subject did not receive study treatment|0|||
143078435|NCT01590797|515826646|FG000|Overall Study|Adverse Event|4|||
143078436|NCT01590797|515826647|FG001|Overall Study|Adverse Event|3|||
143078437|NCT01590797|515826646|FG000|Overall Study|Lack of Efficacy|0|||
143078438|NCT01590797|515826647|FG001|Overall Study|Lack of Efficacy|2|||
143078439|NCT01590797|515826646|FG000|Overall Study|Lost to Follow-up|0|||
143078440|NCT01590797|515826647|FG001|Overall Study|Lost to Follow-up|1|||
143078441|NCT01590797|515826646|FG000|Overall Study|Protocol Violation|4|||
143078442|NCT01590797|515826647|FG001|Overall Study|Protocol Violation|1|||
143078443|NCT01590797|515826646|FG000|Overall Study|Withdrawal by Subject|7|||
143078444|NCT01590797|515826647|FG001|Overall Study|Withdrawal by Subject|5|||
143078445|NCT01590797|515826646|FG000|Overall Study|Other Protocol Specified Criteria|2|||
143078446|NCT01590797|515826647|FG001|Overall Study|Other Protocol Specified Criteria|4|||
143078447|NCT00195338|515826650|FG000|Overall Study|Lost to Follow-up|2|||
143078448|NCT00195338|515826650|FG000|Overall Study|Adverse Event|5|||
143078449|NCT00195338|515826650|FG000|Overall Study|Lack of Efficacy|1|||
143078450|NCT00195338|515826650|FG000|Overall Study|Early closure of the site|4|||
143078451|NCT01085357|515826651|FG000|Overall Study|Adverse Event|1|||
143078452|NCT01085357|515826652|FG001|Overall Study|Adverse Event|1|||
143078453|NCT01085357|515826651|FG000|Overall Study|Subject Decision|4|||
143078454|NCT01085357|515826652|FG001|Overall Study|Subject Decision|3|||
143078455|NCT01085357|515826651|FG000|Overall Study|Investigator Decision|1|||
143078456|NCT01085357|515826652|FG001|Overall Study|Investigator Decision|1|||
143078457|NCT01085357|515826651|FG000|Overall Study|Death|11|||
143078458|NCT01085357|515826652|FG001|Overall Study|Death|1|||
143078459|NCT01085357|515826651|FG000|Overall Study|Lost to Follow-up|2|||
143078460|NCT01085357|515826652|FG001|Overall Study|Lost to Follow-up|0|||
143172758|NCT01240863|516181581|FG000|Open-label Titration Period|Protocol Violation|7|||
143172759|NCT01240863|516181582|FG001|Open-label Titration Period|Protocol Violation|0|||
143172760|NCT01240863|516181583|FG002|Open-label Titration Period|Protocol Violation|0|||
143172761|NCT01240863|516181581|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
143172762|NCT01240863|516181582|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
143172763|NCT01240863|516181583|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
143172764|NCT01240863|516181581|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
143078461|NCT00920790|515826655|FG000|Overall Study|aggravation of general condition|14|||
143078462|NCT01661062|515826656|FG000|Overall Study|Completed Treatment Off Study|3|||
143078463|NCT01661062|515826656|FG000|Overall Study|Withdrawal by Subject|2|||
143078464|NCT01189487|515826661|FG000|Overall Study|Lack of Efficacy|2|||
143078465|NCT01189487|515826661|FG000|Overall Study|Adverse Event|1|||
143078466|NCT04630158|515826662|FG000|Overall Study|Adverse Event|1|||
143078467|NCT04630158|515826663|FG001|Overall Study|Adverse Event|1|||
143078468|NCT04630158|515826664|FG002|Overall Study|Adverse Event|1|||
143078469|NCT04630158|515826662|FG000|Overall Study|Physician Decision|0|||
143078470|NCT04630158|515826663|FG001|Overall Study|Physician Decision|2|||
143078471|NCT04630158|515826664|FG002|Overall Study|Physician Decision|0|||
143078472|NCT04630158|515826662|FG000|Overall Study|Protocol Violation|1|||
143078473|NCT04630158|515826663|FG001|Overall Study|Protocol Violation|0|||
143078474|NCT04630158|515826664|FG002|Overall Study|Protocol Violation|1|||
143078475|NCT04630158|515826662|FG000|Overall Study|Withdrawal by Subject|2|||
143078476|NCT04630158|515826663|FG001|Overall Study|Withdrawal by Subject|1|||
143078477|NCT04630158|515826664|FG002|Overall Study|Withdrawal by Subject|2|||
143078478|NCT05293639|515826665|FG000|Overall Study|Withdrawal by Subject|1|||
143078479|NCT05293639|515826666|FG001|Overall Study|Withdrawal by Subject|1|||
143078480|NCT05293639|515826667|FG002|Overall Study|Withdrawal by Subject|2|||
143078481|NCT05293639|515826665|FG000|Overall Study|Death|0|||
143078482|NCT05293639|515826666|FG001|Overall Study|Death|1|||
143078483|NCT05293639|515826667|FG002|Overall Study|Death|0|||
143172765|NCT01240863|516181582|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
143172766|NCT01240863|516181583|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
143172767|NCT01240863|516181581|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
143172768|NCT01240863|516181582|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
143172769|NCT01240863|516181583|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
143172770|NCT01240863|516181581|FG000|Open-label Titration Period|Other|7|||
143078484|NCT05293639|515826665|FG000|Overall Study|Lost to Follow-up|0|||
143078485|NCT05293639|515826666|FG001|Overall Study|Lost to Follow-up|0|||
143172771|NCT01240863|516181582|FG001|Open-label Titration Period|Other|0|||
143172772|NCT01240863|516181583|FG002|Open-label Titration Period|Other|0|||
143078486|NCT05293639|515826667|FG002|Overall Study|Lost to Follow-up|5|||
143078487|NCT05293639|515826665|FG000|Overall Study|Other|0|||
143078488|NCT05293639|515826666|FG001|Overall Study|Other|0|||
143078489|NCT05293639|515826667|FG002|Overall Study|Other|1|||
143078490|NCT01860677|515826673|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
143078491|NCT01860677|515826674|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
143078492|NCT00642278|515826675|FG000|Overall Study|Adverse Event|2|||
143078493|NCT00642278|515826676|FG001|Overall Study|Adverse Event|1|||
143078494|NCT00642278|515826677|FG002|Overall Study|Adverse Event|3|||
143078495|NCT00642278|515826678|FG003|Overall Study|Adverse Event|1|||
143078496|NCT00642278|515826679|FG004|Overall Study|Adverse Event|2|||
143078497|NCT00642278|515826680|FG005|Overall Study|Adverse Event|2|||
143078498|NCT00642278|515826681|FG006|Overall Study|Adverse Event|0|||
143078499|NCT00642278|515826675|FG000|Overall Study|Lack of Efficacy|0|||
143078500|NCT00642278|515826676|FG001|Overall Study|Lack of Efficacy|1|||
143078501|NCT00642278|515826677|FG002|Overall Study|Lack of Efficacy|0|||
143078502|NCT00642278|515826678|FG003|Overall Study|Lack of Efficacy|0|||
143078503|NCT00642278|515826679|FG004|Overall Study|Lack of Efficacy|0|||
143078504|NCT00642278|515826680|FG005|Overall Study|Lack of Efficacy|0|||
143078505|NCT00642278|515826681|FG006|Overall Study|Lack of Efficacy|0|||
143078506|NCT00642278|515826675|FG000|Overall Study|Lost to Follow-up|5|||
143078507|NCT00642278|515826676|FG001|Overall Study|Lost to Follow-up|1|||
143172773|NCT01240863|516181581|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
143078508|NCT00642278|515826677|FG002|Overall Study|Lost to Follow-up|0|||
143078509|NCT00642278|515826678|FG003|Overall Study|Lost to Follow-up|1|||
143078510|NCT00642278|515826679|FG004|Overall Study|Lost to Follow-up|0|||
143078511|NCT00642278|515826680|FG005|Overall Study|Lost to Follow-up|1|||
143078512|NCT00642278|515826681|FG006|Overall Study|Lost to Follow-up|1|||
143078513|NCT00642278|515826675|FG000|Overall Study|Physician Decision|0|||
143078514|NCT00642278|515826676|FG001|Overall Study|Physician Decision|0|||
143078515|NCT00642278|515826677|FG002|Overall Study|Physician Decision|0|||
143078516|NCT00642278|515826678|FG003|Overall Study|Physician Decision|1|||
143078517|NCT00642278|515826679|FG004|Overall Study|Physician Decision|0|||
143078518|NCT00642278|515826680|FG005|Overall Study|Physician Decision|0|||
143078519|NCT00642278|515826681|FG006|Overall Study|Physician Decision|0|||
143078520|NCT00642278|515826675|FG000|Overall Study|Protocol Violation|0|||
143078521|NCT00642278|515826676|FG001|Overall Study|Protocol Violation|0|||
143078522|NCT00642278|515826677|FG002|Overall Study|Protocol Violation|1|||
143078523|NCT00642278|515826678|FG003|Overall Study|Protocol Violation|1|||
143078524|NCT00642278|515826679|FG004|Overall Study|Protocol Violation|0|||
143078525|NCT00642278|515826680|FG005|Overall Study|Protocol Violation|1|||
143078526|NCT00642278|515826681|FG006|Overall Study|Protocol Violation|2|||
143078527|NCT00642278|515826675|FG000|Overall Study|Withdrawal by Subject|1|||
143078528|NCT00642278|515826676|FG001|Overall Study|Withdrawal by Subject|1|||
143078529|NCT00642278|515826677|FG002|Overall Study|Withdrawal by Subject|1|||
143078530|NCT00642278|515826678|FG003|Overall Study|Withdrawal by Subject|3|||
143078531|NCT00642278|515826679|FG004|Overall Study|Withdrawal by Subject|6|||
143078532|NCT00642278|515826680|FG005|Overall Study|Withdrawal by Subject|2|||
143078533|NCT00642278|515826681|FG006|Overall Study|Withdrawal by Subject|2|||
143078534|NCT00642278|515826675|FG000|Overall Study|Noncompliance with study drug regimen|0|||
143078535|NCT00642278|515826676|FG001|Overall Study|Noncompliance with study drug regimen|0|||
143078536|NCT00642278|515826677|FG002|Overall Study|Noncompliance with study drug regimen|0|||
143078537|NCT00642278|515826678|FG003|Overall Study|Noncompliance with study drug regimen|1|||
143078538|NCT00642278|515826679|FG004|Overall Study|Noncompliance with study drug regimen|0|||
143078539|NCT00642278|515826680|FG005|Overall Study|Noncompliance with study drug regimen|0|||
143078540|NCT00642278|515826681|FG006|Overall Study|Noncompliance with study drug regimen|0|||
143078541|NCT00642278|515826675|FG000|Overall Study|Other|2|||
143078542|NCT00642278|515826676|FG001|Overall Study|Other|1|||
143078543|NCT00642278|515826677|FG002|Overall Study|Other|0|||
143078544|NCT00642278|515826678|FG003|Overall Study|Other|1|||
143078545|NCT00642278|515826679|FG004|Overall Study|Other|0|||
143078546|NCT00642278|515826680|FG005|Overall Study|Other|1|||
143078547|NCT00642278|515826681|FG006|Overall Study|Other|0|||
143078548|NCT03713619|515826682|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
143078549|NCT03713619|515826683|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
143078550|NCT03713619|515826684|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
143078551|NCT03713619|515826685|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
143078552|NCT03713619|515826686|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
143078553|NCT03713619|515826682|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
143078554|NCT03713619|515826683|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
143078555|NCT03713619|515826684|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
143078556|NCT03713619|515826685|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
143078557|NCT03713619|515826686|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
143078558|NCT03713619|515826682|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
143078559|NCT03713619|515826683|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
143078560|NCT03713619|515826684|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
143078561|NCT03713619|515826685|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
143078562|NCT03713619|515826686|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
143078563|NCT03713619|515826682|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
143078564|NCT03713619|515826683|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
143078565|NCT03713619|515826684|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
143078566|NCT03713619|515826685|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
143078567|NCT03713619|515826686|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
143078568|NCT03713619|515826682|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
143078569|NCT03713619|515826683|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
143078570|NCT03713619|515826684|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
143078571|NCT03713619|515826685|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
143078572|NCT03713619|515826686|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
143078573|NCT03713619|515826682|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
143078574|NCT03713619|515826683|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
143078575|NCT03713619|515826684|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
143078576|NCT03713619|515826685|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
143078577|NCT03713619|515826686|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
143078578|NCT03713619|515826682|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
143078579|NCT03713619|515826683|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
143078580|NCT03713619|515826684|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
143078581|NCT03713619|515826685|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
143078582|NCT03713619|515826686|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
143172774|NCT01240863|516181582|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
143172775|NCT01240863|516181583|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
143172776|NCT01240863|516181581|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
143172777|NCT01240863|516181582|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
143172778|NCT01240863|516181583|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
143172779|NCT01240863|516181581|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
143078583|NCT03713619|515826682|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
143078584|NCT03713619|515826683|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
143078585|NCT03713619|515826684|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
143078586|NCT03713619|515826685|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
143078587|NCT03713619|515826686|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
143078588|NCT03713619|515826682|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
143078589|NCT03713619|515826683|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
143078590|NCT03713619|515826684|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
143078591|NCT03713619|515826685|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
143078592|NCT03713619|515826686|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
143078593|NCT03713619|515826682|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
143172780|NCT01240863|516181582|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
143172781|NCT01240863|516181583|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
143172782|NCT01240863|516181581|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
143172783|NCT01240863|516181582|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
143172784|NCT01240863|516181583|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
143172785|NCT01240863|516181581|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
143172786|NCT01240863|516181582|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
143172787|NCT01240863|516181583|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
143172788|NCT01240863|516181581|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
143172789|NCT01240863|516181582|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
143172790|NCT01240863|516181583|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
143172791|NCT01240863|516181581|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
143172792|NCT01240863|516181582|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
143172793|NCT01240863|516181583|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
143078594|NCT03713619|515826683|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
143078595|NCT03713619|515826684|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
143078596|NCT03713619|515826685|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
143078597|NCT03713619|515826686|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
143078598|NCT03713619|515826682|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
143078599|NCT03713619|515826683|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
143078600|NCT03713619|515826684|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
143078601|NCT03713619|515826685|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
143078602|NCT03713619|515826686|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
143078603|NCT03713619|515826682|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
143078604|NCT03713619|515826683|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
143078605|NCT03713619|515826684|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
143078606|NCT03713619|515826685|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
143078607|NCT03713619|515826686|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
143078608|NCT03713619|515826682|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
143078609|NCT03713619|515826683|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
143078610|NCT03713619|515826684|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
143078611|NCT03713619|515826685|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
143078612|NCT03713619|515826686|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
143078613|NCT03185013|515826687|FG000|Overall Study|Withdrawal by Subject|5|||
143078614|NCT03185013|515826688|FG001|Overall Study|Withdrawal by Subject|3|||
143078615|NCT03185013|515826687|FG000|Overall Study|Adverse Event|1|||
143078616|NCT03185013|515826688|FG001|Overall Study|Adverse Event|0|||
143078617|NCT03185013|515826687|FG000|Overall Study|Progressive Disease|1|||
143172794|NCT01240863|516181581|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
143172795|NCT01240863|516181582|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
143078618|NCT03185013|515826688|FG001|Overall Study|Progressive Disease|0|||
143078619|NCT03185013|515826687|FG000|Overall Study|Lost to Follow-up|8|||
143078620|NCT03185013|515826688|FG001|Overall Study|Lost to Follow-up|2|||
143078621|NCT03185013|515826687|FG000|Overall Study|Physician Decision|1|||
143078622|NCT03185013|515826688|FG001|Overall Study|Physician Decision|0|||
143078623|NCT03185013|515826687|FG000|Overall Study|Protocol Deviation|2|||
143078624|NCT03185013|515826688|FG001|Overall Study|Protocol Deviation|0|||
143078625|NCT03185013|515826687|FG000|Overall Study|Reason not Specified|3|||
143078626|NCT03185013|515826688|FG001|Overall Study|Reason not Specified|2|||
143078627|NCT03185013|515826687|FG000|Overall Study|Death|1|||
143078628|NCT03185013|515826688|FG001|Overall Study|Death|0|||
143078629|NCT00197496|515826693|FG000|Baseline to Discharge|not interested|1|||
143078630|NCT00197496|515826694|FG001|Baseline to Discharge|not interested|0|||
143078631|NCT00197496|515826693|FG000|Baseline to Discharge|MRSA|1|||
143078632|NCT00197496|515826694|FG001|Baseline to Discharge|MRSA|0|||
143078633|NCT00197496|515826693|FG000|Baseline to Discharge|Physician Decision|0|||
143078634|NCT00197496|515826694|FG001|Baseline to Discharge|Physician Decision|1|||
143078635|NCT00197496|515826693|FG000|Baseline to Discharge|Protocol Violation|0|||
143078636|NCT00197496|515826694|FG001|Baseline to Discharge|Protocol Violation|1|||
143078637|NCT00197496|515826693|FG000|Follow-up|Lost to Follow-up|2|||
143078638|NCT00197496|515826694|FG001|Follow-up|Lost to Follow-up|1|||
143172796|NCT01240863|516181583|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
143172797|NCT03961308|516181588|FG000|Overall Study|Withdrawal by Subject|1|||
143172798|NCT03961308|516181589|FG001|Overall Study|Withdrawal by Subject|0|||
143172799|NCT03961308|516181588|FG000|Overall Study|Other|1|||
143172800|NCT03961308|516181589|FG001|Overall Study|Other|0|||
143172801|NCT03961308|516181588|FG000|Overall Study|Lost to Follow-up|0|||
143172802|NCT03961308|516181589|FG001|Overall Study|Lost to Follow-up|1|||
143172803|NCT03961308|516181588|FG000|Overall Study|Adverse Event|0|||
143172804|NCT03961308|516181589|FG001|Overall Study|Adverse Event|1|||
143172805|NCT00746811|516181592|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
143172806|NCT00746811|516181593|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
143172807|NCT00659425|516181597|FG000|Overall Study|Disease progression|1|||
143172808|NCT00659425|516181598|FG001|Overall Study|Disease progression|0|||
143172809|NCT00659425|516181599|FG002|Overall Study|Disease progression|0|||
143172810|NCT00659425|516181600|FG003|Overall Study|Disease progression|1|||
143172811|NCT00659425|516181601|FG004|Overall Study|Disease progression|0|||
143172812|NCT00659425|516181602|FG005|Overall Study|Disease progression|2|||
143172813|NCT00659425|516181603|FG006|Overall Study|Disease progression|4|||
143172814|NCT00659425|516181604|FG007|Overall Study|Disease progression|3|||
143172815|NCT00659425|516181605|FG008|Overall Study|Disease progression|5|||
143172816|NCT00659425|516181606|FG009|Overall Study|Disease progression|3|||
143172817|NCT00659425|516181597|FG000|Overall Study|Death|0|||
143172818|NCT00659425|516181598|FG001|Overall Study|Death|0|||
143172819|NCT00659425|516181599|FG002|Overall Study|Death|0|||
143172820|NCT00659425|516181600|FG003|Overall Study|Death|1|||
143172821|NCT00659425|516181601|FG004|Overall Study|Death|0|||
143172822|NCT00659425|516181602|FG005|Overall Study|Death|0|||
143172823|NCT00659425|516181603|FG006|Overall Study|Death|1|||
143172824|NCT00659425|516181604|FG007|Overall Study|Death|0|||
143172825|NCT00659425|516181605|FG008|Overall Study|Death|0|||
143172826|NCT00659425|516181606|FG009|Overall Study|Death|0|||
143172827|NCT00659425|516181597|FG000|Overall Study|Adverse Event|0|||
143172828|NCT00659425|516181598|FG001|Overall Study|Adverse Event|0|||
143172829|NCT00659425|516181599|FG002|Overall Study|Adverse Event|0|||
143172830|NCT00659425|516181600|FG003|Overall Study|Adverse Event|0|||
143172831|NCT00659425|516181601|FG004|Overall Study|Adverse Event|0|||
143172832|NCT00659425|516181602|FG005|Overall Study|Adverse Event|1|||
143172833|NCT00659425|516181603|FG006|Overall Study|Adverse Event|0|||
143172834|NCT00659425|516181604|FG007|Overall Study|Adverse Event|3|||
143172835|NCT00659425|516181605|FG008|Overall Study|Adverse Event|1|||
143172836|NCT00659425|516181606|FG009|Overall Study|Adverse Event|4|||
143172837|NCT00659425|516181597|FG000|Overall Study|Investigator Discretion|0|||
143172838|NCT00659425|516181598|FG001|Overall Study|Investigator Discretion|0|||
143078639|NCT00857584|515826697|FG000|Overall Study|Lack of Efficacy|1|||
143078640|NCT00857584|515826698|FG001|Overall Study|Lack of Efficacy|2|||
143078641|NCT00857584|515826697|FG000|Overall Study|Adverse Event|2|||
143172839|NCT00659425|516181599|FG002|Overall Study|Investigator Discretion|0|||
143172840|NCT00659425|516181600|FG003|Overall Study|Investigator Discretion|0|||
143172841|NCT00659425|516181601|FG004|Overall Study|Investigator Discretion|0|||
143078642|NCT00857584|515826698|FG001|Overall Study|Adverse Event|2|||
143172842|NCT00659425|516181602|FG005|Overall Study|Investigator Discretion|1|||
143078643|NCT00857584|515826697|FG000|Overall Study|Physician Decision|1|||
143078644|NCT00857584|515826698|FG001|Overall Study|Physician Decision|1|||
143078645|NCT00418821|515826699|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
143078646|NCT04619992|515826700|FG000|Overall Study|Withdrawal by Subject|1|||
143078647|NCT04619992|515826701|FG001|Overall Study|Withdrawal by Subject|0|||
143078648|NCT02056392|515826702|FG000|Overall Study|Lost to Follow-up|0|||
143078649|NCT02056392|515826703|FG001|Overall Study|Lost to Follow-up|1|||
143078650|NCT02056392|515826704|FG002|Overall Study|Lost to Follow-up|2|||
143078651|NCT02056392|515826705|FG003|Overall Study|Lost to Follow-up|0|||
143078652|NCT02056392|515826706|FG004|Overall Study|Lost to Follow-up|0|||
143078653|NCT02056392|515826707|FG005|Overall Study|Lost to Follow-up|0|||
143078654|NCT02056392|515826702|FG000|Overall Study|Protocol Violation|1|||
143078655|NCT02056392|515826703|FG001|Overall Study|Protocol Violation|0|||
143078656|NCT02056392|515826704|FG002|Overall Study|Protocol Violation|1|||
143078657|NCT02056392|515826705|FG003|Overall Study|Protocol Violation|0|||
143078658|NCT02056392|515826706|FG004|Overall Study|Protocol Violation|0|||
143078659|NCT02056392|515826707|FG005|Overall Study|Protocol Violation|0|||
143078660|NCT02056392|515826702|FG000|Overall Study|Withdrawal by Subject|1|||
143078661|NCT02056392|515826703|FG001|Overall Study|Withdrawal by Subject|0|||
143078662|NCT02056392|515826704|FG002|Overall Study|Withdrawal by Subject|0|||
143078663|NCT02056392|515826705|FG003|Overall Study|Withdrawal by Subject|0|||
143078664|NCT02056392|515826706|FG004|Overall Study|Withdrawal by Subject|1|||
143078665|NCT02056392|515826707|FG005|Overall Study|Withdrawal by Subject|0|||
143078666|NCT01806506|515826708|FG000|Overall Study|Lost to Follow-up|2|||
143078667|NCT01806506|515826709|FG001|Overall Study|Lost to Follow-up|1|||
143078668|NCT02092467|515826710|FG000|Overall Study|Death|49|||
143078669|NCT02092467|515826711|FG001|Overall Study|Death|66|||
143078670|NCT02092467|515826712|FG002|Overall Study|Death|38|||
143078671|NCT02092467|515826710|FG000|Overall Study|Lost to Follow-up|38|||
143078672|NCT02092467|515826711|FG001|Overall Study|Lost to Follow-up|35|||
143078673|NCT02092467|515826712|FG002|Overall Study|Lost to Follow-up|40|||
143078674|NCT02092467|515826710|FG000|Overall Study|Global Deterioration of Health Status|1|||
143078675|NCT02092467|515826711|FG001|Overall Study|Global Deterioration of Health Status|0|||
143078676|NCT02092467|515826712|FG002|Overall Study|Global Deterioration of Health Status|0|||
143078677|NCT02092467|515826710|FG000|Overall Study|Other|32|||
143078678|NCT02092467|515826711|FG001|Overall Study|Other|30|||
143078679|NCT02092467|515826712|FG002|Overall Study|Other|24|||
143078680|NCT02092467|515826710|FG000|Overall Study|Withdrawal by Subject|282|||
143078681|NCT02092467|515826711|FG001|Overall Study|Withdrawal by Subject|327|||
143078682|NCT02092467|515826712|FG002|Overall Study|Withdrawal by Subject|289|||
143078683|NCT02092467|515826710|FG000|Overall Study|Randomized but not treated|2|||
143078684|NCT02092467|515826711|FG001|Overall Study|Randomized but not treated|1|||
143078685|NCT02092467|515826712|FG002|Overall Study|Randomized but not treated|7|||
143078686|NCT04844762|515826715|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
143078687|NCT04844762|515826716|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
143078688|NCT04844762|515826717|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
143078689|NCT04844762|515826718|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
143078690|NCT04844762|515826719|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
143078691|NCT04844762|515826720|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
143078692|NCT04844762|515826715|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
143078693|NCT04844762|515826716|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
143078694|NCT04844762|515826717|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
143078695|NCT04844762|515826718|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
143078696|NCT04844762|515826719|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
143078697|NCT04844762|515826720|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
143078698|NCT04844762|515826715|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
143078699|NCT04844762|515826716|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
143078700|NCT04844762|515826717|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
143078701|NCT04844762|515826718|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
143172843|NCT00659425|516181603|FG006|Overall Study|Investigator Discretion|0|||
143172844|NCT00659425|516181604|FG007|Overall Study|Investigator Discretion|3|||
143172845|NCT00659425|516181605|FG008|Overall Study|Investigator Discretion|0|||
143172846|NCT00659425|516181606|FG009|Overall Study|Investigator Discretion|0|||
143078702|NCT04844762|515826719|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
143172847|NCT00659425|516181597|FG000|Overall Study|Other|0|||
143078703|NCT04844762|515826720|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
143078704|NCT04844762|515826715|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
143078705|NCT04844762|515826716|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
143078706|NCT04844762|515826717|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
143078707|NCT04844762|515826718|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
143078708|NCT04844762|515826719|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
143078709|NCT04844762|515826720|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
143078710|NCT04844762|515826715|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
143078711|NCT04844762|515826716|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
143078712|NCT04844762|515826717|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
143078713|NCT04844762|515826718|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
143078714|NCT04844762|515826719|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
143078715|NCT04844762|515826720|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
143078716|NCT04844762|515826715|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
143078717|NCT04844762|515826716|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
143078718|NCT04844762|515826717|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
143078719|NCT04844762|515826718|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
143078720|NCT04844762|515826719|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
143078721|NCT04844762|515826720|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
143078722|NCT04844762|515826715|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
143078723|NCT04844762|515826716|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
143078724|NCT04844762|515826717|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
143078725|NCT04844762|515826718|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
143078726|NCT04844762|515826719|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
143078727|NCT04844762|515826720|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
143078728|NCT04844762|515826715|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
143078729|NCT04844762|515826716|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
143078730|NCT04844762|515826717|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
143078731|NCT04844762|515826718|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
143078732|NCT04844762|515826719|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
143078733|NCT04844762|515826720|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
143078734|NCT04844762|515826715|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
143078735|NCT04844762|515826716|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
143078736|NCT04844762|515826717|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
143078737|NCT04844762|515826718|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
143078738|NCT04844762|515826719|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
143078739|NCT04844762|515826720|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
143078740|NCT04844762|515826715|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
143078741|NCT04844762|515826716|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
143078742|NCT04844762|515826717|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
143078743|NCT04844762|515826718|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
143078744|NCT04844762|515826719|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
143078745|NCT04844762|515826720|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
143172848|NCT00659425|516181598|FG001|Overall Study|Other|1|||
143172849|NCT00659425|516181599|FG002|Overall Study|Other|1|||
143172850|NCT00659425|516181600|FG003|Overall Study|Other|2|||
143172851|NCT00659425|516181601|FG004|Overall Study|Other|4|||
143172852|NCT00659425|516181602|FG005|Overall Study|Other|0|||
143172853|NCT00659425|516181603|FG006|Overall Study|Other|3|||
143172854|NCT00659425|516181604|FG007|Overall Study|Other|2|||
143172855|NCT00659425|516181605|FG008|Overall Study|Other|0|||
143172856|NCT00659425|516181606|FG009|Overall Study|Other|6|||
143078746|NCT04844762|515826715|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
143078747|NCT04844762|515826716|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
143078748|NCT04844762|515826717|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
143078749|NCT04844762|515826718|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
143078750|NCT04844762|515826719|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
143078751|NCT04844762|515826720|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
143078752|NCT04400682|515826723|FG000|Period 1|Withdrawal by Subject|1|||
143078753|NCT04400682|515826724|FG001|Period 1|Withdrawal by Subject|4|||
143078754|NCT02105974|515826725|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
143078755|NCT02105974|515826726|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
143078756|NCT02105974|515826727|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
143078757|NCT02105974|515826725|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
143078758|NCT02105974|515826726|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
143078759|NCT02105974|515826727|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
143078760|NCT02105974|515826725|FG000|2 Week Run-in Period|Adverse Event|6|||
143078761|NCT02105974|515826726|FG001|2 Week Run-in Period|Adverse Event|0|||
143078762|NCT02105974|515826727|FG002|2 Week Run-in Period|Adverse Event|0|||
143078763|NCT02105974|515826725|FG000|2 Week Run-in Period|Study closed/terminated|1|||
143078764|NCT02105974|515826726|FG001|2 Week Run-in Period|Study closed/terminated|0|||
143078765|NCT02105974|515826727|FG002|2 Week Run-in Period|Study closed/terminated|0|||
143078766|NCT02105974|515826725|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
143078767|NCT02105974|515826726|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
143078768|NCT02105974|515826727|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
143078769|NCT02105974|515826725|FG000|2 Week Run-in Period|Withdrew consent|23|||
143078770|NCT02105974|515826726|FG001|2 Week Run-in Period|Withdrew consent|0|||
143078771|NCT02105974|515826727|FG002|2 Week Run-in Period|Withdrew consent|0|||
143078772|NCT02105974|515826725|FG000|2 Week Run-in Period|Investigator discretion|8|||
143078773|NCT02105974|515826726|FG001|2 Week Run-in Period|Investigator discretion|0|||
143078774|NCT02105974|515826727|FG002|2 Week Run-in Period|Investigator discretion|0|||
143078775|NCT02105974|515826725|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
143078776|NCT02105974|515826726|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
143078777|NCT02105974|515826727|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
143078778|NCT02105974|515826725|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
143078779|NCT02105974|515826726|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
143078780|NCT02105974|515826727|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
143078781|NCT02105974|515826725|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
143078782|NCT02105974|515826726|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
143078783|NCT02105974|515826727|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
143078784|NCT02105974|515826725|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
143078785|NCT02105974|515826726|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
143078786|NCT02105974|515826727|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
143078787|NCT02105974|515826725|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
143078788|NCT02105974|515826726|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
143078789|NCT02105974|515826727|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
143172857|NCT02293551|516181609|FG000|Part A and B Period 2|Withdrawal by Subject|0|||
143172858|NCT02293551|516181610|FG001|Part A and B Period 2|Withdrawal by Subject|0|||
143172859|NCT02293551|516181611|FG002|Part A and B Period 2|Withdrawal by Subject|0|||
143172860|NCT02293551|516181612|FG003|Part A and B Period 2|Withdrawal by Subject|0|||
143172861|NCT02293551|516181613|FG004|Part A and B Period 2|Withdrawal by Subject|0|||
143172862|NCT02293551|516181614|FG005|Part A and B Period 2|Withdrawal by Subject|1|||
143172863|NCT02293551|516181609|FG000|Part A and B Period 3|Withdrawal by Subject|0|||
143172864|NCT02293551|516181610|FG001|Part A and B Period 3|Withdrawal by Subject|0|||
143172865|NCT02293551|516181611|FG002|Part A and B Period 3|Withdrawal by Subject|0|||
143172866|NCT02293551|516181612|FG003|Part A and B Period 3|Withdrawal by Subject|2|||
143172867|NCT02293551|516181613|FG004|Part A and B Period 3|Withdrawal by Subject|0|||
143078790|NCT02105974|515826725|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
143078791|NCT02105974|515826726|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
143078792|NCT02105974|515826727|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
143078793|NCT02105974|515826725|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
143078794|NCT02105974|515826726|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
143078795|NCT02105974|515826727|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
143078796|NCT00477633|515826728|FG000|Overall Study|Did not receive treatment|23|||
143078797|NCT00477633|515826728|FG000|Overall Study|Adverse Event|143|||
143078798|NCT00477633|515826728|FG000|Overall Study|Pregnancy|23|||
143078799|NCT00477633|515826728|FG000|Overall Study|Lost to Follow-up|271|||
143078800|NCT00477633|515826728|FG000|Overall Study|Withdrawal by Subject|149|||
143078801|NCT00477633|515826728|FG000|Overall Study|Protocol Violation|25|||
143078802|NCT00477633|515826728|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
143078803|NCT02968849|515826729|FG000|Overall Study|Death|8|||
143078804|NCT02968849|515826730|FG001|Overall Study|Death|10|||
143078805|NCT02968849|515826729|FG000|Overall Study|Lost to Follow-up|31|||
143078806|NCT02968849|515826730|FG001|Overall Study|Lost to Follow-up|29|||
143078807|NCT02968849|515826729|FG000|Overall Study|Withdrawal by Subject|73|||
143078808|NCT02968849|515826730|FG001|Overall Study|Withdrawal by Subject|64|||
143078809|NCT02968849|515826729|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
143078810|NCT02968849|515826730|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
143078811|NCT02968849|515826729|FG000|Overall Study|Physician Decision|6|||
143078812|NCT02968849|515826730|FG001|Overall Study|Physician Decision|9|||
143078813|NCT02968849|515826729|FG000|Overall Study|Other|16|||
143078814|NCT02968849|515826730|FG001|Overall Study|Other|10|||
143078815|NCT02203331|515826734|FG000|Overall Study|Pregnancy|1|||
143078816|NCT02203331|515826735|FG001|Overall Study|Pregnancy|0|||
143078817|NCT02203331|515826736|FG002|Overall Study|Pregnancy|0|||
143078818|NCT02203331|515826737|FG003|Overall Study|Pregnancy|0|||
143078819|NCT02203331|515826738|FG004|Overall Study|Pregnancy|2|||
143078820|NCT02203331|515826739|FG005|Overall Study|Pregnancy|0|||
143078821|NCT02203331|515826734|FG000|Overall Study|Withdrawal by Subject|1|||
143078822|NCT02203331|515826735|FG001|Overall Study|Withdrawal by Subject|0|||
143078823|NCT02203331|515826736|FG002|Overall Study|Withdrawal by Subject|1|||
143078824|NCT02203331|515826737|FG003|Overall Study|Withdrawal by Subject|0|||
143078825|NCT02203331|515826738|FG004|Overall Study|Withdrawal by Subject|0|||
143078826|NCT02203331|515826739|FG005|Overall Study|Withdrawal by Subject|3|||
143078827|NCT02203331|515826734|FG000|Overall Study|Adverse Event|4|||
143078828|NCT02203331|515826735|FG001|Overall Study|Adverse Event|8|||
143078829|NCT02203331|515826736|FG002|Overall Study|Adverse Event|3|||
143078830|NCT02203331|515826737|FG003|Overall Study|Adverse Event|4|||
143078831|NCT02203331|515826738|FG004|Overall Study|Adverse Event|3|||
143078832|NCT02203331|515826739|FG005|Overall Study|Adverse Event|3|||
143078833|NCT02203331|515826734|FG000|Overall Study|Other Reasons|1|||
143078834|NCT02203331|515826735|FG001|Overall Study|Other Reasons|2|||
143078835|NCT02203331|515826736|FG002|Overall Study|Other Reasons|0|||
143078836|NCT02203331|515826737|FG003|Overall Study|Other Reasons|2|||
143078837|NCT02203331|515826738|FG004|Overall Study|Other Reasons|0|||
143078838|NCT02203331|515826739|FG005|Overall Study|Other Reasons|0|||
143078839|NCT02203331|515826734|FG000|Overall Study|Lack of Efficacy|0|||
143078840|NCT02203331|515826735|FG001|Overall Study|Lack of Efficacy|2|||
143078841|NCT02203331|515826736|FG002|Overall Study|Lack of Efficacy|1|||
143078842|NCT02203331|515826737|FG003|Overall Study|Lack of Efficacy|0|||
143078843|NCT02203331|515826738|FG004|Overall Study|Lack of Efficacy|0|||
143078844|NCT02203331|515826739|FG005|Overall Study|Lack of Efficacy|1|||
143078845|NCT02203331|515826734|FG000|Overall Study|Protocol Violation|0|||
143078846|NCT02203331|515826735|FG001|Overall Study|Protocol Violation|2|||
143078847|NCT02203331|515826736|FG002|Overall Study|Protocol Violation|0|||
143078848|NCT02203331|515826737|FG003|Overall Study|Protocol Violation|1|||
143078849|NCT02203331|515826738|FG004|Overall Study|Protocol Violation|1|||
143078850|NCT02203331|515826739|FG005|Overall Study|Protocol Violation|0|||
143078851|NCT02203331|515826734|FG000|Overall Study|Lost to Follow-up|0|||
143172868|NCT02293551|516181614|FG005|Part A and B Period 3|Withdrawal by Subject|1|||
143172869|NCT02293551|516181609|FG000|Part A and Part B Period 4|Withdrawal by Subject|0|||
143172870|NCT02293551|516181610|FG001|Part A and Part B Period 4|Withdrawal by Subject|0|||
143172871|NCT02293551|516181611|FG002|Part A and Part B Period 4|Withdrawal by Subject|0|||
143172872|NCT02293551|516181612|FG003|Part A and Part B Period 4|Withdrawal by Subject|2|||
143172873|NCT02293551|516181613|FG004|Part A and Part B Period 4|Withdrawal by Subject|0|||
143172874|NCT02293551|516181614|FG005|Part A and Part B Period 4|Withdrawal by Subject|1|||
143172875|NCT02936323|516181615|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
143172876|NCT02936323|516181616|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
143172877|NCT02936323|516181617|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
143172878|NCT02936323|516181618|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
143172879|NCT02936323|516181619|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
143172880|NCT02936323|516181620|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
143172881|NCT02936323|516181621|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
143172882|NCT02936323|516181622|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
143078852|NCT02203331|515826735|FG001|Overall Study|Lost to Follow-up|0|||
143078853|NCT02203331|515826736|FG002|Overall Study|Lost to Follow-up|0|||
143078854|NCT02203331|515826737|FG003|Overall Study|Lost to Follow-up|0|||
143078855|NCT02203331|515826738|FG004|Overall Study|Lost to Follow-up|1|||
143078856|NCT02203331|515826739|FG005|Overall Study|Lost to Follow-up|0|||
143078857|NCT01177059|515826745|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
143078858|NCT01177059|515826745|FG000|Overall Study|Withdrew consent|2|||
143078859|NCT01177059|515826745|FG000|Overall Study|Lost to Follow-up|18|||
143078860|NCT02925403|515828404|FG000|Overall Study|Lost to Follow-up|0|||
143078861|NCT02925403|515828405|FG001|Overall Study|Lost to Follow-up|1|||
143078862|NCT00459043|515828406|FG000|Overall Study|Withdrawal by Subject|1|||
143078863|NCT00459043|515828407|FG001|Overall Study|Withdrawal by Subject|0|||
143078864|NCT03452137|515828408|FG000|Overall Study|Death|67|||
143078865|NCT03452137|515828409|FG001|Overall Study|Death|70|||
143078866|NCT03452137|515828408|FG000|Overall Study|Lost to Follow-up|4|||
143078867|NCT03452137|515828409|FG001|Overall Study|Lost to Follow-up|2|||
143078868|NCT03452137|515828408|FG000|Overall Study|Physician Decision|0|||
143078869|NCT03452137|515828409|FG001|Overall Study|Physician Decision|1|||
143078870|NCT03452137|515828408|FG000|Overall Study|Study Terminated by Sponsor|120|||
143078871|NCT03452137|515828409|FG001|Overall Study|Study Terminated by Sponsor|121|||
143078872|NCT03452137|515828408|FG000|Overall Study|Withdrawal by Subject|12|||
143078873|NCT03452137|515828409|FG001|Overall Study|Withdrawal by Subject|9|||
143078874|NCT02856802|515828410|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
143078875|NCT02856802|515828411|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
143078876|NCT02856802|515828410|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
143078877|NCT02856802|515828411|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
143078878|NCT02856802|515828410|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
143078879|NCT02856802|515828411|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
143078880|NCT02856802|515828410|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
143078881|NCT02856802|515828411|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
143078882|NCT02856802|515828410|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
143078883|NCT02856802|515828411|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
143078884|NCT02856802|515828410|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
143078885|NCT02856802|515828411|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
143078886|NCT03772717|515828412|FG000|Overall Study|Withdrawal by Subject|2|||
143078887|NCT00587860|515828413|FG000|Overall Study|Lost to Follow-up|2|||
143078888|NCT00587860|515828414|FG001|Overall Study|Lost to Follow-up|2|||
143078889|NCT00587860|515828413|FG000|Overall Study|Withdrawal by Subject|3|||
143078890|NCT00587860|515828414|FG001|Overall Study|Withdrawal by Subject|3|||
143078891|NCT00887289|515828415|FG000|Overall Study|Lack of Efficacy|14|||
143078892|NCT00887289|515828415|FG000|Overall Study|Adverse Event|27|||
143078893|NCT00887289|515828415|FG000|Overall Study|Withdrawal by Subject|26|||
143078894|NCT00887289|515828415|FG000|Overall Study|Lost to Follow-up|8|||
143078895|NCT00887289|515828415|FG000|Overall Study|Other|20|||
143078896|NCT02932306|515828416|FG000|Overall Study|Withdrawal by Subject|16|||
143078897|NCT02932306|515828417|FG001|Overall Study|Withdrawal by Subject|25|||
143078898|NCT02932306|515828416|FG000|Overall Study|Adverse Event|3|||
143078899|NCT02932306|515828417|FG001|Overall Study|Adverse Event|0|||
143078900|NCT02932306|515828416|FG000|Overall Study|Pregnancy|2|||
143078901|NCT02932306|515828417|FG001|Overall Study|Pregnancy|0|||
143078902|NCT02932306|515828416|FG000|Overall Study|Protocol Violation|1|||
143078903|NCT02932306|515828417|FG001|Overall Study|Protocol Violation|1|||
143078904|NCT02932306|515828416|FG000|Overall Study|Noncompliance with Study Drug|1|||
143078905|NCT02932306|515828417|FG001|Overall Study|Noncompliance with Study Drug|1|||
143078906|NCT02932306|515828416|FG000|Overall Study|Lost to Follow-up|36|||
143078907|NCT02932306|515828417|FG001|Overall Study|Lost to Follow-up|40|||
143078908|NCT02932306|515828416|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
143078909|NCT02932306|515828417|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
143078910|NCT02932306|515828416|FG000|Overall Study|Lack of Efficacy|0|||
143078911|NCT02932306|515828417|FG001|Overall Study|Lack of Efficacy|2|||
143078912|NCT02932306|515828416|FG000|Overall Study|Worsening condition|2|||
143078913|NCT02932306|515828417|FG001|Overall Study|Worsening condition|0|||
143078914|NCT02932306|515828416|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
143078915|NCT02932306|515828417|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
143078916|NCT00923273|515828418|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
143078917|NCT00923273|515828419|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
143078918|NCT00923273|515828420|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
143078919|NCT00923273|515828421|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
143078920|NCT00923273|515828422|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
143078921|NCT00923273|515828418|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
143078922|NCT00923273|515828419|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
143078923|NCT00923273|515828420|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
143078924|NCT00923273|515828421|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
143078925|NCT00923273|515828422|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
143078926|NCT00605540|515828423|FG000|Overall Study|Death|15|||
143078927|NCT00605540|515828423|FG000|Overall Study|Lost to Follow-up|23|||
143078928|NCT00509366|515828426|FG000|Overall Study|Not Treated (Screen Failure)|1|||
143078929|NCT00509366|515828427|FG001|Overall Study|Not Treated (Screen Failure)|1|||
143078930|NCT00509366|515828428|FG002|Overall Study|Not Treated (Screen Failure)|1|||
143078931|NCT00509366|515828429|FG003|Overall Study|Not Treated (Screen Failure)|0|||
143078932|NCT00509366|515828430|FG004|Overall Study|Not Treated (Screen Failure)|0|||
143078933|NCT01473524|515828431|FG000|DB Phase|Adverse Event|4|||
143078934|NCT01473524|515828432|FG001|DB Phase|Adverse Event|8|||
143078935|NCT01473524|515828433|FG002|DB Phase|Adverse Event|2|||
143078936|NCT01473524|515828434|FG003|DB Phase|Adverse Event|0|||
143078937|NCT01473524|515828435|FG004|DB Phase|Adverse Event|0|||
143078938|NCT01473524|515828436|FG005|DB Phase|Adverse Event|0|||
143078939|NCT01473524|515828431|FG000|DB Phase|Death|1|||
143078940|NCT01473524|515828432|FG001|DB Phase|Death|0|||
143078941|NCT01473524|515828433|FG002|DB Phase|Death|0|||
143078942|NCT01473524|515828434|FG003|DB Phase|Death|0|||
143078943|NCT01473524|515828435|FG004|DB Phase|Death|0|||
143078944|NCT01473524|515828436|FG005|DB Phase|Death|0|||
143078945|NCT01473524|515828431|FG000|DB Phase|Withdrawal by Subject|2|||
143078946|NCT01473524|515828432|FG001|DB Phase|Withdrawal by Subject|1|||
143078947|NCT01473524|515828433|FG002|DB Phase|Withdrawal by Subject|1|||
143078948|NCT01473524|515828434|FG003|DB Phase|Withdrawal by Subject|0|||
143078949|NCT01473524|515828435|FG004|DB Phase|Withdrawal by Subject|0|||
143078950|NCT01473524|515828436|FG005|DB Phase|Withdrawal by Subject|0|||
143078951|NCT01473524|515828431|FG000|LTSE Phase|Withdrawal by Subject|0|||
143078952|NCT01473524|515828432|FG001|LTSE Phase|Withdrawal by Subject|0|||
143078953|NCT01473524|515828433|FG002|LTSE Phase|Withdrawal by Subject|0|||
143078954|NCT01473524|515828434|FG003|LTSE Phase|Withdrawal by Subject|3|||
143078955|NCT01473524|515828435|FG004|LTSE Phase|Withdrawal by Subject|3|||
143078956|NCT01473524|515828436|FG005|LTSE Phase|Withdrawal by Subject|6|||
143078957|NCT01473524|515828431|FG000|LTSE Phase|Death|0|||
143078958|NCT01473524|515828432|FG001|LTSE Phase|Death|0|||
143078959|NCT01473524|515828433|FG002|LTSE Phase|Death|0|||
143078960|NCT01473524|515828434|FG003|LTSE Phase|Death|0|||
143078961|NCT01473524|515828435|FG004|LTSE Phase|Death|1|||
143078962|NCT01473524|515828436|FG005|LTSE Phase|Death|0|||
143078963|NCT01473524|515828431|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
143078964|NCT01473524|515828432|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
143078965|NCT01473524|515828433|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
143078966|NCT01473524|515828434|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
143078967|NCT01473524|515828435|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
143078968|NCT01473524|515828436|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
143078969|NCT01473524|515828431|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
143078970|NCT01473524|515828432|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
143078971|NCT01473524|515828433|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
143078972|NCT01473524|515828434|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
143078973|NCT01473524|515828435|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
143078974|NCT01473524|515828436|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
143078975|NCT01473524|515828431|FG000|LTSE Phase|Lost to Follow-up|0|||
143078976|NCT01473524|515828432|FG001|LTSE Phase|Lost to Follow-up|0|||
143078977|NCT01473524|515828433|FG002|LTSE Phase|Lost to Follow-up|0|||
143078978|NCT01473524|515828434|FG003|LTSE Phase|Lost to Follow-up|1|||
143078979|NCT01473524|515828435|FG004|LTSE Phase|Lost to Follow-up|3|||
143078980|NCT01473524|515828436|FG005|LTSE Phase|Lost to Follow-up|2|||
143172883|NCT02936323|516181623|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
143172884|NCT02936323|516181624|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
143172885|NCT02936323|516181615|FG000|Phase 1 Dose Escalation|Death|2|||
143172886|NCT02936323|516181616|FG001|Phase 1 Dose Escalation|Death|1|||
143172887|NCT02936323|516181617|FG002|Phase 1 Dose Escalation|Death|3|||
143172888|NCT02936323|516181618|FG003|Phase 1 Dose Escalation|Death|1|||
143172889|NCT02936323|516181619|FG004|Phase 1 Dose Escalation|Death|2|||
143172890|NCT02936323|516181620|FG005|Phase 1 Dose Escalation|Death|3|||
143172891|NCT02936323|516181621|FG006|Phase 1 Dose Escalation|Death|3|||
143172892|NCT02936323|516181622|FG007|Phase 1 Dose Escalation|Death|0|||
143172893|NCT02936323|516181623|FG008|Phase 1 Dose Escalation|Death|0|||
143172894|NCT02936323|516181624|FG009|Phase 1 Dose Escalation|Death|0|||
143172895|NCT02936323|516181615|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
143172896|NCT02936323|516181616|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
143172897|NCT02936323|516181617|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
143172898|NCT02936323|516181618|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
143172899|NCT02936323|516181619|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
143172900|NCT02936323|516181620|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
143172901|NCT02936323|516181621|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
143172902|NCT02936323|516181622|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
143172903|NCT02936323|516181623|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
143172904|NCT02936323|516181624|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
143172905|NCT02936323|516181615|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
143172906|NCT02936323|516181616|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
143172907|NCT02936323|516181617|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
143172908|NCT02936323|516181618|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
143172909|NCT02936323|516181619|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
143172910|NCT02936323|516181620|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
143172911|NCT02936323|516181621|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
143172912|NCT02936323|516181622|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
143172913|NCT02936323|516181623|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
143172914|NCT02936323|516181624|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
143172915|NCT02936323|516181615|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
143172916|NCT02936323|516181616|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
143172917|NCT02936323|516181617|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
143172918|NCT02936323|516181618|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
143172919|NCT02936323|516181619|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
143172920|NCT02936323|516181620|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
143172921|NCT02936323|516181621|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
143172922|NCT02936323|516181622|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
143078981|NCT01473524|515828431|FG000|LTSE Phase|Principal Investigator Decision|0|||
143078982|NCT01473524|515828432|FG001|LTSE Phase|Principal Investigator Decision|0|||
143078983|NCT01473524|515828433|FG002|LTSE Phase|Principal Investigator Decision|0|||
143078984|NCT01473524|515828434|FG003|LTSE Phase|Principal Investigator Decision|1|||
143078985|NCT01473524|515828435|FG004|LTSE Phase|Principal Investigator Decision|1|||
143078986|NCT01473524|515828436|FG005|LTSE Phase|Principal Investigator Decision|3|||
143078987|NCT01473524|515828431|FG000|LTSE Phase|Liver Transplantation|0|||
143078988|NCT01473524|515828432|FG001|LTSE Phase|Liver Transplantation|0|||
143078989|NCT01473524|515828433|FG002|LTSE Phase|Liver Transplantation|0|||
143078990|NCT01473524|515828434|FG003|LTSE Phase|Liver Transplantation|0|||
143078991|NCT01473524|515828435|FG004|LTSE Phase|Liver Transplantation|0|||
143078992|NCT01473524|515828436|FG005|LTSE Phase|Liver Transplantation|1|||
143078993|NCT01473524|515828431|FG000|LTSE Phase|Pregnancy|0|||
143078994|NCT01473524|515828432|FG001|LTSE Phase|Pregnancy|0|||
143078995|NCT01473524|515828433|FG002|LTSE Phase|Pregnancy|0|||
143078996|NCT01473524|515828434|FG003|LTSE Phase|Pregnancy|1|||
143078997|NCT01473524|515828435|FG004|LTSE Phase|Pregnancy|0|||
143078998|NCT01473524|515828436|FG005|LTSE Phase|Pregnancy|0|||
143078999|NCT01473524|515828431|FG000|LTSE Phase|Protocol Violation|0|||
143079000|NCT01473524|515828432|FG001|LTSE Phase|Protocol Violation|0|||
143079001|NCT01473524|515828433|FG002|LTSE Phase|Protocol Violation|0|||
143079002|NCT01473524|515828434|FG003|LTSE Phase|Protocol Violation|0|||
143079003|NCT01473524|515828435|FG004|LTSE Phase|Protocol Violation|0|||
143079004|NCT01473524|515828436|FG005|LTSE Phase|Protocol Violation|1|||
143079005|NCT02119819|515828437|FG000|Overall Study|Adverse Event|3|||
143079006|NCT02119819|515828438|FG001|Overall Study|Adverse Event|1|||
143079007|NCT02119819|515828439|FG002|Overall Study|Adverse Event|2|||
143079008|NCT02119819|515828440|FG003|Overall Study|Adverse Event|3|||
143079009|NCT02119819|515828441|FG004|Overall Study|Adverse Event|0|||
143172923|NCT02936323|516181623|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
143172924|NCT02936323|516181624|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
143079010|NCT02119819|515828442|FG005|Overall Study|Adverse Event|1|||
143079011|NCT02119819|515828437|FG000|Overall Study|Lack of Efficacy|0|||
143079012|NCT02119819|515828438|FG001|Overall Study|Lack of Efficacy|0|||
143079013|NCT02119819|515828439|FG002|Overall Study|Lack of Efficacy|0|||
143079014|NCT02119819|515828440|FG003|Overall Study|Lack of Efficacy|0|||
143079015|NCT02119819|515828441|FG004|Overall Study|Lack of Efficacy|0|||
143079016|NCT02119819|515828442|FG005|Overall Study|Lack of Efficacy|1|||
143079017|NCT02119819|515828437|FG000|Overall Study|Lost to Follow-up|0|||
143079018|NCT02119819|515828438|FG001|Overall Study|Lost to Follow-up|0|||
143079019|NCT02119819|515828439|FG002|Overall Study|Lost to Follow-up|1|||
143366268|NCT00817635|516884612|FG004|Overall Study|Administrative Problems|1|||
143079020|NCT02119819|515828440|FG003|Overall Study|Lost to Follow-up|2|||
143079021|NCT02119819|515828441|FG004|Overall Study|Lost to Follow-up|1|||
143366269|NCT00817635|516884608|FG000|Overall Study|Protocol Violation|5|||
143172925|NCT02936323|516181615|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
143172926|NCT02936323|516181616|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
143172927|NCT02936323|516181617|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
143172928|NCT02936323|516181618|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
143172929|NCT02936323|516181619|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
143172930|NCT02936323|516181620|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
143172931|NCT02936323|516181621|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
143172932|NCT02936323|516181622|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
143172933|NCT02936323|516181623|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
143172934|NCT02936323|516181624|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
143172935|NCT02936323|516181615|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
143172936|NCT02936323|516181616|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
143172937|NCT02936323|516181617|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
143172938|NCT02936323|516181618|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
143172939|NCT02936323|516181619|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
143172940|NCT02936323|516181620|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
143172941|NCT02936323|516181621|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
143172942|NCT02936323|516181622|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
143172943|NCT02936323|516181623|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
143172944|NCT02936323|516181624|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
143172945|NCT02936323|516181615|FG000|Phase 2a Dose Expansion|Death|0|||
143172946|NCT02936323|516181616|FG001|Phase 2a Dose Expansion|Death|0|||
143172947|NCT02936323|516181617|FG002|Phase 2a Dose Expansion|Death|0|||
143172948|NCT02936323|516181618|FG003|Phase 2a Dose Expansion|Death|0|||
143172949|NCT02936323|516181619|FG004|Phase 2a Dose Expansion|Death|0|||
143172950|NCT02936323|516181620|FG005|Phase 2a Dose Expansion|Death|0|||
143172951|NCT02936323|516181621|FG006|Phase 2a Dose Expansion|Death|0|||
143172952|NCT02936323|516181622|FG007|Phase 2a Dose Expansion|Death|4|||
143172953|NCT02936323|516181623|FG008|Phase 2a Dose Expansion|Death|8|||
143172954|NCT02936323|516181624|FG009|Phase 2a Dose Expansion|Death|10|||
143172955|NCT02781558|516181625|FG000|Overall Study|Lost to Follow-up|2|||
143172956|NCT02781558|516181626|FG001|Overall Study|Lost to Follow-up|2|||
143172957|NCT02781558|516181625|FG000|Overall Study|Adverse Event|1|||
143172958|NCT02781558|516181626|FG001|Overall Study|Adverse Event|0|||
143172959|NCT01542788|516181627|FG000|Overall Study|Randomized but Not Treated|2|||
143172960|NCT01542788|516181628|FG001|Overall Study|Randomized but Not Treated|0|||
143172961|NCT01542788|516181627|FG000|Overall Study|Lack of Efficacy|41|||
143172962|NCT01542788|516181628|FG001|Overall Study|Lack of Efficacy|71|||
143172963|NCT01542788|516181627|FG000|Overall Study|Lost to Follow-up|5|||
143172964|NCT01542788|516181628|FG001|Overall Study|Lost to Follow-up|0|||
143172965|NCT01542788|516181627|FG000|Overall Study|Death|3|||
143172966|NCT01542788|516181628|FG001|Overall Study|Death|0|||
143172967|NCT01542788|516181627|FG000|Overall Study|Protocol Violation|2|||
143172968|NCT01542788|516181628|FG001|Overall Study|Protocol Violation|0|||
143172969|NCT01542788|516181627|FG000|Overall Study|Physician Decision|1|||
143172970|NCT01542788|516181628|FG001|Overall Study|Physician Decision|0|||
143172971|NCT01542788|516181627|FG000|Overall Study|Withdrawal by Subject|1|||
143172972|NCT01542788|516181628|FG001|Overall Study|Withdrawal by Subject|0|||
143172973|NCT01729039|516181631|FG000|Overall Study|disqualified|2|||
143172974|NCT01729039|516181632|FG001|Overall Study|disqualified|5|||
143172975|NCT01729039|516181631|FG000|Overall Study|Withdrawal by Subject|8|||
143172976|NCT01729039|516181632|FG001|Overall Study|Withdrawal by Subject|7|||
143172977|NCT05788991|516181633|FG000|Overall Study|Not treated with study medication|1|||
143172978|NCT05788991|516181634|FG001|Overall Study|Not treated with study medication|3|||
143172979|NCT05788991|516181633|FG000|Overall Study|Withdrawal by Subject|1|||
143172980|NCT05788991|516181634|FG001|Overall Study|Withdrawal by Subject|0|||
143172981|NCT05788991|516181633|FG000|Overall Study|Lack of Efficacy|0|||
143172982|NCT05788991|516181634|FG001|Overall Study|Lack of Efficacy|1|||
143172983|NCT05788991|516181633|FG000|Overall Study|Protocol Violation|1|||
143172984|NCT05788991|516181634|FG001|Overall Study|Protocol Violation|2|||
143172985|NCT04712669|516181635|FG000|Double Blind Phase|Adverse Event|4|||
143172986|NCT04712669|516181636|FG001|Double Blind Phase|Adverse Event|4|||
143172987|NCT04712669|516181637|FG002|Double Blind Phase|Adverse Event|3|||
143172988|NCT04712669|516181638|FG003|Double Blind Phase|Adverse Event|0|||
143172989|NCT04712669|516181639|FG004|Double Blind Phase|Adverse Event|0|||
143172990|NCT04712669|516181640|FG005|Double Blind Phase|Adverse Event|0|||
143172991|NCT04712669|516181641|FG006|Double Blind Phase|Adverse Event|0|||
143172992|NCT04712669|516181642|FG007|Double Blind Phase|Adverse Event|0|||
143079022|NCT02119819|515828442|FG005|Overall Study|Lost to Follow-up|2|||
143079023|NCT02119819|515828437|FG000|Overall Study|Physician Decision|1|||
143079024|NCT02119819|515828438|FG001|Overall Study|Physician Decision|1|||
143079025|NCT02119819|515828439|FG002|Overall Study|Physician Decision|0|||
143079026|NCT02119819|515828440|FG003|Overall Study|Physician Decision|0|||
143079027|NCT02119819|515828441|FG004|Overall Study|Physician Decision|0|||
143079028|NCT02119819|515828442|FG005|Overall Study|Physician Decision|1|||
143079029|NCT02119819|515828437|FG000|Overall Study|Withdrawal by Subject|5|||
143079030|NCT02119819|515828438|FG001|Overall Study|Withdrawal by Subject|3|||
143079031|NCT02119819|515828439|FG002|Overall Study|Withdrawal by Subject|0|||
143079032|NCT02119819|515828440|FG003|Overall Study|Withdrawal by Subject|0|||
143079033|NCT02119819|515828441|FG004|Overall Study|Withdrawal by Subject|6|||
143079034|NCT02119819|515828442|FG005|Overall Study|Withdrawal by Subject|10|||
143079035|NCT02119819|515828437|FG000|Overall Study|Jury Duty|0|||
143079036|NCT02119819|515828438|FG001|Overall Study|Jury Duty|0|||
143079037|NCT02119819|515828439|FG002|Overall Study|Jury Duty|1|||
143079038|NCT02119819|515828440|FG003|Overall Study|Jury Duty|0|||
143079039|NCT02119819|515828441|FG004|Overall Study|Jury Duty|0|||
143079040|NCT02119819|515828442|FG005|Overall Study|Jury Duty|0|||
143079041|NCT02119819|515828437|FG000|Overall Study|Protocol Violation|0|||
143079042|NCT02119819|515828438|FG001|Overall Study|Protocol Violation|0|||
143079043|NCT02119819|515828439|FG002|Overall Study|Protocol Violation|0|||
143079044|NCT02119819|515828440|FG003|Overall Study|Protocol Violation|1|||
143079045|NCT02119819|515828441|FG004|Overall Study|Protocol Violation|0|||
143079046|NCT02119819|515828442|FG005|Overall Study|Protocol Violation|0|||
143079047|NCT02119819|515828437|FG000|Overall Study|Left the city to get a job|0|||
143079048|NCT02119819|515828438|FG001|Overall Study|Left the city to get a job|0|||
143366270|NCT00817635|516884609|FG001|Overall Study|Protocol Violation|1|||
143366271|NCT00817635|516884610|FG002|Overall Study|Protocol Violation|3|||
143366272|NCT00817635|516884611|FG003|Overall Study|Protocol Violation|2|||
143079049|NCT02119819|515828439|FG002|Overall Study|Left the city to get a job|0|||
143366273|NCT00817635|516884612|FG004|Overall Study|Protocol Violation|3|||
143366274|NCT03710564|516884613|FG000|Overall Study|Study Terminated by Sponsor|104|||
143366275|NCT03710564|516884614|FG001|Overall Study|Study Terminated by Sponsor|55|||
143079050|NCT02119819|515828440|FG003|Overall Study|Left the city to get a job|1|||
143079051|NCT02119819|515828441|FG004|Overall Study|Left the city to get a job|0|||
143079052|NCT02119819|515828442|FG005|Overall Study|Left the city to get a job|0|||
143079053|NCT04839692|515828444|FG000|Overall Study|Withdrawal by Subject|0|||
143079054|NCT04839692|515828445|FG001|Overall Study|Withdrawal by Subject|3|||
143079055|NCT04839692|515828444|FG000|Overall Study|Physician Decision|1|||
143079056|NCT04839692|515828445|FG001|Overall Study|Physician Decision|0|||
143079057|NCT04497948|515828450|FG000|Overall Study|Death|2|||
143079058|NCT00696787|515828453|FG000|Overall Study|Adverse Event|1|||
143079059|NCT00696787|515828454|FG001|Overall Study|Adverse Event|0|||
143079060|NCT00696787|515828455|FG002|Overall Study|Adverse Event|6|||
143079061|NCT00696787|515828453|FG000|Overall Study|Discontinuation by Sponsor|9|||
143079062|NCT00696787|515828454|FG001|Overall Study|Discontinuation by Sponsor|13|||
143079063|NCT00696787|515828455|FG002|Overall Study|Discontinuation by Sponsor|14|||
143079064|NCT00696787|515828453|FG000|Overall Study|Lack of Efficacy|0|||
143079065|NCT00696787|515828454|FG001|Overall Study|Lack of Efficacy|1|||
143079066|NCT00696787|515828455|FG002|Overall Study|Lack of Efficacy|0|||
143079067|NCT00696787|515828453|FG000|Overall Study|Lost to Follow-up|4|||
143079068|NCT00696787|515828454|FG001|Overall Study|Lost to Follow-up|0|||
143079069|NCT00696787|515828455|FG002|Overall Study|Lost to Follow-up|3|||
143079070|NCT00696787|515828453|FG000|Overall Study|Withdrawal by Subject|0|||
143079071|NCT00696787|515828454|FG001|Overall Study|Withdrawal by Subject|3|||
143079072|NCT00696787|515828455|FG002|Overall Study|Withdrawal by Subject|2|||
143079073|NCT00696787|515828453|FG000|Overall Study|Failed to return|1|||
143079074|NCT00696787|515828454|FG001|Overall Study|Failed to return|3|||
143079075|NCT00696787|515828455|FG002|Overall Study|Failed to return|1|||
143172993|NCT04712669|516181635|FG000|Double Blind Phase|Physician Decision|1|||
143172994|NCT04712669|516181636|FG001|Double Blind Phase|Physician Decision|0|||
143172995|NCT04712669|516181637|FG002|Double Blind Phase|Physician Decision|0|||
143172996|NCT04712669|516181638|FG003|Double Blind Phase|Physician Decision|0|||
143172997|NCT04712669|516181639|FG004|Double Blind Phase|Physician Decision|0|||
143172998|NCT04712669|516181640|FG005|Double Blind Phase|Physician Decision|0|||
143079076|NCT00129389|515828458|FG000|Overall Study|Adverse Event|19|||
143079077|NCT00129389|515828459|FG001|Overall Study|Adverse Event|87|||
143079078|NCT00129389|515828458|FG000|Overall Study|Death|0|||
143079079|NCT00129389|515828459|FG001|Overall Study|Death|1|||
143079080|NCT00129389|515828458|FG000|Overall Study|Lost to Follow-up|2|||
143079081|NCT00129389|515828459|FG001|Overall Study|Lost to Follow-up|1|||
143079082|NCT00129389|515828458|FG000|Overall Study|Physician Decision|0|||
143079083|NCT00129389|515828459|FG001|Overall Study|Physician Decision|4|||
143079084|NCT00129389|515828458|FG000|Overall Study|Protocol Violation|0|||
143079085|NCT00129389|515828459|FG001|Overall Study|Protocol Violation|6|||
143079086|NCT00129389|515828458|FG000|Overall Study|Withdrawal by Subject|9|||
143079087|NCT00129389|515828459|FG001|Overall Study|Withdrawal by Subject|23|||
143079088|NCT00129389|515828458|FG000|Overall Study|Relapse|1|||
143079089|NCT00129389|515828459|FG001|Overall Study|Relapse|0|||
143079090|NCT00129389|515828458|FG000|Overall Study|Not eligible|1|||
143079091|NCT00129389|515828459|FG001|Overall Study|Not eligible|2|||
143079092|NCT00129389|515828458|FG000|Overall Study|Crossed to the other arm|1|||
143079093|NCT00129389|515828459|FG001|Overall Study|Crossed to the other arm|16|||
143079094|NCT02549027|515828461|FG000|Washout After Period 4|Withdrawal by Subject|0|||
143079095|NCT02549027|515828462|FG001|Washout After Period 4|Withdrawal by Subject|1|||
143079096|NCT02549027|515828463|FG002|Washout After Period 4|Withdrawal by Subject|1|||
143079097|NCT02549027|515828464|FG003|Washout After Period 4|Withdrawal by Subject|1|||
143079098|NCT02549027|515828465|FG004|Washout After Period 4|Withdrawal by Subject|0|||
143079099|NCT02549027|515828466|FG005|Washout After Period 4|Withdrawal by Subject|0|||
143079100|NCT02549027|515828461|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
143079101|NCT02549027|515828462|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
143079102|NCT02549027|515828463|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
143079103|NCT02549027|515828464|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
143079104|NCT02549027|515828465|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
143079105|NCT02549027|515828466|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
143079106|NCT02186834|515828467|FG000|Dose Escalation|Death|0|||
143079107|NCT02186834|515828468|FG001|Dose Escalation|Death|0|||
143079108|NCT02186834|515828469|FG002|Dose Escalation|Death|0|||
143079109|NCT02186834|515828470|FG003|Dose Escalation|Death|1|||
143079110|NCT02186834|515828471|FG004|Dose Escalation|Death|0|||
143079111|NCT02186834|515828472|FG005|Dose Escalation|Death|0|||
143079112|NCT02186834|515828467|FG000|Treatment at RP2D|Died prior to treatment|0|||
143079113|NCT02186834|515828468|FG001|Treatment at RP2D|Died prior to treatment|0|||
143079114|NCT02186834|515828469|FG002|Treatment at RP2D|Died prior to treatment|0|||
143079115|NCT02186834|515828470|FG003|Treatment at RP2D|Died prior to treatment|0|||
143079116|NCT02186834|515828471|FG004|Treatment at RP2D|Died prior to treatment|0|||
143079117|NCT02186834|515828472|FG005|Treatment at RP2D|Died prior to treatment|1|||
143079118|NCT03207243|515828482|FG000|Overall Study|Adverse Event|2|||
143079119|NCT03207243|515828483|FG001|Overall Study|Adverse Event|2|||
143079120|NCT03207243|515828482|FG000|Overall Study|Loss of Asthma Control|47|||
143079121|NCT03207243|515828483|FG001|Overall Study|Loss of Asthma Control|31|||
143079122|NCT03207243|515828482|FG000|Overall Study|Withdrawal by Subject|2|||
143079123|NCT03207243|515828483|FG001|Overall Study|Withdrawal by Subject|4|||
143079124|NCT03207243|515828482|FG000|Overall Study|Physician Decision|1|||
143079125|NCT03207243|515828483|FG001|Overall Study|Physician Decision|1|||
143079126|NCT03207243|515828482|FG000|Overall Study|Lost to Follow-up|0|||
143079127|NCT03207243|515828483|FG001|Overall Study|Lost to Follow-up|1|||
143079128|NCT03207243|515828482|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
143079129|NCT03207243|515828483|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
143079130|NCT03207243|515828482|FG000|Overall Study|Protocol Violation|0|||
143079131|NCT03207243|515828483|FG001|Overall Study|Protocol Violation|3|||
143079132|NCT01377987|515828486|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
143079133|NCT01377987|515828487|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
143079134|NCT04611529|515828488|FG000|2-day Follow up|Lost to Follow-up|5|||
143079135|NCT04611529|515828489|FG001|2-day Follow up|Lost to Follow-up|6|||
143079136|NCT04611529|515828490|FG002|2-day Follow up|Lost to Follow-up|3|||
143079137|NCT00741286|515828556|FG000|Overall Study|Lost to Follow-up|15|||
143079138|NCT00741286|515828557|FG001|Overall Study|Lost to Follow-up|10|||
143079139|NCT00741286|515828556|FG000|Overall Study|Adverse Event|1|||
143079140|NCT00741286|515828557|FG001|Overall Study|Adverse Event|6|||
143079141|NCT00741286|515828556|FG000|Overall Study|Protocol Violation|3|||
143079142|NCT00741286|515828557|FG001|Overall Study|Protocol Violation|2|||
143079143|NCT00741286|515828556|FG000|Overall Study|Primary Outcome|1|||
143079144|NCT00741286|515828557|FG001|Overall Study|Primary Outcome|1|||
143079145|NCT01831258|515828558|FG000|Overall Study|Withdrawal by Subject|2|||
143079146|NCT01831258|515828559|FG001|Overall Study|Withdrawal by Subject|1|||
143079147|NCT01831258|515828558|FG000|Overall Study|Lost to Follow-up|3|||
143079148|NCT01831258|515828559|FG001|Overall Study|Lost to Follow-up|2|||
143079149|NCT02842073|515828570|FG000|Overall Study|Withdrawal by Subject|1|||
143079150|NCT05320887|515828573|FG000|Overall Study|Lost to Follow-up|0|||
143079151|NCT05320887|515828574|FG001|Overall Study|Lost to Follow-up|3|||
143079152|NCT05320887|515828575|FG002|Overall Study|Lost to Follow-up|0|||
143079153|NCT05320887|515828576|FG003|Overall Study|Lost to Follow-up|0|||
143079154|NCT02910011|515828577|FG000|Overall Study|Physician Decision|2|||
143079155|NCT04411914|515828578|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
143079156|NCT04411914|515828579|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
143079157|NCT02015065|515828580|FG000|Overall Study|Death on study|1|||
143079158|NCT02015065|515828581|FG001|Overall Study|Death on study|2|||
143079159|NCT02015065|515828582|FG002|Overall Study|Death on study|1|||
143079160|NCT03136965|515828586|FG000|Overall Study|Lost to Follow-up|0|||
143079161|NCT03136965|515828587|FG001|Overall Study|Lost to Follow-up|1|||
143079162|NCT03136965|515828588|FG002|Overall Study|Lost to Follow-up|0|||
143079163|NCT01144715|515828590|FG000|Overall Study|Lost to Follow-up|2|||
143079164|NCT01144715|515828591|FG001|Overall Study|Lost to Follow-up|1|||
143079165|NCT01144715|515828590|FG000|Overall Study|Withdrawal by Subject|2|||
143079166|NCT01144715|515828591|FG001|Overall Study|Withdrawal by Subject|1|||
143079167|NCT01144715|515828590|FG000|Overall Study|Adverse Event|0|||
143079168|NCT01144715|515828591|FG001|Overall Study|Adverse Event|1|||
143079169|NCT03553576|515828592|FG000|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
143079170|NCT03553576|515828593|FG001|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
143079171|NCT03553576|515828592|FG000|Overall Study|Unintentional dural puncture during epidural procedure|0|||
143079172|NCT03553576|515828593|FG001|Overall Study|Unintentional dural puncture during epidural procedure|1|||
143079173|NCT03553576|515828592|FG000|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|0|||
143079174|NCT03553576|515828593|FG001|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|1|||
143079175|NCT03553576|515828592|FG000|Overall Study|Fentanyl and or clonidine administered via epidural catheter|1|||
143079176|NCT03553576|515828593|FG001|Overall Study|Fentanyl and or clonidine administered via epidural catheter|2|||
143079177|NCT03553576|515828592|FG000|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
143079178|NCT03553576|515828593|FG001|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
143079179|NCT03553576|515828592|FG000|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|1|||
143079180|NCT03553576|515828593|FG001|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|0|||
143079181|NCT03553576|515828592|FG000|Overall Study|Physician Decision|2|||
143079182|NCT03553576|515828593|FG001|Overall Study|Physician Decision|5|||
143079183|NCT02552212|515828594|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
143079184|NCT02552212|515828595|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
143079185|NCT02552212|515828596|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
143079186|NCT02552212|515828594|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
143079187|NCT02552212|515828595|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
143079188|NCT02552212|515828596|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
143079189|NCT02552212|515828594|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
143079190|NCT02552212|515828595|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
143079191|NCT02552212|515828596|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
143079192|NCT02552212|515828594|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
143079193|NCT02552212|515828595|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
143079194|NCT02552212|515828596|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
143079195|NCT02552212|515828594|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
143079196|NCT02552212|515828595|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
143079197|NCT02552212|515828596|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
143079198|NCT02552212|515828594|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
143079199|NCT02552212|515828595|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
143079200|NCT02552212|515828596|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
143079201|NCT02552212|515828594|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
143079202|NCT02552212|515828595|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
143079203|NCT02552212|515828596|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
143079204|NCT02552212|515828594|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
143079205|NCT02552212|515828595|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
143079206|NCT02552212|515828596|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
143079207|NCT02552212|515828594|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
143079208|NCT02552212|515828595|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
143079209|NCT02552212|515828596|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
143079210|NCT02552212|515828594|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
143079211|NCT02552212|515828595|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
143079212|NCT02552212|515828596|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
143079213|NCT02552212|515828594|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
143248930|NCT01904773|516465044|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
143079214|NCT02552212|515828595|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
143079215|NCT02552212|515828596|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
143079216|NCT02552212|515828594|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
143079217|NCT02552212|515828595|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
143079218|NCT02552212|515828596|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
143079219|NCT02552212|515828594|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
143079220|NCT02552212|515828595|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
143079221|NCT02552212|515828596|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
143079222|NCT02552212|515828594|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
143079223|NCT02552212|515828595|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
143079224|NCT02552212|515828596|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
143079225|NCT02552212|515828594|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
143079226|NCT02552212|515828595|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
143079227|NCT02552212|515828596|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
143079228|NCT02552212|515828594|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
143079229|NCT02552212|515828595|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
143079230|NCT02552212|515828596|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
143079231|NCT02552212|515828594|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
143079232|NCT02552212|515828595|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
143079233|NCT02552212|515828596|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
143079234|NCT02552212|515828594|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
143079235|NCT02552212|515828595|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
143079236|NCT02552212|515828596|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
143079237|NCT02552212|515828594|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
143079238|NCT02552212|515828595|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
143079239|NCT02552212|515828596|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
143079240|NCT02552212|515828594|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
143079241|NCT02552212|515828595|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
143079242|NCT02552212|515828596|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
143079243|NCT02552212|515828594|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
143079244|NCT02552212|515828595|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
143079245|NCT02552212|515828596|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
143079246|NCT01671332|515828597|FG000|Overall Study|Withdrawal by Subject|1|||
143079247|NCT01671332|515828598|FG001|Overall Study|Withdrawal by Subject|1|||
143079248|NCT02728843|515828599|FG000|Overall Study|Adverse Event|0|||
143079249|NCT02728843|515828600|FG001|Overall Study|Adverse Event|2|||
143079250|NCT02728843|515828601|FG002|Overall Study|Adverse Event|3|||
143079251|NCT02728843|515828602|FG003|Overall Study|Adverse Event|1|||
143079252|NCT02728843|515828603|FG004|Overall Study|Adverse Event|2|||
143079253|NCT02728843|515828599|FG000|Overall Study|Lack of Efficacy|0|||
143079254|NCT02728843|515828600|FG001|Overall Study|Lack of Efficacy|1|||
143172999|NCT04712669|516181641|FG006|Double Blind Phase|Physician Decision|0|||
143173000|NCT04712669|516181642|FG007|Double Blind Phase|Physician Decision|0|||
143173001|NCT04712669|516181635|FG000|Double Blind Phase|Withdrawal by Subject|3|||
143173002|NCT04712669|516181636|FG001|Double Blind Phase|Withdrawal by Subject|6|||
143173003|NCT04712669|516181637|FG002|Double Blind Phase|Withdrawal by Subject|0|||
143173004|NCT04712669|516181638|FG003|Double Blind Phase|Withdrawal by Subject|0|||
143173005|NCT04712669|516181639|FG004|Double Blind Phase|Withdrawal by Subject|0|||
143173006|NCT04712669|516181640|FG005|Double Blind Phase|Withdrawal by Subject|0|||
143173007|NCT04712669|516181641|FG006|Double Blind Phase|Withdrawal by Subject|0|||
143173008|NCT04712669|516181642|FG007|Double Blind Phase|Withdrawal by Subject|0|||
143173009|NCT04712669|516181635|FG000|Double Blind Phase|Termination by Sponsor|0|||
143079255|NCT02728843|515828601|FG002|Overall Study|Lack of Efficacy|1|||
143079256|NCT02728843|515828602|FG003|Overall Study|Lack of Efficacy|0|||
143079257|NCT02728843|515828603|FG004|Overall Study|Lack of Efficacy|0|||
143079258|NCT02728843|515828599|FG000|Overall Study|Protocol Violation|2|||
143079259|NCT02728843|515828600|FG001|Overall Study|Protocol Violation|0|||
143173010|NCT04712669|516181636|FG001|Double Blind Phase|Termination by Sponsor|0|||
143079260|NCT02728843|515828601|FG002|Overall Study|Protocol Violation|4|||
143079261|NCT02728843|515828602|FG003|Overall Study|Protocol Violation|2|||
143079262|NCT02728843|515828603|FG004|Overall Study|Protocol Violation|2|||
143079263|NCT02728843|515828599|FG000|Overall Study|Withdrawal by Subject|1|||
143079264|NCT02728843|515828600|FG001|Overall Study|Withdrawal by Subject|0|||
143079265|NCT02728843|515828601|FG002|Overall Study|Withdrawal by Subject|0|||
143079266|NCT02728843|515828602|FG003|Overall Study|Withdrawal by Subject|1|||
143079267|NCT02728843|515828603|FG004|Overall Study|Withdrawal by Subject|0|||
143079268|NCT02728843|515828599|FG000|Overall Study|Use of rescue medication|0|||
143079269|NCT02728843|515828600|FG001|Overall Study|Use of rescue medication|2|||
143079270|NCT02728843|515828601|FG002|Overall Study|Use of rescue medication|0|||
143079271|NCT02728843|515828602|FG003|Overall Study|Use of rescue medication|2|||
143079272|NCT02728843|515828603|FG004|Overall Study|Use of rescue medication|1|||
143079273|NCT00205803|515828605|FG000|Infant Series|Lost to Follow-up|10|||
143079274|NCT00205803|515828606|FG001|Infant Series|Lost to Follow-up|4|||
143079275|NCT00205803|515828605|FG000|Infant Series|Withdrawal by Subject|2|||
143079276|NCT00205803|515828606|FG001|Infant Series|Withdrawal by Subject|5|||
143079277|NCT00205803|515828605|FG000|Infant Series|Physician Decision|3|||
143079278|NCT00205803|515828606|FG001|Infant Series|Physician Decision|1|||
143079279|NCT00205803|515828605|FG000|Infant Series|Protocol Violation|1|||
143079280|NCT00205803|515828606|FG001|Infant Series|Protocol Violation|0|||
143079281|NCT00205803|515828605|FG000|Infant Series|Lost Kaiser coverage|0|||
143079282|NCT00205803|515828606|FG001|Infant Series|Lost Kaiser coverage|1|||
143079283|NCT00205803|515828605|FG000|Infant Series|Non-compliant|1|||
143079284|NCT00205803|515828606|FG001|Infant Series|Non-compliant|0|||
143079285|NCT00205803|515828605|FG000|Infant Series|Sponsor request|1|||
143079286|NCT00205803|515828606|FG001|Infant Series|Sponsor request|0|||
143079287|NCT00205803|515828605|FG000|After Infant Series|Adverse Event|1|||
143079288|NCT00205803|515828606|FG001|After Infant Series|Adverse Event|1|||
143079289|NCT00205803|515828605|FG000|After Infant Series|Protocol Violation|1|||
143079290|NCT00205803|515828606|FG001|After Infant Series|Protocol Violation|1|||
143079291|NCT00205803|515828605|FG000|After Infant Series|Lost to Follow-up|2|||
143079292|NCT00205803|515828606|FG001|After Infant Series|Lost to Follow-up|1|||
143079293|NCT00205803|515828605|FG000|After Infant Series|Physician Decision|3|||
143079294|NCT00205803|515828606|FG001|After Infant Series|Physician Decision|2|||
143079295|NCT00205803|515828605|FG000|After Infant Series|Withdrawal by Subject|1|||
143079296|NCT00205803|515828606|FG001|After Infant Series|Withdrawal by Subject|4|||
143079297|NCT00205803|515828605|FG000|After Infant Series|Other|10|||
143079298|NCT00205803|515828606|FG001|After Infant Series|Other|4|||
143079299|NCT00205803|515828605|FG000|Toddler Dose|Lost to Follow-up|2|||
143079300|NCT00205803|515828606|FG001|Toddler Dose|Lost to Follow-up|3|||
143079301|NCT00351533|515828607|FG000|Overall Study|Extubated before first BAL|1|||
143079302|NCT00351533|515828608|FG001|Overall Study|Extubated before first BAL|0|||
143079303|NCT00351533|515828607|FG000|Overall Study|Lost to Follow-up|1|||
143079304|NCT00351533|515828608|FG001|Overall Study|Lost to Follow-up|3|||
143079305|NCT00351533|515828607|FG000|Overall Study|Physician Decision|0|||
143079306|NCT00351533|515828608|FG001|Overall Study|Physician Decision|1|||
143079307|NCT00351533|515828607|FG000|Overall Study|Withdrawal by Subject|0|||
143079308|NCT00351533|515828608|FG001|Overall Study|Withdrawal by Subject|1|||
143079309|NCT01200069|515830173|FG000|Overall Study|Withdrawal by Subject|0|||
143079310|NCT01200069|515830174|FG001|Overall Study|Withdrawal by Subject|1|||
143079311|NCT03408639|515830182|FG000|Overall Study|Death|5|||
143079312|NCT03408639|515830183|FG001|Overall Study|Death|5|||
143079313|NCT03408639|515830182|FG000|Overall Study|Lost to Follow-up|1|||
143079314|NCT03408639|515830183|FG001|Overall Study|Lost to Follow-up|4|||
143079315|NCT03408639|515830182|FG000|Overall Study|Withdrawal by Subject|2|||
143079316|NCT03408639|515830183|FG001|Overall Study|Withdrawal by Subject|7|||
143079317|NCT03408639|515830182|FG000|Overall Study|Physician Decision|3|||
143079318|NCT03408639|515830183|FG001|Overall Study|Physician Decision|6|||
143079319|NCT04998851|515830184|FG000|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
143079320|NCT04998851|515830185|FG001|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
143079321|NCT04998851|515830184|FG000|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
143079322|NCT04998851|515830185|FG001|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
143079323|NCT00070499|515830186|FG000|Overall Study|Adverse Event|6|||
143079324|NCT00070499|515830187|FG001|Overall Study|Adverse Event|6|||
143248931|NCT04518995|516465045|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
143248932|NCT04518995|516465046|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
143079325|NCT00070499|515830188|FG002|Overall Study|Adverse Event|19|||
143079326|NCT00070499|515830189|FG003|Overall Study|Adverse Event|15|||
143079327|NCT00070499|515830186|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
143079328|NCT00070499|515830187|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
143079329|NCT00070499|515830188|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
143079330|NCT00070499|515830189|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
143079331|NCT00070499|515830186|FG000|Overall Study|Progression/relapse|4|||
143079332|NCT00070499|515830187|FG001|Overall Study|Progression/relapse|2|||
143079333|NCT00070499|515830188|FG002|Overall Study|Progression/relapse|1|||
143079334|NCT00070499|515830189|FG003|Overall Study|Progression/relapse|4|||
143079335|NCT00070499|515830186|FG000|Overall Study|Death|1|||
143079336|NCT00070499|515830187|FG001|Overall Study|Death|1|||
143079337|NCT00070499|515830188|FG002|Overall Study|Death|1|||
143079338|NCT00070499|515830189|FG003|Overall Study|Death|2|||
143079339|NCT00070499|515830186|FG000|Overall Study|Other - not protocol specified|7|||
143079340|NCT00070499|515830187|FG001|Overall Study|Other - not protocol specified|3|||
143079341|NCT00070499|515830188|FG002|Overall Study|Other - not protocol specified|12|||
143079342|NCT00070499|515830189|FG003|Overall Study|Other - not protocol specified|20|||
143079343|NCT00070499|515830186|FG000|Overall Study|Still on protocol treatment|10|||
143079344|NCT00070499|515830187|FG001|Overall Study|Still on protocol treatment|4|||
143079345|NCT00070499|515830188|FG002|Overall Study|Still on protocol treatment|79|||
143079346|NCT00070499|515830189|FG003|Overall Study|Still on protocol treatment|57|||
143079347|NCT00070499|515830186|FG000|Overall Study|Did not start treatment|1|||
143079348|NCT00070499|515830187|FG001|Overall Study|Did not start treatment|0|||
143079349|NCT00070499|515830188|FG002|Overall Study|Did not start treatment|0|||
143079350|NCT00070499|515830189|FG003|Overall Study|Did not start treatment|2|||
143079351|NCT00070499|515830186|FG000|Overall Study|Not eligible|2|||
143079352|NCT00070499|515830187|FG001|Overall Study|Not eligible|5|||
143079353|NCT00070499|515830188|FG002|Overall Study|Not eligible|3|||
143079354|NCT00070499|515830189|FG003|Overall Study|Not eligible|2|||
143079355|NCT01924754|515830190|FG000|Overall Study|Lost to Follow-up|1|||
143079356|NCT01924754|515830191|FG001|Overall Study|Lost to Follow-up|2|||
143079357|NCT01924754|515830192|FG002|Overall Study|Lost to Follow-up|1|||
143079358|NCT01924754|515830190|FG000|Overall Study|Pregnancy|0|||
143079359|NCT01924754|515830191|FG001|Overall Study|Pregnancy|1|||
143079360|NCT01924754|515830192|FG002|Overall Study|Pregnancy|2|||
143079361|NCT03022084|515830196|FG000|Overall Study|Lost to Follow-up|2|||
143079362|NCT03022084|515830197|FG001|Overall Study|Lost to Follow-up|3|||
143079363|NCT03743415|515830198|FG000|Overall Study|Death|5|||
143079364|NCT03743415|515830199|FG001|Overall Study|Death|3|||
143079365|NCT03743415|515830200|FG002|Overall Study|Death|1|||
143079366|NCT03743415|515830201|FG003|Overall Study|Death|4|||
143079367|NCT03743415|515830202|FG004|Overall Study|Death|0|||
143079368|NCT03743415|515830203|FG005|Overall Study|Death|0|||
143079369|NCT03743415|515830204|FG006|Overall Study|Death|0|||
143079370|NCT03743415|515830205|FG007|Overall Study|Death|0|||
143079371|NCT03743415|515830206|FG008|Overall Study|Death|1|||
143079372|NCT03743415|515830207|FG009|Overall Study|Death|0|||
143079373|NCT03743415|515830198|FG000|Overall Study|Withdrawal by Subject|1|||
143079374|NCT03743415|515830199|FG001|Overall Study|Withdrawal by Subject|0|||
143079375|NCT03743415|515830200|FG002|Overall Study|Withdrawal by Subject|4|||
143079376|NCT03743415|515830201|FG003|Overall Study|Withdrawal by Subject|5|||
143079377|NCT03743415|515830202|FG004|Overall Study|Withdrawal by Subject|5|||
143079378|NCT03743415|515830203|FG005|Overall Study|Withdrawal by Subject|2|||
143079379|NCT03743415|515830204|FG006|Overall Study|Withdrawal by Subject|2|||
143079380|NCT03743415|515830205|FG007|Overall Study|Withdrawal by Subject|5|||
143079381|NCT03743415|515830206|FG008|Overall Study|Withdrawal by Subject|9|||
143079382|NCT03743415|515830207|FG009|Overall Study|Withdrawal by Subject|10|||
143079383|NCT03743415|515830198|FG000|Overall Study|Lost to Follow-up|2|||
143079384|NCT03743415|515830199|FG001|Overall Study|Lost to Follow-up|0|||
143079385|NCT03743415|515830200|FG002|Overall Study|Lost to Follow-up|2|||
143079386|NCT03743415|515830201|FG003|Overall Study|Lost to Follow-up|1|||
143079387|NCT03743415|515830202|FG004|Overall Study|Lost to Follow-up|1|||
143079388|NCT03743415|515830203|FG005|Overall Study|Lost to Follow-up|0|||
143079389|NCT03743415|515830204|FG006|Overall Study|Lost to Follow-up|1|||
143079390|NCT03743415|515830205|FG007|Overall Study|Lost to Follow-up|4|||
143079391|NCT03743415|515830206|FG008|Overall Study|Lost to Follow-up|13|||
143173011|NCT04712669|516181637|FG002|Double Blind Phase|Termination by Sponsor|1|||
143173012|NCT04712669|516181638|FG003|Double Blind Phase|Termination by Sponsor|0|||
143079392|NCT03743415|515830207|FG009|Overall Study|Lost to Follow-up|13|||
143079393|NCT02679235|515830211|FG000|Overall Study|Withdrawal by Subject|3|||
143079394|NCT02679235|515830211|FG000|Overall Study|Adverse Event|1|||
143079395|NCT00094861|515830212|FG000|Overall Study|Adverse Event|5|||
143079396|NCT00094861|515830213|FG001|Overall Study|Adverse Event|2|||
143079397|NCT00094861|515830212|FG000|Overall Study|Withdrawal by Subject|5|||
143079398|NCT00094861|515830213|FG001|Overall Study|Withdrawal by Subject|3|||
143079399|NCT00094861|515830212|FG000|Overall Study|Physician Decision|1|||
143079400|NCT00094861|515830213|FG001|Overall Study|Physician Decision|1|||
143079401|NCT00094861|515830212|FG000|Overall Study|Lost to Follow-up|0|||
143079402|NCT00094861|515830213|FG001|Overall Study|Lost to Follow-up|1|||
143079403|NCT00094861|515830212|FG000|Overall Study|Death|4|||
143079404|NCT00094861|515830213|FG001|Overall Study|Death|2|||
143079405|NCT00094861|515830212|FG000|Overall Study|Other|3|||
143079406|NCT00094861|515830213|FG001|Overall Study|Other|0|||
143079407|NCT00282919|515830216|FG000|Overall Study|Lack of Efficacy|4|||
143079408|NCT00282919|515830216|FG000|Overall Study|Withdrawal by Subject|1|||
143079409|NCT00282919|515830216|FG000|Overall Study|Asymptomatic Parasitemia|2|||
143079410|NCT01433549|515830217|FG000|Phase 2: Second Study Product|Adverse Event|0|||
143079411|NCT01433549|515830218|FG001|Phase 2: Second Study Product|Adverse Event|1|||
143079412|NCT01438996|515830219|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
143079413|NCT01438996|515830220|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
143079414|NCT01438996|515830221|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
143079415|NCT02540850|515830224|FG000|Overall Study|Lost to Follow-up|69|||
143079416|NCT02540850|515830225|FG001|Overall Study|Lost to Follow-up|66|||
143079417|NCT02540850|515830226|FG002|Overall Study|Lost to Follow-up|34|||
143079418|NCT00264550|515830227|FG000|Overall Study|Death|0|||
143079419|NCT00264550|515830228|FG001|Overall Study|Death|3|||
143079420|NCT00264550|515830229|FG002|Overall Study|Death|0|||
143079421|NCT00264550|515830230|FG003|Overall Study|Death|0|||
143079422|NCT00264550|515830227|FG000|Overall Study|Lost to Follow-up|3|||
143079423|NCT00264550|515830228|FG001|Overall Study|Lost to Follow-up|1|||
143079424|NCT00264550|515830229|FG002|Overall Study|Lost to Follow-up|1|||
143079425|NCT00264550|515830230|FG003|Overall Study|Lost to Follow-up|1|||
143079426|NCT00264550|515830227|FG000|Overall Study|Adverse Event|23|||
143079427|NCT00264550|515830228|FG001|Overall Study|Adverse Event|18|||
143079428|NCT00264550|515830229|FG002|Overall Study|Adverse Event|9|||
143079429|NCT00264550|515830230|FG003|Overall Study|Adverse Event|14|||
143079430|NCT00264550|515830227|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
143079431|NCT00264550|515830228|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
143079432|NCT00264550|515830229|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
143079433|NCT00264550|515830230|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
143079434|NCT00264550|515830227|FG000|Overall Study|Discontinued oral study agent|0|||
143079435|NCT00264550|515830228|FG001|Overall Study|Discontinued oral study agent|1|||
143079436|NCT00264550|515830229|FG002|Overall Study|Discontinued oral study agent|0|||
143079437|NCT00264550|515830230|FG003|Overall Study|Discontinued oral study agent|0|||
143079438|NCT00264550|515830227|FG000|Overall Study|Other|13|||
143079439|NCT00264550|515830228|FG001|Overall Study|Other|7|||
143079440|NCT00264550|515830229|FG002|Overall Study|Other|3|||
143079441|NCT00264550|515830230|FG003|Overall Study|Other|9|||
143079442|NCT02246114|515830231|FG000|Overall Study|miscarriage|1|||
143079443|NCT02246114|515830232|FG001|Overall Study|miscarriage|0|||
143079444|NCT02794246|515830236|FG000|Overall Study|Withdrawal by Subject|2|||
143079445|NCT02794246|515830236|FG000|Overall Study|Physician Decision|4|||
143079446|NCT04893018|515830240|FG000|Overall Study|Lost to Follow-up|1|||
143079447|NCT04893018|515830241|FG001|Overall Study|Lost to Follow-up|0|||
143079448|NCT04893018|515830240|FG000|Overall Study|Withdrawal by Subject|2|||
143079449|NCT04893018|515830241|FG001|Overall Study|Withdrawal by Subject|0|||
143079450|NCT04893018|515830240|FG000|Overall Study|Study Terminated|1|||
143079451|NCT04893018|515830241|FG001|Overall Study|Study Terminated|2|||
143079452|NCT02460679|515830251|FG000|Overall Study|Investigator Decision|1|||
143079453|NCT02460679|515830251|FG000|Overall Study|Withdrawal by Subject|4|||
143079454|NCT00339144|515830259|FG000|Overall Study|Disease progression|5|||
143079455|NCT00339144|515830260|FG001|Overall Study|Disease progression|2|||
143173013|NCT04712669|516181639|FG004|Double Blind Phase|Termination by Sponsor|0|||
143173014|NCT04712669|516181640|FG005|Double Blind Phase|Termination by Sponsor|0|||
143173015|NCT04712669|516181641|FG006|Double Blind Phase|Termination by Sponsor|0|||
143173016|NCT04712669|516181642|FG007|Double Blind Phase|Termination by Sponsor|0|||
143173017|NCT04712669|516181635|FG000|Open Label Phase|Adverse Event|0|||
143173018|NCT04712669|516181636|FG001|Open Label Phase|Adverse Event|0|||
143173019|NCT04712669|516181637|FG002|Open Label Phase|Adverse Event|0|||
143173020|NCT04712669|516181638|FG003|Open Label Phase|Adverse Event|1|||
143173021|NCT04712669|516181639|FG004|Open Label Phase|Adverse Event|1|||
143079456|NCT00339144|515830261|FG002|Overall Study|Disease progression|2|||
143079457|NCT00339144|515830259|FG000|Overall Study|Study drug toxicity|3|||
143079458|NCT00339144|515830260|FG001|Overall Study|Study drug toxicity|1|||
143079459|NCT00339144|515830261|FG002|Overall Study|Study drug toxicity|1|||
143079460|NCT00339144|515830259|FG000|Overall Study|Participant's request to discontinuation|1|||
143079461|NCT00339144|515830260|FG001|Overall Study|Participant's request to discontinuation|0|||
143079462|NCT00339144|515830261|FG002|Overall Study|Participant's request to discontinuation|1|||
143079463|NCT00478426|515830262|FG000|Overall Study|Withdrawal by Subject|1|||
143079464|NCT00789737|515830263|FG000|Overall Study|Withdrawal by Subject|13|||
143079465|NCT00789737|515830264|FG001|Overall Study|Withdrawal by Subject|22|||
143079466|NCT00789737|515830263|FG000|Overall Study|Lost to Follow-up|10|||
143079467|NCT00789737|515830264|FG001|Overall Study|Lost to Follow-up|14|||
143079468|NCT00789737|515830263|FG000|Overall Study|Adverse Event|8|||
143079469|NCT00789737|515830264|FG001|Overall Study|Adverse Event|8|||
143079470|NCT00789737|515830263|FG000|Overall Study|Protocol Violation|3|||
143079471|NCT00789737|515830264|FG001|Overall Study|Protocol Violation|0|||
143079472|NCT00789737|515830263|FG000|Overall Study|Lack of Efficacy|3|||
143079473|NCT00789737|515830264|FG001|Overall Study|Lack of Efficacy|0|||
143079474|NCT00789737|515830263|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
143079475|NCT00789737|515830264|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
143079476|NCT00789737|515830263|FG000|Overall Study|Other|11|||
143079477|NCT00789737|515830264|FG001|Overall Study|Other|7|||
143079478|NCT05199090|515830269|FG000|Overall Study|Adverse Event|1|||
143079479|NCT05199090|515830270|FG001|Overall Study|Adverse Event|4|||
143079480|NCT05199090|515830271|FG002|Overall Study|Adverse Event|0|||
143079481|NCT05199090|515830272|FG003|Overall Study|Adverse Event|0|||
143079482|NCT05199090|515830273|FG004|Overall Study|Adverse Event|0|||
143079483|NCT05199090|515830274|FG005|Overall Study|Adverse Event|0|||
143079484|NCT05199090|515830269|FG000|Overall Study|Lost to Follow-up|1|||
143079485|NCT05199090|515830270|FG001|Overall Study|Lost to Follow-up|0|||
143079486|NCT05199090|515830271|FG002|Overall Study|Lost to Follow-up|1|||
143079487|NCT05199090|515830272|FG003|Overall Study|Lost to Follow-up|4|||
143079488|NCT05199090|515830273|FG004|Overall Study|Lost to Follow-up|0|||
143079489|NCT05199090|515830274|FG005|Overall Study|Lost to Follow-up|5|||
143079490|NCT05199090|515830269|FG000|Overall Study|Physician Decision|0|||
143079491|NCT05199090|515830270|FG001|Overall Study|Physician Decision|0|||
143079492|NCT05199090|515830271|FG002|Overall Study|Physician Decision|0|||
143079493|NCT05199090|515830272|FG003|Overall Study|Physician Decision|0|||
143079494|NCT05199090|515830273|FG004|Overall Study|Physician Decision|0|||
143079495|NCT05199090|515830274|FG005|Overall Study|Physician Decision|1|||
143079496|NCT05199090|515830269|FG000|Overall Study|Study terminated by sponsor|0|||
143079497|NCT05199090|515830270|FG001|Overall Study|Study terminated by sponsor|6|||
143079498|NCT05199090|515830271|FG002|Overall Study|Study terminated by sponsor|0|||
143079499|NCT05199090|515830272|FG003|Overall Study|Study terminated by sponsor|0|||
143079500|NCT05199090|515830273|FG004|Overall Study|Study terminated by sponsor|0|||
143079501|NCT05199090|515830274|FG005|Overall Study|Study terminated by sponsor|5|||
143079502|NCT05199090|515830269|FG000|Overall Study|Subject decision|0|||
143079503|NCT05199090|515830270|FG001|Overall Study|Subject decision|4|||
143079504|NCT05199090|515830271|FG002|Overall Study|Subject decision|0|||
143079505|NCT05199090|515830272|FG003|Overall Study|Subject decision|2|||
143079506|NCT05199090|515830273|FG004|Overall Study|Subject decision|5|||
143079507|NCT05199090|515830274|FG005|Overall Study|Subject decision|2|||
143079508|NCT03489109|515830275|FG000|Overall Study|Lost to Follow-up|1|||
143079509|NCT03489109|515830276|FG001|Overall Study|Lost to Follow-up|2|||
143079510|NCT03485365|515830277|FG000|Overall Study|Protocol Violation|0|||
143079511|NCT03485365|515830278|FG001|Overall Study|Protocol Violation|0|||
143079512|NCT03485365|515830279|FG002|Overall Study|Protocol Violation|0|||
143079513|NCT03485365|515830280|FG003|Overall Study|Protocol Violation|1|||
143079514|NCT03485365|515830281|FG004|Overall Study|Protocol Violation|0|||
143079515|NCT03485365|515830282|FG005|Overall Study|Protocol Violation|0|||
143079516|NCT03485365|515830283|FG006|Overall Study|Protocol Violation|1|||
143079517|NCT03485365|515830284|FG007|Overall Study|Protocol Violation|0|||
143079518|NCT03485365|515830285|FG008|Overall Study|Protocol Violation|0|||
143079519|NCT01547130|515830286|FG000|Overall Study|Lost to Follow-up|9|||
143079520|NCT01547130|515830287|FG001|Overall Study|Lost to Follow-up|5|||
143079521|NCT00843635|515830288|FG000|Overall Study|Adverse Event|2|||
143079522|NCT00843635|515830289|FG001|Overall Study|Adverse Event|2|||
143079523|NCT00843635|515830290|FG002|Overall Study|Adverse Event|0|||
143079524|NCT02714426|515830294|FG000|Overall Study|Withdrawal by Subject|2|||
143079525|NCT02714426|515830295|FG001|Overall Study|Withdrawal by Subject|2|||
143079526|NCT00908310|515830299|FG000|Overall Study|Death|37|||
143079527|NCT00908310|515830299|FG000|Overall Study|Withdrawal by Subject|7|||
143079528|NCT00908310|515830299|FG000|Overall Study|Lost to Follow-up|7|||
143079529|NCT00908310|515830299|FG000|Overall Study|Screening failure|5|||
143079530|NCT00908310|515830299|FG000|Overall Study|Other reasons|4|||
143079531|NCT02290223|515830300|FG000|6 Months|Lost to Follow-up|9|||
143079532|NCT02290223|515830301|FG001|6 Months|Lost to Follow-up|6|||
143079533|NCT02290223|515830300|FG000|6 Months|Withdrawal by Subject|5|||
143079534|NCT02290223|515830301|FG001|6 Months|Withdrawal by Subject|0|||
143079535|NCT02290223|515830300|FG000|6 Months|deceased (not related to study)|2|||
143079536|NCT02290223|515830301|FG001|6 Months|deceased (not related to study)|0|||
143079537|NCT02290223|515830300|FG000|12 Months|Lost to Follow-up|16|||
143079538|NCT02290223|515830301|FG001|12 Months|Lost to Follow-up|10|||
143079539|NCT02290223|515830300|FG000|12 Months|Refusal|0|||
143079540|NCT02290223|515830301|FG001|12 Months|Refusal|1|||
143079541|NCT00813800|515830302|FG000|Overall Study|Screen Failure after Consent|2|||
143079542|NCT00813800|515830302|FG000|Overall Study|Adverse Event|1|||
143079543|NCT00813800|515830302|FG000|Overall Study|Worsening of depression|2|||
143079544|NCT00813800|515830302|FG000|Overall Study|Physician Decision|1|||
143079545|NCT03456453|515830303|FG000|Overall Study|Withdrawal by Subject|2|||
143079546|NCT03456453|515830304|FG001|Overall Study|Withdrawal by Subject|0|||
143079547|NCT03456453|515830303|FG000|Overall Study|Not released to community|1|||
143079548|NCT03456453|515830304|FG001|Overall Study|Not released to community|5|||
143079549|NCT03456453|515830303|FG000|Overall Study|Lost to Follow-up|0|||
143079550|NCT03456453|515830304|FG001|Overall Study|Lost to Follow-up|2|||
143079551|NCT02785952|515830305|FG000|Overall Study|Adverse Event|31|||
143079552|NCT02785952|515830306|FG001|Overall Study|Adverse Event|19|||
143079553|NCT02785952|515830305|FG000|Overall Study|Refusal unrelated to adverse events|10|||
143079554|NCT02785952|515830306|FG001|Overall Study|Refusal unrelated to adverse events|5|||
143079555|NCT02785952|515830305|FG000|Overall Study|Disease progression/relapse|61|||
143079556|NCT02785952|515830306|FG001|Overall Study|Disease progression/relapse|89|||
143079557|NCT02785952|515830305|FG000|Overall Study|Death|11|||
143079558|NCT02785952|515830306|FG001|Overall Study|Death|7|||
143079559|NCT02785952|515830305|FG000|Overall Study|Other- not protocol specified|6|||
143079560|NCT02785952|515830306|FG001|Overall Study|Other- not protocol specified|4|||
143079561|NCT02785952|515830305|FG000|Overall Study|On protocol treatment|6|||
143079562|NCT02785952|515830306|FG001|Overall Study|On protocol treatment|3|||
143079563|NCT00896480|515830307|FG000|Overall Study|Disease progression/recurrence|21|||
143079564|NCT02071849|515830313|FG000|6-month Primary Endpoint|Did not receive device|4|||
143079565|NCT02071849|515830313|FG000|6-month Primary Endpoint|Adverse Event|1|||
143079566|NCT02071849|515830313|FG000|2-year Extended Follow-up|Adverse Event|1|||
143079567|NCT03255655|515830314|FG000|Overall Study|Lost to Follow-up|7|||
143079568|NCT03255655|515830315|FG001|Overall Study|Lost to Follow-up|4|||
143079569|NCT00658021|515830317|FG000|28-Week Treatment Period|Adverse Event|3|||
143079570|NCT00658021|515830318|FG001|28-Week Treatment Period|Adverse Event|1|||
143079571|NCT00658021|515830319|FG002|28-Week Treatment Period|Adverse Event|0|||
143079572|NCT00658021|515830317|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
143079573|NCT00658021|515830318|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
143079574|NCT00658021|515830319|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
143079575|NCT00658021|515830317|FG000|28-Week Treatment Period|Protocol Violation|0|||
143079576|NCT00658021|515830318|FG001|28-Week Treatment Period|Protocol Violation|2|||
143079577|NCT00658021|515830319|FG002|28-Week Treatment Period|Protocol Violation|1|||
143079578|NCT00658021|515830317|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
143079579|NCT00658021|515830318|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
143079580|NCT00658021|515830319|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
143079581|NCT00658021|515830317|FG000|28-Week Treatment Period|Physician Decision|1|||
143079582|NCT00658021|515830318|FG001|28-Week Treatment Period|Physician Decision|2|||
143079583|NCT00658021|515830319|FG002|28-Week Treatment Period|Physician Decision|1|||
143079584|NCT00658021|515830317|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
143079585|NCT00658021|515830318|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
143079586|NCT00658021|515830319|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
143079587|NCT00658021|515830317|FG000|28-Week Treatment Period|Loss of glucose control|1|||
143079588|NCT00658021|515830318|FG001|28-Week Treatment Period|Loss of glucose control|1|||
143079589|NCT00658021|515830319|FG002|28-Week Treatment Period|Loss of glucose control|10|||
143079590|NCT00658021|515830317|FG000|28-Week Treatment Period|Other|2|||
143079591|NCT00658021|515830318|FG001|28-Week Treatment Period|Other|3|||
143079592|NCT00658021|515830319|FG002|28-Week Treatment Period|Other|1|||
143079593|NCT00658021|515830317|FG000|28-Week Treatment Period|Did not receive treatment|2|||
143079594|NCT00658021|515830318|FG001|28-Week Treatment Period|Did not receive treatment|0|||
143079595|NCT00658021|515830319|FG002|28-Week Treatment Period|Did not receive treatment|0|||
143079596|NCT00658021|515830317|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
143079597|NCT00658021|515830318|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
143079598|NCT00658021|515830319|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
143079599|NCT00658021|515830317|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
143079600|NCT00658021|515830318|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
143079601|NCT00658021|515830319|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
143173022|NCT04712669|516181640|FG005|Open Label Phase|Adverse Event|3|||
143173023|NCT04712669|516181641|FG006|Open Label Phase|Adverse Event|1|||
143173024|NCT04712669|516181642|FG007|Open Label Phase|Adverse Event|2|||
143173025|NCT04712669|516181635|FG000|Open Label Phase|Death|0|||
143173026|NCT04712669|516181636|FG001|Open Label Phase|Death|0|||
143173027|NCT04712669|516181637|FG002|Open Label Phase|Death|0|||
143079602|NCT02952898|515830327|FG000|Overall Study|Withdrawal by Subject|10|||
143079603|NCT02952898|515830328|FG001|Overall Study|Withdrawal by Subject|8|||
143079604|NCT02952898|515830329|FG002|Overall Study|Withdrawal by Subject|8|||
143079605|NCT02952898|515830327|FG000|Overall Study|Adverse Event|8|||
143079606|NCT02952898|515830328|FG001|Overall Study|Adverse Event|8|||
143079607|NCT02952898|515830329|FG002|Overall Study|Adverse Event|3|||
143079608|NCT02952898|515830327|FG000|Overall Study|Lost to Follow-up|3|||
143079609|NCT02952898|515830328|FG001|Overall Study|Lost to Follow-up|2|||
143173028|NCT04712669|516181638|FG003|Open Label Phase|Death|1|||
143173029|NCT04712669|516181639|FG004|Open Label Phase|Death|0|||
143173030|NCT04712669|516181640|FG005|Open Label Phase|Death|0|||
143173031|NCT04712669|516181641|FG006|Open Label Phase|Death|0|||
143173032|NCT04712669|516181642|FG007|Open Label Phase|Death|0|||
143173033|NCT04712669|516181635|FG000|Open Label Phase|Lack of Efficacy|0|||
143173034|NCT04712669|516181636|FG001|Open Label Phase|Lack of Efficacy|0|||
143173035|NCT04712669|516181637|FG002|Open Label Phase|Lack of Efficacy|0|||
143173036|NCT04712669|516181638|FG003|Open Label Phase|Lack of Efficacy|0|||
143173037|NCT04712669|516181639|FG004|Open Label Phase|Lack of Efficacy|1|||
143173038|NCT04712669|516181640|FG005|Open Label Phase|Lack of Efficacy|0|||
143173039|NCT04712669|516181641|FG006|Open Label Phase|Lack of Efficacy|0|||
143173040|NCT04712669|516181642|FG007|Open Label Phase|Lack of Efficacy|0|||
143173041|NCT04712669|516181635|FG000|Open Label Phase|Lost to Follow-up|0|||
143173042|NCT04712669|516181636|FG001|Open Label Phase|Lost to Follow-up|0|||
143173043|NCT04712669|516181637|FG002|Open Label Phase|Lost to Follow-up|0|||
143173044|NCT04712669|516181638|FG003|Open Label Phase|Lost to Follow-up|0|||
143173045|NCT04712669|516181639|FG004|Open Label Phase|Lost to Follow-up|0|||
143173046|NCT04712669|516181640|FG005|Open Label Phase|Lost to Follow-up|0|||
143173047|NCT04712669|516181641|FG006|Open Label Phase|Lost to Follow-up|1|||
143173048|NCT04712669|516181642|FG007|Open Label Phase|Lost to Follow-up|1|||
143079610|NCT02952898|515830329|FG002|Overall Study|Lost to Follow-up|2|||
143079611|NCT02952898|515830327|FG000|Overall Study|Non-compliance with study drug|1|||
143079612|NCT02952898|515830328|FG001|Overall Study|Non-compliance with study drug|1|||
143079613|NCT02952898|515830329|FG002|Overall Study|Non-compliance with study drug|2|||
143079614|NCT03462459|515830339|FG000|Overall Study|Death|1|||
143079615|NCT03462459|515830340|FG001|Overall Study|Death|0|||
143079616|NCT03462459|515830339|FG000|Overall Study|Lack of Efficacy|2|||
143079617|NCT03462459|515830340|FG001|Overall Study|Lack of Efficacy|4|||
143079618|NCT03462459|515830339|FG000|Overall Study|Lost to Follow-up|1|||
143079619|NCT03462459|515830340|FG001|Overall Study|Lost to Follow-up|3|||
143079620|NCT03462459|515830339|FG000|Overall Study|Unable to complete doses of study drug/placebo|0|||
143079621|NCT03462459|515830340|FG001|Overall Study|Unable to complete doses of study drug/placebo|3|||
143079622|NCT03462459|515830339|FG000|Overall Study|Withdrawal by Subject|3|||
143079623|NCT03462459|515830340|FG001|Overall Study|Withdrawal by Subject|2|||
143079624|NCT03462459|515830339|FG000|Overall Study|Unable to obtain stool samples at visit|0|||
143079625|NCT03462459|515830340|FG001|Overall Study|Unable to obtain stool samples at visit|1|||
143079626|NCT02551666|515830342|FG000|Overall Study|Withdrawal by Subject|1|||
143079627|NCT02551666|515830343|FG001|Overall Study|Withdrawal by Subject|3|||
143079628|NCT04051619|515830344|FG000|2nd Allocation (Cross Over)|Lost to Follow-up|1|||
143079629|NCT04051619|515830345|FG001|2nd Allocation (Cross Over)|Lost to Follow-up|2|||
143079630|NCT04051619|515830344|FG000|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
143079631|NCT04051619|515830345|FG001|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
143079632|NCT03132155|515831849|FG000|Overall Study|Lack of Efficacy|6|||
143079633|NCT03132155|515831849|FG000|Overall Study|Lost to Follow-up|1|||
143079634|NCT03132155|515831849|FG000|Overall Study|Withdrawal by Subject|1|||
143079635|NCT01443728|515831850|FG000|Overall Study|Lost to Follow-up|2|||
143079636|NCT01443728|515831851|FG001|Overall Study|Lost to Follow-up|0|||
143079637|NCT01443728|515831850|FG000|Overall Study|Withdrawal by Subject|1|||
143079638|NCT01443728|515831851|FG001|Overall Study|Withdrawal by Subject|1|||
143079639|NCT01443728|515831850|FG000|Overall Study|Adverse Event|0|||
143079640|NCT01443728|515831851|FG001|Overall Study|Adverse Event|2|||
143079641|NCT02135614|515831852|FG000|Overall Study|Randomized but Not Treated|2|||
143079642|NCT02135614|515831853|FG001|Overall Study|Randomized but Not Treated|1|||
143079643|NCT02135614|515831852|FG000|Overall Study|Adverse Event|0|||
143079644|NCT02135614|515831853|FG001|Overall Study|Adverse Event|1|||
143079645|NCT02135614|515831852|FG000|Overall Study|Death|1|||
143079646|NCT02135614|515831853|FG001|Overall Study|Death|0|||
143079647|NCT02135614|515831852|FG000|Overall Study|Investigator's Discretion|0|||
143079648|NCT02135614|515831853|FG001|Overall Study|Investigator's Discretion|1|||
143079649|NCT02135614|515831852|FG000|Overall Study|Withdrew Consent|2|||
143079650|NCT02135614|515831853|FG001|Overall Study|Withdrew Consent|2|||
143079651|NCT02135614|515831852|FG000|Overall Study|Lost to Follow-up|3|||
143079652|NCT02135614|515831853|FG001|Overall Study|Lost to Follow-up|0|||
143079653|NCT04602546|515831861|FG000|Overall Study|Training|2|||
143079654|NCT04602546|515831862|FG001|Overall Study|Training|2|||
143079655|NCT04602546|515831863|FG002|Overall Study|Training|1|||
143173049|NCT04712669|516181635|FG000|Open Label Phase|Physician Decision|0|||
143173050|NCT04712669|516181636|FG001|Open Label Phase|Physician Decision|0|||
143173051|NCT04712669|516181637|FG002|Open Label Phase|Physician Decision|0|||
143173052|NCT04712669|516181638|FG003|Open Label Phase|Physician Decision|1|||
143079656|NCT04602546|515831864|FG003|Overall Study|Training|2|||
143079657|NCT04602546|515831865|FG004|Overall Study|Training|0|||
143079658|NCT04602546|515831861|FG000|Overall Study|Randomized with disqualified data|2|||
143079659|NCT04602546|515831862|FG001|Overall Study|Randomized with disqualified data|0|||
143079660|NCT04602546|515831863|FG002|Overall Study|Randomized with disqualified data|2|||
143079661|NCT04602546|515831864|FG003|Overall Study|Randomized with disqualified data|5|||
143079662|NCT04602546|515831865|FG004|Overall Study|Randomized with disqualified data|3|||
143079663|NCT00603837|515831866|FG000|Overall Study|Physician Decision|3|||
143079664|NCT00603837|515831867|FG001|Overall Study|Physician Decision|0|||
143079665|NCT00425373|515831868|FG000|Overall Study|Adverse Event|2|||
143079666|NCT00425373|515831869|FG001|Overall Study|Adverse Event|2|||
143079667|NCT00425373|515831870|FG002|Overall Study|Adverse Event|0|||
143079668|NCT00425373|515831871|FG003|Overall Study|Adverse Event|1|||
143079669|NCT00425373|515831872|FG004|Overall Study|Adverse Event|4|||
143079670|NCT00425373|515831873|FG005|Overall Study|Adverse Event|6|||
143079671|NCT00425373|515831874|FG006|Overall Study|Adverse Event|2|||
143079672|NCT00425373|515831875|FG007|Overall Study|Adverse Event|3|||
143079673|NCT00425373|515831876|FG008|Overall Study|Adverse Event|8|||
143079674|NCT00425373|515831868|FG000|Overall Study|Lost to Follow-up|0|||
143079675|NCT00425373|515831869|FG001|Overall Study|Lost to Follow-up|1|||
143079676|NCT00425373|515831870|FG002|Overall Study|Lost to Follow-up|0|||
143079677|NCT00425373|515831871|FG003|Overall Study|Lost to Follow-up|0|||
143079678|NCT00425373|515831872|FG004|Overall Study|Lost to Follow-up|1|||
143079679|NCT00425373|515831873|FG005|Overall Study|Lost to Follow-up|0|||
143079680|NCT00425373|515831874|FG006|Overall Study|Lost to Follow-up|0|||
143079681|NCT00425373|515831875|FG007|Overall Study|Lost to Follow-up|0|||
143079682|NCT00425373|515831876|FG008|Overall Study|Lost to Follow-up|0|||
143079683|NCT00425373|515831868|FG000|Overall Study|Protocol Violation|1|||
143079684|NCT00425373|515831869|FG001|Overall Study|Protocol Violation|0|||
143079685|NCT00425373|515831870|FG002|Overall Study|Protocol Violation|1|||
143079686|NCT00425373|515831871|FG003|Overall Study|Protocol Violation|0|||
143079687|NCT00425373|515831872|FG004|Overall Study|Protocol Violation|0|||
143079688|NCT00425373|515831873|FG005|Overall Study|Protocol Violation|0|||
143079689|NCT00425373|515831874|FG006|Overall Study|Protocol Violation|0|||
143079690|NCT00425373|515831875|FG007|Overall Study|Protocol Violation|5|||
143079691|NCT00425373|515831876|FG008|Overall Study|Protocol Violation|3|||
143079692|NCT00425373|515831868|FG000|Overall Study|Withdrawal by Subject|2|||
143079693|NCT00425373|515831869|FG001|Overall Study|Withdrawal by Subject|0|||
143079694|NCT00425373|515831870|FG002|Overall Study|Withdrawal by Subject|2|||
143079695|NCT00425373|515831871|FG003|Overall Study|Withdrawal by Subject|1|||
143079696|NCT00425373|515831872|FG004|Overall Study|Withdrawal by Subject|4|||
143079697|NCT00425373|515831873|FG005|Overall Study|Withdrawal by Subject|0|||
143173053|NCT04712669|516181639|FG004|Open Label Phase|Physician Decision|0|||
143173054|NCT04712669|516181640|FG005|Open Label Phase|Physician Decision|0|||
143173055|NCT04712669|516181641|FG006|Open Label Phase|Physician Decision|0|||
143173056|NCT04712669|516181642|FG007|Open Label Phase|Physician Decision|0|||
143173057|NCT04712669|516181635|FG000|Open Label Phase|Withdrawal by Subject|0|||
143173058|NCT04712669|516181636|FG001|Open Label Phase|Withdrawal by Subject|0|||
143173059|NCT04712669|516181637|FG002|Open Label Phase|Withdrawal by Subject|0|||
143173060|NCT04712669|516181638|FG003|Open Label Phase|Withdrawal by Subject|1|||
143173061|NCT04712669|516181639|FG004|Open Label Phase|Withdrawal by Subject|5|||
143173062|NCT04712669|516181640|FG005|Open Label Phase|Withdrawal by Subject|5|||
143173063|NCT04712669|516181641|FG006|Open Label Phase|Withdrawal by Subject|0|||
143173064|NCT04712669|516181642|FG007|Open Label Phase|Withdrawal by Subject|4|||
143173065|NCT04712669|516181635|FG000|Open Label Phase|Termination by Sponsor|0|||
143173066|NCT04712669|516181636|FG001|Open Label Phase|Termination by Sponsor|0|||
143173067|NCT04712669|516181637|FG002|Open Label Phase|Termination by Sponsor|0|||
143173068|NCT04712669|516181638|FG003|Open Label Phase|Termination by Sponsor|11|||
143173069|NCT04712669|516181639|FG004|Open Label Phase|Termination by Sponsor|9|||
143173070|NCT04712669|516181640|FG005|Open Label Phase|Termination by Sponsor|14|||
143173071|NCT04712669|516181641|FG006|Open Label Phase|Termination by Sponsor|0|||
143173072|NCT04712669|516181642|FG007|Open Label Phase|Termination by Sponsor|14|||
143079698|NCT00425373|515831874|FG006|Overall Study|Withdrawal by Subject|2|||
143079699|NCT00425373|515831875|FG007|Overall Study|Withdrawal by Subject|2|||
143079700|NCT00425373|515831876|FG008|Overall Study|Withdrawal by Subject|2|||
143173073|NCT04464473|516181643|FG000|Overall Study|New piercing could not be removed for scanning|0|||
143173074|NCT04464473|516181644|FG001|Overall Study|New piercing could not be removed for scanning|0|||
143173075|NCT04464473|516181645|FG002|Overall Study|New piercing could not be removed for scanning|0|||
143248933|NCT04518995|516465047|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
143079701|NCT00425373|515831868|FG000|Overall Study|Lack of Efficacy|0|||
143079702|NCT00425373|515831869|FG001|Overall Study|Lack of Efficacy|0|||
143173076|NCT04464473|516181646|FG003|Overall Study|New piercing could not be removed for scanning|1|||
143248934|NCT04518995|516465045|FG000|Overall Study|Lack of Efficacy|2|||
143248935|NCT04518995|516465046|FG001|Overall Study|Lack of Efficacy|1|||
143079703|NCT00425373|515831870|FG002|Overall Study|Lack of Efficacy|0|||
143079704|NCT00425373|515831871|FG003|Overall Study|Lack of Efficacy|0|||
143079705|NCT00425373|515831872|FG004|Overall Study|Lack of Efficacy|1|||
143079706|NCT00425373|515831873|FG005|Overall Study|Lack of Efficacy|3|||
143079707|NCT00425373|515831874|FG006|Overall Study|Lack of Efficacy|3|||
143079708|NCT00425373|515831875|FG007|Overall Study|Lack of Efficacy|0|||
143079709|NCT00425373|515831876|FG008|Overall Study|Lack of Efficacy|5|||
143079710|NCT00253448|515831877|FG000|Overall Study|Withdrawal by Subject|1|||
143079711|NCT02564887|515831879|FG000|Overall Study|Lost to Follow-up|6|||
143079712|NCT02564887|515831880|FG001|Overall Study|Lost to Follow-up|0|||
143079713|NCT02052011|515831881|FG000|Overall Study|Lost to Follow-up|3|||
143079714|NCT02052011|515831882|FG001|Overall Study|Lost to Follow-up|0|||
143079715|NCT02052011|515831881|FG000|Overall Study|Withdrawal by Subject|1|||
143079716|NCT02052011|515831882|FG001|Overall Study|Withdrawal by Subject|2|||
143079717|NCT00000620|515831883|FG000|Overall Study|Death|86|||
143079718|NCT00000620|515831884|FG001|Overall Study|Death|67|||
143079719|NCT00000620|515831885|FG002|Overall Study|Death|112|||
143079720|NCT00000620|515831886|FG003|Overall Study|Death|126|||
143079721|NCT00000620|515831887|FG004|Overall Study|Death|64|||
143079722|NCT00000620|515831888|FG005|Overall Study|Death|77|||
143079723|NCT00000620|515831889|FG006|Overall Study|Death|91|||
143079724|NCT00000620|515831890|FG007|Overall Study|Death|95|||
143079725|NCT00000620|515831883|FG000|Overall Study|Lost to Follow-up|14|||
143079726|NCT00000620|515831884|FG001|Overall Study|Lost to Follow-up|14|||
143079727|NCT00000620|515831885|FG002|Overall Study|Lost to Follow-up|14|||
143079728|NCT00000620|515831886|FG003|Overall Study|Lost to Follow-up|14|||
143079729|NCT00000620|515831887|FG004|Overall Study|Lost to Follow-up|15|||
143079730|NCT00000620|515831888|FG005|Overall Study|Lost to Follow-up|15|||
143079731|NCT00000620|515831889|FG006|Overall Study|Lost to Follow-up|13|||
143079732|NCT00000620|515831890|FG007|Overall Study|Lost to Follow-up|14|||
143079733|NCT00000620|515831883|FG000|Overall Study|Withdrawal by Subject|40|||
143079734|NCT00000620|515831884|FG001|Overall Study|Withdrawal by Subject|27|||
143079735|NCT00000620|515831885|FG002|Overall Study|Withdrawal by Subject|28|||
143079736|NCT00000620|515831886|FG003|Overall Study|Withdrawal by Subject|27|||
143079737|NCT00000620|515831887|FG004|Overall Study|Withdrawal by Subject|30|||
143079738|NCT00000620|515831888|FG005|Overall Study|Withdrawal by Subject|32|||
143079739|NCT00000620|515831889|FG006|Overall Study|Withdrawal by Subject|32|||
143079740|NCT00000620|515831890|FG007|Overall Study|Withdrawal by Subject|21|||
143079741|NCT00000620|515831883|FG000|Overall Study|missed closeout visit|22|||
143079742|NCT00000620|515831884|FG001|Overall Study|missed closeout visit|28|||
143079743|NCT00000620|515831885|FG002|Overall Study|missed closeout visit|16|||
143079744|NCT00000620|515831886|FG003|Overall Study|missed closeout visit|11|||
143079745|NCT00000620|515831887|FG004|Overall Study|missed closeout visit|26|||
143079746|NCT00000620|515831888|FG005|Overall Study|missed closeout visit|28|||
143079747|NCT00000620|515831889|FG006|Overall Study|missed closeout visit|13|||
143079748|NCT00000620|515831890|FG007|Overall Study|missed closeout visit|16|||
143079749|NCT01851330|515831891|FG000|Overall Study|Lack of Efficacy|10|||
143079750|NCT01851330|515831892|FG001|Overall Study|Lack of Efficacy|9|||
143079751|NCT01851330|515831893|FG002|Overall Study|Lack of Efficacy|2|||
143079752|NCT01851330|515831891|FG000|Overall Study|Lost to Follow-up|1|||
143079753|NCT01851330|515831892|FG001|Overall Study|Lost to Follow-up|6|||
143079754|NCT01851330|515831893|FG002|Overall Study|Lost to Follow-up|9|||
143079755|NCT01851330|515831891|FG000|Overall Study|Withdrew Consent|2|||
143079756|NCT01851330|515831892|FG001|Overall Study|Withdrew Consent|1|||
143079757|NCT01851330|515831893|FG002|Overall Study|Withdrew Consent|0|||
143079758|NCT01851330|515831891|FG000|Overall Study|Investigator's Discretion|0|||
143079759|NCT01851330|515831892|FG001|Overall Study|Investigator's Discretion|0|||
143079760|NCT01851330|515831893|FG002|Overall Study|Investigator's Discretion|1|||
143079761|NCT02648932|515831894|FG000|Overall Study|No transplant|3|||
143079762|NCT02648932|515831895|FG001|Overall Study|No transplant|1|||
143079763|NCT01199016|515831896|FG000|Overall Study|No longer meets eligibility criteria|4|||
143079764|NCT01199016|515831896|FG000|Overall Study|Entrance criteria|5|||
143079765|NCT01199016|515831896|FG000|Overall Study|Protocol Violation|9|||
143173077|NCT04464473|516181647|FG004|Overall Study|New piercing could not be removed for scanning|0|||
143173078|NCT04464473|516181648|FG005|Overall Study|New piercing could not be removed for scanning|0|||
143079766|NCT01199016|515831896|FG000|Overall Study|Other|13|||
143079767|NCT01199016|515831896|FG000|Overall Study|Withdrawal by Subject|21|||
143079768|NCT01199016|515831896|FG000|Overall Study|Lost to Follow-up|25|||
143079769|NCT02960490|515831905|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
143079770|NCT02960490|515831906|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
143173079|NCT04464473|516181643|FG000|Overall Study|Adverse Event|0|||
143079771|NCT02960490|515831907|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
143173080|NCT04464473|516181644|FG001|Overall Study|Adverse Event|0|||
143079772|NCT02960490|515831908|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
143079773|NCT02960490|515831909|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
143173081|NCT04464473|516181645|FG002|Overall Study|Adverse Event|0|||
143079774|NCT02960490|515831910|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
143079775|NCT02960490|515831911|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
143079776|NCT02960490|515831912|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
143079777|NCT02960490|515831913|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
143079778|NCT02960490|515831914|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
143079779|NCT02960490|515831905|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
143079780|NCT02960490|515831906|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
143079781|NCT02960490|515831907|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
143079782|NCT02960490|515831908|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
143079783|NCT02960490|515831909|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
143079784|NCT02960490|515831910|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
143079785|NCT02960490|515831911|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
143079786|NCT02960490|515831912|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
143079787|NCT02960490|515831913|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
143079788|NCT02960490|515831914|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
143079789|NCT02960490|515831905|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
143079790|NCT02960490|515831906|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
143079791|NCT02960490|515831907|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
143079792|NCT02960490|515831908|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
143079793|NCT02960490|515831909|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
143079794|NCT02960490|515831910|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
143079795|NCT02960490|515831911|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
143079796|NCT02960490|515831912|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
143079797|NCT02960490|515831913|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
143079798|NCT02960490|515831914|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
143079799|NCT02960490|515831905|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
143079800|NCT02960490|515831906|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
143079801|NCT02960490|515831907|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
143079802|NCT02960490|515831908|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
143079803|NCT02960490|515831909|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
143173082|NCT04464473|516181646|FG003|Overall Study|Adverse Event|1|||
143173083|NCT04464473|516181647|FG004|Overall Study|Adverse Event|0|||
143173084|NCT04464473|516181648|FG005|Overall Study|Adverse Event|0|||
143173085|NCT04464473|516181643|FG000|Overall Study|Lost to Follow-up|0|||
143173086|NCT04464473|516181644|FG001|Overall Study|Lost to Follow-up|0|||
143173087|NCT04464473|516181645|FG002|Overall Study|Lost to Follow-up|0|||
143173088|NCT04464473|516181646|FG003|Overall Study|Lost to Follow-up|1|||
143173089|NCT04464473|516181647|FG004|Overall Study|Lost to Follow-up|0|||
143173090|NCT04464473|516181648|FG005|Overall Study|Lost to Follow-up|0|||
143173091|NCT03586973|516181658|FG000|Overall Study|Death|15|||
143173092|NCT03586973|516181659|FG001|Overall Study|Death|8|||
143173093|NCT03586973|516181658|FG000|Overall Study|Site Terminated by Sponsor|3|||
143248936|NCT04518995|516465047|FG002|Overall Study|Lack of Efficacy|0|||
143248937|NCT04518995|516465045|FG000|Overall Study|Non-compliance With Study Drug|0|||
143248938|NCT04518995|516465046|FG001|Overall Study|Non-compliance With Study Drug|3|||
143248939|NCT04518995|516465047|FG002|Overall Study|Non-compliance With Study Drug|2|||
143248940|NCT04518995|516465045|FG000|Overall Study|Pregnancy|0|||
143248941|NCT04518995|516465046|FG001|Overall Study|Pregnancy|0|||
143248942|NCT04518995|516465047|FG002|Overall Study|Pregnancy|1|||
143248943|NCT04518995|516465045|FG000|Overall Study|Protocol Violation|2|||
143248944|NCT04518995|516465046|FG001|Overall Study|Protocol Violation|0|||
143248945|NCT04518995|516465047|FG002|Overall Study|Protocol Violation|1|||
143248946|NCT04518995|516465045|FG000|Overall Study|Reason not Specified|4|||
143248947|NCT04518995|516465046|FG001|Overall Study|Reason not Specified|11|||
143248948|NCT04518995|516465047|FG002|Overall Study|Reason not Specified|2|||
143248949|NCT04518995|516465045|FG000|Overall Study|Lost to Follow-up|1|||
143248950|NCT04518995|516465046|FG001|Overall Study|Lost to Follow-up|10|||
143248951|NCT04518995|516465047|FG002|Overall Study|Lost to Follow-up|6|||
143248952|NCT00669409|516465050|FG000|Part 2|Withdrawal by Subject|0|||
143248953|NCT00669409|516465051|FG001|Part 2|Withdrawal by Subject|0|||
143248954|NCT00669409|516465052|FG002|Part 2|Withdrawal by Subject|0|||
143248955|NCT00669409|516465053|FG003|Part 2|Withdrawal by Subject|0|||
143248956|NCT00669409|516465054|FG004|Part 2|Withdrawal by Subject|0|||
143248957|NCT00669409|516465055|FG005|Part 2|Withdrawal by Subject|0|||
143248958|NCT00669409|516465056|FG006|Part 2|Withdrawal by Subject|0|||
143248959|NCT00669409|516465057|FG007|Part 2|Withdrawal by Subject|0|||
143248960|NCT00669409|516465058|FG008|Part 2|Withdrawal by Subject|0|||
143248961|NCT00669409|516465059|FG009|Part 2|Withdrawal by Subject|1|||
143248962|NCT00669409|516465060|FG010|Part 2|Withdrawal by Subject|0|||
143248963|NCT00813943|516465061|FG000|Overall Study|Ongoing at cut-off date|5|||
143248964|NCT00813943|516465062|FG001|Overall Study|Ongoing at cut-off date|5|||
143248965|NCT00813943|516465063|FG002|Overall Study|Ongoing at cut-off date|3|||
143248966|NCT05367492|516465064|FG000|Study Intervention (Week 12)|Withdrawal by Subject|0|||
143248967|NCT05367492|516465065|FG001|Study Intervention (Week 12)|Withdrawal by Subject|2|||
143248968|NCT05367492|516465066|FG002|Study Intervention (Week 12)|Withdrawal by Subject|0|||
143248969|NCT05367492|516465064|FG000|Study Intervention (Week 12)|Lost to Follow-up|0|||
143173094|NCT03586973|516181659|FG001|Overall Study|Site Terminated by Sponsor|6|||
143173095|NCT03586973|516181658|FG000|Overall Study|Withdrawal by Subject|1|||
143173096|NCT03586973|516181659|FG001|Overall Study|Withdrawal by Subject|0|||
143173097|NCT03586973|516181658|FG000|Overall Study|Lost to Follow-up|1|||
143173098|NCT03586973|516181659|FG001|Overall Study|Lost to Follow-up|0|||
143173099|NCT02661672|516181663|FG000|Overall Study|Lost to Follow-up|1|||
143173100|NCT02661672|516181663|FG000|Overall Study|Death|4|||
143173101|NCT01585025|516183018|FG000|Overall Study|Withdrawal by Subject|0|||
143173102|NCT01585025|516183019|FG001|Overall Study|Withdrawal by Subject|3|||
143173103|NCT01585025|516183020|FG002|Overall Study|Withdrawal by Subject|4|||
143173104|NCT00598650|516183023|FG000|Overall Study|Withdrawal by Subject|3|||
143079804|NCT02960490|515831910|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
143079805|NCT02960490|515831911|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
143079806|NCT02960490|515831912|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
143079807|NCT02960490|515831913|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
143079808|NCT02960490|515831914|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
143079809|NCT02960490|515831905|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
143079810|NCT02960490|515831906|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
143079811|NCT02960490|515831907|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
143079812|NCT02960490|515831908|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
143079813|NCT02960490|515831909|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
143079814|NCT02960490|515831910|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
143079815|NCT02960490|515831911|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
143079816|NCT02960490|515831912|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
143079817|NCT02960490|515831913|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
143079818|NCT02960490|515831914|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
143079819|NCT02960490|515831905|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
143079820|NCT02960490|515831906|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
143079821|NCT02960490|515831907|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
143079822|NCT02960490|515831908|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
143079823|NCT02960490|515831909|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
143079824|NCT02960490|515831910|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
143079825|NCT02960490|515831911|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
143079826|NCT02960490|515831912|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
143079827|NCT02960490|515831913|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
143079828|NCT02960490|515831914|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
143079829|NCT02960490|515831905|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
143079830|NCT02960490|515831906|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
143079831|NCT02960490|515831907|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
143079832|NCT02960490|515831908|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
143079833|NCT02960490|515831909|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
143079834|NCT02960490|515831910|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
143079835|NCT02960490|515831911|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
143079836|NCT02960490|515831912|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
143079837|NCT02960490|515831913|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
143079838|NCT02960490|515831914|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
143079839|NCT02960490|515831905|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
143079840|NCT02960490|515831906|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
143079841|NCT02960490|515831907|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
143079842|NCT02960490|515831908|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
143079843|NCT02960490|515831909|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
143079844|NCT02960490|515831910|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
143079845|NCT02960490|515831911|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
143079846|NCT02960490|515831912|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
143079847|NCT02960490|515831913|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
143173105|NCT00598650|516183023|FG000|Overall Study|Adverse Event|18|||
143173106|NCT00598650|516183023|FG000|Overall Study|No treatment for 3 weeks|1|||
143173107|NCT00598650|516183023|FG000|Overall Study|Not eligible|1|||
143173108|NCT00598650|516183023|FG000|Overall Study|Prohibited Concomitant Medication|2|||
143173109|NCT00598650|516183023|FG000|Overall Study|Physician Decision|2|||
143173110|NCT02415556|516183024|FG000|Overall Study|Adverse Event|3|||
143173111|NCT02415556|516183025|FG001|Overall Study|Adverse Event|4|||
143173112|NCT02415556|516183026|FG002|Overall Study|Adverse Event|2|||
143173113|NCT02415556|516183027|FG003|Overall Study|Adverse Event|4|||
143173114|NCT02415556|516183024|FG000|Overall Study|Lost to Follow-up|4|||
143173115|NCT02415556|516183025|FG001|Overall Study|Lost to Follow-up|5|||
143173116|NCT02415556|516183026|FG002|Overall Study|Lost to Follow-up|4|||
143173117|NCT02415556|516183027|FG003|Overall Study|Lost to Follow-up|1|||
143173118|NCT02415556|516183024|FG000|Overall Study|Withdrawal by Subject|13|||
143173119|NCT02415556|516183025|FG001|Overall Study|Withdrawal by Subject|4|||
143079848|NCT02960490|515831914|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
143079849|NCT02960490|515831905|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
143079850|NCT02960490|515831906|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
143079851|NCT02960490|515831907|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
143079852|NCT02960490|515831908|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
143079853|NCT02960490|515831909|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
143079854|NCT02960490|515831910|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
143079855|NCT02960490|515831911|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
143079856|NCT02960490|515831912|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
143079857|NCT02960490|515831913|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
143079858|NCT02960490|515831914|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
143079859|NCT02960490|515831905|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
143079860|NCT02960490|515831906|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
143079861|NCT02960490|515831907|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
143079862|NCT02960490|515831908|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
143079863|NCT02960490|515831909|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
143079864|NCT02960490|515831910|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
143079865|NCT02960490|515831911|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
143079866|NCT02960490|515831912|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
143079867|NCT02960490|515831913|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
143079868|NCT02960490|515831914|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
143079869|NCT02960490|515831905|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
143079870|NCT02960490|515831906|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
143079871|NCT02960490|515831907|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
143079872|NCT02960490|515831908|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
143079873|NCT02960490|515831909|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
143079874|NCT02960490|515831910|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
143248970|NCT05367492|516465065|FG001|Study Intervention (Week 12)|Lost to Follow-up|2|||
143079875|NCT02960490|515831911|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
143079876|NCT02960490|515831912|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
143079877|NCT02960490|515831913|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
143079878|NCT02960490|515831914|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
143079879|NCT02960490|515831905|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
143079880|NCT02960490|515831906|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
143079881|NCT02960490|515831907|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
143079882|NCT02960490|515831908|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
143079883|NCT02960490|515831909|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
143079884|NCT02960490|515831910|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
143079885|NCT02960490|515831911|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
143079886|NCT02960490|515831912|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
143079887|NCT02960490|515831913|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
143079888|NCT02960490|515831914|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
143248971|NCT05367492|516465066|FG002|Study Intervention (Week 12)|Lost to Follow-up|1|||
143248972|NCT05367492|516465064|FG000|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
143248973|NCT05367492|516465065|FG001|Study Follow Up (Week 24)|Withdrawal by Subject|1|||
143248974|NCT05367492|516465066|FG002|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
143248975|NCT05367492|516465064|FG000|Study Follow Up (Week 24)|Lost to Follow-up|0|||
143248976|NCT05367492|516465065|FG001|Study Follow Up (Week 24)|Lost to Follow-up|1|||
143248977|NCT05367492|516465066|FG002|Study Follow Up (Week 24)|Lost to Follow-up|0|||
143248978|NCT04491604|516465071|FG000|Overall Study|Withdrawal by Subject|3|||
143248979|NCT01523275|516465073|FG000|Overall Study|Lost to Follow-up|1|||
143248980|NCT01523275|516465074|FG001|Overall Study|Lost to Follow-up|2|||
143248981|NCT01523275|516465073|FG000|Overall Study|Withdrawal by Subject|1|||
143248982|NCT01523275|516465074|FG001|Overall Study|Withdrawal by Subject|0|||
143248983|NCT04643158|516465075|FG000|Overall Study|Study terminated by sponsor|0|||
143248984|NCT04643158|516465076|FG001|Overall Study|Study terminated by sponsor|0|||
143248985|NCT04643158|516465077|FG002|Overall Study|Study terminated by sponsor|1|||
143248986|NCT04643158|516465078|FG003|Overall Study|Study terminated by sponsor|0|||
143248987|NCT04643158|516465079|FG004|Overall Study|Study terminated by sponsor|0|||
143248988|NCT04643158|516465080|FG005|Overall Study|Study terminated by sponsor|1|||
143248989|NCT04643158|516465081|FG006|Overall Study|Study terminated by sponsor|0|||
143079889|NCT02368314|515831915|FG000|Overall Study|Withdrawal by Subject|2|||
143079890|NCT02368314|515831916|FG001|Overall Study|Withdrawal by Subject|1|||
143079891|NCT02368314|515831915|FG000|Overall Study|Adverse Event|1|||
143079892|NCT02368314|515831916|FG001|Overall Study|Adverse Event|2|||
143248990|NCT04643158|516465075|FG000|Overall Study|Global/country situation|0|||
143248991|NCT04643158|516465076|FG001|Overall Study|Global/country situation|0|||
143248992|NCT04643158|516465077|FG002|Overall Study|Global/country situation|1|||
143248993|NCT04643158|516465078|FG003|Overall Study|Global/country situation|0|||
143079893|NCT01307111|515831917|FG000|IUD Insertion|Lost to Follow-up|2|||
143079894|NCT01307111|515831918|FG001|IUD Insertion|Lost to Follow-up|0|||
143079895|NCT01307111|515831917|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
143079896|NCT01307111|515831918|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
143079897|NCT01994850|515831926|FG000|Overall Study|Physician Decision|1|||
143079898|NCT01994850|515831926|FG000|Overall Study|Withdrawal by Subject|1|||
143079899|NCT00182325|515831931|FG000|Overall Study|Lost to Follow-up|7|||
143079900|NCT00182325|515831932|FG001|Overall Study|Lost to Follow-up|7|||
143079901|NCT00182325|515831931|FG000|Overall Study|Miscarriage|5|||
143079902|NCT00182325|515831932|FG001|Overall Study|Miscarriage|3|||
143079903|NCT00182325|515831931|FG000|Overall Study|Did not complete survey|22|||
143079904|NCT00182325|515831932|FG001|Overall Study|Did not complete survey|43|||
143079905|NCT01420965|515831937|FG000|Overall Study|Withdrawal by Subject|1|||
143079906|NCT01420965|515831938|FG001|Overall Study|Withdrawal by Subject|0|||
143079907|NCT01420965|515831939|FG002|Overall Study|Withdrawal by Subject|0|||
143079908|NCT01420965|515831937|FG000|Overall Study|Adverse Event|0|||
143079909|NCT01420965|515831938|FG001|Overall Study|Adverse Event|1|||
143079910|NCT01420965|515831939|FG002|Overall Study|Adverse Event|0|||
143079911|NCT01890434|515831972|FG000|Overall Study|Adverse Event|8|||
143079912|NCT01890434|515831972|FG000|Overall Study|PCI at external hospital|1|||
143079913|NCT01890434|515831972|FG000|Overall Study|Assessment discrepancy|1|||
143079914|NCT01890434|515831972|FG000|Overall Study|CRC didn't contact participant for FU|1|||
143079915|NCT01890434|515831972|FG000|Overall Study|Could not get whole set of images|1|||
143079916|NCT01890434|515831972|FG000|Overall Study|Decline to return for GSPECT|1|||
143079917|NCT01890434|515831972|FG000|Overall Study|GSPECT at rest was not done|1|||
143079918|NCT01890434|515831972|FG000|Overall Study|Participant didn't complete MRI|1|||
143079919|NCT01890434|515831972|FG000|Overall Study|Uncontactable by phone|1|||
143079920|NCT01890434|515831972|FG000|Overall Study|Moved out of position|1|||
143079921|NCT01890434|515831972|FG000|Overall Study|Unable to contact|1|||
143079922|NCT01890434|515831972|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
143079923|NCT03280381|515831973|FG000|Overall Study|Physician Decision|0|||
143079924|NCT03280381|515831974|FG001|Overall Study|Physician Decision|2|||
143079925|NCT01267994|515831977|FG000|Overall Study|Adverse Event|2|||
143079926|NCT00895414|515831980|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
143079927|NCT00895414|515831981|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
143079928|NCT00895414|515831980|FG000|First Intervention (14 Days)|Physician Decision|0|||
143079929|NCT00895414|515831981|FG001|First Intervention (14 Days)|Physician Decision|1|||
143079930|NCT00252239|515831982|FG000|Overall Study|Withdrawal by Subject|1|||
143079931|NCT00252239|515831983|FG001|Overall Study|Withdrawal by Subject|0|||
143079932|NCT00252239|515831984|FG002|Overall Study|Withdrawal by Subject|0|||
143079933|NCT00252239|515831985|FG003|Overall Study|Withdrawal by Subject|1|||
143079934|NCT00252239|515831982|FG000|Overall Study|Lost to Follow-up|0|||
143079935|NCT00252239|515831983|FG001|Overall Study|Lost to Follow-up|0|||
143079936|NCT00252239|515831984|FG002|Overall Study|Lost to Follow-up|2|||
143079937|NCT00252239|515831985|FG003|Overall Study|Lost to Follow-up|0|||
143079938|NCT01822366|515831988|FG000|Overall Study|Lost to Follow-up|5|||
143079939|NCT01822366|515831989|FG001|Overall Study|Lost to Follow-up|1|||
143079940|NCT01822366|515831990|FG002|Overall Study|Lost to Follow-up|5|||
143079941|NCT01822366|515831991|FG003|Overall Study|Lost to Follow-up|1|||
143079942|NCT01822366|515831988|FG000|Overall Study|Withdrawal by Subject|0|||
143079943|NCT01822366|515831989|FG001|Overall Study|Withdrawal by Subject|6|||
143079944|NCT01822366|515831990|FG002|Overall Study|Withdrawal by Subject|0|||
143079945|NCT01822366|515831991|FG003|Overall Study|Withdrawal by Subject|6|||
143079946|NCT01822366|515831988|FG000|Overall Study|Partial Intervention Completion|0|||
143079947|NCT01822366|515831989|FG001|Overall Study|Partial Intervention Completion|15|||
143079948|NCT01822366|515831990|FG002|Overall Study|Partial Intervention Completion|0|||
143079949|NCT01822366|515831991|FG003|Overall Study|Partial Intervention Completion|15|||
143079950|NCT04868968|515831992|FG000|Overall Study|Lost to Follow-up|1|||
143079951|NCT00384930|515831995|FG000|Overall Study|Adverse Event|5|||
143079952|NCT00384930|515831996|FG001|Overall Study|Adverse Event|4|||
143079953|NCT00384930|515831997|FG002|Overall Study|Adverse Event|12|||
143079954|NCT00384930|515831998|FG003|Overall Study|Adverse Event|11|||
143079955|NCT00384930|515831999|FG004|Overall Study|Adverse Event|14|||
143079956|NCT00384930|515831995|FG000|Overall Study|Entry Criteria Not Met|2|||
143079957|NCT00384930|515831996|FG001|Overall Study|Entry Criteria Not Met|6|||
143173120|NCT02415556|516183026|FG002|Overall Study|Withdrawal by Subject|14|||
143173121|NCT02415556|516183027|FG003|Overall Study|Withdrawal by Subject|12|||
143079958|NCT00384930|515831997|FG002|Overall Study|Entry Criteria Not Met|7|||
143079959|NCT00384930|515831998|FG003|Overall Study|Entry Criteria Not Met|8|||
143079960|NCT00384930|515831999|FG004|Overall Study|Entry Criteria Not Met|4|||
143079961|NCT00384930|515831995|FG000|Overall Study|Lack of Efficacy|1|||
143079962|NCT00384930|515831996|FG001|Overall Study|Lack of Efficacy|1|||
143079963|NCT00384930|515831997|FG002|Overall Study|Lack of Efficacy|2|||
143079964|NCT00384930|515831998|FG003|Overall Study|Lack of Efficacy|1|||
143173122|NCT02415556|516183024|FG000|Overall Study|Physician Decision|1|||
143079965|NCT00384930|515831999|FG004|Overall Study|Lack of Efficacy|2|||
143173123|NCT02415556|516183025|FG001|Overall Study|Physician Decision|3|||
143079966|NCT00384930|515831995|FG000|Overall Study|Lost to Follow-up|5|||
143079967|NCT00384930|515831996|FG001|Overall Study|Lost to Follow-up|3|||
143079968|NCT00384930|515831997|FG002|Overall Study|Lost to Follow-up|0|||
143079969|NCT00384930|515831998|FG003|Overall Study|Lost to Follow-up|4|||
143079970|NCT00384930|515831999|FG004|Overall Study|Lost to Follow-up|6|||
143079971|NCT00384930|515831995|FG000|Overall Study|Physician Decision|0|||
143079972|NCT00384930|515831996|FG001|Overall Study|Physician Decision|1|||
143079973|NCT00384930|515831997|FG002|Overall Study|Physician Decision|1|||
143079974|NCT00384930|515831998|FG003|Overall Study|Physician Decision|0|||
143079975|NCT00384930|515831999|FG004|Overall Study|Physician Decision|1|||
143079976|NCT00384930|515831995|FG000|Overall Study|Protocol Violation|1|||
143079977|NCT00384930|515831996|FG001|Overall Study|Protocol Violation|0|||
143079978|NCT00384930|515831997|FG002|Overall Study|Protocol Violation|1|||
143079979|NCT00384930|515831998|FG003|Overall Study|Protocol Violation|6|||
143079980|NCT00384930|515831999|FG004|Overall Study|Protocol Violation|4|||
143079981|NCT00384930|515831995|FG000|Overall Study|Sponsor Decision|3|||
143079982|NCT00384930|515831996|FG001|Overall Study|Sponsor Decision|4|||
143079983|NCT00384930|515831997|FG002|Overall Study|Sponsor Decision|0|||
143079984|NCT00384930|515831998|FG003|Overall Study|Sponsor Decision|5|||
143079985|NCT00384930|515831999|FG004|Overall Study|Sponsor Decision|0|||
143079986|NCT00384930|515831995|FG000|Overall Study|Withdrawal by Subject|9|||
143079987|NCT00384930|515831996|FG001|Overall Study|Withdrawal by Subject|7|||
143079988|NCT00384930|515831997|FG002|Overall Study|Withdrawal by Subject|7|||
143079989|NCT00384930|515831998|FG003|Overall Study|Withdrawal by Subject|6|||
143079990|NCT00384930|515831999|FG004|Overall Study|Withdrawal by Subject|16|||
143079991|NCT00384930|515831995|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
143079992|NCT00384930|515831996|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
143079993|NCT00384930|515831997|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
143079994|NCT00384930|515831998|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
143079995|NCT00384930|515831999|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
143079996|NCT02181790|515832000|FG000|Overall Study|study terminated|2|||
143079997|NCT02181790|515832001|FG001|Overall Study|study terminated|0|||
143079998|NCT03276078|515832002|FG000|Overall Study|Adverse Event|1|||
143079999|NCT01210612|515832004|FG000|Overall Study|Withdrawal by Subject|0|||
143080000|NCT01210612|515832005|FG001|Overall Study|Withdrawal by Subject|2|||
143080001|NCT01275430|515832011|FG000|Overall Study|Adverse Event|1|||
143080002|NCT01275430|515832011|FG000|Overall Study|No Contrast Injection|6|||
143080003|NCT01275430|515832011|FG000|Overall Study|Device Malfunction|1|||
143080004|NCT01275430|515832011|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
143080005|NCT04988087|515832013|FG000|Overall Study|Adverse Event|4|||
143080006|NCT04988087|515832014|FG001|Overall Study|Adverse Event|0|||
143080007|NCT04988087|515832015|FG002|Overall Study|Adverse Event|0|||
143080008|NCT04988087|515832016|FG003|Overall Study|Adverse Event|0|||
143080009|NCT04988087|515832013|FG000|Overall Study|Withdrawal by Subject|1|||
143080010|NCT04988087|515832014|FG001|Overall Study|Withdrawal by Subject|1|||
143080011|NCT04988087|515832015|FG002|Overall Study|Withdrawal by Subject|0|||
143080012|NCT04988087|515832016|FG003|Overall Study|Withdrawal by Subject|0|||
143080013|NCT04988087|515832013|FG000|Overall Study|Technical problems|7|||
143080014|NCT04988087|515832014|FG001|Overall Study|Technical problems|9|||
143080015|NCT04988087|515832015|FG002|Overall Study|Technical problems|1|||
143080016|NCT04988087|515832016|FG003|Overall Study|Technical problems|2|||
143080017|NCT02752087|515832017|FG000|Washout|Physician Decision|1|||
143080018|NCT02752087|515832018|FG001|Washout|Physician Decision|0|||
143080019|NCT02458287|515832019|FG000|Overall Study|Adverse Event|0|||
143080020|NCT02458287|515832020|FG001|Overall Study|Adverse Event|0|||
143080021|NCT02458287|515832021|FG002|Overall Study|Adverse Event|0|||
143080022|NCT02458287|515832022|FG003|Overall Study|Adverse Event|1|||
143080023|NCT02458287|515832019|FG000|Overall Study|Lost to Follow-up|0|||
143080024|NCT02458287|515832020|FG001|Overall Study|Lost to Follow-up|1|||
143080025|NCT02458287|515832021|FG002|Overall Study|Lost to Follow-up|1|||
143080026|NCT02458287|515832022|FG003|Overall Study|Lost to Follow-up|0|||
143080027|NCT02458287|515832019|FG000|Overall Study|Protocol Violation|0|||
143080028|NCT02458287|515832020|FG001|Overall Study|Protocol Violation|1|||
143080029|NCT02458287|515832021|FG002|Overall Study|Protocol Violation|0|||
143080030|NCT02458287|515832022|FG003|Overall Study|Protocol Violation|0|||
143080031|NCT02458287|515832019|FG000|Overall Study|Withdrawal by Subject|0|||
143080032|NCT02458287|515832020|FG001|Overall Study|Withdrawal by Subject|2|||
143080033|NCT02458287|515832021|FG002|Overall Study|Withdrawal by Subject|2|||
143080034|NCT02458287|515832022|FG003|Overall Study|Withdrawal by Subject|1|||
143080035|NCT02458287|515832019|FG000|Overall Study|Relocated Out of State|0|||
143080036|NCT02458287|515832020|FG001|Overall Study|Relocated Out of State|0|||
143080037|NCT02458287|515832021|FG002|Overall Study|Relocated Out of State|0|||
143080038|NCT02458287|515832022|FG003|Overall Study|Relocated Out of State|1|||
143080039|NCT02613182|515832023|FG000|Overall Study|Death|6|||
143080040|NCT02613182|515832023|FG000|Overall Study|Physician Decision|1|||
143080041|NCT02613182|515832023|FG000|Overall Study|Study Terminated by Sponsor|21|||
143080042|NCT02613182|515832023|FG000|Overall Study|Withdrawal by Subject|6|||
143080043|NCT03968978|515832024|FG000|Overall Study|Adverse Event|1|||
143080044|NCT03968978|515832025|FG001|Overall Study|Adverse Event|0|||
143080045|NCT00025259|515832026|FG000|Overall Study|Death|1|||
143080046|NCT00025259|515832027|FG001|Overall Study|Death|3|||
143080047|NCT00025259|515832028|FG002|Overall Study|Death|0|||
143080048|NCT00025259|515832029|FG003|Overall Study|Death|3|||
143080049|NCT00025259|515832030|FG004|Overall Study|Death|0|||
143080050|NCT00025259|515832031|FG005|Overall Study|Death|1|||
143080051|NCT00025259|515832032|FG006|Overall Study|Death|2|||
143080052|NCT00025259|515832026|FG000|Overall Study|Lack of Efficacy|2|||
143080053|NCT00025259|515832027|FG001|Overall Study|Lack of Efficacy|46|||
143080054|NCT00025259|515832028|FG002|Overall Study|Lack of Efficacy|60|||
143080055|NCT00025259|515832029|FG003|Overall Study|Lack of Efficacy|78|||
143080056|NCT00025259|515832030|FG004|Overall Study|Lack of Efficacy|11|||
143080057|NCT00025259|515832031|FG005|Overall Study|Lack of Efficacy|30|||
143080058|NCT00025259|515832032|FG006|Overall Study|Lack of Efficacy|38|||
143080059|NCT00025259|515832026|FG000|Overall Study|Lost to Follow-up|2|||
143080060|NCT00025259|515832027|FG001|Overall Study|Lost to Follow-up|9|||
143080061|NCT00025259|515832028|FG002|Overall Study|Lost to Follow-up|13|||
143080062|NCT00025259|515832029|FG003|Overall Study|Lost to Follow-up|13|||
143080063|NCT00025259|515832030|FG004|Overall Study|Lost to Follow-up|1|||
143080064|NCT00025259|515832031|FG005|Overall Study|Lost to Follow-up|3|||
143080065|NCT00025259|515832032|FG006|Overall Study|Lost to Follow-up|1|||
143080066|NCT00025259|515832026|FG000|Overall Study|Physician Decision|12|||
143080067|NCT00025259|515832027|FG001|Overall Study|Physician Decision|1|||
143080068|NCT00025259|515832028|FG002|Overall Study|Physician Decision|0|||
143080069|NCT00025259|515832029|FG003|Overall Study|Physician Decision|5|||
143080070|NCT00025259|515832030|FG004|Overall Study|Physician Decision|4|||
143080071|NCT00025259|515832031|FG005|Overall Study|Physician Decision|2|||
143080072|NCT00025259|515832032|FG006|Overall Study|Physician Decision|1|||
143080073|NCT00025259|515832026|FG000|Overall Study|Protocol Violation|3|||
143080074|NCT00025259|515832027|FG001|Overall Study|Protocol Violation|2|||
143080075|NCT00025259|515832028|FG002|Overall Study|Protocol Violation|2|||
143080076|NCT00025259|515832029|FG003|Overall Study|Protocol Violation|1|||
143080077|NCT00025259|515832030|FG004|Overall Study|Protocol Violation|2|||
143080078|NCT00025259|515832031|FG005|Overall Study|Protocol Violation|1|||
143080079|NCT00025259|515832032|FG006|Overall Study|Protocol Violation|3|||
143080080|NCT00025259|515832026|FG000|Overall Study|Withdrawal by Subject|9|||
143080081|NCT00025259|515832027|FG001|Overall Study|Withdrawal by Subject|27|||
143080082|NCT00025259|515832028|FG002|Overall Study|Withdrawal by Subject|6|||
143080083|NCT00025259|515832029|FG003|Overall Study|Withdrawal by Subject|14|||
143080084|NCT00025259|515832030|FG004|Overall Study|Withdrawal by Subject|11|||
143080085|NCT00025259|515832031|FG005|Overall Study|Withdrawal by Subject|8|||
143080086|NCT00025259|515832032|FG006|Overall Study|Withdrawal by Subject|3|||
143080087|NCT00025259|515832026|FG000|Overall Study|Ineligible|14|||
143080088|NCT00025259|515832027|FG001|Overall Study|Ineligible|1|||
143080089|NCT00025259|515832028|FG002|Overall Study|Ineligible|0|||
143080090|NCT00025259|515832029|FG003|Overall Study|Ineligible|0|||
143080091|NCT00025259|515832030|FG004|Overall Study|Ineligible|6|||
143080092|NCT00025259|515832031|FG005|Overall Study|Ineligible|0|||
143080093|NCT00025259|515832032|FG006|Overall Study|Ineligible|1|||
143080094|NCT00025259|515832026|FG000|Overall Study|Randomization error|1|||
143080095|NCT00025259|515832027|FG001|Overall Study|Randomization error|0|||
143080096|NCT00025259|515832028|FG002|Overall Study|Randomization error|0|||
143080097|NCT00025259|515832029|FG003|Overall Study|Randomization error|0|||
143080098|NCT00025259|515832030|FG004|Overall Study|Randomization error|1|||
143080099|NCT00025259|515832031|FG005|Overall Study|Randomization error|7|||
143080100|NCT00025259|515832032|FG006|Overall Study|Randomization error|2|||
143080101|NCT00025259|515832026|FG000|Overall Study|Adverse Event|1|||
143080102|NCT00025259|515832027|FG001|Overall Study|Adverse Event|0|||
143080103|NCT00025259|515832028|FG002|Overall Study|Adverse Event|0|||
143080104|NCT00025259|515832029|FG003|Overall Study|Adverse Event|0|||
143080105|NCT00025259|515832030|FG004|Overall Study|Adverse Event|0|||
143080106|NCT00025259|515832031|FG005|Overall Study|Adverse Event|0|||
143080107|NCT00025259|515832032|FG006|Overall Study|Adverse Event|0|||
143080108|NCT00863772|515832033|FG000|Overall Study|Adverse Event|1|||
143080109|NCT00863772|515832034|FG001|Overall Study|Adverse Event|4|||
143080110|NCT00863772|515832035|FG002|Overall Study|Adverse Event|0|||
143080111|NCT00863772|515832033|FG000|Overall Study|Lack of Efficacy|4|||
143080112|NCT00863772|515832034|FG001|Overall Study|Lack of Efficacy|2|||
143080113|NCT00863772|515832035|FG002|Overall Study|Lack of Efficacy|4|||
143080114|NCT00863772|515832033|FG000|Overall Study|Lost to Follow-up|5|||
143080115|NCT00863772|515832034|FG001|Overall Study|Lost to Follow-up|1|||
143080116|NCT00863772|515832035|FG002|Overall Study|Lost to Follow-up|1|||
143080117|NCT00863772|515832033|FG000|Overall Study|Protocol Violation|2|||
143080118|NCT00863772|515832034|FG001|Overall Study|Protocol Violation|0|||
143080119|NCT00863772|515832035|FG002|Overall Study|Protocol Violation|2|||
143080120|NCT00863772|515832033|FG000|Overall Study|Withdrawal by Subject|4|||
143080121|NCT00863772|515832034|FG001|Overall Study|Withdrawal by Subject|7|||
143080122|NCT00863772|515832035|FG002|Overall Study|Withdrawal by Subject|5|||
143080123|NCT00863772|515832033|FG000|Overall Study|Study terminated by sponsor|44|||
143080124|NCT00863772|515832034|FG001|Overall Study|Study terminated by sponsor|45|||
143080125|NCT00863772|515832035|FG002|Overall Study|Study terminated by sponsor|36|||
143080126|NCT00863772|515832033|FG000|Overall Study|Entered extension study|6|||
143080127|NCT00863772|515832034|FG001|Overall Study|Entered extension study|4|||
143080128|NCT00863772|515832035|FG002|Overall Study|Entered extension study|9|||
143080129|NCT00863772|515832033|FG000|Overall Study|Other|1|||
143080130|NCT00863772|515832034|FG001|Overall Study|Other|2|||
143080131|NCT00863772|515832035|FG002|Overall Study|Other|4|||
143080132|NCT00863772|515832033|FG000|Overall Study|Randomized but not Treated|1|||
143080133|NCT00863772|515832034|FG001|Overall Study|Randomized but not Treated|0|||
143080134|NCT00863772|515832035|FG002|Overall Study|Randomized but not Treated|0|||
143080135|NCT01102374|515832039|FG000|Overall Study|Death|9|||
143080136|NCT01102374|515832040|FG001|Overall Study|Death|13|||
143080137|NCT01102374|515832039|FG000|Overall Study|Lost to Follow-up|7|||
143080138|NCT01102374|515832040|FG001|Overall Study|Lost to Follow-up|6|||
143080139|NCT01104792|515832041|FG000|Overall Study|Adverse Event|77|||
143080140|NCT01104792|515832041|FG000|Overall Study|Insufficient Therapeutic Response|22|||
143080141|NCT01104792|515832041|FG000|Overall Study|Protocol Violation|45|||
143080142|NCT01104792|515832041|FG000|Overall Study|Withdrawal of Consent|179|||
143080143|NCT01104792|515832041|FG000|Overall Study|Lost to Follow-up|43|||
143080144|NCT01104792|515832041|FG000|Overall Study|Reasons Not Specified|27|||
143080145|NCT01104792|515832041|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
143080146|NCT04784533|515832043|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
143080147|NCT04784533|515832044|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
143080148|NCT04784533|515832045|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
143080149|NCT04784533|515832046|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
143080150|NCT04784533|515832047|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
143080151|NCT04784533|515832048|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
143080152|NCT04784533|515832049|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
143080153|NCT04784533|515832050|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
143080154|NCT04784533|515832051|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
143080155|NCT04784533|515832052|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
143080156|NCT04784533|515832043|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
143080157|NCT04784533|515832044|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
143080158|NCT04784533|515832045|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
143080159|NCT04784533|515832046|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
143080160|NCT04784533|515832047|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
143080161|NCT04784533|515832048|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
143080162|NCT04784533|515832049|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
143080163|NCT04784533|515832050|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
143080164|NCT04784533|515832051|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
143080165|NCT04784533|515832052|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
143080166|NCT04784533|515832043|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
143080167|NCT04784533|515832044|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
143080168|NCT04784533|515832045|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
143080169|NCT04784533|515832046|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
143080170|NCT04784533|515832047|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
143080171|NCT04784533|515832048|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
143173124|NCT02415556|516183026|FG002|Overall Study|Physician Decision|1|||
143117404|NCT05459558|515971835|FG000|Overall Study|Withdrawal by Subject|0|||
143117405|NCT05459558|515971836|FG001|Overall Study|Withdrawal by Subject|0|||
143117406|NCT05459558|515971837|FG002|Overall Study|Withdrawal by Subject|2|||
143117407|NCT01777139|515971842|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
143117408|NCT01777139|515971843|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
143117409|NCT01777139|515971842|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
143117410|NCT01777139|515971843|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
143117411|NCT01777139|515971842|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
143080172|NCT04784533|515832049|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
143080173|NCT04784533|515832050|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
143080174|NCT04784533|515832051|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
143080175|NCT04784533|515832052|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
143080176|NCT04784533|515832043|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
143080177|NCT04784533|515832044|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
143080178|NCT04784533|515832045|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
143080179|NCT04784533|515832046|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
143080180|NCT04784533|515832047|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
143080181|NCT04784533|515832048|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
143080182|NCT04784533|515832049|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
143080183|NCT04784533|515832050|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
143080184|NCT04784533|515832051|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
143080185|NCT04784533|515832052|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
143080186|NCT04784533|515832043|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
143080187|NCT04784533|515832044|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
143080188|NCT04784533|515832045|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
143080189|NCT04784533|515832046|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
143080190|NCT04784533|515832047|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
143080191|NCT04784533|515832048|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
143080192|NCT04784533|515832049|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
143080193|NCT04784533|515832050|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
143080194|NCT04784533|515832051|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
143080195|NCT04784533|515832052|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
143080196|NCT04784533|515832043|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
143080197|NCT04784533|515832044|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
143080198|NCT04784533|515832045|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
143080199|NCT04784533|515832046|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
143080200|NCT04784533|515832047|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
143080201|NCT04784533|515832048|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
143080202|NCT04784533|515832049|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
143080203|NCT04784533|515832050|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
143080204|NCT04784533|515832051|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
143080205|NCT04784533|515832052|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
143080206|NCT04784533|515832043|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
143080207|NCT04784533|515832044|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
143080208|NCT04784533|515832045|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
143080209|NCT04784533|515832046|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
143080210|NCT04784533|515832047|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
143080211|NCT04784533|515832048|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
143080212|NCT04784533|515832049|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
143080213|NCT04784533|515832050|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
143080214|NCT04784533|515832051|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
143080215|NCT04784533|515832052|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
143080216|NCT04784533|515832043|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
143080217|NCT04784533|515832044|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
143080218|NCT04784533|515832045|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
143080219|NCT04784533|515832046|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
143080220|NCT04784533|515832047|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
143080221|NCT04784533|515832048|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
143080222|NCT04784533|515832049|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
143080223|NCT04784533|515832050|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
143080224|NCT04784533|515832051|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
143080225|NCT04784533|515832052|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
143080226|NCT04784533|515832043|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
143080227|NCT04784533|515832044|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
143080228|NCT04784533|515832045|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
143080229|NCT04784533|515832046|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
143080230|NCT04784533|515832047|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
143173125|NCT02415556|516183027|FG003|Overall Study|Physician Decision|2|||
143080231|NCT04784533|515832048|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
143080232|NCT04784533|515832049|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
143080233|NCT04784533|515832050|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
143173126|NCT02415556|516183024|FG000|Overall Study|Censored - study completion|4|||
143080234|NCT04784533|515832051|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
143080235|NCT04784533|515832052|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
143173127|NCT02415556|516183025|FG001|Overall Study|Censored - study completion|5|||
143080236|NCT04123561|515832055|FG000|Overall Study|Lost to Follow-up|20|||
143080237|NCT04123561|515832056|FG001|Overall Study|Lost to Follow-up|12|||
143080238|NCT04123561|515832057|FG002|Overall Study|Lost to Follow-up|5|||
143080239|NCT04123561|515832055|FG000|Overall Study|Withdrawal by Subject|9|||
143080240|NCT04123561|515832056|FG001|Overall Study|Withdrawal by Subject|7|||
143080241|NCT04123561|515832057|FG002|Overall Study|Withdrawal by Subject|9|||
143080242|NCT04123561|515832055|FG000|Overall Study|Lack of Efficacy|7|||
143080243|NCT04123561|515832056|FG001|Overall Study|Lack of Efficacy|8|||
143080244|NCT04123561|515832057|FG002|Overall Study|Lack of Efficacy|6|||
143080245|NCT04123561|515832055|FG000|Overall Study|Adverse Event|5|||
143080246|NCT04123561|515832056|FG001|Overall Study|Adverse Event|2|||
143080247|NCT04123561|515832057|FG002|Overall Study|Adverse Event|3|||
143080248|NCT04123561|515832055|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
143080249|NCT04123561|515832056|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
143080250|NCT04123561|515832057|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
143080251|NCT04123561|515832055|FG000|Overall Study|Death|0|||
143080252|NCT04123561|515832056|FG001|Overall Study|Death|0|||
143080253|NCT04123561|515832057|FG002|Overall Study|Death|1|||
143080254|NCT04123561|515832055|FG000|Overall Study|Protocol Violation|0|||
143080255|NCT04123561|515832056|FG001|Overall Study|Protocol Violation|1|||
143080256|NCT04123561|515832057|FG002|Overall Study|Protocol Violation|0|||
143080257|NCT02542605|515832058|FG000|Part B: Challenge Phase|Sponsor decision|1|||
143080258|NCT02542605|515832059|FG001|Part B: Challenge Phase|Sponsor decision|0|||
143080259|NCT02542605|515832060|FG002|Part B: Challenge Phase|Sponsor decision|0|||
143080260|NCT02542605|515832058|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
143080261|NCT02542605|515832059|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
143080262|NCT02542605|515832060|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
143080263|NCT03092219|515833954|FG000|Overall Study|Protocol Violation|7|||
143080264|NCT03092219|515833955|FG001|Overall Study|Protocol Violation|4|||
143080265|NCT05013008|515833956|FG000|Overall Study|Exclusion from mBFAS|5|||
143080266|NCT05013008|515833957|FG001|Overall Study|Exclusion from mBFAS|25|||
143080267|NCT03760185|515833968|FG000|Overall Study|Lost to Follow-up|1|||
143080268|NCT03760185|515833969|FG001|Overall Study|Lost to Follow-up|1|||
143080269|NCT02242045|515833970|FG000|Overall Study|Investigator's Discretion|1|||
143080270|NCT02242045|515833970|FG000|Overall Study|Progressive Disease|2|||
143080271|NCT02242045|515833970|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
143080272|NCT02242045|515833970|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
143080273|NCT00976911|515833973|FG000|Overall Study|Withdrawal by Subject|4|||
143080274|NCT00976911|515833974|FG001|Overall Study|Withdrawal by Subject|6|||
143080275|NCT00976911|515833973|FG000|Overall Study|Death|138|||
143080276|NCT00976911|515833974|FG001|Overall Study|Death|126|||
143080277|NCT00976911|515833973|FG000|Overall Study|Adverse Event|0|||
143080278|NCT00976911|515833974|FG001|Overall Study|Adverse Event|1|||
143080279|NCT00976911|515833973|FG000|Overall Study|Protocol Violation|2|||
143080280|NCT00976911|515833974|FG001|Overall Study|Protocol Violation|0|||
143080281|NCT00976911|515833973|FG000|Overall Study|Other|8|||
143080282|NCT00976911|515833974|FG001|Overall Study|Other|9|||
143080283|NCT00976911|515833973|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
143080284|NCT00976911|515833974|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
143080285|NCT01191944|515833975|FG000|Overall Study|Adverse Event|11|||
143080286|NCT01191944|515833976|FG001|Overall Study|Adverse Event|12|||
143080287|NCT01191944|515833975|FG000|Overall Study|Protocol Violation|1|||
143080288|NCT01191944|515833976|FG001|Overall Study|Protocol Violation|2|||
143080289|NCT01191944|515833975|FG000|Overall Study|Withdrawal by Subject|4|||
143080290|NCT01191944|515833976|FG001|Overall Study|Withdrawal by Subject|2|||
143080291|NCT01191944|515833975|FG000|Overall Study|Other|1|||
143080292|NCT01191944|515833976|FG001|Overall Study|Other|3|||
143080293|NCT02954991|515833979|FG000|Overall Study|Death|92|||
143080294|NCT02954991|515833980|FG001|Overall Study|Death|11|||
143080295|NCT02954991|515833981|FG002|Overall Study|Death|2|||
143080296|NCT02954991|515833979|FG000|Overall Study|Lost to Follow-up|3|||
143080297|NCT02954991|515833980|FG001|Overall Study|Lost to Follow-up|2|||
143080298|NCT02954991|515833981|FG002|Overall Study|Lost to Follow-up|0|||
143080299|NCT02954991|515833979|FG000|Overall Study|Withdrawal by Subject|9|||
143080300|NCT02954991|515833980|FG001|Overall Study|Withdrawal by Subject|8|||
143080301|NCT02954991|515833981|FG002|Overall Study|Withdrawal by Subject|1|||
143080302|NCT02954991|515833979|FG000|Overall Study|Study Terminated by Sponsor|18|||
143080303|NCT02954991|515833980|FG001|Overall Study|Study Terminated by Sponsor|10|||
143080304|NCT02954991|515833981|FG002|Overall Study|Study Terminated by Sponsor|1|||
143080305|NCT02954991|515833979|FG000|Overall Study|Miscellaneous|2|||
143080306|NCT02954991|515833980|FG001|Overall Study|Miscellaneous|1|||
143080307|NCT02954991|515833981|FG002|Overall Study|Miscellaneous|1|||
143080308|NCT01275729|515833986|FG000|Overall Study|Death|3|||
143080309|NCT01275729|515833986|FG000|Overall Study|Withdrawal by Subject|1|||
143080310|NCT02252406|515833987|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
143080311|NCT02252406|515833988|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
143080312|NCT02252406|515833987|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
143080313|NCT02252406|515833988|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
143080314|NCT02252406|515833987|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
143080315|NCT02252406|515833988|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
143080316|NCT02252406|515833987|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
143080317|NCT02252406|515833988|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
143080318|NCT02252406|515833987|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
143080319|NCT02252406|515833988|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
143080320|NCT00005957|515833991|FG000|Overall Study|No treated|3|||
143080321|NCT00005957|515833992|FG001|Overall Study|No treated|9|||
143080322|NCT00005957|515833991|FG000|Overall Study|Crossover to the other arm|5|||
143080323|NCT00005957|515833992|FG001|Overall Study|Crossover to the other arm|19|||
143080324|NCT01174043|515833993|FG000|Overall Study|Disease progression|5|||
143080325|NCT01174043|515833993|FG000|Overall Study|Adverse Event|3|||
143080326|NCT01174043|515833993|FG000|Overall Study|Death|1|||
143080327|NCT01174043|515833993|FG000|Overall Study|Withdrawal by Subject|2|||
143080328|NCT02047734|515833994|FG000|Overall Study|Adverse Event|18|||
143080329|NCT02047734|515833995|FG001|Overall Study|Adverse Event|13|||
143080330|NCT02047734|515833996|FG002|Overall Study|Adverse Event|13|||
143080331|NCT02047734|515833994|FG000|Overall Study|Lack of Efficacy|4|||
143080332|NCT02047734|515833995|FG001|Overall Study|Lack of Efficacy|5|||
143080333|NCT02047734|515833996|FG002|Overall Study|Lack of Efficacy|1|||
143080334|NCT02047734|515833994|FG000|Overall Study|Protocol Violation|3|||
143080335|NCT02047734|515833995|FG001|Overall Study|Protocol Violation|1|||
143080336|NCT02047734|515833996|FG002|Overall Study|Protocol Violation|1|||
143080337|NCT02047734|515833994|FG000|Overall Study|Lost to Follow-up|1|||
143080338|NCT02047734|515833995|FG001|Overall Study|Lost to Follow-up|4|||
143080339|NCT02047734|515833996|FG002|Overall Study|Lost to Follow-up|0|||
143080340|NCT02047734|515833994|FG000|Overall Study|Death|0|||
143080341|NCT02047734|515833995|FG001|Overall Study|Death|1|||
143080342|NCT02047734|515833996|FG002|Overall Study|Death|0|||
143080343|NCT02047734|515833994|FG000|Overall Study|Withdrawal by Subject|30|||
143080344|NCT02047734|515833995|FG001|Overall Study|Withdrawal by Subject|31|||
143080345|NCT02047734|515833996|FG002|Overall Study|Withdrawal by Subject|19|||
143080346|NCT02047734|515833994|FG000|Overall Study|Physician Decision|7|||
143080347|NCT02047734|515833995|FG001|Overall Study|Physician Decision|6|||
143080348|NCT02047734|515833996|FG002|Overall Study|Physician Decision|5|||
143080349|NCT02047734|515833994|FG000|Overall Study|Miscellaneous|2|||
143080350|NCT02047734|515833995|FG001|Overall Study|Miscellaneous|4|||
143080351|NCT02047734|515833996|FG002|Overall Study|Miscellaneous|6|||
143080352|NCT02047734|515833994|FG000|Overall Study|Did Not Receive Study Drug|2|||
143080353|NCT02047734|515833995|FG001|Overall Study|Did Not Receive Study Drug|4|||
143080354|NCT02047734|515833996|FG002|Overall Study|Did Not Receive Study Drug|1|||
143080355|NCT00799825|515833999|FG000|Overall Study|Adverse Event|1|||
143080356|NCT00799825|515833999|FG000|Overall Study|Withdrawal by Subject|6|||
143080357|NCT00799825|515833999|FG000|Overall Study|Lost to Follow-up|38|||
143080358|NCT00799825|515833999|FG000|Overall Study|Pregnancy|3|||
143080359|NCT00582010|515834000|FG000|Overall Study|Death|0|||
143080360|NCT00582010|515834001|FG001|Overall Study|Death|1|||
143080361|NCT02289456|515834006|FG000|Induction Period|Death|2|||
143080362|NCT02289456|515834006|FG000|Induction Period|Adverse Event|11|||
143080363|NCT02289456|515834006|FG000|Induction Period|Progressive Disease (PD)|4|||
143080364|NCT02289456|515834006|FG000|Induction Period|Symptomatic Deterioration|4|||
143080365|NCT02289456|515834006|FG000|Induction Period|Withdrawal by Subject|2|||
143080366|NCT02289456|515834006|FG000|Induction Period|Miscellaneous|1|||
143080367|NCT02289456|515834006|FG000|Monotherapy Period|Death|1|||
143080368|NCT02289456|515834006|FG000|Monotherapy Period|Adverse Event|1|||
143080369|NCT02289456|515834006|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
143080370|NCT02289456|515834006|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
143080371|NCT02289456|515834006|FG000|Monotherapy Period|Withdrawal by Subject|2|||
143080372|NCT02289456|515834006|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
143080373|NCT02289456|515834006|FG000|Monotherapy Period|Miscellaneous|1|||
143080374|NCT01371539|515834007|FG000|Period One: One Week|Lost to Follow-up|0|||
143080375|NCT01371539|515834008|FG001|Period One: One Week|Lost to Follow-up|1|||
143080376|NCT01371539|515834007|FG000|Period Two: One Week|Lost to Follow-up|0|||
143080377|NCT01371539|515834008|FG001|Period Two: One Week|Lost to Follow-up|1|||
143080378|NCT01371539|515834007|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
143080379|NCT01371539|515834008|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
143080380|NCT01371539|515834007|FG000|Period Two: One Week|Time/job conflict|0|||
143080381|NCT01371539|515834008|FG001|Period Two: One Week|Time/job conflict|1|||
143080382|NCT01399658|515834009|FG000|Overall Study|Ineligible|1|||
143080383|NCT01399658|515834009|FG000|Overall Study|Machine Technical Issue|3|||
143080384|NCT01399658|515834009|FG000|Overall Study|Alternative therapy|1|||
143080385|NCT01399658|515834009|FG000|Overall Study|No reason given|1|||
143080386|NCT01721317|515834011|FG000|Overall Study|Study Closed / Terminated|2|||
143080387|NCT01721317|515834012|FG001|Overall Study|Study Closed / Terminated|2|||
143080388|NCT01721317|515834011|FG000|Overall Study|Physician Decision|0|||
143080389|NCT01721317|515834012|FG001|Overall Study|Physician Decision|1|||
143080390|NCT01721317|515834011|FG000|Overall Study|Withdrawal by Subject|0|||
143080391|NCT01721317|515834012|FG001|Overall Study|Withdrawal by Subject|1|||
143080392|NCT00958893|515834021|FG000|Overall Study|Study prematurely terminated|4|||
143080393|NCT02806024|515834024|FG000|Overall Study|Night Delivery|1|||
143080394|NCT02806024|515834025|FG001|Overall Study|Night Delivery|1|||
143080395|NCT02806024|515834024|FG000|Overall Study|DVT during antepartum admission|0|||
143080396|NCT02806024|515834025|FG001|Overall Study|DVT during antepartum admission|1|||
143080397|NCT02892149|515834026|FG000|Overall Study|Death|262|||
143080398|NCT02892149|515834027|FG001|Overall Study|Death|278|||
143080399|NCT02892149|515834026|FG000|Overall Study|Withdrawal by Subject|53|||
143080400|NCT02892149|515834027|FG001|Overall Study|Withdrawal by Subject|47|||
143080401|NCT02892149|515834026|FG000|Overall Study|Lost to Follow-up|37|||
143080402|NCT02892149|515834027|FG001|Overall Study|Lost to Follow-up|31|||
143080403|NCT01098474|515834028|FG000|Active Phase|Other|0|||
143080404|NCT01098474|515834029|FG001|Active Phase|Other|0|||
143080405|NCT01098474|515834030|FG002|Active Phase|Other|3|||
143080406|NCT01098474|515834031|FG003|Active Phase|Other|0|||
143080407|NCT01098474|515834032|FG004|Active Phase|Other|0|||
143080408|NCT01098474|515834033|FG005|Active Phase|Other|0|||
143080409|NCT01098474|515834028|FG000|Active Phase|Withdrawal by Subject|1|||
143080410|NCT01098474|515834029|FG001|Active Phase|Withdrawal by Subject|1|||
143080411|NCT01098474|515834030|FG002|Active Phase|Withdrawal by Subject|2|||
143080412|NCT01098474|515834031|FG003|Active Phase|Withdrawal by Subject|0|||
143080413|NCT01098474|515834032|FG004|Active Phase|Withdrawal by Subject|0|||
143080414|NCT01098474|515834033|FG005|Active Phase|Withdrawal by Subject|0|||
143080415|NCT01098474|515834028|FG000|Active Phase|Lost to Follow-up|1|||
143080416|NCT01098474|515834029|FG001|Active Phase|Lost to Follow-up|0|||
143080417|NCT01098474|515834030|FG002|Active Phase|Lost to Follow-up|0|||
143080418|NCT01098474|515834031|FG003|Active Phase|Lost to Follow-up|0|||
143080419|NCT01098474|515834032|FG004|Active Phase|Lost to Follow-up|0|||
143080420|NCT01098474|515834033|FG005|Active Phase|Lost to Follow-up|0|||
143080421|NCT01098474|515834028|FG000|Follow Up Phase|Travelled out of study area|0|||
143080422|NCT01098474|515834029|FG001|Follow Up Phase|Travelled out of study area|0|||
143080423|NCT01098474|515834030|FG002|Follow Up Phase|Travelled out of study area|0|||
143080424|NCT01098474|515834031|FG003|Follow Up Phase|Travelled out of study area|0|||
143080425|NCT01098474|515834032|FG004|Follow Up Phase|Travelled out of study area|1|||
143080426|NCT01098474|515834033|FG005|Follow Up Phase|Travelled out of study area|0|||
143080427|NCT01098474|515834028|FG000|Follow Up Phase|Other|0|||
143080428|NCT01098474|515834029|FG001|Follow Up Phase|Other|0|||
143080429|NCT01098474|515834030|FG002|Follow Up Phase|Other|0|||
143080430|NCT01098474|515834031|FG003|Follow Up Phase|Other|0|||
143080431|NCT01098474|515834032|FG004|Follow Up Phase|Other|0|||
143080432|NCT01098474|515834033|FG005|Follow Up Phase|Other|4|||
143080433|NCT01098474|515834028|FG000|Follow Up Phase|Withdrawal by Subject|0|||
143080434|NCT01098474|515834029|FG001|Follow Up Phase|Withdrawal by Subject|0|||
143080435|NCT01098474|515834030|FG002|Follow Up Phase|Withdrawal by Subject|0|||
143080436|NCT01098474|515834031|FG003|Follow Up Phase|Withdrawal by Subject|2|||
143080437|NCT01098474|515834032|FG004|Follow Up Phase|Withdrawal by Subject|0|||
143080438|NCT01098474|515834033|FG005|Follow Up Phase|Withdrawal by Subject|1|||
143080439|NCT01098474|515834028|FG000|Follow Up Phase|Lost to Follow-up|0|||
143080440|NCT01098474|515834029|FG001|Follow Up Phase|Lost to Follow-up|0|||
143080441|NCT01098474|515834030|FG002|Follow Up Phase|Lost to Follow-up|0|||
143080442|NCT01098474|515834031|FG003|Follow Up Phase|Lost to Follow-up|0|||
143080443|NCT01098474|515834032|FG004|Follow Up Phase|Lost to Follow-up|1|||
143080444|NCT01098474|515834033|FG005|Follow Up Phase|Lost to Follow-up|0|||
143080445|NCT02655666|515834041|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
143080446|NCT03837743|515834042|FG000|Overall Study|Adverse Event|1|||
143080447|NCT03837743|515834042|FG000|Overall Study|Withdrawal by Subject|2|||
143080448|NCT02257385|515834044|FG000|Overall Study|Adverse Event|12|||
143080449|NCT02257385|515834045|FG001|Overall Study|Adverse Event|8|||
143080450|NCT02257385|515834044|FG000|Overall Study|Lack of Efficacy|1|||
143080451|NCT02257385|515834045|FG001|Overall Study|Lack of Efficacy|2|||
143080452|NCT02257385|515834044|FG000|Overall Study|Protocol Violation|5|||
143080453|NCT02257385|515834045|FG001|Overall Study|Protocol Violation|7|||
143080454|NCT02257385|515834044|FG000|Overall Study|Lost to Follow-up|0|||
143080455|NCT02257385|515834045|FG001|Overall Study|Lost to Follow-up|1|||
143080456|NCT02257385|515834044|FG000|Overall Study|Withdrawal by Subject|4|||
143080457|NCT02257385|515834045|FG001|Overall Study|Withdrawal by Subject|4|||
143080458|NCT02552732|515834050|FG000|Overall Study|Lost to Follow-up|2|||
143080459|NCT02552732|515834050|FG000|Overall Study|Physician Decision|1|||
143080460|NCT02552732|515834050|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
143080461|NCT02552732|515834050|FG000|Overall Study|Withdrawal by Subject|6|||
143080462|NCT01449370|515834053|FG000|Overall Study|Disease Progression|5|||
143080463|NCT01449370|515834054|FG001|Overall Study|Disease Progression|4|||
143080464|NCT01449370|515834055|FG002|Overall Study|Disease Progression|8|||
143080465|NCT01449370|515834056|FG003|Overall Study|Disease Progression|3|||
143248994|NCT04643158|516465079|FG004|Overall Study|Global/country situation|0|||
143248995|NCT04643158|516465080|FG005|Overall Study|Global/country situation|0|||
143080466|NCT01449370|515834057|FG004|Overall Study|Disease Progression|3|||
143080467|NCT01449370|515834058|FG005|Overall Study|Disease Progression|3|||
143080468|NCT01449370|515834059|FG006|Overall Study|Disease Progression|3|||
143080469|NCT01449370|515834060|FG007|Overall Study|Disease Progression|2|||
143080470|NCT01449370|515834061|FG008|Overall Study|Disease Progression|9|||
143080471|NCT01449370|515834062|FG009|Overall Study|Disease Progression|1|||
143080472|NCT01449370|515834063|FG010|Overall Study|Disease Progression|3|||
143080473|NCT01449370|515834064|FG011|Overall Study|Disease Progression|3|||
143080474|NCT01449370|515834065|FG012|Overall Study|Disease Progression|2|||
143080475|NCT01449370|515834066|FG013|Overall Study|Disease Progression|8|||
143080476|NCT01449370|515834067|FG014|Overall Study|Disease Progression|3|||
143080477|NCT01449370|515834068|FG015|Overall Study|Disease Progression|1|||
143080478|NCT01449370|515834069|FG016|Overall Study|Disease Progression|4|||
143080479|NCT01449370|515834070|FG017|Overall Study|Disease Progression|3|||
143080480|NCT01449370|515834071|FG018|Overall Study|Disease Progression|1|||
143080481|NCT01449370|515834072|FG019|Overall Study|Disease Progression|2|||
143080482|NCT01449370|515834073|FG020|Overall Study|Disease Progression|5|||
143080483|NCT01449370|515834074|FG021|Overall Study|Disease Progression|2|||
143080484|NCT01449370|515834075|FG022|Overall Study|Disease Progression|3|||
143080485|NCT01449370|515834076|FG023|Overall Study|Disease Progression|7|||
143080486|NCT01449370|515834077|FG024|Overall Study|Disease Progression|3|||
143080487|NCT01449370|515834053|FG000|Overall Study|Adverse Event|1|||
143080488|NCT01449370|515834054|FG001|Overall Study|Adverse Event|2|||
143080489|NCT01449370|515834055|FG002|Overall Study|Adverse Event|0|||
143080490|NCT01449370|515834056|FG003|Overall Study|Adverse Event|1|||
143080491|NCT01449370|515834057|FG004|Overall Study|Adverse Event|0|||
143080492|NCT01449370|515834058|FG005|Overall Study|Adverse Event|0|||
143080493|NCT01449370|515834059|FG006|Overall Study|Adverse Event|0|||
143080494|NCT01449370|515834060|FG007|Overall Study|Adverse Event|0|||
143080495|NCT01449370|515834061|FG008|Overall Study|Adverse Event|1|||
143080496|NCT01449370|515834062|FG009|Overall Study|Adverse Event|1|||
143080497|NCT01449370|515834063|FG010|Overall Study|Adverse Event|0|||
143080498|NCT01449370|515834064|FG011|Overall Study|Adverse Event|0|||
143080499|NCT01449370|515834065|FG012|Overall Study|Adverse Event|0|||
143080500|NCT01449370|515834066|FG013|Overall Study|Adverse Event|2|||
143080501|NCT01449370|515834067|FG014|Overall Study|Adverse Event|0|||
143080502|NCT01449370|515834068|FG015|Overall Study|Adverse Event|1|||
143080503|NCT01449370|515834069|FG016|Overall Study|Adverse Event|0|||
143080504|NCT01449370|515834070|FG017|Overall Study|Adverse Event|0|||
143080505|NCT01449370|515834071|FG018|Overall Study|Adverse Event|1|||
143080506|NCT01449370|515834072|FG019|Overall Study|Adverse Event|1|||
143080507|NCT01449370|515834073|FG020|Overall Study|Adverse Event|0|||
143080508|NCT01449370|515834074|FG021|Overall Study|Adverse Event|1|||
143080509|NCT01449370|515834075|FG022|Overall Study|Adverse Event|0|||
143080510|NCT01449370|515834076|FG023|Overall Study|Adverse Event|1|||
143080511|NCT01449370|515834077|FG024|Overall Study|Adverse Event|3|||
143080512|NCT01449370|515834053|FG000|Overall Study|Participant Decision|0|||
143080513|NCT01449370|515834054|FG001|Overall Study|Participant Decision|0|||
143080514|NCT01449370|515834055|FG002|Overall Study|Participant Decision|0|||
143080515|NCT01449370|515834056|FG003|Overall Study|Participant Decision|0|||
143080516|NCT01449370|515834057|FG004|Overall Study|Participant Decision|0|||
143080517|NCT01449370|515834058|FG005|Overall Study|Participant Decision|0|||
143080518|NCT01449370|515834059|FG006|Overall Study|Participant Decision|0|||
143080519|NCT01449370|515834060|FG007|Overall Study|Participant Decision|1|||
143080520|NCT01449370|515834061|FG008|Overall Study|Participant Decision|1|||
143080521|NCT01449370|515834062|FG009|Overall Study|Participant Decision|0|||
143080522|NCT01449370|515834063|FG010|Overall Study|Participant Decision|0|||
143080523|NCT01449370|515834064|FG011|Overall Study|Participant Decision|0|||
143080524|NCT01449370|515834065|FG012|Overall Study|Participant Decision|1|||
143080525|NCT01449370|515834066|FG013|Overall Study|Participant Decision|1|||
143080526|NCT01449370|515834067|FG014|Overall Study|Participant Decision|0|||
143080527|NCT01449370|515834068|FG015|Overall Study|Participant Decision|1|||
143080528|NCT01449370|515834069|FG016|Overall Study|Participant Decision|3|||
143080529|NCT01449370|515834070|FG017|Overall Study|Participant Decision|0|||
143080530|NCT01449370|515834071|FG018|Overall Study|Participant Decision|1|||
143080531|NCT01449370|515834072|FG019|Overall Study|Participant Decision|0|||
143080532|NCT01449370|515834073|FG020|Overall Study|Participant Decision|0|||
143080533|NCT01449370|515834074|FG021|Overall Study|Participant Decision|1|||
143080534|NCT01449370|515834075|FG022|Overall Study|Participant Decision|0|||
143080535|NCT01449370|515834076|FG023|Overall Study|Participant Decision|0|||
143080536|NCT01449370|515834077|FG024|Overall Study|Participant Decision|1|||
143080537|NCT01449370|515834053|FG000|Overall Study|Lost to Follow-up|0|||
143080538|NCT01449370|515834054|FG001|Overall Study|Lost to Follow-up|0|||
143080539|NCT01449370|515834055|FG002|Overall Study|Lost to Follow-up|0|||
143080540|NCT01449370|515834056|FG003|Overall Study|Lost to Follow-up|0|||
143080541|NCT01449370|515834057|FG004|Overall Study|Lost to Follow-up|0|||
143080542|NCT01449370|515834058|FG005|Overall Study|Lost to Follow-up|0|||
143080543|NCT01449370|515834059|FG006|Overall Study|Lost to Follow-up|0|||
143080544|NCT01449370|515834060|FG007|Overall Study|Lost to Follow-up|0|||
143080545|NCT01449370|515834061|FG008|Overall Study|Lost to Follow-up|0|||
143080546|NCT01449370|515834062|FG009|Overall Study|Lost to Follow-up|0|||
143080547|NCT01449370|515834063|FG010|Overall Study|Lost to Follow-up|0|||
143080548|NCT01449370|515834064|FG011|Overall Study|Lost to Follow-up|0|||
143080549|NCT01449370|515834065|FG012|Overall Study|Lost to Follow-up|0|||
143080550|NCT01449370|515834066|FG013|Overall Study|Lost to Follow-up|0|||
143080551|NCT01449370|515834067|FG014|Overall Study|Lost to Follow-up|0|||
143080552|NCT01449370|515834068|FG015|Overall Study|Lost to Follow-up|0|||
143080553|NCT01449370|515834069|FG016|Overall Study|Lost to Follow-up|0|||
143080554|NCT01449370|515834070|FG017|Overall Study|Lost to Follow-up|0|||
143080555|NCT01449370|515834071|FG018|Overall Study|Lost to Follow-up|0|||
143080556|NCT01449370|515834072|FG019|Overall Study|Lost to Follow-up|0|||
143080557|NCT01449370|515834073|FG020|Overall Study|Lost to Follow-up|1|||
143080558|NCT01449370|515834074|FG021|Overall Study|Lost to Follow-up|0|||
143080559|NCT01449370|515834075|FG022|Overall Study|Lost to Follow-up|0|||
143080560|NCT01449370|515834076|FG023|Overall Study|Lost to Follow-up|0|||
143080561|NCT01449370|515834077|FG024|Overall Study|Lost to Follow-up|0|||
143080562|NCT01449370|515834053|FG000|Overall Study|Other|0|||
143080563|NCT01449370|515834054|FG001|Overall Study|Other|0|||
143080564|NCT01449370|515834055|FG002|Overall Study|Other|0|||
143080565|NCT01449370|515834056|FG003|Overall Study|Other|0|||
143080566|NCT01449370|515834057|FG004|Overall Study|Other|0|||
143080567|NCT01449370|515834058|FG005|Overall Study|Other|0|||
143080568|NCT01449370|515834059|FG006|Overall Study|Other|0|||
143080569|NCT01449370|515834060|FG007|Overall Study|Other|0|||
143080570|NCT01449370|515834061|FG008|Overall Study|Other|1|||
143080571|NCT01449370|515834062|FG009|Overall Study|Other|1|||
143080572|NCT01449370|515834063|FG010|Overall Study|Other|0|||
143080573|NCT01449370|515834064|FG011|Overall Study|Other|0|||
143080574|NCT01449370|515834065|FG012|Overall Study|Other|0|||
143080575|NCT01449370|515834066|FG013|Overall Study|Other|0|||
143080576|NCT01449370|515834067|FG014|Overall Study|Other|0|||
143080577|NCT01449370|515834068|FG015|Overall Study|Other|0|||
143080578|NCT01449370|515834069|FG016|Overall Study|Other|0|||
143080579|NCT01449370|515834070|FG017|Overall Study|Other|0|||
143080580|NCT01449370|515834071|FG018|Overall Study|Other|0|||
143080581|NCT01449370|515834072|FG019|Overall Study|Other|0|||
143080582|NCT01449370|515834073|FG020|Overall Study|Other|0|||
143080583|NCT01449370|515834074|FG021|Overall Study|Other|0|||
143080584|NCT01449370|515834075|FG022|Overall Study|Other|1|||
143080585|NCT01449370|515834076|FG023|Overall Study|Other|1|||
143080586|NCT01449370|515834077|FG024|Overall Study|Other|0|||
143080587|NCT01449370|515834053|FG000|Overall Study|Medication Prohibited by Protocol|0|||
143080588|NCT01449370|515834054|FG001|Overall Study|Medication Prohibited by Protocol|0|||
143080589|NCT01449370|515834055|FG002|Overall Study|Medication Prohibited by Protocol|0|||
143080590|NCT01449370|515834056|FG003|Overall Study|Medication Prohibited by Protocol|0|||
143080591|NCT01449370|515834057|FG004|Overall Study|Medication Prohibited by Protocol|0|||
143080592|NCT01449370|515834058|FG005|Overall Study|Medication Prohibited by Protocol|0|||
143080593|NCT01449370|515834059|FG006|Overall Study|Medication Prohibited by Protocol|0|||
143080594|NCT01449370|515834060|FG007|Overall Study|Medication Prohibited by Protocol|0|||
143080595|NCT01449370|515834061|FG008|Overall Study|Medication Prohibited by Protocol|0|||
143080596|NCT01449370|515834062|FG009|Overall Study|Medication Prohibited by Protocol|0|||
143080597|NCT01449370|515834063|FG010|Overall Study|Medication Prohibited by Protocol|0|||
143080598|NCT01449370|515834064|FG011|Overall Study|Medication Prohibited by Protocol|0|||
143080599|NCT01449370|515834065|FG012|Overall Study|Medication Prohibited by Protocol|0|||
143080600|NCT01449370|515834066|FG013|Overall Study|Medication Prohibited by Protocol|0|||
143080601|NCT01449370|515834067|FG014|Overall Study|Medication Prohibited by Protocol|0|||
143080602|NCT01449370|515834068|FG015|Overall Study|Medication Prohibited by Protocol|0|||
143248996|NCT04643158|516465081|FG006|Overall Study|Global/country situation|0|||
143080603|NCT01449370|515834069|FG016|Overall Study|Medication Prohibited by Protocol|0|||
143080604|NCT01449370|515834070|FG017|Overall Study|Medication Prohibited by Protocol|0|||
143080605|NCT01449370|515834071|FG018|Overall Study|Medication Prohibited by Protocol|0|||
143080606|NCT01449370|515834072|FG019|Overall Study|Medication Prohibited by Protocol|0|||
143080607|NCT01449370|515834073|FG020|Overall Study|Medication Prohibited by Protocol|0|||
143080608|NCT01449370|515834074|FG021|Overall Study|Medication Prohibited by Protocol|0|||
143080609|NCT01449370|515834075|FG022|Overall Study|Medication Prohibited by Protocol|0|||
143080610|NCT01449370|515834076|FG023|Overall Study|Medication Prohibited by Protocol|1|||
143080611|NCT01449370|515834077|FG024|Overall Study|Medication Prohibited by Protocol|0|||
143080612|NCT01449370|515834053|FG000|Overall Study|Death|0|||
143080613|NCT01449370|515834054|FG001|Overall Study|Death|0|||
143080614|NCT01449370|515834055|FG002|Overall Study|Death|0|||
143080615|NCT01449370|515834056|FG003|Overall Study|Death|0|||
143080616|NCT01449370|515834057|FG004|Overall Study|Death|0|||
143080617|NCT01449370|515834058|FG005|Overall Study|Death|0|||
143080618|NCT01449370|515834059|FG006|Overall Study|Death|0|||
143080619|NCT01449370|515834060|FG007|Overall Study|Death|0|||
143080620|NCT01449370|515834061|FG008|Overall Study|Death|0|||
143080621|NCT01449370|515834062|FG009|Overall Study|Death|0|||
143080622|NCT01449370|515834063|FG010|Overall Study|Death|0|||
143080623|NCT01449370|515834064|FG011|Overall Study|Death|0|||
143080624|NCT01449370|515834065|FG012|Overall Study|Death|0|||
143080625|NCT01449370|515834066|FG013|Overall Study|Death|0|||
143080626|NCT01449370|515834067|FG014|Overall Study|Death|0|||
143080627|NCT01449370|515834068|FG015|Overall Study|Death|0|||
143080628|NCT01449370|515834069|FG016|Overall Study|Death|0|||
143080629|NCT01449370|515834070|FG017|Overall Study|Death|0|||
143080630|NCT01449370|515834071|FG018|Overall Study|Death|0|||
143080631|NCT01449370|515834072|FG019|Overall Study|Death|0|||
143080632|NCT01449370|515834073|FG020|Overall Study|Death|0|||
143080633|NCT01449370|515834074|FG021|Overall Study|Death|0|||
143080634|NCT01449370|515834075|FG022|Overall Study|Death|0|||
143080635|NCT01449370|515834076|FG023|Overall Study|Death|0|||
143080636|NCT01449370|515834077|FG024|Overall Study|Death|1|||
143080637|NCT00086281|515834078|FG000|Phase 1|Adverse Event|0|||
143080638|NCT00086281|515834079|FG001|Phase 1|Adverse Event|0|||
143080639|NCT00086281|515834080|FG002|Phase 1|Adverse Event|0|||
143080640|NCT00086281|515834081|FG003|Phase 1|Adverse Event|0|||
143080641|NCT00086281|515834082|FG004|Phase 1|Adverse Event|0|||
143080642|NCT00086281|515834083|FG005|Phase 1|Adverse Event|0|||
143080643|NCT00086281|515834084|FG006|Phase 1|Adverse Event|0|||
143080644|NCT00086281|515834085|FG007|Phase 1|Adverse Event|0|||
143080645|NCT00086281|515834086|FG008|Phase 1|Adverse Event|0|||
143080646|NCT00086281|515834087|FG009|Phase 1|Adverse Event|1|||
143080647|NCT00086281|515834088|FG010|Phase 1|Adverse Event|2|||
143080648|NCT00086281|515834089|FG011|Phase 1|Adverse Event|1|||
143080649|NCT00086281|515834090|FG012|Phase 1|Adverse Event|1|||
143080650|NCT00086281|515834091|FG013|Phase 1|Adverse Event|1|||
143080651|NCT00086281|515834092|FG014|Phase 1|Adverse Event|2|||
143080652|NCT00086281|515834078|FG000|Phase 1|Protocol Violation|0|||
143080653|NCT00086281|515834079|FG001|Phase 1|Protocol Violation|0|||
143080654|NCT00086281|515834080|FG002|Phase 1|Protocol Violation|0|||
143080655|NCT00086281|515834081|FG003|Phase 1|Protocol Violation|0|||
143080656|NCT00086281|515834082|FG004|Phase 1|Protocol Violation|0|||
143080657|NCT00086281|515834083|FG005|Phase 1|Protocol Violation|0|||
143080658|NCT00086281|515834084|FG006|Phase 1|Protocol Violation|0|||
143080659|NCT00086281|515834085|FG007|Phase 1|Protocol Violation|0|||
143080660|NCT00086281|515834086|FG008|Phase 1|Protocol Violation|0|||
143080661|NCT00086281|515834087|FG009|Phase 1|Protocol Violation|0|||
143080662|NCT00086281|515834088|FG010|Phase 1|Protocol Violation|1|||
143080663|NCT00086281|515834089|FG011|Phase 1|Protocol Violation|0|||
143080664|NCT00086281|515834090|FG012|Phase 1|Protocol Violation|0|||
143080665|NCT00086281|515834091|FG013|Phase 1|Protocol Violation|0|||
143080666|NCT00086281|515834092|FG014|Phase 1|Protocol Violation|0|||
143080667|NCT00086281|515834078|FG000|Phase 1|Serious Adverse Event|0|||
143080668|NCT00086281|515834079|FG001|Phase 1|Serious Adverse Event|0|||
143080669|NCT00086281|515834080|FG002|Phase 1|Serious Adverse Event|0|||
143080670|NCT00086281|515834081|FG003|Phase 1|Serious Adverse Event|0|||
143080671|NCT00086281|515834082|FG004|Phase 1|Serious Adverse Event|0|||
143080672|NCT00086281|515834083|FG005|Phase 1|Serious Adverse Event|0|||
143080673|NCT00086281|515834084|FG006|Phase 1|Serious Adverse Event|0|||
143080674|NCT00086281|515834085|FG007|Phase 1|Serious Adverse Event|0|||
143080675|NCT00086281|515834086|FG008|Phase 1|Serious Adverse Event|0|||
143080676|NCT00086281|515834087|FG009|Phase 1|Serious Adverse Event|0|||
143080677|NCT00086281|515834088|FG010|Phase 1|Serious Adverse Event|0|||
143080678|NCT00086281|515834089|FG011|Phase 1|Serious Adverse Event|0|||
143080679|NCT00086281|515834090|FG012|Phase 1|Serious Adverse Event|0|||
143080680|NCT00086281|515834091|FG013|Phase 1|Serious Adverse Event|0|||
143080681|NCT00086281|515834092|FG014|Phase 1|Serious Adverse Event|1|||
143080682|NCT00086281|515834078|FG000|Phase 2|Adverse Event|0|||
143080683|NCT00086281|515834079|FG001|Phase 2|Adverse Event|0|||
143080684|NCT00086281|515834080|FG002|Phase 2|Adverse Event|0|||
143080685|NCT00086281|515834081|FG003|Phase 2|Adverse Event|0|||
143080686|NCT00086281|515834082|FG004|Phase 2|Adverse Event|0|||
143080687|NCT00086281|515834083|FG005|Phase 2|Adverse Event|0|||
143080688|NCT00086281|515834084|FG006|Phase 2|Adverse Event|0|||
143080689|NCT00086281|515834085|FG007|Phase 2|Adverse Event|0|||
143080690|NCT00086281|515834086|FG008|Phase 2|Adverse Event|0|||
143080691|NCT00086281|515834087|FG009|Phase 2|Adverse Event|0|||
143080692|NCT00086281|515834088|FG010|Phase 2|Adverse Event|0|||
143080693|NCT00086281|515834089|FG011|Phase 2|Adverse Event|0|||
143080694|NCT00086281|515834090|FG012|Phase 2|Adverse Event|1|||
143080695|NCT00086281|515834091|FG013|Phase 2|Adverse Event|1|||
143080696|NCT00086281|515834092|FG014|Phase 2|Adverse Event|0|||
143080697|NCT00534404|515834097|FG000|Overall Study|Death|0|||
143080698|NCT00534404|515834098|FG001|Overall Study|Death|0|||
143080699|NCT00534404|515834099|FG002|Overall Study|Death|2|||
143080700|NCT00534404|515834097|FG000|Overall Study|Withdrawal by Subject|8|||
143080701|NCT00534404|515834098|FG001|Overall Study|Withdrawal by Subject|2|||
143080702|NCT00534404|515834099|FG002|Overall Study|Withdrawal by Subject|38|||
143080703|NCT00534404|515834097|FG000|Overall Study|Removed by study staff|2|||
143080704|NCT00534404|515834098|FG001|Overall Study|Removed by study staff|3|||
143080705|NCT00534404|515834099|FG002|Overall Study|Removed by study staff|1|||
143080706|NCT00534404|515834097|FG000|Overall Study|Lost to Follow-up|170|||
143080707|NCT00534404|515834098|FG001|Overall Study|Lost to Follow-up|138|||
143080708|NCT00534404|515834099|FG002|Overall Study|Lost to Follow-up|201|||
143080709|NCT02996487|515834100|FG000|Overall Study|Lost to Follow-up|1|||
143080710|NCT02996487|515834101|FG001|Overall Study|Lost to Follow-up|1|||
143080711|NCT02996487|515834102|FG002|Overall Study|Lost to Follow-up|0|||
143080712|NCT02996487|515834100|FG000|Overall Study|Death|0|||
143080713|NCT02996487|515834101|FG001|Overall Study|Death|1|||
143080714|NCT02996487|515834102|FG002|Overall Study|Death|0|||
143080715|NCT02996487|515834100|FG000|Overall Study|Withdrawal by Subject|2|||
143080716|NCT02996487|515834101|FG001|Overall Study|Withdrawal by Subject|3|||
143080717|NCT02996487|515834102|FG002|Overall Study|Withdrawal by Subject|0|||
143080718|NCT02027428|515834103|FG000|Induction|Never treated|7|||
143080719|NCT02027428|515834104|FG001|Induction|Never treated|0|||
143080720|NCT02027428|515834105|FG002|Induction|Never treated|0|||
143080721|NCT02027428|515834103|FG000|Induction|Progressive disease|77|||
143080722|NCT02027428|515834104|FG001|Induction|Progressive disease|0|||
143080723|NCT02027428|515834105|FG002|Induction|Progressive disease|0|||
143080724|NCT02027428|515834103|FG000|Induction|Adverse Event|51|||
143080725|NCT02027428|515834104|FG001|Induction|Adverse Event|0|||
143080726|NCT02027428|515834105|FG002|Induction|Adverse Event|0|||
143080727|NCT02027428|515834103|FG000|Induction|Withdrawal by Subject|22|||
143080728|NCT02027428|515834104|FG001|Induction|Withdrawal by Subject|0|||
143080729|NCT02027428|515834105|FG002|Induction|Withdrawal by Subject|0|||
143080730|NCT02027428|515834103|FG000|Induction|Death|21|||
143080731|NCT02027428|515834104|FG001|Induction|Death|0|||
143080732|NCT02027428|515834105|FG002|Induction|Death|0|||
143080733|NCT02027428|515834103|FG000|Induction|Symptomatic deterioration|16|||
143080734|NCT02027428|515834104|FG001|Induction|Symptomatic deterioration|0|||
143080735|NCT02027428|515834105|FG002|Induction|Symptomatic deterioration|0|||
143080736|NCT02027428|515834103|FG000|Induction|Study terminated by sponsor|12|||
143080737|NCT02027428|515834104|FG001|Induction|Study terminated by sponsor|0|||
143080738|NCT02027428|515834105|FG002|Induction|Study terminated by sponsor|0|||
143080739|NCT02027428|515834103|FG000|Induction|Protocol Violation|1|||
143080740|NCT02027428|515834104|FG001|Induction|Protocol Violation|0|||
143080741|NCT02027428|515834105|FG002|Induction|Protocol Violation|0|||
143080742|NCT02027428|515834103|FG000|Induction|Miscellaneous|14|||
143080743|NCT02027428|515834104|FG001|Induction|Miscellaneous|0|||
143080744|NCT02027428|515834105|FG002|Induction|Miscellaneous|0|||
143080745|NCT02027428|515834103|FG000|Induction|Induction Treatment Ongoing|4|||
143080746|NCT02027428|515834104|FG001|Induction|Induction Treatment Ongoing|0|||
143080747|NCT02027428|515834105|FG002|Induction|Induction Treatment Ongoing|0|||
143080748|NCT02027428|515834103|FG000|Maintenance|Death|0|||
143080749|NCT02027428|515834104|FG001|Maintenance|Death|3|||
143080750|NCT02027428|515834105|FG002|Maintenance|Death|2|||
143080751|NCT02027428|515834103|FG000|Maintenance|Adverse Event|0|||
143080752|NCT02027428|515834104|FG001|Maintenance|Adverse Event|21|||
143080753|NCT02027428|515834105|FG002|Maintenance|Adverse Event|1|||
143080754|NCT02027428|515834103|FG000|Maintenance|Progressive disease|0|||
143080755|NCT02027428|515834104|FG001|Maintenance|Progressive disease|84|||
143080756|NCT02027428|515834105|FG002|Maintenance|Progressive disease|47|||
143080757|NCT02027428|515834103|FG000|Maintenance|Symptomatic deterioration|0|||
143080758|NCT02027428|515834104|FG001|Maintenance|Symptomatic deterioration|4|||
143080759|NCT02027428|515834105|FG002|Maintenance|Symptomatic deterioration|1|||
143080760|NCT02027428|515834103|FG000|Maintenance|Withdrawal by Subject|0|||
143080761|NCT02027428|515834104|FG001|Maintenance|Withdrawal by Subject|6|||
143080762|NCT02027428|515834105|FG002|Maintenance|Withdrawal by Subject|5|||
143080763|NCT02027428|515834103|FG000|Maintenance|Protocol Violation|0|||
143080764|NCT02027428|515834104|FG001|Maintenance|Protocol Violation|0|||
143080765|NCT02027428|515834105|FG002|Maintenance|Protocol Violation|1|||
143080766|NCT02027428|515834103|FG000|Maintenance|Other|0|||
143080767|NCT02027428|515834104|FG001|Maintenance|Other|6|||
143080768|NCT02027428|515834105|FG002|Maintenance|Other|3|||
143080769|NCT02027428|515834103|FG000|Survival Follow-up|Death|0|||
143080770|NCT02027428|515834104|FG001|Survival Follow-up|Death|78|||
143080771|NCT02027428|515834105|FG002|Survival Follow-up|Death|45|||
143080772|NCT02027428|515834103|FG000|Survival Follow-up|Lost to Follow-up|0|||
143080773|NCT02027428|515834104|FG001|Survival Follow-up|Lost to Follow-up|1|||
143080774|NCT02027428|515834105|FG002|Survival Follow-up|Lost to Follow-up|1|||
143080775|NCT00315731|515834108|FG000|Overall Study|Lost to Follow-up|1|||
143080776|NCT00315731|515834108|FG000|Overall Study|Death|5|||
143080777|NCT03597464|515834113|FG000|Overall Study|Withdrawal by Subject|4|||
143080778|NCT03597464|515834114|FG001|Overall Study|Withdrawal by Subject|5|||
143080779|NCT03597464|515834113|FG000|Overall Study|Lost to Follow-up|3|||
143173128|NCT02415556|516183026|FG002|Overall Study|Censored - study completion|1|||
143173129|NCT02415556|516183027|FG003|Overall Study|Censored - study completion|0|||
143173130|NCT02415556|516183024|FG000|Overall Study|Family-related issues|0|||
143173131|NCT02415556|516183025|FG001|Overall Study|Family-related issues|0|||
143173132|NCT02415556|516183026|FG002|Overall Study|Family-related issues|0|||
143173133|NCT02415556|516183027|FG003|Overall Study|Family-related issues|1|||
143173134|NCT00560508|516183028|FG000|12 Week Double-blind Period|Adverse Event|3|||
143173135|NCT00560508|516183029|FG001|12 Week Double-blind Period|Adverse Event|2|||
143173136|NCT00560508|516183028|FG000|12 Week Double-blind Period|Protocol Violation|1|||
143173137|NCT00560508|516183029|FG001|12 Week Double-blind Period|Protocol Violation|0|||
143173138|NCT00560508|516183028|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
143173139|NCT00560508|516183029|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
143173140|NCT00560508|516183028|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
143173141|NCT00560508|516183029|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
143173142|NCT00560508|516183028|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
143173143|NCT00560508|516183029|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
143173144|NCT00560508|516183028|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
143173145|NCT00560508|516183029|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
143173146|NCT00560508|516183028|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
143173147|NCT00560508|516183029|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
143173148|NCT01146613|516183030|FG000|Overall Study|Lost to Follow-up|3|||
143173149|NCT01146613|516183031|FG001|Overall Study|Lost to Follow-up|8|||
143173150|NCT01146613|516183030|FG000|Overall Study|Lack of Efficacy|0|||
143173151|NCT01146613|516183031|FG001|Overall Study|Lack of Efficacy|1|||
143173152|NCT01146613|516183030|FG000|Overall Study|Death|1|||
143173153|NCT01146613|516183031|FG001|Overall Study|Death|0|||
143173154|NCT01146613|516183030|FG000|Overall Study|Physician Decision|1|||
143173155|NCT01146613|516183031|FG001|Overall Study|Physician Decision|0|||
143173156|NCT01146613|516183030|FG000|Overall Study|Withdrawal by Subject|0|||
143173157|NCT01146613|516183031|FG001|Overall Study|Withdrawal by Subject|3|||
143173158|NCT01146613|516183030|FG000|Overall Study|schedule conflict|1|||
143173159|NCT01146613|516183031|FG001|Overall Study|schedule conflict|0|||
143173160|NCT01146613|516183030|FG000|Overall Study|Outpatient detox|1|||
143080780|NCT03597464|515834114|FG001|Overall Study|Lost to Follow-up|1|||
143080781|NCT03597464|515834113|FG000|Overall Study|Pregnancy|3|||
143080782|NCT03597464|515834114|FG001|Overall Study|Pregnancy|1|||
143080783|NCT03597464|515834113|FG000|Overall Study|Lack of Efficacy|2|||
143080784|NCT03597464|515834114|FG001|Overall Study|Lack of Efficacy|0|||
143080785|NCT03597464|515834113|FG000|Overall Study|Physician Decision|2|||
143080786|NCT03597464|515834114|FG001|Overall Study|Physician Decision|2|||
143080787|NCT03597464|515834113|FG000|Overall Study|Protocol Violation|1|||
143080788|NCT03597464|515834114|FG001|Overall Study|Protocol Violation|1|||
143080789|NCT03597464|515834113|FG000|Overall Study|Adverse Event|0|||
143080790|NCT03597464|515834114|FG001|Overall Study|Adverse Event|2|||
143080791|NCT03597464|515834113|FG000|Overall Study|Death|0|||
143080792|NCT03597464|515834114|FG001|Overall Study|Death|3|||
143080793|NCT01374269|515834118|FG000|Overall Study|Withdrawal by Subject|4|||
143173161|NCT01146613|516183031|FG001|Overall Study|Outpatient detox|0|||
143173162|NCT00320606|516183032|FG000|Overall Study|Adverse Event|1|||
143173163|NCT00320606|516183032|FG000|Overall Study|Protocol Violation|1|||
143173164|NCT00320606|516183032|FG000|Overall Study|Withdrawal by Subject|1|||
143173165|NCT00399035|516183035|FG000|Overall Study|Death|289|||
143173166|NCT00399035|516183036|FG001|Overall Study|Death|141|||
143173167|NCT00399035|516183037|FG002|Overall Study|Death|234|||
143173168|NCT00399035|516183035|FG000|Overall Study|Lost to Follow-up|2|||
143173169|NCT00399035|516183036|FG001|Overall Study|Lost to Follow-up|1|||
143173170|NCT00399035|516183037|FG002|Overall Study|Lost to Follow-up|5|||
143173171|NCT00399035|516183035|FG000|Overall Study|Withdrawal by Subject|19|||
143173172|NCT00399035|516183036|FG001|Overall Study|Withdrawal by Subject|15|||
143173173|NCT00399035|516183037|FG002|Overall Study|Withdrawal by Subject|12|||
143173174|NCT00399035|516183035|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
143173175|NCT00399035|516183036|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
143173176|NCT00399035|516183037|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
143173177|NCT00399035|516183035|FG000|Overall Study|Severe non-compliance with protocol|2|||
143173178|NCT00399035|516183036|FG001|Overall Study|Severe non-compliance with protocol|1|||
143080794|NCT01374269|515834119|FG001|Overall Study|Withdrawal by Subject|0|||
143080795|NCT01374269|515834118|FG000|Overall Study|Lost to Follow-up|1|||
143080796|NCT01374269|515834119|FG001|Overall Study|Lost to Follow-up|3|||
143080797|NCT01374269|515834118|FG000|Overall Study|closed research|1|||
143080798|NCT01374269|515834119|FG001|Overall Study|closed research|2|||
143080799|NCT00340678|515834120|FG000|Overall Study|Lost to Follow-up|1|||
143173179|NCT00399035|516183037|FG002|Overall Study|Severe non-compliance with protocol|0|||
143173180|NCT02949011|516183038|FG000|Overall Study|Adverse Event|6|||
143173181|NCT02949011|516183039|FG001|Overall Study|Adverse Event|7|||
143080800|NCT00340678|515834121|FG001|Overall Study|Lost to Follow-up|0|||
143080801|NCT00340678|515834122|FG002|Overall Study|Lost to Follow-up|0|||
143080802|NCT00340678|515834123|FG003|Overall Study|Lost to Follow-up|0|||
143080803|NCT01653912|515834124|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
143080804|NCT01653912|515834125|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
143080805|NCT01653912|515834126|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
143080806|NCT01653912|515834127|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
143080807|NCT01653912|515834128|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
143080808|NCT01653912|515834129|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
143080809|NCT01653912|515834124|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
143080810|NCT01653912|515834125|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
143080811|NCT01653912|515834126|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
143080812|NCT01653912|515834127|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
143080813|NCT01653912|515834128|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
143080814|NCT01653912|515834129|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
143080815|NCT01653912|515834124|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
143080816|NCT01653912|515834125|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
143080817|NCT01653912|515834126|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
143080818|NCT01653912|515834127|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
143080819|NCT01653912|515834128|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
143080820|NCT01653912|515834129|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
143080821|NCT01653912|515834124|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
143080822|NCT01653912|515834125|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
143080823|NCT01653912|515834126|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
143080824|NCT01653912|515834127|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
143080825|NCT01653912|515834128|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
143080826|NCT01653912|515834129|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
143080827|NCT01653912|515834124|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
143080828|NCT01653912|515834125|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
143080829|NCT01653912|515834126|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
143080830|NCT01653912|515834127|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
143080831|NCT01653912|515834128|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
143080832|NCT01653912|515834129|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
143080833|NCT01653912|515834124|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
143080834|NCT01653912|515834125|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
143080835|NCT01653912|515834126|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
143080836|NCT01653912|515834127|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
143080837|NCT01653912|515834128|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
143080838|NCT01653912|515834129|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
143080839|NCT01653912|515834124|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
143080840|NCT01653912|515834125|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
143080841|NCT01653912|515834126|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
143080842|NCT01653912|515834127|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
143080843|NCT01653912|515834128|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
143080844|NCT01653912|515834129|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
143080845|NCT00708227|515834130|FG000|Overall Study|Physician Decision|0|||
143080846|NCT00708227|515834131|FG001|Overall Study|Physician Decision|3|||
143080847|NCT00708227|515834132|FG002|Overall Study|Physician Decision|1|||
143080848|NCT00708227|515834133|FG003|Overall Study|Physician Decision|2|||
143080849|NCT00708227|515834130|FG000|Overall Study|Withdrawal by Subject|1|||
143080850|NCT00708227|515834131|FG001|Overall Study|Withdrawal by Subject|2|||
143080851|NCT00708227|515834132|FG002|Overall Study|Withdrawal by Subject|0|||
143080852|NCT00708227|515834133|FG003|Overall Study|Withdrawal by Subject|1|||
143080853|NCT04007991|515834134|FG000|Overall Study|Withdrawal by Subject|1|||
143080854|NCT04007991|515834135|FG001|Overall Study|Withdrawal by Subject|1|||
143080855|NCT04007991|515834134|FG000|Overall Study|Physician Decision|1|||
143080856|NCT04007991|515834135|FG001|Overall Study|Physician Decision|1|||
143080857|NCT04007991|515834134|FG000|Overall Study|Non-compliance with Study Drug|0|||
143080858|NCT04007991|515834135|FG001|Overall Study|Non-compliance with Study Drug|1|||
143080859|NCT04007991|515834134|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
143080860|NCT04007991|515834135|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
143080861|NCT04007991|515834134|FG000|Overall Study|Adverse event, non-fatal|5|||
143080862|NCT04007991|515834135|FG001|Overall Study|Adverse event, non-fatal|0|||
143080863|NCT04007991|515834134|FG000|Overall Study|Lost to Follow-up|2|||
143080864|NCT04007991|515834135|FG001|Overall Study|Lost to Follow-up|1|||
143080865|NCT00278889|515834136|FG000|Overall Study|Withdrawal by Subject|0|||
143080866|NCT00278889|515834137|FG001|Overall Study|Withdrawal by Subject|5|||
143080867|NCT00278889|515834138|FG002|Overall Study|Withdrawal by Subject|3|||
143080868|NCT00278889|515834136|FG000|Overall Study|Lost to Follow-up|1|||
143080869|NCT00278889|515834137|FG001|Overall Study|Lost to Follow-up|1|||
143080870|NCT00278889|515834138|FG002|Overall Study|Lost to Follow-up|0|||
143080871|NCT00278889|515834136|FG000|Overall Study|Death|24|||
143080872|NCT00278889|515834137|FG001|Overall Study|Death|21|||
143080873|NCT00278889|515834138|FG002|Overall Study|Death|17|||
143080874|NCT03654599|515834139|FG000|Overall Study|Lost to Follow-up|14|||
143080875|NCT03654599|515834140|FG001|Overall Study|Lost to Follow-up|12|||
143080876|NCT03654599|515834139|FG000|Overall Study|Death|8|||
143080877|NCT03654599|515834140|FG001|Overall Study|Death|6|||
143080878|NCT03654599|515834139|FG000|Overall Study|Withdrawal by Subject|6|||
143080879|NCT03654599|515834140|FG001|Overall Study|Withdrawal by Subject|4|||
143080880|NCT01243775|515834141|FG000|Overall Study|Withdrawal by Subject|2|||
143080881|NCT05833139|515836598|FG000|Study Period 2|Adverse Event|1|||
143080882|NCT02126826|515836599|FG000|Overall Study|Withdrawal by Subject|0|||
143080883|NCT02126826|515836600|FG001|Overall Study|Withdrawal by Subject|0|||
143080884|NCT02126826|515836601|FG002|Overall Study|Withdrawal by Subject|0|||
143080885|NCT02126826|515836602|FG003|Overall Study|Withdrawal by Subject|1|||
143080886|NCT02126826|515836603|FG004|Overall Study|Withdrawal by Subject|0|||
143080887|NCT02126826|515836604|FG005|Overall Study|Withdrawal by Subject|0|||
143080888|NCT02126826|515836605|FG006|Overall Study|Withdrawal by Subject|0|||
143080889|NCT03278626|515836608|FG000|Overall Study|Death|2|||
143080890|NCT03278626|515836608|FG000|Overall Study|Toxicity|1|||
143080891|NCT03278626|515836608|FG000|Overall Study|Disease Progression|2|||
143080892|NCT04971187|515836610|FG000|Overall Study|Screen failures|2|||
143080893|NCT04981717|515836611|FG000|Overall Study|Protocol Violation|0|||
143080894|NCT04981717|515836612|FG001|Overall Study|Protocol Violation|3|||
143080895|NCT04981717|515836611|FG000|Overall Study|Adverse Event|1|||
143080896|NCT04981717|515836612|FG001|Overall Study|Adverse Event|3|||
143080897|NCT04981717|515836611|FG000|Overall Study|Pregnancy|1|||
143080898|NCT04981717|515836612|FG001|Overall Study|Pregnancy|0|||
143080899|NCT04981717|515836611|FG000|Overall Study|Physician Decision|1|||
143080900|NCT04981717|515836612|FG001|Overall Study|Physician Decision|0|||
143080901|NCT04981717|515836611|FG000|Overall Study|Sponsor Request|157|||
143080902|NCT04981717|515836612|FG001|Overall Study|Sponsor Request|172|||
143080903|NCT04981717|515836611|FG000|Overall Study|Lost to Follow-up|4|||
143080904|NCT04981717|515836612|FG001|Overall Study|Lost to Follow-up|5|||
143080905|NCT04981717|515836611|FG000|Overall Study|Withdrawal by Subject|50|||
143080906|NCT04981717|515836612|FG001|Overall Study|Withdrawal by Subject|37|||
143080907|NCT00591773|515836613|FG000|Overall Study|Adverse Event|9|||
143080908|NCT00591773|515836614|FG001|Overall Study|Adverse Event|9|||
143080909|NCT00591773|515836615|FG002|Overall Study|Adverse Event|6|||
143080910|NCT00591773|515836613|FG000|Overall Study|Protocol Violation|2|||
143080911|NCT00591773|515836614|FG001|Overall Study|Protocol Violation|3|||
143080912|NCT00591773|515836615|FG002|Overall Study|Protocol Violation|0|||
143080913|NCT00591773|515836613|FG000|Overall Study|Lost to Follow-up|1|||
143080914|NCT00591773|515836614|FG001|Overall Study|Lost to Follow-up|4|||
143080915|NCT00591773|515836615|FG002|Overall Study|Lost to Follow-up|1|||
143080916|NCT00591773|515836613|FG000|Overall Study|Withdrawal by Subject|2|||
143080917|NCT00591773|515836614|FG001|Overall Study|Withdrawal by Subject|5|||
143080918|NCT00591773|515836615|FG002|Overall Study|Withdrawal by Subject|3|||
143080919|NCT00591773|515836613|FG000|Overall Study|Lack of Efficacy|1|||
143080920|NCT00591773|515836614|FG001|Overall Study|Lack of Efficacy|2|||
143080921|NCT00591773|515836615|FG002|Overall Study|Lack of Efficacy|2|||
143080922|NCT00591773|515836613|FG000|Overall Study|Other|1|||
143080923|NCT00591773|515836614|FG001|Overall Study|Other|1|||
143080924|NCT00591773|515836615|FG002|Overall Study|Other|4|||
143080925|NCT00287586|515836616|FG000|Overall Study|Withdrew Consent|19|||
143080926|NCT00287586|515836617|FG001|Overall Study|Withdrew Consent|30|||
143080927|NCT00287586|515836616|FG000|Overall Study|Lost to Follow-up|5|||
143080928|NCT00287586|515836617|FG001|Overall Study|Lost to Follow-up|4|||
143080929|NCT00287586|515836616|FG000|Overall Study|Death|2|||
143080930|NCT00287586|515836617|FG001|Overall Study|Death|3|||
143080931|NCT00287586|515836616|FG000|Overall Study|Elevated Hematocrit|3|||
143080932|NCT00287586|515836617|FG001|Overall Study|Elevated Hematocrit|0|||
143080933|NCT00287586|515836616|FG000|Overall Study|Rash|3|||
143080934|NCT00287586|515836617|FG001|Overall Study|Rash|0|||
143173182|NCT02949011|516183040|FG002|Overall Study|Adverse Event|3|||
143080935|NCT00287586|515836616|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
143173183|NCT02949011|516183038|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
143080936|NCT00287586|515836617|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
143080937|NCT00287586|515836616|FG000|Overall Study|Stroke|2|||
143080938|NCT00287586|515836617|FG001|Overall Study|Stroke|0|||
143080939|NCT00287586|515836616|FG000|Overall Study|Myocardial Infarction|1|||
143080940|NCT00287586|515836617|FG001|Overall Study|Myocardial Infarction|0|||
143080941|NCT00287586|515836616|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
143173184|NCT02949011|516183039|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
143080942|NCT00287586|515836617|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
143080943|NCT00287586|515836616|FG000|Overall Study|Cognitive Impairment|1|||
143080944|NCT00287586|515836617|FG001|Overall Study|Cognitive Impairment|0|||
143080945|NCT00287586|515836616|FG000|Overall Study|Pancreatic Cancer|1|||
143080946|NCT00287586|515836617|FG001|Overall Study|Pancreatic Cancer|3|||
143080947|NCT00287586|515836616|FG000|Overall Study|Sleep Apnea|1|||
143080948|NCT00287586|515836617|FG001|Overall Study|Sleep Apnea|0|||
143080949|NCT00287586|515836616|FG000|Overall Study|Shoulder Pain|1|||
143080950|NCT00287586|515836617|FG001|Overall Study|Shoulder Pain|0|||
143173185|NCT02949011|516183040|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
143173186|NCT02949011|516183038|FG000|Overall Study|Protocol Deviation|5|||
143173187|NCT02949011|516183039|FG001|Overall Study|Protocol Deviation|3|||
143173188|NCT02949011|516183040|FG002|Overall Study|Protocol Deviation|3|||
143173189|NCT02949011|516183038|FG000|Overall Study|Lack of Efficacy|0|||
143173190|NCT02949011|516183039|FG001|Overall Study|Lack of Efficacy|2|||
143173191|NCT02949011|516183040|FG002|Overall Study|Lack of Efficacy|0|||
143173192|NCT02949011|516183038|FG000|Overall Study|Withdrawal by Subject|13|||
143173193|NCT02949011|516183039|FG001|Overall Study|Withdrawal by Subject|13|||
143173194|NCT02949011|516183040|FG002|Overall Study|Withdrawal by Subject|21|||
143173195|NCT02949011|516183038|FG000|Overall Study|Lost to Follow-up|7|||
143173196|NCT02949011|516183039|FG001|Overall Study|Lost to Follow-up|5|||
143173197|NCT02949011|516183040|FG002|Overall Study|Lost to Follow-up|5|||
143173198|NCT02949011|516183038|FG000|Overall Study|Death|0|||
143173199|NCT02949011|516183039|FG001|Overall Study|Death|0|||
143173200|NCT02949011|516183040|FG002|Overall Study|Death|1|||
143173201|NCT02949011|516183038|FG000|Overall Study|Miscellaneous|2|||
143173202|NCT02949011|516183039|FG001|Overall Study|Miscellaneous|4|||
143173203|NCT02949011|516183040|FG002|Overall Study|Miscellaneous|6|||
143173204|NCT00742625|516183041|FG000|Remission Induction|Progression|6|||
143173205|NCT00742625|516183041|FG000|Remission Induction|Failed induction|8|||
143173206|NCT00742625|516183041|FG000|Remission Induction|Adverse Event|3|||
143173207|NCT00742625|516183041|FG000|Remission Induction|Death|10|||
143173208|NCT00742625|516183041|FG000|Remission Induction|Refusal|5|||
143173209|NCT00742625|516183041|FG000|Remission Induction|Non protocol treatment|17|||
143173210|NCT00742625|516183041|FG000|Remission Induction|Other, not specified|5|||
143173211|NCT00742625|516183041|FG000|Consolidation|Progression|5|||
143173212|NCT00742625|516183041|FG000|Consolidation|Adverse Event|1|||
143173213|NCT00742625|516183041|FG000|Consolidation|Death|1|||
143173214|NCT00742625|516183041|FG000|Consolidation|Refused|1|||
143173215|NCT00742625|516183041|FG000|Consolidation|Non protocol therapy|13|||
143173216|NCT01128569|516183042|FG000|Washout Period 1|Adverse Event|0|||
143173217|NCT01128569|516183043|FG001|Washout Period 1|Adverse Event|0|||
143173218|NCT01128569|516183044|FG002|Washout Period 1|Adverse Event|1|||
143173219|NCT01128569|516183045|FG003|Washout Period 1|Adverse Event|0|||
143173220|NCT01128569|516183046|FG004|Washout Period 1|Adverse Event|0|||
143173221|NCT01128569|516183047|FG005|Washout Period 1|Adverse Event|0|||
143173222|NCT01128569|516183042|FG000|Treatment Period 2|Withdrawal by Subject|0|||
143173223|NCT01128569|516183043|FG001|Treatment Period 2|Withdrawal by Subject|1|||
143173224|NCT01128569|516183044|FG002|Treatment Period 2|Withdrawal by Subject|0|||
143173225|NCT01128569|516183045|FG003|Treatment Period 2|Withdrawal by Subject|0|||
143173226|NCT01128569|516183046|FG004|Treatment Period 2|Withdrawal by Subject|0|||
143173227|NCT01128569|516183047|FG005|Treatment Period 2|Withdrawal by Subject|0|||
143173228|NCT03338400|516183048|FG000|Overall Study|Lost to Follow-up|1|||
143173229|NCT03338400|516183049|FG001|Overall Study|Lost to Follow-up|2|||
143173230|NCT01865487|516183051|FG000|Overall Study|Lost to Follow-up|0|||
143173231|NCT01865487|516183052|FG001|Overall Study|Lost to Follow-up|0|||
143173232|NCT01865487|516183053|FG002|Overall Study|Lost to Follow-up|0|||
143173233|NCT01865487|516183054|FG003|Overall Study|Lost to Follow-up|1|||
143173234|NCT01865487|516183055|FG004|Overall Study|Lost to Follow-up|0|||
143173235|NCT01865487|516183056|FG005|Overall Study|Lost to Follow-up|0|||
143173236|NCT01865487|516183057|FG006|Overall Study|Lost to Follow-up|1|||
143173237|NCT01865487|516183058|FG007|Overall Study|Lost to Follow-up|0|||
143173238|NCT01865487|516183059|FG008|Overall Study|Lost to Follow-up|0|||
143173239|NCT01865487|516183060|FG009|Overall Study|Lost to Follow-up|0|||
143173240|NCT01865487|516183051|FG000|Overall Study|Withdrawal by Subject|0|||
143173241|NCT01865487|516183052|FG001|Overall Study|Withdrawal by Subject|0|||
143173242|NCT01865487|516183053|FG002|Overall Study|Withdrawal by Subject|0|||
143173243|NCT01865487|516183054|FG003|Overall Study|Withdrawal by Subject|0|||
143173244|NCT01865487|516183055|FG004|Overall Study|Withdrawal by Subject|1|||
143173245|NCT01865487|516183056|FG005|Overall Study|Withdrawal by Subject|0|||
143173246|NCT01865487|516183057|FG006|Overall Study|Withdrawal by Subject|0|||
143173247|NCT01865487|516183058|FG007|Overall Study|Withdrawal by Subject|0|||
143173248|NCT01865487|516183059|FG008|Overall Study|Withdrawal by Subject|0|||
143173249|NCT01865487|516183060|FG009|Overall Study|Withdrawal by Subject|0|||
143173250|NCT02115321|516183064|FG000|Overall Study|Death|1|||
143173251|NCT02115321|516183065|FG001|Overall Study|Death|0|||
143173252|NCT01908140|516183067|FG000|Overall Study|Other or Progressive Disease|5|||
143173253|NCT01908140|516183068|FG001|Overall Study|Other or Progressive Disease|12|||
143173254|NCT01908140|516183067|FG000|Overall Study|Lack of Efficacy|7|||
143173255|NCT01908140|516183068|FG001|Overall Study|Lack of Efficacy|5|||
143173256|NCT01908140|516183067|FG000|Overall Study|Withdrawal by Subject|23|||
143173257|NCT01908140|516183068|FG001|Overall Study|Withdrawal by Subject|24|||
143173258|NCT01908140|516183067|FG000|Overall Study|Lost to Follow-up|1|||
143173259|NCT01908140|516183068|FG001|Overall Study|Lost to Follow-up|6|||
143173260|NCT01908140|516183067|FG000|Overall Study|Protocol Violation|8|||
143173261|NCT01908140|516183068|FG001|Overall Study|Protocol Violation|9|||
143173262|NCT01908140|516183067|FG000|Overall Study|Adverse Event|22|||
143248997|NCT04643158|516465075|FG000|Overall Study|Withdrawal by Subject|0|||
143248998|NCT04643158|516465076|FG001|Overall Study|Withdrawal by Subject|0|||
143248999|NCT04643158|516465077|FG002|Overall Study|Withdrawal by Subject|0|||
143249000|NCT04643158|516465078|FG003|Overall Study|Withdrawal by Subject|0|||
143249001|NCT04643158|516465079|FG004|Overall Study|Withdrawal by Subject|0|||
143249002|NCT04643158|516465080|FG005|Overall Study|Withdrawal by Subject|1|||
143249003|NCT04643158|516465081|FG006|Overall Study|Withdrawal by Subject|0|||
143249004|NCT02350478|516465082|FG000|Overall Study|Lost to Follow-up|5|||
143249005|NCT02350478|516465083|FG001|Overall Study|Lost to Follow-up|1|||
143249006|NCT02779556|516465084|FG000|Baseline|Partial baseline interview completed|1|||
143080951|NCT00287586|515836616|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
143080952|NCT00287586|515836617|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
143080953|NCT00287586|515836616|FG000|Overall Study|Nonadherence|1|||
143080954|NCT00287586|515836617|FG001|Overall Study|Nonadherence|1|||
143080955|NCT00287586|515836616|FG000|Overall Study|Enrolled in Another Study|1|||
143080956|NCT00287586|515836617|FG001|Overall Study|Enrolled in Another Study|0|||
143080957|NCT00287586|515836616|FG000|Overall Study|Major Depression|0|||
143080958|NCT00287586|515836617|FG001|Overall Study|Major Depression|2|||
143080959|NCT00287586|515836616|FG000|Overall Study|Lung Cancer|0|||
143080960|NCT00287586|515836617|FG001|Overall Study|Lung Cancer|2|||
143080961|NCT00287586|515836616|FG000|Overall Study|Elevated IPSS Score|0|||
143080962|NCT00287586|515836617|FG001|Overall Study|Elevated IPSS Score|1|||
143080963|NCT00287586|515836616|FG000|Overall Study|Retroperitoneal Cancer|0|||
143080964|NCT00287586|515836617|FG001|Overall Study|Retroperitoneal Cancer|1|||
143080965|NCT00287586|515836616|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
143080966|NCT00287586|515836617|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
143080967|NCT00287586|515836616|FG000|Overall Study|Mood Swings and Irritability|0|||
143080968|NCT00287586|515836617|FG001|Overall Study|Mood Swings and Irritability|1|||
143080969|NCT00287586|515836616|FG000|Overall Study|Bradycardia|0|||
143080970|NCT00287586|515836617|FG001|Overall Study|Bradycardia|1|||
143080971|NCT00287586|515836616|FG000|Overall Study|Itchy Swollen Eyes|0|||
143080972|NCT00287586|515836617|FG001|Overall Study|Itchy Swollen Eyes|1|||
143080973|NCT00287586|515836616|FG000|Overall Study|Recurrent Melanoma|0|||
143080974|NCT00287586|515836617|FG001|Overall Study|Recurrent Melanoma|1|||
143080975|NCT01762800|515836618|FG000|Overall Study|Adverse Event|8|||
143080976|NCT01762800|515836619|FG001|Overall Study|Adverse Event|13|||
143080977|NCT01762800|515836618|FG000|Overall Study|Lack of Efficacy|3|||
143080978|NCT01762800|515836619|FG001|Overall Study|Lack of Efficacy|2|||
143080979|NCT01762800|515836618|FG000|Overall Study|Study Closed/Terminated|0|||
143080980|NCT01762800|515836619|FG001|Overall Study|Study Closed/Terminated|1|||
143080981|NCT01762800|515836618|FG000|Overall Study|Physician Decision|1|||
143080982|NCT01762800|515836619|FG001|Overall Study|Physician Decision|1|||
143080983|NCT01762800|515836618|FG000|Overall Study|Withdrawal by Subject|7|||
143080984|NCT01762800|515836619|FG001|Overall Study|Withdrawal by Subject|4|||
143080985|NCT02640482|515836620|FG000|Overall Study|Lost to Follow-up|3|||
143080986|NCT02640482|515836621|FG001|Overall Study|Lost to Follow-up|0|||
143080987|NCT00517881|515836622|FG000|Overall Study|Protocol Violation|2|||
143080988|NCT00517881|515836622|FG000|Overall Study|Adverse Event|1|||
143080989|NCT00517881|515836622|FG000|Overall Study|Renal transplantation|2|||
143080990|NCT01207583|515836623|FG000|Overall Study|Withdrawal by Subject|0|||
143080991|NCT01207583|515836624|FG001|Overall Study|Withdrawal by Subject|3|||
143080992|NCT01207583|515836625|FG002|Overall Study|Withdrawal by Subject|1|||
143080993|NCT01207583|515836623|FG000|Overall Study|Participant failed to return|1|||
143080994|NCT01207583|515836624|FG001|Overall Study|Participant failed to return|0|||
143080995|NCT01207583|515836625|FG002|Overall Study|Participant failed to return|0|||
143080996|NCT01207583|515836623|FG000|Overall Study|Lost to Follow-up|0|||
143080997|NCT01207583|515836624|FG001|Overall Study|Lost to Follow-up|2|||
143080998|NCT01207583|515836625|FG002|Overall Study|Lost to Follow-up|0|||
143080999|NCT02906358|515836626|FG000|Overall Study|Withdrawal by Subject|10|||
143081000|NCT02906358|515836627|FG001|Overall Study|Withdrawal by Subject|7|||
143081001|NCT02906358|515836626|FG000|Overall Study|Lost to Follow-up|12|||
143081002|NCT02906358|515836627|FG001|Overall Study|Lost to Follow-up|15|||
143081003|NCT02699684|515836628|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
143081004|NCT02699684|515836629|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
143081005|NCT01145508|515836630|FG000|Overall Study|Adverse Event|1|||
143081006|NCT01145508|515836631|FG001|Overall Study|Adverse Event|0|||
143081007|NCT01145508|515836630|FG000|Overall Study|Death|1|||
143081008|NCT01145508|515836631|FG001|Overall Study|Death|0|||
143081009|NCT01145508|515836630|FG000|Overall Study|Physician Decision|2|||
143081010|NCT01145508|515836631|FG001|Overall Study|Physician Decision|1|||
143081011|NCT01145508|515836630|FG000|Overall Study|Never started treatment|1|||
143081012|NCT01145508|515836631|FG001|Overall Study|Never started treatment|1|||
143081013|NCT02129608|515836634|FG000|Overall Study|Lost to Follow-up|0|||
143081014|NCT02129608|515836635|FG001|Overall Study|Lost to Follow-up|1|||
143081015|NCT02129608|515836636|FG002|Overall Study|Lost to Follow-up|1|||
143081016|NCT02129608|515836634|FG000|Overall Study|Withdrawal by Subject|0|||
143081017|NCT02129608|515836635|FG001|Overall Study|Withdrawal by Subject|0|||
143081018|NCT02129608|515836636|FG002|Overall Study|Withdrawal by Subject|2|||
143081019|NCT00451204|515836645|FG000|Overall Study|Adverse Event|4|||
143081020|NCT00451204|515836646|FG001|Overall Study|Adverse Event|6|||
143081021|NCT00451204|515836645|FG000|Overall Study|Lack of Efficacy|4|||
143081022|NCT00451204|515836646|FG001|Overall Study|Lack of Efficacy|4|||
143081023|NCT00451204|515836645|FG000|Overall Study|Lost to Follow-up|4|||
143081024|NCT00451204|515836646|FG001|Overall Study|Lost to Follow-up|4|||
143081025|NCT00451204|515836645|FG000|Overall Study|Protocol Violation|1|||
143081026|NCT00451204|515836646|FG001|Overall Study|Protocol Violation|0|||
143081027|NCT00451204|515836645|FG000|Overall Study|Patient refusal|8|||
143081028|NCT00451204|515836646|FG001|Overall Study|Patient refusal|4|||
143081029|NCT00451204|515836645|FG000|Overall Study|Other|1|||
143081030|NCT00451204|515836646|FG001|Overall Study|Other|2|||
143081031|NCT02473523|515836647|FG000|Overall Study|Death|1|||
143081032|NCT02473523|515836647|FG000|Overall Study|Lost to Follow-up|1|||
143081033|NCT00576316|515836651|FG000|Overall Study|Adverse Event|9|||
143081034|NCT00576316|515836651|FG000|Overall Study|Withdrawal by Subject|2|||
143081035|NCT00576316|515836651|FG000|Overall Study|Protocol Violation|9|||
143081036|NCT02552303|515836654|FG000|Allocation|Withdrawal by Subject|2|||
143081037|NCT02552303|515836655|FG001|Allocation|Withdrawal by Subject|1|||
143081038|NCT02552303|515836656|FG002|Allocation|Withdrawal by Subject|1|||
143081039|NCT02552303|515836657|FG003|Allocation|Withdrawal by Subject|1|||
143081040|NCT02552303|515836654|FG000|Allocation|ineligible|1|||
143081041|NCT02552303|515836655|FG001|Allocation|ineligible|1|||
143081042|NCT02552303|515836656|FG002|Allocation|ineligible|0|||
143081043|NCT02552303|515836657|FG003|Allocation|ineligible|0|||
143081044|NCT02552303|515836654|FG000|Follow-Up|Lost to Follow-up|0|||
143081045|NCT02552303|515836655|FG001|Follow-Up|Lost to Follow-up|0|||
143081046|NCT02552303|515836656|FG002|Follow-Up|Lost to Follow-up|1|||
143081047|NCT02552303|515836657|FG003|Follow-Up|Lost to Follow-up|0|||
143081048|NCT02552303|515836654|FG000|Follow-Up|ineligible|0|||
143081049|NCT02552303|515836655|FG001|Follow-Up|ineligible|2|||
143081050|NCT02552303|515836656|FG002|Follow-Up|ineligible|0|||
143081051|NCT02552303|515836657|FG003|Follow-Up|ineligible|0|||
143081052|NCT03106987|515836659|FG000|Overall Study|Death|37|||
143081053|NCT03106987|515836660|FG001|Overall Study|Death|22|||
143081054|NCT03106987|515836661|FG002|Overall Study|Death|12|||
143081055|NCT03106987|515836662|FG003|Overall Study|Death|8|||
143081056|NCT03106987|515836659|FG000|Overall Study|Lost to Follow-up|2|||
143081057|NCT03106987|515836660|FG001|Overall Study|Lost to Follow-up|0|||
143081058|NCT03106987|515836661|FG002|Overall Study|Lost to Follow-up|2|||
143081059|NCT03106987|515836662|FG003|Overall Study|Lost to Follow-up|2|||
143081060|NCT03106987|515836659|FG000|Overall Study|Withdrawal by Subject|5|||
143081061|NCT03106987|515836660|FG001|Overall Study|Withdrawal by Subject|1|||
143081062|NCT03106987|515836661|FG002|Overall Study|Withdrawal by Subject|4|||
143081063|NCT03106987|515836662|FG003|Overall Study|Withdrawal by Subject|1|||
143081064|NCT03336528|515836663|FG000|Overall Study|Protocol Violation|1|||
143081065|NCT03336528|515836664|FG001|Overall Study|Protocol Violation|1|||
143081066|NCT03336528|515836663|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
143081067|NCT03336528|515836664|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
143081068|NCT03336528|515836663|FG000|Overall Study|Did not receive study medication|1|||
143081069|NCT03336528|515836664|FG001|Overall Study|Did not receive study medication|2|||
143081070|NCT02952586|515836671|FG000|Lead-In Phase (7 Days)|Death|0|||
143081071|NCT02952586|515836672|FG001|Lead-In Phase (7 Days)|Death|1|||
143081072|NCT02952586|515836671|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
143081073|NCT02952586|515836672|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
143081074|NCT02952586|515836671|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
143081075|NCT02952586|515836672|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
143081076|NCT02952586|515836671|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
143081077|NCT02952586|515836672|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
143081078|NCT02952586|515836671|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
143081079|NCT02952586|515836672|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
143081080|NCT02952586|515836671|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
143081081|NCT02952586|515836672|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
143173263|NCT01908140|516183068|FG001|Overall Study|Adverse Event|23|||
143173264|NCT01307449|516183069|FG000|Overall Study|Adverse Event|1|||
143081082|NCT02952586|515836671|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
143173265|NCT01307449|516183070|FG001|Overall Study|Adverse Event|0|||
143081083|NCT02952586|515836672|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
143081084|NCT02952586|515836671|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
143081085|NCT02952586|515836672|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
143081086|NCT02952586|515836671|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
143081087|NCT02952586|515836672|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
143081088|NCT02952586|515836671|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
143081089|NCT02952586|515836672|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
143081090|NCT02952586|515836671|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
143081091|NCT02952586|515836672|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
143081092|NCT02952586|515836671|FG000|CRT for Cisplatin (63 Days)|Death|3|||
143081093|NCT02952586|515836672|FG001|CRT for Cisplatin (63 Days)|Death|8|||
143081094|NCT02952586|515836671|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
143081095|NCT02952586|515836672|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
143081096|NCT02952586|515836671|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
143081097|NCT02952586|515836672|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
143081098|NCT02952586|515836671|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
143081099|NCT02952586|515836672|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
143081100|NCT02952586|515836671|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
143081101|NCT02952586|515836672|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
143081102|NCT02952586|515836671|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
143081103|NCT02952586|515836672|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
143081104|NCT02952586|515836671|FG000|CRT for Cisplatin (63 Days)|Other|1|||
143081105|NCT02952586|515836672|FG001|CRT for Cisplatin (63 Days)|Other|1|||
143081106|NCT02952586|515836671|FG000|CRT for IMRT (63 Days)|Death|5|||
143081107|NCT02952586|515836672|FG001|CRT for IMRT (63 Days)|Death|8|||
143081108|NCT02952586|515836671|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
143081109|NCT02952586|515836672|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
143081110|NCT02952586|515836671|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
143081111|NCT02952586|515836672|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
143081112|NCT02952586|515836671|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
143081113|NCT02952586|515836672|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
143081114|NCT02952586|515836671|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
143081115|NCT02952586|515836672|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
143081116|NCT02952586|515836671|FG000|CRT for IMRT (63 Days)|Other|1|||
143081117|NCT02952586|515836672|FG001|CRT for IMRT (63 Days)|Other|0|||
143081118|NCT02952586|515836671|FG000|Maintenance Phase (12 Months)|Death|17|||
143081119|NCT02952586|515836672|FG001|Maintenance Phase (12 Months)|Death|11|||
143081120|NCT02952586|515836671|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
143081121|NCT02952586|515836672|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
143081122|NCT02952586|515836671|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
143081123|NCT02952586|515836672|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
143081124|NCT02952586|515836671|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
143081125|NCT02952586|515836672|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
143081126|NCT02952586|515836671|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
143081127|NCT02952586|515836672|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
143081128|NCT02952586|515836671|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
143081129|NCT02952586|515836672|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
143081130|NCT02952586|515836671|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
143081131|NCT02952586|515836672|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
143081132|NCT02952586|515836671|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
143081133|NCT02952586|515836672|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
143081134|NCT02952586|515836671|FG000|Maintenance Phase (12 Months)|Other|2|||
143081135|NCT02952586|515836672|FG001|Maintenance Phase (12 Months)|Other|1|||
143081136|NCT02952586|515836671|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
143081137|NCT02952586|515836672|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
143081138|NCT02952586|515836671|FG000|Follow-Up Phase (90 Days)|Death|12|||
143081139|NCT02952586|515836672|FG001|Follow-Up Phase (90 Days)|Death|10|||
143081140|NCT02952586|515836671|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
143081141|NCT02952586|515836672|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
143081142|NCT02952586|515836671|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
143173266|NCT01307449|516183071|FG002|Overall Study|Adverse Event|0|||
143173267|NCT01307449|516183072|FG003|Overall Study|Adverse Event|0|||
143173268|NCT03218917|516183073|FG000|Overall Study|Adverse Event|3|||
143173269|NCT03218917|516183074|FG001|Overall Study|Adverse Event|3|||
143173270|NCT03218917|516183075|FG002|Overall Study|Adverse Event|2|||
143173271|NCT03218917|516183073|FG000|Overall Study|Subject withdrew consent|2|||
143173272|NCT03218917|516183074|FG001|Overall Study|Subject withdrew consent|4|||
143173273|NCT03218917|516183075|FG002|Overall Study|Subject withdrew consent|10|||
143173274|NCT03218917|516183073|FG000|Overall Study|Physician Decision|0|||
143173275|NCT03218917|516183074|FG001|Overall Study|Physician Decision|1|||
143173276|NCT03218917|516183075|FG002|Overall Study|Physician Decision|1|||
143173277|NCT03218917|516183073|FG000|Overall Study|Lost to Follow-up|1|||
143173278|NCT03218917|516183074|FG001|Overall Study|Lost to Follow-up|0|||
143173279|NCT03218917|516183075|FG002|Overall Study|Lost to Follow-up|0|||
143173280|NCT03218917|516183073|FG000|Overall Study|Reason Missing|0|||
143173281|NCT03218917|516183074|FG001|Overall Study|Reason Missing|2|||
143173282|NCT03218917|516183075|FG002|Overall Study|Reason Missing|0|||
143081143|NCT02952586|515836672|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
143081144|NCT02952586|515836671|FG000|Follow-Up Phase (90 Days)|Other|7|||
143173283|NCT03218917|516183073|FG000|Overall Study|Death|0|||
143173284|NCT03218917|516183074|FG001|Overall Study|Death|1|||
143173285|NCT03218917|516183075|FG002|Overall Study|Death|0|||
143081145|NCT02952586|515836672|FG001|Follow-Up Phase (90 Days)|Other|5|||
143081146|NCT02952586|515836671|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
143081147|NCT02952586|515836672|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
143081148|NCT02952586|515836671|FG000|LT Follow-up (up to 45 Months)|Death|51|||
143081149|NCT02952586|515836672|FG001|LT Follow-up (up to 45 Months)|Death|31|||
143081150|NCT02952586|515836671|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
143081151|NCT02952586|515836672|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
143081152|NCT02952586|515836671|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
143081153|NCT02952586|515836672|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
143081154|NCT02952586|515836671|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
143081155|NCT02952586|515836672|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
143081156|NCT00492778|515836673|FG000|Overall Study|Ineligible by Pathology Review|8|||
143081157|NCT00492778|515836674|FG001|Overall Study|Ineligible by Pathology Review|1|||
143081158|NCT03717012|515836675|FG000|Overall Study|Due to trial termination|1|||
143081159|NCT03717012|515836676|FG001|Overall Study|Due to trial termination|2|||
143081160|NCT03717012|515836675|FG000|Overall Study|Protocol Violation|0|||
143081161|NCT03717012|515836676|FG001|Overall Study|Protocol Violation|2|||
143081162|NCT03717012|515836675|FG000|Overall Study|Adverse Event|0|||
143081163|NCT03717012|515836676|FG001|Overall Study|Adverse Event|1|||
143081164|NCT03717012|515836675|FG000|Overall Study|Lung transplant|0|||
143081165|NCT03717012|515836676|FG001|Overall Study|Lung transplant|1|||
143081166|NCT00789035|515836677|FG000|Overall Study|Adverse Event|0|||
143081167|NCT00789035|515836678|FG001|Overall Study|Adverse Event|2|||
143081168|NCT00789035|515836679|FG002|Overall Study|Adverse Event|0|||
143081169|NCT00789035|515836680|FG003|Overall Study|Adverse Event|1|||
143081170|NCT00789035|515836681|FG004|Overall Study|Adverse Event|3|||
143081171|NCT00789035|515836677|FG000|Overall Study|Lack of Efficacy|3|||
143081172|NCT00789035|515836678|FG001|Overall Study|Lack of Efficacy|0|||
143081173|NCT00789035|515836679|FG002|Overall Study|Lack of Efficacy|0|||
143081174|NCT00789035|515836680|FG003|Overall Study|Lack of Efficacy|0|||
143081175|NCT00789035|515836681|FG004|Overall Study|Lack of Efficacy|2|||
143081176|NCT00789035|515836677|FG000|Overall Study|Protocol Violation|1|||
143081177|NCT00789035|515836678|FG001|Overall Study|Protocol Violation|0|||
143081178|NCT00789035|515836679|FG002|Overall Study|Protocol Violation|0|||
143081179|NCT00789035|515836680|FG003|Overall Study|Protocol Violation|0|||
143081180|NCT00789035|515836681|FG004|Overall Study|Protocol Violation|0|||
143081181|NCT00789035|515836677|FG000|Overall Study|Withdrawal by Subject|0|||
143081182|NCT00789035|515836678|FG001|Overall Study|Withdrawal by Subject|2|||
143081183|NCT00789035|515836679|FG002|Overall Study|Withdrawal by Subject|0|||
143081184|NCT00789035|515836680|FG003|Overall Study|Withdrawal by Subject|0|||
143081185|NCT00789035|515836681|FG004|Overall Study|Withdrawal by Subject|0|||
143081186|NCT00789035|515836677|FG000|Overall Study|Other reason not defined above|2|||
143081187|NCT00789035|515836678|FG001|Overall Study|Other reason not defined above|3|||
143081188|NCT00789035|515836679|FG002|Overall Study|Other reason not defined above|1|||
143081189|NCT00789035|515836680|FG003|Overall Study|Other reason not defined above|0|||
143081190|NCT00789035|515836681|FG004|Overall Study|Other reason not defined above|1|||
143081191|NCT00658879|515836684|FG000|Overall Study|Protocol Violation|1|||
143081192|NCT02640690|515836685|FG000|Overall Study|Lost to Follow-up|7|||
143081193|NCT02640690|515836686|FG001|Overall Study|Lost to Follow-up|7|||
143081194|NCT02640690|515836685|FG000|Overall Study|Withdrawal by Subject|16|||
143081195|NCT02640690|515836686|FG001|Overall Study|Withdrawal by Subject|20|||
143081196|NCT02640690|515836685|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
143081197|NCT02640690|515836686|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
143081198|NCT01520870|515836687|FG000|Overall Study|Withdrawal by Subject|2|||
143081199|NCT01118975|515836688|FG000|Overall Study|Adverse Event|0|||
143081200|NCT01118975|515836689|FG001|Overall Study|Adverse Event|1|||
143081201|NCT01645787|515836690|FG000|Washout (2 Weeks)|Adverse Event|1|||
143081202|NCT01645787|515836691|FG001|Washout (2 Weeks)|Adverse Event|0|||
143081203|NCT02463357|515836692|FG000|Overall Study|Withdrawal by Subject|1|||
143081204|NCT02463357|515836693|FG001|Overall Study|Withdrawal by Subject|0|||
143081205|NCT02463357|515836694|FG002|Overall Study|Withdrawal by Subject|0|||
143081206|NCT02463357|515836695|FG003|Overall Study|Withdrawal by Subject|0|||
143081207|NCT02463357|515836696|FG004|Overall Study|Withdrawal by Subject|0|||
143081208|NCT02463357|515836692|FG000|Overall Study|Withdrawal by Subject|0|||
143081209|NCT02463357|515836693|FG001|Overall Study|Withdrawal by Subject|0|||
143081210|NCT02463357|515836694|FG002|Overall Study|Withdrawal by Subject|0|||
143081211|NCT02463357|515836695|FG003|Overall Study|Withdrawal by Subject|0|||
143081212|NCT02463357|515836696|FG004|Overall Study|Withdrawal by Subject|1|||
143081213|NCT02681510|515836699|FG000|Overall Study|Withdrawal by Subject|1|||
143081214|NCT02681510|515836699|FG000|Overall Study|Lost to Follow-up|9|||
143081215|NCT03097991|515836711|FG000|Overall Study|Didn't meet study criteria|8|||
143081216|NCT03097991|515836712|FG001|Overall Study|Didn't meet study criteria|0|||
143081217|NCT03097991|515836711|FG000|Overall Study|Withdrawal by Subject|12|||
143081218|NCT03097991|515836712|FG001|Overall Study|Withdrawal by Subject|6|||
143081219|NCT03097991|515836711|FG000|Overall Study|Death of Baby|3|||
143081220|NCT03097991|515836712|FG001|Overall Study|Death of Baby|1|||
143081221|NCT03097991|515836711|FG000|Overall Study|Lost to Follow-up|24|||
143081222|NCT03097991|515836712|FG001|Overall Study|Lost to Follow-up|38|||
143081223|NCT03097991|515836711|FG000|Overall Study|Adverse Event|3|||
143081224|NCT03097991|515836712|FG001|Overall Study|Adverse Event|5|||
143081225|NCT01004003|515836714|FG000|Overall Study|Progressive disease|2|||
143081226|NCT01004003|515836715|FG001|Overall Study|Progressive disease|1|||
143081227|NCT01004003|515836716|FG002|Overall Study|Progressive disease|1|||
143081228|NCT01004003|515836717|FG003|Overall Study|Progressive disease|0|||
143081229|NCT01004003|515836718|FG004|Overall Study|Progressive disease|2|||
143081230|NCT01004003|515836719|FG005|Overall Study|Progressive disease|1|||
143081231|NCT01004003|515836720|FG006|Overall Study|Progressive disease|1|||
143081232|NCT01004003|515836721|FG007|Overall Study|Progressive disease|39|||
143081233|NCT01004003|515836722|FG008|Overall Study|Progressive disease|22|||
143081234|NCT01004003|515836714|FG000|Overall Study|Adverse Event|4|||
143081235|NCT01004003|515836715|FG001|Overall Study|Adverse Event|2|||
143081236|NCT01004003|515836716|FG002|Overall Study|Adverse Event|3|||
143081237|NCT01004003|515836717|FG003|Overall Study|Adverse Event|3|||
143081238|NCT01004003|515836718|FG004|Overall Study|Adverse Event|2|||
143081239|NCT01004003|515836719|FG005|Overall Study|Adverse Event|2|||
143081240|NCT01004003|515836720|FG006|Overall Study|Adverse Event|7|||
143081241|NCT01004003|515836721|FG007|Overall Study|Adverse Event|21|||
143081242|NCT01004003|515836722|FG008|Overall Study|Adverse Event|6|||
143081243|NCT01004003|515836714|FG000|Overall Study|Refused to continue taking trial med.|0|||
143081244|NCT01004003|515836715|FG001|Overall Study|Refused to continue taking trial med.|0|||
143081245|NCT01004003|515836716|FG002|Overall Study|Refused to continue taking trial med.|0|||
143081246|NCT01004003|515836717|FG003|Overall Study|Refused to continue taking trial med.|0|||
143081247|NCT01004003|515836718|FG004|Overall Study|Refused to continue taking trial med.|0|||
143081248|NCT01004003|515836719|FG005|Overall Study|Refused to continue taking trial med.|0|||
143081249|NCT01004003|515836720|FG006|Overall Study|Refused to continue taking trial med.|0|||
143081250|NCT01004003|515836721|FG007|Overall Study|Refused to continue taking trial med.|0|||
143081251|NCT01004003|515836722|FG008|Overall Study|Refused to continue taking trial med.|2|||
143081252|NCT01004003|515836714|FG000|Overall Study|Other|0|||
143081253|NCT01004003|515836715|FG001|Overall Study|Other|0|||
143081254|NCT01004003|515836716|FG002|Overall Study|Other|0|||
143081255|NCT01004003|515836717|FG003|Overall Study|Other|0|||
143081256|NCT01004003|515836718|FG004|Overall Study|Other|0|||
143081257|NCT01004003|515836719|FG005|Overall Study|Other|1|||
143081258|NCT01004003|515836720|FG006|Overall Study|Other|0|||
143081259|NCT01004003|515836721|FG007|Overall Study|Other|0|||
143081260|NCT01004003|515836722|FG008|Overall Study|Other|0|||
143081261|NCT00259272|515836723|FG000|Overall Study|Adverse Event|2|||
143081262|NCT00259272|515836724|FG001|Overall Study|Adverse Event|1|||
143081263|NCT00259272|515836725|FG002|Overall Study|Adverse Event|0|||
143081264|NCT00259272|515836726|FG003|Overall Study|Adverse Event|3|||
143081265|NCT00259272|515836723|FG000|Overall Study|Lack of Efficacy|5|||
143081266|NCT00259272|515836724|FG001|Overall Study|Lack of Efficacy|1|||
143081267|NCT00259272|515836725|FG002|Overall Study|Lack of Efficacy|2|||
143081268|NCT00259272|515836726|FG003|Overall Study|Lack of Efficacy|6|||
143081269|NCT00259272|515836723|FG000|Overall Study|Physician Decision|1|||
143081270|NCT00259272|515836724|FG001|Overall Study|Physician Decision|2|||
143081271|NCT00259272|515836725|FG002|Overall Study|Physician Decision|1|||
143081272|NCT00259272|515836726|FG003|Overall Study|Physician Decision|3|||
143081273|NCT00259272|515836723|FG000|Overall Study|Protocol Violation|2|||
143081274|NCT00259272|515836724|FG001|Overall Study|Protocol Violation|0|||
143081275|NCT00259272|515836725|FG002|Overall Study|Protocol Violation|0|||
143081276|NCT00259272|515836726|FG003|Overall Study|Protocol Violation|1|||
143081277|NCT00259272|515836723|FG000|Overall Study|Sponsor Decision|0|||
143081278|NCT00259272|515836724|FG001|Overall Study|Sponsor Decision|1|||
143081279|NCT00259272|515836725|FG002|Overall Study|Sponsor Decision|0|||
143081280|NCT00259272|515836726|FG003|Overall Study|Sponsor Decision|0|||
143081281|NCT00259272|515836723|FG000|Overall Study|Withdrawal by Subject|4|||
143081282|NCT00259272|515836724|FG001|Overall Study|Withdrawal by Subject|2|||
143081283|NCT00259272|515836725|FG002|Overall Study|Withdrawal by Subject|2|||
143081284|NCT00259272|515836726|FG003|Overall Study|Withdrawal by Subject|7|||
143081285|NCT00259272|515836723|FG000|Overall Study|Lost to Follow-up|1|||
143081286|NCT00259272|515836724|FG001|Overall Study|Lost to Follow-up|0|||
143081287|NCT00259272|515836725|FG002|Overall Study|Lost to Follow-up|0|||
143081288|NCT00259272|515836726|FG003|Overall Study|Lost to Follow-up|1|||
143081289|NCT00103610|515836729|FG000|Overall Study|Entered Rescue Procedure|10|||
143081290|NCT00103610|515836730|FG001|Overall Study|Entered Rescue Procedure|52|||
143081291|NCT00103610|515836729|FG000|Overall Study|Death|16|||
143081292|NCT00103610|515836730|FG001|Overall Study|Death|12|||
143081293|NCT00103610|515836729|FG000|Overall Study|Elective Withdrawal|4|||
143081294|NCT00103610|515836730|FG001|Overall Study|Elective Withdrawal|0|||
143081295|NCT00103610|515836729|FG000|Overall Study|Lost to Follow-up|3|||
143081296|NCT00103610|515836730|FG001|Overall Study|Lost to Follow-up|1|||
143081297|NCT00103610|515836729|FG000|Overall Study|Adverse Event|2|||
143081298|NCT00103610|515836730|FG001|Overall Study|Adverse Event|2|||
143081299|NCT00103610|515836729|FG000|Overall Study|Other|2|||
143081300|NCT00103610|515836730|FG001|Overall Study|Other|7|||
143081301|NCT00103610|515836729|FG000|Overall Study|Failed mobilization|1|||
143081302|NCT00103610|515836730|FG001|Overall Study|Failed mobilization|5|||
143081303|NCT00103610|515836729|FG000|Overall Study|Noncompliance|0|||
143081304|NCT00103610|515836730|FG001|Overall Study|Noncompliance|1|||
143081305|NCT03301623|515836731|FG000|Overall Study|Death|3|||
143081306|NCT03301623|515836732|FG001|Overall Study|Death|1|||
143081307|NCT03301623|515836731|FG000|Overall Study|Withdrawal by Subject|11|||
143081308|NCT03301623|515836732|FG001|Overall Study|Withdrawal by Subject|13|||
143081309|NCT03301623|515836731|FG000|Overall Study|Lost to Follow-up|3|||
143081310|NCT03301623|515836732|FG001|Overall Study|Lost to Follow-up|1|||
143081311|NCT04614246|515836735|FG000|Overall Study|Adverse Event|0|||
143081312|NCT04614246|515836736|FG001|Overall Study|Adverse Event|1|||
143081313|NCT04614246|515836737|FG002|Overall Study|Adverse Event|1|||
143081314|NCT04614246|515836738|FG003|Overall Study|Adverse Event|2|||
143081315|NCT04614246|515836739|FG004|Overall Study|Adverse Event|1|||
143081316|NCT04614246|515836735|FG000|Overall Study|Lost to Follow-up|0|||
143081317|NCT04614246|515836736|FG001|Overall Study|Lost to Follow-up|1|||
143081318|NCT04614246|515836737|FG002|Overall Study|Lost to Follow-up|0|||
143081319|NCT04614246|515836738|FG003|Overall Study|Lost to Follow-up|1|||
143081320|NCT04614246|515836739|FG004|Overall Study|Lost to Follow-up|3|||
143081321|NCT04614246|515836735|FG000|Overall Study|Other reason|0|||
143081322|NCT04614246|515836736|FG001|Overall Study|Other reason|1|||
143081323|NCT04614246|515836737|FG002|Overall Study|Other reason|2|||
143081324|NCT04614246|515836738|FG003|Overall Study|Other reason|0|||
143081325|NCT04614246|515836739|FG004|Overall Study|Other reason|0|||
143081326|NCT04614246|515836735|FG000|Overall Study|Withdrawal by Subject|4|||
143081327|NCT04614246|515836736|FG001|Overall Study|Withdrawal by Subject|2|||
143081328|NCT04614246|515836737|FG002|Overall Study|Withdrawal by Subject|4|||
143081329|NCT04614246|515836738|FG003|Overall Study|Withdrawal by Subject|3|||
143081330|NCT04614246|515836739|FG004|Overall Study|Withdrawal by Subject|4|||
143081331|NCT04614246|515836735|FG000|Overall Study|Physician Decision|0|||
143081332|NCT04614246|515836736|FG001|Overall Study|Physician Decision|2|||
143081333|NCT04614246|515836737|FG002|Overall Study|Physician Decision|1|||
143081334|NCT04614246|515836738|FG003|Overall Study|Physician Decision|0|||
143173286|NCT03218917|516183073|FG000|Overall Study|Non-Compliance with Study Drug|0|||
143173287|NCT03218917|516183074|FG001|Overall Study|Non-Compliance with Study Drug|1|||
143173288|NCT03218917|516183075|FG002|Overall Study|Non-Compliance with Study Drug|0|||
143173289|NCT02639390|516183076|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
143173290|NCT02639390|516183077|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
143173291|NCT00698828|516183080|FG000|Overall Study|Adverse Event|3|||
143081335|NCT04614246|515836739|FG004|Overall Study|Physician Decision|0|||
143081336|NCT04614246|515836735|FG000|Overall Study|Study terminated by sponsor|10|||
143081337|NCT04614246|515836736|FG001|Overall Study|Study terminated by sponsor|15|||
143081338|NCT04614246|515836737|FG002|Overall Study|Study terminated by sponsor|12|||
143081339|NCT04614246|515836738|FG003|Overall Study|Study terminated by sponsor|13|||
143081340|NCT04614246|515836739|FG004|Overall Study|Study terminated by sponsor|9|||
143081341|NCT04614246|515836735|FG000|Overall Study|Pregnancy|2|||
143081342|NCT04614246|515836736|FG001|Overall Study|Pregnancy|0|||
143081343|NCT04614246|515836737|FG002|Overall Study|Pregnancy|1|||
143081344|NCT04614246|515836738|FG003|Overall Study|Pregnancy|0|||
143081345|NCT04614246|515836739|FG004|Overall Study|Pregnancy|0|||
143081346|NCT00725205|515836741|FG000|Overall Study|Adverse Event|22|||
143081347|NCT00725205|515836741|FG000|Overall Study|Investigator Discontinued|1|||
143081348|NCT00725205|515836741|FG000|Overall Study|Non-compliance With Protocol|14|||
143081349|NCT00725205|515836741|FG000|Overall Study|Other|8|||
143081350|NCT00725205|515836741|FG000|Overall Study|Protocol Defined Clinical Event|1|||
143081351|NCT00725205|515836741|FG000|Overall Study|Treatment Failure|41|||
143081352|NCT01680497|515836742|FG000|Overall Study|Lost to Follow-up|2|||
143081353|NCT05819203|515836744|FG000|Overall Study|Protocol Violation|1|||
143081354|NCT05819203|515836745|FG001|Overall Study|Protocol Violation|2|||
143081355|NCT05819203|515836744|FG000|Overall Study|Withdrawal by Subject|1|||
143081356|NCT05819203|515836745|FG001|Overall Study|Withdrawal by Subject|0|||
143081357|NCT02682927|515836752|FG000|Overall Study|Adverse Event|0|||
143081358|NCT02682927|515836753|FG001|Overall Study|Adverse Event|0|||
143081359|NCT02682927|515836754|FG002|Overall Study|Adverse Event|5|||
143081360|NCT02682927|515836755|FG003|Overall Study|Adverse Event|1|||
143081361|NCT02682927|515836756|FG004|Overall Study|Adverse Event|0|||
143081362|NCT02682927|515836757|FG005|Overall Study|Adverse Event|2|||
143081363|NCT02682927|515836752|FG000|Overall Study|Death|0|||
143081364|NCT02682927|515836753|FG001|Overall Study|Death|0|||
143081365|NCT02682927|515836754|FG002|Overall Study|Death|0|||
143081366|NCT02682927|515836755|FG003|Overall Study|Death|1|||
143081367|NCT02682927|515836756|FG004|Overall Study|Death|0|||
143081368|NCT02682927|515836757|FG005|Overall Study|Death|0|||
143081369|NCT02682927|515836752|FG000|Overall Study|Lack of Efficacy|1|||
143081370|NCT02682927|515836753|FG001|Overall Study|Lack of Efficacy|0|||
143081371|NCT02682927|515836754|FG002|Overall Study|Lack of Efficacy|0|||
143081372|NCT02682927|515836755|FG003|Overall Study|Lack of Efficacy|1|||
143081373|NCT02682927|515836756|FG004|Overall Study|Lack of Efficacy|0|||
143081374|NCT02682927|515836757|FG005|Overall Study|Lack of Efficacy|0|||
143081375|NCT02682927|515836752|FG000|Overall Study|Other|0|||
143081376|NCT02682927|515836753|FG001|Overall Study|Other|0|||
143081377|NCT02682927|515836754|FG002|Overall Study|Other|0|||
143081378|NCT02682927|515836755|FG003|Overall Study|Other|2|||
143081379|NCT02682927|515836756|FG004|Overall Study|Other|0|||
143081380|NCT02682927|515836757|FG005|Overall Study|Other|0|||
143081381|NCT02682927|515836752|FG000|Overall Study|Withdrawal by Subject|2|||
143081382|NCT02682927|515836753|FG001|Overall Study|Withdrawal by Subject|0|||
143081383|NCT02682927|515836754|FG002|Overall Study|Withdrawal by Subject|1|||
143081384|NCT02682927|515836755|FG003|Overall Study|Withdrawal by Subject|0|||
143081385|NCT02682927|515836756|FG004|Overall Study|Withdrawal by Subject|1|||
143081386|NCT02682927|515836757|FG005|Overall Study|Withdrawal by Subject|1|||
143081387|NCT00996892|515836765|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
143081388|NCT00996892|515836766|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
143081389|NCT00996892|515836767|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
143081390|NCT00996892|515836768|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
143081391|NCT00996892|515836769|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
143081392|NCT00996892|515836770|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
143081393|NCT00996892|515836771|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
143081394|NCT00996892|515836772|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
143081395|NCT00996892|515836773|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
143081396|NCT00996892|515836774|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
143081397|NCT00996892|515836775|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
143081398|NCT00996892|515836776|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
143081399|NCT00996892|515836777|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
143081400|NCT00996892|515836778|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
143081401|NCT00996892|515836779|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
143081402|NCT00996892|515836780|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
143081403|NCT00996892|515836781|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
143081404|NCT00996892|515836782|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
143081405|NCT00996892|515836783|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
143081406|NCT00996892|515836784|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
143081407|NCT00996892|515836765|FG000|Dose-Escalation Stage 1|Death|1|||
143081408|NCT00996892|515836766|FG001|Dose-Escalation Stage 1|Death|0|||
143081409|NCT00996892|515836767|FG002|Dose-Escalation Stage 1|Death|0|||
143081410|NCT00996892|515836768|FG003|Dose-Escalation Stage 1|Death|0|||
143081411|NCT00996892|515836769|FG004|Dose-Escalation Stage 1|Death|0|||
143081412|NCT00996892|515836770|FG005|Dose-Escalation Stage 1|Death|1|||
143081413|NCT00996892|515836771|FG006|Dose-Escalation Stage 1|Death|0|||
143081414|NCT00996892|515836772|FG007|Dose-Escalation Stage 1|Death|0|||
143081415|NCT00996892|515836773|FG008|Dose-Escalation Stage 1|Death|0|||
143081416|NCT00996892|515836774|FG009|Dose-Escalation Stage 1|Death|0|||
143081417|NCT00996892|515836775|FG010|Dose-Escalation Stage 1|Death|0|||
143081418|NCT00996892|515836776|FG011|Dose-Escalation Stage 1|Death|0|||
143081419|NCT00996892|515836777|FG012|Dose-Escalation Stage 1|Death|0|||
143081420|NCT00996892|515836778|FG013|Dose-Escalation Stage 1|Death|0|||
143081421|NCT00996892|515836779|FG014|Dose-Escalation Stage 1|Death|0|||
143081422|NCT00996892|515836780|FG015|Dose-Escalation Stage 1|Death|0|||
143081423|NCT00996892|515836781|FG016|Dose-Escalation Stage 1|Death|0|||
143081424|NCT00996892|515836782|FG017|Dose-Escalation Stage 1|Death|0|||
143081425|NCT00996892|515836783|FG018|Dose-Escalation Stage 1|Death|0|||
143081426|NCT00996892|515836784|FG019|Dose-Escalation Stage 1|Death|0|||
143081427|NCT00996892|515836765|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
143081428|NCT00996892|515836766|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
143081429|NCT00996892|515836767|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
143081430|NCT00996892|515836768|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
143081431|NCT00996892|515836769|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
143081432|NCT00996892|515836770|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
143081433|NCT00996892|515836771|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
143081434|NCT00996892|515836772|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
143081435|NCT00996892|515836773|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
143081436|NCT00996892|515836774|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
143081437|NCT00996892|515836775|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
143081438|NCT00996892|515836776|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
143081439|NCT00996892|515836777|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
143081440|NCT00996892|515836778|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
143081441|NCT00996892|515836779|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
143081442|NCT00996892|515836780|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
143081443|NCT00996892|515836781|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
143081444|NCT00996892|515836782|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
143081445|NCT00996892|515836783|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
143081446|NCT00996892|515836784|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
143081447|NCT00996892|515836765|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
143081448|NCT00996892|515836766|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
143081449|NCT00996892|515836767|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
143081450|NCT00996892|515836768|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
143081451|NCT00996892|515836769|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
143081452|NCT00996892|515836770|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
143081453|NCT00996892|515836771|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
143081454|NCT00996892|515836772|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
143081455|NCT00996892|515836773|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
143081456|NCT00996892|515836774|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
143081457|NCT00996892|515836775|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
143081458|NCT00996892|515836776|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
143081459|NCT00996892|515836777|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
143081460|NCT00996892|515836778|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
143081461|NCT00996892|515836779|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
143081462|NCT00996892|515836780|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
143081463|NCT00996892|515836781|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
143081464|NCT00996892|515836782|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
143081465|NCT00996892|515836783|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
143081466|NCT00996892|515836784|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
143081467|NCT00996892|515836765|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
143081468|NCT00996892|515836766|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
143081469|NCT00996892|515836767|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
143081470|NCT00996892|515836768|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
143081471|NCT00996892|515836769|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
143081472|NCT00996892|515836770|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
143081473|NCT00996892|515836771|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
143081474|NCT00996892|515836772|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
143081475|NCT00996892|515836773|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
143081476|NCT00996892|515836774|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
143081477|NCT00996892|515836775|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
143081478|NCT00996892|515836776|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
143081479|NCT00996892|515836777|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
143081480|NCT00996892|515836778|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
143081481|NCT00996892|515836779|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
143081482|NCT00996892|515836780|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
143081483|NCT00996892|515836781|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
143081484|NCT00996892|515836782|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
143081485|NCT00996892|515836783|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
143081486|NCT00996892|515836784|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
143081487|NCT00996892|515836765|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
143081488|NCT00996892|515836766|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
143081489|NCT00996892|515836767|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
143081490|NCT00996892|515836768|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
143081491|NCT00996892|515836769|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
143081492|NCT00996892|515836770|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
143081493|NCT00996892|515836771|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
143081494|NCT00996892|515836772|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
143081495|NCT00996892|515836773|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
143081496|NCT00996892|515836774|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
143081497|NCT00996892|515836775|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
143081498|NCT00996892|515836776|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
143081499|NCT00996892|515836777|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
143081500|NCT00996892|515836778|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
143081501|NCT00996892|515836779|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
143081502|NCT00996892|515836780|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
143081503|NCT00996892|515836781|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
143081504|NCT00996892|515836782|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
143081505|NCT00996892|515836783|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
143081506|NCT00996892|515836784|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
143081507|NCT00996892|515836765|FG000|Dose-Escalation Stage 1A|Death|0|||
143081508|NCT00996892|515836766|FG001|Dose-Escalation Stage 1A|Death|0|||
143081509|NCT00996892|515836767|FG002|Dose-Escalation Stage 1A|Death|0|||
143081510|NCT00996892|515836768|FG003|Dose-Escalation Stage 1A|Death|0|||
143081511|NCT00996892|515836769|FG004|Dose-Escalation Stage 1A|Death|0|||
143081512|NCT00996892|515836770|FG005|Dose-Escalation Stage 1A|Death|0|||
143081513|NCT00996892|515836771|FG006|Dose-Escalation Stage 1A|Death|0|||
143081514|NCT00996892|515836772|FG007|Dose-Escalation Stage 1A|Death|0|||
143081515|NCT00996892|515836773|FG008|Dose-Escalation Stage 1A|Death|0|||
143081516|NCT00996892|515836774|FG009|Dose-Escalation Stage 1A|Death|2|||
143081517|NCT00996892|515836775|FG010|Dose-Escalation Stage 1A|Death|0|||
143081518|NCT00996892|515836776|FG011|Dose-Escalation Stage 1A|Death|1|||
143081519|NCT00996892|515836777|FG012|Dose-Escalation Stage 1A|Death|1|||
143081520|NCT00996892|515836778|FG013|Dose-Escalation Stage 1A|Death|0|||
143081521|NCT00996892|515836779|FG014|Dose-Escalation Stage 1A|Death|0|||
143081522|NCT00996892|515836780|FG015|Dose-Escalation Stage 1A|Death|0|||
143081523|NCT00996892|515836781|FG016|Dose-Escalation Stage 1A|Death|0|||
143081524|NCT00996892|515836782|FG017|Dose-Escalation Stage 1A|Death|0|||
143081525|NCT00996892|515836783|FG018|Dose-Escalation Stage 1A|Death|0|||
143081526|NCT00996892|515836784|FG019|Dose-Escalation Stage 1A|Death|0|||
143081527|NCT00996892|515836765|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
143081528|NCT00996892|515836766|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
143081529|NCT00996892|515836767|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
143081530|NCT00996892|515836768|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
143081531|NCT00996892|515836769|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
143081532|NCT00996892|515836770|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
143081533|NCT00996892|515836771|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
143081534|NCT00996892|515836772|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
143081535|NCT00996892|515836773|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
143081536|NCT00996892|515836774|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
143081537|NCT00996892|515836775|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
143081538|NCT00996892|515836776|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
143081539|NCT00996892|515836777|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
143081540|NCT00996892|515836778|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
143081541|NCT00996892|515836779|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
143081542|NCT00996892|515836780|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
143081543|NCT00996892|515836781|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
143081544|NCT00996892|515836782|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
143173292|NCT00698828|516183081|FG001|Overall Study|Adverse Event|4|||
143173293|NCT00698828|516183082|FG002|Overall Study|Adverse Event|4|||
143081545|NCT00996892|515836783|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
143081546|NCT00996892|515836784|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
143081547|NCT00996892|515836765|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
143081548|NCT00996892|515836766|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
143081549|NCT00996892|515836767|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
143081550|NCT00996892|515836768|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
143081551|NCT00996892|515836769|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
143081552|NCT00996892|515836770|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
143081553|NCT00996892|515836771|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
143081554|NCT00996892|515836772|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
143081555|NCT00996892|515836773|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
143081556|NCT00996892|515836774|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
143081557|NCT00996892|515836775|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
143081558|NCT00996892|515836776|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
143081559|NCT00996892|515836777|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
143081560|NCT00996892|515836778|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
143081561|NCT00996892|515836779|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
143081562|NCT00996892|515836780|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
143081563|NCT00996892|515836781|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
143081564|NCT00996892|515836782|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
143081565|NCT00996892|515836783|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
143081566|NCT00996892|515836784|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
143081567|NCT00996892|515836765|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
143081568|NCT00996892|515836766|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
143081569|NCT00996892|515836767|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
143081570|NCT00996892|515836768|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
143081571|NCT00996892|515836769|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
143081572|NCT00996892|515836770|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
143081573|NCT00996892|515836771|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
143081574|NCT00996892|515836772|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
143081575|NCT00996892|515836773|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
143081576|NCT00996892|515836774|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
143081577|NCT00996892|515836775|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
143081578|NCT00996892|515836776|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
143081579|NCT00996892|515836777|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
143081580|NCT00996892|515836778|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
143081581|NCT00996892|515836779|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
143081582|NCT00996892|515836780|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
143081583|NCT00996892|515836781|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
143081584|NCT00996892|515836782|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
143081585|NCT00996892|515836783|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
143081586|NCT00996892|515836784|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
143081587|NCT00996892|515836765|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
143081588|NCT00996892|515836766|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
143081589|NCT00996892|515836767|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
143081590|NCT00996892|515836768|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
143081591|NCT00996892|515836769|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
143081592|NCT00996892|515836770|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
143081593|NCT00996892|515836771|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
143173294|NCT00698828|516183080|FG000|Overall Study|Death|0|||
143081594|NCT00996892|515836772|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
143081595|NCT00996892|515836773|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
143081596|NCT00996892|515836774|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
143173295|NCT00698828|516183081|FG001|Overall Study|Death|0|||
143081597|NCT00996892|515836775|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
143081598|NCT00996892|515836776|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
143081599|NCT00996892|515836777|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
143081600|NCT00996892|515836778|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
143081601|NCT00996892|515836779|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
143081602|NCT00996892|515836780|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
143081603|NCT00996892|515836781|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
143081604|NCT00996892|515836782|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
143081605|NCT00996892|515836783|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
143081606|NCT00996892|515836784|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
143081607|NCT00996892|515836765|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
143081608|NCT00996892|515836766|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
143081609|NCT00996892|515836767|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
143081610|NCT00996892|515836768|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
143081611|NCT00996892|515836769|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
143081612|NCT00996892|515836770|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
143081613|NCT00996892|515836771|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
143081614|NCT00996892|515836772|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
143081615|NCT00996892|515836773|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
143081616|NCT00996892|515836774|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
143081617|NCT00996892|515836775|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
143081618|NCT00996892|515836776|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
143081619|NCT00996892|515836777|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
143081620|NCT00996892|515836778|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
143081621|NCT00996892|515836779|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
143081622|NCT00996892|515836780|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
143081623|NCT00996892|515836781|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
143081624|NCT00996892|515836782|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
143081625|NCT00996892|515836783|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
143081626|NCT00996892|515836784|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
143081627|NCT00996892|515836765|FG000|Expansion Stage 2|Adverse Event|0|||
143081628|NCT00996892|515836766|FG001|Expansion Stage 2|Adverse Event|0|||
143081629|NCT00996892|515836767|FG002|Expansion Stage 2|Adverse Event|0|||
143081630|NCT00996892|515836768|FG003|Expansion Stage 2|Adverse Event|0|||
143081631|NCT00996892|515836769|FG004|Expansion Stage 2|Adverse Event|0|||
143081632|NCT00996892|515836770|FG005|Expansion Stage 2|Adverse Event|0|||
143173296|NCT00698828|516183082|FG002|Overall Study|Death|1|||
143173297|NCT00698828|516183080|FG000|Overall Study|Exacerbation of COPD|1|||
143081633|NCT00996892|515836771|FG006|Expansion Stage 2|Adverse Event|0|||
143081634|NCT00996892|515836772|FG007|Expansion Stage 2|Adverse Event|0|||
143081635|NCT00996892|515836773|FG008|Expansion Stage 2|Adverse Event|0|||
143081636|NCT00996892|515836774|FG009|Expansion Stage 2|Adverse Event|0|||
143173298|NCT00698828|516183081|FG001|Overall Study|Exacerbation of COPD|3|||
143081637|NCT00996892|515836775|FG010|Expansion Stage 2|Adverse Event|0|||
143081638|NCT00996892|515836776|FG011|Expansion Stage 2|Adverse Event|0|||
143081639|NCT00996892|515836777|FG012|Expansion Stage 2|Adverse Event|0|||
143081640|NCT00996892|515836778|FG013|Expansion Stage 2|Adverse Event|0|||
143081641|NCT00996892|515836779|FG014|Expansion Stage 2|Adverse Event|0|||
143081642|NCT00996892|515836780|FG015|Expansion Stage 2|Adverse Event|0|||
143081643|NCT00996892|515836781|FG016|Expansion Stage 2|Adverse Event|0|||
143081644|NCT00996892|515836782|FG017|Expansion Stage 2|Adverse Event|0|||
143081645|NCT00996892|515836783|FG018|Expansion Stage 2|Adverse Event|3|||
143081646|NCT00996892|515836784|FG019|Expansion Stage 2|Adverse Event|0|||
143081647|NCT00996892|515836765|FG000|Expansion Stage 2|Death|0|||
143081648|NCT00996892|515836766|FG001|Expansion Stage 2|Death|0|||
143081649|NCT00996892|515836767|FG002|Expansion Stage 2|Death|0|||
143081650|NCT00996892|515836768|FG003|Expansion Stage 2|Death|0|||
143081651|NCT00996892|515836769|FG004|Expansion Stage 2|Death|0|||
143081652|NCT00996892|515836770|FG005|Expansion Stage 2|Death|0|||
143081653|NCT00996892|515836771|FG006|Expansion Stage 2|Death|0|||
143081654|NCT00996892|515836772|FG007|Expansion Stage 2|Death|0|||
143081655|NCT00996892|515836773|FG008|Expansion Stage 2|Death|0|||
143081656|NCT00996892|515836774|FG009|Expansion Stage 2|Death|0|||
143081657|NCT00996892|515836775|FG010|Expansion Stage 2|Death|0|||
143081658|NCT00996892|515836776|FG011|Expansion Stage 2|Death|0|||
143081659|NCT00996892|515836777|FG012|Expansion Stage 2|Death|0|||
143081660|NCT00996892|515836778|FG013|Expansion Stage 2|Death|0|||
143081661|NCT00996892|515836779|FG014|Expansion Stage 2|Death|0|||
143081662|NCT00996892|515836780|FG015|Expansion Stage 2|Death|0|||
143081663|NCT00996892|515836781|FG016|Expansion Stage 2|Death|0|||
143081664|NCT00996892|515836782|FG017|Expansion Stage 2|Death|0|||
143081665|NCT00996892|515836783|FG018|Expansion Stage 2|Death|2|||
143081666|NCT00996892|515836784|FG019|Expansion Stage 2|Death|0|||
143081667|NCT00996892|515836765|FG000|Expansion Stage 2|Physician Decision|0|||
143081668|NCT00996892|515836766|FG001|Expansion Stage 2|Physician Decision|0|||
143081669|NCT00996892|515836767|FG002|Expansion Stage 2|Physician Decision|0|||
143081670|NCT00996892|515836768|FG003|Expansion Stage 2|Physician Decision|0|||
143081671|NCT00996892|515836769|FG004|Expansion Stage 2|Physician Decision|0|||
143081672|NCT00996892|515836770|FG005|Expansion Stage 2|Physician Decision|0|||
143081673|NCT00996892|515836771|FG006|Expansion Stage 2|Physician Decision|0|||
143081674|NCT00996892|515836772|FG007|Expansion Stage 2|Physician Decision|0|||
143081675|NCT00996892|515836773|FG008|Expansion Stage 2|Physician Decision|0|||
143081676|NCT00996892|515836774|FG009|Expansion Stage 2|Physician Decision|0|||
143081677|NCT00996892|515836775|FG010|Expansion Stage 2|Physician Decision|0|||
143081678|NCT00996892|515836776|FG011|Expansion Stage 2|Physician Decision|0|||
143081679|NCT00996892|515836777|FG012|Expansion Stage 2|Physician Decision|0|||
143081680|NCT00996892|515836778|FG013|Expansion Stage 2|Physician Decision|0|||
143081681|NCT00996892|515836779|FG014|Expansion Stage 2|Physician Decision|0|||
143081682|NCT00996892|515836780|FG015|Expansion Stage 2|Physician Decision|0|||
143081683|NCT00996892|515836781|FG016|Expansion Stage 2|Physician Decision|0|||
143081684|NCT00996892|515836782|FG017|Expansion Stage 2|Physician Decision|0|||
143081685|NCT00996892|515836783|FG018|Expansion Stage 2|Physician Decision|1|||
143081686|NCT00996892|515836784|FG019|Expansion Stage 2|Physician Decision|0|||
143081687|NCT00996892|515836765|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
143081688|NCT00996892|515836766|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
143081689|NCT00996892|515836767|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
143081690|NCT00996892|515836768|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
143081691|NCT00996892|515836769|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
143081692|NCT00996892|515836770|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
143081693|NCT00996892|515836771|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
143081694|NCT00996892|515836772|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
143081695|NCT00996892|515836773|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
143081696|NCT00996892|515836774|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
143081697|NCT00996892|515836775|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
143081698|NCT00996892|515836776|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
143081699|NCT00996892|515836777|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
143081700|NCT00996892|515836778|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
143081701|NCT00996892|515836779|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
143081702|NCT00996892|515836780|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
143081703|NCT00996892|515836781|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
143081704|NCT00996892|515836782|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
143173299|NCT00698828|516183082|FG002|Overall Study|Exacerbation of COPD|0|||
143173300|NCT00698828|516183080|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
143081705|NCT00996892|515836783|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
143081706|NCT00996892|515836784|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
143081707|NCT00996892|515836765|FG000|Expansion Stage 2|Disease Progression|0|||
143081708|NCT00996892|515836766|FG001|Expansion Stage 2|Disease Progression|0|||
143081709|NCT00996892|515836767|FG002|Expansion Stage 2|Disease Progression|0|||
143081710|NCT00996892|515836768|FG003|Expansion Stage 2|Disease Progression|0|||
143081711|NCT00996892|515836769|FG004|Expansion Stage 2|Disease Progression|0|||
143081712|NCT00996892|515836770|FG005|Expansion Stage 2|Disease Progression|0|||
143081713|NCT00996892|515836771|FG006|Expansion Stage 2|Disease Progression|0|||
143081714|NCT00996892|515836772|FG007|Expansion Stage 2|Disease Progression|0|||
143081715|NCT00996892|515836773|FG008|Expansion Stage 2|Disease Progression|0|||
143081716|NCT00996892|515836774|FG009|Expansion Stage 2|Disease Progression|0|||
143081717|NCT00996892|515836775|FG010|Expansion Stage 2|Disease Progression|0|||
143081718|NCT00996892|515836776|FG011|Expansion Stage 2|Disease Progression|0|||
143081719|NCT00996892|515836777|FG012|Expansion Stage 2|Disease Progression|0|||
143081720|NCT00996892|515836778|FG013|Expansion Stage 2|Disease Progression|0|||
143081721|NCT00996892|515836779|FG014|Expansion Stage 2|Disease Progression|0|||
143081722|NCT00996892|515836780|FG015|Expansion Stage 2|Disease Progression|0|||
143081723|NCT00996892|515836781|FG016|Expansion Stage 2|Disease Progression|0|||
143173301|NCT00698828|516183081|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
143173302|NCT00698828|516183082|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
143173303|NCT00698828|516183080|FG000|Overall Study|Investigator/Sponsor decision|1|||
143173304|NCT00698828|516183081|FG001|Overall Study|Investigator/Sponsor decision|0|||
143173305|NCT00698828|516183082|FG002|Overall Study|Investigator/Sponsor decision|2|||
143173306|NCT00698828|516183080|FG000|Overall Study|Lost to Follow-up|1|||
143173307|NCT00698828|516183081|FG001|Overall Study|Lost to Follow-up|1|||
143173308|NCT00698828|516183082|FG002|Overall Study|Lost to Follow-up|0|||
143173309|NCT00698828|516183080|FG000|Overall Study|Withdrew consent|0|||
143173310|NCT00698828|516183081|FG001|Overall Study|Withdrew consent|7|||
143173311|NCT00698828|516183082|FG002|Overall Study|Withdrew consent|4|||
143173312|NCT00698828|516183080|FG000|Overall Study|Withdrew consent (not treated)|2|||
143081724|NCT00996892|515836782|FG017|Expansion Stage 2|Disease Progression|0|||
143081725|NCT00996892|515836783|FG018|Expansion Stage 2|Disease Progression|28|||
143081726|NCT00996892|515836784|FG019|Expansion Stage 2|Disease Progression|0|||
143081727|NCT00996892|515836765|FG000|Expansion Stage 2A|Adverse Event|0|||
143081728|NCT00996892|515836766|FG001|Expansion Stage 2A|Adverse Event|0|||
143081729|NCT00996892|515836767|FG002|Expansion Stage 2A|Adverse Event|0|||
143081730|NCT00996892|515836768|FG003|Expansion Stage 2A|Adverse Event|0|||
143081731|NCT00996892|515836769|FG004|Expansion Stage 2A|Adverse Event|0|||
143081732|NCT00996892|515836770|FG005|Expansion Stage 2A|Adverse Event|0|||
143081733|NCT00996892|515836771|FG006|Expansion Stage 2A|Adverse Event|0|||
143081734|NCT00996892|515836772|FG007|Expansion Stage 2A|Adverse Event|0|||
143081735|NCT00996892|515836773|FG008|Expansion Stage 2A|Adverse Event|0|||
143081736|NCT00996892|515836774|FG009|Expansion Stage 2A|Adverse Event|0|||
143081737|NCT00996892|515836775|FG010|Expansion Stage 2A|Adverse Event|0|||
143081738|NCT00996892|515836776|FG011|Expansion Stage 2A|Adverse Event|0|||
143081739|NCT00996892|515836777|FG012|Expansion Stage 2A|Adverse Event|0|||
143081740|NCT00996892|515836778|FG013|Expansion Stage 2A|Adverse Event|0|||
143081741|NCT00996892|515836779|FG014|Expansion Stage 2A|Adverse Event|0|||
143081742|NCT00996892|515836780|FG015|Expansion Stage 2A|Adverse Event|0|||
143081743|NCT00996892|515836781|FG016|Expansion Stage 2A|Adverse Event|0|||
143081744|NCT00996892|515836782|FG017|Expansion Stage 2A|Adverse Event|0|||
143081745|NCT00996892|515836783|FG018|Expansion Stage 2A|Adverse Event|0|||
143081746|NCT00996892|515836784|FG019|Expansion Stage 2A|Adverse Event|8|||
143081747|NCT00996892|515836765|FG000|Expansion Stage 2A|Physician Decision|0|||
143081748|NCT00996892|515836766|FG001|Expansion Stage 2A|Physician Decision|0|||
143081749|NCT00996892|515836767|FG002|Expansion Stage 2A|Physician Decision|0|||
143081750|NCT00996892|515836768|FG003|Expansion Stage 2A|Physician Decision|0|||
143081751|NCT00996892|515836769|FG004|Expansion Stage 2A|Physician Decision|0|||
143081752|NCT00996892|515836770|FG005|Expansion Stage 2A|Physician Decision|0|||
143081753|NCT00996892|515836771|FG006|Expansion Stage 2A|Physician Decision|0|||
143081754|NCT00996892|515836772|FG007|Expansion Stage 2A|Physician Decision|0|||
143081755|NCT00996892|515836773|FG008|Expansion Stage 2A|Physician Decision|0|||
143081756|NCT00996892|515836774|FG009|Expansion Stage 2A|Physician Decision|0|||
143081757|NCT00996892|515836775|FG010|Expansion Stage 2A|Physician Decision|0|||
143081758|NCT00996892|515836776|FG011|Expansion Stage 2A|Physician Decision|0|||
143081759|NCT00996892|515836777|FG012|Expansion Stage 2A|Physician Decision|0|||
143081760|NCT00996892|515836778|FG013|Expansion Stage 2A|Physician Decision|0|||
143081761|NCT00996892|515836779|FG014|Expansion Stage 2A|Physician Decision|0|||
143081762|NCT00996892|515836780|FG015|Expansion Stage 2A|Physician Decision|0|||
143081763|NCT00996892|515836781|FG016|Expansion Stage 2A|Physician Decision|0|||
143081764|NCT00996892|515836782|FG017|Expansion Stage 2A|Physician Decision|0|||
143173313|NCT00698828|516183081|FG001|Overall Study|Withdrew consent (not treated)|0|||
143173314|NCT00698828|516183082|FG002|Overall Study|Withdrew consent (not treated)|0|||
143081765|NCT00996892|515836783|FG018|Expansion Stage 2A|Physician Decision|0|||
143081766|NCT00996892|515836784|FG019|Expansion Stage 2A|Physician Decision|2|||
143081767|NCT00996892|515836765|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
143081768|NCT00996892|515836766|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
143081769|NCT00996892|515836767|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
143081770|NCT00996892|515836768|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
143173315|NCT02013609|516183083|FG000|Overall Study|Withdrawal by Subject|9|||
143173316|NCT02013609|516183083|FG000|Overall Study|Lost to Follow-up|3|||
143173317|NCT02013609|516183083|FG000|Overall Study|Adverse Event|3|||
143081771|NCT00996892|515836769|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
143081772|NCT00996892|515836770|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
143081773|NCT00996892|515836771|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
143081774|NCT00996892|515836772|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
143081775|NCT00996892|515836773|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
143081776|NCT00996892|515836774|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
143081777|NCT00996892|515836775|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
143081778|NCT00996892|515836776|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
143081779|NCT00996892|515836777|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
143081780|NCT00996892|515836778|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
143081781|NCT00996892|515836779|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
143081782|NCT00996892|515836780|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
143081783|NCT00996892|515836781|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
143081784|NCT00996892|515836782|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
143081785|NCT00996892|515836783|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
143081786|NCT00996892|515836784|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
143081787|NCT00996892|515836765|FG000|Expansion Stage 2A|Disease Progression|0|||
143081788|NCT00996892|515836766|FG001|Expansion Stage 2A|Disease Progression|0|||
143081789|NCT00996892|515836767|FG002|Expansion Stage 2A|Disease Progression|0|||
143081790|NCT00996892|515836768|FG003|Expansion Stage 2A|Disease Progression|0|||
143081791|NCT00996892|515836769|FG004|Expansion Stage 2A|Disease Progression|0|||
143173318|NCT02013609|516183083|FG000|Overall Study|Met Withdrawal Criteria|3|||
143366276|NCT03710564|516884613|FG000|Overall Study|Withdrawal by Subject|57|||
143173319|NCT01119287|516183084|FG000|Overall Study|Patient Decision, not related to AE|0|||
143173320|NCT01119287|516183085|FG001|Overall Study|Patient Decision, not related to AE|0|||
143173321|NCT01119287|516183086|FG002|Overall Study|Patient Decision, not related to AE|2|||
143173322|NCT01119287|516183087|FG003|Overall Study|Patient Decision, not related to AE|2|||
143173323|NCT01119287|516183088|FG004|Overall Study|Patient Decision, not related to AE|1|||
143173324|NCT01119287|516183089|FG005|Overall Study|Patient Decision, not related to AE|0|||
143173325|NCT02257684|516183095|FG000|Overall Study|Adverse Event|2|||
143173326|NCT02257684|516183095|FG000|Overall Study|Lack of Efficacy|1|||
143173327|NCT02257684|516183095|FG000|Overall Study|Sponsor's Decision|1|||
143173328|NCT02943473|516183096|FG000|Overall Study|enrolled but not dosed|1|||
143173329|NCT02943473|516183096|FG000|Overall Study|screen failure|1|||
143173330|NCT02943473|516183096|FG000|Overall Study|Physician Decision|4|||
143173331|NCT00431964|516183103|FG000|Overall Study|Adverse Event|1|||
143173332|NCT00431964|516183104|FG001|Overall Study|Adverse Event|0|||
143173333|NCT00431964|516183103|FG000|Overall Study|Lost to Follow-up|1|||
143173334|NCT00431964|516183104|FG001|Overall Study|Lost to Follow-up|2|||
143173335|NCT00431964|516183103|FG000|Overall Study|Physician Decision|2|||
143173336|NCT00431964|516183104|FG001|Overall Study|Physician Decision|2|||
143173337|NCT00431964|516183103|FG000|Overall Study|Withdrawal by Subject|2|||
143173338|NCT00431964|516183104|FG001|Overall Study|Withdrawal by Subject|1|||
143173339|NCT00431964|516183103|FG000|Overall Study|Parental Consent Withdrawn|0|||
143173340|NCT00431964|516183104|FG001|Overall Study|Parental Consent Withdrawn|2|||
143173341|NCT00431964|516183103|FG000|Overall Study|Due to Unstable Health|0|||
143173342|NCT00431964|516183104|FG001|Overall Study|Due to Unstable Health|1|||
143173343|NCT01736917|516183108|FG000|Overall Study|Adverse Event|1|||
143173344|NCT01736917|516183108|FG000|Overall Study|Protocol Violation|10|||
143173345|NCT01911260|516183111|FG000|Supplementation Period|transference or evasion of school|7|||
143173346|NCT01911260|516183112|FG001|Supplementation Period|transference or evasion of school|9|||
143173347|NCT01911260|516183113|FG002|Supplementation Period|transference or evasion of school|7|||
143173348|NCT01911260|516183114|FG003|Supplementation Period|transference or evasion of school|6|||
143173349|NCT01911260|516183111|FG000|Supplementation Period|Adverse Event|2|||
143173350|NCT01911260|516183112|FG001|Supplementation Period|Adverse Event|0|||
143173351|NCT01911260|516183113|FG002|Supplementation Period|Adverse Event|1|||
143173352|NCT01911260|516183114|FG003|Supplementation Period|Adverse Event|0|||
143173353|NCT01911260|516183111|FG000|Supplementation Period|refused to receive supplement|1|||
143173354|NCT01911260|516183112|FG001|Supplementation Period|refused to receive supplement|0|||
143249007|NCT02779556|516465085|FG001|Baseline|Partial baseline interview completed|0|||
143249008|NCT02779556|516465084|FG000|3 Months|Lost to Follow-up|40|||
143249009|NCT02779556|516465085|FG001|3 Months|Lost to Follow-up|29|||
143249010|NCT02779556|516465084|FG000|3 Months|Missed 3 month clinic visit|27|||
143249011|NCT02779556|516465085|FG001|3 Months|Missed 3 month clinic visit|19|||
143249012|NCT02779556|516465084|FG000|6 Month|Lost to Follow-up|33|||
143249013|NCT02779556|516465085|FG001|6 Month|Lost to Follow-up|39|||
143249014|NCT02779556|516465084|FG000|6 Month HbA1c|No value collected during window|69|||
143249015|NCT02779556|516465085|FG001|6 Month HbA1c|No value collected during window|50|||
143249016|NCT02779556|516465084|FG000|12 Month HbA1c|No value collected during window|138|||
143249017|NCT02779556|516465085|FG001|12 Month HbA1c|No value collected during window|102|||
143249018|NCT03110770|516465087|FG000|Overall Study|Death|1|||
143249019|NCT03110770|516465088|FG001|Overall Study|Death|0|||
143249020|NCT03110770|516465089|FG002|Overall Study|Death|0|||
143249021|NCT03110770|516465090|FG003|Overall Study|Death|1|||
143249022|NCT03110770|516465091|FG004|Overall Study|Death|0|||
143366277|NCT03710564|516884614|FG001|Overall Study|Withdrawal by Subject|25|||
143366278|NCT03710564|516884613|FG000|Overall Study|Death|10|||
143173355|NCT01911260|516183113|FG002|Supplementation Period|refused to receive supplement|1|||
143173356|NCT01911260|516183114|FG003|Supplementation Period|refused to receive supplement|0|||
143173357|NCT01911260|516183111|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
143173358|NCT01911260|516183112|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
143173359|NCT01911260|516183113|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
143173360|NCT01911260|516183114|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
143173361|NCT01911260|516183111|FG000|Follow-up Period|transference or evasion of school|13|||
143173362|NCT01911260|516183112|FG001|Follow-up Period|transference or evasion of school|20|||
143173363|NCT01911260|516183113|FG002|Follow-up Period|transference or evasion of school|15|||
143173364|NCT01911260|516183114|FG003|Follow-up Period|transference or evasion of school|12|||
143173365|NCT00654732|516183115|FG000|Overall Study|Adverse Event|4|||
143173366|NCT00654732|516183116|FG001|Overall Study|Adverse Event|6|||
143173367|NCT01734902|516183121|FG000|Overall Study|Other than listed|0|||
143173368|NCT01734902|516183122|FG001|Overall Study|Other than listed|2|||
143173369|NCT00060944|516183125|FG000|Overall Study|Adverse Event|12|||
143173370|NCT00060944|516183126|FG001|Overall Study|Adverse Event|10|||
143173371|NCT00060944|516183125|FG000|Overall Study|Death|2|||
143173372|NCT00060944|516183126|FG001|Overall Study|Death|3|||
143173373|NCT00060944|516183125|FG000|Overall Study|Withdrawal by Subject|18|||
143173374|NCT00060944|516183126|FG001|Overall Study|Withdrawal by Subject|5|||
143173375|NCT00060944|516183125|FG000|Overall Study|Disease Progression|93|||
143173376|NCT00060944|516183126|FG001|Overall Study|Disease Progression|94|||
143173377|NCT00060944|516183125|FG000|Overall Study|Lost to Follow-up|1|||
143173378|NCT00060944|516183126|FG001|Overall Study|Lost to Follow-up|0|||
143173379|NCT00060944|516183125|FG000|Overall Study|Subject Ineligible To Continue|2|||
143173380|NCT00060944|516183126|FG001|Overall Study|Subject Ineligible To Continue|1|||
143173381|NCT00060944|516183125|FG000|Overall Study|Treatment Switch|0|||
143173382|NCT00060944|516183126|FG001|Overall Study|Treatment Switch|13|||
143173383|NCT00060944|516183125|FG000|Overall Study|Other|2|||
143173384|NCT00060944|516183126|FG001|Overall Study|Other|4|||
143173385|NCT00060944|516183125|FG000|Overall Study|randomized but not treated|6|||
143173386|NCT00060944|516183126|FG001|Overall Study|randomized but not treated|4|||
143173387|NCT03383666|516183129|FG000|Overall Study|Withdrawal by Subject|2|||
143173388|NCT03383666|516183129|FG000|Overall Study|Lost to Follow-up|2|||
143173389|NCT03358030|516183138|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
143173390|NCT03358030|516183139|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
143173391|NCT03358030|516183140|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
143173392|NCT03358030|516183141|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
143173393|NCT03358030|516183138|FG000|Overall Study|Ineligibility|0|||
143249023|NCT03110770|516465087|FG000|Overall Study|Enrolled but did not receive product|0|||
143249024|NCT03110770|516465088|FG001|Overall Study|Enrolled but did not receive product|0|||
143249025|NCT03110770|516465089|FG002|Overall Study|Enrolled but did not receive product|0|||
143366279|NCT03710564|516884614|FG001|Overall Study|Death|4|||
143081792|NCT00996892|515836770|FG005|Expansion Stage 2A|Disease Progression|0|||
143081793|NCT00996892|515836771|FG006|Expansion Stage 2A|Disease Progression|0|||
143081794|NCT00996892|515836772|FG007|Expansion Stage 2A|Disease Progression|0|||
143081795|NCT00996892|515836773|FG008|Expansion Stage 2A|Disease Progression|0|||
143081796|NCT00996892|515836774|FG009|Expansion Stage 2A|Disease Progression|0|||
143081797|NCT00996892|515836775|FG010|Expansion Stage 2A|Disease Progression|0|||
143081798|NCT00996892|515836776|FG011|Expansion Stage 2A|Disease Progression|0|||
143081799|NCT00996892|515836777|FG012|Expansion Stage 2A|Disease Progression|0|||
143081800|NCT00996892|515836778|FG013|Expansion Stage 2A|Disease Progression|0|||
143081801|NCT00996892|515836779|FG014|Expansion Stage 2A|Disease Progression|0|||
143081802|NCT00996892|515836780|FG015|Expansion Stage 2A|Disease Progression|0|||
143081803|NCT00996892|515836781|FG016|Expansion Stage 2A|Disease Progression|0|||
143081804|NCT00996892|515836782|FG017|Expansion Stage 2A|Disease Progression|0|||
143081805|NCT00996892|515836783|FG018|Expansion Stage 2A|Disease Progression|0|||
143081806|NCT00996892|515836784|FG019|Expansion Stage 2A|Disease Progression|31|||
143081807|NCT04042376|515836785|FG000|Overall Study|Withdrawal by Subject|1|||
143081808|NCT04042376|515836785|FG000|Overall Study|Death|3|||
143081809|NCT04324073|515838378|FG000|Overall Study|withdrew consent|0|||
143081810|NCT04324073|515838379|FG001|Overall Study|withdrew consent|4|||
143081811|NCT04324073|515838380|FG002|Overall Study|withdrew consent|2|||
143081812|NCT04324073|515838381|FG003|Overall Study|withdrew consent|8|||
143081813|NCT03888066|515838382|FG000|Run-in Phase|Randomization Criterion #1|24|||
143081814|NCT03888066|515838383|FG001|Run-in Phase|Randomization Criterion #1|0|||
143081815|NCT03888066|515838382|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
143081816|NCT03888066|515838383|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
143081817|NCT03888066|515838382|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
143081818|NCT03888066|515838383|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
143081819|NCT03888066|515838382|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
143081820|NCT03888066|515838383|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
143081821|NCT03888066|515838382|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
143081822|NCT03888066|515838383|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
143081823|NCT03888066|515838382|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
143081824|NCT03888066|515838383|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
143081825|NCT03888066|515838382|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
143081826|NCT03888066|515838383|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
143081827|NCT03888066|515838382|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
143081828|NCT03888066|515838383|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
143173394|NCT03358030|516183139|FG001|Overall Study|Ineligibility|0|||
143173395|NCT03358030|516183140|FG002|Overall Study|Ineligibility|0|||
143173396|NCT03358030|516183141|FG003|Overall Study|Ineligibility|2|||
143173397|NCT03358030|516183138|FG000|Overall Study|Voluntary Withdrawal|1|||
143366280|NCT03710564|516884613|FG000|Overall Study|Lost to Follow-up|5|||
143081829|NCT03888066|515838382|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
143081830|NCT03888066|515838383|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
143081831|NCT03888066|515838382|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
143081832|NCT03888066|515838383|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
143081833|NCT03888066|515838382|FG000|Run-in Phase|Randomization Criterion #2|5|||
143081834|NCT03888066|515838383|FG001|Run-in Phase|Randomization Criterion #2|0|||
143081835|NCT03888066|515838382|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
143173398|NCT03358030|516183139|FG001|Overall Study|Voluntary Withdrawal|1|||
143081836|NCT03888066|515838383|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
143249026|NCT03110770|516465090|FG003|Overall Study|Enrolled but did not receive product|8|||
143081837|NCT03888066|515838382|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
143081838|NCT03888066|515838383|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
143081839|NCT03888066|515838382|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
143081840|NCT03888066|515838383|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
143081841|NCT03888066|515838382|FG000|Run-in Phase|Randomization Criterion #3|11|||
143081842|NCT03888066|515838383|FG001|Run-in Phase|Randomization Criterion #3|0|||
143081843|NCT03888066|515838382|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
143081844|NCT03888066|515838383|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
143081845|NCT03888066|515838382|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
143081846|NCT03888066|515838383|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
143081847|NCT03888066|515838382|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
143081848|NCT03888066|515838383|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
143081849|NCT03888066|515838382|FG000|Run-in Phase|Randomization Criterion #4|3|||
143081850|NCT03888066|515838383|FG001|Run-in Phase|Randomization Criterion #4|0|||
143081851|NCT03888066|515838382|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
143081852|NCT03888066|515838383|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
143081853|NCT03888066|515838382|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
143081854|NCT03888066|515838383|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
143081855|NCT03888066|515838382|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
143081856|NCT03888066|515838383|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
143081857|NCT03888066|515838382|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
143081858|NCT03888066|515838383|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
143081859|NCT03888066|515838382|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
143081860|NCT03888066|515838383|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
143081861|NCT03888066|515838382|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
143081862|NCT03888066|515838383|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
143081863|NCT03888066|515838382|FG000|Run-in Phase|AE (Adverse Event)|17|||
143249027|NCT03110770|516465091|FG004|Overall Study|Enrolled but did not receive product|7|||
143249028|NCT03110770|516465087|FG000|Overall Study|Lost to Follow-up|0|||
143249029|NCT03110770|516465088|FG001|Overall Study|Lost to Follow-up|0|||
143249030|NCT03110770|516465089|FG002|Overall Study|Lost to Follow-up|0|||
143249031|NCT03110770|516465090|FG003|Overall Study|Lost to Follow-up|53|||
143249032|NCT03110770|516465091|FG004|Overall Study|Lost to Follow-up|45|||
143249033|NCT03110770|516465087|FG000|Overall Study|Investigator Decision|0|||
143249034|NCT03110770|516465088|FG001|Overall Study|Investigator Decision|0|||
143249035|NCT03110770|516465089|FG002|Overall Study|Investigator Decision|0|||
143249036|NCT03110770|516465090|FG003|Overall Study|Investigator Decision|5|||
143249037|NCT03110770|516465091|FG004|Overall Study|Investigator Decision|3|||
143249038|NCT03110770|516465087|FG000|Overall Study|Withdrawal by Subject|0|||
143249039|NCT03110770|516465088|FG001|Overall Study|Withdrawal by Subject|0|||
143249040|NCT03110770|516465089|FG002|Overall Study|Withdrawal by Subject|0|||
143249041|NCT03110770|516465090|FG003|Overall Study|Withdrawal by Subject|24|||
143249042|NCT03110770|516465091|FG004|Overall Study|Withdrawal by Subject|24|||
143366281|NCT03710564|516884614|FG001|Overall Study|Lost to Follow-up|4|||
143366282|NCT03710564|516884613|FG000|Overall Study|Protocol Violation|3|||
143366283|NCT03710564|516884614|FG001|Overall Study|Protocol Violation|2|||
143366284|NCT03710564|516884613|FG000|Overall Study|Adverse Event|3|||
143081864|NCT03888066|515838383|FG001|Run-in Phase|AE (Adverse Event)|0|||
143081865|NCT03888066|515838382|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
143081866|NCT03888066|515838383|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
143081867|NCT03888066|515838382|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
143081868|NCT03888066|515838383|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
143081869|NCT03888066|515838382|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
143081870|NCT03888066|515838383|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
143081871|NCT03888066|515838382|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
143081872|NCT03888066|515838383|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
143081873|NCT03888066|515838382|FG000|Run-in Phase|Withdrawal by Subject|43|||
143081874|NCT03888066|515838383|FG001|Run-in Phase|Withdrawal by Subject|0|||
143081875|NCT03888066|515838382|FG000|Run-in Phase|AE; Physician Decision|1|||
143081876|NCT03888066|515838383|FG001|Run-in Phase|AE; Physician Decision|0|||
143081877|NCT03888066|515838382|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
143081878|NCT03888066|515838383|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
143081879|NCT03888066|515838382|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
143081880|NCT03888066|515838383|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
143081881|NCT03888066|515838382|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
143081882|NCT03888066|515838383|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
143081883|NCT03888066|515838382|FG000|Run-in Phase|Death|1|||
143081884|NCT03888066|515838383|FG001|Run-in Phase|Death|0|||
143081885|NCT03888066|515838382|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
143081886|NCT03888066|515838383|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
143081887|NCT03888066|515838382|FG000|Run-in Phase|Physician Decision|1|||
143081888|NCT03888066|515838383|FG001|Run-in Phase|Physician Decision|0|||
143081889|NCT03888066|515838382|FG000|Run-in Phase|Protocol Violation|13|||
143081890|NCT03888066|515838383|FG001|Run-in Phase|Protocol Violation|0|||
143081891|NCT03888066|515838382|FG000|Run-in Phase|Sponsor Request|34|||
143081892|NCT03888066|515838383|FG001|Run-in Phase|Sponsor Request|0|||
143081893|NCT03888066|515838382|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
143081894|NCT03888066|515838383|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
143081895|NCT03888066|515838382|FG000|Run-in Phase|Withdrawal Of Consent|1|||
143081896|NCT03888066|515838383|FG001|Run-in Phase|Withdrawal Of Consent|0|||
143081897|NCT03888066|515838382|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
143081898|NCT03888066|515838383|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
143081899|NCT03888066|515838382|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
143081900|NCT03888066|515838383|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
143081901|NCT03888066|515838382|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
143081902|NCT03888066|515838383|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
143081903|NCT03888066|515838382|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
143081904|NCT03888066|515838383|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
143081905|NCT03888066|515838382|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
143081906|NCT03888066|515838383|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
143081907|NCT03888066|515838382|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
143081908|NCT03888066|515838383|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
143081909|NCT03888066|515838382|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
143081910|NCT03888066|515838383|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
143173399|NCT03358030|516183140|FG002|Overall Study|Voluntary Withdrawal|3|||
143081911|NCT03888066|515838382|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
143081912|NCT03888066|515838383|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
143081913|NCT03888066|515838382|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
143081914|NCT03888066|515838383|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
143081915|NCT03888066|515838382|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
143173400|NCT03358030|516183141|FG003|Overall Study|Voluntary Withdrawal|1|||
143173401|NCT03358030|516183138|FG000|Overall Study|Other|0|||
143173402|NCT03358030|516183139|FG001|Overall Study|Other|0|||
143173403|NCT03358030|516183140|FG002|Overall Study|Other|1|||
143173404|NCT03358030|516183141|FG003|Overall Study|Other|0|||
143173405|NCT03342560|516183142|FG000|Overall Study|Lost to Follow-up|2|||
143173406|NCT02604511|516183143|FG000|Overall Study|Adverse Event|3|||
143173407|NCT02604511|516183143|FG000|Overall Study|Disease Progression|4|||
143173408|NCT02604511|516183143|FG000|Overall Study|Withdrawal by Subject|3|||
143173409|NCT02604511|516183143|FG000|Overall Study|Participant ineligible|1|||
143173410|NCT02604511|516183143|FG000|Overall Study|Intercurrent illness|1|||
143173411|NCT03770286|516183144|FG000|Overall Study|Lost to Follow-up|6|||
143173412|NCT03770286|516183145|FG001|Overall Study|Lost to Follow-up|4|||
143173413|NCT03770286|516183146|FG002|Overall Study|Lost to Follow-up|3|||
143173414|NCT03770286|516183144|FG000|Overall Study|Protocol Violation|1|||
143173415|NCT03770286|516183145|FG001|Overall Study|Protocol Violation|0|||
143173416|NCT03770286|516183146|FG002|Overall Study|Protocol Violation|2|||
143173417|NCT02505425|516183147|FG000|Overall Study|Lost to Follow-up|41|||
143173418|NCT02505425|516183148|FG001|Overall Study|Lost to Follow-up|61|||
143173419|NCT02505425|516183149|FG002|Overall Study|Lost to Follow-up|31|||
143173420|NCT02505425|516183150|FG003|Overall Study|Lost to Follow-up|19|||
143173421|NCT02505425|516183147|FG000|Overall Study|Withdrawal by Subject|39|||
143173422|NCT02505425|516183148|FG001|Overall Study|Withdrawal by Subject|9|||
143173423|NCT02505425|516183149|FG002|Overall Study|Withdrawal by Subject|19|||
143173424|NCT02505425|516183150|FG003|Overall Study|Withdrawal by Subject|7|||
143173425|NCT02505425|516183147|FG000|Overall Study|Death|8|||
143173426|NCT02505425|516183148|FG001|Overall Study|Death|12|||
143173427|NCT02505425|516183149|FG002|Overall Study|Death|0|||
143173428|NCT02505425|516183150|FG003|Overall Study|Death|0|||
143173429|NCT02031302|516183151|FG000|Overall Study|Death|115|||
143173430|NCT02031302|516183152|FG001|Overall Study|Death|0|||
143173431|NCT02031302|516183151|FG000|Overall Study|Not treated with study valve system|18|||
143173432|NCT02031302|516183152|FG001|Overall Study|Not treated with study valve system|0|||
143173433|NCT02031302|516183151|FG000|Overall Study|Missed Follow Up|27|||
143173434|NCT02031302|516183152|FG001|Overall Study|Missed Follow Up|0|||
143173435|NCT02031302|516183151|FG000|Overall Study|Lost to Follow-up|4|||
143173436|NCT02031302|516183152|FG001|Overall Study|Lost to Follow-up|0|||
143173437|NCT01816984|516183159|FG000|Overall Study|declining health status|1|||
143173438|NCT05270863|516183171|FG000|Visit 2 First Intervention|Randomization error|0|||
143173439|NCT05270863|516183172|FG001|Visit 2 First Intervention|Randomization error|0|||
143173440|NCT05270863|516183173|FG002|Visit 2 First Intervention|Randomization error|0|||
143173441|NCT05270863|516183174|FG003|Visit 2 First Intervention|Randomization error|1|||
143173442|NCT05270863|516183175|FG004|Visit 2 First Intervention|Randomization error|0|||
143173443|NCT05270863|516183176|FG005|Visit 2 First Intervention|Randomization error|0|||
143173444|NCT05270863|516183171|FG000|First Washout|Withdrawal by Subject|0|||
143173445|NCT05270863|516183172|FG001|First Washout|Withdrawal by Subject|0|||
143173446|NCT05270863|516183173|FG002|First Washout|Withdrawal by Subject|0|||
143173447|NCT05270863|516183174|FG003|First Washout|Withdrawal by Subject|0|||
143173448|NCT05270863|516183175|FG004|First Washout|Withdrawal by Subject|1|||
143173449|NCT05270863|516183176|FG005|First Washout|Withdrawal by Subject|1|||
143173450|NCT05270863|516183171|FG000|First Washout|Lost to Follow-up|0|||
143173451|NCT05270863|516183172|FG001|First Washout|Lost to Follow-up|0|||
143173452|NCT05270863|516183173|FG002|First Washout|Lost to Follow-up|0|||
143173453|NCT05270863|516183174|FG003|First Washout|Lost to Follow-up|0|||
143173454|NCT05270863|516183175|FG004|First Washout|Lost to Follow-up|0|||
143173455|NCT05270863|516183176|FG005|First Washout|Lost to Follow-up|1|||
143173456|NCT05270863|516183171|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
143173457|NCT05270863|516183172|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
143173458|NCT05270863|516183173|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
143173459|NCT05270863|516183174|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
143173460|NCT05270863|516183175|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
143173461|NCT05270863|516183176|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
143173462|NCT05270863|516183171|FG000|Second Washout|Withdrawal by Subject|1|||
143173463|NCT05270863|516183172|FG001|Second Washout|Withdrawal by Subject|1|||
143173464|NCT05270863|516183173|FG002|Second Washout|Withdrawal by Subject|0|||
143173465|NCT05270863|516183174|FG003|Second Washout|Withdrawal by Subject|0|||
143173466|NCT05270863|516183175|FG004|Second Washout|Withdrawal by Subject|0|||
143173467|NCT05270863|516183176|FG005|Second Washout|Withdrawal by Subject|0|||
143173468|NCT05270863|516183171|FG000|Second Washout|Lost to Follow-up|0|||
143366285|NCT03710564|516884614|FG001|Overall Study|Adverse Event|0|||
143366286|NCT03710564|516884613|FG000|Overall Study|Physician Decision|2|||
143366287|NCT03710564|516884614|FG001|Overall Study|Physician Decision|3|||
143173469|NCT05270863|516183172|FG001|Second Washout|Lost to Follow-up|0|||
143173470|NCT05270863|516183173|FG002|Second Washout|Lost to Follow-up|0|||
143173471|NCT05270863|516183174|FG003|Second Washout|Lost to Follow-up|1|||
143173472|NCT05270863|516183175|FG004|Second Washout|Lost to Follow-up|0|||
143173473|NCT05270863|516183176|FG005|Second Washout|Lost to Follow-up|0|||
143173474|NCT02561962|516183177|FG000|Overall Study|Withdrawal by Subject|1|||
143081916|NCT03888066|515838383|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
143081917|NCT03888066|515838382|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
143081918|NCT03888066|515838383|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
143081919|NCT03888066|515838382|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
143081920|NCT03888066|515838383|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
143081921|NCT00974922|515838384|FG000|Overall Study|study terminated|24|||
143081922|NCT00459355|515838385|FG000|Overall Study|Subject no longer met inc criteria|20|||
143081923|NCT00459355|515838386|FG001|Overall Study|Subject no longer met inc criteria|18|||
143081924|NCT01173120|515838390|FG000|Overall Study|Lack of Efficacy|2|||
143081925|NCT01173120|515838390|FG000|Overall Study|Lost to Follow-up|1|||
143081926|NCT01173120|515838390|FG000|Overall Study|Participant Decision|2|||
143081927|NCT01173120|515838390|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
143081928|NCT01173120|515838390|FG000|Overall Study|Switch-Participant Decision|12|||
143081929|NCT01173120|515838390|FG000|Overall Study|Switch-Difficulty With Device|12|||
143081930|NCT03055624|515838393|FG000|Overall Study|Study closed|9|||
143081931|NCT01582152|515838394|FG000|Overall Study|Disease Progression|4|||
143081932|NCT01582152|515838395|FG001|Overall Study|Disease Progression|5|||
143081933|NCT01582152|515838394|FG000|Overall Study|Adverse Event|2|||
143081934|NCT01582152|515838395|FG001|Overall Study|Adverse Event|1|||
143081935|NCT01266031|515838396|FG000|Overall Study|Not treated|0|||
143081936|NCT01266031|515838397|FG001|Overall Study|Not treated|3|||
143081937|NCT01266031|515838398|FG002|Overall Study|Not treated|2|||
143081938|NCT01434810|515838399|FG000|Overall Study|Did not receive treatment|11|||
143081939|NCT01434810|515838400|FG001|Overall Study|Did not receive treatment|3|||
143081940|NCT01434810|515838399|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
143081941|NCT01434810|515838400|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
143081942|NCT02114385|515838402|FG000|Overall Study|Withdrawal by Subject|3|||
143081943|NCT02114385|515838403|FG001|Overall Study|Withdrawal by Subject|2|||
143081944|NCT02114385|515838402|FG000|Overall Study|Lost to Follow-up|0|||
143081945|NCT02114385|515838403|FG001|Overall Study|Lost to Follow-up|6|||
143081946|NCT00230178|515838409|FG000|Overall Study|Adverse Event|1|||
143081947|NCT00230178|515838410|FG001|Overall Study|Adverse Event|5|||
143081948|NCT00230178|515838411|FG002|Overall Study|Adverse Event|2|||
143081949|NCT00230178|515838409|FG000|Overall Study|Withdrawal by Subject|0|||
143081950|NCT00230178|515838410|FG001|Overall Study|Withdrawal by Subject|0|||
143081951|NCT00230178|515838411|FG002|Overall Study|Withdrawal by Subject|1|||
143081952|NCT00230178|515838409|FG000|Overall Study|Various other reasons|3|||
143081953|NCT00230178|515838410|FG001|Overall Study|Various other reasons|2|||
143081954|NCT00230178|515838411|FG002|Overall Study|Various other reasons|4|||
143081955|NCT01753297|515838412|FG000|Overall Study|Lost to Follow-up|7|||
143081956|NCT01753297|515838413|FG001|Overall Study|Lost to Follow-up|2|||
143081957|NCT01753297|515838412|FG000|Overall Study|Withdrawal by Subject|26|||
143081958|NCT01753297|515838413|FG001|Overall Study|Withdrawal by Subject|23|||
143081959|NCT01753297|515838412|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
143081960|NCT01753297|515838413|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
143081961|NCT01753297|515838412|FG000|Overall Study|Death|0|||
143081962|NCT01753297|515838413|FG001|Overall Study|Death|2|||
143081963|NCT01753297|515838412|FG000|Overall Study|Did not attend end of study visit|7|||
143081964|NCT01753297|515838413|FG001|Overall Study|Did not attend end of study visit|8|||
143081965|NCT02533180|515838414|FG000|Overall Study|Death|0|||
143081966|NCT02533180|515838415|FG001|Overall Study|Death|2|||
143081967|NCT02533180|515838414|FG000|Overall Study|Lost to Follow-up|0|||
143081968|NCT02533180|515838415|FG001|Overall Study|Lost to Follow-up|1|||
143081969|NCT02533180|515838414|FG000|Overall Study|Physician Decision|0|||
143081970|NCT02533180|515838415|FG001|Overall Study|Physician Decision|1|||
143173475|NCT02561962|516183178|FG001|Overall Study|Withdrawal by Subject|0|||
143173476|NCT02561962|516183179|FG002|Overall Study|Withdrawal by Subject|0|||
143081971|NCT02533180|515838414|FG000|Overall Study|Withdrawal by Subject|2|||
143081972|NCT02533180|515838415|FG001|Overall Study|Withdrawal by Subject|5|||
143081973|NCT02533180|515838414|FG000|Overall Study|Screen Failure|37|||
143081974|NCT02533180|515838415|FG001|Overall Study|Screen Failure|0|||
143081975|NCT02533180|515838414|FG000|Overall Study|Protocol Deviation|0|||
143173477|NCT02561962|516183180|FG003|Overall Study|Withdrawal by Subject|0|||
143173478|NCT02561962|516183181|FG004|Overall Study|Withdrawal by Subject|1|||
143173479|NCT02561962|516183182|FG005|Overall Study|Withdrawal by Subject|1|||
143173480|NCT02561962|516183183|FG006|Overall Study|Withdrawal by Subject|2|||
143173481|NCT02561962|516183184|FG007|Overall Study|Withdrawal by Subject|1|||
143173482|NCT02561962|516183185|FG008|Overall Study|Withdrawal by Subject|0|||
143173483|NCT02561962|516183177|FG000|Overall Study|Decision by sponsor|0|||
143173484|NCT02561962|516183178|FG001|Overall Study|Decision by sponsor|0|||
143173485|NCT02561962|516183179|FG002|Overall Study|Decision by sponsor|0|||
143173486|NCT02561962|516183180|FG003|Overall Study|Decision by sponsor|0|||
143173487|NCT02561962|516183181|FG004|Overall Study|Decision by sponsor|1|||
143173488|NCT02561962|516183182|FG005|Overall Study|Decision by sponsor|1|||
143173489|NCT02561962|516183183|FG006|Overall Study|Decision by sponsor|0|||
143173490|NCT02561962|516183184|FG007|Overall Study|Decision by sponsor|3|||
143173491|NCT02561962|516183185|FG008|Overall Study|Decision by sponsor|0|||
143173492|NCT02561962|516183177|FG000|Overall Study|Lost to Follow-up|0|||
143173493|NCT02561962|516183178|FG001|Overall Study|Lost to Follow-up|0|||
143173494|NCT02561962|516183179|FG002|Overall Study|Lost to Follow-up|0|||
143173495|NCT02561962|516183180|FG003|Overall Study|Lost to Follow-up|0|||
143173496|NCT02561962|516183181|FG004|Overall Study|Lost to Follow-up|0|||
143173497|NCT02561962|516183182|FG005|Overall Study|Lost to Follow-up|1|||
143173498|NCT02561962|516183183|FG006|Overall Study|Lost to Follow-up|0|||
143173499|NCT02561962|516183184|FG007|Overall Study|Lost to Follow-up|0|||
143173500|NCT02561962|516183185|FG008|Overall Study|Lost to Follow-up|0|||
143173501|NCT01150357|516183186|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
143173502|NCT01150357|516183187|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
143173503|NCT01150357|516183188|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
143173504|NCT01150357|516183186|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
143173505|NCT01150357|516183187|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
143173506|NCT01150357|516183188|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
143173507|NCT01150357|516183186|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
143173508|NCT01150357|516183187|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
143173509|NCT01150357|516183188|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
143173510|NCT01150357|516183186|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
143173511|NCT01150357|516183187|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
143173512|NCT01150357|516183188|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
143173513|NCT01150357|516183186|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
143173514|NCT01150357|516183187|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
143173515|NCT01150357|516183188|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
143173516|NCT01150357|516183186|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
143173517|NCT01150357|516183187|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
143173518|NCT01150357|516183188|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
143173519|NCT01150357|516183186|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
143173520|NCT01150357|516183187|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
143173521|NCT01150357|516183188|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
143173522|NCT02114177|516185238|FG000|Overall Study|Lost to Follow-up|1|||
143173523|NCT02114177|516185239|FG001|Overall Study|Lost to Follow-up|2|||
143173524|NCT02114177|516185238|FG000|Overall Study|Withdrawal by Subject|6|||
143173525|NCT02114177|516185239|FG001|Overall Study|Withdrawal by Subject|1|||
143173526|NCT02114177|516185238|FG000|Overall Study|Other|2|||
143173527|NCT02114177|516185239|FG001|Overall Study|Other|1|||
143173528|NCT01770743|516185240|FG000|Overall Study|Adverse Event|1|||
143173529|NCT01770743|516185241|FG001|Overall Study|Adverse Event|0|||
143173530|NCT01770743|516185242|FG002|Overall Study|Adverse Event|0|||
143173531|NCT01770743|516185243|FG003|Overall Study|Adverse Event|0|||
143173532|NCT01770743|516185244|FG004|Overall Study|Adverse Event|0|||
143173533|NCT01770743|516185240|FG000|Overall Study|Withdrawal by Subject|0|||
143173534|NCT01770743|516185241|FG001|Overall Study|Withdrawal by Subject|0|||
143173535|NCT01770743|516185242|FG002|Overall Study|Withdrawal by Subject|1|||
143173536|NCT01770743|516185243|FG003|Overall Study|Withdrawal by Subject|1|||
143173537|NCT01770743|516185244|FG004|Overall Study|Withdrawal by Subject|1|||
143173538|NCT01770743|516185240|FG000|Overall Study|Lost to Follow-up|0|||
143173539|NCT01770743|516185241|FG001|Overall Study|Lost to Follow-up|2|||
143173540|NCT01770743|516185242|FG002|Overall Study|Lost to Follow-up|0|||
143173541|NCT01770743|516185243|FG003|Overall Study|Lost to Follow-up|0|||
143173542|NCT01770743|516185244|FG004|Overall Study|Lost to Follow-up|1|||
143173543|NCT01770743|516185240|FG000|Overall Study|Sponsor Terminated Subject|1|||
143173544|NCT01770743|516185241|FG001|Overall Study|Sponsor Terminated Subject|0|||
143173545|NCT01770743|516185242|FG002|Overall Study|Sponsor Terminated Subject|0|||
143173546|NCT01770743|516185243|FG003|Overall Study|Sponsor Terminated Subject|1|||
143173547|NCT01770743|516185244|FG004|Overall Study|Sponsor Terminated Subject|0|||
143081976|NCT02533180|515838415|FG001|Overall Study|Protocol Deviation|1|||
143081977|NCT02533180|515838414|FG000|Overall Study|Non-compliance|0|||
143081978|NCT02533180|515838415|FG001|Overall Study|Non-compliance|1|||
143081979|NCT00447876|515838416|FG000|Overall Study|Withdrawal by Subject|1|||
143081980|NCT00447876|515838417|FG001|Overall Study|Withdrawal by Subject|4|||
143081981|NCT00447876|515838416|FG000|Overall Study|Lost to Follow-up|1|||
143081982|NCT00447876|515838417|FG001|Overall Study|Lost to Follow-up|0|||
143081983|NCT00447876|515838416|FG000|Overall Study|Deterioration of symptomology|1|||
143081984|NCT00447876|515838417|FG001|Overall Study|Deterioration of symptomology|0|||
143081985|NCT01609023|515838422|FG000|Overall Study|Lack of Efficacy|3|||
143081986|NCT01609023|515838422|FG000|Overall Study|Withdrawal by Subject|4|||
143081987|NCT01609023|515838422|FG000|Overall Study|Lost to Follow-up|8|||
143081988|NCT01609023|515838422|FG000|Overall Study|Toxicity|3|||
143081989|NCT01609023|515838422|FG000|Overall Study|Disease progression|10|||
143081990|NCT01609023|515838422|FG000|Overall Study|Physician Decision|2|||
143081991|NCT01609023|515838422|FG000|Overall Study|Death|2|||
143081992|NCT01609023|515838422|FG000|Overall Study|Personal reasons|1|||
143081993|NCT02439970|515838425|FG000|Overall Study|Study Terminated|2|||
143081994|NCT02439970|515838426|FG001|Overall Study|Study Terminated|3|||
143081995|NCT02620579|515838432|FG000|Overall Study|Physician Decision|0|||
143173548|NCT01770743|516185240|FG000|Overall Study|Moving Out of State|0|||
143081996|NCT02620579|515838433|FG001|Overall Study|Physician Decision|0|||
143081997|NCT02620579|515838434|FG002|Overall Study|Physician Decision|0|||
143081998|NCT02620579|515838435|FG003|Overall Study|Physician Decision|1|||
143081999|NCT02620579|515838432|FG000|Overall Study|Withdrawal by Subject|0|||
143082000|NCT02620579|515838433|FG001|Overall Study|Withdrawal by Subject|1|||
143082001|NCT02620579|515838434|FG002|Overall Study|Withdrawal by Subject|1|||
143082002|NCT02620579|515838435|FG003|Overall Study|Withdrawal by Subject|0|||
143082003|NCT00796107|515838436|FG000|Overall Study|Lack of Efficacy|1|||
143082004|NCT00796107|515838436|FG000|Overall Study|Progressive Disease|5|||
143082005|NCT04315506|515838445|FG000|Overall Study|Lost to Follow-up|74|||
143082006|NCT04315506|515838446|FG001|Overall Study|Lost to Follow-up|82|||
143082007|NCT04315506|515838445|FG000|Overall Study|Withdrawal by Subject|8|||
143082008|NCT04315506|515838446|FG001|Overall Study|Withdrawal by Subject|8|||
143082009|NCT04315506|515838445|FG000|Overall Study|Physician Decision|0|||
143082010|NCT04315506|515838446|FG001|Overall Study|Physician Decision|1|||
143082011|NCT00378573|515838449|FG000|Treatment Period|Adverse Event|9|||
143082012|NCT00378573|515838449|FG000|Treatment Period|Physician Decision|1|||
143082013|NCT00378573|515838449|FG000|Treatment Period|Withdrawal by Subject|2|||
143082014|NCT00378573|515838449|FG000|Treatment Period|Disease Progression|4|||
143082015|NCT00378573|515838449|FG000|Treatment Period|Sponsor decision to close study|1|||
143082016|NCT00378573|515838449|FG000|Follow-up|Death|12|||
143082017|NCT00378573|515838449|FG000|Follow-up|Lost to Follow-up|1|||
143082018|NCT00378573|515838449|FG000|Follow-up|Withdrawal by Subject|1|||
143082019|NCT02604407|515838454|FG000|Overall Study|Adverse Event|0|||
143082020|NCT02604407|515838455|FG001|Overall Study|Adverse Event|7|||
143082021|NCT02604407|515838456|FG002|Overall Study|Adverse Event|5|||
143082022|NCT02604407|515838454|FG000|Overall Study|Protocol Violation|2|||
143082023|NCT02604407|515838455|FG001|Overall Study|Protocol Violation|0|||
143082024|NCT02604407|515838456|FG002|Overall Study|Protocol Violation|0|||
143082025|NCT02604407|515838454|FG000|Overall Study|Withdrawal by Subject|3|||
143082026|NCT02604407|515838455|FG001|Overall Study|Withdrawal by Subject|3|||
143082027|NCT02604407|515838456|FG002|Overall Study|Withdrawal by Subject|5|||
143082028|NCT02604407|515838454|FG000|Overall Study|Lost to Follow-up|2|||
143082029|NCT02604407|515838455|FG001|Overall Study|Lost to Follow-up|1|||
143082030|NCT02604407|515838456|FG002|Overall Study|Lost to Follow-up|2|||
143082031|NCT02604407|515838454|FG000|Overall Study|Lack of Efficacy|1|||
143082032|NCT02604407|515838455|FG001|Overall Study|Lack of Efficacy|0|||
143082033|NCT02604407|515838456|FG002|Overall Study|Lack of Efficacy|0|||
143082034|NCT02604407|515838454|FG000|Overall Study|Other|3|||
143082035|NCT02604407|515838455|FG001|Overall Study|Other|1|||
143082036|NCT02604407|515838456|FG002|Overall Study|Other|4|||
143082037|NCT00606632|515838457|FG000|Overall Study|Withdrawal by Subject|13|||
143082038|NCT00606632|515838457|FG000|Overall Study|Miscellaneous reasons|9|||
143082039|NCT00704132|515838460|FG000|Overall Study|Clinical Adverse Experience|1|||
143082040|NCT00704132|515838461|FG001|Overall Study|Clinical Adverse Experience|0|||
143082041|NCT00704132|515838460|FG000|Overall Study|Lack of Efficacy|0|||
143082042|NCT00704132|515838461|FG001|Overall Study|Lack of Efficacy|1|||
143082043|NCT00704132|515838460|FG000|Overall Study|Withdrawal by Subject|0|||
143082044|NCT00704132|515838461|FG001|Overall Study|Withdrawal by Subject|1|||
143082045|NCT02756208|515838462|FG000|Overall Study|Withdrawal by Subject|1|||
143249043|NCT03110770|516465087|FG000|Overall Study|Moved from area|5|||
143249044|NCT03110770|516465088|FG001|Overall Study|Moved from area|0|||
143082046|NCT02756208|515838463|FG001|Overall Study|Withdrawal by Subject|0|||
143082047|NCT02756208|515838464|FG002|Overall Study|Withdrawal by Subject|1|||
143082048|NCT02756208|515838465|FG003|Overall Study|Withdrawal by Subject|3|||
143082049|NCT02756208|515838462|FG000|Overall Study|Lost to Follow-up|3|||
143082050|NCT02756208|515838463|FG001|Overall Study|Lost to Follow-up|1|||
143082051|NCT02756208|515838464|FG002|Overall Study|Lost to Follow-up|1|||
143082052|NCT02756208|515838465|FG003|Overall Study|Lost to Follow-up|1|||
143082053|NCT02756208|515838462|FG000|Overall Study|Physician Decision|1|||
143082054|NCT02756208|515838463|FG001|Overall Study|Physician Decision|0|||
143082055|NCT02756208|515838464|FG002|Overall Study|Physician Decision|0|||
143082056|NCT02756208|515838465|FG003|Overall Study|Physician Decision|0|||
143082057|NCT02756208|515838462|FG000|Overall Study|Protocol Violation|0|||
143082058|NCT02756208|515838463|FG001|Overall Study|Protocol Violation|1|||
143082059|NCT02756208|515838464|FG002|Overall Study|Protocol Violation|0|||
143082060|NCT02756208|515838465|FG003|Overall Study|Protocol Violation|0|||
143082061|NCT02585778|515838466|FG000|Overall Study|Adverse Event|17|||
143082062|NCT02585778|515838467|FG001|Overall Study|Adverse Event|4|||
143082063|NCT02585778|515838466|FG000|Overall Study|Participant did not wish to continue|9|||
143082064|NCT02585778|515838467|FG001|Overall Study|Participant did not wish to continue|4|||
143082065|NCT02585778|515838466|FG000|Overall Study|Poor compliance to study protocol|0|||
143082066|NCT02585778|515838467|FG001|Overall Study|Poor compliance to study protocol|2|||
143082067|NCT02585778|515838466|FG000|Overall Study|Death|0|||
143082068|NCT02585778|515838467|FG001|Overall Study|Death|1|||
143082069|NCT02585778|515838466|FG000|Overall Study|Randomized but not treated|1|||
143082070|NCT02585778|515838467|FG001|Overall Study|Randomized but not treated|2|||
143082071|NCT02585778|515838466|FG000|Overall Study|Other than specified above|6|||
143082072|NCT02585778|515838467|FG001|Overall Study|Other than specified above|2|||
143082073|NCT04841577|515838468|FG000|Overall Study|Adverse Event|5|||
143082074|NCT04841577|515838469|FG001|Overall Study|Adverse Event|10|||
143082075|NCT04841577|515838468|FG000|Overall Study|Lost to Follow-up|8|||
143082076|NCT04841577|515838469|FG001|Overall Study|Lost to Follow-up|7|||
143082077|NCT04841577|515838468|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
143082078|NCT04841577|515838469|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
143082079|NCT04841577|515838468|FG000|Overall Study|Other|0|||
143082080|NCT04841577|515838469|FG001|Overall Study|Other|1|||
143082081|NCT00652340|515838470|FG000|Overall Study|Had not progressed.|4|||
143082082|NCT00652340|515838471|FG001|Overall Study|Had not progressed.|3|||
143082083|NCT03682107|515838472|FG000|Overall Study|Withdrawal by Subject|0|||
143082084|NCT03682107|515838473|FG001|Overall Study|Withdrawal by Subject|1|||
143082085|NCT03682107|515838474|FG002|Overall Study|Withdrawal by Subject|0|||
143082086|NCT03682107|515838475|FG003|Overall Study|Withdrawal by Subject|0|||
143082087|NCT03682107|515838476|FG004|Overall Study|Withdrawal by Subject|0|||
143082088|NCT01098487|515838479|FG000|Overall Study|Adverse Event|22|||
143082089|NCT01098487|515838479|FG000|Overall Study|Lack of Efficacy|11|||
143082090|NCT01098487|515838479|FG000|Overall Study|Withdrawal by Subject|7|||
143082091|NCT01098487|515838479|FG000|Overall Study|Lost to Follow-up|3|||
143082092|NCT01098487|515838479|FG000|Overall Study|Physician Decision|1|||
143082093|NCT00345631|515838480|FG000|Overall Study|Withdrawal by Subject|1|||
143082094|NCT00345631|515838481|FG001|Overall Study|Withdrawal by Subject|0|||
143173549|NCT01770743|516185241|FG001|Overall Study|Moving Out of State|1|||
143173550|NCT01770743|516185242|FG002|Overall Study|Moving Out of State|0|||
143173551|NCT01770743|516185243|FG003|Overall Study|Moving Out of State|0|||
143173552|NCT01770743|516185244|FG004|Overall Study|Moving Out of State|0|||
143366288|NCT01167426|516884615|FG000|Overall Study|Lost to Follow-up|6|||
143366289|NCT01167426|516884615|FG000|Overall Study|Protocol Violation|1|||
143366290|NCT01167426|516884615|FG000|Overall Study|Withdrawal by Subject|2|||
143366291|NCT01167426|516884615|FG000|Overall Study|Sponsor Decision|1|||
143366292|NCT04176458|516884617|FG000|Overall Study|Covid 19|4|||
143366293|NCT00003656|516884618|FG000|Overall Study|Adverse Event|0|||
143366294|NCT00003656|516884619|FG001|Overall Study|Adverse Event|1|||
143366295|NCT00763282|516884620|FG000|Overall Study|Withdrawal by Subject|6|||
143366296|NCT00763282|516884621|FG001|Overall Study|Withdrawal by Subject|5|||
143366297|NCT00763282|516884620|FG000|Overall Study|Death|4|||
143366298|NCT00763282|516884621|FG001|Overall Study|Death|3|||
143366299|NCT00763282|516884620|FG000|Overall Study|Lost to Follow-up|22|||
143366300|NCT00763282|516884621|FG001|Overall Study|Lost to Follow-up|26|||
143366301|NCT00335556|516884624|FG000|Overall Study|Death|0|||
143366302|NCT00335556|516884625|FG001|Overall Study|Death|5|||
143366303|NCT00335556|516884626|FG002|Overall Study|Death|0|||
143366304|NCT00335556|516884627|FG003|Overall Study|Death|0|||
143366305|NCT00335556|516884628|FG004|Overall Study|Death|1|||
143366306|NCT00335556|516884629|FG005|Overall Study|Death|0|||
143366307|NCT00335556|516884624|FG000|Overall Study|Lack of Efficacy|0|||
143366308|NCT00335556|516884625|FG001|Overall Study|Lack of Efficacy|19|||
143366309|NCT00335556|516884626|FG002|Overall Study|Lack of Efficacy|3|||
143366310|NCT00335556|516884627|FG003|Overall Study|Lack of Efficacy|3|||
143366311|NCT00335556|516884628|FG004|Overall Study|Lack of Efficacy|0|||
143082095|NCT00345631|515838482|FG002|Overall Study|Withdrawal by Subject|1|||
143082096|NCT00345631|515838480|FG000|Overall Study|Adverse Event|0|||
143082097|NCT00345631|515838481|FG001|Overall Study|Adverse Event|1|||
143082098|NCT00345631|515838482|FG002|Overall Study|Adverse Event|0|||
143082099|NCT00345631|515838480|FG000|Overall Study|Lost to Follow-up|3|||
143082100|NCT00345631|515838481|FG001|Overall Study|Lost to Follow-up|7|||
143082101|NCT00345631|515838482|FG002|Overall Study|Lost to Follow-up|4|||
143366312|NCT00335556|516884629|FG005|Overall Study|Lack of Efficacy|1|||
143366313|NCT00335556|516884624|FG000|Overall Study|Physician Decision|0|||
143366314|NCT00335556|516884625|FG001|Overall Study|Physician Decision|6|||
143366315|NCT00335556|516884626|FG002|Overall Study|Physician Decision|2|||
143366316|NCT00335556|516884627|FG003|Overall Study|Physician Decision|1|||
143366317|NCT00335556|516884628|FG004|Overall Study|Physician Decision|0|||
143082102|NCT00345631|515838480|FG000|Overall Study|Other reasons|0|||
143082103|NCT00345631|515838481|FG001|Overall Study|Other reasons|0|||
143366318|NCT00335556|516884629|FG005|Overall Study|Physician Decision|0|||
143366319|NCT00335556|516884624|FG000|Overall Study|Ineligible|2|||
143366320|NCT00335556|516884625|FG001|Overall Study|Ineligible|0|||
143366321|NCT00335556|516884626|FG002|Overall Study|Ineligible|0|||
143366322|NCT00335556|516884627|FG003|Overall Study|Ineligible|0|||
143366323|NCT00335556|516884628|FG004|Overall Study|Ineligible|0|||
143366324|NCT00335556|516884629|FG005|Overall Study|Ineligible|0|||
143366325|NCT00335556|516884624|FG000|Overall Study|Refusal of further protocol therapy|0|||
143366326|NCT00335556|516884625|FG001|Overall Study|Refusal of further protocol therapy|4|||
143366327|NCT00335556|516884626|FG002|Overall Study|Refusal of further protocol therapy|0|||
143366328|NCT00335556|516884627|FG003|Overall Study|Refusal of further protocol therapy|1|||
143366329|NCT00335556|516884628|FG004|Overall Study|Refusal of further protocol therapy|0|||
143366330|NCT00335556|516884629|FG005|Overall Study|Refusal of further protocol therapy|0|||
143366331|NCT02365298|516884630|FG000|Period 2|incorrect Rx dispensed|1|||
143366332|NCT02365298|516884631|FG001|Period 2|incorrect Rx dispensed|0|||
143366333|NCT02365298|516884630|FG000|Period 2|Discontinued at request of Sponsor|1|||
143366334|NCT02365298|516884631|FG001|Period 2|Discontinued at request of Sponsor|0|||
143366335|NCT02365298|516884630|FG000|Period 2|Test Article longer available|0|||
143366336|NCT02365298|516884631|FG001|Period 2|Test Article longer available|1|||
143366337|NCT02365298|516884630|FG000|Period 2|Protocol Violation|0|||
143366338|NCT02365298|516884631|FG001|Period 2|Protocol Violation|1|||
143366339|NCT03601507|516884643|FG000|Overall Study|Adverse Event|1|||
143366340|NCT00121199|516884646|FG000|Overall Study|Adverse Event|11|||
143366341|NCT00121199|516884646|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
143366342|NCT00121199|516884646|FG000|Overall Study|Progression/Relapse|1|||
143366343|NCT00121199|516884646|FG000|Overall Study|Death|3|||
143366344|NCT00121199|516884646|FG000|Overall Study|Other - Not Protocol Specified|3|||
143366345|NCT00121199|516884646|FG000|Overall Study|Ineligible|9|||
143366346|NCT03168438|516884647|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
143366347|NCT03168438|516884648|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
143366348|NCT01649427|516884651|FG000|Overall Study|Adverse Event|1|||
143366349|NCT01649427|516884652|FG001|Overall Study|Adverse Event|1|||
143366350|NCT01649427|516884651|FG000|Overall Study|Withdrawal by Subject|8|||
143366351|NCT01649427|516884652|FG001|Overall Study|Withdrawal by Subject|7|||
143366352|NCT01649427|516884651|FG000|Overall Study|Lost to Follow-up|0|||
143366353|NCT01649427|516884652|FG001|Overall Study|Lost to Follow-up|1|||
143366354|NCT01649427|516884651|FG000|Overall Study|Graft loss|0|||
143366355|NCT01649427|516884652|FG001|Overall Study|Graft loss|1|||
143366356|NCT01649427|516884651|FG000|Overall Study|Surgical problems during nephrectomy|2|||
143366357|NCT01649427|516884652|FG001|Overall Study|Surgical problems during nephrectomy|2|||
143366358|NCT04927975|516884655|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
143366359|NCT04927975|516884656|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
143366360|NCT04927975|516884657|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
143366361|NCT04927975|516884658|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
143366362|NCT04927975|516884659|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
143366363|NCT04927975|516884660|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
143366364|NCT04927975|516884655|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
143366365|NCT04927975|516884656|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
143366366|NCT04927975|516884657|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
143366367|NCT04927975|516884658|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
143366368|NCT04927975|516884659|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
143366369|NCT04927975|516884660|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
143366370|NCT04927975|516884655|FG000|Period 1 (Baseline-Week 24)|Death|0|||
143366371|NCT04927975|516884656|FG001|Period 1 (Baseline-Week 24)|Death|0|||
143366372|NCT04927975|516884657|FG002|Period 1 (Baseline-Week 24)|Death|0|||
143366373|NCT04927975|516884658|FG003|Period 1 (Baseline-Week 24)|Death|0|||
143366374|NCT04927975|516884659|FG004|Period 1 (Baseline-Week 24)|Death|0|||
143173553|NCT01732536|516185245|FG000|Overall Study|Withdrawal by Subject|1|||
143173554|NCT01732536|516185246|FG001|Overall Study|Withdrawal by Subject|1|||
143173555|NCT00503984|516185247|FG000|Overall Study|Protocol Violation|0|||
143173556|NCT00503984|516185248|FG001|Overall Study|Protocol Violation|1|||
143173557|NCT00503984|516185249|FG002|Overall Study|Protocol Violation|0|||
143173558|NCT00503984|516185250|FG003|Overall Study|Protocol Violation|0|||
143173559|NCT00503984|516185251|FG004|Overall Study|Protocol Violation|0|||
143173560|NCT00503984|516185252|FG005|Overall Study|Protocol Violation|0|||
143366375|NCT04927975|516884660|FG005|Period 1 (Baseline-Week 24)|Death|1|||
143366376|NCT04927975|516884655|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
143366377|NCT04927975|516884656|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
143366378|NCT04927975|516884657|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
143366379|NCT04927975|516884658|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
143366380|NCT04927975|516884659|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
143366381|NCT04927975|516884660|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
143366382|NCT04927975|516884655|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
143366383|NCT04927975|516884656|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
143366384|NCT04927975|516884657|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
143173561|NCT00503984|516185247|FG000|Overall Study|Adverse Event|0|||
143366385|NCT04927975|516884658|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
143366386|NCT04927975|516884659|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
143366387|NCT04927975|516884660|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
143366388|NCT03717194|516884661|FG000|Overall Study|Withdrawal by Subject|2|||
143366389|NCT03717194|516884662|FG001|Overall Study|Withdrawal by Subject|4|||
143366390|NCT03717194|516884661|FG000|Overall Study|Adverse Event|1|||
143366391|NCT03717194|516884662|FG001|Overall Study|Adverse Event|1|||
143366392|NCT00561574|516884663|FG000|Overall Study|Adverse Event|21|||
143366393|NCT00561574|516884664|FG001|Overall Study|Adverse Event|24|||
143366394|NCT00561574|516884663|FG000|Overall Study|Lack of Efficacy|11|||
143366395|NCT00561574|516884664|FG001|Overall Study|Lack of Efficacy|21|||
143366396|NCT00561574|516884663|FG000|Overall Study|Withdrawal by Subject|4|||
143366397|NCT00561574|516884664|FG001|Overall Study|Withdrawal by Subject|4|||
143366398|NCT00561574|516884663|FG000|Overall Study|Reason Unrelated to Trial|6|||
143366399|NCT00561574|516884664|FG001|Overall Study|Reason Unrelated to Trial|2|||
143366400|NCT00561574|516884663|FG000|Overall Study|Lost to Follow-up|1|||
143366401|NCT00561574|516884664|FG001|Overall Study|Lost to Follow-up|0|||
143366402|NCT00561574|516884663|FG000|Overall Study|Other|5|||
143366403|NCT00561574|516884664|FG001|Overall Study|Other|7|||
143366404|NCT00445692|516884665|FG000|Overall Study|Adverse Event|11|||
143366405|NCT00445692|516884665|FG000|Overall Study|Lack of Efficacy|5|||
143366406|NCT00430677|516884672|FG000|Short-term Period|Death|1|||
143366407|NCT00430677|516884673|FG001|Short-term Period|Death|1|||
143366408|NCT00430677|516884674|FG002|Short-term Period|Death|5|||
143366409|NCT00430677|516884672|FG000|Short-term Period|Adverse Event|15|||
143366410|NCT00430677|516884673|FG001|Short-term Period|Adverse Event|13|||
143366411|NCT00430677|516884674|FG002|Short-term Period|Adverse Event|9|||
143366412|NCT00430677|516884672|FG000|Short-term Period|Lack of Efficacy|5|||
143366413|NCT00430677|516884673|FG001|Short-term Period|Lack of Efficacy|6|||
143366414|NCT00430677|516884674|FG002|Short-term Period|Lack of Efficacy|4|||
143366415|NCT00430677|516884672|FG000|Short-term Period|Withdrawal by Subject|1|||
143366416|NCT00430677|516884673|FG001|Short-term Period|Withdrawal by Subject|1|||
143366417|NCT00430677|516884674|FG002|Short-term Period|Withdrawal by Subject|2|||
143366418|NCT00430677|516884672|FG000|Short-term Period|Participant no longer met study criteria|1|||
143366419|NCT00430677|516884673|FG001|Short-term Period|Participant no longer met study criteria|1|||
143366420|NCT00430677|516884674|FG002|Short-term Period|Participant no longer met study criteria|2|||
143366421|NCT00430677|516884672|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
143366422|NCT00430677|516884673|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
143366423|NCT00430677|516884674|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
143366424|NCT00430677|516884672|FG000|Short-term Period|Pregnancy|0|||
143366425|NCT00430677|516884673|FG001|Short-term Period|Pregnancy|2|||
143366426|NCT00430677|516884674|FG002|Short-term Period|Pregnancy|0|||
143366427|NCT00430677|516884672|FG000|Long-term Extension Period|Death|1|||
143366428|NCT00430677|516884673|FG001|Long-term Extension Period|Death|0|||
143366429|NCT00430677|516884674|FG002|Long-term Extension Period|Death|0|||
143366430|NCT00430677|516884672|FG000|Long-term Extension Period|Adverse Event|3|||
143366431|NCT00430677|516884673|FG001|Long-term Extension Period|Adverse Event|2|||
143366432|NCT00430677|516884674|FG002|Long-term Extension Period|Adverse Event|5|||
143366433|NCT00430677|516884672|FG000|Long-term Extension Period|Lack of Efficacy|5|||
143366434|NCT00430677|516884673|FG001|Long-term Extension Period|Lack of Efficacy|3|||
143366435|NCT00430677|516884674|FG002|Long-term Extension Period|Lack of Efficacy|8|||
143366436|NCT00430677|516884672|FG000|Long-term Extension Period|Lost to Follow-up|1|||
143366437|NCT00430677|516884673|FG001|Long-term Extension Period|Lost to Follow-up|1|||
143366438|NCT00430677|516884674|FG002|Long-term Extension Period|Lost to Follow-up|1|||
143366439|NCT00430677|516884672|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
143366440|NCT00430677|516884673|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
143366441|NCT00430677|516884674|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
143366442|NCT00430677|516884672|FG000|Long-term Extension Period|Pregnancy|1|||
143173562|NCT00503984|516185248|FG001|Overall Study|Adverse Event|1|||
143173563|NCT00503984|516185249|FG002|Overall Study|Adverse Event|0|||
143173564|NCT00503984|516185250|FG003|Overall Study|Adverse Event|0|||
143173565|NCT00503984|516185251|FG004|Overall Study|Adverse Event|0|||
143173566|NCT00503984|516185252|FG005|Overall Study|Adverse Event|0|||
143366443|NCT00430677|516884673|FG001|Long-term Extension Period|Pregnancy|1|||
143173567|NCT00503984|516185247|FG000|Overall Study|Death|0|||
143173568|NCT00503984|516185248|FG001|Overall Study|Death|0|||
143366444|NCT00430677|516884674|FG002|Long-term Extension Period|Pregnancy|0|||
143366445|NCT00430677|516884672|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
143173569|NCT00503984|516185249|FG002|Overall Study|Death|0|||
143173570|NCT00503984|516185250|FG003|Overall Study|Death|0|||
143173571|NCT00503984|516185251|FG004|Overall Study|Death|1|||
143366446|NCT00430677|516884673|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
143366447|NCT00430677|516884674|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
143366448|NCT00430677|516884672|FG000|Long-term Extension Period|Other|2|||
143366449|NCT00430677|516884673|FG001|Long-term Extension Period|Other|1|||
143366450|NCT00430677|516884674|FG002|Long-term Extension Period|Other|1|||
143082104|NCT00345631|515838482|FG002|Overall Study|Other reasons|1|||
143082105|NCT03371459|515838490|FG000|Washout|Lost to Follow-up|0|||
143082106|NCT03371459|515838491|FG001|Washout|Lost to Follow-up|1|||
143082107|NCT01589497|515838492|FG000|Overall Study|Withdrawal by Subject|0|||
143082108|NCT01589497|515838493|FG001|Overall Study|Withdrawal by Subject|1|||
143082109|NCT01589497|515838494|FG002|Overall Study|Withdrawal by Subject|0|||
143082110|NCT01589497|515838495|FG003|Overall Study|Withdrawal by Subject|1|||
143082111|NCT01589497|515838492|FG000|Overall Study|Death|1|||
143082112|NCT01589497|515838493|FG001|Overall Study|Death|0|||
143082113|NCT01589497|515838494|FG002|Overall Study|Death|0|||
143082114|NCT01589497|515838495|FG003|Overall Study|Death|0|||
143082115|NCT01589497|515838492|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
143082116|NCT01589497|515838493|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
143082117|NCT01589497|515838494|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
143082118|NCT01589497|515838495|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
143082119|NCT02516553|515838500|FG000|Overall Study|Progressive disease|2|||
143082120|NCT02516553|515838501|FG001|Overall Study|Progressive disease|2|||
143082121|NCT02516553|515838502|FG002|Overall Study|Progressive disease|3|||
143082122|NCT02516553|515838503|FG003|Overall Study|Progressive disease|5|||
143082123|NCT02516553|515838504|FG004|Overall Study|Progressive disease|3|||
143082124|NCT02516553|515838505|FG005|Overall Study|Progressive disease|0|||
143082125|NCT02516553|515838506|FG006|Overall Study|Progressive disease|5|||
143082126|NCT02516553|515838507|FG007|Overall Study|Progressive disease|5|||
143082127|NCT02516553|515838508|FG008|Overall Study|Progressive disease|11|||
143082128|NCT02516553|515838509|FG009|Overall Study|Progressive disease|3|||
143082129|NCT02516553|515838510|FG010|Overall Study|Progressive disease|10|||
143082130|NCT02516553|515838511|FG011|Overall Study|Progressive disease|8|||
143082131|NCT02516553|515838512|FG012|Overall Study|Progressive disease|8|||
143082132|NCT02516553|515838513|FG013|Overall Study|Progressive disease|2|||
143082133|NCT02516553|515838514|FG014|Overall Study|Progressive disease|2|||
143082134|NCT02516553|515838515|FG015|Overall Study|Progressive disease|2|||
143082135|NCT02516553|515838516|FG016|Overall Study|Progressive disease|1|||
143082136|NCT02516553|515838517|FG017|Overall Study|Progressive disease|9|||
143082137|NCT02516553|515838518|FG018|Overall Study|Progressive disease|12|||
143082138|NCT02516553|515838519|FG019|Overall Study|Progressive disease|7|||
143082139|NCT02516553|515838520|FG020|Overall Study|Progressive disease|16|||
143082140|NCT02516553|515838521|FG021|Overall Study|Progressive disease|18|||
143082141|NCT02516553|515838500|FG000|Overall Study|Dose limiting toxicity|0|||
143082142|NCT02516553|515838501|FG001|Overall Study|Dose limiting toxicity|0|||
143082143|NCT02516553|515838502|FG002|Overall Study|Dose limiting toxicity|0|||
143082144|NCT02516553|515838503|FG003|Overall Study|Dose limiting toxicity|0|||
143082145|NCT02516553|515838504|FG004|Overall Study|Dose limiting toxicity|3|||
143082146|NCT02516553|515838505|FG005|Overall Study|Dose limiting toxicity|1|||
143249045|NCT03110770|516465089|FG002|Overall Study|Moved from area|2|||
143249046|NCT03110770|516465090|FG003|Overall Study|Moved from area|42|||
143249047|NCT03110770|516465091|FG004|Overall Study|Moved from area|43|||
143249048|NCT03110770|516465087|FG000|Overall Study|Illness/Injury unrelated to product|0|||
143249049|NCT03110770|516465088|FG001|Overall Study|Illness/Injury unrelated to product|0|||
143249050|NCT03110770|516465089|FG002|Overall Study|Illness/Injury unrelated to product|0|||
143249051|NCT03110770|516465090|FG003|Overall Study|Illness/Injury unrelated to product|0|||
143249052|NCT03110770|516465091|FG004|Overall Study|Illness/Injury unrelated to product|1|||
143249053|NCT02888119|516465096|FG000|Overall Study|Lost to Follow-up|5|||
143249054|NCT02888119|516465097|FG001|Overall Study|Lost to Follow-up|4|||
143249055|NCT02888119|516465098|FG002|Overall Study|Lost to Follow-up|0|||
143249056|NCT01767142|516465099|FG000|Overall Study|Lost to Follow-up|3|||
143249057|NCT00926029|516465106|FG000|Overall Study|Lost to Follow-up|2|||
143249058|NCT00926029|516465107|FG001|Overall Study|Lost to Follow-up|1|||
143249059|NCT00926029|516465108|FG002|Overall Study|Lost to Follow-up|1|||
143249060|NCT02471612|516465109|FG000|Overall Study|Lost to Follow-up|2|||
143249061|NCT03206788|516465110|FG000|Overall Study|Withdrawal by Subject|0|||
143249062|NCT03206788|516465111|FG001|Overall Study|Withdrawal by Subject|1|||
143249063|NCT03206788|516465110|FG000|Overall Study|Adverse Event|0|||
143249064|NCT03206788|516465111|FG001|Overall Study|Adverse Event|1|||
143082147|NCT02516553|515838506|FG006|Overall Study|Dose limiting toxicity|1|||
143082148|NCT02516553|515838507|FG007|Overall Study|Dose limiting toxicity|0|||
143082149|NCT02516553|515838508|FG008|Overall Study|Dose limiting toxicity|1|||
143082150|NCT02516553|515838509|FG009|Overall Study|Dose limiting toxicity|0|||
143082151|NCT02516553|515838510|FG010|Overall Study|Dose limiting toxicity|0|||
143082152|NCT02516553|515838511|FG011|Overall Study|Dose limiting toxicity|1|||
143082153|NCT02516553|515838512|FG012|Overall Study|Dose limiting toxicity|0|||
143082154|NCT02516553|515838513|FG013|Overall Study|Dose limiting toxicity|1|||
143082155|NCT02516553|515838514|FG014|Overall Study|Dose limiting toxicity|0|||
143249065|NCT03206788|516465110|FG000|Overall Study|Physician Decision|0|||
143249066|NCT03206788|516465111|FG001|Overall Study|Physician Decision|1|||
143249067|NCT02082340|516465112|FG000|Overall Study|Lost to Follow-up|1|||
143249068|NCT02082340|516465113|FG001|Overall Study|Lost to Follow-up|1|||
143249069|NCT05573386|516465114|FG000|Overall Study|Withdrawal by Subject|3|||
143082156|NCT02516553|515838515|FG015|Overall Study|Dose limiting toxicity|0|||
143082157|NCT02516553|515838516|FG016|Overall Study|Dose limiting toxicity|1|||
143082158|NCT02516553|515838517|FG017|Overall Study|Dose limiting toxicity|1|||
143082159|NCT02516553|515838518|FG018|Overall Study|Dose limiting toxicity|0|||
143082160|NCT02516553|515838519|FG019|Overall Study|Dose limiting toxicity|2|||
143082161|NCT02516553|515838520|FG020|Overall Study|Dose limiting toxicity|0|||
143082162|NCT02516553|515838521|FG021|Overall Study|Dose limiting toxicity|0|||
143082163|NCT02516553|515838500|FG000|Overall Study|Other Adverse Events|0|||
143082164|NCT02516553|515838501|FG001|Overall Study|Other Adverse Events|0|||
143082165|NCT02516553|515838502|FG002|Overall Study|Other Adverse Events|0|||
143082166|NCT02516553|515838503|FG003|Overall Study|Other Adverse Events|1|||
143082167|NCT02516553|515838504|FG004|Overall Study|Other Adverse Events|0|||
143082168|NCT02516553|515838505|FG005|Overall Study|Other Adverse Events|1|||
143082169|NCT02516553|515838506|FG006|Overall Study|Other Adverse Events|0|||
143082170|NCT02516553|515838507|FG007|Overall Study|Other Adverse Events|0|||
143082171|NCT02516553|515838508|FG008|Overall Study|Other Adverse Events|0|||
143082172|NCT02516553|515838509|FG009|Overall Study|Other Adverse Events|1|||
143082173|NCT02516553|515838510|FG010|Overall Study|Other Adverse Events|3|||
143082174|NCT02516553|515838511|FG011|Overall Study|Other Adverse Events|2|||
143082175|NCT02516553|515838512|FG012|Overall Study|Other Adverse Events|0|||
143082176|NCT02516553|515838513|FG013|Overall Study|Other Adverse Events|1|||
143082177|NCT02516553|515838514|FG014|Overall Study|Other Adverse Events|0|||
143082178|NCT02516553|515838515|FG015|Overall Study|Other Adverse Events|0|||
143082179|NCT02516553|515838516|FG016|Overall Study|Other Adverse Events|0|||
143082180|NCT02516553|515838517|FG017|Overall Study|Other Adverse Events|2|||
143082181|NCT02516553|515838518|FG018|Overall Study|Other Adverse Events|1|||
143082182|NCT02516553|515838519|FG019|Overall Study|Other Adverse Events|2|||
143082183|NCT02516553|515838520|FG020|Overall Study|Other Adverse Events|2|||
143082184|NCT02516553|515838521|FG021|Overall Study|Other Adverse Events|1|||
143082185|NCT02516553|515838500|FG000|Overall Study|Refused to continue trial medication|0|||
143082186|NCT02516553|515838501|FG001|Overall Study|Refused to continue trial medication|0|||
143082187|NCT02516553|515838502|FG002|Overall Study|Refused to continue trial medication|0|||
143082188|NCT02516553|515838503|FG003|Overall Study|Refused to continue trial medication|0|||
143082189|NCT02516553|515838504|FG004|Overall Study|Refused to continue trial medication|0|||
143082190|NCT02516553|515838505|FG005|Overall Study|Refused to continue trial medication|0|||
143082191|NCT02516553|515838506|FG006|Overall Study|Refused to continue trial medication|0|||
143082192|NCT02516553|515838507|FG007|Overall Study|Refused to continue trial medication|0|||
143082193|NCT02516553|515838508|FG008|Overall Study|Refused to continue trial medication|0|||
143082194|NCT02516553|515838509|FG009|Overall Study|Refused to continue trial medication|0|||
143082195|NCT02516553|515838510|FG010|Overall Study|Refused to continue trial medication|1|||
143082196|NCT02516553|515838511|FG011|Overall Study|Refused to continue trial medication|0|||
143082197|NCT02516553|515838512|FG012|Overall Study|Refused to continue trial medication|0|||
143082198|NCT02516553|515838513|FG013|Overall Study|Refused to continue trial medication|0|||
143082199|NCT02516553|515838514|FG014|Overall Study|Refused to continue trial medication|0|||
143082200|NCT02516553|515838515|FG015|Overall Study|Refused to continue trial medication|0|||
143082201|NCT02516553|515838516|FG016|Overall Study|Refused to continue trial medication|0|||
143082202|NCT02516553|515838517|FG017|Overall Study|Refused to continue trial medication|0|||
143082203|NCT02516553|515838518|FG018|Overall Study|Refused to continue trial medication|1|||
143082204|NCT02516553|515838519|FG019|Overall Study|Refused to continue trial medication|0|||
143082205|NCT02516553|515838520|FG020|Overall Study|Refused to continue trial medication|0|||
143082206|NCT02516553|515838521|FG021|Overall Study|Refused to continue trial medication|1|||
143082207|NCT02516553|515838500|FG000|Overall Study|other reasons than listed|0|||
143082208|NCT02516553|515838501|FG001|Overall Study|other reasons than listed|0|||
143082209|NCT02516553|515838502|FG002|Overall Study|other reasons than listed|0|||
143082210|NCT02516553|515838503|FG003|Overall Study|other reasons than listed|0|||
143082211|NCT02516553|515838504|FG004|Overall Study|other reasons than listed|0|||
143173572|NCT00503984|516185252|FG005|Overall Study|Death|0|||
143173573|NCT02122380|516185256|FG000|First Intervention (30 Days)|Adverse Event|1|||
143366451|NCT00430677|516884672|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
143366452|NCT00430677|516884673|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
143366453|NCT00430677|516884674|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
143173574|NCT02122380|516185257|FG001|First Intervention (30 Days)|Adverse Event|0|||
143173575|NCT02122380|516185256|FG000|First Intervention (30 Days)|Physician Decision|0|||
143173576|NCT02122380|516185257|FG001|First Intervention (30 Days)|Physician Decision|1|||
143173577|NCT02122380|516185256|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
143173578|NCT02122380|516185257|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
143173579|NCT02122380|516185256|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
143173580|NCT02122380|516185257|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
143173581|NCT02122380|516185256|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
143173582|NCT02122380|516185257|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
143173583|NCT05111145|516185258|FG000|Overall Study|Commercial drug is available for participant|76|||
143173584|NCT05111145|516185258|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
143173585|NCT02336815|516185259|FG000|Overall Study|Disease Progression|45|||
143173586|NCT02336815|516185260|FG001|Overall Study|Disease Progression|70|||
143173587|NCT02336815|516185259|FG000|Overall Study|Adverse Event|18|||
143173588|NCT02336815|516185260|FG001|Overall Study|Adverse Event|39|||
143173589|NCT02336815|516185259|FG000|Overall Study|Physician Decision|11|||
143173590|NCT02336815|516185260|FG001|Overall Study|Physician Decision|4|||
143173591|NCT02336815|516185259|FG000|Overall Study|Withdrawal by Subject|3|||
143173592|NCT02336815|516185260|FG001|Overall Study|Withdrawal by Subject|2|||
143173593|NCT02336815|516185259|FG000|Overall Study|Lost to Follow-up|1|||
143173594|NCT02336815|516185260|FG001|Overall Study|Lost to Follow-up|3|||
143173595|NCT02336815|516185259|FG000|Overall Study|Other|1|||
143173596|NCT02336815|516185260|FG001|Overall Study|Other|5|||
143173597|NCT00952705|516185261|FG000|Overall Study|Lost to Follow-up|24|||
143173598|NCT00952705|516185262|FG001|Overall Study|Lost to Follow-up|8|||
143173599|NCT00952705|516185263|FG002|Overall Study|Lost to Follow-up|9|||
143173600|NCT00952705|516185261|FG000|Overall Study|Withdrawal by Subject|2|||
143173601|NCT00952705|516185262|FG001|Overall Study|Withdrawal by Subject|1|||
143173602|NCT00952705|516185263|FG002|Overall Study|Withdrawal by Subject|1|||
143173603|NCT00952705|516185261|FG000|Overall Study|Death|2|||
143173604|NCT00952705|516185262|FG001|Overall Study|Death|0|||
143173605|NCT00952705|516185263|FG002|Overall Study|Death|0|||
143173606|NCT00952705|516185261|FG000|Overall Study|Incarcerated post dose|5|||
143173607|NCT00952705|516185262|FG001|Overall Study|Incarcerated post dose|0|||
143173608|NCT00952705|516185263|FG002|Overall Study|Incarcerated post dose|0|||
143173609|NCT00952705|516185261|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
143173610|NCT00952705|516185262|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
143173611|NCT00952705|516185263|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
143173612|NCT00140140|516185264|FG000|Overall Study|Unacceptable toxicity|1|||
143173613|NCT00140140|516185265|FG001|Overall Study|Unacceptable toxicity|1|||
143173614|NCT00140140|516185266|FG002|Overall Study|Unacceptable toxicity|2|||
143173615|NCT00140140|516185264|FG000|Overall Study|Physician Decision|1|||
143173616|NCT00140140|516185265|FG001|Overall Study|Physician Decision|1|||
143173617|NCT00140140|516185266|FG002|Overall Study|Physician Decision|0|||
143173618|NCT03376516|516185267|FG000|Overall Study|Not treated|1|||
143173619|NCT03376516|516185267|FG000|Overall Study|Consent withdrawn|1|||
143173620|NCT01581684|516185268|FG000|Overall Study|Other reason not defined|0|||
143173621|NCT01581684|516185269|FG001|Overall Study|Other reason not defined|0|||
143173622|NCT01581684|516185270|FG002|Overall Study|Other reason not defined|0|||
143173623|NCT01581684|516185271|FG003|Overall Study|Other reason not defined|0|||
143173624|NCT01581684|516185272|FG004|Overall Study|Other reason not defined|0|||
143173625|NCT01581684|516185273|FG005|Overall Study|Other reason not defined|0|||
143173626|NCT01581684|516185274|FG006|Overall Study|Other reason not defined|0|||
143173627|NCT01581684|516185275|FG007|Overall Study|Other reason not defined|0|||
143173628|NCT01581684|516185276|FG008|Overall Study|Other reason not defined|1|||
143173629|NCT01581684|516185277|FG009|Overall Study|Other reason not defined|0|||
143249070|NCT05573386|516465115|FG001|Overall Study|Withdrawal by Subject|2|||
143249071|NCT05246514|516465116|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
143249072|NCT05246514|516465116|FG000|Overall Study|Withdrawal by Subject|1|||
143249073|NCT05246514|516465116|FG000|Overall Study|Death|13|||
143249074|NCT03646123|516465117|FG000|Overall Study|Withdrawal by Subject|2|||
143173630|NCT03728933|516185278|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
143249075|NCT03646123|516465118|FG001|Overall Study|Withdrawal by Subject|2|||
143173631|NCT03728933|516185279|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
143173632|NCT03728933|516185280|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
143173633|NCT03728933|516185278|FG000|Overall Study|Withdrawal by Subject|0|||
143173634|NCT03728933|516185279|FG001|Overall Study|Withdrawal by Subject|0|||
143249076|NCT03646123|516465119|FG002|Overall Study|Withdrawal by Subject|3|||
143173635|NCT03728933|516185280|FG002|Overall Study|Withdrawal by Subject|1|||
143173636|NCT03728933|516185278|FG000|Overall Study|Lost to Follow-up|0|||
143173637|NCT03728933|516185279|FG001|Overall Study|Lost to Follow-up|1|||
143173638|NCT03728933|516185280|FG002|Overall Study|Lost to Follow-up|0|||
143173639|NCT03728933|516185278|FG000|Overall Study|Adverse Event|1|||
143173640|NCT03728933|516185279|FG001|Overall Study|Adverse Event|0|||
143173641|NCT03728933|516185280|FG002|Overall Study|Adverse Event|0|||
143082212|NCT02516553|515838505|FG005|Overall Study|other reasons than listed|0|||
143082213|NCT02516553|515838506|FG006|Overall Study|other reasons than listed|0|||
143082214|NCT02516553|515838507|FG007|Overall Study|other reasons than listed|1|||
143082215|NCT02516553|515838508|FG008|Overall Study|other reasons than listed|1|||
143082216|NCT02516553|515838509|FG009|Overall Study|other reasons than listed|0|||
143082217|NCT02516553|515838510|FG010|Overall Study|other reasons than listed|1|||
143249077|NCT03646123|516465117|FG000|Overall Study|Study termination by sponsor|0|||
143249078|NCT03646123|516465118|FG001|Overall Study|Study termination by sponsor|45|||
143082218|NCT02516553|515838511|FG011|Overall Study|other reasons than listed|1|||
143082219|NCT02516553|515838512|FG012|Overall Study|other reasons than listed|0|||
143082220|NCT02516553|515838513|FG013|Overall Study|other reasons than listed|0|||
143082221|NCT02516553|515838514|FG014|Overall Study|other reasons than listed|0|||
143082222|NCT02516553|515838515|FG015|Overall Study|other reasons than listed|0|||
143082223|NCT02516553|515838516|FG016|Overall Study|other reasons than listed|0|||
143082224|NCT02516553|515838517|FG017|Overall Study|other reasons than listed|0|||
143082225|NCT02516553|515838518|FG018|Overall Study|other reasons than listed|0|||
143082226|NCT02516553|515838519|FG019|Overall Study|other reasons than listed|0|||
143082227|NCT02516553|515838520|FG020|Overall Study|other reasons than listed|2|||
143082228|NCT02516553|515838521|FG021|Overall Study|other reasons than listed|2|||
143082229|NCT03316547|515838523|FG000|Overall Study|Death|3|||
143082230|NCT03316547|515838524|FG001|Overall Study|Death|1|||
143173642|NCT03235050|516185281|FG000|Overall Study|Adverse Event|0|||
143173643|NCT03235050|516185282|FG001|Overall Study|Adverse Event|0|||
143173644|NCT03235050|516185283|FG002|Overall Study|Adverse Event|1|||
143173645|NCT03235050|516185284|FG003|Overall Study|Adverse Event|4|||
143173646|NCT03235050|516185285|FG004|Overall Study|Adverse Event|1|||
143173647|NCT03235050|516185281|FG000|Overall Study|Death|0|||
143173648|NCT03235050|516185282|FG001|Overall Study|Death|0|||
143173649|NCT03235050|516185283|FG002|Overall Study|Death|0|||
143173650|NCT03235050|516185284|FG003|Overall Study|Death|2|||
143173651|NCT03235050|516185285|FG004|Overall Study|Death|1|||
143173652|NCT03235050|516185281|FG000|Overall Study|Lost to Follow-up|1|||
143173653|NCT03235050|516185282|FG001|Overall Study|Lost to Follow-up|2|||
143173654|NCT03235050|516185283|FG002|Overall Study|Lost to Follow-up|1|||
143173655|NCT03235050|516185284|FG003|Overall Study|Lost to Follow-up|2|||
143173656|NCT03235050|516185285|FG004|Overall Study|Lost to Follow-up|0|||
143173657|NCT03235050|516185281|FG000|Overall Study|Withdrawal by Subject|3|||
143173658|NCT03235050|516185282|FG001|Overall Study|Withdrawal by Subject|2|||
143173659|NCT03235050|516185283|FG002|Overall Study|Withdrawal by Subject|2|||
143173660|NCT03235050|516185284|FG003|Overall Study|Withdrawal by Subject|5|||
143173661|NCT03235050|516185285|FG004|Overall Study|Withdrawal by Subject|7|||
143173662|NCT03235050|516185281|FG000|Overall Study|Other reasons|0|||
143173663|NCT03235050|516185282|FG001|Overall Study|Other reasons|1|||
143173664|NCT03235050|516185283|FG002|Overall Study|Other reasons|0|||
143173665|NCT03235050|516185284|FG003|Overall Study|Other reasons|1|||
143173666|NCT03235050|516185285|FG004|Overall Study|Other reasons|2|||
143173667|NCT00492557|516185286|FG000|Overall Study|Subject request|12|||
143173668|NCT00492557|516185287|FG001|Overall Study|Subject request|11|||
143173669|NCT00492557|516185286|FG000|Overall Study|Protocol Violation|7|||
143173670|NCT00492557|516185287|FG001|Overall Study|Protocol Violation|8|||
143173671|NCT00492557|516185286|FG000|Overall Study|Other|2|||
143173672|NCT00492557|516185287|FG001|Overall Study|Other|2|||
143173673|NCT00492557|516185286|FG000|Overall Study|Death|1|||
143173674|NCT00492557|516185287|FG001|Overall Study|Death|1|||
143173675|NCT00492557|516185286|FG000|Overall Study|Adverse Event|1|||
143173676|NCT00492557|516185287|FG001|Overall Study|Adverse Event|0|||
143173677|NCT00492557|516185286|FG000|Overall Study|Failed to return|1|||
143173678|NCT00492557|516185287|FG001|Overall Study|Failed to return|0|||
143173679|NCT00492557|516185286|FG000|Overall Study|Lost to Follow-up|0|||
143173680|NCT00492557|516185287|FG001|Overall Study|Lost to Follow-up|1|||
143173681|NCT03423602|516185292|FG000|Overall Study|Death|1|||
143173682|NCT03423602|516185292|FG000|Overall Study|Lost to Follow-up|6|||
143173683|NCT03423602|516185292|FG000|Overall Study|Protocol Violation|1|||
143173684|NCT03423602|516185292|FG000|Overall Study|Withdrawal by Subject|4|||
143173685|NCT04778592|516185293|FG000|Overall Study|Adverse Event|1|||
143173686|NCT04778592|516185294|FG001|Overall Study|Adverse Event|2|||
143173687|NCT04778592|516185293|FG000|Overall Study|Withdrawal by Subject|1|||
143173688|NCT04778592|516185294|FG001|Overall Study|Withdrawal by Subject|2|||
143173689|NCT03423121|516185295|FG000|Overall Study|Lost to Follow-up|2|||
143082231|NCT03316547|515838523|FG000|Overall Study|Lost to Follow-up|6|||
143082232|NCT03316547|515838524|FG001|Overall Study|Lost to Follow-up|6|||
143082233|NCT03316547|515838523|FG000|Overall Study|Withdrawal by Subject|3|||
143082234|NCT03316547|515838524|FG001|Overall Study|Withdrawal by Subject|2|||
143082235|NCT03316547|515838523|FG000|Overall Study|Transfer to another hospital|6|||
143082236|NCT03316547|515838524|FG001|Overall Study|Transfer to another hospital|4|||
143082237|NCT01987479|515838525|FG000|Overall Study|Protocol Violation|1|||
143082238|NCT01987479|515838525|FG000|Overall Study|Physician Decision|2|||
143082239|NCT01987479|515838525|FG000|Overall Study|Participant/legal guardian decision|1|||
143082240|NCT01987479|515838525|FG000|Overall Study|Other|5|||
143082241|NCT01987479|515838525|FG000|Overall Study|Lost to Follow-up|1|||
143082242|NCT01987479|515838525|FG000|Overall Study|Adverse Event|7|||
143082243|NCT05314816|515838526|FG000|Overall Study|Lost to Follow-up|5|||
143082244|NCT05314816|515838527|FG001|Overall Study|Lost to Follow-up|0|||
143249079|NCT03646123|516465119|FG002|Overall Study|Study termination by sponsor|139|||
143249080|NCT03646123|516465117|FG000|Overall Study|Lost to Follow-up|4|||
143249081|NCT03646123|516465118|FG001|Overall Study|Lost to Follow-up|10|||
143249082|NCT03646123|516465119|FG002|Overall Study|Lost to Follow-up|10|||
143249083|NCT03646123|516465117|FG000|Overall Study|Death|2|||
143082245|NCT05314816|515838528|FG002|Overall Study|Lost to Follow-up|1|||
143082246|NCT05314816|515838526|FG000|Overall Study|Protocol Violation|13|||
143082247|NCT05314816|515838527|FG001|Overall Study|Protocol Violation|8|||
143249084|NCT03646123|516465118|FG001|Overall Study|Death|1|||
143173690|NCT03423121|516185296|FG001|Overall Study|Lost to Follow-up|6|||
143173691|NCT03423121|516185295|FG000|Overall Study|Adverse Event|1|||
143173692|NCT03423121|516185296|FG001|Overall Study|Adverse Event|0|||
143173693|NCT04102007|516185297|FG000|Overall Study|Adverse Event|4|||
143173694|NCT04102007|516185297|FG000|Overall Study|Lost to Follow-up|3|||
143173695|NCT04102007|516185297|FG000|Overall Study|Withdrawal by Subject|12|||
143173696|NCT04102007|516185297|FG000|Overall Study|Eligibility Violation|5|||
143173697|NCT04102007|516185297|FG000|Overall Study|Lack of Efficacy|6|||
143173698|NCT04102007|516185297|FG000|Overall Study|Protocol Deviation|5|||
143173699|NCT04102007|516185297|FG000|Overall Study|Protocol Compliance|1|||
143173700|NCT04102007|516185297|FG000|Overall Study|Withdrew Treatment|2|||
143173701|NCT04102007|516185297|FG000|Overall Study|Pregnancy|1|||
143173702|NCT05173974|516185298|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
143173703|NCT05173974|516185299|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
143173704|NCT05173974|516185300|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
143173705|NCT05173974|516185301|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
143173706|NCT05173974|516185298|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
143173707|NCT05173974|516185299|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
143173708|NCT05173974|516185300|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
143173709|NCT05173974|516185301|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
143173710|NCT03289143|516185302|FG000|Overall Study|Caregiver Unavailability|1|||
143173711|NCT03289143|516185303|FG001|Overall Study|Caregiver Unavailability|1|||
143173712|NCT03289143|516185304|FG002|Overall Study|Caregiver Unavailability|0|||
143173713|NCT03289143|516185305|FG003|Overall Study|Caregiver Unavailability|0|||
143173714|NCT03289143|516185302|FG000|Overall Study|Research Department Closure|0|||
143173715|NCT03289143|516185303|FG001|Overall Study|Research Department Closure|0|||
143173716|NCT03289143|516185304|FG002|Overall Study|Research Department Closure|1|||
143173717|NCT03289143|516185305|FG003|Overall Study|Research Department Closure|0|||
143173718|NCT03289143|516185302|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
143173719|NCT03289143|516185303|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
143173720|NCT03289143|516185304|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
143173721|NCT03289143|516185305|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
143173722|NCT03289143|516185302|FG000|Overall Study|Medical Monitor Decision|1|||
143173723|NCT03289143|516185303|FG001|Overall Study|Medical Monitor Decision|0|||
143173724|NCT03289143|516185304|FG002|Overall Study|Medical Monitor Decision|0|||
143249085|NCT03646123|516465119|FG002|Overall Study|Death|1|||
143249086|NCT03646123|516465117|FG000|Overall Study|Other|2|||
143249087|NCT03646123|516465118|FG001|Overall Study|Other|0|||
143249088|NCT03646123|516465119|FG002|Overall Study|Other|2|||
143249089|NCT04195893|516465122|FG000|Second Intervention|Withdrawal by Subject|1|||
143082248|NCT05314816|515838528|FG002|Overall Study|Protocol Violation|0|||
143082249|NCT03996447|515840345|FG000|First MRI Examination|Adverse Event|2|||
143082250|NCT03996447|515840346|FG001|First MRI Examination|Adverse Event|0|||
143082251|NCT03996447|515840345|FG000|First MRI Examination|Withdrawal by Subject|1|||
143082252|NCT03996447|515840346|FG001|First MRI Examination|Withdrawal by Subject|2|||
143082253|NCT03996447|515840345|FG000|First MRI Examination|Protocol Violation|0|||
143082254|NCT03996447|515840346|FG001|First MRI Examination|Protocol Violation|1|||
143082255|NCT03996447|515840345|FG000|Washout|Adverse Event|2|||
143082256|NCT03996447|515840346|FG001|Washout|Adverse Event|0|||
143082257|NCT03996447|515840345|FG000|Washout|Follow-up unavailable due to COVID-19 pandemic|2|||
143082258|NCT03996447|515840346|FG001|Washout|Follow-up unavailable due to COVID-19 pandemic|1|||
143082259|NCT03996447|515840345|FG000|Washout|Withdrawal by Subject|0|||
143082260|NCT03996447|515840346|FG001|Washout|Withdrawal by Subject|1|||
143082261|NCT03996447|515840345|FG000|Washout|Other reason|1|||
143082262|NCT03996447|515840346|FG001|Washout|Other reason|1|||
143082263|NCT02207634|515840347|FG000|Overall Study|Withdrawal by Subject|21|||
143082264|NCT02207634|515840348|FG001|Overall Study|Withdrawal by Subject|31|||
143082265|NCT02207634|515840347|FG000|Overall Study|Lost to Follow-up|1|||
143082266|NCT02207634|515840348|FG001|Overall Study|Lost to Follow-up|0|||
143082267|NCT02077140|515840349|FG000|Overall Study|Lost to Follow-up|4|||
143082268|NCT02077140|515840350|FG001|Overall Study|Lost to Follow-up|1|||
143082269|NCT02077140|515840351|FG002|Overall Study|Lost to Follow-up|2|||
143082270|NCT02077140|515840352|FG003|Overall Study|Lost to Follow-up|2|||
143082271|NCT02077140|515840353|FG004|Overall Study|Lost to Follow-up|3|||
143082272|NCT02077140|515840349|FG000|Overall Study|Withdrawal by Subject|0|||
143082273|NCT02077140|515840350|FG001|Overall Study|Withdrawal by Subject|1|||
143082274|NCT02077140|515840351|FG002|Overall Study|Withdrawal by Subject|0|||
143082275|NCT02077140|515840352|FG003|Overall Study|Withdrawal by Subject|2|||
143082276|NCT02077140|515840353|FG004|Overall Study|Withdrawal by Subject|2|||
143082277|NCT00618371|515840356|FG000|Overall Study|Withdrawal by Subject|2|||
143082278|NCT00113763|515840357|FG000|Overall Study|Adverse Event|5|||
143082279|NCT00113763|515840358|FG001|Overall Study|Adverse Event|2|||
143082280|NCT00113763|515840357|FG000|Overall Study|Disease Progression|28|||
143082281|NCT00113763|515840358|FG001|Overall Study|Disease Progression|14|||
143082282|NCT00113763|515840357|FG000|Overall Study|Lost to Follow-up|10|||
143082283|NCT00113763|515840358|FG001|Overall Study|Lost to Follow-up|0|||
143082284|NCT00113763|515840357|FG000|Overall Study|Withdrawal by Subject|1|||
143082285|NCT00113763|515840358|FG001|Overall Study|Withdrawal by Subject|4|||
143082286|NCT00113763|515840357|FG000|Overall Study|Other|27|||
143082287|NCT00113763|515840358|FG001|Overall Study|Other|6|||
143082288|NCT00113763|515840357|FG000|Overall Study|Non-compliance|1|||
143082289|NCT00113763|515840358|FG001|Overall Study|Non-compliance|0|||
143082290|NCT00113763|515840357|FG000|Overall Study|Ongoing|1|||
143082291|NCT00113763|515840358|FG001|Overall Study|Ongoing|0|||
143082292|NCT02847260|515840361|FG000|Overall Study|Adverse Event|3|||
143082293|NCT02847260|515840361|FG000|Overall Study|Withdrawal by Subject|2|||
143082294|NCT02847260|515840361|FG000|Overall Study|Clinical Deterioration|1|||
143082295|NCT02847260|515840361|FG000|Overall Study|Physician Decision|1|||
143082296|NCT01383707|515840362|FG000|Overall Study|Consent withdrawal|6|||
143082297|NCT01383707|515840362|FG000|Overall Study|Death|19|||
143082298|NCT01383707|515840362|FG000|Overall Study|Other|8|||
143082299|NCT01383707|515840362|FG000|Overall Study|Sponsor's decision|2|||
143082300|NCT01383707|515840362|FG000|Overall Study|Adverse Event|14|||
143082301|NCT01383707|515840362|FG000|Overall Study|Progressive disease|23|||
143082302|NCT03104400|515840363|FG000|Period 1 (Week 1 - 56)|Adverse Event|5|||
143082303|NCT03104400|515840364|FG001|Period 1 (Week 1 - 56)|Adverse Event|7|||
143082304|NCT03104400|515840365|FG002|Period 1 (Week 1 - 56)|Adverse Event|11|||
143082305|NCT03104400|515840366|FG003|Period 1 (Week 1 - 56)|Adverse Event|9|||
143082306|NCT03104400|515840367|FG004|Period 1 (Week 1 - 56)|Adverse Event|21|||
143082307|NCT03104400|515840368|FG005|Period 1 (Week 1 - 56)|Adverse Event|0|||
143082308|NCT03104400|515840369|FG006|Period 1 (Week 1 - 56)|Adverse Event|0|||
143082309|NCT03104400|515840370|FG007|Period 1 (Week 1 - 56)|Adverse Event|0|||
143082310|NCT03104400|515840371|FG008|Period 1 (Week 1 - 56)|Adverse Event|0|||
143082311|NCT03104400|515840372|FG009|Period 1 (Week 1 - 56)|Adverse Event|0|||
143082312|NCT03104400|515840363|FG000|Period 1 (Week 1 - 56)|Withdrawal by Subject|17|||
143082313|NCT03104400|515840364|FG001|Period 1 (Week 1 - 56)|Withdrawal by Subject|20|||
143082314|NCT03104400|515840365|FG002|Period 1 (Week 1 - 56)|Withdrawal by Subject|29|||
143082315|NCT03104400|515840366|FG003|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
143082316|NCT03104400|515840367|FG004|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
143082317|NCT03104400|515840368|FG005|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
143082318|NCT03104400|515840369|FG006|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
143082319|NCT03104400|515840370|FG007|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
143082320|NCT03104400|515840371|FG008|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
143082321|NCT03104400|515840372|FG009|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
143082322|NCT03104400|515840363|FG000|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
143082323|NCT03104400|515840364|FG001|Period 1 (Week 1 - 56)|Lost to Follow-up|1|||
143082324|NCT03104400|515840365|FG002|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
143082325|NCT03104400|515840366|FG003|Period 1 (Week 1 - 56)|Lost to Follow-up|8|||
143082326|NCT03104400|515840367|FG004|Period 1 (Week 1 - 56)|Lost to Follow-up|7|||
143082327|NCT03104400|515840368|FG005|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
143082328|NCT03104400|515840369|FG006|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
143082329|NCT03104400|515840370|FG007|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
143082330|NCT03104400|515840371|FG008|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
143082331|NCT03104400|515840372|FG009|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
143082332|NCT03104400|515840363|FG000|Period 1 (Week 1 - 56)|Lack of Efficacy|6|||
143082333|NCT03104400|515840364|FG001|Period 1 (Week 1 - 56)|Lack of Efficacy|3|||
143082334|NCT03104400|515840365|FG002|Period 1 (Week 1 - 56)|Lack of Efficacy|8|||
143082335|NCT03104400|515840366|FG003|Period 1 (Week 1 - 56)|Lack of Efficacy|2|||
143082336|NCT03104400|515840367|FG004|Period 1 (Week 1 - 56)|Lack of Efficacy|1|||
143082337|NCT03104400|515840368|FG005|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
143082338|NCT03104400|515840369|FG006|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
143082339|NCT03104400|515840370|FG007|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
143082340|NCT03104400|515840371|FG008|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
143082341|NCT03104400|515840372|FG009|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
143082342|NCT03104400|515840363|FG000|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
143082343|NCT03104400|515840364|FG001|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
143082344|NCT03104400|515840365|FG002|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
143082345|NCT03104400|515840366|FG003|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|1|||
143082346|NCT03104400|515840367|FG004|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
143082347|NCT03104400|515840368|FG005|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
143082348|NCT03104400|515840369|FG006|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
143082349|NCT03104400|515840370|FG007|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
143082350|NCT03104400|515840371|FG008|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
143082351|NCT03104400|515840372|FG009|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
143082352|NCT03104400|515840363|FG000|Period 1 (Week 1 - 56)|Other, not specified|2|||
143082353|NCT03104400|515840364|FG001|Period 1 (Week 1 - 56)|Other, not specified|3|||
143082354|NCT03104400|515840365|FG002|Period 1 (Week 1 - 56)|Other, not specified|7|||
143082355|NCT03104400|515840366|FG003|Period 1 (Week 1 - 56)|Other, not specified|6|||
143082356|NCT03104400|515840367|FG004|Period 1 (Week 1 - 56)|Other, not specified|4|||
143082357|NCT03104400|515840368|FG005|Period 1 (Week 1 - 56)|Other, not specified|0|||
143082358|NCT03104400|515840369|FG006|Period 1 (Week 1 - 56)|Other, not specified|0|||
143082359|NCT03104400|515840370|FG007|Period 1 (Week 1 - 56)|Other, not specified|0|||
143082360|NCT03104400|515840371|FG008|Period 1 (Week 1 - 56)|Other, not specified|0|||
143082361|NCT03104400|515840372|FG009|Period 1 (Week 1 - 56)|Other, not specified|0|||
143082362|NCT03104400|515840363|FG000|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
143082363|NCT03104400|515840364|FG001|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
143082364|NCT03104400|515840365|FG002|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
143082365|NCT03104400|515840366|FG003|Period 1 (Week 1 - 56)|Did not receive study drug|1|||
143082366|NCT03104400|515840367|FG004|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
143082367|NCT03104400|515840368|FG005|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
143082368|NCT03104400|515840369|FG006|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
143082369|NCT03104400|515840370|FG007|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
143082370|NCT03104400|515840371|FG008|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
143082371|NCT03104400|515840372|FG009|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
143082372|NCT03104400|515840363|FG000|Period 2 Week 56 - 260)|Adverse Event|0|||
143082373|NCT03104400|515840364|FG001|Period 2 Week 56 - 260)|Adverse Event|0|||
143082374|NCT03104400|515840365|FG002|Period 2 Week 56 - 260)|Adverse Event|0|||
143082375|NCT03104400|515840366|FG003|Period 2 Week 56 - 260)|Adverse Event|0|||
143082376|NCT03104400|515840367|FG004|Period 2 Week 56 - 260)|Adverse Event|0|||
143082377|NCT03104400|515840368|FG005|Period 2 Week 56 - 260)|Adverse Event|14|||
143082378|NCT03104400|515840369|FG006|Period 2 Week 56 - 260)|Adverse Event|17|||
143082379|NCT03104400|515840370|FG007|Period 2 Week 56 - 260)|Adverse Event|14|||
143082380|NCT03104400|515840371|FG008|Period 2 Week 56 - 260)|Adverse Event|28|||
143082381|NCT03104400|515840372|FG009|Period 2 Week 56 - 260)|Adverse Event|28|||
143082382|NCT03104400|515840363|FG000|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
143082383|NCT03104400|515840364|FG001|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
143082384|NCT03104400|515840365|FG002|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
143082385|NCT03104400|515840366|FG003|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
143082386|NCT03104400|515840367|FG004|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
143082387|NCT03104400|515840368|FG005|Period 2 Week 56 - 260)|Withdrawal by Subject|11|||
143082388|NCT03104400|515840369|FG006|Period 2 Week 56 - 260)|Withdrawal by Subject|21|||
143082389|NCT03104400|515840370|FG007|Period 2 Week 56 - 260)|Withdrawal by Subject|45|||
143082390|NCT03104400|515840371|FG008|Period 2 Week 56 - 260)|Withdrawal by Subject|44|||
143082391|NCT03104400|515840372|FG009|Period 2 Week 56 - 260)|Withdrawal by Subject|32|||
143082392|NCT03104400|515840363|FG000|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
143082393|NCT03104400|515840364|FG001|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
143082394|NCT03104400|515840365|FG002|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
143082395|NCT03104400|515840366|FG003|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
143082396|NCT03104400|515840367|FG004|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
143082397|NCT03104400|515840368|FG005|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
143082398|NCT03104400|515840369|FG006|Period 2 Week 56 - 260)|Lost to Follow-up|6|||
143082399|NCT03104400|515840370|FG007|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
143082400|NCT03104400|515840371|FG008|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
143082401|NCT03104400|515840372|FG009|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
143082402|NCT03104400|515840363|FG000|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
143082403|NCT03104400|515840364|FG001|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
143082404|NCT03104400|515840365|FG002|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
143082405|NCT03104400|515840366|FG003|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
143082406|NCT03104400|515840367|FG004|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
143082407|NCT03104400|515840368|FG005|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
143082408|NCT03104400|515840369|FG006|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
143082409|NCT03104400|515840370|FG007|Period 2 Week 56 - 260)|Lack of Efficacy|9|||
143082410|NCT03104400|515840371|FG008|Period 2 Week 56 - 260)|Lack of Efficacy|6|||
143082411|NCT03104400|515840372|FG009|Period 2 Week 56 - 260)|Lack of Efficacy|7|||
143082412|NCT03104400|515840363|FG000|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
143082413|NCT03104400|515840364|FG001|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
143082414|NCT03104400|515840365|FG002|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
143082415|NCT03104400|515840366|FG003|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
143082416|NCT03104400|515840367|FG004|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
143082417|NCT03104400|515840368|FG005|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
143082418|NCT03104400|515840369|FG006|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
143082419|NCT03104400|515840370|FG007|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
143173725|NCT03289143|516185305|FG003|Overall Study|Medical Monitor Decision|0|||
143173726|NCT03289143|516185302|FG000|Overall Study|Participant Non-Compliance|0|||
143173727|NCT03289143|516185303|FG001|Overall Study|Participant Non-Compliance|0|||
143173728|NCT03289143|516185304|FG002|Overall Study|Participant Non-Compliance|1|||
143173729|NCT03289143|516185305|FG003|Overall Study|Participant Non-Compliance|0|||
143173730|NCT03289143|516185302|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
143173731|NCT03289143|516185303|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
143082420|NCT03104400|515840371|FG008|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
143082421|NCT03104400|515840372|FG009|Period 2 Week 56 - 260)|COVIID-19 infection|3|||
143082422|NCT03104400|515840363|FG000|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
143082423|NCT03104400|515840364|FG001|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
143082424|NCT03104400|515840365|FG002|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
143082425|NCT03104400|515840366|FG003|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
143082426|NCT03104400|515840367|FG004|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
143082427|NCT03104400|515840368|FG005|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
143082428|NCT03104400|515840369|FG006|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
143082429|NCT03104400|515840370|FG007|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
143082430|NCT03104400|515840371|FG008|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
143082431|NCT03104400|515840372|FG009|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
143082432|NCT03104400|515840363|FG000|Period 2 Week 56 - 260)|Other, not specified|0|||
143082433|NCT03104400|515840364|FG001|Period 2 Week 56 - 260)|Other, not specified|0|||
143082434|NCT03104400|515840365|FG002|Period 2 Week 56 - 260)|Other, not specified|0|||
143082435|NCT03104400|515840366|FG003|Period 2 Week 56 - 260)|Other, not specified|0|||
143082436|NCT03104400|515840367|FG004|Period 2 Week 56 - 260)|Other, not specified|0|||
143082437|NCT03104400|515840368|FG005|Period 2 Week 56 - 260)|Other, not specified|10|||
143082438|NCT03104400|515840369|FG006|Period 2 Week 56 - 260)|Other, not specified|7|||
143082439|NCT03104400|515840370|FG007|Period 2 Week 56 - 260)|Other, not specified|17|||
143082440|NCT03104400|515840371|FG008|Period 2 Week 56 - 260)|Other, not specified|12|||
143082441|NCT03104400|515840372|FG009|Period 2 Week 56 - 260)|Other, not specified|18|||
143082442|NCT03104400|515840363|FG000|Period 2 Week 56 - 260)|Other|0|||
143082443|NCT03104400|515840364|FG001|Period 2 Week 56 - 260)|Other|0|||
143082444|NCT03104400|515840365|FG002|Period 2 Week 56 - 260)|Other|0|||
143082445|NCT03104400|515840366|FG003|Period 2 Week 56 - 260)|Other|0|||
143082446|NCT03104400|515840367|FG004|Period 2 Week 56 - 260)|Other|0|||
143082447|NCT03104400|515840368|FG005|Period 2 Week 56 - 260)|Other|0|||
143082448|NCT03104400|515840369|FG006|Period 2 Week 56 - 260)|Other|0|||
143082449|NCT03104400|515840370|FG007|Period 2 Week 56 - 260)|Other|0|||
143082450|NCT03104400|515840371|FG008|Period 2 Week 56 - 260)|Other|1|||
143082451|NCT03104400|515840372|FG009|Period 2 Week 56 - 260)|Other|1|||
143082452|NCT02013817|515840373|FG000|Overall Study|Adverse Event|12|||
143082453|NCT02013817|515840373|FG000|Overall Study|Withdrawal by Subject|4|||
143082454|NCT02013817|515840373|FG000|Overall Study|Death|2|||
143082455|NCT02013817|515840373|FG000|Overall Study|Other|9|||
143082456|NCT00855894|515840374|FG000|Overall Study|Death|31|||
143082457|NCT00855894|515840374|FG000|Overall Study|Patient's decision|1|||
143082458|NCT00855894|515840374|FG000|Overall Study|Disease progression|1|||
143082459|NCT02111603|515840378|FG000|Overall Study|Withdrawal by Subject|1|||
143082460|NCT00794339|515840382|FG000|Overall Study|Withdrawal by Subject|3|||
143082461|NCT00794339|515840382|FG000|Overall Study|Ineligible|4|||
143082462|NCT00794339|515840382|FG000|Overall Study|Tx prior to ATSM|3|||
143082463|NCT00794339|515840382|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
143082464|NCT00794339|515840382|FG000|Overall Study|Tx not per protocol|1|||
143082465|NCT04974749|515840401|FG000|Overall Study|Withdrawal by Subject|2|||
143082466|NCT04974749|515840401|FG000|Overall Study|Gestation|1|||
143082467|NCT00362336|515840402|FG000|Overall Study|Serious Adverse Event|1|||
143082468|NCT00362336|515840403|FG001|Overall Study|Serious Adverse Event|0|||
143082469|NCT00362336|515840404|FG002|Overall Study|Serious Adverse Event|1|||
143082470|NCT00362336|515840402|FG000|Overall Study|Protocol Violation|0|||
143082471|NCT00362336|515840403|FG001|Overall Study|Protocol Violation|0|||
143082472|NCT00362336|515840404|FG002|Overall Study|Protocol Violation|1|||
143082473|NCT00362336|515840402|FG000|Overall Study|Lost to Follow-up|6|||
143082474|NCT00362336|515840403|FG001|Overall Study|Lost to Follow-up|4|||
143082475|NCT00362336|515840404|FG002|Overall Study|Lost to Follow-up|0|||
143082476|NCT00362336|515840402|FG000|Overall Study|Withdrawal by Subject|3|||
143082477|NCT00362336|515840403|FG001|Overall Study|Withdrawal by Subject|3|||
143082478|NCT00362336|515840404|FG002|Overall Study|Withdrawal by Subject|1|||
143082479|NCT00741338|515840413|FG000|Overall Study|Adverse Event|0|||
143082480|NCT00741338|515840414|FG001|Overall Study|Adverse Event|1|||
143082481|NCT03593395|515840415|FG000|Overall Study|Lost to Follow-up|48|||
143082482|NCT03593395|515840416|FG001|Overall Study|Lost to Follow-up|3|||
143082483|NCT03593395|515840415|FG000|Overall Study|Withdrawal by Subject|5|||
143082484|NCT03593395|515840416|FG001|Overall Study|Withdrawal by Subject|24|||
143082485|NCT03593395|515840415|FG000|Overall Study|Death|2|||
143082486|NCT03593395|515840416|FG001|Overall Study|Death|3|||
143082487|NCT03593395|515840415|FG000|Overall Study|Physician Decision|0|||
143082488|NCT03593395|515840416|FG001|Overall Study|Physician Decision|6|||
143082489|NCT03593395|515840415|FG000|Overall Study|Participant Relocated|19|||
143082490|NCT03593395|515840416|FG001|Overall Study|Participant Relocated|3|||
143082491|NCT03593395|515840415|FG000|Overall Study|No Information|1|||
143082492|NCT03593395|515840416|FG001|Overall Study|No Information|7|||
143082493|NCT03713632|515840417|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
143082494|NCT03713632|515840418|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
143082495|NCT03713632|515840419|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
143082496|NCT03713632|515840420|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
143082497|NCT03713632|515840421|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
143082498|NCT03713632|515840417|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
143082499|NCT03713632|515840418|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
143082500|NCT03713632|515840419|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
143082501|NCT03713632|515840420|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
143082502|NCT03713632|515840421|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
143082503|NCT03713632|515840417|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
143082504|NCT03713632|515840418|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
143082505|NCT03713632|515840419|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
143082506|NCT03713632|515840420|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
143082507|NCT03713632|515840421|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
143082508|NCT03713632|515840417|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
143082509|NCT03713632|515840418|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
143082510|NCT03713632|515840419|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
143082511|NCT03713632|515840420|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
143082512|NCT03713632|515840421|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
143082513|NCT03713632|515840417|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
143082514|NCT03713632|515840418|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
143082515|NCT03713632|515840419|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
143082516|NCT03713632|515840420|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
143082517|NCT03713632|515840421|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
143082518|NCT03713632|515840417|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
143082519|NCT03713632|515840418|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
143082520|NCT03713632|515840419|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
143082521|NCT03713632|515840420|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
143082522|NCT03713632|515840421|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
143082523|NCT03713632|515840417|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
143082524|NCT03713632|515840418|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
143082525|NCT03713632|515840419|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
143082526|NCT03713632|515840420|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
143082527|NCT03713632|515840421|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
143082528|NCT03713632|515840417|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
143082529|NCT03713632|515840418|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
143082530|NCT03713632|515840419|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
143082531|NCT03713632|515840420|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
143082532|NCT03713632|515840421|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
143082533|NCT03713632|515840417|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
143082534|NCT03713632|515840418|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
143082535|NCT03713632|515840419|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
143082536|NCT03713632|515840420|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
143082537|NCT03713632|515840421|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
143082538|NCT03713632|515840417|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
143082539|NCT03713632|515840418|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
143082540|NCT03713632|515840419|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
143082541|NCT03713632|515840420|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
143082542|NCT03713632|515840421|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
143082543|NCT03713632|515840417|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
143082544|NCT03713632|515840418|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
143082545|NCT03713632|515840419|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
143082546|NCT03713632|515840420|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
143082547|NCT03713632|515840421|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
143082548|NCT03713632|515840417|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
143082549|NCT03713632|515840418|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
143082550|NCT03713632|515840419|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
143082551|NCT03713632|515840420|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
143082552|NCT03713632|515840421|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
143082553|NCT03713632|515840417|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
143082554|NCT03713632|515840418|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
143082555|NCT03713632|515840419|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
143082556|NCT03713632|515840420|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
143082557|NCT03713632|515840421|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
143173732|NCT03289143|516185304|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
143082558|NCT03713632|515840417|FG000|Treatment Period 2 (After Week 16)|Death|0|||
143082559|NCT03713632|515840418|FG001|Treatment Period 2 (After Week 16)|Death|1|||
143082560|NCT03713632|515840419|FG002|Treatment Period 2 (After Week 16)|Death|0|||
143082561|NCT03713632|515840420|FG003|Treatment Period 2 (After Week 16)|Death|0|||
143082562|NCT03713632|515840421|FG004|Treatment Period 2 (After Week 16)|Death|0|||
143082563|NCT03713632|515840417|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
143082564|NCT03713632|515840418|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
143082565|NCT03713632|515840419|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
143082566|NCT03713632|515840420|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
143082567|NCT03713632|515840421|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
143082568|NCT01524978|515840425|FG000|Overall Study|Other|16|||
143082569|NCT01524978|515840426|FG001|Overall Study|Other|2|||
143082570|NCT01524978|515840427|FG002|Overall Study|Other|1|||
143082571|NCT01524978|515840428|FG003|Overall Study|Other|2|||
143082572|NCT01524978|515840429|FG004|Overall Study|Other|1|||
143082573|NCT01524978|515840430|FG005|Overall Study|Other|3|||
143082574|NCT01524978|515840431|FG006|Overall Study|Other|17|||
143173733|NCT03289143|516185305|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
143082575|NCT01524978|515840432|FG007|Overall Study|Other|1|||
143082576|NCT01524978|515840433|FG008|Overall Study|Other|2|||
143082577|NCT01524978|515840434|FG009|Overall Study|Other|2|||
143082578|NCT01524978|515840435|FG010|Overall Study|Other|5|||
143082579|NCT01524978|515840425|FG000|Overall Study|Withdrawal by Subject|12|||
143082580|NCT01524978|515840426|FG001|Overall Study|Withdrawal by Subject|0|||
143082581|NCT01524978|515840427|FG002|Overall Study|Withdrawal by Subject|1|||
143082582|NCT01524978|515840428|FG003|Overall Study|Withdrawal by Subject|1|||
143082583|NCT01524978|515840429|FG004|Overall Study|Withdrawal by Subject|3|||
143082584|NCT01524978|515840430|FG005|Overall Study|Withdrawal by Subject|1|||
143082585|NCT01524978|515840431|FG006|Overall Study|Withdrawal by Subject|6|||
143082586|NCT01524978|515840432|FG007|Overall Study|Withdrawal by Subject|2|||
143082587|NCT01524978|515840433|FG008|Overall Study|Withdrawal by Subject|4|||
143082588|NCT01524978|515840434|FG009|Overall Study|Withdrawal by Subject|0|||
143082589|NCT01524978|515840435|FG010|Overall Study|Withdrawal by Subject|5|||
143082590|NCT01524978|515840425|FG000|Overall Study|Lost to Follow-up|0|||
143082591|NCT01524978|515840426|FG001|Overall Study|Lost to Follow-up|0|||
143082592|NCT01524978|515840427|FG002|Overall Study|Lost to Follow-up|3|||
143082593|NCT01524978|515840428|FG003|Overall Study|Lost to Follow-up|0|||
143082594|NCT01524978|515840429|FG004|Overall Study|Lost to Follow-up|1|||
143082595|NCT01524978|515840430|FG005|Overall Study|Lost to Follow-up|1|||
143082596|NCT01524978|515840431|FG006|Overall Study|Lost to Follow-up|2|||
143082597|NCT01524978|515840432|FG007|Overall Study|Lost to Follow-up|0|||
143249090|NCT04195893|516465123|FG001|Second Intervention|Withdrawal by Subject|0|||
143249091|NCT01802073|516465124|FG000|Overall Study|Lost to Follow-up|0|||
143082598|NCT01524978|515840433|FG008|Overall Study|Lost to Follow-up|1|||
143249092|NCT01802073|516465125|FG001|Overall Study|Lost to Follow-up|1|||
143082599|NCT01524978|515840434|FG009|Overall Study|Lost to Follow-up|1|||
143082600|NCT01524978|515840435|FG010|Overall Study|Lost to Follow-up|1|||
143082601|NCT01524978|515840425|FG000|Overall Study|Death|34|||
143082602|NCT01524978|515840426|FG001|Overall Study|Death|2|||
143082603|NCT01524978|515840427|FG002|Overall Study|Death|5|||
143082604|NCT01524978|515840428|FG003|Overall Study|Death|24|||
143082605|NCT01524978|515840429|FG004|Overall Study|Death|4|||
143082606|NCT01524978|515840430|FG005|Overall Study|Death|4|||
143082607|NCT01524978|515840431|FG006|Overall Study|Death|1|||
143082608|NCT01524978|515840432|FG007|Overall Study|Death|9|||
143082609|NCT01524978|515840433|FG008|Overall Study|Death|5|||
143082610|NCT01524978|515840434|FG009|Overall Study|Death|6|||
143082611|NCT01524978|515840435|FG010|Overall Study|Death|17|||
143082612|NCT03066258|515840440|FG000|Overall Study|Death|1|||
143082613|NCT03066258|515840441|FG001|Overall Study|Death|0|||
143082614|NCT03066258|515840442|FG002|Overall Study|Death|0|||
143082615|NCT03066258|515840443|FG003|Overall Study|Death|0|||
143082616|NCT03066258|515840444|FG004|Overall Study|Death|1|||
143082617|NCT02165735|515840445|FG000|Overall Study|Lost to Follow-up|12|||
143082618|NCT02165735|515840446|FG001|Overall Study|Lost to Follow-up|10|||
143173734|NCT03289143|516185302|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
143173735|NCT03289143|516185303|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
143173736|NCT03289143|516185304|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
143173737|NCT03289143|516185305|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
143173738|NCT03289143|516185302|FG000|Overall Study|Caregiver Passed Away|1|||
143173739|NCT03289143|516185303|FG001|Overall Study|Caregiver Passed Away|0|||
143173740|NCT03289143|516185304|FG002|Overall Study|Caregiver Passed Away|0|||
143173741|NCT03289143|516185305|FG003|Overall Study|Caregiver Passed Away|0|||
143173742|NCT03289143|516185302|FG000|Overall Study|Physician Decision|0|||
143173743|NCT03289143|516185303|FG001|Overall Study|Physician Decision|2|||
143173744|NCT03289143|516185304|FG002|Overall Study|Physician Decision|2|||
143173745|NCT03289143|516185305|FG003|Overall Study|Physician Decision|2|||
143173746|NCT03289143|516185302|FG000|Overall Study|Protocol Deviation|2|||
143173747|NCT03289143|516185303|FG001|Overall Study|Protocol Deviation|1|||
143173748|NCT03289143|516185304|FG002|Overall Study|Protocol Deviation|3|||
143082619|NCT02165735|515840445|FG000|Overall Study|Withdrawal by Subject|3|||
143082620|NCT02165735|515840446|FG001|Overall Study|Withdrawal by Subject|0|||
143082621|NCT02165735|515840445|FG000|Overall Study|Participant indicated lack of time|1|||
143082622|NCT02165735|515840446|FG001|Overall Study|Participant indicated lack of time|3|||
143082623|NCT02165735|515840445|FG000|Overall Study|Protocol Violation|0|||
143173749|NCT03289143|516185305|FG003|Overall Study|Protocol Deviation|1|||
143173750|NCT03289143|516185302|FG000|Overall Study|Study Terminated By Sponsor|101|||
143173751|NCT03289143|516185303|FG001|Overall Study|Study Terminated By Sponsor|75|||
143173752|NCT03289143|516185304|FG002|Overall Study|Study Terminated By Sponsor|100|||
143173753|NCT03289143|516185305|FG003|Overall Study|Study Terminated By Sponsor|69|||
143173754|NCT03289143|516185302|FG000|Overall Study|Withdrawal by Subject|14|||
143173755|NCT03289143|516185303|FG001|Overall Study|Withdrawal by Subject|6|||
143173756|NCT03289143|516185304|FG002|Overall Study|Withdrawal by Subject|14|||
143173757|NCT03289143|516185305|FG003|Overall Study|Withdrawal by Subject|12|||
143173758|NCT03289143|516185302|FG000|Overall Study|Adverse Event|10|||
143173759|NCT03289143|516185303|FG001|Overall Study|Adverse Event|7|||
143173760|NCT03289143|516185304|FG002|Overall Study|Adverse Event|6|||
143173761|NCT03289143|516185305|FG003|Overall Study|Adverse Event|5|||
143173762|NCT03289143|516185302|FG000|Overall Study|Death|2|||
143173763|NCT03289143|516185303|FG001|Overall Study|Death|0|||
143173764|NCT03289143|516185304|FG002|Overall Study|Death|2|||
143173765|NCT03289143|516185305|FG003|Overall Study|Death|1|||
143173766|NCT03289143|516185302|FG000|Overall Study|Lost to Follow-up|2|||
143173767|NCT03289143|516185303|FG001|Overall Study|Lost to Follow-up|1|||
143173768|NCT03289143|516185304|FG002|Overall Study|Lost to Follow-up|1|||
143173769|NCT03289143|516185305|FG003|Overall Study|Lost to Follow-up|0|||
143173770|NCT03289143|516185302|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
143173771|NCT03289143|516185303|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
143173772|NCT03289143|516185304|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
143173773|NCT03289143|516185305|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
143173774|NCT03289143|516185302|FG000|Overall Study|Withdrawal by Caregiver|0|||
143173775|NCT03289143|516185303|FG001|Overall Study|Withdrawal by Caregiver|1|||
143173776|NCT03289143|516185304|FG002|Overall Study|Withdrawal by Caregiver|0|||
143173777|NCT03289143|516185305|FG003|Overall Study|Withdrawal by Caregiver|0|||
143173778|NCT03289143|516185302|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
143173779|NCT03289143|516185303|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
143173780|NCT03289143|516185304|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
143173781|NCT03289143|516185305|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
143173782|NCT03289143|516185302|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
143173783|NCT03289143|516185303|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
143173784|NCT03289143|516185304|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
143173785|NCT03289143|516185305|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
143173786|NCT00948688|516185306|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
143173787|NCT00948688|516185307|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
143173788|NCT00948688|516185306|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
143173789|NCT00948688|516185307|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
143173790|NCT00948688|516185306|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
143173791|NCT00948688|516185307|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
143173792|NCT03610048|516185311|FG000|Overall Study|Study terminated by sponsor|84|||
143173793|NCT03610048|516185311|FG000|Overall Study|Adverse Event|32|||
143173794|NCT03610048|516185311|FG000|Overall Study|Withdrawal by Subject|31|||
143173795|NCT03610048|516185311|FG000|Overall Study|Lost to Follow-up|8|||
143173796|NCT03610048|516185311|FG000|Overall Study|Other|4|||
143173797|NCT03610048|516185311|FG000|Overall Study|Physician Decision|1|||
143173798|NCT03610048|516185311|FG000|Overall Study|Pregnancy|1|||
143173799|NCT01155050|516185312|FG000|Overall Study|Lost to Follow-up|15|||
143173800|NCT01155050|516185313|FG001|Overall Study|Lost to Follow-up|20|||
143173801|NCT01155050|516185314|FG002|Overall Study|Lost to Follow-up|19|||
143173802|NCT01155050|516185315|FG003|Overall Study|Lost to Follow-up|22|||
143173803|NCT02136914|516185316|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
143173804|NCT02136914|516185317|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
143173805|NCT02136914|516185316|FG000|Overall Study|Withdrawal by Subject|3|||
143173806|NCT02136914|516185317|FG001|Overall Study|Withdrawal by Subject|10|||
143173807|NCT02136914|516185316|FG000|Overall Study|Subject Unwilling to Proceed|7|||
143173808|NCT02136914|516185317|FG001|Overall Study|Subject Unwilling to Proceed|2|||
143173809|NCT02136914|516185316|FG000|Overall Study|Lost to Follow-up|1|||
143173810|NCT02136914|516185317|FG001|Overall Study|Lost to Follow-up|1|||
143173811|NCT02136914|516185316|FG000|Overall Study|Did Not Receive Study Drug|2|||
143173812|NCT02136914|516185317|FG001|Overall Study|Did Not Receive Study Drug|0|||
143173813|NCT02136914|516185316|FG000|Overall Study|Lack of Efficacy|1|||
143173814|NCT02136914|516185317|FG001|Overall Study|Lack of Efficacy|0|||
143173815|NCT02136914|516185316|FG000|Overall Study|Death|0|||
143173816|NCT02136914|516185317|FG001|Overall Study|Death|1|||
143173817|NCT00329030|516185318|FG000|Overall Study|Withdrawal by Subject|1|||
143173818|NCT00329030|516185319|FG001|Overall Study|Withdrawal by Subject|3|||
143173819|NCT00329030|516185318|FG000|Overall Study|Progressive Disease|6|||
143173820|NCT00329030|516185319|FG001|Overall Study|Progressive Disease|2|||
143173821|NCT00329030|516185318|FG000|Overall Study|Ineligible Pathology|1|||
143173822|NCT00329030|516185319|FG001|Overall Study|Ineligible Pathology|1|||
143173823|NCT00325143|516185320|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
143173824|NCT00325143|516185320|FG000|Overall Study|Migrated/moved from study area|1|||
143173825|NCT00325143|516185320|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
143173826|NCT00325143|516185320|FG000|Overall Study|Withdrawal by Subject|8|||
143173827|NCT03036852|516185321|FG000|Overall Study|Death|2|||
143173828|NCT03036852|516185321|FG000|Overall Study|Lack of Efficacy|2|||
143173829|NCT03036852|516185321|FG000|Overall Study|Adverse Event|1|||
143173830|NCT03036852|516185321|FG000|Overall Study|Lost to Follow-up|1|||
143173831|NCT02431325|516185322|FG000|Overall Study|Adverse Event|3|||
143173832|NCT02431325|516185323|FG001|Overall Study|Adverse Event|0|||
143173833|NCT02431325|516185322|FG000|Overall Study|Lost to Follow-up|0|||
143173834|NCT02431325|516185323|FG001|Overall Study|Lost to Follow-up|1|||
143173835|NCT02431325|516185322|FG000|Overall Study|Withdrawal by Subject|1|||
143173836|NCT02431325|516185323|FG001|Overall Study|Withdrawal by Subject|2|||
143173837|NCT02431325|516185322|FG000|Overall Study|Declined to take study medication|1|||
143173838|NCT02431325|516185323|FG001|Overall Study|Declined to take study medication|0|||
143173839|NCT02431325|516185322|FG000|Overall Study|Withdrew before starting study medication|1|||
143173840|NCT02431325|516185323|FG001|Overall Study|Withdrew before starting study medication|0|||
143173841|NCT02431325|516185322|FG000|Overall Study|Placebo shortage|2|||
143173842|NCT02431325|516185323|FG001|Overall Study|Placebo shortage|0|||
143173843|NCT01213082|516185326|FG000|Overall Study|Lost to Follow-up|6|||
143173844|NCT01213082|516185327|FG001|Overall Study|Lost to Follow-up|7|||
143173845|NCT01213082|516185328|FG002|Overall Study|Lost to Follow-up|4|||
143173846|NCT01213082|516185326|FG000|Overall Study|Physician Decision|0|||
143173847|NCT01213082|516185327|FG001|Overall Study|Physician Decision|0|||
143173848|NCT01213082|516185328|FG002|Overall Study|Physician Decision|1|||
143173849|NCT01531998|516185334|FG000|Overall Study|Withdrawal by Subject|3|||
143173850|NCT01076010|516185339|FG000|Overall Study|Death|15|||
143082624|NCT02165735|515840446|FG001|Overall Study|Protocol Violation|1|||
143082625|NCT02784795|515840447|FG000|Overall Study|Progressive Disease|2|||
143082626|NCT02784795|515840448|FG001|Overall Study|Progressive Disease|1|||
143082627|NCT02784795|515840449|FG002|Overall Study|Progressive Disease|1|||
143082628|NCT02784795|515840450|FG003|Overall Study|Progressive Disease|0|||
143082629|NCT02784795|515840451|FG004|Overall Study|Progressive Disease|2|||
143082630|NCT02784795|515840452|FG005|Overall Study|Progressive Disease|0|||
143082631|NCT02784795|515840453|FG006|Overall Study|Progressive Disease|2|||
143082632|NCT02784795|515840454|FG007|Overall Study|Progressive Disease|0|||
143082633|NCT02784795|515840455|FG008|Overall Study|Progressive Disease|0|||
143082634|NCT02784795|515840456|FG009|Overall Study|Progressive Disease|0|||
143082635|NCT02784795|515840457|FG010|Overall Study|Progressive Disease|1|||
143082636|NCT02784795|515840458|FG011|Overall Study|Progressive Disease|0|||
143082637|NCT02784795|515840447|FG000|Overall Study|Adverse Event|1|||
143082638|NCT02784795|515840448|FG001|Overall Study|Adverse Event|0|||
143082639|NCT02784795|515840449|FG002|Overall Study|Adverse Event|0|||
143082640|NCT02784795|515840450|FG003|Overall Study|Adverse Event|1|||
143082641|NCT02784795|515840451|FG004|Overall Study|Adverse Event|0|||
143082642|NCT02784795|515840452|FG005|Overall Study|Adverse Event|0|||
143082643|NCT02784795|515840453|FG006|Overall Study|Adverse Event|1|||
143082644|NCT02784795|515840454|FG007|Overall Study|Adverse Event|0|||
143082645|NCT02784795|515840455|FG008|Overall Study|Adverse Event|0|||
143082646|NCT02784795|515840456|FG009|Overall Study|Adverse Event|0|||
143082647|NCT02784795|515840457|FG010|Overall Study|Adverse Event|0|||
143082648|NCT02784795|515840458|FG011|Overall Study|Adverse Event|2|||
143082649|NCT02784795|515840447|FG000|Overall Study|Withdrawal by Subject|1|||
143082650|NCT02784795|515840448|FG001|Overall Study|Withdrawal by Subject|0|||
143082651|NCT02784795|515840449|FG002|Overall Study|Withdrawal by Subject|2|||
143082652|NCT02784795|515840450|FG003|Overall Study|Withdrawal by Subject|1|||
143082653|NCT02784795|515840451|FG004|Overall Study|Withdrawal by Subject|3|||
143082654|NCT02784795|515840452|FG005|Overall Study|Withdrawal by Subject|0|||
143082655|NCT02784795|515840453|FG006|Overall Study|Withdrawal by Subject|0|||
143082656|NCT02784795|515840454|FG007|Overall Study|Withdrawal by Subject|1|||
143082657|NCT02784795|515840455|FG008|Overall Study|Withdrawal by Subject|0|||
143173851|NCT01076010|516185340|FG001|Overall Study|Death|1|||
143173852|NCT01076010|516185341|FG002|Overall Study|Death|0|||
143173853|NCT01076010|516185339|FG000|Overall Study|Adverse Event|7|||
143173854|NCT01076010|516185340|FG001|Overall Study|Adverse Event|2|||
143173855|NCT01076010|516185341|FG002|Overall Study|Adverse Event|0|||
143173856|NCT01076010|516185339|FG000|Overall Study|Progressive disease|90|||
143173857|NCT01076010|516185340|FG001|Overall Study|Progressive disease|30|||
143173858|NCT01076010|516185341|FG002|Overall Study|Progressive disease|1|||
143173859|NCT01076010|516185339|FG000|Overall Study|Lack of Efficacy|4|||
143173860|NCT01076010|516185340|FG001|Overall Study|Lack of Efficacy|0|||
143173861|NCT01076010|516185341|FG002|Overall Study|Lack of Efficacy|0|||
143082658|NCT02784795|515840456|FG009|Overall Study|Withdrawal by Subject|0|||
143082659|NCT02784795|515840457|FG010|Overall Study|Withdrawal by Subject|0|||
143082660|NCT02784795|515840458|FG011|Overall Study|Withdrawal by Subject|2|||
143082661|NCT02784795|515840447|FG000|Overall Study|Death|0|||
143082662|NCT02784795|515840448|FG001|Overall Study|Death|0|||
143082663|NCT02784795|515840449|FG002|Overall Study|Death|0|||
143082664|NCT02784795|515840450|FG003|Overall Study|Death|0|||
143082665|NCT02784795|515840451|FG004|Overall Study|Death|1|||
143082666|NCT02784795|515840452|FG005|Overall Study|Death|0|||
143082667|NCT02784795|515840453|FG006|Overall Study|Death|0|||
143082668|NCT02784795|515840454|FG007|Overall Study|Death|0|||
143082669|NCT02784795|515840455|FG008|Overall Study|Death|0|||
143082670|NCT02784795|515840456|FG009|Overall Study|Death|0|||
143082671|NCT02784795|515840457|FG010|Overall Study|Death|0|||
143082672|NCT02784795|515840458|FG011|Overall Study|Death|0|||
143082673|NCT02784795|515840447|FG000|Overall Study|Physician Decision|0|||
143082674|NCT02784795|515840448|FG001|Overall Study|Physician Decision|0|||
143082675|NCT02784795|515840449|FG002|Overall Study|Physician Decision|0|||
143082676|NCT02784795|515840450|FG003|Overall Study|Physician Decision|0|||
143082677|NCT02784795|515840451|FG004|Overall Study|Physician Decision|0|||
143082678|NCT02784795|515840452|FG005|Overall Study|Physician Decision|0|||
143082679|NCT02784795|515840453|FG006|Overall Study|Physician Decision|1|||
143082680|NCT02784795|515840454|FG007|Overall Study|Physician Decision|0|||
143082681|NCT02784795|515840455|FG008|Overall Study|Physician Decision|0|||
143082682|NCT02784795|515840456|FG009|Overall Study|Physician Decision|0|||
143082683|NCT02784795|515840457|FG010|Overall Study|Physician Decision|0|||
143082684|NCT02784795|515840458|FG011|Overall Study|Physician Decision|0|||
143082685|NCT00626561|515840459|FG000|Overall Study|Withdrawal by Subject|2|||
143082686|NCT00626561|515840459|FG000|Overall Study|Disease Progression|2|||
143082687|NCT00595309|515840462|FG000|Overall Study|Lost to Follow-up|1|||
143082688|NCT00595309|515840462|FG000|Overall Study|planned vaccination against yellow fever|1|||
143082689|NCT00595309|515840462|FG000|Overall Study|acute infection after V0|1|||
143082690|NCT00595309|515840462|FG000|Overall Study|personal reason|1|||
143082691|NCT00101283|515840463|FG000|Overall Study|Withdrawal by Subject|0|||
143082692|NCT00101283|515840464|FG001|Overall Study|Withdrawal by Subject|1|||
143082693|NCT00101283|515840463|FG000|Overall Study|Insurance Refusal|0|||
143082694|NCT00101283|515840464|FG001|Overall Study|Insurance Refusal|1|||
143082695|NCT00101283|515840463|FG000|Overall Study|Prostate Cancer Recurrence|0|||
143082696|NCT00101283|515840464|FG001|Overall Study|Prostate Cancer Recurrence|1|||
143082697|NCT03993379|515840465|FG000|Overall Study|The study was terminated early due to business decision.|0|||
143082698|NCT03993379|515840466|FG001|Overall Study|The study was terminated early due to business decision.|2|||
143082699|NCT03993379|515840467|FG002|Overall Study|The study was terminated early due to business decision.|0|||
143082700|NCT03993379|515840468|FG003|Overall Study|The study was terminated early due to business decision.|0|||
143082701|NCT03993379|515840465|FG000|Overall Study|Withdrawal by Subject|0|||
143082702|NCT03993379|515840466|FG001|Overall Study|Withdrawal by Subject|1|||
143082703|NCT03993379|515840467|FG002|Overall Study|Withdrawal by Subject|0|||
143082704|NCT03993379|515840468|FG003|Overall Study|Withdrawal by Subject|0|||
143082705|NCT00398866|515840469|FG000|Overall Study|Adverse Event|1|||
143082706|NCT00398866|515840470|FG001|Overall Study|Adverse Event|0|||
143082707|NCT00398866|515840471|FG002|Overall Study|Adverse Event|0|||
143082708|NCT00398866|515840469|FG000|Overall Study|Lack of Efficacy|0|||
143082709|NCT00398866|515840470|FG001|Overall Study|Lack of Efficacy|0|||
143082710|NCT00398866|515840471|FG002|Overall Study|Lack of Efficacy|1|||
143082711|NCT00398866|515840469|FG000|Overall Study|Lost to Follow-up|7|||
143082712|NCT00398866|515840470|FG001|Overall Study|Lost to Follow-up|6|||
143082713|NCT00398866|515840471|FG002|Overall Study|Lost to Follow-up|4|||
143082714|NCT00398866|515840469|FG000|Overall Study|Withdrawal by Subject|5|||
143082715|NCT00398866|515840470|FG001|Overall Study|Withdrawal by Subject|1|||
143082716|NCT00398866|515840471|FG002|Overall Study|Withdrawal by Subject|2|||
143082717|NCT00398866|515840469|FG000|Overall Study|Unable to complete requirements of study|1|||
143082718|NCT00398866|515840470|FG001|Overall Study|Unable to complete requirements of study|1|||
143082719|NCT00398866|515840471|FG002|Overall Study|Unable to complete requirements of study|1|||
143082720|NCT00711880|515840474|FG000|Overall Study|Adverse Event|11|||
143082721|NCT00711880|515840475|FG001|Overall Study|Adverse Event|2|||
143082722|NCT00711880|515840474|FG000|Overall Study|Patient non-compliance|1|||
143082723|NCT00711880|515840475|FG001|Overall Study|Patient non-compliance|0|||
143173862|NCT01076010|516185339|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
143366454|NCT03425539|516884677|FG000|Overall Study|Randomized but not treated|0|||
143173863|NCT01076010|516185340|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
143173864|NCT01076010|516185341|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
143173865|NCT01076010|516185339|FG000|Overall Study|Significant Surgical Procedure|0|||
143173866|NCT01076010|516185340|FG001|Overall Study|Significant Surgical Procedure|1|||
143173867|NCT01076010|516185341|FG002|Overall Study|Significant Surgical Procedure|0|||
143173868|NCT01076010|516185339|FG000|Overall Study|Protocol Violation|0|||
143173869|NCT01076010|516185340|FG001|Overall Study|Protocol Violation|1|||
143173870|NCT01076010|516185341|FG002|Overall Study|Protocol Violation|0|||
143173871|NCT01076010|516185339|FG000|Overall Study|Noncompliance|1|||
143173872|NCT01076010|516185340|FG001|Overall Study|Noncompliance|1|||
143173873|NCT01076010|516185341|FG002|Overall Study|Noncompliance|0|||
143173874|NCT01076010|516185339|FG000|Overall Study|Withdrawal by Subject|3|||
143173875|NCT01076010|516185340|FG001|Overall Study|Withdrawal by Subject|0|||
143173876|NCT01076010|516185341|FG002|Overall Study|Withdrawal by Subject|1|||
143173877|NCT01076010|516185339|FG000|Overall Study|Other|5|||
143173878|NCT01076010|516185340|FG001|Overall Study|Other|2|||
143173879|NCT01076010|516185341|FG002|Overall Study|Other|0|||
143173880|NCT04661033|516185345|FG000|Overall Study|Adverse Event|0|||
143173881|NCT04661033|516185346|FG001|Overall Study|Adverse Event|0|||
143366455|NCT03425539|516884678|FG001|Overall Study|Randomized but not treated|1|||
143366456|NCT03425539|516884677|FG000|Overall Study|Adverse Event|2|||
143366457|NCT03425539|516884678|FG001|Overall Study|Adverse Event|2|||
143366458|NCT03425539|516884677|FG000|Overall Study|Withdrawal by Subject|3|||
143173882|NCT04661033|516185347|FG002|Overall Study|Adverse Event|1|||
143173883|NCT04661033|516185348|FG003|Overall Study|Adverse Event|0|||
143173884|NCT04661033|516185345|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
143173885|NCT04661033|516185346|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
143173886|NCT04661033|516185347|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
143082724|NCT00711880|515840474|FG000|Overall Study|Lack of Efficacy|1|||
143082725|NCT00711880|515840475|FG001|Overall Study|Lack of Efficacy|5|||
143082726|NCT00442962|515840478|FG000|Overall Study|Pregnancy|1|||
143082727|NCT00442962|515840478|FG000|Overall Study|Lost to Follow-up|7|||
143082728|NCT00191191|515840479|FG000|Overall Study|Entry Criteria Exclusion|2|||
143082729|NCT00191191|515840480|FG001|Overall Study|Entry Criteria Exclusion|0|||
143082730|NCT00191191|515840479|FG000|Overall Study|Treated with Another Systemic Agent|1|||
143082731|NCT00191191|515840480|FG001|Overall Study|Treated with Another Systemic Agent|1|||
143082732|NCT00191191|515840479|FG000|Overall Study|Adverse Event|11|||
143082733|NCT00191191|515840480|FG001|Overall Study|Adverse Event|21|||
143082734|NCT00191191|515840479|FG000|Overall Study|Progressive Disease|84|||
143082735|NCT00191191|515840480|FG001|Overall Study|Progressive Disease|72|||
143082736|NCT00191191|515840479|FG000|Overall Study|Toxicity After Dose Reduction|7|||
143082737|NCT00191191|515840480|FG001|Overall Study|Toxicity After Dose Reduction|8|||
143082738|NCT00191191|515840479|FG000|Overall Study|Family/Caregiver Decision|5|||
143082739|NCT00191191|515840480|FG001|Overall Study|Family/Caregiver Decision|7|||
143082740|NCT00191191|515840479|FG000|Overall Study|Lost to Follow-up|1|||
143082741|NCT00191191|515840480|FG001|Overall Study|Lost to Follow-up|0|||
143082742|NCT00191191|515840479|FG000|Overall Study|Physician Decision|3|||
143082743|NCT00191191|515840480|FG001|Overall Study|Physician Decision|2|||
143082744|NCT00191191|515840479|FG000|Overall Study|Good Clinical Practice Violation|0|||
143082745|NCT00191191|515840480|FG001|Overall Study|Good Clinical Practice Violation|1|||
143082746|NCT04238650|515840481|FG000|Overall Study|Withdrawal by Subject|0|||
143082747|NCT04238650|515840482|FG001|Overall Study|Withdrawal by Subject|1|||
143082748|NCT03633825|515840483|FG000|Enrollment|Did not post on network|5066|||
143082749|NCT03633825|515840484|FG001|Enrollment|Did not post on network|5080|||
143082750|NCT03633825|515840483|FG000|Enrollment|Post not classified as crisis|13967|||
143082751|NCT03633825|515840484|FG001|Enrollment|Post not classified as crisis|13757|||
143082752|NCT03633825|515840483|FG000|Follow up|Lost to Follow-up|478|||
143082753|NCT03633825|515840484|FG001|Follow up|Lost to Follow-up|450|||
143082754|NCT03348163|515840485|FG000|Overall Study|Withdrawal by Subject|2|||
143082755|NCT03348163|515840486|FG001|Overall Study|Withdrawal by Subject|0|||
143082756|NCT00356525|515840489|FG000|Overall Study|Progressive Disease|8|||
143082757|NCT00356525|515840490|FG001|Overall Study|Progressive Disease|5|||
143082758|NCT00356525|515840491|FG002|Overall Study|Progressive Disease|4|||
143082759|NCT00356525|515840492|FG003|Overall Study|Progressive Disease|2|||
143082760|NCT00356525|515840489|FG000|Overall Study|Adverse Event|1|||
143082761|NCT00356525|515840490|FG001|Overall Study|Adverse Event|3|||
143082762|NCT00356525|515840491|FG002|Overall Study|Adverse Event|1|||
143082763|NCT00356525|515840492|FG003|Overall Study|Adverse Event|1|||
143082764|NCT00356525|515840489|FG000|Overall Study|Lost to Follow-up|1|||
143082765|NCT00356525|515840490|FG001|Overall Study|Lost to Follow-up|0|||
143082766|NCT00356525|515840491|FG002|Overall Study|Lost to Follow-up|0|||
143082767|NCT00356525|515840492|FG003|Overall Study|Lost to Follow-up|0|||
143082768|NCT00356525|515840489|FG000|Overall Study|Physician Decision|2|||
143082769|NCT00356525|515840490|FG001|Overall Study|Physician Decision|2|||
143082770|NCT00356525|515840491|FG002|Overall Study|Physician Decision|2|||
143082771|NCT00356525|515840492|FG003|Overall Study|Physician Decision|1|||
143082772|NCT00356525|515840489|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
143082773|NCT00356525|515840490|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
143082774|NCT00356525|515840491|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
143082775|NCT00356525|515840492|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
143082776|NCT00356525|515840489|FG000|Overall Study|Withdrawal by Subject|1|||
143082777|NCT00356525|515840490|FG001|Overall Study|Withdrawal by Subject|1|||
143082778|NCT00356525|515840491|FG002|Overall Study|Withdrawal by Subject|0|||
143082779|NCT00356525|515840492|FG003|Overall Study|Withdrawal by Subject|3|||
143082780|NCT00356525|515840489|FG000|Overall Study|Death|0|||
143082781|NCT00356525|515840490|FG001|Overall Study|Death|0|||
143082782|NCT00356525|515840491|FG002|Overall Study|Death|0|||
143082783|NCT00356525|515840492|FG003|Overall Study|Death|1|||
143082784|NCT00356525|515840489|FG000|Overall Study|Sponsor Decision|0|||
143082785|NCT00356525|515840490|FG001|Overall Study|Sponsor Decision|0|||
143082786|NCT00356525|515840491|FG002|Overall Study|Sponsor Decision|0|||
143082787|NCT00356525|515840492|FG003|Overall Study|Sponsor Decision|1|||
143082788|NCT00214383|515840498|FG000|Overall Study|Lost to Follow-up|16|||
143082789|NCT00214383|515840499|FG001|Overall Study|Lost to Follow-up|26|||
143082790|NCT00879411|515840500|FG000|Overall Study|lost to follow-up (non-AE)|162|||
143082791|NCT01038297|515840501|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
143082792|NCT01038297|515840502|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
143082793|NCT01038297|515840503|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
143082794|NCT01685840|515840514|FG000|Overall Study|Death|77|||
143082795|NCT01685840|515840515|FG001|Overall Study|Death|66|||
143082796|NCT01685840|515840514|FG000|Overall Study|Lost to Follow-up|27|||
143082797|NCT01685840|515840515|FG001|Overall Study|Lost to Follow-up|25|||
143082798|NCT01685840|515840514|FG000|Overall Study|Physician Decision|3|||
143082799|NCT01685840|515840515|FG001|Overall Study|Physician Decision|7|||
143082800|NCT01685840|515840514|FG000|Overall Study|Withdrawal by Subject|14|||
143082801|NCT01685840|515840515|FG001|Overall Study|Withdrawal by Subject|17|||
143082802|NCT01685840|515840514|FG000|Overall Study|Futility|197|||
143082803|NCT01685840|515840515|FG001|Overall Study|Futility|200|||
143082804|NCT01685840|515840514|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
143082805|NCT01685840|515840515|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
143082806|NCT00710866|515840516|FG000|Overall Study|Protocol Violation|5|||
143082807|NCT00710866|515840517|FG001|Overall Study|Protocol Violation|4|||
143082808|NCT00710866|515840516|FG000|Overall Study|Withdrawal by Subject|2|||
143082809|NCT00710866|515840517|FG001|Overall Study|Withdrawal by Subject|1|||
143082810|NCT00710866|515840516|FG000|Overall Study|Lost to Follow-up|1|||
143082811|NCT00710866|515840517|FG001|Overall Study|Lost to Follow-up|0|||
143082812|NCT00710866|515840516|FG000|Overall Study|Failed to meet eligibility|1|||
143082813|NCT00710866|515840517|FG001|Overall Study|Failed to meet eligibility|1|||
143082814|NCT04759768|515840524|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
143082815|NCT04759768|515840525|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
143082816|NCT04759768|515840524|FG000|Washout (7 Days)|Physician Decision|0|||
143082817|NCT04759768|515840525|FG001|Washout (7 Days)|Physician Decision|1|||
143082818|NCT01128543|515840526|FG000|Overall Study|Withdrawal by Subject|3|||
143082819|NCT01128543|515840526|FG000|Overall Study|Protocol Violation|1|||
143082820|NCT03516513|515840527|FG000|Overall Study|Withdrawal by Subject|2|||
143249093|NCT01802073|516465124|FG000|Overall Study|Non-compliant|4|||
143249094|NCT01802073|516465125|FG001|Overall Study|Non-compliant|2|||
143082821|NCT03516513|515840528|FG001|Overall Study|Withdrawal by Subject|2|||
143082822|NCT03516513|515840529|FG002|Overall Study|Withdrawal by Subject|0|||
143249095|NCT01802073|516465124|FG000|Overall Study|Withdrawal by Subject|1|||
143082823|NCT03516513|515840530|FG003|Overall Study|Withdrawal by Subject|0|||
143082824|NCT01130597|515840531|FG000|Overall Study|Protocol-specified (High K+)|1|||
143082825|NCT01130597|515840531|FG000|Overall Study|Adverse Event|4|||
143082826|NCT01130597|515840531|FG000|Overall Study|Death|1|||
143082827|NCT01130597|515840531|FG000|Overall Study|Protocol Violation|1|||
143082828|NCT03052127|515840532|FG000|Overall Study|Withdrawal by Subject|0|||
143249096|NCT01802073|516465125|FG001|Overall Study|Withdrawal by Subject|1|||
143249097|NCT01802073|516465124|FG000|Overall Study|Physician Decision|0|||
143249098|NCT01802073|516465125|FG001|Overall Study|Physician Decision|7|||
143249099|NCT00918736|516465128|FG000|Overall Study|Withdrawal by Subject|4|||
143249100|NCT03462511|516465132|FG000|Overall Study|Withdrawal by Subject|2|||
143249101|NCT03462511|516465133|FG001|Overall Study|Withdrawal by Subject|3|||
143249102|NCT02925416|516465134|FG000|Overall Study|Adverse Event|2|||
143249103|NCT02925416|516465135|FG001|Overall Study|Adverse Event|0|||
143082829|NCT03052127|515840533|FG001|Overall Study|Withdrawal by Subject|0|||
143082830|NCT03052127|515840534|FG002|Overall Study|Withdrawal by Subject|0|||
143082831|NCT03052127|515840535|FG003|Overall Study|Withdrawal by Subject|0|||
143082832|NCT03052127|515840536|FG004|Overall Study|Withdrawal by Subject|0|||
143082833|NCT03052127|515840537|FG005|Overall Study|Withdrawal by Subject|0|||
143082834|NCT03052127|515840538|FG006|Overall Study|Withdrawal by Subject|0|||
143082835|NCT03052127|515840539|FG007|Overall Study|Withdrawal by Subject|1|||
143082836|NCT03052127|515840540|FG008|Overall Study|Withdrawal by Subject|1|||
143082837|NCT03052127|515840541|FG009|Overall Study|Withdrawal by Subject|1|||
143082838|NCT03052127|515840542|FG010|Overall Study|Withdrawal by Subject|0|||
143082839|NCT03052127|515840543|FG011|Overall Study|Withdrawal by Subject|0|||
143082840|NCT03052127|515840532|FG000|Overall Study|Discontinuation by Sponsor|0|||
143082841|NCT03052127|515840533|FG001|Overall Study|Discontinuation by Sponsor|0|||
143082842|NCT03052127|515840534|FG002|Overall Study|Discontinuation by Sponsor|0|||
143082843|NCT03052127|515840535|FG003|Overall Study|Discontinuation by Sponsor|0|||
143082844|NCT03052127|515840536|FG004|Overall Study|Discontinuation by Sponsor|0|||
143082845|NCT03052127|515840537|FG005|Overall Study|Discontinuation by Sponsor|0|||
143082846|NCT03052127|515840538|FG006|Overall Study|Discontinuation by Sponsor|0|||
143082847|NCT03052127|515840539|FG007|Overall Study|Discontinuation by Sponsor|0|||
143082848|NCT03052127|515840540|FG008|Overall Study|Discontinuation by Sponsor|4|||
143082849|NCT03052127|515840541|FG009|Overall Study|Discontinuation by Sponsor|2|||
143082850|NCT03052127|515840542|FG010|Overall Study|Discontinuation by Sponsor|5|||
143082851|NCT03052127|515840543|FG011|Overall Study|Discontinuation by Sponsor|13|||
143082852|NCT03052127|515840532|FG000|Overall Study|Inability to comply with trial requirements|0|||
143082853|NCT03052127|515840533|FG001|Overall Study|Inability to comply with trial requirements|0|||
143082854|NCT03052127|515840534|FG002|Overall Study|Inability to comply with trial requirements|1|||
143082855|NCT03052127|515840535|FG003|Overall Study|Inability to comply with trial requirements|0|||
143082856|NCT03052127|515840536|FG004|Overall Study|Inability to comply with trial requirements|0|||
143082857|NCT03052127|515840537|FG005|Overall Study|Inability to comply with trial requirements|0|||
143082858|NCT03052127|515840538|FG006|Overall Study|Inability to comply with trial requirements|0|||
143082859|NCT03052127|515840539|FG007|Overall Study|Inability to comply with trial requirements|0|||
143082860|NCT03052127|515840540|FG008|Overall Study|Inability to comply with trial requirements|0|||
143082861|NCT03052127|515840541|FG009|Overall Study|Inability to comply with trial requirements|0|||
143082862|NCT03052127|515840542|FG010|Overall Study|Inability to comply with trial requirements|0|||
143082863|NCT03052127|515840543|FG011|Overall Study|Inability to comply with trial requirements|0|||
143082864|NCT03052127|515840532|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
143082865|NCT03052127|515840533|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
143082866|NCT03052127|515840534|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
143082867|NCT03052127|515840535|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
143082868|NCT03052127|515840536|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
143082869|NCT03052127|515840537|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
143082870|NCT03052127|515840538|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
143082871|NCT03052127|515840539|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
143082872|NCT03052127|515840540|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
143082873|NCT03052127|515840541|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
143082874|NCT03052127|515840542|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
143082875|NCT03052127|515840543|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
143082876|NCT03922529|515842428|FG000|Overall Study|Withdrawal by Subject|13|||
143082877|NCT03922529|515842429|FG001|Overall Study|Withdrawal by Subject|12|||
143082878|NCT03922529|515842428|FG000|Overall Study|Death|7|||
143082879|NCT03922529|515842429|FG001|Overall Study|Death|12|||
143082880|NCT03922529|515842428|FG000|Overall Study|Lost to Follow-up|12|||
143082881|NCT03922529|515842429|FG001|Overall Study|Lost to Follow-up|19|||
143082882|NCT03922529|515842428|FG000|Overall Study|Adverse Event|1|||
143082883|NCT03922529|515842429|FG001|Overall Study|Adverse Event|0|||
143082884|NCT03922529|515842428|FG000|Overall Study|Death after withdrawal|1|||
143082885|NCT03922529|515842429|FG001|Overall Study|Death after withdrawal|0|||
143082886|NCT03922529|515842428|FG000|Overall Study|Participant was contacted for final visit and declined to complete|1|||
143082887|NCT03922529|515842429|FG001|Overall Study|Participant was contacted for final visit and declined to complete|0|||
143082888|NCT03922529|515842428|FG000|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|1|||
143082889|NCT03922529|515842429|FG001|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|0|||
143082890|NCT02017015|515842430|FG000|Overall Study|Adverse Event|9|||
143082891|NCT02017015|515842430|FG000|Overall Study|Withdrawal by Subject|21|||
143082892|NCT02017015|515842430|FG000|Overall Study|Death|4|||
143082893|NCT02017015|515842430|FG000|Overall Study|Progressive Disease|31|||
143082894|NCT02017015|515842430|FG000|Overall Study|Non-compliance with study drug|2|||
143082895|NCT02017015|515842430|FG000|Overall Study|Physician Decision|2|||
143082896|NCT02260570|515842431|FG000|Overall Study|Withdrawal by Subject|2|||
143082897|NCT02260570|515842432|FG001|Overall Study|Withdrawal by Subject|1|||
143082898|NCT02260570|515842431|FG000|Overall Study|Physician Decision|1|||
143082899|NCT02260570|515842432|FG001|Overall Study|Physician Decision|1|||
143082900|NCT04034927|515842433|FG000|Overall Study|Adverse Event|4|||
143082901|NCT04034927|515842434|FG001|Overall Study|Adverse Event|9|||
143082902|NCT04034927|515842433|FG000|Overall Study|Death|0|||
143082903|NCT04034927|515842434|FG001|Overall Study|Death|1|||
143082904|NCT04034927|515842433|FG000|Overall Study|Withdrawal by Subject|0|||
143082905|NCT04034927|515842434|FG001|Overall Study|Withdrawal by Subject|3|||
143082906|NCT04034927|515842433|FG000|Overall Study|Still on Treatment|2|||
143082907|NCT04034927|515842434|FG001|Overall Study|Still on Treatment|1|||
143249104|NCT00200356|516465136|FG000|Overall Study|Lack of Efficacy|3|||
143082908|NCT04034927|515842433|FG000|Overall Study|Other|1|||
143082909|NCT04034927|515842434|FG001|Overall Study|Other|1|||
143082910|NCT04158245|515842435|FG000|Overall Study|Lost to Follow-up|1|||
143082911|NCT04458922|515842436|FG000|Overall Study|Withdrawal by Subject|1|||
143082912|NCT04458922|515842437|FG001|Overall Study|Withdrawal by Subject|0|||
143082913|NCT04458922|515842438|FG002|Overall Study|Withdrawal by Subject|2|||
143082914|NCT04458922|515842436|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
143082915|NCT04458922|515842437|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
143082916|NCT04458922|515842438|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
143082917|NCT04458922|515842436|FG000|Overall Study|Adverse Event|1|||
143082918|NCT04458922|515842437|FG001|Overall Study|Adverse Event|0|||
143082919|NCT04458922|515842438|FG002|Overall Study|Adverse Event|0|||
143082920|NCT04458922|515842436|FG000|Overall Study|Started new study|0|||
143082921|NCT04458922|515842437|FG001|Overall Study|Started new study|0|||
143082922|NCT04458922|515842438|FG002|Overall Study|Started new study|1|||
143082923|NCT04458922|515842436|FG000|Overall Study|Progressive disease|6|||
143082924|NCT04458922|515842437|FG001|Overall Study|Progressive disease|8|||
143082925|NCT04458922|515842438|FG002|Overall Study|Progressive disease|2|||
143082926|NCT04458922|515842436|FG000|Overall Study|Death|1|||
143082927|NCT04458922|515842437|FG001|Overall Study|Death|0|||
143082928|NCT04458922|515842438|FG002|Overall Study|Death|2|||
143082929|NCT04458922|515842436|FG000|Overall Study|Participant started chemotherapy|0|||
143082930|NCT04458922|515842437|FG001|Overall Study|Participant started chemotherapy|1|||
143082931|NCT04458922|515842438|FG002|Overall Study|Participant started chemotherapy|0|||
143082932|NCT00369486|515842441|FG000|4-Week Visit|Missed visit|2|||
143082933|NCT00369486|515842442|FG001|4-Week Visit|Missed visit|2|||
143082934|NCT00369486|515842443|FG002|4-Week Visit|Missed visit|0|||
143082935|NCT00369486|515842444|FG003|4-Week Visit|Missed visit|2|||
143082936|NCT00369486|515842445|FG004|4-Week Visit|Missed visit|1|||
143082937|NCT00369486|515842441|FG000|4-Week Visit|Dropped|0|||
143082938|NCT00369486|515842442|FG001|4-Week Visit|Dropped|0|||
143082939|NCT00369486|515842443|FG002|4-Week Visit|Dropped|1|||
143082940|NCT00369486|515842444|FG003|4-Week Visit|Dropped|0|||
143082941|NCT00369486|515842445|FG004|4-Week Visit|Dropped|0|||
143082942|NCT00369486|515842441|FG000|8-Week Visit|Missed visit|0|||
143082943|NCT00369486|515842442|FG001|8-Week Visit|Missed visit|1|||
143082944|NCT00369486|515842443|FG002|8-Week Visit|Missed visit|0|||
143082945|NCT00369486|515842444|FG003|8-Week Visit|Missed visit|0|||
143082946|NCT00369486|515842445|FG004|8-Week Visit|Missed visit|1|||
143082947|NCT00369486|515842441|FG000|8-Week Visit|Dropped|0|||
143082948|NCT00369486|515842442|FG001|8-Week Visit|Dropped|0|||
143082949|NCT00369486|515842443|FG002|8-Week Visit|Dropped|0|||
143082950|NCT00369486|515842444|FG003|8-Week Visit|Dropped|1|||
143082951|NCT00369486|515842445|FG004|8-Week Visit|Dropped|0|||
143082952|NCT00369486|515842441|FG000|17-Week Visit|Missed visit|0|||
143082953|NCT00369486|515842442|FG001|17-Week Visit|Missed visit|0|||
143082954|NCT00369486|515842443|FG002|17-Week Visit|Missed visit|1|||
143082955|NCT00369486|515842444|FG003|17-Week Visit|Missed visit|1|||
143082956|NCT00369486|515842445|FG004|17-Week Visit|Missed visit|1|||
143082957|NCT00369486|515842441|FG000|34-Week Visit|Dropped|0|||
143082958|NCT00369486|515842442|FG001|34-Week Visit|Dropped|1|||
143082959|NCT00369486|515842443|FG002|34-Week Visit|Dropped|1|||
143082960|NCT00369486|515842444|FG003|34-Week Visit|Dropped|3|||
143082961|NCT00369486|515842445|FG004|34-Week Visit|Dropped|3|||
143082962|NCT01810302|515842452|FG000|Overall Study|Death|1|||
143082963|NCT01810302|515842453|FG001|Overall Study|Death|0|||
143082964|NCT01810302|515842452|FG000|Overall Study|Physician Decision|0|||
143082965|NCT01810302|515842453|FG001|Overall Study|Physician Decision|1|||
143082966|NCT01659125|515842457|FG000|Overall Study|Withdrawal by Subject|2|||
143082967|NCT01659125|515842457|FG000|Overall Study|Lost to Follow-up|7|||
143082968|NCT01659125|515842457|FG000|Overall Study|Technical Problem|1|||
143082969|NCT01659125|515842457|FG000|Overall Study|Time Constraints|2|||
143082970|NCT01659125|515842457|FG000|Overall Study|Failed to Start Treatment|2|||
143082971|NCT04856930|515842458|FG000|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|6|||
143082972|NCT04856930|515842459|FG001|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|5|||
143082973|NCT04856930|515842460|FG002|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|4|||
143082974|NCT04856930|515842458|FG000|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|3|||
143082975|NCT04856930|515842459|FG001|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|1|||
143082976|NCT04856930|515842460|FG002|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|0|||
143082977|NCT04856930|515842458|FG000|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
143082978|NCT04856930|515842459|FG001|Placebo-controlled Period (16 Weeks)|Pregnancy|1|||
143082979|NCT04856930|515842460|FG002|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
143082980|NCT04856930|515842458|FG000|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
143082981|NCT04856930|515842459|FG001|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
143082982|NCT04856930|515842460|FG002|Placebo-controlled Period (16 Weeks)|Protocol Violation|1|||
143082983|NCT04856930|515842458|FG000|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
143082984|NCT04856930|515842459|FG001|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
143082985|NCT04856930|515842460|FG002|Placebo-controlled Period (16 Weeks)|Adverse Event|1|||
143082986|NCT04856930|515842458|FG000|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
143082987|NCT04856930|515842459|FG001|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
143082988|NCT04856930|515842460|FG002|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
143082989|NCT04856930|515842458|FG000|Extension Period (16 Weeks)|Withdrawal by Subject|9|||
143082990|NCT04856930|515842459|FG001|Extension Period (16 Weeks)|Withdrawal by Subject|5|||
143082991|NCT04856930|515842460|FG002|Extension Period (16 Weeks)|Withdrawal by Subject|1|||
143082992|NCT04856930|515842458|FG000|Extension Period (16 Weeks)|Lost to Follow-up|2|||
143082993|NCT04856930|515842459|FG001|Extension Period (16 Weeks)|Lost to Follow-up|5|||
143082994|NCT04856930|515842460|FG002|Extension Period (16 Weeks)|Lost to Follow-up|1|||
143082995|NCT04856930|515842458|FG000|Extension Period (16 Weeks)|Adverse Event|1|||
143082996|NCT04856930|515842459|FG001|Extension Period (16 Weeks)|Adverse Event|0|||
143082997|NCT04856930|515842460|FG002|Extension Period (16 Weeks)|Adverse Event|1|||
143082998|NCT04856930|515842458|FG000|Extension Period (16 Weeks)|Pregnancy|0|||
143082999|NCT04856930|515842459|FG001|Extension Period (16 Weeks)|Pregnancy|0|||
143249105|NCT00200356|516465137|FG001|Overall Study|Lack of Efficacy|3|||
143083000|NCT04856930|515842460|FG002|Extension Period (16 Weeks)|Pregnancy|2|||
143083001|NCT04856930|515842458|FG000|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
143083002|NCT04856930|515842459|FG001|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
143083003|NCT04856930|515842460|FG002|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
143083004|NCT04856930|515842458|FG000|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
143083005|NCT04856930|515842459|FG001|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
143083006|NCT04856930|515842460|FG002|Extension Period (16 Weeks)|Stopped participation by Sponsor|2|||
143083007|NCT04856930|515842458|FG000|Extension Period (16 Weeks)|Other than specified|0|||
143083008|NCT04856930|515842459|FG001|Extension Period (16 Weeks)|Other than specified|0|||
143083009|NCT04856930|515842460|FG002|Extension Period (16 Weeks)|Other than specified|1|||
143083010|NCT04856930|515842458|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
143083011|NCT04856930|515842459|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
143083012|NCT04856930|515842460|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
143083013|NCT04856930|515842458|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
143083014|NCT04856930|515842459|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
143083015|NCT04856930|515842460|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|1|||
143083016|NCT04856930|515842458|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
143083017|NCT04856930|515842459|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
143083018|NCT04856930|515842460|FG002|Follow-up Period (8 Weeks)|Adverse Event|1|||
143083019|NCT04856930|515842458|FG000|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
143083020|NCT04856930|515842459|FG001|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
143083021|NCT04856930|515842460|FG002|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|17|||
143083022|NCT02465398|515842466|FG000|Overall Study|Death|7|||
143083023|NCT02465398|515842466|FG000|Overall Study|Revision|7|||
143083024|NCT02465398|515842466|FG000|Overall Study|did not receive study device|1|||
143083025|NCT02465398|515842466|FG000|Overall Study|Withdrawal by Subject|1|||
143083026|NCT02465398|515842466|FG000|Overall Study|Lost to Follow-up|14|||
143083027|NCT00678210|515842467|FG000|Overall Study|Adverse Event|1|||
143083028|NCT00678210|515842468|FG001|Overall Study|Adverse Event|2|||
143083029|NCT00678210|515842469|FG002|Overall Study|Adverse Event|3|||
143083030|NCT00678210|515842470|FG003|Overall Study|Adverse Event|3|||
143083031|NCT00678210|515842467|FG000|Overall Study|Lack of Efficacy|2|||
143083032|NCT00678210|515842468|FG001|Overall Study|Lack of Efficacy|3|||
143083033|NCT00678210|515842469|FG002|Overall Study|Lack of Efficacy|1|||
143083034|NCT00678210|515842470|FG003|Overall Study|Lack of Efficacy|9|||
143083035|NCT00678210|515842467|FG000|Overall Study|Lost to Follow-up|4|||
143083036|NCT00678210|515842468|FG001|Overall Study|Lost to Follow-up|2|||
143083037|NCT00678210|515842469|FG002|Overall Study|Lost to Follow-up|0|||
143083038|NCT00678210|515842470|FG003|Overall Study|Lost to Follow-up|1|||
143083039|NCT00678210|515842467|FG000|Overall Study|Withdrawal by Subject|3|||
143083040|NCT00678210|515842468|FG001|Overall Study|Withdrawal by Subject|4|||
143083041|NCT00678210|515842469|FG002|Overall Study|Withdrawal by Subject|1|||
143083042|NCT00678210|515842470|FG003|Overall Study|Withdrawal by Subject|7|||
143083043|NCT00678210|515842467|FG000|Overall Study|Other|1|||
143083044|NCT00678210|515842468|FG001|Overall Study|Other|0|||
143083045|NCT00678210|515842469|FG002|Overall Study|Other|1|||
143083046|NCT00678210|515842470|FG003|Overall Study|Other|0|||
143083047|NCT04825912|515842471|FG000|Overall Study|Death|3|||
143083048|NCT04825912|515842471|FG000|Overall Study|Withdrawal by Subject|1|||
143083049|NCT01009814|515842472|FG000|Overall Study|No longer met study criteria|1|||
143249106|NCT00200356|516465136|FG000|Overall Study|Protocol Violation|4|||
143249107|NCT00200356|516465137|FG001|Overall Study|Protocol Violation|4|||
143249108|NCT00200356|516465136|FG000|Overall Study|Nontreatment|1|||
143083050|NCT01009814|515842473|FG001|Overall Study|No longer met study criteria|1|||
143249109|NCT00200356|516465137|FG001|Overall Study|Nontreatment|0|||
143083051|NCT01009814|515842474|FG002|Overall Study|No longer met study criteria|0|||
143083052|NCT01009814|515842475|FG003|Overall Study|No longer met study criteria|0|||
143083053|NCT01009814|515842476|FG004|Overall Study|No longer met study criteria|0|||
143083054|NCT01611857|515842484|FG000|Overall Study|Withdrawal by Subject|0|||
143083055|NCT01611857|515842485|FG001|Overall Study|Withdrawal by Subject|2|||
143083056|NCT02075515|515842486|FG000|Overall Study|Serious Adverse Event|1|||
143083057|NCT02075515|515842487|FG001|Overall Study|Serious Adverse Event|1|||
143083058|NCT02075515|515842488|FG002|Overall Study|Serious Adverse Event|1|||
143083059|NCT02075515|515842486|FG000|Overall Study|Non-Serious Adverse Event|0|||
143083060|NCT02075515|515842487|FG001|Overall Study|Non-Serious Adverse Event|1|||
143083061|NCT02075515|515842488|FG002|Overall Study|Non-Serious Adverse Event|0|||
143083062|NCT02075515|515842486|FG000|Overall Study|Withdrawal by Subject|2|||
143083063|NCT02075515|515842487|FG001|Overall Study|Withdrawal by Subject|0|||
143083064|NCT02075515|515842488|FG002|Overall Study|Withdrawal by Subject|1|||
143083065|NCT02075515|515842486|FG000|Overall Study|Lost to Follow-up|1|||
143083066|NCT02075515|515842487|FG001|Overall Study|Lost to Follow-up|3|||
143083067|NCT02075515|515842488|FG002|Overall Study|Lost to Follow-up|6|||
143083068|NCT01372748|515842491|FG000|Overall Study|Lost to Follow-up|16|||
143083069|NCT01372748|515842492|FG001|Overall Study|Lost to Follow-up|34|||
143083070|NCT01372748|515842491|FG000|Overall Study|Withdrawal by Subject|7|||
143083071|NCT01372748|515842492|FG001|Overall Study|Withdrawal by Subject|5|||
143083072|NCT00134901|515842493|FG000|Overall Study|Lost to Follow-up|5|||
143083073|NCT00134901|515842494|FG001|Overall Study|Lost to Follow-up|5|||
143083074|NCT00134901|515842493|FG000|Overall Study|discontinued intervention|12|||
143083075|NCT00134901|515842494|FG001|Overall Study|discontinued intervention|10|||
143083076|NCT03908437|515842495|FG000|Overall Study|Death|0|||
143083077|NCT03908437|515842496|FG001|Overall Study|Death|1|||
143083078|NCT03908437|515842495|FG000|Overall Study|Lost to Follow-up|31|||
143083079|NCT03908437|515842496|FG001|Overall Study|Lost to Follow-up|24|||
143083080|NCT05445492|515842499|FG000|Overall Study|Physician Decision|1|||
143083081|NCT01295320|515842500|FG000|Overall Study|Adverse Event|2|||
143083082|NCT01295320|515842500|FG000|Overall Study|Lost to Follow-up|4|||
143083083|NCT01295320|515842500|FG000|Overall Study|Withdrawal by Subject|2|||
143083084|NCT01295320|515842500|FG000|Overall Study|Subject was bedridden|1|||
143083085|NCT01295320|515842500|FG000|Overall Study|Unable to travel|1|||
143083086|NCT05124691|515842501|FG000|Phase II|Eligibility criteria|0|||
143083087|NCT05124691|515842502|FG001|Phase II|Eligibility criteria|1|||
143083088|NCT05124691|515842503|FG002|Phase II|Eligibility criteria|0|||
143083089|NCT05124691|515842501|FG000|Phase II|Withdrawal by Subject|6|||
143083090|NCT05124691|515842502|FG001|Phase II|Withdrawal by Subject|2|||
143083091|NCT05124691|515842503|FG002|Phase II|Withdrawal by Subject|3|||
143083092|NCT05124691|515842501|FG000|Phase III|Withdrawal by Subject|6|||
143083093|NCT05124691|515842502|FG001|Phase III|Withdrawal by Subject|4|||
143083094|NCT05124691|515842503|FG002|Phase III|Withdrawal by Subject|4|||
143083095|NCT05124691|515842501|FG000|Phase III|Lost to Follow-up|1|||
143249110|NCT03679754|516465140|FG000|Overall Study|Investigator request|1|||
143249111|NCT00964171|516465141|FG000|Overall Study|Death|5|||
143249112|NCT02872935|516465142|FG000|Overall Study|Other|0|||
143249113|NCT02872935|516465143|FG001|Overall Study|Other|1|||
143083096|NCT05124691|515842502|FG001|Phase III|Lost to Follow-up|0|||
143083097|NCT05124691|515842503|FG002|Phase III|Lost to Follow-up|0|||
143083098|NCT03509467|515842504|FG000|Overall Study|Withdrawal by Subject|5|||
143083099|NCT03509467|515842505|FG001|Overall Study|Withdrawal by Subject|1|||
143249114|NCT05343624|516465144|FG000|Overall Study|Chart review not completed|1|||
143083100|NCT03509467|515842506|FG002|Overall Study|Withdrawal by Subject|6|||
143083101|NCT03509467|515842507|FG003|Overall Study|Withdrawal by Subject|7|||
143083102|NCT03509467|515842508|FG004|Overall Study|Withdrawal by Subject|10|||
143083103|NCT03509467|515842509|FG005|Overall Study|Withdrawal by Subject|10|||
143083104|NCT03509467|515842510|FG006|Overall Study|Withdrawal by Subject|10|||
143083105|NCT03509467|515842511|FG007|Overall Study|Withdrawal by Subject|10|||
143083106|NCT03509467|515842504|FG000|Overall Study|Death|0|||
143083107|NCT03509467|515842505|FG001|Overall Study|Death|0|||
143083108|NCT03509467|515842506|FG002|Overall Study|Death|2|||
143083109|NCT03509467|515842507|FG003|Overall Study|Death|2|||
143083110|NCT03509467|515842508|FG004|Overall Study|Death|1|||
143083111|NCT03509467|515842509|FG005|Overall Study|Death|0|||
143083112|NCT03509467|515842510|FG006|Overall Study|Death|1|||
143083113|NCT03509467|515842511|FG007|Overall Study|Death|0|||
143083114|NCT03509467|515842504|FG000|Overall Study|Proxy Withdrawal|0|||
143083115|NCT03509467|515842505|FG001|Overall Study|Proxy Withdrawal|0|||
143083116|NCT03509467|515842506|FG002|Overall Study|Proxy Withdrawal|0|||
143083117|NCT03509467|515842507|FG003|Overall Study|Proxy Withdrawal|0|||
143083118|NCT03509467|515842508|FG004|Overall Study|Proxy Withdrawal|0|||
143083119|NCT03509467|515842509|FG005|Overall Study|Proxy Withdrawal|0|||
143083120|NCT03509467|515842510|FG006|Overall Study|Proxy Withdrawal|0|||
143083121|NCT03509467|515842511|FG007|Overall Study|Proxy Withdrawal|1|||
143083122|NCT00428116|515842512|FG000|Overall Study|Death|1|||
143083123|NCT00428116|515842513|FG001|Overall Study|Death|0|||
143083124|NCT00428116|515842512|FG000|Overall Study|Withdrawal by Subject|1|||
143083125|NCT00428116|515842513|FG001|Overall Study|Withdrawal by Subject|0|||
143083126|NCT00428116|515842512|FG000|Overall Study|Lost to Follow-up|1|||
143083127|NCT00428116|515842513|FG001|Overall Study|Lost to Follow-up|0|||
143083128|NCT02125877|515842514|FG000|Overall Study|Physician Decision|1|||
143083129|NCT02125877|515842515|FG001|Overall Study|Physician Decision|0|||
143083130|NCT02125877|515842514|FG000|Overall Study|Death|0|||
143083131|NCT02125877|515842515|FG001|Overall Study|Death|1|||
143083132|NCT02125877|515842514|FG000|Overall Study|Administrative problems|0|||
143083133|NCT02125877|515842515|FG001|Overall Study|Administrative problems|1|||
143083134|NCT02125877|515842514|FG000|Overall Study|Participant/guardian decision|0|||
143083135|NCT02125877|515842515|FG001|Overall Study|Participant/guardian decision|2|||
143083136|NCT02125877|515842514|FG000|Overall Study|Withdrawal by Subject|2|||
143083137|NCT02125877|515842515|FG001|Overall Study|Withdrawal by Subject|1|||
143083138|NCT02125877|515842514|FG000|Overall Study|Protocol deviation|4|||
143083139|NCT02125877|515842515|FG001|Overall Study|Protocol deviation|1|||
143083140|NCT02125877|515842514|FG000|Overall Study|Adverse Event|6|||
143083141|NCT02125877|515842515|FG001|Overall Study|Adverse Event|4|||
143083142|NCT01141205|515842516|FG000|Overall Study|Physician Decision|1|||
143083143|NCT01141205|515842517|FG001|Overall Study|Physician Decision|1|||
143083144|NCT01141205|515842516|FG000|Overall Study|Lost to Follow-up|1|||
143083145|NCT01141205|515842517|FG001|Overall Study|Lost to Follow-up|0|||
143083146|NCT01141205|515842516|FG000|Overall Study|Withdrawal by Subject|1|||
143083147|NCT01141205|515842517|FG001|Overall Study|Withdrawal by Subject|1|||
143083148|NCT02800642|515842518|FG000|Overall Study|Death|3|||
143083149|NCT02800642|515842518|FG000|Overall Study|Other|10|||
143083150|NCT02800642|515842518|FG000|Overall Study|Physician Decision|2|||
143083151|NCT02800642|515842518|FG000|Overall Study|Adverse Event|6|||
143173887|NCT04661033|516185348|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
143173888|NCT04661033|516185345|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
143083152|NCT02800642|515842518|FG000|Overall Study|Withdrawal by Subject|3|||
143083153|NCT02800642|515842518|FG000|Overall Study|Lost to Follow-up|1|||
143083154|NCT02374346|515842519|FG000|Overall Study|operated or discharged during weekend|48|||
143083155|NCT01941498|515842522|FG000|Overall Study|Relocated out of state|1|||
143083156|NCT00396565|515842527|FG000|Overall Study|Physician Decision|3|||
143083157|NCT00396565|515842528|FG001|Overall Study|Physician Decision|1|||
143083158|NCT00396565|515842529|FG002|Overall Study|Physician Decision|2|||
143083159|NCT00396565|515842527|FG000|Overall Study|Adverse Event|5|||
143083160|NCT00396565|515842528|FG001|Overall Study|Adverse Event|13|||
143083161|NCT00396565|515842529|FG002|Overall Study|Adverse Event|3|||
143083162|NCT00396565|515842527|FG000|Overall Study|Withdrawal by Subject|8|||
143083163|NCT00396565|515842528|FG001|Overall Study|Withdrawal by Subject|13|||
143083164|NCT00396565|515842529|FG002|Overall Study|Withdrawal by Subject|1|||
143083165|NCT00396565|515842527|FG000|Overall Study|Lack of Efficacy|32|||
143083166|NCT00396565|515842528|FG001|Overall Study|Lack of Efficacy|64|||
143083167|NCT00396565|515842529|FG002|Overall Study|Lack of Efficacy|11|||
143083168|NCT04487067|515842532|FG000|Overall Study|Adverse Event|3|||
143083169|NCT04487067|515842532|FG000|Overall Study|Death Other Than Progressive Disease|60|||
143083170|NCT04487067|515842532|FG000|Overall Study|Death Due To Progressive Disease|40|||
143249115|NCT00329797|516465145|FG000|Overall Study|Protocol Violation|1|||
143249116|NCT00329797|516465146|FG001|Overall Study|Protocol Violation|0|||
143249117|NCT00329797|516465145|FG000|Overall Study|Withdrawal by Subject|6|||
143249118|NCT00329797|516465146|FG001|Overall Study|Withdrawal by Subject|6|||
143249119|NCT01396070|516465161|FG000|Overall Study|Withdrawal by Subject|2|||
143249120|NCT01396070|516465161|FG000|Overall Study|Death|2|||
143249121|NCT01396070|516465161|FG000|Overall Study|Adverse Event|8|||
143249122|NCT01396070|516465161|FG000|Overall Study|Physician Decision|3|||
143249123|NCT01396070|516465161|FG000|Overall Study|Lack of Efficacy|4|||
143249124|NCT04254913|516465162|FG000|Overall Study|Adverse Event|1|||
143249125|NCT02695420|516465163|FG000|Overall Study|Death|0|||
143249126|NCT02695420|516465164|FG001|Overall Study|Death|1|||
143249127|NCT02695420|516465165|FG002|Overall Study|Death|0|||
143366459|NCT03425539|516884678|FG001|Overall Study|Withdrawal by Subject|0|||
143366460|NCT03425539|516884677|FG000|Overall Study|Lost to Follow-up|0|||
143366461|NCT03425539|516884678|FG001|Overall Study|Lost to Follow-up|1|||
143083171|NCT04487067|515842532|FG000|Overall Study|Lost to Follow-up|3|||
143083172|NCT04487067|515842532|FG000|Overall Study|Progressive Disease|1|||
143083173|NCT04487067|515842532|FG000|Overall Study|Protocol Violation|3|||
143249128|NCT02695420|516465166|FG003|Overall Study|Death|0|||
143249129|NCT02929407|516465167|FG000|Overall Study|Adverse Event|1|||
143249130|NCT03037580|516465168|FG000|Overall Study|Withdrawal by Subject|3|||
143249131|NCT03037580|516465169|FG001|Overall Study|Withdrawal by Subject|0|||
143249132|NCT03037580|516465168|FG000|Overall Study|Adverse Event|1|||
143366462|NCT01137292|516884679|FG000|Overall Study|Death|30|||
143083174|NCT04487067|515842532|FG000|Overall Study|Participant Discontinued From Study as per Protocol|6|||
143083175|NCT04487067|515842532|FG000|Overall Study|Withdrawal by Subject|15|||
143083176|NCT05299528|515842533|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
143083177|NCT05299528|515842534|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
143083178|NCT05299528|515842535|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
143083179|NCT05299528|515842536|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
143083180|NCT05299528|515842537|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
143083181|NCT05299528|515842538|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
143083182|NCT05299528|515842539|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
143083183|NCT05299528|515842533|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
143083184|NCT05299528|515842534|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
143083185|NCT05299528|515842535|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
143083186|NCT05299528|515842536|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
143083187|NCT05299528|515842537|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
143083188|NCT05299528|515842538|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
143083189|NCT05299528|515842539|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
143083190|NCT05299528|515842533|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
143083191|NCT05299528|515842534|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
143083192|NCT05299528|515842535|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
143083193|NCT05299528|515842536|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
143083194|NCT05299528|515842537|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
143083195|NCT05299528|515842538|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
143083196|NCT05299528|515842539|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
143083197|NCT04324021|515842540|FG000|Overall Study|Adverse Event|1|||
143083198|NCT04324021|515842541|FG001|Overall Study|Adverse Event|0|||
143083199|NCT04324021|515842542|FG002|Overall Study|Adverse Event|0|||
143083200|NCT04324021|515842540|FG000|Overall Study|Lack of Efficacy|0|||
143083201|NCT04324021|515842541|FG001|Overall Study|Lack of Efficacy|0|||
143083202|NCT04324021|515842542|FG002|Overall Study|Lack of Efficacy|1|||
143083203|NCT04324021|515842540|FG000|Overall Study|Death|1|||
143083204|NCT04324021|515842541|FG001|Overall Study|Death|1|||
143083205|NCT04324021|515842542|FG002|Overall Study|Death|0|||
143083206|NCT04877457|515842543|FG000|Overall Study|Early termination of study due to low enrollment|2|||
143083207|NCT04877457|515842544|FG001|Overall Study|Early termination of study due to low enrollment|1|||
143083208|NCT00246324|515842545|FG000|Overall Study|Withdrawal by Subject|1|||
143083209|NCT02006732|515842546|FG000|Overall Study|Adverse Event|10|||
143083210|NCT02006732|515842547|FG001|Overall Study|Adverse Event|7|||
143083211|NCT02006732|515842548|FG002|Overall Study|Adverse Event|4|||
143083212|NCT02006732|515842549|FG003|Overall Study|Adverse Event|2|||
143083213|NCT02006732|515842546|FG000|Overall Study|Lack of Efficacy|6|||
143083214|NCT02006732|515842547|FG001|Overall Study|Lack of Efficacy|3|||
143083215|NCT02006732|515842548|FG002|Overall Study|Lack of Efficacy|1|||
143083216|NCT02006732|515842549|FG003|Overall Study|Lack of Efficacy|1|||
143083217|NCT02006732|515842546|FG000|Overall Study|Protocol Violation|1|||
143083218|NCT02006732|515842547|FG001|Overall Study|Protocol Violation|1|||
143083219|NCT02006732|515842548|FG002|Overall Study|Protocol Violation|0|||
143083220|NCT02006732|515842549|FG003|Overall Study|Protocol Violation|0|||
143083221|NCT02006732|515842546|FG000|Overall Study|Lost to Follow-up|0|||
143083222|NCT02006732|515842547|FG001|Overall Study|Lost to Follow-up|1|||
143083223|NCT02006732|515842548|FG002|Overall Study|Lost to Follow-up|0|||
143083224|NCT02006732|515842549|FG003|Overall Study|Lost to Follow-up|0|||
143083225|NCT02006732|515842546|FG000|Overall Study|Withdrawal by Subject|3|||
143083226|NCT02006732|515842547|FG001|Overall Study|Withdrawal by Subject|0|||
143083227|NCT02006732|515842548|FG002|Overall Study|Withdrawal by Subject|4|||
143083228|NCT02006732|515842549|FG003|Overall Study|Withdrawal by Subject|1|||
143083229|NCT00299130|515842550|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
143083230|NCT00299130|515842551|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
143083231|NCT00299130|515842552|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
143083232|NCT00299130|515842550|FG000|Treatment Period (up to 5 Years)|Death|1|||
143083233|NCT00299130|515842551|FG001|Treatment Period (up to 5 Years)|Death|3|||
143083234|NCT00299130|515842552|FG002|Treatment Period (up to 5 Years)|Death|1|||
143083235|NCT00299130|515842550|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
143083236|NCT00299130|515842551|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
143083237|NCT00299130|515842552|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
143083238|NCT00299130|515842550|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
143083239|NCT00299130|515842551|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
143083240|NCT00299130|515842552|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
143083241|NCT00299130|515842550|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
143083242|NCT00299130|515842551|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
143083243|NCT00299130|515842552|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
143083244|NCT00299130|515842550|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
143083245|NCT00299130|515842551|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
143083246|NCT00299130|515842552|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
143083247|NCT00299130|515842550|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
143083248|NCT00299130|515842551|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
143083249|NCT00299130|515842552|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
143083250|NCT00299130|515842550|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
143083251|NCT00299130|515842551|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
143083252|NCT00299130|515842552|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
143083253|NCT00299130|515842550|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
143083254|NCT00299130|515842551|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
143083255|NCT00299130|515842552|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
143083256|NCT00299130|515842550|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
143083257|NCT00299130|515842551|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
143083258|NCT00299130|515842552|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
143083259|NCT00299130|515842550|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
143083260|NCT00299130|515842551|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
143083261|NCT00299130|515842552|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
143083262|NCT00299130|515842550|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
143083263|NCT00299130|515842551|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
143083264|NCT00299130|515842552|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
143083265|NCT00299130|515842550|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
143083266|NCT00299130|515842551|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
143083267|NCT00299130|515842552|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
143083268|NCT00299130|515842550|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
143083269|NCT00299130|515842551|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
143083270|NCT00299130|515842552|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
143083271|NCT00299130|515842550|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
143083272|NCT00299130|515842551|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
143083273|NCT00299130|515842552|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
143083274|NCT00299130|515842550|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
143083275|NCT00299130|515842551|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
143083276|NCT00299130|515842552|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
143083277|NCT00299130|515842550|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
143083278|NCT00299130|515842551|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
143083279|NCT00299130|515842552|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
143083280|NCT02211417|515842553|FG000|Overall Study|Withdrawal by Subject|11|||
143083281|NCT02211417|515842554|FG001|Overall Study|Withdrawal by Subject|8|||
143083282|NCT02211417|515842553|FG000|Overall Study|Protocol Violation|1|||
143083283|NCT02211417|515842554|FG001|Overall Study|Protocol Violation|0|||
143083284|NCT02211417|515842553|FG000|Overall Study|Pregnancy|0|||
143083285|NCT02211417|515842554|FG001|Overall Study|Pregnancy|1|||
143083286|NCT02211417|515842553|FG000|Overall Study|Lost to Follow-up|2|||
143083287|NCT02211417|515842554|FG001|Overall Study|Lost to Follow-up|3|||
143083288|NCT02211417|515842553|FG000|Overall Study|Adverse Event|1|||
143083289|NCT02211417|515842554|FG001|Overall Study|Adverse Event|4|||
143083290|NCT01198132|515842555|FG000|Overall Study|Withdrawal by Subject|4|||
143083291|NCT01198132|515842556|FG001|Overall Study|Withdrawal by Subject|5|||
143083292|NCT01198132|515842555|FG000|Overall Study|Physician Decision|5|||
143083293|NCT01198132|515842556|FG001|Overall Study|Physician Decision|4|||
143083294|NCT01198132|515842555|FG000|Overall Study|Other Unspecified|3|||
143083295|NCT01198132|515842556|FG001|Overall Study|Other Unspecified|6|||
143083296|NCT01198132|515842555|FG000|Overall Study|Lack of Efficacy|2|||
143083297|NCT01198132|515842556|FG001|Overall Study|Lack of Efficacy|3|||
143083298|NCT01198132|515842555|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
143083299|NCT01198132|515842556|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
143083300|NCT01198132|515842555|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
143083301|NCT01198132|515842556|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
143083302|NCT01198132|515842555|FG000|Overall Study|Adverse Event|0|||
143083303|NCT01198132|515842556|FG001|Overall Study|Adverse Event|1|||
143083304|NCT01198132|515842555|FG000|Overall Study|Protocol Violation|1|||
143083305|NCT01198132|515842556|FG001|Overall Study|Protocol Violation|0|||
143083306|NCT01755091|515842557|FG000|Overall Study|Withdrawal by Subject|6|||
143083307|NCT01755091|515842558|FG001|Overall Study|Withdrawal by Subject|1|||
143083308|NCT01755091|515842559|FG002|Overall Study|Withdrawal by Subject|3|||
143083309|NCT01755091|515842557|FG000|Overall Study|Adverse Event|1|||
143083310|NCT01755091|515842558|FG001|Overall Study|Adverse Event|1|||
143083311|NCT01755091|515842559|FG002|Overall Study|Adverse Event|1|||
143083312|NCT01755091|515842557|FG000|Overall Study|Lost to Follow-up|1|||
143083313|NCT01755091|515842558|FG001|Overall Study|Lost to Follow-up|0|||
143083314|NCT01755091|515842559|FG002|Overall Study|Lost to Follow-up|1|||
143083315|NCT01755091|515842557|FG000|Overall Study|Physician Decision|1|||
143083316|NCT01755091|515842558|FG001|Overall Study|Physician Decision|1|||
143083317|NCT01755091|515842559|FG002|Overall Study|Physician Decision|2|||
143083318|NCT01885195|515842560|FG000|Overall Study|Adverse Event|29|||
143083319|NCT01885195|515842560|FG000|Overall Study|Death|1|||
143083320|NCT01885195|515842560|FG000|Overall Study|Disease Progression|67|||
143083321|NCT01885195|515842560|FG000|Overall Study|Protocol Deviation|2|||
143083322|NCT01885195|515842560|FG000|Overall Study|Physician Decision|3|||
143083323|NCT01885195|515842560|FG000|Overall Study|Patient/guardian decision|8|||
143083324|NCT03390426|515842561|FG000|Overall Study|Protocol Violation|0|||
143083325|NCT03390426|515842562|FG001|Overall Study|Protocol Violation|1|||
143083326|NCT00548093|515842567|FG000|Overall Study|Death|33|||
143083327|NCT00548093|515842568|FG001|Overall Study|Death|13|||
143083328|NCT00548093|515842567|FG000|Overall Study|Lost to Follow-up|3|||
143083329|NCT00548093|515842568|FG001|Overall Study|Lost to Follow-up|1|||
143083330|NCT00548093|515842567|FG000|Overall Study|Objective progression or relapse|1|||
143083331|NCT00548093|515842568|FG001|Overall Study|Objective progression or relapse|1|||
143083332|NCT00548093|515842567|FG000|Overall Study|Other|11|||
143083333|NCT00548093|515842568|FG001|Overall Study|Other|1|||
143083334|NCT00548093|515842567|FG000|Overall Study|Withdrawal by Subject|1|||
143083335|NCT00548093|515842568|FG001|Overall Study|Withdrawal by Subject|0|||
143083336|NCT00548093|515842567|FG000|Overall Study|Completed post-treatment follow-up|1|||
143083337|NCT00548093|515842568|FG001|Overall Study|Completed post-treatment follow-up|0|||
143083338|NCT01982812|515842569|FG000|Overall Study|Death|1|||
143083339|NCT01982812|515842570|FG001|Overall Study|Death|5|||
143083340|NCT01982812|515842569|FG000|Overall Study|Adverse Event|0|||
143249133|NCT03037580|516465169|FG001|Overall Study|Adverse Event|0|||
143249134|NCT03037580|516465168|FG000|Overall Study|Study Terminated by Sponsor|12|||
143083341|NCT01982812|515842570|FG001|Overall Study|Adverse Event|5|||
143083342|NCT02185053|515842571|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
143083343|NCT02185053|515842572|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
143083344|NCT02185053|515842573|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
143083345|NCT02185053|515842571|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
143117412|NCT01777139|515971843|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
143083346|NCT02185053|515842572|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
143083347|NCT02185053|515842573|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
143083348|NCT02185053|515842571|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
143083349|NCT02185053|515842572|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
143083350|NCT02185053|515842573|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
143083351|NCT02185053|515842571|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
143083352|NCT02185053|515842572|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
143083353|NCT02185053|515842573|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
143083354|NCT02185053|515842571|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
143083355|NCT02185053|515842572|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
143083356|NCT02185053|515842573|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
143083357|NCT02185053|515842571|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
143083358|NCT02185053|515842572|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
143083359|NCT02185053|515842573|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
143083360|NCT02185053|515842571|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
143083361|NCT02185053|515842572|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
143083362|NCT02185053|515842573|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
143083363|NCT02185053|515842571|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
143083364|NCT02185053|515842572|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
143083365|NCT02185053|515842573|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
143083366|NCT02521376|515842579|FG000|Overall Study|Enrolled, But Not Treated|1|||
143083367|NCT02521376|515842580|FG001|Overall Study|Enrolled, But Not Treated|0|||
143083368|NCT02521376|515842581|FG002|Overall Study|Enrolled, But Not Treated|0|||
143083369|NCT02521376|515842582|FG003|Overall Study|Enrolled, But Not Treated|0|||
143083370|NCT00509795|515842583|FG000|Overall Study|Adverse Event|4|||
143083371|NCT00509795|515842584|FG001|Overall Study|Adverse Event|3|||
143083372|NCT00509795|515842585|FG002|Overall Study|Adverse Event|5|||
143083373|NCT00509795|515842586|FG003|Overall Study|Adverse Event|4|||
143083374|NCT00509795|515842583|FG000|Overall Study|Death|3|||
143083375|NCT00509795|515842584|FG001|Overall Study|Death|1|||
143083376|NCT00509795|515842585|FG002|Overall Study|Death|2|||
143083377|NCT00509795|515842586|FG003|Overall Study|Death|7|||
143083378|NCT00509795|515842583|FG000|Overall Study|Lack of Efficacy|0|||
143083379|NCT00509795|515842584|FG001|Overall Study|Lack of Efficacy|0|||
143083380|NCT00509795|515842585|FG002|Overall Study|Lack of Efficacy|2|||
143083381|NCT00509795|515842586|FG003|Overall Study|Lack of Efficacy|2|||
143083382|NCT00509795|515842583|FG000|Overall Study|Lost to Follow-up|1|||
143083383|NCT00509795|515842584|FG001|Overall Study|Lost to Follow-up|2|||
143083384|NCT00509795|515842585|FG002|Overall Study|Lost to Follow-up|4|||
143083385|NCT00509795|515842586|FG003|Overall Study|Lost to Follow-up|4|||
143083386|NCT00509795|515842583|FG000|Overall Study|OTHER|1|||
143083387|NCT00509795|515842584|FG001|Overall Study|OTHER|0|||
143083388|NCT00509795|515842585|FG002|Overall Study|OTHER|4|||
143083389|NCT00509795|515842586|FG003|Overall Study|OTHER|1|||
143083390|NCT00509795|515842583|FG000|Overall Study|Protocol Violation|3|||
143083391|NCT00509795|515842584|FG001|Overall Study|Protocol Violation|0|||
143083392|NCT00509795|515842585|FG002|Overall Study|Protocol Violation|3|||
143083393|NCT00509795|515842586|FG003|Overall Study|Protocol Violation|1|||
143083394|NCT00509795|515842583|FG000|Overall Study|Withdrawal by Subject|10|||
143083395|NCT00509795|515842584|FG001|Overall Study|Withdrawal by Subject|5|||
143083396|NCT00509795|515842585|FG002|Overall Study|Withdrawal by Subject|7|||
143083397|NCT00509795|515842586|FG003|Overall Study|Withdrawal by Subject|8|||
143083398|NCT01277601|515844808|FG000|Overall Study|Adverse Event|5|||
143083399|NCT01277601|515844809|FG001|Overall Study|Adverse Event|3|||
143083400|NCT01277601|515844810|FG002|Overall Study|Adverse Event|0|||
143083401|NCT01277601|515844811|FG003|Overall Study|Adverse Event|7|||
143083402|NCT01277601|515844808|FG000|Overall Study|Withdrawal by Subject|18|||
143083403|NCT01277601|515844809|FG001|Overall Study|Withdrawal by Subject|21|||
143083404|NCT01277601|515844810|FG002|Overall Study|Withdrawal by Subject|8|||
143083405|NCT01277601|515844811|FG003|Overall Study|Withdrawal by Subject|17|||
143083406|NCT01277601|515844808|FG000|Overall Study|Lost to Follow-up|7|||
143083407|NCT01277601|515844809|FG001|Overall Study|Lost to Follow-up|9|||
143083408|NCT01277601|515844810|FG002|Overall Study|Lost to Follow-up|4|||
143083409|NCT01277601|515844811|FG003|Overall Study|Lost to Follow-up|2|||
143083410|NCT01277601|515844808|FG000|Overall Study|Physician Decision|3|||
143083411|NCT01277601|515844809|FG001|Overall Study|Physician Decision|5|||
143083412|NCT01277601|515844810|FG002|Overall Study|Physician Decision|1|||
143083413|NCT01277601|515844811|FG003|Overall Study|Physician Decision|6|||
143083414|NCT01277601|515844808|FG000|Overall Study|Pregnancy|2|||
143083415|NCT01277601|515844809|FG001|Overall Study|Pregnancy|2|||
143083416|NCT01277601|515844810|FG002|Overall Study|Pregnancy|4|||
143083417|NCT01277601|515844811|FG003|Overall Study|Pregnancy|1|||
143083418|NCT01277601|515844808|FG000|Overall Study|Noncompliance with Study Drug|1|||
143083419|NCT01277601|515844809|FG001|Overall Study|Noncompliance with Study Drug|3|||
143083420|NCT01277601|515844810|FG002|Overall Study|Noncompliance with Study Drug|2|||
143173889|NCT04661033|516185346|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
143083421|NCT01277601|515844811|FG003|Overall Study|Noncompliance with Study Drug|0|||
143083422|NCT01277601|515844808|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
143083423|NCT01277601|515844809|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
143083424|NCT01277601|515844810|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
143083425|NCT01277601|515844811|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
143083426|NCT01277601|515844808|FG000|Overall Study|Protocol Violation|0|||
143083427|NCT01277601|515844809|FG001|Overall Study|Protocol Violation|2|||
143083428|NCT01277601|515844810|FG002|Overall Study|Protocol Violation|5|||
143083429|NCT01277601|515844811|FG003|Overall Study|Protocol Violation|0|||
143083430|NCT01277601|515844808|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
143083431|NCT01277601|515844809|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
143083432|NCT01277601|515844810|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
143083433|NCT01277601|515844811|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
143083434|NCT02291510|515844813|FG000|Overall Study|Adverse Event|0|||
143083435|NCT02291510|515844814|FG001|Overall Study|Adverse Event|0|||
143083436|NCT02291510|515844815|FG002|Overall Study|Adverse Event|0|||
143083437|NCT02291510|515844816|FG003|Overall Study|Adverse Event|1|||
143083438|NCT03765788|515844819|FG000|Overall Study|Subject decision|2|||
143173890|NCT04661033|516185347|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
143173891|NCT04661033|516185348|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
143173892|NCT04661033|516185345|FG000|Overall Study|Early discontinuation as per PI|1|||
143173893|NCT04661033|516185346|FG001|Overall Study|Early discontinuation as per PI|0|||
143173894|NCT04661033|516185347|FG002|Overall Study|Early discontinuation as per PI|0|||
143173895|NCT04661033|516185348|FG003|Overall Study|Early discontinuation as per PI|0|||
143173896|NCT00565409|516185351|FG000|Period 1 Open Label|Adverse Event|17|||
143173897|NCT00565409|516185352|FG001|Period 1 Open Label|Adverse Event|0|||
143173898|NCT00565409|516185353|FG002|Period 1 Open Label|Adverse Event|0|||
143173899|NCT00565409|516185354|FG003|Period 1 Open Label|Adverse Event|0|||
143173900|NCT00565409|516185351|FG000|Period 1 Open Label|Death|2|||
143173901|NCT00565409|516185352|FG001|Period 1 Open Label|Death|0|||
143173902|NCT00565409|516185353|FG002|Period 1 Open Label|Death|0|||
143173903|NCT00565409|516185354|FG003|Period 1 Open Label|Death|0|||
143173904|NCT00565409|516185351|FG000|Period 1 Open Label|Lost to Follow-up|1|||
143173905|NCT00565409|516185352|FG001|Period 1 Open Label|Lost to Follow-up|0|||
143173906|NCT00565409|516185353|FG002|Period 1 Open Label|Lost to Follow-up|0|||
143173907|NCT00565409|516185354|FG003|Period 1 Open Label|Lost to Follow-up|0|||
143173908|NCT00565409|516185351|FG000|Period 1 Open Label|Other|21|||
143173909|NCT00565409|516185352|FG001|Period 1 Open Label|Other|0|||
143173910|NCT00565409|516185353|FG002|Period 1 Open Label|Other|0|||
143173911|NCT00565409|516185354|FG003|Period 1 Open Label|Other|0|||
143173912|NCT00565409|516185351|FG000|Period 1 Open Label|Protocol Violation|14|||
143173913|NCT00565409|516185352|FG001|Period 1 Open Label|Protocol Violation|0|||
143173914|NCT00565409|516185353|FG002|Period 1 Open Label|Protocol Violation|0|||
143173915|NCT00565409|516185354|FG003|Period 1 Open Label|Protocol Violation|0|||
143173916|NCT00565409|516185351|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
143173917|NCT00565409|516185352|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
143083439|NCT03765788|515844820|FG001|Overall Study|Subject decision|3|||
143083440|NCT03765788|515844819|FG000|Overall Study|Physician Decision|2|||
143083441|NCT03765788|515844820|FG001|Overall Study|Physician Decision|4|||
143083442|NCT03765788|515844819|FG000|Overall Study|Death|0|||
143083443|NCT03765788|515844820|FG001|Overall Study|Death|1|||
143083444|NCT03765788|515844819|FG000|Overall Study|Lost to Follow-up|1|||
143083445|NCT03765788|515844820|FG001|Overall Study|Lost to Follow-up|0|||
143173918|NCT00565409|516185353|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
143173919|NCT00565409|516185354|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
143173920|NCT00565409|516185351|FG000|Period 1 Open Label|no conclusion of participation record|1|||
143083446|NCT01433055|515844821|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
143083447|NCT01433055|515844822|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
143083448|NCT01433055|515844821|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
143083449|NCT01433055|515844822|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
143083450|NCT04172597|515844825|FG000|Overall Study|Disease Progression|0|||
143083451|NCT04172597|515844826|FG001|Overall Study|Disease Progression|0|||
143083452|NCT04172597|515844827|FG002|Overall Study|Disease Progression|0|||
143083453|NCT04172597|515844828|FG003|Overall Study|Disease Progression|0|||
143083454|NCT04172597|515844829|FG004|Overall Study|Disease Progression|1|||
143083455|NCT04414618|515844830|FG000|Overall Study|Death|3|||
143083456|NCT04414618|515844831|FG001|Overall Study|Death|3|||
143083457|NCT04414618|515844830|FG000|Overall Study|Withdrawal by Subject|2|||
143083458|NCT04414618|515844831|FG001|Overall Study|Withdrawal by Subject|1|||
143083459|NCT04414618|515844830|FG000|Overall Study|Lost to Follow-up|2|||
143083460|NCT04414618|515844831|FG001|Overall Study|Lost to Follow-up|3|||
143083461|NCT04414618|515844830|FG000|Overall Study|Physician Decision|1|||
143083462|NCT04414618|515844831|FG001|Overall Study|Physician Decision|0|||
143083463|NCT01121562|515844832|FG000|Overall Study|Objective progression or relapse|8|||
143083464|NCT01121562|515844832|FG000|Overall Study|Withdrawal by Subject|1|||
143083465|NCT01121562|515844832|FG000|Overall Study|Adverse Event|1|||
143083466|NCT01121562|515844832|FG000|Overall Study|Sponsor Decision|1|||
143083467|NCT01121562|515844832|FG000|Overall Study|Met study discontinuation criteria|1|||
143083468|NCT00616421|515844833|FG000|Overall Study|Withdrawal by Subject|9|||
143083469|NCT00616421|515844834|FG001|Overall Study|Withdrawal by Subject|11|||
143083470|NCT00616421|515844835|FG002|Overall Study|Withdrawal by Subject|8|||
143083471|NCT00616421|515844833|FG000|Overall Study|Lost to Follow-up|12|||
143083472|NCT00616421|515844834|FG001|Overall Study|Lost to Follow-up|26|||
143083473|NCT00616421|515844835|FG002|Overall Study|Lost to Follow-up|30|||
143083474|NCT00616421|515844833|FG000|Overall Study|Inappropriate enrollment|3|||
143083475|NCT00616421|515844834|FG001|Overall Study|Inappropriate enrollment|0|||
143083476|NCT00616421|515844835|FG002|Overall Study|Inappropriate enrollment|1|||
143083477|NCT00616421|515844833|FG000|Overall Study|Administrative reason|1|||
143083478|NCT00616421|515844834|FG001|Overall Study|Administrative reason|0|||
143083479|NCT00616421|515844835|FG002|Overall Study|Administrative reason|0|||
143083480|NCT00616421|515844833|FG000|Overall Study|Protocol Violation|0|||
143083481|NCT00616421|515844834|FG001|Overall Study|Protocol Violation|1|||
143083482|NCT00616421|515844835|FG002|Overall Study|Protocol Violation|2|||
143083483|NCT00616421|515844833|FG000|Overall Study|Unable to classify|1|||
143083484|NCT00616421|515844834|FG001|Overall Study|Unable to classify|0|||
143083485|NCT00616421|515844835|FG002|Overall Study|Unable to classify|0|||
143083486|NCT02661217|515844836|FG000|Overall Study|Physician Decision|12|||
143083487|NCT02661217|515844837|FG001|Overall Study|Physician Decision|15|||
143083488|NCT02661217|515844836|FG000|Overall Study|Lost to Follow-up|1|||
143083489|NCT02661217|515844837|FG001|Overall Study|Lost to Follow-up|4|||
143083490|NCT02661217|515844836|FG000|Overall Study|Protocol Deviation|0|||
143083491|NCT02661217|515844837|FG001|Overall Study|Protocol Deviation|4|||
143083492|NCT02661217|515844836|FG000|Overall Study|Non-compliance with study treatment|5|||
143083493|NCT02661217|515844837|FG001|Overall Study|Non-compliance with study treatment|5|||
143083494|NCT02661217|515844836|FG000|Overall Study|Death|21|||
143083495|NCT02661217|515844837|FG001|Overall Study|Death|15|||
143083496|NCT02661217|515844836|FG000|Overall Study|Adverse Event|10|||
143083497|NCT02661217|515844837|FG001|Overall Study|Adverse Event|8|||
143083498|NCT02661217|515844836|FG000|Overall Study|Withdrawal by Subject|15|||
143083499|NCT02661217|515844837|FG001|Overall Study|Withdrawal by Subject|19|||
143083500|NCT02661217|515844836|FG000|Overall Study|Did not enter follow-up epoch|7|||
143083501|NCT02661217|515844837|FG001|Overall Study|Did not enter follow-up epoch|10|||
143083502|NCT02661217|515844836|FG000|Overall Study|Death - no study drug received|1|||
143173921|NCT00565409|516185352|FG001|Period 1 Open Label|no conclusion of participation record|0|||
143083503|NCT02661217|515844837|FG001|Overall Study|Death - no study drug received|2|||
143083504|NCT02661217|515844836|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
143083505|NCT02661217|515844837|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
143083506|NCT02540083|515844841|FG000|Overall Study|Withdrawal by Subject|16|||
143083507|NCT02797171|515844842|FG000|Overall Study|Lost to Follow-up|2|||
143083508|NCT02797171|515844843|FG001|Overall Study|Lost to Follow-up|0|||
143083509|NCT02797171|515844844|FG002|Overall Study|Lost to Follow-up|2|||
143083510|NCT02797171|515844845|FG003|Overall Study|Lost to Follow-up|1|||
143083511|NCT02797171|515844846|FG004|Overall Study|Lost to Follow-up|2|||
143083512|NCT02797171|515844847|FG005|Overall Study|Lost to Follow-up|0|||
143083513|NCT02797171|515844842|FG000|Overall Study|Withdrawal by Subject|1|||
143083514|NCT02797171|515844843|FG001|Overall Study|Withdrawal by Subject|1|||
143083515|NCT02797171|515844844|FG002|Overall Study|Withdrawal by Subject|0|||
143083516|NCT02797171|515844845|FG003|Overall Study|Withdrawal by Subject|0|||
143083517|NCT02797171|515844846|FG004|Overall Study|Withdrawal by Subject|0|||
143083518|NCT02797171|515844847|FG005|Overall Study|Withdrawal by Subject|0|||
143083519|NCT02797171|515844842|FG000|Overall Study|Protocol Violation|1|||
143083520|NCT02797171|515844843|FG001|Overall Study|Protocol Violation|0|||
143083521|NCT02797171|515844844|FG002|Overall Study|Protocol Violation|0|||
143083522|NCT02797171|515844845|FG003|Overall Study|Protocol Violation|0|||
143083523|NCT02797171|515844846|FG004|Overall Study|Protocol Violation|0|||
143083524|NCT02797171|515844847|FG005|Overall Study|Protocol Violation|0|||
143083525|NCT02797171|515844842|FG000|Overall Study|Participant unable to adhere|0|||
143083526|NCT02797171|515844843|FG001|Overall Study|Participant unable to adhere|1|||
143083527|NCT02797171|515844844|FG002|Overall Study|Participant unable to adhere|0|||
143083528|NCT02797171|515844845|FG003|Overall Study|Participant unable to adhere|0|||
143083529|NCT02797171|515844846|FG004|Overall Study|Participant unable to adhere|0|||
143083530|NCT02797171|515844847|FG005|Overall Study|Participant unable to adhere|0|||
143083531|NCT02797171|515844842|FG000|Overall Study|Not Randomized|0|||
143083532|NCT02797171|515844843|FG001|Overall Study|Not Randomized|0|||
143083533|NCT02797171|515844844|FG002|Overall Study|Not Randomized|0|||
143083534|NCT02797171|515844845|FG003|Overall Study|Not Randomized|0|||
143083535|NCT02797171|515844846|FG004|Overall Study|Not Randomized|0|||
143083536|NCT02797171|515844847|FG005|Overall Study|Not Randomized|1|||
143083537|NCT04071405|515844848|FG000|Overall Study|Protocol Violation|3|||
143083538|NCT02422797|515844849|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
143083539|NCT02422797|515844850|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
143083540|NCT02422797|515844849|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
143083541|NCT02422797|515844850|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
143083542|NCT02422797|515844849|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
143083543|NCT02422797|515844850|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
143083544|NCT02422797|515844849|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
143083545|NCT02422797|515844850|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
143083546|NCT02422797|515844849|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
143083547|NCT02422797|515844850|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
143083548|NCT02422797|515844849|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
143083549|NCT02422797|515844850|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
143083550|NCT02422797|515844849|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
143083551|NCT02422797|515844850|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
143083552|NCT02422797|515844849|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
143083553|NCT02422797|515844850|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
143083554|NCT02422797|515844849|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
143083555|NCT02422797|515844850|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
143083556|NCT02422797|515844849|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
143083557|NCT02422797|515844850|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
143083558|NCT02422797|515844849|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
143083559|NCT02422797|515844850|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
143083560|NCT02422797|515844849|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
143083561|NCT02422797|515844850|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
143083562|NCT02422797|515844849|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
143083563|NCT02422797|515844850|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
143083564|NCT02422797|515844849|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
143083565|NCT02422797|515844850|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
143083566|NCT02422797|515844849|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
143083567|NCT02422797|515844850|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
143083568|NCT02422797|515844849|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
143083569|NCT02422797|515844850|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
143083570|NCT02422797|515844849|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
143083571|NCT02422797|515844850|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
143083572|NCT02422797|515844849|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
143083573|NCT02422797|515844850|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
143083574|NCT02422797|515844849|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
143083575|NCT02422797|515844850|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
143173922|NCT00565409|516185353|FG002|Period 1 Open Label|no conclusion of participation record|0|||
143173923|NCT00565409|516185354|FG003|Period 1 Open Label|no conclusion of participation record|0|||
143173924|NCT00565409|516185351|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
143173925|NCT00565409|516185352|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
143173926|NCT00565409|516185353|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
143173927|NCT00565409|516185354|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
143173928|NCT00565409|516185351|FG000|Period 2 Double-Blind|Adverse Event|0|||
143173929|NCT00565409|516185352|FG001|Period 2 Double-Blind|Adverse Event|7|||
143173930|NCT00565409|516185353|FG002|Period 2 Double-Blind|Adverse Event|4|||
143173931|NCT00565409|516185354|FG003|Period 2 Double-Blind|Adverse Event|5|||
143173932|NCT00565409|516185351|FG000|Period 2 Double-Blind|Death|0|||
143173933|NCT00565409|516185352|FG001|Period 2 Double-Blind|Death|2|||
143173934|NCT00565409|516185353|FG002|Period 2 Double-Blind|Death|0|||
143173935|NCT00565409|516185354|FG003|Period 2 Double-Blind|Death|0|||
143173936|NCT00565409|516185351|FG000|Period 2 Double-Blind|Protocol Violation|0|||
143173937|NCT00565409|516185352|FG001|Period 2 Double-Blind|Protocol Violation|4|||
143173938|NCT00565409|516185353|FG002|Period 2 Double-Blind|Protocol Violation|6|||
143173939|NCT00565409|516185354|FG003|Period 2 Double-Blind|Protocol Violation|2|||
143173940|NCT00565409|516185351|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
143173941|NCT00565409|516185352|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
143173942|NCT00565409|516185353|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
143173943|NCT00565409|516185354|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
143173944|NCT00565409|516185351|FG000|Period 2 Double-Blind|Other|0|||
143173945|NCT00565409|516185352|FG001|Period 2 Double-Blind|Other|4|||
143173946|NCT00565409|516185353|FG002|Period 2 Double-Blind|Other|5|||
143173947|NCT00565409|516185354|FG003|Period 2 Double-Blind|Other|9|||
143173948|NCT00565409|516185351|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
143173949|NCT00565409|516185352|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
143173950|NCT00565409|516185353|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
143173951|NCT00565409|516185354|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
143173952|NCT03440008|516185355|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
143173953|NCT03440008|516185356|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
143173954|NCT03440008|516185355|FG000|Overall Study|Withdrawal by Subject|1|||
143173955|NCT03440008|516185356|FG001|Overall Study|Withdrawal by Subject|0|||
143173956|NCT03498716|516185370|FG000|Overall Study|Withdrawal by Subject|88|||
143173957|NCT03498716|516185371|FG001|Overall Study|Withdrawal by Subject|73|||
143173958|NCT03498716|516185370|FG000|Overall Study|Study Terminated By Sponsor|933|||
143173959|NCT03498716|516185371|FG001|Overall Study|Study Terminated By Sponsor|927|||
143366463|NCT01137292|516884679|FG000|Overall Study|Adverse Event|3|||
143173960|NCT03498716|516185370|FG000|Overall Study|Lost to Follow-up|15|||
143173961|NCT03498716|516185371|FG001|Overall Study|Lost to Follow-up|26|||
143173962|NCT03498716|516185370|FG000|Overall Study|Disease Relapse|0|||
143173963|NCT03498716|516185371|FG001|Overall Study|Disease Relapse|1|||
143173964|NCT03498716|516185370|FG000|Overall Study|Death|58|||
143173965|NCT03498716|516185371|FG001|Overall Study|Death|72|||
143173966|NCT03498716|516185370|FG000|Overall Study|Physician Decision|4|||
143173967|NCT03498716|516185371|FG001|Overall Study|Physician Decision|2|||
143173968|NCT01570387|516185372|FG000|Overall Study|Adverse Event|1|||
143173969|NCT01570387|516185373|FG001|Overall Study|Adverse Event|0|||
143173970|NCT01570387|516185374|FG002|Overall Study|Adverse Event|0|||
143173971|NCT01570387|516185375|FG003|Overall Study|Adverse Event|0|||
143173972|NCT01570387|516185372|FG000|Overall Study|Death|0|||
143173973|NCT01570387|516185373|FG001|Overall Study|Death|0|||
143173974|NCT01570387|516185374|FG002|Overall Study|Death|0|||
143173975|NCT01570387|516185375|FG003|Overall Study|Death|1|||
143173976|NCT01570387|516185372|FG000|Overall Study|Withdrawal by Subject|0|||
143173977|NCT01570387|516185373|FG001|Overall Study|Withdrawal by Subject|0|||
143173978|NCT01570387|516185374|FG002|Overall Study|Withdrawal by Subject|0|||
143173979|NCT01570387|516185375|FG003|Overall Study|Withdrawal by Subject|1|||
143173980|NCT01987557|516185376|FG000|Overall Study|Protocol Violation|1|||
143173981|NCT01987557|516185377|FG001|Overall Study|Protocol Violation|0|||
143366464|NCT01137292|516884679|FG000|Overall Study|Lack of Efficacy|13|||
143366465|NCT01137292|516884679|FG000|Overall Study|Lost to Follow-up|1|||
143173982|NCT01987557|516185378|FG002|Overall Study|Protocol Violation|1|||
143173983|NCT01987557|516185376|FG000|Overall Study|Withdrawal by Subject|2|||
143173984|NCT01987557|516185377|FG001|Overall Study|Withdrawal by Subject|1|||
143173985|NCT01987557|516185378|FG002|Overall Study|Withdrawal by Subject|2|||
143173986|NCT01987557|516185376|FG000|Overall Study|Adverse Event|0|||
143173987|NCT01987557|516185377|FG001|Overall Study|Adverse Event|2|||
143366466|NCT01137292|516884679|FG000|Overall Study|Other|7|||
143083576|NCT02422797|515844849|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
143083577|NCT02422797|515844850|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
143083578|NCT02422797|515844849|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
143083579|NCT02422797|515844850|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
143083580|NCT02301390|515844855|FG000|Overall Study|Withdrawal by Subject|3|||
143083581|NCT02301390|515844856|FG001|Overall Study|Withdrawal by Subject|5|||
143083582|NCT02301390|515844855|FG000|Overall Study|Protocol Violation|1|||
143083583|NCT02301390|515844856|FG001|Overall Study|Protocol Violation|0|||
143083584|NCT02301390|515844855|FG000|Overall Study|Physician Decision|1|||
143083585|NCT02301390|515844856|FG001|Overall Study|Physician Decision|0|||
143083586|NCT02301390|515844855|FG000|Overall Study|Lost to Follow-up|0|||
143083587|NCT02301390|515844856|FG001|Overall Study|Lost to Follow-up|1|||
143083588|NCT02301390|515844855|FG000|Overall Study|Death|2|||
143083589|NCT02301390|515844856|FG001|Overall Study|Death|2|||
143083590|NCT02301390|515844855|FG000|Overall Study|Procedure not completed|0|||
143083591|NCT02301390|515844856|FG001|Overall Study|Procedure not completed|4|||
143083592|NCT02301390|515844855|FG000|Overall Study|Missed multiple visits|1|||
143083593|NCT02301390|515844856|FG001|Overall Study|Missed multiple visits|1|||
143083594|NCT02301390|515844855|FG000|Overall Study|study terminated|2|||
143083595|NCT02301390|515844856|FG001|Overall Study|study terminated|0|||
143083596|NCT00185588|515844857|FG000|Overall Study|Adverse Event|3|||
143083597|NCT00185588|515844858|FG001|Overall Study|Adverse Event|1|||
143083598|NCT00185588|515844859|FG002|Overall Study|Adverse Event|4|||
143083599|NCT00185588|515844860|FG003|Overall Study|Adverse Event|2|||
143083600|NCT00185588|515844857|FG000|Overall Study|Lost to Follow-up|0|||
143083601|NCT00185588|515844858|FG001|Overall Study|Lost to Follow-up|0|||
143083602|NCT00185588|515844859|FG002|Overall Study|Lost to Follow-up|1|||
143083603|NCT00185588|515844860|FG003|Overall Study|Lost to Follow-up|2|||
143083604|NCT00185588|515844857|FG000|Overall Study|Withdrawal by Subject|0|||
143083605|NCT00185588|515844858|FG001|Overall Study|Withdrawal by Subject|1|||
143083606|NCT00185588|515844859|FG002|Overall Study|Withdrawal by Subject|0|||
143083607|NCT00185588|515844860|FG003|Overall Study|Withdrawal by Subject|0|||
143083608|NCT00185588|515844857|FG000|Overall Study|Physician Decision|0|||
143083609|NCT00185588|515844858|FG001|Overall Study|Physician Decision|0|||
143083610|NCT00185588|515844859|FG002|Overall Study|Physician Decision|1|||
143083611|NCT00185588|515844860|FG003|Overall Study|Physician Decision|0|||
143083612|NCT02481869|515844861|FG000|Overall Study|Lost to Follow-up|3|||
143083613|NCT02481869|515844862|FG001|Overall Study|Lost to Follow-up|4|||
143083614|NCT02481869|515844861|FG000|Overall Study|Withdrawal by Subject|2|||
143083615|NCT02481869|515844862|FG001|Overall Study|Withdrawal by Subject|0|||
143083616|NCT04289363|515844864|FG000|Overall Study|Lost to Follow-up|14|||
143173988|NCT01987557|516185378|FG002|Overall Study|Adverse Event|0|||
143173989|NCT01823289|516185384|FG000|Overall Study|Lost to Follow-up|5|||
143173990|NCT01823289|516185384|FG000|Overall Study|Adverse Event|5|||
143173991|NCT01823289|516185384|FG000|Overall Study|Lack of Efficacy|1|||
143173992|NCT01823289|516185384|FG000|Overall Study|Physician Decision|9|||
143173993|NCT01823289|516185384|FG000|Overall Study|Administered contraindicated medicine|1|||
143173994|NCT01823289|516185384|FG000|Overall Study|Transaminase increased more than 3 times|1|||
143173995|NCT01823289|516185384|FG000|Overall Study|Drug affected efficacy and safety|1|||
143173996|NCT01823289|516185384|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
143173997|NCT00956293|516185385|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
143249135|NCT03037580|516465169|FG001|Overall Study|Study Terminated by Sponsor|15|||
143249136|NCT03037580|516465168|FG000|Overall Study|Death|0|||
143249137|NCT03037580|516465169|FG001|Overall Study|Death|1|||
143249138|NCT02878798|516465172|FG000|Overall Study|Withdrawal by Subject|5|||
143249139|NCT02878798|516465173|FG001|Overall Study|Withdrawal by Subject|4|||
143249140|NCT02878798|516465172|FG000|Overall Study|Lost to Follow-up|2|||
143249141|NCT02878798|516465173|FG001|Overall Study|Lost to Follow-up|2|||
143249142|NCT02878798|516465172|FG000|Overall Study|Protocol Violation|0|||
143249143|NCT02878798|516465173|FG001|Overall Study|Protocol Violation|1|||
143366467|NCT02040844|516884682|FG000|Overall Study|Adverse Event|0|||
143366468|NCT02040844|516884683|FG001|Overall Study|Adverse Event|0|||
143083617|NCT04289363|515844865|FG001|Overall Study|Lost to Follow-up|0|||
143083618|NCT03790657|515844866|FG000|Overall Study|Adverse Event|1|||
143083619|NCT03790657|515844867|FG001|Overall Study|Adverse Event|1|||
143083620|NCT03790657|515844866|FG000|Overall Study|Withdrawal by Subject|1|||
143083621|NCT03790657|515844867|FG001|Overall Study|Withdrawal by Subject|1|||
143083622|NCT03126435|515844868|FG000|Overall Study|Death|90|||
143083623|NCT03126435|515844869|FG001|Overall Study|Death|84|||
143083624|NCT03126435|515844868|FG000|Overall Study|Lost to Follow-up|4|||
143083625|NCT03126435|515844869|FG001|Overall Study|Lost to Follow-up|3|||
143083626|NCT03126435|515844868|FG000|Overall Study|Physician Decision|0|||
143173998|NCT00956293|516185386|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
143173999|NCT00956293|516185387|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
143249144|NCT01761240|516465174|FG000|Overall Study|Progressive disease:radiology assessment|3|||
143083627|NCT03126435|515844869|FG001|Overall Study|Physician Decision|1|||
143083628|NCT03126435|515844868|FG000|Overall Study|Withdrawal by Subject|6|||
143083629|NCT03126435|515844869|FG001|Overall Study|Withdrawal by Subject|12|||
143083630|NCT03126435|515844868|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
143083631|NCT03126435|515844869|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
143083632|NCT03971474|515844871|FG000|Overall Study|Adverse Event|11|||
143083633|NCT03971474|515844872|FG001|Overall Study|Adverse Event|7|||
143083634|NCT03971474|515844871|FG000|Overall Study|Refusal unrelated to adverse event|5|||
143083635|NCT03971474|515844872|FG001|Overall Study|Refusal unrelated to adverse event|1|||
143083636|NCT03971474|515844871|FG000|Overall Study|Progression/relapse|40|||
143083637|NCT03971474|515844872|FG001|Overall Study|Progression/relapse|47|||
143083638|NCT03971474|515844871|FG000|Overall Study|Death|6|||
143083639|NCT03971474|515844872|FG001|Overall Study|Death|3|||
143083640|NCT03971474|515844871|FG000|Overall Study|Other - not protocol specified|5|||
143083641|NCT03971474|515844872|FG001|Overall Study|Other - not protocol specified|4|||
143083642|NCT03971474|515844871|FG000|Overall Study|On treatment|0|||
143083643|NCT03971474|515844872|FG001|Overall Study|On treatment|7|||
143083644|NCT01807065|515844873|FG000|Overall Study|Receive no sip-T due to IV access|1|||
143083645|NCT01807065|515844874|FG001|Overall Study|Receive no sip-T due to IV access|1|||
143083646|NCT01482312|515844876|FG000|Period 1, 90 Minutes of Wear|Other|1|||
143083647|NCT01482312|515844877|FG001|Period 1, 90 Minutes of Wear|Other|0|||
143083648|NCT01482312|515844878|FG002|Period 1, 90 Minutes of Wear|Other|0|||
143083649|NCT01482312|515844876|FG000|Period 2, 90 Minutes of Wear|Other|1|||
143083650|NCT01482312|515844877|FG001|Period 2, 90 Minutes of Wear|Other|0|||
143083651|NCT01482312|515844878|FG002|Period 2, 90 Minutes of Wear|Other|0|||
143083652|NCT01699815|515844879|FG000|Overall Study|Protocol Violation|4|||
143083653|NCT01699815|515844880|FG001|Overall Study|Protocol Violation|7|||
143083654|NCT01699815|515844879|FG000|Overall Study|record could not be located|1|||
143083655|NCT01699815|515844880|FG001|Overall Study|record could not be located|0|||
143083656|NCT01699815|515844879|FG000|Overall Study|Adverse Event|0|||
143083657|NCT01699815|515844880|FG001|Overall Study|Adverse Event|1|||
143083658|NCT05246670|515844885|FG000|Overall Study|Withdrawal by Subject|2|||
143083659|NCT05246670|515844886|FG001|Overall Study|Withdrawal by Subject|3|||
143083660|NCT05246670|515844887|FG002|Overall Study|Withdrawal by Subject|0|||
143083661|NCT05246670|515844888|FG003|Overall Study|Withdrawal by Subject|1|||
143083662|NCT05246670|515844885|FG000|Overall Study|Adverse Event|0|||
143083663|NCT05246670|515844886|FG001|Overall Study|Adverse Event|0|||
143083664|NCT05246670|515844887|FG002|Overall Study|Adverse Event|1|||
143083665|NCT05246670|515844888|FG003|Overall Study|Adverse Event|0|||
143083666|NCT05246670|515844885|FG000|Overall Study|Physician Decision|1|||
143083667|NCT05246670|515844886|FG001|Overall Study|Physician Decision|0|||
143083668|NCT05246670|515844887|FG002|Overall Study|Physician Decision|0|||
143083669|NCT05246670|515844888|FG003|Overall Study|Physician Decision|0|||
143083670|NCT05246670|515844885|FG000|Overall Study|Protocol Violation|1|||
143083671|NCT05246670|515844886|FG001|Overall Study|Protocol Violation|0|||
143083672|NCT05246670|515844887|FG002|Overall Study|Protocol Violation|0|||
143083673|NCT05246670|515844888|FG003|Overall Study|Protocol Violation|0|||
143083674|NCT03154125|515844889|FG000|Overall Study|Lost to Follow-up|11|||
143083675|NCT03154125|515844890|FG001|Overall Study|Lost to Follow-up|11|||
143083676|NCT03154125|515844891|FG002|Overall Study|Lost to Follow-up|0|||
143083677|NCT03154125|515844889|FG000|Overall Study|Withdrawal by Subject|49|||
143083678|NCT03154125|515844890|FG001|Overall Study|Withdrawal by Subject|55|||
143083679|NCT03154125|515844891|FG002|Overall Study|Withdrawal by Subject|8|||
143083680|NCT03154125|515844889|FG000|Overall Study|Physician Decision|13|||
143083681|NCT03154125|515844890|FG001|Overall Study|Physician Decision|6|||
143083682|NCT03154125|515844891|FG002|Overall Study|Physician Decision|0|||
143083683|NCT03154125|515844889|FG000|Overall Study|Protocol Violation|3|||
143083684|NCT03154125|515844890|FG001|Overall Study|Protocol Violation|5|||
143083685|NCT03154125|515844891|FG002|Overall Study|Protocol Violation|0|||
143083686|NCT00799058|515844892|FG000|Overall Study|Withdrawal by Subject|2|||
143083687|NCT00799058|515844893|FG001|Overall Study|Withdrawal by Subject|2|||
143083688|NCT00799058|515844894|FG002|Overall Study|Withdrawal by Subject|2|||
143083689|NCT00799058|515844892|FG000|Overall Study|Lost to Follow-up|1|||
143083690|NCT00799058|515844893|FG001|Overall Study|Lost to Follow-up|2|||
143083691|NCT00799058|515844894|FG002|Overall Study|Lost to Follow-up|1|||
143083692|NCT00799058|515844892|FG000|Overall Study|Adverse Event|0|||
143083693|NCT00799058|515844893|FG001|Overall Study|Adverse Event|2|||
143083694|NCT00799058|515844894|FG002|Overall Study|Adverse Event|0|||
143083695|NCT00799058|515844892|FG000|Overall Study|Pregnancy|1|||
143083696|NCT00799058|515844893|FG001|Overall Study|Pregnancy|0|||
143083697|NCT00799058|515844894|FG002|Overall Study|Pregnancy|0|||
143083698|NCT00799058|515844892|FG000|Overall Study|Not adherent|3|||
143083699|NCT00799058|515844893|FG001|Overall Study|Not adherent|2|||
143083700|NCT00799058|515844894|FG002|Overall Study|Not adherent|1|||
143083701|NCT00799058|515844892|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
143083702|NCT00799058|515844893|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
143083703|NCT00799058|515844894|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
143083704|NCT00799058|515844892|FG000|Overall Study|IP dispensing error|1|||
143083705|NCT00799058|515844893|FG001|Overall Study|IP dispensing error|0|||
143083706|NCT00799058|515844894|FG002|Overall Study|IP dispensing error|0|||
143083707|NCT00799058|515844892|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
143083708|NCT00799058|515844893|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
143083709|NCT00799058|515844894|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
143083710|NCT00799058|515844892|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
143083711|NCT00799058|515844893|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
143083712|NCT00799058|515844894|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
143083713|NCT00799058|515844892|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
143083714|NCT00799058|515844893|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
143083715|NCT00799058|515844894|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
143083716|NCT00799058|515844892|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
143083717|NCT00799058|515844893|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
143083718|NCT00799058|515844894|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
143083719|NCT00810511|515844895|FG000|Overall Study|Protocol Violation|0|||
143083720|NCT00810511|515844896|FG001|Overall Study|Protocol Violation|1|||
143083721|NCT00810511|515844895|FG000|Overall Study|Lack of Efficacy|9|||
143083722|NCT00810511|515844896|FG001|Overall Study|Lack of Efficacy|1|||
143083723|NCT00810511|515844895|FG000|Overall Study|death in the family|0|||
143083724|NCT00810511|515844896|FG001|Overall Study|death in the family|1|||
143083725|NCT00810511|515844895|FG000|Overall Study|Lost to Follow-up|1|||
143083726|NCT00810511|515844896|FG001|Overall Study|Lost to Follow-up|0|||
143083727|NCT00810511|515844895|FG000|Overall Study|deposits on contact lens|0|||
143083728|NCT00810511|515844896|FG001|Overall Study|deposits on contact lens|1|||
143083729|NCT02088697|515844897|FG000|Period I|Physician Decision|1|||
143083730|NCT02088697|515844898|FG001|Period I|Physician Decision|4|||
143083731|NCT02088697|515844897|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
143083732|NCT02088697|515844898|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
143174000|NCT00956293|516185385|FG000|Main Period (Pre-randomization)|Death|0|||
143174001|NCT00956293|516185386|FG001|Main Period (Pre-randomization)|Death|0|||
143174002|NCT00956293|516185387|FG002|Main Period (Pre-randomization)|Death|1|||
143174003|NCT00956293|516185385|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
143174004|NCT00956293|516185386|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
143174005|NCT00956293|516185387|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
143174006|NCT00956293|516185385|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
143174007|NCT00956293|516185386|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
143174008|NCT00956293|516185387|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
143174009|NCT00956293|516185385|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
143174010|NCT00956293|516185386|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
143174011|NCT00956293|516185387|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
143174012|NCT00956293|516185385|FG000|Main Period (Pre-randomization)|Graft loss|0|||
143174013|NCT00956293|516185386|FG001|Main Period (Pre-randomization)|Graft loss|0|||
143174014|NCT00956293|516185387|FG002|Main Period (Pre-randomization)|Graft loss|7|||
143174015|NCT00956293|516185385|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
143174016|NCT00956293|516185386|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
143174017|NCT00956293|516185387|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
143174018|NCT00956293|516185385|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
143174019|NCT00956293|516185386|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
143174020|NCT00956293|516185387|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
143174021|NCT00956293|516185385|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
143174022|NCT00956293|516185386|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
143174023|NCT00956293|516185387|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
143174024|NCT00956293|516185385|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
143174025|NCT00956293|516185386|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
143174026|NCT00956293|516185387|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
143174027|NCT00956293|516185385|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
143174028|NCT00956293|516185386|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
143366469|NCT02040844|516884684|FG002|Overall Study|Adverse Event|1|||
143083733|NCT00462904|515844899|FG000|Overall Study|Lost to Follow-up|1|||
143083734|NCT04342819|515844900|FG000|Overall Study|Declined|4|||
143174029|NCT00956293|516185387|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
143174030|NCT00956293|516185385|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
143174031|NCT00956293|516185386|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
143174032|NCT00956293|516185387|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
143174033|NCT00956293|516185385|FG000|Main Period (Randomization)|Adverse Event|0|||
143083735|NCT04342819|515844900|FG000|Overall Study|Not meeeting selection criteria|1|||
143083736|NCT02287922|515844901|FG000|Overall Study|Adverse Event|1|||
143083737|NCT02287922|515844902|FG001|Overall Study|Adverse Event|1|||
143083738|NCT02287922|515844903|FG002|Overall Study|Adverse Event|3|||
143083739|NCT02287922|515844904|FG003|Overall Study|Adverse Event|4|||
143083740|NCT02287922|515844901|FG000|Overall Study|Withdrawal by Subject|1|||
143083741|NCT02287922|515844902|FG001|Overall Study|Withdrawal by Subject|1|||
143083742|NCT02287922|515844903|FG002|Overall Study|Withdrawal by Subject|1|||
143083743|NCT02287922|515844904|FG003|Overall Study|Withdrawal by Subject|2|||
143083744|NCT02287922|515844901|FG000|Overall Study|Lost to Follow-up|0|||
143249145|NCT01761240|516465175|FG001|Overall Study|Progressive disease:radiology assessment|3|||
143249146|NCT01761240|516465176|FG002|Overall Study|Progressive disease:radiology assessment|0|||
143249147|NCT01761240|516465177|FG003|Overall Study|Progressive disease:radiology assessment|0|||
143249148|NCT01761240|516465178|FG004|Overall Study|Progressive disease:radiology assessment|0|||
143249149|NCT01761240|516465174|FG000|Overall Study|Progressive disease:clinical assessment|0|||
143249150|NCT01761240|516465175|FG001|Overall Study|Progressive disease:clinical assessment|0|||
143249151|NCT01761240|516465176|FG002|Overall Study|Progressive disease:clinical assessment|3|||
143249152|NCT01761240|516465177|FG003|Overall Study|Progressive disease:clinical assessment|1|||
143249153|NCT01761240|516465178|FG004|Overall Study|Progressive disease:clinical assessment|0|||
143249154|NCT01761240|516465174|FG000|Overall Study|Withdrawal by Subject|0|||
143249155|NCT01761240|516465175|FG001|Overall Study|Withdrawal by Subject|0|||
143249156|NCT01761240|516465176|FG002|Overall Study|Withdrawal by Subject|0|||
143249157|NCT01761240|516465177|FG003|Overall Study|Withdrawal by Subject|3|||
143249158|NCT01761240|516465178|FG004|Overall Study|Withdrawal by Subject|1|||
143249159|NCT01761240|516465174|FG000|Overall Study|Adverse Event|0|||
143249160|NCT01761240|516465175|FG001|Overall Study|Adverse Event|0|||
143249161|NCT01761240|516465176|FG002|Overall Study|Adverse Event|0|||
143249162|NCT01761240|516465177|FG003|Overall Study|Adverse Event|1|||
143249163|NCT01761240|516465178|FG004|Overall Study|Adverse Event|6|||
143249164|NCT01761240|516465174|FG000|Overall Study|Death|0|||
143249165|NCT01761240|516465175|FG001|Overall Study|Death|1|||
143249166|NCT01761240|516465176|FG002|Overall Study|Death|1|||
143249167|NCT01761240|516465177|FG003|Overall Study|Death|2|||
143249168|NCT01761240|516465178|FG004|Overall Study|Death|1|||
143249169|NCT01761240|516465174|FG000|Overall Study|Non-compliance|0|||
143249170|NCT01761240|516465175|FG001|Overall Study|Non-compliance|0|||
143249171|NCT01761240|516465176|FG002|Overall Study|Non-compliance|1|||
143249172|NCT01761240|516465177|FG003|Overall Study|Non-compliance|0|||
143249173|NCT01761240|516465178|FG004|Overall Study|Non-compliance|0|||
143249174|NCT01324401|516465179|FG000|Overall Study|Withdrawn before any treatment|0|||
143249175|NCT01324401|516465180|FG001|Overall Study|Withdrawn before any treatment|3|||
143249176|NCT01324401|516465179|FG000|Overall Study|Adverse Event|1|||
143249177|NCT01324401|516465180|FG001|Overall Study|Adverse Event|3|||
143249178|NCT00934440|516465186|FG000|Overall Study|Lost to Follow-up|1|||
143249179|NCT01014910|516465187|FG000|Overall Study|Withdrawal by Subject|0|||
143249180|NCT01014910|516465188|FG001|Overall Study|Withdrawal by Subject|2|||
143249181|NCT02873429|516465189|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
143249182|NCT02873429|516465190|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
143249183|NCT02873429|516465189|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
143249184|NCT02873429|516465190|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
143249185|NCT02873429|516465189|FG000|16 Weeks|Lost to Follow-up|3|||
143249186|NCT02873429|516465190|FG001|16 Weeks|Lost to Follow-up|0|||
143249187|NCT01794338|516466823|FG000|Overall Study|Death|2|||
143249188|NCT01794338|516466824|FG001|Overall Study|Death|0|||
143249189|NCT01794338|516466823|FG000|Overall Study|Lost to Follow-up|6|||
143249190|NCT01794338|516466824|FG001|Overall Study|Lost to Follow-up|9|||
143083745|NCT02287922|515844902|FG001|Overall Study|Lost to Follow-up|0|||
143083746|NCT02287922|515844903|FG002|Overall Study|Lost to Follow-up|1|||
143083747|NCT02287922|515844904|FG003|Overall Study|Lost to Follow-up|0|||
143083748|NCT02287922|515844901|FG000|Overall Study|Sponsor's decision|0|||
143249191|NCT01754402|516466825|FG000|Overall Study|Death|0|||
143249192|NCT01754402|516466826|FG001|Overall Study|Death|0|||
143249193|NCT01754402|516466827|FG002|Overall Study|Death|1|||
143249194|NCT01754402|516466825|FG000|Overall Study|Adverse Event|2|||
143249195|NCT01754402|516466826|FG001|Overall Study|Adverse Event|2|||
143249196|NCT01754402|516466827|FG002|Overall Study|Adverse Event|1|||
143249197|NCT01754402|516466825|FG000|Overall Study|Withdrawal by Subject|0|||
143083749|NCT02287922|515844902|FG001|Overall Study|Sponsor's decision|0|||
143083750|NCT02287922|515844903|FG002|Overall Study|Sponsor's decision|0|||
143083751|NCT02287922|515844904|FG003|Overall Study|Sponsor's decision|1|||
143083752|NCT02287922|515844901|FG000|Overall Study|Other|1|||
143083753|NCT02287922|515844902|FG001|Overall Study|Other|0|||
143249198|NCT01754402|516466826|FG001|Overall Study|Withdrawal by Subject|0|||
143249199|NCT01754402|516466827|FG002|Overall Study|Withdrawal by Subject|1|||
143249200|NCT01754402|516466825|FG000|Overall Study|Lack of Efficacy|0|||
143249201|NCT01754402|516466826|FG001|Overall Study|Lack of Efficacy|0|||
143083754|NCT02287922|515844903|FG002|Overall Study|Other|2|||
143083755|NCT02287922|515844904|FG003|Overall Study|Other|0|||
143083756|NCT01569295|515844905|FG000|Overall Study|Progressive Disease|75|||
143083757|NCT01569295|515844906|FG001|Overall Study|Progressive Disease|139|||
143083758|NCT01569295|515844905|FG000|Overall Study|Adverse Event|39|||
143083759|NCT01569295|515844906|FG001|Overall Study|Adverse Event|14|||
143083760|NCT01569295|515844905|FG000|Overall Study|Withdrawal by Subject|25|||
143083761|NCT01569295|515844906|FG001|Overall Study|Withdrawal by Subject|12|||
143083762|NCT01569295|515844905|FG000|Overall Study|Death|19|||
143083763|NCT01569295|515844906|FG001|Overall Study|Death|15|||
143083764|NCT01569295|515844905|FG000|Overall Study|Physician Decision|13|||
143083765|NCT01569295|515844906|FG001|Overall Study|Physician Decision|18|||
143083766|NCT01569295|515844905|FG000|Overall Study|Study Terminated by Sponsor|24|||
143083767|NCT01569295|515844906|FG001|Overall Study|Study Terminated by Sponsor|2|||
143083768|NCT01569295|515844905|FG000|Overall Study|Other Reason not Specified|3|||
143083769|NCT01569295|515844906|FG001|Overall Study|Other Reason not Specified|5|||
143083770|NCT01569295|515844905|FG000|Overall Study|Non-Compliance with Study Drug|6|||
143083771|NCT01569295|515844906|FG001|Overall Study|Non-Compliance with Study Drug|1|||
143083772|NCT01569295|515844905|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
143083773|NCT01569295|515844906|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
143083774|NCT01569295|515844905|FG000|Overall Study|Lost to Follow-up|1|||
143083775|NCT01569295|515844906|FG001|Overall Study|Lost to Follow-up|1|||
143083776|NCT03597295|515844907|FG000|Overall Study|Death|70|||
143083777|NCT03597295|515844907|FG000|Overall Study|Lost to Follow-up|7|||
143083778|NCT05211726|515844908|FG000|Overall Study|Withdrawal by Subject|2|||
143083779|NCT05211726|515844909|FG001|Overall Study|Withdrawal by Subject|3|||
143083780|NCT05211726|515844908|FG000|Overall Study|Protocol Violation|0|||
143083781|NCT05211726|515844909|FG001|Overall Study|Protocol Violation|1|||
143083782|NCT02508935|515844910|FG000|Overall Study|Withdrawal by Subject|1|||
143083783|NCT02508935|515844910|FG000|Overall Study|Withdrawal by Caregiver|8|||
143083784|NCT02508935|515844910|FG000|Overall Study|Pain Score <4|1|||
143083785|NCT02508935|515844910|FG000|Overall Study|Emesis|3|||
143083786|NCT02508935|515844910|FG000|Overall Study|Adverse Event|3|||
143083787|NCT02508935|515844910|FG000|Overall Study|Protocol Violation|1|||
143083788|NCT02508935|515844910|FG000|Overall Study|Physician Decision|1|||
143083789|NCT02508935|515844910|FG000|Overall Study|Trial terminated by sponsor|5|||
143083790|NCT01973595|515844911|FG000|Washout|Withdrawal by Subject|1|||
143083791|NCT01973595|515844912|FG001|Washout|Withdrawal by Subject|0|||
143083792|NCT01973595|515844913|FG002|Washout|Withdrawal by Subject|1|||
143083793|NCT01973595|515844914|FG003|Washout|Withdrawal by Subject|0|||
143083794|NCT02676765|515844917|FG000|Overall Study|Lost to Follow-up|0|||
143083795|NCT02676765|515844918|FG001|Overall Study|Lost to Follow-up|1|||
143083796|NCT03340974|515844922|FG000|Completion of Study -Long Term Follow up|Death|8|||
143083797|NCT03340974|515844923|FG001|Completion of Study -Long Term Follow up|Death|5|||
143249202|NCT01754402|516466827|FG002|Overall Study|Lack of Efficacy|1|||
143249203|NCT01282463|516466828|FG000|Overall Study|Lost to Follow-up|1|||
143249204|NCT01282463|516466829|FG001|Overall Study|Lost to Follow-up|0|||
143249205|NCT01282463|516466830|FG002|Overall Study|Lost to Follow-up|0|||
143249206|NCT01282463|516466828|FG000|Overall Study|Withdrawal by Subject|6|||
143249207|NCT01282463|516466829|FG001|Overall Study|Withdrawal by Subject|2|||
143249208|NCT01282463|516466830|FG002|Overall Study|Withdrawal by Subject|3|||
143249209|NCT01282463|516466828|FG000|Overall Study|"Never Treated Death"|0|||
143249210|NCT01282463|516466829|FG001|Overall Study|"Never Treated Death"|1|||
143249211|NCT01282463|516466830|FG002|Overall Study|"Never Treated Death"|0|||
143249212|NCT01282463|516466828|FG000|Overall Study|"Never Treated PD"|0|||
143249213|NCT01282463|516466829|FG001|Overall Study|"Never Treated PD"|1|||
143249214|NCT01282463|516466830|FG002|Overall Study|"Never Treated PD"|0|||
143249215|NCT01282463|516466828|FG000|Overall Study|Protocol Violation|0|||
143249216|NCT01282463|516466829|FG001|Overall Study|Protocol Violation|0|||
143249217|NCT01282463|516466830|FG002|Overall Study|Protocol Violation|1|||
143249218|NCT01282463|516466828|FG000|Overall Study|Physician Decision|1|||
143249219|NCT01282463|516466829|FG001|Overall Study|Physician Decision|0|||
143249220|NCT01282463|516466830|FG002|Overall Study|Physician Decision|0|||
143249221|NCT03320824|516466831|FG000|Overall Study|Withdrawal by Subject|8|||
143249222|NCT03320824|516466832|FG001|Overall Study|Withdrawal by Subject|1|||
143249223|NCT03320824|516466831|FG000|Overall Study|Lost to Follow-up|10|||
143249224|NCT03320824|516466832|FG001|Overall Study|Lost to Follow-up|1|||
143366470|NCT02040844|516884682|FG000|Overall Study|Withdrawal by Subject|16|||
143083798|NCT03340974|515844924|FG002|Completion of Study -Long Term Follow up|Death|5|||
143083799|NCT03340974|515844925|FG003|Completion of Study -Long Term Follow up|Death|7|||
143083800|NCT03340974|515844922|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
143083801|NCT03340974|515844923|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
143083802|NCT03340974|515844924|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
143083803|NCT03340974|515844925|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
143249225|NCT03320824|516466831|FG000|Overall Study|moved out of state|0|||
143249226|NCT03320824|516466832|FG001|Overall Study|moved out of state|1|||
143249227|NCT03320824|516466831|FG000|Overall Study|could not complete final visit|0|||
143249228|NCT03320824|516466832|FG001|Overall Study|could not complete final visit|1|||
143249229|NCT01239992|516466835|FG000|Overall Study|Withdrawal by Subject|2|||
143249230|NCT00745849|516466836|FG000|First Intervention|Withdrawal by Subject|0|||
143249231|NCT00745849|516466837|FG001|First Intervention|Withdrawal by Subject|1|||
143249232|NCT00745849|516466836|FG000|First Intervention|Lost to Follow-up|1|||
143249233|NCT00745849|516466837|FG001|First Intervention|Lost to Follow-up|1|||
143249234|NCT00745849|516466836|FG000|Second Intervention|Lost to Follow-up|2|||
143083804|NCT03340974|515844922|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
143083805|NCT03340974|515844923|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
143083806|NCT03340974|515844924|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
143083807|NCT03340974|515844925|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
143083808|NCT03340974|515844922|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
143249235|NCT00745849|516466837|FG001|Second Intervention|Lost to Follow-up|1|||
143249236|NCT02617485|516466841|FG000|Treatment and Observation Period|Adverse Event|9|||
143249237|NCT02617485|516466842|FG001|Treatment and Observation Period|Adverse Event|1|||
143249238|NCT02617485|516466841|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
143249239|NCT02617485|516466842|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
143249240|NCT02617485|516466841|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
143249241|NCT02617485|516466842|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
143249242|NCT02617485|516466841|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
143249243|NCT02617485|516466842|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
143249244|NCT02617485|516466841|FG000|Treatment and Observation Period|Physician Decision|0|||
143249245|NCT02617485|516466842|FG001|Treatment and Observation Period|Physician Decision|1|||
143249246|NCT02617485|516466841|FG000|Follow-up Period|Adverse Event|1|||
143366471|NCT02040844|516884683|FG001|Overall Study|Withdrawal by Subject|22|||
143366472|NCT02040844|516884684|FG002|Overall Study|Withdrawal by Subject|25|||
143083809|NCT03340974|515844923|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
143249247|NCT02617485|516466842|FG001|Follow-up Period|Adverse Event|0|||
143249248|NCT02617485|516466841|FG000|Follow-up Period|Withdrawal by Subject|1|||
143249249|NCT02617485|516466842|FG001|Follow-up Period|Withdrawal by Subject|0|||
143249250|NCT02617485|516466841|FG000|Follow-up Period|Disease progression|2|||
143366473|NCT02040844|516884682|FG000|Overall Study|Lost to Follow-up|12|||
143083810|NCT03340974|515844924|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
143083811|NCT03340974|515844925|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
143083812|NCT00490841|515844929|FG000|Overall Study|Death|5|||
143083813|NCT00490841|515844929|FG000|Overall Study|Withdrawal by Subject|4|||
143083814|NCT00490841|515844929|FG000|Overall Study|Lost to Follow-up|1|||
143083815|NCT00490841|515844929|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
143083816|NCT02779855|515844932|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
143083817|NCT02779855|515844933|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
143083818|NCT02779855|515844934|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
143083819|NCT01301729|515844935|FG000|Overall Study|Withdrawal by Subject|2|||
143083820|NCT01301729|515844935|FG000|Overall Study|Participant did not Return for Treatment|1|||
143083821|NCT01301729|515844935|FG000|Overall Study|Violated Selection Criteria|1|||
143083822|NCT00143247|515844938|FG000|Overall Study|Death|8|||
143083823|NCT00143247|515844938|FG000|Overall Study|Adverse Event|19|||
143083824|NCT00143247|515844938|FG000|Overall Study|Lack of Efficacy|3|||
143083825|NCT00143247|515844938|FG000|Overall Study|Withdrawal by Subject|55|||
143083826|NCT00143247|515844938|FG000|Overall Study|Study terminated by sponsor|31|||
143083827|NCT00143247|515844938|FG000|Overall Study|Protocol Violation|15|||
143083828|NCT00143247|515844938|FG000|Overall Study|Lost to Follow-up|12|||
143083829|NCT00143247|515844938|FG000|Overall Study|following inaccurate lab adverse event|1|||
143083830|NCT00143247|515844938|FG000|Overall Study|Other|12|||
143083831|NCT02933255|515844941|FG000|Overall Study|Discontinued due to study closure.|1|||
143083832|NCT02933255|515844942|FG001|Overall Study|Discontinued due to study closure.|0|||
143083833|NCT02766283|515844943|FG000|Overall Study|Lost to Follow-up|27|||
143083834|NCT00912912|515844950|FG000|Overall Study|Withdrawal by Subject|1|||
143083835|NCT00912912|515844950|FG000|Overall Study|Disease Progression|3|||
143083836|NCT03207867|515844951|FG000|Overall Study|Adverse Event|1|||
143083837|NCT03207867|515844952|FG001|Overall Study|Adverse Event|0|||
143083838|NCT03207867|515844953|FG002|Overall Study|Adverse Event|1|||
143083839|NCT03207867|515844954|FG003|Overall Study|Adverse Event|0|||
143083840|NCT03207867|515844955|FG004|Overall Study|Adverse Event|0|||
143083841|NCT03207867|515844956|FG005|Overall Study|Adverse Event|2|||
143083842|NCT03207867|515844957|FG006|Overall Study|Adverse Event|1|||
143083843|NCT03207867|515844958|FG007|Overall Study|Adverse Event|1|||
143083844|NCT03207867|515844959|FG008|Overall Study|Adverse Event|2|||
143083845|NCT03207867|515844960|FG009|Overall Study|Adverse Event|2|||
143083846|NCT03207867|515844961|FG010|Overall Study|Adverse Event|0|||
143083847|NCT03207867|515844962|FG011|Overall Study|Adverse Event|0|||
143083848|NCT03207867|515844963|FG012|Overall Study|Adverse Event|0|||
143083849|NCT03207867|515844964|FG013|Overall Study|Adverse Event|0|||
143083850|NCT03207867|515844965|FG014|Overall Study|Adverse Event|0|||
143083851|NCT03207867|515844966|FG015|Overall Study|Adverse Event|0|||
143083852|NCT03207867|515844967|FG016|Overall Study|Adverse Event|3|||
143083853|NCT03207867|515844968|FG017|Overall Study|Adverse Event|1|||
143083854|NCT03207867|515844969|FG018|Overall Study|Adverse Event|2|||
143083855|NCT03207867|515844970|FG019|Overall Study|Adverse Event|1|||
143083856|NCT03207867|515844971|FG020|Overall Study|Adverse Event|0|||
143083857|NCT03207867|515844972|FG021|Overall Study|Adverse Event|0|||
143083858|NCT03207867|515844973|FG022|Overall Study|Adverse Event|0|||
143083859|NCT03207867|515844974|FG023|Overall Study|Adverse Event|0|||
143083860|NCT03207867|515844951|FG000|Overall Study|Death|0|||
143083861|NCT03207867|515844952|FG001|Overall Study|Death|0|||
143083862|NCT03207867|515844953|FG002|Overall Study|Death|0|||
143083863|NCT03207867|515844954|FG003|Overall Study|Death|0|||
143083864|NCT03207867|515844955|FG004|Overall Study|Death|0|||
143174034|NCT00956293|516185386|FG001|Main Period (Randomization)|Adverse Event|15|||
143174035|NCT00956293|516185387|FG002|Main Period (Randomization)|Adverse Event|0|||
143174036|NCT00956293|516185385|FG000|Follow-up Period|Follow-up period was terminated.|20|||
143174037|NCT00956293|516185386|FG001|Follow-up Period|Follow-up period was terminated.|32|||
143174038|NCT00956293|516185387|FG002|Follow-up Period|Follow-up period was terminated.|0|||
143174039|NCT02359903|516185388|FG000|Overall Study|Adverse Event|0|||
143174040|NCT02359903|516185389|FG001|Overall Study|Adverse Event|2|||
143174041|NCT05899829|516185390|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
143174042|NCT05899829|516185391|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
143174043|NCT05899829|516185390|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
143083865|NCT03207867|515844956|FG005|Overall Study|Death|1|||
143083866|NCT03207867|515844957|FG006|Overall Study|Death|0|||
143083867|NCT03207867|515844958|FG007|Overall Study|Death|3|||
143083868|NCT03207867|515844959|FG008|Overall Study|Death|1|||
143083869|NCT03207867|515844960|FG009|Overall Study|Death|2|||
143083870|NCT03207867|515844961|FG010|Overall Study|Death|0|||
143083871|NCT03207867|515844962|FG011|Overall Study|Death|1|||
143083872|NCT03207867|515844963|FG012|Overall Study|Death|0|||
143083873|NCT03207867|515844964|FG013|Overall Study|Death|1|||
143083874|NCT03207867|515844965|FG014|Overall Study|Death|0|||
143083875|NCT03207867|515844966|FG015|Overall Study|Death|0|||
143083876|NCT03207867|515844967|FG016|Overall Study|Death|0|||
143083877|NCT03207867|515844968|FG017|Overall Study|Death|2|||
143366474|NCT02040844|516884683|FG001|Overall Study|Lost to Follow-up|9|||
143366475|NCT02040844|516884684|FG002|Overall Study|Lost to Follow-up|13|||
143366476|NCT02040844|516884682|FG000|Overall Study|Missing|13|||
143366477|NCT02040844|516884683|FG001|Overall Study|Missing|3|||
143083878|NCT03207867|515844969|FG018|Overall Study|Death|0|||
143083879|NCT03207867|515844970|FG019|Overall Study|Death|1|||
143083880|NCT03207867|515844971|FG020|Overall Study|Death|0|||
143083881|NCT03207867|515844972|FG021|Overall Study|Death|0|||
143083882|NCT03207867|515844973|FG022|Overall Study|Death|0|||
143249251|NCT02617485|516466842|FG001|Follow-up Period|Disease progression|1|||
143249252|NCT02617485|516466841|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
143249253|NCT02617485|516466842|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
143249254|NCT02617485|516466841|FG000|Follow-up Period|Patient needed radiotherapy|9|||
143249255|NCT02617485|516466842|FG001|Follow-up Period|Patient needed radiotherapy|5|||
143249256|NCT02617485|516466841|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
143249257|NCT02617485|516466842|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
143249258|NCT00220779|516466843|FG000|Overall Study|Adverse Event|1|||
143249259|NCT00220779|516466844|FG001|Overall Study|Adverse Event|0|||
143249260|NCT00220779|516466845|FG002|Overall Study|Adverse Event|0|||
143249261|NCT00220779|516466843|FG000|Overall Study|Withdrawal by Subject|1|||
143366478|NCT02040844|516884684|FG002|Overall Study|Missing|2|||
143366479|NCT02040844|516884682|FG000|Overall Study|Non-specified|8|||
143366480|NCT02040844|516884683|FG001|Overall Study|Non-specified|2|||
143083883|NCT03207867|515844974|FG023|Overall Study|Death|0|||
143083884|NCT03207867|515844951|FG000|Overall Study|Physician Decision|3|||
143083885|NCT03207867|515844952|FG001|Overall Study|Physician Decision|5|||
143249262|NCT00220779|516466844|FG001|Overall Study|Withdrawal by Subject|4|||
143249263|NCT00220779|516466845|FG002|Overall Study|Withdrawal by Subject|1|||
143366481|NCT02040844|516884684|FG002|Overall Study|Non-specified|5|||
143366482|NCT02040844|516884682|FG000|Overall Study|Concomitant medication|1|||
143174044|NCT05899829|516185391|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
143174045|NCT00636181|516185394|FG000|Overall Study|Withdrawal by Subject|8|||
143174046|NCT00636181|516185395|FG001|Overall Study|Withdrawal by Subject|6|||
143174047|NCT00636181|516185396|FG002|Overall Study|Withdrawal by Subject|10|||
143174048|NCT04549454|516185397|FG000|T1 to T2|Lost to Follow-up|22|||
143174049|NCT04549454|516185398|FG001|T1 to T2|Lost to Follow-up|26|||
143174050|NCT04549454|516185397|FG000|T1 to T3|Lost to Follow-up|31|||
143174051|NCT04549454|516185398|FG001|T1 to T3|Lost to Follow-up|36|||
143174052|NCT00867035|516185399|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
143174053|NCT00867035|516185400|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
143174054|NCT00867035|516185399|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
143174055|NCT00867035|516185400|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
143174056|NCT05076045|516185401|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
143174057|NCT05076045|516185402|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
143174058|NCT02993263|516185408|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
143174059|NCT00545779|516185413|FG000|Overall Study|Violation of selection criteria at entry|8|||
143174060|NCT00545779|516185413|FG000|Overall Study|Other protocol violation|1|||
143366483|NCT02040844|516884683|FG001|Overall Study|Concomitant medication|3|||
143366484|NCT02040844|516884684|FG002|Overall Study|Concomitant medication|1|||
143366485|NCT01080131|516884685|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
143366486|NCT01080131|516884686|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
143366487|NCT01080131|516884685|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
143083886|NCT03207867|515844953|FG002|Overall Study|Physician Decision|0|||
143083887|NCT03207867|515844954|FG003|Overall Study|Physician Decision|3|||
143083888|NCT03207867|515844955|FG004|Overall Study|Physician Decision|2|||
143083889|NCT03207867|515844956|FG005|Overall Study|Physician Decision|0|||
143083890|NCT03207867|515844957|FG006|Overall Study|Physician Decision|0|||
143083891|NCT03207867|515844958|FG007|Overall Study|Physician Decision|0|||
143083892|NCT03207867|515844959|FG008|Overall Study|Physician Decision|4|||
143083893|NCT03207867|515844960|FG009|Overall Study|Physician Decision|2|||
143083894|NCT03207867|515844961|FG010|Overall Study|Physician Decision|0|||
143083895|NCT03207867|515844962|FG011|Overall Study|Physician Decision|4|||
143083896|NCT03207867|515844963|FG012|Overall Study|Physician Decision|0|||
143083897|NCT03207867|515844964|FG013|Overall Study|Physician Decision|0|||
143083898|NCT03207867|515844965|FG014|Overall Study|Physician Decision|2|||
143083899|NCT03207867|515844966|FG015|Overall Study|Physician Decision|1|||
143083900|NCT03207867|515844967|FG016|Overall Study|Physician Decision|1|||
143083901|NCT03207867|515844968|FG017|Overall Study|Physician Decision|2|||
143083902|NCT03207867|515844969|FG018|Overall Study|Physician Decision|1|||
143083903|NCT03207867|515844970|FG019|Overall Study|Physician Decision|3|||
143083904|NCT03207867|515844971|FG020|Overall Study|Physician Decision|0|||
143083905|NCT03207867|515844972|FG021|Overall Study|Physician Decision|0|||
143083906|NCT03207867|515844973|FG022|Overall Study|Physician Decision|0|||
143174061|NCT00545779|516185413|FG000|Overall Study|Did not cooperate|7|||
143249264|NCT00220779|516466843|FG000|Overall Study|Non-compliance|1|||
143249265|NCT00220779|516466844|FG001|Overall Study|Non-compliance|0|||
143249266|NCT00220779|516466845|FG002|Overall Study|Non-compliance|0|||
143249267|NCT00220779|516466843|FG000|Overall Study|Too time consuming|1|||
143249268|NCT00220779|516466844|FG001|Overall Study|Too time consuming|0|||
143249269|NCT00220779|516466845|FG002|Overall Study|Too time consuming|0|||
143249270|NCT00220779|516466843|FG000|Overall Study|Pregnancy|0|||
143249271|NCT00220779|516466844|FG001|Overall Study|Pregnancy|0|||
143249272|NCT00220779|516466845|FG002|Overall Study|Pregnancy|2|||
143249273|NCT00220779|516466843|FG000|Overall Study|Lack of Efficacy|3|||
143249274|NCT00220779|516466844|FG001|Overall Study|Lack of Efficacy|0|||
143249275|NCT00220779|516466845|FG002|Overall Study|Lack of Efficacy|1|||
143249276|NCT01235598|516466853|FG000|Overall Study|Adverse Event|0|||
143249277|NCT01235598|516466854|FG001|Overall Study|Adverse Event|3|||
143249278|NCT01235598|516466853|FG000|Overall Study|Lack of Efficacy|0|||
143249279|NCT01235598|516466854|FG001|Overall Study|Lack of Efficacy|1|||
143249280|NCT01235598|516466853|FG000|Overall Study|Withdrawal by Subject|1|||
143249281|NCT01235598|516466854|FG001|Overall Study|Withdrawal by Subject|0|||
143249282|NCT00387790|516466855|FG000|Overall Study|Adverse Event|5|||
143366488|NCT01080131|516884686|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
143083907|NCT03207867|515844974|FG023|Overall Study|Physician Decision|0|||
143083908|NCT03207867|515844951|FG000|Overall Study|Progressive Disease|7|||
143083909|NCT03207867|515844952|FG001|Overall Study|Progressive Disease|7|||
143083910|NCT03207867|515844953|FG002|Overall Study|Progressive Disease|9|||
143083911|NCT03207867|515844954|FG003|Overall Study|Progressive Disease|10|||
143249283|NCT00387790|516466855|FG000|Overall Study|Lack of Efficacy|2|||
143249284|NCT00387790|516466855|FG000|Overall Study|Physician Decision|2|||
143249285|NCT00387790|516466855|FG000|Overall Study|Withdrawal by Subject|3|||
143249286|NCT00387790|516466855|FG000|Overall Study|Ineligible for study|2|||
143249287|NCT01874340|516466856|FG000|Overall Study|Study terminated by Sponsor|6|||
143249288|NCT01874340|516466857|FG001|Overall Study|Study terminated by Sponsor|8|||
143174062|NCT00545779|516185413|FG000|Overall Study|Withdrawal by Subject|20|||
143174063|NCT00545779|516185413|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
143249289|NCT01874340|516466858|FG002|Overall Study|Study terminated by Sponsor|8|||
143366489|NCT01080131|516884685|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
143366490|NCT01080131|516884686|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
143366491|NCT01080131|516884685|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
143366492|NCT01080131|516884686|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
143366493|NCT01080131|516884685|FG000|Core Study (0- 12 Weeks)|Death|1|||
143366494|NCT01080131|516884686|FG001|Core Study (0- 12 Weeks)|Death|0|||
143366495|NCT01080131|516884685|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
143366496|NCT01080131|516884686|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
143366497|NCT01080131|516884685|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
143366498|NCT01080131|516884686|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
143366499|NCT01080131|516884685|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
143366500|NCT01080131|516884686|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
143366501|NCT01080131|516884685|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
143366502|NCT01080131|516884686|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
143366503|NCT01080131|516884685|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
143366504|NCT01080131|516884686|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
143366505|NCT01080131|516884685|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
143366506|NCT01080131|516884686|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
143366507|NCT01080131|516884685|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
143366508|NCT01080131|516884686|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
143366509|NCT01080131|516884685|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
143366510|NCT01080131|516884686|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
143366511|NCT00299702|516884689|FG000|Overall Study|Death|1|||
143366512|NCT00299702|516884690|FG001|Overall Study|Death|0|||
143366513|NCT00299702|516884689|FG000|Overall Study|Adverse Event|0|||
143366514|NCT00299702|516884690|FG001|Overall Study|Adverse Event|4|||
143366515|NCT00299702|516884689|FG000|Overall Study|Lost to Follow-up|18|||
143366516|NCT00299702|516884690|FG001|Overall Study|Lost to Follow-up|10|||
143366517|NCT00299702|516884689|FG000|Overall Study|Withdrawal by Subject|25|||
143083912|NCT03207867|515844955|FG004|Overall Study|Progressive Disease|11|||
143083913|NCT03207867|515844956|FG005|Overall Study|Progressive Disease|10|||
143083914|NCT03207867|515844957|FG006|Overall Study|Progressive Disease|9|||
143083915|NCT03207867|515844958|FG007|Overall Study|Progressive Disease|8|||
143083916|NCT03207867|515844959|FG008|Overall Study|Progressive Disease|19|||
143083917|NCT03207867|515844960|FG009|Overall Study|Progressive Disease|23|||
143083918|NCT03207867|515844961|FG010|Overall Study|Progressive Disease|2|||
143083919|NCT03207867|515844962|FG011|Overall Study|Progressive Disease|24|||
143083920|NCT03207867|515844963|FG012|Overall Study|Progressive Disease|3|||
143083921|NCT03207867|515844964|FG013|Overall Study|Progressive Disease|11|||
143083922|NCT03207867|515844965|FG014|Overall Study|Progressive Disease|9|||
143083923|NCT03207867|515844966|FG015|Overall Study|Progressive Disease|5|||
143083924|NCT03207867|515844967|FG016|Overall Study|Progressive Disease|10|||
143083925|NCT03207867|515844968|FG017|Overall Study|Progressive Disease|14|||
143083926|NCT03207867|515844969|FG018|Overall Study|Progressive Disease|13|||
143083927|NCT03207867|515844970|FG019|Overall Study|Progressive Disease|14|||
143083928|NCT03207867|515844971|FG020|Overall Study|Progressive Disease|6|||
143083929|NCT03207867|515844972|FG021|Overall Study|Progressive Disease|3|||
143083930|NCT03207867|515844973|FG022|Overall Study|Progressive Disease|3|||
143083931|NCT03207867|515844974|FG023|Overall Study|Progressive Disease|3|||
143083932|NCT03207867|515844951|FG000|Overall Study|Patient/guardian Decision|0|||
143083933|NCT03207867|515844952|FG001|Overall Study|Patient/guardian Decision|0|||
143174064|NCT00545779|516185413|FG000|Overall Study|Failure to return|3|||
143174065|NCT01405196|516185414|FG000|Overall Study|Study Terminated by Sponsor|0|||
143174066|NCT01405196|516185415|FG001|Overall Study|Study Terminated by Sponsor|0|||
143174067|NCT01405196|516185416|FG002|Overall Study|Study Terminated by Sponsor|9|||
143174068|NCT01405196|516185417|FG003|Overall Study|Study Terminated by Sponsor|0|||
143174069|NCT01405196|516185414|FG000|Overall Study|Other|2|||
143174070|NCT01405196|516185415|FG001|Overall Study|Other|2|||
143174071|NCT01405196|516185416|FG002|Overall Study|Other|5|||
143174072|NCT01405196|516185417|FG003|Overall Study|Other|0|||
143174073|NCT01405196|516185414|FG000|Overall Study|Withdrawal by Subject|4|||
143174074|NCT01405196|516185415|FG001|Overall Study|Withdrawal by Subject|6|||
143174075|NCT01405196|516185416|FG002|Overall Study|Withdrawal by Subject|3|||
143366518|NCT00299702|516884690|FG001|Overall Study|Withdrawal by Subject|23|||
143083934|NCT03207867|515844953|FG002|Overall Study|Patient/guardian Decision|1|||
143083935|NCT03207867|515844954|FG003|Overall Study|Patient/guardian Decision|1|||
143083936|NCT03207867|515844955|FG004|Overall Study|Patient/guardian Decision|1|||
143083937|NCT03207867|515844956|FG005|Overall Study|Patient/guardian Decision|2|||
143083938|NCT03207867|515844957|FG006|Overall Study|Patient/guardian Decision|1|||
143174076|NCT01405196|516185417|FG003|Overall Study|Withdrawal by Subject|6|||
143083939|NCT03207867|515844958|FG007|Overall Study|Patient/guardian Decision|0|||
143174077|NCT01405196|516185414|FG000|Overall Study|Adverse Event|2|||
143174078|NCT01405196|516185415|FG001|Overall Study|Adverse Event|2|||
143249290|NCT01874340|516466859|FG003|Overall Study|Study terminated by Sponsor|4|||
143249291|NCT01874340|516466856|FG000|Overall Study|Withdrawal by Subject|0|||
143249292|NCT01874340|516466857|FG001|Overall Study|Withdrawal by Subject|0|||
143249293|NCT01874340|516466858|FG002|Overall Study|Withdrawal by Subject|0|||
143249294|NCT01874340|516466859|FG003|Overall Study|Withdrawal by Subject|1|||
143249295|NCT03539549|516466860|FG000|Overall Study|Adverse Event|12|||
143249296|NCT03539549|516466860|FG000|Overall Study|Lost to Follow-up|1|||
143249297|NCT03539549|516466860|FG000|Overall Study|Death|2|||
143249298|NCT03539549|516466860|FG000|Overall Study|Progressive Disease|1|||
143249299|NCT03539549|516466860|FG000|Overall Study|Reason not Specified|1|||
143249300|NCT02864862|516466862|FG000|Overall Study|Lost to Follow-up|1|||
143249301|NCT02864862|516466863|FG001|Overall Study|Lost to Follow-up|0|||
143249302|NCT02864862|516466864|FG002|Overall Study|Lost to Follow-up|1|||
143249303|NCT02864862|516466862|FG000|Overall Study|Protocol Violation|0|||
143249304|NCT02864862|516466863|FG001|Overall Study|Protocol Violation|0|||
143249305|NCT02864862|516466864|FG002|Overall Study|Protocol Violation|1|||
143249306|NCT03263702|516466865|FG000|Overall Study|Lost to Follow-up|2|||
143249307|NCT03263702|516466866|FG001|Overall Study|Lost to Follow-up|2|||
143249308|NCT03263702|516466865|FG000|Overall Study|Withdrawal by Subject|1|||
143249309|NCT03263702|516466866|FG001|Overall Study|Withdrawal by Subject|2|||
143249310|NCT03598114|516466867|FG000|Overall Study|Staff turnover/left the program|3|||
143249311|NCT03598114|516466868|FG001|Overall Study|Staff turnover/left the program|39|||
143249312|NCT00612807|516466869|FG000|Overall Study|Withdrawal by Subject|2|||
143249313|NCT00612807|516466870|FG001|Overall Study|Withdrawal by Subject|0|||
143249314|NCT00744042|516466875|FG000|Overall Study|Withdrawal by Subject|1|||
143083940|NCT03207867|515844959|FG008|Overall Study|Patient/guardian Decision|1|||
143083941|NCT03207867|515844960|FG009|Overall Study|Patient/guardian Decision|0|||
143083942|NCT03207867|515844961|FG010|Overall Study|Patient/guardian Decision|0|||
143083943|NCT03207867|515844962|FG011|Overall Study|Patient/guardian Decision|1|||
143083944|NCT03207867|515844963|FG012|Overall Study|Patient/guardian Decision|0|||
143083945|NCT03207867|515844964|FG013|Overall Study|Patient/guardian Decision|1|||
143083946|NCT03207867|515844965|FG014|Overall Study|Patient/guardian Decision|2|||
143083947|NCT03207867|515844966|FG015|Overall Study|Patient/guardian Decision|0|||
143083948|NCT03207867|515844967|FG016|Overall Study|Patient/guardian Decision|1|||
143083949|NCT03207867|515844968|FG017|Overall Study|Patient/guardian Decision|3|||
143083950|NCT03207867|515844969|FG018|Overall Study|Patient/guardian Decision|4|||
143083951|NCT03207867|515844970|FG019|Overall Study|Patient/guardian Decision|1|||
143083952|NCT03207867|515844971|FG020|Overall Study|Patient/guardian Decision|0|||
143083953|NCT03207867|515844972|FG021|Overall Study|Patient/guardian Decision|0|||
143083954|NCT03207867|515844973|FG022|Overall Study|Patient/guardian Decision|0|||
143083955|NCT03207867|515844974|FG023|Overall Study|Patient/guardian Decision|0|||
143083956|NCT02447744|515844975|FG000|Overall Study|Withdrawal by Subject|3|||
143083957|NCT02447744|515844976|FG001|Overall Study|Withdrawal by Subject|1|||
143083958|NCT02447744|515844975|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
143083959|NCT02447744|515844976|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
143083960|NCT00306995|515844977|FG000|Study Part I|Withdrawal by Subject|0|||
143083961|NCT00306995|515844978|FG001|Study Part I|Withdrawal by Subject|0|||
143083962|NCT00306995|515844979|FG002|Study Part I|Withdrawal by Subject|0|||
143083963|NCT00306995|515844980|FG003|Study Part I|Withdrawal by Subject|0|||
143083964|NCT00306995|515844981|FG004|Study Part I|Withdrawal by Subject|0|||
143083965|NCT00306995|515844982|FG005|Study Part I|Withdrawal by Subject|0|||
143083966|NCT00306995|515844983|FG006|Study Part I|Withdrawal by Subject|1|||
143083967|NCT00306995|515844977|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
143083968|NCT00306995|515844978|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
143083969|NCT00306995|515844979|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
143083970|NCT00306995|515844980|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
143083971|NCT00306995|515844981|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
143083972|NCT00306995|515844982|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
143083973|NCT00306995|515844983|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
143249315|NCT00853567|516466877|FG000|Overall Study|Study prematurely terminated|71|||
143249316|NCT00782834|516466883|FG000|Treatment Phase|fibrous tumor not GIST|1|||
143366519|NCT00299702|516884689|FG000|Overall Study|Pregnancy|0|||
143249317|NCT02055118|516466884|FG000|Overall Study|Withdrawal by Subject|0|||
143249318|NCT02055118|516466885|FG001|Overall Study|Withdrawal by Subject|2|||
143249319|NCT02055118|516466886|FG002|Overall Study|Withdrawal by Subject|0|||
143249320|NCT02281383|516466888|FG000|Overall Study|Progressive Disease|1|||
143249321|NCT02281383|516466888|FG000|Overall Study|Withdrawal by Subject|6|||
143249322|NCT02281383|516466888|FG000|Overall Study|Protocol Violation|2|||
143083974|NCT05422625|515844984|FG000|Overall Study|Withdrawal by Subject|1|||
143083975|NCT05422625|515844985|FG001|Overall Study|Withdrawal by Subject|0|||
143083976|NCT01496976|515846608|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
143083977|NCT05938621|515846609|FG000|Overall Study|Lost to Follow-up|1|||
143083978|NCT05938621|515846610|FG001|Overall Study|Lost to Follow-up|5|||
143083979|NCT05938621|515846611|FG002|Overall Study|Lost to Follow-up|2|||
143083980|NCT05938621|515846612|FG003|Overall Study|Lost to Follow-up|2|||
143083981|NCT03598790|515846613|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
143083982|NCT03598790|515846614|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
143083983|NCT03598790|515846615|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
143083984|NCT03598790|515846616|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
143083985|NCT03598790|515846617|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
143083986|NCT03598790|515846618|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
143083987|NCT03598790|515846619|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
143083988|NCT03598790|515846620|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
143083989|NCT03598790|515846621|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
143083990|NCT03598790|515846613|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
143083991|NCT03598790|515846614|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
143083992|NCT03598790|515846615|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
143083993|NCT03598790|515846616|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
143083994|NCT03598790|515846617|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
143083995|NCT03598790|515846618|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
143083996|NCT03598790|515846619|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
143083997|NCT03598790|515846620|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
143083998|NCT03598790|515846621|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
143083999|NCT03598790|515846613|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
143084000|NCT03598790|515846614|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
143084001|NCT03598790|515846615|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
143084002|NCT03598790|515846616|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
143084003|NCT03598790|515846617|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
143084004|NCT03598790|515846618|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
143084005|NCT03598790|515846619|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
143084006|NCT03598790|515846620|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
143084007|NCT03598790|515846621|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
143084008|NCT03598790|515846613|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
143084009|NCT03598790|515846614|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
143084010|NCT03598790|515846615|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
143084011|NCT03598790|515846616|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
143084012|NCT03598790|515846617|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
143084013|NCT03598790|515846618|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
143084014|NCT03598790|515846619|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
143084015|NCT03598790|515846620|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
143366520|NCT00299702|516884690|FG001|Overall Study|Pregnancy|1|||
143366521|NCT00299702|516884689|FG000|Overall Study|Insufficient Response|4|||
143366522|NCT00299702|516884690|FG001|Overall Study|Insufficient Response|3|||
143366523|NCT00299702|516884689|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
143366524|NCT00299702|516884690|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
143366525|NCT00751036|516884691|FG000|Overall Study|Disease Progression|28|||
143366526|NCT00751036|516884692|FG001|Overall Study|Disease Progression|29|||
143366527|NCT00751036|516884691|FG000|Overall Study|Adverse Event|6|||
143366528|NCT00751036|516884692|FG001|Overall Study|Adverse Event|4|||
143366529|NCT00751036|516884691|FG000|Overall Study|Administrative Problems|3|||
143366530|NCT00751036|516884692|FG001|Overall Study|Administrative Problems|4|||
143366531|NCT00751036|516884691|FG000|Overall Study|Withdrawal by Subject|5|||
143366532|NCT00751036|516884692|FG001|Overall Study|Withdrawal by Subject|2|||
143366533|NCT00751036|516884691|FG000|Overall Study|Death|3|||
143366534|NCT00751036|516884692|FG001|Overall Study|Death|3|||
143366535|NCT00751036|516884691|FG000|Overall Study|Lost to Follow-up|0|||
143366536|NCT00751036|516884692|FG001|Overall Study|Lost to Follow-up|1|||
143366537|NCT00751036|516884691|FG000|Overall Study|Protocol Violation|1|||
143366538|NCT00751036|516884692|FG001|Overall Study|Protocol Violation|0|||
143366539|NCT00751036|516884691|FG000|Overall Study|Missing end of Treatment Page|2|||
143366540|NCT00751036|516884692|FG001|Overall Study|Missing end of Treatment Page|3|||
143366541|NCT04580407|516884693|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
143366542|NCT00681811|516884698|FG000|Overall Study|Adverse Event|1|||
143366543|NCT00681811|516884699|FG001|Overall Study|Adverse Event|1|||
143366544|NCT00681811|516884698|FG000|Overall Study|Withdrawal by Subject|2|||
143366545|NCT00681811|516884699|FG001|Overall Study|Withdrawal by Subject|2|||
143366546|NCT00681811|516884698|FG000|Overall Study|Non-compliance|0|||
143084016|NCT03598790|515846621|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
143084017|NCT03598790|515846613|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
143084018|NCT03598790|515846614|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
143084019|NCT03598790|515846615|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
143084020|NCT03598790|515846616|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
143084021|NCT03598790|515846617|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
143084022|NCT03598790|515846618|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
143084023|NCT03598790|515846619|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
143084024|NCT03598790|515846620|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
143084025|NCT03598790|515846621|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
143084026|NCT03598790|515846613|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
143084027|NCT03598790|515846614|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
143084028|NCT03598790|515846615|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
143084029|NCT03598790|515846616|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
143084030|NCT03598790|515846617|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
143084031|NCT03598790|515846618|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
143084032|NCT03598790|515846619|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
143084033|NCT03598790|515846620|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
143084034|NCT03598790|515846621|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
143084035|NCT03598790|515846613|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
143084036|NCT03598790|515846614|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
143084037|NCT03598790|515846615|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
143084038|NCT03598790|515846616|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
143084039|NCT03598790|515846617|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
143084040|NCT03598790|515846618|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
143084041|NCT03598790|515846619|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
143084042|NCT03598790|515846620|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
143084043|NCT03598790|515846621|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
143084044|NCT03598790|515846613|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
143084045|NCT03598790|515846614|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
143174079|NCT01405196|516185416|FG002|Overall Study|Adverse Event|0|||
143366547|NCT00681811|516884699|FG001|Overall Study|Non-compliance|1|||
143366548|NCT02068885|516884700|FG000|Overall Study|Withdrew|3|||
143366549|NCT02068885|516884701|FG001|Overall Study|Withdrew|5|||
143366550|NCT02068885|516884702|FG002|Overall Study|Withdrew|8|||
143366551|NCT00828919|516884703|FG000|Overall Study|Death|0|||
143366552|NCT00828919|516884704|FG001|Overall Study|Death|1|||
143366553|NCT00828919|516884705|FG002|Overall Study|Death|2|||
143366554|NCT00828919|516884706|FG003|Overall Study|Death|0|||
143366555|NCT00828919|516884707|FG004|Overall Study|Death|0|||
143366556|NCT00828919|516884703|FG000|Overall Study|Adverse Event|2|||
143366557|NCT00828919|516884704|FG001|Overall Study|Adverse Event|2|||
143366558|NCT00828919|516884705|FG002|Overall Study|Adverse Event|2|||
143366559|NCT00828919|516884706|FG003|Overall Study|Adverse Event|1|||
143366560|NCT00828919|516884707|FG004|Overall Study|Adverse Event|3|||
143084046|NCT03598790|515846615|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
143084047|NCT03598790|515846616|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
143084048|NCT03598790|515846617|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
143084049|NCT03598790|515846618|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
143084050|NCT03598790|515846619|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
143084051|NCT03598790|515846620|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
143084052|NCT03598790|515846621|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
143084053|NCT03598790|515846613|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
143084054|NCT03598790|515846614|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
143084055|NCT03598790|515846615|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
143084056|NCT03598790|515846616|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
143084057|NCT03598790|515846617|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
143084058|NCT03598790|515846618|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
143084059|NCT03598790|515846619|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
143084060|NCT03598790|515846620|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
143084061|NCT03598790|515846621|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
143084062|NCT03598790|515846613|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
143084063|NCT03598790|515846614|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
143084064|NCT03598790|515846615|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
143084065|NCT03598790|515846616|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
143084066|NCT03598790|515846617|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
143084067|NCT03598790|515846618|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
143084068|NCT03598790|515846619|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
143084069|NCT03598790|515846620|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
143084070|NCT03598790|515846621|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
143084071|NCT03598790|515846613|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
143084072|NCT03598790|515846614|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
143084073|NCT03598790|515846615|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
143084074|NCT03598790|515846616|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
143084075|NCT03598790|515846617|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
143084076|NCT03598790|515846618|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
143084077|NCT03598790|515846619|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
143084078|NCT03598790|515846620|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
143084079|NCT03598790|515846621|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
143084080|NCT03598790|515846613|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
143084081|NCT03598790|515846614|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
143174080|NCT01405196|516185417|FG003|Overall Study|Adverse Event|2|||
143174081|NCT01405196|516185414|FG000|Overall Study|Death|1|||
143174082|NCT01405196|516185415|FG001|Overall Study|Death|0|||
143174083|NCT01405196|516185416|FG002|Overall Study|Death|3|||
143174084|NCT01405196|516185417|FG003|Overall Study|Death|0|||
143174085|NCT01405196|516185414|FG000|Overall Study|Lost to Follow-up|2|||
143174086|NCT01405196|516185415|FG001|Overall Study|Lost to Follow-up|2|||
143174087|NCT01405196|516185416|FG002|Overall Study|Lost to Follow-up|3|||
143174088|NCT01405196|516185417|FG003|Overall Study|Lost to Follow-up|1|||
143174089|NCT00542178|516185418|FG000|Overall Study|did not complete year 4 follow-up|75|||
143174090|NCT00542178|516185419|FG001|Overall Study|did not complete year 4 follow-up|80|||
143174091|NCT00542178|516185420|FG002|Overall Study|did not complete year 4 follow-up|74|||
143174092|NCT00542178|516185421|FG003|Overall Study|did not complete year 4 follow-up|62|||
143174093|NCT00542178|516185422|FG004|Overall Study|did not complete year 4 follow-up|64|||
143084082|NCT03598790|515846615|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
143084083|NCT03598790|515846616|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
143084084|NCT03598790|515846617|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
143084085|NCT03598790|515846618|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
143084086|NCT03598790|515846619|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
143084087|NCT03598790|515846620|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
143084088|NCT03598790|515846621|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
143084089|NCT03598790|515846613|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
143084090|NCT03598790|515846614|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
143084091|NCT03598790|515846615|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
143084092|NCT03598790|515846616|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
143084093|NCT03598790|515846617|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
143084094|NCT03598790|515846618|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
143084095|NCT03598790|515846619|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
143084096|NCT03598790|515846620|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
143084097|NCT03598790|515846621|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
143084098|NCT03598790|515846613|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
143084099|NCT03598790|515846614|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
143084100|NCT03598790|515846615|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
143084101|NCT03598790|515846616|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
143084102|NCT03598790|515846617|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
143084103|NCT03598790|515846618|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
143084104|NCT03598790|515846619|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
143084105|NCT03598790|515846620|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
143084106|NCT03598790|515846621|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
143084107|NCT03598790|515846613|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
143084108|NCT03598790|515846614|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
143084109|NCT03598790|515846615|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
143084110|NCT03598790|515846616|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
143084111|NCT03598790|515846617|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
143084112|NCT03598790|515846618|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
143366561|NCT00828919|516884703|FG000|Overall Study|Objective progression or relapse|4|||
143084113|NCT03598790|515846619|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
143174094|NCT00542178|516185423|FG005|Overall Study|did not complete year 4 follow-up|89|||
143174095|NCT00542178|516185424|FG006|Overall Study|did not complete year 4 follow-up|87|||
143174096|NCT00542178|516185425|FG007|Overall Study|did not complete year 4 follow-up|85|||
143174097|NCT02611037|516185426|FG000|Overall Study|Withdrawal prior to treatment|2|||
143174098|NCT02611037|516185427|FG001|Overall Study|Withdrawal prior to treatment|0|||
143174099|NCT00829998|516185428|FG000|Washout|Adverse Event|0|||
143174100|NCT00829998|516185429|FG001|Washout|Adverse Event|1|||
143174101|NCT00269113|516187023|FG000|Overall Study|Adverse Event|14|||
143174102|NCT00269113|516187024|FG001|Overall Study|Adverse Event|7|||
143174103|NCT00269113|516187023|FG000|Overall Study|Lack of Efficacy|35|||
143174104|NCT00269113|516187024|FG001|Overall Study|Lack of Efficacy|18|||
143174105|NCT00269113|516187023|FG000|Overall Study|Early Improvement|2|||
143174106|NCT00269113|516187024|FG001|Overall Study|Early Improvement|0|||
143174107|NCT00269113|516187023|FG000|Overall Study|Withdrawal by Subject|0|||
143174108|NCT00269113|516187024|FG001|Overall Study|Withdrawal by Subject|2|||
143174109|NCT00269113|516187023|FG000|Overall Study|Death|6|||
143174110|NCT00269113|516187024|FG001|Overall Study|Death|2|||
143174111|NCT00269113|516187023|FG000|Overall Study|Lost to Follow-up|2|||
143174112|NCT00269113|516187024|FG001|Overall Study|Lost to Follow-up|1|||
143174113|NCT00269113|516187023|FG000|Overall Study|Protocol Violation|15|||
143174114|NCT00269113|516187024|FG001|Overall Study|Protocol Violation|5|||
143174115|NCT00269113|516187023|FG000|Overall Study|Other|0|||
143174116|NCT00269113|516187024|FG001|Overall Study|Other|2|||
143174117|NCT00639457|516187025|FG000|Overall Study|Withdrawal by Subject|2|||
143174118|NCT00639457|516187026|FG001|Overall Study|Withdrawal by Subject|3|||
143174119|NCT01621178|516187030|FG000|Overall Study|Adverse Event|5|||
143174120|NCT01621178|516187031|FG001|Overall Study|Adverse Event|2|||
143174121|NCT01621178|516187032|FG002|Overall Study|Adverse Event|8|||
143174122|NCT01621178|516187030|FG000|Overall Study|Death|6|||
143174123|NCT01621178|516187031|FG001|Overall Study|Death|7|||
143174124|NCT01621178|516187032|FG002|Overall Study|Death|2|||
143174125|NCT01621178|516187030|FG000|Overall Study|Lost to Follow-up|1|||
143174126|NCT01621178|516187031|FG001|Overall Study|Lost to Follow-up|2|||
143174127|NCT01621178|516187032|FG002|Overall Study|Lost to Follow-up|1|||
143174128|NCT01621178|516187030|FG000|Overall Study|Withdrawal by Subject|14|||
143174129|NCT01621178|516187031|FG001|Overall Study|Withdrawal by Subject|17|||
143174130|NCT01621178|516187032|FG002|Overall Study|Withdrawal by Subject|18|||
143174131|NCT01621178|516187030|FG000|Overall Study|Physician Decision|5|||
143084114|NCT03598790|515846620|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
143084115|NCT03598790|515846621|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
143084116|NCT03598790|515846613|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
143084117|NCT03598790|515846614|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
143084118|NCT03598790|515846615|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
143084119|NCT03598790|515846616|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
143084120|NCT03598790|515846617|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
143084121|NCT03598790|515846618|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
143084122|NCT03598790|515846619|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
143084123|NCT03598790|515846620|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
143084124|NCT03598790|515846621|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
143084125|NCT03598790|515846613|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
143084126|NCT03598790|515846614|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
143084127|NCT03598790|515846615|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
143084128|NCT03598790|515846616|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
143084129|NCT03598790|515846617|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
143084130|NCT03598790|515846618|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
143084131|NCT03598790|515846619|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
143084132|NCT03598790|515846620|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
143084133|NCT03598790|515846621|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
143084134|NCT03598790|515846613|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
143084135|NCT03598790|515846614|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
143084136|NCT03598790|515846615|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
143084137|NCT03598790|515846616|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
143084138|NCT03598790|515846617|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
143249323|NCT02281383|516466888|FG000|Overall Study|Death|1|||
143249324|NCT02281383|516466888|FG000|Overall Study|Adverse Event|2|||
143249325|NCT01215097|516466890|FG000|Overall Study|Adverse Event|1|||
143249326|NCT01215097|516466891|FG001|Overall Study|Adverse Event|3|||
143249327|NCT01215097|516466890|FG000|Overall Study|Protocol Violation|0|||
143249328|NCT01215097|516466891|FG001|Overall Study|Protocol Violation|2|||
143249329|NCT01215097|516466890|FG000|Overall Study|Lost to Follow-up|2|||
143249330|NCT01215097|516466891|FG001|Overall Study|Lost to Follow-up|0|||
143249331|NCT01215097|516466890|FG000|Overall Study|Withdrawal by Subject|6|||
143249332|NCT01215097|516466891|FG001|Overall Study|Withdrawal by Subject|3|||
143249333|NCT01215097|516466890|FG000|Overall Study|Lack of Efficacy|0|||
143249334|NCT01215097|516466891|FG001|Overall Study|Lack of Efficacy|3|||
143249335|NCT01215097|516466890|FG000|Overall Study|patient's refusal to come|2|||
143249336|NCT01215097|516466891|FG001|Overall Study|patient's refusal to come|2|||
143249337|NCT01215097|516466890|FG000|Overall Study|patient's private reason|1|||
143249338|NCT01215097|516466891|FG001|Overall Study|patient's private reason|1|||
143249339|NCT02259088|516466892|FG000|Overall Study|Adverse Event|6|||
143249340|NCT02259088|516466893|FG001|Overall Study|Adverse Event|4|||
143249341|NCT02259088|516466892|FG000|Overall Study|Lost to Follow-up|2|||
143249342|NCT02259088|516466893|FG001|Overall Study|Lost to Follow-up|0|||
143249343|NCT02259088|516466892|FG000|Overall Study|Death|2|||
143249344|NCT02259088|516466893|FG001|Overall Study|Death|0|||
143249345|NCT02259088|516466892|FG000|Overall Study|Physician Decision|5|||
143249346|NCT02259088|516466893|FG001|Overall Study|Physician Decision|2|||
143249347|NCT02259088|516466892|FG000|Overall Study|Protocol deviation|5|||
143249348|NCT02259088|516466893|FG001|Overall Study|Protocol deviation|0|||
143249349|NCT02259088|516466892|FG000|Overall Study|Subject/guardian decision|8|||
143249350|NCT02259088|516466893|FG001|Overall Study|Subject/guardian decision|8|||
143249351|NCT02252939|516466895|FG000|Overall Study|Lost to Follow-up|3|||
143249352|NCT01516034|516466896|FG000|Overall Study|Physician Decision|1|||
143249353|NCT01516034|516466896|FG000|Overall Study|Lack of Efficacy|7|||
143249354|NCT01818752|516466897|FG000|Overall Study|Adverse Event|64|||
143249355|NCT01818752|516466898|FG001|Overall Study|Adverse Event|74|||
143249356|NCT01818752|516466897|FG000|Overall Study|Death|14|||
143249357|NCT01818752|516466898|FG001|Overall Study|Death|18|||
143249358|NCT01818752|516466897|FG000|Overall Study|Non-compliance|16|||
143249359|NCT01818752|516466898|FG001|Overall Study|Non-compliance|20|||
143249360|NCT01818752|516466897|FG000|Overall Study|Withdrawal by Subject|15|||
143249361|NCT01818752|516466898|FG001|Overall Study|Withdrawal by Subject|14|||
143249362|NCT01818752|516466897|FG000|Overall Study|Physician Decision|9|||
143249363|NCT01818752|516466898|FG001|Overall Study|Physician Decision|8|||
143366562|NCT00828919|516884704|FG001|Overall Study|Objective progression or relapse|4|||
143366563|NCT00828919|516884705|FG002|Overall Study|Objective progression or relapse|11|||
143366564|NCT00828919|516884706|FG003|Overall Study|Objective progression or relapse|0|||
143366565|NCT00828919|516884707|FG004|Overall Study|Objective progression or relapse|5|||
143366566|NCT00828919|516884703|FG000|Overall Study|No longer willing to participate in study|0|||
143366567|NCT00828919|516884704|FG001|Overall Study|No longer willing to participate in study|0|||
143366568|NCT00828919|516884705|FG002|Overall Study|No longer willing to participate in study|2|||
143084139|NCT03598790|515846618|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
143084140|NCT03598790|515846619|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
143084141|NCT03598790|515846620|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
143084142|NCT03598790|515846621|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
143084143|NCT03598790|515846613|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
143084144|NCT03598790|515846614|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
143084145|NCT03598790|515846615|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
143084146|NCT03598790|515846616|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
143084147|NCT03598790|515846617|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
143084148|NCT03598790|515846618|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
143084149|NCT03598790|515846619|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
143084150|NCT03598790|515846620|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
143084151|NCT03598790|515846621|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
143084152|NCT03598790|515846613|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
143084153|NCT03598790|515846614|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
143084154|NCT03598790|515846615|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
143084155|NCT03598790|515846616|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
143084156|NCT03598790|515846617|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
143084157|NCT03598790|515846618|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
143084158|NCT03598790|515846619|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
143084159|NCT03598790|515846620|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
143084160|NCT03598790|515846621|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
143084161|NCT03598790|515846613|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
143084162|NCT03598790|515846614|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
143084163|NCT03598790|515846615|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
143084164|NCT03598790|515846616|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
143084165|NCT03598790|515846617|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
143084166|NCT03598790|515846618|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
143084167|NCT03598790|515846619|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
143084168|NCT03598790|515846620|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
143084169|NCT03598790|515846621|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
143084170|NCT03598790|515846613|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
143084171|NCT03598790|515846614|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
143084172|NCT03598790|515846615|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
143084173|NCT03598790|515846616|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
143084174|NCT03598790|515846617|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
143084175|NCT03598790|515846618|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
143084176|NCT03598790|515846619|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
143084177|NCT03598790|515846620|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
143084178|NCT03598790|515846621|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
143084179|NCT03598790|515846613|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
143084180|NCT03598790|515846614|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
143084181|NCT03598790|515846615|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
143084182|NCT03598790|515846616|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
143174132|NCT01621178|516187031|FG001|Overall Study|Physician Decision|2|||
143174133|NCT01621178|516187032|FG002|Overall Study|Physician Decision|7|||
143174134|NCT00105534|516187033|FG000|Overall Study|Adverse Event|2|||
143174135|NCT00105534|516187034|FG001|Overall Study|Adverse Event|5|||
143174136|NCT00105534|516187033|FG000|Overall Study|Protocol Violation|1|||
143174137|NCT00105534|516187034|FG001|Overall Study|Protocol Violation|4|||
143174138|NCT00105534|516187033|FG000|Overall Study|Withdrawal by Subject|6|||
143174139|NCT00105534|516187034|FG001|Overall Study|Withdrawal by Subject|6|||
143174140|NCT00105534|516187033|FG000|Overall Study|Lost to Follow-up|5|||
143174141|NCT00105534|516187034|FG001|Overall Study|Lost to Follow-up|1|||
143174142|NCT00105534|516187033|FG000|Overall Study|Lack of Efficacy|7|||
143174143|NCT00105534|516187034|FG001|Overall Study|Lack of Efficacy|15|||
143174144|NCT00105534|516187033|FG000|Overall Study|Treatment unmasked|1|||
143174145|NCT00105534|516187034|FG001|Overall Study|Treatment unmasked|0|||
143174146|NCT00105534|516187033|FG000|Overall Study|Other Reason|0|||
143174147|NCT00105534|516187034|FG001|Overall Study|Other Reason|2|||
143174148|NCT02935192|516187035|FG000|Overall Study|Withdrawal by Subject|8|||
143174149|NCT02935192|516187036|FG001|Overall Study|Withdrawal by Subject|4|||
143174150|NCT02896257|516187038|FG000|Providers|Without eligible patients|21|||
143174151|NCT02896257|516187039|FG001|Providers|Without eligible patients|28|||
143174152|NCT02896257|516187038|FG000|Patients|PFT entry criteria not met|43|||
143174153|NCT02896257|516187039|FG001|Patients|PFT entry criteria not met|50|||
143174154|NCT02896257|516187038|FG000|Patients|No capacity to review|8|||
143174155|NCT02896257|516187039|FG001|Patients|No capacity to review|11|||
143174156|NCT02896257|516187038|FG000|Patients|Appointment rescheduled/cancelled|5|||
143174157|NCT02896257|516187039|FG001|Patients|Appointment rescheduled/cancelled|7|||
143174158|NCT02896257|516187038|FG000|Patients|PCP not assigned a clinic|4|||
143174159|NCT02896257|516187039|FG001|Patients|PCP not assigned a clinic|0|||
143174160|NCT02896257|516187038|FG000|Patients|No history of COPD|0|||
143174161|NCT02896257|516187039|FG001|Patients|No history of COPD|1|||
143174162|NCT02896257|516187038|FG000|Patients|Deceased between review and index date|0|||
143174163|NCT02896257|516187039|FG001|Patients|Deceased between review and index date|1|||
143174164|NCT02896257|516187038|FG000|Patients|No ICS Rx upon review|1|||
143174165|NCT02896257|516187039|FG001|Patients|No ICS Rx upon review|1|||
143174166|NCT02896257|516187038|FG000|Patients|Protocol Violation|2|||
143174167|NCT02896257|516187039|FG001|Patients|Protocol Violation|1|||
143174168|NCT02896257|516187038|FG000|Patients|Hospice care|0|||
143174169|NCT02896257|516187039|FG001|Patients|Hospice care|1|||
143174170|NCT02465931|516187040|FG000|Overall Study|Lost to Follow-up|9|||
143174171|NCT02465931|516187041|FG001|Overall Study|Lost to Follow-up|11|||
143174172|NCT02465931|516187040|FG000|Overall Study|Protocol Violation|1|||
143174173|NCT02465931|516187041|FG001|Overall Study|Protocol Violation|0|||
143174174|NCT02465931|516187040|FG000|Overall Study|Withdrawal by Subject|1|||
143174175|NCT02465931|516187041|FG001|Overall Study|Withdrawal by Subject|0|||
143174176|NCT01192126|516187042|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
143174177|NCT01192126|516187043|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
143174178|NCT01192126|516187042|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
143174179|NCT01192126|516187043|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
143174180|NCT01354223|516187044|FG000|Overall Study|Withdrawal by Subject|3|||
143174181|NCT01354223|516187045|FG001|Overall Study|Withdrawal by Subject|1|||
143174182|NCT00730756|516187049|FG000|Overall Study|Adverse Event|2|||
143174183|NCT00730756|516187050|FG001|Overall Study|Adverse Event|0|||
143174184|NCT00730756|516187049|FG000|Overall Study|Lack of Efficacy|1|||
143174185|NCT00730756|516187050|FG001|Overall Study|Lack of Efficacy|1|||
143174186|NCT00730756|516187049|FG000|Overall Study|Protocol Deviation|1|||
143174187|NCT00730756|516187050|FG001|Overall Study|Protocol Deviation|2|||
143174188|NCT00730756|516187049|FG000|Overall Study|Lost to Follow-up|0|||
143174189|NCT00730756|516187050|FG001|Overall Study|Lost to Follow-up|1|||
143174190|NCT00730756|516187049|FG000|Overall Study|Withdrew Consent|0|||
143174191|NCT00730756|516187050|FG001|Overall Study|Withdrew Consent|1|||
143174192|NCT02660229|516187051|FG000|Overall Study|Adverse Event|2|||
143174193|NCT02660229|516187052|FG001|Overall Study|Adverse Event|0|||
143174194|NCT02660229|516187051|FG000|Overall Study|Withdrawal by Subject|0|||
143174195|NCT02660229|516187052|FG001|Overall Study|Withdrawal by Subject|1|||
143174196|NCT01693367|516187053|FG000|Overall Study|Withdrawal by Subject|1|||
143174197|NCT01693367|516187054|FG001|Overall Study|Withdrawal by Subject|1|||
143174198|NCT01693367|516187053|FG000|Overall Study|Physician Decision|0|||
143174199|NCT01693367|516187054|FG001|Overall Study|Physician Decision|1|||
143174200|NCT03046446|516187057|FG000|Overall Study|Lack of Efficacy|7|||
143084183|NCT03598790|515846617|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
143084184|NCT03598790|515846618|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
143084185|NCT03598790|515846619|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
143084186|NCT03598790|515846620|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
143084187|NCT03598790|515846621|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
143084188|NCT03598790|515846613|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
143084189|NCT03598790|515846614|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
143084190|NCT03598790|515846615|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
143084191|NCT03598790|515846616|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
143084192|NCT03598790|515846617|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
143084193|NCT03598790|515846618|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
143084194|NCT03598790|515846619|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
143084195|NCT03598790|515846620|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
143084196|NCT03598790|515846621|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
143084197|NCT03598790|515846613|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
143084198|NCT03598790|515846614|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
143084199|NCT03598790|515846615|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
143084200|NCT03598790|515846616|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
143174201|NCT03046446|516187057|FG000|Overall Study|Adverse Event|6|||
143174202|NCT03046446|516187057|FG000|Overall Study|Lost to Follow-up|3|||
143174203|NCT03046446|516187057|FG000|Overall Study|Withdrawal by Subject|14|||
143174204|NCT03046446|516187057|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
143174205|NCT03046446|516187057|FG000|Overall Study|Disease Progression (see caveats)|25|||
143174206|NCT03046446|516187057|FG000|Overall Study|Non OA related knee surgery|1|||
143174207|NCT02808897|516187058|FG000|Overall Study|Lost to Follow-up|9|||
143174208|NCT02808897|516187059|FG001|Overall Study|Lost to Follow-up|11|||
143174209|NCT03012334|516187060|FG000|Period 1|Withdrawal by Subject|0|||
143174210|NCT03012334|516187061|FG001|Period 1|Withdrawal by Subject|0|||
143174211|NCT03012334|516187062|FG002|Period 1|Withdrawal by Subject|0|||
143174212|NCT03012334|516187063|FG003|Period 1|Withdrawal by Subject|0|||
143174213|NCT03012334|516187064|FG004|Period 1|Withdrawal by Subject|0|||
143174214|NCT03012334|516187065|FG005|Period 1|Withdrawal by Subject|0|||
143174215|NCT03012334|516187066|FG006|Period 1|Withdrawal by Subject|0|||
143174216|NCT03012334|516187067|FG007|Period 1|Withdrawal by Subject|0|||
143174217|NCT03012334|516187068|FG008|Period 1|Withdrawal by Subject|0|||
143174218|NCT03012334|516187069|FG009|Period 1|Withdrawal by Subject|1|||
143174219|NCT03012334|516187060|FG000|Period 2|Withdrawal by Subject|0|||
143174220|NCT03012334|516187061|FG001|Period 2|Withdrawal by Subject|1|||
143174221|NCT03012334|516187062|FG002|Period 2|Withdrawal by Subject|0|||
143174222|NCT03012334|516187063|FG003|Period 2|Withdrawal by Subject|0|||
143174223|NCT03012334|516187064|FG004|Period 2|Withdrawal by Subject|0|||
143174224|NCT03012334|516187065|FG005|Period 2|Withdrawal by Subject|0|||
143174225|NCT03012334|516187066|FG006|Period 2|Withdrawal by Subject|0|||
143174226|NCT03012334|516187067|FG007|Period 2|Withdrawal by Subject|0|||
143174227|NCT03012334|516187068|FG008|Period 2|Withdrawal by Subject|0|||
143174228|NCT03012334|516187069|FG009|Period 2|Withdrawal by Subject|0|||
143174229|NCT03012334|516187060|FG000|Period 2|Protocol Violation|0|||
143174230|NCT03012334|516187061|FG001|Period 2|Protocol Violation|0|||
143174231|NCT03012334|516187062|FG002|Period 2|Protocol Violation|1|||
143174232|NCT03012334|516187063|FG003|Period 2|Protocol Violation|0|||
143174233|NCT03012334|516187064|FG004|Period 2|Protocol Violation|0|||
143174234|NCT03012334|516187065|FG005|Period 2|Protocol Violation|0|||
143174235|NCT03012334|516187066|FG006|Period 2|Protocol Violation|0|||
143174236|NCT03012334|516187067|FG007|Period 2|Protocol Violation|1|||
143174237|NCT03012334|516187068|FG008|Period 2|Protocol Violation|0|||
143174238|NCT03012334|516187069|FG009|Period 2|Protocol Violation|0|||
143174239|NCT03012334|516187060|FG000|Period 4|Non-Compliance|0|||
143174240|NCT03012334|516187061|FG001|Period 4|Non-Compliance|0|||
143174241|NCT03012334|516187062|FG002|Period 4|Non-Compliance|0|||
143174242|NCT03012334|516187063|FG003|Period 4|Non-Compliance|0|||
143084201|NCT03598790|515846617|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
143174243|NCT03012334|516187064|FG004|Period 4|Non-Compliance|0|||
143174244|NCT03012334|516187065|FG005|Period 4|Non-Compliance|0|||
143174245|NCT03012334|516187066|FG006|Period 4|Non-Compliance|1|||
143174246|NCT03012334|516187067|FG007|Period 4|Non-Compliance|0|||
143174247|NCT03012334|516187068|FG008|Period 4|Non-Compliance|0|||
143174248|NCT03012334|516187069|FG009|Period 4|Non-Compliance|0|||
143174249|NCT03012334|516187060|FG000|Period 4|Adverse Event|0|||
143174250|NCT03012334|516187061|FG001|Period 4|Adverse Event|0|||
143174251|NCT03012334|516187062|FG002|Period 4|Adverse Event|0|||
143174252|NCT03012334|516187063|FG003|Period 4|Adverse Event|0|||
143174253|NCT03012334|516187064|FG004|Period 4|Adverse Event|0|||
143174254|NCT03012334|516187065|FG005|Period 4|Adverse Event|0|||
143174255|NCT03012334|516187066|FG006|Period 4|Adverse Event|0|||
143174256|NCT03012334|516187067|FG007|Period 4|Adverse Event|0|||
143174257|NCT03012334|516187068|FG008|Period 4|Adverse Event|1|||
143174258|NCT03012334|516187069|FG009|Period 4|Adverse Event|0|||
143084202|NCT03598790|515846618|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
143084203|NCT03598790|515846619|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
143084204|NCT03598790|515846620|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
143084205|NCT03598790|515846621|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
143084206|NCT03598790|515846613|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
143084207|NCT03598790|515846614|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
143084208|NCT03598790|515846615|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
143084209|NCT03598790|515846616|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
143084210|NCT03598790|515846617|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
143084211|NCT03598790|515846618|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
143084212|NCT03598790|515846619|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
143084213|NCT03598790|515846620|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
143084214|NCT03598790|515846621|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
143084215|NCT05292183|515846623|FG000|Overall Study|Adverse Event|1|||
143084216|NCT01059786|515846624|FG000|Overall Study|Did not receive 6 cycles.|0|||
143084217|NCT01059786|515846625|FG001|Overall Study|Did not receive 6 cycles.|0|||
143084218|NCT01059786|515846626|FG002|Overall Study|Did not receive 6 cycles.|4|||
143084219|NCT01059786|515846627|FG003|Overall Study|Did not receive 6 cycles.|1|||
143084220|NCT01059786|515846628|FG004|Overall Study|Did not receive 6 cycles.|0|||
143084221|NCT00371033|515846629|FG000|Overall Study|Lost to Follow-up|3|||
143084222|NCT00371033|515846630|FG001|Overall Study|Lost to Follow-up|2|||
143084223|NCT00371033|515846629|FG000|Overall Study|No longer interested|2|||
143084224|NCT00371033|515846630|FG001|Overall Study|No longer interested|0|||
143084225|NCT00371033|515846629|FG000|Overall Study|Uknown|3|||
143084226|NCT00371033|515846630|FG001|Overall Study|Uknown|1|||
143084227|NCT03203850|515846633|FG000|Overall Study|Subject/guardian decision|4|||
143084228|NCT03203850|515846634|FG001|Overall Study|Subject/guardian decision|3|||
143084229|NCT03203850|515846633|FG000|Overall Study|Adverse Event|3|||
143084230|NCT03203850|515846634|FG001|Overall Study|Adverse Event|0|||
143084231|NCT03203850|515846633|FG000|Overall Study|Death|1|||
143084232|NCT03203850|515846634|FG001|Overall Study|Death|0|||
143084233|NCT01769456|515846637|FG000|Overall Study|Lost to Follow-up|19|||
143084234|NCT01769456|515846637|FG000|Overall Study|Withdrawal by Subject|3|||
143084235|NCT01769456|515846637|FG000|Overall Study|Did not receive PCC intervention|6|||
143084236|NCT01769456|515846637|FG000|Overall Study|Moved out of the area|3|||
143084237|NCT01769456|515846637|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
143084238|NCT01769456|515846637|FG000|Overall Study|Parental request to youth to withdraw|1|||
143084239|NCT05244122|515846648|FG000|Overall Study|Withdrawal by Subject|318|||
143084240|NCT03965689|515846649|FG000|Overall Study|Too sick to get study intervention|2|||
143084241|NCT01214655|515846650|FG000|Part A|Progressive Disease|7|||
143084242|NCT01214655|515846651|FG001|Part A|Progressive Disease|0|||
143084243|NCT01214655|515846652|FG002|Part A|Progressive Disease|0|||
143084244|NCT01214655|515846650|FG000|Part A|Physician Decision|1|||
143366569|NCT00828919|516884706|FG003|Overall Study|No longer willing to participate in study|0|||
143366570|NCT00828919|516884707|FG004|Overall Study|No longer willing to participate in study|0|||
143366571|NCT00828919|516884703|FG000|Overall Study|Insufficient Clinical Response|0|||
143084245|NCT01214655|515846651|FG001|Part A|Physician Decision|0|||
143084246|NCT01214655|515846652|FG002|Part A|Physician Decision|0|||
143084247|NCT01214655|515846650|FG000|Part B|Progressive disease|0|||
143084248|NCT01214655|515846651|FG001|Part B|Progressive disease|10|||
143084249|NCT01214655|515846652|FG002|Part B|Progressive disease|0|||
143084250|NCT01214655|515846650|FG000|Part B|Death|0|||
143084251|NCT01214655|515846651|FG001|Part B|Death|1|||
143084252|NCT01214655|515846652|FG002|Part B|Death|0|||
143084253|NCT01214655|515846650|FG000|Part B|Withdrawal by Subject|0|||
143084254|NCT01214655|515846651|FG001|Part B|Withdrawal by Subject|2|||
143084255|NCT01214655|515846652|FG002|Part B|Withdrawal by Subject|0|||
143084256|NCT01214655|515846650|FG000|Part C|Progressive Disease|0|||
143084257|NCT01214655|515846651|FG001|Part C|Progressive Disease|0|||
143084258|NCT01214655|515846652|FG002|Part C|Progressive Disease|5|||
143084259|NCT01214655|515846650|FG000|Part C|Death|0|||
143084260|NCT01214655|515846651|FG001|Part C|Death|0|||
143084261|NCT01214655|515846652|FG002|Part C|Death|1|||
143084262|NCT01214655|515846650|FG000|Part C|Physician Decision|0|||
143084263|NCT01214655|515846651|FG001|Part C|Physician Decision|0|||
143084264|NCT01214655|515846652|FG002|Part C|Physician Decision|1|||
143084265|NCT01977417|515846660|FG000|Overall Study|Adverse Event|1|||
143084266|NCT01977417|515846661|FG001|Overall Study|Adverse Event|0|||
143084267|NCT01977417|515846660|FG000|Overall Study|Withdrawal by Subject|2|||
143084268|NCT01977417|515846661|FG001|Overall Study|Withdrawal by Subject|4|||
143084269|NCT01977417|515846660|FG000|Overall Study|Female enrollment goal met|0|||
143084270|NCT01977417|515846661|FG001|Overall Study|Female enrollment goal met|2|||
143174259|NCT02286895|516187070|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
143174260|NCT02286895|516187071|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
143174261|NCT02286895|516187070|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
143174262|NCT02286895|516187071|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
143174263|NCT02286895|516187070|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
143174264|NCT02286895|516187071|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
143174265|NCT01541371|516187078|FG000|Overall Study|Withdrawal by Subject|14|||
143174266|NCT01541371|516187078|FG000|Overall Study|Lost to Follow-up|21|||
143174267|NCT01541371|516187078|FG000|Overall Study|Adverse Event|15|||
143174268|NCT01541371|516187078|FG000|Overall Study|Lack of Efficacy|12|||
143174269|NCT01541371|516187078|FG000|Overall Study|Protocol Violation|6|||
143174270|NCT01541371|516187078|FG000|Overall Study|Study medication non-compliance|3|||
143174271|NCT01541371|516187078|FG000|Overall Study|Other|6|||
143174272|NCT02441218|516187079|FG000|Overall Study|Death|503|||
143174273|NCT02441218|516187080|FG001|Overall Study|Death|553|||
143174274|NCT02441218|516187079|FG000|Overall Study|Withdrawal by Subject|73|||
143084271|NCT01692626|515846662|FG000|Overall Study|Death|0|||
143174275|NCT02441218|516187080|FG001|Overall Study|Withdrawal by Subject|58|||
143174276|NCT02441218|516187079|FG000|Overall Study|Lost to Follow-up|2|||
143174277|NCT02441218|516187080|FG001|Overall Study|Lost to Follow-up|1|||
143174278|NCT00163189|516187083|FG000|Overall Study|Other|6|||
143174279|NCT00163189|516187083|FG000|Overall Study|Lost to Follow-up|1|||
143174280|NCT00163189|516187083|FG000|Overall Study|Protocol Violation|2|||
143174281|NCT00163189|516187083|FG000|Overall Study|Death|3|||
143174282|NCT00163189|516187083|FG000|Overall Study|Adverse Event|6|||
143174283|NCT00163189|516187083|FG000|Overall Study|Lack of Efficacy|7|||
143174284|NCT00163189|516187083|FG000|Overall Study|Study terminated by sponsor|11|||
143174285|NCT00163189|516187083|FG000|Overall Study|Withdrawal by Subject|11|||
143174286|NCT00163189|516187083|FG000|Overall Study|Did not meet continuation criterion|16|||
143174287|NCT02154061|516187084|FG000|Overall Study|Pregnancy|1|||
143174288|NCT02154061|516187085|FG001|Overall Study|Pregnancy|0|||
143174289|NCT02154061|516187084|FG000|Overall Study|enrolled but not vaccinated|1|||
143174290|NCT02154061|516187085|FG001|Overall Study|enrolled but not vaccinated|0|||
143174291|NCT01936831|516187086|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
143174292|NCT01936831|516187087|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
143174293|NCT01936831|516187088|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
143174294|NCT01936831|516187089|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
143174295|NCT01936831|516187090|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
143084272|NCT01692626|515846663|FG001|Overall Study|Death|1|||
143084273|NCT01692626|515846662|FG000|Overall Study|Adverse Event|2|||
143084274|NCT01692626|515846663|FG001|Overall Study|Adverse Event|3|||
143084275|NCT01692626|515846662|FG000|Overall Study|Protocol Violation|1|||
143084276|NCT01692626|515846663|FG001|Overall Study|Protocol Violation|2|||
143084277|NCT01692626|515846662|FG000|Overall Study|Withdrawal by Subject|1|||
143084278|NCT01692626|515846663|FG001|Overall Study|Withdrawal by Subject|0|||
143084279|NCT02794870|515846671|FG000|Overall Study|Withdrawal by Subject|2|||
143084280|NCT02794870|515846672|FG001|Overall Study|Withdrawal by Subject|0|||
143174296|NCT01936831|516187091|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
143174297|NCT01936831|516187092|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
143174298|NCT01936831|516187093|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
143174299|NCT01936831|516187094|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
143174300|NCT03435380|516187095|FG000|Overall Study|Death|1|||
143174301|NCT03435380|516187096|FG001|Overall Study|Death|2|||
143174302|NCT03435380|516187097|FG002|Overall Study|Death|1|||
143084281|NCT02437903|515846673|FG000|Overall Study|Adverse Event|1|||
143084282|NCT02437903|515846673|FG000|Overall Study|Withdrawal by Subject|1|||
143174303|NCT03435380|516187095|FG000|Overall Study|Lost to Follow-up|12|||
143174304|NCT03435380|516187096|FG001|Overall Study|Lost to Follow-up|8|||
143174305|NCT03435380|516187097|FG002|Overall Study|Lost to Follow-up|6|||
143174306|NCT03435380|516187095|FG000|Overall Study|Physician Decision|1|||
143174307|NCT03435380|516187096|FG001|Overall Study|Physician Decision|0|||
143174308|NCT03435380|516187097|FG002|Overall Study|Physician Decision|0|||
143174309|NCT03435380|516187095|FG000|Overall Study|Withdrawal by Subject|0|||
143174310|NCT03435380|516187096|FG001|Overall Study|Withdrawal by Subject|1|||
143174311|NCT03435380|516187097|FG002|Overall Study|Withdrawal by Subject|1|||
143174312|NCT03435380|516187095|FG000|Overall Study|Ineligible|0|||
143174313|NCT03435380|516187096|FG001|Overall Study|Ineligible|1|||
143174314|NCT03435380|516187097|FG002|Overall Study|Ineligible|1|||
143174315|NCT02133573|516187103|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
143174316|NCT02133573|516187104|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
143174317|NCT02133573|516187103|FG000|Overall Study|Child Deaths|3|||
143174318|NCT02133573|516187104|FG001|Overall Study|Child Deaths|5|||
143174319|NCT02133573|516187103|FG000|Overall Study|Child Declined Follow Ups|2|||
143174320|NCT02133573|516187104|FG001|Overall Study|Child Declined Follow Ups|1|||
143174321|NCT02133573|516187103|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
143174322|NCT02133573|516187104|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
143174323|NCT00454116|516187106|FG000|Overall Study|Adverse Event|5|||
143174324|NCT00454116|516187107|FG001|Overall Study|Adverse Event|11|||
143174325|NCT00454116|516187108|FG002|Overall Study|Adverse Event|9|||
143174326|NCT00454116|516187106|FG000|Overall Study|Condition under investigation worsened|17|||
143174327|NCT00454116|516187107|FG001|Overall Study|Condition under investigation worsened|13|||
143174328|NCT00454116|516187108|FG002|Overall Study|Condition under investigation worsened|18|||
143174329|NCT00454116|516187106|FG000|Overall Study|Withdrawal by Subject|3|||
143174330|NCT00454116|516187107|FG001|Overall Study|Withdrawal by Subject|3|||
143174331|NCT00454116|516187108|FG002|Overall Study|Withdrawal by Subject|1|||
143174332|NCT00454116|516187106|FG000|Overall Study|Other|2|||
143174333|NCT00454116|516187107|FG001|Overall Study|Other|2|||
143174334|NCT00454116|516187108|FG002|Overall Study|Other|0|||
143174335|NCT01917318|516187111|FG000|First Treatment|Withdrawal by Subject|0|||
143174336|NCT01917318|516187112|FG001|First Treatment|Withdrawal by Subject|1|||
143249364|NCT01818752|516466897|FG000|Overall Study|Disease Progression|54|||
143249365|NCT01818752|516466898|FG001|Overall Study|Disease Progression|48|||
143174337|NCT01008618|516187113|FG000|Period 1 (Titration Period)|Physician Decision|2|||
143174338|NCT01008618|516187114|FG001|Period 1 (Titration Period)|Physician Decision|0|||
143174339|NCT01008618|516187115|FG002|Period 1 (Titration Period)|Physician Decision|0|||
143174340|NCT01008618|516187113|FG000|Period 1 (Titration Period)|Adverse Event|33|||
143174341|NCT01008618|516187114|FG001|Period 1 (Titration Period)|Adverse Event|0|||
143174342|NCT01008618|516187115|FG002|Period 1 (Titration Period)|Adverse Event|0|||
143084283|NCT02437903|515846673|FG000|Overall Study|Lost to Follow-up|3|||
143084284|NCT01427608|515846674|FG000|Overall Study|Death|1|||
143084285|NCT01427608|515846675|FG001|Overall Study|Death|0|||
143084286|NCT01427608|515846674|FG000|Overall Study|Withdrawal by Subject|7|||
143084287|NCT01427608|515846675|FG001|Overall Study|Withdrawal by Subject|3|||
143084288|NCT01427608|515846674|FG000|Overall Study|Relapsed-all cause|13|||
143084289|NCT01427608|515846675|FG001|Overall Study|Relapsed-all cause|34|||
143084290|NCT01427608|515846674|FG000|Overall Study|Events not attributed to study meds|0|||
143084291|NCT01427608|515846675|FG001|Overall Study|Events not attributed to study meds|1|||
143084292|NCT02276807|515846679|FG000|Overall Study|Withdrawal by Subject|8|||
143084293|NCT02276807|515846680|FG001|Overall Study|Withdrawal by Subject|7|||
143084294|NCT02276807|515846679|FG000|Overall Study|Lost to Follow-up|10|||
143084295|NCT02276807|515846680|FG001|Overall Study|Lost to Follow-up|10|||
143249366|NCT01818752|516466897|FG000|Overall Study|Other|7|||
143249367|NCT01818752|516466898|FG001|Overall Study|Other|8|||
143249368|NCT01818752|516466897|FG000|Overall Study|Continuing Treatment|1|||
143249369|NCT01818752|516466898|FG001|Overall Study|Continuing Treatment|4|||
143249370|NCT01818752|516466897|FG000|Overall Study|Randomized but not Dosed|7|||
143249371|NCT01818752|516466898|FG001|Overall Study|Randomized but not Dosed|4|||
143249372|NCT01033448|516466899|FG000|Overall Study|Withdrawal by Subject|4|||
143249373|NCT01033448|516466899|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
143249374|NCT01033448|516466899|FG000|Overall Study|Lost to Follow-up|3|||
143249375|NCT01033448|516466899|FG000|Overall Study|Withdrew due to other reasons|3|||
143249376|NCT01033448|516466899|FG000|Overall Study|Unknown disposition|1|||
143249377|NCT04270370|516466900|FG000|Overall Study|Lost to Follow-up|1|||
143249378|NCT04270370|516466901|FG001|Overall Study|Lost to Follow-up|0|||
143249379|NCT04270370|516466902|FG002|Overall Study|Lost to Follow-up|0|||
143249380|NCT04270370|516466903|FG003|Overall Study|Lost to Follow-up|0|||
143249381|NCT04270370|516466904|FG004|Overall Study|Lost to Follow-up|0|||
143249382|NCT04270370|516466905|FG005|Overall Study|Lost to Follow-up|0|||
143249383|NCT04270370|516466906|FG006|Overall Study|Lost to Follow-up|0|||
143249384|NCT04270370|516466907|FG007|Overall Study|Lost to Follow-up|0|||
143249385|NCT04270370|516466908|FG008|Overall Study|Lost to Follow-up|1|||
143249386|NCT04270370|516466909|FG009|Overall Study|Lost to Follow-up|0|||
143249387|NCT04270370|516466910|FG010|Overall Study|Lost to Follow-up|0|||
143084296|NCT02652949|515846683|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
143084297|NCT02652949|515846683|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
143084298|NCT02652949|515846683|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
143084299|NCT02652949|515846683|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
143084300|NCT02652949|515846683|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
143249388|NCT04270370|516466911|FG011|Overall Study|Lost to Follow-up|0|||
143249389|NCT01324141|516466912|FG000|Overall Study|Declined to participate before treatment started|1|||
143249390|NCT01324141|516466912|FG000|Overall Study|Disease progression on study|1|||
143249391|NCT02560025|516466918|FG000|Overall Study|Ineligible after consent/ registration|3|||
143084301|NCT02652949|515846683|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
143084302|NCT02652949|515846683|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
143084303|NCT02652949|515846683|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
143084304|NCT02652949|515846683|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
143084305|NCT02652949|515846683|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
143084306|NCT02652949|515846683|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
143084307|NCT02652949|515846683|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
143084308|NCT02652949|515846683|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
143084309|NCT02652949|515846683|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
143084310|NCT02652949|515846683|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
143084311|NCT02652949|515846683|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
143084312|NCT02652949|515846683|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
143084313|NCT04152291|515846684|FG000|Overall Study|Covid-19 restrictions|27|||
143084314|NCT04152291|515846684|FG000|Overall Study|Withdrawal by Subject|3|||
143084315|NCT02455518|515846685|FG000|Overall Study|Protocol Violation|0|||
143084316|NCT02455518|515846686|FG001|Overall Study|Protocol Violation|1|||
143084317|NCT02455518|515846687|FG002|Overall Study|Protocol Violation|1|||
143084318|NCT02455518|515846688|FG003|Overall Study|Protocol Violation|3|||
143084319|NCT04223752|515846692|FG000|Overall Study|Participant enrolled in error|0|||
143084320|NCT04223752|515846693|FG001|Overall Study|Participant enrolled in error|0|||
143084321|NCT04223752|515846694|FG002|Overall Study|Participant enrolled in error|0|||
143084322|NCT04223752|515846695|FG003|Overall Study|Participant enrolled in error|0|||
143084323|NCT04223752|515846696|FG004|Overall Study|Participant enrolled in error|1|||
143084324|NCT04223752|515846692|FG000|Overall Study|Death|0|||
143084325|NCT04223752|515846693|FG001|Overall Study|Death|0|||
143084326|NCT04223752|515846694|FG002|Overall Study|Death|0|||
143084327|NCT04223752|515846695|FG003|Overall Study|Death|2|||
143084328|NCT04223752|515846696|FG004|Overall Study|Death|1|||
143084329|NCT04868500|515846704|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
143084330|NCT04868500|515846705|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
143174343|NCT01008618|516187113|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
143174344|NCT01008618|516187114|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
143174345|NCT01008618|516187115|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
143174346|NCT01008618|516187113|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
143174347|NCT01008618|516187114|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
143174348|NCT01008618|516187115|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
143174349|NCT01008618|516187113|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
143174350|NCT01008618|516187114|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
143174351|NCT01008618|516187115|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
143174352|NCT01008618|516187113|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
143174353|NCT01008618|516187114|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
143174354|NCT01008618|516187115|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
143174355|NCT01008618|516187113|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
143174356|NCT01008618|516187114|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
143084331|NCT04868500|515846704|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
143084332|NCT04868500|515846705|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
143084333|NCT04697069|515846710|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
143084334|NCT04697069|515846711|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
143084335|NCT04697069|515846710|FG000|Overall Study|Study termination|2|||
143084336|NCT04697069|515846711|FG001|Overall Study|Study termination|1|||
143084337|NCT03071276|515846712|FG000|Overall Study|Adverse Event|1|||
143084338|NCT03071276|515846712|FG000|Overall Study|Lack of Efficacy|14|||
143084339|NCT05794503|515846713|FG000|Overall Study|Operation Cancelled|2|||
143084340|NCT05794503|515846714|FG001|Overall Study|Operation Cancelled|0|||
143084341|NCT05794503|515846713|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
143084342|NCT05794503|515846714|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
143084343|NCT05794503|515846713|FG000|Overall Study|Protocol Violation|1|||
143084344|NCT05794503|515846714|FG001|Overall Study|Protocol Violation|0|||
143084345|NCT00447993|515846717|FG000|Overall Study|Lost to Follow-up|0|||
143084346|NCT00447993|515846718|FG001|Overall Study|Lost to Follow-up|0|||
143084347|NCT00447993|515846719|FG002|Overall Study|Lost to Follow-up|2|||
143084348|NCT00447993|515846720|FG003|Overall Study|Lost to Follow-up|2|||
143084349|NCT00447993|515846717|FG000|Overall Study|Withdrawal by Subject|0|||
143084350|NCT00447993|515846718|FG001|Overall Study|Withdrawal by Subject|0|||
143084351|NCT00447993|515846719|FG002|Overall Study|Withdrawal by Subject|2|||
143084352|NCT00447993|515846720|FG003|Overall Study|Withdrawal by Subject|2|||
143084353|NCT02503787|515846725|FG000|Enrollment|Withdrawal by Subject|6|||
143084354|NCT02503787|515846725|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
143084355|NCT02503787|515846725|FG000|Enrollment|Physician Decision|2|||
143084356|NCT02503787|515846725|FG000|Enrollment|Insurance issue|2|||
143084357|NCT02503787|515846725|FG000|Enrollment|Lost to Follow-up|1|||
143084358|NCT02503787|515846725|FG000|Enrollment|Study closure|1|||
143084359|NCT02503787|515846725|FG000|Enrollment|Adverse Event|1|||
143174357|NCT01008618|516187115|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
143174358|NCT01008618|516187113|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
143174359|NCT01008618|516187114|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
143174360|NCT01008618|516187115|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
143174361|NCT01008618|516187113|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
143174362|NCT01008618|516187114|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
143174363|NCT01008618|516187115|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
143174364|NCT01008618|516187113|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
143174365|NCT01008618|516187114|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
143174366|NCT01008618|516187115|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
143174367|NCT01008618|516187113|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
143174368|NCT01008618|516187114|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
143174369|NCT01008618|516187115|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
143174370|NCT01008618|516187113|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
143174371|NCT01008618|516187114|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
143249392|NCT02703337|516466921|FG000|Period One (Part A)|Withdrawal by Subject|0|||
143084360|NCT02503787|515846725|FG000|Enrollment|Protocol Violation|1|||
143084361|NCT02503787|515846725|FG000|Enrollment|Inability to implant system|1|||
143084362|NCT02503787|515846725|FG000|Enrollment|Unable to be programmed|1|||
143084363|NCT02503787|515846725|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
143084364|NCT02503787|515846725|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
143174372|NCT01008618|516187115|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
143249393|NCT02703337|516466922|FG001|Period One (Part A)|Withdrawal by Subject|0|||
143249394|NCT02703337|516466923|FG002|Period One (Part A)|Withdrawal by Subject|0|||
143249395|NCT02703337|516466924|FG003|Period One (Part A)|Withdrawal by Subject|0|||
143249396|NCT02703337|516466925|FG004|Period One (Part A)|Withdrawal by Subject|1|||
143249397|NCT02703337|516466926|FG005|Period One (Part A)|Withdrawal by Subject|0|||
143249398|NCT02703337|516466927|FG006|Period One (Part A)|Withdrawal by Subject|0|||
143249399|NCT02703337|516466928|FG007|Period One (Part A)|Withdrawal by Subject|0|||
143249400|NCT02745080|516466933|FG000|Overall Study|Adverse Event|13|||
143249401|NCT02745080|516466934|FG001|Overall Study|Adverse Event|21|||
143249402|NCT02745080|516466933|FG000|Overall Study|Lack of Efficacy|11|||
143249403|NCT02745080|516466934|FG001|Overall Study|Lack of Efficacy|23|||
143249404|NCT02745080|516466933|FG000|Overall Study|Lost to Follow-up|3|||
143084365|NCT02503787|515846725|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
143084366|NCT02503787|515846725|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
143084367|NCT02503787|515846725|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
143084368|NCT02503787|515846725|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
143084369|NCT04700137|515846726|FG000|Overall Study|Lost to Follow-up|1|||
143084370|NCT04700137|515846727|FG001|Overall Study|Lost to Follow-up|6|||
143084371|NCT04700137|515846728|FG002|Overall Study|Lost to Follow-up|1|||
143084372|NCT04700137|515846729|FG003|Overall Study|Lost to Follow-up|1|||
143084373|NCT04700137|515846726|FG000|Overall Study|Withdrawal by Subject|0|||
143084374|NCT04700137|515846727|FG001|Overall Study|Withdrawal by Subject|0|||
143084375|NCT04700137|515846728|FG002|Overall Study|Withdrawal by Subject|1|||
143084376|NCT04700137|515846729|FG003|Overall Study|Withdrawal by Subject|0|||
143084377|NCT04700137|515846726|FG000|Overall Study|Death|0|||
143084378|NCT04700137|515846727|FG001|Overall Study|Death|0|||
143084379|NCT04700137|515846728|FG002|Overall Study|Death|1|||
143084380|NCT04700137|515846729|FG003|Overall Study|Death|0|||
143084381|NCT04787627|515846730|FG000|Overall Study|Withdrawal by Subject|3|||
143084382|NCT04787627|515846731|FG001|Overall Study|Withdrawal by Subject|0|||
143084383|NCT04787627|515846730|FG000|Overall Study|Physician Decision|2|||
143084384|NCT04787627|515846731|FG001|Overall Study|Physician Decision|0|||
143084385|NCT04787627|515846730|FG000|Overall Study|Excluded|0|||
143084386|NCT04787627|515846731|FG001|Overall Study|Excluded|1|||
143084387|NCT02924727|515846736|FG000|Overall Study|Withdrawal by Subject|2|||
143084388|NCT02924727|515846737|FG001|Overall Study|Withdrawal by Subject|4|||
143084389|NCT02924727|515846736|FG000|Overall Study|Lost to Follow-up|2|||
143084390|NCT02924727|515846737|FG001|Overall Study|Lost to Follow-up|5|||
143084391|NCT02924727|515846736|FG000|Overall Study|Death|221|||
143084392|NCT02924727|515846737|FG001|Overall Study|Death|247|||
143084393|NCT02924727|515846736|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
143084394|NCT02924727|515846737|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
143084395|NCT03694327|515846738|FG000|Overall Study|Lost to Follow-up|13|||
143084396|NCT03694327|515846739|FG001|Overall Study|Lost to Follow-up|23|||
143084397|NCT01464931|515846742|FG000|Overall Study|Withdrawal by Subject|1|||
143084398|NCT01464931|515846743|FG001|Overall Study|Withdrawal by Subject|0|||
143084399|NCT00174954|515846744|FG000|Overall Study|Adverse Event|2|||
143084400|NCT00174954|515846744|FG000|Overall Study|No tophi found in MRI|1|||
143084401|NCT00174954|515846744|FG000|Overall Study|Physician Decision|1|||
143084402|NCT00307437|515846745|FG000|Controlled Period|Adverse Event|7|||
143084403|NCT00307437|515846746|FG001|Controlled Period|Adverse Event|2|||
143084404|NCT00307437|515846747|FG002|Controlled Period|Adverse Event|5|||
143084405|NCT00307437|515846748|FG003|Controlled Period|Adverse Event|0|||
143084406|NCT00307437|515846749|FG004|Controlled Period|Adverse Event|0|||
143084407|NCT00307437|515846750|FG005|Controlled Period|Adverse Event|0|||
143084408|NCT00307437|515846751|FG006|Controlled Period|Adverse Event|0|||
143084409|NCT00307437|515846745|FG000|Controlled Period|Death|0|||
143084410|NCT00307437|515846746|FG001|Controlled Period|Death|0|||
143084411|NCT00307437|515846747|FG002|Controlled Period|Death|1|||
143084412|NCT00307437|515846748|FG003|Controlled Period|Death|0|||
143084413|NCT00307437|515846749|FG004|Controlled Period|Death|0|||
143249405|NCT02745080|516466934|FG001|Overall Study|Lost to Follow-up|3|||
143249406|NCT02745080|516466933|FG000|Overall Study|Physician Decision|3|||
143249407|NCT02745080|516466934|FG001|Overall Study|Physician Decision|0|||
143084414|NCT00307437|515846750|FG005|Controlled Period|Death|0|||
143084415|NCT00307437|515846751|FG006|Controlled Period|Death|0|||
143084416|NCT00307437|515846745|FG000|Controlled Period|Lack of Efficacy|2|||
143084417|NCT00307437|515846746|FG001|Controlled Period|Lack of Efficacy|0|||
143084418|NCT00307437|515846747|FG002|Controlled Period|Lack of Efficacy|0|||
143084419|NCT00307437|515846748|FG003|Controlled Period|Lack of Efficacy|0|||
143084420|NCT00307437|515846749|FG004|Controlled Period|Lack of Efficacy|0|||
143084421|NCT00307437|515846750|FG005|Controlled Period|Lack of Efficacy|0|||
143249408|NCT02745080|516466933|FG000|Overall Study|Protocol Violation|3|||
143249409|NCT02745080|516466934|FG001|Overall Study|Protocol Violation|1|||
143084422|NCT00307437|515846751|FG006|Controlled Period|Lack of Efficacy|0|||
143084423|NCT00307437|515846745|FG000|Controlled Period|Lost to Follow-up|2|||
143249410|NCT02745080|516466933|FG000|Overall Study|Withdrawal by Subject|22|||
143084424|NCT00307437|515846746|FG001|Controlled Period|Lost to Follow-up|3|||
143084425|NCT00307437|515846747|FG002|Controlled Period|Lost to Follow-up|0|||
143084426|NCT00307437|515846748|FG003|Controlled Period|Lost to Follow-up|0|||
143084427|NCT00307437|515846749|FG004|Controlled Period|Lost to Follow-up|0|||
143084428|NCT00307437|515846750|FG005|Controlled Period|Lost to Follow-up|0|||
143084429|NCT00307437|515846751|FG006|Controlled Period|Lost to Follow-up|0|||
143084430|NCT00307437|515846745|FG000|Controlled Period|Other|5|||
143084431|NCT00307437|515846746|FG001|Controlled Period|Other|1|||
143084432|NCT00307437|515846747|FG002|Controlled Period|Other|3|||
143084433|NCT00307437|515846748|FG003|Controlled Period|Other|0|||
143084434|NCT00307437|515846749|FG004|Controlled Period|Other|0|||
143084435|NCT00307437|515846750|FG005|Controlled Period|Other|0|||
143084436|NCT00307437|515846751|FG006|Controlled Period|Other|0|||
143084437|NCT00307437|515846745|FG000|After Controlled Period|Adverse Event|0|||
143084438|NCT00307437|515846746|FG001|After Controlled Period|Adverse Event|0|||
143084439|NCT00307437|515846747|FG002|After Controlled Period|Adverse Event|0|||
143084440|NCT00307437|515846748|FG003|After Controlled Period|Adverse Event|18|||
143084441|NCT00307437|515846749|FG004|After Controlled Period|Adverse Event|16|||
143084442|NCT00307437|515846750|FG005|After Controlled Period|Adverse Event|31|||
143084443|NCT00307437|515846751|FG006|After Controlled Period|Adverse Event|40|||
143084444|NCT00307437|515846745|FG000|After Controlled Period|Death|0|||
143084445|NCT00307437|515846746|FG001|After Controlled Period|Death|0|||
143084446|NCT00307437|515846747|FG002|After Controlled Period|Death|0|||
143084447|NCT00307437|515846748|FG003|After Controlled Period|Death|3|||
143084448|NCT00307437|515846749|FG004|After Controlled Period|Death|1|||
143084449|NCT00307437|515846750|FG005|After Controlled Period|Death|1|||
143084450|NCT00307437|515846751|FG006|After Controlled Period|Death|3|||
143084451|NCT00307437|515846745|FG000|After Controlled Period|Lack of Efficacy|0|||
143084452|NCT00307437|515846746|FG001|After Controlled Period|Lack of Efficacy|0|||
143084453|NCT00307437|515846747|FG002|After Controlled Period|Lack of Efficacy|0|||
143084454|NCT00307437|515846748|FG003|After Controlled Period|Lack of Efficacy|15|||
143084455|NCT00307437|515846749|FG004|After Controlled Period|Lack of Efficacy|17|||
143084456|NCT00307437|515846750|FG005|After Controlled Period|Lack of Efficacy|37|||
143084457|NCT00307437|515846751|FG006|After Controlled Period|Lack of Efficacy|24|||
143084458|NCT00307437|515846745|FG000|After Controlled Period|Lost to Follow-up|0|||
143084459|NCT00307437|515846746|FG001|After Controlled Period|Lost to Follow-up|0|||
143084460|NCT00307437|515846747|FG002|After Controlled Period|Lost to Follow-up|0|||
143084461|NCT00307437|515846748|FG003|After Controlled Period|Lost to Follow-up|7|||
143366572|NCT00828919|516884704|FG001|Overall Study|Insufficient Clinical Response|1|||
143084462|NCT00307437|515846749|FG004|After Controlled Period|Lost to Follow-up|12|||
143084463|NCT00307437|515846750|FG005|After Controlled Period|Lost to Follow-up|13|||
143084464|NCT00307437|515846751|FG006|After Controlled Period|Lost to Follow-up|18|||
143084465|NCT00307437|515846745|FG000|After Controlled Period|Other|0|||
143084466|NCT00307437|515846746|FG001|After Controlled Period|Other|0|||
143084467|NCT00307437|515846747|FG002|After Controlled Period|Other|0|||
143084468|NCT00307437|515846748|FG003|After Controlled Period|Other|15|||
143084469|NCT00307437|515846749|FG004|After Controlled Period|Other|9|||
143084470|NCT00307437|515846750|FG005|After Controlled Period|Other|40|||
143084471|NCT00307437|515846751|FG006|After Controlled Period|Other|28|||
143084472|NCT00338728|515846753|FG000|Overall Study|Screen Failure|14|||
143084473|NCT00805961|515846757|FG000|Modality Therapy|Withdrawal by Subject|1|||
143084474|NCT00805961|515846757|FG000|Modality Therapy|Adverse Event|1|||
143084475|NCT00805961|515846757|FG000|Modality Therapy|Disease Progression|2|||
143084476|NCT00805961|515846757|FG000|Treatment-Free Interval|Adverse Event|3|||
143084477|NCT00805961|515846757|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
143084478|NCT00805961|515846757|FG000|Treatment-Free Interval|Physician Decision|1|||
143084479|NCT00805961|515846757|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
143084480|NCT00805961|515846757|FG000|Maintenance Treatment|Lack of Efficacy|13|||
143084481|NCT00805961|515846757|FG000|Maintenance Treatment|Intercurrent Illness|7|||
143084482|NCT00805961|515846757|FG000|Maintenance Treatment|Adverse Event|6|||
143084483|NCT00805961|515846757|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
143084484|NCT00805961|515846757|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
143084485|NCT00805961|515846757|FG000|Maintenance Treatment|Withdrawn Consent|1|||
143084486|NCT04380961|515846758|FG000|Overall Study|Lost to Follow-up|17|||
143084487|NCT04380961|515846759|FG001|Overall Study|Lost to Follow-up|11|||
143084488|NCT04380961|515846758|FG000|Overall Study|Withdrawal by Subject|3|||
143084489|NCT04380961|515846759|FG001|Overall Study|Withdrawal by Subject|0|||
143084490|NCT04380961|515846758|FG000|Overall Study|Death|22|||
143084491|NCT04380961|515846759|FG001|Overall Study|Death|16|||
143084492|NCT04380961|515846758|FG000|Overall Study|Other|1|||
143084493|NCT04380961|515846759|FG001|Overall Study|Other|0|||
143084494|NCT04380961|515846758|FG000|Overall Study|Randomized but Not Treated|1|||
143084495|NCT04380961|515846759|FG001|Overall Study|Randomized but Not Treated|2|||
143084496|NCT04803305|515846760|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
143084497|NCT04803305|515846761|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
143084498|NCT04803305|515846760|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
143084499|NCT04803305|515846761|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
143084500|NCT04803305|515846760|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
143084501|NCT04803305|515846761|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
143084502|NCT04803305|515846760|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
143084503|NCT04803305|515846761|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
143084504|NCT04803305|515846760|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
143084505|NCT04803305|515846761|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
143084506|NCT04803305|515846760|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
143084507|NCT04803305|515846761|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
143084508|NCT04803305|515846760|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
143084509|NCT04803305|515846761|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
143084510|NCT04803305|515846760|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
143084511|NCT04803305|515846761|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
143084512|NCT01862484|515846762|FG000|Overall Study|Lack of Efficacy|1|||
143084513|NCT01862484|515846763|FG001|Overall Study|Lack of Efficacy|1|||
143084514|NCT01862484|515846762|FG000|Overall Study|Lost to Follow-up|1|||
143084515|NCT01862484|515846763|FG001|Overall Study|Lost to Follow-up|2|||
143084516|NCT01862484|515846762|FG000|Overall Study|Protocol Violation|0|||
143084517|NCT01862484|515846763|FG001|Overall Study|Protocol Violation|2|||
143084518|NCT01862484|515846762|FG000|Overall Study|Withdrawal by Subject|0|||
143084519|NCT01862484|515846763|FG001|Overall Study|Withdrawal by Subject|3|||
143084520|NCT00721227|515846764|FG000|Overall Study|Lost to Follow-up|3|||
143084521|NCT00721227|515846765|FG001|Overall Study|Lost to Follow-up|0|||
143084522|NCT00721227|515846764|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
143084523|NCT00721227|515846765|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
143084524|NCT00993421|515846766|FG000|Overall Study|Adverse Event|2|||
143084525|NCT00993421|515846767|FG001|Overall Study|Adverse Event|7|||
143084526|NCT00993421|515846768|FG002|Overall Study|Adverse Event|6|||
143084527|NCT00993421|515846769|FG003|Overall Study|Adverse Event|9|||
143084528|NCT00993421|515846770|FG004|Overall Study|Adverse Event|5|||
143084529|NCT00993421|515846771|FG005|Overall Study|Adverse Event|7|||
143084530|NCT00993421|515846772|FG006|Overall Study|Adverse Event|1|||
143084531|NCT00993421|515846766|FG000|Overall Study|Sponsor Decision|36|||
143084532|NCT00993421|515846767|FG001|Overall Study|Sponsor Decision|31|||
143084533|NCT00993421|515846768|FG002|Overall Study|Sponsor Decision|28|||
143084534|NCT00993421|515846769|FG003|Overall Study|Sponsor Decision|30|||
143084535|NCT00993421|515846770|FG004|Overall Study|Sponsor Decision|38|||
143084536|NCT00993421|515846771|FG005|Overall Study|Sponsor Decision|30|||
143084537|NCT00993421|515846772|FG006|Overall Study|Sponsor Decision|29|||
143084538|NCT00993421|515846766|FG000|Overall Study|Lost to Follow-up|3|||
143084539|NCT00993421|515846767|FG001|Overall Study|Lost to Follow-up|5|||
143084540|NCT00993421|515846768|FG002|Overall Study|Lost to Follow-up|5|||
143084541|NCT00993421|515846769|FG003|Overall Study|Lost to Follow-up|0|||
143084542|NCT00993421|515846770|FG004|Overall Study|Lost to Follow-up|0|||
143084543|NCT00993421|515846771|FG005|Overall Study|Lost to Follow-up|0|||
143084544|NCT00993421|515846772|FG006|Overall Study|Lost to Follow-up|6|||
143084545|NCT00993421|515846766|FG000|Overall Study|Withdrawal by Subject|3|||
143084546|NCT00993421|515846767|FG001|Overall Study|Withdrawal by Subject|2|||
143084547|NCT00993421|515846768|FG002|Overall Study|Withdrawal by Subject|3|||
143084548|NCT00993421|515846769|FG003|Overall Study|Withdrawal by Subject|3|||
143084549|NCT00993421|515846770|FG004|Overall Study|Withdrawal by Subject|3|||
143084550|NCT00993421|515846771|FG005|Overall Study|Withdrawal by Subject|5|||
143084551|NCT00993421|515846772|FG006|Overall Study|Withdrawal by Subject|3|||
143084552|NCT00993421|515846766|FG000|Overall Study|Death|0|||
143084553|NCT00993421|515846767|FG001|Overall Study|Death|0|||
143084554|NCT00993421|515846768|FG002|Overall Study|Death|0|||
143084555|NCT00993421|515846769|FG003|Overall Study|Death|0|||
143084556|NCT00993421|515846770|FG004|Overall Study|Death|0|||
143084557|NCT00993421|515846771|FG005|Overall Study|Death|0|||
143084558|NCT00993421|515846772|FG006|Overall Study|Death|1|||
143084559|NCT00993421|515846766|FG000|Overall Study|Entry Criteria Exclusion|0|||
143084560|NCT00993421|515846767|FG001|Overall Study|Entry Criteria Exclusion|0|||
143084561|NCT00993421|515846768|FG002|Overall Study|Entry Criteria Exclusion|1|||
143084562|NCT00993421|515846769|FG003|Overall Study|Entry Criteria Exclusion|3|||
143084563|NCT00993421|515846770|FG004|Overall Study|Entry Criteria Exclusion|0|||
143084564|NCT00993421|515846771|FG005|Overall Study|Entry Criteria Exclusion|1|||
143084565|NCT00993421|515846772|FG006|Overall Study|Entry Criteria Exclusion|0|||
143084566|NCT00993421|515846766|FG000|Overall Study|Physician Decision|0|||
143084567|NCT00993421|515846767|FG001|Overall Study|Physician Decision|0|||
143084568|NCT00993421|515846768|FG002|Overall Study|Physician Decision|0|||
143084569|NCT00993421|515846769|FG003|Overall Study|Physician Decision|0|||
143084570|NCT00993421|515846770|FG004|Overall Study|Physician Decision|0|||
143084571|NCT00993421|515846771|FG005|Overall Study|Physician Decision|1|||
143084572|NCT00993421|515846772|FG006|Overall Study|Physician Decision|1|||
143084573|NCT00993421|515846766|FG000|Overall Study|Protocol Violation|0|||
143084574|NCT00993421|515846767|FG001|Overall Study|Protocol Violation|0|||
143084575|NCT00993421|515846768|FG002|Overall Study|Protocol Violation|0|||
143084576|NCT00993421|515846769|FG003|Overall Study|Protocol Violation|0|||
143084577|NCT00993421|515846770|FG004|Overall Study|Protocol Violation|0|||
143174373|NCT02927795|516187116|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
143174374|NCT02927795|516187116|FG000|Overall Study|Not Treated|4|||
143174375|NCT01534481|516187117|FG000|Overall Study|Lost to Follow-up|29|||
143174376|NCT01534481|516187118|FG001|Overall Study|Lost to Follow-up|24|||
143174377|NCT01534481|516187117|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
143174378|NCT01534481|516187118|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
143174379|NCT01130337|516187119|FG000|Overall Study|Withdrawal by Subject|3|||
143174380|NCT01130337|516187119|FG000|Overall Study|Principal investigator decision|1|||
143174381|NCT01130337|516187119|FG000|Overall Study|Death|1|||
143174382|NCT01130337|516187119|FG000|Overall Study|Disease progression|1|||
143174383|NCT01130337|516187119|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
143174384|NCT01130337|516187119|FG000|Overall Study|Surgical resection (R2)|1|||
143174385|NCT05525910|516187120|FG000|Period 4|Per sponsor due to study timelines|0|||
143174386|NCT05525910|516187121|FG001|Period 4|Per sponsor due to study timelines|0|||
143174387|NCT05525910|516187122|FG002|Period 4|Per sponsor due to study timelines|1|||
143174388|NCT05525910|516187123|FG003|Period 4|Per sponsor due to study timelines|1|||
143174389|NCT05525910|516187124|FG004|Period 4|Per sponsor due to study timelines|1|||
143174390|NCT03886493|516187126|FG000|Overall Study|Adverse Event|1|||
143174391|NCT00181844|516187127|FG000|Signed Consent|Withdrawal by Subject|5|||
143174392|NCT00181844|516187127|FG000|Signed Consent|Did not meet entrance criteria|7|||
143174393|NCT00181844|516187127|FG000|Exposed to Study Medication|Adverse Event|10|||
143174394|NCT00181844|516187127|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
143174395|NCT00181844|516187127|FG000|Exposed to Study Medication|Non-compliance|2|||
143174396|NCT00181844|516187127|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
143174397|NCT00181844|516187127|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
143174398|NCT03179761|516187129|FG000|Overall Study|Death|2|||
143174399|NCT03179761|516187130|FG001|Overall Study|Death|5|||
143174400|NCT03179761|516187129|FG000|Overall Study|Lost to Follow-up|2|||
143174401|NCT03179761|516187130|FG001|Overall Study|Lost to Follow-up|2|||
143174402|NCT03179761|516187129|FG000|Overall Study|Protocol Violation|1|||
143174403|NCT03179761|516187130|FG001|Overall Study|Protocol Violation|0|||
143174404|NCT03179761|516187129|FG000|Overall Study|Withdrawal by Subject|1|||
143174405|NCT03179761|516187130|FG001|Overall Study|Withdrawal by Subject|4|||
143174406|NCT03179761|516187129|FG000|Overall Study|Investigator Request|0|||
143174407|NCT03179761|516187130|FG001|Overall Study|Investigator Request|2|||
143174408|NCT02284191|516187133|FG000|Overall Study|Withdrawal by Subject|1|||
143174409|NCT02284191|516187134|FG001|Overall Study|Withdrawal by Subject|3|||
143174410|NCT02284191|516187133|FG000|Overall Study|Lost to Follow-up|1|||
143174411|NCT02284191|516187134|FG001|Overall Study|Lost to Follow-up|0|||
143174412|NCT03139448|516187138|FG000|Overall Study|Lack of Efficacy|6|||
143084578|NCT00993421|515846771|FG005|Overall Study|Protocol Violation|2|||
143084579|NCT00993421|515846772|FG006|Overall Study|Protocol Violation|1|||
143174413|NCT03139448|516187139|FG001|Overall Study|Lack of Efficacy|7|||
143174414|NCT03139448|516187138|FG000|Overall Study|Location of procedure changed|2|||
143174415|NCT03139448|516187139|FG001|Overall Study|Location of procedure changed|8|||
143174416|NCT03139448|516187138|FG000|Overall Study|Withdrawal by Subject|3|||
143174417|NCT03139448|516187139|FG001|Overall Study|Withdrawal by Subject|6|||
143174418|NCT03139448|516187138|FG000|Overall Study|Screen fail|1|||
143174419|NCT03139448|516187139|FG001|Overall Study|Screen fail|3|||
143084580|NCT02759692|515846773|FG000|Period 1|Test article no longer available|1|||
143084581|NCT02759692|515846774|FG001|Period 1|Test article no longer available|1|||
143084582|NCT02759692|515846773|FG000|Period 1|No longer meets eligibility criteria.|1|||
143084583|NCT02759692|515846774|FG001|Period 1|No longer meets eligibility criteria.|0|||
143084584|NCT02759692|515846773|FG000|Period 1|Miss-Randomized|1|||
143084585|NCT02759692|515846774|FG001|Period 1|Miss-Randomized|1|||
143084586|NCT02759692|515846773|FG000|Period 2|Lost to Follow-up|1|||
143084587|NCT02759692|515846774|FG001|Period 2|Lost to Follow-up|0|||
143084588|NCT02759692|515846773|FG000|Period 2|Test article no longer available|0|||
143084589|NCT02759692|515846774|FG001|Period 2|Test article no longer available|1|||
143084590|NCT03514017|515846777|FG000|Overall Study|Death|1|||
143084591|NCT03514017|515846777|FG000|Overall Study|Adverse Event|1|||
143084592|NCT00352417|515846780|FG000|Overall Study|Adverse Event|1|||
143084593|NCT00352417|515846781|FG001|Overall Study|Adverse Event|0|||
143084594|NCT00352417|515846780|FG000|Overall Study|Protocol Violation|0|||
143084595|NCT00352417|515846781|FG001|Overall Study|Protocol Violation|2|||
143084596|NCT00352417|515846780|FG000|Overall Study|Withdrawal by Subject|1|||
143084597|NCT00352417|515846781|FG001|Overall Study|Withdrawal by Subject|2|||
143084598|NCT00352417|515846780|FG000|Overall Study|Lost to Follow-up|1|||
143084599|NCT00352417|515846781|FG001|Overall Study|Lost to Follow-up|0|||
143084600|NCT00352417|515846780|FG000|Overall Study|Schedule Change|2|||
143084601|NCT00352417|515846781|FG001|Overall Study|Schedule Change|1|||
143084602|NCT04559347|515848259|FG000|Overall Study|Death|1|||
143084603|NCT04559347|515848260|FG001|Overall Study|Death|0|||
143084604|NCT04559347|515848259|FG000|Overall Study|Thoracotomy conversion|1|||
143084605|NCT04559347|515848260|FG001|Overall Study|Thoracotomy conversion|1|||
143084606|NCT04559347|515848259|FG000|Overall Study|Provider unavailable|2|||
143084607|NCT04559347|515848260|FG001|Overall Study|Provider unavailable|1|||
143084608|NCT04559347|515848259|FG000|Overall Study|Other|2|||
143084609|NCT04559347|515848260|FG001|Overall Study|Other|1|||
143084610|NCT03816878|515848266|FG000|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|1|||
143084611|NCT03816878|515848267|FG001|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|0|||
143084612|NCT03816878|515848266|FG000|Overall Study|Volunteer taken off study due to incarceration|0|||
143084613|NCT03816878|515848267|FG001|Overall Study|Volunteer taken off study due to incarceration|1|||
143084614|NCT03355469|515848268|FG000|Overall Study|COVID-19|3|||
143084615|NCT03355469|515848269|FG001|Overall Study|COVID-19|2|||
143084616|NCT03355469|515848270|FG002|Overall Study|COVID-19|3|||
143084617|NCT03355469|515848271|FG003|Overall Study|COVID-19|3|||
143084618|NCT03355469|515848268|FG000|Overall Study|Lost to Follow-up|1|||
143084619|NCT03355469|515848269|FG001|Overall Study|Lost to Follow-up|0|||
143084620|NCT03355469|515848270|FG002|Overall Study|Lost to Follow-up|1|||
143084621|NCT03355469|515848271|FG003|Overall Study|Lost to Follow-up|0|||
143084622|NCT03355469|515848268|FG000|Overall Study|Withdrawal by Subject|2|||
143084623|NCT03355469|515848269|FG001|Overall Study|Withdrawal by Subject|1|||
143084624|NCT03355469|515848270|FG002|Overall Study|Withdrawal by Subject|0|||
143084625|NCT03355469|515848271|FG003|Overall Study|Withdrawal by Subject|3|||
143084626|NCT01495702|515848272|FG000|Randomized Phase|Randomized But Not Treated|1|||
143084627|NCT01495702|515848273|FG001|Randomized Phase|Randomized But Not Treated|4|||
143084628|NCT01495702|515848272|FG000|Randomized Phase|Adverse Event|2|||
143084629|NCT01495702|515848273|FG001|Randomized Phase|Adverse Event|2|||
143084630|NCT01495702|515848272|FG000|Randomized Phase|Death|1|||
143084631|NCT01495702|515848273|FG001|Randomized Phase|Death|0|||
143084632|NCT01495702|515848272|FG000|Randomized Phase|Lack of Efficacy|2|||
143084633|NCT01495702|515848273|FG001|Randomized Phase|Lack of Efficacy|0|||
143084634|NCT01495702|515848272|FG000|Randomized Phase|Investigators Discretion|2|||
143084635|NCT01495702|515848273|FG001|Randomized Phase|Investigators Discretion|0|||
143084636|NCT01495702|515848272|FG000|Randomized Phase|Withdrew Consent|10|||
143084637|NCT01495702|515848273|FG001|Randomized Phase|Withdrew Consent|18|||
143084638|NCT01495702|515848272|FG000|Randomized Phase|Lost to Follow-up|4|||
143084639|NCT01495702|515848273|FG001|Randomized Phase|Lost to Follow-up|3|||
143084640|NCT01495702|515848272|FG000|Randomized Phase|Participant Noncompliance|1|||
143084641|NCT01495702|515848273|FG001|Randomized Phase|Participant Noncompliance|0|||
143084642|NCT01495702|515848272|FG000|Randomized Phase|Protocol Violation|3|||
143084643|NCT01495702|515848273|FG001|Randomized Phase|Protocol Violation|1|||
143084644|NCT04152863|515848274|FG000|Overall Study|Death|13|||
143084645|NCT04152863|515848275|FG001|Overall Study|Death|12|||
143084646|NCT04152863|515848276|FG002|Overall Study|Death|7|||
143084647|NCT04152863|515848274|FG000|Overall Study|Physician Decision|1|||
143084648|NCT04152863|515848275|FG001|Overall Study|Physician Decision|1|||
143249411|NCT02745080|516466934|FG001|Overall Study|Withdrawal by Subject|41|||
143249412|NCT00282308|516466935|FG000|Treatment Period|Lost to Follow-up|1|||
143084649|NCT04152863|515848276|FG002|Overall Study|Physician Decision|1|||
143084650|NCT04152863|515848274|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
143084651|NCT04152863|515848275|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
143084652|NCT04152863|515848276|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
143084653|NCT04152863|515848274|FG000|Overall Study|Withdrawal by Subject|2|||
143084654|NCT04152863|515848275|FG001|Overall Study|Withdrawal by Subject|1|||
143084655|NCT04152863|515848276|FG002|Overall Study|Withdrawal by Subject|3|||
143084656|NCT05223920|515848277|FG000|Overall Study|Adverse Event|6|||
143084657|NCT05223920|515848278|FG001|Overall Study|Adverse Event|3|||
143084658|NCT05223920|515848277|FG000|Overall Study|Death|2|||
143084659|NCT05223920|515848278|FG001|Overall Study|Death|0|||
143084660|NCT05223920|515848277|FG000|Overall Study|Disease Progression|1|||
143084661|NCT05223920|515848278|FG001|Overall Study|Disease Progression|2|||
143084662|NCT05223920|515848277|FG000|Overall Study|Physician Decision|1|||
143174420|NCT03139448|516187138|FG000|Overall Study|Physician Decision|0|||
143174421|NCT03139448|516187139|FG001|Overall Study|Physician Decision|2|||
143174422|NCT00760552|516187140|FG000|Overall Study|Death|2|||
143174423|NCT00760552|516187141|FG001|Overall Study|Death|0|||
143174424|NCT00760552|516187140|FG000|Overall Study|Lost to Follow-up|11|||
143174425|NCT00760552|516187141|FG001|Overall Study|Lost to Follow-up|10|||
143174426|NCT01880957|516187142|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
143174427|NCT01880957|516187143|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
143174428|NCT01880957|516187142|FG000|Overall Study|Lost to Follow-up|11|||
143174429|NCT01880957|516187143|FG001|Overall Study|Lost to Follow-up|0|||
143174430|NCT01880957|516187142|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
143174431|NCT01880957|516187143|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
143174432|NCT01378117|516187144|FG000|Overall Study|withdrawal|2|||
143174433|NCT01378117|516187145|FG001|Overall Study|withdrawal|1|||
143174434|NCT01378117|516187146|FG002|Overall Study|withdrawal|2|||
143174435|NCT01378117|516187144|FG000|Overall Study|discharged before med given|2|||
143174436|NCT01378117|516187145|FG001|Overall Study|discharged before med given|0|||
143174437|NCT01378117|516187146|FG002|Overall Study|discharged before med given|1|||
143174438|NCT01854528|516187147|FG000|Overall Study|Adverse Event|0|||
143174439|NCT01854528|516187148|FG001|Overall Study|Adverse Event|4|||
143174440|NCT01854528|516187147|FG000|Overall Study|Withdrawal by Subject|0|||
143174441|NCT01854528|516187148|FG001|Overall Study|Withdrawal by Subject|2|||
143174442|NCT01854528|516187147|FG000|Overall Study|Virologic Failure|0|||
143174443|NCT01854528|516187148|FG001|Overall Study|Virologic Failure|9|||
143174444|NCT02961244|516187149|FG000|Overall Study|Protocol Violation|0|||
143174445|NCT02961244|516187150|FG001|Overall Study|Protocol Violation|1|||
143174446|NCT02961244|516187149|FG000|Overall Study|Withdrawal by Subject|1|||
143174447|NCT02961244|516187150|FG001|Overall Study|Withdrawal by Subject|2|||
143174448|NCT02961244|516187149|FG000|Overall Study|Surgery plan change after study approval|0|||
143174449|NCT02961244|516187150|FG001|Overall Study|Surgery plan change after study approval|2|||
143174450|NCT02961244|516187149|FG000|Overall Study|Lost to Follow-up|0|||
143174451|NCT02961244|516187150|FG001|Overall Study|Lost to Follow-up|2|||
143174452|NCT02961244|516187149|FG000|Overall Study|İnadequate data|0|||
143174453|NCT02961244|516187150|FG001|Overall Study|İnadequate data|2|||
143174454|NCT01696643|516187151|FG000|Overall Study|Adverse Event|15|||
143174455|NCT01696643|516187152|FG001|Overall Study|Adverse Event|7|||
143174456|NCT01696643|516187151|FG000|Overall Study|Death|1|||
143174457|NCT01696643|516187152|FG001|Overall Study|Death|2|||
143174458|NCT01696643|516187151|FG000|Overall Study|Lack of Efficacy|3|||
143174459|NCT01696643|516187152|FG001|Overall Study|Lack of Efficacy|0|||
143174460|NCT01696643|516187151|FG000|Overall Study|Lost to Follow-up|67|||
143174461|NCT01696643|516187152|FG001|Overall Study|Lost to Follow-up|67|||
143174462|NCT01696643|516187151|FG000|Overall Study|Physician Decision|3|||
143174463|NCT01696643|516187152|FG001|Overall Study|Physician Decision|2|||
143174464|NCT01696643|516187151|FG000|Overall Study|Pregnancy|0|||
143174465|NCT01696643|516187152|FG001|Overall Study|Pregnancy|1|||
143174466|NCT01696643|516187151|FG000|Overall Study|Protocol Violation|7|||
143174467|NCT01696643|516187152|FG001|Overall Study|Protocol Violation|7|||
143174468|NCT01696643|516187151|FG000|Overall Study|Study Terminated by Sponsor|286|||
143174469|NCT01696643|516187152|FG001|Overall Study|Study Terminated by Sponsor|294|||
143174470|NCT01696643|516187151|FG000|Overall Study|Withdrawal by Subject|142|||
143174471|NCT01696643|516187152|FG001|Overall Study|Withdrawal by Subject|149|||
143174472|NCT01696643|516187151|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
143174473|NCT01696643|516187152|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
143174474|NCT01696643|516187151|FG000|Overall Study|Site Error|2|||
143174475|NCT01696643|516187152|FG001|Overall Study|Site Error|1|||
143084663|NCT05223920|515848278|FG001|Overall Study|Physician Decision|2|||
143084664|NCT05223920|515848277|FG000|Overall Study|Sponsor decision|11|||
143084665|NCT05223920|515848278|FG001|Overall Study|Sponsor decision|9|||
143084666|NCT05223920|515848277|FG000|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|29|||
143084667|NCT05223920|515848278|FG001|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|7|||
143084668|NCT05223920|515848277|FG000|Overall Study|Subject decision|1|||
143084669|NCT05223920|515848278|FG001|Overall Study|Subject decision|0|||
143084670|NCT05223920|515848277|FG000|Overall Study|Withdrawal by Subject|1|||
143084671|NCT05223920|515848278|FG001|Overall Study|Withdrawal by Subject|6|||
143084672|NCT00261950|515848285|FG000|Overall Study|Lost to Follow-up|2|||
143084673|NCT00261950|515848285|FG000|Overall Study|Death|6|||
143084674|NCT00261950|515848285|FG000|Overall Study|Withdrawal by Subject|5|||
143084675|NCT00261950|515848285|FG000|Overall Study|Other|1|||
143084676|NCT00261950|515848285|FG000|Overall Study|Physician Decision|1|||
143084677|NCT00261950|515848285|FG000|Overall Study|Protocol specified Criteria|11|||
143084678|NCT01023035|515848286|FG000|Treatment Period|Adverse Event|27|||
143084679|NCT01023035|515848287|FG001|Treatment Period|Adverse Event|32|||
143084680|NCT01023035|515848288|FG002|Treatment Period|Adverse Event|50|||
143249413|NCT00282308|516466936|FG001|Treatment Period|Lost to Follow-up|0|||
143249414|NCT00282308|516466937|FG002|Treatment Period|Lost to Follow-up|0|||
143249415|NCT00282308|516466935|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
143249416|NCT00282308|516466936|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
143249417|NCT00282308|516466937|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
143249418|NCT00282308|516466935|FG000|Treatment Period|Adverse Event|0|||
143249419|NCT00282308|516466936|FG001|Treatment Period|Adverse Event|2|||
143249420|NCT00282308|516466937|FG002|Treatment Period|Adverse Event|0|||
143249421|NCT00282308|516466935|FG000|Treatment Period|Not Treated with Study Drug|1|||
143249422|NCT00282308|516466936|FG001|Treatment Period|Not Treated with Study Drug|0|||
143249423|NCT00282308|516466937|FG002|Treatment Period|Not Treated with Study Drug|0|||
143249424|NCT00282308|516466935|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
143249425|NCT00282308|516466936|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
143249426|NCT00282308|516466937|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
143249427|NCT00282308|516466935|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
143249428|NCT00282308|516466936|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
143249429|NCT00282308|516466937|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
143249430|NCT00282308|516466935|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
143249431|NCT00282308|516466936|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
143249432|NCT00282308|516466937|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
143249433|NCT00282308|516466935|FG000|Safety Follow-up Period|Adverse Event|0|||
143249434|NCT00282308|516466936|FG001|Safety Follow-up Period|Adverse Event|0|||
143249435|NCT00282308|516466937|FG002|Safety Follow-up Period|Adverse Event|1|||
143249436|NCT00282308|516466935|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
143084681|NCT01023035|515848286|FG000|Treatment Period|Non-Medical Reasons|19|||
143084682|NCT01023035|515848287|FG001|Treatment Period|Non-Medical Reasons|22|||
143366573|NCT00828919|516884705|FG002|Overall Study|Insufficient Clinical Response|2|||
143366574|NCT00828919|516884706|FG003|Overall Study|Insufficient Clinical Response|0|||
143366575|NCT00828919|516884707|FG004|Overall Study|Insufficient Clinical Response|0|||
143366576|NCT00828919|516884703|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
143366577|NCT00828919|516884704|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
143366578|NCT00828919|516884705|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
143366579|NCT00828919|516884706|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
143366580|NCT00828919|516884707|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
143366581|NCT00828919|516884703|FG000|Overall Study|Other|1|||
143366582|NCT00828919|516884704|FG001|Overall Study|Other|0|||
143366583|NCT00828919|516884705|FG002|Overall Study|Other|1|||
143366584|NCT00828919|516884706|FG003|Overall Study|Other|1|||
143366585|NCT00828919|516884707|FG004|Overall Study|Other|0|||
143366586|NCT00828919|516884703|FG000|Overall Study|Lost to Follow-up|0|||
143366587|NCT00828919|516884704|FG001|Overall Study|Lost to Follow-up|1|||
143366588|NCT00828919|516884705|FG002|Overall Study|Lost to Follow-up|0|||
143366589|NCT00828919|516884706|FG003|Overall Study|Lost to Follow-up|0|||
143366590|NCT00828919|516884707|FG004|Overall Study|Lost to Follow-up|0|||
143366591|NCT05567159|516884710|FG000|Overall Study|Adverse Event|4|||
143366592|NCT05567159|516884710|FG000|Overall Study|Physician Decision|3|||
143366593|NCT05567159|516884710|FG000|Overall Study|Protocol deviation|1|||
143366594|NCT02501811|516884712|FG000|Overall Study|Death|1|||
143366595|NCT02501811|516884713|FG001|Overall Study|Death|3|||
143366596|NCT02501811|516884714|FG002|Overall Study|Death|2|||
143366597|NCT02501811|516884715|FG003|Overall Study|Death|3|||
143366598|NCT02501811|516884712|FG000|Overall Study|Withdrawal by Subject|3|||
143366599|NCT02501811|516884713|FG001|Overall Study|Withdrawal by Subject|3|||
143366600|NCT02501811|516884714|FG002|Overall Study|Withdrawal by Subject|2|||
143366601|NCT02501811|516884715|FG003|Overall Study|Withdrawal by Subject|3|||
143366602|NCT02501811|516884712|FG000|Overall Study|Lost to Follow-up|0|||
143366603|NCT02501811|516884713|FG001|Overall Study|Lost to Follow-up|0|||
143366604|NCT02501811|516884714|FG002|Overall Study|Lost to Follow-up|2|||
143366605|NCT02501811|516884715|FG003|Overall Study|Lost to Follow-up|1|||
143366606|NCT00991276|516887131|FG000|First Intervention Period|Adverse Event|0|||
143366607|NCT00991276|516887132|FG001|First Intervention Period|Adverse Event|1|||
143366608|NCT00991276|516887133|FG002|First Intervention Period|Adverse Event|0|||
143366609|NCT00991276|516887134|FG003|First Intervention Period|Adverse Event|1|||
143366610|NCT00991276|516887135|FG004|First Intervention Period|Adverse Event|0|||
143366611|NCT00991276|516887136|FG005|First Intervention Period|Adverse Event|0|||
143366612|NCT00991276|516887131|FG000|First Intervention Period|Protocol Violation|0|||
143366613|NCT00991276|516887132|FG001|First Intervention Period|Protocol Violation|0|||
143366614|NCT00991276|516887133|FG002|First Intervention Period|Protocol Violation|0|||
143366615|NCT00991276|516887134|FG003|First Intervention Period|Protocol Violation|0|||
143366616|NCT00991276|516887135|FG004|First Intervention Period|Protocol Violation|2|||
143366617|NCT00991276|516887136|FG005|First Intervention Period|Protocol Violation|0|||
143366618|NCT00991276|516887131|FG000|First Intervention Period|Insufficient clinical response|0|||
143366619|NCT00991276|516887132|FG001|First Intervention Period|Insufficient clinical response|0|||
143366620|NCT00991276|516887133|FG002|First Intervention Period|Insufficient clinical response|0|||
143366621|NCT00991276|516887134|FG003|First Intervention Period|Insufficient clinical response|0|||
143366622|NCT00991276|516887135|FG004|First Intervention Period|Insufficient clinical response|1|||
143366623|NCT00991276|516887136|FG005|First Intervention Period|Insufficient clinical response|0|||
143249437|NCT00282308|516466936|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
143249438|NCT00282308|516466937|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
143249439|NCT00282308|516466935|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
143249440|NCT00282308|516466936|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
143249441|NCT00282308|516466937|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
143249442|NCT00282308|516466935|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
143249443|NCT00282308|516466936|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
143249444|NCT00282308|516466937|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
143249445|NCT01001325|516466940|FG000|Overall Study|Lost to Follow-up|16|||
143249446|NCT01001325|516466941|FG001|Overall Study|Lost to Follow-up|10|||
143366624|NCT00991276|516887131|FG000|First Intervention Period|Other|0|||
143366625|NCT00991276|516887132|FG001|First Intervention Period|Other|0|||
143366626|NCT00991276|516887133|FG002|First Intervention Period|Other|0|||
143366627|NCT00991276|516887134|FG003|First Intervention Period|Other|1|||
143366628|NCT00991276|516887135|FG004|First Intervention Period|Other|1|||
143366629|NCT00991276|516887136|FG005|First Intervention Period|Other|0|||
143366630|NCT00991276|516887131|FG000|First Intervention Period|Withdrawal by Subject|0|||
143366631|NCT00991276|516887132|FG001|First Intervention Period|Withdrawal by Subject|1|||
143084683|NCT01023035|515848288|FG002|Treatment Period|Non-Medical Reasons|44|||
143084684|NCT01023035|515848286|FG000|Treatment Period|Treatment Failure|26|||
143084685|NCT01023035|515848287|FG001|Treatment Period|Treatment Failure|31|||
143084686|NCT01023035|515848288|FG002|Treatment Period|Treatment Failure|24|||
143084687|NCT01023035|515848286|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
143084688|NCT01023035|515848287|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
143084689|NCT01023035|515848288|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
143084690|NCT01023035|515848286|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
143084691|NCT01023035|515848287|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
143084692|NCT01023035|515848288|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
143084693|NCT02370238|515848289|FG000|Overall Study|Death|42|||
143084694|NCT02370238|515848290|FG001|Overall Study|Death|35|||
143084695|NCT02370238|515848289|FG000|Overall Study|Lost to Follow-up|1|||
143084696|NCT02370238|515848290|FG001|Overall Study|Lost to Follow-up|3|||
143084697|NCT02370238|515848289|FG000|Overall Study|Withdrawal by Subject|2|||
143084698|NCT02370238|515848290|FG001|Overall Study|Withdrawal by Subject|6|||
143084699|NCT02370238|515848289|FG000|Overall Study|Other|2|||
143084700|NCT02370238|515848290|FG001|Overall Study|Other|1|||
143084701|NCT01153425|515848293|FG000|Overall Study|Withdrawal by Subject|3|||
143084702|NCT01153425|515848294|FG001|Overall Study|Withdrawal by Subject|3|||
143084703|NCT00445432|515848297|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
143084704|NCT00445432|515848298|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
143084705|NCT00445432|515848299|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
143084706|NCT00445432|515848300|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
143084707|NCT00445432|515848297|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
143174476|NCT01696643|516187151|FG000|Overall Study|Participant Incarcerated|0|||
143174477|NCT01696643|516187152|FG001|Overall Study|Participant Incarcerated|1|||
143174478|NCT01696643|516187151|FG000|Overall Study|Medical Monitor Decision|0|||
143174479|NCT01696643|516187152|FG001|Overall Study|Medical Monitor Decision|2|||
143174480|NCT01696643|516187151|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
143174481|NCT01696643|516187152|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
143174482|NCT00518180|516187154|FG000|Overall Study|Withdrawal by Subject|29|||
143174483|NCT00518180|516187155|FG001|Overall Study|Withdrawal by Subject|30|||
143174484|NCT00518180|516187156|FG002|Overall Study|Withdrawal by Subject|42|||
143174485|NCT00518180|516187154|FG000|Overall Study|Lost to Follow-up|30|||
143174486|NCT00518180|516187155|FG001|Overall Study|Lost to Follow-up|28|||
143174487|NCT00518180|516187156|FG002|Overall Study|Lost to Follow-up|34|||
143249447|NCT01001325|516466940|FG000|Overall Study|Protocol Violation|2|||
143249448|NCT01001325|516466941|FG001|Overall Study|Protocol Violation|0|||
143249449|NCT00899431|516466944|FG000|Overall Study|Physician Decision|1|||
143249450|NCT00899431|516466945|FG001|Overall Study|Physician Decision|0|||
143249451|NCT00899431|516466946|FG002|Overall Study|Physician Decision|0|||
143249452|NCT00661427|516466947|FG000|Overall Study|Adverse Event|5|||
143249453|NCT00661427|516466948|FG001|Overall Study|Adverse Event|5|||
143249454|NCT00661427|516466947|FG000|Overall Study|Patient not treated|0|||
143249455|NCT00661427|516466948|FG001|Overall Study|Patient not treated|2|||
143249456|NCT01821560|516466949|FG000|Overall Study|Lost to Follow-up|5|||
143249457|NCT01821560|516466950|FG001|Overall Study|Lost to Follow-up|5|||
143249458|NCT01821560|516466949|FG000|Overall Study|Withdrawal by Subject|1|||
143249459|NCT01821560|516466950|FG001|Overall Study|Withdrawal by Subject|1|||
143249460|NCT01821560|516466949|FG000|Overall Study|Protocol Violation|0|||
143249461|NCT01821560|516466950|FG001|Overall Study|Protocol Violation|1|||
143249462|NCT00531427|516466951|FG000|Overall Study|Withdrawal by Subject|7|||
143249463|NCT00531427|516466952|FG001|Overall Study|Withdrawal by Subject|13|||
143249464|NCT00531427|516466951|FG000|Overall Study|Adverse Event|44|||
143249465|NCT00531427|516466952|FG001|Overall Study|Adverse Event|30|||
143249466|NCT00531427|516466951|FG000|Overall Study|Lost to Follow-up|4|||
143249467|NCT00531427|516466952|FG001|Overall Study|Lost to Follow-up|3|||
143249468|NCT00531427|516466951|FG000|Overall Study|Lack of Efficacy|14|||
143249469|NCT00531427|516466952|FG001|Overall Study|Lack of Efficacy|39|||
143249470|NCT00531427|516466951|FG000|Overall Study|Administrative|4|||
143249471|NCT00531427|516466952|FG001|Overall Study|Administrative|9|||
143249472|NCT01338298|516466953|FG000|Overall Study|Withdrawal by Subject|1|||
143249473|NCT01338298|516466954|FG001|Overall Study|Withdrawal by Subject|1|||
143249474|NCT01338298|516466953|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
143249475|NCT01338298|516466954|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
143249476|NCT01338298|516466953|FG000|Overall Study|Administrative error|0|||
143174488|NCT00518180|516187154|FG000|Overall Study|Administrative reason|0|||
143249477|NCT01338298|516466954|FG001|Overall Study|Administrative error|1|||
143249478|NCT01338298|516466953|FG000|Overall Study|Positive symptom worsening|1|||
143084708|NCT00445432|515848298|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
143084709|NCT00445432|515848299|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
143084710|NCT00445432|515848300|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
143249479|NCT01338298|516466954|FG001|Overall Study|Positive symptom worsening|0|||
143084711|NCT00445432|515848297|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
143084712|NCT00445432|515848298|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
143084713|NCT00445432|515848299|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
143084714|NCT00445432|515848300|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
143084715|NCT00445432|515848297|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
143084716|NCT00445432|515848298|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
143084717|NCT00445432|515848299|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
143084718|NCT00445432|515848300|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
143084719|NCT00445432|515848297|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
143084720|NCT00445432|515848298|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
143084721|NCT00445432|515848299|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
143084722|NCT00445432|515848300|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
143084723|NCT00445432|515848297|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
143084724|NCT00445432|515848298|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
143084725|NCT00445432|515848299|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
143084726|NCT00445432|515848300|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
143084727|NCT00445432|515848297|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
143084728|NCT00445432|515848298|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
143084729|NCT00445432|515848299|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
143084730|NCT00445432|515848300|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
143084731|NCT02789137|515848301|FG000|Overall Study|Dropped out/Died|58|||
143084732|NCT01937871|515848302|FG000|Overall Study|Adverse Event|6|||
143084733|NCT01937871|515848303|FG001|Overall Study|Adverse Event|6|||
143084734|NCT01937871|515848304|FG002|Overall Study|Adverse Event|2|||
143084735|NCT01937871|515848302|FG000|Overall Study|Lost to Follow-up|8|||
143084736|NCT01937871|515848303|FG001|Overall Study|Lost to Follow-up|2|||
143084737|NCT01937871|515848304|FG002|Overall Study|Lost to Follow-up|4|||
143084738|NCT01937871|515848302|FG000|Overall Study|Withdrawal by Subject|9|||
143084739|NCT01937871|515848303|FG001|Overall Study|Withdrawal by Subject|6|||
143084740|NCT01937871|515848304|FG002|Overall Study|Withdrawal by Subject|4|||
143084741|NCT01937871|515848302|FG000|Overall Study|Physician Decision|0|||
143084742|NCT01937871|515848303|FG001|Overall Study|Physician Decision|1|||
143084743|NCT01937871|515848304|FG002|Overall Study|Physician Decision|0|||
143084744|NCT01937871|515848302|FG000|Overall Study|Entry Criteria Not Met|1|||
143084745|NCT01937871|515848303|FG001|Overall Study|Entry Criteria Not Met|2|||
143084746|NCT01937871|515848304|FG002|Overall Study|Entry Criteria Not Met|1|||
143084747|NCT01090414|515848305|FG000|Study 101-99|Progressive Disease|28|||
143084748|NCT01090414|515848306|FG001|Study 101-99|Progressive Disease|48|||
143084749|NCT01090414|515848307|FG002|Study 101-99|Progressive Disease|10|||
143084750|NCT01090414|515848308|FG003|Study 101-99|Progressive Disease|4|||
143084751|NCT01090414|515848305|FG000|Study 101-99|Adverse Event|10|||
143084752|NCT01090414|515848306|FG001|Study 101-99|Adverse Event|28|||
143084753|NCT01090414|515848307|FG002|Study 101-99|Adverse Event|18|||
143084754|NCT01090414|515848308|FG003|Study 101-99|Adverse Event|0|||
143084755|NCT01090414|515848305|FG000|Study 101-99|Investigator Request|1|||
143084756|NCT01090414|515848306|FG001|Study 101-99|Investigator Request|11|||
143084757|NCT01090414|515848307|FG002|Study 101-99|Investigator Request|4|||
143084758|NCT01090414|515848308|FG003|Study 101-99|Investigator Request|0|||
143174489|NCT00518180|516187155|FG001|Overall Study|Administrative reason|2|||
143084759|NCT01090414|515848305|FG000|Study 101-99|Death|3|||
143084760|NCT01090414|515848306|FG001|Study 101-99|Death|8|||
143084761|NCT01090414|515848307|FG002|Study 101-99|Death|1|||
143084762|NCT01090414|515848308|FG003|Study 101-99|Death|0|||
143084763|NCT01090414|515848305|FG000|Study 101-99|Sponsor Discontinued Study|0|||
143084764|NCT01090414|515848306|FG001|Study 101-99|Sponsor Discontinued Study|7|||
143084765|NCT01090414|515848307|FG002|Study 101-99|Sponsor Discontinued Study|5|||
143084766|NCT01090414|515848308|FG003|Study 101-99|Sponsor Discontinued Study|0|||
143084767|NCT01090414|515848305|FG000|Study 101-99|Other (Unknown Reasons)|3|||
143084768|NCT01090414|515848306|FG001|Study 101-99|Other (Unknown Reasons)|3|||
143084769|NCT01090414|515848307|FG002|Study 101-99|Other (Unknown Reasons)|0|||
143084770|NCT01090414|515848308|FG003|Study 101-99|Other (Unknown Reasons)|0|||
143084771|NCT01090414|515848305|FG000|Study 101-99|Withdrew Consent|0|||
143084772|NCT01090414|515848306|FG001|Study 101-99|Withdrew Consent|2|||
143084773|NCT01090414|515848307|FG002|Study 101-99|Withdrew Consent|3|||
143084774|NCT01090414|515848308|FG003|Study 101-99|Withdrew Consent|1|||
143084775|NCT01090414|515848305|FG000|Study 101-99|Participant Request|3|||
143174490|NCT00518180|516187156|FG002|Overall Study|Administrative reason|2|||
143174491|NCT00518180|516187154|FG000|Overall Study|Protocol Violation|5|||
143174492|NCT00518180|516187155|FG001|Overall Study|Protocol Violation|7|||
143174493|NCT00518180|516187156|FG002|Overall Study|Protocol Violation|4|||
143174494|NCT00518180|516187154|FG000|Overall Study|Unable to classify|0|||
143174495|NCT00518180|516187155|FG001|Overall Study|Unable to classify|2|||
143174496|NCT00518180|516187156|FG002|Overall Study|Unable to classify|0|||
143174497|NCT00518180|516187154|FG000|Overall Study|Adverse Event|1|||
143084776|NCT01090414|515848306|FG001|Study 101-99|Participant Request|1|||
143174498|NCT00518180|516187155|FG001|Overall Study|Adverse Event|0|||
143084777|NCT01090414|515848307|FG002|Study 101-99|Participant Request|0|||
143084778|NCT01090414|515848308|FG003|Study 101-99|Participant Request|0|||
143084779|NCT05219448|515848309|FG000|Overall Study|Lost to Follow-up|9|||
143084780|NCT05219448|515848310|FG001|Overall Study|Lost to Follow-up|0|||
143084781|NCT00911300|515848312|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
143084782|NCT00911300|515848313|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
143084783|NCT00911300|515848312|FG000|Overall Study|Death|1|||
143084784|NCT00911300|515848313|FG001|Overall Study|Death|0|||
143084785|NCT00911300|515848312|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
143084786|NCT00911300|515848313|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
143084787|NCT00911300|515848312|FG000|Overall Study|Adverse Event|14|||
143084788|NCT00911300|515848313|FG001|Overall Study|Adverse Event|6|||
143084789|NCT00911300|515848312|FG000|Overall Study|Protocol Violation|3|||
143084790|NCT00911300|515848313|FG001|Overall Study|Protocol Violation|2|||
143084791|NCT00911300|515848312|FG000|Overall Study|Consent Withdrawn|4|||
143084792|NCT00911300|515848313|FG001|Overall Study|Consent Withdrawn|12|||
143084793|NCT00911300|515848312|FG000|Overall Study|Coronary Angiography Performed|1|||
143084794|NCT00911300|515848313|FG001|Overall Study|Coronary Angiography Performed|0|||
143084795|NCT00911300|515848312|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
143084796|NCT00911300|515848313|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
143084797|NCT00911300|515848312|FG000|Overall Study|Received Commercial Treatment|1|||
143084798|NCT00911300|515848313|FG001|Overall Study|Received Commercial Treatment|0|||
143084799|NCT00911300|515848312|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
143084800|NCT00911300|515848313|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
143084801|NCT00911300|515848312|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
143084802|NCT00911300|515848313|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
143174499|NCT00518180|516187156|FG002|Overall Study|Adverse Event|0|||
143174500|NCT02951780|516187157|FG000|Period 1|Adverse Event|0|||
143174501|NCT02951780|516187158|FG001|Period 1|Adverse Event|0|||
143174502|NCT02951780|516187159|FG002|Period 1|Adverse Event|0|||
143174503|NCT02951780|516187160|FG003|Period 1|Adverse Event|1|||
143174504|NCT02951780|516187161|FG004|Period 1|Adverse Event|0|||
143174505|NCT02951780|516187162|FG005|Period 1|Adverse Event|0|||
143174506|NCT02951780|516187163|FG006|Period 1|Adverse Event|0|||
143174507|NCT02951780|516187164|FG007|Period 1|Adverse Event|0|||
143174508|NCT02951780|516187165|FG008|Period 1|Adverse Event|0|||
143174509|NCT02951780|516187157|FG000|Period 1|Scheduling Conflicts|0|||
143174510|NCT02951780|516187158|FG001|Period 1|Scheduling Conflicts|0|||
143174511|NCT02951780|516187159|FG002|Period 1|Scheduling Conflicts|0|||
143174512|NCT02951780|516187160|FG003|Period 1|Scheduling Conflicts|0|||
143174513|NCT02951780|516187161|FG004|Period 1|Scheduling Conflicts|0|||
143174514|NCT02951780|516187162|FG005|Period 1|Scheduling Conflicts|0|||
143174515|NCT02951780|516187163|FG006|Period 1|Scheduling Conflicts|0|||
143174516|NCT02951780|516187164|FG007|Period 1|Scheduling Conflicts|1|||
143174517|NCT02951780|516187165|FG008|Period 1|Scheduling Conflicts|0|||
143174518|NCT02951780|516187157|FG000|Period 2|Scheduling Conflicts|0|||
143174519|NCT02951780|516187158|FG001|Period 2|Scheduling Conflicts|0|||
143174520|NCT02951780|516187159|FG002|Period 2|Scheduling Conflicts|0|||
143174521|NCT02951780|516187160|FG003|Period 2|Scheduling Conflicts|0|||
143174522|NCT02951780|516187161|FG004|Period 2|Scheduling Conflicts|0|||
143174523|NCT02951780|516187162|FG005|Period 2|Scheduling Conflicts|0|||
143084803|NCT00911300|515848312|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
143084804|NCT00911300|515848313|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
143084805|NCT00911300|515848312|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
143084806|NCT00911300|515848313|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
143174524|NCT02951780|516187163|FG006|Period 2|Scheduling Conflicts|0|||
143084807|NCT00911300|515848312|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
143174525|NCT02951780|516187164|FG007|Period 2|Scheduling Conflicts|1|||
143174526|NCT02951780|516187165|FG008|Period 2|Scheduling Conflicts|0|||
143174527|NCT02289469|516187168|FG000|Overall Study|Unable to match a control|6|||
143174528|NCT02289469|516187169|FG001|Overall Study|Unable to match a control|0|||
143084808|NCT00911300|515848313|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
143084809|NCT00911300|515848312|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
143084810|NCT00911300|515848313|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
143084811|NCT00911300|515848312|FG000|Overall Study|International Normalized Ratio Too High|0|||
143084812|NCT00911300|515848313|FG001|Overall Study|International Normalized Ratio Too High|1|||
143084813|NCT00911300|515848312|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
143084814|NCT00911300|515848313|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
143084815|NCT00911300|515848312|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
143084816|NCT00911300|515848313|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
143084817|NCT00911300|515848312|FG000|Overall Study|Physician Decision|0|||
143084818|NCT00911300|515848313|FG001|Overall Study|Physician Decision|1|||
143084819|NCT00911300|515848312|FG000|Overall Study|Treatment Stopped by Mistake|0|||
143084820|NCT00911300|515848313|FG001|Overall Study|Treatment Stopped by Mistake|1|||
143084821|NCT00911300|515848312|FG000|Overall Study|Randomized; No Study Medication Received|0|||
143084822|NCT00911300|515848313|FG001|Overall Study|Randomized; No Study Medication Received|2|||
143084823|NCT03022370|515848314|FG000|Overall Study|Death|6|||
143084824|NCT03022370|515848315|FG001|Overall Study|Death|12|||
143084825|NCT03022370|515848314|FG000|Overall Study|Lost to Follow-up|174|||
143084826|NCT03022370|515848315|FG001|Overall Study|Lost to Follow-up|109|||
143084827|NCT00668317|515848316|FG000|Overall Study|Adverse Event|2|||
143084828|NCT00699816|515848319|FG000|Overall Study|Protocol Violation|1|||
143084829|NCT00699816|515848320|FG001|Overall Study|Protocol Violation|3|||
143084830|NCT03668808|515848322|FG000|First Intervention|Withdrawal by Subject|2|||
143084831|NCT03668808|515848323|FG001|First Intervention|Withdrawal by Subject|2|||
143084832|NCT01526655|515848324|FG000|Overall Study|Withdrawal by Subject|0|||
143084833|NCT01526655|515848325|FG001|Overall Study|Withdrawal by Subject|1|||
143084834|NCT00280735|515848326|FG000|Overall Study|Adverse Event|5|||
143084835|NCT00280735|515848326|FG000|Overall Study|Lack of Efficacy|3|||
143084836|NCT00280735|515848326|FG000|Overall Study|Withdrawal by Subject|8|||
143084837|NCT00280735|515848326|FG000|Overall Study|Intercurrent Illness|2|||
143084838|NCT02001987|515848328|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
143084839|NCT02001987|515848328|FG000|Core Study Period (24 Weeks)|Death|1|||
143084840|NCT02001987|515848328|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
143084841|NCT02001987|515848328|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
143084842|NCT02001987|515848328|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
143366632|NCT00991276|516887133|FG002|First Intervention Period|Withdrawal by Subject|0|||
143366633|NCT00991276|516887134|FG003|First Intervention Period|Withdrawal by Subject|1|||
143366634|NCT00991276|516887135|FG004|First Intervention Period|Withdrawal by Subject|0|||
143366635|NCT00991276|516887136|FG005|First Intervention Period|Withdrawal by Subject|1|||
143084843|NCT02001987|515848328|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
143084844|NCT02001987|515848328|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
143084845|NCT02001987|515848328|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
143084846|NCT02001987|515848328|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
143084847|NCT02001987|515848328|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
143084848|NCT02001987|515848328|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
143084849|NCT02001987|515848328|FG000|LTE Period (52 Weeks)|Other|3|||
143084850|NCT03607487|515848341|FG000|Overall Study|Withdrawal by Subject|2|||
143084851|NCT03607487|515848342|FG001|Overall Study|Withdrawal by Subject|0|||
143084852|NCT03607487|515848343|FG002|Overall Study|Withdrawal by Subject|0|||
143084853|NCT03607487|515848344|FG003|Overall Study|Withdrawal by Subject|1|||
143084854|NCT01884337|515848345|FG000|Treatment|Adverse Event|2|||
143084855|NCT01884337|515848346|FG001|Treatment|Adverse Event|2|||
143084856|NCT01884337|515848345|FG000|Treatment|Subj. request to discont. treatment|2|||
143084857|NCT01884337|515848346|FG001|Treatment|Subj. request to discont. treatment|0|||
143084858|NCT01884337|515848345|FG000|Follow-up Period|Lost to Follow-up|1|||
143084859|NCT01884337|515848346|FG001|Follow-up Period|Lost to Follow-up|1|||
143084860|NCT04759703|515848352|FG000|Overall Study|Withdrawal by Subject|4|||
143084861|NCT04759703|515848353|FG001|Overall Study|Withdrawal by Subject|9|||
143084862|NCT04759703|515848352|FG000|Overall Study|Adverse Event|1|||
143084863|NCT04759703|515848353|FG001|Overall Study|Adverse Event|0|||
143084864|NCT04759703|515848352|FG000|Overall Study|Lost to Follow-up|2|||
143084865|NCT04759703|515848353|FG001|Overall Study|Lost to Follow-up|0|||
143084866|NCT04186845|515848361|FG000|Overall Study|Death|2|||
143084867|NCT04186845|515848361|FG000|Overall Study|Lost to Follow-up|1|||
143084868|NCT04186845|515848361|FG000|Overall Study|Physician Decision|1|||
143084869|NCT04186845|515848361|FG000|Overall Study|Protocol Violation|1|||
143084870|NCT04186845|515848361|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
143084871|NCT04186845|515848361|FG000|Overall Study|Biopsy ordered but not done|1|||
143084872|NCT04186845|515848361|FG000|Overall Study|It was previously confirmed|1|||
143084873|NCT04186845|515848361|FG000|Overall Study|Patient cancelled scheduled scans|2|||
143084874|NCT04186845|515848361|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
143084875|NCT04186845|515848361|FG000|Overall Study|Subject refused confirmatory imaging|1|||
143366636|NCT00991276|516887131|FG000|First Intervention Period|Lost to Follow-up|0|||
143084876|NCT04186845|515848361|FG000|Overall Study|Too small to biopsy|1|||
143084877|NCT05061420|515848362|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
143084878|NCT05061420|515848363|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
143084879|NCT05061420|515848364|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
143084880|NCT05061420|515848362|FG000|Overall Study|Progressive disease|11|||
143084881|NCT05061420|515848363|FG001|Overall Study|Progressive disease|15|||
143084882|NCT05061420|515848364|FG002|Overall Study|Progressive disease|14|||
143084883|NCT05061420|515848362|FG000|Overall Study|Withdrawal by Subject|2|||
143249480|NCT01338298|516466953|FG000|Overall Study|Depressive symptoms and nausea|1|||
143249481|NCT01338298|516466954|FG001|Overall Study|Depressive symptoms and nausea|0|||
143249482|NCT01338298|516466953|FG000|Overall Study|Non-adherence|1|||
143249483|NCT01338298|516466954|FG001|Overall Study|Non-adherence|0|||
143249484|NCT02872285|516466955|FG000|Overall Study|Withdrawal by Subject|2|||
143249485|NCT02872285|516466956|FG001|Overall Study|Withdrawal by Subject|0|||
143249486|NCT02872285|516466955|FG000|Overall Study|Lost to Follow-up|2|||
143249487|NCT02872285|516466956|FG001|Overall Study|Lost to Follow-up|2|||
143249488|NCT02872285|516466955|FG000|Overall Study|Discontinued due to back surgery|1|||
143249489|NCT02872285|516466956|FG001|Overall Study|Discontinued due to back surgery|0|||
143249490|NCT02660983|516466958|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
143249491|NCT02660983|516466959|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
143249492|NCT02660983|516466958|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
143249493|NCT02660983|516466959|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
143249494|NCT02660983|516466958|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
143249495|NCT02660983|516466959|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
143249496|NCT02660983|516466958|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
143249497|NCT02660983|516466959|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
143249498|NCT02660983|516466958|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
143249499|NCT02660983|516466959|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
143249500|NCT02660983|516466958|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
143249501|NCT02660983|516466959|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
143249502|NCT02660983|516466958|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
143249503|NCT02660983|516466959|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
143249504|NCT00721968|516466962|FG000|Overall Study|Lost to Follow-up|2|||
143249505|NCT00721968|516466963|FG001|Overall Study|Lost to Follow-up|0|||
143249506|NCT05601544|516466964|FG000|Phase 2 Period 1|Adverse Event|0|||
143249507|NCT05601544|516466965|FG001|Phase 2 Period 1|Adverse Event|1|||
143249508|NCT05601544|516466966|FG002|Phase 2 Period 1|Adverse Event|0|||
143249509|NCT05601544|516466967|FG003|Phase 2 Period 1|Adverse Event|0|||
143249510|NCT05601544|516466968|FG004|Phase 2 Period 1|Adverse Event|0|||
143249511|NCT05601544|516466969|FG005|Phase 2 Period 1|Adverse Event|0|||
143249512|NCT02970942|516466970|FG000|Overall Study|Death|0|||
143249513|NCT02970942|516466971|FG001|Overall Study|Death|1|||
143249514|NCT02970942|516466972|FG002|Overall Study|Death|0|||
143366637|NCT00991276|516887132|FG001|First Intervention Period|Lost to Follow-up|1|||
143249515|NCT02970942|516466973|FG003|Overall Study|Death|0|||
143249516|NCT02970942|516466970|FG000|Overall Study|Lost to Follow-up|1|||
143366638|NCT00991276|516887133|FG002|First Intervention Period|Lost to Follow-up|0|||
143084884|NCT05061420|515848363|FG001|Overall Study|Withdrawal by Subject|0|||
143084885|NCT05061420|515848364|FG002|Overall Study|Withdrawal by Subject|1|||
143249517|NCT02970942|516466971|FG001|Overall Study|Lost to Follow-up|0|||
143249518|NCT02970942|516466972|FG002|Overall Study|Lost to Follow-up|2|||
143249519|NCT02970942|516466973|FG003|Overall Study|Lost to Follow-up|1|||
143249520|NCT02970942|516466970|FG000|Overall Study|Withdrawal by Subject|3|||
143366639|NCT00991276|516887134|FG003|First Intervention Period|Lost to Follow-up|1|||
143366640|NCT00991276|516887135|FG004|First Intervention Period|Lost to Follow-up|0|||
143366641|NCT00991276|516887136|FG005|First Intervention Period|Lost to Follow-up|0|||
143249521|NCT02970942|516466971|FG001|Overall Study|Withdrawal by Subject|5|||
143249522|NCT02970942|516466972|FG002|Overall Study|Withdrawal by Subject|3|||
143249523|NCT02970942|516466973|FG003|Overall Study|Withdrawal by Subject|2|||
143249524|NCT00727441|516468685|FG000|Overall Study|Disease Progression|11|||
143249525|NCT00727441|516468686|FG001|Overall Study|Disease Progression|14|||
143249526|NCT00727441|516468687|FG002|Overall Study|Disease Progression|17|||
143249527|NCT00727441|516468685|FG000|Overall Study|Eligibility|7|||
143249528|NCT00727441|516468686|FG001|Overall Study|Eligibility|5|||
143249529|NCT00727441|516468687|FG002|Overall Study|Eligibility|7|||
143249530|NCT00727441|516468685|FG000|Overall Study|Death|0|||
143249531|NCT00727441|516468686|FG001|Overall Study|Death|1|||
143249532|NCT00727441|516468687|FG002|Overall Study|Death|1|||
143249533|NCT00727441|516468685|FG000|Overall Study|Physician Decision|0|||
143249534|NCT00727441|516468686|FG001|Overall Study|Physician Decision|1|||
143249535|NCT00727441|516468687|FG002|Overall Study|Physician Decision|0|||
143249536|NCT00727441|516468685|FG000|Overall Study|Withdrawal by Subject|0|||
143249537|NCT00727441|516468686|FG001|Overall Study|Withdrawal by Subject|1|||
143249538|NCT00727441|516468687|FG002|Overall Study|Withdrawal by Subject|0|||
143249539|NCT00535288|516468688|FG000|Overall Study|Adverse Event|20|||
143249540|NCT00535288|516468689|FG001|Overall Study|Adverse Event|19|||
143249541|NCT00535288|516468690|FG002|Overall Study|Adverse Event|25|||
143249542|NCT00535288|516468691|FG003|Overall Study|Adverse Event|20|||
143249543|NCT00535288|516468692|FG004|Overall Study|Adverse Event|30|||
143084886|NCT05061420|515848362|FG000|Overall Study|Not related to COVID-19|2|||
143249544|NCT00535288|516468688|FG000|Overall Study|Lost to Follow-up|0|||
143249545|NCT00535288|516468689|FG001|Overall Study|Lost to Follow-up|3|||
143249546|NCT00535288|516468690|FG002|Overall Study|Lost to Follow-up|0|||
143366642|NCT00991276|516887131|FG000|Second Intervention Period|Adverse Event|0|||
143084887|NCT05061420|515848363|FG001|Overall Study|Not related to COVID-19|0|||
143249547|NCT00535288|516468691|FG003|Overall Study|Lost to Follow-up|0|||
143249548|NCT00535288|516468692|FG004|Overall Study|Lost to Follow-up|0|||
143249549|NCT00535288|516468688|FG000|Overall Study|Lack of Efficacy|26|||
143249550|NCT00535288|516468689|FG001|Overall Study|Lack of Efficacy|3|||
143366643|NCT00991276|516887132|FG001|Second Intervention Period|Adverse Event|2|||
143249551|NCT00535288|516468690|FG002|Overall Study|Lack of Efficacy|4|||
143249552|NCT00535288|516468691|FG003|Overall Study|Lack of Efficacy|4|||
143249553|NCT00535288|516468692|FG004|Overall Study|Lack of Efficacy|7|||
143249554|NCT00535288|516468688|FG000|Overall Study|Unwilling to cooperate|6|||
143366644|NCT00991276|516887133|FG002|Second Intervention Period|Adverse Event|0|||
143084888|NCT05061420|515848364|FG002|Overall Study|Not related to COVID-19|0|||
143249555|NCT00535288|516468689|FG001|Overall Study|Unwilling to cooperate|6|||
143249556|NCT00535288|516468690|FG002|Overall Study|Unwilling to cooperate|3|||
143084889|NCT01814553|515848365|FG000|Overall Study|PD per clinical progression|6|||
143084890|NCT01814553|515848366|FG001|Overall Study|PD per clinical progression|8|||
143084891|NCT01814553|515848365|FG000|Overall Study|Other Adverse Event|4|||
143084892|NCT01814553|515848366|FG001|Overall Study|Other Adverse Event|5|||
143084893|NCT01814553|515848365|FG000|Overall Study|Withdrawal by Subject|1|||
143084894|NCT01814553|515848366|FG001|Overall Study|Withdrawal by Subject|1|||
143084895|NCT01814553|515848365|FG000|Overall Study|Other than stated|7|||
143084896|NCT01814553|515848366|FG001|Overall Study|Other than stated|8|||
143084897|NCT04138823|515848370|FG000|Overall Study|Clinical disease progression|0|||
143084898|NCT04138823|515848371|FG001|Overall Study|Clinical disease progression|0|||
143084899|NCT04138823|515848372|FG002|Overall Study|Clinical disease progression|1|||
143084900|NCT04138823|515848370|FG000|Overall Study|Objective disease progression|3|||
143084901|NCT04138823|515848371|FG001|Overall Study|Objective disease progression|2|||
143084902|NCT04138823|515848372|FG002|Overall Study|Objective disease progression|5|||
143084903|NCT03138655|515848373|FG000|Overall Study|Adverse Event|2|||
143084904|NCT03138655|515848374|FG001|Overall Study|Adverse Event|1|||
143084905|NCT03138655|515848375|FG002|Overall Study|Adverse Event|2|||
143084906|NCT03138655|515848376|FG003|Overall Study|Adverse Event|1|||
143084907|NCT03138655|515848377|FG004|Overall Study|Adverse Event|1|||
143084908|NCT03138655|515848378|FG005|Overall Study|Adverse Event|4|||
143084909|NCT03138655|515848379|FG006|Overall Study|Adverse Event|2|||
143084910|NCT03138655|515848380|FG007|Overall Study|Adverse Event|2|||
143084911|NCT03138655|515848373|FG000|Overall Study|Withdrawal by Subject|0|||
143084912|NCT03138655|515848374|FG001|Overall Study|Withdrawal by Subject|1|||
143084913|NCT03138655|515848375|FG002|Overall Study|Withdrawal by Subject|0|||
143084914|NCT03138655|515848376|FG003|Overall Study|Withdrawal by Subject|0|||
143084915|NCT03138655|515848377|FG004|Overall Study|Withdrawal by Subject|0|||
143084916|NCT03138655|515848378|FG005|Overall Study|Withdrawal by Subject|0|||
143084917|NCT03138655|515848379|FG006|Overall Study|Withdrawal by Subject|1|||
143084918|NCT03138655|515848380|FG007|Overall Study|Withdrawal by Subject|0|||
143084919|NCT03138655|515848373|FG000|Overall Study|Reason not Specified|1|||
143084920|NCT03138655|515848374|FG001|Overall Study|Reason not Specified|0|||
143084921|NCT03138655|515848375|FG002|Overall Study|Reason not Specified|0|||
143084922|NCT03138655|515848376|FG003|Overall Study|Reason not Specified|2|||
143084923|NCT03138655|515848377|FG004|Overall Study|Reason not Specified|1|||
143084924|NCT03138655|515848378|FG005|Overall Study|Reason not Specified|1|||
143084925|NCT03138655|515848379|FG006|Overall Study|Reason not Specified|0|||
143084926|NCT03138655|515848380|FG007|Overall Study|Reason not Specified|0|||
143084927|NCT02859142|515848381|FG000|Overall Study|Adverse Event|1|||
143084928|NCT02859142|515848382|FG001|Overall Study|Adverse Event|2|||
143084929|NCT02859142|515848381|FG000|Overall Study|Lost to Follow-up|1|||
143084930|NCT02859142|515848382|FG001|Overall Study|Lost to Follow-up|4|||
143084931|NCT02859142|515848381|FG000|Overall Study|Withdrawal by Subject|2|||
143084932|NCT02859142|515848382|FG001|Overall Study|Withdrawal by Subject|0|||
143084933|NCT02859142|515848381|FG000|Overall Study|Scheduling difficulties|0|||
143084934|NCT02859142|515848382|FG001|Overall Study|Scheduling difficulties|3|||
143084935|NCT03290079|515848383|FG000|Overall Study|Death|2|||
143084936|NCT02466685|515848384|FG000|Overall Study|Adverse Event|5|||
143084937|NCT02466685|515848385|FG001|Overall Study|Adverse Event|2|||
143249557|NCT00535288|516468691|FG003|Overall Study|Unwilling to cooperate|3|||
143249558|NCT00535288|516468692|FG004|Overall Study|Unwilling to cooperate|4|||
143249559|NCT00535288|516468688|FG000|Overall Study|Other|2|||
143249560|NCT00535288|516468689|FG001|Overall Study|Other|1|||
143249561|NCT00535288|516468690|FG002|Overall Study|Other|1|||
143249562|NCT00535288|516468691|FG003|Overall Study|Other|2|||
143249563|NCT00535288|516468692|FG004|Overall Study|Other|1|||
143249564|NCT01129583|516468693|FG000|Overall Study|Death|1|||
143249565|NCT01129583|516468694|FG001|Overall Study|Death|0|||
143249566|NCT01129583|516468693|FG000|Overall Study|Lost to Follow-up|1|||
143084938|NCT02466685|515848384|FG000|Overall Study|Lost to Follow-up|1|||
143084939|NCT02466685|515848385|FG001|Overall Study|Lost to Follow-up|1|||
143084940|NCT02466685|515848384|FG000|Overall Study|Withdrawal by Subject|1|||
143084941|NCT02466685|515848385|FG001|Overall Study|Withdrawal by Subject|0|||
143084942|NCT02466685|515848384|FG000|Overall Study|Physician Decision|1|||
143084943|NCT02466685|515848385|FG001|Overall Study|Physician Decision|1|||
143084944|NCT01277211|515848388|FG000|Overall Study|Adverse Event|60|||
143249567|NCT01129583|516468694|FG001|Overall Study|Lost to Follow-up|1|||
143249568|NCT01129583|516468693|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
143084945|NCT01277211|515848389|FG001|Overall Study|Adverse Event|22|||
143084946|NCT01277211|515848388|FG000|Overall Study|Pregnancy|9|||
143084947|NCT01277211|515848389|FG001|Overall Study|Pregnancy|4|||
143084948|NCT01277211|515848388|FG000|Overall Study|Lost to Follow-up|14|||
143084949|NCT01277211|515848389|FG001|Overall Study|Lost to Follow-up|9|||
143084950|NCT01277211|515848388|FG000|Overall Study|Did not wish to continue|17|||
143084951|NCT01277211|515848389|FG001|Overall Study|Did not wish to continue|0|||
143084952|NCT01277211|515848388|FG000|Overall Study|Withdrew Consent|9|||
143084953|NCT01277211|515848389|FG001|Overall Study|Withdrew Consent|9|||
143084954|NCT01277211|515848388|FG000|Overall Study|Non-compliance with protocol|13|||
143084955|NCT01277211|515848389|FG001|Overall Study|Non-compliance with protocol|4|||
143084956|NCT01277211|515848388|FG000|Overall Study|Did not meet protocol eligibility|1|||
143084957|NCT01277211|515848389|FG001|Overall Study|Did not meet protocol eligibility|0|||
143084958|NCT01277211|515848388|FG000|Overall Study|Administrative|3|||
143084959|NCT01277211|515848389|FG001|Overall Study|Administrative|0|||
143084960|NCT01277211|515848388|FG000|Overall Study|Pregnancy wish|0|||
143084961|NCT01277211|515848389|FG001|Overall Study|Pregnancy wish|2|||
143084962|NCT01277211|515848388|FG000|Overall Study|Discontinued prior to treatment|24|||
143084963|NCT01277211|515848389|FG001|Overall Study|Discontinued prior to treatment|13|||
143084964|NCT03452943|515848390|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
143084965|NCT03452943|515848391|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
143084966|NCT03452943|515848390|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
143084967|NCT03452943|515848391|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
143084968|NCT03452943|515848390|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
143084969|NCT03452943|515848391|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
143084970|NCT03452943|515848390|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
143084971|NCT03452943|515848391|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
143084972|NCT03452943|515848390|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
143249569|NCT01129583|516468694|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
143249570|NCT02848729|516468702|FG000|Overall Study|Withdrawal by Subject|1|||
143249571|NCT02848729|516468703|FG001|Overall Study|Withdrawal by Subject|0|||
143249572|NCT02848729|516468702|FG000|Overall Study|Emesis|15|||
143249573|NCT02848729|516468703|FG001|Overall Study|Emesis|11|||
143249574|NCT00791076|516468707|FG000|Overall Study|Study was terminated,PI left institution|8|||
143249575|NCT02248675|516468708|FG000|Overall Study|Lost to Follow-up|3|||
143249576|NCT02248675|516468709|FG001|Overall Study|Lost to Follow-up|1|||
143249577|NCT03390101|516468712|FG000|Weeks 0-12|Withdrawal by Subject|0|||
143249578|NCT03390101|516468713|FG001|Weeks 0-12|Withdrawal by Subject|1|||
143249579|NCT03390101|516468714|FG002|Weeks 0-12|Withdrawal by Subject|1|||
143249580|NCT03390101|516468712|FG000|Weeks 0-12|Lost to Follow-up|0|||
143249581|NCT03390101|516468713|FG001|Weeks 0-12|Lost to Follow-up|1|||
143249582|NCT03390101|516468714|FG002|Weeks 0-12|Lost to Follow-up|0|||
143249583|NCT03390101|516468712|FG000|Weeks 12-54|Withdrawal by Subject|0|||
143249584|NCT03390101|516468713|FG001|Weeks 12-54|Withdrawal by Subject|3|||
143249585|NCT03390101|516468714|FG002|Weeks 12-54|Withdrawal by Subject|1|||
143249586|NCT03390101|516468712|FG000|Weeks 12-54|Pregnancy|1|||
143249587|NCT03390101|516468713|FG001|Weeks 12-54|Pregnancy|0|||
143249588|NCT03390101|516468714|FG002|Weeks 12-54|Pregnancy|0|||
143249589|NCT03390101|516468712|FG000|Weeks 12-54|Adverse Event|2|||
143249590|NCT03390101|516468713|FG001|Weeks 12-54|Adverse Event|1|||
143249591|NCT03390101|516468714|FG002|Weeks 12-54|Adverse Event|1|||
143249592|NCT01511055|516468715|FG000|Overall Study|Withdrawal by Subject|6|||
143249593|NCT00830869|516468716|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
143249594|NCT00830869|516468717|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
143249595|NCT00830869|516468718|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
143249596|NCT00830869|516468719|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
143249597|NCT00830869|516468720|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
143249598|NCT00830869|516468721|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
143249599|NCT00830869|516468722|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
143366645|NCT00991276|516887134|FG003|Second Intervention Period|Adverse Event|1|||
143366646|NCT00991276|516887135|FG004|Second Intervention Period|Adverse Event|1|||
143366647|NCT00991276|516887136|FG005|Second Intervention Period|Adverse Event|0|||
143366648|NCT00991276|516887131|FG000|Second Intervention Period|Protocol Violation|1|||
143084973|NCT03452943|515848391|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
143084974|NCT03452943|515848390|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
143084975|NCT03452943|515848391|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
143249600|NCT00830869|516468723|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
143249601|NCT00830869|516468724|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
143249602|NCT00830869|516468725|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
143084976|NCT05180227|515848392|FG000|Overall Study|Hypertension at screening|1|||
143084977|NCT05180227|515848392|FG000|Overall Study|Lost to Follow-up|1|||
143249603|NCT00830869|516468726|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
143249604|NCT00830869|516468727|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
143249605|NCT00830869|516468716|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
143249606|NCT00830869|516468717|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
143249607|NCT00830869|516468718|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
143249608|NCT00830869|516468719|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
143249609|NCT00830869|516468720|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
143249610|NCT00830869|516468721|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
143249611|NCT00830869|516468722|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
143249612|NCT00830869|516468723|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
143249613|NCT00830869|516468724|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
143249614|NCT00830869|516468725|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
143249615|NCT00830869|516468726|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
143249616|NCT00830869|516468727|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
143249617|NCT00830869|516468716|FG000|Period 1: Part 1|Adverse Event|0|||
143249618|NCT00830869|516468717|FG001|Period 1: Part 1|Adverse Event|0|||
143249619|NCT00830869|516468718|FG002|Period 1: Part 1|Adverse Event|0|||
143249620|NCT00830869|516468719|FG003|Period 1: Part 1|Adverse Event|0|||
143249621|NCT00830869|516468720|FG004|Period 1: Part 1|Adverse Event|0|||
143249622|NCT00830869|516468721|FG005|Period 1: Part 1|Adverse Event|1|||
143249623|NCT00830869|516468722|FG006|Period 1: Part 1|Adverse Event|1|||
143084978|NCT03548337|515848393|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
143084979|NCT03548337|515848394|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
143084980|NCT03548337|515848393|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
143084981|NCT03548337|515848394|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
143084982|NCT03548337|515848393|FG000|Infant Series|Lost to Follow-up|2|||
143084983|NCT03548337|515848394|FG001|Infant Series|Lost to Follow-up|1|||
143084984|NCT03548337|515848393|FG000|Infant Series|Adverse Event|0|||
143084985|NCT03548337|515848394|FG001|Infant Series|Adverse Event|2|||
143084986|NCT03548337|515848393|FG000|Infant Series|Randomized but Not Vaccinated|1|||
143084987|NCT03548337|515848394|FG001|Infant Series|Randomized but Not Vaccinated|0|||
143084988|NCT03548337|515848393|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
143084989|NCT03548337|515848394|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
143084990|NCT02359994|515848396|FG000|Overall Population Study|Adverse Event|1|||
143084991|NCT02359994|515848397|FG001|Overall Population Study|Adverse Event|1|||
143084992|NCT02359994|515848396|FG000|Overall Population Study|Death|1|||
143084993|NCT02359994|515848397|FG001|Overall Population Study|Death|5|||
143084994|NCT02359994|515848396|FG000|Overall Population Study|Lost to Follow-up|1|||
143084995|NCT02359994|515848397|FG001|Overall Population Study|Lost to Follow-up|1|||
143084996|NCT02359994|515848396|FG000|Overall Population Study|Withdrawal by Subject|1|||
143084997|NCT02359994|515848397|FG001|Overall Population Study|Withdrawal by Subject|0|||
143084998|NCT02359994|515848396|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
143084999|NCT02359994|515848397|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
143085000|NCT02359994|515848396|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
143085001|NCT02359994|515848397|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
143085002|NCT02359994|515848396|FG000|Extended Oncology 24-Month Survival|Death|19|||
143085003|NCT02359994|515848397|FG001|Extended Oncology 24-Month Survival|Death|21|||
143085004|NCT02359994|515848396|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
143085005|NCT02359994|515848397|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
143085006|NCT01893346|515848402|FG000|Overall Study|Lost to Follow-up|0|||
143085007|NCT01893346|515848403|FG001|Overall Study|Lost to Follow-up|1|||
143085008|NCT01893346|515848404|FG002|Overall Study|Lost to Follow-up|0|||
143085009|NCT01893346|515848405|FG003|Overall Study|Lost to Follow-up|0|||
143085010|NCT01893346|515848402|FG000|Overall Study|Protocol Violation|1|||
143085011|NCT01893346|515848403|FG001|Overall Study|Protocol Violation|0|||
143085012|NCT01893346|515848404|FG002|Overall Study|Protocol Violation|0|||
143085013|NCT01893346|515848405|FG003|Overall Study|Protocol Violation|0|||
143085014|NCT01893346|515848402|FG000|Overall Study|Withdrawal by Subject|2|||
143249624|NCT00830869|516468723|FG007|Period 1: Part 1|Adverse Event|0|||
143249625|NCT00830869|516468724|FG008|Period 1: Part 1|Adverse Event|0|||
143249626|NCT00830869|516468725|FG009|Period 1: Part 1|Adverse Event|0|||
143249627|NCT00830869|516468726|FG010|Period 1: Part 1|Adverse Event|0|||
143249628|NCT00830869|516468727|FG011|Period 1: Part 1|Adverse Event|0|||
143249629|NCT00830869|516468716|FG000|Period 1: Part 1|Progressive disease|1|||
143249630|NCT00830869|516468717|FG001|Period 1: Part 1|Progressive disease|0|||
143249631|NCT00830869|516468718|FG002|Period 1: Part 1|Progressive disease|1|||
143249632|NCT00830869|516468719|FG003|Period 1: Part 1|Progressive disease|6|||
143249633|NCT00830869|516468720|FG004|Period 1: Part 1|Progressive disease|4|||
143249634|NCT00830869|516468721|FG005|Period 1: Part 1|Progressive disease|4|||
143249635|NCT00830869|516468722|FG006|Period 1: Part 1|Progressive disease|1|||
143085015|NCT01893346|515848403|FG001|Overall Study|Withdrawal by Subject|0|||
143085016|NCT01893346|515848404|FG002|Overall Study|Withdrawal by Subject|0|||
143249636|NCT00830869|516468723|FG007|Period 1: Part 1|Progressive disease|0|||
143085017|NCT01893346|515848405|FG003|Overall Study|Withdrawal by Subject|0|||
143085018|NCT01632280|515848408|FG000|Overall Study|Withdrawal by Subject|1|||
143085019|NCT01632280|515848409|FG001|Overall Study|Withdrawal by Subject|0|||
143085020|NCT01954745|515848410|FG000|Overall Study|Radiological Progression|11|||
143085021|NCT01954745|515848410|FG000|Overall Study|Clinical Progression|5|||
143085022|NCT01954745|515848410|FG000|Overall Study|Adverse Event|2|||
143085023|NCT01954745|515848410|FG000|Overall Study|Death|1|||
143085024|NCT01708941|515850205|FG000|Overall Study|Adverse Event|4|||
143085025|NCT01708941|515850206|FG001|Overall Study|Adverse Event|6|||
143085026|NCT01708941|515850207|FG002|Overall Study|Adverse Event|1|||
143085027|NCT01708941|515850208|FG003|Overall Study|Adverse Event|0|||
143085028|NCT01708941|515850205|FG000|Overall Study|Death|1|||
143085029|NCT01708941|515850206|FG001|Overall Study|Death|1|||
143085030|NCT01708941|515850207|FG002|Overall Study|Death|2|||
143085031|NCT01708941|515850208|FG003|Overall Study|Death|14|||
143085032|NCT01708941|515850205|FG000|Overall Study|Withdrawal by Subject|1|||
143085033|NCT01708941|515850206|FG001|Overall Study|Withdrawal by Subject|0|||
143085034|NCT01708941|515850207|FG002|Overall Study|Withdrawal by Subject|3|||
143085035|NCT01708941|515850208|FG003|Overall Study|Withdrawal by Subject|4|||
143085036|NCT01708941|515850205|FG000|Overall Study|Disease progression|9|||
143085037|NCT01708941|515850206|FG001|Overall Study|Disease progression|10|||
143085038|NCT01708941|515850207|FG002|Overall Study|Disease progression|8|||
143085039|NCT01708941|515850208|FG003|Overall Study|Disease progression|0|||
143085040|NCT01708941|515850205|FG000|Overall Study|Alternative therapy|0|||
143085041|NCT01708941|515850206|FG001|Overall Study|Alternative therapy|0|||
143085042|NCT01708941|515850207|FG002|Overall Study|Alternative therapy|2|||
143085043|NCT01708941|515850208|FG003|Overall Study|Alternative therapy|0|||
143085044|NCT01708941|515850205|FG000|Overall Study|Ineligible and never started treatment|1|||
143085045|NCT01708941|515850206|FG001|Overall Study|Ineligible and never started treatment|0|||
143085046|NCT01708941|515850207|FG002|Overall Study|Ineligible and never started treatment|1|||
143085047|NCT01708941|515850208|FG003|Overall Study|Ineligible and never started treatment|0|||
143085048|NCT01708941|515850205|FG000|Overall Study|Never started treatment|2|||
143085049|NCT01708941|515850206|FG001|Overall Study|Never started treatment|1|||
143085050|NCT01708941|515850207|FG002|Overall Study|Never started treatment|0|||
143085051|NCT01708941|515850208|FG003|Overall Study|Never started treatment|0|||
143085052|NCT01708941|515850205|FG000|Overall Study|Ineligible|0|||
143085053|NCT01708941|515850206|FG001|Overall Study|Ineligible|0|||
143085054|NCT01708941|515850207|FG002|Overall Study|Ineligible|2|||
143085055|NCT01708941|515850208|FG003|Overall Study|Ineligible|0|||
143085056|NCT02731638|515850209|FG000|Overall Study|Lost to Follow-up|6|||
143085057|NCT02731638|515850210|FG001|Overall Study|Lost to Follow-up|9|||
143085058|NCT05626231|515850211|FG000|Provider Enrollment|Worked part-time|4|||
143085059|NCT05626231|515850211|FG000|Provider Enrollment|On leave (e.g., parental leave)|3|||
143085060|NCT05626231|515850211|FG000|Provider Enrollment|Non-clinical employee|1|||
143085061|NCT05626231|515850211|FG000|Provider Enrollment|Provider does not see clients|3|||
143085062|NCT05626231|515850211|FG000|Provider Enrollment|Other|5|||
143085063|NCT02454608|515850212|FG000|Double-Blind Period|Lack of Efficacy|0|||
143085064|NCT02454608|515850213|FG001|Double-Blind Period|Lack of Efficacy|2|||
143085065|NCT02454608|515850214|FG002|Double-Blind Period|Lack of Efficacy|0|||
143085066|NCT02454608|515850212|FG000|Open Label Period|Lost to Follow-up|0|||
143085067|NCT02454608|515850213|FG001|Open Label Period|Lost to Follow-up|0|||
143085068|NCT02454608|515850214|FG002|Open Label Period|Lost to Follow-up|11|||
143085069|NCT02454608|515850212|FG000|Open Label Period|Withdrawal by Subject|0|||
143085070|NCT02454608|515850213|FG001|Open Label Period|Withdrawal by Subject|0|||
143085071|NCT02454608|515850214|FG002|Open Label Period|Withdrawal by Subject|8|||
143085072|NCT02717455|515850215|FG000|Overall Study|Adverse Event|1|||
143085073|NCT02717455|515850216|FG001|Overall Study|Adverse Event|0|||
143085074|NCT02717455|515850217|FG002|Overall Study|Adverse Event|0|||
143085075|NCT02717455|515850218|FG003|Overall Study|Adverse Event|2|||
143085076|NCT02717455|515850219|FG004|Overall Study|Adverse Event|2|||
143085077|NCT02717455|515850220|FG005|Overall Study|Adverse Event|2|||
143085078|NCT02717455|515850215|FG000|Overall Study|Withdrawal by Subject|1|||
143085079|NCT02717455|515850216|FG001|Overall Study|Withdrawal by Subject|1|||
143085080|NCT02717455|515850217|FG002|Overall Study|Withdrawal by Subject|0|||
143085081|NCT02717455|515850218|FG003|Overall Study|Withdrawal by Subject|2|||
143085082|NCT02717455|515850219|FG004|Overall Study|Withdrawal by Subject|2|||
143085083|NCT02717455|515850220|FG005|Overall Study|Withdrawal by Subject|1|||
143085084|NCT02717455|515850215|FG000|Overall Study|Death|1|||
143085085|NCT02717455|515850216|FG001|Overall Study|Death|0|||
143085086|NCT02717455|515850217|FG002|Overall Study|Death|0|||
143085087|NCT02717455|515850218|FG003|Overall Study|Death|0|||
143085088|NCT02717455|515850219|FG004|Overall Study|Death|1|||
143085089|NCT02717455|515850220|FG005|Overall Study|Death|0|||
143085090|NCT02717455|515850215|FG000|Overall Study|Did not receive study drug|0|||
143085091|NCT02717455|515850216|FG001|Overall Study|Did not receive study drug|0|||
143085092|NCT02717455|515850217|FG002|Overall Study|Did not receive study drug|0|||
143085093|NCT02717455|515850218|FG003|Overall Study|Did not receive study drug|1|||
143085094|NCT02717455|515850219|FG004|Overall Study|Did not receive study drug|0|||
143085095|NCT02717455|515850220|FG005|Overall Study|Did not receive study drug|1|||
143085096|NCT02717455|515850215|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
143085097|NCT02717455|515850216|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
143085098|NCT02717455|515850217|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
143085099|NCT02717455|515850218|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
143085100|NCT02717455|515850219|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
143085101|NCT02717455|515850220|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
143085102|NCT02717455|515850215|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
143085103|NCT02717455|515850216|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
143085104|NCT02717455|515850217|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
143085105|NCT02717455|515850218|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
143085106|NCT02717455|515850219|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
143085107|NCT02717455|515850220|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
143085108|NCT00064987|515850222|FG000|Overall Study|Physician Decision|3|||
143085109|NCT00064987|515850223|FG001|Overall Study|Physician Decision|0|||
143085110|NCT02969382|515850224|FG000|Overall Study|Adverse Event|8|||
143085111|NCT02969382|515850225|FG001|Overall Study|Adverse Event|10|||
143085112|NCT02969382|515850224|FG000|Overall Study|Lack of Efficacy|4|||
143085113|NCT02969382|515850225|FG001|Overall Study|Lack of Efficacy|5|||
143085114|NCT02969382|515850224|FG000|Overall Study|Death|0|||
143085115|NCT02969382|515850225|FG001|Overall Study|Death|1|||
143085116|NCT02969382|515850224|FG000|Overall Study|PROTOCOL DEVIATION|0|||
143085117|NCT02969382|515850225|FG001|Overall Study|PROTOCOL DEVIATION|1|||
143085118|NCT02969382|515850224|FG000|Overall Study|Withdrawal by Subject|14|||
143085119|NCT02969382|515850225|FG001|Overall Study|Withdrawal by Subject|9|||
143085120|NCT00764881|515850226|FG000|Overall Study|Adverse Event|5|||
143366649|NCT00991276|516887132|FG001|Second Intervention Period|Protocol Violation|0|||
143366650|NCT00991276|516887133|FG002|Second Intervention Period|Protocol Violation|0|||
143366651|NCT00991276|516887134|FG003|Second Intervention Period|Protocol Violation|0|||
143366652|NCT00991276|516887135|FG004|Second Intervention Period|Protocol Violation|0|||
143174529|NCT03508050|516187170|FG000|Overall Study|Pleural adhesions|1|||
143174530|NCT03508050|516187171|FG001|Overall Study|Pleural adhesions|0|||
143174531|NCT03508050|516187170|FG000|Overall Study|Mucus plug|1|||
143174532|NCT03508050|516187171|FG001|Overall Study|Mucus plug|0|||
143174533|NCT03508050|516187170|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
143174534|NCT03508050|516187171|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
143174535|NCT03508050|516187170|FG000|Overall Study|Sustained desaturation|0|||
143174536|NCT03508050|516187171|FG001|Overall Study|Sustained desaturation|1|||
143174537|NCT01082614|516187172|FG000|Overall Study|Adverse Event|1|||
143174538|NCT01082614|516187173|FG001|Overall Study|Adverse Event|4|||
143174539|NCT01082614|516187172|FG000|Overall Study|Equipment Malfunction|0|||
143174540|NCT01082614|516187173|FG001|Overall Study|Equipment Malfunction|1|||
143174541|NCT01082614|516187172|FG000|Overall Study|Physician Decision|2|||
143174542|NCT01082614|516187173|FG001|Overall Study|Physician Decision|0|||
143174543|NCT03710889|516187176|FG000|Overall Study|Adverse Event|2|||
143174544|NCT03710889|516187176|FG000|Overall Study|Protocol Deviation|1|||
143174545|NCT00570713|516187177|FG000|Overall Study|Adverse Event|16|||
143174546|NCT00570713|516187178|FG001|Overall Study|Adverse Event|9|||
143085121|NCT00764881|515850227|FG001|Overall Study|Adverse Event|1|||
143085122|NCT00764881|515850226|FG000|Overall Study|Withdrawal by Subject|1|||
143085123|NCT00764881|515850227|FG001|Overall Study|Withdrawal by Subject|3|||
143085124|NCT00764881|515850226|FG000|Overall Study|Protocol Violation|2|||
143085125|NCT00764881|515850227|FG001|Overall Study|Protocol Violation|2|||
143085126|NCT00764881|515850226|FG000|Overall Study|Lost to Follow-up|2|||
143085127|NCT00764881|515850227|FG001|Overall Study|Lost to Follow-up|0|||
143085128|NCT00764881|515850226|FG000|Overall Study|Noncompliant|1|||
143085129|NCT00764881|515850227|FG001|Overall Study|Noncompliant|0|||
143085130|NCT00764881|515850226|FG000|Overall Study|Accidentally discontinued study drug|1|||
143085131|NCT00764881|515850227|FG001|Overall Study|Accidentally discontinued study drug|0|||
143085132|NCT00764881|515850226|FG000|Overall Study|Wished to become pregnant|1|||
143085133|NCT00764881|515850227|FG001|Overall Study|Wished to become pregnant|0|||
143085134|NCT00764881|515850226|FG000|Overall Study|Carcinoma detected|1|||
143085135|NCT00764881|515850227|FG001|Overall Study|Carcinoma detected|0|||
143085136|NCT00764881|515850226|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
143085137|NCT00764881|515850227|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
143085138|NCT00764881|515850226|FG000|Overall Study|no treatment or no observation|2|||
143085139|NCT00764881|515850227|FG001|Overall Study|no treatment or no observation|2|||
143085140|NCT05256134|515850228|FG000|Overall Study|Study Terminated by Sponsor|11|||
143085141|NCT05256134|515850229|FG001|Overall Study|Study Terminated by Sponsor|10|||
143085142|NCT05256134|515850228|FG000|Overall Study|Withdrawal by Subject|1|||
143085143|NCT05256134|515850229|FG001|Overall Study|Withdrawal by Subject|3|||
143085144|NCT01567462|515850230|FG000|Overall Study|Withdrawal by Subject|4|||
143085145|NCT01567462|515850231|FG001|Overall Study|Withdrawal by Subject|7|||
143085146|NCT00886015|515850232|FG000|Overall Study|Death|0|||
143085147|NCT00886015|515850233|FG001|Overall Study|Death|2|||
143085148|NCT02548156|515850238|FG000|Washout Period 1|Lost to Follow-up|0|||
143085149|NCT02548156|515850239|FG001|Washout Period 1|Lost to Follow-up|0|||
143085150|NCT02548156|515850240|FG002|Washout Period 1|Lost to Follow-up|0|||
143085151|NCT02548156|515850241|FG003|Washout Period 1|Lost to Follow-up|0|||
143174547|NCT00570713|516187177|FG000|Overall Study|Death|7|||
143174548|NCT00570713|516187178|FG001|Overall Study|Death|7|||
143174549|NCT00570713|516187177|FG000|Overall Study|Lack of Efficacy|40|||
143174550|NCT00570713|516187178|FG001|Overall Study|Lack of Efficacy|49|||
143174551|NCT00570713|516187177|FG000|Overall Study|Physician Decision|2|||
143174552|NCT00570713|516187178|FG001|Overall Study|Physician Decision|2|||
143174553|NCT00570713|516187177|FG000|Overall Study|Withdrawal by Subject|3|||
143174554|NCT00570713|516187178|FG001|Overall Study|Withdrawal by Subject|3|||
143174555|NCT00570713|516187177|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
143174556|NCT00570713|516187178|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
143174557|NCT04881760|516187179|FG000|Overall Study|Adverse Event|0|||
143174558|NCT04881760|516187180|FG001|Overall Study|Adverse Event|1|||
143174559|NCT04881760|516187181|FG002|Overall Study|Adverse Event|1|||
143174560|NCT04881760|516187182|FG003|Overall Study|Adverse Event|0|||
143174561|NCT04881760|516187183|FG004|Overall Study|Adverse Event|1|||
143174562|NCT04881760|516187184|FG005|Overall Study|Adverse Event|1|||
143174563|NCT04881760|516187185|FG006|Overall Study|Adverse Event|2|||
143174564|NCT04881760|516187179|FG000|Overall Study|Death|0|||
143174565|NCT04881760|516187180|FG001|Overall Study|Death|0|||
143174566|NCT04881760|516187181|FG002|Overall Study|Death|0|||
143174567|NCT04881760|516187182|FG003|Overall Study|Death|1|||
143174568|NCT04881760|516187183|FG004|Overall Study|Death|0|||
143174569|NCT04881760|516187184|FG005|Overall Study|Death|0|||
143174570|NCT04881760|516187185|FG006|Overall Study|Death|0|||
143174571|NCT04881760|516187179|FG000|Overall Study|Lost to Follow-up|5|||
143174572|NCT04881760|516187180|FG001|Overall Study|Lost to Follow-up|7|||
143174573|NCT04881760|516187181|FG002|Overall Study|Lost to Follow-up|5|||
143174574|NCT04881760|516187182|FG003|Overall Study|Lost to Follow-up|1|||
143174575|NCT04881760|516187183|FG004|Overall Study|Lost to Follow-up|2|||
143174576|NCT04881760|516187184|FG005|Overall Study|Lost to Follow-up|4|||
143174577|NCT04881760|516187185|FG006|Overall Study|Lost to Follow-up|4|||
143174578|NCT04881760|516187179|FG000|Overall Study|Withdrawal by Subject|13|||
143174579|NCT04881760|516187180|FG001|Overall Study|Withdrawal by Subject|1|||
143249637|NCT00830869|516468724|FG008|Period 1: Part 1|Progressive disease|0|||
143249638|NCT00830869|516468725|FG009|Period 1: Part 1|Progressive disease|0|||
143085152|NCT02548156|515850242|FG004|Washout Period 1|Lost to Follow-up|1|||
143085153|NCT02548156|515850243|FG005|Washout Period 1|Lost to Follow-up|0|||
143085154|NCT01625988|515850252|FG000|Overall Study|Lost to Follow-up|5|||
143174580|NCT04881760|516187181|FG002|Overall Study|Withdrawal by Subject|1|||
143174581|NCT04881760|516187182|FG003|Overall Study|Withdrawal by Subject|4|||
143085155|NCT01625988|515850253|FG001|Overall Study|Lost to Follow-up|6|||
143085156|NCT01625988|515850252|FG000|Overall Study|Withdrawal by Subject|8|||
143085157|NCT01625988|515850253|FG001|Overall Study|Withdrawal by Subject|3|||
143085158|NCT01625988|515850252|FG000|Overall Study|Adverse Event|0|||
143085159|NCT01625988|515850253|FG001|Overall Study|Adverse Event|1|||
143085160|NCT01625988|515850252|FG000|Overall Study|Lack of Efficacy|0|||
143085161|NCT01625988|515850253|FG001|Overall Study|Lack of Efficacy|1|||
143174582|NCT04881760|516187183|FG004|Overall Study|Withdrawal by Subject|2|||
143174583|NCT04881760|516187184|FG005|Overall Study|Withdrawal by Subject|1|||
143174584|NCT04881760|516187185|FG006|Overall Study|Withdrawal by Subject|2|||
143174585|NCT04881760|516187179|FG000|Overall Study|Randomized but Never Treated|0|||
143174586|NCT04881760|516187180|FG001|Overall Study|Randomized but Never Treated|0|||
143085162|NCT01625988|515850252|FG000|Overall Study|Randomized Inappropriately|1|||
143085163|NCT01625988|515850253|FG001|Overall Study|Randomized Inappropriately|0|||
143085164|NCT01625988|515850252|FG000|Overall Study|Protocol Violation|0|||
143085165|NCT01625988|515850253|FG001|Overall Study|Protocol Violation|2|||
143085166|NCT00444587|515850256|FG000|Overall Study|Death|2|||
143085167|NCT00444587|515850257|FG001|Overall Study|Death|1|||
143085168|NCT00444587|515850256|FG000|Overall Study|Progression of the disease|73|||
143085169|NCT00444587|515850257|FG001|Overall Study|Progression of the disease|8|||
143085170|NCT00444587|515850256|FG000|Overall Study|Refused treatment/did not cooperate|4|||
143085171|NCT00444587|515850257|FG001|Overall Study|Refused treatment/did not cooperate|1|||
143085172|NCT00444587|515850256|FG000|Overall Study|Investigator decision|3|||
143085173|NCT00444587|515850257|FG001|Overall Study|Investigator decision|0|||
143085174|NCT00444587|515850256|FG000|Overall Study|Protocol Violation|1|||
143085175|NCT00444587|515850257|FG001|Overall Study|Protocol Violation|0|||
143085176|NCT00444587|515850256|FG000|Overall Study|Missing|0|||
143085177|NCT00444587|515850257|FG001|Overall Study|Missing|5|||
143085178|NCT00196326|515850258|FG000|Overall Study|Did not meet protocol requirements|64|||
143085179|NCT00196326|515850258|FG000|Overall Study|Non-compliance with the protocol|81|||
143085180|NCT00196326|515850258|FG000|Overall Study|Physician Decision|3|||
143085181|NCT00196326|515850258|FG000|Overall Study|Withdrawal by Subject|225|||
143085182|NCT00196326|515850258|FG000|Overall Study|Adverse Event|253|||
143085183|NCT00196326|515850258|FG000|Overall Study|Pregnancy|34|||
143085184|NCT00196326|515850258|FG000|Overall Study|Lost to Follow-up|304|||
143085185|NCT00196326|515850258|FG000|Overall Study|Other|22|||
143085186|NCT01473407|515850267|FG000|Overall Study|Physician Decision|1|||
143085187|NCT01473407|515850268|FG001|Overall Study|Physician Decision|4|||
143085188|NCT01473407|515850267|FG000|Overall Study|Lost to Follow-up|10|||
143085189|NCT01473407|515850268|FG001|Overall Study|Lost to Follow-up|4|||
143085190|NCT01473407|515850267|FG000|Overall Study|Adverse Event|8|||
143085191|NCT01473407|515850268|FG001|Overall Study|Adverse Event|8|||
143085192|NCT01473407|515850267|FG000|Overall Study|Randomization Error|3|||
143085193|NCT01473407|515850268|FG001|Overall Study|Randomization Error|1|||
143085194|NCT01473407|515850267|FG000|Overall Study|Withdrawal by Subject|4|||
143085195|NCT01473407|515850268|FG001|Overall Study|Withdrawal by Subject|7|||
143085196|NCT01473407|515850267|FG000|Overall Study|Kidney Transplant|7|||
143085197|NCT01473407|515850268|FG001|Overall Study|Kidney Transplant|6|||
143085198|NCT01473407|515850267|FG000|Overall Study|Vacation/Travel|1|||
143085199|NCT01473407|515850268|FG001|Overall Study|Vacation/Travel|1|||
143085200|NCT01473407|515850267|FG000|Overall Study|Elevated Hemoglobin|1|||
143085201|NCT01473407|515850268|FG001|Overall Study|Elevated Hemoglobin|0|||
143085202|NCT01473407|515850267|FG000|Overall Study|Patient Received Aranesp|1|||
143085203|NCT01473407|515850268|FG001|Overall Study|Patient Received Aranesp|0|||
143085204|NCT01473407|515850267|FG000|Overall Study|Patient Lost Green Card Status|1|||
143085205|NCT01473407|515850268|FG001|Overall Study|Patient Lost Green Card Status|0|||
143085206|NCT01473407|515850267|FG000|Overall Study|Temperature Excursion|2|||
143085207|NCT01473407|515850268|FG001|Overall Study|Temperature Excursion|3|||
143085208|NCT01473407|515850267|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
143085209|NCT01473407|515850268|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
143085210|NCT01473407|515850267|FG000|Overall Study|Sponsor's Decision|10|||
143085211|NCT01473407|515850268|FG001|Overall Study|Sponsor's Decision|10|||
143085212|NCT01473407|515850267|FG000|Overall Study|Site Closure|1|||
143085213|NCT01473407|515850268|FG001|Overall Study|Site Closure|0|||
143085214|NCT00369941|515850269|FG000|Overall Study|Never Treated|1|||
143085215|NCT00369941|515850270|FG001|Overall Study|Never Treated|2|||
143085216|NCT00369941|515850269|FG000|Overall Study|Adverse Event|14|||
143085217|NCT00369941|515850270|FG001|Overall Study|Adverse Event|28|||
143085218|NCT00369941|515850269|FG000|Overall Study|Lack of Efficacy|6|||
143085219|NCT00369941|515850270|FG001|Overall Study|Lack of Efficacy|10|||
143085220|NCT00369941|515850269|FG000|Overall Study|Lost to Follow-up|12|||
143085221|NCT00369941|515850270|FG001|Overall Study|Lost to Follow-up|22|||
143085222|NCT00369941|515850269|FG000|Overall Study|Protocol Violation|5|||
143085223|NCT00369941|515850270|FG001|Overall Study|Protocol Violation|3|||
143085224|NCT00369941|515850269|FG000|Overall Study|Withdrawal by Subject|5|||
143085225|NCT00369941|515850270|FG001|Overall Study|Withdrawal by Subject|18|||
143085226|NCT00369941|515850269|FG000|Overall Study|Pregnancy|4|||
143085227|NCT00369941|515850270|FG001|Overall Study|Pregnancy|2|||
143085228|NCT00369941|515850269|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
143085229|NCT00369941|515850270|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
143085230|NCT00369941|515850269|FG000|Overall Study|Moved|11|||
143085231|NCT00369941|515850270|FG001|Overall Study|Moved|5|||
143085232|NCT00369941|515850269|FG000|Overall Study|Treatment with Prohibited Medication|3|||
143085233|NCT00369941|515850270|FG001|Overall Study|Treatment with Prohibited Medication|1|||
143085234|NCT00369941|515850269|FG000|Overall Study|Employment Interfered with Study Visits|1|||
143085235|NCT00369941|515850270|FG001|Overall Study|Employment Interfered with Study Visits|0|||
143085236|NCT00369941|515850269|FG000|Overall Study|Study Site Terminated|2|||
143085237|NCT00369941|515850270|FG001|Overall Study|Study Site Terminated|0|||
143085238|NCT00369941|515850269|FG000|Overall Study|Miscellaneous|3|||
143085239|NCT00369941|515850270|FG001|Overall Study|Miscellaneous|3|||
143085240|NCT01027702|515850271|FG000|Overall Study|Received subsequent therapy|1|||
143085241|NCT01027702|515850272|FG001|Overall Study|Received subsequent therapy|2|||
143085242|NCT01027702|515850273|FG002|Overall Study|Received subsequent therapy|0|||
143085243|NCT01027702|515850274|FG003|Overall Study|Received subsequent therapy|4|||
143085244|NCT01027702|515850275|FG004|Overall Study|Received subsequent therapy|1|||
143085245|NCT01027702|515850276|FG005|Overall Study|Received subsequent therapy|0|||
143085246|NCT01027702|515850277|FG006|Overall Study|Received subsequent therapy|1|||
143085247|NCT01027702|515850271|FG000|Overall Study|Death|0|||
143085248|NCT01027702|515850272|FG001|Overall Study|Death|0|||
143085249|NCT01027702|515850273|FG002|Overall Study|Death|1|||
143085250|NCT01027702|515850274|FG003|Overall Study|Death|0|||
143174587|NCT04881760|516187181|FG002|Overall Study|Randomized but Never Treated|0|||
143174588|NCT04881760|516187182|FG003|Overall Study|Randomized but Never Treated|1|||
143174589|NCT04881760|516187183|FG004|Overall Study|Randomized but Never Treated|0|||
143174590|NCT04881760|516187184|FG005|Overall Study|Randomized but Never Treated|0|||
143174591|NCT04881760|516187185|FG006|Overall Study|Randomized but Never Treated|0|||
143174592|NCT04881760|516187179|FG000|Overall Study|Inadvertent Enrollment|2|||
143174593|NCT04881760|516187180|FG001|Overall Study|Inadvertent Enrollment|0|||
143174594|NCT04881760|516187181|FG002|Overall Study|Inadvertent Enrollment|0|||
143174595|NCT04881760|516187182|FG003|Overall Study|Inadvertent Enrollment|0|||
143174596|NCT04881760|516187183|FG004|Overall Study|Inadvertent Enrollment|0|||
143174597|NCT04881760|516187184|FG005|Overall Study|Inadvertent Enrollment|0|||
143174598|NCT04881760|516187185|FG006|Overall Study|Inadvertent Enrollment|0|||
143174599|NCT04881760|516187179|FG000|Overall Study|Site Closure|0|||
143174600|NCT04881760|516187180|FG001|Overall Study|Site Closure|0|||
143174601|NCT04881760|516187181|FG002|Overall Study|Site Closure|0|||
143174602|NCT04881760|516187182|FG003|Overall Study|Site Closure|1|||
143174603|NCT04881760|516187183|FG004|Overall Study|Site Closure|0|||
143174604|NCT04881760|516187184|FG005|Overall Study|Site Closure|0|||
143174605|NCT04881760|516187185|FG006|Overall Study|Site Closure|0|||
143085251|NCT01027702|515850275|FG004|Overall Study|Death|0|||
143085252|NCT01027702|515850276|FG005|Overall Study|Death|0|||
143085253|NCT01027702|515850277|FG006|Overall Study|Death|0|||
143085254|NCT00403585|515850278|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
143085255|NCT00403585|515850278|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
143085256|NCT00403585|515850278|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
143085257|NCT02964312|515850285|FG000|Overall Study|Lost to Follow-up|28|||
143085258|NCT02964312|515850285|FG000|Overall Study|Withdrawal by Subject|11|||
143085259|NCT02964312|515850285|FG000|Overall Study|Lack of Efficacy|10|||
143085260|NCT02964312|515850285|FG000|Overall Study|Did not consent to long-term FU|14|||
143085261|NCT02964312|515850285|FG000|Overall Study|Death|1|||
143085262|NCT02862730|515850286|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
143085263|NCT02862730|515850287|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
143085264|NCT02862730|515850288|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
143174606|NCT01538199|516187186|FG000|Overall Study|Lost to Follow-up|1|||
143174607|NCT01538199|516187187|FG001|Overall Study|Lost to Follow-up|2|||
143085265|NCT02862730|515850289|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
143085266|NCT02862730|515850290|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
143085267|NCT02862730|515850291|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
143085268|NCT02862730|515850292|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
143085269|NCT02862730|515850286|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
143085270|NCT02862730|515850287|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
143085271|NCT02862730|515850288|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
143085272|NCT02862730|515850289|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
143085273|NCT02862730|515850290|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
143085274|NCT02862730|515850291|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
143085275|NCT02862730|515850292|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
143085276|NCT02862730|515850286|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
143085277|NCT02862730|515850287|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
143085278|NCT02862730|515850288|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
143085279|NCT02862730|515850289|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
143085280|NCT02862730|515850290|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
143085281|NCT02862730|515850291|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
143085282|NCT02862730|515850292|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
143085283|NCT02862730|515850286|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
143085284|NCT02862730|515850287|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
143085285|NCT02862730|515850288|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
143085286|NCT02862730|515850289|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
143085287|NCT02862730|515850290|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
143085288|NCT02862730|515850291|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
143085289|NCT02862730|515850292|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
143085290|NCT03685344|515850293|FG000|Overall Study|Withdrawal by Subject|1|||
143085291|NCT03685344|515850294|FG001|Overall Study|Withdrawal by Subject|1|||
143085292|NCT03685344|515850295|FG002|Overall Study|Withdrawal by Subject|2|||
143085293|NCT03685344|515850296|FG003|Overall Study|Withdrawal by Subject|0|||
143085294|NCT03685344|515850293|FG000|Overall Study|Physician Decision|1|||
143085295|NCT03685344|515850294|FG001|Overall Study|Physician Decision|1|||
143085296|NCT03685344|515850295|FG002|Overall Study|Physician Decision|5|||
143085297|NCT03685344|515850296|FG003|Overall Study|Physician Decision|0|||
143085298|NCT03685344|515850293|FG000|Overall Study|Death|1|||
143085299|NCT03685344|515850294|FG001|Overall Study|Death|1|||
143085300|NCT03685344|515850295|FG002|Overall Study|Death|0|||
143085301|NCT03685344|515850296|FG003|Overall Study|Death|0|||
143085302|NCT02121652|515850299|FG000|Overall Study|Lost to Follow-up|2|||
143085303|NCT02121652|515850300|FG001|Overall Study|Lost to Follow-up|1|||
143085304|NCT02121652|515850299|FG000|Overall Study|Death|1|||
143085305|NCT02121652|515850300|FG001|Overall Study|Death|0|||
143085306|NCT02121652|515850299|FG000|Overall Study|Withdrawal by Subject|3|||
143085307|NCT02121652|515850300|FG001|Overall Study|Withdrawal by Subject|3|||
143085308|NCT03639779|515850309|FG000|Overall Study|Lost to Follow-up|1|||
143085309|NCT02413229|515850310|FG000|Overall Study|Adverse Event|0|||
143249639|NCT00830869|516468726|FG010|Period 1: Part 1|Progressive disease|0|||
143249640|NCT00830869|516468727|FG011|Period 1: Part 1|Progressive disease|0|||
143249641|NCT00830869|516468716|FG000|Period 2: Part 2|Protocol Violation|0|||
143249642|NCT00830869|516468717|FG001|Period 2: Part 2|Protocol Violation|0|||
143249643|NCT00830869|516468718|FG002|Period 2: Part 2|Protocol Violation|0|||
143249644|NCT00830869|516468719|FG003|Period 2: Part 2|Protocol Violation|0|||
143249645|NCT00830869|516468720|FG004|Period 2: Part 2|Protocol Violation|0|||
143366653|NCT00991276|516887136|FG005|Second Intervention Period|Protocol Violation|0|||
143085310|NCT02413229|515850311|FG001|Overall Study|Adverse Event|0|||
143085311|NCT02413229|515850312|FG002|Overall Study|Adverse Event|0|||
143085312|NCT02413229|515850313|FG003|Overall Study|Adverse Event|1|||
143085313|NCT02413229|515850314|FG004|Overall Study|Adverse Event|0|||
143085314|NCT02413229|515850315|FG005|Overall Study|Adverse Event|0|||
143085315|NCT02413229|515850316|FG006|Overall Study|Adverse Event|0|||
143085316|NCT02413229|515850317|FG007|Overall Study|Adverse Event|1|||
143085317|NCT02413229|515850310|FG000|Overall Study|Lost to Follow-up|0|||
143085318|NCT02413229|515850311|FG001|Overall Study|Lost to Follow-up|0|||
143085319|NCT02413229|515850312|FG002|Overall Study|Lost to Follow-up|1|||
143249646|NCT00830869|516468721|FG005|Period 2: Part 2|Protocol Violation|0|||
143249647|NCT00830869|516468722|FG006|Period 2: Part 2|Protocol Violation|0|||
143085320|NCT02413229|515850313|FG003|Overall Study|Lost to Follow-up|0|||
143085321|NCT02413229|515850314|FG004|Overall Study|Lost to Follow-up|2|||
143085322|NCT02413229|515850315|FG005|Overall Study|Lost to Follow-up|0|||
143085323|NCT02413229|515850316|FG006|Overall Study|Lost to Follow-up|0|||
143085324|NCT02413229|515850317|FG007|Overall Study|Lost to Follow-up|0|||
143085325|NCT02413229|515850310|FG000|Overall Study|Withdrawal by Subject|1|||
143085326|NCT02413229|515850311|FG001|Overall Study|Withdrawal by Subject|1|||
143085327|NCT02413229|515850312|FG002|Overall Study|Withdrawal by Subject|0|||
143085328|NCT02413229|515850313|FG003|Overall Study|Withdrawal by Subject|0|||
143085329|NCT02413229|515850314|FG004|Overall Study|Withdrawal by Subject|1|||
143085330|NCT02413229|515850315|FG005|Overall Study|Withdrawal by Subject|0|||
143085331|NCT02413229|515850316|FG006|Overall Study|Withdrawal by Subject|0|||
143085332|NCT02413229|515850317|FG007|Overall Study|Withdrawal by Subject|2|||
143085333|NCT02413229|515850310|FG000|Overall Study|Progressive Disease|0|||
143085334|NCT02413229|515850311|FG001|Overall Study|Progressive Disease|0|||
143085335|NCT02413229|515850312|FG002|Overall Study|Progressive Disease|0|||
143085336|NCT02413229|515850313|FG003|Overall Study|Progressive Disease|0|||
143085337|NCT02413229|515850314|FG004|Overall Study|Progressive Disease|0|||
143085338|NCT02413229|515850315|FG005|Overall Study|Progressive Disease|0|||
143085339|NCT02413229|515850316|FG006|Overall Study|Progressive Disease|0|||
143085340|NCT02413229|515850317|FG007|Overall Study|Progressive Disease|1|||
143085341|NCT01232452|515850318|FG000|Overall Study|Adverse Event|17|||
143085342|NCT01232452|515850319|FG001|Overall Study|Adverse Event|15|||
143085343|NCT01232452|515850318|FG000|Overall Study|Withdrawal by Subject|11|||
143085344|NCT01232452|515850319|FG001|Overall Study|Withdrawal by Subject|8|||
143085345|NCT01232452|515850318|FG000|Overall Study|Physician Decision|8|||
143085346|NCT01232452|515850319|FG001|Overall Study|Physician Decision|12|||
143085347|NCT01232452|515850318|FG000|Overall Study|Protocol entry criterion not met|0|||
143085348|NCT01232452|515850319|FG001|Overall Study|Protocol entry criterion not met|2|||
143085349|NCT01232452|515850318|FG000|Overall Study|Sponsor Decision|3|||
143085350|NCT01232452|515850319|FG001|Overall Study|Sponsor Decision|1|||
143249648|NCT00830869|516468723|FG007|Period 2: Part 2|Protocol Violation|1|||
143249649|NCT00830869|516468724|FG008|Period 2: Part 2|Protocol Violation|0|||
143249650|NCT00830869|516468725|FG009|Period 2: Part 2|Protocol Violation|1|||
143249651|NCT00830869|516468726|FG010|Period 2: Part 2|Protocol Violation|0|||
143249652|NCT00830869|516468727|FG011|Period 2: Part 2|Protocol Violation|0|||
143249653|NCT00830869|516468716|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
143249654|NCT00830869|516468717|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
143249655|NCT00830869|516468718|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
143249656|NCT00830869|516468719|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
143249657|NCT00830869|516468720|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
143249658|NCT00830869|516468721|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
143249659|NCT00830869|516468722|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
143249660|NCT00830869|516468723|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
143249661|NCT00830869|516468724|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
143249662|NCT00830869|516468725|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
143249663|NCT00830869|516468726|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
143249664|NCT00830869|516468727|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
143249665|NCT00830869|516468716|FG000|Period 2: Part 2|Adverse Event|0|||
143249666|NCT00830869|516468717|FG001|Period 2: Part 2|Adverse Event|0|||
143249667|NCT00830869|516468718|FG002|Period 2: Part 2|Adverse Event|0|||
143249668|NCT00830869|516468719|FG003|Period 2: Part 2|Adverse Event|0|||
143366654|NCT00991276|516887131|FG000|Second Intervention Period|Other|0|||
143366655|NCT00991276|516887132|FG001|Second Intervention Period|Other|0|||
143085351|NCT01232452|515850318|FG000|Overall Study|Protocol Violation|0|||
143085352|NCT01232452|515850319|FG001|Overall Study|Protocol Violation|1|||
143085353|NCT00247676|515850320|FG000|Overall Study|Death|5|||
143085354|NCT00247676|515850320|FG000|Overall Study|Adverse Event|11|||
143085355|NCT00247676|515850320|FG000|Overall Study|Lack of Efficacy|15|||
143085356|NCT00247676|515850320|FG000|Overall Study|Other|3|||
143085357|NCT00247676|515850320|FG000|Overall Study|Withdrawal by Subject|2|||
143085358|NCT03594071|515850321|FG000|Overall Study|Re-operation|3|||
143085359|NCT03594071|515850321|FG000|Overall Study|Missed visit|2|||
143085360|NCT00560391|515850324|FG000|Overall Study|Still on treatment|0|||
143085361|NCT00560391|515850325|FG001|Overall Study|Still on treatment|0|||
143085362|NCT00560391|515850326|FG002|Overall Study|Still on treatment|0|||
143249669|NCT00830869|516468720|FG004|Period 2: Part 2|Adverse Event|0|||
143249670|NCT00830869|516468721|FG005|Period 2: Part 2|Adverse Event|0|||
143085363|NCT00560391|515850327|FG003|Overall Study|Still on treatment|1|||
143085364|NCT00560391|515850328|FG004|Overall Study|Still on treatment|2|||
143085365|NCT01965860|515850329|FG000|Overall Study|Pregnancy|1|||
143085366|NCT01965860|515850330|FG001|Overall Study|Pregnancy|0|||
143085367|NCT01965860|515850331|FG002|Overall Study|Pregnancy|1|||
143085368|NCT01965860|515850329|FG000|Overall Study|Logistics|1|||
143085369|NCT01965860|515850330|FG001|Overall Study|Logistics|0|||
143085370|NCT01965860|515850331|FG002|Overall Study|Logistics|0|||
143085371|NCT02064296|515850332|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
143085372|NCT02064296|515850333|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
143249671|NCT00830869|516468722|FG006|Period 2: Part 2|Adverse Event|0|||
143085373|NCT02064296|515850334|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
143085374|NCT02064296|515850332|FG000|Intervention|Withdrawal by Subject|0|||
143085375|NCT02064296|515850333|FG001|Intervention|Withdrawal by Subject|1|||
143085376|NCT02064296|515850334|FG002|Intervention|Withdrawal by Subject|2|||
143085377|NCT02288325|515850335|FG000|Run-in Period|Adverse Event|48|||
143085378|NCT02288325|515850336|FG001|Run-in Period|Adverse Event|0|||
143085379|NCT02288325|515850337|FG002|Run-in Period|Adverse Event|0|||
143085380|NCT02288325|515850335|FG000|Run-in Period|Lack of Efficacy|16|||
143085381|NCT02288325|515850336|FG001|Run-in Period|Lack of Efficacy|0|||
143085382|NCT02288325|515850337|FG002|Run-in Period|Lack of Efficacy|0|||
143085383|NCT02288325|515850335|FG000|Run-in Period|Withdrawal of Consent|28|||
143085384|NCT02288325|515850336|FG001|Run-in Period|Withdrawal of Consent|0|||
143085385|NCT02288325|515850337|FG002|Run-in Period|Withdrawal of Consent|0|||
143085386|NCT02288325|515850335|FG000|Run-in Period|Lost to Follow-up|25|||
143085387|NCT02288325|515850336|FG001|Run-in Period|Lost to Follow-up|0|||
143085388|NCT02288325|515850337|FG002|Run-in Period|Lost to Follow-up|0|||
143085389|NCT02288325|515850335|FG000|Run-in Period|Protocol Violation|17|||
143085390|NCT02288325|515850336|FG001|Run-in Period|Protocol Violation|0|||
143085391|NCT02288325|515850337|FG002|Run-in Period|Protocol Violation|0|||
143085392|NCT02288325|515850335|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
143085393|NCT02288325|515850336|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
143085394|NCT02288325|515850337|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
143085395|NCT02288325|515850335|FG000|Run-in Period|Reason not Specified|8|||
143085396|NCT02288325|515850336|FG001|Run-in Period|Reason not Specified|0|||
143085397|NCT02288325|515850337|FG002|Run-in Period|Reason not Specified|0|||
143085398|NCT02288325|515850335|FG000|Stabilization Period|Adverse Event|13|||
143085399|NCT02288325|515850336|FG001|Stabilization Period|Adverse Event|0|||
143085400|NCT02288325|515850337|FG002|Stabilization Period|Adverse Event|0|||
143085401|NCT02288325|515850335|FG000|Stabilization Period|Lack of Efficacy|22|||
143085402|NCT02288325|515850336|FG001|Stabilization Period|Lack of Efficacy|0|||
143085403|NCT02288325|515850337|FG002|Stabilization Period|Lack of Efficacy|0|||
143085404|NCT02288325|515850335|FG000|Stabilization Period|Withdrawal of Consent|23|||
143085405|NCT02288325|515850336|FG001|Stabilization Period|Withdrawal of Consent|0|||
143085406|NCT02288325|515850337|FG002|Stabilization Period|Withdrawal of Consent|0|||
143085407|NCT02288325|515850335|FG000|Stabilization Period|Lost to Follow-up|12|||
143085408|NCT02288325|515850336|FG001|Stabilization Period|Lost to Follow-up|0|||
143085409|NCT02288325|515850337|FG002|Stabilization Period|Lost to Follow-up|0|||
143085410|NCT02288325|515850335|FG000|Stabilization Period|Protocol Violation|8|||
143085411|NCT02288325|515850336|FG001|Stabilization Period|Protocol Violation|0|||
143085412|NCT02288325|515850337|FG002|Stabilization Period|Protocol Violation|0|||
143085413|NCT02288325|515850335|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
143085414|NCT02288325|515850336|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
143085415|NCT02288325|515850337|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
143085416|NCT02288325|515850335|FG000|Stabilization Period|Reason not Specified|15|||
143085417|NCT02288325|515850336|FG001|Stabilization Period|Reason not Specified|0|||
143174608|NCT01538199|516187188|FG002|Overall Study|Lost to Follow-up|1|||
143174609|NCT01538199|516187189|FG003|Overall Study|Lost to Follow-up|0|||
143174610|NCT01538199|516187186|FG000|Overall Study|participant did not have time|1|||
143174611|NCT01538199|516187187|FG001|Overall Study|participant did not have time|0|||
143085418|NCT02288325|515850337|FG002|Stabilization Period|Reason not Specified|0|||
143085419|NCT02288325|515850335|FG000|Double-blind Treatment Period|Adverse Event|0|||
143085420|NCT02288325|515850336|FG001|Double-blind Treatment Period|Adverse Event|2|||
143085421|NCT02288325|515850337|FG002|Double-blind Treatment Period|Adverse Event|5|||
143085422|NCT02288325|515850335|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
143085423|NCT02288325|515850336|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
143085424|NCT02288325|515850337|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
143085425|NCT02288325|515850335|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
143085426|NCT02288325|515850336|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
143085427|NCT02288325|515850337|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
143085428|NCT02288325|515850335|FG000|Double-blind Treatment Period|Protocol Violation|0|||
143085429|NCT02288325|515850336|FG001|Double-blind Treatment Period|Protocol Violation|1|||
143085430|NCT02288325|515850337|FG002|Double-blind Treatment Period|Protocol Violation|2|||
143085431|NCT02288325|515850335|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
143085432|NCT02288325|515850336|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
143085433|NCT02288325|515850337|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
143085434|NCT02288325|515850335|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
143085435|NCT02288325|515850336|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
143085436|NCT02288325|515850337|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
143085437|NCT03735121|515850342|FG000|Overall Study|Death|3|||
143085438|NCT03735121|515850343|FG001|Overall Study|Death|6|||
143085439|NCT03735121|515850344|FG002|Overall Study|Death|8|||
143085440|NCT03735121|515850345|FG003|Overall Study|Death|37|||
143085441|NCT03735121|515850346|FG004|Overall Study|Death|86|||
143085442|NCT03735121|515850342|FG000|Overall Study|Withdrawal by Subject|1|||
143085443|NCT03735121|515850343|FG001|Overall Study|Withdrawal by Subject|1|||
143085444|NCT03735121|515850344|FG002|Overall Study|Withdrawal by Subject|3|||
143085445|NCT03735121|515850345|FG003|Overall Study|Withdrawal by Subject|4|||
143085446|NCT03735121|515850346|FG004|Overall Study|Withdrawal by Subject|2|||
143085447|NCT03735121|515850342|FG000|Overall Study|Progressive Disease|0|||
143085448|NCT03735121|515850343|FG001|Overall Study|Progressive Disease|0|||
143085449|NCT03735121|515850344|FG002|Overall Study|Progressive Disease|1|||
143085450|NCT03735121|515850345|FG003|Overall Study|Progressive Disease|0|||
143085451|NCT03735121|515850346|FG004|Overall Study|Progressive Disease|0|||
143085452|NCT03735121|515850342|FG000|Overall Study|Lost to Follow-up|0|||
143085453|NCT03735121|515850343|FG001|Overall Study|Lost to Follow-up|0|||
143085454|NCT03735121|515850344|FG002|Overall Study|Lost to Follow-up|0|||
143085455|NCT03735121|515850345|FG003|Overall Study|Lost to Follow-up|0|||
143085456|NCT03735121|515850346|FG004|Overall Study|Lost to Follow-up|1|||
143085457|NCT03735121|515850342|FG000|Overall Study|Ongoing|3|||
143174612|NCT01538199|516187188|FG002|Overall Study|participant did not have time|0|||
143174613|NCT01538199|516187189|FG003|Overall Study|participant did not have time|2|||
143174614|NCT01538199|516187186|FG000|Overall Study|Lack of Efficacy|0|||
143174615|NCT01538199|516187187|FG001|Overall Study|Lack of Efficacy|1|||
143085458|NCT03735121|515850343|FG001|Overall Study|Ongoing|3|||
143085459|NCT03735121|515850344|FG002|Overall Study|Ongoing|26|||
143085460|NCT03735121|515850345|FG003|Overall Study|Ongoing|83|||
143085461|NCT03735121|515850346|FG004|Overall Study|Ongoing|158|||
143085462|NCT04036110|515850347|FG000|Overall Study|Lost to Follow-up|3|||
143085463|NCT04036110|515850348|FG001|Overall Study|Lost to Follow-up|2|||
143085464|NCT04036110|515850349|FG002|Overall Study|Lost to Follow-up|1|||
143085465|NCT04036110|515850347|FG000|Overall Study|Study Suspended|4|||
143174616|NCT01538199|516187188|FG002|Overall Study|Lack of Efficacy|0|||
143085466|NCT04036110|515850348|FG001|Overall Study|Study Suspended|5|||
143085467|NCT04036110|515850349|FG002|Overall Study|Study Suspended|1|||
143085468|NCT02296931|515850356|FG000|Overall Study|Protocol Violation|0|||
143085469|NCT02296931|515850357|FG001|Overall Study|Protocol Violation|2|||
143085470|NCT01590277|515850358|FG000|Overall Study|Withdrawal by Subject|3|||
143085471|NCT01590277|515850358|FG000|Overall Study|Withdrawal by Subject|2|||
143085472|NCT01590277|515850358|FG000|Overall Study|Withdrawal by Subject|1|||
143085473|NCT01590277|515850358|FG000|Overall Study|Withdrawal by Subject|1|||
143085474|NCT04386616|515850359|FG000|Overall Study|Death|22|||
143085475|NCT04386616|515850360|FG001|Overall Study|Death|22|||
143085476|NCT04386616|515850361|FG002|Overall Study|Death|21|||
143085477|NCT04386616|515850359|FG000|Overall Study|Lost to Follow-up|5|||
143085478|NCT04386616|515850360|FG001|Overall Study|Lost to Follow-up|8|||
143085479|NCT04386616|515850361|FG002|Overall Study|Lost to Follow-up|6|||
143085480|NCT04386616|515850359|FG000|Overall Study|Withdrawal by Subject|2|||
143085481|NCT04386616|515850360|FG001|Overall Study|Withdrawal by Subject|4|||
143085482|NCT04386616|515850361|FG002|Overall Study|Withdrawal by Subject|1|||
143085483|NCT04386616|515850359|FG000|Overall Study|Adverse Event|1|||
143085484|NCT04386616|515850360|FG001|Overall Study|Adverse Event|1|||
143085485|NCT04386616|515850361|FG002|Overall Study|Adverse Event|0|||
143085486|NCT01377012|515850362|FG000|Core Study|Study terminated by Sponsor|47|||
143085487|NCT01377012|515850363|FG001|Core Study|Study terminated by Sponsor|54|||
143085488|NCT01377012|515850364|FG002|Core Study|Study terminated by Sponsor|46|||
143085489|NCT01377012|515850362|FG000|Core Study|Technical problems|1|||
143085490|NCT01377012|515850363|FG001|Core Study|Technical problems|0|||
143085491|NCT01377012|515850364|FG002|Core Study|Technical problems|0|||
143085492|NCT01377012|515850362|FG000|Core Study|Withdrawal by Subject|15|||
143085493|NCT01377012|515850363|FG001|Core Study|Withdrawal by Subject|23|||
143085494|NCT01377012|515850364|FG002|Core Study|Withdrawal by Subject|18|||
143085495|NCT01377012|515850362|FG000|Core Study|Protocol Violation|7|||
143085496|NCT01377012|515850363|FG001|Core Study|Protocol Violation|3|||
143085497|NCT01377012|515850364|FG002|Core Study|Protocol Violation|2|||
143085498|NCT01377012|515850362|FG000|Core Study|Pregnancy|0|||
143085499|NCT01377012|515850363|FG001|Core Study|Pregnancy|0|||
143249672|NCT00830869|516468723|FG007|Period 2: Part 2|Adverse Event|4|||
143085500|NCT01377012|515850364|FG002|Core Study|Pregnancy|1|||
143085501|NCT01377012|515850362|FG000|Core Study|Physician Decision|5|||
143085502|NCT01377012|515850363|FG001|Core Study|Physician Decision|4|||
143085503|NCT01377012|515850364|FG002|Core Study|Physician Decision|10|||
143085504|NCT01377012|515850362|FG000|Core Study|Non-Compliant with study treatment|0|||
143085505|NCT01377012|515850363|FG001|Core Study|Non-Compliant with study treatment|0|||
143085506|NCT01377012|515850364|FG002|Core Study|Non-Compliant with study treatment|1|||
143085507|NCT01377012|515850362|FG000|Core Study|No Longer require treatment|0|||
143085508|NCT01377012|515850363|FG001|Core Study|No Longer require treatment|0|||
143085509|NCT01377012|515850364|FG002|Core Study|No Longer require treatment|1|||
143085510|NCT01377012|515850362|FG000|Core Study|Lost to Follow-up|7|||
143085511|NCT01377012|515850363|FG001|Core Study|Lost to Follow-up|5|||
143085512|NCT01377012|515850364|FG002|Core Study|Lost to Follow-up|4|||
143085513|NCT01377012|515850362|FG000|Core Study|Lack of Efficacy|41|||
143085514|NCT01377012|515850363|FG001|Core Study|Lack of Efficacy|28|||
143085515|NCT01377012|515850364|FG002|Core Study|Lack of Efficacy|37|||
143085516|NCT01377012|515850362|FG000|Core Study|Death|1|||
143085517|NCT01377012|515850363|FG001|Core Study|Death|1|||
143085518|NCT01377012|515850364|FG002|Core Study|Death|1|||
143085519|NCT01377012|515850362|FG000|Core Study|Adverse Event|10|||
143085520|NCT01377012|515850363|FG001|Core Study|Adverse Event|14|||
143085521|NCT01377012|515850364|FG002|Core Study|Adverse Event|13|||
143085522|NCT01377012|515850362|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
143249673|NCT00830869|516468724|FG008|Period 2: Part 2|Adverse Event|3|||
143085523|NCT01377012|515850363|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
143085524|NCT01377012|515850364|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
143085525|NCT01377012|515850362|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
143085526|NCT01377012|515850363|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
143085527|NCT01377012|515850364|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
143085528|NCT01377012|515850362|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
143085529|NCT01377012|515850363|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
143085530|NCT01377012|515850364|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
143085531|NCT01377012|515850362|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
143085532|NCT01377012|515850363|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
143085533|NCT01377012|515850364|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
143085534|NCT01377012|515850362|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
143085535|NCT01377012|515850363|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
143249674|NCT00830869|516468725|FG009|Period 2: Part 2|Adverse Event|2|||
143249675|NCT00830869|516468726|FG010|Period 2: Part 2|Adverse Event|2|||
143249676|NCT00830869|516468727|FG011|Period 2: Part 2|Adverse Event|0|||
143249677|NCT00830869|516468716|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
143249678|NCT00830869|516468717|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
143249679|NCT00830869|516468718|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
143249680|NCT00830869|516468719|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
143249681|NCT00830869|516468720|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
143249682|NCT00830869|516468721|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
143085536|NCT01377012|515850364|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
143085537|NCT01377012|515850362|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
143085538|NCT01377012|515850363|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
143085539|NCT01377012|515850364|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
143085540|NCT03736031|515850370|FG000|Overall Study|Death|2|||
143085541|NCT03736031|515850371|FG001|Overall Study|Death|4|||
143085542|NCT03736031|515850370|FG000|Overall Study|Lost to Follow-up|21|||
143085543|NCT03736031|515850371|FG001|Overall Study|Lost to Follow-up|2|||
143085544|NCT03736031|515850370|FG000|Overall Study|Withdrawal by Subject|9|||
143085545|NCT03736031|515850371|FG001|Overall Study|Withdrawal by Subject|0|||
143085546|NCT00451178|515850374|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
143249683|NCT00830869|516468722|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
143249684|NCT00830869|516468723|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
143249685|NCT00830869|516468724|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
143249686|NCT00830869|516468725|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
143249687|NCT00830869|516468726|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
143249688|NCT00830869|516468727|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
143249689|NCT00830869|516468716|FG000|Period 2: Part 2|Progressive disease|0|||
143249690|NCT00830869|516468717|FG001|Period 2: Part 2|Progressive disease|0|||
143085547|NCT00451178|515850375|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
143085548|NCT00451178|515850374|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
143085549|NCT00451178|515850375|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
143085550|NCT00451178|515850374|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
143085551|NCT00451178|515850375|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
143085552|NCT00451178|515850374|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
143085553|NCT00451178|515850375|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
143085554|NCT00451178|515850374|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
143085555|NCT00451178|515850375|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
143085556|NCT00451178|515850374|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
143085557|NCT00451178|515850375|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
143085558|NCT00451178|515850374|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
143085559|NCT00451178|515850375|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
143085560|NCT00451178|515850374|FG000|Prior to Maintenance Therapy|PD|2|||
143085561|NCT00451178|515850375|FG001|Prior to Maintenance Therapy|PD|0|||
143085562|NCT00451178|515850374|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
143085563|NCT00451178|515850375|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
143085564|NCT00451178|515850374|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
143085565|NCT00451178|515850375|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
143085566|NCT00451178|515850374|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
143085567|NCT00451178|515850375|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
143085568|NCT00451178|515850374|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
143085569|NCT00451178|515850375|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
143085570|NCT00451178|515850374|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
143085571|NCT00451178|515850375|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
143085572|NCT00451178|515850374|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
143085573|NCT00451178|515850375|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
143085574|NCT00451178|515850374|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
143085575|NCT00451178|515850375|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
143085576|NCT02215967|515850376|FG000|Overall Study|Patient became ineligible for treatment|0|||
143085577|NCT02215967|515850377|FG001|Overall Study|Patient became ineligible for treatment|0|||
143085578|NCT02215967|515850378|FG002|Overall Study|Patient became ineligible for treatment|0|||
143085579|NCT02215967|515850379|FG003|Overall Study|Patient became ineligible for treatment|3|||
143085580|NCT02215967|515850376|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
143085581|NCT02215967|515850377|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
143085582|NCT02215967|515850378|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
143085583|NCT02215967|515850379|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
143085584|NCT04460885|515852279|FG000|Overall Study|Withdrawal by Subject|6|||
143085585|NCT04460885|515852280|FG001|Overall Study|Withdrawal by Subject|8|||
143085586|NCT04460885|515852279|FG000|Overall Study|Site closure|1|||
143085587|NCT04460885|515852280|FG001|Overall Study|Site closure|0|||
143085588|NCT04460885|515852279|FG000|Overall Study|Death|5|||
143085589|NCT04460885|515852280|FG001|Overall Study|Death|4|||
143085590|NCT04460885|515852279|FG000|Overall Study|Physician Decision|2|||
143085591|NCT04460885|515852280|FG001|Overall Study|Physician Decision|1|||
143174617|NCT01538199|516187189|FG003|Overall Study|Lack of Efficacy|0|||
143174618|NCT02081586|516187190|FG000|Overall Study|Lost to Follow-up|0|||
143174619|NCT02081586|516187191|FG001|Overall Study|Lost to Follow-up|1|||
143174620|NCT02081586|516187192|FG002|Overall Study|Lost to Follow-up|0|||
143174621|NCT02081586|516187193|FG003|Overall Study|Lost to Follow-up|1|||
143174622|NCT02081586|516187190|FG000|Overall Study|Head injury not related to study|0|||
143174623|NCT02081586|516187191|FG001|Overall Study|Head injury not related to study|0|||
143174624|NCT02081586|516187192|FG002|Overall Study|Head injury not related to study|1|||
143174625|NCT02081586|516187193|FG003|Overall Study|Head injury not related to study|0|||
143181473|NCT03706430|516211756|FG000|Overall Study|Subject had gel nail polish|1|||
143181474|NCT03706430|516211756|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
143181475|NCT03706430|516211756|FG000|Overall Study|Cancelled Case|6|||
143181476|NCT03706430|516211756|FG000|Overall Study|Physician Decision|2|||
143181477|NCT02891226|516211760|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
143181478|NCT02891226|516211761|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
143085592|NCT04460885|515852279|FG000|Overall Study|Lost to Follow-up|4|||
143085593|NCT04460885|515852280|FG001|Overall Study|Lost to Follow-up|4|||
143085594|NCT04205812|515852281|FG000|Randomized Treatment Period|Ongoing|28|||
143085595|NCT04205812|515852282|FG001|Randomized Treatment Period|Ongoing|138|||
143085596|NCT04205812|515852281|FG000|Randomized Treatment Period|Death|94|||
143181479|NCT02891226|516211762|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
143181480|NCT02891226|516211763|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
143366656|NCT00991276|516887133|FG002|Second Intervention Period|Other|0|||
143085597|NCT04205812|515852282|FG001|Randomized Treatment Period|Death|226|||
143085598|NCT04205812|515852281|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
143085599|NCT04205812|515852282|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
143085600|NCT04205812|515852281|FG000|Randomized Treatment Period|Physician Decision|1|||
143085601|NCT04205812|515852282|FG001|Randomized Treatment Period|Physician Decision|4|||
143085602|NCT04205812|515852281|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
143085603|NCT04205812|515852282|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
143085604|NCT04205812|515852281|FG000|Randomized Treatment Period|Progressive Disease|0|||
143085605|NCT04205812|515852282|FG001|Randomized Treatment Period|Progressive Disease|1|||
143085606|NCT04205812|515852281|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
143085607|NCT04205812|515852282|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
143085608|NCT04205812|515852281|FG000|Monotherapy Treatment Period|Ongoing|17|||
143085609|NCT04205812|515852282|FG001|Monotherapy Treatment Period|Ongoing|0|||
143085610|NCT04205812|515852281|FG000|Monotherapy Treatment Period|Death|39|||
143085611|NCT04205812|515852282|FG001|Monotherapy Treatment Period|Death|0|||
143085612|NCT04205812|515852281|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
143085613|NCT04205812|515852282|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
143085614|NCT04205812|515852281|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
143085615|NCT04205812|515852282|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
143085616|NCT06419907|515852287|FG000|Overall Study|Protocol Violation|0|||
143085617|NCT06419907|515852288|FG001|Overall Study|Protocol Violation|3|||
143085618|NCT06419907|515852289|FG002|Overall Study|Protocol Violation|0|||
143085619|NCT06419907|515852290|FG003|Overall Study|Protocol Violation|1|||
143085620|NCT06419907|515852287|FG000|Overall Study|Lost to Follow-up|0|||
143085621|NCT06419907|515852288|FG001|Overall Study|Lost to Follow-up|0|||
143085622|NCT06419907|515852289|FG002|Overall Study|Lost to Follow-up|2|||
143085623|NCT06419907|515852290|FG003|Overall Study|Lost to Follow-up|1|||
143085624|NCT05929651|515852291|FG000|Overall Study|Protocol Deviation|1|||
143085625|NCT05929651|515852291|FG000|Overall Study|Withdrawal by participant's parents/legally acceptable representatives|2|||
143085626|NCT05026177|515852292|FG000|Overall Study|Adverse Event|33|||
143085627|NCT05026177|515852293|FG001|Overall Study|Adverse Event|33|||
143085628|NCT05026177|515852294|FG002|Overall Study|Adverse Event|17|||
143085629|NCT05026177|515852292|FG000|Overall Study|Lost to Follow-up|7|||
143085630|NCT05026177|515852293|FG001|Overall Study|Lost to Follow-up|6|||
143085631|NCT05026177|515852294|FG002|Overall Study|Lost to Follow-up|8|||
143085632|NCT05026177|515852292|FG000|Overall Study|Noncompliance with study drug|6|||
143085633|NCT05026177|515852293|FG001|Overall Study|Noncompliance with study drug|2|||
143085634|NCT05026177|515852294|FG002|Overall Study|Noncompliance with study drug|1|||
143085635|NCT05026177|515852292|FG000|Overall Study|Physician Decision|4|||
143085636|NCT05026177|515852293|FG001|Overall Study|Physician Decision|1|||
143085637|NCT05026177|515852294|FG002|Overall Study|Physician Decision|0|||
143085638|NCT05026177|515852292|FG000|Overall Study|Sponsor requests subject to be withdrawn|0|||
143085639|NCT05026177|515852293|FG001|Overall Study|Sponsor requests subject to be withdrawn|0|||
143085640|NCT05026177|515852294|FG002|Overall Study|Sponsor requests subject to be withdrawn|3|||
143085641|NCT05026177|515852292|FG000|Overall Study|Withdrawal by Subject|53|||
143085642|NCT05026177|515852293|FG001|Overall Study|Withdrawal by Subject|51|||
143085643|NCT05026177|515852294|FG002|Overall Study|Withdrawal by Subject|55|||
143085644|NCT05026177|515852292|FG000|Overall Study|Protocol Violation|0|||
143085645|NCT05026177|515852293|FG001|Overall Study|Protocol Violation|1|||
143085646|NCT05026177|515852294|FG002|Overall Study|Protocol Violation|0|||
143085647|NCT05026177|515852292|FG000|Overall Study|Study terminated by sponsor|70|||
143085648|NCT05026177|515852293|FG001|Overall Study|Study terminated by sponsor|74|||
143085649|NCT05026177|515852294|FG002|Overall Study|Study terminated by sponsor|67|||
143174626|NCT01492426|516188488|FG000|Treatment|Death|0|||
143366657|NCT00991276|516887134|FG003|Second Intervention Period|Other|1|||
143366658|NCT00991276|516887135|FG004|Second Intervention Period|Other|0|||
143085650|NCT05026177|515852292|FG000|Overall Study|Unavailability/noncompliance of study partner|2|||
143085651|NCT05026177|515852293|FG001|Overall Study|Unavailability/noncompliance of study partner|1|||
143085652|NCT05026177|515852294|FG002|Overall Study|Unavailability/noncompliance of study partner|1|||
143085653|NCT05026177|515852292|FG000|Overall Study|Starting alternative treatment|0|||
143085654|NCT05026177|515852293|FG001|Overall Study|Starting alternative treatment|1|||
143085655|NCT05026177|515852294|FG002|Overall Study|Starting alternative treatment|1|||
143085656|NCT05026177|515852292|FG000|Overall Study|Noncompliance with study procedures|0|||
143085657|NCT05026177|515852293|FG001|Overall Study|Noncompliance with study procedures|1|||
143085658|NCT05026177|515852294|FG002|Overall Study|Noncompliance with study procedures|1|||
143085659|NCT05026177|515852292|FG000|Overall Study|Met stopping criteria|0|||
143085660|NCT05026177|515852293|FG001|Overall Study|Met stopping criteria|0|||
143085661|NCT05026177|515852294|FG002|Overall Study|Met stopping criteria|1|||
143174627|NCT01492426|516188489|FG001|Treatment|Death|1|||
143366659|NCT00991276|516887136|FG005|Second Intervention Period|Other|1|||
143085662|NCT05026177|515852292|FG000|Overall Study|Health issues preventing continuation|0|||
143085663|NCT05026177|515852293|FG001|Overall Study|Health issues preventing continuation|0|||
143085664|NCT05026177|515852294|FG002|Overall Study|Health issues preventing continuation|1|||
143085665|NCT05026177|515852292|FG000|Overall Study|Randomized in error, not treated|0|||
143085666|NCT05026177|515852293|FG001|Overall Study|Randomized in error, not treated|0|||
143085667|NCT05026177|515852294|FG002|Overall Study|Randomized in error, not treated|2|||
143085668|NCT00733005|515852295|FG000|Overall Study|Adverse Event|0|||
143085669|NCT00733005|515852296|FG001|Overall Study|Adverse Event|1|||
143085670|NCT00733005|515852295|FG000|Overall Study|Treatment Failure|0|||
143085671|NCT00733005|515852296|FG001|Overall Study|Treatment Failure|1|||
143085672|NCT00733005|515852295|FG000|Overall Study|Withdrawal by Subject|0|||
143085673|NCT00733005|515852296|FG001|Overall Study|Withdrawal by Subject|1|||
143085674|NCT00733005|515852295|FG000|Overall Study|Protocol Violation|2|||
143085675|NCT00733005|515852296|FG001|Overall Study|Protocol Violation|0|||
143085676|NCT01644617|515852305|FG000|Overall Study|Withdrawal by Subject|3|||
143085677|NCT01644617|515852306|FG001|Overall Study|Withdrawal by Subject|4|||
143085678|NCT01644617|515852307|FG002|Overall Study|Withdrawal by Subject|1|||
143085679|NCT01644617|515852305|FG000|Overall Study|Lost to Follow-up|0|||
143085680|NCT01644617|515852306|FG001|Overall Study|Lost to Follow-up|1|||
143085681|NCT01644617|515852307|FG002|Overall Study|Lost to Follow-up|0|||
143085682|NCT01644617|515852305|FG000|Overall Study|Adverse Event|3|||
143085683|NCT01644617|515852306|FG001|Overall Study|Adverse Event|0|||
143085684|NCT01644617|515852307|FG002|Overall Study|Adverse Event|6|||
143085685|NCT01895777|515852314|FG000|Overall Study|Adverse Event|1|||
143085686|NCT01895777|515852315|FG001|Overall Study|Adverse Event|2|||
143085687|NCT01895777|515852314|FG000|Overall Study|Lost to Follow-up|2|||
143085688|NCT01895777|515852315|FG001|Overall Study|Lost to Follow-up|0|||
143085689|NCT01895777|515852314|FG000|Overall Study|Not treated|1|||
143085690|NCT01895777|515852315|FG001|Overall Study|Not treated|0|||
143085691|NCT01895777|515852314|FG000|Overall Study|Other reasons|3|||
143085692|NCT01895777|515852315|FG001|Overall Study|Other reasons|2|||
143085693|NCT01895777|515852314|FG000|Overall Study|Non-compliance with the CTP|2|||
143085694|NCT01895777|515852315|FG001|Overall Study|Non-compliance with the CTP|1|||
143366660|NCT00991276|516887131|FG000|Third Intervention Period|Protocol Violation|1|||
143085695|NCT02829918|515852330|FG000|Overall Study|Death|2|||
143085696|NCT02829918|515852330|FG000|Overall Study|Withdrawal by Subject|4|||
143085697|NCT02829918|515852330|FG000|Overall Study|Adverse Event|1|||
143085698|NCT02829918|515852330|FG000|Overall Study|Progression|1|||
143085699|NCT03142191|515852331|FG000|Placebo Controlled Period|Death|0|||
143085700|NCT03142191|515852332|FG001|Placebo Controlled Period|Death|1|||
143085701|NCT03142191|515852333|FG002|Placebo Controlled Period|Death|1|||
143085702|NCT03142191|515852334|FG003|Placebo Controlled Period|Death|0|||
143085703|NCT03142191|515852335|FG004|Placebo Controlled Period|Death|0|||
143085704|NCT03142191|515852331|FG000|Placebo Controlled Period|Adverse Event|4|||
143085705|NCT03142191|515852332|FG001|Placebo Controlled Period|Adverse Event|5|||
143085706|NCT03142191|515852333|FG002|Placebo Controlled Period|Adverse Event|1|||
143085707|NCT03142191|515852334|FG003|Placebo Controlled Period|Adverse Event|0|||
143085708|NCT03142191|515852335|FG004|Placebo Controlled Period|Adverse Event|0|||
143085709|NCT03142191|515852331|FG000|Placebo Controlled Period|Progressive Disease|1|||
143085710|NCT03142191|515852332|FG001|Placebo Controlled Period|Progressive Disease|0|||
143085711|NCT03142191|515852333|FG002|Placebo Controlled Period|Progressive Disease|1|||
143085712|NCT03142191|515852334|FG003|Placebo Controlled Period|Progressive Disease|0|||
143085713|NCT03142191|515852335|FG004|Placebo Controlled Period|Progressive Disease|0|||
143085714|NCT03142191|515852331|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
143085715|NCT03142191|515852332|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
143085716|NCT03142191|515852333|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
143085717|NCT03142191|515852334|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
143174628|NCT01492426|516188488|FG000|Treatment|Other|1|||
143174629|NCT01492426|516188489|FG001|Treatment|Other|0|||
143174630|NCT01492426|516188488|FG000|Treatment|Adverse Event|25|||
143174631|NCT01492426|516188489|FG001|Treatment|Adverse Event|25|||
143174632|NCT01492426|516188488|FG000|Treatment|Lack of Efficacy|38|||
143174633|NCT01492426|516188489|FG001|Treatment|Lack of Efficacy|5|||
143174634|NCT01492426|516188488|FG000|Treatment|Participant withdrew consent|1|||
143174635|NCT01492426|516188489|FG001|Treatment|Participant withdrew consent|2|||
143174636|NCT01492426|516188488|FG000|Treatment|Poor compliance/noncompliance|1|||
143174637|NCT01492426|516188489|FG001|Treatment|Poor compliance/noncompliance|0|||
143174638|NCT01492426|516188488|FG000|Treatment|Subject requested discontinue study drug|7|||
143174639|NCT01492426|516188489|FG001|Treatment|Subject requested discontinue study drug|3|||
143174640|NCT01492426|516188488|FG000|Treatment|Lost to Follow-up|9|||
143174641|NCT01492426|516188489|FG001|Treatment|Lost to Follow-up|4|||
143174642|NCT01492426|516188488|FG000|Treatment|Participant does not meet study criteria|1|||
143174643|NCT01492426|516188489|FG001|Treatment|Participant does not meet study criteria|0|||
143174644|NCT01492426|516188488|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
143085718|NCT03142191|515852335|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
143085719|NCT03142191|515852331|FG000|Placebo Controlled Period|Other Reasons|1|||
143085720|NCT03142191|515852332|FG001|Placebo Controlled Period|Other Reasons|0|||
143085721|NCT03142191|515852333|FG002|Placebo Controlled Period|Other Reasons|0|||
143085722|NCT03142191|515852334|FG003|Placebo Controlled Period|Other Reasons|0|||
143085723|NCT03142191|515852335|FG004|Placebo Controlled Period|Other Reasons|0|||
143085724|NCT03142191|515852331|FG000|Active Treatment Extension Period|Death|2|||
143085725|NCT03142191|515852332|FG001|Active Treatment Extension Period|Death|1|||
143085726|NCT03142191|515852333|FG002|Active Treatment Extension Period|Death|1|||
143085727|NCT03142191|515852334|FG003|Active Treatment Extension Period|Death|1|||
143085728|NCT03142191|515852335|FG004|Active Treatment Extension Period|Death|0|||
143085729|NCT03142191|515852331|FG000|Active Treatment Extension Period|Adverse Event|6|||
143085730|NCT03142191|515852332|FG001|Active Treatment Extension Period|Adverse Event|5|||
143085731|NCT03142191|515852333|FG002|Active Treatment Extension Period|Adverse Event|4|||
143085732|NCT03142191|515852334|FG003|Active Treatment Extension Period|Adverse Event|1|||
143085733|NCT03142191|515852335|FG004|Active Treatment Extension Period|Adverse Event|0|||
143085734|NCT03142191|515852331|FG000|Active Treatment Extension Period|Progressive Disease|10|||
143085735|NCT03142191|515852332|FG001|Active Treatment Extension Period|Progressive Disease|5|||
143085736|NCT03142191|515852333|FG002|Active Treatment Extension Period|Progressive Disease|4|||
143085737|NCT03142191|515852334|FG003|Active Treatment Extension Period|Progressive Disease|1|||
143085738|NCT03142191|515852335|FG004|Active Treatment Extension Period|Progressive Disease|2|||
143085739|NCT03142191|515852331|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
143085740|NCT03142191|515852332|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
143085741|NCT03142191|515852333|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
143085742|NCT03142191|515852334|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
143085743|NCT03142191|515852335|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
143085744|NCT03142191|515852331|FG000|Active Treatment Extension Period|Physician Decision|2|||
143085745|NCT03142191|515852332|FG001|Active Treatment Extension Period|Physician Decision|0|||
143085746|NCT03142191|515852333|FG002|Active Treatment Extension Period|Physician Decision|0|||
143085747|NCT03142191|515852334|FG003|Active Treatment Extension Period|Physician Decision|0|||
143085748|NCT03142191|515852335|FG004|Active Treatment Extension Period|Physician Decision|0|||
143085749|NCT03142191|515852331|FG000|Active Treatment Extension Period|Other Reasons|3|||
143085750|NCT03142191|515852332|FG001|Active Treatment Extension Period|Other Reasons|3|||
143085751|NCT03142191|515852333|FG002|Active Treatment Extension Period|Other Reasons|3|||
143085752|NCT03142191|515852334|FG003|Active Treatment Extension Period|Other Reasons|8|||
143085753|NCT03142191|515852335|FG004|Active Treatment Extension Period|Other Reasons|3|||
143085754|NCT03142191|515852331|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
143085755|NCT03142191|515852332|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
143085756|NCT03142191|515852333|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
143085757|NCT03142191|515852334|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
143085758|NCT03142191|515852335|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
143085759|NCT01130493|515852336|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
143085760|NCT01130493|515852337|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
143174645|NCT01492426|516188489|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
143174646|NCT01492426|516188488|FG000|Follow-Up|Death|1|||
143174647|NCT01492426|516188489|FG001|Follow-Up|Death|0|||
143174648|NCT01492426|516188488|FG000|Follow-Up|Other|4|||
143174649|NCT01492426|516188489|FG001|Follow-Up|Other|2|||
143174650|NCT01492426|516188488|FG000|Follow-Up|Participant Withdrew Consent|6|||
143174651|NCT01492426|516188489|FG001|Follow-Up|Participant Withdrew Consent|1|||
143174652|NCT01492426|516188488|FG000|Follow-Up|Lost to Follow-up|12|||
143174653|NCT01492426|516188489|FG001|Follow-Up|Lost to Follow-up|6|||
143174654|NCT00652743|516188490|FG000|Months 12-18|Lost to Follow-up|1|||
143174655|NCT00652743|516188491|FG001|Months 12-18|Lost to Follow-up|2|||
143174656|NCT00652743|516188492|FG002|Months 12-18|Lost to Follow-up|7|||
143085761|NCT01130493|515852338|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
143085762|NCT01130493|515852336|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
143085763|NCT01130493|515852337|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
143085764|NCT01130493|515852338|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
143085765|NCT01130493|515852336|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
143174657|NCT00652743|516188490|FG000|Months 24-30|Other|5|||
143085766|NCT01130493|515852337|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
143085767|NCT01130493|515852338|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
143085768|NCT01130493|515852336|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
143085769|NCT01130493|515852337|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
143174658|NCT00652743|516188491|FG001|Months 24-30|Other|1|||
143174659|NCT00652743|516188492|FG002|Months 24-30|Other|11|||
143174660|NCT00652743|516188490|FG000|Months 36-42|Serious Adverse Events|0|||
143085770|NCT01130493|515852338|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
143085771|NCT01130493|515852336|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
143085772|NCT01130493|515852337|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
143085773|NCT01130493|515852338|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
143085774|NCT01130493|515852336|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
143085775|NCT01130493|515852337|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
143085776|NCT01130493|515852338|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
143085777|NCT01130493|515852336|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
143085778|NCT01130493|515852337|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
143085779|NCT01130493|515852338|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
143085780|NCT01130493|515852336|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
143085781|NCT01130493|515852337|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
143085782|NCT01130493|515852338|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
143085783|NCT01130493|515852336|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
143085784|NCT01130493|515852337|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
143085785|NCT01130493|515852338|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
143085786|NCT01130493|515852336|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
143085787|NCT01130493|515852337|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
143085788|NCT01130493|515852338|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
143085789|NCT01130493|515852336|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
143085790|NCT01130493|515852337|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
143085791|NCT01130493|515852338|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
143085792|NCT01130493|515852336|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
143085793|NCT01130493|515852337|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
143085794|NCT01130493|515852338|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
143085795|NCT01130493|515852336|FG000|Part 2: OLE|Adverse Event|0|||
143085796|NCT01130493|515852337|FG001|Part 2: OLE|Adverse Event|2|||
143085797|NCT01130493|515852338|FG002|Part 2: OLE|Adverse Event|1|||
143085798|NCT01130493|515852336|FG000|Part 2: OLE|Withdrawal by Subject|0|||
143085799|NCT01130493|515852337|FG001|Part 2: OLE|Withdrawal by Subject|1|||
143085800|NCT01130493|515852338|FG002|Part 2: OLE|Withdrawal by Subject|4|||
143174661|NCT00652743|516188491|FG001|Months 36-42|Serious Adverse Events|1|||
143174662|NCT00652743|516188492|FG002|Months 36-42|Serious Adverse Events|1|||
143174663|NCT00652743|516188490|FG000|Months 36-42|Withdrawal by Subject|1|||
143174664|NCT00652743|516188491|FG001|Months 36-42|Withdrawal by Subject|1|||
143174665|NCT00652743|516188492|FG002|Months 36-42|Withdrawal by Subject|0|||
143174666|NCT00652743|516188490|FG000|Months 36-42|Lost to Follow-up|0|||
143174667|NCT00652743|516188491|FG001|Months 36-42|Lost to Follow-up|1|||
143174668|NCT00652743|516188492|FG002|Months 36-42|Lost to Follow-up|0|||
143174669|NCT00652743|516188490|FG000|Months 36-42|Migrated/moved from study area|1|||
143174670|NCT00652743|516188491|FG001|Months 36-42|Migrated/moved from study area|0|||
143174671|NCT00652743|516188492|FG002|Months 36-42|Migrated/moved from study area|0|||
143174672|NCT00652743|516188490|FG000|Months 36-42|Other|4|||
143174673|NCT00652743|516188491|FG001|Months 36-42|Other|2|||
143174674|NCT00652743|516188492|FG002|Months 36-42|Other|8|||
143174675|NCT02026011|516188495|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
143174676|NCT02026011|516188496|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
143174677|NCT02026011|516188495|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
143085801|NCT00879086|515852339|FG000|Overall Study|Adverse Event|3|||
143085802|NCT00879086|515852340|FG001|Overall Study|Adverse Event|15|||
143085803|NCT00879086|515852339|FG000|Overall Study|Participant choice|2|||
143085804|NCT00879086|515852340|FG001|Overall Study|Participant choice|2|||
143085805|NCT00879086|515852339|FG000|Overall Study|Progression of disease|40|||
143174678|NCT02026011|516188496|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
143174679|NCT02026011|516188495|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
143174680|NCT02026011|516188496|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
143174681|NCT02026011|516188495|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
143174682|NCT02026011|516188496|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
143174683|NCT05010070|516188497|FG000|Overall Study|Lost to Follow-up|1|||
143174684|NCT05010070|516188497|FG000|Overall Study|Withdrawal by Subject|1|||
143174685|NCT00939107|516188498|FG000|Overall Study|Lost to Follow-up|14|||
143085806|NCT00879086|515852340|FG001|Overall Study|Progression of disease|26|||
143085807|NCT00879086|515852339|FG000|Overall Study|Withdrawal of consent|2|||
143085808|NCT00879086|515852340|FG001|Overall Study|Withdrawal of consent|1|||
143085809|NCT00879086|515852339|FG000|Overall Study|Other|4|||
143085810|NCT00879086|515852340|FG001|Overall Study|Other|6|||
143085811|NCT00879086|515852339|FG000|Overall Study|Death|1|||
143085812|NCT00879086|515852340|FG001|Overall Study|Death|2|||
143174686|NCT00939107|516188499|FG001|Overall Study|Lost to Follow-up|12|||
143085813|NCT02969044|515852341|FG000|Overall Study|Withdrawal by Subject|2|||
143085814|NCT02969044|515852342|FG001|Overall Study|Withdrawal by Subject|6|||
143085815|NCT02969044|515852341|FG000|Overall Study|Adverse Event|3|||
143174687|NCT01246960|516188506|FG000|Overall Study|Lost to Follow-up|3|||
143174688|NCT01246960|516188507|FG001|Overall Study|Lost to Follow-up|1|||
143174689|NCT01246960|516188506|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
143174690|NCT01246960|516188507|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
143174691|NCT02921789|516188508|FG000|Overall Study|Adverse Event|0|||
143174692|NCT02921789|516188509|FG001|Overall Study|Adverse Event|1|||
143174693|NCT02921789|516188508|FG000|Overall Study|Lost to Follow-up|1|||
143174694|NCT02921789|516188509|FG001|Overall Study|Lost to Follow-up|0|||
143174695|NCT02921789|516188508|FG000|Overall Study|Protocol Deviation|2|||
143174696|NCT02921789|516188509|FG001|Overall Study|Protocol Deviation|0|||
143174697|NCT02921789|516188508|FG000|Overall Study|Withdrawal by Subject|2|||
143174698|NCT02921789|516188509|FG001|Overall Study|Withdrawal by Subject|1|||
143174699|NCT02921789|516188508|FG000|Overall Study|Miscellaneous|3|||
143249691|NCT00830869|516468718|FG002|Period 2: Part 2|Progressive disease|0|||
143249692|NCT00830869|516468719|FG003|Period 2: Part 2|Progressive disease|0|||
143249693|NCT00830869|516468720|FG004|Period 2: Part 2|Progressive disease|0|||
143249694|NCT00830869|516468721|FG005|Period 2: Part 2|Progressive disease|0|||
143249695|NCT00830869|516468722|FG006|Period 2: Part 2|Progressive disease|0|||
143249696|NCT00830869|516468723|FG007|Period 2: Part 2|Progressive disease|14|||
143249697|NCT00830869|516468724|FG008|Period 2: Part 2|Progressive disease|11|||
143249698|NCT00830869|516468725|FG009|Period 2: Part 2|Progressive disease|12|||
143249699|NCT00830869|516468726|FG010|Period 2: Part 2|Progressive disease|8|||
143249700|NCT00830869|516468727|FG011|Period 2: Part 2|Progressive disease|15|||
143249701|NCT00830869|516468716|FG000|Period 2: Part 2|Other|0|||
143249702|NCT00830869|516468717|FG001|Period 2: Part 2|Other|0|||
143249703|NCT00830869|516468718|FG002|Period 2: Part 2|Other|0|||
143249704|NCT00830869|516468719|FG003|Period 2: Part 2|Other|0|||
143249705|NCT00830869|516468720|FG004|Period 2: Part 2|Other|0|||
143249706|NCT00830869|516468721|FG005|Period 2: Part 2|Other|0|||
143249707|NCT00830869|516468722|FG006|Period 2: Part 2|Other|0|||
143249708|NCT00830869|516468723|FG007|Period 2: Part 2|Other|0|||
143249709|NCT00830869|516468724|FG008|Period 2: Part 2|Other|0|||
143249710|NCT00830869|516468725|FG009|Period 2: Part 2|Other|1|||
143249711|NCT00830869|516468726|FG010|Period 2: Part 2|Other|0|||
143249712|NCT00830869|516468727|FG011|Period 2: Part 2|Other|0|||
143249713|NCT00281658|516468732|FG000|Randomized Phase|Adverse Event|0|||
143249714|NCT00281658|516468733|FG001|Randomized Phase|Adverse Event|2|||
143249715|NCT00281658|516468734|FG002|Randomized Phase|Adverse Event|0|||
143249716|NCT00281658|516468735|FG003|Randomized Phase|Adverse Event|0|||
143249717|NCT00281658|516468732|FG000|Randomized Phase|Lost to Follow-up|34|||
143249718|NCT00281658|516468733|FG001|Randomized Phase|Lost to Follow-up|27|||
143249719|NCT00281658|516468734|FG002|Randomized Phase|Lost to Follow-up|0|||
143249720|NCT00281658|516468735|FG003|Randomized Phase|Lost to Follow-up|0|||
143249721|NCT00281658|516468732|FG000|Randomized Phase|Withdrawal by Subject|8|||
143249722|NCT00281658|516468733|FG001|Randomized Phase|Withdrawal by Subject|7|||
143249723|NCT00281658|516468734|FG002|Randomized Phase|Withdrawal by Subject|0|||
143249724|NCT00281658|516468735|FG003|Randomized Phase|Withdrawal by Subject|0|||
143249725|NCT00281658|516468732|FG000|Randomized Phase|Study closed/terminated|1|||
143249726|NCT00281658|516468733|FG001|Randomized Phase|Study closed/terminated|1|||
143249727|NCT00281658|516468734|FG002|Randomized Phase|Study closed/terminated|0|||
143249728|NCT00281658|516468735|FG003|Randomized Phase|Study closed/terminated|0|||
143249729|NCT00281658|516468732|FG000|Randomized Phase|Disease progression|36|||
143249730|NCT00281658|516468733|FG001|Randomized Phase|Disease progression|27|||
143249731|NCT00281658|516468734|FG002|Randomized Phase|Disease progression|0|||
143249732|NCT00281658|516468735|FG003|Randomized Phase|Disease progression|0|||
143249733|NCT00281658|516468732|FG000|Randomized Phase|Physician Decision|1|||
143249734|NCT00281658|516468733|FG001|Randomized Phase|Physician Decision|1|||
143249735|NCT00281658|516468734|FG002|Randomized Phase|Physician Decision|0|||
143249736|NCT00281658|516468735|FG003|Randomized Phase|Physician Decision|0|||
143249737|NCT00281658|516468732|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
143174700|NCT02921789|516188509|FG001|Overall Study|Miscellaneous|2|||
143249738|NCT00281658|516468733|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
143249739|NCT00281658|516468734|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
143249740|NCT00281658|516468735|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
143249741|NCT00281658|516468732|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
143249742|NCT00281658|516468733|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
143174701|NCT04099277|516188510|FG000|Overall Study|Physician Decision|1|||
143174702|NCT04099277|516188510|FG000|Overall Study|Withdrawal by Subject|1|||
143174703|NCT00305877|516188511|FG000|Overall Study|Lack of Efficacy|6|||
143174704|NCT00305877|516188512|FG001|Overall Study|Lack of Efficacy|9|||
143174705|NCT00305877|516188511|FG000|Overall Study|Adverse Event|9|||
143174706|NCT00305877|516188512|FG001|Overall Study|Adverse Event|14|||
143174707|NCT00305877|516188511|FG000|Overall Study|Death|0|||
143249743|NCT00281658|516468734|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
143249744|NCT00281658|516468735|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
143249745|NCT00281658|516468732|FG000|Randomized Phase|Treatment ongoing|1|||
143249746|NCT00281658|516468733|FG001|Randomized Phase|Treatment ongoing|0|||
143085816|NCT02969044|515852342|FG001|Overall Study|Adverse Event|0|||
143085817|NCT04728802|515852343|FG000|Overall Study|Withdrawal by Subject|4|||
143085818|NCT04728802|515852344|FG001|Overall Study|Withdrawal by Subject|20|||
143085819|NCT04728802|515852343|FG000|Overall Study|Physician Decision|7|||
143085820|NCT04728802|515852344|FG001|Overall Study|Physician Decision|7|||
143085821|NCT04728802|515852343|FG000|Overall Study|Protocol Violation|10|||
143085822|NCT04728802|515852344|FG001|Overall Study|Protocol Violation|4|||
143085823|NCT04728802|515852343|FG000|Overall Study|Transfer|1|||
143085824|NCT04728802|515852344|FG001|Overall Study|Transfer|0|||
143085825|NCT04728802|515852343|FG000|Overall Study|Death|4|||
143085826|NCT04728802|515852344|FG001|Overall Study|Death|5|||
143085827|NCT04728802|515852343|FG000|Overall Study|Other|3|||
143085828|NCT04728802|515852344|FG001|Overall Study|Other|0|||
143085829|NCT04650204|515852345|FG000|Overall Study|Study was Terminated|2|||
143085830|NCT04650204|515852346|FG001|Overall Study|Study was Terminated|1|||
143085831|NCT01330303|515852347|FG000|Period 1|Adverse Event|1|||
143085832|NCT01330303|515852348|FG001|Period 1|Adverse Event|0|||
143085833|NCT01330303|515852347|FG000|Period 1|Protocol Violation|0|||
143085834|NCT01330303|515852348|FG001|Period 1|Protocol Violation|1|||
143085835|NCT01330303|515852347|FG000|Period 1|Withdrawal by Subject|0|||
143085836|NCT01330303|515852348|FG001|Period 1|Withdrawal by Subject|1|||
143085837|NCT01107197|515852349|FG000|Overall Study|Death|12|||
143085838|NCT01107197|515852350|FG001|Overall Study|Death|10|||
143085839|NCT01107197|515852349|FG000|Overall Study|Lost to Follow-up|5|||
143085840|NCT01107197|515852350|FG001|Overall Study|Lost to Follow-up|8|||
143085841|NCT01107197|515852349|FG000|Overall Study|Withdrawal by Subject|3|||
143085842|NCT01107197|515852350|FG001|Overall Study|Withdrawal by Subject|5|||
143085843|NCT02593110|515852352|FG000|Overall Study|Withdrawal by Subject|0|||
143085844|NCT02593110|515852353|FG001|Overall Study|Withdrawal by Subject|3|||
143085845|NCT02593110|515852354|FG002|Overall Study|Withdrawal by Subject|3|||
143085846|NCT02593110|515852355|FG003|Overall Study|Withdrawal by Subject|2|||
143085847|NCT02593110|515852352|FG000|Overall Study|Death|0|||
143085848|NCT02593110|515852353|FG001|Overall Study|Death|0|||
143085849|NCT02593110|515852354|FG002|Overall Study|Death|1|||
143085850|NCT02593110|515852355|FG003|Overall Study|Death|0|||
143085851|NCT01911273|515852357|FG000|Overall Study|Progression of Disease|1|||
143085852|NCT01911273|515852358|FG001|Overall Study|Progression of Disease|0|||
143085853|NCT01911273|515852357|FG000|Overall Study|Withdrawal by Subject|0|||
143085854|NCT01911273|515852358|FG001|Overall Study|Withdrawal by Subject|2|||
143085855|NCT00839254|515852360|FG000|Overall Study|Protocol Violation|0|||
143085856|NCT00839254|515852361|FG001|Overall Study|Protocol Violation|1|||
143085857|NCT00839254|515852362|FG002|Overall Study|Protocol Violation|1|||
143085858|NCT00839254|515852363|FG003|Overall Study|Protocol Violation|1|||
143085859|NCT00839254|515852364|FG004|Overall Study|Protocol Violation|0|||
143085860|NCT00839254|515852365|FG005|Overall Study|Protocol Violation|0|||
143085861|NCT00839254|515852366|FG006|Overall Study|Protocol Violation|1|||
143085862|NCT00839254|515852367|FG007|Overall Study|Protocol Violation|2|||
143085863|NCT00839254|515852360|FG000|Overall Study|Physician Decision|0|||
143085864|NCT00839254|515852361|FG001|Overall Study|Physician Decision|1|||
143085865|NCT00839254|515852362|FG002|Overall Study|Physician Decision|0|||
143085866|NCT00839254|515852363|FG003|Overall Study|Physician Decision|0|||
143085867|NCT00839254|515852364|FG004|Overall Study|Physician Decision|0|||
143085868|NCT00839254|515852365|FG005|Overall Study|Physician Decision|0|||
143174708|NCT00305877|516188512|FG001|Overall Study|Death|1|||
143174709|NCT00305877|516188511|FG000|Overall Study|Withdrawal by Subject|4|||
143174710|NCT00305877|516188512|FG001|Overall Study|Withdrawal by Subject|2|||
143174711|NCT00305877|516188511|FG000|Overall Study|Physician Decision|1|||
143174712|NCT00305877|516188512|FG001|Overall Study|Physician Decision|1|||
143174713|NCT00305877|516188511|FG000|Overall Study|Never start treatment|2|||
143174714|NCT00305877|516188512|FG001|Overall Study|Never start treatment|5|||
143174715|NCT00305877|516188511|FG000|Overall Study|Ineligible|2|||
143174716|NCT00305877|516188512|FG001|Overall Study|Ineligible|1|||
143085869|NCT00839254|515852366|FG006|Overall Study|Physician Decision|0|||
143085870|NCT00839254|515852367|FG007|Overall Study|Physician Decision|1|||
143085871|NCT00839254|515852360|FG000|Overall Study|Wrong treatment number allocation|0|||
143085872|NCT00839254|515852361|FG001|Overall Study|Wrong treatment number allocation|1|||
143085873|NCT00839254|515852362|FG002|Overall Study|Wrong treatment number allocation|0|||
143085874|NCT00839254|515852363|FG003|Overall Study|Wrong treatment number allocation|0|||
143085875|NCT00839254|515852364|FG004|Overall Study|Wrong treatment number allocation|0|||
143085876|NCT00839254|515852365|FG005|Overall Study|Wrong treatment number allocation|1|||
143085877|NCT00839254|515852366|FG006|Overall Study|Wrong treatment number allocation|0|||
143085878|NCT00839254|515852367|FG007|Overall Study|Wrong treatment number allocation|0|||
143085879|NCT00839254|515852360|FG000|Overall Study|Adverse Event|12|||
143085880|NCT00839254|515852361|FG001|Overall Study|Adverse Event|6|||
143085881|NCT00839254|515852362|FG002|Overall Study|Adverse Event|3|||
143085882|NCT00839254|515852363|FG003|Overall Study|Adverse Event|5|||
143085883|NCT00839254|515852364|FG004|Overall Study|Adverse Event|2|||
143085884|NCT00839254|515852365|FG005|Overall Study|Adverse Event|1|||
143174717|NCT00305877|516188511|FG000|Overall Study|Transportation issue with daily RT|0|||
143085885|NCT00839254|515852366|FG006|Overall Study|Adverse Event|0|||
143085886|NCT00839254|515852367|FG007|Overall Study|Adverse Event|1|||
143085887|NCT00839254|515852360|FG000|Overall Study|Withdrawal by Subject|87|||
143085888|NCT00839254|515852361|FG001|Overall Study|Withdrawal by Subject|53|||
143085889|NCT00839254|515852362|FG002|Overall Study|Withdrawal by Subject|54|||
143085890|NCT00839254|515852363|FG003|Overall Study|Withdrawal by Subject|32|||
143085891|NCT00839254|515852364|FG004|Overall Study|Withdrawal by Subject|27|||
143085892|NCT00839254|515852365|FG005|Overall Study|Withdrawal by Subject|15|||
143085893|NCT00839254|515852366|FG006|Overall Study|Withdrawal by Subject|22|||
143085894|NCT00839254|515852367|FG007|Overall Study|Withdrawal by Subject|9|||
143085895|NCT00839254|515852360|FG000|Overall Study|Wrong group allocation|0|||
143085896|NCT00839254|515852361|FG001|Overall Study|Wrong group allocation|0|||
143085897|NCT00839254|515852362|FG002|Overall Study|Wrong group allocation|0|||
143085898|NCT00839254|515852363|FG003|Overall Study|Wrong group allocation|0|||
143085899|NCT00839254|515852364|FG004|Overall Study|Wrong group allocation|0|||
143085900|NCT00839254|515852365|FG005|Overall Study|Wrong group allocation|0|||
143085901|NCT00839254|515852366|FG006|Overall Study|Wrong group allocation|1|||
143085902|NCT00839254|515852367|FG007|Overall Study|Wrong group allocation|0|||
143085903|NCT00839254|515852360|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
143085904|NCT00839254|515852361|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
143174718|NCT00305877|516188512|FG001|Overall Study|Transportation issue with daily RT|1|||
143174719|NCT01126190|516188515|FG000|Double-Blind Phase|Death|0|||
143174720|NCT01126190|516188516|FG001|Double-Blind Phase|Death|1|||
143174721|NCT01126190|516188517|FG002|Double-Blind Phase|Death|0|||
143174722|NCT01126190|516188515|FG000|Double-Blind Phase|Adverse Event|1|||
143174723|NCT01126190|516188516|FG001|Double-Blind Phase|Adverse Event|2|||
143174724|NCT01126190|516188517|FG002|Double-Blind Phase|Adverse Event|0|||
143174725|NCT01126190|516188515|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
143174726|NCT01126190|516188516|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
143174727|NCT01126190|516188517|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
143174728|NCT01126190|516188515|FG000|Double-Blind Phase|Request of Investigator|1|||
143085905|NCT00839254|515852362|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
143085906|NCT00839254|515852363|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
143085907|NCT00839254|515852364|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
143174729|NCT01126190|516188516|FG001|Double-Blind Phase|Request of Investigator|0|||
143174730|NCT01126190|516188517|FG002|Double-Blind Phase|Request of Investigator|0|||
143085908|NCT00839254|515852365|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
143085909|NCT00839254|515852366|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
143085910|NCT00839254|515852367|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
143085911|NCT00839254|515852360|FG000|Overall Study|Withdrawn due to non-compliance|2|||
143085912|NCT00839254|515852361|FG001|Overall Study|Withdrawn due to non-compliance|0|||
143085913|NCT00839254|515852362|FG002|Overall Study|Withdrawn due to non-compliance|0|||
143085914|NCT00839254|515852363|FG003|Overall Study|Withdrawn due to non-compliance|0|||
143085915|NCT00839254|515852364|FG004|Overall Study|Withdrawn due to non-compliance|0|||
143085916|NCT00839254|515852365|FG005|Overall Study|Withdrawn due to non-compliance|0|||
143085917|NCT00839254|515852366|FG006|Overall Study|Withdrawn due to non-compliance|0|||
143085918|NCT00839254|515852367|FG007|Overall Study|Withdrawn due to non-compliance|0|||
143085919|NCT00839254|515852360|FG000|Overall Study|Lost to Follow-up|51|||
143085920|NCT00839254|515852361|FG001|Overall Study|Lost to Follow-up|30|||
143085921|NCT00839254|515852362|FG002|Overall Study|Lost to Follow-up|32|||
143085922|NCT00839254|515852363|FG003|Overall Study|Lost to Follow-up|24|||
143085923|NCT00839254|515852364|FG004|Overall Study|Lost to Follow-up|8|||
143085924|NCT00839254|515852365|FG005|Overall Study|Lost to Follow-up|8|||
143085925|NCT00839254|515852366|FG006|Overall Study|Lost to Follow-up|4|||
143085926|NCT00839254|515852367|FG007|Overall Study|Lost to Follow-up|2|||
143085927|NCT04597632|515852370|FG000|Overall Study|Withdrawal by Subject|10|||
143085928|NCT04597632|515852370|FG000|Overall Study|Lost to Follow-up|1|||
143085929|NCT04597632|515852370|FG000|Overall Study|Death|1|||
143085930|NCT04597632|515852370|FG000|Overall Study|Adverse Event|5|||
143085931|NCT01823835|515852371|FG000|Overall Study|Adverse Event|0|||
143085932|NCT01823835|515852372|FG001|Overall Study|Adverse Event|0|||
143085933|NCT01823835|515852373|FG002|Overall Study|Adverse Event|0|||
143085934|NCT01823835|515852374|FG003|Overall Study|Adverse Event|0|||
143085935|NCT01823835|515852375|FG004|Overall Study|Adverse Event|1|||
143085936|NCT01823835|515852376|FG005|Overall Study|Adverse Event|0|||
143085937|NCT01823835|515852377|FG006|Overall Study|Adverse Event|1|||
143085938|NCT01823835|515852378|FG007|Overall Study|Adverse Event|0|||
143085939|NCT01823835|515852379|FG008|Overall Study|Adverse Event|0|||
143085940|NCT01823835|515852380|FG009|Overall Study|Adverse Event|0|||
143085941|NCT01823835|515852381|FG010|Overall Study|Adverse Event|1|||
143085942|NCT01823835|515852382|FG011|Overall Study|Adverse Event|2|||
143085943|NCT01823835|515852383|FG012|Overall Study|Adverse Event|0|||
143085944|NCT01823835|515852384|FG013|Overall Study|Adverse Event|0|||
143085945|NCT01823835|515852385|FG014|Overall Study|Adverse Event|0|||
143085946|NCT01823835|515852371|FG000|Overall Study|Physician Decision|0|||
143085947|NCT01823835|515852372|FG001|Overall Study|Physician Decision|0|||
143085948|NCT01823835|515852373|FG002|Overall Study|Physician Decision|0|||
143085949|NCT01823835|515852374|FG003|Overall Study|Physician Decision|0|||
143085950|NCT01823835|515852375|FG004|Overall Study|Physician Decision|0|||
143085951|NCT01823835|515852376|FG005|Overall Study|Physician Decision|0|||
143085952|NCT01823835|515852377|FG006|Overall Study|Physician Decision|0|||
143085953|NCT01823835|515852378|FG007|Overall Study|Physician Decision|0|||
143085954|NCT01823835|515852379|FG008|Overall Study|Physician Decision|0|||
143085955|NCT01823835|515852380|FG009|Overall Study|Physician Decision|0|||
143085956|NCT01823835|515852381|FG010|Overall Study|Physician Decision|0|||
143085957|NCT01823835|515852382|FG011|Overall Study|Physician Decision|2|||
143085958|NCT01823835|515852383|FG012|Overall Study|Physician Decision|0|||
143085959|NCT01823835|515852384|FG013|Overall Study|Physician Decision|0|||
143085960|NCT01823835|515852385|FG014|Overall Study|Physician Decision|0|||
143085961|NCT01823835|515852371|FG000|Overall Study|Progressive Disease|3|||
143085962|NCT01823835|515852372|FG001|Overall Study|Progressive Disease|4|||
143085963|NCT01823835|515852373|FG002|Overall Study|Progressive Disease|3|||
143085964|NCT01823835|515852374|FG003|Overall Study|Progressive Disease|6|||
143085965|NCT01823835|515852375|FG004|Overall Study|Progressive Disease|4|||
143085966|NCT01823835|515852376|FG005|Overall Study|Progressive Disease|6|||
143085967|NCT01823835|515852377|FG006|Overall Study|Progressive Disease|5|||
143085968|NCT01823835|515852378|FG007|Overall Study|Progressive Disease|3|||
143174731|NCT01126190|516188515|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
143174732|NCT01126190|516188516|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
143085969|NCT01823835|515852379|FG008|Overall Study|Progressive Disease|3|||
143085970|NCT01823835|515852380|FG009|Overall Study|Progressive Disease|18|||
143085971|NCT01823835|515852381|FG010|Overall Study|Progressive Disease|8|||
143085972|NCT01823835|515852382|FG011|Overall Study|Progressive Disease|46|||
143085973|NCT01823835|515852383|FG012|Overall Study|Progressive Disease|18|||
143085974|NCT01823835|515852384|FG013|Overall Study|Progressive Disease|4|||
143085975|NCT01823835|515852385|FG014|Overall Study|Progressive Disease|6|||
143085976|NCT01823835|515852371|FG000|Overall Study|Study Termination|0|||
143085977|NCT01823835|515852372|FG001|Overall Study|Study Termination|0|||
143085978|NCT01823835|515852373|FG002|Overall Study|Study Termination|0|||
143085979|NCT01823835|515852374|FG003|Overall Study|Study Termination|0|||
143174733|NCT01126190|516188517|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
143085980|NCT01823835|515852375|FG004|Overall Study|Study Termination|1|||
143085981|NCT01823835|515852376|FG005|Overall Study|Study Termination|0|||
143085982|NCT01823835|515852377|FG006|Overall Study|Study Termination|0|||
143085983|NCT01823835|515852378|FG007|Overall Study|Study Termination|0|||
143085984|NCT01823835|515852379|FG008|Overall Study|Study Termination|0|||
143085985|NCT01823835|515852380|FG009|Overall Study|Study Termination|0|||
143085986|NCT01823835|515852381|FG010|Overall Study|Study Termination|0|||
143085987|NCT01823835|515852382|FG011|Overall Study|Study Termination|1|||
143085988|NCT01823835|515852383|FG012|Overall Study|Study Termination|0|||
143085989|NCT01823835|515852384|FG013|Overall Study|Study Termination|0|||
143085990|NCT01823835|515852385|FG014|Overall Study|Study Termination|0|||
143085991|NCT01823835|515852371|FG000|Overall Study|Withdrawal by Subject|0|||
143085992|NCT01823835|515852372|FG001|Overall Study|Withdrawal by Subject|0|||
143085993|NCT01823835|515852373|FG002|Overall Study|Withdrawal by Subject|1|||
143085994|NCT01823835|515852374|FG003|Overall Study|Withdrawal by Subject|0|||
143085995|NCT01823835|515852375|FG004|Overall Study|Withdrawal by Subject|0|||
143085996|NCT01823835|515852376|FG005|Overall Study|Withdrawal by Subject|0|||
143085997|NCT01823835|515852377|FG006|Overall Study|Withdrawal by Subject|0|||
143085998|NCT01823835|515852378|FG007|Overall Study|Withdrawal by Subject|0|||
143085999|NCT01823835|515852379|FG008|Overall Study|Withdrawal by Subject|0|||
143086000|NCT01823835|515852380|FG009|Overall Study|Withdrawal by Subject|1|||
143086001|NCT01823835|515852381|FG010|Overall Study|Withdrawal by Subject|1|||
143086002|NCT01823835|515852382|FG011|Overall Study|Withdrawal by Subject|2|||
143086003|NCT01823835|515852383|FG012|Overall Study|Withdrawal by Subject|1|||
143086004|NCT01823835|515852384|FG013|Overall Study|Withdrawal by Subject|0|||
143086005|NCT01823835|515852385|FG014|Overall Study|Withdrawal by Subject|0|||
143086006|NCT03017612|515852386|FG000|Overall Study|Adverse Event|2|||
143086007|NCT01320150|515852387|FG000|Overall Study|Protocol Violation|15|||
143086008|NCT01320150|515852387|FG000|Overall Study|Withdrawal by Subject|5|||
143086009|NCT01320150|515852387|FG000|Overall Study|Death|2|||
143086010|NCT01320150|515852387|FG000|Overall Study|Lost to Follow-up|44|||
143086011|NCT04895982|515852388|FG000|Overall Study|Withdrawal by Subject|0|||
143086012|NCT04895982|515852389|FG001|Overall Study|Withdrawal by Subject|0|||
143086013|NCT04895982|515852390|FG002|Overall Study|Withdrawal by Subject|0|||
143086014|NCT04895982|515852391|FG003|Overall Study|Withdrawal by Subject|0|||
143086015|NCT04895982|515852392|FG004|Overall Study|Withdrawal by Subject|0|||
143086016|NCT04895982|515852393|FG005|Overall Study|Withdrawal by Subject|1|||
143086017|NCT04895982|515852394|FG006|Overall Study|Withdrawal by Subject|1|||
143086018|NCT04895982|515852395|FG007|Overall Study|Withdrawal by Subject|0|||
143086019|NCT04895982|515852396|FG008|Overall Study|Withdrawal by Subject|0|||
143086020|NCT04895982|515852397|FG009|Overall Study|Withdrawal by Subject|1|||
143086021|NCT04895982|515852398|FG010|Overall Study|Withdrawal by Subject|0|||
143249747|NCT00281658|516468734|FG002|Randomized Phase|Treatment ongoing|0|||
143249748|NCT00281658|516468735|FG003|Randomized Phase|Treatment ongoing|0|||
143249749|NCT00281658|516468732|FG000|Open Label Phase|Adverse Event|0|||
143249750|NCT00281658|516468733|FG001|Open Label Phase|Adverse Event|0|||
143249751|NCT00281658|516468734|FG002|Open Label Phase|Adverse Event|1|||
143249752|NCT00281658|516468735|FG003|Open Label Phase|Adverse Event|0|||
143249753|NCT00281658|516468732|FG000|Open Label Phase|Lost to Follow-up|0|||
143249754|NCT00281658|516468733|FG001|Open Label Phase|Lost to Follow-up|0|||
143249755|NCT00281658|516468734|FG002|Open Label Phase|Lost to Follow-up|16|||
143249756|NCT00281658|516468735|FG003|Open Label Phase|Lost to Follow-up|2|||
143366661|NCT00991276|516887132|FG001|Third Intervention Period|Protocol Violation|0|||
143366662|NCT00991276|516887133|FG002|Third Intervention Period|Protocol Violation|0|||
143366663|NCT00991276|516887134|FG003|Third Intervention Period|Protocol Violation|0|||
143366664|NCT00991276|516887135|FG004|Third Intervention Period|Protocol Violation|0|||
143366665|NCT00991276|516887136|FG005|Third Intervention Period|Protocol Violation|0|||
143366666|NCT00991276|516887131|FG000|Third Intervention Period|Other|0|||
143366667|NCT00991276|516887132|FG001|Third Intervention Period|Other|0|||
143366668|NCT00991276|516887133|FG002|Third Intervention Period|Other|0|||
143366669|NCT00991276|516887134|FG003|Third Intervention Period|Other|0|||
143366670|NCT00991276|516887135|FG004|Third Intervention Period|Other|0|||
143086022|NCT04895982|515852399|FG011|Overall Study|Withdrawal by Subject|1|||
143086023|NCT04895982|515852388|FG000|Overall Study|Withdrawal by parent/guardian|2|||
143086024|NCT04895982|515852389|FG001|Overall Study|Withdrawal by parent/guardian|3|||
143086025|NCT04895982|515852390|FG002|Overall Study|Withdrawal by parent/guardian|3|||
143366671|NCT00991276|516887136|FG005|Third Intervention Period|Other|1|||
143086026|NCT04895982|515852391|FG003|Overall Study|Withdrawal by parent/guardian|1|||
143086027|NCT04895982|515852392|FG004|Overall Study|Withdrawal by parent/guardian|3|||
143086028|NCT04895982|515852393|FG005|Overall Study|Withdrawal by parent/guardian|2|||
143086029|NCT04895982|515852394|FG006|Overall Study|Withdrawal by parent/guardian|1|||
143086030|NCT04895982|515852395|FG007|Overall Study|Withdrawal by parent/guardian|0|||
143086031|NCT04895982|515852396|FG008|Overall Study|Withdrawal by parent/guardian|3|||
143086032|NCT04895982|515852397|FG009|Overall Study|Withdrawal by parent/guardian|0|||
143086033|NCT04895982|515852398|FG010|Overall Study|Withdrawal by parent/guardian|0|||
143086034|NCT04895982|515852399|FG011|Overall Study|Withdrawal by parent/guardian|0|||
143086035|NCT04895982|515852388|FG000|Overall Study|Other|0|||
143086036|NCT04895982|515852389|FG001|Overall Study|Other|0|||
143249757|NCT00281658|516468732|FG000|Open Label Phase|Withdrawal by Subject|0|||
143086037|NCT04895982|515852390|FG002|Overall Study|Other|1|||
143086038|NCT04895982|515852391|FG003|Overall Study|Other|1|||
143086039|NCT04895982|515852392|FG004|Overall Study|Other|0|||
143086040|NCT04895982|515852393|FG005|Overall Study|Other|0|||
143086041|NCT04895982|515852394|FG006|Overall Study|Other|0|||
143086042|NCT04895982|515852395|FG007|Overall Study|Other|0|||
143086043|NCT04895982|515852396|FG008|Overall Study|Other|0|||
143086044|NCT04895982|515852397|FG009|Overall Study|Other|1|||
143086045|NCT04895982|515852398|FG010|Overall Study|Other|0|||
143086046|NCT04895982|515852399|FG011|Overall Study|Other|0|||
143086047|NCT04895982|515852388|FG000|Overall Study|Protocol Violation|0|||
143086048|NCT04895982|515852389|FG001|Overall Study|Protocol Violation|0|||
143086049|NCT04895982|515852390|FG002|Overall Study|Protocol Violation|1|||
143086050|NCT04895982|515852391|FG003|Overall Study|Protocol Violation|1|||
143086051|NCT04895982|515852392|FG004|Overall Study|Protocol Violation|1|||
143086052|NCT04895982|515852393|FG005|Overall Study|Protocol Violation|0|||
143086053|NCT04895982|515852394|FG006|Overall Study|Protocol Violation|0|||
143086054|NCT04895982|515852395|FG007|Overall Study|Protocol Violation|1|||
143086055|NCT04895982|515852396|FG008|Overall Study|Protocol Violation|0|||
143086056|NCT04895982|515852397|FG009|Overall Study|Protocol Violation|0|||
143086057|NCT04895982|515852398|FG010|Overall Study|Protocol Violation|0|||
143086058|NCT04895982|515852399|FG011|Overall Study|Protocol Violation|0|||
143086059|NCT04895982|515852388|FG000|Overall Study|Lost to Follow-up|0|||
143086060|NCT04895982|515852389|FG001|Overall Study|Lost to Follow-up|0|||
143086061|NCT04895982|515852390|FG002|Overall Study|Lost to Follow-up|1|||
143086062|NCT04895982|515852391|FG003|Overall Study|Lost to Follow-up|0|||
143086063|NCT04895982|515852392|FG004|Overall Study|Lost to Follow-up|0|||
143086064|NCT04895982|515852393|FG005|Overall Study|Lost to Follow-up|1|||
143086065|NCT04895982|515852394|FG006|Overall Study|Lost to Follow-up|0|||
143174734|NCT01126190|516188515|FG000|Double-Blind Phase|Non-compliance|1|||
143174735|NCT01126190|516188516|FG001|Double-Blind Phase|Non-compliance|0|||
143174736|NCT01126190|516188517|FG002|Double-Blind Phase|Non-compliance|0|||
143174737|NCT01126190|516188515|FG000|Double-Blind Phase|Lost to Follow-up|1|||
143174738|NCT01126190|516188516|FG001|Double-Blind Phase|Lost to Follow-up|3|||
143174739|NCT01126190|516188517|FG002|Double-Blind Phase|Lost to Follow-up|0|||
143174740|NCT01126190|516188515|FG000|Open-Label Phase|Death|0|||
143174741|NCT01126190|516188516|FG001|Open-Label Phase|Death|0|||
143174742|NCT01126190|516188517|FG002|Open-Label Phase|Death|1|||
143174743|NCT01126190|516188515|FG000|Open-Label Phase|Adverse Event|0|||
143174744|NCT01126190|516188516|FG001|Open-Label Phase|Adverse Event|0|||
143174745|NCT01126190|516188517|FG002|Open-Label Phase|Adverse Event|4|||
143174746|NCT01126190|516188515|FG000|Open-Label Phase|Withdrawal by Subject|0|||
143174747|NCT01126190|516188516|FG001|Open-Label Phase|Withdrawal by Subject|0|||
143174748|NCT01126190|516188517|FG002|Open-Label Phase|Withdrawal by Subject|6|||
143174749|NCT00524121|516188518|FG000|Overall Study|Disease progression|6|||
143174750|NCT00524121|516188518|FG000|Overall Study|Adverse Event|4|||
143174751|NCT00524121|516188518|FG000|Overall Study|Patient refused|2|||
143174752|NCT00524121|516188518|FG000|Overall Study|Other|1|||
143174753|NCT00524121|516188518|FG000|Overall Study|Death|1|||
143174754|NCT00524121|516188518|FG000|Overall Study|Not treated (became ineligible)|4|||
143174755|NCT00524121|516188518|FG000|Overall Study|Not treated (changed mind)|1|||
143174756|NCT01446874|516188519|FG000|Overall Study|Not eligible|1|||
143174757|NCT01446874|516188520|FG001|Overall Study|Not eligible|0|||
143249758|NCT00281658|516468733|FG001|Open Label Phase|Withdrawal by Subject|0|||
143249759|NCT00281658|516468734|FG002|Open Label Phase|Withdrawal by Subject|3|||
143249760|NCT00281658|516468735|FG003|Open Label Phase|Withdrawal by Subject|2|||
143249761|NCT00281658|516468732|FG000|Open Label Phase|Disease progression|0|||
143249762|NCT00281658|516468733|FG001|Open Label Phase|Disease progression|0|||
143249763|NCT00281658|516468734|FG002|Open Label Phase|Disease progression|18|||
143086066|NCT04895982|515852395|FG007|Overall Study|Lost to Follow-up|0|||
143086067|NCT04895982|515852396|FG008|Overall Study|Lost to Follow-up|1|||
143086068|NCT04895982|515852397|FG009|Overall Study|Lost to Follow-up|0|||
143086069|NCT04895982|515852398|FG010|Overall Study|Lost to Follow-up|0|||
143086070|NCT04895982|515852399|FG011|Overall Study|Lost to Follow-up|0|||
143086071|NCT04895982|515852388|FG000|Overall Study|Refused further study procedures|0|||
143086072|NCT04895982|515852389|FG001|Overall Study|Refused further study procedures|0|||
143086073|NCT04895982|515852390|FG002|Overall Study|Refused further study procedures|1|||
143086074|NCT04895982|515852391|FG003|Overall Study|Refused further study procedures|0|||
143086075|NCT04895982|515852392|FG004|Overall Study|Refused further study procedures|0|||
143174758|NCT01446874|516188521|FG002|Overall Study|Not eligible|0|||
143174759|NCT01446874|516188519|FG000|Overall Study|No surgery/No qualifying surgery|1|||
143174760|NCT01446874|516188520|FG001|Overall Study|No surgery/No qualifying surgery|0|||
143086076|NCT04895982|515852393|FG005|Overall Study|Refused further study procedures|0|||
143174761|NCT01446874|516188521|FG002|Overall Study|No surgery/No qualifying surgery|12|||
143249764|NCT00281658|516468735|FG003|Open Label Phase|Disease progression|0|||
143086077|NCT04895982|515852394|FG006|Overall Study|Refused further study procedures|0|||
143086078|NCT04895982|515852395|FG007|Overall Study|Refused further study procedures|0|||
143086079|NCT04895982|515852396|FG008|Overall Study|Refused further study procedures|0|||
143086080|NCT04895982|515852397|FG009|Overall Study|Refused further study procedures|0|||
143086081|NCT04895982|515852398|FG010|Overall Study|Refused further study procedures|0|||
143086082|NCT04895982|515852399|FG011|Overall Study|Refused further study procedures|0|||
143086083|NCT00919854|515852402|FG000|Overall Study|Adverse Event|1|||
143086084|NCT00985491|515852403|FG000|Overall Study|Adverse Event|8|||
143086085|NCT00985491|515852403|FG000|Overall Study|device migration|7|||
143086086|NCT00985491|515852403|FG000|Overall Study|Withdrawal by Subject|1|||
143086087|NCT00985491|515852403|FG000|Overall Study|implant failure|3|||
143086088|NCT00489827|515852408|FG000|Overall Study|Intraoperative exclusion criteria|1|||
143174762|NCT01446874|516188519|FG000|Overall Study|Non-compliance|0|||
143174763|NCT01446874|516188520|FG001|Overall Study|Non-compliance|4|||
143086089|NCT00489827|515852409|FG001|Overall Study|Intraoperative exclusion criteria|1|||
143086090|NCT00489827|515852408|FG000|Overall Study|Intraoperative exclusion criteria|1|||
143086091|NCT00489827|515852409|FG001|Overall Study|Intraoperative exclusion criteria|1|||
143174764|NCT01446874|516188521|FG002|Overall Study|Non-compliance|0|||
143174765|NCT01446874|516188519|FG000|Overall Study|Antibiotics for pre-op infection|0|||
143086092|NCT03086551|515852438|FG000|First Intervention|Failure to meet inclusion criterion|1|||
143086093|NCT03086551|515852439|FG001|First Intervention|Failure to meet inclusion criterion|0|||
143086094|NCT03086551|515852438|FG000|First Intervention|Lost to Follow-up|0|||
143086095|NCT03086551|515852439|FG001|First Intervention|Lost to Follow-up|1|||
143086096|NCT03086551|515852438|FG000|Washout|Lost to Follow-up|1|||
143086097|NCT03086551|515852439|FG001|Washout|Lost to Follow-up|2|||
143086098|NCT03086551|515852438|FG000|Washout|Withdrawal by Subject|2|||
143086099|NCT03086551|515852439|FG001|Washout|Withdrawal by Subject|1|||
143086100|NCT00625872|515852442|FG000|Overall Study|Withdrawal by Subject|1|||
143086101|NCT00625872|515852443|FG001|Overall Study|Withdrawal by Subject|0|||
143086102|NCT00625872|515852442|FG000|Overall Study|Does not meet inclusion criteria|1|||
143086103|NCT00625872|515852443|FG001|Overall Study|Does not meet inclusion criteria|0|||
143086104|NCT00625872|515852442|FG000|Overall Study|Terminated by sponsor|2|||
143086105|NCT00625872|515852443|FG001|Overall Study|Terminated by sponsor|5|||
143086106|NCT00625872|515852442|FG000|Overall Study|Randomized but not treated|0|||
143174766|NCT01446874|516188520|FG001|Overall Study|Antibiotics for pre-op infection|0|||
143249765|NCT00281658|516468732|FG000|Open Label Phase|Physician Decision|0|||
143174767|NCT01446874|516188521|FG002|Overall Study|Antibiotics for pre-op infection|2|||
143174768|NCT01446874|516188519|FG000|Overall Study|Withdrawal by Subject|0|||
143174769|NCT01446874|516188520|FG001|Overall Study|Withdrawal by Subject|0|||
143174770|NCT01446874|516188521|FG002|Overall Study|Withdrawal by Subject|4|||
143174771|NCT01977898|516188522|FG000|Overall Study|Non functioning catheter|1|||
143174772|NCT01977898|516188523|FG001|Overall Study|Non functioning catheter|1|||
143174773|NCT01466491|516188527|FG000|Overall Study|Protocol Violation|0|||
143174774|NCT01466491|516188528|FG001|Overall Study|Protocol Violation|3|||
143174775|NCT01466491|516188529|FG002|Overall Study|Protocol Violation|2|||
143174776|NCT01466491|516188530|FG003|Overall Study|Protocol Violation|0|||
143174777|NCT01466491|516188527|FG000|Overall Study|Missing Data|0|||
143174778|NCT01466491|516188528|FG001|Overall Study|Missing Data|0|||
143174779|NCT01466491|516188529|FG002|Overall Study|Missing Data|1|||
143174780|NCT01466491|516188530|FG003|Overall Study|Missing Data|0|||
143174781|NCT02727322|516188531|FG000|Overall Study|Withdrawal by Subject|1|||
143174782|NCT02727322|516188532|FG001|Overall Study|Withdrawal by Subject|1|||
143174783|NCT02727322|516188531|FG000|Overall Study|Protocol Violation|1|||
143174784|NCT02727322|516188532|FG001|Overall Study|Protocol Violation|0|||
143174785|NCT02852967|516188533|FG000|Overall Study|Adverse Event|3|||
143174786|NCT02852967|516188534|FG001|Overall Study|Adverse Event|1|||
143174787|NCT02852967|516188535|FG002|Overall Study|Adverse Event|0|||
143174788|NCT02852967|516188536|FG003|Overall Study|Adverse Event|1|||
143174789|NCT02852967|516188537|FG004|Overall Study|Adverse Event|0|||
143174790|NCT02852967|516188533|FG000|Overall Study|Death|1|||
143174791|NCT02852967|516188534|FG001|Overall Study|Death|0|||
143174792|NCT02852967|516188535|FG002|Overall Study|Death|0|||
143174793|NCT02852967|516188536|FG003|Overall Study|Death|0|||
143174794|NCT02852967|516188537|FG004|Overall Study|Death|0|||
143174795|NCT02852967|516188533|FG000|Overall Study|Lost to Follow-up|1|||
143174796|NCT02852967|516188534|FG001|Overall Study|Lost to Follow-up|2|||
143174797|NCT02852967|516188535|FG002|Overall Study|Lost to Follow-up|3|||
143174798|NCT02852967|516188536|FG003|Overall Study|Lost to Follow-up|4|||
143174799|NCT02852967|516188537|FG004|Overall Study|Lost to Follow-up|4|||
143174800|NCT02852967|516188533|FG000|Overall Study|Withdrawal by Subject|6|||
143174801|NCT02852967|516188534|FG001|Overall Study|Withdrawal by Subject|12|||
143174802|NCT02852967|516188535|FG002|Overall Study|Withdrawal by Subject|7|||
143174803|NCT02852967|516188536|FG003|Overall Study|Withdrawal by Subject|10|||
143174804|NCT02852967|516188537|FG004|Overall Study|Withdrawal by Subject|10|||
143086107|NCT00625872|515852443|FG001|Overall Study|Randomized but not treated|1|||
143174805|NCT02852967|516188533|FG000|Overall Study|SAE|0|||
143174806|NCT02852967|516188534|FG001|Overall Study|SAE|0|||
143086108|NCT04208750|515852444|FG000|Overall Study|Lost to Follow-up|16|||
143086109|NCT04208750|515852445|FG001|Overall Study|Lost to Follow-up|15|||
143174807|NCT02852967|516188535|FG002|Overall Study|SAE|0|||
143174808|NCT02852967|516188536|FG003|Overall Study|SAE|3|||
143174809|NCT02852967|516188537|FG004|Overall Study|SAE|0|||
143174810|NCT02852967|516188533|FG000|Overall Study|Elevated Liver Enzymes|2|||
143174811|NCT02852967|516188534|FG001|Overall Study|Elevated Liver Enzymes|0|||
143174812|NCT02852967|516188535|FG002|Overall Study|Elevated Liver Enzymes|0|||
143249766|NCT00281658|516468733|FG001|Open Label Phase|Physician Decision|0|||
143249767|NCT00281658|516468734|FG002|Open Label Phase|Physician Decision|1|||
143174813|NCT02852967|516188536|FG003|Overall Study|Elevated Liver Enzymes|2|||
143086110|NCT02201277|515852446|FG000|Overall Study|Death|3|||
143174814|NCT02852967|516188537|FG004|Overall Study|Elevated Liver Enzymes|2|||
143086111|NCT02201277|515852447|FG001|Overall Study|Death|4|||
143086112|NCT02201277|515852446|FG000|Overall Study|Lost to Follow-up|2|||
143086113|NCT02201277|515852447|FG001|Overall Study|Lost to Follow-up|1|||
143086114|NCT02201277|515852446|FG000|Overall Study|Failed retrieval|1|||
143086115|NCT02201277|515852447|FG001|Overall Study|Failed retrieval|0|||
143086116|NCT02201277|515852446|FG000|Overall Study|Physician Decision|1|||
143249768|NCT00281658|516468735|FG003|Open Label Phase|Physician Decision|0|||
143249769|NCT00281658|516468732|FG000|Open Label Phase|Relocation of patient|0|||
143249770|NCT00281658|516468733|FG001|Open Label Phase|Relocation of patient|0|||
143249771|NCT00281658|516468734|FG002|Open Label Phase|Relocation of patient|1|||
143249772|NCT00281658|516468735|FG003|Open Label Phase|Relocation of patient|0|||
143249773|NCT00281658|516468732|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
143249774|NCT00281658|516468733|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
143249775|NCT00281658|516468734|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
143249776|NCT00281658|516468735|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
143249777|NCT04590248|516468736|FG000|Overall Study|Lost to Follow-up|1|||
143249778|NCT04590248|516468736|FG000|Overall Study|Withdrawal by Subject|16|||
143249779|NCT04590248|516468736|FG000|Overall Study|Other|2|||
143249780|NCT02052414|516468739|FG000|Overall Study|Adverse Event|12|||
143249781|NCT02052414|516468739|FG000|Overall Study|Lack of Efficacy|2|||
143249782|NCT02052414|516468739|FG000|Overall Study|Withdrawal by Subject|3|||
143249783|NCT02704143|516468745|FG000|Overall Study|disease progression|10|||
143249784|NCT00395343|516468746|FG000|Overall Study|Adverse Event|13|||
143249785|NCT00395343|516468747|FG001|Overall Study|Adverse Event|5|||
143249786|NCT00395343|516468746|FG000|Overall Study|Lack of Efficacy|0|||
143249787|NCT00395343|516468747|FG001|Overall Study|Lack of Efficacy|1|||
143249788|NCT00395343|516468746|FG000|Overall Study|Lost to Follow-up|4|||
143249789|NCT00395343|516468747|FG001|Overall Study|Lost to Follow-up|4|||
143249790|NCT00395343|516468746|FG000|Overall Study|Physician Decision|2|||
143249791|NCT00395343|516468747|FG001|Overall Study|Physician Decision|4|||
143249792|NCT00395343|516468746|FG000|Overall Study|Protocol Violation|6|||
143249793|NCT00395343|516468747|FG001|Overall Study|Protocol Violation|8|||
143249794|NCT00395343|516468746|FG000|Overall Study|Withdrawal by Subject|11|||
143249795|NCT00395343|516468747|FG001|Overall Study|Withdrawal by Subject|12|||
143249796|NCT00395343|516468746|FG000|Overall Study|Other|5|||
143249797|NCT00395343|516468747|FG001|Overall Study|Other|2|||
143249798|NCT01206322|516468751|FG000|Overall Study|Adverse Event|0|||
143249799|NCT01206322|516468752|FG001|Overall Study|Adverse Event|0|||
143249800|NCT01206322|516468753|FG002|Overall Study|Adverse Event|0|||
143249801|NCT01206322|516468754|FG003|Overall Study|Adverse Event|1|||
143249802|NCT00689117|516468755|FG000|Overall Study|Adverse Event|6|||
143249803|NCT00689117|516468756|FG001|Overall Study|Adverse Event|0|||
143249804|NCT00689117|516468757|FG002|Overall Study|Adverse Event|5|||
143249805|NCT00689117|516468758|FG003|Overall Study|Adverse Event|0|||
143249806|NCT00689117|516468755|FG000|Overall Study|Lost to Follow-up|26|||
143249807|NCT00689117|516468756|FG001|Overall Study|Lost to Follow-up|19|||
143249808|NCT00689117|516468757|FG002|Overall Study|Lost to Follow-up|17|||
143249809|NCT00689117|516468758|FG003|Overall Study|Lost to Follow-up|11|||
143249810|NCT00689117|516468755|FG000|Overall Study|Lack of Efficacy|1|||
143249811|NCT00689117|516468756|FG001|Overall Study|Lack of Efficacy|2|||
143249812|NCT00689117|516468757|FG002|Overall Study|Lack of Efficacy|2|||
143249813|NCT00689117|516468758|FG003|Overall Study|Lack of Efficacy|2|||
143249814|NCT00689117|516468755|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
143249815|NCT00689117|516468756|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
143249816|NCT00689117|516468757|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
143249817|NCT00689117|516468758|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
143249818|NCT00689117|516468755|FG000|Overall Study|Withdrawal by Subject|19|||
143086117|NCT02201277|515852447|FG001|Overall Study|Physician Decision|0|||
143086118|NCT05192889|515852453|FG000|Block 1: All Eligible Patients|Death|2|||
143086119|NCT05192889|515852454|FG001|Block 1: All Eligible Patients|Death|0|||
143086120|NCT05192889|515852455|FG002|Block 1: All Eligible Patients|Death|0|||
143086121|NCT05192889|515852453|FG000|Block 2b - Dose Level 1|Adverse Event|0|||
143086122|NCT05192889|515852454|FG001|Block 2b - Dose Level 1|Adverse Event|0|||
143249819|NCT00689117|516468756|FG001|Overall Study|Withdrawal by Subject|18|||
143249820|NCT00689117|516468757|FG002|Overall Study|Withdrawal by Subject|26|||
143249821|NCT00689117|516468758|FG003|Overall Study|Withdrawal by Subject|13|||
143249822|NCT00689117|516468755|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
143249823|NCT00689117|516468756|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
143249824|NCT00689117|516468757|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
143249825|NCT00689117|516468758|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
143249826|NCT00689117|516468755|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
143366672|NCT00991276|516887131|FG000|Third Intervention Period|Adverse Event|0|||
143366673|NCT00991276|516887132|FG001|Third Intervention Period|Adverse Event|0|||
143366674|NCT00991276|516887133|FG002|Third Intervention Period|Adverse Event|1|||
143366675|NCT00991276|516887134|FG003|Third Intervention Period|Adverse Event|0|||
143366676|NCT00991276|516887135|FG004|Third Intervention Period|Adverse Event|0|||
143366677|NCT00991276|516887136|FG005|Third Intervention Period|Adverse Event|0|||
143366678|NCT00991276|516887131|FG000|Third Intervention Period|Withdrawal by Subject|0|||
143366679|NCT00991276|516887132|FG001|Third Intervention Period|Withdrawal by Subject|0|||
143366680|NCT00991276|516887133|FG002|Third Intervention Period|Withdrawal by Subject|0|||
143366681|NCT00991276|516887134|FG003|Third Intervention Period|Withdrawal by Subject|1|||
143366682|NCT00991276|516887135|FG004|Third Intervention Period|Withdrawal by Subject|0|||
143366683|NCT00991276|516887136|FG005|Third Intervention Period|Withdrawal by Subject|0|||
143366684|NCT01268891|516887137|FG000|Overall Study|Adverse Event|3|||
143366685|NCT01268891|516887138|FG001|Overall Study|Adverse Event|7|||
143366686|NCT01268891|516887137|FG000|Overall Study|Lack of Efficacy|1|||
143366687|NCT01268891|516887138|FG001|Overall Study|Lack of Efficacy|0|||
143366688|NCT01268891|516887137|FG000|Overall Study|Withdrawal of Consent|3|||
143366689|NCT01268891|516887138|FG001|Overall Study|Withdrawal of Consent|1|||
143366690|NCT01268891|516887137|FG000|Overall Study|Administrative or other reason(s)|1|||
143366691|NCT01268891|516887138|FG001|Overall Study|Administrative or other reason(s)|0|||
143366692|NCT02049866|516887145|FG000|Overall Study|Withdrawal by Subject|1|||
143366693|NCT01117480|516887146|FG000|Overall Study|Protocol Violation|8|||
143366694|NCT01117480|516887146|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
143366695|NCT02955069|516887147|FG000|Overall Study|Adverse Event|7|||
143366696|NCT02955069|516887148|FG001|Overall Study|Adverse Event|2|||
143366697|NCT02955069|516887147|FG000|Overall Study|Death|7|||
143366698|NCT02955069|516887148|FG001|Overall Study|Death|3|||
143366699|NCT02955069|516887147|FG000|Overall Study|Physician Decision|10|||
143366700|NCT02955069|516887148|FG001|Overall Study|Physician Decision|2|||
143366701|NCT02955069|516887147|FG000|Overall Study|Progressive disease|64|||
143366702|NCT02955069|516887148|FG001|Overall Study|Progressive disease|13|||
143366703|NCT02955069|516887147|FG000|Overall Study|Study terminated by sponsor|4|||
143366704|NCT02955069|516887148|FG001|Overall Study|Study terminated by sponsor|0|||
143366705|NCT02955069|516887147|FG000|Overall Study|Subject/Guardian decision|3|||
143366706|NCT02955069|516887148|FG001|Overall Study|Subject/Guardian decision|1|||
143366707|NCT02232178|516887150|FG000|Overall Study|Lost to Follow-up|0|||
143366708|NCT02232178|516887151|FG001|Overall Study|Lost to Follow-up|1|||
143366709|NCT02232178|516887152|FG002|Overall Study|Lost to Follow-up|0|||
143366710|NCT02232178|516887150|FG000|Overall Study|ineligibility|0|||
143366711|NCT02232178|516887151|FG001|Overall Study|ineligibility|0|||
143366712|NCT02232178|516887152|FG002|Overall Study|ineligibility|1|||
143366713|NCT02232178|516887150|FG000|Overall Study|surgical complication|1|||
143366714|NCT02232178|516887151|FG001|Overall Study|surgical complication|0|||
143366715|NCT02232178|516887152|FG002|Overall Study|surgical complication|0|||
143366716|NCT01149681|516887153|FG000|Overall Study|Withdrawal by Subject|7|||
143366717|NCT01149681|516887153|FG000|Overall Study|Progressive disease|1|||
143366718|NCT01149681|516887153|FG000|Overall Study|Physician Decision|2|||
143366719|NCT01149681|516887153|FG000|Overall Study|adverse events nonrelated study drug|2|||
143366720|NCT03107611|516887155|FG000|Overall Study|Adverse Event|1|||
143366721|NCT03107611|516887156|FG001|Overall Study|Adverse Event|0|||
143366722|NCT03107611|516887157|FG002|Overall Study|Adverse Event|2|||
143366723|NCT03107611|516887155|FG000|Overall Study|Lost to Follow-up|3|||
143366724|NCT03107611|516887156|FG001|Overall Study|Lost to Follow-up|3|||
143366725|NCT03107611|516887157|FG002|Overall Study|Lost to Follow-up|3|||
143366726|NCT03107611|516887155|FG000|Overall Study|Protocol Violation|0|||
143366727|NCT03107611|516887156|FG001|Overall Study|Protocol Violation|0|||
143366728|NCT03107611|516887157|FG002|Overall Study|Protocol Violation|1|||
143086123|NCT05192889|515852455|FG002|Block 2b - Dose Level 1|Adverse Event|1|||
143086124|NCT05192889|515852453|FG000|Block 2b - Dose Level 1|Refused Therapy|0|||
143086125|NCT05192889|515852454|FG001|Block 2b - Dose Level 1|Refused Therapy|0|||
143086126|NCT05192889|515852455|FG002|Block 2b - Dose Level 1|Refused Therapy|2|||
143366729|NCT03107611|516887155|FG000|Overall Study|Withdrawal by Subject|1|||
143366730|NCT03107611|516887156|FG001|Overall Study|Withdrawal by Subject|0|||
143366731|NCT03107611|516887157|FG002|Overall Study|Withdrawal by Subject|1|||
143366732|NCT03107611|516887155|FG000|Overall Study|Worsening signs/symptoms|2|||
143366733|NCT03107611|516887156|FG001|Overall Study|Worsening signs/symptoms|1|||
143366734|NCT03107611|516887157|FG002|Overall Study|Worsening signs/symptoms|2|||
143366735|NCT01876511|516887160|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
143366736|NCT01876511|516887161|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
143366737|NCT01876511|516887162|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
143366738|NCT01876511|516887160|FG000|Overall Study|Death (unrelated)|3|||
143366739|NCT01876511|516887161|FG001|Overall Study|Death (unrelated)|0|||
143366740|NCT01876511|516887162|FG002|Overall Study|Death (unrelated)|2|||
143366741|NCT01876511|516887160|FG000|Overall Study|Drug-related Toxicity|5|||
143086127|NCT02586688|515854362|FG000|Overall Study|Lost to Follow-up|2|||
143086128|NCT02586688|515854363|FG001|Overall Study|Lost to Follow-up|1|||
143086129|NCT02586688|515854362|FG000|Overall Study|Withdrawal by Subject|1|||
143086130|NCT02586688|515854363|FG001|Overall Study|Withdrawal by Subject|1|||
143086131|NCT02586688|515854362|FG000|Overall Study|Adverse Event|3|||
143086132|NCT02586688|515854363|FG001|Overall Study|Adverse Event|1|||
143086133|NCT04856917|515854364|FG000|Overall Study|Withdrawal by Subject|4|||
143086134|NCT04856917|515854365|FG001|Overall Study|Withdrawal by Subject|3|||
143086135|NCT04856917|515854366|FG002|Overall Study|Withdrawal by Subject|1|||
143086136|NCT04856917|515854364|FG000|Overall Study|Lost to Follow-up|3|||
143086137|NCT04856917|515854365|FG001|Overall Study|Lost to Follow-up|1|||
143086138|NCT04856917|515854366|FG002|Overall Study|Lost to Follow-up|1|||
143086139|NCT04856917|515854364|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
143086140|NCT04856917|515854365|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
143086141|NCT04856917|515854366|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
143086142|NCT04856917|515854364|FG000|Overall Study|Other|1|||
143086143|NCT04856917|515854365|FG001|Overall Study|Other|1|||
143086144|NCT04856917|515854366|FG002|Overall Study|Other|0|||
143086145|NCT03560037|515854367|FG000|Overall Study|Protocol Violation|1|||
143086146|NCT03560037|515854368|FG001|Overall Study|Protocol Violation|0|||
143086147|NCT03560037|515854367|FG000|Overall Study|Physician Decision|0|||
143086148|NCT03560037|515854368|FG001|Overall Study|Physician Decision|1|||
143086149|NCT03620708|515854369|FG000|Overall Study|Lost to Follow-up|1|||
143086150|NCT03620708|515854370|FG001|Overall Study|Lost to Follow-up|1|||
143086151|NCT03620708|515854371|FG002|Overall Study|Lost to Follow-up|2|||
143086152|NCT03620708|515854369|FG000|Overall Study|Withdrawal by Subject|0|||
143086153|NCT03620708|515854370|FG001|Overall Study|Withdrawal by Subject|0|||
143086154|NCT03620708|515854371|FG002|Overall Study|Withdrawal by Subject|1|||
143086155|NCT06195930|515854374|FG000|Overall Study|Adverse Event|4|||
143086156|NCT03631199|515854375|FG000|Overall Study|Progressive disease|9|||
143086157|NCT03631199|515854376|FG001|Overall Study|Progressive disease|5|||
143086158|NCT03631199|515854377|FG002|Overall Study|Progressive disease|5|||
143086159|NCT03631199|515854378|FG003|Overall Study|Progressive disease|149|||
143086160|NCT03631199|515854379|FG004|Overall Study|Progressive disease|148|||
143086161|NCT03631199|515854375|FG000|Overall Study|Physician Decision|0|||
143086162|NCT03631199|515854376|FG001|Overall Study|Physician Decision|2|||
143086163|NCT03631199|515854377|FG002|Overall Study|Physician Decision|3|||
143086164|NCT03631199|515854378|FG003|Overall Study|Physician Decision|19|||
143086165|NCT03631199|515854379|FG004|Overall Study|Physician Decision|13|||
143174815|NCT02852967|516188533|FG000|Overall Study|Physician Decision|0|||
143174816|NCT02852967|516188534|FG001|Overall Study|Physician Decision|0|||
143174817|NCT02852967|516188535|FG002|Overall Study|Physician Decision|0|||
143174818|NCT02852967|516188536|FG003|Overall Study|Physician Decision|1|||
143174819|NCT02852967|516188537|FG004|Overall Study|Physician Decision|0|||
143174820|NCT02852967|516188533|FG000|Overall Study|Lack of Efficacy|0|||
143174821|NCT02852967|516188534|FG001|Overall Study|Lack of Efficacy|1|||
143174822|NCT02852967|516188535|FG002|Overall Study|Lack of Efficacy|0|||
143174823|NCT02852967|516188536|FG003|Overall Study|Lack of Efficacy|0|||
143174824|NCT02852967|516188537|FG004|Overall Study|Lack of Efficacy|0|||
143174825|NCT02852967|516188533|FG000|Overall Study|Non-compliance|0|||
143174826|NCT02852967|516188534|FG001|Overall Study|Non-compliance|0|||
143174827|NCT02852967|516188535|FG002|Overall Study|Non-compliance|1|||
143174828|NCT02852967|516188536|FG003|Overall Study|Non-compliance|1|||
143174829|NCT02852967|516188537|FG004|Overall Study|Non-compliance|0|||
143174830|NCT02852967|516188533|FG000|Overall Study|Dispensing Drug Violation|0|||
143174831|NCT02852967|516188534|FG001|Overall Study|Dispensing Drug Violation|0|||
143174832|NCT02852967|516188535|FG002|Overall Study|Dispensing Drug Violation|1|||
143174833|NCT02852967|516188536|FG003|Overall Study|Dispensing Drug Violation|0|||
143174834|NCT02852967|516188537|FG004|Overall Study|Dispensing Drug Violation|0|||
143174835|NCT02852967|516188533|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
143174836|NCT02852967|516188534|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
143174837|NCT02852967|516188535|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
143174838|NCT02852967|516188536|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
143174839|NCT02852967|516188537|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
143174840|NCT01049373|516188538|FG000|Overall Study|Protocol Violation|9|||
143174841|NCT01049373|516188539|FG001|Overall Study|Protocol Violation|9|||
143174842|NCT01049373|516188538|FG000|Overall Study|Withdrawal by Subject|8|||
143174843|NCT01049373|516188539|FG001|Overall Study|Withdrawal by Subject|5|||
143174844|NCT01049373|516188538|FG000|Overall Study|Adverse Event|3|||
143174845|NCT01049373|516188539|FG001|Overall Study|Adverse Event|3|||
143174846|NCT01049373|516188538|FG000|Overall Study|Lost to Follow-up|9|||
143174847|NCT01049373|516188539|FG001|Overall Study|Lost to Follow-up|4|||
143174848|NCT01049373|516188538|FG000|Overall Study|no evaluable study values|9|||
143174849|NCT01049373|516188539|FG001|Overall Study|no evaluable study values|21|||
143174850|NCT01049373|516188538|FG000|Overall Study|Other|1|||
143174851|NCT01049373|516188539|FG001|Overall Study|Other|1|||
143174852|NCT01049373|516188538|FG000|Overall Study|Non-cooperation|0|||
143174853|NCT01049373|516188539|FG001|Overall Study|Non-cooperation|1|||
143174854|NCT00339040|516188540|FG000|Stage I|Not able to attend clinic|1|||
143174855|NCT00339040|516188541|FG001|Stage I|Not able to attend clinic|0|||
143174856|NCT00339040|516188540|FG000|Stage I|Protocol Violation|1|||
143174857|NCT00339040|516188541|FG001|Stage I|Protocol Violation|1|||
143174858|NCT00339040|516188540|FG000|Stage II|Lost to Follow-up|3|||
143174859|NCT00339040|516188541|FG001|Stage II|Lost to Follow-up|0|||
143174860|NCT00339040|516188540|FG000|Stage II|Withdrawal by Subject|1|||
143174861|NCT00339040|516188541|FG001|Stage II|Withdrawal by Subject|2|||
143174862|NCT00339040|516188540|FG000|Stage II|Protocol Violation|3|||
143174863|NCT00339040|516188541|FG001|Stage II|Protocol Violation|0|||
143174864|NCT00339040|516188540|FG000|Stage II|Not able to attend clinic|1|||
143174865|NCT00339040|516188541|FG001|Stage II|Not able to attend clinic|0|||
143086166|NCT03631199|515854375|FG000|Overall Study|Adverse Event|1|||
143086167|NCT03631199|515854376|FG001|Overall Study|Adverse Event|1|||
143086168|NCT03631199|515854377|FG002|Overall Study|Adverse Event|0|||
143086169|NCT03631199|515854378|FG003|Overall Study|Adverse Event|28|||
143086170|NCT03631199|515854379|FG004|Overall Study|Adverse Event|29|||
143086171|NCT03631199|515854375|FG000|Overall Study|Death|0|||
143086172|NCT03631199|515854376|FG001|Overall Study|Death|1|||
143086173|NCT03631199|515854377|FG002|Overall Study|Death|0|||
143174866|NCT00339040|516188540|FG000|Stage II|Site closing|2|||
143174867|NCT00339040|516188541|FG001|Stage II|Site closing|0|||
143174868|NCT01073293|516188542|FG000|Overall Study|Lost to Follow-up|0|||
143174869|NCT01073293|516188543|FG001|Overall Study|Lost to Follow-up|1|||
143174870|NCT01073293|516188542|FG000|Overall Study|Withdrawal by Subject|5|||
143174871|NCT01073293|516188543|FG001|Overall Study|Withdrawal by Subject|10|||
143174872|NCT00256126|516188544|FG000|Overall Study|Adverse Event|1|||
143174873|NCT00256126|516188545|FG001|Overall Study|Adverse Event|0|||
143174874|NCT00256126|516188544|FG000|Overall Study|Other|1|||
143174875|NCT00256126|516188545|FG001|Overall Study|Other|2|||
143174876|NCT01788943|516188548|FG000|Overall Study|Withdrawal by Subject|1|||
143174877|NCT01788943|516188549|FG001|Overall Study|Withdrawal by Subject|0|||
143174878|NCT02581891|516188550|FG000|Overall Study|Adverse Event|4|||
143174879|NCT02581891|516188551|FG001|Overall Study|Adverse Event|6|||
143174880|NCT02581891|516188550|FG000|Overall Study|Death|3|||
143174881|NCT02581891|516188551|FG001|Overall Study|Death|4|||
143174882|NCT02581891|516188550|FG000|Overall Study|Lost to Follow-up|1|||
143174883|NCT02581891|516188551|FG001|Overall Study|Lost to Follow-up|2|||
143174884|NCT02581891|516188550|FG000|Overall Study|Physician Decision|0|||
143174885|NCT02581891|516188551|FG001|Overall Study|Physician Decision|1|||
143174886|NCT02581891|516188550|FG000|Overall Study|Withdrawal by Subject|4|||
143174887|NCT02581891|516188551|FG001|Overall Study|Withdrawal by Subject|5|||
143174888|NCT02581891|516188550|FG000|Overall Study|Other Reasons|3|||
143174889|NCT02581891|516188551|FG001|Overall Study|Other Reasons|1|||
143174890|NCT02581891|516188550|FG000|Overall Study|Discontinued during followup|1|||
143174891|NCT02581891|516188551|FG001|Overall Study|Discontinued during followup|0|||
143174892|NCT01832727|516188555|FG000|Overall Study|Adverse Event|4|||
143174893|NCT01832727|516188556|FG001|Overall Study|Adverse Event|6|||
143174894|NCT01832727|516188557|FG002|Overall Study|Adverse Event|1|||
143174895|NCT01832727|516188558|FG003|Overall Study|Adverse Event|0|||
143174896|NCT01832727|516188559|FG004|Overall Study|Adverse Event|1|||
143174897|NCT01832727|516188560|FG005|Overall Study|Adverse Event|1|||
143174898|NCT01832727|516188561|FG006|Overall Study|Adverse Event|2|||
143174899|NCT01832727|516188562|FG007|Overall Study|Adverse Event|1|||
143174900|NCT01832727|516188563|FG008|Overall Study|Adverse Event|9|||
143174901|NCT01832727|516188555|FG000|Overall Study|Disease progression|3|||
143174902|NCT01832727|516188556|FG001|Overall Study|Disease progression|0|||
143174903|NCT01832727|516188557|FG002|Overall Study|Disease progression|2|||
143174904|NCT01832727|516188558|FG003|Overall Study|Disease progression|1|||
143174905|NCT01832727|516188559|FG004|Overall Study|Disease progression|3|||
143174906|NCT01832727|516188560|FG005|Overall Study|Disease progression|3|||
143174907|NCT01832727|516188561|FG006|Overall Study|Disease progression|6|||
143174908|NCT01832727|516188562|FG007|Overall Study|Disease progression|2|||
143174909|NCT01832727|516188563|FG008|Overall Study|Disease progression|7|||
143174910|NCT01832727|516188555|FG000|Overall Study|Lost to Follow-up|0|||
143174911|NCT01832727|516188556|FG001|Overall Study|Lost to Follow-up|0|||
143174912|NCT01832727|516188557|FG002|Overall Study|Lost to Follow-up|0|||
143174913|NCT01832727|516188558|FG003|Overall Study|Lost to Follow-up|1|||
143174914|NCT01832727|516188559|FG004|Overall Study|Lost to Follow-up|0|||
143174915|NCT01832727|516188560|FG005|Overall Study|Lost to Follow-up|0|||
143174916|NCT01832727|516188561|FG006|Overall Study|Lost to Follow-up|0|||
143174917|NCT01832727|516188562|FG007|Overall Study|Lost to Follow-up|0|||
143174918|NCT01832727|516188563|FG008|Overall Study|Lost to Follow-up|0|||
143174919|NCT01832727|516188555|FG000|Overall Study|Physician Decision|1|||
143174920|NCT01832727|516188556|FG001|Overall Study|Physician Decision|0|||
143174921|NCT01832727|516188557|FG002|Overall Study|Physician Decision|0|||
143174922|NCT01832727|516188558|FG003|Overall Study|Physician Decision|1|||
143174923|NCT01832727|516188559|FG004|Overall Study|Physician Decision|0|||
143174924|NCT01832727|516188560|FG005|Overall Study|Physician Decision|1|||
143174925|NCT01832727|516188561|FG006|Overall Study|Physician Decision|0|||
143174926|NCT01832727|516188562|FG007|Overall Study|Physician Decision|0|||
143174927|NCT01832727|516188563|FG008|Overall Study|Physician Decision|0|||
143174928|NCT01832727|516188555|FG000|Overall Study|Withdrawal by Subject|1|||
143174929|NCT01832727|516188556|FG001|Overall Study|Withdrawal by Subject|1|||
143174930|NCT01832727|516188557|FG002|Overall Study|Withdrawal by Subject|0|||
143174931|NCT01832727|516188558|FG003|Overall Study|Withdrawal by Subject|1|||
143174932|NCT01832727|516188559|FG004|Overall Study|Withdrawal by Subject|0|||
143174933|NCT01832727|516188560|FG005|Overall Study|Withdrawal by Subject|1|||
143174934|NCT01832727|516188561|FG006|Overall Study|Withdrawal by Subject|0|||
143174935|NCT01832727|516188562|FG007|Overall Study|Withdrawal by Subject|2|||
143174936|NCT01832727|516188563|FG008|Overall Study|Withdrawal by Subject|1|||
143174937|NCT01832727|516188555|FG000|Overall Study|Study terminated by sponsor|0|||
143174938|NCT01832727|516188556|FG001|Overall Study|Study terminated by sponsor|0|||
143174939|NCT01832727|516188557|FG002|Overall Study|Study terminated by sponsor|0|||
143174940|NCT01832727|516188558|FG003|Overall Study|Study terminated by sponsor|0|||
143174941|NCT01832727|516188559|FG004|Overall Study|Study terminated by sponsor|0|||
143174942|NCT01832727|516188560|FG005|Overall Study|Study terminated by sponsor|0|||
143174943|NCT01832727|516188561|FG006|Overall Study|Study terminated by sponsor|0|||
143174944|NCT01832727|516188562|FG007|Overall Study|Study terminated by sponsor|1|||
143174945|NCT01832727|516188563|FG008|Overall Study|Study terminated by sponsor|1|||
143174946|NCT03434834|516188564|FG000|Overall Study|unable to swallow OCT probe|16|||
143174947|NCT01812057|516188569|FG000|Overall Study|Protocol Violation|1|||
143174948|NCT01812057|516188570|FG001|Overall Study|Protocol Violation|0|||
143366742|NCT01876511|516887161|FG001|Overall Study|Drug-related Toxicity|1|||
143366743|NCT01876511|516887162|FG002|Overall Study|Drug-related Toxicity|6|||
143366744|NCT01876511|516887160|FG000|Overall Study|Patient Decision|3|||
143366745|NCT01876511|516887161|FG001|Overall Study|Patient Decision|0|||
143366746|NCT01876511|516887162|FG002|Overall Study|Patient Decision|6|||
143366747|NCT01876511|516887160|FG000|Overall Study|Physician Decision|1|||
143366748|NCT01876511|516887161|FG001|Overall Study|Physician Decision|0|||
143366749|NCT01876511|516887162|FG002|Overall Study|Physician Decision|1|||
143366750|NCT02131324|516887167|FG000|Overall Study|Withdrawal by Subject|1|||
143366751|NCT02131324|516887168|FG001|Overall Study|Withdrawal by Subject|2|||
143366752|NCT02131324|516887167|FG000|Overall Study|Lost to Follow-up|1|||
143366753|NCT02131324|516887168|FG001|Overall Study|Lost to Follow-up|1|||
143366754|NCT00891618|516887169|FG000|Overall Study|Withdrawal by Subject|1|||
143366755|NCT05419557|516887170|FG000|Overall Study|Lost to Follow-up|11|||
143366756|NCT05419557|516887171|FG001|Overall Study|Lost to Follow-up|4|||
143366757|NCT00920686|516887172|FG000|Overall Study|Lost to Follow-up|2|||
143366758|NCT00920686|516887173|FG001|Overall Study|Lost to Follow-up|3|||
143366759|NCT00920686|516887174|FG002|Overall Study|Lost to Follow-up|1|||
143366760|NCT00920686|516887172|FG000|Overall Study|Study drug dosing criteria not met|17|||
143366761|NCT00920686|516887173|FG001|Overall Study|Study drug dosing criteria not met|19|||
143366762|NCT00920686|516887174|FG002|Overall Study|Study drug dosing criteria not met|12|||
143366763|NCT00601640|516887175|FG000|Overall Study|Withdrawal by Subject|3|||
143366764|NCT00601640|516887176|FG001|Overall Study|Withdrawal by Subject|0|||
143366765|NCT00601640|516887177|FG002|Overall Study|Withdrawal by Subject|7|||
143366766|NCT00601640|516887175|FG000|Overall Study|Death|1|||
143366767|NCT00601640|516887176|FG001|Overall Study|Death|0|||
143366768|NCT00601640|516887177|FG002|Overall Study|Death|0|||
143366769|NCT00601640|516887175|FG000|Overall Study|Adverse Event|0|||
143366770|NCT00601640|516887176|FG001|Overall Study|Adverse Event|4|||
143366771|NCT00601640|516887177|FG002|Overall Study|Adverse Event|2|||
143366772|NCT00601640|516887175|FG000|Overall Study|intercurrent illness|1|||
143366773|NCT00601640|516887176|FG001|Overall Study|intercurrent illness|0|||
143366774|NCT00601640|516887177|FG002|Overall Study|intercurrent illness|0|||
143366775|NCT00601640|516887175|FG000|Overall Study|change in eligibility status|0|||
143366776|NCT00601640|516887176|FG001|Overall Study|change in eligibility status|1|||
143366777|NCT00601640|516887177|FG002|Overall Study|change in eligibility status|1|||
143366778|NCT01674569|516887178|FG000|Overall Study|Adverse Event|0|||
143366779|NCT01674569|516887179|FG001|Overall Study|Adverse Event|2|||
143366780|NCT01674569|516887180|FG002|Overall Study|Adverse Event|0|||
143366781|NCT01674569|516887181|FG003|Overall Study|Adverse Event|1|||
143366782|NCT01674569|516887182|FG004|Overall Study|Adverse Event|2|||
143366783|NCT01674569|516887183|FG005|Overall Study|Adverse Event|2|||
143174949|NCT01812057|516188569|FG000|Overall Study|Physician Decision|1|||
143174950|NCT01812057|516188570|FG001|Overall Study|Physician Decision|0|||
143174951|NCT01657305|516188573|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
143174952|NCT01657305|516188573|FG000|Overall Study|Withdrawal by Subject|4|||
143174953|NCT01657305|516188573|FG000|Overall Study|Adverse Event|1|||
143174954|NCT01657305|516188573|FG000|Overall Study|Lost to Follow-up|1|||
143174955|NCT01657305|516188573|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
143174956|NCT00967616|516188580|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
143174957|NCT00967616|516188581|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
143174958|NCT00967616|516188580|FG000|Overall Study|Death|0|||
143174959|NCT00967616|516188581|FG001|Overall Study|Death|3|||
143174960|NCT00967616|516188580|FG000|Overall Study|Withdrawal by Subject|8|||
143174961|NCT00967616|516188581|FG001|Overall Study|Withdrawal by Subject|4|||
143174962|NCT00967616|516188580|FG000|Overall Study|Progressive Disease|31|||
143366784|NCT01674569|516887178|FG000|Overall Study|Protocol Violation|0|||
143366785|NCT01674569|516887179|FG001|Overall Study|Protocol Violation|1|||
143366786|NCT01674569|516887180|FG002|Overall Study|Protocol Violation|1|||
143366787|NCT01674569|516887181|FG003|Overall Study|Protocol Violation|0|||
143366788|NCT01674569|516887182|FG004|Overall Study|Protocol Violation|0|||
143174963|NCT00967616|516188581|FG001|Overall Study|Progressive Disease|18|||
143174964|NCT00967616|516188580|FG000|Overall Study|Other|8|||
143249827|NCT00689117|516468756|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
143366789|NCT01674569|516887183|FG005|Overall Study|Protocol Violation|0|||
143174965|NCT00967616|516188581|FG001|Overall Study|Other|8|||
143086174|NCT03631199|515854378|FG003|Overall Study|Death|35|||
143086175|NCT03631199|515854379|FG004|Overall Study|Death|48|||
143086176|NCT03631199|515854375|FG000|Overall Study|Subject decision|0|||
143086177|NCT03631199|515854376|FG001|Overall Study|Subject decision|1|||
143086178|NCT03631199|515854377|FG002|Overall Study|Subject decision|0|||
143086179|NCT03631199|515854378|FG003|Overall Study|Subject decision|12|||
143086180|NCT03631199|515854379|FG004|Overall Study|Subject decision|12|||
143086181|NCT03631199|515854375|FG000|Overall Study|No treated|0|||
143174966|NCT00967616|516188580|FG000|Overall Study|Protocol Violation|1|||
143086182|NCT03631199|515854376|FG001|Overall Study|No treated|0|||
143086183|NCT03631199|515854377|FG002|Overall Study|No treated|0|||
143086184|NCT03631199|515854378|FG003|Overall Study|No treated|0|||
143086185|NCT03631199|515854379|FG004|Overall Study|No treated|1|||
143086186|NCT03631199|515854375|FG000|Overall Study|Treatment ongoing|0|||
143086187|NCT03631199|515854376|FG001|Overall Study|Treatment ongoing|1|||
143086188|NCT03631199|515854377|FG002|Overall Study|Treatment ongoing|1|||
143086189|NCT03631199|515854378|FG003|Overall Study|Treatment ongoing|76|||
143086190|NCT03631199|515854379|FG004|Overall Study|Treatment ongoing|71|||
143086191|NCT03631199|515854375|FG000|Overall Study|Guardian decision|0|||
143086192|NCT03631199|515854376|FG001|Overall Study|Guardian decision|0|||
143086193|NCT03631199|515854377|FG002|Overall Study|Guardian decision|0|||
143086194|NCT03631199|515854378|FG003|Overall Study|Guardian decision|1|||
143086195|NCT03631199|515854379|FG004|Overall Study|Guardian decision|1|||
143086196|NCT00233948|515854382|FG000|Overall Study|Adverse Event|1|||
143086197|NCT00233948|515854383|FG001|Overall Study|Adverse Event|0|||
143174967|NCT00967616|516188581|FG001|Overall Study|Protocol Violation|0|||
143086198|NCT00233948|515854384|FG002|Overall Study|Adverse Event|0|||
143174968|NCT00508482|516188582|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
143174969|NCT00508482|516188583|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
143174970|NCT00508482|516188584|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
143174971|NCT00508482|516188582|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
143174972|NCT00508482|516188583|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
143174973|NCT00508482|516188584|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
143174974|NCT00508482|516188582|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
143174975|NCT00508482|516188583|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
143174976|NCT00508482|516188584|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
143174977|NCT01374425|516188585|FG000|Overall Study|Radiographic Disease Progression|86|||
143174978|NCT01374425|516188586|FG001|Overall Study|Radiographic Disease Progression|81|||
143174979|NCT01374425|516188585|FG000|Overall Study|Clinical Disease Progression|9|||
143174980|NCT01374425|516188586|FG001|Overall Study|Clinical Disease Progression|6|||
143174981|NCT01374425|516188585|FG000|Overall Study|Adverse Event|29|||
143174982|NCT01374425|516188586|FG001|Overall Study|Adverse Event|18|||
143174983|NCT01374425|516188585|FG000|Overall Study|Death (Progression of Disease)|1|||
143174984|NCT01374425|516188586|FG001|Overall Study|Death (Progression of Disease)|0|||
143174985|NCT01374425|516188585|FG000|Overall Study|Death (Adverse Event)|2|||
143174986|NCT01374425|516188586|FG001|Overall Study|Death (Adverse Event)|4|||
143174987|NCT01374425|516188585|FG000|Overall Study|Withdrawal by Subject|6|||
143174988|NCT01374425|516188586|FG001|Overall Study|Withdrawal by Subject|7|||
143174989|NCT01374425|516188585|FG000|Overall Study|Refused Treatment|10|||
143174990|NCT01374425|516188586|FG001|Overall Study|Refused Treatment|24|||
143174991|NCT01374425|516188585|FG000|Overall Study|Protocol Violation|2|||
143174992|NCT01374425|516188586|FG001|Overall Study|Protocol Violation|3|||
143174993|NCT01374425|516188585|FG000|Overall Study|Sponsor Decision|0|||
143174994|NCT01374425|516188586|FG001|Overall Study|Sponsor Decision|1|||
143174995|NCT01374425|516188585|FG000|Overall Study|Lost to Follow-up|2|||
143174996|NCT01374425|516188586|FG001|Overall Study|Lost to Follow-up|1|||
143174997|NCT01374425|516188585|FG000|Overall Study|Other|41|||
143174998|NCT01374425|516188586|FG001|Overall Study|Other|43|||
143174999|NCT00271544|516188595|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
143175000|NCT00271544|516188595|FG000|Overall Study|Model 4196 lead not attempted|9|||
143175001|NCT00271544|516188595|FG000|Overall Study|Implant not attempted|4|||
143175002|NCT04704193|516188599|FG000|Overall Study|Withdrawal by Subject|1|||
143175003|NCT03984188|516188606|FG000|Overall Study|Death|2|||
143175004|NCT03984188|516188607|FG001|Overall Study|Death|4|||
143175005|NCT03984188|516188606|FG000|Overall Study|Physician Decision|0|||
143175006|NCT03984188|516188607|FG001|Overall Study|Physician Decision|2|||
143175007|NCT03984188|516188606|FG000|Overall Study|Lost to Follow-up|3|||
143175008|NCT03984188|516188607|FG001|Overall Study|Lost to Follow-up|2|||
143175009|NCT03984188|516188606|FG000|Overall Study|Withdrawal by Subject|6|||
143175010|NCT03984188|516188607|FG001|Overall Study|Withdrawal by Subject|0|||
143175011|NCT03384875|516188608|FG000|Overall Study|Death|1|||
143175012|NCT03384875|516188609|FG001|Overall Study|Death|1|||
143175013|NCT03384875|516188610|FG002|Overall Study|Death|0|||
143175014|NCT03384875|516188608|FG000|Overall Study|Reason not provided|1|||
143175015|NCT03384875|516188609|FG001|Overall Study|Reason not provided|0|||
143175016|NCT03384875|516188610|FG002|Overall Study|Reason not provided|0|||
143175017|NCT02735421|516190425|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
143175018|NCT02735421|516190425|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
143175019|NCT02735421|516190425|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
143175020|NCT02735421|516190425|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
143086199|NCT00233948|515854385|FG003|Overall Study|Adverse Event|0|||
143086200|NCT00233948|515854386|FG004|Overall Study|Adverse Event|0|||
143086201|NCT00233948|515854387|FG005|Overall Study|Adverse Event|0|||
143086202|NCT03573830|515854388|FG000|Overall Study|Dropped without completing treatment|0|||
143175021|NCT02735421|516190425|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
143175022|NCT02735421|516190425|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
143175023|NCT02735421|516190425|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
143086203|NCT03573830|515854389|FG001|Overall Study|Dropped without completing treatment|7|||
143086204|NCT03573830|515854388|FG000|Overall Study|Lost to Follow-up|4|||
143086205|NCT03573830|515854389|FG001|Overall Study|Lost to Follow-up|0|||
143086206|NCT03284723|515854394|FG000|Overall Study|Death|0|||
143086207|NCT03284723|515854395|FG001|Overall Study|Death|0|||
143086208|NCT03284723|515854396|FG002|Overall Study|Death|0|||
143086209|NCT03284723|515854397|FG003|Overall Study|Death|1|||
143086210|NCT03284723|515854398|FG004|Overall Study|Death|0|||
143086211|NCT03284723|515854399|FG005|Overall Study|Death|0|||
143086212|NCT03284723|515854400|FG006|Overall Study|Death|1|||
143086213|NCT03284723|515854401|FG007|Overall Study|Death|0|||
143086214|NCT03284723|515854402|FG008|Overall Study|Death|0|||
143086215|NCT03284723|515854403|FG009|Overall Study|Death|2|||
143086216|NCT03284723|515854404|FG010|Overall Study|Death|1|||
143086217|NCT03284723|515854405|FG011|Overall Study|Death|0|||
143086218|NCT03284723|515854394|FG000|Overall Study|Lost to Follow-up|0|||
143086219|NCT03284723|515854395|FG001|Overall Study|Lost to Follow-up|0|||
143086220|NCT03284723|515854396|FG002|Overall Study|Lost to Follow-up|0|||
143086221|NCT03284723|515854397|FG003|Overall Study|Lost to Follow-up|0|||
143086222|NCT03284723|515854398|FG004|Overall Study|Lost to Follow-up|0|||
143086223|NCT03284723|515854399|FG005|Overall Study|Lost to Follow-up|2|||
143086224|NCT03284723|515854400|FG006|Overall Study|Lost to Follow-up|1|||
143086225|NCT03284723|515854401|FG007|Overall Study|Lost to Follow-up|0|||
143249828|NCT00689117|516468757|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
143249829|NCT00689117|516468758|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
143249830|NCT00689117|516468755|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
143249831|NCT00689117|516468756|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
143249832|NCT00689117|516468757|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
143249833|NCT00689117|516468758|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
143249834|NCT00689117|516468755|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
143249835|NCT00689117|516468756|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
143249836|NCT00689117|516468757|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
143249837|NCT00689117|516468758|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
143249838|NCT00689117|516468755|FG000|Overall Study|Use of Prohibitive Medication|2|||
143249839|NCT00689117|516468756|FG001|Overall Study|Use of Prohibitive Medication|1|||
143249840|NCT00689117|516468757|FG002|Overall Study|Use of Prohibitive Medication|3|||
143249841|NCT00689117|516468758|FG003|Overall Study|Use of Prohibitive Medication|0|||
143249842|NCT00689117|516468755|FG000|Overall Study|Pregnancy|0|||
143249843|NCT00689117|516468756|FG001|Overall Study|Pregnancy|2|||
143249844|NCT00689117|516468757|FG002|Overall Study|Pregnancy|0|||
143249845|NCT00689117|516468758|FG003|Overall Study|Pregnancy|2|||
143249846|NCT00689117|516468755|FG000|Overall Study|Incarceration|2|||
143249847|NCT00689117|516468756|FG001|Overall Study|Incarceration|0|||
143249848|NCT00689117|516468757|FG002|Overall Study|Incarceration|0|||
143249849|NCT00689117|516468758|FG003|Overall Study|Incarceration|0|||
143249850|NCT00689117|516468755|FG000|Overall Study|Fear of Birth Defects|0|||
143249851|NCT00689117|516468756|FG001|Overall Study|Fear of Birth Defects|0|||
143249852|NCT00689117|516468757|FG002|Overall Study|Fear of Birth Defects|1|||
143249853|NCT00689117|516468758|FG003|Overall Study|Fear of Birth Defects|0|||
143249854|NCT00689117|516468755|FG000|Overall Study|Transportation|1|||
143249855|NCT00689117|516468756|FG001|Overall Study|Transportation|0|||
143249856|NCT00689117|516468757|FG002|Overall Study|Transportation|0|||
143249857|NCT00689117|516468758|FG003|Overall Study|Transportation|0|||
143249858|NCT00689117|516468755|FG000|Overall Study|Patient Withdrew from Study|0|||
143249859|NCT00689117|516468756|FG001|Overall Study|Patient Withdrew from Study|0|||
143249860|NCT00689117|516468757|FG002|Overall Study|Patient Withdrew from Study|0|||
143249861|NCT00689117|516468758|FG003|Overall Study|Patient Withdrew from Study|1|||
143249862|NCT00689117|516468755|FG000|Overall Study|Personal Reason|0|||
143249863|NCT00689117|516468756|FG001|Overall Study|Personal Reason|1|||
143249864|NCT00689117|516468757|FG002|Overall Study|Personal Reason|0|||
143249865|NCT00689117|516468758|FG003|Overall Study|Personal Reason|0|||
143249866|NCT00689117|516468755|FG000|Overall Study|Dispensing Error|0|||
143086226|NCT03284723|515854402|FG008|Overall Study|Lost to Follow-up|0|||
143086227|NCT03284723|515854403|FG009|Overall Study|Lost to Follow-up|2|||
143086228|NCT03284723|515854404|FG010|Overall Study|Lost to Follow-up|0|||
143249867|NCT00689117|516468756|FG001|Overall Study|Dispensing Error|1|||
143249868|NCT00689117|516468757|FG002|Overall Study|Dispensing Error|0|||
143249869|NCT00689117|516468758|FG003|Overall Study|Dispensing Error|0|||
143249870|NCT01589653|516468764|FG000|Overall Study|Protocol Violation|3|||
143249871|NCT01589653|516468765|FG001|Overall Study|Protocol Violation|1|||
143086229|NCT03284723|515854405|FG011|Overall Study|Lost to Follow-up|0|||
143086230|NCT03284723|515854394|FG000|Overall Study|Study Terminated By Sponsor|0|||
143086231|NCT03284723|515854395|FG001|Overall Study|Study Terminated By Sponsor|0|||
143086232|NCT03284723|515854396|FG002|Overall Study|Study Terminated By Sponsor|0|||
143086233|NCT03284723|515854397|FG003|Overall Study|Study Terminated By Sponsor|0|||
143086234|NCT03284723|515854398|FG004|Overall Study|Study Terminated By Sponsor|1|||
143366790|NCT01674569|516887178|FG000|Overall Study|Withdrawal by Subject|0|||
143086235|NCT03284723|515854399|FG005|Overall Study|Study Terminated By Sponsor|0|||
143086236|NCT03284723|515854400|FG006|Overall Study|Study Terminated By Sponsor|0|||
143086237|NCT03284723|515854401|FG007|Overall Study|Study Terminated By Sponsor|0|||
143086238|NCT03284723|515854402|FG008|Overall Study|Study Terminated By Sponsor|1|||
143086239|NCT03284723|515854403|FG009|Overall Study|Study Terminated By Sponsor|1|||
143086240|NCT03284723|515854404|FG010|Overall Study|Study Terminated By Sponsor|1|||
143086241|NCT03284723|515854405|FG011|Overall Study|Study Terminated By Sponsor|1|||
143086242|NCT03284723|515854394|FG000|Overall Study|Withdrawal by Subject|0|||
143086243|NCT03284723|515854395|FG001|Overall Study|Withdrawal by Subject|0|||
143086244|NCT03284723|515854396|FG002|Overall Study|Withdrawal by Subject|0|||
143086245|NCT03284723|515854397|FG003|Overall Study|Withdrawal by Subject|0|||
143086246|NCT03284723|515854398|FG004|Overall Study|Withdrawal by Subject|5|||
143086247|NCT03284723|515854399|FG005|Overall Study|Withdrawal by Subject|3|||
143086248|NCT03284723|515854400|FG006|Overall Study|Withdrawal by Subject|1|||
143086249|NCT03284723|515854401|FG007|Overall Study|Withdrawal by Subject|0|||
143086250|NCT03284723|515854402|FG008|Overall Study|Withdrawal by Subject|6|||
143086251|NCT03284723|515854403|FG009|Overall Study|Withdrawal by Subject|0|||
143086252|NCT03284723|515854404|FG010|Overall Study|Withdrawal by Subject|3|||
143086253|NCT03284723|515854405|FG011|Overall Study|Withdrawal by Subject|1|||
143086254|NCT03284723|515854394|FG000|Overall Study|Other|1|||
143086255|NCT03284723|515854395|FG001|Overall Study|Other|0|||
143086256|NCT03284723|515854396|FG002|Overall Study|Other|1|||
143086257|NCT03284723|515854397|FG003|Overall Study|Other|0|||
143086258|NCT03284723|515854398|FG004|Overall Study|Other|1|||
143086259|NCT03284723|515854399|FG005|Overall Study|Other|0|||
143086260|NCT03284723|515854400|FG006|Overall Study|Other|0|||
143086261|NCT03284723|515854401|FG007|Overall Study|Other|0|||
143086262|NCT03284723|515854402|FG008|Overall Study|Other|0|||
143086263|NCT03284723|515854403|FG009|Overall Study|Other|0|||
143086264|NCT03284723|515854404|FG010|Overall Study|Other|1|||
143086265|NCT03284723|515854405|FG011|Overall Study|Other|0|||
143366791|NCT01674569|516887179|FG001|Overall Study|Withdrawal by Subject|0|||
143366792|NCT01674569|516887180|FG002|Overall Study|Withdrawal by Subject|1|||
143366793|NCT01674569|516887181|FG003|Overall Study|Withdrawal by Subject|0|||
143366794|NCT01674569|516887182|FG004|Overall Study|Withdrawal by Subject|0|||
143366795|NCT01674569|516887183|FG005|Overall Study|Withdrawal by Subject|0|||
143366796|NCT00567164|516887184|FG000|Overall Study|Withdrawal by Subject|171|||
143086266|NCT03284723|515854394|FG000|Overall Study|Adverse Event|0|||
143086267|NCT03284723|515854395|FG001|Overall Study|Adverse Event|0|||
143086268|NCT03284723|515854396|FG002|Overall Study|Adverse Event|0|||
143086269|NCT03284723|515854397|FG003|Overall Study|Adverse Event|0|||
143086270|NCT03284723|515854398|FG004|Overall Study|Adverse Event|0|||
143366797|NCT00567164|516887185|FG001|Overall Study|Withdrawal by Subject|21|||
143366798|NCT00567164|516887186|FG002|Overall Study|Withdrawal by Subject|17|||
143366799|NCT00567164|516887184|FG000|Overall Study|Protocol Violation|23|||
143366800|NCT00567164|516887185|FG001|Overall Study|Protocol Violation|4|||
143366801|NCT00567164|516887186|FG002|Overall Study|Protocol Violation|2|||
143366802|NCT00567164|516887184|FG000|Overall Study|Adverse Event|92|||
143366803|NCT00567164|516887185|FG001|Overall Study|Adverse Event|13|||
143086271|NCT03284723|515854399|FG005|Overall Study|Adverse Event|0|||
143086272|NCT03284723|515854400|FG006|Overall Study|Adverse Event|0|||
143086273|NCT03284723|515854401|FG007|Overall Study|Adverse Event|0|||
143086274|NCT03284723|515854402|FG008|Overall Study|Adverse Event|1|||
143086275|NCT03284723|515854403|FG009|Overall Study|Adverse Event|0|||
143086276|NCT03284723|515854404|FG010|Overall Study|Adverse Event|0|||
143086277|NCT03284723|515854405|FG011|Overall Study|Adverse Event|0|||
143086278|NCT00615199|515854406|FG000|Overall Study|Adverse Event|3|||
143366804|NCT00567164|516887186|FG002|Overall Study|Adverse Event|9|||
143086279|NCT00615199|515854407|FG001|Overall Study|Adverse Event|1|||
143086280|NCT00615199|515854408|FG002|Overall Study|Adverse Event|1|||
143086281|NCT00615199|515854409|FG003|Overall Study|Adverse Event|0|||
143086282|NCT00615199|515854406|FG000|Overall Study|Lack of Efficacy|2|||
143086283|NCT00615199|515854407|FG001|Overall Study|Lack of Efficacy|0|||
143086284|NCT00615199|515854408|FG002|Overall Study|Lack of Efficacy|0|||
143086285|NCT00615199|515854409|FG003|Overall Study|Lack of Efficacy|1|||
143366805|NCT00567164|516887184|FG000|Overall Study|Death|0|||
143366806|NCT00567164|516887185|FG001|Overall Study|Death|0|||
143086286|NCT00615199|515854406|FG000|Overall Study|Lost to Follow-up|1|||
143086287|NCT00615199|515854407|FG001|Overall Study|Lost to Follow-up|0|||
143366807|NCT00567164|516887186|FG002|Overall Study|Death|1|||
143086288|NCT00615199|515854408|FG002|Overall Study|Lost to Follow-up|0|||
143086289|NCT00615199|515854409|FG003|Overall Study|Lost to Follow-up|0|||
143366808|NCT00567164|516887184|FG000|Overall Study|Lost to Follow-up|202|||
143366809|NCT00567164|516887185|FG001|Overall Study|Lost to Follow-up|23|||
143366810|NCT00567164|516887186|FG002|Overall Study|Lost to Follow-up|21|||
143366811|NCT00567164|516887184|FG000|Overall Study|Pregnancy|20|||
143366812|NCT00567164|516887185|FG001|Overall Study|Pregnancy|4|||
143366813|NCT00567164|516887186|FG002|Overall Study|Pregnancy|6|||
143366814|NCT00567164|516887184|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
143366815|NCT00567164|516887185|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
143366816|NCT00567164|516887186|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
143366817|NCT00567164|516887184|FG000|Overall Study|Missing|1|||
143366818|NCT00567164|516887185|FG001|Overall Study|Missing|0|||
143366819|NCT00567164|516887186|FG002|Overall Study|Missing|0|||
143366820|NCT02974010|516887189|FG000|Overall Study|Lost to Follow-up|3|||
143366821|NCT02974010|516887190|FG001|Overall Study|Lost to Follow-up|1|||
143366822|NCT02974010|516887191|FG002|Overall Study|Lost to Follow-up|0|||
143366823|NCT02974010|516887192|FG003|Overall Study|Lost to Follow-up|0|||
143366824|NCT02974010|516887189|FG000|Overall Study|Withdrawal by Subject|2|||
143366825|NCT02974010|516887190|FG001|Overall Study|Withdrawal by Subject|1|||
143366826|NCT02974010|516887191|FG002|Overall Study|Withdrawal by Subject|0|||
143366827|NCT02974010|516887192|FG003|Overall Study|Withdrawal by Subject|0|||
143366828|NCT02974010|516887189|FG000|Overall Study|Adverse Event|0|||
143366829|NCT02974010|516887190|FG001|Overall Study|Adverse Event|1|||
143366830|NCT02974010|516887191|FG002|Overall Study|Adverse Event|0|||
143366831|NCT02974010|516887192|FG003|Overall Study|Adverse Event|0|||
143366832|NCT02974010|516887189|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
143366833|NCT02974010|516887190|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
143366834|NCT02974010|516887191|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
143366835|NCT02974010|516887192|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
143366836|NCT02974010|516887189|FG000|Overall Study|Lack of Efficacy|0|||
143366837|NCT02974010|516887190|FG001|Overall Study|Lack of Efficacy|0|||
143366838|NCT02974010|516887191|FG002|Overall Study|Lack of Efficacy|1|||
143366839|NCT02974010|516887192|FG003|Overall Study|Lack of Efficacy|0|||
143366840|NCT01941316|516887193|FG000|Overall Study|Adverse Event|0|||
143366841|NCT01941316|516887194|FG001|Overall Study|Adverse Event|1|||
143366842|NCT01941316|516887195|FG002|Overall Study|Adverse Event|0|||
143366843|NCT01941316|516887196|FG003|Overall Study|Adverse Event|7|||
143366844|NCT01941316|516887193|FG000|Overall Study|Progressive Disease|3|||
143366845|NCT01941316|516887194|FG001|Overall Study|Progressive Disease|6|||
143366846|NCT01941316|516887195|FG002|Overall Study|Progressive Disease|2|||
143366847|NCT01941316|516887196|FG003|Overall Study|Progressive Disease|29|||
143366848|NCT01941316|516887193|FG000|Overall Study|Withdrawal by Subject|0|||
143366849|NCT01941316|516887194|FG001|Overall Study|Withdrawal by Subject|2|||
143366850|NCT01941316|516887195|FG002|Overall Study|Withdrawal by Subject|1|||
143366851|NCT01941316|516887196|FG003|Overall Study|Withdrawal by Subject|8|||
143366852|NCT01941316|516887193|FG000|Overall Study|Death|0|||
143366853|NCT01941316|516887194|FG001|Overall Study|Death|0|||
143366854|NCT01941316|516887195|FG002|Overall Study|Death|0|||
143366855|NCT01941316|516887196|FG003|Overall Study|Death|3|||
143366856|NCT01941316|516887193|FG000|Overall Study|Physician Decision|0|||
143366857|NCT01941316|516887194|FG001|Overall Study|Physician Decision|0|||
143366858|NCT01941316|516887195|FG002|Overall Study|Physician Decision|0|||
143366859|NCT01941316|516887196|FG003|Overall Study|Physician Decision|3|||
143366860|NCT01941316|516887193|FG000|Overall Study|Protocol Violation|0|||
143366861|NCT01941316|516887194|FG001|Overall Study|Protocol Violation|0|||
143366862|NCT01941316|516887195|FG002|Overall Study|Protocol Violation|0|||
143366863|NCT01941316|516887196|FG003|Overall Study|Protocol Violation|3|||
143366864|NCT01941316|516887193|FG000|Overall Study|Intercurrent illness|0|||
143366865|NCT01941316|516887194|FG001|Overall Study|Intercurrent illness|0|||
143366866|NCT01941316|516887195|FG002|Overall Study|Intercurrent illness|0|||
143366867|NCT01941316|516887196|FG003|Overall Study|Intercurrent illness|1|||
143366868|NCT01941316|516887193|FG000|Overall Study|Other, not specified|0|||
143366869|NCT01941316|516887194|FG001|Overall Study|Other, not specified|0|||
143366870|NCT01941316|516887195|FG002|Overall Study|Other, not specified|0|||
143366871|NCT01941316|516887196|FG003|Overall Study|Other, not specified|1|||
143366872|NCT03441984|516887197|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
143366873|NCT03441984|516887198|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
143366874|NCT03441984|516887199|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
143366875|NCT03441984|516887200|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
143366876|NCT03441984|516887201|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
143366877|NCT03441984|516887202|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
143366878|NCT03441984|516887203|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
143366879|NCT03441984|516887204|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
143366880|NCT03441984|516887205|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
143366881|NCT03441984|516887206|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
143366882|NCT03441984|516887207|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
143086290|NCT00615199|515854406|FG000|Overall Study|Other|0|||
143086291|NCT00615199|515854407|FG001|Overall Study|Other|0|||
143086292|NCT00615199|515854408|FG002|Overall Study|Other|0|||
143086293|NCT00615199|515854409|FG003|Overall Study|Other|1|||
143086294|NCT00615199|515854406|FG000|Overall Study|Withdrawal by Subject|2|||
143086295|NCT00615199|515854407|FG001|Overall Study|Withdrawal by Subject|1|||
143086296|NCT00615199|515854408|FG002|Overall Study|Withdrawal by Subject|0|||
143086297|NCT00615199|515854409|FG003|Overall Study|Withdrawal by Subject|0|||
143086298|NCT00524420|515854424|FG000|Overall Study|Lack of Efficacy|1|||
143086299|NCT00524420|515854425|FG001|Overall Study|Lack of Efficacy|0|||
143086300|NCT02932462|515854430|FG000|Overall Study|Adverse Event|1|||
143175024|NCT03549338|516190426|FG000|Overall Study|Progressive Disease|1|||
143175025|NCT03549338|516190427|FG001|Overall Study|Progressive Disease|0|||
143175026|NCT03549338|516190428|FG002|Overall Study|Progressive Disease|0|||
143175027|NCT03549338|516190426|FG000|Overall Study|Clinical Progression|0|||
143175028|NCT03549338|516190427|FG001|Overall Study|Clinical Progression|1|||
143175029|NCT03549338|516190428|FG002|Overall Study|Clinical Progression|0|||
143175030|NCT01250054|516190429|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
143175031|NCT01250054|516190430|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
143175032|NCT00529243|516190436|FG000|Overall Study|Adverse Event|1|||
143175033|NCT00529243|516190436|FG000|Overall Study|Death|1|||
143175034|NCT00529243|516190436|FG000|Overall Study|Relocated|1|||
143175035|NCT03257358|516190437|FG000|Overall Study|Adverse Event|25|||
143175036|NCT03257358|516190438|FG001|Overall Study|Adverse Event|12|||
143175037|NCT03257358|516190437|FG000|Overall Study|Lack of Efficacy|1|||
143175038|NCT03257358|516190438|FG001|Overall Study|Lack of Efficacy|1|||
143175039|NCT03257358|516190437|FG000|Overall Study|Lost to Follow-up|12|||
143175040|NCT03257358|516190438|FG001|Overall Study|Lost to Follow-up|4|||
143175041|NCT03257358|516190437|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
143175042|NCT03257358|516190438|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
143175043|NCT03257358|516190437|FG000|Overall Study|Physician Decision|2|||
143175044|NCT03257358|516190438|FG001|Overall Study|Physician Decision|2|||
143175045|NCT03257358|516190437|FG000|Overall Study|Protocol Violation|5|||
143175046|NCT03257358|516190438|FG001|Overall Study|Protocol Violation|3|||
143175047|NCT03257358|516190437|FG000|Overall Study|Technical problems|4|||
143175048|NCT03257358|516190438|FG001|Overall Study|Technical problems|1|||
143175049|NCT03257358|516190437|FG000|Overall Study|Withdrawal by Subject|8|||
143175050|NCT03257358|516190438|FG001|Overall Study|Withdrawal by Subject|3|||
143175051|NCT03257358|516190437|FG000|Overall Study|Withdrawal of informed consent|9|||
143175052|NCT03257358|516190438|FG001|Overall Study|Withdrawal of informed consent|5|||
143175053|NCT03257358|516190437|FG000|Overall Study|New therapy for study indication|1|||
143175054|NCT03257358|516190438|FG001|Overall Study|New therapy for study indication|0|||
143175055|NCT03257358|516190437|FG000|Overall Study|No longer requires treatment|0|||
143175056|NCT03257358|516190438|FG001|Overall Study|No longer requires treatment|1|||
143175057|NCT01248793|516190439|FG000|Overall Study|Lost to Follow-up|0|||
143175058|NCT01248793|516190440|FG001|Overall Study|Lost to Follow-up|1|||
143175059|NCT01248793|516190439|FG000|Overall Study|Adverse Event|1|||
143175060|NCT01248793|516190440|FG001|Overall Study|Adverse Event|1|||
143175061|NCT01248793|516190439|FG000|Overall Study|Protocol Violation|0|||
143175062|NCT01248793|516190440|FG001|Overall Study|Protocol Violation|1|||
143175063|NCT01248793|516190439|FG000|Overall Study|Withdrawal by Subject|3|||
143175064|NCT01248793|516190440|FG001|Overall Study|Withdrawal by Subject|3|||
143175065|NCT01114737|516190441|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
143175066|NCT01114737|516190442|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
143175067|NCT01114737|516190441|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
143175068|NCT01114737|516190442|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
143175069|NCT01114737|516190441|FG000|Randomized Treatment Period|Pregnancy|1|||
143175070|NCT01114737|516190442|FG001|Randomized Treatment Period|Pregnancy|0|||
143175071|NCT01114737|516190441|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
143175072|NCT01114737|516190442|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
143175073|NCT01114737|516190441|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
143175074|NCT01114737|516190442|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
143175075|NCT01114737|516190441|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
143175076|NCT01114737|516190442|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
143086301|NCT02932462|515854431|FG001|Overall Study|Adverse Event|2|||
143175077|NCT01840943|516190443|FG000|Overall Study|Withdrawal by Subject|5|||
143175078|NCT01840943|516190444|FG001|Overall Study|Withdrawal by Subject|6|||
143175079|NCT01840943|516190443|FG000|Overall Study|Physician Decision|4|||
143175080|NCT01840943|516190444|FG001|Overall Study|Physician Decision|2|||
143175081|NCT01840943|516190443|FG000|Overall Study|Lost to Follow-up|4|||
143175082|NCT01840943|516190444|FG001|Overall Study|Lost to Follow-up|4|||
143175083|NCT01135992|516190447|FG000|Overall Study|Adverse Event|1|||
143175084|NCT01135992|516190447|FG000|Overall Study|Lack of Efficacy|1|||
143086302|NCT02932462|515854430|FG000|Overall Study|Lost to Follow-up|4|||
143086303|NCT02932462|515854431|FG001|Overall Study|Lost to Follow-up|1|||
143086304|NCT02932462|515854430|FG000|Overall Study|Protocol Violation|0|||
143086305|NCT02932462|515854431|FG001|Overall Study|Protocol Violation|5|||
143249872|NCT01589653|516468764|FG000|Overall Study|Withdrawal criteria|4|||
143249873|NCT01589653|516468765|FG001|Overall Study|Withdrawal criteria|7|||
143249874|NCT01589653|516468764|FG000|Overall Study|Unclassified|0|||
143249875|NCT01589653|516468765|FG001|Overall Study|Unclassified|3|||
143249876|NCT01536067|516468766|FG000|Overall Study|Disease Progression|1|||
143249877|NCT02386189|516468769|FG000|Overall Study|Lost to Follow-up|2|||
143249878|NCT02386189|516468770|FG001|Overall Study|Lost to Follow-up|3|||
143249879|NCT02386189|516468769|FG000|Overall Study|Withdrawal by Subject|1|||
143249880|NCT02386189|516468770|FG001|Overall Study|Withdrawal by Subject|0|||
143249881|NCT02386189|516468769|FG000|Overall Study|Death|1|||
143249882|NCT02386189|516468770|FG001|Overall Study|Death|0|||
143249883|NCT04657666|516468771|FG000|Period 1|Withdrawal of participant consent|2|||
143249884|NCT04657666|516468772|FG001|Period 1|Withdrawal of participant consent|1|||
143249885|NCT04657666|516468771|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
143249886|NCT04657666|516468772|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
143249887|NCT04657666|516468771|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
143249888|NCT04657666|516468772|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
143249889|NCT04657666|516468771|FG000|Period 2|Other|2|||
143249890|NCT04657666|516468772|FG001|Period 2|Other|0|||
143249891|NCT04657666|516468771|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
143249892|NCT04657666|516468772|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
143249893|NCT00606905|516468773|FG000|Overall Study|No Pregnancy|9|||
143249894|NCT00606905|516468774|FG001|Overall Study|No Pregnancy|6|||
143249895|NCT00606905|516468773|FG000|Overall Study|Non-Index Pregnancy|1|||
143249896|NCT00606905|516468774|FG001|Overall Study|Non-Index Pregnancy|4|||
143249897|NCT00606905|516468773|FG000|Overall Study|Withdrew|5|||
143249898|NCT00606905|516468774|FG001|Overall Study|Withdrew|5|||
143249899|NCT03120351|516468775|FG000|Overall Study|Physician Decision|1|||
143249900|NCT03120351|516468776|FG001|Overall Study|Physician Decision|1|||
143249901|NCT01022398|516468785|FG000|Overall Study|Study terminated|2|||
143249902|NCT01022398|516468786|FG001|Overall Study|Study terminated|2|||
143249903|NCT03319745|516468788|FG000|Overall Study|Death|1|||
143249904|NCT03319745|516468788|FG000|Overall Study|Toxicity Precluding Surgery|1|||
143249905|NCT01317550|516468789|FG000|Overall Study|Withdrawal by Subject|1|||
143249906|NCT01317550|516468790|FG001|Overall Study|Withdrawal by Subject|0|||
143086306|NCT02932462|515854430|FG000|Overall Study|Withdrawal by Subject|1|||
143086307|NCT02932462|515854431|FG001|Overall Study|Withdrawal by Subject|4|||
143086308|NCT02932462|515854430|FG000|Overall Study|Non-Compliance With Study Drug|0|||
143086309|NCT02932462|515854431|FG001|Overall Study|Non-Compliance With Study Drug|1|||
143086310|NCT02932462|515854430|FG000|Overall Study|Progressive Disease|1|||
143086311|NCT02932462|515854431|FG001|Overall Study|Progressive Disease|0|||
143086312|NCT01750190|515854432|FG000|Overall Study|Adverse Event|47|||
143086313|NCT01750190|515854433|FG001|Overall Study|Adverse Event|19|||
143086314|NCT01750190|515854432|FG000|Overall Study|Death|38|||
143086315|NCT01750190|515854433|FG001|Overall Study|Death|11|||
143086316|NCT01750190|515854432|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
143086317|NCT01750190|515854433|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
143086318|NCT01750190|515854432|FG000|Overall Study|Lost to Follow-up|28|||
143086319|NCT01750190|515854433|FG001|Overall Study|Lost to Follow-up|7|||
143086320|NCT01750190|515854432|FG000|Overall Study|Physician Decision|16|||
143086321|NCT01750190|515854433|FG001|Overall Study|Physician Decision|17|||
143086322|NCT01750190|515854432|FG000|Overall Study|Protocol Violation|6|||
143086323|NCT01750190|515854433|FG001|Overall Study|Protocol Violation|5|||
143086324|NCT01750190|515854432|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
143249907|NCT01317550|516468791|FG002|Overall Study|Withdrawal by Subject|0|||
143249908|NCT01317550|516468792|FG003|Overall Study|Withdrawal by Subject|0|||
143249909|NCT01317550|516468789|FG000|Overall Study|Lack of compliance study med|1|||
143249910|NCT01317550|516468790|FG001|Overall Study|Lack of compliance study med|0|||
143249911|NCT01317550|516468791|FG002|Overall Study|Lack of compliance study med|0|||
143086325|NCT01750190|515854433|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
143086326|NCT01750190|515854432|FG000|Overall Study|Withdrawal by Subject|83|||
143086327|NCT01750190|515854433|FG001|Overall Study|Withdrawal by Subject|89|||
143086328|NCT01750190|515854432|FG000|Overall Study|Kidney Transplant|8|||
143249912|NCT01317550|516468792|FG003|Overall Study|Lack of compliance study med|0|||
143249913|NCT00870103|516468793|FG000|Overall Study|Physician Decision|2|||
143249914|NCT00870103|516468793|FG000|Overall Study|Lost to Follow-up|2|||
143249915|NCT03255629|516468794|FG000|Overall Study|Adverse Event|1|||
143086329|NCT01750190|515854433|FG001|Overall Study|Kidney Transplant|4|||
143086330|NCT01750190|515854432|FG000|Overall Study|Dialysis|22|||
143086331|NCT01750190|515854433|FG001|Overall Study|Dialysis|8|||
143086332|NCT01750190|515854432|FG000|Overall Study|Other than Specified|13|||
143086333|NCT01750190|515854433|FG001|Overall Study|Other than Specified|4|||
143086334|NCT02955212|515854434|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
143086335|NCT02955212|515854435|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
143086336|NCT02955212|515854434|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
143086337|NCT02955212|515854435|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
143086338|NCT02955212|515854434|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
143086339|NCT02955212|515854435|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
143086340|NCT02955212|515854434|FG000|Period 1: Double-blind Treatment Period|Other|3|||
143086341|NCT02955212|515854435|FG001|Period 1: Double-blind Treatment Period|Other|2|||
143086342|NCT02955212|515854434|FG000|Period 2: Open-label Extension|Adverse Event|11|||
143086343|NCT02955212|515854435|FG001|Period 2: Open-label Extension|Adverse Event|7|||
143086344|NCT02955212|515854434|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
143086345|NCT02955212|515854435|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
143086346|NCT02955212|515854434|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
143086347|NCT02955212|515854435|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
143086348|NCT02955212|515854434|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
143086349|NCT02955212|515854435|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
143086350|NCT02955212|515854434|FG000|Period 2: Open-label Extension|Other|2|||
143086351|NCT02955212|515854435|FG001|Period 2: Open-label Extension|Other|4|||
143086352|NCT02009722|515854436|FG000|Overall Study|Protocol Violation|1|||
143086353|NCT02009722|515854437|FG001|Overall Study|Protocol Violation|2|||
143086354|NCT02009722|515854436|FG000|Overall Study|Did not receive intervention|0|||
143086355|NCT02009722|515854437|FG001|Overall Study|Did not receive intervention|1|||
143086356|NCT02454933|515854444|FG000|Overall Study|Progressive disease|10|||
143086357|NCT02454933|515854445|FG001|Overall Study|Progressive disease|7|||
143086358|NCT02454933|515854444|FG000|Overall Study|Adverse Event|1|||
143086359|NCT02454933|515854445|FG001|Overall Study|Adverse Event|1|||
143086360|NCT02454933|515854444|FG000|Overall Study|Withdrawal by Subject|0|||
143086361|NCT02454933|515854445|FG001|Overall Study|Withdrawal by Subject|3|||
143086362|NCT02454933|515854444|FG000|Overall Study|Lost to Follow-up|1|||
143086363|NCT02454933|515854445|FG001|Overall Study|Lost to Follow-up|0|||
143086364|NCT04753216|515854446|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
143086365|NCT04753216|515854446|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
143086366|NCT04753216|515854446|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
143086367|NCT03571828|515854449|FG000|Overall Study|Withdrawal by Subject|1|||
143086368|NCT03571828|515854450|FG001|Overall Study|Withdrawal by Subject|0|||
143086369|NCT03571828|515854449|FG000|Overall Study|Decision by sponsor|5|||
143086370|NCT03571828|515854450|FG001|Overall Study|Decision by sponsor|1|||
143086371|NCT03571828|515854449|FG000|Overall Study|Death|2|||
143086372|NCT03571828|515854450|FG001|Overall Study|Death|0|||
143086373|NCT00666328|515854451|FG000|Overall Study|Death|2|||
143086374|NCT00666328|515854451|FG000|Overall Study|Lost to Follow-up|2|||
143086375|NCT00666328|515854451|FG000|Overall Study|No longer met eligibility criteria|1|||
143086376|NCT01137071|515854453|FG000|Overall Study|Disease Progression|11|||
143086377|NCT01137071|515854453|FG000|Overall Study|Withdrawal by Subject|2|||
143086378|NCT01137071|515854453|FG000|Overall Study|Wrongly Included|1|||
143086379|NCT02565511|515854454|FG000|Overall Study|Study terminated by Sponsor|35|||
143086380|NCT02565511|515854455|FG001|Overall Study|Study terminated by Sponsor|22|||
143086381|NCT02565511|515854456|FG002|Overall Study|Study terminated by Sponsor|235|||
143086382|NCT02565511|515854457|FG003|Overall Study|Study terminated by Sponsor|156|||
143086383|NCT02565511|515854454|FG000|Overall Study|Withdrawal by Subject|3|||
143086384|NCT02565511|515854455|FG001|Overall Study|Withdrawal by Subject|0|||
143086385|NCT02565511|515854456|FG002|Overall Study|Withdrawal by Subject|12|||
143086386|NCT02565511|515854457|FG003|Overall Study|Withdrawal by Subject|5|||
143086387|NCT02565511|515854454|FG000|Overall Study|Adverse Event|0|||
143086388|NCT02565511|515854455|FG001|Overall Study|Adverse Event|0|||
143086389|NCT02565511|515854456|FG002|Overall Study|Adverse Event|1|||
143086390|NCT02565511|515854457|FG003|Overall Study|Adverse Event|1|||
143086391|NCT02565511|515854454|FG000|Overall Study|Lost to Follow-up|4|||
143086392|NCT02565511|515854455|FG001|Overall Study|Lost to Follow-up|1|||
143086393|NCT02565511|515854456|FG002|Overall Study|Lost to Follow-up|0|||
143086394|NCT02565511|515854457|FG003|Overall Study|Lost to Follow-up|1|||
143086395|NCT02565511|515854454|FG000|Overall Study|Physician Decision|0|||
143086396|NCT02565511|515854455|FG001|Overall Study|Physician Decision|0|||
143086397|NCT02565511|515854456|FG002|Overall Study|Physician Decision|0|||
143086398|NCT02565511|515854457|FG003|Overall Study|Physician Decision|1|||
143086399|NCT02565511|515854454|FG000|Overall Study|Protocol deviation|0|||
143086400|NCT02565511|515854455|FG001|Overall Study|Protocol deviation|0|||
143086401|NCT02565511|515854456|FG002|Overall Study|Protocol deviation|3|||
143086402|NCT02565511|515854457|FG003|Overall Study|Protocol deviation|0|||
143086403|NCT04807400|515854458|FG000|Overall Study|Adverse Event|2|||
143086404|NCT04807400|515854459|FG001|Overall Study|Adverse Event|3|||
143086405|NCT04807400|515854460|FG002|Overall Study|Adverse Event|3|||
143086406|NCT04807400|515854458|FG000|Overall Study|Death|2|||
143086407|NCT04807400|515854459|FG001|Overall Study|Death|0|||
143086408|NCT04807400|515854460|FG002|Overall Study|Death|0|||
143086409|NCT04807400|515854458|FG000|Overall Study|Lost to Follow-up|8|||
143086410|NCT04807400|515854459|FG001|Overall Study|Lost to Follow-up|6|||
143086411|NCT04807400|515854460|FG002|Overall Study|Lost to Follow-up|6|||
143086412|NCT04807400|515854458|FG000|Overall Study|Non-Compliance With Study Drug|0|||
143086413|NCT04807400|515854459|FG001|Overall Study|Non-Compliance With Study Drug|4|||
143086414|NCT04807400|515854460|FG002|Overall Study|Non-Compliance With Study Drug|1|||
143086415|NCT04807400|515854458|FG000|Overall Study|Participant Decision|20|||
143086416|NCT04807400|515854459|FG001|Overall Study|Participant Decision|19|||
143086417|NCT04807400|515854460|FG002|Overall Study|Participant Decision|26|||
143086418|NCT04807400|515854458|FG000|Overall Study|Physician Decision|0|||
143086419|NCT04807400|515854459|FG001|Overall Study|Physician Decision|1|||
143086420|NCT04807400|515854460|FG002|Overall Study|Physician Decision|0|||
143086421|NCT04807400|515854458|FG000|Overall Study|Protocol Violation|4|||
143086422|NCT04807400|515854459|FG001|Overall Study|Protocol Violation|3|||
143086423|NCT04807400|515854460|FG002|Overall Study|Protocol Violation|7|||
143086424|NCT04807400|515854458|FG000|Overall Study|Withdrawal by Subject|13|||
143086425|NCT04807400|515854459|FG001|Overall Study|Withdrawal by Subject|9|||
143086426|NCT04807400|515854460|FG002|Overall Study|Withdrawal by Subject|20|||
143086427|NCT04807400|515854458|FG000|Overall Study|Mis-randomized|1|||
143086428|NCT04807400|515854459|FG001|Overall Study|Mis-randomized|0|||
143086429|NCT04807400|515854460|FG002|Overall Study|Mis-randomized|0|||
143086430|NCT03656744|515854461|FG000|Overall Study|Adverse Event|1|||
143086431|NCT03656744|515854462|FG001|Overall Study|Adverse Event|4|||
143086432|NCT03656744|515854463|FG002|Overall Study|Adverse Event|1|||
143086433|NCT03656744|515854461|FG000|Overall Study|Protocol Violation|1|||
143086434|NCT03656744|515854462|FG001|Overall Study|Protocol Violation|0|||
143086435|NCT03656744|515854463|FG002|Overall Study|Protocol Violation|0|||
143086436|NCT03656744|515854461|FG000|Overall Study|Lost to Follow-up|2|||
143086437|NCT03656744|515854462|FG001|Overall Study|Lost to Follow-up|2|||
143086438|NCT03656744|515854463|FG002|Overall Study|Lost to Follow-up|0|||
143086439|NCT03656744|515854461|FG000|Overall Study|Withdrawal by Subject|0|||
143086440|NCT03656744|515854462|FG001|Overall Study|Withdrawal by Subject|1|||
143086441|NCT03656744|515854463|FG002|Overall Study|Withdrawal by Subject|0|||
143086442|NCT03656744|515854461|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
143086443|NCT03656744|515854462|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
143086444|NCT03656744|515854463|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
143086445|NCT01332292|515854467|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
143086446|NCT01332292|515854468|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
143249916|NCT03255629|516468795|FG001|Overall Study|Adverse Event|0|||
143249917|NCT03255629|516468794|FG000|Overall Study|did not experience hypoglycemia|2|||
143249918|NCT03255629|516468795|FG001|Overall Study|did not experience hypoglycemia|1|||
143249919|NCT04540198|516468796|FG000|Overall Study|Lost to Follow-up|25|||
143249920|NCT04540198|516468797|FG001|Overall Study|Lost to Follow-up|23|||
143249921|NCT04540198|516468796|FG000|Overall Study|Withdrawal by Subject|15|||
143249922|NCT04540198|516468797|FG001|Overall Study|Withdrawal by Subject|9|||
143249923|NCT04540198|516468796|FG000|Overall Study|Discontinued|1|||
143249924|NCT04540198|516468797|FG001|Overall Study|Discontinued|0|||
143249925|NCT03330002|516468801|FG000|Overall Study|Lost to Follow-up|15|||
143249926|NCT03330002|516468801|FG000|Overall Study|Death|7|||
143249927|NCT00833417|516468802|FG000|Overall Study|Adverse Event|5|||
143249928|NCT00833417|516468803|FG001|Overall Study|Adverse Event|16|||
143249929|NCT00833417|516468802|FG000|Overall Study|Death|1|||
143249930|NCT00833417|516468803|FG001|Overall Study|Death|3|||
143249931|NCT00833417|516468802|FG000|Overall Study|Lost to Follow-up|1|||
143249932|NCT00833417|516468803|FG001|Overall Study|Lost to Follow-up|2|||
143249933|NCT00833417|516468802|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
143249934|NCT00833417|516468803|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
143249935|NCT00833417|516468802|FG000|Overall Study|Patient Decision to Withdraw|4|||
143249936|NCT00833417|516468803|FG001|Overall Study|Patient Decision to Withdraw|23|||
143249937|NCT00833417|516468802|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
143249938|NCT00833417|516468803|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
143249939|NCT00833417|516468802|FG000|Overall Study|Disease Progression|18|||
143249940|NCT00833417|516468803|FG001|Overall Study|Disease Progression|17|||
143249941|NCT00833417|516468802|FG000|Overall Study|Reason Not Specified|0|||
143249942|NCT00833417|516468803|FG001|Overall Study|Reason Not Specified|1|||
143249943|NCT01625260|516468804|FG000|Overall Study|Adverse Event|3|||
143249944|NCT01625260|516468805|FG001|Overall Study|Adverse Event|0|||
143249945|NCT01625260|516468804|FG000|Overall Study|Study Terminated by Investigator|2|||
143249946|NCT01625260|516468805|FG001|Overall Study|Study Terminated by Investigator|0|||
143249947|NCT01625260|516468804|FG000|Overall Study|Disease Progression|2|||
143249948|NCT01625260|516468805|FG001|Overall Study|Disease Progression|0|||
143249949|NCT01625260|516468804|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
143249950|NCT01625260|516468805|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
143249951|NCT01776307|516468808|FG000|Overall Study|Not dosed|0|||
143249952|NCT01776307|516468809|FG001|Overall Study|Not dosed|0|||
143249953|NCT01776307|516468810|FG002|Overall Study|Not dosed|1|||
143249954|NCT03083990|516468811|FG000|Overall Study|Adverse Event|1|||
143249955|NCT03083990|516468812|FG001|Overall Study|Adverse Event|0|||
143249956|NCT02424578|516468813|FG000|Overall Study|Withdrawal by Subject|0|||
143249957|NCT02424578|516468814|FG001|Overall Study|Withdrawal by Subject|1|||
143249958|NCT00862082|516468816|FG000|Overall Study|Sponsor decision to terminate the study|5|||
143249959|NCT00862082|516468817|FG001|Overall Study|Sponsor decision to terminate the study|0|||
143366883|NCT03441984|516887208|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
143366884|NCT04555044|516887215|FG000|Overall Study|Adverse Event|0|||
143366885|NCT04555044|516887216|FG001|Overall Study|Adverse Event|1|||
143366886|NCT04088188|516887218|FG000|Overall Study|Withdrawal by Subject|2|||
143366887|NCT04088188|516887219|FG001|Overall Study|Withdrawal by Subject|0|||
143249960|NCT00862082|516468816|FG000|Overall Study|Withdrawal by Subject|0|||
143249961|NCT00862082|516468817|FG001|Overall Study|Withdrawal by Subject|1|||
143249962|NCT00776919|516468818|FG000|Overall Study|Withdrawal by Subject|16|||
143249963|NCT00776919|516468819|FG001|Overall Study|Withdrawal by Subject|14|||
143249964|NCT00776919|516468820|FG002|Overall Study|Withdrawal by Subject|15|||
143249965|NCT00776919|516468821|FG003|Overall Study|Withdrawal by Subject|26|||
143249966|NCT00776919|516468818|FG000|Overall Study|Lost to Follow-up|8|||
143249967|NCT00776919|516468819|FG001|Overall Study|Lost to Follow-up|12|||
143249968|NCT00776919|516468820|FG002|Overall Study|Lost to Follow-up|11|||
143366888|NCT04088188|516887218|FG000|Overall Study|Adverse Event|2|||
143366889|NCT04088188|516887219|FG001|Overall Study|Adverse Event|0|||
143366890|NCT02107014|516887226|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
143366891|NCT03761784|516887227|FG000|Overall Study|Adverse Event|4|||
143366892|NCT03761784|516887228|FG001|Overall Study|Adverse Event|0|||
143366893|NCT03761784|516887227|FG000|Overall Study|Lost to Follow-up|10|||
143366894|NCT03761784|516887228|FG001|Overall Study|Lost to Follow-up|7|||
143366895|NCT03761784|516887227|FG000|Overall Study|Pregnancy|1|||
143366896|NCT03761784|516887228|FG001|Overall Study|Pregnancy|0|||
143366897|NCT03761784|516887227|FG000|Overall Study|Protocol Violation|2|||
143366898|NCT03761784|516887228|FG001|Overall Study|Protocol Violation|0|||
143366899|NCT03761784|516887227|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
143366900|NCT03761784|516887228|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
143366901|NCT03761784|516887227|FG000|Overall Study|Withdrawal by Subject|9|||
143366902|NCT03761784|516887228|FG001|Overall Study|Withdrawal by Subject|4|||
143366903|NCT03761784|516887227|FG000|Overall Study|Physician Decision|1|||
143366904|NCT03761784|516887228|FG001|Overall Study|Physician Decision|0|||
143366905|NCT03761784|516887227|FG000|Overall Study|Other Than Specified|1|||
143366906|NCT03761784|516887228|FG001|Overall Study|Other Than Specified|0|||
143366907|NCT00586339|516887229|FG000|Overall Study|Withdrawal by Subject|1|||
143366908|NCT00586339|516887230|FG001|Overall Study|Withdrawal by Subject|3|||
143366909|NCT00586339|516887231|FG002|Overall Study|Withdrawal by Subject|1|||
143366910|NCT00586339|516887229|FG000|Overall Study|Migrated/moved from study area|3|||
143366911|NCT00586339|516887230|FG001|Overall Study|Migrated/moved from study area|2|||
143366912|NCT00586339|516887231|FG002|Overall Study|Migrated/moved from study area|4|||
143366913|NCT00586339|516887229|FG000|Overall Study|Lost to Follow-up|3|||
143366914|NCT00586339|516887230|FG001|Overall Study|Lost to Follow-up|2|||
143366915|NCT00586339|516887231|FG002|Overall Study|Lost to Follow-up|1|||
143366916|NCT00746330|516887232|FG000|Period 1|Abnormal test procedure result|0|||
143366917|NCT00746330|516887233|FG001|Period 1|Abnormal test procedure result|0|||
143366918|NCT00746330|516887234|FG002|Period 1|Abnormal test procedure result|1|||
143366919|NCT00746330|516887235|FG003|Period 1|Abnormal test procedure result|0|||
143366920|NCT01981850|516887236|FG000|Main Phase Stage 1|Death|2|||
143366921|NCT01981850|516887237|FG001|Main Phase Stage 1|Death|0|||
143366922|NCT01981850|516887238|FG002|Main Phase Stage 1|Death|0|||
143249969|NCT00776919|516468821|FG003|Overall Study|Lost to Follow-up|8|||
143249970|NCT00776919|516468818|FG000|Overall Study|Adverse Event|1|||
143249971|NCT00776919|516468819|FG001|Overall Study|Adverse Event|0|||
143249972|NCT00776919|516468820|FG002|Overall Study|Adverse Event|2|||
143249973|NCT00776919|516468821|FG003|Overall Study|Adverse Event|2|||
143249974|NCT00776919|516468818|FG000|Overall Study|Protocol Violation|1|||
143249975|NCT00776919|516468819|FG001|Overall Study|Protocol Violation|2|||
143249976|NCT00776919|516468820|FG002|Overall Study|Protocol Violation|0|||
143249977|NCT00776919|516468821|FG003|Overall Study|Protocol Violation|1|||
143249978|NCT00776919|516468818|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
143249979|NCT00776919|516468819|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
143249980|NCT00776919|516468820|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
143249981|NCT00776919|516468821|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
143249982|NCT00635999|516468823|FG000|Overall Study|Withdrawal by Subject|4|||
143249983|NCT00635999|516468824|FG001|Overall Study|Withdrawal by Subject|2|||
143249984|NCT00635999|516468825|FG002|Overall Study|Withdrawal by Subject|1|||
143249985|NCT01798849|516468826|FG000|Overall Study|Physician Decision|0|||
143249986|NCT01798849|516468827|FG001|Overall Study|Physician Decision|0|||
143249987|NCT01798849|516468828|FG002|Overall Study|Physician Decision|1|||
143249988|NCT02410343|516468831|FG000|Core Period (24 Weeks)|Adverse Event|1|||
143249989|NCT02410343|516468832|FG001|Core Period (24 Weeks)|Adverse Event|0|||
143249990|NCT02410343|516468831|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
143249991|NCT02410343|516468832|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
143249992|NCT02410343|516468831|FG000|Extension Period (12 Months)|Adverse Event|1|||
143249993|NCT02410343|516468832|FG001|Extension Period (12 Months)|Adverse Event|0|||
143249994|NCT02410343|516468831|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
143249995|NCT02410343|516468832|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
143249996|NCT00335764|516468838|FG000|Overall Study|wrong histology|1|||
143249997|NCT00335764|516468839|FG001|Overall Study|wrong histology|0|||
143249998|NCT00335764|516468840|FG002|Overall Study|wrong histology|0|||
143249999|NCT00335764|516468841|FG003|Overall Study|wrong histology|0|||
143250000|NCT00335764|516468842|FG004|Overall Study|wrong histology|1|||
143250001|NCT01065454|516468843|FG000|Treatment|Adverse Event|7|||
143250002|NCT01065454|516468844|FG001|Treatment|Adverse Event|4|||
143250003|NCT01065454|516468845|FG002|Treatment|Adverse Event|3|||
143250004|NCT01065454|516468846|FG003|Treatment|Adverse Event|6|||
143250005|NCT01065454|516468843|FG000|Treatment|Death|1|||
143250006|NCT01065454|516468844|FG001|Treatment|Death|0|||
143250007|NCT01065454|516468845|FG002|Treatment|Death|0|||
143250008|NCT01065454|516468846|FG003|Treatment|Death|0|||
143086447|NCT01332292|515854467|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
143086448|NCT01332292|515854468|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
143086449|NCT01332292|515854467|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
143086450|NCT01332292|515854468|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
143086451|NCT00098774|515854470|FG000|Overall Study|Adverse Event|2|||
143086452|NCT00098774|515854470|FG000|Overall Study|Disease Progression|9|||
143086453|NCT00098774|515854470|FG000|Overall Study|Withdrawal by Subject|1|||
143086454|NCT00098774|515854470|FG000|Overall Study|Failed (to respond) during induction|4|||
143086455|NCT00098774|515854470|FG000|Overall Study|Physician Decision|2|||
143086456|NCT00796757|515854471|FG000|Overall Study|Withdrawal by Subject|14|||
143086457|NCT00796757|515854471|FG000|Overall Study|Death|61|||
143175085|NCT01135992|516190447|FG000|Overall Study|Protocol Violation|2|||
143175086|NCT01135992|516190447|FG000|Overall Study|Withdrawal criteria|10|||
143175087|NCT01135992|516190447|FG000|Overall Study|Unclassified|7|||
143175088|NCT02580877|516190448|FG000|Overall Study|Withdrawal by Subject|1|||
143366923|NCT01981850|516887239|FG003|Main Phase Stage 1|Death|0|||
143366924|NCT01981850|516887240|FG004|Main Phase Stage 1|Death|0|||
143366925|NCT01981850|516887241|FG005|Main Phase Stage 1|Death|0|||
143086458|NCT00796757|515854471|FG000|Overall Study|Protocol Violation|1|||
143086459|NCT00796757|515854471|FG000|Overall Study|Participant noncompliance|1|||
143086460|NCT00796757|515854471|FG000|Overall Study|Investigator's decision|2|||
143086461|NCT00796757|515854471|FG000|Overall Study|Other|7|||
143086462|NCT02096744|515854474|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
143175089|NCT02580877|516190449|FG001|Overall Study|Withdrawal by Subject|3|||
143175090|NCT02580877|516190448|FG000|Overall Study|Adverse Event|0|||
143175091|NCT02580877|516190449|FG001|Overall Study|Adverse Event|1|||
143175092|NCT02903823|516190450|FG000|Overall Study|Physician Decision|5|||
143175093|NCT02903823|516190450|FG000|Overall Study|Could not advance catheter|1|||
143175094|NCT02903823|516190450|FG000|Overall Study|Catheter dislodgement|1|||
143175095|NCT00355030|516190457|FG000|Study Period 1 Treatment|Adverse Event|1|||
143175096|NCT00355030|516190458|FG001|Study Period 1 Treatment|Adverse Event|1|||
143175097|NCT00355030|516190457|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
143175098|NCT00355030|516190458|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
143175099|NCT00355030|516190457|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
143175100|NCT00355030|516190458|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
143175101|NCT00355030|516190457|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
143175102|NCT00355030|516190458|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
143175103|NCT00355030|516190457|FG000|Study Period 1 Treatment|Physician Decision|0|||
143175104|NCT00355030|516190458|FG001|Study Period 1 Treatment|Physician Decision|1|||
143175105|NCT00355030|516190457|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
143175106|NCT00355030|516190458|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
143175107|NCT00355030|516190457|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
143175108|NCT00355030|516190458|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
143175109|NCT00355030|516190457|FG000|Study Period 1 Treatment|Other|2|||
143175110|NCT00355030|516190458|FG001|Study Period 1 Treatment|Other|6|||
143175111|NCT00355030|516190457|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
143366926|NCT01981850|516887242|FG006|Main Phase Stage 1|Death|0|||
143086463|NCT02096744|515854475|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
143086464|NCT02096744|515854474|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
143086465|NCT02096744|515854475|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
143086466|NCT02096744|515854474|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
143086467|NCT02096744|515854475|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
143086468|NCT01070953|515854477|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
143086469|NCT01070953|515854477|FG000|Participants for Safety Evaluation|Off-label use|283|||
143086470|NCT01070953|515854477|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
143086471|NCT01070953|515854477|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
143086472|NCT01070953|515854477|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
143086473|NCT01070953|515854477|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
143086474|NCT01070953|515854477|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
143086475|NCT01070953|515854477|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
143086476|NCT01070953|515854477|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
143086477|NCT01070953|515854477|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
143086478|NCT01957176|515854478|FG000|Overall Study|Adverse Event|2|||
143086479|NCT01957176|515854479|FG001|Overall Study|Adverse Event|0|||
143086480|NCT01957176|515854478|FG000|Overall Study|Physician Decision|2|||
143086481|NCT01957176|515854479|FG001|Overall Study|Physician Decision|1|||
143086482|NCT01957176|515854478|FG000|Overall Study|Withdrawal by Subject|1|||
143086483|NCT01957176|515854479|FG001|Overall Study|Withdrawal by Subject|0|||
143086484|NCT01512160|515854481|FG000|Overall Study|Lost to Follow-up|1|||
143086485|NCT01512160|515854482|FG001|Overall Study|Lost to Follow-up|0|||
143086486|NCT01512160|515854483|FG002|Overall Study|Lost to Follow-up|0|||
143086487|NCT01512160|515854484|FG003|Overall Study|Lost to Follow-up|0|||
143175112|NCT00355030|516190458|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
143086488|NCT01512160|515854481|FG000|Overall Study|Withdrawal by Subject|1|||
143086489|NCT01512160|515854482|FG001|Overall Study|Withdrawal by Subject|0|||
143086490|NCT01512160|515854483|FG002|Overall Study|Withdrawal by Subject|0|||
143086491|NCT01512160|515854484|FG003|Overall Study|Withdrawal by Subject|1|||
143175113|NCT00355030|516190457|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
143086492|NCT00866359|515854485|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
143086493|NCT00866359|515854486|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
143175114|NCT00355030|516190458|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
143175115|NCT01123148|516190459|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
143175116|NCT01123148|516190459|FG000|Overall Study|Didn't meet milestone criteria|1|||
143175117|NCT01747915|516190460|FG000|Overall Study|Other|1|||
143175118|NCT01747915|516190461|FG001|Overall Study|Other|1|||
143175119|NCT01747915|516190462|FG002|Overall Study|Other|1|||
143175120|NCT01747915|516190460|FG000|Overall Study|Adverse Event|8|||
143175121|NCT01747915|516190461|FG001|Overall Study|Adverse Event|5|||
143175122|NCT01747915|516190462|FG002|Overall Study|Adverse Event|2|||
143175123|NCT01747915|516190460|FG000|Overall Study|Death|0|||
143175124|NCT01747915|516190461|FG001|Overall Study|Death|0|||
143175125|NCT01747915|516190462|FG002|Overall Study|Death|1|||
143175126|NCT01747915|516190460|FG000|Overall Study|Lack of Efficacy|0|||
143175127|NCT01747915|516190461|FG001|Overall Study|Lack of Efficacy|1|||
143175128|NCT01747915|516190462|FG002|Overall Study|Lack of Efficacy|0|||
143175129|NCT01747915|516190460|FG000|Overall Study|Lost to Follow-up|1|||
143175130|NCT01747915|516190461|FG001|Overall Study|Lost to Follow-up|0|||
143175131|NCT01747915|516190462|FG002|Overall Study|Lost to Follow-up|0|||
143175132|NCT01747915|516190460|FG000|Overall Study|Withdrawal by Subject|4|||
143175133|NCT01747915|516190461|FG001|Overall Study|Withdrawal by Subject|4|||
143175134|NCT01747915|516190462|FG002|Overall Study|Withdrawal by Subject|1|||
143175135|NCT01747915|516190460|FG000|Overall Study|Protocol Violation|1|||
143175136|NCT01747915|516190461|FG001|Overall Study|Protocol Violation|0|||
143175137|NCT01747915|516190462|FG002|Overall Study|Protocol Violation|0|||
143175138|NCT01747915|516190460|FG000|Overall Study|Pregnancy|0|||
143175139|NCT01747915|516190461|FG001|Overall Study|Pregnancy|0|||
143175140|NCT01747915|516190462|FG002|Overall Study|Pregnancy|1|||
143175141|NCT00690794|516190465|FG000|Overall Study|Adverse Event|12|||
143175142|NCT00690794|516190466|FG001|Overall Study|Adverse Event|10|||
143175143|NCT00690794|516190465|FG000|Overall Study|Lost to Follow-up|1|||
143175144|NCT00690794|516190466|FG001|Overall Study|Lost to Follow-up|4|||
143175145|NCT00690794|516190465|FG000|Overall Study|Withdrawal by Subject|0|||
143175146|NCT00690794|516190466|FG001|Overall Study|Withdrawal by Subject|9|||
143175147|NCT00690794|516190465|FG000|Overall Study|Protocol Violation|6|||
143175148|NCT00690794|516190466|FG001|Overall Study|Protocol Violation|7|||
143175149|NCT00690794|516190465|FG000|Overall Study|Noncompliance|1|||
143175150|NCT00690794|516190466|FG001|Overall Study|Noncompliance|2|||
143175151|NCT00690794|516190465|FG000|Overall Study|Other not specified|1|||
143175152|NCT00690794|516190466|FG001|Overall Study|Other not specified|3|||
143175153|NCT01496287|516190467|FG000|Overall Study|Lost to Follow-up|1|||
143175154|NCT01496287|516190467|FG000|Overall Study|Incomplete anesthesia|5|||
143175155|NCT01823107|516190468|FG000|Overall Study|Withdrawal by Subject|1|||
143175156|NCT00305448|516190469|FG000|Overall Study|Protocol Violation|0|||
143175157|NCT00305448|516190470|FG001|Overall Study|Protocol Violation|1|||
143175158|NCT00305448|516190471|FG002|Overall Study|Protocol Violation|0|||
143175159|NCT00305448|516190469|FG000|Overall Study|Withdrawal by Subject|2|||
143175160|NCT00305448|516190470|FG001|Overall Study|Withdrawal by Subject|0|||
143175161|NCT00305448|516190471|FG002|Overall Study|Withdrawal by Subject|1|||
143175162|NCT00305448|516190469|FG000|Overall Study|Adverse Event|1|||
143175163|NCT00305448|516190470|FG001|Overall Study|Adverse Event|0|||
143175164|NCT00305448|516190471|FG002|Overall Study|Adverse Event|1|||
143175165|NCT00305448|516190469|FG000|Overall Study|Disease Progression|27|||
143175166|NCT00305448|516190470|FG001|Overall Study|Disease Progression|31|||
143175167|NCT00305448|516190471|FG002|Overall Study|Disease Progression|28|||
143175168|NCT00305448|516190469|FG000|Overall Study|Subjective Disease Progression|1|||
143175169|NCT00305448|516190470|FG001|Overall Study|Subjective Disease Progression|2|||
143175170|NCT00305448|516190471|FG002|Overall Study|Subjective Disease Progression|2|||
143175171|NCT00305448|516190469|FG000|Overall Study|Tumor Marker Elevation|0|||
143175172|NCT00305448|516190470|FG001|Overall Study|Tumor Marker Elevation|0|||
143175173|NCT00305448|516190471|FG002|Overall Study|Tumor Marker Elevation|1|||
143175174|NCT01343888|516190472|FG000|Overall Study|Adverse Event|12|||
143175175|NCT01343888|516190473|FG001|Overall Study|Adverse Event|22|||
143175176|NCT01343888|516190474|FG002|Overall Study|Adverse Event|5|||
143175177|NCT01343888|516190472|FG000|Overall Study|Lack of Efficacy|9|||
143175178|NCT01343888|516190473|FG001|Overall Study|Lack of Efficacy|9|||
143175179|NCT01343888|516190474|FG002|Overall Study|Lack of Efficacy|13|||
143175180|NCT01343888|516190472|FG000|Overall Study|Lost to Follow-up|0|||
143175181|NCT01343888|516190473|FG001|Overall Study|Lost to Follow-up|2|||
143175182|NCT01343888|516190474|FG002|Overall Study|Lost to Follow-up|1|||
143175183|NCT01343888|516190472|FG000|Overall Study|Protocol Violation|0|||
143175184|NCT01343888|516190473|FG001|Overall Study|Protocol Violation|2|||
143175185|NCT01343888|516190474|FG002|Overall Study|Protocol Violation|0|||
143175186|NCT01343888|516190472|FG000|Overall Study|Withdrawal by Subject|4|||
143175187|NCT01343888|516190473|FG001|Overall Study|Withdrawal by Subject|4|||
143175188|NCT01343888|516190474|FG002|Overall Study|Withdrawal by Subject|2|||
143175189|NCT01343888|516190472|FG000|Overall Study|other than stated above|0|||
143175190|NCT01343888|516190473|FG001|Overall Study|other than stated above|0|||
143086494|NCT00866359|515854487|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
143086495|NCT00866359|515854488|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
143086496|NCT00866359|515854485|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
143086497|NCT00866359|515854486|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
143086498|NCT00866359|515854487|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
143086499|NCT00866359|515854488|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
143086500|NCT00866359|515854485|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
143086501|NCT00866359|515854486|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
143175191|NCT01343888|516190474|FG002|Overall Study|other than stated above|1|||
143086502|NCT00866359|515854487|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
143086503|NCT00866359|515854488|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
143086504|NCT00866359|515854485|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
143086505|NCT00866359|515854486|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
143086506|NCT00866359|515854487|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
143086507|NCT00866359|515854488|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
143086508|NCT00866359|515854485|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
143086509|NCT00866359|515854486|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
143086510|NCT00866359|515854487|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
143086511|NCT00866359|515854488|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
143086512|NCT00866359|515854485|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
143086513|NCT00866359|515854486|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
143086514|NCT00866359|515854487|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
143086515|NCT00866359|515854488|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
143086516|NCT02163057|515854489|FG000|Overall Study|Participant Refusal to Continue|2|||
143175192|NCT00077974|516190475|FG000|Overall Study|Adverse Event|22|||
143175193|NCT00077974|516190475|FG000|Overall Study|Protocol Violation|1|||
143175194|NCT00077974|516190475|FG000|Overall Study|Withdrawal by Subject|3|||
143175195|NCT00077974|516190475|FG000|Overall Study|Lack of Efficacy|76|||
143175196|NCT00077974|516190475|FG000|Overall Study|Decision of Sponsor|2|||
143175197|NCT00800735|516190487|FG000|Overall Study|Administrative/Other|2|||
143175198|NCT00800735|516190487|FG000|Overall Study|Insufficient Therapeutic Response|2|||
143175199|NCT00800735|516190487|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
143366927|NCT01981850|516887243|FG007|Main Phase Stage 1|Death|0|||
143175200|NCT00800735|516190487|FG000|Overall Study|Withdrew Consent|3|||
143086517|NCT02163057|515854490|FG001|Overall Study|Participant Refusal to Continue|2|||
143086518|NCT02163057|515854489|FG000|Overall Study|Participant Significant Noncompliance|0|||
143086519|NCT02163057|515854490|FG001|Overall Study|Participant Significant Noncompliance|1|||
143086520|NCT02163057|515854489|FG000|Overall Study|Progression of Disease|1|||
143086521|NCT02163057|515854490|FG001|Overall Study|Progression of Disease|2|||
143175201|NCT03273907|516190488|FG000|Overall Study|Death|1|||
143175202|NCT03273907|516190488|FG000|Overall Study|Lost to Follow-up|4|||
143175203|NCT03273907|516190488|FG000|Overall Study|Withdrawal by Subject|2|||
143366928|NCT01981850|516887244|FG008|Main Phase Stage 1|Death|0|||
143086522|NCT01625091|515854491|FG000|Intervention|Death|1|||
143086523|NCT01625091|515854492|FG001|Intervention|Death|1|||
143086524|NCT01625091|515854491|FG000|Intervention|Withdrawal by Subject|4|||
143086525|NCT01625091|515854492|FG001|Intervention|Withdrawal by Subject|1|||
143086526|NCT01625091|515854491|FG000|Intervention|Adverse Event|0|||
143086527|NCT01625091|515854492|FG001|Intervention|Adverse Event|2|||
143086528|NCT01625091|515854491|FG000|Intervention|Lost to Follow-up|4|||
143086529|NCT01625091|515854492|FG001|Intervention|Lost to Follow-up|4|||
143086530|NCT01625091|515854491|FG000|Intervention|Study termination|2|||
143086531|NCT01625091|515854492|FG001|Intervention|Study termination|3|||
143086532|NCT01625091|515854491|FG000|Post-intervention|Death|0|||
143086533|NCT01625091|515854492|FG001|Post-intervention|Death|1|||
143086534|NCT01625091|515854491|FG000|Post-intervention|Lost to Follow-up|2|||
143086535|NCT01625091|515854492|FG001|Post-intervention|Lost to Follow-up|0|||
143086536|NCT01625091|515854491|FG000|Post-intervention|Study termination|2|||
143086537|NCT01625091|515854492|FG001|Post-intervention|Study termination|1|||
143086538|NCT00768248|515854496|FG000|Overall Study|Research coordinator didn't collect data|1|||
143086539|NCT00768248|515854497|FG001|Overall Study|Research coordinator didn't collect data|1|||
143175204|NCT03273907|516190488|FG000|Overall Study|COVID 19|2|||
143175205|NCT00110214|516190489|FG000|Overall Study|Never started treatment|21|||
143175206|NCT00110214|516190490|FG001|Overall Study|Never started treatment|20|||
143175207|NCT00110214|516190489|FG000|Overall Study|Disease progression or death|260|||
143175208|NCT00110214|516190490|FG001|Overall Study|Disease progression or death|151|||
143175209|NCT00110214|516190489|FG000|Overall Study|Adverse Event|115|||
143175210|NCT00110214|516190490|FG001|Overall Study|Adverse Event|192|||
143175211|NCT00110214|516190489|FG000|Overall Study|Refused further treatment|52|||
143175212|NCT00110214|516190490|FG001|Overall Study|Refused further treatment|65|||
143175213|NCT00110214|516190489|FG000|Overall Study|Other (not specified)|61|||
143175214|NCT00110214|516190490|FG001|Overall Study|Other (not specified)|75|||
143175215|NCT01016067|516190492|FG000|Overall Study|Lost to Follow-up|1|||
143175216|NCT01016067|516190493|FG001|Overall Study|Lost to Follow-up|2|||
143175217|NCT01016067|516190492|FG000|Overall Study|Physician Decision|1|||
143175218|NCT01016067|516190493|FG001|Overall Study|Physician Decision|1|||
143175219|NCT01016067|516190492|FG000|Overall Study|Withdrew due to Relocation|0|||
143175220|NCT01016067|516190493|FG001|Overall Study|Withdrew due to Relocation|1|||
143175221|NCT00501644|516190495|FG000|Overall Study|Adverse Event|4|||
143175222|NCT00501644|516190495|FG000|Overall Study|Withdrawal by Subject|1|||
143175223|NCT02553629|516190496|FG000|Overall Study|Logistic reasons|3|||
143175224|NCT02553629|516190497|FG001|Overall Study|Logistic reasons|6|||
143175225|NCT00696878|516190503|FG000|Overall Study|Adverse Event|8|||
143175226|NCT00696878|516190503|FG000|Overall Study|Withdrawal by Subject|87|||
143175227|NCT00696878|516190503|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
143175228|NCT00696878|516190503|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
143175229|NCT00696878|516190503|FG000|Overall Study|Trial stopped|32|||
143175230|NCT00696878|516190503|FG000|Overall Study|Other reason (not specified)|55|||
143175231|NCT02259114|516190508|FG000|Overall Study|Progressive Disease|14|||
143175232|NCT02259114|516190509|FG001|Overall Study|Progressive Disease|2|||
143175233|NCT02259114|516190510|FG002|Overall Study|Progressive Disease|10|||
143175234|NCT02259114|516190511|FG003|Overall Study|Progressive Disease|2|||
143175235|NCT02259114|516190512|FG004|Overall Study|Progressive Disease|5|||
143175236|NCT02259114|516190508|FG000|Overall Study|Adverse Event|2|||
143366929|NCT01981850|516887245|FG009|Main Phase Stage 1|Death|0|||
143086540|NCT01547390|515854498|FG000|Overall Study|Withdrawal by Subject|10|||
143086541|NCT01547390|515854499|FG001|Overall Study|Withdrawal by Subject|7|||
143086542|NCT01547390|515854498|FG000|Overall Study|termination of pregnancy|0|||
143175237|NCT02259114|516190509|FG001|Overall Study|Adverse Event|1|||
143086543|NCT01547390|515854499|FG001|Overall Study|termination of pregnancy|1|||
143086544|NCT01547390|515854498|FG000|Overall Study|Lost to Follow-up|0|||
143086545|NCT01547390|515854499|FG001|Overall Study|Lost to Follow-up|2|||
143086546|NCT01547390|515854498|FG000|Overall Study|Adverse Event|3|||
143086547|NCT01547390|515854499|FG001|Overall Study|Adverse Event|0|||
143175238|NCT02259114|516190510|FG002|Overall Study|Adverse Event|0|||
143175239|NCT02259114|516190511|FG003|Overall Study|Adverse Event|0|||
143175240|NCT02259114|516190512|FG004|Overall Study|Adverse Event|1|||
143175241|NCT02259114|516190508|FG000|Overall Study|Death|3|||
143175242|NCT02259114|516190509|FG001|Overall Study|Death|0|||
143175243|NCT02259114|516190510|FG002|Overall Study|Death|1|||
143175244|NCT02259114|516190511|FG003|Overall Study|Death|0|||
143086548|NCT01959295|515854502|FG000|Overall Study|Adverse Event|2|||
143086549|NCT01959295|515854503|FG001|Overall Study|Adverse Event|0|||
143086550|NCT01959295|515854502|FG000|Overall Study|Lost to Follow-up|0|||
143086551|NCT01959295|515854503|FG001|Overall Study|Lost to Follow-up|2|||
143086552|NCT01959295|515854502|FG000|Overall Study|Physician Decision|2|||
143086553|NCT01959295|515854503|FG001|Overall Study|Physician Decision|3|||
143086554|NCT01959295|515854502|FG000|Overall Study|Protocol Violation|16|||
143086555|NCT01959295|515854503|FG001|Overall Study|Protocol Violation|5|||
143086556|NCT01959295|515854502|FG000|Overall Study|Withdrawal by Subject|3|||
143086557|NCT01959295|515854503|FG001|Overall Study|Withdrawal by Subject|1|||
143086558|NCT01959295|515854502|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
143086559|NCT01959295|515854503|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
143086560|NCT04917861|515854504|FG000|Main Study (196 Days)|Adverse Event|0|||
143086561|NCT04917861|515854505|FG001|Main Study (196 Days)|Adverse Event|1|||
143086562|NCT04917861|515854506|FG002|Main Study (196 Days)|Adverse Event|0|||
143175245|NCT02259114|516190512|FG004|Overall Study|Death|0|||
143175246|NCT02259114|516190508|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
143175247|NCT02259114|516190509|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
143175248|NCT02259114|516190510|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
143175249|NCT02259114|516190511|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
143175250|NCT02259114|516190512|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
143175251|NCT02259114|516190508|FG000|Overall Study|Withdrawal by Subject|0|||
143175252|NCT02259114|516190509|FG001|Overall Study|Withdrawal by Subject|0|||
143175253|NCT02259114|516190510|FG002|Overall Study|Withdrawal by Subject|1|||
143175254|NCT02259114|516190511|FG003|Overall Study|Withdrawal by Subject|1|||
143175255|NCT02259114|516190512|FG004|Overall Study|Withdrawal by Subject|0|||
143175256|NCT02259114|516190508|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
143175257|NCT02259114|516190509|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
143175258|NCT02259114|516190510|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
143175259|NCT02259114|516190511|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
143175260|NCT02259114|516190512|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
143175261|NCT02259114|516190508|FG000|Overall Study|Not Treated|1|||
143175262|NCT02259114|516190509|FG001|Overall Study|Not Treated|0|||
143175263|NCT02259114|516190510|FG002|Overall Study|Not Treated|0|||
143175264|NCT02259114|516190511|FG003|Overall Study|Not Treated|0|||
143175265|NCT02259114|516190512|FG004|Overall Study|Not Treated|0|||
143175266|NCT03937479|516190513|FG000|Overall Study|Adverse Event|2|||
143175267|NCT03937479|516190514|FG001|Overall Study|Adverse Event|3|||
143175268|NCT03937479|516190515|FG002|Overall Study|Adverse Event|0|||
143175269|NCT03937479|516190516|FG003|Overall Study|Adverse Event|0|||
143175270|NCT03937479|516190517|FG004|Overall Study|Adverse Event|1|||
143175271|NCT03937479|516190513|FG000|Overall Study|Withdrawal by Subject|3|||
143175272|NCT03937479|516190514|FG001|Overall Study|Withdrawal by Subject|5|||
143175273|NCT03937479|516190515|FG002|Overall Study|Withdrawal by Subject|2|||
143175274|NCT03937479|516190516|FG003|Overall Study|Withdrawal by Subject|2|||
143175275|NCT03937479|516190517|FG004|Overall Study|Withdrawal by Subject|1|||
143175276|NCT03937479|516190513|FG000|Overall Study|Protocol Violation|5|||
143175277|NCT03937479|516190514|FG001|Overall Study|Protocol Violation|6|||
143175278|NCT03937479|516190515|FG002|Overall Study|Protocol Violation|4|||
143175279|NCT03937479|516190516|FG003|Overall Study|Protocol Violation|3|||
143175280|NCT03937479|516190517|FG004|Overall Study|Protocol Violation|2|||
143175281|NCT03937479|516190513|FG000|Overall Study|Lost to Follow-up|0|||
143175282|NCT03937479|516190514|FG001|Overall Study|Lost to Follow-up|1|||
143250009|NCT01065454|516468843|FG000|Treatment|Non-compliance|1|||
143250010|NCT01065454|516468844|FG001|Treatment|Non-compliance|0|||
143086563|NCT04917861|515854507|FG003|Main Study (196 Days)|Adverse Event|0|||
143086564|NCT04917861|515854504|FG000|Main Study (196 Days)|Death|0|||
143086565|NCT04917861|515854505|FG001|Main Study (196 Days)|Death|0|||
143175283|NCT03937479|516190515|FG002|Overall Study|Lost to Follow-up|0|||
143175284|NCT03937479|516190516|FG003|Overall Study|Lost to Follow-up|1|||
143175285|NCT03937479|516190517|FG004|Overall Study|Lost to Follow-up|0|||
143175286|NCT03937479|516190513|FG000|Overall Study|Physician Decision|0|||
143175287|NCT03937479|516190514|FG001|Overall Study|Physician Decision|0|||
143175288|NCT03937479|516190515|FG002|Overall Study|Physician Decision|1|||
143175289|NCT03937479|516190516|FG003|Overall Study|Physician Decision|0|||
143175290|NCT03937479|516190517|FG004|Overall Study|Physician Decision|1|||
143175291|NCT04436744|516190522|FG000|Overall Study|Adverse Event|1|||
143366930|NCT01981850|516887236|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
143366931|NCT01981850|516887237|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
143086566|NCT04917861|515854506|FG002|Main Study (196 Days)|Death|0|||
143086567|NCT04917861|515854507|FG003|Main Study (196 Days)|Death|1|||
143086568|NCT04917861|515854504|FG000|Main Study (196 Days)|Lost to Follow-up|14|||
143086569|NCT04917861|515854505|FG001|Main Study (196 Days)|Lost to Follow-up|26|||
143086570|NCT04917861|515854506|FG002|Main Study (196 Days)|Lost to Follow-up|20|||
143086571|NCT04917861|515854507|FG003|Main Study (196 Days)|Lost to Follow-up|11|||
143086572|NCT04917861|515854504|FG000|Main Study (196 Days)|Physician Decision|0|||
143086573|NCT04917861|515854505|FG001|Main Study (196 Days)|Physician Decision|0|||
143086574|NCT04917861|515854506|FG002|Main Study (196 Days)|Physician Decision|0|||
143086575|NCT04917861|515854507|FG003|Main Study (196 Days)|Physician Decision|1|||
143086576|NCT04917861|515854504|FG000|Main Study (196 Days)|Pregnancy|1|||
143086577|NCT04917861|515854505|FG001|Main Study (196 Days)|Pregnancy|1|||
143086578|NCT04917861|515854506|FG002|Main Study (196 Days)|Pregnancy|0|||
143086579|NCT04917861|515854507|FG003|Main Study (196 Days)|Pregnancy|0|||
143086580|NCT04917861|515854504|FG000|Main Study (196 Days)|Withdrawal by Subject|14|||
143086581|NCT04917861|515854505|FG001|Main Study (196 Days)|Withdrawal by Subject|7|||
143086582|NCT04917861|515854506|FG002|Main Study (196 Days)|Withdrawal by Subject|6|||
143086583|NCT04917861|515854507|FG003|Main Study (196 Days)|Withdrawal by Subject|8|||
143086584|NCT04917861|515854504|FG000|Main Study (196 Days)|Other Than Specified|1|||
143086585|NCT04917861|515854505|FG001|Main Study (196 Days)|Other Than Specified|0|||
143086586|NCT04917861|515854506|FG002|Main Study (196 Days)|Other Than Specified|1|||
143086587|NCT04917861|515854507|FG003|Main Study (196 Days)|Other Than Specified|2|||
143086588|NCT04917861|515854504|FG000|Extension Period (Day 197 to Day 700)|Lost to Follow-up|8|||
143086589|NCT04917861|515854505|FG001|Extension Period (Day 197 to Day 700)|Lost to Follow-up|3|||
143086590|NCT04917861|515854506|FG002|Extension Period (Day 197 to Day 700)|Lost to Follow-up|5|||
143086591|NCT04917861|515854507|FG003|Extension Period (Day 197 to Day 700)|Lost to Follow-up|11|||
143086592|NCT04917861|515854504|FG000|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
143086593|NCT04917861|515854505|FG001|Extension Period (Day 197 to Day 700)|Pregnancy|0|||
143086594|NCT04917861|515854506|FG002|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
143086595|NCT04917861|515854507|FG003|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
143086596|NCT04917861|515854504|FG000|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
143086597|NCT04917861|515854505|FG001|Extension Period (Day 197 to Day 700)|Protocol Violation|1|||
143086598|NCT04917861|515854506|FG002|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
143086599|NCT04917861|515854507|FG003|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
143086600|NCT04917861|515854504|FG000|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|6|||
143086601|NCT04917861|515854505|FG001|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
143086602|NCT04917861|515854506|FG002|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
143086603|NCT04917861|515854507|FG003|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|10|||
143086604|NCT04917861|515854504|FG000|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
143086605|NCT04917861|515854505|FG001|Extension Period (Day 197 to Day 700)|Other Than Specified|0|||
143086606|NCT04917861|515854506|FG002|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
143086607|NCT04917861|515854507|FG003|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
143086608|NCT04917861|515854504|FG000|Extension Period (Day 197 to Day 700)|Death|0|||
143086609|NCT04917861|515854505|FG001|Extension Period (Day 197 to Day 700)|Death|1|||
143086610|NCT04917861|515854506|FG002|Extension Period (Day 197 to Day 700)|Death|0|||
143086611|NCT04917861|515854507|FG003|Extension Period (Day 197 to Day 700)|Death|0|||
143086612|NCT01128179|515854508|FG000|Overall Study|Death|1|||
143250011|NCT01065454|516468845|FG002|Treatment|Non-compliance|0|||
143086613|NCT01128179|515854509|FG001|Overall Study|Death|0|||
143086614|NCT01128179|515854508|FG000|Overall Study|Protocol Violation|1|||
143086615|NCT01128179|515854509|FG001|Overall Study|Protocol Violation|0|||
143250012|NCT01065454|516468846|FG003|Treatment|Non-compliance|1|||
143366932|NCT01981850|516887238|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
143175292|NCT04436744|516190523|FG001|Overall Study|Adverse Event|1|||
143175293|NCT04436744|516190522|FG000|Overall Study|Death|1|||
143175294|NCT04436744|516190523|FG001|Overall Study|Death|0|||
143175295|NCT04436744|516190522|FG000|Overall Study|Lost to Follow-up|0|||
143175296|NCT04436744|516190523|FG001|Overall Study|Lost to Follow-up|2|||
143175297|NCT04436744|516190522|FG000|Overall Study|Physician Decision|0|||
143175298|NCT04436744|516190523|FG001|Overall Study|Physician Decision|1|||
143175299|NCT04436744|516190522|FG000|Overall Study|Progressive Disease|0|||
143366933|NCT01981850|516887239|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
143175300|NCT04436744|516190523|FG001|Overall Study|Progressive Disease|4|||
143175301|NCT04436744|516190522|FG000|Overall Study|Protocol Deviation|1|||
143175302|NCT04436744|516190523|FG001|Overall Study|Protocol Deviation|1|||
143366934|NCT01981850|516887240|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
143366935|NCT01981850|516887241|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
143366936|NCT01981850|516887242|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
143366937|NCT01981850|516887243|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
143366938|NCT01981850|516887244|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
143366939|NCT01981850|516887245|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
143366940|NCT01981850|516887236|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
143366941|NCT01981850|516887237|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
143366942|NCT01981850|516887238|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
143366943|NCT01981850|516887239|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
143366944|NCT01981850|516887240|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
143366945|NCT01981850|516887241|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
143366946|NCT01981850|516887242|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
143366947|NCT01981850|516887243|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
143366948|NCT01981850|516887244|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
143366949|NCT01981850|516887245|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
143366950|NCT01981850|516887236|FG000|Main Phase Stage 1|Various reasons|0|||
143366951|NCT01981850|516887237|FG001|Main Phase Stage 1|Various reasons|0|||
143366952|NCT01981850|516887238|FG002|Main Phase Stage 1|Various reasons|2|||
143366953|NCT01981850|516887239|FG003|Main Phase Stage 1|Various reasons|0|||
143366954|NCT01981850|516887240|FG004|Main Phase Stage 1|Various reasons|0|||
143366955|NCT01981850|516887241|FG005|Main Phase Stage 1|Various reasons|0|||
143366956|NCT01981850|516887242|FG006|Main Phase Stage 1|Various reasons|0|||
143366957|NCT01981850|516887243|FG007|Main Phase Stage 1|Various reasons|0|||
143366958|NCT01981850|516887244|FG008|Main Phase Stage 1|Various reasons|0|||
143366959|NCT01981850|516887245|FG009|Main Phase Stage 1|Various reasons|0|||
143366960|NCT01981850|516887236|FG000|Main Phase Stage 2|Adverse Event|0|||
143366961|NCT01981850|516887237|FG001|Main Phase Stage 2|Adverse Event|0|||
143366962|NCT01981850|516887238|FG002|Main Phase Stage 2|Adverse Event|0|||
143366963|NCT01981850|516887239|FG003|Main Phase Stage 2|Adverse Event|0|||
143366964|NCT01981850|516887240|FG004|Main Phase Stage 2|Adverse Event|6|||
143366965|NCT01981850|516887241|FG005|Main Phase Stage 2|Adverse Event|5|||
143366966|NCT01981850|516887242|FG006|Main Phase Stage 2|Adverse Event|7|||
143366967|NCT01981850|516887243|FG007|Main Phase Stage 2|Adverse Event|0|||
143366968|NCT01981850|516887244|FG008|Main Phase Stage 2|Adverse Event|0|||
143366969|NCT01981850|516887245|FG009|Main Phase Stage 2|Adverse Event|0|||
143366970|NCT01981850|516887236|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
143366971|NCT01981850|516887237|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
143366972|NCT01981850|516887238|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
143366973|NCT01981850|516887239|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
143366974|NCT01981850|516887240|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
143175303|NCT04436744|516190522|FG000|Overall Study|Withdrawal by Subject|1|||
143366975|NCT01981850|516887241|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
143366976|NCT01981850|516887242|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
143366977|NCT01981850|516887243|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
143366978|NCT01981850|516887244|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
143366979|NCT01981850|516887245|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
143366980|NCT01981850|516887236|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
143366981|NCT01981850|516887237|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
143366982|NCT01981850|516887238|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
143366983|NCT01981850|516887239|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
143366984|NCT01981850|516887240|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
143175304|NCT04436744|516190523|FG001|Overall Study|Withdrawal by Subject|2|||
143175305|NCT01133847|516190524|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
143175306|NCT01133847|516190525|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
143175307|NCT01133847|516190526|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
143175308|NCT01133847|516190524|FG000|Follow-Up Phase|Lost to Follow-up|1|||
143175309|NCT01133847|516190525|FG001|Follow-Up Phase|Lost to Follow-up|3|||
143175310|NCT01133847|516190526|FG002|Follow-Up Phase|Lost to Follow-up|7|||
143175311|NCT03789292|516190527|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
143175312|NCT03789292|516190528|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
143175313|NCT03789292|516190529|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
143175314|NCT03789292|516190527|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
143175315|NCT03789292|516190528|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
143366985|NCT01981850|516887241|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
143366986|NCT01981850|516887242|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
143366987|NCT01981850|516887243|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
143366988|NCT01981850|516887244|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
143366989|NCT01981850|516887245|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
143366990|NCT01981850|516887236|FG000|Main Phase Stage 2|Various reasons|0|||
143250013|NCT01065454|516468843|FG000|Treatment|Protocol Decision|0|||
143366991|NCT01981850|516887237|FG001|Main Phase Stage 2|Various reasons|0|||
143366992|NCT01981850|516887238|FG002|Main Phase Stage 2|Various reasons|0|||
143366993|NCT01981850|516887239|FG003|Main Phase Stage 2|Various reasons|0|||
143086616|NCT02694328|515854510|FG000|Overall Study|Adverse Event|27|||
143086617|NCT02694328|515854511|FG001|Overall Study|Adverse Event|33|||
143086618|NCT02694328|515854510|FG000|Overall Study|Withdrawal by Subject|27|||
143086619|NCT02694328|515854511|FG001|Overall Study|Withdrawal by Subject|23|||
143086620|NCT02694328|515854510|FG000|Overall Study|Lost to Follow-up|26|||
143086621|NCT02694328|515854511|FG001|Overall Study|Lost to Follow-up|22|||
143086622|NCT02694328|515854510|FG000|Overall Study|Noncompliant with study drug|11|||
143086623|NCT02694328|515854511|FG001|Overall Study|Noncompliant with study drug|8|||
143086624|NCT02694328|515854510|FG000|Overall Study|Incarceration|1|||
143086625|NCT02694328|515854511|FG001|Overall Study|Incarceration|1|||
143086626|NCT02694328|515854510|FG000|Overall Study|Lack of Efficacy|1|||
143086627|NCT02694328|515854511|FG001|Overall Study|Lack of Efficacy|2|||
143086628|NCT02694328|515854510|FG000|Overall Study|Pregnancy|1|||
143086629|NCT02694328|515854511|FG001|Overall Study|Pregnancy|1|||
143086630|NCT02694328|515854510|FG000|Overall Study|Protocol Violation|6|||
143086631|NCT02694328|515854511|FG001|Overall Study|Protocol Violation|5|||
143086632|NCT02694328|515854510|FG000|Overall Study|Abnormal Laboratory Value|0|||
143086633|NCT02694328|515854511|FG001|Overall Study|Abnormal Laboratory Value|3|||
143086634|NCT01260701|515854513|FG000|Overall Study|Adverse Event|9|||
143086635|NCT01260701|515854513|FG000|Overall Study|Withdrawal by Subject|2|||
143086636|NCT01260701|515854513|FG000|Overall Study|Progression|53|||
143086637|NCT01260701|515854513|FG000|Overall Study|Death|2|||
143086638|NCT01260701|515854513|FG000|Overall Study|Not protocol specified|3|||
143366994|NCT01981850|516887240|FG004|Main Phase Stage 2|Various reasons|2|||
143366995|NCT01981850|516887241|FG005|Main Phase Stage 2|Various reasons|0|||
143366996|NCT01981850|516887242|FG006|Main Phase Stage 2|Various reasons|1|||
143086639|NCT01260701|515854513|FG000|Overall Study|Under review|1|||
143366997|NCT01981850|516887243|FG007|Main Phase Stage 2|Various reasons|0|||
143086640|NCT01260701|515854513|FG000|Overall Study|Ineligible|4|||
143086641|NCT01260701|515854513|FG000|Overall Study|Did not begin protocol therapy|1|||
143086642|NCT00720382|515854514|FG000|Overall Study|Adverse Event|54|||
143086643|NCT00720382|515854515|FG001|Overall Study|Adverse Event|17|||
143086644|NCT00720382|515854514|FG000|Overall Study|Lack of Efficacy|18|||
143086645|NCT00720382|515854515|FG001|Overall Study|Lack of Efficacy|7|||
143086646|NCT00720382|515854514|FG000|Overall Study|Non-Compliance|15|||
143086647|NCT00720382|515854515|FG001|Overall Study|Non-Compliance|5|||
143086648|NCT00720382|515854514|FG000|Overall Study|Withdrawal by Subject|47|||
143086649|NCT00720382|515854515|FG001|Overall Study|Withdrawal by Subject|11|||
143086650|NCT00720382|515854514|FG000|Overall Study|Lost to Follow-up|28|||
143086651|NCT00720382|515854515|FG001|Overall Study|Lost to Follow-up|14|||
143086652|NCT00720382|515854514|FG000|Overall Study|administrative|14|||
143086653|NCT00720382|515854515|FG001|Overall Study|administrative|5|||
143086654|NCT01290302|515856220|FG000|Overall Study|Adverse Event|2|||
143086655|NCT01290302|515856221|FG001|Overall Study|Adverse Event|0|||
143086656|NCT01290302|515856220|FG000|Overall Study|Withdrawal by Subject|1|||
143086657|NCT01290302|515856221|FG001|Overall Study|Withdrawal by Subject|0|||
143086658|NCT01290302|515856220|FG000|Overall Study|Physician Decision|0|||
143086659|NCT01290302|515856221|FG001|Overall Study|Physician Decision|2|||
143086660|NCT01290302|515856220|FG000|Overall Study|Expiration of time for screening window|1|||
143086661|NCT01290302|515856221|FG001|Overall Study|Expiration of time for screening window|0|||
143086662|NCT05221320|515856232|FG000|Overall Study|Lack of Efficacy|3|||
143086663|NCT05221320|515856233|FG001|Overall Study|Lack of Efficacy|7|||
143086664|NCT05221320|515856234|FG002|Overall Study|Lack of Efficacy|10|||
143086665|NCT05221320|515856235|FG003|Overall Study|Lack of Efficacy|1|||
143086666|NCT05221320|515856236|FG004|Overall Study|Lack of Efficacy|0|||
143086667|NCT05221320|515856237|FG005|Overall Study|Lack of Efficacy|0|||
143086668|NCT05221320|515856232|FG000|Overall Study|Physician Decision|1|||
143086669|NCT05221320|515856233|FG001|Overall Study|Physician Decision|0|||
143086670|NCT05221320|515856234|FG002|Overall Study|Physician Decision|3|||
143086671|NCT05221320|515856235|FG003|Overall Study|Physician Decision|1|||
143086672|NCT05221320|515856236|FG004|Overall Study|Physician Decision|0|||
143086673|NCT05221320|515856237|FG005|Overall Study|Physician Decision|0|||
143086674|NCT05221320|515856232|FG000|Overall Study|Withdrawal by Subject|0|||
143086675|NCT05221320|515856233|FG001|Overall Study|Withdrawal by Subject|3|||
143086676|NCT05221320|515856234|FG002|Overall Study|Withdrawal by Subject|1|||
143086677|NCT05221320|515856235|FG003|Overall Study|Withdrawal by Subject|0|||
143086678|NCT05221320|515856236|FG004|Overall Study|Withdrawal by Subject|0|||
143086679|NCT05221320|515856237|FG005|Overall Study|Withdrawal by Subject|0|||
143086680|NCT05221320|515856232|FG000|Overall Study|Death|0|||
143086681|NCT05221320|515856233|FG001|Overall Study|Death|5|||
143175316|NCT03789292|516190529|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
143175317|NCT03789292|516190527|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
143175318|NCT03789292|516190528|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
143175319|NCT03789292|516190529|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
143175320|NCT03789292|516190527|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
143175321|NCT03789292|516190528|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
143175322|NCT03789292|516190529|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
143175323|NCT03789292|516190527|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
143175324|NCT03789292|516190528|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
143175325|NCT03789292|516190529|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
143175326|NCT03789292|516190527|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
143175327|NCT03789292|516190528|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
143175328|NCT03789292|516190529|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
143175329|NCT03789292|516190527|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
143175330|NCT03789292|516190528|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
143175331|NCT03789292|516190529|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
143175332|NCT03789292|516190527|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
143175333|NCT03789292|516190528|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
143175334|NCT03789292|516190529|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
143175335|NCT03789292|516190527|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
143175336|NCT03789292|516190528|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
143175337|NCT03789292|516190529|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
143175338|NCT03789292|516190527|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
143175339|NCT03789292|516190528|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
143175340|NCT03789292|516190529|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
143175341|NCT03789292|516190527|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
143175342|NCT03789292|516190528|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
143175343|NCT03789292|516190529|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
143175344|NCT03789292|516190527|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
143175345|NCT03789292|516190528|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
143175346|NCT03789292|516190529|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
143175347|NCT03789292|516190527|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
143175348|NCT03789292|516190528|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
143175349|NCT03789292|516190529|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
143175350|NCT00575666|516190530|FG000|Overall Study|Withdrawal by Subject|3|||
143175351|NCT00575666|516190531|FG001|Overall Study|Withdrawal by Subject|2|||
143175352|NCT00575666|516190530|FG000|Overall Study|Physician Decision|1|||
143175353|NCT00575666|516190531|FG001|Overall Study|Physician Decision|1|||
143175354|NCT00546481|516190532|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
143366998|NCT01981850|516887244|FG008|Main Phase Stage 2|Various reasons|0|||
143086682|NCT05221320|515856234|FG002|Overall Study|Death|6|||
143086683|NCT05221320|515856235|FG003|Overall Study|Death|0|||
143086684|NCT05221320|515856236|FG004|Overall Study|Death|1|||
143086685|NCT05221320|515856237|FG005|Overall Study|Death|0|||
143086686|NCT06473519|515856238|FG000|Overall Study|Lost to Follow-up|2|||
143086687|NCT06473519|515856239|FG001|Overall Study|Lost to Follow-up|5|||
143086688|NCT06473519|515856238|FG000|Overall Study|Withdrawal by Subject|1|||
143086689|NCT06473519|515856239|FG001|Overall Study|Withdrawal by Subject|4|||
143086690|NCT06473519|515856238|FG000|Overall Study|Randomized but not vaccinated|1|||
143086691|NCT06473519|515856239|FG001|Overall Study|Randomized but not vaccinated|2|||
143086692|NCT02514447|515856243|FG000|Overall Study|Withdrawal by Subject|3|||
143086693|NCT02514447|515856244|FG001|Overall Study|Withdrawal by Subject|1|||
143086694|NCT02514447|515856245|FG002|Overall Study|Withdrawal by Subject|1|||
143086695|NCT02514447|515856246|FG003|Overall Study|Withdrawal by Subject|0|||
143086696|NCT02514447|515856247|FG004|Overall Study|Withdrawal by Subject|0|||
143086697|NCT02514447|515856248|FG005|Overall Study|Withdrawal by Subject|0|||
143086698|NCT02514447|515856249|FG006|Overall Study|Withdrawal by Subject|0|||
143086699|NCT02514447|515856250|FG007|Overall Study|Withdrawal by Subject|1|||
143086700|NCT02514447|515856251|FG008|Overall Study|Withdrawal by Subject|1|||
143086701|NCT02514447|515856243|FG000|Overall Study|Death|24|||
143086702|NCT02514447|515856244|FG001|Overall Study|Death|28|||
143086703|NCT02514447|515856245|FG002|Overall Study|Death|29|||
143086704|NCT02514447|515856246|FG003|Overall Study|Death|0|||
143086705|NCT02514447|515856247|FG004|Overall Study|Death|3|||
143086706|NCT02514447|515856248|FG005|Overall Study|Death|4|||
143086707|NCT02514447|515856249|FG006|Overall Study|Death|8|||
143086708|NCT02514447|515856250|FG007|Overall Study|Death|6|||
143086709|NCT02514447|515856251|FG008|Overall Study|Death|5|||
143086710|NCT02514447|515856243|FG000|Overall Study|Lost to Follow-up|1|||
143086711|NCT02514447|515856244|FG001|Overall Study|Lost to Follow-up|0|||
143086712|NCT02514447|515856245|FG002|Overall Study|Lost to Follow-up|0|||
143086713|NCT02514447|515856246|FG003|Overall Study|Lost to Follow-up|0|||
143086714|NCT02514447|515856247|FG004|Overall Study|Lost to Follow-up|0|||
143086715|NCT02514447|515856248|FG005|Overall Study|Lost to Follow-up|0|||
143086716|NCT02514447|515856249|FG006|Overall Study|Lost to Follow-up|0|||
143086717|NCT02514447|515856250|FG007|Overall Study|Lost to Follow-up|0|||
143086718|NCT02514447|515856251|FG008|Overall Study|Lost to Follow-up|1|||
143086719|NCT02514447|515856243|FG000|Overall Study|Sponsor Termination of Study|0|||
143086720|NCT02514447|515856244|FG001|Overall Study|Sponsor Termination of Study|1|||
143086721|NCT02514447|515856245|FG002|Overall Study|Sponsor Termination of Study|1|||
143086722|NCT02514447|515856246|FG003|Overall Study|Sponsor Termination of Study|0|||
143086723|NCT02514447|515856247|FG004|Overall Study|Sponsor Termination of Study|0|||
143086724|NCT02514447|515856248|FG005|Overall Study|Sponsor Termination of Study|0|||
143086725|NCT02514447|515856249|FG006|Overall Study|Sponsor Termination of Study|0|||
143086726|NCT02514447|515856250|FG007|Overall Study|Sponsor Termination of Study|0|||
143086727|NCT02514447|515856251|FG008|Overall Study|Sponsor Termination of Study|0|||
143086728|NCT02514447|515856243|FG000|Overall Study|Study completion per Investigator|1|||
143175355|NCT00546481|516190533|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
143175356|NCT00546481|516190534|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
143086729|NCT02514447|515856244|FG001|Overall Study|Study completion per Investigator|0|||
143086730|NCT02514447|515856245|FG002|Overall Study|Study completion per Investigator|1|||
143086731|NCT02514447|515856246|FG003|Overall Study|Study completion per Investigator|2|||
143086732|NCT02514447|515856247|FG004|Overall Study|Study completion per Investigator|0|||
143086733|NCT02514447|515856248|FG005|Overall Study|Study completion per Investigator|0|||
143250014|NCT01065454|516468844|FG001|Treatment|Protocol Decision|0|||
143086734|NCT02514447|515856249|FG006|Overall Study|Study completion per Investigator|0|||
143086735|NCT02514447|515856250|FG007|Overall Study|Study completion per Investigator|0|||
143086736|NCT02514447|515856251|FG008|Overall Study|Study completion per Investigator|1|||
143086737|NCT03300817|515856253|FG000|Overall Study|Withdrawal by Subject|1|||
143086738|NCT03300817|515856253|FG000|Overall Study|Adverse Event|1|||
143086739|NCT03300817|515856253|FG000|Overall Study|Subject Found to be Ineligible|2|||
143086740|NCT00265759|515856254|FG000|Overall Study|Withdrawal by Subject|0|||
143086741|NCT00265759|515856255|FG001|Overall Study|Withdrawal by Subject|1|||
143086742|NCT00265759|515856256|FG002|Overall Study|Withdrawal by Subject|2|||
143086743|NCT00265759|515856257|FG003|Overall Study|Withdrawal by Subject|2|||
143086744|NCT00265759|515856254|FG000|Overall Study|Cancel|0|||
143086745|NCT00265759|515856255|FG001|Overall Study|Cancel|0|||
143175357|NCT00546481|516190532|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
143366999|NCT01981850|516887245|FG009|Main Phase Stage 2|Various reasons|0|||
143367000|NCT01981850|516887236|FG000|Main Phase Stage 2|Progressive Disease|0|||
143367001|NCT01981850|516887237|FG001|Main Phase Stage 2|Progressive Disease|0|||
143367002|NCT01981850|516887238|FG002|Main Phase Stage 2|Progressive Disease|0|||
143367003|NCT01981850|516887239|FG003|Main Phase Stage 2|Progressive Disease|0|||
143367004|NCT01981850|516887240|FG004|Main Phase Stage 2|Progressive Disease|0|||
143367005|NCT01981850|516887241|FG005|Main Phase Stage 2|Progressive Disease|6|||
143175358|NCT00546481|516190533|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
143175359|NCT00546481|516190534|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
143175360|NCT00546481|516190532|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
143175361|NCT00546481|516190533|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
143175362|NCT00546481|516190534|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
143175363|NCT00546481|516190532|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
143175364|NCT00546481|516190533|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
143175365|NCT00546481|516190534|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
143175366|NCT00546481|516190532|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
143175367|NCT00546481|516190533|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
143175368|NCT00546481|516190534|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
143175369|NCT00546481|516190532|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
143175370|NCT00546481|516190533|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
143175371|NCT00546481|516190534|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
143175372|NCT00546481|516190532|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
143175373|NCT00546481|516190533|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
143175374|NCT00546481|516190534|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
143175375|NCT00546481|516190532|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
143175376|NCT00546481|516190533|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
143175377|NCT00546481|516190534|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
143175378|NCT00546481|516190532|FG000|Maintenance Phase (CERA)|Other Reason|0|||
143175379|NCT00546481|516190533|FG001|Maintenance Phase (CERA)|Other Reason|0|||
143175380|NCT00546481|516190534|FG002|Maintenance Phase (CERA)|Other Reason|1|||
143175381|NCT00950651|516190537|FG000|Overall Study|Adverse Event|17|||
143175382|NCT00950651|516190538|FG001|Overall Study|Adverse Event|20|||
143175383|NCT00950651|516190537|FG000|Overall Study|Death|1|||
143175384|NCT00950651|516190538|FG001|Overall Study|Death|0|||
143175385|NCT00950651|516190537|FG000|Overall Study|Lack of Efficacy|2|||
143175386|NCT00950651|516190538|FG001|Overall Study|Lack of Efficacy|2|||
143175387|NCT00950651|516190537|FG000|Overall Study|Protocol Violation|3|||
143175388|NCT00950651|516190538|FG001|Overall Study|Protocol Violation|4|||
143175389|NCT00950651|516190537|FG000|Overall Study|Withdrawal by Subject|8|||
143175390|NCT00950651|516190538|FG001|Overall Study|Withdrawal by Subject|9|||
143175391|NCT03783780|516190541|FG000|Overall Study|Withdrawn prior to completion|1|||
143175392|NCT03768427|516190542|FG000|Overall Study|Death|0|||
143175393|NCT03768427|516190543|FG001|Overall Study|Death|0|||
143175394|NCT03768427|516190544|FG002|Overall Study|Death|1|||
143175395|NCT03768427|516190545|FG003|Overall Study|Death|0|||
143175396|NCT03768427|516190542|FG000|Overall Study|Lost to Follow-up|2|||
143175397|NCT03768427|516190543|FG001|Overall Study|Lost to Follow-up|0|||
143175398|NCT03768427|516190544|FG002|Overall Study|Lost to Follow-up|0|||
143175399|NCT03768427|516190545|FG003|Overall Study|Lost to Follow-up|0|||
143175400|NCT03768427|516190542|FG000|Overall Study|Physician Decision|3|||
143175401|NCT03768427|516190543|FG001|Overall Study|Physician Decision|2|||
143175402|NCT03768427|516190544|FG002|Overall Study|Physician Decision|4|||
143175403|NCT03768427|516190545|FG003|Overall Study|Physician Decision|4|||
143175404|NCT03768427|516190542|FG000|Overall Study|Withdrawal by Subject|7|||
143175405|NCT03768427|516190543|FG001|Overall Study|Withdrawal by Subject|2|||
143175406|NCT03768427|516190544|FG002|Overall Study|Withdrawal by Subject|6|||
143175407|NCT03768427|516190545|FG003|Overall Study|Withdrawal by Subject|7|||
143175408|NCT01644643|516190548|FG000|Overall Study|Death|1|||
143175409|NCT01644643|516190549|FG001|Overall Study|Death|0|||
143175410|NCT01644643|516190550|FG002|Overall Study|Death|3|||
143175411|NCT01644643|516190551|FG003|Overall Study|Death|3|||
143175412|NCT01644643|516190548|FG000|Overall Study|Lost to Follow-up|0|||
143175413|NCT01644643|516190549|FG001|Overall Study|Lost to Follow-up|0|||
143175414|NCT01644643|516190550|FG002|Overall Study|Lost to Follow-up|0|||
143175415|NCT01644643|516190551|FG003|Overall Study|Lost to Follow-up|4|||
143175416|NCT01644643|516190548|FG000|Overall Study|Withdrawal by Subject|1|||
143175417|NCT01644643|516190549|FG001|Overall Study|Withdrawal by Subject|0|||
143175418|NCT01644643|516190550|FG002|Overall Study|Withdrawal by Subject|2|||
143175419|NCT01644643|516190551|FG003|Overall Study|Withdrawal by Subject|1|||
143175420|NCT01644643|516190548|FG000|Overall Study|Other Eligibility criteria|0|||
143175421|NCT01644643|516190549|FG001|Overall Study|Other Eligibility criteria|0|||
143175422|NCT01644643|516190550|FG002|Overall Study|Other Eligibility criteria|0|||
143175423|NCT01644643|516190551|FG003|Overall Study|Other Eligibility criteria|2|||
143175424|NCT02850978|516190556|FG000|Overall Study|Uncollectable CRF|27|||
143175425|NCT02850978|516190556|FG000|Overall Study|No visit since the first visit|35|||
143175426|NCT02850978|516190556|FG000|Overall Study|Adverse Event|81|||
143175427|NCT02850978|516190556|FG000|Overall Study|Lack of Efficacy|40|||
143175428|NCT02850978|516190556|FG000|Overall Study|Improvement in condition|34|||
143175429|NCT02850978|516190556|FG000|Overall Study|Lost to Follow-up|121|||
143175430|NCT02850978|516190556|FG000|Overall Study|Reason not listed|88|||
143175431|NCT02765399|516190561|FG000|Overall Study|Nausea|1|||
143175432|NCT02765399|516190562|FG001|Overall Study|Nausea|0|||
143175433|NCT00120627|516190567|FG000|Overall Study|Withdrawal by Subject|5|||
143250015|NCT01065454|516468845|FG002|Treatment|Protocol Decision|3|||
143250016|NCT01065454|516468846|FG003|Treatment|Protocol Decision|2|||
143250017|NCT01065454|516468843|FG000|Treatment|Protocol Violation|1|||
143250018|NCT01065454|516468844|FG001|Treatment|Protocol Violation|0|||
143250019|NCT01065454|516468845|FG002|Treatment|Protocol Violation|1|||
143250020|NCT01065454|516468846|FG003|Treatment|Protocol Violation|0|||
143250021|NCT01065454|516468843|FG000|Treatment|Withdrawal by Subject|3|||
143250022|NCT01065454|516468844|FG001|Treatment|Withdrawal by Subject|1|||
143250023|NCT01065454|516468845|FG002|Treatment|Withdrawal by Subject|2|||
143250024|NCT01065454|516468846|FG003|Treatment|Withdrawal by Subject|3|||
143250025|NCT01065454|516468843|FG000|Follow up|Adverse Event|1|||
143250026|NCT01065454|516468844|FG001|Follow up|Adverse Event|0|||
143250027|NCT01065454|516468845|FG002|Follow up|Adverse Event|0|||
143250028|NCT01065454|516468846|FG003|Follow up|Adverse Event|1|||
143250029|NCT01065454|516468843|FG000|Follow up|Death|0|||
143250030|NCT01065454|516468844|FG001|Follow up|Death|1|||
143250031|NCT01065454|516468845|FG002|Follow up|Death|1|||
143250032|NCT01065454|516468846|FG003|Follow up|Death|0|||
143250033|NCT01065454|516468843|FG000|Follow up|Lost to Follow-up|0|||
143250034|NCT01065454|516468844|FG001|Follow up|Lost to Follow-up|0|||
143250035|NCT01065454|516468845|FG002|Follow up|Lost to Follow-up|0|||
143250036|NCT01065454|516468846|FG003|Follow up|Lost to Follow-up|1|||
143250037|NCT01065454|516468843|FG000|Follow up|Progressive disease|0|||
143250038|NCT01065454|516468844|FG001|Follow up|Progressive disease|0|||
143250039|NCT01065454|516468845|FG002|Follow up|Progressive disease|0|||
143250040|NCT01065454|516468846|FG003|Follow up|Progressive disease|1|||
143250041|NCT01065454|516468843|FG000|Follow up|Withdrawal by Subject|1|||
143250042|NCT01065454|516468844|FG001|Follow up|Withdrawal by Subject|1|||
143250043|NCT01065454|516468845|FG002|Follow up|Withdrawal by Subject|1|||
143250044|NCT01065454|516468846|FG003|Follow up|Withdrawal by Subject|0|||
143250045|NCT01065454|516468843|FG000|Follow up|study ongoing|37|||
143250046|NCT01065454|516468844|FG001|Follow up|study ongoing|22|||
143250047|NCT01065454|516468845|FG002|Follow up|study ongoing|15|||
143250048|NCT01065454|516468846|FG003|Follow up|study ongoing|41|||
143250049|NCT05688670|516468847|FG000|Overall Study|Change in surgery plan|1|||
143086746|NCT00265759|515856256|FG002|Overall Study|Cancel|0|||
143086747|NCT00265759|515856257|FG003|Overall Study|Cancel|3|||
143086748|NCT00265759|515856254|FG000|Overall Study|Ineligible|0|||
143086749|NCT00265759|515856255|FG001|Overall Study|Ineligible|0|||
143086750|NCT00265759|515856256|FG002|Overall Study|Ineligible|0|||
143086751|NCT00265759|515856257|FG003|Overall Study|Ineligible|1|||
143086752|NCT00265759|515856254|FG000|Overall Study|Bilateral disease|0|||
143086753|NCT00265759|515856255|FG001|Overall Study|Bilateral disease|0|||
143086754|NCT00265759|515856256|FG002|Overall Study|Bilateral disease|0|||
143086755|NCT00265759|515856257|FG003|Overall Study|Bilateral disease|2|||
143086756|NCT00265759|515856254|FG000|Overall Study|Discontinued due to intolerability|0|||
143086757|NCT00265759|515856255|FG001|Overall Study|Discontinued due to intolerability|0|||
143086758|NCT00265759|515856256|FG002|Overall Study|Discontinued due to intolerability|0|||
143086759|NCT00265759|515856257|FG003|Overall Study|Discontinued due to intolerability|1|||
143086760|NCT03729596|515856259|FG000|Overall Study|Death|3|||
143086761|NCT03729596|515856260|FG001|Overall Study|Death|5|||
143086762|NCT03729596|515856261|FG002|Overall Study|Death|4|||
143086763|NCT03729596|515856262|FG003|Overall Study|Death|1|||
143086764|NCT03729596|515856263|FG004|Overall Study|Death|0|||
143086765|NCT03729596|515856264|FG005|Overall Study|Death|34|||
143086766|NCT03729596|515856265|FG006|Overall Study|Death|18|||
143086767|NCT03729596|515856266|FG007|Overall Study|Death|14|||
143086768|NCT03729596|515856267|FG008|Overall Study|Death|19|||
143086769|NCT03729596|515856268|FG009|Overall Study|Death|9|||
143086770|NCT03729596|515856259|FG000|Overall Study|Lost to Follow-up|0|||
143086771|NCT03729596|515856260|FG001|Overall Study|Lost to Follow-up|0|||
143086772|NCT03729596|515856261|FG002|Overall Study|Lost to Follow-up|0|||
143086773|NCT03729596|515856262|FG003|Overall Study|Lost to Follow-up|0|||
143250050|NCT05688670|516468848|FG001|Overall Study|Change in surgery plan|4|||
143250051|NCT05688670|516468847|FG000|Overall Study|Inability to extubate|1|||
143250052|NCT05688670|516468848|FG001|Overall Study|Inability to extubate|2|||
143250053|NCT05688670|516468847|FG000|Overall Study|Day of surgery cancellation|0|||
143250054|NCT05688670|516468848|FG001|Overall Study|Day of surgery cancellation|1|||
143086774|NCT03729596|515856263|FG004|Overall Study|Lost to Follow-up|0|||
143250055|NCT05688670|516468847|FG000|Overall Study|Reintubated on PCICU arrival|0|||
143086775|NCT03729596|515856264|FG005|Overall Study|Lost to Follow-up|0|||
143086776|NCT03729596|515856265|FG006|Overall Study|Lost to Follow-up|1|||
143086777|NCT03729596|515856266|FG007|Overall Study|Lost to Follow-up|0|||
143250056|NCT05688670|516468848|FG001|Overall Study|Reintubated on PCICU arrival|1|||
143250057|NCT02051933|516471126|FG000|Overall Study|Physician Decision|0|||
143250058|NCT02051933|516471127|FG001|Overall Study|Physician Decision|1|||
143250059|NCT01954927|516471128|FG000|Overall Study|Withdrawal by Subject|3|||
143175434|NCT00120627|516190568|FG001|Overall Study|Withdrawal by Subject|5|||
143175435|NCT01677988|516190569|FG000|Overall Study|Lack of Efficacy|2|||
143175436|NCT00907621|516190576|FG000|Overall Study|Lost to Follow-up|6|||
143175437|NCT00907621|516190577|FG001|Overall Study|Lost to Follow-up|3|||
143175438|NCT00907621|516190576|FG000|Overall Study|intercurrent febrile illness|1|||
143175439|NCT00907621|516190577|FG001|Overall Study|intercurrent febrile illness|1|||
143175440|NCT00902330|516190580|FG000|Overall Study|Too overwhelmed by treatment|2|||
143175441|NCT00902330|516190581|FG001|Overall Study|Too overwhelmed by treatment|5|||
143175442|NCT00902330|516190580|FG000|Overall Study|Adverse Event|1|||
143175443|NCT00902330|516190581|FG001|Overall Study|Adverse Event|0|||
143175444|NCT00902330|516190580|FG000|Overall Study|No post baseline data|1|||
143175445|NCT00902330|516190581|FG001|Overall Study|No post baseline data|0|||
143175446|NCT00165789|516190582|FG000|Overall Study|Adverse Event|0|||
143175447|NCT00165789|516190583|FG001|Overall Study|Adverse Event|3|||
143175448|NCT00165789|516190584|FG002|Overall Study|Adverse Event|0|||
143175449|NCT00165789|516190585|FG003|Overall Study|Adverse Event|12|||
143175450|NCT00165789|516190582|FG000|Overall Study|Withdrawal by Subject|0|||
143175451|NCT00165789|516190583|FG001|Overall Study|Withdrawal by Subject|1|||
143175452|NCT00165789|516190584|FG002|Overall Study|Withdrawal by Subject|1|||
143175453|NCT00165789|516190585|FG003|Overall Study|Withdrawal by Subject|2|||
143250060|NCT01954927|516471129|FG001|Overall Study|Withdrawal by Subject|1|||
143250061|NCT00109590|516471130|FG000|Overall Study|Lost to Follow-up|1|||
143250062|NCT00109590|516471131|FG001|Overall Study|Lost to Follow-up|0|||
143250063|NCT00109590|516471132|FG002|Overall Study|Lost to Follow-up|1|||
143250064|NCT00109590|516471130|FG000|Overall Study|Never Started Treatment|1|||
143250065|NCT00109590|516471131|FG001|Overall Study|Never Started Treatment|2|||
143250066|NCT00109590|516471132|FG002|Overall Study|Never Started Treatment|3|||
143250067|NCT02123251|516471133|FG000|Overall Study|Death|1|||
143250068|NCT02123251|516471134|FG001|Overall Study|Death|1|||
143250069|NCT02123251|516471133|FG000|Overall Study|Withdrawal by Subject|0|||
143250070|NCT02123251|516471134|FG001|Overall Study|Withdrawal by Subject|3|||
143250071|NCT02123251|516471133|FG000|Overall Study|Lost Medicaid eligibility|29|||
143250072|NCT02123251|516471134|FG001|Overall Study|Lost Medicaid eligibility|22|||
143250073|NCT02123251|516471133|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
143250074|NCT02123251|516471134|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
143250075|NCT01221285|516471135|FG000|Overall Study|Withdrawal by Subject|1|||
143250076|NCT00588861|516471136|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
143250077|NCT00588861|516471137|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
143250078|NCT00588861|516471136|FG000|6 Months|Patients did not return for follow-up|98|||
143250079|NCT00588861|516471137|FG001|6 Months|Patients did not return for follow-up|73|||
143250080|NCT00588861|516471136|FG000|1 Year|Patients did not return for follow-up|89|||
143250081|NCT00588861|516471137|FG001|1 Year|Patients did not return for follow-up|82|||
143250082|NCT00588861|516471136|FG000|2 Years|Patients did not return for follow-up|92|||
143250083|NCT00588861|516471137|FG001|2 Years|Patients did not return for follow-up|87|||
143250084|NCT00588861|516471136|FG000|4 Years|Patients did not return for follow-up|91|||
143250085|NCT00588861|516471137|FG001|4 Years|Patients did not return for follow-up|103|||
143250086|NCT00588861|516471136|FG000|6 Years|Patients did not return for follow-up|104|||
143250087|NCT00588861|516471137|FG001|6 Years|Patients did not return for follow-up|109|||
143250088|NCT00588861|516471136|FG000|8 Years|Patients did not return for follow-up|105|||
143250089|NCT00588861|516471137|FG001|8 Years|Patients did not return for follow-up|114|||
143250090|NCT00588861|516471136|FG000|10 Years|Incomplete due to study termination|107|||
143250091|NCT00588861|516471137|FG001|10 Years|Incomplete due to study termination|114|||
143250092|NCT01343693|516471142|FG000|Overall Study|Lost to Follow-up|9|||
143250093|NCT02551991|516471143|FG000|Overall Study|Death|5|||
143250094|NCT02551991|516471144|FG001|Overall Study|Death|7|||
143250095|NCT02551991|516471145|FG002|Overall Study|Death|8|||
143250096|NCT02551991|516471146|FG003|Overall Study|Death|7|||
143250097|NCT02551991|516471147|FG004|Overall Study|Death|17|||
143250098|NCT02551991|516471143|FG000|Overall Study|Withdrawal by Subject|1|||
143175454|NCT01816048|516190586|FG000|Overall Study|Adverse Event|1|||
143250099|NCT02551991|516471144|FG001|Overall Study|Withdrawal by Subject|0|||
143250100|NCT02551991|516471145|FG002|Overall Study|Withdrawal by Subject|0|||
143250101|NCT02551991|516471146|FG003|Overall Study|Withdrawal by Subject|0|||
143250102|NCT02551991|516471147|FG004|Overall Study|Withdrawal by Subject|2|||
143250103|NCT02551991|516471143|FG000|Overall Study|Lost to Follow-up|0|||
143250104|NCT02551991|516471144|FG001|Overall Study|Lost to Follow-up|0|||
143250105|NCT02551991|516471145|FG002|Overall Study|Lost to Follow-up|1|||
143250106|NCT02551991|516471146|FG003|Overall Study|Lost to Follow-up|0|||
143250107|NCT02551991|516471147|FG004|Overall Study|Lost to Follow-up|0|||
143175455|NCT01816048|516190586|FG000|Overall Study|Death|1|||
143175456|NCT01816048|516190586|FG000|Overall Study|Withdrawal by Subject|1|||
143250108|NCT02551991|516471143|FG000|Overall Study|Sponsor Decision|1|||
143175457|NCT01816048|516190586|FG000|Overall Study|Disease Progression|3|||
143175458|NCT03950856|516190587|FG000|Overall Study|Death|1|||
143175459|NCT03950856|516190588|FG001|Overall Study|Death|2|||
143175460|NCT03950856|516190589|FG002|Overall Study|Death|0|||
143086778|NCT03729596|515856267|FG008|Overall Study|Lost to Follow-up|0|||
143086779|NCT03729596|515856268|FG009|Overall Study|Lost to Follow-up|1|||
143086780|NCT03729596|515856259|FG000|Overall Study|protocol amendment|0|||
143086781|NCT03729596|515856260|FG001|Overall Study|protocol amendment|1|||
143086782|NCT03729596|515856261|FG002|Overall Study|protocol amendment|3|||
143086783|NCT03729596|515856262|FG003|Overall Study|protocol amendment|6|||
143086784|NCT03729596|515856263|FG004|Overall Study|protocol amendment|5|||
143086785|NCT03729596|515856264|FG005|Overall Study|protocol amendment|0|||
143086786|NCT03729596|515856265|FG006|Overall Study|protocol amendment|0|||
143086787|NCT03729596|515856266|FG007|Overall Study|protocol amendment|0|||
143250109|NCT02551991|516471144|FG001|Overall Study|Sponsor Decision|0|||
143250110|NCT02551991|516471145|FG002|Overall Study|Sponsor Decision|1|||
143250111|NCT02551991|516471146|FG003|Overall Study|Sponsor Decision|0|||
143250112|NCT02551991|516471147|FG004|Overall Study|Sponsor Decision|5|||
143250113|NCT02551991|516471143|FG000|Overall Study|Other|0|||
143250114|NCT02551991|516471144|FG001|Overall Study|Other|0|||
143250115|NCT02551991|516471145|FG002|Overall Study|Other|0|||
143250116|NCT02551991|516471146|FG003|Overall Study|Other|0|||
143250117|NCT02551991|516471147|FG004|Overall Study|Other|1|||
143250118|NCT02151773|516471148|FG000|Overall Study|Protocol Deviation|64|||
143250119|NCT04605991|516471149|FG000|Overall Study|Adverse Event|5|||
143250120|NCT04605991|516471149|FG000|Overall Study|Lack of Efficacy|1|||
143250121|NCT04605991|516471149|FG000|Overall Study|Lost to Follow-up|8|||
143250122|NCT04605991|516471149|FG000|Overall Study|Physician Decision|4|||
143250123|NCT04605991|516471149|FG000|Overall Study|Withdrawal by Subject|14|||
143250124|NCT04605991|516471149|FG000|Overall Study|Non-compliance with study|1|||
143250125|NCT00615901|516471150|FG000|Overall Study|Withdrawal by Subject|2|||
143250126|NCT00615901|516471150|FG000|Overall Study|Adverse Event|7|||
143250127|NCT02527200|516471153|FG000|Overall Study|Withdrawal by Subject|3|||
143250128|NCT02527200|516471154|FG001|Overall Study|Withdrawal by Subject|2|||
143250129|NCT02527200|516471155|FG002|Overall Study|Withdrawal by Subject|1|||
143250130|NCT02527200|516471156|FG003|Overall Study|Withdrawal by Subject|0|||
143250131|NCT02527200|516471153|FG000|Overall Study|Unclassified|0|||
143250132|NCT02527200|516471154|FG001|Overall Study|Unclassified|1|||
143250133|NCT02527200|516471155|FG002|Overall Study|Unclassified|0|||
143250134|NCT02527200|516471156|FG003|Overall Study|Unclassified|0|||
143250135|NCT02527200|516471153|FG000|Overall Study|Lost to Follow-up|0|||
143250136|NCT02527200|516471154|FG001|Overall Study|Lost to Follow-up|0|||
143250137|NCT02527200|516471155|FG002|Overall Study|Lost to Follow-up|1|||
143250138|NCT02527200|516471156|FG003|Overall Study|Lost to Follow-up|0|||
143250139|NCT00966875|516471158|FG000|Part A|Adverse Event|2|||
143250140|NCT00966875|516471159|FG001|Part A|Adverse Event|1|||
143250141|NCT00966875|516471160|FG002|Part A|Adverse Event|0|||
143250142|NCT00966875|516471161|FG003|Part A|Adverse Event|1|||
143250143|NCT00966875|516471162|FG004|Part A|Adverse Event|0|||
143250144|NCT00966875|516471163|FG005|Part A|Adverse Event|1|||
143250145|NCT00966875|516471164|FG006|Part A|Adverse Event|0|||
143250146|NCT00966875|516471165|FG007|Part A|Adverse Event|3|||
143250147|NCT00966875|516471166|FG008|Part A|Adverse Event|3|||
143250148|NCT00966875|516471158|FG000|Part A|Entry Criteria|0|||
143250149|NCT00966875|516471159|FG001|Part A|Entry Criteria|0|||
143250150|NCT00966875|516471160|FG002|Part A|Entry Criteria|0|||
143250151|NCT00966875|516471161|FG003|Part A|Entry Criteria|0|||
143250152|NCT00966875|516471162|FG004|Part A|Entry Criteria|0|||
143250153|NCT00966875|516471163|FG005|Part A|Entry Criteria|2|||
143250154|NCT00966875|516471164|FG006|Part A|Entry Criteria|0|||
143250155|NCT00966875|516471165|FG007|Part A|Entry Criteria|0|||
143250156|NCT00966875|516471166|FG008|Part A|Entry Criteria|0|||
143250157|NCT00966875|516471158|FG000|Part A|Lack of Efficacy|0|||
143250158|NCT00966875|516471159|FG001|Part A|Lack of Efficacy|1|||
143250159|NCT00966875|516471160|FG002|Part A|Lack of Efficacy|0|||
143250160|NCT00966875|516471161|FG003|Part A|Lack of Efficacy|0|||
143250161|NCT00966875|516471162|FG004|Part A|Lack of Efficacy|0|||
143250162|NCT00966875|516471163|FG005|Part A|Lack of Efficacy|0|||
143250163|NCT00966875|516471164|FG006|Part A|Lack of Efficacy|4|||
143250164|NCT00966875|516471165|FG007|Part A|Lack of Efficacy|0|||
143250165|NCT00966875|516471166|FG008|Part A|Lack of Efficacy|0|||
143250166|NCT00966875|516471158|FG000|Part A|Lost to Follow-up|2|||
143250167|NCT00966875|516471159|FG001|Part A|Lost to Follow-up|0|||
143250168|NCT00966875|516471160|FG002|Part A|Lost to Follow-up|0|||
143250169|NCT00966875|516471161|FG003|Part A|Lost to Follow-up|0|||
143086788|NCT03729596|515856267|FG008|Overall Study|protocol amendment|0|||
143250170|NCT00966875|516471162|FG004|Part A|Lost to Follow-up|0|||
143250171|NCT00966875|516471163|FG005|Part A|Lost to Follow-up|1|||
143250172|NCT00966875|516471164|FG006|Part A|Lost to Follow-up|0|||
143250173|NCT00966875|516471165|FG007|Part A|Lost to Follow-up|0|||
143250174|NCT00966875|516471166|FG008|Part A|Lost to Follow-up|0|||
143250175|NCT00966875|516471158|FG000|Part A|Parent/Caregiver Decision|0|||
143250176|NCT00966875|516471159|FG001|Part A|Parent/Caregiver Decision|0|||
143086789|NCT03729596|515856268|FG009|Overall Study|protocol amendment|0|||
143086790|NCT03729596|515856259|FG000|Overall Study|Withdrawal by Subject|0|||
143086791|NCT03729596|515856260|FG001|Overall Study|Withdrawal by Subject|0|||
143086792|NCT03729596|515856261|FG002|Overall Study|Withdrawal by Subject|0|||
143086793|NCT03729596|515856262|FG003|Overall Study|Withdrawal by Subject|0|||
143086794|NCT03729596|515856263|FG004|Overall Study|Withdrawal by Subject|0|||
143086795|NCT03729596|515856264|FG005|Overall Study|Withdrawal by Subject|4|||
143175461|NCT03950856|516190590|FG003|Overall Study|Death|0|||
143175462|NCT03950856|516190587|FG000|Overall Study|Lost to Follow-up|5|||
143175463|NCT03950856|516190588|FG001|Overall Study|Lost to Follow-up|6|||
143175464|NCT03950856|516190589|FG002|Overall Study|Lost to Follow-up|8|||
143175465|NCT03950856|516190590|FG003|Overall Study|Lost to Follow-up|2|||
143175466|NCT03950856|516190587|FG000|Overall Study|Protocol Violation|2|||
143175467|NCT03950856|516190588|FG001|Overall Study|Protocol Violation|0|||
143175468|NCT03950856|516190589|FG002|Overall Study|Protocol Violation|0|||
143175469|NCT03950856|516190590|FG003|Overall Study|Protocol Violation|1|||
143175470|NCT03950856|516190587|FG000|Overall Study|Withdrawal by Subject|4|||
143175471|NCT03950856|516190588|FG001|Overall Study|Withdrawal by Subject|1|||
143175472|NCT03950856|516190589|FG002|Overall Study|Withdrawal by Subject|3|||
143175473|NCT03950856|516190590|FG003|Overall Study|Withdrawal by Subject|1|||
143086796|NCT03729596|515856265|FG006|Overall Study|Withdrawal by Subject|2|||
143086797|NCT03729596|515856266|FG007|Overall Study|Withdrawal by Subject|3|||
143175474|NCT03950856|516190587|FG000|Overall Study|Unable to phone|7|||
143086798|NCT03729596|515856267|FG008|Overall Study|Withdrawal by Subject|2|||
143175475|NCT03950856|516190588|FG001|Overall Study|Unable to phone|6|||
143175476|NCT03950856|516190589|FG002|Overall Study|Unable to phone|7|||
143086799|NCT03729596|515856268|FG009|Overall Study|Withdrawal by Subject|3|||
143086800|NCT03729596|515856259|FG000|Overall Study|study terminated by sponsor|0|||
143086801|NCT03729596|515856260|FG001|Overall Study|study terminated by sponsor|0|||
143086802|NCT03729596|515856261|FG002|Overall Study|study terminated by sponsor|0|||
143086803|NCT03729596|515856262|FG003|Overall Study|study terminated by sponsor|0|||
143086804|NCT03729596|515856263|FG004|Overall Study|study terminated by sponsor|1|||
143086805|NCT03729596|515856264|FG005|Overall Study|study terminated by sponsor|3|||
143086806|NCT03729596|515856265|FG006|Overall Study|study terminated by sponsor|0|||
143086807|NCT03729596|515856266|FG007|Overall Study|study terminated by sponsor|1|||
143086808|NCT03729596|515856267|FG008|Overall Study|study terminated by sponsor|0|||
143086809|NCT03729596|515856268|FG009|Overall Study|study terminated by sponsor|0|||
143086810|NCT03130777|515856269|FG000|Overall Study|Death|0|||
143086811|NCT03130777|515856270|FG001|Overall Study|Death|1|||
143086812|NCT03130777|515856269|FG000|Overall Study|Did not meet eligibility criteria|1|||
143086813|NCT03130777|515856270|FG001|Overall Study|Did not meet eligibility criteria|0|||
143086814|NCT05109611|515856271|FG000|Overall Study|Adverse Event|13|||
143086815|NCT05109611|515856272|FG001|Overall Study|Adverse Event|10|||
143086816|NCT05109611|515856271|FG000|Overall Study|Withdrawal by Subject|1|||
143086817|NCT05109611|515856272|FG001|Overall Study|Withdrawal by Subject|0|||
143086818|NCT05109611|515856271|FG000|Overall Study|Lost to Follow-up|1|||
143086819|NCT05109611|515856272|FG001|Overall Study|Lost to Follow-up|2|||
143175477|NCT03950856|516190590|FG003|Overall Study|Unable to phone|2|||
143175478|NCT02121509|516190591|FG000|Washout Period (35 Days)|Adverse Event|1|||
143175479|NCT02121509|516190592|FG001|Washout Period (35 Days)|Adverse Event|1|||
143175480|NCT02121509|516190593|FG002|Washout Period (35 Days)|Adverse Event|0|||
143175481|NCT02121509|516190594|FG003|Washout Period (35 Days)|Adverse Event|0|||
143175482|NCT02121509|516190591|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
143175483|NCT02121509|516190592|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
143175484|NCT02121509|516190593|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
143175485|NCT02121509|516190594|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
143175486|NCT02121509|516190591|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
143175487|NCT02121509|516190592|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
143175488|NCT02121509|516190593|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
143175489|NCT02121509|516190594|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
143175490|NCT03402841|516190600|FG000|Overall Study|Withdrawal by Subject|3|||
143175491|NCT03402841|516190600|FG000|Overall Study|Lost to Follow-up|2|||
143175492|NCT03402841|516190600|FG000|Overall Study|Death|146|||
143175493|NCT01978145|516192253|FG000|Treatment Period 1|Adverse Event|1|||
143175494|NCT01978145|516192254|FG001|Treatment Period 1|Adverse Event|9|||
143175495|NCT01978145|516192253|FG000|Treatment Period 1|Physician Decision|1|||
143175496|NCT01978145|516192254|FG001|Treatment Period 1|Physician Decision|0|||
143175497|NCT01978145|516192253|FG000|Treatment Period 1|Withdrawal by Subject|5|||
143175498|NCT01978145|516192254|FG001|Treatment Period 1|Withdrawal by Subject|4|||
143175499|NCT01978145|516192253|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
143175500|NCT01978145|516192254|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
143175501|NCT01978145|516192253|FG000|Washout Period 1|Adverse Event|0|||
143175502|NCT01978145|516192254|FG001|Washout Period 1|Adverse Event|1|||
143175503|NCT01978145|516192253|FG000|Washout Period 1|Withdrawal by Subject|1|||
143175504|NCT01978145|516192254|FG001|Washout Period 1|Withdrawal by Subject|1|||
143175505|NCT01978145|516192253|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
143175506|NCT01978145|516192254|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
143175507|NCT01978145|516192253|FG000|Treatment Period 2|Adverse Event|3|||
143175508|NCT01978145|516192254|FG001|Treatment Period 2|Adverse Event|3|||
143175509|NCT01978145|516192253|FG000|Treatment Period 2|Protocol Violation|0|||
143175510|NCT01978145|516192254|FG001|Treatment Period 2|Protocol Violation|1|||
143175511|NCT01978145|516192253|FG000|Treatment Period 2|Lost to Follow-up|1|||
143086820|NCT05109611|515856271|FG000|Overall Study|Protocol Violation|0|||
143086821|NCT05109611|515856272|FG001|Overall Study|Protocol Violation|4|||
143086822|NCT05109611|515856271|FG000|Overall Study|Information unavailable|1|||
143086823|NCT05109611|515856272|FG001|Overall Study|Information unavailable|1|||
143086824|NCT03690388|515856273|FG000|Overall Study|Adverse Event|8|||
143086825|NCT03690388|515856274|FG001|Overall Study|Adverse Event|1|||
143086826|NCT03690388|515856273|FG000|Overall Study|Radiographic Progression|14|||
143086827|NCT03690388|515856274|FG001|Overall Study|Radiographic Progression|29|||
143086828|NCT03690388|515856273|FG000|Overall Study|Clinical deterioration|10|||
143086829|NCT03690388|515856274|FG001|Overall Study|Clinical deterioration|6|||
143086830|NCT03690388|515856273|FG000|Overall Study|Withdrawal by Subject|2|||
143086831|NCT03690388|515856274|FG001|Overall Study|Withdrawal by Subject|0|||
143086832|NCT03690388|515856273|FG000|Overall Study|Lack of Efficacy|1|||
143086833|NCT03690388|515856274|FG001|Overall Study|Lack of Efficacy|0|||
143086834|NCT03690388|515856273|FG000|Overall Study|Lost to Follow-up|1|||
143086835|NCT03690388|515856274|FG001|Overall Study|Lost to Follow-up|0|||
143086836|NCT02653625|515856275|FG000|Overall Study|Adverse Event|1|||
143086837|NCT02653625|515856275|FG000|Overall Study|Non-compliance with Study Drug|1|||
143086838|NCT02653625|515856275|FG000|Overall Study|Protocol Violation|1|||
143086839|NCT02653625|515856275|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
143086840|NCT02090725|515856276|FG000|Overall Study|Withdrawal by Subject|1|||
143086841|NCT02090725|515856276|FG000|Overall Study|participants moved from area|3|||
143086842|NCT01720225|515856281|FG000|Overall Study|Withdrawal by Subject|0|||
143086843|NCT01720225|515856282|FG001|Overall Study|Withdrawal by Subject|1|||
143086844|NCT01720225|515856281|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
143086845|NCT01720225|515856282|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
143086846|NCT00661193|515856286|FG000|Overall Study|Adverse Event|2|||
143086847|NCT00661193|515856287|FG001|Overall Study|Adverse Event|1|||
143086848|NCT00661193|515856286|FG000|Overall Study|Withdrawal by Subject|3|||
143086849|NCT00661193|515856287|FG001|Overall Study|Withdrawal by Subject|1|||
143086850|NCT00661193|515856286|FG000|Overall Study|Progression|27|||
143086851|NCT00661193|515856287|FG001|Overall Study|Progression|24|||
143086852|NCT00661193|515856286|FG000|Overall Study|Not protocol specified|1|||
143086853|NCT00661193|515856287|FG001|Overall Study|Not protocol specified|0|||
143086854|NCT02738138|515856289|FG000|Overall Study|Adverse Event|0|||
143086855|NCT02738138|515856290|FG001|Overall Study|Adverse Event|1|||
143086856|NCT02738138|515856289|FG000|Overall Study|Lost to Follow-up|2|||
143086857|NCT02738138|515856290|FG001|Overall Study|Lost to Follow-up|0|||
143086858|NCT02738138|515856289|FG000|Overall Study|Other - not further specified|1|||
143086859|NCT02738138|515856290|FG001|Overall Study|Other - not further specified|0|||
143086860|NCT01995513|515856293|FG000|Period 1: First Open Label Treatment|Other|34|||
143086861|NCT01995513|515856294|FG001|Period 1: First Open Label Treatment|Other|0|||
143086862|NCT01995513|515856295|FG002|Period 1: First Open Label Treatment|Other|0|||
143086863|NCT01995513|515856296|FG003|Period 1: First Open Label Treatment|Other|0|||
143086864|NCT01995513|515856293|FG000|Period 1: First Open Label Treatment|Death|14|||
143086865|NCT01995513|515856294|FG001|Period 1: First Open Label Treatment|Death|0|||
143086866|NCT01995513|515856295|FG002|Period 1: First Open Label Treatment|Death|0|||
143086867|NCT01995513|515856296|FG003|Period 1: First Open Label Treatment|Death|0|||
143086868|NCT01995513|515856293|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
143086869|NCT01995513|515856294|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
143086870|NCT01995513|515856295|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
143086871|NCT01995513|515856296|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
143086872|NCT01995513|515856293|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
143086873|NCT01995513|515856294|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
143086874|NCT01995513|515856295|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
143175512|NCT01978145|516192254|FG001|Treatment Period 2|Lost to Follow-up|1|||
143175513|NCT01978145|516192253|FG000|Treatment Period 2|Withdrawal by Subject|7|||
143086875|NCT01995513|515856296|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
143086876|NCT01995513|515856293|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
143086877|NCT01995513|515856294|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
143086878|NCT01995513|515856295|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
143086879|NCT01995513|515856296|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
143175514|NCT01978145|516192254|FG001|Treatment Period 2|Withdrawal by Subject|4|||
143086880|NCT01995513|515856293|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
143175515|NCT01978145|516192253|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
143175516|NCT01978145|516192254|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
143175517|NCT00322049|516192255|FG000|Overall Study|Moved out of area|0|||
143175518|NCT00322049|516192256|FG001|Overall Study|Moved out of area|0|||
143175519|NCT00322049|516192257|FG002|Overall Study|Moved out of area|0|||
143175520|NCT00322049|516192258|FG003|Overall Study|Moved out of area|1|||
143175521|NCT00322049|516192255|FG000|Overall Study|Infected with Dengue during study|0|||
143175522|NCT00322049|516192256|FG001|Overall Study|Infected with Dengue during study|1|||
143175523|NCT00322049|516192257|FG002|Overall Study|Infected with Dengue during study|0|||
143175524|NCT00322049|516192258|FG003|Overall Study|Infected with Dengue during study|0|||
143175525|NCT01173679|516192259|FG000|Overall Study|Death|1|||
143175526|NCT00755807|516192262|FG000|Acute Phase|Adverse Event|16|||
143175527|NCT00755807|516192263|FG001|Acute Phase|Adverse Event|5|||
143175528|NCT00755807|516192262|FG000|Acute Phase|Protocol Violation|1|||
143175529|NCT00755807|516192263|FG001|Acute Phase|Protocol Violation|3|||
143175530|NCT00755807|516192262|FG000|Acute Phase|Withdrawal by Subject|1|||
143175531|NCT00755807|516192263|FG001|Acute Phase|Withdrawal by Subject|2|||
143175532|NCT00755807|516192262|FG000|Acute Phase|Lack of Efficacy|0|||
143175533|NCT00755807|516192263|FG001|Acute Phase|Lack of Efficacy|1|||
143175534|NCT00755807|516192262|FG000|Acute Phase|Physician Decision|0|||
143175535|NCT00755807|516192263|FG001|Acute Phase|Physician Decision|1|||
143175536|NCT00755807|516192262|FG000|Open-label Extension Phase|Adverse Event|7|||
143175537|NCT00755807|516192263|FG001|Open-label Extension Phase|Adverse Event|7|||
143175538|NCT00755807|516192262|FG000|Open-label Extension Phase|Protocol Violation|5|||
143175539|NCT00755807|516192263|FG001|Open-label Extension Phase|Protocol Violation|2|||
143175540|NCT00755807|516192262|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
143175541|NCT00755807|516192263|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
143175542|NCT00755807|516192262|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
143175543|NCT00755807|516192263|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
143175544|NCT00755807|516192262|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
143175545|NCT00755807|516192263|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
143175546|NCT00755807|516192262|FG000|Open-label Extension Phase|Sponsor Decision|0|||
143175547|NCT00755807|516192263|FG001|Open-label Extension Phase|Sponsor Decision|1|||
143175548|NCT00272792|516192266|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
143175549|NCT00272792|516192267|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
143175550|NCT00272792|516192266|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
143086881|NCT01995513|515856294|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
143086882|NCT01995513|515856295|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
143086883|NCT01995513|515856296|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
143086884|NCT01995513|515856293|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
143086885|NCT01995513|515856294|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
143086886|NCT01995513|515856295|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
143086887|NCT01995513|515856296|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
143086888|NCT01995513|515856293|FG000|Period 1: Second Open Label Treatment|Other|0|||
143086889|NCT01995513|515856294|FG001|Period 1: Second Open Label Treatment|Other|2|||
143086890|NCT01995513|515856295|FG002|Period 1: Second Open Label Treatment|Other|0|||
143086891|NCT01995513|515856296|FG003|Period 1: Second Open Label Treatment|Other|0|||
143086892|NCT01995513|515856293|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
143086893|NCT01995513|515856294|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
143086894|NCT01995513|515856295|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
143086895|NCT01995513|515856296|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
143086896|NCT01995513|515856293|FG000|Period 2: Double Blind Treatment|Death|0|||
143086897|NCT01995513|515856294|FG001|Period 2: Double Blind Treatment|Death|0|||
143086898|NCT01995513|515856295|FG002|Period 2: Double Blind Treatment|Death|0|||
143086899|NCT01995513|515856296|FG003|Period 2: Double Blind Treatment|Death|1|||
143175551|NCT00272792|516192267|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
143175552|NCT00272792|516192266|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
143175553|NCT00272792|516192267|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
143175554|NCT00272792|516192266|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
143175555|NCT00272792|516192267|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
143175556|NCT01047007|516192269|FG000|Overall Study|Adverse Event|0|||
143175557|NCT01047007|516192270|FG001|Overall Study|Adverse Event|2|||
143086900|NCT01995513|515856293|FG000|Period 2: Double Blind Treatment|Other|0|||
143086901|NCT01995513|515856294|FG001|Period 2: Double Blind Treatment|Other|0|||
143086902|NCT01995513|515856295|FG002|Period 2: Double Blind Treatment|Other|3|||
143086903|NCT01995513|515856296|FG003|Period 2: Double Blind Treatment|Other|3|||
143086904|NCT01995513|515856293|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
143086905|NCT01995513|515856294|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
143086906|NCT01995513|515856295|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
143086907|NCT01995513|515856296|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
143086908|NCT01995513|515856293|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
143086909|NCT01995513|515856294|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
143086910|NCT01995513|515856295|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
143086911|NCT01995513|515856296|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
143086912|NCT01995513|515856293|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
143086913|NCT01995513|515856294|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
143086914|NCT01995513|515856295|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
143086915|NCT01995513|515856296|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
143086916|NCT01995513|515856293|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
143086917|NCT01995513|515856294|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
143086918|NCT01995513|515856295|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
143086919|NCT01995513|515856296|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
143086920|NCT02071225|515856310|FG000|Overall Study|Withdrawal of Consent|2|||
143086921|NCT02071225|515856310|FG000|Overall Study|Protocol Deviation|1|||
143086922|NCT02071225|515856310|FG000|Overall Study|Lost to Follow-up|2|||
143086923|NCT02071225|515856310|FG000|Overall Study|Death|25|||
143086924|NCT01342081|515856311|FG000|Overall Study|Did not receive allocated intervention|0|||
143086925|NCT01342081|515856312|FG001|Overall Study|Did not receive allocated intervention|0|||
143086926|NCT01342081|515856313|FG002|Overall Study|Did not receive allocated intervention|1|||
143086927|NCT01342081|515856311|FG000|Overall Study|Adverse Event|1|||
143086928|NCT01342081|515856312|FG001|Overall Study|Adverse Event|0|||
143086929|NCT01342081|515856313|FG002|Overall Study|Adverse Event|0|||
143086930|NCT01342081|515856311|FG000|Overall Study|Physician Decision|0|||
143086931|NCT01342081|515856312|FG001|Overall Study|Physician Decision|1|||
143086932|NCT01342081|515856313|FG002|Overall Study|Physician Decision|0|||
143086933|NCT01342081|515856311|FG000|Overall Study|Withdrawal by Subject|1|||
143086934|NCT01342081|515856312|FG001|Overall Study|Withdrawal by Subject|1|||
143086935|NCT01342081|515856313|FG002|Overall Study|Withdrawal by Subject|0|||
143086936|NCT03910673|515856324|FG000|Overall Study|Adverse Event|0|||
143086937|NCT03910673|515856325|FG001|Overall Study|Adverse Event|0|||
143086938|NCT03910673|515856326|FG002|Overall Study|Adverse Event|0|||
143086939|NCT03910673|515856327|FG003|Overall Study|Adverse Event|2|||
143175558|NCT01047007|516192271|FG002|Overall Study|Adverse Event|1|||
143175559|NCT01047007|516192272|FG003|Overall Study|Adverse Event|0|||
143175560|NCT01047007|516192269|FG000|Overall Study|Progressive Disease|2|||
143086940|NCT03910673|515856328|FG004|Overall Study|Adverse Event|0|||
143175561|NCT01047007|516192270|FG001|Overall Study|Progressive Disease|4|||
143175562|NCT01047007|516192271|FG002|Overall Study|Progressive Disease|1|||
143086941|NCT02536846|515856331|FG000|Overall Study|Withdrawal by Subject|1|||
143086942|NCT04388553|515856332|FG000|Overall Study|Protocol Violation|1|||
143086943|NCT04388553|515856333|FG001|Overall Study|Protocol Violation|0|||
143086944|NCT02123446|515856334|FG000|Washout Period (1 Day)|Physician Decision|1|||
143086945|NCT02123446|515856335|FG001|Washout Period (1 Day)|Physician Decision|0|||
143086946|NCT04604795|515856336|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
143086947|NCT04604795|515856337|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
143086948|NCT04604795|515856338|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
143086949|NCT04604795|515856339|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
143086950|NCT04604795|515856340|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
143175563|NCT01047007|516192272|FG003|Overall Study|Progressive Disease|0|||
143175564|NCT03759600|516192281|FG000|Overall Study|Adverse Event|2|||
143175565|NCT03759600|516192281|FG000|Overall Study|Progressive Disease|15|||
143086951|NCT04604795|515856341|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
143086952|NCT04604795|515856342|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
143175566|NCT03759600|516192281|FG000|Overall Study|Site Terminated by Sponsor|3|||
143175567|NCT02332187|516192282|FG000|Overall Study|Withdrawal by Subject|2|||
143175568|NCT02332187|516192283|FG001|Overall Study|Withdrawal by Subject|2|||
143175569|NCT02332187|516192282|FG000|Overall Study|Adverse Event|0|||
143175570|NCT02332187|516192283|FG001|Overall Study|Adverse Event|1|||
143175571|NCT04108273|516192284|FG000|Overall Study|COVID Pandemic|1|||
143175572|NCT04108273|516192285|FG001|Overall Study|COVID Pandemic|0|||
143175573|NCT00506142|516192286|FG000|Overall Study|Adverse Event|8|||
143175574|NCT00506142|516192287|FG001|Overall Study|Adverse Event|7|||
143175575|NCT00506142|516192286|FG000|Overall Study|Lack of Efficacy|21|||
143175576|NCT00506142|516192287|FG001|Overall Study|Lack of Efficacy|7|||
143175577|NCT00506142|516192286|FG000|Overall Study|Withdrawal by Subject|4|||
143175578|NCT00506142|516192287|FG001|Overall Study|Withdrawal by Subject|5|||
143175579|NCT00506142|516192286|FG000|Overall Study|Physician Decision|1|||
143175580|NCT00506142|516192287|FG001|Overall Study|Physician Decision|0|||
143175581|NCT00506142|516192286|FG000|Overall Study|New health condition|1|||
143367006|NCT01981850|516887242|FG006|Main Phase Stage 2|Progressive Disease|6|||
143175582|NCT00506142|516192287|FG001|Overall Study|New health condition|0|||
143086953|NCT04604795|515856343|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
143086954|NCT04604795|515856344|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
143086955|NCT04604795|515856345|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
143086956|NCT04604795|515856336|FG000|Part B: Up to Day 14|Adverse Event|0|||
143086957|NCT04604795|515856337|FG001|Part B: Up to Day 14|Adverse Event|0|||
143086958|NCT04604795|515856338|FG002|Part B: Up to Day 14|Adverse Event|0|||
143086959|NCT04604795|515856339|FG003|Part B: Up to Day 14|Adverse Event|0|||
143086960|NCT04604795|515856340|FG004|Part B: Up to Day 14|Adverse Event|2|||
143086961|NCT04604795|515856341|FG005|Part B: Up to Day 14|Adverse Event|1|||
143086962|NCT04604795|515856342|FG006|Part B: Up to Day 14|Adverse Event|0|||
143086963|NCT04604795|515856343|FG007|Part B: Up to Day 14|Adverse Event|0|||
143086964|NCT04604795|515856344|FG008|Part B: Up to Day 14|Adverse Event|0|||
143086965|NCT04604795|515856345|FG009|Part B: Up to Day 14|Adverse Event|0|||
143086966|NCT04604795|515856336|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
143086967|NCT04604795|515856337|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
143250177|NCT00966875|516471160|FG002|Part A|Parent/Caregiver Decision|0|||
143250178|NCT00966875|516471161|FG003|Part A|Parent/Caregiver Decision|1|||
143250179|NCT00966875|516471162|FG004|Part A|Parent/Caregiver Decision|0|||
143250180|NCT00966875|516471163|FG005|Part A|Parent/Caregiver Decision|0|||
143250181|NCT00966875|516471164|FG006|Part A|Parent/Caregiver Decision|0|||
143250182|NCT00966875|516471165|FG007|Part A|Parent/Caregiver Decision|0|||
143250183|NCT00966875|516471166|FG008|Part A|Parent/Caregiver Decision|0|||
143250184|NCT00966875|516471158|FG000|Part A|Physician Decision|0|||
143250185|NCT00966875|516471159|FG001|Part A|Physician Decision|0|||
143250186|NCT00966875|516471160|FG002|Part A|Physician Decision|0|||
143086968|NCT04604795|515856338|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
143086969|NCT04604795|515856339|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
143086970|NCT04604795|515856340|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
143086971|NCT04604795|515856341|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
143086972|NCT04604795|515856342|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
143086973|NCT04604795|515856343|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
143086974|NCT04604795|515856344|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
143086975|NCT04604795|515856345|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
143086976|NCT04604795|515856336|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
143086977|NCT04604795|515856337|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
143086978|NCT04604795|515856338|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
143086979|NCT04604795|515856339|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
143086980|NCT04604795|515856340|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
143086981|NCT04604795|515856341|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
143086982|NCT04604795|515856342|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
143086983|NCT04604795|515856343|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
143086984|NCT04604795|515856344|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
143086985|NCT04604795|515856345|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
143086986|NCT04604795|515856336|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
143086987|NCT04604795|515856337|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
143086988|NCT04604795|515856338|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
143086989|NCT04604795|515856339|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
143086990|NCT04604795|515856340|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
143086991|NCT04604795|515856341|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
143086992|NCT04604795|515856342|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
143086993|NCT04604795|515856343|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
143086994|NCT04604795|515856344|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
143086995|NCT04604795|515856345|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
143250187|NCT00966875|516471161|FG003|Part A|Physician Decision|0|||
143250188|NCT00966875|516471162|FG004|Part A|Physician Decision|1|||
143250189|NCT00966875|516471163|FG005|Part A|Physician Decision|0|||
143250190|NCT00966875|516471164|FG006|Part A|Physician Decision|1|||
143250191|NCT00966875|516471165|FG007|Part A|Physician Decision|0|||
143250192|NCT00966875|516471166|FG008|Part A|Physician Decision|2|||
143250193|NCT00966875|516471158|FG000|Part A|Sponsor Decision|0|||
143250194|NCT00966875|516471159|FG001|Part A|Sponsor Decision|0|||
143250195|NCT00966875|516471160|FG002|Part A|Sponsor Decision|1|||
143086996|NCT04604795|515856336|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
143086997|NCT04604795|515856337|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
143086998|NCT04604795|515856338|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
143086999|NCT04604795|515856339|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
143087000|NCT04604795|515856340|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
143087001|NCT04604795|515856341|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
143087002|NCT04604795|515856342|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
143087003|NCT04604795|515856343|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
143087004|NCT04604795|515856344|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
143087005|NCT04604795|515856345|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
143250196|NCT00966875|516471161|FG003|Part A|Sponsor Decision|0|||
143087006|NCT02445963|515856347|FG000|Overall Study|Lost to Follow-up|1|||
143087007|NCT02445963|515856348|FG001|Overall Study|Lost to Follow-up|0|||
143087008|NCT02445963|515856349|FG002|Overall Study|Lost to Follow-up|0|||
143087009|NCT02445963|515856350|FG003|Overall Study|Lost to Follow-up|0|||
143087010|NCT02445963|515856347|FG000|Overall Study|Change in employment|1|||
143250197|NCT00966875|516471162|FG004|Part A|Sponsor Decision|1|||
143250198|NCT00966875|516471163|FG005|Part A|Sponsor Decision|0|||
143250199|NCT00966875|516471164|FG006|Part A|Sponsor Decision|0|||
143250200|NCT00966875|516471165|FG007|Part A|Sponsor Decision|2|||
143250201|NCT00966875|516471166|FG008|Part A|Sponsor Decision|1|||
143087011|NCT02445963|515856348|FG001|Overall Study|Change in employment|0|||
143087012|NCT02445963|515856349|FG002|Overall Study|Change in employment|0|||
143087013|NCT02445963|515856350|FG003|Overall Study|Change in employment|0|||
143087014|NCT02445963|515856347|FG000|Overall Study|Symptoms post-vaccination|0|||
143087015|NCT02445963|515856348|FG001|Overall Study|Symptoms post-vaccination|0|||
143087016|NCT02445963|515856349|FG002|Overall Study|Symptoms post-vaccination|1|||
143087017|NCT02445963|515856350|FG003|Overall Study|Symptoms post-vaccination|0|||
143087018|NCT02517463|515856364|FG000|Overall Study|Lost to Follow-up|5|||
143087019|NCT02517463|515856365|FG001|Overall Study|Lost to Follow-up|2|||
143087020|NCT03449446|515856366|FG000|Overall Study|Randomized but Never Treated|0|||
143087021|NCT03449446|515856367|FG001|Overall Study|Randomized but Never Treated|0|||
143087022|NCT03449446|515856368|FG002|Overall Study|Randomized but Never Treated|1|||
143087023|NCT03449446|515856369|FG003|Overall Study|Randomized but Never Treated|1|||
143087024|NCT03449446|515856370|FG004|Overall Study|Randomized but Never Treated|1|||
143087025|NCT03449446|515856371|FG005|Overall Study|Randomized but Never Treated|0|||
143087026|NCT03449446|515856372|FG006|Overall Study|Randomized but Never Treated|0|||
143087027|NCT03449446|515856366|FG000|Overall Study|Unknown Reason|33|||
143087028|NCT03449446|515856367|FG001|Overall Study|Unknown Reason|1|||
143087029|NCT03449446|515856368|FG002|Overall Study|Unknown Reason|1|||
143087030|NCT03449446|515856369|FG003|Overall Study|Unknown Reason|1|||
143087031|NCT03449446|515856370|FG004|Overall Study|Unknown Reason|2|||
143087032|NCT03449446|515856371|FG005|Overall Study|Unknown Reason|2|||
143087033|NCT03449446|515856372|FG006|Overall Study|Unknown Reason|0|||
143087034|NCT03449446|515856366|FG000|Overall Study|Withdrew Consent|1|||
143087035|NCT03449446|515856367|FG001|Overall Study|Withdrew Consent|3|||
143087036|NCT03449446|515856368|FG002|Overall Study|Withdrew Consent|1|||
143087037|NCT03449446|515856369|FG003|Overall Study|Withdrew Consent|4|||
143087038|NCT03449446|515856370|FG004|Overall Study|Withdrew Consent|4|||
143087039|NCT03449446|515856371|FG005|Overall Study|Withdrew Consent|4|||
143250202|NCT00966875|516471158|FG000|Part A|Withdrawal by Subject|2|||
143250203|NCT00966875|516471159|FG001|Part A|Withdrawal by Subject|2|||
143250204|NCT00966875|516471160|FG002|Part A|Withdrawal by Subject|1|||
143250205|NCT00966875|516471161|FG003|Part A|Withdrawal by Subject|1|||
143250206|NCT00966875|516471162|FG004|Part A|Withdrawal by Subject|3|||
143250207|NCT00966875|516471163|FG005|Part A|Withdrawal by Subject|0|||
143250208|NCT00966875|516471164|FG006|Part A|Withdrawal by Subject|5|||
143250209|NCT00966875|516471165|FG007|Part A|Withdrawal by Subject|1|||
143250210|NCT00966875|516471166|FG008|Part A|Withdrawal by Subject|1|||
143250211|NCT00966875|516471158|FG000|Part A|Protocol Violation|0|||
143250212|NCT00966875|516471159|FG001|Part A|Protocol Violation|0|||
143250213|NCT00966875|516471160|FG002|Part A|Protocol Violation|0|||
143250214|NCT00966875|516471161|FG003|Part A|Protocol Violation|0|||
143250215|NCT00966875|516471162|FG004|Part A|Protocol Violation|0|||
143250216|NCT00966875|516471163|FG005|Part A|Protocol Violation|0|||
143250217|NCT00966875|516471164|FG006|Part A|Protocol Violation|2|||
143250218|NCT00966875|516471165|FG007|Part A|Protocol Violation|1|||
143250219|NCT00966875|516471166|FG008|Part A|Protocol Violation|1|||
143250220|NCT00966875|516471158|FG000|Part B|Adverse Event|0|||
143250221|NCT00966875|516471159|FG001|Part B|Adverse Event|1|||
143250222|NCT00966875|516471160|FG002|Part B|Adverse Event|1|||
143250223|NCT00966875|516471161|FG003|Part B|Adverse Event|0|||
143250224|NCT00966875|516471162|FG004|Part B|Adverse Event|1|||
143250225|NCT00966875|516471163|FG005|Part B|Adverse Event|0|||
143250226|NCT00966875|516471164|FG006|Part B|Adverse Event|5|||
143250227|NCT00966875|516471165|FG007|Part B|Adverse Event|2|||
143250228|NCT00966875|516471166|FG008|Part B|Adverse Event|2|||
143250229|NCT00966875|516471158|FG000|Part B|Death|0|||
143250230|NCT00966875|516471159|FG001|Part B|Death|0|||
143250231|NCT00966875|516471160|FG002|Part B|Death|1|||
143250232|NCT00966875|516471161|FG003|Part B|Death|0|||
143250233|NCT00966875|516471162|FG004|Part B|Death|0|||
143250234|NCT00966875|516471163|FG005|Part B|Death|0|||
143087040|NCT03449446|515856372|FG006|Overall Study|Withdrew Consent|1|||
143087041|NCT03449446|515856366|FG000|Overall Study|Adverse Event|1|||
143087042|NCT03449446|515856367|FG001|Overall Study|Adverse Event|2|||
143087043|NCT03449446|515856368|FG002|Overall Study|Adverse Event|1|||
143250235|NCT00966875|516471164|FG006|Part B|Death|0|||
143087044|NCT03449446|515856369|FG003|Overall Study|Adverse Event|0|||
143087045|NCT03449446|515856370|FG004|Overall Study|Adverse Event|0|||
143087046|NCT03449446|515856371|FG005|Overall Study|Adverse Event|2|||
143250236|NCT00966875|516471165|FG007|Part B|Death|1|||
143087047|NCT03449446|515856372|FG006|Overall Study|Adverse Event|0|||
143087048|NCT03449446|515856366|FG000|Overall Study|Lost to Follow-up|0|||
143250237|NCT00966875|516471166|FG008|Part B|Death|0|||
143250238|NCT00966875|516471158|FG000|Part B|Lack of Efficacy|2|||
143087049|NCT03449446|515856367|FG001|Overall Study|Lost to Follow-up|0|||
143250239|NCT00966875|516471159|FG001|Part B|Lack of Efficacy|1|||
143250240|NCT00966875|516471160|FG002|Part B|Lack of Efficacy|1|||
143250241|NCT00966875|516471161|FG003|Part B|Lack of Efficacy|1|||
143250242|NCT00966875|516471162|FG004|Part B|Lack of Efficacy|2|||
143250243|NCT00966875|516471163|FG005|Part B|Lack of Efficacy|3|||
143250244|NCT00966875|516471164|FG006|Part B|Lack of Efficacy|12|||
143087050|NCT03449446|515856368|FG002|Overall Study|Lost to Follow-up|2|||
143087051|NCT03449446|515856369|FG003|Overall Study|Lost to Follow-up|1|||
143087052|NCT03449446|515856370|FG004|Overall Study|Lost to Follow-up|3|||
143087053|NCT03449446|515856371|FG005|Overall Study|Lost to Follow-up|0|||
143087054|NCT03449446|515856372|FG006|Overall Study|Lost to Follow-up|0|||
143087055|NCT03449446|515856366|FG000|Overall Study|Investigator's Discretion|0|||
143087056|NCT03449446|515856367|FG001|Overall Study|Investigator's Discretion|1|||
143087057|NCT03449446|515856368|FG002|Overall Study|Investigator's Discretion|1|||
143087058|NCT03449446|515856369|FG003|Overall Study|Investigator's Discretion|2|||
143087059|NCT03449446|515856370|FG004|Overall Study|Investigator's Discretion|0|||
143087060|NCT03449446|515856371|FG005|Overall Study|Investigator's Discretion|0|||
143087061|NCT03449446|515856372|FG006|Overall Study|Investigator's Discretion|0|||
143087062|NCT03449446|515856366|FG000|Overall Study|Non Compliance with Study Drug|1|||
143087063|NCT03449446|515856367|FG001|Overall Study|Non Compliance with Study Drug|0|||
143087064|NCT03449446|515856368|FG002|Overall Study|Non Compliance with Study Drug|0|||
143087065|NCT03449446|515856369|FG003|Overall Study|Non Compliance with Study Drug|0|||
143087066|NCT03449446|515856370|FG004|Overall Study|Non Compliance with Study Drug|0|||
143087067|NCT03449446|515856371|FG005|Overall Study|Non Compliance with Study Drug|0|||
143087068|NCT03449446|515856372|FG006|Overall Study|Non Compliance with Study Drug|0|||
143087069|NCT03449446|515856366|FG000|Overall Study|Protocol Violation|0|||
143087070|NCT03449446|515856367|FG001|Overall Study|Protocol Violation|0|||
143087071|NCT03449446|515856368|FG002|Overall Study|Protocol Violation|0|||
143087072|NCT03449446|515856369|FG003|Overall Study|Protocol Violation|0|||
143087073|NCT03449446|515856370|FG004|Overall Study|Protocol Violation|1|||
143087074|NCT03449446|515856371|FG005|Overall Study|Protocol Violation|1|||
143087075|NCT03449446|515856372|FG006|Overall Study|Protocol Violation|0|||
143175583|NCT02808429|516192291|FG000|Overall Study|Lost to Follow-up|1|||
143175584|NCT02808429|516192292|FG001|Overall Study|Lost to Follow-up|0|||
143175585|NCT02808429|516192293|FG002|Overall Study|Lost to Follow-up|0|||
143175586|NCT02808429|516192291|FG000|Overall Study|Protocol Violation|0|||
143175587|NCT02808429|516192292|FG001|Overall Study|Protocol Violation|1|||
143087076|NCT03449446|515856366|FG000|Overall Study|Death|0|||
143087077|NCT03449446|515856367|FG001|Overall Study|Death|0|||
143087078|NCT03449446|515856368|FG002|Overall Study|Death|0|||
143087079|NCT03449446|515856369|FG003|Overall Study|Death|0|||
143087080|NCT03449446|515856370|FG004|Overall Study|Death|1|||
143087081|NCT03449446|515856371|FG005|Overall Study|Death|0|||
143087082|NCT03449446|515856372|FG006|Overall Study|Death|0|||
143087083|NCT00143390|515856373|FG000|Overall Study|Death|2|||
143087084|NCT00143390|515856374|FG001|Overall Study|Death|0|||
143175588|NCT02808429|516192293|FG002|Overall Study|Protocol Violation|0|||
143175589|NCT02808429|516192291|FG000|Overall Study|Premature study termination by sponsor|2|||
143175590|NCT02808429|516192292|FG001|Overall Study|Premature study termination by sponsor|0|||
143175591|NCT02808429|516192293|FG002|Overall Study|Premature study termination by sponsor|1|||
143175592|NCT02808429|516192291|FG000|Overall Study|Relocation|0|||
143087085|NCT00143390|515856373|FG000|Overall Study|Not meeting entry criteria|2|||
143087086|NCT00143390|515856374|FG001|Overall Study|Not meeting entry criteria|5|||
143087087|NCT00143390|515856373|FG000|Overall Study|Withdrawal by Subject|4|||
143087088|NCT00143390|515856374|FG001|Overall Study|Withdrawal by Subject|4|||
143087089|NCT00143390|515856373|FG000|Overall Study|Progressive disease|119|||
143087090|NCT00143390|515856374|FG001|Overall Study|Progressive disease|115|||
143087091|NCT00143390|515856373|FG000|Overall Study|Protocol Violation|2|||
143087092|NCT00143390|515856374|FG001|Overall Study|Protocol Violation|0|||
143087093|NCT00143390|515856373|FG000|Overall Study|Study termination|10|||
143087094|NCT00143390|515856374|FG001|Overall Study|Study termination|15|||
143087095|NCT00143390|515856373|FG000|Overall Study|Adverse Event|9|||
143087096|NCT00143390|515856374|FG001|Overall Study|Adverse Event|8|||
143087097|NCT00143390|515856373|FG000|Overall Study|Other|1|||
143087098|NCT00143390|515856374|FG001|Overall Study|Other|2|||
143087099|NCT02764151|515856377|FG000|Overall Study|Subject refused further follow-up|0|||
143087100|NCT02764151|515856378|FG001|Overall Study|Subject refused further follow-up|0|||
143087101|NCT02764151|515856379|FG002|Overall Study|Subject refused further follow-up|0|||
143087102|NCT02764151|515856380|FG003|Overall Study|Subject refused further follow-up|1|||
143087103|NCT02764151|515856377|FG000|Overall Study|Other|0|||
143087104|NCT02764151|515856378|FG001|Overall Study|Other|0|||
143087105|NCT02764151|515856379|FG002|Overall Study|Other|0|||
143087106|NCT02764151|515856380|FG003|Overall Study|Other|2|||
143087107|NCT01450683|515856381|FG000|Overall Study|Adverse Event|2|||
143087108|NCT02108912|515856383|FG000|Overall Study|Lost to Follow-up|1|||
143087109|NCT02108912|515856384|FG001|Overall Study|Lost to Follow-up|1|||
143087110|NCT02108912|515856383|FG000|Overall Study|lack of transportation|1|||
143087111|NCT02108912|515856384|FG001|Overall Study|lack of transportation|0|||
143175593|NCT02808429|516192292|FG001|Overall Study|Relocation|0|||
143175594|NCT02808429|516192293|FG002|Overall Study|Relocation|1|||
143087112|NCT02108912|515856383|FG000|Overall Study|high blood pressure|1|||
143087113|NCT02108912|515856384|FG001|Overall Study|high blood pressure|0|||
143175595|NCT00856609|516192297|FG000|Overall Study|Adverse Event|1|||
143175596|NCT00856609|516192298|FG001|Overall Study|Adverse Event|0|||
143175597|NCT00783432|516192299|FG000|Overall Study|Adverse Event|22|||
143175598|NCT00783432|516192300|FG001|Overall Study|Adverse Event|17|||
143175599|NCT00783432|516192299|FG000|Overall Study|Lack of Efficacy|20|||
143175600|NCT00783432|516192300|FG001|Overall Study|Lack of Efficacy|21|||
143175601|NCT00783432|516192299|FG000|Overall Study|Lost to Follow-up|11|||
143175602|NCT00783432|516192300|FG001|Overall Study|Lost to Follow-up|6|||
143175603|NCT00783432|516192299|FG000|Overall Study|Withdrawal by Subject|23|||
143175604|NCT00783432|516192300|FG001|Overall Study|Withdrawal by Subject|20|||
143175605|NCT00783432|516192299|FG000|Overall Study|subject moved|3|||
143175606|NCT00783432|516192300|FG001|Overall Study|subject moved|5|||
143175607|NCT00783432|516192299|FG000|Overall Study|Protocol Violation|6|||
143175608|NCT00783432|516192300|FG001|Overall Study|Protocol Violation|9|||
143175609|NCT01436110|516192301|FG000|Overall Study|Lack of Efficacy|23|||
143175610|NCT01436110|516192302|FG001|Overall Study|Lack of Efficacy|14|||
143250245|NCT00966875|516471165|FG007|Part B|Lack of Efficacy|9|||
143250246|NCT00966875|516471166|FG008|Part B|Lack of Efficacy|6|||
143250247|NCT00966875|516471158|FG000|Part B|Lost to Follow-up|0|||
143250248|NCT00966875|516471159|FG001|Part B|Lost to Follow-up|0|||
143250249|NCT00966875|516471160|FG002|Part B|Lost to Follow-up|0|||
143250250|NCT00966875|516471161|FG003|Part B|Lost to Follow-up|1|||
143250251|NCT00966875|516471162|FG004|Part B|Lost to Follow-up|0|||
143250252|NCT00966875|516471163|FG005|Part B|Lost to Follow-up|0|||
143250253|NCT00966875|516471164|FG006|Part B|Lost to Follow-up|0|||
143250254|NCT00966875|516471165|FG007|Part B|Lost to Follow-up|0|||
143250255|NCT00966875|516471166|FG008|Part B|Lost to Follow-up|1|||
143250256|NCT00966875|516471158|FG000|Part B|Physician Decision|0|||
143250257|NCT00966875|516471159|FG001|Part B|Physician Decision|0|||
143250258|NCT00966875|516471160|FG002|Part B|Physician Decision|1|||
143250259|NCT00966875|516471161|FG003|Part B|Physician Decision|0|||
143087114|NCT05022212|515856390|FG000|Overall Study|Lost to Follow-up|0|||
143087115|NCT05022212|515856391|FG001|Overall Study|Lost to Follow-up|2|||
143087116|NCT02729909|515856392|FG000|Overall Study|Lost to Follow-up|0|||
143087117|NCT02729909|515856393|FG001|Overall Study|Lost to Follow-up|1|||
143087118|NCT02729909|515856392|FG000|Overall Study|Lack of Efficacy|0|||
143087119|NCT02729909|515856393|FG001|Overall Study|Lack of Efficacy|2|||
143087120|NCT02729909|515856392|FG000|Overall Study|Significant Protocol Deviation|0|||
143087121|NCT02729909|515856393|FG001|Overall Study|Significant Protocol Deviation|2|||
143250260|NCT00966875|516471162|FG004|Part B|Physician Decision|2|||
143250261|NCT00966875|516471163|FG005|Part B|Physician Decision|1|||
143175611|NCT01436110|516192303|FG002|Overall Study|Lack of Efficacy|9|||
143175612|NCT01436110|516192301|FG000|Overall Study|Withdrawal by Subject|6|||
143250262|NCT00966875|516471164|FG006|Part B|Physician Decision|0|||
143250263|NCT00966875|516471165|FG007|Part B|Physician Decision|0|||
143087122|NCT02729909|515856392|FG000|Overall Study|Voluntary Withdrawal|1|||
143087123|NCT02729909|515856393|FG001|Overall Study|Voluntary Withdrawal|0|||
143087124|NCT03713593|515858668|FG000|Overall Study|Sponsor Decision|73|||
143087125|NCT03713593|515858669|FG001|Overall Study|Sponsor Decision|41|||
143087126|NCT03713593|515858668|FG000|Overall Study|Lost to Follow-up|2|||
143087127|NCT03713593|515858669|FG001|Overall Study|Lost to Follow-up|1|||
143087128|NCT03713593|515858668|FG000|Overall Study|Death|314|||
143087129|NCT03713593|515858669|FG001|Overall Study|Death|349|||
143087130|NCT03713593|515858668|FG000|Overall Study|Withdrawal by Subject|6|||
143087131|NCT03713593|515858669|FG001|Overall Study|Withdrawal by Subject|8|||
143087132|NCT02498613|515858670|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
143087133|NCT02498613|515858671|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
143087134|NCT02498613|515858672|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
143087135|NCT02498613|515858673|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
143087136|NCT02498613|515858670|FG000|Overall Study|Withdrawal by Subject|3|||
143087137|NCT02498613|515858671|FG001|Overall Study|Withdrawal by Subject|1|||
143087138|NCT02498613|515858672|FG002|Overall Study|Withdrawal by Subject|0|||
143087139|NCT02498613|515858673|FG003|Overall Study|Withdrawal by Subject|0|||
143087140|NCT05168202|515858674|FG000|Overall Study|Progressive Disease|4|||
143087141|NCT05168202|515858675|FG001|Overall Study|Progressive Disease|4|||
143087142|NCT05168202|515858676|FG002|Overall Study|Progressive Disease|2|||
143087143|NCT05168202|515858677|FG003|Overall Study|Progressive Disease|3|||
143087144|NCT05168202|515858678|FG004|Overall Study|Progressive Disease|2|||
143087145|NCT05168202|515858679|FG005|Overall Study|Progressive Disease|3|||
143087146|NCT05168202|515858680|FG006|Overall Study|Progressive Disease|2|||
143087147|NCT05168202|515858674|FG000|Overall Study|Adverse Event|2|||
143087148|NCT05168202|515858675|FG001|Overall Study|Adverse Event|1|||
143087149|NCT05168202|515858676|FG002|Overall Study|Adverse Event|4|||
143087150|NCT05168202|515858677|FG003|Overall Study|Adverse Event|4|||
143087151|NCT05168202|515858678|FG004|Overall Study|Adverse Event|3|||
143087152|NCT05168202|515858679|FG005|Overall Study|Adverse Event|2|||
143087153|NCT05168202|515858680|FG006|Overall Study|Adverse Event|0|||
143087154|NCT05168202|515858674|FG000|Overall Study|Lack of Efficacy|0|||
143087155|NCT05168202|515858675|FG001|Overall Study|Lack of Efficacy|1|||
143087156|NCT05168202|515858676|FG002|Overall Study|Lack of Efficacy|1|||
143087157|NCT05168202|515858677|FG003|Overall Study|Lack of Efficacy|0|||
143250264|NCT00966875|516471166|FG008|Part B|Physician Decision|2|||
143250265|NCT00966875|516471158|FG000|Part B|Sponsor Decision|1|||
143250266|NCT00966875|516471159|FG001|Part B|Sponsor Decision|0|||
143250267|NCT00966875|516471160|FG002|Part B|Sponsor Decision|0|||
143250268|NCT00966875|516471161|FG003|Part B|Sponsor Decision|0|||
143250269|NCT00966875|516471162|FG004|Part B|Sponsor Decision|0|||
143250270|NCT00966875|516471163|FG005|Part B|Sponsor Decision|1|||
143250271|NCT00966875|516471164|FG006|Part B|Sponsor Decision|0|||
143250272|NCT00966875|516471165|FG007|Part B|Sponsor Decision|2|||
143250273|NCT00966875|516471166|FG008|Part B|Sponsor Decision|1|||
143250274|NCT00966875|516471158|FG000|Part B|Withdrawal by Subject|2|||
143250275|NCT00966875|516471159|FG001|Part B|Withdrawal by Subject|1|||
143250276|NCT00966875|516471160|FG002|Part B|Withdrawal by Subject|2|||
143250277|NCT00966875|516471161|FG003|Part B|Withdrawal by Subject|1|||
143250278|NCT00966875|516471162|FG004|Part B|Withdrawal by Subject|2|||
143250279|NCT00966875|516471163|FG005|Part B|Withdrawal by Subject|1|||
143250280|NCT00966875|516471164|FG006|Part B|Withdrawal by Subject|4|||
143250281|NCT00966875|516471165|FG007|Part B|Withdrawal by Subject|5|||
143250282|NCT00966875|516471166|FG008|Part B|Withdrawal by Subject|5|||
143250283|NCT00966875|516471158|FG000|Part B|Entry Criteria|0|||
143250284|NCT00966875|516471159|FG001|Part B|Entry Criteria|0|||
143250285|NCT00966875|516471160|FG002|Part B|Entry Criteria|0|||
143250286|NCT00966875|516471161|FG003|Part B|Entry Criteria|0|||
143250287|NCT00966875|516471162|FG004|Part B|Entry Criteria|0|||
143250288|NCT00966875|516471163|FG005|Part B|Entry Criteria|0|||
143250289|NCT00966875|516471164|FG006|Part B|Entry Criteria|1|||
143250290|NCT00966875|516471165|FG007|Part B|Entry Criteria|0|||
143250291|NCT00966875|516471166|FG008|Part B|Entry Criteria|1|||
143250292|NCT00444678|516471167|FG000|Overall Study|Toxicity|11|||
143250293|NCT00444678|516471167|FG000|Overall Study|Disease Progression|12|||
143250294|NCT00444678|516471167|FG000|Overall Study|Death|3|||
143250295|NCT00444678|516471167|FG000|Overall Study|Physician Decision|3|||
143250296|NCT00444678|516471167|FG000|Overall Study|Withdrawal by Subject|2|||
143250297|NCT04250077|516471168|FG000|Overall Study|Withdrawal by Subject|0|||
143250298|NCT04250077|516471169|FG001|Overall Study|Withdrawal by Subject|1|||
143250299|NCT04250077|516471170|FG002|Overall Study|Withdrawal by Subject|0|||
143250300|NCT04250077|516471168|FG000|Overall Study|Lost to Follow-up|2|||
143250301|NCT04250077|516471169|FG001|Overall Study|Lost to Follow-up|3|||
143250302|NCT04250077|516471170|FG002|Overall Study|Lost to Follow-up|0|||
143250303|NCT01086358|516471171|FG000|First Intervention|Lost to Follow-up|9|||
143250304|NCT01086358|516471172|FG001|First Intervention|Lost to Follow-up|4|||
143250305|NCT01086358|516471171|FG000|First Intervention|Withdrawal by Subject|0|||
143250306|NCT01086358|516471172|FG001|First Intervention|Withdrawal by Subject|1|||
143250307|NCT01086358|516471171|FG000|Second Intervention|Lost to Follow-up|4|||
143250308|NCT01086358|516471172|FG001|Second Intervention|Lost to Follow-up|4|||
143250309|NCT03899805|516471173|FG000|Overall Study|Physician Decision|3|||
143250310|NCT03899805|516471174|FG001|Overall Study|Physician Decision|0|||
143250311|NCT03899805|516471175|FG002|Overall Study|Physician Decision|2|||
143250312|NCT03899805|516471173|FG000|Overall Study|Withdrawal by Subject|1|||
143250313|NCT03899805|516471174|FG001|Overall Study|Withdrawal by Subject|0|||
143250314|NCT03899805|516471175|FG002|Overall Study|Withdrawal by Subject|2|||
143250315|NCT03899805|516471173|FG000|Overall Study|Progressive Disease|10|||
143250316|NCT03899805|516471174|FG001|Overall Study|Progressive Disease|18|||
143250317|NCT03899805|516471175|FG002|Overall Study|Progressive Disease|12|||
143250318|NCT03899805|516471173|FG000|Overall Study|Adverse Event|3|||
143250319|NCT03899805|516471174|FG001|Overall Study|Adverse Event|1|||
143250320|NCT03899805|516471175|FG002|Overall Study|Adverse Event|0|||
143250321|NCT03899805|516471173|FG000|Overall Study|Death|2|||
143250322|NCT03899805|516471174|FG001|Overall Study|Death|0|||
143250323|NCT03899805|516471175|FG002|Overall Study|Death|0|||
143250324|NCT03899805|516471173|FG000|Overall Study|Came off for surgery|0|||
143250325|NCT03899805|516471174|FG001|Overall Study|Came off for surgery|0|||
143250326|NCT03899805|516471175|FG002|Overall Study|Came off for surgery|1|||
143250327|NCT03317405|516471176|FG000|Overall Study|Withdrawal by Subject|1|||
143250328|NCT03317405|516471177|FG001|Overall Study|Withdrawal by Subject|0|||
143250329|NCT03317405|516471178|FG002|Overall Study|Withdrawal by Subject|0|||
143250330|NCT03317405|516471176|FG000|Overall Study|Physician Decision|0|||
143250331|NCT03317405|516471177|FG001|Overall Study|Physician Decision|0|||
143250332|NCT03317405|516471178|FG002|Overall Study|Physician Decision|1|||
143250333|NCT03317405|516471176|FG000|Overall Study|Surgery Rescheduled|0|||
143250334|NCT03317405|516471177|FG001|Overall Study|Surgery Rescheduled|1|||
143250335|NCT03317405|516471178|FG002|Overall Study|Surgery Rescheduled|0|||
143250336|NCT04075734|516471181|FG000|Overall Study|Lost to Follow-up|1|||
143250337|NCT04075734|516471182|FG001|Overall Study|Lost to Follow-up|1|||
143250338|NCT04075734|516471183|FG002|Overall Study|Lost to Follow-up|0|||
143250339|NCT04075734|516471181|FG000|Overall Study|Withdrawal by Subject|3|||
143250340|NCT04075734|516471182|FG001|Overall Study|Withdrawal by Subject|0|||
143250341|NCT04075734|516471183|FG002|Overall Study|Withdrawal by Subject|0|||
143250342|NCT01137604|516471184|FG000|Overall Study|Adverse Event|3|||
143250343|NCT01137604|516471185|FG001|Overall Study|Adverse Event|6|||
143087158|NCT05168202|515858678|FG004|Overall Study|Lack of Efficacy|1|||
143087159|NCT05168202|515858679|FG005|Overall Study|Lack of Efficacy|2|||
143087160|NCT05168202|515858680|FG006|Overall Study|Lack of Efficacy|2|||
143087161|NCT05168202|515858674|FG000|Overall Study|Withdrawal by Subject|0|||
143087162|NCT05168202|515858675|FG001|Overall Study|Withdrawal by Subject|0|||
143087163|NCT05168202|515858676|FG002|Overall Study|Withdrawal by Subject|1|||
143087164|NCT05168202|515858677|FG003|Overall Study|Withdrawal by Subject|1|||
143087165|NCT05168202|515858678|FG004|Overall Study|Withdrawal by Subject|1|||
143087166|NCT05168202|515858679|FG005|Overall Study|Withdrawal by Subject|1|||
143087167|NCT05168202|515858680|FG006|Overall Study|Withdrawal by Subject|0|||
143087168|NCT05168202|515858674|FG000|Overall Study|Disease Relapse|0|||
143087169|NCT05168202|515858675|FG001|Overall Study|Disease Relapse|1|||
143087170|NCT05168202|515858676|FG002|Overall Study|Disease Relapse|0|||
143087171|NCT05168202|515858677|FG003|Overall Study|Disease Relapse|1|||
143087172|NCT05168202|515858678|FG004|Overall Study|Disease Relapse|1|||
143087173|NCT05168202|515858679|FG005|Overall Study|Disease Relapse|0|||
143087174|NCT05168202|515858680|FG006|Overall Study|Disease Relapse|0|||
143087175|NCT05168202|515858674|FG000|Overall Study|Other Reasons|0|||
143087176|NCT05168202|515858675|FG001|Overall Study|Other Reasons|0|||
143087177|NCT05168202|515858676|FG002|Overall Study|Other Reasons|0|||
143087178|NCT05168202|515858677|FG003|Overall Study|Other Reasons|0|||
143087179|NCT05168202|515858678|FG004|Overall Study|Other Reasons|0|||
143087180|NCT05168202|515858679|FG005|Overall Study|Other Reasons|2|||
143087181|NCT05168202|515858680|FG006|Overall Study|Other Reasons|1|||
143087182|NCT05168202|515858674|FG000|Overall Study|Physician Decision|0|||
143087183|NCT05168202|515858675|FG001|Overall Study|Physician Decision|1|||
143087184|NCT05168202|515858676|FG002|Overall Study|Physician Decision|1|||
143087185|NCT05168202|515858677|FG003|Overall Study|Physician Decision|0|||
143087186|NCT05168202|515858678|FG004|Overall Study|Physician Decision|0|||
143087187|NCT05168202|515858679|FG005|Overall Study|Physician Decision|0|||
143087188|NCT05168202|515858680|FG006|Overall Study|Physician Decision|0|||
143087189|NCT05168202|515858674|FG000|Overall Study|Study Terminated by Sponsor|0|||
143087190|NCT05168202|515858675|FG001|Overall Study|Study Terminated by Sponsor|0|||
143087191|NCT05168202|515858676|FG002|Overall Study|Study Terminated by Sponsor|0|||
143087192|NCT05168202|515858677|FG003|Overall Study|Study Terminated by Sponsor|1|||
143087193|NCT05168202|515858678|FG004|Overall Study|Study Terminated by Sponsor|0|||
143087194|NCT05168202|515858679|FG005|Overall Study|Study Terminated by Sponsor|0|||
143087195|NCT05168202|515858680|FG006|Overall Study|Study Terminated by Sponsor|0|||
143087196|NCT04011722|515858685|FG000|30 Days|Death|5|||
143087197|NCT04011722|515858686|FG001|30 Days|Death|1|||
143087198|NCT04011722|515858685|FG000|1 Year|Death|13|||
143087199|NCT04011722|515858686|FG001|1 Year|Death|5|||
143087200|NCT04011722|515858685|FG000|1 Year|Withdrawal by Subject|8|||
143087201|NCT04011722|515858686|FG001|1 Year|Withdrawal by Subject|2|||
143087202|NCT04011722|515858685|FG000|1 Year|Missed Visit|6|||
143087203|NCT04011722|515858686|FG001|1 Year|Missed Visit|1|||
143087204|NCT04011722|515858685|FG000|1 Year|Pending Visit|0|||
143087205|NCT04011722|515858686|FG001|1 Year|Pending Visit|11|||
143087206|NCT04011722|515858685|FG000|1 Year|Not Yet Due|0|||
143087207|NCT04011722|515858686|FG001|1 Year|Not Yet Due|9|||
143087208|NCT04011722|515858685|FG000|2 Year|Death|16|||
143087209|NCT04011722|515858686|FG001|2 Year|Death|1|||
143087210|NCT04011722|515858685|FG000|2 Year|Withdrawal by Subject|10|||
143087211|NCT04011722|515858686|FG001|2 Year|Withdrawal by Subject|1|||
143087212|NCT04011722|515858685|FG000|2 Year|Missed Visit|9|||
143087213|NCT04011722|515858686|FG001|2 Year|Missed Visit|0|||
143367007|NCT01981850|516887243|FG007|Main Phase Stage 2|Progressive Disease|0|||
143367008|NCT01981850|516887244|FG008|Main Phase Stage 2|Progressive Disease|0|||
143367009|NCT01981850|516887245|FG009|Main Phase Stage 2|Progressive Disease|0|||
143367010|NCT01981850|516887236|FG000|Open Label Extension (OLE)|Adverse Event|0|||
143087214|NCT04011722|515858685|FG000|2 Year|Visit Pending|1|||
143087215|NCT04011722|515858686|FG001|2 Year|Visit Pending|3|||
143087216|NCT04011722|515858685|FG000|2 Year|Not Yet Due|43|||
143087217|NCT04011722|515858686|FG001|2 Year|Not Yet Due|54|||
143087218|NCT04011722|515858685|FG000|3 Year|Death|10|||
143087219|NCT04011722|515858686|FG001|3 Year|Death|0|||
143087220|NCT04011722|515858685|FG000|3 Year|Withdrawal by Subject|2|||
143087221|NCT04011722|515858686|FG001|3 Year|Withdrawal by Subject|0|||
143087222|NCT04011722|515858685|FG000|3 Year|Missed Visit|2|||
143087223|NCT04011722|515858686|FG001|3 Year|Missed Visit|0|||
143087224|NCT04011722|515858685|FG000|3 Year|Pending Visit|34|||
143087225|NCT04011722|515858686|FG001|3 Year|Pending Visit|0|||
143087226|NCT04011722|515858685|FG000|3 Year|Not Yet Due|99|||
143087227|NCT04011722|515858686|FG001|3 Year|Not Yet Due|0|||
143087228|NCT05061134|515858689|FG000|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|19|||
143087229|NCT05061134|515858690|FG001|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|3|||
143087230|NCT05061134|515858691|FG002|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|6|||
143087231|NCT05061134|515858689|FG000|Overall Study|Subject not treated|0|||
143087232|NCT05061134|515858690|FG001|Overall Study|Subject not treated|0|||
143087233|NCT05061134|515858691|FG002|Overall Study|Subject not treated|2|||
143087234|NCT05061134|515858689|FG000|Overall Study|Other|0|||
143087235|NCT05061134|515858690|FG001|Overall Study|Other|0|||
143087236|NCT05061134|515858691|FG002|Overall Study|Other|9|||
143087237|NCT05061134|515858689|FG000|Overall Study|Withdrawal by Subject|9|||
143087238|NCT05061134|515858690|FG001|Overall Study|Withdrawal by Subject|8|||
143087239|NCT05061134|515858691|FG002|Overall Study|Withdrawal by Subject|5|||
143087240|NCT05061134|515858689|FG000|Overall Study|Study Terminated by Sponsor|22|||
143087241|NCT05061134|515858690|FG001|Overall Study|Study Terminated by Sponsor|14|||
143087242|NCT05061134|515858691|FG002|Overall Study|Study Terminated by Sponsor|7|||
143087243|NCT05061134|515858689|FG000|Overall Study|Progressive Disease|1|||
143087244|NCT05061134|515858690|FG001|Overall Study|Progressive Disease|2|||
143087245|NCT05061134|515858691|FG002|Overall Study|Progressive Disease|0|||
143087246|NCT05061134|515858689|FG000|Overall Study|Patient Is on Survival Follow Up Beyond DCO|1|||
143087247|NCT05061134|515858690|FG001|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
143087248|NCT05061134|515858691|FG002|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
143087249|NCT05061134|515858689|FG000|Overall Study|Lost to Follow-up|1|||
143087250|NCT05061134|515858690|FG001|Overall Study|Lost to Follow-up|0|||
143087251|NCT05061134|515858691|FG002|Overall Study|Lost to Follow-up|0|||
143087252|NCT05061134|515858689|FG000|Overall Study|Physician Decision|1|||
143087253|NCT05061134|515858690|FG001|Overall Study|Physician Decision|1|||
143087254|NCT05061134|515858691|FG002|Overall Study|Physician Decision|0|||
143087255|NCT05061134|515858689|FG000|Overall Study|Disease progression|1|||
143087256|NCT05061134|515858690|FG001|Overall Study|Disease progression|0|||
143087257|NCT05061134|515858691|FG002|Overall Study|Disease progression|0|||
143087258|NCT05061134|515858689|FG000|Overall Study|Death|43|||
143087259|NCT05061134|515858690|FG001|Overall Study|Death|23|||
143087260|NCT05061134|515858691|FG002|Overall Study|Death|14|||
143087261|NCT05061134|515858689|FG000|Overall Study|Database lock|2|||
143087262|NCT05061134|515858690|FG001|Overall Study|Database lock|0|||
143087263|NCT05061134|515858691|FG002|Overall Study|Database lock|0|||
143087264|NCT03999996|515858695|FG000|Prior to Booster|Adverse Event|2|||
143087265|NCT03999996|515858696|FG001|Prior to Booster|Adverse Event|0|||
143087266|NCT03999996|515858697|FG002|Prior to Booster|Adverse Event|0|||
143087267|NCT03999996|515858698|FG003|Prior to Booster|Adverse Event|0|||
143087268|NCT03999996|515858695|FG000|Prior to Booster|Lost to Follow-up|17|||
143087269|NCT03999996|515858696|FG001|Prior to Booster|Lost to Follow-up|22|||
143087270|NCT03999996|515858697|FG002|Prior to Booster|Lost to Follow-up|0|||
143087271|NCT03999996|515858698|FG003|Prior to Booster|Lost to Follow-up|0|||
143087272|NCT03999996|515858695|FG000|Prior to Booster|Withdrawal of Consent|51|||
143087273|NCT03999996|515858696|FG001|Prior to Booster|Withdrawal of Consent|8|||
143087274|NCT03999996|515858697|FG002|Prior to Booster|Withdrawal of Consent|0|||
143087275|NCT03999996|515858698|FG003|Prior to Booster|Withdrawal of Consent|0|||
143087276|NCT03999996|515858695|FG000|Prior to Booster|Death|0|||
143087277|NCT03999996|515858696|FG001|Prior to Booster|Death|1|||
143087278|NCT03999996|515858697|FG002|Prior to Booster|Death|0|||
143087279|NCT03999996|515858698|FG003|Prior to Booster|Death|0|||
143087280|NCT03999996|515858695|FG000|Prior to Booster|Reason Not Specified|27|||
143087281|NCT03999996|515858696|FG001|Prior to Booster|Reason Not Specified|4|||
143250344|NCT01137604|516471186|FG002|Overall Study|Adverse Event|9|||
143250345|NCT01137604|516471187|FG003|Overall Study|Adverse Event|9|||
143087282|NCT03999996|515858697|FG002|Prior to Booster|Reason Not Specified|0|||
143087283|NCT03999996|515858698|FG003|Prior to Booster|Reason Not Specified|0|||
143087284|NCT03999996|515858695|FG000|Booster Phase|Lost to Follow-up|0|||
143087285|NCT03999996|515858696|FG001|Booster Phase|Lost to Follow-up|0|||
143087286|NCT03999996|515858697|FG002|Booster Phase|Lost to Follow-up|3|||
143250346|NCT01137604|516471184|FG000|Overall Study|Participant Choice|0|||
143087287|NCT03999996|515858698|FG003|Booster Phase|Lost to Follow-up|3|||
143250347|NCT01137604|516471185|FG001|Overall Study|Participant Choice|2|||
143087288|NCT03999996|515858695|FG000|Booster Phase|Withdrawal of Consent|0|||
143087289|NCT03999996|515858696|FG001|Booster Phase|Withdrawal of Consent|0|||
143087290|NCT03999996|515858697|FG002|Booster Phase|Withdrawal of Consent|0|||
143087291|NCT03999996|515858698|FG003|Booster Phase|Withdrawal of Consent|1|||
143087292|NCT03999996|515858695|FG000|Booster Phase|Reason Not Specified|0|||
143087293|NCT03999996|515858696|FG001|Booster Phase|Reason Not Specified|0|||
143087294|NCT03999996|515858697|FG002|Booster Phase|Reason Not Specified|0|||
143087295|NCT03999996|515858698|FG003|Booster Phase|Reason Not Specified|1|||
143087296|NCT00266630|515858705|FG000|Overall Study|Adverse Event|8|||
143087297|NCT00266630|515858706|FG001|Overall Study|Adverse Event|6|||
143087298|NCT00266630|515858705|FG000|Overall Study|Lack of Efficacy|1|||
143087299|NCT00266630|515858706|FG001|Overall Study|Lack of Efficacy|4|||
143087300|NCT00266630|515858705|FG000|Overall Study|Entry Criteria not met|1|||
143087301|NCT00266630|515858706|FG001|Overall Study|Entry Criteria not met|0|||
143087302|NCT00266630|515858705|FG000|Overall Study|Protocol Violation|1|||
143087303|NCT00266630|515858706|FG001|Overall Study|Protocol Violation|3|||
143087304|NCT00266630|515858705|FG000|Overall Study|Physician Decision|1|||
143087305|NCT00266630|515858706|FG001|Overall Study|Physician Decision|2|||
143087306|NCT00266630|515858705|FG000|Overall Study|Withdrawal by Subject|10|||
143087307|NCT00266630|515858706|FG001|Overall Study|Withdrawal by Subject|2|||
143087308|NCT00266630|515858705|FG000|Overall Study|Lost to Follow-up|1|||
143087309|NCT00266630|515858706|FG001|Overall Study|Lost to Follow-up|0|||
143087310|NCT00266630|515858705|FG000|Overall Study|Other|19|||
143087311|NCT00266630|515858706|FG001|Overall Study|Other|11|||
143087312|NCT03410056|515858707|FG000|Overall Study|Decision by Sponsor|0|||
143087313|NCT03410056|515858708|FG001|Overall Study|Decision by Sponsor|0|||
143087314|NCT03410056|515858709|FG002|Overall Study|Decision by Sponsor|3|||
143087315|NCT03410056|515858710|FG003|Overall Study|Decision by Sponsor|0|||
143087316|NCT03410056|515858711|FG004|Overall Study|Decision by Sponsor|0|||
143087317|NCT03410056|515858712|FG005|Overall Study|Decision by Sponsor|0|||
143087318|NCT03410056|515858713|FG006|Overall Study|Decision by Sponsor|0|||
143087319|NCT03410056|515858707|FG000|Overall Study|Withdrawal by Subject|0|||
143087320|NCT03410056|515858708|FG001|Overall Study|Withdrawal by Subject|2|||
143087321|NCT03410056|515858709|FG002|Overall Study|Withdrawal by Subject|5|||
143087322|NCT03410056|515858710|FG003|Overall Study|Withdrawal by Subject|5|||
143087323|NCT03410056|515858711|FG004|Overall Study|Withdrawal by Subject|0|||
143087324|NCT03410056|515858712|FG005|Overall Study|Withdrawal by Subject|0|||
143087325|NCT03410056|515858713|FG006|Overall Study|Withdrawal by Subject|0|||
143087326|NCT05377749|515858720|FG000|3 Weeks|Lost to Follow-up|2|||
143087327|NCT05377749|515858721|FG001|3 Weeks|Lost to Follow-up|4|||
143087328|NCT05377749|515858720|FG000|3 Weeks|Withdrawal by Subject|1|||
143087329|NCT05377749|515858721|FG001|3 Weeks|Withdrawal by Subject|1|||
143087330|NCT01499095|515858722|FG000|Overall Study|Randomized But Not Treated|1|||
143087331|NCT01499095|515858723|FG001|Overall Study|Randomized But Not Treated|1|||
143087332|NCT01499095|515858722|FG000|Overall Study|Adverse Event|12|||
143087333|NCT01499095|515858723|FG001|Overall Study|Adverse Event|7|||
143087334|NCT01499095|515858722|FG000|Overall Study|Lack of Efficacy|2|||
143087335|NCT01499095|515858723|FG001|Overall Study|Lack of Efficacy|1|||
143087336|NCT01499095|515858722|FG000|Overall Study|Protocol Violation|6|||
143087337|NCT01499095|515858723|FG001|Overall Study|Protocol Violation|7|||
143087338|NCT01499095|515858722|FG000|Overall Study|Received Rescue Therapy|32|||
143087339|NCT01499095|515858723|FG001|Overall Study|Received Rescue Therapy|40|||
143367011|NCT01981850|516887237|FG001|Open Label Extension (OLE)|Adverse Event|0|||
143367012|NCT01981850|516887238|FG002|Open Label Extension (OLE)|Adverse Event|0|||
143367013|NCT01981850|516887239|FG003|Open Label Extension (OLE)|Adverse Event|0|||
143087340|NCT01499095|515858722|FG000|Overall Study|Diverse Reasons|22|||
143087341|NCT01499095|515858723|FG001|Overall Study|Diverse Reasons|25|||
143087342|NCT01499095|515858722|FG000|Overall Study|Lost to Follow-up|6|||
143087343|NCT01499095|515858723|FG001|Overall Study|Lost to Follow-up|4|||
143087344|NCT01499095|515858722|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
143087345|NCT01499095|515858723|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
143087346|NCT01499095|515858722|FG000|Overall Study|Hypoglycemia|3|||
143087347|NCT01499095|515858723|FG001|Overall Study|Hypoglycemia|1|||
143087348|NCT01499095|515858722|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
143087349|NCT01499095|515858723|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
143087350|NCT01499095|515858722|FG000|Overall Study|Change in Injection Schedule|2|||
143087351|NCT01499095|515858723|FG001|Overall Study|Change in Injection Schedule|0|||
143087352|NCT01499095|515858722|FG000|Overall Study|Perceived Lack of Efficacy|1|||
143087353|NCT01499095|515858723|FG001|Overall Study|Perceived Lack of Efficacy|1|||
143087354|NCT04358081|515858724|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
143087355|NCT04358081|515858725|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
143087356|NCT04358081|515858726|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
143087357|NCT04358081|515858724|FG000|Treatment Phase of Study|Adverse Event|1|||
143087358|NCT04358081|515858725|FG001|Treatment Phase of Study|Adverse Event|0|||
143087359|NCT04358081|515858726|FG002|Treatment Phase of Study|Adverse Event|1|||
143087360|NCT04358081|515858724|FG000|Treatment Phase of Study|Physician Decision|2|||
143087361|NCT04358081|515858725|FG001|Treatment Phase of Study|Physician Decision|0|||
143087362|NCT04358081|515858726|FG002|Treatment Phase of Study|Physician Decision|1|||
143087363|NCT04358081|515858724|FG000|Treatment Phase of Study|Protocol Violation|1|||
143087364|NCT04358081|515858725|FG001|Treatment Phase of Study|Protocol Violation|0|||
143087365|NCT04358081|515858726|FG002|Treatment Phase of Study|Protocol Violation|0|||
143087366|NCT04358081|515858724|FG000|Study Completion Phase|Death|0|||
143175613|NCT01436110|516192302|FG001|Overall Study|Withdrawal by Subject|8|||
143367014|NCT01981850|516887240|FG004|Open Label Extension (OLE)|Adverse Event|0|||
143367015|NCT01981850|516887241|FG005|Open Label Extension (OLE)|Adverse Event|0|||
143087367|NCT04358081|515858725|FG001|Study Completion Phase|Death|0|||
143087368|NCT04358081|515858726|FG002|Study Completion Phase|Death|1|||
143087369|NCT04358081|515858724|FG000|Study Completion Phase|Lost to Follow-up|1|||
143087370|NCT04358081|515858725|FG001|Study Completion Phase|Lost to Follow-up|0|||
143087371|NCT04358081|515858726|FG002|Study Completion Phase|Lost to Follow-up|1|||
143087372|NCT01368497|515858727|FG000|Overall Study|Lost to Follow-up|2|||
143087373|NCT01130532|515858728|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
143087374|NCT01130532|515858729|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
143087375|NCT01130532|515858730|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
143087376|NCT01130532|515858731|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
143087377|NCT01130532|515858728|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
143087378|NCT01130532|515858729|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
143087379|NCT01130532|515858730|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
143087380|NCT01130532|515858731|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
143087381|NCT01130532|515858728|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
143087382|NCT01130532|515858729|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
143087383|NCT01130532|515858730|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
143087384|NCT01130532|515858731|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
143087385|NCT01130532|515858728|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
143087386|NCT01130532|515858729|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
143087387|NCT01130532|515858730|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
143087388|NCT01130532|515858731|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
143087389|NCT01130532|515858728|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
143087390|NCT01130532|515858729|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
143087391|NCT01130532|515858730|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
143087392|NCT01130532|515858731|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
143087393|NCT01130532|515858728|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
143087394|NCT01130532|515858729|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
143087395|NCT01130532|515858730|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
143087396|NCT01130532|515858731|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
143087397|NCT01130532|515858728|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
143087398|NCT01130532|515858729|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
143087399|NCT01130532|515858730|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
143087400|NCT01130532|515858731|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
143087401|NCT01130532|515858728|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
143087402|NCT01130532|515858729|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
143087403|NCT01130532|515858730|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
143087404|NCT01130532|515858731|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
143087405|NCT01130532|515858728|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
143087406|NCT01130532|515858729|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
143087407|NCT01130532|515858730|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
143087408|NCT01130532|515858731|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
143087409|NCT01130532|515858728|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
143087410|NCT01130532|515858729|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
143087411|NCT01130532|515858730|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
143087412|NCT01130532|515858731|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
143087413|NCT01130532|515858728|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
143087414|NCT01130532|515858729|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
143087415|NCT01130532|515858730|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
143087416|NCT01130532|515858731|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
143087417|NCT02762929|515858732|FG000|Overall Study|Adverse Event|0|||
143087418|NCT02762929|515858733|FG001|Overall Study|Adverse Event|0|||
143087419|NCT02762929|515858734|FG002|Overall Study|Adverse Event|0|||
143087420|NCT02762929|515858735|FG003|Overall Study|Adverse Event|1|||
143087421|NCT02762929|515858736|FG004|Overall Study|Adverse Event|0|||
143087422|NCT02762929|515858737|FG005|Overall Study|Adverse Event|0|||
143087423|NCT02762929|515858732|FG000|Overall Study|Lost to Follow-up|1|||
143087424|NCT02762929|515858733|FG001|Overall Study|Lost to Follow-up|2|||
143087425|NCT02762929|515858734|FG002|Overall Study|Lost to Follow-up|0|||
143087426|NCT02762929|515858735|FG003|Overall Study|Lost to Follow-up|1|||
143087427|NCT02762929|515858736|FG004|Overall Study|Lost to Follow-up|0|||
143175614|NCT01436110|516192303|FG002|Overall Study|Withdrawal by Subject|4|||
143175615|NCT01436110|516192301|FG000|Overall Study|Adverse Event|2|||
143175616|NCT01436110|516192302|FG001|Overall Study|Adverse Event|1|||
143087428|NCT02762929|515858737|FG005|Overall Study|Lost to Follow-up|0|||
143087429|NCT02762929|515858732|FG000|Overall Study|Withdrawal by Subject|0|||
143087430|NCT02762929|515858733|FG001|Overall Study|Withdrawal by Subject|1|||
143175617|NCT01436110|516192303|FG002|Overall Study|Adverse Event|2|||
143175618|NCT01436110|516192301|FG000|Overall Study|Physician Decision|3|||
143175619|NCT01436110|516192302|FG001|Overall Study|Physician Decision|1|||
143087431|NCT02762929|515858734|FG002|Overall Study|Withdrawal by Subject|0|||
143087432|NCT02762929|515858735|FG003|Overall Study|Withdrawal by Subject|0|||
143175620|NCT01436110|516192303|FG002|Overall Study|Physician Decision|1|||
143367016|NCT01981850|516887242|FG006|Open Label Extension (OLE)|Adverse Event|0|||
143087433|NCT02762929|515858736|FG004|Overall Study|Withdrawal by Subject|0|||
143087434|NCT02762929|515858737|FG005|Overall Study|Withdrawal by Subject|0|||
143087435|NCT02762929|515858732|FG000|Overall Study|exclusionary medication disclosed late|0|||
143175621|NCT01436110|516192301|FG000|Overall Study|Lost to Follow-up|1|||
143087436|NCT02762929|515858733|FG001|Overall Study|exclusionary medication disclosed late|0|||
143367017|NCT01981850|516887243|FG007|Open Label Extension (OLE)|Adverse Event|2|||
143367018|NCT01981850|516887244|FG008|Open Label Extension (OLE)|Adverse Event|1|||
143367019|NCT01981850|516887245|FG009|Open Label Extension (OLE)|Adverse Event|8|||
143367020|NCT01981850|516887236|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
143367021|NCT01981850|516887237|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
143367022|NCT01981850|516887238|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
143367023|NCT01981850|516887239|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
143367024|NCT01981850|516887240|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
143367025|NCT01981850|516887241|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
143367026|NCT01981850|516887242|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
143367027|NCT01981850|516887243|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
143367028|NCT01981850|516887244|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
143367029|NCT01981850|516887245|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
143367030|NCT01981850|516887236|FG000|Open Label Extension (OLE)|Various reasons|0|||
143367031|NCT01981850|516887237|FG001|Open Label Extension (OLE)|Various reasons|0|||
143087437|NCT02762929|515858734|FG002|Overall Study|exclusionary medication disclosed late|0|||
143087438|NCT02762929|515858735|FG003|Overall Study|exclusionary medication disclosed late|1|||
143087439|NCT02762929|515858736|FG004|Overall Study|exclusionary medication disclosed late|0|||
143087440|NCT02762929|515858737|FG005|Overall Study|exclusionary medication disclosed late|0|||
143087441|NCT02656303|515858738|FG000|Overall Study|Adverse Event|3|||
143087442|NCT02656303|515858739|FG001|Overall Study|Adverse Event|2|||
143087443|NCT02656303|515858740|FG002|Overall Study|Adverse Event|0|||
143087444|NCT02656303|515858738|FG000|Overall Study|Death|12|||
143087445|NCT02656303|515858739|FG001|Overall Study|Death|4|||
143087446|NCT02656303|515858740|FG002|Overall Study|Death|1|||
143087447|NCT02656303|515858738|FG000|Overall Study|Lack of Efficacy|1|||
143087448|NCT02656303|515858739|FG001|Overall Study|Lack of Efficacy|0|||
143087449|NCT02656303|515858740|FG002|Overall Study|Lack of Efficacy|0|||
143087450|NCT02656303|515858738|FG000|Overall Study|Non-Compliance with Study|1|||
143087451|NCT02656303|515858739|FG001|Overall Study|Non-Compliance with Study|1|||
143087452|NCT02656303|515858740|FG002|Overall Study|Non-Compliance with Study|0|||
143367032|NCT01981850|516887238|FG002|Open Label Extension (OLE)|Various reasons|0|||
143367033|NCT01981850|516887239|FG003|Open Label Extension (OLE)|Various reasons|0|||
143367034|NCT01981850|516887240|FG004|Open Label Extension (OLE)|Various reasons|0|||
143367035|NCT01981850|516887241|FG005|Open Label Extension (OLE)|Various reasons|0|||
143087453|NCT02656303|515858738|FG000|Overall Study|Investigator Decision|2|||
143087454|NCT02656303|515858739|FG001|Overall Study|Investigator Decision|1|||
143087455|NCT02656303|515858740|FG002|Overall Study|Investigator Decision|0|||
143087456|NCT02656303|515858738|FG000|Overall Study|Progressive Disease|25|||
143087457|NCT02656303|515858739|FG001|Overall Study|Progressive Disease|14|||
143087458|NCT02656303|515858740|FG002|Overall Study|Progressive Disease|10|||
143087459|NCT02656303|515858738|FG000|Overall Study|Study Terminated by Sponsor|20|||
143087460|NCT02656303|515858739|FG001|Overall Study|Study Terminated by Sponsor|7|||
143087461|NCT02656303|515858740|FG002|Overall Study|Study Terminated by Sponsor|5|||
143087462|NCT02656303|515858738|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
143087463|NCT02656303|515858739|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
143087464|NCT02656303|515858740|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
143087465|NCT02656303|515858738|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
143087466|NCT02656303|515858739|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
143087467|NCT02656303|515858740|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
143087468|NCT02656303|515858738|FG000|Overall Study|Reason not Specified|1|||
143087469|NCT02656303|515858739|FG001|Overall Study|Reason not Specified|1|||
143087470|NCT02656303|515858740|FG002|Overall Study|Reason not Specified|2|||
143087471|NCT03041311|515858743|FG000|Overall Study|Death|39|||
143087472|NCT03041311|515858744|FG001|Overall Study|Death|42|||
143087473|NCT03041311|515858743|FG000|Overall Study|Lost to Follow-up|0|||
143087474|NCT03041311|515858744|FG001|Overall Study|Lost to Follow-up|1|||
143087475|NCT03041311|515858743|FG000|Overall Study|Withdrawal by Subject|8|||
143087476|NCT03041311|515858744|FG001|Overall Study|Withdrawal by Subject|5|||
143087477|NCT03041311|515858743|FG000|Overall Study|Sponsor Terminated Study|2|||
143087478|NCT03041311|515858744|FG001|Overall Study|Sponsor Terminated Study|4|||
143087479|NCT03041311|515858743|FG000|Overall Study|Disease Progression|3|||
143175622|NCT01436110|516192302|FG001|Overall Study|Lost to Follow-up|1|||
143175623|NCT01436110|516192303|FG002|Overall Study|Lost to Follow-up|3|||
143175624|NCT01436110|516192301|FG000|Overall Study|Protocol Violation|3|||
143175625|NCT01436110|516192302|FG001|Overall Study|Protocol Violation|1|||
143175626|NCT01436110|516192303|FG002|Overall Study|Protocol Violation|1|||
143175627|NCT01436110|516192301|FG000|Overall Study|Did Not Receive Trial Medication|1|||
143175628|NCT01436110|516192302|FG001|Overall Study|Did Not Receive Trial Medication|0|||
143250348|NCT01137604|516471186|FG002|Overall Study|Participant Choice|2|||
143250349|NCT01137604|516471187|FG003|Overall Study|Participant Choice|0|||
143250350|NCT01137604|516471184|FG000|Overall Study|Withdrawal of consent|0|||
143250351|NCT01137604|516471185|FG001|Overall Study|Withdrawal of consent|0|||
143250352|NCT01137604|516471186|FG002|Overall Study|Withdrawal of consent|0|||
143250353|NCT01137604|516471187|FG003|Overall Study|Withdrawal of consent|2|||
143250354|NCT01137604|516471184|FG000|Overall Study|Clinical progression/deterioration|1|||
143250355|NCT01137604|516471185|FG001|Overall Study|Clinical progression/deterioration|2|||
143250356|NCT01137604|516471186|FG002|Overall Study|Clinical progression/deterioration|2|||
143250357|NCT01137604|516471187|FG003|Overall Study|Clinical progression/deterioration|0|||
143250358|NCT00591318|516471188|FG000|Overall Study|Lack of Efficacy|2|||
143250359|NCT00591318|516471189|FG001|Overall Study|Lack of Efficacy|0|||
143250360|NCT00591318|516471188|FG000|Overall Study|Adverse Event|2|||
143250361|NCT00591318|516471189|FG001|Overall Study|Adverse Event|0|||
143250362|NCT00435045|516471192|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
143250363|NCT00435045|516471193|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
143250364|NCT00435045|516471192|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
143250365|NCT00435045|516471193|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
143250366|NCT00435045|516471192|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
143250367|NCT00435045|516471193|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
143250368|NCT00435045|516471192|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
143250369|NCT00435045|516471193|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
143250370|NCT00435045|516471192|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
143250371|NCT00435045|516471193|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
143250372|NCT00435045|516471192|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
143250373|NCT00435045|516471193|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
143250374|NCT00435045|516471192|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
143250375|NCT00435045|516471193|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
143250376|NCT00435045|516471192|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
143250377|NCT00435045|516471193|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
143250378|NCT00435045|516471192|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
143250379|NCT00435045|516471193|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
143250380|NCT00435045|516471192|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
143087480|NCT03041311|515858744|FG001|Overall Study|Disease Progression|1|||
143087481|NCT03041311|515858743|FG000|Overall Study|Randomized in error, did not receive drug|2|||
143087482|NCT03041311|515858744|FG001|Overall Study|Randomized in error, did not receive drug|0|||
143087483|NCT00443729|515858745|FG000|Overall Study|Never Treated|0|||
143175629|NCT01436110|516192303|FG002|Overall Study|Did Not Receive Trial Medication|3|||
143087484|NCT00443729|515858746|FG001|Overall Study|Never Treated|1|||
143087485|NCT00443729|515858745|FG000|Overall Study|Lack of Efficacy|4|||
143087486|NCT00443729|515858746|FG001|Overall Study|Lack of Efficacy|2|||
143087487|NCT00443729|515858745|FG000|Overall Study|Lost to Follow-up|0|||
143087488|NCT00443729|515858746|FG001|Overall Study|Lost to Follow-up|1|||
143087489|NCT00443729|515858745|FG000|Overall Study|Physician Decision|2|||
143087490|NCT00443729|515858746|FG001|Overall Study|Physician Decision|1|||
143087491|NCT00443729|515858745|FG000|Overall Study|Protocol Violation|1|||
143087492|NCT00443729|515858746|FG001|Overall Study|Protocol Violation|1|||
143087493|NCT00443729|515858745|FG000|Overall Study|Withdrawal by Subject|3|||
143087494|NCT00443729|515858746|FG001|Overall Study|Withdrawal by Subject|1|||
143087495|NCT01842438|515858747|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
143087496|NCT01842438|515858748|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
143087497|NCT01842438|515858747|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
143087498|NCT01842438|515858748|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
143087499|NCT01842438|515858747|FG000|T2: 6month Follow-up|Death|0|||
143087500|NCT01842438|515858748|FG001|T2: 6month Follow-up|Death|1|||
143087501|NCT00782626|515858752|FG000|Overall Study|Adverse Event|1|||
143087502|NCT00782626|515858752|FG000|Overall Study|Progressive Disease|5|||
143087503|NCT00782626|515858752|FG000|Overall Study|Other Complicating Disease|1|||
143087504|NCT04909853|515858753|FG000|Part 1|Assigned but not treated|0|||
143087505|NCT04909853|515858754|FG001|Part 1|Assigned but not treated|0|||
143087506|NCT04909853|515858755|FG002|Part 1|Assigned but not treated|1|||
143087507|NCT04909853|515858756|FG003|Part 1|Assigned but not treated|0|||
143087508|NCT04909853|515858753|FG000|Part 2|Adverse Event|0|||
143087509|NCT04909853|515858754|FG001|Part 2|Adverse Event|0|||
143087510|NCT04909853|515858755|FG002|Part 2|Adverse Event|0|||
143087511|NCT04909853|515858756|FG003|Part 2|Adverse Event|1|||
143087512|NCT04054765|515858757|FG000|Baseline|Withdrawal by Subject|5|||
143087513|NCT04054765|515858758|FG001|Baseline|Withdrawal by Subject|3|||
143087514|NCT04054765|515858757|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
143087515|NCT04054765|515858758|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
143087516|NCT04054765|515858757|FG000|3-month Follow up|Withdrawal by Subject|0|||
143087517|NCT04054765|515858758|FG001|3-month Follow up|Withdrawal by Subject|3|||
143087518|NCT04054765|515858757|FG000|6-month Follow up|Lost to Follow-up|32|||
143087519|NCT04054765|515858758|FG001|6-month Follow up|Lost to Follow-up|32|||
143087520|NCT00077207|515858760|FG000|Overall Study|Adverse Event|5|||
143087521|NCT00077207|515858760|FG000|Overall Study|Lack of Efficacy|12|||
143087522|NCT00077207|515858760|FG000|Overall Study|Physician Decision|6|||
143087523|NCT00077207|515858760|FG000|Overall Study|Withdrawal by Subject|6|||
143087524|NCT00077207|515858760|FG000|Overall Study|Ineligible|1|||
143087525|NCT02366689|515858761|FG000|Overall Study|Withdrawal by Subject|1|||
143087526|NCT02366689|515858762|FG001|Overall Study|Withdrawal by Subject|0|||
143087527|NCT02366689|515858763|FG002|Overall Study|Withdrawal by Subject|1|||
143087528|NCT02366689|515858761|FG000|Overall Study|Lost to Follow-up|3|||
143087529|NCT02366689|515858762|FG001|Overall Study|Lost to Follow-up|2|||
143087530|NCT02366689|515858763|FG002|Overall Study|Lost to Follow-up|0|||
143087531|NCT02366689|515858761|FG000|Overall Study|Pregnancy|0|||
143087532|NCT02366689|515858762|FG001|Overall Study|Pregnancy|1|||
143087533|NCT02366689|515858763|FG002|Overall Study|Pregnancy|1|||
143087534|NCT03283566|515858764|FG000|Overall Study|Lost to Follow-up|1|||
143087535|NCT03283566|515858765|FG001|Overall Study|Lost to Follow-up|2|||
143087536|NCT01068262|515858768|FG000|Overall Study|Adverse Event|2|||
143087537|NCT01068262|515858769|FG001|Overall Study|Adverse Event|0|||
143087538|NCT01068262|515858770|FG002|Overall Study|Adverse Event|1|||
143087539|NCT01068262|515858771|FG003|Overall Study|Adverse Event|0|||
143087540|NCT01068262|515858768|FG000|Overall Study|Protocol Violation|1|||
143087541|NCT01068262|515858769|FG001|Overall Study|Protocol Violation|0|||
143087542|NCT01068262|515858770|FG002|Overall Study|Protocol Violation|0|||
143087543|NCT01068262|515858771|FG003|Overall Study|Protocol Violation|0|||
143087544|NCT01068262|515858768|FG000|Overall Study|Withdrawal by Subject|0|||
143175630|NCT01088503|516192304|FG000|Overall Study|Withdrawal by Subject|118|||
143087545|NCT01068262|515858769|FG001|Overall Study|Withdrawal by Subject|1|||
143087546|NCT01068262|515858770|FG002|Overall Study|Withdrawal by Subject|0|||
143087547|NCT01068262|515858771|FG003|Overall Study|Withdrawal by Subject|0|||
143087548|NCT04182490|515858772|FG000|Overall Study|Withdrawal by Subject|3|||
143087549|NCT04182490|515858773|FG001|Overall Study|Withdrawal by Subject|3|||
143087550|NCT04182490|515858772|FG000|Overall Study|Lost to Follow-up|0|||
143175631|NCT01088503|516192305|FG001|Overall Study|Withdrawal by Subject|327|||
143087551|NCT04182490|515858773|FG001|Overall Study|Lost to Follow-up|1|||
143087552|NCT04182490|515858772|FG000|Overall Study|Physician Decision|0|||
143087553|NCT04182490|515858773|FG001|Overall Study|Physician Decision|1|||
143087554|NCT00853099|515858774|FG000|Double-blind Period|Adverse Event|7|||
143175632|NCT01088503|516192306|FG002|Overall Study|Withdrawal by Subject|10|||
143175633|NCT01088503|516192304|FG000|Overall Study|Death|64|||
143087555|NCT00853099|515858775|FG001|Double-blind Period|Adverse Event|9|||
143087556|NCT00853099|515858776|FG002|Double-blind Period|Adverse Event|13|||
143087557|NCT00853099|515858777|FG003|Double-blind Period|Adverse Event|0|||
143087558|NCT00853099|515858774|FG000|Double-blind Period|Withdrawal by Subject|2|||
143087559|NCT00853099|515858775|FG001|Double-blind Period|Withdrawal by Subject|3|||
143087560|NCT00853099|515858776|FG002|Double-blind Period|Withdrawal by Subject|0|||
143087561|NCT00853099|515858777|FG003|Double-blind Period|Withdrawal by Subject|0|||
143087562|NCT00853099|515858774|FG000|Double-blind Period|Lack of Efficacy|14|||
143087563|NCT00853099|515858775|FG001|Double-blind Period|Lack of Efficacy|17|||
143087564|NCT00853099|515858776|FG002|Double-blind Period|Lack of Efficacy|16|||
143087565|NCT00853099|515858777|FG003|Double-blind Period|Lack of Efficacy|0|||
143087566|NCT00853099|515858774|FG000|Double-blind Period|Other|0|||
143087567|NCT00853099|515858775|FG001|Double-blind Period|Other|0|||
143087568|NCT00853099|515858776|FG002|Double-blind Period|Other|1|||
143367036|NCT01981850|516887242|FG006|Open Label Extension (OLE)|Various reasons|0|||
143367037|NCT01981850|516887243|FG007|Open Label Extension (OLE)|Various reasons|3|||
143367038|NCT01981850|516887244|FG008|Open Label Extension (OLE)|Various reasons|1|||
143367039|NCT01981850|516887245|FG009|Open Label Extension (OLE)|Various reasons|3|||
143367040|NCT01981850|516887236|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
143367041|NCT01981850|516887237|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
143367042|NCT01981850|516887238|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
143367043|NCT01981850|516887239|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
143367044|NCT01981850|516887240|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
143367045|NCT01981850|516887241|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
143367046|NCT01981850|516887242|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
143367047|NCT01981850|516887243|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
143367048|NCT01981850|516887244|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
143367049|NCT01981850|516887245|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
143367050|NCT01981850|516887236|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
143367051|NCT01981850|516887237|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
143367052|NCT01981850|516887238|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
143367053|NCT01981850|516887239|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
143367054|NCT01981850|516887240|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
143367055|NCT01981850|516887241|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
143367056|NCT01981850|516887242|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
143367057|NCT01981850|516887243|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
143367058|NCT01981850|516887244|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
143367059|NCT01981850|516887245|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
143367060|NCT01981850|516887236|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
143367061|NCT01981850|516887237|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
143367062|NCT01981850|516887238|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
143367063|NCT01981850|516887239|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
143367064|NCT01981850|516887240|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
143367065|NCT01981850|516887241|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
143367066|NCT01981850|516887242|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
143367067|NCT01981850|516887243|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
143367068|NCT01981850|516887244|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
143367069|NCT01981850|516887245|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
143367070|NCT02524288|516887246|FG000|Overall Study|Adverse Event|115|||
143367071|NCT02524288|516887246|FG000|Overall Study|Lost to Follow-up|216|||
143367072|NCT02524288|516887246|FG000|Overall Study|Non-Compliance With Protocol|32|||
143367073|NCT02524288|516887246|FG000|Overall Study|Non-Compliance With Study Drug|14|||
143367074|NCT02524288|516887246|FG000|Overall Study|Pregnancy Wish|6|||
143367075|NCT02524288|516887246|FG000|Overall Study|Protocol Violation|6|||
143367076|NCT02524288|516887246|FG000|Overall Study|Screen Failure|2|||
143367077|NCT02524288|516887246|FG000|Overall Study|Site Discontinued Study Participation|1|||
143367078|NCT02524288|516887246|FG000|Overall Study|Study Terminated By Sponsor|1417|||
143367079|NCT02524288|516887246|FG000|Overall Study|Subject Moved|32|||
143367080|NCT02524288|516887246|FG000|Overall Study|Withdrawal by Subject|76|||
143367081|NCT02524288|516887246|FG000|Overall Study|Pregnancy|22|||
143087569|NCT00853099|515858777|FG003|Double-blind Period|Other|0|||
143087570|NCT00853099|515858774|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
143087571|NCT00853099|515858775|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
143367082|NCT02524288|516887246|FG000|Overall Study|Physician Decision|2|||
143367083|NCT00517933|516887248|FG000|Period 1|Death|2|||
143367084|NCT00517933|516887249|FG001|Period 1|Death|1|||
143367085|NCT00517933|516887248|FG000|Period 1|Adverse Event|4|||
143367086|NCT00517933|516887249|FG001|Period 1|Adverse Event|4|||
143087572|NCT00853099|515858776|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
143087573|NCT00853099|515858777|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
143087574|NCT00853099|515858774|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
143175634|NCT01088503|516192305|FG001|Overall Study|Death|358|||
143367087|NCT00517933|516887248|FG000|Period 1|Lost to Follow-up|2|||
143087575|NCT00853099|515858775|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
143087576|NCT00853099|515858776|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
143087577|NCT00853099|515858777|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
143087578|NCT00853099|515858774|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
143087579|NCT00853099|515858775|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
143087580|NCT00853099|515858776|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
143087581|NCT00853099|515858777|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
143087582|NCT00853099|515858774|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
143087583|NCT00853099|515858775|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
143087584|NCT00853099|515858776|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
143087585|NCT00853099|515858777|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
143087586|NCT00853099|515858774|FG000|Double-blind + Open-label Periods|Other|0|||
143087587|NCT00853099|515858775|FG001|Double-blind + Open-label Periods|Other|0|||
143087588|NCT00853099|515858776|FG002|Double-blind + Open-label Periods|Other|0|||
143087589|NCT00853099|515858777|FG003|Double-blind + Open-label Periods|Other|6|||
143087590|NCT03280264|515858778|FG000|Overall Study|Adverse Event|1|||
143087591|NCT03280264|515858778|FG000|Overall Study|Physician Decision|1|||
143087592|NCT03280264|515858778|FG000|Overall Study|Withdrawal by Subject|1|||
143087593|NCT00577863|515858780|FG000|Overall Study|Adverse Event|4|||
143087594|NCT00577863|515858781|FG001|Overall Study|Adverse Event|2|||
143087595|NCT00577863|515858780|FG000|Overall Study|Death|1|||
143087596|NCT00577863|515858781|FG001|Overall Study|Death|0|||
143087597|NCT00577863|515858780|FG000|Overall Study|Lost to Follow-up|2|||
143087598|NCT00577863|515858781|FG001|Overall Study|Lost to Follow-up|2|||
143087599|NCT00577863|515858780|FG000|Overall Study|Entry Criteria Exclusion|1|||
143087600|NCT00577863|515858781|FG001|Overall Study|Entry Criteria Exclusion|0|||
143087601|NCT00577863|515858780|FG000|Overall Study|Withdrawal by Subject|0|||
143087602|NCT00577863|515858781|FG001|Overall Study|Withdrawal by Subject|2|||
143087603|NCT00577863|515858780|FG000|Overall Study|Sponsor Decision|2|||
143087604|NCT00577863|515858781|FG001|Overall Study|Sponsor Decision|7|||
143087605|NCT00577863|515858780|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
143087606|NCT00577863|515858781|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
143087607|NCT00110396|515858791|FG000|Overall Study|Adverse Event|15|||
143087608|NCT00110396|515858791|FG000|Overall Study|Lost to Follow-up|1|||
143087609|NCT00110396|515858791|FG000|Overall Study|Administration of plasmapheresis|1|||
143087610|NCT00110396|515858791|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
143087611|NCT00110396|515858791|FG000|Overall Study|Lack of Efficacy|1|||
143087612|NCT00110396|515858791|FG000|Overall Study|Decided not to continue treatment|1|||
143087613|NCT00110396|515858791|FG000|Overall Study|Patient non-compliance|1|||
143087614|NCT00110396|515858791|FG000|Overall Study|Patient refused to continue|1|||
143087615|NCT00110396|515858791|FG000|Overall Study|Patient refused to participate|1|||
143087616|NCT00110396|515858791|FG000|Overall Study|Patient will|1|||
143087617|NCT00110396|515858791|FG000|Overall Study|Patient's decision|1|||
143087618|NCT00110396|515858791|FG000|Overall Study|Participation in MS vaccine study|1|||
143087619|NCT00110396|515858791|FG000|Overall Study|Pregnancy|1|||
143087620|NCT00110396|515858791|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
143087621|NCT00110396|515858791|FG000|Overall Study|Protocol Violation|2|||
143087622|NCT00110396|515858791|FG000|Overall Study|Patient refused to come back|1|||
143087623|NCT00110396|515858791|FG000|Overall Study|The patient has refused|2|||
143175635|NCT01088503|516192306|FG002|Overall Study|Death|7|||
143175636|NCT01847092|516192307|FG000|Overall Study|Adverse Event|12|||
143175637|NCT01847092|516192308|FG001|Overall Study|Adverse Event|3|||
143087624|NCT00110396|515858791|FG000|Overall Study|The patient has refused to visit site|1|||
143087625|NCT00110396|515858791|FG000|Overall Study|Patient is to be administered copaxone|1|||
143087626|NCT02414958|515858792|FG000|Overall Study|Adverse Event|6|||
143175638|NCT01847092|516192307|FG000|Overall Study|Withdrawal by Subject|5|||
143175639|NCT01847092|516192308|FG001|Overall Study|Withdrawal by Subject|5|||
143087627|NCT02414958|515858793|FG001|Overall Study|Adverse Event|6|||
143087628|NCT02414958|515858794|FG002|Overall Study|Adverse Event|3|||
143087629|NCT02414958|515858792|FG000|Overall Study|Protocol Violation|10|||
143087630|NCT02414958|515858793|FG001|Overall Study|Protocol Violation|3|||
143087631|NCT02414958|515858794|FG002|Overall Study|Protocol Violation|1|||
143087632|NCT02414958|515858792|FG000|Overall Study|Lost to Follow-up|7|||
143087633|NCT02414958|515858793|FG001|Overall Study|Lost to Follow-up|4|||
143087634|NCT02414958|515858794|FG002|Overall Study|Lost to Follow-up|0|||
143087635|NCT02414958|515858792|FG000|Overall Study|Withdrawal by Subject|5|||
143087636|NCT02414958|515858793|FG001|Overall Study|Withdrawal by Subject|3|||
143087637|NCT02414958|515858794|FG002|Overall Study|Withdrawal by Subject|5|||
143087638|NCT02414958|515858792|FG000|Overall Study|Other than specified|4|||
143087639|NCT02414958|515858793|FG001|Overall Study|Other than specified|4|||
143087640|NCT02414958|515858794|FG002|Overall Study|Other than specified|5|||
143087641|NCT03885661|515858799|FG000|Overall Study|Withdrawal by Subject|0|||
143087642|NCT03885661|515858800|FG001|Overall Study|Withdrawal by Subject|1|||
143087643|NCT03885661|515858799|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
143087644|NCT03885661|515858800|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
143087645|NCT05064397|515858801|FG000|Overall Study|Adverse Event|4|||
143087646|NCT05064397|515858801|FG000|Overall Study|Lack of Efficacy|12|||
143087647|NCT05064397|515858801|FG000|Overall Study|Withdrawal by Subject|3|||
143087648|NCT05064397|515858801|FG000|Overall Study|Lost to Follow-up|1|||
143087649|NCT05064397|515858801|FG000|Overall Study|Other reasons|3|||
143087650|NCT02232984|515858802|FG000|Overall Study|Withdrawal by Subject|5|||
143087651|NCT02232984|515858802|FG000|Overall Study|Death|1|||
143087652|NCT02232984|515858802|FG000|Overall Study|Investigator withdrawal|10|||
143087653|NCT02232984|515858802|FG000|Overall Study|Device implant unsuccessful|53|||
143087654|NCT02232984|515858802|FG000|Overall Study|not disclosed by site|7|||
143087655|NCT02232984|515858802|FG000|Overall Study|Protocol Violation|1|||
143087656|NCT00769379|515858805|FG000|Overall Study|No follow up data mapped to Other.|3|||
143087657|NCT00769379|515858806|FG001|Overall Study|No follow up data mapped to Other.|13|||
143087658|NCT03934541|515858807|FG000|Overall Study|Study Terminated by Sponsor|0|||
143087659|NCT03934541|515858808|FG001|Overall Study|Study Terminated by Sponsor|1|||
143087660|NCT03934541|515858809|FG002|Overall Study|Study Terminated by Sponsor|0|||
143087661|NCT03934541|515858810|FG003|Overall Study|Study Terminated by Sponsor|0|||
143087662|NCT00344448|515858811|FG000|Screening|Withdrawal by Subject|0|||
143087663|NCT00344448|515858812|FG001|Screening|Withdrawal by Subject|1|||
143087664|NCT00344448|515858811|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
143087665|NCT00344448|515858812|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
143087666|NCT00344448|515858811|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
143087667|NCT00344448|515858812|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
143087668|NCT00344448|515858811|FG000|Open Label|Withdrawal by Subject|1|||
143087669|NCT00344448|515858812|FG001|Open Label|Withdrawal by Subject|1|||
143087670|NCT00344448|515858811|FG000|Open Label|Study terminated|1|||
143087671|NCT00344448|515858812|FG001|Open Label|Study terminated|0|||
143087672|NCT02673775|515858816|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
143087673|NCT02673775|515858817|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
143087674|NCT02673775|515858816|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
143087675|NCT02673775|515858817|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
143087676|NCT02673775|515858816|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
143087677|NCT02673775|515858817|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
143087678|NCT02673775|515858816|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
143087679|NCT02673775|515858817|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
143087680|NCT02441686|515858818|FG000|Induction|Adverse Event|4|||
143087681|NCT02441686|515858818|FG000|Induction|Complicating disease|1|||
143087682|NCT02441686|515858818|FG000|Induction|Physician Decision|1|||
143087683|NCT02441686|515858818|FG000|Induction|Withdrawal by Subject|1|||
143087684|NCT02441686|515858818|FG000|Induction|Did not receive treatment|1|||
143087685|NCT02441686|515858818|FG000|Maintenance|Remaining on Treatment|23|||
143087686|NCT02441686|515858818|FG000|Maintenance|Physician Decision|1|||
143087687|NCT02441686|515858818|FG000|Maintenance|Adverse Event|3|||
143087688|NCT02441686|515858818|FG000|Maintenance|Progressive Disease|10|||
143087689|NCT02441686|515858818|FG000|Maintenance|Withdrawal by Subject|1|||
143087690|NCT03762239|515858821|FG000|Overall Study|Appointment to the doctor|1|||
143087691|NCT03762239|515858822|FG001|Overall Study|Appointment to the doctor|1|||
143087692|NCT04471428|515858823|FG000|Overall Study|Withdrawal by Subject|29|||
143087693|NCT04471428|515858824|FG001|Overall Study|Withdrawal by Subject|1|||
143087694|NCT04471428|515858823|FG000|Overall Study|Physician Decision|0|||
143087695|NCT04471428|515858824|FG001|Overall Study|Physician Decision|1|||
143087696|NCT04471428|515858823|FG000|Overall Study|Reason Not Specified|0|||
143087697|NCT04471428|515858824|FG001|Overall Study|Reason Not Specified|2|||
143367088|NCT00517933|516887249|FG001|Period 1|Lost to Follow-up|0|||
143367089|NCT00517933|516887248|FG000|Period 1|Underwent lung transplant|0|||
143367090|NCT00517933|516887249|FG001|Period 1|Underwent lung transplant|1|||
143367091|NCT00517933|516887248|FG000|Period 2|Death|2|||
143367092|NCT00517933|516887249|FG001|Period 2|Death|4|||
143367093|NCT00517933|516887248|FG000|Period 2|Adverse Event|2|||
143367094|NCT00517933|516887249|FG001|Period 2|Adverse Event|4|||
143367095|NCT00517933|516887248|FG000|Period 2|Physician Decision|1|||
143367096|NCT00517933|516887249|FG001|Period 2|Physician Decision|0|||
143367097|NCT00517933|516887248|FG000|Period 2|Withdrawal by Subject|1|||
143367098|NCT00517933|516887249|FG001|Period 2|Withdrawal by Subject|3|||
143367099|NCT00517933|516887248|FG000|Period 2|Underwent lung transplant|0|||
143367100|NCT00517933|516887249|FG001|Period 2|Underwent lung transplant|2|||
143367101|NCT01467700|516887250|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
143367102|NCT01467700|516887251|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
143367103|NCT01467700|516887252|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
143367104|NCT01467700|516887253|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
143087698|NCT04471428|515858823|FG000|Overall Study|Death|106|||
143087699|NCT04471428|515858824|FG001|Overall Study|Death|114|||
143087700|NCT04471428|515858823|FG000|Overall Study|Ongoing in the study|45|||
143087701|NCT04471428|515858824|FG001|Overall Study|Ongoing in the study|68|||
143087702|NCT00535405|515858827|FG000|Overall Study|Adverse Event|6|||
143087703|NCT00535405|515858828|FG001|Overall Study|Adverse Event|8|||
143087704|NCT00535405|515858829|FG002|Overall Study|Adverse Event|3|||
143087705|NCT00535405|515858830|FG003|Overall Study|Adverse Event|8|||
143087706|NCT00535405|515858831|FG004|Overall Study|Adverse Event|6|||
143087707|NCT00535405|515858827|FG000|Overall Study|Lost to Follow-up|1|||
143087708|NCT00535405|515858828|FG001|Overall Study|Lost to Follow-up|3|||
143087709|NCT00535405|515858829|FG002|Overall Study|Lost to Follow-up|3|||
143087710|NCT00535405|515858830|FG003|Overall Study|Lost to Follow-up|2|||
143087711|NCT00535405|515858831|FG004|Overall Study|Lost to Follow-up|1|||
143087712|NCT00535405|515858827|FG000|Overall Study|Physician Decision|3|||
143087713|NCT00535405|515858828|FG001|Overall Study|Physician Decision|2|||
143087714|NCT00535405|515858829|FG002|Overall Study|Physician Decision|0|||
143087715|NCT00535405|515858830|FG003|Overall Study|Physician Decision|1|||
143087716|NCT00535405|515858831|FG004|Overall Study|Physician Decision|1|||
143087717|NCT00535405|515858827|FG000|Overall Study|Protocol Violation|2|||
143087718|NCT00535405|515858828|FG001|Overall Study|Protocol Violation|2|||
143087719|NCT00535405|515858829|FG002|Overall Study|Protocol Violation|2|||
143087720|NCT00535405|515858830|FG003|Overall Study|Protocol Violation|1|||
143087721|NCT00535405|515858831|FG004|Overall Study|Protocol Violation|0|||
143087722|NCT00535405|515858827|FG000|Overall Study|Withdrawal by Subject|5|||
143087723|NCT00535405|515858828|FG001|Overall Study|Withdrawal by Subject|11|||
143087724|NCT00535405|515858829|FG002|Overall Study|Withdrawal by Subject|10|||
143087725|NCT00535405|515858830|FG003|Overall Study|Withdrawal by Subject|10|||
143087726|NCT00535405|515858831|FG004|Overall Study|Withdrawal by Subject|8|||
143087727|NCT03151304|515858832|FG000|Overall Study|Termination of study by Sponsor|23|||
143087728|NCT03151304|515858832|FG000|Overall Study|missing|3|||
143087729|NCT03151304|515858832|FG000|Overall Study|Withdrawal by Subject|8|||
143087730|NCT03151304|515858832|FG000|Overall Study|multiple reasons|30|||
143087731|NCT03519087|515858833|FG000|Clinic Evaluation|Physician Decision|15|||
143087732|NCT03519087|515858834|FG001|Clinic Evaluation|Physician Decision|18|||
143087733|NCT03519087|515858835|FG002|Clinic Evaluation|Physician Decision|0|||
143087734|NCT03519087|515858836|FG003|Clinic Evaluation|Physician Decision|0|||
143087735|NCT03519087|515858837|FG004|Clinic Evaluation|Physician Decision|0|||
143087736|NCT03519087|515858833|FG000|Clinic Evaluation|Protocol Violation|1|||
143087737|NCT03519087|515858834|FG001|Clinic Evaluation|Protocol Violation|0|||
143087738|NCT03519087|515858835|FG002|Clinic Evaluation|Protocol Violation|0|||
143087739|NCT03519087|515858836|FG003|Clinic Evaluation|Protocol Violation|0|||
143087740|NCT03519087|515858837|FG004|Clinic Evaluation|Protocol Violation|0|||
143367105|NCT01467700|516887250|FG000|Overall Study|Major Protocol Deviation|3|||
143367106|NCT01467700|516887251|FG001|Overall Study|Major Protocol Deviation|3|||
143367107|NCT01467700|516887252|FG002|Overall Study|Major Protocol Deviation|2|||
143367108|NCT01467700|516887253|FG003|Overall Study|Major Protocol Deviation|3|||
143367109|NCT01467700|516887250|FG000|Overall Study|Lost to Follow-up|6|||
143367110|NCT01467700|516887251|FG001|Overall Study|Lost to Follow-up|5|||
143367111|NCT01467700|516887252|FG002|Overall Study|Lost to Follow-up|2|||
143087741|NCT03519087|515858833|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
143087742|NCT03519087|515858834|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
143087743|NCT03519087|515858835|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
143367112|NCT01467700|516887253|FG003|Overall Study|Lost to Follow-up|3|||
143250381|NCT00435045|516471193|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
143250382|NCT00435045|516471192|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
143250383|NCT00435045|516471193|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
143250384|NCT03672097|516471194|FG000|Period 1|Withdrawal by Subject|2|||
143250385|NCT03672097|516471194|FG000|Period 1|Adverse Event|1|||
143250386|NCT03672097|516471194|FG000|Period 1|Did not receive treatment|1|||
143250387|NCT03672097|516471194|FG000|Period 2|Withdrawal by Subject|3|||
143250388|NCT03672097|516471194|FG000|Period 2|Other|1|||
143250389|NCT03087617|516471196|FG000|Overall Study|Lost to Follow-up|32|||
143250390|NCT03087617|516471197|FG001|Overall Study|Lost to Follow-up|30|||
143250391|NCT03087617|516471198|FG002|Overall Study|Lost to Follow-up|30|||
143250392|NCT03087617|516471199|FG003|Overall Study|Lost to Follow-up|39|||
143250393|NCT01433289|516471203|FG000|Overall Study|Pregnancy|0|||
143250394|NCT01433289|516471204|FG001|Overall Study|Pregnancy|1|||
143250395|NCT01433289|516471205|FG002|Overall Study|Pregnancy|0|||
143250396|NCT01433289|516471206|FG003|Overall Study|Pregnancy|0|||
143250397|NCT00470834|516471207|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
143250398|NCT00470834|516471208|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
143250399|NCT00470834|516471207|FG000|Treatment Period (18 Months)|Adverse Event|7|||
143250400|NCT00470834|516471208|FG001|Treatment Period (18 Months)|Adverse Event|6|||
143250401|NCT00470834|516471207|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
143087744|NCT03519087|515858836|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
143087745|NCT03519087|515858837|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
143087746|NCT03519087|515858833|FG000|Re-randomization for Treatment|Not appropriate|2|||
143087747|NCT03519087|515858834|FG001|Re-randomization for Treatment|Not appropriate|3|||
143087748|NCT03519087|515858835|FG002|Re-randomization for Treatment|Not appropriate|0|||
143087749|NCT03519087|515858836|FG003|Re-randomization for Treatment|Not appropriate|0|||
143087750|NCT03519087|515858837|FG004|Re-randomization for Treatment|Not appropriate|0|||
143087751|NCT03519087|515858833|FG000|Laboratory Testing|Lost to Follow-up|0|||
143087752|NCT03519087|515858834|FG001|Laboratory Testing|Lost to Follow-up|0|||
143087753|NCT03519087|515858835|FG002|Laboratory Testing|Lost to Follow-up|2|||
143087754|NCT03519087|515858836|FG003|Laboratory Testing|Lost to Follow-up|3|||
143087755|NCT03519087|515858837|FG004|Laboratory Testing|Lost to Follow-up|6|||
143087756|NCT03519087|515858833|FG000|Laboratory Testing|Protocol Violation|0|||
143087757|NCT03519087|515858834|FG001|Laboratory Testing|Protocol Violation|0|||
143087758|NCT03519087|515858835|FG002|Laboratory Testing|Protocol Violation|0|||
143087759|NCT03519087|515858836|FG003|Laboratory Testing|Protocol Violation|1|||
143087760|NCT03519087|515858837|FG004|Laboratory Testing|Protocol Violation|0|||
143087761|NCT04194645|515858840|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
143087762|NCT04194645|515858841|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
143087763|NCT04194645|515858842|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
143087764|NCT04194645|515858843|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
143087765|NCT04194645|515858844|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
143087766|NCT04194645|515858845|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
143087767|NCT04194645|515858846|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
143087768|NCT04194645|515858847|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
143087769|NCT04194645|515858848|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
143087770|NCT04194645|515858849|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
143087771|NCT04194645|515858850|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
143087772|NCT04194645|515858851|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
143087773|NCT04194645|515858852|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
143087774|NCT04194645|515858853|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
143087775|NCT04194645|515858854|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
143087776|NCT03404674|515858855|FG000|Overall Study|Inability to Attend Future Visits|0|||
143087777|NCT03404674|515858856|FG001|Overall Study|Inability to Attend Future Visits|1|||
143087778|NCT03404674|515858857|FG002|Overall Study|Inability to Attend Future Visits|1|||
143087779|NCT03404674|515858858|FG003|Overall Study|Inability to Attend Future Visits|0|||
143087780|NCT03404674|515858859|FG004|Overall Study|Inability to Attend Future Visits|0|||
143087781|NCT03404674|515858860|FG005|Overall Study|Inability to Attend Future Visits|0|||
143087782|NCT03404674|515858855|FG000|Overall Study|Behavioral Problems|0|||
143087783|NCT03404674|515858856|FG001|Overall Study|Behavioral Problems|0|||
143087784|NCT03404674|515858857|FG002|Overall Study|Behavioral Problems|1|||
143087785|NCT03404674|515858858|FG003|Overall Study|Behavioral Problems|0|||
143250402|NCT00470834|516471208|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
143250403|NCT00470834|516471207|FG000|Treatment Period (18 Months)|Physician Decision|4|||
143250404|NCT00470834|516471208|FG001|Treatment Period (18 Months)|Physician Decision|4|||
143250405|NCT00470834|516471207|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
143250406|NCT00470834|516471208|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
143250407|NCT00470834|516471207|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
143250408|NCT00470834|516471208|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
143250409|NCT00470834|516471207|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
143250410|NCT00470834|516471208|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
143250411|NCT00470834|516471207|FG000|Treatment Period (18 Months)|Non-compliance|1|||
143250412|NCT00470834|516471208|FG001|Treatment Period (18 Months)|Non-compliance|0|||
143250413|NCT00470834|516471207|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
143250414|NCT00470834|516471208|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
143250415|NCT00470834|516471207|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
143250416|NCT00470834|516471208|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
143250417|NCT00470834|516471207|FG000|Extension Period (24 Months)|Adverse Event|3|||
143250418|NCT00470834|516471208|FG001|Extension Period (24 Months)|Adverse Event|4|||
143250419|NCT00470834|516471207|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
143250420|NCT00470834|516471208|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
143250421|NCT00470834|516471207|FG000|Extension Period (24 Months)|Physician Decision|4|||
143250422|NCT00470834|516471208|FG001|Extension Period (24 Months)|Physician Decision|3|||
143250423|NCT00470834|516471207|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
143250424|NCT00470834|516471208|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
143250425|NCT00470834|516471207|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
143250426|NCT00470834|516471208|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
143250427|NCT00470834|516471207|FG000|Extension Period (24 Months)|Non-compliance|0|||
143250428|NCT00470834|516471208|FG001|Extension Period (24 Months)|Non-compliance|1|||
143250429|NCT00470834|516471207|FG000|Extension Period (24 Months)|Disease Progression|0|||
143250430|NCT00470834|516471208|FG001|Extension Period (24 Months)|Disease Progression|1|||
143250431|NCT02640508|516471218|FG000|Overall Study|Death|19|||
143250432|NCT02640508|516471218|FG000|Overall Study|Withdrawal by Subject|8|||
143250433|NCT02640508|516471218|FG000|Overall Study|Physician Decision|1|||
143250434|NCT02640508|516471218|FG000|Overall Study|Lost to Follow-up|1|||
143250435|NCT05405257|516471219|FG000|Overall Study|Withdrawal by Subject|1|||
143250436|NCT03116152|516471220|FG000|Overall Study|Disease Progression|49|||
143250437|NCT03116152|516471221|FG001|Overall Study|Disease Progression|47|||
143250438|NCT03116152|516471220|FG000|Overall Study|Death|5|||
143250439|NCT03116152|516471221|FG001|Overall Study|Death|2|||
143250440|NCT03116152|516471220|FG000|Overall Study|Adverse Event|21|||
143250441|NCT03116152|516471221|FG001|Overall Study|Adverse Event|7|||
143250442|NCT03116152|516471220|FG000|Overall Study|Protocol Violation|2|||
143250443|NCT03116152|516471221|FG001|Overall Study|Protocol Violation|2|||
143250444|NCT03116152|516471220|FG000|Overall Study|Withdrawal by Subject|0|||
143250445|NCT03116152|516471221|FG001|Overall Study|Withdrawal by Subject|1|||
143087786|NCT03404674|515858859|FG004|Overall Study|Behavioral Problems|0|||
143087787|NCT03404674|515858860|FG005|Overall Study|Behavioral Problems|0|||
143250446|NCT03116152|516471220|FG000|Overall Study|Physician Decision|3|||
143250447|NCT03116152|516471221|FG001|Overall Study|Physician Decision|2|||
143250448|NCT03116152|516471220|FG000|Overall Study|other|11|||
143087788|NCT03404674|515858855|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
143250449|NCT03116152|516471221|FG001|Overall Study|other|34|||
143250450|NCT00862641|516471222|FG000|Overall Study|Randomized, but drug not received|1|||
143250451|NCT00862641|516471223|FG001|Overall Study|Randomized, but drug not received|4|||
143250452|NCT00862641|516471224|FG002|Overall Study|Randomized, but drug not received|1|||
143250453|NCT00862641|516471225|FG003|Overall Study|Randomized, but drug not received|4|||
143087789|NCT03404674|515858856|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
143087790|NCT03404674|515858857|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
143087791|NCT03404674|515858858|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
143087792|NCT03404674|515858859|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
143087793|NCT03404674|515858860|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
143087794|NCT02290405|515858861|FG000|Overall Study|Withdrawal by Subject|1|||
143087795|NCT02290405|515858862|FG001|Overall Study|Withdrawal by Subject|0|||
143087796|NCT03541317|515858867|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
143087797|NCT03541317|515858868|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
143087798|NCT03541317|515858869|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
143087799|NCT03541317|515858870|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
143087800|NCT03541317|515858871|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
143087801|NCT03541317|515858872|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
143087802|NCT02286843|515858873|FG000|Overall Study|Not Treated|4|||
143087803|NCT02286843|515858873|FG000|Overall Study|Protocol Violation|1|||
143087804|NCT02286843|515858873|FG000|Overall Study|Withdrawal by Subject|1|||
143087805|NCT01855828|515858880|FG000|Overall Study|Adverse Event|1|||
143087806|NCT01855828|515858880|FG000|Overall Study|Withdrawal by Subject|1|||
143087807|NCT01866098|515858881|FG000|Overall Study|Lost to Follow-up|11|||
143087808|NCT01866098|515858882|FG001|Overall Study|Lost to Follow-up|18|||
143087809|NCT01866098|515858883|FG002|Overall Study|Lost to Follow-up|13|||
143087810|NCT01866098|515858881|FG000|Overall Study|Physician Decision|0|||
143087811|NCT01866098|515858882|FG001|Overall Study|Physician Decision|1|||
143087812|NCT01866098|515858883|FG002|Overall Study|Physician Decision|2|||
143087813|NCT01866098|515858881|FG000|Overall Study|Adverse Event|1|||
143087814|NCT01866098|515858882|FG001|Overall Study|Adverse Event|5|||
143087815|NCT01866098|515858883|FG002|Overall Study|Adverse Event|4|||
143087816|NCT01866098|515858881|FG000|Overall Study|Protocol Violation|1|||
143087817|NCT01866098|515858882|FG001|Overall Study|Protocol Violation|0|||
143087818|NCT01866098|515858883|FG002|Overall Study|Protocol Violation|0|||
143087819|NCT01866098|515858881|FG000|Overall Study|Withdrawal by Subject|1|||
143087820|NCT01866098|515858882|FG001|Overall Study|Withdrawal by Subject|2|||
143087821|NCT01866098|515858883|FG002|Overall Study|Withdrawal by Subject|0|||
143087822|NCT01866098|515858881|FG000|Overall Study|Unrelated Hospitalization|2|||
143087823|NCT01866098|515858882|FG001|Overall Study|Unrelated Hospitalization|0|||
143087824|NCT01866098|515858883|FG002|Overall Study|Unrelated Hospitalization|1|||
143087825|NCT01866098|515858881|FG000|Overall Study|Non-compliance|1|||
143087826|NCT01866098|515858882|FG001|Overall Study|Non-compliance|0|||
143087827|NCT01866098|515858883|FG002|Overall Study|Non-compliance|1|||
143087828|NCT01866098|515858881|FG000|Overall Study|Pregnancy|2|||
143087829|NCT01866098|515858882|FG001|Overall Study|Pregnancy|0|||
143087830|NCT01866098|515858883|FG002|Overall Study|Pregnancy|0|||
143087831|NCT01866098|515858881|FG000|Overall Study|Death|0|||
143087832|NCT01866098|515858882|FG001|Overall Study|Death|1|||
143087833|NCT01866098|515858883|FG002|Overall Study|Death|0|||
143087834|NCT04239027|515858884|FG000|Overall Study|Adverse Event|4|||
143087835|NCT04239027|515858884|FG000|Overall Study|Withdrawal by Subject|9|||
143087836|NCT04239027|515858884|FG000|Overall Study|Death|1|||
143087837|NCT04239027|515858884|FG000|Overall Study|Physician Decision|9|||
143087838|NCT04239027|515858884|FG000|Overall Study|Lost to Follow-up|2|||
143087839|NCT04239027|515858884|FG000|Overall Study|Lack of Efficacy|1|||
143087840|NCT03172494|515858885|FG000|Overall Study|Adverse Event|5|||
143087841|NCT03172494|515858886|FG001|Overall Study|Adverse Event|1|||
143087842|NCT03172494|515858887|FG002|Overall Study|Adverse Event|15|||
143087843|NCT03172494|515858885|FG000|Overall Study|Protocol Violation|3|||
143087844|NCT03172494|515858886|FG001|Overall Study|Protocol Violation|2|||
143087845|NCT03172494|515858887|FG002|Overall Study|Protocol Violation|1|||
143087846|NCT03172494|515858885|FG000|Overall Study|Lack of Efficacy|0|||
143087847|NCT03172494|515858886|FG001|Overall Study|Lack of Efficacy|0|||
143087848|NCT03172494|515858887|FG002|Overall Study|Lack of Efficacy|4|||
143087849|NCT03172494|515858885|FG000|Overall Study|Pregnancy|0|||
143087850|NCT03172494|515858886|FG001|Overall Study|Pregnancy|1|||
143087851|NCT03172494|515858887|FG002|Overall Study|Pregnancy|0|||
143087852|NCT03172494|515858885|FG000|Overall Study|Withdrawal by Subject|10|||
143087853|NCT03172494|515858886|FG001|Overall Study|Withdrawal by Subject|8|||
143087854|NCT03172494|515858887|FG002|Overall Study|Withdrawal by Subject|8|||
143087855|NCT03172494|515858885|FG000|Overall Study|Severe hypoglycaemic episode|0|||
143087856|NCT03172494|515858886|FG001|Overall Study|Severe hypoglycaemic episode|0|||
143087857|NCT03172494|515858887|FG002|Overall Study|Severe hypoglycaemic episode|1|||
143087858|NCT03172494|515858885|FG000|Overall Study|Non-compliance towards treatment|2|||
143087859|NCT03172494|515858886|FG001|Overall Study|Non-compliance towards treatment|0|||
143087860|NCT03172494|515858887|FG002|Overall Study|Non-compliance towards treatment|0|||
143087861|NCT00001521|515860467|FG000|Overall Study|Withdrawal by Subject|3|||
143087862|NCT00001521|515860468|FG001|Overall Study|Withdrawal by Subject|3|||
143087863|NCT00001521|515860467|FG000|Overall Study|Physician Decision|1|||
143087864|NCT00001521|515860468|FG001|Overall Study|Physician Decision|1|||
143087865|NCT00001521|515860467|FG000|Overall Study|Noncompliant|6|||
143087866|NCT00001521|515860468|FG001|Overall Study|Noncompliant|3|||
143087867|NCT04848480|515860469|FG000|Main Phase (26 Weeks)|Death|1|||
143087868|NCT04848480|515860470|FG001|Main Phase (26 Weeks)|Death|0|||
143087869|NCT04848480|515860469|FG000|Main Phase (26 Weeks)|Lost to Follow-up|1|||
143087870|NCT04848480|515860470|FG001|Main Phase (26 Weeks)|Lost to Follow-up|1|||
143087871|NCT04848480|515860469|FG000|Main Phase (26 Weeks)|Withdrawal by Subject|9|||
143087872|NCT04848480|515860470|FG001|Main Phase (26 Weeks)|Withdrawal by Subject|7|||
143087873|NCT04848480|515860469|FG000|Extension Phase (26 Weeks)|Physician Decision|1|||
143087874|NCT04848480|515860470|FG001|Extension Phase (26 Weeks)|Physician Decision|0|||
143087875|NCT04848480|515860469|FG000|Extension Phase (26 Weeks)|Lost to Follow-up|0|||
143087876|NCT04848480|515860470|FG001|Extension Phase (26 Weeks)|Lost to Follow-up|1|||
143087877|NCT04848480|515860469|FG000|Extension Phase (26 Weeks)|Withdrawal by Subject|4|||
143087878|NCT04848480|515860470|FG001|Extension Phase (26 Weeks)|Withdrawal by Subject|2|||
143087879|NCT03176134|515860471|FG000|Overall Study|Lost to Follow-up|0|||
143087880|NCT03176134|515860472|FG001|Overall Study|Lost to Follow-up|2|||
143087881|NCT03176134|515860473|FG002|Overall Study|Lost to Follow-up|0|||
143087882|NCT03176134|515860474|FG003|Overall Study|Lost to Follow-up|0|||
143087883|NCT03176134|515860475|FG004|Overall Study|Lost to Follow-up|0|||
143087884|NCT03176134|515860476|FG005|Overall Study|Lost to Follow-up|0|||
143087885|NCT03176134|515860477|FG006|Overall Study|Lost to Follow-up|0|||
143087886|NCT03176134|515860478|FG007|Overall Study|Lost to Follow-up|0|||
143087887|NCT03176134|515860471|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
143087888|NCT03176134|515860472|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
143087889|NCT03176134|515860473|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
143087890|NCT03176134|515860474|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
143087891|NCT03176134|515860475|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
143250454|NCT03179605|516471226|FG000|Overall Study|Withdrawal by Subject|1|||
143250455|NCT00711477|516471227|FG000|Overall Study|Adverse Event|3|||
143250456|NCT00711477|516471228|FG001|Overall Study|Adverse Event|1|||
143250457|NCT00711477|516471227|FG000|Overall Study|Lost to Follow-up|0|||
143250458|NCT00711477|516471228|FG001|Overall Study|Lost to Follow-up|1|||
143250459|NCT00711477|516471227|FG000|Overall Study|Noncompliance|0|||
143250460|NCT00711477|516471228|FG001|Overall Study|Noncompliance|1|||
143250461|NCT02636361|516471229|FG000|Period 4|Physician Decision|0|||
143250462|NCT02636361|516471230|FG001|Period 4|Physician Decision|0|||
143250463|NCT02636361|516471231|FG002|Period 4|Physician Decision|0|||
143250464|NCT02636361|516471232|FG003|Period 4|Physician Decision|1|||
143250465|NCT02636361|516471233|FG004|Period 4|Physician Decision|0|||
143250466|NCT02036853|516471238|FG000|Overall Study|Adverse Event|0|||
143250467|NCT02036853|516471239|FG001|Overall Study|Adverse Event|2|||
143250468|NCT02036853|516471238|FG000|Overall Study|Lack of Efficacy|0|||
143250469|NCT02036853|516471239|FG001|Overall Study|Lack of Efficacy|2|||
143250470|NCT02036853|516471238|FG000|Overall Study|Physician Decision|0|||
143250471|NCT02036853|516471239|FG001|Overall Study|Physician Decision|1|||
143250472|NCT02036853|516471238|FG000|Overall Study|Withdrawal by Subject|0|||
143250473|NCT02036853|516471239|FG001|Overall Study|Withdrawal by Subject|1|||
143250474|NCT00228553|516471240|FG000|Overall Study|Adverse Event|112|||
143250475|NCT00228553|516471240|FG000|Overall Study|Lack of Efficacy|34|||
143250476|NCT00228553|516471240|FG000|Overall Study|Lost to Follow-up|67|||
143250477|NCT00228553|516471240|FG000|Overall Study|Physician Decision|48|||
143250478|NCT00228553|516471240|FG000|Overall Study|Protocol Violation|6|||
143250479|NCT00228553|516471240|FG000|Overall Study|Withdrawal by Subject|115|||
143250480|NCT00228553|516471240|FG000|Overall Study|Pregnancy|2|||
143250481|NCT00228553|516471240|FG000|Overall Study|Miscellaneous|46|||
143250482|NCT04556383|516471243|FG000|PCP|Lack of Efficacy|28|||
143250483|NCT04556383|516471244|FG001|PCP|Lack of Efficacy|23|||
143250484|NCT04556383|516471245|FG002|PCP|Lack of Efficacy|23|||
143250485|NCT04556383|516471246|FG003|PCP|Lack of Efficacy|0|||
143087892|NCT03176134|515860476|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
143250486|NCT04556383|516471243|FG000|PCP|Study terminated by sponsor|15|||
143087893|NCT03176134|515860477|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
143250487|NCT04556383|516471244|FG001|PCP|Study terminated by sponsor|13|||
143250488|NCT04556383|516471245|FG002|PCP|Study terminated by sponsor|16|||
143250489|NCT04556383|516471246|FG003|PCP|Study terminated by sponsor|0|||
143250490|NCT04556383|516471243|FG000|PCP|Withdrawal by Subject|8|||
143250491|NCT04556383|516471244|FG001|PCP|Withdrawal by Subject|6|||
143250492|NCT04556383|516471245|FG002|PCP|Withdrawal by Subject|6|||
143250493|NCT04556383|516471246|FG003|PCP|Withdrawal by Subject|0|||
143087894|NCT03176134|515860478|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
143087895|NCT01996241|515860484|FG000|Overall Study|Lost to Follow-up|252|||
143087896|NCT01996241|515860485|FG001|Overall Study|Lost to Follow-up|235|||
143087897|NCT01811472|515860486|FG000|Overall Study|Adverse Event|1|||
143087898|NCT01811472|515860487|FG001|Overall Study|Adverse Event|0|||
143087899|NCT01811472|515860488|FG002|Overall Study|Adverse Event|4|||
143087900|NCT01811472|515860486|FG000|Overall Study|Lost to Follow-up|0|||
143087901|NCT01811472|515860487|FG001|Overall Study|Lost to Follow-up|0|||
143087902|NCT01811472|515860488|FG002|Overall Study|Lost to Follow-up|1|||
143087903|NCT01811472|515860486|FG000|Overall Study|Subject/guardian decision|1|||
143087904|NCT01811472|515860487|FG001|Overall Study|Subject/guardian decision|0|||
143087905|NCT01811472|515860488|FG002|Overall Study|Subject/guardian decision|0|||
143087906|NCT03288714|515860491|FG000|Overall Study|Lost to Follow-up|2|||
143087907|NCT03288714|515860492|FG001|Overall Study|Lost to Follow-up|1|||
143087908|NCT03288714|515860491|FG000|Overall Study|Non-compliance with study schedule|2|||
143087909|NCT03288714|515860492|FG001|Overall Study|Non-compliance with study schedule|0|||
143087910|NCT03288714|515860491|FG000|Overall Study|Withdrawal by Subject|3|||
143087911|NCT03288714|515860492|FG001|Overall Study|Withdrawal by Subject|1|||
143087912|NCT03288714|515860491|FG000|Overall Study|Clinical Worsening|2|||
143087913|NCT03288714|515860492|FG001|Overall Study|Clinical Worsening|1|||
143087914|NCT03288714|515860491|FG000|Overall Study|Adverse Event|1|||
143087915|NCT03288714|515860492|FG001|Overall Study|Adverse Event|0|||
143087916|NCT04882241|515860493|FG000|Overall Study|Ongoing in study|46|||
143087917|NCT04882241|515860494|FG001|Overall Study|Ongoing in study|48|||
143087918|NCT04882241|515860495|FG002|Overall Study|Ongoing in study|0|||
143087919|NCT04882241|515860496|FG003|Overall Study|Ongoing in study|0|||
143087920|NCT04882241|515860493|FG000|Overall Study|Death|13|||
143087921|NCT04882241|515860494|FG001|Overall Study|Death|13|||
143087922|NCT04882241|515860495|FG002|Overall Study|Death|0|||
143087923|NCT04882241|515860496|FG003|Overall Study|Death|0|||
143087924|NCT05024747|515860501|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
143087925|NCT05024747|515860502|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
143087926|NCT05024747|515860501|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
143087927|NCT05024747|515860502|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
143087928|NCT05024747|515860501|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
143087929|NCT05024747|515860502|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
143087930|NCT04428034|515860503|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
143087931|NCT02556801|515860504|FG000|Overall Study|Lost to Follow-up|1|||
143087932|NCT02556801|515860505|FG001|Overall Study|Lost to Follow-up|0|||
143087933|NCT02556801|515860506|FG002|Overall Study|Lost to Follow-up|2|||
143087934|NCT02556801|515860507|FG003|Overall Study|Lost to Follow-up|0|||
143087935|NCT02556801|515860504|FG000|Overall Study|Withdrawal by Subject|1|||
143087936|NCT02556801|515860505|FG001|Overall Study|Withdrawal by Subject|1|||
143087937|NCT02556801|515860506|FG002|Overall Study|Withdrawal by Subject|1|||
143087938|NCT02556801|515860507|FG003|Overall Study|Withdrawal by Subject|0|||
143087939|NCT02556801|515860504|FG000|Overall Study|Protocol Violation|0|||
143087940|NCT02556801|515860505|FG001|Overall Study|Protocol Violation|3|||
143087941|NCT02556801|515860506|FG002|Overall Study|Protocol Violation|1|||
143087942|NCT02556801|515860507|FG003|Overall Study|Protocol Violation|1|||
143087943|NCT02556801|515860504|FG000|Overall Study|Adverse Event|0|||
143087944|NCT02556801|515860505|FG001|Overall Study|Adverse Event|2|||
143087945|NCT02556801|515860506|FG002|Overall Study|Adverse Event|0|||
143087946|NCT02556801|515860507|FG003|Overall Study|Adverse Event|3|||
143087947|NCT02556801|515860504|FG000|Overall Study|Pregnancy|0|||
143087948|NCT02556801|515860505|FG001|Overall Study|Pregnancy|1|||
143087949|NCT02556801|515860506|FG002|Overall Study|Pregnancy|0|||
143087950|NCT02556801|515860507|FG003|Overall Study|Pregnancy|0|||
143087951|NCT02556801|515860504|FG000|Overall Study|Personal reasons patient|0|||
143087952|NCT02556801|515860505|FG001|Overall Study|Personal reasons patient|0|||
143087953|NCT02556801|515860506|FG002|Overall Study|Personal reasons patient|0|||
143087954|NCT02556801|515860507|FG003|Overall Study|Personal reasons patient|1|||
143087955|NCT01942993|515860508|FG000|Overall Study|Lost to Follow-up|1|||
143087956|NCT01942993|515860508|FG000|Overall Study|Physician Decision|1|||
143087957|NCT01350271|515860509|FG000|Overall Study|Lost to Follow-up|21|||
143087958|NCT01350271|515860510|FG001|Overall Study|Lost to Follow-up|17|||
143175640|NCT01847092|516192307|FG000|Overall Study|Protocol Specified|8|||
143175641|NCT01847092|516192308|FG001|Overall Study|Protocol Specified|0|||
143087959|NCT01350271|515860511|FG002|Overall Study|Lost to Follow-up|26|||
143087960|NCT02906670|515860515|FG000|Cohort 1, QW|Radiological Progression|1|||
143087961|NCT02906670|515860516|FG001|Cohort 1, QW|Radiological Progression|0|||
143087962|NCT02906670|515860517|FG002|Cohort 1, QW|Radiological Progression|0|||
143087963|NCT02906670|515860518|FG003|Cohort 1, QW|Radiological Progression|0|||
143087964|NCT02906670|515860519|FG004|Cohort 1, QW|Radiological Progression|0|||
143175642|NCT01847092|516192307|FG000|Overall Study|Physician Decision|1|||
143175643|NCT01847092|516192308|FG001|Overall Study|Physician Decision|1|||
143087965|NCT02906670|515860520|FG005|Cohort 1, QW|Radiological Progression|0|||
143087966|NCT02906670|515860521|FG006|Cohort 1, QW|Radiological Progression|0|||
143087967|NCT02906670|515860522|FG007|Cohort 1, QW|Radiological Progression|0|||
143087968|NCT02906670|515860523|FG008|Cohort 1, QW|Radiological Progression|0|||
143087969|NCT02906670|515860524|FG009|Cohort 1, QW|Radiological Progression|0|||
143087970|NCT02906670|515860515|FG000|Cohort 2, QW|Radiological Progression|0|||
143087971|NCT02906670|515860516|FG001|Cohort 2, QW|Radiological Progression|1|||
143087972|NCT02906670|515860517|FG002|Cohort 2, QW|Radiological Progression|0|||
143087973|NCT02906670|515860518|FG003|Cohort 2, QW|Radiological Progression|0|||
143087974|NCT02906670|515860519|FG004|Cohort 2, QW|Radiological Progression|0|||
143087975|NCT02906670|515860520|FG005|Cohort 2, QW|Radiological Progression|0|||
143087976|NCT02906670|515860521|FG006|Cohort 2, QW|Radiological Progression|0|||
143087977|NCT02906670|515860522|FG007|Cohort 2, QW|Radiological Progression|0|||
143087978|NCT02906670|515860523|FG008|Cohort 2, QW|Radiological Progression|0|||
143087979|NCT02906670|515860524|FG009|Cohort 2, QW|Radiological Progression|0|||
143087980|NCT02906670|515860515|FG000|Cohort 3, QW|Radiological Progression|0|||
143087981|NCT02906670|515860516|FG001|Cohort 3, QW|Radiological Progression|0|||
143087982|NCT02906670|515860517|FG002|Cohort 3, QW|Radiological Progression|2|||
143087983|NCT02906670|515860518|FG003|Cohort 3, QW|Radiological Progression|0|||
143087984|NCT02906670|515860519|FG004|Cohort 3, QW|Radiological Progression|0|||
143087985|NCT02906670|515860520|FG005|Cohort 3, QW|Radiological Progression|0|||
143087986|NCT02906670|515860521|FG006|Cohort 3, QW|Radiological Progression|0|||
143175644|NCT01847092|516192307|FG000|Overall Study|Protocol Violation|0|||
143175645|NCT01847092|516192308|FG001|Overall Study|Protocol Violation|2|||
143087987|NCT02906670|515860522|FG007|Cohort 3, QW|Radiological Progression|0|||
143087988|NCT02906670|515860523|FG008|Cohort 3, QW|Radiological Progression|0|||
143087989|NCT02906670|515860524|FG009|Cohort 3, QW|Radiological Progression|0|||
143175646|NCT03604497|516192310|FG000|Overall Study|Protocol Violation|52|||
143175647|NCT00811954|516192311|FG000|Overall Study|Death|10|||
143175648|NCT00811954|516192312|FG001|Overall Study|Death|6|||
143250494|NCT04556383|516471243|FG000|PCP|Adverse Event|1|||
143250495|NCT04556383|516471244|FG001|PCP|Adverse Event|7|||
143250496|NCT04556383|516471245|FG002|PCP|Adverse Event|7|||
143250497|NCT04556383|516471246|FG003|PCP|Adverse Event|0|||
143087990|NCT02906670|515860515|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
143250498|NCT04556383|516471243|FG000|PCP|Other, Not Specified|1|||
143087991|NCT02906670|515860516|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
143087992|NCT02906670|515860517|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
143087993|NCT02906670|515860518|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
143087994|NCT02906670|515860519|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
143087995|NCT02906670|515860520|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
143087996|NCT02906670|515860521|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
143087997|NCT02906670|515860522|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
143087998|NCT02906670|515860523|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
143087999|NCT02906670|515860524|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
143088000|NCT02906670|515860515|FG000|Cohort 4, Q2W|Radiological Progression|0|||
143088001|NCT02906670|515860516|FG001|Cohort 4, Q2W|Radiological Progression|0|||
143088002|NCT02906670|515860517|FG002|Cohort 4, Q2W|Radiological Progression|0|||
143088003|NCT02906670|515860518|FG003|Cohort 4, Q2W|Radiological Progression|0|||
143088004|NCT02906670|515860519|FG004|Cohort 4, Q2W|Radiological Progression|0|||
143088005|NCT02906670|515860520|FG005|Cohort 4, Q2W|Radiological Progression|1|||
143088006|NCT02906670|515860521|FG006|Cohort 4, Q2W|Radiological Progression|0|||
143088007|NCT02906670|515860522|FG007|Cohort 4, Q2W|Radiological Progression|0|||
143088008|NCT02906670|515860523|FG008|Cohort 4, Q2W|Radiological Progression|0|||
143088009|NCT02906670|515860524|FG009|Cohort 4, Q2W|Radiological Progression|0|||
143088010|NCT02906670|515860515|FG000|Cohort 4, Q2W|Clinical Progression|0|||
143088011|NCT02906670|515860516|FG001|Cohort 4, Q2W|Clinical Progression|0|||
143088012|NCT02906670|515860517|FG002|Cohort 4, Q2W|Clinical Progression|0|||
143088013|NCT02906670|515860518|FG003|Cohort 4, Q2W|Clinical Progression|0|||
143088014|NCT02906670|515860519|FG004|Cohort 4, Q2W|Clinical Progression|0|||
143088015|NCT02906670|515860520|FG005|Cohort 4, Q2W|Clinical Progression|2|||
143088016|NCT02906670|515860521|FG006|Cohort 4, Q2W|Clinical Progression|0|||
143088017|NCT02906670|515860522|FG007|Cohort 4, Q2W|Clinical Progression|0|||
143088018|NCT02906670|515860523|FG008|Cohort 4, Q2W|Clinical Progression|0|||
143088019|NCT02906670|515860524|FG009|Cohort 4, Q2W|Clinical Progression|0|||
143088020|NCT02906670|515860515|FG000|Cohort 5, Q2W|Radiological Progression|0|||
143088021|NCT02906670|515860516|FG001|Cohort 5, Q2W|Radiological Progression|0|||
143088022|NCT02906670|515860517|FG002|Cohort 5, Q2W|Radiological Progression|0|||
143250499|NCT04556383|516471244|FG001|PCP|Other, Not Specified|2|||
143250500|NCT04556383|516471245|FG002|PCP|Other, Not Specified|1|||
143250501|NCT04556383|516471246|FG003|PCP|Other, Not Specified|0|||
143250502|NCT04556383|516471243|FG000|PCP|Protocol Violation|1|||
143250503|NCT04556383|516471244|FG001|PCP|Protocol Violation|0|||
143250504|NCT04556383|516471245|FG002|PCP|Protocol Violation|1|||
143250505|NCT04556383|516471246|FG003|PCP|Protocol Violation|0|||
143250506|NCT04556383|516471243|FG000|PCP|Lost to Follow-up|1|||
143250507|NCT04556383|516471244|FG001|PCP|Lost to Follow-up|0|||
143250508|NCT04556383|516471245|FG002|PCP|Lost to Follow-up|0|||
143250509|NCT04556383|516471246|FG003|PCP|Lost to Follow-up|0|||
143250510|NCT04556383|516471243|FG000|PCP|Physician Decision|0|||
143250511|NCT04556383|516471244|FG001|PCP|Physician Decision|1|||
143250512|NCT04556383|516471245|FG002|PCP|Physician Decision|0|||
143250513|NCT04556383|516471246|FG003|PCP|Physician Decision|0|||
143250514|NCT04556383|516471243|FG000|PCP|Site terminated by sponsor|0|||
143250515|NCT04556383|516471244|FG001|PCP|Site terminated by sponsor|1|||
143250516|NCT04556383|516471245|FG002|PCP|Site terminated by sponsor|0|||
143250517|NCT04556383|516471246|FG003|PCP|Site terminated by sponsor|0|||
143250518|NCT04556383|516471243|FG000|OLE|Study terminated by sponsor|0|||
143250519|NCT04556383|516471244|FG001|OLE|Study terminated by sponsor|0|||
143088023|NCT02906670|515860518|FG003|Cohort 5, Q2W|Radiological Progression|0|||
143250520|NCT04556383|516471245|FG002|OLE|Study terminated by sponsor|0|||
143250521|NCT04556383|516471246|FG003|OLE|Study terminated by sponsor|68|||
143250522|NCT04556383|516471243|FG000|OLE|Withdrawal by Subject|0|||
143250523|NCT04556383|516471244|FG001|OLE|Withdrawal by Subject|0|||
143250524|NCT04556383|516471245|FG002|OLE|Withdrawal by Subject|0|||
143250525|NCT04556383|516471246|FG003|OLE|Withdrawal by Subject|10|||
143088024|NCT02906670|515860519|FG004|Cohort 5, Q2W|Radiological Progression|0|||
143088025|NCT02906670|515860520|FG005|Cohort 5, Q2W|Radiological Progression|0|||
143088026|NCT02906670|515860521|FG006|Cohort 5, Q2W|Radiological Progression|4|||
143250526|NCT04556383|516471243|FG000|OLE|Lack of Efficacy|0|||
143250527|NCT04556383|516471244|FG001|OLE|Lack of Efficacy|0|||
143250528|NCT04556383|516471245|FG002|OLE|Lack of Efficacy|0|||
143250529|NCT04556383|516471246|FG003|OLE|Lack of Efficacy|7|||
143250530|NCT04556383|516471243|FG000|OLE|Adverse Event|0|||
143088027|NCT02906670|515860522|FG007|Cohort 5, Q2W|Radiological Progression|0|||
143088028|NCT02906670|515860523|FG008|Cohort 5, Q2W|Radiological Progression|0|||
143250531|NCT04556383|516471244|FG001|OLE|Adverse Event|0|||
143250532|NCT04556383|516471245|FG002|OLE|Adverse Event|0|||
143250533|NCT04556383|516471246|FG003|OLE|Adverse Event|2|||
143250534|NCT04556383|516471243|FG000|OLE|Other, Not Specified|0|||
143250535|NCT04556383|516471244|FG001|OLE|Other, Not Specified|0|||
143088029|NCT02906670|515860524|FG009|Cohort 5, Q2W|Radiological Progression|0|||
143088030|NCT02906670|515860515|FG000|Cohort 5, Q2W|Clinical Progression|0|||
143088031|NCT02906670|515860516|FG001|Cohort 5, Q2W|Clinical Progression|0|||
143088032|NCT02906670|515860517|FG002|Cohort 5, Q2W|Clinical Progression|0|||
143088033|NCT02906670|515860518|FG003|Cohort 5, Q2W|Clinical Progression|0|||
143088034|NCT02906670|515860519|FG004|Cohort 5, Q2W|Clinical Progression|0|||
143088035|NCT02906670|515860520|FG005|Cohort 5, Q2W|Clinical Progression|0|||
143088036|NCT02906670|515860521|FG006|Cohort 5, Q2W|Clinical Progression|1|||
143088037|NCT02906670|515860522|FG007|Cohort 5, Q2W|Clinical Progression|0|||
143088038|NCT02906670|515860523|FG008|Cohort 5, Q2W|Clinical Progression|0|||
143088039|NCT02906670|515860524|FG009|Cohort 5, Q2W|Clinical Progression|0|||
143088040|NCT02906670|515860515|FG000|Cohort 5, Q2W|Adverse Event|0|||
143088041|NCT02906670|515860516|FG001|Cohort 5, Q2W|Adverse Event|0|||
143088042|NCT02906670|515860517|FG002|Cohort 5, Q2W|Adverse Event|0|||
143088043|NCT02906670|515860518|FG003|Cohort 5, Q2W|Adverse Event|0|||
143088044|NCT02906670|515860519|FG004|Cohort 5, Q2W|Adverse Event|0|||
143088045|NCT02906670|515860520|FG005|Cohort 5, Q2W|Adverse Event|0|||
143088046|NCT02906670|515860521|FG006|Cohort 5, Q2W|Adverse Event|1|||
143088047|NCT02906670|515860522|FG007|Cohort 5, Q2W|Adverse Event|0|||
143088048|NCT02906670|515860523|FG008|Cohort 5, Q2W|Adverse Event|0|||
143088049|NCT02906670|515860524|FG009|Cohort 5, Q2W|Adverse Event|0|||
143088050|NCT02906670|515860515|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
143088051|NCT02906670|515860516|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
143088052|NCT02906670|515860517|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
143088053|NCT02906670|515860518|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
143088054|NCT02906670|515860519|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
143088055|NCT02906670|515860520|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
143088056|NCT02906670|515860521|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
143088057|NCT02906670|515860522|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
143088058|NCT02906670|515860523|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
143088059|NCT02906670|515860524|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
143088060|NCT02906670|515860515|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
143088061|NCT02906670|515860516|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
143088062|NCT02906670|515860517|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
143088063|NCT02906670|515860518|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
143088064|NCT02906670|515860519|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
143088065|NCT02906670|515860520|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
143088066|NCT02906670|515860521|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
143088067|NCT02906670|515860522|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
143088068|NCT02906670|515860523|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
143088069|NCT02906670|515860524|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
143088070|NCT02906670|515860515|FG000|Cohort 5P, Q2W|Adverse Event|0|||
143088071|NCT02906670|515860516|FG001|Cohort 5P, Q2W|Adverse Event|0|||
143088072|NCT02906670|515860517|FG002|Cohort 5P, Q2W|Adverse Event|0|||
143088073|NCT02906670|515860518|FG003|Cohort 5P, Q2W|Adverse Event|0|||
143088074|NCT02906670|515860519|FG004|Cohort 5P, Q2W|Adverse Event|0|||
143088075|NCT02906670|515860520|FG005|Cohort 5P, Q2W|Adverse Event|0|||
143088076|NCT02906670|515860521|FG006|Cohort 5P, Q2W|Adverse Event|0|||
143088077|NCT02906670|515860522|FG007|Cohort 5P, Q2W|Adverse Event|1|||
143088078|NCT02906670|515860523|FG008|Cohort 5P, Q2W|Adverse Event|0|||
143088079|NCT02906670|515860524|FG009|Cohort 5P, Q2W|Adverse Event|0|||
143088080|NCT02906670|515860515|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
143088081|NCT02906670|515860516|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
143088082|NCT02906670|515860517|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
143088083|NCT02906670|515860518|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
143088084|NCT02906670|515860519|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
143088085|NCT02906670|515860520|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
143088086|NCT02906670|515860521|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
143088087|NCT02906670|515860522|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
143088088|NCT02906670|515860523|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
143088089|NCT02906670|515860524|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
143088090|NCT02906670|515860515|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
143088091|NCT02906670|515860516|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
143088092|NCT02906670|515860517|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
143088093|NCT02906670|515860518|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
143088094|NCT02906670|515860519|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
143088095|NCT02906670|515860520|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
143088096|NCT02906670|515860521|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
143088097|NCT02906670|515860522|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
143088098|NCT02906670|515860523|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
143088099|NCT02906670|515860524|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
143088100|NCT02906670|515860515|FG000|Cohort 4P, QW|Radiological Progression|0|||
143088101|NCT02906670|515860516|FG001|Cohort 4P, QW|Radiological Progression|0|||
143088102|NCT02906670|515860517|FG002|Cohort 4P, QW|Radiological Progression|0|||
143088103|NCT02906670|515860518|FG003|Cohort 4P, QW|Radiological Progression|3|||
143088104|NCT02906670|515860519|FG004|Cohort 4P, QW|Radiological Progression|0|||
143088105|NCT02906670|515860520|FG005|Cohort 4P, QW|Radiological Progression|0|||
143088106|NCT02906670|515860521|FG006|Cohort 4P, QW|Radiological Progression|0|||
143088107|NCT02906670|515860522|FG007|Cohort 4P, QW|Radiological Progression|0|||
143088108|NCT02906670|515860523|FG008|Cohort 4P, QW|Radiological Progression|0|||
143088109|NCT02906670|515860524|FG009|Cohort 4P, QW|Radiological Progression|0|||
143088110|NCT02906670|515860515|FG000|Cohort 7P, Q2W|Adverse Event|0|||
143088111|NCT02906670|515860516|FG001|Cohort 7P, Q2W|Adverse Event|0|||
143088112|NCT02906670|515860517|FG002|Cohort 7P, Q2W|Adverse Event|0|||
143088113|NCT02906670|515860518|FG003|Cohort 7P, Q2W|Adverse Event|0|||
143088114|NCT02906670|515860519|FG004|Cohort 7P, Q2W|Adverse Event|0|||
143088115|NCT02906670|515860520|FG005|Cohort 7P, Q2W|Adverse Event|0|||
143088116|NCT02906670|515860521|FG006|Cohort 7P, Q2W|Adverse Event|0|||
143088117|NCT02906670|515860522|FG007|Cohort 7P, Q2W|Adverse Event|0|||
143088118|NCT02906670|515860523|FG008|Cohort 7P, Q2W|Adverse Event|0|||
143088119|NCT02906670|515860524|FG009|Cohort 7P, Q2W|Adverse Event|1|||
143088120|NCT02906670|515860515|FG000|Cohort 7P, Q2W|Physician Decision|0|||
143088121|NCT02906670|515860516|FG001|Cohort 7P, Q2W|Physician Decision|0|||
143088122|NCT02906670|515860517|FG002|Cohort 7P, Q2W|Physician Decision|0|||
143088123|NCT02906670|515860518|FG003|Cohort 7P, Q2W|Physician Decision|0|||
143088124|NCT02906670|515860519|FG004|Cohort 7P, Q2W|Physician Decision|0|||
143088125|NCT02906670|515860520|FG005|Cohort 7P, Q2W|Physician Decision|0|||
143088126|NCT02906670|515860521|FG006|Cohort 7P, Q2W|Physician Decision|0|||
143088127|NCT02906670|515860522|FG007|Cohort 7P, Q2W|Physician Decision|0|||
143088128|NCT02906670|515860523|FG008|Cohort 7P, Q2W|Physician Decision|0|||
143088129|NCT02906670|515860524|FG009|Cohort 7P, Q2W|Physician Decision|1|||
143088130|NCT02906670|515860515|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
143088131|NCT02906670|515860516|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
143088132|NCT02906670|515860517|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
143088133|NCT02906670|515860518|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
143088134|NCT02906670|515860519|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
143088135|NCT02906670|515860520|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
143088136|NCT02906670|515860521|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
143088137|NCT02906670|515860522|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
143088138|NCT02906670|515860523|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
143088139|NCT02906670|515860524|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
143088140|NCT02906670|515860515|FG000|Cohort 5P, QW|Radiological Progression|0|||
143088141|NCT02906670|515860516|FG001|Cohort 5P, QW|Radiological Progression|0|||
143088142|NCT02906670|515860517|FG002|Cohort 5P, QW|Radiological Progression|0|||
143088143|NCT02906670|515860518|FG003|Cohort 5P, QW|Radiological Progression|0|||
143088144|NCT02906670|515860519|FG004|Cohort 5P, QW|Radiological Progression|3|||
143088145|NCT02906670|515860520|FG005|Cohort 5P, QW|Radiological Progression|0|||
143088146|NCT02906670|515860521|FG006|Cohort 5P, QW|Radiological Progression|0|||
143088147|NCT02906670|515860522|FG007|Cohort 5P, QW|Radiological Progression|0|||
143088148|NCT02906670|515860523|FG008|Cohort 5P, QW|Radiological Progression|0|||
143088149|NCT02906670|515860524|FG009|Cohort 5P, QW|Radiological Progression|0|||
143088150|NCT01349192|515860525|FG000|Overall Study|Protocol Violation|0|||
143088151|NCT01349192|515860526|FG001|Overall Study|Protocol Violation|1|||
143088152|NCT01349192|515860525|FG000|Overall Study|Withdrawal by Subject|0|||
143088153|NCT01349192|515860526|FG001|Overall Study|Withdrawal by Subject|2|||
143088154|NCT01349192|515860525|FG000|Overall Study|Lost to Follow-up|1|||
143088155|NCT01349192|515860526|FG001|Overall Study|Lost to Follow-up|3|||
143088156|NCT01349192|515860525|FG000|Overall Study|Failure to adhere to Protocol|2|||
143088157|NCT01349192|515860526|FG001|Overall Study|Failure to adhere to Protocol|0|||
143088158|NCT01973439|515860527|FG000|Overall Study|Lost samples from one PK Day|2|||
143088159|NCT01973439|515860527|FG000|Overall Study|Vomiting after commencing once daily|1|||
143088160|NCT01973439|515860527|FG000|Overall Study|PK curve incomplete|2|||
143088161|NCT02038010|515860528|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
143088162|NCT02038010|515860529|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
143088163|NCT02038010|515860530|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
143088164|NCT02038010|515860531|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
143088165|NCT02038010|515860528|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
143088166|NCT02038010|515860529|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
143088167|NCT02038010|515860530|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
143088168|NCT02038010|515860531|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
143088169|NCT02038010|515860528|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
143088170|NCT02038010|515860529|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
143175649|NCT00811954|516192313|FG002|Overall Study|Death|13|||
143088171|NCT02038010|515860530|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
143088172|NCT02038010|515860531|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
143088173|NCT02038010|515860528|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
143088174|NCT02038010|515860529|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
143088175|NCT02038010|515860530|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
143088176|NCT02038010|515860531|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
143088177|NCT02038010|515860528|FG000|Follow Up|Death|4|||
143088178|NCT02038010|515860529|FG001|Follow Up|Death|3|||
143088179|NCT02038010|515860530|FG002|Follow Up|Death|0|||
143088180|NCT02038010|515860531|FG003|Follow Up|Death|0|||
143175650|NCT00811954|516192311|FG000|Overall Study|Lost to Follow-up|29|||
143088181|NCT02038010|515860528|FG000|Follow Up|Other|3|||
143088182|NCT02038010|515860529|FG001|Follow Up|Other|0|||
143088183|NCT02038010|515860530|FG002|Follow Up|Other|0|||
143088184|NCT02038010|515860531|FG003|Follow Up|Other|0|||
143088185|NCT03908125|515860536|FG000|Overall Study|Withdrawal by Subject|92|||
143088186|NCT03908125|515860536|FG000|Overall Study|Lost to Follow-up|8|||
143088187|NCT02262325|515860537|FG000|Overall Study|Death|16|||
143088188|NCT02262325|515860537|FG000|Overall Study|Lost to Follow-up|1|||
143088189|NCT02815995|515860538|FG000|Overall Study|Disease Progression|3|||
143088190|NCT02815995|515860539|FG001|Overall Study|Disease Progression|7|||
143175651|NCT00811954|516192312|FG001|Overall Study|Lost to Follow-up|23|||
143088191|NCT02815995|515860540|FG002|Overall Study|Disease Progression|2|||
143088192|NCT02815995|515860541|FG003|Overall Study|Disease Progression|4|||
143088193|NCT02815995|515860542|FG004|Overall Study|Disease Progression|3|||
143088194|NCT02815995|515860543|FG005|Overall Study|Disease Progression|9|||
143088195|NCT02815995|515860544|FG006|Overall Study|Disease Progression|3|||
143088196|NCT02815995|515860545|FG007|Overall Study|Disease Progression|1|||
143088197|NCT02815995|515860538|FG000|Overall Study|Adverse Event|1|||
143088198|NCT02815995|515860539|FG001|Overall Study|Adverse Event|2|||
143088199|NCT02815995|515860540|FG002|Overall Study|Adverse Event|2|||
143088200|NCT02815995|515860541|FG003|Overall Study|Adverse Event|0|||
143088201|NCT02815995|515860542|FG004|Overall Study|Adverse Event|0|||
143088202|NCT02815995|515860543|FG005|Overall Study|Adverse Event|1|||
143088203|NCT02815995|515860544|FG006|Overall Study|Adverse Event|0|||
143088204|NCT02815995|515860545|FG007|Overall Study|Adverse Event|0|||
143088205|NCT02815995|515860538|FG000|Overall Study|Pregnancy|0|||
143088206|NCT02815995|515860539|FG001|Overall Study|Pregnancy|0|||
143088207|NCT02815995|515860540|FG002|Overall Study|Pregnancy|0|||
143088208|NCT02815995|515860541|FG003|Overall Study|Pregnancy|0|||
143088209|NCT02815995|515860542|FG004|Overall Study|Pregnancy|0|||
143088210|NCT02815995|515860543|FG005|Overall Study|Pregnancy|0|||
143088211|NCT02815995|515860544|FG006|Overall Study|Pregnancy|1|||
143088212|NCT02815995|515860545|FG007|Overall Study|Pregnancy|0|||
143088213|NCT01071915|515860546|FG000|Overall Study|Adverse Event|3|||
143088214|NCT01071915|515860546|FG000|Overall Study|Physician Decision|2|||
143088215|NCT01071915|515860546|FG000|Overall Study|Withdrawal by Subject|2|||
143088216|NCT01071915|515860546|FG000|Overall Study|Miscellaneous Reasons|2|||
143088217|NCT00114140|515860547|FG000|Overall Study|Protocol Violation|7|||
143175652|NCT00811954|516192313|FG002|Overall Study|Lost to Follow-up|34|||
143175653|NCT00811954|516192311|FG000|Overall Study|Not able to get to clinic|28|||
143175654|NCT00811954|516192312|FG001|Overall Study|Not able to get to clinic|35|||
143088218|NCT03076775|515860550|FG000|Overall Study|Lost to Follow-up|1|||
143175655|NCT00811954|516192313|FG002|Overall Study|Not able to get to clinic|30|||
143088219|NCT03076775|515860551|FG001|Overall Study|Lost to Follow-up|0|||
143088220|NCT01783886|515860552|FG000|Overall Study|Lost to Follow-up|0|||
143088221|NCT01783886|515860553|FG001|Overall Study|Lost to Follow-up|3|||
143088222|NCT01783886|515860554|FG002|Overall Study|Lost to Follow-up|0|||
143088223|NCT01783886|515860552|FG000|Overall Study|Protocol deviation|0|||
143088224|NCT01783886|515860553|FG001|Overall Study|Protocol deviation|0|||
143088225|NCT01783886|515860554|FG002|Overall Study|Protocol deviation|2|||
143088226|NCT01783886|515860552|FG000|Overall Study|Withdrawal of consent by participant|1|||
143088227|NCT01783886|515860553|FG001|Overall Study|Withdrawal of consent by participant|3|||
143088228|NCT01783886|515860554|FG002|Overall Study|Withdrawal of consent by participant|4|||
143088229|NCT01783886|515860552|FG000|Overall Study|Adverse Event|4|||
143088230|NCT01783886|515860553|FG001|Overall Study|Adverse Event|5|||
143088231|NCT01783886|515860554|FG002|Overall Study|Adverse Event|4|||
143088232|NCT04542057|515860555|FG000|Overall Study|Death|3|||
143088233|NCT04542057|515860556|FG001|Overall Study|Death|1|||
143088234|NCT04542057|515860555|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
143088235|NCT04542057|515860556|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
143088236|NCT04542057|515860555|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
143088237|NCT04542057|515860556|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
143088238|NCT04542057|515860555|FG000|Overall Study|Adverse Event|15|||
143088239|NCT04542057|515860556|FG001|Overall Study|Adverse Event|6|||
143088240|NCT04542057|515860555|FG000|Overall Study|COVID-19 adverse event|6|||
143088241|NCT04542057|515860556|FG001|Overall Study|COVID-19 adverse event|4|||
143088242|NCT04542057|515860555|FG000|Overall Study|Lack of Efficacy|2|||
143088243|NCT04542057|515860556|FG001|Overall Study|Lack of Efficacy|5|||
143088244|NCT04542057|515860555|FG000|Overall Study|Study terminated by sponsor|1|||
143088245|NCT04542057|515860556|FG001|Overall Study|Study terminated by sponsor|0|||
143088246|NCT04542057|515860555|FG000|Overall Study|Investigator discretion|2|||
143088247|NCT04542057|515860556|FG001|Overall Study|Investigator discretion|1|||
143088248|NCT04542057|515860555|FG000|Overall Study|Withdrawal by Subject|52|||
143088249|NCT04542057|515860556|FG001|Overall Study|Withdrawal by Subject|30|||
143088250|NCT04542057|515860555|FG000|Overall Study|Lost to Follow-up|8|||
143088251|NCT04542057|515860556|FG001|Overall Study|Lost to Follow-up|11|||
143088252|NCT04542057|515860555|FG000|Overall Study|Other|2|||
143088253|NCT04542057|515860556|FG001|Overall Study|Other|2|||
143088254|NCT00104572|515860557|FG000|Overall Study|Withdrawal by Subject|3|||
143088255|NCT00104572|515860558|FG001|Overall Study|Withdrawal by Subject|3|||
143088256|NCT00104572|515860559|FG002|Overall Study|Withdrawal by Subject|0|||
143367113|NCT01467700|516887250|FG000|Overall Study|Voluntary Withdrawal|5|||
143367114|NCT01467700|516887251|FG001|Overall Study|Voluntary Withdrawal|7|||
143088257|NCT00940316|515860562|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
143088258|NCT00940316|515860563|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
143088259|NCT00940316|515860564|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
143088260|NCT00940316|515860562|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
143088261|NCT00940316|515860563|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
143088262|NCT00940316|515860564|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
143088263|NCT00940316|515860562|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
143088264|NCT00940316|515860563|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
143088265|NCT00940316|515860564|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
143088266|NCT00940316|515860562|FG000|Treated After Cycle 5|Adverse Event|0|||
143088267|NCT00940316|515860563|FG001|Treated After Cycle 5|Adverse Event|0|||
143088268|NCT00940316|515860564|FG002|Treated After Cycle 5|Adverse Event|1|||
143088269|NCT00940316|515860562|FG000|Treated After Cycle 5|Progressive disease|0|||
143088270|NCT00940316|515860563|FG001|Treated After Cycle 5|Progressive disease|1|||
143088271|NCT00940316|515860564|FG002|Treated After Cycle 5|Progressive disease|0|||
143088272|NCT02324582|515860566|FG000|Overall Study|Screen Failures|0|||
143088273|NCT02324582|515860567|FG001|Overall Study|Screen Failures|5|||
143088274|NCT00770328|515860579|FG000|Overall Study|Adverse Event|11|||
143088275|NCT00770328|515860580|FG001|Overall Study|Adverse Event|2|||
143088276|NCT00770328|515860579|FG000|Overall Study|Lost to Follow-up|2|||
143088277|NCT00770328|515860580|FG001|Overall Study|Lost to Follow-up|2|||
143088278|NCT03164616|515860583|FG000|Overall Study|Death|250|||
143088279|NCT03164616|515860584|FG001|Overall Study|Death|264|||
143088280|NCT03164616|515860585|FG002|Overall Study|Death|279|||
143088281|NCT03164616|515860583|FG000|Overall Study|Lost to Follow-up|2|||
143088282|NCT03164616|515860584|FG001|Overall Study|Lost to Follow-up|2|||
143088283|NCT03164616|515860585|FG002|Overall Study|Lost to Follow-up|2|||
143088284|NCT03164616|515860583|FG000|Overall Study|Withdrawal by Subject|6|||
143088285|NCT03164616|515860584|FG001|Overall Study|Withdrawal by Subject|7|||
143088286|NCT03164616|515860585|FG002|Overall Study|Withdrawal by Subject|16|||
143088287|NCT00111241|515860589|FG000|Overall Study|Lost to Follow-up|1|||
143088288|NCT00111241|515860590|FG001|Overall Study|Lost to Follow-up|0|||
143088289|NCT00111241|515860589|FG000|Overall Study|Withdrawal by Subject|4|||
143088290|NCT00111241|515860590|FG001|Overall Study|Withdrawal by Subject|0|||
143088291|NCT00111241|515860589|FG000|Overall Study|Protocol Violation|9|||
143088292|NCT00111241|515860590|FG001|Overall Study|Protocol Violation|8|||
143088293|NCT00111241|515860589|FG000|Overall Study|Adverse Event|1|||
143088294|NCT00111241|515860590|FG001|Overall Study|Adverse Event|0|||
143088295|NCT04502212|515860591|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
143088296|NCT04502212|515860591|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
143088297|NCT00952731|515860608|FG000|Overall Study|Drug supply expired|1|||
143088298|NCT00952731|515860609|FG001|Overall Study|Drug supply expired|0|||
143088299|NCT01449812|515860610|FG000|Overall Study|Migrated/moved from study area|1|||
143088300|NCT01449812|515860611|FG001|Overall Study|Migrated/moved from study area|0|||
143088301|NCT01449812|515860612|FG002|Overall Study|Migrated/moved from study area|0|||
143088302|NCT01449812|515860610|FG000|Overall Study|Withdrawal by Subject|0|||
143088303|NCT01449812|515860611|FG001|Overall Study|Withdrawal by Subject|0|||
143088304|NCT01449812|515860612|FG002|Overall Study|Withdrawal by Subject|1|||
143088305|NCT01449812|515860610|FG000|Overall Study|Lost to Follow-up|1|||
143088306|NCT01449812|515860611|FG001|Overall Study|Lost to Follow-up|0|||
143088307|NCT01449812|515860612|FG002|Overall Study|Lost to Follow-up|0|||
143088308|NCT03180645|515860614|FG000|Overall Study|Adverse Event|0|||
143088309|NCT03180645|515860615|FG001|Overall Study|Adverse Event|1|||
143088310|NCT03180645|515860616|FG002|Overall Study|Adverse Event|2|||
143175656|NCT00811954|516192311|FG000|Overall Study|Not willing to adhere to requirements|12|||
143175657|NCT00811954|516192312|FG001|Overall Study|Not willing to adhere to requirements|2|||
143175658|NCT00811954|516192313|FG002|Overall Study|Not willing to adhere to requirements|16|||
143175659|NCT00811954|516192311|FG000|Overall Study|Withdraw consent prior study completion|4|||
143175660|NCT00811954|516192312|FG001|Overall Study|Withdraw consent prior study completion|6|||
143175661|NCT00811954|516192313|FG002|Overall Study|Withdraw consent prior study completion|5|||
143175662|NCT00811954|516192311|FG000|Overall Study|Site Closure|4|||
143175663|NCT00811954|516192312|FG001|Overall Study|Site Closure|0|||
143175664|NCT00811954|516192313|FG002|Overall Study|Site Closure|1|||
143175665|NCT00811954|516192311|FG000|Overall Study|Severe Debilitation|2|||
143175666|NCT00811954|516192312|FG001|Overall Study|Severe Debilitation|0|||
143175667|NCT00811954|516192313|FG002|Overall Study|Severe Debilitation|1|||
143175668|NCT00811954|516192311|FG000|Overall Study|Complete Protocol: No follow-up|0|||
143175669|NCT00811954|516192312|FG001|Overall Study|Complete Protocol: No follow-up|0|||
143175670|NCT00811954|516192313|FG002|Overall Study|Complete Protocol: No follow-up|1|||
143175671|NCT00186628|516192315|FG000|Overall Study|Death|2|||
143175672|NCT00186628|516192315|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
143250536|NCT04556383|516471245|FG002|OLE|Other, Not Specified|0|||
143088311|NCT00852202|515860621|FG000|Overall Study|Adverse Event|2|||
143088312|NCT00852202|515860622|FG001|Overall Study|Adverse Event|3|||
143088313|NCT00852202|515860623|FG002|Overall Study|Adverse Event|7|||
143088314|NCT00852202|515860621|FG000|Overall Study|Lack of Efficacy|4|||
143088315|NCT00852202|515860622|FG001|Overall Study|Lack of Efficacy|1|||
143175673|NCT01331681|516192316|FG000|Overall Study|Adverse Event|10|||
143175674|NCT01331681|516192317|FG001|Overall Study|Adverse Event|13|||
143175675|NCT01331681|516192318|FG002|Overall Study|Adverse Event|10|||
143250537|NCT04556383|516471246|FG003|OLE|Other, Not Specified|2|||
143088316|NCT00852202|515860623|FG002|Overall Study|Lack of Efficacy|2|||
143088317|NCT00852202|515860621|FG000|Overall Study|Protocol Violation|2|||
143088318|NCT00852202|515860622|FG001|Overall Study|Protocol Violation|2|||
143088319|NCT00852202|515860623|FG002|Overall Study|Protocol Violation|7|||
143088320|NCT00852202|515860621|FG000|Overall Study|Withdrawal by Subject|3|||
143088321|NCT00852202|515860622|FG001|Overall Study|Withdrawal by Subject|1|||
143088322|NCT00852202|515860623|FG002|Overall Study|Withdrawal by Subject|2|||
143088323|NCT00852202|515860621|FG000|Overall Study|Lost to Follow-up|5|||
143088324|NCT00852202|515860622|FG001|Overall Study|Lost to Follow-up|5|||
143088325|NCT00852202|515860623|FG002|Overall Study|Lost to Follow-up|6|||
143088326|NCT00852202|515860621|FG000|Overall Study|pregnancy,moving away and surgery|1|||
143088327|NCT00852202|515860622|FG001|Overall Study|pregnancy,moving away and surgery|0|||
143088328|NCT00852202|515860623|FG002|Overall Study|pregnancy,moving away and surgery|2|||
143088329|NCT01682811|515860626|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
143088330|NCT01682811|515860627|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
143088331|NCT01682811|515860628|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
143088332|NCT01682811|515860629|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
143088333|NCT01682811|515860630|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
143088334|NCT01682811|515860631|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
143088335|NCT01682811|515860632|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
143088336|NCT01682811|515860626|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
143088337|NCT01682811|515860627|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
143088338|NCT01682811|515860628|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
143088339|NCT01682811|515860629|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
143088340|NCT01682811|515860630|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
143088341|NCT01682811|515860631|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
143088342|NCT01682811|515860632|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
143088343|NCT01682811|515860626|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
143088344|NCT01682811|515860627|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
143088345|NCT01682811|515860628|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
143088346|NCT01682811|515860629|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
143088347|NCT01682811|515860630|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
143088348|NCT01682811|515860631|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
143088349|NCT01682811|515860632|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
143088350|NCT01682811|515860626|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
143088351|NCT01682811|515860627|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
143088352|NCT01682811|515860628|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
143088353|NCT01682811|515860629|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
143088354|NCT01682811|515860630|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
143088355|NCT01682811|515860631|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
143088356|NCT01682811|515860632|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
143088357|NCT06082843|515862709|FG000|Overall Study|Withdrawal by Subject|0|||
143088358|NCT06082843|515862710|FG001|Overall Study|Withdrawal by Subject|2|||
143088359|NCT06082843|515862709|FG000|Overall Study|Study terminated by sponsor|12|||
143088360|NCT06082843|515862710|FG001|Overall Study|Study terminated by sponsor|8|||
143088361|NCT05878093|515862714|FG000|Overall Study|Withdrawal by Subject|3|||
143088362|NCT05878093|515862715|FG001|Overall Study|Withdrawal by Subject|1|||
143088363|NCT04100018|515862719|FG000|Pre-Treatment Period|Not Reported|0|||
143088364|NCT04100018|515862720|FG001|Pre-Treatment Period|Not Reported|4|||
143088365|NCT04100018|515862719|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
143088366|NCT04100018|515862720|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
143088367|NCT04100018|515862719|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
143088368|NCT04100018|515862720|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
143088369|NCT04100018|515862719|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
143088370|NCT04100018|515862720|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
143088371|NCT04100018|515862719|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
143088372|NCT04100018|515862720|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
143088373|NCT04100018|515862719|FG000|Treatment Period|Ongoing Treatment|1|||
143088374|NCT04100018|515862720|FG001|Treatment Period|Ongoing Treatment|0|||
143088375|NCT04100018|515862719|FG000|Treatment Period|Other Reason|26|||
143088376|NCT04100018|515862720|FG001|Treatment Period|Other Reason|37|||
143088377|NCT04100018|515862719|FG000|Treatment Period|Completed treatment as per protocol|1|||
143088378|NCT04100018|515862720|FG001|Treatment Period|Completed treatment as per protocol|2|||
143088379|NCT04100018|515862719|FG000|Treatment Period|Maximum clinical benefit|3|||
143088380|NCT04100018|515862720|FG001|Treatment Period|Maximum clinical benefit|0|||
143088381|NCT04100018|515862719|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
143088382|NCT04100018|515862720|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
143175676|NCT01331681|516192316|FG000|Overall Study|Death|6|||
143175677|NCT01331681|516192317|FG001|Overall Study|Death|6|||
143175678|NCT01331681|516192318|FG002|Overall Study|Death|2|||
143175679|NCT01331681|516192316|FG000|Overall Study|Lack of Efficacy|0|||
143175680|NCT01331681|516192317|FG001|Overall Study|Lack of Efficacy|1|||
143175681|NCT01331681|516192318|FG002|Overall Study|Lack of Efficacy|0|||
143175682|NCT01331681|516192316|FG000|Overall Study|Withdrawal by Subject|12|||
143175683|NCT01331681|516192317|FG001|Overall Study|Withdrawal by Subject|8|||
143175684|NCT01331681|516192318|FG002|Overall Study|Withdrawal by Subject|15|||
143175685|NCT01331681|516192316|FG000|Overall Study|Protocol Violation|1|||
143175686|NCT01331681|516192317|FG001|Overall Study|Protocol Violation|1|||
143175687|NCT01331681|516192318|FG002|Overall Study|Protocol Violation|0|||
143175688|NCT01331681|516192316|FG000|Overall Study|Lost to Follow-up|2|||
143175689|NCT01331681|516192317|FG001|Overall Study|Lost to Follow-up|4|||
143175690|NCT01331681|516192318|FG002|Overall Study|Lost to Follow-up|1|||
143175691|NCT01331681|516192316|FG000|Overall Study|Physician Decision|2|||
143175692|NCT01331681|516192317|FG001|Overall Study|Physician Decision|0|||
143175693|NCT01331681|516192318|FG002|Overall Study|Physician Decision|4|||
143175694|NCT01331681|516192316|FG000|Overall Study|Therapeutic procedure required|1|||
143175695|NCT01331681|516192317|FG001|Overall Study|Therapeutic procedure required|0|||
143175696|NCT01331681|516192318|FG002|Overall Study|Therapeutic procedure required|0|||
143175697|NCT01331681|516192316|FG000|Overall Study|Sponsor decision|1|||
143175698|NCT01331681|516192317|FG001|Overall Study|Sponsor decision|1|||
143175699|NCT01331681|516192318|FG002|Overall Study|Sponsor decision|0|||
143175700|NCT01331681|516192316|FG000|Overall Study|Switching to other therapy|0|||
143175701|NCT01331681|516192317|FG001|Overall Study|Switching to other therapy|0|||
143175702|NCT01331681|516192318|FG002|Overall Study|Switching to other therapy|1|||
143175703|NCT01331681|516192316|FG000|Overall Study|Not Received Study Treatment|0|||
143175704|NCT01331681|516192317|FG001|Overall Study|Not Received Study Treatment|0|||
143175705|NCT01331681|516192318|FG002|Overall Study|Not Received Study Treatment|2|||
143175706|NCT00658541|516192323|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
143175707|NCT00658541|516192324|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
143175708|NCT00658541|516192323|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
143175709|NCT00658541|516192324|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
143175710|NCT00269087|516192325|FG000|Overall Study|Adverse Event|20|||
143175711|NCT00269087|516192325|FG000|Overall Study|Withdrawal by Subject|1|||
143175712|NCT00269087|516192325|FG000|Overall Study|Exacerbation of COPD|13|||
143175713|NCT04828707|516192328|FG000|Overall Study|Lost to Follow-up|3|||
143175714|NCT04828707|516192329|FG001|Overall Study|Lost to Follow-up|2|||
143175715|NCT04828707|516192328|FG000|Overall Study|Withdrawal by Subject|2|||
143175716|NCT04828707|516192329|FG001|Overall Study|Withdrawal by Subject|1|||
143175717|NCT02394561|516192335|FG000|CORE Phase|Adverse Event|7|||
143175718|NCT02394561|516192336|FG001|CORE Phase|Adverse Event|9|||
143175719|NCT02394561|516192335|FG000|CORE Phase|Death|0|||
143175720|NCT02394561|516192336|FG001|CORE Phase|Death|1|||
143175721|NCT02394561|516192335|FG000|CORE Phase|Pregnancy|1|||
143175722|NCT02394561|516192336|FG001|CORE Phase|Pregnancy|0|||
143175723|NCT02394561|516192335|FG000|CORE Phase|Lost to Follow-up|1|||
143175724|NCT02394561|516192336|FG001|CORE Phase|Lost to Follow-up|0|||
143175725|NCT02394561|516192335|FG000|CORE Phase|Physician Decision|1|||
143175726|NCT02394561|516192336|FG001|CORE Phase|Physician Decision|1|||
143175727|NCT02394561|516192335|FG000|CORE Phase|Withdrawal by Subject|2|||
143175728|NCT02394561|516192336|FG001|CORE Phase|Withdrawal by Subject|2|||
143175729|NCT02394561|516192335|FG000|CORE Phase|Lack of Efficacy|1|||
143175730|NCT02394561|516192336|FG001|CORE Phase|Lack of Efficacy|6|||
143175731|NCT02394561|516192335|FG000|Extension Phase|Adverse Event|6|||
143175732|NCT02394561|516192336|FG001|Extension Phase|Adverse Event|1|||
143175733|NCT02394561|516192335|FG000|Extension Phase|Death|0|||
143175734|NCT02394561|516192336|FG001|Extension Phase|Death|1|||
143175735|NCT02394561|516192335|FG000|Extension Phase|Protocol Violation|1|||
143175736|NCT02394561|516192336|FG001|Extension Phase|Protocol Violation|0|||
143175737|NCT02394561|516192335|FG000|Extension Phase|Lost to Follow-up|1|||
143175738|NCT02394561|516192336|FG001|Extension Phase|Lost to Follow-up|0|||
143175739|NCT02394561|516192335|FG000|Extension Phase|Physician Decision|0|||
143175740|NCT02394561|516192336|FG001|Extension Phase|Physician Decision|2|||
143175741|NCT02394561|516192335|FG000|Extension Phase|Withdrawal by Subject|0|||
143175742|NCT02394561|516192336|FG001|Extension Phase|Withdrawal by Subject|5|||
143175743|NCT02394561|516192335|FG000|Extension Phase|Lack of Efficacy|3|||
143175744|NCT02394561|516192336|FG001|Extension Phase|Lack of Efficacy|3|||
143175745|NCT02750930|516192337|FG000|Overall Study|Study closed/terminated|8|||
143175746|NCT02761642|516192338|FG000|Overall Study|Did not Receive Study Treatment|3|||
143250538|NCT04556383|516471243|FG000|OLE|Death|0|||
143250539|NCT04556383|516471244|FG001|OLE|Death|0|||
143250540|NCT04556383|516471245|FG002|OLE|Death|0|||
143175747|NCT02761642|516192338|FG000|Overall Study|Adverse Event|13|||
143175748|NCT02761642|516192338|FG000|Overall Study|Withdrawal by Subject|2|||
143175749|NCT02761642|516192338|FG000|Overall Study|Non-compliant|7|||
143175750|NCT02761642|516192338|FG000|Overall Study|Death|3|||
143175751|NCT02761642|516192338|FG000|Overall Study|Lack of Efficacy|20|||
143250541|NCT04556383|516471246|FG003|OLE|Death|1|||
143088383|NCT04100018|515862719|FG000|Treatment Period|Study drug toxicity|67|||
143088384|NCT04100018|515862720|FG001|Treatment Period|Study drug toxicity|28|||
143088385|NCT04100018|515862719|FG000|Treatment Period|Disease Progression|284|||
143088386|NCT04100018|515862720|FG001|Treatment Period|Disease Progression|327|||
143088387|NCT04100018|515862719|FG000|Treatment Period|Administrative reasons by sponsor|16|||
143088388|NCT04100018|515862720|FG001|Treatment Period|Administrative reasons by sponsor|30|||
143088389|NCT04100018|515862719|FG000|Treatment Period|Poor/Non-Compliance|1|||
143175752|NCT02761642|516192338|FG000|Overall Study|Physician Decision|1|||
143088390|NCT04100018|515862720|FG001|Treatment Period|Poor/Non-Compliance|0|||
143088391|NCT04100018|515862719|FG000|Treatment Period|Lost to Follow-up|2|||
143088392|NCT04100018|515862720|FG001|Treatment Period|Lost to Follow-up|2|||
143088393|NCT04100018|515862719|FG000|Treatment Period|Death|16|||
143088394|NCT04100018|515862720|FG001|Treatment Period|Death|11|||
143175753|NCT02761642|516192338|FG000|Overall Study|Reason Unspecified|21|||
143175754|NCT02756403|516192339|FG000|Overall Study|Unable to swallow medication|0|||
143088395|NCT04100018|515862719|FG000|Treatment Period|Participant withdrew consent|10|||
143088396|NCT04100018|515862720|FG001|Treatment Period|Participant withdrew consent|10|||
143088397|NCT04100018|515862719|FG000|Treatment Period|Participant request to discontinue study treatment|33|||
143088398|NCT04100018|515862720|FG001|Treatment Period|Participant request to discontinue study treatment|32|||
143088399|NCT04100018|515862719|FG000|Treatment Period|Adverse Event|14|||
143088400|NCT04100018|515862720|FG001|Treatment Period|Adverse Event|6|||
143088401|NCT04100018|515862719|FG000|Treatment Period|Lack of Efficacy|4|||
143088402|NCT04100018|515862720|FG001|Treatment Period|Lack of Efficacy|2|||
143088403|NCT03989102|515862721|FG000|Year 1|Withdrawal by Subject|6|||
143088404|NCT03989102|515862722|FG001|Year 1|Withdrawal by Subject|2|||
143088405|NCT03989102|515862723|FG002|Year 1|Withdrawal by Subject|7|||
143250542|NCT04556383|516471243|FG000|OLE|Lost to Follow-up|0|||
143088406|NCT03989102|515862721|FG000|Year 1|Lost to Follow-up|5|||
143088407|NCT03989102|515862722|FG001|Year 1|Lost to Follow-up|2|||
143088408|NCT03989102|515862723|FG002|Year 1|Lost to Follow-up|5|||
143088409|NCT03989102|515862721|FG000|Year 1|Subject met withdrawal criteria|1|||
143088410|NCT03989102|515862722|FG001|Year 1|Subject met withdrawal criteria|0|||
143088411|NCT03989102|515862723|FG002|Year 1|Subject met withdrawal criteria|1|||
143088412|NCT03989102|515862721|FG000|Year 2|Lost to Follow-up|7|||
143088413|NCT03989102|515862722|FG001|Year 2|Lost to Follow-up|3|||
143088414|NCT03989102|515862723|FG002|Year 2|Lost to Follow-up|4|||
143088415|NCT03989102|515862721|FG000|Year 2|Withdrawal by Subject|3|||
143088416|NCT03989102|515862722|FG001|Year 2|Withdrawal by Subject|1|||
143088417|NCT03989102|515862723|FG002|Year 2|Withdrawal by Subject|2|||
143088418|NCT03989102|515862721|FG000|Year 2|Subject non-compliant|3|||
143088419|NCT03989102|515862722|FG001|Year 2|Subject non-compliant|2|||
143088420|NCT03989102|515862723|FG002|Year 2|Subject non-compliant|0|||
143088421|NCT03989102|515862721|FG000|Year 2|Travel|1|||
143088422|NCT03989102|515862722|FG001|Year 2|Travel|0|||
143088423|NCT03989102|515862723|FG002|Year 2|Travel|1|||
143088424|NCT03989102|515862721|FG000|Year 2|P16 missing|4|||
143250543|NCT04556383|516471244|FG001|OLE|Lost to Follow-up|0|||
143088425|NCT03989102|515862722|FG001|Year 2|P16 missing|2|||
143088426|NCT03989102|515862723|FG002|Year 2|P16 missing|1|||
143088427|NCT03989102|515862721|FG000|Year 2|P11 missing|1|||
143088428|NCT03989102|515862722|FG001|Year 2|P11 missing|3|||
143088429|NCT03989102|515862723|FG002|Year 2|P11 missing|7|||
143088430|NCT03989102|515862721|FG000|Year 2|Definitive displacement outside the study site|0|||
143088431|NCT03989102|515862722|FG001|Year 2|Definitive displacement outside the study site|1|||
143088432|NCT03989102|515862723|FG002|Year 2|Definitive displacement outside the study site|0|||
143088433|NCT03989102|515862721|FG000|Year 2|Subject missed last study visit|0|||
143088434|NCT03989102|515862722|FG001|Year 2|Subject missed last study visit|1|||
143088435|NCT03989102|515862723|FG002|Year 2|Subject missed last study visit|0|||
143088436|NCT03989102|515862721|FG000|Year 2|Death|0|||
143088437|NCT03989102|515862722|FG001|Year 2|Death|1|||
143088438|NCT03989102|515862723|FG002|Year 2|Death|0|||
143088439|NCT03989102|515862721|FG000|Year 2|Subject not reachable|0|||
143088440|NCT03989102|515862722|FG001|Year 2|Subject not reachable|0|||
143088441|NCT03989102|515862723|FG002|Year 2|Subject not reachable|1|||
143088442|NCT03989102|515862721|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
143088443|NCT03989102|515862722|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
143088444|NCT03989102|515862723|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
143088445|NCT03989102|515862721|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
143088446|NCT03989102|515862722|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
143088447|NCT03989102|515862723|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
143088448|NCT03989102|515862721|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
143088449|NCT03989102|515862722|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
143088450|NCT03989102|515862723|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
143088451|NCT03989102|515862721|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
143088452|NCT03989102|515862722|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
143088453|NCT03989102|515862723|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
143088454|NCT03989102|515862721|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
143088455|NCT03989102|515862722|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
143088456|NCT03989102|515862723|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
143088457|NCT03989102|515862721|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
143088458|NCT03989102|515862722|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
143088459|NCT03989102|515862723|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
143088460|NCT01290068|515862729|FG000|Overall Study|Adverse Event|1|||
143088461|NCT01290068|515862730|FG001|Overall Study|Adverse Event|3|||
143088462|NCT01290068|515862729|FG000|Overall Study|Lost to Follow-up|3|||
143088463|NCT01290068|515862730|FG001|Overall Study|Lost to Follow-up|0|||
143088464|NCT01290068|515862729|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
143088465|NCT01290068|515862730|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
143088466|NCT01290068|515862729|FG000|Overall Study|Other|3|||
143088467|NCT01290068|515862730|FG001|Overall Study|Other|1|||
143088468|NCT03718832|515862733|FG000|Analysis Sample|Withdrawal by Subject|18|||
143088469|NCT03718832|515862734|FG001|Analysis Sample|Withdrawal by Subject|15|||
143088470|NCT03718832|515862733|FG000|Analysis Sample|Legal hold on data|1|||
143088471|NCT03718832|515862734|FG001|Analysis Sample|Legal hold on data|0|||
143088472|NCT03718832|515862733|FG000|Analysis Sample|Participant from treated household|0|||
143088473|NCT03718832|515862734|FG001|Analysis Sample|Participant from treated household|1|||
143088474|NCT03718832|515862733|FG000|6-month HbA1c Sample|Lost to Follow-up|60|||
143088475|NCT03718832|515862734|FG001|6-month HbA1c Sample|Lost to Follow-up|56|||
143088476|NCT03052751|515862735|FG000|Dosing Period 1|Adverse Event|0|||
143088477|NCT03052751|515862736|FG001|Dosing Period 1|Adverse Event|1|||
143088478|NCT03052751|515862737|FG002|Dosing Period 1|Adverse Event|0|||
143088479|NCT03052751|515862738|FG003|Dosing Period 1|Adverse Event|0|||
143088480|NCT03052751|515862739|FG004|Dosing Period 1|Adverse Event|0|||
143088481|NCT03052751|515862740|FG005|Dosing Period 1|Adverse Event|0|||
143088482|NCT03052751|515862735|FG000|Dosing Period 2|Adverse Event|0|||
143088483|NCT03052751|515862736|FG001|Dosing Period 2|Adverse Event|0|||
143088484|NCT03052751|515862737|FG002|Dosing Period 2|Adverse Event|3|||
143088485|NCT03052751|515862738|FG003|Dosing Period 2|Adverse Event|0|||
143088486|NCT03052751|515862739|FG004|Dosing Period 2|Adverse Event|0|||
143088487|NCT03052751|515862740|FG005|Dosing Period 2|Adverse Event|0|||
143088488|NCT03052751|515862735|FG000|Observation Period|Adverse Event|0|||
143088489|NCT03052751|515862736|FG001|Observation Period|Adverse Event|0|||
143088490|NCT03052751|515862737|FG002|Observation Period|Adverse Event|0|||
143088491|NCT03052751|515862738|FG003|Observation Period|Adverse Event|0|||
143088492|NCT03052751|515862739|FG004|Observation Period|Adverse Event|1|||
143088493|NCT03052751|515862740|FG005|Observation Period|Adverse Event|0|||
143088494|NCT00970593|515862741|FG000|Overall Study|Adverse Event|1|||
143088495|NCT00970593|515862742|FG001|Overall Study|Adverse Event|1|||
143088496|NCT00970593|515862743|FG002|Overall Study|Adverse Event|0|||
143088497|NCT00970593|515862744|FG003|Overall Study|Adverse Event|0|||
143088498|NCT00970593|515862745|FG004|Overall Study|Adverse Event|0|||
143088499|NCT00970593|515862746|FG005|Overall Study|Adverse Event|0|||
143088500|NCT00970593|515862747|FG006|Overall Study|Adverse Event|0|||
143088501|NCT00970593|515862741|FG000|Overall Study|Discontinuation of study by sponsor|0|||
143088502|NCT00970593|515862742|FG001|Overall Study|Discontinuation of study by sponsor|0|||
143088503|NCT00970593|515862743|FG002|Overall Study|Discontinuation of study by sponsor|5|||
143088504|NCT00970593|515862744|FG003|Overall Study|Discontinuation of study by sponsor|0|||
143088505|NCT00970593|515862745|FG004|Overall Study|Discontinuation of study by sponsor|0|||
143088506|NCT00970593|515862746|FG005|Overall Study|Discontinuation of study by sponsor|0|||
143088507|NCT00970593|515862747|FG006|Overall Study|Discontinuation of study by sponsor|2|||
143088508|NCT00970593|515862741|FG000|Overall Study|Withdrawal by Subject|0|||
143088509|NCT00970593|515862742|FG001|Overall Study|Withdrawal by Subject|0|||
143088510|NCT00970593|515862743|FG002|Overall Study|Withdrawal by Subject|1|||
143088511|NCT00970593|515862744|FG003|Overall Study|Withdrawal by Subject|0|||
143088512|NCT00970593|515862745|FG004|Overall Study|Withdrawal by Subject|0|||
143088513|NCT00970593|515862746|FG005|Overall Study|Withdrawal by Subject|0|||
143088514|NCT00970593|515862747|FG006|Overall Study|Withdrawal by Subject|0|||
143088515|NCT00470535|515862749|FG000|Overall Study|Disease Progression|13|||
143088516|NCT00470535|515862749|FG000|Overall Study|Withdrawal by Subject|1|||
143088517|NCT00470535|515862749|FG000|Overall Study|Adverse Event|1|||
143088518|NCT00470535|515862749|FG000|Overall Study|Death|1|||
143088519|NCT00470535|515862749|FG000|Overall Study|Other|2|||
143088520|NCT04108299|515862750|FG000|Overall Study|Not interested in participating|2|||
143088521|NCT04108299|515862751|FG001|Overall Study|Not interested in participating|1|||
143088522|NCT04108299|515862752|FG002|Overall Study|Not interested in participating|2|||
143088523|NCT04108299|515862753|FG003|Overall Study|Not interested in participating|1|||
143088524|NCT04123405|515862754|FG000|Overall Study|Adverse Event|1|||
143088525|NCT04123405|515862755|FG001|Overall Study|Adverse Event|2|||
143088526|NCT04123405|515862756|FG002|Overall Study|Adverse Event|3|||
143088527|NCT04123405|515862757|FG003|Overall Study|Adverse Event|3|||
143088528|NCT04123405|515862754|FG000|Overall Study|Exclusion criteria met|1|||
143088529|NCT04123405|515862755|FG001|Overall Study|Exclusion criteria met|2|||
143088530|NCT04123405|515862756|FG002|Overall Study|Exclusion criteria met|0|||
143088531|NCT04123405|515862757|FG003|Overall Study|Exclusion criteria met|2|||
143088532|NCT04123405|515862754|FG000|Overall Study|Withdrawal by Subject|1|||
143088533|NCT04123405|515862755|FG001|Overall Study|Withdrawal by Subject|3|||
143088534|NCT04123405|515862756|FG002|Overall Study|Withdrawal by Subject|0|||
143088535|NCT04123405|515862757|FG003|Overall Study|Withdrawal by Subject|2|||
143088536|NCT04123405|515862754|FG000|Overall Study|Contact to subject lost|0|||
143088537|NCT04123405|515862755|FG001|Overall Study|Contact to subject lost|0|||
143088538|NCT04123405|515862756|FG002|Overall Study|Contact to subject lost|0|||
143250544|NCT04556383|516471245|FG002|OLE|Lost to Follow-up|0|||
143250545|NCT04556383|516471246|FG003|OLE|Lost to Follow-up|1|||
143250546|NCT02720042|516471249|FG000|Overall Study|Death|3|||
143250547|NCT02720042|516471249|FG000|Overall Study|Lost to Follow-up|4|||
143250548|NCT02720042|516471249|FG000|Overall Study|Withdrawal by Subject|1|||
143250549|NCT02720042|516471249|FG000|Overall Study|Physician Decision|3|||
143250550|NCT02720042|516471249|FG000|Overall Study|Phasix Mesh explanted|1|||
143088539|NCT04123405|515862757|FG003|Overall Study|Contact to subject lost|1|||
143088540|NCT04123405|515862754|FG000|Overall Study|screening failure|1|||
143088541|NCT04123405|515862755|FG001|Overall Study|screening failure|0|||
143088542|NCT04123405|515862756|FG002|Overall Study|screening failure|0|||
143250551|NCT02720042|516471249|FG000|Overall Study|unable due to non-study-related illness|3|||
143250552|NCT00884741|516471250|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
143250553|NCT00884741|516471251|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
143250554|NCT00884741|516471252|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
143250555|NCT00884741|516471253|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
143088543|NCT04123405|515862757|FG003|Overall Study|screening failure|0|||
143088544|NCT00662649|515862758|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
143088545|NCT00662649|515862759|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
143088546|NCT00662649|515862760|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
143088547|NCT00662649|515862761|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
143088548|NCT00662649|515862762|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
143088549|NCT00662649|515862758|FG000|Core Study (24 Months)|Adverse Event|22|||
143088550|NCT00662649|515862759|FG001|Core Study (24 Months)|Adverse Event|13|||
143088551|NCT00662649|515862760|FG002|Core Study (24 Months)|Adverse Event|18|||
143088552|NCT00662649|515862761|FG003|Core Study (24 Months)|Adverse Event|0|||
143088553|NCT00662649|515862762|FG004|Core Study (24 Months)|Adverse Event|0|||
143088554|NCT00662649|515862758|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
143088555|NCT00662649|515862759|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
143088556|NCT00662649|515862760|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
143088557|NCT00662649|515862761|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
143250556|NCT00884741|516471250|FG000|Step 1 Registration: Tissue Screening|Death|3|||
143250557|NCT00884741|516471251|FG001|Step 1 Registration: Tissue Screening|Death|0|||
143250558|NCT00884741|516471252|FG002|Step 1 Registration: Tissue Screening|Death|0|||
143250559|NCT00884741|516471253|FG003|Step 1 Registration: Tissue Screening|Death|0|||
143250560|NCT00884741|516471250|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
143250561|NCT00884741|516471251|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
143250562|NCT00884741|516471252|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
143088558|NCT00662649|515862762|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
143088559|NCT00662649|515862758|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
143088560|NCT00662649|515862759|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
143088561|NCT00662649|515862760|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
143088562|NCT00662649|515862761|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
143088563|NCT00662649|515862762|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
143088564|NCT00662649|515862758|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
143088565|NCT00662649|515862759|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
143088566|NCT00662649|515862760|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
143088567|NCT00662649|515862761|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
143088568|NCT00662649|515862762|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
143088569|NCT00662649|515862758|FG000|Core Study (24 Months)|Protocol Violation|5|||
143088570|NCT00662649|515862759|FG001|Core Study (24 Months)|Protocol Violation|5|||
143088571|NCT00662649|515862760|FG002|Core Study (24 Months)|Protocol Violation|4|||
143088572|NCT00662649|515862761|FG003|Core Study (24 Months)|Protocol Violation|0|||
143088573|NCT00662649|515862762|FG004|Core Study (24 Months)|Protocol Violation|0|||
143250563|NCT00884741|516471253|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
143250564|NCT00884741|516471250|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
143088574|NCT00662649|515862758|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
143088575|NCT00662649|515862759|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
143088576|NCT00662649|515862760|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
143088577|NCT00662649|515862761|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
143088578|NCT00662649|515862762|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
143088579|NCT00662649|515862758|FG000|Core Study (24 Months)|Death|1|||
143088580|NCT00662649|515862759|FG001|Core Study (24 Months)|Death|0|||
143088581|NCT00662649|515862760|FG002|Core Study (24 Months)|Death|2|||
143088582|NCT00662649|515862761|FG003|Core Study (24 Months)|Death|0|||
143088583|NCT00662649|515862762|FG004|Core Study (24 Months)|Death|0|||
143088584|NCT00662649|515862758|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
143088585|NCT00662649|515862759|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
143088586|NCT00662649|515862760|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
143088587|NCT00662649|515862761|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
143088588|NCT00662649|515862762|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
143088589|NCT00662649|515862758|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
143088590|NCT00662649|515862759|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
143088591|NCT00662649|515862760|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
143088592|NCT00662649|515862761|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
143088593|NCT00662649|515862762|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
143088594|NCT00662649|515862758|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
143088595|NCT00662649|515862759|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
143088596|NCT00662649|515862760|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
143088597|NCT00662649|515862761|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
143088598|NCT00662649|515862762|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
143088599|NCT00662649|515862758|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
143088600|NCT00662649|515862759|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
143088601|NCT00662649|515862760|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
143088602|NCT00662649|515862761|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
143088603|NCT00662649|515862762|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
143088604|NCT00662649|515862758|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
143088605|NCT00662649|515862759|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
143088606|NCT00662649|515862760|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
143088607|NCT00662649|515862761|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
143088608|NCT00662649|515862762|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
143088609|NCT00662649|515862758|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
143088610|NCT00662649|515862759|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
143088611|NCT00662649|515862760|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
143088612|NCT00662649|515862761|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
143088613|NCT00662649|515862762|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
143088614|NCT00662649|515862758|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
143088615|NCT00662649|515862759|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
143088616|NCT00662649|515862760|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
143088617|NCT00662649|515862761|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
143088618|NCT00662649|515862762|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
143088619|NCT00662649|515862758|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
143088620|NCT00662649|515862759|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
143088621|NCT00662649|515862760|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
143088622|NCT00662649|515862761|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
143088623|NCT00662649|515862762|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
143088624|NCT00662649|515862758|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
143088625|NCT00662649|515862759|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
143250565|NCT00884741|516471251|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
143250566|NCT00884741|516471252|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
143250567|NCT00884741|516471253|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
143250568|NCT00884741|516471250|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
143250569|NCT00884741|516471251|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
143250570|NCT00884741|516471252|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
143250571|NCT00884741|516471253|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
143250572|NCT00884741|516471250|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
143088626|NCT00662649|515862760|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
143088627|NCT00662649|515862761|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
143088628|NCT00662649|515862762|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
143088629|NCT00545714|515862763|FG000|Induction Phase (6 Months)|Physician Decision|3|||
143088630|NCT00545714|515862763|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
143088631|NCT00545714|515862763|FG000|Induction Phase (6 Months)|Disease Progression|1|||
143088632|NCT00545714|515862763|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
143088633|NCT00545714|515862763|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
143088634|NCT00545714|515862763|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
143088635|NCT00545714|515862763|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
143088636|NCT00545714|515862763|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
143088637|NCT00545714|515862763|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
143088638|NCT00545714|515862763|FG000|Maintenance Phase (36 Months)|Death|2|||
143088639|NCT04176250|515862776|FG000|Overall Study|Adverse Event|0|||
143250573|NCT00884741|516471251|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
143088640|NCT04176250|515862777|FG001|Overall Study|Adverse Event|1|||
143088641|NCT04176250|515862778|FG002|Overall Study|Adverse Event|0|||
143088642|NCT04176250|515862779|FG003|Overall Study|Adverse Event|1|||
143088643|NCT04176250|515862780|FG004|Overall Study|Adverse Event|0|||
143088644|NCT04176250|515862781|FG005|Overall Study|Adverse Event|1|||
143088645|NCT04176250|515862776|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
143088646|NCT04176250|515862777|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
143088647|NCT04176250|515862778|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
143088648|NCT04176250|515862779|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
143088649|NCT04176250|515862780|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
143088650|NCT04176250|515862781|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
143088651|NCT04176250|515862776|FG000|Overall Study|Withdrawal by Subject|0|||
143088652|NCT04176250|515862777|FG001|Overall Study|Withdrawal by Subject|0|||
143088653|NCT04176250|515862778|FG002|Overall Study|Withdrawal by Subject|0|||
143088654|NCT04176250|515862779|FG003|Overall Study|Withdrawal by Subject|0|||
143088655|NCT04176250|515862780|FG004|Overall Study|Withdrawal by Subject|0|||
143088656|NCT04176250|515862781|FG005|Overall Study|Withdrawal by Subject|1|||
143088657|NCT04176250|515862776|FG000|Overall Study|Randomized in error|0|||
143088658|NCT04176250|515862777|FG001|Overall Study|Randomized in error|0|||
143088659|NCT04176250|515862778|FG002|Overall Study|Randomized in error|0|||
143088660|NCT04176250|515862779|FG003|Overall Study|Randomized in error|0|||
143088661|NCT04176250|515862780|FG004|Overall Study|Randomized in error|1|||
143088662|NCT04176250|515862781|FG005|Overall Study|Randomized in error|0|||
143088663|NCT01431079|515862791|FG000|Overall Study|Lost to Follow-up|35|||
143088664|NCT01431079|515862792|FG001|Overall Study|Lost to Follow-up|39|||
143088665|NCT01202175|515862793|FG000|Overall Study|Lost to Follow-up|2|||
143088666|NCT01202175|515862793|FG000|Overall Study|Withdrawal by Subject|1|||
143088667|NCT01202175|515862793|FG000|Overall Study|Adverse Event|2|||
143088668|NCT02790437|515862794|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
143088669|NCT02790437|515862795|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
143088670|NCT02790437|515862794|FG000|Overall Study|Adverse Event|1|||
143088671|NCT02790437|515862795|FG001|Overall Study|Adverse Event|0|||
143088672|NCT02790437|515862794|FG000|Overall Study|Withdrawal by Subject|1|||
143088673|NCT02790437|515862795|FG001|Overall Study|Withdrawal by Subject|0|||
143088674|NCT04688671|515862801|FG000|Overall Study|Adverse Event|3|||
143088675|NCT04688671|515862802|FG001|Overall Study|Adverse Event|1|||
143088676|NCT04688671|515862801|FG000|Overall Study|Withdrawal by Subject|3|||
143088677|NCT04688671|515862802|FG001|Overall Study|Withdrawal by Subject|1|||
143088678|NCT04688671|515862801|FG000|Overall Study|Lack of Efficacy|1|||
143088679|NCT04688671|515862802|FG001|Overall Study|Lack of Efficacy|1|||
143088680|NCT04688671|515862801|FG000|Overall Study|Protocol Violation|1|||
143088681|NCT04688671|515862802|FG001|Overall Study|Protocol Violation|0|||
143088682|NCT04688671|515862801|FG000|Overall Study|Lost to Follow-up|0|||
143088683|NCT04688671|515862802|FG001|Overall Study|Lost to Follow-up|1|||
143088684|NCT01626690|515862803|FG000|Overall Study|Protocol Violation|1|||
143088685|NCT01626690|515862804|FG001|Overall Study|Protocol Violation|0|||
143088686|NCT01626690|515862803|FG000|Overall Study|Adverse Event|1|||
143088687|NCT01626690|515862804|FG001|Overall Study|Adverse Event|0|||
143250574|NCT00884741|516471252|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
143088688|NCT04720053|515862805|FG000|Overall Study|Lost to Follow-up|12|||
143088689|NCT00245466|515862806|FG000|Overall Study|Adverse Event|2|||
143088690|NCT00245466|515862807|FG001|Overall Study|Adverse Event|8|||
143088691|NCT00245466|515862808|FG002|Overall Study|Adverse Event|4|||
143088692|NCT00245466|515862806|FG000|Overall Study|Low prostate specific antigen suppr|16|||
143088693|NCT00245466|515862807|FG001|Overall Study|Low prostate specific antigen suppr|14|||
143088694|NCT00245466|515862808|FG002|Overall Study|Low prostate specific antigen suppr|5|||
143088695|NCT00245466|515862806|FG000|Overall Study|Insufficient testosterone suppr|12|||
143088696|NCT00245466|515862807|FG001|Overall Study|Insufficient testosterone suppr|12|||
143088697|NCT00245466|515862808|FG002|Overall Study|Insufficient testosterone suppr|21|||
143088698|NCT00245466|515862806|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
143088699|NCT00245466|515862807|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
143088700|NCT00245466|515862808|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
143088701|NCT00245466|515862806|FG000|Overall Study|Withdrawal by Subject|2|||
143088702|NCT00245466|515862807|FG001|Overall Study|Withdrawal by Subject|2|||
143088703|NCT00245466|515862808|FG002|Overall Study|Withdrawal by Subject|1|||
143088704|NCT00245466|515862806|FG000|Overall Study|Lost to Follow-up|3|||
143088705|NCT00245466|515862807|FG001|Overall Study|Lost to Follow-up|0|||
143088706|NCT00245466|515862808|FG002|Overall Study|Lost to Follow-up|0|||
143088707|NCT00245466|515862806|FG000|Overall Study|Disease progression|0|||
143088708|NCT00245466|515862807|FG001|Overall Study|Disease progression|3|||
143088709|NCT00245466|515862808|FG002|Overall Study|Disease progression|1|||
143088710|NCT00245466|515862806|FG000|Overall Study|Protocol Violation|1|||
143088711|NCT00245466|515862807|FG001|Overall Study|Protocol Violation|2|||
143088712|NCT00245466|515862808|FG002|Overall Study|Protocol Violation|2|||
143088713|NCT00245466|515862806|FG000|Overall Study|Death|0|||
143088714|NCT00245466|515862807|FG001|Overall Study|Death|2|||
143088715|NCT00245466|515862808|FG002|Overall Study|Death|0|||
143088716|NCT00245466|515862806|FG000|Overall Study|Administrative reasons|0|||
143088717|NCT00245466|515862807|FG001|Overall Study|Administrative reasons|1|||
143088718|NCT00245466|515862808|FG002|Overall Study|Administrative reasons|0|||
143088719|NCT02016183|515862811|FG000|Overall Study|Case Report Forms Uncollected|13|||
143088720|NCT02016183|515862811|FG000|Overall Study|Protocol Violation|52|||
143088721|NCT00996489|515862812|FG000|Overall Study|Device failure|45|||
143088722|NCT00996489|515862812|FG000|Overall Study|Discontinued|116|||
143088723|NCT00129545|515862815|FG000|Overall Study|Death|5|||
143250575|NCT00884741|516471253|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
143088724|NCT00129545|515862816|FG001|Overall Study|Death|60|||
143088725|NCT00129545|515862817|FG002|Overall Study|Death|44|||
143088726|NCT00129545|515862815|FG000|Overall Study|Withdrawal by Subject|3|||
143088727|NCT00129545|515862816|FG001|Overall Study|Withdrawal by Subject|18|||
143088728|NCT00129545|515862817|FG002|Overall Study|Withdrawal by Subject|44|||
143250576|NCT00884741|516471250|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
143250577|NCT00884741|516471251|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
143250578|NCT00884741|516471252|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
143250579|NCT00884741|516471253|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
143250580|NCT00884741|516471250|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
143250581|NCT00884741|516471251|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
143250582|NCT00884741|516471252|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
143250583|NCT00884741|516471253|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
143250584|NCT00884741|516471250|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
143250585|NCT00884741|516471251|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
143250586|NCT00884741|516471252|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
143250587|NCT00884741|516471253|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
143250588|NCT00884741|516471250|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
143250589|NCT00884741|516471251|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
143250590|NCT00884741|516471252|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
143250591|NCT00884741|516471253|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
143250592|NCT00884741|516471250|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
143250593|NCT00884741|516471251|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
143250594|NCT00884741|516471252|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
143250595|NCT00884741|516471253|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
143250596|NCT00884741|516471250|FG000|Randomization|Protocol Violation|0|||
143250597|NCT00884741|516471251|FG001|Randomization|Protocol Violation|0|||
143250598|NCT00884741|516471252|FG002|Randomization|Protocol Violation|8|||
143250599|NCT00884741|516471253|FG003|Randomization|Protocol Violation|8|||
143250600|NCT03060551|516471258|FG000|Overall Study|Withdrawal by Subject|1|||
143250601|NCT03060551|516471258|FG000|Overall Study|Adverse Event|1|||
143250602|NCT04629066|516471259|FG000|Overall Study|Lost to Follow-up|3|||
143250603|NCT04629066|516471260|FG001|Overall Study|Lost to Follow-up|2|||
143250604|NCT04359901|516471265|FG000|Overall Study|Withdrawal by Subject|0|||
143250605|NCT04359901|516471266|FG001|Overall Study|Withdrawal by Subject|1|||
143088729|NCT00129545|515862815|FG000|Overall Study|Lost to Follow-up|2|||
143088730|NCT00129545|515862816|FG001|Overall Study|Lost to Follow-up|22|||
143088731|NCT00129545|515862817|FG002|Overall Study|Lost to Follow-up|13|||
143088732|NCT00129545|515862815|FG000|Overall Study|Physician Decision|0|||
143088733|NCT00129545|515862816|FG001|Overall Study|Physician Decision|3|||
143088734|NCT00129545|515862817|FG002|Overall Study|Physician Decision|10|||
143088735|NCT00129545|515862815|FG000|Overall Study|Device not implanted|16|||
143088736|NCT00129545|515862816|FG001|Overall Study|Device not implanted|61|||
143250606|NCT04359901|516471265|FG000|Overall Study|Death|6|||
143250607|NCT04359901|516471266|FG001|Overall Study|Death|2|||
143250608|NCT02509026|516471270|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
143250609|NCT02509026|516471270|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
143250610|NCT02509026|516471270|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
143250611|NCT02509026|516471270|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
143250612|NCT02509026|516471270|FG000|Induction Period (24 Weeks)|Other|2|||
143250613|NCT02509026|516471270|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
143250614|NCT02509026|516471270|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
143250615|NCT02509026|516471270|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
143250616|NCT02509026|516471270|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
143250617|NCT02509026|516471270|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
143250618|NCT02509026|516471270|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
143250619|NCT02509026|516471270|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
143250620|NCT02509026|516471270|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
143250621|NCT00243841|516471274|FG000|Overall Study|Physician Decision|0|||
143250622|NCT00243841|516471275|FG001|Overall Study|Physician Decision|0|||
143250623|NCT00243841|516471276|FG002|Overall Study|Physician Decision|1|||
143250624|NCT00243841|516471277|FG003|Overall Study|Physician Decision|0|||
143250625|NCT00243841|516471278|FG004|Overall Study|Physician Decision|0|||
143250626|NCT00243841|516471279|FG005|Overall Study|Physician Decision|2|||
143250627|NCT04303195|516471280|FG000|Overall Study|Adverse Event|1|||
143250628|NCT04303195|516471281|FG001|Overall Study|Adverse Event|3|||
143250629|NCT04303195|516471282|FG002|Overall Study|Adverse Event|7|||
143250630|NCT04303195|516471283|FG003|Overall Study|Adverse Event|0|||
143250631|NCT04303195|516471280|FG000|Overall Study|Lost to Follow-up|1|||
143250632|NCT04303195|516471281|FG001|Overall Study|Lost to Follow-up|0|||
143250633|NCT04303195|516471282|FG002|Overall Study|Lost to Follow-up|1|||
143250634|NCT04303195|516471283|FG003|Overall Study|Lost to Follow-up|4|||
143250635|NCT04303195|516471280|FG000|Overall Study|Withdrawal by Subject|3|||
143250636|NCT04303195|516471281|FG001|Overall Study|Withdrawal by Subject|1|||
143250637|NCT04303195|516471282|FG002|Overall Study|Withdrawal by Subject|1|||
143250638|NCT04303195|516471283|FG003|Overall Study|Withdrawal by Subject|1|||
143250639|NCT04303195|516471280|FG000|Overall Study|No study drug administered or protocol deviation|0|||
143250640|NCT04303195|516471281|FG001|Overall Study|No study drug administered or protocol deviation|2|||
143250641|NCT04303195|516471282|FG002|Overall Study|No study drug administered or protocol deviation|0|||
143250642|NCT04303195|516471283|FG003|Overall Study|No study drug administered or protocol deviation|2|||
143250643|NCT01097005|516471287|FG000|Overall Study|Case Report Form not collected|18|||
143250644|NCT01097005|516471287|FG000|Overall Study|Subjects cannot visit the hospital|1|||
143250645|NCT01097005|516471287|FG000|Overall Study|Poor medication compliance|1|||
143250646|NCT01097005|516471287|FG000|Overall Study|No examination data available|244|||
143250647|NCT01097005|516471287|FG000|Overall Study|Deviation from exclusion criteria|37|||
143250648|NCT01097005|516471287|FG000|Overall Study|Adverse Event|14|||
143250649|NCT01097005|516471287|FG000|Overall Study|Discontinuance by complication|50|||
143250650|NCT04627285|516471288|FG000|Overall Study|Adverse Event|0|||
143250651|NCT04627285|516471289|FG001|Overall Study|Adverse Event|2|||
143250652|NCT04627285|516471288|FG000|Overall Study|Lost to Follow-up|1|||
143250653|NCT04627285|516471289|FG001|Overall Study|Lost to Follow-up|0|||
143250654|NCT04627285|516471288|FG000|Overall Study|Withdrawal by Subject|1|||
143250655|NCT04627285|516471289|FG001|Overall Study|Withdrawal by Subject|1|||
143250656|NCT04627285|516471288|FG000|Overall Study|Sponsor decision|5|||
143250657|NCT04627285|516471289|FG001|Overall Study|Sponsor decision|0|||
143250658|NCT04627285|516471288|FG000|Overall Study|Participant left country; aunt informed the site|0|||
143250659|NCT04627285|516471289|FG001|Overall Study|Participant left country; aunt informed the site|1|||
143250660|NCT03254459|516472853|FG000|Overall Study|Adverse Event|7|||
143250661|NCT03254459|516472854|FG001|Overall Study|Adverse Event|20|||
143250662|NCT03254459|516472853|FG000|Overall Study|Withdrawal by Subject Consent|3|||
143250663|NCT03254459|516472854|FG001|Overall Study|Withdrawal by Subject Consent|1|||
143250664|NCT03254459|516472853|FG000|Overall Study|Lost to Follow-up|0|||
143250665|NCT03254459|516472854|FG001|Overall Study|Lost to Follow-up|1|||
143250666|NCT03254459|516472853|FG000|Overall Study|Miscellaneous|0|||
143250667|NCT03254459|516472854|FG001|Overall Study|Miscellaneous|1|||
143250668|NCT03745820|516472856|FG000|Overall Study|Adverse Event|0|||
143250669|NCT03745820|516472857|FG001|Overall Study|Adverse Event|3|||
143250670|NCT03745820|516472858|FG002|Overall Study|Adverse Event|2|||
143250671|NCT03745820|516472856|FG000|Overall Study|Non-Compliance with Study Drug|4|||
143250672|NCT03745820|516472857|FG001|Overall Study|Non-Compliance with Study Drug|3|||
143250673|NCT03745820|516472858|FG002|Overall Study|Non-Compliance with Study Drug|0|||
143250674|NCT03745820|516472856|FG000|Overall Study|Withdrawal by Subject|4|||
143250675|NCT03745820|516472857|FG001|Overall Study|Withdrawal by Subject|4|||
143250676|NCT03745820|516472858|FG002|Overall Study|Withdrawal by Subject|4|||
143088737|NCT00129545|515862817|FG002|Overall Study|Device not implanted|0|||
143088738|NCT04660331|515862822|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
143088739|NCT04660331|515862823|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
143088740|NCT04660331|515862824|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
143088741|NCT01640249|515862828|FG000|Period 1|Withdrawal by Subject|1|||
143088742|NCT01640249|515862829|FG001|Period 1|Withdrawal by Subject|0|||
143088743|NCT01640249|515862830|FG002|Period 1|Withdrawal by Subject|0|||
143088744|NCT01640249|515862831|FG003|Period 1|Withdrawal by Subject|0|||
143088745|NCT01640249|515862832|FG004|Period 1|Withdrawal by Subject|0|||
143088746|NCT01640249|515862833|FG005|Period 1|Withdrawal by Subject|1|||
143088747|NCT01640249|515862834|FG006|Period 1|Withdrawal by Subject|0|||
143088748|NCT00065156|515862837|FG000|Overall Study|Adverse Event|37|||
143088749|NCT00065156|515862837|FG000|Overall Study|Lack of Efficacy|52|||
143088750|NCT00065156|515862837|FG000|Overall Study|Withdrawal by Subject|8|||
143088751|NCT00065156|515862837|FG000|Overall Study|Lost to Follow-up|1|||
143088752|NCT00065156|515862837|FG000|Overall Study|Death|11|||
143088753|NCT00065156|515862837|FG000|Overall Study|Study Closed by Sponsor|2|||
143088754|NCT00065156|515862837|FG000|Overall Study|Disease Progression|7|||
143088755|NCT00065156|515862837|FG000|Overall Study|Investigator Decision|2|||
143088756|NCT00065156|515862837|FG000|Overall Study|Non-Compliance|2|||
143088757|NCT00065156|515862837|FG000|Overall Study|Loss of Response|1|||
143088758|NCT00065156|515862837|FG000|Overall Study|Secondary Malign Disease|1|||
143088759|NCT00100828|515862838|FG000|Overall Study|Physician Decision|6|||
143088760|NCT01176513|515862839|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
143088761|NCT02308124|515862840|FG000|Overall Study|Lost to Follow-up|6|||
143088762|NCT02308124|515862841|FG001|Overall Study|Lost to Follow-up|6|||
143088763|NCT02308124|515862842|FG002|Overall Study|Lost to Follow-up|6|||
143088764|NCT02308124|515862840|FG000|Overall Study|Adverse Event|0|||
143088765|NCT02308124|515862841|FG001|Overall Study|Adverse Event|2|||
143088766|NCT02308124|515862842|FG002|Overall Study|Adverse Event|2|||
143088767|NCT01184079|515862843|FG000|Overall Study|Lost to Follow-up|14|||
143088768|NCT01184079|515862844|FG001|Overall Study|Lost to Follow-up|2|||
143088769|NCT04233073|515862845|FG000|Overall Study|Death|5|||
143088770|NCT00041132|515862846|FG000|Overall Study|Adverse Event|19|||
143088771|NCT00041132|515862846|FG000|Overall Study|Death|1|||
143088772|NCT00041132|515862846|FG000|Overall Study|Not Eligible|7|||
143088773|NCT00041132|515862846|FG000|Overall Study|Withdrawal by Subject|1|||
143088774|NCT00041132|515862846|FG000|Overall Study|Physician Decision|2|||
143088775|NCT01808573|515862848|FG000|Overall Study|Death|212|||
143088776|NCT01808573|515862849|FG001|Overall Study|Death|240|||
143088777|NCT01808573|515862848|FG000|Overall Study|Withdrawal by Subject|12|||
143088778|NCT01808573|515862849|FG001|Overall Study|Withdrawal by Subject|10|||
143088779|NCT01808573|515862848|FG000|Overall Study|Lost to Follow-up|3|||
143088780|NCT01808573|515862849|FG001|Overall Study|Lost to Follow-up|0|||
143088781|NCT01808573|515862848|FG000|Overall Study|Discontinuation of study by sponsor|79|||
143088782|NCT01808573|515862849|FG001|Overall Study|Discontinuation of study by sponsor|64|||
143088783|NCT01808573|515862848|FG000|Overall Study|Randomized in Error|1|||
143088784|NCT01808573|515862849|FG001|Overall Study|Randomized in Error|0|||
143088785|NCT01256502|515862850|FG000|Overall Study|Had scaffold removed|4|||
143088786|NCT01256502|515862850|FG000|Overall Study|Personal reasons|5|||
143088787|NCT01256502|515862850|FG000|Overall Study|Protocol deviation|1|||
143088788|NCT01523002|515862851|FG000|Period 1|Withdrawal by Subject|1|||
143088789|NCT01523002|515862852|FG001|Period 1|Withdrawal by Subject|3|||
143088790|NCT01523002|515862851|FG000|Period 1|Lost to Follow-up|1|||
143088791|NCT01523002|515862852|FG001|Period 1|Lost to Follow-up|0|||
143088792|NCT01523002|515862851|FG000|Period 1|Adverse Event|0|||
143088793|NCT01523002|515862852|FG001|Period 1|Adverse Event|8|||
143088794|NCT01523002|515862851|FG000|Period 2|Withdrawal by Subject|4|||
143088795|NCT01523002|515862852|FG001|Period 2|Withdrawal by Subject|1|||
143088796|NCT01523002|515862851|FG000|Period 2|Adverse Event|2|||
143088797|NCT01523002|515862852|FG001|Period 2|Adverse Event|5|||
143088798|NCT01523002|515862851|FG000|Period 3|Withdrawal by Subject|1|||
143175755|NCT02756403|516192340|FG001|Overall Study|Unable to swallow medication|1|||
143175756|NCT02756403|516192341|FG002|Overall Study|Unable to swallow medication|1|||
143175757|NCT02756403|516192342|FG003|Overall Study|Unable to swallow medication|1|||
143175758|NCT02756403|516192339|FG000|Overall Study|Did not complete Procedure|0|||
143175759|NCT02756403|516192340|FG001|Overall Study|Did not complete Procedure|1|||
143175760|NCT02756403|516192341|FG002|Overall Study|Did not complete Procedure|0|||
143175761|NCT02756403|516192342|FG003|Overall Study|Did not complete Procedure|0|||
143175762|NCT02756403|516192339|FG000|Overall Study|Changed Mind About Procedure|0|||
143088799|NCT01523002|515862852|FG001|Period 3|Withdrawal by Subject|0|||
143088800|NCT01523002|515862851|FG000|Period 3|Adverse Event|3|||
143088801|NCT01523002|515862852|FG001|Period 3|Adverse Event|0|||
143088802|NCT03953612|515862853|FG000|Overall Study|Randomized but did not start|1|||
143088803|NCT03953612|515862854|FG001|Overall Study|Randomized but did not start|1|||
143088804|NCT03953612|515862855|FG002|Overall Study|Randomized but did not start|1|||
143088805|NCT03953612|515862853|FG000|Overall Study|Withdrawal by Subject|2|||
143088806|NCT03953612|515862854|FG001|Overall Study|Withdrawal by Subject|1|||
143088807|NCT03953612|515862855|FG002|Overall Study|Withdrawal by Subject|0|||
143088808|NCT00489255|515862856|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
143088809|NCT00489255|515862857|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
143088810|NCT00489255|515862856|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
143088811|NCT00489255|515862857|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
143088812|NCT00489255|515862856|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
143088813|NCT00489255|515862857|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
143088814|NCT00489255|515862856|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
143088815|NCT00489255|515862857|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
143088816|NCT00489255|515862856|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
143088817|NCT00489255|515862857|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
143088818|NCT00489255|515862856|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
143088819|NCT00489255|515862857|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
143088820|NCT00489255|515862856|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
143088821|NCT00489255|515862857|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
143175763|NCT02756403|516192340|FG001|Overall Study|Changed Mind About Procedure|0|||
143175764|NCT02756403|516192341|FG002|Overall Study|Changed Mind About Procedure|1|||
143175765|NCT02756403|516192342|FG003|Overall Study|Changed Mind About Procedure|0|||
143175766|NCT02756403|516192339|FG000|Overall Study|Protocol Violation|0|||
143175767|NCT02756403|516192340|FG001|Overall Study|Protocol Violation|1|||
143175768|NCT02756403|516192341|FG002|Overall Study|Protocol Violation|0|||
143175769|NCT02756403|516192342|FG003|Overall Study|Protocol Violation|1|||
143175770|NCT00527618|516192343|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
143175771|NCT00527618|516192344|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
143175772|NCT00527618|516192343|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
143175773|NCT00527618|516192344|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
143175774|NCT00527618|516192343|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
143175775|NCT00527618|516192344|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
143175776|NCT00527618|516192343|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
143175777|NCT00527618|516192344|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
143088822|NCT00489255|515862856|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
143088823|NCT00489255|515862857|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
143088824|NCT00489255|515862856|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
143175778|NCT00527618|516192343|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
143175779|NCT00527618|516192344|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
143088825|NCT00489255|515862857|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
143088826|NCT00489255|515862856|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
143088827|NCT00489255|515862857|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
143088828|NCT03485352|515862858|FG000|Overall Study|Lost to Follow-up|9|||
143088829|NCT05101343|515862877|FG000|Overall Study|Withdrawal by Subject|2|||
143088830|NCT05101343|515862878|FG001|Overall Study|Withdrawal by Subject|1|||
143088831|NCT04779879|515862879|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
143088832|NCT04779879|515862880|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
143088833|NCT04779879|515862881|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
143088834|NCT04779879|515862882|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
143088835|NCT04779879|515862883|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
143088836|NCT04779879|515862884|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
143088837|NCT04779879|515862879|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
143088838|NCT04779879|515862880|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
143088839|NCT04779879|515862881|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
143088840|NCT04779879|515862882|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
143088841|NCT04779879|515862883|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
143088842|NCT04779879|515862884|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
143088843|NCT04779879|515862879|FG000|Part C: Up to Week 36|Death|0|||
143367115|NCT01467700|516887252|FG002|Overall Study|Voluntary Withdrawal|6|||
143088844|NCT04779879|515862880|FG001|Part C: Up to Week 36|Death|0|||
143088845|NCT04779879|515862881|FG002|Part C: Up to Week 36|Death|0|||
143088846|NCT04779879|515862882|FG003|Part C: Up to Week 36|Death|0|||
143088847|NCT04779879|515862883|FG004|Part C: Up to Week 36|Death|0|||
143088848|NCT04779879|515862884|FG005|Part C: Up to Week 36|Death|1|||
143088849|NCT04779879|515862879|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
143088850|NCT04779879|515862880|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
143088851|NCT04779879|515862881|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
143088852|NCT04779879|515862882|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
143088853|NCT04779879|515862883|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
143088854|NCT04779879|515862884|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
143088855|NCT02854527|515862885|FG000|Overall Study|Adverse Event|0|||
143088856|NCT02854527|515862886|FG001|Overall Study|Adverse Event|0|||
143088857|NCT02854527|515862887|FG002|Overall Study|Adverse Event|0|||
143088858|NCT02854527|515862888|FG003|Overall Study|Adverse Event|0|||
143088859|NCT02854527|515862889|FG004|Overall Study|Adverse Event|1|||
143088860|NCT02854527|515862890|FG005|Overall Study|Adverse Event|0|||
143088861|NCT02854527|515862891|FG006|Overall Study|Adverse Event|0|||
143088862|NCT02854527|515862892|FG007|Overall Study|Adverse Event|0|||
143088863|NCT02854527|515862893|FG008|Overall Study|Adverse Event|0|||
143088864|NCT02854527|515862894|FG009|Overall Study|Adverse Event|0|||
143088865|NCT02854527|515862885|FG000|Overall Study|Lost to Follow-up|0|||
143088866|NCT02854527|515862886|FG001|Overall Study|Lost to Follow-up|0|||
143088867|NCT02854527|515862887|FG002|Overall Study|Lost to Follow-up|0|||
143088868|NCT02854527|515862888|FG003|Overall Study|Lost to Follow-up|1|||
143088869|NCT02854527|515862889|FG004|Overall Study|Lost to Follow-up|0|||
143088870|NCT02854527|515862890|FG005|Overall Study|Lost to Follow-up|0|||
143088871|NCT02854527|515862891|FG006|Overall Study|Lost to Follow-up|0|||
143088872|NCT02854527|515862892|FG007|Overall Study|Lost to Follow-up|0|||
143088873|NCT02854527|515862893|FG008|Overall Study|Lost to Follow-up|0|||
143088874|NCT02854527|515862894|FG009|Overall Study|Lost to Follow-up|0|||
143088875|NCT02603146|515864420|FG000|Overall Study|Lost to Follow-up|5|||
143088876|NCT02603146|515864421|FG001|Overall Study|Lost to Follow-up|6|||
143088877|NCT02603146|515864420|FG000|Overall Study|Withdrawal by Subject|8|||
143088878|NCT02603146|515864421|FG001|Overall Study|Withdrawal by Subject|10|||
143088879|NCT02603146|515864420|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
143088880|NCT02603146|515864421|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
143088881|NCT02603146|515864420|FG000|Overall Study|Participant moved|2|||
143088882|NCT02603146|515864421|FG001|Overall Study|Participant moved|0|||
143088883|NCT02603146|515864420|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
143088884|NCT02603146|515864421|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
143088885|NCT03493685|515864424|FG000|Overall Study|Death|4|||
143088886|NCT03493685|515864425|FG001|Overall Study|Death|3|||
143088887|NCT03493685|515864424|FG000|Overall Study|Lost to Follow-up|3|||
143088888|NCT03493685|515864425|FG001|Overall Study|Lost to Follow-up|2|||
143088889|NCT03493685|515864424|FG000|Overall Study|Physician Decision|2|||
143088890|NCT03493685|515864425|FG001|Overall Study|Physician Decision|0|||
143088891|NCT03493685|515864424|FG000|Overall Study|Withdrawal by Subject|7|||
143088892|NCT03493685|515864425|FG001|Overall Study|Withdrawal by Subject|11|||
143088893|NCT04452669|515864426|FG000|Overall Study|Death|1|||
143088894|NCT04452669|515864427|FG001|Overall Study|Death|4|||
143088895|NCT04653454|515864430|FG000|Overall Study|Withdrawal by Subject|1|||
143088896|NCT04653454|515864430|FG000|Overall Study|Physician Decision|40|||
143088897|NCT05126693|515864431|FG000|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|2|||
143088898|NCT05126693|515864432|FG001|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|0|||
143088899|NCT05126693|515864431|FG000|Pre-BoNT/ Pre-3DfUS|No 3DGA|4|||
143088900|NCT05126693|515864432|FG001|Pre-BoNT/ Pre-3DfUS|No 3DGA|0|||
143088901|NCT05126693|515864431|FG000|Pre-BoNT/ Pre-3DfUS|Insufficient matching|0|||
143088902|NCT05126693|515864432|FG001|Pre-BoNT/ Pre-3DfUS|Insufficient matching|10|||
143088903|NCT00696423|515864433|FG000|Overall Study|Lost to Follow-up|0|||
143088904|NCT00696423|515864434|FG001|Overall Study|Lost to Follow-up|5|||
143088905|NCT00818766|515864438|FG000|Overall Study|Could not be Contacted on Day 28|11|||
143088906|NCT00818766|515864439|FG001|Overall Study|Could not be Contacted on Day 28|10|||
143088907|NCT00818766|515864438|FG000|Overall Study|Death|1|||
143088908|NCT00818766|515864439|FG001|Overall Study|Death|0|||
143088909|NCT00818766|515864438|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
143088910|NCT00818766|515864439|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
143088911|NCT04515147|515864440|FG000|Overall Study|Withdrawal by Subject|1|||
143088912|NCT04515147|515864441|FG001|Overall Study|Withdrawal by Subject|0|||
143088913|NCT04515147|515864442|FG002|Overall Study|Withdrawal by Subject|10|||
143088914|NCT04515147|515864443|FG003|Overall Study|Withdrawal by Subject|18|||
143088915|NCT04515147|515864444|FG004|Overall Study|Withdrawal by Subject|1|||
143088916|NCT04515147|515864445|FG005|Overall Study|Withdrawal by Subject|8|||
143088917|NCT04515147|515864440|FG000|Overall Study|Lost to Follow-up|0|||
143088918|NCT04515147|515864441|FG001|Overall Study|Lost to Follow-up|1|||
143088919|NCT04515147|515864442|FG002|Overall Study|Lost to Follow-up|5|||
143088920|NCT04515147|515864443|FG003|Overall Study|Lost to Follow-up|6|||
143088921|NCT04515147|515864444|FG004|Overall Study|Lost to Follow-up|2|||
143088922|NCT04515147|515864445|FG005|Overall Study|Lost to Follow-up|1|||
143088923|NCT04515147|515864440|FG000|Overall Study|Adverse Event|0|||
143088924|NCT04515147|515864441|FG001|Overall Study|Adverse Event|0|||
143088925|NCT04515147|515864442|FG002|Overall Study|Adverse Event|0|||
143088926|NCT04515147|515864443|FG003|Overall Study|Adverse Event|2|||
143088927|NCT04515147|515864444|FG004|Overall Study|Adverse Event|0|||
143088928|NCT04515147|515864445|FG005|Overall Study|Adverse Event|0|||
143088929|NCT04515147|515864440|FG000|Overall Study|Miscellaneous|0|||
143088930|NCT04515147|515864441|FG001|Overall Study|Miscellaneous|0|||
143088931|NCT04515147|515864442|FG002|Overall Study|Miscellaneous|0|||
143088932|NCT04515147|515864443|FG003|Overall Study|Miscellaneous|1|||
143088933|NCT04515147|515864444|FG004|Overall Study|Miscellaneous|0|||
143088934|NCT04515147|515864445|FG005|Overall Study|Miscellaneous|1|||
143088935|NCT02760004|515864449|FG000|Overall Study|Lost to Follow-up|13|||
143088936|NCT02760004|515864450|FG001|Overall Study|Lost to Follow-up|22|||
143088937|NCT02719184|515864455|FG000|Overall Study|Other than listed|1|||
143088938|NCT02719184|515864456|FG001|Overall Study|Other than listed|12|||
143088939|NCT02719184|515864457|FG002|Overall Study|Other than listed|13|||
143088940|NCT02719184|515864458|FG003|Overall Study|Other than listed|22|||
143175780|NCT00527618|516192343|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
143175781|NCT00527618|516192344|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
143175782|NCT00776789|516192347|FG000|Overall Study|Consent refusal|2|||
143175783|NCT00776789|516192348|FG001|Overall Study|Consent refusal|2|||
143250677|NCT03745820|516472856|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
143250678|NCT03745820|516472857|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
143250679|NCT03745820|516472858|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
143250680|NCT03745820|516472856|FG000|Overall Study|Lost to Follow-up|2|||
143250681|NCT03745820|516472857|FG001|Overall Study|Lost to Follow-up|0|||
143250682|NCT03745820|516472858|FG002|Overall Study|Lost to Follow-up|3|||
143250683|NCT03745820|516472856|FG000|Overall Study|Reason not Specified|2|||
143250684|NCT03745820|516472857|FG001|Overall Study|Reason not Specified|4|||
143250685|NCT03745820|516472858|FG002|Overall Study|Reason not Specified|1|||
143250686|NCT00507728|516472859|FG000|Randomization to Month 3|Lost to Follow-up|15|||
143250687|NCT00507728|516472860|FG001|Randomization to Month 3|Lost to Follow-up|14|||
143250688|NCT00507728|516472861|FG002|Randomization to Month 3|Lost to Follow-up|20|||
143250689|NCT00507728|516472859|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
143250690|NCT00507728|516472860|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
143250691|NCT00507728|516472861|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
143250692|NCT01024309|516472868|FG000|Overall Study|Physician Decision|4|||
143250693|NCT01024309|516472869|FG001|Overall Study|Physician Decision|0|||
143250694|NCT01024309|516472868|FG000|Overall Study|Withdrawal by Subject|4|||
143250695|NCT01024309|516472869|FG001|Overall Study|Withdrawal by Subject|4|||
143250696|NCT02745145|516472872|FG000|Overall Study|Adverse Event|1|||
143250697|NCT02745145|516472873|FG001|Overall Study|Adverse Event|0|||
143250698|NCT02745145|516472874|FG002|Overall Study|Adverse Event|0|||
143250699|NCT02745145|516472872|FG000|Overall Study|Death|0|||
143175784|NCT00776789|516192347|FG000|Overall Study|Poor quality video|1|||
143175785|NCT00776789|516192348|FG001|Overall Study|Poor quality video|1|||
143175786|NCT00421148|516192350|FG000|Overall Study|Lost to Follow-up|0|||
143175787|NCT00421148|516192351|FG001|Overall Study|Lost to Follow-up|0|||
143175788|NCT00421148|516192352|FG002|Overall Study|Lost to Follow-up|0|||
143175789|NCT00421148|516192353|FG003|Overall Study|Lost to Follow-up|0|||
143175790|NCT00421148|516192354|FG004|Overall Study|Lost to Follow-up|0|||
143175791|NCT00421148|516192355|FG005|Overall Study|Lost to Follow-up|0|||
143175792|NCT00421148|516192356|FG006|Overall Study|Lost to Follow-up|0|||
143175793|NCT00421148|516192357|FG007|Overall Study|Lost to Follow-up|0|||
143175794|NCT00421148|516192358|FG008|Overall Study|Lost to Follow-up|0|||
143175795|NCT00421148|516192359|FG009|Overall Study|Lost to Follow-up|0|||
143250700|NCT02745145|516472873|FG001|Overall Study|Death|1|||
143250701|NCT02745145|516472874|FG002|Overall Study|Death|0|||
143088941|NCT02719184|515864459|FG004|Overall Study|Other than listed|9|||
143088942|NCT02719184|515864455|FG000|Overall Study|Withdrawal by Subject|5|||
143088943|NCT02719184|515864456|FG001|Overall Study|Withdrawal by Subject|3|||
143175796|NCT00421148|516192360|FG010|Overall Study|Lost to Follow-up|0|||
143175797|NCT00421148|516192361|FG011|Overall Study|Lost to Follow-up|0|||
143088944|NCT02719184|515864457|FG002|Overall Study|Withdrawal by Subject|6|||
143250702|NCT02745145|516472872|FG000|Overall Study|Progressive disease|0|||
143088945|NCT02719184|515864458|FG003|Overall Study|Withdrawal by Subject|6|||
143088946|NCT02719184|515864459|FG004|Overall Study|Withdrawal by Subject|0|||
143088947|NCT02719184|515864455|FG000|Overall Study|Lost to Follow-up|0|||
143088948|NCT02719184|515864456|FG001|Overall Study|Lost to Follow-up|4|||
143088949|NCT02719184|515864457|FG002|Overall Study|Lost to Follow-up|1|||
143088950|NCT02719184|515864458|FG003|Overall Study|Lost to Follow-up|3|||
143088951|NCT02719184|515864459|FG004|Overall Study|Lost to Follow-up|0|||
143088952|NCT02719184|515864455|FG000|Overall Study|Protocol Violation|0|||
143088953|NCT02719184|515864456|FG001|Overall Study|Protocol Violation|3|||
143175798|NCT00421148|516192362|FG012|Overall Study|Lost to Follow-up|0|||
143175799|NCT00421148|516192363|FG013|Overall Study|Lost to Follow-up|0|||
143175800|NCT00421148|516192364|FG014|Overall Study|Lost to Follow-up|0|||
143175801|NCT00421148|516192365|FG015|Overall Study|Lost to Follow-up|0|||
143175802|NCT00421148|516192366|FG016|Overall Study|Lost to Follow-up|0|||
143175803|NCT00421148|516192367|FG017|Overall Study|Lost to Follow-up|1|||
143175804|NCT00421148|516192368|FG018|Overall Study|Lost to Follow-up|0|||
143175805|NCT00421148|516192369|FG019|Overall Study|Lost to Follow-up|0|||
143175806|NCT00421148|516192350|FG000|Overall Study|Withdrawal by Subject|0|||
143175807|NCT00421148|516192351|FG001|Overall Study|Withdrawal by Subject|0|||
143175808|NCT00421148|516192352|FG002|Overall Study|Withdrawal by Subject|0|||
143175809|NCT00421148|516192353|FG003|Overall Study|Withdrawal by Subject|0|||
143175810|NCT00421148|516192354|FG004|Overall Study|Withdrawal by Subject|0|||
143175811|NCT00421148|516192355|FG005|Overall Study|Withdrawal by Subject|0|||
143175812|NCT00421148|516192356|FG006|Overall Study|Withdrawal by Subject|0|||
143175813|NCT00421148|516192357|FG007|Overall Study|Withdrawal by Subject|0|||
143175814|NCT00421148|516192358|FG008|Overall Study|Withdrawal by Subject|0|||
143175815|NCT00421148|516192359|FG009|Overall Study|Withdrawal by Subject|0|||
143175816|NCT00421148|516192360|FG010|Overall Study|Withdrawal by Subject|0|||
143175817|NCT00421148|516192361|FG011|Overall Study|Withdrawal by Subject|0|||
143175818|NCT00421148|516192362|FG012|Overall Study|Withdrawal by Subject|0|||
143175819|NCT00421148|516192363|FG013|Overall Study|Withdrawal by Subject|0|||
143175820|NCT00421148|516192364|FG014|Overall Study|Withdrawal by Subject|0|||
143175821|NCT00421148|516192365|FG015|Overall Study|Withdrawal by Subject|0|||
143175822|NCT00421148|516192366|FG016|Overall Study|Withdrawal by Subject|0|||
143175823|NCT00421148|516192367|FG017|Overall Study|Withdrawal by Subject|1|||
143175824|NCT00421148|516192368|FG018|Overall Study|Withdrawal by Subject|0|||
143175825|NCT00421148|516192369|FG019|Overall Study|Withdrawal by Subject|0|||
143175826|NCT00421148|516192350|FG000|Overall Study|Protocol Violation|0|||
143175827|NCT00421148|516192351|FG001|Overall Study|Protocol Violation|0|||
143175828|NCT00421148|516192352|FG002|Overall Study|Protocol Violation|0|||
143175829|NCT00421148|516192353|FG003|Overall Study|Protocol Violation|0|||
143175830|NCT00421148|516192354|FG004|Overall Study|Protocol Violation|0|||
143175831|NCT00421148|516192355|FG005|Overall Study|Protocol Violation|1|||
143175832|NCT00421148|516192356|FG006|Overall Study|Protocol Violation|0|||
143175833|NCT00421148|516192357|FG007|Overall Study|Protocol Violation|0|||
143175834|NCT00421148|516192358|FG008|Overall Study|Protocol Violation|0|||
143175835|NCT00421148|516192359|FG009|Overall Study|Protocol Violation|0|||
143175836|NCT00421148|516192360|FG010|Overall Study|Protocol Violation|0|||
143175837|NCT00421148|516192361|FG011|Overall Study|Protocol Violation|0|||
143175838|NCT00421148|516192362|FG012|Overall Study|Protocol Violation|0|||
143175839|NCT00421148|516192363|FG013|Overall Study|Protocol Violation|0|||
143175840|NCT00421148|516192364|FG014|Overall Study|Protocol Violation|0|||
143175841|NCT00421148|516192365|FG015|Overall Study|Protocol Violation|0|||
143175842|NCT00421148|516192366|FG016|Overall Study|Protocol Violation|0|||
143175843|NCT00421148|516192367|FG017|Overall Study|Protocol Violation|0|||
143175844|NCT00421148|516192368|FG018|Overall Study|Protocol Violation|1|||
143175845|NCT00421148|516192369|FG019|Overall Study|Protocol Violation|0|||
143175846|NCT01253369|516192371|FG000|Overall Study|Adverse Event|4|||
143175847|NCT01253369|516192371|FG000|Overall Study|Withdrawal by Subject|2|||
143175848|NCT01253369|516192371|FG000|Overall Study|Death|1|||
143175849|NCT01253369|516192371|FG000|Overall Study|Progressive disease|23|||
143250703|NCT02745145|516472873|FG001|Overall Study|Progressive disease|0|||
143250704|NCT02745145|516472874|FG002|Overall Study|Progressive disease|1|||
143250705|NCT02745145|516472872|FG000|Overall Study|Withdrew consent|1|||
143088954|NCT02719184|515864457|FG002|Overall Study|Protocol Violation|0|||
143088955|NCT02719184|515864458|FG003|Overall Study|Protocol Violation|2|||
143175850|NCT01253369|516192371|FG000|Overall Study|Not Evaluable|3|||
143175851|NCT01055613|516192373|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
143175852|NCT01055613|516192374|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
143175853|NCT01055613|516192373|FG000|Overall Study|Unacceptable lens fit|1|||
143088956|NCT02719184|515864459|FG004|Overall Study|Protocol Violation|0|||
143175854|NCT01055613|516192374|FG001|Overall Study|Unacceptable lens fit|0|||
143175855|NCT01055613|516192373|FG000|Overall Study|Discomfort|2|||
143175856|NCT01055613|516192374|FG001|Overall Study|Discomfort|1|||
143175857|NCT01055613|516192373|FG000|Overall Study|Lost to Follow-up|1|||
143175858|NCT01055613|516192374|FG001|Overall Study|Lost to Follow-up|1|||
143175859|NCT01055613|516192373|FG000|Overall Study|Protocol Violation|1|||
143175860|NCT01055613|516192374|FG001|Overall Study|Protocol Violation|1|||
143250706|NCT02745145|516472873|FG001|Overall Study|Withdrew consent|1|||
143088957|NCT02719184|515864455|FG000|Overall Study|Adverse Event|0|||
143088958|NCT02719184|515864456|FG001|Overall Study|Adverse Event|0|||
143088959|NCT02719184|515864457|FG002|Overall Study|Adverse Event|0|||
143088960|NCT02719184|515864458|FG003|Overall Study|Adverse Event|3|||
143088961|NCT02719184|515864459|FG004|Overall Study|Adverse Event|0|||
143088962|NCT01026194|515864468|FG000|Period 1：Double Blind Period|Adverse Event|2|||
143088963|NCT01026194|515864469|FG001|Period 1：Double Blind Period|Adverse Event|1|||
143250707|NCT02745145|516472874|FG002|Overall Study|Withdrew consent|1|||
143250708|NCT02745145|516472872|FG000|Overall Study|Study Termination|8|||
143250709|NCT02745145|516472873|FG001|Overall Study|Study Termination|3|||
143250710|NCT02745145|516472874|FG002|Overall Study|Study Termination|7|||
143250711|NCT00796445|516472875|FG000|Overall Study|Protocol Violation|5|||
143250712|NCT00796445|516472876|FG001|Overall Study|Protocol Violation|3|||
143250713|NCT00796445|516472875|FG000|Overall Study|Adverse event, serious fatal|10|||
143250714|NCT00796445|516472876|FG001|Overall Study|Adverse event, serious fatal|5|||
143250715|NCT00796445|516472875|FG000|Overall Study|Adverse event, non-fatal|4|||
143250716|NCT00796445|516472876|FG001|Overall Study|Adverse event, non-fatal|0|||
143088964|NCT01026194|515864468|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
143088965|NCT01026194|515864469|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
143088966|NCT01026194|515864468|FG000|Period 1：Double Blind Period|Physician Decision|0|||
143088967|NCT01026194|515864469|FG001|Period 1：Double Blind Period|Physician Decision|4|||
143088968|NCT01026194|515864468|FG000|Period 2：Open-label Period|Adverse Event|4|||
143088969|NCT01026194|515864469|FG001|Period 2：Open-label Period|Adverse Event|5|||
143088970|NCT01026194|515864468|FG000|Period 2：Open-label Period|Physician Decision|3|||
143088971|NCT01026194|515864469|FG001|Period 2：Open-label Period|Physician Decision|1|||
143088972|NCT01026194|515864468|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
143088973|NCT01026194|515864469|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
143088974|NCT02515331|515864472|FG000|Overall Study|Withdrawal by Subject|0|||
143088975|NCT02515331|515864473|FG001|Overall Study|Withdrawal by Subject|0|||
143088976|NCT02515331|515864474|FG002|Overall Study|Withdrawal by Subject|1|||
143088977|NCT02515331|515864472|FG000|Overall Study|Protocol deviation|0|||
143088978|NCT02515331|515864473|FG001|Overall Study|Protocol deviation|0|||
143088979|NCT02515331|515864474|FG002|Overall Study|Protocol deviation|3|||
143088980|NCT02515331|515864472|FG000|Overall Study|Adverse Event|2|||
143088981|NCT02515331|515864473|FG001|Overall Study|Adverse Event|0|||
143088982|NCT02515331|515864474|FG002|Overall Study|Adverse Event|0|||
143088983|NCT00124748|515864475|FG000|Overall Study|Adverse Event|8|||
143088984|NCT00124748|515864476|FG001|Overall Study|Adverse Event|39|||
143088985|NCT00124748|515864475|FG000|Overall Study|Abnormal laboratory Value|2|||
143088986|NCT00124748|515864476|FG001|Overall Study|Abnormal laboratory Value|2|||
143088987|NCT00124748|515864475|FG000|Overall Study|Abnormal Procedure|0|||
143088988|NCT00124748|515864476|FG001|Overall Study|Abnormal Procedure|1|||
143088989|NCT00124748|515864475|FG000|Overall Study|Lack of Efficacy|20|||
143088990|NCT00124748|515864476|FG001|Overall Study|Lack of Efficacy|41|||
143088991|NCT00124748|515864475|FG000|Overall Study|No longer requires study drug|1|||
143088992|NCT00124748|515864476|FG001|Overall Study|No longer requires study drug|1|||
143088993|NCT00124748|515864475|FG000|Overall Study|Protocol Violation|3|||
143088994|NCT00124748|515864476|FG001|Overall Study|Protocol Violation|1|||
143088995|NCT00124748|515864475|FG000|Overall Study|Withdrawal by Subject|5|||
143088996|NCT00124748|515864476|FG001|Overall Study|Withdrawal by Subject|15|||
143088997|NCT00124748|515864475|FG000|Overall Study|Lost to Follow-up|2|||
143088998|NCT00124748|515864476|FG001|Overall Study|Lost to Follow-up|7|||
143088999|NCT00124748|515864475|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
143089000|NCT00124748|515864476|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
143089001|NCT00124748|515864475|FG000|Overall Study|Death|1|||
143089002|NCT00124748|515864476|FG001|Overall Study|Death|3|||
143089003|NCT00322712|515864477|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
143250717|NCT00796445|516472875|FG000|Overall Study|Disease progression/recurrence|537|||
143089004|NCT03889886|515864478|FG000|Overall Study|Other|0|||
143089005|NCT03889886|515864479|FG001|Overall Study|Other|1|||
143089006|NCT03889886|515864480|FG002|Overall Study|Other|0|||
143089007|NCT03889886|515864481|FG003|Overall Study|Other|1|||
143089008|NCT03889886|515864478|FG000|Overall Study|Withdrawal by Subject|0|||
143089009|NCT03889886|515864479|FG001|Overall Study|Withdrawal by Subject|0|||
143089010|NCT03889886|515864480|FG002|Overall Study|Withdrawal by Subject|1|||
143089011|NCT03889886|515864481|FG003|Overall Study|Withdrawal by Subject|0|||
143089012|NCT03889886|515864478|FG000|Overall Study|Adverse Event|0|||
143089013|NCT03889886|515864479|FG001|Overall Study|Adverse Event|0|||
143089014|NCT03889886|515864480|FG002|Overall Study|Adverse Event|0|||
143089015|NCT03889886|515864481|FG003|Overall Study|Adverse Event|6|||
143089016|NCT00758524|515864484|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
143089017|NCT00758524|515864485|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
143089018|NCT00758524|515864486|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
143089019|NCT00758524|515864487|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
143089020|NCT00758524|515864488|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
143089021|NCT00758524|515864489|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
143089022|NCT00758524|515864490|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
143089023|NCT00758524|515864491|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
143089024|NCT00758524|515864492|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
143089025|NCT00758524|515864493|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
143089026|NCT00758524|515864494|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
143089027|NCT00758524|515864495|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
143089028|NCT00758524|515864496|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
143089029|NCT00758524|515864497|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
143089030|NCT00758524|515864498|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
143089031|NCT00758524|515864499|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
143089032|NCT00758524|515864500|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
143089033|NCT00758524|515864484|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
143089034|NCT00758524|515864485|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
143089035|NCT00758524|515864486|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
143089036|NCT00758524|515864487|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
143089037|NCT00758524|515864488|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
143089038|NCT00758524|515864489|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
143089039|NCT00758524|515864490|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
143089040|NCT00758524|515864491|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
143089041|NCT00758524|515864492|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
143089042|NCT00758524|515864493|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
143089043|NCT00758524|515864494|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
143089044|NCT00758524|515864495|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
143089045|NCT00758524|515864496|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
143089046|NCT00758524|515864497|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
143175861|NCT01055613|516192373|FG000|Overall Study|Subject Disinterest|1|||
143175862|NCT01055613|516192374|FG001|Overall Study|Subject Disinterest|1|||
143175863|NCT02103062|516192377|FG000|Overall Study|Adverse Event|1|||
143175864|NCT02103062|516192378|FG001|Overall Study|Adverse Event|2|||
143175865|NCT02103062|516192377|FG000|Overall Study|Progressive Disease|17|||
143175866|NCT02103062|516192378|FG001|Overall Study|Progressive Disease|20|||
143175867|NCT02103062|516192377|FG000|Overall Study|Death|0|||
143175868|NCT02103062|516192378|FG001|Overall Study|Death|1|||
143175869|NCT01822665|516192381|FG000|Overall Study|Adverse Event|3|||
143175870|NCT01822665|516192381|FG000|Overall Study|Other Reason|5|||
143175871|NCT04540367|516192382|FG000|Overall Study|Withdrawal by Subject|0|||
143175872|NCT04540367|516192383|FG001|Overall Study|Withdrawal by Subject|0|||
143175873|NCT04540367|516192384|FG002|Overall Study|Withdrawal by Subject|0|||
143175874|NCT04540367|516192385|FG003|Overall Study|Withdrawal by Subject|2|||
143175875|NCT04540367|516192382|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
143175876|NCT04540367|516192383|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
143175877|NCT04540367|516192384|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
143175878|NCT04540367|516192385|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
143175879|NCT04540367|516192382|FG000|Overall Study|Adverse Event|0|||
143175880|NCT04540367|516192383|FG001|Overall Study|Adverse Event|0|||
143175881|NCT04540367|516192384|FG002|Overall Study|Adverse Event|1|||
143089047|NCT00758524|515864498|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
143175882|NCT04540367|516192385|FG003|Overall Study|Adverse Event|1|||
143175883|NCT04290624|516192388|FG000|Overall Study|Adverse Event|1|||
143175884|NCT04290624|516192389|FG001|Overall Study|Adverse Event|0|||
143175885|NCT03571971|516192390|FG000|Overall Study|Lost to Follow-up|2|||
143175886|NCT03571971|516192391|FG001|Overall Study|Lost to Follow-up|2|||
143089048|NCT00758524|515864499|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
143089049|NCT00758524|515864500|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
143089050|NCT00758524|515864484|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
143089051|NCT00758524|515864485|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
143089052|NCT00758524|515864486|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
143089053|NCT00758524|515864487|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
143089054|NCT00758524|515864488|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
143089055|NCT00758524|515864489|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
143089056|NCT00758524|515864490|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
143089057|NCT00758524|515864491|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
143089058|NCT00758524|515864492|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
143089059|NCT00758524|515864493|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
143089060|NCT00758524|515864494|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
143089061|NCT00758524|515864495|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
143089062|NCT00758524|515864496|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
143089063|NCT00758524|515864497|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
143089064|NCT00758524|515864498|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
143089065|NCT00758524|515864499|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
143089066|NCT00758524|515864500|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
143089067|NCT00758524|515864484|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
143089068|NCT00758524|515864485|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
143089069|NCT00758524|515864486|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
143089070|NCT00758524|515864487|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
143089071|NCT00758524|515864488|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
143089072|NCT00758524|515864489|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
143089073|NCT00758524|515864490|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
143089074|NCT00758524|515864491|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
143089075|NCT00758524|515864492|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
143089076|NCT00758524|515864493|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
143089077|NCT00758524|515864494|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
143089078|NCT00758524|515864495|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
143089079|NCT00758524|515864496|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
143089080|NCT00758524|515864497|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
143089081|NCT00758524|515864498|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
143089082|NCT00758524|515864499|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
143089083|NCT00758524|515864500|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
143089084|NCT00758524|515864484|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
143089085|NCT00758524|515864485|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
143089086|NCT00758524|515864486|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
143089087|NCT00758524|515864487|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
143089088|NCT00758524|515864488|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
143089089|NCT00758524|515864489|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
143089090|NCT00758524|515864490|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
143089091|NCT00758524|515864491|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
143089092|NCT00758524|515864492|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
143089093|NCT00758524|515864493|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
143089094|NCT00758524|515864494|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
143089095|NCT00758524|515864495|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
143089096|NCT00758524|515864496|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
143089097|NCT00758524|515864497|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
143089098|NCT00758524|515864498|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
143089099|NCT00758524|515864499|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
143089100|NCT00758524|515864500|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
143089101|NCT00758524|515864484|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
143089102|NCT00758524|515864485|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
143089103|NCT00758524|515864486|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
143089104|NCT00758524|515864487|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
143089105|NCT00758524|515864488|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
143175887|NCT03571971|516192390|FG000|Overall Study|Protocol Violation|2|||
143089106|NCT00758524|515864489|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
143089107|NCT00758524|515864490|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
143089108|NCT00758524|515864491|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
143089109|NCT00758524|515864492|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
143089110|NCT00758524|515864493|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
143089111|NCT00758524|515864494|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
143089112|NCT00758524|515864495|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
143089113|NCT00758524|515864496|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
143089114|NCT00758524|515864497|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
143089115|NCT00758524|515864498|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
143089116|NCT00758524|515864499|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
143089117|NCT00758524|515864500|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
143089118|NCT00758524|515864484|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
143089119|NCT00758524|515864485|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
143089120|NCT00758524|515864486|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
143089121|NCT00758524|515864487|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
143089122|NCT00758524|515864488|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
143089123|NCT00758524|515864489|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
143089124|NCT00758524|515864490|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
143089125|NCT00758524|515864491|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
143089126|NCT00758524|515864492|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
143089127|NCT00758524|515864493|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
143089128|NCT00758524|515864494|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
143089129|NCT00758524|515864495|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
143089130|NCT00758524|515864496|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
143089131|NCT00758524|515864497|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
143089132|NCT00758524|515864498|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
143089133|NCT00758524|515864499|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
143089134|NCT00758524|515864500|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
143089135|NCT00758524|515864484|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
143089136|NCT00758524|515864485|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
143089137|NCT00758524|515864486|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
143089138|NCT00758524|515864487|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
143089139|NCT00758524|515864488|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
143089140|NCT00758524|515864489|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
143089141|NCT00758524|515864490|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
143089142|NCT00758524|515864491|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
143089143|NCT00758524|515864492|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
143089144|NCT00758524|515864493|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
143089145|NCT00758524|515864494|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
143089146|NCT00758524|515864495|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
143089147|NCT00758524|515864496|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
143089148|NCT00758524|515864497|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
143089149|NCT00758524|515864498|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
143089150|NCT00758524|515864499|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
143089151|NCT00758524|515864500|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
143089152|NCT00758524|515864484|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
143089153|NCT00758524|515864485|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
143089154|NCT00758524|515864486|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
143089155|NCT00758524|515864487|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
143089156|NCT00758524|515864488|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
143089157|NCT00758524|515864489|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
143089158|NCT00758524|515864490|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
143089159|NCT00758524|515864491|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
143089160|NCT00758524|515864492|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
143089161|NCT00758524|515864493|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
143089162|NCT00758524|515864494|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
143089163|NCT00758524|515864495|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
143250718|NCT00796445|516472876|FG001|Overall Study|Disease progression/recurrence|268|||
143250719|NCT00796445|516472875|FG000|Overall Study|Other|10|||
143250720|NCT00796445|516472876|FG001|Overall Study|Other|7|||
143250721|NCT00796445|516472875|FG000|Overall Study|Withdrawal by Subject|18|||
143250722|NCT00796445|516472876|FG001|Overall Study|Withdrawal by Subject|9|||
143250723|NCT00796445|516472875|FG000|Overall Study|Invalid Informed Consent Form|1|||
143089164|NCT00758524|515864496|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
143089165|NCT00758524|515864497|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
143089166|NCT00758524|515864498|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
143089167|NCT00758524|515864499|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
143089168|NCT00758524|515864500|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
143089169|NCT00758524|515864484|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
143089170|NCT00758524|515864485|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
143089171|NCT00758524|515864486|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
143089172|NCT00758524|515864487|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
143089173|NCT00758524|515864488|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
143089174|NCT00758524|515864489|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
143089175|NCT00758524|515864490|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
143089176|NCT00758524|515864491|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
143089177|NCT00758524|515864492|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
143089178|NCT00758524|515864493|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
143089179|NCT00758524|515864494|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
143089180|NCT00758524|515864495|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
143089181|NCT00758524|515864496|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
143089182|NCT00758524|515864497|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
143089183|NCT00758524|515864498|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
143089184|NCT00758524|515864499|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
143089185|NCT00758524|515864500|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
143089186|NCT00276484|515864501|FG000|Overall Study|Adverse Event|4|||
143089187|NCT00276484|515864502|FG001|Overall Study|Adverse Event|7|||
143089188|NCT00276484|515864501|FG000|Overall Study|Lost to Follow-up|1|||
143089189|NCT00276484|515864502|FG001|Overall Study|Lost to Follow-up|1|||
143089190|NCT00276484|515864501|FG000|Overall Study|Protocol Violation|0|||
143089191|NCT00276484|515864502|FG001|Overall Study|Protocol Violation|1|||
143089192|NCT00276484|515864501|FG000|Overall Study|Withdrawal by Subject|4|||
143089193|NCT00276484|515864502|FG001|Overall Study|Withdrawal by Subject|3|||
143089194|NCT00276484|515864501|FG000|Overall Study|Could not take time off work|0|||
143089195|NCT00276484|515864502|FG001|Overall Study|Could not take time off work|1|||
143089196|NCT04747470|515864511|FG000|Overall Study|Death|0|||
143089197|NCT04747470|515864512|FG001|Overall Study|Death|3|||
143089198|NCT04747470|515864513|FG002|Overall Study|Death|2|||
143089199|NCT04747470|515864514|FG003|Overall Study|Death|2|||
143089200|NCT04747470|515864515|FG004|Overall Study|Death|2|||
143089201|NCT04747470|515864516|FG005|Overall Study|Death|0|||
143089202|NCT04747470|515864517|FG006|Overall Study|Death|0|||
143089203|NCT04747470|515864518|FG007|Overall Study|Death|0|||
143089204|NCT04747470|515864519|FG008|Overall Study|Death|0|||
143089205|NCT04747470|515864520|FG009|Overall Study|Death|0|||
143089206|NCT04747470|515864521|FG010|Overall Study|Death|0|||
143089207|NCT04747470|515864511|FG000|Overall Study|Withdrew Consent|0|||
143089208|NCT04747470|515864512|FG001|Overall Study|Withdrew Consent|0|||
143089209|NCT04747470|515864513|FG002|Overall Study|Withdrew Consent|0|||
143089210|NCT04747470|515864514|FG003|Overall Study|Withdrew Consent|1|||
143089211|NCT04747470|515864515|FG004|Overall Study|Withdrew Consent|0|||
143089212|NCT04747470|515864516|FG005|Overall Study|Withdrew Consent|0|||
143089213|NCT04747470|515864517|FG006|Overall Study|Withdrew Consent|0|||
143089214|NCT04747470|515864518|FG007|Overall Study|Withdrew Consent|0|||
143089215|NCT04747470|515864519|FG008|Overall Study|Withdrew Consent|0|||
143089216|NCT04747470|515864520|FG009|Overall Study|Withdrew Consent|0|||
143089217|NCT04747470|515864521|FG010|Overall Study|Withdrew Consent|0|||
143089218|NCT04747470|515864511|FG000|Overall Study|Study Terminated by Sponsor|0|||
143089219|NCT04747470|515864512|FG001|Overall Study|Study Terminated by Sponsor|0|||
143089220|NCT04747470|515864513|FG002|Overall Study|Study Terminated by Sponsor|1|||
143089221|NCT04747470|515864514|FG003|Overall Study|Study Terminated by Sponsor|0|||
143089222|NCT04747470|515864515|FG004|Overall Study|Study Terminated by Sponsor|2|||
143089223|NCT04747470|515864516|FG005|Overall Study|Study Terminated by Sponsor|0|||
143175888|NCT03571971|516192391|FG001|Overall Study|Protocol Violation|3|||
143175889|NCT03571971|516192390|FG000|Overall Study|Withdrawal by Subject|2|||
143175890|NCT03571971|516192391|FG001|Overall Study|Withdrawal by Subject|0|||
143175891|NCT03571971|516192390|FG000|Overall Study|Incomplete primary outcome data|2|||
143175892|NCT03571971|516192391|FG001|Overall Study|Incomplete primary outcome data|0|||
143175893|NCT04067492|516192392|FG000|Overall Study|Lost to Follow-up|0|||
143175894|NCT04067492|516192393|FG001|Overall Study|Lost to Follow-up|0|||
143175895|NCT04067492|516192394|FG002|Overall Study|Lost to Follow-up|0|||
143175896|NCT04067492|516192395|FG003|Overall Study|Lost to Follow-up|0|||
143175897|NCT04067492|516192396|FG004|Overall Study|Lost to Follow-up|0|||
143175898|NCT04067492|516192397|FG005|Overall Study|Lost to Follow-up|1|||
143175899|NCT04067492|516192392|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
143175900|NCT04067492|516192393|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
143089224|NCT04747470|515864517|FG006|Overall Study|Study Terminated by Sponsor|0|||
143089225|NCT04747470|515864518|FG007|Overall Study|Study Terminated by Sponsor|0|||
143089226|NCT04747470|515864519|FG008|Overall Study|Study Terminated by Sponsor|0|||
143089227|NCT04747470|515864520|FG009|Overall Study|Study Terminated by Sponsor|0|||
143089228|NCT04747470|515864521|FG010|Overall Study|Study Terminated by Sponsor|0|||
143089229|NCT01960257|515864522|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
143089230|NCT01960257|515864523|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
143089231|NCT01960257|515864524|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
143089232|NCT01960257|515864522|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
143089233|NCT01960257|515864523|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
143089234|NCT01960257|515864524|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
143089235|NCT01960257|515864522|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
143089236|NCT01960257|515864523|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
143089237|NCT01960257|515864524|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
143089238|NCT03749330|515864525|FG000|Overall Study|Clinicians left work in the CICU|0|||
143089239|NCT03749330|515864526|FG001|Overall Study|Clinicians left work in the CICU|2|||
143089240|NCT03749330|515864527|FG002|Overall Study|Clinicians left work in the CICU|0|||
143089241|NCT03749330|515864528|FG003|Overall Study|Clinicians left work in the CICU|0|||
143089242|NCT03749330|515864529|FG004|Overall Study|Clinicians left work in the CICU|0|||
143089243|NCT03749330|515864530|FG005|Overall Study|Clinicians left work in the CICU|0|||
143089244|NCT01125189|515864531|FG000|Treatment Period|Lack of Efficacy|15|||
143089245|NCT01125189|515864532|FG001|Treatment Period|Lack of Efficacy|18|||
143089246|NCT01125189|515864533|FG002|Treatment Period|Lack of Efficacy|25|||
143089247|NCT01125189|515864531|FG000|Treatment Period|Adverse Event|7|||
143089248|NCT01125189|515864532|FG001|Treatment Period|Adverse Event|8|||
143089249|NCT01125189|515864533|FG002|Treatment Period|Adverse Event|8|||
143089250|NCT01125189|515864531|FG000|Treatment Period|Withdrawal by Subject|3|||
143089251|NCT01125189|515864532|FG001|Treatment Period|Withdrawal by Subject|1|||
143089252|NCT01125189|515864533|FG002|Treatment Period|Withdrawal by Subject|1|||
143089253|NCT01125189|515864531|FG000|Treatment Period|Death|1|||
143089254|NCT01125189|515864532|FG001|Treatment Period|Death|0|||
143089255|NCT01125189|515864533|FG002|Treatment Period|Death|0|||
143089256|NCT01125189|515864531|FG000|Treatment Period|Lost to Follow-up|1|||
143089257|NCT01125189|515864532|FG001|Treatment Period|Lost to Follow-up|2|||
143089258|NCT01125189|515864533|FG002|Treatment Period|Lost to Follow-up|1|||
143089259|NCT01125189|515864531|FG000|Treatment Period|Poor compliance/noncompliance|0|||
143089260|NCT01125189|515864532|FG001|Treatment Period|Poor compliance/noncompliance|1|||
143089261|NCT01125189|515864533|FG002|Treatment Period|Poor compliance/noncompliance|0|||
143089262|NCT01125189|515864531|FG000|Treatment Period|Participants requested to discontinue|1|||
143089263|NCT01125189|515864532|FG001|Treatment Period|Participants requested to discontinue|3|||
143089264|NCT01125189|515864533|FG002|Treatment Period|Participants requested to discontinue|4|||
143089265|NCT01125189|515864531|FG000|Treatment Period|Other reasons|1|||
143089266|NCT01125189|515864532|FG001|Treatment Period|Other reasons|1|||
143089267|NCT01125189|515864533|FG002|Treatment Period|Other reasons|0|||
143089268|NCT01125189|515864531|FG000|Treatment Period|Completed 24 week treatment period only|2|||
143089269|NCT01125189|515864532|FG001|Treatment Period|Completed 24 week treatment period only|1|||
143089270|NCT01125189|515864533|FG002|Treatment Period|Completed 24 week treatment period only|2|||
143089271|NCT01125189|515864531|FG000|Follow up Period|Withdrawal by Subject|3|||
143089272|NCT01125189|515864532|FG001|Follow up Period|Withdrawal by Subject|2|||
143089273|NCT01125189|515864533|FG002|Follow up Period|Withdrawal by Subject|5|||
143089274|NCT01125189|515864531|FG000|Follow up Period|Death|1|||
143089275|NCT01125189|515864532|FG001|Follow up Period|Death|0|||
143089276|NCT01125189|515864533|FG002|Follow up Period|Death|0|||
143089277|NCT01125189|515864531|FG000|Follow up Period|Lost to Follow-up|12|||
143089278|NCT01125189|515864532|FG001|Follow up Period|Lost to Follow-up|9|||
143089279|NCT01125189|515864533|FG002|Follow up Period|Lost to Follow-up|6|||
143089280|NCT01125189|515864531|FG000|Follow up Period|Other reasons|4|||
143089281|NCT01125189|515864532|FG001|Follow up Period|Other reasons|4|||
143089282|NCT01125189|515864533|FG002|Follow up Period|Other reasons|5|||
143089283|NCT01518322|515864534|FG000|Overall Study|FeNO measurement was missing|13|||
143089284|NCT01269918|515864535|FG000|Overall Study|Did not receive study drug|0|||
143089285|NCT01269918|515864536|FG001|Overall Study|Did not receive study drug|3|||
143089286|NCT00856193|515864539|FG000|Period 2|Abnormal test procedure results|0|||
143089287|NCT00856193|515864540|FG001|Period 2|Abnormal test procedure results|1|||
143089288|NCT00856193|515864539|FG000|Period 2|Lost to Follow-up|0|||
143089289|NCT00856193|515864540|FG001|Period 2|Lost to Follow-up|1|||
143089290|NCT02635984|515864542|FG000|Overall Study|Lost to Follow-up|2|||
143089291|NCT02635984|515864543|FG001|Overall Study|Lost to Follow-up|4|||
143089292|NCT02635984|515864542|FG000|Overall Study|Study Arm Closed|1|||
143089293|NCT02635984|515864543|FG001|Overall Study|Study Arm Closed|0|||
143089294|NCT00307086|515864544|FG000|Overall Study|ineligible|5|||
143089295|NCT01487525|515864545|FG000|Overall Study|Withdrawal by Subject|0|||
143089296|NCT01487525|515864546|FG001|Overall Study|Withdrawal by Subject|1|||
143089297|NCT01870778|515864549|FG000|Overall Study|Withdrawal by Subject|8|||
143089298|NCT01870778|515864550|FG001|Overall Study|Withdrawal by Subject|7|||
143089299|NCT01870778|515864549|FG000|Overall Study|Lost to Follow-up|0|||
143089300|NCT01870778|515864550|FG001|Overall Study|Lost to Follow-up|2|||
143089301|NCT04583735|515864551|FG000|Double-masked Treatment Period|Adverse Event|0|||
143089302|NCT04583735|515864552|FG001|Double-masked Treatment Period|Adverse Event|1|||
143089303|NCT04583735|515864551|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
143089304|NCT04583735|515864552|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
143089305|NCT04583735|515864551|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
143089306|NCT04583735|515864552|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
143089307|NCT04583735|515864551|FG000|Open-label Treatment Period|Adverse Event|1|||
143089308|NCT04583735|515864552|FG001|Open-label Treatment Period|Adverse Event|1|||
143089309|NCT04583735|515864551|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
143089310|NCT04583735|515864552|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
143175901|NCT04067492|516192394|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
143089311|NCT04583735|515864551|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
143089312|NCT04583735|515864552|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
143089313|NCT01215136|515864553|FG000|Overall Study|Adverse Event|2|||
143089314|NCT01215136|515864554|FG001|Overall Study|Adverse Event|9|||
143089315|NCT01215136|515864553|FG000|Overall Study|Disease Progression|3|||
143089316|NCT01215136|515864554|FG001|Overall Study|Disease Progression|14|||
143089317|NCT01215136|515864553|FG000|Overall Study|Symptomatic Deterioration|1|||
143089318|NCT01215136|515864554|FG001|Overall Study|Symptomatic Deterioration|1|||
143089319|NCT01215136|515864553|FG000|Overall Study|Death|0|||
143089320|NCT01215136|515864554|FG001|Overall Study|Death|2|||
143089321|NCT01215136|515864553|FG000|Overall Study|Withdrawal by Subject|0|||
143089322|NCT01215136|515864554|FG001|Overall Study|Withdrawal by Subject|1|||
143089323|NCT00995774|515864561|FG000|Training Period 2|Withdrawal by Subject|2|||
143089324|NCT00995774|515864562|FG001|Training Period 2|Withdrawal by Subject|0|||
143089325|NCT02905032|515864564|FG000|Overall Study|Withdrawal by Subject|2|||
143089326|NCT02905032|515864565|FG001|Overall Study|Withdrawal by Subject|0|||
143089327|NCT02905032|515864566|FG002|Overall Study|Withdrawal by Subject|0|||
143089328|NCT02905032|515864564|FG000|Overall Study|Protocol Violation|6|||
143089329|NCT02905032|515864565|FG001|Overall Study|Protocol Violation|12|||
143089330|NCT02905032|515864566|FG002|Overall Study|Protocol Violation|0|||
143089331|NCT00739063|515864567|FG000|Overall Study|Screen failures|8|||
143089332|NCT00711243|515866089|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
143089333|NCT00711243|515866090|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
143089334|NCT00711243|515866091|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
143089335|NCT00711243|515866092|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
143089336|NCT00711243|515866093|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
143089337|NCT00711243|515866094|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
143089338|NCT00711243|515866089|FG000|Reached First Response/4 Cycles|Death|0|||
143089339|NCT00711243|515866090|FG001|Reached First Response/4 Cycles|Death|0|||
143089340|NCT00711243|515866091|FG002|Reached First Response/4 Cycles|Death|0|||
143089341|NCT00711243|515866092|FG003|Reached First Response/4 Cycles|Death|0|||
143089342|NCT00711243|515866093|FG004|Reached First Response/4 Cycles|Death|0|||
143089343|NCT00711243|515866094|FG005|Reached First Response/4 Cycles|Death|2|||
143089344|NCT00711243|515866089|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
143089345|NCT00711243|515866090|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
143175902|NCT04067492|516192395|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
143175903|NCT04067492|516192396|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
143175904|NCT04067492|516192397|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
143175905|NCT04067492|516192392|FG000|Overall Study|COVID-19 epidemiological situation|0|||
143175906|NCT04067492|516192393|FG001|Overall Study|COVID-19 epidemiological situation|0|||
143175907|NCT04067492|516192394|FG002|Overall Study|COVID-19 epidemiological situation|0|||
143175908|NCT04067492|516192395|FG003|Overall Study|COVID-19 epidemiological situation|1|||
143175909|NCT04067492|516192396|FG004|Overall Study|COVID-19 epidemiological situation|0|||
143175910|NCT04067492|516192397|FG005|Overall Study|COVID-19 epidemiological situation|0|||
143175911|NCT00656370|516192404|FG000|Overall Study|Screen Failures|7|||
143175912|NCT00656370|516192404|FG000|Overall Study|Alternates|3|||
143175913|NCT04021290|516192409|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
143175914|NCT04021290|516192410|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
143175915|NCT04021290|516192411|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
143175916|NCT04021290|516192409|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
143175917|NCT04021290|516192410|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
143175918|NCT04021290|516192411|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
143175919|NCT04021290|516192409|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
143175920|NCT04021290|516192410|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
143175921|NCT04021290|516192411|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
143175922|NCT04021290|516192409|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
143175923|NCT04021290|516192410|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
143175924|NCT04021290|516192411|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
143175925|NCT04021290|516192409|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
143089346|NCT00711243|515866091|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
143089347|NCT00711243|515866092|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
143175926|NCT04021290|516192410|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
143175927|NCT04021290|516192411|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
143089348|NCT00711243|515866093|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
143089349|NCT00711243|515866094|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
143175928|NCT04021290|516192409|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
143089350|NCT00711243|515866089|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
143089351|NCT00711243|515866090|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
143089352|NCT00711243|515866091|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
143089353|NCT00711243|515866092|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
143089354|NCT00711243|515866093|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
143089355|NCT00711243|515866094|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
143089356|NCT00711243|515866089|FG000|Treated Cycle 5 After First Response|Death|0|||
143089357|NCT00711243|515866090|FG001|Treated Cycle 5 After First Response|Death|0|||
143089358|NCT00711243|515866091|FG002|Treated Cycle 5 After First Response|Death|0|||
143089359|NCT00711243|515866092|FG003|Treated Cycle 5 After First Response|Death|0|||
143089360|NCT00711243|515866093|FG004|Treated Cycle 5 After First Response|Death|0|||
143089361|NCT00711243|515866094|FG005|Treated Cycle 5 After First Response|Death|2|||
143089362|NCT00711243|515866089|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
143089363|NCT00711243|515866090|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
143089364|NCT00711243|515866091|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
143089365|NCT00711243|515866092|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
143089366|NCT00711243|515866093|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
143089367|NCT00711243|515866094|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
143089368|NCT00711243|515866089|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
143089369|NCT00711243|515866090|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
143089370|NCT00711243|515866091|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
143089371|NCT00711243|515866092|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
143089372|NCT00711243|515866093|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
143089373|NCT00711243|515866094|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
143089374|NCT02070965|515866103|FG000|Overall Study|Lost to Follow-up|0|||
143089375|NCT02070965|515866104|FG001|Overall Study|Lost to Follow-up|1|||
143089376|NCT02070965|515866105|FG002|Overall Study|Lost to Follow-up|0|||
143089377|NCT02070965|515866103|FG000|Overall Study|Withdrawal by Subject|1|||
143089378|NCT02070965|515866104|FG001|Overall Study|Withdrawal by Subject|1|||
143089379|NCT02070965|515866105|FG002|Overall Study|Withdrawal by Subject|1|||
143089380|NCT02070965|515866103|FG000|Overall Study|Subject moved|1|||
143089381|NCT02070965|515866104|FG001|Overall Study|Subject moved|0|||
143089382|NCT02070965|515866105|FG002|Overall Study|Subject moved|0|||
143089383|NCT00942357|515866111|FG000|Overall Study|Ineligible|37|||
143089384|NCT00942357|515866112|FG001|Overall Study|Ineligible|40|||
143175929|NCT04021290|516192410|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
143175930|NCT04021290|516192411|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
143175931|NCT04021290|516192409|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
143175932|NCT04021290|516192410|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
143175933|NCT04021290|516192411|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
143175934|NCT04021290|516192409|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
143175935|NCT04021290|516192410|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
143175936|NCT04021290|516192411|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
143175937|NCT04021290|516192409|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
143089385|NCT00707239|515866118|FG000|Overall Study|Adverse Event|5|||
143089386|NCT00707239|515866119|FG001|Overall Study|Adverse Event|3|||
143089387|NCT00707239|515866120|FG002|Overall Study|Adverse Event|2|||
143089388|NCT00707239|515866118|FG000|Overall Study|Death|3|||
143250724|NCT00796445|516472876|FG001|Overall Study|Invalid Informed Consent Form|0|||
143367116|NCT01467700|516887253|FG003|Overall Study|Voluntary Withdrawal|2|||
143367117|NCT01467700|516887250|FG000|Overall Study|Study Termination|6|||
143367118|NCT01467700|516887251|FG001|Overall Study|Study Termination|5|||
143089389|NCT00707239|515866119|FG001|Overall Study|Death|1|||
143089390|NCT00707239|515866120|FG002|Overall Study|Death|3|||
143089391|NCT00707239|515866118|FG000|Overall Study|Physician Decision|1|||
143089392|NCT00707239|515866119|FG001|Overall Study|Physician Decision|1|||
143089393|NCT00707239|515866120|FG002|Overall Study|Physician Decision|2|||
143089394|NCT00707239|515866118|FG000|Overall Study|Protocol Violation|0|||
143089395|NCT00707239|515866119|FG001|Overall Study|Protocol Violation|0|||
143089396|NCT00707239|515866120|FG002|Overall Study|Protocol Violation|1|||
143089397|NCT00707239|515866118|FG000|Overall Study|Lack of Efficacy|1|||
143089398|NCT00707239|515866119|FG001|Overall Study|Lack of Efficacy|2|||
143089399|NCT00707239|515866120|FG002|Overall Study|Lack of Efficacy|0|||
143089400|NCT00707239|515866118|FG000|Overall Study|Randomized, but not treated|1|||
143089401|NCT00707239|515866119|FG001|Overall Study|Randomized, but not treated|1|||
143089402|NCT00707239|515866120|FG002|Overall Study|Randomized, but not treated|1|||
143367119|NCT01467700|516887252|FG002|Overall Study|Study Termination|10|||
143367120|NCT01467700|516887253|FG003|Overall Study|Study Termination|7|||
143367121|NCT01467700|516887250|FG000|Overall Study|Pregnancy|0|||
143367122|NCT01467700|516887251|FG001|Overall Study|Pregnancy|1|||
143367123|NCT01467700|516887252|FG002|Overall Study|Pregnancy|1|||
143367124|NCT01467700|516887253|FG003|Overall Study|Pregnancy|0|||
143367125|NCT01467700|516887250|FG000|Overall Study|Lack of Efficacy|2|||
143367126|NCT01467700|516887251|FG001|Overall Study|Lack of Efficacy|0|||
143367127|NCT01467700|516887252|FG002|Overall Study|Lack of Efficacy|2|||
143367128|NCT01467700|516887253|FG003|Overall Study|Lack of Efficacy|1|||
143367129|NCT01467700|516887250|FG000|Overall Study|Reason not Specified|1|||
143367130|NCT01467700|516887251|FG001|Overall Study|Reason not Specified|3|||
143089403|NCT00707239|515866118|FG000|Overall Study|Other|8|||
143089404|NCT00707239|515866119|FG001|Overall Study|Other|3|||
143089405|NCT00707239|515866120|FG002|Overall Study|Other|5|||
143089406|NCT01778530|515866121|FG000|Overall Study|Progression on study|1|||
143089407|NCT01778530|515866121|FG000|Overall Study|Adverse event/side effect|1|||
143089408|NCT03472014|515866122|FG000|Overall Study|Lost to Follow-up|4|||
143089409|NCT00793871|515866123|FG000|Overall Study|Death|50|||
143089410|NCT00793871|515866123|FG000|Overall Study|Lost to Follow-up|3|||
143089411|NCT00793871|515866123|FG000|Overall Study|Study terminated by the Sponsor|7|||
143089412|NCT01928472|515866124|FG000|Overall Study|Death|0|||
143089413|NCT01928472|515866125|FG001|Overall Study|Death|0|||
143089414|NCT01928472|515866126|FG002|Overall Study|Death|1|||
143089415|NCT01928472|515866127|FG003|Overall Study|Death|0|||
143089416|NCT01928472|515866124|FG000|Overall Study|Withdrawal by Subject|4|||
143089417|NCT01928472|515866125|FG001|Overall Study|Withdrawal by Subject|4|||
143089418|NCT01928472|515866126|FG002|Overall Study|Withdrawal by Subject|1|||
143089419|NCT01928472|515866127|FG003|Overall Study|Withdrawal by Subject|2|||
143089420|NCT01928472|515866124|FG000|Overall Study|Lost to Follow-up|2|||
143089421|NCT01928472|515866125|FG001|Overall Study|Lost to Follow-up|3|||
143089422|NCT01928472|515866126|FG002|Overall Study|Lost to Follow-up|4|||
143089423|NCT01928472|515866127|FG003|Overall Study|Lost to Follow-up|0|||
143089424|NCT01928472|515866124|FG000|Overall Study|Administrative Reason|2|||
143089425|NCT01928472|515866125|FG001|Overall Study|Administrative Reason|1|||
143089426|NCT01928472|515866126|FG002|Overall Study|Administrative Reason|0|||
143089427|NCT01928472|515866127|FG003|Overall Study|Administrative Reason|0|||
143089428|NCT01928472|515866124|FG000|Overall Study|Unclassified|0|||
143089429|NCT01928472|515866125|FG001|Overall Study|Unclassified|0|||
143089430|NCT01928472|515866126|FG002|Overall Study|Unclassified|1|||
143089431|NCT01928472|515866127|FG003|Overall Study|Unclassified|0|||
143089432|NCT01308424|515866129|FG000|Baseline Eligibility|Screen Failures|71|||
143367131|NCT01467700|516887252|FG002|Overall Study|Reason not Specified|2|||
143367132|NCT01467700|516887253|FG003|Overall Study|Reason not Specified|8|||
143367133|NCT03523962|516887254|FG000|Closed Fractures|Death|86|||
143089433|NCT01308424|515866130|FG001|Baseline Eligibility|Screen Failures|0|||
143089434|NCT01308424|515866131|FG002|Baseline Eligibility|Screen Failures|0|||
143089435|NCT01308424|515866129|FG000|Randomization|Adverse Event|0|||
143089436|NCT01308424|515866130|FG001|Randomization|Adverse Event|1|||
143089437|NCT01308424|515866131|FG002|Randomization|Adverse Event|1|||
143089438|NCT01308424|515866129|FG000|Randomization|Lost to Follow-up|0|||
143089439|NCT01308424|515866130|FG001|Randomization|Lost to Follow-up|1|||
143089440|NCT01308424|515866131|FG002|Randomization|Lost to Follow-up|0|||
143089441|NCT01308424|515866129|FG000|Randomization|Physician Decision|0|||
143089442|NCT01308424|515866130|FG001|Randomization|Physician Decision|1|||
143089443|NCT01308424|515866131|FG002|Randomization|Physician Decision|1|||
143089444|NCT05767905|515866132|FG000|Overall Study|Adverse Event|0|||
143089445|NCT05767905|515866133|FG001|Overall Study|Adverse Event|0|||
143089446|NCT05767905|515866134|FG002|Overall Study|Adverse Event|1|||
143367134|NCT03523962|516887255|FG001|Closed Fractures|Death|71|||
143367135|NCT03523962|516887256|FG002|Closed Fractures|Death|0|||
143089447|NCT03535740|515866135|FG000|Overall Study|Death|44|||
143089448|NCT03535740|515866135|FG000|Overall Study|Lost to Follow-up|1|||
143089449|NCT03535740|515866135|FG000|Overall Study|Withdrawal by Subject|13|||
143089450|NCT03535740|515866135|FG000|Overall Study|Site terminated by Sponsor|45|||
143367136|NCT03523962|516887257|FG003|Closed Fractures|Death|0|||
143367137|NCT03523962|516887254|FG000|Closed Fractures|Lost to Follow-up|62|||
143367138|NCT03523962|516887255|FG001|Closed Fractures|Lost to Follow-up|36|||
143089451|NCT02766335|515866141|FG000|Initial Registration|Adverse Event|6|||
143089452|NCT02766335|515866142|FG001|Initial Registration|Adverse Event|3|||
143089453|NCT02766335|515866143|FG002|Initial Registration|Adverse Event|0|||
143089454|NCT02766335|515866141|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
143089455|NCT02766335|515866142|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
143089456|NCT02766335|515866143|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
143089457|NCT02766335|515866141|FG000|Initial Registration|Progression/relapse|49|||
143089458|NCT02766335|515866142|FG001|Initial Registration|Progression/relapse|15|||
143089459|NCT02766335|515866143|FG002|Initial Registration|Progression/relapse|0|||
143089460|NCT02766335|515866141|FG000|Initial Registration|Death|1|||
143089461|NCT02766335|515866142|FG001|Initial Registration|Death|3|||
143089462|NCT02766335|515866143|FG002|Initial Registration|Death|0|||
143089463|NCT02766335|515866141|FG000|Initial Registration|not protocol specified|1|||
143089464|NCT02766335|515866142|FG001|Initial Registration|not protocol specified|9|||
143089465|NCT02766335|515866143|FG002|Initial Registration|not protocol specified|0|||
143089466|NCT02766335|515866141|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
143089467|NCT02766335|515866142|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
143089468|NCT02766335|515866143|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
143089469|NCT02766335|515866141|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
143089470|NCT02766335|515866142|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
143089471|NCT02766335|515866143|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
143089472|NCT03645863|515866145|FG000|Overall Study|Withdrawal by Subject|1|||
143089473|NCT03645863|515866146|FG001|Overall Study|Withdrawal by Subject|0|||
143089474|NCT03645863|515866147|FG002|Overall Study|Withdrawal by Subject|0|||
143089475|NCT03624192|515866153|FG000|Overall Study|Lost to Follow-up|1|||
143089476|NCT03624192|515866154|FG001|Overall Study|Lost to Follow-up|1|||
143089477|NCT01841593|515866155|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
143089478|NCT01841593|515866156|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
143089479|NCT01841593|515866155|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
143089480|NCT01841593|515866156|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
143089481|NCT00312338|515866161|FG000|Overall Study|Adverse Event|7|||
143089482|NCT00312338|515866162|FG001|Overall Study|Adverse Event|2|||
143175938|NCT04021290|516192410|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
143175939|NCT04021290|516192411|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
143175940|NCT04021290|516192409|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
143175941|NCT04021290|516192410|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
143175942|NCT04021290|516192411|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
143175943|NCT04021290|516192409|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
143175944|NCT04021290|516192410|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
143175945|NCT04021290|516192411|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
143175946|NCT04021290|516192409|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
143175947|NCT04021290|516192410|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
143175948|NCT04021290|516192411|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
143175949|NCT00543985|516192412|FG000|Overall Study|Withdrawal by Subject|4|||
143175950|NCT01280968|516192413|FG000|Overall Study|Lost to Follow-up|8|||
143175951|NCT01280968|516192414|FG001|Overall Study|Lost to Follow-up|2|||
143175952|NCT01280968|516192413|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
143175953|NCT01280968|516192414|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
143175954|NCT01280968|516192413|FG000|Overall Study|Commuting Problems|2|||
143175955|NCT01280968|516192414|FG001|Overall Study|Commuting Problems|0|||
143175956|NCT01280968|516192413|FG000|Overall Study|Anxiety|2|||
143175957|NCT01280968|516192414|FG001|Overall Study|Anxiety|0|||
143175958|NCT01280968|516192413|FG000|Overall Study|Adverse Event|1|||
143175959|NCT01280968|516192414|FG001|Overall Study|Adverse Event|0|||
143175960|NCT01280968|516192413|FG000|Overall Study|Scheduling Conflicts|1|||
143175961|NCT01280968|516192414|FG001|Overall Study|Scheduling Conflicts|1|||
143175962|NCT01280968|516192413|FG000|Overall Study|Pre-existing Neurological Condition|1|||
143175963|NCT01280968|516192414|FG001|Overall Study|Pre-existing Neurological Condition|0|||
143175964|NCT01280968|516192413|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
143175965|NCT01280968|516192414|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
143175966|NCT01214837|516192415|FG000|Overall Study|Death|0|||
143175967|NCT01214837|516192416|FG001|Overall Study|Death|0|||
143175968|NCT01214837|516192417|FG002|Overall Study|Death|1|||
143367139|NCT03523962|516887256|FG002|Closed Fractures|Lost to Follow-up|0|||
143089483|NCT00312338|515866161|FG000|Overall Study|Lost to Follow-up|9|||
143089484|NCT00312338|515866162|FG001|Overall Study|Lost to Follow-up|1|||
143089485|NCT00312338|515866161|FG000|Overall Study|Withdrawal by Subject|4|||
143089486|NCT00312338|515866162|FG001|Overall Study|Withdrawal by Subject|0|||
143089487|NCT00312338|515866161|FG000|Overall Study|Subsequent infection|2|||
143175969|NCT01214837|516192415|FG000|Overall Study|Adverse Event|1|||
143089488|NCT00312338|515866162|FG001|Overall Study|Subsequent infection|0|||
143367140|NCT03523962|516887257|FG003|Closed Fractures|Lost to Follow-up|0|||
143175970|NCT01214837|516192416|FG001|Overall Study|Adverse Event|2|||
143175971|NCT01214837|516192417|FG002|Overall Study|Adverse Event|1|||
143175972|NCT01214837|516192415|FG000|Overall Study|Withdrawal by Subject|27|||
143175973|NCT01214837|516192416|FG001|Overall Study|Withdrawal by Subject|36|||
143175974|NCT01214837|516192417|FG002|Overall Study|Withdrawal by Subject|28|||
143175975|NCT01214837|516192415|FG000|Overall Study|Lost to Follow-up|20|||
143175976|NCT01214837|516192416|FG001|Overall Study|Lost to Follow-up|15|||
143175977|NCT01214837|516192417|FG002|Overall Study|Lost to Follow-up|21|||
143175978|NCT01214837|516192415|FG000|Overall Study|Inappropriate Enrolment|0|||
143175979|NCT01214837|516192416|FG001|Overall Study|Inappropriate Enrolment|1|||
143175980|NCT01214837|516192417|FG002|Overall Study|Inappropriate Enrolment|2|||
143175981|NCT01214837|516192415|FG000|Overall Study|Administrative Reason|2|||
143175982|NCT01214837|516192416|FG001|Overall Study|Administrative Reason|6|||
143175983|NCT01214837|516192417|FG002|Overall Study|Administrative Reason|4|||
143175984|NCT01214837|516192415|FG000|Overall Study|Protocol Violation|3|||
143175985|NCT01214837|516192416|FG001|Overall Study|Protocol Violation|1|||
143175986|NCT01214837|516192417|FG002|Overall Study|Protocol Violation|5|||
143175987|NCT01214837|516192415|FG000|Overall Study|Unable to Classify|1|||
143175988|NCT01214837|516192416|FG001|Overall Study|Unable to Classify|3|||
143175989|NCT01214837|516192417|FG002|Overall Study|Unable to Classify|0|||
143175990|NCT01088906|516192418|FG000|Overall Study|Inclusion error|1|||
143175991|NCT01088906|516192418|FG000|Overall Study|Did not receive study treatment|3|||
143175992|NCT01088906|516192418|FG000|Overall Study|Missing data|1|||
143175993|NCT02391311|516194015|FG000|Overall Study|Lost to Follow-up|2|||
143175994|NCT02391311|516194016|FG001|Overall Study|Lost to Follow-up|1|||
143175995|NCT02391311|516194015|FG000|Overall Study|deemed ineligible after baseline|1|||
143175996|NCT02391311|516194016|FG001|Overall Study|deemed ineligible after baseline|1|||
143175997|NCT00925002|516194021|FG000|Overall Study|Other|1|||
143175998|NCT00925002|516194022|FG001|Overall Study|Other|4|||
143175999|NCT00925002|516194023|FG002|Overall Study|Other|0|||
143176000|NCT00925002|516194021|FG000|Overall Study|Death|1|||
143176001|NCT00925002|516194022|FG001|Overall Study|Death|1|||
143176002|NCT00925002|516194023|FG002|Overall Study|Death|5|||
143176003|NCT00925002|516194021|FG000|Overall Study|Adverse Event|3|||
143176004|NCT00925002|516194022|FG001|Overall Study|Adverse Event|1|||
143176005|NCT00925002|516194023|FG002|Overall Study|Adverse Event|2|||
143176006|NCT00925002|516194021|FG000|Overall Study|Participant withdrew consent|1|||
143176007|NCT00925002|516194022|FG001|Overall Study|Participant withdrew consent|3|||
143176008|NCT00925002|516194023|FG002|Overall Study|Participant withdrew consent|3|||
143176009|NCT00002766|516194024|FG000|Overall Study|Withdrawal by Subject|0|||
143176010|NCT00002766|516194025|FG001|Overall Study|Withdrawal by Subject|1|||
143176011|NCT00002766|516194024|FG000|Overall Study|Patient Not Treated|1|||
143176012|NCT00002766|516194025|FG001|Overall Study|Patient Not Treated|2|||
143176013|NCT00002766|516194024|FG000|Overall Study|Adverse Event|1|||
143176014|NCT00002766|516194025|FG001|Overall Study|Adverse Event|1|||
143176015|NCT00002766|516194024|FG000|Overall Study|Protocol Violation|1|||
143176016|NCT00002766|516194025|FG001|Overall Study|Protocol Violation|0|||
143176017|NCT00328172|516194028|FG000|Overall Study|Adverse Event|3|||
143176018|NCT00328172|516194029|FG001|Overall Study|Adverse Event|2|||
143176019|NCT00328172|516194030|FG002|Overall Study|Adverse Event|1|||
143176020|NCT00328172|516194031|FG003|Overall Study|Adverse Event|2|||
143176021|NCT00328172|516194032|FG004|Overall Study|Adverse Event|1|||
143176022|NCT00328172|516194028|FG000|Overall Study|Protocol Violation|0|||
143176023|NCT00328172|516194029|FG001|Overall Study|Protocol Violation|1|||
143176024|NCT00328172|516194030|FG002|Overall Study|Protocol Violation|1|||
143176025|NCT00328172|516194031|FG003|Overall Study|Protocol Violation|0|||
143176026|NCT00328172|516194032|FG004|Overall Study|Protocol Violation|0|||
143176027|NCT00328172|516194028|FG000|Overall Study|Lost to Follow-up|1|||
143176028|NCT00328172|516194029|FG001|Overall Study|Lost to Follow-up|1|||
143176029|NCT00328172|516194030|FG002|Overall Study|Lost to Follow-up|2|||
143176030|NCT00328172|516194031|FG003|Overall Study|Lost to Follow-up|1|||
143176031|NCT00328172|516194032|FG004|Overall Study|Lost to Follow-up|1|||
143176032|NCT00328172|516194028|FG000|Overall Study|Withdrawal by Subject|1|||
143176033|NCT00328172|516194029|FG001|Overall Study|Withdrawal by Subject|1|||
143176034|NCT00328172|516194030|FG002|Overall Study|Withdrawal by Subject|1|||
143176035|NCT00328172|516194031|FG003|Overall Study|Withdrawal by Subject|6|||
143176036|NCT00328172|516194032|FG004|Overall Study|Withdrawal by Subject|0|||
143176037|NCT00328172|516194028|FG000|Overall Study|Lack of Efficacy|14|||
143176038|NCT00328172|516194029|FG001|Overall Study|Lack of Efficacy|9|||
143176039|NCT00328172|516194030|FG002|Overall Study|Lack of Efficacy|4|||
143176040|NCT00328172|516194031|FG003|Overall Study|Lack of Efficacy|4|||
143176041|NCT00328172|516194032|FG004|Overall Study|Lack of Efficacy|3|||
143176042|NCT00328172|516194028|FG000|Overall Study|Other reason (not specified)|3|||
143089489|NCT00262028|515866163|FG000|Overall Study|Withdrawal by Subject|6|||
143089490|NCT00262028|515866164|FG001|Overall Study|Withdrawal by Subject|3|||
143089491|NCT00262028|515866165|FG002|Overall Study|Withdrawal by Subject|6|||
143089492|NCT00262028|515866166|FG003|Overall Study|Withdrawal by Subject|5|||
143089493|NCT00262028|515866167|FG004|Overall Study|Withdrawal by Subject|2|||
143089494|NCT00262028|515866168|FG005|Overall Study|Withdrawal by Subject|3|||
143089495|NCT00262028|515866169|FG006|Overall Study|Withdrawal by Subject|5|||
143089496|NCT00262028|515866170|FG007|Overall Study|Withdrawal by Subject|7|||
143089497|NCT00262028|515866171|FG008|Overall Study|Withdrawal by Subject|2|||
143089498|NCT00262028|515866163|FG000|Overall Study|Lost to Follow-up|7|||
143089499|NCT00262028|515866164|FG001|Overall Study|Lost to Follow-up|7|||
143089500|NCT00262028|515866165|FG002|Overall Study|Lost to Follow-up|5|||
143089501|NCT00262028|515866166|FG003|Overall Study|Lost to Follow-up|5|||
143089502|NCT00262028|515866167|FG004|Overall Study|Lost to Follow-up|4|||
143089503|NCT00262028|515866168|FG005|Overall Study|Lost to Follow-up|3|||
143089504|NCT00262028|515866169|FG006|Overall Study|Lost to Follow-up|3|||
143089505|NCT00262028|515866170|FG007|Overall Study|Lost to Follow-up|5|||
143089506|NCT00262028|515866171|FG008|Overall Study|Lost to Follow-up|6|||
143089507|NCT00262028|515866163|FG000|Overall Study|Administrative Reason|11|||
143089508|NCT00262028|515866164|FG001|Overall Study|Administrative Reason|14|||
143089509|NCT00262028|515866165|FG002|Overall Study|Administrative Reason|9|||
143089510|NCT00262028|515866166|FG003|Overall Study|Administrative Reason|12|||
143089511|NCT00262028|515866167|FG004|Overall Study|Administrative Reason|6|||
143089512|NCT00262028|515866168|FG005|Overall Study|Administrative Reason|7|||
143089513|NCT00262028|515866169|FG006|Overall Study|Administrative Reason|4|||
143089514|NCT00262028|515866170|FG007|Overall Study|Administrative Reason|6|||
143089515|NCT00262028|515866171|FG008|Overall Study|Administrative Reason|10|||
143089516|NCT00262028|515866163|FG000|Overall Study|Protocol Violation|0|||
143089517|NCT00262028|515866164|FG001|Overall Study|Protocol Violation|0|||
143089518|NCT00262028|515866165|FG002|Overall Study|Protocol Violation|0|||
143089519|NCT00262028|515866166|FG003|Overall Study|Protocol Violation|1|||
143089520|NCT00262028|515866167|FG004|Overall Study|Protocol Violation|0|||
143089521|NCT00262028|515866168|FG005|Overall Study|Protocol Violation|0|||
143089522|NCT00262028|515866169|FG006|Overall Study|Protocol Violation|0|||
143089523|NCT00262028|515866170|FG007|Overall Study|Protocol Violation|0|||
143089524|NCT00262028|515866171|FG008|Overall Study|Protocol Violation|0|||
143089525|NCT00262028|515866163|FG000|Overall Study|Unable to classify|0|||
143089526|NCT00262028|515866164|FG001|Overall Study|Unable to classify|3|||
143089527|NCT00262028|515866165|FG002|Overall Study|Unable to classify|0|||
143089528|NCT00262028|515866166|FG003|Overall Study|Unable to classify|0|||
143089529|NCT00262028|515866167|FG004|Overall Study|Unable to classify|0|||
143089530|NCT00262028|515866168|FG005|Overall Study|Unable to classify|0|||
143089531|NCT00262028|515866169|FG006|Overall Study|Unable to classify|0|||
143089532|NCT00262028|515866170|FG007|Overall Study|Unable to classify|0|||
143089533|NCT00262028|515866171|FG008|Overall Study|Unable to classify|1|||
143176043|NCT00328172|516194029|FG001|Overall Study|Other reason (not specified)|0|||
143176044|NCT00328172|516194030|FG002|Overall Study|Other reason (not specified)|1|||
143176045|NCT00328172|516194031|FG003|Overall Study|Other reason (not specified)|0|||
143176046|NCT00328172|516194032|FG004|Overall Study|Other reason (not specified)|0|||
143176047|NCT00558636|516194033|FG000|Treatment|Adverse Event|9|||
143176048|NCT00558636|516194034|FG001|Treatment|Adverse Event|2|||
143176049|NCT00558636|516194033|FG000|Treatment|Withdrawal by Subject|2|||
143176050|NCT00558636|516194034|FG001|Treatment|Withdrawal by Subject|0|||
143176051|NCT00558636|516194033|FG000|Treatment|Premature termination of the study|35|||
143176052|NCT00558636|516194034|FG001|Treatment|Premature termination of the study|37|||
143176053|NCT00558636|516194033|FG000|Treatment|Disease progression|1|||
143176054|NCT00558636|516194034|FG001|Treatment|Disease progression|5|||
143176055|NCT00558636|516194033|FG000|Follow-up|Premature termination of the study|12|||
143176056|NCT00558636|516194034|FG001|Follow-up|Premature termination of the study|7|||
143176057|NCT01990742|516194035|FG000|Overall Study|Withdrawal by facility|407|||
143176058|NCT01990742|516194036|FG001|Overall Study|Withdrawal by facility|1083|||
143176059|NCT01990742|516194035|FG000|Overall Study|Facility closed|0|||
143176060|NCT01990742|516194036|FG001|Overall Study|Facility closed|270|||
143176061|NCT03443687|516194037|FG000|Overall Study|Lost to Follow-up|3|||
143176062|NCT03443687|516194038|FG001|Overall Study|Lost to Follow-up|5|||
143176063|NCT03443687|516194037|FG000|Overall Study|Withdrawal by Subject|1|||
143176064|NCT03443687|516194038|FG001|Overall Study|Withdrawal by Subject|0|||
143089534|NCT00613171|515866172|FG000|Overall Study|Adverse Event|7|||
143089535|NCT00613171|515866172|FG000|Overall Study|Withdrawal by Subject|3|||
143089536|NCT00613171|515866172|FG000|Overall Study|Reason not Specified|4|||
143089537|NCT01197911|515866173|FG000|Overall Study|Adverse Event|0|||
143089538|NCT01197911|515866174|FG001|Overall Study|Adverse Event|0|||
143089539|NCT01197911|515866175|FG002|Overall Study|Adverse Event|1|||
143089540|NCT01526057|515866176|FG000|Overall Study|Withdrawal by Subject|3|||
143089541|NCT01526057|515866177|FG001|Overall Study|Withdrawal by Subject|2|||
143089542|NCT01526057|515866178|FG002|Overall Study|Withdrawal by Subject|2|||
143089543|NCT01526057|515866176|FG000|Overall Study|Adverse Event|3|||
143176065|NCT03443687|516194037|FG000|Overall Study|Discontinued intervention|1|||
143176066|NCT03443687|516194038|FG001|Overall Study|Discontinued intervention|1|||
143176067|NCT03500211|516194042|FG000|Overall Study|Withdrawal by Subject|1|||
143089544|NCT01526057|515866177|FG001|Overall Study|Adverse Event|1|||
143089545|NCT01526057|515866178|FG002|Overall Study|Adverse Event|1|||
143089546|NCT01526057|515866176|FG000|Overall Study|Death|1|||
143089547|NCT01526057|515866177|FG001|Overall Study|Death|0|||
143176068|NCT03500211|516194043|FG001|Overall Study|Withdrawal by Subject|1|||
143176069|NCT04460183|516194044|FG000|Overall Study|Lost to Follow-up|3|||
143176070|NCT04460183|516194045|FG001|Overall Study|Lost to Follow-up|1|||
143176071|NCT04460183|516194044|FG000|Overall Study|Withdrawal by Subject|1|||
143176072|NCT04460183|516194045|FG001|Overall Study|Withdrawal by Subject|0|||
143176073|NCT00487981|516194046|FG000|Overall Study|Hypothyroidism diagnosis|1|||
143176074|NCT03848416|516194047|FG000|Overall Study|Withdrawal by Subject|1|||
143176075|NCT03848416|516194048|FG001|Overall Study|Withdrawal by Subject|0|||
143089548|NCT01526057|515866178|FG002|Overall Study|Death|0|||
143089549|NCT01526057|515866176|FG000|Overall Study|Lost to Follow-up|1|||
143089550|NCT01526057|515866177|FG001|Overall Study|Lost to Follow-up|0|||
143089551|NCT01526057|515866178|FG002|Overall Study|Lost to Follow-up|1|||
143176076|NCT03848416|516194049|FG002|Overall Study|Withdrawal by Subject|0|||
143176077|NCT03848416|516194047|FG000|Overall Study|Death|0|||
143176078|NCT03848416|516194048|FG001|Overall Study|Death|0|||
143176079|NCT03848416|516194049|FG002|Overall Study|Death|1|||
143176080|NCT01063348|516194055|FG000|Overall Study|Lost to Follow-up|3|||
143176081|NCT01063348|516194056|FG001|Overall Study|Lost to Follow-up|10|||
143176082|NCT05518461|516194057|FG000|Overall Study|Lost to Follow-up|25|||
143176083|NCT03326063|516194059|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
143176084|NCT03326063|516194060|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
143176085|NCT01188967|516194061|FG000|Overall Study|Withdrawal by Subject|1|||
143176086|NCT01188967|516194062|FG001|Overall Study|Withdrawal by Subject|1|||
143176087|NCT01188967|516194061|FG000|Overall Study|Physician Decision|1|||
143176088|NCT01188967|516194062|FG001|Overall Study|Physician Decision|1|||
143176089|NCT01188967|516194061|FG000|Overall Study|Lost to Follow-up|3|||
143176090|NCT01188967|516194062|FG001|Overall Study|Lost to Follow-up|2|||
143176091|NCT01876381|516194063|FG000|Overall Study|Lack of Efficacy|5|||
143176092|NCT01876381|516194063|FG000|Overall Study|Physician Decision|1|||
143176093|NCT01876381|516194063|FG000|Overall Study|Withdrawal by Subject|1|||
143176094|NCT00523978|516194066|FG000|Overall Study|Withdrawal by Subject|3|||
143176095|NCT00523978|516194067|FG001|Overall Study|Withdrawal by Subject|7|||
143176096|NCT00523978|516194066|FG000|Overall Study|Screen Failures|5|||
143176097|NCT00523978|516194067|FG001|Overall Study|Screen Failures|1|||
143176098|NCT00523978|516194066|FG000|Overall Study|Death|1|||
143176099|NCT00523978|516194067|FG001|Overall Study|Death|0|||
143176100|NCT00332696|516194068|FG000|Overall Study|Death|24|||
143176101|NCT00332696|516194069|FG001|Overall Study|Death|14|||
143176102|NCT00332696|516194068|FG000|Overall Study|Insufficient therapeutic effect|4|||
143176103|NCT00332696|516194069|FG001|Overall Study|Insufficient therapeutic effect|11|||
143176104|NCT00332696|516194068|FG000|Overall Study|Adverse Event|1|||
143176105|NCT00332696|516194069|FG001|Overall Study|Adverse Event|2|||
143176106|NCT00332696|516194068|FG000|Overall Study|Condition does not justify treatment|0|||
143176107|NCT00332696|516194069|FG001|Overall Study|Condition does not justify treatment|2|||
143176108|NCT00332696|516194068|FG000|Overall Study|Lost to Follow-up|0|||
143176109|NCT00332696|516194069|FG001|Overall Study|Lost to Follow-up|1|||
143176110|NCT00332696|516194068|FG000|Overall Study|Withdrawal by Subject|1|||
143089552|NCT01526057|515866176|FG000|Overall Study|Other|1|||
143089553|NCT01526057|515866177|FG001|Overall Study|Other|0|||
143176111|NCT00332696|516194069|FG001|Overall Study|Withdrawal by Subject|0|||
143176112|NCT00382174|516194070|FG000|Overall Study|Lost to Follow-up|1|||
143176113|NCT00382174|516194071|FG001|Overall Study|Lost to Follow-up|4|||
143176114|NCT00382174|516194072|FG002|Overall Study|Lost to Follow-up|5|||
143250725|NCT00388583|516472879|FG000|Overall Study|Protocol Violation|1|||
143250726|NCT00388583|516472880|FG001|Overall Study|Protocol Violation|0|||
143250727|NCT00388583|516472879|FG000|Overall Study|Withdrawal by Subject|3|||
143250728|NCT00388583|516472880|FG001|Overall Study|Withdrawal by Subject|3|||
143250729|NCT00388583|516472879|FG000|Overall Study|Serious Adverse Event|2|||
143089554|NCT01526057|515866178|FG002|Overall Study|Other|1|||
143176115|NCT00382174|516194070|FG000|Overall Study|Adverse Event|1|||
143250730|NCT00388583|516472880|FG001|Overall Study|Serious Adverse Event|0|||
143089555|NCT01526057|515866176|FG000|Overall Study|Protocol Violation|0|||
143176116|NCT00382174|516194071|FG001|Overall Study|Adverse Event|4|||
143176117|NCT00382174|516194072|FG002|Overall Study|Adverse Event|5|||
143176118|NCT00382174|516194070|FG000|Overall Study|Withdrawal by Subject|1|||
143176119|NCT00382174|516194071|FG001|Overall Study|Withdrawal by Subject|4|||
143176120|NCT00382174|516194072|FG002|Overall Study|Withdrawal by Subject|5|||
143176121|NCT00382174|516194070|FG000|Overall Study|Non compliance|1|||
143176122|NCT00382174|516194071|FG001|Overall Study|Non compliance|0|||
143176123|NCT00382174|516194072|FG002|Overall Study|Non compliance|1|||
143176124|NCT00382174|516194070|FG000|Overall Study|Physician Decision|0|||
143089556|NCT01526057|515866177|FG001|Overall Study|Protocol Violation|0|||
143176125|NCT00382174|516194071|FG001|Overall Study|Physician Decision|2|||
143089557|NCT01526057|515866178|FG002|Overall Study|Protocol Violation|1|||
143089558|NCT01169350|515866181|FG000|Overall Study|Physician Decision|3|||
143089559|NCT01169350|515866181|FG000|Overall Study|Lost to Follow-up|2|||
143089560|NCT02553772|515866183|FG000|Overall Study|Adverse Event|2|||
143089561|NCT02553772|515866184|FG001|Overall Study|Adverse Event|3|||
143089562|NCT02553772|515866183|FG000|Overall Study|Lost to Follow-up|2|||
143089563|NCT02553772|515866184|FG001|Overall Study|Lost to Follow-up|1|||
143089564|NCT02553772|515866183|FG000|Overall Study|Withdrawal of Consent|1|||
143089565|NCT02553772|515866184|FG001|Overall Study|Withdrawal of Consent|1|||
143089566|NCT02553772|515866183|FG000|Overall Study|Lack of Efficacy|1|||
143089567|NCT02553772|515866184|FG001|Overall Study|Lack of Efficacy|0|||
143089568|NCT02553772|515866183|FG000|Overall Study|Other Miscellaneous Reasons|0|||
143089569|NCT02553772|515866184|FG001|Overall Study|Other Miscellaneous Reasons|1|||
143089570|NCT05724589|515866185|FG000|Overall Study|Lost to Follow-up|1|||
143089571|NCT00786409|515866186|FG000|Overall Study|Withdrawal by Subject|2|||
143089572|NCT00786409|515866186|FG000|Overall Study|Adverse Event|2|||
143089573|NCT00786409|515866186|FG000|Overall Study|Pregnancy|2|||
143089574|NCT00786409|515866186|FG000|Overall Study|Lost to Follow-up|1|||
143089575|NCT00610129|515866187|FG000|Overall Study|Not treated since patients ineligible|3|||
143089576|NCT02273388|515866192|FG000|Overall Study|Adverse Event|0|||
143089577|NCT02273388|515866193|FG001|Overall Study|Adverse Event|0|||
143089578|NCT02273388|515866194|FG002|Overall Study|Adverse Event|0|||
143089579|NCT02273388|515866195|FG003|Overall Study|Adverse Event|0|||
143089580|NCT02273388|515866196|FG004|Overall Study|Adverse Event|0|||
143089581|NCT02273388|515866197|FG005|Overall Study|Adverse Event|0|||
143089582|NCT02273388|515866198|FG006|Overall Study|Adverse Event|1|||
143089583|NCT02273388|515866199|FG007|Overall Study|Adverse Event|2|||
143089584|NCT02273388|515866200|FG008|Overall Study|Adverse Event|0|||
143089585|NCT02273388|515866201|FG009|Overall Study|Adverse Event|0|||
143089586|NCT02273388|515866202|FG010|Overall Study|Adverse Event|0|||
143089587|NCT02273388|515866203|FG011|Overall Study|Adverse Event|0|||
143089588|NCT02273388|515866192|FG000|Overall Study|Adverse Event study disease worse|4|||
143089589|NCT02273388|515866193|FG001|Overall Study|Adverse Event study disease worse|3|||
143089590|NCT02273388|515866194|FG002|Overall Study|Adverse Event study disease worse|3|||
143089591|NCT02273388|515866195|FG003|Overall Study|Adverse Event study disease worse|2|||
143089592|NCT02273388|515866196|FG004|Overall Study|Adverse Event study disease worse|4|||
143089593|NCT02273388|515866197|FG005|Overall Study|Adverse Event study disease worse|3|||
143089594|NCT02273388|515866198|FG006|Overall Study|Adverse Event study disease worse|14|||
143089595|NCT02273388|515866199|FG007|Overall Study|Adverse Event study disease worse|6|||
143089596|NCT02273388|515866200|FG008|Overall Study|Adverse Event study disease worse|6|||
143089597|NCT02273388|515866201|FG009|Overall Study|Adverse Event study disease worse|5|||
143089598|NCT02273388|515866202|FG010|Overall Study|Adverse Event study disease worse|10|||
143089599|NCT02273388|515866203|FG011|Overall Study|Adverse Event study disease worse|1|||
143089600|NCT02273388|515866192|FG000|Overall Study|Sponsor decision|0|||
143089601|NCT02273388|515866193|FG001|Overall Study|Sponsor decision|0|||
143089602|NCT02273388|515866194|FG002|Overall Study|Sponsor decision|0|||
143089603|NCT02273388|515866195|FG003|Overall Study|Sponsor decision|0|||
143089604|NCT02273388|515866196|FG004|Overall Study|Sponsor decision|0|||
143089605|NCT02273388|515866197|FG005|Overall Study|Sponsor decision|0|||
143089606|NCT02273388|515866198|FG006|Overall Study|Sponsor decision|0|||
143089607|NCT02273388|515866199|FG007|Overall Study|Sponsor decision|0|||
143089608|NCT02273388|515866200|FG008|Overall Study|Sponsor decision|0|||
143089609|NCT02273388|515866201|FG009|Overall Study|Sponsor decision|0|||
143089610|NCT02273388|515866202|FG010|Overall Study|Sponsor decision|0|||
143089611|NCT02273388|515866203|FG011|Overall Study|Sponsor decision|1|||
143089612|NCT01042093|515866204|FG000|Overall Study|Protocol Violation|2|||
143089613|NCT01042093|515866205|FG001|Overall Study|Protocol Violation|2|||
143089614|NCT01042093|515866206|FG002|Overall Study|Protocol Violation|2|||
143089615|NCT01042093|515866207|FG003|Overall Study|Protocol Violation|3|||
143089616|NCT01042093|515866204|FG000|Overall Study|Withdrawal by Subject|0|||
143089617|NCT01042093|515866205|FG001|Overall Study|Withdrawal by Subject|0|||
143089618|NCT01042093|515866206|FG002|Overall Study|Withdrawal by Subject|0|||
143089619|NCT01042093|515866207|FG003|Overall Study|Withdrawal by Subject|1|||
143089620|NCT04331808|515866208|FG000|Overall Study|Withdrew consent|1|||
143089621|NCT04331808|515866209|FG001|Overall Study|Withdrew consent|0|||
143089622|NCT04331808|515866210|FG002|Overall Study|Withdrew consent|2|||
143089623|NCT04331808|515866211|FG003|Overall Study|Withdrew consent|3|||
143089624|NCT01329900|515866215|FG000|Overall Study|Elevated creatinine/renal function|1|||
143089625|NCT00141778|515866219|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
143089626|NCT00141778|515866220|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
143089627|NCT00141778|515866221|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
143089628|NCT00141778|515866219|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
143089629|NCT00141778|515866220|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
143089630|NCT00141778|515866221|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
143176126|NCT00382174|516194072|FG002|Overall Study|Physician Decision|2|||
143089631|NCT00141778|515866219|FG000|Started Study Medication|Withdrawal by Subject|0|||
143089632|NCT00141778|515866220|FG001|Started Study Medication|Withdrawal by Subject|2|||
143089633|NCT00141778|515866221|FG002|Started Study Medication|Withdrawal by Subject|0|||
143089634|NCT00141778|515866219|FG000|Started Study Medication|Difficulty Swallowing|0|||
143089635|NCT00141778|515866220|FG001|Started Study Medication|Difficulty Swallowing|1|||
143089636|NCT00141778|515866221|FG002|Started Study Medication|Difficulty Swallowing|0|||
143089637|NCT00141778|515866219|FG000|Started Study Medication|Chest Discomfort|0|||
143089638|NCT00141778|515866220|FG001|Started Study Medication|Chest Discomfort|0|||
143089639|NCT00141778|515866221|FG002|Started Study Medication|Chest Discomfort|1|||
143089640|NCT01982955|515866222|FG000|Overall Study|Randomized but not treated|0|||
143089641|NCT01982955|515866223|FG001|Overall Study|Randomized but not treated|0|||
143089642|NCT01982955|515866224|FG002|Overall Study|Randomized but not treated|0|||
143089643|NCT01982955|515866225|FG003|Overall Study|Randomized but not treated|1|||
143089644|NCT01982955|515866226|FG004|Overall Study|Randomized but not treated|0|||
143089645|NCT04467840|515868411|FG000|Overall Study|Death|35|||
143089646|NCT04467840|515868412|FG001|Overall Study|Death|39|||
143089647|NCT04467840|515868411|FG000|Overall Study|Withdrawal by Subject|8|||
143089648|NCT04467840|515868412|FG001|Overall Study|Withdrawal by Subject|4|||
143089649|NCT04467840|515868411|FG000|Overall Study|Adverse Event|2|||
143089650|NCT04467840|515868412|FG001|Overall Study|Adverse Event|0|||
143089651|NCT04467840|515868411|FG000|Overall Study|Lost to Follow-up|1|||
143089652|NCT04467840|515868412|FG001|Overall Study|Lost to Follow-up|3|||
143089653|NCT04467840|515868411|FG000|Overall Study|Physician Decision|1|||
143089654|NCT04467840|515868412|FG001|Overall Study|Physician Decision|0|||
143089655|NCT04467840|515868411|FG000|Overall Study|Other|1|||
143089656|NCT04467840|515868412|FG001|Overall Study|Other|5|||
143089657|NCT04467840|515868411|FG000|Overall Study|Missing study completion status|3|||
143089658|NCT04467840|515868412|FG001|Overall Study|Missing study completion status|1|||
143089659|NCT05201794|515868415|FG000|Overall Study|Withdrawal by Subject|13|||
143089660|NCT05201794|515868416|FG001|Overall Study|Withdrawal by Subject|12|||
143089661|NCT05201794|515868417|FG002|Overall Study|Withdrawal by Subject|14|||
143089662|NCT05201794|515868418|FG003|Overall Study|Withdrawal by Subject|0|||
143089663|NCT05201794|515868415|FG000|Overall Study|Adverse Event|5|||
143089664|NCT05201794|515868416|FG001|Overall Study|Adverse Event|5|||
143089665|NCT05201794|515868417|FG002|Overall Study|Adverse Event|4|||
143089666|NCT05201794|515868418|FG003|Overall Study|Adverse Event|0|||
143089667|NCT05201794|515868415|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
143089668|NCT05201794|515868416|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
143089669|NCT05201794|515868417|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|4|||
143089670|NCT05201794|515868418|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
143089671|NCT05201794|515868415|FG000|Overall Study|Non-Compliance With Study Drug|2|||
143089672|NCT05201794|515868416|FG001|Overall Study|Non-Compliance With Study Drug|3|||
143089673|NCT05201794|515868417|FG002|Overall Study|Non-Compliance With Study Drug|3|||
143089674|NCT05201794|515868418|FG003|Overall Study|Non-Compliance With Study Drug|0|||
143089675|NCT05201794|515868415|FG000|Overall Study|Physician Decision|1|||
143089676|NCT05201794|515868416|FG001|Overall Study|Physician Decision|3|||
143089677|NCT05201794|515868417|FG002|Overall Study|Physician Decision|2|||
143089678|NCT05201794|515868418|FG003|Overall Study|Physician Decision|0|||
143089679|NCT05201794|515868415|FG000|Overall Study|Lost to Follow-up|2|||
143089680|NCT05201794|515868416|FG001|Overall Study|Lost to Follow-up|2|||
143089681|NCT05201794|515868417|FG002|Overall Study|Lost to Follow-up|0|||
143089682|NCT05201794|515868418|FG003|Overall Study|Lost to Follow-up|0|||
143089683|NCT05201794|515868415|FG000|Overall Study|Non-Compliance With Study Schedule|1|||
143089684|NCT05201794|515868416|FG001|Overall Study|Non-Compliance With Study Schedule|1|||
143089685|NCT05201794|515868417|FG002|Overall Study|Non-Compliance With Study Schedule|1|||
143089686|NCT05201794|515868418|FG003|Overall Study|Non-Compliance With Study Schedule|0|||
143089687|NCT05201794|515868415|FG000|Overall Study|Protocol Violation|2|||
143089688|NCT05201794|515868416|FG001|Overall Study|Protocol Violation|0|||
143089689|NCT05201794|515868417|FG002|Overall Study|Protocol Violation|1|||
143089690|NCT05201794|515868418|FG003|Overall Study|Protocol Violation|0|||
143089691|NCT05201794|515868415|FG000|Overall Study|Death|1|||
143089692|NCT05201794|515868416|FG001|Overall Study|Death|0|||
143089693|NCT05201794|515868417|FG002|Overall Study|Death|0|||
143089694|NCT05201794|515868418|FG003|Overall Study|Death|0|||
143089695|NCT05201794|515868415|FG000|Overall Study|Site Terminated By Sponsor|0|||
143089696|NCT05201794|515868416|FG001|Overall Study|Site Terminated By Sponsor|1|||
143089697|NCT05201794|515868417|FG002|Overall Study|Site Terminated By Sponsor|0|||
143089698|NCT05201794|515868418|FG003|Overall Study|Site Terminated By Sponsor|0|||
143089699|NCT05201794|515868415|FG000|Overall Study|Other|3|||
143089700|NCT05201794|515868416|FG001|Overall Study|Other|3|||
143089701|NCT05201794|515868417|FG002|Overall Study|Other|3|||
143089702|NCT05201794|515868418|FG003|Overall Study|Other|0|||
143089703|NCT05201794|515868415|FG000|Overall Study|Randomized But Not Treated|1|||
143089704|NCT05201794|515868416|FG001|Overall Study|Randomized But Not Treated|2|||
143089705|NCT05201794|515868417|FG002|Overall Study|Randomized But Not Treated|1|||
143089706|NCT05201794|515868418|FG003|Overall Study|Randomized But Not Treated|0|||
143089707|NCT02848001|515868423|FG000|Overall Study|other reasons|0|||
143089708|NCT02848001|515868424|FG001|Overall Study|other reasons|0|||
143089709|NCT02848001|515868425|FG002|Overall Study|other reasons|1|||
143089710|NCT02848001|515868426|FG003|Overall Study|other reasons|0|||
143089711|NCT02848001|515868427|FG004|Overall Study|other reasons|4|||
143089712|NCT02848001|515868428|FG005|Overall Study|other reasons|1|||
143089713|NCT02848001|515868429|FG006|Overall Study|other reasons|0|||
143089714|NCT02848001|515868430|FG007|Overall Study|other reasons|2|||
143089715|NCT02848001|515868431|FG008|Overall Study|other reasons|2|||
143089716|NCT02848001|515868432|FG009|Overall Study|other reasons|3|||
143089717|NCT02848001|515868433|FG010|Overall Study|other reasons|0|||
143089718|NCT02848001|515868434|FG011|Overall Study|other reasons|1|||
143089719|NCT02848001|515868435|FG012|Overall Study|other reasons|1|||
143089720|NCT02848001|515868436|FG013|Overall Study|other reasons|0|||
143089721|NCT02848001|515868437|FG014|Overall Study|other reasons|0|||
143089722|NCT02848001|515868438|FG015|Overall Study|other reasons|2|||
143089723|NCT02848001|515868439|FG016|Overall Study|other reasons|1|||
143089724|NCT02848001|515868423|FG000|Overall Study|Lack of Efficacy|0|||
143089725|NCT02848001|515868424|FG001|Overall Study|Lack of Efficacy|1|||
143089726|NCT02848001|515868425|FG002|Overall Study|Lack of Efficacy|1|||
143089727|NCT02848001|515868426|FG003|Overall Study|Lack of Efficacy|2|||
143089728|NCT02848001|515868427|FG004|Overall Study|Lack of Efficacy|3|||
143089729|NCT02848001|515868428|FG005|Overall Study|Lack of Efficacy|0|||
143089730|NCT02848001|515868429|FG006|Overall Study|Lack of Efficacy|1|||
143089731|NCT02848001|515868430|FG007|Overall Study|Lack of Efficacy|0|||
143089732|NCT02848001|515868431|FG008|Overall Study|Lack of Efficacy|0|||
143089733|NCT02848001|515868432|FG009|Overall Study|Lack of Efficacy|1|||
143089734|NCT02848001|515868433|FG010|Overall Study|Lack of Efficacy|0|||
143089735|NCT02848001|515868434|FG011|Overall Study|Lack of Efficacy|2|||
143089736|NCT02848001|515868435|FG012|Overall Study|Lack of Efficacy|0|||
143089737|NCT02848001|515868436|FG013|Overall Study|Lack of Efficacy|2|||
143089738|NCT02848001|515868437|FG014|Overall Study|Lack of Efficacy|2|||
143089739|NCT02848001|515868438|FG015|Overall Study|Lack of Efficacy|0|||
143089740|NCT02848001|515868439|FG016|Overall Study|Lack of Efficacy|0|||
143089741|NCT02848001|515868423|FG000|Overall Study|Progressive Disease|2|||
143089742|NCT02848001|515868424|FG001|Overall Study|Progressive Disease|1|||
143089743|NCT02848001|515868425|FG002|Overall Study|Progressive Disease|0|||
143089744|NCT02848001|515868426|FG003|Overall Study|Progressive Disease|4|||
143089745|NCT02848001|515868427|FG004|Overall Study|Progressive Disease|3|||
143089746|NCT02848001|515868428|FG005|Overall Study|Progressive Disease|0|||
143089747|NCT02848001|515868429|FG006|Overall Study|Progressive Disease|4|||
143089748|NCT02848001|515868430|FG007|Overall Study|Progressive Disease|1|||
143089749|NCT02848001|515868431|FG008|Overall Study|Progressive Disease|0|||
143089750|NCT02848001|515868432|FG009|Overall Study|Progressive Disease|2|||
143089751|NCT02848001|515868433|FG010|Overall Study|Progressive Disease|3|||
143089752|NCT02848001|515868434|FG011|Overall Study|Progressive Disease|2|||
143089753|NCT02848001|515868435|FG012|Overall Study|Progressive Disease|1|||
143089754|NCT02848001|515868436|FG013|Overall Study|Progressive Disease|0|||
143089755|NCT02848001|515868437|FG014|Overall Study|Progressive Disease|2|||
143089756|NCT02848001|515868438|FG015|Overall Study|Progressive Disease|4|||
143089757|NCT02848001|515868439|FG016|Overall Study|Progressive Disease|0|||
143089758|NCT02848001|515868423|FG000|Overall Study|Adverse Event|0|||
143089759|NCT02848001|515868424|FG001|Overall Study|Adverse Event|0|||
143089760|NCT02848001|515868425|FG002|Overall Study|Adverse Event|0|||
143089761|NCT02848001|515868426|FG003|Overall Study|Adverse Event|0|||
143089762|NCT02848001|515868427|FG004|Overall Study|Adverse Event|2|||
143089763|NCT02848001|515868428|FG005|Overall Study|Adverse Event|0|||
143089764|NCT02848001|515868429|FG006|Overall Study|Adverse Event|0|||
143089765|NCT02848001|515868430|FG007|Overall Study|Adverse Event|0|||
143089766|NCT02848001|515868431|FG008|Overall Study|Adverse Event|0|||
143089767|NCT02848001|515868432|FG009|Overall Study|Adverse Event|1|||
143089768|NCT02848001|515868433|FG010|Overall Study|Adverse Event|0|||
143089769|NCT02848001|515868434|FG011|Overall Study|Adverse Event|1|||
143089770|NCT02848001|515868435|FG012|Overall Study|Adverse Event|1|||
143089771|NCT02848001|515868436|FG013|Overall Study|Adverse Event|0|||
143089772|NCT02848001|515868437|FG014|Overall Study|Adverse Event|2|||
143089773|NCT02848001|515868438|FG015|Overall Study|Adverse Event|0|||
143089774|NCT02848001|515868439|FG016|Overall Study|Adverse Event|0|||
143089775|NCT02848001|515868423|FG000|Overall Study|Death|0|||
143089776|NCT02848001|515868424|FG001|Overall Study|Death|0|||
143089777|NCT02848001|515868425|FG002|Overall Study|Death|0|||
143089778|NCT02848001|515868426|FG003|Overall Study|Death|1|||
143089779|NCT02848001|515868427|FG004|Overall Study|Death|3|||
143089780|NCT02848001|515868428|FG005|Overall Study|Death|1|||
143089781|NCT02848001|515868429|FG006|Overall Study|Death|2|||
143089782|NCT02848001|515868430|FG007|Overall Study|Death|3|||
143089783|NCT02848001|515868431|FG008|Overall Study|Death|4|||
143089784|NCT02848001|515868432|FG009|Overall Study|Death|1|||
143089785|NCT02848001|515868433|FG010|Overall Study|Death|0|||
143089786|NCT02848001|515868434|FG011|Overall Study|Death|1|||
143089787|NCT02848001|515868435|FG012|Overall Study|Death|3|||
143089788|NCT02848001|515868436|FG013|Overall Study|Death|0|||
143089789|NCT02848001|515868437|FG014|Overall Study|Death|2|||
143089790|NCT02848001|515868438|FG015|Overall Study|Death|3|||
143089791|NCT02848001|515868439|FG016|Overall Study|Death|0|||
143089792|NCT02848001|515868423|FG000|Overall Study|Physician Decision|0|||
143089793|NCT02848001|515868424|FG001|Overall Study|Physician Decision|0|||
143089794|NCT02848001|515868425|FG002|Overall Study|Physician Decision|0|||
143089795|NCT02848001|515868426|FG003|Overall Study|Physician Decision|0|||
143089796|NCT02848001|515868427|FG004|Overall Study|Physician Decision|0|||
143089797|NCT02848001|515868428|FG005|Overall Study|Physician Decision|0|||
143089798|NCT02848001|515868429|FG006|Overall Study|Physician Decision|0|||
143089799|NCT02848001|515868430|FG007|Overall Study|Physician Decision|0|||
143089800|NCT02848001|515868431|FG008|Overall Study|Physician Decision|1|||
143089801|NCT02848001|515868432|FG009|Overall Study|Physician Decision|1|||
143089802|NCT02848001|515868433|FG010|Overall Study|Physician Decision|0|||
143089803|NCT02848001|515868434|FG011|Overall Study|Physician Decision|0|||
143089804|NCT02848001|515868435|FG012|Overall Study|Physician Decision|2|||
143089805|NCT02848001|515868436|FG013|Overall Study|Physician Decision|0|||
143089806|NCT02848001|515868437|FG014|Overall Study|Physician Decision|0|||
143089807|NCT02848001|515868438|FG015|Overall Study|Physician Decision|0|||
143089808|NCT02848001|515868439|FG016|Overall Study|Physician Decision|0|||
143089809|NCT02848001|515868423|FG000|Overall Study|Withdrawal by Subject|0|||
143089810|NCT02848001|515868424|FG001|Overall Study|Withdrawal by Subject|0|||
143089811|NCT02848001|515868425|FG002|Overall Study|Withdrawal by Subject|0|||
143089812|NCT02848001|515868426|FG003|Overall Study|Withdrawal by Subject|0|||
143089813|NCT02848001|515868427|FG004|Overall Study|Withdrawal by Subject|0|||
143089814|NCT02848001|515868428|FG005|Overall Study|Withdrawal by Subject|1|||
143089815|NCT02848001|515868429|FG006|Overall Study|Withdrawal by Subject|1|||
143089816|NCT02848001|515868430|FG007|Overall Study|Withdrawal by Subject|1|||
143089817|NCT02848001|515868431|FG008|Overall Study|Withdrawal by Subject|0|||
143089818|NCT02848001|515868432|FG009|Overall Study|Withdrawal by Subject|0|||
143089819|NCT02848001|515868433|FG010|Overall Study|Withdrawal by Subject|0|||
143089820|NCT02848001|515868434|FG011|Overall Study|Withdrawal by Subject|0|||
143089821|NCT02848001|515868435|FG012|Overall Study|Withdrawal by Subject|0|||
143089822|NCT02848001|515868436|FG013|Overall Study|Withdrawal by Subject|0|||
143089823|NCT02848001|515868437|FG014|Overall Study|Withdrawal by Subject|0|||
143089824|NCT02848001|515868438|FG015|Overall Study|Withdrawal by Subject|0|||
143089825|NCT02848001|515868439|FG016|Overall Study|Withdrawal by Subject|0|||
143089826|NCT00118157|515868443|FG000|Overall Study|Adverse Event|2|||
143176127|NCT00382174|516194070|FG000|Overall Study|Failed to meet criteria|0|||
143089827|NCT00118157|515868443|FG000|Overall Study|Death|8|||
143089828|NCT00118157|515868443|FG000|Overall Study|Withdrawal by Subject|2|||
143089829|NCT05989672|515868444|FG000|Overall Study|Adverse Event|3|||
143089830|NCT05989672|515868445|FG001|Overall Study|Adverse Event|0|||
143089831|NCT05989672|515868446|FG002|Overall Study|Adverse Event|0|||
143089832|NCT01962103|515868450|FG000|Phase 1|Adverse Event|4|||
143089833|NCT01962103|515868451|FG001|Phase 1|Adverse Event|0|||
143089834|NCT01962103|515868452|FG002|Phase 1|Adverse Event|2|||
143089835|NCT01962103|515868453|FG003|Phase 1|Adverse Event|1|||
143089836|NCT01962103|515868454|FG004|Phase 1|Adverse Event|2|||
143089837|NCT01962103|515868455|FG005|Phase 1|Adverse Event|2|||
143089838|NCT01962103|515868456|FG006|Phase 1|Adverse Event|0|||
143089839|NCT01962103|515868457|FG007|Phase 1|Adverse Event|0|||
143089840|NCT01962103|515868458|FG008|Phase 1|Adverse Event|0|||
143089841|NCT01962103|515868450|FG000|Phase 1|Progressive Disease|8|||
143089842|NCT01962103|515868451|FG001|Phase 1|Progressive Disease|6|||
143089843|NCT01962103|515868452|FG002|Phase 1|Progressive Disease|8|||
143089844|NCT01962103|515868453|FG003|Phase 1|Progressive Disease|4|||
143089845|NCT01962103|515868454|FG004|Phase 1|Progressive Disease|5|||
143176128|NCT00382174|516194071|FG001|Overall Study|Failed to meet criteria|1|||
143089846|NCT01962103|515868455|FG005|Phase 1|Progressive Disease|4|||
143176129|NCT00382174|516194072|FG002|Overall Study|Failed to meet criteria|1|||
143176130|NCT00382174|516194070|FG000|Overall Study|Wounds merged|0|||
143089847|NCT01962103|515868456|FG006|Phase 1|Progressive Disease|0|||
143089848|NCT01962103|515868457|FG007|Phase 1|Progressive Disease|0|||
143176131|NCT00382174|516194071|FG001|Overall Study|Wounds merged|2|||
143176132|NCT00382174|516194072|FG002|Overall Study|Wounds merged|2|||
143089849|NCT01962103|515868458|FG008|Phase 1|Progressive Disease|0|||
143089850|NCT01962103|515868450|FG000|Phase 1|Withdrawal by Subject|0|||
143089851|NCT01962103|515868451|FG001|Phase 1|Withdrawal by Subject|0|||
143089852|NCT01962103|515868452|FG002|Phase 1|Withdrawal by Subject|0|||
143089853|NCT01962103|515868453|FG003|Phase 1|Withdrawal by Subject|2|||
143089854|NCT01962103|515868454|FG004|Phase 1|Withdrawal by Subject|0|||
143089855|NCT01962103|515868455|FG005|Phase 1|Withdrawal by Subject|0|||
143176133|NCT04577781|516194073|FG000|Overall Study|Adverse Event|2|||
143176134|NCT04577781|516194074|FG001|Overall Study|Adverse Event|2|||
143176135|NCT04577781|516194073|FG000|Overall Study|Physician Decision|1|||
143176136|NCT04577781|516194074|FG001|Overall Study|Physician Decision|0|||
143176137|NCT04103450|516194076|FG000|Overall Study|Adverse Event|4|||
143176138|NCT04103450|516194077|FG001|Overall Study|Adverse Event|2|||
143176139|NCT04103450|516194076|FG000|Overall Study|Lack of Efficacy|3|||
143176140|NCT04103450|516194077|FG001|Overall Study|Lack of Efficacy|0|||
143176141|NCT04103450|516194076|FG000|Overall Study|Withdrawal by Subject|5|||
143176142|NCT04103450|516194077|FG001|Overall Study|Withdrawal by Subject|3|||
143367141|NCT03523962|516887254|FG000|Closed Fractures|Withdrawal by Subject|19|||
143367142|NCT03523962|516887255|FG001|Closed Fractures|Withdrawal by Subject|29|||
143367143|NCT03523962|516887256|FG002|Closed Fractures|Withdrawal by Subject|0|||
143367144|NCT03523962|516887257|FG003|Closed Fractures|Withdrawal by Subject|0|||
143089856|NCT01962103|515868456|FG006|Phase 1|Withdrawal by Subject|0|||
143089857|NCT01962103|515868457|FG007|Phase 1|Withdrawal by Subject|0|||
143089858|NCT01962103|515868458|FG008|Phase 1|Withdrawal by Subject|0|||
143089859|NCT01962103|515868450|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
143089860|NCT01962103|515868451|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
143089861|NCT01962103|515868452|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
143089862|NCT01962103|515868453|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
143089863|NCT01962103|515868454|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
143089864|NCT01962103|515868455|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
143089865|NCT01962103|515868456|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
143089866|NCT01962103|515868457|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
143089867|NCT01962103|515868458|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
143089868|NCT01962103|515868450|FG000|Phase 1|Physician Decision|0|||
143089869|NCT01962103|515868451|FG001|Phase 1|Physician Decision|0|||
143089870|NCT01962103|515868452|FG002|Phase 1|Physician Decision|0|||
143089871|NCT01962103|515868453|FG003|Phase 1|Physician Decision|1|||
143089872|NCT01962103|515868454|FG004|Phase 1|Physician Decision|0|||
143089873|NCT01962103|515868455|FG005|Phase 1|Physician Decision|0|||
143089874|NCT01962103|515868456|FG006|Phase 1|Physician Decision|0|||
143089875|NCT01962103|515868457|FG007|Phase 1|Physician Decision|0|||
143089876|NCT01962103|515868458|FG008|Phase 1|Physician Decision|0|||
143089877|NCT01962103|515868450|FG000|Phase 1|Symptomatic Deterioration|3|||
143089878|NCT01962103|515868451|FG001|Phase 1|Symptomatic Deterioration|2|||
143089879|NCT01962103|515868452|FG002|Phase 1|Symptomatic Deterioration|2|||
143089880|NCT01962103|515868453|FG003|Phase 1|Symptomatic Deterioration|2|||
143089881|NCT01962103|515868454|FG004|Phase 1|Symptomatic Deterioration|1|||
143089882|NCT01962103|515868455|FG005|Phase 1|Symptomatic Deterioration|1|||
143089883|NCT01962103|515868456|FG006|Phase 1|Symptomatic Deterioration|0|||
143089884|NCT01962103|515868457|FG007|Phase 1|Symptomatic Deterioration|0|||
143089885|NCT01962103|515868458|FG008|Phase 1|Symptomatic Deterioration|0|||
143089886|NCT01962103|515868450|FG000|Phase 1|Miscellaneous|1|||
143089887|NCT01962103|515868451|FG001|Phase 1|Miscellaneous|0|||
143089888|NCT01962103|515868452|FG002|Phase 1|Miscellaneous|0|||
143089889|NCT01962103|515868453|FG003|Phase 1|Miscellaneous|0|||
143089890|NCT01962103|515868454|FG004|Phase 1|Miscellaneous|0|||
143176143|NCT04103450|516194076|FG000|Overall Study|Lost to Follow-up|1|||
143089891|NCT01962103|515868455|FG005|Phase 1|Miscellaneous|0|||
143089892|NCT01962103|515868456|FG006|Phase 1|Miscellaneous|0|||
143176144|NCT04103450|516194077|FG001|Overall Study|Lost to Follow-up|2|||
143176145|NCT04103450|516194076|FG000|Overall Study|Physician Decision|1|||
143367145|NCT03523962|516887254|FG000|Closed Fractures|Incarceration|1|||
143367146|NCT03523962|516887255|FG001|Closed Fractures|Incarceration|4|||
143089893|NCT01962103|515868457|FG007|Phase 1|Miscellaneous|0|||
143089894|NCT01962103|515868458|FG008|Phase 1|Miscellaneous|0|||
143089895|NCT01962103|515868450|FG000|Phase 2|Adverse Event|0|||
143089896|NCT01962103|515868451|FG001|Phase 2|Adverse Event|0|||
143089897|NCT01962103|515868452|FG002|Phase 2|Adverse Event|0|||
143367147|NCT03523962|516887256|FG002|Closed Fractures|Incarceration|0|||
143250731|NCT00388583|516472879|FG000|Overall Study|Did not receive vaccine|0|||
143250732|NCT00388583|516472880|FG001|Overall Study|Did not receive vaccine|1|||
143089898|NCT01962103|515868453|FG003|Phase 2|Adverse Event|0|||
143089899|NCT01962103|515868454|FG004|Phase 2|Adverse Event|0|||
143089900|NCT01962103|515868455|FG005|Phase 2|Adverse Event|0|||
143089901|NCT01962103|515868456|FG006|Phase 2|Adverse Event|1|||
143089902|NCT01962103|515868457|FG007|Phase 2|Adverse Event|0|||
143089903|NCT01962103|515868458|FG008|Phase 2|Adverse Event|3|||
143176146|NCT04103450|516194077|FG001|Overall Study|Physician Decision|2|||
143176147|NCT04103450|516194076|FG000|Overall Study|Protocol Violation|1|||
143176148|NCT04103450|516194077|FG001|Overall Study|Protocol Violation|0|||
143176149|NCT04103450|516194076|FG000|Overall Study|Other|1|||
143176150|NCT04103450|516194077|FG001|Overall Study|Other|1|||
143176151|NCT02712788|516194080|FG000|Overall Study|Physician Decision|1|||
143089904|NCT01962103|515868450|FG000|Phase 2|Progressive Disease|0|||
143089905|NCT01962103|515868451|FG001|Phase 2|Progressive Disease|0|||
143089906|NCT01962103|515868452|FG002|Phase 2|Progressive Disease|0|||
143089907|NCT01962103|515868453|FG003|Phase 2|Progressive Disease|0|||
143089908|NCT01962103|515868454|FG004|Phase 2|Progressive Disease|0|||
143089909|NCT01962103|515868455|FG005|Phase 2|Progressive Disease|0|||
143089910|NCT01962103|515868456|FG006|Phase 2|Progressive Disease|11|||
143176152|NCT02712788|516194081|FG001|Overall Study|Physician Decision|0|||
143176153|NCT02712788|516194080|FG000|Overall Study|Protocol Violation|1|||
143250733|NCT05194579|516472881|FG000|Overall Study|Lost to Follow-up|2|||
143250734|NCT05194579|516472882|FG001|Overall Study|Lost to Follow-up|3|||
143250735|NCT05194579|516472881|FG000|Overall Study|Withdrawal by Subject|3|||
143250736|NCT05194579|516472882|FG001|Overall Study|Withdrawal by Subject|4|||
143250737|NCT05194579|516472881|FG000|Overall Study|Refused further study procedures|0|||
143250738|NCT05194579|516472882|FG001|Overall Study|Refused further study procedures|1|||
143250739|NCT05194579|516472881|FG000|Overall Study|Protocol deviation|1|||
143250740|NCT05194579|516472882|FG001|Overall Study|Protocol deviation|0|||
143250741|NCT03595228|516472887|FG000|Overall Study|Death|2|||
143250742|NCT03595228|516472887|FG000|Overall Study|Lack of Efficacy|13|||
143250743|NCT03595228|516472887|FG000|Overall Study|Withdrawal by Subject|3|||
143250744|NCT03595228|516472887|FG000|Overall Study|Withdrawal by Sponsor|1|||
143250745|NCT03232333|516472888|FG000|Overall Study|Infection or Osteomyelitis|9|||
143250746|NCT03232333|516472888|FG000|Overall Study|Lost to Follow-up|4|||
143250747|NCT03232333|516472888|FG000|Overall Study|Withdrawal by Subject|2|||
143250748|NCT01253811|516472889|FG000|Overall Study|Withdrawal criteria|1|||
143250749|NCT01087736|516472890|FG000|Overall Study|Lost to Follow-up|1|||
143250750|NCT01087736|516472891|FG001|Overall Study|Lost to Follow-up|0|||
143250751|NCT01087736|516472890|FG000|Overall Study|Death|0|||
143250752|NCT01087736|516472891|FG001|Overall Study|Death|1|||
143250753|NCT01087736|516472890|FG000|Overall Study|Withdrawal by Subject|0|||
143250754|NCT01087736|516472891|FG001|Overall Study|Withdrawal by Subject|1|||
143250755|NCT00567255|516472893|FG000|Overall Study|Adverse Event|241|||
143250756|NCT00567255|516472894|FG001|Overall Study|Adverse Event|68|||
143250757|NCT00567255|516472893|FG000|Overall Study|Lost to Follow-up|77|||
143250758|NCT00567255|516472894|FG001|Overall Study|Lost to Follow-up|48|||
143250759|NCT00567255|516472893|FG000|Overall Study|Withdrawal by Subject|75|||
143250760|NCT00567255|516472894|FG001|Overall Study|Withdrawal by Subject|56|||
143250761|NCT00567255|516472893|FG000|Overall Study|Lack of Efficacy|19|||
143250762|NCT00567255|516472894|FG001|Overall Study|Lack of Efficacy|33|||
143250763|NCT00567255|516472893|FG000|Overall Study|Protocol Violation|20|||
143250764|NCT00567255|516472894|FG001|Overall Study|Protocol Violation|8|||
143250765|NCT00567255|516472893|FG000|Overall Study|Pregnancy|6|||
143250766|NCT00567255|516472894|FG001|Overall Study|Pregnancy|0|||
143250767|NCT00567255|516472893|FG000|Overall Study|Drug noncompliance,moved,other|25|||
143250768|NCT00567255|516472894|FG001|Overall Study|Drug noncompliance,moved,other|15|||
143250769|NCT01743001|516472897|FG000|Overall Study|Physician Decision|1|||
143250770|NCT01743001|516472898|FG001|Overall Study|Physician Decision|0|||
143250771|NCT01743001|516472897|FG000|Overall Study|Pregnancy|1|||
143250772|NCT01743001|516472898|FG001|Overall Study|Pregnancy|0|||
143089911|NCT01962103|515868457|FG007|Phase 2|Progressive Disease|12|||
143089912|NCT01962103|515868458|FG008|Phase 2|Progressive Disease|11|||
143250773|NCT01743001|516472897|FG000|Overall Study|Death|1|||
143250774|NCT01743001|516472898|FG001|Overall Study|Death|0|||
143250775|NCT03052426|516472901|FG000|Overall Study|Withdrawal by Subject|0|||
143250776|NCT03052426|516472902|FG001|Overall Study|Withdrawal by Subject|1|||
143250777|NCT03052426|516472903|FG002|Overall Study|Withdrawal by Subject|0|||
143250778|NCT03052426|516472901|FG000|Overall Study|Lost to Follow-up|2|||
143089913|NCT01962103|515868450|FG000|Phase 2|Symptomatic Deterioration|0|||
143089914|NCT01962103|515868451|FG001|Phase 2|Symptomatic Deterioration|0|||
143250779|NCT03052426|516472902|FG001|Overall Study|Lost to Follow-up|0|||
143250780|NCT03052426|516472903|FG002|Overall Study|Lost to Follow-up|1|||
143089915|NCT01962103|515868452|FG002|Phase 2|Symptomatic Deterioration|0|||
143089916|NCT01962103|515868453|FG003|Phase 2|Symptomatic Deterioration|0|||
143250781|NCT01565343|516472906|FG000|Overall Study|Administrative decision/technical issues|1|||
143250782|NCT01565343|516472907|FG001|Overall Study|Administrative decision/technical issues|0|||
143089917|NCT01962103|515868454|FG004|Phase 2|Symptomatic Deterioration|0|||
143089918|NCT01962103|515868455|FG005|Phase 2|Symptomatic Deterioration|0|||
143089919|NCT01962103|515868456|FG006|Phase 2|Symptomatic Deterioration|2|||
143089920|NCT01962103|515868457|FG007|Phase 2|Symptomatic Deterioration|2|||
143089921|NCT01962103|515868458|FG008|Phase 2|Symptomatic Deterioration|0|||
143089922|NCT01321749|515868459|FG000|Overall Study|Lost to Follow-up|4|||
143089923|NCT01321749|515868460|FG001|Overall Study|Lost to Follow-up|11|||
143089924|NCT01321749|515868459|FG000|Overall Study|Protocol Violation|4|||
143089925|NCT01321749|515868460|FG001|Overall Study|Protocol Violation|7|||
143089926|NCT01321749|515868459|FG000|Overall Study|Withdrawal by Subject|5|||
143089927|NCT01321749|515868460|FG001|Overall Study|Withdrawal by Subject|4|||
143089928|NCT02094300|515868465|FG000|Overall Study|Death|7|||
143089929|NCT02094300|515868465|FG000|Overall Study|Lost to Follow-up|10|||
143089930|NCT02094300|515868465|FG000|Overall Study|Still be eligible for follow-up|3|||
143089931|NCT00725491|515868468|FG000|Overall Study|Adverse Event|3|||
143089932|NCT00725491|515868469|FG001|Overall Study|Adverse Event|2|||
143089933|NCT00725491|515868468|FG000|Overall Study|Pregnancy|0|||
143089934|NCT00725491|515868469|FG001|Overall Study|Pregnancy|3|||
143089935|NCT00725491|515868468|FG000|Overall Study|Risk for hyperstimulation|2|||
143089936|NCT00725491|515868469|FG001|Overall Study|Risk for hyperstimulation|9|||
143089937|NCT00725491|515868468|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
143089938|NCT00725491|515868469|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
143089939|NCT00725491|515868468|FG000|Overall Study|Fertilization failure|0|||
143089940|NCT00725491|515868469|FG001|Overall Study|Fertilization failure|1|||
143089941|NCT00725491|515868468|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
143089942|NCT00725491|515868469|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
143089943|NCT01495000|515868472|FG000|Overall Study|Lost to Follow-up|2|||
143089944|NCT01495000|515868473|FG001|Overall Study|Lost to Follow-up|2|||
143089945|NCT01495000|515868472|FG000|Overall Study|Protocol Violation|1|||
143089946|NCT01495000|515868473|FG001|Overall Study|Protocol Violation|0|||
143089947|NCT01495000|515868472|FG000|Overall Study|Withdrawal by Subject|10|||
143089948|NCT01495000|515868473|FG001|Overall Study|Withdrawal by Subject|10|||
143089949|NCT03347110|515868477|FG000|Overall Study|Other (Participant is incarcerated)|1|||
143089950|NCT03347110|515868477|FG000|Overall Study|Withdrawal by Subject|9|||
143089951|NCT03347110|515868477|FG000|Overall Study|Lost to Follow-up|1|||
143089952|NCT03347110|515868477|FG000|Overall Study|Lack of Efficacy|2|||
143089953|NCT03347110|515868477|FG000|Overall Study|Adverse Event, non-fatal|9|||
143089954|NCT02105467|515868478|FG000|Period 1|Lost to Follow-up|1|||
143089955|NCT02105467|515868479|FG001|Period 1|Lost to Follow-up|0|||
143089956|NCT02105467|515868478|FG000|Period 1|Death|1|||
143089957|NCT02105467|515868479|FG001|Period 1|Death|0|||
143089958|NCT02105467|515868478|FG000|Period 2|Lost to Follow-up|1|||
143089959|NCT02105467|515868479|FG001|Period 2|Lost to Follow-up|0|||
143089960|NCT02105467|515868478|FG000|Period 2|Death|1|||
143089961|NCT02105467|515868479|FG001|Period 2|Death|0|||
143089962|NCT02105467|515868478|FG000|Period 2|Withdrawal by Subject|0|||
143089963|NCT02105467|515868479|FG001|Period 2|Withdrawal by Subject|2|||
143089964|NCT02105467|515868478|FG000|Period 3|Lost to Follow-up|0|||
143089965|NCT02105467|515868479|FG001|Period 3|Lost to Follow-up|1|||
143089966|NCT02676882|515868483|FG000|Overall Study|Adverse Event|1|||
143089967|NCT02676882|515868484|FG001|Overall Study|Adverse Event|0|||
143089968|NCT02676882|515868483|FG000|Overall Study|Lost to Follow-up|1|||
143089969|NCT02676882|515868484|FG001|Overall Study|Lost to Follow-up|0|||
143089970|NCT02676882|515868483|FG000|Overall Study|Withdrawal by Subject|1|||
143089971|NCT02676882|515868484|FG001|Overall Study|Withdrawal by Subject|2|||
143089972|NCT00958828|515868486|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
143089973|NCT00958828|515868487|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
143367148|NCT03523962|516887257|FG003|Closed Fractures|Incarceration|0|||
143367149|NCT03523962|516887254|FG000|Open Fractures|Death|0|||
143367150|NCT03523962|516887255|FG001|Open Fractures|Death|0|||
143367151|NCT03523962|516887256|FG002|Open Fractures|Death|11|||
143089974|NCT00958828|515868486|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
143089975|NCT00958828|515868487|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
143089976|NCT02687451|515868494|FG000|Overall Study|Withdrawal by Subject|1|||
143089977|NCT02687451|515868495|FG001|Overall Study|Withdrawal by Subject|0|||
143089978|NCT02687451|515868496|FG002|Overall Study|Withdrawal by Subject|0|||
143089979|NCT02687451|515868497|FG003|Overall Study|Withdrawal by Subject|0|||
143089980|NCT02687451|515868498|FG004|Overall Study|Withdrawal by Subject|0|||
143089981|NCT02687451|515868499|FG005|Overall Study|Withdrawal by Subject|1|||
143089982|NCT00811733|515868504|FG000|Overall Study|Investigator Discretion|10|||
143367152|NCT03523962|516887257|FG003|Open Fractures|Death|6|||
143367153|NCT03523962|516887254|FG000|Open Fractures|Lost to Follow-up|0|||
143176154|NCT02712788|516194081|FG001|Overall Study|Protocol Violation|0|||
143176155|NCT00940602|516194085|FG000|Overall Study|Administrative problems|1|||
143176156|NCT00940602|516194086|FG001|Overall Study|Administrative problems|1|||
143089983|NCT00811733|515868505|FG001|Overall Study|Investigator Discretion|8|||
143089984|NCT00811733|515868504|FG000|Overall Study|Withdrawal by Subject|1|||
143089985|NCT00811733|515868505|FG001|Overall Study|Withdrawal by Subject|2|||
143089986|NCT02500589|515868506|FG000|Overall Study|Withdrawal by Subject|11|||
143089987|NCT02500589|515868507|FG001|Overall Study|Withdrawal by Subject|14|||
143089988|NCT02500589|515868506|FG000|Overall Study|Lost to Follow-up|10|||
143089989|NCT02500589|515868507|FG001|Overall Study|Lost to Follow-up|12|||
143089990|NCT02500589|515868506|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
143089991|NCT02500589|515868507|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
143089992|NCT02500589|515868506|FG000|Overall Study|Death|7|||
143089993|NCT02500589|515868507|FG001|Overall Study|Death|5|||
143176157|NCT00940602|516194085|FG000|Overall Study|Patient/guardian decision|13|||
143176158|NCT00940602|516194086|FG001|Overall Study|Patient/guardian decision|28|||
143367154|NCT03523962|516887255|FG001|Open Fractures|Lost to Follow-up|0|||
143089994|NCT01958437|515868508|FG000|Overall Study|Incidental MRI findings|0|||
143176159|NCT00940602|516194085|FG000|Overall Study|Physician Decision|8|||
143176160|NCT00940602|516194086|FG001|Overall Study|Physician Decision|5|||
143176161|NCT00940602|516194085|FG000|Overall Study|Pregnancy|1|||
143176162|NCT00940602|516194086|FG001|Overall Study|Pregnancy|0|||
143176163|NCT00940602|516194085|FG000|Overall Study|Protocol Deviation (untreated)|1|||
143176164|NCT00940602|516194086|FG001|Overall Study|Protocol Deviation (untreated)|0|||
143176165|NCT00940602|516194085|FG000|Overall Study|Disease progression|8|||
143176166|NCT00940602|516194086|FG001|Overall Study|Disease progression|2|||
143176167|NCT00940602|516194085|FG000|Overall Study|Death|38|||
143176168|NCT00940602|516194086|FG001|Overall Study|Death|19|||
143176169|NCT00940602|516194085|FG000|Overall Study|Lost to Follow-up|3|||
143176170|NCT00940602|516194086|FG001|Overall Study|Lost to Follow-up|1|||
143176171|NCT00940602|516194085|FG000|Overall Study|Patient withdrew consent|26|||
143176172|NCT00940602|516194086|FG001|Overall Study|Patient withdrew consent|13|||
143176173|NCT00940602|516194085|FG000|Overall Study|Adverse Event|7|||
143176174|NCT00940602|516194086|FG001|Overall Study|Adverse Event|2|||
143176175|NCT00940602|516194085|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
143176176|NCT00940602|516194086|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
143176177|NCT01463033|516194087|FG000|Overall Study|Lost to Follow-up|4|||
143176178|NCT01463033|516194088|FG001|Overall Study|Lost to Follow-up|4|||
143089995|NCT01958437|515868509|FG001|Overall Study|Incidental MRI findings|0|||
143089996|NCT01958437|515868510|FG002|Overall Study|Incidental MRI findings|1|||
143089997|NCT01958437|515868511|FG003|Overall Study|Incidental MRI findings|1|||
143089998|NCT03442751|515868512|FG000|Overall Study|Withdrawal by Subject|3|||
143089999|NCT03442751|515868513|FG001|Overall Study|Withdrawal by Subject|1|||
143090000|NCT03442751|515868512|FG000|Overall Study|Lost to Follow-up|3|||
143090001|NCT03442751|515868513|FG001|Overall Study|Lost to Follow-up|0|||
143090002|NCT05198518|515868515|FG000|Screening Visit|Deemed unable to participate|58|||
143090003|NCT05198518|515868516|FG001|Screening Visit|Deemed unable to participate|0|||
143090004|NCT05198518|515868517|FG002|Screening Visit|Deemed unable to participate|0|||
143090005|NCT03125798|515868518|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
143090006|NCT03125798|515868519|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
143090007|NCT03125798|515868518|FG000|Overall Study|Conversion to thoracotomy|7|||
143090008|NCT03125798|515868519|FG001|Overall Study|Conversion to thoracotomy|7|||
143090009|NCT03200717|515868530|FG000|Overall Study|Progressive disease|24|||
143090010|NCT03200717|515868531|FG001|Overall Study|Progressive disease|5|||
143090011|NCT03200717|515868530|FG000|Overall Study|Adverse Event|11|||
143090012|NCT03200717|515868531|FG001|Overall Study|Adverse Event|8|||
143090013|NCT03200717|515868530|FG000|Overall Study|Physician Decision|3|||
143090014|NCT03200717|515868531|FG001|Overall Study|Physician Decision|2|||
143090015|NCT03200717|515868530|FG000|Overall Study|Death|2|||
143090016|NCT03200717|515868531|FG001|Overall Study|Death|0|||
143090017|NCT03200717|515868530|FG000|Overall Study|Subject/Guardian Decision|1|||
143090018|NCT03200717|515868531|FG001|Overall Study|Subject/Guardian Decision|0|||
143090019|NCT03629184|515868532|FG000|Overall Study|Withdrawal by Subject|2|||
143090020|NCT03629184|515868533|FG001|Overall Study|Withdrawal by Subject|1|||
143090021|NCT03629184|515868532|FG000|Overall Study|Physician Decision|1|||
143090022|NCT03629184|515868533|FG001|Overall Study|Physician Decision|0|||
143176179|NCT01463033|516194087|FG000|Overall Study|Death|3|||
143176180|NCT01463033|516194088|FG001|Overall Study|Death|2|||
143367155|NCT03523962|516887256|FG002|Open Fractures|Lost to Follow-up|15|||
143176181|NCT02230189|516194089|FG000|Overall Study|Withdrawal by Subject|3|||
143176182|NCT02230189|516194090|FG001|Overall Study|Withdrawal by Subject|0|||
143176183|NCT02230189|516194091|FG002|Overall Study|Withdrawal by Subject|1|||
143176184|NCT02230189|516194089|FG000|Overall Study|Lost to Follow-up|1|||
143176185|NCT02230189|516194090|FG001|Overall Study|Lost to Follow-up|0|||
143176186|NCT02230189|516194091|FG002|Overall Study|Lost to Follow-up|0|||
143367156|NCT03523962|516887257|FG003|Open Fractures|Lost to Follow-up|8|||
143090023|NCT01461538|515868534|FG000|Overall Study|Death|15|||
143090024|NCT01461538|515868535|FG001|Overall Study|Death|6|||
143090025|NCT01461538|515868536|FG002|Overall Study|Death|2|||
143090026|NCT01461538|515868534|FG000|Overall Study|Study Stopped by Sponsor|2|||
143090027|NCT01461538|515868535|FG001|Overall Study|Study Stopped by Sponsor|1|||
143090028|NCT01461538|515868536|FG002|Overall Study|Study Stopped by Sponsor|0|||
143090029|NCT01461538|515868534|FG000|Overall Study|Withdrawal by Subject|1|||
143090030|NCT01461538|515868535|FG001|Overall Study|Withdrawal by Subject|1|||
143090031|NCT01461538|515868536|FG002|Overall Study|Withdrawal by Subject|0|||
143090032|NCT03447743|515868537|FG000|Overall Study|Withdrawal by Subject|2|||
143090033|NCT03447743|515868537|FG000|Overall Study|Lost to Follow-up|3|||
143090034|NCT03447743|515868537|FG000|Overall Study|Adverse Event|1|||
143090035|NCT03447743|515868537|FG000|Overall Study|Did not meet criteria to continue|1|||
143090036|NCT02046603|515868538|FG000|Overall Study|Other|11|||
143090037|NCT02046603|515868539|FG001|Overall Study|Other|66|||
143090038|NCT02046603|515868538|FG000|Overall Study|Protocol Violation|0|||
143090039|NCT02046603|515868539|FG001|Overall Study|Protocol Violation|1|||
143090040|NCT02046603|515868538|FG000|Overall Study|Participant/legal guardian decision|1|||
143090041|NCT02046603|515868539|FG001|Overall Study|Participant/legal guardian decision|3|||
143090042|NCT02046603|515868538|FG000|Overall Study|Physician Decision|2|||
143090043|NCT02046603|515868539|FG001|Overall Study|Physician Decision|1|||
143090044|NCT02046603|515868538|FG000|Overall Study|Lost to Follow-up|1|||
143090045|NCT02046603|515868539|FG001|Overall Study|Lost to Follow-up|2|||
143090046|NCT02046603|515868538|FG000|Overall Study|Death|0|||
143090047|NCT02046603|515868539|FG001|Overall Study|Death|1|||
143090048|NCT02046603|515868538|FG000|Overall Study|Adverse Event|0|||
143090049|NCT02046603|515868539|FG001|Overall Study|Adverse Event|1|||
143090050|NCT02461160|515868540|FG000|Overall Study|Lost to Follow-up|0|||
143090051|NCT02461160|515868541|FG001|Overall Study|Lost to Follow-up|0|||
143090052|NCT02461160|515868542|FG002|Overall Study|Lost to Follow-up|0|||
143090053|NCT02461160|515868543|FG003|Overall Study|Lost to Follow-up|0|||
143090054|NCT02461160|515868544|FG004|Overall Study|Lost to Follow-up|0|||
143090055|NCT02461160|515868545|FG005|Overall Study|Lost to Follow-up|0|||
143090056|NCT02461160|515868546|FG006|Overall Study|Lost to Follow-up|0|||
143090057|NCT02461160|515868547|FG007|Overall Study|Lost to Follow-up|1|||
143090058|NCT02461160|515868548|FG008|Overall Study|Lost to Follow-up|0|||
143090059|NCT02461160|515868549|FG009|Overall Study|Lost to Follow-up|0|||
143090060|NCT02461160|515868550|FG010|Overall Study|Lost to Follow-up|0|||
143090061|NCT02461160|515868551|FG011|Overall Study|Lost to Follow-up|0|||
143090062|NCT02461160|515868552|FG012|Overall Study|Lost to Follow-up|0|||
143090063|NCT00193050|515868553|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
143090064|NCT00193050|515868553|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
143090065|NCT00193050|515868553|FG000|Neoadjuvant Treatment|Physician Decision|2|||
143090066|NCT00193050|515868553|FG000|Neoadjuvant Treatment|Adverse Event|2|||
143090067|NCT00193050|515868553|FG000|Adjuvant|Physician Decision|5|||
143090068|NCT00193050|515868553|FG000|Adjuvant|Intercurrent Hospitalization|3|||
143090069|NCT00193050|515868553|FG000|Adjuvant|Lack of Efficacy|2|||
143090070|NCT00061932|515868554|FG000|Overall Study|Withdrawal by Subject|13|||
143090071|NCT00061932|515868555|FG001|Overall Study|Withdrawal by Subject|4|||
143090072|NCT02899962|515868556|FG000|Open-label Phase|Adverse Event|2|||
143090073|NCT02899962|515868557|FG001|Open-label Phase|Adverse Event|0|||
143090074|NCT02899962|515868558|FG002|Open-label Phase|Adverse Event|0|||
143090075|NCT02899962|515868556|FG000|Open-label Phase|Lost to Follow-up|9|||
143090076|NCT02899962|515868557|FG001|Open-label Phase|Lost to Follow-up|0|||
143090077|NCT02899962|515868558|FG002|Open-label Phase|Lost to Follow-up|0|||
143090078|NCT02899962|515868556|FG000|Open-label Phase|Other reasons|9|||
143090079|NCT02899962|515868557|FG001|Open-label Phase|Other reasons|0|||
143090080|NCT02899962|515868558|FG002|Open-label Phase|Other reasons|0|||
143090081|NCT02899962|515868556|FG000|Open-label Phase|Withdrawal by Subject|7|||
143090082|NCT02899962|515868557|FG001|Open-label Phase|Withdrawal by Subject|0|||
143090083|NCT02899962|515868558|FG002|Open-label Phase|Withdrawal by Subject|0|||
143090084|NCT02899962|515868556|FG000|Maintenance Phase|Adverse Event|0|||
143090085|NCT02899962|515868557|FG001|Maintenance Phase|Adverse Event|2|||
143090086|NCT02899962|515868558|FG002|Maintenance Phase|Adverse Event|1|||
143090087|NCT02899962|515868556|FG000|Maintenance Phase|Death|0|||
143090088|NCT02899962|515868557|FG001|Maintenance Phase|Death|0|||
143090089|NCT02899962|515868558|FG002|Maintenance Phase|Death|1|||
143090090|NCT02899962|515868556|FG000|Maintenance Phase|Lack of Efficacy|0|||
143090091|NCT02899962|515868557|FG001|Maintenance Phase|Lack of Efficacy|20|||
143090092|NCT02899962|515868558|FG002|Maintenance Phase|Lack of Efficacy|16|||
143090093|NCT02899962|515868556|FG000|Maintenance Phase|Lost to Follow-up|0|||
143090094|NCT02899962|515868557|FG001|Maintenance Phase|Lost to Follow-up|12|||
143090095|NCT02899962|515868558|FG002|Maintenance Phase|Lost to Follow-up|14|||
143090096|NCT02899962|515868556|FG000|Maintenance Phase|Other reasons|0|||
143090097|NCT02899962|515868557|FG001|Maintenance Phase|Other reasons|9|||
143090098|NCT02899962|515868558|FG002|Maintenance Phase|Other reasons|13|||
143090099|NCT02899962|515868556|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
143090100|NCT02899962|515868557|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
143090101|NCT02899962|515868558|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
143090102|NCT02899962|515868556|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
143090103|NCT02899962|515868557|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
143090104|NCT02899962|515868558|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
143090105|NCT02899962|515868556|FG000|Maintenance Phase|Withdrawal by Subject|0|||
143090106|NCT02899962|515868557|FG001|Maintenance Phase|Withdrawal by Subject|30|||
143090107|NCT02899962|515868558|FG002|Maintenance Phase|Withdrawal by Subject|36|||
143090108|NCT01245283|515868559|FG000|Overall Study|Lost to Follow-up|14|||
143090109|NCT01245283|515868560|FG001|Overall Study|Lost to Follow-up|11|||
143090110|NCT01245283|515868561|FG002|Overall Study|Lost to Follow-up|11|||
143090111|NCT03567980|515868564|FG000|Overall Study|Adverse Event|1|||
143090112|NCT01610492|515868565|FG000|Overall Study|Adverse Event|1|||
143090113|NCT01610492|515868565|FG000|Overall Study|Lack of Efficacy|3|||
143090114|NCT01610492|515868565|FG000|Overall Study|Other: Reached stopping criteria|1|||
143090115|NCT01610492|515868565|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
143090116|NCT01459783|515868566|FG000|Baseline to 6 Months|Death|1|||
143090117|NCT01459783|515868567|FG001|Baseline to 6 Months|Death|0|||
143090118|NCT01459783|515868566|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
143090119|NCT01459783|515868567|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
143090120|NCT01459783|515868566|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
143090121|NCT01459783|515868567|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
143090122|NCT01459783|515868566|FG000|6 Months to 12 Months|Death|0|||
143090123|NCT01459783|515868567|FG001|6 Months to 12 Months|Death|1|||
143090124|NCT01459783|515868566|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
143090125|NCT01459783|515868567|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
143090126|NCT01459783|515868566|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
143090127|NCT01459783|515868567|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
143090128|NCT01459783|515868566|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
143090129|NCT01459783|515868567|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
143090130|NCT04211831|515868568|FG000|Overall Study|Withdrawal by Subject|4|||
143090131|NCT04211831|515868569|FG001|Overall Study|Withdrawal by Subject|1|||
143090132|NCT04211831|515868570|FG002|Overall Study|Withdrawal by Subject|1|||
143090133|NCT04211831|515868568|FG000|Overall Study|Protocol Violation|0|||
143090134|NCT04211831|515868569|FG001|Overall Study|Protocol Violation|0|||
143090135|NCT04211831|515868570|FG002|Overall Study|Protocol Violation|1|||
143090136|NCT04211831|515868568|FG000|Overall Study|Adverse Event|0|||
143090137|NCT04211831|515868569|FG001|Overall Study|Adverse Event|1|||
143090138|NCT04211831|515868570|FG002|Overall Study|Adverse Event|0|||
143090139|NCT04211831|515868568|FG000|Overall Study|Lack of Efficacy|0|||
143090140|NCT04211831|515868569|FG001|Overall Study|Lack of Efficacy|0|||
143090141|NCT04211831|515868570|FG002|Overall Study|Lack of Efficacy|1|||
143090142|NCT04211831|515868568|FG000|Overall Study|Lost to Follow-up|0|||
143090143|NCT04211831|515868569|FG001|Overall Study|Lost to Follow-up|0|||
143090144|NCT04211831|515868570|FG002|Overall Study|Lost to Follow-up|2|||
143090145|NCT04211831|515868568|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
143090146|NCT04211831|515868569|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
143090147|NCT04211831|515868570|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
143090148|NCT04211831|515868568|FG000|Overall Study|Other|0|||
143090149|NCT04211831|515868569|FG001|Overall Study|Other|1|||
143090150|NCT04211831|515868570|FG002|Overall Study|Other|0|||
143090151|NCT04871776|515868571|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
143090152|NCT04871776|515868572|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
143090153|NCT04871776|515868573|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
143090154|NCT04871776|515868571|FG000|Overall Study|Did not meet eligibility criteria|1|||
143090155|NCT04871776|515868572|FG001|Overall Study|Did not meet eligibility criteria|1|||
143090156|NCT04871776|515868573|FG002|Overall Study|Did not meet eligibility criteria|1|||
143090157|NCT06389487|515868577|FG000|Overall Study|Lost to Follow-up|9|||
143090158|NCT06389487|515868578|FG001|Overall Study|Lost to Follow-up|5|||
143090159|NCT06389487|515868579|FG002|Overall Study|Lost to Follow-up|13|||
143090160|NCT06389487|515868577|FG000|Overall Study|Protocol Violation|0|||
143090161|NCT06389487|515868578|FG001|Overall Study|Protocol Violation|0|||
143090162|NCT06389487|515868579|FG002|Overall Study|Protocol Violation|2|||
143090163|NCT06389487|515868577|FG000|Overall Study|Withdrawal by Subject|2|||
143090164|NCT06389487|515868578|FG001|Overall Study|Withdrawal by Subject|2|||
143090165|NCT06389487|515868579|FG002|Overall Study|Withdrawal by Subject|1|||
143090166|NCT06389487|515868577|FG000|Overall Study|Other|1|||
143090167|NCT06389487|515868578|FG001|Overall Study|Other|0|||
143090168|NCT06389487|515868579|FG002|Overall Study|Other|1|||
143090169|NCT05620082|515868583|FG000|Overall Study|Discharged before study end|1|||
143090170|NCT05620082|515868584|FG001|Overall Study|Discharged before study end|4|||
143090171|NCT05620082|515868585|FG002|Overall Study|Discharged before study end|0|||
143090172|NCT05620082|515868583|FG000|Overall Study|Moved to a different ward|1|||
143090173|NCT05620082|515868584|FG001|Overall Study|Moved to a different ward|0|||
143090174|NCT05620082|515868585|FG002|Overall Study|Moved to a different ward|0|||
143090175|NCT05620082|515868583|FG000|Overall Study|Feeling too unwell|1|||
143090176|NCT05620082|515868584|FG001|Overall Study|Feeling too unwell|0|||
143090177|NCT05620082|515868585|FG002|Overall Study|Feeling too unwell|0|||
143090178|NCT05655546|515870049|FG000|Overall Study|Withdrawal by Subject|2|||
143090179|NCT05655546|515870050|FG001|Overall Study|Withdrawal by Subject|4|||
143090180|NCT04576507|515870057|FG000|Overall Study|Adverse Event|4|||
143090181|NCT04576507|515870057|FG000|Overall Study|Withdrawal by Subject|1|||
143090182|NCT05525520|515870060|FG000|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|0|||
143090183|NCT05525520|515870061|FG001|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|2|||
143090184|NCT05525520|515870060|FG000|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
143090185|NCT05525520|515870061|FG001|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
143090186|NCT02721732|515870062|FG000|Overall Study|Adverse Event|2|||
143090187|NCT02721732|515870063|FG001|Overall Study|Adverse Event|0|||
143090188|NCT02721732|515870064|FG002|Overall Study|Adverse Event|2|||
143090189|NCT02721732|515870065|FG003|Overall Study|Adverse Event|0|||
143090190|NCT02721732|515870066|FG004|Overall Study|Adverse Event|1|||
143090191|NCT02721732|515870067|FG005|Overall Study|Adverse Event|0|||
143090192|NCT02721732|515870068|FG006|Overall Study|Adverse Event|1|||
143090193|NCT02721732|515870069|FG007|Overall Study|Adverse Event|0|||
143090194|NCT02721732|515870070|FG008|Overall Study|Adverse Event|1|||
143090195|NCT02721732|515870071|FG009|Overall Study|Adverse Event|1|||
143090196|NCT02721732|515870062|FG000|Overall Study|Death|0|||
143090197|NCT02721732|515870063|FG001|Overall Study|Death|0|||
143090198|NCT02721732|515870064|FG002|Overall Study|Death|0|||
143090199|NCT02721732|515870065|FG003|Overall Study|Death|0|||
143090200|NCT02721732|515870066|FG004|Overall Study|Death|1|||
143090201|NCT02721732|515870067|FG005|Overall Study|Death|0|||
143090202|NCT02721732|515870068|FG006|Overall Study|Death|1|||
143090203|NCT02721732|515870069|FG007|Overall Study|Death|0|||
143090204|NCT02721732|515870070|FG008|Overall Study|Death|0|||
143090205|NCT02721732|515870071|FG009|Overall Study|Death|1|||
143090206|NCT02721732|515870062|FG000|Overall Study|Lack of Efficacy|12|||
143090207|NCT02721732|515870063|FG001|Overall Study|Lack of Efficacy|11|||
143090208|NCT02721732|515870064|FG002|Overall Study|Lack of Efficacy|18|||
143090209|NCT02721732|515870065|FG003|Overall Study|Lack of Efficacy|5|||
143090210|NCT02721732|515870066|FG004|Overall Study|Lack of Efficacy|21|||
143176187|NCT02230189|516194089|FG000|Overall Study|Physician Decision|1|||
143176188|NCT02230189|516194090|FG001|Overall Study|Physician Decision|0|||
143367157|NCT03523962|516887254|FG000|Open Fractures|Withdrawal by Subject|0|||
143367158|NCT03523962|516887255|FG001|Open Fractures|Withdrawal by Subject|0|||
143090211|NCT02721732|515870067|FG005|Overall Study|Lack of Efficacy|2|||
143090212|NCT02721732|515870068|FG006|Overall Study|Lack of Efficacy|8|||
143176189|NCT02230189|516194091|FG002|Overall Study|Physician Decision|0|||
143176190|NCT01368614|516194095|FG000|Screening Period|Screen Failure|58|||
143176191|NCT01368614|516194096|FG001|Screening Period|Screen Failure|0|||
143176192|NCT01368614|516194097|FG002|Screening Period|Screen Failure|0|||
143176193|NCT01368614|516194098|FG003|Screening Period|Screen Failure|0|||
143176194|NCT01368614|516194095|FG000|Study Period|Withdrawal by Subject|0|||
143176195|NCT01368614|516194096|FG001|Study Period|Withdrawal by Subject|1|||
143176196|NCT01368614|516194097|FG002|Study Period|Withdrawal by Subject|1|||
143176197|NCT01368614|516194098|FG003|Study Period|Withdrawal by Subject|3|||
143176198|NCT01368614|516194095|FG000|Study Period|Lost to Follow-up|0|||
143176199|NCT01368614|516194096|FG001|Study Period|Lost to Follow-up|0|||
143176200|NCT01368614|516194097|FG002|Study Period|Lost to Follow-up|1|||
143176201|NCT01368614|516194098|FG003|Study Period|Lost to Follow-up|0|||
143176202|NCT01847755|516194102|FG000|Overall Study|Adverse Event|2|||
143176203|NCT01847755|516194102|FG000|Overall Study|Withdrawal by Subject|2|||
143176204|NCT01847755|516194102|FG000|Overall Study|Physician Decision|1|||
143176205|NCT02347085|516194105|FG000|Overall Study|Adverse Event|2|||
143176206|NCT02347085|516194105|FG000|Overall Study|Lack of Efficacy|1|||
143176207|NCT02347085|516194105|FG000|Overall Study|Withdrawal by Subject|4|||
143176208|NCT02347085|516194105|FG000|Overall Study|Lost to Follow-up|1|||
143090213|NCT02721732|515870069|FG007|Overall Study|Lack of Efficacy|11|||
143090214|NCT02721732|515870070|FG008|Overall Study|Lack of Efficacy|10|||
143090215|NCT02721732|515870071|FG009|Overall Study|Lack of Efficacy|20|||
143090216|NCT02721732|515870062|FG000|Overall Study|Physician Decision|0|||
143090217|NCT02721732|515870063|FG001|Overall Study|Physician Decision|0|||
143090218|NCT02721732|515870064|FG002|Overall Study|Physician Decision|1|||
143090219|NCT02721732|515870065|FG003|Overall Study|Physician Decision|0|||
143090220|NCT02721732|515870066|FG004|Overall Study|Physician Decision|0|||
143090221|NCT02721732|515870067|FG005|Overall Study|Physician Decision|0|||
143090222|NCT02721732|515870068|FG006|Overall Study|Physician Decision|0|||
143090223|NCT02721732|515870069|FG007|Overall Study|Physician Decision|0|||
143090224|NCT02721732|515870070|FG008|Overall Study|Physician Decision|0|||
143090225|NCT02721732|515870071|FG009|Overall Study|Physician Decision|0|||
143090226|NCT02721732|515870062|FG000|Overall Study|Withdrawal by Subject|1|||
143090227|NCT02721732|515870063|FG001|Overall Study|Withdrawal by Subject|0|||
143090228|NCT02721732|515870064|FG002|Overall Study|Withdrawal by Subject|0|||
143090229|NCT02721732|515870065|FG003|Overall Study|Withdrawal by Subject|0|||
143090230|NCT02721732|515870066|FG004|Overall Study|Withdrawal by Subject|3|||
143090231|NCT02721732|515870067|FG005|Overall Study|Withdrawal by Subject|0|||
143090232|NCT02721732|515870068|FG006|Overall Study|Withdrawal by Subject|1|||
143090233|NCT02721732|515870069|FG007|Overall Study|Withdrawal by Subject|1|||
143090234|NCT02721732|515870070|FG008|Overall Study|Withdrawal by Subject|0|||
143090235|NCT02721732|515870071|FG009|Overall Study|Withdrawal by Subject|1|||
143090236|NCT02721732|515870062|FG000|Overall Study|Participant Choice|1|||
143176209|NCT02347085|516194105|FG000|Overall Study|Protocol Criteria|2|||
143176210|NCT02271529|516194106|FG000|Overall Study|Withdrawal by Subject|1|||
143176211|NCT01904721|516194108|FG000|Overall Study|Other Reasons|0|||
143090237|NCT02721732|515870063|FG001|Overall Study|Participant Choice|0|||
143090238|NCT02721732|515870064|FG002|Overall Study|Participant Choice|0|||
143090239|NCT02721732|515870065|FG003|Overall Study|Participant Choice|0|||
143090240|NCT02721732|515870066|FG004|Overall Study|Participant Choice|0|||
143090241|NCT02721732|515870067|FG005|Overall Study|Participant Choice|0|||
143176212|NCT01904721|516194109|FG001|Overall Study|Other Reasons|0|||
143176213|NCT01904721|516194110|FG002|Overall Study|Other Reasons|1|||
143176214|NCT01904721|516194111|FG003|Overall Study|Other Reasons|1|||
143176215|NCT01904721|516194112|FG004|Overall Study|Other Reasons|2|||
143176216|NCT01904721|516194113|FG005|Overall Study|Other Reasons|2|||
143176217|NCT01904721|516194114|FG006|Overall Study|Other Reasons|2|||
143176218|NCT01904721|516194108|FG000|Overall Study|Personal Reasons|0|||
143176219|NCT01904721|516194109|FG001|Overall Study|Personal Reasons|0|||
143176220|NCT01904721|516194110|FG002|Overall Study|Personal Reasons|0|||
143176221|NCT01904721|516194111|FG003|Overall Study|Personal Reasons|0|||
143176222|NCT01904721|516194112|FG004|Overall Study|Personal Reasons|2|||
143176223|NCT01904721|516194113|FG005|Overall Study|Personal Reasons|3|||
143176224|NCT01904721|516194114|FG006|Overall Study|Personal Reasons|3|||
143176225|NCT01904721|516194108|FG000|Overall Study|Lost to Follow-up|0|||
143176226|NCT01904721|516194109|FG001|Overall Study|Lost to Follow-up|0|||
143176227|NCT01904721|516194110|FG002|Overall Study|Lost to Follow-up|0|||
143176228|NCT01904721|516194111|FG003|Overall Study|Lost to Follow-up|0|||
143367159|NCT03523962|516887256|FG002|Open Fractures|Withdrawal by Subject|6|||
143090242|NCT02721732|515870068|FG006|Overall Study|Participant Choice|0|||
143176229|NCT01904721|516194112|FG004|Overall Study|Lost to Follow-up|1|||
143176230|NCT01904721|516194113|FG005|Overall Study|Lost to Follow-up|3|||
143367160|NCT03523962|516887257|FG003|Open Fractures|Withdrawal by Subject|2|||
143090243|NCT02721732|515870069|FG007|Overall Study|Participant Choice|0|||
143090244|NCT02721732|515870070|FG008|Overall Study|Participant Choice|0|||
143090245|NCT02721732|515870071|FG009|Overall Study|Participant Choice|1|||
143090246|NCT02721732|515870062|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
143090247|NCT02721732|515870063|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
143090248|NCT02721732|515870064|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
143090249|NCT02721732|515870065|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
143090250|NCT02721732|515870066|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
143090251|NCT02721732|515870067|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
143090252|NCT02721732|515870068|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
143090253|NCT02721732|515870069|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
143090254|NCT02721732|515870070|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
143090255|NCT02721732|515870071|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
143090256|NCT02721732|515870062|FG000|Overall Study|Progression and withdrew consent|1|||
143090257|NCT02721732|515870063|FG001|Overall Study|Progression and withdrew consent|1|||
143090258|NCT02721732|515870064|FG002|Overall Study|Progression and withdrew consent|0|||
143090259|NCT02721732|515870065|FG003|Overall Study|Progression and withdrew consent|0|||
143090260|NCT02721732|515870066|FG004|Overall Study|Progression and withdrew consent|0|||
143090261|NCT02721732|515870067|FG005|Overall Study|Progression and withdrew consent|0|||
143090262|NCT02721732|515870068|FG006|Overall Study|Progression and withdrew consent|0|||
143090263|NCT02721732|515870069|FG007|Overall Study|Progression and withdrew consent|0|||
143090264|NCT02721732|515870070|FG008|Overall Study|Progression and withdrew consent|0|||
143090265|NCT02721732|515870071|FG009|Overall Study|Progression and withdrew consent|1|||
143090266|NCT02721732|515870062|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
143090267|NCT02721732|515870063|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
143090268|NCT02721732|515870064|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
143090269|NCT02721732|515870065|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
143090270|NCT02721732|515870066|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
143090271|NCT02721732|515870067|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
143090272|NCT02721732|515870068|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
143090273|NCT02721732|515870069|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
143090274|NCT02721732|515870070|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
143090275|NCT02721732|515870071|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
143090276|NCT04179838|515870072|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
143090277|NCT04179838|515870073|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
143090278|NCT04179838|515870072|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
143090279|NCT04179838|515870073|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
143090280|NCT02763046|515870078|FG000|Overall Study|Adverse Event|5|||
143090281|NCT02763046|515870079|FG001|Overall Study|Adverse Event|4|||
143090282|NCT02763046|515870080|FG002|Overall Study|Adverse Event|0|||
143090283|NCT02763046|515870078|FG000|Overall Study|Lack of Efficacy|1|||
143090284|NCT02763046|515870079|FG001|Overall Study|Lack of Efficacy|1|||
143090285|NCT02763046|515870080|FG002|Overall Study|Lack of Efficacy|3|||
143176231|NCT01904721|516194114|FG006|Overall Study|Lost to Follow-up|1|||
143176232|NCT01904721|516194108|FG000|Overall Study|Lack of Efficacy|0|||
143176233|NCT01904721|516194109|FG001|Overall Study|Lack of Efficacy|0|||
143176234|NCT01904721|516194110|FG002|Overall Study|Lack of Efficacy|0|||
143176235|NCT01904721|516194111|FG003|Overall Study|Lack of Efficacy|0|||
143176236|NCT01904721|516194112|FG004|Overall Study|Lack of Efficacy|0|||
143176237|NCT01904721|516194113|FG005|Overall Study|Lack of Efficacy|0|||
143176238|NCT01904721|516194114|FG006|Overall Study|Lack of Efficacy|1|||
143176239|NCT01904721|516194108|FG000|Overall Study|Adverse Event|0|||
143176240|NCT01904721|516194109|FG001|Overall Study|Adverse Event|0|||
143176241|NCT01904721|516194110|FG002|Overall Study|Adverse Event|0|||
143176242|NCT01904721|516194111|FG003|Overall Study|Adverse Event|0|||
143176243|NCT01904721|516194112|FG004|Overall Study|Adverse Event|3|||
143176244|NCT01904721|516194113|FG005|Overall Study|Adverse Event|1|||
143176245|NCT01904721|516194114|FG006|Overall Study|Adverse Event|0|||
143176246|NCT01957865|516194115|FG000|Overall Study|Found HIV negative|0|||
143176247|NCT01957865|516194116|FG001|Overall Study|Found HIV negative|0|||
143176248|NCT01957865|516194117|FG002|Overall Study|Found HIV negative|1|||
143176249|NCT01957865|516194115|FG000|Overall Study|Lost to Follow-up|0|||
143090286|NCT02763046|515870078|FG000|Overall Study|Physician Decision|1|||
143176250|NCT01957865|516194116|FG001|Overall Study|Lost to Follow-up|2|||
143176251|NCT01957865|516194117|FG002|Overall Study|Lost to Follow-up|2|||
143176252|NCT01077063|516194121|FG000|Overall Study|Adverse Event|3|||
143176253|NCT01077063|516194122|FG001|Overall Study|Adverse Event|0|||
143176254|NCT01077063|516194121|FG000|Overall Study|Death|1|||
143176255|NCT01077063|516194122|FG001|Overall Study|Death|1|||
143176256|NCT01077063|516194121|FG000|Overall Study|Withdrawal by Subject|0|||
143176257|NCT01077063|516194122|FG001|Overall Study|Withdrawal by Subject|2|||
143090287|NCT02763046|515870079|FG001|Overall Study|Physician Decision|0|||
143090288|NCT02763046|515870080|FG002|Overall Study|Physician Decision|1|||
143090289|NCT02763046|515870078|FG000|Overall Study|Subject/guardian decision|2|||
143090290|NCT02763046|515870079|FG001|Overall Study|Subject/guardian decision|0|||
143090291|NCT02763046|515870080|FG002|Overall Study|Subject/guardian decision|4|||
143090292|NCT01067105|515870085|FG000|Overall Study|Adverse Event|14|||
143090293|NCT01067105|515870085|FG000|Overall Study|Protocol Violation|48|||
143090294|NCT01067105|515870085|FG000|Overall Study|Withdrawal by Subject|36|||
143090295|NCT01067105|515870085|FG000|Overall Study|Lost to Follow-up|6|||
143090296|NCT01067105|515870085|FG000|Overall Study|Physician Decision|6|||
143090297|NCT01067105|515870085|FG000|Overall Study|Other|31|||
143090298|NCT02203357|515870089|FG000|Overall Study|Lost to Follow-up|58|||
143090299|NCT02203357|515870090|FG001|Overall Study|Lost to Follow-up|66|||
143090300|NCT02203357|515870091|FG002|Overall Study|Lost to Follow-up|70|||
143090301|NCT02439216|515870092|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
143090302|NCT02439216|515870093|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
143090303|NCT02439216|515870094|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
143090304|NCT02439216|515870095|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
143090305|NCT02439216|515870096|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
143090306|NCT02439216|515870097|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
143090307|NCT02439216|515870098|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
143090308|NCT02439216|515870099|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
143090309|NCT02439216|515870100|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
143090310|NCT02439216|515870092|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
143090311|NCT02439216|515870093|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
143090312|NCT02439216|515870094|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
143090313|NCT02439216|515870095|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
143090314|NCT02439216|515870096|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
143090315|NCT02439216|515870097|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
143090316|NCT02439216|515870098|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
143090317|NCT02439216|515870099|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
143090318|NCT02439216|515870100|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
143090319|NCT02439216|515870092|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
143090320|NCT02439216|515870093|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
143090321|NCT02439216|515870094|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
143090322|NCT02439216|515870095|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
143090323|NCT02439216|515870096|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
143090324|NCT02439216|515870097|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
143090325|NCT02439216|515870098|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
143090326|NCT02439216|515870099|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
143090327|NCT02439216|515870100|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
143090328|NCT02439216|515870092|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
143090329|NCT02439216|515870093|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
143090330|NCT02439216|515870094|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
143090331|NCT02439216|515870095|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
143090332|NCT02439216|515870096|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
143090333|NCT02439216|515870097|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
143090334|NCT02439216|515870098|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
143090335|NCT02439216|515870099|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
143090336|NCT02439216|515870100|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
143090337|NCT02439216|515870092|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
143090338|NCT02439216|515870093|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
143090339|NCT02439216|515870094|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
143090340|NCT02439216|515870095|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
143090341|NCT02439216|515870096|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
143090342|NCT02439216|515870097|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
143090343|NCT02439216|515870098|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
143090344|NCT02439216|515870099|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
143090345|NCT02439216|515870100|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
143090346|NCT02493660|515870107|FG000|Overall Study|Physician Decision|0|||
143090347|NCT02493660|515870108|FG001|Overall Study|Physician Decision|1|||
143090348|NCT02493660|515870107|FG000|Overall Study|Adverse Event|4|||
143090349|NCT02493660|515870108|FG001|Overall Study|Adverse Event|2|||
143090350|NCT02493660|515870107|FG000|Overall Study|Withdrawal by Subject|2|||
143090351|NCT02493660|515870108|FG001|Overall Study|Withdrawal by Subject|3|||
143090352|NCT02493660|515870107|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
143090353|NCT02493660|515870108|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
143090354|NCT02493660|515870107|FG000|Overall Study|Protocol Violation|0|||
143090355|NCT02493660|515870108|FG001|Overall Study|Protocol Violation|1|||
143090356|NCT02493660|515870107|FG000|Overall Study|Death|0|||
143090357|NCT02493660|515870108|FG001|Overall Study|Death|1|||
143090358|NCT02493660|515870107|FG000|Overall Study|Lost to Follow-up|2|||
143090359|NCT02493660|515870108|FG001|Overall Study|Lost to Follow-up|4|||
143090360|NCT01050530|515870109|FG000|Overall Study|Adverse Event|6|||
143090361|NCT01050530|515870110|FG001|Overall Study|Adverse Event|3|||
143090362|NCT01050530|515870109|FG000|Overall Study|Lack of Efficacy|1|||
143090363|NCT01050530|515870110|FG001|Overall Study|Lack of Efficacy|4|||
143090364|NCT01050530|515870109|FG000|Overall Study|Withdrawal by Subject|0|||
143090365|NCT01050530|515870110|FG001|Overall Study|Withdrawal by Subject|3|||
143090366|NCT01050530|515870109|FG000|Overall Study|Protocol Violation|1|||
143090367|NCT01050530|515870110|FG001|Overall Study|Protocol Violation|0|||
143090368|NCT02288312|515870111|FG000|Overall Study|Pregnancy|1|||
143090369|NCT02288312|515870112|FG001|Overall Study|Pregnancy|0|||
143090370|NCT02288312|515870113|FG002|Overall Study|Pregnancy|0|||
143090371|NCT01276041|515870114|FG000|Overall Study|Adverse Event|2|||
143090372|NCT01276041|515870114|FG000|Overall Study|Protocol Violation|1|||
143090373|NCT01113892|515870124|FG000|Overall Study|Lost to Follow-up|2|||
143090374|NCT01113892|515870125|FG001|Overall Study|Lost to Follow-up|2|||
143090375|NCT01113892|515870124|FG000|Overall Study|Withdrawal by Subject|1|||
143090376|NCT01113892|515870125|FG001|Overall Study|Withdrawal by Subject|1|||
143090377|NCT01113892|515870124|FG000|Overall Study|Death|2|||
143090378|NCT01113892|515870125|FG001|Overall Study|Death|4|||
143090379|NCT01113892|515870124|FG000|Overall Study|Graft no longer evaluable|9|||
143090380|NCT01113892|515870125|FG001|Overall Study|Graft no longer evaluable|9|||
143090381|NCT01960413|515870126|FG000|Overall Study|Withdrawal by Subject|1|||
143090382|NCT01960413|515870127|FG001|Overall Study|Withdrawal by Subject|1|||
143090383|NCT01960413|515870126|FG000|Overall Study|Physician Decision|1|||
143090384|NCT01960413|515870127|FG001|Overall Study|Physician Decision|0|||
143090385|NCT01960413|515870126|FG000|Overall Study|Lost to Follow-up|2|||
143090386|NCT01960413|515870127|FG001|Overall Study|Lost to Follow-up|0|||
143090387|NCT04886596|515870128|FG000|Overall Study|Adverse Event|442|||
143090388|NCT04886596|515870129|FG001|Overall Study|Adverse Event|441|||
143090389|NCT04886596|515870128|FG000|Overall Study|Lost to Follow-up|448|||
143090390|NCT04886596|515870129|FG001|Overall Study|Lost to Follow-up|465|||
143090391|NCT04886596|515870128|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|1715|||
143090392|NCT04886596|515870129|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1726|||
143090393|NCT04886596|515870128|FG000|Overall Study|Migrated/moved from the study area|201|||
143090394|NCT04886596|515870129|FG001|Overall Study|Migrated/moved from the study area|184|||
143090395|NCT04886596|515870128|FG000|Overall Study|Other|298|||
143090396|NCT04886596|515870129|FG001|Overall Study|Other|326|||
143090397|NCT02603887|515870130|FG000|Stage 1|Adverse Event|4|||
143090398|NCT02603887|515870130|FG000|Stage 1|Disease progression|1|||
143090399|NCT02603887|515870130|FG000|Stage 2|FDA guidance|1|||
143090400|NCT00948155|515870133|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
143090401|NCT00948155|515870134|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
143090402|NCT00948155|515870133|FG000|Washout 14 Days|Lost to Follow-up|1|||
143090403|NCT00948155|515870134|FG001|Washout 14 Days|Lost to Follow-up|2|||
143176258|NCT00553631|516194123|FG000|Overall Study|Withdrawal by Subject|0|||
143176259|NCT00553631|516194124|FG001|Overall Study|Withdrawal by Subject|1|||
143176260|NCT00553631|516194123|FG000|Overall Study|Lost to Follow-up|1|||
143176261|NCT00553631|516194124|FG001|Overall Study|Lost to Follow-up|0|||
143176262|NCT00648037|516194127|FG000|Overall Study|Not Treated|1|||
143176263|NCT00648037|516194127|FG000|Overall Study|Withdrawal by Subject|1|||
143176264|NCT00648037|516194127|FG000|Overall Study|Adverse Event|11|||
143176265|NCT00648037|516194127|FG000|Overall Study|Relapse|2|||
143176266|NCT00648037|516194127|FG000|Overall Study|Other|1|||
143176267|NCT00881894|516194129|FG000|Overall Study|Consent withdrawn|0|||
143090404|NCT04620746|515870135|FG000|Overall Study|Adverse Event|2|||
143090405|NCT04620746|515870136|FG001|Overall Study|Adverse Event|0|||
143176268|NCT00881894|516194130|FG001|Overall Study|Consent withdrawn|1|||
143176269|NCT00881894|516194129|FG000|Overall Study|Other reasons for premature termination|1|||
143176270|NCT00881894|516194130|FG001|Overall Study|Other reasons for premature termination|2|||
143176271|NCT01284959|516194131|FG000|Overall Study|Withdrawal by Subject|1|||
143367161|NCT03523962|516887254|FG000|Open Fractures|Incarceration|0|||
143090406|NCT04620746|515870135|FG000|Overall Study|Uniterpretable skin test|1|||
143090407|NCT04620746|515870136|FG001|Overall Study|Uniterpretable skin test|0|||
143090408|NCT04620746|515870135|FG000|Overall Study|Withdrawal by Subject|0|||
143090409|NCT04620746|515870136|FG001|Overall Study|Withdrawal by Subject|1|||
143090410|NCT03473925|515870137|FG000|Overall Study|Death|48|||
143090411|NCT03473925|515870138|FG001|Overall Study|Death|44|||
143090412|NCT03473925|515870137|FG000|Overall Study|Sponsor Decision|2|||
143090413|NCT03473925|515870138|FG001|Overall Study|Sponsor Decision|7|||
143090414|NCT03473925|515870137|FG000|Overall Study|Withdrawal by Subject|1|||
143090415|NCT03473925|515870138|FG001|Overall Study|Withdrawal by Subject|3|||
143090416|NCT03473925|515870137|FG000|Overall Study|Not Treated|1|||
143090417|NCT03473925|515870138|FG001|Overall Study|Not Treated|1|||
143090418|NCT03411863|515870139|FG000|Overall Study|Withdrawal by Subject|3|||
143090419|NCT03411863|515870140|FG001|Overall Study|Withdrawal by Subject|1|||
143090420|NCT03411863|515870139|FG000|Overall Study|Physician Decision|0|||
143090421|NCT03411863|515870140|FG001|Overall Study|Physician Decision|1|||
143090422|NCT00124917|515870143|FG000|Overall Study|Physician Decision|3|||
143090423|NCT00951496|515870151|FG000|Overall Study|Did not initiate study treatment|10|||
143090424|NCT00951496|515870152|FG001|Overall Study|Did not initiate study treatment|8|||
143090425|NCT00951496|515870153|FG002|Overall Study|Did not initiate study treatment|13|||
143090426|NCT04870710|515870156|FG000|Overall Study|Lost to Follow-up|3|||
143090427|NCT00476190|515870157|FG000|Overall Study|Ineligible|1|||
143090428|NCT00476190|515870158|FG001|Overall Study|Ineligible|1|||
143090429|NCT00476190|515870157|FG000|Overall Study|Induction Death|2|||
143090430|NCT00476190|515870158|FG001|Overall Study|Induction Death|0|||
143090431|NCT00476190|515870157|FG000|Overall Study|Induction Failure|2|||
143090432|NCT00476190|515870158|FG001|Overall Study|Induction Failure|4|||
143090433|NCT00476190|515870157|FG000|Overall Study|Lost to Follow-up|1|||
143090434|NCT00476190|515870158|FG001|Overall Study|Lost to Follow-up|0|||
143090435|NCT00476190|515870157|FG000|Overall Study|Relapse/Progression|5|||
143090436|NCT00476190|515870158|FG001|Overall Study|Relapse/Progression|2|||
143090437|NCT00476190|515870157|FG000|Overall Study|Remission Death|0|||
143090438|NCT00476190|515870158|FG001|Overall Study|Remission Death|1|||
143090439|NCT00476190|515870157|FG000|Overall Study|Transplant in first Complete Remission (CR)|15|||
143090440|NCT00476190|515870158|FG001|Overall Study|Transplant in first Complete Remission (CR)|6|||
143090441|NCT00476190|515870157|FG000|Overall Study|Withdrawal by Subject|6|||
143090442|NCT00476190|515870158|FG001|Overall Study|Withdrawal by Subject|2|||
143090443|NCT00476190|515870157|FG000|Overall Study|Other|9|||
143090444|NCT00476190|515870158|FG001|Overall Study|Other|10|||
143090445|NCT02189837|515870159|FG000|Overall Study|Withdrawal by Subject|2|||
143090446|NCT02189837|515870160|FG001|Overall Study|Withdrawal by Subject|1|||
143090447|NCT02189837|515870161|FG002|Overall Study|Withdrawal by Subject|3|||
143090448|NCT02189837|515870162|FG003|Overall Study|Withdrawal by Subject|1|||
143090449|NCT02189837|515870159|FG000|Overall Study|Sponsor Decision|0|||
143090450|NCT02189837|515870160|FG001|Overall Study|Sponsor Decision|0|||
143176272|NCT01284959|516194132|FG001|Overall Study|Withdrawal by Subject|0|||
143176273|NCT01284959|516194133|FG002|Overall Study|Withdrawal by Subject|0|||
143176274|NCT01284959|516194131|FG000|Overall Study|Adverse Event|0|||
143176275|NCT01284959|516194132|FG001|Overall Study|Adverse Event|0|||
143176276|NCT01284959|516194133|FG002|Overall Study|Adverse Event|1|||
143176277|NCT00363311|516194134|FG000|Overall Study|Adverse Event|6|||
143176278|NCT00363311|516194135|FG001|Overall Study|Adverse Event|4|||
143176279|NCT00363311|516194134|FG000|Overall Study|Lost to Follow-up|3|||
143176280|NCT00363311|516194135|FG001|Overall Study|Lost to Follow-up|0|||
143176281|NCT00363311|516194134|FG000|Overall Study|Protocol Violation|1|||
143176282|NCT00363311|516194135|FG001|Overall Study|Protocol Violation|2|||
143176283|NCT00363311|516194134|FG000|Overall Study|Withdrawal by Subject|12|||
143176284|NCT00363311|516194135|FG001|Overall Study|Withdrawal by Subject|6|||
143176285|NCT00363311|516194134|FG000|Overall Study|Physician Decision|1|||
143176286|NCT00363311|516194135|FG001|Overall Study|Physician Decision|1|||
143176287|NCT00363311|516194134|FG000|Overall Study|Sponsor Terminated Study|2|||
143176288|NCT00363311|516194135|FG001|Overall Study|Sponsor Terminated Study|2|||
143176289|NCT00363311|516194134|FG000|Overall Study|Disease Progression|46|||
143176290|NCT00363311|516194135|FG001|Overall Study|Disease Progression|26|||
143176291|NCT00363311|516194134|FG000|Overall Study|Non-Compliance|1|||
143176292|NCT00363311|516194135|FG001|Overall Study|Non-Compliance|1|||
143176293|NCT00363311|516194134|FG000|Overall Study|Participant Refused Biopsy|1|||
143176294|NCT00363311|516194135|FG001|Overall Study|Participant Refused Biopsy|0|||
143176295|NCT00363311|516194134|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
143176296|NCT00363311|516194135|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
143090451|NCT02189837|515870161|FG002|Overall Study|Sponsor Decision|0|||
143090452|NCT02189837|515870162|FG003|Overall Study|Sponsor Decision|1|||
143090453|NCT02198963|515870163|FG000|Overall Study|Adverse Event|1|||
143090454|NCT02198963|515870163|FG000|Overall Study|Withdrawal by Subject|6|||
143090455|NCT00281957|515870169|FG000|Overall Study|Adverse Event|7|||
143090456|NCT00281957|515870170|FG001|Overall Study|Adverse Event|2|||
143090457|NCT00281957|515870169|FG000|Overall Study|Death|1|||
143090458|NCT00281957|515870170|FG001|Overall Study|Death|0|||
143090459|NCT00281957|515870169|FG000|Overall Study|Progression/relapse|47|||
143176297|NCT00363311|516194134|FG000|Overall Study|Participant Opted for Treatment|1|||
143090460|NCT00281957|515870170|FG001|Overall Study|Progression/relapse|35|||
143090461|NCT00281957|515870169|FG000|Overall Study|Not protocol specified|8|||
143090462|NCT00281957|515870170|FG001|Overall Study|Not protocol specified|1|||
143090463|NCT00281957|515870169|FG000|Overall Study|Not eligible|1|||
143090464|NCT00281957|515870170|FG001|Overall Study|Not eligible|2|||
143090465|NCT00281957|515870169|FG000|Overall Study|Did not start treatment|3|||
143090466|NCT00281957|515870170|FG001|Overall Study|Did not start treatment|1|||
143090467|NCT00281957|515870169|FG000|Overall Study|Refusal unrelated to adverse events|0|||
143090468|NCT00281957|515870170|FG001|Overall Study|Refusal unrelated to adverse events|1|||
143090469|NCT01876446|515870171|FG000|Overall Study|Death|0|||
143090470|NCT01876446|515870172|FG001|Overall Study|Death|1|||
143090471|NCT01876446|515870171|FG000|Overall Study|Withdrawal by Subject|1|||
143090472|NCT01876446|515870172|FG001|Overall Study|Withdrawal by Subject|2|||
143090473|NCT01876446|515870171|FG000|Overall Study|Physician Decision|1|||
143090474|NCT01876446|515870172|FG001|Overall Study|Physician Decision|3|||
143114964|NCT02326298|515962471|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
143114965|NCT02326298|515962458|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
143114966|NCT02326298|515962459|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
143114967|NCT02326298|515962460|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
143114968|NCT02326298|515962461|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
143114969|NCT02326298|515962462|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
143114970|NCT02326298|515962463|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
143114971|NCT02326298|515962464|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
143114972|NCT02326298|515962465|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
143114973|NCT02326298|515962466|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
143114974|NCT02326298|515962467|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
143114975|NCT02326298|515962468|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
143114976|NCT02326298|515962469|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
143114977|NCT02326298|515962470|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
143114978|NCT02326298|515962471|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
143114979|NCT02326298|515962458|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
143114980|NCT02326298|515962459|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
143114981|NCT02326298|515962460|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
143114982|NCT02326298|515962461|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
143114983|NCT02326298|515962462|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
143114984|NCT02326298|515962463|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
143114985|NCT02326298|515962464|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
143114986|NCT02326298|515962465|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
143114987|NCT02326298|515962466|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
143114988|NCT02326298|515962467|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
143114989|NCT02326298|515962468|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
143114990|NCT02326298|515962469|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
143114991|NCT02326298|515962470|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
143114992|NCT02326298|515962471|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
143114993|NCT02326298|515962458|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
143114994|NCT02326298|515962459|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
143114995|NCT02326298|515962460|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
143114996|NCT02326298|515962461|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
143114997|NCT02326298|515962462|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
143114998|NCT02326298|515962463|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
143114999|NCT02326298|515962464|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
143115000|NCT02326298|515962465|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
143115001|NCT02326298|515962466|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
143090475|NCT01168232|515871792|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
143090476|NCT01168232|515871792|FG000|Overall Study|Ineligible- Wrong cell type|6|||
143090477|NCT01168232|515871792|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
143090478|NCT03657797|515871793|FG000|Overall Study|Lost to Follow-up|0|||
143090479|NCT03657797|515871794|FG001|Overall Study|Lost to Follow-up|1|||
143090480|NCT03657797|515871795|FG002|Overall Study|Lost to Follow-up|1|||
143250783|NCT01565343|516472908|FG002|Overall Study|Administrative decision/technical issues|0|||
143250784|NCT01853839|516472914|FG000|Overall Study|Violated inclusion criteria|2|||
143250785|NCT01853839|516472914|FG000|Overall Study|Not meet ITT population definition|58|||
143250786|NCT01853839|516472914|FG000|Overall Study|End of treatment visit too early|33|||
143090481|NCT03657797|515871796|FG003|Overall Study|Lost to Follow-up|0|||
143090482|NCT03657797|515871793|FG000|Overall Study|Physician Decision|0|||
143250787|NCT01853839|516472914|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
143250788|NCT01018810|516472915|FG000|Overall Study|Withdrawal by Subject|0|||
143250789|NCT01018810|516472916|FG001|Overall Study|Withdrawal by Subject|1|||
143250790|NCT01018810|516472917|FG002|Overall Study|Withdrawal by Subject|0|||
143250791|NCT01018810|516472918|FG003|Overall Study|Withdrawal by Subject|0|||
143250792|NCT01018810|516472919|FG004|Overall Study|Withdrawal by Subject|0|||
143250793|NCT01018810|516472915|FG000|Overall Study|Sponsor Decision|2|||
143250794|NCT01018810|516472916|FG001|Overall Study|Sponsor Decision|0|||
143250795|NCT01018810|516472917|FG002|Overall Study|Sponsor Decision|1|||
143250796|NCT01018810|516472918|FG003|Overall Study|Sponsor Decision|1|||
143250797|NCT01018810|516472919|FG004|Overall Study|Sponsor Decision|1|||
143250798|NCT04145219|516472920|FG000|Overall Study|Adverse Event|18|||
143250799|NCT04145219|516472921|FG001|Overall Study|Adverse Event|6|||
143250800|NCT04145219|516472920|FG000|Overall Study|Lost to Follow-up|2|||
143250801|NCT04145219|516472921|FG001|Overall Study|Lost to Follow-up|3|||
143250802|NCT04145219|516472920|FG000|Overall Study|Physician Decision|0|||
143250803|NCT04145219|516472921|FG001|Overall Study|Physician Decision|2|||
143250804|NCT04145219|516472920|FG000|Overall Study|Withdrawal by Subject|12|||
143250805|NCT04145219|516472921|FG001|Overall Study|Withdrawal by Subject|8|||
143250806|NCT04145219|516472920|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
143250807|NCT04145219|516472921|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
143250808|NCT01640314|516472922|FG000|Overall Study|Protocol Violation|0|||
143250809|NCT01640314|516472923|FG001|Overall Study|Protocol Violation|1|||
143250810|NCT01290796|516472924|FG000|Overall Study|Lost to Follow-up|21|||
143250811|NCT01290796|516472924|FG000|Overall Study|Withdrawal by Subject|4|||
143250812|NCT01290796|516472924|FG000|Overall Study|Physician Decision|2|||
143250813|NCT01290796|516472924|FG000|Overall Study|Secondary Surgical Intervention|2|||
143367162|NCT03523962|516887255|FG001|Open Fractures|Incarceration|0|||
143090483|NCT03657797|515871794|FG001|Overall Study|Physician Decision|1|||
143090484|NCT03657797|515871795|FG002|Overall Study|Physician Decision|0|||
143090485|NCT03657797|515871796|FG003|Overall Study|Physician Decision|0|||
143090486|NCT03657797|515871793|FG000|Overall Study|Withdrawal by Subject|0|||
143090487|NCT03657797|515871794|FG001|Overall Study|Withdrawal by Subject|1|||
143090488|NCT03657797|515871795|FG002|Overall Study|Withdrawal by Subject|2|||
143090489|NCT03657797|515871796|FG003|Overall Study|Withdrawal by Subject|0|||
143090490|NCT03657797|515871793|FG000|Overall Study|Adverse Event|0|||
143090491|NCT03657797|515871794|FG001|Overall Study|Adverse Event|0|||
143090492|NCT03657797|515871795|FG002|Overall Study|Adverse Event|2|||
143090493|NCT03657797|515871796|FG003|Overall Study|Adverse Event|0|||
143090494|NCT02115269|515871797|FG000|Overall Study|Lost to Follow-up|43|||
143090495|NCT02115269|515871797|FG000|Overall Study|Did not complete patient diary|3|||
143090496|NCT02115269|515871797|FG000|Overall Study|Moved to another city|7|||
143090497|NCT02115269|515871797|FG000|Overall Study|Withdrawal by Subject|2|||
143090498|NCT02115269|515871797|FG000|Overall Study|Didn't take study drug|2|||
143250814|NCT01290796|516472924|FG000|Overall Study|Withdrawal by Sponsor|1|||
143250815|NCT02709538|516472926|FG000|Overall Study|Adverse Event|13|||
143250816|NCT02709538|516472927|FG001|Overall Study|Adverse Event|2|||
143250817|NCT02709538|516472928|FG002|Overall Study|Adverse Event|3|||
143090499|NCT00086684|515871798|FG000|Overall Study|Adverse Event|12|||
143090500|NCT00086684|515871799|FG001|Overall Study|Adverse Event|17|||
143090501|NCT00086684|515871800|FG002|Overall Study|Adverse Event|14|||
143090502|NCT00086684|515871798|FG000|Overall Study|Lack of Efficacy|6|||
143090503|NCT00086684|515871799|FG001|Overall Study|Lack of Efficacy|6|||
143090504|NCT00086684|515871800|FG002|Overall Study|Lack of Efficacy|5|||
143090505|NCT00086684|515871798|FG000|Overall Study|Lost to Follow-up|15|||
143090506|NCT00086684|515871799|FG001|Overall Study|Lost to Follow-up|8|||
143090507|NCT00086684|515871800|FG002|Overall Study|Lost to Follow-up|10|||
143090508|NCT00086684|515871798|FG000|Overall Study|Protocol Violation|8|||
143090509|NCT00086684|515871799|FG001|Overall Study|Protocol Violation|3|||
143090510|NCT00086684|515871800|FG002|Overall Study|Protocol Violation|0|||
143090511|NCT00086684|515871798|FG000|Overall Study|Withdrawal by Subject|0|||
143090512|NCT00086684|515871799|FG001|Overall Study|Withdrawal by Subject|4|||
143090513|NCT00086684|515871800|FG002|Overall Study|Withdrawal by Subject|10|||
143090514|NCT00086684|515871798|FG000|Overall Study|NONCOMPLIANCE|5|||
143090515|NCT00086684|515871799|FG001|Overall Study|NONCOMPLIANCE|7|||
143090516|NCT00086684|515871800|FG002|Overall Study|NONCOMPLIANCE|6|||
143090517|NCT00086684|515871798|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
143090518|NCT00086684|515871799|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
143090519|NCT00086684|515871800|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
143090520|NCT00086684|515871798|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
143090521|NCT00086684|515871799|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
143090522|NCT00086684|515871800|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
143090523|NCT00086684|515871798|FG000|Overall Study|Other|4|||
143090524|NCT00086684|515871799|FG001|Overall Study|Other|2|||
143090525|NCT00086684|515871800|FG002|Overall Study|Other|3|||
143090526|NCT00840749|515871801|FG000|Overall Study|Death|1|||
143090527|NCT00840749|515871802|FG001|Overall Study|Death|2|||
143090528|NCT00840749|515871801|FG000|Overall Study|not treated on study arm|11|||
143090529|NCT00840749|515871802|FG001|Overall Study|not treated on study arm|11|||
143090530|NCT00840749|515871801|FG000|Overall Study|study closed|19|||
143090531|NCT00840749|515871802|FG001|Overall Study|study closed|14|||
143090532|NCT02569801|515871803|FG000|Overall Study|Withdrawal by Subject|9|||
143090533|NCT02569801|515871804|FG001|Overall Study|Withdrawal by Subject|9|||
143090534|NCT02569801|515871803|FG000|Overall Study|Sponsor Decision|13|||
143176298|NCT00363311|516194135|FG001|Overall Study|Participant Opted for Treatment|0|||
143176299|NCT00363311|516194134|FG000|Overall Study|Participant Moved to Another Country|1|||
143176300|NCT00363311|516194135|FG001|Overall Study|Participant Moved to Another Country|0|||
143090535|NCT02569801|515871804|FG001|Overall Study|Sponsor Decision|14|||
143176301|NCT00363311|516194134|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
143176302|NCT00363311|516194135|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
143176303|NCT00363311|516194134|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
143176304|NCT00363311|516194135|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
143176305|NCT00363311|516194134|FG000|Overall Study|Participant Moved to Louisiana|0|||
143176306|NCT00363311|516194135|FG001|Overall Study|Participant Moved to Louisiana|1|||
143176307|NCT01182298|516194138|FG000|Overall Study|Lack of Efficacy|4|||
143176308|NCT01182298|516194138|FG000|Overall Study|Withdrawal by Subject|2|||
143176309|NCT01595529|516194139|FG000|Overall Study|Adverse Event|2|||
143176310|NCT01595529|516194140|FG001|Overall Study|Adverse Event|0|||
143176311|NCT01595529|516194139|FG000|Overall Study|Subject Non-Compliant|2|||
143176312|NCT01595529|516194140|FG001|Overall Study|Subject Non-Compliant|0|||
143176313|NCT01595529|516194139|FG000|Overall Study|Lost to Follow-up|8|||
143176314|NCT01595529|516194140|FG001|Overall Study|Lost to Follow-up|14|||
143176315|NCT01595529|516194139|FG000|Overall Study|Protocol Violation|1|||
143176316|NCT01595529|516194140|FG001|Overall Study|Protocol Violation|2|||
143176317|NCT01595529|516194139|FG000|Overall Study|Physician Decision|1|||
143176318|NCT01595529|516194140|FG001|Overall Study|Physician Decision|0|||
143176319|NCT01595529|516194139|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
143176320|NCT01595529|516194140|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
143090536|NCT02569801|515871803|FG000|Overall Study|Progressive Disease|2|||
143090537|NCT02569801|515871804|FG001|Overall Study|Progressive Disease|7|||
143090538|NCT02569801|515871803|FG000|Overall Study|Lost to Follow-up|0|||
143090539|NCT02569801|515871804|FG001|Overall Study|Lost to Follow-up|1|||
143090540|NCT02569801|515871803|FG000|Overall Study|Death|12|||
143090541|NCT02569801|515871804|FG001|Overall Study|Death|4|||
143090542|NCT02756611|515871805|FG000|Overall Study|Death|70|||
143176321|NCT01595529|516194139|FG000|Overall Study|Administrative Decision|1|||
143176322|NCT01595529|516194140|FG001|Overall Study|Administrative Decision|0|||
143176323|NCT01595529|516194139|FG000|Overall Study|Entry Failure/Screening Failure|6|||
143176324|NCT01595529|516194140|FG001|Overall Study|Entry Failure/Screening Failure|1|||
143176325|NCT04016714|516194141|FG000|Overall Study|Death|1|||
143176326|NCT04016714|516194142|FG001|Overall Study|Death|0|||
143090543|NCT02756611|515871805|FG000|Overall Study|Withdrawal by Subject|2|||
143090544|NCT02756611|515871805|FG000|Overall Study|Lost to Follow-up|3|||
143176327|NCT04016714|516194141|FG000|Overall Study|Lost to Follow-up|3|||
143090545|NCT02756611|515871805|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
143090546|NCT02756611|515871805|FG000|Overall Study|Other|10|||
143090547|NCT03518008|515871808|FG000|Period 2, Second Week of Wear|Family emergency|0|||
143090548|NCT03518008|515871809|FG001|Period 2, Second Week of Wear|Family emergency|1|||
143090549|NCT01125917|515871812|FG000|Overall Study|Adverse Event|43|||
143090550|NCT01125917|515871812|FG000|Overall Study|Lost to Follow-up|23|||
143090551|NCT01125917|515871812|FG000|Overall Study|Withdrawal by Subject|31|||
143090552|NCT01125917|515871812|FG000|Overall Study|Administrative|223|||
143090553|NCT01125917|515871812|FG000|Overall Study|Lack of Efficacy|19|||
143090554|NCT04421131|515871813|FG000|Overall Study|Lost to Follow-up|1|||
143090555|NCT04421131|515871813|FG000|Overall Study|Protocol Violation|2|||
143090556|NCT04421131|515871813|FG000|Overall Study|App crashed|5|||
143090557|NCT04338022|515871814|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|56|||
143090558|NCT04338022|515871815|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|72|||
143090559|NCT04338022|515871814|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|6|||
143090560|NCT04338022|515871815|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|5|||
143090561|NCT04338022|515871814|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|19|||
143090562|NCT04338022|515871815|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|23|||
143090563|NCT04338022|515871814|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|56|||
143090564|NCT04338022|515871815|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|55|||
143090565|NCT04338022|515871814|FG000|Double-blind Treatment Period: 156 Weeks|Death|1|||
143090566|NCT04338022|515871815|FG001|Double-blind Treatment Period: 156 Weeks|Death|1|||
143090567|NCT04338022|515871814|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
143090568|NCT04338022|515871815|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
143090569|NCT04338022|515871814|FG000|Double-blind Treatment Period: 156 Weeks|Other Reason|24|||
143090570|NCT04338022|515871815|FG001|Double-blind Treatment Period: 156 Weeks|Other Reason|14|||
143090571|NCT04338022|515871814|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
143090572|NCT04338022|515871815|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
143090573|NCT04338022|515871814|FG000|Double-blind Extension: 96 Weeks|Lack of Efficacy|1|||
143090574|NCT04338022|515871815|FG001|Double-blind Extension: 96 Weeks|Lack of Efficacy|2|||
143090575|NCT04338022|515871814|FG000|Double-blind Extension: 96 Weeks|Withdrawal by Subject|0|||
143090576|NCT04338022|515871815|FG001|Double-blind Extension: 96 Weeks|Withdrawal by Subject|1|||
143090577|NCT04338022|515871814|FG000|Double-blind Extension: 96 Weeks|Adverse Event|2|||
143090578|NCT04338022|515871815|FG001|Double-blind Extension: 96 Weeks|Adverse Event|0|||
143090579|NCT04338022|515871814|FG000|Double-blind Extension: 96 Weeks|Lost to Follow-up|0|||
143090580|NCT04338022|515871815|FG001|Double-blind Extension: 96 Weeks|Lost to Follow-up|1|||
143090581|NCT04338022|515871814|FG000|Double-blind Extension: 96 Weeks|Other Reason|3|||
143090582|NCT04338022|515871815|FG001|Double-blind Extension: 96 Weeks|Other Reason|9|||
143090583|NCT04338022|515871814|FG000|Open Label Extension: 96 Weeks|Study Termination|0|||
143090584|NCT04338022|515871815|FG001|Open Label Extension: 96 Weeks|Study Termination|3|||
143090585|NCT04782076|515871818|FG000|Overall Study|Family Emergency|1|||
143090586|NCT02466321|515871823|FG000|Overall Study|Death|26|||
143090587|NCT02466321|515871823|FG000|Overall Study|Revision|6|||
143090588|NCT02466321|515871823|FG000|Overall Study|Lost to Follow-up|60|||
143090589|NCT02466321|515871823|FG000|Overall Study|Did not receive study device|1|||
143090590|NCT00243412|515871827|FG000|Overall Study|Death|0|||
143090591|NCT00243412|515871828|FG001|Overall Study|Death|1|||
143090592|NCT00243412|515871827|FG000|Overall Study|Adverse Event|4|||
143090593|NCT00243412|515871828|FG001|Overall Study|Adverse Event|2|||
143090594|NCT00243412|515871827|FG000|Overall Study|Lost to Follow-up|0|||
143090595|NCT00243412|515871828|FG001|Overall Study|Lost to Follow-up|1|||
143090596|NCT00243412|515871827|FG000|Overall Study|Physician Decision|1|||
143090597|NCT00243412|515871828|FG001|Overall Study|Physician Decision|1|||
143090598|NCT00243412|515871827|FG000|Overall Study|Withdrawal by Subject|4|||
143090599|NCT00243412|515871828|FG001|Overall Study|Withdrawal by Subject|5|||
143090600|NCT00243412|515871827|FG000|Overall Study|Other|1|||
143090601|NCT00243412|515871828|FG001|Overall Study|Other|1|||
143090602|NCT00822692|515871829|FG000|Overall Study|Lost to Follow-up|17|||
143090603|NCT00822692|515871830|FG001|Overall Study|Lost to Follow-up|25|||
143090604|NCT03281876|515871832|FG000|Overall Study|Adverse Event|4|||
143090605|NCT03281876|515871833|FG001|Overall Study|Adverse Event|15|||
143090606|NCT03281876|515871832|FG000|Overall Study|Lost to Follow-up|1|||
143090607|NCT03281876|515871833|FG001|Overall Study|Lost to Follow-up|4|||
143090608|NCT03281876|515871832|FG000|Overall Study|Withdrawal by Subject|11|||
143090609|NCT03281876|515871833|FG001|Overall Study|Withdrawal by Subject|15|||
143090610|NCT03281876|515871832|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
143090611|NCT03281876|515871833|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143090612|NCT03281876|515871832|FG000|Overall Study|OTHER|5|||
143090613|NCT03281876|515871833|FG001|Overall Study|OTHER|5|||
143090614|NCT02208089|515871834|FG000|Overall Study|Withdrawal by Subject|1|||
143090615|NCT02208089|515871835|FG001|Overall Study|Withdrawal by Subject|0|||
143090616|NCT02208089|515871834|FG000|Overall Study|Lost to Follow-up|6|||
143090617|NCT02208089|515871835|FG001|Overall Study|Lost to Follow-up|0|||
143090618|NCT02443740|515871836|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
143090619|NCT02443740|515871837|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
143090620|NCT02443740|515871838|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
143090621|NCT02443740|515871839|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
143090622|NCT02443740|515871840|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
143090623|NCT02443740|515871841|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
143090624|NCT02443740|515871842|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
143090625|NCT02443740|515871843|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
143090626|NCT02443740|515871844|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
143090627|NCT02443740|515871845|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
143090628|NCT02443740|515871846|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
143090629|NCT02443740|515871836|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
143090630|NCT02443740|515871837|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
143090631|NCT02443740|515871838|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
143090632|NCT02443740|515871839|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
143090633|NCT02443740|515871840|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
143090634|NCT02443740|515871841|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
143090635|NCT02443740|515871842|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
143090636|NCT02443740|515871843|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
143090637|NCT02443740|515871844|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
143090638|NCT02443740|515871845|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
143090639|NCT02443740|515871846|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
143090640|NCT02443740|515871836|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
143090641|NCT02443740|515871837|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
143090642|NCT02443740|515871838|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
143090643|NCT02443740|515871839|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
143367163|NCT03523962|516887256|FG002|Open Fractures|Incarceration|1|||
143090644|NCT02443740|515871840|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
143090645|NCT02443740|515871841|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
143090646|NCT02443740|515871842|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
143090647|NCT02443740|515871843|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
143090648|NCT02443740|515871844|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
143090649|NCT02443740|515871845|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
143090650|NCT02443740|515871846|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
143090651|NCT00456300|515871847|FG000|Overall Study|Adverse Event|1|||
143090652|NCT00456300|515871848|FG001|Overall Study|Adverse Event|0|||
143090653|NCT02452476|515871849|FG000|Overall Study|Death|4|||
143090654|NCT02452476|515871850|FG001|Overall Study|Death|7|||
143090655|NCT02452476|515871849|FG000|Overall Study|Lost to Follow-up|1|||
143090656|NCT02452476|515871850|FG001|Overall Study|Lost to Follow-up|1|||
143090657|NCT02452476|515871849|FG000|Overall Study|Physician Decision|1|||
143090658|NCT02452476|515871850|FG001|Overall Study|Physician Decision|1|||
143090659|NCT02452476|515871849|FG000|Overall Study|Not treated|5|||
143090660|NCT02452476|515871850|FG001|Overall Study|Not treated|1|||
143090661|NCT00683657|515871853|FG000|Overall Study|Adverse Event|0|||
143090662|NCT00683657|515871854|FG001|Overall Study|Adverse Event|1|||
143090663|NCT00683657|515871853|FG000|Overall Study|Subject Withdrew Consent|1|||
143367164|NCT03523962|516887257|FG003|Open Fractures|Incarceration|0|||
143090664|NCT00683657|515871854|FG001|Overall Study|Subject Withdrew Consent|0|||
143090665|NCT01074944|515871861|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
143090666|NCT01074944|515871862|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
143090667|NCT01074944|515871863|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
143090668|NCT01074944|515871864|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
143090669|NCT01074944|515871865|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
143090670|NCT01074944|515871861|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
143090671|NCT01074944|515871862|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
143090672|NCT01074944|515871863|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
143090673|NCT01074944|515871864|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
143090674|NCT01074944|515871865|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
143090675|NCT01074944|515871861|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
143090676|NCT01074944|515871862|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
143090677|NCT01074944|515871863|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
143090678|NCT01074944|515871864|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
143090679|NCT01074944|515871865|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
143090680|NCT01074944|515871861|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
143090681|NCT01074944|515871862|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
143090682|NCT01074944|515871863|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
143090683|NCT01074944|515871864|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
143090684|NCT01074944|515871865|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
143176328|NCT04016714|516194142|FG001|Overall Study|Lost to Follow-up|1|||
143176329|NCT04016714|516194141|FG000|Overall Study|Physician Decision|3|||
143176330|NCT04016714|516194142|FG001|Overall Study|Physician Decision|3|||
143176331|NCT04016714|516194141|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
143176332|NCT04016714|516194142|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
143176333|NCT02629861|516194148|FG000|Overall Study|Adverse Event|7|||
143176334|NCT02629861|516194149|FG001|Overall Study|Adverse Event|5|||
143176335|NCT02629861|516194150|FG002|Overall Study|Adverse Event|4|||
143176336|NCT02629861|516194148|FG000|Overall Study|Withdrawal by Subject|5|||
143176337|NCT02629861|516194149|FG001|Overall Study|Withdrawal by Subject|8|||
143176338|NCT02629861|516194150|FG002|Overall Study|Withdrawal by Subject|13|||
143176339|NCT02629861|516194148|FG000|Overall Study|Protocol Violation|2|||
143090685|NCT01074944|515871861|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
143176340|NCT02629861|516194149|FG001|Overall Study|Protocol Violation|3|||
143176341|NCT02629861|516194150|FG002|Overall Study|Protocol Violation|7|||
143176342|NCT02629861|516194148|FG000|Overall Study|Lost to Follow-up|12|||
143176343|NCT02629861|516194149|FG001|Overall Study|Lost to Follow-up|9|||
143176344|NCT02629861|516194150|FG002|Overall Study|Lost to Follow-up|4|||
143176345|NCT02629861|516194148|FG000|Overall Study|Other|1|||
143176346|NCT02629861|516194149|FG001|Overall Study|Other|1|||
143176347|NCT02629861|516194150|FG002|Overall Study|Other|0|||
143176348|NCT02629861|516194148|FG000|Overall Study|Pregnancy|2|||
143176349|NCT02629861|516194149|FG001|Overall Study|Pregnancy|1|||
143176350|NCT02629861|516194150|FG002|Overall Study|Pregnancy|0|||
143176351|NCT00959907|516194151|FG000|Overall Study|Protocol Violation|0|||
143176352|NCT00959907|516194152|FG001|Overall Study|Protocol Violation|1|||
143176353|NCT00959907|516194151|FG000|Overall Study|Adverse Event|1|||
143176354|NCT00959907|516194152|FG001|Overall Study|Adverse Event|0|||
143090686|NCT01074944|515871862|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
143090687|NCT01074944|515871863|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
143090688|NCT01074944|515871864|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
143090689|NCT01074944|515871865|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
143090690|NCT01074944|515871861|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
143090691|NCT01074944|515871862|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
143090692|NCT01074944|515871863|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
143090693|NCT01074944|515871864|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
143090694|NCT01074944|515871865|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
143176355|NCT00959907|516194151|FG000|Overall Study|Withdrawal by Subject|2|||
143176356|NCT00959907|516194152|FG001|Overall Study|Withdrawal by Subject|0|||
143176357|NCT03958331|516194153|FG000|Overall Study|Withdrawal by Subject|3|||
143176358|NCT03958331|516194154|FG001|Overall Study|Withdrawal by Subject|1|||
143176359|NCT03958331|516194155|FG002|Overall Study|Withdrawal by Subject|5|||
143176360|NCT03958331|516194153|FG000|Overall Study|Weaned from medicine|2|||
143176361|NCT03958331|516194154|FG001|Overall Study|Weaned from medicine|0|||
143176362|NCT03958331|516194155|FG002|Overall Study|Weaned from medicine|0|||
143176363|NCT03958331|516194153|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
143176364|NCT03958331|516194154|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
143176365|NCT03958331|516194155|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
143176366|NCT01847443|516194160|FG000|Study Period 1|Withdrawal by Subject|0|||
143176367|NCT01847443|516194161|FG001|Study Period 1|Withdrawal by Subject|1|||
143176368|NCT01847443|516194162|FG002|Study Period 1|Withdrawal by Subject|0|||
143176369|NCT01847443|516194163|FG003|Study Period 1|Withdrawal by Subject|0|||
143176370|NCT01847443|516194160|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
143176371|NCT01847443|516194161|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
143176372|NCT01847443|516194162|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
143176373|NCT01847443|516194163|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
143176374|NCT01847443|516194160|FG000|Washout Period Before Study Period 2|Other reason|1|||
143176375|NCT01847443|516194161|FG001|Washout Period Before Study Period 2|Other reason|0|||
143176376|NCT01847443|516194162|FG002|Washout Period Before Study Period 2|Other reason|0|||
143176377|NCT01847443|516194163|FG003|Washout Period Before Study Period 2|Other reason|0|||
143176378|NCT01847443|516194160|FG000|Washout Period Before Study Period 3|Other reason|1|||
143176379|NCT01847443|516194161|FG001|Washout Period Before Study Period 3|Other reason|0|||
143176380|NCT01847443|516194162|FG002|Washout Period Before Study Period 3|Other reason|0|||
143176381|NCT01847443|516194163|FG003|Washout Period Before Study Period 3|Other reason|0|||
143176382|NCT01847443|516194160|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
143176383|NCT01847443|516194161|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
143176384|NCT01847443|516194162|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
143176385|NCT01847443|516194163|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
143176386|NCT01847443|516194160|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
143176387|NCT01847443|516194161|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
143176388|NCT01847443|516194162|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
143176389|NCT01847443|516194163|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
143176390|NCT03391882|516194166|FG000|Study Overall|Adverse Event|3|||
143090695|NCT01074944|515871861|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
143090696|NCT01074944|515871862|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
143090697|NCT01074944|515871863|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
143090698|NCT01074944|515871864|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
143090699|NCT01074944|515871865|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
143090700|NCT01074944|515871861|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
143090701|NCT01074944|515871862|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
143090702|NCT01074944|515871863|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
143090703|NCT01074944|515871864|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
143090704|NCT01074944|515871865|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
143090705|NCT01074944|515871861|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
143090706|NCT01074944|515871862|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
143090707|NCT01074944|515871863|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
143090708|NCT01074944|515871864|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
143090709|NCT01074944|515871865|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
143090710|NCT01074944|515871861|FG000|Long Term Treatment|Adverse Event|0|||
143090711|NCT01074944|515871862|FG001|Long Term Treatment|Adverse Event|0|||
143090712|NCT01074944|515871863|FG002|Long Term Treatment|Adverse Event|0|||
143090713|NCT01074944|515871864|FG003|Long Term Treatment|Adverse Event|3|||
143090714|NCT01074944|515871865|FG004|Long Term Treatment|Adverse Event|0|||
143090715|NCT01074944|515871861|FG000|Long Term Treatment|Lost to Follow-up|0|||
143090716|NCT01074944|515871862|FG001|Long Term Treatment|Lost to Follow-up|0|||
143090717|NCT01074944|515871863|FG002|Long Term Treatment|Lost to Follow-up|0|||
143090718|NCT01074944|515871864|FG003|Long Term Treatment|Lost to Follow-up|2|||
143090719|NCT01074944|515871865|FG004|Long Term Treatment|Lost to Follow-up|0|||
143090720|NCT01074944|515871861|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
143090721|NCT01074944|515871862|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
143090722|NCT01074944|515871863|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
143090723|NCT01074944|515871864|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
143090724|NCT01074944|515871865|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
143090725|NCT01074944|515871861|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
143090726|NCT01074944|515871862|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
143090727|NCT01074944|515871863|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
143090728|NCT01074944|515871864|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
143090729|NCT01074944|515871865|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
143090730|NCT01074944|515871861|FG000|Long Term Treatment|Withdrawal by Subject|0|||
143090731|NCT01074944|515871862|FG001|Long Term Treatment|Withdrawal by Subject|0|||
143090732|NCT01074944|515871863|FG002|Long Term Treatment|Withdrawal by Subject|0|||
143090733|NCT01074944|515871864|FG003|Long Term Treatment|Withdrawal by Subject|2|||
143090734|NCT01074944|515871865|FG004|Long Term Treatment|Withdrawal by Subject|0|||
143090735|NCT01074944|515871861|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
143090736|NCT01074944|515871862|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
143090737|NCT01074944|515871863|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
143090738|NCT01074944|515871864|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
143090739|NCT01074944|515871865|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
143090740|NCT01074944|515871861|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
143090741|NCT01074944|515871862|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
143090742|NCT01074944|515871863|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
143090743|NCT01074944|515871864|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
143090744|NCT01074944|515871865|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
143090745|NCT02348112|515871867|FG000|Overall Study|Withdrawal by Subject|32|||
143090746|NCT02348112|515871868|FG001|Overall Study|Withdrawal by Subject|29|||
143090747|NCT02348112|515871867|FG000|Overall Study|Lost to Follow-up|24|||
143090748|NCT02348112|515871868|FG001|Overall Study|Lost to Follow-up|20|||
143090749|NCT02348112|515871867|FG000|Overall Study|Physician Decision|17|||
143090750|NCT02348112|515871868|FG001|Overall Study|Physician Decision|15|||
143090751|NCT02348112|515871867|FG000|Overall Study|Site closed due to PI leaving|0|||
143090752|NCT02348112|515871868|FG001|Overall Study|Site closed due to PI leaving|30|||
143090753|NCT02348112|515871867|FG000|Overall Study|Sponsor withdrawal|0|||
143090754|NCT02348112|515871868|FG001|Overall Study|Sponsor withdrawal|7|||
143090755|NCT02348112|515871867|FG000|Overall Study|Death|0|||
143090756|NCT02348112|515871868|FG001|Overall Study|Death|1|||
143090757|NCT01408043|515871869|FG000|Overall Study|unable to collect cells|1|||
143090758|NCT03552380|515871872|FG000|Study Treatment|Disease Progression|3|||
143176391|NCT03391882|516194167|FG001|Study Overall|Adverse Event|6|||
143176392|NCT03391882|516194168|FG002|Study Overall|Adverse Event|1|||
143176393|NCT03391882|516194169|FG003|Study Overall|Adverse Event|1|||
143176394|NCT03391882|516194170|FG004|Study Overall|Adverse Event|3|||
143176395|NCT03391882|516194171|FG005|Study Overall|Adverse Event|1|||
143176396|NCT03391882|516194166|FG000|Study Overall|Lack of Efficacy|13|||
143090759|NCT03552380|515871873|FG001|Study Treatment|Disease Progression|4|||
143090760|NCT03552380|515871872|FG000|Study Treatment|Adverse Event|2|||
143090761|NCT03552380|515871873|FG001|Study Treatment|Adverse Event|2|||
143090762|NCT03552380|515871872|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
143090763|NCT03552380|515871873|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
143090764|NCT03552380|515871872|FG000|Follow up|Death|3|||
143090765|NCT03552380|515871873|FG001|Follow up|Death|4|||
143090766|NCT03552380|515871872|FG000|Follow up|Site IRB terminated|0|||
143090767|NCT03552380|515871873|FG001|Follow up|Site IRB terminated|1|||
143090768|NCT02072980|515871874|FG000|Period 2, Second Wear|Adverse Event|0|||
143090769|NCT02072980|515871875|FG001|Period 2, Second Wear|Adverse Event|1|||
143090770|NCT02431364|515871876|FG000|Overall Study|Adverse Event|0|||
143090771|NCT02431364|515871877|FG001|Overall Study|Adverse Event|1|||
143090772|NCT02431364|515871878|FG002|Overall Study|Adverse Event|0|||
143090773|NCT02431364|515871879|FG003|Overall Study|Adverse Event|0|||
143090774|NCT02431364|515871880|FG004|Overall Study|Adverse Event|0|||
143090775|NCT02431364|515871876|FG000|Overall Study|Randomized but never treated|0|||
143090776|NCT02431364|515871877|FG001|Overall Study|Randomized but never treated|0|||
143090777|NCT02431364|515871878|FG002|Overall Study|Randomized but never treated|0|||
143090778|NCT02431364|515871879|FG003|Overall Study|Randomized but never treated|1|||
143090779|NCT02431364|515871880|FG004|Overall Study|Randomized but never treated|0|||
143090780|NCT00916383|515871881|FG000|Overall Study|Adverse Event|1|||
143090781|NCT00916383|515871881|FG000|Overall Study|Death|1|||
143090782|NCT00916383|515871881|FG000|Overall Study|Protocol Violation|1|||
143090783|NCT00473590|515871882|FG000|Overall Study|Adverse Event|3|||
143090784|NCT00473590|515871883|FG001|Overall Study|Adverse Event|3|||
143090785|NCT00473590|515871882|FG000|Overall Study|Death|4|||
143090786|NCT00473590|515871883|FG001|Overall Study|Death|2|||
143090787|NCT00473590|515871882|FG000|Overall Study|Progression not resulting in death|24|||
143090788|NCT00473590|515871883|FG001|Overall Study|Progression not resulting in death|20|||
143090789|NCT00473590|515871882|FG000|Overall Study|Non-protocol-specified therapy|7|||
143090790|NCT00473590|515871883|FG001|Overall Study|Non-protocol-specified therapy|5|||
143090791|NCT00473590|515871882|FG000|Overall Study|Physician Decision|2|||
143090792|NCT00473590|515871883|FG001|Overall Study|Physician Decision|4|||
143090793|NCT00473590|515871882|FG000|Overall Study|Withdrawal by Subject|5|||
143090794|NCT00473590|515871883|FG001|Overall Study|Withdrawal by Subject|3|||
143090795|NCT00473590|515871882|FG000|Overall Study|Other|0|||
143090796|NCT00473590|515871883|FG001|Overall Study|Other|1|||
143090797|NCT02575833|515871892|FG000|Overall Study|Withdrawal by Subject|0|||
143090798|NCT02575833|515871893|FG001|Overall Study|Withdrawal by Subject|1|||
143090799|NCT02575833|515871892|FG000|Overall Study|Lost to Follow-up|1|||
143090800|NCT02575833|515871893|FG001|Overall Study|Lost to Follow-up|0|||
143090801|NCT03093259|515871894|FG000|Overall Study|Adverse Event|1|||
143090802|NCT03093259|515871895|FG001|Overall Study|Adverse Event|0|||
143090803|NCT03093259|515871894|FG000|Overall Study|Withdrawal by Subject|1|||
143090804|NCT03093259|515871895|FG001|Overall Study|Withdrawal by Subject|0|||
143090805|NCT01757275|515871896|FG000|Overall Study|Lost to Follow-up|1|||
143090806|NCT01757275|515871897|FG001|Overall Study|Lost to Follow-up|2|||
143090807|NCT01757275|515871896|FG000|Overall Study|Adverse Event|3|||
143090808|NCT01757275|515871897|FG001|Overall Study|Adverse Event|3|||
143090809|NCT01757275|515871896|FG000|Overall Study|Withdrawal by Subject|2|||
143090810|NCT01757275|515871897|FG001|Overall Study|Withdrawal by Subject|4|||
143090811|NCT01757275|515871896|FG000|Overall Study|Not treated|3|||
143090812|NCT01757275|515871897|FG001|Overall Study|Not treated|4|||
143090813|NCT01821807|515871898|FG000|Overall Study|Lost to Follow-up|3|||
143090814|NCT01821807|515871899|FG001|Overall Study|Lost to Follow-up|1|||
143090815|NCT02633787|515871902|FG000|Overall Study|Withdrawal by Subject|1|||
143090816|NCT01401452|515871903|FG000|Overall Study|Adverse reaction|9|||
143090817|NCT01401452|515871903|FG000|Overall Study|Lost to Follow-up|12|||
143090818|NCT01401452|515871903|FG000|Overall Study|Lack of Efficacy|30|||
143090819|NCT01401452|515871903|FG000|Overall Study|Participant developed breast cancer|1|||
143090820|NCT01401452|515871903|FG000|Overall Study|Tx stopped due to financial reasons|1|||
143090821|NCT01401452|515871903|FG000|Overall Study|Tx stopped by psychiatrist|1|||
143090822|NCT01401452|515871903|FG000|Overall Study|No more visits within the 36 wk followup|4|||
143090823|NCT01401452|515871903|FG000|Overall Study|Subject did not come to follow up visits|2|||
143176397|NCT03391882|516194167|FG001|Study Overall|Lack of Efficacy|9|||
143176398|NCT03391882|516194168|FG002|Study Overall|Lack of Efficacy|0|||
143176399|NCT03391882|516194169|FG003|Study Overall|Lack of Efficacy|0|||
143176400|NCT03391882|516194170|FG004|Study Overall|Lack of Efficacy|0|||
143176401|NCT03391882|516194171|FG005|Study Overall|Lack of Efficacy|0|||
143090824|NCT01401452|515871903|FG000|Overall Study|Subject didn't return for routine visits|1|||
143090825|NCT01401452|515871903|FG000|Overall Study|Subject moved to another city|1|||
143090826|NCT01401452|515871903|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
143090827|NCT01401452|515871903|FG000|Overall Study|Psoriatic arthritis|1|||
143090828|NCT01401452|515871903|FG000|Overall Study|Participant stopped Tx|2|||
143090829|NCT01401452|515871903|FG000|Overall Study|Discontinuation for personal reasons|1|||
143090830|NCT01401452|515871903|FG000|Overall Study|Treatment failure|1|||
143090831|NCT01401452|515871903|FG000|Overall Study|Unsatisfactory output|1|||
143090832|NCT01401452|515871903|FG000|Overall Study|Subject withdrew because of Tx success|1|||
143090833|NCT01401452|515871903|FG000|Overall Study|Subject chose to discontinue treatment|1|||
143090834|NCT01401452|515871903|FG000|Overall Study|Participant withdrew consent|1|||
143090835|NCT02404805|515871904|FG000|Overall Study|Withdrawal by Subject|1|||
143090836|NCT02404805|515871905|FG001|Overall Study|Withdrawal by Subject|0|||
143090837|NCT02404805|515871906|FG002|Overall Study|Withdrawal by Subject|0|||
143090838|NCT02404805|515871907|FG003|Overall Study|Withdrawal by Subject|0|||
143090839|NCT02404805|515871908|FG004|Overall Study|Withdrawal by Subject|0|||
143090840|NCT02404805|515871909|FG005|Overall Study|Withdrawal by Subject|0|||
143090841|NCT02601014|515871911|FG000|Overall Study|Adverse Event|3|||
143090842|NCT02601014|515871912|FG001|Overall Study|Adverse Event|3|||
143090843|NCT02601014|515871911|FG000|Overall Study|Death|3|||
143090844|NCT02601014|515871912|FG001|Overall Study|Death|1|||
143090845|NCT02601014|515871911|FG000|Overall Study|Disease progression|4|||
143090846|NCT02601014|515871912|FG001|Overall Study|Disease progression|8|||
143090847|NCT01168427|515871913|FG000|Overall Study|Patient exited prior to implant|1|||
143090848|NCT01256879|515871914|FG000|Overall Study|Withdrawal by Subject|1|||
143090849|NCT00625820|515871915|FG000|Overall Study|Withdrawal by Subject|1|||
143090850|NCT00640315|515871916|FG000|Overall Study|Withdrawal by Subject|0|||
143090851|NCT00640315|515871917|FG001|Overall Study|Withdrawal by Subject|1|||
143090852|NCT00967330|515871919|FG000|Overall Study|Protocol Violation|3|||
143090853|NCT00967330|515871920|FG001|Overall Study|Protocol Violation|4|||
143090854|NCT00967330|515871919|FG000|Overall Study|Regular|10|||
143090855|NCT00967330|515871920|FG001|Overall Study|Regular|3|||
143090856|NCT00967330|515871919|FG000|Overall Study|Withdrawal by Subject|6|||
143090857|NCT00967330|515871920|FG001|Overall Study|Withdrawal by Subject|0|||
143090858|NCT00967330|515871919|FG000|Overall Study|Lost to Follow-up|1|||
143090859|NCT00967330|515871920|FG001|Overall Study|Lost to Follow-up|1|||
143090860|NCT00967330|515871919|FG000|Overall Study|Death|102|||
143090861|NCT00967330|515871920|FG001|Overall Study|Death|51|||
143090862|NCT00967330|515871919|FG000|Overall Study|Severe protocol deviation|0|||
143090863|NCT00967330|515871920|FG001|Overall Study|Severe protocol deviation|1|||
143090864|NCT04720105|515871921|FG000|Overall Study|Lack of Efficacy|1|||
143090865|NCT04720105|515871921|FG000|Overall Study|Lost to Follow-up|1|||
143090866|NCT04720105|515871921|FG000|Overall Study|Withdrawal by Subject|3|||
143090867|NCT04135937|515871923|FG000|Overall Study|Lost to Follow-up|2|||
143090868|NCT04135937|515871923|FG000|Overall Study|Withdrawal by Subject|1|||
143090869|NCT02548143|515871924|FG000|Overall Study|Adverse Event|1|||
143090870|NCT02548143|515871925|FG001|Overall Study|Adverse Event|0|||
143090871|NCT02548143|515871924|FG000|Overall Study|Withdrawal by Subject|0|||
143090872|NCT02548143|515871925|FG001|Overall Study|Withdrawal by Subject|1|||
143090873|NCT06018129|515871927|FG000|Overall Study|Death|1|||
143090874|NCT06018129|515871928|FG001|Overall Study|Death|1|||
143090875|NCT06018129|515871929|FG002|Overall Study|Death|2|||
143090876|NCT06018129|515871927|FG000|Overall Study|Sponsor Decision|2|||
143090877|NCT06018129|515871928|FG001|Overall Study|Sponsor Decision|2|||
143090878|NCT06018129|515871929|FG002|Overall Study|Sponsor Decision|1|||
143090879|NCT00858273|515871933|FG000|Overall Study|Protocol Violation|3|||
143090880|NCT00858273|515871934|FG001|Overall Study|Protocol Violation|5|||
143090881|NCT01730053|515873776|FG000|Overall Study|Participant moved|0|||
143090882|NCT01730053|515873777|FG001|Overall Study|Participant moved|0|||
143090883|NCT01730053|515873778|FG002|Overall Study|Participant moved|1|||
143090884|NCT01730053|515873779|FG003|Overall Study|Participant moved|0|||
143090885|NCT01730053|515873780|FG004|Overall Study|Participant moved|0|||
143090886|NCT01730053|515873781|FG005|Overall Study|Participant moved|0|||
143090887|NCT01730053|515873776|FG000|Overall Study|Physician Decision|0|||
143090888|NCT01730053|515873777|FG001|Overall Study|Physician Decision|0|||
143090889|NCT01730053|515873778|FG002|Overall Study|Physician Decision|0|||
143250818|NCT02709538|516472926|FG000|Overall Study|Lack of Efficacy|1|||
143250819|NCT02709538|516472927|FG001|Overall Study|Lack of Efficacy|0|||
143250820|NCT02709538|516472928|FG002|Overall Study|Lack of Efficacy|0|||
143250821|NCT02709538|516472926|FG000|Overall Study|Lost to Follow-up|24|||
143250822|NCT02709538|516472927|FG001|Overall Study|Lost to Follow-up|8|||
143090890|NCT01730053|515873779|FG003|Overall Study|Physician Decision|1|||
143090891|NCT01730053|515873780|FG004|Overall Study|Physician Decision|0|||
143090892|NCT01730053|515873781|FG005|Overall Study|Physician Decision|0|||
143090893|NCT01730053|515873776|FG000|Overall Study|Adverse Event|2|||
143090894|NCT01730053|515873777|FG001|Overall Study|Adverse Event|6|||
143090895|NCT01730053|515873778|FG002|Overall Study|Adverse Event|3|||
143090896|NCT01730053|515873779|FG003|Overall Study|Adverse Event|3|||
143090897|NCT01730053|515873780|FG004|Overall Study|Adverse Event|2|||
143090898|NCT01730053|515873781|FG005|Overall Study|Adverse Event|2|||
143090899|NCT01730053|515873776|FG000|Overall Study|Poor compliance to protocol|1|||
143090900|NCT01730053|515873777|FG001|Overall Study|Poor compliance to protocol|2|||
143090901|NCT01730053|515873778|FG002|Overall Study|Poor compliance to protocol|2|||
143090902|NCT01730053|515873779|FG003|Overall Study|Poor compliance to protocol|0|||
143090903|NCT01730053|515873780|FG004|Overall Study|Poor compliance to protocol|0|||
143090904|NCT01730053|515873781|FG005|Overall Study|Poor compliance to protocol|2|||
143090905|NCT01730053|515873776|FG000|Overall Study|Other than specified|2|||
143090906|NCT01730053|515873777|FG001|Overall Study|Other than specified|6|||
143090907|NCT01730053|515873778|FG002|Overall Study|Other than specified|5|||
143176402|NCT03391882|516194166|FG000|Study Overall|Withdrawal by Subject|3|||
143176403|NCT03391882|516194167|FG001|Study Overall|Withdrawal by Subject|3|||
143176404|NCT03391882|516194168|FG002|Study Overall|Withdrawal by Subject|2|||
143176405|NCT03391882|516194169|FG003|Study Overall|Withdrawal by Subject|2|||
143176406|NCT03391882|516194170|FG004|Study Overall|Withdrawal by Subject|1|||
143176407|NCT03391882|516194171|FG005|Study Overall|Withdrawal by Subject|3|||
143176408|NCT03391882|516194166|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
143176409|NCT03391882|516194167|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
143176410|NCT03391882|516194168|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
143176411|NCT03391882|516194169|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
143176412|NCT03391882|516194170|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
143176413|NCT03391882|516194171|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
143176414|NCT03391882|516194166|FG000|Study Overall|Protocol Violation|1|||
143176415|NCT03391882|516194167|FG001|Study Overall|Protocol Violation|0|||
143176416|NCT03391882|516194168|FG002|Study Overall|Protocol Violation|0|||
143176417|NCT03391882|516194169|FG003|Study Overall|Protocol Violation|0|||
143176418|NCT03391882|516194170|FG004|Study Overall|Protocol Violation|0|||
143176419|NCT03391882|516194171|FG005|Study Overall|Protocol Violation|0|||
143176420|NCT03391882|516194166|FG000|Part A - Titration Phase|Adverse Event|3|||
143176421|NCT03391882|516194167|FG001|Part A - Titration Phase|Adverse Event|6|||
143176422|NCT03391882|516194168|FG002|Part A - Titration Phase|Adverse Event|0|||
143176423|NCT03391882|516194169|FG003|Part A - Titration Phase|Adverse Event|0|||
143176424|NCT03391882|516194170|FG004|Part A - Titration Phase|Adverse Event|0|||
143176425|NCT03391882|516194171|FG005|Part A - Titration Phase|Adverse Event|0|||
143176426|NCT03391882|516194166|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
143176427|NCT03391882|516194167|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
143176428|NCT03391882|516194168|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
143176429|NCT03391882|516194169|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
143176430|NCT03391882|516194170|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
143176431|NCT03391882|516194171|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
143176432|NCT03391882|516194166|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
143176433|NCT03391882|516194167|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
143176434|NCT03391882|516194168|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
143176435|NCT03391882|516194169|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
143176436|NCT03391882|516194170|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
143176437|NCT03391882|516194171|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
143176438|NCT03391882|516194166|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
143176439|NCT03391882|516194167|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
143176440|NCT03391882|516194168|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
143176441|NCT03391882|516194169|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
143176442|NCT03391882|516194170|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
143250823|NCT02709538|516472928|FG002|Overall Study|Lost to Follow-up|4|||
143250824|NCT02709538|516472926|FG000|Overall Study|Physician Decision|1|||
143250825|NCT02709538|516472927|FG001|Overall Study|Physician Decision|0|||
143250826|NCT02709538|516472928|FG002|Overall Study|Physician Decision|0|||
143250827|NCT02709538|516472926|FG000|Overall Study|Withdrawal by Subject|40|||
143250828|NCT02709538|516472927|FG001|Overall Study|Withdrawal by Subject|7|||
143250829|NCT02709538|516472928|FG002|Overall Study|Withdrawal by Subject|4|||
143250830|NCT02709538|516472926|FG000|Overall Study|Non-compliance with study procedures|5|||
143250831|NCT02709538|516472927|FG001|Overall Study|Non-compliance with study procedures|0|||
143250832|NCT02709538|516472928|FG002|Overall Study|Non-compliance with study procedures|0|||
143250833|NCT02709538|516472926|FG000|Overall Study|Non-compliance with study drug|2|||
143250834|NCT02709538|516472927|FG001|Overall Study|Non-compliance with study drug|0|||
143250835|NCT02709538|516472928|FG002|Overall Study|Non-compliance with study drug|0|||
143250836|NCT02709538|516472926|FG000|Overall Study|Protocol deviation|10|||
143250837|NCT02709538|516472927|FG001|Overall Study|Protocol deviation|4|||
143176443|NCT03391882|516194171|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
143090908|NCT01730053|515873779|FG003|Overall Study|Other than specified|4|||
143176444|NCT03391882|516194166|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
143176445|NCT03391882|516194167|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
143176446|NCT03391882|516194168|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
143176447|NCT03391882|516194169|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
143250838|NCT02709538|516472928|FG002|Overall Study|Protocol deviation|4|||
143367165|NCT01081145|516887267|FG000|Open-Label Phase|Lack of Efficacy|56|||
143090909|NCT01730053|515873780|FG004|Overall Study|Other than specified|7|||
143090910|NCT01730053|515873781|FG005|Overall Study|Other than specified|9|||
143090911|NCT01470248|515873782|FG000|Overall Study|Withdrawal by Subject|1|||
143090912|NCT05085834|515873783|FG000|Overall Study|Lost to Follow-up|9|||
143090913|NCT05085834|515873784|FG001|Overall Study|Lost to Follow-up|2|||
143090914|NCT05085834|515873783|FG000|Overall Study|Adverse Event|6|||
143090915|NCT05085834|515873784|FG001|Overall Study|Adverse Event|0|||
143090916|NCT05085834|515873783|FG000|Overall Study|Death|1|||
143090917|NCT05085834|515873784|FG001|Overall Study|Death|0|||
143090918|NCT05085834|515873783|FG000|Overall Study|Inability to swallow the pill|0|||
143090919|NCT05085834|515873784|FG001|Overall Study|Inability to swallow the pill|1|||
143090920|NCT05364931|515873789|FG000|Overall Study|Adverse Event|0|||
143090921|NCT05364931|515873790|FG001|Overall Study|Adverse Event|2|||
143090922|NCT05364931|515873791|FG002|Overall Study|Adverse Event|1|||
143090923|NCT05364931|515873792|FG003|Overall Study|Adverse Event|0|||
143090924|NCT05364931|515873789|FG000|Overall Study|Lost to Follow-up|1|||
143090925|NCT05364931|515873790|FG001|Overall Study|Lost to Follow-up|0|||
143090926|NCT05364931|515873791|FG002|Overall Study|Lost to Follow-up|0|||
143090927|NCT05364931|515873792|FG003|Overall Study|Lost to Follow-up|0|||
143090928|NCT05364931|515873789|FG000|Overall Study|Withdrawal by Subject|1|||
143090929|NCT05364931|515873790|FG001|Overall Study|Withdrawal by Subject|1|||
143090930|NCT05364931|515873791|FG002|Overall Study|Withdrawal by Subject|3|||
143090931|NCT05364931|515873792|FG003|Overall Study|Withdrawal by Subject|2|||
143090932|NCT05364931|515873789|FG000|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
143090933|NCT05364931|515873790|FG001|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|1|||
143090934|NCT05364931|515873791|FG002|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
143090935|NCT05364931|515873792|FG003|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
143090936|NCT05364931|515873789|FG000|Overall Study|Discontinued|1|||
143090937|NCT05364931|515873790|FG001|Overall Study|Discontinued|0|||
143090938|NCT05364931|515873791|FG002|Overall Study|Discontinued|0|||
143090939|NCT05364931|515873792|FG003|Overall Study|Discontinued|0|||
143090940|NCT05842967|515873793|FG000|Period 1: SSA|Adverse Event|1|||
143090941|NCT05842967|515873794|FG001|Period 1: SSA|Adverse Event|1|||
143090942|NCT05842967|515873795|FG002|Period 1: SSA|Adverse Event|0|||
143090943|NCT05842967|515873796|FG003|Period 1: SSA|Adverse Event|0|||
143090944|NCT05842967|515873793|FG000|Period 1: SSA|Death|1|||
143090945|NCT05842967|515873794|FG001|Period 1: SSA|Death|0|||
143090946|NCT05842967|515873795|FG002|Period 1: SSA|Death|0|||
143090947|NCT05842967|515873796|FG003|Period 1: SSA|Death|0|||
143090948|NCT05842967|515873793|FG000|Period 1: SSA|Lost to Follow-up|16|||
143090949|NCT05842967|515873794|FG001|Period 1: SSA|Lost to Follow-up|4|||
143090950|NCT05842967|515873795|FG002|Period 1: SSA|Lost to Follow-up|0|||
143090951|NCT05842967|515873796|FG003|Period 1: SSA|Lost to Follow-up|0|||
143090952|NCT05842967|515873793|FG000|Period 1: SSA|Physician Decision|1|||
143090953|NCT05842967|515873794|FG001|Period 1: SSA|Physician Decision|0|||
143090954|NCT05842967|515873795|FG002|Period 1: SSA|Physician Decision|0|||
143090955|NCT05842967|515873796|FG003|Period 1: SSA|Physician Decision|0|||
143090956|NCT05842967|515873793|FG000|Period 1: SSA|Withdrawal by Subject|2|||
143090957|NCT05842967|515873794|FG001|Period 1: SSA|Withdrawal by Subject|2|||
143090958|NCT05842967|515873795|FG002|Period 1: SSA|Withdrawal by Subject|0|||
143090959|NCT05842967|515873796|FG003|Period 1: SSA|Withdrawal by Subject|0|||
143090960|NCT05842967|515873793|FG000|Period 1: SSA|Randomized but not vaccinated|1|||
143090961|NCT05842967|515873794|FG001|Period 1: SSA|Randomized but not vaccinated|2|||
143090962|NCT05842967|515873795|FG002|Period 1: SSA|Randomized but not vaccinated|0|||
143090963|NCT05842967|515873796|FG003|Period 1: SSA|Randomized but not vaccinated|0|||
143090964|NCT05842967|515873793|FG000|Period 2: SSB|Adverse Event|0|||
143090965|NCT05842967|515873794|FG001|Period 2: SSB|Adverse Event|0|||
143090966|NCT05842967|515873795|FG002|Period 2: SSB|Adverse Event|2|||
143090967|NCT05842967|515873796|FG003|Period 2: SSB|Adverse Event|0|||
143090968|NCT05842967|515873793|FG000|Period 2: SSB|Lost to Follow-up|0|||
143090969|NCT05842967|515873794|FG001|Period 2: SSB|Lost to Follow-up|0|||
143090970|NCT05842967|515873795|FG002|Period 2: SSB|Lost to Follow-up|4|||
143090971|NCT05842967|515873796|FG003|Period 2: SSB|Lost to Follow-up|3|||
143090972|NCT05842967|515873793|FG000|Period 2: SSB|Withdrawal by Subject|0|||
143090973|NCT05842967|515873794|FG001|Period 2: SSB|Withdrawal by Subject|0|||
143090974|NCT05842967|515873795|FG002|Period 2: SSB|Withdrawal by Subject|1|||
143090975|NCT05842967|515873796|FG003|Period 2: SSB|Withdrawal by Subject|0|||
143090976|NCT05842967|515873793|FG000|Period 2: SSB|Enrolled but not vaccinated|0|||
143090977|NCT05842967|515873794|FG001|Period 2: SSB|Enrolled but not vaccinated|0|||
143090978|NCT05842967|515873795|FG002|Period 2: SSB|Enrolled but not vaccinated|5|||
143090979|NCT05842967|515873796|FG003|Period 2: SSB|Enrolled but not vaccinated|9|||
143090980|NCT05842967|515873793|FG000|Period 2: SSB|Protocol Violation|0|||
143090981|NCT05842967|515873794|FG001|Period 2: SSB|Protocol Violation|0|||
143090982|NCT05842967|515873795|FG002|Period 2: SSB|Protocol Violation|0|||
143090983|NCT05842967|515873796|FG003|Period 2: SSB|Protocol Violation|1|||
143090984|NCT01402570|515873802|FG000|Overall Study|Adverse Event|1|||
143090985|NCT03642262|515873805|FG000|Period 1|Withdrawal by Subject|1|||
143090986|NCT03642262|515873806|FG001|Period 1|Withdrawal by Subject|1|||
143090987|NCT03642262|515873805|FG000|Period 1|Adverse Event|0|||
143090988|NCT03642262|515873806|FG001|Period 1|Adverse Event|1|||
143090989|NCT01557504|515873807|FG000|Overall Study|Physician Decision|1|||
143090990|NCT01557504|515873808|FG001|Overall Study|Physician Decision|0|||
143090991|NCT02572570|515873813|FG000|Overall Study|Study Terminated|27|||
143090992|NCT00513695|515873814|FG000|Overall Study|Discontinued therapy|2|||
143090993|NCT00513695|515873814|FG000|Overall Study|Progression prior to surgery|3|||
143090994|NCT01417156|515873815|FG000|Overall Study|Adverse Event|12|||
143090995|NCT01417156|515873815|FG000|Overall Study|Protocol Violation|2|||
143090996|NCT02302833|515873818|FG000|Overall Study|Lost to Follow-up|3|||
143090997|NCT05017246|515873819|FG000|Overall Study|Withdrawal by Subject|5|||
143090998|NCT05017246|515873820|FG001|Overall Study|Withdrawal by Subject|3|||
143250839|NCT02709538|516472926|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
143090999|NCT05017246|515873819|FG000|Overall Study|Determined to be ineligible|0|||
143091000|NCT05017246|515873820|FG001|Overall Study|Determined to be ineligible|1|||
143091001|NCT05017246|515873819|FG000|Overall Study|Withdrawn due to patient being given heparin|0|||
143091002|NCT05017246|515873820|FG001|Overall Study|Withdrawn due to patient being given heparin|1|||
143091003|NCT05017246|515873819|FG000|Overall Study|Technical failure|1|||
143091004|NCT05017246|515873820|FG001|Overall Study|Technical failure|3|||
143091005|NCT00485264|515873823|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
143091006|NCT00485264|515873824|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
143091007|NCT00485264|515873825|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
143091008|NCT00485264|515873826|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
143091009|NCT00485264|515873827|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
143091010|NCT00485264|515873828|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
143091011|NCT00485264|515873823|FG000|Overall Study|Death|1|||
143091012|NCT00485264|515873824|FG001|Overall Study|Death|0|||
143091013|NCT00485264|515873825|FG002|Overall Study|Death|0|||
143091014|NCT00485264|515873826|FG003|Overall Study|Death|0|||
143091015|NCT00485264|515873827|FG004|Overall Study|Death|1|||
143091016|NCT00485264|515873828|FG005|Overall Study|Death|0|||
143091017|NCT00485264|515873823|FG000|Overall Study|Adverse Event|1|||
143091018|NCT00485264|515873824|FG001|Overall Study|Adverse Event|0|||
143091019|NCT00485264|515873825|FG002|Overall Study|Adverse Event|2|||
143091020|NCT00485264|515873826|FG003|Overall Study|Adverse Event|3|||
143091021|NCT00485264|515873827|FG004|Overall Study|Adverse Event|1|||
143091022|NCT00485264|515873828|FG005|Overall Study|Adverse Event|3|||
143091023|NCT00485264|515873823|FG000|Overall Study|Pregnancy|4|||
143091024|NCT00485264|515873824|FG001|Overall Study|Pregnancy|0|||
143091025|NCT00485264|515873825|FG002|Overall Study|Pregnancy|0|||
143250840|NCT02709538|516472927|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
143250841|NCT02709538|516472928|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
143250842|NCT02709538|516472926|FG000|Overall Study|Other|16|||
143250843|NCT02709538|516472927|FG001|Overall Study|Other|7|||
143250844|NCT02709538|516472928|FG002|Overall Study|Other|5|||
143250845|NCT00835211|516472929|FG000|First Intervention|Withdrawal by Subject|0|||
143250846|NCT00835211|516472930|FG001|First Intervention|Withdrawal by Subject|1|||
143250847|NCT00835211|516472929|FG000|Washout: 7 Days|Adverse Event|2|||
143250848|NCT00835211|516472930|FG001|Washout: 7 Days|Adverse Event|1|||
143250849|NCT00835211|516472929|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
143250850|NCT00835211|516472930|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
143250851|NCT02343549|516472932|FG000|Overall Study|Death|11|||
143250852|NCT02343549|516472932|FG000|Overall Study|Withdrawal by Subject|2|||
143250853|NCT02160041|516472933|FG000|Overall Study|Adverse Event|11|||
143250854|NCT02160041|516472933|FG000|Overall Study|Death|2|||
143250855|NCT02160041|516472933|FG000|Overall Study|disease progression|57|||
143091026|NCT00485264|515873826|FG003|Overall Study|Pregnancy|0|||
143091027|NCT00485264|515873827|FG004|Overall Study|Pregnancy|0|||
143091028|NCT00485264|515873828|FG005|Overall Study|Pregnancy|0|||
143091029|NCT00485264|515873823|FG000|Overall Study|Disallowed Medication|0|||
143250856|NCT02160041|516472933|FG000|Overall Study|Protocol Violation|1|||
143250857|NCT02160041|516472933|FG000|Overall Study|non-compliance with study|1|||
143250858|NCT02160041|516472933|FG000|Overall Study|Physician Decision|3|||
143091030|NCT00485264|515873824|FG001|Overall Study|Disallowed Medication|0|||
143091031|NCT00485264|515873825|FG002|Overall Study|Disallowed Medication|0|||
143091032|NCT00485264|515873826|FG003|Overall Study|Disallowed Medication|0|||
143250859|NCT02160041|516472933|FG000|Overall Study|Withdrawal by Subject|8|||
143250860|NCT02160041|516472933|FG000|Overall Study|study terminated by by sponsor|1|||
143091033|NCT00485264|515873827|FG004|Overall Study|Disallowed Medication|0|||
143091034|NCT00485264|515873828|FG005|Overall Study|Disallowed Medication|1|||
143091035|NCT00485264|515873823|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
143091036|NCT00485264|515873824|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
143091037|NCT00485264|515873825|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
143091038|NCT00485264|515873826|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
143091039|NCT00485264|515873827|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
143091040|NCT00485264|515873828|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
143091041|NCT00485264|515873823|FG000|Overall Study|Lack of Efficacy|0|||
143091042|NCT00485264|515873824|FG001|Overall Study|Lack of Efficacy|1|||
143091043|NCT00485264|515873825|FG002|Overall Study|Lack of Efficacy|0|||
143091044|NCT00485264|515873826|FG003|Overall Study|Lack of Efficacy|0|||
143091045|NCT00485264|515873827|FG004|Overall Study|Lack of Efficacy|0|||
143091046|NCT00485264|515873828|FG005|Overall Study|Lack of Efficacy|0|||
143091047|NCT00485264|515873823|FG000|Overall Study|Guardian Consent Withdrawn|1|||
143091048|NCT00485264|515873824|FG001|Overall Study|Guardian Consent Withdrawn|0|||
143091049|NCT00485264|515873825|FG002|Overall Study|Guardian Consent Withdrawn|0|||
143091050|NCT00485264|515873826|FG003|Overall Study|Guardian Consent Withdrawn|0|||
143091051|NCT00485264|515873827|FG004|Overall Study|Guardian Consent Withdrawn|1|||
143091052|NCT00485264|515873828|FG005|Overall Study|Guardian Consent Withdrawn|0|||
143091053|NCT00485264|515873823|FG000|Overall Study|Physician Decision|0|||
143091054|NCT00485264|515873824|FG001|Overall Study|Physician Decision|2|||
143091055|NCT00485264|515873825|FG002|Overall Study|Physician Decision|0|||
143091056|NCT00485264|515873826|FG003|Overall Study|Physician Decision|0|||
143091057|NCT00485264|515873827|FG004|Overall Study|Physician Decision|0|||
143091058|NCT00485264|515873828|FG005|Overall Study|Physician Decision|0|||
143091059|NCT00485264|515873823|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
143091060|NCT00485264|515873824|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
143091061|NCT00485264|515873825|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
143091062|NCT00485264|515873826|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
143091063|NCT00485264|515873827|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
143091064|NCT00485264|515873828|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
143091065|NCT00485264|515873823|FG000|Overall Study|Not Able to Attend Clinic|5|||
143091066|NCT00485264|515873824|FG001|Overall Study|Not Able to Attend Clinic|0|||
143091067|NCT00485264|515873825|FG002|Overall Study|Not Able to Attend Clinic|0|||
143091068|NCT00485264|515873826|FG003|Overall Study|Not Able to Attend Clinic|1|||
143091069|NCT00485264|515873827|FG004|Overall Study|Not Able to Attend Clinic|1|||
143091070|NCT00485264|515873828|FG005|Overall Study|Not Able to Attend Clinic|2|||
143091071|NCT00485264|515873823|FG000|Overall Study|Non-Compliant|17|||
143091072|NCT00485264|515873824|FG001|Overall Study|Non-Compliant|2|||
143091073|NCT00485264|515873825|FG002|Overall Study|Non-Compliant|1|||
143091074|NCT00485264|515873826|FG003|Overall Study|Non-Compliant|0|||
143091075|NCT00485264|515873827|FG004|Overall Study|Non-Compliant|1|||
143091076|NCT00485264|515873828|FG005|Overall Study|Non-Compliant|0|||
143091077|NCT00485264|515873823|FG000|Overall Study|Lost to Follow-up|2|||
143091078|NCT00485264|515873824|FG001|Overall Study|Lost to Follow-up|1|||
143091079|NCT00485264|515873825|FG002|Overall Study|Lost to Follow-up|1|||
143091080|NCT00485264|515873826|FG003|Overall Study|Lost to Follow-up|0|||
143091081|NCT00485264|515873827|FG004|Overall Study|Lost to Follow-up|0|||
143091082|NCT00485264|515873828|FG005|Overall Study|Lost to Follow-up|1|||
143091083|NCT00485264|515873823|FG000|Overall Study|Other Reason|3|||
143091084|NCT00485264|515873824|FG001|Overall Study|Other Reason|0|||
143091085|NCT00485264|515873825|FG002|Overall Study|Other Reason|0|||
143091086|NCT00485264|515873826|FG003|Overall Study|Other Reason|0|||
143091087|NCT00485264|515873827|FG004|Overall Study|Other Reason|0|||
143091088|NCT00485264|515873828|FG005|Overall Study|Other Reason|0|||
143091089|NCT03499067|515873829|FG000|First Intervention|Physician Decision|2|||
143091090|NCT03499067|515873830|FG001|First Intervention|Physician Decision|1|||
143091091|NCT03499067|515873829|FG000|First Intervention|Withdrawal by Subject|3|||
143091092|NCT03499067|515873830|FG001|First Intervention|Withdrawal by Subject|6|||
143091093|NCT00654095|515873831|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
143091094|NCT00654095|515873831|FG000|Overall Study|Elevated triglyceride level (2)|1|||
143091095|NCT00654095|515873831|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
143091096|NCT00654095|515873831|FG000|Overall Study|Adverse Event|11|||
143091097|NCT00654095|515873831|FG000|Overall Study|Withdrawal by Subject|5|||
143091098|NCT00654095|515873831|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
143091099|NCT00654095|515873831|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
143091100|NCT00654095|515873831|FG000|Overall Study|Did not meet inclusion criteria|1|||
143091101|NCT02392481|515873832|FG000|Overall Study|Adverse Event|0|||
143091102|NCT02392481|515873833|FG001|Overall Study|Adverse Event|0|||
143091103|NCT02392481|515873834|FG002|Overall Study|Adverse Event|1|||
143091104|NCT02392481|515873835|FG003|Overall Study|Adverse Event|2|||
143091105|NCT02392481|515873832|FG000|Overall Study|Withdrawal by Subject|0|||
143091106|NCT02392481|515873833|FG001|Overall Study|Withdrawal by Subject|0|||
143091107|NCT02392481|515873834|FG002|Overall Study|Withdrawal by Subject|1|||
143091108|NCT02392481|515873835|FG003|Overall Study|Withdrawal by Subject|0|||
143091109|NCT02548832|515873837|FG000|Overall Study|Lost to Follow-up|2|||
143091110|NCT02548832|515873838|FG001|Overall Study|Lost to Follow-up|2|||
143091111|NCT02548832|515873839|FG002|Overall Study|Lost to Follow-up|2|||
143091112|NCT03565900|515873840|FG000|Overall Study|Disposition Unknown|4|||
143091113|NCT03565900|515873841|FG001|Overall Study|Disposition Unknown|1|||
143091114|NCT03565900|515873840|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
143091115|NCT03565900|515873841|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
143091116|NCT03565900|515873840|FG000|Overall Study|Withdrawal by Subject|4|||
143091117|NCT03565900|515873841|FG001|Overall Study|Withdrawal by Subject|5|||
143091118|NCT03565900|515873840|FG000|Overall Study|Randomized By Mistake|0|||
143176448|NCT03391882|516194170|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
143250861|NCT01403948|516472934|FG000|Overall Study|Progressive disease|0|||
143091119|NCT03565900|515873841|FG001|Overall Study|Randomized By Mistake|2|||
143091120|NCT03565900|515873840|FG000|Overall Study|Physician Decision|7|||
143091121|NCT03565900|515873841|FG001|Overall Study|Physician Decision|11|||
143091122|NCT03565900|515873840|FG000|Overall Study|Death|9|||
143091123|NCT03565900|515873841|FG001|Overall Study|Death|7|||
143091124|NCT02058069|515873842|FG000|Overall Study|Exclusion due to implant size|5|||
143091125|NCT02058069|515873842|FG000|Overall Study|Withdrawal by Subject|6|||
143091126|NCT03743051|515873859|FG000|Overall Study|Adverse Event|5|||
143091127|NCT03743051|515873860|FG001|Overall Study|Adverse Event|9|||
143091128|NCT03743051|515873859|FG000|Overall Study|Death|27|||
143091129|NCT03743051|515873860|FG001|Overall Study|Death|26|||
143091130|NCT03743051|515873859|FG000|Overall Study|Lost to Follow-up|4|||
143091131|NCT03743051|515873860|FG001|Overall Study|Lost to Follow-up|8|||
143091132|NCT03743051|515873859|FG000|Overall Study|Withdrawal by Subject|32|||
143091133|NCT03743051|515873860|FG001|Overall Study|Withdrawal by Subject|19|||
143091134|NCT03743051|515873859|FG000|Overall Study|Physician Decision|10|||
143091135|NCT03743051|515873860|FG001|Overall Study|Physician Decision|15|||
143091136|NCT03743051|515873859|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
143091137|NCT03743051|515873860|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
143091138|NCT03652051|515873863|FG000|Stage 1|Adverse Event|0|||
143091139|NCT03652051|515873864|FG001|Stage 1|Adverse Event|5|||
143091140|NCT03652051|515873865|FG002|Stage 1|Adverse Event|7|||
143091141|NCT03652051|515873866|FG003|Stage 1|Adverse Event|1|||
143091142|NCT03652051|515873863|FG000|Stage 1|Withdrawal by Subject|0|||
143091143|NCT03652051|515873864|FG001|Stage 1|Withdrawal by Subject|0|||
143091144|NCT03652051|515873865|FG002|Stage 1|Withdrawal by Subject|1|||
143091145|NCT03652051|515873866|FG003|Stage 1|Withdrawal by Subject|0|||
143091146|NCT03652051|515873863|FG000|Stage 2|Adverse Event|0|||
143091147|NCT03652051|515873864|FG001|Stage 2|Adverse Event|2|||
143091148|NCT03652051|515873865|FG002|Stage 2|Adverse Event|1|||
143091149|NCT03652051|515873866|FG003|Stage 2|Adverse Event|0|||
143091150|NCT03652051|515873863|FG000|Stage 2|Protocol Violation|0|||
143091151|NCT03652051|515873864|FG001|Stage 2|Protocol Violation|1|||
143091152|NCT03652051|515873865|FG002|Stage 2|Protocol Violation|6|||
143091153|NCT03652051|515873866|FG003|Stage 2|Protocol Violation|0|||
143091154|NCT03652051|515873863|FG000|Stage 2|Lost to Follow-up|0|||
143091155|NCT03652051|515873864|FG001|Stage 2|Lost to Follow-up|2|||
143091156|NCT03652051|515873865|FG002|Stage 2|Lost to Follow-up|0|||
143176449|NCT03391882|516194171|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
143176450|NCT03391882|516194166|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
143176451|NCT03391882|516194167|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
143091157|NCT03652051|515873866|FG003|Stage 2|Lost to Follow-up|3|||
143091158|NCT03652051|515873863|FG000|Stage 2|Withdrawal by Subject|0|||
143091159|NCT03652051|515873864|FG001|Stage 2|Withdrawal by Subject|11|||
143091160|NCT03652051|515873865|FG002|Stage 2|Withdrawal by Subject|9|||
143091161|NCT03652051|515873866|FG003|Stage 2|Withdrawal by Subject|3|||
143091162|NCT02394600|515873867|FG000|Overall Study|Adverse Event|3|||
143091163|NCT02394600|515873868|FG001|Overall Study|Adverse Event|0|||
143091164|NCT02394600|515873867|FG000|Overall Study|Lost to Follow-up|0|||
143091165|NCT02394600|515873868|FG001|Overall Study|Lost to Follow-up|1|||
143176452|NCT03391882|516194168|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
143176453|NCT03391882|516194169|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
143091166|NCT02394600|515873867|FG000|Overall Study|Withdrawal by Subject|0|||
143091167|NCT02394600|515873868|FG001|Overall Study|Withdrawal by Subject|1|||
143091168|NCT02394600|515873867|FG000|Overall Study|Protocol Violation|1|||
143091169|NCT02394600|515873868|FG001|Overall Study|Protocol Violation|0|||
143091170|NCT00428246|515873869|FG000|Overall Study|Withdrawal by Subject|0|||
143091171|NCT00428246|515873870|FG001|Overall Study|Withdrawal by Subject|0|||
143091172|NCT00428246|515873871|FG002|Overall Study|Withdrawal by Subject|1|||
143091173|NCT00428246|515873869|FG000|Overall Study|Adverse Event|1|||
143091174|NCT00428246|515873870|FG001|Overall Study|Adverse Event|0|||
143091175|NCT00428246|515873871|FG002|Overall Study|Adverse Event|0|||
143091176|NCT00791778|515873875|FG000|Double-blind Treatment|Adverse Event|49|||
143091177|NCT00791778|515873876|FG001|Double-blind Treatment|Adverse Event|9|||
143091178|NCT00791778|515873875|FG000|Double-blind Treatment|Physician Decision|6|||
143091179|NCT00791778|515873876|FG001|Double-blind Treatment|Physician Decision|26|||
143091180|NCT00791778|515873875|FG000|Double-blind Treatment|Protocol Violation|0|||
143091181|NCT00791778|515873876|FG001|Double-blind Treatment|Protocol Violation|4|||
143091182|NCT00791778|515873875|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
143091183|NCT00791778|515873876|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
143091184|NCT00791778|515873875|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
143091185|NCT00791778|515873876|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
143091186|NCT00791778|515873875|FG000|Follow-up|Withdrawal by Subject|3|||
143091187|NCT00791778|515873876|FG001|Follow-up|Withdrawal by Subject|0|||
143091188|NCT00791778|515873875|FG000|Follow-up|Lost to Follow-up|2|||
143091189|NCT00791778|515873876|FG001|Follow-up|Lost to Follow-up|1|||
143091190|NCT03164551|515873884|FG000|Overall Study|Imaging discontinued prior completion|8|||
143091191|NCT03164551|515873885|FG001|Overall Study|Imaging discontinued prior completion|0|||
143091192|NCT03164551|515873884|FG000|Overall Study|Participant was non-compliant|1|||
143091193|NCT03164551|515873885|FG001|Overall Study|Participant was non-compliant|0|||
143091194|NCT03164551|515873884|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
143091195|NCT03164551|515873885|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
143091196|NCT03164551|515873884|FG000|Overall Study|Other|8|||
143091197|NCT03164551|515873885|FG001|Overall Study|Other|2|||
143091198|NCT01515423|515873886|FG000|Open Label Phase|Adverse Event|57|||
143091199|NCT01515423|515873887|FG001|Open Label Phase|Adverse Event|0|||
143091200|NCT01515423|515873888|FG002|Open Label Phase|Adverse Event|0|||
143091201|NCT01515423|515873886|FG000|Open Label Phase|Death|2|||
143091202|NCT01515423|515873887|FG001|Open Label Phase|Death|0|||
143091203|NCT01515423|515873888|FG002|Open Label Phase|Death|0|||
143091204|NCT01515423|515873886|FG000|Open Label Phase|Lack of Efficacy|117|||
143091205|NCT01515423|515873887|FG001|Open Label Phase|Lack of Efficacy|0|||
143091206|NCT01515423|515873888|FG002|Open Label Phase|Lack of Efficacy|0|||
143091207|NCT01515423|515873886|FG000|Open Label Phase|Lost to Follow-up|21|||
143091208|NCT01515423|515873887|FG001|Open Label Phase|Lost to Follow-up|0|||
143091209|NCT01515423|515873888|FG002|Open Label Phase|Lost to Follow-up|0|||
143091210|NCT01515423|515873886|FG000|Open Label Phase|Withdrawal by Subject|118|||
143091211|NCT01515423|515873887|FG001|Open Label Phase|Withdrawal by Subject|0|||
143367166|NCT01081145|516887268|FG001|Open-Label Phase|Lack of Efficacy|0|||
143091212|NCT01515423|515873888|FG002|Open Label Phase|Withdrawal by Subject|0|||
143091213|NCT01515423|515873886|FG000|Open Label Phase|excluded from DB Phase|70|||
143091214|NCT01515423|515873887|FG001|Open Label Phase|excluded from DB Phase|0|||
143091215|NCT01515423|515873888|FG002|Open Label Phase|excluded from DB Phase|0|||
143091216|NCT01515423|515873886|FG000|Open Label Phase|Other|28|||
143091217|NCT01515423|515873887|FG001|Open Label Phase|Other|0|||
143091218|NCT01515423|515873888|FG002|Open Label Phase|Other|0|||
143091219|NCT01515423|515873886|FG000|DOUBLE BLIND|Adverse Event|0|||
143091220|NCT01515423|515873887|FG001|DOUBLE BLIND|Adverse Event|15|||
143091221|NCT01515423|515873888|FG002|DOUBLE BLIND|Adverse Event|13|||
143091222|NCT01515423|515873886|FG000|DOUBLE BLIND|Death|0|||
143367167|NCT01081145|516887267|FG000|Open-Label Phase|Response criteria not met|46|||
143091223|NCT01515423|515873887|FG001|DOUBLE BLIND|Death|1|||
143091224|NCT01515423|515873888|FG002|DOUBLE BLIND|Death|2|||
143091225|NCT01515423|515873886|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
143091226|NCT01515423|515873887|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
143091227|NCT01515423|515873888|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
143091228|NCT01515423|515873886|FG000|DOUBLE BLIND|Pregnancy|0|||
143091229|NCT01515423|515873887|FG001|DOUBLE BLIND|Pregnancy|2|||
143091230|NCT01515423|515873888|FG002|DOUBLE BLIND|Pregnancy|0|||
143091231|NCT01515423|515873886|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
143091232|NCT01515423|515873887|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
143091233|NCT01515423|515873888|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
143091234|NCT01515423|515873886|FG000|DOUBLE BLIND|Other|0|||
143091235|NCT01515423|515873887|FG001|DOUBLE BLIND|Other|6|||
143091236|NCT01515423|515873888|FG002|DOUBLE BLIND|Other|12|||
143091237|NCT01515423|515873886|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
143367168|NCT01081145|516887268|FG001|Open-Label Phase|Response criteria not met|0|||
143091238|NCT01515423|515873887|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
143091239|NCT01515423|515873888|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
143091240|NCT02501928|515873896|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
143367169|NCT01081145|516887267|FG000|Open-Label Phase|Adverse Event|42|||
143367170|NCT01081145|516887268|FG001|Open-Label Phase|Adverse Event|0|||
143176454|NCT03391882|516194170|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
143176455|NCT03391882|516194171|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
143176456|NCT03391882|516194166|FG000|Part B - Treatment Phase|Adverse Event|0|||
143176457|NCT03391882|516194167|FG001|Part B - Treatment Phase|Adverse Event|0|||
143176458|NCT03391882|516194168|FG002|Part B - Treatment Phase|Adverse Event|1|||
143176459|NCT03391882|516194169|FG003|Part B - Treatment Phase|Adverse Event|1|||
143176460|NCT03391882|516194170|FG004|Part B - Treatment Phase|Adverse Event|3|||
143176461|NCT03391882|516194171|FG005|Part B - Treatment Phase|Adverse Event|1|||
143176462|NCT03391882|516194166|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
143176463|NCT03391882|516194167|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
143176464|NCT03391882|516194168|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
143176465|NCT03391882|516194169|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
143176466|NCT03391882|516194170|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
143176467|NCT03391882|516194171|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
143176468|NCT04422431|516194172|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
143176469|NCT04422431|516194172|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
143176470|NCT04422431|516194172|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
143176471|NCT04422431|516194172|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
143176472|NCT04422431|516194172|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
143176473|NCT04422431|516194172|FG000|Extension Period (48 Weeks)|Other than specified|2|||
143176474|NCT01174563|516194173|FG000|Overall Study|Progressive Disease|45|||
143176475|NCT01174563|516194173|FG000|Overall Study|Death|5|||
143176476|NCT01174563|516194173|FG000|Overall Study|Investigator's Discretion|5|||
143176477|NCT01174563|516194173|FG000|Overall Study|Participant Withdrew Consent|3|||
143176478|NCT01174563|516194173|FG000|Overall Study|Rash Adverse Event|1|||
143176479|NCT01174563|516194173|FG000|Overall Study|Sponsor's decision|1|||
143176480|NCT02317627|516194181|FG000|Overall Study|Withdrawal by Subject|0|||
143176481|NCT02317627|516194182|FG001|Overall Study|Withdrawal by Subject|1|||
143176482|NCT02317627|516194183|FG002|Overall Study|Withdrawal by Subject|1|||
143176483|NCT02317627|516194181|FG000|Overall Study|Lost to Follow-up|2|||
143176484|NCT02317627|516194182|FG001|Overall Study|Lost to Follow-up|0|||
143176485|NCT02317627|516194183|FG002|Overall Study|Lost to Follow-up|0|||
143176486|NCT02317627|516194181|FG000|Overall Study|Stopped by Investigator|0|||
143176487|NCT02317627|516194182|FG001|Overall Study|Stopped by Investigator|1|||
143176488|NCT02317627|516194183|FG002|Overall Study|Stopped by Investigator|0|||
143176489|NCT02317627|516194181|FG000|Overall Study|Adverse Event|0|||
143176490|NCT02317627|516194182|FG001|Overall Study|Adverse Event|2|||
143176491|NCT02317627|516194183|FG002|Overall Study|Adverse Event|3|||
143176492|NCT02317627|516194181|FG000|Overall Study|Non-compliance with study drug|0|||
143176493|NCT02317627|516194182|FG001|Overall Study|Non-compliance with study drug|1|||
143176494|NCT02317627|516194183|FG002|Overall Study|Non-compliance with study drug|0|||
143176495|NCT00279214|516194184|FG000|Overall Study|Physician Decision|3|||
143176496|NCT00279214|516194185|FG001|Overall Study|Physician Decision|2|||
143176497|NCT04749914|516194186|FG000|Period 1|Adverse Event|1|||
143176498|NCT04749914|516194187|FG001|Period 1|Adverse Event|0|||
143176499|NCT04749914|516194188|FG002|Period 1|Adverse Event|0|||
143176500|NCT04749914|516194189|FG003|Period 1|Adverse Event|0|||
143176501|NCT04749914|516194186|FG000|Period 1|Withdrawal by Subject|1|||
143176502|NCT04749914|516194187|FG001|Period 1|Withdrawal by Subject|0|||
143176503|NCT04749914|516194188|FG002|Period 1|Withdrawal by Subject|1|||
143176504|NCT04749914|516194189|FG003|Period 1|Withdrawal by Subject|0|||
143176505|NCT00038948|516194190|FG000|Overall Study|Adverse Event|131|||
143176506|NCT00038948|516194191|FG001|Overall Study|Adverse Event|43|||
143176507|NCT00038948|516194190|FG000|Overall Study|Lost to Follow-up|4|||
143176508|NCT00038948|516194191|FG001|Overall Study|Lost to Follow-up|4|||
143176509|NCT00038948|516194190|FG000|Overall Study|Nonmedical event|5|||
143176510|NCT00038948|516194191|FG001|Overall Study|Nonmedical event|7|||
143176511|NCT00038948|516194190|FG000|Overall Study|Withdrawal by Subject|23|||
143176512|NCT00038948|516194191|FG001|Overall Study|Withdrawal by Subject|10|||
143176513|NCT00038948|516194190|FG000|Overall Study|Protocol Violation|3|||
143250862|NCT01403948|516472935|FG001|Overall Study|Progressive disease|2|||
143250863|NCT01403948|516472936|FG002|Overall Study|Progressive disease|2|||
143176514|NCT00038948|516194191|FG001|Overall Study|Protocol Violation|7|||
143176515|NCT00038948|516194190|FG000|Overall Study|Lack of Efficacy|3|||
143176516|NCT00038948|516194191|FG001|Overall Study|Lack of Efficacy|6|||
143176517|NCT02670473|516194192|FG000|Overall Study|Withdrawal by Subject|1|||
143176518|NCT01404234|516194193|FG000|Overall Study|Withdrawal by Subject|2|||
143176519|NCT03247829|516196146|FG000|Overall Study|Death|3|||
143250864|NCT01403948|516472937|FG003|Overall Study|Progressive disease|4|||
143176520|NCT03247829|516196147|FG001|Overall Study|Death|4|||
143176521|NCT03247829|516196146|FG000|Overall Study|Enter Hospice Care|1|||
143176522|NCT03247829|516196147|FG001|Overall Study|Enter Hospice Care|0|||
143176523|NCT03247829|516196146|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
143176524|NCT03247829|516196147|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
143176525|NCT03247829|516196146|FG000|Overall Study|LVAD Explant|1|||
143176526|NCT03247829|516196147|FG001|Overall Study|LVAD Explant|1|||
143176527|NCT03247829|516196146|FG000|Overall Study|Transplant|1|||
143091241|NCT02501928|515873897|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
143091242|NCT02501928|515873898|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
143091243|NCT02501928|515873899|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
143091244|NCT02501928|515873900|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
143091245|NCT02501928|515873901|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
143091246|NCT00838526|515873905|FG000|Overall Study|Adverse Event|3|||
143091247|NCT00838526|515873906|FG001|Overall Study|Adverse Event|12|||
143091248|NCT00838526|515873905|FG000|Overall Study|Lost to Follow-up|4|||
143091249|NCT00838526|515873906|FG001|Overall Study|Lost to Follow-up|12|||
143091250|NCT00838526|515873905|FG000|Overall Study|Withdrawal by Subject|4|||
143091251|NCT00838526|515873906|FG001|Overall Study|Withdrawal by Subject|5|||
143091252|NCT00838526|515873905|FG000|Overall Study|Lack of Efficacy|2|||
143091253|NCT00838526|515873906|FG001|Overall Study|Lack of Efficacy|3|||
143091254|NCT00838526|515873905|FG000|Overall Study|Other|11|||
143091255|NCT00838526|515873906|FG001|Overall Study|Other|7|||
143091256|NCT00931411|515873915|FG000|First Intervention - 42 Days|Adverse Event|2|||
143091257|NCT00931411|515873916|FG001|First Intervention - 42 Days|Adverse Event|3|||
143091258|NCT00931411|515873915|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
143091259|NCT00931411|515873916|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
143091260|NCT00931411|515873915|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
143091261|NCT00931411|515873916|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
143091262|NCT02860546|515873921|FG000|Overall Study|Clinical Progression|6|||
143091263|NCT02860546|515873921|FG000|Overall Study|Radiological Progression|12|||
143091264|NCT02586155|515873927|FG000|Overall Study|Adverse Event|2|||
143091265|NCT02586155|515873928|FG001|Overall Study|Adverse Event|3|||
143091266|NCT02586155|515873927|FG000|Overall Study|Withdrawal by Subject|31|||
143091267|NCT02586155|515873928|FG001|Overall Study|Withdrawal by Subject|24|||
143091268|NCT02586155|515873927|FG000|Overall Study|Lost to Follow-up|7|||
143091269|NCT02586155|515873928|FG001|Overall Study|Lost to Follow-up|13|||
143091270|NCT02586155|515873927|FG000|Overall Study|Death|61|||
143091271|NCT02586155|515873928|FG001|Overall Study|Death|72|||
143091272|NCT02586155|515873927|FG000|Overall Study|Other reasons|26|||
143091273|NCT02586155|515873928|FG001|Overall Study|Other reasons|15|||
143091274|NCT01112059|515873930|FG000|Overall Study|Withdrawal by Subject|1|||
143091275|NCT01112059|515873931|FG001|Overall Study|Withdrawal by Subject|0|||
143091276|NCT03367819|515873933|FG000|Overall Study|Adverse Event|4|||
143091277|NCT03367819|515873934|FG001|Overall Study|Adverse Event|4|||
143091278|NCT03367819|515873933|FG000|Overall Study|Progressive Disease|15|||
143091279|NCT03367819|515873934|FG001|Overall Study|Progressive Disease|13|||
143091280|NCT03367819|515873933|FG000|Overall Study|Withdrawal by Subject|1|||
143091281|NCT03367819|515873934|FG001|Overall Study|Withdrawal by Subject|0|||
143091282|NCT03367819|515873933|FG000|Overall Study|Other|4|||
143091283|NCT03367819|515873934|FG001|Overall Study|Other|2|||
143091284|NCT00982657|515873937|FG000|Overall Study|Death|1|||
143091285|NCT00982657|515873938|FG001|Overall Study|Death|0|||
143091286|NCT00982657|515873939|FG002|Overall Study|Death|1|||
143091287|NCT00982657|515873940|FG003|Overall Study|Death|1|||
143091288|NCT00982657|515873937|FG000|Overall Study|Withdrawal by Subject|0|||
143091289|NCT00982657|515873938|FG001|Overall Study|Withdrawal by Subject|0|||
143091290|NCT00982657|515873939|FG002|Overall Study|Withdrawal by Subject|1|||
143091291|NCT00982657|515873940|FG003|Overall Study|Withdrawal by Subject|3|||
143176528|NCT03247829|516196147|FG001|Overall Study|Transplant|1|||
143176529|NCT01856322|516196150|FG000|Overall Study|off study due to lack of accrual|0|||
143176530|NCT01856322|516196151|FG001|Overall Study|off study due to lack of accrual|0|||
143176531|NCT01856322|516196152|FG002|Overall Study|off study due to lack of accrual|3|||
143176532|NCT00427011|516196153|FG000|Overall Study|Adverse Event|10|||
143176533|NCT00427011|516196153|FG000|Overall Study|Withdrawal by Subject|1|||
143176534|NCT00427011|516196153|FG000|Overall Study|Lack of Efficacy|2|||
143176535|NCT00427011|516196153|FG000|Overall Study|Other|12|||
143176536|NCT00288015|516196154|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
143250865|NCT01403948|516472938|FG004|Overall Study|Progressive disease|2|||
143091292|NCT00982657|515873937|FG000|Overall Study|Other|0|||
143091293|NCT00982657|515873938|FG001|Overall Study|Other|0|||
143091294|NCT00982657|515873939|FG002|Overall Study|Other|0|||
143091295|NCT00982657|515873940|FG003|Overall Study|Other|4|||
143091296|NCT00982657|515873937|FG000|Overall Study|On going at date of cut-off|0|||
143091297|NCT00982657|515873938|FG001|Overall Study|On going at date of cut-off|0|||
143091298|NCT00982657|515873939|FG002|Overall Study|On going at date of cut-off|0|||
143091299|NCT00982657|515873940|FG003|Overall Study|On going at date of cut-off|1|||
143091300|NCT00445146|515873941|FG000|Overall Study|Withdrew Consent|29|||
143091301|NCT00445146|515873941|FG000|Overall Study|Lack of Efficacy|28|||
143091302|NCT00445146|515873941|FG000|Overall Study|Investigator's Discretion|22|||
143091303|NCT00445146|515873941|FG000|Overall Study|Adverse Event|13|||
143091304|NCT00445146|515873941|FG000|Overall Study|Lost to Follow-up|13|||
143091305|NCT00445146|515873941|FG000|Overall Study|Death|9|||
143091306|NCT00445146|515873941|FG000|Overall Study|Protocol Violation|4|||
143091307|NCT00445146|515873941|FG000|Overall Study|Pregnancy|1|||
143091308|NCT00397514|515873942|FG000|Overall Study|Withdrawal by Subject|1|||
143091309|NCT00397514|515873942|FG000|Overall Study|Pacing wire malfunction|1|||
143091310|NCT00397514|515873942|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
143091311|NCT00397514|515873942|FG000|Overall Study|early extubation|2|||
143091312|NCT00397514|515873942|FG000|Overall Study|poor echocardiographic windows|1|||
143091313|NCT02456740|515873944|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
143091314|NCT02456740|515873945|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
143091315|NCT02456740|515873946|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
143091316|NCT02456740|515873947|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
143091317|NCT02456740|515873948|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
143091318|NCT02456740|515873949|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
143091319|NCT02456740|515873950|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
143091320|NCT02456740|515873951|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
143091321|NCT02456740|515873952|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
143091322|NCT02456740|515873944|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
143091323|NCT02456740|515873945|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
143091324|NCT02456740|515873946|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
143091325|NCT02456740|515873947|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
143091326|NCT02456740|515873948|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
143091327|NCT02456740|515873949|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
143091328|NCT02456740|515873950|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
143091329|NCT02456740|515873951|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
143091330|NCT02456740|515873952|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
143091331|NCT02456740|515873944|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
143091332|NCT02456740|515873945|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
143091333|NCT02456740|515873946|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
143091334|NCT02456740|515873947|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
143091335|NCT02456740|515873948|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
143091336|NCT02456740|515873949|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
143091337|NCT02456740|515873950|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
143091338|NCT02456740|515873951|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
143091339|NCT02456740|515873952|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
143091340|NCT02456740|515873944|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
143091341|NCT02456740|515873945|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
143091342|NCT02456740|515873946|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
143091343|NCT02456740|515873947|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
143091344|NCT02456740|515873948|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
143091345|NCT02456740|515873949|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
143091346|NCT02456740|515873950|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
143091347|NCT02456740|515873951|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
143250866|NCT01403948|516472939|FG005|Overall Study|Progressive disease|6|||
143250867|NCT01403948|516472940|FG006|Overall Study|Progressive disease|2|||
143250868|NCT01403948|516472941|FG007|Overall Study|Progressive disease|4|||
143250869|NCT01403948|516472942|FG008|Overall Study|Progressive disease|5|||
143250870|NCT01403948|516472943|FG009|Overall Study|Progressive disease|5|||
143250871|NCT01403948|516472934|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
143250872|NCT01403948|516472935|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
143250873|NCT01403948|516472936|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
143250874|NCT01403948|516472937|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
143367171|NCT01081145|516887267|FG000|Open-Label Phase|Withdrawal by Subject|41|||
143091348|NCT02456740|515873952|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
143091349|NCT02456740|515873944|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
143091350|NCT02456740|515873945|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
143091351|NCT02456740|515873946|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
143367172|NCT01081145|516887268|FG001|Open-Label Phase|Withdrawal by Subject|0|||
143367173|NCT01081145|516887267|FG000|Open-Label Phase|Other|12|||
143367174|NCT01081145|516887268|FG001|Open-Label Phase|Other|0|||
143091352|NCT02456740|515873947|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
143091353|NCT02456740|515873948|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
143091354|NCT02456740|515873949|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
143091355|NCT02456740|515873950|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
143091356|NCT02456740|515873951|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
143091357|NCT02456740|515873952|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
143091358|NCT02456740|515873944|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
143091359|NCT02456740|515873945|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
143091360|NCT02456740|515873946|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
143091361|NCT02456740|515873947|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
143091362|NCT02456740|515873948|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
143091363|NCT02456740|515873949|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
143091364|NCT02456740|515873950|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
143091365|NCT02456740|515873951|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
143091366|NCT02456740|515873952|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
143091367|NCT02456740|515873944|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
143091368|NCT02456740|515873945|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
143091369|NCT02456740|515873946|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
143091370|NCT02456740|515873947|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
143091371|NCT02456740|515873948|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
143091372|NCT02456740|515873949|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
143091373|NCT02456740|515873950|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
143091374|NCT02456740|515873951|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
143091375|NCT02456740|515873952|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
143091376|NCT02623725|515873954|FG000|Overall Study|Non compliance with protocol|9|||
143091377|NCT02623725|515873955|FG001|Overall Study|Non compliance with protocol|3|||
143091378|NCT02623725|515873954|FG000|Overall Study|Serious adverse event|0|||
143091379|NCT02623725|515873955|FG001|Overall Study|Serious adverse event|2|||
143091380|NCT02623725|515873954|FG000|Overall Study|Withdrawal by Subject|7|||
143091381|NCT02623725|515873955|FG001|Overall Study|Withdrawal by Subject|1|||
143091382|NCT02698163|515873958|FG000|Overall Study|Lost to Follow-up|0|||
143091383|NCT02698163|515873959|FG001|Overall Study|Lost to Follow-up|1|||
143091384|NCT05373108|515873960|FG000|Overall Study|Withdrawal by Subject|2|||
143091385|NCT02892331|515873961|FG000|Overall Study|Withdrawal by Subject|0|||
143091386|NCT02892331|515873962|FG001|Overall Study|Withdrawal by Subject|1|||
143091387|NCT02892331|515873963|FG002|Overall Study|Withdrawal by Subject|1|||
143091388|NCT02892331|515873961|FG000|Overall Study|Sick family member|0|||
143091389|NCT02892331|515873962|FG001|Overall Study|Sick family member|0|||
143091390|NCT02892331|515873963|FG002|Overall Study|Sick family member|1|||
143091391|NCT02892331|515873961|FG000|Overall Study|Corona virus pandemic|1|||
143091392|NCT02892331|515873962|FG001|Overall Study|Corona virus pandemic|0|||
143091393|NCT02892331|515873963|FG002|Overall Study|Corona virus pandemic|1|||
143091394|NCT02892331|515873961|FG000|Overall Study|Lost to Follow-up|1|||
143091395|NCT02892331|515873962|FG001|Overall Study|Lost to Follow-up|0|||
143091396|NCT02892331|515873963|FG002|Overall Study|Lost to Follow-up|1|||
143091397|NCT02892331|515873961|FG000|Overall Study|Blood pressure was too elevated|0|||
143091398|NCT02892331|515873962|FG001|Overall Study|Blood pressure was too elevated|1|||
143091399|NCT02892331|515873963|FG002|Overall Study|Blood pressure was too elevated|0|||
143091400|NCT02892331|515873961|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
143091401|NCT02892331|515873962|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
143091402|NCT02892331|515873963|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
143091403|NCT01133067|515873964|FG000|Overall Study|Death|136|||
143091404|NCT01133067|515873964|FG000|Overall Study|Lost to Follow-up|3|||
143091405|NCT00349973|515873968|FG000|Overall Study|Adverse Event|3|||
143091406|NCT00349973|515873969|FG001|Overall Study|Adverse Event|3|||
143091407|NCT00349973|515873968|FG000|Overall Study|Withdrawal by Subject|1|||
143091408|NCT00349973|515873969|FG001|Overall Study|Withdrawal by Subject|0|||
143091409|NCT02654054|515873970|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
143091410|NCT02654054|515873971|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
143176537|NCT00288015|516196154|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
143091411|NCT02654054|515873972|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
143091412|NCT02654054|515873970|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
143091413|NCT02654054|515873971|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
143091414|NCT02654054|515873972|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
143176538|NCT00288015|516196154|FG000|First Response Assessment|Withdrawal by Subject|1|||
143091415|NCT02654054|515873970|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
143091416|NCT02654054|515873971|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
143091417|NCT02654054|515873972|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
143091418|NCT02654054|515873970|FG000|Post-Treatment Follow-Up Period|Other|1|||
143091419|NCT02654054|515873971|FG001|Post-Treatment Follow-Up Period|Other|0|||
143091420|NCT02654054|515873972|FG002|Post-Treatment Follow-Up Period|Other|4|||
143091421|NCT02654054|515873970|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
143091422|NCT02654054|515873971|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
143091423|NCT02654054|515873972|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
143091424|NCT04075487|515875857|FG000|Overall Study|Withdrawal by Subject|1|||
143091425|NCT05016960|515875860|FG000|Overall Study|Withdrawal by Subject|1|||
143091426|NCT05016960|515875861|FG001|Overall Study|Withdrawal by Subject|9|||
143091427|NCT00725283|515875864|FG000|Overall Study|Missing Code|3|||
143091428|NCT00725283|515875864|FG000|Overall Study|Death|5|||
143091429|NCT00725283|515875864|FG000|Overall Study|Other|6|||
143091430|NCT00725283|515875864|FG000|Overall Study|Withdrawal by Subject|10|||
143091431|NCT01823328|515875866|FG000|Overall Study|Withdrawal by Subject|8|||
143091432|NCT01823328|515875867|FG001|Overall Study|Withdrawal by Subject|6|||
143091433|NCT01103180|515875877|FG000|Overall Study|Withdrawal by Subject|8|||
143091434|NCT01103180|515875878|FG001|Overall Study|Withdrawal by Subject|13|||
143091435|NCT01103180|515875877|FG000|Overall Study|Lost to Follow-up|13|||
143091436|NCT01103180|515875878|FG001|Overall Study|Lost to Follow-up|7|||
143091437|NCT01103180|515875877|FG000|Overall Study|Physician Decision|1|||
143091438|NCT01103180|515875878|FG001|Overall Study|Physician Decision|0|||
143091439|NCT01103180|515875877|FG000|Overall Study|Protocol Violation|0|||
143091440|NCT01103180|515875878|FG001|Overall Study|Protocol Violation|1|||
143091441|NCT01173523|515875879|FG000|Overall Study|Clinical Progression|1|||
143091442|NCT01173523|515875880|FG001|Overall Study|Clinical Progression|1|||
143091443|NCT01173523|515875879|FG000|Overall Study|Progressive Disease|10|||
143091444|NCT01173523|515875880|FG001|Overall Study|Progressive Disease|8|||
143091445|NCT01173523|515875879|FG000|Overall Study|Other|2|||
143091446|NCT01173523|515875880|FG001|Overall Study|Other|3|||
143091447|NCT01866826|515875883|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
143091448|NCT01866826|515875884|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
143091449|NCT01866826|515875883|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
143091450|NCT01866826|515875884|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
143091451|NCT01866826|515875883|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
143091452|NCT01866826|515875884|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
143091453|NCT00742209|515875886|FG000|Overall Study|Adverse Event|11|||
143091454|NCT00742209|515875887|FG001|Overall Study|Adverse Event|4|||
143091455|NCT00742209|515875888|FG002|Overall Study|Adverse Event|17|||
143091456|NCT00742209|515875889|FG003|Overall Study|Adverse Event|16|||
143091457|NCT00742209|515875890|FG004|Overall Study|Adverse Event|13|||
143091458|NCT00742209|515875886|FG000|Overall Study|Participant Withdrew Consent|8|||
143091459|NCT00742209|515875887|FG001|Overall Study|Participant Withdrew Consent|4|||
143091460|NCT00742209|515875888|FG002|Overall Study|Participant Withdrew Consent|14|||
143091461|NCT00742209|515875889|FG003|Overall Study|Participant Withdrew Consent|7|||
143091462|NCT00742209|515875890|FG004|Overall Study|Participant Withdrew Consent|4|||
143091463|NCT00742209|515875886|FG000|Overall Study|Protocol Violation|6|||
143091464|NCT00742209|515875887|FG001|Overall Study|Protocol Violation|5|||
143091465|NCT00742209|515875888|FG002|Overall Study|Protocol Violation|4|||
143091466|NCT00742209|515875889|FG003|Overall Study|Protocol Violation|5|||
143091467|NCT00742209|515875890|FG004|Overall Study|Protocol Violation|3|||
143091468|NCT00742209|515875886|FG000|Overall Study|Lost to Follow-up|3|||
143091469|NCT00742209|515875887|FG001|Overall Study|Lost to Follow-up|4|||
143091470|NCT00742209|515875888|FG002|Overall Study|Lost to Follow-up|5|||
143091471|NCT00742209|515875889|FG003|Overall Study|Lost to Follow-up|5|||
143091472|NCT00742209|515875890|FG004|Overall Study|Lost to Follow-up|3|||
143091473|NCT00742209|515875886|FG000|Overall Study|Lack of Efficacy|6|||
143091474|NCT00742209|515875887|FG001|Overall Study|Lack of Efficacy|1|||
143091475|NCT00742209|515875888|FG002|Overall Study|Lack of Efficacy|1|||
143091476|NCT00742209|515875889|FG003|Overall Study|Lack of Efficacy|3|||
143091477|NCT00742209|515875890|FG004|Overall Study|Lack of Efficacy|1|||
143091478|NCT00742209|515875886|FG000|Overall Study|Investigator Discretion|0|||
143091479|NCT00742209|515875887|FG001|Overall Study|Investigator Discretion|0|||
143091480|NCT00742209|515875888|FG002|Overall Study|Investigator Discretion|5|||
143091481|NCT00742209|515875889|FG003|Overall Study|Investigator Discretion|1|||
143091482|NCT00742209|515875890|FG004|Overall Study|Investigator Discretion|1|||
143091483|NCT01514461|515875891|FG000|Overall Study|Adverse Event|2|||
143091484|NCT01514461|515875892|FG001|Overall Study|Adverse Event|1|||
143091485|NCT01514461|515875893|FG002|Overall Study|Adverse Event|3|||
143091486|NCT01514461|515875891|FG000|Overall Study|Physician Decision|1|||
143091487|NCT01514461|515875892|FG001|Overall Study|Physician Decision|1|||
143091488|NCT01514461|515875893|FG002|Overall Study|Physician Decision|0|||
143091489|NCT01514461|515875891|FG000|Overall Study|Patient/guardian decision|1|||
143091490|NCT01514461|515875892|FG001|Overall Study|Patient/guardian decision|1|||
143091491|NCT01514461|515875893|FG002|Overall Study|Patient/guardian decision|1|||
143091492|NCT01514461|515875891|FG000|Overall Study|Death|1|||
143091493|NCT01514461|515875892|FG001|Overall Study|Death|0|||
143091494|NCT01514461|515875893|FG002|Overall Study|Death|0|||
143091495|NCT02440464|515875894|FG000|Overall Study|Withdrawal by Subject|3|||
143091496|NCT02440464|515875895|FG001|Overall Study|Withdrawal by Subject|2|||
143091497|NCT03359850|515875901|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
143091498|NCT03359850|515875902|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
143091499|NCT03359850|515875901|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
143091500|NCT03359850|515875902|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
143091501|NCT03359850|515875901|FG000|Extension Phase (Up to 28 Months)|Death|2|||
143091502|NCT03359850|515875902|FG001|Extension Phase (Up to 28 Months)|Death|4|||
143091503|NCT03359850|515875901|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
143091504|NCT03359850|515875902|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
143091505|NCT03359850|515875901|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
143091506|NCT03359850|515875902|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
143091507|NCT00116779|515875904|FG000|Overall Study|Adverse Event|4|||
143091508|NCT00116779|515875905|FG001|Overall Study|Adverse Event|2|||
143091509|NCT00116779|515875904|FG000|Overall Study|Protocol Violation|1|||
143091510|NCT00116779|515875905|FG001|Overall Study|Protocol Violation|4|||
143091511|NCT00116779|515875904|FG000|Overall Study|Withdrawal by Subject|4|||
143091512|NCT00116779|515875905|FG001|Overall Study|Withdrawal by Subject|1|||
143091513|NCT00116779|515875904|FG000|Overall Study|Inadequate testosterone suppression|7|||
143091514|NCT00116779|515875905|FG001|Overall Study|Inadequate testosterone suppression|9|||
143091515|NCT00116779|515875904|FG000|Overall Study|Physician Decision|3|||
143091516|NCT00116779|515875905|FG001|Overall Study|Physician Decision|1|||
143091517|NCT00116779|515875904|FG000|Overall Study|Elevated PSA levels|2|||
143091518|NCT00116779|515875905|FG001|Overall Study|Elevated PSA levels|2|||
143091519|NCT01321879|515875906|FG000|Overall Study|Lack of Efficacy|5|||
143091520|NCT01321879|515875906|FG000|Overall Study|Adverse Event|5|||
143091521|NCT01321879|515875906|FG000|Overall Study|Death|3|||
143091522|NCT01321879|515875906|FG000|Overall Study|Withdrawal by Subject|1|||
143091523|NCT00711087|515875907|FG000|Overall Study|Lost to Follow-up|1|||
143091524|NCT00711087|515875908|FG001|Overall Study|Lost to Follow-up|0|||
143091525|NCT02289729|515875909|FG000|Overall Study|Lack of Efficacy|3|||
143091526|NCT02289729|515875909|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
143091527|NCT02289729|515875909|FG000|Overall Study|Withdrawal by Subject|1|||
143091528|NCT02289729|515875909|FG000|Overall Study|Death|1|||
143091529|NCT01320293|515875910|FG000|Overall Study|Lack of Efficacy|1|||
143091530|NCT01320293|515875910|FG000|Overall Study|Adverse Event|1|||
143091531|NCT00470470|515875911|FG000|Overall Study|Adverse Event|2|||
143091532|NCT00470470|515875911|FG000|Overall Study|Death|2|||
143091533|NCT00470470|515875911|FG000|Overall Study|Not treated|1|||
143091534|NCT03483012|515875912|FG000|Overall Study|Lack of Efficacy|6|||
143091535|NCT01949662|515875918|FG000|Overall Study|Death|9|||
143091536|NCT01949662|515875919|FG001|Overall Study|Death|7|||
143091537|NCT01949662|515875918|FG000|Overall Study|Discharged before an agitation event|8|||
143091538|NCT01949662|515875919|FG001|Overall Study|Discharged before an agitation event|3|||
143091539|NCT01949662|515875918|FG000|Overall Study|Dropped out|1|||
143091540|NCT01949662|515875919|FG001|Overall Study|Dropped out|3|||
143091541|NCT01949662|515875918|FG000|Overall Study|Ineligible|0|||
143091542|NCT01949662|515875919|FG001|Overall Study|Ineligible|1|||
143091543|NCT02291237|515875920|FG000|Overall Study|Study Terminated by Sponsor|72|||
143091544|NCT02291237|515875921|FG001|Overall Study|Study Terminated by Sponsor|67|||
143091545|NCT02291237|515875920|FG000|Overall Study|Adverse Event|1|||
143091546|NCT02291237|515875921|FG001|Overall Study|Adverse Event|3|||
143091547|NCT02291237|515875920|FG000|Overall Study|Investigator's Discretion|0|||
143250875|NCT01403948|516472938|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
143250876|NCT01403948|516472939|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
143250877|NCT01403948|516472940|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
143250878|NCT01403948|516472941|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
143091548|NCT02291237|515875921|FG001|Overall Study|Investigator's Discretion|3|||
143091549|NCT02291237|515875920|FG000|Overall Study|Withdrew Consent|11|||
143091550|NCT02291237|515875921|FG001|Overall Study|Withdrew Consent|11|||
143091551|NCT02291237|515875920|FG000|Overall Study|Lost to Follow-up|0|||
143091552|NCT02291237|515875921|FG001|Overall Study|Lost to Follow-up|2|||
143091553|NCT02291237|515875920|FG000|Overall Study|Subject Required Prohibited Medication|2|||
143091554|NCT02291237|515875921|FG001|Overall Study|Subject Required Prohibited Medication|0|||
143091555|NCT00729937|515875924|FG000|Overall Study|Lost to Follow-up|49|||
143091556|NCT00729937|515875925|FG001|Overall Study|Lost to Follow-up|58|||
143091557|NCT00729937|515875926|FG002|Overall Study|Lost to Follow-up|18|||
143091558|NCT00729937|515875927|FG003|Overall Study|Lost to Follow-up|33|||
143250879|NCT01403948|516472942|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
143091559|NCT00729937|515875928|FG004|Overall Study|Lost to Follow-up|18|||
143091560|NCT00729937|515875929|FG005|Overall Study|Lost to Follow-up|23|||
143250880|NCT01403948|516472943|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
143091561|NCT00729937|515875924|FG000|Overall Study|Physician Decision|7|||
143091562|NCT00729937|515875925|FG001|Overall Study|Physician Decision|16|||
143091563|NCT00729937|515875926|FG002|Overall Study|Physician Decision|2|||
143091564|NCT00729937|515875927|FG003|Overall Study|Physician Decision|0|||
143091565|NCT00729937|515875928|FG004|Overall Study|Physician Decision|5|||
143091566|NCT00729937|515875929|FG005|Overall Study|Physician Decision|8|||
143091567|NCT00729937|515875924|FG000|Overall Study|Death|1|||
143091568|NCT00729937|515875925|FG001|Overall Study|Death|0|||
143091569|NCT00729937|515875926|FG002|Overall Study|Death|1|||
143091570|NCT00729937|515875927|FG003|Overall Study|Death|0|||
143091571|NCT00729937|515875928|FG004|Overall Study|Death|0|||
143091572|NCT00729937|515875929|FG005|Overall Study|Death|1|||
143091573|NCT00729937|515875924|FG000|Overall Study|Withdrawal by Subject|3|||
143091574|NCT00729937|515875925|FG001|Overall Study|Withdrawal by Subject|5|||
143091575|NCT00729937|515875926|FG002|Overall Study|Withdrawal by Subject|6|||
143091576|NCT00729937|515875927|FG003|Overall Study|Withdrawal by Subject|0|||
143091577|NCT00729937|515875928|FG004|Overall Study|Withdrawal by Subject|4|||
143091578|NCT00729937|515875929|FG005|Overall Study|Withdrawal by Subject|2|||
143091579|NCT00729937|515875924|FG000|Overall Study|Randomized but not treated|12|||
143091580|NCT00729937|515875925|FG001|Overall Study|Randomized but not treated|6|||
143091581|NCT00729937|515875926|FG002|Overall Study|Randomized but not treated|1|||
143091582|NCT00729937|515875927|FG003|Overall Study|Randomized but not treated|0|||
143091583|NCT00729937|515875928|FG004|Overall Study|Randomized but not treated|1|||
143091584|NCT00729937|515875929|FG005|Overall Study|Randomized but not treated|3|||
143091585|NCT00729937|515875924|FG000|Overall Study|Did not meet eligibility criteria|2|||
143091586|NCT00729937|515875925|FG001|Overall Study|Did not meet eligibility criteria|1|||
143091587|NCT00729937|515875926|FG002|Overall Study|Did not meet eligibility criteria|0|||
143091588|NCT00729937|515875927|FG003|Overall Study|Did not meet eligibility criteria|0|||
143091589|NCT00729937|515875928|FG004|Overall Study|Did not meet eligibility criteria|0|||
143091590|NCT00729937|515875929|FG005|Overall Study|Did not meet eligibility criteria|0|||
143091591|NCT00729937|515875924|FG000|Overall Study|Incarcerated|0|||
143091592|NCT00729937|515875925|FG001|Overall Study|Incarcerated|2|||
143091593|NCT00729937|515875926|FG002|Overall Study|Incarcerated|1|||
143091594|NCT00729937|515875927|FG003|Overall Study|Incarcerated|1|||
143091595|NCT00729937|515875928|FG004|Overall Study|Incarcerated|0|||
143091596|NCT00729937|515875929|FG005|Overall Study|Incarcerated|0|||
143091597|NCT01478373|515875931|FG000|Treatment Phase|Protocol Violation|1|||
143091598|NCT01478373|515875931|FG000|Survival Phase|Adverse Event|8|||
143091599|NCT01478373|515875931|FG000|Survival Phase|Protocol Violation|1|||
143091600|NCT01478373|515875931|FG000|Survival Phase|crossover to another study|2|||
143091601|NCT01478373|515875931|FG000|Survival Phase|Progressive Disease|27|||
143091602|NCT01998841|515875937|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
143091603|NCT01998841|515875938|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
143091604|NCT01998841|515875939|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
143091605|NCT01998841|515875940|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
143091606|NCT01998841|515875941|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
143091607|NCT01998841|515875937|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
143091608|NCT01998841|515875938|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
143091609|NCT01998841|515875939|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
143091610|NCT01998841|515875940|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
143091611|NCT01998841|515875941|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
143091612|NCT02552121|515875942|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
143091613|NCT02552121|515875943|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
143091614|NCT02552121|515875944|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
143091615|NCT02552121|515875945|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
143091616|NCT02552121|515875946|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
143091617|NCT02552121|515875947|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
143091618|NCT02552121|515875948|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
143250881|NCT01403948|516472934|FG000|Overall Study|Lost to Follow-up|0|||
143250882|NCT01403948|516472935|FG001|Overall Study|Lost to Follow-up|0|||
143250883|NCT01403948|516472936|FG002|Overall Study|Lost to Follow-up|0|||
143091619|NCT02552121|515875949|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
143091620|NCT02552121|515875942|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
143091621|NCT02552121|515875943|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
143091622|NCT02552121|515875944|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
143091623|NCT02552121|515875945|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
143091624|NCT02552121|515875946|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
143091625|NCT02552121|515875947|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
143091626|NCT02552121|515875948|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
143250884|NCT01403948|516472937|FG003|Overall Study|Lost to Follow-up|0|||
143091627|NCT02552121|515875949|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
143091628|NCT02552121|515875942|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
143250885|NCT01403948|516472938|FG004|Overall Study|Lost to Follow-up|0|||
143176539|NCT00288015|516196154|FG000|First Response Assessment|Death|1|||
143176540|NCT00288015|516196154|FG000|First Response Assessment|Physician Decision|2|||
143176541|NCT00288015|516196154|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
143176542|NCT00288015|516196154|FG000|Follow up for Survival x 2 Years|Death|13|||
143176543|NCT00288015|516196154|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
143176544|NCT00288015|516196154|FG000|Follow up for Survival x 2 Years|Other|9|||
143176545|NCT00443703|516196155|FG000|Overall Study|Never Treated|3|||
143176546|NCT00443703|516196156|FG001|Overall Study|Never Treated|1|||
143176547|NCT00443703|516196155|FG000|Overall Study|Adverse Event|7|||
143176548|NCT00443703|516196156|FG001|Overall Study|Adverse Event|3|||
143176549|NCT00443703|516196155|FG000|Overall Study|Lack of Efficacy|3|||
143176550|NCT00443703|516196156|FG001|Overall Study|Lack of Efficacy|1|||
143176551|NCT00443703|516196155|FG000|Overall Study|Lost to Follow-up|0|||
143176552|NCT00443703|516196156|FG001|Overall Study|Lost to Follow-up|4|||
143176553|NCT00443703|516196155|FG000|Overall Study|Physician Decision|4|||
143176554|NCT00443703|516196156|FG001|Overall Study|Physician Decision|2|||
143176555|NCT00443703|516196155|FG000|Overall Study|Protocol Violation|1|||
143176556|NCT00443703|516196156|FG001|Overall Study|Protocol Violation|1|||
143176557|NCT00443703|516196155|FG000|Overall Study|Withdrawal by Subject|9|||
143176558|NCT00443703|516196156|FG001|Overall Study|Withdrawal by Subject|6|||
143176559|NCT00443703|516196155|FG000|Overall Study|Progressive Disease|1|||
143176560|NCT00443703|516196156|FG001|Overall Study|Progressive Disease|0|||
143176561|NCT01669902|516196162|FG000|Overall Study|Adverse Event|11|||
143176562|NCT01669902|516196162|FG000|Overall Study|Lack of Efficacy|10|||
143176563|NCT01669902|516196162|FG000|Overall Study|Other|8|||
143176564|NCT00457392|516196163|FG000|Overall Study|Objective Progression or Relapse|229|||
143176565|NCT00457392|516196164|FG001|Overall Study|Objective Progression or Relapse|296|||
143176566|NCT00457392|516196163|FG000|Overall Study|Death|106|||
143176567|NCT00457392|516196164|FG001|Overall Study|Death|106|||
143176568|NCT00457392|516196163|FG000|Overall Study|Adverse Event|84|||
143176569|NCT00457392|516196164|FG001|Overall Study|Adverse Event|41|||
143176570|NCT00457392|516196163|FG000|Overall Study|Global Deterioration of Health Status|22|||
143176571|NCT00457392|516196164|FG001|Overall Study|Global Deterioration of Health Status|8|||
143176572|NCT00457392|516196163|FG000|Overall Study|Withdrawal by Subject|14|||
143176573|NCT00457392|516196164|FG001|Overall Study|Withdrawal by Subject|8|||
143176574|NCT00457392|516196163|FG000|Overall Study|Lost to Follow-up|6|||
143176575|NCT00457392|516196164|FG001|Overall Study|Lost to Follow-up|7|||
143176576|NCT00457392|516196163|FG000|Overall Study|Protocol Violation|4|||
143176577|NCT00457392|516196164|FG001|Overall Study|Protocol Violation|3|||
143250886|NCT01403948|516472939|FG005|Overall Study|Lost to Follow-up|0|||
143176578|NCT00457392|516196163|FG000|Overall Study|Other|7|||
143176579|NCT00457392|516196164|FG001|Overall Study|Other|4|||
143176580|NCT00457392|516196163|FG000|Overall Study|Study Terminated by Sponsor|1|||
143176581|NCT00457392|516196164|FG001|Overall Study|Study Terminated by Sponsor|4|||
143367175|NCT01081145|516887267|FG000|Open-Label Phase|Lost to Follow-up|11|||
143367176|NCT01081145|516887268|FG001|Open-Label Phase|Lost to Follow-up|0|||
143367177|NCT01081145|516887267|FG000|Open-Label Phase|Protocol Violation|4|||
143367178|NCT01081145|516887268|FG001|Open-Label Phase|Protocol Violation|0|||
143367179|NCT01081145|516887267|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
143367180|NCT01081145|516887268|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
143367181|NCT01081145|516887267|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
143367182|NCT01081145|516887268|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
143367183|NCT01081145|516887267|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
143367184|NCT01081145|516887268|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
143367185|NCT01081145|516887267|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
143367186|NCT01081145|516887268|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
143367187|NCT01081145|516887267|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
143367188|NCT01081145|516887268|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
143367189|NCT01081145|516887267|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
143367190|NCT01081145|516887268|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
143367191|NCT01081145|516887267|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
143367192|NCT01081145|516887268|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
143367193|NCT03235349|516887274|FG000|Overall Study|Adverse Event|1|||
143367194|NCT03235349|516887274|FG000|Overall Study|Other|1|||
143367195|NCT01018511|516887276|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
143091629|NCT02552121|515875943|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
143091630|NCT02552121|515875944|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
143091631|NCT02552121|515875945|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
143091632|NCT02552121|515875946|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
143091633|NCT02552121|515875947|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
143091634|NCT02552121|515875948|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
143091635|NCT02552121|515875949|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
143091636|NCT02552121|515875942|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
143091637|NCT02552121|515875943|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
143091638|NCT02552121|515875944|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
143091639|NCT02552121|515875945|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
143091640|NCT02552121|515875946|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
143091641|NCT02552121|515875947|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
143091642|NCT02552121|515875948|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
143091643|NCT02552121|515875949|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
143091644|NCT02552121|515875942|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
143091645|NCT02552121|515875943|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
143091646|NCT02552121|515875944|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
143091647|NCT02552121|515875945|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
143091648|NCT02552121|515875946|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
143091649|NCT02552121|515875947|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
143091650|NCT02552121|515875948|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
143091651|NCT02552121|515875949|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
143091652|NCT02552121|515875942|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
143091653|NCT02552121|515875943|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
143091654|NCT02552121|515875944|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
143091655|NCT02552121|515875945|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
143091656|NCT02552121|515875946|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
143091657|NCT02552121|515875947|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
143091658|NCT02552121|515875948|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
143091659|NCT02552121|515875949|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
143091660|NCT02552121|515875942|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
143091661|NCT02552121|515875943|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
143091662|NCT02552121|515875944|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
143091663|NCT02552121|515875945|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
143091664|NCT02552121|515875946|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
143091665|NCT02552121|515875947|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
143091666|NCT02552121|515875948|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
143091667|NCT02552121|515875949|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
143091668|NCT02552121|515875942|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
143367196|NCT01018511|516887277|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
143367197|NCT01018511|516887278|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
143367198|NCT01018511|516887279|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
143367199|NCT01018511|516887276|FG000|Overall Study|Adverse Event|5|||
143091669|NCT02552121|515875943|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
143091670|NCT02552121|515875944|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
143091671|NCT02552121|515875945|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
143091672|NCT02552121|515875946|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
143091673|NCT02552121|515875947|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
143091674|NCT02552121|515875948|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
143091675|NCT02552121|515875949|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
143091676|NCT02552121|515875942|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
143091677|NCT02552121|515875943|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
143091678|NCT02552121|515875944|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
143091679|NCT02552121|515875945|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
143091680|NCT02552121|515875946|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
143091681|NCT02552121|515875947|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
143091682|NCT02552121|515875948|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
143091683|NCT02552121|515875949|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
143091684|NCT02552121|515875942|FG000|Part 2: Cohort Expansion|Death|0|||
143250887|NCT01403948|516472940|FG006|Overall Study|Lost to Follow-up|0|||
143091685|NCT02552121|515875943|FG001|Part 2: Cohort Expansion|Death|0|||
143250888|NCT01403948|516472941|FG007|Overall Study|Lost to Follow-up|0|||
143250889|NCT01403948|516472942|FG008|Overall Study|Lost to Follow-up|0|||
143250890|NCT01403948|516472943|FG009|Overall Study|Lost to Follow-up|1|||
143091686|NCT02552121|515875944|FG002|Part 2: Cohort Expansion|Death|1|||
143091687|NCT02552121|515875945|FG003|Part 2: Cohort Expansion|Death|0|||
143091688|NCT02552121|515875946|FG004|Part 2: Cohort Expansion|Death|0|||
143091689|NCT02552121|515875947|FG005|Part 2: Cohort Expansion|Death|0|||
143091690|NCT02552121|515875948|FG006|Part 2: Cohort Expansion|Death|0|||
143091691|NCT02552121|515875949|FG007|Part 2: Cohort Expansion|Death|0|||
143091692|NCT00972595|515875950|FG000|Period 1|Adverse Event|1|||
143091693|NCT00972595|515875951|FG001|Period 1|Adverse Event|0|||
143091694|NCT01522456|515875952|FG000|Overall Study|Adverse Event|2|||
143091695|NCT01522456|515875952|FG000|Overall Study|Lost to Follow-up|2|||
143091696|NCT01522456|515875952|FG000|Overall Study|Withdrawal by Subject|2|||
143091697|NCT01522456|515875952|FG000|Overall Study|Pregnancy|1|||
143091698|NCT01522456|515875952|FG000|Overall Study|Tolerability Assessment|1|||
143091699|NCT04052620|515875953|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
143250891|NCT01403948|516472934|FG000|Overall Study|Refused cont. medication|0|||
143250892|NCT01403948|516472935|FG001|Overall Study|Refused cont. medication|0|||
143250893|NCT01403948|516472936|FG002|Overall Study|Refused cont. medication|0|||
143250894|NCT01403948|516472937|FG003|Overall Study|Refused cont. medication|0|||
143250895|NCT01403948|516472938|FG004|Overall Study|Refused cont. medication|1|||
143250896|NCT01403948|516472939|FG005|Overall Study|Refused cont. medication|0|||
143250897|NCT01403948|516472940|FG006|Overall Study|Refused cont. medication|0|||
143250898|NCT01403948|516472941|FG007|Overall Study|Refused cont. medication|0|||
143250899|NCT01403948|516472942|FG008|Overall Study|Refused cont. medication|0|||
143250900|NCT01403948|516472943|FG009|Overall Study|Refused cont. medication|1|||
143250901|NCT01403948|516472934|FG000|Overall Study|other than above|1|||
143250902|NCT01403948|516472935|FG001|Overall Study|other than above|2|||
143250903|NCT01403948|516472936|FG002|Overall Study|other than above|1|||
143250904|NCT01403948|516472937|FG003|Overall Study|other than above|0|||
143250905|NCT01403948|516472938|FG004|Overall Study|other than above|1|||
143091700|NCT04052620|515875954|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
143091701|NCT04052620|515875953|FG000|Overall Study|Withdrawal by Subject|1|||
143091702|NCT04052620|515875954|FG001|Overall Study|Withdrawal by Subject|0|||
143091703|NCT04052620|515875953|FG000|Overall Study|Lost to Follow-up|1|||
143091704|NCT04052620|515875954|FG001|Overall Study|Lost to Follow-up|1|||
143091705|NCT04052620|515875953|FG000|Overall Study|Adverse Event|1|||
143091706|NCT04052620|515875954|FG001|Overall Study|Adverse Event|0|||
143091707|NCT04052620|515875953|FG000|Overall Study|Subject did not meet study Criteria|0|||
143091708|NCT04052620|515875954|FG001|Overall Study|Subject did not meet study Criteria|1|||
143091709|NCT04052620|515875953|FG000|Overall Study|Screened failure, randomized by mistake|0|||
143091710|NCT04052620|515875954|FG001|Overall Study|Screened failure, randomized by mistake|1|||
143091711|NCT04052620|515875953|FG000|Overall Study|Personal reasons|2|||
143091712|NCT04052620|515875954|FG001|Overall Study|Personal reasons|4|||
143091713|NCT04052620|515875953|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
143091714|NCT04052620|515875954|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
143091715|NCT02201784|515875955|FG000|Overall Study|Failure to achieve adequate block|2|||
143091716|NCT02201784|515875956|FG001|Overall Study|Failure to achieve adequate block|0|||
143091717|NCT00258960|515875957|FG000|Overall Study|Death|2|||
143091718|NCT00258960|515875957|FG000|Overall Study|Disease Progression|7|||
143250906|NCT01403948|516472939|FG005|Overall Study|other than above|1|||
143250907|NCT01403948|516472940|FG006|Overall Study|other than above|2|||
143250908|NCT01403948|516472941|FG007|Overall Study|other than above|0|||
143250909|NCT01403948|516472942|FG008|Overall Study|other than above|0|||
143250910|NCT01403948|516472943|FG009|Overall Study|other than above|0|||
143250911|NCT04450381|516472944|FG000|Overall Study|Protocol Violation|4|||
143091719|NCT00258960|515875957|FG000|Overall Study|Adverse Event|4|||
143091720|NCT00258960|515875957|FG000|Overall Study|Physician Decision|1|||
143091721|NCT00258960|515875957|FG000|Overall Study|Withdrawal by Subject|1|||
143091722|NCT00258960|515875957|FG000|Overall Study|Mistake|2|||
143091723|NCT00550459|515875958|FG000|Overall Study|Adverse Event|0|||
143091724|NCT00550459|515875959|FG001|Overall Study|Adverse Event|2|||
143091725|NCT00550459|515875958|FG000|Overall Study|Withdrawal by Subject|1|||
143091726|NCT00550459|515875959|FG001|Overall Study|Withdrawal by Subject|1|||
143091727|NCT00584454|515875960|FG000|Overall Study|Adverse Event|1|||
143091728|NCT00584454|515875960|FG000|Overall Study|Relocation|1|||
143250912|NCT04450381|516472944|FG000|Overall Study|Wrong device setting|2|||
143250913|NCT01090323|516472945|FG000|Overall Study|Adverse Event|12|||
143250914|NCT01090323|516472946|FG001|Overall Study|Adverse Event|2|||
143250915|NCT01090323|516472945|FG000|Overall Study|Abnormal Lab Values|3|||
143250916|NCT01090323|516472946|FG001|Overall Study|Abnormal Lab Values|1|||
143091729|NCT00584454|515875960|FG000|Overall Study|Clinical Hold|2|||
143091730|NCT01742897|515875961|FG000|Overall Study|Adverse Event|3|||
143091731|NCT01742897|515875961|FG000|Overall Study|Withdrawal by Subject|1|||
143091732|NCT01742897|515875961|FG000|Overall Study|Other|1|||
143091733|NCT00725920|515875964|FG000|Overall Study|Lack of Efficacy|3|||
143091734|NCT00725920|515875965|FG001|Overall Study|Lack of Efficacy|6|||
143091735|NCT03918629|515875966|FG000|Overall Study|Adverse Event|19|||
143091736|NCT03918629|515875967|FG001|Overall Study|Adverse Event|20|||
143091737|NCT03918629|515875966|FG000|Overall Study|Death|14|||
143091738|NCT03918629|515875967|FG001|Overall Study|Death|7|||
143091739|NCT03918629|515875966|FG000|Overall Study|Lost to Follow-up|36|||
143091740|NCT03918629|515875967|FG001|Overall Study|Lost to Follow-up|28|||
143091741|NCT03918629|515875966|FG000|Overall Study|Physician Decision|1|||
143091742|NCT03918629|515875967|FG001|Overall Study|Physician Decision|0|||
143091743|NCT03918629|515875966|FG000|Overall Study|Protocol Violation|7|||
143091744|NCT03918629|515875967|FG001|Overall Study|Protocol Violation|4|||
143091745|NCT03918629|515875966|FG000|Overall Study|Withdrawal by Subject|47|||
143091746|NCT03918629|515875967|FG001|Overall Study|Withdrawal by Subject|47|||
143091747|NCT03918629|515875966|FG000|Overall Study|Other|7|||
143091748|NCT03918629|515875967|FG001|Overall Study|Other|11|||
143091749|NCT03918629|515875966|FG000|Overall Study|Randomized but not vaccinated|2|||
143091750|NCT03918629|515875967|FG001|Overall Study|Randomized but not vaccinated|1|||
143091751|NCT00752128|515875968|FG000|Overall Study|Withdrawal by Subject|4|||
143091752|NCT02286713|515875974|FG000|One Week Follow-Up|Death|1|||
143091753|NCT02286713|515875975|FG001|One Week Follow-Up|Death|0|||
143091754|NCT02286713|515875974|FG000|One Week Follow-Up|Lost to Follow-up|17|||
143091755|NCT02286713|515875975|FG001|One Week Follow-Up|Lost to Follow-up|21|||
143091756|NCT02286713|515875974|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
143091757|NCT02286713|515875975|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
143091758|NCT02286713|515875974|FG000|Three Month Follow-Up|Death|1|||
143091759|NCT02286713|515875975|FG001|Three Month Follow-Up|Death|1|||
143091760|NCT02286713|515875974|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
143091761|NCT02286713|515875975|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
143250917|NCT01090323|516472945|FG000|Overall Study|Abnormal Test Procedure Results|2|||
143250918|NCT01090323|516472946|FG001|Overall Study|Abnormal Test Procedure Results|0|||
143250919|NCT01090323|516472945|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
143250920|NCT01090323|516472946|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
143250921|NCT01090323|516472945|FG000|Overall Study|Condition no longer requires drug|5|||
143250922|NCT01090323|516472946|FG001|Overall Study|Condition no longer requires drug|4|||
143250923|NCT01090323|516472945|FG000|Overall Study|Protocol Violation|2|||
143250924|NCT01090323|516472946|FG001|Overall Study|Protocol Violation|1|||
143250925|NCT01090323|516472945|FG000|Overall Study|Withdrew consent|33|||
143250926|NCT01090323|516472946|FG001|Overall Study|Withdrew consent|11|||
143250927|NCT01090323|516472945|FG000|Overall Study|Lost to Follow-up|11|||
143250928|NCT01090323|516472946|FG001|Overall Study|Lost to Follow-up|6|||
143250929|NCT01090323|516472945|FG000|Overall Study|Administrative problems|6|||
143250930|NCT01090323|516472946|FG001|Overall Study|Administrative problems|4|||
143250931|NCT01090323|516472945|FG000|Overall Study|Death|1|||
143250932|NCT01090323|516472946|FG001|Overall Study|Death|2|||
143091762|NCT02286713|515875974|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
143250933|NCT01090323|516472945|FG000|Overall Study|Stopped end of core|7|||
143250934|NCT01090323|516472946|FG001|Overall Study|Stopped end of core|0|||
143250935|NCT01090323|516472945|FG000|Overall Study|Stopped end of extension 1#|3|||
143250936|NCT01090323|516472946|FG001|Overall Study|Stopped end of extension 1#|1|||
143250937|NCT05498701|516472947|FG000|Period 3|Adverse Event|1|||
143250938|NCT05498701|516472948|FG001|Period 3|Adverse Event|0|||
143250939|NCT01864005|516472949|FG000|Overall Study|Protocol Violation|0|||
143250940|NCT01864005|516472950|FG001|Overall Study|Protocol Violation|1|||
143250941|NCT01864005|516472949|FG000|Overall Study|Withdrawal by Subject|0|||
143250942|NCT01864005|516472950|FG001|Overall Study|Withdrawal by Subject|1|||
143091763|NCT02286713|515875975|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
143091764|NCT02286713|515875974|FG000|Six Month Follow-Up|Death|2|||
143250943|NCT01864005|516472949|FG000|Overall Study|Incorrect enrolment|1|||
143250944|NCT01864005|516472950|FG001|Overall Study|Incorrect enrolment|0|||
143250945|NCT01864005|516472949|FG000|Overall Study|Disease need|1|||
143091765|NCT02286713|515875975|FG001|Six Month Follow-Up|Death|0|||
143091766|NCT02286713|515875974|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
143091767|NCT02286713|515875975|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
143091768|NCT04314037|515875977|FG000|Treatment Period 2|Adverse Event|1|||
143250946|NCT01864005|516472950|FG001|Overall Study|Disease need|1|||
143250947|NCT01864005|516472949|FG000|Overall Study|Need GP IIb/IIIa|1|||
143091769|NCT04314037|515875978|FG001|Treatment Period 2|Adverse Event|0|||
143091770|NCT04314037|515875977|FG000|Treatment Period 3|Protocol Violation|1|||
143250948|NCT01864005|516472950|FG001|Overall Study|Need GP IIb/IIIa|3|||
143250949|NCT00763698|516472956|FG000|Overall Study|Unsuccessful Implant|5|||
143250950|NCT00763698|516472956|FG000|Overall Study|Death|4|||
143091771|NCT04314037|515875978|FG001|Treatment Period 3|Protocol Violation|0|||
143091772|NCT04314037|515875977|FG000|Treatment Period 3|Adverse Event|0|||
143091773|NCT04314037|515875978|FG001|Treatment Period 3|Adverse Event|1|||
143091774|NCT00273182|515875979|FG000|Overall Study|Death|450|||
143091775|NCT00273182|515875979|FG000|Overall Study|Lost to Follow-up|88|||
143091776|NCT00273182|515875979|FG000|Overall Study|Withdrawal by Subject|257|||
143250951|NCT00763698|516472956|FG000|Overall Study|Withdrawal by Subject|1|||
143250952|NCT02184572|516472957|FG000|Overall Study|Lost to Follow-up|29|||
143250953|NCT02184572|516472958|FG001|Overall Study|Lost to Follow-up|21|||
143091777|NCT00273182|515875979|FG000|Overall Study|Device/System Explant|154|||
143091778|NCT00273182|515875979|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
143091779|NCT00856492|515875982|FG000|Overall Study|Ineligible or withdrew consent|1|||
143091780|NCT00856492|515875983|FG001|Overall Study|Ineligible or withdrew consent|1|||
143091781|NCT00856492|515875984|FG002|Overall Study|Ineligible or withdrew consent|2|||
143091782|NCT03832686|515875985|FG000|Overall Study|Lost to Follow-up|6|||
143091783|NCT03832686|515875986|FG001|Overall Study|Lost to Follow-up|9|||
143091784|NCT03832686|515875985|FG000|Overall Study|Discontinued Intervention|5|||
143091785|NCT03832686|515875986|FG001|Overall Study|Discontinued Intervention|4|||
143091786|NCT02235454|515875989|FG000|Overall Study|Withdrawal by Subject|2|||
143091787|NCT03323398|515875990|FG000|Overall Study|Other than Specified|0|||
143091788|NCT03323398|515875991|FG001|Overall Study|Other than Specified|1|||
143091789|NCT03323398|515875992|FG002|Overall Study|Other than Specified|2|||
143091790|NCT03323398|515875993|FG003|Overall Study|Other than Specified|0|||
143091791|NCT03323398|515875994|FG004|Overall Study|Other than Specified|0|||
143091792|NCT03323398|515875995|FG005|Overall Study|Other than Specified|0|||
143091793|NCT03323398|515875996|FG006|Overall Study|Other than Specified|1|||
143091794|NCT03323398|515875997|FG007|Overall Study|Other than Specified|0|||
143091795|NCT03323398|515875998|FG008|Overall Study|Other than Specified|2|||
143091796|NCT03323398|515875990|FG000|Overall Study|Lost to Follow-up|1|||
143091797|NCT03323398|515875991|FG001|Overall Study|Lost to Follow-up|2|||
143091798|NCT03323398|515875992|FG002|Overall Study|Lost to Follow-up|1|||
143091799|NCT03323398|515875993|FG003|Overall Study|Lost to Follow-up|0|||
143091800|NCT03323398|515875994|FG004|Overall Study|Lost to Follow-up|0|||
143091801|NCT03323398|515875995|FG005|Overall Study|Lost to Follow-up|0|||
143091802|NCT03323398|515875996|FG006|Overall Study|Lost to Follow-up|0|||
143091803|NCT03323398|515875997|FG007|Overall Study|Lost to Follow-up|0|||
143091804|NCT03323398|515875998|FG008|Overall Study|Lost to Follow-up|0|||
143091805|NCT03323398|515875990|FG000|Overall Study|Death|4|||
143091806|NCT03323398|515875991|FG001|Overall Study|Death|6|||
143091807|NCT03323398|515875992|FG002|Overall Study|Death|2|||
143091808|NCT03323398|515875993|FG003|Overall Study|Death|2|||
143091809|NCT03323398|515875994|FG004|Overall Study|Death|1|||
143091810|NCT03323398|515875995|FG005|Overall Study|Death|2|||
143091811|NCT03323398|515875996|FG006|Overall Study|Death|0|||
143091812|NCT03323398|515875997|FG007|Overall Study|Death|0|||
143091813|NCT03323398|515875998|FG008|Overall Study|Death|6|||
143091814|NCT03323398|515875990|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
143091815|NCT03323398|515875991|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
143091816|NCT03323398|515875992|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
143091817|NCT03323398|515875993|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
143091818|NCT03323398|515875994|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
143091819|NCT03323398|515875995|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
143091820|NCT03323398|515875996|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
143091821|NCT03323398|515875997|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
143091822|NCT03323398|515875998|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
143091823|NCT03323398|515875990|FG000|Overall Study|Withdrawal by Subject|2|||
143091824|NCT03323398|515875991|FG001|Overall Study|Withdrawal by Subject|1|||
143091825|NCT03323398|515875992|FG002|Overall Study|Withdrawal by Subject|3|||
143091826|NCT03323398|515875993|FG003|Overall Study|Withdrawal by Subject|0|||
143091827|NCT03323398|515875994|FG004|Overall Study|Withdrawal by Subject|0|||
143091828|NCT03323398|515875995|FG005|Overall Study|Withdrawal by Subject|1|||
143091829|NCT03323398|515875996|FG006|Overall Study|Withdrawal by Subject|0|||
143091830|NCT03323398|515875997|FG007|Overall Study|Withdrawal by Subject|0|||
143091831|NCT03323398|515875998|FG008|Overall Study|Withdrawal by Subject|0|||
143091832|NCT03323398|515875990|FG000|Overall Study|Participant was Put on Hospice|0|||
143250954|NCT02184572|516472957|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
143091833|NCT03323398|515875991|FG001|Overall Study|Participant was Put on Hospice|0|||
143091834|NCT03323398|515875992|FG002|Overall Study|Participant was Put on Hospice|0|||
143091835|NCT03323398|515875993|FG003|Overall Study|Participant was Put on Hospice|0|||
143091836|NCT03323398|515875994|FG004|Overall Study|Participant was Put on Hospice|0|||
143091837|NCT03323398|515875995|FG005|Overall Study|Participant was Put on Hospice|0|||
143250955|NCT02184572|516472958|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
143250956|NCT02184572|516472957|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
143091838|NCT03323398|515875996|FG006|Overall Study|Participant was Put on Hospice|1|||
143091839|NCT03323398|515875997|FG007|Overall Study|Participant was Put on Hospice|0|||
143091840|NCT03323398|515875998|FG008|Overall Study|Participant was Put on Hospice|0|||
143091841|NCT03323398|515875990|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
143091842|NCT03323398|515875991|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
143091843|NCT03323398|515875992|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
143091844|NCT03323398|515875993|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
143091845|NCT03323398|515875994|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
143091846|NCT03323398|515875995|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
143091847|NCT03323398|515875996|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
143176582|NCT00457392|516196163|FG000|Overall Study|Randomized, Not Treated|7|||
143176583|NCT00457392|516196164|FG001|Overall Study|Randomized, Not Treated|3|||
143176584|NCT00980148|516196165|FG000|Overall Study|Discharged from facility|89|||
143176585|NCT00980148|516196166|FG001|Overall Study|Discharged from facility|96|||
143176586|NCT00980148|516196165|FG000|Overall Study|Received other antichlamydia treatment|20|||
143176587|NCT00980148|516196166|FG001|Overall Study|Received other antichlamydia treatment|14|||
143176588|NCT00980148|516196165|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
143176589|NCT00980148|516196166|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
143176590|NCT00980148|516196165|FG000|Overall Study|Various other reasons|8|||
143176591|NCT00980148|516196166|FG001|Overall Study|Various other reasons|9|||
143176592|NCT01462929|516196173|FG000|Overall Study|Adverse Event|3|||
143176593|NCT01462929|516196174|FG001|Overall Study|Adverse Event|3|||
143176594|NCT01462929|516196175|FG002|Overall Study|Adverse Event|4|||
143176595|NCT01462929|516196173|FG000|Overall Study|Withdrawal by Subject|2|||
143176596|NCT01462929|516196174|FG001|Overall Study|Withdrawal by Subject|1|||
143176597|NCT01462929|516196175|FG002|Overall Study|Withdrawal by Subject|0|||
143176598|NCT01462929|516196173|FG000|Overall Study|Lack of Efficacy|0|||
143176599|NCT01462929|516196174|FG001|Overall Study|Lack of Efficacy|0|||
143176600|NCT01462929|516196175|FG002|Overall Study|Lack of Efficacy|1|||
143176601|NCT01815424|516196178|FG000|Week 0 to 16|Adverse Event|1|||
143176602|NCT01815424|516196179|FG001|Week 0 to 16|Adverse Event|3|||
143176603|NCT01815424|516196180|FG002|Week 0 to 16|Adverse Event|3|||
143176604|NCT01815424|516196181|FG003|Week 0 to 16|Adverse Event|0|||
143176605|NCT01815424|516196182|FG004|Week 0 to 16|Adverse Event|0|||
143176606|NCT01815424|516196178|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
143176607|NCT01815424|516196179|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
143176608|NCT01815424|516196180|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
143176609|NCT01815424|516196181|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
143176610|NCT01815424|516196182|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
143176611|NCT01815424|516196178|FG000|Week 0 to 16|Lost to Follow-up|0|||
143176612|NCT01815424|516196179|FG001|Week 0 to 16|Lost to Follow-up|1|||
143176613|NCT01815424|516196180|FG002|Week 0 to 16|Lost to Follow-up|0|||
143176614|NCT01815424|516196181|FG003|Week 0 to 16|Lost to Follow-up|0|||
143176615|NCT01815424|516196182|FG004|Week 0 to 16|Lost to Follow-up|0|||
143176616|NCT01815424|516196178|FG000|Week 0 to 16|Withdrawal by Subject|0|||
143176617|NCT01815424|516196179|FG001|Week 0 to 16|Withdrawal by Subject|0|||
143176618|NCT01815424|516196180|FG002|Week 0 to 16|Withdrawal by Subject|1|||
143176619|NCT01815424|516196181|FG003|Week 0 to 16|Withdrawal by Subject|0|||
143176620|NCT01815424|516196182|FG004|Week 0 to 16|Withdrawal by Subject|0|||
143176621|NCT01815424|516196178|FG000|Week 0 to 16|Other|1|||
143176622|NCT01815424|516196179|FG001|Week 0 to 16|Other|0|||
143176623|NCT01815424|516196180|FG002|Week 0 to 16|Other|3|||
143176624|NCT01815424|516196181|FG003|Week 0 to 16|Other|0|||
143176625|NCT01815424|516196182|FG004|Week 0 to 16|Other|0|||
143176626|NCT01815424|516196178|FG000|Week 0 to 16|Protocol Violation|1|||
143176627|NCT01815424|516196179|FG001|Week 0 to 16|Protocol Violation|0|||
143091848|NCT03323398|515875997|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
143091849|NCT03323398|515875998|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
143091850|NCT03641469|515875999|FG000|Overall Study|Ineligible|2|||
143176628|NCT01815424|516196180|FG002|Week 0 to 16|Protocol Violation|0|||
143176629|NCT01815424|516196181|FG003|Week 0 to 16|Protocol Violation|0|||
143091851|NCT03641469|515875999|FG000|Overall Study|Withdrawal by Subject|5|||
143091852|NCT03641469|515875999|FG000|Overall Study|Physician Decision|1|||
143091853|NCT03641469|515875999|FG000|Overall Study|Protocol Violation|1|||
143091854|NCT03641469|515875999|FG000|Overall Study|Lost to Follow-up|2|||
143091855|NCT04199104|515878231|FG000|Overall Study|Death|148|||
143091856|NCT04199104|515878232|FG001|Overall Study|Death|134|||
143091857|NCT04199104|515878231|FG000|Overall Study|Lost to Follow-up|1|||
143091858|NCT04199104|515878232|FG001|Overall Study|Lost to Follow-up|1|||
143091859|NCT04199104|515878231|FG000|Overall Study|Withdrawal by Subject|4|||
143091860|NCT04199104|515878232|FG001|Overall Study|Withdrawal by Subject|4|||
143091861|NCT04199104|515878231|FG000|Overall Study|Participants Ongoing|103|||
143091862|NCT04199104|515878232|FG001|Overall Study|Participants Ongoing|116|||
143091863|NCT00070564|515878236|FG000|Overall Study|Progression|2|||
143091864|NCT00070564|515878237|FG001|Overall Study|Progression|4|||
143091865|NCT00070564|515878238|FG002|Overall Study|Progression|7|||
143091866|NCT00070564|515878239|FG003|Overall Study|Progression|7|||
143091867|NCT00070564|515878240|FG004|Overall Study|Progression|1|||
143091868|NCT00070564|515878241|FG005|Overall Study|Progression|0|||
143091869|NCT00070564|515878236|FG000|Overall Study|Delinquent|1|||
143091870|NCT00070564|515878237|FG001|Overall Study|Delinquent|4|||
143091871|NCT00070564|515878238|FG002|Overall Study|Delinquent|2|||
143091872|NCT00070564|515878239|FG003|Overall Study|Delinquent|0|||
143091873|NCT00070564|515878240|FG004|Overall Study|Delinquent|0|||
143091874|NCT00070564|515878241|FG005|Overall Study|Delinquent|0|||
143091875|NCT00070564|515878236|FG000|Overall Study|Adverse Event|150|||
143091876|NCT00070564|515878237|FG001|Overall Study|Adverse Event|142|||
143091877|NCT00070564|515878238|FG002|Overall Study|Adverse Event|120|||
143091878|NCT00070564|515878239|FG003|Overall Study|Adverse Event|108|||
143091879|NCT00070564|515878240|FG004|Overall Study|Adverse Event|63|||
143091880|NCT00070564|515878241|FG005|Overall Study|Adverse Event|36|||
143091881|NCT00070564|515878236|FG000|Overall Study|Death|4|||
143091882|NCT00070564|515878237|FG001|Overall Study|Death|1|||
143091883|NCT00070564|515878238|FG002|Overall Study|Death|5|||
143091884|NCT00070564|515878239|FG003|Overall Study|Death|3|||
143091885|NCT00070564|515878240|FG004|Overall Study|Death|0|||
143091886|NCT00070564|515878241|FG005|Overall Study|Death|1|||
143091887|NCT00070564|515878236|FG000|Overall Study|Other, not protocol specified|17|||
143091888|NCT00070564|515878237|FG001|Overall Study|Other, not protocol specified|15|||
143091889|NCT00070564|515878238|FG002|Overall Study|Other, not protocol specified|14|||
143091890|NCT00070564|515878239|FG003|Overall Study|Other, not protocol specified|19|||
143091891|NCT00070564|515878240|FG004|Overall Study|Other, not protocol specified|6|||
143091892|NCT00070564|515878241|FG005|Overall Study|Other, not protocol specified|7|||
143091893|NCT00070564|515878236|FG000|Overall Study|Withdrawal by Subject|26|||
143091894|NCT00070564|515878237|FG001|Overall Study|Withdrawal by Subject|37|||
143091895|NCT00070564|515878238|FG002|Overall Study|Withdrawal by Subject|23|||
143091896|NCT00070564|515878239|FG003|Overall Study|Withdrawal by Subject|30|||
143091897|NCT00070564|515878240|FG004|Overall Study|Withdrawal by Subject|8|||
143091898|NCT00070564|515878241|FG005|Overall Study|Withdrawal by Subject|8|||
143091899|NCT00070564|515878236|FG000|Overall Study|Not reported|0|||
143091900|NCT00070564|515878237|FG001|Overall Study|Not reported|0|||
143091901|NCT00070564|515878238|FG002|Overall Study|Not reported|0|||
143091902|NCT00070564|515878239|FG003|Overall Study|Not reported|0|||
143091903|NCT00070564|515878240|FG004|Overall Study|Not reported|1|||
143091904|NCT00070564|515878241|FG005|Overall Study|Not reported|0|||
143091905|NCT04796961|515878242|FG000|Overall Study|Lost to Follow-up|10|||
143091906|NCT04796961|515878242|FG000|Overall Study|Withdrawal by Subject|3|||
143091907|NCT04796961|515878242|FG000|Overall Study|Left Organization|10|||
143091908|NCT02325973|515878245|FG000|Overall Study|Death|5|||
143091909|NCT02325973|515878245|FG000|Overall Study|Withdrawal by subject or investigator|16|||
143091910|NCT03428958|515878250|FG000|Overall Study|Adverse Event|0|||
143091911|NCT03428958|515878251|FG001|Overall Study|Adverse Event|0|||
143091912|NCT03428958|515878252|FG002|Overall Study|Adverse Event|0|||
143091913|NCT03428958|515878253|FG003|Overall Study|Adverse Event|1|||
143091914|NCT03428958|515878254|FG004|Overall Study|Adverse Event|0|||
143091915|NCT03428958|515878255|FG005|Overall Study|Adverse Event|2|||
143091916|NCT03428958|515878256|FG006|Overall Study|Adverse Event|1|||
143091917|NCT03428958|515878257|FG007|Overall Study|Adverse Event|0|||
143091918|NCT03428958|515878258|FG008|Overall Study|Adverse Event|0|||
143091919|NCT03428958|515878259|FG009|Overall Study|Adverse Event|0|||
143091920|NCT03428958|515878260|FG010|Overall Study|Adverse Event|0|||
143091921|NCT03428958|515878261|FG011|Overall Study|Adverse Event|0|||
143091922|NCT03428958|515878262|FG012|Overall Study|Adverse Event|0|||
143091923|NCT03428958|515878263|FG013|Overall Study|Adverse Event|0|||
143091924|NCT03428958|515878264|FG014|Overall Study|Adverse Event|0|||
143091925|NCT03428958|515878265|FG015|Overall Study|Adverse Event|0|||
143091926|NCT03428958|515878266|FG016|Overall Study|Adverse Event|0|||
143091927|NCT03428958|515878250|FG000|Overall Study|Clinical Progression|2|||
143091928|NCT03428958|515878251|FG001|Overall Study|Clinical Progression|3|||
143091929|NCT03428958|515878252|FG002|Overall Study|Clinical Progression|2|||
143091930|NCT03428958|515878253|FG003|Overall Study|Clinical Progression|1|||
143091931|NCT03428958|515878254|FG004|Overall Study|Clinical Progression|0|||
143091932|NCT03428958|515878255|FG005|Overall Study|Clinical Progression|2|||
143091933|NCT03428958|515878256|FG006|Overall Study|Clinical Progression|0|||
143091934|NCT03428958|515878257|FG007|Overall Study|Clinical Progression|0|||
143091935|NCT03428958|515878258|FG008|Overall Study|Clinical Progression|0|||
143091936|NCT03428958|515878259|FG009|Overall Study|Clinical Progression|0|||
143091937|NCT03428958|515878260|FG010|Overall Study|Clinical Progression|0|||
143091938|NCT03428958|515878261|FG011|Overall Study|Clinical Progression|0|||
143091939|NCT03428958|515878262|FG012|Overall Study|Clinical Progression|0|||
143091940|NCT03428958|515878263|FG013|Overall Study|Clinical Progression|0|||
143091941|NCT03428958|515878264|FG014|Overall Study|Clinical Progression|0|||
143091942|NCT03428958|515878265|FG015|Overall Study|Clinical Progression|0|||
143091943|NCT03428958|515878266|FG016|Overall Study|Clinical Progression|0|||
143250957|NCT02184572|516472958|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
143250958|NCT02184572|516472957|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
143250959|NCT02184572|516472958|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
143250960|NCT02184572|516472957|FG000|Overall Study|Traveling Outside The Country|1|||
143250961|NCT02184572|516472958|FG001|Overall Study|Traveling Outside The Country|0|||
143250962|NCT02184572|516472957|FG000|Overall Study|Withdrawal by Subject|14|||
143091944|NCT03428958|515878250|FG000|Overall Study|Progression per RECIST|6|||
143091945|NCT03428958|515878251|FG001|Overall Study|Progression per RECIST|6|||
143091946|NCT03428958|515878252|FG002|Overall Study|Progression per RECIST|7|||
143250963|NCT02184572|516472958|FG001|Overall Study|Withdrawal by Subject|9|||
143091947|NCT03428958|515878253|FG003|Overall Study|Progression per RECIST|4|||
143091948|NCT03428958|515878254|FG004|Overall Study|Progression per RECIST|0|||
143250964|NCT00638183|516472962|FG000|Overall Study|Adverse Event|23|||
143250965|NCT00638183|516472962|FG000|Overall Study|Lack of Efficacy|14|||
143250966|NCT00638183|516472962|FG000|Overall Study|Physician Decision|9|||
143176630|NCT01815424|516196182|FG004|Week 0 to 16|Protocol Violation|0|||
143176631|NCT01815424|516196178|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
143176632|NCT01815424|516196179|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
143176633|NCT01815424|516196180|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
143176634|NCT01815424|516196181|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
143176635|NCT01815424|516196182|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
143176636|NCT01815424|516196178|FG000|Week 16 to 52|Other|0|||
143176637|NCT01815424|516196179|FG001|Week 16 to 52|Other|1|||
143176638|NCT01815424|516196180|FG002|Week 16 to 52|Other|0|||
143176639|NCT01815424|516196181|FG003|Week 16 to 52|Other|0|||
143176640|NCT01815424|516196182|FG004|Week 16 to 52|Other|0|||
143176641|NCT01815424|516196178|FG000|Week 16 to 52|Adverse Event|0|||
143250967|NCT00638183|516472962|FG000|Overall Study|Lost to Follow-up|46|||
143250968|NCT00638183|516472962|FG000|Overall Study|Other reason not defined above|27|||
143250969|NCT00006409|516472963|FG000|Baseline|Protocol Violation|48|||
143250970|NCT00006409|516472964|FG001|Baseline|Protocol Violation|70|||
143250971|NCT00006409|516472965|FG002|Baseline|Protocol Violation|0|||
143250972|NCT00006409|516472966|FG003|Baseline|Protocol Violation|0|||
143250973|NCT00006409|516472967|FG004|Baseline|Protocol Violation|0|||
143250974|NCT00006409|516472968|FG005|Baseline|Protocol Violation|0|||
143250975|NCT00006409|516472963|FG000|Post-2 Year Intervention|Protocol Violation|0|||
143250976|NCT00006409|516472964|FG001|Post-2 Year Intervention|Protocol Violation|0|||
143250977|NCT00006409|516472965|FG002|Post-2 Year Intervention|Protocol Violation|251|||
143250978|NCT00006409|516472966|FG003|Post-2 Year Intervention|Protocol Violation|168|||
143250979|NCT00006409|516472967|FG004|Post-2 Year Intervention|Protocol Violation|0|||
143250980|NCT00006409|516472968|FG005|Post-2 Year Intervention|Protocol Violation|0|||
143250981|NCT00006409|516472963|FG000|Post-3 Year Intervention|Protocol Violation|0|||
143250982|NCT00006409|516472964|FG001|Post-3 Year Intervention|Protocol Violation|0|||
143250983|NCT00006409|516472965|FG002|Post-3 Year Intervention|Protocol Violation|0|||
143250984|NCT00006409|516472966|FG003|Post-3 Year Intervention|Protocol Violation|0|||
143176642|NCT01815424|516196179|FG001|Week 16 to 52|Adverse Event|0|||
143250985|NCT00006409|516472967|FG004|Post-3 Year Intervention|Protocol Violation|62|||
143250986|NCT00006409|516472968|FG005|Post-3 Year Intervention|Protocol Violation|62|||
143250987|NCT02059291|516472969|FG000|Epoch 2|Lack of Efficacy|0|||
143091949|NCT03428958|515878255|FG005|Overall Study|Progression per RECIST|7|||
143091950|NCT03428958|515878256|FG006|Overall Study|Progression per RECIST|8|||
143091951|NCT03428958|515878257|FG007|Overall Study|Progression per RECIST|0|||
143091952|NCT03428958|515878258|FG008|Overall Study|Progression per RECIST|0|||
143091953|NCT03428958|515878259|FG009|Overall Study|Progression per RECIST|0|||
143091954|NCT03428958|515878260|FG010|Overall Study|Progression per RECIST|0|||
143091955|NCT03428958|515878261|FG011|Overall Study|Progression per RECIST|0|||
143091956|NCT03428958|515878262|FG012|Overall Study|Progression per RECIST|1|||
143091957|NCT03428958|515878263|FG013|Overall Study|Progression per RECIST|0|||
143091958|NCT03428958|515878264|FG014|Overall Study|Progression per RECIST|0|||
143091959|NCT03428958|515878265|FG015|Overall Study|Progression per RECIST|0|||
143091960|NCT03428958|515878266|FG016|Overall Study|Progression per RECIST|0|||
143091961|NCT03428958|515878250|FG000|Overall Study|Death|2|||
143091962|NCT03428958|515878251|FG001|Overall Study|Death|2|||
143091963|NCT03428958|515878252|FG002|Overall Study|Death|0|||
143091964|NCT03428958|515878253|FG003|Overall Study|Death|0|||
143091965|NCT03428958|515878254|FG004|Overall Study|Death|0|||
143091966|NCT03428958|515878255|FG005|Overall Study|Death|7|||
143091967|NCT03428958|515878256|FG006|Overall Study|Death|9|||
143091968|NCT03428958|515878257|FG007|Overall Study|Death|6|||
143091969|NCT03428958|515878258|FG008|Overall Study|Death|0|||
143091970|NCT03428958|515878259|FG009|Overall Study|Death|0|||
143091971|NCT03428958|515878260|FG010|Overall Study|Death|3|||
143091972|NCT03428958|515878261|FG011|Overall Study|Death|0|||
143091973|NCT03428958|515878262|FG012|Overall Study|Death|4|||
143091974|NCT03428958|515878263|FG013|Overall Study|Death|0|||
143091975|NCT03428958|515878264|FG014|Overall Study|Death|0|||
143091976|NCT03428958|515878265|FG015|Overall Study|Death|0|||
143091977|NCT03428958|515878266|FG016|Overall Study|Death|0|||
143091978|NCT03428958|515878250|FG000|Overall Study|Lost to Follow-up|0|||
143091979|NCT03428958|515878251|FG001|Overall Study|Lost to Follow-up|0|||
143091980|NCT03428958|515878252|FG002|Overall Study|Lost to Follow-up|0|||
143091981|NCT03428958|515878253|FG003|Overall Study|Lost to Follow-up|0|||
143091982|NCT03428958|515878254|FG004|Overall Study|Lost to Follow-up|0|||
143091983|NCT03428958|515878255|FG005|Overall Study|Lost to Follow-up|1|||
143091984|NCT03428958|515878256|FG006|Overall Study|Lost to Follow-up|1|||
143091985|NCT03428958|515878257|FG007|Overall Study|Lost to Follow-up|0|||
143091986|NCT03428958|515878258|FG008|Overall Study|Lost to Follow-up|0|||
143091987|NCT03428958|515878259|FG009|Overall Study|Lost to Follow-up|0|||
143091988|NCT03428958|515878260|FG010|Overall Study|Lost to Follow-up|0|||
143091989|NCT03428958|515878261|FG011|Overall Study|Lost to Follow-up|0|||
143091990|NCT03428958|515878262|FG012|Overall Study|Lost to Follow-up|0|||
143091991|NCT03428958|515878263|FG013|Overall Study|Lost to Follow-up|0|||
143091992|NCT03428958|515878264|FG014|Overall Study|Lost to Follow-up|0|||
143091993|NCT03428958|515878265|FG015|Overall Study|Lost to Follow-up|0|||
143091994|NCT03428958|515878266|FG016|Overall Study|Lost to Follow-up|0|||
143091995|NCT03428958|515878250|FG000|Overall Study|Physician/Sponsor Decision|1|||
143091996|NCT03428958|515878251|FG001|Overall Study|Physician/Sponsor Decision|0|||
143091997|NCT03428958|515878252|FG002|Overall Study|Physician/Sponsor Decision|1|||
143091998|NCT03428958|515878253|FG003|Overall Study|Physician/Sponsor Decision|0|||
143091999|NCT03428958|515878254|FG004|Overall Study|Physician/Sponsor Decision|0|||
143092000|NCT03428958|515878255|FG005|Overall Study|Physician/Sponsor Decision|2|||
143092001|NCT03428958|515878256|FG006|Overall Study|Physician/Sponsor Decision|2|||
143092002|NCT03428958|515878257|FG007|Overall Study|Physician/Sponsor Decision|2|||
143092003|NCT03428958|515878258|FG008|Overall Study|Physician/Sponsor Decision|0|||
143092004|NCT03428958|515878259|FG009|Overall Study|Physician/Sponsor Decision|0|||
143092005|NCT03428958|515878260|FG010|Overall Study|Physician/Sponsor Decision|2|||
143092006|NCT03428958|515878261|FG011|Overall Study|Physician/Sponsor Decision|0|||
143092007|NCT03428958|515878262|FG012|Overall Study|Physician/Sponsor Decision|4|||
143092008|NCT03428958|515878263|FG013|Overall Study|Physician/Sponsor Decision|0|||
143092009|NCT03428958|515878264|FG014|Overall Study|Physician/Sponsor Decision|0|||
143092010|NCT03428958|515878265|FG015|Overall Study|Physician/Sponsor Decision|0|||
143092011|NCT03428958|515878266|FG016|Overall Study|Physician/Sponsor Decision|0|||
143092012|NCT03428958|515878250|FG000|Overall Study|Withdrawal by Subject|0|||
143092013|NCT03428958|515878251|FG001|Overall Study|Withdrawal by Subject|0|||
143092014|NCT03428958|515878252|FG002|Overall Study|Withdrawal by Subject|2|||
143092015|NCT03428958|515878253|FG003|Overall Study|Withdrawal by Subject|0|||
143092016|NCT03428958|515878254|FG004|Overall Study|Withdrawal by Subject|0|||
143092017|NCT03428958|515878255|FG005|Overall Study|Withdrawal by Subject|2|||
143092018|NCT03428958|515878256|FG006|Overall Study|Withdrawal by Subject|4|||
143092019|NCT03428958|515878257|FG007|Overall Study|Withdrawal by Subject|1|||
143092020|NCT03428958|515878258|FG008|Overall Study|Withdrawal by Subject|0|||
143092021|NCT03428958|515878259|FG009|Overall Study|Withdrawal by Subject|0|||
143092022|NCT03428958|515878260|FG010|Overall Study|Withdrawal by Subject|0|||
143092023|NCT03428958|515878261|FG011|Overall Study|Withdrawal by Subject|0|||
143092024|NCT03428958|515878262|FG012|Overall Study|Withdrawal by Subject|0|||
143092025|NCT03428958|515878263|FG013|Overall Study|Withdrawal by Subject|0|||
143092026|NCT03428958|515878264|FG014|Overall Study|Withdrawal by Subject|0|||
143092027|NCT03428958|515878265|FG015|Overall Study|Withdrawal by Subject|0|||
143092028|NCT03428958|515878266|FG016|Overall Study|Withdrawal by Subject|0|||
143092029|NCT03874117|515878267|FG000|First Intervention (4 Weeks)|received kidney transplant|1|||
143092030|NCT03874117|515878268|FG001|First Intervention (4 Weeks)|received kidney transplant|0|||
143092031|NCT03874117|515878267|FG000|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
143092032|NCT03874117|515878268|FG001|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
143092033|NCT03874117|515878267|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
143092034|NCT03874117|515878268|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
143092035|NCT03874117|515878267|FG000|First Intervention (4 Weeks)|hospitalized for infection|0|||
143092036|NCT03874117|515878268|FG001|First Intervention (4 Weeks)|hospitalized for infection|1|||
143092037|NCT03874117|515878267|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
143092038|NCT03874117|515878268|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
143092039|NCT05012098|515878269|FG000|Overall Study|Disease progression|5|||
143092040|NCT05012098|515878270|FG001|Overall Study|Disease progression|2|||
143092041|NCT05012098|515878269|FG000|Overall Study|Adverse Event|1|||
143092042|NCT05012098|515878270|FG001|Overall Study|Adverse Event|0|||
143092043|NCT05012098|515878269|FG000|Overall Study|Withdrawal by Subject|1|||
143092044|NCT05012098|515878270|FG001|Overall Study|Withdrawal by Subject|0|||
143092045|NCT05012098|515878269|FG000|Overall Study|Discontinuation per protocol|1|||
143092046|NCT05012098|515878270|FG001|Overall Study|Discontinuation per protocol|0|||
143092047|NCT05258773|515878271|FG000|Overall Study|Screen Failure|1|||
143092048|NCT05258773|515878272|FG001|Overall Study|Screen Failure|1|||
143092049|NCT05258773|515878271|FG000|Overall Study|Adverse Event|1|||
143092050|NCT05258773|515878272|FG001|Overall Study|Adverse Event|0|||
143092051|NCT05258773|515878271|FG000|Overall Study|Withdrawal by Subject|0|||
143092052|NCT05258773|515878272|FG001|Overall Study|Withdrawal by Subject|1|||
143092053|NCT03018288|515878273|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
143092054|NCT03018288|515878274|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
143092055|NCT03018288|515878275|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
143092056|NCT03018288|515878276|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
143092057|NCT03018288|515878273|FG000|Overall Study|Participant withdrew consent.|0|||
143092058|NCT03018288|515878274|FG001|Overall Study|Participant withdrew consent.|0|||
143092059|NCT03018288|515878275|FG002|Overall Study|Participant withdrew consent.|1|||
143092060|NCT03018288|515878276|FG003|Overall Study|Participant withdrew consent.|0|||
143092061|NCT03018288|515878273|FG000|Overall Study|Switched to alternative treatment.|0|||
143092062|NCT03018288|515878274|FG001|Overall Study|Switched to alternative treatment.|0|||
143092063|NCT03018288|515878275|FG002|Overall Study|Switched to alternative treatment.|1|||
143092064|NCT03018288|515878276|FG003|Overall Study|Switched to alternative treatment.|0|||
143092065|NCT03018288|515878273|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
143092066|NCT03018288|515878274|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
143092067|NCT03018288|515878275|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
143092068|NCT03018288|515878276|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
143092069|NCT03018288|515878273|FG000|Overall Study|Screen failures|0|||
143092070|NCT03018288|515878274|FG001|Overall Study|Screen failures|0|||
143092071|NCT03018288|515878275|FG002|Overall Study|Screen failures|0|||
143092072|NCT03018288|515878276|FG003|Overall Study|Screen failures|51|||
143092073|NCT03018288|515878273|FG000|Overall Study|Chose treatment outside of UNC|0|||
143092074|NCT03018288|515878274|FG001|Overall Study|Chose treatment outside of UNC|0|||
143092075|NCT03018288|515878275|FG002|Overall Study|Chose treatment outside of UNC|0|||
143092076|NCT03018288|515878276|FG003|Overall Study|Chose treatment outside of UNC|1|||
143092077|NCT03018288|515878273|FG000|Overall Study|Unable to comply with protocol requirements|1|||
143092078|NCT03018288|515878274|FG001|Overall Study|Unable to comply with protocol requirements|1|||
143092079|NCT03018288|515878275|FG002|Overall Study|Unable to comply with protocol requirements|0|||
143092080|NCT03018288|515878276|FG003|Overall Study|Unable to comply with protocol requirements|1|||
143092081|NCT03018288|515878273|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
143367200|NCT01018511|516887277|FG001|Overall Study|Adverse Event|9|||
143092082|NCT03018288|515878274|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
143092083|NCT03018288|515878275|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
143092084|NCT03018288|515878276|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
143092085|NCT03018288|515878273|FG000|Overall Study|Physician Decision|0|||
143092086|NCT03018288|515878274|FG001|Overall Study|Physician Decision|0|||
143092087|NCT03018288|515878275|FG002|Overall Study|Physician Decision|0|||
143092088|NCT03018288|515878276|FG003|Overall Study|Physician Decision|1|||
143092089|NCT01490086|515878280|FG000|Overall Study|Consent withdrawn|4|||
143092090|NCT01490086|515878281|FG001|Overall Study|Consent withdrawn|4|||
143092091|NCT01490086|515878282|FG002|Overall Study|Consent withdrawn|3|||
143367201|NCT01018511|516887278|FG002|Overall Study|Adverse Event|13|||
143092092|NCT01490086|515878283|FG003|Overall Study|Consent withdrawn|0|||
143092093|NCT01490086|515878284|FG004|Overall Study|Consent withdrawn|1|||
143092094|NCT01490086|515878280|FG000|Overall Study|Non-compliance|0|||
143092095|NCT01490086|515878281|FG001|Overall Study|Non-compliance|1|||
143092096|NCT01490086|515878282|FG002|Overall Study|Non-compliance|0|||
143367202|NCT01018511|516887279|FG003|Overall Study|Adverse Event|10|||
143367203|NCT01018511|516887276|FG000|Overall Study|Lack of Efficacy|4|||
143367204|NCT01018511|516887277|FG001|Overall Study|Lack of Efficacy|1|||
143367205|NCT01018511|516887278|FG002|Overall Study|Lack of Efficacy|1|||
143367206|NCT01018511|516887279|FG003|Overall Study|Lack of Efficacy|2|||
143367207|NCT01018511|516887276|FG000|Overall Study|Withdrawal by Subject|6|||
143367208|NCT01018511|516887277|FG001|Overall Study|Withdrawal by Subject|5|||
143367209|NCT01018511|516887278|FG002|Overall Study|Withdrawal by Subject|11|||
143367210|NCT01018511|516887279|FG003|Overall Study|Withdrawal by Subject|9|||
143367211|NCT01018511|516887276|FG000|Overall Study|Lost to Follow-up|0|||
143367212|NCT01018511|516887277|FG001|Overall Study|Lost to Follow-up|0|||
143367213|NCT01018511|516887278|FG002|Overall Study|Lost to Follow-up|1|||
143367214|NCT01018511|516887279|FG003|Overall Study|Lost to Follow-up|0|||
143367215|NCT01018511|516887276|FG000|Overall Study|Protocol Violation|5|||
143367216|NCT01018511|516887277|FG001|Overall Study|Protocol Violation|8|||
143367217|NCT01018511|516887278|FG002|Overall Study|Protocol Violation|7|||
143367218|NCT01018511|516887279|FG003|Overall Study|Protocol Violation|9|||
143092097|NCT01490086|515878283|FG003|Overall Study|Non-compliance|0|||
143092098|NCT01490086|515878284|FG004|Overall Study|Non-compliance|0|||
143367219|NCT01018511|516887276|FG000|Overall Study|Miscellaneous|0|||
143367220|NCT01018511|516887277|FG001|Overall Study|Miscellaneous|2|||
143092099|NCT01490086|515878280|FG000|Overall Study|Abnormal laboratory findings|1|||
143092100|NCT01490086|515878281|FG001|Overall Study|Abnormal laboratory findings|0|||
143367221|NCT01018511|516887278|FG002|Overall Study|Miscellaneous|0|||
143367222|NCT01018511|516887279|FG003|Overall Study|Miscellaneous|0|||
143367223|NCT04523181|516887280|FG000|Overall Study|Withdrawal by Subject|4|||
143092101|NCT01490086|515878282|FG002|Overall Study|Abnormal laboratory findings|0|||
143092102|NCT01490086|515878283|FG003|Overall Study|Abnormal laboratory findings|0|||
143092103|NCT01490086|515878284|FG004|Overall Study|Abnormal laboratory findings|0|||
143092104|NCT01490086|515878280|FG000|Overall Study|Lost to Follow-up|0|||
143092105|NCT01490086|515878281|FG001|Overall Study|Lost to Follow-up|0|||
143092106|NCT01490086|515878282|FG002|Overall Study|Lost to Follow-up|0|||
143092107|NCT01490086|515878283|FG003|Overall Study|Lost to Follow-up|0|||
143092108|NCT01490086|515878284|FG004|Overall Study|Lost to Follow-up|1|||
143092109|NCT01490086|515878280|FG000|Overall Study|Physician Decision|3|||
143092110|NCT01490086|515878281|FG001|Overall Study|Physician Decision|4|||
143092111|NCT01490086|515878282|FG002|Overall Study|Physician Decision|2|||
143092112|NCT01490086|515878283|FG003|Overall Study|Physician Decision|3|||
143092113|NCT01490086|515878284|FG004|Overall Study|Physician Decision|1|||
143092114|NCT01490086|515878280|FG000|Overall Study|Adverse Event|0|||
143092115|NCT01490086|515878281|FG001|Overall Study|Adverse Event|0|||
143092116|NCT01490086|515878282|FG002|Overall Study|Adverse Event|1|||
143092117|NCT01490086|515878283|FG003|Overall Study|Adverse Event|2|||
143092118|NCT01490086|515878284|FG004|Overall Study|Adverse Event|0|||
143092119|NCT01490086|515878280|FG000|Overall Study|Lack of Efficacy|0|||
143092120|NCT01490086|515878281|FG001|Overall Study|Lack of Efficacy|3|||
143092121|NCT01490086|515878282|FG002|Overall Study|Lack of Efficacy|1|||
143092122|NCT01490086|515878283|FG003|Overall Study|Lack of Efficacy|0|||
143092123|NCT01490086|515878284|FG004|Overall Study|Lack of Efficacy|8|||
143092124|NCT01490086|515878280|FG000|Overall Study|Worsening of symptoms|0|||
143092125|NCT01490086|515878281|FG001|Overall Study|Worsening of symptoms|1|||
143092126|NCT01490086|515878282|FG002|Overall Study|Worsening of symptoms|0|||
143092127|NCT01490086|515878283|FG003|Overall Study|Worsening of symptoms|1|||
143092128|NCT01490086|515878284|FG004|Overall Study|Worsening of symptoms|0|||
143092129|NCT01490086|515878280|FG000|Overall Study|Subject uncontrollable and abusive|0|||
143092130|NCT01490086|515878281|FG001|Overall Study|Subject uncontrollable and abusive|1|||
143092131|NCT01490086|515878282|FG002|Overall Study|Subject uncontrollable and abusive|0|||
143092132|NCT01490086|515878283|FG003|Overall Study|Subject uncontrollable and abusive|0|||
143092133|NCT01490086|515878284|FG004|Overall Study|Subject uncontrollable and abusive|0|||
143092134|NCT01490086|515878280|FG000|Overall Study|Subject left hospital|0|||
143092135|NCT01490086|515878281|FG001|Overall Study|Subject left hospital|1|||
143092136|NCT01490086|515878282|FG002|Overall Study|Subject left hospital|0|||
143092137|NCT01490086|515878283|FG003|Overall Study|Subject left hospital|1|||
143092138|NCT01490086|515878284|FG004|Overall Study|Subject left hospital|0|||
143092139|NCT04510090|515878287|FG000|FE-HS|Withdrawal by Subject|0|||
143092140|NCT04510090|515878288|FG001|FE-HS|Withdrawal by Subject|0|||
143092141|NCT04510090|515878289|FG002|FE-HS|Withdrawal by Subject|0|||
143092142|NCT04510090|515878290|FG003|FE-HS|Withdrawal by Subject|0|||
143092143|NCT04510090|515878291|FG004|FE-HS|Withdrawal by Subject|1|||
143092144|NCT04510090|515878292|FG005|FE-HS|Withdrawal by Subject|0|||
143092145|NCT04510090|515878293|FG006|FE-HS|Withdrawal by Subject|0|||
143092146|NCT04510090|515878294|FG007|FE-HS|Withdrawal by Subject|0|||
143092147|NCT05825404|515878295|FG000|First Intervention (Weeks 2-5)|Death|0|||
143092148|NCT05825404|515878296|FG001|First Intervention (Weeks 2-5)|Death|1|||
143092149|NCT05825404|515878295|FG000|Second Intervention (Weeks 8-11)|Death|0|||
143092150|NCT05825404|515878296|FG001|Second Intervention (Weeks 8-11)|Death|1|||
143092151|NCT01127256|515878297|FG000|Overall Study|Adverse Event|13|||
143092152|NCT01127256|515878298|FG001|Overall Study|Adverse Event|13|||
143092153|NCT01127256|515878297|FG000|Overall Study|Lack of Efficacy|4|||
143092154|NCT01127256|515878298|FG001|Overall Study|Lack of Efficacy|0|||
143092155|NCT01127256|515878297|FG000|Overall Study|Lost to Follow-up|16|||
143092156|NCT01127256|515878298|FG001|Overall Study|Lost to Follow-up|17|||
143092157|NCT01127256|515878297|FG000|Overall Study|Withdrawal by Subject|5|||
143092158|NCT01127256|515878298|FG001|Overall Study|Withdrawal by Subject|9|||
143092159|NCT01127256|515878297|FG000|Overall Study|Protocol Violation|1|||
143092160|NCT01127256|515878298|FG001|Overall Study|Protocol Violation|0|||
143092161|NCT01749826|515878299|FG000|Overall Study|Study Terminated|20|||
143092162|NCT01749826|515878300|FG001|Overall Study|Study Terminated|0|||
143092163|NCT01922037|515878301|FG000|Overall Study|Withdrawal by Subject|2|||
143092164|NCT01922037|515878302|FG001|Overall Study|Withdrawal by Subject|44|||
143092165|NCT01922037|515878301|FG000|Overall Study|Adverse Event|1|||
143092166|NCT01922037|515878302|FG001|Overall Study|Adverse Event|7|||
143092167|NCT01922037|515878301|FG000|Overall Study|Death|0|||
143092168|NCT01922037|515878302|FG001|Overall Study|Death|5|||
143092169|NCT01922037|515878301|FG000|Overall Study|Pregnancy|0|||
143092170|NCT01922037|515878302|FG001|Overall Study|Pregnancy|2|||
143092171|NCT01922037|515878301|FG000|Overall Study|Participant non-compliance|4|||
143092172|NCT01922037|515878302|FG001|Overall Study|Participant non-compliance|46|||
143092173|NCT01922037|515878301|FG000|Overall Study|Investigator/Sponsor decision|1|||
143092174|NCT01922037|515878302|FG001|Overall Study|Investigator/Sponsor decision|4|||
143092175|NCT01922037|515878301|FG000|Overall Study|Other unspecified|2|||
143092176|NCT01922037|515878302|FG001|Overall Study|Other unspecified|66|||
143092177|NCT00679211|515878303|FG000|Overall Study|Progressive disease|82|||
143092178|NCT00679211|515878303|FG000|Overall Study|Adverse Event|7|||
143092179|NCT00679211|515878303|FG000|Overall Study|Withdrawal by Subject|2|||
143092180|NCT00679211|515878303|FG000|Overall Study|Physician Decision|5|||
143092181|NCT00679211|515878303|FG000|Overall Study|Refused to undergo protocol procedures|1|||
143092182|NCT00679211|515878303|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
143092183|NCT00679211|515878303|FG000|Overall Study|Other|1|||
143092184|NCT00931528|515878304|FG000|Overall Study|Protocol Violation|9|||
143092185|NCT00931528|515878305|FG001|Overall Study|Protocol Violation|12|||
143092186|NCT00931528|515878304|FG000|Overall Study|Withdrawal by Subject|4|||
143092187|NCT00931528|515878305|FG001|Overall Study|Withdrawal by Subject|12|||
143092188|NCT00931528|515878304|FG000|Overall Study|Lost to Follow-up|6|||
143092189|NCT00931528|515878305|FG001|Overall Study|Lost to Follow-up|13|||
143092190|NCT00931528|515878304|FG000|Overall Study|Assessment outside of Time Frame|22|||
143092191|NCT00931528|515878305|FG001|Overall Study|Assessment outside of Time Frame|23|||
143092192|NCT00413699|515878308|FG000|Initial Period|Death|25|||
143092193|NCT00413699|515878309|FG001|Initial Period|Death|30|||
143092194|NCT00413699|515878310|FG002|Initial Period|Death|0|||
143092195|NCT00413699|515878308|FG000|Initial Period|Lack of Efficacy|59|||
143092196|NCT00413699|515878309|FG001|Initial Period|Lack of Efficacy|115|||
143092197|NCT00413699|515878310|FG002|Initial Period|Lack of Efficacy|0|||
143092198|NCT00413699|515878308|FG000|Initial Period|Lost to Follow-up|31|||
143092199|NCT00413699|515878309|FG001|Initial Period|Lost to Follow-up|101|||
143092200|NCT00413699|515878310|FG002|Initial Period|Lost to Follow-up|0|||
143092201|NCT00413699|515878308|FG000|Initial Period|Protocol Violation|38|||
143092202|NCT00413699|515878309|FG001|Initial Period|Protocol Violation|89|||
143092203|NCT00413699|515878310|FG002|Initial Period|Protocol Violation|0|||
143092204|NCT00413699|515878308|FG000|Initial Period|Pregnancy|10|||
143092205|NCT00413699|515878309|FG001|Initial Period|Pregnancy|8|||
143092206|NCT00413699|515878310|FG002|Initial Period|Pregnancy|0|||
143092207|NCT00413699|515878308|FG000|Initial Period|Did not meet entrance criteria|2|||
143092208|NCT00413699|515878309|FG001|Initial Period|Did not meet entrance criteria|2|||
143092209|NCT00413699|515878310|FG002|Initial Period|Did not meet entrance criteria|0|||
143092210|NCT00413699|515878308|FG000|Initial Period|Medication error without adverse event|0|||
143092211|NCT00413699|515878309|FG001|Initial Period|Medication error without adverse event|1|||
143092212|NCT00413699|515878310|FG002|Initial Period|Medication error without adverse event|0|||
143092213|NCT00413699|515878308|FG000|Initial Period|Study terminated by Sponsor|0|||
143092214|NCT00413699|515878309|FG001|Initial Period|Study terminated by Sponsor|1|||
143092215|NCT00413699|515878310|FG002|Initial Period|Study terminated by Sponsor|0|||
143092216|NCT00413699|515878308|FG000|Initial Period|Other|67|||
143092217|NCT00413699|515878309|FG001|Initial Period|Other|211|||
143092218|NCT00413699|515878310|FG002|Initial Period|Other|0|||
143092219|NCT00413699|515878308|FG000|Initial Period|Adverse event related to study drug|178|||
143092220|NCT00413699|515878309|FG001|Initial Period|Adverse event related to study drug|527|||
143092221|NCT00413699|515878310|FG002|Initial Period|Adverse event related to study drug|0|||
143092222|NCT00413699|515878308|FG000|Initial Period|Adverse event not related to study drug|113|||
143092223|NCT00413699|515878309|FG001|Initial Period|Adverse event not related to study drug|248|||
143092224|NCT00413699|515878310|FG002|Initial Period|Adverse event not related to study drug|0|||
143092225|NCT00413699|515878308|FG000|Initial Period|Missing end of study page|0|||
143092226|NCT00413699|515878309|FG001|Initial Period|Missing end of study page|4|||
143092227|NCT00413699|515878310|FG002|Initial Period|Missing end of study page|0|||
143092228|NCT00413699|515878308|FG000|Initial Period|No longer willing to participate|116|||
143092229|NCT00413699|515878309|FG001|Initial Period|No longer willing to participate|368|||
143092230|NCT00413699|515878310|FG002|Initial Period|No longer willing to participate|0|||
143092231|NCT00413699|515878308|FG000|Extension Period|No Longer Willing to Participate|0|||
143092232|NCT00413699|515878309|FG001|Extension Period|No Longer Willing to Participate|0|||
143092233|NCT00413699|515878310|FG002|Extension Period|No Longer Willing to Participate|2|||
143092234|NCT00413699|515878308|FG000|Extension Period|Protocol Violation|0|||
143092235|NCT00413699|515878309|FG001|Extension Period|Protocol Violation|0|||
143092236|NCT00413699|515878310|FG002|Extension Period|Protocol Violation|1|||
143092237|NCT00413699|515878308|FG000|Extension Period|Adverse Event|0|||
143092238|NCT00413699|515878309|FG001|Extension Period|Adverse Event|0|||
143092239|NCT00413699|515878310|FG002|Extension Period|Adverse Event|2|||
143092240|NCT00075816|515878311|FG000|Overall Study|Did not undergo transplantation|14|||
143092241|NCT00075816|515878312|FG001|Overall Study|Did not undergo transplantation|11|||
143092242|NCT03511105|515878313|FG000|Overall Study|Adverse Event|1|||
143092243|NCT03511105|515878314|FG001|Overall Study|Adverse Event|0|||
143092244|NCT03511105|515878313|FG000|Overall Study|Withdrew consent|1|||
143092245|NCT03511105|515878314|FG001|Overall Study|Withdrew consent|0|||
143092246|NCT02810457|515878315|FG000|Overall Study|Randomised but no treatment received|2|||
143092247|NCT02810457|515878316|FG001|Overall Study|Randomised but no treatment received|1|||
143092248|NCT02810457|515878315|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
143092249|NCT02810457|515878316|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
143092250|NCT02810457|515878315|FG000|Overall Study|Adverse Event|37|||
143092251|NCT02810457|515878316|FG001|Overall Study|Adverse Event|43|||
143092252|NCT02810457|515878315|FG000|Overall Study|Patient decision|31|||
143092253|NCT02810457|515878316|FG001|Overall Study|Patient decision|35|||
143092254|NCT02810457|515878315|FG000|Overall Study|Patient lost to follow-up|2|||
143092255|NCT02810457|515878316|FG001|Overall Study|Patient lost to follow-up|2|||
143092256|NCT02810457|515878315|FG000|Overall Study|Death|39|||
143092257|NCT02810457|515878316|FG001|Overall Study|Death|28|||
143092258|NCT02810457|515878315|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
143092259|NCT02810457|515878316|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
143092260|NCT02810457|515878315|FG000|Overall Study|Clinical progression|15|||
143092261|NCT02810457|515878316|FG001|Overall Study|Clinical progression|16|||
143092262|NCT02810457|515878315|FG000|Overall Study|Investigator decision|3|||
143092263|NCT02810457|515878316|FG001|Overall Study|Investigator decision|2|||
143092264|NCT02810457|515878315|FG000|Overall Study|Patient ineligibility|3|||
143092265|NCT02810457|515878316|FG001|Overall Study|Patient ineligibility|0|||
143092266|NCT02810457|515878315|FG000|Overall Study|Miscalculated PD|1|||
143092267|NCT02810457|515878316|FG001|Overall Study|Miscalculated PD|0|||
143092268|NCT02810457|515878315|FG000|Overall Study|Physician Decision|0|||
143092269|NCT02810457|515878316|FG001|Overall Study|Physician Decision|1|||
143092270|NCT02750618|515878317|FG000|Overall Study|Withdrawal by Subject|1|||
143092271|NCT02019472|515878318|FG000|Overall Study|Adverse Event|14|||
143092272|NCT02019472|515878319|FG001|Overall Study|Adverse Event|23|||
143092273|NCT02019472|515878320|FG002|Overall Study|Adverse Event|17|||
143092274|NCT02019472|515878318|FG000|Overall Study|Death|0|||
143092275|NCT02019472|515878319|FG001|Overall Study|Death|1|||
143092276|NCT02019472|515878320|FG002|Overall Study|Death|1|||
143092277|NCT02019472|515878318|FG000|Overall Study|Lack of Efficacy|7|||
143092278|NCT02019472|515878319|FG001|Overall Study|Lack of Efficacy|4|||
143092279|NCT02019472|515878320|FG002|Overall Study|Lack of Efficacy|4|||
143092280|NCT02019472|515878318|FG000|Overall Study|Lost to Follow-up|0|||
143092281|NCT02019472|515878319|FG001|Overall Study|Lost to Follow-up|2|||
143092282|NCT02019472|515878320|FG002|Overall Study|Lost to Follow-up|1|||
143092283|NCT02019472|515878318|FG000|Overall Study|Physician Decision|1|||
143092284|NCT02019472|515878319|FG001|Overall Study|Physician Decision|2|||
143092285|NCT02019472|515878320|FG002|Overall Study|Physician Decision|0|||
143092286|NCT02019472|515878318|FG000|Overall Study|Pregnancy|1|||
143092287|NCT02019472|515878319|FG001|Overall Study|Pregnancy|2|||
143092288|NCT02019472|515878320|FG002|Overall Study|Pregnancy|2|||
143092289|NCT02019472|515878318|FG000|Overall Study|Withdrawal by Subject|11|||
143092290|NCT02019472|515878319|FG001|Overall Study|Withdrawal by Subject|10|||
143092291|NCT02019472|515878320|FG002|Overall Study|Withdrawal by Subject|11|||
143092292|NCT02019472|515878318|FG000|Overall Study|Other|3|||
143092293|NCT02019472|515878319|FG001|Overall Study|Other|8|||
143092294|NCT02019472|515878320|FG002|Overall Study|Other|6|||
143092295|NCT02157935|515878321|FG000|Overall Study|Withdrawal by Subject|25|||
143092296|NCT02157935|515878322|FG001|Overall Study|Withdrawal by Subject|39|||
143092297|NCT02157935|515878321|FG000|Overall Study|Screen failure|1|||
143250988|NCT02059291|516472970|FG001|Epoch 2|Lack of Efficacy|0|||
143250989|NCT02059291|516472971|FG002|Epoch 2|Lack of Efficacy|0|||
143250990|NCT02059291|516472972|FG003|Epoch 2|Lack of Efficacy|1|||
143250991|NCT02059291|516472973|FG004|Epoch 2|Lack of Efficacy|0|||
143250992|NCT02059291|516472974|FG005|Epoch 2|Lack of Efficacy|1|||
143250993|NCT02059291|516472975|FG006|Epoch 2|Lack of Efficacy|0|||
143250994|NCT02059291|516472976|FG007|Epoch 2|Lack of Efficacy|0|||
143250995|NCT02059291|516472977|FG008|Epoch 2|Lack of Efficacy|0|||
143250996|NCT02059291|516472978|FG009|Epoch 2|Lack of Efficacy|0|||
143250997|NCT02059291|516472979|FG010|Epoch 2|Lack of Efficacy|0|||
143250998|NCT02059291|516472980|FG011|Epoch 2|Lack of Efficacy|0|||
143250999|NCT02059291|516472981|FG012|Epoch 2|Lack of Efficacy|0|||
143251000|NCT02059291|516472982|FG013|Epoch 2|Lack of Efficacy|0|||
143251001|NCT02059291|516472983|FG014|Epoch 2|Lack of Efficacy|0|||
143251002|NCT02059291|516472984|FG015|Epoch 2|Lack of Efficacy|0|||
143251003|NCT02059291|516472985|FG016|Epoch 2|Lack of Efficacy|0|||
143251004|NCT02059291|516472986|FG017|Epoch 2|Lack of Efficacy|0|||
143251005|NCT02059291|516472987|FG018|Epoch 2|Lack of Efficacy|0|||
143251006|NCT02059291|516472988|FG019|Epoch 2|Lack of Efficacy|0|||
143251007|NCT02059291|516472989|FG020|Epoch 2|Lack of Efficacy|0|||
143251008|NCT02059291|516472990|FG021|Epoch 2|Lack of Efficacy|0|||
143251009|NCT02059291|516472991|FG022|Epoch 2|Lack of Efficacy|0|||
143251010|NCT02059291|516472992|FG023|Epoch 2|Lack of Efficacy|0|||
143251011|NCT02059291|516472993|FG024|Epoch 2|Lack of Efficacy|0|||
143251012|NCT02059291|516472969|FG000|Epoch 2|Adverse Event|0|||
143251013|NCT02059291|516472970|FG001|Epoch 2|Adverse Event|0|||
143251014|NCT02059291|516472971|FG002|Epoch 2|Adverse Event|1|||
143367224|NCT04523181|516887281|FG001|Overall Study|Withdrawal by Subject|5|||
143092298|NCT02157935|515878322|FG001|Overall Study|Screen failure|2|||
143251015|NCT02059291|516472972|FG003|Epoch 2|Adverse Event|1|||
143251016|NCT02059291|516472973|FG004|Epoch 2|Adverse Event|0|||
143251017|NCT02059291|516472974|FG005|Epoch 2|Adverse Event|0|||
143251018|NCT02059291|516472975|FG006|Epoch 2|Adverse Event|0|||
143251019|NCT02059291|516472976|FG007|Epoch 2|Adverse Event|1|||
143251020|NCT02059291|516472977|FG008|Epoch 2|Adverse Event|1|||
143251021|NCT02059291|516472978|FG009|Epoch 2|Adverse Event|0|||
143251022|NCT02059291|516472979|FG010|Epoch 2|Adverse Event|0|||
143251023|NCT02059291|516472980|FG011|Epoch 2|Adverse Event|0|||
143251024|NCT02059291|516472981|FG012|Epoch 2|Adverse Event|0|||
143251025|NCT02059291|516472982|FG013|Epoch 2|Adverse Event|0|||
143092299|NCT02157935|515878321|FG000|Overall Study|Protocol Violation|1|||
143092300|NCT02157935|515878322|FG001|Overall Study|Protocol Violation|0|||
143092301|NCT02157935|515878321|FG000|Overall Study|Progressive disease|0|||
143092302|NCT02157935|515878322|FG001|Overall Study|Progressive disease|2|||
143092303|NCT02157935|515878321|FG000|Overall Study|Other|5|||
143092304|NCT02157935|515878322|FG001|Overall Study|Other|12|||
143092305|NCT02157935|515878321|FG000|Overall Study|Lack of Efficacy|0|||
143092306|NCT02157935|515878322|FG001|Overall Study|Lack of Efficacy|1|||
143092307|NCT02157935|515878321|FG000|Overall Study|Death|4|||
143092308|NCT02157935|515878322|FG001|Overall Study|Death|4|||
143092309|NCT02157935|515878321|FG000|Overall Study|Adverse Event|3|||
143092310|NCT02157935|515878322|FG001|Overall Study|Adverse Event|5|||
143092311|NCT05516108|515878323|FG000|Overall Study|Time Commitment|3|||
143092312|NCT05516108|515878324|FG001|Overall Study|Time Commitment|1|||
143092313|NCT05516108|515878323|FG000|Overall Study|Reason Unknown|2|||
143092314|NCT05516108|515878324|FG001|Overall Study|Reason Unknown|4|||
143092315|NCT03664232|515878329|FG000|Overall Study|Withdrawal by Subject|0|||
143092316|NCT03664232|515878330|FG001|Overall Study|Withdrawal by Subject|1|||
143092317|NCT03664232|515878331|FG002|Overall Study|Withdrawal by Subject|0|||
143092318|NCT03664232|515878332|FG003|Overall Study|Withdrawal by Subject|1|||
143092319|NCT03664232|515878329|FG000|Overall Study|Adverse Event|0|||
143092320|NCT03664232|515878330|FG001|Overall Study|Adverse Event|0|||
143092321|NCT03664232|515878331|FG002|Overall Study|Adverse Event|1|||
143092322|NCT03664232|515878332|FG003|Overall Study|Adverse Event|0|||
143092323|NCT03664232|515878329|FG000|Overall Study|Other-Non-compliance with study drug|0|||
143092324|NCT03664232|515878330|FG001|Overall Study|Other-Non-compliance with study drug|1|||
143092325|NCT03664232|515878331|FG002|Overall Study|Other-Non-compliance with study drug|0|||
143092326|NCT03664232|515878332|FG003|Overall Study|Other-Non-compliance with study drug|2|||
143092327|NCT03664232|515878329|FG000|Overall Study|Other-Unspecified|0|||
143092328|NCT03664232|515878330|FG001|Overall Study|Other-Unspecified|3|||
143092329|NCT03664232|515878331|FG002|Overall Study|Other-Unspecified|0|||
143092330|NCT03664232|515878332|FG003|Overall Study|Other-Unspecified|1|||
143092331|NCT03664232|515878329|FG000|Overall Study|- Withdrawal by Parent/Guardian|0|||
143092332|NCT03664232|515878330|FG001|Overall Study|- Withdrawal by Parent/Guardian|0|||
143092333|NCT03664232|515878331|FG002|Overall Study|- Withdrawal by Parent/Guardian|0|||
143092334|NCT03664232|515878332|FG003|Overall Study|- Withdrawal by Parent/Guardian|1|||
143092335|NCT00709995|515878333|FG000|Overall Study|Adverse Event|4|||
143092336|NCT00709995|515878334|FG001|Overall Study|Adverse Event|2|||
143092337|NCT00709995|515878333|FG000|Overall Study|Withdrawal by Subject|1|||
143092338|NCT00709995|515878334|FG001|Overall Study|Withdrawal by Subject|3|||
143092339|NCT02222922|515878342|FG000|Overall Study|Death|0|||
143092340|NCT02222922|515878343|FG001|Overall Study|Death|0|||
143092341|NCT02222922|515878344|FG002|Overall Study|Death|0|||
143092342|NCT02222922|515878345|FG003|Overall Study|Death|0|||
143092343|NCT02222922|515878346|FG004|Overall Study|Death|13|||
143092344|NCT02222922|515878347|FG005|Overall Study|Death|0|||
143092345|NCT02222922|515878348|FG006|Overall Study|Death|0|||
143092346|NCT02222922|515878349|FG007|Overall Study|Death|0|||
143092347|NCT02222922|515878350|FG008|Overall Study|Death|2|||
143092348|NCT02222922|515878342|FG000|Overall Study|Lost to Follow-up|0|||
143092349|NCT02222922|515878343|FG001|Overall Study|Lost to Follow-up|0|||
143092350|NCT02222922|515878344|FG002|Overall Study|Lost to Follow-up|1|||
143092351|NCT02222922|515878345|FG003|Overall Study|Lost to Follow-up|0|||
143092352|NCT02222922|515878346|FG004|Overall Study|Lost to Follow-up|9|||
143092353|NCT02222922|515878347|FG005|Overall Study|Lost to Follow-up|1|||
143092354|NCT02222922|515878348|FG006|Overall Study|Lost to Follow-up|0|||
143092355|NCT02222922|515878349|FG007|Overall Study|Lost to Follow-up|0|||
143092356|NCT02222922|515878350|FG008|Overall Study|Lost to Follow-up|0|||
143092357|NCT02222922|515878342|FG000|Overall Study|Other|0|||
143092358|NCT02222922|515878343|FG001|Overall Study|Other|0|||
143092359|NCT02222922|515878344|FG002|Overall Study|Other|0|||
143092360|NCT02222922|515878345|FG003|Overall Study|Other|2|||
143092361|NCT02222922|515878346|FG004|Overall Study|Other|10|||
143092362|NCT02222922|515878347|FG005|Overall Study|Other|2|||
143092363|NCT02222922|515878348|FG006|Overall Study|Other|2|||
143092364|NCT02222922|515878349|FG007|Overall Study|Other|4|||
143092365|NCT02222922|515878350|FG008|Overall Study|Other|1|||
143092366|NCT02222922|515878342|FG000|Overall Study|Participant refused further follow-up|1|||
143092367|NCT02222922|515878343|FG001|Overall Study|Participant refused further follow-up|0|||
143092368|NCT02222922|515878344|FG002|Overall Study|Participant refused further follow-up|0|||
143367225|NCT04523181|516887280|FG000|Overall Study|Lost to Follow-up|2|||
143092369|NCT02222922|515878345|FG003|Overall Study|Participant refused further follow-up|1|||
143092370|NCT02222922|515878346|FG004|Overall Study|Participant refused further follow-up|6|||
143092371|NCT02222922|515878347|FG005|Overall Study|Participant refused further follow-up|0|||
143092372|NCT02222922|515878348|FG006|Overall Study|Participant refused further follow-up|0|||
143092373|NCT02222922|515878349|FG007|Overall Study|Participant refused further follow-up|0|||
143092374|NCT02222922|515878350|FG008|Overall Study|Participant refused further follow-up|3|||
143092375|NCT01254643|515878351|FG000|Overall Study|Withdrawal by Subject|1|||
143092376|NCT03817125|515878353|FG000|Overall Study|Adverse Event|1|||
143092377|NCT03817125|515878354|FG001|Overall Study|Adverse Event|0|||
143092378|NCT03817125|515878353|FG000|Overall Study|Physician Decision|0|||
143092379|NCT03817125|515878354|FG001|Overall Study|Physician Decision|1|||
143092380|NCT03817125|515878353|FG000|Overall Study|Lack of Efficacy|1|||
143092381|NCT03817125|515878354|FG001|Overall Study|Lack of Efficacy|5|||
143092382|NCT02002221|515878355|FG000|Overall Study|Adverse Event|2|||
143092383|NCT02002221|515878356|FG001|Overall Study|Adverse Event|1|||
143092384|NCT02002221|515878355|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
143092385|NCT02002221|515878356|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
143092386|NCT02002221|515878355|FG000|Overall Study|Patient withdrew consent|0|||
143092387|NCT02002221|515878356|FG001|Overall Study|Patient withdrew consent|1|||
143092388|NCT00942084|515878357|FG000|Overall Study|Death|2|||
143367226|NCT04523181|516887281|FG001|Overall Study|Lost to Follow-up|3|||
143367227|NCT04523181|516887280|FG000|Overall Study|Physician Decision|1|||
143367228|NCT04523181|516887281|FG001|Overall Study|Physician Decision|0|||
143367229|NCT04523181|516887280|FG000|Overall Study|Transferred to external facility.|1|||
143367230|NCT04523181|516887281|FG001|Overall Study|Transferred to external facility.|1|||
143367231|NCT04305912|516887282|FG000|First Intervention|COVID-19 Suspension|2|||
143367232|NCT04305912|516887283|FG001|First Intervention|COVID-19 Suspension|0|||
143367233|NCT04305912|516887282|FG000|First Intervention|Withdrawal by Subject|0|||
143367234|NCT04305912|516887283|FG001|First Intervention|Withdrawal by Subject|1|||
143367235|NCT04305912|516887282|FG000|Second Intervention|Adverse Event|0|||
143367236|NCT04305912|516887283|FG001|Second Intervention|Adverse Event|1|||
143367237|NCT01348087|516887288|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
143367238|NCT01348087|516887288|FG000|Overall Study|Administrative problems|79|||
143367239|NCT01348087|516887288|FG000|Overall Study|protocol deviation|1|||
143367240|NCT01348087|516887288|FG000|Overall Study|Lost to Follow-up|1|||
143367241|NCT01348087|516887288|FG000|Overall Study|Subject withdrew consent|7|||
143367242|NCT01348087|516887288|FG000|Overall Study|Adverse Event|25|||
143367243|NCT00117988|516887293|FG000|Overall Study|Death|3|||
143367244|NCT00117988|516887293|FG000|Overall Study|Adverse Event|1|||
143367245|NCT02482233|516887298|FG000|Overall Study|Lost to Follow-up|1|||
143367246|NCT02482233|516887299|FG001|Overall Study|Lost to Follow-up|1|||
143367247|NCT04888585|516887300|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
143367248|NCT04888585|516887301|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
143367249|NCT04888585|516887302|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
143367250|NCT04888585|516887303|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
143367251|NCT04888585|516887304|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
143367252|NCT04888585|516887305|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
143367253|NCT04888585|516887306|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
143367254|NCT04888585|516887307|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
143367255|NCT04888585|516887308|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
143367256|NCT04888585|516887309|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
143367257|NCT04888585|516887310|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
143367258|NCT04888585|516887300|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
143367259|NCT04888585|516887301|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
143367260|NCT04888585|516887302|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
143367261|NCT04888585|516887303|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
143367262|NCT04888585|516887304|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
143367263|NCT04888585|516887305|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
143092389|NCT01998919|515878358|FG000|Overall Study|Death|2|||
143092390|NCT01998919|515878359|FG001|Overall Study|Death|2|||
143092391|NCT01998919|515878358|FG000|Overall Study|Adverse Event|0|||
143092392|NCT01998919|515878359|FG001|Overall Study|Adverse Event|5|||
143092393|NCT01998919|515878358|FG000|Overall Study|Disease progression|31|||
143092394|NCT01998919|515878359|FG001|Overall Study|Disease progression|22|||
143092395|NCT01998919|515878358|FG000|Overall Study|Withdrawal by Subject|2|||
143092396|NCT01998919|515878359|FG001|Overall Study|Withdrawal by Subject|4|||
143092397|NCT01998919|515878358|FG000|Overall Study|Lost to Follow-up|2|||
143092398|NCT01998919|515878359|FG001|Overall Study|Lost to Follow-up|0|||
143092399|NCT01998919|515878358|FG000|Overall Study|Other|5|||
143367264|NCT04888585|516887306|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
143367265|NCT04888585|516887307|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
143367266|NCT04888585|516887308|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
143367267|NCT04888585|516887309|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
143092400|NCT01998919|515878359|FG001|Overall Study|Other|2|||
143092401|NCT01037218|515878362|FG000|Overall Study|Adverse Event|4|||
143092402|NCT01037218|515878363|FG001|Overall Study|Adverse Event|2|||
143092403|NCT01037218|515878364|FG002|Overall Study|Adverse Event|2|||
143092404|NCT01037218|515878365|FG003|Overall Study|Adverse Event|1|||
143092405|NCT01037218|515878362|FG000|Overall Study|Lack of Efficacy|0|||
143092406|NCT01037218|515878363|FG001|Overall Study|Lack of Efficacy|2|||
143092407|NCT01037218|515878364|FG002|Overall Study|Lack of Efficacy|1|||
143092408|NCT01037218|515878365|FG003|Overall Study|Lack of Efficacy|5|||
143092409|NCT01037218|515878362|FG000|Overall Study|Lost to Follow-up|3|||
143092410|NCT01037218|515878363|FG001|Overall Study|Lost to Follow-up|5|||
143092411|NCT01037218|515878364|FG002|Overall Study|Lost to Follow-up|4|||
143092412|NCT01037218|515878365|FG003|Overall Study|Lost to Follow-up|2|||
143092413|NCT01037218|515878362|FG000|Overall Study|Withdrawal by Subject|6|||
143092414|NCT01037218|515878363|FG001|Overall Study|Withdrawal by Subject|7|||
143092415|NCT01037218|515878364|FG002|Overall Study|Withdrawal by Subject|7|||
143092416|NCT01037218|515878365|FG003|Overall Study|Withdrawal by Subject|4|||
143092417|NCT01037218|515878362|FG000|Overall Study|Partner Withdrew Consent|0|||
143092418|NCT01037218|515878363|FG001|Overall Study|Partner Withdrew Consent|3|||
143092419|NCT01037218|515878364|FG002|Overall Study|Partner Withdrew Consent|2|||
143092420|NCT01037218|515878365|FG003|Overall Study|Partner Withdrew Consent|1|||
143092421|NCT01037218|515878362|FG000|Overall Study|Protocol Violation|0|||
143092422|NCT01037218|515878363|FG001|Overall Study|Protocol Violation|0|||
143092423|NCT01037218|515878364|FG002|Overall Study|Protocol Violation|2|||
143092424|NCT01037218|515878365|FG003|Overall Study|Protocol Violation|2|||
143092425|NCT01037218|515878362|FG000|Overall Study|Various|3|||
143092426|NCT01037218|515878363|FG001|Overall Study|Various|2|||
143092427|NCT01037218|515878364|FG002|Overall Study|Various|3|||
143092428|NCT01037218|515878365|FG003|Overall Study|Various|1|||
143092429|NCT01068860|515878366|FG000|Overall Study|Withdrawal by Subject|0|||
143092430|NCT01068860|515878367|FG001|Overall Study|Withdrawal by Subject|0|||
143092431|NCT01068860|515878368|FG002|Overall Study|Withdrawal by Subject|0|||
143092432|NCT01068860|515878369|FG003|Overall Study|Withdrawal by Subject|0|||
143092433|NCT01068860|515878370|FG004|Overall Study|Withdrawal by Subject|0|||
143092434|NCT01068860|515878371|FG005|Overall Study|Withdrawal by Subject|2|||
143092435|NCT01068860|515878372|FG006|Overall Study|Withdrawal by Subject|0|||
143092436|NCT01068860|515878373|FG007|Overall Study|Withdrawal by Subject|0|||
143092437|NCT01068860|515878374|FG008|Overall Study|Withdrawal by Subject|0|||
143092438|NCT01068860|515878375|FG009|Overall Study|Withdrawal by Subject|3|||
143092439|NCT01068860|515878366|FG000|Overall Study|Administrative problems; misrandomized|0|||
143092440|NCT01068860|515878367|FG001|Overall Study|Administrative problems; misrandomized|0|||
143092441|NCT01068860|515878368|FG002|Overall Study|Administrative problems; misrandomized|0|||
143092442|NCT01068860|515878369|FG003|Overall Study|Administrative problems; misrandomized|1|||
143092443|NCT01068860|515878370|FG004|Overall Study|Administrative problems; misrandomized|0|||
143092444|NCT01068860|515878371|FG005|Overall Study|Administrative problems; misrandomized|0|||
143092445|NCT01068860|515878372|FG006|Overall Study|Administrative problems; misrandomized|0|||
143092446|NCT01068860|515878373|FG007|Overall Study|Administrative problems; misrandomized|0|||
143092447|NCT01068860|515878374|FG008|Overall Study|Administrative problems; misrandomized|0|||
143092448|NCT01068860|515878375|FG009|Overall Study|Administrative problems; misrandomized|1|||
143092449|NCT01068860|515878366|FG000|Overall Study|Lost to Follow-up|0|||
143092450|NCT01068860|515878367|FG001|Overall Study|Lost to Follow-up|1|||
143092451|NCT01068860|515878368|FG002|Overall Study|Lost to Follow-up|0|||
143092452|NCT01068860|515878369|FG003|Overall Study|Lost to Follow-up|0|||
143092453|NCT01068860|515878370|FG004|Overall Study|Lost to Follow-up|0|||
143092454|NCT01068860|515878371|FG005|Overall Study|Lost to Follow-up|0|||
143092455|NCT01068860|515878372|FG006|Overall Study|Lost to Follow-up|0|||
143092456|NCT01068860|515878373|FG007|Overall Study|Lost to Follow-up|0|||
143092457|NCT01068860|515878374|FG008|Overall Study|Lost to Follow-up|0|||
143092458|NCT01068860|515878375|FG009|Overall Study|Lost to Follow-up|0|||
143092459|NCT02568072|515878376|FG000|Overall Study|Unavailable for appointment|23|||
143092460|NCT02568072|515878376|FG000|Overall Study|Unable to contact|3|||
143092461|NCT02568072|515878376|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
143092462|NCT02568072|515878376|FG000|Overall Study|Withdrawal by Subject|1|||
143092463|NCT02568072|515878376|FG000|Overall Study|Sustained injury, marathon not run|24|||
143092464|NCT00897715|515878380|FG000|Overall Study|Lost to Follow-up|0|||
143092465|NCT00897715|515878381|FG001|Overall Study|Lost to Follow-up|1|||
143092466|NCT00897715|515878380|FG000|Overall Study|Physician Decision|1|||
143092467|NCT00897715|515878381|FG001|Overall Study|Physician Decision|0|||
143092468|NCT00897715|515878380|FG000|Overall Study|increased risk of infection|1|||
143092469|NCT00897715|515878381|FG001|Overall Study|increased risk of infection|0|||
143092470|NCT02714218|515878383|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
143092471|NCT02714218|515878384|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
143092472|NCT02714218|515878385|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
143092473|NCT02714218|515878383|FG000|Pre-Treatment Period|Other reasons|0|||
143092474|NCT02714218|515878384|FG001|Pre-Treatment Period|Other reasons|1|||
143092475|NCT02714218|515878385|FG002|Pre-Treatment Period|Other reasons|0|||
143092476|NCT02714218|515878383|FG000|Treatment Period|Disease Progression|55|||
143092477|NCT02714218|515878384|FG001|Treatment Period|Disease Progression|52|||
143092478|NCT02714218|515878385|FG002|Treatment Period|Disease Progression|14|||
143092479|NCT02714218|515878383|FG000|Treatment Period|Study drug toxicity|46|||
143092480|NCT02714218|515878384|FG001|Treatment Period|Study drug toxicity|70|||
143092481|NCT02714218|515878385|FG002|Treatment Period|Study drug toxicity|6|||
143092482|NCT02714218|515878383|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
143092483|NCT02714218|515878384|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
143092484|NCT02714218|515878385|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
143092485|NCT02714218|515878383|FG000|Treatment Period|Request to discontinue treatment|1|||
143251026|NCT02059291|516472983|FG014|Epoch 2|Adverse Event|0|||
143251027|NCT02059291|516472984|FG015|Epoch 2|Adverse Event|0|||
143251028|NCT02059291|516472985|FG016|Epoch 2|Adverse Event|0|||
143251029|NCT02059291|516472986|FG017|Epoch 2|Adverse Event|0|||
143251030|NCT02059291|516472987|FG018|Epoch 2|Adverse Event|0|||
143251031|NCT02059291|516472988|FG019|Epoch 2|Adverse Event|0|||
143251032|NCT02059291|516472989|FG020|Epoch 2|Adverse Event|0|||
143251033|NCT02059291|516472990|FG021|Epoch 2|Adverse Event|0|||
143251034|NCT02059291|516472991|FG022|Epoch 2|Adverse Event|0|||
143251035|NCT02059291|516472992|FG023|Epoch 2|Adverse Event|0|||
143251036|NCT02059291|516472993|FG024|Epoch 2|Adverse Event|0|||
143251037|NCT02059291|516472969|FG000|Epoch 2|Withdrawal by Subject|0|||
143251038|NCT02059291|516472970|FG001|Epoch 2|Withdrawal by Subject|1|||
143251039|NCT02059291|516472971|FG002|Epoch 2|Withdrawal by Subject|0|||
143251040|NCT02059291|516472972|FG003|Epoch 2|Withdrawal by Subject|0|||
143251041|NCT02059291|516472973|FG004|Epoch 2|Withdrawal by Subject|0|||
143251042|NCT02059291|516472974|FG005|Epoch 2|Withdrawal by Subject|1|||
143251043|NCT02059291|516472975|FG006|Epoch 2|Withdrawal by Subject|0|||
143251044|NCT02059291|516472976|FG007|Epoch 2|Withdrawal by Subject|0|||
143251045|NCT02059291|516472977|FG008|Epoch 2|Withdrawal by Subject|1|||
143251046|NCT02059291|516472978|FG009|Epoch 2|Withdrawal by Subject|0|||
143251047|NCT02059291|516472979|FG010|Epoch 2|Withdrawal by Subject|0|||
143092486|NCT02714218|515878384|FG001|Treatment Period|Request to discontinue treatment|4|||
143092487|NCT02714218|515878385|FG002|Treatment Period|Request to discontinue treatment|1|||
143092488|NCT02714218|515878383|FG000|Treatment Period|Participant withdrew consent|2|||
143092489|NCT02714218|515878384|FG001|Treatment Period|Participant withdrew consent|2|||
143092490|NCT02714218|515878385|FG002|Treatment Period|Participant withdrew consent|0|||
143092491|NCT02714218|515878383|FG000|Treatment Period|Maximum clinical benefit|4|||
143092492|NCT02714218|515878384|FG001|Treatment Period|Maximum clinical benefit|2|||
143092493|NCT02714218|515878385|FG002|Treatment Period|Maximum clinical benefit|0|||
143092494|NCT02714218|515878383|FG000|Treatment Period|Administrative reason by sponsor|2|||
143092495|NCT02714218|515878384|FG001|Treatment Period|Administrative reason by sponsor|1|||
143092496|NCT02714218|515878385|FG002|Treatment Period|Administrative reason by sponsor|0|||
143092497|NCT02714218|515878383|FG000|Treatment Period|Other reasons|6|||
143092498|NCT02714218|515878384|FG001|Treatment Period|Other reasons|6|||
143092499|NCT02714218|515878385|FG002|Treatment Period|Other reasons|0|||
143092500|NCT02714218|515878383|FG000|Treatment Period|Completed treatment as per protocol|36|||
143092501|NCT02714218|515878384|FG001|Treatment Period|Completed treatment as per protocol|27|||
143092502|NCT02714218|515878385|FG002|Treatment Period|Completed treatment as per protocol|3|||
143092503|NCT02714218|515878383|FG000|Treatment Period|Not reported|9|||
143092504|NCT02714218|515878384|FG001|Treatment Period|Not reported|6|||
143092505|NCT02714218|515878385|FG002|Treatment Period|Not reported|0|||
143092506|NCT01199939|515878386|FG000|Overall Study|Adverse Event|4|||
143092507|NCT01199939|515878386|FG000|Overall Study|Protocol Violation|3|||
143092508|NCT01199939|515878386|FG000|Overall Study|Lost to Follow-up|2|||
143092509|NCT01199939|515878386|FG000|Overall Study|Reached a virologic endpoint|4|||
143092510|NCT03875508|515878389|FG000|Overall Study|Adverse Event|1|||
143092511|NCT03875508|515878389|FG000|Overall Study|Lost to Follow-up|8|||
143092512|NCT03875508|515878389|FG000|Overall Study|Lack of Efficacy|1|||
143092513|NCT03875508|515878389|FG000|Overall Study|Other, not specified|2|||
143092514|NCT02857816|515878391|FG000|Overall Study|Screen Failure|33|||
143092515|NCT02857816|515878391|FG000|Overall Study|Withdrawal by Subject|4|||
143092516|NCT02857816|515878391|FG000|Overall Study|Lost to Follow-up|1|||
143092517|NCT01597778|515878392|FG000|Overall Study|Death|7|||
143251048|NCT02059291|516472980|FG011|Epoch 2|Withdrawal by Subject|0|||
143092518|NCT01597778|515878393|FG001|Overall Study|Death|10|||
143092519|NCT01597778|515878392|FG000|Overall Study|Withdrawal by Subject|3|||
143092520|NCT01597778|515878393|FG001|Overall Study|Withdrawal by Subject|4|||
143092521|NCT01597778|515878392|FG000|Overall Study|Adverse Event|1|||
143092522|NCT01597778|515878393|FG001|Overall Study|Adverse Event|1|||
143092523|NCT01597778|515878392|FG000|Overall Study|Protocol Violation|1|||
143092524|NCT01597778|515878393|FG001|Overall Study|Protocol Violation|11|||
143251049|NCT02059291|516472981|FG012|Epoch 2|Withdrawal by Subject|0|||
143251050|NCT02059291|516472982|FG013|Epoch 2|Withdrawal by Subject|0|||
143251051|NCT02059291|516472983|FG014|Epoch 2|Withdrawal by Subject|0|||
143251052|NCT02059291|516472984|FG015|Epoch 2|Withdrawal by Subject|0|||
143251053|NCT02059291|516472985|FG016|Epoch 2|Withdrawal by Subject|0|||
143251054|NCT02059291|516472986|FG017|Epoch 2|Withdrawal by Subject|0|||
143251055|NCT02059291|516472987|FG018|Epoch 2|Withdrawal by Subject|0|||
143092525|NCT01597778|515878392|FG000|Overall Study|Transplanted off protocol|2|||
143092526|NCT01597778|515878393|FG001|Overall Study|Transplanted off protocol|3|||
143092527|NCT03326193|515878394|FG000|Overall Study|Sponsor decision|35|||
143092528|NCT01406574|515878397|FG000|Overall Study|Adverse Event|0|||
143092529|NCT01406574|515878398|FG001|Overall Study|Adverse Event|0|||
143367268|NCT04888585|516887310|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
143367269|NCT04888585|516887300|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
143367270|NCT04888585|516887301|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
143367271|NCT04888585|516887302|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
143367272|NCT04888585|516887303|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
143367273|NCT04888585|516887304|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
143367274|NCT04888585|516887305|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
143367275|NCT04888585|516887306|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
143367276|NCT04888585|516887307|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
143367277|NCT04888585|516887308|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
143367278|NCT04888585|516887309|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
143367279|NCT04888585|516887310|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
143367280|NCT04888585|516887300|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
143367281|NCT04888585|516887301|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
143367282|NCT04888585|516887302|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
143367283|NCT04888585|516887303|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
143367284|NCT04888585|516887304|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
143367285|NCT04888585|516887305|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
143367286|NCT04888585|516887306|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
143092530|NCT01406574|515878399|FG002|Overall Study|Adverse Event|1|||
143092531|NCT01406574|515878400|FG003|Overall Study|Adverse Event|3|||
143367287|NCT04888585|516887307|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
143367288|NCT04888585|516887308|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
143367289|NCT04888585|516887309|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
143367290|NCT04888585|516887310|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
143367291|NCT04888585|516887300|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
143367292|NCT04888585|516887301|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
143367293|NCT04888585|516887302|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
143367294|NCT04888585|516887303|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
143367295|NCT04888585|516887304|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
143367296|NCT04888585|516887305|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
143367297|NCT04888585|516887306|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
143367298|NCT04888585|516887307|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
143367299|NCT04888585|516887308|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
143367300|NCT04888585|516887309|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
143367301|NCT04888585|516887310|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
143367302|NCT04888585|516887300|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
143367303|NCT04888585|516887301|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
143367304|NCT04888585|516887302|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
143367305|NCT04888585|516887303|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
143367306|NCT04888585|516887304|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
143367307|NCT04888585|516887305|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
143367308|NCT04888585|516887306|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
143367309|NCT04888585|516887307|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
143367310|NCT04888585|516887308|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
143367311|NCT04888585|516887309|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
143367312|NCT04888585|516887310|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
143367313|NCT04888585|516887300|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
143367314|NCT04888585|516887301|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
143367315|NCT04888585|516887302|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
143367316|NCT04888585|516887303|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
143367317|NCT04888585|516887304|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
143367318|NCT04888585|516887305|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
143367319|NCT04888585|516887306|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
143092532|NCT01406574|515878397|FG000|Overall Study|Physician Decision|0|||
143092533|NCT01406574|515878398|FG001|Overall Study|Physician Decision|0|||
143092534|NCT01406574|515878399|FG002|Overall Study|Physician Decision|0|||
143092535|NCT01406574|515878400|FG003|Overall Study|Physician Decision|1|||
143092536|NCT01406574|515878397|FG000|Overall Study|Withdrawal by Subject|0|||
143092537|NCT01406574|515878398|FG001|Overall Study|Withdrawal by Subject|1|||
143092538|NCT01406574|515878399|FG002|Overall Study|Withdrawal by Subject|0|||
143092539|NCT01406574|515878400|FG003|Overall Study|Withdrawal by Subject|0|||
143092540|NCT01406574|515878397|FG000|Overall Study|Definite progression of primary disease|1|||
143092541|NCT01406574|515878398|FG001|Overall Study|Definite progression of primary disease|0|||
143092542|NCT01406574|515878399|FG002|Overall Study|Definite progression of primary disease|0|||
143092543|NCT01406574|515878400|FG003|Overall Study|Definite progression of primary disease|0|||
143092544|NCT03759392|515878405|FG000|Overall Study|Adverse Event|12|||
143092545|NCT03759392|515878406|FG001|Overall Study|Adverse Event|4|||
143092546|NCT03759392|515878405|FG000|Overall Study|Death|2|||
143092547|NCT03759392|515878406|FG001|Overall Study|Death|1|||
143092548|NCT03759392|515878405|FG000|Overall Study|Withdrawal by Subject|2|||
143092549|NCT03759392|515878406|FG001|Overall Study|Withdrawal by Subject|0|||
143092550|NCT03759392|515878405|FG000|Overall Study|Protocol Violation|2|||
143092551|NCT03759392|515878406|FG001|Overall Study|Protocol Violation|0|||
143092552|NCT03759392|515878405|FG000|Overall Study|Physician Decision|0|||
143092553|NCT03759392|515878406|FG001|Overall Study|Physician Decision|1|||
143092554|NCT03759392|515878405|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
143092555|NCT03759392|515878406|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
143092556|NCT03759392|515878405|FG000|Overall Study|No longer able to take medicines|1|||
143092557|NCT03759392|515878406|FG001|Overall Study|No longer able to take medicines|0|||
143092558|NCT03759392|515878405|FG000|Overall Study|Stopped taking study drug|1|||
143092559|NCT03759392|515878406|FG001|Overall Study|Stopped taking study drug|0|||
143092560|NCT01891864|515878410|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
143092561|NCT01891864|515878411|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
143092562|NCT01891864|515878412|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
143092563|NCT01891864|515878413|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
143092564|NCT01891864|515878414|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
143092565|NCT01891864|515878415|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
143092566|NCT01891864|515878410|FG000|Treatment Period 1|Physician Decision|0|||
143092567|NCT01891864|515878411|FG001|Treatment Period 1|Physician Decision|1|||
143092568|NCT01891864|515878412|FG002|Treatment Period 1|Physician Decision|0|||
143092569|NCT01891864|515878413|FG003|Treatment Period 1|Physician Decision|0|||
143092570|NCT01891864|515878414|FG004|Treatment Period 1|Physician Decision|0|||
143092571|NCT01891864|515878415|FG005|Treatment Period 1|Physician Decision|0|||
143092572|NCT01891864|515878410|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
143092573|NCT01891864|515878411|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
143092574|NCT01891864|515878412|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
143092575|NCT01891864|515878413|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
143092576|NCT01891864|515878414|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
143092577|NCT01891864|515878415|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
143092578|NCT01891864|515878410|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
143092579|NCT01891864|515878411|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
143092580|NCT01891864|515878412|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
143092581|NCT01891864|515878413|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
143092582|NCT01891864|515878414|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
143092583|NCT01891864|515878415|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
143092584|NCT01891864|515878410|FG000|Treatment Period 1|Withdrawal by Subject|2|||
143092585|NCT01891864|515878411|FG001|Treatment Period 1|Withdrawal by Subject|5|||
143092586|NCT01891864|515878412|FG002|Treatment Period 1|Withdrawal by Subject|0|||
143092587|NCT01891864|515878413|FG003|Treatment Period 1|Withdrawal by Subject|0|||
143092588|NCT01891864|515878414|FG004|Treatment Period 1|Withdrawal by Subject|0|||
143092589|NCT01891864|515878415|FG005|Treatment Period 1|Withdrawal by Subject|0|||
143367320|NCT04888585|516887307|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
143176643|NCT01815424|516196180|FG002|Week 16 to 52|Adverse Event|0|||
143176644|NCT01815424|516196181|FG003|Week 16 to 52|Adverse Event|0|||
143176645|NCT01815424|516196182|FG004|Week 16 to 52|Adverse Event|1|||
143176646|NCT01815424|516196178|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
143176647|NCT01815424|516196179|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
143176648|NCT01815424|516196180|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
143176649|NCT01815424|516196181|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
143176650|NCT01815424|516196182|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
143176651|NCT01815424|516196178|FG000|Week 16 to 52|Lost to Follow-up|0|||
143176652|NCT01815424|516196179|FG001|Week 16 to 52|Lost to Follow-up|2|||
143176653|NCT01815424|516196180|FG002|Week 16 to 52|Lost to Follow-up|0|||
143176654|NCT01815424|516196181|FG003|Week 16 to 52|Lost to Follow-up|2|||
143176655|NCT01815424|516196182|FG004|Week 16 to 52|Lost to Follow-up|1|||
143176656|NCT01815424|516196178|FG000|Week 16 to 52|Withdrawal by Subject|1|||
143176657|NCT01815424|516196179|FG001|Week 16 to 52|Withdrawal by Subject|2|||
143176658|NCT01815424|516196180|FG002|Week 16 to 52|Withdrawal by Subject|0|||
143176659|NCT01815424|516196181|FG003|Week 16 to 52|Withdrawal by Subject|0|||
143176660|NCT01815424|516196182|FG004|Week 16 to 52|Withdrawal by Subject|0|||
143176661|NCT01309204|516196183|FG000|Overall Study|Adverse Event|48|||
143176662|NCT01309204|516196184|FG001|Overall Study|Adverse Event|58|||
143176663|NCT01309204|516196183|FG000|Overall Study|Lost to Follow-up|2|||
143176664|NCT01309204|516196184|FG001|Overall Study|Lost to Follow-up|2|||
143176665|NCT01309204|516196183|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
143176666|NCT01309204|516196184|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
143176667|NCT01309204|516196183|FG000|Overall Study|Inadequate control of IOP|4|||
143176668|NCT01309204|516196184|FG001|Overall Study|Inadequate control of IOP|4|||
143176669|NCT01309204|516196183|FG000|Overall Study|Other|4|||
143176670|NCT01309204|516196184|FG001|Overall Study|Other|1|||
143176671|NCT04723355|516196185|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
143176672|NCT04723355|516196185|FG000|Overall Study|Errors in the informed consent form|2|||
143176673|NCT03374358|516196186|FG000|Overall Study|Withdrawal by Subject|0|||
143176674|NCT03374358|516196187|FG001|Overall Study|Withdrawal by Subject|2|||
143176675|NCT03183063|516196188|FG000|Overall Study|Withdrawal by Subject|2|||
143176676|NCT03183063|516196189|FG001|Overall Study|Withdrawal by Subject|0|||
143176677|NCT03183063|516196190|FG002|Overall Study|Withdrawal by Subject|0|||
143176678|NCT03183063|516196188|FG000|Overall Study|Physician Decision|3|||
143092590|NCT01891864|515878410|FG000|Treatment Period 1|Lost to Follow-up|1|||
143092591|NCT01891864|515878411|FG001|Treatment Period 1|Lost to Follow-up|0|||
143092592|NCT01891864|515878412|FG002|Treatment Period 1|Lost to Follow-up|0|||
143092593|NCT01891864|515878413|FG003|Treatment Period 1|Lost to Follow-up|0|||
143092594|NCT01891864|515878414|FG004|Treatment Period 1|Lost to Follow-up|0|||
143092595|NCT01891864|515878415|FG005|Treatment Period 1|Lost to Follow-up|0|||
143092596|NCT01891864|515878410|FG000|Treatment Period 2|Protocol Violation|0|||
143092597|NCT01891864|515878411|FG001|Treatment Period 2|Protocol Violation|0|||
143092598|NCT01891864|515878412|FG002|Treatment Period 2|Protocol Violation|0|||
143092599|NCT01891864|515878413|FG003|Treatment Period 2|Protocol Violation|1|||
143092600|NCT01891864|515878414|FG004|Treatment Period 2|Protocol Violation|0|||
143092601|NCT01891864|515878415|FG005|Treatment Period 2|Protocol Violation|0|||
143092602|NCT01891864|515878410|FG000|Treatment Period 2|Physician Decision|0|||
143092603|NCT01891864|515878411|FG001|Treatment Period 2|Physician Decision|0|||
143092604|NCT01891864|515878412|FG002|Treatment Period 2|Physician Decision|1|||
143092605|NCT01891864|515878413|FG003|Treatment Period 2|Physician Decision|0|||
143092606|NCT01891864|515878414|FG004|Treatment Period 2|Physician Decision|0|||
143092607|NCT01891864|515878415|FG005|Treatment Period 2|Physician Decision|0|||
143092608|NCT01891864|515878410|FG000|Treatment Period 2|Site Termination|0|||
143092609|NCT01891864|515878411|FG001|Treatment Period 2|Site Termination|0|||
143092610|NCT01891864|515878412|FG002|Treatment Period 2|Site Termination|1|||
143092611|NCT01891864|515878413|FG003|Treatment Period 2|Site Termination|2|||
143092612|NCT01891864|515878414|FG004|Treatment Period 2|Site Termination|0|||
143092613|NCT01891864|515878415|FG005|Treatment Period 2|Site Termination|0|||
143092614|NCT01891864|515878410|FG000|Treatment Period 2|Lack of Efficacy|0|||
143092615|NCT01891864|515878411|FG001|Treatment Period 2|Lack of Efficacy|0|||
143092616|NCT01891864|515878412|FG002|Treatment Period 2|Lack of Efficacy|1|||
143176679|NCT03183063|516196189|FG001|Overall Study|Physician Decision|4|||
143176680|NCT03183063|516196190|FG002|Overall Study|Physician Decision|4|||
143176681|NCT00688467|516196192|FG000|Treatment Period 1|Adverse Event|2|||
143176682|NCT00688467|516196193|FG001|Treatment Period 1|Adverse Event|1|||
143176683|NCT00688467|516196192|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
143176684|NCT00688467|516196193|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
143176685|NCT00688467|516196192|FG000|Treatment Period 2|Protocol Violation|0|||
143176686|NCT00688467|516196193|FG001|Treatment Period 2|Protocol Violation|1|||
143176687|NCT00688467|516196192|FG000|Treatment Period 2|Adverse Event|0|||
143176688|NCT00688467|516196193|FG001|Treatment Period 2|Adverse Event|1|||
143092617|NCT01891864|515878413|FG003|Treatment Period 2|Lack of Efficacy|0|||
143092618|NCT01891864|515878414|FG004|Treatment Period 2|Lack of Efficacy|1|||
143092619|NCT01891864|515878415|FG005|Treatment Period 2|Lack of Efficacy|0|||
143176689|NCT01881009|516196206|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
143092620|NCT01891864|515878410|FG000|Treatment Period 2|Adverse Event|0|||
143092621|NCT01891864|515878411|FG001|Treatment Period 2|Adverse Event|0|||
143092622|NCT01891864|515878412|FG002|Treatment Period 2|Adverse Event|1|||
143092623|NCT01891864|515878413|FG003|Treatment Period 2|Adverse Event|2|||
143092624|NCT01891864|515878414|FG004|Treatment Period 2|Adverse Event|0|||
143092625|NCT01891864|515878415|FG005|Treatment Period 2|Adverse Event|4|||
143092626|NCT01891864|515878410|FG000|Treatment Period 2|Termination of Site|0|||
143092627|NCT01891864|515878411|FG001|Treatment Period 2|Termination of Site|0|||
143092628|NCT01891864|515878412|FG002|Treatment Period 2|Termination of Site|0|||
143092629|NCT01891864|515878413|FG003|Treatment Period 2|Termination of Site|0|||
143092630|NCT01891864|515878414|FG004|Treatment Period 2|Termination of Site|2|||
143092631|NCT01891864|515878415|FG005|Treatment Period 2|Termination of Site|0|||
143092632|NCT01891864|515878410|FG000|Treatment Period 2|Withdrawal by Subject|0|||
143092633|NCT01891864|515878411|FG001|Treatment Period 2|Withdrawal by Subject|0|||
143092634|NCT01891864|515878412|FG002|Treatment Period 2|Withdrawal by Subject|3|||
143092635|NCT01891864|515878413|FG003|Treatment Period 2|Withdrawal by Subject|4|||
143092636|NCT01891864|515878414|FG004|Treatment Period 2|Withdrawal by Subject|1|||
143092637|NCT01891864|515878415|FG005|Treatment Period 2|Withdrawal by Subject|1|||
143092638|NCT01891864|515878410|FG000|Extension Period|Lack of Efficacy|0|||
143092639|NCT01891864|515878411|FG001|Extension Period|Lack of Efficacy|0|||
143092640|NCT01891864|515878412|FG002|Extension Period|Lack of Efficacy|0|||
143092641|NCT01891864|515878413|FG003|Extension Period|Lack of Efficacy|1|||
143092642|NCT01891864|515878414|FG004|Extension Period|Lack of Efficacy|1|||
143092643|NCT01891864|515878415|FG005|Extension Period|Lack of Efficacy|0|||
143092644|NCT01891864|515878410|FG000|Extension Period|Pregnancy|0|||
143092645|NCT01891864|515878411|FG001|Extension Period|Pregnancy|0|||
143092646|NCT01891864|515878412|FG002|Extension Period|Pregnancy|1|||
143092647|NCT01891864|515878413|FG003|Extension Period|Pregnancy|0|||
143176690|NCT01881009|516196207|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
143176691|NCT02216526|516196211|FG000|Overall Study|Adverse Event|1|||
143176692|NCT02216526|516196212|FG001|Overall Study|Adverse Event|1|||
143176693|NCT02216526|516196213|FG002|Overall Study|Adverse Event|0|||
143176694|NCT02216526|516196211|FG000|Overall Study|Death|0|||
143176695|NCT02216526|516196212|FG001|Overall Study|Death|1|||
143176696|NCT02216526|516196213|FG002|Overall Study|Death|3|||
143176697|NCT02216526|516196211|FG000|Overall Study|Protocol Violation|2|||
143176698|NCT02216526|516196212|FG001|Overall Study|Protocol Violation|0|||
143176699|NCT02216526|516196213|FG002|Overall Study|Protocol Violation|2|||
143176700|NCT02216526|516196211|FG000|Overall Study|Hospitalization|2|||
143176701|NCT02216526|516196212|FG001|Overall Study|Hospitalization|1|||
143176702|NCT02216526|516196213|FG002|Overall Study|Hospitalization|3|||
143092648|NCT01891864|515878414|FG004|Extension Period|Pregnancy|0|||
143092649|NCT01891864|515878415|FG005|Extension Period|Pregnancy|0|||
143092650|NCT01891864|515878410|FG000|Extension Period|Adverse Event|0|||
143092651|NCT01891864|515878411|FG001|Extension Period|Adverse Event|0|||
143092652|NCT01891864|515878412|FG002|Extension Period|Adverse Event|4|||
143092653|NCT01891864|515878413|FG003|Extension Period|Adverse Event|2|||
143176703|NCT00461708|516196214|FG000|Overall Study|Adverse Event|17|||
143176704|NCT00461708|516196215|FG001|Overall Study|Adverse Event|7|||
143176705|NCT00461708|516196214|FG000|Overall Study|Lack of Efficacy|68|||
143092654|NCT01891864|515878414|FG004|Extension Period|Adverse Event|2|||
143092655|NCT01891864|515878415|FG005|Extension Period|Adverse Event|0|||
143092656|NCT01891864|515878410|FG000|Extension Period|Withdrawal by Subject|0|||
143092657|NCT01891864|515878411|FG001|Extension Period|Withdrawal by Subject|0|||
143092658|NCT01891864|515878412|FG002|Extension Period|Withdrawal by Subject|1|||
143092659|NCT01891864|515878413|FG003|Extension Period|Withdrawal by Subject|2|||
143092660|NCT01891864|515878414|FG004|Extension Period|Withdrawal by Subject|4|||
143092661|NCT01891864|515878415|FG005|Extension Period|Withdrawal by Subject|0|||
143092662|NCT01891864|515878410|FG000|Extension Period|Lost to Follow-up|0|||
143092663|NCT01891864|515878411|FG001|Extension Period|Lost to Follow-up|0|||
143092664|NCT01891864|515878412|FG002|Extension Period|Lost to Follow-up|2|||
143092665|NCT01891864|515878413|FG003|Extension Period|Lost to Follow-up|0|||
143092666|NCT01891864|515878414|FG004|Extension Period|Lost to Follow-up|0|||
143092667|NCT01891864|515878415|FG005|Extension Period|Lost to Follow-up|0|||
143092668|NCT01709500|515878416|FG000|Overall Study|Randomized but not treated|0|||
143092669|NCT01709500|515878417|FG001|Overall Study|Randomized but not treated|1|||
143092670|NCT01709500|515878416|FG000|Overall Study|Adverse Event|5|||
143092671|NCT01709500|515878417|FG001|Overall Study|Adverse Event|1|||
143092672|NCT01709500|515878416|FG000|Overall Study|Poor compliance to protocol|2|||
143092673|NCT01709500|515878417|FG001|Overall Study|Poor compliance to protocol|1|||
143092674|NCT01709500|515878416|FG000|Overall Study|Other|3|||
143092675|NCT01709500|515878417|FG001|Overall Study|Other|1|||
143092676|NCT01709500|515878416|FG000|Overall Study|Related to IMP administration|1|||
143092677|NCT01709500|515878417|FG001|Overall Study|Related to IMP administration|0|||
143092678|NCT01709500|515878416|FG000|Overall Study|Treatment ongoing|156|||
143092679|NCT01709500|515878417|FG001|Overall Study|Treatment ongoing|78|||
143092680|NCT00420420|515878418|FG000|Overall Study|Adverse Event|5|||
143092681|NCT00420420|515878419|FG001|Overall Study|Adverse Event|3|||
143092682|NCT00420420|515878418|FG000|Overall Study|Protocol Violation|1|||
143092683|NCT00420420|515878419|FG001|Overall Study|Protocol Violation|1|||
143092684|NCT00420420|515878418|FG000|Overall Study|Withdrawal by Subject|1|||
143092685|NCT00420420|515878419|FG001|Overall Study|Withdrawal by Subject|0|||
143092686|NCT00420420|515878418|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
143092687|NCT00420420|515878419|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
143092688|NCT00955617|515878420|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
143092689|NCT00955617|515878421|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
143092690|NCT00955617|515878420|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
143092691|NCT00955617|515878421|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
143092692|NCT00955617|515878420|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
143092693|NCT00955617|515878421|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
143092694|NCT00955617|515878420|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
143092695|NCT00955617|515878421|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
143092696|NCT06025721|515880283|FG000|Overall Study|Physician Decision|1|||
143092697|NCT06025721|515880283|FG000|Overall Study|Protocol Violation|1|||
143092698|NCT06025721|515880283|FG000|Overall Study|Incarceration|1|||
143092699|NCT03103087|515880287|FG000|Overall Study|Did not receive any study drug|1|||
143092700|NCT03103087|515880288|FG001|Overall Study|Did not receive any study drug|0|||
143092701|NCT03103087|515880289|FG002|Overall Study|Did not receive any study drug|0|||
143092702|NCT03103087|515880287|FG000|Overall Study|Protocol Violation|1|||
143092703|NCT03103087|515880288|FG001|Overall Study|Protocol Violation|2|||
143092704|NCT03103087|515880289|FG002|Overall Study|Protocol Violation|1|||
143092705|NCT03103087|515880287|FG000|Overall Study|Lack of Efficacy|2|||
143092706|NCT03103087|515880288|FG001|Overall Study|Lack of Efficacy|1|||
143092707|NCT03103087|515880289|FG002|Overall Study|Lack of Efficacy|1|||
143092708|NCT03103087|515880287|FG000|Overall Study|Pregnancy|0|||
143092709|NCT03103087|515880288|FG001|Overall Study|Pregnancy|0|||
143092710|NCT03103087|515880289|FG002|Overall Study|Pregnancy|1|||
143092711|NCT03103087|515880287|FG000|Overall Study|Adverse Event|2|||
143092712|NCT03103087|515880288|FG001|Overall Study|Adverse Event|15|||
143092713|NCT03103087|515880289|FG002|Overall Study|Adverse Event|6|||
143092714|NCT03103087|515880287|FG000|Overall Study|Withdrawal by Subject|13|||
143092715|NCT03103087|515880288|FG001|Overall Study|Withdrawal by Subject|6|||
143092716|NCT03103087|515880289|FG002|Overall Study|Withdrawal by Subject|6|||
143092717|NCT03103087|515880287|FG000|Overall Study|Lost to Follow-up|4|||
143092718|NCT03103087|515880288|FG001|Overall Study|Lost to Follow-up|2|||
143092719|NCT03103087|515880289|FG002|Overall Study|Lost to Follow-up|7|||
143092720|NCT03103087|515880287|FG000|Overall Study|Other reason not reported|1|||
143092721|NCT03103087|515880288|FG001|Overall Study|Other reason not reported|3|||
143092722|NCT03103087|515880289|FG002|Overall Study|Other reason not reported|5|||
143092723|NCT02832687|515880290|FG000|Overall Study|Adverse Event|0|||
143092724|NCT02832687|515880291|FG001|Overall Study|Adverse Event|2|||
143092725|NCT03192488|515880292|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
143092726|NCT03192488|515880293|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
143092727|NCT03192488|515880294|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
143092728|NCT03192488|515880295|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
143092729|NCT03192488|515880296|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
143092730|NCT03192488|515880297|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
143092731|NCT03192488|515880292|FG000|Third Intervention (d1)|Adverse Event|0|||
143092732|NCT03192488|515880293|FG001|Third Intervention (d1)|Adverse Event|0|||
143092733|NCT03192488|515880294|FG002|Third Intervention (d1)|Adverse Event|0|||
143092734|NCT03192488|515880295|FG003|Third Intervention (d1)|Adverse Event|0|||
143092735|NCT03192488|515880296|FG004|Third Intervention (d1)|Adverse Event|1|||
143092736|NCT03192488|515880297|FG005|Third Intervention (d1)|Adverse Event|0|||
143092737|NCT03588910|515880299|FG000|Overall Study|Withdrawal by Subject|1|||
143092738|NCT03588910|515880300|FG001|Overall Study|Withdrawal by Subject|0|||
143092739|NCT03588910|515880299|FG000|Overall Study|Allergy|2|||
143092740|NCT03588910|515880300|FG001|Overall Study|Allergy|0|||
143092741|NCT03588910|515880299|FG000|Overall Study|Protocol Violation|0|||
143092742|NCT03588910|515880300|FG001|Overall Study|Protocol Violation|3|||
143092743|NCT03588910|515880299|FG000|Overall Study|Did not complete Day 1 Survey|5|||
143092744|NCT03588910|515880300|FG001|Overall Study|Did not complete Day 1 Survey|10|||
143092745|NCT03588910|515880299|FG000|Overall Study|Did not complete Day 7 Survey|5|||
143092746|NCT03588910|515880300|FG001|Overall Study|Did not complete Day 7 Survey|2|||
143092747|NCT02547428|515880301|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
143092748|NCT02547428|515880302|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
143092749|NCT02547428|515880301|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
143092750|NCT02547428|515880302|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
143092751|NCT02547428|515880301|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
143092752|NCT02547428|515880302|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
143092753|NCT02547428|515880301|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
143092754|NCT02547428|515880302|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
143092755|NCT02547428|515880301|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
143092756|NCT02547428|515880302|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
143092757|NCT02547428|515880301|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
143092758|NCT02547428|515880302|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
143092759|NCT02547428|515880301|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
143092760|NCT02547428|515880302|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
143092761|NCT02547428|515880301|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
143092762|NCT02547428|515880302|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
143092763|NCT04429503|515880305|FG000|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|2|||
143092764|NCT04429503|515880306|FG001|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|1|||
143092765|NCT04429503|515880307|FG002|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
143092766|NCT04429503|515880308|FG003|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
143092767|NCT04429503|515880309|FG004|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
143092768|NCT04429503|515880310|FG005|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
143092769|NCT04429503|515880305|FG000|Main Study (Up to Wk 96)|Adverse Event|1|||
143092770|NCT04429503|515880306|FG001|Main Study (Up to Wk 96)|Adverse Event|9|||
143092771|NCT04429503|515880307|FG002|Main Study (Up to Wk 96)|Adverse Event|2|||
143092772|NCT04429503|515880308|FG003|Main Study (Up to Wk 96)|Adverse Event|0|||
143092773|NCT04429503|515880309|FG004|Main Study (Up to Wk 96)|Adverse Event|0|||
143092774|NCT04429503|515880310|FG005|Main Study (Up to Wk 96)|Adverse Event|0|||
143092775|NCT04429503|515880305|FG000|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|2|||
143092776|NCT04429503|515880306|FG001|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|9|||
143092777|NCT04429503|515880307|FG002|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|3|||
143092778|NCT04429503|515880308|FG003|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
143092779|NCT04429503|515880309|FG004|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
143092780|NCT04429503|515880310|FG005|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
143092781|NCT04429503|515880305|FG000|Main Study (Up to Wk 96)|Withdrawal by Subject|9|||
143092782|NCT04429503|515880306|FG001|Main Study (Up to Wk 96)|Withdrawal by Subject|17|||
143092783|NCT04429503|515880307|FG002|Main Study (Up to Wk 96)|Withdrawal by Subject|8|||
143092784|NCT04429503|515880308|FG003|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
143092785|NCT04429503|515880309|FG004|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
143092786|NCT04429503|515880310|FG005|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
143092787|NCT04429503|515880305|FG000|Main Study (Up to Wk 96)|Lost to Follow-up|5|||
143092788|NCT04429503|515880306|FG001|Main Study (Up to Wk 96)|Lost to Follow-up|19|||
143092789|NCT04429503|515880307|FG002|Main Study (Up to Wk 96)|Lost to Follow-up|7|||
143092790|NCT04429503|515880308|FG003|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
143092791|NCT04429503|515880309|FG004|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
143092792|NCT04429503|515880310|FG005|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
143092793|NCT04429503|515880305|FG000|Main Study (Up to Wk 96)|Death|9|||
143092794|NCT04429503|515880306|FG001|Main Study (Up to Wk 96)|Death|18|||
143092795|NCT04429503|515880307|FG002|Main Study (Up to Wk 96)|Death|5|||
143092796|NCT04429503|515880308|FG003|Main Study (Up to Wk 96)|Death|0|||
143092797|NCT04429503|515880309|FG004|Main Study (Up to Wk 96)|Death|0|||
143092798|NCT04429503|515880310|FG005|Main Study (Up to Wk 96)|Death|0|||
143092799|NCT04429503|515880305|FG000|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
143092800|NCT04429503|515880306|FG001|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
143092801|NCT04429503|515880307|FG002|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
143092802|NCT04429503|515880308|FG003|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|1|||
143092803|NCT04429503|515880309|FG004|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
143092804|NCT04429503|515880310|FG005|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
143092805|NCT04429503|515880305|FG000|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
143092806|NCT04429503|515880306|FG001|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
143092807|NCT04429503|515880307|FG002|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
143092808|NCT04429503|515880308|FG003|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
143092809|NCT04429503|515880309|FG004|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
143092810|NCT04429503|515880310|FG005|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
143092811|NCT04429503|515880305|FG000|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
143092812|NCT04429503|515880306|FG001|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
143092813|NCT04429503|515880307|FG002|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
143092814|NCT04429503|515880308|FG003|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
143092815|NCT04429503|515880309|FG004|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|3|||
143092816|NCT04429503|515880310|FG005|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|2|||
143092817|NCT04429503|515880305|FG000|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
143092818|NCT04429503|515880306|FG001|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
143092819|NCT04429503|515880307|FG002|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
143092820|NCT04429503|515880308|FG003|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
143092821|NCT04429503|515880309|FG004|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|10|||
143092822|NCT04429503|515880310|FG005|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
143092823|NCT04429503|515880305|FG000|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
143092824|NCT04429503|515880306|FG001|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
143092825|NCT04429503|515880307|FG002|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
143092826|NCT04429503|515880308|FG003|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|3|||
143092827|NCT04429503|515880309|FG004|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
143092828|NCT04429503|515880310|FG005|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
143092829|NCT04429503|515880305|FG000|Extension Phase (Wk 96 to Wk 156)|Death|0|||
143092830|NCT04429503|515880306|FG001|Extension Phase (Wk 96 to Wk 156)|Death|0|||
143092831|NCT04429503|515880307|FG002|Extension Phase (Wk 96 to Wk 156)|Death|0|||
143092832|NCT04429503|515880308|FG003|Extension Phase (Wk 96 to Wk 156)|Death|2|||
143092833|NCT04429503|515880309|FG004|Extension Phase (Wk 96 to Wk 156)|Death|7|||
143092834|NCT04429503|515880310|FG005|Extension Phase (Wk 96 to Wk 156)|Death|2|||
143092835|NCT02717507|515880311|FG000|Overall Study|Lost to Follow-up|5|||
143092836|NCT02717507|515880312|FG001|Overall Study|Lost to Follow-up|8|||
143367321|NCT04888585|516887308|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
143367322|NCT04888585|516887309|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
143367323|NCT04888585|516887310|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
143367324|NCT04888585|516887300|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
143367325|NCT04888585|516887301|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
143367326|NCT04888585|516887302|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
143367327|NCT04888585|516887303|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
143367328|NCT04888585|516887304|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
143367329|NCT04888585|516887305|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
143367330|NCT04888585|516887306|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
143092837|NCT02717507|515880311|FG000|Overall Study|Pregnancy|1|||
143092838|NCT02717507|515880312|FG001|Overall Study|Pregnancy|1|||
143092839|NCT02717507|515880311|FG000|Overall Study|Protocol Violation|2|||
143092840|NCT02717507|515880312|FG001|Overall Study|Protocol Violation|2|||
143092841|NCT02717507|515880311|FG000|Overall Study|Withdrawal by Subject|20|||
143092842|NCT02717507|515880312|FG001|Overall Study|Withdrawal by Subject|20|||
143092843|NCT02717507|515880311|FG000|Overall Study|Relapse|1|||
143092844|NCT02717507|515880312|FG001|Overall Study|Relapse|1|||
143092845|NCT02717507|515880311|FG000|Overall Study|Cardiac Event|2|||
143092846|NCT02717507|515880312|FG001|Overall Study|Cardiac Event|6|||
143092847|NCT02003209|515880313|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
143092848|NCT02003209|515880314|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
143092849|NCT00638508|515880315|FG000|Overall Study|Physician Decision|5|||
143092850|NCT00638508|515880316|FG001|Overall Study|Physician Decision|2|||
143092851|NCT03500198|515880317|FG000|Overall Study|Lost to Follow-up|0|||
143092852|NCT03500198|515880318|FG001|Overall Study|Lost to Follow-up|1|||
143092853|NCT00595621|515880324|FG000|Open Label Run in|Adverse Event|1|||
143092854|NCT00595621|515880325|FG001|Open Label Run in|Adverse Event|0|||
143092855|NCT00595621|515880324|FG000|Open Label Run in|Physician Decision|1|||
143092856|NCT00595621|515880325|FG001|Open Label Run in|Physician Decision|0|||
143092857|NCT00595621|515880324|FG000|Open Label Run in|Withdrawal by Subject|1|||
143092858|NCT00595621|515880325|FG001|Open Label Run in|Withdrawal by Subject|0|||
143092859|NCT00595621|515880324|FG000|Randomization and Study|Adverse Event|2|||
143092860|NCT00595621|515880325|FG001|Randomization and Study|Adverse Event|0|||
143092861|NCT00595621|515880324|FG000|Randomization and Study|Withdrawal by Subject|0|||
143092862|NCT00595621|515880325|FG001|Randomization and Study|Withdrawal by Subject|1|||
143092863|NCT00324987|515880326|FG000|Overall Study|Adverse Event|2|||
143092864|NCT00324987|515880327|FG001|Overall Study|Adverse Event|1|||
143092865|NCT00324987|515880326|FG000|Overall Study|Withdrawal by Subject|1|||
143092866|NCT00324987|515880327|FG001|Overall Study|Withdrawal by Subject|1|||
143092867|NCT00324987|515880326|FG000|Overall Study|Progression|1|||
143092868|NCT00324987|515880327|FG001|Overall Study|Progression|1|||
143092869|NCT00324987|515880326|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
143092870|NCT00324987|515880327|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
143092871|NCT02502149|515880328|FG000|Intermediate|Discontinued prematurely|1|||
143092872|NCT02502149|515880329|FG001|Intermediate|Discontinued prematurely|0|||
143092873|NCT02502149|515880330|FG002|Intermediate|Discontinued prematurely|0|||
143092874|NCT02502149|515880331|FG003|Intermediate|Discontinued prematurely|0|||
143092875|NCT02502149|515880332|FG004|Intermediate|Discontinued prematurely|0|||
143092876|NCT00927589|515880335|FG000|Overall Study|Death|1|||
143092877|NCT00927589|515880335|FG000|Overall Study|Physician Decision|1|||
143092878|NCT00927589|515880335|FG000|Overall Study|Withdrawal by Subject|3|||
143092879|NCT00927589|515880335|FG000|Overall Study|Adverse Event|2|||
143092880|NCT00927589|515880335|FG000|Overall Study|Disease Progression|8|||
143092881|NCT00927589|515880335|FG000|Overall Study|Non-compliance|1|||
143092882|NCT00513240|515880337|FG000|Overall Study|Did not have intended surgery|3|||
143092883|NCT00513240|515880338|FG001|Overall Study|Did not have intended surgery|0|||
143092884|NCT00513240|515880337|FG000|Overall Study|Death|3|||
143092885|NCT00513240|515880338|FG001|Overall Study|Death|3|||
143092886|NCT00513240|515880337|FG000|Overall Study|Withdrawal by Subject|7|||
143092887|NCT00513240|515880338|FG001|Overall Study|Withdrawal by Subject|4|||
143092888|NCT05263908|515880339|FG000|Overall Study|No informed consent for publication of study results|397|||
143092889|NCT05263908|515880339|FG000|Overall Study|CRF not collected|1|||
143092890|NCT02088177|515880344|FG000|Overall Study|Lost to Follow-up|3|||
143092891|NCT01894919|515880346|FG000|Overall Study|Withdrawal by Subject|1|||
143092892|NCT01894919|515880347|FG001|Overall Study|Withdrawal by Subject|0|||
143092893|NCT01894919|515880348|FG002|Overall Study|Withdrawal by Subject|0|||
143092894|NCT01894919|515880349|FG003|Overall Study|Withdrawal by Subject|0|||
143092895|NCT01894919|515880350|FG004|Overall Study|Withdrawal by Subject|1|||
143092896|NCT01894919|515880351|FG005|Overall Study|Withdrawal by Subject|0|||
143092897|NCT01894919|515880352|FG006|Overall Study|Withdrawal by Subject|0|||
143092898|NCT01894919|515880353|FG007|Overall Study|Withdrawal by Subject|0|||
143092899|NCT01894919|515880354|FG008|Overall Study|Withdrawal by Subject|0|||
143092900|NCT01894919|515880355|FG009|Overall Study|Withdrawal by Subject|1|||
143092901|NCT01894919|515880356|FG010|Overall Study|Withdrawal by Subject|1|||
143092902|NCT01894919|515880357|FG011|Overall Study|Withdrawal by Subject|0|||
143092903|NCT01894919|515880358|FG012|Overall Study|Withdrawal by Subject|0|||
143092904|NCT01894919|515880346|FG000|Overall Study|Adverse Event|0|||
143092905|NCT01894919|515880347|FG001|Overall Study|Adverse Event|0|||
143092906|NCT01894919|515880348|FG002|Overall Study|Adverse Event|0|||
143092907|NCT01894919|515880349|FG003|Overall Study|Adverse Event|0|||
143092908|NCT01894919|515880350|FG004|Overall Study|Adverse Event|0|||
143092909|NCT01894919|515880351|FG005|Overall Study|Adverse Event|0|||
143092910|NCT01894919|515880352|FG006|Overall Study|Adverse Event|0|||
143092911|NCT01894919|515880353|FG007|Overall Study|Adverse Event|0|||
143092912|NCT01894919|515880354|FG008|Overall Study|Adverse Event|0|||
143092913|NCT01894919|515880355|FG009|Overall Study|Adverse Event|0|||
143092914|NCT01894919|515880356|FG010|Overall Study|Adverse Event|1|||
143092915|NCT01894919|515880357|FG011|Overall Study|Adverse Event|0|||
143092916|NCT01894919|515880358|FG012|Overall Study|Adverse Event|0|||
143092917|NCT01894919|515880346|FG000|Overall Study|Other-Unspecified|1|||
143092918|NCT01894919|515880347|FG001|Overall Study|Other-Unspecified|0|||
143092919|NCT01894919|515880348|FG002|Overall Study|Other-Unspecified|0|||
143092920|NCT01894919|515880349|FG003|Overall Study|Other-Unspecified|0|||
143092921|NCT01894919|515880350|FG004|Overall Study|Other-Unspecified|0|||
143092922|NCT01894919|515880351|FG005|Overall Study|Other-Unspecified|0|||
143092923|NCT01894919|515880352|FG006|Overall Study|Other-Unspecified|0|||
143092924|NCT01894919|515880353|FG007|Overall Study|Other-Unspecified|0|||
143092925|NCT01894919|515880354|FG008|Overall Study|Other-Unspecified|0|||
143092926|NCT01894919|515880355|FG009|Overall Study|Other-Unspecified|0|||
143092927|NCT01894919|515880356|FG010|Overall Study|Other-Unspecified|0|||
143092928|NCT01894919|515880357|FG011|Overall Study|Other-Unspecified|0|||
143092929|NCT01894919|515880358|FG012|Overall Study|Other-Unspecified|0|||
143092930|NCT01894919|515880346|FG000|Overall Study|Lost to Follow-up|0|||
143092931|NCT01894919|515880347|FG001|Overall Study|Lost to Follow-up|0|||
143092932|NCT01894919|515880348|FG002|Overall Study|Lost to Follow-up|0|||
143092933|NCT01894919|515880349|FG003|Overall Study|Lost to Follow-up|0|||
143092934|NCT01894919|515880350|FG004|Overall Study|Lost to Follow-up|2|||
143092935|NCT01894919|515880351|FG005|Overall Study|Lost to Follow-up|0|||
143092936|NCT01894919|515880352|FG006|Overall Study|Lost to Follow-up|0|||
143092937|NCT01894919|515880353|FG007|Overall Study|Lost to Follow-up|0|||
143092938|NCT01894919|515880354|FG008|Overall Study|Lost to Follow-up|0|||
143092939|NCT01894919|515880355|FG009|Overall Study|Lost to Follow-up|0|||
143092940|NCT01894919|515880356|FG010|Overall Study|Lost to Follow-up|0|||
143092941|NCT01894919|515880357|FG011|Overall Study|Lost to Follow-up|0|||
143092942|NCT01894919|515880358|FG012|Overall Study|Lost to Follow-up|0|||
143092943|NCT00882518|515880359|FG000|Overall Study|Adverse Event|9|||
143092944|NCT00882518|515880360|FG001|Overall Study|Adverse Event|18|||
143092945|NCT00882518|515880359|FG000|Overall Study|Withdrawal by Subject|9|||
143092946|NCT00882518|515880360|FG001|Overall Study|Withdrawal by Subject|13|||
143092947|NCT00882518|515880359|FG000|Overall Study|Lack of Efficacy|12|||
143092948|NCT00882518|515880360|FG001|Overall Study|Lack of Efficacy|9|||
143092949|NCT00882518|515880359|FG000|Overall Study|Severe non-compliance to protocol|3|||
143092950|NCT00882518|515880360|FG001|Overall Study|Severe non-compliance to protocol|1|||
143092951|NCT00882518|515880359|FG000|Overall Study|Incorrect enrolment|4|||
143092952|NCT00882518|515880360|FG001|Overall Study|Incorrect enrolment|2|||
143092953|NCT00882518|515880359|FG000|Overall Study|Central lab closure for National day|1|||
143092954|NCT00882518|515880360|FG001|Overall Study|Central lab closure for National day|0|||
143092955|NCT00882518|515880359|FG000|Overall Study|Allocating random number by mistake|0|||
143092956|NCT00882518|515880360|FG001|Overall Study|Allocating random number by mistake|1|||
143092957|NCT03711188|515880361|FG000|Overall Study|Disease progression|11|||
143092958|NCT03711188|515880361|FG000|Overall Study|Adverse Event|1|||
143092959|NCT01433471|515880362|FG000|Overall Study|Withdrawal by Subject|0|||
143092960|NCT01433471|515880363|FG001|Overall Study|Withdrawal by Subject|1|||
143092961|NCT03238651|515880368|FG000|Overall Study|Other|0|||
143092962|NCT03238651|515880369|FG001|Overall Study|Other|0|||
143092963|NCT03238651|515880370|FG002|Overall Study|Other|0|||
143092964|NCT03238651|515880371|FG003|Overall Study|Other|0|||
143092965|NCT03238651|515880372|FG004|Overall Study|Other|1|||
143092966|NCT03238651|515880368|FG000|Overall Study|Progressive Disease|2|||
143092967|NCT03238651|515880369|FG001|Overall Study|Progressive Disease|2|||
143092968|NCT03238651|515880370|FG002|Overall Study|Progressive Disease|2|||
143092969|NCT03238651|515880371|FG003|Overall Study|Progressive Disease|2|||
143092970|NCT03238651|515880372|FG004|Overall Study|Progressive Disease|0|||
143092971|NCT03238651|515880368|FG000|Overall Study|Withdrawal by Subject|0|||
143092972|NCT03238651|515880369|FG001|Overall Study|Withdrawal by Subject|1|||
143092973|NCT03238651|515880370|FG002|Overall Study|Withdrawal by Subject|0|||
143092974|NCT03238651|515880371|FG003|Overall Study|Withdrawal by Subject|1|||
143092975|NCT03238651|515880372|FG004|Overall Study|Withdrawal by Subject|0|||
143092976|NCT03238651|515880368|FG000|Overall Study|Adverse Event|1|||
143092977|NCT03238651|515880369|FG001|Overall Study|Adverse Event|3|||
143092978|NCT03238651|515880370|FG002|Overall Study|Adverse Event|2|||
143092979|NCT03238651|515880371|FG003|Overall Study|Adverse Event|0|||
143092980|NCT03238651|515880372|FG004|Overall Study|Adverse Event|0|||
143092981|NCT02137252|515880373|FG000|Overall Study|trial terminated early|2|||
143092982|NCT02137252|515880374|FG001|Overall Study|trial terminated early|1|||
143092983|NCT04341363|515880375|FG000|Overall Study|Adverse Event|1|||
143092984|NCT04341363|515880375|FG000|Overall Study|Withdrawal by Subject|1|||
143092985|NCT00063934|515880376|FG000|Overall Study|Ineligible|1|||
143251056|NCT02059291|516472988|FG019|Epoch 2|Withdrawal by Subject|0|||
143251057|NCT02059291|516472989|FG020|Epoch 2|Withdrawal by Subject|0|||
143251058|NCT02059291|516472990|FG021|Epoch 2|Withdrawal by Subject|0|||
143251059|NCT02059291|516472991|FG022|Epoch 2|Withdrawal by Subject|0|||
143251060|NCT02059291|516472992|FG023|Epoch 2|Withdrawal by Subject|0|||
143251061|NCT02059291|516472993|FG024|Epoch 2|Withdrawal by Subject|0|||
143251062|NCT02059291|516472969|FG000|Epoch 3|Physician Decision|0|||
143251063|NCT02059291|516472970|FG001|Epoch 3|Physician Decision|0|||
143251064|NCT02059291|516472971|FG002|Epoch 3|Physician Decision|0|||
143251065|NCT02059291|516472972|FG003|Epoch 3|Physician Decision|0|||
143251066|NCT02059291|516472973|FG004|Epoch 3|Physician Decision|0|||
143251067|NCT02059291|516472974|FG005|Epoch 3|Physician Decision|0|||
143251068|NCT02059291|516472975|FG006|Epoch 3|Physician Decision|0|||
143251069|NCT02059291|516472976|FG007|Epoch 3|Physician Decision|0|||
143251070|NCT02059291|516472977|FG008|Epoch 3|Physician Decision|0|||
143251071|NCT02059291|516472978|FG009|Epoch 3|Physician Decision|0|||
143251072|NCT02059291|516472979|FG010|Epoch 3|Physician Decision|0|||
143251073|NCT02059291|516472980|FG011|Epoch 3|Physician Decision|0|||
143251074|NCT02059291|516472981|FG012|Epoch 3|Physician Decision|0|||
143092986|NCT01930162|515880377|FG000|Overall Study|Abnormal test procedure result(s)|4|||
143092987|NCT01930162|515880377|FG000|Overall Study|Death|1|||
143092988|NCT02550561|515880378|FG000|Overall Study|Lost to Follow-up|5|||
143092989|NCT02550561|515880378|FG000|Overall Study|Withdrawal by Subject|1|||
143092990|NCT03051100|515880380|FG000|Overall Study|Withdrawal by Subject|1|||
143251075|NCT02059291|516472982|FG013|Epoch 3|Physician Decision|1|||
143251076|NCT02059291|516472983|FG014|Epoch 3|Physician Decision|0|||
143092991|NCT03051100|515880381|FG001|Overall Study|Withdrawal by Subject|0|||
143092992|NCT03776357|515880384|FG000|Overall Study|Lost to Follow-up|3|||
143092993|NCT03335475|515880387|FG000|Overall Study|Did not wear accelerometer|4|||
143092994|NCT03335475|515880388|FG001|Overall Study|Did not wear accelerometer|0|||
143251077|NCT02059291|516472984|FG015|Epoch 3|Physician Decision|1|||
143251078|NCT02059291|516472985|FG016|Epoch 3|Physician Decision|0|||
143092995|NCT03335475|515880387|FG000|Overall Study|Withdrawal by Subject|0|||
143092996|NCT03335475|515880388|FG001|Overall Study|Withdrawal by Subject|1|||
143092997|NCT06481709|515880389|FG000|Overall Study|Withdrawal by Subject|0|||
143092998|NCT06481709|515880390|FG001|Overall Study|Withdrawal by Subject|0|||
143092999|NCT06481709|515880391|FG002|Overall Study|Withdrawal by Subject|2|||
143093000|NCT06481709|515880392|FG003|Overall Study|Withdrawal by Subject|0|||
143093001|NCT05921903|515880393|FG000|Overall Study|Unsolicited non-SAE|0|||
143093002|NCT05921903|515880394|FG001|Overall Study|Unsolicited non-SAE|1|||
143093003|NCT05921903|515880395|FG002|Overall Study|Unsolicited non-SAE|0|||
143093004|NCT05921903|515880393|FG000|Overall Study|SAEs/pIMDs/AESIs specific to SOT|0|||
143093005|NCT05921903|515880394|FG001|Overall Study|SAEs/pIMDs/AESIs specific to SOT|3|||
143093006|NCT05921903|515880395|FG002|Overall Study|SAEs/pIMDs/AESIs specific to SOT|1|||
143093007|NCT05921903|515880393|FG000|Overall Study|Ongoing at the time of Primary Completion Analysis|129|||
143093008|NCT05921903|515880394|FG001|Overall Study|Ongoing at the time of Primary Completion Analysis|126|||
143093009|NCT05921903|515880395|FG002|Overall Study|Ongoing at the time of Primary Completion Analysis|112|||
143093010|NCT00789854|515880398|FG000|Overall Study|Adverse Event|28|||
143093011|NCT00789854|515880399|FG001|Overall Study|Adverse Event|23|||
143093012|NCT00789854|515880400|FG002|Overall Study|Adverse Event|18|||
143093013|NCT00789854|515880398|FG000|Overall Study|Lost to Follow-up|1|||
143093014|NCT00789854|515880399|FG001|Overall Study|Lost to Follow-up|1|||
143093015|NCT00789854|515880400|FG002|Overall Study|Lost to Follow-up|4|||
143093016|NCT00789854|515880398|FG000|Overall Study|Withdrawal by Subject|9|||
143093017|NCT00789854|515880399|FG001|Overall Study|Withdrawal by Subject|6|||
143093018|NCT00789854|515880400|FG002|Overall Study|Withdrawal by Subject|17|||
143093019|NCT00789854|515880398|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
143093020|NCT00789854|515880399|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
143093021|NCT00789854|515880400|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
143093022|NCT00789854|515880398|FG000|Overall Study|Severe non-compliance to the protocol|3|||
143093023|NCT00789854|515880399|FG001|Overall Study|Severe non-compliance to the protocol|0|||
143093024|NCT00789854|515880400|FG002|Overall Study|Severe non-compliance to the protocol|0|||
143093025|NCT00789854|515880398|FG000|Overall Study|Safety reasons|0|||
143093026|NCT00789854|515880399|FG001|Overall Study|Safety reasons|0|||
143093027|NCT00789854|515880400|FG002|Overall Study|Safety reasons|2|||
143093028|NCT00789854|515880398|FG000|Overall Study|Other|6|||
143093029|NCT00789854|515880399|FG001|Overall Study|Other|0|||
143093030|NCT00789854|515880400|FG002|Overall Study|Other|5|||
143093031|NCT00923013|515880401|FG000|Overall Study|Refused further treatment|0|||
143093032|NCT00923013|515880402|FG001|Overall Study|Refused further treatment|1|||
143093033|NCT00923013|515880403|FG002|Overall Study|Refused further treatment|2|||
143093034|NCT00923013|515880404|FG003|Overall Study|Refused further treatment|0|||
143093035|NCT00923013|515880405|FG004|Overall Study|Refused further treatment|0|||
143093036|NCT00923013|515880406|FG005|Overall Study|Refused further treatment|0|||
143093037|NCT00923013|515880401|FG000|Overall Study|Switched to alternative treatment|0|||
143093038|NCT00923013|515880402|FG001|Overall Study|Switched to alternative treatment|1|||
143093039|NCT00923013|515880403|FG002|Overall Study|Switched to alternative treatment|0|||
143093040|NCT00923013|515880404|FG003|Overall Study|Switched to alternative treatment|0|||
143093041|NCT00923013|515880405|FG004|Overall Study|Switched to alternative treatment|0|||
143093042|NCT00923013|515880406|FG005|Overall Study|Switched to alternative treatment|0|||
143093043|NCT00923013|515880401|FG000|Overall Study|Death on study|2|||
143093044|NCT00923013|515880402|FG001|Overall Study|Death on study|2|||
143093045|NCT00923013|515880403|FG002|Overall Study|Death on study|0|||
143093046|NCT00923013|515880404|FG003|Overall Study|Death on study|1|||
143093047|NCT00923013|515880405|FG004|Overall Study|Death on study|0|||
143093048|NCT00923013|515880406|FG005|Overall Study|Death on study|0|||
143093049|NCT05366010|515880408|FG000|Overall Study|Withdrawal by Subject|1|||
143093050|NCT05366010|515880408|FG000|Overall Study|Protocol Violation|1|||
143093051|NCT05366010|515880408|FG000|Overall Study|Lost to Follow-up|2|||
143093052|NCT05366010|515880408|FG000|Overall Study|Screen Failure|2|||
143093053|NCT05906628|515880409|FG000|16-Week DBVC Period|Lack of Efficacy|0|||
143093054|NCT05906628|515880410|FG001|16-Week DBVC Period|Lack of Efficacy|1|||
143093055|NCT05906628|515880409|FG000|16-Week DBVC Period|Lost to Follow-up|2|||
143093056|NCT05906628|515880410|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
143093057|NCT05906628|515880409|FG000|16-Week DBVC Period|Protocol Violation|4|||
143093058|NCT05906628|515880410|FG001|16-Week DBVC Period|Protocol Violation|2|||
143093059|NCT05906628|515880409|FG000|16-Week DBVC Period|Withdrawal by Subject|4|||
143093060|NCT05906628|515880410|FG001|16-Week DBVC Period|Withdrawal by Subject|11|||
143093061|NCT05906628|515880409|FG000|16-Week OLE Period|Death|1|||
143093062|NCT05906628|515880410|FG001|16-Week OLE Period|Death|0|||
143093063|NCT05906628|515880409|FG000|16-Week OLE Period|Lost to Follow-up|1|||
143093064|NCT05906628|515880410|FG001|16-Week OLE Period|Lost to Follow-up|1|||
143093065|NCT05906628|515880409|FG000|16-Week OLE Period|Protocol Violation|0|||
143093066|NCT05906628|515880410|FG001|16-Week OLE Period|Protocol Violation|1|||
143093067|NCT05906628|515880409|FG000|16-Week OLE Period|Withdrawal by Subject|6|||
143093068|NCT05906628|515880410|FG001|16-Week OLE Period|Withdrawal by Subject|4|||
143093069|NCT01108718|515880411|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
143093070|NCT01108718|515880412|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
143093071|NCT05317312|515880413|FG000|Overall Study|Withdrawal by Subject|0|||
143093072|NCT05317312|515880414|FG001|Overall Study|Withdrawal by Subject|1|||
143093073|NCT05317312|515880415|FG002|Overall Study|Withdrawal by Subject|0|||
143093074|NCT05317312|515880416|FG003|Overall Study|Withdrawal by Subject|0|||
143093075|NCT05317312|515880413|FG000|Overall Study|Lost to Follow-up|0|||
143093076|NCT05317312|515880414|FG001|Overall Study|Lost to Follow-up|0|||
143093077|NCT05317312|515880415|FG002|Overall Study|Lost to Follow-up|0|||
143093078|NCT05317312|515880416|FG003|Overall Study|Lost to Follow-up|1|||
143093079|NCT05317312|515880413|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
143093080|NCT05317312|515880414|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
143093081|NCT05317312|515880415|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
143093082|NCT05317312|515880416|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
143093083|NCT01060072|515880417|FG000|Overall Study|Adverse Event|1|||
143093084|NCT01060072|515880418|FG001|Overall Study|Adverse Event|1|||
143093085|NCT01060072|515880417|FG000|Overall Study|Physician Decision|0|||
143093086|NCT01060072|515880418|FG001|Overall Study|Physician Decision|2|||
143093087|NCT01060072|515880417|FG000|Overall Study|Protocol Violation|0|||
143093088|NCT01060072|515880418|FG001|Overall Study|Protocol Violation|1|||
143093089|NCT01060072|515880417|FG000|Overall Study|Acute cholecystitis|1|||
143093090|NCT01060072|515880418|FG001|Overall Study|Acute cholecystitis|0|||
143093091|NCT01060072|515880417|FG000|Overall Study|Excluded Medications|0|||
143093092|NCT01060072|515880418|FG001|Overall Study|Excluded Medications|1|||
143093093|NCT00235755|515880419|FG000|4-Week Titration Phase|Adverse Event|6|||
143093094|NCT00235755|515880420|FG001|4-Week Titration Phase|Adverse Event|14|||
143093095|NCT00235755|515880421|FG002|4-Week Titration Phase|Adverse Event|20|||
143093096|NCT00235755|515880419|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
143093097|NCT00235755|515880420|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
143093098|NCT00235755|515880421|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
143093099|NCT00235755|515880419|FG000|4-Week Titration Phase|Protocol Violation|2|||
143093100|NCT00235755|515880420|FG001|4-Week Titration Phase|Protocol Violation|2|||
143093101|NCT00235755|515880421|FG002|4-Week Titration Phase|Protocol Violation|1|||
143093102|NCT00235755|515880419|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
143093103|NCT00235755|515880420|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
143093104|NCT00235755|515880421|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
143093105|NCT00235755|515880419|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
143093106|NCT00235755|515880420|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
143093107|NCT00235755|515880421|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
143093108|NCT00235755|515880419|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
143093109|NCT00235755|515880420|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
143093110|NCT00235755|515880421|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
143093111|NCT00235755|515880419|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
143093112|NCT00235755|515880420|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
143093113|NCT00235755|515880421|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
143093114|NCT00235755|515880419|FG000|12-Week Maintenance Phase|Adverse Event|8|||
143093115|NCT00235755|515880420|FG001|12-Week Maintenance Phase|Adverse Event|12|||
143093116|NCT00235755|515880421|FG002|12-Week Maintenance Phase|Adverse Event|26|||
143093117|NCT00235755|515880419|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
143093118|NCT00235755|515880420|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
143093119|NCT00235755|515880421|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
143093120|NCT00235755|515880419|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
143093121|NCT00235755|515880420|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
143093122|NCT00235755|515880421|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
143093123|NCT00235755|515880419|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
143093124|NCT00235755|515880420|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
143093125|NCT00235755|515880421|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
143093126|NCT00235755|515880419|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
143093127|NCT00235755|515880420|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
143093128|NCT00235755|515880421|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
143093129|NCT00235755|515880419|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
143093130|NCT00235755|515880420|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
143093131|NCT00235755|515880421|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
143093132|NCT00837148|515880422|FG000|Overall Study|Adverse Event|1|||
143093133|NCT00837148|515880422|FG000|Overall Study|Death|1|||
143093134|NCT01422213|515880425|FG000|Overall Study|Adverse Event|8|||
143093135|NCT01422213|515880426|FG001|Overall Study|Adverse Event|7|||
143093136|NCT01422213|515880427|FG002|Overall Study|Adverse Event|11|||
143093137|NCT01422213|515880425|FG000|Overall Study|Lack of Efficacy|10|||
143093138|NCT01422213|515880426|FG001|Overall Study|Lack of Efficacy|2|||
143093139|NCT01422213|515880427|FG002|Overall Study|Lack of Efficacy|2|||
143093140|NCT01422213|515880425|FG000|Overall Study|Non-compliance with study drug|0|||
143093141|NCT01422213|515880426|FG001|Overall Study|Non-compliance with study drug|1|||
143093142|NCT01422213|515880427|FG002|Overall Study|Non-compliance with study drug|0|||
143093143|NCT01422213|515880425|FG000|Overall Study|Protocol Violation|0|||
143093144|NCT01422213|515880426|FG001|Overall Study|Protocol Violation|2|||
143093145|NCT01422213|515880427|FG002|Overall Study|Protocol Violation|4|||
143093146|NCT01422213|515880425|FG000|Overall Study|Withdrawal of Consent|7|||
143093147|NCT01422213|515880426|FG001|Overall Study|Withdrawal of Consent|3|||
143093148|NCT01422213|515880427|FG002|Overall Study|Withdrawal of Consent|5|||
143093149|NCT01422213|515880425|FG000|Overall Study|Lost to Follow-up|3|||
143093150|NCT01422213|515880426|FG001|Overall Study|Lost to Follow-up|3|||
143093151|NCT01422213|515880427|FG002|Overall Study|Lost to Follow-up|5|||
143093152|NCT01422213|515880425|FG000|Overall Study|Administrative or Other Reason(s)|5|||
143093153|NCT01422213|515880426|FG001|Overall Study|Administrative or Other Reason(s)|4|||
143093154|NCT01422213|515880427|FG002|Overall Study|Administrative or Other Reason(s)|2|||
143093155|NCT01532934|515880434|FG000|Overall Study|Lost to Follow-up|11|||
143093156|NCT01532934|515880435|FG001|Overall Study|Lost to Follow-up|11|||
143093157|NCT01532934|515880434|FG000|Overall Study|In controlled environment|3|||
143093158|NCT01532934|515880435|FG001|Overall Study|In controlled environment|2|||
143093159|NCT03181633|515880436|FG000|Overall Study|Withdrawal by Subject|1|||
143093160|NCT03181633|515880436|FG000|Overall Study|Missing follow-up visit|1|||
143093161|NCT01149863|515880439|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
143093162|NCT05479435|515880440|FG000|Overall Study|Withdrawal by Subject|1|||
143093163|NCT05479435|515880441|FG001|Overall Study|Withdrawal by Subject|0|||
143093164|NCT05479435|515880442|FG002|Overall Study|Withdrawal by Subject|0|||
143093165|NCT05479435|515880440|FG000|Overall Study|Covid 19|0|||
143093166|NCT05479435|515880441|FG001|Overall Study|Covid 19|0|||
143093167|NCT05479435|515880442|FG002|Overall Study|Covid 19|2|||
143093168|NCT00868530|515880445|FG000|Overall Study|Adverse Event|3|||
143093169|NCT00868530|515880445|FG000|Overall Study|Lost to Follow-up|1|||
143093170|NCT04023396|515882130|FG000|Overall Study|Adverse Event|16|||
143093171|NCT04023396|515882130|FG000|Overall Study|Death|1|||
143093172|NCT04023396|515882130|FG000|Overall Study|Lost to Follow-up|1|||
143093173|NCT04023396|515882130|FG000|Overall Study|Withdrawal by Subject|14|||
143093174|NCT04023396|515882130|FG000|Overall Study|Pregnancy|4|||
143093175|NCT04023396|515882130|FG000|Overall Study|Lack of Efficacy|3|||
143093176|NCT04023396|515882130|FG000|Overall Study|Physician Decision|4|||
143093177|NCT04023396|515882130|FG000|Overall Study|Other reason (e.g., Ukraine Crisis)|10|||
143093178|NCT04075825|515882133|FG000|Overall Study|Withdrawal by Subject|6|||
143093179|NCT04075825|515882134|FG001|Overall Study|Withdrawal by Subject|8|||
143093180|NCT04075825|515882133|FG000|Overall Study|Physician Decision|3|||
143093181|NCT04075825|515882134|FG001|Overall Study|Physician Decision|1|||
143093182|NCT04075825|515882133|FG000|Overall Study|Lost to Follow-up|5|||
143093183|NCT04075825|515882134|FG001|Overall Study|Lost to Follow-up|1|||
143093184|NCT04075825|515882133|FG000|Overall Study|Participation in New Clinical Trial|1|||
143093185|NCT04075825|515882134|FG001|Overall Study|Participation in New Clinical Trial|1|||
143093186|NCT04075825|515882133|FG000|Overall Study|Reason Not Specified|2|||
143251079|NCT02059291|516472986|FG017|Epoch 3|Physician Decision|0|||
143251080|NCT02059291|516472987|FG018|Epoch 3|Physician Decision|0|||
143251081|NCT02059291|516472988|FG019|Epoch 3|Physician Decision|0|||
143251082|NCT02059291|516472989|FG020|Epoch 3|Physician Decision|0|||
143251083|NCT02059291|516472990|FG021|Epoch 3|Physician Decision|0|||
143251084|NCT02059291|516472991|FG022|Epoch 3|Physician Decision|0|||
143251085|NCT02059291|516472992|FG023|Epoch 3|Physician Decision|0|||
143251086|NCT02059291|516472993|FG024|Epoch 3|Physician Decision|0|||
143251087|NCT02059291|516472969|FG000|Epoch 3|Adverse Event|0|||
143251088|NCT02059291|516472970|FG001|Epoch 3|Adverse Event|0|||
143251089|NCT02059291|516472971|FG002|Epoch 3|Adverse Event|0|||
143251090|NCT02059291|516472972|FG003|Epoch 3|Adverse Event|0|||
143251091|NCT02059291|516472973|FG004|Epoch 3|Adverse Event|0|||
143251092|NCT02059291|516472974|FG005|Epoch 3|Adverse Event|0|||
143251093|NCT02059291|516472975|FG006|Epoch 3|Adverse Event|0|||
143251094|NCT02059291|516472976|FG007|Epoch 3|Adverse Event|0|||
143251095|NCT02059291|516472977|FG008|Epoch 3|Adverse Event|0|||
143093187|NCT04075825|515882134|FG001|Overall Study|Reason Not Specified|2|||
143093188|NCT02513160|515882135|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
143251096|NCT02059291|516472978|FG009|Epoch 3|Adverse Event|0|||
143251097|NCT02059291|516472979|FG010|Epoch 3|Adverse Event|0|||
143251098|NCT02059291|516472980|FG011|Epoch 3|Adverse Event|0|||
143251099|NCT02059291|516472981|FG012|Epoch 3|Adverse Event|0|||
143251100|NCT02059291|516472982|FG013|Epoch 3|Adverse Event|0|||
143093189|NCT02513160|515882136|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
143093190|NCT02513160|515882137|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
143093191|NCT02513160|515882138|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
143093192|NCT02513160|515882135|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
143093193|NCT02513160|515882136|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
143093194|NCT02513160|515882137|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
143093195|NCT02513160|515882138|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
143251101|NCT02059291|516472983|FG014|Epoch 3|Adverse Event|0|||
143093196|NCT02513160|515882135|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
143093197|NCT02513160|515882136|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
143093198|NCT02513160|515882137|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
143093199|NCT02513160|515882138|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
143093200|NCT02513160|515882135|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
143093201|NCT02513160|515882136|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
143093202|NCT02513160|515882137|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
143093203|NCT02513160|515882138|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
143093204|NCT02513160|515882135|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
143093205|NCT02513160|515882136|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
143093206|NCT02513160|515882137|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
143093207|NCT02513160|515882138|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
143093208|NCT02513160|515882135|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
143093209|NCT02513160|515882136|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
143093210|NCT02513160|515882137|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
143093211|NCT02513160|515882138|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
143093212|NCT02513160|515882135|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
143093213|NCT02513160|515882136|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
143093214|NCT02513160|515882137|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
143093215|NCT02513160|515882138|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
143093216|NCT02513160|515882135|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
143093217|NCT02513160|515882136|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
143093218|NCT02513160|515882137|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
143093219|NCT02513160|515882138|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
143093220|NCT02513160|515882135|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
143093221|NCT02513160|515882136|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
143093222|NCT02513160|515882137|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
143093223|NCT02513160|515882138|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
143093224|NCT02513160|515882135|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
143093225|NCT02513160|515882136|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
143093226|NCT02513160|515882137|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
143093227|NCT02513160|515882138|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
143093228|NCT02513160|515882135|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
143093229|NCT02513160|515882136|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
143093230|NCT02513160|515882137|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
143093231|NCT02513160|515882138|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
143093232|NCT02513160|515882135|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
143093233|NCT02513160|515882136|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
143093234|NCT02513160|515882137|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
143093235|NCT02513160|515882138|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
143093236|NCT02861586|515882141|FG000|Overall Study|Withdrawal by Subject|1|||
143093237|NCT02861586|515882142|FG001|Overall Study|Withdrawal by Subject|2|||
143093238|NCT02861586|515882143|FG002|Overall Study|Withdrawal by Subject|0|||
143093239|NCT02861586|515882144|FG003|Overall Study|Withdrawal by Subject|0|||
143093240|NCT02861586|515882145|FG004|Overall Study|Withdrawal by Subject|0|||
143093241|NCT02861586|515882146|FG005|Overall Study|Withdrawal by Subject|1|||
143093242|NCT02861586|515882147|FG006|Overall Study|Withdrawal by Subject|1|||
143093243|NCT02861586|515882148|FG007|Overall Study|Withdrawal by Subject|0|||
143093244|NCT02861586|515882141|FG000|Overall Study|Lost to Follow-up|3|||
143093245|NCT02861586|515882142|FG001|Overall Study|Lost to Follow-up|1|||
143093246|NCT02861586|515882143|FG002|Overall Study|Lost to Follow-up|1|||
143093247|NCT02861586|515882144|FG003|Overall Study|Lost to Follow-up|0|||
143093248|NCT02861586|515882145|FG004|Overall Study|Lost to Follow-up|0|||
143093249|NCT02861586|515882146|FG005|Overall Study|Lost to Follow-up|3|||
143093250|NCT02861586|515882147|FG006|Overall Study|Lost to Follow-up|0|||
143093251|NCT02861586|515882148|FG007|Overall Study|Lost to Follow-up|0|||
143093252|NCT02861586|515882141|FG000|Overall Study|Adverse Event|0|||
143093253|NCT02861586|515882142|FG001|Overall Study|Adverse Event|0|||
143093254|NCT02861586|515882143|FG002|Overall Study|Adverse Event|0|||
143093255|NCT02861586|515882144|FG003|Overall Study|Adverse Event|0|||
143093256|NCT02861586|515882145|FG004|Overall Study|Adverse Event|0|||
143093257|NCT02861586|515882146|FG005|Overall Study|Adverse Event|1|||
143093258|NCT02861586|515882147|FG006|Overall Study|Adverse Event|0|||
143093259|NCT02861586|515882148|FG007|Overall Study|Adverse Event|0|||
143093260|NCT04581824|515882150|FG000|Overall Study|Lost to Follow-up|1|||
143093261|NCT04581824|515882151|FG001|Overall Study|Lost to Follow-up|0|||
143093262|NCT04581824|515882150|FG000|Overall Study|Withdrawal by Subject|2|||
143093263|NCT04581824|515882151|FG001|Overall Study|Withdrawal by Subject|7|||
143093264|NCT04581824|515882150|FG000|Overall Study|Study terminated by sponsor|37|||
143093265|NCT04581824|515882151|FG001|Overall Study|Study terminated by sponsor|23|||
143093266|NCT04796909|515882152|FG000|Overall Study|Withdrawal by Subject|1|||
143093267|NCT04796909|515882153|FG001|Overall Study|Withdrawal by Subject|1|||
143093268|NCT04815083|515882154|FG000|Overall Study|Physician Decision|1|||
143093269|NCT04815083|515882154|FG000|Overall Study|Study pause|2|||
143093270|NCT04815083|515882154|FG000|Overall Study|Screening failure|4|||
143093271|NCT02764762|515882159|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
143093272|NCT02764762|515882159|FG000|Overall Study|Lost to Follow-up|4|||
143093273|NCT02764762|515882159|FG000|Overall Study|Voluntary Withdrawal|8|||
143093274|NCT02764762|515882159|FG000|Overall Study|Site Termination|1|||
143093275|NCT02764762|515882159|FG000|Overall Study|Lack of Efficacy|16|||
143093276|NCT02764762|515882159|FG000|Overall Study|Reason not Specified|1|||
143093277|NCT01479465|515882160|FG000|Overall Study|Disease Progression|9|||
143093278|NCT01479465|515882161|FG001|Overall Study|Disease Progression|61|||
143093279|NCT01479465|515882162|FG002|Overall Study|Disease Progression|65|||
143093280|NCT01479465|515882163|FG003|Overall Study|Disease Progression|70|||
143093281|NCT01479465|515882160|FG000|Overall Study|Study Discontinued by Sponsor|0|||
143093282|NCT01479465|515882161|FG001|Overall Study|Study Discontinued by Sponsor|7|||
143093283|NCT01479465|515882162|FG002|Overall Study|Study Discontinued by Sponsor|5|||
143093284|NCT01479465|515882163|FG003|Overall Study|Study Discontinued by Sponsor|3|||
143093285|NCT01479465|515882160|FG000|Overall Study|Adverse Event|0|||
143093286|NCT01479465|515882161|FG001|Overall Study|Adverse Event|3|||
143093287|NCT01479465|515882162|FG002|Overall Study|Adverse Event|6|||
143093288|NCT01479465|515882163|FG003|Overall Study|Adverse Event|4|||
143093289|NCT01479465|515882160|FG000|Overall Study|Investigator Discretion|1|||
143093290|NCT01479465|515882161|FG001|Overall Study|Investigator Discretion|4|||
143093291|NCT01479465|515882162|FG002|Overall Study|Investigator Discretion|2|||
143093292|NCT01479465|515882163|FG003|Overall Study|Investigator Discretion|4|||
143093293|NCT01479465|515882160|FG000|Overall Study|Subject Request|1|||
143093294|NCT01479465|515882161|FG001|Overall Study|Subject Request|3|||
143093295|NCT01479465|515882162|FG002|Overall Study|Subject Request|4|||
143093296|NCT01479465|515882163|FG003|Overall Study|Subject Request|2|||
143093297|NCT01479465|515882160|FG000|Overall Study|Subject Withdrew Consent|0|||
143093298|NCT01479465|515882161|FG001|Overall Study|Subject Withdrew Consent|5|||
143093299|NCT01479465|515882162|FG002|Overall Study|Subject Withdrew Consent|2|||
143093300|NCT01479465|515882163|FG003|Overall Study|Subject Withdrew Consent|1|||
143093301|NCT01479465|515882160|FG000|Overall Study|Protocol Violation|0|||
143093302|NCT01479465|515882161|FG001|Overall Study|Protocol Violation|1|||
143093303|NCT01479465|515882162|FG002|Overall Study|Protocol Violation|1|||
143093304|NCT01479465|515882163|FG003|Overall Study|Protocol Violation|0|||
143093305|NCT01479465|515882160|FG000|Overall Study|Death|0|||
143093306|NCT01479465|515882161|FG001|Overall Study|Death|0|||
143093307|NCT01479465|515882162|FG002|Overall Study|Death|0|||
143093308|NCT01479465|515882163|FG003|Overall Study|Death|1|||
143093309|NCT01479465|515882160|FG000|Overall Study|Lost to Follow-up|0|||
143093310|NCT01479465|515882161|FG001|Overall Study|Lost to Follow-up|0|||
143093311|NCT01479465|515882162|FG002|Overall Study|Lost to Follow-up|1|||
143093312|NCT01479465|515882163|FG003|Overall Study|Lost to Follow-up|0|||
143093313|NCT01439802|515882164|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
143093314|NCT01439802|515882164|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
143093315|NCT02968576|515882165|FG000|Overall Study|Pregnancy|0|||
143093316|NCT02968576|515882166|FG001|Overall Study|Pregnancy|1|||
143093317|NCT01651117|515882169|FG000|Overall Study|Death|2|||
143093318|NCT01651117|515882170|FG001|Overall Study|Death|3|||
143093319|NCT01651117|515882171|FG002|Overall Study|Death|2|||
143251102|NCT02059291|516472984|FG015|Epoch 3|Adverse Event|1|||
143251103|NCT02059291|516472985|FG016|Epoch 3|Adverse Event|0|||
143093320|NCT01651117|515882172|FG003|Overall Study|Death|2|||
143093321|NCT01641640|515882173|FG000|Overall Study|Enrolled but not treated|1|||
143093322|NCT01641640|515882173|FG000|Overall Study|Efficacy failure|29|||
143093323|NCT01641640|515882173|FG000|Overall Study|Lost to Follow-up|3|||
143093324|NCT01641640|515882173|FG000|Overall Study|Withdrawal by Subject|2|||
143093325|NCT01641640|515882173|FG000|Overall Study|Adverse Event|1|||
143093326|NCT01234350|515882175|FG000|Overall Study|Adverse Event|277|||
143093327|NCT01234350|515882176|FG001|Overall Study|Adverse Event|92|||
143093328|NCT01234350|515882175|FG000|Overall Study|Withdrawal by Subject|61|||
143093329|NCT01234350|515882176|FG001|Overall Study|Withdrawal by Subject|36|||
143093330|NCT01234350|515882175|FG000|Overall Study|Lost to Follow-up|115|||
143093331|NCT01234350|515882176|FG001|Overall Study|Lost to Follow-up|47|||
143093332|NCT01234350|515882175|FG000|Overall Study|Covers a diverse set of reasons|234|||
143093333|NCT01234350|515882176|FG001|Overall Study|Covers a diverse set of reasons|92|||
143093334|NCT02792517|515882186|FG000|Overall Study|Withdrawal by Subject|10|||
143093335|NCT02792517|515882186|FG000|Overall Study|Decision by Sponsor|7|||
143251104|NCT02059291|516472986|FG017|Epoch 3|Adverse Event|0|||
143093336|NCT02792517|515882186|FG000|Overall Study|Lost to Follow-up|3|||
143093337|NCT01686373|515882187|FG000|Overall Study|Lost to Follow-up|3|||
143093338|NCT01686373|515882188|FG001|Overall Study|Lost to Follow-up|0|||
143093339|NCT01686373|515882187|FG000|Overall Study|Withdrawal by Subject|0|||
143251105|NCT02059291|516472987|FG018|Epoch 3|Adverse Event|0|||
143093340|NCT01686373|515882188|FG001|Overall Study|Withdrawal by Subject|1|||
143251106|NCT02059291|516472988|FG019|Epoch 3|Adverse Event|0|||
143093341|NCT01686373|515882187|FG000|Overall Study|Adverse Event|0|||
143093342|NCT01686373|515882188|FG001|Overall Study|Adverse Event|1|||
143093343|NCT01836471|515882195|FG000|Overall Study|Pregnancy|1|||
143093344|NCT01836471|515882196|FG001|Overall Study|Pregnancy|0|||
143093345|NCT01836471|515882197|FG002|Overall Study|Pregnancy|0|||
143093346|NCT01836471|515882198|FG003|Overall Study|Pregnancy|0|||
143093347|NCT01836471|515882199|FG004|Overall Study|Pregnancy|0|||
143093348|NCT01836471|515882195|FG000|Overall Study|Withdrawal by Subject|3|||
143093349|NCT01836471|515882196|FG001|Overall Study|Withdrawal by Subject|4|||
143093350|NCT01836471|515882197|FG002|Overall Study|Withdrawal by Subject|1|||
143093351|NCT01836471|515882198|FG003|Overall Study|Withdrawal by Subject|0|||
143093352|NCT01836471|515882199|FG004|Overall Study|Withdrawal by Subject|2|||
143093353|NCT01836471|515882195|FG000|Overall Study|Physician Decision|0|||
143093354|NCT01836471|515882196|FG001|Overall Study|Physician Decision|1|||
143093355|NCT01836471|515882197|FG002|Overall Study|Physician Decision|0|||
143093356|NCT01836471|515882198|FG003|Overall Study|Physician Decision|0|||
143093357|NCT01836471|515882199|FG004|Overall Study|Physician Decision|0|||
143093358|NCT01836471|515882195|FG000|Overall Study|Lost to Follow-up|0|||
143093359|NCT01836471|515882196|FG001|Overall Study|Lost to Follow-up|0|||
143093360|NCT01836471|515882197|FG002|Overall Study|Lost to Follow-up|0|||
143093361|NCT01836471|515882198|FG003|Overall Study|Lost to Follow-up|1|||
143093362|NCT01836471|515882199|FG004|Overall Study|Lost to Follow-up|1|||
143093363|NCT01836471|515882195|FG000|Overall Study|Adverse Event|6|||
143093364|NCT01836471|515882196|FG001|Overall Study|Adverse Event|3|||
143093365|NCT01836471|515882197|FG002|Overall Study|Adverse Event|1|||
143093366|NCT01836471|515882198|FG003|Overall Study|Adverse Event|1|||
143093367|NCT01836471|515882199|FG004|Overall Study|Adverse Event|2|||
143093368|NCT01836471|515882195|FG000|Overall Study|Non compliance with tx|1|||
143093369|NCT01836471|515882196|FG001|Overall Study|Non compliance with tx|1|||
143093370|NCT01836471|515882197|FG002|Overall Study|Non compliance with tx|0|||
143093371|NCT01836471|515882198|FG003|Overall Study|Non compliance with tx|0|||
143093372|NCT01836471|515882199|FG004|Overall Study|Non compliance with tx|0|||
143093373|NCT02570308|515882205|FG000|Overall Study|Death|1|||
143093374|NCT02570308|515882206|FG001|Overall Study|Death|5|||
143093375|NCT02570308|515882207|FG002|Overall Study|Death|4|||
143093376|NCT02570308|515882208|FG003|Overall Study|Death|4|||
143093377|NCT02570308|515882209|FG004|Overall Study|Death|69|||
143093378|NCT02570308|515882205|FG000|Overall Study|Lost to Follow-up|0|||
143093379|NCT02570308|515882206|FG001|Overall Study|Lost to Follow-up|0|||
143093380|NCT02570308|515882207|FG002|Overall Study|Lost to Follow-up|0|||
143093381|NCT02570308|515882208|FG003|Overall Study|Lost to Follow-up|0|||
143093382|NCT02570308|515882209|FG004|Overall Study|Lost to Follow-up|2|||
143093383|NCT02570308|515882205|FG000|Overall Study|Withdrawal by Subject|0|||
143093384|NCT02570308|515882206|FG001|Overall Study|Withdrawal by Subject|0|||
143093385|NCT02570308|515882207|FG002|Overall Study|Withdrawal by Subject|0|||
143093386|NCT02570308|515882208|FG003|Overall Study|Withdrawal by Subject|0|||
143093387|NCT02570308|515882209|FG004|Overall Study|Withdrawal by Subject|1|||
143093388|NCT02570308|515882205|FG000|Overall Study|Other|0|||
143093389|NCT02570308|515882206|FG001|Overall Study|Other|0|||
143093390|NCT02570308|515882207|FG002|Overall Study|Other|0|||
143093391|NCT02570308|515882208|FG003|Overall Study|Other|0|||
143093392|NCT02570308|515882209|FG004|Overall Study|Other|2|||
143093393|NCT02069015|515882210|FG000|Overall Study|Lost to Follow-up|39|||
143093394|NCT02069015|515882211|FG001|Overall Study|Lost to Follow-up|32|||
143093395|NCT02069015|515882210|FG000|Overall Study|Withdrawal by Subject|1|||
143093396|NCT02069015|515882211|FG001|Overall Study|Withdrawal by Subject|1|||
143093397|NCT02285361|515882212|FG000|Overall Study|Protocol Violation|43|||
143093398|NCT02285361|515882212|FG000|Overall Study|Lost to Follow-up|5|||
143093399|NCT02285361|515882212|FG000|Overall Study|Not taken GIOTRIF|2|||
143093400|NCT02285361|515882212|FG000|Overall Study|Consented prior to the contract date|1|||
143093401|NCT05506046|515882213|FG000|Overall Study|Lost to Follow-up|89|||
143093402|NCT05506046|515882214|FG001|Overall Study|Lost to Follow-up|101|||
143093403|NCT05506046|515882215|FG002|Overall Study|Lost to Follow-up|102|||
143093404|NCT05506046|515882216|FG003|Overall Study|Lost to Follow-up|99|||
143093405|NCT01283464|515882217|FG000|Overall Study|Lost to Follow-up|0|||
143093406|NCT01283464|515882218|FG001|Overall Study|Lost to Follow-up|1|||
143093407|NCT01283464|515882217|FG000|Overall Study|Withdrawal by Subject|1|||
143093408|NCT01283464|515882218|FG001|Overall Study|Withdrawal by Subject|0|||
143093409|NCT01283464|515882217|FG000|Overall Study|Physician Decision|1|||
143093410|NCT01283464|515882218|FG001|Overall Study|Physician Decision|0|||
143093411|NCT01778855|515882219|FG000|Overall Study|Death|0|||
143093412|NCT01778855|515882220|FG001|Overall Study|Death|1|||
143093413|NCT02059135|515882221|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
143093414|NCT02059135|515882222|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
143176706|NCT00461708|516196215|FG001|Overall Study|Lack of Efficacy|20|||
143093415|NCT02059135|515882221|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
143093416|NCT02059135|515882222|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
143093417|NCT02059135|515882221|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
143093418|NCT02059135|515882222|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
143093419|NCT02059135|515882221|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
143093420|NCT02059135|515882222|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
143093421|NCT02059135|515882221|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
143093422|NCT02059135|515882222|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
143093423|NCT02059135|515882221|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
143093424|NCT02059135|515882222|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
143093425|NCT02059135|515882221|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
143093426|NCT02059135|515882222|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
143093427|NCT02059135|515882221|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
143093428|NCT02059135|515882222|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
143093429|NCT00191477|515882224|FG000|Overall Study|Tumor Recurrence|49|||
143093430|NCT00191477|515882225|FG001|Overall Study|Tumor Recurrence|48|||
143093431|NCT00191477|515882224|FG000|Overall Study|Death, Study Disease|1|||
143093432|NCT00191477|515882225|FG001|Overall Study|Death, Study Disease|1|||
143093433|NCT00191477|515882224|FG000|Overall Study|Death, Other Cause|3|||
143093434|NCT00191477|515882225|FG001|Overall Study|Death, Other Cause|6|||
143093435|NCT00191477|515882224|FG000|Overall Study|Lost to Follow-up|23|||
143093436|NCT00191477|515882225|FG001|Overall Study|Lost to Follow-up|21|||
143093437|NCT00191477|515882224|FG000|Overall Study|Protocol Violation|1|||
143093438|NCT00191477|515882225|FG001|Overall Study|Protocol Violation|1|||
143093439|NCT00191477|515882224|FG000|Overall Study|Treatment Change|2|||
143093440|NCT00191477|515882225|FG001|Overall Study|Treatment Change|0|||
143093441|NCT00191477|515882224|FG000|Overall Study|Withdrawal by Subject|2|||
143093442|NCT00191477|515882225|FG001|Overall Study|Withdrawal by Subject|0|||
143093443|NCT00191477|515882224|FG000|Overall Study|Other|2|||
143093444|NCT00191477|515882225|FG001|Overall Study|Other|0|||
143093445|NCT00191477|515882224|FG000|Overall Study|Not Eligible|41|||
143093446|NCT00191477|515882225|FG001|Overall Study|Not Eligible|38|||
143093447|NCT00191477|515882224|FG000|Overall Study|Pathological Specimen Lost|1|||
143093448|NCT00191477|515882225|FG001|Overall Study|Pathological Specimen Lost|0|||
143093449|NCT00191477|515882224|FG000|Overall Study|Discontinued Prior to Instillation|13|||
143093450|NCT00191477|515882225|FG001|Overall Study|Discontinued Prior to Instillation|14|||
143093451|NCT02411656|515882229|FG000|Overall Study|Adverse Event|4|||
143093452|NCT02411656|515882229|FG000|Overall Study|Clinical Progression|33|||
143093453|NCT00586703|515882231|FG000|Overall Study|Death|12|||
143093454|NCT03762265|515882232|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
143093455|NCT03762265|515882233|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
143093456|NCT03762265|515882232|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
143093457|NCT03762265|515882233|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
143093458|NCT03762265|515882232|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
143093459|NCT03762265|515882233|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
143093460|NCT03762265|515882232|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
143093461|NCT03762265|515882233|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
143093462|NCT03762265|515882232|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
143093463|NCT03762265|515882233|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
143093464|NCT03762265|515882232|FG000|BT Period: Weeks 1 to 37|Other|0|||
143093465|NCT03762265|515882233|FG001|BT Period: Weeks 1 to 37|Other|1|||
143093466|NCT03762265|515882232|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
143093467|NCT03762265|515882233|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
143093468|NCT03762265|515882232|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
143093469|NCT03762265|515882233|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
143093470|NCT03762265|515882232|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
143093471|NCT03762265|515882233|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
143093472|NCT03762265|515882232|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
143093473|NCT03762265|515882233|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
143093474|NCT03762265|515882232|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
143093475|NCT03762265|515882233|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
143093476|NCT03762265|515882232|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
143093477|NCT03762265|515882233|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
143093478|NCT03762265|515882232|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
143093479|NCT03762265|515882233|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
143093480|NCT03762265|515882232|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
143093481|NCT03762265|515882233|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
143093482|NCT03762265|515882232|FG000|LTE Period: Weeks 61 to 109|Other|1|||
143093483|NCT03762265|515882233|FG001|LTE Period: Weeks 61 to 109|Other|0|||
143093484|NCT00806403|515882234|FG000|Overall Study|Death|4|||
143093485|NCT00806403|515882235|FG001|Overall Study|Death|3|||
143093486|NCT00765102|515882236|FG000|Overall Study|Progressive disease|18|||
143093487|NCT00765102|515882236|FG000|Overall Study|Adverse Event|6|||
143093488|NCT00765102|515882236|FG000|Overall Study|Physician Decision|4|||
143093489|NCT00765102|515882236|FG000|Overall Study|Withdrawal by Subject|2|||
143093490|NCT00765102|515882236|FG000|Overall Study|Protocol Violation|1|||
143093491|NCT01147068|515882245|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
143093492|NCT01147068|515882246|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
143093493|NCT01147068|515882247|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
143093494|NCT01147068|515882248|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
143093495|NCT01147068|515882249|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
143093496|NCT01147068|515882250|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
143093497|NCT01147068|515882251|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
143093498|NCT01147068|515882245|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
143093499|NCT01147068|515882246|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
143093500|NCT01147068|515882247|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
143093501|NCT01147068|515882248|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
143093502|NCT01147068|515882249|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
143093503|NCT01147068|515882250|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
143093504|NCT01147068|515882251|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
143093505|NCT01147068|515882245|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
143093506|NCT01147068|515882246|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
143093507|NCT01147068|515882247|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
143093508|NCT01147068|515882248|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
143093509|NCT01147068|515882249|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
143093510|NCT01147068|515882250|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
143093511|NCT01147068|515882251|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
143093512|NCT01147068|515882245|FG000|Subjects That Received 2nd Dose|Other|0|||
143093513|NCT01147068|515882246|FG001|Subjects That Received 2nd Dose|Other|3|||
143093514|NCT01147068|515882247|FG002|Subjects That Received 2nd Dose|Other|3|||
143093515|NCT01147068|515882248|FG003|Subjects That Received 2nd Dose|Other|0|||
143093516|NCT01147068|515882249|FG004|Subjects That Received 2nd Dose|Other|1|||
143093517|NCT01147068|515882250|FG005|Subjects That Received 2nd Dose|Other|0|||
143093518|NCT01147068|515882251|FG006|Subjects That Received 2nd Dose|Other|0|||
143093519|NCT01147068|515882245|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
143093520|NCT01147068|515882246|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
143093521|NCT01147068|515882247|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
143093522|NCT01147068|515882248|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
143093523|NCT01147068|515882249|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
143093524|NCT01147068|515882250|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
143093525|NCT01147068|515882251|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
143093526|NCT01147068|515882245|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
143093527|NCT01147068|515882246|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
143093528|NCT01147068|515882247|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
143093529|NCT01147068|515882248|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
143093530|NCT01147068|515882249|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
143093531|NCT01147068|515882250|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
143093532|NCT01147068|515882251|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
143093533|NCT01147068|515882245|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
143093534|NCT01147068|515882246|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
143093535|NCT01147068|515882247|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
143093536|NCT01147068|515882248|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
143093537|NCT01147068|515882249|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
143093538|NCT01147068|515882250|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
143093539|NCT01147068|515882251|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
143093540|NCT05271175|515882253|FG000|One Week Follow up|Lost to Follow-up|10|||
143093541|NCT05271175|515882254|FG001|One Week Follow up|Lost to Follow-up|7|||
143093542|NCT05271175|515882255|FG002|One Week Follow up|Lost to Follow-up|5|||
143093543|NCT05271175|515882253|FG000|One Month Follow up|Lost to Follow-up|12|||
143093544|NCT05271175|515882254|FG001|One Month Follow up|Lost to Follow-up|7|||
143093545|NCT05271175|515882255|FG002|One Month Follow up|Lost to Follow-up|9|||
143093546|NCT05271175|515882253|FG000|Six Months Follow up|Lost to Follow-up|8|||
143093547|NCT05271175|515882254|FG001|Six Months Follow up|Lost to Follow-up|2|||
143093548|NCT05271175|515882255|FG002|Six Months Follow up|Lost to Follow-up|2|||
143093549|NCT00991887|515882256|FG000|Overall Study|Lost to Follow-up|2|||
143093550|NCT00991887|515882257|FG001|Overall Study|Lost to Follow-up|1|||
143093551|NCT01306305|515882258|FG000|Overall Study|Lost to Follow-up|1|||
143093552|NCT01306305|515882259|FG001|Overall Study|Lost to Follow-up|0|||
143093553|NCT01306305|515882258|FG000|Overall Study|Withdrew consent|1|||
143093554|NCT01306305|515882259|FG001|Overall Study|Withdrew consent|0|||
143093555|NCT04030299|515882260|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
143093556|NCT04030299|515882260|FG000|Overall Study|Withdrawal by Subject|3|||
143093557|NCT01964976|515882261|FG000|Overall Study|Protocol Violation|31|||
143093558|NCT00699998|515882262|FG000|Overall Study|Withdrawal by Subject|194|||
143093559|NCT00699998|515882263|FG001|Overall Study|Withdrawal by Subject|83|||
143093560|NCT00699998|515882264|FG002|Overall Study|Withdrawal by Subject|202|||
143093561|NCT00699998|515882265|FG003|Overall Study|Withdrawal by Subject|80|||
143093562|NCT00699998|515882262|FG000|Overall Study|Physician Decision|3|||
143093563|NCT00699998|515882263|FG001|Overall Study|Physician Decision|2|||
143093564|NCT00699998|515882264|FG002|Overall Study|Physician Decision|1|||
143093565|NCT00699998|515882265|FG003|Overall Study|Physician Decision|1|||
143093566|NCT00699998|515882262|FG000|Overall Study|Lost to Follow-up|2|||
143093567|NCT00699998|515882263|FG001|Overall Study|Lost to Follow-up|1|||
143093568|NCT00699998|515882264|FG002|Overall Study|Lost to Follow-up|3|||
143093569|NCT00699998|515882265|FG003|Overall Study|Lost to Follow-up|1|||
143093570|NCT04616612|515882268|FG000|Overall Study|Lost to Follow-up|6|||
143093571|NCT04616612|515882269|FG001|Overall Study|Lost to Follow-up|3|||
143093572|NCT04740918|515882271|FG000|Overall Study|Study Terminated by Sponsor|41|||
143093573|NCT04740918|515882272|FG001|Overall Study|Study Terminated by Sponsor|32|||
143093574|NCT04740918|515882271|FG000|Overall Study|Death|3|||
143093575|NCT04740918|515882272|FG001|Overall Study|Death|6|||
143093576|NCT04740918|515882271|FG000|Overall Study|Withdrawal by Subject|5|||
143093577|NCT04740918|515882272|FG001|Overall Study|Withdrawal by Subject|4|||
143093578|NCT04740918|515882271|FG000|Overall Study|Lost to Follow-up|1|||
143093579|NCT04740918|515882272|FG001|Overall Study|Lost to Follow-up|3|||
143093580|NCT04740918|515882271|FG000|Overall Study|Progressive disease|0|||
143093581|NCT04740918|515882272|FG001|Overall Study|Progressive disease|1|||
143093582|NCT02964247|515882274|FG000|Overall Study|Lost to Follow-up|2|||
143093583|NCT02964247|515882275|FG001|Overall Study|Lost to Follow-up|0|||
143093584|NCT02964247|515882274|FG000|Overall Study|Withdrawal by Subject|1|||
143093585|NCT02964247|515882275|FG001|Overall Study|Withdrawal by Subject|2|||
143093586|NCT03170544|515882276|FG000|Part 1|Lost to Follow-up|1|||
143093587|NCT03170544|515882277|FG001|Part 1|Lost to Follow-up|0|||
143093588|NCT03170544|515882278|FG002|Part 1|Lost to Follow-up|0|||
143093589|NCT03170544|515882279|FG003|Part 1|Lost to Follow-up|0|||
143093590|NCT03170544|515882280|FG004|Part 1|Lost to Follow-up|0|||
143093591|NCT03170544|515882281|FG005|Part 1|Lost to Follow-up|0|||
143093592|NCT03170544|515882282|FG006|Part 1|Lost to Follow-up|0|||
143093593|NCT03170544|515882283|FG007|Part 1|Lost to Follow-up|0|||
143093594|NCT03170544|515882284|FG008|Part 1|Lost to Follow-up|0|||
143251107|NCT02059291|516472989|FG020|Epoch 3|Adverse Event|0|||
143251108|NCT02059291|516472990|FG021|Epoch 3|Adverse Event|0|||
143251109|NCT02059291|516472991|FG022|Epoch 3|Adverse Event|0|||
143251110|NCT02059291|516472992|FG023|Epoch 3|Adverse Event|0|||
143251111|NCT02059291|516472993|FG024|Epoch 3|Adverse Event|0|||
143251112|NCT02059291|516472969|FG000|Epoch 3|Lack of Efficacy|0|||
143251113|NCT02059291|516472970|FG001|Epoch 3|Lack of Efficacy|0|||
143251114|NCT02059291|516472971|FG002|Epoch 3|Lack of Efficacy|0|||
143251115|NCT02059291|516472972|FG003|Epoch 3|Lack of Efficacy|0|||
143251116|NCT02059291|516472973|FG004|Epoch 3|Lack of Efficacy|0|||
143251117|NCT02059291|516472974|FG005|Epoch 3|Lack of Efficacy|0|||
143251118|NCT02059291|516472975|FG006|Epoch 3|Lack of Efficacy|0|||
143251119|NCT02059291|516472976|FG007|Epoch 3|Lack of Efficacy|0|||
143093595|NCT03170544|515882285|FG009|Part 1|Lost to Follow-up|0|||
143093596|NCT03170544|515882286|FG010|Part 1|Lost to Follow-up|0|||
143093597|NCT03170544|515882287|FG011|Part 1|Lost to Follow-up|0|||
143093598|NCT03170544|515882276|FG000|Part 1|Not treated|0|||
143093599|NCT03170544|515882277|FG001|Part 1|Not treated|0|||
143093600|NCT03170544|515882278|FG002|Part 1|Not treated|0|||
143093601|NCT03170544|515882279|FG003|Part 1|Not treated|1|||
143093602|NCT03170544|515882280|FG004|Part 1|Not treated|0|||
143093603|NCT03170544|515882281|FG005|Part 1|Not treated|0|||
143093604|NCT03170544|515882282|FG006|Part 1|Not treated|0|||
143093605|NCT03170544|515882283|FG007|Part 1|Not treated|0|||
143093606|NCT03170544|515882284|FG008|Part 1|Not treated|0|||
143093607|NCT03170544|515882285|FG009|Part 1|Not treated|0|||
143093608|NCT03170544|515882286|FG010|Part 1|Not treated|0|||
143093609|NCT03170544|515882287|FG011|Part 1|Not treated|0|||
143093610|NCT02546986|515883861|FG000|Treatment Period|Progressive Disease|20|||
143251120|NCT02059291|516472977|FG008|Epoch 3|Lack of Efficacy|0|||
143251121|NCT02059291|516472978|FG009|Epoch 3|Lack of Efficacy|0|||
143251122|NCT02059291|516472979|FG010|Epoch 3|Lack of Efficacy|0|||
143093611|NCT02546986|515883862|FG001|Treatment Period|Progressive Disease|22|||
143093612|NCT02546986|515883861|FG000|Treatment Period|Adverse Event|14|||
143093613|NCT02546986|515883862|FG001|Treatment Period|Adverse Event|6|||
143093614|NCT02546986|515883861|FG000|Treatment Period|Symptomatic Deterioration|4|||
143093615|NCT02546986|515883862|FG001|Treatment Period|Symptomatic Deterioration|3|||
143093616|NCT02546986|515883861|FG000|Treatment Period|Death|3|||
143093617|NCT02546986|515883862|FG001|Treatment Period|Death|4|||
143093618|NCT02546986|515883861|FG000|Treatment Period|Physician Decision|1|||
143093619|NCT02546986|515883862|FG001|Treatment Period|Physician Decision|2|||
143093620|NCT02546986|515883861|FG000|Treatment Period|Protocol Violation|1|||
143093621|NCT02546986|515883862|FG001|Treatment Period|Protocol Violation|0|||
143093622|NCT02546986|515883861|FG000|Treatment Period|Withdrawal by Subject|1|||
143093623|NCT02546986|515883862|FG001|Treatment Period|Withdrawal by Subject|1|||
143093624|NCT02546986|515883861|FG000|Treatment Period|Non-compliance with Study Drug|0|||
143093625|NCT02546986|515883862|FG001|Treatment Period|Non-compliance with Study Drug|1|||
143093626|NCT02546986|515883861|FG000|Treatment Period|Study Terminated by Sponsor|0|||
143093627|NCT02546986|515883862|FG001|Treatment Period|Study Terminated by Sponsor|1|||
143093628|NCT02546986|515883861|FG000|Treatment Period|Miscellaneous|7|||
143093629|NCT02546986|515883862|FG001|Treatment Period|Miscellaneous|9|||
143093630|NCT02546986|515883861|FG000|Survival Follow-Up Phase|Missing Status|3|||
143093631|NCT02546986|515883862|FG001|Survival Follow-Up Phase|Missing Status|5|||
143093632|NCT02546986|515883861|FG000|Survival Follow-Up Phase|Death|18|||
143093633|NCT02546986|515883862|FG001|Survival Follow-Up Phase|Death|12|||
143093634|NCT02546986|515883861|FG000|Survival Follow-Up Phase|Alive|13|||
143093635|NCT02546986|515883862|FG001|Survival Follow-Up Phase|Alive|16|||
143093636|NCT02546986|515883861|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
143093637|NCT02546986|515883862|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
143093638|NCT04563754|515883863|FG000|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|11|||
143093639|NCT04563754|515883864|FG001|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|6|||
143093640|NCT04563754|515883865|FG002|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|0|||
143093641|NCT04563754|515883863|FG000|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
143093642|NCT04563754|515883864|FG001|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
143093643|NCT04563754|515883865|FG002|HRME Procedure|Optimization/validation of 3D imaging and HRME|18|||
143093644|NCT04563754|515883863|FG000|Follow up|Lost to Follow-up|61|||
143093645|NCT04563754|515883864|FG001|Follow up|Lost to Follow-up|23|||
143093646|NCT04563754|515883865|FG002|Follow up|Lost to Follow-up|5|||
143093647|NCT04563754|515883863|FG000|Follow up|Death|0|||
143093648|NCT04563754|515883864|FG001|Follow up|Death|2|||
143093649|NCT04563754|515883865|FG002|Follow up|Death|0|||
143093650|NCT04563754|515883863|FG000|Follow up|Ongoing|0|||
143093651|NCT04563754|515883864|FG001|Follow up|Ongoing|28|||
143093652|NCT04563754|515883865|FG002|Follow up|Ongoing|0|||
143093653|NCT04021914|515883866|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
143093654|NCT03879135|515883867|FG000|Overall Study|Physician Decision|0|||
143093655|NCT03879135|515883868|FG001|Overall Study|Physician Decision|0|||
143093656|NCT03879135|515883869|FG002|Overall Study|Physician Decision|0|||
143093657|NCT03879135|515883870|FG003|Overall Study|Physician Decision|1|||
143093658|NCT03879135|515883871|FG004|Overall Study|Physician Decision|0|||
143093659|NCT03879135|515883872|FG005|Overall Study|Physician Decision|0|||
143093660|NCT03879135|515883867|FG000|Overall Study|Withdrawal by Subject|0|||
143093661|NCT03879135|515883868|FG001|Overall Study|Withdrawal by Subject|0|||
143093662|NCT03879135|515883869|FG002|Overall Study|Withdrawal by Subject|0|||
143093663|NCT03879135|515883870|FG003|Overall Study|Withdrawal by Subject|0|||
143093664|NCT03879135|515883871|FG004|Overall Study|Withdrawal by Subject|0|||
143093665|NCT03879135|515883872|FG005|Overall Study|Withdrawal by Subject|1|||
143093666|NCT03879135|515883867|FG000|Overall Study|Site Closed by Sponsor|0|||
143093667|NCT03879135|515883868|FG001|Overall Study|Site Closed by Sponsor|0|||
143093668|NCT03879135|515883869|FG002|Overall Study|Site Closed by Sponsor|0|||
143093669|NCT03879135|515883870|FG003|Overall Study|Site Closed by Sponsor|1|||
143093670|NCT03879135|515883871|FG004|Overall Study|Site Closed by Sponsor|1|||
143093671|NCT03879135|515883872|FG005|Overall Study|Site Closed by Sponsor|0|||
143093672|NCT04162847|515883873|FG000|Overall Study|Withdrawal by Subject|7|||
143093673|NCT04162847|515883874|FG001|Overall Study|Withdrawal by Subject|1|||
143093674|NCT03985800|515883875|FG000|Overall Study|Death|1|||
143093675|NCT03985800|515883876|FG001|Overall Study|Death|2|||
143093676|NCT03985800|515883875|FG000|Overall Study|Withdrawal by Subject|3|||
143093677|NCT03985800|515883876|FG001|Overall Study|Withdrawal by Subject|6|||
143093678|NCT03985800|515883875|FG000|Overall Study|Protocol Violation|2|||
143093679|NCT03985800|515883876|FG001|Overall Study|Protocol Violation|0|||
143093680|NCT01415518|515883879|FG000|Overall Study|Withdrawal by Subject|2|||
143093681|NCT01415518|515883880|FG001|Overall Study|Withdrawal by Subject|12|||
143093682|NCT01415518|515883879|FG000|Overall Study|Protocol Violation|6|||
143093683|NCT01415518|515883880|FG001|Overall Study|Protocol Violation|8|||
143093684|NCT01415518|515883879|FG000|Overall Study|Lost to Follow-up|3|||
143093685|NCT01415518|515883880|FG001|Overall Study|Lost to Follow-up|5|||
143367331|NCT04888585|516887307|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
143367332|NCT04888585|516887308|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
143367333|NCT04888585|516887309|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
143367334|NCT04888585|516887310|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
143093686|NCT01415518|515883879|FG000|Overall Study|Adverse Event|3|||
143093687|NCT01415518|515883880|FG001|Overall Study|Adverse Event|4|||
143093688|NCT01415518|515883879|FG000|Overall Study|Death|1|||
143093689|NCT01415518|515883880|FG001|Overall Study|Death|1|||
143093690|NCT01415518|515883879|FG000|Overall Study|Condition under Investigation Worsened|1|||
143093691|NCT01415518|515883880|FG001|Overall Study|Condition under Investigation Worsened|1|||
143093692|NCT02243605|515883881|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
143093693|NCT02243605|515883882|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
143093694|NCT02243605|515883881|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
143093695|NCT02243605|515883882|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
143093696|NCT02243605|515883881|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
143093697|NCT02243605|515883882|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
143093698|NCT02243605|515883881|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
143093699|NCT02243605|515883882|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
143093700|NCT02243605|515883881|FG000|Stage 2 - Final Analysis Population|Progression|0|||
143093701|NCT02243605|515883882|FG001|Stage 2 - Final Analysis Population|Progression|1|||
143093702|NCT03593525|515883883|FG000|Overall Study|Withdrawal by Subject|1|||
143093703|NCT03593525|515883884|FG001|Overall Study|Withdrawal by Subject|0|||
143093704|NCT03593525|515883883|FG000|Overall Study|Lost to Follow-up|7|||
143093705|NCT03593525|515883884|FG001|Overall Study|Lost to Follow-up|5|||
143176707|NCT00461708|516196214|FG000|Overall Study|Physician Decision|10|||
143176708|NCT00461708|516196215|FG001|Overall Study|Physician Decision|4|||
143176709|NCT00461708|516196214|FG000|Overall Study|Withdrawal by Subject|8|||
143176710|NCT00461708|516196215|FG001|Overall Study|Withdrawal by Subject|2|||
143093706|NCT01002989|515883885|FG000|Overall Study|exclusion criteria, no consent|5|||
143093707|NCT01892501|515883886|FG000|Overall Study|Protocol Violation|2|||
143176711|NCT00461708|516196214|FG000|Overall Study|Other|4|||
143093708|NCT01892501|515883886|FG000|Overall Study|Puncture not carried out|9|||
143093709|NCT01892501|515883886|FG000|Overall Study|Radiological monitoring not carried out|5|||
143093710|NCT01892501|515883886|FG000|Overall Study|Non-contributory histological result|12|||
143093711|NCT00370552|515883891|FG000|Overall Study|Adverse Event|2|||
143093712|NCT00370552|515883892|FG001|Overall Study|Adverse Event|2|||
143093713|NCT00370552|515883893|FG002|Overall Study|Adverse Event|2|||
143093714|NCT00370552|515883891|FG000|Overall Study|Disease progression|23|||
143093715|NCT00370552|515883892|FG001|Overall Study|Disease progression|23|||
143093716|NCT00370552|515883893|FG002|Overall Study|Disease progression|15|||
143093717|NCT00370552|515883891|FG000|Overall Study|Maximum clinical benefit|3|||
143093718|NCT00370552|515883892|FG001|Overall Study|Maximum clinical benefit|5|||
143093719|NCT00370552|515883893|FG002|Overall Study|Maximum clinical benefit|5|||
143093720|NCT00370552|515883891|FG000|Overall Study|Poor or noncompliance|0|||
143093721|NCT00370552|515883892|FG001|Overall Study|Poor or noncompliance|0|||
143093722|NCT00370552|515883893|FG002|Overall Study|Poor or noncompliance|1|||
143093723|NCT00370552|515883891|FG000|Overall Study|Study drug toxicity|11|||
143093724|NCT00370552|515883892|FG001|Overall Study|Study drug toxicity|8|||
143093725|NCT00370552|515883893|FG002|Overall Study|Study drug toxicity|6|||
143093726|NCT00370552|515883891|FG000|Overall Study|Withdrawal by Subject|2|||
143093727|NCT00370552|515883892|FG001|Overall Study|Withdrawal by Subject|0|||
143093728|NCT00370552|515883893|FG002|Overall Study|Withdrawal by Subject|1|||
143093729|NCT00370552|515883891|FG000|Overall Study|Still on treatment|1|||
143093730|NCT00370552|515883892|FG001|Overall Study|Still on treatment|3|||
143093731|NCT00370552|515883893|FG002|Overall Study|Still on treatment|2|||
143093732|NCT00370552|515883891|FG000|Overall Study|Never treated|1|||
143093733|NCT00370552|515883892|FG001|Overall Study|Never treated|0|||
143093734|NCT00370552|515883893|FG002|Overall Study|Never treated|0|||
143093735|NCT00370552|515883891|FG000|Overall Study|Physician Decision|1|||
143093736|NCT00370552|515883892|FG001|Overall Study|Physician Decision|1|||
143093737|NCT00370552|515883893|FG002|Overall Study|Physician Decision|0|||
143093738|NCT00370552|515883891|FG000|Overall Study|Investigator decision|2|||
143093739|NCT00370552|515883892|FG001|Overall Study|Investigator decision|1|||
143093740|NCT00370552|515883893|FG002|Overall Study|Investigator decision|0|||
143093741|NCT00370552|515883891|FG000|Overall Study|High risk of allergic reaction|0|||
143093742|NCT00370552|515883892|FG001|Overall Study|High risk of allergic reaction|1|||
143093743|NCT00370552|515883893|FG002|Overall Study|High risk of allergic reaction|0|||
143093744|NCT00370552|515883891|FG000|Overall Study|Planned radiation for palliation|0|||
143093745|NCT00370552|515883892|FG001|Overall Study|Planned radiation for palliation|1|||
143093746|NCT00370552|515883893|FG002|Overall Study|Planned radiation for palliation|0|||
143093747|NCT01062425|515883902|FG000|Overall Study|Protocol Violation|3|||
143093748|NCT01062425|515883903|FG001|Overall Study|Protocol Violation|6|||
143093749|NCT02342678|515883904|FG000|Overall Study|Lost to Follow-up|0|||
143093750|NCT02342678|515883905|FG001|Overall Study|Lost to Follow-up|1|||
143093751|NCT02342678|515883904|FG000|Overall Study|Too busy to complete study|0|||
143093752|NCT02342678|515883905|FG001|Overall Study|Too busy to complete study|2|||
143093753|NCT02342678|515883904|FG000|Overall Study|Family illness/emergency|0|||
143093754|NCT02342678|515883905|FG001|Overall Study|Family illness/emergency|1|||
143093755|NCT02342678|515883904|FG000|Overall Study|Illness/medical reason|1|||
143093756|NCT02342678|515883905|FG001|Overall Study|Illness/medical reason|1|||
143093757|NCT02383017|515883906|FG000|Overall Study|Injury Sustained Outside Study|1|||
143093758|NCT02383017|515883907|FG001|Overall Study|Injury Sustained Outside Study|0|||
143093759|NCT02383017|515883906|FG000|Overall Study|Compliance|3|||
143093760|NCT02383017|515883907|FG001|Overall Study|Compliance|2|||
143093761|NCT02383017|515883906|FG000|Overall Study|Found to be Hypogonadal|1|||
143093762|NCT02383017|515883907|FG001|Overall Study|Found to be Hypogonadal|0|||
143093763|NCT00289848|515883908|FG000|Overall Study|Adverse Event|6|||
143093764|NCT00289848|515883909|FG001|Overall Study|Adverse Event|4|||
143093765|NCT00289848|515883908|FG000|Overall Study|Death|1|||
143093766|NCT00289848|515883909|FG001|Overall Study|Death|0|||
143093767|NCT00289848|515883908|FG000|Overall Study|Lack of Efficacy|20|||
143093768|NCT00289848|515883909|FG001|Overall Study|Lack of Efficacy|24|||
143093769|NCT00289848|515883908|FG000|Overall Study|Lost to Follow-up|3|||
143093770|NCT00289848|515883909|FG001|Overall Study|Lost to Follow-up|1|||
143093771|NCT00289848|515883908|FG000|Overall Study|Protocol Violation|5|||
143093772|NCT00289848|515883909|FG001|Overall Study|Protocol Violation|2|||
143093773|NCT00289848|515883908|FG000|Overall Study|Withdrawal by Subject|5|||
143093774|NCT00289848|515883909|FG001|Overall Study|Withdrawal by Subject|11|||
143093775|NCT00289848|515883908|FG000|Overall Study|Patient Moved|6|||
143093776|NCT00289848|515883909|FG001|Overall Study|Patient Moved|2|||
143093777|NCT00289848|515883908|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
143093778|NCT00289848|515883909|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
143093779|NCT03428152|515883911|FG000|Overall Study|Physician Decision|4|||
143093780|NCT03428152|515883912|FG001|Overall Study|Physician Decision|2|||
143093781|NCT03428152|515883911|FG000|Overall Study|Protocol Violation|3|||
143093782|NCT03428152|515883912|FG001|Overall Study|Protocol Violation|5|||
143093783|NCT03428152|515883911|FG000|Overall Study|Lack of Efficacy|0|||
143093784|NCT03428152|515883912|FG001|Overall Study|Lack of Efficacy|4|||
143093785|NCT00395629|515883913|FG000|Core Study|Adverse Event|0|||
143093786|NCT00395629|515883914|FG001|Core Study|Adverse Event|3|||
143093787|NCT00395629|515883915|FG002|Core Study|Adverse Event|4|||
143093788|NCT00395629|515883913|FG000|Core Study|Abnormal laboratory value(s)|0|||
143093789|NCT00395629|515883914|FG001|Core Study|Abnormal laboratory value(s)|0|||
143093790|NCT00395629|515883915|FG002|Core Study|Abnormal laboratory value(s)|1|||
143251123|NCT02059291|516472980|FG011|Epoch 3|Lack of Efficacy|0|||
143251124|NCT02059291|516472981|FG012|Epoch 3|Lack of Efficacy|0|||
143251125|NCT02059291|516472982|FG013|Epoch 3|Lack of Efficacy|0|||
143251126|NCT02059291|516472983|FG014|Epoch 3|Lack of Efficacy|0|||
143251127|NCT02059291|516472984|FG015|Epoch 3|Lack of Efficacy|3|||
143093791|NCT00395629|515883913|FG000|Core Study|Protocol Violation|1|||
143093792|NCT00395629|515883914|FG001|Core Study|Protocol Violation|0|||
143093793|NCT00395629|515883915|FG002|Core Study|Protocol Violation|0|||
143093794|NCT00395629|515883913|FG000|Core Study|Withdrawal by Subject|0|||
143093795|NCT00395629|515883914|FG001|Core Study|Withdrawal by Subject|1|||
143251128|NCT02059291|516472985|FG016|Epoch 3|Lack of Efficacy|0|||
143093796|NCT00395629|515883915|FG002|Core Study|Withdrawal by Subject|1|||
143093797|NCT00395629|515883913|FG000|Core Study|Lost to Follow-up|0|||
143093798|NCT00395629|515883914|FG001|Core Study|Lost to Follow-up|0|||
143093799|NCT00395629|515883915|FG002|Core Study|Lost to Follow-up|1|||
143251129|NCT02059291|516472986|FG017|Epoch 3|Lack of Efficacy|0|||
143251130|NCT02059291|516472987|FG018|Epoch 3|Lack of Efficacy|0|||
143367335|NCT03822351|516887311|FG000|Overall Study|Death|27|||
143367336|NCT03822351|516887312|FG001|Overall Study|Death|23|||
143367337|NCT03822351|516887313|FG002|Overall Study|Death|24|||
143367338|NCT03822351|516887311|FG000|Overall Study|Lost to Follow-up|6|||
143367339|NCT03822351|516887312|FG001|Overall Study|Lost to Follow-up|2|||
143367340|NCT03822351|516887313|FG002|Overall Study|Lost to Follow-up|1|||
143367341|NCT03822351|516887311|FG000|Overall Study|Withdrawal by Subject|10|||
143367342|NCT03822351|516887312|FG001|Overall Study|Withdrawal by Subject|4|||
143367343|NCT03822351|516887313|FG002|Overall Study|Withdrawal by Subject|6|||
143367344|NCT03822351|516887311|FG000|Overall Study|Progressive Disease|2|||
143367345|NCT03822351|516887312|FG001|Overall Study|Progressive Disease|1|||
143367346|NCT03822351|516887313|FG002|Overall Study|Progressive Disease|0|||
143367347|NCT03822351|516887311|FG000|Overall Study|Not Treated|1|||
143367348|NCT03822351|516887312|FG001|Overall Study|Not Treated|1|||
143367349|NCT03822351|516887313|FG002|Overall Study|Not Treated|1|||
143367350|NCT02738840|516889316|FG000|Overall Study|MRI Scan not Performed|5|||
143367351|NCT02738840|516889316|FG000|Overall Study|Lost to Follow-up|1|||
143367352|NCT02738840|516889316|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
143367353|NCT02738840|516889316|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
143367354|NCT01311648|516889319|FG000|Main Study|Protocol Violation|0|||
143367355|NCT01311648|516889320|FG001|Main Study|Protocol Violation|1|||
143367356|NCT01311648|516889319|FG000|Main Study|Adverse Event|0|||
143367357|NCT01311648|516889320|FG001|Main Study|Adverse Event|1|||
143367358|NCT01311648|516889319|FG000|Main Study|Inhibitor management|0|||
143093800|NCT00395629|515883913|FG000|Extension Study|Adverse Event|0|||
143093801|NCT00395629|515883914|FG001|Extension Study|Adverse Event|0|||
143093802|NCT00395629|515883915|FG002|Extension Study|Adverse Event|2|||
143367359|NCT01311648|516889320|FG001|Main Study|Inhibitor management|17|||
143367360|NCT01311648|516889319|FG000|Main Study|Withdrawal by Subject|0|||
143367361|NCT01311648|516889320|FG001|Main Study|Withdrawal by Subject|2|||
143367362|NCT01311648|516889319|FG000|Extension Study|Physician Decision|0|||
143093803|NCT00395629|515883913|FG000|Extension Study|Administrative problems|0|||
143093804|NCT00395629|515883914|FG001|Extension Study|Administrative problems|0|||
143093805|NCT00395629|515883915|FG002|Extension Study|Administrative problems|1|||
143093806|NCT03534687|515883916|FG000|Overall Study|Lost to Follow-up|7|||
143093807|NCT03534687|515883917|FG001|Overall Study|Lost to Follow-up|2|||
143093808|NCT01286467|515883923|FG000|Overall Study|Death|1|||
143093809|NCT01286467|515883924|FG001|Overall Study|Death|1|||
143093810|NCT01286467|515883925|FG002|Overall Study|Death|1|||
143093811|NCT01286467|515883926|FG003|Overall Study|Death|0|||
143093812|NCT01286467|515883923|FG000|Overall Study|Lost to Follow-up|0|||
143093813|NCT01286467|515883924|FG001|Overall Study|Lost to Follow-up|0|||
143093814|NCT01286467|515883925|FG002|Overall Study|Lost to Follow-up|0|||
143093815|NCT01286467|515883926|FG003|Overall Study|Lost to Follow-up|1|||
143093816|NCT01286467|515883923|FG000|Overall Study|Withdrawal by Subject|0|||
143093817|NCT01286467|515883924|FG001|Overall Study|Withdrawal by Subject|0|||
143093818|NCT01286467|515883925|FG002|Overall Study|Withdrawal by Subject|1|||
143093819|NCT01286467|515883926|FG003|Overall Study|Withdrawal by Subject|0|||
143093820|NCT01286467|515883923|FG000|Overall Study|Physician Decision|0|||
143093821|NCT01286467|515883924|FG001|Overall Study|Physician Decision|0|||
143093822|NCT01286467|515883925|FG002|Overall Study|Physician Decision|0|||
143093823|NCT01286467|515883926|FG003|Overall Study|Physician Decision|1|||
143093824|NCT01286467|515883923|FG000|Overall Study|Disease progression|3|||
143093825|NCT01286467|515883924|FG001|Overall Study|Disease progression|2|||
143093826|NCT01286467|515883925|FG002|Overall Study|Disease progression|2|||
143093827|NCT01286467|515883926|FG003|Overall Study|Disease progression|3|||
143093828|NCT01286467|515883923|FG000|Overall Study|Adverse Event|0|||
143093829|NCT01286467|515883924|FG001|Overall Study|Adverse Event|1|||
143093830|NCT01286467|515883925|FG002|Overall Study|Adverse Event|2|||
143093831|NCT01286467|515883926|FG003|Overall Study|Adverse Event|3|||
143367363|NCT01311648|516889320|FG001|Extension Study|Physician Decision|1|||
143367364|NCT01311648|516889319|FG000|Extension Study|ITI therapy with marketed product|0|||
143367365|NCT01311648|516889320|FG001|Extension Study|ITI therapy with marketed product|1|||
143367366|NCT01311648|516889319|FG000|Extension Study|Incorrect visit planning|0|||
143093832|NCT01286467|515883923|FG000|Overall Study|Study drug stop longer than 14 days|0|||
143093833|NCT01286467|515883924|FG001|Overall Study|Study drug stop longer than 14 days|0|||
143093834|NCT01286467|515883925|FG002|Overall Study|Study drug stop longer than 14 days|1|||
143093835|NCT01286467|515883926|FG003|Overall Study|Study drug stop longer than 14 days|0|||
143367367|NCT01311648|516889320|FG001|Extension Study|Incorrect visit planning|1|||
143367368|NCT01311648|516889319|FG000|Extension Study|Family's decision|0|||
143367369|NCT01311648|516889320|FG001|Extension Study|Family's decision|1|||
143367370|NCT01311648|516889319|FG000|Extension Study|Failure of ITI therapy|0|||
143093836|NCT01058642|515883927|FG000|Treatment Period 1|Adverse Event|0|||
143093837|NCT01058642|515883928|FG001|Treatment Period 1|Adverse Event|1|||
143093838|NCT01058642|515883929|FG002|Treatment Period 1|Adverse Event|1|||
143251131|NCT02059291|516472988|FG019|Epoch 3|Lack of Efficacy|0|||
143367371|NCT01311648|516889320|FG001|Extension Study|Failure of ITI therapy|3|||
143367372|NCT01311648|516889319|FG000|Extension Study|Long travel|0|||
143367373|NCT01311648|516889320|FG001|Extension Study|Long travel|1|||
143367374|NCT01311648|516889319|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
143367375|NCT01311648|516889320|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
143367376|NCT01311648|516889319|FG000|Extension Study|Withdrawal by Subject|0|||
143367377|NCT01311648|516889320|FG001|Extension Study|Withdrawal by Subject|1|||
143093839|NCT01058642|515883930|FG003|Treatment Period 1|Adverse Event|0|||
143093840|NCT01058642|515883927|FG000|Treatment Period 1|Physician Decision|0|||
143093841|NCT01058642|515883928|FG001|Treatment Period 1|Physician Decision|0|||
143093842|NCT01058642|515883929|FG002|Treatment Period 1|Physician Decision|1|||
143093843|NCT01058642|515883930|FG003|Treatment Period 1|Physician Decision|0|||
143093844|NCT01058642|515883927|FG000|Treatment Period 1|Withdrawal by Subject|1|||
143093845|NCT01058642|515883928|FG001|Treatment Period 1|Withdrawal by Subject|0|||
143093846|NCT01058642|515883929|FG002|Treatment Period 1|Withdrawal by Subject|0|||
143093847|NCT01058642|515883930|FG003|Treatment Period 1|Withdrawal by Subject|0|||
143093848|NCT01058642|515883927|FG000|Treatment Period 1|Lack of Efficacy|0|||
143093849|NCT01058642|515883928|FG001|Treatment Period 1|Lack of Efficacy|0|||
143093850|NCT01058642|515883929|FG002|Treatment Period 1|Lack of Efficacy|0|||
143093851|NCT01058642|515883930|FG003|Treatment Period 1|Lack of Efficacy|1|||
143093852|NCT01058642|515883927|FG000|Treatment Period 1|Protocol Violation|0|||
143093853|NCT01058642|515883928|FG001|Treatment Period 1|Protocol Violation|0|||
143093854|NCT01058642|515883929|FG002|Treatment Period 1|Protocol Violation|0|||
143093855|NCT01058642|515883930|FG003|Treatment Period 1|Protocol Violation|1|||
143093856|NCT01058642|515883927|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
143093857|NCT01058642|515883928|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
143093858|NCT01058642|515883929|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
143093859|NCT01058642|515883930|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
143093860|NCT03305848|515883931|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
143093861|NCT03305848|515883931|FG000|Overall Study|Physician Decision|2|||
143093862|NCT02224157|515883932|FG000|Overall Study|Severe non-compliance to protocol|2|||
143093863|NCT02224157|515883933|FG001|Overall Study|Severe non-compliance to protocol|2|||
143093864|NCT02224157|515883932|FG000|Overall Study|Other|13|||
143093865|NCT02224157|515883933|FG001|Overall Study|Other|10|||
143093866|NCT02224157|515883932|FG000|Overall Study|Subject decision|58|||
143093867|NCT02224157|515883933|FG001|Overall Study|Subject decision|50|||
143093868|NCT02224157|515883932|FG000|Overall Study|Prematurely closed site|4|||
143093869|NCT02224157|515883933|FG001|Overall Study|Prematurely closed site|2|||
143093870|NCT02224157|515883932|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
143093871|NCT02224157|515883933|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
143093872|NCT02224157|515883932|FG000|Overall Study|Lost to Follow-up|27|||
143093873|NCT02224157|515883933|FG001|Overall Study|Lost to Follow-up|35|||
143093874|NCT02224157|515883932|FG000|Overall Study|Death|1|||
143093875|NCT02224157|515883933|FG001|Overall Study|Death|1|||
143093876|NCT02224157|515883932|FG000|Overall Study|Adverse Event|1|||
143093877|NCT02224157|515883933|FG001|Overall Study|Adverse Event|3|||
143093878|NCT04578535|515883936|FG000|Overall Study|Lost to Follow-up|1|||
143093879|NCT04578535|515883937|FG001|Overall Study|Lost to Follow-up|0|||
143093880|NCT04578535|515883938|FG002|Overall Study|Lost to Follow-up|0|||
143093881|NCT04578535|515883939|FG003|Overall Study|Lost to Follow-up|1|||
143093882|NCT04578535|515883940|FG004|Overall Study|Lost to Follow-up|0|||
143093883|NCT04578535|515883941|FG005|Overall Study|Lost to Follow-up|2|||
143093884|NCT04578535|515883936|FG000|Overall Study|Pregnancy|1|||
143093885|NCT04578535|515883937|FG001|Overall Study|Pregnancy|0|||
143093886|NCT04578535|515883938|FG002|Overall Study|Pregnancy|0|||
143093887|NCT04578535|515883939|FG003|Overall Study|Pregnancy|0|||
143093888|NCT04578535|515883940|FG004|Overall Study|Pregnancy|0|||
143093889|NCT04578535|515883941|FG005|Overall Study|Pregnancy|0|||
143093890|NCT04578535|515883936|FG000|Overall Study|Withdrawal by Subject|0|||
143093891|NCT04578535|515883937|FG001|Overall Study|Withdrawal by Subject|0|||
143093892|NCT04578535|515883938|FG002|Overall Study|Withdrawal by Subject|0|||
143093893|NCT04578535|515883939|FG003|Overall Study|Withdrawal by Subject|1|||
143093894|NCT04578535|515883940|FG004|Overall Study|Withdrawal by Subject|1|||
143093895|NCT04578535|515883941|FG005|Overall Study|Withdrawal by Subject|5|||
143093896|NCT04578535|515883936|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
143093897|NCT04578535|515883937|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
143176712|NCT00461708|516196215|FG001|Overall Study|Other|4|||
143093898|NCT04578535|515883938|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
143093899|NCT04578535|515883939|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
143093900|NCT04578535|515883940|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
143093901|NCT04578535|515883941|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
143093902|NCT02301169|515883946|FG000|Overall Study|Adverse Event|1|||
143093903|NCT02301169|515883947|FG001|Overall Study|Adverse Event|0|||
143093904|NCT03839628|515883948|FG000|Overall Study|Withdrawal by Subject|1|||
143093905|NCT01707290|515883953|FG000|Overall Study|Adverse event (AE)|1|||
143093906|NCT01707290|515883954|FG001|Overall Study|Adverse event (AE)|0|||
143093907|NCT01707290|515883953|FG000|Overall Study|Physician Decision|1|||
143093908|NCT01707290|515883954|FG001|Overall Study|Physician Decision|0|||
143093909|NCT01707290|515883953|FG000|Overall Study|Lost to Follow-up|3|||
143093910|NCT01707290|515883954|FG001|Overall Study|Lost to Follow-up|0|||
143093911|NCT01707290|515883953|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
143093912|NCT01707290|515883954|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
143093913|NCT01707290|515883953|FG000|Overall Study|Commercial drug available|60|||
143093914|NCT01707290|515883954|FG001|Overall Study|Commercial drug available|1|||
143093915|NCT01707290|515883953|FG000|Overall Study|Other unspecified|17|||
143093916|NCT01707290|515883954|FG001|Overall Study|Other unspecified|0|||
143093917|NCT01198470|515883955|FG000|Overall Study|Adverse Event|2|||
143093918|NCT04383327|515883956|FG000|Overall Study|Lost to Follow-up|112|||
143093919|NCT04383327|515883957|FG001|Overall Study|Lost to Follow-up|14|||
143093920|NCT04383327|515883958|FG002|Overall Study|Lost to Follow-up|78|||
143093921|NCT04383327|515883959|FG003|Overall Study|Lost to Follow-up|13|||
143093922|NCT04383327|515883960|FG004|Overall Study|Lost to Follow-up|110|||
143093923|NCT04383327|515883961|FG005|Overall Study|Lost to Follow-up|13|||
143093924|NCT04383327|515883962|FG006|Overall Study|Lost to Follow-up|74|||
143093925|NCT04383327|515883963|FG007|Overall Study|Lost to Follow-up|13|||
143093926|NCT04383327|515883964|FG008|Overall Study|Lost to Follow-up|78|||
143093927|NCT04383327|515883965|FG009|Overall Study|Lost to Follow-up|10|||
143093928|NCT04383327|515883966|FG010|Overall Study|Lost to Follow-up|160|||
143093929|NCT04383327|515883967|FG011|Overall Study|Lost to Follow-up|13|||
143093930|NCT00226499|515883977|FG000|Overall Study|Adverse Event|10|||
143093931|NCT00226499|515883978|FG001|Overall Study|Adverse Event|6|||
143093932|NCT00226499|515883979|FG002|Overall Study|Adverse Event|3|||
143093933|NCT00226499|515883977|FG000|Overall Study|Others|1064|||
143093934|NCT00226499|515883978|FG001|Overall Study|Others|1066|||
143093935|NCT00226499|515883979|FG002|Overall Study|Others|356|||
143093936|NCT00946920|515883980|FG000|Overall Study|Withdrawal by Subject|28|||
143093937|NCT00946920|515883981|FG001|Overall Study|Withdrawal by Subject|15|||
143093938|NCT00946920|515883980|FG000|Overall Study|Lost to Follow-up|2|||
143093939|NCT00946920|515883981|FG001|Overall Study|Lost to Follow-up|2|||
143093940|NCT00946920|515883980|FG000|Overall Study|Physician Decision|5|||
143093941|NCT00946920|515883981|FG001|Overall Study|Physician Decision|2|||
143093942|NCT00946920|515883980|FG000|Overall Study|Adverse Event|41|||
143093943|NCT00946920|515883981|FG001|Overall Study|Adverse Event|14|||
143093944|NCT00946920|515883980|FG000|Overall Study|Protocol Violation|16|||
143093945|NCT00946920|515883981|FG001|Overall Study|Protocol Violation|8|||
143093946|NCT00946920|515883980|FG000|Overall Study|Miscellaneous reasons|18|||
143093947|NCT00946920|515883981|FG001|Overall Study|Miscellaneous reasons|3|||
143093948|NCT01288079|515883982|FG000|Overall Study|Withdrawal by Subject|2|||
143093949|NCT01288079|515883983|FG001|Overall Study|Withdrawal by Subject|4|||
143093950|NCT01288079|515883984|FG002|Overall Study|Withdrawal by Subject|1|||
143093951|NCT01288079|515883985|FG003|Overall Study|Withdrawal by Subject|0|||
143093952|NCT01288079|515883982|FG000|Overall Study|Adverse Event|2|||
143093953|NCT01288079|515883983|FG001|Overall Study|Adverse Event|1|||
143093954|NCT01288079|515883984|FG002|Overall Study|Adverse Event|2|||
143093955|NCT01288079|515883985|FG003|Overall Study|Adverse Event|3|||
143093956|NCT01288079|515883982|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
143093957|NCT01288079|515883983|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
143093958|NCT01288079|515883984|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
143093959|NCT01288079|515883985|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
143093960|NCT01288079|515883982|FG000|Overall Study|Condition under Investigation Worsened|0|||
143093961|NCT01288079|515883983|FG001|Overall Study|Condition under Investigation Worsened|0|||
143093962|NCT01288079|515883984|FG002|Overall Study|Condition under Investigation Worsened|0|||
143093963|NCT01288079|515883985|FG003|Overall Study|Condition under Investigation Worsened|1|||
143093964|NCT01288079|515883982|FG000|Overall Study|Lack of Efficacy|2|||
143093965|NCT01288079|515883983|FG001|Overall Study|Lack of Efficacy|2|||
143093966|NCT01288079|515883984|FG002|Overall Study|Lack of Efficacy|0|||
143093967|NCT01288079|515883985|FG003|Overall Study|Lack of Efficacy|2|||
143176713|NCT00461708|516196214|FG000|Overall Study|Death|8|||
143176714|NCT00461708|516196215|FG001|Overall Study|Death|1|||
143367378|NCT01311648|516889319|FG000|Extension Study|Inhibitor management|0|||
143093968|NCT01288079|515883982|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
143093969|NCT01288079|515883983|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
143093970|NCT01288079|515883984|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
143176715|NCT02750514|516196216|FG000|Track 1|Disease progression|20|||
143093971|NCT01288079|515883985|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
143093972|NCT01288079|515883982|FG000|Overall Study|Lost to Follow-up|1|||
143093973|NCT01288079|515883983|FG001|Overall Study|Lost to Follow-up|1|||
143093974|NCT01288079|515883984|FG002|Overall Study|Lost to Follow-up|1|||
143093975|NCT01288079|515883985|FG003|Overall Study|Lost to Follow-up|0|||
143093976|NCT01288079|515883982|FG000|Overall Study|Other or Study Termination|11|||
143093977|NCT01288079|515883983|FG001|Overall Study|Other or Study Termination|15|||
143093978|NCT01288079|515883984|FG002|Overall Study|Other or Study Termination|14|||
143093979|NCT01288079|515883985|FG003|Overall Study|Other or Study Termination|8|||
143093980|NCT01530464|515883986|FG000|Washout (24h)|Withdrawal by Subject|1|||
143093981|NCT01530464|515883987|FG001|Washout (24h)|Withdrawal by Subject|0|||
143093982|NCT01530464|515883986|FG000|Washout (24h)|Withdrawal by Subject|0|||
143093983|NCT01530464|515883987|FG001|Washout (24h)|Withdrawal by Subject|1|||
143093984|NCT02387840|515883988|FG000|Overall Study|Death|0|||
143093985|NCT02387840|515883989|FG001|Overall Study|Death|0|||
143093986|NCT02387840|515883990|FG002|Overall Study|Death|0|||
143093987|NCT02387840|515883991|FG003|Overall Study|Death|0|||
143093988|NCT02387840|515883992|FG004|Overall Study|Death|0|||
143093989|NCT02387840|515883993|FG005|Overall Study|Death|1|||
143093990|NCT03539302|515883997|FG000|Overall Study|Spontaneous cardio version|0|||
143093991|NCT03539302|515883998|FG001|Overall Study|Spontaneous cardio version|0|||
143093992|NCT03539302|515883999|FG002|Overall Study|Spontaneous cardio version|0|||
143093993|NCT03539302|515884000|FG003|Overall Study|Spontaneous cardio version|0|||
143093994|NCT03539302|515884001|FG004|Overall Study|Spontaneous cardio version|0|||
143093995|NCT03539302|515884002|FG005|Overall Study|Spontaneous cardio version|1|||
143093996|NCT03539302|515884003|FG006|Overall Study|Spontaneous cardio version|1|||
143093997|NCT02107131|515884006|FG000|Overall Study|Lost to Follow-up|4|||
143093998|NCT02107131|515884007|FG001|Overall Study|Lost to Follow-up|4|||
143093999|NCT02107131|515884006|FG000|Overall Study|Physician Decision|1|||
143094000|NCT02107131|515884007|FG001|Overall Study|Physician Decision|0|||
143094001|NCT02107131|515884006|FG000|Overall Study|Withdrawal by Subject|2|||
143094002|NCT02107131|515884007|FG001|Overall Study|Withdrawal by Subject|0|||
143094003|NCT02107131|515884006|FG000|Overall Study|mental instability|1|||
143094004|NCT02107131|515884007|FG001|Overall Study|mental instability|0|||
143094005|NCT02107131|515884006|FG000|Overall Study|Death|0|||
143094006|NCT02107131|515884007|FG001|Overall Study|Death|1|||
143094007|NCT02107131|515884006|FG000|Overall Study|Protocol Violation|0|||
143094008|NCT02107131|515884007|FG001|Overall Study|Protocol Violation|4|||
143094009|NCT01609790|515884008|FG000|Overall Study|Protocol Violation|1|||
143094010|NCT01609790|515884009|FG001|Overall Study|Protocol Violation|7|||
143094011|NCT01609790|515884010|FG002|Overall Study|Protocol Violation|8|||
143094012|NCT05207865|515885855|FG000|Open-Label Treatment Phase|Adverse Event|7|||
143094013|NCT05207865|515885855|FG000|Open-Label Treatment Phase|Lost to Follow-up|8|||
143094014|NCT05207865|515885855|FG000|Open-Label Treatment Phase|Non-compliance|3|||
143094015|NCT05207865|515885855|FG000|Open-Label Treatment Phase|Other|17|||
143094016|NCT05207865|515885855|FG000|Open-Label Treatment Phase|Physician Decision|2|||
143094017|NCT05207865|515885855|FG000|Open-Label Treatment Phase|Pregnancy|1|||
143094018|NCT05207865|515885855|FG000|Open-Label Treatment Phase|Protocol Violation|1|||
143094019|NCT05207865|515885855|FG000|Open-Label Treatment Phase|Protocol-specified withdrawal criterion met|14|||
143094020|NCT05207865|515885855|FG000|Open-Label Treatment Phase|Withdrawal by Subject|10|||
143094021|NCT05207865|515885855|FG000|Follow-up Phase|Lost to Follow-up|1|||
143094022|NCT05207865|515885855|FG000|Follow-up Phase|Non-compliance|1|||
143094023|NCT05207865|515885855|FG000|Follow-up Phase|Not reported|2|||
143094024|NCT05207865|515885855|FG000|Follow-up Phase|Not collected|11|||
143094025|NCT02068508|515885859|FG000|Overall Study|Case report forms uncollected|27|||
143094026|NCT02068508|515885859|FG000|Overall Study|Patient did not visit the study site|1|||
143094027|NCT02068508|515885859|FG000|Overall Study|Protocol Violation|4|||
143094028|NCT00813150|515885860|FG000|Treatment Period|Adverse Event|16|||
143094029|NCT00813150|515885861|FG001|Treatment Period|Adverse Event|15|||
143094030|NCT00813150|515885860|FG000|Treatment Period|Death|2|||
143094031|NCT00813150|515885861|FG001|Treatment Period|Death|0|||
143094032|NCT00813150|515885860|FG000|Treatment Period|Progressive disease|1|||
143094033|NCT00813150|515885861|FG001|Treatment Period|Progressive disease|0|||
143094034|NCT00813150|515885860|FG000|Treatment Period|Complete response|0|||
143094035|NCT00813150|515885861|FG001|Treatment Period|Complete response|1|||
143094036|NCT00813150|515885860|FG000|Treatment Period|Stable disease|1|||
143094037|NCT00813150|515885861|FG001|Treatment Period|Stable disease|2|||
143094038|NCT00813150|515885860|FG000|Treatment Period|Protocol Violation|3|||
143094039|NCT00813150|515885861|FG001|Treatment Period|Protocol Violation|4|||
143251132|NCT02059291|516472989|FG020|Epoch 3|Lack of Efficacy|0|||
143251133|NCT02059291|516472990|FG021|Epoch 3|Lack of Efficacy|0|||
143094040|NCT00813150|515885860|FG000|Treatment Period|Withdrawal by Subject|5|||
143094041|NCT00813150|515885861|FG001|Treatment Period|Withdrawal by Subject|3|||
143094042|NCT00813150|515885860|FG000|Treatment Period|Non compliance|0|||
143094043|NCT00813150|515885861|FG001|Treatment Period|Non compliance|1|||
143094044|NCT00813150|515885860|FG000|Treatment Period|Reason not specified|3|||
143094045|NCT00813150|515885861|FG001|Treatment Period|Reason not specified|4|||
143251134|NCT02059291|516472991|FG022|Epoch 3|Lack of Efficacy|0|||
143367379|NCT01311648|516889320|FG001|Extension Study|Inhibitor management|2|||
143367380|NCT04057196|516889321|FG000|Overall Study|Withdrawal by Subject|3|||
143367381|NCT04057196|516889321|FG000|Overall Study|Death|3|||
143367382|NCT02466516|516889323|FG000|Overall Study|Adverse Event|1|||
143367383|NCT02466516|516889324|FG001|Overall Study|Adverse Event|1|||
143367384|NCT02466516|516889325|FG002|Overall Study|Adverse Event|0|||
143367385|NCT02466516|516889326|FG003|Overall Study|Adverse Event|0|||
143367386|NCT02466516|516889327|FG004|Overall Study|Adverse Event|0|||
143367387|NCT02466516|516889323|FG000|Overall Study|Withdrew Consent|1|||
143367388|NCT02466516|516889324|FG001|Overall Study|Withdrew Consent|0|||
143367389|NCT02466516|516889325|FG002|Overall Study|Withdrew Consent|0|||
143367390|NCT02466516|516889326|FG003|Overall Study|Withdrew Consent|0|||
143367391|NCT02466516|516889327|FG004|Overall Study|Withdrew Consent|0|||
143367392|NCT02466516|516889323|FG000|Overall Study|Lost to Follow-up|2|||
143367393|NCT02466516|516889324|FG001|Overall Study|Lost to Follow-up|0|||
143367394|NCT02466516|516889325|FG002|Overall Study|Lost to Follow-up|1|||
143094046|NCT00813150|515885860|FG000|Treatment Period|Data not available|1|||
143094047|NCT00813150|515885861|FG001|Treatment Period|Data not available|2|||
143094048|NCT00813150|515885860|FG000|Long Term Follow-up|Death|0|||
143094049|NCT00813150|515885861|FG001|Long Term Follow-up|Death|4|||
143094050|NCT00813150|515885860|FG000|Long Term Follow-up|Other|0|||
143094051|NCT00813150|515885861|FG001|Long Term Follow-up|Other|3|||
143094052|NCT00813150|515885860|FG000|Long Term Follow-up|Lost to Follow-up|2|||
143094053|NCT00813150|515885861|FG001|Long Term Follow-up|Lost to Follow-up|0|||
143094054|NCT00813150|515885860|FG000|Long Term Follow-up|Progression/Relapse|22|||
143094055|NCT00813150|515885861|FG001|Long Term Follow-up|Progression/Relapse|24|||
143094056|NCT05423093|515885869|FG000|Consented Participants - Baseline Comple|Lost to Follow-up|2|||
143094057|NCT05423093|515885869|FG000|Consented Participants - Baseline Comple|Withdrawal by Subject|2|||
143094058|NCT05423093|515885869|FG000|Attended Intervention Session|Lost to Follow-up|3|||
143094059|NCT05423093|515885869|FG000|Completed Post-intervention Measures|Lost to Follow-up|3|||
143094060|NCT05423093|515885869|FG000|6-month Post Intervention Data Collected|Lost to Follow-up|2|||
143094061|NCT04173507|515885874|FG000|Overall Study|On Treatment|3|||
143094062|NCT04173507|515885874|FG000|Overall Study|Adverse Event|3|||
143094063|NCT04173507|515885874|FG000|Overall Study|Progression/Relapse|34|||
143094064|NCT04173507|515885874|FG000|Overall Study|Death|2|||
143094065|NCT00210210|515885875|FG000|Overall Study|Withdrawal by Subject|3|||
143094066|NCT00210210|515885876|FG001|Overall Study|Withdrawal by Subject|2|||
143094067|NCT00210210|515885875|FG000|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|3|||
143094068|NCT00210210|515885876|FG001|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|9|||
143094069|NCT04231825|515885877|FG000|Overall Study|Protocol Violation|3|||
143094070|NCT04231825|515885878|FG001|Overall Study|Protocol Violation|3|||
143094071|NCT04231825|515885877|FG000|Overall Study|Lost to Follow-up|0|||
143094072|NCT04231825|515885878|FG001|Overall Study|Lost to Follow-up|1|||
143094073|NCT01662635|515885879|FG000|Overall Study|scarce samples for evaluation|30|||
143094074|NCT02445248|515885882|FG000|Overall Study|Death|45|||
143094075|NCT02445248|515885883|FG001|Overall Study|Death|12|||
143094076|NCT02445248|515885882|FG000|Overall Study|Progressive disease|13|||
143094077|NCT02445248|515885883|FG001|Overall Study|Progressive disease|1|||
143094078|NCT02445248|515885882|FG000|Overall Study|Subject decision|8|||
143094079|NCT02445248|515885883|FG001|Overall Study|Subject decision|0|||
143094080|NCT02445248|515885882|FG000|Overall Study|Physician Decision|5|||
143094081|NCT02445248|515885883|FG001|Overall Study|Physician Decision|0|||
143094082|NCT02445248|515885882|FG000|Overall Study|Adverse Event|1|||
143094083|NCT02445248|515885883|FG001|Overall Study|Adverse Event|0|||
143094084|NCT02445248|515885882|FG000|Overall Study|Lost to Follow-up|1|||
143094085|NCT02445248|515885883|FG001|Overall Study|Lost to Follow-up|0|||
143094086|NCT01217112|515885884|FG000|Overall Study|Adverse Event|0|||
143094087|NCT01217112|515885885|FG001|Overall Study|Adverse Event|2|||
143094088|NCT01217112|515885886|FG002|Overall Study|Adverse Event|0|||
143094089|NCT01217112|515885887|FG003|Overall Study|Adverse Event|2|||
143094090|NCT01217112|515885888|FG004|Overall Study|Adverse Event|0|||
143094091|NCT01217112|515885884|FG000|Overall Study|Withdrawal by Subject|0|||
143094092|NCT01217112|515885885|FG001|Overall Study|Withdrawal by Subject|0|||
143094093|NCT01217112|515885886|FG002|Overall Study|Withdrawal by Subject|1|||
143094094|NCT01217112|515885887|FG003|Overall Study|Withdrawal by Subject|0|||
143094095|NCT01217112|515885888|FG004|Overall Study|Withdrawal by Subject|0|||
143094096|NCT01217112|515885884|FG000|Overall Study|Physician Decision|0|||
143094097|NCT01217112|515885885|FG001|Overall Study|Physician Decision|0|||
143094098|NCT01217112|515885886|FG002|Overall Study|Physician Decision|0|||
143094099|NCT01217112|515885887|FG003|Overall Study|Physician Decision|0|||
143367395|NCT02466516|516889326|FG003|Overall Study|Lost to Follow-up|0|||
143094100|NCT01217112|515885888|FG004|Overall Study|Physician Decision|1|||
143367396|NCT02466516|516889327|FG004|Overall Study|Lost to Follow-up|0|||
143367397|NCT03712930|516889328|FG000|Overall Study|Death|7|||
143367398|NCT03712930|516889328|FG000|Overall Study|Physician Decision|1|||
143094101|NCT02596971|515885889|FG000|Overall Study|Death|5|||
143094102|NCT02596971|515885890|FG001|Overall Study|Death|1|||
143094103|NCT02596971|515885891|FG002|Overall Study|Death|5|||
143094104|NCT02596971|515885889|FG000|Overall Study|Withdrawal by Subject|5|||
143094105|NCT02596971|515885890|FG001|Overall Study|Withdrawal by Subject|1|||
143094106|NCT02596971|515885891|FG002|Overall Study|Withdrawal by Subject|4|||
143094107|NCT01401361|515885892|FG000|Overall Study|Withdrawal by Subject|16|||
143094108|NCT01401361|515885892|FG000|Overall Study|Lack of Efficacy|6|||
143094109|NCT01401361|515885892|FG000|Overall Study|Physician Decision|1|||
143094110|NCT01401361|515885892|FG000|Overall Study|Lost to Follow-up|3|||
143094111|NCT01401361|515885892|FG000|Overall Study|Subject/family decision post procedure|2|||
143094112|NCT00595920|515885893|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
143094113|NCT00351468|515885894|FG000|Overall Study|Adverse Event|42|||
143094114|NCT00351468|515885894|FG000|Overall Study|Withdrawal by Subject|39|||
143094115|NCT00351468|515885894|FG000|Overall Study|Various -follow up w clinical team|39|||
143094116|NCT00351468|515885894|FG000|Overall Study|Lack of Efficacy|32|||
143094117|NCT00351468|515885894|FG000|Overall Study|Non-compliance|8|||
143094118|NCT00351468|515885894|FG000|Overall Study|Lost to Follow-up|4|||
143094119|NCT00351468|515885894|FG000|Overall Study|Protocol Violation|3|||
143094120|NCT00611923|515885895|FG000|Overall Study|Withdrawal by Subject|2|||
143094121|NCT00611923|515885896|FG001|Overall Study|Withdrawal by Subject|2|||
143094122|NCT04565145|515885897|FG000|Overall Study|Withdrawal by Subject|1|||
143094123|NCT04565145|515885898|FG001|Overall Study|Withdrawal by Subject|1|||
143094124|NCT03096314|515885899|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
143251135|NCT02059291|516472992|FG023|Epoch 3|Lack of Efficacy|0|||
143251136|NCT02059291|516472993|FG024|Epoch 3|Lack of Efficacy|0|||
143094125|NCT03096314|515885900|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
143251137|NCT02059291|516472969|FG000|Epoch 3|Withdrawal by Subject|0|||
143251138|NCT02059291|516472970|FG001|Epoch 3|Withdrawal by Subject|0|||
143251139|NCT02059291|516472971|FG002|Epoch 3|Withdrawal by Subject|0|||
143251140|NCT02059291|516472972|FG003|Epoch 3|Withdrawal by Subject|0|||
143251141|NCT02059291|516472973|FG004|Epoch 3|Withdrawal by Subject|0|||
143251142|NCT02059291|516472974|FG005|Epoch 3|Withdrawal by Subject|0|||
143251143|NCT02059291|516472975|FG006|Epoch 3|Withdrawal by Subject|0|||
143251144|NCT02059291|516472976|FG007|Epoch 3|Withdrawal by Subject|0|||
143251145|NCT02059291|516472977|FG008|Epoch 3|Withdrawal by Subject|0|||
143251146|NCT02059291|516472978|FG009|Epoch 3|Withdrawal by Subject|0|||
143251147|NCT02059291|516472979|FG010|Epoch 3|Withdrawal by Subject|0|||
143251148|NCT02059291|516472980|FG011|Epoch 3|Withdrawal by Subject|0|||
143251149|NCT02059291|516472981|FG012|Epoch 3|Withdrawal by Subject|0|||
143251150|NCT02059291|516472982|FG013|Epoch 3|Withdrawal by Subject|0|||
143251151|NCT02059291|516472983|FG014|Epoch 3|Withdrawal by Subject|0|||
143251152|NCT02059291|516472984|FG015|Epoch 3|Withdrawal by Subject|1|||
143251153|NCT02059291|516472985|FG016|Epoch 3|Withdrawal by Subject|0|||
143251154|NCT02059291|516472986|FG017|Epoch 3|Withdrawal by Subject|0|||
143251155|NCT02059291|516472987|FG018|Epoch 3|Withdrawal by Subject|0|||
143251156|NCT02059291|516472988|FG019|Epoch 3|Withdrawal by Subject|0|||
143251157|NCT02059291|516472989|FG020|Epoch 3|Withdrawal by Subject|0|||
143251158|NCT02059291|516472990|FG021|Epoch 3|Withdrawal by Subject|0|||
143251159|NCT02059291|516472991|FG022|Epoch 3|Withdrawal by Subject|0|||
143251160|NCT02059291|516472992|FG023|Epoch 3|Withdrawal by Subject|0|||
143251161|NCT02059291|516472993|FG024|Epoch 3|Withdrawal by Subject|0|||
143094126|NCT04225715|515885901|FG000|Overall Study|Reason not Specified|1|||
143094127|NCT04225715|515885902|FG001|Overall Study|Reason not Specified|0|||
143094128|NCT04225715|515885903|FG002|Overall Study|Reason not Specified|0|||
143094129|NCT04225715|515885904|FG003|Overall Study|Reason not Specified|0|||
143094130|NCT04225715|515885905|FG004|Overall Study|Reason not Specified|0|||
143251162|NCT02059291|516472969|FG000|Epoch 4|Adverse Event|0|||
143251163|NCT02059291|516472970|FG001|Epoch 4|Adverse Event|0|||
143251164|NCT02059291|516472971|FG002|Epoch 4|Adverse Event|0|||
143094131|NCT04225715|515885906|FG005|Overall Study|Reason not Specified|0|||
143094132|NCT04225715|515885907|FG006|Overall Study|Reason not Specified|0|||
143094133|NCT04225715|515885908|FG007|Overall Study|Reason not Specified|0|||
143094134|NCT04225715|515885909|FG008|Overall Study|Reason not Specified|0|||
143094135|NCT04225715|515885901|FG000|Overall Study|Protocol Violation|1|||
143094136|NCT04225715|515885902|FG001|Overall Study|Protocol Violation|0|||
143094137|NCT04225715|515885903|FG002|Overall Study|Protocol Violation|0|||
143094138|NCT04225715|515885904|FG003|Overall Study|Protocol Violation|0|||
143094139|NCT04225715|515885905|FG004|Overall Study|Protocol Violation|0|||
143094140|NCT04225715|515885906|FG005|Overall Study|Protocol Violation|9|||
143094141|NCT04225715|515885907|FG006|Overall Study|Protocol Violation|0|||
143094142|NCT04225715|515885908|FG007|Overall Study|Protocol Violation|0|||
143094143|NCT04225715|515885909|FG008|Overall Study|Protocol Violation|0|||
143094144|NCT04225715|515885901|FG000|Overall Study|Withdrawal by Subject|4|||
143094145|NCT04225715|515885902|FG001|Overall Study|Withdrawal by Subject|1|||
143094146|NCT04225715|515885903|FG002|Overall Study|Withdrawal by Subject|1|||
143094147|NCT04225715|515885904|FG003|Overall Study|Withdrawal by Subject|0|||
143094148|NCT04225715|515885905|FG004|Overall Study|Withdrawal by Subject|3|||
143094149|NCT04225715|515885906|FG005|Overall Study|Withdrawal by Subject|1|||
143094150|NCT04225715|515885907|FG006|Overall Study|Withdrawal by Subject|1|||
143094151|NCT04225715|515885908|FG007|Overall Study|Withdrawal by Subject|1|||
143094152|NCT04225715|515885909|FG008|Overall Study|Withdrawal by Subject|0|||
143094153|NCT04225715|515885901|FG000|Overall Study|Adverse Event|0|||
143094154|NCT04225715|515885902|FG001|Overall Study|Adverse Event|0|||
143094155|NCT04225715|515885903|FG002|Overall Study|Adverse Event|0|||
143094156|NCT04225715|515885904|FG003|Overall Study|Adverse Event|0|||
143094157|NCT04225715|515885905|FG004|Overall Study|Adverse Event|0|||
143094158|NCT04225715|515885906|FG005|Overall Study|Adverse Event|0|||
143094159|NCT04225715|515885907|FG006|Overall Study|Adverse Event|0|||
143094160|NCT04225715|515885908|FG007|Overall Study|Adverse Event|0|||
143094161|NCT04225715|515885909|FG008|Overall Study|Adverse Event|1|||
143176716|NCT02750514|516196217|FG001|Track 1|Disease progression|1|||
143176717|NCT02750514|516196218|FG002|Track 1|Disease progression|0|||
143176718|NCT02750514|516196219|FG003|Track 1|Disease progression|1|||
143176719|NCT02750514|516196220|FG004|Track 1|Disease progression|0|||
143176720|NCT02750514|516196216|FG000|Track 1|Adverse event unrelated to study drug|1|||
143176721|NCT02750514|516196217|FG001|Track 1|Adverse event unrelated to study drug|0|||
143176722|NCT02750514|516196218|FG002|Track 1|Adverse event unrelated to study drug|0|||
143176723|NCT02750514|516196219|FG003|Track 1|Adverse event unrelated to study drug|0|||
143176724|NCT02750514|516196220|FG004|Track 1|Adverse event unrelated to study drug|0|||
143176725|NCT02750514|516196216|FG000|Track 1|Study drug toxicity|4|||
143176726|NCT02750514|516196217|FG001|Track 1|Study drug toxicity|1|||
143094162|NCT04225715|515885901|FG000|Overall Study|Arm Terminated By Sponsor|0|||
143094163|NCT04225715|515885902|FG001|Overall Study|Arm Terminated By Sponsor|0|||
143094164|NCT04225715|515885903|FG002|Overall Study|Arm Terminated By Sponsor|0|||
143094165|NCT04225715|515885904|FG003|Overall Study|Arm Terminated By Sponsor|0|||
143094166|NCT04225715|515885905|FG004|Overall Study|Arm Terminated By Sponsor|0|||
143094167|NCT04225715|515885906|FG005|Overall Study|Arm Terminated By Sponsor|0|||
143094168|NCT04225715|515885907|FG006|Overall Study|Arm Terminated By Sponsor|0|||
143094169|NCT04225715|515885908|FG007|Overall Study|Arm Terminated By Sponsor|17|||
143094170|NCT04225715|515885909|FG008|Overall Study|Arm Terminated By Sponsor|18|||
143094171|NCT02512302|515885910|FG000|Period 1|Adverse Event|0|||
143094172|NCT02512302|515885911|FG001|Period 1|Adverse Event|1|||
143094173|NCT02512302|515885912|FG002|Period 1|Adverse Event|0|||
143094174|NCT02512302|515885913|FG003|Period 1|Adverse Event|0|||
143094175|NCT02512302|515885914|FG004|Period 1|Adverse Event|0|||
143094176|NCT02512302|515885915|FG005|Period 1|Adverse Event|0|||
143094177|NCT02512302|515885916|FG006|Period 1|Adverse Event|0|||
143094178|NCT02512302|515885917|FG007|Period 1|Adverse Event|0|||
143094179|NCT02512302|515885918|FG008|Period 1|Adverse Event|0|||
143094180|NCT02512302|515885919|FG009|Period 1|Adverse Event|0|||
143094181|NCT02512302|515885910|FG000|Period 2|Adverse Event|0|||
143094182|NCT02512302|515885911|FG001|Period 2|Adverse Event|0|||
143094183|NCT02512302|515885912|FG002|Period 2|Adverse Event|0|||
143094184|NCT02512302|515885913|FG003|Period 2|Adverse Event|0|||
143094185|NCT02512302|515885914|FG004|Period 2|Adverse Event|0|||
143094186|NCT02512302|515885915|FG005|Period 2|Adverse Event|0|||
143094187|NCT02512302|515885916|FG006|Period 2|Adverse Event|0|||
143094188|NCT02512302|515885917|FG007|Period 2|Adverse Event|0|||
143094189|NCT02512302|515885918|FG008|Period 2|Adverse Event|0|||
143094190|NCT02512302|515885919|FG009|Period 2|Adverse Event|1|||
143094191|NCT02512302|515885910|FG000|Period 3|Lost to Follow-up|0|||
143094192|NCT02512302|515885911|FG001|Period 3|Lost to Follow-up|0|||
143094193|NCT02512302|515885912|FG002|Period 3|Lost to Follow-up|1|||
143094194|NCT02512302|515885913|FG003|Period 3|Lost to Follow-up|0|||
143094195|NCT02512302|515885914|FG004|Period 3|Lost to Follow-up|0|||
143094196|NCT02512302|515885915|FG005|Period 3|Lost to Follow-up|0|||
143094197|NCT02512302|515885916|FG006|Period 3|Lost to Follow-up|0|||
143094198|NCT02512302|515885917|FG007|Period 3|Lost to Follow-up|0|||
143094199|NCT02512302|515885918|FG008|Period 3|Lost to Follow-up|0|||
143094200|NCT02512302|515885919|FG009|Period 3|Lost to Follow-up|0|||
143094201|NCT02512302|515885910|FG000|Period 4|Adverse Event|0|||
143094202|NCT02512302|515885911|FG001|Period 4|Adverse Event|0|||
143094203|NCT02512302|515885912|FG002|Period 4|Adverse Event|0|||
143094204|NCT02512302|515885913|FG003|Period 4|Adverse Event|0|||
143094205|NCT02512302|515885914|FG004|Period 4|Adverse Event|0|||
143094206|NCT02512302|515885915|FG005|Period 4|Adverse Event|0|||
143094207|NCT02512302|515885916|FG006|Period 4|Adverse Event|1|||
143094208|NCT02512302|515885917|FG007|Period 4|Adverse Event|0|||
143094209|NCT02512302|515885918|FG008|Period 4|Adverse Event|0|||
143094210|NCT02512302|515885919|FG009|Period 4|Adverse Event|0|||
143094211|NCT00471822|515885920|FG000|Overall Study|Protocol Violation|2|||
143094212|NCT04570670|515885921|FG000|Overall Study|Withdrawal by Subject|1|||
143094213|NCT04570670|515885922|FG001|Overall Study|Withdrawal by Subject|0|||
143094214|NCT00683618|515885923|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
143094215|NCT00683618|515885924|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
143094216|NCT00683618|515885925|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
143094217|NCT00683618|515885923|FG000|Randomised Treatment Period|Protocol Violation|0|||
143094218|NCT00683618|515885924|FG001|Randomised Treatment Period|Protocol Violation|1|||
143094219|NCT00683618|515885925|FG002|Randomised Treatment Period|Protocol Violation|0|||
143094220|NCT00683618|515885923|FG000|Randomised Treatment Period|Adverse Event|2|||
143094221|NCT00683618|515885924|FG001|Randomised Treatment Period|Adverse Event|0|||
143094222|NCT00683618|515885925|FG002|Randomised Treatment Period|Adverse Event|2|||
143094223|NCT00683618|515885923|FG000|Randomised Treatment Period|Reason not provided|0|||
143094224|NCT00683618|515885924|FG001|Randomised Treatment Period|Reason not provided|0|||
143094225|NCT00683618|515885925|FG002|Randomised Treatment Period|Reason not provided|2|||
143094226|NCT00683618|515885923|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
143094227|NCT00683618|515885924|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
143094228|NCT00683618|515885925|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
143094229|NCT00683618|515885923|FG000|Extension Treatment Period|Adverse Event|1|||
143094230|NCT00683618|515885924|FG001|Extension Treatment Period|Adverse Event|0|||
143094231|NCT00683618|515885925|FG002|Extension Treatment Period|Adverse Event|0|||
143094232|NCT00683618|515885923|FG000|Extension Treatment Period|Protocol Violation|1|||
143094233|NCT00683618|515885924|FG001|Extension Treatment Period|Protocol Violation|0|||
143094234|NCT00683618|515885925|FG002|Extension Treatment Period|Protocol Violation|0|||
143094235|NCT03318861|515885929|FG000|Overall Study|Death|2|||
143094236|NCT03318861|515885930|FG001|Overall Study|Death|3|||
143094237|NCT03318861|515885931|FG002|Overall Study|Death|3|||
143094238|NCT03318861|515885932|FG003|Overall Study|Death|2|||
143094239|NCT03318861|515885933|FG004|Overall Study|Death|2|||
143094240|NCT03318861|515885929|FG000|Overall Study|Enrolled But Never Treated|0|||
143094241|NCT03318861|515885930|FG001|Overall Study|Enrolled But Never Treated|1|||
143094242|NCT03318861|515885931|FG002|Overall Study|Enrolled But Never Treated|0|||
143094243|NCT03318861|515885932|FG003|Overall Study|Enrolled But Never Treated|1|||
143094244|NCT03318861|515885933|FG004|Overall Study|Enrolled But Never Treated|1|||
143094245|NCT03318861|515885929|FG000|Overall Study|Informed Consent Withdraw|0|||
143094246|NCT03318861|515885930|FG001|Overall Study|Informed Consent Withdraw|0|||
143094247|NCT03318861|515885931|FG002|Overall Study|Informed Consent Withdraw|0|||
143094248|NCT03318861|515885932|FG003|Overall Study|Informed Consent Withdraw|1|||
143094249|NCT03318861|515885933|FG004|Overall Study|Informed Consent Withdraw|0|||
143094250|NCT03318861|515885929|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
143094251|NCT03318861|515885930|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
143094252|NCT03318861|515885931|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
143094253|NCT03318861|515885932|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
143094254|NCT03318861|515885933|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
143094255|NCT00917852|515885934|FG000|Overall Study|Death|6|||
143094256|NCT00471081|515885935|FG000|Active Phase|Protocol Violation|1|||
143094257|NCT00471081|515885936|FG001|Active Phase|Protocol Violation|1|||
143094258|NCT00471081|515885935|FG000|Active Phase|Withdrawal by Subject|0|||
143094259|NCT00471081|515885936|FG001|Active Phase|Withdrawal by Subject|3|||
143094260|NCT00471081|515885935|FG000|Active Phase|Lost to Follow-up|0|||
143094261|NCT00471081|515885936|FG001|Active Phase|Lost to Follow-up|1|||
143094262|NCT00471081|515885935|FG000|Active Phase|Lost health plan/insurance|1|||
143094263|NCT00471081|515885936|FG001|Active Phase|Lost health plan/insurance|8|||
143094264|NCT00471081|515885935|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
143094265|NCT00471081|515885936|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
143094266|NCT00471081|515885935|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
143094267|NCT00471081|515885936|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
143094268|NCT00471081|515885935|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
143094269|NCT00471081|515885936|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
143094270|NCT02844933|515885937|FG000|Overall Study|Discontinued due to premature termination of study|3|||
143094271|NCT02844933|515885938|FG001|Overall Study|Discontinued due to premature termination of study|2|||
143094272|NCT02393950|515885939|FG000|Overall Study|Adverse Event|1|||
143094273|NCT02393950|515885940|FG001|Overall Study|Adverse Event|0|||
143094274|NCT02393950|515885939|FG000|Overall Study|Withdrawal by Subject|0|||
143094275|NCT02393950|515885940|FG001|Overall Study|Withdrawal by Subject|1|||
143094276|NCT04335123|515885942|FG000|Overall Study|Withdrawal by Subject|2|||
143094277|NCT04335123|515885943|FG001|Overall Study|Withdrawal by Subject|0|||
143094278|NCT04335123|515885942|FG000|Overall Study|Physician Decision|2|||
143094279|NCT04335123|515885943|FG001|Overall Study|Physician Decision|0|||
143094280|NCT05486091|515885944|FG000|Overall Study|Withdrawal by Subject|1|||
143094281|NCT05486091|515885944|FG000|Overall Study|Lost to Follow-up|2|||
143094282|NCT00460603|515885954|FG000|Phase 1|Death|1|||
143094283|NCT00460603|515885955|FG001|Phase 1|Death|0|||
143094284|NCT00460603|515885956|FG002|Phase 1|Death|0|||
143094285|NCT00460603|515885957|FG003|Phase 1|Death|2|||
143094286|NCT00460603|515885958|FG004|Phase 1|Death|0|||
143094287|NCT00460603|515885959|FG005|Phase 1|Death|0|||
143094288|NCT00460603|515885960|FG006|Phase 1|Death|0|||
143094289|NCT00460603|515885961|FG007|Phase 1|Death|0|||
143094290|NCT00460603|515885962|FG008|Phase 1|Death|1|||
143094291|NCT00460603|515885963|FG009|Phase 1|Death|0|||
143094292|NCT00460603|515885964|FG010|Phase 1|Death|0|||
143094293|NCT00460603|515885965|FG011|Phase 1|Death|0|||
143094294|NCT00460603|515885954|FG000|Phase 1|Adverse Event|3|||
143094295|NCT00460603|515885955|FG001|Phase 1|Adverse Event|1|||
143094296|NCT00460603|515885956|FG002|Phase 1|Adverse Event|1|||
143094297|NCT00460603|515885957|FG003|Phase 1|Adverse Event|2|||
143094298|NCT00460603|515885958|FG004|Phase 1|Adverse Event|0|||
143094299|NCT00460603|515885959|FG005|Phase 1|Adverse Event|0|||
143094300|NCT00460603|515885960|FG006|Phase 1|Adverse Event|3|||
143094301|NCT00460603|515885961|FG007|Phase 1|Adverse Event|0|||
143094302|NCT00460603|515885962|FG008|Phase 1|Adverse Event|4|||
143094303|NCT00460603|515885963|FG009|Phase 1|Adverse Event|0|||
143094304|NCT00460603|515885964|FG010|Phase 1|Adverse Event|0|||
143094305|NCT00460603|515885965|FG011|Phase 1|Adverse Event|0|||
143094306|NCT00460603|515885954|FG000|Phase 1|Lack of Efficacy|1|||
143094307|NCT00460603|515885955|FG001|Phase 1|Lack of Efficacy|0|||
143094308|NCT00460603|515885956|FG002|Phase 1|Lack of Efficacy|1|||
143094309|NCT00460603|515885957|FG003|Phase 1|Lack of Efficacy|2|||
143094310|NCT00460603|515885958|FG004|Phase 1|Lack of Efficacy|2|||
143176727|NCT02750514|516196218|FG002|Track 1|Study drug toxicity|0|||
143094311|NCT00460603|515885959|FG005|Phase 1|Lack of Efficacy|2|||
143094312|NCT00460603|515885960|FG006|Phase 1|Lack of Efficacy|2|||
143094313|NCT00460603|515885961|FG007|Phase 1|Lack of Efficacy|2|||
143094314|NCT00460603|515885962|FG008|Phase 1|Lack of Efficacy|11|||
143094315|NCT00460603|515885963|FG009|Phase 1|Lack of Efficacy|0|||
143094316|NCT00460603|515885964|FG010|Phase 1|Lack of Efficacy|0|||
143094317|NCT00460603|515885965|FG011|Phase 1|Lack of Efficacy|0|||
143094318|NCT00460603|515885954|FG000|Phase 1|Withdrawal by Subject|1|||
143094319|NCT00460603|515885955|FG001|Phase 1|Withdrawal by Subject|2|||
143094320|NCT00460603|515885956|FG002|Phase 1|Withdrawal by Subject|1|||
143094321|NCT00460603|515885957|FG003|Phase 1|Withdrawal by Subject|1|||
143094322|NCT00460603|515885958|FG004|Phase 1|Withdrawal by Subject|3|||
143094323|NCT00460603|515885959|FG005|Phase 1|Withdrawal by Subject|0|||
143094324|NCT00460603|515885960|FG006|Phase 1|Withdrawal by Subject|1|||
143094325|NCT00460603|515885961|FG007|Phase 1|Withdrawal by Subject|0|||
143094326|NCT00460603|515885962|FG008|Phase 1|Withdrawal by Subject|2|||
143094327|NCT00460603|515885963|FG009|Phase 1|Withdrawal by Subject|0|||
143094328|NCT00460603|515885964|FG010|Phase 1|Withdrawal by Subject|0|||
143094329|NCT00460603|515885965|FG011|Phase 1|Withdrawal by Subject|0|||
143094330|NCT00460603|515885954|FG000|Phase 1|Other|0|||
143094331|NCT00460603|515885955|FG001|Phase 1|Other|3|||
143094332|NCT00460603|515885956|FG002|Phase 1|Other|1|||
143094333|NCT00460603|515885957|FG003|Phase 1|Other|1|||
143094334|NCT00460603|515885958|FG004|Phase 1|Other|1|||
143094335|NCT00460603|515885959|FG005|Phase 1|Other|2|||
143094336|NCT00460603|515885960|FG006|Phase 1|Other|0|||
143094337|NCT00460603|515885961|FG007|Phase 1|Other|1|||
143094338|NCT00460603|515885962|FG008|Phase 1|Other|0|||
143094339|NCT00460603|515885963|FG009|Phase 1|Other|0|||
143094340|NCT00460603|515885964|FG010|Phase 1|Other|0|||
143094341|NCT00460603|515885965|FG011|Phase 1|Other|0|||
143094342|NCT00460603|515885954|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
143094343|NCT00460603|515885955|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
143094344|NCT00460603|515885956|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
143094345|NCT00460603|515885957|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
143094346|NCT00460603|515885958|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
143094347|NCT00460603|515885959|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
143094348|NCT00460603|515885960|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
143094349|NCT00460603|515885961|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
143094350|NCT00460603|515885962|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
143094351|NCT00460603|515885963|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
143094352|NCT00460603|515885964|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
143094353|NCT00460603|515885965|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
143094354|NCT00460603|515885954|FG000|Phase 2|Adverse Event|0|||
143094355|NCT00460603|515885955|FG001|Phase 2|Adverse Event|0|||
143094356|NCT00460603|515885956|FG002|Phase 2|Adverse Event|0|||
143094357|NCT00460603|515885957|FG003|Phase 2|Adverse Event|0|||
143176728|NCT02750514|516196219|FG003|Track 1|Study drug toxicity|1|||
143176729|NCT02750514|516196220|FG004|Track 1|Study drug toxicity|0|||
143176730|NCT02750514|516196216|FG000|Track 1|Participant request to discontinue|1|||
143176731|NCT02750514|516196217|FG001|Track 1|Participant request to discontinue|0|||
143176732|NCT02750514|516196218|FG002|Track 1|Participant request to discontinue|0|||
143176733|NCT02750514|516196219|FG003|Track 1|Participant request to discontinue|0|||
143176734|NCT02750514|516196220|FG004|Track 1|Participant request to discontinue|0|||
143176735|NCT02750514|516196216|FG000|Track 1|Other reasons|1|||
143176736|NCT02750514|516196217|FG001|Track 1|Other reasons|0|||
143176737|NCT02750514|516196218|FG002|Track 1|Other reasons|0|||
143176738|NCT02750514|516196219|FG003|Track 1|Other reasons|0|||
143176739|NCT02750514|516196220|FG004|Track 1|Other reasons|0|||
143176740|NCT02750514|516196216|FG000|Track 2|Disease progression|4|||
143176741|NCT02750514|516196217|FG001|Track 2|Disease progression|5|||
143176742|NCT02750514|516196218|FG002|Track 2|Disease progression|2|||
143176743|NCT02750514|516196219|FG003|Track 2|Disease progression|5|||
143176744|NCT02750514|516196220|FG004|Track 2|Disease progression|0|||
143176745|NCT02750514|516196216|FG000|Track 2|Adverse event unrelated to study drug|1|||
143176746|NCT02750514|516196217|FG001|Track 2|Adverse event unrelated to study drug|0|||
143176747|NCT02750514|516196218|FG002|Track 2|Adverse event unrelated to study drug|0|||
143176748|NCT02750514|516196219|FG003|Track 2|Adverse event unrelated to study drug|0|||
143176749|NCT02750514|516196220|FG004|Track 2|Adverse event unrelated to study drug|0|||
143176750|NCT02750514|516196216|FG000|Track 2|Study drug toxicity|1|||
143176751|NCT02750514|516196217|FG001|Track 2|Study drug toxicity|2|||
143176752|NCT02750514|516196218|FG002|Track 2|Study drug toxicity|0|||
143094358|NCT00460603|515885958|FG004|Phase 2|Adverse Event|0|||
143176753|NCT02750514|516196219|FG003|Track 2|Study drug toxicity|2|||
143176754|NCT02750514|516196220|FG004|Track 2|Study drug toxicity|0|||
143094359|NCT00460603|515885959|FG005|Phase 2|Adverse Event|0|||
143094360|NCT00460603|515885960|FG006|Phase 2|Adverse Event|0|||
143094361|NCT00460603|515885961|FG007|Phase 2|Adverse Event|0|||
143094362|NCT00460603|515885962|FG008|Phase 2|Adverse Event|0|||
143094363|NCT00460603|515885963|FG009|Phase 2|Adverse Event|12|||
143094364|NCT00460603|515885964|FG010|Phase 2|Adverse Event|9|||
143094365|NCT00460603|515885965|FG011|Phase 2|Adverse Event|10|||
143094366|NCT00460603|515885954|FG000|Phase 2|Death|0|||
143094367|NCT00460603|515885955|FG001|Phase 2|Death|0|||
143094368|NCT00460603|515885956|FG002|Phase 2|Death|0|||
143094369|NCT00460603|515885957|FG003|Phase 2|Death|0|||
143094370|NCT00460603|515885958|FG004|Phase 2|Death|0|||
143094371|NCT00460603|515885959|FG005|Phase 2|Death|0|||
143094372|NCT00460603|515885960|FG006|Phase 2|Death|0|||
143176755|NCT02750514|516196216|FG000|Track 2|Participant withdrew consent|0|||
143176756|NCT02750514|516196217|FG001|Track 2|Participant withdrew consent|1|||
143094373|NCT00460603|515885961|FG007|Phase 2|Death|0|||
143094374|NCT00460603|515885962|FG008|Phase 2|Death|0|||
143094375|NCT00460603|515885963|FG009|Phase 2|Death|4|||
143094376|NCT00460603|515885964|FG010|Phase 2|Death|2|||
143094377|NCT00460603|515885965|FG011|Phase 2|Death|2|||
143094378|NCT00460603|515885954|FG000|Phase 2|Protocol Violation|0|||
143094379|NCT00460603|515885955|FG001|Phase 2|Protocol Violation|0|||
143094380|NCT00460603|515885956|FG002|Phase 2|Protocol Violation|0|||
143094381|NCT00460603|515885957|FG003|Phase 2|Protocol Violation|0|||
143094382|NCT00460603|515885958|FG004|Phase 2|Protocol Violation|0|||
143094383|NCT00460603|515885959|FG005|Phase 2|Protocol Violation|0|||
143094384|NCT00460603|515885960|FG006|Phase 2|Protocol Violation|0|||
143094385|NCT00460603|515885961|FG007|Phase 2|Protocol Violation|0|||
143094386|NCT00460603|515885962|FG008|Phase 2|Protocol Violation|0|||
143094387|NCT00460603|515885963|FG009|Phase 2|Protocol Violation|1|||
143094388|NCT00460603|515885964|FG010|Phase 2|Protocol Violation|1|||
143094389|NCT00460603|515885965|FG011|Phase 2|Protocol Violation|0|||
143094390|NCT00460603|515885954|FG000|Phase 2|Lost to Follow-up|0|||
143094391|NCT00460603|515885955|FG001|Phase 2|Lost to Follow-up|0|||
143094392|NCT00460603|515885956|FG002|Phase 2|Lost to Follow-up|0|||
143094393|NCT00460603|515885957|FG003|Phase 2|Lost to Follow-up|0|||
143094394|NCT00460603|515885958|FG004|Phase 2|Lost to Follow-up|0|||
143094395|NCT00460603|515885959|FG005|Phase 2|Lost to Follow-up|0|||
143094396|NCT00460603|515885960|FG006|Phase 2|Lost to Follow-up|0|||
143094397|NCT00460603|515885961|FG007|Phase 2|Lost to Follow-up|0|||
143094398|NCT00460603|515885962|FG008|Phase 2|Lost to Follow-up|0|||
143094399|NCT00460603|515885963|FG009|Phase 2|Lost to Follow-up|1|||
143094400|NCT00460603|515885964|FG010|Phase 2|Lost to Follow-up|0|||
143094401|NCT00460603|515885965|FG011|Phase 2|Lost to Follow-up|0|||
143094402|NCT00460603|515885954|FG000|Phase 2|Other|0|||
143094403|NCT00460603|515885955|FG001|Phase 2|Other|0|||
143094404|NCT00460603|515885956|FG002|Phase 2|Other|0|||
143094405|NCT00460603|515885957|FG003|Phase 2|Other|0|||
143094406|NCT00460603|515885958|FG004|Phase 2|Other|0|||
143094407|NCT00460603|515885959|FG005|Phase 2|Other|0|||
143094408|NCT00460603|515885960|FG006|Phase 2|Other|0|||
143094409|NCT00460603|515885961|FG007|Phase 2|Other|0|||
143094410|NCT00460603|515885962|FG008|Phase 2|Other|0|||
143094411|NCT00460603|515885963|FG009|Phase 2|Other|6|||
143094412|NCT00460603|515885964|FG010|Phase 2|Other|16|||
143094413|NCT00460603|515885965|FG011|Phase 2|Other|7|||
143094414|NCT00460603|515885954|FG000|Phase 2|Objective Progression or Relapse|0|||
143094415|NCT00460603|515885955|FG001|Phase 2|Objective Progression or Relapse|0|||
143094416|NCT00460603|515885956|FG002|Phase 2|Objective Progression or Relapse|0|||
143094417|NCT00460603|515885957|FG003|Phase 2|Objective Progression or Relapse|0|||
143094418|NCT00460603|515885958|FG004|Phase 2|Objective Progression or Relapse|0|||
143094419|NCT00460603|515885959|FG005|Phase 2|Objective Progression or Relapse|0|||
143094420|NCT00460603|515885960|FG006|Phase 2|Objective Progression or Relapse|0|||
143176757|NCT02750514|516196218|FG002|Track 2|Participant withdrew consent|0|||
143176758|NCT02750514|516196219|FG003|Track 2|Participant withdrew consent|0|||
143176759|NCT02750514|516196220|FG004|Track 2|Participant withdrew consent|0|||
143176760|NCT02750514|516196216|FG000|Track 3|Disease progression|0|||
143176761|NCT02750514|516196217|FG001|Track 3|Disease progression|24|||
143176762|NCT02750514|516196218|FG002|Track 3|Disease progression|13|||
143176763|NCT02750514|516196219|FG003|Track 3|Disease progression|14|||
143176764|NCT02750514|516196220|FG004|Track 3|Disease progression|0|||
143176765|NCT02750514|516196216|FG000|Track 3|Adverse event unrelated to study drug|0|||
143176766|NCT02750514|516196217|FG001|Track 3|Adverse event unrelated to study drug|1|||
143176767|NCT02750514|516196218|FG002|Track 3|Adverse event unrelated to study drug|1|||
143094421|NCT00460603|515885961|FG007|Phase 2|Objective Progression or Relapse|0|||
143094422|NCT00460603|515885962|FG008|Phase 2|Objective Progression or Relapse|0|||
143094423|NCT00460603|515885963|FG009|Phase 2|Objective Progression or Relapse|9|||
143094424|NCT00460603|515885964|FG010|Phase 2|Objective Progression or Relapse|10|||
143094425|NCT00460603|515885965|FG011|Phase 2|Objective Progression or Relapse|17|||
143094426|NCT00460603|515885954|FG000|Phase 2|Global Deterioration of Health Status|0|||
143094427|NCT00460603|515885955|FG001|Phase 2|Global Deterioration of Health Status|0|||
143094428|NCT00460603|515885956|FG002|Phase 2|Global Deterioration of Health Status|0|||
143094429|NCT00460603|515885957|FG003|Phase 2|Global Deterioration of Health Status|0|||
143094430|NCT00460603|515885958|FG004|Phase 2|Global Deterioration of Health Status|0|||
143094431|NCT00460603|515885959|FG005|Phase 2|Global Deterioration of Health Status|0|||
143094432|NCT00460603|515885960|FG006|Phase 2|Global Deterioration of Health Status|0|||
143094433|NCT00460603|515885961|FG007|Phase 2|Global Deterioration of Health Status|0|||
143251165|NCT02059291|516472972|FG003|Epoch 4|Adverse Event|0|||
143094434|NCT00460603|515885962|FG008|Phase 2|Global Deterioration of Health Status|0|||
143094435|NCT00460603|515885963|FG009|Phase 2|Global Deterioration of Health Status|0|||
143094436|NCT00460603|515885964|FG010|Phase 2|Global Deterioration of Health Status|1|||
143094437|NCT00460603|515885965|FG011|Phase 2|Global Deterioration of Health Status|0|||
143094438|NCT00460603|515885954|FG000|Phase 2|Withdrawal by Subject|0|||
143094439|NCT00460603|515885955|FG001|Phase 2|Withdrawal by Subject|0|||
143094440|NCT00460603|515885956|FG002|Phase 2|Withdrawal by Subject|0|||
143094441|NCT00460603|515885957|FG003|Phase 2|Withdrawal by Subject|0|||
143094442|NCT00460603|515885958|FG004|Phase 2|Withdrawal by Subject|0|||
143094443|NCT00460603|515885959|FG005|Phase 2|Withdrawal by Subject|0|||
143094444|NCT00460603|515885960|FG006|Phase 2|Withdrawal by Subject|0|||
143094445|NCT00460603|515885961|FG007|Phase 2|Withdrawal by Subject|0|||
143094446|NCT00460603|515885962|FG008|Phase 2|Withdrawal by Subject|0|||
143094447|NCT00460603|515885963|FG009|Phase 2|Withdrawal by Subject|5|||
143094448|NCT00460603|515885964|FG010|Phase 2|Withdrawal by Subject|4|||
143094449|NCT00460603|515885965|FG011|Phase 2|Withdrawal by Subject|5|||
143094450|NCT00460603|515885954|FG000|Phase 2|Randomized, but not treated|0|||
143094451|NCT00460603|515885955|FG001|Phase 2|Randomized, but not treated|0|||
143094452|NCT00460603|515885956|FG002|Phase 2|Randomized, but not treated|0|||
143094453|NCT00460603|515885957|FG003|Phase 2|Randomized, but not treated|0|||
143094454|NCT00460603|515885958|FG004|Phase 2|Randomized, but not treated|0|||
143094455|NCT00460603|515885959|FG005|Phase 2|Randomized, but not treated|0|||
143094456|NCT00460603|515885960|FG006|Phase 2|Randomized, but not treated|0|||
143094457|NCT00460603|515885961|FG007|Phase 2|Randomized, but not treated|0|||
143176768|NCT02750514|516196219|FG003|Track 3|Adverse event unrelated to study drug|1|||
143176769|NCT02750514|516196220|FG004|Track 3|Adverse event unrelated to study drug|0|||
143176770|NCT02750514|516196216|FG000|Track 3|Study drug toxicity|0|||
143176771|NCT02750514|516196217|FG001|Track 3|Study drug toxicity|3|||
143176772|NCT02750514|516196218|FG002|Track 3|Study drug toxicity|0|||
143176773|NCT02750514|516196219|FG003|Track 3|Study drug toxicity|1|||
143176774|NCT02750514|516196220|FG004|Track 3|Study drug toxicity|0|||
143176775|NCT02750514|516196216|FG000|Track 3|Participant request to discontinue|0|||
143094458|NCT00460603|515885962|FG008|Phase 2|Randomized, but not treated|0|||
143176776|NCT02750514|516196217|FG001|Track 3|Participant request to discontinue|2|||
143176777|NCT02750514|516196218|FG002|Track 3|Participant request to discontinue|0|||
143176778|NCT02750514|516196219|FG003|Track 3|Participant request to discontinue|0|||
143176779|NCT02750514|516196220|FG004|Track 3|Participant request to discontinue|0|||
143176780|NCT02750514|516196216|FG000|Track 3|Participant withdrew consent|0|||
143176781|NCT02750514|516196217|FG001|Track 3|Participant withdrew consent|3|||
143176782|NCT02750514|516196218|FG002|Track 3|Participant withdrew consent|1|||
143176783|NCT02750514|516196219|FG003|Track 3|Participant withdrew consent|0|||
143094459|NCT00460603|515885963|FG009|Phase 2|Randomized, but not treated|3|||
143094460|NCT00460603|515885964|FG010|Phase 2|Randomized, but not treated|0|||
143094461|NCT00460603|515885965|FG011|Phase 2|Randomized, but not treated|0|||
143094462|NCT03802825|515885968|FG000|Overall Study|Lost to follow-up for intervention|12|||
143094463|NCT03802825|515885969|FG001|Overall Study|Lost to follow-up for intervention|3|||
143094464|NCT03802825|515885968|FG000|Overall Study|Received only 1 component of intervention|0|||
143094465|NCT03802825|515885969|FG001|Overall Study|Received only 1 component of intervention|13|||
143094466|NCT01051960|515885973|FG000|Overall Study|Adverse Event|1|||
143094467|NCT04537078|515885976|FG000|Overall Study|Protocol Violation|3|||
143094468|NCT04537078|515885977|FG001|Overall Study|Protocol Violation|2|||
143094469|NCT04537078|515885976|FG000|Overall Study|Lost to Follow-up|1|||
143094470|NCT04537078|515885977|FG001|Overall Study|Lost to Follow-up|0|||
143094471|NCT04537078|515885976|FG000|Overall Study|Withdrawal by Subject|0|||
143094472|NCT04537078|515885977|FG001|Overall Study|Withdrawal by Subject|1|||
143094473|NCT01293695|515885981|FG000|Overall Study|Withdrawal by Subject|7|||
143094474|NCT01293695|515885982|FG001|Overall Study|Withdrawal by Subject|1|||
143094475|NCT01293695|515885981|FG000|Overall Study|Lost to Follow-up|8|||
143094476|NCT01293695|515885982|FG001|Overall Study|Lost to Follow-up|6|||
143094477|NCT01082328|515885983|FG000|Overall Study|Adverse Event|1|||
143094478|NCT00957801|515885984|FG000|Overall Study|Withdrawal by Subject|0|||
143094479|NCT00957801|515885985|FG001|Overall Study|Withdrawal by Subject|0|||
143094480|NCT00957801|515885986|FG002|Overall Study|Withdrawal by Subject|0|||
143094481|NCT00957801|515885987|FG003|Overall Study|Withdrawal by Subject|1|||
143094482|NCT00031590|515885988|FG000|Overall Study|Adverse Event|1|||
143094483|NCT00031590|515885988|FG000|Overall Study|Withdrawal by parents|2|||
143094484|NCT02755103|515885995|FG000|Overall Study|Lost to Follow-up|17|||
143094485|NCT02755103|515885996|FG001|Overall Study|Lost to Follow-up|15|||
143094486|NCT02755103|515885995|FG000|Overall Study|Death|0|||
143094487|NCT02755103|515885996|FG001|Overall Study|Death|1|||
143094488|NCT02755103|515885995|FG000|Overall Study|Physician Decision|0|||
143094489|NCT02755103|515885996|FG001|Overall Study|Physician Decision|1|||
143094490|NCT02755103|515885995|FG000|Overall Study|Pregnancy|0|||
143094491|NCT02755103|515885996|FG001|Overall Study|Pregnancy|1|||
143094492|NCT02755103|515885995|FG000|Overall Study|Withdrawal by Subject|3|||
143094493|NCT02755103|515885996|FG001|Overall Study|Withdrawal by Subject|0|||
143094494|NCT00658723|515885997|FG000|Overall Study|Lost to Follow-up|0|||
143094495|NCT00658723|515885998|FG001|Overall Study|Lost to Follow-up|2|||
143094496|NCT00658723|515885999|FG002|Overall Study|Lost to Follow-up|2|||
143094497|NCT00658723|515885997|FG000|Overall Study|Death|2|||
143094498|NCT00658723|515885998|FG001|Overall Study|Death|1|||
143094499|NCT00658723|515885999|FG002|Overall Study|Death|4|||
143094500|NCT00658723|515885997|FG000|Overall Study|Scheduling Issue|1|||
143094501|NCT00658723|515885998|FG001|Overall Study|Scheduling Issue|1|||
143094502|NCT00658723|515885999|FG002|Overall Study|Scheduling Issue|0|||
143094503|NCT00658723|515885997|FG000|Overall Study|Withdrawal by Subject|1|||
143094504|NCT00658723|515885998|FG001|Overall Study|Withdrawal by Subject|0|||
143094505|NCT00658723|515885999|FG002|Overall Study|Withdrawal by Subject|1|||
143094506|NCT00380874|515886000|FG000|Overall Study|Adverse Event|7|||
143094507|NCT00380874|515886001|FG001|Overall Study|Adverse Event|7|||
143094508|NCT00380874|515886000|FG000|Overall Study|Death|1|||
143094509|NCT00380874|515886001|FG001|Overall Study|Death|0|||
143094510|NCT00380874|515886000|FG000|Overall Study|Withdrawal by Subject|2|||
143094511|NCT00380874|515886001|FG001|Overall Study|Withdrawal by Subject|1|||
143094512|NCT00380874|515886000|FG000|Overall Study|Not related to study drug|3|||
143094513|NCT00380874|515886001|FG001|Overall Study|Not related to study drug|2|||
143094514|NCT02314026|515886002|FG000|Overall Study|Protocol Violation|28|||
143094515|NCT02949973|515886003|FG000|Overall Study|Physician Decision|1|||
143094516|NCT01882985|515886004|FG000|Overall Study|Lost to Follow-up|1|||
143094517|NCT01882985|515886004|FG000|Overall Study|Withdrawal by Subject|1|||
143094518|NCT02844543|515887330|FG000|Overall Study|Withdrawal by Subject|4|||
143094519|NCT02844543|515887330|FG000|Overall Study|Did not meet eligibility criteria|1|||
143094520|NCT03349060|515887331|FG000|Overall Study|Adverse Event|9|||
143094521|NCT03349060|515887332|FG001|Overall Study|Adverse Event|9|||
143094522|NCT03349060|515887333|FG002|Overall Study|Adverse Event|7|||
143094523|NCT03349060|515887331|FG000|Overall Study|Lack of Efficacy|1|||
143094524|NCT03349060|515887332|FG001|Overall Study|Lack of Efficacy|0|||
143094525|NCT03349060|515887333|FG002|Overall Study|Lack of Efficacy|2|||
143094526|NCT03349060|515887331|FG000|Overall Study|Lost to Follow-up|2|||
143094527|NCT03349060|515887332|FG001|Overall Study|Lost to Follow-up|1|||
143094528|NCT03349060|515887333|FG002|Overall Study|Lost to Follow-up|1|||
143094529|NCT03349060|515887331|FG000|Overall Study|Protocol Violation|2|||
143094530|NCT03349060|515887332|FG001|Overall Study|Protocol Violation|2|||
143094531|NCT03349060|515887333|FG002|Overall Study|Protocol Violation|1|||
143094532|NCT03349060|515887331|FG000|Overall Study|Withdrawal by Subject|5|||
143094533|NCT03349060|515887332|FG001|Overall Study|Withdrawal by Subject|3|||
143094534|NCT03349060|515887333|FG002|Overall Study|Withdrawal by Subject|4|||
143094535|NCT03349060|515887331|FG000|Overall Study|Medication error,no linked adverse event|0|||
143094536|NCT03349060|515887332|FG001|Overall Study|Medication error,no linked adverse event|0|||
143094537|NCT03349060|515887333|FG002|Overall Study|Medication error,no linked adverse event|1|||
143094538|NCT03349060|515887331|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
143094539|NCT03349060|515887332|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
143094540|NCT03349060|515887333|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
143094541|NCT03349060|515887331|FG000|Overall Study|Other|2|||
143094542|NCT03349060|515887332|FG001|Overall Study|Other|1|||
143094543|NCT03349060|515887333|FG002|Overall Study|Other|0|||
143094544|NCT00955409|515887334|FG000|Overall Study|Lack of Efficacy|1|||
143094545|NCT00955409|515887335|FG001|Overall Study|Lack of Efficacy|0|||
143094546|NCT00955409|515887336|FG002|Overall Study|Lack of Efficacy|0|||
143094547|NCT00955409|515887337|FG003|Overall Study|Lack of Efficacy|0|||
143251166|NCT02059291|516472973|FG004|Epoch 4|Adverse Event|0|||
143251167|NCT02059291|516472974|FG005|Epoch 4|Adverse Event|0|||
143251168|NCT02059291|516472975|FG006|Epoch 4|Adverse Event|0|||
143251169|NCT02059291|516472976|FG007|Epoch 4|Adverse Event|0|||
143251170|NCT02059291|516472977|FG008|Epoch 4|Adverse Event|0|||
143251171|NCT02059291|516472978|FG009|Epoch 4|Adverse Event|0|||
143251172|NCT02059291|516472979|FG010|Epoch 4|Adverse Event|0|||
143251173|NCT02059291|516472980|FG011|Epoch 4|Adverse Event|0|||
143251174|NCT02059291|516472981|FG012|Epoch 4|Adverse Event|0|||
143251175|NCT02059291|516472982|FG013|Epoch 4|Adverse Event|0|||
143251176|NCT02059291|516472983|FG014|Epoch 4|Adverse Event|0|||
143251177|NCT02059291|516472984|FG015|Epoch 4|Adverse Event|0|||
143251178|NCT02059291|516472985|FG016|Epoch 4|Adverse Event|1|||
143251179|NCT02059291|516472986|FG017|Epoch 4|Adverse Event|0|||
143251180|NCT02059291|516472987|FG018|Epoch 4|Adverse Event|0|||
143251181|NCT02059291|516472988|FG019|Epoch 4|Adverse Event|0|||
143251182|NCT02059291|516472989|FG020|Epoch 4|Adverse Event|0|||
143251183|NCT02059291|516472990|FG021|Epoch 4|Adverse Event|0|||
143251184|NCT02059291|516472991|FG022|Epoch 4|Adverse Event|1|||
143251185|NCT02059291|516472992|FG023|Epoch 4|Adverse Event|0|||
143251186|NCT02059291|516472993|FG024|Epoch 4|Adverse Event|0|||
143094548|NCT00955409|515887338|FG004|Overall Study|Lack of Efficacy|0|||
143094549|NCT00955409|515887339|FG005|Overall Study|Lack of Efficacy|0|||
143094550|NCT00955409|515887340|FG006|Overall Study|Lack of Efficacy|0|||
143251187|NCT02059291|516472969|FG000|Epoch 4|Pregnancy|0|||
143251188|NCT02059291|516472970|FG001|Epoch 4|Pregnancy|0|||
143251189|NCT02059291|516472971|FG002|Epoch 4|Pregnancy|0|||
143251190|NCT02059291|516472972|FG003|Epoch 4|Pregnancy|0|||
143251191|NCT02059291|516472973|FG004|Epoch 4|Pregnancy|0|||
143251192|NCT02059291|516472974|FG005|Epoch 4|Pregnancy|0|||
143367399|NCT03712930|516889328|FG000|Overall Study|Study Terminated by Sponsor|3|||
143367400|NCT03712930|516889328|FG000|Overall Study|Progressive Disease|2|||
143367401|NCT03895034|516889329|FG000|Overall Study|Lost to Follow-up|2|||
143367402|NCT01118377|516889330|FG000|Overall Study|Did Not Receive Study Medication|1|||
143367403|NCT01118377|516889330|FG000|Overall Study|Death|38|||
143367404|NCT01118377|516889330|FG000|Overall Study|Failure to Return|3|||
143094551|NCT00955409|515887341|FG007|Overall Study|Lack of Efficacy|0|||
143094552|NCT00955409|515887342|FG008|Overall Study|Lack of Efficacy|0|||
143094553|NCT00955409|515887343|FG009|Overall Study|Lack of Efficacy|0|||
143094554|NCT00955409|515887334|FG000|Overall Study|Withdrawal by Subject|1|||
143094555|NCT00955409|515887335|FG001|Overall Study|Withdrawal by Subject|0|||
143094556|NCT00955409|515887336|FG002|Overall Study|Withdrawal by Subject|5|||
143094557|NCT00955409|515887337|FG003|Overall Study|Withdrawal by Subject|2|||
143094558|NCT00955409|515887338|FG004|Overall Study|Withdrawal by Subject|0|||
143094559|NCT00955409|515887339|FG005|Overall Study|Withdrawal by Subject|0|||
143094560|NCT00955409|515887340|FG006|Overall Study|Withdrawal by Subject|2|||
143094561|NCT00955409|515887341|FG007|Overall Study|Withdrawal by Subject|0|||
143094562|NCT00955409|515887342|FG008|Overall Study|Withdrawal by Subject|1|||
143094563|NCT00955409|515887343|FG009|Overall Study|Withdrawal by Subject|0|||
143094564|NCT00955409|515887334|FG000|Overall Study|Caregiver Request|2|||
143094565|NCT00955409|515887335|FG001|Overall Study|Caregiver Request|0|||
143094566|NCT00955409|515887336|FG002|Overall Study|Caregiver Request|6|||
143094567|NCT00955409|515887337|FG003|Overall Study|Caregiver Request|5|||
143094568|NCT00955409|515887338|FG004|Overall Study|Caregiver Request|0|||
143094569|NCT00955409|515887339|FG005|Overall Study|Caregiver Request|2|||
143094570|NCT00955409|515887340|FG006|Overall Study|Caregiver Request|3|||
143094571|NCT00955409|515887341|FG007|Overall Study|Caregiver Request|1|||
143094572|NCT00955409|515887342|FG008|Overall Study|Caregiver Request|3|||
143094573|NCT00955409|515887343|FG009|Overall Study|Caregiver Request|0|||
143094574|NCT00955409|515887334|FG000|Overall Study|Investigator Request|0|||
143094575|NCT00955409|515887335|FG001|Overall Study|Investigator Request|0|||
143094576|NCT00955409|515887336|FG002|Overall Study|Investigator Request|1|||
143094577|NCT00955409|515887337|FG003|Overall Study|Investigator Request|0|||
143094578|NCT00955409|515887338|FG004|Overall Study|Investigator Request|0|||
143094579|NCT00955409|515887339|FG005|Overall Study|Investigator Request|0|||
143094580|NCT00955409|515887340|FG006|Overall Study|Investigator Request|0|||
143094581|NCT00955409|515887341|FG007|Overall Study|Investigator Request|0|||
143367405|NCT00646451|516889337|FG000|Overall Study|Adverse Event|3|||
143094582|NCT00955409|515887342|FG008|Overall Study|Investigator Request|0|||
143094583|NCT00955409|515887343|FG009|Overall Study|Investigator Request|0|||
143094584|NCT00955409|515887334|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
143094585|NCT00955409|515887335|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
143367406|NCT00646451|516889338|FG001|Overall Study|Adverse Event|0|||
143367407|NCT00646451|516889337|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
143094586|NCT00955409|515887336|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
143094587|NCT00955409|515887337|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
143094588|NCT00955409|515887338|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
143094589|NCT00955409|515887339|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
143094590|NCT00955409|515887340|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
143094591|NCT00955409|515887341|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
143094592|NCT00955409|515887342|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
143094593|NCT00955409|515887343|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
143094594|NCT00955409|515887334|FG000|Overall Study|Lost to Follow-up|0|||
143094595|NCT00955409|515887335|FG001|Overall Study|Lost to Follow-up|0|||
143094596|NCT00955409|515887336|FG002|Overall Study|Lost to Follow-up|1|||
143094597|NCT00955409|515887337|FG003|Overall Study|Lost to Follow-up|0|||
143094598|NCT00955409|515887338|FG004|Overall Study|Lost to Follow-up|0|||
143094599|NCT00955409|515887339|FG005|Overall Study|Lost to Follow-up|0|||
143094600|NCT00955409|515887340|FG006|Overall Study|Lost to Follow-up|1|||
143094601|NCT00955409|515887341|FG007|Overall Study|Lost to Follow-up|0|||
143094602|NCT00955409|515887342|FG008|Overall Study|Lost to Follow-up|0|||
143094603|NCT00955409|515887343|FG009|Overall Study|Lost to Follow-up|0|||
143094604|NCT00955409|515887334|FG000|Overall Study|Failed to Return|2|||
143094605|NCT00955409|515887335|FG001|Overall Study|Failed to Return|0|||
143094606|NCT00955409|515887336|FG002|Overall Study|Failed to Return|0|||
143251193|NCT02059291|516472975|FG006|Epoch 4|Pregnancy|0|||
143251194|NCT02059291|516472976|FG007|Epoch 4|Pregnancy|0|||
143251195|NCT02059291|516472977|FG008|Epoch 4|Pregnancy|0|||
143251196|NCT02059291|516472978|FG009|Epoch 4|Pregnancy|0|||
143094607|NCT00955409|515887337|FG003|Overall Study|Failed to Return|0|||
143094608|NCT00955409|515887338|FG004|Overall Study|Failed to Return|0|||
143251197|NCT02059291|516472979|FG010|Epoch 4|Pregnancy|0|||
143094609|NCT00955409|515887339|FG005|Overall Study|Failed to Return|0|||
143094610|NCT00955409|515887340|FG006|Overall Study|Failed to Return|0|||
143094611|NCT00955409|515887341|FG007|Overall Study|Failed to Return|2|||
143094612|NCT00955409|515887342|FG008|Overall Study|Failed to Return|0|||
143094613|NCT00955409|515887343|FG009|Overall Study|Failed to Return|0|||
143094614|NCT00955409|515887334|FG000|Overall Study|Adverse Event (AE)|2|||
143094615|NCT00955409|515887335|FG001|Overall Study|Adverse Event (AE)|0|||
143094616|NCT00955409|515887336|FG002|Overall Study|Adverse Event (AE)|0|||
143094617|NCT00955409|515887337|FG003|Overall Study|Adverse Event (AE)|0|||
143367408|NCT00646451|516889338|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
143367409|NCT03181958|516889339|FG000|Overall Study|Lost to Follow-up|17|||
143367410|NCT03181958|516889340|FG001|Overall Study|Lost to Follow-up|21|||
143367411|NCT03181958|516889341|FG002|Overall Study|Lost to Follow-up|15|||
143367412|NCT00109967|516889346|FG000|Overall Study|Cancel Prior to Treatment|2|||
143367413|NCT00109967|516889347|FG001|Overall Study|Cancel Prior to Treatment|0|||
143367414|NCT00109967|516889346|FG000|Overall Study|Adverse Event|12|||
143367415|NCT00109967|516889347|FG001|Overall Study|Adverse Event|1|||
143367416|NCT00109967|516889346|FG000|Overall Study|Withdrawal by Subject|5|||
143367417|NCT00109967|516889347|FG001|Overall Study|Withdrawal by Subject|0|||
143367418|NCT00109967|516889346|FG000|Overall Study|Physician Decision|1|||
143367419|NCT00109967|516889347|FG001|Overall Study|Physician Decision|3|||
143367420|NCT00109967|516889346|FG000|Overall Study|Death|0|||
143367421|NCT00109967|516889347|FG001|Overall Study|Death|2|||
143367422|NCT01977612|516889354|FG000|Overall Study|Lost to Follow-up|1|||
143367423|NCT01977612|516889355|FG001|Overall Study|Lost to Follow-up|1|||
143367424|NCT02715258|516889356|FG000|Overall Study|Withdrawal by Subject|6|||
143367425|NCT02715258|516889357|FG001|Overall Study|Withdrawal by Subject|1|||
143367426|NCT02715258|516889356|FG000|Overall Study|Lost to Follow-up|7|||
143367427|NCT02715258|516889357|FG001|Overall Study|Lost to Follow-up|1|||
143367428|NCT02715258|516889356|FG000|Overall Study|Terminated by Sponsor|0|||
143367429|NCT02715258|516889357|FG001|Overall Study|Terminated by Sponsor|1|||
143367430|NCT02715258|516889356|FG000|Overall Study|Death|0|||
143367431|NCT02715258|516889357|FG001|Overall Study|Death|1|||
143367432|NCT02715258|516889356|FG000|Overall Study|Subject non-compliant|1|||
143367433|NCT02715258|516889357|FG001|Overall Study|Subject non-compliant|1|||
143367434|NCT02715258|516889356|FG000|Overall Study|GCP violation|2|||
143367435|NCT02715258|516889357|FG001|Overall Study|GCP violation|1|||
143367436|NCT01720446|516889359|FG000|Overall Study|Lost to Follow-up|12|||
143094618|NCT00955409|515887338|FG004|Overall Study|Adverse Event (AE)|0|||
143367437|NCT01720446|516889360|FG001|Overall Study|Lost to Follow-up|6|||
143367438|NCT01720446|516889361|FG002|Overall Study|Lost to Follow-up|16|||
143367439|NCT01720446|516889362|FG003|Overall Study|Lost to Follow-up|16|||
143367440|NCT01720446|516889359|FG000|Overall Study|Withdrawal by Subject|2|||
143367441|NCT01720446|516889360|FG001|Overall Study|Withdrawal by Subject|5|||
143094619|NCT00955409|515887339|FG005|Overall Study|Adverse Event (AE)|1|||
143094620|NCT00955409|515887340|FG006|Overall Study|Adverse Event (AE)|2|||
143094621|NCT00955409|515887341|FG007|Overall Study|Adverse Event (AE)|0|||
143094622|NCT00955409|515887342|FG008|Overall Study|Adverse Event (AE)|2|||
143367442|NCT01720446|516889361|FG002|Overall Study|Withdrawal by Subject|4|||
143367443|NCT01720446|516889362|FG003|Overall Study|Withdrawal by Subject|4|||
143367444|NCT01020838|516889363|FG000|Overall Study|Death|90|||
143094623|NCT00955409|515887343|FG009|Overall Study|Adverse Event (AE)|0|||
143094624|NCT00955409|515887334|FG000|Overall Study|Reason not Specified|2|||
143094625|NCT00955409|515887335|FG001|Overall Study|Reason not Specified|1|||
143094626|NCT00955409|515887336|FG002|Overall Study|Reason not Specified|13|||
143094627|NCT00955409|515887337|FG003|Overall Study|Reason not Specified|1|||
143094628|NCT00955409|515887338|FG004|Overall Study|Reason not Specified|2|||
143094629|NCT00955409|515887339|FG005|Overall Study|Reason not Specified|0|||
143094630|NCT00955409|515887340|FG006|Overall Study|Reason not Specified|16|||
143094631|NCT00955409|515887341|FG007|Overall Study|Reason not Specified|0|||
143094632|NCT00955409|515887342|FG008|Overall Study|Reason not Specified|8|||
143094633|NCT00955409|515887343|FG009|Overall Study|Reason not Specified|1|||
143094634|NCT00485732|515887344|FG000|Overall Study|Protocol Violation|1|||
143094635|NCT00485732|515887345|FG001|Overall Study|Protocol Violation|3|||
143094636|NCT00485732|515887344|FG000|Overall Study|Withdrawal by Subject|5|||
143094637|NCT00485732|515887345|FG001|Overall Study|Withdrawal by Subject|4|||
143094638|NCT00485732|515887344|FG000|Overall Study|Lost to Follow-up|2|||
143094639|NCT00485732|515887345|FG001|Overall Study|Lost to Follow-up|2|||
143094640|NCT00803790|515887346|FG000|Period 1|Adverse Event|0|||
143094641|NCT00803790|515887347|FG001|Period 1|Adverse Event|1|||
143094642|NCT00803790|515887348|FG002|Period 1|Adverse Event|0|||
143094643|NCT00803790|515887349|FG003|Period 1|Adverse Event|0|||
143094644|NCT00803790|515887346|FG000|Period 1|Lost to Follow-up|1|||
143094645|NCT00803790|515887347|FG001|Period 1|Lost to Follow-up|2|||
143094646|NCT00803790|515887348|FG002|Period 1|Lost to Follow-up|0|||
143094647|NCT00803790|515887349|FG003|Period 1|Lost to Follow-up|0|||
143094648|NCT00803790|515887346|FG000|Period 1|Withdrawal by Subject|8|||
143094649|NCT00803790|515887347|FG001|Period 1|Withdrawal by Subject|6|||
143094650|NCT00803790|515887348|FG002|Period 1|Withdrawal by Subject|0|||
143094651|NCT00803790|515887349|FG003|Period 1|Withdrawal by Subject|0|||
143094652|NCT00803790|515887346|FG000|Period 1|positive drug screen or personal reasons|0|||
143094653|NCT00803790|515887347|FG001|Period 1|positive drug screen or personal reasons|3|||
143094654|NCT00803790|515887348|FG002|Period 1|positive drug screen or personal reasons|0|||
143094655|NCT00803790|515887349|FG003|Period 1|positive drug screen or personal reasons|4|||
143094656|NCT00803790|515887346|FG000|Period 1|Protocol Violation|0|||
143094657|NCT00803790|515887347|FG001|Period 1|Protocol Violation|0|||
143094658|NCT00803790|515887348|FG002|Period 1|Protocol Violation|1|||
143094659|NCT00803790|515887349|FG003|Period 1|Protocol Violation|0|||
143094660|NCT00803790|515887346|FG000|Period 2|Adverse Event|0|||
143094661|NCT00803790|515887347|FG001|Period 2|Adverse Event|0|||
143094662|NCT00803790|515887348|FG002|Period 2|Adverse Event|1|||
143094663|NCT00803790|515887349|FG003|Period 2|Adverse Event|1|||
143094664|NCT00803790|515887346|FG000|Period 2|Withdrawal by Subject|1|||
143094665|NCT00803790|515887347|FG001|Period 2|Withdrawal by Subject|0|||
143094666|NCT00803790|515887348|FG002|Period 2|Withdrawal by Subject|0|||
143094667|NCT00803790|515887349|FG003|Period 2|Withdrawal by Subject|0|||
143094668|NCT00803790|515887346|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
143094669|NCT00803790|515887347|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
143094670|NCT00803790|515887348|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
143094671|NCT00803790|515887349|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
143094672|NCT04710576|515887350|FG000|Overall Study|Participants still in the study|73|||
143094673|NCT04710576|515887351|FG001|Overall Study|Participants still in the study|70|||
143094674|NCT04710576|515887352|FG002|Overall Study|Participants still in the study|60|||
143251198|NCT02059291|516472980|FG011|Epoch 4|Pregnancy|0|||
143251199|NCT02059291|516472981|FG012|Epoch 4|Pregnancy|0|||
143251200|NCT02059291|516472982|FG013|Epoch 4|Pregnancy|0|||
143251201|NCT02059291|516472983|FG014|Epoch 4|Pregnancy|0|||
143251202|NCT02059291|516472984|FG015|Epoch 4|Pregnancy|0|||
143251203|NCT02059291|516472985|FG016|Epoch 4|Pregnancy|1|||
143251204|NCT02059291|516472986|FG017|Epoch 4|Pregnancy|0|||
143251205|NCT02059291|516472987|FG018|Epoch 4|Pregnancy|0|||
143251206|NCT02059291|516472988|FG019|Epoch 4|Pregnancy|0|||
143094675|NCT04710576|515887350|FG000|Overall Study|Death|2|||
143094676|NCT04710576|515887351|FG001|Overall Study|Death|7|||
143094677|NCT04710576|515887352|FG002|Overall Study|Death|12|||
143094678|NCT04710576|515887350|FG000|Overall Study|Withdrawal by Subject|4|||
143094679|NCT04710576|515887351|FG001|Overall Study|Withdrawal by Subject|3|||
143251207|NCT02059291|516472989|FG020|Epoch 4|Pregnancy|0|||
143251208|NCT02059291|516472990|FG021|Epoch 4|Pregnancy|0|||
143251209|NCT02059291|516472991|FG022|Epoch 4|Pregnancy|0|||
143094680|NCT04710576|515887352|FG002|Overall Study|Withdrawal by Subject|7|||
143094681|NCT04710576|515887350|FG000|Overall Study|Sponsor decision|1|||
143094682|NCT04710576|515887351|FG001|Overall Study|Sponsor decision|0|||
143094683|NCT04710576|515887352|FG002|Overall Study|Sponsor decision|0|||
143094684|NCT01880554|515887353|FG000|Overall Study|Protocol Violation|14|||
143094685|NCT01880554|515887353|FG000|Overall Study|Simon's design requirements|2|||
143094686|NCT05734157|515887354|FG000|Overall Study|Death|3|||
143094687|NCT05734157|515887354|FG000|Overall Study|Withdrawal by Subject|2|||
143094688|NCT05734157|515887354|FG000|Overall Study|Lost to Follow-up|1|||
143251210|NCT02059291|516472992|FG023|Epoch 4|Pregnancy|0|||
143251211|NCT02059291|516472993|FG024|Epoch 4|Pregnancy|0|||
143251212|NCT02059291|516472969|FG000|Epoch 4|Withdrawal by Subject|0|||
143094689|NCT05734157|515887354|FG000|Overall Study|Telephone call|3|||
143094690|NCT00838903|515887359|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
143094691|NCT00838903|515887360|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
143094692|NCT00838903|515887361|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
143094693|NCT00838903|515887362|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
143094694|NCT00838903|515887359|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
143094695|NCT00838903|515887360|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
143094696|NCT00838903|515887361|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
143094697|NCT00838903|515887362|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
143094698|NCT00838903|515887359|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
143094699|NCT00838903|515887360|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
143094700|NCT00838903|515887361|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
143094701|NCT00838903|515887362|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
143094702|NCT00838903|515887359|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
143094703|NCT00838903|515887360|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
143094704|NCT00838903|515887361|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
143094705|NCT00838903|515887362|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
143094706|NCT00838903|515887359|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
143094707|NCT00838903|515887360|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
143094708|NCT00838903|515887361|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
143094709|NCT00838903|515887362|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
143094710|NCT00838903|515887359|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
143094711|NCT00838903|515887360|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
143094712|NCT00838903|515887361|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
143094713|NCT00838903|515887362|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
143094714|NCT00838903|515887359|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
143094715|NCT00838903|515887360|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
143251213|NCT02059291|516472970|FG001|Epoch 4|Withdrawal by Subject|0|||
143251214|NCT02059291|516472971|FG002|Epoch 4|Withdrawal by Subject|0|||
143251215|NCT02059291|516472972|FG003|Epoch 4|Withdrawal by Subject|0|||
143094716|NCT00838903|515887361|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
143094717|NCT00838903|515887362|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
143094718|NCT00838903|515887359|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
143094719|NCT00838903|515887360|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
143094720|NCT00838903|515887361|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
143094721|NCT00838903|515887362|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
143094722|NCT00838903|515887359|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
143094723|NCT00838903|515887360|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
143094724|NCT00838903|515887361|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
143094725|NCT00838903|515887362|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
143094726|NCT00838903|515887359|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
143094727|NCT00838903|515887360|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
143094728|NCT00838903|515887361|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
143094729|NCT00838903|515887362|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
143094730|NCT00838903|515887359|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
143094731|NCT00838903|515887360|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
143094732|NCT00838903|515887361|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
143094733|NCT00838903|515887362|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
143094734|NCT00838903|515887359|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
143094735|NCT00838903|515887360|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
143094736|NCT00838903|515887361|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
143094737|NCT00838903|515887362|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
143094738|NCT00838903|515887359|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
143094739|NCT00838903|515887360|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
143094740|NCT00838903|515887361|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
143094741|NCT00838903|515887362|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
143094742|NCT00838903|515887359|FG000|Treatment Period (156 Weeks)|Site closed|0|||
143094743|NCT00838903|515887360|FG001|Treatment Period (156 Weeks)|Site closed|0|||
143094744|NCT00838903|515887361|FG002|Treatment Period (156 Weeks)|Site closed|1|||
143251216|NCT02059291|516472973|FG004|Epoch 4|Withdrawal by Subject|0|||
143251217|NCT02059291|516472974|FG005|Epoch 4|Withdrawal by Subject|0|||
143251218|NCT02059291|516472975|FG006|Epoch 4|Withdrawal by Subject|0|||
143251219|NCT02059291|516472976|FG007|Epoch 4|Withdrawal by Subject|0|||
143094745|NCT00838903|515887362|FG003|Treatment Period (156 Weeks)|Site closed|0|||
143094746|NCT00838903|515887359|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
143094747|NCT00838903|515887360|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
143251220|NCT02059291|516472977|FG008|Epoch 4|Withdrawal by Subject|0|||
143251221|NCT02059291|516472978|FG009|Epoch 4|Withdrawal by Subject|0|||
143094748|NCT00838903|515887361|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
143094749|NCT00838903|515887362|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
143094750|NCT00838903|515887359|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
143094751|NCT00838903|515887360|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
143094752|NCT00838903|515887361|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
143094753|NCT00838903|515887362|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
143094754|NCT00838903|515887359|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
143094755|NCT00838903|515887360|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
143094756|NCT00838903|515887361|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
143094757|NCT00838903|515887362|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
143094758|NCT00838903|515887359|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
143094759|NCT00838903|515887360|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
143094760|NCT00838903|515887361|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
143094761|NCT00838903|515887362|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
143094762|NCT00838903|515887359|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
143094763|NCT00838903|515887360|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
143094764|NCT00838903|515887361|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
143094765|NCT00838903|515887362|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
143094766|NCT00838903|515887359|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
143094767|NCT00838903|515887360|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
143094768|NCT00838903|515887361|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
143094769|NCT00838903|515887362|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
143094770|NCT00838903|515887359|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
143094771|NCT00838903|515887360|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
143094772|NCT00838903|515887361|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
143094773|NCT00838903|515887362|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
143094774|NCT00838903|515887359|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
143094775|NCT00838903|515887360|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
143094776|NCT00838903|515887361|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
143094777|NCT00838903|515887362|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
143094778|NCT00838903|515887359|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
143094779|NCT00838903|515887360|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
143094780|NCT00838903|515887361|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
143094781|NCT00838903|515887362|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
143094782|NCT00838903|515887359|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
143094783|NCT00838903|515887360|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
143094784|NCT00838903|515887361|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
143094785|NCT00838903|515887362|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
143094786|NCT00838903|515887359|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
143094787|NCT00838903|515887360|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
143094788|NCT00838903|515887361|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
143094789|NCT00838903|515887362|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
143094790|NCT00838903|515887359|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
143094791|NCT00838903|515887360|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
143094792|NCT00838903|515887361|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
143094793|NCT00838903|515887362|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
143094794|NCT00838903|515887359|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
143094795|NCT00838903|515887360|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
143094796|NCT00838903|515887361|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
143094797|NCT00838903|515887362|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
143094798|NCT00838903|515887359|FG000|Follow-up Period (8 Weeks)|Missing|1|||
143094799|NCT00838903|515887360|FG001|Follow-up Period (8 Weeks)|Missing|2|||
143094800|NCT00838903|515887361|FG002|Follow-up Period (8 Weeks)|Missing|1|||
143094801|NCT00838903|515887362|FG003|Follow-up Period (8 Weeks)|Missing|1|||
143094802|NCT01909934|515887370|FG000|Overall Study|Withdrawal by Subject|3|||
143094803|NCT01909934|515887370|FG000|Overall Study|Lost to Follow-up|1|||
143094804|NCT01909934|515887370|FG000|Overall Study|Death|25|||
143251222|NCT02059291|516472979|FG010|Epoch 4|Withdrawal by Subject|0|||
143176784|NCT02750514|516196220|FG004|Track 3|Participant withdrew consent|0|||
143176785|NCT02750514|516196216|FG000|Track 3|Other reasons|0|||
143176786|NCT02750514|516196217|FG001|Track 3|Other reasons|3|||
143176787|NCT02750514|516196218|FG002|Track 3|Other reasons|0|||
143176788|NCT02750514|516196219|FG003|Track 3|Other reasons|0|||
143176789|NCT02750514|516196220|FG004|Track 3|Other reasons|0|||
143176790|NCT02750514|516196216|FG000|Track 4|Study drug toxicity|0|||
143176791|NCT02750514|516196217|FG001|Track 4|Study drug toxicity|6|||
143176792|NCT02750514|516196218|FG002|Track 4|Study drug toxicity|0|||
143176793|NCT02750514|516196219|FG003|Track 4|Study drug toxicity|5|||
143176794|NCT02750514|516196220|FG004|Track 4|Study drug toxicity|0|||
143176795|NCT02750514|516196216|FG000|Track 4|Participant request to discontinue|0|||
143176796|NCT02750514|516196217|FG001|Track 4|Participant request to discontinue|1|||
143251223|NCT02059291|516472980|FG011|Epoch 4|Withdrawal by Subject|0|||
143251224|NCT02059291|516472981|FG012|Epoch 4|Withdrawal by Subject|0|||
143251225|NCT02059291|516472982|FG013|Epoch 4|Withdrawal by Subject|0|||
143251226|NCT02059291|516472983|FG014|Epoch 4|Withdrawal by Subject|0|||
143251227|NCT02059291|516472984|FG015|Epoch 4|Withdrawal by Subject|0|||
143251228|NCT02059291|516472985|FG016|Epoch 4|Withdrawal by Subject|0|||
143251229|NCT02059291|516472986|FG017|Epoch 4|Withdrawal by Subject|0|||
143251230|NCT02059291|516472987|FG018|Epoch 4|Withdrawal by Subject|0|||
143251231|NCT02059291|516472988|FG019|Epoch 4|Withdrawal by Subject|0|||
143251232|NCT02059291|516472989|FG020|Epoch 4|Withdrawal by Subject|1|||
143251233|NCT02059291|516472990|FG021|Epoch 4|Withdrawal by Subject|0|||
143251234|NCT02059291|516472991|FG022|Epoch 4|Withdrawal by Subject|0|||
143251235|NCT02059291|516472992|FG023|Epoch 4|Withdrawal by Subject|0|||
143251236|NCT02059291|516472993|FG024|Epoch 4|Withdrawal by Subject|0|||
143251237|NCT02059291|516472969|FG000|Epoch 4|Lack of Efficacy|0|||
143251238|NCT02059291|516472970|FG001|Epoch 4|Lack of Efficacy|0|||
143251239|NCT02059291|516472971|FG002|Epoch 4|Lack of Efficacy|0|||
143251240|NCT02059291|516472972|FG003|Epoch 4|Lack of Efficacy|0|||
143251241|NCT02059291|516472973|FG004|Epoch 4|Lack of Efficacy|0|||
143251242|NCT02059291|516472974|FG005|Epoch 4|Lack of Efficacy|0|||
143251243|NCT02059291|516472975|FG006|Epoch 4|Lack of Efficacy|0|||
143251244|NCT02059291|516472976|FG007|Epoch 4|Lack of Efficacy|0|||
143251245|NCT02059291|516472977|FG008|Epoch 4|Lack of Efficacy|0|||
143251246|NCT02059291|516472978|FG009|Epoch 4|Lack of Efficacy|0|||
143176797|NCT02750514|516196218|FG002|Track 4|Participant request to discontinue|0|||
143176798|NCT02750514|516196219|FG003|Track 4|Participant request to discontinue|1|||
143176799|NCT02750514|516196220|FG004|Track 4|Participant request to discontinue|0|||
143176800|NCT02750514|516196216|FG000|Track 4|Participant withdrew consent|0|||
143176801|NCT02750514|516196217|FG001|Track 4|Participant withdrew consent|1|||
143176802|NCT02750514|516196218|FG002|Track 4|Participant withdrew consent|0|||
143176803|NCT02750514|516196219|FG003|Track 4|Participant withdrew consent|0|||
143176804|NCT02750514|516196220|FG004|Track 4|Participant withdrew consent|0|||
143176805|NCT02750514|516196216|FG000|Track 4|Other reasons|0|||
143176806|NCT02750514|516196217|FG001|Track 4|Other reasons|5|||
143176807|NCT02750514|516196218|FG002|Track 4|Other reasons|0|||
143176808|NCT02750514|516196219|FG003|Track 4|Other reasons|3|||
143176809|NCT02750514|516196220|FG004|Track 4|Other reasons|0|||
143176810|NCT02750514|516196216|FG000|Track 4|Disease progression|0|||
143176811|NCT02750514|516196217|FG001|Track 4|Disease progression|33|||
143176812|NCT02750514|516196218|FG002|Track 4|Disease progression|0|||
143176813|NCT02750514|516196219|FG003|Track 4|Disease progression|32|||
143176814|NCT02750514|516196220|FG004|Track 4|Disease progression|0|||
143176815|NCT02750514|516196216|FG000|Track 4|Adverse event unrelated to study drug|0|||
143176816|NCT02750514|516196217|FG001|Track 4|Adverse event unrelated to study drug|5|||
143176817|NCT02750514|516196218|FG002|Track 4|Adverse event unrelated to study drug|0|||
143176818|NCT02750514|516196219|FG003|Track 4|Adverse event unrelated to study drug|0|||
143176819|NCT02750514|516196220|FG004|Track 4|Adverse event unrelated to study drug|0|||
143176820|NCT02750514|516196216|FG000|Track 4|Death|0|||
143176821|NCT02750514|516196217|FG001|Track 4|Death|0|||
143176822|NCT02750514|516196218|FG002|Track 4|Death|0|||
143176823|NCT02750514|516196219|FG003|Track 4|Death|1|||
143176824|NCT02750514|516196220|FG004|Track 4|Death|0|||
143176825|NCT02750514|516196216|FG000|Track 5|Disease progression|0|||
143251247|NCT02059291|516472979|FG010|Epoch 4|Lack of Efficacy|0|||
143251248|NCT02059291|516472980|FG011|Epoch 4|Lack of Efficacy|0|||
143251249|NCT02059291|516472981|FG012|Epoch 4|Lack of Efficacy|0|||
143251250|NCT02059291|516472982|FG013|Epoch 4|Lack of Efficacy|0|||
143251251|NCT02059291|516472983|FG014|Epoch 4|Lack of Efficacy|0|||
143094805|NCT01909934|515887370|FG000|Overall Study|Withdrawal of Informed Consent|1|||
143094806|NCT01909934|515887370|FG000|Overall Study|Reason Not Specified|1|||
143094807|NCT03810092|515887371|FG000|Overall Study|no ground support|17|||
143094808|NCT03810092|515887371|FG000|Overall Study|ADL not done at J0|16|||
143094809|NCT03810092|515887371|FG000|Overall Study|No hemoglobin measure at J5|27|||
143094810|NCT03380429|515887372|FG000|Overall Study|Physician Decision|0|||
143094811|NCT03380429|515887373|FG001|Overall Study|Physician Decision|1|||
143094812|NCT03380429|515887374|FG002|Overall Study|Physician Decision|0|||
143094813|NCT03380429|515887375|FG003|Overall Study|Physician Decision|1|||
143094814|NCT03380429|515887376|FG004|Overall Study|Physician Decision|1|||
143094815|NCT03380429|515887372|FG000|Overall Study|Withdrawal by Subject|3|||
143094816|NCT03380429|515887373|FG001|Overall Study|Withdrawal by Subject|3|||
143094817|NCT03380429|515887374|FG002|Overall Study|Withdrawal by Subject|5|||
143094818|NCT03380429|515887375|FG003|Overall Study|Withdrawal by Subject|2|||
143094819|NCT03380429|515887376|FG004|Overall Study|Withdrawal by Subject|1|||
143094820|NCT03380429|515887372|FG000|Overall Study|Lost to Follow-up|0|||
143094821|NCT03380429|515887373|FG001|Overall Study|Lost to Follow-up|2|||
143094822|NCT03380429|515887374|FG002|Overall Study|Lost to Follow-up|4|||
143094823|NCT03380429|515887375|FG003|Overall Study|Lost to Follow-up|3|||
143094824|NCT03380429|515887376|FG004|Overall Study|Lost to Follow-up|1|||
143094825|NCT03380429|515887372|FG000|Overall Study|Protocol Violation|1|||
143094826|NCT03380429|515887373|FG001|Overall Study|Protocol Violation|0|||
143094827|NCT03380429|515887374|FG002|Overall Study|Protocol Violation|1|||
143094828|NCT03380429|515887375|FG003|Overall Study|Protocol Violation|0|||
143094829|NCT03380429|515887376|FG004|Overall Study|Protocol Violation|1|||
143094830|NCT03380429|515887372|FG000|Overall Study|Lack of Efficacy|0|||
143094831|NCT03380429|515887373|FG001|Overall Study|Lack of Efficacy|0|||
143094832|NCT03380429|515887374|FG002|Overall Study|Lack of Efficacy|0|||
143094833|NCT03380429|515887375|FG003|Overall Study|Lack of Efficacy|2|||
143094834|NCT03380429|515887376|FG004|Overall Study|Lack of Efficacy|1|||
143094835|NCT03380429|515887372|FG000|Overall Study|Adverse Event|1|||
143094836|NCT03380429|515887373|FG001|Overall Study|Adverse Event|1|||
143094837|NCT03380429|515887374|FG002|Overall Study|Adverse Event|1|||
143094838|NCT03380429|515887375|FG003|Overall Study|Adverse Event|2|||
143094839|NCT03380429|515887376|FG004|Overall Study|Adverse Event|0|||
143094840|NCT04760626|515887379|FG000|Overall Study|Withdrawal by Subject|24|||
143094841|NCT04760626|515887380|FG001|Overall Study|Withdrawal by Subject|20|||
143094842|NCT04760626|515887379|FG000|Overall Study|Lost to Follow-up|14|||
143094843|NCT04760626|515887380|FG001|Overall Study|Lost to Follow-up|19|||
143176826|NCT02750514|516196217|FG001|Track 5|Disease progression|0|||
143094844|NCT04760626|515887379|FG000|Overall Study|Physician Decision|3|||
143094845|NCT04760626|515887380|FG001|Overall Study|Physician Decision|5|||
143094846|NCT04760626|515887379|FG000|Overall Study|Death|3|||
143094847|NCT04760626|515887380|FG001|Overall Study|Death|6|||
143251252|NCT02059291|516472984|FG015|Epoch 4|Lack of Efficacy|0|||
143251253|NCT02059291|516472985|FG016|Epoch 4|Lack of Efficacy|0|||
143251254|NCT02059291|516472986|FG017|Epoch 4|Lack of Efficacy|0|||
143251255|NCT02059291|516472987|FG018|Epoch 4|Lack of Efficacy|0|||
143251256|NCT02059291|516472988|FG019|Epoch 4|Lack of Efficacy|0|||
143094848|NCT04760626|515887379|FG000|Overall Study|Site closure|1|||
143251257|NCT02059291|516472989|FG020|Epoch 4|Lack of Efficacy|0|||
143251258|NCT02059291|516472990|FG021|Epoch 4|Lack of Efficacy|0|||
143251259|NCT02059291|516472991|FG022|Epoch 4|Lack of Efficacy|0|||
143094849|NCT04760626|515887380|FG001|Overall Study|Site closure|0|||
143094850|NCT03193853|515887383|FG000|Overall Study|Death|6|||
143094851|NCT04129125|515887384|FG000|Overall Study|Participants did not meet eligibility criteria|65|||
143094852|NCT04129125|515887384|FG000|Overall Study|Study device was not used|3|||
143094853|NCT01827111|515887387|FG000|Overall Study|Disease Progression|1|||
143094854|NCT02962648|515887388|FG000|Overall Study|Withdrawal by Subject|3|||
143094855|NCT02962648|515887388|FG000|Overall Study|Lost to Follow-up|3|||
143094856|NCT02962648|515887388|FG000|Overall Study|Physician Decision|1|||
143094857|NCT02962648|515887388|FG000|Overall Study|Subject had problems with transportation|2|||
143094858|NCT01924689|515887389|FG000|Overall Study|Death|0|||
143094859|NCT01924689|515887390|FG001|Overall Study|Death|1|||
143094860|NCT01924689|515887391|FG002|Overall Study|Death|0|||
143094861|NCT01924689|515887392|FG003|Overall Study|Death|1|||
143094862|NCT01924689|515887393|FG004|Overall Study|Death|0|||
143094863|NCT01924689|515887394|FG005|Overall Study|Death|0|||
143094864|NCT01924689|515887389|FG000|Overall Study|Disease progression|0|||
143094865|NCT01924689|515887390|FG001|Overall Study|Disease progression|0|||
143094866|NCT01924689|515887391|FG002|Overall Study|Disease progression|2|||
143094867|NCT01924689|515887392|FG003|Overall Study|Disease progression|0|||
143094868|NCT01924689|515887393|FG004|Overall Study|Disease progression|3|||
143094869|NCT01924689|515887394|FG005|Overall Study|Disease progression|2|||
143094870|NCT01924689|515887389|FG000|Overall Study|New therapy or study|3|||
143367445|NCT01020838|516889363|FG000|Overall Study|Adverse Event|1|||
143367446|NCT01020838|516889363|FG000|Overall Study|Withdrawal by Subject|9|||
143367447|NCT01020838|516889363|FG000|Overall Study|Lost to Follow-up|6|||
143367448|NCT01020838|516889363|FG000|Overall Study|Most common: Study ended by sponsor|77|||
143367449|NCT01570751|516889364|FG000|Period A (16 Weeks)|Protocol Violation|1|||
143367450|NCT01570751|516889365|FG001|Period A (16 Weeks)|Protocol Violation|1|||
143094871|NCT01924689|515887390|FG001|Overall Study|New therapy or study|2|||
143094872|NCT01924689|515887391|FG002|Overall Study|New therapy or study|1|||
143094873|NCT01924689|515887392|FG003|Overall Study|New therapy or study|4|||
143094874|NCT01924689|515887393|FG004|Overall Study|New therapy or study|2|||
143094875|NCT01924689|515887394|FG005|Overall Study|New therapy or study|0|||
143094876|NCT01924689|515887389|FG000|Overall Study|Withdrawal of consent|0|||
143094877|NCT01924689|515887390|FG001|Overall Study|Withdrawal of consent|0|||
143094878|NCT01924689|515887391|FG002|Overall Study|Withdrawal of consent|1|||
143094879|NCT01924689|515887392|FG003|Overall Study|Withdrawal of consent|1|||
143094880|NCT01924689|515887393|FG004|Overall Study|Withdrawal of consent|0|||
143094881|NCT01924689|515887394|FG005|Overall Study|Withdrawal of consent|0|||
143367451|NCT01570751|516889364|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
143367452|NCT01570751|516889365|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
143094882|NCT01924689|515887389|FG000|Overall Study|Other|0|||
143094883|NCT01924689|515887390|FG001|Overall Study|Other|0|||
143094884|NCT01924689|515887391|FG002|Overall Study|Other|0|||
143367453|NCT01570751|516889364|FG000|Period A (16 Weeks)|Unclassified|2|||
143251260|NCT02059291|516472992|FG023|Epoch 4|Lack of Efficacy|1|||
143094885|NCT01924689|515887392|FG003|Overall Study|Other|0|||
143094886|NCT01924689|515887393|FG004|Overall Study|Other|1|||
143094887|NCT01924689|515887394|FG005|Overall Study|Other|0|||
143094888|NCT03267212|515887395|FG000|First Intervention|Lost to Follow-up|0|||
143094889|NCT03267212|515887396|FG001|First Intervention|Lost to Follow-up|2|||
143094890|NCT03267212|515887395|FG000|First Intervention|Withdrawal by Subject|1|||
143094891|NCT03267212|515887396|FG001|First Intervention|Withdrawal by Subject|1|||
143094892|NCT03267212|515887395|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
143094893|NCT03267212|515887396|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
143094894|NCT05303194|515887399|FG000|Overall Study|Lost to Follow-up|1|||
143094895|NCT05303194|515887400|FG001|Overall Study|Lost to Follow-up|1|||
143094896|NCT05303194|515887399|FG000|Overall Study|Withdrawal by Subject|0|||
143094897|NCT05303194|515887400|FG001|Overall Study|Withdrawal by Subject|1|||
143094898|NCT04837196|515887401|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
143094899|NCT04837196|515887402|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|3|||
143094900|NCT04837196|515887403|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
143094901|NCT04837196|515887404|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
143094902|NCT04837196|515887405|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|4|||
143094903|NCT04837196|515887401|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
143094904|NCT04837196|515887402|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|4|||
143094905|NCT04837196|515887403|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|0|||
143094906|NCT04837196|515887404|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
143094907|NCT04837196|515887405|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
143094908|NCT04837196|515887401|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
143094909|NCT04837196|515887402|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|1|||
143094910|NCT04837196|515887403|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
143094911|NCT04837196|515887404|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
143094912|NCT04837196|515887405|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
143094913|NCT04837196|515887401|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
143094914|NCT04837196|515887402|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
143094915|NCT04837196|515887403|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|1|||
143094916|NCT04837196|515887404|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
143094917|NCT04837196|515887405|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
143094918|NCT04837196|515887401|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
143094919|NCT04837196|515887402|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
143094920|NCT04837196|515887403|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|1|||
143094921|NCT04837196|515887404|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
143094922|NCT04837196|515887405|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
143094923|NCT01289678|515887406|FG000|Overall Study|Physician Decision|6|||
143094924|NCT01597973|515887407|FG000|Overall Study|Found ineligible before study medication started|4|||
143094925|NCT01597973|515887408|FG001|Overall Study|Found ineligible before study medication started|2|||
143094926|NCT01597973|515887407|FG000|Overall Study|Eligible pathogen not confirmed|14|||
143094927|NCT01597973|515887408|FG001|Overall Study|Eligible pathogen not confirmed|15|||
143094928|NCT01597973|515887407|FG000|Overall Study|LAR not authorized to consent|0|||
143094929|NCT01597973|515887408|FG001|Overall Study|LAR not authorized to consent|1|||
143094930|NCT01597973|515887407|FG000|Overall Study|Ineligible due to early seizures|1|||
143094931|NCT01597973|515887408|FG001|Overall Study|Ineligible due to early seizures|0|||
143094932|NCT01597973|515887407|FG000|Overall Study|Ineligible due to non-target infection|1|||
143094933|NCT01597973|515887408|FG001|Overall Study|Ineligible due to non-target infection|1|||
143094934|NCT02723344|515887409|FG000|Overall Study|Lost to Follow-up|0|||
143094935|NCT02723344|515887410|FG001|Overall Study|Lost to Follow-up|4|||
143251261|NCT02059291|516472993|FG024|Epoch 4|Lack of Efficacy|0|||
143251262|NCT01989208|516472994|FG000|200 mg (7 Days)|Protocol Violation|0|||
143094936|NCT00908544|515887411|FG000|Overall Study|Withdrawal by Subject|2|||
143094937|NCT00908544|515887412|FG001|Overall Study|Withdrawal by Subject|4|||
143094938|NCT00908544|515887411|FG000|Overall Study|Lack of Efficacy|0|||
143094939|NCT00908544|515887412|FG001|Overall Study|Lack of Efficacy|1|||
143094940|NCT00908544|515887411|FG000|Overall Study|Pregnancy|1|||
143094941|NCT00908544|515887412|FG001|Overall Study|Pregnancy|0|||
143094942|NCT00908544|515887411|FG000|Overall Study|Relocation abroad|1|||
143094943|NCT00908544|515887412|FG001|Overall Study|Relocation abroad|1|||
143094944|NCT00908544|515887411|FG000|Overall Study|Unable to visit sutdy center|1|||
143094945|NCT00908544|515887412|FG001|Overall Study|Unable to visit sutdy center|0|||
143094946|NCT00740636|515887415|FG000|Overall Study|Adverse Event|0|||
143094947|NCT00740636|515887416|FG001|Overall Study|Adverse Event|2|||
143094948|NCT00740636|515887415|FG000|Overall Study|Patient Ineligible|0|||
143094949|NCT00740636|515887416|FG001|Overall Study|Patient Ineligible|1|||
143094950|NCT00740636|515887415|FG000|Overall Study|Patient Not Treated|0|||
143094951|NCT00740636|515887416|FG001|Overall Study|Patient Not Treated|1|||
143094952|NCT00740636|515887415|FG000|Overall Study|Progressive Disease|1|||
143094953|NCT00740636|515887416|FG001|Overall Study|Progressive Disease|0|||
143094954|NCT00740636|515887415|FG000|Overall Study|Death|1|||
143094955|NCT00740636|515887416|FG001|Overall Study|Death|0|||
143094956|NCT02174627|515887418|FG000|Overall Study|Missing|0|||
143094957|NCT02174627|515887419|FG001|Overall Study|Missing|1|||
143094958|NCT02174627|515887418|FG000|Overall Study|Incorrect enrolment before randomization|0|||
143094959|NCT02174627|515887419|FG001|Overall Study|Incorrect enrolment before randomization|1|||
143094960|NCT02174627|515887418|FG000|Overall Study|Participant decision|84|||
143094961|NCT02174627|515887419|FG001|Overall Study|Participant decision|128|||
143094962|NCT04564092|515887420|FG000|Overall Study|Withdrawal by Subject|1|||
143094963|NCT01831635|515887422|FG000|Overall Study|Withdrawal by Subject|0|||
143094964|NCT01831635|515887423|FG001|Overall Study|Withdrawal by Subject|2|||
143094965|NCT01831635|515887424|FG002|Overall Study|Withdrawal by Subject|0|||
143094966|NCT02362360|515887430|FG000|Period 1|Lack of Efficacy|1|||
143094967|NCT02362360|515887431|FG001|Period 1|Lack of Efficacy|0|||
143094968|NCT02362360|515887430|FG000|Period 1|Withdrawal by Subject|2|||
143094969|NCT02362360|515887431|FG001|Period 1|Withdrawal by Subject|1|||
143094970|NCT02208362|515887432|FG000|Overall Study|Participant did not complete treatment|0|||
143094971|NCT02208362|515887433|FG001|Overall Study|Participant did not complete treatment|1|||
143094972|NCT02208362|515887434|FG002|Overall Study|Participant did not complete treatment|0|||
143094973|NCT02208362|515887435|FG003|Overall Study|Participant did not complete treatment|0|||
143094974|NCT02208362|515887436|FG004|Overall Study|Participant did not complete treatment|0|||
143094975|NCT02208362|515887437|FG005|Overall Study|Participant did not complete treatment|0|||
143094976|NCT02208362|515887438|FG006|Overall Study|Participant did not complete treatment|1|||
143094977|NCT02208362|515887439|FG007|Overall Study|Participant did not complete treatment|1|||
143094978|NCT02208362|515887440|FG008|Overall Study|Participant did not complete treatment|2|||
143094979|NCT02208362|515887441|FG009|Overall Study|Participant did not complete treatment|0|||
143094980|NCT02208362|515887442|FG010|Overall Study|Participant did not complete treatment|1|||
143094981|NCT02208362|515887443|FG011|Overall Study|Participant did not complete treatment|0|||
143094982|NCT02208362|515887432|FG000|Overall Study|Participant received disallowed treatment|0|||
143094983|NCT02208362|515887433|FG001|Overall Study|Participant received disallowed treatment|0|||
143094984|NCT02208362|515887434|FG002|Overall Study|Participant received disallowed treatment|0|||
143094985|NCT02208362|515887435|FG003|Overall Study|Participant received disallowed treatment|0|||
143094986|NCT02208362|515887436|FG004|Overall Study|Participant received disallowed treatment|0|||
143094987|NCT02208362|515887437|FG005|Overall Study|Participant received disallowed treatment|0|||
143094988|NCT02208362|515887438|FG006|Overall Study|Participant received disallowed treatment|0|||
143094989|NCT02208362|515887439|FG007|Overall Study|Participant received disallowed treatment|0|||
143094990|NCT02208362|515887440|FG008|Overall Study|Participant received disallowed treatment|1|||
143094991|NCT02208362|515887441|FG009|Overall Study|Participant received disallowed treatment|0|||
143094992|NCT02208362|515887442|FG010|Overall Study|Participant received disallowed treatment|0|||
143094993|NCT02208362|515887443|FG011|Overall Study|Participant received disallowed treatment|0|||
143094994|NCT00739882|515888981|FG000|Double-blind Period|Adverse Event|1|||
143094995|NCT00739882|515888982|FG001|Double-blind Period|Adverse Event|2|||
143094996|NCT00739882|515888981|FG000|Double-blind Period|Protocol Violation|1|||
143094997|NCT00739882|515888982|FG001|Double-blind Period|Protocol Violation|0|||
143094998|NCT00739882|515888981|FG000|Double-blind Period|Lack of Efficacy|1|||
143094999|NCT00739882|515888982|FG001|Double-blind Period|Lack of Efficacy|1|||
143095000|NCT00739882|515888981|FG000|Double-blind Period|Other|16|||
143095001|NCT00739882|515888982|FG001|Double-blind Period|Other|8|||
143095002|NCT00739882|515888981|FG000|Open-label Period|Adverse Event|1|||
143095003|NCT00739882|515888982|FG001|Open-label Period|Adverse Event|0|||
143095004|NCT00739882|515888981|FG000|Open-label Period|Other|9|||
143095005|NCT00739882|515888982|FG001|Open-label Period|Other|5|||
143095006|NCT01611935|515888983|FG000|Overall Study|Family Declined Participation|1|||
143095007|NCT01611935|515888984|FG001|Overall Study|Family Declined Participation|0|||
143095008|NCT05177484|515888985|FG000|Overall Study|Withdrawn as not anaemic post operatively|1|||
143095009|NCT05177484|515888986|FG001|Overall Study|Withdrawn as not anaemic post operatively|0|||
143095010|NCT05177484|515888985|FG000|Overall Study|Inadvertently withdrawn|3|||
143095011|NCT05177484|515888986|FG001|Overall Study|Inadvertently withdrawn|1|||
143095012|NCT05177484|515888985|FG000|Overall Study|Withdrawn as not given standard care, given IV iron|0|||
143095013|NCT05177484|515888986|FG001|Overall Study|Withdrawn as not given standard care, given IV iron|1|||
143095014|NCT02549859|515888987|FG000|Long-term 60 Hz DBS|Study Closed|1|||
143095015|NCT00729612|515888990|FG000|Overall Study|Non evaluable for response|10|||
143095016|NCT04067050|515888991|FG000|One Month|Lost to Follow-up|4|||
143095017|NCT04067050|515888992|FG001|One Month|Lost to Follow-up|0|||
143095018|NCT04067050|515888991|FG000|Two Month|Lost to Follow-up|1|||
143251263|NCT01989208|516472995|FG001|200 mg (7 Days)|Protocol Violation|1|||
143095019|NCT04067050|515888992|FG001|Two Month|Lost to Follow-up|0|||
143095020|NCT04067050|515888991|FG000|Two Month|Adverse Event|1|||
143095021|NCT04067050|515888992|FG001|Two Month|Adverse Event|0|||
143251264|NCT04975438|516472996|FG000|Overall Study|Lost to Follow-up|1|||
143251265|NCT04975438|516472997|FG001|Overall Study|Lost to Follow-up|0|||
143251266|NCT04975438|516472998|FG002|Overall Study|Lost to Follow-up|1|||
143095022|NCT03003962|515888995|FG000|Overall Study|Withdrawal by Subject|5|||
143095023|NCT03003962|515888996|FG001|Overall Study|Withdrawal by Subject|17|||
143095024|NCT03003962|515888995|FG000|Overall Study|Death|274|||
143251267|NCT04975438|516472999|FG003|Overall Study|Lost to Follow-up|0|||
143251268|NCT04975438|516472996|FG000|Overall Study|Withdrawal by Subject|1|||
143095025|NCT03003962|515888996|FG001|Overall Study|Death|277|||
143095026|NCT03003962|515888995|FG000|Overall Study|Participants ongoing at DCO|55|||
143095027|NCT03003962|515888996|FG001|Overall Study|Participants ongoing at DCO|40|||
143095028|NCT03871543|515888997|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
143095029|NCT03871543|515888997|FG000|Period 1|Investigator Error|1|||
143095030|NCT03871543|515888997|FG000|Period 1|Protocol Violation|2|||
143095031|NCT03871543|515888997|FG000|Period 1|COVID-19 Related|1|||
143095032|NCT03871543|515888997|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
143095033|NCT03871543|515888997|FG000|Period 1|Withdrawal by Subject|10|||
143095034|NCT03871543|515888997|FG000|Period 2|Adverse Event|1|||
143095035|NCT03871543|515888997|FG000|Period 2|Withdrawal by Subject|1|||
143095036|NCT00360282|515888999|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
143095037|NCT00360282|515889000|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
143095038|NCT00360282|515889001|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
143095039|NCT00360282|515889002|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
143095040|NCT00360282|515888999|FG000|Second Intervention|Adverse Event|0|||
143095041|NCT00360282|515889000|FG001|Second Intervention|Adverse Event|1|||
143095042|NCT00360282|515889001|FG002|Second Intervention|Adverse Event|0|||
143095043|NCT00360282|515889002|FG003|Second Intervention|Adverse Event|0|||
143095044|NCT00314340|515889003|FG000|Overall Study|lost interest|1|||
143095045|NCT02626026|515889007|FG000|Overall Study|Randomized but Never Treated|0|||
143095046|NCT02626026|515889008|FG001|Overall Study|Randomized but Never Treated|0|||
143095047|NCT02626026|515889009|FG002|Overall Study|Randomized but Never Treated|0|||
143095048|NCT02626026|515889010|FG003|Overall Study|Randomized but Never Treated|0|||
143095049|NCT02626026|515889011|FG004|Overall Study|Randomized but Never Treated|1|||
143095050|NCT02626026|515889012|FG005|Overall Study|Randomized but Never Treated|0|||
143095051|NCT01568892|515889013|FG000|Open-label Phase|Adverse Event|2|||
143095052|NCT01568892|515889014|FG001|Open-label Phase|Adverse Event|0|||
143095053|NCT01568892|515889013|FG000|Open-label Phase|Lack of Efficacy|4|||
143095054|NCT01568892|515889014|FG001|Open-label Phase|Lack of Efficacy|2|||
143095055|NCT01568892|515889013|FG000|Open-label Phase|Lost to Follow-up|0|||
143176827|NCT02750514|516196218|FG002|Track 5|Disease progression|0|||
143176828|NCT02750514|516196219|FG003|Track 5|Disease progression|0|||
143176829|NCT02750514|516196220|FG004|Track 5|Disease progression|34|||
143176830|NCT02750514|516196216|FG000|Track 5|Adverse event unrelated to study drug|0|||
143176831|NCT02750514|516196217|FG001|Track 5|Adverse event unrelated to study drug|0|||
143176832|NCT02750514|516196218|FG002|Track 5|Adverse event unrelated to study drug|0|||
143176833|NCT02750514|516196219|FG003|Track 5|Adverse event unrelated to study drug|0|||
143176834|NCT02750514|516196220|FG004|Track 5|Adverse event unrelated to study drug|2|||
143176835|NCT02750514|516196216|FG000|Track 5|Study drug toxicity|0|||
143176836|NCT02750514|516196217|FG001|Track 5|Study drug toxicity|0|||
143176837|NCT02750514|516196218|FG002|Track 5|Study drug toxicity|0|||
143176838|NCT02750514|516196219|FG003|Track 5|Study drug toxicity|0|||
143176839|NCT02750514|516196220|FG004|Track 5|Study drug toxicity|2|||
143176840|NCT02750514|516196216|FG000|Track 5|Participant request to discontinue|0|||
143176841|NCT02750514|516196217|FG001|Track 5|Participant request to discontinue|0|||
143176842|NCT02750514|516196218|FG002|Track 5|Participant request to discontinue|0|||
143176843|NCT02750514|516196219|FG003|Track 5|Participant request to discontinue|0|||
143176844|NCT02750514|516196220|FG004|Track 5|Participant request to discontinue|3|||
143176845|NCT02750514|516196216|FG000|Track 5|Other reasons|0|||
143176846|NCT02750514|516196217|FG001|Track 5|Other reasons|0|||
143176847|NCT02750514|516196218|FG002|Track 5|Other reasons|0|||
143176848|NCT02750514|516196219|FG003|Track 5|Other reasons|0|||
143176849|NCT02750514|516196220|FG004|Track 5|Other reasons|2|||
143176850|NCT01882465|516196221|FG000|Period 1|Lens Discomfort|0|||
143176851|NCT01882465|516196222|FG001|Period 1|Lens Discomfort|0|||
143176852|NCT01882465|516196223|FG002|Period 1|Lens Discomfort|0|||
143176853|NCT01882465|516196224|FG003|Period 1|Lens Discomfort|1|||
143176854|NCT01882465|516196225|FG004|Period 1|Lens Discomfort|0|||
143176855|NCT01882465|516196226|FG005|Period 1|Lens Discomfort|0|||
143176856|NCT01882465|516196227|FG006|Period 1|Lens Discomfort|0|||
143176857|NCT01882465|516196221|FG000|Period 1|Withdrawal by Subject|0|||
143176858|NCT01882465|516196222|FG001|Period 1|Withdrawal by Subject|0|||
143176859|NCT01882465|516196223|FG002|Period 1|Withdrawal by Subject|0|||
143176860|NCT01882465|516196224|FG003|Period 1|Withdrawal by Subject|0|||
143176861|NCT01882465|516196225|FG004|Period 1|Withdrawal by Subject|0|||
143176862|NCT01882465|516196226|FG005|Period 1|Withdrawal by Subject|0|||
143095056|NCT01568892|515889014|FG001|Open-label Phase|Lost to Follow-up|1|||
143095057|NCT03922308|515889015|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
143095058|NCT03922308|515889016|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
143095059|NCT03922308|515889017|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
143095060|NCT03922308|515889015|FG000|Overall Study|Lost to Follow-up|1|||
143095061|NCT03922308|515889016|FG001|Overall Study|Lost to Follow-up|0|||
143095062|NCT03922308|515889017|FG002|Overall Study|Lost to Follow-up|0|||
143095063|NCT03922308|515889015|FG000|Overall Study|Reason not Specified|0|||
143095064|NCT03922308|515889016|FG001|Overall Study|Reason not Specified|2|||
143095065|NCT03922308|515889017|FG002|Overall Study|Reason not Specified|1|||
143095066|NCT01704495|515889018|FG000|Subjects Randomized|Other Reason|3|||
143095067|NCT01704495|515889019|FG001|Subjects Randomized|Other Reason|2|||
143095068|NCT01704495|515889020|FG002|Subjects Randomized|Other Reason|3|||
143095069|NCT01704495|515889021|FG003|Subjects Randomized|Other Reason|2|||
143095070|NCT01704495|515889018|FG000|Subjects Randomized|Discontinuation criteria met|4|||
143095071|NCT01704495|515889019|FG001|Subjects Randomized|Discontinuation criteria met|2|||
143095072|NCT01704495|515889020|FG002|Subjects Randomized|Discontinuation criteria met|2|||
143095073|NCT01704495|515889021|FG003|Subjects Randomized|Discontinuation criteria met|0|||
143095074|NCT01704495|515889018|FG000|Subjects Randomized|Adverse Event|8|||
143095075|NCT01704495|515889019|FG001|Subjects Randomized|Adverse Event|2|||
143095076|NCT01704495|515889020|FG002|Subjects Randomized|Adverse Event|0|||
143095077|NCT01704495|515889021|FG003|Subjects Randomized|Adverse Event|7|||
143095078|NCT01704495|515889018|FG000|Subjects Randomized|Withdrawal by Subject|5|||
143095079|NCT01704495|515889019|FG001|Subjects Randomized|Withdrawal by Subject|5|||
143095080|NCT01704495|515889020|FG002|Subjects Randomized|Withdrawal by Subject|5|||
143095081|NCT01704495|515889021|FG003|Subjects Randomized|Withdrawal by Subject|5|||
143176863|NCT01882465|516196227|FG006|Period 1|Withdrawal by Subject|1|||
143095082|NCT01704495|515889018|FG000|Subjects Randomized|Protocol Violation|1|||
143176864|NCT01882465|516196221|FG000|Period 2|Protocol Violation|0|||
143176865|NCT01882465|516196222|FG001|Period 2|Protocol Violation|0|||
143176866|NCT01882465|516196223|FG002|Period 2|Protocol Violation|0|||
143095083|NCT01704495|515889019|FG001|Subjects Randomized|Protocol Violation|1|||
143095084|NCT01704495|515889020|FG002|Subjects Randomized|Protocol Violation|2|||
143095085|NCT01704495|515889021|FG003|Subjects Randomized|Protocol Violation|0|||
143095086|NCT01704495|515889018|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
143095087|NCT01704495|515889019|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
143095088|NCT01704495|515889020|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
143095089|NCT01704495|515889021|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
143095090|NCT01704495|515889018|FG000|Optional Safety Extension|Adverse Event|0|||
143095091|NCT01704495|515889019|FG001|Optional Safety Extension|Adverse Event|4|||
143095092|NCT01704495|515889020|FG002|Optional Safety Extension|Adverse Event|0|||
143095093|NCT01704495|515889021|FG003|Optional Safety Extension|Adverse Event|1|||
143095094|NCT01704495|515889018|FG000|Optional Safety Extension|Other reason|27|||
143095095|NCT01704495|515889019|FG001|Optional Safety Extension|Other reason|29|||
143095096|NCT01704495|515889020|FG002|Optional Safety Extension|Other reason|30|||
143095097|NCT01704495|515889021|FG003|Optional Safety Extension|Other reason|28|||
143095098|NCT01704495|515889018|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
143095099|NCT01704495|515889019|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
143095100|NCT01704495|515889020|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
143095101|NCT01704495|515889021|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
143095102|NCT01256450|515889022|FG000|Open-label Titration|Adverse Event|39|||
143095103|NCT01256450|515889023|FG001|Open-label Titration|Adverse Event|0|||
143095104|NCT01256450|515889024|FG002|Open-label Titration|Adverse Event|0|||
143095105|NCT01256450|515889022|FG000|Open-label Titration|Lost to Follow-up|7|||
143095106|NCT01256450|515889023|FG001|Open-label Titration|Lost to Follow-up|0|||
143095107|NCT01256450|515889024|FG002|Open-label Titration|Lost to Follow-up|0|||
143095108|NCT01256450|515889022|FG000|Open-label Titration|Lack of analgesic effect|30|||
143095109|NCT01256450|515889023|FG001|Open-label Titration|Lack of analgesic effect|0|||
143095110|NCT01256450|515889024|FG002|Open-label Titration|Lack of analgesic effect|0|||
143095111|NCT01256450|515889022|FG000|Open-label Titration|Non-compliance|9|||
143095112|NCT01256450|515889023|FG001|Open-label Titration|Non-compliance|0|||
143095113|NCT01256450|515889024|FG002|Open-label Titration|Non-compliance|0|||
143095114|NCT01256450|515889022|FG000|Open-label Titration|Screen failure|1|||
143095115|NCT01256450|515889023|FG001|Open-label Titration|Screen failure|0|||
143095116|NCT01256450|515889024|FG002|Open-label Titration|Screen failure|0|||
143095117|NCT01256450|515889022|FG000|Open-label Titration|Other|13|||
143095118|NCT01256450|515889023|FG001|Open-label Titration|Other|0|||
143367454|NCT01570751|516889365|FG001|Period A (16 Weeks)|Unclassified|3|||
143095119|NCT01256450|515889024|FG002|Open-label Titration|Other|0|||
143095120|NCT01256450|515889022|FG000|Double-blind Treatment|Adverse Event|0|||
143095121|NCT01256450|515889023|FG001|Double-blind Treatment|Adverse Event|8|||
143095122|NCT01256450|515889024|FG002|Double-blind Treatment|Adverse Event|6|||
143095123|NCT01256450|515889022|FG000|Double-blind Treatment|Lost to Follow-up|0|||
143095124|NCT01256450|515889023|FG001|Double-blind Treatment|Lost to Follow-up|1|||
143095125|NCT01256450|515889024|FG002|Double-blind Treatment|Lost to Follow-up|7|||
143095126|NCT01256450|515889022|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
143367455|NCT01570751|516889364|FG000|Period B (16 Weeks)|Adverse Event|1|||
143095127|NCT01256450|515889023|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
143095128|NCT01256450|515889024|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
143095129|NCT01256450|515889022|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
143095130|NCT01256450|515889023|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
143095131|NCT01256450|515889024|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
143095132|NCT01256450|515889022|FG000|Double-blind Treatment|Non-compliance|0|||
143251269|NCT04975438|516472997|FG001|Overall Study|Withdrawal by Subject|0|||
143251270|NCT04975438|516472998|FG002|Overall Study|Withdrawal by Subject|0|||
143251271|NCT04975438|516472999|FG003|Overall Study|Withdrawal by Subject|0|||
143251272|NCT04973436|516473000|FG000|Overall Study|Lost to Follow-up|3|||
143251273|NCT04973436|516473000|FG000|Overall Study|Withdrawal by Subject|1|||
143251274|NCT04973436|516473000|FG000|Overall Study|Death|2|||
143251275|NCT00566696|516473001|FG000|Overall Study|Met Exclusion Criteria|2|||
143251276|NCT00566696|516473001|FG000|Overall Study|Muromonab not available|1|||
143251277|NCT00566696|516473001|FG000|Overall Study|Health Status Change|1|||
143251278|NCT00566696|516473001|FG000|Overall Study|Physician Decision|1|||
143251279|NCT00566696|516473001|FG000|Overall Study|Non-Patient Donors|37|||
143251280|NCT00080899|516473005|FG000|Overall Study|Adverse Event|1|||
143095133|NCT01256450|515889023|FG001|Double-blind Treatment|Non-compliance|5|||
143095134|NCT01256450|515889024|FG002|Double-blind Treatment|Non-compliance|4|||
143095135|NCT01256450|515889022|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
143095136|NCT01256450|515889023|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
143095137|NCT01256450|515889024|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
143251281|NCT01276054|516473010|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
143251282|NCT01276054|516473011|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
143095138|NCT01256450|515889022|FG000|Double-blind Treatment|Other|0|||
143095139|NCT01256450|515889023|FG001|Double-blind Treatment|Other|9|||
143095140|NCT01256450|515889024|FG002|Double-blind Treatment|Other|12|||
143095141|NCT02375971|515889025|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
143095142|NCT02375971|515889026|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
143095143|NCT02375971|515889027|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
143095144|NCT02375971|515889025|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
143095145|NCT02375971|515889026|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
143095146|NCT02375971|515889027|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
143095147|NCT02375971|515889025|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
143095148|NCT02375971|515889026|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
143095149|NCT02375971|515889027|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
143095150|NCT02375971|515889025|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
143095151|NCT02375971|515889026|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
143095152|NCT02375971|515889027|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
143095153|NCT02375971|515889025|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
143095154|NCT02375971|515889026|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
143095155|NCT02375971|515889027|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
143095156|NCT02375971|515889025|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
143095157|NCT02375971|515889026|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
143095158|NCT02375971|515889027|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
143095159|NCT02375971|515889025|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
143095160|NCT02375971|515889026|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
143095161|NCT02375971|515889027|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
143095162|NCT02375971|515889025|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
143095163|NCT02375971|515889026|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
143095164|NCT02375971|515889027|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
143095165|NCT03866512|515889028|FG000|Overall Study|Lost to Follow-up|1|||
143095166|NCT03866512|515889029|FG001|Overall Study|Lost to Follow-up|2|||
143095167|NCT03866512|515889030|FG002|Overall Study|Lost to Follow-up|1|||
143095168|NCT03866512|515889028|FG000|Overall Study|Cannulation issues|0|||
143095169|NCT03866512|515889029|FG001|Overall Study|Cannulation issues|1|||
143095170|NCT03866512|515889030|FG002|Overall Study|Cannulation issues|2|||
143095171|NCT03376789|515889038|FG000|Overall Study|Withdrawal by Subject|3|||
143095172|NCT03376789|515889039|FG001|Overall Study|Withdrawal by Subject|5|||
143095173|NCT03376789|515889038|FG000|Overall Study|Protocol Violation|0|||
143095174|NCT03376789|515889039|FG001|Overall Study|Protocol Violation|1|||
143095175|NCT03376789|515889038|FG000|Overall Study|Adverse Event|0|||
143095176|NCT03376789|515889039|FG001|Overall Study|Adverse Event|1|||
143095177|NCT03376789|515889038|FG000|Overall Study|Lost to Follow-up|1|||
143095178|NCT03376789|515889039|FG001|Overall Study|Lost to Follow-up|1|||
143251283|NCT00787267|516473012|FG000|Overall Study|Screen failure/Ineligible|10|||
143095179|NCT03376789|515889038|FG000|Overall Study|Per sponsor due to noncompliance|1|||
143095180|NCT03376789|515889039|FG001|Overall Study|Per sponsor due to noncompliance|0|||
143095181|NCT03376789|515889038|FG000|Overall Study|Subject off study medication|0|||
143095182|NCT03376789|515889039|FG001|Overall Study|Subject off study medication|1|||
143095183|NCT04177095|515889047|FG000|Overall Study|Withdrawal by Subject|3|||
143095184|NCT04177095|515889047|FG000|Overall Study|Screen Failure|3|||
143095185|NCT04177095|515889047|FG000|Overall Study|Problems with the Trugraf assay|1|||
143095186|NCT00777296|515889048|FG000|Overall Study|Adverse Event|0|||
143095187|NCT00777296|515889049|FG001|Overall Study|Adverse Event|1|||
143095188|NCT00777296|515889050|FG002|Overall Study|Adverse Event|0|||
143095189|NCT00777296|515889051|FG003|Overall Study|Adverse Event|1|||
143095190|NCT00777296|515889048|FG000|Overall Study|Withdrawal by Subject|1|||
143095191|NCT00777296|515889049|FG001|Overall Study|Withdrawal by Subject|0|||
143095192|NCT00777296|515889050|FG002|Overall Study|Withdrawal by Subject|0|||
143095193|NCT00777296|515889051|FG003|Overall Study|Withdrawal by Subject|0|||
143095194|NCT00777296|515889048|FG000|Overall Study|CRF form not completed|0|||
143095195|NCT00777296|515889049|FG001|Overall Study|CRF form not completed|0|||
143095196|NCT00777296|515889050|FG002|Overall Study|CRF form not completed|2|||
143095197|NCT00777296|515889051|FG003|Overall Study|CRF form not completed|0|||
143095198|NCT03876743|515889054|FG000|Overall Study|Lost to Follow-up|6|||
143095199|NCT03876743|515889055|FG001|Overall Study|Lost to Follow-up|4|||
143095200|NCT03876743|515889056|FG002|Overall Study|Lost to Follow-up|4|||
143095201|NCT03876743|515889057|FG003|Overall Study|Lost to Follow-up|7|||
143095202|NCT03889418|515889058|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
143095203|NCT03889418|515889059|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
143095204|NCT03889418|515889060|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
143095205|NCT03889418|515889061|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
143095206|NCT03889418|515889062|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
143095207|NCT03889418|515889063|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
143095208|NCT03889418|515889064|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
143095209|NCT03889418|515889065|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
143095210|NCT03889418|515889066|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
143095211|NCT03889418|515889067|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
143095212|NCT03889418|515889058|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
143095213|NCT03889418|515889059|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
143095214|NCT03889418|515889060|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
143095215|NCT03889418|515889061|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
143095216|NCT03889418|515889062|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
143095217|NCT03889418|515889063|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
143095218|NCT03889418|515889064|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
143095219|NCT03889418|515889065|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
143095220|NCT03889418|515889066|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
143095221|NCT03889418|515889067|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
143095222|NCT03889418|515889058|FG000|October-December 2019 (Month 7-9)|Death|0|||
143095223|NCT03889418|515889059|FG001|October-December 2019 (Month 7-9)|Death|0|||
143095224|NCT03889418|515889060|FG002|October-December 2019 (Month 7-9)|Death|0|||
143095225|NCT03889418|515889061|FG003|October-December 2019 (Month 7-9)|Death|0|||
143095226|NCT03889418|515889062|FG004|October-December 2019 (Month 7-9)|Death|0|||
143095227|NCT03889418|515889063|FG005|October-December 2019 (Month 7-9)|Death|0|||
143095228|NCT03889418|515889064|FG006|October-December 2019 (Month 7-9)|Death|0|||
143095229|NCT03889418|515889065|FG007|October-December 2019 (Month 7-9)|Death|0|||
143095230|NCT03889418|515889066|FG008|October-December 2019 (Month 7-9)|Death|1|||
143095231|NCT03889418|515889067|FG009|October-December 2019 (Month 7-9)|Death|0|||
143095232|NCT03889418|515889058|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
143095233|NCT03889418|515889059|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
143095234|NCT03889418|515889060|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
143095235|NCT03889418|515889061|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
143095236|NCT03889418|515889062|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
143251284|NCT00787267|516473012|FG000|Overall Study|No Reason Provided|1|||
143095237|NCT03889418|515889063|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
143095238|NCT03889418|515889064|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
143095239|NCT03889418|515889065|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
143095240|NCT03889418|515889066|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
143095241|NCT03889418|515889067|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
143095242|NCT03889418|515889058|FG000|April - June 2020 (Month 13-15)|Death|0|||
143095243|NCT03889418|515889059|FG001|April - June 2020 (Month 13-15)|Death|1|||
143095244|NCT03889418|515889060|FG002|April - June 2020 (Month 13-15)|Death|0|||
143095245|NCT03889418|515889061|FG003|April - June 2020 (Month 13-15)|Death|0|||
143095246|NCT03889418|515889062|FG004|April - June 2020 (Month 13-15)|Death|0|||
143095247|NCT03889418|515889063|FG005|April - June 2020 (Month 13-15)|Death|0|||
143095248|NCT03889418|515889064|FG006|April - June 2020 (Month 13-15)|Death|0|||
143095249|NCT03889418|515889065|FG007|April - June 2020 (Month 13-15)|Death|0|||
143095250|NCT03889418|515889066|FG008|April - June 2020 (Month 13-15)|Death|0|||
143095251|NCT03889418|515889067|FG009|April - June 2020 (Month 13-15)|Death|0|||
143095252|NCT03889418|515889058|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
143095253|NCT03889418|515889059|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
143095254|NCT03889418|515889060|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
143095255|NCT03889418|515889061|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
143095256|NCT03889418|515889062|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
143095257|NCT03889418|515889063|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
143367456|NCT01570751|516889365|FG001|Period B (16 Weeks)|Adverse Event|0|||
143367457|NCT01570751|516889364|FG000|Period B (16 Weeks)|Protocol Violation|0|||
143367458|NCT01570751|516889365|FG001|Period B (16 Weeks)|Protocol Violation|1|||
143095258|NCT03889418|515889064|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
143095259|NCT03889418|515889065|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
143095260|NCT03889418|515889066|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
143095261|NCT03889418|515889067|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
143367459|NCT01233050|516889366|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
143367460|NCT01233050|516889367|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
143367461|NCT04582877|516889368|FG000|Overall Study|Did not use device measurement|5|||
143367462|NCT04582877|516889368|FG000|Overall Study|No fractional flow reserve test results|2|||
143367463|NCT04582877|516889368|FG000|Overall Study|Protocol Violation|1|||
143367464|NCT02299635|516889369|FG000|Overall Study|Adverse Event|2|||
143367465|NCT02299635|516889369|FG000|Overall Study|Death|1|||
143367466|NCT02299635|516889369|FG000|Overall Study|Global deterioration of health status|1|||
143367467|NCT02299635|516889369|FG000|Overall Study|Objective progression or relapse|10|||
143367468|NCT02299635|516889369|FG000|Overall Study|Withdrawal by Subject|2|||
143367469|NCT02299635|516889369|FG000|Overall Study|Other|3|||
143367470|NCT01599325|516889370|FG000|Primary Parent Phase|Adverse Event|5|||
143367471|NCT01599325|516889370|FG000|Primary Parent Phase|Disease Progression|7|||
143367472|NCT01599325|516889370|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
143367473|NCT01599325|516889370|FG000|Primary Parent Phase|Death|13|||
143367474|NCT01599325|516889370|FG000|Primary Parent Phase|Protocol Violation|1|||
143367475|NCT01599325|516889370|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
143367476|NCT01599325|516889370|FG000|Primary Parent Phase|Other|2|||
143367477|NCT01599325|516889370|FG000|Extension Phase|Study Closure|1|||
143367478|NCT01599325|516889370|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
143367479|NCT01599325|516889370|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
143367480|NCT01599325|516889370|FG000|Extension Phase|Disease Progression|1|||
143367481|NCT01599325|516889370|FG000|Extension Phase|Withdrawal by Subject|8|||
143367482|NCT00320489|516889372|FG000|Overall Study|Adverse Event|26|||
143367483|NCT00320489|516889373|FG001|Overall Study|Adverse Event|25|||
143367484|NCT00320489|516889372|FG000|Overall Study|Clinical Relapse|26|||
143367485|NCT00320489|516889373|FG001|Overall Study|Clinical Relapse|20|||
143367486|NCT00320489|516889372|FG000|Overall Study|Death|0|||
143367487|NCT00320489|516889373|FG001|Overall Study|Death|2|||
143367488|NCT00320489|516889372|FG000|Overall Study|Entry Criteria Exclusion|2|||
143367489|NCT00320489|516889373|FG001|Overall Study|Entry Criteria Exclusion|4|||
143367490|NCT00320489|516889372|FG000|Overall Study|Lack of Efficacy|16|||
143367491|NCT00320489|516889373|FG001|Overall Study|Lack of Efficacy|7|||
143367492|NCT00320489|516889372|FG000|Overall Study|Lost to Follow-up|21|||
143367493|NCT00320489|516889373|FG001|Overall Study|Lost to Follow-up|22|||
143367494|NCT00320489|516889372|FG000|Overall Study|Physician Decision|8|||
143367495|NCT00320489|516889373|FG001|Overall Study|Physician Decision|8|||
143367496|NCT00320489|516889372|FG000|Overall Study|Protocol Violation|4|||
143367497|NCT00320489|516889373|FG001|Overall Study|Protocol Violation|4|||
143367498|NCT00320489|516889372|FG000|Overall Study|Sponsor Decision|3|||
143367499|NCT00320489|516889373|FG001|Overall Study|Sponsor Decision|3|||
143367500|NCT00320489|516889372|FG000|Overall Study|Withdrawal by Subject|39|||
143367501|NCT00320489|516889373|FG001|Overall Study|Withdrawal by Subject|41|||
143367502|NCT01190150|516889374|FG000|First Treatment|Withdrawal by Subject|1|||
143367503|NCT01190150|516889375|FG001|First Treatment|Withdrawal by Subject|0|||
143095262|NCT03889418|515889058|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
143095263|NCT03889418|515889059|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
143095264|NCT03889418|515889060|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
143095265|NCT03889418|515889061|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
143095266|NCT03889418|515889062|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
143095267|NCT03889418|515889063|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
143251285|NCT00787267|516473012|FG000|Overall Study|Withdrawal by Subject|1|||
143251286|NCT00865280|516473013|FG000|Overall Study|Withdrawal by Subject|4|||
143095268|NCT03889418|515889064|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
143095269|NCT03889418|515889065|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
143095270|NCT03889418|515889066|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
143095271|NCT03889418|515889067|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
143095272|NCT03889418|515889058|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
143095273|NCT03889418|515889059|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
143095274|NCT03889418|515889060|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
143095275|NCT03889418|515889061|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
143095276|NCT03889418|515889062|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
143095277|NCT03889418|515889063|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
143095278|NCT03889418|515889064|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
143095279|NCT03889418|515889065|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
143095280|NCT03889418|515889066|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
143095281|NCT03889418|515889067|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
143095282|NCT00092118|515889069|FG000|Overall Study|Adverse Event|35|||
143095283|NCT00092118|515889070|FG001|Overall Study|Adverse Event|32|||
143095284|NCT00092118|515889069|FG000|Overall Study|Lack of Efficacy|12|||
143095285|NCT00092118|515889070|FG001|Overall Study|Lack of Efficacy|14|||
143095286|NCT00092118|515889069|FG000|Overall Study|Lost to Follow-up|4|||
143095287|NCT00092118|515889070|FG001|Overall Study|Lost to Follow-up|3|||
143095288|NCT00092118|515889069|FG000|Overall Study|Protocol Violation|23|||
143095289|NCT00092118|515889070|FG001|Overall Study|Protocol Violation|25|||
143095290|NCT00092118|515889069|FG000|Overall Study|Withdrawal by Subject|4|||
143095291|NCT00092118|515889070|FG001|Overall Study|Withdrawal by Subject|10|||
143095292|NCT00092118|515889069|FG000|Overall Study|Other|6|||
143095293|NCT00092118|515889070|FG001|Overall Study|Other|5|||
143095294|NCT01139125|515889072|FG000|Overall Study|Withdrawal by Subject|1|||
143095295|NCT03751098|515889073|FG000|Overall Study|Withdrawal by Subject|0|||
143095296|NCT03751098|515889074|FG001|Overall Study|Withdrawal by Subject|1|||
143095297|NCT01592786|515889075|FG000|Overall Study|Adverse Event|60|||
143095298|NCT01592786|515889075|FG000|Overall Study|Lack of Efficacy|19|||
143095299|NCT01592786|515889075|FG000|Overall Study|Protocol Violation|14|||
143095300|NCT01592786|515889075|FG000|Overall Study|Withdrawal by Subject|23|||
143095301|NCT01592786|515889075|FG000|Overall Study|Lost to Follow-up|19|||
143095302|NCT01592786|515889075|FG000|Overall Study|Other|3|||
143095303|NCT02172664|515889081|FG000|Overall Study|Lost to Follow-up|4|||
143095304|NCT02172664|515889082|FG001|Overall Study|Lost to Follow-up|4|||
143095305|NCT02172664|515889081|FG000|Overall Study|Death|1|||
143095306|NCT02172664|515889082|FG001|Overall Study|Death|1|||
143095307|NCT02172664|515889081|FG000|Overall Study|Moved out of area|1|||
143095308|NCT02172664|515889082|FG001|Overall Study|Moved out of area|1|||
143095309|NCT02729025|515889095|FG000|Overall Study|Sponsor Decision|0|||
143095310|NCT02729025|515889096|FG001|Overall Study|Sponsor Decision|1|||
143095311|NCT03525678|515889099|FG000|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|8|||
143095312|NCT03525678|515889100|FG001|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
143095313|NCT03525678|515889101|FG002|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
143095314|NCT03525678|515889102|FG003|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
143095315|NCT03525678|515889103|FG004|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
143095316|NCT03525678|515889099|FG000|Main Study (Day 1 to 186 Weeks)|Physician Decision|2|||
143095317|NCT03525678|515889100|FG001|Main Study (Day 1 to 186 Weeks)|Physician Decision|4|||
143095318|NCT03525678|515889101|FG002|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
143095319|NCT03525678|515889102|FG003|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
143095320|NCT03525678|515889103|FG004|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
143095321|NCT03525678|515889099|FG000|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
143095322|NCT03525678|515889100|FG001|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|1|||
143095323|NCT03525678|515889101|FG002|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
143095324|NCT03525678|515889102|FG003|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
143095325|NCT03525678|515889103|FG004|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
143095326|NCT03525678|515889099|FG000|Main Study (Day 1 to 186 Weeks)|Death|70|||
143095327|NCT03525678|515889100|FG001|Main Study (Day 1 to 186 Weeks)|Death|80|||
143095328|NCT03525678|515889101|FG002|Main Study (Day 1 to 186 Weeks)|Death|16|||
143095329|NCT03525678|515889102|FG003|Main Study (Day 1 to 186 Weeks)|Death|0|||
143095330|NCT03525678|515889103|FG004|Main Study (Day 1 to 186 Weeks)|Death|0|||
143095331|NCT03525678|515889099|FG000|Main Study (Day 1 to 186 Weeks)|other reasons|14|||
143095332|NCT03525678|515889100|FG001|Main Study (Day 1 to 186 Weeks)|other reasons|10|||
143095333|NCT03525678|515889101|FG002|Main Study (Day 1 to 186 Weeks)|other reasons|5|||
143095334|NCT03525678|515889102|FG003|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
143095335|NCT03525678|515889103|FG004|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
143095336|NCT03525678|515889099|FG000|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|1|||
143095337|NCT03525678|515889100|FG001|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|2|||
143095338|NCT03525678|515889101|FG002|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
143095339|NCT03525678|515889102|FG003|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
143095340|NCT03525678|515889103|FG004|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
143095341|NCT00437021|515890155|FG000|Overall Study|Adverse Event|0|||
143095342|NCT00437021|515890156|FG001|Overall Study|Adverse Event|0|||
143095343|NCT00437021|515890157|FG002|Overall Study|Adverse Event|0|||
143095344|NCT00437021|515890158|FG003|Overall Study|Adverse Event|0|||
143251287|NCT00865280|516473014|FG001|Overall Study|Withdrawal by Subject|1|||
143251288|NCT00865280|516473013|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
143251289|NCT00865280|516473014|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
143095345|NCT00437021|515890159|FG004|Overall Study|Adverse Event|0|||
143095346|NCT00437021|515890160|FG005|Overall Study|Adverse Event|0|||
143095347|NCT00437021|515890161|FG006|Overall Study|Adverse Event|1|||
143095348|NCT00437021|515890162|FG007|Overall Study|Adverse Event|0|||
143095349|NCT00437021|515890163|FG008|Overall Study|Adverse Event|0|||
143095350|NCT00437021|515890164|FG009|Overall Study|Adverse Event|0|||
143095351|NCT00437021|515890165|FG010|Overall Study|Adverse Event|0|||
143095352|NCT00437021|515890166|FG011|Overall Study|Adverse Event|0|||
143095353|NCT00437021|515890155|FG000|Overall Study|Lost to Follow-up|0|||
143095354|NCT00437021|515890156|FG001|Overall Study|Lost to Follow-up|3|||
143095355|NCT00437021|515890157|FG002|Overall Study|Lost to Follow-up|0|||
143095356|NCT00437021|515890158|FG003|Overall Study|Lost to Follow-up|0|||
143095357|NCT00437021|515890159|FG004|Overall Study|Lost to Follow-up|0|||
143095358|NCT00437021|515890160|FG005|Overall Study|Lost to Follow-up|2|||
143095359|NCT00437021|515890161|FG006|Overall Study|Lost to Follow-up|0|||
143095360|NCT00437021|515890162|FG007|Overall Study|Lost to Follow-up|1|||
143095361|NCT00437021|515890163|FG008|Overall Study|Lost to Follow-up|0|||
143095362|NCT00437021|515890164|FG009|Overall Study|Lost to Follow-up|0|||
143095363|NCT00437021|515890165|FG010|Overall Study|Lost to Follow-up|0|||
143095364|NCT00437021|515890166|FG011|Overall Study|Lost to Follow-up|0|||
143095365|NCT00437021|515890155|FG000|Overall Study|Withdrawal by Subject|2|||
143095366|NCT00437021|515890156|FG001|Overall Study|Withdrawal by Subject|1|||
143095367|NCT00437021|515890157|FG002|Overall Study|Withdrawal by Subject|0|||
143095368|NCT00437021|515890158|FG003|Overall Study|Withdrawal by Subject|0|||
143095369|NCT00437021|515890159|FG004|Overall Study|Withdrawal by Subject|0|||
143095370|NCT00437021|515890160|FG005|Overall Study|Withdrawal by Subject|0|||
143095371|NCT00437021|515890161|FG006|Overall Study|Withdrawal by Subject|0|||
143095372|NCT00437021|515890162|FG007|Overall Study|Withdrawal by Subject|0|||
143095373|NCT00437021|515890163|FG008|Overall Study|Withdrawal by Subject|0|||
143095374|NCT00437021|515890164|FG009|Overall Study|Withdrawal by Subject|0|||
143095375|NCT00437021|515890165|FG010|Overall Study|Withdrawal by Subject|0|||
143095376|NCT00437021|515890166|FG011|Overall Study|Withdrawal by Subject|0|||
143095377|NCT05161481|515890167|FG000|Overall Study|Withdrawal of consent|0|||
143095378|NCT05161481|515890168|FG001|Overall Study|Withdrawal of consent|1|||
143095379|NCT05161481|515890169|FG002|Overall Study|Withdrawal of consent|1|||
143095380|NCT05161481|515890167|FG000|Overall Study|Study terminated by sponsor|3|||
143095381|NCT05161481|515890168|FG001|Overall Study|Study terminated by sponsor|3|||
143095382|NCT05161481|515890169|FG002|Overall Study|Study terminated by sponsor|2|||
143095383|NCT05161481|515890167|FG000|Overall Study|Adverse Event|3|||
143095384|NCT05161481|515890168|FG001|Overall Study|Adverse Event|0|||
143095385|NCT05161481|515890169|FG002|Overall Study|Adverse Event|6|||
143095386|NCT05161481|515890167|FG000|Overall Study|Randomised in error and was not treated|1|||
143095387|NCT05161481|515890168|FG001|Overall Study|Randomised in error and was not treated|0|||
143095388|NCT05161481|515890169|FG002|Overall Study|Randomised in error and was not treated|0|||
143095389|NCT05161481|515890167|FG000|Overall Study|Subject decision|0|||
143095390|NCT05161481|515890168|FG001|Overall Study|Subject decision|0|||
143095391|NCT05161481|515890169|FG002|Overall Study|Subject decision|1|||
143095392|NCT05573464|515890170|FG000|12-week Treatment Period|Discontinued intervention - other reason|10|||
143095393|NCT05573464|515890171|FG001|12-week Treatment Period|Discontinued intervention - other reason|4|||
143095394|NCT05573464|515890170|FG000|12-week Treatment Period|Withdrawal by Subject|8|||
143095395|NCT05573464|515890171|FG001|12-week Treatment Period|Withdrawal by Subject|5|||
143095396|NCT05573464|515890170|FG000|12-week Treatment Period|Protocol Violation|3|||
143095397|NCT05573464|515890171|FG001|12-week Treatment Period|Protocol Violation|1|||
143095398|NCT05573464|515890170|FG000|12-week Treatment Period|Physician Decision|1|||
143095399|NCT05573464|515890171|FG001|12-week Treatment Period|Physician Decision|2|||
143095400|NCT05573464|515890170|FG000|12-week Treatment Period|Lost to Follow-up|2|||
143095401|NCT05573464|515890171|FG001|12-week Treatment Period|Lost to Follow-up|0|||
143095402|NCT05573464|515890170|FG000|12-week Treatment Period|Adverse Event|20|||
143095403|NCT05573464|515890171|FG001|12-week Treatment Period|Adverse Event|9|||
143095404|NCT05573464|515890170|FG000|12-week Treatment Period|Protocol-specified withdrawal criterion met|1|||
143095405|NCT05573464|515890171|FG001|12-week Treatment Period|Protocol-specified withdrawal criterion met|0|||
143095406|NCT05573464|515890170|FG000|12-week Treatment Period|Randomised, not treated|0|||
143095407|NCT05573464|515890171|FG001|12-week Treatment Period|Randomised, not treated|1|||
143095408|NCT05573464|515890170|FG000|52-week Treatment Period|Discontinued intervention - other reason|9|||
143095409|NCT05573464|515890171|FG001|52-week Treatment Period|Discontinued intervention - other reason|8|||
143095410|NCT05573464|515890170|FG000|52-week Treatment Period|Withdrawal by Subject|9|||
143095411|NCT05573464|515890171|FG001|52-week Treatment Period|Withdrawal by Subject|5|||
143095412|NCT05573464|515890170|FG000|52-week Treatment Period|Protocol Violation|1|||
143095413|NCT05573464|515890171|FG001|52-week Treatment Period|Protocol Violation|1|||
143095414|NCT05573464|515890170|FG000|52-week Treatment Period|Physician Decision|2|||
143095415|NCT05573464|515890171|FG001|52-week Treatment Period|Physician Decision|2|||
143095416|NCT05573464|515890170|FG000|52-week Treatment Period|Lost to Follow-up|1|||
143095417|NCT05573464|515890171|FG001|52-week Treatment Period|Lost to Follow-up|1|||
143095418|NCT05573464|515890170|FG000|52-week Treatment Period|Adverse Event|11|||
143095419|NCT05573464|515890171|FG001|52-week Treatment Period|Adverse Event|8|||
143095420|NCT05573464|515890170|FG000|52-week Treatment Period|Death|1|||
143095421|NCT05573464|515890171|FG001|52-week Treatment Period|Death|1|||
143095422|NCT04632927|515890172|FG000|Overall Study|Adverse Event|0|||
143095423|NCT04632927|515890173|FG001|Overall Study|Adverse Event|1|||
143095424|NCT04632927|515890172|FG000|Overall Study|Lack of Efficacy|0|||
143095425|NCT04632927|515890173|FG001|Overall Study|Lack of Efficacy|4|||
143095426|NCT04632927|515890172|FG000|Overall Study|Loss of efficacy|0|||
143095427|NCT04632927|515890173|FG001|Overall Study|Loss of efficacy|1|||
143095428|NCT04632927|515890172|FG000|Overall Study|Non-compliance with study drug|0|||
143095429|NCT04632927|515890173|FG001|Overall Study|Non-compliance with study drug|1|||
143095430|NCT04632927|515890172|FG000|Overall Study|Physician Decision|0|||
143095431|NCT04632927|515890173|FG001|Overall Study|Physician Decision|1|||
143095432|NCT04632927|515890172|FG000|Overall Study|Subject decision|0|||
143095433|NCT04632927|515890173|FG001|Overall Study|Subject decision|1|||
143095434|NCT04632927|515890172|FG000|Overall Study|Withdrawal by Subject|0|||
143095435|NCT04632927|515890173|FG001|Overall Study|Withdrawal by Subject|1|||
143095436|NCT03971071|515890180|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
143095437|NCT03971071|515890181|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
143095438|NCT03971071|515890182|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
143095439|NCT03971071|515890183|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
143095440|NCT03971071|515890184|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
143095441|NCT03971071|515890180|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
143095442|NCT03971071|515890181|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
143095443|NCT03971071|515890182|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
143095444|NCT03971071|515890183|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
143176867|NCT01882465|516196224|FG003|Period 2|Protocol Violation|0|||
143095445|NCT03971071|515890184|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
143095446|NCT03971071|515890180|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
143095447|NCT03971071|515890181|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
143095448|NCT03971071|515890182|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
143095449|NCT03971071|515890183|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
143095450|NCT03971071|515890184|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
143095451|NCT03971071|515890180|FG000|Open-label Treatment Period|Sponsor decision|0|||
143095452|NCT03971071|515890181|FG001|Open-label Treatment Period|Sponsor decision|0|||
143095453|NCT03971071|515890182|FG002|Open-label Treatment Period|Sponsor decision|0|||
143095454|NCT03971071|515890183|FG003|Open-label Treatment Period|Sponsor decision|0|||
143095455|NCT03971071|515890184|FG004|Open-label Treatment Period|Sponsor decision|1|||
143095456|NCT03971071|515890180|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
143095457|NCT03971071|515890181|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
143095458|NCT03971071|515890182|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
143095459|NCT03971071|515890183|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
143095460|NCT03971071|515890184|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
143095461|NCT03971071|515890180|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
143095462|NCT03971071|515890181|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
143095463|NCT03971071|515890182|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
143251290|NCT00865280|516473013|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
143251291|NCT00865280|516473014|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
143251292|NCT00865280|516473013|FG000|Overall Study|Exclusion Condition|1|||
143251293|NCT00865280|516473014|FG001|Overall Study|Exclusion Condition|0|||
143251294|NCT00865280|516473013|FG000|Overall Study|Adverse Event|0|||
143251295|NCT00865280|516473014|FG001|Overall Study|Adverse Event|1|||
143251296|NCT04534686|516473017|FG000|Baseline Measurement|Lost to Follow-up|4|||
143251297|NCT04534686|516473018|FG001|Baseline Measurement|Lost to Follow-up|6|||
143251298|NCT04534686|516473017|FG000|Baseline Measurement|Withdrawal by Subject|3|||
143251299|NCT04534686|516473018|FG001|Baseline Measurement|Withdrawal by Subject|1|||
143251300|NCT04534686|516473017|FG000|Intervention|Withdrawal by Subject|2|||
143251301|NCT04534686|516473018|FG001|Intervention|Withdrawal by Subject|2|||
143251302|NCT00146848|516473019|FG000|Pre-randomization|Death|19|||
143251303|NCT00146848|516473020|FG001|Pre-randomization|Death|0|||
143251304|NCT00146848|516473021|FG002|Pre-randomization|Death|0|||
143251305|NCT00146848|516473019|FG000|Pre-randomization|Lost to Follow-up|70|||
143251306|NCT00146848|516473020|FG001|Pre-randomization|Lost to Follow-up|0|||
143251307|NCT00146848|516473021|FG002|Pre-randomization|Lost to Follow-up|0|||
143251308|NCT00146848|516473019|FG000|Pre-randomization|Physician Decision|8|||
143251309|NCT00146848|516473020|FG001|Pre-randomization|Physician Decision|0|||
143251310|NCT00146848|516473021|FG002|Pre-randomization|Physician Decision|0|||
143251311|NCT00146848|516473019|FG000|Pre-randomization|Protocol Violation|172|||
143251312|NCT00146848|516473020|FG001|Pre-randomization|Protocol Violation|0|||
143251313|NCT00146848|516473021|FG002|Pre-randomization|Protocol Violation|0|||
143251314|NCT00146848|516473019|FG000|Pre-randomization|Withdrawal by Subject|40|||
143251315|NCT00146848|516473020|FG001|Pre-randomization|Withdrawal by Subject|0|||
143251316|NCT00146848|516473021|FG002|Pre-randomization|Withdrawal by Subject|0|||
143251317|NCT00146848|516473019|FG000|Post-randomization|Lost to Follow-up|12|||
143251318|NCT00146848|516473020|FG001|Post-randomization|Lost to Follow-up|15|||
143251319|NCT00146848|516473021|FG002|Post-randomization|Lost to Follow-up|12|||
143095464|NCT03971071|515890183|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
143095465|NCT03971071|515890184|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
143095466|NCT03334435|515890189|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
143095467|NCT03334435|515890190|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
143095468|NCT03334435|515890191|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
143095469|NCT03334435|515890192|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
143367504|NCT01190150|516889374|FG000|Washout|Withdrawal by Subject|0|||
143095470|NCT03334435|515890193|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
143095471|NCT03334435|515890194|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
143095472|NCT03334435|515890195|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
143095473|NCT03334435|515890196|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
143095474|NCT03334435|515890197|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
143095475|NCT03334435|515890198|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
143095476|NCT03334435|515890199|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
143095477|NCT03334435|515890200|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
143095478|NCT03334435|515890201|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
143095479|NCT03334435|515890202|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
143095480|NCT03334435|515890203|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
143095481|NCT03334435|515890189|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
143095482|NCT03334435|515890190|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
143095483|NCT03334435|515890191|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
143095484|NCT03334435|515890192|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
143095485|NCT03334435|515890193|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
143095486|NCT03334435|515890194|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
143095487|NCT03334435|515890195|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
143095488|NCT03334435|515890196|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
143095489|NCT03334435|515890197|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
143095490|NCT03334435|515890198|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
143095491|NCT03334435|515890199|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
143095492|NCT03334435|515890200|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
143095493|NCT03334435|515890201|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
143095494|NCT03334435|515890202|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
143095495|NCT03334435|515890203|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
143095496|NCT03334435|515890189|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
143095497|NCT03334435|515890190|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
143095498|NCT03334435|515890191|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
143095499|NCT03334435|515890192|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
143095500|NCT03334435|515890193|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
143095501|NCT03334435|515890194|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
143095502|NCT03334435|515890195|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
143095503|NCT03334435|515890196|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
143095504|NCT03334435|515890197|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
143095505|NCT03334435|515890198|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
143095506|NCT03334435|515890199|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
143095507|NCT03334435|515890200|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
143095508|NCT03334435|515890201|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
143095509|NCT03334435|515890202|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
143095510|NCT03334435|515890203|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
143095511|NCT03334435|515890189|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
143095512|NCT03334435|515890190|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
143095513|NCT03334435|515890191|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
143095514|NCT03334435|515890192|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
143095515|NCT03334435|515890193|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
143095516|NCT03334435|515890194|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
143251320|NCT00146848|516473019|FG000|Post-randomization|Withdrawn|26|||
143251321|NCT00146848|516473020|FG001|Post-randomization|Withdrawn|32|||
143251322|NCT00146848|516473021|FG002|Post-randomization|Withdrawn|27|||
143251323|NCT00246740|516473022|FG000|Initial Enrollment|Death|1|||
143251324|NCT00246740|516473023|FG001|Initial Enrollment|Death|0|||
143251325|NCT00246740|516473022|FG000|Initial Enrollment|Additional surgery scheduled|0|||
143095517|NCT03334435|515890195|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
143095518|NCT03334435|515890196|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
143095519|NCT03334435|515890197|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
143251326|NCT00246740|516473023|FG001|Initial Enrollment|Additional surgery scheduled|2|||
143095520|NCT03334435|515890198|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
143095521|NCT03334435|515890199|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
143095522|NCT03334435|515890200|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
143095523|NCT03334435|515890201|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
143095524|NCT03334435|515890202|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
143095525|NCT03334435|515890203|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
143095526|NCT03334435|515890189|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
143095527|NCT03334435|515890190|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
143095528|NCT03334435|515890191|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
143095529|NCT03334435|515890192|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
143095530|NCT03334435|515890193|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
143095531|NCT03334435|515890194|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
143095532|NCT03334435|515890195|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
143095533|NCT03334435|515890196|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
143095534|NCT03334435|515890197|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
143095535|NCT03334435|515890198|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
143095536|NCT03334435|515890199|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
143095537|NCT03334435|515890200|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
143095538|NCT03334435|515890201|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
143095539|NCT03334435|515890202|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
143095540|NCT03334435|515890203|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
143095541|NCT03334435|515890189|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
143095542|NCT03334435|515890190|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
143095543|NCT03334435|515890191|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
143095544|NCT03334435|515890192|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
143095545|NCT03334435|515890193|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
143095546|NCT03334435|515890194|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
143095547|NCT03334435|515890195|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
143095548|NCT03334435|515890196|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
143095549|NCT03334435|515890197|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
143095550|NCT03334435|515890198|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
143095551|NCT03334435|515890199|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
143095552|NCT03334435|515890200|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
143176868|NCT01882465|516196225|FG004|Period 2|Protocol Violation|1|||
143251327|NCT00246740|516473022|FG000|Initial Enrollment|Surgery schedule change|4|||
143251328|NCT00246740|516473023|FG001|Initial Enrollment|Surgery schedule change|4|||
143251329|NCT00246740|516473022|FG000|Initial Enrollment|Other|1|||
143251330|NCT00246740|516473023|FG001|Initial Enrollment|Other|2|||
143251331|NCT00101452|516473024|FG000|Overall Study|Adverse Event|2|||
143251332|NCT00101452|516473025|FG001|Overall Study|Adverse Event|0|||
143251333|NCT00101452|516473026|FG002|Overall Study|Adverse Event|1|||
143251334|NCT00101452|516473024|FG000|Overall Study|Lost to Follow-up|13|||
143251335|NCT00101452|516473025|FG001|Overall Study|Lost to Follow-up|8|||
143251336|NCT00101452|516473026|FG002|Overall Study|Lost to Follow-up|14|||
143251337|NCT00101452|516473024|FG000|Overall Study|Withdrawal by Subject|10|||
143251338|NCT00101452|516473025|FG001|Overall Study|Withdrawal by Subject|14|||
143095553|NCT03334435|515890201|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
143095554|NCT03334435|515890202|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
143095555|NCT03334435|515890203|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
143095556|NCT03334435|515890189|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
143095557|NCT03334435|515890190|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
143095558|NCT03334435|515890191|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
143095559|NCT03334435|515890192|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
143095560|NCT03334435|515890193|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
143251339|NCT00101452|516473026|FG002|Overall Study|Withdrawal by Subject|9|||
143251340|NCT00101452|516473024|FG000|Overall Study|Baseline Fail|2|||
143251341|NCT00101452|516473025|FG001|Overall Study|Baseline Fail|1|||
143251342|NCT00101452|516473026|FG002|Overall Study|Baseline Fail|2|||
143251343|NCT00101452|516473024|FG000|Overall Study|Physician Decision|0|||
143251344|NCT00101452|516473025|FG001|Overall Study|Physician Decision|3|||
143095561|NCT03334435|515890194|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
143095562|NCT03334435|515890195|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
143095563|NCT03334435|515890196|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
143095564|NCT03334435|515890197|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
143095565|NCT03334435|515890198|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
143367505|NCT01190150|516889375|FG001|Washout|Withdrawal by Subject|1|||
143367506|NCT01190150|516889374|FG000|Washout|Difficulty in adherence|0|||
143367507|NCT01190150|516889375|FG001|Washout|Difficulty in adherence|1|||
143095566|NCT03334435|515890199|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
143095567|NCT03334435|515890200|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
143095568|NCT03334435|515890201|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
143095569|NCT03334435|515890202|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
143095570|NCT03334435|515890203|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
143095571|NCT03334435|515890189|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
143095572|NCT03334435|515890190|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
143095573|NCT03334435|515890191|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
143095574|NCT03334435|515890192|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
143095575|NCT03334435|515890193|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
143095576|NCT03334435|515890194|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
143367508|NCT02750709|516889376|FG000|Treatment Period 1|Adverse Event|0|||
143095577|NCT03334435|515890195|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
143095578|NCT03334435|515890196|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
143095579|NCT03334435|515890197|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
143251345|NCT00101452|516473026|FG002|Overall Study|Physician Decision|2|||
143251346|NCT00101452|516473024|FG000|Overall Study|Protocol Violation|2|||
143367509|NCT02750709|516889377|FG001|Treatment Period 1|Adverse Event|0|||
143367510|NCT02750709|516889378|FG002|Treatment Period 1|Adverse Event|0|||
143095580|NCT03334435|515890198|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
143095581|NCT03334435|515890199|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
143095582|NCT03334435|515890200|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
143095583|NCT03334435|515890201|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
143095584|NCT03334435|515890202|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
143095585|NCT03334435|515890203|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
143095586|NCT03334435|515890189|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
143095587|NCT03334435|515890190|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
143095588|NCT03334435|515890191|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
143095589|NCT03334435|515890192|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
143251347|NCT00101452|516473025|FG001|Overall Study|Protocol Violation|1|||
143251348|NCT00101452|516473026|FG002|Overall Study|Protocol Violation|3|||
143251349|NCT00101452|516473024|FG000|Overall Study|Other|15|||
143251350|NCT00101452|516473025|FG001|Overall Study|Other|16|||
143251351|NCT00101452|516473026|FG002|Overall Study|Other|12|||
143251352|NCT01536392|516473027|FG000|Overall Study|Adverse Event|2|||
143251353|NCT01536392|516473028|FG001|Overall Study|Adverse Event|2|||
143251354|NCT01536392|516473027|FG000|Overall Study|Physician Decision|2|||
143251355|NCT01536392|516473028|FG001|Overall Study|Physician Decision|3|||
143251356|NCT01536392|516473027|FG000|Overall Study|Withdrawal by Subject|3|||
143251357|NCT01536392|516473028|FG001|Overall Study|Withdrawal by Subject|6|||
143251358|NCT01536392|516473027|FG000|Overall Study|Non Compliance|3|||
143251359|NCT01536392|516473028|FG001|Overall Study|Non Compliance|4|||
143251360|NCT01536392|516473027|FG000|Overall Study|Completed therapy early|3|||
143251361|NCT01536392|516473028|FG001|Overall Study|Completed therapy early|0|||
143251362|NCT03753789|516473029|FG000|Overall Study|Withdrawal by Subject|2|||
143251363|NCT02537015|516473039|FG000|Overall Study|Adverse Event|3|||
143251364|NCT02537015|516473039|FG000|Overall Study|Withdrawal by Subject|2|||
143251365|NCT02537015|516473039|FG000|Overall Study|Other Miscellaneous Reasons|1|||
143251366|NCT03425253|516473042|FG000|Overall Study|Adverse Event|2|||
143251367|NCT03425253|516473042|FG000|Overall Study|Lost to Follow-up|3|||
143095590|NCT03334435|515890193|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
143095591|NCT03334435|515890194|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
143095592|NCT03334435|515890195|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
143095593|NCT03334435|515890196|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
143095594|NCT03334435|515890197|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
143095595|NCT03334435|515890198|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
143095596|NCT03334435|515890199|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
143176869|NCT01882465|516196226|FG005|Period 2|Protocol Violation|0|||
143176870|NCT01882465|516196227|FG006|Period 2|Protocol Violation|0|||
143176871|NCT01464879|516196228|FG000|Overall Study|Physician Decision|1|||
143176872|NCT01464879|516196228|FG000|Overall Study|Non-compliance|1|||
143176873|NCT00244621|516196229|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
143176874|NCT00244621|516196230|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
143176875|NCT00244621|516196231|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
143176876|NCT00244621|516196229|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
143176877|NCT00244621|516196230|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
143176878|NCT00244621|516196231|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
143176879|NCT00244621|516196229|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
143176880|NCT00244621|516196230|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
143176881|NCT00244621|516196231|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
143176882|NCT00244621|516196229|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
143176883|NCT00244621|516196230|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
143176884|NCT00244621|516196231|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
143176885|NCT00244621|516196229|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
143176886|NCT00244621|516196230|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
143176887|NCT00244621|516196231|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
143176888|NCT00244621|516196229|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
143176889|NCT00244621|516196230|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
143176890|NCT00244621|516196231|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
143176891|NCT00244621|516196229|FG000|Open-label Treatment Period|Adverse Event|0|||
143176892|NCT00244621|516196230|FG001|Open-label Treatment Period|Adverse Event|0|||
143176893|NCT00244621|516196231|FG002|Open-label Treatment Period|Adverse Event|1|||
143176894|NCT00244621|516196229|FG000|Open-label Treatment Period|Moved abroad|0|||
143176895|NCT00244621|516196230|FG001|Open-label Treatment Period|Moved abroad|0|||
143176896|NCT00244621|516196231|FG002|Open-label Treatment Period|Moved abroad|1|||
143176897|NCT01193101|516196232|FG000|Overall Study|Adverse Event|0|||
143176898|NCT01193101|516196233|FG001|Overall Study|Adverse Event|1|||
143176899|NCT01193101|516196234|FG002|Overall Study|Adverse Event|1|||
143176900|NCT01193101|516196235|FG003|Overall Study|Adverse Event|3|||
143176901|NCT01193101|516196232|FG000|Overall Study|Lack of Efficacy|3|||
143176902|NCT01193101|516196233|FG001|Overall Study|Lack of Efficacy|1|||
143176903|NCT01193101|516196234|FG002|Overall Study|Lack of Efficacy|0|||
143176904|NCT01193101|516196235|FG003|Overall Study|Lack of Efficacy|8|||
143251368|NCT03425253|516473042|FG000|Overall Study|Withdrew Consent|6|||
143251369|NCT03425253|516473042|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
143251370|NCT00617669|516474174|FG000|Overall Study|Withdrawal by Subject|71|||
143251371|NCT00617669|516474175|FG001|Overall Study|Withdrawal by Subject|77|||
143251372|NCT00617669|516474174|FG000|Overall Study|Lost to Follow-up|3|||
143251373|NCT00617669|516474175|FG001|Overall Study|Lost to Follow-up|2|||
143251374|NCT00617669|516474174|FG000|Overall Study|Adverse Event|87|||
143251375|NCT00617669|516474175|FG001|Overall Study|Adverse Event|76|||
143251376|NCT00617669|516474174|FG000|Overall Study|Protocol Violation|2|||
143251377|NCT00617669|516474175|FG001|Overall Study|Protocol Violation|3|||
143251378|NCT00617669|516474174|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
143251379|NCT00617669|516474175|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
143251380|NCT00617669|516474174|FG000|Overall Study|Patients randomized but not treated|2|||
143251381|NCT00617669|516474175|FG001|Overall Study|Patients randomized but not treated|3|||
143251382|NCT03680742|516474176|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
143251383|NCT02894502|516474177|FG000|Baseline|Withdrawal by Subject|24|||
143251384|NCT02894502|516474178|FG001|Baseline|Withdrawal by Subject|31|||
143251385|NCT02894502|516474179|FG002|Baseline|Withdrawal by Subject|36|||
143251386|NCT02894502|516474177|FG000|Baseline|Death|3|||
143251387|NCT02894502|516474178|FG001|Baseline|Death|1|||
143251388|NCT02894502|516474179|FG002|Baseline|Death|9|||
143251389|NCT02894502|516474177|FG000|First Follow up|Withdrawal by Subject|32|||
143095597|NCT03334435|515890200|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
143095598|NCT03334435|515890201|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
143095599|NCT03334435|515890202|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
143251390|NCT02894502|516474178|FG001|First Follow up|Withdrawal by Subject|29|||
143251391|NCT02894502|516474179|FG002|First Follow up|Withdrawal by Subject|37|||
143095600|NCT03334435|515890203|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
143095601|NCT03334435|515890189|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
143251392|NCT02894502|516474177|FG000|First Follow up|Death|2|||
143251393|NCT02894502|516474178|FG001|First Follow up|Death|2|||
143095602|NCT03334435|515890190|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
143095603|NCT03334435|515890191|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
143095604|NCT03334435|515890192|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
143095605|NCT03334435|515890193|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
143095606|NCT03334435|515890194|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
143095607|NCT03334435|515890195|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
143095608|NCT03334435|515890196|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
143095609|NCT03334435|515890197|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
143095610|NCT03334435|515890198|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
143095611|NCT03334435|515890199|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
143095612|NCT03334435|515890200|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
143095613|NCT03334435|515890201|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
143095614|NCT03334435|515890202|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
143095615|NCT03334435|515890203|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
143095616|NCT03334435|515890189|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
143251394|NCT02894502|516474179|FG002|First Follow up|Death|3|||
143251395|NCT02894502|516474177|FG000|Second Follow up|Withdrawal by Subject|13|||
143251396|NCT02894502|516474178|FG001|Second Follow up|Withdrawal by Subject|15|||
143251397|NCT02894502|516474179|FG002|Second Follow up|Withdrawal by Subject|13|||
143251398|NCT02894502|516474177|FG000|Second Follow up|Death|2|||
143251399|NCT02894502|516474178|FG001|Second Follow up|Death|3|||
143251400|NCT02894502|516474179|FG002|Second Follow up|Death|1|||
143251401|NCT02894502|516474177|FG000|Third Follow up|Withdrawal by Subject|5|||
143251402|NCT02894502|516474178|FG001|Third Follow up|Withdrawal by Subject|6|||
143251403|NCT02894502|516474179|FG002|Third Follow up|Withdrawal by Subject|3|||
143251404|NCT02894502|516474177|FG000|Third Follow up|Death|1|||
143251405|NCT02894502|516474178|FG001|Third Follow up|Death|1|||
143251406|NCT02894502|516474179|FG002|Third Follow up|Death|0|||
143095617|NCT03334435|515890190|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
143095618|NCT03334435|515890191|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
143095619|NCT03334435|515890192|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
143095620|NCT03334435|515890193|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
143095621|NCT03334435|515890194|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
143251407|NCT04343235|516474180|FG000|Overall Study|Lost to Follow-up|3|||
143251408|NCT04343235|516474181|FG001|Overall Study|Lost to Follow-up|2|||
143251409|NCT01763996|516474182|FG000|Treatment Period 2|Adverse Event|0|||
143251410|NCT01763996|516474183|FG001|Treatment Period 2|Adverse Event|1|||
143251411|NCT01788215|516474188|FG000|Overall Study|Withdrawal by Subject|0|||
143251412|NCT01788215|516474189|FG001|Overall Study|Withdrawal by Subject|1|||
143251413|NCT01788215|516474188|FG000|Overall Study|Lost to Follow-up|2|||
143251414|NCT01788215|516474189|FG001|Overall Study|Lost to Follow-up|0|||
143251415|NCT02365480|516474192|FG000|Overall Study|Withdrawal by Subject|2|||
143251416|NCT02365480|516474193|FG001|Overall Study|Withdrawal by Subject|0|||
143251417|NCT03091348|516474194|FG000|Overall Study|Lost to Follow-up|2|||
143251418|NCT03091348|516474195|FG001|Overall Study|Lost to Follow-up|1|||
143251419|NCT00706342|516474196|FG000|Overall Study|Adverse Event|3|||
143251420|NCT00706342|516474196|FG000|Overall Study|Not responding to treatment|2|||
143367511|NCT02750709|516889379|FG003|Treatment Period 1|Adverse Event|0|||
143367512|NCT02750709|516889380|FG004|Treatment Period 1|Adverse Event|0|||
143367513|NCT02750709|516889381|FG005|Treatment Period 1|Adverse Event|1|||
143095622|NCT03334435|515890195|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
143251421|NCT00706342|516474196|FG000|Overall Study|Withdrawn due to failure to respond|1|||
143251422|NCT00706342|516474196|FG000|Overall Study|Death|1|||
143367514|NCT03256344|516889382|FG000|Overall Study|Death|6|||
143251423|NCT00706342|516474196|FG000|Overall Study|Withdrew from the study on his own.|1|||
143367515|NCT03256344|516889383|FG001|Overall Study|Death|22|||
143095623|NCT03334435|515890196|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
143095624|NCT03334435|515890197|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
143095625|NCT03334435|515890198|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
143095626|NCT03334435|515890199|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
143095627|NCT03334435|515890200|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
143095628|NCT03334435|515890201|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
143095629|NCT03334435|515890202|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
143095630|NCT03334435|515890203|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
143095631|NCT03334435|515890189|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
143095632|NCT03334435|515890190|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
143095633|NCT03334435|515890191|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
143095634|NCT03334435|515890192|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
143095635|NCT03334435|515890193|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
143095636|NCT03334435|515890194|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
143095637|NCT03334435|515890195|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
143095638|NCT03334435|515890196|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
143095639|NCT03334435|515890197|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
143095640|NCT03334435|515890198|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
143095641|NCT03334435|515890199|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
143095642|NCT03334435|515890200|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
143095643|NCT03334435|515890201|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
143095644|NCT03334435|515890202|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
143095645|NCT03334435|515890203|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
143095646|NCT03334435|515890189|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
143095647|NCT03334435|515890190|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
143095648|NCT03334435|515890191|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
143095649|NCT03334435|515890192|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
143095650|NCT03334435|515890193|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
143095651|NCT03334435|515890194|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
143095652|NCT03334435|515890195|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
143095653|NCT03334435|515890196|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
143095654|NCT03334435|515890197|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
143095655|NCT03334435|515890198|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
143095656|NCT03334435|515890199|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
143095657|NCT03334435|515890200|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
143095658|NCT03334435|515890201|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
143095659|NCT03334435|515890202|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
143095660|NCT03334435|515890203|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
143095661|NCT03334435|515890189|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
143095662|NCT03334435|515890190|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
143095663|NCT03334435|515890191|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
143095664|NCT03334435|515890192|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
143095665|NCT03334435|515890193|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
143095666|NCT03334435|515890194|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
143095667|NCT03334435|515890195|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
143095668|NCT03334435|515890196|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
143095669|NCT03334435|515890197|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
143095670|NCT03334435|515890198|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
143095671|NCT03334435|515890199|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
143095672|NCT03334435|515890200|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
143095673|NCT03334435|515890201|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
143095674|NCT03334435|515890202|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
143095675|NCT03334435|515890203|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
143095676|NCT03334435|515890189|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
143095677|NCT03334435|515890190|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
143095678|NCT03334435|515890191|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
143095679|NCT03334435|515890192|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
143095680|NCT03334435|515890193|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
143095681|NCT03334435|515890194|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
143095682|NCT03334435|515890195|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
143095683|NCT03334435|515890196|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
143095684|NCT03334435|515890197|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
143095685|NCT03334435|515890198|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
143095686|NCT03334435|515890199|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
143095687|NCT03334435|515890200|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
143095688|NCT03334435|515890201|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
143095689|NCT03334435|515890202|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
143095690|NCT03334435|515890203|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
143095691|NCT03334435|515890189|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
143095692|NCT03334435|515890190|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
143095693|NCT03334435|515890191|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
143095694|NCT03334435|515890192|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
143095695|NCT03334435|515890193|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
143095696|NCT03334435|515890194|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
143095697|NCT03334435|515890195|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
143095698|NCT03334435|515890196|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
143095699|NCT03334435|515890197|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
143095700|NCT03334435|515890198|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
143095701|NCT03334435|515890199|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
143095702|NCT03334435|515890200|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
143095703|NCT03334435|515890201|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
143095704|NCT03334435|515890202|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
143095705|NCT03334435|515890203|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
143251424|NCT00706342|516474196|FG000|Overall Study|Investigator discretion|2|||
143251425|NCT00706342|516474196|FG000|Overall Study|Non-responder Week 12|1|||
143251426|NCT00706342|516474196|FG000|Overall Study|Ongoing|6|||
143251427|NCT00706342|516474196|FG000|Overall Study|WIthdrawal of consent|1|||
143251428|NCT03704636|516474198|FG000|Overall Study|Inadequate Venous Flow|3|||
143251429|NCT02969655|516474199|FG000|Overall Study|Withdrawal by Subject|3|||
143251430|NCT02969655|516474200|FG001|Overall Study|Withdrawal by Subject|2|||
143251431|NCT02969655|516474199|FG000|Overall Study|Physician Decision|4|||
143251432|NCT02969655|516474200|FG001|Overall Study|Physician Decision|3|||
143095706|NCT03334435|515890189|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
143095707|NCT03334435|515890190|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
143095708|NCT03334435|515890191|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
143095709|NCT03334435|515890192|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
143095710|NCT03334435|515890193|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
143095711|NCT03334435|515890194|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
143095712|NCT03334435|515890195|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
143095713|NCT03334435|515890196|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
143095714|NCT03334435|515890197|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
143095715|NCT03334435|515890198|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
143095716|NCT03334435|515890199|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
143095717|NCT03334435|515890200|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
143095718|NCT03334435|515890201|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
143095719|NCT03334435|515890202|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
143095720|NCT03334435|515890203|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
143095721|NCT03334435|515890189|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
143095722|NCT03334435|515890190|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
143095723|NCT03334435|515890191|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
143095724|NCT03334435|515890192|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
143095725|NCT03334435|515890193|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
143095726|NCT03334435|515890194|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
143095727|NCT03334435|515890195|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
143095728|NCT03334435|515890196|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
143095729|NCT03334435|515890197|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
143095730|NCT03334435|515890198|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
143095731|NCT03334435|515890199|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
143095732|NCT03334435|515890200|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
143095733|NCT03334435|515890201|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
143095734|NCT03334435|515890202|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
143095735|NCT03334435|515890203|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
143095736|NCT03334435|515890189|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
143095737|NCT03334435|515890190|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
143095738|NCT03334435|515890191|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
143095739|NCT03334435|515890192|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
143095740|NCT03334435|515890193|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
143095741|NCT03334435|515890194|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
143095742|NCT03334435|515890195|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
143095743|NCT03334435|515890196|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
143095744|NCT03334435|515890197|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
143095745|NCT03334435|515890198|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
143095746|NCT03334435|515890199|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
143095747|NCT03334435|515890200|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
143095748|NCT03334435|515890201|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
143095749|NCT03334435|515890202|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
143095750|NCT03334435|515890203|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
143095751|NCT03922321|515890204|FG000|Overall Study|Participant Moved|1|||
143095752|NCT03922321|515890204|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
143095753|NCT01139775|515890207|FG000|Overall Study|Adverse Event|0|||
143095754|NCT01139775|515890208|FG001|Overall Study|Adverse Event|6|||
143095755|NCT01139775|515890209|FG002|Overall Study|Adverse Event|2|||
143095756|NCT01139775|515890207|FG000|Overall Study|Protocol Violation|0|||
143095757|NCT01139775|515890208|FG001|Overall Study|Protocol Violation|5|||
143095758|NCT01139775|515890209|FG002|Overall Study|Protocol Violation|0|||
143095759|NCT01139775|515890207|FG000|Overall Study|Withdrawal by Subject|1|||
143095760|NCT01139775|515890208|FG001|Overall Study|Withdrawal by Subject|0|||
143095761|NCT01139775|515890209|FG002|Overall Study|Withdrawal by Subject|2|||
143095762|NCT01139775|515890207|FG000|Overall Study|Physician Decision|0|||
143095763|NCT01139775|515890208|FG001|Overall Study|Physician Decision|2|||
143095764|NCT01139775|515890209|FG002|Overall Study|Physician Decision|2|||
143095765|NCT01787292|515890213|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
143095766|NCT01787292|515890214|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
143095767|NCT01787292|515890213|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
143095768|NCT01787292|515890214|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
143095769|NCT00468819|515890215|FG000|Overall Study|Withdrawal by Subject|4|||
143095770|NCT00468819|515890216|FG001|Overall Study|Withdrawal by Subject|0|||
143095771|NCT00468819|515890217|FG002|Overall Study|Withdrawal by Subject|1|||
143095772|NCT00468819|515890215|FG000|Overall Study|Lost to Follow-up|0|||
143095773|NCT00468819|515890216|FG001|Overall Study|Lost to Follow-up|0|||
143095774|NCT00468819|515890217|FG002|Overall Study|Lost to Follow-up|1|||
143095775|NCT00468819|515890215|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
143095776|NCT00468819|515890216|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
143095777|NCT00468819|515890217|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
143095778|NCT01565889|515890218|FG000|Part A|Withdrawal by Subject|1|||
143095779|NCT01565889|515890219|FG001|Part A|Withdrawal by Subject|0|||
143095780|NCT01565889|515890220|FG002|Part A|Withdrawal by Subject|0|||
143095781|NCT01565889|515890221|FG003|Part A|Withdrawal by Subject|0|||
143095782|NCT01565889|515890222|FG004|Part A|Withdrawal by Subject|0|||
143095783|NCT01565889|515890223|FG005|Part A|Withdrawal by Subject|0|||
143095784|NCT01565889|515890218|FG000|Part B|Withdrawal by Subject|0|||
143095785|NCT01565889|515890219|FG001|Part B|Withdrawal by Subject|0|||
143095786|NCT01565889|515890220|FG002|Part B|Withdrawal by Subject|0|||
143095787|NCT01565889|515890221|FG003|Part B|Withdrawal by Subject|0|||
143095788|NCT01565889|515890222|FG004|Part B|Withdrawal by Subject|0|||
143095789|NCT01565889|515890223|FG005|Part B|Withdrawal by Subject|1|||
143095790|NCT01565889|515890218|FG000|Part B|Lack of Efficacy|0|||
143095791|NCT01565889|515890219|FG001|Part B|Lack of Efficacy|0|||
143095792|NCT01565889|515890220|FG002|Part B|Lack of Efficacy|0|||
143095793|NCT01565889|515890221|FG003|Part B|Lack of Efficacy|0|||
143095794|NCT01565889|515890222|FG004|Part B|Lack of Efficacy|0|||
143095795|NCT01565889|515890223|FG005|Part B|Lack of Efficacy|2|||
143095796|NCT01565889|515890218|FG000|Part B|Lost to Follow-up|0|||
143095797|NCT01565889|515890219|FG001|Part B|Lost to Follow-up|0|||
143095798|NCT01565889|515890220|FG002|Part B|Lost to Follow-up|0|||
143095799|NCT01565889|515890221|FG003|Part B|Lost to Follow-up|0|||
143095800|NCT01565889|515890222|FG004|Part B|Lost to Follow-up|0|||
143095801|NCT01565889|515890223|FG005|Part B|Lost to Follow-up|1|||
143095802|NCT01326845|515890224|FG000|Overall Study|Administrative Problems|5|||
143095803|NCT01326845|515890225|FG001|Overall Study|Administrative Problems|2|||
143095804|NCT01326845|515890224|FG000|Overall Study|Adverse Event|1|||
143095805|NCT01326845|515890225|FG001|Overall Study|Adverse Event|0|||
143095806|NCT01326845|515890224|FG000|Overall Study|Misisng|1|||
143095807|NCT01326845|515890225|FG001|Overall Study|Misisng|3|||
143095808|NCT02524847|515890226|FG000|Overall Study|Adverse Event|4|||
143095809|NCT02524847|515890226|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
143095810|NCT02524847|515890226|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
143095811|NCT02524847|515890226|FG000|Overall Study|Death|1|||
143095812|NCT02524847|515890226|FG000|Overall Study|Reason not Specified|1|||
143095813|NCT01213966|515890234|FG000|Overall Study|Protocol Violation|1|||
143095814|NCT01213966|515890235|FG001|Overall Study|Protocol Violation|0|||
143095815|NCT01213966|515890236|FG002|Overall Study|Protocol Violation|3|||
143095816|NCT01213966|515890237|FG003|Overall Study|Protocol Violation|1|||
143095817|NCT00503698|515890241|FG000|Overall Study|Protocol Violation|5|||
143095818|NCT00503698|515890242|FG001|Overall Study|Protocol Violation|6|||
143095819|NCT00503698|515890241|FG000|Overall Study|Adverse Event|52|||
143095820|NCT00503698|515890242|FG001|Overall Study|Adverse Event|41|||
143095821|NCT00503698|515890241|FG000|Overall Study|Death|1|||
143095822|NCT00503698|515890242|FG001|Overall Study|Death|0|||
143095823|NCT00503698|515890241|FG000|Overall Study|Lack of Efficacy|3|||
143095824|NCT00503698|515890242|FG001|Overall Study|Lack of Efficacy|4|||
143095825|NCT00503698|515890241|FG000|Overall Study|Trial terminated|216|||
143095826|NCT00503698|515890242|FG001|Overall Study|Trial terminated|253|||
143095827|NCT00503698|515890241|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
143251433|NCT02969655|516474199|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
143095828|NCT00503698|515890242|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
143095829|NCT00503698|515890241|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
143095830|NCT00503698|515890242|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
143095831|NCT00503698|515890241|FG000|Overall Study|Any condition in exclusion criteria|4|||
143095832|NCT00503698|515890242|FG001|Overall Study|Any condition in exclusion criteria|6|||
143095833|NCT00503698|515890241|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
143095834|NCT00503698|515890242|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
143095835|NCT00503698|515890241|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
143095836|NCT00503698|515890242|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
143095837|NCT00503698|515890241|FG000|Overall Study|Critically ill|2|||
143095838|NCT00503698|515890242|FG001|Overall Study|Critically ill|0|||
143095839|NCT00503698|515890241|FG000|Overall Study|Unclassified|48|||
143095840|NCT00503698|515890242|FG001|Overall Study|Unclassified|32|||
143095841|NCT00503698|515890241|FG000|Overall Study|Not exposed to trial drug|11|||
143095842|NCT00503698|515890242|FG001|Overall Study|Not exposed to trial drug|6|||
143095843|NCT00682786|515890243|FG000|Overall Study|Withdrawal by Subject|2|||
143095844|NCT00682786|515890244|FG001|Overall Study|Withdrawal by Subject|2|||
143095845|NCT00682786|515890243|FG000|Overall Study|Did not receive irinotecan|0|||
143095846|NCT00682786|515890244|FG001|Overall Study|Did not receive irinotecan|1|||
143095847|NCT00359424|515890247|FG000|Overall Study|Death|99|||
143095848|NCT00359424|515890248|FG001|Overall Study|Death|58|||
143095849|NCT00359424|515890247|FG000|Overall Study|Lost to Follow-up|19|||
143095850|NCT00359424|515890248|FG001|Overall Study|Lost to Follow-up|7|||
143095851|NCT00359424|515890247|FG000|Overall Study|Withdrawal by Subject|10|||
143095852|NCT00359424|515890248|FG001|Overall Study|Withdrawal by Subject|2|||
143095853|NCT00359424|515890247|FG000|Overall Study|follow up not conducted|2|||
143095854|NCT00359424|515890248|FG001|Overall Study|follow up not conducted|0|||
143095855|NCT02259010|515890251|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
143095856|NCT04762160|515890252|FG000|Overall Study|Study terminated early due to business reasons|5|||
143095857|NCT01591096|515890254|FG000|Overall Study|Adverse Event|1|||
143095858|NCT04146012|515890255|FG000|Overall Study|Study Terminated|30|||
143095859|NCT04146012|515890256|FG001|Overall Study|Study Terminated|15|||
143095860|NCT01546025|515890257|FG000|Overall Study|Lost to Follow-up|0|||
143095861|NCT01546025|515890258|FG001|Overall Study|Lost to Follow-up|1|||
143095862|NCT05966584|515890262|FG000|Overall Study|Lost to Follow-up|1|||
143095863|NCT05142722|515891569|FG000|Overall Study|Lost to Follow-up|16|||
143095864|NCT05142722|515891570|FG001|Overall Study|Lost to Follow-up|38|||
143095865|NCT05142722|515891569|FG000|Overall Study|Withdrawal by Subject|20|||
143095866|NCT05142722|515891570|FG001|Overall Study|Withdrawal by Subject|27|||
143095867|NCT05142722|515891569|FG000|Overall Study|Death|11|||
143095868|NCT05142722|515891570|FG001|Overall Study|Death|17|||
143095869|NCT05142722|515891569|FG000|Overall Study|Physician Decision|0|||
143095870|NCT05142722|515891570|FG001|Overall Study|Physician Decision|1|||
143095871|NCT05142722|515891569|FG000|Overall Study|Participant Moved Away|0|||
143095872|NCT05142722|515891570|FG001|Overall Study|Participant Moved Away|2|||
143095873|NCT05142722|515891569|FG000|Overall Study|Adverse Event|2|||
143095874|NCT05142722|515891570|FG001|Overall Study|Adverse Event|1|||
143095875|NCT02141438|515891571|FG000|Overall Study|Death|1308|||
143095876|NCT02141438|515891571|FG000|Overall Study|Lost to Follow-up|84|||
143095877|NCT02141438|515891571|FG000|Overall Study|Withdrawal by Subject|52|||
143095878|NCT02141438|515891571|FG000|Overall Study|Physician Decision|1|||
143095879|NCT02141438|515891571|FG000|Overall Study|Patients without documented end of observation due to premature site closure|5|||
143095880|NCT03896503|515891574|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
143095881|NCT03896503|515891575|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
143095882|NCT03896503|515891576|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
143095883|NCT03896503|515891577|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
143095884|NCT03896503|515891578|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
143095885|NCT03896503|515891579|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
143095886|NCT03896503|515891580|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
143095887|NCT03896503|515891581|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
143095888|NCT03896503|515891574|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
143095889|NCT03896503|515891575|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
143095890|NCT03896503|515891576|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
143095891|NCT03896503|515891577|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
143095892|NCT03896503|515891578|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
143095893|NCT03896503|515891579|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
143095894|NCT03896503|515891580|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
143095895|NCT03896503|515891581|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
143095896|NCT03896503|515891574|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
143095897|NCT03896503|515891575|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
143095898|NCT03896503|515891576|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
143095899|NCT03896503|515891577|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
143095900|NCT03896503|515891578|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
143095901|NCT03896503|515891579|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
143095902|NCT03896503|515891580|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
143095903|NCT03896503|515891581|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
143095904|NCT03896503|515891574|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
143095905|NCT03896503|515891575|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
143095906|NCT03896503|515891576|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
143095907|NCT03896503|515891577|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
143095908|NCT03896503|515891578|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
143095909|NCT03896503|515891579|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
143095910|NCT03896503|515891580|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
143095911|NCT03896503|515891581|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
143095912|NCT03896503|515891574|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
143095913|NCT03896503|515891575|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
143095914|NCT03896503|515891576|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
143095915|NCT03896503|515891577|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
143095916|NCT03896503|515891578|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
143095917|NCT03896503|515891579|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
143095918|NCT03896503|515891580|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
143095919|NCT03896503|515891581|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
143095920|NCT03896503|515891574|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
143095921|NCT03896503|515891575|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
143095922|NCT03896503|515891576|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
143095923|NCT03896503|515891577|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
143095924|NCT03896503|515891578|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
143095925|NCT03896503|515891579|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
143095926|NCT03896503|515891580|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
143095927|NCT03896503|515891581|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
143095928|NCT03896503|515891574|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
143095929|NCT03896503|515891575|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
143095930|NCT03896503|515891576|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
143095931|NCT03896503|515891577|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
143095932|NCT03896503|515891578|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
143095933|NCT03896503|515891579|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
143095934|NCT03896503|515891580|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
143095935|NCT03896503|515891581|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
143095936|NCT03896503|515891574|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
143095937|NCT03896503|515891575|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
143095938|NCT03896503|515891576|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
143095939|NCT03896503|515891577|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
143095940|NCT03896503|515891578|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
143095941|NCT03896503|515891579|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
143095942|NCT03896503|515891580|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
143095943|NCT03896503|515891581|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
143095944|NCT03896503|515891574|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
143095945|NCT03896503|515891575|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
143095946|NCT03896503|515891576|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
143095947|NCT03896503|515891577|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
143095948|NCT03896503|515891578|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
143176905|NCT01193101|516196232|FG000|Overall Study|Withdrawal by Subject|2|||
143176906|NCT01193101|516196233|FG001|Overall Study|Withdrawal by Subject|4|||
143176907|NCT01193101|516196234|FG002|Overall Study|Withdrawal by Subject|1|||
143176908|NCT01193101|516196235|FG003|Overall Study|Withdrawal by Subject|1|||
143176909|NCT01193101|516196232|FG000|Overall Study|Administrative problems|0|||
143176910|NCT01193101|516196233|FG001|Overall Study|Administrative problems|0|||
143176911|NCT01193101|516196234|FG002|Overall Study|Administrative problems|1|||
143176912|NCT01193101|516196235|FG003|Overall Study|Administrative problems|0|||
143176913|NCT01193101|516196232|FG000|Overall Study|Abnormal test procedure results|0|||
143176914|NCT01193101|516196233|FG001|Overall Study|Abnormal test procedure results|1|||
143176915|NCT01193101|516196234|FG002|Overall Study|Abnormal test procedure results|0|||
143176916|NCT01193101|516196235|FG003|Overall Study|Abnormal test procedure results|0|||
143095949|NCT03896503|515891579|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
143095950|NCT03896503|515891580|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
143095951|NCT03896503|515891581|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
143095952|NCT03896503|515891574|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
143367516|NCT03256344|516889382|FG000|Overall Study|Withdrawal by Subject|3|||
143367517|NCT03256344|516889383|FG001|Overall Study|Withdrawal by Subject|3|||
143367518|NCT03256344|516889382|FG000|Overall Study|Sponsor Decision|1|||
143095953|NCT03896503|515891575|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
143095954|NCT03896503|515891576|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
143095955|NCT03896503|515891577|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
143095956|NCT03896503|515891578|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
143095957|NCT03896503|515891579|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
143095958|NCT03896503|515891580|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
143095959|NCT03896503|515891581|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
143095960|NCT03896503|515891574|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
143095961|NCT03896503|515891575|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
143095962|NCT03896503|515891576|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
143095963|NCT03896503|515891577|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
143095964|NCT03896503|515891578|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
143095965|NCT03896503|515891579|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
143095966|NCT03896503|515891580|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
143095967|NCT03896503|515891581|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
143095968|NCT04846569|515891582|FG000|Overall Study|Withdrawal by Subject|3|||
143095969|NCT04846569|515891583|FG001|Overall Study|Withdrawal by Subject|1|||
143095970|NCT01894841|515891589|FG000|Overall Study|Withdrawal by Subject|9|||
143095971|NCT01894841|515891590|FG001|Overall Study|Withdrawal by Subject|4|||
143095972|NCT01894841|515891589|FG000|Overall Study|Withdrawn by investigator|2|||
143095973|NCT01894841|515891590|FG001|Overall Study|Withdrawn by investigator|2|||
143095974|NCT01894841|515891589|FG000|Overall Study|Lost to Follow-up|7|||
143095975|NCT01894841|515891590|FG001|Overall Study|Lost to Follow-up|3|||
143095976|NCT04227197|515891594|FG000|Randomization|Protocol Violation|1|||
143095977|NCT04227197|515891595|FG001|Randomization|Protocol Violation|0|||
143095978|NCT04227197|515891594|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
143095979|NCT04227197|515891595|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
143095980|NCT04227197|515891594|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
143095981|NCT04227197|515891595|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
143095982|NCT04227197|515891594|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
143095983|NCT04227197|515891595|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
143095984|NCT04227197|515891594|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
143095985|NCT04227197|515891595|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
143095986|NCT04227197|515891594|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
143095987|NCT04227197|515891595|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
143095988|NCT04227197|515891594|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
143095989|NCT04227197|515891595|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
143095990|NCT00708552|515891600|FG000|Overall Study|Adverse Event|10|||
143095991|NCT00708552|515891601|FG001|Overall Study|Adverse Event|3|||
143095992|NCT00708552|515891602|FG002|Overall Study|Adverse Event|4|||
143095993|NCT00708552|515891603|FG003|Overall Study|Adverse Event|6|||
143095994|NCT00708552|515891600|FG000|Overall Study|Lack of Efficacy|0|||
143367519|NCT03256344|516889383|FG001|Overall Study|Sponsor Decision|0|||
143367520|NCT00580801|516889392|FG000|Overall Study|Physician Decision|1|||
143367521|NCT00580801|516889393|FG001|Overall Study|Physician Decision|0|||
143367522|NCT00580801|516889394|FG002|Overall Study|Physician Decision|0|||
143367523|NCT00580801|516889392|FG000|Overall Study|Adverse Event|2|||
143367524|NCT00580801|516889393|FG001|Overall Study|Adverse Event|0|||
143367525|NCT00580801|516889394|FG002|Overall Study|Adverse Event|0|||
143367526|NCT00580801|516889392|FG000|Overall Study|Lost to Follow-up|2|||
143367527|NCT00580801|516889393|FG001|Overall Study|Lost to Follow-up|0|||
143367528|NCT00580801|516889394|FG002|Overall Study|Lost to Follow-up|0|||
143095995|NCT00708552|515891601|FG001|Overall Study|Lack of Efficacy|4|||
143367529|NCT00580801|516889392|FG000|Overall Study|Reached a virologic endpoint|0|||
143367530|NCT00580801|516889393|FG001|Overall Study|Reached a virologic endpoint|1|||
143367531|NCT00580801|516889394|FG002|Overall Study|Reached a virologic endpoint|2|||
143095996|NCT00708552|515891602|FG002|Overall Study|Lack of Efficacy|1|||
143095997|NCT00708552|515891603|FG003|Overall Study|Lack of Efficacy|0|||
143095998|NCT00708552|515891600|FG000|Overall Study|Protocol Violation|0|||
143367532|NCT00580801|516889392|FG000|Overall Study|Participant non-compliant|0|||
143367533|NCT00580801|516889393|FG001|Overall Study|Participant non-compliant|0|||
143367534|NCT00580801|516889394|FG002|Overall Study|Participant non-compliant|1|||
143095999|NCT00708552|515891601|FG001|Overall Study|Protocol Violation|0|||
143096000|NCT00708552|515891602|FG002|Overall Study|Protocol Violation|2|||
143096001|NCT00708552|515891603|FG003|Overall Study|Protocol Violation|4|||
143096002|NCT00708552|515891600|FG000|Overall Study|Lost to Follow-up|4|||
143096003|NCT00708552|515891601|FG001|Overall Study|Lost to Follow-up|2|||
143096004|NCT00708552|515891602|FG002|Overall Study|Lost to Follow-up|0|||
143096005|NCT00708552|515891603|FG003|Overall Study|Lost to Follow-up|1|||
143096006|NCT00708552|515891600|FG000|Overall Study|Physician Decision|1|||
143096007|NCT00708552|515891601|FG001|Overall Study|Physician Decision|2|||
143096008|NCT00708552|515891602|FG002|Overall Study|Physician Decision|0|||
143096009|NCT00708552|515891603|FG003|Overall Study|Physician Decision|0|||
143096010|NCT00708552|515891600|FG000|Overall Study|Withdrawal by Subject|12|||
143096011|NCT00708552|515891601|FG001|Overall Study|Withdrawal by Subject|7|||
143096012|NCT00708552|515891602|FG002|Overall Study|Withdrawal by Subject|8|||
143096013|NCT00708552|515891603|FG003|Overall Study|Withdrawal by Subject|10|||
143096014|NCT03214224|515891606|FG000|Overall Study|Protocol Violation|1|||
143096015|NCT03214224|515891606|FG000|Overall Study|Withdrawal by Subject|2|||
143096016|NCT03214224|515891606|FG000|Overall Study|Practice controls or therapists|6|||
143096017|NCT02712320|515891607|FG000|Overall Study|Lost to Follow-up|1|||
143096018|NCT02712320|515891607|FG000|Overall Study|Withdrawal by Subject|1|||
143096019|NCT02712320|515891607|FG000|Overall Study|Transferred to another facility|1|||
143096020|NCT02712320|515891607|FG000|Overall Study|Treating with the prohibited medications|2|||
143096021|NCT00568451|515891608|FG000|Overall Study|Disease Progression|0|||
143096022|NCT00568451|515891609|FG001|Overall Study|Disease Progression|0|||
143096023|NCT00568451|515891610|FG002|Overall Study|Disease Progression|2|||
143096024|NCT00568451|515891611|FG003|Overall Study|Disease Progression|7|||
143096025|NCT00444535|515891612|FG000|Overall Study|Withdrawal by Subject|5|||
143096026|NCT00444535|515891612|FG000|Overall Study|Physician Decision|5|||
143096027|NCT00444535|515891612|FG000|Overall Study|progressive disease|1|||
143096028|NCT00444535|515891612|FG000|Overall Study|Adverse Event|2|||
143096029|NCT05005507|515891613|FG000|Overall Study|Premature termination of study|1|||
143096030|NCT03313180|515891617|FG000|Overall Study|Adverse Event|120|||
143096031|NCT03313180|515891617|FG000|Overall Study|Lost to Follow-up|3|||
143096032|NCT03313180|515891617|FG000|Overall Study|Withdrawal by Subject|39|||
143096033|NCT03313180|515891617|FG000|Overall Study|Other than listed above|15|||
143096034|NCT03313180|515891617|FG000|Overall Study|Covid-19 related|2|||
143096035|NCT01697748|515891619|FG000|Overall Study|ineligible skin incision|1|||
143096036|NCT01697748|515891620|FG001|Overall Study|ineligible skin incision|2|||
143096037|NCT01697748|515891619|FG000|Overall Study|ineligible uterine incision|4|||
143096038|NCT01697748|515891620|FG001|Overall Study|ineligible uterine incision|1|||
143096039|NCT01697748|515891619|FG000|Overall Study|Lost to Follow-up|53|||
143096040|NCT01697748|515891620|FG001|Overall Study|Lost to Follow-up|65|||
143096041|NCT00832455|515891621|FG000|Overall Study|Adverse Event|13|||
143096042|NCT00832455|515891621|FG000|Overall Study|Lost to Follow-up|26|||
143096043|NCT00832455|515891621|FG000|Overall Study|Protocol Violation|4|||
143096044|NCT00832455|515891621|FG000|Overall Study|Withdrawal by Subject|17|||
143096045|NCT00832455|515891621|FG000|Overall Study|Screening Failure|2|||
143096046|NCT00832455|515891621|FG000|Overall Study|Stopped Medication|4|||
143096047|NCT00832455|515891621|FG000|Overall Study|Parent misunderstood study|1|||
143096048|NCT00832455|515891621|FG000|Overall Study|Parent dissatisfied|1|||
143096049|NCT00832455|515891621|FG000|Overall Study|No improvement|3|||
143096050|NCT00832455|515891621|FG000|Overall Study|Patient moved|1|||
143096051|NCT02556775|515891622|FG000|Overall Study|Withdrawal by Subject|1|||
143096052|NCT02556775|515891623|FG001|Overall Study|Withdrawal by Subject|0|||
143096053|NCT02556775|515891624|FG002|Overall Study|Withdrawal by Subject|1|||
143096054|NCT02556775|515891625|FG003|Overall Study|Withdrawal by Subject|0|||
143096055|NCT02556775|515891622|FG000|Overall Study|Lost to Follow-up|1|||
143096056|NCT02556775|515891623|FG001|Overall Study|Lost to Follow-up|0|||
143096057|NCT02556775|515891624|FG002|Overall Study|Lost to Follow-up|0|||
143096058|NCT02556775|515891625|FG003|Overall Study|Lost to Follow-up|0|||
143096059|NCT02025725|515891628|FG000|Overall Study|Adverse Event|5|||
143096060|NCT02025725|515891629|FG001|Overall Study|Adverse Event|0|||
143096061|NCT02025725|515891628|FG000|Overall Study|Lost to Follow-up|2|||
143096062|NCT02025725|515891629|FG001|Overall Study|Lost to Follow-up|0|||
143096063|NCT02025725|515891628|FG000|Overall Study|Protocol Violation|1|||
143096064|NCT02025725|515891629|FG001|Overall Study|Protocol Violation|1|||
143096065|NCT02025725|515891628|FG000|Overall Study|Withdrawal by Subject|3|||
143096066|NCT02025725|515891629|FG001|Overall Study|Withdrawal by Subject|2|||
143096067|NCT02025725|515891628|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
143096068|NCT02025725|515891629|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
143096069|NCT02946463|515891630|FG000|Primary Evaluation Period|Physician Decision|0|||
143096070|NCT02946463|515891631|FG001|Primary Evaluation Period|Physician Decision|1|||
143096071|NCT02946463|515891632|FG002|Primary Evaluation Period|Physician Decision|0|||
143096072|NCT02946463|515891633|FG003|Primary Evaluation Period|Physician Decision|0|||
143096073|NCT02946463|515891630|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
143096074|NCT02946463|515891631|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
143096075|NCT02946463|515891632|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
143096076|NCT02946463|515891633|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
143096077|NCT02946463|515891630|FG000|Extension Period|Death|4|||
143096078|NCT02946463|515891631|FG001|Extension Period|Death|4|||
143096079|NCT02946463|515891632|FG002|Extension Period|Death|0|||
143096080|NCT02946463|515891633|FG003|Extension Period|Death|0|||
143096081|NCT02946463|515891630|FG000|Extension Period|Withdrawal by Subject|4|||
143096082|NCT02946463|515891631|FG001|Extension Period|Withdrawal by Subject|3|||
143096083|NCT02946463|515891632|FG002|Extension Period|Withdrawal by Subject|0|||
143096084|NCT02946463|515891633|FG003|Extension Period|Withdrawal by Subject|0|||
143096085|NCT02946463|515891630|FG000|Extension Period|Other than specified|2|||
143096086|NCT02946463|515891631|FG001|Extension Period|Other than specified|3|||
143096087|NCT02946463|515891632|FG002|Extension Period|Other than specified|2|||
143096088|NCT02946463|515891633|FG003|Extension Period|Other than specified|0|||
143096089|NCT02946463|515891630|FG000|Extension Period|Physician Decision|1|||
143096090|NCT02946463|515891631|FG001|Extension Period|Physician Decision|4|||
143096091|NCT02946463|515891632|FG002|Extension Period|Physician Decision|0|||
143096092|NCT02946463|515891633|FG003|Extension Period|Physician Decision|0|||
143096093|NCT02946463|515891630|FG000|Extension Period|Pregnancy|3|||
143096094|NCT02946463|515891631|FG001|Extension Period|Pregnancy|1|||
143096095|NCT02946463|515891632|FG002|Extension Period|Pregnancy|0|||
143096096|NCT02946463|515891633|FG003|Extension Period|Pregnancy|0|||
143096097|NCT02946463|515891630|FG000|Extension Period|Adverse Event|1|||
143096098|NCT02946463|515891631|FG001|Extension Period|Adverse Event|2|||
143096099|NCT02946463|515891632|FG002|Extension Period|Adverse Event|0|||
143096100|NCT02946463|515891633|FG003|Extension Period|Adverse Event|0|||
143096101|NCT02946463|515891630|FG000|Extension Period|Lost to Follow-up|1|||
143096102|NCT02946463|515891631|FG001|Extension Period|Lost to Follow-up|0|||
143096103|NCT02946463|515891632|FG002|Extension Period|Lost to Follow-up|0|||
143096104|NCT02946463|515891633|FG003|Extension Period|Lost to Follow-up|0|||
143096105|NCT05581641|515891634|FG000|Overall Study|Withdrawal by Subject|0|||
143096106|NCT05581641|515891635|FG001|Overall Study|Withdrawal by Subject|1|||
143096107|NCT05581641|515891636|FG002|Overall Study|Withdrawal by Subject|3|||
143096108|NCT05581641|515891637|FG003|Overall Study|Withdrawal by Subject|1|||
143096109|NCT05581641|515891634|FG000|Overall Study|Lost to Follow-up|0|||
143096110|NCT05581641|515891635|FG001|Overall Study|Lost to Follow-up|1|||
143096111|NCT05581641|515891636|FG002|Overall Study|Lost to Follow-up|0|||
143096112|NCT05581641|515891637|FG003|Overall Study|Lost to Follow-up|1|||
143096113|NCT05581641|515891634|FG000|Overall Study|Protocol Violation|1|||
143096114|NCT05581641|515891635|FG001|Overall Study|Protocol Violation|0|||
143096115|NCT05581641|515891636|FG002|Overall Study|Protocol Violation|0|||
143096116|NCT05581641|515891637|FG003|Overall Study|Protocol Violation|0|||
143096117|NCT05581641|515891634|FG000|Overall Study|Other|1|||
143096118|NCT05581641|515891635|FG001|Overall Study|Other|0|||
143096119|NCT05581641|515891636|FG002|Overall Study|Other|2|||
143096120|NCT05581641|515891637|FG003|Overall Study|Other|1|||
143096121|NCT00450437|515891638|FG000|Overall Study|Withdrawal by Subject|10|||
143096122|NCT00450437|515891639|FG001|Overall Study|Withdrawal by Subject|2|||
143096123|NCT00450437|515891640|FG002|Overall Study|Withdrawal by Subject|0|||
143096124|NCT00450437|515891641|FG003|Overall Study|Withdrawal by Subject|1|||
143096125|NCT00450437|515891638|FG000|Overall Study|Lost to Follow-up|31|||
143096126|NCT00450437|515891639|FG001|Overall Study|Lost to Follow-up|12|||
143096127|NCT00450437|515891640|FG002|Overall Study|Lost to Follow-up|19|||
143096128|NCT00450437|515891641|FG003|Overall Study|Lost to Follow-up|9|||
143096129|NCT00450437|515891638|FG000|Overall Study|Protocol Violation|0|||
143096130|NCT00450437|515891639|FG001|Overall Study|Protocol Violation|1|||
143096131|NCT00450437|515891640|FG002|Overall Study|Protocol Violation|0|||
143367535|NCT00580801|516889392|FG000|Overall Study|Travel|1|||
143096132|NCT00450437|515891641|FG003|Overall Study|Protocol Violation|1|||
143096133|NCT00450437|515891638|FG000|Overall Study|Inappropriate enrollment|4|||
143096134|NCT00450437|515891639|FG001|Overall Study|Inappropriate enrollment|1|||
143096135|NCT00450437|515891640|FG002|Overall Study|Inappropriate enrollment|3|||
143096136|NCT00450437|515891641|FG003|Overall Study|Inappropriate enrollment|0|||
143096137|NCT00450437|515891638|FG000|Overall Study|Administrative reason|0|||
143096138|NCT00450437|515891639|FG001|Overall Study|Administrative reason|0|||
143096139|NCT00450437|515891640|FG002|Overall Study|Administrative reason|1|||
143096140|NCT00450437|515891641|FG003|Overall Study|Administrative reason|0|||
143367536|NCT00580801|516889393|FG001|Overall Study|Travel|0|||
143367537|NCT00580801|516889394|FG002|Overall Study|Travel|0|||
143096141|NCT00450437|515891638|FG000|Overall Study|Unable to Classify|1|||
143096142|NCT00450437|515891639|FG001|Overall Study|Unable to Classify|0|||
143096143|NCT00450437|515891640|FG002|Overall Study|Unable to Classify|1|||
143096144|NCT00450437|515891641|FG003|Overall Study|Unable to Classify|0|||
143096145|NCT05691712|515891642|FG000|Overall Study|Adverse Event|0|||
143096146|NCT05691712|515891643|FG001|Overall Study|Adverse Event|1|||
143096147|NCT05691712|515891644|FG002|Overall Study|Adverse Event|2|||
143096148|NCT05691712|515891645|FG003|Overall Study|Adverse Event|1|||
143096149|NCT05691712|515891642|FG000|Overall Study|Withdrawal by Subject|2|||
143096150|NCT05691712|515891643|FG001|Overall Study|Withdrawal by Subject|3|||
143096151|NCT05691712|515891644|FG002|Overall Study|Withdrawal by Subject|3|||
143096152|NCT05691712|515891645|FG003|Overall Study|Withdrawal by Subject|1|||
143096153|NCT05691712|515891642|FG000|Overall Study|Death|1|||
143096154|NCT05691712|515891643|FG001|Overall Study|Death|0|||
143096155|NCT05691712|515891644|FG002|Overall Study|Death|0|||
143096156|NCT05691712|515891645|FG003|Overall Study|Death|0|||
143096157|NCT05691712|515891642|FG000|Overall Study|Pregnancy|0|||
143096158|NCT05691712|515891643|FG001|Overall Study|Pregnancy|1|||
143096159|NCT05691712|515891644|FG002|Overall Study|Pregnancy|0|||
143096160|NCT05691712|515891645|FG003|Overall Study|Pregnancy|0|||
143096161|NCT05691712|515891642|FG000|Overall Study|Assigned Treatment by Mistake|1|||
143096162|NCT05691712|515891643|FG001|Overall Study|Assigned Treatment by Mistake|0|||
143096163|NCT05691712|515891644|FG002|Overall Study|Assigned Treatment by Mistake|0|||
143096164|NCT05691712|515891645|FG003|Overall Study|Assigned Treatment by Mistake|1|||
143096165|NCT02492867|515891646|FG000|Overall Study|Alternate therapy|1|||
143096166|NCT02492867|515891646|FG000|Overall Study|Withdrawal by Subject|2|||
143096167|NCT02492867|515891646|FG000|Overall Study|Disease progression after treatment started|1|||
143096168|NCT02492867|515891646|FG000|Overall Study|Death|1|||
143096169|NCT03296527|515891647|FG000|Overall Study|Adverse Event|15|||
143096170|NCT03296527|515891648|FG001|Overall Study|Adverse Event|33|||
143096171|NCT03296527|515891647|FG000|Overall Study|Protocol Deviation|4|||
143096172|NCT03296527|515891648|FG001|Overall Study|Protocol Deviation|0|||
143096173|NCT03296527|515891647|FG000|Overall Study|Participant withdrew consent|3|||
143096174|NCT03296527|515891648|FG001|Overall Study|Participant withdrew consent|1|||
143096175|NCT03296527|515891647|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
143096176|NCT03296527|515891648|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
143096177|NCT03296527|515891647|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
143096178|NCT03296527|515891648|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
143096179|NCT03296527|515891647|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
143096180|NCT03296527|515891648|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
143096181|NCT03296527|515891647|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
143096182|NCT03296527|515891648|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
143096183|NCT03296527|515891647|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
143096184|NCT03296527|515891648|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
143096185|NCT04352101|515891650|FG000|Overall Study|Physician Decision|2|||
143096186|NCT04352101|515891651|FG001|Overall Study|Physician Decision|1|||
143096187|NCT00122382|515891652|FG000|Double-Blind Study|Adverse Event|9|||
143096188|NCT00122382|515891653|FG001|Double-Blind Study|Adverse Event|11|||
143096189|NCT00122382|515891654|FG002|Double-Blind Study|Adverse Event|0|||
143096190|NCT00122382|515891652|FG000|Double-Blind Study|Death|2|||
143096191|NCT00122382|515891653|FG001|Double-Blind Study|Death|2|||
143096192|NCT00122382|515891654|FG002|Double-Blind Study|Death|0|||
143096193|NCT00122382|515891652|FG000|Double-Blind Study|Lack of Efficacy|0|||
143096194|NCT00122382|515891653|FG001|Double-Blind Study|Lack of Efficacy|8|||
143096195|NCT00122382|515891654|FG002|Double-Blind Study|Lack of Efficacy|0|||
143096196|NCT00122382|515891652|FG000|Double-Blind Study|Lost to Follow-up|2|||
143096197|NCT00122382|515891653|FG001|Double-Blind Study|Lost to Follow-up|1|||
143096198|NCT00122382|515891654|FG002|Double-Blind Study|Lost to Follow-up|0|||
143096199|NCT00122382|515891652|FG000|Double-Blind Study|Pregnancy|2|||
143096200|NCT00122382|515891653|FG001|Double-Blind Study|Pregnancy|0|||
143096201|NCT00122382|515891654|FG002|Double-Blind Study|Pregnancy|0|||
143096202|NCT00122382|515891652|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
143096203|NCT00122382|515891653|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
143096204|NCT00122382|515891654|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
143096205|NCT00122382|515891652|FG000|Double-Blind Study|Withdrawal of Consent|7|||
143096206|NCT00122382|515891653|FG001|Double-Blind Study|Withdrawal of Consent|3|||
143096207|NCT00122382|515891654|FG002|Double-Blind Study|Withdrawal of Consent|0|||
143096208|NCT00122382|515891652|FG000|Double-Blind Study|Protocol Violation|1|||
143096209|NCT00122382|515891653|FG001|Double-Blind Study|Protocol Violation|0|||
143096210|NCT00122382|515891654|FG002|Double-Blind Study|Protocol Violation|0|||
143096211|NCT00122382|515891652|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
143096212|NCT00122382|515891653|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
143367538|NCT02595398|516889395|FG000|Overall Study|Non-compliance|1|||
143096213|NCT00122382|515891654|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
143096214|NCT00122382|515891652|FG000|Double-Blind Study|Randomized but not treated|0|||
143096215|NCT00122382|515891653|FG001|Double-Blind Study|Randomized but not treated|2|||
143096216|NCT00122382|515891654|FG002|Double-Blind Study|Randomized but not treated|0|||
143096217|NCT00122382|515891652|FG000|Open-Label Study|Adverse Event|0|||
143096218|NCT00122382|515891653|FG001|Open-Label Study|Adverse Event|0|||
143096219|NCT00122382|515891654|FG002|Open-Label Study|Adverse Event|11|||
143096220|NCT00122382|515891652|FG000|Open-Label Study|Death|0|||
143096221|NCT00122382|515891653|FG001|Open-Label Study|Death|0|||
143096222|NCT00122382|515891654|FG002|Open-Label Study|Death|2|||
143096223|NCT00122382|515891652|FG000|Open-Label Study|Lack of Efficacy|0|||
143096224|NCT00122382|515891653|FG001|Open-Label Study|Lack of Efficacy|0|||
143096225|NCT00122382|515891654|FG002|Open-Label Study|Lack of Efficacy|3|||
143096226|NCT00122382|515891652|FG000|Open-Label Study|Lost to Follow-up|0|||
143096227|NCT00122382|515891653|FG001|Open-Label Study|Lost to Follow-up|0|||
143096228|NCT00122382|515891654|FG002|Open-Label Study|Lost to Follow-up|3|||
143096229|NCT00122382|515891652|FG000|Open-Label Study|Pregnancy|0|||
143096230|NCT00122382|515891653|FG001|Open-Label Study|Pregnancy|0|||
143096231|NCT00122382|515891654|FG002|Open-Label Study|Pregnancy|2|||
143096232|NCT00122382|515891652|FG000|Open-Label Study|Poor/Non-Compliance|0|||
143096233|NCT00122382|515891653|FG001|Open-Label Study|Poor/Non-Compliance|0|||
143096234|NCT00122382|515891654|FG002|Open-Label Study|Poor/Non-Compliance|1|||
143096235|NCT00122382|515891652|FG000|Open-Label Study|Withdrawal of Consent|0|||
143096236|NCT00122382|515891653|FG001|Open-Label Study|Withdrawal of Consent|0|||
143096237|NCT00122382|515891654|FG002|Open-Label Study|Withdrawal of Consent|4|||
143096238|NCT02040805|515891656|FG000|Overall Study|Lost to Follow-up|14|||
143096239|NCT02040805|515891657|FG001|Overall Study|Lost to Follow-up|9|||
143096240|NCT02040805|515891656|FG000|Overall Study|Withdrawal by Subject|28|||
143096241|NCT02040805|515891657|FG001|Overall Study|Withdrawal by Subject|41|||
143096242|NCT03591874|515891660|FG000|Overall Study|Adverse Event|4|||
143096243|NCT03591874|515891661|FG001|Overall Study|Adverse Event|0|||
143096244|NCT03591874|515891660|FG000|Overall Study|Withdrawal by Subject|2|||
143096245|NCT03591874|515891661|FG001|Overall Study|Withdrawal by Subject|1|||
143096246|NCT03591874|515891660|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
143096247|NCT03591874|515891661|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
143096248|NCT03591874|515891660|FG000|Overall Study|On Study at Time of Study Termination|12|||
143096249|NCT03591874|515891661|FG001|Overall Study|On Study at Time of Study Termination|6|||
143096250|NCT00071110|515891662|FG000|Overall Study|Protocol Violation|0|||
143096251|NCT00071110|515891663|FG001|Overall Study|Protocol Violation|4|||
143096252|NCT02166333|515891664|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
143096253|NCT02166333|515891665|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
143096254|NCT02166333|515891666|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
143096255|NCT02166333|515891667|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
143096256|NCT02166333|515891668|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
143096257|NCT02166333|515891669|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
143096258|NCT02166333|515891664|FG000|Stage 1|Death|4|||
143251434|NCT02969655|516474200|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
143251435|NCT02969655|516474199|FG000|Overall Study|Adverse Event|10|||
143251436|NCT02969655|516474200|FG001|Overall Study|Adverse Event|8|||
143251437|NCT01510769|516474201|FG000|Overall Study|Adverse Event|7|||
143096259|NCT02166333|515891665|FG001|Stage 1|Death|0|||
143096260|NCT02166333|515891666|FG002|Stage 1|Death|2|||
143096261|NCT02166333|515891667|FG003|Stage 1|Death|0|||
143096262|NCT02166333|515891668|FG004|Stage 1|Death|3|||
143096263|NCT02166333|515891669|FG005|Stage 1|Death|2|||
143096264|NCT02166333|515891664|FG000|Stage 1|Lost to Follow-up|12|||
143096265|NCT02166333|515891665|FG001|Stage 1|Lost to Follow-up|0|||
143096266|NCT02166333|515891666|FG002|Stage 1|Lost to Follow-up|6|||
143096267|NCT02166333|515891667|FG003|Stage 1|Lost to Follow-up|0|||
143096268|NCT02166333|515891668|FG004|Stage 1|Lost to Follow-up|3|||
143096269|NCT02166333|515891669|FG005|Stage 1|Lost to Follow-up|3|||
143096270|NCT02166333|515891664|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
143096271|NCT02166333|515891665|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
143096272|NCT02166333|515891666|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
143096273|NCT02166333|515891667|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
143096274|NCT02166333|515891668|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
143096275|NCT02166333|515891669|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
143096276|NCT02166333|515891664|FG000|Stage 2|Death|4|||
143096277|NCT02166333|515891665|FG001|Stage 2|Death|2|||
143096278|NCT02166333|515891666|FG002|Stage 2|Death|1|||
143096279|NCT02166333|515891667|FG003|Stage 2|Death|0|||
143096280|NCT02166333|515891668|FG004|Stage 2|Death|0|||
143096281|NCT02166333|515891669|FG005|Stage 2|Death|1|||
143096282|NCT02166333|515891664|FG000|Stage 2|Lost to Follow-up|23|||
143096283|NCT02166333|515891665|FG001|Stage 2|Lost to Follow-up|4|||
143096284|NCT02166333|515891666|FG002|Stage 2|Lost to Follow-up|11|||
143251438|NCT01510769|516474202|FG001|Overall Study|Adverse Event|6|||
143251439|NCT01510769|516474203|FG002|Overall Study|Adverse Event|4|||
143096285|NCT02166333|515891667|FG003|Stage 2|Lost to Follow-up|9|||
143096286|NCT02166333|515891668|FG004|Stage 2|Lost to Follow-up|3|||
143096287|NCT02166333|515891669|FG005|Stage 2|Lost to Follow-up|6|||
143096288|NCT02269098|515891670|FG000|Overall Study|Lost to Follow-up|14|||
143096289|NCT02269098|515891671|FG001|Overall Study|Lost to Follow-up|9|||
143096290|NCT03655405|515891677|FG000|Overall Study|Death after initial data collection|4|||
143096291|NCT03655405|515891678|FG001|Overall Study|Death after initial data collection|2|||
143096292|NCT03655405|515891677|FG000|Overall Study|Died before initial data collection|1|||
143096293|NCT03655405|515891678|FG001|Overall Study|Died before initial data collection|2|||
143096294|NCT03655405|515891677|FG000|Overall Study|Protocol Violation|0|||
143096295|NCT03655405|515891678|FG001|Overall Study|Protocol Violation|1|||
143096296|NCT02859337|515891681|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
143096297|NCT02859337|515891682|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
143096298|NCT02859337|515891683|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
143096299|NCT02859337|515891681|FG000|Overall Study|Withdrawal by Subject|3|||
143096300|NCT02859337|515891682|FG001|Overall Study|Withdrawal by Subject|1|||
143096301|NCT02859337|515891683|FG002|Overall Study|Withdrawal by Subject|0|||
143096302|NCT02859337|515891681|FG000|Overall Study|Lost to Follow-up|1|||
143096303|NCT02859337|515891682|FG001|Overall Study|Lost to Follow-up|0|||
143096304|NCT02859337|515891683|FG002|Overall Study|Lost to Follow-up|0|||
143096305|NCT03817190|515891689|FG000|Overall Study|Early Termination|13|||
143096306|NCT03817190|515891690|FG001|Overall Study|Early Termination|20|||
143096307|NCT03817190|515891689|FG000|Overall Study|Adverse Event|10|||
143096308|NCT03817190|515891690|FG001|Overall Study|Adverse Event|17|||
143096309|NCT03817190|515891689|FG000|Overall Study|Withdrawal by Subject|12|||
143096310|NCT03817190|515891690|FG001|Overall Study|Withdrawal by Subject|8|||
143096311|NCT03817190|515891689|FG000|Overall Study|Lost to Follow-up|11|||
143096312|NCT03817190|515891690|FG001|Overall Study|Lost to Follow-up|7|||
143096313|NCT03817190|515891689|FG000|Overall Study|Lack of Efficacy|7|||
143096314|NCT03817190|515891690|FG001|Overall Study|Lack of Efficacy|5|||
143096315|NCT03817190|515891689|FG000|Overall Study|Investigator Decision|5|||
143096316|NCT03817190|515891690|FG001|Overall Study|Investigator Decision|1|||
143096317|NCT03817190|515891689|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
143096318|NCT03817190|515891690|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
143096319|NCT03817190|515891689|FG000|Overall Study|Lack of Contact|1|||
143096320|NCT03817190|515891690|FG001|Overall Study|Lack of Contact|0|||
143096321|NCT03817190|515891689|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
143096322|NCT03817190|515891690|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
143096323|NCT05514873|515891691|FG000|Main Treatment Period|Subject's lack of compliance with study procedures|1|||
143096324|NCT05514873|515891691|FG000|Main Treatment Period|Adverse Event|2|||
143096325|NCT05514873|515891691|FG000|Extension Treatment Period|Lost to Follow-up|3|||
143096326|NCT05086744|515893479|FG000|Part A|Adverse Event|0|||
143251440|NCT01510769|516474201|FG000|Overall Study|Gout Flare|0|||
143251441|NCT01510769|516474202|FG001|Overall Study|Gout Flare|3|||
143251442|NCT01510769|516474203|FG002|Overall Study|Gout Flare|1|||
143251443|NCT01510769|516474201|FG000|Overall Study|Protocol Violation|11|||
143251444|NCT01510769|516474202|FG001|Overall Study|Protocol Violation|10|||
143251445|NCT01510769|516474203|FG002|Overall Study|Protocol Violation|9|||
143251446|NCT01510769|516474201|FG000|Overall Study|Lost to Follow-up|5|||
143251447|NCT01510769|516474202|FG001|Overall Study|Lost to Follow-up|1|||
143251448|NCT01510769|516474203|FG002|Overall Study|Lost to Follow-up|5|||
143251449|NCT01510769|516474201|FG000|Overall Study|Withdrawal by Subject|3|||
143251450|NCT01510769|516474202|FG001|Overall Study|Withdrawal by Subject|4|||
143251451|NCT01510769|516474203|FG002|Overall Study|Withdrawal by Subject|3|||
143251452|NCT01510769|516474201|FG000|Overall Study|Death|1|||
143251453|NCT01510769|516474202|FG001|Overall Study|Death|1|||
143251454|NCT01510769|516474203|FG002|Overall Study|Death|0|||
143251455|NCT02466659|516474204|FG000|Overall Study|Lost to Follow-up|5|||
143251456|NCT02466659|516474205|FG001|Overall Study|Lost to Follow-up|2|||
143251457|NCT00929643|516474208|FG000|Overall Study|Protocol Violation|2|||
143251458|NCT00145977|516474212|FG000|Overall Study|Lack of Efficacy|0|||
143251459|NCT00145977|516474213|FG001|Overall Study|Lack of Efficacy|4|||
143096327|NCT05086744|515893480|FG001|Part A|Adverse Event|1|||
143251460|NCT00145977|516474212|FG000|Overall Study|Lost to Follow-up|1|||
143251461|NCT00145977|516474213|FG001|Overall Study|Lost to Follow-up|0|||
143251462|NCT00145977|516474212|FG000|Overall Study|Withdrawal by Subject|1|||
143251463|NCT00145977|516474213|FG001|Overall Study|Withdrawal by Subject|0|||
143096328|NCT05086744|515893479|FG000|Part A|Lack of Efficacy|3|||
143096329|NCT05086744|515893480|FG001|Part A|Lack of Efficacy|0|||
143096330|NCT05086744|515893479|FG000|Part A|Protocol deviation|1|||
143096331|NCT05086744|515893480|FG001|Part A|Protocol deviation|0|||
143096332|NCT05086744|515893479|FG000|Part A|Subject decision|1|||
143251464|NCT01578850|516474214|FG000|Period 1|Insufficient Clinical Response|1|||
143251465|NCT01578850|516474215|FG001|Period 1|Insufficient Clinical Response|0|||
143251466|NCT01578850|516474216|FG002|Period 1|Insufficient Clinical Response|0|||
143251467|NCT01578850|516474214|FG000|Period 1|Adverse Event|11|||
143251468|NCT01578850|516474215|FG001|Period 1|Adverse Event|0|||
143096333|NCT05086744|515893480|FG001|Part A|Subject decision|0|||
143096334|NCT05086744|515893479|FG000|Part B|Adverse Event|0|||
143096335|NCT05086744|515893480|FG001|Part B|Adverse Event|1|||
143096336|NCT05086744|515893479|FG000|Part B|Lack of Efficacy|0|||
143096337|NCT05086744|515893480|FG001|Part B|Lack of Efficacy|1|||
143096338|NCT05086744|515893479|FG000|Part B|Study terminated by sponsor|1|||
143096339|NCT05086744|515893480|FG001|Part B|Study terminated by sponsor|6|||
143096340|NCT04767282|515893492|FG000|Overall Study|Refused or did not begin surveys|6|||
143096341|NCT04767282|515893493|FG001|Overall Study|Refused or did not begin surveys|2|||
143096342|NCT04767282|515893494|FG002|Overall Study|Refused or did not begin surveys|2|||
143096343|NCT04767282|515893492|FG000|Overall Study|Duplicate household previously enrolled|2|||
143096344|NCT04767282|515893493|FG001|Overall Study|Duplicate household previously enrolled|0|||
143096345|NCT04767282|515893494|FG002|Overall Study|Duplicate household previously enrolled|8|||
143096346|NCT04767282|515893492|FG000|Overall Study|Unable to confirm legal guardian|0|||
143096347|NCT04767282|515893493|FG001|Overall Study|Unable to confirm legal guardian|2|||
143096348|NCT04767282|515893494|FG002|Overall Study|Unable to confirm legal guardian|8|||
143096349|NCT04767282|515893492|FG000|Overall Study|Withdrawal by Subject|0|||
143096350|NCT04767282|515893493|FG001|Overall Study|Withdrawal by Subject|0|||
143096351|NCT04767282|515893494|FG002|Overall Study|Withdrawal by Subject|6|||
143096352|NCT04767282|515893492|FG000|Overall Study|Survey comprehension challenges|4|||
143096353|NCT04767282|515893493|FG001|Overall Study|Survey comprehension challenges|0|||
143096354|NCT04767282|515893494|FG002|Overall Study|Survey comprehension challenges|0|||
143096355|NCT00536939|515893495|FG000|Overall Study|Withdrawal by Subject|1|||
143096356|NCT00536939|515893496|FG001|Overall Study|Withdrawal by Subject|0|||
143096357|NCT00536939|515893495|FG000|Overall Study|Other Complicating Disease|1|||
143096358|NCT00536939|515893496|FG001|Overall Study|Other Complicating Disease|0|||
143096359|NCT00529087|515893501|FG000|Overall Study|Adverse Event|10|||
143096360|NCT00529087|515893502|FG001|Overall Study|Adverse Event|13|||
143096361|NCT00529087|515893503|FG002|Overall Study|Adverse Event|4|||
143096362|NCT00529087|515893501|FG000|Overall Study|Lost to Follow-up|6|||
143096363|NCT00529087|515893502|FG001|Overall Study|Lost to Follow-up|4|||
143096364|NCT00529087|515893503|FG002|Overall Study|Lost to Follow-up|1|||
143096365|NCT00529087|515893501|FG000|Overall Study|Protocol Violation|8|||
143096366|NCT00529087|515893502|FG001|Overall Study|Protocol Violation|7|||
143096367|NCT00529087|515893503|FG002|Overall Study|Protocol Violation|6|||
143096368|NCT00529087|515893501|FG000|Overall Study|Withdrawal by Subject|3|||
143096369|NCT00529087|515893502|FG001|Overall Study|Withdrawal by Subject|3|||
143096370|NCT00529087|515893503|FG002|Overall Study|Withdrawal by Subject|3|||
143096371|NCT00529087|515893501|FG000|Overall Study|Protocol deviation|1|||
143096372|NCT00529087|515893502|FG001|Overall Study|Protocol deviation|1|||
143096373|NCT00529087|515893503|FG002|Overall Study|Protocol deviation|2|||
143096374|NCT00318474|515893504|FG000|Overall Study|Adverse Event|1|||
143096375|NCT00318474|515893505|FG001|Overall Study|Adverse Event|1|||
143096376|NCT00318474|515893504|FG000|Overall Study|Lost to Follow-up|0|||
143096377|NCT00318474|515893505|FG001|Overall Study|Lost to Follow-up|1|||
143096378|NCT00318474|515893504|FG000|Overall Study|Pregnancy|0|||
143096379|NCT00318474|515893505|FG001|Overall Study|Pregnancy|2|||
143096380|NCT00318474|515893504|FG000|Overall Study|Protocol Violation|1|||
143096381|NCT00318474|515893505|FG001|Overall Study|Protocol Violation|0|||
143096382|NCT00318474|515893504|FG000|Overall Study|Withdrawal by Subject|3|||
143096383|NCT00318474|515893505|FG001|Overall Study|Withdrawal by Subject|2|||
143096384|NCT00318474|515893504|FG000|Overall Study|Fall in GFR|3|||
143096385|NCT00318474|515893505|FG001|Overall Study|Fall in GFR|3|||
143096386|NCT00318474|515893504|FG000|Overall Study|Post-therapy hyperflycemia|0|||
143096387|NCT00318474|515893505|FG001|Overall Study|Post-therapy hyperflycemia|1|||
143096388|NCT00318474|515893504|FG000|Overall Study|Trial terminated|10|||
143096389|NCT00318474|515893505|FG001|Overall Study|Trial terminated|7|||
143096390|NCT01735916|515893514|FG000|Overall Study|Subject not eligible to be randomized|11|||
143096391|NCT01735916|515893515|FG001|Overall Study|Subject not eligible to be randomized|0|||
143096392|NCT01735916|515893516|FG002|Overall Study|Subject not eligible to be randomized|0|||
143096393|NCT01735916|515893514|FG000|Overall Study|Early termination of study by sponsor|4|||
143096394|NCT01735916|515893515|FG001|Overall Study|Early termination of study by sponsor|19|||
143096395|NCT01735916|515893516|FG002|Overall Study|Early termination of study by sponsor|7|||
143096396|NCT01735916|515893514|FG000|Overall Study|Withdrawal by Subject|3|||
143096397|NCT01735916|515893515|FG001|Overall Study|Withdrawal by Subject|0|||
143096398|NCT01735916|515893516|FG002|Overall Study|Withdrawal by Subject|0|||
143096399|NCT02275546|515893538|FG000|Treatment Period 2|Withdrawal by Subject|2|||
143096400|NCT02275546|515893539|FG001|Treatment Period 2|Withdrawal by Subject|1|||
143096401|NCT02275546|515893538|FG000|Treatment Period 2|Protocol Violation|0|||
143176917|NCT00811720|516196236|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
143096402|NCT02275546|515893539|FG001|Treatment Period 2|Protocol Violation|1|||
143096403|NCT02955355|515893548|FG000|Overall Study|Adverse Event|4|||
143096404|NCT02955355|515893548|FG000|Overall Study|Death|1|||
143096405|NCT02955355|515893548|FG000|Overall Study|Physician Decision|21|||
143096406|NCT02955355|515893548|FG000|Overall Study|Site Terminated by Sponsor|35|||
143096407|NCT02955355|515893548|FG000|Overall Study|Withdrawal by Subject|19|||
143096408|NCT02955355|515893548|FG000|Overall Study|Reason Not Specified|5|||
143096409|NCT02612623|515893549|FG000|Overall Study|Withdrawal by Subject|0|||
143096410|NCT02612623|515893550|FG001|Overall Study|Withdrawal by Subject|1|||
143096411|NCT02612623|515893551|FG002|Overall Study|Withdrawal by Subject|0|||
143096412|NCT02612623|515893552|FG003|Overall Study|Withdrawal by Subject|0|||
143096413|NCT02612623|515893549|FG000|Overall Study|Adverse Event|1|||
143096414|NCT02612623|515893550|FG001|Overall Study|Adverse Event|0|||
143096415|NCT02612623|515893551|FG002|Overall Study|Adverse Event|1|||
143096416|NCT02612623|515893552|FG003|Overall Study|Adverse Event|0|||
143096417|NCT00333983|515893553|FG000|Overall Study|Lost to Follow-up|2|||
143096418|NCT00333983|515893554|FG001|Overall Study|Lost to Follow-up|1|||
143096419|NCT00333983|515893555|FG002|Overall Study|Lost to Follow-up|0|||
143096420|NCT00333983|515893553|FG000|Overall Study|Adverse Event|1|||
143096421|NCT00333983|515893554|FG001|Overall Study|Adverse Event|1|||
143096422|NCT00333983|515893555|FG002|Overall Study|Adverse Event|1|||
143096423|NCT00333983|515893553|FG000|Overall Study|Withdrawal by Subject|0|||
143096424|NCT00333983|515893554|FG001|Overall Study|Withdrawal by Subject|3|||
143096425|NCT00333983|515893555|FG002|Overall Study|Withdrawal by Subject|1|||
143096426|NCT01209949|515893565|FG000|Overall Study|Lost to Follow-up|3|||
143096427|NCT04878432|515893570|FG000|Overall Study|Adverse Event|1|||
143096428|NCT04878432|515893570|FG000|Overall Study|Death|2|||
143096429|NCT04878432|515893570|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
143096430|NCT04878432|515893570|FG000|Overall Study|Withdrawal by Subject|6|||
143096431|NCT04878432|515893570|FG000|Overall Study|Progressive Disease|7|||
143251469|NCT01578850|516474216|FG002|Period 1|Adverse Event|0|||
143251470|NCT01578850|516474214|FG000|Period 1|Death|1|||
143251471|NCT01578850|516474215|FG001|Period 1|Death|0|||
143251472|NCT01578850|516474216|FG002|Period 1|Death|0|||
143251473|NCT01578850|516474214|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
143251474|NCT01578850|516474215|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
143251475|NCT01578850|516474216|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
143251476|NCT01578850|516474214|FG000|Period 1|Withdrawal by Subject|9|||
143251477|NCT01578850|516474215|FG001|Period 1|Withdrawal by Subject|0|||
143251478|NCT01578850|516474216|FG002|Period 1|Withdrawal by Subject|0|||
143251479|NCT01578850|516474214|FG000|Period 1|Study Terminated by Sponsor|3|||
143251480|NCT01578850|516474215|FG001|Period 1|Study Terminated by Sponsor|0|||
143251481|NCT01578850|516474216|FG002|Period 1|Study Terminated by Sponsor|0|||
143251482|NCT01578850|516474214|FG000|Period 2|Insufficient Clinical Response|0|||
143251483|NCT01578850|516474215|FG001|Period 2|Insufficient Clinical Response|1|||
143251484|NCT01578850|516474216|FG002|Period 2|Insufficient Clinical Response|0|||
143251485|NCT01578850|516474214|FG000|Period 2|Adverse Event|0|||
143251486|NCT01578850|516474215|FG001|Period 2|Adverse Event|3|||
143251487|NCT01578850|516474216|FG002|Period 2|Adverse Event|6|||
143251488|NCT01578850|516474214|FG000|Period 2|Lost to Follow-up|0|||
143251489|NCT01578850|516474215|FG001|Period 2|Lost to Follow-up|1|||
143251490|NCT01578850|516474216|FG002|Period 2|Lost to Follow-up|2|||
143251491|NCT01578850|516474214|FG000|Period 2|Withdrawal by Subject|0|||
143251492|NCT01578850|516474215|FG001|Period 2|Withdrawal by Subject|2|||
143251493|NCT01578850|516474216|FG002|Period 2|Withdrawal by Subject|2|||
143251494|NCT01578850|516474214|FG000|Period 2|Study Terminated by Sponsor|0|||
143251495|NCT01578850|516474215|FG001|Period 2|Study Terminated by Sponsor|5|||
143251496|NCT01578850|516474216|FG002|Period 2|Study Terminated by Sponsor|4|||
143251497|NCT01578850|516474214|FG000|Period 2|Unspecified Reasons|0|||
143251498|NCT01578850|516474215|FG001|Period 2|Unspecified Reasons|1|||
143251499|NCT01578850|516474216|FG002|Period 2|Unspecified Reasons|0|||
143251500|NCT01711216|516474221|FG000|Overall Study|Adverse Event|4|||
143251501|NCT01711216|516474221|FG000|Overall Study|Pregnancy|56|||
143251502|NCT01711216|516474221|FG000|Overall Study|Withdrawal by Subject|6|||
143096432|NCT04878432|515893570|FG000|Overall Study|New Therapy for Study Indication|7|||
143251503|NCT01711216|516474221|FG000|Overall Study|Lost to Follow-up|46|||
143251504|NCT01711216|516474221|FG000|Overall Study|variety of other minor reasons|83|||
143251505|NCT01711216|516474221|FG000|Overall Study|no reason specified|22|||
143251506|NCT02228980|516474222|FG000|Overall Study|Adverse Event|14|||
143251507|NCT02228980|516474223|FG001|Overall Study|Adverse Event|0|||
143251508|NCT02228980|516474224|FG002|Overall Study|Adverse Event|0|||
143096433|NCT04878432|515893570|FG000|Overall Study|Physician Decision|11|||
143096434|NCT02075203|515893574|FG000|Overall Study|Withdrawal by Subject|1|||
143096435|NCT02075203|515893575|FG001|Overall Study|Withdrawal by Subject|0|||
143096436|NCT02075203|515893576|FG002|Overall Study|Withdrawal by Subject|1|||
143096437|NCT02075203|515893574|FG000|Overall Study|Adverse Event|1|||
143251509|NCT02228980|516474225|FG003|Overall Study|Adverse Event|0|||
143251510|NCT02228980|516474222|FG000|Overall Study|Protocol Violation|7|||
143096438|NCT02075203|515893575|FG001|Overall Study|Adverse Event|0|||
143096439|NCT02075203|515893576|FG002|Overall Study|Adverse Event|0|||
143096440|NCT02075203|515893574|FG000|Overall Study|participant refused to use contraception|1|||
143096441|NCT02075203|515893575|FG001|Overall Study|participant refused to use contraception|0|||
143096442|NCT02075203|515893576|FG002|Overall Study|participant refused to use contraception|0|||
143096443|NCT00350207|515893577|FG000|Overall Study|Adverse Event|5|||
143096444|NCT00350207|515893578|FG001|Overall Study|Adverse Event|2|||
143096445|NCT00350207|515893579|FG002|Overall Study|Adverse Event|2|||
143096446|NCT00350207|515893577|FG000|Overall Study|Lack of Efficacy|1|||
143096447|NCT00350207|515893578|FG001|Overall Study|Lack of Efficacy|0|||
143096448|NCT00350207|515893579|FG002|Overall Study|Lack of Efficacy|2|||
143096449|NCT00350207|515893577|FG000|Overall Study|Lost to Follow-up|1|||
143096450|NCT00350207|515893578|FG001|Overall Study|Lost to Follow-up|0|||
143096451|NCT00350207|515893579|FG002|Overall Study|Lost to Follow-up|1|||
143096452|NCT00350207|515893577|FG000|Overall Study|Withdrawal by Subject|0|||
143096453|NCT00350207|515893578|FG001|Overall Study|Withdrawal by Subject|1|||
143096454|NCT00350207|515893579|FG002|Overall Study|Withdrawal by Subject|1|||
143096455|NCT00350207|515893577|FG000|Overall Study|Other|1|||
143096456|NCT00350207|515893578|FG001|Overall Study|Other|3|||
143096457|NCT00350207|515893579|FG002|Overall Study|Other|1|||
143096458|NCT00495391|515893580|FG000|Overall Study|Lack of Efficacy|34|||
143096459|NCT00495391|515893581|FG001|Overall Study|Lack of Efficacy|18|||
143096460|NCT00495391|515893580|FG000|Overall Study|Withdrawal by Subject|2|||
143096461|NCT00495391|515893581|FG001|Overall Study|Withdrawal by Subject|3|||
143096462|NCT05344560|515893584|FG000|Period 1|Subject out of visit window|1|||
143096463|NCT05344560|515893585|FG001|Period 1|Subject out of visit window|1|||
143096464|NCT05344560|515893584|FG000|Period 2|Covid-19 Related|1|||
143096465|NCT05344560|515893585|FG001|Period 2|Covid-19 Related|0|||
143096466|NCT05344560|515893584|FG000|Period 2|Adverse Event|1|||
143096467|NCT05344560|515893585|FG001|Period 2|Adverse Event|0|||
143096468|NCT05344560|515893584|FG000|Period 2|Subject out of visit window|1|||
143096469|NCT05344560|515893585|FG001|Period 2|Subject out of visit window|1|||
143096470|NCT05344560|515893584|FG000|Period 3|Subject out of visit window|1|||
143096471|NCT05344560|515893585|FG001|Period 3|Subject out of visit window|0|||
143096472|NCT03817853|515893586|FG000|Induction Phase|Adverse Event|5|||
143096473|NCT03817853|515893587|FG001|Induction Phase|Adverse Event|0|||
143096474|NCT03817853|515893588|FG002|Induction Phase|Adverse Event|0|||
143096475|NCT03817853|515893586|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
143096476|NCT03817853|515893587|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
143096477|NCT03817853|515893588|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
143096478|NCT03817853|515893586|FG000|Induction Phase|Physician Decision|2|||
143096479|NCT03817853|515893587|FG001|Induction Phase|Physician Decision|0|||
143096480|NCT03817853|515893588|FG002|Induction Phase|Physician Decision|0|||
143096481|NCT03817853|515893586|FG000|Induction Phase|Progressive Disease|6|||
143096482|NCT03817853|515893587|FG001|Induction Phase|Progressive Disease|0|||
143096483|NCT03817853|515893588|FG002|Induction Phase|Progressive Disease|0|||
143096484|NCT03817853|515893586|FG000|Induction Phase|Withdrawal by Subject|4|||
143096485|NCT03817853|515893587|FG001|Induction Phase|Withdrawal by Subject|0|||
143096486|NCT03817853|515893588|FG002|Induction Phase|Withdrawal by Subject|0|||
143096487|NCT03817853|515893586|FG000|Maintenance Phase|Adverse Event|0|||
143096488|NCT03817853|515893587|FG001|Maintenance Phase|Adverse Event|8|||
143096489|NCT03817853|515893588|FG002|Maintenance Phase|Adverse Event|0|||
143096490|NCT03817853|515893586|FG000|Maintenance Phase|Death|0|||
143096491|NCT03817853|515893587|FG001|Maintenance Phase|Death|5|||
143096492|NCT03817853|515893588|FG002|Maintenance Phase|Death|0|||
143096493|NCT03817853|515893586|FG000|Maintenance Phase|Progressive Disease|0|||
143096494|NCT03817853|515893587|FG001|Maintenance Phase|Progressive Disease|7|||
143096495|NCT03817853|515893588|FG002|Maintenance Phase|Progressive Disease|0|||
143096496|NCT03817853|515893586|FG000|Maintenance Phase|Withdrawal by Subject|0|||
143096497|NCT03817853|515893587|FG001|Maintenance Phase|Withdrawal by Subject|2|||
143096498|NCT03817853|515893588|FG002|Maintenance Phase|Withdrawal by Subject|0|||
143096499|NCT03817853|515893586|FG000|Maintenance Phase|Physician Decision|0|||
143096500|NCT03817853|515893587|FG001|Maintenance Phase|Physician Decision|1|||
143096501|NCT03817853|515893588|FG002|Maintenance Phase|Physician Decision|0|||
143096502|NCT03817853|515893586|FG000|Maintenance Phase|Various reasons|0|||
143096503|NCT03817853|515893587|FG001|Maintenance Phase|Various reasons|4|||
143096504|NCT03817853|515893588|FG002|Maintenance Phase|Various reasons|0|||
143096505|NCT03817853|515893586|FG000|Maintenance Phase|Protocol Deviation|0|||
143367539|NCT02595398|516889396|FG001|Overall Study|Non-compliance|0|||
143096506|NCT03817853|515893587|FG001|Maintenance Phase|Protocol Deviation|1|||
143096507|NCT03817853|515893588|FG002|Maintenance Phase|Protocol Deviation|0|||
143096508|NCT03817853|515893586|FG000|Follow-up Phase|Adverse Event|0|||
143096509|NCT03817853|515893587|FG001|Follow-up Phase|Adverse Event|0|||
143096510|NCT03817853|515893588|FG002|Follow-up Phase|Adverse Event|2|||
143096511|NCT03817853|515893586|FG000|Follow-up Phase|Death|0|||
143096512|NCT03817853|515893587|FG001|Follow-up Phase|Death|0|||
143176918|NCT00811720|516196237|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
143176919|NCT00811720|516196236|FG000|All Treated Patients|Adverse Event|20|||
143176920|NCT00811720|516196237|FG001|All Treated Patients|Adverse Event|62|||
143176921|NCT00811720|516196236|FG000|All Treated Patients|Lack of Efficacy|22|||
143176922|NCT00811720|516196237|FG001|All Treated Patients|Lack of Efficacy|18|||
143096513|NCT03817853|515893588|FG002|Follow-up Phase|Death|1|||
143176923|NCT00811720|516196236|FG000|All Treated Patients|Non-compliance|0|||
143176924|NCT00811720|516196237|FG001|All Treated Patients|Non-compliance|14|||
143176925|NCT00811720|516196236|FG000|All Treated Patients|Protocol Violation|9|||
143176926|NCT00811720|516196237|FG001|All Treated Patients|Protocol Violation|16|||
143176927|NCT00811720|516196236|FG000|All Treated Patients|Withdrawal by Subject|28|||
143176928|NCT00811720|516196237|FG001|All Treated Patients|Withdrawal by Subject|34|||
143176929|NCT00811720|516196236|FG000|All Treated Patients|Lost to Follow-up|10|||
143096514|NCT03817853|515893586|FG000|Follow-up Phase|Progressive Disease|0|||
143096515|NCT03817853|515893587|FG001|Follow-up Phase|Progressive Disease|0|||
143096516|NCT03817853|515893588|FG002|Follow-up Phase|Progressive Disease|3|||
143096517|NCT03817853|515893586|FG000|Follow-up Phase|Withdrawal by Subject|0|||
143096518|NCT03817853|515893587|FG001|Follow-up Phase|Withdrawal by Subject|0|||
143096519|NCT03817853|515893588|FG002|Follow-up Phase|Withdrawal by Subject|1|||
143096520|NCT00391768|515893589|FG000|Overall Study|Withdrawal by Subject|0|||
143096521|NCT00391768|515893590|FG001|Overall Study|Withdrawal by Subject|0|||
143096522|NCT00391768|515893591|FG002|Overall Study|Withdrawal by Subject|1|||
143096523|NCT00391768|515893592|FG003|Overall Study|Withdrawal by Subject|0|||
143096524|NCT00391768|515893593|FG004|Overall Study|Withdrawal by Subject|0|||
143096525|NCT00391768|515893594|FG005|Overall Study|Withdrawal by Subject|1|||
143096526|NCT00391768|515893595|FG006|Overall Study|Withdrawal by Subject|1|||
143251511|NCT02228980|516474223|FG001|Overall Study|Protocol Violation|0|||
143251512|NCT02228980|516474224|FG002|Overall Study|Protocol Violation|0|||
143251513|NCT02228980|516474225|FG003|Overall Study|Protocol Violation|0|||
143251514|NCT02228980|516474222|FG000|Overall Study|Withdrawal by Subject|3|||
143251515|NCT02228980|516474223|FG001|Overall Study|Withdrawal by Subject|3|||
143251516|NCT02228980|516474224|FG002|Overall Study|Withdrawal by Subject|2|||
143367540|NCT02595398|516889395|FG000|Overall Study|Withdrawal by Subject|2|||
143367541|NCT02595398|516889396|FG001|Overall Study|Withdrawal by Subject|1|||
143367542|NCT02595398|516889395|FG000|Overall Study|Lost to Follow-up|1|||
143367543|NCT02595398|516889396|FG001|Overall Study|Lost to Follow-up|0|||
143367544|NCT01664104|516889398|FG000|Overall Study|Adverse Event|6|||
143367545|NCT01664104|516889398|FG000|Overall Study|Lack of Efficacy|2|||
143367546|NCT01664104|516889398|FG000|Overall Study|Withdrawal by Subject|1|||
143367547|NCT01664104|516889398|FG000|Overall Study|Lost to Follow-up|4|||
143367548|NCT01664104|516889398|FG000|Overall Study|Other|1|||
143367549|NCT01664104|516889398|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
143367550|NCT03586167|516889399|FG000|Overall Study|Other|1|||
143367551|NCT03586167|516889400|FG001|Overall Study|Other|0|||
143367552|NCT04109118|516889401|FG000|Overall Study|Lost to Follow-up|3|||
143367553|NCT03394027|516889402|FG000|Overall Study|Ineligible|3|||
143367554|NCT03394027|516889403|FG001|Overall Study|Ineligible|1|||
143367555|NCT03394027|516889404|FG002|Overall Study|Ineligible|3|||
143367556|NCT03394027|516889402|FG000|Overall Study|Participant declined to participate before treatment started|0|||
143367557|NCT03394027|516889403|FG001|Overall Study|Participant declined to participate before treatment started|0|||
143367558|NCT03394027|516889404|FG002|Overall Study|Participant declined to participate before treatment started|1|||
143367559|NCT01268566|516889407|FG000|Overall Study|Lost to Follow-up|1|||
143367560|NCT01268566|516889407|FG000|Overall Study|Withdrawal by Subject|12|||
143367561|NCT01268566|516889407|FG000|Overall Study|Death|30|||
143367562|NCT02138916|516889408|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
143367563|NCT02138916|516889409|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
143367564|NCT02138916|516889410|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
143367565|NCT02138916|516889408|FG000|Overall Study|Death|14|||
143367566|NCT02138916|516889409|FG001|Overall Study|Death|11|||
143367567|NCT02138916|516889410|FG002|Overall Study|Death|12|||
143367568|NCT02138916|516889408|FG000|Overall Study|Withdrawal by Subject|27|||
143096527|NCT00391768|515893589|FG000|Overall Study|Lost to Follow-up|0|||
143096528|NCT00391768|515893590|FG001|Overall Study|Lost to Follow-up|0|||
143096529|NCT00391768|515893591|FG002|Overall Study|Lost to Follow-up|0|||
143096530|NCT00391768|515893592|FG003|Overall Study|Lost to Follow-up|1|||
143096531|NCT00391768|515893593|FG004|Overall Study|Lost to Follow-up|2|||
143096532|NCT00391768|515893594|FG005|Overall Study|Lost to Follow-up|2|||
143096533|NCT00391768|515893595|FG006|Overall Study|Lost to Follow-up|3|||
143096534|NCT01620138|515893596|FG000|Overall Study|Withdrawal by Subject|3|||
143096535|NCT01620138|515893597|FG001|Overall Study|Withdrawal by Subject|0|||
143096536|NCT01620138|515893596|FG000|Overall Study|Lack of Efficacy|1|||
143096537|NCT01620138|515893597|FG001|Overall Study|Lack of Efficacy|0|||
143096538|NCT01620138|515893596|FG000|Overall Study|Adverse Event|2|||
143096539|NCT01620138|515893597|FG001|Overall Study|Adverse Event|0|||
143096540|NCT00449865|515893600|FG000|Overall Study|Withdrawal by Subject|110|||
143096541|NCT00449865|515893601|FG001|Overall Study|Withdrawal by Subject|110|||
143096542|NCT00449865|515893600|FG000|Overall Study|Lost to Follow-up|36|||
143096543|NCT00449865|515893601|FG001|Overall Study|Lost to Follow-up|37|||
143096544|NCT00449865|515893600|FG000|Overall Study|Physician Decision|13|||
143096545|NCT00449865|515893601|FG001|Overall Study|Physician Decision|12|||
143096546|NCT00449865|515893600|FG000|Overall Study|Death|31|||
143096547|NCT00449865|515893601|FG001|Overall Study|Death|40|||
143096548|NCT00449865|515893600|FG000|Overall Study|Protocol Violation|8|||
143096549|NCT00449865|515893601|FG001|Overall Study|Protocol Violation|7|||
143096550|NCT00449865|515893600|FG000|Overall Study|Study was stopped|324|||
143096551|NCT00449865|515893601|FG001|Overall Study|Study was stopped|328|||
143096552|NCT00406367|515893602|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
143096553|NCT00406367|515893603|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
143367569|NCT02138916|516889409|FG001|Overall Study|Withdrawal by Subject|31|||
143367570|NCT02138916|516889410|FG002|Overall Study|Withdrawal by Subject|32|||
143367571|NCT02138916|516889408|FG000|Overall Study|Study specific withdrawal criteria|0|||
143367572|NCT02138916|516889409|FG001|Overall Study|Study specific withdrawal criteria|0|||
143367573|NCT02138916|516889410|FG002|Overall Study|Study specific withdrawal criteria|1|||
143096554|NCT00406367|515893602|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
143096555|NCT00406367|515893603|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
143096556|NCT00406367|515893602|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
143096557|NCT00406367|515893603|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
143096558|NCT00406367|515893602|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
143096559|NCT00406367|515893603|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
143367574|NCT02138916|516889408|FG000|Overall Study|incorrect enrolment|1|||
143367575|NCT02138916|516889409|FG001|Overall Study|incorrect enrolment|1|||
143367576|NCT02138916|516889410|FG002|Overall Study|incorrect enrolment|0|||
143096560|NCT00406367|515893602|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
143096561|NCT00406367|515893603|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
143096562|NCT00406367|515893602|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
143096563|NCT00406367|515893603|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
143096564|NCT00406367|515893602|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
143096565|NCT00406367|515893603|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
143096566|NCT00406367|515893602|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
143096567|NCT00406367|515893603|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
143096568|NCT00406367|515893602|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
143096569|NCT00406367|515893603|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
143096570|NCT00406367|515893602|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
143096571|NCT00406367|515893603|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
143096572|NCT00406367|515893602|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
143096573|NCT00406367|515893603|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
143096574|NCT00406367|515893602|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
143096575|NCT00406367|515893603|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
143096576|NCT00171210|515893604|FG000|Overall Study|Adverse Event|16|||
143096577|NCT00171210|515893605|FG001|Overall Study|Adverse Event|27|||
143096578|NCT00171210|515893604|FG000|Overall Study|Abnormal laboratory value(s)|6|||
143096579|NCT00171210|515893605|FG001|Overall Study|Abnormal laboratory value(s)|3|||
143096580|NCT00171210|515893604|FG000|Overall Study|Abnormal test procedure result(s)|0|||
143096581|NCT00171210|515893605|FG001|Overall Study|Abnormal test procedure result(s)|1|||
143096582|NCT00171210|515893604|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
143096583|NCT00171210|515893605|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
143096584|NCT00171210|515893604|FG000|Overall Study|Protocol Violation|0|||
143096585|NCT00171210|515893605|FG001|Overall Study|Protocol Violation|2|||
143096586|NCT00171210|515893604|FG000|Overall Study|Withdrawal by Subject|32|||
143096587|NCT00171210|515893605|FG001|Overall Study|Withdrawal by Subject|30|||
143096588|NCT00171210|515893604|FG000|Overall Study|Lost to Follow-up|1|||
143096589|NCT00171210|515893605|FG001|Overall Study|Lost to Follow-up|0|||
143096590|NCT00171210|515893604|FG000|Overall Study|Administrative problems|1|||
143096591|NCT00171210|515893605|FG001|Overall Study|Administrative problems|1|||
143096592|NCT00171210|515893604|FG000|Overall Study|Death|2|||
143096593|NCT00171210|515893605|FG001|Overall Study|Death|3|||
143096594|NCT00171210|515893604|FG000|Overall Study|Stopped at end of core|0|||
143096595|NCT00171210|515893605|FG001|Overall Study|Stopped at end of core|32|||
143096596|NCT00171210|515893604|FG000|Overall Study|Stopped at end of extension 1|0|||
143096597|NCT00171210|515893605|FG001|Overall Study|Stopped at end of extension 1|1|||
143096598|NCT03187301|515893608|FG000|Titration Period|Adverse Event|0|||
143251517|NCT02228980|516474225|FG003|Overall Study|Withdrawal by Subject|3|||
143251518|NCT02929498|516474226|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
143251519|NCT02929498|516474227|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
143251520|NCT02929498|516474228|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
143251521|NCT02929498|516474226|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
143251522|NCT02929498|516474227|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
143251523|NCT02929498|516474228|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
143251524|NCT00750152|516474231|FG000|Overall Study|Adverse Event|2|||
143251525|NCT00750152|516474232|FG001|Overall Study|Adverse Event|1|||
143251526|NCT00750152|516474231|FG000|Overall Study|Lost to Follow-up|8|||
143251527|NCT00750152|516474232|FG001|Overall Study|Lost to Follow-up|13|||
143251528|NCT00750152|516474231|FG000|Overall Study|Withdrawal by Subject|3|||
143096599|NCT03187301|515893609|FG001|Titration Period|Adverse Event|0|||
143251529|NCT00750152|516474232|FG001|Overall Study|Withdrawal by Subject|3|||
143096600|NCT03187301|515893610|FG002|Titration Period|Adverse Event|0|||
143096601|NCT03187301|515893611|FG003|Titration Period|Adverse Event|0|||
143096602|NCT03187301|515893612|FG004|Titration Period|Adverse Event|0|||
143096603|NCT03187301|515893613|FG005|Titration Period|Adverse Event|0|||
143096604|NCT03187301|515893614|FG006|Titration Period|Adverse Event|5|||
143096605|NCT03187301|515893608|FG000|Titration Period|Withdrawal by Subject|0|||
143096606|NCT03187301|515893609|FG001|Titration Period|Withdrawal by Subject|0|||
143096607|NCT03187301|515893610|FG002|Titration Period|Withdrawal by Subject|0|||
143096608|NCT03187301|515893611|FG003|Titration Period|Withdrawal by Subject|0|||
143096609|NCT03187301|515893612|FG004|Titration Period|Withdrawal by Subject|0|||
143096610|NCT03187301|515893613|FG005|Titration Period|Withdrawal by Subject|0|||
143096611|NCT03187301|515893614|FG006|Titration Period|Withdrawal by Subject|1|||
143096612|NCT03187301|515893608|FG000|Titration Period|Exclusion Criteria Met|0|||
143096613|NCT03187301|515893609|FG001|Titration Period|Exclusion Criteria Met|0|||
143096614|NCT03187301|515893610|FG002|Titration Period|Exclusion Criteria Met|0|||
143096615|NCT03187301|515893611|FG003|Titration Period|Exclusion Criteria Met|0|||
143096616|NCT03187301|515893612|FG004|Titration Period|Exclusion Criteria Met|0|||
143096617|NCT03187301|515893613|FG005|Titration Period|Exclusion Criteria Met|0|||
143096618|NCT03187301|515893614|FG006|Titration Period|Exclusion Criteria Met|1|||
143096619|NCT03187301|515893608|FG000|Pre-Intervention|Withdrawal by Subject|1|||
143096620|NCT03187301|515893609|FG001|Pre-Intervention|Withdrawal by Subject|0|||
143096621|NCT03187301|515893610|FG002|Pre-Intervention|Withdrawal by Subject|0|||
143096622|NCT03187301|515893611|FG003|Pre-Intervention|Withdrawal by Subject|0|||
143096623|NCT03187301|515893612|FG004|Pre-Intervention|Withdrawal by Subject|0|||
143096624|NCT03187301|515893613|FG005|Pre-Intervention|Withdrawal by Subject|0|||
143096625|NCT03187301|515893614|FG006|Pre-Intervention|Withdrawal by Subject|0|||
143096626|NCT03252535|515893616|FG000|Overall Study|Withdrawal by Subject|1|||
143096627|NCT03252535|515893617|FG001|Overall Study|Withdrawal by Subject|0|||
143096628|NCT03252535|515893618|FG002|Overall Study|Withdrawal by Subject|0|||
143096629|NCT03252535|515893616|FG000|Overall Study|Physician Decision|0|||
143096630|NCT03252535|515893617|FG001|Overall Study|Physician Decision|1|||
143096631|NCT03252535|515893618|FG002|Overall Study|Physician Decision|0|||
143096632|NCT03252535|515893616|FG000|Overall Study|Met discontinuation criteria|0|||
143096633|NCT03252535|515893617|FG001|Overall Study|Met discontinuation criteria|1|||
143096634|NCT03252535|515893618|FG002|Overall Study|Met discontinuation criteria|0|||
143096635|NCT00461630|515893623|FG000|Overall Study|Death|798|||
143096636|NCT00461630|515893624|FG001|Overall Study|Death|732|||
143096637|NCT00461630|515893623|FG000|Overall Study|Lost to Follow-up|108|||
143096638|NCT00461630|515893624|FG001|Overall Study|Lost to Follow-up|95|||
143096639|NCT00997373|515893629|FG000|Overall Study|Withdrawal by Subject|5|||
143096640|NCT00997373|515893630|FG001|Overall Study|Withdrawal by Subject|0|||
143096641|NCT00997373|515893629|FG000|Overall Study|wrong tumor type|4|||
143096642|NCT00997373|515893630|FG001|Overall Study|wrong tumor type|0|||
143096643|NCT00997373|515893629|FG000|Overall Study|could not have hysterectomy|6|||
143096644|NCT00997373|515893630|FG001|Overall Study|could not have hysterectomy|0|||
143096645|NCT01346059|515893631|FG000|Overall Study|Withdrawal by Subject|1|||
143096646|NCT01346059|515893632|FG001|Overall Study|Withdrawal by Subject|0|||
143096647|NCT01753310|515893633|FG000|Overall Study|Entered into open label extension study|25|||
143096648|NCT01753310|515893634|FG001|Overall Study|Entered into open label extension study|22|||
143096649|NCT01753310|515893633|FG000|Overall Study|Adverse Event|1|||
143096650|NCT01753310|515893634|FG001|Overall Study|Adverse Event|0|||
143367577|NCT02138916|516889408|FG000|Overall Study|Severe non-compliance|1|||
143096651|NCT01753310|515893633|FG000|Overall Study|Lost to Follow-up|2|||
143096652|NCT01753310|515893634|FG001|Overall Study|Lost to Follow-up|0|||
143096653|NCT01753310|515893633|FG000|Overall Study|Subject decision|2|||
143096654|NCT01753310|515893634|FG001|Overall Study|Subject decision|2|||
143096655|NCT01753310|515893633|FG000|Overall Study|Sponsor decision|1|||
143096656|NCT01753310|515893634|FG001|Overall Study|Sponsor decision|0|||
143096657|NCT01753310|515893633|FG000|Overall Study|Withdrawal by Subject|1|||
143096658|NCT01753310|515893634|FG001|Overall Study|Withdrawal by Subject|0|||
143096659|NCT02022202|515893635|FG000|Overall Study|Withdrawal by Subject|2|||
143096660|NCT02022202|515893635|FG000|Overall Study|Disease Progression|3|||
143096661|NCT02022202|515893635|FG000|Overall Study|Desire go to immediately to surgery|3|||
143096662|NCT01445730|515893639|FG000|Overall Study|Adverse Event|1|||
143096663|NCT01445730|515893639|FG000|Overall Study|For the advice of a dentist|1|||
143096664|NCT01445730|515893639|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
143096665|NCT01167140|515893642|FG000|Overall Study|Withdrawal by Subject|1|||
143096666|NCT03805412|515893643|FG000|Overall Study|Lost to Follow-up|0|||
143096667|NCT03805412|515893644|FG001|Overall Study|Lost to Follow-up|1|||
143096668|NCT01611883|515893645|FG000|Overall Study|Adverse Event|1|||
143096669|NCT01611883|515893646|FG001|Overall Study|Adverse Event|1|||
143096670|NCT02389829|515893647|FG000|Overall Study|Lost to Follow-up|0|||
143096671|NCT02389829|515893648|FG001|Overall Study|Lost to Follow-up|1|||
143096672|NCT00734994|515893649|FG000|Overall Study|Withdrawal by Subject|1|||
143096673|NCT00571727|515893652|FG000|Overall Study|Did not enter in this study|1|||
143096674|NCT00571727|515893652|FG000|Overall Study|Non-compliance|4|||
143096675|NCT00571727|515893652|FG000|Overall Study|Lost to Follow-up|30|||
143096676|NCT00571727|515893652|FG000|Overall Study|Poor growth|1|||
143096677|NCT00571727|515893652|FG000|Overall Study|Parent/patient decision|2|||
143096678|NCT00571727|515893652|FG000|Overall Study|Participant transferred to commercial drug|14|||
143096679|NCT00571727|515893652|FG000|Overall Study|Unable to provide study drug|6|||
143096680|NCT00571727|515893652|FG000|Overall Study|On-treatment at end of study|8|||
143096681|NCT02747108|515893653|FG000|Overall Study|Death|2|||
143096682|NCT02747108|515893654|FG001|Overall Study|Death|2|||
143096683|NCT02747108|515893653|FG000|Overall Study|Withdrawal by Subject|1|||
143096684|NCT02747108|515893654|FG001|Overall Study|Withdrawal by Subject|0|||
143096685|NCT02747108|515893653|FG000|Overall Study|Protocol Violation|2|||
143096686|NCT02747108|515893654|FG001|Overall Study|Protocol Violation|0|||
143096687|NCT00824772|515895336|FG000|Overall Study|Withdrawal by Subject|8|||
143096688|NCT02954601|515895342|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
143096689|NCT02954601|515895343|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
143096690|NCT02954601|515895344|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
143096691|NCT02954601|515895345|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
143096692|NCT01379768|515895348|FG000|Overall Study|Adverse Event|1|||
143096693|NCT01379768|515895349|FG001|Overall Study|Adverse Event|1|||
143096694|NCT01379768|515895350|FG002|Overall Study|Adverse Event|0|||
143096695|NCT01379768|515895348|FG000|Overall Study|Lost to Follow-up|2|||
143096696|NCT01379768|515895349|FG001|Overall Study|Lost to Follow-up|0|||
143096697|NCT01379768|515895350|FG002|Overall Study|Lost to Follow-up|0|||
143096698|NCT05266053|515895359|FG000|Overall Study|Withdrawal by Subject|8|||
143096699|NCT05266053|515895360|FG001|Overall Study|Withdrawal by Subject|4|||
143096700|NCT02996968|515895361|FG000|Overall Study|Withdrawal by Subject|1|||
143096701|NCT02996968|515895362|FG001|Overall Study|Withdrawal by Subject|0|||
143096702|NCT01671007|515895365|FG000|Overall Study|Other reasons than listed|166|||
143096703|NCT01671007|515895366|FG001|Overall Study|Other reasons than listed|373|||
143096704|NCT01671007|515895367|FG002|Overall Study|Other reasons than listed|197|||
143096705|NCT01671007|515895368|FG003|Overall Study|Other reasons than listed|228|||
143096706|NCT01671007|515895369|FG004|Overall Study|Other reasons than listed|14|||
143096707|NCT01671007|515895370|FG005|Overall Study|Other reasons than listed|71|||
143096708|NCT01671007|515895371|FG006|Overall Study|Other reasons than listed|17|||
143096709|NCT01671007|515895372|FG007|Overall Study|Other reasons than listed|66|||
143096710|NCT01671007|515895373|FG008|Overall Study|Other reasons than listed|0|||
143096711|NCT01671007|515895365|FG000|Overall Study|Withdrawal by Subject|36|||
143096712|NCT01671007|515895366|FG001|Overall Study|Withdrawal by Subject|59|||
143096713|NCT01671007|515895367|FG002|Overall Study|Withdrawal by Subject|53|||
143096714|NCT01671007|515895368|FG003|Overall Study|Withdrawal by Subject|58|||
143096715|NCT01671007|515895369|FG004|Overall Study|Withdrawal by Subject|4|||
143096716|NCT01671007|515895370|FG005|Overall Study|Withdrawal by Subject|15|||
143096717|NCT01671007|515895371|FG006|Overall Study|Withdrawal by Subject|1|||
143176930|NCT00811720|516196237|FG001|All Treated Patients|Lost to Follow-up|16|||
143176931|NCT00811720|516196236|FG000|All Treated Patients|Other Reason|7|||
143096718|NCT01671007|515895372|FG007|Overall Study|Withdrawal by Subject|19|||
143176932|NCT00811720|516196237|FG001|All Treated Patients|Other Reason|4|||
143176933|NCT03894891|516196238|FG000|Overall Study|Withdrawal by Subject|1|||
143176934|NCT03894891|516196238|FG000|Overall Study|Completed protocol treatment per protocol|5|||
143176935|NCT01824290|516196240|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
143176936|NCT01824290|516196241|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
143176937|NCT01824290|516196242|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
143096719|NCT01671007|515895373|FG008|Overall Study|Withdrawal by Subject|0|||
143096720|NCT01671007|515895365|FG000|Overall Study|Lost to Follow-up|93|||
143096721|NCT01671007|515895366|FG001|Overall Study|Lost to Follow-up|142|||
143096722|NCT01671007|515895367|FG002|Overall Study|Lost to Follow-up|91|||
143096723|NCT01671007|515895368|FG003|Overall Study|Lost to Follow-up|63|||
143096724|NCT01671007|515895369|FG004|Overall Study|Lost to Follow-up|7|||
143096725|NCT01671007|515895370|FG005|Overall Study|Lost to Follow-up|20|||
143096726|NCT01671007|515895371|FG006|Overall Study|Lost to Follow-up|2|||
143096727|NCT01671007|515895372|FG007|Overall Study|Lost to Follow-up|28|||
143096728|NCT01671007|515895373|FG008|Overall Study|Lost to Follow-up|0|||
143096729|NCT01671007|515895365|FG000|Overall Study|No end of study case report form|3|||
143096730|NCT01671007|515895366|FG001|Overall Study|No end of study case report form|1|||
143096731|NCT01671007|515895367|FG002|Overall Study|No end of study case report form|0|||
143096732|NCT01671007|515895368|FG003|Overall Study|No end of study case report form|2|||
143096733|NCT01671007|515895369|FG004|Overall Study|No end of study case report form|0|||
143096734|NCT01671007|515895370|FG005|Overall Study|No end of study case report form|0|||
143096735|NCT01671007|515895371|FG006|Overall Study|No end of study case report form|0|||
143096736|NCT01671007|515895372|FG007|Overall Study|No end of study case report form|0|||
143096737|NCT01671007|515895373|FG008|Overall Study|No end of study case report form|0|||
143096738|NCT01671007|515895365|FG000|Overall Study|Not eligible|23|||
143096739|NCT01671007|515895366|FG001|Overall Study|Not eligible|76|||
143096740|NCT01671007|515895367|FG002|Overall Study|Not eligible|25|||
143096741|NCT01671007|515895368|FG003|Overall Study|Not eligible|17|||
143096742|NCT01671007|515895369|FG004|Overall Study|Not eligible|0|||
143096743|NCT01671007|515895370|FG005|Overall Study|Not eligible|6|||
143096744|NCT01671007|515895371|FG006|Overall Study|Not eligible|1|||
143096745|NCT01671007|515895372|FG007|Overall Study|Not eligible|19|||
143096746|NCT01671007|515895373|FG008|Overall Study|Not eligible|0|||
143096747|NCT01966120|515895374|FG000|Overall Study|Withdrawal by Subject|0|||
143096748|NCT01966120|515895375|FG001|Overall Study|Withdrawal by Subject|5|||
143096749|NCT01966120|515895374|FG000|Overall Study|Lost to Follow-up|1|||
143096750|NCT01966120|515895375|FG001|Overall Study|Lost to Follow-up|1|||
143096751|NCT00442897|515895378|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
143096752|NCT00442897|515895379|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
143096753|NCT00442897|515895378|FG000|Base Study (12 Week Follow-up)|Death|0|||
143096754|NCT00442897|515895379|FG001|Base Study (12 Week Follow-up)|Death|1|||
143096755|NCT00442897|515895378|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
143096756|NCT00442897|515895379|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
143096757|NCT00442897|515895378|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
143096758|NCT00442897|515895379|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
143096759|NCT00442897|515895378|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
143096760|NCT00442897|515895379|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
143096761|NCT00442897|515895378|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
143096762|NCT00442897|515895379|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
143096763|NCT00442897|515895378|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
143096764|NCT00442897|515895379|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
143096765|NCT00442897|515895378|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
143251530|NCT00750152|516474231|FG000|Overall Study|Physician Decision|1|||
143251531|NCT00750152|516474232|FG001|Overall Study|Physician Decision|1|||
143251532|NCT00750152|516474231|FG000|Overall Study|Non-compliance|0|||
143251533|NCT00750152|516474232|FG001|Overall Study|Non-compliance|1|||
143251534|NCT00750152|516474231|FG000|Overall Study|Termination by sponsor|1|||
143251535|NCT00750152|516474232|FG001|Overall Study|Termination by sponsor|0|||
143251536|NCT00750152|516474231|FG000|Overall Study|Other|7|||
143251537|NCT00750152|516474232|FG001|Overall Study|Other|8|||
143251538|NCT00715910|516474233|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
143251539|NCT00715910|516474234|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
143251540|NCT00715910|516474235|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
143251541|NCT00715910|516474236|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
143367578|NCT02138916|516889409|FG001|Overall Study|Severe non-compliance|2|||
143367579|NCT02138916|516889410|FG002|Overall Study|Severe non-compliance|1|||
143367580|NCT02138916|516889408|FG000|Overall Study|Lost to Follow-up|4|||
143367581|NCT02138916|516889409|FG001|Overall Study|Lost to Follow-up|2|||
143367582|NCT02138916|516889410|FG002|Overall Study|Lost to Follow-up|3|||
143367583|NCT02138916|516889408|FG000|Overall Study|Adverse Event|4|||
143367584|NCT02138916|516889409|FG001|Overall Study|Adverse Event|4|||
143096766|NCT00442897|515895379|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
143096767|NCT04498182|515895380|FG000|Overall Study|Adverse Event|2|||
143096768|NCT04498182|515895381|FG001|Overall Study|Adverse Event|3|||
143096769|NCT04498182|515895382|FG002|Overall Study|Adverse Event|2|||
143096770|NCT04498182|515895380|FG000|Overall Study|Withdrawal of Consent|3|||
143096771|NCT04498182|515895381|FG001|Overall Study|Withdrawal of Consent|4|||
143096772|NCT04498182|515895382|FG002|Overall Study|Withdrawal of Consent|3|||
143096773|NCT04498182|515895380|FG000|Overall Study|Non-Compliant|1|||
143096774|NCT04498182|515895381|FG001|Overall Study|Non-Compliant|0|||
143096775|NCT04498182|515895382|FG002|Overall Study|Non-Compliant|1|||
143096776|NCT04498182|515895380|FG000|Overall Study|Lost to Follow-up|0|||
143096777|NCT04498182|515895381|FG001|Overall Study|Lost to Follow-up|0|||
143096778|NCT04498182|515895382|FG002|Overall Study|Lost to Follow-up|1|||
143096779|NCT04498182|515895380|FG000|Overall Study|Investigator Decision|0|||
143096780|NCT04498182|515895381|FG001|Overall Study|Investigator Decision|0|||
143096781|NCT04498182|515895382|FG002|Overall Study|Investigator Decision|1|||
143096782|NCT04498182|515895380|FG000|Overall Study|Protocol Violation|1|||
143096783|NCT04498182|515895381|FG001|Overall Study|Protocol Violation|0|||
143096784|NCT04498182|515895382|FG002|Overall Study|Protocol Violation|2|||
143096785|NCT02182843|515895383|FG000|Overall Study|Withdrawal by Subject|7|||
143096786|NCT02182843|515895383|FG000|Overall Study|Lost to Follow-up|2|||
143096787|NCT02182843|515895383|FG000|Overall Study|Adverse Event|1|||
143096788|NCT00891020|515895386|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
143096789|NCT00891020|515895387|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
143096790|NCT00891020|515895388|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
143096791|NCT00891020|515895386|FG000|24 Week Treatment Period|Death|0|||
143096792|NCT00891020|515895387|FG001|24 Week Treatment Period|Death|2|||
143096793|NCT00891020|515895388|FG002|24 Week Treatment Period|Death|0|||
143096794|NCT00891020|515895386|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
143096795|NCT00891020|515895387|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
143096796|NCT00891020|515895388|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
143096797|NCT00891020|515895386|FG000|24 Week Treatment Period|Failure to return|4|||
143096798|NCT00891020|515895387|FG001|24 Week Treatment Period|Failure to return|5|||
143096799|NCT00891020|515895388|FG002|24 Week Treatment Period|Failure to return|5|||
143096800|NCT00891020|515895386|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
143096801|NCT00891020|515895387|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
143096802|NCT00891020|515895388|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
143096803|NCT00891020|515895386|FG000|24 Week Treatment Period|Other protocol violation|1|||
143096804|NCT00891020|515895387|FG001|24 Week Treatment Period|Other protocol violation|1|||
143096805|NCT00891020|515895388|FG002|24 Week Treatment Period|Other protocol violation|2|||
143096806|NCT00891020|515895386|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
143096807|NCT00891020|515895387|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
143096808|NCT00891020|515895388|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
143096809|NCT00891020|515895386|FG000|24 Week Treatment Period|Withdrew consent|6|||
143096810|NCT00891020|515895387|FG001|24 Week Treatment Period|Withdrew consent|3|||
143096811|NCT00891020|515895388|FG002|24 Week Treatment Period|Withdrew consent|15|||
143096812|NCT00891020|515895386|FG000|24 Week Treatment Period|Administrative/Other|5|||
143096813|NCT00891020|515895387|FG001|24 Week Treatment Period|Administrative/Other|6|||
143096814|NCT00891020|515895388|FG002|24 Week Treatment Period|Administrative/Other|1|||
143096815|NCT00891020|515895386|FG000|Long-term Extension Period|Adverse Event|1|||
143096816|NCT00891020|515895387|FG001|Long-term Extension Period|Adverse Event|11|||
143096817|NCT00891020|515895388|FG002|Long-term Extension Period|Adverse Event|10|||
143096818|NCT00891020|515895386|FG000|Long-term Extension Period|Death|0|||
143096819|NCT00891020|515895387|FG001|Long-term Extension Period|Death|0|||
143096820|NCT00891020|515895388|FG002|Long-term Extension Period|Death|1|||
143096821|NCT00891020|515895386|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
143096822|NCT00891020|515895387|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
143096823|NCT00891020|515895388|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
143096824|NCT00891020|515895386|FG000|Long-term Extension Period|Protocol Violation|0|||
143096825|NCT00891020|515895387|FG001|Long-term Extension Period|Protocol Violation|1|||
143096826|NCT00891020|515895388|FG002|Long-term Extension Period|Protocol Violation|1|||
143096827|NCT00891020|515895386|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
143096828|NCT00891020|515895387|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
143251542|NCT00715910|516474237|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
143251543|NCT00715910|516474238|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
143251544|NCT00715910|516474233|FG000|Booster and ESFU Phase|Other|0|||
143251545|NCT00715910|516474234|FG001|Booster and ESFU Phase|Other|0|||
143251546|NCT00715910|516474235|FG002|Booster and ESFU Phase|Other|0|||
143251547|NCT00715910|516474236|FG003|Booster and ESFU Phase|Other|5|||
143251548|NCT00715910|516474237|FG004|Booster and ESFU Phase|Other|1|||
143251549|NCT00715910|516474238|FG005|Booster and ESFU Phase|Other|0|||
143251550|NCT05477108|516474239|FG000|Overall Study|Participants randomized, not treated|1|||
143251551|NCT05477108|516474240|FG001|Overall Study|Participants randomized, not treated|1|||
143096829|NCT00891020|515895388|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
143096830|NCT00891020|515895386|FG000|Long-term Extension Period|Failure to return|0|||
143096831|NCT00891020|515895387|FG001|Long-term Extension Period|Failure to return|2|||
143251552|NCT05477108|516474241|FG002|Overall Study|Participants randomized, not treated|1|||
143096832|NCT00891020|515895388|FG002|Long-term Extension Period|Failure to return|3|||
143096833|NCT00891020|515895386|FG000|Long-term Extension Period|Administrative|1|||
143096834|NCT00891020|515895387|FG001|Long-term Extension Period|Administrative|2|||
143096835|NCT00891020|515895388|FG002|Long-term Extension Period|Administrative|2|||
143096836|NCT02588612|515895396|FG000|Overall Study|Physician Decision|1|||
143096837|NCT02588612|515895396|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
143096838|NCT02588612|515895396|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
143096839|NCT02588612|515895396|FG000|Overall Study|Death prior to T-cell infusion|1|||
143096840|NCT00320710|515895397|FG000|Overall Study|Disease progression|24|||
143096841|NCT00320710|515895398|FG001|Overall Study|Disease progression|19|||
143096842|NCT00320710|515895399|FG002|Overall Study|Disease progression|2|||
143096843|NCT00320710|515895397|FG000|Overall Study|Death|10|||
143251553|NCT05477108|516474239|FG000|Overall Study|Physician Decision|0|||
143096844|NCT00320710|515895398|FG001|Overall Study|Death|7|||
143096845|NCT00320710|515895399|FG002|Overall Study|Death|1|||
143096846|NCT00320710|515895397|FG000|Overall Study|Administrative problems|1|||
143096847|NCT00320710|515895398|FG001|Overall Study|Administrative problems|2|||
143096848|NCT00320710|515895399|FG002|Overall Study|Administrative problems|0|||
143096849|NCT00320710|515895397|FG000|Overall Study|Withdrawal by Subject|20|||
143096850|NCT00320710|515895398|FG001|Overall Study|Withdrawal by Subject|26|||
143096851|NCT00320710|515895399|FG002|Overall Study|Withdrawal by Subject|1|||
143096852|NCT00320710|515895397|FG000|Overall Study|Protocol Violation|6|||
143096853|NCT00320710|515895398|FG001|Overall Study|Protocol Violation|5|||
143096854|NCT00320710|515895399|FG002|Overall Study|Protocol Violation|0|||
143096855|NCT00320710|515895397|FG000|Overall Study|Abnormal test procedure result(s)|2|||
143096856|NCT00320710|515895398|FG001|Overall Study|Abnormal test procedure result(s)|0|||
143096857|NCT00320710|515895399|FG002|Overall Study|Abnormal test procedure result(s)|0|||
143096858|NCT00320710|515895397|FG000|Overall Study|Abnormal laboratory value(s)|12|||
143096859|NCT00320710|515895398|FG001|Overall Study|Abnormal laboratory value(s)|3|||
143096860|NCT00320710|515895399|FG002|Overall Study|Abnormal laboratory value(s)|0|||
143096861|NCT00320710|515895397|FG000|Overall Study|Adverse Event|18|||
143096862|NCT00320710|515895398|FG001|Overall Study|Adverse Event|14|||
143096863|NCT00320710|515895399|FG002|Overall Study|Adverse Event|1|||
143096864|NCT00320710|515895397|FG000|Overall Study|Lost to Follow-up|1|||
143096865|NCT00320710|515895398|FG001|Overall Study|Lost to Follow-up|0|||
143096866|NCT00320710|515895399|FG002|Overall Study|Lost to Follow-up|0|||
143096867|NCT03448419|515895400|FG000|Overall Study|Adverse Event|10|||
143096868|NCT03448419|515895401|FG001|Overall Study|Adverse Event|9|||
143096869|NCT03448419|515895400|FG000|Overall Study|Lost to Follow-up|0|||
143251554|NCT05477108|516474240|FG001|Overall Study|Physician Decision|0|||
143251555|NCT05477108|516474241|FG002|Overall Study|Physician Decision|1|||
143251556|NCT05477108|516474239|FG000|Overall Study|withdrawn from study|0|||
143251557|NCT05477108|516474240|FG001|Overall Study|withdrawn from study|0|||
143251558|NCT05477108|516474241|FG002|Overall Study|withdrawn from study|1|||
143251559|NCT00334113|516474243|FG000|Overall Study|Lost to Follow-up|2|||
143251560|NCT00334113|516474244|FG001|Overall Study|Lost to Follow-up|2|||
143251561|NCT00334113|516474243|FG000|Overall Study|Withdrawal by Subject|0|||
143251562|NCT00334113|516474244|FG001|Overall Study|Withdrawal by Subject|1|||
143251563|NCT01165216|516474249|FG000|Overall Study|Adverse Event|6|||
143251564|NCT01165216|516474250|FG001|Overall Study|Adverse Event|3|||
143251565|NCT01165216|516474249|FG000|Overall Study|Withdrawal by Subject|1|||
143251566|NCT01165216|516474250|FG001|Overall Study|Withdrawal by Subject|1|||
143251567|NCT01165216|516474249|FG000|Overall Study|Disease progression|1|||
143251568|NCT01165216|516474250|FG001|Overall Study|Disease progression|3|||
143251569|NCT01379508|516474251|FG000|Treatment to Week 104|Adverse Event|2|||
143251570|NCT01379508|516474252|FG001|Treatment to Week 104|Adverse Event|0|||
143251571|NCT01379508|516474253|FG002|Treatment to Week 104|Adverse Event|5|||
143367585|NCT02138916|516889410|FG002|Overall Study|Adverse Event|3|||
143367586|NCT03563053|516889413|FG000|Overall Study|Withdrawal by Subject|17|||
143096870|NCT03448419|515895401|FG001|Overall Study|Lost to Follow-up|2|||
143096871|NCT03448419|515895400|FG000|Overall Study|Withdrawal by Subject|3|||
143251572|NCT01379508|516474254|FG003|Treatment to Week 104|Adverse Event|0|||
143251573|NCT01379508|516474251|FG000|Treatment to Week 104|Abnormal lab value|1|||
143251574|NCT01379508|516474252|FG001|Treatment to Week 104|Abnormal lab value|0|||
143096872|NCT03448419|515895401|FG001|Overall Study|Withdrawal by Subject|1|||
143096873|NCT03448419|515895400|FG000|Overall Study|Not treated|0|||
143096874|NCT03448419|515895401|FG001|Overall Study|Not treated|1|||
143096875|NCT03448419|515895400|FG000|Overall Study|Patient did not attend all visits|0|||
143096876|NCT03448419|515895401|FG001|Overall Study|Patient did not attend all visits|2|||
143251575|NCT01379508|516474253|FG002|Treatment to Week 104|Abnormal lab value|0|||
143251576|NCT01379508|516474254|FG003|Treatment to Week 104|Abnormal lab value|0|||
143367587|NCT03563053|516889413|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
143096877|NCT03448419|515895400|FG000|Overall Study|Withdrawn by Sponsor|0|||
143096878|NCT03448419|515895401|FG001|Overall Study|Withdrawn by Sponsor|1|||
143096879|NCT02841995|515895402|FG000|Overall Study|Disease progression|5|||
143096880|NCT02841995|515895403|FG001|Overall Study|Disease progression|11|||
143096881|NCT02841995|515895404|FG002|Overall Study|Disease progression|8|||
143096882|NCT02841995|515895402|FG000|Overall Study|Withdrawal by Subject|2|||
143096883|NCT02841995|515895403|FG001|Overall Study|Withdrawal by Subject|4|||
143096884|NCT02841995|515895404|FG002|Overall Study|Withdrawal by Subject|4|||
143096885|NCT02841995|515895402|FG000|Overall Study|Adverse Event|2|||
143096886|NCT02841995|515895403|FG001|Overall Study|Adverse Event|0|||
143096887|NCT02841995|515895404|FG002|Overall Study|Adverse Event|1|||
143096888|NCT02841995|515895402|FG000|Overall Study|Investigator decision|2|||
143096889|NCT02841995|515895403|FG001|Overall Study|Investigator decision|0|||
143096890|NCT02841995|515895404|FG002|Overall Study|Investigator decision|1|||
143096891|NCT02841995|515895402|FG000|Overall Study|Death|0|||
143096892|NCT02841995|515895403|FG001|Overall Study|Death|0|||
143367588|NCT03563053|516889413|FG000|Overall Study|Adverse Event|3|||
143003200|NCT01049360|515548752|FG008|Period 4|Protocol Violation|0|||
143003201|NCT01049360|515548753|FG009|Period 4|Protocol Violation|0|||
143003202|NCT01049360|515548754|FG010|Period 4|Protocol Violation|0|||
143003203|NCT01049360|515548755|FG011|Period 4|Protocol Violation|0|||
143003204|NCT01049360|515548756|FG012|Period 4|Protocol Violation|0|||
143003205|NCT01049360|515548757|FG013|Period 4|Protocol Violation|0|||
143003206|NCT01049360|515548758|FG014|Period 4|Protocol Violation|0|||
143003207|NCT01049360|515548759|FG015|Period 4|Protocol Violation|0|||
143003208|NCT01049360|515548760|FG016|Period 4|Protocol Violation|0|||
143003209|NCT01049360|515548761|FG017|Period 4|Protocol Violation|1|||
143003210|NCT01049360|515548762|FG018|Period 4|Protocol Violation|0|||
143003211|NCT01049360|515548763|FG019|Period 4|Protocol Violation|0|||
143003212|NCT01049360|515548744|FG000|Period 4|Withdrawal by Subject|0|||
143003213|NCT01049360|515548745|FG001|Period 4|Withdrawal by Subject|0|||
143003214|NCT01049360|515548746|FG002|Period 4|Withdrawal by Subject|0|||
143003215|NCT01049360|515548747|FG003|Period 4|Withdrawal by Subject|1|||
143003216|NCT01049360|515548748|FG004|Period 4|Withdrawal by Subject|0|||
143003217|NCT01049360|515548749|FG005|Period 4|Withdrawal by Subject|0|||
143003218|NCT01049360|515548750|FG006|Period 4|Withdrawal by Subject|0|||
143003219|NCT01049360|515548751|FG007|Period 4|Withdrawal by Subject|0|||
143003220|NCT01049360|515548752|FG008|Period 4|Withdrawal by Subject|0|||
143003221|NCT01049360|515548753|FG009|Period 4|Withdrawal by Subject|0|||
143003222|NCT01049360|515548754|FG010|Period 4|Withdrawal by Subject|0|||
143003223|NCT01049360|515548755|FG011|Period 4|Withdrawal by Subject|0|||
143003224|NCT01049360|515548756|FG012|Period 4|Withdrawal by Subject|0|||
143003225|NCT01049360|515548757|FG013|Period 4|Withdrawal by Subject|0|||
143003226|NCT01049360|515548758|FG014|Period 4|Withdrawal by Subject|0|||
143003227|NCT01049360|515548759|FG015|Period 4|Withdrawal by Subject|0|||
143003228|NCT01049360|515548760|FG016|Period 4|Withdrawal by Subject|0|||
143003229|NCT01049360|515548761|FG017|Period 4|Withdrawal by Subject|0|||
143003230|NCT01049360|515548762|FG018|Period 4|Withdrawal by Subject|0|||
143003231|NCT01049360|515548763|FG019|Period 4|Withdrawal by Subject|0|||
143003232|NCT00429026|515548764|FG000|Overall Study|Inevaluable for response.|40|||
143003233|NCT01012765|515548765|FG000|Treatment Period 1|Adverse Event|1|||
143003234|NCT01012765|515548766|FG001|Treatment Period 1|Adverse Event|0|||
143003235|NCT01012765|515548767|FG002|Treatment Period 1|Adverse Event|1|||
143003236|NCT01012765|515548768|FG003|Treatment Period 1|Adverse Event|0|||
143003237|NCT01012765|515548769|FG004|Treatment Period 1|Adverse Event|0|||
143003238|NCT01012765|515548770|FG005|Treatment Period 1|Adverse Event|0|||
143003239|NCT01012765|515548765|FG000|Treatment Period 1|Withdrawal by Subject|2|||
143003240|NCT01012765|515548766|FG001|Treatment Period 1|Withdrawal by Subject|0|||
143003241|NCT01012765|515548767|FG002|Treatment Period 1|Withdrawal by Subject|0|||
143003242|NCT01012765|515548768|FG003|Treatment Period 1|Withdrawal by Subject|0|||
143003243|NCT01012765|515548769|FG004|Treatment Period 1|Withdrawal by Subject|0|||
143003244|NCT01012765|515548770|FG005|Treatment Period 1|Withdrawal by Subject|0|||
143003245|NCT01012765|515548765|FG000|Treatment Period 1|Administrative problems|0|||
143003246|NCT01012765|515548766|FG001|Treatment Period 1|Administrative problems|0|||
143003247|NCT01012765|515548767|FG002|Treatment Period 1|Administrative problems|1|||
143003248|NCT01012765|515548768|FG003|Treatment Period 1|Administrative problems|1|||
143003249|NCT01012765|515548769|FG004|Treatment Period 1|Administrative problems|1|||
143003250|NCT01012765|515548770|FG005|Treatment Period 1|Administrative problems|0|||
143003251|NCT01012765|515548765|FG000|Treatment Period 1|Protocol Violation|0|||
143003252|NCT01012765|515548766|FG001|Treatment Period 1|Protocol Violation|0|||
143003253|NCT01012765|515548767|FG002|Treatment Period 1|Protocol Violation|0|||
143003254|NCT01012765|515548768|FG003|Treatment Period 1|Protocol Violation|2|||
143003255|NCT01012765|515548769|FG004|Treatment Period 1|Protocol Violation|1|||
143096893|NCT02841995|515895404|FG002|Overall Study|Death|2|||
143096894|NCT02841995|515895402|FG000|Overall Study|Noncompliance to protocol|1|||
143096895|NCT02841995|515895403|FG001|Overall Study|Noncompliance to protocol|0|||
143096896|NCT02841995|515895404|FG002|Overall Study|Noncompliance to protocol|0|||
143096897|NCT02841995|515895402|FG000|Overall Study|Sponsor decision|1|||
143096898|NCT02841995|515895403|FG001|Overall Study|Sponsor decision|0|||
143096899|NCT02841995|515895404|FG002|Overall Study|Sponsor decision|0|||
143096900|NCT02841995|515895402|FG000|Overall Study|Other|4|||
143096901|NCT02841995|515895403|FG001|Overall Study|Other|1|||
143096902|NCT02841995|515895404|FG002|Overall Study|Other|5|||
143096903|NCT03809663|515895405|FG000|Overall Study|Decision by sponsor|24|||
143096904|NCT03809663|515895406|FG001|Overall Study|Decision by sponsor|18|||
143096905|NCT03809663|515895407|FG002|Overall Study|Decision by sponsor|20|||
143096906|NCT03809663|515895408|FG003|Overall Study|Decision by sponsor|20|||
143096907|NCT03809663|515895409|FG004|Overall Study|Decision by sponsor|0|||
143096908|NCT03809663|515895410|FG005|Overall Study|Decision by sponsor|0|||
143096909|NCT03809663|515895405|FG000|Overall Study|Withdrawal by Subject|26|||
143096910|NCT03809663|515895406|FG001|Overall Study|Withdrawal by Subject|22|||
143096911|NCT03809663|515895407|FG002|Overall Study|Withdrawal by Subject|27|||
143096912|NCT03809663|515895408|FG003|Overall Study|Withdrawal by Subject|26|||
143096913|NCT03809663|515895409|FG004|Overall Study|Withdrawal by Subject|0|||
143096914|NCT03809663|515895410|FG005|Overall Study|Withdrawal by Subject|0|||
143096915|NCT03809663|515895405|FG000|Overall Study|Lost to Follow-up|1|||
143096916|NCT03809663|515895406|FG001|Overall Study|Lost to Follow-up|4|||
143096917|NCT03809663|515895407|FG002|Overall Study|Lost to Follow-up|1|||
143096918|NCT03809663|515895408|FG003|Overall Study|Lost to Follow-up|1|||
143096919|NCT03809663|515895409|FG004|Overall Study|Lost to Follow-up|0|||
143096920|NCT03809663|515895410|FG005|Overall Study|Lost to Follow-up|0|||
143096921|NCT01703260|515895411|FG000|Overall Study|Adverse Event|1|||
143096922|NCT01703260|515895412|FG001|Overall Study|Adverse Event|2|||
143096923|NCT01703260|515895413|FG002|Overall Study|Adverse Event|2|||
143251577|NCT01379508|516474251|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
143251578|NCT01379508|516474252|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
143251579|NCT01379508|516474253|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
143251580|NCT01379508|516474254|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
143251581|NCT01379508|516474251|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
143251582|NCT01379508|516474252|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
143251583|NCT01379508|516474253|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
143251584|NCT01379508|516474254|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
143251585|NCT01379508|516474251|FG000|Treatment to Week 104|Lost to Follow-up|5|||
143096924|NCT01703260|515895411|FG000|Overall Study|Lost to Follow-up|1|||
143096925|NCT01703260|515895412|FG001|Overall Study|Lost to Follow-up|0|||
143096926|NCT01703260|515895413|FG002|Overall Study|Lost to Follow-up|0|||
143096927|NCT01703260|515895411|FG000|Overall Study|Withdrawal by Subject|0|||
143096928|NCT01703260|515895412|FG001|Overall Study|Withdrawal by Subject|0|||
143096929|NCT01703260|515895413|FG002|Overall Study|Withdrawal by Subject|1|||
143096930|NCT01703260|515895411|FG000|Overall Study|Study Termination|1|||
143251586|NCT01379508|516474252|FG001|Treatment to Week 104|Lost to Follow-up|0|||
143096931|NCT01703260|515895412|FG001|Overall Study|Study Termination|2|||
143096932|NCT01703260|515895413|FG002|Overall Study|Study Termination|0|||
143096933|NCT02632409|515895414|FG000|Randomized|AE unrelated to study Drug|0|||
143096934|NCT02632409|515895415|FG001|Randomized|AE unrelated to study Drug|1|||
143096935|NCT02632409|515895414|FG000|Randomized|Participant withdrew consent|2|||
143096936|NCT02632409|515895415|FG001|Randomized|Participant withdrew consent|1|||
143096937|NCT02632409|515895414|FG000|Randomized|No Longer meets study criteria|5|||
143096938|NCT02632409|515895415|FG001|Randomized|No Longer meets study criteria|0|||
143096939|NCT02632409|515895414|FG000|Randomized|other reasons|1|||
143096940|NCT02632409|515895415|FG001|Randomized|other reasons|0|||
143096941|NCT02632409|515895414|FG000|Treatment Period|Ongoing Treatment|20|||
143096942|NCT02632409|515895415|FG001|Treatment Period|Ongoing Treatment|21|||
143367589|NCT03563053|516889413|FG000|Overall Study|Physician Decision|1|||
143003329|NCT05664672|515548801|FG005|Overall Study|Adverse Event|1|||
143003330|NCT05664672|515548796|FG000|Overall Study|Withdrawal by Subject|0|||
143003331|NCT05664672|515548797|FG001|Overall Study|Withdrawal by Subject|1|||
143003332|NCT05664672|515548798|FG002|Overall Study|Withdrawal by Subject|3|||
143003333|NCT05664672|515548799|FG003|Overall Study|Withdrawal by Subject|0|||
143003334|NCT05664672|515548800|FG004|Overall Study|Withdrawal by Subject|5|||
143003335|NCT05664672|515548801|FG005|Overall Study|Withdrawal by Subject|6|||
143003336|NCT05664672|515548796|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
143003337|NCT05664672|515548797|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
143003338|NCT05664672|515548798|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
143003339|NCT05664672|515548799|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
143003340|NCT05664672|515548800|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
143003341|NCT05664672|515548801|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
143003342|NCT05664672|515548796|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
143003343|NCT05664672|515548797|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
143003344|NCT05664672|515548798|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
143003345|NCT05664672|515548799|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
143003346|NCT05664672|515548800|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
143003347|NCT05664672|515548801|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
143003348|NCT04095039|515548804|FG000|Overall Study|Withdrawal by Subject|2|||
143003349|NCT04095039|515548805|FG001|Overall Study|Withdrawal by Subject|16|||
143003350|NCT04095039|515548804|FG000|Overall Study|Transplanted|21|||
143003351|NCT04095039|515548805|FG001|Overall Study|Transplanted|24|||
143003352|NCT04095039|515548804|FG000|Overall Study|Transferred to Non-study Facility|47|||
143003353|NCT04095039|515548805|FG001|Overall Study|Transferred to Non-study Facility|44|||
143003354|NCT04095039|515548804|FG000|Overall Study|Withdrawal from internvention target|0|||
143003355|NCT04095039|515548805|FG001|Overall Study|Withdrawal from internvention target|2|||
143003356|NCT04095039|515548804|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
143003357|NCT04095039|515548805|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
143003358|NCT04095039|515548804|FG000|Overall Study|Cacliphylaxis|0|||
143003359|NCT04095039|515548805|FG001|Overall Study|Cacliphylaxis|1|||
143003360|NCT04095039|515548804|FG000|Overall Study|Pregnancy|1|||
143003361|NCT04095039|515548805|FG001|Overall Study|Pregnancy|0|||
143003362|NCT04034225|515548808|FG000|Overall Study|Death|3|||
143003363|NCT04034225|515548808|FG000|Overall Study|Withdrawal by Subject|2|||
143003364|NCT04034225|515548808|FG000|Overall Study|Study termination by Sponsor|18|||
143003365|NCT04034225|515548808|FG000|Overall Study|Physician Decision|1|||
143003366|NCT04034225|515548808|FG000|Overall Study|Lack of Efficacy|1|||
143003367|NCT01326481|515548811|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
143003368|NCT00307736|515548812|FG000|Overall Study|Adverse Event|0|||
143003369|NCT00307736|515548813|FG001|Overall Study|Adverse Event|0|||
143003370|NCT00307736|515548814|FG002|Overall Study|Adverse Event|1|||
143003371|NCT00307736|515548815|FG003|Overall Study|Adverse Event|3|||
143003372|NCT00307736|515548812|FG000|Overall Study|Withdrawal by Subject|0|||
143003373|NCT00307736|515548813|FG001|Overall Study|Withdrawal by Subject|0|||
143003374|NCT00307736|515548814|FG002|Overall Study|Withdrawal by Subject|2|||
143003375|NCT00307736|515548815|FG003|Overall Study|Withdrawal by Subject|0|||
143003376|NCT00129220|515548821|FG000|Study Period II|Adverse Event|9|||
143003377|NCT00129220|515548822|FG001|Study Period II|Adverse Event|5|||
143003378|NCT00129220|515548823|FG002|Study Period II|Adverse Event|7|||
143003379|NCT00129220|515548821|FG000|Study Period II|Lack of Efficacy|15|||
143003380|NCT00129220|515548822|FG001|Study Period II|Lack of Efficacy|1|||
143003381|NCT00129220|515548823|FG002|Study Period II|Lack of Efficacy|28|||
143003382|NCT00129220|515548821|FG000|Study Period II|Entry Criteria Not Met|2|||
143003383|NCT00129220|515548822|FG001|Study Period II|Entry Criteria Not Met|0|||
143003384|NCT00129220|515548823|FG002|Study Period II|Entry Criteria Not Met|2|||
143003385|NCT00129220|515548821|FG000|Study Period II|Protocol Violation|4|||
143096943|NCT02632409|515895414|FG000|Treatment Period|Disease Recurrence|147|||
143096944|NCT02632409|515895415|FG001|Treatment Period|Disease Recurrence|90|||
143096945|NCT02632409|515895414|FG000|Treatment Period|Study Drug Toxicity|8|||
143096946|NCT02632409|515895415|FG001|Treatment Period|Study Drug Toxicity|49|||
143096947|NCT02632409|515895414|FG000|Treatment Period|Death|1|||
143096948|NCT02632409|515895415|FG001|Treatment Period|Death|0|||
143096949|NCT02632409|515895414|FG000|Treatment Period|AE unrelated to study drug|15|||
143096950|NCT02632409|515895415|FG001|Treatment Period|AE unrelated to study drug|16|||
143096951|NCT02632409|515895414|FG000|Treatment Period|Request to discontinue treatment|4|||
143096952|NCT02632409|515895415|FG001|Treatment Period|Request to discontinue treatment|19|||
143096953|NCT02632409|515895414|FG000|Treatment Period|Participant withdrew consent|7|||
143096954|NCT02632409|515895415|FG001|Treatment Period|Participant withdrew consent|5|||
143096955|NCT02632409|515895414|FG000|Treatment Period|Lost to Follow-up|0|||
143096956|NCT02632409|515895415|FG001|Treatment Period|Lost to Follow-up|1|||
143096957|NCT02632409|515895414|FG000|Treatment Period|Maximum clinical benefit|1|||
143096958|NCT02632409|515895415|FG001|Treatment Period|Maximum clinical benefit|0|||
143096959|NCT02632409|515895414|FG000|Treatment Period|No longer meets study criteria|3|||
143096960|NCT02632409|515895415|FG001|Treatment Period|No longer meets study criteria|0|||
143096961|NCT02632409|515895414|FG000|Treatment Period|Administrative Reason by sponsor|0|||
143096962|NCT02632409|515895415|FG001|Treatment Period|Administrative Reason by sponsor|1|||
143096963|NCT02632409|515895414|FG000|Treatment Period|Other Reasons|10|||
143096964|NCT02632409|515895415|FG001|Treatment Period|Other Reasons|6|||
143096965|NCT04426006|515895416|FG000|Inclusion|Protocol Violation|1|||
143096966|NCT04426006|515895416|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
143096967|NCT04426006|515895416|FG000|Inclusion|Blood sample at inclusion not done|1|||
143096968|NCT04426006|515895416|FG000|3 Months|Lost to Follow-up|17|||
143096969|NCT04426006|515895416|FG000|12 Months|Lost to Follow-up|38|||
143096970|NCT00720213|515895419|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
143096971|NCT00720213|515895420|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
143096972|NCT00720213|515895421|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
143096973|NCT01808066|515895423|FG000|Overall Study|Withdrawal by Subject|15|||
143096974|NCT01420068|515895425|FG000|Overall Study|Administrative problems|1|||
143096975|NCT01420068|515895426|FG001|Overall Study|Administrative problems|3|||
143096976|NCT01420068|515895425|FG000|Overall Study|Withdrawal by Subject|1|||
143096977|NCT01420068|515895426|FG001|Overall Study|Withdrawal by Subject|2|||
143096978|NCT01252095|515895427|FG000|Overall Study|Disease progression|1|||
143096979|NCT01252095|515895428|FG001|Overall Study|Disease progression|0|||
143096980|NCT00745901|515895429|FG000|Overall Study|Adverse Event|3|||
143096981|NCT00745901|515895430|FG001|Overall Study|Adverse Event|4|||
143096982|NCT00745901|515895429|FG000|Overall Study|Protocol Violation|0|||
143096983|NCT00745901|515895430|FG001|Overall Study|Protocol Violation|1|||
143096984|NCT00745901|515895429|FG000|Overall Study|Withdrawal by Subject|1|||
143096985|NCT00745901|515895430|FG001|Overall Study|Withdrawal by Subject|0|||
143096986|NCT00745901|515895429|FG000|Overall Study|Lost to Follow-up|7|||
143096987|NCT00745901|515895430|FG001|Overall Study|Lost to Follow-up|4|||
143096988|NCT00745901|515895429|FG000|Overall Study|Pregnancy|2|||
143096989|NCT00745901|515895430|FG001|Overall Study|Pregnancy|4|||
143367590|NCT03563053|516889413|FG000|Overall Study|study terminated by sponsor|71|||
143367591|NCT02081391|516889414|FG000|12-hour Treatment|Withdrawal by Subject|3|||
143367592|NCT02081391|516889415|FG001|12-hour Treatment|Withdrawal by Subject|2|||
143367593|NCT02081391|516889416|FG002|12-hour Treatment|Withdrawal by Subject|0|||
143367594|NCT02081391|516889417|FG003|12-hour Treatment|Withdrawal by Subject|0|||
143367595|NCT02081391|516889414|FG000|12-hour Treatment|Physician Decision|4|||
143096990|NCT00745901|515895429|FG000|Overall Study|Lack of compliance|2|||
143096991|NCT00745901|515895430|FG001|Overall Study|Lack of compliance|2|||
143096992|NCT00745901|515895429|FG000|Overall Study|Patient's next menses did not start with|1|||
143096993|NCT00745901|515895430|FG001|Overall Study|Patient's next menses did not start with|0|||
143096994|NCT00745901|515895429|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
143096995|NCT00745901|515895430|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
143367596|NCT02081391|516889415|FG001|12-hour Treatment|Physician Decision|1|||
143367597|NCT02081391|516889416|FG002|12-hour Treatment|Physician Decision|0|||
143096996|NCT00745901|515895429|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
143096997|NCT00745901|515895430|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
143096998|NCT00745901|515895429|FG000|Overall Study|Patient didn't take any study medication|7|||
143096999|NCT00745901|515895430|FG001|Overall Study|Patient didn't take any study medication|3|||
143097000|NCT00884117|515895433|FG000|Overall Study|Adverse Event|2|||
143097001|NCT00884117|515895433|FG000|Overall Study|Withdrawal by Subject|89|||
143097002|NCT00884117|515895433|FG000|Overall Study|Death|3|||
143097003|NCT00884117|515895433|FG000|Overall Study|Lost to Follow-up|143|||
143097004|NCT00884117|515895433|FG000|Overall Study|Other|12|||
143097005|NCT00952068|515895435|FG000|Overall Study|Adverse Event|3|||
143097006|NCT00952068|515895435|FG000|Overall Study|Withdrawal by Subject|4|||
143097007|NCT04390763|515895437|FG000|Safety run-in Part|Adverse Event|4|||
143097008|NCT04390763|515895438|FG001|Safety run-in Part|Adverse Event|0|||
143097009|NCT04390763|515895439|FG002|Safety run-in Part|Adverse Event|0|||
143097010|NCT04390763|515895440|FG003|Safety run-in Part|Adverse Event|0|||
143097011|NCT04390763|515895437|FG000|Safety run-in Part|Physician Decision|1|||
143097012|NCT04390763|515895438|FG001|Safety run-in Part|Physician Decision|0|||
143097013|NCT04390763|515895439|FG002|Safety run-in Part|Physician Decision|0|||
143097014|NCT04390763|515895440|FG003|Safety run-in Part|Physician Decision|0|||
143097015|NCT04390763|515895437|FG000|Safety run-in Part|Progressive Disease|6|||
143097016|NCT04390763|515895438|FG001|Safety run-in Part|Progressive Disease|0|||
143097017|NCT04390763|515895439|FG002|Safety run-in Part|Progressive Disease|0|||
143097018|NCT04390763|515895440|FG003|Safety run-in Part|Progressive Disease|0|||
143097019|NCT04390763|515895437|FG000|Randomized Part|Adverse Event|0|||
143097020|NCT04390763|515895438|FG001|Randomized Part|Adverse Event|11|||
143097021|NCT04390763|515895439|FG002|Randomized Part|Adverse Event|5|||
143097022|NCT04390763|515895440|FG003|Randomized Part|Adverse Event|5|||
143097023|NCT04390763|515895437|FG000|Randomized Part|Death|0|||
143097024|NCT04390763|515895438|FG001|Randomized Part|Death|3|||
143097025|NCT04390763|515895439|FG002|Randomized Part|Death|4|||
143097026|NCT04390763|515895440|FG003|Randomized Part|Death|2|||
143097027|NCT04390763|515895437|FG000|Randomized Part|Physician Decision|0|||
143097028|NCT04390763|515895438|FG001|Randomized Part|Physician Decision|2|||
143097029|NCT04390763|515895439|FG002|Randomized Part|Physician Decision|2|||
143097030|NCT04390763|515895440|FG003|Randomized Part|Physician Decision|9|||
143097031|NCT04390763|515895437|FG000|Randomized Part|Progressive Disease|0|||
143097032|NCT04390763|515895438|FG001|Randomized Part|Progressive Disease|24|||
143097033|NCT04390763|515895439|FG002|Randomized Part|Progressive Disease|31|||
143097034|NCT04390763|515895440|FG003|Randomized Part|Progressive Disease|23|||
143097035|NCT04390763|515895437|FG000|Randomized Part|Study terminated by sponsor|0|||
143097036|NCT04390763|515895438|FG001|Randomized Part|Study terminated by sponsor|1|||
143097037|NCT04390763|515895439|FG002|Randomized Part|Study terminated by sponsor|0|||
143097038|NCT04390763|515895440|FG003|Randomized Part|Study terminated by sponsor|0|||
143097039|NCT04390763|515895437|FG000|Randomized Part|Participant Decision|0|||
143097040|NCT04390763|515895438|FG001|Randomized Part|Participant Decision|5|||
143097041|NCT04390763|515895439|FG002|Randomized Part|Participant Decision|7|||
143097042|NCT04390763|515895440|FG003|Randomized Part|Participant Decision|6|||
143097043|NCT04390763|515895437|FG000|Randomized Part|Not treated|0|||
143097044|NCT04390763|515895438|FG001|Randomized Part|Not treated|4|||
143097045|NCT04390763|515895439|FG002|Randomized Part|Not treated|2|||
143097046|NCT04390763|515895440|FG003|Randomized Part|Not treated|7|||
143097047|NCT04340843|515895441|FG000|Overall Study|Adverse Event|0|||
143097048|NCT04340843|515895442|FG001|Overall Study|Adverse Event|2|||
143097049|NCT04340843|515895441|FG000|Overall Study|Withdrawal by Subject|0|||
143097050|NCT04340843|515895442|FG001|Overall Study|Withdrawal by Subject|2|||
143097051|NCT01956773|515895449|FG000|Overall Study|Lost to Follow-up|628|||
143097052|NCT01956773|515895450|FG001|Overall Study|Lost to Follow-up|1|||
143097053|NCT01383174|515895451|FG000|3 Month Assessment|Death|0|||
143097054|NCT01383174|515895452|FG001|3 Month Assessment|Death|1|||
143097055|NCT01383174|515895451|FG000|3 Month Assessment|Lost to Follow-up|2|||
143097056|NCT01383174|515895452|FG001|3 Month Assessment|Lost to Follow-up|0|||
143097057|NCT01383174|515895451|FG000|3 Month Assessment|Refused to complete|4|||
143097058|NCT01383174|515895452|FG001|3 Month Assessment|Refused to complete|0|||
143097059|NCT01383174|515895451|FG000|6 Month Assessment|Lost to Follow-up|1|||
143097060|NCT01383174|515895452|FG001|6 Month Assessment|Lost to Follow-up|1|||
143097061|NCT01383174|515895451|FG000|6 Month Assessment|Refused to complete|4|||
143097062|NCT01383174|515895452|FG001|6 Month Assessment|Refused to complete|0|||
143097063|NCT01153815|515895453|FG000|Overall Study|Adverse Event|3|||
143097064|NCT01153815|515895454|FG001|Overall Study|Adverse Event|1|||
143097065|NCT01153815|515895453|FG000|Overall Study|Withdrawal by Subject|6|||
143097066|NCT01153815|515895454|FG001|Overall Study|Withdrawal by Subject|4|||
143097067|NCT01786993|515895457|FG000|Overall Study|Death|6|||
143097068|NCT01786993|515895458|FG001|Overall Study|Death|7|||
143097069|NCT01786993|515895457|FG000|Overall Study|Withdrawal by Subject|3|||
143097070|NCT01786993|515895458|FG001|Overall Study|Withdrawal by Subject|2|||
143097071|NCT01786993|515895457|FG000|Overall Study|Lost to Follow-up|0|||
143097072|NCT01786993|515895458|FG001|Overall Study|Lost to Follow-up|1|||
143097073|NCT01786993|515895457|FG000|Overall Study|Subject Non-Compliance|1|||
143097074|NCT01786993|515895458|FG001|Overall Study|Subject Non-Compliance|0|||
143097075|NCT01786993|515895457|FG000|Overall Study|System Explant|1|||
143097076|NCT01786993|515895458|FG001|Overall Study|System Explant|0|||
143097077|NCT01786993|515895457|FG000|Overall Study|Hospice Admission|1|||
143097078|NCT01786993|515895458|FG001|Overall Study|Hospice Admission|0|||
143097079|NCT01890122|515895459|FG000|Overall Study|Adverse Event|1|||
143097080|NCT01890122|515895460|FG001|Overall Study|Adverse Event|1|||
143097081|NCT01890122|515895461|FG002|Overall Study|Adverse Event|1|||
143097082|NCT01890122|515895462|FG003|Overall Study|Adverse Event|2|||
143097083|NCT01890122|515895459|FG000|Overall Study|Major Protocol Deviation|3|||
143097084|NCT01890122|515895460|FG001|Overall Study|Major Protocol Deviation|1|||
143097085|NCT01890122|515895461|FG002|Overall Study|Major Protocol Deviation|0|||
143097086|NCT01890122|515895462|FG003|Overall Study|Major Protocol Deviation|1|||
143097087|NCT01890122|515895459|FG000|Overall Study|Lost to Follow-up|0|||
143097088|NCT01890122|515895460|FG001|Overall Study|Lost to Follow-up|1|||
143097089|NCT01890122|515895461|FG002|Overall Study|Lost to Follow-up|2|||
143097090|NCT01890122|515895462|FG003|Overall Study|Lost to Follow-up|2|||
143097091|NCT01890122|515895459|FG000|Overall Study|Voluntary Withdrawal|8|||
143097092|NCT01890122|515895460|FG001|Overall Study|Voluntary Withdrawal|8|||
143097093|NCT01890122|515895461|FG002|Overall Study|Voluntary Withdrawal|2|||
143097094|NCT01890122|515895462|FG003|Overall Study|Voluntary Withdrawal|11|||
143097095|NCT01890122|515895459|FG000|Overall Study|Lack of Efficacy|14|||
143097096|NCT01890122|515895460|FG001|Overall Study|Lack of Efficacy|24|||
143097097|NCT01890122|515895461|FG002|Overall Study|Lack of Efficacy|7|||
143097098|NCT01890122|515895462|FG003|Overall Study|Lack of Efficacy|41|||
143097099|NCT01890122|515895459|FG000|Overall Study|Reason not Specified|0|||
143097100|NCT01890122|515895460|FG001|Overall Study|Reason not Specified|1|||
143097101|NCT01890122|515895461|FG002|Overall Study|Reason not Specified|1|||
143097102|NCT01890122|515895462|FG003|Overall Study|Reason not Specified|2|||
143097103|NCT01890122|515895459|FG000|Overall Study|Randomized but not Treated|1|||
143097104|NCT01890122|515895460|FG001|Overall Study|Randomized but not Treated|1|||
143097105|NCT01890122|515895461|FG002|Overall Study|Randomized but not Treated|0|||
143097106|NCT01890122|515895462|FG003|Overall Study|Randomized but not Treated|0|||
143097107|NCT02169271|515895463|FG000|Overall Study|Protocol Violation|1|||
143097108|NCT02169271|515895464|FG001|Overall Study|Protocol Violation|2|||
143097109|NCT02462603|515895465|FG000|Overall Study|Investigator Decision|1|||
143097110|NCT02462603|515895465|FG000|Overall Study|Non-Compliance|1|||
143097111|NCT02462603|515895465|FG000|Overall Study|Withdrawal by Subject|2|||
143097112|NCT03194542|515895466|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
143097113|NCT03194542|515895467|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
143097114|NCT03194542|515895468|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
143097115|NCT03194542|515895469|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
143097116|NCT03194542|515895466|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
143097117|NCT03194542|515895467|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
143097118|NCT03194542|515895468|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
143097119|NCT03194542|515895469|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
143097120|NCT03194542|515895466|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
143097121|NCT03194542|515895467|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
143097122|NCT03194542|515895468|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
143097123|NCT03194542|515895469|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
143097124|NCT03194542|515895466|FG000|Overall Study|Loss of Response|4|||
143097125|NCT03194542|515895467|FG001|Overall Study|Loss of Response|2|||
143097126|NCT03194542|515895468|FG002|Overall Study|Loss of Response|3|||
143097127|NCT03194542|515895469|FG003|Overall Study|Loss of Response|4|||
143097128|NCT03194542|515895466|FG000|Overall Study|Physician Decision|0|||
143097129|NCT03194542|515895467|FG001|Overall Study|Physician Decision|1|||
143097130|NCT03194542|515895468|FG002|Overall Study|Physician Decision|0|||
143097131|NCT03194542|515895469|FG003|Overall Study|Physician Decision|0|||
143097132|NCT03194542|515895466|FG000|Overall Study|Lack of Efficacy|2|||
143097133|NCT03194542|515895467|FG001|Overall Study|Lack of Efficacy|2|||
143097134|NCT03194542|515895468|FG002|Overall Study|Lack of Efficacy|2|||
143097135|NCT03194542|515895469|FG003|Overall Study|Lack of Efficacy|6|||
143097136|NCT03194542|515895466|FG000|Overall Study|Withdrawal by Subject|2|||
143097137|NCT03194542|515895467|FG001|Overall Study|Withdrawal by Subject|1|||
143097138|NCT03194542|515895468|FG002|Overall Study|Withdrawal by Subject|5|||
143097139|NCT03194542|515895469|FG003|Overall Study|Withdrawal by Subject|4|||
143097140|NCT03194542|515895466|FG000|Overall Study|Progressive Disease|1|||
143097141|NCT03194542|515895467|FG001|Overall Study|Progressive Disease|0|||
143097142|NCT03194542|515895468|FG002|Overall Study|Progressive Disease|1|||
143097143|NCT03194542|515895469|FG003|Overall Study|Progressive Disease|1|||
143097144|NCT03194542|515895466|FG000|Overall Study|Adverse Event|1|||
143097145|NCT03194542|515895467|FG001|Overall Study|Adverse Event|2|||
143097146|NCT03194542|515895468|FG002|Overall Study|Adverse Event|0|||
143097147|NCT03194542|515895469|FG003|Overall Study|Adverse Event|5|||
143097148|NCT03194542|515895466|FG000|Overall Study|Death|1|||
143097149|NCT03194542|515895467|FG001|Overall Study|Death|2|||
143097150|NCT03194542|515895468|FG002|Overall Study|Death|0|||
143097151|NCT03194542|515895469|FG003|Overall Study|Death|5|||
143097152|NCT03194542|515895466|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
143097153|NCT03194542|515895467|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
143097154|NCT03194542|515895468|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
143097155|NCT03194542|515895469|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
143097156|NCT01991743|515895470|FG000|Overall Study|external cephalic version not performed|0|||
143097157|NCT01991743|515895471|FG001|Overall Study|external cephalic version not performed|0|||
143097158|NCT01991743|515895472|FG002|Overall Study|external cephalic version not performed|1|||
143097159|NCT01991743|515895473|FG003|Overall Study|external cephalic version not performed|0|||
143097160|NCT03830333|515895475|FG000|Overall Study|Death|0|||
143097161|NCT03830333|515895476|FG001|Overall Study|Death|1|||
143097162|NCT03830333|515895475|FG000|Overall Study|Withdrawal by Subject|5|||
143097163|NCT03830333|515895476|FG001|Overall Study|Withdrawal by Subject|1|||
143097164|NCT03830333|515895475|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
143097165|NCT03830333|515895476|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
143097166|NCT00722137|515895477|FG000|Overall Study|Overt Disease Progression|5|||
143097167|NCT00722137|515895478|FG001|Overall Study|Overt Disease Progression|4|||
143097168|NCT00722137|515895477|FG000|Overall Study|Adverse Event|17|||
143097169|NCT00722137|515895478|FG001|Overall Study|Adverse Event|21|||
143097170|NCT00722137|515895477|FG000|Overall Study|Death|12|||
143097171|NCT00722137|515895478|FG001|Overall Study|Death|7|||
143097172|NCT00722137|515895477|FG000|Overall Study|Withdrawal by Subject|6|||
143097173|NCT00722137|515895478|FG001|Overall Study|Withdrawal by Subject|9|||
143097174|NCT00722137|515895477|FG000|Overall Study|Other Reason Unknown|3|||
143097175|NCT00722137|515895478|FG001|Overall Study|Other Reason Unknown|4|||
143097176|NCT00722137|515895477|FG000|Overall Study|Randomized But Not Treated|2|||
143097177|NCT00722137|515895478|FG001|Overall Study|Randomized But Not Treated|3|||
143097178|NCT00848718|515895483|FG000|Overall Study|Adverse Event|2|||
143097179|NCT00848718|515895484|FG001|Overall Study|Adverse Event|2|||
143097180|NCT00848718|515895485|FG002|Overall Study|Adverse Event|1|||
143097181|NCT00848718|515895486|FG003|Overall Study|Adverse Event|1|||
143097182|NCT00848718|515895487|FG004|Overall Study|Adverse Event|1|||
143097183|NCT00848718|515895488|FG005|Overall Study|Adverse Event|0|||
143097184|NCT00848718|515895489|FG006|Overall Study|Adverse Event|0|||
143097185|NCT00848718|515895490|FG007|Overall Study|Adverse Event|1|||
143097186|NCT00848718|515895491|FG008|Overall Study|Adverse Event|1|||
143097187|NCT00848718|515895492|FG009|Overall Study|Adverse Event|0|||
143097188|NCT00848718|515895493|FG010|Overall Study|Adverse Event|0|||
143097189|NCT00848718|515895494|FG011|Overall Study|Adverse Event|0|||
143097190|NCT00848718|515895495|FG012|Overall Study|Adverse Event|2|||
143097191|NCT00848718|515895483|FG000|Overall Study|Lack of Efficacy|0|||
143097192|NCT00848718|515895484|FG001|Overall Study|Lack of Efficacy|0|||
143097193|NCT00848718|515895485|FG002|Overall Study|Lack of Efficacy|1|||
143097194|NCT00848718|515895486|FG003|Overall Study|Lack of Efficacy|0|||
143097195|NCT00848718|515895487|FG004|Overall Study|Lack of Efficacy|0|||
143097196|NCT00848718|515895488|FG005|Overall Study|Lack of Efficacy|0|||
143097197|NCT00848718|515895489|FG006|Overall Study|Lack of Efficacy|1|||
143097198|NCT00848718|515895490|FG007|Overall Study|Lack of Efficacy|0|||
143097199|NCT00848718|515895491|FG008|Overall Study|Lack of Efficacy|0|||
143097200|NCT00848718|515895492|FG009|Overall Study|Lack of Efficacy|0|||
143097201|NCT00848718|515895493|FG010|Overall Study|Lack of Efficacy|0|||
143097202|NCT00848718|515895494|FG011|Overall Study|Lack of Efficacy|0|||
143097203|NCT00848718|515895495|FG012|Overall Study|Lack of Efficacy|0|||
143097204|NCT00848718|515895483|FG000|Overall Study|Physician Decision|0|||
143097205|NCT00848718|515895484|FG001|Overall Study|Physician Decision|1|||
143097206|NCT00848718|515895485|FG002|Overall Study|Physician Decision|0|||
143097207|NCT00848718|515895486|FG003|Overall Study|Physician Decision|0|||
143097208|NCT00848718|515895487|FG004|Overall Study|Physician Decision|1|||
143097209|NCT00848718|515895488|FG005|Overall Study|Physician Decision|1|||
143097210|NCT00848718|515895489|FG006|Overall Study|Physician Decision|0|||
143097211|NCT00848718|515895490|FG007|Overall Study|Physician Decision|0|||
143097212|NCT00848718|515895491|FG008|Overall Study|Physician Decision|1|||
143097213|NCT00848718|515895492|FG009|Overall Study|Physician Decision|2|||
143097214|NCT00848718|515895493|FG010|Overall Study|Physician Decision|0|||
143097215|NCT00848718|515895494|FG011|Overall Study|Physician Decision|0|||
143097216|NCT00848718|515895495|FG012|Overall Study|Physician Decision|1|||
143097217|NCT00848718|515895483|FG000|Overall Study|Progressive disease before treatment|1|||
143097218|NCT00848718|515895484|FG001|Overall Study|Progressive disease before treatment|5|||
143097219|NCT00848718|515895485|FG002|Overall Study|Progressive disease before treatment|1|||
143097220|NCT00848718|515895486|FG003|Overall Study|Progressive disease before treatment|3|||
143097221|NCT00848718|515895487|FG004|Overall Study|Progressive disease before treatment|4|||
143097222|NCT00848718|515895488|FG005|Overall Study|Progressive disease before treatment|4|||
143097223|NCT00848718|515895489|FG006|Overall Study|Progressive disease before treatment|2|||
143097224|NCT00848718|515895490|FG007|Overall Study|Progressive disease before treatment|1|||
143097225|NCT00848718|515895491|FG008|Overall Study|Progressive disease before treatment|2|||
143097226|NCT00848718|515895492|FG009|Overall Study|Progressive disease before treatment|7|||
143097227|NCT00848718|515895493|FG010|Overall Study|Progressive disease before treatment|3|||
143097228|NCT00848718|515895494|FG011|Overall Study|Progressive disease before treatment|6|||
143097229|NCT00848718|515895495|FG012|Overall Study|Progressive disease before treatment|2|||
143097230|NCT00848718|515895483|FG000|Overall Study|Protocol Violation|0|||
143097231|NCT00848718|515895484|FG001|Overall Study|Protocol Violation|1|||
143097232|NCT00848718|515895485|FG002|Overall Study|Protocol Violation|0|||
143097233|NCT00848718|515895486|FG003|Overall Study|Protocol Violation|0|||
143097234|NCT00848718|515895487|FG004|Overall Study|Protocol Violation|0|||
143097235|NCT00848718|515895488|FG005|Overall Study|Protocol Violation|0|||
143097236|NCT00848718|515895489|FG006|Overall Study|Protocol Violation|0|||
143097237|NCT00848718|515895490|FG007|Overall Study|Protocol Violation|1|||
143097238|NCT00848718|515895491|FG008|Overall Study|Protocol Violation|0|||
143097239|NCT00848718|515895492|FG009|Overall Study|Protocol Violation|0|||
143097240|NCT00848718|515895493|FG010|Overall Study|Protocol Violation|0|||
143097241|NCT00848718|515895494|FG011|Overall Study|Protocol Violation|0|||
143097242|NCT00848718|515895495|FG012|Overall Study|Protocol Violation|1|||
143097243|NCT00848718|515895483|FG000|Overall Study|Withdrawal by Subject|1|||
143097244|NCT00848718|515895484|FG001|Overall Study|Withdrawal by Subject|0|||
143097245|NCT00848718|515895485|FG002|Overall Study|Withdrawal by Subject|0|||
143097246|NCT00848718|515895486|FG003|Overall Study|Withdrawal by Subject|1|||
143097247|NCT00848718|515895487|FG004|Overall Study|Withdrawal by Subject|0|||
143097248|NCT00848718|515895488|FG005|Overall Study|Withdrawal by Subject|0|||
143097249|NCT00848718|515895489|FG006|Overall Study|Withdrawal by Subject|0|||
143097250|NCT00848718|515895490|FG007|Overall Study|Withdrawal by Subject|0|||
143097251|NCT00848718|515895491|FG008|Overall Study|Withdrawal by Subject|0|||
143097252|NCT00848718|515895492|FG009|Overall Study|Withdrawal by Subject|0|||
143097253|NCT00848718|515895493|FG010|Overall Study|Withdrawal by Subject|1|||
143097254|NCT00848718|515895494|FG011|Overall Study|Withdrawal by Subject|0|||
143097255|NCT00848718|515895495|FG012|Overall Study|Withdrawal by Subject|0|||
143097256|NCT00848718|515895483|FG000|Overall Study|Progressive disease during treatment|3|||
143097257|NCT00848718|515895484|FG001|Overall Study|Progressive disease during treatment|0|||
143097258|NCT00848718|515895485|FG002|Overall Study|Progressive disease during treatment|3|||
143097259|NCT00848718|515895486|FG003|Overall Study|Progressive disease during treatment|0|||
143251587|NCT01379508|516474253|FG002|Treatment to Week 104|Lost to Follow-up|3|||
143251588|NCT01379508|516474254|FG003|Treatment to Week 104|Lost to Follow-up|0|||
143097260|NCT00848718|515895487|FG004|Overall Study|Progressive disease during treatment|0|||
143097261|NCT00848718|515895488|FG005|Overall Study|Progressive disease during treatment|0|||
143251589|NCT01379508|516474251|FG000|Treatment to Week 104|Administrative problems|3|||
143097262|NCT00848718|515895489|FG006|Overall Study|Progressive disease during treatment|0|||
143097263|NCT00848718|515895490|FG007|Overall Study|Progressive disease during treatment|2|||
143097264|NCT00848718|515895491|FG008|Overall Study|Progressive disease during treatment|0|||
143097265|NCT00848718|515895492|FG009|Overall Study|Progressive disease during treatment|0|||
143097266|NCT00848718|515895493|FG010|Overall Study|Progressive disease during treatment|0|||
143097267|NCT00848718|515895494|FG011|Overall Study|Progressive disease during treatment|0|||
143097268|NCT00848718|515895495|FG012|Overall Study|Progressive disease during treatment|2|||
143097269|NCT04390113|515895496|FG000|Overall Study|Not Treated|0|||
143097270|NCT04390113|515895497|FG001|Overall Study|Not Treated|1|||
143097271|NCT04390113|515895496|FG000|Overall Study|Adverse Event|1|||
143097272|NCT04390113|515895497|FG001|Overall Study|Adverse Event|0|||
143097273|NCT04390113|515895496|FG000|Overall Study|Death|2|||
143097274|NCT04390113|515895497|FG001|Overall Study|Death|1|||
143097275|NCT04390113|515895496|FG000|Overall Study|Physician Decision|1|||
143097276|NCT04390113|515895497|FG001|Overall Study|Physician Decision|3|||
143097277|NCT04390113|515895496|FG000|Overall Study|Study Terminated by Sponsor|5|||
143097278|NCT04390113|515895497|FG001|Overall Study|Study Terminated by Sponsor|3|||
143097279|NCT04390113|515895496|FG000|Overall Study|Withdrawal by Subject|10|||
143097280|NCT04390113|515895497|FG001|Overall Study|Withdrawal by Subject|5|||
143097281|NCT04390113|515895496|FG000|Overall Study|Other|1|||
143097282|NCT04390113|515895497|FG001|Overall Study|Other|0|||
143097283|NCT04390113|515895496|FG000|Overall Study|Missing|0|||
143097284|NCT04390113|515895497|FG001|Overall Study|Missing|1|||
143097285|NCT00030901|515895499|FG000|Initial Registration|Ineligible|167|||
143097286|NCT00030901|515895500|FG001|Initial Registration|Ineligible|0|||
143097287|NCT00030901|515895501|FG002|Initial Registration|Ineligible|0|||
143097288|NCT00030901|515895499|FG000|Randomization|Adverse Event|0|||
143097289|NCT00030901|515895500|FG001|Randomization|Adverse Event|11|||
143097290|NCT00030901|515895501|FG002|Randomization|Adverse Event|7|||
143097291|NCT00030901|515895499|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
143097292|NCT00030901|515895500|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
143097293|NCT00030901|515895501|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
143097294|NCT00030901|515895499|FG000|Randomization|Progression/Relapse|0|||
143097295|NCT00030901|515895500|FG001|Randomization|Progression/Relapse|22|||
143097296|NCT00030901|515895501|FG002|Randomization|Progression/Relapse|21|||
143097297|NCT00030901|515895499|FG000|Randomization|Death|0|||
143097298|NCT00030901|515895500|FG001|Randomization|Death|1|||
143097299|NCT00030901|515895501|FG002|Randomization|Death|3|||
143097300|NCT00030901|515895499|FG000|Randomization|Other|0|||
143097301|NCT00030901|515895500|FG001|Randomization|Other|36|||
143097302|NCT00030901|515895501|FG002|Randomization|Other|33|||
143097303|NCT00030901|515895499|FG000|Randomization|Ineligible|0|||
143097304|NCT00030901|515895500|FG001|Randomization|Ineligible|15|||
143097305|NCT00030901|515895501|FG002|Randomization|Ineligible|14|||
143251590|NCT01379508|516474252|FG001|Treatment to Week 104|Administrative problems|1|||
143251591|NCT01379508|516474253|FG002|Treatment to Week 104|Administrative problems|0|||
143251592|NCT01379508|516474254|FG003|Treatment to Week 104|Administrative problems|0|||
143251593|NCT01379508|516474251|FG000|Treatment to Week 104|Protocol Violation|1|||
143097306|NCT02576847|515895504|FG000|Overall Study|Adverse Event|27|||
143251594|NCT01379508|516474252|FG001|Treatment to Week 104|Protocol Violation|1|||
143097307|NCT02576847|515895504|FG000|Overall Study|Lost to Follow-up|22|||
143097308|NCT02576847|515895504|FG000|Overall Study|Physician Decision|1|||
143097309|NCT02576847|515895504|FG000|Overall Study|Pregnancy|1|||
143097310|NCT02576847|515895504|FG000|Overall Study|Protocol Violation|3|||
143097311|NCT02576847|515895504|FG000|Overall Study|Withdrawal by Subject|78|||
143097312|NCT02576847|515895504|FG000|Overall Study|Other|5|||
143097313|NCT01806051|515895505|FG000|Overall Study|Withdrawal by Subject|6|||
143097314|NCT01622673|515895508|FG000|Treatment Period 1|Withdrawal by Subject|0|||
143097315|NCT01622673|515895509|FG001|Treatment Period 1|Withdrawal by Subject|0|||
143097316|NCT01622673|515895510|FG002|Treatment Period 1|Withdrawal by Subject|0|||
143097317|NCT01622673|515895511|FG003|Treatment Period 1|Withdrawal by Subject|1|||
143097318|NCT01622673|515895512|FG004|Treatment Period 1|Withdrawal by Subject|0|||
143097319|NCT01622673|515895513|FG005|Treatment Period 1|Withdrawal by Subject|0|||
143097320|NCT01622673|515895508|FG000|Treatment Period 1|Protocol Violation|0|||
143097321|NCT01622673|515895509|FG001|Treatment Period 1|Protocol Violation|1|||
143097322|NCT01622673|515895510|FG002|Treatment Period 1|Protocol Violation|0|||
143097323|NCT01622673|515895511|FG003|Treatment Period 1|Protocol Violation|0|||
143097324|NCT01622673|515895512|FG004|Treatment Period 1|Protocol Violation|0|||
143097325|NCT01622673|515895513|FG005|Treatment Period 1|Protocol Violation|0|||
143097326|NCT01622673|515895508|FG000|Treatment Period 2|Withdrawal by Subject|0|||
143097327|NCT01622673|515895509|FG001|Treatment Period 2|Withdrawal by Subject|0|||
143097328|NCT01622673|515895510|FG002|Treatment Period 2|Withdrawal by Subject|0|||
143097329|NCT01622673|515895511|FG003|Treatment Period 2|Withdrawal by Subject|1|||
143097330|NCT01622673|515895512|FG004|Treatment Period 2|Withdrawal by Subject|0|||
143097331|NCT01622673|515895513|FG005|Treatment Period 2|Withdrawal by Subject|0|||
143097332|NCT01622673|515895508|FG000|Treatment Period 3|Protocol Violation|0|||
143097333|NCT01622673|515895509|FG001|Treatment Period 3|Protocol Violation|1|||
143097334|NCT01622673|515895510|FG002|Treatment Period 3|Protocol Violation|0|||
143097335|NCT01622673|515895511|FG003|Treatment Period 3|Protocol Violation|0|||
143097336|NCT01622673|515895512|FG004|Treatment Period 3|Protocol Violation|0|||
143097337|NCT01622673|515895513|FG005|Treatment Period 3|Protocol Violation|0|||
143097338|NCT04955691|515896993|FG000|Period 2|Discontinued intervention|1|||
143097339|NCT04955691|515896994|FG001|Period 2|Discontinued intervention|2|||
143097340|NCT05795153|515896995|FG000|Overall Study|Adverse Event|2|||
143097341|NCT05795153|515896995|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
143097342|NCT05795153|515896995|FG000|Overall Study|Lost to Follow-up|1|||
143097343|NCT05795153|515896995|FG000|Overall Study|Subject decision|2|||
143097344|NCT03760744|515896996|FG000|Overall Study|Lost to Follow-up|3|||
143097345|NCT03760744|515896997|FG001|Overall Study|Lost to Follow-up|0|||
143097346|NCT04050462|515896998|FG000|Overall Study|Withdrawal by Subject|1|||
143097347|NCT04050462|515896999|FG001|Overall Study|Withdrawal by Subject|0|||
143097348|NCT04050462|515897000|FG002|Overall Study|Withdrawal by Subject|0|||
143097349|NCT05151744|515897001|FG000|Overall Study|Adverse Event|6|||
143097350|NCT05151744|515897002|FG001|Overall Study|Adverse Event|2|||
143097351|NCT05151744|515897001|FG000|Overall Study|Death|1|||
143097352|NCT05151744|515897002|FG001|Overall Study|Death|2|||
143097353|NCT05151744|515897001|FG000|Overall Study|Lack of Efficacy|1|||
143097354|NCT05151744|515897002|FG001|Overall Study|Lack of Efficacy|1|||
143097355|NCT05151744|515897001|FG000|Overall Study|Lost to Follow-up|2|||
143097356|NCT05151744|515897002|FG001|Overall Study|Lost to Follow-up|2|||
143097357|NCT05151744|515897001|FG000|Overall Study|Need for Rescue Treatment|0|||
143097358|NCT05151744|515897002|FG001|Overall Study|Need for Rescue Treatment|1|||
143097359|NCT05151744|515897001|FG000|Overall Study|Non-compliance with Study Drug|0|||
143097360|NCT05151744|515897002|FG001|Overall Study|Non-compliance with Study Drug|1|||
143097361|NCT05151744|515897001|FG000|Overall Study|Reason not Specified|10|||
143097362|NCT05151744|515897002|FG001|Overall Study|Reason not Specified|0|||
143097363|NCT05151744|515897001|FG000|Overall Study|Physician Decision|2|||
143097364|NCT05151744|515897002|FG001|Overall Study|Physician Decision|1|||
143097365|NCT05151744|515897001|FG000|Overall Study|Protocol Violation|1|||
143097366|NCT05151744|515897002|FG001|Overall Study|Protocol Violation|0|||
143097367|NCT05151744|515897001|FG000|Overall Study|Withdrawal by Subject|6|||
143097368|NCT05151744|515897002|FG001|Overall Study|Withdrawal by Subject|3|||
143097369|NCT05228470|515897003|FG000|Overall Study|Death|6|||
143097370|NCT05228470|515897004|FG001|Overall Study|Death|11|||
143097371|NCT05228470|515897003|FG000|Overall Study|Withdrawal by Subject|1|||
143097372|NCT05228470|515897004|FG001|Overall Study|Withdrawal by Subject|8|||
143097373|NCT05228470|515897003|FG000|Overall Study|Ongoing|1|||
143097374|NCT05228470|515897004|FG001|Overall Study|Ongoing|11|||
143097375|NCT04053868|515897005|FG000|Overall Study|Withdrawal by Subject|1|||
143097376|NCT04053868|515897006|FG001|Overall Study|Withdrawal by Subject|0|||
143097377|NCT05731700|515897007|FG000|Overall Study|Death|1|||
143097378|NCT01068678|515897016|FG000|Overall Study|Lack of Efficacy|3|||
143097379|NCT01068678|515897017|FG001|Overall Study|Lack of Efficacy|2|||
143097380|NCT01068678|515897016|FG000|Overall Study|Protocol Violation|5|||
143097381|NCT01068678|515897017|FG001|Overall Study|Protocol Violation|1|||
143097382|NCT01068678|515897016|FG000|Overall Study|Withdrawal criteria|12|||
143097383|NCT01068678|515897017|FG001|Overall Study|Withdrawal criteria|6|||
143097384|NCT01068678|515897016|FG000|Overall Study|Unclassified|18|||
143097385|NCT01068678|515897017|FG001|Overall Study|Unclassified|15|||
143097386|NCT00570687|515897020|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
143097387|NCT00570687|515897021|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
143097388|NCT00570687|515897022|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
143097389|NCT00570687|515897023|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
143097390|NCT00570687|515897024|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
143097391|NCT00570687|515897025|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
143097392|NCT00570687|515897026|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
143367598|NCT02081391|516889417|FG003|12-hour Treatment|Physician Decision|0|||
143367599|NCT02081391|516889414|FG000|12-hour Treatment|Lack of Efficacy|3|||
143367600|NCT02081391|516889415|FG001|12-hour Treatment|Lack of Efficacy|0|||
143367601|NCT02081391|516889416|FG002|12-hour Treatment|Lack of Efficacy|0|||
143367602|NCT02081391|516889417|FG003|12-hour Treatment|Lack of Efficacy|0|||
143367603|NCT02081391|516889414|FG000|12-hour Treatment|Adverse Event|4|||
143367604|NCT02081391|516889415|FG001|12-hour Treatment|Adverse Event|2|||
143097393|NCT00570687|515897027|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
143097394|NCT00570687|515897028|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
143097395|NCT00570687|515897029|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
143097396|NCT00570687|515897020|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
143097397|NCT00570687|515897021|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
143097398|NCT00570687|515897022|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
143097399|NCT00570687|515897023|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
143097400|NCT00570687|515897024|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
143097401|NCT00570687|515897025|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
143097402|NCT00570687|515897026|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
143097403|NCT00570687|515897027|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
143097404|NCT00570687|515897028|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
143097405|NCT00570687|515897029|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
143097406|NCT00570687|515897020|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
143097407|NCT00570687|515897021|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
143097408|NCT00570687|515897022|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
143097409|NCT00570687|515897023|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
143097410|NCT00570687|515897024|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
143097411|NCT00570687|515897025|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
143097412|NCT00570687|515897026|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
143097413|NCT00570687|515897027|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
143097414|NCT00570687|515897028|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
143097415|NCT00570687|515897029|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
143097416|NCT03055338|515897030|FG000|Overall Study|Lost to Follow-up|9|||
143097417|NCT03055338|515897031|FG001|Overall Study|Lost to Follow-up|2|||
143097418|NCT03055338|515897032|FG002|Overall Study|Lost to Follow-up|3|||
143251595|NCT01379508|516474253|FG002|Treatment to Week 104|Protocol Violation|1|||
143097419|NCT03055338|515897030|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
143097420|NCT03055338|515897031|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
143251596|NCT01379508|516474254|FG003|Treatment to Week 104|Protocol Violation|0|||
143251597|NCT01379508|516474251|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
143251598|NCT01379508|516474252|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
143251599|NCT01379508|516474253|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
143251600|NCT01379508|516474254|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
143251601|NCT01379508|516474251|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
143251602|NCT01379508|516474252|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
143251603|NCT01379508|516474253|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
143251604|NCT01379508|516474254|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
143251605|NCT01379508|516474251|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
143097421|NCT03055338|515897032|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
143097422|NCT03055338|515897030|FG000|Overall Study|Physician Decision|0|||
143097423|NCT03055338|515897031|FG001|Overall Study|Physician Decision|0|||
143097424|NCT03055338|515897032|FG002|Overall Study|Physician Decision|2|||
143367605|NCT02081391|516889416|FG002|12-hour Treatment|Adverse Event|0|||
143097425|NCT03055338|515897030|FG000|Overall Study|Withdrawal by Subject|9|||
143097426|NCT03055338|515897031|FG001|Overall Study|Withdrawal by Subject|8|||
143097427|NCT03055338|515897032|FG002|Overall Study|Withdrawal by Subject|7|||
143097428|NCT00975611|515897033|FG000|Overall Study|Screen Fail|16|||
143097429|NCT00975611|515897033|FG000|Overall Study|Physician Decision|1|||
143097430|NCT03058705|515897034|FG000|Overall Study|Withdrawal by Subject|2|||
143097431|NCT03058705|515897034|FG000|Overall Study|Physician Decision|2|||
143097432|NCT03771898|515897035|FG000|Overall Study|Adverse Event|1|||
143097433|NCT03771898|515897036|FG001|Overall Study|Adverse Event|0|||
143097434|NCT03771898|515897037|FG002|Overall Study|Adverse Event|0|||
143097435|NCT03771898|515897038|FG003|Overall Study|Adverse Event|0|||
143097436|NCT03771898|515897039|FG004|Overall Study|Adverse Event|0|||
143097437|NCT03771898|515897035|FG000|Overall Study|Lost to Follow-up|1|||
143097438|NCT03771898|515897036|FG001|Overall Study|Lost to Follow-up|1|||
143097439|NCT03771898|515897037|FG002|Overall Study|Lost to Follow-up|1|||
143097440|NCT03771898|515897038|FG003|Overall Study|Lost to Follow-up|0|||
143097441|NCT03771898|515897039|FG004|Overall Study|Lost to Follow-up|0|||
143097442|NCT03771898|515897035|FG000|Overall Study|Withdrawal by parent/guardian|1|||
143097443|NCT03771898|515897036|FG001|Overall Study|Withdrawal by parent/guardian|1|||
143097444|NCT03771898|515897037|FG002|Overall Study|Withdrawal by parent/guardian|0|||
143251606|NCT01379508|516474252|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
143097445|NCT03771898|515897038|FG003|Overall Study|Withdrawal by parent/guardian|0|||
143097446|NCT03771898|515897039|FG004|Overall Study|Withdrawal by parent/guardian|0|||
143251607|NCT01379508|516474253|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
143251608|NCT01379508|516474254|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
143251609|NCT01379508|516474251|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
143251610|NCT01379508|516474252|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
143251611|NCT01379508|516474253|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
143251612|NCT01379508|516474254|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
143251613|NCT01808092|516474257|FG000|Overall Study|Death|39|||
143251614|NCT01808092|516474258|FG001|Overall Study|Death|29|||
143251615|NCT01808092|516474257|FG000|Overall Study|Lost to Follow-up|3|||
143251616|NCT01808092|516474258|FG001|Overall Study|Lost to Follow-up|7|||
143251617|NCT01808092|516474257|FG000|Overall Study|Withdrawal by Subject|9|||
143251618|NCT01808092|516474258|FG001|Overall Study|Withdrawal by Subject|4|||
143251619|NCT01808092|516474257|FG000|Overall Study|Other Eligibility criteria|3|||
143251620|NCT01808092|516474258|FG001|Overall Study|Other Eligibility criteria|5|||
143251621|NCT02626624|516474261|FG000|Overall Study|Adverse Event|1|||
143251622|NCT02626624|516474261|FG000|Overall Study|Lost to Follow-up|3|||
143251623|NCT02626624|516474261|FG000|Overall Study|Protocol Violation|4|||
143251624|NCT02626624|516474261|FG000|Overall Study|Death|2|||
143251625|NCT04614324|516474264|FG000|Overall Study|Lost to Follow-up|3|||
143251626|NCT04614324|516474264|FG000|Overall Study|Physician Decision|1|||
143251627|NCT04614324|516474264|FG000|Overall Study|Withdrawal by Subject|2|||
143251628|NCT04614324|516474264|FG000|Overall Study|Remaining in Follow up|123|||
143251629|NCT05141448|516474265|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
143251630|NCT05141448|516474266|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
143251631|NCT05141448|516474267|FG002|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
143251632|NCT05141448|516474268|FG003|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
143251633|NCT05141448|516474269|FG004|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
143251634|NCT05141448|516474270|FG005|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
143251635|NCT05141448|516474265|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
143251636|NCT05141448|516474266|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
143251637|NCT05141448|516474267|FG002|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
143251638|NCT05141448|516474268|FG003|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
143251639|NCT05141448|516474269|FG004|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
143097447|NCT03771898|515897035|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
143097448|NCT03771898|515897036|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
143097449|NCT03771898|515897037|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
143097450|NCT03771898|515897038|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
143097451|NCT03771898|515897039|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
143251640|NCT05141448|516474270|FG005|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
143251641|NCT05141448|516474265|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
143251642|NCT05141448|516474266|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
143251643|NCT05141448|516474267|FG002|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
143251644|NCT05141448|516474268|FG003|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
143367606|NCT02081391|516889417|FG003|12-hour Treatment|Adverse Event|0|||
143367607|NCT02081391|516889414|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
143097452|NCT01467713|515897040|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
143097453|NCT01467713|515897041|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
143097454|NCT01467713|515897042|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
143367608|NCT02081391|516889415|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
143367609|NCT02081391|516889416|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
143367610|NCT02081391|516889417|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
143367611|NCT02081391|516889414|FG000|12-hour Treatment|Further reasons|2|||
143367612|NCT02081391|516889415|FG001|12-hour Treatment|Further reasons|1|||
143367613|NCT02081391|516889416|FG002|12-hour Treatment|Further reasons|0|||
143367614|NCT02081391|516889417|FG003|12-hour Treatment|Further reasons|0|||
143367615|NCT02081391|516889414|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
143367616|NCT02081391|516889415|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
143367617|NCT02081391|516889416|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
143097455|NCT01467713|515897043|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
143367618|NCT02081391|516889417|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
143367619|NCT02081391|516889414|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
143367620|NCT02081391|516889415|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
143367621|NCT02081391|516889416|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
143367622|NCT02081391|516889417|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
143367623|NCT02081391|516889414|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
143367624|NCT02081391|516889415|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
143097456|NCT01467713|515897040|FG000|Overall Study|Major Protocol Deviation|2|||
143097457|NCT01467713|515897041|FG001|Overall Study|Major Protocol Deviation|4|||
143097458|NCT01467713|515897042|FG002|Overall Study|Major Protocol Deviation|4|||
143097459|NCT01467713|515897043|FG003|Overall Study|Major Protocol Deviation|1|||
143097460|NCT01467713|515897040|FG000|Overall Study|Lost to Follow-up|9|||
143097461|NCT01467713|515897041|FG001|Overall Study|Lost to Follow-up|12|||
143097462|NCT01467713|515897042|FG002|Overall Study|Lost to Follow-up|6|||
143097463|NCT01467713|515897043|FG003|Overall Study|Lost to Follow-up|9|||
143097464|NCT01467713|515897040|FG000|Overall Study|Voluntary Withdrawal|18|||
143097465|NCT01467713|515897041|FG001|Overall Study|Voluntary Withdrawal|14|||
143097466|NCT01467713|515897042|FG002|Overall Study|Voluntary Withdrawal|21|||
143097467|NCT01467713|515897043|FG003|Overall Study|Voluntary Withdrawal|20|||
143097468|NCT01467713|515897040|FG000|Overall Study|Study Termination|23|||
143097469|NCT01467713|515897041|FG001|Overall Study|Study Termination|33|||
143097470|NCT01467713|515897042|FG002|Overall Study|Study Termination|28|||
143097471|NCT01467713|515897043|FG003|Overall Study|Study Termination|29|||
143097472|NCT01467713|515897040|FG000|Overall Study|Pregnancy|0|||
143097473|NCT01467713|515897041|FG001|Overall Study|Pregnancy|1|||
143097474|NCT01467713|515897042|FG002|Overall Study|Pregnancy|1|||
143097475|NCT01467713|515897043|FG003|Overall Study|Pregnancy|3|||
143097476|NCT01467713|515897040|FG000|Overall Study|Relapse|35|||
143097477|NCT01467713|515897041|FG001|Overall Study|Relapse|25|||
143097478|NCT01467713|515897042|FG002|Overall Study|Relapse|28|||
143097479|NCT01467713|515897043|FG003|Overall Study|Relapse|35|||
143097480|NCT01467713|515897040|FG000|Overall Study|Reason not Specified|6|||
143097481|NCT01467713|515897041|FG001|Overall Study|Reason not Specified|11|||
143097482|NCT01467713|515897042|FG002|Overall Study|Reason not Specified|8|||
143097483|NCT01467713|515897043|FG003|Overall Study|Reason not Specified|7|||
143097484|NCT01120184|515897044|FG000|Overall Study|Adverse Event|0|||
143097485|NCT01120184|515897045|FG001|Overall Study|Adverse Event|1|||
143097486|NCT01120184|515897046|FG002|Overall Study|Adverse Event|0|||
143097487|NCT01120184|515897044|FG000|Overall Study|Lost to Follow-up|13|||
143097488|NCT01120184|515897045|FG001|Overall Study|Lost to Follow-up|13|||
143097489|NCT01120184|515897046|FG002|Overall Study|Lost to Follow-up|11|||
143097490|NCT01120184|515897044|FG000|Overall Study|Physician Decision|9|||
143097491|NCT01120184|515897045|FG001|Overall Study|Physician Decision|1|||
143097492|NCT01120184|515897046|FG002|Overall Study|Physician Decision|3|||
143097493|NCT01120184|515897044|FG000|Overall Study|Reason not Specified|8|||
143097494|NCT01120184|515897045|FG001|Overall Study|Reason not Specified|3|||
143097495|NCT01120184|515897046|FG002|Overall Study|Reason not Specified|12|||
143097496|NCT01120184|515897044|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
143097497|NCT01120184|515897045|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
143097498|NCT01120184|515897046|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
143097499|NCT01120184|515897044|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
143097500|NCT01120184|515897045|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
143097501|NCT01120184|515897046|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
143097502|NCT01120184|515897044|FG000|Overall Study|Death|170|||
143097503|NCT01120184|515897045|FG001|Overall Study|Death|176|||
143097504|NCT01120184|515897046|FG002|Overall Study|Death|169|||
143367625|NCT02081391|516889416|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
143367626|NCT02081391|516889417|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
143367627|NCT02081391|516889414|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
143367628|NCT02081391|516889415|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
143367629|NCT02081391|516889416|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
143367630|NCT02081391|516889417|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
143367631|NCT02081391|516889414|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
143367632|NCT02081391|516889415|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
143367633|NCT02081391|516889416|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
143367634|NCT02081391|516889417|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
143367635|NCT02081391|516889414|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
143367636|NCT02081391|516889415|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
143367637|NCT02081391|516889416|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
143367638|NCT02081391|516889417|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
143367639|NCT01458275|516889418|FG000|Overall Study|Adverse Event|3|||
143367640|NCT01458275|516889419|FG001|Overall Study|Adverse Event|4|||
143367641|NCT01458275|516889420|FG002|Overall Study|Adverse Event|1|||
143367642|NCT01458275|516889418|FG000|Overall Study|Lost to Follow-up|3|||
143367643|NCT01458275|516889419|FG001|Overall Study|Lost to Follow-up|2|||
143367644|NCT01458275|516889420|FG002|Overall Study|Lost to Follow-up|5|||
143367645|NCT01458275|516889418|FG000|Overall Study|Protocol Violation|5|||
143367646|NCT01458275|516889419|FG001|Overall Study|Protocol Violation|5|||
143367647|NCT01458275|516889420|FG002|Overall Study|Protocol Violation|2|||
143367648|NCT01458275|516889418|FG000|Overall Study|Withdrawal by Subject|3|||
143367649|NCT01458275|516889419|FG001|Overall Study|Withdrawal by Subject|2|||
143367650|NCT01458275|516889420|FG002|Overall Study|Withdrawal by Subject|1|||
143367651|NCT00813488|516889421|FG000|Titration Period 1|Adverse Event|6|||
143097505|NCT00570141|515897047|FG000|Overall Study|Adverse Event|1|||
143097506|NCT00570141|515897047|FG000|Overall Study|Missed visits|1|||
143097507|NCT00570141|515897047|FG000|Overall Study|Lost to Follow-up|1|||
143097508|NCT03270657|515897051|FG000|Overall Study|Withdrawal by Subject|1|||
143097509|NCT00455403|515897052|FG000|Overall Study|Lost to Follow-up|2|||
143097510|NCT00455403|515897053|FG001|Overall Study|Lost to Follow-up|1|||
143097511|NCT00455403|515897052|FG000|Overall Study|Withdrawal by Subject|1|||
143097512|NCT00455403|515897053|FG001|Overall Study|Withdrawal by Subject|3|||
143097513|NCT00455403|515897052|FG000|Overall Study|Protocol Violation|0|||
143097514|NCT00455403|515897053|FG001|Overall Study|Protocol Violation|2|||
143097515|NCT04509076|515897054|FG000|Overall Study|Withdrawal by Subject|1|||
143097516|NCT04509076|515897055|FG001|Overall Study|Withdrawal by Subject|2|||
143097517|NCT04509076|515897054|FG000|Overall Study|Lost to Follow-up|1|||
143097518|NCT04509076|515897055|FG001|Overall Study|Lost to Follow-up|2|||
143097519|NCT01343043|515897058|FG000|Overall Study|Disease progression before treatment|1|||
143097520|NCT01343043|515897059|FG001|Overall Study|Disease progression before treatment|0|||
143097521|NCT01343043|515897060|FG002|Overall Study|Disease progression before treatment|0|||
143097522|NCT01343043|515897061|FG003|Overall Study|Disease progression before treatment|0|||
143097523|NCT01343043|515897058|FG000|Overall Study|Withdrawal by Subject|1|||
143097524|NCT01343043|515897059|FG001|Overall Study|Withdrawal by Subject|0|||
143097525|NCT01343043|515897060|FG002|Overall Study|Withdrawal by Subject|0|||
143097526|NCT01343043|515897061|FG003|Overall Study|Withdrawal by Subject|0|||
143097527|NCT01343043|515897058|FG000|Overall Study|Death|1|||
143097528|NCT01343043|515897059|FG001|Overall Study|Death|1|||
143097529|NCT01343043|515897060|FG002|Overall Study|Death|0|||
143097530|NCT01343043|515897061|FG003|Overall Study|Death|1|||
143097531|NCT00925704|515897062|FG000|First Intervention|Withdrew consent|0|||
143097532|NCT00925704|515897063|FG001|First Intervention|Withdrew consent|0|||
143097533|NCT00925704|515897064|FG002|First Intervention|Withdrew consent|0|||
143097534|NCT00925704|515897065|FG003|First Intervention|Withdrew consent|1|||
143097535|NCT00925704|515897066|FG004|First Intervention|Withdrew consent|1|||
143097536|NCT00925704|515897067|FG005|First Intervention|Withdrew consent|0|||
143097537|NCT00925704|515897062|FG000|Second Intervention|Withdrawal by Subject|1|||
143097538|NCT00925704|515897063|FG001|Second Intervention|Withdrawal by Subject|0|||
143097539|NCT00925704|515897064|FG002|Second Intervention|Withdrawal by Subject|0|||
143097540|NCT00925704|515897065|FG003|Second Intervention|Withdrawal by Subject|0|||
143367652|NCT00813488|516889422|FG001|Titration Period 1|Adverse Event|1|||
143367653|NCT00813488|516889421|FG000|Titration Period 1|Lack of Efficacy|9|||
143367654|NCT00813488|516889422|FG001|Titration Period 1|Lack of Efficacy|7|||
143367655|NCT00813488|516889421|FG000|Titration Period 1|Withdrawal by Subject|2|||
143367656|NCT00813488|516889422|FG001|Titration Period 1|Withdrawal by Subject|2|||
143367657|NCT00813488|516889421|FG000|Titration Period 1|Protocol Violation|4|||
143367658|NCT00813488|516889422|FG001|Titration Period 1|Protocol Violation|3|||
143367659|NCT00813488|516889421|FG000|Titration Period 1|Non-compliance to study medication|4|||
143097541|NCT00925704|515897066|FG004|Second Intervention|Withdrawal by Subject|1|||
143097542|NCT00925704|515897067|FG005|Second Intervention|Withdrawal by Subject|0|||
143097543|NCT00925704|515897062|FG000|Third Intervention|Withdrew consent|0|||
143097544|NCT00925704|515897063|FG001|Third Intervention|Withdrew consent|0|||
143097545|NCT00925704|515897064|FG002|Third Intervention|Withdrew consent|0|||
143097546|NCT00925704|515897065|FG003|Third Intervention|Withdrew consent|0|||
143097547|NCT00925704|515897066|FG004|Third Intervention|Withdrew consent|0|||
143097548|NCT00925704|515897067|FG005|Third Intervention|Withdrew consent|1|||
143097549|NCT00502242|515897070|FG000|Overall Study|Lack of Efficacy|1|||
143097550|NCT00502242|515897071|FG001|Overall Study|Lack of Efficacy|11|||
143097551|NCT00502242|515897070|FG000|Overall Study|Adverse Event|31|||
143097552|NCT00502242|515897071|FG001|Overall Study|Adverse Event|20|||
143097553|NCT00502242|515897070|FG000|Overall Study|Physician Decision|2|||
143097554|NCT00502242|515897071|FG001|Overall Study|Physician Decision|3|||
143097555|NCT00502242|515897070|FG000|Overall Study|Other - Unspecified|8|||
143097556|NCT00502242|515897071|FG001|Overall Study|Other - Unspecified|14|||
143097557|NCT00502242|515897070|FG000|Overall Study|Protocol Violation|3|||
143097558|NCT00502242|515897071|FG001|Overall Study|Protocol Violation|1|||
143097559|NCT00502242|515897070|FG000|Overall Study|Withdrawal by Subject|6|||
143097560|NCT00502242|515897071|FG001|Overall Study|Withdrawal by Subject|7|||
143251645|NCT05141448|516474269|FG004|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
143251646|NCT05141448|516474270|FG005|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
143097561|NCT03207815|515897072|FG000|Overall Study|Protocol Violation|3|||
143097562|NCT03207815|515897073|FG001|Overall Study|Protocol Violation|1|||
143097563|NCT03207815|515897072|FG000|Overall Study|Adverse Event|1|||
143097564|NCT03207815|515897073|FG001|Overall Study|Adverse Event|2|||
143097565|NCT03207815|515897072|FG000|Overall Study|Lost to Follow-up|1|||
143097566|NCT03207815|515897073|FG001|Overall Study|Lost to Follow-up|2|||
143097567|NCT03207815|515897072|FG000|Overall Study|Investigator's Discretion|1|||
143097568|NCT03207815|515897073|FG001|Overall Study|Investigator's Discretion|1|||
143097569|NCT03207815|515897072|FG000|Overall Study|Lack of Efficacy|0|||
143097570|NCT03207815|515897073|FG001|Overall Study|Lack of Efficacy|1|||
143097571|NCT03207815|515897072|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
143097572|NCT03207815|515897073|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
143097573|NCT03207815|515897072|FG000|Overall Study|Withdrew Consent|1|||
143097574|NCT03207815|515897073|FG001|Overall Study|Withdrew Consent|0|||
143097575|NCT01812109|515897074|FG000|Overall Study|research personnel delay|16|||
143097576|NCT01812109|515897074|FG000|Overall Study|NIRS Unattainable|17|||
143097577|NCT00506415|515897089|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
143097578|NCT00506415|515897090|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
143097579|NCT00506415|515897091|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
143097580|NCT00506415|515897092|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
143097581|NCT00506415|515897089|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
143097582|NCT00506415|515897090|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
143097583|NCT00506415|515897091|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
143097584|NCT00506415|515897092|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
143097585|NCT00506415|515897089|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
143097586|NCT00506415|515897090|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
143097587|NCT00506415|515897091|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
143097588|NCT00506415|515897092|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
143097589|NCT00506415|515897089|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
143097590|NCT00506415|515897090|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
143097591|NCT00506415|515897091|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
143097592|NCT00506415|515897092|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
143251647|NCT05141448|516474265|FG000|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
143251648|NCT05141448|516474266|FG001|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
143097593|NCT00506415|515897089|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
143097594|NCT00506415|515897090|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
143097595|NCT00506415|515897091|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
143097596|NCT00506415|515897092|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
143097597|NCT00506415|515897089|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
143097598|NCT00506415|515897090|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
143097599|NCT00506415|515897091|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
143097600|NCT00506415|515897092|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
143097601|NCT00506415|515897089|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
143097602|NCT00506415|515897090|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
143097603|NCT00506415|515897091|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
143097604|NCT00506415|515897092|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
143097605|NCT00506415|515897089|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
143097606|NCT00506415|515897090|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
143097607|NCT00506415|515897091|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
143097608|NCT00506415|515897092|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
143097609|NCT00506415|515897089|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
143097610|NCT00506415|515897090|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
143097611|NCT00506415|515897091|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
143097612|NCT00506415|515897092|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
143097613|NCT00506415|515897089|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
143097614|NCT00506415|515897090|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
143097615|NCT00506415|515897091|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
143097616|NCT00506415|515897092|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
143097617|NCT00506415|515897089|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
143097618|NCT00506415|515897090|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
143097619|NCT00506415|515897091|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
143097620|NCT00506415|515897092|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
143097621|NCT00506415|515897089|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
143097622|NCT00506415|515897090|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
143097623|NCT00506415|515897091|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
143097624|NCT00506415|515897092|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
143097625|NCT00506415|515897089|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
143097626|NCT00506415|515897090|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
143097627|NCT00506415|515897091|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
143097628|NCT00506415|515897092|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
143097629|NCT00506415|515897089|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
143251649|NCT05141448|516474267|FG002|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
143251650|NCT05141448|516474268|FG003|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
143251651|NCT05141448|516474269|FG004|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
143251652|NCT05141448|516474270|FG005|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
143251653|NCT05141448|516474265|FG000|Period 2|COVID-19 Related|0|||
143251654|NCT05141448|516474266|FG001|Period 2|COVID-19 Related|0|||
143251655|NCT05141448|516474267|FG002|Period 2|COVID-19 Related|0|||
143251656|NCT05141448|516474268|FG003|Period 2|COVID-19 Related|1|||
143251657|NCT05141448|516474269|FG004|Period 2|COVID-19 Related|0|||
143251658|NCT05141448|516474270|FG005|Period 2|COVID-19 Related|1|||
143251659|NCT05141448|516474265|FG000|3|Covid-19 related|2|||
143251660|NCT05141448|516474266|FG001|3|Covid-19 related|0|||
143251661|NCT05141448|516474267|FG002|3|Covid-19 related|0|||
143251662|NCT05141448|516474268|FG003|3|Covid-19 related|0|||
143251663|NCT05141448|516474269|FG004|3|Covid-19 related|0|||
143251664|NCT05141448|516474270|FG005|3|Covid-19 related|1|||
143251665|NCT05141448|516474265|FG000|4|Unsatisfactory Visual Response due to Test Article|1|||
143251666|NCT05141448|516474266|FG001|4|Unsatisfactory Visual Response due to Test Article|0|||
143251667|NCT05141448|516474267|FG002|4|Unsatisfactory Visual Response due to Test Article|0|||
143251668|NCT05141448|516474268|FG003|4|Unsatisfactory Visual Response due to Test Article|0|||
143251669|NCT05141448|516474269|FG004|4|Unsatisfactory Visual Response due to Test Article|0|||
143251670|NCT05141448|516474270|FG005|4|Unsatisfactory Visual Response due to Test Article|0|||
143251671|NCT01031836|516476261|FG000|Stage I|Adverse Event|1|||
143251672|NCT01031836|516476262|FG001|Stage I|Adverse Event|1|||
143251673|NCT01031836|516476263|FG002|Stage I|Adverse Event|0|||
143251674|NCT01031836|516476264|FG003|Stage I|Adverse Event|0|||
143251675|NCT01031836|516476265|FG004|Stage I|Adverse Event|0|||
143251676|NCT01031836|516476266|FG005|Stage I|Adverse Event|0|||
143251677|NCT01031836|516476261|FG000|Stage I|Other|0|||
143251678|NCT01031836|516476262|FG001|Stage I|Other|1|||
143251679|NCT01031836|516476263|FG002|Stage I|Other|0|||
143251680|NCT01031836|516476264|FG003|Stage I|Other|0|||
143251681|NCT01031836|516476265|FG004|Stage I|Other|0|||
143251682|NCT01031836|516476266|FG005|Stage I|Other|1|||
143251683|NCT01031836|516476261|FG000|Stage II|Adverse Event|0|||
143251684|NCT01031836|516476262|FG001|Stage II|Adverse Event|0|||
143251685|NCT01031836|516476263|FG002|Stage II|Adverse Event|2|||
143251686|NCT01031836|516476264|FG003|Stage II|Adverse Event|2|||
143251687|NCT01031836|516476265|FG004|Stage II|Adverse Event|1|||
143003463|NCT02646566|515550641|FG002|Overall Study|Lost to Follow-up|5|||
143003464|NCT02646566|515550639|FG000|Overall Study|Treatment failure|1|||
143003465|NCT02646566|515550640|FG001|Overall Study|Treatment failure|0|||
143003466|NCT02646566|515550641|FG002|Overall Study|Treatment failure|0|||
143003467|NCT02064231|515550646|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
143003468|NCT02064231|515550647|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
143003469|NCT02064231|515550648|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
143003470|NCT02064231|515550649|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
143003471|NCT02064231|515550646|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
143003472|NCT02064231|515550647|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
143003473|NCT02064231|515550648|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
143003474|NCT02064231|515550649|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
143003475|NCT02064231|515550646|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
143003476|NCT02064231|515550647|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
143003477|NCT02064231|515550648|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
143003478|NCT02064231|515550649|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
143003479|NCT02064231|515550646|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
143003480|NCT02064231|515550647|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
143003481|NCT02064231|515550648|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
143003482|NCT02064231|515550649|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
143003483|NCT00718809|515550651|FG000|Overall Study|Disease progression|9|||
143003484|NCT00718809|515550652|FG001|Overall Study|Disease progression|7|||
143003485|NCT00718809|515550651|FG000|Overall Study|Adverse Event|1|||
143003486|NCT00718809|515550652|FG001|Overall Study|Adverse Event|1|||
143003487|NCT00718809|515550651|FG000|Overall Study|Withdrawal by Subject|0|||
143003488|NCT00718809|515550652|FG001|Overall Study|Withdrawal by Subject|1|||
143003489|NCT00718809|515550651|FG000|Overall Study|Lost to Follow-up|1|||
143251688|NCT01031836|516476266|FG005|Stage II|Adverse Event|1|||
143251689|NCT01031836|516476261|FG000|Stage II|Other|2|||
143251690|NCT01031836|516476262|FG001|Stage II|Other|0|||
143251691|NCT01031836|516476263|FG002|Stage II|Other|0|||
143251692|NCT01031836|516476264|FG003|Stage II|Other|1|||
143251693|NCT01031836|516476265|FG004|Stage II|Other|1|||
143251694|NCT01031836|516476266|FG005|Stage II|Other|0|||
143251695|NCT01948193|516476267|FG000|Overall Study|Serious event|2|||
143251696|NCT01948193|516476267|FG000|Overall Study|Lost to Follow-up|7|||
143003490|NCT00718809|515550652|FG001|Overall Study|Lost to Follow-up|0|||
143097630|NCT00506415|515897090|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
143097631|NCT00506415|515897091|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
143097632|NCT00506415|515897092|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
143097633|NCT00506415|515897089|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
143097634|NCT00506415|515897090|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
143097635|NCT00506415|515897091|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
143097636|NCT00506415|515897092|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
143097637|NCT00506415|515897089|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
143097638|NCT00506415|515897090|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
143097639|NCT00506415|515897091|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
143097640|NCT00506415|515897092|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
143097641|NCT00506415|515897089|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
143097642|NCT00506415|515897090|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
143097643|NCT00506415|515897091|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
143097644|NCT00506415|515897092|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
143097645|NCT00506415|515897089|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
143097646|NCT00506415|515897090|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
143097647|NCT00506415|515897091|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
143097648|NCT00506415|515897092|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
143097649|NCT00506415|515897089|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
143097650|NCT00506415|515897090|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
143251697|NCT00490529|516476268|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
143251698|NCT00490529|516476268|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
143251699|NCT00490529|516476268|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
143251700|NCT00490529|516476268|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
143367660|NCT00813488|516889422|FG001|Titration Period 1|Non-compliance to study medication|1|||
143367661|NCT00813488|516889421|FG000|Titration Period 1|Non-compliance to study procedures|2|||
143367662|NCT00813488|516889422|FG001|Titration Period 1|Non-compliance to study procedures|2|||
143003491|NCT00718809|515550651|FG000|Overall Study|Noncompliance|1|||
143003492|NCT00718809|515550652|FG001|Overall Study|Noncompliance|0|||
143003493|NCT00463385|515550653|FG000|Overall Study|Other|4|||
143003494|NCT00463385|515550654|FG001|Overall Study|Other|3|||
143003495|NCT00463385|515550655|FG002|Overall Study|Other|6|||
143003496|NCT00463385|515550656|FG003|Overall Study|Other|4|||
143003497|NCT00463385|515550653|FG000|Overall Study|Adverse Event|5|||
143003498|NCT00463385|515550654|FG001|Overall Study|Adverse Event|8|||
143003499|NCT00463385|515550655|FG002|Overall Study|Adverse Event|4|||
143003500|NCT00463385|515550656|FG003|Overall Study|Adverse Event|2|||
143003501|NCT00463385|515550653|FG000|Overall Study|Lack of Efficacy|6|||
143003502|NCT00463385|515550654|FG001|Overall Study|Lack of Efficacy|6|||
143003503|NCT00463385|515550655|FG002|Overall Study|Lack of Efficacy|7|||
143003504|NCT00463385|515550656|FG003|Overall Study|Lack of Efficacy|9|||
143003505|NCT00463385|515550653|FG000|Overall Study|Withdrawal by Subject|3|||
143003506|NCT00463385|515550654|FG001|Overall Study|Withdrawal by Subject|3|||
143003507|NCT00463385|515550655|FG002|Overall Study|Withdrawal by Subject|3|||
143003508|NCT00463385|515550656|FG003|Overall Study|Withdrawal by Subject|4|||
143003509|NCT00463385|515550653|FG000|Overall Study|Lost to Follow-up|0|||
143003510|NCT00463385|515550654|FG001|Overall Study|Lost to Follow-up|0|||
143003511|NCT00463385|515550655|FG002|Overall Study|Lost to Follow-up|0|||
143003512|NCT00463385|515550656|FG003|Overall Study|Lost to Follow-up|1|||
143003513|NCT00463385|515550653|FG000|Overall Study|Death|2|||
143003514|NCT00463385|515550654|FG001|Overall Study|Death|1|||
143003515|NCT00463385|515550655|FG002|Overall Study|Death|2|||
143003516|NCT00463385|515550656|FG003|Overall Study|Death|0|||
143003517|NCT00463385|515550653|FG000|Overall Study|Missing|2|||
143003518|NCT00463385|515550654|FG001|Overall Study|Missing|0|||
143003519|NCT00463385|515550655|FG002|Overall Study|Missing|0|||
143003520|NCT00463385|515550656|FG003|Overall Study|Missing|2|||
143003521|NCT00463385|515550653|FG000|Overall Study|1 participant received commercial drug|0|||
143003522|NCT00463385|515550654|FG001|Overall Study|1 participant received commercial drug|1|||
143003523|NCT00463385|515550655|FG002|Overall Study|1 participant received commercial drug|0|||
143003524|NCT00463385|515550656|FG003|Overall Study|1 participant received commercial drug|0|||
143251701|NCT00490529|516476268|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
143251702|NCT00490529|516476268|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
143251703|NCT03467152|516476269|FG000|Overall Study|Adverse Event|4|||
143097651|NCT00506415|515897091|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
143097652|NCT00506415|515897092|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
143097653|NCT00506415|515897089|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
143097654|NCT00506415|515897090|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
143097655|NCT00506415|515897091|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
143097656|NCT00506415|515897092|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
143097657|NCT00506415|515897089|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
143097658|NCT00506415|515897090|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
143097659|NCT00506415|515897091|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
143097660|NCT00506415|515897092|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
143097661|NCT00506415|515897089|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
143097662|NCT00506415|515897090|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
143097663|NCT00506415|515897091|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
143097664|NCT00506415|515897092|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
143097665|NCT00506415|515897089|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
143097666|NCT00506415|515897090|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
143097667|NCT00506415|515897091|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
143097668|NCT00506415|515897092|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
143097669|NCT00506415|515897089|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
143097670|NCT00506415|515897090|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
143097671|NCT00506415|515897091|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
143097672|NCT00506415|515897092|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
143097673|NCT04578457|515897093|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
143097674|NCT04578457|515897093|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
143097675|NCT04578457|515897093|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
143097676|NCT04578457|515897093|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
143097677|NCT02275819|515897103|FG000|Overall Study|Adverse Event|0|||
143097678|NCT02275819|515897104|FG001|Overall Study|Adverse Event|1|||
143097679|NCT02211209|515897110|FG000|Overall Study|Investigator judgment|0|||
143097680|NCT02211209|515897111|FG001|Overall Study|Investigator judgment|1|||
143097681|NCT02211209|515897110|FG000|Overall Study|Voluntary withdrawal|1|||
143097682|NCT02211209|515897111|FG001|Overall Study|Voluntary withdrawal|4|||
143097683|NCT02211209|515897110|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
143097684|NCT02211209|515897111|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
143097685|NCT02211209|515897110|FG000|Overall Study|Reason Not Specified|1|||
143097686|NCT02211209|515897111|FG001|Overall Study|Reason Not Specified|0|||
143097687|NCT02792062|515897115|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
143097688|NCT02792062|515897116|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
143097689|NCT02792062|515897117|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
143251704|NCT03467152|516476270|FG001|Overall Study|Adverse Event|5|||
143251705|NCT03467152|516476271|FG002|Overall Study|Adverse Event|0|||
143251706|NCT03467152|516476269|FG000|Overall Study|Subject Choice|1|||
143251707|NCT03467152|516476270|FG001|Overall Study|Subject Choice|3|||
143251708|NCT03467152|516476271|FG002|Overall Study|Subject Choice|0|||
143251709|NCT03467152|516476269|FG000|Overall Study|Lost to Follow-up|1|||
143251710|NCT03467152|516476270|FG001|Overall Study|Lost to Follow-up|0|||
143251711|NCT03467152|516476271|FG002|Overall Study|Lost to Follow-up|0|||
143251712|NCT03467152|516476269|FG000|Overall Study|Withdrawal by Subject|4|||
143251713|NCT03467152|516476270|FG001|Overall Study|Withdrawal by Subject|2|||
143251714|NCT03467152|516476271|FG002|Overall Study|Withdrawal by Subject|0|||
143251715|NCT03467152|516476269|FG000|Overall Study|Others|3|||
143251716|NCT03467152|516476270|FG001|Overall Study|Others|0|||
143251717|NCT03467152|516476271|FG002|Overall Study|Others|0|||
143251718|NCT03467152|516476269|FG000|Overall Study|Not treated|3|||
143251719|NCT03467152|516476270|FG001|Overall Study|Not treated|1|||
143251720|NCT03467152|516476271|FG002|Overall Study|Not treated|6|||
143251721|NCT00945906|516476272|FG000|Overall Study|Withdrawal by Subject|1|||
143251722|NCT00945906|516476272|FG000|Overall Study|Did not want to return for last visit|2|||
143251723|NCT00945906|516476272|FG000|Overall Study|Unable to return for last visit|2|||
143251724|NCT00945906|516476272|FG000|Overall Study|Moved to another country|2|||
143251725|NCT03700684|516476274|FG000|Overall Study|COVID-19|0|||
143251726|NCT03700684|516476275|FG001|Overall Study|COVID-19|0|||
143251727|NCT03700684|516476276|FG002|Overall Study|COVID-19|2|||
143097690|NCT02792062|515897118|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
143097691|NCT02792062|515897119|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
143251728|NCT01120782|516476277|FG000|Overall Study|Test article shipping error|11|||
143251729|NCT04140227|516476278|FG000|Overall Study|Withdrawal by Subject|26|||
143251730|NCT04140227|516476278|FG000|Overall Study|Lost to Follow-up|8|||
143097692|NCT02792062|515897120|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
143097693|NCT02230904|515897121|FG000|Overall Study|Safety follow up could not take place|0|||
143097694|NCT02230904|515897122|FG001|Overall Study|Safety follow up could not take place|1|||
143097695|NCT01681212|515897123|FG000|Overall Study|No longer met study criteria|5|||
143097696|NCT01681212|515897123|FG000|Overall Study|Administrative reason by sponsor|1|||
143097697|NCT01464424|515897124|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
143097698|NCT01464424|515897125|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
143097699|NCT01464333|515897129|FG000|Overall Study|Adverse Event|34|||
143097700|NCT01464333|515897129|FG000|Overall Study|Lack of Efficacy|72|||
143097701|NCT01464333|515897129|FG000|Overall Study|Withdrawal by Subject|11|||
143097702|NCT01464333|515897129|FG000|Overall Study|Other|4|||
143097703|NCT01464333|515897129|FG000|Overall Study|No Hospital Visit|42|||
143367663|NCT00813488|516889421|FG000|Titration Period 1|Technical Difficulties|0|||
143367664|NCT00813488|516889422|FG001|Titration Period 1|Technical Difficulties|1|||
143367665|NCT00813488|516889421|FG000|Titration Period 2|Adverse Event|2|||
143367666|NCT00813488|516889422|FG001|Titration Period 2|Adverse Event|3|||
143367667|NCT00813488|516889421|FG000|Titration Period 2|Lack of Efficacy|8|||
143367668|NCT00813488|516889422|FG001|Titration Period 2|Lack of Efficacy|4|||
143367669|NCT00813488|516889421|FG000|Titration Period 2|Protocol Violation|3|||
143367670|NCT00813488|516889422|FG001|Titration Period 2|Protocol Violation|2|||
143367671|NCT00813488|516889421|FG000|Titration Period 2|Lost to Follow-up|1|||
143367672|NCT00813488|516889422|FG001|Titration Period 2|Lost to Follow-up|0|||
143367673|NCT00813488|516889421|FG000|Titration Period 2|Non-compliance with study procedures|2|||
143097704|NCT05047211|515897131|FG000|Overall Study|Lost to Follow-up|8|||
143097705|NCT05047211|515897132|FG001|Overall Study|Lost to Follow-up|5|||
143097706|NCT02187198|515897133|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
143097707|NCT02187198|515897134|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
143097708|NCT02187198|515897133|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
143097709|NCT02187198|515897134|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
143097710|NCT00561392|515897135|FG000|Overall Study|Adverse Event|38|||
143097711|NCT00561392|515897135|FG000|Overall Study|Lack of Efficacy|2|||
143097712|NCT00561392|515897135|FG000|Overall Study|Protocol Violation|1|||
143097713|NCT00561392|515897135|FG000|Overall Study|Withdrawal by Subject|8|||
143097714|NCT00561392|515897135|FG000|Overall Study|Administrative problems|4|||
143097715|NCT05600283|515897139|FG000|Overall Study|Withdrawal by Subject|3|||
143097716|NCT05600283|515897140|FG001|Overall Study|Withdrawal by Subject|8|||
143097717|NCT05600283|515897139|FG000|Overall Study|invalid individual swab|1|||
143097718|NCT05600283|515897140|FG001|Overall Study|invalid individual swab|0|||
143097719|NCT05600283|515897139|FG000|Overall Study|missing clinician collection|3|||
143367674|NCT00813488|516889422|FG001|Titration Period 2|Non-compliance with study procedures|1|||
143367675|NCT00813488|516889421|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
143367676|NCT00813488|516889422|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
143367677|NCT00813488|516889421|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
143367678|NCT00813488|516889422|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
143367679|NCT00813488|516889421|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
143367680|NCT00813488|516889422|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
143367681|NCT00813488|516889421|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
143367682|NCT00813488|516889422|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
143097720|NCT05600283|515897140|FG001|Overall Study|missing clinician collection|0|||
143097721|NCT05600283|515897139|FG000|Overall Study|screening failure|0|||
143367683|NCT00813488|516889421|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
143367684|NCT00813488|516889422|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
143367685|NCT00813488|516889421|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
143367686|NCT00813488|516889422|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
143367687|NCT00813488|516889421|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
143367688|NCT00813488|516889422|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
143367689|NCT00813488|516889421|FG000|Double-blind Treatment Period 2|Other|1|||
143097722|NCT05600283|515897140|FG001|Overall Study|screening failure|2|||
143097723|NCT02867592|515897141|FG000|Overall Study|Adverse Event|3|||
143097724|NCT02867592|515897142|FG001|Overall Study|Adverse Event|0|||
143097725|NCT02867592|515897143|FG002|Overall Study|Adverse Event|2|||
143097726|NCT02867592|515897144|FG003|Overall Study|Adverse Event|1|||
143097727|NCT02867592|515897145|FG004|Overall Study|Adverse Event|1|||
143097728|NCT02867592|515897146|FG005|Overall Study|Adverse Event|5|||
143097729|NCT02867592|515897141|FG000|Overall Study|Death|0|||
143097730|NCT02867592|515897142|FG001|Overall Study|Death|0|||
143097731|NCT02867592|515897143|FG002|Overall Study|Death|0|||
143097732|NCT02867592|515897144|FG003|Overall Study|Death|1|||
143097733|NCT02867592|515897145|FG004|Overall Study|Death|0|||
143097734|NCT02867592|515897146|FG005|Overall Study|Death|1|||
143097735|NCT02867592|515897141|FG000|Overall Study|Lack of Efficacy|8|||
143097736|NCT02867592|515897142|FG001|Overall Study|Lack of Efficacy|10|||
143097737|NCT02867592|515897143|FG002|Overall Study|Lack of Efficacy|8|||
143097738|NCT02867592|515897144|FG003|Overall Study|Lack of Efficacy|8|||
143097739|NCT02867592|515897145|FG004|Overall Study|Lack of Efficacy|12|||
143097740|NCT02867592|515897146|FG005|Overall Study|Lack of Efficacy|17|||
143097741|NCT02867592|515897141|FG000|Overall Study|Physician Decision|1|||
143097742|NCT02867592|515897142|FG001|Overall Study|Physician Decision|2|||
143097743|NCT02867592|515897143|FG002|Overall Study|Physician Decision|2|||
143097744|NCT02867592|515897144|FG003|Overall Study|Physician Decision|0|||
143097745|NCT02867592|515897145|FG004|Overall Study|Physician Decision|5|||
143097746|NCT02867592|515897146|FG005|Overall Study|Physician Decision|1|||
143097747|NCT02867592|515897141|FG000|Overall Study|Protocol Violation|0|||
143097748|NCT02867592|515897142|FG001|Overall Study|Protocol Violation|0|||
143097749|NCT02867592|515897143|FG002|Overall Study|Protocol Violation|0|||
143097750|NCT02867592|515897144|FG003|Overall Study|Protocol Violation|0|||
143097751|NCT02867592|515897145|FG004|Overall Study|Protocol Violation|1|||
143097752|NCT02867592|515897146|FG005|Overall Study|Protocol Violation|1|||
143097753|NCT02867592|515897141|FG000|Overall Study|Withdrawal by Subject|0|||
143097754|NCT02867592|515897142|FG001|Overall Study|Withdrawal by Subject|1|||
143097755|NCT02867592|515897143|FG002|Overall Study|Withdrawal by Subject|0|||
143097756|NCT02867592|515897144|FG003|Overall Study|Withdrawal by Subject|1|||
143097757|NCT02867592|515897145|FG004|Overall Study|Withdrawal by Subject|3|||
143097758|NCT02867592|515897146|FG005|Overall Study|Withdrawal by Subject|3|||
143097759|NCT02867592|515897141|FG000|Overall Study|Ineligible|1|||
143097760|NCT02867592|515897142|FG001|Overall Study|Ineligible|1|||
143097761|NCT02867592|515897143|FG002|Overall Study|Ineligible|0|||
143097762|NCT02867592|515897144|FG003|Overall Study|Ineligible|0|||
143097763|NCT02867592|515897145|FG004|Overall Study|Ineligible|2|||
143097764|NCT02867592|515897146|FG005|Overall Study|Ineligible|0|||
143097765|NCT02867592|515897141|FG000|Overall Study|No Treatment|1|||
143097766|NCT02867592|515897142|FG001|Overall Study|No Treatment|0|||
143097767|NCT02867592|515897143|FG002|Overall Study|No Treatment|0|||
143097768|NCT02867592|515897144|FG003|Overall Study|No Treatment|0|||
143097769|NCT02867592|515897145|FG004|Overall Study|No Treatment|0|||
143251731|NCT04140227|516476278|FG000|Overall Study|Adverse Event|8|||
143251732|NCT04140227|516476278|FG000|Overall Study|Death|1|||
143251733|NCT04140227|516476278|FG000|Overall Study|Other|3|||
143251734|NCT04140227|516476278|FG000|Overall Study|Protocol Violation|2|||
143251735|NCT00361634|516476289|FG000|Overall Study|Lost to Follow-up|1|||
143251736|NCT00361634|516476289|FG000|Overall Study|Withdrawal by Subject|1|||
143251737|NCT05315908|516476290|FG000|Overall Study|Lost to Follow-up|4477|||
143251738|NCT05315908|516476291|FG001|Overall Study|Lost to Follow-up|4606|||
143251739|NCT00294762|516476292|FG000|Overall Study|Did not receive study treatment|3|||
143251740|NCT00294762|516476293|FG001|Overall Study|Did not receive study treatment|3|||
143251741|NCT02937584|516476294|FG000|Period 1|Adverse Event|1|||
143251742|NCT02937584|516476295|FG001|Period 1|Adverse Event|2|||
143251743|NCT02937584|516476294|FG000|Washout|Adverse Event|0|||
143251744|NCT02937584|516476295|FG001|Washout|Adverse Event|1|||
143251745|NCT00635219|516476296|FG000|Overall Study|Adverse Event|12|||
143097770|NCT02867592|515897146|FG005|Overall Study|No Treatment|0|||
143251746|NCT00635219|516476297|FG001|Overall Study|Adverse Event|10|||
143251747|NCT00635219|516476298|FG002|Overall Study|Adverse Event|18|||
143097771|NCT02867592|515897141|FG000|Overall Study|Still on Therapy|0|||
143097772|NCT02867592|515897142|FG001|Overall Study|Still on Therapy|0|||
143097773|NCT02867592|515897143|FG002|Overall Study|Still on Therapy|0|||
143097774|NCT02867592|515897144|FG003|Overall Study|Still on Therapy|0|||
143097775|NCT02867592|515897145|FG004|Overall Study|Still on Therapy|1|||
143097776|NCT02867592|515897146|FG005|Overall Study|Still on Therapy|0|||
143097777|NCT02867592|515897141|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
143097778|NCT02867592|515897142|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
143251748|NCT00635219|516476299|FG003|Overall Study|Adverse Event|15|||
143251749|NCT00635219|516476300|FG004|Overall Study|Adverse Event|19|||
143251750|NCT00635219|516476296|FG000|Overall Study|Lack of Efficacy|5|||
143097779|NCT02867592|515897143|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
143176938|NCT01824290|516196243|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
143176939|NCT01824290|516196240|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
143176940|NCT01824290|516196241|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
143251751|NCT00635219|516476297|FG001|Overall Study|Lack of Efficacy|6|||
143367690|NCT00813488|516889422|FG001|Double-blind Treatment Period 2|Other|0|||
143367691|NCT00813488|516889421|FG000|Open-label Extension|Adverse Event|1|||
143367692|NCT00813488|516889422|FG001|Open-label Extension|Adverse Event|2|||
143367693|NCT00813488|516889421|FG000|Open-label Extension|Lack of Efficacy|3|||
143367694|NCT00813488|516889422|FG001|Open-label Extension|Lack of Efficacy|0|||
143367695|NCT00813488|516889421|FG000|Open-label Extension|Withdrawal by Subject|0|||
143367696|NCT00813488|516889422|FG001|Open-label Extension|Withdrawal by Subject|2|||
143367697|NCT00813488|516889421|FG000|Open-label Extension|Protocol Violation|1|||
143367698|NCT00813488|516889422|FG001|Open-label Extension|Protocol Violation|2|||
143367699|NCT00813488|516889421|FG000|Open-label Extension|Non-compliance study medication|4|||
143251752|NCT00635219|516476298|FG002|Overall Study|Lack of Efficacy|3|||
143251753|NCT00635219|516476299|FG003|Overall Study|Lack of Efficacy|4|||
143251754|NCT00635219|516476300|FG004|Overall Study|Lack of Efficacy|6|||
143251755|NCT00635219|516476296|FG000|Overall Study|Non-compliance With Study Product|0|||
143251756|NCT00635219|516476297|FG001|Overall Study|Non-compliance With Study Product|0|||
143251757|NCT00635219|516476298|FG002|Overall Study|Non-compliance With Study Product|0|||
143251758|NCT00635219|516476299|FG003|Overall Study|Non-compliance With Study Product|2|||
143251759|NCT00635219|516476300|FG004|Overall Study|Non-compliance With Study Product|1|||
143097780|NCT02867592|515897144|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
143097781|NCT02867592|515897145|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
143097782|NCT02867592|515897146|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
143097783|NCT02867592|515897141|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
143097784|NCT02867592|515897142|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
143097785|NCT02867592|515897143|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
143097786|NCT02867592|515897144|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
143097787|NCT02867592|515897145|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
143097788|NCT02867592|515897146|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
143097789|NCT00365794|515897150|FG000|Overall Study|Withdrawal by Subject|2|||
143097790|NCT02554682|515897151|FG000|Overall Study|Lost to Follow-up|11|||
143097791|NCT02554682|515897152|FG001|Overall Study|Lost to Follow-up|9|||
143097792|NCT02554682|515897153|FG002|Overall Study|Lost to Follow-up|4|||
143097793|NCT02554682|515897154|FG003|Overall Study|Lost to Follow-up|3|||
143097794|NCT02554682|515897155|FG004|Overall Study|Lost to Follow-up|2|||
143097795|NCT02554682|515897156|FG005|Overall Study|Lost to Follow-up|1|||
143097796|NCT02554682|515897157|FG006|Overall Study|Lost to Follow-up|6|||
143097797|NCT02554682|515897158|FG007|Overall Study|Lost to Follow-up|6|||
143097798|NCT02554682|515897159|FG008|Overall Study|Lost to Follow-up|2|||
143097799|NCT02554682|515897160|FG009|Overall Study|Lost to Follow-up|2|||
143097800|NCT02554682|515897151|FG000|Overall Study|Withdrawal by Subject|2|||
143097801|NCT02554682|515897152|FG001|Overall Study|Withdrawal by Subject|1|||
143097802|NCT02554682|515897153|FG002|Overall Study|Withdrawal by Subject|0|||
143097803|NCT02554682|515897154|FG003|Overall Study|Withdrawal by Subject|0|||
143251760|NCT00635219|516476296|FG000|Overall Study|Protocol Violation|0|||
143251761|NCT00635219|516476297|FG001|Overall Study|Protocol Violation|2|||
143251762|NCT00635219|516476298|FG002|Overall Study|Protocol Violation|3|||
143251763|NCT00635219|516476299|FG003|Overall Study|Protocol Violation|2|||
143251764|NCT00635219|516476300|FG004|Overall Study|Protocol Violation|4|||
143251765|NCT00635219|516476296|FG000|Overall Study|Withdrawal of Consent|8|||
143251766|NCT00635219|516476297|FG001|Overall Study|Withdrawal of Consent|6|||
143251767|NCT00635219|516476298|FG002|Overall Study|Withdrawal of Consent|8|||
143251768|NCT00635219|516476299|FG003|Overall Study|Withdrawal of Consent|11|||
143251769|NCT00635219|516476300|FG004|Overall Study|Withdrawal of Consent|8|||
143251770|NCT00635219|516476296|FG000|Overall Study|Lost to Follow-up|0|||
143251771|NCT00635219|516476297|FG001|Overall Study|Lost to Follow-up|0|||
143251772|NCT00635219|516476298|FG002|Overall Study|Lost to Follow-up|2|||
143251773|NCT00635219|516476299|FG003|Overall Study|Lost to Follow-up|0|||
143251774|NCT00635219|516476300|FG004|Overall Study|Lost to Follow-up|3|||
143251775|NCT00635219|516476296|FG000|Overall Study|Administrative or Other Reasons|0|||
143251776|NCT00635219|516476297|FG001|Overall Study|Administrative or Other Reasons|1|||
143251777|NCT00635219|516476298|FG002|Overall Study|Administrative or Other Reasons|1|||
143251778|NCT00635219|516476299|FG003|Overall Study|Administrative or Other Reasons|0|||
143251779|NCT00635219|516476300|FG004|Overall Study|Administrative or Other Reasons|1|||
143251780|NCT02238080|516476309|FG000|Overall Study|Death|13|||
143097804|NCT02554682|515897155|FG004|Overall Study|Withdrawal by Subject|0|||
143097805|NCT02554682|515897156|FG005|Overall Study|Withdrawal by Subject|0|||
143097806|NCT02554682|515897157|FG006|Overall Study|Withdrawal by Subject|0|||
143097807|NCT02554682|515897158|FG007|Overall Study|Withdrawal by Subject|0|||
143097808|NCT02554682|515897159|FG008|Overall Study|Withdrawal by Subject|0|||
143097809|NCT02554682|515897160|FG009|Overall Study|Withdrawal by Subject|0|||
143251781|NCT02238080|516476309|FG000|Overall Study|Treatment interrupted|6|||
143251782|NCT02238080|516476309|FG000|Overall Study|Withdrawal by Subject|2|||
143251783|NCT02238080|516476309|FG000|Overall Study|Other|4|||
143251784|NCT01738646|516476310|FG000|Overall Study|Still Receiving Treatment|2|||
143251785|NCT01598129|516476311|FG000|Overall Study|Disease progression|6|||
143251786|NCT01598129|516476311|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
143251787|NCT01598129|516476311|FG000|Overall Study|Withdrawal by Subject|1|||
143251788|NCT00505076|516476312|FG000|Overall Study|Adverse Event|1|||
143251789|NCT00505076|516476313|FG001|Overall Study|Adverse Event|0|||
143251790|NCT00505076|516476314|FG002|Overall Study|Adverse Event|1|||
143251791|NCT00505076|516476312|FG000|Overall Study|Protocol Violation|2|||
143097810|NCT02554682|515897151|FG000|Overall Study|Physician Decision|2|||
143097811|NCT02554682|515897152|FG001|Overall Study|Physician Decision|2|||
143097812|NCT02554682|515897153|FG002|Overall Study|Physician Decision|0|||
143097813|NCT02554682|515897154|FG003|Overall Study|Physician Decision|0|||
143097814|NCT02554682|515897155|FG004|Overall Study|Physician Decision|0|||
143097815|NCT02554682|515897156|FG005|Overall Study|Physician Decision|0|||
143097816|NCT02554682|515897157|FG006|Overall Study|Physician Decision|0|||
143097817|NCT02554682|515897158|FG007|Overall Study|Physician Decision|0|||
143097818|NCT02554682|515897159|FG008|Overall Study|Physician Decision|0|||
143097819|NCT02554682|515897160|FG009|Overall Study|Physician Decision|0|||
143097820|NCT04526288|515897161|FG000|Overall Study|Disease Progression|1|||
143097821|NCT04526288|515897162|FG001|Overall Study|Disease Progression|0|||
143097822|NCT00594165|515897163|FG000|Overall Study|Major protocol violation|1|||
143097823|NCT00594165|515897163|FG000|Overall Study|Lack of Efficacy|12|||
143097824|NCT00594165|515897163|FG000|Overall Study|Adverse Event|52|||
143097825|NCT00594165|515897163|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
143097826|NCT00594165|515897163|FG000|Overall Study|Subject withdrew consent|27|||
143097827|NCT00594165|515897163|FG000|Overall Study|Study ended per sponsor|102|||
143097828|NCT00594165|515897163|FG000|Overall Study|Lost to Follow-up|4|||
143097829|NCT00594165|515897163|FG000|Overall Study|Other: PI discretion|5|||
143097830|NCT00594165|515897163|FG000|Overall Study|Other: Subject moving|3|||
143097831|NCT00594165|515897163|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
143097832|NCT00594165|515897163|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
143097833|NCT00594165|515897163|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
143097834|NCT00594165|515897163|FG000|Overall Study|Other: Site terminated participation|2|||
143097835|NCT04010240|515899535|FG000|Overall Study|IHC not performed|2299|||
143097836|NCT05343000|515899536|FG000|Overall Study|Physician Decision|2|||
143097837|NCT02632175|515899540|FG000|Overall Study|Withdrawal by Subject|6|||
143097838|NCT02632175|515899540|FG000|Overall Study|Lost to Follow-up|1|||
143097839|NCT02632175|515899540|FG000|Overall Study|Lack of Efficacy|18|||
143097840|NCT02632175|515899540|FG000|Overall Study|Required alternative (or prohibited) therapy|1|||
143097841|NCT02632175|515899540|FG000|Overall Study|Subject noncompliance|3|||
143097842|NCT02632175|515899540|FG000|Overall Study|other|2|||
143097843|NCT04623216|515899541|FG000|Overall Study|Death|5|||
143097844|NCT04623216|515899542|FG001|Overall Study|Death|2|||
143097845|NCT04623216|515899543|FG002|Overall Study|Death|0|||
143097846|NCT04623216|515899544|FG003|Overall Study|Death|0|||
143097847|NCT04623216|515899541|FG000|Overall Study|Terminated by Sponsor|3|||
143097848|NCT04623216|515899542|FG001|Overall Study|Terminated by Sponsor|2|||
143097849|NCT04623216|515899543|FG002|Overall Study|Terminated by Sponsor|2|||
143097850|NCT04623216|515899544|FG003|Overall Study|Terminated by Sponsor|0|||
143097851|NCT04623216|515899541|FG000|Overall Study|Physician Decision|1|||
143097852|NCT04623216|515899542|FG001|Overall Study|Physician Decision|0|||
143097853|NCT04623216|515899543|FG002|Overall Study|Physician Decision|0|||
143097854|NCT04623216|515899544|FG003|Overall Study|Physician Decision|0|||
143097855|NCT03521154|515899547|FG000|Overall Study|Ongoing study at data cut-off|111|||
143097856|NCT03521154|515899548|FG001|Overall Study|Ongoing study at data cut-off|52|||
143097857|NCT05468164|515899549|FG000|Treatment Period 4|Adverse Event|0|||
143097858|NCT05468164|515899550|FG001|Treatment Period 4|Adverse Event|0|||
143097859|NCT05468164|515899551|FG002|Treatment Period 4|Adverse Event|0|||
143097860|NCT05468164|515899552|FG003|Treatment Period 4|Adverse Event|1|||
143097861|NCT05386680|515899553|FG000|Overall Study|Guardian decision|2|||
143097862|NCT03827291|515899554|FG000|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|5|||
143097863|NCT03827291|515899555|FG001|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|0|||
143097864|NCT04795466|515899556|FG000|Overall Study|Adverse Event|3|||
143097865|NCT04795466|515899557|FG001|Overall Study|Adverse Event|1|||
143097866|NCT04795466|515899556|FG000|Overall Study|Physician Decision|1|||
143097867|NCT04795466|515899557|FG001|Overall Study|Physician Decision|0|||
143097868|NCT04795466|515899556|FG000|Overall Study|Withdrawal by Subject|2|||
143097869|NCT04795466|515899557|FG001|Overall Study|Withdrawal by Subject|1|||
143097870|NCT04652726|515899558|FG000|Part 1 (Double-blind Period)|Physician Decision|1|||
143097871|NCT04652726|515899559|FG001|Part 1 (Double-blind Period)|Physician Decision|0|||
143097872|NCT04652726|515899560|FG002|Part 1 (Double-blind Period)|Physician Decision|0|||
143097873|NCT04652726|515899558|FG000|Part 1 (Double-blind Period)|Participant/guardian decision|1|||
143097874|NCT04652726|515899559|FG001|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
143097875|NCT04652726|515899560|FG002|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
143097876|NCT01102257|515899569|FG000|Overall Study|Adverse Event|1|||
143097877|NCT01102257|515899570|FG001|Overall Study|Adverse Event|0|||
143097878|NCT01102257|515899569|FG000|Overall Study|Adverse Event|1|||
143251792|NCT00505076|516476313|FG001|Overall Study|Protocol Violation|1|||
143097879|NCT01102257|515899570|FG001|Overall Study|Adverse Event|0|||
143097880|NCT04066244|515899575|FG000|Part 2 (Cohort 5)|Adverse Event|0|||
143097881|NCT04066244|515899576|FG001|Part 2 (Cohort 5)|Adverse Event|0|||
143097882|NCT04066244|515899577|FG002|Part 2 (Cohort 5)|Adverse Event|0|||
143097883|NCT04066244|515899578|FG003|Part 2 (Cohort 5)|Adverse Event|0|||
143097884|NCT04066244|515899579|FG004|Part 2 (Cohort 5)|Adverse Event|0|||
143097885|NCT04066244|515899580|FG005|Part 2 (Cohort 5)|Adverse Event|1|||
143097886|NCT04066244|515899575|FG000|Part 2 (Cohort 5)|Death|0|||
143097887|NCT04066244|515899576|FG001|Part 2 (Cohort 5)|Death|0|||
143097888|NCT04066244|515899577|FG002|Part 2 (Cohort 5)|Death|0|||
143097889|NCT04066244|515899578|FG003|Part 2 (Cohort 5)|Death|0|||
143097890|NCT04066244|515899579|FG004|Part 2 (Cohort 5)|Death|0|||
143097891|NCT04066244|515899580|FG005|Part 2 (Cohort 5)|Death|2|||
143097892|NCT04066244|515899575|FG000|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
143097893|NCT04066244|515899576|FG001|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
143097894|NCT04066244|515899577|FG002|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
143097895|NCT04066244|515899578|FG003|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
143097896|NCT04066244|515899579|FG004|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
143097897|NCT04066244|515899580|FG005|Part 2 (Cohort 5)|Study terminated by sponsor|1|||
143097898|NCT04066244|515899575|FG000|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
143097899|NCT04066244|515899576|FG001|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
143097900|NCT04066244|515899577|FG002|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
143097901|NCT04066244|515899578|FG003|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
143097902|NCT04066244|515899579|FG004|Part 2 (Cohort 5)|Withdrawal by Subject|1|||
143097903|NCT04066244|515899580|FG005|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
143097904|NCT03752970|515899581|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
143097905|NCT03752970|515899582|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
143097906|NCT03752970|515899583|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
143097907|NCT03752970|515899581|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
143097908|NCT03752970|515899582|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
143097909|NCT03752970|515899583|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
143097910|NCT03752970|515899581|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
143097911|NCT03752970|515899582|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
143097912|NCT03752970|515899583|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
143097913|NCT03752970|515899581|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
143097914|NCT03752970|515899582|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
143251793|NCT00505076|516476314|FG002|Overall Study|Protocol Violation|2|||
143251794|NCT00505076|516476312|FG000|Overall Study|Withdrawal by Subject|0|||
143251795|NCT00505076|516476313|FG001|Overall Study|Withdrawal by Subject|1|||
143251796|NCT00505076|516476314|FG002|Overall Study|Withdrawal by Subject|2|||
143251797|NCT04093024|516476317|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
143251798|NCT04093024|516476318|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
143251799|NCT04093024|516476317|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
143251800|NCT04093024|516476318|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
143251801|NCT04093024|516476317|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
143251802|NCT04093024|516476318|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
143251803|NCT04093024|516476317|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
143251804|NCT04093024|516476318|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
143251805|NCT00647270|516476323|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
143251806|NCT00647270|516476324|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
143251807|NCT00647270|516476325|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
143251808|NCT00647270|516476323|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
143251809|NCT00647270|516476324|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
143251810|NCT00647270|516476325|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
143251811|NCT00647270|516476323|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
143251812|NCT00647270|516476324|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
143251813|NCT00647270|516476325|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
143251814|NCT00647270|516476323|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
143251815|NCT00647270|516476324|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
143251816|NCT00647270|516476325|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
143251817|NCT00647270|516476323|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
143251818|NCT00647270|516476324|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
143097915|NCT03752970|515899583|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
143097916|NCT03752970|515899581|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
143097917|NCT03752970|515899582|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
143097918|NCT03752970|515899583|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
143097919|NCT03976362|515899584|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
143097920|NCT03976362|515899585|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
143097921|NCT03976362|515899586|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
143097922|NCT03976362|515899584|FG000|Induction Phase|Death|62|||
143097923|NCT03976362|515899585|FG001|Induction Phase|Death|0|||
143097924|NCT03976362|515899586|FG002|Induction Phase|Death|0|||
143097925|NCT03976362|515899584|FG000|Maintenance Phase|Participants Ongoing|0|||
143097926|NCT03976362|515899585|FG001|Maintenance Phase|Participants Ongoing|106|||
143097927|NCT03976362|515899586|FG002|Maintenance Phase|Participants Ongoing|103|||
143097928|NCT03976362|515899584|FG000|Maintenance Phase|Withdrawal by Subject|0|||
143097929|NCT03976362|515899585|FG001|Maintenance Phase|Withdrawal by Subject|4|||
143097930|NCT03976362|515899586|FG002|Maintenance Phase|Withdrawal by Subject|4|||
143097931|NCT03976362|515899584|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
143097932|NCT03976362|515899585|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
143097933|NCT03976362|515899586|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
143097934|NCT03976362|515899584|FG000|Maintenance Phase|Death|0|||
143097935|NCT03976362|515899585|FG001|Maintenance Phase|Death|186|||
143097936|NCT03976362|515899586|FG002|Maintenance Phase|Death|187|||
143097937|NCT02525783|515899588|FG000|Overall Study|Lost to Follow-up|10|||
143097938|NCT00866281|515899589|FG000|Overall Study|Adverse Event|1|||
143097939|NCT00866281|515899590|FG001|Overall Study|Adverse Event|0|||
143097940|NCT00866281|515899589|FG000|Overall Study|Withdrawal by participants|3|||
143097941|NCT00866281|515899590|FG001|Overall Study|Withdrawal by participants|0|||
143097942|NCT00866281|515899589|FG000|Overall Study|Disease progression|3|||
143097943|NCT00866281|515899590|FG001|Overall Study|Disease progression|11|||
143097944|NCT00866281|515899589|FG000|Overall Study|New cancer therapy|0|||
143097945|NCT00866281|515899590|FG001|Overall Study|New cancer therapy|4|||
143097946|NCT01100086|515899591|FG000|Period 1|Withdrawal by Subject|1|||
143097947|NCT01100086|515899592|FG001|Period 1|Withdrawal by Subject|0|||
143097948|NCT04630002|515899597|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
143097949|NCT04630002|515899598|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
143097950|NCT04630002|515899599|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
143097951|NCT04630002|515899597|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
143097952|NCT04630002|515899598|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
143097953|NCT04630002|515899599|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
143097954|NCT04630002|515899597|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
143003525|NCT00344968|515550657|FG000|Overall Study|Adverse Event|5|||
143003526|NCT00344968|515550658|FG001|Overall Study|Adverse Event|4|||
143003527|NCT00344968|515550659|FG002|Overall Study|Adverse Event|15|||
143003528|NCT00344968|515550657|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
143003529|NCT00344968|515550658|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
143003530|NCT00344968|515550659|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
143003531|NCT00344968|515550657|FG000|Overall Study|Protocol Violation|2|||
143003532|NCT00344968|515550658|FG001|Overall Study|Protocol Violation|2|||
143003533|NCT00344968|515550659|FG002|Overall Study|Protocol Violation|5|||
143003534|NCT00344968|515550657|FG000|Overall Study|Withdrawal by Subject|14|||
143003535|NCT00344968|515550658|FG001|Overall Study|Withdrawal by Subject|31|||
143003536|NCT00344968|515550659|FG002|Overall Study|Withdrawal by Subject|27|||
143003537|NCT00344968|515550657|FG000|Overall Study|Lost to Follow-up|24|||
143003538|NCT00344968|515550658|FG001|Overall Study|Lost to Follow-up|37|||
143003539|NCT00344968|515550659|FG002|Overall Study|Lost to Follow-up|37|||
143003540|NCT00344968|515550657|FG000|Overall Study|Death|11|||
143003541|NCT00344968|515550658|FG001|Overall Study|Death|27|||
143003542|NCT00344968|515550659|FG002|Overall Study|Death|31|||
143003543|NCT00344968|515550657|FG000|Overall Study|Other|0|||
143003544|NCT00344968|515550658|FG001|Overall Study|Other|1|||
143003545|NCT00344968|515550659|FG002|Overall Study|Other|0|||
143003546|NCT03735680|515550660|FG000|Overall Study|Withdrawal by Subject|0|||
143003547|NCT03735680|515550661|FG001|Overall Study|Withdrawal by Subject|1|||
143003548|NCT03735680|515550662|FG002|Overall Study|Withdrawal by Subject|0|||
143003549|NCT03735680|515550663|FG003|Overall Study|Withdrawal by Subject|0|||
143003550|NCT03735680|515550664|FG004|Overall Study|Withdrawal by Subject|0|||
143003551|NCT03735680|515550665|FG005|Overall Study|Withdrawal by Subject|1|||
143003552|NCT03735680|515550660|FG000|Overall Study|Patient unable or unwilling to continue|0|||
143003553|NCT03735680|515550661|FG001|Overall Study|Patient unable or unwilling to continue|0|||
143003554|NCT03735680|515550662|FG002|Overall Study|Patient unable or unwilling to continue|1|||
143003555|NCT03735680|515550663|FG003|Overall Study|Patient unable or unwilling to continue|0|||
143003556|NCT03735680|515550664|FG004|Overall Study|Patient unable or unwilling to continue|0|||
143003557|NCT03735680|515550665|FG005|Overall Study|Patient unable or unwilling to continue|0|||
143003558|NCT00503035|515550670|FG000|Overall Study|Lost to Follow-up|2|||
143003559|NCT00503035|515550670|FG000|Overall Study|Physician Decision|3|||
143003560|NCT00503035|515550670|FG000|Overall Study|Ineligible|15|||
143003561|NCT05028816|515550671|FG000|Overall Study|Lost to Follow-up|5|||
143003562|NCT05028816|515550672|FG001|Overall Study|Lost to Follow-up|3|||
143003563|NCT05028816|515550671|FG000|Overall Study|Withdrawal by Subject|4|||
143097955|NCT04630002|515899598|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
143097956|NCT04630002|515899599|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
143097957|NCT04630002|515899597|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
143097958|NCT04630002|515899598|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
143097959|NCT04630002|515899599|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
143097960|NCT04630002|515899597|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
143097961|NCT04630002|515899598|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
143097962|NCT04630002|515899599|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
143097963|NCT04630002|515899597|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
143097964|NCT04630002|515899598|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
143097965|NCT04630002|515899599|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
143097966|NCT04630002|515899597|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
143097967|NCT04630002|515899598|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
143097968|NCT04630002|515899599|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
143097969|NCT04630002|515899597|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
143097970|NCT04630002|515899598|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
143097971|NCT04630002|515899599|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
143097972|NCT03321968|515899602|FG000|Overall Study|Withdrawal by Subject|1|||
143097973|NCT03321968|515899603|FG001|Overall Study|Withdrawal by Subject|2|||
143097974|NCT03321968|515899604|FG002|Overall Study|Withdrawal by Subject|1|||
143097975|NCT03321968|515899602|FG000|Overall Study|Lost to Follow-up|2|||
143097976|NCT03321968|515899603|FG001|Overall Study|Lost to Follow-up|0|||
143097977|NCT03321968|515899604|FG002|Overall Study|Lost to Follow-up|1|||
143097978|NCT03321968|515899602|FG000|Overall Study|Other than specified|0|||
143097979|NCT03321968|515899603|FG001|Overall Study|Other than specified|0|||
143097980|NCT03321968|515899604|FG002|Overall Study|Other than specified|1|||
143097981|NCT03822468|515899605|FG000|Treatment Period|Progressive disease|98|||
143097982|NCT03822468|515899606|FG001|Treatment Period|Progressive disease|94|||
143097983|NCT03822468|515899605|FG000|Treatment Period|Adverse Event|21|||
143097984|NCT03822468|515899606|FG001|Treatment Period|Adverse Event|24|||
143097985|NCT03822468|515899605|FG000|Treatment Period|Withdrawal by Subject|9|||
143097986|NCT03822468|515899606|FG001|Treatment Period|Withdrawal by Subject|5|||
143097987|NCT03822468|515899605|FG000|Treatment Period|Physician Decision|9|||
143097988|NCT03822468|515899606|FG001|Treatment Period|Physician Decision|7|||
143097989|NCT03822468|515899605|FG000|Treatment Period|Protocol Violation|2|||
143097990|NCT03822468|515899606|FG001|Treatment Period|Protocol Violation|1|||
143097991|NCT03822468|515899605|FG000|Treatment Period|Death|2|||
143097992|NCT03822468|515899606|FG001|Treatment Period|Death|3|||
143097993|NCT03822468|515899605|FG000|Treatment Period|Lost to Follow-up|1|||
143176941|NCT01824290|516196242|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
143176942|NCT01824290|516196243|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
143176943|NCT01824290|516196240|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
143176944|NCT01824290|516196241|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
143176945|NCT01824290|516196242|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
143176946|NCT01824290|516196243|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
143176947|NCT01824290|516196240|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
143176948|NCT01824290|516196241|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
143176949|NCT01824290|516196242|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
143176950|NCT01824290|516196243|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
143176951|NCT01824290|516196240|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
143176952|NCT01824290|516196241|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
143176953|NCT01824290|516196242|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
143176954|NCT01824290|516196243|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
143176955|NCT01824290|516196240|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
143176956|NCT01824290|516196241|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
143176957|NCT01824290|516196242|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
143176958|NCT01824290|516196243|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
143176959|NCT01490918|516196244|FG000|Overall Study|Lost to Follow-up|2|||
143251819|NCT00647270|516476325|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
143176960|NCT01490918|516196245|FG001|Overall Study|Lost to Follow-up|1|||
143176961|NCT01490918|516196246|FG002|Overall Study|Lost to Follow-up|0|||
143097994|NCT03822468|515899606|FG001|Treatment Period|Lost to Follow-up|1|||
143097995|NCT03822468|515899605|FG000|Treatment Period|Sponsor decision|46|||
143097996|NCT03822468|515899606|FG001|Treatment Period|Sponsor decision|53|||
143097997|NCT03822468|515899605|FG000|Post-treatment Efficacy Follow-up|Progressive disease|11|||
143097998|NCT03822468|515899606|FG001|Post-treatment Efficacy Follow-up|Progressive disease|14|||
143097999|NCT03822468|515899605|FG000|Post-treatment Efficacy Follow-up|Withdrawal by Subject|4|||
143098000|NCT03822468|515899606|FG001|Post-treatment Efficacy Follow-up|Withdrawal by Subject|3|||
143098001|NCT03822468|515899605|FG000|Post-treatment Efficacy Follow-up|Death|1|||
143098002|NCT03822468|515899606|FG001|Post-treatment Efficacy Follow-up|Death|0|||
143098003|NCT03822468|515899605|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
143098004|NCT03822468|515899606|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
143098005|NCT03822468|515899605|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
143098006|NCT03822468|515899606|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
143098007|NCT03822468|515899605|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
143098008|NCT03822468|515899606|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
143098009|NCT03822468|515899605|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|3|||
143098010|NCT03822468|515899606|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|7|||
143098011|NCT01532518|515899607|FG000|Overall Study|Withdrawal by Subject|0|||
143098012|NCT01532518|515899608|FG001|Overall Study|Withdrawal by Subject|0|||
143098013|NCT01532518|515899609|FG002|Overall Study|Withdrawal by Subject|1|||
143098014|NCT01575834|515899610|FG000|Overall Study|Withdrawal by Subject|352|||
143098015|NCT01575834|515899611|FG001|Overall Study|Withdrawal by Subject|390|||
143098016|NCT01575834|515899610|FG000|Overall Study|Death|81|||
143098017|NCT01575834|515899611|FG001|Overall Study|Death|74|||
143098018|NCT01575834|515899610|FG000|Overall Study|Other|70|||
143098019|NCT01575834|515899611|FG001|Overall Study|Other|70|||
143098020|NCT01575834|515899610|FG000|Overall Study|Adverse Event|63|||
143098021|NCT01575834|515899611|FG001|Overall Study|Adverse Event|61|||
143098022|NCT01575834|515899610|FG000|Overall Study|Lost to Follow-up|55|||
143098023|NCT01575834|515899611|FG001|Overall Study|Lost to Follow-up|68|||
143098024|NCT01575834|515899610|FG000|Overall Study|Noncompliance|52|||
143098025|NCT01575834|515899611|FG001|Overall Study|Noncompliance|27|||
143098026|NCT01575834|515899610|FG000|Overall Study|Administrative decision|15|||
143098027|NCT01575834|515899611|FG001|Overall Study|Administrative decision|33|||
143098028|NCT01575834|515899610|FG000|Overall Study|Ineligibility Determined|5|||
143098029|NCT01575834|515899611|FG001|Overall Study|Ineligibility Determined|8|||
143098030|NCT01575834|515899610|FG000|Overall Study|Protocol Deviation|4|||
143098031|NCT01575834|515899611|FG001|Overall Study|Protocol Deviation|3|||
143098032|NCT01575834|515899610|FG000|Overall Study|Requirement for Alternative Therapy|2|||
143098033|NCT01575834|515899611|FG001|Overall Study|Requirement for Alternative Therapy|4|||
143098034|NCT01741688|515899612|FG000|Overall Study|Lack of insurance coverage|2|||
143098035|NCT01741688|515899612|FG000|Overall Study|Withdrawal by Subject|1|||
143098036|NCT02282813|515899615|FG000|Overall Study|Withdrawal by Subject|4|||
143098037|NCT02282813|515899616|FG001|Overall Study|Withdrawal by Subject|5|||
143098038|NCT02282813|515899617|FG002|Overall Study|Withdrawal by Subject|0|||
143098039|NCT02282813|515899615|FG000|Overall Study|Adverse Event|3|||
143098040|NCT02282813|515899616|FG001|Overall Study|Adverse Event|10|||
143098041|NCT02282813|515899617|FG002|Overall Study|Adverse Event|1|||
143098042|NCT02282813|515899615|FG000|Overall Study|Subject non-compliance|1|||
143098043|NCT02282813|515899616|FG001|Overall Study|Subject non-compliance|4|||
143098044|NCT02282813|515899617|FG002|Overall Study|Subject non-compliance|0|||
143098045|NCT02282813|515899615|FG000|Overall Study|Physician Decision|0|||
143098046|NCT02282813|515899616|FG001|Overall Study|Physician Decision|3|||
143098047|NCT02282813|515899617|FG002|Overall Study|Physician Decision|1|||
143098048|NCT02282813|515899615|FG000|Overall Study|Lost to Follow-up|2|||
143098049|NCT02282813|515899616|FG001|Overall Study|Lost to Follow-up|0|||
143098050|NCT02282813|515899617|FG002|Overall Study|Lost to Follow-up|1|||
143098051|NCT02282813|515899615|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
143098052|NCT02282813|515899616|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
143098053|NCT02282813|515899617|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
143098054|NCT02282813|515899615|FG000|Overall Study|Lack of Efficacy|1|||
143098055|NCT02282813|515899616|FG001|Overall Study|Lack of Efficacy|0|||
143098056|NCT02282813|515899617|FG002|Overall Study|Lack of Efficacy|0|||
143098057|NCT02282813|515899615|FG000|Overall Study|Administrative reasons|0|||
143098058|NCT02282813|515899616|FG001|Overall Study|Administrative reasons|1|||
143098059|NCT02282813|515899617|FG002|Overall Study|Administrative reasons|0|||
143098060|NCT00463047|515899619|FG000|Titration Period 1|Adverse Event|10|||
143098061|NCT00463047|515899620|FG001|Titration Period 1|Adverse Event|8|||
143098062|NCT00463047|515899619|FG000|Titration Period 1|Lack of Efficacy|10|||
143098063|NCT00463047|515899620|FG001|Titration Period 1|Lack of Efficacy|4|||
143098064|NCT00463047|515899619|FG000|Titration Period 1|Lost to Follow-up|2|||
143098065|NCT00463047|515899620|FG001|Titration Period 1|Lost to Follow-up|0|||
143098066|NCT00463047|515899619|FG000|Titration Period 1|Non-compliance with study medication|3|||
143098067|NCT00463047|515899620|FG001|Titration Period 1|Non-compliance with study medication|5|||
143098068|NCT00463047|515899619|FG000|Titration Period 1|Protocol Violation|5|||
143098069|NCT00463047|515899620|FG001|Titration Period 1|Protocol Violation|5|||
143098070|NCT00463047|515899619|FG000|Titration Period 1|Withdrawal by Subject|3|||
143098071|NCT00463047|515899620|FG001|Titration Period 1|Withdrawal by Subject|5|||
143098072|NCT00463047|515899619|FG000|Titration Period 1|Non-compliance procedures|4|||
143098073|NCT00463047|515899620|FG001|Titration Period 1|Non-compliance procedures|10|||
143098074|NCT00463047|515899619|FG000|Titration Period 1|Other|0|||
143098075|NCT00463047|515899620|FG001|Titration Period 1|Other|2|||
143098076|NCT00463047|515899619|FG000|Titration Period 2|Adverse Event|9|||
143098077|NCT00463047|515899620|FG001|Titration Period 2|Adverse Event|9|||
143098078|NCT00463047|515899619|FG000|Titration Period 2|Lack of Efficacy|6|||
143098079|NCT00463047|515899620|FG001|Titration Period 2|Lack of Efficacy|4|||
143098080|NCT00463047|515899619|FG000|Titration Period 2|Withdrawal by Subject|1|||
143098081|NCT00463047|515899620|FG001|Titration Period 2|Withdrawal by Subject|0|||
143098082|NCT00463047|515899619|FG000|Titration Period 2|Protocol Violation|2|||
143098083|NCT00463047|515899620|FG001|Titration Period 2|Protocol Violation|3|||
143098084|NCT00463047|515899619|FG000|Titration Period 2|Lost to Follow-up|1|||
143098085|NCT00463047|515899620|FG001|Titration Period 2|Lost to Follow-up|2|||
143098086|NCT00463047|515899619|FG000|Titration Period 2|Non-compliance study medication|4|||
143098087|NCT00463047|515899620|FG001|Titration Period 2|Non-compliance study medication|2|||
143098088|NCT00463047|515899619|FG000|Titration Period 2|Non-compliance procedures|4|||
143098089|NCT00463047|515899620|FG001|Titration Period 2|Non-compliance procedures|1|||
143098090|NCT00463047|515899619|FG000|Titration Period 2|Other|3|||
143098091|NCT00463047|515899620|FG001|Titration Period 2|Other|2|||
143098092|NCT00463047|515899619|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
143098093|NCT00463047|515899620|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
143098094|NCT00463047|515899619|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
143098095|NCT00463047|515899620|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
143098096|NCT00463047|515899619|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
143098097|NCT00463047|515899620|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
143098098|NCT00463047|515899619|FG000|Double-Blind Treatment Period 1|Other|1|||
143098099|NCT00463047|515899620|FG001|Double-Blind Treatment Period 1|Other|0|||
143098100|NCT00463047|515899619|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
143098101|NCT00463047|515899620|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
143098102|NCT00463047|515899619|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
143098103|NCT00463047|515899620|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
143098104|NCT00463047|515899619|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
143098105|NCT00463047|515899620|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
143098106|NCT02220764|515899624|FG000|Overall Study|Lost to Follow-up|3|||
143098107|NCT02220764|515899625|FG001|Overall Study|Lost to Follow-up|1|||
143098108|NCT02220764|515899624|FG000|Overall Study|Death|1|||
143098109|NCT02220764|515899625|FG001|Overall Study|Death|0|||
143098110|NCT03020992|515899626|FG000|Overall Study|Adverse Event|5|||
143098111|NCT03020992|515899626|FG000|Overall Study|Withdrawal by Subject|1|||
143098112|NCT03493854|515899627|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
143098113|NCT03493854|515899628|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
143098114|NCT03493854|515899627|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
143098115|NCT03493854|515899628|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
143098116|NCT03493854|515899627|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
143098117|NCT03493854|515899628|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
143098118|NCT03493854|515899627|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
143098119|NCT03493854|515899628|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
143098120|NCT03493854|515899627|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
143098121|NCT03493854|515899628|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
143098122|NCT03493854|515899627|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
143098123|NCT03493854|515899628|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
143098124|NCT03493854|515899627|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
143098125|NCT03493854|515899628|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
143098126|NCT03493854|515899627|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
143098127|NCT03493854|515899628|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
143098128|NCT03493854|515899627|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
143098129|NCT03493854|515899628|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
143098130|NCT03493854|515899627|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
143098131|NCT03493854|515899628|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
143098132|NCT03493854|515899627|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
143098133|NCT03493854|515899628|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
143098134|NCT03493854|515899627|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
143098135|NCT03493854|515899628|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
143098136|NCT03493854|515899627|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
143098137|NCT03493854|515899628|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
143098138|NCT03493854|515899627|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
143098139|NCT03493854|515899628|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
143098140|NCT03493854|515899627|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
143098141|NCT03493854|515899628|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
143098142|NCT03493854|515899627|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
143098143|NCT03493854|515899628|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
143098144|NCT03493854|515899627|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
143098145|NCT03493854|515899628|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
143098146|NCT03493854|515899627|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
143098147|NCT03493854|515899628|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
143098148|NCT00739661|515899631|FG000|Overall Study|Adverse Event|2|||
143098149|NCT00739661|515899632|FG001|Overall Study|Adverse Event|0|||
143098150|NCT00739661|515899631|FG000|Overall Study|Physician decision to withdraw patient|1|||
143098151|NCT00739661|515899632|FG001|Overall Study|Physician decision to withdraw patient|0|||
143098152|NCT00739661|515899631|FG000|Overall Study|Patient decision to withdraw|9|||
143098153|NCT00739661|515899632|FG001|Overall Study|Patient decision to withdraw|4|||
143098154|NCT00739661|515899631|FG000|Overall Study|Disease progression, radiographic|33|||
143098155|NCT00739661|515899632|FG001|Overall Study|Disease progression, radiographic|37|||
143098156|NCT00739661|515899631|FG000|Overall Study|Reason for discontinuation not available|1|||
143098157|NCT00739661|515899632|FG001|Overall Study|Reason for discontinuation not available|1|||
143098158|NCT00410813|515899633|FG000|Overall Study|Adverse Event|6|||
143098159|NCT00410813|515899634|FG001|Overall Study|Adverse Event|11|||
143098160|NCT00410813|515899633|FG000|Overall Study|Progression|32|||
143098161|NCT00410813|515899634|FG001|Overall Study|Progression|21|||
143098162|NCT00410813|515899633|FG000|Overall Study|Not protocol specified|3|||
143098163|NCT00410813|515899634|FG001|Overall Study|Not protocol specified|4|||
143098164|NCT00410813|515899633|FG000|Overall Study|Ineligible|2|||
143098165|NCT00410813|515899634|FG001|Overall Study|Ineligible|4|||
143098166|NCT00410813|515899633|FG000|Overall Study|Death|0|||
143098167|NCT00410813|515899634|FG001|Overall Study|Death|2|||
143098168|NCT02198664|515899635|FG000|Overall Study|Adverse Event|2|||
143098169|NCT02198664|515899636|FG001|Overall Study|Adverse Event|0|||
143098170|NCT02198664|515899635|FG000|Overall Study|Withdrawal by Subject|11|||
143098171|NCT02198664|515899636|FG001|Overall Study|Withdrawal by Subject|8|||
143098172|NCT02198664|515899635|FG000|Overall Study|Failure to tolerate|2|||
143098173|NCT02198664|515899636|FG001|Overall Study|Failure to tolerate|0|||
143098174|NCT02198664|515899635|FG000|Overall Study|Not stated|1|||
143098175|NCT02198664|515899636|FG001|Overall Study|Not stated|0|||
143098176|NCT04278417|515899647|FG000|Overall Study|Withdrawal by Subject|20|||
143098177|NCT04278417|515899648|FG001|Overall Study|Withdrawal by Subject|20|||
143098178|NCT04278417|515899647|FG000|Overall Study|Progressive disease|0|||
143098179|NCT04278417|515899648|FG001|Overall Study|Progressive disease|2|||
143098180|NCT04278417|515899647|FG000|Overall Study|Physician Decision|4|||
143098181|NCT04278417|515899648|FG001|Overall Study|Physician Decision|6|||
143098182|NCT04278417|515899647|FG000|Overall Study|Lost to Follow-up|11|||
143098183|NCT04278417|515899648|FG001|Overall Study|Lost to Follow-up|13|||
143098184|NCT04278417|515899647|FG000|Overall Study|Death|8|||
143098185|NCT04278417|515899648|FG001|Overall Study|Death|9|||
143367700|NCT00813488|516889422|FG001|Open-label Extension|Non-compliance study medication|0|||
143003639|NCT05450198|515550690|FG002|Overall Study|Lost to Follow-up|2|||
143003640|NCT05450198|515550691|FG003|Overall Study|Lost to Follow-up|1|||
143003641|NCT01982942|515550692|FG000|Overall Study|Adverse Event|10|||
143003642|NCT01982942|515550693|FG001|Overall Study|Adverse Event|5|||
143003643|NCT01982942|515550692|FG000|Overall Study|Lost to Follow-up|4|||
143003644|NCT01982942|515550693|FG001|Overall Study|Lost to Follow-up|3|||
143003645|NCT01982942|515550692|FG000|Overall Study|Multiple sclerosis progression|3|||
143003646|NCT01982942|515550693|FG001|Overall Study|Multiple sclerosis progression|2|||
143003647|NCT01982942|515550692|FG000|Overall Study|Wanted to try therapy not permitted|1|||
143003648|NCT01982942|515550693|FG001|Overall Study|Wanted to try therapy not permitted|0|||
143003649|NCT01982942|515550692|FG000|Overall Study|Subject declined future visits|0|||
143003650|NCT01982942|515550693|FG001|Overall Study|Subject declined future visits|1|||
143003651|NCT01982942|515550692|FG000|Overall Study|Left geographical area|2|||
143003652|NCT01982942|515550693|FG001|Overall Study|Left geographical area|0|||
143003653|NCT01982942|515550692|FG000|Overall Study|Too many pills|1|||
143003654|NCT01982942|515550693|FG001|Overall Study|Too many pills|0|||
143003655|NCT01982942|515550692|FG000|Overall Study|MS Relapse|0|||
143003656|NCT01982942|515550693|FG001|Overall Study|MS Relapse|1|||
143003657|NCT01982942|515550692|FG000|Overall Study|Chose to join a stem cell trial|0|||
143003658|NCT01982942|515550693|FG001|Overall Study|Chose to join a stem cell trial|1|||
143003659|NCT01982942|515550692|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
143003660|NCT01982942|515550693|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
143003661|NCT04576702|515550694|FG000|Overall Study|Death|1|||
143003662|NCT04576702|515550695|FG001|Overall Study|Death|0|||
143003663|NCT04576702|515550696|FG002|Overall Study|Death|0|||
143367701|NCT00813488|516889421|FG000|Open-label Extension|Non-compliance study procedures|2|||
143367702|NCT00813488|516889422|FG001|Open-label Extension|Non-compliance study procedures|1|||
143367703|NCT00813488|516889421|FG000|Open-label Extension|Other|1|||
143367704|NCT00813488|516889422|FG001|Open-label Extension|Other|0|||
143367705|NCT02926937|516889423|FG000|Overall Study|Adverse Event|0|||
143367706|NCT02926937|516889424|FG001|Overall Study|Adverse Event|1|||
143367707|NCT02926937|516889425|FG002|Overall Study|Adverse Event|1|||
143367708|NCT02926937|516889423|FG000|Overall Study|Poor Compliance to Protocol|1|||
143367709|NCT02926937|516889424|FG001|Overall Study|Poor Compliance to Protocol|0|||
143367710|NCT02926937|516889425|FG002|Overall Study|Poor Compliance to Protocol|0|||
143367711|NCT02926937|516889423|FG000|Overall Study|Lost to Follow-up|4|||
143098186|NCT04278417|515899647|FG000|Overall Study|Adverse Event|3|||
143098187|NCT04278417|515899648|FG001|Overall Study|Adverse Event|5|||
143098188|NCT06509438|515899649|FG000|Overall Study|Adverse Event|1|||
143098189|NCT06509438|515899649|FG000|Overall Study|Lost to Follow-up|3|||
143098190|NCT02883062|515899650|FG000|Overall Study|Withdrawal by Subject|6|||
143098191|NCT02883062|515899651|FG001|Overall Study|Withdrawal by Subject|0|||
143098192|NCT01262872|515899653|FG000|Step 2|Death|0|||
143098193|NCT01262872|515899654|FG001|Step 2|Death|0|||
143098194|NCT01262872|515899655|FG002|Step 2|Death|0|||
143098195|NCT01262872|515899656|FG003|Step 2|Death|1|||
143098196|NCT01262872|515899657|FG004|Step 2|Death|0|||
143098197|NCT01262872|515899658|FG005|Step 2|Death|2|||
143098198|NCT01262872|515899659|FG006|Step 2|Death|2|||
143098199|NCT01262872|515899660|FG007|Step 2|Death|1|||
143098200|NCT01262872|515899653|FG000|Step 2|Protocol Violation|0|||
143098201|NCT01262872|515899654|FG001|Step 2|Protocol Violation|0|||
143098202|NCT01262872|515899655|FG002|Step 2|Protocol Violation|1|||
143098203|NCT01262872|515899656|FG003|Step 2|Protocol Violation|0|||
143098204|NCT01262872|515899657|FG004|Step 2|Protocol Violation|0|||
143098205|NCT01262872|515899658|FG005|Step 2|Protocol Violation|0|||
143098206|NCT01262872|515899659|FG006|Step 2|Protocol Violation|3|||
143098207|NCT01262872|515899660|FG007|Step 2|Protocol Violation|1|||
143098208|NCT01262872|515899653|FG000|Step 2|Withdrawal by Subject|0|||
143098209|NCT01262872|515899654|FG001|Step 2|Withdrawal by Subject|0|||
143098210|NCT01262872|515899655|FG002|Step 2|Withdrawal by Subject|4|||
143098211|NCT01262872|515899656|FG003|Step 2|Withdrawal by Subject|6|||
143098212|NCT01262872|515899657|FG004|Step 2|Withdrawal by Subject|3|||
143367712|NCT02926937|516889424|FG001|Overall Study|Lost to Follow-up|5|||
143367713|NCT02926937|516889425|FG002|Overall Study|Lost to Follow-up|0|||
143367714|NCT02926937|516889423|FG000|Overall Study|At the Participant's own Request|11|||
143098213|NCT01262872|515899658|FG005|Step 2|Withdrawal by Subject|1|||
143098214|NCT01262872|515899659|FG006|Step 2|Withdrawal by Subject|2|||
143098215|NCT01262872|515899660|FG007|Step 2|Withdrawal by Subject|1|||
143098216|NCT01262872|515899653|FG000|Step 2|Migrated/moved from study area|0|||
143098217|NCT01262872|515899654|FG001|Step 2|Migrated/moved from study area|0|||
143098218|NCT01262872|515899655|FG002|Step 2|Migrated/moved from study area|4|||
143098219|NCT01262872|515899656|FG003|Step 2|Migrated/moved from study area|3|||
143098220|NCT01262872|515899657|FG004|Step 2|Migrated/moved from study area|2|||
143367715|NCT02926937|516889424|FG001|Overall Study|At the Participant's own Request|5|||
143367716|NCT02926937|516889425|FG002|Overall Study|At the Participant's own Request|8|||
143098221|NCT01262872|515899658|FG005|Step 2|Migrated/moved from study area|6|||
143098222|NCT01262872|515899659|FG006|Step 2|Migrated/moved from study area|2|||
143098223|NCT01262872|515899660|FG007|Step 2|Migrated/moved from study area|3|||
143098224|NCT01000155|515899661|FG000|Overall Study|Withdrawal by Subject|1|||
143098225|NCT01000155|515899661|FG000|Overall Study|Adverse Event|1|||
143098226|NCT02062450|515899662|FG000|Overall Study|No follow-up visit|124|||
143098227|NCT04926831|515899663|FG000|Overall Study|Withdrawal by Subject|2|||
143098228|NCT04926831|515899663|FG000|Overall Study|Adverse Event|2|||
143098229|NCT04025879|515899664|FG000|Randomization|Participant withdrew consent|0|||
143098230|NCT04025879|515899665|FG001|Randomization|Participant withdrew consent|1|||
143098231|NCT04025879|515899664|FG000|Randomization|Participant no longer met study criteria|1|||
143098232|NCT04025879|515899665|FG001|Randomization|Participant no longer met study criteria|1|||
143098233|NCT04025879|515899664|FG000|Treatment|Ongoing treatment|10|||
143098234|NCT04025879|515899665|FG001|Treatment|Ongoing treatment|8|||
143098235|NCT04025879|515899664|FG000|Treatment|Disease progression/recurrence|36|||
143098236|NCT04025879|515899665|FG001|Treatment|Disease progression/recurrence|72|||
143098237|NCT04025879|515899664|FG000|Treatment|Study drug toxicity|36|||
143098238|NCT04025879|515899665|FG001|Treatment|Study drug toxicity|13|||
143098239|NCT04025879|515899664|FG000|Treatment|Death|2|||
143098240|NCT04025879|515899665|FG001|Treatment|Death|0|||
143098241|NCT04025879|515899664|FG000|Treatment|Adverse event unrelated to study drug|21|||
143098242|NCT04025879|515899665|FG001|Treatment|Adverse event unrelated to study drug|14|||
143098243|NCT04025879|515899664|FG000|Treatment|Participant request to discontinue study treatment|16|||
143098244|NCT04025879|515899665|FG001|Treatment|Participant request to discontinue study treatment|8|||
143098245|NCT04025879|515899664|FG000|Treatment|Participant withdrew consent|1|||
143098246|NCT04025879|515899665|FG001|Treatment|Participant withdrew consent|3|||
143098247|NCT04025879|515899664|FG000|Treatment|Participant no longer meets study criteria|3|||
143098248|NCT04025879|515899665|FG001|Treatment|Participant no longer meets study criteria|2|||
143098249|NCT04025879|515899664|FG000|Treatment|Lost to Follow-up|1|||
143098250|NCT04025879|515899665|FG001|Treatment|Lost to Follow-up|0|||
143098251|NCT04025879|515899664|FG000|Treatment|Other reasons|15|||
143098252|NCT04025879|515899665|FG001|Treatment|Other reasons|17|||
143098253|NCT04025879|515899664|FG000|Treatment|Administrative reason by sponsor|0|||
143098254|NCT04025879|515899665|FG001|Treatment|Administrative reason by sponsor|1|||
143098255|NCT04025879|515899664|FG000|Treatment|Not reported|2|||
143098256|NCT04025879|515899665|FG001|Treatment|Not reported|0|||
143098257|NCT03482635|515899666|FG000|Overall Study|Lack of Efficacy|0|||
143098258|NCT03482635|515899667|FG001|Overall Study|Lack of Efficacy|0|||
143098259|NCT03482635|515899668|FG002|Overall Study|Lack of Efficacy|1|||
143098260|NCT03482635|515899669|FG003|Overall Study|Lack of Efficacy|3|||
143098261|NCT03482635|515899666|FG000|Overall Study|Adverse Event|2|||
143098262|NCT03482635|515899667|FG001|Overall Study|Adverse Event|2|||
143098263|NCT03482635|515899668|FG002|Overall Study|Adverse Event|0|||
143098264|NCT03482635|515899669|FG003|Overall Study|Adverse Event|3|||
143098265|NCT03482635|515899666|FG000|Overall Study|Withdrawal by Subject|2|||
143098266|NCT03482635|515899667|FG001|Overall Study|Withdrawal by Subject|1|||
143098267|NCT03482635|515899668|FG002|Overall Study|Withdrawal by Subject|0|||
143098268|NCT03482635|515899669|FG003|Overall Study|Withdrawal by Subject|1|||
143098269|NCT03482635|515899666|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
143098270|NCT03482635|515899667|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
143098271|NCT03482635|515899668|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
143098272|NCT03482635|515899669|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
143098273|NCT03482635|515899666|FG000|Overall Study|Not treated|0|||
143098274|NCT03482635|515899667|FG001|Overall Study|Not treated|0|||
143098275|NCT03482635|515899668|FG002|Overall Study|Not treated|0|||
143098276|NCT03482635|515899669|FG003|Overall Study|Not treated|1|||
143098277|NCT04745689|515899674|FG000|Overall Study|Death|9|||
143098278|NCT04745689|515899675|FG001|Overall Study|Death|6|||
143098279|NCT04745689|515899674|FG000|Overall Study|Lost to Follow-up|1|||
143098280|NCT04745689|515899675|FG001|Overall Study|Lost to Follow-up|0|||
143098281|NCT04745689|515899674|FG000|Overall Study|Withdrawal by Subject|2|||
143176962|NCT01490918|516196244|FG000|Overall Study|Withdrawal by Subject|7|||
143098282|NCT04745689|515899675|FG001|Overall Study|Withdrawal by Subject|0|||
143098283|NCT04745689|515899674|FG000|Overall Study|Study terminated by sponsor|10|||
143098284|NCT04745689|515899675|FG001|Overall Study|Study terminated by sponsor|3|||
143098285|NCT04495829|515899683|FG000|Overall Study|Lost to Follow-up|2|||
143098286|NCT04495829|515899683|FG000|Overall Study|Inclusion criterion not met|3|||
143098287|NCT03644342|515899684|FG000|Overall Study|Adverse Event|2|||
143098288|NCT03644342|515899685|FG001|Overall Study|Adverse Event|0|||
143098289|NCT03644342|515899684|FG000|Overall Study|Protocol Violation|0|||
143098290|NCT03644342|515899685|FG001|Overall Study|Protocol Violation|1|||
143098291|NCT02503540|515899688|FG000|Overall Study|Death|2|||
143098292|NCT02503540|515899688|FG000|Overall Study|Withdrawal by Subject|1|||
143098293|NCT01804946|515899692|FG000|Overall Study|Protocol Violation|1|||
143098294|NCT01804946|515899693|FG001|Overall Study|Protocol Violation|0|||
143098295|NCT01804946|515899692|FG000|Overall Study|Adverse Event|0|||
143098296|NCT01804946|515899693|FG001|Overall Study|Adverse Event|1|||
143098297|NCT01804946|515899692|FG000|Overall Study|Insufficient data available|0|||
143098298|NCT01804946|515899693|FG001|Overall Study|Insufficient data available|1|||
143098299|NCT01804946|515899692|FG000|Overall Study|Do not meet inclusion criteria|1|||
143098300|NCT01804946|515899693|FG001|Overall Study|Do not meet inclusion criteria|2|||
143098301|NCT01486446|515899694|FG000|Overall Study|Adverse Event|1|||
143098302|NCT01486446|515899695|FG001|Overall Study|Adverse Event|0|||
143098303|NCT00985504|515899700|FG000|Acute Treatment Period|Adverse Event|3|||
143098304|NCT00985504|515899701|FG001|Acute Treatment Period|Adverse Event|4|||
143098305|NCT00985504|515899700|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
143003664|NCT04576702|515550697|FG003|Overall Study|Death|0|||
143003665|NCT04576702|515550694|FG000|Overall Study|Withdrawal by Subject|0|||
143003666|NCT04576702|515550695|FG001|Overall Study|Withdrawal by Subject|2|||
143003667|NCT04576702|515550696|FG002|Overall Study|Withdrawal by Subject|1|||
143003668|NCT04576702|515550697|FG003|Overall Study|Withdrawal by Subject|0|||
143003669|NCT04576702|515550694|FG000|Overall Study|Lost to Follow-up|3|||
143003670|NCT04576702|515550695|FG001|Overall Study|Lost to Follow-up|3|||
143003671|NCT04576702|515550696|FG002|Overall Study|Lost to Follow-up|3|||
143003672|NCT04576702|515550697|FG003|Overall Study|Lost to Follow-up|4|||
143003673|NCT01319422|515550698|FG000|Overall Study|Withdrawal by Subject|1|||
143003674|NCT01319422|515550699|FG001|Overall Study|Withdrawal by Subject|0|||
143003675|NCT00465101|515550702|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
143003676|NCT00465101|515550702|FG000|Overall Study|Change in health precluded follow up|4|||
143003677|NCT00465101|515550702|FG000|Overall Study|Did not meet study criteria|4|||
143003678|NCT00465101|515550702|FG000|Overall Study|Lost to Follow-up|5|||
143003679|NCT00465101|515550702|FG000|Overall Study|Other|6|||
143003680|NCT00465101|515550702|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
143003681|NCT00465101|515550702|FG000|Overall Study|Patient postponed procedure|1|||
143003682|NCT00465101|515550702|FG000|Overall Study|Site closed due to IRB expiration|1|||
143003683|NCT00465101|515550702|FG000|Overall Study|Unable to obtain IRB approval|1|||
143003684|NCT00465101|515550702|FG000|Overall Study|Death|3|||
143003685|NCT00465101|515550702|FG000|Overall Study|Withdrawal by Subject|25|||
143003686|NCT00465101|515550702|FG000|Overall Study|Physician Decision|1|||
143003687|NCT00465101|515550702|FG000|Overall Study|Withdrew consent prior to procedure|3|||
143003688|NCT03099096|515550703|FG000|Overall Study|Adverse Event|1|||
143003689|NCT03099096|515550703|FG000|Overall Study|Physician Decision|1|||
143003690|NCT02067728|515550705|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
143003691|NCT02067728|515550706|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
143003692|NCT02067728|515550705|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
143003693|NCT02067728|515550706|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
143003694|NCT02067728|515550705|FG000|6 Month Measurements|Unable to attend|114|||
143003695|NCT02067728|515550706|FG001|6 Month Measurements|Unable to attend|97|||
143003696|NCT04338685|515550707|FG000|Overall Study|Death|3|||
143003697|NCT04338685|515550708|FG001|Overall Study|Death|4|||
143003698|NCT04338685|515550709|FG002|Overall Study|Death|2|||
143003699|NCT04338685|515550710|FG003|Overall Study|Death|4|||
143003700|NCT04338685|515550711|FG004|Overall Study|Death|4|||
143003701|NCT04338685|515550712|FG005|Overall Study|Death|8|||
143003702|NCT04338685|515550713|FG006|Overall Study|Death|1|||
143003703|NCT04338685|515550714|FG007|Overall Study|Death|0|||
143003704|NCT04338685|515550715|FG008|Overall Study|Death|0|||
143003705|NCT04338685|515550707|FG000|Overall Study|Study terminated by Sponsor|0|||
143003706|NCT04338685|515550708|FG001|Overall Study|Study terminated by Sponsor|0|||
143003707|NCT04338685|515550709|FG002|Overall Study|Study terminated by Sponsor|1|||
143003708|NCT04338685|515550710|FG003|Overall Study|Study terminated by Sponsor|4|||
143003709|NCT04338685|515550711|FG004|Overall Study|Study terminated by Sponsor|0|||
143003710|NCT04338685|515550712|FG005|Overall Study|Study terminated by Sponsor|5|||
143003711|NCT04338685|515550713|FG006|Overall Study|Study terminated by Sponsor|2|||
143003712|NCT04338685|515550714|FG007|Overall Study|Study terminated by Sponsor|4|||
143003713|NCT04338685|515550715|FG008|Overall Study|Study terminated by Sponsor|1|||
143003714|NCT04338685|515550707|FG000|Overall Study|Withdrawal by Subject|1|||
143003715|NCT04338685|515550708|FG001|Overall Study|Withdrawal by Subject|2|||
143003716|NCT04338685|515550709|FG002|Overall Study|Withdrawal by Subject|0|||
143003717|NCT04338685|515550710|FG003|Overall Study|Withdrawal by Subject|2|||
143003718|NCT04338685|515550711|FG004|Overall Study|Withdrawal by Subject|0|||
143003719|NCT04338685|515550712|FG005|Overall Study|Withdrawal by Subject|5|||
143098306|NCT00985504|515899701|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
143098307|NCT00985504|515899700|FG000|Acute Treatment Period|Protocol Violation|2|||
143098308|NCT00985504|515899701|FG001|Acute Treatment Period|Protocol Violation|0|||
143098309|NCT00985504|515899700|FG000|Acute Treatment Period|Sponsor Decision|0|||
143098310|NCT00985504|515899701|FG001|Acute Treatment Period|Sponsor Decision|1|||
143098311|NCT00985504|515899700|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
143098312|NCT00985504|515899701|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
143098313|NCT00985504|515899700|FG000|Optimization Period|Adverse Event|7|||
143098314|NCT00985504|515899701|FG001|Optimization Period|Adverse Event|9|||
143098315|NCT00985504|515899700|FG000|Optimization Period|Death|0|||
143098316|NCT00985504|515899701|FG001|Optimization Period|Death|1|||
143098317|NCT00985504|515899700|FG000|Optimization Period|Lack of Efficacy|5|||
143098318|NCT00985504|515899701|FG001|Optimization Period|Lack of Efficacy|3|||
143098319|NCT00985504|515899700|FG000|Optimization Period|Lost to Follow-up|0|||
143098320|NCT00985504|515899701|FG001|Optimization Period|Lost to Follow-up|1|||
143098321|NCT00985504|515899700|FG000|Optimization Period|Physician Decision|1|||
143098322|NCT00985504|515899701|FG001|Optimization Period|Physician Decision|0|||
143098323|NCT00985504|515899700|FG000|Optimization Period|Protocol Violation|3|||
143098324|NCT00985504|515899701|FG001|Optimization Period|Protocol Violation|1|||
143098325|NCT00985504|515899700|FG000|Optimization Period|Withdrawal by Subject|10|||
143098326|NCT00985504|515899701|FG001|Optimization Period|Withdrawal by Subject|8|||
143098327|NCT03103152|515899702|FG000|Overall Study|Physician Decision|5|||
143098328|NCT03103152|515899703|FG001|Overall Study|Physician Decision|2|||
143098329|NCT03103152|515899704|FG002|Overall Study|Physician Decision|6|||
143098330|NCT03103152|515899705|FG003|Overall Study|Physician Decision|3|||
143098331|NCT03103152|515899706|FG004|Overall Study|Physician Decision|3|||
143176963|NCT01490918|516196245|FG001|Overall Study|Withdrawal by Subject|8|||
143176964|NCT01490918|516196246|FG002|Overall Study|Withdrawal by Subject|3|||
143176965|NCT01490918|516196244|FG000|Overall Study|Adverse Event|0|||
143176966|NCT01490918|516196245|FG001|Overall Study|Adverse Event|0|||
143176967|NCT01490918|516196246|FG002|Overall Study|Adverse Event|1|||
143176968|NCT01490918|516196244|FG000|Overall Study|other cause|4|||
143176969|NCT01490918|516196245|FG001|Overall Study|other cause|5|||
143176970|NCT01490918|516196246|FG002|Overall Study|other cause|8|||
143176971|NCT02967679|516196247|FG000|Overall Study|Adverse Event|1|||
143176972|NCT00114127|516196249|FG000|Overall Study|Adverse Event|2|||
143176973|NCT00114127|516196250|FG001|Overall Study|Adverse Event|1|||
143176974|NCT00114127|516196249|FG000|Overall Study|Lost to Follow-up|1|||
143176975|NCT00114127|516196250|FG001|Overall Study|Lost to Follow-up|0|||
143176976|NCT00114127|516196249|FG000|Overall Study|Withdrawal by Subject|1|||
143176977|NCT00114127|516196250|FG001|Overall Study|Withdrawal by Subject|3|||
143176978|NCT03188263|516196251|FG000|Overall Study|Withdrawal by Subject|3|||
143176979|NCT03188263|516196252|FG001|Overall Study|Withdrawal by Subject|0|||
143176980|NCT03188263|516196251|FG000|Overall Study|Physician Decision|1|||
143176981|NCT03188263|516196252|FG001|Overall Study|Physician Decision|0|||
143176982|NCT00699413|516196253|FG000|Overall Study|Withdrawal by Subject|0|||
143176983|NCT00699413|516196254|FG001|Overall Study|Withdrawal by Subject|2|||
143176984|NCT00699413|516196253|FG000|Overall Study|Study terminated by sponsor|4|||
143176985|NCT00699413|516196254|FG001|Overall Study|Study terminated by sponsor|2|||
143176986|NCT02779777|516196255|FG000|Overall Study|Disease Progression|1|||
143176987|NCT02779777|516196256|FG001|Overall Study|Disease Progression|0|||
143176988|NCT02779777|516196257|FG002|Overall Study|Disease Progression|0|||
143176989|NCT02779777|516196255|FG000|Overall Study|Adverse Event|3|||
143176990|NCT02779777|516196256|FG001|Overall Study|Adverse Event|1|||
143176991|NCT02779777|516196257|FG002|Overall Study|Adverse Event|0|||
143176992|NCT02779777|516196255|FG000|Overall Study|Physician Decision|9|||
143176993|NCT02779777|516196256|FG001|Overall Study|Physician Decision|0|||
143176994|NCT02779777|516196257|FG002|Overall Study|Physician Decision|1|||
143176995|NCT02779777|516196255|FG000|Overall Study|Withdrawal by Subject|1|||
143176996|NCT02779777|516196256|FG001|Overall Study|Withdrawal by Subject|0|||
143176997|NCT02779777|516196257|FG002|Overall Study|Withdrawal by Subject|0|||
143176998|NCT00469833|516196258|FG000|Overall Study|No IV access|2|||
143098332|NCT03103152|515899707|FG005|Overall Study|Physician Decision|1|||
143176999|NCT03289533|516196259|FG000|Overall Study|Death|12|||
143177000|NCT03289533|516196259|FG000|Overall Study|Terminated from study by sponsor|10|||
143177001|NCT00539240|516196260|FG000|Overall Study|Withdrawal by Subject|0|||
143177002|NCT00539240|516196261|FG001|Overall Study|Withdrawal by Subject|2|||
143177003|NCT00539240|516196262|FG002|Overall Study|Withdrawal by Subject|0|||
143177004|NCT00539240|516196260|FG000|Overall Study|Protocol Violation|1|||
143177005|NCT00539240|516196261|FG001|Overall Study|Protocol Violation|1|||
143098333|NCT03103152|515899702|FG000|Overall Study|Protocol Violation|2|||
143098334|NCT03103152|515899703|FG001|Overall Study|Protocol Violation|2|||
143098335|NCT03103152|515899704|FG002|Overall Study|Protocol Violation|1|||
143098336|NCT03103152|515899705|FG003|Overall Study|Protocol Violation|2|||
143177006|NCT00539240|516196262|FG002|Overall Study|Protocol Violation|4|||
143098337|NCT03103152|515899706|FG004|Overall Study|Protocol Violation|1|||
143098338|NCT03103152|515899707|FG005|Overall Study|Protocol Violation|1|||
143098339|NCT03103152|515899702|FG000|Overall Study|Inter-current illness|0|||
143098340|NCT03103152|515899703|FG001|Overall Study|Inter-current illness|0|||
143098341|NCT03103152|515899704|FG002|Overall Study|Inter-current illness|1|||
143098342|NCT03103152|515899705|FG003|Overall Study|Inter-current illness|0|||
143098343|NCT03103152|515899706|FG004|Overall Study|Inter-current illness|0|||
143098344|NCT03103152|515899707|FG005|Overall Study|Inter-current illness|0|||
143098345|NCT03103152|515899702|FG000|Overall Study|Death|0|||
143098346|NCT03103152|515899703|FG001|Overall Study|Death|1|||
143098347|NCT03103152|515899704|FG002|Overall Study|Death|0|||
143098348|NCT03103152|515899705|FG003|Overall Study|Death|0|||
143098349|NCT03103152|515899706|FG004|Overall Study|Death|0|||
143098350|NCT03103152|515899707|FG005|Overall Study|Death|0|||
143098351|NCT03103152|515899702|FG000|Overall Study|Adverse Event|0|||
143098352|NCT03103152|515899703|FG001|Overall Study|Adverse Event|0|||
143098353|NCT03103152|515899704|FG002|Overall Study|Adverse Event|1|||
143098354|NCT03103152|515899705|FG003|Overall Study|Adverse Event|0|||
143098355|NCT03103152|515899706|FG004|Overall Study|Adverse Event|0|||
143098356|NCT03103152|515899707|FG005|Overall Study|Adverse Event|1|||
143098357|NCT03103152|515899702|FG000|Overall Study|Withdrawal by Subject|1|||
143098358|NCT03103152|515899703|FG001|Overall Study|Withdrawal by Subject|0|||
143098359|NCT03103152|515899704|FG002|Overall Study|Withdrawal by Subject|1|||
143098360|NCT03103152|515899705|FG003|Overall Study|Withdrawal by Subject|1|||
143098361|NCT03103152|515899706|FG004|Overall Study|Withdrawal by Subject|1|||
143098362|NCT03103152|515899707|FG005|Overall Study|Withdrawal by Subject|1|||
143098363|NCT03103152|515899702|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
143098364|NCT03103152|515899703|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
143098365|NCT03103152|515899704|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
143098366|NCT03103152|515899705|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
143098367|NCT03103152|515899706|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
143098368|NCT03103152|515899707|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
143098369|NCT03103152|515899702|FG000|Overall Study|Unacceptable side effects|0|||
143098370|NCT03103152|515899703|FG001|Overall Study|Unacceptable side effects|0|||
143098371|NCT03103152|515899704|FG002|Overall Study|Unacceptable side effects|0|||
143098372|NCT03103152|515899705|FG003|Overall Study|Unacceptable side effects|0|||
143098373|NCT03103152|515899706|FG004|Overall Study|Unacceptable side effects|0|||
143098374|NCT03103152|515899707|FG005|Overall Study|Unacceptable side effects|1|||
143098375|NCT03103152|515899702|FG000|Overall Study|Lost to Follow-up|0|||
143098376|NCT03103152|515899703|FG001|Overall Study|Lost to Follow-up|1|||
143098377|NCT03103152|515899704|FG002|Overall Study|Lost to Follow-up|0|||
143098378|NCT03103152|515899705|FG003|Overall Study|Lost to Follow-up|1|||
143251820|NCT00647270|516476323|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
143251821|NCT00647270|516476324|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
143251822|NCT00647270|516476325|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
143251823|NCT00647270|516476323|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
143251824|NCT00647270|516476324|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
143251825|NCT00647270|516476325|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
143251826|NCT03615040|516476326|FG000|Overall Study|Withdrawal by Subject|2|||
143251827|NCT03615040|516476327|FG001|Overall Study|Withdrawal by Subject|1|||
143251828|NCT03615040|516476326|FG000|Overall Study|Physician Decision|2|||
143251829|NCT03615040|516476327|FG001|Overall Study|Physician Decision|2|||
143251830|NCT03615040|516476326|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
143251831|NCT03615040|516476327|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
143251832|NCT03615040|516476326|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
143098379|NCT03103152|515899706|FG004|Overall Study|Lost to Follow-up|0|||
143098380|NCT03103152|515899707|FG005|Overall Study|Lost to Follow-up|1|||
143098381|NCT03103152|515899702|FG000|Overall Study|Testicular pain|0|||
143251833|NCT03615040|516476327|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
143098382|NCT03103152|515899703|FG001|Overall Study|Testicular pain|0|||
143098383|NCT03103152|515899704|FG002|Overall Study|Testicular pain|0|||
143098384|NCT03103152|515899705|FG003|Overall Study|Testicular pain|1|||
143098385|NCT03103152|515899706|FG004|Overall Study|Testicular pain|0|||
143098386|NCT03103152|515899707|FG005|Overall Study|Testicular pain|0|||
143098387|NCT03474965|515899708|FG000|Overall Study|Pregnancy|1|||
143098388|NCT03474965|515899709|FG001|Overall Study|Pregnancy|0|||
143098389|NCT03474965|515899710|FG002|Overall Study|Pregnancy|0|||
143098390|NCT03474965|515899711|FG003|Overall Study|Pregnancy|0|||
143251834|NCT03615040|516476326|FG000|Overall Study|Death|0|||
143251835|NCT03615040|516476327|FG001|Overall Study|Death|2|||
143098391|NCT03474965|515899708|FG000|Overall Study|Lost to Follow-up|0|||
143098392|NCT03474965|515899709|FG001|Overall Study|Lost to Follow-up|0|||
143098393|NCT03474965|515899710|FG002|Overall Study|Lost to Follow-up|1|||
143098394|NCT03474965|515899711|FG003|Overall Study|Lost to Follow-up|0|||
143098395|NCT03474965|515899708|FG000|Overall Study|Death|1|||
143098396|NCT03474965|515899709|FG001|Overall Study|Death|0|||
143098397|NCT03474965|515899710|FG002|Overall Study|Death|0|||
143098398|NCT03474965|515899711|FG003|Overall Study|Death|0|||
143098399|NCT03474965|515899708|FG000|Overall Study|Adverse Event|1|||
143098400|NCT03474965|515899709|FG001|Overall Study|Adverse Event|0|||
143098401|NCT03474965|515899710|FG002|Overall Study|Adverse Event|0|||
143098402|NCT03474965|515899711|FG003|Overall Study|Adverse Event|1|||
143098403|NCT03474965|515899708|FG000|Overall Study|Physician Decision|3|||
143098404|NCT03474965|515899709|FG001|Overall Study|Physician Decision|1|||
143098405|NCT03474965|515899710|FG002|Overall Study|Physician Decision|2|||
143098406|NCT03474965|515899711|FG003|Overall Study|Physician Decision|0|||
143098407|NCT03474965|515899708|FG000|Overall Study|Participant Decision|7|||
143098408|NCT03474965|515899709|FG001|Overall Study|Participant Decision|0|||
143098409|NCT03474965|515899710|FG002|Overall Study|Participant Decision|1|||
143098410|NCT03474965|515899711|FG003|Overall Study|Participant Decision|0|||
143098411|NCT03474965|515899708|FG000|Overall Study|Guardian Decision|4|||
143098412|NCT03474965|515899709|FG001|Overall Study|Guardian Decision|2|||
143098413|NCT03474965|515899710|FG002|Overall Study|Guardian Decision|7|||
143098414|NCT03474965|515899711|FG003|Overall Study|Guardian Decision|2|||
143098415|NCT03668119|515901936|FG000|Pre-treatment|Disease Progression|1|||
143098416|NCT03668119|515901937|FG001|Pre-treatment|Disease Progression|0|||
143098417|NCT03668119|515901936|FG000|Treatment|Disease Progression|76|||
143098418|NCT03668119|515901937|FG001|Treatment|Disease Progression|57|||
143098419|NCT03668119|515901936|FG000|Treatment|Study drug toxicity|19|||
143098420|NCT03668119|515901937|FG001|Treatment|Study drug toxicity|1|||
143251836|NCT01541397|516476328|FG000|Overall Study|Study ended prior to data collection|4|||
143251837|NCT01541397|516476329|FG001|Overall Study|Study ended prior to data collection|2|||
143251838|NCT01128621|516476330|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
143251839|NCT01128621|516476331|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
143251840|NCT02267317|516476332|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
143251841|NCT02267317|516476333|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
143251842|NCT02267317|516476334|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
143251843|NCT02267317|516476335|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
143251844|NCT02267317|516476336|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
143251845|NCT02267317|516476337|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
143251846|NCT02267317|516476332|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
143251847|NCT02267317|516476333|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
143251848|NCT02267317|516476334|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
143251849|NCT02267317|516476335|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
143251850|NCT02267317|516476336|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
143251851|NCT02267317|516476337|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
143251852|NCT00233454|516476340|FG000|Overall Study|Death|6|||
143251853|NCT01639729|516476346|FG000|Overall Study|Withdrawal by Subject|1|||
143251854|NCT01639729|516476347|FG001|Overall Study|Withdrawal by Subject|0|||
143251855|NCT01639729|516476348|FG002|Overall Study|Withdrawal by Subject|1|||
143251856|NCT01639729|516476349|FG003|Overall Study|Withdrawal by Subject|1|||
143251857|NCT01639729|516476350|FG004|Overall Study|Withdrawal by Subject|0|||
143251858|NCT01639729|516476351|FG005|Overall Study|Withdrawal by Subject|0|||
143251859|NCT00759564|516476352|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
143251860|NCT00759564|516476353|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
143251861|NCT00759564|516476354|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
143251862|NCT00759564|516476355|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
143251863|NCT00759564|516476356|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
143098421|NCT03668119|515901936|FG000|Treatment|Death|3|||
143098422|NCT03668119|515901937|FG001|Treatment|Death|0|||
143098423|NCT03668119|515901936|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
143098424|NCT03668119|515901937|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
143098425|NCT03668119|515901936|FG000|Treatment|Withdrawal by Subject|1|||
143251864|NCT03726996|516476360|FG000|Overall Study|Parent's decision|2|||
143251865|NCT03726996|516476360|FG000|Overall Study|Study early termination|2|||
143098426|NCT03668119|515901937|FG001|Treatment|Withdrawal by Subject|1|||
143098427|NCT03668119|515901936|FG000|Treatment|Participant request to discontinue study treatment|3|||
143098428|NCT03668119|515901937|FG001|Treatment|Participant request to discontinue study treatment|1|||
143098429|NCT03668119|515901936|FG000|Treatment|Maximum Clinical Benefit|0|||
143098430|NCT03668119|515901937|FG001|Treatment|Maximum Clinical Benefit|1|||
143098431|NCT03668119|515901936|FG000|Treatment|Participants completed treatment|27|||
143098432|NCT03668119|515901937|FG001|Treatment|Participants completed treatment|11|||
143098433|NCT03668119|515901936|FG000|Treatment|Other reasons|2|||
143098434|NCT03668119|515901937|FG001|Treatment|Other reasons|1|||
143367717|NCT02926937|516889423|FG000|Overall Study|Reason not Specified|3|||
143367718|NCT02926937|516889424|FG001|Overall Study|Reason not Specified|4|||
143367719|NCT02926937|516889425|FG002|Overall Study|Reason not Specified|2|||
143367720|NCT01559090|516889426|FG000|Stage I|Withdrawal by Subject|2|||
143367721|NCT01559090|516889427|FG001|Stage I|Withdrawal by Subject|2|||
143367722|NCT01559090|516889428|FG002|Stage I|Withdrawal by Subject|3|||
143367723|NCT01559090|516889426|FG000|Stage II|Withdrawal by Subject|1|||
143367724|NCT01559090|516889427|FG001|Stage II|Withdrawal by Subject|0|||
143367725|NCT01559090|516889428|FG002|Stage II|Withdrawal by Subject|0|||
143367726|NCT03677375|516889430|FG000|Overall Study|Incomplete procedure|8|||
143367727|NCT03677375|516889430|FG000|Overall Study|Adverse Event|3|||
143367728|NCT03677375|516889430|FG000|Overall Study|Physician Decision|1|||
143367729|NCT01729871|516889433|FG000|Overall Study|Adverse Event|7|||
143098435|NCT03769168|515901938|FG000|Overall Study|Adverse Event|0|||
143098436|NCT03769168|515901939|FG001|Overall Study|Adverse Event|1|||
143098437|NCT03769168|515901938|FG000|Overall Study|Lack of Efficacy|2|||
143098438|NCT03769168|515901939|FG001|Overall Study|Lack of Efficacy|4|||
143098439|NCT03769168|515901938|FG000|Overall Study|Post study access to treatment|3|||
143098440|NCT03769168|515901939|FG001|Overall Study|Post study access to treatment|11|||
143098441|NCT03769168|515901938|FG000|Overall Study|Physician Decision|1|||
143098442|NCT03769168|515901939|FG001|Overall Study|Physician Decision|4|||
143098443|NCT03769168|515901938|FG000|Overall Study|Subject Decision|2|||
143098444|NCT03769168|515901939|FG001|Overall Study|Subject Decision|4|||
143098445|NCT03769168|515901938|FG000|Overall Study|Guardian decision|1|||
143098446|NCT03769168|515901939|FG001|Overall Study|Guardian decision|0|||
143098447|NCT05336227|515901940|FG000|Overall Study|Adverse Event|1|||
143098448|NCT05336227|515901941|FG001|Overall Study|Adverse Event|0|||
143098449|NCT05336227|515901940|FG000|Overall Study|Lost to Follow-up|2|||
143098450|NCT05336227|515901941|FG001|Overall Study|Lost to Follow-up|0|||
143098451|NCT05336227|515901940|FG000|Overall Study|Withdrawal by Subject|1|||
143098452|NCT05336227|515901941|FG001|Overall Study|Withdrawal by Subject|0|||
143098453|NCT03100903|515901944|FG000|Overall Study|Withdrawal by Subject|0|||
143098454|NCT03100903|515901945|FG001|Overall Study|Withdrawal by Subject|0|||
143098455|NCT03100903|515901946|FG002|Overall Study|Withdrawal by Subject|1|||
143098456|NCT04659993|515901947|FG000|Overall Study|Withdrawal by Subject|2|||
143098457|NCT04659993|515901947|FG000|Overall Study|Lost to Follow-up|2|||
143098458|NCT05400655|515901948|FG000|Part 1A: Period 2|Withdrawal by Subject|0|||
143098459|NCT05400655|515901949|FG001|Part 1A: Period 2|Withdrawal by Subject|0|||
143098460|NCT05400655|515901950|FG002|Part 1A: Period 2|Withdrawal by Subject|0|||
143098461|NCT05400655|515901951|FG003|Part 1A: Period 2|Withdrawal by Subject|1|||
143367730|NCT01729871|516889434|FG001|Overall Study|Adverse Event|7|||
143367731|NCT01729871|516889433|FG000|Overall Study|Death|0|||
143367732|NCT01729871|516889434|FG001|Overall Study|Death|1|||
143367733|NCT01729871|516889433|FG000|Overall Study|Lack of Efficacy|0|||
143098462|NCT05400655|515901952|FG004|Part 1A: Period 2|Withdrawal by Subject|0|||
143098463|NCT05400655|515901953|FG005|Part 1A: Period 2|Withdrawal by Subject|0|||
143098464|NCT05400655|515901954|FG006|Part 1A: Period 2|Withdrawal by Subject|0|||
143098465|NCT05400655|515901955|FG007|Part 1A: Period 2|Withdrawal by Subject|0|||
143098466|NCT05400655|515901956|FG008|Part 1A: Period 2|Withdrawal by Subject|0|||
143098467|NCT05400655|515901957|FG009|Part 1A: Period 2|Withdrawal by Subject|0|||
143098468|NCT05400655|515901958|FG010|Part 1A: Period 2|Withdrawal by Subject|0|||
143177007|NCT00539240|516196260|FG000|Overall Study|Lost to Follow-up|2|||
143367734|NCT01729871|516889434|FG001|Overall Study|Lack of Efficacy|1|||
143098469|NCT05400655|515901959|FG011|Part 1A: Period 2|Withdrawal by Subject|0|||
143098470|NCT05400655|515901960|FG012|Part 1A: Period 2|Withdrawal by Subject|0|||
143098471|NCT05400655|515901961|FG013|Part 1A: Period 2|Withdrawal by Subject|0|||
143098472|NCT05400655|515901962|FG014|Part 1A: Period 2|Withdrawal by Subject|0|||
143098473|NCT05400655|515901963|FG015|Part 1A: Period 2|Withdrawal by Subject|0|||
143098474|NCT05400655|515901964|FG016|Part 1A: Period 2|Withdrawal by Subject|0|||
143098475|NCT05400655|515901965|FG017|Part 1A: Period 2|Withdrawal by Subject|0|||
143098476|NCT05400655|515901966|FG018|Part 1A: Period 2|Withdrawal by Subject|0|||
143098477|NCT05400655|515901967|FG019|Part 1A: Period 2|Withdrawal by Subject|0|||
143098478|NCT05400655|515901968|FG020|Part 1A: Period 2|Withdrawal by Subject|0|||
143098479|NCT05400655|515901969|FG021|Part 1A: Period 2|Withdrawal by Subject|0|||
143098480|NCT05400655|515901948|FG000|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
143098481|NCT05400655|515901949|FG001|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
143098482|NCT05400655|515901950|FG002|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
143098483|NCT05400655|515901951|FG003|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
143098484|NCT05400655|515901952|FG004|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
143098485|NCT05400655|515901953|FG005|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
143098486|NCT05400655|515901954|FG006|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
143098487|NCT05400655|515901955|FG007|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
143098488|NCT05400655|515901956|FG008|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
143098489|NCT05400655|515901957|FG009|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
143098490|NCT05400655|515901958|FG010|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
143098491|NCT05400655|515901959|FG011|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
143098492|NCT05400655|515901960|FG012|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
143098493|NCT05400655|515901961|FG013|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
143098494|NCT05400655|515901962|FG014|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
143098495|NCT05400655|515901963|FG015|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
143098496|NCT05400655|515901964|FG016|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
143098497|NCT05400655|515901965|FG017|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
143098498|NCT05400655|515901966|FG018|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
143098499|NCT05400655|515901967|FG019|Part 1B/Part 2 - Period 1|Withdrawal by Subject|2|||
143098500|NCT05400655|515901968|FG020|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
143098501|NCT05400655|515901969|FG021|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
143098502|NCT05400655|515901948|FG000|Part 1B/Part 2 - Period 1|Adverse Event|0|||
143098503|NCT05400655|515901949|FG001|Part 1B/Part 2 - Period 1|Adverse Event|0|||
143098504|NCT05400655|515901950|FG002|Part 1B/Part 2 - Period 1|Adverse Event|0|||
143098505|NCT05400655|515901951|FG003|Part 1B/Part 2 - Period 1|Adverse Event|0|||
143098506|NCT05400655|515901952|FG004|Part 1B/Part 2 - Period 1|Adverse Event|0|||
143098507|NCT05400655|515901953|FG005|Part 1B/Part 2 - Period 1|Adverse Event|0|||
143098508|NCT05400655|515901954|FG006|Part 1B/Part 2 - Period 1|Adverse Event|0|||
143098509|NCT05400655|515901955|FG007|Part 1B/Part 2 - Period 1|Adverse Event|0|||
143098510|NCT05400655|515901956|FG008|Part 1B/Part 2 - Period 1|Adverse Event|0|||
143098511|NCT05400655|515901957|FG009|Part 1B/Part 2 - Period 1|Adverse Event|0|||
143098512|NCT05400655|515901958|FG010|Part 1B/Part 2 - Period 1|Adverse Event|0|||
143098513|NCT05400655|515901959|FG011|Part 1B/Part 2 - Period 1|Adverse Event|0|||
143098514|NCT05400655|515901960|FG012|Part 1B/Part 2 - Period 1|Adverse Event|0|||
143098515|NCT05400655|515901961|FG013|Part 1B/Part 2 - Period 1|Adverse Event|1|||
143098516|NCT05400655|515901962|FG014|Part 1B/Part 2 - Period 1|Adverse Event|0|||
143098517|NCT05400655|515901963|FG015|Part 1B/Part 2 - Period 1|Adverse Event|0|||
143098518|NCT05400655|515901964|FG016|Part 1B/Part 2 - Period 1|Adverse Event|2|||
143098519|NCT05400655|515901965|FG017|Part 1B/Part 2 - Period 1|Adverse Event|0|||
143367735|NCT01729871|516889433|FG000|Overall Study|Physician Decision|0|||
143367736|NCT01729871|516889434|FG001|Overall Study|Physician Decision|2|||
143177008|NCT00539240|516196261|FG001|Overall Study|Lost to Follow-up|3|||
143177009|NCT00539240|516196262|FG002|Overall Study|Lost to Follow-up|1|||
143177010|NCT00539240|516196260|FG000|Overall Study|Adverse Event|3|||
143177011|NCT00539240|516196261|FG001|Overall Study|Adverse Event|1|||
143177012|NCT00539240|516196262|FG002|Overall Study|Adverse Event|10|||
143177013|NCT00730886|516196263|FG000|Overall Study|Lost to Follow-up|1|||
143177014|NCT00730886|516196264|FG001|Overall Study|Lost to Follow-up|0|||
143177015|NCT00730886|516196263|FG000|Overall Study|Physician Decision|1|||
143177016|NCT00730886|516196264|FG001|Overall Study|Physician Decision|0|||
143177017|NCT01991483|516196265|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
143177018|NCT01991483|516196266|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
143177019|NCT01991483|516196267|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
143098520|NCT05400655|515901966|FG018|Part 1B/Part 2 - Period 1|Adverse Event|1|||
143098521|NCT05400655|515901967|FG019|Part 1B/Part 2 - Period 1|Adverse Event|0|||
143098522|NCT05400655|515901968|FG020|Part 1B/Part 2 - Period 1|Adverse Event|0|||
143098523|NCT05400655|515901969|FG021|Part 1B/Part 2 - Period 1|Adverse Event|0|||
143098524|NCT05400655|515901948|FG000|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
143098525|NCT05400655|515901949|FG001|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
143177020|NCT01991483|516196268|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
143177021|NCT01991483|516196265|FG000|Dose Level 600 mg|Physician Decision|0|||
143367737|NCT01729871|516889433|FG000|Overall Study|Protocol Violation|1|||
143098526|NCT05400655|515901950|FG002|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
143098527|NCT05400655|515901951|FG003|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
143098528|NCT05400655|515901952|FG004|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
143098529|NCT05400655|515901953|FG005|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
143098530|NCT05400655|515901954|FG006|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
143098531|NCT05400655|515901955|FG007|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
143098532|NCT05400655|515901956|FG008|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
143098533|NCT05400655|515901957|FG009|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
143098534|NCT05400655|515901958|FG010|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
143098535|NCT05400655|515901959|FG011|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
143098536|NCT05400655|515901960|FG012|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
143098537|NCT05400655|515901961|FG013|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
143098538|NCT05400655|515901962|FG014|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
143098539|NCT05400655|515901963|FG015|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
143098540|NCT05400655|515901964|FG016|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
143098541|NCT05400655|515901965|FG017|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
143098542|NCT05400655|515901966|FG018|Part 1B/Part 2 - Period 1|Lost to Follow-up|3|||
143098543|NCT05400655|515901967|FG019|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
143098544|NCT05400655|515901968|FG020|Part 1B/Part 2 - Period 1|Lost to Follow-up|7|||
143098545|NCT05400655|515901969|FG021|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
143098546|NCT05400655|515901948|FG000|Part 1B/Part 2 - Period 1|Physician Decision|0|||
143098547|NCT05400655|515901949|FG001|Part 1B/Part 2 - Period 1|Physician Decision|0|||
143098548|NCT05400655|515901950|FG002|Part 1B/Part 2 - Period 1|Physician Decision|0|||
143098549|NCT05400655|515901951|FG003|Part 1B/Part 2 - Period 1|Physician Decision|0|||
143098550|NCT05400655|515901952|FG004|Part 1B/Part 2 - Period 1|Physician Decision|0|||
143098551|NCT05400655|515901953|FG005|Part 1B/Part 2 - Period 1|Physician Decision|0|||
143098552|NCT05400655|515901954|FG006|Part 1B/Part 2 - Period 1|Physician Decision|0|||
143098553|NCT05400655|515901955|FG007|Part 1B/Part 2 - Period 1|Physician Decision|0|||
143098554|NCT05400655|515901956|FG008|Part 1B/Part 2 - Period 1|Physician Decision|0|||
143098555|NCT05400655|515901957|FG009|Part 1B/Part 2 - Period 1|Physician Decision|0|||
143098556|NCT05400655|515901958|FG010|Part 1B/Part 2 - Period 1|Physician Decision|0|||
143098557|NCT05400655|515901959|FG011|Part 1B/Part 2 - Period 1|Physician Decision|0|||
143098558|NCT05400655|515901960|FG012|Part 1B/Part 2 - Period 1|Physician Decision|0|||
143098559|NCT05400655|515901961|FG013|Part 1B/Part 2 - Period 1|Physician Decision|0|||
143098560|NCT05400655|515901962|FG014|Part 1B/Part 2 - Period 1|Physician Decision|0|||
143098561|NCT05400655|515901963|FG015|Part 1B/Part 2 - Period 1|Physician Decision|0|||
143098562|NCT05400655|515901964|FG016|Part 1B/Part 2 - Period 1|Physician Decision|0|||
143098563|NCT05400655|515901965|FG017|Part 1B/Part 2 - Period 1|Physician Decision|3|||
143098564|NCT05400655|515901966|FG018|Part 1B/Part 2 - Period 1|Physician Decision|2|||
143098565|NCT05400655|515901967|FG019|Part 1B/Part 2 - Period 1|Physician Decision|0|||
143098566|NCT05400655|515901968|FG020|Part 1B/Part 2 - Period 1|Physician Decision|0|||
143098567|NCT05400655|515901969|FG021|Part 1B/Part 2 - Period 1|Physician Decision|0|||
143098568|NCT05400655|515901948|FG000|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
143098569|NCT05400655|515901949|FG001|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
143098570|NCT05400655|515901950|FG002|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
143098571|NCT05400655|515901951|FG003|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
143098572|NCT05400655|515901952|FG004|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
143098573|NCT05400655|515901953|FG005|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
143098574|NCT05400655|515901954|FG006|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
143098575|NCT05400655|515901955|FG007|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
143098576|NCT05400655|515901956|FG008|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
143098577|NCT05400655|515901957|FG009|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
143098578|NCT05400655|515901958|FG010|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
143098579|NCT05400655|515901959|FG011|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
143098580|NCT05400655|515901960|FG012|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
143098581|NCT05400655|515901961|FG013|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
143098582|NCT05400655|515901962|FG014|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
143098583|NCT05400655|515901963|FG015|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
143098584|NCT05400655|515901964|FG016|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
143098585|NCT05400655|515901965|FG017|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
143098586|NCT05400655|515901966|FG018|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
143098587|NCT05400655|515901967|FG019|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
143098588|NCT05400655|515901968|FG020|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
143098589|NCT05400655|515901969|FG021|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
143098590|NCT01682226|515901970|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
143098591|NCT01682226|515901970|FG000|Overall Study|Participants did not receive treatment|2|||
143098592|NCT01682226|515901970|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
143098593|NCT03263936|515901971|FG000|Overall Study|Adverse Event|0|||
143098594|NCT03263936|515901972|FG001|Overall Study|Adverse Event|1|||
143098595|NCT03263936|515901973|FG002|Overall Study|Adverse Event|0|||
143098596|NCT03263936|515901971|FG000|Overall Study|Death|0|||
143098597|NCT03263936|515901972|FG001|Overall Study|Death|1|||
143098598|NCT03263936|515901973|FG002|Overall Study|Death|0|||
143098599|NCT03123120|515901974|FG000|Overall Study|Lost to Follow-up|0|||
143098600|NCT03123120|515901975|FG001|Overall Study|Lost to Follow-up|1|||
143098601|NCT03123120|515901974|FG000|Overall Study|Withdrawal by Subject|0|||
143098602|NCT03123120|515901975|FG001|Overall Study|Withdrawal by Subject|1|||
143098603|NCT03135548|515901976|FG000|Overall Study|Lost to Follow-up|3|||
143098604|NCT03135548|515901977|FG001|Overall Study|Lost to Follow-up|0|||
143098605|NCT03135548|515901978|FG002|Overall Study|Lost to Follow-up|0|||
143098606|NCT03135548|515901976|FG000|Overall Study|Withdrawal by Subject|2|||
143098607|NCT03135548|515901977|FG001|Overall Study|Withdrawal by Subject|2|||
143098608|NCT03135548|515901978|FG002|Overall Study|Withdrawal by Subject|1|||
143098609|NCT03135548|515901976|FG000|Overall Study|Other than listed|0|||
143098610|NCT03135548|515901977|FG001|Overall Study|Other than listed|2|||
143098611|NCT03135548|515901978|FG002|Overall Study|Other than listed|2|||
143098612|NCT02088554|515901979|FG000|Overall Study|Exited before procedure|130|||
143098613|NCT02088554|515901979|FG000|Overall Study|Attempted but not implanted|31|||
143098614|NCT02088554|515901979|FG000|Overall Study|Implant not attempted|19|||
143098615|NCT02088554|515901979|FG000|Overall Study|Pending next visit|532|||
143098616|NCT02088554|515901979|FG000|Overall Study|Death|170|||
143098617|NCT02088554|515901979|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
143098618|NCT02088554|515901979|FG000|Overall Study|Lost to Follow-up|23|||
143098619|NCT02088554|515901979|FG000|Overall Study|Explanted|32|||
143098620|NCT02088554|515901979|FG000|Overall Study|Any other reason not covered by previous categories|11|||
143098621|NCT00454246|515901995|FG000|Overall Study|Adverse Event|2|||
143098622|NCT00454246|515901996|FG001|Overall Study|Adverse Event|2|||
143098623|NCT00454246|515901997|FG002|Overall Study|Adverse Event|0|||
143098624|NCT00454246|515901995|FG000|Overall Study|Violation of selection criteria at entry|6|||
143098625|NCT00454246|515901996|FG001|Overall Study|Violation of selection criteria at entry|0|||
143098626|NCT00454246|515901997|FG002|Overall Study|Violation of selection criteria at entry|0|||
143098627|NCT00454246|515901995|FG000|Overall Study|Protocol Violation|1|||
143098628|NCT00454246|515901996|FG001|Overall Study|Protocol Violation|0|||
143098629|NCT00454246|515901997|FG002|Overall Study|Protocol Violation|0|||
143098630|NCT00454246|515901995|FG000|Overall Study|Refused Treatment|1|||
143098631|NCT00454246|515901996|FG001|Overall Study|Refused Treatment|1|||
143098632|NCT00454246|515901997|FG002|Overall Study|Refused Treatment|0|||
143098633|NCT00454246|515901995|FG000|Overall Study|Failure to return|1|||
143098634|NCT00454246|515901996|FG001|Overall Study|Failure to return|0|||
143098635|NCT00454246|515901997|FG002|Overall Study|Failure to return|0|||
143098636|NCT00454246|515901995|FG000|Overall Study|Early termination of study|62|||
143098637|NCT00454246|515901996|FG001|Overall Study|Early termination of study|26|||
143098638|NCT00454246|515901997|FG002|Overall Study|Early termination of study|9|||
143098639|NCT02283268|515901998|FG000|Overall Study|Withdrawal by Subject|1|||
143098640|NCT00833105|515901999|FG000|Overall Study|Withdrawal by Subject|1|||
143098641|NCT00833105|515901999|FG000|Overall Study|Adverse Event|2|||
143098642|NCT03656068|515902000|FG000|Overall Study|Withdrawal by Subject|4|||
143098643|NCT03656068|515902000|FG000|Overall Study|Adverse Event|1|||
143098644|NCT05326529|515902001|FG000|Overall Study|Lack of Efficacy|0|||
143177022|NCT01991483|516196266|FG001|Dose Level 600 mg|Physician Decision|0|||
143177023|NCT01991483|516196267|FG002|Dose Level 600 mg|Physician Decision|1|||
143177024|NCT01991483|516196268|FG003|Dose Level 600 mg|Physician Decision|0|||
143177025|NCT01991483|516196265|FG000|Dose Level 1000 mg|Protocol Violation|0|||
143177026|NCT01991483|516196266|FG001|Dose Level 1000 mg|Protocol Violation|0|||
143177027|NCT01991483|516196267|FG002|Dose Level 1000 mg|Protocol Violation|0|||
143177028|NCT01991483|516196268|FG003|Dose Level 1000 mg|Protocol Violation|1|||
143177029|NCT02030821|516196271|FG000|Overall Study|Physician Decision|2|||
143177030|NCT02030821|516196272|FG001|Overall Study|Physician Decision|2|||
143177031|NCT02030821|516196273|FG002|Overall Study|Physician Decision|5|||
143177032|NCT02030821|516196274|FG003|Overall Study|Physician Decision|2|||
143177033|NCT00716274|516196276|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
143251866|NCT03180619|516476361|FG000|Overall Study|Withdrew Consent|5|||
143098645|NCT05326529|515902002|FG001|Overall Study|Lack of Efficacy|1|||
143098646|NCT05326529|515902003|FG002|Overall Study|Lack of Efficacy|0|||
143098647|NCT05326529|515902001|FG000|Overall Study|Physician Decision|0|||
143098648|NCT05326529|515902002|FG001|Overall Study|Physician Decision|0|||
143098649|NCT05326529|515902003|FG002|Overall Study|Physician Decision|2|||
143098650|NCT02395848|515902004|FG000|Overall Study|Lost to Follow-up|2|||
143251867|NCT03180619|516476362|FG001|Overall Study|Withdrew Consent|0|||
143098651|NCT01754129|515902005|FG000|Overall Study|Death|13|||
143098652|NCT01754129|515902005|FG000|Overall Study|Duodopa discontinuation|9|||
143098653|NCT01754129|515902005|FG000|Overall Study|Lost to Follow-up|7|||
143098654|NCT01754129|515902005|FG000|Overall Study|Withdrew consent|1|||
143098655|NCT01754129|515902005|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
143177034|NCT00716274|516196277|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
143098656|NCT02126579|515902006|FG000|Overall Study|disease progression|0|||
143251868|NCT03180619|516476363|FG002|Overall Study|Withdrew Consent|2|||
143251869|NCT03180619|516476361|FG000|Overall Study|Death|2|||
143098657|NCT02126579|515902007|FG001|Overall Study|disease progression|0|||
143098658|NCT02126579|515902008|FG002|Overall Study|disease progression|0|||
143098659|NCT02126579|515902009|FG003|Overall Study|disease progression|1|||
143098660|NCT02126579|515902010|FG004|Overall Study|disease progression|0|||
143098661|NCT02126579|515902011|FG005|Overall Study|disease progression|0|||
143098662|NCT02126579|515902012|FG006|Overall Study|disease progression|1|||
143098663|NCT01780038|515902014|FG000|Overall Study|Lost to Follow-up|4|||
143098664|NCT01780038|515902015|FG001|Overall Study|Lost to Follow-up|1|||
143098665|NCT01085630|515902016|FG000|Overall Study|Insufficient data|1|||
143098666|NCT01085630|515902017|FG001|Overall Study|Insufficient data|0|||
143098667|NCT01085630|515902016|FG000|Overall Study|Ineligible|3|||
143098668|NCT01085630|515902017|FG001|Overall Study|Ineligible|0|||
143098669|NCT02366637|515902023|FG000|First Intervention Period|Adverse Event|0|||
143098670|NCT02366637|515902024|FG001|First Intervention Period|Adverse Event|1|||
143098671|NCT02366637|515902023|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
143098672|NCT02366637|515902024|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
143098673|NCT02366637|515902023|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
143098674|NCT02366637|515902024|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
143098675|NCT03168711|515902027|FG000|Overall Study|Adverse Event|2|||
143098676|NCT03168711|515902028|FG001|Overall Study|Adverse Event|0|||
143098677|NCT03168711|515902027|FG000|Overall Study|Withdrawal by Subject|0|||
143098678|NCT03168711|515902028|FG001|Overall Study|Withdrawal by Subject|1|||
143098679|NCT03168711|515902027|FG000|Overall Study|Death|0|||
143098680|NCT03168711|515902028|FG001|Overall Study|Death|1|||
143098681|NCT01609010|515902029|FG000|Overall Study|Stable disease (SD)|22|||
143098682|NCT01609010|515902030|FG001|Overall Study|Stable disease (SD)|16|||
143098683|NCT01609010|515902029|FG000|Overall Study|Progressive disease (PD)|8|||
143098684|NCT01609010|515902030|FG001|Overall Study|Progressive disease (PD)|10|||
143098685|NCT01609010|515902029|FG000|Overall Study|Adverse Event|3|||
143098686|NCT01609010|515902030|FG001|Overall Study|Adverse Event|6|||
143098687|NCT01609010|515902029|FG000|Overall Study|Withdrawal by Subject|2|||
143098688|NCT01609010|515902030|FG001|Overall Study|Withdrawal by Subject|2|||
143098689|NCT01609010|515902029|FG000|Overall Study|Other|2|||
143098690|NCT01609010|515902030|FG001|Overall Study|Other|0|||
143098691|NCT01609010|515902029|FG000|Overall Study|Other malignancy|1|||
143098692|NCT01609010|515902030|FG001|Overall Study|Other malignancy|0|||
143098693|NCT01609010|515902029|FG000|Overall Study|Pathology review|2|||
143098694|NCT01609010|515902030|FG001|Overall Study|Pathology review|1|||
143177035|NCT00716274|516196278|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
143177036|NCT00716274|516196279|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
143177037|NCT00716274|516196280|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
143177038|NCT00716274|516196281|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
143177039|NCT00716274|516196276|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
143177040|NCT00716274|516196277|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
143177041|NCT00716274|516196278|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
143177042|NCT00716274|516196279|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
143251870|NCT03180619|516476362|FG001|Overall Study|Death|1|||
143251871|NCT03180619|516476363|FG002|Overall Study|Death|2|||
143251872|NCT03180619|516476361|FG000|Overall Study|Adverse Event|2|||
143251873|NCT03180619|516476362|FG001|Overall Study|Adverse Event|0|||
143251874|NCT03180619|516476363|FG002|Overall Study|Adverse Event|1|||
143251875|NCT03180619|516476361|FG000|Overall Study|Investigator's discretion|2|||
143251876|NCT03180619|516476362|FG001|Overall Study|Investigator's discretion|0|||
143251877|NCT03180619|516476363|FG002|Overall Study|Investigator's discretion|1|||
143251878|NCT03531632|516476364|FG000|Overall Study|Adverse Event|0|||
143251879|NCT03531632|516476365|FG001|Overall Study|Adverse Event|0|||
143251880|NCT03531632|516476366|FG002|Overall Study|Adverse Event|1|||
143251881|NCT03531632|516476364|FG000|Overall Study|Death|4|||
143251882|NCT03531632|516476365|FG001|Overall Study|Death|0|||
143098695|NCT01609010|515902029|FG000|Overall Study|Protocol Violation|1|||
143098696|NCT01609010|515902030|FG001|Overall Study|Protocol Violation|1|||
143098697|NCT01609010|515902029|FG000|Overall Study|New cancer|1|||
143098698|NCT01609010|515902030|FG001|Overall Study|New cancer|0|||
143098699|NCT01609010|515902029|FG000|Overall Study|Lost to Follow-up|1|||
143098700|NCT01609010|515902030|FG001|Overall Study|Lost to Follow-up|1|||
143098701|NCT03581123|515902033|FG000|2-month Follow-up|Withdrawal by Subject|5|||
143098702|NCT03581123|515902034|FG001|2-month Follow-up|Withdrawal by Subject|4|||
143098703|NCT03581123|515902035|FG002|2-month Follow-up|Withdrawal by Subject|6|||
143251883|NCT03531632|516476366|FG002|Overall Study|Death|14|||
143251884|NCT03531632|516476364|FG000|Overall Study|Study Terminated|1|||
143177043|NCT00716274|516196280|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
143251885|NCT03531632|516476365|FG001|Overall Study|Study Terminated|3|||
143098704|NCT03581123|515902036|FG003|2-month Follow-up|Withdrawal by Subject|4|||
143098705|NCT03581123|515902033|FG000|2-month Follow-up|Lost to Follow-up|8|||
143251886|NCT03531632|516476366|FG002|Overall Study|Study Terminated|11|||
143367738|NCT01729871|516889434|FG001|Overall Study|Protocol Violation|0|||
143098706|NCT03581123|515902034|FG001|2-month Follow-up|Lost to Follow-up|1|||
143098707|NCT03581123|515902035|FG002|2-month Follow-up|Lost to Follow-up|2|||
143098708|NCT03581123|515902036|FG003|2-month Follow-up|Lost to Follow-up|2|||
143098709|NCT03581123|515902033|FG000|6-Month Follow-up|Withdrawal by Subject|2|||
143098710|NCT03581123|515902034|FG001|6-Month Follow-up|Withdrawal by Subject|0|||
143098711|NCT03581123|515902035|FG002|6-Month Follow-up|Withdrawal by Subject|1|||
143098712|NCT03581123|515902036|FG003|6-Month Follow-up|Withdrawal by Subject|2|||
143098713|NCT03581123|515902033|FG000|6-Month Follow-up|Lost to Follow-up|3|||
143098714|NCT03581123|515902034|FG001|6-Month Follow-up|Lost to Follow-up|3|||
143098715|NCT03581123|515902035|FG002|6-Month Follow-up|Lost to Follow-up|1|||
143098716|NCT03581123|515902036|FG003|6-Month Follow-up|Lost to Follow-up|1|||
143098717|NCT03581123|515902033|FG000|12-Month Follow-up|Lost to Follow-up|4|||
143098718|NCT03581123|515902034|FG001|12-Month Follow-up|Lost to Follow-up|3|||
143098719|NCT03581123|515902035|FG002|12-Month Follow-up|Lost to Follow-up|4|||
143098720|NCT03581123|515902036|FG003|12-Month Follow-up|Lost to Follow-up|5|||
143098721|NCT02044302|515902043|FG000|Overall Study|study terminated|2|||
143098722|NCT02044302|515902044|FG001|Overall Study|study terminated|0|||
143098723|NCT03877068|515902045|FG000|Overall Study|Physician Decision|9|||
143098724|NCT03877068|515902046|FG001|Overall Study|Physician Decision|3|||
143098725|NCT01346696|515902047|FG000|Overall Study|Death|1|||
143098726|NCT00630825|515902048|FG000|Overall Study|Adverse Event|4|||
143098727|NCT00630825|515902049|FG001|Overall Study|Adverse Event|4|||
143098728|NCT00630825|515902050|FG002|Overall Study|Adverse Event|3|||
143098729|NCT00630825|515902051|FG003|Overall Study|Adverse Event|1|||
143098730|NCT00630825|515902048|FG000|Overall Study|Entry Criteria Not Met|1|||
143098731|NCT00630825|515902049|FG001|Overall Study|Entry Criteria Not Met|0|||
143098732|NCT00630825|515902050|FG002|Overall Study|Entry Criteria Not Met|2|||
143098733|NCT00630825|515902051|FG003|Overall Study|Entry Criteria Not Met|1|||
143098734|NCT00630825|515902048|FG000|Overall Study|Lost to Follow-up|1|||
143098735|NCT00630825|515902049|FG001|Overall Study|Lost to Follow-up|1|||
143098736|NCT00630825|515902050|FG002|Overall Study|Lost to Follow-up|1|||
143098737|NCT00630825|515902051|FG003|Overall Study|Lost to Follow-up|1|||
143098738|NCT00630825|515902048|FG000|Overall Study|Physician Decision|1|||
143098739|NCT00630825|515902049|FG001|Overall Study|Physician Decision|0|||
143098740|NCT00630825|515902050|FG002|Overall Study|Physician Decision|0|||
143098741|NCT00630825|515902051|FG003|Overall Study|Physician Decision|0|||
143098742|NCT00630825|515902048|FG000|Overall Study|Withdrawal by Subject|2|||
143098743|NCT00630825|515902049|FG001|Overall Study|Withdrawal by Subject|2|||
143098744|NCT00630825|515902050|FG002|Overall Study|Withdrawal by Subject|2|||
143098745|NCT00630825|515902051|FG003|Overall Study|Withdrawal by Subject|3|||
143098746|NCT02042014|515902052|FG000|Overall Study|Adverse Event|1|||
143098747|NCT02042014|515902052|FG000|Overall Study|Physician Decision|7|||
143098748|NCT04610346|515902053|FG000|Overall Study|Withdrawal by Subject|1|||
143098749|NCT04610346|515902054|FG001|Overall Study|Withdrawal by Subject|1|||
143098750|NCT04610346|515902053|FG000|Overall Study|did not complete shelter onboarding|2|||
143098751|NCT04610346|515902054|FG001|Overall Study|did not complete shelter onboarding|1|||
143098752|NCT00558467|515902056|FG000|Overall Study|Adverse Event|1|||
143098753|NCT00558467|515902057|FG001|Overall Study|Adverse Event|2|||
143098754|NCT00558467|515902056|FG000|Overall Study|Lack of Efficacy|0|||
143098755|NCT00558467|515902057|FG001|Overall Study|Lack of Efficacy|1|||
143098756|NCT00558467|515902056|FG000|Overall Study|Patient moving out of state|0|||
143098757|NCT00558467|515902057|FG001|Overall Study|Patient moving out of state|1|||
143098758|NCT00931255|515902060|FG000|Overall Study|Follow up biopsy not done|2|||
143098759|NCT00931255|515902061|FG001|Overall Study|Follow up biopsy not done|3|||
143098760|NCT00427648|515902070|FG000|Overall Study|Protocol Violation|1|||
143098761|NCT00427648|515902071|FG001|Overall Study|Protocol Violation|2|||
143098762|NCT00427648|515902070|FG000|Overall Study|Adverse Event|0|||
143098763|NCT00427648|515902071|FG001|Overall Study|Adverse Event|1|||
143098764|NCT01609296|515902074|FG000|Overall Study|Death|253|||
143177044|NCT00716274|516196281|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
143177045|NCT00716274|516196276|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
143177046|NCT00716274|516196277|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
143177047|NCT00716274|516196278|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
143177048|NCT00716274|516196279|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
143177049|NCT00716274|516196280|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
143177050|NCT00716274|516196281|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
143367739|NCT01729871|516889433|FG000|Overall Study|Withdrawal by Subject|0|||
143098765|NCT01609296|515902074|FG000|Overall Study|Withdrawal by Subject|151|||
143098766|NCT01609296|515902074|FG000|Overall Study|Lost to Follow-up|21|||
143098767|NCT01609296|515902074|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
143098768|NCT01609296|515902074|FG000|Overall Study|missed visit but known to be alive|28|||
143098769|NCT00386360|515902075|FG000|Overall Study|Adverse Event|4|||
143177051|NCT00716274|516196276|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
143098770|NCT00386360|515902076|FG001|Overall Study|Adverse Event|2|||
143177052|NCT00716274|516196277|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
143177053|NCT00716274|516196278|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
143177054|NCT00716274|516196279|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
143177055|NCT00716274|516196280|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
143177056|NCT00716274|516196281|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
143177057|NCT00716274|516196276|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
143177058|NCT00716274|516196277|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
143177059|NCT00716274|516196278|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
143177060|NCT00716274|516196279|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
143177061|NCT00716274|516196280|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
143177062|NCT00716274|516196281|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
143177063|NCT00716274|516196276|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
143177064|NCT00716274|516196277|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
143177065|NCT00716274|516196278|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
143177066|NCT00716274|516196279|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
143177067|NCT00716274|516196280|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
143177068|NCT00716274|516196281|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
143177069|NCT00716274|516196276|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
143177070|NCT00716274|516196277|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
143177071|NCT00716274|516196278|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
143177072|NCT00716274|516196279|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
143177073|NCT00716274|516196280|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
143177074|NCT00716274|516196281|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
143177075|NCT00716274|516196276|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
143177076|NCT00716274|516196277|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
143177077|NCT00716274|516196278|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
143177078|NCT00716274|516196279|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
143177079|NCT00716274|516196280|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
143177080|NCT00716274|516196281|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
143177081|NCT00716274|516196276|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
143177082|NCT00716274|516196277|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
143177083|NCT00716274|516196278|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
143177084|NCT00716274|516196279|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
143177085|NCT00716274|516196280|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
143177086|NCT00716274|516196281|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
143177087|NCT00716274|516196276|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
143177088|NCT00716274|516196277|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
143177089|NCT00716274|516196278|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
143177090|NCT00716274|516196279|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
143177091|NCT00716274|516196280|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
143177092|NCT00716274|516196281|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
143177093|NCT01171677|516196282|FG000|Overall Study|Withdrawal by Subject|0|||
143177094|NCT01171677|516196283|FG001|Overall Study|Withdrawal by Subject|3|||
143177095|NCT01171677|516196282|FG000|Overall Study|Adverse Event|1|||
143177096|NCT01171677|516196283|FG001|Overall Study|Adverse Event|0|||
143177097|NCT01171677|516196282|FG000|Overall Study|completed <70% IntenSati classes|5|||
143177098|NCT01171677|516196283|FG001|Overall Study|completed <70% IntenSati classes|0|||
143177099|NCT01152437|516196293|FG000|Overall Study|Other Adverse Event|8|||
143177100|NCT01152437|516196294|FG001|Overall Study|Other Adverse Event|1|||
143177101|NCT01152437|516196295|FG002|Overall Study|Other Adverse Event|7|||
143177102|NCT01152437|516196293|FG000|Overall Study|Not treated|0|||
143177103|NCT01152437|516196294|FG001|Overall Study|Not treated|1|||
143177104|NCT01152437|516196295|FG002|Overall Study|Not treated|2|||
143177105|NCT01152437|516196293|FG000|Overall Study|Progressive disease|27|||
143177106|NCT01152437|516196294|FG001|Overall Study|Progressive disease|13|||
143177107|NCT01152437|516196295|FG002|Overall Study|Progressive disease|32|||
143177108|NCT01152437|516196293|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
143177109|NCT01152437|516196294|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
143177110|NCT01152437|516196295|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
143177111|NCT02015039|516196296|FG000|Overall Study|Not eligible|0|||
143177112|NCT02015039|516196297|FG001|Overall Study|Not eligible|1|||
143177113|NCT01900665|516196299|FG000|Placebo Controlled Period|Death|9|||
143177114|NCT01900665|516196300|FG001|Placebo Controlled Period|Death|16|||
143177115|NCT01900665|516196299|FG000|Placebo Controlled Period|Adverse Event|48|||
143177116|NCT01900665|516196300|FG001|Placebo Controlled Period|Adverse Event|39|||
143177117|NCT01900665|516196299|FG000|Placebo Controlled Period|Protocol Violation|1|||
143177118|NCT01900665|516196300|FG001|Placebo Controlled Period|Protocol Violation|7|||
143177119|NCT01900665|516196299|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
143177120|NCT01900665|516196300|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
143177121|NCT01900665|516196299|FG000|Placebo Controlled Period|Physician Decision|11|||
143177122|NCT01900665|516196300|FG001|Placebo Controlled Period|Physician Decision|7|||
143098771|NCT00386360|515902075|FG000|Overall Study|Physician Decision|2|||
143098772|NCT00386360|515902076|FG001|Overall Study|Physician Decision|2|||
143098773|NCT00386360|515902075|FG000|Overall Study|Lost to Follow-up|0|||
143098774|NCT00386360|515902076|FG001|Overall Study|Lost to Follow-up|2|||
143098775|NCT00386360|515902075|FG000|Overall Study|Protocol Violation|0|||
143098776|NCT00386360|515902076|FG001|Overall Study|Protocol Violation|3|||
143098777|NCT00386360|515902075|FG000|Overall Study|Withdrawal by Subject|3|||
143098778|NCT00386360|515902076|FG001|Overall Study|Withdrawal by Subject|6|||
143098779|NCT00386360|515902075|FG000|Overall Study|Did not take any study medication|0|||
143098780|NCT00386360|515902076|FG001|Overall Study|Did not take any study medication|2|||
143098781|NCT01684423|515902079|FG000|Overall Study|Withdrawal by Subject|0|||
143098782|NCT01684423|515902080|FG001|Overall Study|Withdrawal by Subject|0|||
143098783|NCT01684423|515902081|FG002|Overall Study|Withdrawal by Subject|1|||
143098784|NCT01684423|515902082|FG003|Overall Study|Withdrawal by Subject|0|||
143098785|NCT01684423|515902083|FG004|Overall Study|Withdrawal by Subject|0|||
143098786|NCT02155283|515902084|FG000|Overall Study|Lost to Follow-up|3|||
143098787|NCT02155283|515902084|FG000|Overall Study|Withdrawal by Subject|1|||
143098788|NCT02155283|515902084|FG000|Overall Study|Protocol Violation|3|||
143098789|NCT04157348|515902091|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
143098790|NCT04157348|515902092|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
143098791|NCT04157348|515902091|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
143098792|NCT04157348|515902092|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
143098793|NCT04157348|515902091|FG000|Double-blind Treatment Period|Adverse Event|0|||
143098794|NCT04157348|515902092|FG001|Double-blind Treatment Period|Adverse Event|1|||
143098795|NCT04157348|515902091|FG000|Open-label Extension Period|Adverse Event|1|||
143098796|NCT04157348|515902092|FG001|Open-label Extension Period|Adverse Event|1|||
143098797|NCT04157348|515902091|FG000|Open-label Extension Period|Death|0|||
143098798|NCT04157348|515902092|FG001|Open-label Extension Period|Death|1|||
143098799|NCT04157348|515902091|FG000|Open-label Extension Period|Lack of Efficacy|2|||
143098800|NCT04157348|515902092|FG001|Open-label Extension Period|Lack of Efficacy|2|||
143098801|NCT04157348|515902091|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
143098802|NCT04157348|515902092|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
143098803|NCT04157348|515902091|FG000|Open-label Extension Period|Ongoing|60|||
143098804|NCT04157348|515902092|FG001|Open-label Extension Period|Ongoing|57|||
143098805|NCT04157348|515902091|FG000|Open-label Extension Period|other reasons|1|||
143098806|NCT04157348|515902092|FG001|Open-label Extension Period|other reasons|1|||
143098807|NCT05000164|515902093|FG000|Overall Study|Adverse Event|1|||
143098808|NCT05000164|515902093|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
143098809|NCT05000164|515902093|FG000|Overall Study|Lens Discomfort|3|||
143098810|NCT05000164|515902093|FG000|Overall Study|Withdrew Consent during Study|2|||
143098811|NCT05000164|515902093|FG000|Overall Study|Subject Withdrawn by PI|2|||
143098812|NCT05000164|515902093|FG000|Overall Study|Other Fractured Test Article|1|||
143098813|NCT02861807|515902094|FG000|Overall Study|Lost to Follow-up|7|||
143098814|NCT02861807|515902095|FG001|Overall Study|Lost to Follow-up|6|||
143098815|NCT02861807|515902094|FG000|Overall Study|Withdrawal by Subject|5|||
143098816|NCT02861807|515902095|FG001|Overall Study|Withdrawal by Subject|8|||
143098817|NCT01006122|515902096|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
143098818|NCT01006122|515902097|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
143098819|NCT01006122|515902096|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
143098820|NCT01006122|515902097|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
143098821|NCT01006122|515902096|FG000|First Double-blind Intervention Period|Pregnancy|0|||
143098822|NCT01006122|515902097|FG001|First Double-blind Intervention Period|Pregnancy|1|||
143098823|NCT01006122|515902096|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
143098824|NCT01006122|515902097|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
143098825|NCT01006122|515902096|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
143098826|NCT01006122|515902097|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
143177123|NCT01900665|516196299|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
143098827|NCT01006122|515902096|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
143098828|NCT01006122|515902097|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
143098829|NCT01006122|515902096|FG000|First Double-blind Intervention Period|Other|3|||
143098830|NCT01006122|515902097|FG001|First Double-blind Intervention Period|Other|0|||
143098831|NCT01006122|515902096|FG000|First Double-blind Intervention Period|Adverse Event|0|||
143098832|NCT01006122|515902097|FG001|First Double-blind Intervention Period|Adverse Event|4|||
143098833|NCT01006122|515902096|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
143098834|NCT01006122|515902097|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
143098835|NCT01006122|515902096|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
143098836|NCT01006122|515902097|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
143098837|NCT01006122|515902096|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
143098838|NCT01006122|515902097|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
143098839|NCT01006122|515902096|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
143098840|NCT01006122|515902097|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
143098841|NCT01006122|515902096|FG000|Second Double-blind Intervention Period|Death|0|||
143098842|NCT01006122|515902097|FG001|Second Double-blind Intervention Period|Death|1|||
143098843|NCT02712554|515902102|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
143098844|NCT02712554|515902103|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
143098845|NCT02712554|515902102|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
143098846|NCT02712554|515902103|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
143098847|NCT02712554|515902102|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
143098848|NCT02712554|515902103|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
143098849|NCT02712554|515902102|FG000|Part B: Qualification Phase|Adverse Event|0|||
143098850|NCT02712554|515902103|FG001|Part B: Qualification Phase|Adverse Event|1|||
143098851|NCT02712554|515902102|FG000|Part B: Treatment Phase|Adverse Event|0|||
143098852|NCT02712554|515902103|FG001|Part B: Treatment Phase|Adverse Event|1|||
143098853|NCT02712554|515902102|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
143098854|NCT02712554|515902103|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
143098855|NCT02712554|515902102|FG000|Part B: Treatment Phase|Other|0|||
143098856|NCT02712554|515902103|FG001|Part B: Treatment Phase|Other|1|||
143098857|NCT03859427|515902104|FG000|Overall Study|Withdrawal by Subject|4|||
143098858|NCT03859427|515902105|FG001|Overall Study|Withdrawal by Subject|7|||
143098859|NCT03859427|515902104|FG000|Overall Study|Decision by sponsor|0|||
143098860|NCT03859427|515902105|FG001|Overall Study|Decision by sponsor|3|||
143098861|NCT03859427|515902104|FG000|Overall Study|Lost to Follow-up|3|||
143098862|NCT03859427|515902105|FG001|Overall Study|Lost to Follow-up|2|||
143098863|NCT03859427|515902104|FG000|Overall Study|Death|22|||
143098864|NCT03859427|515902105|FG001|Overall Study|Death|25|||
143098865|NCT01662492|515902106|FG000|Overall Study|Other miscellaneous reasons.|1|||
143098866|NCT01662492|515902107|FG001|Overall Study|Other miscellaneous reasons.|0|||
143098867|NCT01662492|515902108|FG002|Overall Study|Other miscellaneous reasons.|1|||
143098868|NCT01662492|515902106|FG000|Overall Study|Withdrawal by Subject|0|||
143098869|NCT01662492|515902107|FG001|Overall Study|Withdrawal by Subject|0|||
143098870|NCT01662492|515902108|FG002|Overall Study|Withdrawal by Subject|1|||
143098871|NCT01662492|515902106|FG000|Overall Study|Protocol Violation|1|||
143098872|NCT01662492|515902107|FG001|Overall Study|Protocol Violation|0|||
143098873|NCT01662492|515902108|FG002|Overall Study|Protocol Violation|0|||
143098874|NCT01662492|515902106|FG000|Overall Study|Lost to Follow-up|0|||
143177124|NCT01900665|516196300|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
143177125|NCT01900665|516196299|FG000|Placebo Controlled Period|Caregiver Decision|33|||
143177126|NCT01900665|516196300|FG001|Placebo Controlled Period|Caregiver Decision|41|||
143177127|NCT01900665|516196299|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
143098875|NCT01662492|515902107|FG001|Overall Study|Lost to Follow-up|0|||
143098876|NCT01662492|515902108|FG002|Overall Study|Lost to Follow-up|2|||
143098877|NCT01662492|515902106|FG000|Overall Study|Lack of Efficacy|1|||
143098878|NCT01662492|515902107|FG001|Overall Study|Lack of Efficacy|1|||
143098879|NCT01662492|515902108|FG002|Overall Study|Lack of Efficacy|2|||
143098880|NCT00979654|515902109|FG000|Overall Study|Lost to Follow-up|1|||
143098881|NCT00979654|515902109|FG000|Overall Study|Withdrawal by Subject|22|||
143177128|NCT01900665|516196300|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
143098882|NCT00979654|515902109|FG000|Overall Study|Death|1|||
143098883|NCT00979654|515902109|FG000|Overall Study|Lack of Efficacy|6|||
143098884|NCT00979654|515902109|FG000|Overall Study|Adverse Event|1|||
143098885|NCT00979654|515902109|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
143098886|NCT00979654|515902109|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
143098887|NCT00979654|515902109|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
143098888|NCT00979654|515902109|FG000|Overall Study|Serious Adverse Event|1|||
143098889|NCT00979654|515902109|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
143098890|NCT01129557|515902112|FG000|Overall Study|Adverse Event|1|||
143098891|NCT01129557|515902113|FG001|Overall Study|Adverse Event|2|||
143098892|NCT01129557|515902114|FG002|Overall Study|Adverse Event|2|||
143098893|NCT01129557|515902112|FG000|Overall Study|Novartis terminated study early|3|||
143098894|NCT01129557|515902113|FG001|Overall Study|Novartis terminated study early|3|||
143098895|NCT01129557|515902114|FG002|Overall Study|Novartis terminated study early|2|||
143098896|NCT05483686|515903662|FG000|Overall Study|Lost to Follow-up|5|||
143098897|NCT05483686|515903663|FG001|Overall Study|Lost to Follow-up|7|||
143098898|NCT05780983|515903669|FG000|Overall Study|Withdrawal by Subject|1|||
143098899|NCT04541589|515903673|FG000|Treatment Period|Adverse Event|8|||
143098900|NCT04541589|515903674|FG001|Treatment Period|Adverse Event|2|||
143098901|NCT04541589|515903673|FG000|Treatment Period|Physician Decision|3|||
143098902|NCT04541589|515903674|FG001|Treatment Period|Physician Decision|1|||
143098903|NCT04541589|515903673|FG000|Treatment Period|Subject decision|7|||
143098904|NCT04541589|515903674|FG001|Treatment Period|Subject decision|4|||
143098905|NCT04541589|515903673|FG000|Treatment Period|Withdrawal by Subject|1|||
143098906|NCT04541589|515903674|FG001|Treatment Period|Withdrawal by Subject|0|||
143098907|NCT04541589|515903673|FG000|Safety Follow-up Period|Adverse Event|2|||
143098908|NCT04541589|515903674|FG001|Safety Follow-up Period|Adverse Event|1|||
143098909|NCT04541589|515903673|FG000|Safety Follow-up Period|Physician Decision|1|||
143098910|NCT04541589|515903674|FG001|Safety Follow-up Period|Physician Decision|0|||
143098911|NCT04541589|515903673|FG000|Safety Follow-up Period|Subject decision|5|||
143098912|NCT04541589|515903674|FG001|Safety Follow-up Period|Subject decision|3|||
143098913|NCT04541589|515903673|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
143098914|NCT04541589|515903674|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
143098915|NCT02770170|515903678|FG000|Overall Study|Withdrawal by Subject|0|||
143098916|NCT02770170|515903679|FG001|Overall Study|Withdrawal by Subject|0|||
143098917|NCT02770170|515903680|FG002|Overall Study|Withdrawal by Subject|0|||
143098918|NCT02770170|515903681|FG003|Overall Study|Withdrawal by Subject|2|||
143098919|NCT02770170|515903678|FG000|Overall Study|due to pregnancy|1|||
143098920|NCT02770170|515903679|FG001|Overall Study|due to pregnancy|0|||
143098921|NCT02770170|515903680|FG002|Overall Study|due to pregnancy|0|||
143098922|NCT02770170|515903681|FG003|Overall Study|due to pregnancy|0|||
143098923|NCT02770170|515903678|FG000|Overall Study|Lack of Efficacy|2|||
143098924|NCT02770170|515903679|FG001|Overall Study|Lack of Efficacy|0|||
143098925|NCT02770170|515903680|FG002|Overall Study|Lack of Efficacy|0|||
143098926|NCT02770170|515903681|FG003|Overall Study|Lack of Efficacy|1|||
143098927|NCT02770170|515903678|FG000|Overall Study|Adverse Event|4|||
143098928|NCT02770170|515903679|FG001|Overall Study|Adverse Event|3|||
143098929|NCT02770170|515903680|FG002|Overall Study|Adverse Event|5|||
143098930|NCT02770170|515903681|FG003|Overall Study|Adverse Event|3|||
143098931|NCT02770170|515903678|FG000|Overall Study|due to disease worsening|0|||
143098932|NCT02770170|515903679|FG001|Overall Study|due to disease worsening|0|||
143098933|NCT02770170|515903680|FG002|Overall Study|due to disease worsening|0|||
143098934|NCT02770170|515903681|FG003|Overall Study|due to disease worsening|1|||
143098935|NCT06028438|515903682|FG000|Overall Study|Adverse Event|3|||
143098936|NCT06028438|515903683|FG001|Overall Study|Adverse Event|9|||
143098937|NCT06028438|515903682|FG000|Overall Study|Lack of Efficacy|1|||
143098938|NCT06028438|515903683|FG001|Overall Study|Lack of Efficacy|1|||
143098939|NCT06028438|515903682|FG000|Overall Study|Lost to Follow-up|1|||
143098940|NCT06028438|515903683|FG001|Overall Study|Lost to Follow-up|0|||
143098941|NCT06028438|515903682|FG000|Overall Study|Withdrawal by Subject|1|||
143098942|NCT06028438|515903683|FG001|Overall Study|Withdrawal by Subject|0|||
143098943|NCT06028438|515903682|FG000|Overall Study|Other|3|||
143098944|NCT06028438|515903683|FG001|Overall Study|Other|3|||
143098945|NCT05625802|515903684|FG000|Overall Study|Lost to Follow-up|1|||
143098946|NCT05625802|515903685|FG001|Overall Study|Lost to Follow-up|0|||
143098947|NCT04195685|515903686|FG000|Overall Study|Withdrawal by Subject|6|||
143098948|NCT04195685|515903687|FG001|Overall Study|Withdrawal by Subject|2|||
143098949|NCT04195685|515903686|FG000|Overall Study|Lost to Follow-up|1|||
143098950|NCT04195685|515903687|FG001|Overall Study|Lost to Follow-up|4|||
143098951|NCT00162981|515903688|FG000|Overall Study|Adverse Event|2|||
143098952|NCT00162981|515903689|FG001|Overall Study|Adverse Event|5|||
143098953|NCT00162981|515903688|FG000|Overall Study|Withdrawal by Subject|1|||
143098954|NCT00162981|515903689|FG001|Overall Study|Withdrawal by Subject|1|||
143098955|NCT00162981|515903688|FG000|Overall Study|Physician Decision|1|||
143098956|NCT00162981|515903689|FG001|Overall Study|Physician Decision|0|||
143098957|NCT02877004|515903690|FG000|Overall Study|Pregnancy|0|||
143177129|NCT01900665|516196299|FG000|Open Label Period|Adverse Event|16|||
143177130|NCT01900665|516196300|FG001|Open Label Period|Adverse Event|20|||
143177131|NCT01900665|516196299|FG000|Open Label Period|Death|5|||
143177132|NCT01900665|516196300|FG001|Open Label Period|Death|6|||
143177133|NCT01900665|516196299|FG000|Open Label Period|Lost to Follow-up|1|||
143177134|NCT01900665|516196300|FG001|Open Label Period|Lost to Follow-up|1|||
143177135|NCT01900665|516196299|FG000|Open Label Period|Parent/Caregiver Decision|33|||
143177136|NCT01900665|516196300|FG001|Open Label Period|Parent/Caregiver Decision|34|||
143177137|NCT01900665|516196299|FG000|Open Label Period|Physician Decision|4|||
143177138|NCT01900665|516196300|FG001|Open Label Period|Physician Decision|4|||
143177139|NCT01900665|516196299|FG000|Open Label Period|Protocol Violation|0|||
143177140|NCT01900665|516196300|FG001|Open Label Period|Protocol Violation|1|||
143177141|NCT01900665|516196299|FG000|Open Label Period|Sponsor Decision|802|||
143177142|NCT01900665|516196300|FG001|Open Label Period|Sponsor Decision|765|||
143177143|NCT01900665|516196299|FG000|Open Label Period|Withdrawal by Subject|20|||
143177144|NCT01900665|516196300|FG001|Open Label Period|Withdrawal by Subject|28|||
143177145|NCT01074931|516196302|FG000|Overall Study|Economic reasons|1|||
143177146|NCT01074931|516196302|FG000|Overall Study|Death|5|||
143177147|NCT00953706|516196305|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
143177148|NCT00953706|516196306|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
143177149|NCT00953706|516196307|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
143177150|NCT00953706|516196308|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
143177151|NCT00953706|516196305|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
143177152|NCT00953706|516196306|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
143177153|NCT00953706|516196307|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
143177154|NCT00953706|516196308|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
143177155|NCT00953706|516196305|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
143177156|NCT00953706|516196306|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
143177157|NCT00953706|516196307|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
143177158|NCT00953706|516196308|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
143177159|NCT00953706|516196305|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
143177160|NCT00953706|516196306|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
143177161|NCT00953706|516196307|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
143177162|NCT00953706|516196308|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
143177163|NCT00953706|516196305|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
143177164|NCT00953706|516196306|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
143177165|NCT00953706|516196307|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
143177166|NCT00953706|516196308|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
143177167|NCT00953706|516196305|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
143177168|NCT00953706|516196306|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
143177169|NCT00953706|516196307|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
143177170|NCT00953706|516196308|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
143177171|NCT00953706|516196305|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
143177172|NCT00953706|516196306|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
143098958|NCT02877004|515903691|FG001|Overall Study|Pregnancy|0|||
143098959|NCT02877004|515903692|FG002|Overall Study|Pregnancy|1|||
143098960|NCT02356588|515903694|FG000|Overall Study|Lack of Efficacy|4|||
143098961|NCT02356588|515903695|FG001|Overall Study|Lack of Efficacy|10|||
143098962|NCT02356588|515903694|FG000|Overall Study|Adverse Event|0|||
143098963|NCT02356588|515903695|FG001|Overall Study|Adverse Event|2|||
143098964|NCT02356588|515903694|FG000|Overall Study|Withdrawal by Subject|1|||
143098965|NCT02356588|515903695|FG001|Overall Study|Withdrawal by Subject|0|||
143098966|NCT02356588|515903694|FG000|Overall Study|Protocol Violation|0|||
143098967|NCT02356588|515903695|FG001|Overall Study|Protocol Violation|1|||
143098968|NCT01418378|515903696|FG000|Overall Study|Death|1|||
143098969|NCT01418378|515903697|FG001|Overall Study|Death|2|||
143098970|NCT01418378|515903696|FG000|Overall Study|Physician Decision|0|||
143098971|NCT01418378|515903697|FG001|Overall Study|Physician Decision|1|||
143098972|NCT01418378|515903696|FG000|Overall Study|ligament imbalance|0|||
143098973|NCT01418378|515903697|FG001|Overall Study|ligament imbalance|1|||
143098974|NCT01418378|515903696|FG000|Overall Study|developed chronic myopathy|0|||
143098975|NCT01418378|515903697|FG001|Overall Study|developed chronic myopathy|1|||
143098976|NCT03150719|515903700|FG000|Overall Study|Adverse Event|0|||
143098977|NCT03150719|515903701|FG001|Overall Study|Adverse Event|1|||
143098978|NCT03150719|515903700|FG000|Overall Study|Death|0|||
143098979|NCT03150719|515903701|FG001|Overall Study|Death|1|||
143098980|NCT03150719|515903700|FG000|Overall Study|Other|1|||
143098981|NCT03150719|515903701|FG001|Overall Study|Other|0|||
143098982|NCT01790984|515903702|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
143098983|NCT01790984|515903703|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
143098984|NCT01790984|515903704|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
143098985|NCT01790984|515903705|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
143098986|NCT01051791|515903709|FG000|Overall Study|Failed screening|3|||
143098987|NCT01051791|515903709|FG000|Overall Study|Withdrawal by Subject|1|||
143098988|NCT01372618|515903714|FG000|Overall Study|PI Died. Study Terminated|9|||
143098989|NCT04548193|515903717|FG000|Overall Study|Lost to Follow-up|0|||
143098990|NCT04548193|515903718|FG001|Overall Study|Lost to Follow-up|1|||
143098991|NCT04548193|515903717|FG000|Overall Study|Death|0|||
143098992|NCT04548193|515903718|FG001|Overall Study|Death|1|||
143098993|NCT04548193|515903717|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
143098994|NCT04548193|515903718|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
143098995|NCT04548193|515903717|FG000|Overall Study|Withdrawal by Subject|2|||
143098996|NCT04548193|515903718|FG001|Overall Study|Withdrawal by Subject|2|||
143098997|NCT01372995|515903719|FG000|Overall Study|Spouse withdrew participant from study|0|||
143098998|NCT01372995|515903720|FG001|Overall Study|Spouse withdrew participant from study|1|||
143098999|NCT01372995|515903721|FG002|Overall Study|Spouse withdrew participant from study|0|||
143099000|NCT01372995|515903719|FG000|Overall Study|Physician Decision|0|||
143099001|NCT01372995|515903720|FG001|Overall Study|Physician Decision|0|||
143099002|NCT01372995|515903721|FG002|Overall Study|Physician Decision|1|||
143099003|NCT02019264|515903722|FG000|Overall Study|Not treated|6|||
143099004|NCT02019264|515903723|FG001|Overall Study|Not treated|4|||
143099005|NCT02019264|515903722|FG000|Overall Study|Lost to Follow-up|50|||
143099006|NCT02019264|515903723|FG001|Overall Study|Lost to Follow-up|47|||
143099007|NCT02019264|515903722|FG000|Overall Study|Withdrawal by Subject|142|||
143099008|NCT02019264|515903723|FG001|Overall Study|Withdrawal by Subject|117|||
143099009|NCT02019264|515903722|FG000|Overall Study|Administrative reason|36|||
143099010|NCT02019264|515903723|FG001|Overall Study|Administrative reason|28|||
143099011|NCT02019264|515903722|FG000|Overall Study|Missing|14|||
143099012|NCT02019264|515903723|FG001|Overall Study|Missing|11|||
143099013|NCT03123393|515903729|FG000|Overall Study|Study Terminated by Sponsor|6|||
143099014|NCT03123393|515903730|FG001|Overall Study|Study Terminated by Sponsor|9|||
143099015|NCT03123393|515903729|FG000|Overall Study|Withdrawal by Subject|2|||
143099016|NCT03123393|515903730|FG001|Overall Study|Withdrawal by Subject|1|||
143099017|NCT03123393|515903729|FG000|Overall Study|Reason not Specified|13|||
143099018|NCT03123393|515903730|FG001|Overall Study|Reason not Specified|13|||
143099019|NCT00558701|515903732|FG000|Overall Study|Protocol Deviations|1|||
143099020|NCT00558701|515903733|FG001|Overall Study|Protocol Deviations|4|||
143099021|NCT01297517|515903734|FG000|Overall Study|Adverse Event|21|||
143099022|NCT01297517|515903735|FG001|Overall Study|Adverse Event|7|||
143099023|NCT01297517|515903736|FG002|Overall Study|Adverse Event|16|||
143099024|NCT01297517|515903734|FG000|Overall Study|Lost to Follow-up|1|||
143177173|NCT00953706|516196307|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
143177174|NCT00953706|516196308|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
143177175|NCT00953706|516196305|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
143099025|NCT01297517|515903735|FG001|Overall Study|Lost to Follow-up|0|||
143177176|NCT00953706|516196306|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
143177177|NCT00953706|516196307|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
143177178|NCT00953706|516196308|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
143099026|NCT01297517|515903736|FG002|Overall Study|Lost to Follow-up|1|||
143099027|NCT01297517|515903734|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
143099028|NCT01297517|515903735|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
143099029|NCT01297517|515903736|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
143251887|NCT02743611|516476367|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
143099030|NCT01297517|515903734|FG000|Overall Study|Noncompliance|1|||
143099031|NCT01297517|515903735|FG001|Overall Study|Noncompliance|0|||
143099032|NCT01297517|515903736|FG002|Overall Study|Noncompliance|0|||
143099033|NCT01297517|515903734|FG000|Overall Study|Protocol Violation|1|||
143099034|NCT01297517|515903735|FG001|Overall Study|Protocol Violation|1|||
143099035|NCT01297517|515903736|FG002|Overall Study|Protocol Violation|1|||
143099036|NCT01297517|515903734|FG000|Overall Study|Inadequate Control of IOP|1|||
143099037|NCT01297517|515903735|FG001|Overall Study|Inadequate Control of IOP|1|||
143099038|NCT01297517|515903736|FG002|Overall Study|Inadequate Control of IOP|2|||
143099039|NCT00628212|515903737|FG000|Overall Study|Adverse Event|2|||
143099040|NCT00628212|515903738|FG001|Overall Study|Adverse Event|0|||
143099041|NCT00628212|515903739|FG002|Overall Study|Adverse Event|1|||
143099042|NCT00628212|515903740|FG003|Overall Study|Adverse Event|2|||
143099043|NCT00628212|515903737|FG000|Overall Study|Physician Decision|1|||
143099044|NCT00628212|515903738|FG001|Overall Study|Physician Decision|1|||
143099045|NCT00628212|515903739|FG002|Overall Study|Physician Decision|2|||
143099046|NCT00628212|515903740|FG003|Overall Study|Physician Decision|3|||
143099047|NCT00546377|515903741|FG000|Overall Study|Deemed ineligible|1|||
143099048|NCT00546377|515903741|FG000|Overall Study|Adverse Event|6|||
143099049|NCT00529308|515903747|FG000|Overall Study|Withdrawal by Subject|1|||
143099050|NCT00529308|515903748|FG001|Overall Study|Withdrawal by Subject|1|||
143099051|NCT00812981|515903749|FG000|Overall Study|Other|0|||
143099052|NCT00812981|515903750|FG001|Overall Study|Other|1|||
143099053|NCT04666259|515903753|FG000|Treatment Phase|Physician Decision|9|||
143099054|NCT04666259|515903754|FG001|Treatment Phase|Physician Decision|3|||
143099055|NCT04666259|515903755|FG002|Treatment Phase|Physician Decision|3|||
143099056|NCT04666259|515903753|FG000|Treatment Phase|Adverse Event|3|||
143099057|NCT04666259|515903754|FG001|Treatment Phase|Adverse Event|1|||
143099058|NCT04666259|515903755|FG002|Treatment Phase|Adverse Event|0|||
143099059|NCT04666259|515903753|FG000|Treatment Phase|Subject decision|1|||
143099060|NCT04666259|515903754|FG001|Treatment Phase|Subject decision|2|||
143099061|NCT04666259|515903755|FG002|Treatment Phase|Subject decision|0|||
143099062|NCT04666259|515903753|FG000|Treatment Phase|Progressive disease|0|||
143099063|NCT04666259|515903754|FG001|Treatment Phase|Progressive disease|1|||
143099064|NCT04666259|515903755|FG002|Treatment Phase|Progressive disease|0|||
143099065|NCT04666259|515903753|FG000|Treatment Phase|Enrolled but not treated and discontinued|1|||
143099066|NCT04666259|515903754|FG001|Treatment Phase|Enrolled but not treated and discontinued|0|||
143099067|NCT04666259|515903755|FG002|Treatment Phase|Enrolled but not treated and discontinued|0|||
143099068|NCT04666259|515903753|FG000|Safety Follow-up Phase|Physician Decision|2|||
143099069|NCT04666259|515903754|FG001|Safety Follow-up Phase|Physician Decision|0|||
143099070|NCT04666259|515903755|FG002|Safety Follow-up Phase|Physician Decision|0|||
143099071|NCT04666259|515903753|FG000|Safety Follow-up Phase|Subject decision|1|||
143099072|NCT04666259|515903754|FG001|Safety Follow-up Phase|Subject decision|0|||
143099073|NCT04666259|515903755|FG002|Safety Follow-up Phase|Subject decision|0|||
143099074|NCT04666259|515903753|FG000|Safety Follow-up Phase|Death|0|||
143099075|NCT04666259|515903754|FG001|Safety Follow-up Phase|Death|1|||
143099076|NCT04666259|515903755|FG002|Safety Follow-up Phase|Death|0|||
143099077|NCT02677922|515903756|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
143099078|NCT02677922|515903757|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
143099079|NCT02677922|515903758|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
143099080|NCT02677922|515903759|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
143099081|NCT02677922|515903760|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
143099082|NCT02677922|515903761|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
143099083|NCT02677922|515903756|FG000|Treatment Period|Adverse Event|0|||
143099084|NCT02677922|515903757|FG001|Treatment Period|Adverse Event|0|||
143099085|NCT02677922|515903758|FG002|Treatment Period|Adverse Event|1|||
143099086|NCT02677922|515903759|FG003|Treatment Period|Adverse Event|3|||
143099087|NCT02677922|515903760|FG004|Treatment Period|Adverse Event|5|||
143099088|NCT02677922|515903761|FG005|Treatment Period|Adverse Event|2|||
143099089|NCT02677922|515903756|FG000|Treatment Period|Progressive Disease|1|||
143099090|NCT02677922|515903757|FG001|Treatment Period|Progressive Disease|1|||
143099091|NCT02677922|515903758|FG002|Treatment Period|Progressive Disease|0|||
143099092|NCT02677922|515903759|FG003|Treatment Period|Progressive Disease|0|||
143099093|NCT02677922|515903760|FG004|Treatment Period|Progressive Disease|8|||
143099094|NCT02677922|515903761|FG005|Treatment Period|Progressive Disease|7|||
143099095|NCT02677922|515903756|FG000|Treatment Period|Lack of Efficacy|0|||
143099096|NCT02677922|515903757|FG001|Treatment Period|Lack of Efficacy|0|||
143099097|NCT02677922|515903758|FG002|Treatment Period|Lack of Efficacy|0|||
143099098|NCT02677922|515903759|FG003|Treatment Period|Lack of Efficacy|1|||
143099099|NCT02677922|515903760|FG004|Treatment Period|Lack of Efficacy|1|||
143099100|NCT02677922|515903761|FG005|Treatment Period|Lack of Efficacy|6|||
143099101|NCT02677922|515903756|FG000|Treatment Period|Withdrawal by Subject|0|||
143099102|NCT02677922|515903757|FG001|Treatment Period|Withdrawal by Subject|0|||
143099103|NCT02677922|515903758|FG002|Treatment Period|Withdrawal by Subject|1|||
143099104|NCT02677922|515903759|FG003|Treatment Period|Withdrawal by Subject|3|||
143099105|NCT02677922|515903760|FG004|Treatment Period|Withdrawal by Subject|5|||
143099106|NCT02677922|515903761|FG005|Treatment Period|Withdrawal by Subject|5|||
143099107|NCT02677922|515903756|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
143099108|NCT02677922|515903757|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
143099109|NCT02677922|515903758|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
143099110|NCT02677922|515903759|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
143099111|NCT02677922|515903760|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
143099112|NCT02677922|515903761|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
143099113|NCT02677922|515903756|FG000|Treatment Period|Disease Relapse|0|||
143099114|NCT02677922|515903757|FG001|Treatment Period|Disease Relapse|0|||
143099115|NCT02677922|515903758|FG002|Treatment Period|Disease Relapse|0|||
143099116|NCT02677922|515903759|FG003|Treatment Period|Disease Relapse|3|||
143099117|NCT02677922|515903760|FG004|Treatment Period|Disease Relapse|6|||
143099118|NCT02677922|515903761|FG005|Treatment Period|Disease Relapse|1|||
143099119|NCT02677922|515903756|FG000|Treatment Period|Allogeneic HSCT|1|||
143099120|NCT02677922|515903757|FG001|Treatment Period|Allogeneic HSCT|0|||
143099121|NCT02677922|515903758|FG002|Treatment Period|Allogeneic HSCT|0|||
143099122|NCT02677922|515903759|FG003|Treatment Period|Allogeneic HSCT|1|||
143099123|NCT02677922|515903760|FG004|Treatment Period|Allogeneic HSCT|4|||
143099124|NCT02677922|515903761|FG005|Treatment Period|Allogeneic HSCT|1|||
143099125|NCT02677922|515903756|FG000|Treatment Period|Other Reasons|0|||
143099126|NCT02677922|515903757|FG001|Treatment Period|Other Reasons|0|||
143099127|NCT02677922|515903758|FG002|Treatment Period|Other Reasons|0|||
143099128|NCT02677922|515903759|FG003|Treatment Period|Other Reasons|1|||
143099129|NCT02677922|515903760|FG004|Treatment Period|Other Reasons|3|||
143099130|NCT02677922|515903761|FG005|Treatment Period|Other Reasons|5|||
143099131|NCT02677922|515903756|FG000|Treatment Period|Death|0|||
143099132|NCT02677922|515903757|FG001|Treatment Period|Death|0|||
143099133|NCT02677922|515903758|FG002|Treatment Period|Death|0|||
143099134|NCT02677922|515903759|FG003|Treatment Period|Death|0|||
143099135|NCT02677922|515903760|FG004|Treatment Period|Death|12|||
143099136|NCT02677922|515903761|FG005|Treatment Period|Death|1|||
143099137|NCT02677922|515903756|FG000|Treatment Period|Non-compliance with Study Drug|0|||
143099138|NCT02677922|515903757|FG001|Treatment Period|Non-compliance with Study Drug|0|||
143099139|NCT02677922|515903758|FG002|Treatment Period|Non-compliance with Study Drug|0|||
143099140|NCT02677922|515903759|FG003|Treatment Period|Non-compliance with Study Drug|0|||
143099141|NCT02677922|515903760|FG004|Treatment Period|Non-compliance with Study Drug|1|||
143099142|NCT02677922|515903761|FG005|Treatment Period|Non-compliance with Study Drug|0|||
143099143|NCT02677922|515903756|FG000|Treatment Period|Physician Decision|0|||
143099144|NCT02677922|515903757|FG001|Treatment Period|Physician Decision|0|||
143099145|NCT02677922|515903758|FG002|Treatment Period|Physician Decision|0|||
143099146|NCT02677922|515903759|FG003|Treatment Period|Physician Decision|0|||
143099147|NCT02677922|515903760|FG004|Treatment Period|Physician Decision|0|||
143099148|NCT02677922|515903761|FG005|Treatment Period|Physician Decision|1|||
143099149|NCT02677922|515903756|FG000|Treatment Period|Symptomatic Deterioration|0|||
143099150|NCT02677922|515903757|FG001|Treatment Period|Symptomatic Deterioration|0|||
143099151|NCT02677922|515903758|FG002|Treatment Period|Symptomatic Deterioration|0|||
143099152|NCT02677922|515903759|FG003|Treatment Period|Symptomatic Deterioration|0|||
143099153|NCT02677922|515903760|FG004|Treatment Period|Symptomatic Deterioration|1|||
143099154|NCT02677922|515903761|FG005|Treatment Period|Symptomatic Deterioration|0|||
143099155|NCT05343364|515903762|FG000|Overall Study|Miscellaneous|0|||
143099156|NCT05343364|515903763|FG001|Overall Study|Miscellaneous|1|||
143099157|NCT03331796|515903764|FG000|Allocation and Primary Endpoint|Pandemic Disruption|0|||
143099158|NCT03331796|515903765|FG001|Allocation and Primary Endpoint|Pandemic Disruption|1|||
143099159|NCT03331796|515903766|FG002|Allocation and Primary Endpoint|Pandemic Disruption|1|||
143099160|NCT03331796|515903764|FG000|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
143099161|NCT03331796|515903765|FG001|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
143099162|NCT03331796|515903766|FG002|Allocation and Primary Endpoint|Withdrawal by Subject|1|||
143099163|NCT03331796|515903764|FG000|Extended Follow-up|Adverse Event|1|||
143099164|NCT03331796|515903765|FG001|Extended Follow-up|Adverse Event|0|||
143099165|NCT03331796|515903766|FG002|Extended Follow-up|Adverse Event|1|||
143099166|NCT03331796|515903764|FG000|Extended Follow-up|Lost to Follow-up|0|||
143099167|NCT03331796|515903765|FG001|Extended Follow-up|Lost to Follow-up|0|||
143367740|NCT01729871|516889434|FG001|Overall Study|Withdrawal by Subject|3|||
143099168|NCT03331796|515903766|FG002|Extended Follow-up|Lost to Follow-up|1|||
143099169|NCT03331796|515903764|FG000|Extended Follow-up|Withdrawal by Subject|1|||
143099170|NCT03331796|515903765|FG001|Extended Follow-up|Withdrawal by Subject|0|||
143099171|NCT03331796|515903766|FG002|Extended Follow-up|Withdrawal by Subject|0|||
143099172|NCT03331796|515903764|FG000|Extended Follow-up|Termination of Funding|0|||
143099173|NCT03331796|515903765|FG001|Extended Follow-up|Termination of Funding|1|||
143099174|NCT03331796|515903766|FG002|Extended Follow-up|Termination of Funding|0|||
143099175|NCT01422889|515903774|FG000|Overall Study|No Data Entered for Study Stent|9|||
143099176|NCT01580670|515903775|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
143099177|NCT01580670|515903775|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
143099178|NCT02748356|515903776|FG000|Overall Study|Withdrawal by Subject|1|||
143099179|NCT00996125|515903777|FG000|Overall Study|Adverse Event|0|||
143099180|NCT00996125|515903778|FG001|Overall Study|Adverse Event|2|||
143099181|NCT00996125|515903777|FG000|Overall Study|Lost to Follow-up|1|||
143099182|NCT00996125|515903778|FG001|Overall Study|Lost to Follow-up|6|||
143099183|NCT00996125|515903777|FG000|Overall Study|Withdrawal by Subject|4|||
143099184|NCT00996125|515903778|FG001|Overall Study|Withdrawal by Subject|3|||
143099185|NCT00488644|515903780|FG000|Overall Study|Not Eligible|1|||
143099186|NCT00488644|515903780|FG000|Overall Study|Not Evaluable|1|||
143099187|NCT04331067|515903781|FG000|Overall Study|Adverse Event|1|||
143099188|NCT04331067|515903782|FG001|Overall Study|Adverse Event|3|||
143099189|NCT04331067|515903783|FG002|Overall Study|Adverse Event|1|||
143099190|NCT04331067|515903781|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
143099191|NCT04331067|515903782|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
143099192|NCT04331067|515903783|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
143099193|NCT05870371|515903784|FG000|Overall Study|Nonadherence (missed appointmetns).|24|||
143099194|NCT05870371|515903785|FG001|Overall Study|Nonadherence (missed appointmetns).|24|||
143099195|NCT02203721|515903791|FG000|Overall Study|Lost to Follow-up|1|||
143099196|NCT02203721|515903792|FG001|Overall Study|Lost to Follow-up|0|||
143099197|NCT02203721|515903791|FG000|Overall Study|Death|0|||
143099198|NCT02203721|515903792|FG001|Overall Study|Death|2|||
143099199|NCT02203721|515903791|FG000|Overall Study|Illness|0|||
143099200|NCT02203721|515903792|FG001|Overall Study|Illness|1|||
143099201|NCT00153179|515903793|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
143099202|NCT00153179|515903794|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
143099203|NCT00153179|515903795|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
143099204|NCT00153179|515903796|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
143099205|NCT01367886|515903797|FG000|Overall Study|Lost to Follow-up|4|||
143099206|NCT01367886|515903797|FG000|Overall Study|Lack of Efficacy|2|||
143099207|NCT01367886|515903797|FG000|Overall Study|Death|1|||
143099208|NCT03711786|515903800|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
143251888|NCT02743611|516476368|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
143099209|NCT03711786|515903801|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
143099210|NCT03711786|515903800|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
143099211|NCT03711786|515903801|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
143099212|NCT03711786|515903800|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
143099213|NCT03711786|515903801|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
143099214|NCT03711786|515903800|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
143099215|NCT03711786|515903801|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
143099216|NCT03711786|515903800|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
143099217|NCT03711786|515903801|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
143099218|NCT03711786|515903800|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
143099219|NCT03711786|515903801|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
143099220|NCT00669669|515903802|FG000|Overall Study|To late to start treatment|1|||
143099221|NCT03379727|515903806|FG000|Overall Study|Lack of Efficacy|73|||
143099222|NCT03379727|515903806|FG000|Overall Study|Adverse Event|32|||
143099223|NCT03379727|515903806|FG000|Overall Study|Death|18|||
143099224|NCT03379727|515903806|FG000|Overall Study|Patient/guardian decision|17|||
143099225|NCT03379727|515903806|FG000|Overall Study|Physician Decision|104|||
143099226|NCT03379727|515903806|FG000|Overall Study|Protocol Violation|4|||
143099227|NCT03379727|515903806|FG000|Overall Study|Lost to Follow-up|1|||
143099228|NCT01205776|515903809|FG000|Overall Study|Lost to Follow-up|53|||
143099229|NCT01205776|515903810|FG001|Overall Study|Lost to Follow-up|61|||
143099230|NCT01205776|515903809|FG000|Overall Study|Withdrawal by Subject|11|||
143099231|NCT01205776|515903810|FG001|Overall Study|Withdrawal by Subject|34|||
143099232|NCT02418182|515903811|FG000|Overall Study|Unable to re-consent|18|||
143099233|NCT02418182|515903812|FG001|Overall Study|Unable to re-consent|15|||
143099234|NCT02418182|515903811|FG000|Overall Study|Lost to Follow-up|0|||
143099235|NCT02418182|515903812|FG001|Overall Study|Lost to Follow-up|2|||
143099236|NCT02431676|515903813|FG000|Overall Study|no lab obtained|0|||
143099237|NCT02431676|515903814|FG001|Overall Study|no lab obtained|1|||
143099238|NCT02431676|515903815|FG002|Overall Study|no lab obtained|2|||
143099239|NCT03782792|515905813|FG000|Overall Study|Patient left the country|0|||
143099240|NCT03782792|515905814|FG001|Overall Study|Patient left the country|1|||
143099241|NCT03782792|515905813|FG000|Overall Study|Withdrawal by Subject|1|||
143099242|NCT03782792|515905814|FG001|Overall Study|Withdrawal by Subject|2|||
143099243|NCT02159053|515905815|FG000|Overall Study|Death|2|||
143099244|NCT02159053|515905816|FG001|Overall Study|Death|0|||
143099245|NCT02159053|515905817|FG002|Overall Study|Death|1|||
143099246|NCT02159053|515905815|FG000|Overall Study|Physician Decision|0|||
143099247|NCT02159053|515905816|FG001|Overall Study|Physician Decision|1|||
143099248|NCT02159053|515905817|FG002|Overall Study|Physician Decision|1|||
143099249|NCT02159053|515905815|FG000|Overall Study|Lack of Efficacy|3|||
143099250|NCT02159053|515905816|FG001|Overall Study|Lack of Efficacy|4|||
143099251|NCT02159053|515905817|FG002|Overall Study|Lack of Efficacy|7|||
143099252|NCT02159053|515905815|FG000|Overall Study|Adverse Event|7|||
143099253|NCT02159053|515905816|FG001|Overall Study|Adverse Event|6|||
143251889|NCT02743611|516476369|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
143251890|NCT02743611|516476370|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
143251891|NCT00600119|516476371|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
143251892|NCT00600119|516476372|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
143251893|NCT00600119|516476373|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
143251894|NCT00600119|516476374|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
143251895|NCT00600119|516476375|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
143251896|NCT00600119|516476376|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
143251897|NCT00600119|516476371|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
143251898|NCT00600119|516476372|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
143251899|NCT00600119|516476373|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
143251900|NCT00600119|516476374|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
143367741|NCT01729871|516889433|FG000|Overall Study|Other|4|||
143367742|NCT01729871|516889434|FG001|Overall Study|Other|9|||
143099254|NCT02159053|515905817|FG002|Overall Study|Adverse Event|5|||
143099255|NCT02159053|515905815|FG000|Overall Study|Participants/guardian decision|8|||
143099256|NCT02159053|515905816|FG001|Overall Study|Participants/guardian decision|10|||
143099257|NCT02159053|515905817|FG002|Overall Study|Participants/guardian decision|6|||
143099258|NCT01540487|515905818|FG000|Overall Study|Protocol Violation|1|||
143099259|NCT01540487|515905819|FG001|Overall Study|Protocol Violation|0|||
143099260|NCT00617890|515905820|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
143099261|NCT00617890|515905821|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
143099262|NCT00617890|515905822|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
143099263|NCT00617890|515905823|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
143099264|NCT00617890|515905820|FG000|Overall Study|Lack of Efficacy|23|||
143099265|NCT00617890|515905821|FG001|Overall Study|Lack of Efficacy|26|||
143099266|NCT00617890|515905822|FG002|Overall Study|Lack of Efficacy|30|||
143099267|NCT00617890|515905823|FG003|Overall Study|Lack of Efficacy|97|||
143099268|NCT00617890|515905820|FG000|Overall Study|Lost to Follow-up|0|||
143099269|NCT00617890|515905821|FG001|Overall Study|Lost to Follow-up|0|||
143099270|NCT00617890|515905822|FG002|Overall Study|Lost to Follow-up|1|||
143099271|NCT00617890|515905823|FG003|Overall Study|Lost to Follow-up|2|||
143099272|NCT00617890|515905820|FG000|Overall Study|Withdrawal by Subject|4|||
143099273|NCT00617890|515905821|FG001|Overall Study|Withdrawal by Subject|1|||
143099274|NCT00617890|515905822|FG002|Overall Study|Withdrawal by Subject|0|||
143099275|NCT00617890|515905823|FG003|Overall Study|Withdrawal by Subject|2|||
143099276|NCT00617890|515905820|FG000|Overall Study|Protocol Violation|2|||
143099277|NCT00617890|515905821|FG001|Overall Study|Protocol Violation|1|||
143099278|NCT00617890|515905822|FG002|Overall Study|Protocol Violation|0|||
143099279|NCT00617890|515905823|FG003|Overall Study|Protocol Violation|0|||
143099280|NCT00617890|515905820|FG000|Overall Study|Adverse Event|1|||
143099281|NCT00617890|515905821|FG001|Overall Study|Adverse Event|0|||
143099282|NCT00617890|515905822|FG002|Overall Study|Adverse Event|3|||
143099283|NCT00617890|515905823|FG003|Overall Study|Adverse Event|8|||
143099284|NCT00617890|515905820|FG000|Overall Study|Not treated|1|||
143099285|NCT00617890|515905821|FG001|Overall Study|Not treated|0|||
143099286|NCT00617890|515905822|FG002|Overall Study|Not treated|1|||
143099287|NCT00617890|515905823|FG003|Overall Study|Not treated|1|||
143099288|NCT03503370|515905824|FG000|Overall Study|Death|3|||
143099289|NCT03503370|515905825|FG001|Overall Study|Death|1|||
143099290|NCT03483961|515905826|FG000|Overall Study|Lost to Follow-up|7|||
143099291|NCT03483961|515905827|FG001|Overall Study|Lost to Follow-up|6|||
143099292|NCT03483961|515905828|FG002|Overall Study|Lost to Follow-up|6|||
143099293|NCT03483961|515905829|FG003|Overall Study|Lost to Follow-up|6|||
143099294|NCT03483961|515905830|FG004|Overall Study|Lost to Follow-up|6|||
143099295|NCT03483961|515905831|FG005|Overall Study|Lost to Follow-up|4|||
143099296|NCT03483961|515905832|FG006|Overall Study|Lost to Follow-up|4|||
143099297|NCT03483961|515905833|FG007|Overall Study|Lost to Follow-up|11|||
143099298|NCT03483961|515905834|FG008|Overall Study|Lost to Follow-up|1|||
143099299|NCT03483961|515905835|FG009|Overall Study|Lost to Follow-up|0|||
143099300|NCT03483961|515905826|FG000|Overall Study|Withdrawal by Subject|3|||
143099301|NCT03483961|515905827|FG001|Overall Study|Withdrawal by Subject|4|||
143099302|NCT03483961|515905828|FG002|Overall Study|Withdrawal by Subject|5|||
143099303|NCT03483961|515905829|FG003|Overall Study|Withdrawal by Subject|3|||
143099304|NCT03483961|515905830|FG004|Overall Study|Withdrawal by Subject|4|||
143099305|NCT03483961|515905831|FG005|Overall Study|Withdrawal by Subject|2|||
143367743|NCT03971357|516889435|FG000|Overall Study|Lack of Efficacy|0|||
143099306|NCT03483961|515905832|FG006|Overall Study|Withdrawal by Subject|1|||
143099307|NCT03483961|515905833|FG007|Overall Study|Withdrawal by Subject|2|||
143099308|NCT03483961|515905834|FG008|Overall Study|Withdrawal by Subject|1|||
143099309|NCT03483961|515905835|FG009|Overall Study|Withdrawal by Subject|0|||
143367744|NCT03971357|516889436|FG001|Overall Study|Lack of Efficacy|1|||
143099310|NCT03483961|515905826|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
143099311|NCT03483961|515905827|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
143099312|NCT03483961|515905828|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
143099313|NCT03483961|515905829|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
143099314|NCT03483961|515905830|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
143099315|NCT03483961|515905831|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
143099316|NCT03483961|515905832|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
143099317|NCT03483961|515905833|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
143099318|NCT03483961|515905834|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
143099319|NCT03483961|515905835|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
143099320|NCT03483961|515905826|FG000|Overall Study|Adverse Event|0|||
143099321|NCT03483961|515905827|FG001|Overall Study|Adverse Event|0|||
143099322|NCT03483961|515905828|FG002|Overall Study|Adverse Event|1|||
143099323|NCT03483961|515905829|FG003|Overall Study|Adverse Event|0|||
143099324|NCT03483961|515905830|FG004|Overall Study|Adverse Event|0|||
143099325|NCT03483961|515905831|FG005|Overall Study|Adverse Event|0|||
143099326|NCT03483961|515905832|FG006|Overall Study|Adverse Event|0|||
143099327|NCT03483961|515905833|FG007|Overall Study|Adverse Event|0|||
143099328|NCT03483961|515905834|FG008|Overall Study|Adverse Event|0|||
143099329|NCT03483961|515905835|FG009|Overall Study|Adverse Event|0|||
143099330|NCT04003636|515905837|FG000|Overall Study|Death|409|||
143099331|NCT04003636|515905838|FG001|Overall Study|Death|443|||
143099332|NCT04003636|515905837|FG000|Overall Study|Lost to Follow-up|0|||
143099333|NCT04003636|515905838|FG001|Overall Study|Lost to Follow-up|1|||
143099334|NCT04003636|515905837|FG000|Overall Study|Withdrawal by Subject|5|||
143099335|NCT04003636|515905838|FG001|Overall Study|Withdrawal by Subject|2|||
143099336|NCT04003636|515905837|FG000|Overall Study|Participant On-going|119|||
143099337|NCT04003636|515905838|FG001|Overall Study|Participant On-going|90|||
143099338|NCT00298272|515905839|FG000|Double-blind Phase|Adverse Event|2|||
143099339|NCT00298272|515905840|FG001|Double-blind Phase|Adverse Event|0|||
143099340|NCT00298272|515905839|FG000|Double-blind Phase|Failure to Return|2|||
143099341|NCT00298272|515905840|FG001|Double-blind Phase|Failure to Return|0|||
143099342|NCT00298272|515905839|FG000|Double-blind Phase|Protocol Violation|2|||
143099343|NCT00298272|515905840|FG001|Double-blind Phase|Protocol Violation|0|||
143099344|NCT00298272|515905839|FG000|Double-blind Phase|Withdrawal by Subject|2|||
143099345|NCT00298272|515905840|FG001|Double-blind Phase|Withdrawal by Subject|0|||
143099346|NCT00298272|515905839|FG000|Open Label Retreatment Phase|Adverse Event|1|||
143099347|NCT00298272|515905840|FG001|Open Label Retreatment Phase|Adverse Event|2|||
143099348|NCT00298272|515905839|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
143099349|NCT00298272|515905840|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
143099350|NCT00298272|515905839|FG000|Open Label Retreatment Phase|Failure to Return|1|||
143099351|NCT00298272|515905840|FG001|Open Label Retreatment Phase|Failure to Return|0|||
143099352|NCT00298272|515905839|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
143099353|NCT00298272|515905840|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
143099354|NCT00298272|515905839|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
143099355|NCT00298272|515905840|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
143099356|NCT00298272|515905839|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
143099357|NCT00298272|515905840|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
143099358|NCT00298272|515905839|FG000|Safety Follow-up Phase|Failure to Return|1|||
143099359|NCT00298272|515905840|FG001|Safety Follow-up Phase|Failure to Return|1|||
143099360|NCT00298272|515905839|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
143099361|NCT00298272|515905840|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
143099362|NCT00298272|515905839|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
143099363|NCT00298272|515905840|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
143099364|NCT00457002|515905841|FG000|Overall Study|Death|40|||
143099365|NCT00457002|515905842|FG001|Overall Study|Death|47|||
143099366|NCT00457002|515905841|FG000|Overall Study|Adverse Event|284|||
143099367|NCT00457002|515905842|FG001|Overall Study|Adverse Event|260|||
143099368|NCT00457002|515905841|FG000|Overall Study|Withdrawal by Subject|299|||
143099369|NCT00457002|515905842|FG001|Overall Study|Withdrawal by Subject|271|||
143099370|NCT00457002|515905841|FG000|Overall Study|Lost to Follow-up|72|||
143099371|NCT00457002|515905842|FG001|Overall Study|Lost to Follow-up|71|||
143099372|NCT00457002|515905841|FG000|Overall Study|Poor/Non-compliance|46|||
143099373|NCT00457002|515905842|FG001|Overall Study|Poor/Non-compliance|33|||
143099374|NCT00457002|515905841|FG000|Overall Study|No longer met criteria|41|||
143099375|NCT00457002|515905842|FG001|Overall Study|No longer met criteria|37|||
143099376|NCT00457002|515905841|FG000|Overall Study|Administrative reason by Sponsor|1|||
143099377|NCT00457002|515905842|FG001|Overall Study|Administrative reason by Sponsor|0|||
143099378|NCT00457002|515905841|FG000|Overall Study|non-specified|29|||
143099379|NCT00457002|515905842|FG001|Overall Study|non-specified|38|||
143099380|NCT00457002|515905841|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
143099381|NCT00457002|515905842|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
143099382|NCT02898597|515905843|FG000|Overall Study|Protocol Violation|4|||
143099383|NCT02898597|515905844|FG001|Overall Study|Protocol Violation|2|||
143099384|NCT02898597|515905843|FG000|Overall Study|Lost to Follow-up|0|||
143099385|NCT02898597|515905844|FG001|Overall Study|Lost to Follow-up|9|||
143099386|NCT02898597|515905843|FG000|Overall Study|Death|0|||
143099387|NCT02898597|515905844|FG001|Overall Study|Death|1|||
143099388|NCT00154284|515905845|FG000|Overall Study|Adverse Event|6|||
143099389|NCT00154284|515905846|FG001|Overall Study|Adverse Event|9|||
143099390|NCT00154284|515905845|FG000|Overall Study|Abnormal laboratory value(s)|0|||
143099391|NCT00154284|515905846|FG001|Overall Study|Abnormal laboratory value(s)|1|||
143099392|NCT00154284|515905845|FG000|Overall Study|Lack of Efficacy|1|||
143099393|NCT00154284|515905846|FG001|Overall Study|Lack of Efficacy|2|||
143099394|NCT00154284|515905845|FG000|Overall Study|Protocol Violation|0|||
143099395|NCT00154284|515905846|FG001|Overall Study|Protocol Violation|1|||
143099396|NCT00326716|515905847|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
143099397|NCT00326716|515905848|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
143099398|NCT00326716|515905849|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
143099399|NCT00326716|515905850|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
143099400|NCT05253573|515905851|FG000|Overall Study|Death|1|||
143099401|NCT05253573|515905852|FG001|Overall Study|Death|0|||
143099402|NCT01344824|515905853|FG000|Overall Study|Adverse Event|15|||
143099403|NCT01344824|515905853|FG000|Overall Study|Withdrawal by Subject|6|||
143099404|NCT01344824|515905853|FG000|Overall Study|Other complicating disease|1|||
143099405|NCT01344824|515905853|FG000|Overall Study|Progression|15|||
143177179|NCT00953706|516196305|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
143177180|NCT00953706|516196306|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
143177181|NCT00953706|516196307|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
143177182|NCT00953706|516196308|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
143177183|NCT00953706|516196305|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
143177184|NCT00953706|516196306|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
143177185|NCT00953706|516196307|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
143177186|NCT00953706|516196308|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
143177187|NCT00953706|516196305|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
143177188|NCT00953706|516196306|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
143177189|NCT00953706|516196307|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
143177190|NCT00953706|516196308|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
143177191|NCT05414175|516196309|FG000|Overall Study|Withdrawal by Subject|1|||
143177192|NCT05414175|516196309|FG000|Overall Study|Other Reasons|1|||
143177193|NCT00027560|516196310|FG000|Overall Study|Withdrawal by Subject|1|||
143177194|NCT00457626|516196311|FG000|Overall Study|Adverse Event|3|||
143177195|NCT00457626|516196311|FG000|Overall Study|Administrative Problems|2|||
143177196|NCT00457626|516196311|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
143177197|NCT03559270|516196312|FG000|Overall Study|Adverse Event|6|||
143177198|NCT03559270|516196313|FG001|Overall Study|Adverse Event|5|||
143177199|NCT03559270|516196314|FG002|Overall Study|Adverse Event|3|||
143177200|NCT03559270|516196315|FG003|Overall Study|Adverse Event|0|||
143177201|NCT03559270|516196312|FG000|Overall Study|Lack of Efficacy|34|||
143177202|NCT03559270|516196313|FG001|Overall Study|Lack of Efficacy|52|||
143177203|NCT03559270|516196314|FG002|Overall Study|Lack of Efficacy|37|||
143177204|NCT03559270|516196315|FG003|Overall Study|Lack of Efficacy|2|||
143177205|NCT03559270|516196312|FG000|Overall Study|Death|0|||
143177206|NCT03559270|516196313|FG001|Overall Study|Death|2|||
143177207|NCT03559270|516196314|FG002|Overall Study|Death|0|||
143177208|NCT03559270|516196315|FG003|Overall Study|Death|0|||
143177209|NCT03559270|516196312|FG000|Overall Study|Lost to Follow-up|16|||
143177210|NCT03559270|516196313|FG001|Overall Study|Lost to Follow-up|4|||
143177211|NCT03559270|516196314|FG002|Overall Study|Lost to Follow-up|12|||
143177212|NCT03559270|516196315|FG003|Overall Study|Lost to Follow-up|3|||
143177213|NCT03559270|516196312|FG000|Overall Study|Sponsor Decision|38|||
143177214|NCT03559270|516196313|FG001|Overall Study|Sponsor Decision|31|||
143177215|NCT03559270|516196314|FG002|Overall Study|Sponsor Decision|35|||
143177216|NCT03559270|516196315|FG003|Overall Study|Sponsor Decision|18|||
143177217|NCT03559270|516196312|FG000|Overall Study|Withdrawal by Subject|19|||
143177218|NCT03559270|516196313|FG001|Overall Study|Withdrawal by Subject|21|||
143177219|NCT03559270|516196314|FG002|Overall Study|Withdrawal by Subject|18|||
143177220|NCT03559270|516196315|FG003|Overall Study|Withdrawal by Subject|7|||
143099406|NCT01295671|515905858|FG000|Overall Study|Lost to Follow-up|4|||
143099407|NCT01295671|515905859|FG001|Overall Study|Lost to Follow-up|6|||
143099408|NCT01295671|515905860|FG002|Overall Study|Lost to Follow-up|3|||
143099409|NCT01295671|515905858|FG000|Overall Study|Withdrawal by Subject|3|||
143099410|NCT01295671|515905859|FG001|Overall Study|Withdrawal by Subject|1|||
143177221|NCT03559270|516196312|FG000|Overall Study|Physician Decision|3|||
143177222|NCT03559270|516196313|FG001|Overall Study|Physician Decision|2|||
143177223|NCT03559270|516196314|FG002|Overall Study|Physician Decision|1|||
143177224|NCT03559270|516196315|FG003|Overall Study|Physician Decision|0|||
143177225|NCT03559270|516196312|FG000|Overall Study|Pregnancy|0|||
143099411|NCT01295671|515905860|FG002|Overall Study|Withdrawal by Subject|0|||
143099412|NCT01436370|515905861|FG000|Overall Study|Lost to Follow-up|0|||
143099413|NCT01436370|515905862|FG001|Overall Study|Lost to Follow-up|0|||
143099414|NCT01436370|515905863|FG002|Overall Study|Lost to Follow-up|0|||
143099415|NCT01436370|515905864|FG003|Overall Study|Lost to Follow-up|0|||
143099416|NCT01436370|515905865|FG004|Overall Study|Lost to Follow-up|1|||
143099417|NCT01436370|515905866|FG005|Overall Study|Lost to Follow-up|0|||
143099418|NCT01436370|515905867|FG006|Overall Study|Lost to Follow-up|0|||
143099419|NCT01436370|515905868|FG007|Overall Study|Lost to Follow-up|0|||
143099420|NCT02276560|515905869|FG000|Overall Study|Adverse Event|1|||
143099421|NCT02276560|515905870|FG001|Overall Study|Adverse Event|0|||
143099422|NCT02276560|515905871|FG002|Overall Study|Adverse Event|0|||
143099423|NCT02609607|515905875|FG000|Overall Study|Lost to Follow-up|0|||
143099424|NCT02609607|515905876|FG001|Overall Study|Lost to Follow-up|1|||
143099425|NCT02309411|515905882|FG000|Overall Study|Physician Decision|1|||
143099426|NCT02309411|515905883|FG001|Overall Study|Physician Decision|0|||
143099427|NCT02309411|515905884|FG002|Overall Study|Physician Decision|0|||
143099428|NCT02309411|515905882|FG000|Overall Study|Withdrawal by Subject|1|||
143099429|NCT02309411|515905883|FG001|Overall Study|Withdrawal by Subject|1|||
143099430|NCT02309411|515905884|FG002|Overall Study|Withdrawal by Subject|0|||
143099431|NCT00651261|515905885|FG000|Overall Study|Adverse Event|32|||
143099432|NCT00651261|515905886|FG001|Overall Study|Adverse Event|22|||
143099433|NCT00651261|515905885|FG000|Overall Study|Death|18|||
143099434|NCT00651261|515905886|FG001|Overall Study|Death|18|||
143099435|NCT00651261|515905885|FG000|Overall Study|Withdrawal by Subject|22|||
143099436|NCT00651261|515905886|FG001|Overall Study|Withdrawal by Subject|40|||
143099437|NCT00651261|515905885|FG000|Overall Study|Induction failure|24|||
143099438|NCT00651261|515905886|FG001|Overall Study|Induction failure|35|||
143099439|NCT00651261|515905885|FG000|Overall Study|Disease progression|58|||
143099440|NCT00651261|515905886|FG001|Overall Study|Disease progression|58|||
143099441|NCT00651261|515905885|FG000|Overall Study|Alternative therapy|109|||
143099442|NCT00651261|515905886|FG001|Overall Study|Alternative therapy|107|||
143177226|NCT03559270|516196313|FG001|Overall Study|Pregnancy|1|||
143177227|NCT03559270|516196314|FG002|Overall Study|Pregnancy|0|||
143177228|NCT03559270|516196315|FG003|Overall Study|Pregnancy|0|||
143177229|NCT03559270|516196312|FG000|Overall Study|Protocol Violation|1|||
143177230|NCT03559270|516196313|FG001|Overall Study|Protocol Violation|0|||
143177231|NCT03559270|516196314|FG002|Overall Study|Protocol Violation|2|||
143177232|NCT03559270|516196315|FG003|Overall Study|Protocol Violation|0|||
143177233|NCT00441272|516197830|FG000|Overall Study|Study terminated prior to enrollment|25|||
143177234|NCT00441272|516197831|FG001|Overall Study|Study terminated prior to enrollment|25|||
143177235|NCT00954447|516197832|FG000|Overall Study|Adverse Event|33|||
143177236|NCT00954447|516197833|FG001|Overall Study|Adverse Event|25|||
143177237|NCT00954447|516197832|FG000|Overall Study|Lack of Efficacy|17|||
143177238|NCT00954447|516197833|FG001|Overall Study|Lack of Efficacy|3|||
143177239|NCT00954447|516197832|FG000|Overall Study|Protocol Violation|5|||
143177240|NCT00954447|516197833|FG001|Overall Study|Protocol Violation|7|||
143177241|NCT00954447|516197832|FG000|Overall Study|Lost to Follow-up|8|||
143177242|NCT00954447|516197833|FG001|Overall Study|Lost to Follow-up|14|||
143177243|NCT00954447|516197832|FG000|Overall Study|Withdrawal by Subject|26|||
143177244|NCT00954447|516197833|FG001|Overall Study|Withdrawal by Subject|21|||
143177245|NCT00954447|516197832|FG000|Overall Study|Other|21|||
143177246|NCT00954447|516197833|FG001|Overall Study|Other|18|||
143177247|NCT04592341|516197834|FG000|Overall Study|Physician Decision|5|||
143177248|NCT04592341|516197834|FG000|Overall Study|Study Terminated by Sponsor|5|||
143177249|NCT04592341|516197834|FG000|Overall Study|Withdrawal by Subject|53|||
143177250|NCT04592341|516197834|FG000|Overall Study|Lost to Follow-up|3|||
143177251|NCT04592341|516197834|FG000|Overall Study|Death|1|||
143099443|NCT00651261|515905885|FG000|Overall Study|Other disease or participant decisions|23|||
143099444|NCT00651261|515905886|FG001|Overall Study|Other disease or participant decisions|23|||
143099445|NCT00651261|515905885|FG000|Overall Study|Never treated|5|||
143099446|NCT00651261|515905886|FG001|Overall Study|Never treated|3|||
143099447|NCT01134107|515905888|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
143099448|NCT01134107|515905889|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
143099449|NCT01134107|515905888|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
143099450|NCT01134107|515905889|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
143099451|NCT01134107|515905888|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
143099452|NCT01134107|515905889|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
143099453|NCT01134107|515905888|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
143099454|NCT01134107|515905889|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
143177252|NCT04592341|516197834|FG000|Overall Study|Adverse Event|5|||
143177253|NCT04592341|516197834|FG000|Overall Study|other|4|||
143177254|NCT00692003|516197835|FG000|Overall Study|Sponsor Decision|5|||
143177255|NCT00692003|516197836|FG001|Overall Study|Sponsor Decision|1|||
143177256|NCT00661830|516197837|FG000|Overall Study|Death|37|||
143177257|NCT00661830|516197838|FG001|Overall Study|Death|33|||
143177258|NCT00661830|516197837|FG000|Overall Study|Lost to Follow-up|1|||
143177259|NCT00661830|516197838|FG001|Overall Study|Lost to Follow-up|3|||
143251901|NCT00600119|516476375|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
143251902|NCT00600119|516476376|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
143251903|NCT00600119|516476371|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
143251904|NCT00600119|516476372|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
143251905|NCT00600119|516476373|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
143251906|NCT00600119|516476374|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
143251907|NCT00600119|516476375|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
143251908|NCT00600119|516476376|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
143251909|NCT00600119|516476371|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
143251910|NCT00600119|516476372|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
143251911|NCT00600119|516476373|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
143251912|NCT00600119|516476374|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
143251913|NCT00600119|516476375|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
143251914|NCT00600119|516476376|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
143251915|NCT00600119|516476371|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
143251916|NCT00600119|516476372|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
143251917|NCT00600119|516476373|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
143251918|NCT00600119|516476374|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
143251919|NCT00600119|516476375|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
143251920|NCT00600119|516476376|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
143251921|NCT00600119|516476371|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
143251922|NCT00600119|516476372|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
143251923|NCT00600119|516476373|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
143251924|NCT00600119|516476374|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
143251925|NCT00600119|516476375|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
143251926|NCT00600119|516476376|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
143251927|NCT00600119|516476371|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
143251928|NCT00600119|516476372|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
143251929|NCT00600119|516476373|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
143251930|NCT00600119|516476374|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
143251931|NCT00600119|516476375|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
143251932|NCT00600119|516476376|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
143251933|NCT00600119|516476371|FG000|Double-blind Treatment Period|Other|0|||
143251934|NCT00600119|516476372|FG001|Double-blind Treatment Period|Other|0|||
143251935|NCT00600119|516476373|FG002|Double-blind Treatment Period|Other|0|||
143251936|NCT00600119|516476374|FG003|Double-blind Treatment Period|Other|0|||
143251937|NCT00600119|516476375|FG004|Double-blind Treatment Period|Other|2|||
143251938|NCT00600119|516476376|FG005|Double-blind Treatment Period|Other|1|||
143251939|NCT00600119|516476371|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
143251940|NCT00600119|516476372|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
143251941|NCT00600119|516476373|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
143251942|NCT00600119|516476374|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
143251943|NCT00600119|516476375|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
143251944|NCT00600119|516476376|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
143251945|NCT00600119|516476371|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
143251946|NCT00600119|516476372|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
143251947|NCT00600119|516476373|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
143251948|NCT00600119|516476374|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
143251949|NCT00600119|516476375|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
143099455|NCT01134107|515905888|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
143099456|NCT01134107|515905889|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
143099457|NCT01134107|515905888|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
143099458|NCT01134107|515905889|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
143099459|NCT01134107|515905888|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
143099460|NCT01134107|515905889|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
143099461|NCT00687271|515905890|FG000|Overall Study|Adverse Event|1|||
143099462|NCT00687271|515905891|FG001|Overall Study|Adverse Event|3|||
143099463|NCT00687271|515905892|FG002|Overall Study|Adverse Event|1|||
143099464|NCT00687271|515905893|FG003|Overall Study|Adverse Event|0|||
143099465|NCT00687271|515905890|FG000|Overall Study|Lost to Follow-up|0|||
143099466|NCT00687271|515905891|FG001|Overall Study|Lost to Follow-up|1|||
143099467|NCT00687271|515905892|FG002|Overall Study|Lost to Follow-up|0|||
143099468|NCT00687271|515905893|FG003|Overall Study|Lost to Follow-up|0|||
143251950|NCT00600119|516476376|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
143251951|NCT00600119|516476371|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
143251952|NCT00600119|516476372|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
143251953|NCT00600119|516476373|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
143251954|NCT00600119|516476374|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
143251955|NCT00600119|516476375|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
143251956|NCT00600119|516476376|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
143251957|NCT00600119|516476371|FG000|Double-blind Treatment Period|Physician Decision|2|||
143251958|NCT00600119|516476372|FG001|Double-blind Treatment Period|Physician Decision|0|||
143251959|NCT00600119|516476373|FG002|Double-blind Treatment Period|Physician Decision|0|||
143251960|NCT00600119|516476374|FG003|Double-blind Treatment Period|Physician Decision|0|||
143251961|NCT00600119|516476375|FG004|Double-blind Treatment Period|Physician Decision|0|||
143251962|NCT00600119|516476376|FG005|Double-blind Treatment Period|Physician Decision|0|||
143251963|NCT00600119|516476371|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
143251964|NCT00600119|516476372|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
143251965|NCT00600119|516476373|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
143251966|NCT00600119|516476374|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
143251967|NCT00600119|516476375|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
143251968|NCT00600119|516476376|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
143251969|NCT00600119|516476371|FG000|Double-blind Treatment Period|Adverse Event|1|||
143251970|NCT00600119|516476372|FG001|Double-blind Treatment Period|Adverse Event|1|||
143251971|NCT00600119|516476373|FG002|Double-blind Treatment Period|Adverse Event|0|||
143251972|NCT00600119|516476374|FG003|Double-blind Treatment Period|Adverse Event|1|||
143251973|NCT00600119|516476375|FG004|Double-blind Treatment Period|Adverse Event|2|||
143251974|NCT00600119|516476376|FG005|Double-blind Treatment Period|Adverse Event|10|||
143251975|NCT00600119|516476371|FG000|Follow-up Period|Adverse Event|0|||
143251976|NCT00600119|516476372|FG001|Follow-up Period|Adverse Event|0|||
143251977|NCT00600119|516476373|FG002|Follow-up Period|Adverse Event|0|||
143251978|NCT00600119|516476374|FG003|Follow-up Period|Adverse Event|0|||
143251979|NCT00600119|516476375|FG004|Follow-up Period|Adverse Event|0|||
143251980|NCT00600119|516476376|FG005|Follow-up Period|Adverse Event|1|||
143251981|NCT00600119|516476371|FG000|Follow-up Period|Other|1|||
143251982|NCT00600119|516476372|FG001|Follow-up Period|Other|0|||
143251983|NCT00600119|516476373|FG002|Follow-up Period|Other|0|||
143251984|NCT00600119|516476374|FG003|Follow-up Period|Other|0|||
143251985|NCT00600119|516476375|FG004|Follow-up Period|Other|0|||
143251986|NCT00600119|516476376|FG005|Follow-up Period|Other|0|||
143251987|NCT00729469|516476377|FG000|Overall Study|Adverse Event|14|||
143251988|NCT00729469|516476378|FG001|Overall Study|Adverse Event|25|||
143251989|NCT00729469|516476377|FG000|Overall Study|Lost to Follow-up|9|||
143251990|NCT00729469|516476378|FG001|Overall Study|Lost to Follow-up|9|||
143251991|NCT00729469|516476377|FG000|Overall Study|Protocol Violation|2|||
143251992|NCT00729469|516476378|FG001|Overall Study|Protocol Violation|1|||
143251993|NCT00729469|516476377|FG000|Overall Study|Withdrawal by Subject|19|||
143251994|NCT00729469|516476378|FG001|Overall Study|Withdrawal by Subject|8|||
143251995|NCT00729469|516476377|FG000|Overall Study|Other-Not mentioned|9|||
143251996|NCT00729469|516476378|FG001|Overall Study|Other-Not mentioned|4|||
143251997|NCT00561977|516476381|FG000|Overall Study|Withdrawal by Subject|0|||
143251998|NCT00561977|516476382|FG001|Overall Study|Withdrawal by Subject|2|||
143251999|NCT00561977|516476383|FG002|Overall Study|Withdrawal by Subject|1|||
143252000|NCT00561977|516476381|FG000|Overall Study|Pregnancy|0|||
143252001|NCT00561977|516476382|FG001|Overall Study|Pregnancy|1|||
143252002|NCT00561977|516476383|FG002|Overall Study|Pregnancy|1|||
143252003|NCT00977080|516476384|FG000|Overall Study|Adverse Event|2|||
143252004|NCT00977080|516476385|FG001|Overall Study|Adverse Event|7|||
143252005|NCT00977080|516476386|FG002|Overall Study|Adverse Event|7|||
143252006|NCT00977080|516476387|FG003|Overall Study|Adverse Event|7|||
143252007|NCT00977080|516476384|FG000|Overall Study|Withdrawal by Subject|1|||
143252008|NCT00977080|516476385|FG001|Overall Study|Withdrawal by Subject|5|||
143252009|NCT00977080|516476386|FG002|Overall Study|Withdrawal by Subject|1|||
143252010|NCT00977080|516476387|FG003|Overall Study|Withdrawal by Subject|5|||
143252011|NCT00977080|516476384|FG000|Overall Study|Protocol Violation|7|||
143252012|NCT00977080|516476385|FG001|Overall Study|Protocol Violation|3|||
143252013|NCT00977080|516476386|FG002|Overall Study|Protocol Violation|4|||
143252014|NCT00977080|516476387|FG003|Overall Study|Protocol Violation|3|||
143252015|NCT00977080|516476384|FG000|Overall Study|Noncompliance|0|||
143252016|NCT00977080|516476385|FG001|Overall Study|Noncompliance|2|||
143252017|NCT00977080|516476386|FG002|Overall Study|Noncompliance|1|||
143252018|NCT00977080|516476387|FG003|Overall Study|Noncompliance|0|||
143252019|NCT00977080|516476384|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
143252020|NCT00977080|516476385|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
143099469|NCT00687271|515905890|FG000|Overall Study|Protocol Violation|2|||
143099470|NCT00687271|515905891|FG001|Overall Study|Protocol Violation|1|||
143099471|NCT00687271|515905892|FG002|Overall Study|Protocol Violation|1|||
143099472|NCT00687271|515905893|FG003|Overall Study|Protocol Violation|0|||
143099473|NCT00687271|515905890|FG000|Overall Study|Withdrawal by Subject|0|||
143099474|NCT00687271|515905891|FG001|Overall Study|Withdrawal by Subject|1|||
143099475|NCT00687271|515905892|FG002|Overall Study|Withdrawal by Subject|3|||
143099476|NCT00687271|515905893|FG003|Overall Study|Withdrawal by Subject|0|||
143099477|NCT02027545|515905895|FG000|Overall Study|Failed to sign HIPAA|0|||
143099478|NCT02027545|515905896|FG001|Overall Study|Failed to sign HIPAA|2|||
143099479|NCT02027545|515905895|FG000|Overall Study|Failed to attend study visit|2|||
143099480|NCT02027545|515905896|FG001|Overall Study|Failed to attend study visit|0|||
143099481|NCT02027545|515905895|FG000|Overall Study|Protocol Violation|1|||
143099482|NCT02027545|515905896|FG001|Overall Study|Protocol Violation|0|||
143099483|NCT02693106|515905898|FG000|Overall Study|No time|3|||
143099484|NCT03351608|515905899|FG000|Overall Study|Lost to Follow-up|0|||
143099485|NCT03351608|515905900|FG001|Overall Study|Lost to Follow-up|1|||
143099486|NCT03351608|515905901|FG002|Overall Study|Lost to Follow-up|1|||
143099487|NCT03351608|515905902|FG003|Overall Study|Lost to Follow-up|1|||
143099488|NCT03351608|515905903|FG004|Overall Study|Lost to Follow-up|1|||
143099489|NCT03351608|515905899|FG000|Overall Study|Physician Decision|1|||
143099490|NCT03351608|515905900|FG001|Overall Study|Physician Decision|0|||
143099491|NCT03351608|515905901|FG002|Overall Study|Physician Decision|0|||
143099492|NCT03351608|515905902|FG003|Overall Study|Physician Decision|2|||
143099493|NCT03351608|515905903|FG004|Overall Study|Physician Decision|1|||
143099494|NCT03351608|515905899|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
143099495|NCT03351608|515905900|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
143099496|NCT03351608|515905901|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
143099497|NCT03351608|515905902|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
143099498|NCT03351608|515905903|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
143099499|NCT03351608|515905899|FG000|Overall Study|Withdrawal by parent/guardian|0|||
143099500|NCT03351608|515905900|FG001|Overall Study|Withdrawal by parent/guardian|0|||
143099501|NCT03351608|515905901|FG002|Overall Study|Withdrawal by parent/guardian|1|||
143099502|NCT03351608|515905902|FG003|Overall Study|Withdrawal by parent/guardian|1|||
143099503|NCT03351608|515905903|FG004|Overall Study|Withdrawal by parent/guardian|0|||
143099504|NCT03351608|515905899|FG000|Overall Study|Other|0|||
143099505|NCT03351608|515905900|FG001|Overall Study|Other|1|||
143099506|NCT03351608|515905901|FG002|Overall Study|Other|1|||
143099507|NCT03351608|515905902|FG003|Overall Study|Other|3|||
143099508|NCT03351608|515905903|FG004|Overall Study|Other|0|||
143099509|NCT02727478|515905904|FG000|Overall Study|Withdrawal by Subject|8|||
143252021|NCT00977080|516476386|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
143252022|NCT00977080|516476387|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
143252023|NCT00977080|516476384|FG000|Overall Study|Required kidney transplantation|1|||
143252024|NCT00977080|516476385|FG001|Overall Study|Required kidney transplantation|3|||
143099510|NCT02727478|515905905|FG001|Overall Study|Withdrawal by Subject|10|||
143099511|NCT02633293|515905906|FG000|Overall Study|Death|56|||
143099512|NCT02633293|515905906|FG000|Overall Study|Progressive Disease|12|||
143099513|NCT02633293|515905906|FG000|Overall Study|Adverse Event|29|||
143099514|NCT02633293|515905906|FG000|Overall Study|Withdrawal by Subject|41|||
143099515|NCT02633293|515905906|FG000|Overall Study|Protocol Violation|1|||
143099516|NCT02633293|515905906|FG000|Overall Study|Lost to Follow-up|1|||
143099517|NCT02633293|515905906|FG000|Overall Study|Study Terminated by Sponsor|24|||
143099518|NCT02633293|515905906|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
143099519|NCT02633293|515905906|FG000|Overall Study|Lung Transplant|5|||
143099520|NCT02633293|515905906|FG000|Overall Study|Lack of Efficacy|2|||
143099521|NCT02633293|515905906|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
143099522|NCT01017874|515905907|FG000|Overall Study|Withdrawal by Subject|23|||
143099523|NCT01017874|515905908|FG001|Overall Study|Withdrawal by Subject|20|||
143099524|NCT01017874|515905907|FG000|Overall Study|Sponsor decision|3|||
143099525|NCT01017874|515905908|FG001|Overall Study|Sponsor decision|1|||
143099526|NCT01017874|515905907|FG000|Overall Study|Lost to Follow-up|3|||
143099527|NCT01017874|515905908|FG001|Overall Study|Lost to Follow-up|2|||
143099528|NCT01017874|515905907|FG000|Overall Study|Physician Decision|1|||
143099529|NCT01017874|515905908|FG001|Overall Study|Physician Decision|3|||
143099530|NCT00808210|515905909|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
143099531|NCT00808210|515905910|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
143099532|NCT00808210|515905909|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
143099533|NCT00808210|515905910|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
143099534|NCT00808210|515905909|FG000|Double-Blind TX Period|Adverse Event|0|||
143099535|NCT00808210|515905910|FG001|Double-Blind TX Period|Adverse Event|1|||
143099536|NCT00808210|515905909|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
143099537|NCT00808210|515905910|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
143099538|NCT00808210|515905909|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
143099539|NCT00808210|515905910|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
143099540|NCT00808210|515905909|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
143099541|NCT00808210|515905910|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
143099542|NCT00778817|515905915|FG000|Overall Study|Adverse Event|2|||
143099543|NCT00778817|515905915|FG000|Overall Study|Withdrawal by Subject|2|||
143099544|NCT01954056|515905916|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
143099545|NCT01954056|515905917|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
143099546|NCT00507455|515905924|FG000|Overall Study|Adverse Event|3|||
143099547|NCT00507455|515905925|FG001|Overall Study|Adverse Event|3|||
143099548|NCT00507455|515905926|FG002|Overall Study|Adverse Event|6|||
143099549|NCT00507455|515905924|FG000|Overall Study|Withdrawal by Subject|2|||
143099550|NCT00507455|515905925|FG001|Overall Study|Withdrawal by Subject|1|||
143099551|NCT00507455|515905926|FG002|Overall Study|Withdrawal by Subject|2|||
143099552|NCT00507455|515905924|FG000|Overall Study|Protocol Violation|4|||
143099553|NCT00507455|515905925|FG001|Overall Study|Protocol Violation|1|||
143099554|NCT00507455|515905926|FG002|Overall Study|Protocol Violation|1|||
143099555|NCT00507455|515905924|FG000|Overall Study|Lost to Follow-up|2|||
143099556|NCT00507455|515905925|FG001|Overall Study|Lost to Follow-up|0|||
143099557|NCT00507455|515905926|FG002|Overall Study|Lost to Follow-up|2|||
143099558|NCT00507455|515905924|FG000|Overall Study|Lack of Efficacy|0|||
143099559|NCT00507455|515905925|FG001|Overall Study|Lack of Efficacy|1|||
143099560|NCT00507455|515905926|FG002|Overall Study|Lack of Efficacy|0|||
143099561|NCT00507455|515905924|FG000|Overall Study|Other - miscellaneous reason|1|||
143099562|NCT00507455|515905925|FG001|Overall Study|Other - miscellaneous reason|0|||
143099563|NCT00507455|515905926|FG002|Overall Study|Other - miscellaneous reason|1|||
143099564|NCT03309943|515905927|FG000|Overall Study|Withdrawal by Subject|0|||
143099565|NCT03309943|515905928|FG001|Overall Study|Withdrawal by Subject|1|||
143099566|NCT03309943|515905927|FG000|Overall Study|Inappropriate behavior towards staff|0|||
143099567|NCT03309943|515905928|FG001|Overall Study|Inappropriate behavior towards staff|1|||
143099568|NCT02914613|515905929|FG000|Overall Study|Withdrawal by Subject|1|||
143099569|NCT02914613|515905930|FG001|Overall Study|Withdrawal by Subject|2|||
143099570|NCT02914613|515905929|FG000|Overall Study|Adverse Event|1|||
143099571|NCT02914613|515905930|FG001|Overall Study|Adverse Event|0|||
143177260|NCT00661830|516197837|FG000|Overall Study|Withdrawal by Subject|1|||
143177261|NCT00661830|516197838|FG001|Overall Study|Withdrawal by Subject|1|||
143177262|NCT00661830|516197837|FG000|Overall Study|Other reason|1|||
143177263|NCT00661830|516197838|FG001|Overall Study|Other reason|5|||
143177264|NCT00488514|516197839|FG000|Overall Study|Adverse Event|41|||
143177265|NCT00488514|516197839|FG000|Overall Study|Lost to Follow-up|44|||
143177266|NCT00488514|516197839|FG000|Overall Study|Protocol Violation|32|||
143177267|NCT00488514|516197839|FG000|Overall Study|Withdrawal by Subject|106|||
143177268|NCT00488514|516197839|FG000|Overall Study|Lack of Efficacy|28|||
143177269|NCT00488514|516197839|FG000|Overall Study|Did not meet criteria for treatment|30|||
143177270|NCT00488514|516197839|FG000|Overall Study|Postive drug screen|1|||
143177271|NCT00488514|516197839|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
143177272|NCT00488514|516197839|FG000|Overall Study|Investigator decision|1|||
143177273|NCT00488514|516197839|FG000|Overall Study|Participant had too few migraines|5|||
143177274|NCT00488514|516197839|FG000|Overall Study|Increase in number of migraines|2|||
143177275|NCT00488514|516197839|FG000|Overall Study|Increased use of concomitant medication|1|||
143177276|NCT00517699|516197842|FG000|Overall Study|Withdrawal by Subject|1|||
143252025|NCT00977080|516476386|FG002|Overall Study|Required kidney transplantation|3|||
143252026|NCT00977080|516476387|FG003|Overall Study|Required kidney transplantation|1|||
143252027|NCT00977080|516476384|FG000|Overall Study|Travel for family reasons|1|||
143099572|NCT00789373|515905931|FG000|Induction|Adverse Event|64|||
143099573|NCT00789373|515905932|FG001|Induction|Adverse Event|0|||
143177277|NCT00517699|516197842|FG000|Overall Study|Lack of Efficacy|1|||
143099574|NCT00789373|515905933|FG002|Induction|Adverse Event|0|||
143177278|NCT00517699|516197842|FG000|Overall Study|Administrative error|1|||
143177279|NCT00517699|516197842|FG000|Overall Study|Study terminated by Sponsor|2|||
143099575|NCT00789373|515905931|FG000|Induction|Death Due to study disease|24|||
143099576|NCT00789373|515905932|FG001|Induction|Death Due to study disease|0|||
143099577|NCT00789373|515905933|FG002|Induction|Death Due to study disease|0|||
143099578|NCT00789373|515905931|FG000|Induction|Death due to adverse event|19|||
143099579|NCT00789373|515905932|FG001|Induction|Death due to adverse event|0|||
143099580|NCT00789373|515905933|FG002|Induction|Death due to adverse event|0|||
143099581|NCT00789373|515905931|FG000|Induction|Death due to toxicity|11|||
143099582|NCT00789373|515905932|FG001|Induction|Death due to toxicity|0|||
143099583|NCT00789373|515905933|FG002|Induction|Death due to toxicity|0|||
143099584|NCT00789373|515905931|FG000|Induction|Death due to procedure|1|||
143099585|NCT00789373|515905932|FG001|Induction|Death due to procedure|0|||
143099586|NCT00789373|515905933|FG002|Induction|Death due to procedure|0|||
143099587|NCT00789373|515905931|FG000|Induction|Investigator decision|7|||
143099588|NCT00789373|515905932|FG001|Induction|Investigator decision|0|||
143099589|NCT00789373|515905933|FG002|Induction|Investigator decision|0|||
143099590|NCT00789373|515905931|FG000|Induction|Protocol entry criteria not met|9|||
143099591|NCT00789373|515905932|FG001|Induction|Protocol entry criteria not met|0|||
143099592|NCT00789373|515905933|FG002|Induction|Protocol entry criteria not met|0|||
143099593|NCT00789373|515905931|FG000|Induction|Lost to Follow-up|6|||
143099594|NCT00789373|515905932|FG001|Induction|Lost to Follow-up|0|||
143099595|NCT00789373|515905933|FG002|Induction|Lost to Follow-up|0|||
143099596|NCT00789373|515905931|FG000|Induction|Protocol Violation|1|||
143099597|NCT00789373|515905932|FG001|Induction|Protocol Violation|0|||
143099598|NCT00789373|515905933|FG002|Induction|Protocol Violation|0|||
143099599|NCT00789373|515905931|FG000|Induction|Progressive Disease|220|||
143099600|NCT00789373|515905932|FG001|Induction|Progressive Disease|0|||
143099601|NCT00789373|515905933|FG002|Induction|Progressive Disease|0|||
143099602|NCT00789373|515905931|FG000|Induction|Withdrawal by Subject|37|||
143099603|NCT00789373|515905932|FG001|Induction|Withdrawal by Subject|0|||
143099604|NCT00789373|515905933|FG002|Induction|Withdrawal by Subject|0|||
143099605|NCT00789373|515905931|FG000|Maintenance|Adverse Event|0|||
143099606|NCT00789373|515905932|FG001|Maintenance|Adverse Event|65|||
143099607|NCT00789373|515905933|FG002|Maintenance|Adverse Event|12|||
143099608|NCT00789373|515905931|FG000|Maintenance|Death due to study disease|0|||
143099609|NCT00789373|515905932|FG001|Maintenance|Death due to study disease|3|||
143099610|NCT00789373|515905933|FG002|Maintenance|Death due to study disease|1|||
143099611|NCT00789373|515905931|FG000|Maintenance|Death due to adverse event|0|||
143099612|NCT00789373|515905932|FG001|Maintenance|Death due to adverse event|4|||
143099613|NCT00789373|515905933|FG002|Maintenance|Death due to adverse event|1|||
143099614|NCT00789373|515905931|FG000|Maintenance|Death due to toxicity|0|||
143099615|NCT00789373|515905932|FG001|Maintenance|Death due to toxicity|1|||
143099616|NCT00789373|515905933|FG002|Maintenance|Death due to toxicity|2|||
143099617|NCT00789373|515905931|FG000|Maintenance|Investigator Decision|0|||
143099618|NCT00789373|515905932|FG001|Maintenance|Investigator Decision|4|||
143099619|NCT00789373|515905933|FG002|Maintenance|Investigator Decision|2|||
143099620|NCT00789373|515905931|FG000|Maintenance|Protocol entry criteria not met|0|||
143099621|NCT00789373|515905932|FG001|Maintenance|Protocol entry criteria not met|2|||
143099622|NCT00789373|515905933|FG002|Maintenance|Protocol entry criteria not met|0|||
143099623|NCT00789373|515905931|FG000|Maintenance|Lost to Follow-up|0|||
143099624|NCT00789373|515905932|FG001|Maintenance|Lost to Follow-up|2|||
143099625|NCT00789373|515905933|FG002|Maintenance|Lost to Follow-up|0|||
143099626|NCT00789373|515905931|FG000|Maintenance|Progressive Disease|0|||
143099627|NCT00789373|515905932|FG001|Maintenance|Progressive Disease|253|||
143099628|NCT00789373|515905933|FG002|Maintenance|Progressive Disease|152|||
143099629|NCT00789373|515905931|FG000|Maintenance|Withdrawal by Subject|0|||
143099630|NCT00789373|515905932|FG001|Maintenance|Withdrawal by Subject|21|||
143099631|NCT00789373|515905933|FG002|Maintenance|Withdrawal by Subject|8|||
143099632|NCT00789373|515905931|FG000|Maintenance|Sponsor Decision|0|||
143099633|NCT00789373|515905932|FG001|Maintenance|Sponsor Decision|0|||
143099634|NCT00789373|515905933|FG002|Maintenance|Sponsor Decision|2|||
143099635|NCT00789373|515905931|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
143099636|NCT00789373|515905932|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
143099637|NCT00789373|515905933|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
143099638|NCT04178122|515905935|FG000|Overall Study|Withdrawal by Subject|1|||
143099639|NCT04178122|515905936|FG001|Overall Study|Withdrawal by Subject|1|||
143099640|NCT04178122|515905935|FG000|Overall Study|Death|2|||
143099641|NCT04178122|515905936|FG001|Overall Study|Death|0|||
143099642|NCT04178122|515905935|FG000|Overall Study|Did not complete testing|3|||
143252028|NCT00977080|516476385|FG001|Overall Study|Travel for family reasons|0|||
143099643|NCT04178122|515905936|FG001|Overall Study|Did not complete testing|13|||
143099644|NCT01753570|515905943|FG000|Overall Study|Adverse Event|1|||
143099645|NCT01753570|515905944|FG001|Overall Study|Adverse Event|0|||
143099646|NCT01753570|515905945|FG002|Overall Study|Adverse Event|1|||
143099647|NCT01753570|515905943|FG000|Overall Study|Physician Decision|0|||
143099648|NCT01753570|515905944|FG001|Overall Study|Physician Decision|1|||
143099649|NCT01753570|515905945|FG002|Overall Study|Physician Decision|0|||
143099650|NCT01753570|515905943|FG000|Overall Study|Withdrawal by Subject|1|||
143099651|NCT01753570|515905944|FG001|Overall Study|Withdrawal by Subject|4|||
143099652|NCT01753570|515905945|FG002|Overall Study|Withdrawal by Subject|0|||
143099653|NCT01791894|515905946|FG000|Overall Study|Adverse Event|1|||
143099654|NCT02268916|515905947|FG000|Overall Study|Lost to Follow-up|1|||
143099655|NCT02268916|515905948|FG001|Overall Study|Lost to Follow-up|1|||
143099656|NCT02268916|515905947|FG000|Overall Study|Withdrawal by Subject|6|||
143099657|NCT02268916|515905948|FG001|Overall Study|Withdrawal by Subject|5|||
143099658|NCT02268916|515905947|FG000|Overall Study|Participant did not have diabetes|1|||
143099659|NCT02268916|515905948|FG001|Overall Study|Participant did not have diabetes|0|||
143099660|NCT02268916|515905947|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
143099661|NCT02268916|515905948|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
143099662|NCT03926117|515905951|FG000|Overall Study|Unclassified|1|||
143099663|NCT03926117|515905952|FG001|Overall Study|Unclassified|4|||
143099664|NCT03926117|515905953|FG002|Overall Study|Unclassified|1|||
143099665|NCT03926117|515905954|FG003|Overall Study|Unclassified|4|||
143099666|NCT03926117|515905951|FG000|Overall Study|Withdrawal by Subject|3|||
143099667|NCT03926117|515905952|FG001|Overall Study|Withdrawal by Subject|0|||
143099668|NCT03926117|515905953|FG002|Overall Study|Withdrawal by Subject|1|||
143099669|NCT03926117|515905954|FG003|Overall Study|Withdrawal by Subject|1|||
143099670|NCT03926117|515905951|FG000|Overall Study|Lost to Follow-up|0|||
143099671|NCT03926117|515905952|FG001|Overall Study|Lost to Follow-up|2|||
143099672|NCT03926117|515905953|FG002|Overall Study|Lost to Follow-up|1|||
143099673|NCT03926117|515905954|FG003|Overall Study|Lost to Follow-up|0|||
143099674|NCT03926117|515905951|FG000|Overall Study|Adverse Event|1|||
143099675|NCT03926117|515905952|FG001|Overall Study|Adverse Event|2|||
143099676|NCT03926117|515905953|FG002|Overall Study|Adverse Event|3|||
143099677|NCT03926117|515905954|FG003|Overall Study|Adverse Event|1|||
143099678|NCT03926117|515905951|FG000|Overall Study|Randomized but not treated|1|||
143099679|NCT03926117|515905952|FG001|Overall Study|Randomized but not treated|1|||
143099680|NCT03926117|515905953|FG002|Overall Study|Randomized but not treated|0|||
143099681|NCT03926117|515905954|FG003|Overall Study|Randomized but not treated|1|||
143099682|NCT04830969|515905956|FG000|Overall Study|Withdrawal by Subject|6|||
143099683|NCT04830969|515905957|FG001|Overall Study|Withdrawal by Subject|2|||
143099684|NCT04830969|515905956|FG000|Overall Study|Protocol Violation|3|||
143099685|NCT04830969|515905957|FG001|Overall Study|Protocol Violation|9|||
143099686|NCT04830969|515905956|FG000|Overall Study|Lost to Follow-up|4|||
143099687|NCT04830969|515905957|FG001|Overall Study|Lost to Follow-up|4|||
143099688|NCT05107492|515905960|FG000|Overall Study|Lost to Follow-up|1|||
143099689|NCT05107492|515905961|FG001|Overall Study|Lost to Follow-up|0|||
143099690|NCT04495751|515905966|FG000|Overall Study|Withdrawal by Subject|1|||
143099691|NCT04495751|515905967|FG001|Overall Study|Withdrawal by Subject|0|||
143099692|NCT04495751|515905966|FG000|Overall Study|Lost to Follow-up|1|||
143099693|NCT04495751|515905967|FG001|Overall Study|Lost to Follow-up|0|||
143099694|NCT03289754|515905968|FG000|Overall Study|Screen Failure or Failure to Meet Follow-up|3|||
143099695|NCT04873934|515905969|FG000|Overall Study|Adverse Event|0|||
143252029|NCT00977080|516476386|FG002|Overall Study|Travel for family reasons|0|||
143252030|NCT00977080|516476387|FG003|Overall Study|Travel for family reasons|0|||
143252031|NCT01616693|516476388|FG000|Evaluated for Safety|Physician Decision|1|||
143252032|NCT01616693|516476389|FG001|Evaluated for Safety|Physician Decision|0|||
143252033|NCT01616693|516476390|FG002|Evaluated for Safety|Physician Decision|1|||
143099696|NCT04873934|515905970|FG001|Overall Study|Adverse Event|1|||
143099697|NCT04873934|515905969|FG000|Overall Study|Death|0|||
143099698|NCT04873934|515905970|FG001|Overall Study|Death|2|||
143099699|NCT04873934|515905969|FG000|Overall Study|Lost to Follow-up|13|||
143099700|NCT04873934|515905970|FG001|Overall Study|Lost to Follow-up|9|||
143099701|NCT04873934|515905969|FG000|Overall Study|Physician Decision|1|||
143099702|NCT04873934|515905970|FG001|Overall Study|Physician Decision|1|||
143252034|NCT01616693|516476391|FG003|Evaluated for Safety|Physician Decision|0|||
143252035|NCT01616693|516476388|FG000|Received Both Vaccines|Adverse Event|2|||
143252036|NCT01616693|516476389|FG001|Received Both Vaccines|Adverse Event|0|||
143252037|NCT01616693|516476390|FG002|Received Both Vaccines|Adverse Event|0|||
143099703|NCT04873934|515905969|FG000|Overall Study|Protocol deviation|2|||
143099704|NCT04873934|515905970|FG001|Overall Study|Protocol deviation|1|||
143099705|NCT04873934|515905969|FG000|Overall Study|Subject decision|1|||
143099706|NCT04873934|515905970|FG001|Overall Study|Subject decision|8|||
143099707|NCT04873934|515905969|FG000|Overall Study|Withdrew consent|0|||
143099708|NCT04873934|515905970|FG001|Overall Study|Withdrew consent|4|||
143099709|NCT04873934|515905969|FG000|Overall Study|Missing|1|||
143099710|NCT04873934|515905970|FG001|Overall Study|Missing|0|||
143099711|NCT00708461|515905974|FG000|Overall Study|Lost to Follow-up|18|||
143099712|NCT00708461|515905975|FG001|Overall Study|Lost to Follow-up|11|||
143099713|NCT00708461|515905974|FG000|Overall Study|Withdrawal by Subject|8|||
143099714|NCT00708461|515905975|FG001|Overall Study|Withdrawal by Subject|9|||
143099715|NCT00708461|515905974|FG000|Overall Study|left workforce|115|||
143099716|NCT00708461|515905975|FG001|Overall Study|left workforce|180|||
143099717|NCT03584854|515905976|FG000|Overall Study|Primary outcome not measured|1|||
143099718|NCT03584854|515905977|FG001|Overall Study|Primary outcome not measured|2|||
143099719|NCT02907177|515905978|FG000|Overall Study|Death|0|||
143099720|NCT02907177|515905979|FG001|Overall Study|Death|1|||
143099721|NCT02907177|515905978|FG000|Overall Study|Physician Decision|3|||
143099722|NCT02907177|515905979|FG001|Overall Study|Physician Decision|3|||
143099723|NCT02907177|515905978|FG000|Overall Study|Withdrawal by Subject|15|||
143099724|NCT02907177|515905979|FG001|Overall Study|Withdrawal by Subject|7|||
143099725|NCT02907177|515905978|FG000|Overall Study|Sponsor's Decision|50|||
143099726|NCT02907177|515905979|FG001|Overall Study|Sponsor's Decision|57|||
143099727|NCT04681066|515905980|FG000|Overall Study|Lost to Follow-up|3|||
143099728|NCT04681066|515905981|FG001|Overall Study|Lost to Follow-up|1|||
143099729|NCT04681066|515905982|FG002|Overall Study|Lost to Follow-up|2|||
143099730|NCT04681066|515905983|FG003|Overall Study|Lost to Follow-up|1|||
143099731|NCT04681066|515905980|FG000|Overall Study|Withdrawal by Subject|2|||
143099732|NCT04681066|515905981|FG001|Overall Study|Withdrawal by Subject|1|||
143099733|NCT04681066|515905982|FG002|Overall Study|Withdrawal by Subject|0|||
143099734|NCT04681066|515905983|FG003|Overall Study|Withdrawal by Subject|3|||
143099735|NCT04681066|515905980|FG000|Overall Study|Death|0|||
143099736|NCT04681066|515905981|FG001|Overall Study|Death|1|||
143099737|NCT04681066|515905982|FG002|Overall Study|Death|0|||
143099738|NCT04681066|515905983|FG003|Overall Study|Death|0|||
143099739|NCT00987337|515905987|FG000|Overall Study|Adverse Event|10|||
143099740|NCT00987337|515905988|FG001|Overall Study|Adverse Event|9|||
143099741|NCT00987337|515905989|FG002|Overall Study|Adverse Event|8|||
143099742|NCT00987337|515905987|FG000|Overall Study|Insufficient Virologic Response|10|||
143099743|NCT00987337|515905988|FG001|Overall Study|Insufficient Virologic Response|7|||
143099744|NCT00987337|515905989|FG002|Overall Study|Insufficient Virologic Response|12|||
143099745|NCT00987337|515905987|FG000|Overall Study|Virologic Breakthrough|2|||
143099746|NCT00987337|515905988|FG001|Overall Study|Virologic Breakthrough|2|||
143099747|NCT00987337|515905989|FG002|Overall Study|Virologic Breakthrough|8|||
143099748|NCT00987337|515905987|FG000|Overall Study|Lost to Follow-up|10|||
143099749|NCT00987337|515905988|FG001|Overall Study|Lost to Follow-up|6|||
143099750|NCT00987337|515905989|FG002|Overall Study|Lost to Follow-up|2|||
143099751|NCT00987337|515905987|FG000|Overall Study|Withdrawal by Subject|6|||
143099752|NCT00987337|515905988|FG001|Overall Study|Withdrawal by Subject|9|||
143099753|NCT00987337|515905989|FG002|Overall Study|Withdrawal by Subject|9|||
143099754|NCT00987337|515905987|FG000|Overall Study|Other|0|||
143099755|NCT00987337|515905988|FG001|Overall Study|Other|2|||
143099756|NCT00987337|515905989|FG002|Overall Study|Other|5|||
143099757|NCT00987337|515905987|FG000|Overall Study|Protocol Violation|1|||
143099758|NCT00987337|515905988|FG001|Overall Study|Protocol Violation|0|||
143099759|NCT00987337|515905989|FG002|Overall Study|Protocol Violation|2|||
143099760|NCT00987337|515905987|FG000|Overall Study|Participant Relapsed|18|||
143099761|NCT00987337|515905988|FG001|Overall Study|Participant Relapsed|20|||
143099762|NCT00987337|515905989|FG002|Overall Study|Participant Relapsed|5|||
143099763|NCT05271370|515907576|FG000|Overall Study|Study early termination|8|||
143099764|NCT05271370|515907577|FG001|Overall Study|Study early termination|16|||
143099765|NCT05271370|515907578|FG002|Overall Study|Study early termination|29|||
143099766|NCT02151851|515907579|FG000|Overall Study|Lack of Efficacy|67|||
143099767|NCT02151851|515907580|FG001|Overall Study|Lack of Efficacy|94|||
143099768|NCT02151851|515907579|FG000|Overall Study|Protocol Violation|0|||
143099769|NCT02151851|515907580|FG001|Overall Study|Protocol Violation|1|||
143099770|NCT02151851|515907579|FG000|Overall Study|Withdrawal by Subject|2|||
143099771|NCT02151851|515907580|FG001|Overall Study|Withdrawal by Subject|5|||
143099772|NCT02151851|515907579|FG000|Overall Study|Medical impairment|1|||
143099773|NCT02151851|515907580|FG001|Overall Study|Medical impairment|0|||
143099774|NCT02151851|515907579|FG000|Overall Study|Low compliance to study visits|0|||
143099775|NCT02151851|515907580|FG001|Overall Study|Low compliance to study visits|1|||
143099776|NCT02151851|515907579|FG000|Overall Study|Subject entered into study in error|0|||
143099777|NCT02151851|515907580|FG001|Overall Study|Subject entered into study in error|1|||
143099778|NCT02151851|515907579|FG000|Overall Study|Adverse Event|6|||
143099779|NCT02151851|515907580|FG001|Overall Study|Adverse Event|28|||
143099780|NCT03048747|515907581|FG000|Overall Study|Adverse Event|2|||
143099781|NCT03048747|515907581|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
143099782|NCT03048747|515907581|FG000|Overall Study|Physician Decision|1|||
143099783|NCT00915018|515907582|FG000|Overall Study|Death|75|||
143099784|NCT00915018|515907583|FG001|Overall Study|Death|70|||
143099785|NCT00915018|515907582|FG000|Overall Study|Lost to Follow-up|10|||
143099786|NCT00915018|515907583|FG001|Overall Study|Lost to Follow-up|5|||
143099787|NCT00915018|515907582|FG000|Overall Study|Withdrawal by Subject|38|||
143099788|NCT00915018|515907583|FG001|Overall Study|Withdrawal by Subject|27|||
143099789|NCT00915018|515907582|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
143099790|NCT00915018|515907583|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
143099791|NCT04168112|515907584|FG000|Overall Study|Lost to Follow-up|1|||
143099792|NCT04168112|515907585|FG001|Overall Study|Lost to Follow-up|0|||
143099793|NCT04168112|515907584|FG000|Overall Study|Withdrawal by Subject|1|||
143099794|NCT04168112|515907585|FG001|Overall Study|Withdrawal by Subject|0|||
143099795|NCT00684411|515907586|FG000|Overall Study|New Primary Cancer|1|||
143099796|NCT00684411|515907586|FG000|Overall Study|Disease Progression|10|||
143099797|NCT00684411|515907586|FG000|Overall Study|Adverse Event|1|||
143099798|NCT06152224|515907598|FG000|Overall Study|Withdrawal by Subject|1|||
143099799|NCT06152224|515907599|FG001|Overall Study|Withdrawal by Subject|0|||
143099800|NCT06152224|515907598|FG000|Overall Study|Lost to Follow-up|0|||
143099801|NCT06152224|515907599|FG001|Overall Study|Lost to Follow-up|1|||
143099802|NCT06152224|515907598|FG000|Overall Study|On Follow Up|18|||
143099803|NCT06152224|515907599|FG001|Overall Study|On Follow Up|18|||
143099804|NCT00288626|515907603|FG000|Overall Study|Death|3|||
143099805|NCT00288626|515907603|FG000|Overall Study|Withdrawal by Subject|4|||
143099806|NCT01081769|515907608|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
143099807|NCT01081769|515907609|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
143099808|NCT01081769|515907608|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
143099809|NCT01081769|515907609|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
143099810|NCT01081769|515907608|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
143099811|NCT01081769|515907609|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
143099812|NCT01081769|515907608|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
143099813|NCT01081769|515907609|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
143099814|NCT01081769|515907608|FG000|CORE Intent-To-Treat|Adverse Event|14|||
143099815|NCT01081769|515907609|FG001|CORE Intent-To-Treat|Adverse Event|11|||
143099816|NCT01081769|515907608|FG000|CORE Intent-To-Treat|Death|1|||
143099817|NCT01081769|515907609|FG001|CORE Intent-To-Treat|Death|1|||
143099818|NCT01081769|515907608|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
143252038|NCT01616693|516476391|FG003|Received Both Vaccines|Adverse Event|0|||
143252039|NCT01616693|516476388|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
143252040|NCT01616693|516476389|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
143252041|NCT01616693|516476390|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
143252042|NCT01616693|516476391|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
143252043|NCT01616693|516476388|FG000|Received Both Vaccines|Lost to Follow-up|4|||
143099819|NCT01081769|515907609|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
143099820|NCT01081769|515907608|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
143099821|NCT01081769|515907609|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
143099822|NCT01081769|515907608|FG000|CORE Intent-To-Treat|Pregnancy|1|||
143099823|NCT01081769|515907609|FG001|CORE Intent-To-Treat|Pregnancy|0|||
143099824|NCT01081769|515907608|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
143099825|NCT01081769|515907609|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
143252044|NCT01616693|516476389|FG001|Received Both Vaccines|Lost to Follow-up|3|||
143252045|NCT01616693|516476390|FG002|Received Both Vaccines|Lost to Follow-up|4|||
143252046|NCT01616693|516476391|FG003|Received Both Vaccines|Lost to Follow-up|4|||
143252047|NCT01616693|516476388|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
143099826|NCT01081769|515907608|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
143099827|NCT01081769|515907609|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
143099828|NCT01081769|515907608|FG000|CORE Intent-To-Treat|Other|0|||
143252048|NCT01616693|516476389|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
143367745|NCT01143077|516889437|FG000|Overall Study|Lack of Efficacy|0|||
143099829|NCT01081769|515907609|FG001|CORE Intent-To-Treat|Other|1|||
143099830|NCT01081769|515907608|FG000|CORE Intent-To-Treat|Ineligibility|3|||
143099831|NCT01081769|515907609|FG001|CORE Intent-To-Treat|Ineligibility|4|||
143099832|NCT01081769|515907608|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
143099833|NCT01081769|515907609|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
143099834|NCT01081769|515907608|FG000|CORE Intent-To-Treat|Patient Moved|2|||
143099835|NCT01081769|515907609|FG001|CORE Intent-To-Treat|Patient Moved|2|||
143099836|NCT00105079|515907614|FG000|Overall Study|Adverse Event|5|||
143099837|NCT00105079|515907615|FG001|Overall Study|Adverse Event|12|||
143099838|NCT00105079|515907614|FG000|Overall Study|Death|3|||
143099839|NCT00105079|515907615|FG001|Overall Study|Death|1|||
143099840|NCT00105079|515907614|FG000|Overall Study|Lost to Follow-up|12|||
143099841|NCT00105079|515907615|FG001|Overall Study|Lost to Follow-up|12|||
143099842|NCT00105079|515907614|FG000|Overall Study|Lack of Efficacy|9|||
143099843|NCT00105079|515907615|FG001|Overall Study|Lack of Efficacy|3|||
143099844|NCT00105079|515907614|FG000|Overall Study|Refused treatment|6|||
143099845|NCT00105079|515907615|FG001|Overall Study|Refused treatment|4|||
143099846|NCT00105079|515907614|FG000|Overall Study|Violation of selection criteria at entry|0|||
143099847|NCT00105079|515907615|FG001|Overall Study|Violation of selection criteria at entry|2|||
143099848|NCT00105079|515907614|FG000|Overall Study|Protocol Violation|1|||
143099849|NCT00105079|515907615|FG001|Overall Study|Protocol Violation|0|||
143099850|NCT00105079|515907614|FG000|Overall Study|Other|3|||
143099851|NCT00105079|515907615|FG001|Overall Study|Other|1|||
143099852|NCT01464593|515907616|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
143099853|NCT00026494|515907629|FG000|Overall Study|Withdrawal by Subject|1|||
143099854|NCT00026494|515907630|FG001|Overall Study|Withdrawal by Subject|0|||
143099855|NCT00026494|515907631|FG002|Overall Study|Withdrawal by Subject|1|||
143099856|NCT00026494|515907632|FG003|Overall Study|Withdrawal by Subject|0|||
143099857|NCT00026494|515907629|FG000|Overall Study|Patient non-compliance|1|||
143099858|NCT00026494|515907630|FG001|Overall Study|Patient non-compliance|0|||
143099859|NCT00026494|515907631|FG002|Overall Study|Patient non-compliance|0|||
143099860|NCT00026494|515907632|FG003|Overall Study|Patient non-compliance|0|||
143099861|NCT00026494|515907629|FG000|Overall Study|Patient not treated|0|||
143099862|NCT00026494|515907630|FG001|Overall Study|Patient not treated|0|||
143099863|NCT00026494|515907631|FG002|Overall Study|Patient not treated|2|||
143099864|NCT00026494|515907632|FG003|Overall Study|Patient not treated|0|||
143099865|NCT00026494|515907629|FG000|Overall Study|Clinical progression|0|||
143099866|NCT00026494|515907630|FG001|Overall Study|Clinical progression|0|||
143099867|NCT00026494|515907631|FG002|Overall Study|Clinical progression|3|||
143099868|NCT00026494|515907632|FG003|Overall Study|Clinical progression|0|||
143099869|NCT01455597|515907633|FG000|Overall Study|Adverse Event|7|||
143099870|NCT01455597|515907634|FG001|Overall Study|Adverse Event|0|||
143099871|NCT01455597|515907635|FG002|Overall Study|Adverse Event|5|||
143099872|NCT01455597|515907636|FG003|Overall Study|Adverse Event|1|||
143099873|NCT01455597|515907633|FG000|Overall Study|Lack of Efficacy|0|||
143099874|NCT01455597|515907634|FG001|Overall Study|Lack of Efficacy|1|||
143099875|NCT01455597|515907635|FG002|Overall Study|Lack of Efficacy|2|||
143099876|NCT01455597|515907636|FG003|Overall Study|Lack of Efficacy|0|||
143099877|NCT01455597|515907633|FG000|Overall Study|Lost to Follow-up|3|||
143177280|NCT00756275|516197843|FG000|Overall Study|Lost to Follow-up|25|||
143177281|NCT00756275|516197844|FG001|Overall Study|Lost to Follow-up|21|||
143177282|NCT00756275|516197843|FG000|Overall Study|Withdrawal by Subject|4|||
143177283|NCT00756275|516197844|FG001|Overall Study|Withdrawal by Subject|7|||
143177284|NCT04971967|516197845|FG000|Overall Study|Lost to Follow-up|6|||
143367746|NCT01143077|516889438|FG001|Overall Study|Lack of Efficacy|2|||
143099878|NCT01455597|515907634|FG001|Overall Study|Lost to Follow-up|0|||
143099879|NCT01455597|515907635|FG002|Overall Study|Lost to Follow-up|2|||
143099880|NCT01455597|515907636|FG003|Overall Study|Lost to Follow-up|1|||
143099881|NCT01455597|515907633|FG000|Overall Study|Withdrew Consent|6|||
143099882|NCT01455597|515907634|FG001|Overall Study|Withdrew Consent|5|||
143099883|NCT01455597|515907635|FG002|Overall Study|Withdrew Consent|8|||
143099884|NCT01455597|515907636|FG003|Overall Study|Withdrew Consent|5|||
143099885|NCT01455597|515907633|FG000|Overall Study|Reason not Specified|1|||
143099886|NCT01455597|515907634|FG001|Overall Study|Reason not Specified|2|||
143099887|NCT01455597|515907635|FG002|Overall Study|Reason not Specified|3|||
143099888|NCT01455597|515907636|FG003|Overall Study|Reason not Specified|3|||
143099889|NCT01737710|515907637|FG000|Overall Study|Lost to Follow-up|0|||
143099890|NCT01737710|515907638|FG001|Overall Study|Lost to Follow-up|2|||
143099891|NCT01737710|515907639|FG002|Overall Study|Lost to Follow-up|2|||
143099892|NCT01737710|515907640|FG003|Overall Study|Lost to Follow-up|0|||
143177285|NCT04971967|516197846|FG001|Overall Study|Lost to Follow-up|7|||
143177286|NCT00938912|516197847|FG000|Overall Study|Withdrawal by Subject|28|||
143252049|NCT01616693|516476390|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
143252050|NCT01616693|516476391|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
143252051|NCT00275340|516476396|FG000|Overall Study|Lost to Follow-up|2|||
143177287|NCT00938912|516197847|FG000|Overall Study|Lost to Follow-up|4|||
143177288|NCT00938912|516197847|FG000|Overall Study|Lack of Efficacy|43|||
143177289|NCT00938912|516197847|FG000|Overall Study|Adverse event, non-fatal|24|||
143177290|NCT00938912|516197847|FG000|Overall Study|Adverse event, fatal|1|||
143177291|NCT00938912|516197847|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
143177292|NCT00938912|516197847|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
143177293|NCT00938912|516197847|FG000|Overall Study|Participant needed prohibit medication|1|||
143177294|NCT00938912|516197847|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
143177295|NCT00938912|516197847|FG000|Overall Study|Did not meet Eligibility criteria|1|||
143177296|NCT00938912|516197847|FG000|Overall Study|Participant relocated not related to AE|1|||
143177297|NCT00938912|516197847|FG000|Overall Study|Participant moved to another city|1|||
143177298|NCT00938912|516197847|FG000|Overall Study|Participant experienced break through seizures|1|||
143177299|NCT00938912|516197847|FG000|Overall Study|No longer wished to participate in the study|1|||
143177300|NCT00938912|516197847|FG000|Overall Study|Protocol Deviation|2|||
143177301|NCT03341637|516197848|FG000|Overall Study|Lost to Follow-up|1|||
143177302|NCT03341637|516197849|FG001|Overall Study|Lost to Follow-up|0|||
143177303|NCT03341637|516197848|FG000|Overall Study|Withdrawal by Subject|3|||
143177304|NCT03341637|516197849|FG001|Overall Study|Withdrawal by Subject|3|||
143177305|NCT03341637|516197848|FG000|Overall Study|Reason not Specified|1|||
143252052|NCT00275340|516476397|FG001|Overall Study|Lost to Follow-up|4|||
143252053|NCT01950013|516476398|FG000|Overall Study|Withdrawal by Subject|0|||
143252054|NCT01950013|516476399|FG001|Overall Study|Withdrawal by Subject|2|||
143252055|NCT01950013|516476400|FG002|Overall Study|Withdrawal by Subject|0|||
143252056|NCT01419197|516476404|FG000|Overall Study|Death|247|||
143252057|NCT01419197|516476405|FG001|Overall Study|Death|122|||
143252058|NCT01419197|516476404|FG000|Overall Study|Physician Decision|4|||
143252059|NCT01419197|516476405|FG001|Overall Study|Physician Decision|4|||
143099893|NCT01737710|515907641|FG004|Overall Study|Lost to Follow-up|0|||
143099894|NCT01737710|515907637|FG000|Overall Study|Withdrawal by Subject|1|||
143099895|NCT01737710|515907638|FG001|Overall Study|Withdrawal by Subject|1|||
143099896|NCT01737710|515907639|FG002|Overall Study|Withdrawal by Subject|1|||
143099897|NCT01737710|515907640|FG003|Overall Study|Withdrawal by Subject|0|||
143099898|NCT01737710|515907641|FG004|Overall Study|Withdrawal by Subject|0|||
143099899|NCT01737710|515907637|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
143099900|NCT01737710|515907638|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
143099901|NCT01737710|515907639|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
143099902|NCT01737710|515907640|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
143099903|NCT01737710|515907641|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
143099904|NCT03850496|515907642|FG000|Overall Study|Withdrawal by Subject|1|||
143099905|NCT03850496|515907643|FG001|Overall Study|Withdrawal by Subject|0|||
143099906|NCT03850496|515907644|FG002|Overall Study|Withdrawal by Subject|0|||
143099907|NCT03850496|515907642|FG000|Overall Study|Lost to Follow-up|0|||
143099908|NCT03850496|515907643|FG001|Overall Study|Lost to Follow-up|1|||
143099909|NCT03850496|515907644|FG002|Overall Study|Lost to Follow-up|4|||
143099910|NCT03777436|515907648|FG000|Placebo-controlled Phase|Adverse Event|8|||
143099911|NCT03777436|515907649|FG001|Placebo-controlled Phase|Adverse Event|10|||
143099912|NCT03777436|515907650|FG002|Placebo-controlled Phase|Adverse Event|0|||
143099913|NCT03777436|515907648|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
143099914|NCT03777436|515907649|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
143099915|NCT03777436|515907650|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
143099916|NCT03777436|515907648|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
143099917|NCT03777436|515907649|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
143099918|NCT03777436|515907650|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
143099919|NCT03777436|515907648|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
143177306|NCT03341637|516197849|FG001|Overall Study|Reason not Specified|1|||
143177307|NCT00887159|516197850|FG000|Overall Study|Disease progression|6|||
143177308|NCT00887159|516197851|FG001|Overall Study|Disease progression|39|||
143252060|NCT01419197|516476404|FG000|Overall Study|Non-compliance|3|||
143099920|NCT03777436|515907649|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
143252061|NCT01419197|516476405|FG001|Overall Study|Non-compliance|1|||
143099921|NCT03777436|515907650|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
143099922|NCT03777436|515907648|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
143099923|NCT03777436|515907649|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
143099924|NCT03777436|515907650|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
143099925|NCT03777436|515907648|FG000|Placebo-controlled Phase|Physician Decision|0|||
143177309|NCT00887159|516197852|FG002|Overall Study|Disease progression|33|||
143177310|NCT00887159|516197850|FG000|Overall Study|Adverse Event|3|||
143252062|NCT01419197|516476404|FG000|Overall Study|Withdrawal by Subject|33|||
143177311|NCT00887159|516197851|FG001|Overall Study|Adverse Event|4|||
143177312|NCT00887159|516197852|FG002|Overall Study|Adverse Event|17|||
143177313|NCT00887159|516197850|FG000|Overall Study|Death|2|||
143099926|NCT03777436|515907649|FG001|Placebo-controlled Phase|Physician Decision|1|||
143099927|NCT03777436|515907650|FG002|Placebo-controlled Phase|Physician Decision|0|||
143099928|NCT03777436|515907648|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
143099929|NCT03777436|515907649|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
143099930|NCT03777436|515907650|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
143099931|NCT03777436|515907648|FG000|Apremilast Extension Phase|Adverse Event|0|||
143099932|NCT03777436|515907649|FG001|Apremilast Extension Phase|Adverse Event|0|||
143099933|NCT03777436|515907650|FG002|Apremilast Extension Phase|Adverse Event|6|||
143099934|NCT03777436|515907648|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
143099935|NCT03777436|515907649|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
143099936|NCT03777436|515907650|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
143099937|NCT03777436|515907648|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
143099938|NCT03777436|515907649|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
143099939|NCT03777436|515907650|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
143099940|NCT03777436|515907648|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
143099941|NCT03777436|515907649|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
143099942|NCT03777436|515907650|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
143099943|NCT03777436|515907648|FG000|Apremilast Extension Phase|Miscellaneous|0|||
143099944|NCT03777436|515907649|FG001|Apremilast Extension Phase|Miscellaneous|0|||
143099945|NCT03777436|515907650|FG002|Apremilast Extension Phase|Miscellaneous|1|||
143099946|NCT00656292|515907656|FG000|Overall Study|Withdrawal by Subject|2|||
143099947|NCT00656292|515907657|FG001|Overall Study|Withdrawal by Subject|3|||
143099948|NCT00656292|515907656|FG000|Overall Study|Screen failure|1|||
143099949|NCT00656292|515907657|FG001|Overall Study|Screen failure|2|||
143099950|NCT03674112|515907658|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
143099951|NCT03674112|515907659|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
143099952|NCT03674112|515907658|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
143099953|NCT03674112|515907659|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
143099954|NCT03674112|515907658|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
143099955|NCT03674112|515907659|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
143099956|NCT03674112|515907658|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
143099957|NCT03674112|515907659|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
143099958|NCT03674112|515907658|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
143099959|NCT03674112|515907659|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
143099960|NCT03674112|515907658|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
143099961|NCT03674112|515907659|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
143099962|NCT03674112|515907658|FG000|Follow-Up Period (≥3 Years)|Death|2|||
143099963|NCT03674112|515907659|FG001|Follow-Up Period (≥3 Years)|Death|0|||
143099964|NCT03674112|515907658|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
143099965|NCT03674112|515907659|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
143099966|NCT00568061|515907664|FG000|Overall Study|Inclusion / exclusion criteria|5|||
143099967|NCT00568061|515907665|FG001|Overall Study|Inclusion / exclusion criteria|1|||
143099968|NCT00568061|515907664|FG000|Overall Study|Adverse Event|0|||
143099969|NCT00568061|515907665|FG001|Overall Study|Adverse Event|1|||
143099970|NCT05027451|515907666|FG000|Overall Study|Lost to Follow-up|1|||
143099971|NCT05027451|515907667|FG001|Overall Study|Lost to Follow-up|1|||
143099972|NCT02693002|515907668|FG000|Overall Study|Withdrawal by Subject|1|||
143099973|NCT02693002|515907669|FG001|Overall Study|Withdrawal by Subject|0|||
143099974|NCT02105987|515907673|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
143099975|NCT02105987|515907674|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
143099976|NCT02105987|515907675|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
143099977|NCT02105987|515907676|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
143099978|NCT02105987|515907677|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
143099979|NCT02105987|515907678|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
143099980|NCT02105987|515907673|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
143099981|NCT02105987|515907674|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
143099982|NCT02105987|515907675|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
143099983|NCT02105987|515907676|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
143099984|NCT02105987|515907677|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
143099985|NCT02105987|515907678|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
143099986|NCT02105987|515907673|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
143099987|NCT02105987|515907674|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
143099988|NCT02105987|515907675|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
143099989|NCT02105987|515907676|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
143099990|NCT02105987|515907677|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
143099991|NCT02105987|515907678|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
143099992|NCT02105987|515907673|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
143099993|NCT02105987|515907674|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
143099994|NCT02105987|515907675|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
143099995|NCT02105987|515907676|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
143099996|NCT02105987|515907677|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
143099997|NCT02105987|515907678|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
143099998|NCT02105987|515907673|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
143099999|NCT02105987|515907674|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
143100000|NCT02105987|515907675|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
143100001|NCT02105987|515907676|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
143100002|NCT02105987|515907677|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
143100003|NCT02105987|515907678|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
143100004|NCT02105987|515907673|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
143100005|NCT02105987|515907674|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
143100006|NCT02105987|515907675|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
143100007|NCT02105987|515907676|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
143100008|NCT02105987|515907677|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
143100009|NCT02105987|515907678|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
143100010|NCT02105987|515907673|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
143100011|NCT02105987|515907674|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
143100012|NCT02105987|515907675|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
143100013|NCT02105987|515907676|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
143100014|NCT02105987|515907677|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
143100015|NCT02105987|515907678|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
143100016|NCT02105987|515907673|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
143100017|NCT02105987|515907674|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
143100018|NCT02105987|515907675|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
143100019|NCT02105987|515907676|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
143100020|NCT02105987|515907677|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
143100021|NCT02105987|515907678|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
143100022|NCT02105987|515907673|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
143100023|NCT02105987|515907674|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
143100024|NCT02105987|515907675|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
143100025|NCT02105987|515907676|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
143100026|NCT02105987|515907677|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
143100027|NCT02105987|515907678|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
143100028|NCT02105987|515907673|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
143100029|NCT02105987|515907674|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
143100030|NCT02105987|515907675|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
143100031|NCT02105987|515907676|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
143100032|NCT02105987|515907677|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
143100033|NCT02105987|515907678|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
143100034|NCT02105987|515907673|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
143100035|NCT02105987|515907674|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
143100036|NCT02105987|515907675|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
143100037|NCT02105987|515907676|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
143100038|NCT02105987|515907677|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
143100039|NCT02105987|515907678|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
143100040|NCT02105987|515907673|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
143100041|NCT02105987|515907674|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
143100042|NCT02105987|515907675|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
143100043|NCT02105987|515907676|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
143100044|NCT02105987|515907677|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
143100045|NCT02105987|515907678|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
143100046|NCT02105987|515907673|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
143100047|NCT02105987|515907674|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
143100048|NCT02105987|515907675|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
143100049|NCT02105987|515907676|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
143100050|NCT02105987|515907677|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
143100051|NCT02105987|515907678|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
143100052|NCT02105987|515907673|FG000|Continuation Phase|Protocol Violation|0|||
143100053|NCT02105987|515907674|FG001|Continuation Phase|Protocol Violation|0|||
143100054|NCT02105987|515907675|FG002|Continuation Phase|Protocol Violation|0|||
143177314|NCT00887159|516197851|FG001|Overall Study|Death|2|||
143177315|NCT00887159|516197852|FG002|Overall Study|Death|0|||
143177316|NCT00887159|516197850|FG000|Overall Study|Withdrawal by Subject|4|||
143177317|NCT00887159|516197851|FG001|Overall Study|Withdrawal by Subject|4|||
143177318|NCT00887159|516197852|FG002|Overall Study|Withdrawal by Subject|2|||
143177319|NCT00887159|516197850|FG000|Overall Study|Alternative therapy|2|||
143177320|NCT00887159|516197851|FG001|Overall Study|Alternative therapy|0|||
143177321|NCT00887159|516197852|FG002|Overall Study|Alternative therapy|0|||
143177322|NCT00887159|516197850|FG000|Overall Study|Physician Decision|1|||
143177323|NCT00887159|516197851|FG001|Overall Study|Physician Decision|1|||
143177324|NCT00887159|516197852|FG002|Overall Study|Physician Decision|0|||
143177325|NCT00887159|516197850|FG000|Overall Study|Sympomatic deterioration|1|||
143177326|NCT00887159|516197851|FG001|Overall Study|Sympomatic deterioration|0|||
143177327|NCT00887159|516197852|FG002|Overall Study|Sympomatic deterioration|0|||
143177328|NCT00887159|516197850|FG000|Overall Study|Treatment delayed|1|||
143177329|NCT00887159|516197851|FG001|Overall Study|Treatment delayed|1|||
143177330|NCT00887159|516197852|FG002|Overall Study|Treatment delayed|0|||
143177331|NCT00887159|516197850|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
143177332|NCT00887159|516197851|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
143177333|NCT00887159|516197852|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
143177334|NCT00887159|516197850|FG000|Overall Study|Received more tx instead of observation|1|||
143177335|NCT00887159|516197851|FG001|Overall Study|Received more tx instead of observation|0|||
143177336|NCT00887159|516197852|FG002|Overall Study|Received more tx instead of observation|0|||
143177337|NCT00887159|516197850|FG000|Overall Study|Ineligible|5|||
143177338|NCT00887159|516197851|FG001|Overall Study|Ineligible|1|||
143177339|NCT00887159|516197852|FG002|Overall Study|Ineligible|0|||
143177340|NCT00887159|516197850|FG000|Overall Study|Never started assigned therapy|3|||
143177341|NCT00887159|516197851|FG001|Overall Study|Never started assigned therapy|3|||
143177342|NCT00887159|516197852|FG002|Overall Study|Never started assigned therapy|4|||
143177343|NCT00803738|516197858|FG000|Overall Study|Adverse Event|3|||
143177344|NCT00803738|516197859|FG001|Overall Study|Adverse Event|5|||
143177345|NCT00803738|516197858|FG000|Overall Study|Lost to Follow-up|4|||
143177346|NCT00803738|516197859|FG001|Overall Study|Lost to Follow-up|4|||
143177347|NCT00803738|516197858|FG000|Overall Study|Protocol Violation|18|||
143177348|NCT00803738|516197859|FG001|Overall Study|Protocol Violation|10|||
143177349|NCT00803738|516197858|FG000|Overall Study|Withdrawal by Subject|1|||
143177350|NCT00803738|516197859|FG001|Overall Study|Withdrawal by Subject|4|||
143177351|NCT00803738|516197858|FG000|Overall Study|Lack of Efficacy|10|||
143177352|NCT00803738|516197859|FG001|Overall Study|Lack of Efficacy|16|||
143177353|NCT00803738|516197858|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
143177354|NCT00803738|516197859|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
143177355|NCT00803738|516197858|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
143177356|NCT00803738|516197859|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
143177357|NCT06164691|516197860|FG000|Overall Study|Withdrawal by Subject|2|||
143177358|NCT06164691|516197861|FG001|Overall Study|Withdrawal by Subject|0|||
143177359|NCT06164691|516197862|FG002|Overall Study|Withdrawal by Subject|0|||
143177360|NCT00812955|516197863|FG000|Overall Study|Adverse Event|7|||
143177361|NCT00812955|516197864|FG001|Overall Study|Adverse Event|6|||
143177362|NCT00812955|516197865|FG002|Overall Study|Adverse Event|3|||
143177363|NCT00812955|516197866|FG003|Overall Study|Adverse Event|4|||
143177364|NCT00812955|516197863|FG000|Overall Study|Lost to Follow-up|2|||
143177365|NCT00812955|516197864|FG001|Overall Study|Lost to Follow-up|1|||
143177366|NCT00812955|516197865|FG002|Overall Study|Lost to Follow-up|1|||
143177367|NCT00812955|516197866|FG003|Overall Study|Lost to Follow-up|2|||
143177368|NCT00812955|516197863|FG000|Overall Study|Withdrawal by Subject|1|||
143177369|NCT00812955|516197864|FG001|Overall Study|Withdrawal by Subject|0|||
143177370|NCT00812955|516197865|FG002|Overall Study|Withdrawal by Subject|1|||
143177371|NCT00812955|516197866|FG003|Overall Study|Withdrawal by Subject|2|||
143177372|NCT00812955|516197863|FG000|Overall Study|randomized in error|0|||
143177373|NCT00812955|516197864|FG001|Overall Study|randomized in error|0|||
143177374|NCT00812955|516197865|FG002|Overall Study|randomized in error|1|||
143177375|NCT00812955|516197866|FG003|Overall Study|randomized in error|0|||
143177376|NCT01127633|516197868|FG000|Overall Study|Adverse Event|74|||
143177377|NCT01127633|516197869|FG001|Overall Study|Adverse Event|73|||
143177378|NCT01127633|516197868|FG000|Overall Study|Death|40|||
143177379|NCT01127633|516197869|FG001|Overall Study|Death|43|||
143177380|NCT01127633|516197868|FG000|Overall Study|Lost to Follow-up|4|||
143177381|NCT01127633|516197869|FG001|Overall Study|Lost to Follow-up|0|||
143177382|NCT01127633|516197868|FG000|Overall Study|Parent/Caregiver Decision|246|||
143177383|NCT01127633|516197869|FG001|Overall Study|Parent/Caregiver Decision|228|||
143367747|NCT01143077|516889439|FG002|Overall Study|Lack of Efficacy|1|||
143367748|NCT01143077|516889437|FG000|Overall Study|Adverse Event|5|||
143177384|NCT01127633|516197868|FG000|Overall Study|Physician Decision|60|||
143177385|NCT01127633|516197869|FG001|Overall Study|Physician Decision|45|||
143177386|NCT01127633|516197868|FG000|Overall Study|Withdrawal by Subject|57|||
143177387|NCT01127633|516197869|FG001|Overall Study|Withdrawal by Subject|72|||
143177388|NCT01127633|516197868|FG000|Overall Study|Sponsor Decision|163|||
143100055|NCT02105987|515907676|FG003|Continuation Phase|Protocol Violation|0|||
143100056|NCT02105987|515907677|FG004|Continuation Phase|Protocol Violation|1|||
143100057|NCT02105987|515907678|FG005|Continuation Phase|Protocol Violation|0|||
143100058|NCT01796392|515907692|FG000|Overall Study|Withdrawal by Subject|2|||
143100059|NCT01796392|515907693|FG001|Overall Study|Withdrawal by Subject|0|||
143100060|NCT01796392|515907692|FG000|Overall Study|Death|5|||
143100061|NCT01796392|515907693|FG001|Overall Study|Death|1|||
143100062|NCT01796392|515907692|FG000|Overall Study|Excluded for medical reasons|1|||
143100063|NCT01796392|515907693|FG001|Overall Study|Excluded for medical reasons|2|||
143100064|NCT01796392|515907692|FG000|Overall Study|Lost to Follow-up|1|||
143100065|NCT01796392|515907693|FG001|Overall Study|Lost to Follow-up|0|||
143100066|NCT04639219|515907694|FG000|Overall Study|Withdrawal by Subject|8|||
143100067|NCT04639219|515907694|FG000|Overall Study|Lost to Follow-up|6|||
143100068|NCT04639219|515907694|FG000|Overall Study|Death|55|||
143100069|NCT00564850|515907695|FG000|Overall Study|Protocol Violation|2|||
143100070|NCT02640664|515907696|FG000|Epoch 1|Withdrawal of informed consent|1|||
143100071|NCT02640664|515907697|FG001|Epoch 1|Withdrawal of informed consent|0|||
143100072|NCT02640664|515907698|FG002|Epoch 1|Withdrawal of informed consent|0|||
143100073|NCT02640664|515907696|FG000|Epoch 1|Death|0|||
143100074|NCT02640664|515907697|FG001|Epoch 1|Death|0|||
143100075|NCT02640664|515907698|FG002|Epoch 1|Death|1|||
143100076|NCT02640664|515907696|FG000|Epoch 2|Withdrawal of informed consent|3|||
143100077|NCT02640664|515907697|FG001|Epoch 2|Withdrawal of informed consent|4|||
143100078|NCT02640664|515907698|FG002|Epoch 2|Withdrawal of informed consent|2|||
143100079|NCT02640664|515907696|FG000|Epoch 2|Subject/guardian decision|0|||
143100080|NCT02640664|515907697|FG001|Epoch 2|Subject/guardian decision|2|||
143100081|NCT02640664|515907698|FG002|Epoch 2|Subject/guardian decision|2|||
143100082|NCT02640664|515907696|FG000|Epoch 2|Lost to Follow-up|3|||
143100083|NCT02640664|515907697|FG001|Epoch 2|Lost to Follow-up|4|||
143100084|NCT02640664|515907698|FG002|Epoch 2|Lost to Follow-up|1|||
143100085|NCT02640664|515907696|FG000|Epoch 2|Death|0|||
143100086|NCT02640664|515907697|FG001|Epoch 2|Death|0|||
143100087|NCT02640664|515907698|FG002|Epoch 2|Death|1|||
143100088|NCT00314327|515907699|FG000|Overall Study|Withdrawal by Subject|1|||
143100089|NCT01205269|515907700|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
143100090|NCT01205269|515907701|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
143100091|NCT01205269|515907702|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
143100092|NCT01205269|515907703|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
143100093|NCT01205269|515907704|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
143100094|NCT01205269|515907705|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
143100095|NCT01408303|515907706|FG000|Overall Study|Adverse Event|3|||
143100096|NCT01408303|515907707|FG001|Overall Study|Adverse Event|7|||
143100097|NCT01408303|515907708|FG002|Overall Study|Adverse Event|2|||
143100098|NCT01408303|515907706|FG000|Overall Study|Lost to Follow-up|0|||
143100099|NCT01408303|515907707|FG001|Overall Study|Lost to Follow-up|1|||
143100100|NCT01408303|515907708|FG002|Overall Study|Lost to Follow-up|2|||
143100101|NCT01408303|515907706|FG000|Overall Study|Withdrawal by Subject|2|||
143100102|NCT01408303|515907707|FG001|Overall Study|Withdrawal by Subject|3|||
143100103|NCT01408303|515907708|FG002|Overall Study|Withdrawal by Subject|1|||
143100104|NCT01408303|515907706|FG000|Overall Study|Protocol Violation|0|||
143100105|NCT01408303|515907707|FG001|Overall Study|Protocol Violation|1|||
143100106|NCT01408303|515907708|FG002|Overall Study|Protocol Violation|0|||
143100107|NCT01408303|515907706|FG000|Overall Study|Noncompliance|1|||
143100108|NCT01408303|515907707|FG001|Overall Study|Noncompliance|0|||
143100109|NCT01408303|515907708|FG002|Overall Study|Noncompliance|1|||
143100110|NCT04031846|515907711|FG000|Overall Study|Lost to Follow-up|4|||
143100111|NCT04031846|515907712|FG001|Overall Study|Lost to Follow-up|4|||
143100112|NCT04031846|515907711|FG000|Overall Study|Physician Decision|0|||
143100113|NCT04031846|515907712|FG001|Overall Study|Physician Decision|1|||
143100114|NCT04031846|515907711|FG000|Overall Study|Protocol Violation|1|||
143100115|NCT04031846|515907712|FG001|Overall Study|Protocol Violation|1|||
143100116|NCT04031846|515907711|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
143100117|NCT04031846|515907712|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
143100118|NCT06868654|515907713|FG000|Overall Study|Death|4|||
143100119|NCT06868654|515907714|FG001|Overall Study|Death|14|||
143100120|NCT06868654|515907713|FG000|Overall Study|Lost to Follow-up|0|||
143100121|NCT06868654|515907714|FG001|Overall Study|Lost to Follow-up|1|||
143100122|NCT06868654|515907713|FG000|Overall Study|Withdrawal by Subject|5|||
143100123|NCT06868654|515907714|FG001|Overall Study|Withdrawal by Subject|3|||
143100124|NCT06868654|515907713|FG000|Overall Study|Physician Decision|0|||
143100125|NCT06868654|515907714|FG001|Overall Study|Physician Decision|1|||
143100126|NCT06868654|515907713|FG000|Overall Study|Ongoing|23|||
143100127|NCT06868654|515907714|FG001|Overall Study|Ongoing|21|||
143100128|NCT02134015|515907717|FG000|Overall Study|Protocol Violation|0|||
143100129|NCT02134015|515907718|FG001|Overall Study|Protocol Violation|1|||
143100130|NCT02134015|515907717|FG000|Overall Study|Death|2|||
143100131|NCT02134015|515907718|FG001|Overall Study|Death|1|||
143100132|NCT02134015|515907717|FG000|Overall Study|Reason not provided|1|||
143100133|NCT02134015|515907718|FG001|Overall Study|Reason not provided|2|||
143100134|NCT02134015|515907717|FG000|Overall Study|Clinical progression|14|||
143100135|NCT02134015|515907718|FG001|Overall Study|Clinical progression|7|||
143100136|NCT02134015|515907717|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
143100137|NCT02134015|515907718|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
143100138|NCT02134015|515907717|FG000|Overall Study|Study terminated by sponsor|2|||
143100139|NCT02134015|515907718|FG001|Overall Study|Study terminated by sponsor|3|||
143100140|NCT02134015|515907717|FG000|Overall Study|Adverse Event|9|||
143100141|NCT02134015|515907718|FG001|Overall Study|Adverse Event|10|||
143100142|NCT02134015|515907717|FG000|Overall Study|Withdrawal by Subject|3|||
143100143|NCT02134015|515907718|FG001|Overall Study|Withdrawal by Subject|7|||
143100144|NCT03867201|515907719|FG000|Double-Blind Period Until Week 12|Lack of Efficacy|1|||
143100145|NCT03867201|515907720|FG001|Double-Blind Period Until Week 12|Lack of Efficacy|0|||
143100146|NCT03867201|515907719|FG000|Double-Blind Period Until Week 12|Withdrawal by Subject|1|||
143100147|NCT03867201|515907720|FG001|Double-Blind Period Until Week 12|Withdrawal by Subject|2|||
143100148|NCT03867201|515907719|FG000|Double-Blind Period Until Week 12|Protocol Violation|1|||
143100149|NCT03867201|515907720|FG001|Double-Blind Period Until Week 12|Protocol Violation|2|||
143100150|NCT03867201|515907719|FG000|Double-Blind Period Until Week 12|Pregnancy|1|||
143100151|NCT03867201|515907720|FG001|Double-Blind Period Until Week 12|Pregnancy|1|||
143100152|NCT03867201|515907719|FG000|Double-Blind Period Until Week 12|Adverse Event|2|||
143100153|NCT03867201|515907720|FG001|Double-Blind Period Until Week 12|Adverse Event|1|||
143100154|NCT03867201|515907719|FG000|Open-Label Period From Week 12|Adverse Event|5|||
143100155|NCT03867201|515907720|FG001|Open-Label Period From Week 12|Adverse Event|11|||
143100156|NCT03867201|515907719|FG000|Open-Label Period From Week 12|Lost to Follow-up|1|||
143100157|NCT03867201|515907720|FG001|Open-Label Period From Week 12|Lost to Follow-up|0|||
143100158|NCT03867201|515907719|FG000|Open-Label Period From Week 12|Physician Decision|6|||
143100159|NCT03867201|515907720|FG001|Open-Label Period From Week 12|Physician Decision|3|||
143100160|NCT03867201|515907719|FG000|Open-Label Period From Week 12|Pregnancy|2|||
143100161|NCT03867201|515907720|FG001|Open-Label Period From Week 12|Pregnancy|2|||
143100162|NCT03867201|515907719|FG000|Open-Label Period From Week 12|Protocol Violation|2|||
143100163|NCT03867201|515907720|FG001|Open-Label Period From Week 12|Protocol Violation|0|||
143100164|NCT03867201|515907719|FG000|Open-Label Period From Week 12|Withdrawal by Subject|90|||
143100165|NCT03867201|515907720|FG001|Open-Label Period From Week 12|Withdrawal by Subject|85|||
143100166|NCT03867201|515907719|FG000|Open-Label Period From Week 12|No longer clinically benefiting|12|||
143100167|NCT03867201|515907720|FG001|Open-Label Period From Week 12|No longer clinically benefiting|10|||
143100168|NCT03867201|515907719|FG000|Open-Label Period From Week 12|New Therapy for Study Indication|1|||
143100169|NCT03867201|515907720|FG001|Open-Label Period From Week 12|New Therapy for Study Indication|0|||
143100170|NCT05763875|515907721|FG000|Overall Study|Subject decision|5|||
143100171|NCT05763875|515907722|FG001|Overall Study|Subject decision|2|||
143100172|NCT05763875|515907723|FG002|Overall Study|Subject decision|1|||
143100173|NCT05763875|515907721|FG000|Overall Study|Lost to Follow-up|4|||
143100174|NCT05763875|515907722|FG001|Overall Study|Lost to Follow-up|1|||
143100175|NCT05763875|515907723|FG002|Overall Study|Lost to Follow-up|2|||
143100176|NCT05763875|515907721|FG000|Overall Study|Adverse Event|1|||
143100177|NCT05763875|515907722|FG001|Overall Study|Adverse Event|0|||
143100178|NCT05763875|515907723|FG002|Overall Study|Adverse Event|0|||
143100179|NCT04015518|515907724|FG000|Overall Study|Adverse Event|6|||
143100180|NCT04015518|515907725|FG001|Overall Study|Adverse Event|1|||
143100181|NCT04015518|515907726|FG002|Overall Study|Adverse Event|1|||
143100182|NCT04015518|515907727|FG003|Overall Study|Adverse Event|3|||
143100183|NCT04015518|515907728|FG004|Overall Study|Adverse Event|3|||
143100184|NCT04015518|515907724|FG000|Overall Study|Lack of Efficacy|1|||
143177389|NCT01127633|516197869|FG001|Overall Study|Sponsor Decision|195|||
143177390|NCT01127633|516197868|FG000|Overall Study|Protocol Violation|8|||
143177391|NCT01127633|516197869|FG001|Overall Study|Protocol Violation|16|||
143177392|NCT01127633|516197868|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
143177393|NCT01127633|516197869|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
143177394|NCT01127633|516197868|FG000|Overall Study|Not treated|1|||
143177395|NCT01127633|516197869|FG001|Overall Study|Not treated|0|||
143177396|NCT02805790|516197872|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
143177397|NCT02805790|516197873|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
143177398|NCT02897115|516197878|FG000|Overall Study|Early termination of study by sponsor|11|||
143252063|NCT01419197|516476405|FG001|Overall Study|Withdrawal by Subject|32|||
143252064|NCT01419197|516476404|FG000|Overall Study|Study Completed by Sponsor|103|||
143100185|NCT04015518|515907725|FG001|Overall Study|Lack of Efficacy|0|||
143100186|NCT04015518|515907726|FG002|Overall Study|Lack of Efficacy|1|||
143100187|NCT04015518|515907727|FG003|Overall Study|Lack of Efficacy|0|||
143100188|NCT04015518|515907728|FG004|Overall Study|Lack of Efficacy|4|||
143100189|NCT04015518|515907724|FG000|Overall Study|Lost to Follow-up|0|||
143100190|NCT04015518|515907725|FG001|Overall Study|Lost to Follow-up|0|||
143100191|NCT04015518|515907726|FG002|Overall Study|Lost to Follow-up|0|||
143100192|NCT04015518|515907727|FG003|Overall Study|Lost to Follow-up|0|||
143100193|NCT04015518|515907728|FG004|Overall Study|Lost to Follow-up|1|||
143177399|NCT02897115|516197879|FG001|Overall Study|Early termination of study by sponsor|8|||
143177400|NCT00856323|516197881|FG000|Overall Study|Withdrawal by Subject|2|||
143252065|NCT01419197|516476405|FG001|Overall Study|Study Completed by Sponsor|34|||
143100194|NCT04015518|515907724|FG000|Overall Study|Withdrawal by Subject|0|||
143100195|NCT04015518|515907725|FG001|Overall Study|Withdrawal by Subject|1|||
143100196|NCT04015518|515907726|FG002|Overall Study|Withdrawal by Subject|0|||
143100197|NCT04015518|515907727|FG003|Overall Study|Withdrawal by Subject|1|||
143100198|NCT04015518|515907728|FG004|Overall Study|Withdrawal by Subject|1|||
143100199|NCT04015518|515907724|FG000|Overall Study|Patient did not come for consecutive visits|0|||
143100200|NCT04015518|515907725|FG001|Overall Study|Patient did not come for consecutive visits|1|||
143100201|NCT04015518|515907726|FG002|Overall Study|Patient did not come for consecutive visits|0|||
143100202|NCT04015518|515907727|FG003|Overall Study|Patient did not come for consecutive visits|0|||
143100203|NCT04015518|515907728|FG004|Overall Study|Patient did not come for consecutive visits|0|||
143100204|NCT04015518|515907724|FG000|Overall Study|not willing to travel due to Covid-19|0|||
143100205|NCT04015518|515907725|FG001|Overall Study|not willing to travel due to Covid-19|0|||
143100206|NCT04015518|515907726|FG002|Overall Study|not willing to travel due to Covid-19|1|||
143100207|NCT04015518|515907727|FG003|Overall Study|not willing to travel due to Covid-19|0|||
143100208|NCT04015518|515907728|FG004|Overall Study|not willing to travel due to Covid-19|0|||
143100209|NCT04015518|515907724|FG000|Overall Study|Patient wants to discontinue treatment|0|||
143100210|NCT04015518|515907725|FG001|Overall Study|Patient wants to discontinue treatment|0|||
143100211|NCT04015518|515907726|FG002|Overall Study|Patient wants to discontinue treatment|0|||
143100212|NCT04015518|515907727|FG003|Overall Study|Patient wants to discontinue treatment|1|||
143100213|NCT04015518|515907728|FG004|Overall Study|Patient wants to discontinue treatment|0|||
143100214|NCT04015518|515907724|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
143100215|NCT04015518|515907725|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
143100216|NCT04015518|515907726|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
143100217|NCT04015518|515907727|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
143100218|NCT04015518|515907728|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
143100219|NCT04015518|515907724|FG000|Overall Study|Pregnancy|0|||
143100220|NCT04015518|515907725|FG001|Overall Study|Pregnancy|0|||
143100221|NCT04015518|515907726|FG002|Overall Study|Pregnancy|0|||
143100222|NCT04015518|515907727|FG003|Overall Study|Pregnancy|0|||
143100223|NCT04015518|515907728|FG004|Overall Study|Pregnancy|1|||
143100224|NCT04015518|515907724|FG000|Overall Study|Personal reasons|1|||
143100225|NCT04015518|515907725|FG001|Overall Study|Personal reasons|0|||
143100226|NCT04015518|515907726|FG002|Overall Study|Personal reasons|0|||
143100227|NCT04015518|515907727|FG003|Overall Study|Personal reasons|0|||
143100228|NCT04015518|515907728|FG004|Overall Study|Personal reasons|1|||
143100229|NCT04015518|515907724|FG000|Overall Study|Withdrew consent|1|||
143100230|NCT04015518|515907725|FG001|Overall Study|Withdrew consent|0|||
143100231|NCT04015518|515907726|FG002|Overall Study|Withdrew consent|0|||
143100232|NCT04015518|515907727|FG003|Overall Study|Withdrew consent|0|||
143100233|NCT04015518|515907728|FG004|Overall Study|Withdrew consent|0|||
143100234|NCT04015518|515907724|FG000|Overall Study|Prostate carcinoma|1|||
143100235|NCT04015518|515907725|FG001|Overall Study|Prostate carcinoma|0|||
143100236|NCT04015518|515907726|FG002|Overall Study|Prostate carcinoma|0|||
143100237|NCT04015518|515907727|FG003|Overall Study|Prostate carcinoma|0|||
143100238|NCT04015518|515907728|FG004|Overall Study|Prostate carcinoma|0|||
143100239|NCT04015518|515907724|FG000|Overall Study|Could not keep appointments due to work|1|||
143100240|NCT04015518|515907725|FG001|Overall Study|Could not keep appointments due to work|0|||
143252066|NCT01419197|516476404|FG000|Overall Study|Reason Not Specified|0|||
143367749|NCT01143077|516889438|FG001|Overall Study|Adverse Event|6|||
143100241|NCT04015518|515907726|FG002|Overall Study|Could not keep appointments due to work|0|||
143100242|NCT04015518|515907727|FG003|Overall Study|Could not keep appointments due to work|0|||
143100243|NCT04015518|515907728|FG004|Overall Study|Could not keep appointments due to work|0|||
143100244|NCT00433511|515909021|FG000|Step 1|Adverse Event|50|||
143100245|NCT00433511|515909022|FG001|Step 1|Adverse Event|157|||
143100246|NCT00433511|515909023|FG002|Step 1|Adverse Event|153|||
143100247|NCT00433511|515909021|FG000|Step 1|Withdrawal by Subject|45|||
143100248|NCT00433511|515909022|FG001|Step 1|Withdrawal by Subject|143|||
143100249|NCT00433511|515909023|FG002|Step 1|Withdrawal by Subject|154|||
143100250|NCT00433511|515909021|FG000|Step 1|Death|3|||
143100251|NCT00433511|515909022|FG001|Step 1|Death|1|||
143100252|NCT00433511|515909023|FG002|Step 1|Death|1|||
143100253|NCT00433511|515909021|FG000|Step 1|Physician Decision|1|||
143100254|NCT00433511|515909022|FG001|Step 1|Physician Decision|4|||
143100255|NCT00433511|515909023|FG002|Step 1|Physician Decision|3|||
143100256|NCT00433511|515909021|FG000|Step 1|Never started protocol therapy|28|||
143100257|NCT00433511|515909022|FG001|Step 1|Never started protocol therapy|64|||
143100258|NCT00433511|515909023|FG002|Step 1|Never started protocol therapy|66|||
143100259|NCT00433511|515909021|FG000|Step 1|Alternative therapy|2|||
143100260|NCT00433511|515909022|FG001|Step 1|Alternative therapy|1|||
143100261|NCT00433511|515909023|FG002|Step 1|Alternative therapy|3|||
143100262|NCT00433511|515909021|FG000|Step 1|Disease progression, relapse|5|||
143100263|NCT00433511|515909022|FG001|Step 1|Disease progression, relapse|3|||
143100264|NCT00433511|515909023|FG002|Step 1|Disease progression, relapse|3|||
143100265|NCT00433511|515909021|FG000|Step 1|Other complicating disease|2|||
143100266|NCT00433511|515909022|FG001|Step 1|Other complicating disease|6|||
143100267|NCT00433511|515909023|FG002|Step 1|Other complicating disease|3|||
143100268|NCT00433511|515909021|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
143100269|NCT00433511|515909022|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
143100270|NCT00433511|515909023|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
143100271|NCT00433511|515909021|FG000|Step 1|Suspected recurrence|0|||
143100272|NCT00433511|515909022|FG001|Step 1|Suspected recurrence|1|||
143100273|NCT00433511|515909023|FG002|Step 1|Suspected recurrence|0|||
143100274|NCT00433511|515909021|FG000|Step 1|Insurance/drug distribution issues|0|||
143100275|NCT00433511|515909022|FG001|Step 1|Insurance/drug distribution issues|1|||
143100276|NCT00433511|515909023|FG002|Step 1|Insurance/drug distribution issues|2|||
143100277|NCT00433511|515909021|FG000|Step 1|Patient moved|0|||
143100278|NCT00433511|515909022|FG001|Step 1|Patient moved|0|||
143100279|NCT00433511|515909023|FG002|Step 1|Patient moved|1|||
143100280|NCT00433511|515909021|FG000|Step 2 (Arm D)|Adverse Event|0|||
143100281|NCT00433511|515909022|FG001|Step 2 (Arm D)|Adverse Event|0|||
143100282|NCT00433511|515909023|FG002|Step 2 (Arm D)|Adverse Event|135|||
143100283|NCT00433511|515909021|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
143100284|NCT00433511|515909022|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
143100285|NCT00433511|515909023|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
143100286|NCT00433511|515909021|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
143100287|NCT00433511|515909022|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
143100288|NCT00433511|515909023|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
143100289|NCT00433511|515909021|FG000|Step 2 (Arm D)|Physician Decision|0|||
143100290|NCT00433511|515909022|FG001|Step 2 (Arm D)|Physician Decision|0|||
143100291|NCT00433511|515909023|FG002|Step 2 (Arm D)|Physician Decision|9|||
143100292|NCT00433511|515909021|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
143100293|NCT00433511|515909022|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
143100294|NCT00433511|515909023|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
143100295|NCT00433511|515909021|FG000|Step 2 (Arm D)|Other complicating disease|0|||
143100296|NCT00433511|515909022|FG001|Step 2 (Arm D)|Other complicating disease|0|||
143100297|NCT00433511|515909023|FG002|Step 2 (Arm D)|Other complicating disease|3|||
143100298|NCT00433511|515909021|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
143100299|NCT00433511|515909022|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
143100300|NCT00433511|515909023|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
143100301|NCT00433511|515909021|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
143100302|NCT00433511|515909022|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
143100303|NCT00433511|515909023|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
143100304|NCT00433511|515909021|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
143100305|NCT00433511|515909022|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
143100306|NCT00433511|515909023|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
143100307|NCT00433511|515909021|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
143100308|NCT00433511|515909022|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
143100309|NCT00433511|515909023|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
143100310|NCT02640950|515909024|FG000|Overall Study|Adverse Event|1|||
143100311|NCT02640950|515909024|FG000|Overall Study|Withdrawal by Subject|1|||
143100312|NCT01623310|515909025|FG000|Overall Study|Adverse Event|21|||
143100313|NCT01623310|515909025|FG000|Overall Study|Lost to Follow-up|18|||
143100314|NCT01623310|515909025|FG000|Overall Study|Lack of Efficacy|6|||
143100315|NCT01623310|515909025|FG000|Overall Study|Protocol Violation|6|||
143100316|NCT01623310|515909025|FG000|Overall Study|Withdrawal by Subject|25|||
143100317|NCT01623310|515909025|FG000|Overall Study|Became potentially child-bearing|1|||
143100318|NCT01623310|515909025|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
143100319|NCT01623310|515909025|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
143100320|NCT02582242|515909027|FG000|Overall Study|Adverse Event|4|||
143100321|NCT02582242|515909028|FG001|Overall Study|Adverse Event|3|||
143100322|NCT02582242|515909027|FG000|Overall Study|Protocol Violation|3|||
143100323|NCT02582242|515909028|FG001|Overall Study|Protocol Violation|1|||
143100324|NCT02582242|515909027|FG000|Overall Study|Lost to Follow-up|0|||
143100325|NCT02582242|515909028|FG001|Overall Study|Lost to Follow-up|1|||
143100326|NCT02582242|515909027|FG000|Overall Study|Withdrawal by Subject|11|||
143100327|NCT02582242|515909028|FG001|Overall Study|Withdrawal by Subject|11|||
143100328|NCT02582242|515909027|FG000|Overall Study|Unclassified|2|||
143100329|NCT02582242|515909028|FG001|Overall Study|Unclassified|1|||
143100330|NCT00300885|515909029|FG000|Treatment|Adverse Event|134|||
143100331|NCT00300885|515909030|FG001|Treatment|Adverse Event|82|||
143100332|NCT00300885|515909029|FG000|Treatment|Death|20|||
143100333|NCT00300885|515909030|FG001|Treatment|Death|7|||
143100334|NCT00300885|515909029|FG000|Treatment|Lack of Efficacy|1|||
143100335|NCT00300885|515909030|FG001|Treatment|Lack of Efficacy|1|||
143100336|NCT00300885|515909029|FG000|Treatment|Lost to Follow-up|3|||
143100337|NCT00300885|515909030|FG001|Treatment|Lost to Follow-up|2|||
143100338|NCT00300885|515909029|FG000|Treatment|Physician Decision|4|||
143100339|NCT00300885|515909030|FG001|Treatment|Physician Decision|5|||
143100340|NCT00300885|515909029|FG000|Treatment|Protocol Violation|11|||
143100341|NCT00300885|515909030|FG001|Treatment|Protocol Violation|11|||
143100342|NCT00300885|515909029|FG000|Treatment|Withdrawal by Subject|26|||
143100343|NCT00300885|515909030|FG001|Treatment|Withdrawal by Subject|23|||
143100344|NCT00300885|515909029|FG000|Treatment|Disease progression|171|||
143100345|NCT00300885|515909030|FG001|Treatment|Disease progression|238|||
143100346|NCT00300885|515909029|FG000|Treatment|Random code broken (subject died)|0|||
143100347|NCT00300885|515909030|FG001|Treatment|Random code broken (subject died)|1|||
143100348|NCT00300885|515909029|FG000|Treatment|Non-compliant with study medication|3|||
143100349|NCT00300885|515909030|FG001|Treatment|Non-compliant with study medication|4|||
143100350|NCT00300885|515909029|FG000|Follow-up|Death|141|||
143100351|NCT00300885|515909030|FG001|Follow-up|Death|163|||
143100352|NCT00300885|515909029|FG000|Follow-up|Lost to Follow-up|11|||
143100353|NCT00300885|515909030|FG001|Follow-up|Lost to Follow-up|7|||
143100354|NCT00300885|515909029|FG000|Follow-up|Withdrawal by Subject|26|||
143100355|NCT00300885|515909030|FG001|Follow-up|Withdrawal by Subject|25|||
143100356|NCT02058537|515909031|FG000|Overall Study|Withdrawal by Subject|1|||
143100357|NCT03337113|515909032|FG000|Overall Study|Adverse Event|1|||
143100358|NCT03337113|515909033|FG001|Overall Study|Adverse Event|1|||
143100359|NCT03337113|515909034|FG002|Overall Study|Adverse Event|0|||
143100360|NCT03337113|515909035|FG003|Overall Study|Adverse Event|1|||
143100361|NCT03337113|515909032|FG000|Overall Study|Physician Decision|0|||
143100362|NCT03337113|515909033|FG001|Overall Study|Physician Decision|2|||
143100363|NCT03337113|515909034|FG002|Overall Study|Physician Decision|0|||
143100364|NCT03337113|515909035|FG003|Overall Study|Physician Decision|1|||
143100365|NCT03337113|515909032|FG000|Overall Study|Withdrawal by Subject|0|||
143100366|NCT03337113|515909033|FG001|Overall Study|Withdrawal by Subject|0|||
143100367|NCT03337113|515909034|FG002|Overall Study|Withdrawal by Subject|1|||
143100368|NCT03337113|515909035|FG003|Overall Study|Withdrawal by Subject|0|||
143100369|NCT02476578|515909040|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
143252067|NCT01419197|516476405|FG001|Overall Study|Reason Not Specified|1|||
143252068|NCT01419197|516476404|FG000|Overall Study|Lost to Follow-up|14|||
143252069|NCT01419197|516476405|FG001|Overall Study|Lost to Follow-up|4|||
143252070|NCT01781299|516476406|FG000|Overall Study|Withdrawal by Subject|0|||
143252071|NCT01781299|516476407|FG001|Overall Study|Withdrawal by Subject|1|||
143252072|NCT00653939|516476412|FG000|Overall Study|Adverse Event|1|||
143252073|NCT00653939|516476413|FG001|Overall Study|Adverse Event|3|||
143252074|NCT00653939|516476412|FG000|Overall Study|Withdrawal by Subject|3|||
143252075|NCT00653939|516476413|FG001|Overall Study|Withdrawal by Subject|3|||
143252076|NCT00653939|516476412|FG000|Overall Study|Physician Decision|4|||
143252077|NCT00653939|516476413|FG001|Overall Study|Physician Decision|0|||
143252078|NCT00653939|516476412|FG000|Overall Study|Disease Progression|2|||
143252079|NCT00653939|516476413|FG001|Overall Study|Disease Progression|3|||
143252080|NCT00653939|516476412|FG000|Overall Study|Other|2|||
143252081|NCT00653939|516476413|FG001|Overall Study|Other|6|||
143100370|NCT02476578|515909041|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
143100371|NCT02476578|515909040|FG000|Overall Study|Lost to Follow-up|6|||
143100372|NCT02476578|515909041|FG001|Overall Study|Lost to Follow-up|13|||
143100373|NCT01964222|515909042|FG000|Overall Study|Lost to Follow-up|7|||
143100374|NCT01964222|515909043|FG001|Overall Study|Lost to Follow-up|5|||
143100375|NCT01964222|515909042|FG000|Overall Study|Withdrawal by Subject|6|||
143100376|NCT01964222|515909043|FG001|Overall Study|Withdrawal by Subject|6|||
143100377|NCT01964222|515909042|FG000|Overall Study|Screening Failure|2|||
143100378|NCT01964222|515909043|FG001|Overall Study|Screening Failure|0|||
143100379|NCT00441129|515909050|FG000|Overall Study|Withdrawal by Subject|6|||
143100380|NCT00441129|515909051|FG001|Overall Study|Withdrawal by Subject|14|||
143100381|NCT03412734|515909052|FG000|Overall Study|Incorrect labeling of samples|2|||
143100382|NCT03412734|515909053|FG001|Overall Study|Incorrect labeling of samples|0|||
143100383|NCT03412734|515909052|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
143252082|NCT02032238|516476414|FG000|Overall Study|Lost to Follow-up|2|||
143252083|NCT02032238|516476415|FG001|Overall Study|Lost to Follow-up|0|||
143252084|NCT00612105|516476416|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
143100384|NCT03412734|515909053|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
143100385|NCT04747886|515909054|FG000|Overall Study|Withdrawal by Subject|1|||
143252085|NCT00612105|516476417|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
143252086|NCT00612105|516476416|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
143252087|NCT00612105|516476417|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
143367750|NCT01143077|516889439|FG002|Overall Study|Adverse Event|5|||
143100386|NCT04747886|515909055|FG001|Overall Study|Withdrawal by Subject|4|||
143100387|NCT03259425|515909058|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
143100388|NCT03363776|515909059|FG000|Overall Study|Progressive disease|2|||
143100389|NCT03363776|515909060|FG001|Overall Study|Progressive disease|3|||
143100390|NCT03363776|515909061|FG002|Overall Study|Progressive disease|1|||
143100391|NCT03363776|515909059|FG000|Overall Study|Study drug toxicity|0|||
143100392|NCT03363776|515909060|FG001|Overall Study|Study drug toxicity|0|||
143100393|NCT03363776|515909061|FG002|Overall Study|Study drug toxicity|1|||
143100394|NCT03363776|515909059|FG000|Overall Study|Death|1|||
143100395|NCT03363776|515909060|FG001|Overall Study|Death|0|||
143100396|NCT03363776|515909061|FG002|Overall Study|Death|0|||
143100397|NCT01282372|515909063|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
143100398|NCT01282372|515909063|FG000|Overall Study|Lost to Follow-up|23|||
143100399|NCT01282372|515909063|FG000|Overall Study|Withdrawal by Subject|11|||
143100400|NCT01282372|515909063|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
143100401|NCT01282372|515909063|FG000|Overall Study|Death|1|||
143100402|NCT01282372|515909063|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
143100403|NCT01282372|515909063|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
143100404|NCT01282372|515909063|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
143100405|NCT01282372|515909063|FG000|Overall Study|Adverse Event|12|||
143100406|NCT02527434|515909065|FG000|Overall Study|Lost to Follow-up|2|||
143100407|NCT02527434|515909066|FG001|Overall Study|Lost to Follow-up|2|||
143100408|NCT02527434|515909067|FG002|Overall Study|Lost to Follow-up|0|||
143100409|NCT02527434|515909065|FG000|Overall Study|Death|19|||
143100410|NCT02527434|515909066|FG001|Overall Study|Death|6|||
143100411|NCT02527434|515909067|FG002|Overall Study|Death|17|||
143100412|NCT02527434|515909065|FG000|Overall Study|Withdrawal by Subject|5|||
143100413|NCT02527434|515909066|FG001|Overall Study|Withdrawal by Subject|3|||
143100414|NCT02527434|515909067|FG002|Overall Study|Withdrawal by Subject|3|||
143100415|NCT02527434|515909065|FG000|Overall Study|Reason Not Specified|1|||
143100416|NCT02527434|515909066|FG001|Overall Study|Reason Not Specified|0|||
143100417|NCT02527434|515909067|FG002|Overall Study|Reason Not Specified|0|||
143100418|NCT02527434|515909065|FG000|Overall Study|Site closure|1|||
143100419|NCT02527434|515909066|FG001|Overall Study|Site closure|0|||
143100420|NCT02527434|515909067|FG002|Overall Study|Site closure|0|||
143100421|NCT00713258|515909068|FG000|Overall Study|Adverse Event|2|||
143100422|NCT00713258|515909069|FG001|Overall Study|Adverse Event|4|||
143100423|NCT00713258|515909068|FG000|Overall Study|Non-Compliance|2|||
143100424|NCT00713258|515909069|FG001|Overall Study|Non-Compliance|1|||
143100425|NCT00713258|515909068|FG000|Overall Study|Other|1|||
143100426|NCT00713258|515909069|FG001|Overall Study|Other|1|||
143100427|NCT02199795|515909075|FG000|Overall Study|no longer met inclusion criteria|1|||
143100428|NCT02199795|515909076|FG001|Overall Study|no longer met inclusion criteria|0|||
143100429|NCT02199795|515909075|FG000|Overall Study|withdrew due to shoulder pain|1|||
143100430|NCT02199795|515909076|FG001|Overall Study|withdrew due to shoulder pain|0|||
143100431|NCT05310071|515909091|FG000|Overall Study|Death|0|||
143100432|NCT05310071|515909092|FG001|Overall Study|Death|3|||
143100433|NCT05310071|515909091|FG000|Overall Study|Adverse Event|4|||
143100434|NCT05310071|515909092|FG001|Overall Study|Adverse Event|31|||
143100435|NCT05310071|515909091|FG000|Overall Study|Lack of Efficacy - Based on Participant Perception|0|||
143100436|NCT05310071|515909092|FG001|Overall Study|Lack of Efficacy - Based on Participant Perception|2|||
143100437|NCT05310071|515909091|FG000|Overall Study|Protocol Deviation|2|||
143100438|NCT05310071|515909092|FG001|Overall Study|Protocol Deviation|0|||
143100439|NCT05310071|515909091|FG000|Overall Study|Randomized by Mistake|0|||
143100440|NCT05310071|515909092|FG001|Overall Study|Randomized by Mistake|1|||
143100441|NCT05310071|515909091|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
143100442|NCT05310071|515909092|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
143177401|NCT01119443|516197886|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
143177402|NCT01119443|516197887|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
143177403|NCT02329743|516197890|FG000|Overall Study|Adverse Event|1|||
143177404|NCT02329743|516197891|FG001|Overall Study|Adverse Event|1|||
143100443|NCT05310071|515909091|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
143100444|NCT05310071|515909092|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
143100445|NCT05310071|515909091|FG000|Overall Study|Site Terminated by Sponsor|0|||
143100446|NCT05310071|515909092|FG001|Overall Study|Site Terminated by Sponsor|2|||
143100447|NCT05310071|515909091|FG000|Overall Study|Study Terminated by Sponsor|282|||
143100448|NCT05310071|515909092|FG001|Overall Study|Study Terminated by Sponsor|559|||
143100449|NCT05310071|515909091|FG000|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|14|||
143100450|NCT05310071|515909092|FG001|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|17|||
143100451|NCT05310071|515909091|FG000|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|2|||
143100452|NCT05310071|515909092|FG001|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|6|||
143100453|NCT05310071|515909091|FG000|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|1|||
143100454|NCT05310071|515909092|FG001|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|3|||
143177405|NCT02329743|516197892|FG002|Overall Study|Adverse Event|3|||
143100455|NCT05310071|515909091|FG000|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|8|||
143100456|NCT05310071|515909092|FG001|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|17|||
143100457|NCT05310071|515909091|FG000|Overall Study|Withdrawal by Participant - Other|25|||
143100458|NCT05310071|515909092|FG001|Overall Study|Withdrawal by Participant - Other|30|||
143100459|NCT05310071|515909091|FG000|Overall Study|Lost to Follow-up|2|||
143100460|NCT05310071|515909092|FG001|Overall Study|Lost to Follow-up|4|||
143100461|NCT05310071|515909091|FG000|Overall Study|Reason Not Specified|1|||
143100462|NCT05310071|515909092|FG001|Overall Study|Reason Not Specified|3|||
143100463|NCT02418949|515909093|FG000|Overall Study|Withdrawal by Subject|1|||
143100464|NCT02418949|515909094|FG001|Overall Study|Withdrawal by Subject|0|||
143100465|NCT02418949|515909095|FG002|Overall Study|Withdrawal by Subject|1|||
143100466|NCT02418949|515909096|FG003|Overall Study|Withdrawal by Subject|1|||
143100467|NCT02418949|515909093|FG000|Overall Study|Lost to Follow-up|1|||
143100468|NCT02418949|515909094|FG001|Overall Study|Lost to Follow-up|0|||
143100469|NCT02418949|515909095|FG002|Overall Study|Lost to Follow-up|1|||
143100470|NCT02418949|515909096|FG003|Overall Study|Lost to Follow-up|0|||
143100471|NCT02418949|515909093|FG000|Overall Study|Physician Decision|1|||
143100472|NCT02418949|515909094|FG001|Overall Study|Physician Decision|1|||
143100473|NCT02418949|515909095|FG002|Overall Study|Physician Decision|1|||
143100474|NCT02418949|515909096|FG003|Overall Study|Physician Decision|0|||
143100475|NCT00237458|515909101|FG000|Overall Study|Lack of Efficacy|1|||
143100476|NCT00237458|515909101|FG000|Overall Study|Adverse Event|1|||
143100477|NCT00237458|515909101|FG000|Overall Study|Withdrawal by Subject|1|||
143100478|NCT02977572|515909102|FG000|Overall Study|Exclusion criterion|2|||
143100479|NCT02977572|515909103|FG001|Overall Study|Exclusion criterion|2|||
143100480|NCT05236764|515909104|FG000|Overall Study|In follow up (ongoing)|1|||
143100481|NCT05236764|515909104|FG000|Overall Study|Taken off study - secondary graft failure|1|||
143100482|NCT05236764|515909104|FG000|Overall Study|Death|1|||
143100483|NCT04339062|515909105|FG000|Overall Study|Death|0|||
143100484|NCT04339062|515909106|FG001|Overall Study|Death|1|||
143100485|NCT03218826|515909107|FG000|Overall Study|Non-compliance with protocol|1|||
143100486|NCT03218826|515909108|FG001|Overall Study|Non-compliance with protocol|0|||
143100487|NCT03218826|515909109|FG002|Overall Study|Non-compliance with protocol|2|||
143100488|NCT03218826|515909110|FG003|Overall Study|Non-compliance with protocol|1|||
143100489|NCT03218826|515909111|FG004|Overall Study|Non-compliance with protocol|1|||
143100490|NCT01197534|515909112|FG000|Overall Study|Not reported|16|||
143100491|NCT01197534|515909113|FG001|Overall Study|Not reported|10|||
143100492|NCT01197534|515909114|FG002|Overall Study|Not reported|16|||
143177406|NCT02329743|516197890|FG000|Overall Study|Lost to Follow-up|1|||
143177407|NCT02329743|516197891|FG001|Overall Study|Lost to Follow-up|0|||
143177408|NCT02329743|516197892|FG002|Overall Study|Lost to Follow-up|1|||
143177409|NCT02329743|516197890|FG000|Overall Study|Withdrawal by Subject|4|||
143177410|NCT02329743|516197891|FG001|Overall Study|Withdrawal by Subject|4|||
143177411|NCT02329743|516197892|FG002|Overall Study|Withdrawal by Subject|1|||
143177412|NCT02329743|516197890|FG000|Overall Study|Other|0|||
143177413|NCT02329743|516197891|FG001|Overall Study|Other|2|||
143177414|NCT02329743|516197892|FG002|Overall Study|Other|3|||
143177415|NCT01428219|516197894|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
143177416|NCT00775268|516197908|FG000|Baseline|Drug not synthesize dose|1|||
143177417|NCT00775268|516197909|FG001|Baseline|Drug not synthesize dose|0|||
143177418|NCT00775268|516197908|FG000|Baseline|Not treated-ineligible per CT|0|||
143177419|NCT00775268|516197909|FG001|Baseline|Not treated-ineligible per CT|1|||
143177420|NCT00775268|516197908|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
143177421|NCT00775268|516197909|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
143177422|NCT00775268|516197908|FG000|After Completion|Participant missed scan appointment|1|||
143177423|NCT00775268|516197909|FG001|After Completion|Participant missed scan appointment|0|||
143177424|NCT00825994|516197910|FG000|Overall Study|Withdrawal by Subject|2|||
143177425|NCT00825994|516197910|FG000|Overall Study|Lost to Follow-up|1|||
143177426|NCT00825994|516197910|FG000|Overall Study|Protocol Violation|1|||
143177427|NCT00825994|516197910|FG000|Overall Study|Placebo Responder at V2|1|||
143177428|NCT00616642|516197914|FG000|Overall Study|Withdrawal by Subject|0|||
143177429|NCT00616642|516197915|FG001|Overall Study|Withdrawal by Subject|1|||
143100493|NCT01197534|515909112|FG000|Overall Study|Enrolment in long term extension|57|||
143100494|NCT01197534|515909113|FG001|Overall Study|Enrolment in long term extension|66|||
143100495|NCT01197534|515909114|FG002|Overall Study|Enrolment in long term extension|119|||
143100496|NCT01197534|515909112|FG000|Overall Study|Severe non-compliance to protocol|3|||
143100497|NCT01197534|515909113|FG001|Overall Study|Severe non-compliance to protocol|4|||
143100498|NCT01197534|515909114|FG002|Overall Study|Severe non-compliance to protocol|1|||
143177430|NCT04232943|516197917|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
143177431|NCT04232943|516197918|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
143177432|NCT04232943|516197919|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
143177433|NCT04232943|516197917|FG000|Overall Study|Withdrawal by Subject|1|||
143100499|NCT01197534|515909112|FG000|Overall Study|Lack of therapeutic response|9|||
143100500|NCT01197534|515909113|FG001|Overall Study|Lack of therapeutic response|4|||
143100501|NCT01197534|515909114|FG002|Overall Study|Lack of therapeutic response|9|||
143100502|NCT01197534|515909112|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
143100503|NCT01197534|515909113|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
143100504|NCT01197534|515909114|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
143100505|NCT01197534|515909112|FG000|Overall Study|Lost to Follow-up|1|||
143100506|NCT01197534|515909113|FG001|Overall Study|Lost to Follow-up|4|||
143100507|NCT01197534|515909114|FG002|Overall Study|Lost to Follow-up|2|||
143100508|NCT01197534|515909112|FG000|Overall Study|Adverse Event|35|||
143100509|NCT01197534|515909113|FG001|Overall Study|Adverse Event|36|||
143100510|NCT01197534|515909114|FG002|Overall Study|Adverse Event|24|||
143100511|NCT00703157|515909117|FG000|Overall Study|Lost to Follow-up|0|||
143100512|NCT00703157|515909118|FG001|Overall Study|Lost to Follow-up|1|||
143100513|NCT00703157|515909117|FG000|Overall Study|source data permanently lost/ other|4|||
143100514|NCT00703157|515909118|FG001|Overall Study|source data permanently lost/ other|1|||
143100515|NCT02670525|515909121|FG000|Overall Study|Death|94|||
143100516|NCT02670525|515909122|FG001|Overall Study|Death|14|||
143100517|NCT02670525|515909121|FG000|Overall Study|Lost to Follow-up|4|||
143100518|NCT02670525|515909122|FG001|Overall Study|Lost to Follow-up|1|||
143100519|NCT02670525|515909121|FG000|Overall Study|Subject withdrew consent|1|||
143100520|NCT02670525|515909122|FG001|Overall Study|Subject withdrew consent|0|||
143100521|NCT02670525|515909121|FG000|Overall Study|Unknown, data entry delayed|123|||
143100522|NCT02670525|515909122|FG001|Overall Study|Unknown, data entry delayed|78|||
143100523|NCT02505217|515909123|FG000|Overall Study|Withdrawal by Subject|1|||
143100524|NCT02505217|515909124|FG001|Overall Study|Withdrawal by Subject|2|||
143100525|NCT03517540|515909130|FG000|Overall Study|Protocol Violation|2|||
143100526|NCT03517540|515909131|FG001|Overall Study|Protocol Violation|0|||
143100527|NCT03517540|515909132|FG002|Overall Study|Protocol Violation|0|||
143100528|NCT03517540|515909133|FG003|Overall Study|Protocol Violation|1|||
143100529|NCT03517540|515909130|FG000|Overall Study|Adverse Event|9|||
143100530|NCT03517540|515909131|FG001|Overall Study|Adverse Event|3|||
143100531|NCT03517540|515909132|FG002|Overall Study|Adverse Event|8|||
143100532|NCT03517540|515909133|FG003|Overall Study|Adverse Event|1|||
143100533|NCT03517540|515909130|FG000|Overall Study|Withdrawal by Subject|3|||
143100534|NCT03517540|515909131|FG001|Overall Study|Withdrawal by Subject|4|||
143100535|NCT03517540|515909132|FG002|Overall Study|Withdrawal by Subject|1|||
143100536|NCT03517540|515909133|FG003|Overall Study|Withdrawal by Subject|3|||
143100537|NCT01207687|515909138|FG000|Overall Study|Adverse Event|1|||
143100538|NCT01207687|515909138|FG000|Overall Study|Withdrawal by Subject|1|||
143100539|NCT01801865|515909139|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
143100540|NCT01801865|515909139|FG000|Overall Study|Physician Decision|7|||
143100541|NCT01777282|515909142|FG000|Overall Study|Persistent Hyperglycemia|0|||
143100542|NCT01777282|515909143|FG001|Overall Study|Persistent Hyperglycemia|0|||
143100543|NCT01777282|515909144|FG002|Overall Study|Persistent Hyperglycemia|1|||
143100544|NCT01777282|515909145|FG003|Overall Study|Persistent Hyperglycemia|0|||
143100545|NCT01777282|515909146|FG004|Overall Study|Persistent Hyperglycemia|0|||
143100546|NCT01777282|515909142|FG000|Overall Study|New Antidiabetic Medication|0|||
143100547|NCT01777282|515909143|FG001|Overall Study|New Antidiabetic Medication|0|||
143100548|NCT01777282|515909144|FG002|Overall Study|New Antidiabetic Medication|1|||
143100549|NCT01777282|515909145|FG003|Overall Study|New Antidiabetic Medication|0|||
143100550|NCT01777282|515909146|FG004|Overall Study|New Antidiabetic Medication|0|||
143100551|NCT01777282|515909142|FG000|Overall Study|Adverse Event|4|||
143100552|NCT01777282|515909143|FG001|Overall Study|Adverse Event|4|||
143100553|NCT01777282|515909144|FG002|Overall Study|Adverse Event|2|||
143100554|NCT01777282|515909145|FG003|Overall Study|Adverse Event|1|||
143100555|NCT01777282|515909146|FG004|Overall Study|Adverse Event|3|||
143100556|NCT01777282|515909142|FG000|Overall Study|Withdrawal by Subject|4|||
143100557|NCT01777282|515909143|FG001|Overall Study|Withdrawal by Subject|0|||
143100558|NCT01777282|515909144|FG002|Overall Study|Withdrawal by Subject|0|||
143100559|NCT01777282|515909145|FG003|Overall Study|Withdrawal by Subject|1|||
143100560|NCT01777282|515909146|FG004|Overall Study|Withdrawal by Subject|2|||
143100561|NCT01777282|515909142|FG000|Overall Study|Protocol Violation|2|||
143100562|NCT01777282|515909143|FG001|Overall Study|Protocol Violation|0|||
143100563|NCT01777282|515909144|FG002|Overall Study|Protocol Violation|1|||
143100564|NCT01777282|515909145|FG003|Overall Study|Protocol Violation|0|||
143252088|NCT00612105|516476416|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
143252089|NCT00612105|516476417|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
143100565|NCT01777282|515909146|FG004|Overall Study|Protocol Violation|2|||
143100566|NCT01777282|515909142|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
143100567|NCT01777282|515909143|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
143100568|NCT01777282|515909144|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
143100569|NCT01777282|515909145|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
143100570|NCT01777282|515909146|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
143100571|NCT00550745|515909147|FG000|Overall Study|Death|20|||
143100572|NCT00550745|515909148|FG001|Overall Study|Death|16|||
143100573|NCT00550745|515909147|FG000|Overall Study|Lost to Follow-up|45|||
143100574|NCT00550745|515909148|FG001|Overall Study|Lost to Follow-up|30|||
143100575|NCT00550745|515909147|FG000|Overall Study|Physician Decision|0|||
143100576|NCT00550745|515909148|FG001|Overall Study|Physician Decision|2|||
143100577|NCT00550745|515909147|FG000|Overall Study|Protocol Violation|4|||
143100578|NCT00550745|515909148|FG001|Overall Study|Protocol Violation|2|||
143100579|NCT00550745|515909147|FG000|Overall Study|Withdrawal by Subject|17|||
143100580|NCT00550745|515909148|FG001|Overall Study|Withdrawal by Subject|10|||
143100581|NCT00550745|515909147|FG000|Overall Study|Screen failure|1|||
143100582|NCT00550745|515909148|FG001|Overall Study|Screen failure|0|||
143100583|NCT00764660|515909149|FG000|Overall Study|Adverse Event|6|||
143100584|NCT00764660|515909150|FG001|Overall Study|Adverse Event|3|||
143100585|NCT00764660|515909149|FG000|Overall Study|Lost to Follow-up|3|||
143100586|NCT00764660|515909150|FG001|Overall Study|Lost to Follow-up|4|||
143100587|NCT00764660|515909149|FG000|Overall Study|Withdrawal by Subject|7|||
143100588|NCT00764660|515909150|FG001|Overall Study|Withdrawal by Subject|3|||
143100589|NCT00764660|515909149|FG000|Overall Study|Noncompliance With Protocol|5|||
143100590|NCT00764660|515909150|FG001|Overall Study|Noncompliance With Protocol|1|||
143100591|NCT00764660|515909149|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
143100592|NCT00764660|515909150|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
143100593|NCT01131455|515909151|FG000|Overall Study|Death of PI|6|||
143100594|NCT01131455|515909152|FG001|Overall Study|Death of PI|4|||
143100595|NCT01131455|515909153|FG002|Overall Study|Death of PI|0|||
143100596|NCT04545489|515910726|FG000|Overall Study|Withdrawal by Subject|12|||
143100597|NCT04545489|515910727|FG001|Overall Study|Withdrawal by Subject|4|||
143100598|NCT04545489|515910726|FG000|Overall Study|Lost to Follow-up|17|||
143100599|NCT04545489|515910727|FG001|Overall Study|Lost to Follow-up|18|||
143100600|NCT04545489|515910726|FG000|Overall Study|12month BP not collected|4|||
143100601|NCT04545489|515910727|FG001|Overall Study|12month BP not collected|4|||
143100602|NCT00652626|515910728|FG000|Initial Treatment Phase|Adverse Event|0|||
143100603|NCT00652626|515910729|FG001|Initial Treatment Phase|Adverse Event|0|||
143100604|NCT00652626|515910730|FG002|Initial Treatment Phase|Adverse Event|0|||
143100605|NCT00652626|515910731|FG003|Initial Treatment Phase|Adverse Event|0|||
143100606|NCT00652626|515910732|FG004|Initial Treatment Phase|Adverse Event|1|||
143100607|NCT00652626|515910733|FG005|Initial Treatment Phase|Adverse Event|0|||
143100608|NCT00652626|515910734|FG006|Initial Treatment Phase|Adverse Event|0|||
143100609|NCT00652626|515910728|FG000|Initial Treatment Phase|Protocol Violation|0|||
143100610|NCT00652626|515910729|FG001|Initial Treatment Phase|Protocol Violation|0|||
143100611|NCT00652626|515910730|FG002|Initial Treatment Phase|Protocol Violation|0|||
143100612|NCT00652626|515910731|FG003|Initial Treatment Phase|Protocol Violation|1|||
143100613|NCT00652626|515910732|FG004|Initial Treatment Phase|Protocol Violation|0|||
143100614|NCT00652626|515910733|FG005|Initial Treatment Phase|Protocol Violation|0|||
143100615|NCT00652626|515910734|FG006|Initial Treatment Phase|Protocol Violation|0|||
143100616|NCT00652626|515910728|FG000|Initial Treatment Phase|Physician Decision|0|||
143100617|NCT00652626|515910729|FG001|Initial Treatment Phase|Physician Decision|0|||
143100618|NCT00652626|515910730|FG002|Initial Treatment Phase|Physician Decision|0|||
143100619|NCT00652626|515910731|FG003|Initial Treatment Phase|Physician Decision|0|||
143100620|NCT00652626|515910732|FG004|Initial Treatment Phase|Physician Decision|1|||
143100621|NCT00652626|515910733|FG005|Initial Treatment Phase|Physician Decision|0|||
143100622|NCT00652626|515910734|FG006|Initial Treatment Phase|Physician Decision|0|||
143100623|NCT00652626|515910728|FG000|Initial Treatment Phase|Sponsor Request|0|||
143100624|NCT00652626|515910729|FG001|Initial Treatment Phase|Sponsor Request|0|||
143100625|NCT00652626|515910730|FG002|Initial Treatment Phase|Sponsor Request|1|||
143100626|NCT00652626|515910731|FG003|Initial Treatment Phase|Sponsor Request|0|||
143100627|NCT00652626|515910732|FG004|Initial Treatment Phase|Sponsor Request|0|||
143100628|NCT00652626|515910733|FG005|Initial Treatment Phase|Sponsor Request|0|||
143100629|NCT00652626|515910734|FG006|Initial Treatment Phase|Sponsor Request|0|||
143100630|NCT00652626|515910728|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
143100631|NCT00652626|515910729|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
143100632|NCT00652626|515910730|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
143100633|NCT00652626|515910731|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
143177434|NCT04232943|516197918|FG001|Overall Study|Withdrawal by Subject|1|||
143100634|NCT00652626|515910732|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
143177435|NCT04232943|516197919|FG002|Overall Study|Withdrawal by Subject|0|||
143177436|NCT01673646|516197925|FG000|Overall Study|Adverse Event|2|||
143100635|NCT00652626|515910733|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
143100636|NCT00652626|515910734|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
143100637|NCT00652626|515910728|FG000|Extension Phase|Withdrawal by Subject|0|||
143100638|NCT00652626|515910729|FG001|Extension Phase|Withdrawal by Subject|0|||
143100639|NCT00652626|515910730|FG002|Extension Phase|Withdrawal by Subject|0|||
143177437|NCT01673646|516197926|FG001|Overall Study|Adverse Event|1|||
143100640|NCT00652626|515910731|FG003|Extension Phase|Withdrawal by Subject|0|||
143100641|NCT00652626|515910732|FG004|Extension Phase|Withdrawal by Subject|0|||
143100642|NCT00652626|515910733|FG005|Extension Phase|Withdrawal by Subject|2|||
143100643|NCT00652626|515910734|FG006|Extension Phase|Withdrawal by Subject|0|||
143100644|NCT00652626|515910728|FG000|Extension Phase|Adverse Event|0|||
143100645|NCT00652626|515910729|FG001|Extension Phase|Adverse Event|0|||
143100646|NCT00652626|515910730|FG002|Extension Phase|Adverse Event|0|||
143100647|NCT00652626|515910731|FG003|Extension Phase|Adverse Event|0|||
143100648|NCT00652626|515910732|FG004|Extension Phase|Adverse Event|0|||
143100649|NCT00652626|515910733|FG005|Extension Phase|Adverse Event|2|||
143100650|NCT00652626|515910734|FG006|Extension Phase|Adverse Event|1|||
143100651|NCT00652626|515910728|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
143100652|NCT00652626|515910729|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
143100653|NCT00652626|515910730|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
143100654|NCT00652626|515910731|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
143100655|NCT00652626|515910732|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
143100656|NCT00652626|515910733|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
143100657|NCT00652626|515910734|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
143100658|NCT00652626|515910728|FG000|Extension Phase|Physician Decision|0|||
143100659|NCT00652626|515910729|FG001|Extension Phase|Physician Decision|0|||
143100660|NCT00652626|515910730|FG002|Extension Phase|Physician Decision|0|||
143100661|NCT00652626|515910731|FG003|Extension Phase|Physician Decision|0|||
143100662|NCT00652626|515910732|FG004|Extension Phase|Physician Decision|0|||
143100663|NCT00652626|515910733|FG005|Extension Phase|Physician Decision|1|||
143100664|NCT00652626|515910734|FG006|Extension Phase|Physician Decision|1|||
143100665|NCT00652626|515910728|FG000|Extension Phase|Death|0|||
143100666|NCT00652626|515910729|FG001|Extension Phase|Death|0|||
143100667|NCT00652626|515910730|FG002|Extension Phase|Death|0|||
143100668|NCT00652626|515910731|FG003|Extension Phase|Death|0|||
143100669|NCT00652626|515910732|FG004|Extension Phase|Death|0|||
143100670|NCT00652626|515910733|FG005|Extension Phase|Death|1|||
143100671|NCT00652626|515910734|FG006|Extension Phase|Death|1|||
143100672|NCT00566020|515910737|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
143100673|NCT00566020|515910738|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
143100674|NCT00566020|515910737|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
143100675|NCT00566020|515910738|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
143100676|NCT00566020|515910737|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
143100677|NCT00566020|515910738|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
143100678|NCT00566020|515910737|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
143100679|NCT00566020|515910738|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
143100680|NCT00566020|515910737|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
143100681|NCT00566020|515910738|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
143100682|NCT00566020|515910737|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
143100683|NCT00566020|515910738|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
143100684|NCT00459290|515910739|FG000|Overall Study|Adverse Event|3|||
143100685|NCT00459290|515910739|FG000|Overall Study|Ineligible|2|||
143100686|NCT03491462|515910748|FG000|Overall Study|Lost to Follow-up|2|||
143100687|NCT03491462|515910749|FG001|Overall Study|Lost to Follow-up|0|||
143100688|NCT03491462|515910748|FG000|Overall Study|Adverse Event|11|||
143100689|NCT03491462|515910749|FG001|Overall Study|Adverse Event|1|||
143100690|NCT03491462|515910748|FG000|Overall Study|Physician Decision|3|||
143100691|NCT03491462|515910749|FG001|Overall Study|Physician Decision|0|||
143100692|NCT03491462|515910748|FG000|Overall Study|Withdrawal by Subject|22|||
143100693|NCT03491462|515910749|FG001|Overall Study|Withdrawal by Subject|15|||
143100694|NCT04938180|515910750|FG000|Overall Study|Adverse Event|1|||
143100695|NCT00423332|515910754|FG000|Overall Study|Adverse Event|6|||
143100696|NCT00423332|515910755|FG001|Overall Study|Adverse Event|2|||
143100697|NCT00423332|515910754|FG000|Overall Study|Withdrawal by Subject|1|||
143100698|NCT00423332|515910755|FG001|Overall Study|Withdrawal by Subject|0|||
143100699|NCT00423332|515910754|FG000|Overall Study|Condition under investigation worsened|1|||
143367751|NCT01143077|516889437|FG000|Overall Study|Lost to Follow-up|2|||
143367752|NCT01143077|516889438|FG001|Overall Study|Lost to Follow-up|3|||
143367753|NCT01143077|516889439|FG002|Overall Study|Lost to Follow-up|4|||
143367754|NCT01143077|516889437|FG000|Overall Study|Protocol Violation|2|||
143100700|NCT00423332|515910755|FG001|Overall Study|Condition under investigation worsened|1|||
143100701|NCT00423332|515910754|FG000|Overall Study|Progressive at Week 6|0|||
143100702|NCT00423332|515910755|FG001|Overall Study|Progressive at Week 6|1|||
143100703|NCT00423332|515910754|FG000|Overall Study|Unblinded before 12 weeks|1|||
143100704|NCT00423332|515910755|FG001|Overall Study|Unblinded before 12 weeks|3|||
143100705|NCT00644917|515910757|FG000|Overall Study|Withdrawal by Subject|2|||
143100706|NCT00758485|515910758|FG000|Overall Study|Lost to Follow-up|0|||
143100707|NCT00758485|515910759|FG001|Overall Study|Lost to Follow-up|1|||
143100708|NCT00758485|515910758|FG000|Overall Study|Not Treated|1|||
143100709|NCT00758485|515910759|FG001|Overall Study|Not Treated|2|||
143100710|NCT00921557|515910760|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
143100711|NCT00921557|515910761|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
143100712|NCT00921557|515910762|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
143100713|NCT00921557|515910760|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
143100714|NCT00921557|515910761|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
143367755|NCT01143077|516889438|FG001|Overall Study|Protocol Violation|0|||
143100715|NCT00921557|515910762|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
143100716|NCT00921557|515910760|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
143100717|NCT00921557|515910761|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
143100718|NCT00921557|515910762|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
143100719|NCT00921557|515910760|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
143100720|NCT00921557|515910761|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
143100721|NCT00921557|515910762|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
143100722|NCT00921557|515910760|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
143100723|NCT00921557|515910761|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
143100724|NCT00921557|515910762|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
143100725|NCT02097238|515910781|FG000|Overall Study|Death|1|||
143100726|NCT02097238|515910781|FG000|Overall Study|Physician Decision|1|||
143100727|NCT02097238|515910781|FG000|Overall Study|Progressive Disease|17|||
143100728|NCT01106911|515910782|FG000|Overall Study|Physician Decision|2|||
143100729|NCT01106911|515910782|FG000|Overall Study|deemed ineligible after screening|3|||
143100730|NCT01814696|515910783|FG000|Overall Study|Withdrawal by Subject|1|||
143100731|NCT01814696|515910784|FG001|Overall Study|Withdrawal by Subject|0|||
143100732|NCT01814696|515910783|FG000|Overall Study|Randomized to wrong group|1|||
143100733|NCT01814696|515910784|FG001|Overall Study|Randomized to wrong group|0|||
143100734|NCT01322490|515910785|FG000|Treatment Period|Adverse Event|12|||
143100735|NCT01322490|515910786|FG001|Treatment Period|Adverse Event|18|||
143100736|NCT01322490|515910787|FG002|Treatment Period|Adverse Event|15|||
143100737|NCT01322490|515910785|FG000|Treatment Period|Death|5|||
143100738|NCT01322490|515910786|FG001|Treatment Period|Death|7|||
143100739|NCT01322490|515910787|FG002|Treatment Period|Death|3|||
143100740|NCT01322490|515910785|FG000|Treatment Period|Lack of Efficacy|89|||
143100741|NCT01322490|515910786|FG001|Treatment Period|Lack of Efficacy|100|||
143100742|NCT01322490|515910787|FG002|Treatment Period|Lack of Efficacy|112|||
143100743|NCT01322490|515910785|FG000|Treatment Period|Physician Decision|0|||
143100744|NCT01322490|515910786|FG001|Treatment Period|Physician Decision|2|||
143100745|NCT01322490|515910787|FG002|Treatment Period|Physician Decision|1|||
143100746|NCT01322490|515910785|FG000|Treatment Period|Protocol Violation|7|||
143100747|NCT01322490|515910786|FG001|Treatment Period|Protocol Violation|5|||
143100748|NCT01322490|515910787|FG002|Treatment Period|Protocol Violation|4|||
143100749|NCT01322490|515910785|FG000|Treatment Period|Withdrawal by Subject|14|||
143100750|NCT01322490|515910786|FG001|Treatment Period|Withdrawal by Subject|16|||
143100751|NCT01322490|515910787|FG002|Treatment Period|Withdrawal by Subject|11|||
143100752|NCT01322490|515910785|FG000|Treatment Period|Non-compliance with study drug|0|||
143100753|NCT01322490|515910786|FG001|Treatment Period|Non-compliance with study drug|0|||
143100754|NCT01322490|515910787|FG002|Treatment Period|Non-compliance with study drug|1|||
143100755|NCT01322490|515910785|FG000|Treatment Period|Other per report|2|||
143100756|NCT01322490|515910786|FG001|Treatment Period|Other per report|2|||
143100757|NCT01322490|515910787|FG002|Treatment Period|Other per report|1|||
143100758|NCT01322490|515910785|FG000|Treatment Period|Randomized but Not Treated|3|||
143100759|NCT01322490|515910786|FG001|Treatment Period|Randomized but Not Treated|3|||
143100760|NCT01322490|515910787|FG002|Treatment Period|Randomized but Not Treated|5|||
143100761|NCT01322490|515910785|FG000|Long Term Follow-up Period|Death|235|||
143100762|NCT01322490|515910786|FG001|Long Term Follow-up Period|Death|239|||
143100763|NCT01322490|515910787|FG002|Long Term Follow-up Period|Death|236|||
143100764|NCT01322490|515910785|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
143100765|NCT01322490|515910786|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
143100766|NCT01322490|515910787|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
143100767|NCT01322490|515910785|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
143100768|NCT01322490|515910786|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
143100769|NCT01322490|515910787|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
143100770|NCT01322490|515910785|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
143100771|NCT01322490|515910786|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
143100772|NCT01322490|515910787|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
143177438|NCT01673646|516197927|FG002|Overall Study|Adverse Event|1|||
143177439|NCT01673646|516197925|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
143177440|NCT01673646|516197926|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
143177441|NCT01673646|516197927|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
143177442|NCT01673646|516197925|FG000|Overall Study|Condition no longer requires study drug|0|||
143100773|NCT01322490|515910785|FG000|Long Term Follow-up Period|Other per report|3|||
143100774|NCT01322490|515910786|FG001|Long Term Follow-up Period|Other per report|2|||
143100775|NCT01322490|515910787|FG002|Long Term Follow-up Period|Other per report|2|||
143100776|NCT01322490|515910785|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
143100777|NCT01322490|515910786|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
143100778|NCT01322490|515910787|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
143100779|NCT00984542|515910788|FG000|Overall Study|disease progression|19|||
143177443|NCT01673646|516197926|FG001|Overall Study|Condition no longer requires study drug|1|||
143177444|NCT01673646|516197927|FG002|Overall Study|Condition no longer requires study drug|0|||
143177445|NCT01673646|516197925|FG000|Overall Study|Withdrawal by Subject|0|||
143100780|NCT00984542|515910788|FG000|Overall Study|toxicity|7|||
143100781|NCT00984542|515910788|FG000|Overall Study|Death|7|||
143100782|NCT00984542|515910788|FG000|Overall Study|complicating disease|3|||
143100783|NCT00984542|515910788|FG000|Overall Study|Withdrawal by Subject|3|||
143100784|NCT00984542|515910788|FG000|Overall Study|clinical deterioration|2|||
143100785|NCT02343939|515910789|FG000|Overall Study|Death|0|||
143100786|NCT02343939|515910790|FG001|Overall Study|Death|15|||
143100787|NCT02343939|515910791|FG002|Overall Study|Death|4|||
143100788|NCT02343939|515910792|FG003|Overall Study|Death|2|||
143100789|NCT02343939|515910793|FG004|Overall Study|Death|5|||
143100790|NCT02343939|515910794|FG005|Overall Study|Death|11|||
143100791|NCT02343939|515910795|FG006|Overall Study|Death|8|||
143100792|NCT02343939|515910796|FG007|Overall Study|Death|22|||
143100793|NCT02343939|515910797|FG008|Overall Study|Death|1|||
143100794|NCT02343939|515910789|FG000|Overall Study|Study terminated by sponsor|0|||
143100795|NCT02343939|515910790|FG001|Overall Study|Study terminated by sponsor|27|||
143100796|NCT02343939|515910791|FG002|Overall Study|Study terminated by sponsor|0|||
143100797|NCT02343939|515910792|FG003|Overall Study|Study terminated by sponsor|1|||
143100798|NCT02343939|515910793|FG004|Overall Study|Study terminated by sponsor|1|||
143100799|NCT02343939|515910794|FG005|Overall Study|Study terminated by sponsor|5|||
143100800|NCT02343939|515910795|FG006|Overall Study|Study terminated by sponsor|3|||
143100801|NCT02343939|515910796|FG007|Overall Study|Study terminated by sponsor|4|||
143100802|NCT02343939|515910797|FG008|Overall Study|Study terminated by sponsor|0|||
143100803|NCT02343939|515910789|FG000|Overall Study|Withdrew consent|3|||
143100804|NCT02343939|515910790|FG001|Overall Study|Withdrew consent|6|||
143100805|NCT02343939|515910791|FG002|Overall Study|Withdrew consent|1|||
143100806|NCT02343939|515910792|FG003|Overall Study|Withdrew consent|2|||
143100807|NCT02343939|515910793|FG004|Overall Study|Withdrew consent|2|||
143100808|NCT02343939|515910794|FG005|Overall Study|Withdrew consent|0|||
143100809|NCT02343939|515910795|FG006|Overall Study|Withdrew consent|0|||
143100810|NCT02343939|515910796|FG007|Overall Study|Withdrew consent|8|||
143100811|NCT02343939|515910797|FG008|Overall Study|Withdrew consent|6|||
143100812|NCT02343939|515910789|FG000|Overall Study|Treatment failure|0|||
143100813|NCT02343939|515910790|FG001|Overall Study|Treatment failure|0|||
143100814|NCT02343939|515910791|FG002|Overall Study|Treatment failure|0|||
143100815|NCT02343939|515910792|FG003|Overall Study|Treatment failure|0|||
143100816|NCT02343939|515910793|FG004|Overall Study|Treatment failure|0|||
143100817|NCT02343939|515910794|FG005|Overall Study|Treatment failure|0|||
143100818|NCT02343939|515910795|FG006|Overall Study|Treatment failure|2|||
143100819|NCT02343939|515910796|FG007|Overall Study|Treatment failure|1|||
143100820|NCT02343939|515910797|FG008|Overall Study|Treatment failure|0|||
143100821|NCT02343939|515910789|FG000|Overall Study|Investigator's discretion|0|||
143100822|NCT02343939|515910790|FG001|Overall Study|Investigator's discretion|0|||
143100823|NCT02343939|515910791|FG002|Overall Study|Investigator's discretion|0|||
143100824|NCT02343939|515910792|FG003|Overall Study|Investigator's discretion|1|||
143100825|NCT02343939|515910793|FG004|Overall Study|Investigator's discretion|0|||
143100826|NCT02343939|515910794|FG005|Overall Study|Investigator's discretion|0|||
143100827|NCT02343939|515910795|FG006|Overall Study|Investigator's discretion|1|||
143100828|NCT02343939|515910796|FG007|Overall Study|Investigator's discretion|0|||
143100829|NCT02343939|515910797|FG008|Overall Study|Investigator's discretion|0|||
143100830|NCT02343939|515910789|FG000|Overall Study|Adverse Event|0|||
143100831|NCT02343939|515910790|FG001|Overall Study|Adverse Event|0|||
143100832|NCT02343939|515910791|FG002|Overall Study|Adverse Event|0|||
143100833|NCT02343939|515910792|FG003|Overall Study|Adverse Event|0|||
143100834|NCT02343939|515910793|FG004|Overall Study|Adverse Event|0|||
143100835|NCT02343939|515910794|FG005|Overall Study|Adverse Event|1|||
143100836|NCT02343939|515910795|FG006|Overall Study|Adverse Event|0|||
143100837|NCT02343939|515910796|FG007|Overall Study|Adverse Event|0|||
143100838|NCT02343939|515910797|FG008|Overall Study|Adverse Event|0|||
143100839|NCT02343939|515910789|FG000|Overall Study|Never Treated With ENTO|0|||
143252090|NCT00612105|516476416|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
143252091|NCT00612105|516476417|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
143100840|NCT02343939|515910790|FG001|Overall Study|Never Treated With ENTO|0|||
143100841|NCT02343939|515910791|FG002|Overall Study|Never Treated With ENTO|0|||
143100842|NCT02343939|515910792|FG003|Overall Study|Never Treated With ENTO|0|||
143100843|NCT02343939|515910793|FG004|Overall Study|Never Treated With ENTO|0|||
143100844|NCT02343939|515910794|FG005|Overall Study|Never Treated With ENTO|0|||
143100845|NCT02343939|515910795|FG006|Overall Study|Never Treated With ENTO|1|||
143100846|NCT02343939|515910796|FG007|Overall Study|Never Treated With ENTO|2|||
143100847|NCT02343939|515910797|FG008|Overall Study|Never Treated With ENTO|0|||
143100848|NCT02684097|515910800|FG000|Overall Study|Lack of Efficacy|13|||
143100849|NCT02684097|515910801|FG001|Overall Study|Lack of Efficacy|6|||
143100850|NCT00462709|515910802|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
143100851|NCT00462709|515910802|FG000|Overall Study|Lost to Follow-up|10|||
143100852|NCT00462709|515910802|FG000|Overall Study|Withdrawal by Subject|8|||
143100853|NCT00462709|515910802|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
143100854|NCT00462709|515910802|FG000|Overall Study|Death|2|||
143252092|NCT00612105|516476416|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
143100855|NCT00462709|515910802|FG000|Overall Study|Logistical reasons|2|||
143100856|NCT00462709|515910802|FG000|Overall Study|Physician Decision|1|||
143100857|NCT00462709|515910802|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
143100858|NCT00460811|515910803|FG000|Overall Study|Adverse Event|4|||
143100859|NCT00460811|515910804|FG001|Overall Study|Adverse Event|6|||
143100860|NCT00460811|515910805|FG002|Overall Study|Adverse Event|3|||
143100861|NCT00460811|515910806|FG003|Overall Study|Adverse Event|10|||
143100862|NCT00460811|515910807|FG004|Overall Study|Adverse Event|2|||
143100863|NCT00460811|515910803|FG000|Overall Study|Noncompliance|1|||
143100864|NCT00460811|515910804|FG001|Overall Study|Noncompliance|0|||
143100865|NCT00460811|515910805|FG002|Overall Study|Noncompliance|0|||
143100866|NCT00460811|515910806|FG003|Overall Study|Noncompliance|2|||
143100867|NCT00460811|515910807|FG004|Overall Study|Noncompliance|1|||
143100868|NCT00460811|515910803|FG000|Overall Study|Withdrawal by Subject|7|||
143100869|NCT00460811|515910804|FG001|Overall Study|Withdrawal by Subject|7|||
143100870|NCT00460811|515910805|FG002|Overall Study|Withdrawal by Subject|6|||
143100871|NCT00460811|515910806|FG003|Overall Study|Withdrawal by Subject|3|||
143100872|NCT00460811|515910807|FG004|Overall Study|Withdrawal by Subject|11|||
143100873|NCT00460811|515910803|FG000|Overall Study|Physician Decision|1|||
143100874|NCT00460811|515910804|FG001|Overall Study|Physician Decision|0|||
143100875|NCT00460811|515910805|FG002|Overall Study|Physician Decision|0|||
143100876|NCT00460811|515910806|FG003|Overall Study|Physician Decision|0|||
143100877|NCT00460811|515910807|FG004|Overall Study|Physician Decision|0|||
143100878|NCT00460811|515910803|FG000|Overall Study|Lost to Follow-up|3|||
143100879|NCT00460811|515910804|FG001|Overall Study|Lost to Follow-up|2|||
143100880|NCT00460811|515910805|FG002|Overall Study|Lost to Follow-up|5|||
143100881|NCT00460811|515910806|FG003|Overall Study|Lost to Follow-up|3|||
143100882|NCT00460811|515910807|FG004|Overall Study|Lost to Follow-up|6|||
143100883|NCT00425750|515910811|FG000|Overall Study|Death|1|||
143100884|NCT00425750|515910811|FG000|Overall Study|Withdrawal by Subject|3|||
143100885|NCT00425750|515910811|FG000|Overall Study|Adverse Event|3|||
143100886|NCT00425750|515910811|FG000|Overall Study|Progression of disease|18|||
143100887|NCT02064816|515910812|FG000|Overall Study|Adverse Event|3|||
143100888|NCT02064816|515910813|FG001|Overall Study|Adverse Event|2|||
143100889|NCT02064816|515910812|FG000|Overall Study|Withdrawal by Subject|2|||
143100890|NCT02064816|515910813|FG001|Overall Study|Withdrawal by Subject|1|||
143100891|NCT02064816|515910812|FG000|Overall Study|Lost to Follow-up|2|||
143100892|NCT02064816|515910813|FG001|Overall Study|Lost to Follow-up|1|||
143100893|NCT02064816|515910812|FG000|Overall Study|Therapeutic failure|0|||
143100894|NCT02064816|515910813|FG001|Overall Study|Therapeutic failure|1|||
143100895|NCT02064816|515910812|FG000|Overall Study|Other|1|||
143100896|NCT02064816|515910813|FG001|Overall Study|Other|3|||
143100897|NCT01757184|515910818|FG000|Double-blind Period|Adverse Event|1|||
143100898|NCT01757184|515910819|FG001|Double-blind Period|Adverse Event|0|||
143100899|NCT01757184|515910820|FG002|Double-blind Period|Adverse Event|0|||
143100900|NCT01757184|515910821|FG003|Double-blind Period|Adverse Event|0|||
143100901|NCT01757184|515910818|FG000|Open-label Period|Lost to Follow-up|0|||
143100902|NCT01757184|515910819|FG001|Open-label Period|Lost to Follow-up|0|||
143100903|NCT01757184|515910820|FG002|Open-label Period|Lost to Follow-up|2|||
143100904|NCT01757184|515910821|FG003|Open-label Period|Lost to Follow-up|0|||
143100905|NCT01757184|515910818|FG000|Open-label Period|Withdrawal by Subject|0|||
143100906|NCT01757184|515910819|FG001|Open-label Period|Withdrawal by Subject|0|||
143100907|NCT01757184|515910820|FG002|Open-label Period|Withdrawal by Subject|1|||
143100908|NCT01757184|515910821|FG003|Open-label Period|Withdrawal by Subject|1|||
143100909|NCT01757184|515910818|FG000|Open-label Period|Discontinued by Sponsor|0|||
143100910|NCT01757184|515910819|FG001|Open-label Period|Discontinued by Sponsor|0|||
143100911|NCT01757184|515910820|FG002|Open-label Period|Discontinued by Sponsor|1|||
143100912|NCT01757184|515910821|FG003|Open-label Period|Discontinued by Sponsor|2|||
143100913|NCT04468347|515910824|FG000|Overall Study|Withdrawal by Subject|0|||
143100914|NCT04468347|515910825|FG001|Overall Study|Withdrawal by Subject|1|||
143100915|NCT04468347|515910826|FG002|Overall Study|Withdrawal by Subject|3|||
143100916|NCT04468347|515910827|FG003|Overall Study|Withdrawal by Subject|3|||
143100917|NCT04468347|515910824|FG000|Overall Study|Lost to Follow-up|0|||
143100918|NCT04468347|515910825|FG001|Overall Study|Lost to Follow-up|0|||
143100919|NCT04468347|515910826|FG002|Overall Study|Lost to Follow-up|1|||
143100920|NCT04468347|515910827|FG003|Overall Study|Lost to Follow-up|1|||
143100921|NCT04468347|515910824|FG000|Overall Study|Physician Decision|1|||
143100922|NCT04468347|515910825|FG001|Overall Study|Physician Decision|0|||
143100923|NCT04468347|515910826|FG002|Overall Study|Physician Decision|2|||
143100924|NCT04468347|515910827|FG003|Overall Study|Physician Decision|0|||
143100925|NCT04468347|515910824|FG000|Overall Study|Protocol Violation|1|||
143100926|NCT04468347|515910825|FG001|Overall Study|Protocol Violation|0|||
143100927|NCT04468347|515910826|FG002|Overall Study|Protocol Violation|0|||
143100928|NCT04468347|515910827|FG003|Overall Study|Protocol Violation|0|||
143100929|NCT01732458|515910828|FG000|Overall Study|Lost to Follow-up|0|||
143100930|NCT01732458|515910829|FG001|Overall Study|Lost to Follow-up|2|||
143100931|NCT01732458|515910830|FG002|Overall Study|Lost to Follow-up|0|||
143100932|NCT01732458|515910831|FG003|Overall Study|Lost to Follow-up|0|||
143100933|NCT01732458|515910828|FG000|Overall Study|Non-Compliance With Study Drug|0|||
143100934|NCT01732458|515910829|FG001|Overall Study|Non-Compliance With Study Drug|0|||
143100935|NCT01732458|515910830|FG002|Overall Study|Non-Compliance With Study Drug|1|||
143100936|NCT01732458|515910831|FG003|Overall Study|Non-Compliance With Study Drug|0|||
143100937|NCT01732458|515910828|FG000|Overall Study|Physician Decision|1|||
143100938|NCT01732458|515910829|FG001|Overall Study|Physician Decision|2|||
143100939|NCT01732458|515910830|FG002|Overall Study|Physician Decision|2|||
143100940|NCT01732458|515910831|FG003|Overall Study|Physician Decision|0|||
143100941|NCT01732458|515910828|FG000|Overall Study|Protocol Violation|2|||
143100942|NCT01732458|515910829|FG001|Overall Study|Protocol Violation|0|||
143100943|NCT01732458|515910830|FG002|Overall Study|Protocol Violation|0|||
143100944|NCT01732458|515910831|FG003|Overall Study|Protocol Violation|2|||
143100945|NCT01732458|515910828|FG000|Overall Study|Screen Failure|0|||
143100946|NCT01732458|515910829|FG001|Overall Study|Screen Failure|1|||
143100947|NCT01732458|515910830|FG002|Overall Study|Screen Failure|0|||
143100948|NCT01732458|515910831|FG003|Overall Study|Screen Failure|0|||
143100949|NCT03515811|515910832|FG000|Overall Study|Lost to Follow-up|2|||
143100950|NCT03515811|515910833|FG001|Overall Study|Lost to Follow-up|1|||
143100951|NCT03515811|515910832|FG000|Overall Study|Protocol Violation|1|||
143100952|NCT03515811|515910833|FG001|Overall Study|Protocol Violation|1|||
143100953|NCT03515811|515910832|FG000|Overall Study|Death|1|||
143100954|NCT03515811|515910833|FG001|Overall Study|Death|1|||
143100955|NCT03515811|515910832|FG000|Overall Study|Withdrawal by Subject|0|||
143100956|NCT03515811|515910833|FG001|Overall Study|Withdrawal by Subject|2|||
143100957|NCT03515811|515910832|FG000|Overall Study|Technical Problems|1|||
143100958|NCT03515811|515910833|FG001|Overall Study|Technical Problems|0|||
143100959|NCT03515811|515910832|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
143100960|NCT03515811|515910833|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
143100961|NCT03515811|515910832|FG000|Overall Study|COVID-19|0|||
143100962|NCT03515811|515910833|FG001|Overall Study|COVID-19|1|||
143100963|NCT02589639|515910845|FG000|Overall Study|Lost to Follow-up|1|||
143100964|NCT02589639|515910846|FG001|Overall Study|Lost to Follow-up|0|||
143100965|NCT02589639|515910847|FG002|Overall Study|Lost to Follow-up|0|||
143100966|NCT02589639|515910845|FG000|Overall Study|Protocol Violation|1|||
143100967|NCT02589639|515910846|FG001|Overall Study|Protocol Violation|0|||
143100968|NCT02589639|515910847|FG002|Overall Study|Protocol Violation|0|||
143100969|NCT02589639|515910845|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
143100970|NCT02589639|515910846|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
143100971|NCT02589639|515910847|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
143100972|NCT02589639|515910845|FG000|Overall Study|Adverse Event|4|||
143100973|NCT02589639|515910846|FG001|Overall Study|Adverse Event|5|||
143100974|NCT02589639|515910847|FG002|Overall Study|Adverse Event|3|||
143100975|NCT02589639|515910845|FG000|Overall Study|Other reason than specified above|1|||
143100976|NCT02589639|515910846|FG001|Overall Study|Other reason than specified above|2|||
143100977|NCT02589639|515910847|FG002|Overall Study|Other reason than specified above|1|||
143100978|NCT02589639|515910845|FG000|Overall Study|Not Treated|0|||
143100979|NCT02589639|515910846|FG001|Overall Study|Not Treated|3|||
143100980|NCT02589639|515910847|FG002|Overall Study|Not Treated|0|||
143100981|NCT01276756|515910848|FG000|Overall Study|Lost to Follow-up|2|||
143100982|NCT01276756|515910849|FG001|Overall Study|Lost to Follow-up|0|||
143100983|NCT01276756|515910848|FG000|Overall Study|Adverse Event|3|||
143100984|NCT01276756|515910849|FG001|Overall Study|Adverse Event|2|||
143100985|NCT00347009|515910850|FG000|Overall Study|Death|1|||
143100986|NCT00347009|515910850|FG000|Overall Study|Adverse Event|6|||
143100987|NCT00347009|515910850|FG000|Overall Study|Withdrawal by Subject|3|||
143100988|NCT00347009|515910850|FG000|Overall Study|Physician Decision|5|||
143100989|NCT00347009|515910850|FG000|Overall Study|Lost to Follow-up|4|||
143100990|NCT00347009|515910850|FG000|Overall Study|Protocol Violation|2|||
143100991|NCT00347009|515910850|FG000|Overall Study|Adverse Laboratory Experience|1|||
143100992|NCT00347009|515910850|FG000|Overall Study|Insufficient Viral Suppression|3|||
143100993|NCT00347009|515910850|FG000|Overall Study|Increased ALT/HBV DNA|1|||
143100994|NCT00347009|515910850|FG000|Overall Study|Serious Adverse Event|1|||
143100995|NCT05868577|515910851|FG000|Overall Study|Lost to Follow-up|5|||
143100996|NCT05868577|515910852|FG001|Overall Study|Lost to Follow-up|5|||
143100997|NCT02522884|515910853|FG000|Overall Study|Withdrawal by Subject|6|||
143100998|NCT02522884|515910853|FG000|Overall Study|Death|3|||
143100999|NCT02522884|515910853|FG000|Overall Study|Missed 12-month Follow-up|9|||
143367756|NCT01143077|516889439|FG002|Overall Study|Protocol Violation|0|||
143101000|NCT00591565|515910856|FG000|Overall Study|lost follow up, withdrawn|5|||
143101001|NCT03564119|515910857|FG000|Overall Study|Adverse Event|4|||
143101002|NCT03564119|515910858|FG001|Overall Study|Adverse Event|0|||
143101003|NCT03564119|515910857|FG000|Overall Study|Lost to Follow-up|1|||
143101004|NCT03564119|515910858|FG001|Overall Study|Lost to Follow-up|4|||
143101005|NCT03564119|515910857|FG000|Overall Study|Protocol Violation|1|||
143101006|NCT03564119|515910858|FG001|Overall Study|Protocol Violation|0|||
143101007|NCT03564119|515910857|FG000|Overall Study|Withdrawal by Subject|9|||
143101008|NCT03564119|515910858|FG001|Overall Study|Withdrawal by Subject|4|||
143101009|NCT03564119|515910857|FG000|Overall Study|Other Than Specified|0|||
143101010|NCT03564119|515910858|FG001|Overall Study|Other Than Specified|1|||
143101011|NCT00634036|515910859|FG000|Overall Study|Lost to Follow-up|1|||
143101012|NCT00634036|515910860|FG001|Overall Study|Lost to Follow-up|1|||
143101013|NCT00634036|515910859|FG000|Overall Study|Withdrawal by Subject|1|||
143101014|NCT00634036|515910860|FG001|Overall Study|Withdrawal by Subject|1|||
143101015|NCT03896022|515910862|FG000|Overall Study|Withdrawal by Subject|1|||
143101016|NCT03896022|515910863|FG001|Overall Study|Withdrawal by Subject|0|||
143101017|NCT03896022|515910864|FG002|Overall Study|Withdrawal by Subject|0|||
143101018|NCT03896022|515910862|FG000|Overall Study|Did not have procedure|3|||
143101019|NCT03896022|515910863|FG001|Overall Study|Did not have procedure|0|||
143101020|NCT03896022|515910864|FG002|Overall Study|Did not have procedure|0|||
143101021|NCT01863667|515910869|FG000|Overall Study|Adverse Event|1|||
143101022|NCT01863667|515910870|FG001|Overall Study|Adverse Event|0|||
143101023|NCT01863667|515910869|FG000|Overall Study|Study terminated by Sponsor|30|||
143101024|NCT01863667|515910870|FG001|Overall Study|Study terminated by Sponsor|30|||
143101025|NCT01863667|515910869|FG000|Overall Study|Withdrawal by Subject|2|||
143101026|NCT01863667|515910870|FG001|Overall Study|Withdrawal by Subject|2|||
143101027|NCT00615550|515910871|FG000|Overall Study|Lost to Follow-up|6|||
143101028|NCT00615550|515910872|FG001|Overall Study|Lost to Follow-up|1|||
143101029|NCT02741076|515910873|FG000|Overall Study|Adverse Event|0|||
143101030|NCT02741076|515910874|FG001|Overall Study|Adverse Event|1|||
143101031|NCT02741076|515910875|FG002|Overall Study|Adverse Event|1|||
143101032|NCT02741076|515910876|FG003|Overall Study|Adverse Event|0|||
143101033|NCT02741076|515910873|FG000|Overall Study|Lack of Efficacy|1|||
143101034|NCT02741076|515910874|FG001|Overall Study|Lack of Efficacy|0|||
143101035|NCT02741076|515910875|FG002|Overall Study|Lack of Efficacy|0|||
143101036|NCT02741076|515910876|FG003|Overall Study|Lack of Efficacy|0|||
143101037|NCT02741076|515910873|FG000|Overall Study|Withdrawal by Subject|0|||
143101038|NCT02741076|515910874|FG001|Overall Study|Withdrawal by Subject|1|||
143101039|NCT02741076|515910875|FG002|Overall Study|Withdrawal by Subject|0|||
143101040|NCT02741076|515910876|FG003|Overall Study|Withdrawal by Subject|0|||
143101041|NCT02741076|515910873|FG000|Overall Study|Sponsor Request|2|||
143101042|NCT02741076|515910874|FG001|Overall Study|Sponsor Request|3|||
143101043|NCT02741076|515910875|FG002|Overall Study|Sponsor Request|0|||
143101044|NCT02741076|515910876|FG003|Overall Study|Sponsor Request|1|||
143101045|NCT02741076|515910873|FG000|Overall Study|No additional information available|0|||
143101046|NCT02741076|515910874|FG001|Overall Study|No additional information available|0|||
143101047|NCT02741076|515910875|FG002|Overall Study|No additional information available|1|||
143101048|NCT02741076|515910876|FG003|Overall Study|No additional information available|1|||
143101049|NCT01779440|515910877|FG000|Overall Study|Withdrawal by Subject|3|||
143101050|NCT01779440|515910878|FG001|Overall Study|Withdrawal by Subject|5|||
143101051|NCT00523848|515910879|FG000|Overall Study|Adverse Event|11|||
143101052|NCT00523848|515910879|FG000|Overall Study|Withdrawal by Subject|2|||
143101053|NCT00523848|515910879|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
143101054|NCT00523848|515910879|FG000|Overall Study|Disease Progression|5|||
143101055|NCT00523848|515910879|FG000|Overall Study|Other, unspecified|4|||
143101056|NCT00961350|515910881|FG000|Overall Study|Adverse Event|18|||
143101057|NCT00961350|515910882|FG001|Overall Study|Adverse Event|33|||
143101058|NCT00961350|515910881|FG000|Overall Study|Withdrawal by Subject|10|||
143101059|NCT00961350|515910882|FG001|Overall Study|Withdrawal by Subject|10|||
143101060|NCT00961350|515910881|FG000|Overall Study|Lost to Follow-up|3|||
143101061|NCT00961350|515910882|FG001|Overall Study|Lost to Follow-up|3|||
143101062|NCT00961350|515910881|FG000|Overall Study|Misc|16|||
143101063|NCT00961350|515910882|FG001|Overall Study|Misc|21|||
143101064|NCT04284774|515910887|FG000|Overall Study|Progressive disease|5|||
143101065|NCT06360588|515912634|FG000|Overall Study|Adverse Event|3|||
143101066|NCT06360588|515912634|FG000|Overall Study|Death|2|||
143101067|NCT06360588|515912634|FG000|Overall Study|Disease Progression|14|||
143101068|NCT06360588|515912634|FG000|Overall Study|Withdrawal by Subject|1|||
143101069|NCT06360588|515912634|FG000|Overall Study|Lack of Efficacy|1|||
143101070|NCT06360588|515912634|FG000|Overall Study|Ineligible|1|||
143101071|NCT00347958|515912635|FG000|Overall Study|Adverse Event|1|||
143101072|NCT00347958|515912635|FG000|Overall Study|Protocol Violation|2|||
143101073|NCT00347958|515912635|FG000|Overall Study|Withdrawal by Subject|1|||
143101074|NCT00754234|515912636|FG000|Overall Study|Withdrawal by Subject|3|||
143101075|NCT03868930|515912637|FG000|Intervention & Post-Treatment Assessment|Lost to Follow-up|3|||
143101076|NCT03868930|515912638|FG001|Intervention & Post-Treatment Assessment|Lost to Follow-up|1|||
143252093|NCT00612105|516476417|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
143252094|NCT00612105|516476416|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
143252095|NCT00612105|516476417|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
143252096|NCT00612105|516476416|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
143252097|NCT00612105|516476417|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
143252098|NCT00612105|516476416|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
143252099|NCT00612105|516476417|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
143252100|NCT00612105|516476416|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
143003865|NCT03039699|515550769|FG001|Overall Study|Bacterial infection|28|||
143003866|NCT02569996|515550770|FG000|Overall Study|Adverse Event|6|||
143003867|NCT02569996|515550770|FG000|Overall Study|Physician Decision|3|||
143003868|NCT02569996|515550770|FG000|Overall Study|Progression of the disease|18|||
143003869|NCT02569996|515550770|FG000|Overall Study|New anti-lymphoma treatment|1|||
143003870|NCT02569996|515550770|FG000|Overall Study|Non-compliance|9|||
143003871|NCT02569996|515550770|FG000|Overall Study|Withdrawal by Subject|5|||
143003872|NCT02569996|515550770|FG000|Overall Study|Lost to Follow-up|5|||
143003873|NCT02569996|515550770|FG000|Overall Study|Complete remission|7|||
143003874|NCT02569996|515550770|FG000|Overall Study|Unknown reason|1|||
143003875|NCT01349816|515550773|FG000|Overall Study|Withdrawal by Subject|4|||
143003876|NCT01349816|515550773|FG000|Overall Study|Physician Decision|1|||
143003877|NCT01349816|515550773|FG000|Overall Study|Adverse Event|14|||
143003878|NCT01349816|515550773|FG000|Overall Study|Lost to Follow-up|2|||
143003879|NCT01349816|515550773|FG000|Overall Study|Protocol Violation|1|||
143003880|NCT01349816|515550773|FG000|Overall Study|Protocol-specified criteria|8|||
143003881|NCT01397409|515550774|FG000|Stage 2|Adverse Event|0|||
143003882|NCT01397409|515550775|FG001|Stage 2|Adverse Event|0|||
143003883|NCT01397409|515550776|FG002|Stage 2|Adverse Event|0|||
143003884|NCT01397409|515550777|FG003|Stage 2|Adverse Event|0|||
143003885|NCT01397409|515550778|FG004|Stage 2|Adverse Event|6|||
143003886|NCT01397409|515550779|FG005|Stage 2|Adverse Event|3|||
143003887|NCT01397409|515550780|FG006|Stage 2|Adverse Event|0|||
143003888|NCT01397409|515550781|FG007|Stage 2|Adverse Event|0|||
143003889|NCT01397409|515550782|FG008|Stage 2|Adverse Event|0|||
143003890|NCT01397409|515550783|FG009|Stage 2|Adverse Event|0|||
143003891|NCT01397409|515550774|FG000|Stage 2|Personal Reasons|0|||
143003892|NCT01397409|515550775|FG001|Stage 2|Personal Reasons|0|||
143003893|NCT01397409|515550776|FG002|Stage 2|Personal Reasons|0|||
143003894|NCT01397409|515550777|FG003|Stage 2|Personal Reasons|0|||
143003895|NCT01397409|515550778|FG004|Stage 2|Personal Reasons|1|||
143003896|NCT01397409|515550779|FG005|Stage 2|Personal Reasons|0|||
143003897|NCT01397409|515550780|FG006|Stage 2|Personal Reasons|0|||
143003898|NCT01397409|515550781|FG007|Stage 2|Personal Reasons|0|||
143003899|NCT01397409|515550782|FG008|Stage 2|Personal Reasons|0|||
143003900|NCT01397409|515550783|FG009|Stage 2|Personal Reasons|0|||
143003901|NCT01397409|515550774|FG000|Stage 2|Other Miscellaneous Reasons|0|||
143003902|NCT01397409|515550775|FG001|Stage 2|Other Miscellaneous Reasons|0|||
143003903|NCT01397409|515550776|FG002|Stage 2|Other Miscellaneous Reasons|0|||
143003904|NCT01397409|515550777|FG003|Stage 2|Other Miscellaneous Reasons|0|||
143003905|NCT01397409|515550778|FG004|Stage 2|Other Miscellaneous Reasons|1|||
143003906|NCT01397409|515550779|FG005|Stage 2|Other Miscellaneous Reasons|1|||
143003907|NCT01397409|515550780|FG006|Stage 2|Other Miscellaneous Reasons|0|||
143003908|NCT01397409|515550781|FG007|Stage 2|Other Miscellaneous Reasons|0|||
143003909|NCT01397409|515550782|FG008|Stage 2|Other Miscellaneous Reasons|0|||
143003910|NCT01397409|515550783|FG009|Stage 2|Other Miscellaneous Reasons|0|||
143003911|NCT01397409|515550774|FG000|Stage 3|Adverse Event|0|||
143003912|NCT01397409|515550775|FG001|Stage 3|Adverse Event|0|||
143003913|NCT01397409|515550776|FG002|Stage 3|Adverse Event|0|||
143003914|NCT01397409|515550777|FG003|Stage 3|Adverse Event|0|||
143003915|NCT01397409|515550778|FG004|Stage 3|Adverse Event|0|||
143003916|NCT01397409|515550779|FG005|Stage 3|Adverse Event|0|||
143003917|NCT01397409|515550780|FG006|Stage 3|Adverse Event|0|||
143003918|NCT01397409|515550781|FG007|Stage 3|Adverse Event|1|||
143003919|NCT01397409|515550782|FG008|Stage 3|Adverse Event|0|||
143003920|NCT01397409|515550783|FG009|Stage 3|Adverse Event|0|||
143003921|NCT01397409|515550774|FG000|Stage 3|Other Miscellaneous Reasons|0|||
143003922|NCT01397409|515550775|FG001|Stage 3|Other Miscellaneous Reasons|0|||
143003923|NCT01397409|515550776|FG002|Stage 3|Other Miscellaneous Reasons|0|||
143003924|NCT01397409|515550777|FG003|Stage 3|Other Miscellaneous Reasons|0|||
143003925|NCT01397409|515550778|FG004|Stage 3|Other Miscellaneous Reasons|0|||
143003926|NCT01397409|515550779|FG005|Stage 3|Other Miscellaneous Reasons|0|||
143003927|NCT01397409|515550780|FG006|Stage 3|Other Miscellaneous Reasons|0|||
143003928|NCT01397409|515550781|FG007|Stage 3|Other Miscellaneous Reasons|1|||
143003929|NCT01397409|515550782|FG008|Stage 3|Other Miscellaneous Reasons|0|||
143003930|NCT01397409|515550783|FG009|Stage 3|Other Miscellaneous Reasons|0|||
143003931|NCT02911285|515550784|FG000|Overall Study|Lost to Follow-up|8|||
143003932|NCT02911285|515550785|FG001|Overall Study|Lost to Follow-up|5|||
143101077|NCT03868930|515912637|FG000|Intervention & Post-Treatment Assessment|Physician Decision|1|||
143101078|NCT03868930|515912638|FG001|Intervention & Post-Treatment Assessment|Physician Decision|4|||
143101079|NCT03868930|515912637|FG000|Intervention & Post-Treatment Assessment|Did not start treatment|18|||
143101080|NCT03868930|515912638|FG001|Intervention & Post-Treatment Assessment|Did not start treatment|16|||
143101081|NCT03868930|515912637|FG000|Intervention & Post-Treatment Assessment|Withdrawal by Subject|25|||
143101082|NCT03868930|515912638|FG001|Intervention & Post-Treatment Assessment|Withdrawal by Subject|17|||
143101083|NCT03868930|515912637|FG000|Follow-Up Assessment|Lost to Follow-up|9|||
143101084|NCT03868930|515912638|FG001|Follow-Up Assessment|Lost to Follow-up|12|||
143101085|NCT04432831|515912639|FG000|Overall Study|Withdrawal by Subject|24|||
143101086|NCT04432831|515912640|FG001|Overall Study|Withdrawal by Subject|28|||
143101087|NCT04432831|515912641|FG002|Overall Study|Withdrawal by Subject|21|||
143101088|NCT04432831|515912639|FG000|Overall Study|Death|23|||
143101089|NCT04432831|515912640|FG001|Overall Study|Death|23|||
143101090|NCT04432831|515912641|FG002|Overall Study|Death|17|||
143101091|NCT04432831|515912639|FG000|Overall Study|Lost to Follow-up|15|||
143101092|NCT04432831|515912640|FG001|Overall Study|Lost to Follow-up|15|||
143101093|NCT04432831|515912641|FG002|Overall Study|Lost to Follow-up|12|||
143101094|NCT04432831|515912639|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
143101095|NCT04432831|515912640|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
143101096|NCT04432831|515912641|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
143101097|NCT04432831|515912639|FG000|Overall Study|Reason Not Specified|7|||
143101098|NCT04432831|515912640|FG001|Overall Study|Reason Not Specified|11|||
143101099|NCT04432831|515912641|FG002|Overall Study|Reason Not Specified|9|||
143101100|NCT04432831|515912639|FG000|Overall Study|Adverse Event|7|||
143101101|NCT04432831|515912640|FG001|Overall Study|Adverse Event|7|||
143101102|NCT04432831|515912641|FG002|Overall Study|Adverse Event|7|||
143101103|NCT04432831|515912639|FG000|Overall Study|Physician Decision|1|||
143101104|NCT04432831|515912640|FG001|Overall Study|Physician Decision|3|||
143101105|NCT04432831|515912641|FG002|Overall Study|Physician Decision|6|||
143101106|NCT04432831|515912639|FG000|Overall Study|Protocol Violation|1|||
143101107|NCT04432831|515912640|FG001|Overall Study|Protocol Violation|0|||
143101108|NCT04432831|515912641|FG002|Overall Study|Protocol Violation|2|||
143101109|NCT04432831|515912639|FG000|Overall Study|Pregnancy|0|||
143177446|NCT01673646|516197926|FG001|Overall Study|Withdrawal by Subject|2|||
143177447|NCT01673646|516197927|FG002|Overall Study|Withdrawal by Subject|2|||
143177448|NCT01673646|516197925|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
143177449|NCT01673646|516197926|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
143177450|NCT01673646|516197927|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
143177451|NCT01194245|516197928|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
143101110|NCT04432831|515912640|FG001|Overall Study|Pregnancy|1|||
143101111|NCT04432831|515912641|FG002|Overall Study|Pregnancy|0|||
143101112|NCT04432831|515912639|FG000|Overall Study|Lack of Efficacy|0|||
143101113|NCT04432831|515912640|FG001|Overall Study|Lack of Efficacy|0|||
143101114|NCT04432831|515912641|FG002|Overall Study|Lack of Efficacy|2|||
143101115|NCT03056638|515912650|FG000|Overall Study|Death|1|||
143101116|NCT03056638|515912651|FG001|Overall Study|Death|0|||
143101117|NCT00734162|515912653|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
143101118|NCT00734162|515912654|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
143101119|NCT00734162|515912655|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
143101120|NCT00734162|515912656|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
143177452|NCT01194245|516197929|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
143177453|NCT01194245|516197930|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
143177454|NCT01194245|516197931|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
143101121|NCT00734162|515912653|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
143101122|NCT00734162|515912654|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
143101123|NCT00734162|515912655|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
143101124|NCT00734162|515912656|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
143101125|NCT00734162|515912653|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
143101126|NCT00734162|515912654|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
143101127|NCT00734162|515912655|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
143101128|NCT00734162|515912656|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
143101129|NCT00734162|515912653|FG000|Open-Label Phase|Withdrew Consent|1|||
143101130|NCT00734162|515912654|FG001|Open-Label Phase|Withdrew Consent|0|||
143101131|NCT00734162|515912655|FG002|Open-Label Phase|Withdrew Consent|1|||
143101132|NCT00734162|515912656|FG003|Open-Label Phase|Withdrew Consent|1|||
143101133|NCT00734162|515912653|FG000|Open-Label Phase|Lost to Follow-up|1|||
143101134|NCT00734162|515912654|FG001|Open-Label Phase|Lost to Follow-up|2|||
143101135|NCT00734162|515912655|FG002|Open-Label Phase|Lost to Follow-up|0|||
143101136|NCT00734162|515912656|FG003|Open-Label Phase|Lost to Follow-up|1|||
143101137|NCT00734162|515912653|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
143101138|NCT00734162|515912654|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
143101139|NCT00734162|515912655|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
143101140|NCT00734162|515912656|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
143101141|NCT01568034|515912657|FG000|Overall Study|Withdrawal by Subject|1|||
143101142|NCT01568034|515912658|FG001|Overall Study|Withdrawal by Subject|0|||
143101143|NCT01568034|515912659|FG002|Overall Study|Withdrawal by Subject|0|||
143101144|NCT01568034|515912660|FG003|Overall Study|Withdrawal by Subject|0|||
143101145|NCT00728468|515912661|FG000|Overall Study|Enrolled but not treated|1|||
143101146|NCT00728468|515912661|FG000|Overall Study|Death|1|||
143101147|NCT00728468|515912661|FG000|Overall Study|Protocol Violation|4|||
143101148|NCT00728468|515912661|FG000|Overall Study|Objective progression or relapse|9|||
143101149|NCT00728468|515912661|FG000|Overall Study|Study terminated by sponsor|1|||
143101150|NCT01262287|515912662|FG000|Overall Study|Lost to Follow-up|2|||
143101151|NCT01262287|515912663|FG001|Overall Study|Lost to Follow-up|1|||
143101152|NCT00596687|515912664|FG000|Overall Study|< 24 hours of insulin treatment|8|||
143101153|NCT00596687|515912665|FG001|Overall Study|< 24 hours of insulin treatment|6|||
143101154|NCT00596687|515912664|FG000|Overall Study|continuous insulin infusion during TPN|2|||
143101155|NCT00596687|515912665|FG001|Overall Study|continuous insulin infusion during TPN|1|||
143101156|NCT00596687|515912664|FG000|Overall Study|Withdrawal by Subject|3|||
143101157|NCT00596687|515912665|FG001|Overall Study|Withdrawal by Subject|1|||
143101158|NCT00596687|515912664|FG000|Overall Study|cancelled surgery|1|||
143101159|NCT00596687|515912665|FG001|Overall Study|cancelled surgery|1|||
143101160|NCT00932373|515912666|FG000|Overall Study|Progressive disease|3|||
143101161|NCT00932373|515912667|FG001|Overall Study|Progressive disease|1|||
143101162|NCT00932373|515912668|FG002|Overall Study|Progressive disease|0|||
143101163|NCT00932373|515912669|FG003|Overall Study|Progressive disease|0|||
143101164|NCT00932373|515912670|FG004|Overall Study|Progressive disease|10|||
143101165|NCT00932373|515912671|FG005|Overall Study|Progressive disease|1|||
143101166|NCT00932373|515912672|FG006|Overall Study|Progressive disease|0|||
143101167|NCT00932373|515912673|FG007|Overall Study|Progressive disease|2|||
143101168|NCT00932373|515912674|FG008|Overall Study|Progressive disease|1|||
143101169|NCT00932373|515912675|FG009|Overall Study|Progressive disease|9|||
143101170|NCT00932373|515912676|FG010|Overall Study|Progressive disease|2|||
143101171|NCT00932373|515912666|FG000|Overall Study|Adverse Event|0|||
143101172|NCT00932373|515912667|FG001|Overall Study|Adverse Event|0|||
143101173|NCT00932373|515912668|FG002|Overall Study|Adverse Event|0|||
143101174|NCT00932373|515912669|FG003|Overall Study|Adverse Event|0|||
143101175|NCT00932373|515912670|FG004|Overall Study|Adverse Event|2|||
143101176|NCT00932373|515912671|FG005|Overall Study|Adverse Event|1|||
143101177|NCT00932373|515912672|FG006|Overall Study|Adverse Event|0|||
143101178|NCT00932373|515912673|FG007|Overall Study|Adverse Event|1|||
143101179|NCT00932373|515912674|FG008|Overall Study|Adverse Event|0|||
143101180|NCT00932373|515912675|FG009|Overall Study|Adverse Event|2|||
143101181|NCT00932373|515912676|FG010|Overall Study|Adverse Event|1|||
143101182|NCT00932373|515912666|FG000|Overall Study|Physician Decision|0|||
143101183|NCT00932373|515912667|FG001|Overall Study|Physician Decision|0|||
143101184|NCT00932373|515912668|FG002|Overall Study|Physician Decision|1|||
143101185|NCT00932373|515912669|FG003|Overall Study|Physician Decision|0|||
143101186|NCT00932373|515912670|FG004|Overall Study|Physician Decision|2|||
143101187|NCT00932373|515912671|FG005|Overall Study|Physician Decision|0|||
143101188|NCT00932373|515912672|FG006|Overall Study|Physician Decision|0|||
143101189|NCT00932373|515912673|FG007|Overall Study|Physician Decision|0|||
143101190|NCT00932373|515912674|FG008|Overall Study|Physician Decision|0|||
143101191|NCT00932373|515912675|FG009|Overall Study|Physician Decision|1|||
143101192|NCT00932373|515912676|FG010|Overall Study|Physician Decision|0|||
143101193|NCT00932373|515912666|FG000|Overall Study|Dose limiting toxicity|0|||
143101194|NCT00932373|515912667|FG001|Overall Study|Dose limiting toxicity|0|||
143101195|NCT00932373|515912668|FG002|Overall Study|Dose limiting toxicity|0|||
143101196|NCT00932373|515912669|FG003|Overall Study|Dose limiting toxicity|0|||
143101197|NCT00932373|515912670|FG004|Overall Study|Dose limiting toxicity|0|||
143101198|NCT00932373|515912671|FG005|Overall Study|Dose limiting toxicity|1|||
143101199|NCT00932373|515912672|FG006|Overall Study|Dose limiting toxicity|0|||
143101200|NCT00932373|515912673|FG007|Overall Study|Dose limiting toxicity|0|||
143101201|NCT00932373|515912674|FG008|Overall Study|Dose limiting toxicity|0|||
143101202|NCT00932373|515912675|FG009|Overall Study|Dose limiting toxicity|0|||
143101203|NCT00932373|515912676|FG010|Overall Study|Dose limiting toxicity|0|||
143101204|NCT00932373|515912666|FG000|Overall Study|Withdrawal by Subject|0|||
143101205|NCT00932373|515912667|FG001|Overall Study|Withdrawal by Subject|0|||
143101206|NCT00932373|515912668|FG002|Overall Study|Withdrawal by Subject|0|||
143101207|NCT00932373|515912669|FG003|Overall Study|Withdrawal by Subject|0|||
143101208|NCT00932373|515912670|FG004|Overall Study|Withdrawal by Subject|0|||
143101209|NCT00932373|515912671|FG005|Overall Study|Withdrawal by Subject|0|||
143101210|NCT00932373|515912672|FG006|Overall Study|Withdrawal by Subject|0|||
143101211|NCT00932373|515912673|FG007|Overall Study|Withdrawal by Subject|0|||
143101212|NCT00932373|515912674|FG008|Overall Study|Withdrawal by Subject|1|||
143177455|NCT01194245|516197932|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
143177456|NCT01194245|516197928|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
143177457|NCT01194245|516197929|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
143177458|NCT01194245|516197930|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
143177459|NCT01194245|516197931|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
143177460|NCT01194245|516197932|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
143101213|NCT00932373|515912675|FG009|Overall Study|Withdrawal by Subject|0|||
143177461|NCT01194245|516197928|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
143177462|NCT01194245|516197929|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
143177463|NCT01194245|516197930|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
143177464|NCT01194245|516197931|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
143177465|NCT01194245|516197932|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
143177466|NCT01194245|516197928|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
143101214|NCT00932373|515912676|FG010|Overall Study|Withdrawal by Subject|0|||
143101215|NCT00932373|515912666|FG000|Overall Study|Clinical progression|0|||
143101216|NCT00932373|515912667|FG001|Overall Study|Clinical progression|0|||
143101217|NCT00932373|515912668|FG002|Overall Study|Clinical progression|0|||
143101218|NCT00932373|515912669|FG003|Overall Study|Clinical progression|0|||
143101219|NCT00932373|515912670|FG004|Overall Study|Clinical progression|0|||
143101220|NCT00932373|515912671|FG005|Overall Study|Clinical progression|0|||
143101221|NCT00932373|515912672|FG006|Overall Study|Clinical progression|1|||
143101222|NCT00932373|515912673|FG007|Overall Study|Clinical progression|0|||
143101223|NCT00932373|515912674|FG008|Overall Study|Clinical progression|0|||
143101224|NCT00932373|515912675|FG009|Overall Study|Clinical progression|0|||
143101225|NCT00932373|515912676|FG010|Overall Study|Clinical progression|0|||
143101226|NCT00932373|515912666|FG000|Overall Study|Lack of Efficacy|0|||
143101227|NCT00932373|515912667|FG001|Overall Study|Lack of Efficacy|0|||
143101228|NCT00932373|515912668|FG002|Overall Study|Lack of Efficacy|0|||
143101229|NCT00932373|515912669|FG003|Overall Study|Lack of Efficacy|0|||
143101230|NCT00932373|515912670|FG004|Overall Study|Lack of Efficacy|0|||
143101231|NCT00932373|515912671|FG005|Overall Study|Lack of Efficacy|0|||
143101232|NCT00932373|515912672|FG006|Overall Study|Lack of Efficacy|0|||
143101233|NCT00932373|515912673|FG007|Overall Study|Lack of Efficacy|0|||
143101234|NCT00932373|515912674|FG008|Overall Study|Lack of Efficacy|0|||
143101235|NCT00932373|515912675|FG009|Overall Study|Lack of Efficacy|1|||
143101236|NCT00932373|515912676|FG010|Overall Study|Lack of Efficacy|0|||
143101237|NCT06098339|515912677|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
143101238|NCT06098339|515912678|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
143101239|NCT06098339|515912677|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
143101240|NCT06098339|515912678|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
143101241|NCT03831113|515912680|FG000|Overall Study|Withdrawal by Subject|0|||
143101242|NCT03831113|515912681|FG001|Overall Study|Withdrawal by Subject|2|||
143101243|NCT03831113|515912680|FG000|Overall Study|Protocol Violation|0|||
143101244|NCT03831113|515912681|FG001|Overall Study|Protocol Violation|9|||
143101245|NCT04134767|515912682|FG000|Overall Study|Death|0|||
143101246|NCT04134767|515912683|FG001|Overall Study|Death|1|||
143101247|NCT04134767|515912682|FG000|Overall Study|Removed for harassing staff|0|||
143101248|NCT04134767|515912683|FG001|Overall Study|Removed for harassing staff|1|||
143101249|NCT04134767|515912682|FG000|Overall Study|Lost to Follow-up|44|||
143101250|NCT04134767|515912683|FG001|Overall Study|Lost to Follow-up|40|||
143101251|NCT00638404|515912684|FG000|Overall Study|Physician Decision|8|||
143101252|NCT00638404|515912685|FG001|Overall Study|Physician Decision|0|||
143101253|NCT02492984|515912686|FG000|Overall Study|Adverse Event|1|||
143101254|NCT02492984|515912687|FG001|Overall Study|Adverse Event|0|||
143101255|NCT02492984|515912686|FG000|Overall Study|Protocol Violation|1|||
143101256|NCT02492984|515912687|FG001|Overall Study|Protocol Violation|0|||
143101257|NCT02492984|515912686|FG000|Overall Study|Withdrawal by Subject|1|||
143101258|NCT02492984|515912687|FG001|Overall Study|Withdrawal by Subject|0|||
143101259|NCT02101736|515912688|FG000|Overall Study|Protocol Violation|3|||
143101260|NCT02101736|515912689|FG001|Overall Study|Protocol Violation|0|||
143101261|NCT02101736|515912688|FG000|Overall Study|Withdrawal by Subject|1|||
143101262|NCT02101736|515912689|FG001|Overall Study|Withdrawal by Subject|1|||
143101263|NCT00839800|515912694|FG000|Overall Study|Adverse Event|8|||
143101264|NCT00839800|515912695|FG001|Overall Study|Adverse Event|12|||
143101265|NCT00839800|515912694|FG000|Overall Study|Lost to Follow-up|31|||
143101266|NCT00839800|515912695|FG001|Overall Study|Lost to Follow-up|26|||
143101267|NCT00839800|515912694|FG000|Overall Study|Withdrawal by Subject|28|||
143101268|NCT00839800|515912695|FG001|Overall Study|Withdrawal by Subject|34|||
143101269|NCT00839800|515912694|FG000|Overall Study|Incorrect Enrolment|3|||
143101270|NCT00839800|515912695|FG001|Overall Study|Incorrect Enrolment|3|||
143101271|NCT00839800|515912694|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
143101272|NCT00839800|515912695|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
143101273|NCT00839800|515912694|FG000|Overall Study|Safety Reasons|2|||
143101274|NCT00839800|515912695|FG001|Overall Study|Safety Reasons|1|||
143101275|NCT00839800|515912694|FG000|Overall Study|Other|8|||
143101276|NCT00839800|515912695|FG001|Overall Study|Other|14|||
143101277|NCT00839800|515912694|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
143177467|NCT01194245|516197929|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
143177468|NCT01194245|516197930|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
143177469|NCT01194245|516197931|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
143101278|NCT00839800|515912695|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
143101279|NCT02510664|515912700|FG000|Overall Study|Transferred Care|9|||
143101280|NCT02510664|515912701|FG001|Overall Study|Transferred Care|9|||
143101281|NCT02510664|515912702|FG002|Overall Study|Transferred Care|0|||
143101282|NCT02510664|515912700|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
143101283|NCT02510664|515912701|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
143101284|NCT02510664|515912702|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
143101285|NCT02510664|515912700|FG000|Overall Study|Time Constraints|1|||
143101286|NCT02510664|515912701|FG001|Overall Study|Time Constraints|1|||
143101287|NCT02510664|515912702|FG002|Overall Study|Time Constraints|0|||
143252101|NCT00612105|516476417|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
143252102|NCT00612105|516476416|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
143252103|NCT00612105|516476417|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
143101288|NCT02801617|515912704|FG000|Overall Study|Protocol Violation|2|||
143101289|NCT02801617|515912705|FG001|Overall Study|Protocol Violation|6|||
143101290|NCT04090060|515912711|FG000|Overall Study|Lost to Follow-up|76|||
143101291|NCT04090060|515912712|FG001|Overall Study|Lost to Follow-up|77|||
143101292|NCT01164579|515912713|FG000|Overall Study|Lack of Efficacy|0|||
143101293|NCT01164579|515912714|FG001|Overall Study|Lack of Efficacy|0|||
143101294|NCT01164579|515912715|FG002|Overall Study|Lack of Efficacy|6|||
143101295|NCT01164579|515912713|FG000|Overall Study|Lost to Follow-up|1|||
143101296|NCT01164579|515912714|FG001|Overall Study|Lost to Follow-up|1|||
143101297|NCT01164579|515912715|FG002|Overall Study|Lost to Follow-up|0|||
143101298|NCT01164579|515912713|FG000|Overall Study|Withdrawal by Subject|2|||
143101299|NCT01164579|515912714|FG001|Overall Study|Withdrawal by Subject|5|||
143101300|NCT01164579|515912715|FG002|Overall Study|Withdrawal by Subject|3|||
143101301|NCT01164579|515912713|FG000|Overall Study|Protocol Violation|0|||
143101302|NCT01164579|515912714|FG001|Overall Study|Protocol Violation|1|||
143101303|NCT01164579|515912715|FG002|Overall Study|Protocol Violation|2|||
143101304|NCT01164579|515912713|FG000|Overall Study|Adverse Event|4|||
143101305|NCT01164579|515912714|FG001|Overall Study|Adverse Event|2|||
143101306|NCT01164579|515912715|FG002|Overall Study|Adverse Event|5|||
143101307|NCT01164579|515912713|FG000|Overall Study|Reason not specified|1|||
143101308|NCT01164579|515912714|FG001|Overall Study|Reason not specified|0|||
143101309|NCT01164579|515912715|FG002|Overall Study|Reason not specified|0|||
143101310|NCT02176655|515912716|FG000|Overall Study|Subjects did not treat|6|||
143101311|NCT06110494|515912717|FG000|Overall Study|Protocol Violation|2|||
143101312|NCT06110494|515912718|FG001|Overall Study|Protocol Violation|0|||
143101313|NCT06110494|515912719|FG002|Overall Study|Protocol Violation|1|||
143101314|NCT06110494|515912717|FG000|Overall Study|Dixon's test for outlier analysis|1|||
143101315|NCT06110494|515912718|FG001|Overall Study|Dixon's test for outlier analysis|1|||
143101316|NCT06110494|515912719|FG002|Overall Study|Dixon's test for outlier analysis|0|||
143101317|NCT00302328|515912720|FG000|Overall Study|Physician Decision|0|||
143101318|NCT00302328|515912721|FG001|Overall Study|Physician Decision|1|||
143101319|NCT00302328|515912722|FG002|Overall Study|Physician Decision|0|||
143101320|NCT01288937|515912725|FG000|Overall Study|Adverse Event|1|||
143101321|NCT01288937|515912726|FG001|Overall Study|Adverse Event|0|||
143101322|NCT01718535|515912727|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
143101323|NCT01718535|515912728|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
143101324|NCT01718535|515912729|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
143101325|NCT01718535|515912730|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
143101326|NCT01718535|515912731|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
143101327|NCT01718535|515912732|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
143101328|NCT01718535|515912733|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
143101329|NCT01718535|515912734|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
143101330|NCT01718535|515912735|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
143101331|NCT01718535|515912736|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
143101332|NCT01073605|515912740|FG000|Overall Study|Ongoing at Cutoff Date|1|||
143101333|NCT01073605|515912741|FG001|Overall Study|Ongoing at Cutoff Date|1|||
143101334|NCT01073605|515912742|FG002|Overall Study|Ongoing at Cutoff Date|0|||
143101335|NCT01073605|515912740|FG000|Overall Study|Adverse Event|2|||
143101336|NCT01073605|515912741|FG001|Overall Study|Adverse Event|1|||
143101337|NCT01073605|515912742|FG002|Overall Study|Adverse Event|0|||
143101338|NCT01073605|515912740|FG000|Overall Study|Lost to Follow-up|3|||
143101339|NCT01073605|515912741|FG001|Overall Study|Lost to Follow-up|4|||
143101340|NCT01073605|515912742|FG002|Overall Study|Lost to Follow-up|9|||
143101341|NCT01073605|515912740|FG000|Overall Study|Other|25|||
143101342|NCT01073605|515912741|FG001|Overall Study|Other|21|||
143101343|NCT01073605|515912742|FG002|Overall Study|Other|29|||
143101344|NCT01073605|515912740|FG000|Overall Study|Withdrawal by Subject|31|||
143101345|NCT01073605|515912741|FG001|Overall Study|Withdrawal by Subject|39|||
143252104|NCT00612105|516476416|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
143252105|NCT00612105|516476417|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
143101346|NCT01073605|515912742|FG002|Overall Study|Withdrawal by Subject|22|||
143101347|NCT01073605|515912740|FG000|Overall Study|Randomized But Not Treated|0|||
143101348|NCT01073605|515912741|FG001|Overall Study|Randomized But Not Treated|1|||
143101349|NCT01073605|515912742|FG002|Overall Study|Randomized But Not Treated|1|||
143101350|NCT03018080|515912743|FG000|Overall Study|Death|12|||
143101351|NCT03018080|515912744|FG001|Overall Study|Death|19|||
143101352|NCT01019694|515912747|FG000|Overall Study|Adverse Event|12|||
143101353|NCT01019694|515912748|FG001|Overall Study|Adverse Event|16|||
143101354|NCT01019694|515912749|FG002|Overall Study|Adverse Event|19|||
143101355|NCT01019694|515912747|FG000|Overall Study|Protocol Violation|2|||
143101356|NCT01019694|515912748|FG001|Overall Study|Protocol Violation|6|||
143252106|NCT00612105|516476416|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
143252107|NCT00612105|516476417|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
143252108|NCT00717236|516476418|FG000|Double-Blind Period|Adverse Event|33|||
143252109|NCT00717236|516476419|FG001|Double-Blind Period|Adverse Event|6|||
143252110|NCT00717236|516476418|FG000|Double-Blind Period|Lack of Efficacy|6|||
143252111|NCT00717236|516476419|FG001|Double-Blind Period|Lack of Efficacy|6|||
143101357|NCT01019694|515912749|FG002|Overall Study|Protocol Violation|4|||
143101358|NCT01019694|515912747|FG000|Overall Study|Lost to Follow-up|5|||
143101359|NCT01019694|515912748|FG001|Overall Study|Lost to Follow-up|3|||
143101360|NCT01019694|515912749|FG002|Overall Study|Lost to Follow-up|3|||
143101361|NCT01019694|515912747|FG000|Overall Study|Withdrawal by Subject|4|||
143101362|NCT01019694|515912748|FG001|Overall Study|Withdrawal by Subject|6|||
143101363|NCT01019694|515912749|FG002|Overall Study|Withdrawal by Subject|12|||
143101364|NCT01019694|515912747|FG000|Overall Study|Not treated|0|||
143101365|NCT01019694|515912748|FG001|Overall Study|Not treated|2|||
143101366|NCT01019694|515912749|FG002|Overall Study|Not treated|3|||
143101367|NCT01019694|515912747|FG000|Overall Study|Other reason (not specified)|1|||
143101368|NCT01019694|515912748|FG001|Overall Study|Other reason (not specified)|5|||
143101369|NCT01019694|515912749|FG002|Overall Study|Other reason (not specified)|6|||
143101370|NCT02035202|515912756|FG000|Overall Study|Lost to Follow-up|8|||
143101371|NCT02035202|515912757|FG001|Overall Study|Lost to Follow-up|16|||
143101372|NCT02035202|515912758|FG002|Overall Study|Lost to Follow-up|2|||
143101373|NCT00685399|515912760|FG000|Treatment Period 1|Withdrawal by Subject|2|||
143101374|NCT00685399|515912761|FG001|Treatment Period 1|Withdrawal by Subject|0|||
143101375|NCT00685399|515912762|FG002|Treatment Period 1|Withdrawal by Subject|0|||
143101376|NCT00685399|515912763|FG003|Treatment Period 1|Withdrawal by Subject|0|||
143101377|NCT00685399|515912764|FG004|Treatment Period 1|Withdrawal by Subject|0|||
143101378|NCT00685399|515912765|FG005|Treatment Period 1|Withdrawal by Subject|0|||
143101379|NCT00685399|515912766|FG006|Treatment Period 1|Withdrawal by Subject|0|||
143101380|NCT00685399|515912767|FG007|Treatment Period 1|Withdrawal by Subject|0|||
143101381|NCT00685399|515912760|FG000|Treatment Period 1|Protocol Violation|1|||
143101382|NCT00685399|515912761|FG001|Treatment Period 1|Protocol Violation|0|||
143101383|NCT00685399|515912762|FG002|Treatment Period 1|Protocol Violation|0|||
143101384|NCT00685399|515912763|FG003|Treatment Period 1|Protocol Violation|0|||
143101385|NCT00685399|515912764|FG004|Treatment Period 1|Protocol Violation|0|||
143101386|NCT00685399|515912765|FG005|Treatment Period 1|Protocol Violation|0|||
143101387|NCT00685399|515912766|FG006|Treatment Period 1|Protocol Violation|0|||
143101388|NCT00685399|515912767|FG007|Treatment Period 1|Protocol Violation|0|||
143101389|NCT00685399|515912760|FG000|Treatment Period 1|Administrative|2|||
143101390|NCT00685399|515912761|FG001|Treatment Period 1|Administrative|0|||
143101391|NCT00685399|515912762|FG002|Treatment Period 1|Administrative|0|||
143101392|NCT00685399|515912763|FG003|Treatment Period 1|Administrative|0|||
143101393|NCT00685399|515912764|FG004|Treatment Period 1|Administrative|0|||
143101394|NCT00685399|515912765|FG005|Treatment Period 1|Administrative|0|||
143101395|NCT00685399|515912766|FG006|Treatment Period 1|Administrative|0|||
143101396|NCT00685399|515912767|FG007|Treatment Period 1|Administrative|0|||
143101397|NCT00685399|515912760|FG000|Treatment Period 1|Lack of Efficacy|1|||
143101398|NCT00685399|515912761|FG001|Treatment Period 1|Lack of Efficacy|0|||
143101399|NCT00685399|515912762|FG002|Treatment Period 1|Lack of Efficacy|0|||
143101400|NCT00685399|515912763|FG003|Treatment Period 1|Lack of Efficacy|0|||
143101401|NCT00685399|515912764|FG004|Treatment Period 1|Lack of Efficacy|0|||
143101402|NCT00685399|515912765|FG005|Treatment Period 1|Lack of Efficacy|0|||
143101403|NCT00685399|515912766|FG006|Treatment Period 1|Lack of Efficacy|0|||
143101404|NCT00685399|515912767|FG007|Treatment Period 1|Lack of Efficacy|0|||
143101405|NCT00685399|515912760|FG000|Treatment Period 2|Administrative Problems|0|||
143101406|NCT00685399|515912761|FG001|Treatment Period 2|Administrative Problems|2|||
143101407|NCT00685399|515912762|FG002|Treatment Period 2|Administrative Problems|1|||
143101408|NCT00685399|515912763|FG003|Treatment Period 2|Administrative Problems|0|||
143101409|NCT00685399|515912764|FG004|Treatment Period 2|Administrative Problems|0|||
143101410|NCT00685399|515912765|FG005|Treatment Period 2|Administrative Problems|0|||
143252112|NCT00717236|516476418|FG000|Double-Blind Period|Lost to Follow-up|3|||
143252113|NCT00717236|516476419|FG001|Double-Blind Period|Lost to Follow-up|5|||
143101411|NCT00685399|515912766|FG006|Treatment Period 2|Administrative Problems|0|||
143101412|NCT00685399|515912767|FG007|Treatment Period 2|Administrative Problems|0|||
143101413|NCT00685399|515912760|FG000|Treatment Period 2|Withdrawal by Subject|0|||
143101414|NCT00685399|515912761|FG001|Treatment Period 2|Withdrawal by Subject|0|||
143101415|NCT00685399|515912762|FG002|Treatment Period 2|Withdrawal by Subject|0|||
143101416|NCT00685399|515912763|FG003|Treatment Period 2|Withdrawal by Subject|0|||
143252114|NCT00717236|516476418|FG000|Double-Blind Period|Withdrawal by Subject|10|||
143252115|NCT00717236|516476419|FG001|Double-Blind Period|Withdrawal by Subject|2|||
143101417|NCT00685399|515912764|FG004|Treatment Period 2|Withdrawal by Subject|0|||
143101418|NCT00685399|515912765|FG005|Treatment Period 2|Withdrawal by Subject|0|||
143101419|NCT00685399|515912766|FG006|Treatment Period 2|Withdrawal by Subject|0|||
143101420|NCT00685399|515912767|FG007|Treatment Period 2|Withdrawal by Subject|2|||
143252116|NCT00717236|516476418|FG000|Double-Blind Period|Loss of efficacy|3|||
143252117|NCT00717236|516476419|FG001|Double-Blind Period|Loss of efficacy|0|||
143101421|NCT00685399|515912760|FG000|Treatment Period 2|Adverse Event|0|||
143101422|NCT00685399|515912761|FG001|Treatment Period 2|Adverse Event|0|||
143101423|NCT00685399|515912762|FG002|Treatment Period 2|Adverse Event|0|||
143101424|NCT00685399|515912763|FG003|Treatment Period 2|Adverse Event|0|||
143101425|NCT00685399|515912764|FG004|Treatment Period 2|Adverse Event|0|||
143101426|NCT00685399|515912765|FG005|Treatment Period 2|Adverse Event|1|||
143101427|NCT00685399|515912766|FG006|Treatment Period 2|Adverse Event|0|||
143101428|NCT00685399|515912767|FG007|Treatment Period 2|Adverse Event|0|||
143101429|NCT00685399|515912760|FG000|Treatment Period 2|Lack of Efficacy|0|||
143101430|NCT00685399|515912761|FG001|Treatment Period 2|Lack of Efficacy|10|||
143101431|NCT00685399|515912762|FG002|Treatment Period 2|Lack of Efficacy|2|||
143101432|NCT00685399|515912763|FG003|Treatment Period 2|Lack of Efficacy|0|||
143101433|NCT00685399|515912764|FG004|Treatment Period 2|Lack of Efficacy|0|||
143101434|NCT00685399|515912765|FG005|Treatment Period 2|Lack of Efficacy|1|||
143101435|NCT00685399|515912766|FG006|Treatment Period 2|Lack of Efficacy|0|||
143101436|NCT00685399|515912767|FG007|Treatment Period 2|Lack of Efficacy|0|||
143101437|NCT00685399|515912760|FG000|Extension|Administrative Issues|0|||
143101438|NCT00685399|515912761|FG001|Extension|Administrative Issues|0|||
143101439|NCT00685399|515912762|FG002|Extension|Administrative Issues|0|||
143101440|NCT00685399|515912763|FG003|Extension|Administrative Issues|1|||
143101441|NCT00685399|515912764|FG004|Extension|Administrative Issues|0|||
143101442|NCT00685399|515912765|FG005|Extension|Administrative Issues|0|||
143101443|NCT00685399|515912766|FG006|Extension|Administrative Issues|0|||
143101444|NCT00685399|515912767|FG007|Extension|Administrative Issues|0|||
143101445|NCT00685399|515912760|FG000|Extension|Withdrawal by Subject|0|||
143101446|NCT00685399|515912761|FG001|Extension|Withdrawal by Subject|0|||
143101447|NCT00685399|515912762|FG002|Extension|Withdrawal by Subject|0|||
143101448|NCT00685399|515912763|FG003|Extension|Withdrawal by Subject|1|||
143101449|NCT00685399|515912764|FG004|Extension|Withdrawal by Subject|0|||
143101450|NCT00685399|515912765|FG005|Extension|Withdrawal by Subject|0|||
143101451|NCT00685399|515912766|FG006|Extension|Withdrawal by Subject|0|||
143101452|NCT00685399|515912767|FG007|Extension|Withdrawal by Subject|0|||
143101453|NCT00685399|515912760|FG000|Extension|Protocol Violation|0|||
143101454|NCT00685399|515912761|FG001|Extension|Protocol Violation|0|||
143101455|NCT00685399|515912762|FG002|Extension|Protocol Violation|0|||
143101456|NCT00685399|515912763|FG003|Extension|Protocol Violation|1|||
143101457|NCT00685399|515912764|FG004|Extension|Protocol Violation|0|||
143101458|NCT00685399|515912765|FG005|Extension|Protocol Violation|0|||
143101459|NCT00685399|515912766|FG006|Extension|Protocol Violation|0|||
143101460|NCT00685399|515912767|FG007|Extension|Protocol Violation|0|||
143101461|NCT00685399|515912760|FG000|Extension|Lack of Efficacy|0|||
143101462|NCT00685399|515912761|FG001|Extension|Lack of Efficacy|0|||
143101463|NCT00685399|515912762|FG002|Extension|Lack of Efficacy|0|||
143101464|NCT00685399|515912763|FG003|Extension|Lack of Efficacy|2|||
143101465|NCT00685399|515912764|FG004|Extension|Lack of Efficacy|0|||
143101466|NCT00685399|515912765|FG005|Extension|Lack of Efficacy|0|||
143101467|NCT00685399|515912766|FG006|Extension|Lack of Efficacy|0|||
143101468|NCT00685399|515912767|FG007|Extension|Lack of Efficacy|0|||
143101469|NCT00685399|515912760|FG000|Extension|Adverse Event|0|||
143101470|NCT00685399|515912761|FG001|Extension|Adverse Event|0|||
143101471|NCT00685399|515912762|FG002|Extension|Adverse Event|0|||
143101472|NCT00685399|515912763|FG003|Extension|Adverse Event|2|||
143101473|NCT00685399|515912764|FG004|Extension|Adverse Event|0|||
143101474|NCT00685399|515912765|FG005|Extension|Adverse Event|0|||
143101475|NCT00685399|515912766|FG006|Extension|Adverse Event|0|||
143101476|NCT00685399|515912767|FG007|Extension|Adverse Event|0|||
143101477|NCT00869999|515912768|FG000|Overall Study|Withdrawal by Subject|1|||
143101478|NCT00869999|515912768|FG000|Overall Study|removed prior to starting therapy|1|||
143101479|NCT01303172|515912804|FG000|Overall Study|Physician Decision|9|||
143101480|NCT01303172|515912805|FG001|Overall Study|Physician Decision|6|||
143101481|NCT01303172|515912804|FG000|Overall Study|Adverse Event|5|||
143101482|NCT01303172|515912805|FG001|Overall Study|Adverse Event|2|||
143101483|NCT01303172|515912804|FG000|Overall Study|Withdrawal by Subject|4|||
143101484|NCT01303172|515912805|FG001|Overall Study|Withdrawal by Subject|2|||
143101485|NCT01303172|515912804|FG000|Overall Study|Death|20|||
143101486|NCT01303172|515912805|FG001|Overall Study|Death|7|||
143101487|NCT01303172|515912804|FG000|Overall Study|Lack of Efficacy|25|||
143101488|NCT01303172|515912805|FG001|Overall Study|Lack of Efficacy|17|||
143101489|NCT02097745|515912806|FG000|Overall Study|Adverse Event|25|||
143101490|NCT02097745|515912806|FG000|Overall Study|Death|16|||
143101491|NCT02097745|515912806|FG000|Overall Study|Failure to Return|14|||
143101492|NCT02097745|515912806|FG000|Overall Study|Administrative/Other|27|||
143101493|NCT02097745|515912806|FG000|Overall Study|Reason Not Specified|96|||
143101494|NCT02099110|515912809|FG000|Overall Study|Protocol Violation|2|||
143101495|NCT02099110|515912810|FG001|Overall Study|Protocol Violation|1|||
143101496|NCT02099110|515912811|FG002|Overall Study|Protocol Violation|0|||
143101497|NCT02099110|515912812|FG003|Overall Study|Protocol Violation|3|||
143101498|NCT02099110|515912813|FG004|Overall Study|Protocol Violation|1|||
143101499|NCT02099110|515912809|FG000|Overall Study|Participant moved|1|||
143101500|NCT02099110|515912810|FG001|Overall Study|Participant moved|1|||
143101501|NCT02099110|515912811|FG002|Overall Study|Participant moved|1|||
143101502|NCT02099110|515912812|FG003|Overall Study|Participant moved|0|||
143101503|NCT02099110|515912813|FG004|Overall Study|Participant moved|2|||
143101504|NCT02099110|515912809|FG000|Overall Study|Withdrawal by Subject|7|||
143101505|NCT02099110|515912810|FG001|Overall Study|Withdrawal by Subject|11|||
143101506|NCT02099110|515912811|FG002|Overall Study|Withdrawal by Subject|13|||
143101507|NCT02099110|515912812|FG003|Overall Study|Withdrawal by Subject|9|||
143101508|NCT02099110|515912813|FG004|Overall Study|Withdrawal by Subject|13|||
143101509|NCT02099110|515912809|FG000|Overall Study|Adverse Event|3|||
143101510|NCT02099110|515912810|FG001|Overall Study|Adverse Event|5|||
143101511|NCT02099110|515912811|FG002|Overall Study|Adverse Event|2|||
143101512|NCT02099110|515912812|FG003|Overall Study|Adverse Event|3|||
143101513|NCT02099110|515912813|FG004|Overall Study|Adverse Event|2|||
143101514|NCT02099110|515912809|FG000|Overall Study|Lost to Follow-up|6|||
143101515|NCT02099110|515912810|FG001|Overall Study|Lost to Follow-up|12|||
143101516|NCT02099110|515912811|FG002|Overall Study|Lost to Follow-up|11|||
143101517|NCT02099110|515912812|FG003|Overall Study|Lost to Follow-up|5|||
143101518|NCT02099110|515912813|FG004|Overall Study|Lost to Follow-up|6|||
143101519|NCT02099110|515912809|FG000|Overall Study|Death|0|||
143101520|NCT02099110|515912810|FG001|Overall Study|Death|1|||
143101521|NCT02099110|515912811|FG002|Overall Study|Death|0|||
143101522|NCT02099110|515912812|FG003|Overall Study|Death|0|||
143101523|NCT02099110|515912813|FG004|Overall Study|Death|0|||
143101524|NCT02099110|515912809|FG000|Overall Study|Screen failure|0|||
143101525|NCT02099110|515912810|FG001|Overall Study|Screen failure|0|||
143101526|NCT02099110|515912811|FG002|Overall Study|Screen failure|0|||
143101527|NCT02099110|515912812|FG003|Overall Study|Screen failure|0|||
143101528|NCT02099110|515912813|FG004|Overall Study|Screen failure|1|||
143101529|NCT02099110|515912809|FG000|Overall Study|Non-compliance with study drug|2|||
143101530|NCT02099110|515912810|FG001|Overall Study|Non-compliance with study drug|0|||
143101531|NCT02099110|515912811|FG002|Overall Study|Non-compliance with study drug|0|||
143101532|NCT02099110|515912812|FG003|Overall Study|Non-compliance with study drug|0|||
143101533|NCT02099110|515912813|FG004|Overall Study|Non-compliance with study drug|1|||
143101534|NCT02099110|515912809|FG000|Overall Study|Physician Decision|3|||
143101535|NCT02099110|515912810|FG001|Overall Study|Physician Decision|0|||
143101536|NCT02099110|515912811|FG002|Overall Study|Physician Decision|1|||
143101537|NCT02099110|515912812|FG003|Overall Study|Physician Decision|2|||
143101538|NCT02099110|515912813|FG004|Overall Study|Physician Decision|1|||
143101539|NCT02630251|515912816|FG000|Overall Study|Physician Decision|0|||
143101540|NCT02630251|515912817|FG001|Overall Study|Physician Decision|0|||
143101541|NCT02630251|515912818|FG002|Overall Study|Physician Decision|1|||
143101542|NCT02630251|515912819|FG003|Overall Study|Physician Decision|0|||
143177470|NCT01194245|516197932|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
143177471|NCT01194245|516197928|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
143177472|NCT01194245|516197929|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
143177473|NCT01194245|516197930|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
143177474|NCT01194245|516197931|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
143177475|NCT01194245|516197932|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
143177476|NCT01194245|516197928|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
143177477|NCT01194245|516197929|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
143177478|NCT01194245|516197930|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
143101543|NCT02968173|515912820|FG000|Overall Study|Withdrawal by Subject|1|||
143101544|NCT04586244|515912821|FG000|Overall Study|Lost to Follow-up|1|||
143101545|NCT04586244|515912822|FG001|Overall Study|Lost to Follow-up|0|||
143101546|NCT04586244|515912823|FG002|Overall Study|Lost to Follow-up|0|||
143101547|NCT04586244|515912824|FG003|Overall Study|Lost to Follow-up|1|||
143101548|NCT04586244|515912825|FG004|Overall Study|Lost to Follow-up|0|||
143101549|NCT04586244|515912821|FG000|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
143101550|NCT04586244|515912822|FG001|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|1|||
143101551|NCT04586244|515912823|FG002|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
143101552|NCT04586244|515912824|FG003|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
143101553|NCT04586244|515912825|FG004|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
143101554|NCT03627546|515912828|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
143101555|NCT03627546|515912829|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
143101556|NCT03627546|515912830|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
143101557|NCT03627546|515912828|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
143101558|NCT03627546|515912829|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
143101559|NCT03627546|515912830|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
143101560|NCT01537042|515912833|FG000|Overall Study|Adverse Event|0|||
143101561|NCT01537042|515912834|FG001|Overall Study|Adverse Event|2|||
143101562|NCT01537042|515912833|FG000|Overall Study|Lack of Efficacy|0|||
143101563|NCT01537042|515912834|FG001|Overall Study|Lack of Efficacy|1|||
143101564|NCT01537042|515912833|FG000|Overall Study|Protocol Violation|0|||
143101565|NCT01537042|515912834|FG001|Overall Study|Protocol Violation|1|||
143101566|NCT01537042|515912833|FG000|Overall Study|Other|0|||
143101567|NCT01537042|515912834|FG001|Overall Study|Other|1|||
143101568|NCT02965573|515912835|FG000|Overall Study|Lack of Efficacy|1|||
143101569|NCT02965573|515912836|FG001|Overall Study|Lack of Efficacy|0|||
143101570|NCT00086619|515912837|FG000|Overall Study|Withdrawal by Subject|6|||
143101571|NCT00086619|515912838|FG001|Overall Study|Withdrawal by Subject|6|||
143101572|NCT00086619|515912837|FG000|Overall Study|Adverse Event|8|||
143101573|NCT00086619|515912838|FG001|Overall Study|Adverse Event|10|||
143101574|NCT00086619|515912837|FG000|Overall Study|Protocol Violation|1|||
143101575|NCT00086619|515912838|FG001|Overall Study|Protocol Violation|1|||
143101576|NCT01500382|515912839|FG000|Washout Period|Study site went out of business|0|||
143101577|NCT01500382|515912840|FG001|Washout Period|Study site went out of business|0|||
143101578|NCT01500382|515912841|FG002|Washout Period|Study site went out of business|1|||
143101579|NCT01500382|515912842|FG003|Washout Period|Study site went out of business|0|||
143101580|NCT02186873|515914603|FG000|Overall Study|Adverse Event|1|||
143101581|NCT02186873|515914604|FG001|Overall Study|Adverse Event|3|||
143101582|NCT02186873|515914603|FG000|Overall Study|Lack of Efficacy|0|||
143101583|NCT02186873|515914604|FG001|Overall Study|Lack of Efficacy|1|||
143101584|NCT02186873|515914603|FG000|Overall Study|Lost to Follow-up|1|||
143101585|NCT02186873|515914604|FG001|Overall Study|Lost to Follow-up|2|||
143101586|NCT02186873|515914603|FG000|Overall Study|Withdrawal by Subject|7|||
143101587|NCT02186873|515914604|FG001|Overall Study|Withdrawal by Subject|2|||
143101588|NCT03694002|515914605|FG000|Overall Study|Progression|4|||
143101589|NCT03694002|515914606|FG001|Overall Study|Progression|2|||
143101590|NCT03694002|515914605|FG000|Overall Study|Adverse Event|2|||
143101591|NCT03694002|515914606|FG001|Overall Study|Adverse Event|0|||
143101592|NCT03694002|515914605|FG000|Overall Study|Other not protocol specified|1|||
143101593|NCT03694002|515914606|FG001|Overall Study|Other not protocol specified|0|||
143101594|NCT03694002|515914605|FG000|Overall Study|Ineligible|0|||
143101595|NCT03694002|515914606|FG001|Overall Study|Ineligible|1|||
143101596|NCT03694002|515914605|FG000|Overall Study|Withdrew consent before starting treatment|0|||
143101597|NCT03694002|515914606|FG001|Overall Study|Withdrew consent before starting treatment|3|||
143101598|NCT05678959|515914607|FG000|Overall Study|Study Terminated by Sponsor|76|||
143101599|NCT05678959|515914608|FG001|Overall Study|Study Terminated by Sponsor|76|||
143101600|NCT05678959|515914607|FG000|Overall Study|Physician Decision|2|||
143101601|NCT05678959|515914608|FG001|Overall Study|Physician Decision|3|||
143101602|NCT05678959|515914607|FG000|Overall Study|Adverse Event|1|||
143101603|NCT05678959|515914608|FG001|Overall Study|Adverse Event|1|||
143101604|NCT05678959|515914607|FG000|Overall Study|Guardian Decision|1|||
143101605|NCT05678959|515914608|FG001|Overall Study|Guardian Decision|0|||
143101606|NCT05678959|515914607|FG000|Overall Study|Protocol Deviation|0|||
143252118|NCT00717236|516476418|FG000|Double-Blind Period|Other: Death|1|||
143252119|NCT00717236|516476419|FG001|Double-Blind Period|Other: Death|0|||
143252120|NCT00717236|516476418|FG000|Double-Blind Period|Other: Pregnancy|1|||
143252121|NCT00717236|516476419|FG001|Double-Blind Period|Other: Pregnancy|0|||
143252122|NCT00717236|516476418|FG000|Double-Blind Period|Other: Protocol Violation|2|||
143252123|NCT00717236|516476419|FG001|Double-Blind Period|Other: Protocol Violation|0|||
143101607|NCT05678959|515914608|FG001|Overall Study|Protocol Deviation|1|||
143101608|NCT05678959|515914607|FG000|Overall Study|Subject Decision|1|||
143101609|NCT05678959|515914608|FG001|Overall Study|Subject Decision|0|||
143252124|NCT00717236|516476418|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
143101610|NCT05678959|515914607|FG000|Overall Study|Technical Problem|0|||
143101611|NCT05678959|515914608|FG001|Overall Study|Technical Problem|1|||
143101612|NCT01481766|515914609|FG000|4 months|Lost to Follow-up|3|||
143101613|NCT01481766|515914610|FG001|4 months|Lost to Follow-up|2|||
143252125|NCT00717236|516476419|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
143101614|NCT01481766|515914611|FG002|4 months|Lost to Follow-up|1|||
143101615|NCT01481766|515914612|FG003|4 months|Lost to Follow-up|5|||
143101616|NCT01481766|515914609|FG000|12 months|Lost to Follow-up|7|||
143101617|NCT01481766|515914610|FG001|12 months|Lost to Follow-up|8|||
143101618|NCT01481766|515914611|FG002|12 months|Lost to Follow-up|5|||
143101619|NCT01481766|515914612|FG003|12 months|Lost to Follow-up|3|||
143101620|NCT02530125|515914621|FG000|Completed Treatment|Early termination of study|1|||
143101621|NCT02530125|515914621|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
143101622|NCT00356603|515914622|FG000|Overall Study|Other|6|||
143101623|NCT00356603|515914623|FG001|Overall Study|Other|3|||
143101624|NCT00468481|515914624|FG000|Overall Study|Adverse Event|13|||
143101625|NCT00468481|515914625|FG001|Overall Study|Adverse Event|3|||
143101626|NCT00468481|515914624|FG000|Overall Study|Lost to Follow-up|25|||
143101627|NCT00468481|515914625|FG001|Overall Study|Lost to Follow-up|8|||
143101628|NCT00468481|515914624|FG000|Overall Study|Pregnancy|2|||
143101629|NCT00468481|515914625|FG001|Overall Study|Pregnancy|0|||
143101630|NCT00468481|515914624|FG000|Overall Study|Protocol Violation|18|||
143101631|NCT00468481|515914625|FG001|Overall Study|Protocol Violation|8|||
143101632|NCT00468481|515914624|FG000|Overall Study|Withdrawal by Subject|12|||
143101633|NCT00468481|515914625|FG001|Overall Study|Withdrawal by Subject|3|||
143101634|NCT00468481|515914624|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
143101635|NCT00468481|515914625|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
143101636|NCT00468481|515914624|FG000|Overall Study|Prohibited Medication|1|||
143101637|NCT00468481|515914625|FG001|Overall Study|Prohibited Medication|1|||
143101638|NCT00468481|515914624|FG000|Overall Study|Egg Donor|1|||
143101639|NCT00468481|515914625|FG001|Overall Study|Egg Donor|0|||
143101640|NCT00468481|515914624|FG000|Overall Study|Moved out of area|4|||
143101641|NCT00468481|515914625|FG001|Overall Study|Moved out of area|1|||
143101642|NCT00468481|515914624|FG000|Overall Study|Non-Compliance|5|||
143101643|NCT00468481|515914625|FG001|Overall Study|Non-Compliance|0|||
143101644|NCT00468481|515914624|FG000|Overall Study|Other|6|||
143101645|NCT00468481|515914625|FG001|Overall Study|Other|0|||
143101646|NCT02282631|515914626|FG000|Overall Study|Lost to Follow-up|2|||
143101647|NCT02282631|515914627|FG001|Overall Study|Lost to Follow-up|0|||
143101648|NCT01515865|515914629|FG000|Part A (Open-label)|Other|3|||
143101649|NCT01515865|515914630|FG001|Part A (Open-label)|Other|0|||
143101650|NCT01515865|515914631|FG002|Part A (Open-label)|Other|0|||
143101651|NCT01515865|515914629|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
143101652|NCT01515865|515914630|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
143101653|NCT01515865|515914631|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
143101654|NCT01515865|515914629|FG000|Part B (Open-label)|Other|1|||
143101655|NCT01515865|515914630|FG001|Part B (Open-label)|Other|0|||
143101656|NCT01515865|515914631|FG002|Part B (Open-label)|Other|0|||
143101657|NCT03691207|515914632|FG000|Overall Study|Death|41|||
143101658|NCT03691207|515914633|FG001|Overall Study|Death|26|||
143101659|NCT03691207|515914632|FG000|Overall Study|Lost to Follow-up|1|||
143101660|NCT03691207|515914633|FG001|Overall Study|Lost to Follow-up|1|||
143101661|NCT03691207|515914632|FG000|Overall Study|Withdrawal by Subject|2|||
143101662|NCT03691207|515914633|FG001|Overall Study|Withdrawal by Subject|8|||
143101663|NCT03691207|515914632|FG000|Overall Study|Sponsor decision|1|||
143101664|NCT03691207|515914633|FG001|Overall Study|Sponsor decision|7|||
143101665|NCT03656692|515914636|FG000|Overall Study|Worsening of disease activity|2|||
143101666|NCT03656692|515914636|FG000|Overall Study|Physician Decision|1|||
143101667|NCT02498444|515914637|FG000|Overall Study|Withdrawal by Subject|3|||
143101668|NCT02498444|515914638|FG001|Overall Study|Withdrawal by Subject|0|||
143101669|NCT02498444|515914637|FG000|Overall Study|Physician Decision|1|||
143101670|NCT02498444|515914638|FG001|Overall Study|Physician Decision|0|||
143101671|NCT02453334|515914639|FG000|Overall Study|Death|15|||
143101672|NCT02453334|515914640|FG001|Overall Study|Death|13|||
143101673|NCT02453334|515914639|FG000|Overall Study|Adverse Event|2|||
143101674|NCT02453334|515914640|FG001|Overall Study|Adverse Event|1|||
143101675|NCT02453334|515914639|FG000|Overall Study|Lost to Follow-up|5|||
143101676|NCT02453334|515914640|FG001|Overall Study|Lost to Follow-up|9|||
143101677|NCT02453334|515914639|FG000|Overall Study|Physician Decision|1|||
143101678|NCT02453334|515914640|FG001|Overall Study|Physician Decision|0|||
143101679|NCT02453334|515914639|FG000|Overall Study|Withdrawal by Subject|17|||
143101680|NCT02453334|515914640|FG001|Overall Study|Withdrawal by Subject|13|||
143101681|NCT02453334|515914639|FG000|Overall Study|Other reason|1|||
143101682|NCT02453334|515914640|FG001|Overall Study|Other reason|4|||
143101683|NCT04478695|515914641|FG000|Overall Study|Death|1|||
143101684|NCT04478695|515914642|FG001|Overall Study|Death|0|||
143101685|NCT00402688|515914643|FG000|Overall Study|Adverse Event|12|||
143101686|NCT00402688|515914644|FG001|Overall Study|Adverse Event|9|||
143101687|NCT00402688|515914645|FG002|Overall Study|Adverse Event|3|||
143101688|NCT00402688|515914643|FG000|Overall Study|Withdrawal by Subject|3|||
143101689|NCT00402688|515914644|FG001|Overall Study|Withdrawal by Subject|1|||
143101690|NCT00402688|515914645|FG002|Overall Study|Withdrawal by Subject|1|||
143101691|NCT00402688|515914643|FG000|Overall Study|Physician Decision|0|||
143101692|NCT00402688|515914644|FG001|Overall Study|Physician Decision|0|||
143101693|NCT00402688|515914645|FG002|Overall Study|Physician Decision|1|||
143101694|NCT00402688|515914643|FG000|Overall Study|Lack of Efficacy|4|||
143101695|NCT00402688|515914644|FG001|Overall Study|Lack of Efficacy|4|||
143101696|NCT00402688|515914645|FG002|Overall Study|Lack of Efficacy|5|||
143101697|NCT00402688|515914643|FG000|Overall Study|Protocol Violation|1|||
143101698|NCT00402688|515914644|FG001|Overall Study|Protocol Violation|1|||
143101699|NCT00402688|515914645|FG002|Overall Study|Protocol Violation|1|||
143101700|NCT00402688|515914643|FG000|Overall Study|Lost to Follow-up|1|||
143101701|NCT00402688|515914644|FG001|Overall Study|Lost to Follow-up|0|||
143101702|NCT00402688|515914645|FG002|Overall Study|Lost to Follow-up|2|||
143101703|NCT00402688|515914643|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
143101704|NCT00402688|515914644|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
143101705|NCT00402688|515914645|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
143101706|NCT00402688|515914643|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
143101707|NCT00402688|515914644|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
143101708|NCT00402688|515914645|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
143101709|NCT00402688|515914643|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
143101710|NCT00402688|515914644|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
143101711|NCT00402688|515914645|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
143101712|NCT00927862|515914646|FG000|Overall Study|Missing data needed for endpt analyses|27|||
143101713|NCT00927862|515914647|FG001|Overall Study|Missing data needed for endpt analyses|45|||
143101714|NCT02347774|515914648|FG000|Study Participation|Lost to Follow-up|3|||
143101715|NCT02347774|515914649|FG001|Study Participation|Lost to Follow-up|6|||
143101716|NCT02347774|515914650|FG002|Study Participation|Lost to Follow-up|2|||
143101717|NCT02347774|515914648|FG000|Study Participation|Withdrawal by Subject|8|||
143101718|NCT02347774|515914649|FG001|Study Participation|Withdrawal by Subject|9|||
143101719|NCT02347774|515914650|FG002|Study Participation|Withdrawal by Subject|15|||
143101720|NCT02347774|515914648|FG000|Study Participation|Adverse Event|1|||
143101721|NCT02347774|515914649|FG001|Study Participation|Adverse Event|4|||
143101722|NCT02347774|515914650|FG002|Study Participation|Adverse Event|6|||
143101723|NCT02347774|515914648|FG000|Study Participation|withdrew consent|1|||
143101724|NCT02347774|515914649|FG001|Study Participation|withdrew consent|1|||
143101725|NCT02347774|515914650|FG002|Study Participation|withdrew consent|1|||
143101726|NCT02347774|515914648|FG000|Study Participation|Met Prolonged QT criteria|1|||
143101727|NCT02347774|515914649|FG001|Study Participation|Met Prolonged QT criteria|0|||
143101728|NCT02347774|515914650|FG002|Study Participation|Met Prolonged QT criteria|0|||
143101729|NCT02347774|515914648|FG000|Study Participation|non-compliance with study drug|0|||
143101730|NCT02347774|515914649|FG001|Study Participation|non-compliance with study drug|1|||
143101731|NCT02347774|515914650|FG002|Study Participation|non-compliance with study drug|0|||
143101732|NCT02347774|515914648|FG000|Study Participation|incarceration|1|||
143101733|NCT02347774|515914649|FG001|Study Participation|incarceration|0|||
143101734|NCT02347774|515914650|FG002|Study Participation|incarceration|0|||
143101735|NCT02347774|515914648|FG000|Study Participation|randomized in error|0|||
143101736|NCT02347774|515914649|FG001|Study Participation|randomized in error|0|||
143101737|NCT02347774|515914650|FG002|Study Participation|randomized in error|1|||
143101738|NCT02347774|515914648|FG000|On Study Treatment|Adverse Event|9|||
143101739|NCT02347774|515914649|FG001|On Study Treatment|Adverse Event|15|||
143101740|NCT02347774|515914650|FG002|On Study Treatment|Adverse Event|19|||
143101741|NCT02347774|515914648|FG000|On Study Treatment|Lack of Efficacy|3|||
143101742|NCT02347774|515914649|FG001|On Study Treatment|Lack of Efficacy|0|||
143177479|NCT01194245|516197931|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
143101743|NCT02347774|515914650|FG002|On Study Treatment|Lack of Efficacy|2|||
143101744|NCT02347774|515914648|FG000|On Study Treatment|non-complicance with study medication|0|||
143101745|NCT02347774|515914649|FG001|On Study Treatment|non-complicance with study medication|2|||
143101746|NCT02347774|515914650|FG002|On Study Treatment|non-complicance with study medication|0|||
143101747|NCT02347774|515914648|FG000|On Study Treatment|Protocol Violation|0|||
143101748|NCT02347774|515914649|FG001|On Study Treatment|Protocol Violation|0|||
143101749|NCT02347774|515914650|FG002|On Study Treatment|Protocol Violation|1|||
143101750|NCT02347774|515914648|FG000|On Study Treatment|withdrew consent|9|||
143101751|NCT02347774|515914649|FG001|On Study Treatment|withdrew consent|8|||
143101752|NCT02347774|515914650|FG002|On Study Treatment|withdrew consent|12|||
143177480|NCT01194245|516197932|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
143101753|NCT02347774|515914648|FG000|On Study Treatment|Lost to Follow-up|2|||
143101754|NCT02347774|515914649|FG001|On Study Treatment|Lost to Follow-up|6|||
143101755|NCT02347774|515914650|FG002|On Study Treatment|Lost to Follow-up|1|||
143101756|NCT02347774|515914648|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
143101757|NCT02347774|515914649|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
143101758|NCT02347774|515914650|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
143101759|NCT02347774|515914648|FG000|On Study Treatment|ranomized in error|0|||
143101760|NCT02347774|515914649|FG001|On Study Treatment|ranomized in error|0|||
143101761|NCT02347774|515914650|FG002|On Study Treatment|ranomized in error|1|||
143101762|NCT00820248|515914651|FG000|Overall Study|No treated|4|||
143101763|NCT00820248|515914652|FG001|Overall Study|No treated|1|||
143101764|NCT04157296|515914654|FG000|Overall Study|Withdrawal by Subject|0|||
143101765|NCT04157296|515914655|FG001|Overall Study|Withdrawal by Subject|1|||
143101766|NCT04157296|515914654|FG000|Overall Study|Did not obtain second fMRI.|0|||
143101767|NCT04157296|515914655|FG001|Overall Study|Did not obtain second fMRI.|1|||
143101768|NCT04157296|515914654|FG000|Overall Study|MRI failed/no second fMRI|0|||
143101769|NCT04157296|515914655|FG001|Overall Study|MRI failed/no second fMRI|1|||
143101770|NCT02237196|515914656|FG000|Overall Study|Adverse Event|0|||
143101771|NCT02237196|515914657|FG001|Overall Study|Adverse Event|1|||
143101772|NCT02237196|515914658|FG002|Overall Study|Adverse Event|1|||
143101773|NCT02237196|515914659|FG003|Overall Study|Adverse Event|0|||
143101774|NCT02237196|515914656|FG000|Overall Study|Lost to Follow-up|4|||
143101775|NCT02237196|515914657|FG001|Overall Study|Lost to Follow-up|2|||
143101776|NCT02237196|515914658|FG002|Overall Study|Lost to Follow-up|4|||
143101777|NCT02237196|515914659|FG003|Overall Study|Lost to Follow-up|6|||
143101778|NCT02237196|515914656|FG000|Overall Study|Physician Decision|2|||
143101779|NCT02237196|515914657|FG001|Overall Study|Physician Decision|0|||
143101780|NCT02237196|515914658|FG002|Overall Study|Physician Decision|0|||
143101781|NCT02237196|515914659|FG003|Overall Study|Physician Decision|1|||
143101782|NCT02237196|515914656|FG000|Overall Study|Pregnancy|0|||
143101783|NCT02237196|515914657|FG001|Overall Study|Pregnancy|0|||
143101784|NCT02237196|515914658|FG002|Overall Study|Pregnancy|1|||
143101785|NCT02237196|515914659|FG003|Overall Study|Pregnancy|1|||
143101786|NCT02237196|515914656|FG000|Overall Study|Withdrawal by Subject|1|||
143101787|NCT02237196|515914657|FG001|Overall Study|Withdrawal by Subject|1|||
143252126|NCT00717236|516476418|FG000|Double-Blind Period|Other: Site withdrew|2|||
143101788|NCT02237196|515914658|FG002|Overall Study|Withdrawal by Subject|4|||
143101789|NCT02237196|515914659|FG003|Overall Study|Withdrawal by Subject|1|||
143101790|NCT02237196|515914656|FG000|Overall Study|Site Error|1|||
143101791|NCT02237196|515914657|FG001|Overall Study|Site Error|2|||
143101792|NCT02237196|515914658|FG002|Overall Study|Site Error|0|||
143101793|NCT02237196|515914659|FG003|Overall Study|Site Error|2|||
143101794|NCT00267969|515914666|FG000|Controlled Period|Adverse Event|6|||
143101795|NCT00267969|515914667|FG001|Controlled Period|Adverse Event|0|||
143101796|NCT00267969|515914668|FG002|Controlled Period|Adverse Event|2|||
143101797|NCT00267969|515914669|FG003|Controlled Period|Adverse Event|0|||
143101798|NCT00267969|515914670|FG004|Controlled Period|Adverse Event|0|||
143101799|NCT00267969|515914671|FG005|Controlled Period|Adverse Event|0|||
143101800|NCT00267969|515914672|FG006|Controlled Period|Adverse Event|0|||
143101801|NCT00267969|515914666|FG000|Controlled Period|Lack of Efficacy|3|||
143101802|NCT00267969|515914667|FG001|Controlled Period|Lack of Efficacy|0|||
143101803|NCT00267969|515914668|FG002|Controlled Period|Lack of Efficacy|1|||
143101804|NCT00267969|515914669|FG003|Controlled Period|Lack of Efficacy|0|||
143101805|NCT00267969|515914670|FG004|Controlled Period|Lack of Efficacy|0|||
143101806|NCT00267969|515914671|FG005|Controlled Period|Lack of Efficacy|0|||
143101807|NCT00267969|515914672|FG006|Controlled Period|Lack of Efficacy|0|||
143101808|NCT00267969|515914666|FG000|Controlled Period|Lost to Follow-up|1|||
143101809|NCT00267969|515914667|FG001|Controlled Period|Lost to Follow-up|0|||
143101810|NCT00267969|515914668|FG002|Controlled Period|Lost to Follow-up|1|||
143101811|NCT00267969|515914669|FG003|Controlled Period|Lost to Follow-up|0|||
143101812|NCT00267969|515914670|FG004|Controlled Period|Lost to Follow-up|0|||
143101813|NCT00267969|515914671|FG005|Controlled Period|Lost to Follow-up|0|||
143101814|NCT00267969|515914672|FG006|Controlled Period|Lost to Follow-up|0|||
143101815|NCT00267969|515914666|FG000|Controlled Period|Randomized but not treated|0|||
143101816|NCT00267969|515914667|FG001|Controlled Period|Randomized but not treated|0|||
143101817|NCT00267969|515914668|FG002|Controlled Period|Randomized but not treated|1|||
143101818|NCT00267969|515914669|FG003|Controlled Period|Randomized but not treated|0|||
143101819|NCT00267969|515914670|FG004|Controlled Period|Randomized but not treated|0|||
143101820|NCT00267969|515914671|FG005|Controlled Period|Randomized but not treated|0|||
143101821|NCT00267969|515914672|FG006|Controlled Period|Randomized but not treated|0|||
143101822|NCT00267969|515914666|FG000|Controlled Period|Other|2|||
143101823|NCT00267969|515914667|FG001|Controlled Period|Other|1|||
143101824|NCT00267969|515914668|FG002|Controlled Period|Other|6|||
143101825|NCT00267969|515914669|FG003|Controlled Period|Other|0|||
143101826|NCT00267969|515914670|FG004|Controlled Period|Other|0|||
143101827|NCT00267969|515914671|FG005|Controlled Period|Other|0|||
143101828|NCT00267969|515914672|FG006|Controlled Period|Other|0|||
143101829|NCT00267969|515914666|FG000|After Controlled Period|Adverse Event|0|||
143101830|NCT00267969|515914667|FG001|After Controlled Period|Adverse Event|0|||
143101831|NCT00267969|515914668|FG002|After Controlled Period|Adverse Event|0|||
143101832|NCT00267969|515914669|FG003|After Controlled Period|Adverse Event|7|||
143101833|NCT00267969|515914670|FG004|After Controlled Period|Adverse Event|8|||
143101834|NCT00267969|515914671|FG005|After Controlled Period|Adverse Event|23|||
143101835|NCT00267969|515914672|FG006|After Controlled Period|Adverse Event|21|||
143101836|NCT00267969|515914666|FG000|After Controlled Period|Death|0|||
143101837|NCT00267969|515914667|FG001|After Controlled Period|Death|0|||
143101838|NCT00267969|515914668|FG002|After Controlled Period|Death|0|||
143101839|NCT00267969|515914669|FG003|After Controlled Period|Death|1|||
143101840|NCT00267969|515914670|FG004|After Controlled Period|Death|2|||
143101841|NCT00267969|515914671|FG005|After Controlled Period|Death|0|||
143101842|NCT00267969|515914672|FG006|After Controlled Period|Death|1|||
143101843|NCT00267969|515914666|FG000|After Controlled Period|Lack of Efficacy|0|||
143101844|NCT00267969|515914667|FG001|After Controlled Period|Lack of Efficacy|0|||
143101845|NCT00267969|515914668|FG002|After Controlled Period|Lack of Efficacy|0|||
143101846|NCT00267969|515914669|FG003|After Controlled Period|Lack of Efficacy|10|||
143101847|NCT00267969|515914670|FG004|After Controlled Period|Lack of Efficacy|6|||
143101848|NCT00267969|515914671|FG005|After Controlled Period|Lack of Efficacy|28|||
143101849|NCT00267969|515914672|FG006|After Controlled Period|Lack of Efficacy|15|||
143101850|NCT00267969|515914666|FG000|After Controlled Period|Lost to Follow-up|0|||
143101851|NCT00267969|515914667|FG001|After Controlled Period|Lost to Follow-up|0|||
143101852|NCT00267969|515914668|FG002|After Controlled Period|Lost to Follow-up|0|||
143101853|NCT00267969|515914669|FG003|After Controlled Period|Lost to Follow-up|5|||
143101854|NCT00267969|515914670|FG004|After Controlled Period|Lost to Follow-up|8|||
143101855|NCT00267969|515914671|FG005|After Controlled Period|Lost to Follow-up|9|||
143101856|NCT00267969|515914672|FG006|After Controlled Period|Lost to Follow-up|10|||
143101857|NCT00267969|515914666|FG000|After Controlled Period|Other|0|||
143101858|NCT00267969|515914667|FG001|After Controlled Period|Other|0|||
143101859|NCT00267969|515914668|FG002|After Controlled Period|Other|0|||
143101860|NCT00267969|515914669|FG003|After Controlled Period|Other|13|||
143101861|NCT00267969|515914670|FG004|After Controlled Period|Other|11|||
143101862|NCT00267969|515914671|FG005|After Controlled Period|Other|22|||
143101863|NCT00267969|515914672|FG006|After Controlled Period|Other|25|||
143101864|NCT00862823|515914675|FG000|First Intervention|Withdrawal by Subject|1|||
143101865|NCT00862823|515914676|FG001|First Intervention|Withdrawal by Subject|1|||
143101866|NCT00887315|515914677|FG000|Overall Study|Study termination|7|||
143101867|NCT00887315|515914678|FG001|Overall Study|Study termination|4|||
143101868|NCT02049814|515914686|FG000|Overall Study|Reason not Specified|4|||
143101869|NCT02049814|515914687|FG001|Overall Study|Reason not Specified|3|||
143101870|NCT02049814|515914686|FG000|Overall Study|Pregnancy|1|||
143101871|NCT02049814|515914687|FG001|Overall Study|Pregnancy|0|||
143101872|NCT02049814|515914686|FG000|Overall Study|Lost to Follow-up|2|||
143101873|NCT02049814|515914687|FG001|Overall Study|Lost to Follow-up|3|||
143101874|NCT02049814|515914686|FG000|Overall Study|Serious Protocol Violation|5|||
143101875|NCT02049814|515914687|FG001|Overall Study|Serious Protocol Violation|7|||
143101876|NCT02049814|515914686|FG000|Overall Study|Study Termination|0|||
143101877|NCT02049814|515914687|FG001|Overall Study|Study Termination|1|||
143101878|NCT02049814|515914686|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
143101879|NCT02049814|515914687|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
143101880|NCT02049814|515914686|FG000|Overall Study|Voluntary withdrawal|9|||
143101881|NCT02049814|515914687|FG001|Overall Study|Voluntary withdrawal|8|||
143252127|NCT00717236|516476419|FG001|Double-Blind Period|Other: Site withdrew|0|||
143101882|NCT01431716|515914695|FG000|Overall Study|Withdrawal of consent|1|||
143101883|NCT00954941|515914696|FG000|Overall Study|Received treatment at home|1|||
143101884|NCT00954941|515914697|FG001|Overall Study|Received treatment at home|0|||
143101885|NCT00954941|515914696|FG000|Overall Study|Withdrawal by Subject|1|||
143101886|NCT00954941|515914697|FG001|Overall Study|Withdrawal by Subject|0|||
143101887|NCT00954941|515914696|FG000|Overall Study|Insurance Denial|2|||
143101888|NCT00954941|515914697|FG001|Overall Study|Insurance Denial|2|||
143101889|NCT00954941|515914696|FG000|Overall Study|Physician Decision|2|||
143101890|NCT00954941|515914697|FG001|Overall Study|Physician Decision|2|||
143101891|NCT00954941|515914696|FG000|Overall Study|Ineligible|2|||
143101892|NCT00954941|515914697|FG001|Overall Study|Ineligible|2|||
143101893|NCT00954941|515914696|FG000|Overall Study|Adverse Event|0|||
143101894|NCT00954941|515914697|FG001|Overall Study|Adverse Event|1|||
143101895|NCT00356148|515914700|FG000|Overall Study|Reoperation within 30 days|2|||
143101896|NCT00356148|515914701|FG001|Overall Study|Reoperation within 30 days|1|||
143101897|NCT05708976|515914729|FG000|Overall Study|Withdrawal by Subject|0|||
143101898|NCT05708976|515914730|FG001|Overall Study|Withdrawal by Subject|1|||
143101899|NCT02477826|515914731|FG000|Pre-Treatment|Adverse events unrelated to study drug|0|||
143101900|NCT02477826|515914732|FG001|Pre-Treatment|Adverse events unrelated to study drug|1|||
143101901|NCT02477826|515914733|FG002|Pre-Treatment|Adverse events unrelated to study drug|2|||
143101902|NCT02477826|515914734|FG003|Pre-Treatment|Adverse events unrelated to study drug|1|||
143101903|NCT02477826|515914735|FG004|Pre-Treatment|Adverse events unrelated to study drug|0|||
143101904|NCT02477826|515914736|FG005|Pre-Treatment|Adverse events unrelated to study drug|0|||
143101905|NCT02477826|515914737|FG006|Pre-Treatment|Adverse events unrelated to study drug|1|||
143101906|NCT02477826|515914738|FG007|Pre-Treatment|Adverse events unrelated to study drug|5|||
143101907|NCT02477826|515914739|FG008|Pre-Treatment|Adverse events unrelated to study drug|0|||
143101908|NCT02477826|515914740|FG009|Pre-Treatment|Adverse events unrelated to study drug|0|||
143101909|NCT02477826|515914731|FG000|Pre-Treatment|Other reasons|4|||
143101910|NCT02477826|515914732|FG001|Pre-Treatment|Other reasons|1|||
143101911|NCT02477826|515914733|FG002|Pre-Treatment|Other reasons|4|||
143101912|NCT02477826|515914734|FG003|Pre-Treatment|Other reasons|1|||
143101913|NCT02477826|515914735|FG004|Pre-Treatment|Other reasons|4|||
143101914|NCT02477826|515914736|FG005|Pre-Treatment|Other reasons|2|||
143101915|NCT02477826|515914737|FG006|Pre-Treatment|Other reasons|0|||
143101916|NCT02477826|515914738|FG007|Pre-Treatment|Other reasons|0|||
143101917|NCT02477826|515914739|FG008|Pre-Treatment|Other reasons|0|||
143101918|NCT02477826|515914740|FG009|Pre-Treatment|Other reasons|0|||
143101919|NCT02477826|515914731|FG000|Pre-Treatment|Subject no longer meets study criteria|1|||
143101920|NCT02477826|515914732|FG001|Pre-Treatment|Subject no longer meets study criteria|2|||
143101921|NCT02477826|515914733|FG002|Pre-Treatment|Subject no longer meets study criteria|1|||
143101922|NCT02477826|515914734|FG003|Pre-Treatment|Subject no longer meets study criteria|0|||
143101923|NCT02477826|515914735|FG004|Pre-Treatment|Subject no longer meets study criteria|1|||
143101924|NCT02477826|515914736|FG005|Pre-Treatment|Subject no longer meets study criteria|0|||
143101925|NCT02477826|515914737|FG006|Pre-Treatment|Subject no longer meets study criteria|0|||
143101926|NCT02477826|515914738|FG007|Pre-Treatment|Subject no longer meets study criteria|1|||
143252128|NCT00717236|516476418|FG000|Double-Blind Period|Other: Screening failure|1|||
143252129|NCT00717236|516476419|FG001|Double-Blind Period|Other: Screening failure|0|||
143252130|NCT00717236|516476418|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
143101927|NCT02477826|515914739|FG008|Pre-Treatment|Subject no longer meets study criteria|0|||
143101928|NCT02477826|515914740|FG009|Pre-Treatment|Subject no longer meets study criteria|0|||
143101929|NCT02477826|515914731|FG000|Pre-Treatment|Subject withdrew consent|0|||
143101930|NCT02477826|515914732|FG001|Pre-Treatment|Subject withdrew consent|0|||
143101931|NCT02477826|515914733|FG002|Pre-Treatment|Subject withdrew consent|3|||
143101932|NCT02477826|515914734|FG003|Pre-Treatment|Subject withdrew consent|0|||
143101933|NCT02477826|515914735|FG004|Pre-Treatment|Subject withdrew consent|0|||
143101934|NCT02477826|515914736|FG005|Pre-Treatment|Subject withdrew consent|1|||
143101935|NCT02477826|515914737|FG006|Pre-Treatment|Subject withdrew consent|0|||
143101936|NCT02477826|515914738|FG007|Pre-Treatment|Subject withdrew consent|1|||
143101937|NCT02477826|515914739|FG008|Pre-Treatment|Subject withdrew consent|0|||
143101938|NCT02477826|515914740|FG009|Pre-Treatment|Subject withdrew consent|3|||
143101939|NCT02477826|515914731|FG000|Pre-Treatment|Subject request to discontinue study treatment|0|||
143101940|NCT02477826|515914732|FG001|Pre-Treatment|Subject request to discontinue study treatment|1|||
143101941|NCT02477826|515914733|FG002|Pre-Treatment|Subject request to discontinue study treatment|0|||
143101942|NCT02477826|515914734|FG003|Pre-Treatment|Subject request to discontinue study treatment|0|||
143101943|NCT02477826|515914735|FG004|Pre-Treatment|Subject request to discontinue study treatment|0|||
143101944|NCT02477826|515914736|FG005|Pre-Treatment|Subject request to discontinue study treatment|0|||
143101945|NCT02477826|515914737|FG006|Pre-Treatment|Subject request to discontinue study treatment|0|||
143101946|NCT02477826|515914738|FG007|Pre-Treatment|Subject request to discontinue study treatment|0|||
143101947|NCT02477826|515914739|FG008|Pre-Treatment|Subject request to discontinue study treatment|0|||
143101948|NCT02477826|515914740|FG009|Pre-Treatment|Subject request to discontinue study treatment|1|||
143101949|NCT02477826|515914731|FG000|Pre-Treatment|Death|0|||
143101950|NCT02477826|515914732|FG001|Pre-Treatment|Death|0|||
143101951|NCT02477826|515914733|FG002|Pre-Treatment|Death|0|||
143101952|NCT02477826|515914734|FG003|Pre-Treatment|Death|0|||
143101953|NCT02477826|515914735|FG004|Pre-Treatment|Death|0|||
143101954|NCT02477826|515914736|FG005|Pre-Treatment|Death|0|||
143101955|NCT02477826|515914737|FG006|Pre-Treatment|Death|1|||
143101956|NCT02477826|515914738|FG007|Pre-Treatment|Death|0|||
143101957|NCT02477826|515914739|FG008|Pre-Treatment|Death|0|||
143101958|NCT02477826|515914740|FG009|Pre-Treatment|Death|0|||
143101959|NCT02477826|515914731|FG000|Treatment Period|Not reported|8|||
143101960|NCT02477826|515914732|FG001|Treatment Period|Not reported|6|||
143101961|NCT02477826|515914733|FG002|Treatment Period|Not reported|4|||
143101962|NCT02477826|515914734|FG003|Treatment Period|Not reported|4|||
143101963|NCT02477826|515914735|FG004|Treatment Period|Not reported|2|||
143101964|NCT02477826|515914736|FG005|Treatment Period|Not reported|1|||
143101965|NCT02477826|515914737|FG006|Treatment Period|Not reported|14|||
143101966|NCT02477826|515914738|FG007|Treatment Period|Not reported|8|||
143101967|NCT02477826|515914739|FG008|Treatment Period|Not reported|5|||
143101968|NCT02477826|515914740|FG009|Treatment Period|Not reported|2|||
143101969|NCT02477826|515914731|FG000|Treatment Period|Other reasons|5|||
143101970|NCT02477826|515914732|FG001|Treatment Period|Other reasons|6|||
143101971|NCT02477826|515914733|FG002|Treatment Period|Other reasons|12|||
143367757|NCT01143077|516889437|FG000|Overall Study|Withdrawal by Subject|4|||
143367758|NCT01143077|516889438|FG001|Overall Study|Withdrawal by Subject|3|||
143101972|NCT02477826|515914734|FG003|Treatment Period|Other reasons|7|||
143101973|NCT02477826|515914735|FG004|Treatment Period|Other reasons|5|||
143101974|NCT02477826|515914736|FG005|Treatment Period|Other reasons|1|||
143101975|NCT02477826|515914737|FG006|Treatment Period|Other reasons|8|||
143101976|NCT02477826|515914738|FG007|Treatment Period|Other reasons|8|||
143101977|NCT02477826|515914739|FG008|Treatment Period|Other reasons|21|||
143101978|NCT02477826|515914740|FG009|Treatment Period|Other reasons|1|||
143101979|NCT02477826|515914731|FG000|Treatment Period|Administrative reason by sponsor|0|||
143101980|NCT02477826|515914732|FG001|Treatment Period|Administrative reason by sponsor|3|||
143101981|NCT02477826|515914733|FG002|Treatment Period|Administrative reason by sponsor|0|||
143101982|NCT02477826|515914734|FG003|Treatment Period|Administrative reason by sponsor|0|||
143101983|NCT02477826|515914735|FG004|Treatment Period|Administrative reason by sponsor|0|||
143101984|NCT02477826|515914736|FG005|Treatment Period|Administrative reason by sponsor|0|||
143101985|NCT02477826|515914737|FG006|Treatment Period|Administrative reason by sponsor|0|||
143101986|NCT02477826|515914738|FG007|Treatment Period|Administrative reason by sponsor|0|||
143101987|NCT02477826|515914739|FG008|Treatment Period|Administrative reason by sponsor|0|||
143101988|NCT02477826|515914740|FG009|Treatment Period|Administrative reason by sponsor|0|||
143101989|NCT02477826|515914731|FG000|Treatment Period|Participant meet no longer study criteria|1|||
143101990|NCT02477826|515914732|FG001|Treatment Period|Participant meet no longer study criteria|1|||
143101991|NCT02477826|515914733|FG002|Treatment Period|Participant meet no longer study criteria|0|||
143101992|NCT02477826|515914734|FG003|Treatment Period|Participant meet no longer study criteria|0|||
143101993|NCT02477826|515914735|FG004|Treatment Period|Participant meet no longer study criteria|1|||
143101994|NCT02477826|515914736|FG005|Treatment Period|Participant meet no longer study criteria|1|||
143101995|NCT02477826|515914737|FG006|Treatment Period|Participant meet no longer study criteria|0|||
143101996|NCT02477826|515914738|FG007|Treatment Period|Participant meet no longer study criteria|1|||
143101997|NCT02477826|515914739|FG008|Treatment Period|Participant meet no longer study criteria|0|||
143101998|NCT02477826|515914740|FG009|Treatment Period|Participant meet no longer study criteria|0|||
143101999|NCT02477826|515914731|FG000|Treatment Period|Poor/Non Compliance|1|||
143102000|NCT02477826|515914732|FG001|Treatment Period|Poor/Non Compliance|0|||
143102001|NCT02477826|515914733|FG002|Treatment Period|Poor/Non Compliance|2|||
143102002|NCT02477826|515914734|FG003|Treatment Period|Poor/Non Compliance|0|||
143102003|NCT02477826|515914735|FG004|Treatment Period|Poor/Non Compliance|0|||
143102004|NCT02477826|515914736|FG005|Treatment Period|Poor/Non Compliance|1|||
143102005|NCT02477826|515914737|FG006|Treatment Period|Poor/Non Compliance|1|||
143102006|NCT02477826|515914738|FG007|Treatment Period|Poor/Non Compliance|0|||
143102007|NCT02477826|515914739|FG008|Treatment Period|Poor/Non Compliance|0|||
143102008|NCT02477826|515914740|FG009|Treatment Period|Poor/Non Compliance|1|||
143102009|NCT02477826|515914731|FG000|Treatment Period|Maximum Clinical Benefit|3|||
143102010|NCT02477826|515914732|FG001|Treatment Period|Maximum Clinical Benefit|3|||
143102011|NCT02477826|515914733|FG002|Treatment Period|Maximum Clinical Benefit|1|||
143102012|NCT02477826|515914734|FG003|Treatment Period|Maximum Clinical Benefit|1|||
143102013|NCT02477826|515914735|FG004|Treatment Period|Maximum Clinical Benefit|3|||
143102014|NCT02477826|515914736|FG005|Treatment Period|Maximum Clinical Benefit|0|||
143102015|NCT02477826|515914737|FG006|Treatment Period|Maximum Clinical Benefit|3|||
143102016|NCT02477826|515914738|FG007|Treatment Period|Maximum Clinical Benefit|2|||
143102017|NCT02477826|515914739|FG008|Treatment Period|Maximum Clinical Benefit|2|||
143102018|NCT02477826|515914740|FG009|Treatment Period|Maximum Clinical Benefit|2|||
143102019|NCT02477826|515914731|FG000|Treatment Period|Lost to Follow-up|0|||
143102020|NCT02477826|515914732|FG001|Treatment Period|Lost to Follow-up|0|||
143102021|NCT02477826|515914733|FG002|Treatment Period|Lost to Follow-up|1|||
143102022|NCT02477826|515914734|FG003|Treatment Period|Lost to Follow-up|1|||
143367759|NCT01143077|516889439|FG002|Overall Study|Withdrawal by Subject|3|||
143102023|NCT02477826|515914735|FG004|Treatment Period|Lost to Follow-up|0|||
143102024|NCT02477826|515914736|FG005|Treatment Period|Lost to Follow-up|0|||
143102025|NCT02477826|515914737|FG006|Treatment Period|Lost to Follow-up|2|||
143102026|NCT02477826|515914738|FG007|Treatment Period|Lost to Follow-up|2|||
143102027|NCT02477826|515914739|FG008|Treatment Period|Lost to Follow-up|0|||
143102028|NCT02477826|515914740|FG009|Treatment Period|Lost to Follow-up|0|||
143102029|NCT02477826|515914731|FG000|Treatment Period|Participant withdrew Consent|5|||
143102030|NCT02477826|515914732|FG001|Treatment Period|Participant withdrew Consent|5|||
143102031|NCT02477826|515914733|FG002|Treatment Period|Participant withdrew Consent|3|||
143102032|NCT02477826|515914734|FG003|Treatment Period|Participant withdrew Consent|3|||
143102033|NCT02477826|515914735|FG004|Treatment Period|Participant withdrew Consent|1|||
143102034|NCT02477826|515914736|FG005|Treatment Period|Participant withdrew Consent|3|||
143102035|NCT02477826|515914737|FG006|Treatment Period|Participant withdrew Consent|3|||
143102036|NCT02477826|515914738|FG007|Treatment Period|Participant withdrew Consent|3|||
143102037|NCT02477826|515914739|FG008|Treatment Period|Participant withdrew Consent|2|||
143102038|NCT02477826|515914740|FG009|Treatment Period|Participant withdrew Consent|3|||
143102039|NCT02477826|515914731|FG000|Treatment Period|Participant request to discontinue treatment|5|||
143102040|NCT02477826|515914732|FG001|Treatment Period|Participant request to discontinue treatment|3|||
143102041|NCT02477826|515914733|FG002|Treatment Period|Participant request to discontinue treatment|15|||
143102042|NCT02477826|515914734|FG003|Treatment Period|Participant request to discontinue treatment|5|||
143102043|NCT02477826|515914735|FG004|Treatment Period|Participant request to discontinue treatment|3|||
143102044|NCT02477826|515914736|FG005|Treatment Period|Participant request to discontinue treatment|6|||
143102045|NCT02477826|515914737|FG006|Treatment Period|Participant request to discontinue treatment|13|||
143102046|NCT02477826|515914738|FG007|Treatment Period|Participant request to discontinue treatment|15|||
143102047|NCT02477826|515914739|FG008|Treatment Period|Participant request to discontinue treatment|4|||
143102048|NCT02477826|515914740|FG009|Treatment Period|Participant request to discontinue treatment|18|||
143102049|NCT02477826|515914731|FG000|Treatment Period|Adverse event unrelated to study drug|23|||
143102050|NCT02477826|515914732|FG001|Treatment Period|Adverse event unrelated to study drug|29|||
143102051|NCT02477826|515914733|FG002|Treatment Period|Adverse event unrelated to study drug|22|||
143102052|NCT02477826|515914734|FG003|Treatment Period|Adverse event unrelated to study drug|18|||
143102053|NCT02477826|515914735|FG004|Treatment Period|Adverse event unrelated to study drug|11|||
143102054|NCT02477826|515914736|FG005|Treatment Period|Adverse event unrelated to study drug|15|||
143102055|NCT02477826|515914737|FG006|Treatment Period|Adverse event unrelated to study drug|25|||
143102056|NCT02477826|515914738|FG007|Treatment Period|Adverse event unrelated to study drug|19|||
143102057|NCT02477826|515914739|FG008|Treatment Period|Adverse event unrelated to study drug|4|||
143102058|NCT02477826|515914740|FG009|Treatment Period|Adverse event unrelated to study drug|2|||
143102059|NCT02477826|515914731|FG000|Treatment Period|Death|4|||
143102060|NCT02477826|515914732|FG001|Treatment Period|Death|7|||
143102061|NCT02477826|515914733|FG002|Treatment Period|Death|0|||
143102062|NCT02477826|515914734|FG003|Treatment Period|Death|0|||
143102063|NCT02477826|515914735|FG004|Treatment Period|Death|1|||
143102064|NCT02477826|515914736|FG005|Treatment Period|Death|2|||
143102065|NCT02477826|515914737|FG006|Treatment Period|Death|6|||
143102066|NCT02477826|515914738|FG007|Treatment Period|Death|5|||
143102067|NCT02477826|515914739|FG008|Treatment Period|Death|9|||
143102068|NCT02477826|515914740|FG009|Treatment Period|Death|0|||
143102069|NCT02477826|515914731|FG000|Treatment Period|Study Drug Toxicity|79|||
143102070|NCT02477826|515914732|FG001|Treatment Period|Study Drug Toxicity|51|||
143102071|NCT02477826|515914733|FG002|Treatment Period|Study Drug Toxicity|31|||
143102072|NCT02477826|515914734|FG003|Treatment Period|Study Drug Toxicity|39|||
143102073|NCT02477826|515914735|FG004|Treatment Period|Study Drug Toxicity|12|||
143102074|NCT02477826|515914736|FG005|Treatment Period|Study Drug Toxicity|25|||
143102075|NCT02477826|515914737|FG006|Treatment Period|Study Drug Toxicity|52|||
143102076|NCT02477826|515914738|FG007|Treatment Period|Study Drug Toxicity|30|||
143102077|NCT02477826|515914739|FG008|Treatment Period|Study Drug Toxicity|20|||
143102078|NCT02477826|515914740|FG009|Treatment Period|Study Drug Toxicity|9|||
143177481|NCT03824392|516197933|FG000|Overall Study|Adverse Event|1|||
143177482|NCT03824392|516197934|FG001|Overall Study|Adverse Event|0|||
143177483|NCT03824392|516197935|FG002|Overall Study|Adverse Event|0|||
143102079|NCT02477826|515914731|FG000|Treatment Period|Disease progression|212|||
143102080|NCT02477826|515914732|FG001|Treatment Period|Disease progression|240|||
143102081|NCT02477826|515914733|FG002|Treatment Period|Disease progression|202|||
143102082|NCT02477826|515914734|FG003|Treatment Period|Disease progression|93|||
143102083|NCT02477826|515914735|FG004|Treatment Period|Disease progression|113|||
143102084|NCT02477826|515914736|FG005|Treatment Period|Disease progression|96|||
143102085|NCT02477826|515914737|FG006|Treatment Period|Disease progression|208|||
143102086|NCT02477826|515914738|FG007|Treatment Period|Disease progression|195|||
143102087|NCT02477826|515914739|FG008|Treatment Period|Disease progression|59|||
143102088|NCT02477826|515914740|FG009|Treatment Period|Disease progression|46|||
143102089|NCT02477826|515914731|FG000|Treatment Period|Pregnancy|0|||
143102090|NCT02477826|515914732|FG001|Treatment Period|Pregnancy|0|||
143102091|NCT02477826|515914733|FG002|Treatment Period|Pregnancy|0|||
143102092|NCT02477826|515914734|FG003|Treatment Period|Pregnancy|0|||
143102093|NCT02477826|515914735|FG004|Treatment Period|Pregnancy|0|||
143102094|NCT02477826|515914736|FG005|Treatment Period|Pregnancy|0|||
143102095|NCT02477826|515914737|FG006|Treatment Period|Pregnancy|0|||
143102096|NCT02477826|515914738|FG007|Treatment Period|Pregnancy|0|||
143102097|NCT02477826|515914739|FG008|Treatment Period|Pregnancy|0|||
143102098|NCT02477826|515914740|FG009|Treatment Period|Pregnancy|1|||
143102099|NCT02477826|515914731|FG000|Treatment Period|Other|0|||
143102100|NCT02477826|515914732|FG001|Treatment Period|Other|0|||
143102101|NCT02477826|515914733|FG002|Treatment Period|Other|0|||
143102102|NCT02477826|515914734|FG003|Treatment Period|Other|0|||
143102103|NCT02477826|515914735|FG004|Treatment Period|Other|0|||
143102104|NCT02477826|515914736|FG005|Treatment Period|Other|0|||
143102105|NCT02477826|515914737|FG006|Treatment Period|Other|0|||
143102106|NCT02477826|515914738|FG007|Treatment Period|Other|0|||
143102107|NCT02477826|515914739|FG008|Treatment Period|Other|0|||
143102108|NCT02477826|515914740|FG009|Treatment Period|Other|1|||
143102109|NCT00183885|515914743|FG000|Overall Study|Adverse Event|11|||
143102110|NCT00183885|515914743|FG000|Overall Study|Death|1|||
143102111|NCT00183885|515914743|FG000|Overall Study|Lost to Follow-up|3|||
143102112|NCT00183885|515914743|FG000|Overall Study|Physician Decision|6|||
143102113|NCT00183885|515914743|FG000|Overall Study|Withdrawal by Subject|5|||
143102114|NCT00183885|515914743|FG000|Overall Study|Switched to alternative treatment|8|||
143102115|NCT00183885|515914743|FG000|Overall Study|Treatment delayed too long|4|||
143102116|NCT00183885|515914743|FG000|Overall Study|Developed second malignancy|1|||
143102117|NCT00014495|515914744|FG000|Overall Study|Death|0|||
143102118|NCT00014495|515914745|FG001|Overall Study|Death|0|||
143102119|NCT00014495|515914746|FG002|Overall Study|Death|1|||
143102120|NCT00014495|515914747|FG003|Overall Study|Death|0|||
143102121|NCT00014495|515914744|FG000|Overall Study|Clinical deterioration|0|||
143102122|NCT00014495|515914745|FG001|Overall Study|Clinical deterioration|0|||
143102123|NCT00014495|515914746|FG002|Overall Study|Clinical deterioration|0|||
143102124|NCT00014495|515914747|FG003|Overall Study|Clinical deterioration|1|||
143102125|NCT02929589|515914748|FG000|Overall Study|Withdrawal by Subject|1|||
143102126|NCT02929589|515914749|FG001|Overall Study|Withdrawal by Subject|0|||
143102127|NCT02929589|515914750|FG002|Overall Study|Withdrawal by Subject|0|||
143102128|NCT02929589|515914751|FG003|Overall Study|Withdrawal by Subject|0|||
143102129|NCT02929589|515914748|FG000|Overall Study|Physician Decision|2|||
143102130|NCT02929589|515914749|FG001|Overall Study|Physician Decision|0|||
143102131|NCT02929589|515914750|FG002|Overall Study|Physician Decision|0|||
143102132|NCT02929589|515914751|FG003|Overall Study|Physician Decision|0|||
143102133|NCT02091089|515914752|FG000|Overall Study|Lost to Follow-up|2|||
143102134|NCT00994461|515914761|FG000|Overall Study|Adverse Event|2|||
143102135|NCT00994461|515914762|FG001|Overall Study|Adverse Event|1|||
143102136|NCT00994461|515914763|FG002|Overall Study|Adverse Event|0|||
143102137|NCT02593097|515914775|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
143102138|NCT02593097|515914776|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
143102139|NCT02593097|515914775|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
143102140|NCT02593097|515914776|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
143102141|NCT02593097|515914775|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
143102142|NCT02593097|515914776|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
143102143|NCT02593097|515914775|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
143102144|NCT02593097|515914776|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
143102145|NCT02593097|515914775|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
143102146|NCT02593097|515914776|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
143102147|NCT00315458|515914780|FG000|Overall Study|Administrative|0|||
143102148|NCT00315458|515914781|FG001|Overall Study|Administrative|3|||
143102149|NCT00315458|515914782|FG002|Overall Study|Administrative|8|||
143102150|NCT00315458|515914783|FG003|Overall Study|Administrative|21|||
143102151|NCT00315458|515914780|FG000|Overall Study|Adverse Event|2|||
143102152|NCT00315458|515914781|FG001|Overall Study|Adverse Event|4|||
143102153|NCT00315458|515914782|FG002|Overall Study|Adverse Event|23|||
143102154|NCT00315458|515914783|FG003|Overall Study|Adverse Event|3|||
143102155|NCT00315458|515914780|FG000|Overall Study|Lost to Follow-up|1|||
143102156|NCT00315458|515914781|FG001|Overall Study|Lost to Follow-up|2|||
143102157|NCT00315458|515914782|FG002|Overall Study|Lost to Follow-up|0|||
143102158|NCT00315458|515914783|FG003|Overall Study|Lost to Follow-up|2|||
143102159|NCT00315458|515914780|FG000|Overall Study|Withdrawal by Subject|0|||
143102160|NCT00315458|515914781|FG001|Overall Study|Withdrawal by Subject|3|||
143102161|NCT00315458|515914782|FG002|Overall Study|Withdrawal by Subject|0|||
143102162|NCT00315458|515914783|FG003|Overall Study|Withdrawal by Subject|2|||
143102163|NCT00315458|515914780|FG000|Overall Study|Lack of Efficacy|0|||
143102164|NCT00315458|515914781|FG001|Overall Study|Lack of Efficacy|0|||
143102165|NCT00315458|515914782|FG002|Overall Study|Lack of Efficacy|20|||
143102166|NCT00315458|515914783|FG003|Overall Study|Lack of Efficacy|1|||
143102167|NCT00315458|515914780|FG000|Overall Study|Did not qualify|0|||
143102168|NCT00315458|515914781|FG001|Overall Study|Did not qualify|0|||
143102169|NCT00315458|515914782|FG002|Overall Study|Did not qualify|1|||
143102170|NCT00315458|515914783|FG003|Overall Study|Did not qualify|0|||
143102171|NCT00489918|515914784|FG000|Overall Study|Withdrawal by Subject|2|||
143102172|NCT00489918|515914785|FG001|Overall Study|Withdrawal by Subject|1|||
143102173|NCT00489918|515914786|FG002|Overall Study|Withdrawal by Subject|1|||
143102174|NCT00489918|515914787|FG003|Overall Study|Withdrawal by Subject|0|||
143102175|NCT00489918|515914788|FG004|Overall Study|Withdrawal by Subject|1|||
143102176|NCT00489918|515914784|FG000|Overall Study|Adverse Event|0|||
143102177|NCT00489918|515914785|FG001|Overall Study|Adverse Event|1|||
143102178|NCT00489918|515914786|FG002|Overall Study|Adverse Event|1|||
143102179|NCT00489918|515914787|FG003|Overall Study|Adverse Event|0|||
143102180|NCT00489918|515914788|FG004|Overall Study|Adverse Event|0|||
143102181|NCT00489918|515914784|FG000|Overall Study|Lost to Follow-up|0|||
143102182|NCT00489918|515914785|FG001|Overall Study|Lost to Follow-up|0|||
143102183|NCT00489918|515914786|FG002|Overall Study|Lost to Follow-up|1|||
143102184|NCT00489918|515914787|FG003|Overall Study|Lost to Follow-up|1|||
143102185|NCT00489918|515914788|FG004|Overall Study|Lost to Follow-up|0|||
143102186|NCT00489918|515914784|FG000|Overall Study|Physician Decision|0|||
143102187|NCT00489918|515914785|FG001|Overall Study|Physician Decision|0|||
143102188|NCT00489918|515914786|FG002|Overall Study|Physician Decision|1|||
143102189|NCT00489918|515914787|FG003|Overall Study|Physician Decision|0|||
143102190|NCT00489918|515914788|FG004|Overall Study|Physician Decision|0|||
143102191|NCT02748213|515914789|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
143102192|NCT02748213|515914790|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
143102193|NCT02748213|515914789|FG000|Overall Study|Abnormal Laboratory Test|1|||
143102194|NCT02748213|515914790|FG001|Overall Study|Abnormal Laboratory Test|0|||
143102195|NCT02748213|515914789|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
143102196|NCT02748213|515914790|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
143102197|NCT02748213|515914789|FG000|Overall Study|Death|5|||
143102198|NCT02748213|515914790|FG001|Overall Study|Death|3|||
143102199|NCT02748213|515914789|FG000|Overall Study|Insufficient Therapeutic Response|56|||
143102200|NCT02748213|515914790|FG001|Overall Study|Insufficient Therapeutic Response|57|||
143102201|NCT02748213|515914789|FG000|Overall Study|Violation of Selection Criteria|2|||
143102202|NCT02748213|515914790|FG001|Overall Study|Violation of Selection Criteria|0|||
143102203|NCT02748213|515914789|FG000|Overall Study|Protocol Violation|6|||
143102204|NCT02748213|515914790|FG001|Overall Study|Protocol Violation|4|||
143102205|NCT02748213|515914789|FG000|Overall Study|Refused Treatment*|6|||
143102206|NCT02748213|515914790|FG001|Overall Study|Refused Treatment*|6|||
143102207|NCT02748213|515914789|FG000|Overall Study|Failure to Return|1|||
143102208|NCT02748213|515914790|FG001|Overall Study|Failure to Return|0|||
143102209|NCT02748213|515914789|FG000|Overall Study|Other|30|||
143102210|NCT02748213|515914790|FG001|Overall Study|Other|29|||
143102211|NCT03817229|515914791|FG000|Intervention Period-Stage 1|Withdrawal by Subject|6|||
143102212|NCT03817229|515914792|FG001|Intervention Period-Stage 1|Withdrawal by Subject|8|||
143102213|NCT03817229|515914793|FG002|Intervention Period-Stage 1|Withdrawal by Subject|0|||
143102214|NCT03817229|515914794|FG003|Intervention Period-Stage 1|Withdrawal by Subject|0|||
143102215|NCT03817229|515914791|FG000|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
143102216|NCT03817229|515914792|FG001|Intervention Period-Stage 1|Withdrawn by Study Team|1|||
143102217|NCT03817229|515914793|FG002|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
143102218|NCT03817229|515914794|FG003|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
143102219|NCT03817229|515914791|FG000|Intervention Period-Stage 1|Weaned from medication|0|||
143102220|NCT03817229|515914792|FG001|Intervention Period-Stage 1|Weaned from medication|3|||
143102221|NCT03817229|515914793|FG002|Intervention Period-Stage 1|Weaned from medication|0|||
143102222|NCT03817229|515914794|FG003|Intervention Period-Stage 1|Weaned from medication|0|||
143102223|NCT03817229|515914791|FG000|Intervention Period-Stage 2|Withdrawal by Subject|1|||
143102224|NCT03817229|515914792|FG001|Intervention Period-Stage 2|Withdrawal by Subject|0|||
143102225|NCT03817229|515914793|FG002|Intervention Period-Stage 2|Withdrawal by Subject|1|||
143102226|NCT03817229|515914794|FG003|Intervention Period-Stage 2|Withdrawal by Subject|10|||
143177484|NCT03824392|516197936|FG003|Overall Study|Adverse Event|0|||
143102227|NCT03817229|515914791|FG000|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
143102228|NCT03817229|515914792|FG001|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
143102229|NCT03817229|515914793|FG002|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
143102230|NCT03817229|515914794|FG003|Intervention Period-Stage 2|Withdrawal by Study Team|3|||
143102231|NCT03817229|515914791|FG000|Intervention Period-Stage 2|Weaned from medication|0|||
143102232|NCT03817229|515914792|FG001|Intervention Period-Stage 2|Weaned from medication|0|||
143102233|NCT03817229|515914793|FG002|Intervention Period-Stage 2|Weaned from medication|0|||
143102234|NCT03817229|515914794|FG003|Intervention Period-Stage 2|Weaned from medication|1|||
143102235|NCT03817229|515914791|FG000|Post-Intervention|Withdrawal by Subject|6|||
143102236|NCT03817229|515914792|FG001|Post-Intervention|Withdrawal by Subject|0|||
143102237|NCT03817229|515914793|FG002|Post-Intervention|Withdrawal by Subject|2|||
143102238|NCT03817229|515914794|FG003|Post-Intervention|Withdrawal by Subject|2|||
143102239|NCT03817229|515914791|FG000|Post-Intervention|Withdrawal by Study Team|3|||
143102240|NCT03817229|515914792|FG001|Post-Intervention|Withdrawal by Study Team|1|||
143102241|NCT03817229|515914793|FG002|Post-Intervention|Withdrawal by Study Team|1|||
143102242|NCT03817229|515914794|FG003|Post-Intervention|Withdrawal by Study Team|4|||
143102243|NCT03817229|515914791|FG000|Post-Intervention|Weaned from medication|3|||
143102244|NCT03817229|515914792|FG001|Post-Intervention|Weaned from medication|0|||
143102245|NCT03817229|515914793|FG002|Post-Intervention|Weaned from medication|2|||
143102246|NCT03817229|515914794|FG003|Post-Intervention|Weaned from medication|1|||
143102247|NCT03817229|515914791|FG000|Post-Intervention|Transferred care to another institution|1|||
143102248|NCT03817229|515914792|FG001|Post-Intervention|Transferred care to another institution|0|||
143102249|NCT03817229|515914793|FG002|Post-Intervention|Transferred care to another institution|0|||
143102250|NCT03817229|515914794|FG003|Post-Intervention|Transferred care to another institution|0|||
143102251|NCT03817229|515914791|FG000|Post-Intervention|Change in parental guardianship|0|||
143102252|NCT03817229|515914792|FG001|Post-Intervention|Change in parental guardianship|0|||
143102253|NCT03817229|515914793|FG002|Post-Intervention|Change in parental guardianship|1|||
143102254|NCT03817229|515914794|FG003|Post-Intervention|Change in parental guardianship|0|||
143102255|NCT03817229|515914791|FG000|Follow-up 1|Ineligible for this follow-up visit due to study timing|7|||
143102256|NCT03817229|515914792|FG001|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
143102257|NCT03817229|515914793|FG002|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
143102258|NCT03817229|515914794|FG003|Follow-up 1|Ineligible for this follow-up visit due to study timing|3|||
143102259|NCT03817229|515914791|FG000|Follow-up 1|Withdrawal by Subject|1|||
143102260|NCT03817229|515914792|FG001|Follow-up 1|Withdrawal by Subject|2|||
143102261|NCT03817229|515914793|FG002|Follow-up 1|Withdrawal by Subject|0|||
143102262|NCT03817229|515914794|FG003|Follow-up 1|Withdrawal by Subject|0|||
143102263|NCT03817229|515914791|FG000|Follow-up 1|Withdrawal by Study Team|3|||
143102264|NCT03817229|515914792|FG001|Follow-up 1|Withdrawal by Study Team|1|||
143102265|NCT03817229|515914793|FG002|Follow-up 1|Withdrawal by Study Team|0|||
143102266|NCT03817229|515914794|FG003|Follow-up 1|Withdrawal by Study Team|0|||
143102267|NCT03817229|515914791|FG000|Follow-up 1|Wean from medication|3|||
143102268|NCT03817229|515914792|FG001|Follow-up 1|Wean from medication|4|||
143102269|NCT03817229|515914793|FG002|Follow-up 1|Wean from medication|0|||
143102270|NCT03817229|515914794|FG003|Follow-up 1|Wean from medication|1|||
143102271|NCT03817229|515914791|FG000|Follow-up 1|Transferred care to another hospital|1|||
143102272|NCT03817229|515914792|FG001|Follow-up 1|Transferred care to another hospital|0|||
143177485|NCT03824392|516197933|FG000|Overall Study|Investigator Decision|0|||
143177486|NCT03824392|516197934|FG001|Overall Study|Investigator Decision|1|||
143177487|NCT03824392|516197935|FG002|Overall Study|Investigator Decision|0|||
143177488|NCT03824392|516197936|FG003|Overall Study|Investigator Decision|0|||
143177489|NCT03824392|516197933|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
143177490|NCT03824392|516197934|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
143177491|NCT03824392|516197935|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
143252131|NCT00717236|516476419|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
143252132|NCT00717236|516476418|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
143252133|NCT00717236|516476419|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
143252134|NCT00717236|516476418|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
143252135|NCT00717236|516476419|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
143252136|NCT00717236|516476418|FG000|Double-Blind Period|Other: History of cancer|1|||
143252137|NCT00717236|516476419|FG001|Double-Blind Period|Other: History of cancer|0|||
143252138|NCT00717236|516476418|FG000|Double-Blind Period|Other: Sponsor request|1|||
143102273|NCT03817229|515914793|FG002|Follow-up 1|Transferred care to another hospital|0|||
143102274|NCT03817229|515914794|FG003|Follow-up 1|Transferred care to another hospital|0|||
143102275|NCT03817229|515914791|FG000|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
143102276|NCT03817229|515914792|FG001|Follow-up 2|Ineligible for this follow-up visit due to study timing|3|||
143252139|NCT00717236|516476419|FG001|Double-Blind Period|Other: Sponsor request|0|||
143252140|NCT00717236|516476418|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
143252141|NCT00717236|516476419|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
143252142|NCT00717236|516476418|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
143102277|NCT03817229|515914793|FG002|Follow-up 2|Ineligible for this follow-up visit due to study timing|1|||
143102278|NCT03817229|515914794|FG003|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
143102279|NCT03817229|515914791|FG000|Follow-up 2|Withdrawal by Subject|2|||
143102280|NCT03817229|515914792|FG001|Follow-up 2|Withdrawal by Subject|0|||
143102281|NCT03817229|515914793|FG002|Follow-up 2|Withdrawal by Subject|1|||
143102282|NCT03817229|515914794|FG003|Follow-up 2|Withdrawal by Subject|1|||
143102283|NCT03817229|515914791|FG000|Follow-up 2|Withdrawal by Study Team|2|||
143102284|NCT03817229|515914792|FG001|Follow-up 2|Withdrawal by Study Team|0|||
143102285|NCT03817229|515914793|FG002|Follow-up 2|Withdrawal by Study Team|1|||
143102286|NCT03817229|515914794|FG003|Follow-up 2|Withdrawal by Study Team|0|||
143102287|NCT03817229|515914791|FG000|Follow-up 2|Wean from medication|1|||
143252143|NCT00717236|516476419|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
143102288|NCT03817229|515914792|FG001|Follow-up 2|Wean from medication|0|||
143102289|NCT03817229|515914793|FG002|Follow-up 2|Wean from medication|0|||
143102290|NCT03817229|515914794|FG003|Follow-up 2|Wean from medication|0|||
143102291|NCT03817229|515914791|FG000|Follow-up 2|Transferred care|0|||
143102292|NCT03817229|515914792|FG001|Follow-up 2|Transferred care|0|||
143102293|NCT03817229|515914793|FG002|Follow-up 2|Transferred care|1|||
143102294|NCT03817229|515914794|FG003|Follow-up 2|Transferred care|0|||
143102295|NCT01209520|515914795|FG000|Overall Study|Withdrawal by Subject|3|||
143102296|NCT01760655|515916380|FG000|Overall Study|Death|18|||
143102297|NCT01760655|515916380|FG000|Overall Study|Physician Decision|1|||
143102298|NCT01108341|515916382|FG000|Overall Study|Death|2|||
143102299|NCT01108341|515916382|FG000|Overall Study|Withdrawal by Subject|1|||
143102300|NCT01108341|515916382|FG000|Overall Study|Lost to Follow-up|1|||
143102301|NCT01108341|515916382|FG000|Overall Study|Other|1|||
143102302|NCT04402138|515916383|FG000|Overall Study|Progressive Disease|2|||
143252144|NCT00717236|516476418|FG000|Double-Blind Period|Other: Subject moved|1|||
143252145|NCT00717236|516476419|FG001|Double-Blind Period|Other: Subject moved|1|||
143252146|NCT00717236|516476418|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
143252147|NCT00717236|516476419|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
143102303|NCT04402138|515916383|FG000|Overall Study|Adverse Event|1|||
143102304|NCT04390503|515916385|FG000|Overall Study|Physician Decision|2|||
143102305|NCT04390503|515916386|FG001|Overall Study|Physician Decision|1|||
143102306|NCT04390503|515916385|FG000|Overall Study|Adverse Event|1|||
143102307|NCT04390503|515916386|FG001|Overall Study|Adverse Event|0|||
143102308|NCT01637922|515916388|FG000|Overall Study|Adverse Event|0|||
143102309|NCT01637922|515916389|FG001|Overall Study|Adverse Event|1|||
143102310|NCT01637922|515916388|FG000|Overall Study|Protocol Violation|0|||
143102311|NCT01637922|515916389|FG001|Overall Study|Protocol Violation|1|||
143102312|NCT01637922|515916388|FG000|Overall Study|Withdrawal by Subject|0|||
143102313|NCT01637922|515916389|FG001|Overall Study|Withdrawal by Subject|3|||
143102314|NCT01637922|515916388|FG000|Overall Study|Lost to Follow-up|2|||
143102315|NCT01637922|515916389|FG001|Overall Study|Lost to Follow-up|0|||
143102316|NCT03508726|515916390|FG000|Overall Study|Withdrawal by Subject|0|||
143102317|NCT03508726|515916391|FG001|Overall Study|Withdrawal by Subject|1|||
143252148|NCT00717236|516476418|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
143252149|NCT00717236|516476419|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
143252150|NCT00717236|516476418|FG000|Double-Blind Period|Other: Transportation problems|0|||
143102318|NCT01841762|515916392|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
143102319|NCT01841762|515916392|FG000|Treatment Period|Adverse Event|16|||
143102320|NCT01841762|515916392|FG000|Treatment Period|Death|1|||
143102321|NCT01841762|515916392|FG000|Treatment Period|Withdrawal by Subject|7|||
143102322|NCT01841762|515916392|FG000|Treatment Period|Lost to Follow-up|1|||
143252151|NCT00717236|516476419|FG001|Double-Blind Period|Other: Transportation problems|1|||
143102323|NCT01841762|515916392|FG000|Treatment Period|Physician Decision|2|||
143102324|NCT01841762|515916392|FG000|Treatment Period|Other, including non-compliance|5|||
143252152|NCT00717236|516476418|FG000|Double-Blind Period|Other: Investigator Decision|0|||
143102325|NCT01841762|515916392|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
143102326|NCT01841762|515916392|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
143102327|NCT01841762|515916392|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
143102328|NCT01841762|515916392|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
143102329|NCT01270464|515916393|FG000|Overall Study|Protocol Violation|4|||
143102330|NCT01270464|515916394|FG001|Overall Study|Protocol Violation|3|||
143102331|NCT01270464|515916395|FG002|Overall Study|Protocol Violation|2|||
143102332|NCT01270464|515916393|FG000|Overall Study|Lack of Efficacy|2|||
143102333|NCT01270464|515916394|FG001|Overall Study|Lack of Efficacy|3|||
143102334|NCT01270464|515916395|FG002|Overall Study|Lack of Efficacy|1|||
143102335|NCT01270464|515916393|FG000|Overall Study|Adverse Event|9|||
143102336|NCT01270464|515916394|FG001|Overall Study|Adverse Event|1|||
143102337|NCT01270464|515916395|FG002|Overall Study|Adverse Event|7|||
143102338|NCT01270464|515916393|FG000|Overall Study|Withdrawal by Subject|2|||
143102339|NCT01270464|515916394|FG001|Overall Study|Withdrawal by Subject|1|||
143102340|NCT01270464|515916395|FG002|Overall Study|Withdrawal by Subject|4|||
143102341|NCT01270464|515916393|FG000|Overall Study|Lost to Follow-up|2|||
143102342|NCT01270464|515916394|FG001|Overall Study|Lost to Follow-up|3|||
143102343|NCT01270464|515916395|FG002|Overall Study|Lost to Follow-up|1|||
143102344|NCT01270464|515916393|FG000|Overall Study|Other|1|||
143102345|NCT01270464|515916394|FG001|Overall Study|Other|1|||
143102346|NCT01270464|515916395|FG002|Overall Study|Other|3|||
143102347|NCT02448537|515916396|FG000|Overall Study|Withdrawal by Subject|1|||
143102348|NCT02448537|515916397|FG001|Overall Study|Withdrawal by Subject|1|||
143102349|NCT02448537|515916398|FG002|Overall Study|Withdrawal by Subject|1|||
143102350|NCT03981900|515916400|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
143177492|NCT03824392|516197936|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
143177493|NCT00800982|516197944|FG000|Overall Study|Lost to Follow-up|1|||
143177494|NCT00800982|516197945|FG001|Overall Study|Lost to Follow-up|2|||
143102351|NCT03981900|515916400|FG000|Overall Study|Adverse Event|5|||
143102352|NCT03981900|515916400|FG000|Overall Study|Protocol Violation|1|||
143102353|NCT03981900|515916400|FG000|Overall Study|Withdrawal by Subject|7|||
143102354|NCT03981900|515916400|FG000|Overall Study|Lost to Follow-up|46|||
143102355|NCT03981900|515916400|FG000|Overall Study|Decision of the researcher|3|||
143102356|NCT03981900|515916400|FG000|Overall Study|Death|3|||
143102357|NCT03981900|515916400|FG000|Overall Study|Other|5|||
143102358|NCT05656534|515916404|FG000|Overall Study|Withdrawal by Subject|1|||
143102359|NCT05656534|515916405|FG001|Overall Study|Withdrawal by Subject|1|||
143102360|NCT05656534|515916406|FG002|Overall Study|Withdrawal by Subject|0|||
143102361|NCT05656534|515916407|FG003|Overall Study|Withdrawal by Subject|0|||
143102362|NCT05656534|515916404|FG000|Overall Study|Physician Decision|1|||
143102363|NCT05656534|515916405|FG001|Overall Study|Physician Decision|1|||
143102364|NCT05656534|515916406|FG002|Overall Study|Physician Decision|0|||
143102365|NCT05656534|515916407|FG003|Overall Study|Physician Decision|0|||
143102366|NCT02509507|515916411|FG000|Overall Study|Death|21|||
143102367|NCT02509507|515916412|FG001|Overall Study|Death|3|||
143102368|NCT02509507|515916413|FG002|Overall Study|Death|22|||
143102369|NCT02509507|515916414|FG003|Overall Study|Death|14|||
143102370|NCT02509507|515916415|FG004|Overall Study|Death|8|||
143102371|NCT02509507|515916416|FG005|Overall Study|Death|12|||
143102372|NCT02509507|515916417|FG006|Overall Study|Death|5|||
143102373|NCT02509507|515916418|FG007|Overall Study|Death|4|||
143102374|NCT02509507|515916419|FG008|Overall Study|Death|8|||
143102375|NCT02509507|515916411|FG000|Overall Study|Lost to Follow-up|0|||
143102376|NCT02509507|515916412|FG001|Overall Study|Lost to Follow-up|1|||
143102377|NCT02509507|515916413|FG002|Overall Study|Lost to Follow-up|0|||
143102378|NCT02509507|515916414|FG003|Overall Study|Lost to Follow-up|0|||
143102379|NCT02509507|515916415|FG004|Overall Study|Lost to Follow-up|0|||
143102380|NCT02509507|515916416|FG005|Overall Study|Lost to Follow-up|2|||
143102381|NCT02509507|515916417|FG006|Overall Study|Lost to Follow-up|0|||
143102382|NCT02509507|515916418|FG007|Overall Study|Lost to Follow-up|0|||
143102383|NCT02509507|515916419|FG008|Overall Study|Lost to Follow-up|0|||
143102384|NCT02509507|515916411|FG000|Overall Study|Withdrawal by Subject|2|||
143102385|NCT02509507|515916412|FG001|Overall Study|Withdrawal by Subject|0|||
143102386|NCT02509507|515916413|FG002|Overall Study|Withdrawal by Subject|1|||
143102387|NCT02509507|515916414|FG003|Overall Study|Withdrawal by Subject|4|||
143102388|NCT02509507|515916415|FG004|Overall Study|Withdrawal by Subject|1|||
143102389|NCT02509507|515916416|FG005|Overall Study|Withdrawal by Subject|3|||
143102390|NCT02509507|515916417|FG006|Overall Study|Withdrawal by Subject|4|||
143102391|NCT02509507|515916418|FG007|Overall Study|Withdrawal by Subject|0|||
143102392|NCT02509507|515916419|FG008|Overall Study|Withdrawal by Subject|1|||
143102393|NCT02490371|515916423|FG000|Overall Study|Lost to Follow-up|1|||
143102394|NCT02490371|515916424|FG001|Overall Study|Lost to Follow-up|1|||
143102395|NCT01163851|515916427|FG000|Overall Study|Site Closure|0|||
143102396|NCT01163851|515916428|FG001|Overall Study|Site Closure|1|||
143102397|NCT01163851|515916427|FG000|Overall Study|Enrolled but not treated|1|||
143102398|NCT01163851|515916428|FG001|Overall Study|Enrolled but not treated|0|||
143102399|NCT00740792|515916429|FG000|Overall Study|Adverse Event|3|||
143102400|NCT00740792|515916430|FG001|Overall Study|Adverse Event|1|||
143102401|NCT00740792|515916431|FG002|Overall Study|Adverse Event|1|||
143102402|NCT00740792|515916432|FG003|Overall Study|Adverse Event|3|||
143102403|NCT00740792|515916429|FG000|Overall Study|Lack of Efficacy|1|||
143102404|NCT00740792|515916430|FG001|Overall Study|Lack of Efficacy|1|||
143102405|NCT00740792|515916431|FG002|Overall Study|Lack of Efficacy|0|||
143102406|NCT00740792|515916432|FG003|Overall Study|Lack of Efficacy|3|||
143102407|NCT00740792|515916429|FG000|Overall Study|Lost to Follow-up|2|||
143102408|NCT00740792|515916430|FG001|Overall Study|Lost to Follow-up|1|||
143102409|NCT00740792|515916431|FG002|Overall Study|Lost to Follow-up|0|||
143367760|NCT01143077|516889437|FG000|Overall Study|Non-compliance with study drug|0|||
143102410|NCT00740792|515916432|FG003|Overall Study|Lost to Follow-up|0|||
143102411|NCT00740792|515916429|FG000|Overall Study|Protocol Violation|0|||
143102412|NCT00740792|515916430|FG001|Overall Study|Protocol Violation|1|||
143102413|NCT00740792|515916431|FG002|Overall Study|Protocol Violation|0|||
143102414|NCT00740792|515916432|FG003|Overall Study|Protocol Violation|2|||
143102415|NCT00740792|515916429|FG000|Overall Study|Withdrawal by Subject|1|||
143102416|NCT00740792|515916430|FG001|Overall Study|Withdrawal by Subject|1|||
143102417|NCT00740792|515916431|FG002|Overall Study|Withdrawal by Subject|0|||
143102418|NCT00740792|515916432|FG003|Overall Study|Withdrawal by Subject|0|||
143102419|NCT00740792|515916429|FG000|Overall Study|administrative|3|||
143102420|NCT00740792|515916430|FG001|Overall Study|administrative|3|||
143102421|NCT00740792|515916431|FG002|Overall Study|administrative|8|||
143102422|NCT00740792|515916432|FG003|Overall Study|administrative|2|||
143102423|NCT00912743|515916435|FG000|Overall Study|Adverse Event|3|||
143102424|NCT00912743|515916436|FG001|Overall Study|Adverse Event|1|||
143177495|NCT00800982|516197944|FG000|Overall Study|Withdrawal by Subject|0|||
143177496|NCT00800982|516197945|FG001|Overall Study|Withdrawal by Subject|1|||
143177497|NCT00800982|516197944|FG000|Overall Study|Patient moved out of state|1|||
143177498|NCT00800982|516197945|FG001|Overall Study|Patient moved out of state|0|||
143177499|NCT03092479|516197953|FG000|Overall Study|Lost to Follow-up|3|||
143177500|NCT03092479|516197954|FG001|Overall Study|Lost to Follow-up|2|||
143177501|NCT03092479|516197953|FG000|Overall Study|Withdrawal by Subject|4|||
143177502|NCT03092479|516197954|FG001|Overall Study|Withdrawal by Subject|0|||
143177503|NCT03913130|516197957|FG000|Overall Study|Sponsor Decision|1|||
143102425|NCT00912743|515916435|FG000|Overall Study|Lack of Efficacy|9|||
143102426|NCT00912743|515916436|FG001|Overall Study|Lack of Efficacy|18|||
143102427|NCT00912743|515916435|FG000|Overall Study|Toxicity|0|||
143102428|NCT00912743|515916436|FG001|Overall Study|Toxicity|1|||
143102429|NCT00912743|515916435|FG000|Overall Study|End of treatment form was not collected|1|||
143102430|NCT00912743|515916436|FG001|Overall Study|End of treatment form was not collected|0|||
143102431|NCT00179660|515916446|FG000|Overall Study|Adverse Event|7|||
143102432|NCT00179660|515916446|FG000|Overall Study|Lack of therapeutic effect|28|||
143102433|NCT00179660|515916446|FG000|Overall Study|Withdrawal by Subject|2|||
143102434|NCT00179660|515916446|FG000|Overall Study|Lost to Follow-up|1|||
143102435|NCT00179660|515916446|FG000|Overall Study|Death|3|||
143102436|NCT00179660|515916446|FG000|Overall Study|Other - Unspecified|9|||
143252153|NCT00717236|516476419|FG001|Double-Blind Period|Other: Investigator Decision|1|||
143252154|NCT00717236|516476418|FG000|Open-Label Period|Adverse Event|29|||
143252155|NCT00717236|516476419|FG001|Open-Label Period|Adverse Event|4|||
143102437|NCT00178685|515916449|FG000|Overall Study|Death|3|||
143102438|NCT00178685|515916450|FG001|Overall Study|Death|3|||
143102439|NCT00178685|515916451|FG002|Overall Study|Death|6|||
143102440|NCT00178685|515916449|FG000|Overall Study|Lost to Follow-up|100|||
143102441|NCT00178685|515916450|FG001|Overall Study|Lost to Follow-up|187|||
143102442|NCT00178685|515916451|FG002|Overall Study|Lost to Follow-up|183|||
143102443|NCT00178685|515916449|FG000|Overall Study|Withdrawal by Subject|8|||
143102444|NCT00178685|515916450|FG001|Overall Study|Withdrawal by Subject|14|||
143102445|NCT00178685|515916451|FG002|Overall Study|Withdrawal by Subject|7|||
143102446|NCT04112043|515916452|FG000|Overall Study|Withdrawal by Subject|1|||
143102447|NCT04112043|515916453|FG001|Overall Study|Withdrawal by Subject|1|||
143102448|NCT04112043|515916454|FG002|Overall Study|Withdrawal by Subject|1|||
143102449|NCT04112043|515916452|FG000|Overall Study|Taking NR supplement|1|||
143102450|NCT04112043|515916453|FG001|Overall Study|Taking NR supplement|0|||
143102451|NCT04112043|515916454|FG002|Overall Study|Taking NR supplement|0|||
143102452|NCT04112043|515916452|FG000|Overall Study|Adverse Event|0|||
143102453|NCT04112043|515916453|FG001|Overall Study|Adverse Event|1|||
143102454|NCT04112043|515916454|FG002|Overall Study|Adverse Event|0|||
143102455|NCT04075682|515916457|FG000|Overall Study|Lost to Follow-up|5|||
143102456|NCT04075682|515916458|FG001|Overall Study|Lost to Follow-up|5|||
143102457|NCT04075682|515916459|FG002|Overall Study|Lost to Follow-up|2|||
143102458|NCT04075682|515916460|FG003|Overall Study|Lost to Follow-up|2|||
143102459|NCT04075682|515916457|FG000|Overall Study|Withdrawal by Subject|1|||
143102460|NCT04075682|515916458|FG001|Overall Study|Withdrawal by Subject|0|||
143102461|NCT04075682|515916459|FG002|Overall Study|Withdrawal by Subject|1|||
143102462|NCT04075682|515916460|FG003|Overall Study|Withdrawal by Subject|0|||
143102463|NCT04075682|515916457|FG000|Overall Study|Protocol Violation|0|||
143102464|NCT04075682|515916458|FG001|Overall Study|Protocol Violation|1|||
143252156|NCT00717236|516476418|FG000|Open-Label Period|Lack of Efficacy|30|||
143252157|NCT00717236|516476419|FG001|Open-Label Period|Lack of Efficacy|8|||
143252158|NCT00717236|516476418|FG000|Open-Label Period|Lost to Follow-up|28|||
143252159|NCT00717236|516476419|FG001|Open-Label Period|Lost to Follow-up|4|||
143252160|NCT00717236|516476418|FG000|Open-Label Period|Withdrawal by Subject|20|||
143252161|NCT00717236|516476419|FG001|Open-Label Period|Withdrawal by Subject|2|||
143252162|NCT00717236|516476418|FG000|Open-Label Period|Loss of Efficacy|6|||
143252163|NCT00717236|516476419|FG001|Open-Label Period|Loss of Efficacy|1|||
143252164|NCT00717236|516476418|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
143252165|NCT00717236|516476419|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
143252166|NCT00717236|516476418|FG000|Open-Label Period|Other: Lack of Compliance|1|||
143252167|NCT00717236|516476419|FG001|Open-Label Period|Other: Lack of Compliance|1|||
143252168|NCT00717236|516476418|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
143252169|NCT00717236|516476419|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
143102465|NCT04075682|515916459|FG002|Overall Study|Protocol Violation|1|||
143102466|NCT04075682|515916460|FG003|Overall Study|Protocol Violation|0|||
143102467|NCT04075682|515916457|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
143102468|NCT04075682|515916458|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
143102469|NCT04075682|515916459|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
143102470|NCT04075682|515916460|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
143102471|NCT04075682|515916457|FG000|Overall Study|Lost study phone the first day of study participation|0|||
143117370|NCT01313221|515971826|FG000|Overall Study|Withdrawal by Subject|2|||
143252170|NCT00717236|516476418|FG000|Open-Label Period|Other: Moved|1|||
143252171|NCT00717236|516476419|FG001|Open-Label Period|Other: Moved|0|||
143102472|NCT04075682|515916458|FG001|Overall Study|Lost study phone the first day of study participation|1|||
143102473|NCT04075682|515916459|FG002|Overall Study|Lost study phone the first day of study participation|0|||
143102474|NCT04075682|515916460|FG003|Overall Study|Lost study phone the first day of study participation|0|||
143102475|NCT00955955|515916461|FG000|Overall Study|Lost to Follow-up|2|||
143252172|NCT00717236|516476418|FG000|Open-Label Period|Other: Investigator Decision|1|||
143252173|NCT00717236|516476419|FG001|Open-Label Period|Other: Investigator Decision|0|||
143252174|NCT00717236|516476418|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
143252175|NCT00717236|516476419|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
143252176|NCT00717236|516476418|FG000|Open-Label Period|Other: Sponsor Request|3|||
143102476|NCT00955955|515916462|FG001|Overall Study|Lost to Follow-up|0|||
143102477|NCT00955955|515916463|FG002|Overall Study|Lost to Follow-up|0|||
143102478|NCT00708214|515916464|FG000|Overall Study|Other Adverse Event|3|||
143102479|NCT00708214|515916465|FG001|Overall Study|Other Adverse Event|6|||
143102480|NCT00708214|515916466|FG002|Overall Study|Other Adverse Event|2|||
143102481|NCT00708214|515916464|FG000|Overall Study|Other|0|||
143102482|NCT00708214|515916465|FG001|Overall Study|Other|1|||
143102483|NCT00708214|515916466|FG002|Overall Study|Other|1|||
143102484|NCT00708214|515916464|FG000|Overall Study|Progressive Disease|4|||
143102485|NCT00708214|515916465|FG001|Overall Study|Progressive Disease|6|||
143102486|NCT00708214|515916466|FG002|Overall Study|Progressive Disease|5|||
143102487|NCT03533114|515916467|FG000|Overall|Adverse Event|16|||
143102488|NCT03533114|515916468|FG001|Overall|Adverse Event|11|||
143102489|NCT03533114|515916467|FG000|Overall|Consent Withdrawal by Participant|7|||
143102490|NCT03533114|515916468|FG001|Overall|Consent Withdrawal by Participant|6|||
143102491|NCT03533114|515916467|FG000|Overall|Lack of Efficacy|5|||
143102492|NCT03533114|515916468|FG001|Overall|Lack of Efficacy|3|||
143102493|NCT03533114|515916467|FG000|Overall|Lost to Follow-up|1|||
143102494|NCT03533114|515916468|FG001|Overall|Lost to Follow-up|1|||
143102495|NCT03533114|515916467|FG000|Overall|Physician Decision|0|||
143102496|NCT03533114|515916468|FG001|Overall|Physician Decision|2|||
143102497|NCT03533114|515916467|FG000|Overall|Protocol deviation|1|||
143102498|NCT03533114|515916468|FG001|Overall|Protocol deviation|1|||
143102499|NCT03533114|515916467|FG000|Overall|Failure to meet randomization criteria|1|||
143102500|NCT03533114|515916468|FG001|Overall|Failure to meet randomization criteria|2|||
143102501|NCT03533114|515916467|FG000|Overall|Non-Compliance with study drug|0|||
143102502|NCT03533114|515916468|FG001|Overall|Non-Compliance with study drug|1|||
143102503|NCT03533114|515916467|FG000|Overall|Other|0|||
143102504|NCT03533114|515916468|FG001|Overall|Other|1|||
143102505|NCT03533114|515916467|FG000|Open Label Titration and Optimization|Adverse Event|11|||
143102506|NCT03533114|515916468|FG001|Open Label Titration and Optimization|Adverse Event|8|||
143102507|NCT03533114|515916467|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
143102508|NCT03533114|515916468|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
143102509|NCT03533114|515916467|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
143102510|NCT03533114|515916468|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
143102511|NCT03533114|515916467|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
143102512|NCT03533114|515916468|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
143102513|NCT03533114|515916467|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
143102514|NCT03533114|515916468|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
143102515|NCT03533114|515916467|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
143102516|NCT03533114|515916468|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
143102517|NCT03533114|515916467|FG000|Stable Dose|Adverse Event|0|||
143102518|NCT03533114|515916468|FG001|Stable Dose|Adverse Event|2|||
143102519|NCT03533114|515916467|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
143102520|NCT03533114|515916468|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
143102521|NCT03533114|515916467|FG000|Stable Dose|Lack of Efficacy|1|||
143102522|NCT03533114|515916468|FG001|Stable Dose|Lack of Efficacy|0|||
143102523|NCT03533114|515916467|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
143102524|NCT03533114|515916468|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
143102525|NCT03533114|515916467|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
143102526|NCT03533114|515916468|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
143102527|NCT03533114|515916467|FG000|Open-Label Safety Extension|Adverse Event|3|||
143102528|NCT03533114|515916468|FG001|Open-Label Safety Extension|Adverse Event|0|||
143102529|NCT03533114|515916467|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
143102530|NCT03533114|515916468|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
143252177|NCT00717236|516476419|FG001|Open-Label Period|Other: Sponsor Request|0|||
143102531|NCT03533114|515916467|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
143102532|NCT03533114|515916468|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
143102533|NCT03533114|515916467|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
143102534|NCT03533114|515916468|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
143102535|NCT03533114|515916467|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
143102536|NCT03533114|515916468|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
143102537|NCT03852264|515916469|FG000|Third Research Visit|Lost to Follow-up|1|||
143102538|NCT03852264|515916470|FG001|Third Research Visit|Lost to Follow-up|0|||
143102539|NCT02016105|515916471|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
143102540|NCT02016105|515916472|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
143102541|NCT02016105|515916473|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
143252178|NCT00717236|516476418|FG000|Open-Label Period|Other: Cataract Surgery|1|||
143004007|NCT01241591|515553053|FG002|Overall Study|Lost to Follow-up|2|||
143177504|NCT00444106|516197962|FG000|Overall Study|Lost to Follow-up|2|||
143177505|NCT00444106|516197963|FG001|Overall Study|Lost to Follow-up|1|||
143177506|NCT00444106|516197964|FG002|Overall Study|Lost to Follow-up|0|||
143177507|NCT00444106|516197962|FG000|Overall Study|Abnormal Test Procedure Results|0|||
143177508|NCT00444106|516197963|FG001|Overall Study|Abnormal Test Procedure Results|0|||
143177509|NCT00444106|516197964|FG002|Overall Study|Abnormal Test Procedure Results|1|||
143177510|NCT01085214|516197965|FG000|Overall Study|Alternate treatment required|1|||
143177511|NCT01634152|516197979|FG000|Overall Study|Adverse Event|2|||
143177512|NCT01634152|516197980|FG001|Overall Study|Adverse Event|0|||
143177513|NCT01634152|516197981|FG002|Overall Study|Adverse Event|2|||
143177514|NCT01634152|516197979|FG000|Overall Study|Consent withdrawn not due to AE|1|||
143177515|NCT01634152|516197980|FG001|Overall Study|Consent withdrawn not due to AE|0|||
143177516|NCT01634152|516197981|FG002|Overall Study|Consent withdrawn not due to AE|1|||
143177517|NCT01634152|516197979|FG000|Overall Study|Not treated|0|||
143177518|NCT01634152|516197980|FG001|Overall Study|Not treated|1|||
143177519|NCT01634152|516197981|FG002|Overall Study|Not treated|0|||
143177520|NCT01634152|516197979|FG000|Overall Study|Other reason not defined above|1|||
143177521|NCT01634152|516197980|FG001|Overall Study|Other reason not defined above|0|||
143177522|NCT01634152|516197981|FG002|Overall Study|Other reason not defined above|1|||
143177523|NCT04046939|516197982|FG000|Primary Assessment Period|Adverse Event|1|||
143177524|NCT04046939|516197983|FG001|Primary Assessment Period|Adverse Event|0|||
143177525|NCT04046939|516197984|FG002|Primary Assessment Period|Adverse Event|0|||
143177526|NCT04046939|516197985|FG003|Primary Assessment Period|Adverse Event|0|||
143177527|NCT04046939|516197982|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
143177528|NCT04046939|516197983|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
143177529|NCT04046939|516197984|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
143177530|NCT04046939|516197985|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
143177531|NCT04046939|516197982|FG000|Primary Assessment Period|Physician Decision|0|||
143177532|NCT04046939|516197983|FG001|Primary Assessment Period|Physician Decision|0|||
143177533|NCT04046939|516197984|FG002|Primary Assessment Period|Physician Decision|1|||
143177534|NCT04046939|516197985|FG003|Primary Assessment Period|Physician Decision|0|||
143177535|NCT04046939|516197982|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
143177536|NCT04046939|516197983|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
143177537|NCT04046939|516197984|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
143177538|NCT04046939|516197985|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
143177539|NCT00403130|516197986|FG000|2 Years From Start of Treatment|Not Eligible|3|||
143177540|NCT00403130|516197986|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
143177541|NCT00403130|516197986|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
143177542|NCT00403130|516197986|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
143177543|NCT00806260|516197987|FG000|Period 1 (1 Day)|Adverse Event|0|||
143177544|NCT00806260|516197988|FG001|Period 1 (1 Day)|Adverse Event|0|||
143177545|NCT00806260|516197989|FG002|Period 1 (1 Day)|Adverse Event|0|||
143367761|NCT01143077|516889438|FG001|Overall Study|Non-compliance with study drug|1|||
143367762|NCT01143077|516889439|FG002|Overall Study|Non-compliance with study drug|1|||
143102542|NCT02016105|515916474|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
143102543|NCT02016105|515916475|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
143102544|NCT02016105|515916476|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
143102545|NCT02016105|515916471|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
143102546|NCT02016105|515916472|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
143102547|NCT02016105|515916473|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
143102548|NCT02016105|515916474|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
143102549|NCT02016105|515916475|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
143102550|NCT02016105|515916476|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
143102551|NCT02016105|515916471|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
143102552|NCT02016105|515916472|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
143102553|NCT02016105|515916473|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
143102554|NCT02016105|515916474|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
143102555|NCT02016105|515916475|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
143102556|NCT02016105|515916476|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
143102557|NCT02016105|515916471|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
143102558|NCT02016105|515916472|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
143102559|NCT02016105|515916473|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
143102560|NCT02016105|515916474|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
143102561|NCT02016105|515916475|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
143102562|NCT02016105|515916476|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
143102563|NCT02016105|515916471|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
143102564|NCT02016105|515916472|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
143102565|NCT02016105|515916473|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
143102566|NCT02016105|515916474|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
143102567|NCT02016105|515916475|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
143102568|NCT02016105|515916476|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
143102569|NCT02016105|515916471|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
143102570|NCT02016105|515916472|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
143102571|NCT02016105|515916473|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
143102572|NCT02016105|515916474|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
143102573|NCT02016105|515916475|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
143102574|NCT02016105|515916476|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
143177546|NCT00806260|516197990|FG003|Period 1 (1 Day)|Adverse Event|0|||
143177547|NCT00806260|516197991|FG004|Period 1 (1 Day)|Adverse Event|3|||
143177548|NCT00806260|516197992|FG005|Period 1 (1 Day)|Adverse Event|0|||
143177549|NCT00806260|516197987|FG000|Period 2|Adverse Event|0|||
143177550|NCT00806260|516197988|FG001|Period 2|Adverse Event|0|||
143177551|NCT00806260|516197989|FG002|Period 2|Adverse Event|0|||
143177552|NCT00806260|516197990|FG003|Period 2|Adverse Event|1|||
143177553|NCT00806260|516197991|FG004|Period 2|Adverse Event|0|||
143177554|NCT00806260|516197992|FG005|Period 2|Adverse Event|0|||
143177555|NCT00806260|516197987|FG000|Period 2|Protocol Violation|1|||
143177556|NCT00806260|516197988|FG001|Period 2|Protocol Violation|0|||
143177557|NCT00806260|516197989|FG002|Period 2|Protocol Violation|1|||
143177558|NCT00806260|516197990|FG003|Period 2|Protocol Violation|0|||
143004008|NCT01241591|515553054|FG003|Overall Study|Lost to Follow-up|2|||
143177559|NCT00806260|516197991|FG004|Period 2|Protocol Violation|0|||
143177560|NCT00806260|516197992|FG005|Period 2|Protocol Violation|0|||
143177561|NCT00806260|516197987|FG000|Period 2|Need to take concomitant medication|1|||
143004009|NCT01241591|515553051|FG000|Overall Study|Screen Failure|3|||
143177562|NCT00806260|516197988|FG001|Period 2|Need to take concomitant medication|0|||
143177563|NCT00806260|516197989|FG002|Period 2|Need to take concomitant medication|0|||
143177564|NCT00806260|516197990|FG003|Period 2|Need to take concomitant medication|0|||
143177565|NCT00806260|516197991|FG004|Period 2|Need to take concomitant medication|0|||
143004010|NCT01241591|515553052|FG001|Overall Study|Screen Failure|2|||
143004011|NCT01241591|515553053|FG002|Overall Study|Screen Failure|1|||
143004012|NCT01241591|515553054|FG003|Overall Study|Screen Failure|0|||
143004013|NCT01241591|515553051|FG000|Overall Study|Withdrawal by Subject|6|||
143004014|NCT01241591|515553052|FG001|Overall Study|Withdrawal by Subject|4|||
143004015|NCT01241591|515553053|FG002|Overall Study|Withdrawal by Subject|2|||
143004016|NCT01241591|515553054|FG003|Overall Study|Withdrawal by Subject|2|||
143004017|NCT01241591|515553051|FG000|Overall Study|Other|0|||
143004018|NCT01241591|515553052|FG001|Overall Study|Other|1|||
143004019|NCT01241591|515553053|FG002|Overall Study|Other|0|||
143004020|NCT01241591|515553054|FG003|Overall Study|Other|1|||
143004021|NCT01241591|515553051|FG000|Overall Study|Adverse Event|3|||
143004022|NCT01241591|515553052|FG001|Overall Study|Adverse Event|11|||
143004023|NCT01241591|515553053|FG002|Overall Study|Adverse Event|12|||
143004024|NCT01241591|515553054|FG003|Overall Study|Adverse Event|4|||
143004025|NCT01945034|515553055|FG000|Overall Study|Medication Error|0|||
143004026|NCT01945034|515553056|FG001|Overall Study|Medication Error|1|||
143177566|NCT00806260|516197992|FG005|Period 2|Need to take concomitant medication|0|||
143177567|NCT00806260|516197987|FG000|Period 2|sponsor request|0|||
143177568|NCT00806260|516197988|FG001|Period 2|sponsor request|0|||
143177569|NCT00806260|516197989|FG002|Period 2|sponsor request|1|||
143252179|NCT00717236|516476419|FG001|Open-Label Period|Other: Cataract Surgery|0|||
143252180|NCT00717236|516476418|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
143252181|NCT00717236|516476419|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
143252182|NCT00717236|516476418|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
143252183|NCT00717236|516476419|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
143252184|NCT00717236|516476418|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
143252185|NCT00717236|516476419|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
143252186|NCT00475982|516476420|FG000|Overall Study|surgery rescheduled|7|||
143252187|NCT00475982|516476421|FG001|Overall Study|surgery rescheduled|3|||
143252188|NCT01105767|516476422|FG000|Overall Study|Lost to Follow-up|1160|||
143252189|NCT01105767|516476423|FG001|Overall Study|Lost to Follow-up|1614|||
143252190|NCT01105767|516476424|FG002|Overall Study|Lost to Follow-up|1184|||
143252191|NCT00743106|516476425|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
143252192|NCT00743106|516476426|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
143252193|NCT00783198|516476435|FG000|Overall Study|Adverse Event|15|||
143102575|NCT02016105|515916471|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
143102576|NCT02016105|515916472|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
143102577|NCT02016105|515916473|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
143102578|NCT02016105|515916474|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
143102579|NCT02016105|515916475|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
143102580|NCT02016105|515916476|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
143102581|NCT02016105|515916471|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
143102582|NCT02016105|515916472|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
143102583|NCT02016105|515916473|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
143102584|NCT02016105|515916474|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
143102585|NCT02016105|515916475|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
143102586|NCT02016105|515916476|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
143102587|NCT02016105|515916471|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
143102588|NCT02016105|515916472|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
143102589|NCT02016105|515916473|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
143102590|NCT02016105|515916474|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
143102591|NCT02016105|515916475|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
143102592|NCT02016105|515916476|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
143102593|NCT02016105|515916471|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
143102594|NCT02016105|515916472|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
143102595|NCT02016105|515916473|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
143102596|NCT02016105|515916474|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
143102597|NCT02016105|515916475|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
143102598|NCT02016105|515916476|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
143102599|NCT02016105|515916471|FG000|TREATMENT PERIOD 2|Death|0|||
143252194|NCT00783198|516476436|FG001|Overall Study|Adverse Event|19|||
143252195|NCT00783198|516476437|FG002|Overall Study|Adverse Event|3|||
143252196|NCT00783198|516476435|FG000|Overall Study|Lost to Follow-up|11|||
143252197|NCT00783198|516476436|FG001|Overall Study|Lost to Follow-up|1|||
143252198|NCT00783198|516476437|FG002|Overall Study|Lost to Follow-up|7|||
143252199|NCT00783198|516476435|FG000|Overall Study|Withdrawal by Subject|22|||
143252200|NCT00783198|516476436|FG001|Overall Study|Withdrawal by Subject|14|||
143252201|NCT00783198|516476437|FG002|Overall Study|Withdrawal by Subject|20|||
143252202|NCT00783198|516476435|FG000|Overall Study|Noncompliance with protocol|7|||
143252203|NCT00783198|516476436|FG001|Overall Study|Noncompliance with protocol|7|||
143252204|NCT00783198|516476437|FG002|Overall Study|Noncompliance with protocol|10|||
143252205|NCT00783198|516476435|FG000|Overall Study|Did not meet protocol eligibility|0|||
143252206|NCT00783198|516476436|FG001|Overall Study|Did not meet protocol eligibility|1|||
143252207|NCT00783198|516476437|FG002|Overall Study|Did not meet protocol eligibility|0|||
143252208|NCT00783198|516476435|FG000|Overall Study|Administrative|2|||
143252209|NCT00783198|516476436|FG001|Overall Study|Administrative|1|||
143252210|NCT00783198|516476437|FG002|Overall Study|Administrative|2|||
143252211|NCT00271505|516476439|FG000|Overall Study|Screen Failure|3|||
143252212|NCT00271505|516476439|FG000|Overall Study|Adverse Event|1|||
143252213|NCT00271505|516476439|FG000|Overall Study|Death|1|||
143252214|NCT00119678|516476440|FG000|Double-blind Treatment Period|Death|1|||
143102600|NCT02016105|515916472|FG001|TREATMENT PERIOD 2|Death|0|||
143102601|NCT02016105|515916473|FG002|TREATMENT PERIOD 2|Death|0|||
143102602|NCT02016105|515916474|FG003|TREATMENT PERIOD 2|Death|0|||
143102603|NCT02016105|515916475|FG004|TREATMENT PERIOD 2|Death|0|||
143252215|NCT00119678|516476441|FG001|Double-blind Treatment Period|Death|0|||
143252216|NCT00119678|516476440|FG000|Double-blind Treatment Period|Adverse Event|7|||
143252217|NCT00119678|516476441|FG001|Double-blind Treatment Period|Adverse Event|1|||
143252218|NCT00119678|516476440|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
143252219|NCT00119678|516476441|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
143252220|NCT00119678|516476440|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
143252221|NCT00119678|516476441|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
143252222|NCT00119678|516476440|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
143252223|NCT00119678|516476441|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
143102604|NCT02016105|515916476|FG005|TREATMENT PERIOD 2|Death|1|||
143102605|NCT02016105|515916471|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
143102606|NCT02016105|515916472|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
143102607|NCT02016105|515916473|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
143102608|NCT02016105|515916474|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
143102609|NCT02016105|515916475|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
143102610|NCT02016105|515916476|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
143102611|NCT02016105|515916471|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
143102612|NCT02016105|515916472|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
143102613|NCT02016105|515916473|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
143102614|NCT02016105|515916474|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
143102615|NCT02016105|515916475|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
143102616|NCT02016105|515916476|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
143102617|NCT02016105|515916471|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
143102618|NCT02016105|515916472|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
143102619|NCT02016105|515916473|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
143102620|NCT02016105|515916474|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
143102621|NCT02016105|515916475|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
143102622|NCT02016105|515916476|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
143102623|NCT02016105|515916471|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
143102624|NCT02016105|515916472|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
143102625|NCT02016105|515916473|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
143102626|NCT02016105|515916474|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
143102627|NCT02016105|515916475|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
143102628|NCT02016105|515916476|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
143102629|NCT02016105|515916471|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
143102630|NCT02016105|515916472|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
143102631|NCT02016105|515916473|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
143102632|NCT02016105|515916474|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
143102633|NCT02016105|515916475|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
143102634|NCT02016105|515916476|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
143102635|NCT02016105|515916471|FG000|EXTENSION PERIOD|Adverse Event|0|||
143102636|NCT02016105|515916472|FG001|EXTENSION PERIOD|Adverse Event|0|||
143102637|NCT02016105|515916473|FG002|EXTENSION PERIOD|Adverse Event|2|||
143102638|NCT02016105|515916474|FG003|EXTENSION PERIOD|Adverse Event|0|||
143102639|NCT02016105|515916475|FG004|EXTENSION PERIOD|Adverse Event|1|||
143102640|NCT02016105|515916476|FG005|EXTENSION PERIOD|Adverse Event|0|||
143102641|NCT02016105|515916471|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
143102642|NCT02016105|515916472|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
143102643|NCT02016105|515916473|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
143102644|NCT02016105|515916474|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
143102645|NCT02016105|515916475|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
143102646|NCT02016105|515916476|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
143102647|NCT02016105|515916471|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
143102648|NCT02016105|515916472|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
143102649|NCT02016105|515916473|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
143102650|NCT02016105|515916474|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
143102651|NCT02016105|515916475|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
143177570|NCT00806260|516197990|FG003|Period 2|sponsor request|1|||
143177571|NCT00806260|516197991|FG004|Period 2|sponsor request|0|||
143177572|NCT00806260|516197992|FG005|Period 2|sponsor request|0|||
143177573|NCT00806260|516197987|FG000|Period 3|Protocol Violation|0|||
143177574|NCT00806260|516197988|FG001|Period 3|Protocol Violation|1|||
143177575|NCT00806260|516197989|FG002|Period 3|Protocol Violation|1|||
143177576|NCT00806260|516197990|FG003|Period 3|Protocol Violation|0|||
143177577|NCT00806260|516197991|FG004|Period 3|Protocol Violation|0|||
143177578|NCT00806260|516197992|FG005|Period 3|Protocol Violation|0|||
143177579|NCT00806260|516197987|FG000|Period 3|Pregnancy|1|||
143177580|NCT00806260|516197988|FG001|Period 3|Pregnancy|0|||
143177581|NCT00806260|516197989|FG002|Period 3|Pregnancy|0|||
143177582|NCT00806260|516197990|FG003|Period 3|Pregnancy|0|||
143177583|NCT00806260|516197991|FG004|Period 3|Pregnancy|0|||
143177584|NCT00806260|516197992|FG005|Period 3|Pregnancy|0|||
143177585|NCT00237042|516197993|FG000|Treatment|Became ineligible post-randomization|0|||
143177586|NCT00237042|516197994|FG001|Treatment|Became ineligible post-randomization|1|||
143177587|NCT00237042|516197995|FG002|Treatment|Became ineligible post-randomization|16|||
143177588|NCT00237042|516197993|FG000|Treatment|Moved out of state|1|||
143177589|NCT00237042|516197994|FG001|Treatment|Moved out of state|1|||
143177590|NCT00237042|516197995|FG002|Treatment|Moved out of state|1|||
143177591|NCT00237042|516197993|FG000|Treatment|Completed no treatment|5|||
143177592|NCT00237042|516197994|FG001|Treatment|Completed no treatment|5|||
143177593|NCT00237042|516197995|FG002|Treatment|Completed no treatment|21|||
143177594|NCT00237042|516197993|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
143177595|NCT00237042|516197994|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
143177596|NCT00237042|516197995|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
143177597|NCT00237042|516197993|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
143102652|NCT02016105|515916476|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
143102653|NCT02016105|515916471|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
143102654|NCT02016105|515916472|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
143102655|NCT02016105|515916473|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
143102656|NCT02016105|515916474|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
143102657|NCT02016105|515916475|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
143102658|NCT02016105|515916476|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
143102659|NCT02865499|515916477|FG000|Baseline|Adverse Event|1|||
143102660|NCT02865499|515916477|FG000|Baseline|Withdrawal by Subject|1|||
143102661|NCT02792192|515916478|FG000|Overall Study|Death|1|||
143102662|NCT02792192|515916479|FG001|Overall Study|Death|0|||
143102663|NCT02792192|515916480|FG002|Overall Study|Death|0|||
143102664|NCT02792192|515916481|FG003|Overall Study|Death|0|||
143102665|NCT02792192|515916478|FG000|Overall Study|Informed Consent Withdrawn|4|||
143102666|NCT02792192|515916479|FG001|Overall Study|Informed Consent Withdrawn|0|||
143102667|NCT02792192|515916480|FG002|Overall Study|Informed Consent Withdrawn|0|||
143102668|NCT02792192|515916481|FG003|Overall Study|Informed Consent Withdrawn|0|||
143102669|NCT02792192|515916478|FG000|Overall Study|Physician Decision|1|||
143102670|NCT02792192|515916479|FG001|Overall Study|Physician Decision|0|||
143102671|NCT02792192|515916480|FG002|Overall Study|Physician Decision|0|||
143102672|NCT02792192|515916481|FG003|Overall Study|Physician Decision|0|||
143102673|NCT02792192|515916478|FG000|Overall Study|Progressive Disease|0|||
143102674|NCT02792192|515916479|FG001|Overall Study|Progressive Disease|1|||
143102675|NCT02792192|515916480|FG002|Overall Study|Progressive Disease|0|||
143102676|NCT02792192|515916481|FG003|Overall Study|Progressive Disease|0|||
143102677|NCT02792192|515916478|FG000|Overall Study|Study Terminated By Sponsor|6|||
143102678|NCT02792192|515916479|FG001|Overall Study|Study Terminated By Sponsor|10|||
143102679|NCT02792192|515916480|FG002|Overall Study|Study Terminated By Sponsor|0|||
143102680|NCT02792192|515916481|FG003|Overall Study|Study Terminated By Sponsor|0|||
143102681|NCT01430403|515916482|FG000|Overall Study|Lost to Follow-up|5|||
143102682|NCT01430403|515916483|FG001|Overall Study|Lost to Follow-up|5|||
143102683|NCT01430403|515916484|FG002|Overall Study|Lost to Follow-up|3|||
143102684|NCT01430403|515916482|FG000|Overall Study|Physician Decision|1|||
143102685|NCT01430403|515916483|FG001|Overall Study|Physician Decision|0|||
143102686|NCT01430403|515916484|FG002|Overall Study|Physician Decision|0|||
143102687|NCT01430403|515916482|FG000|Overall Study|Protocol Violation|2|||
143102688|NCT01430403|515916483|FG001|Overall Study|Protocol Violation|3|||
143102689|NCT01430403|515916484|FG002|Overall Study|Protocol Violation|2|||
143102690|NCT01430403|515916482|FG000|Overall Study|Withdrawal by Subject|9|||
143102691|NCT01430403|515916483|FG001|Overall Study|Withdrawal by Subject|1|||
143102692|NCT01430403|515916484|FG002|Overall Study|Withdrawal by Subject|3|||
143102693|NCT04481789|515916485|FG000|Period 1|Withdrawal by Subject|1|||
143102694|NCT04481789|515916486|FG001|Period 1|Withdrawal by Subject|0|||
143102695|NCT04481789|515916487|FG002|Period 1|Withdrawal by Subject|0|||
143177598|NCT00237042|516197994|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
143177599|NCT00237042|516197995|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
143177600|NCT01897532|516197996|FG000|Discontinuation From Treatment|Not Treated|7|||
143177601|NCT01897532|516197997|FG001|Discontinuation From Treatment|Not Treated|5|||
143177602|NCT01897532|516197996|FG000|Discontinuation From Treatment|Other reason than specified|196|||
143177603|NCT01897532|516197997|FG001|Discontinuation From Treatment|Other reason than specified|176|||
143177604|NCT01897532|516197996|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
143177605|NCT01897532|516197997|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
143177606|NCT01897532|516197996|FG000|Discontinuation From Treatment|Non compliance|24|||
143177607|NCT01897532|516197997|FG001|Discontinuation From Treatment|Non compliance|15|||
143177608|NCT01897532|516197996|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
143177609|NCT01897532|516197997|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
143177610|NCT01897532|516197996|FG000|Discontinuation From Trial|Not Treated|7|||
143177611|NCT01897532|516197997|FG001|Discontinuation From Trial|Not Treated|5|||
143177612|NCT01897532|516197996|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
143177613|NCT01897532|516197997|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
143177614|NCT03132467|516197999|FG000|Overall Study|Adverse Event|2|||
143177615|NCT03132467|516197999|FG000|Overall Study|Withdrawal by Subject|2|||
143177616|NCT05223673|516198000|FG000|Overall Study|Protocol Violation|1|||
143102696|NCT04481789|515916488|FG003|Period 1|Withdrawal by Subject|0|||
143102697|NCT04481789|515916489|FG004|Period 1|Withdrawal by Subject|0|||
143102698|NCT04481789|515916490|FG005|Period 1|Withdrawal by Subject|0|||
143102699|NCT03124407|515916493|FG000|Overall Study|Lost to Follow-up|1|||
143102700|NCT03124407|515916494|FG001|Overall Study|Lost to Follow-up|0|||
143102701|NCT03124407|515916495|FG002|Overall Study|Lost to Follow-up|0|||
143177617|NCT05223673|516198000|FG000|Overall Study|Study termination|6|||
143177618|NCT01783444|516199776|FG000|Treatment Phase|Adverse Event|9|||
143102702|NCT03124407|515916496|FG003|Overall Study|Lost to Follow-up|0|||
143102703|NCT03124407|515916493|FG000|Overall Study|Adverse Event|0|||
143102704|NCT03124407|515916494|FG001|Overall Study|Adverse Event|0|||
143102705|NCT03124407|515916495|FG002|Overall Study|Adverse Event|1|||
143252224|NCT00119678|516476440|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
143252225|NCT00119678|516476441|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
143252226|NCT00119678|516476440|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
143252227|NCT00119678|516476441|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
143252228|NCT00119678|516476440|FG000|Double-blind Treatment Period|Pregnancy|0|||
143252229|NCT00119678|516476441|FG001|Double-blind Treatment Period|Pregnancy|2|||
143252230|NCT00119678|516476440|FG000|Double-blind Treatment Period|Not treated|1|||
143252231|NCT00119678|516476441|FG001|Double-blind Treatment Period|Not treated|2|||
143252232|NCT00119678|516476440|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
143252233|NCT00119678|516476441|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
143252234|NCT00119678|516476440|FG000|Open-label Treatment Period|Death|1|||
143252235|NCT00119678|516476441|FG001|Open-label Treatment Period|Death|0|||
143252236|NCT00119678|516476440|FG000|Open-label Treatment Period|Adverse Event|3|||
143252237|NCT00119678|516476441|FG001|Open-label Treatment Period|Adverse Event|0|||
143252238|NCT00119678|516476440|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
143252239|NCT00119678|516476441|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
143252240|NCT00119678|516476440|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
143252241|NCT00119678|516476441|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
143252242|NCT00119678|516476440|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
143252243|NCT00119678|516476441|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
143252244|NCT00119678|516476440|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
143252245|NCT00119678|516476441|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
143004027|NCT01945034|515553057|FG002|Overall Study|Medication Error|0|||
143252246|NCT00119678|516476440|FG000|Open-label Treatment Period|Pregnancy|1|||
143102706|NCT03124407|515916496|FG003|Overall Study|Adverse Event|0|||
143102707|NCT01860040|515916499|FG000|Overall Study|Withdrawal by Subject|1|||
143102708|NCT01860040|515916500|FG001|Overall Study|Withdrawal by Subject|0|||
143102709|NCT01931995|515916501|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
143102710|NCT01931995|515916502|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
143102711|NCT01931995|515916501|FG000|First Intervention (1 Day)|Physician Decision|1|||
143102712|NCT01931995|515916502|FG001|First Intervention (1 Day)|Physician Decision|1|||
143102713|NCT01931995|515916501|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
143102714|NCT01931995|515916502|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
143102715|NCT00554515|515916506|FG000|Overall Study|Withdrawal by Subject|3|||
143102716|NCT00554515|515916506|FG000|Overall Study|Disease progression|52|||
143102717|NCT00554515|515916506|FG000|Overall Study|Physician Decision|18|||
143102718|NCT00554515|515916506|FG000|Overall Study|Withdrawal by Subject|11|||
143102719|NCT00554515|515916506|FG000|Overall Study|Adverse Event|9|||
143102720|NCT00554515|515916506|FG000|Overall Study|Death|2|||
143004028|NCT01945034|515553055|FG000|Overall Study|Withdrawal by Subject|0|||
143004029|NCT01945034|515553056|FG001|Overall Study|Withdrawal by Subject|3|||
143004030|NCT01945034|515553057|FG002|Overall Study|Withdrawal by Subject|1|||
143004031|NCT01945034|515553055|FG000|Overall Study|Other|0|||
143004032|NCT01945034|515553056|FG001|Overall Study|Other|1|||
143004033|NCT01945034|515553057|FG002|Overall Study|Other|3|||
143004034|NCT01945034|515553055|FG000|Overall Study|Lost to Follow-up|0|||
143004035|NCT01945034|515553056|FG001|Overall Study|Lost to Follow-up|0|||
143004036|NCT01945034|515553057|FG002|Overall Study|Lost to Follow-up|2|||
143004037|NCT01945034|515553055|FG000|Overall Study|Protocol Violation|1|||
143004038|NCT01945034|515553056|FG001|Overall Study|Protocol Violation|0|||
143004039|NCT01945034|515553057|FG002|Overall Study|Protocol Violation|1|||
143004040|NCT02389621|515553060|FG000|Treatment Period|Withdrawal by Subject|1|||
143004041|NCT02389621|515553061|FG001|Treatment Period|Withdrawal by Subject|1|||
143004042|NCT02389621|515553060|FG000|Posttreatment Period|Adverse Event|3|||
143004043|NCT02389621|515553061|FG001|Posttreatment Period|Adverse Event|1|||
143004044|NCT02389621|515553060|FG000|Posttreatment Period|Withdrawal by Subject|3|||
143004045|NCT02389621|515553061|FG001|Posttreatment Period|Withdrawal by Subject|2|||
143004046|NCT02389621|515553060|FG000|Posttreatment Period|Lost to Follow-up|1|||
143004047|NCT02389621|515553061|FG001|Posttreatment Period|Lost to Follow-up|1|||
143004048|NCT02389621|515553060|FG000|Posttreatment Period|Other - Miscellaneous|2|||
143004049|NCT02389621|515553061|FG001|Posttreatment Period|Other - Miscellaneous|0|||
143004050|NCT01151085|515553064|FG000|Overall Study|Lost to Follow-up|31|||
143004051|NCT01151085|515553064|FG000|Overall Study|Protocol Violation|25|||
143004052|NCT02059265|515553065|FG000|Overall Study|Ineligible|4|||
143004053|NCT00489411|515553066|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
143004054|NCT00489411|515553067|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
143367763|NCT01143077|516889437|FG000|Overall Study|Administrative|1|||
143367764|NCT01143077|516889438|FG001|Overall Study|Administrative|0|||
143367765|NCT01143077|516889439|FG002|Overall Study|Administrative|0|||
143367766|NCT01143077|516889437|FG000|Overall Study|Principal Investigator Decision|2|||
143367767|NCT01143077|516889438|FG001|Overall Study|Principal Investigator Decision|0|||
143367768|NCT01143077|516889439|FG002|Overall Study|Principal Investigator Decision|1|||
143367769|NCT00124982|516889440|FG000|Short-term Period|Death|1|||
143367770|NCT00124982|516889441|FG001|Short-term Period|Death|1|||
143367771|NCT00124982|516889442|FG002|Short-term Period|Death|0|||
143367772|NCT00124982|516889440|FG000|Short-term Period|Adverse Event|17|||
143367773|NCT00124982|516889441|FG001|Short-term Period|Adverse Event|22|||
143367774|NCT00124982|516889442|FG002|Short-term Period|Adverse Event|0|||
143102721|NCT00554515|515916506|FG000|Overall Study|Achieved Stable Disease|7|||
143102722|NCT00554515|515916506|FG000|Overall Study|Other|1|||
143102723|NCT00554515|515916506|FG000|Overall Study|Misc|15|||
143102724|NCT03759587|515916507|FG000|Overall Study|Adverse Event|5|||
143102725|NCT03759587|515916507|FG000|Overall Study|Progressive Disease|10|||
143102726|NCT03759587|515916507|FG000|Overall Study|Site Terminated by Sponsor|3|||
143102727|NCT03759587|515916507|FG000|Overall Study|Withdrawal by Subject|1|||
143102728|NCT00665431|515916509|FG000|Overall Study|Adverse Event|16|||
143102729|NCT00665431|515916510|FG001|Overall Study|Adverse Event|22|||
143102730|NCT00665431|515916511|FG002|Overall Study|Adverse Event|6|||
143102731|NCT00665431|515916509|FG000|Overall Study|Withdrawal by Subject|17|||
143102732|NCT00665431|515916510|FG001|Overall Study|Withdrawal by Subject|25|||
143102733|NCT00665431|515916511|FG002|Overall Study|Withdrawal by Subject|15|||
143102734|NCT00665431|515916509|FG000|Overall Study|Lost to Follow-up|3|||
143102735|NCT00665431|515916510|FG001|Overall Study|Lost to Follow-up|3|||
143102736|NCT00665431|515916511|FG002|Overall Study|Lost to Follow-up|1|||
143102737|NCT00665431|515916509|FG000|Overall Study|Other|4|||
143102738|NCT00665431|515916510|FG001|Overall Study|Other|7|||
143102739|NCT00665431|515916511|FG002|Overall Study|Other|2|||
143177619|NCT01783444|516199777|FG001|Treatment Phase|Adverse Event|20|||
143177620|NCT01783444|516199778|FG002|Treatment Phase|Adverse Event|19|||
143177621|NCT01783444|516199776|FG000|Treatment Phase|Disease Progression|76|||
143177622|NCT01783444|516199777|FG001|Treatment Phase|Disease Progression|66|||
143177623|NCT01783444|516199778|FG002|Treatment Phase|Disease Progression|64|||
143177624|NCT01783444|516199776|FG000|Treatment Phase|Death|2|||
143177625|NCT01783444|516199777|FG001|Treatment Phase|Death|2|||
143177626|NCT01783444|516199778|FG002|Treatment Phase|Death|2|||
143177627|NCT01783444|516199776|FG000|Treatment Phase|Protocol Violation|1|||
143177628|NCT01783444|516199777|FG001|Treatment Phase|Protocol Violation|1|||
143177629|NCT01783444|516199778|FG002|Treatment Phase|Protocol Violation|2|||
143177630|NCT01783444|516199776|FG000|Treatment Phase|Withdrawal by Subject|6|||
143177631|NCT01783444|516199777|FG001|Treatment Phase|Withdrawal by Subject|8|||
143177632|NCT01783444|516199778|FG002|Treatment Phase|Withdrawal by Subject|9|||
143177633|NCT01783444|516199776|FG000|Treatment Phase|Administrative problems|2|||
143177634|NCT01783444|516199777|FG001|Treatment Phase|Administrative problems|0|||
143177635|NCT01783444|516199778|FG002|Treatment Phase|Administrative problems|1|||
143177636|NCT01783444|516199776|FG000|Treatment Phase|Physician Decision|8|||
143177637|NCT01783444|516199777|FG001|Treatment Phase|Physician Decision|6|||
143177638|NCT01783444|516199778|FG002|Treatment Phase|Physician Decision|5|||
143177639|NCT01783444|516199776|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
143177640|NCT01783444|516199777|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
143177641|NCT01783444|516199778|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
143177642|NCT01783444|516199776|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
143177643|NCT01783444|516199777|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
143177644|NCT01783444|516199778|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
143177645|NCT01783444|516199776|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
143177646|NCT01783444|516199777|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
143177647|NCT01783444|516199778|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
143177648|NCT01783444|516199776|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
143177649|NCT01783444|516199777|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
143177650|NCT01783444|516199778|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
143177651|NCT01783444|516199776|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
143177652|NCT01783444|516199777|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
143102740|NCT02347813|515916515|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
143102741|NCT02347813|515916516|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
143102742|NCT02347813|515916515|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
143102743|NCT02347813|515916516|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
143177653|NCT01783444|516199778|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
143181481|NCT02891226|516211764|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
143367775|NCT00124982|516889440|FG000|Short-term Period|Lack of Efficacy|32|||
143367776|NCT00124982|516889441|FG001|Short-term Period|Lack of Efficacy|73|||
143367777|NCT00124982|516889442|FG002|Short-term Period|Lack of Efficacy|0|||
143252247|NCT00119678|516476441|FG001|Open-label Treatment Period|Pregnancy|0|||
143252248|NCT00119678|516476440|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
143252249|NCT00119678|516476441|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
143252250|NCT01134705|516476444|FG000|Overall Study|Adverse Event|1|||
143252251|NCT01134705|516476445|FG001|Overall Study|Adverse Event|7|||
143252252|NCT01134705|516476444|FG000|Overall Study|Withdrawal by Subject|6|||
143252253|NCT01134705|516476445|FG001|Overall Study|Withdrawal by Subject|6|||
143252254|NCT01134705|516476444|FG000|Overall Study|Pregnancy|1|||
143252255|NCT01134705|516476445|FG001|Overall Study|Pregnancy|0|||
143252256|NCT01134705|516476444|FG000|Overall Study|Lost to Follow-up|5|||
143252257|NCT01134705|516476445|FG001|Overall Study|Lost to Follow-up|2|||
143252258|NCT01134705|516476444|FG000|Overall Study|Protocol Violation|1|||
143252259|NCT01134705|516476445|FG001|Overall Study|Protocol Violation|1|||
143252260|NCT01134705|516476444|FG000|Overall Study|Other|1|||
143252261|NCT01134705|516476445|FG001|Overall Study|Other|6|||
143252262|NCT00509145|516476446|FG000|Overall Study|Death|0|||
143252263|NCT00509145|516476447|FG001|Overall Study|Death|2|||
143252264|NCT00509145|516476446|FG000|Overall Study|Adverse Event|42|||
143252265|NCT00509145|516476447|FG001|Overall Study|Adverse Event|28|||
143252266|NCT00509145|516476446|FG000|Overall Study|Withdrawal by Subject|32|||
143252267|NCT00509145|516476447|FG001|Overall Study|Withdrawal by Subject|38|||
143252268|NCT00509145|516476446|FG000|Overall Study|Physician Decision|11|||
143252269|NCT00509145|516476447|FG001|Overall Study|Physician Decision|14|||
143252270|NCT00509145|516476446|FG000|Overall Study|Protocol Violation|1|||
143252271|NCT00509145|516476447|FG001|Overall Study|Protocol Violation|6|||
143252272|NCT00509145|516476446|FG000|Overall Study|Pregnancy|3|||
143252273|NCT00509145|516476447|FG001|Overall Study|Pregnancy|8|||
143252274|NCT00509145|516476446|FG000|Overall Study|Lost to Follow-up|6|||
143252275|NCT00509145|516476447|FG001|Overall Study|Lost to Follow-up|5|||
143252276|NCT00509145|516476446|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
143252277|NCT00509145|516476447|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
143252278|NCT00509145|516476446|FG000|Overall Study|Other|6|||
143252279|NCT00509145|516476447|FG001|Overall Study|Other|6|||
143252280|NCT01994889|516476448|FG000|Overall Study|Adverse Event|5|||
143252281|NCT01994889|516476449|FG001|Overall Study|Adverse Event|12|||
143252282|NCT01994889|516476450|FG002|Overall Study|Adverse Event|11|||
143252283|NCT01994889|516476448|FG000|Overall Study|Cardiac Device Implantation|0|||
143252284|NCT01994889|516476449|FG001|Overall Study|Cardiac Device Implantation|2|||
143252285|NCT01994889|516476450|FG002|Overall Study|Cardiac Device Implantation|0|||
143252286|NCT01994889|516476448|FG000|Overall Study|Organ Transplantation|1|||
143252287|NCT01994889|516476449|FG001|Overall Study|Organ Transplantation|5|||
143252288|NCT01994889|516476450|FG002|Overall Study|Organ Transplantation|5|||
143252289|NCT01994889|516476448|FG000|Overall Study|No longer willing to participate|8|||
143252290|NCT01994889|516476449|FG001|Overall Study|No longer willing to participate|17|||
143252291|NCT01994889|516476450|FG002|Overall Study|No longer willing to participate|37|||
143252292|NCT01994889|516476448|FG000|Overall Study|Lost to Follow-up|0|||
143252293|NCT01994889|516476449|FG001|Overall Study|Lost to Follow-up|1|||
143252294|NCT01994889|516476450|FG002|Overall Study|Lost to Follow-up|0|||
143252295|NCT01994889|516476448|FG000|Overall Study|Protocol Violation|0|||
143252296|NCT01994889|516476449|FG001|Overall Study|Protocol Violation|1|||
143252297|NCT01994889|516476450|FG002|Overall Study|Protocol Violation|1|||
143252298|NCT01994889|516476448|FG000|Overall Study|Death|14|||
143252299|NCT01994889|516476449|FG001|Overall Study|Death|25|||
143252300|NCT01994889|516476450|FG002|Overall Study|Death|38|||
143252301|NCT02674204|516476451|FG000|Overall Study|Adverse Event|1|||
143252302|NCT02674204|516476452|FG001|Overall Study|Adverse Event|0|||
143252303|NCT02874144|516476453|FG000|Overall Study|Lost to Follow-up|3|||
143252304|NCT02874144|516476454|FG001|Overall Study|Lost to Follow-up|5|||
143252305|NCT01347580|516478586|FG000|Overall Study|Withdrawal by Subject|13|||
143252306|NCT01347580|516478587|FG001|Overall Study|Withdrawal by Subject|23|||
143252307|NCT01347580|516478586|FG000|Overall Study|Death|30|||
143252308|NCT01347580|516478587|FG001|Overall Study|Death|19|||
143252309|NCT01347580|516478586|FG000|Overall Study|Protocol Violation|10|||
143004212|NCT01038609|515553132|FG001|Overall Study|Death in the Family|0|||
143004213|NCT01038609|515553133|FG002|Overall Study|Death in the Family|0|||
143004214|NCT01038609|515553134|FG003|Overall Study|Death in the Family|0|||
143004215|NCT01038609|515553135|FG004|Overall Study|Death in the Family|0|||
143004216|NCT01038609|515553131|FG000|Overall Study|Refusal of Blood Draws|0|||
143004217|NCT01038609|515553132|FG001|Overall Study|Refusal of Blood Draws|1|||
143004218|NCT01038609|515553133|FG002|Overall Study|Refusal of Blood Draws|0|||
143004219|NCT01038609|515553134|FG003|Overall Study|Refusal of Blood Draws|0|||
143004220|NCT01038609|515553135|FG004|Overall Study|Refusal of Blood Draws|0|||
143004221|NCT01314261|515553136|FG000|Overall Study|Adverse Event|1|||
143004222|NCT01314261|515553137|FG001|Overall Study|Adverse Event|0|||
143004223|NCT01314261|515553138|FG002|Overall Study|Adverse Event|0|||
143004224|NCT01314261|515553139|FG003|Overall Study|Adverse Event|0|||
143004225|NCT01314261|515553136|FG000|Overall Study|Withdrawal by Subject|0|||
143004226|NCT01314261|515553137|FG001|Overall Study|Withdrawal by Subject|3|||
143102744|NCT02837731|515916519|FG000|Allocation|Admitted to General Floor|3|||
143102745|NCT02837731|515916520|FG001|Allocation|Admitted to General Floor|4|||
143102746|NCT02837731|515916519|FG000|Allocation|Immediate surgery/withdrew|2|||
143102747|NCT02837731|515916520|FG001|Allocation|Immediate surgery/withdrew|0|||
143102748|NCT02837731|515916519|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
143102749|NCT02837731|515916520|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
143102750|NCT02837731|515916519|FG000|Allocation|Withdrawal by Subject|2|||
143102751|NCT02837731|515916520|FG001|Allocation|Withdrawal by Subject|0|||
143102752|NCT02837731|515916519|FG000|Allocation|Device not available|1|||
143102753|NCT02837731|515916520|FG001|Allocation|Device not available|0|||
143102754|NCT02837731|515916519|FG000|Allocation|Protocol not implemented|7|||
143102755|NCT02837731|515916520|FG001|Allocation|Protocol not implemented|0|||
143102756|NCT02837731|515916519|FG000|Allocation|Moribund/Do not resuscitate|2|||
143102757|NCT02837731|515916520|FG001|Allocation|Moribund/Do not resuscitate|0|||
143102758|NCT02837731|515916519|FG000|Allocation|Did not meet sepsis criteria|1|||
143102759|NCT02837731|515916520|FG001|Allocation|Did not meet sepsis criteria|2|||
143102760|NCT02837731|515916519|FG000|Allocation|Known aortic abnormalities|0|||
143102761|NCT02837731|515916520|FG001|Allocation|Known aortic abnormalities|1|||
143102762|NCT02644668|515916523|FG000|Overall Study|Adverse Event|2|||
143102763|NCT02644668|515916524|FG001|Overall Study|Adverse Event|0|||
143102764|NCT02644668|515916525|FG002|Overall Study|Adverse Event|1|||
143102765|NCT02644668|515916523|FG000|Overall Study|Protocol Violation|0|||
143102766|NCT02644668|515916524|FG001|Overall Study|Protocol Violation|0|||
143102767|NCT02644668|515916525|FG002|Overall Study|Protocol Violation|1|||
143102768|NCT02644668|515916523|FG000|Overall Study|Withdrawal by Subject|0|||
143102769|NCT02644668|515916524|FG001|Overall Study|Withdrawal by Subject|0|||
143102770|NCT02644668|515916525|FG002|Overall Study|Withdrawal by Subject|1|||
143102771|NCT01921101|515916527|FG000|Overall Study|Death|16|||
143102772|NCT01921101|515916528|FG001|Overall Study|Death|6|||
143102773|NCT03291431|515916529|FG000|Overall Study|Protocol Violation|2|||
143102774|NCT03291431|515916530|FG001|Overall Study|Protocol Violation|1|||
143102775|NCT03291431|515916529|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
143102776|NCT03291431|515916530|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
143102777|NCT03291431|515916529|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
143102778|NCT03291431|515916530|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
143102779|NCT01136356|515917946|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
143102780|NCT01136356|515917947|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
143102781|NCT01136356|515917946|FG000|First 18-day Withdrawal|Physician Decision|1|||
143102782|NCT01136356|515917947|FG001|First 18-day Withdrawal|Physician Decision|0|||
143102783|NCT01136356|515917946|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
143102784|NCT01136356|515917947|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
143102785|NCT02875613|515917948|FG000|Overall Study|Withdrawal by Subject|1|||
143102786|NCT02875613|515917948|FG000|Overall Study|Screen Failure|1|||
143102787|NCT01750697|515917949|FG000|Overall Study|Transferred Back to Local Hospital|1|||
143102788|NCT01750697|515917949|FG000|Overall Study|Physician and Family Decision|1|||
143102789|NCT01750697|515917949|FG000|Overall Study|Transferred to Adult Services|5|||
143102790|NCT01750697|515917949|FG000|Overall Study|Physician Decision|1|||
143102791|NCT01750697|515917949|FG000|Overall Study|Withdrawal by Subject|1|||
143102792|NCT01057810|515917950|FG000|Overall Study|Disease progression|156|||
143102793|NCT01057810|515917951|FG001|Overall Study|Disease progression|197|||
143102794|NCT01057810|515917950|FG000|Overall Study|Study drug toxicity|5|||
143102795|NCT01057810|515917951|FG001|Overall Study|Study drug toxicity|114|||
143102796|NCT01057810|515917950|FG000|Overall Study|Adverse event unrelated to study drug|13|||
143102797|NCT01057810|515917951|FG001|Overall Study|Adverse event unrelated to study drug|29|||
143102798|NCT01057810|515917950|FG000|Overall Study|Withdrawal by Subject|10|||
143102799|NCT01057810|515917951|FG001|Overall Study|Withdrawal by Subject|25|||
143102800|NCT01057810|515917950|FG000|Overall Study|Death|2|||
143102801|NCT01057810|515917951|FG001|Overall Study|Death|12|||
143102802|NCT01057810|515917950|FG000|Overall Study|Maximum clinical benefit|5|||
143102803|NCT01057810|515917951|FG001|Overall Study|Maximum clinical benefit|5|||
143102804|NCT01057810|515917950|FG000|Overall Study|Poor/non-compliance|0|||
143102805|NCT01057810|515917951|FG001|Overall Study|Poor/non-compliance|1|||
143102806|NCT01057810|515917950|FG000|Overall Study|No longer met study criteria|0|||
143102807|NCT01057810|515917951|FG001|Overall Study|No longer met study criteria|1|||
143102808|NCT01057810|515917950|FG000|Overall Study|Other|7|||
143102809|NCT01057810|515917951|FG001|Overall Study|Other|14|||
143177654|NCT01783444|516199776|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
143177655|NCT01783444|516199777|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
143102810|NCT02088905|515917952|FG000|Overall Study|Withdrawal by Subject|5|||
143102811|NCT02088905|515917953|FG001|Overall Study|Withdrawal by Subject|1|||
143102812|NCT00619892|515917955|FG000|Overall Study|Adverse Event|3|||
143102813|NCT00619892|515917956|FG001|Overall Study|Adverse Event|0|||
143102814|NCT00619892|515917955|FG000|Overall Study|Lost to Follow-up|0|||
143102815|NCT00619892|515917956|FG001|Overall Study|Lost to Follow-up|1|||
143102816|NCT00619892|515917955|FG000|Overall Study|Intercurrent illness|0|||
143102817|NCT00619892|515917956|FG001|Overall Study|Intercurrent illness|1|||
143102818|NCT01562782|515917960|FG000|Overall Study|Withdrawal by Subject|3|||
143102819|NCT01562782|515917961|FG001|Overall Study|Withdrawal by Subject|3|||
143102820|NCT01562782|515917960|FG000|Overall Study|screen failure|1|||
143102821|NCT01562782|515917961|FG001|Overall Study|screen failure|2|||
143102822|NCT00857896|515917966|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
143177656|NCT01783444|516199778|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
143177657|NCT00552071|516199779|FG000|Overall Study|Adverse Event|1|||
143177658|NCT00552071|516199780|FG001|Overall Study|Adverse Event|0|||
143177659|NCT00552071|516199779|FG000|Overall Study|Lack of Efficacy|1|||
143177660|NCT00552071|516199780|FG001|Overall Study|Lack of Efficacy|0|||
143177661|NCT00552071|516199779|FG000|Overall Study|Physician Decision|1|||
143177662|NCT00552071|516199780|FG001|Overall Study|Physician Decision|0|||
143177663|NCT00552071|516199779|FG000|Overall Study|Pregnancy|1|||
143177664|NCT00552071|516199780|FG001|Overall Study|Pregnancy|0|||
143177665|NCT00552071|516199779|FG000|Overall Study|Death|0|||
143177666|NCT00552071|516199780|FG001|Overall Study|Death|1|||
143177667|NCT00552071|516199779|FG000|Overall Study|Withdrawal by Subject|0|||
143177668|NCT00552071|516199780|FG001|Overall Study|Withdrawal by Subject|1|||
143177669|NCT00937495|516199785|FG000|Overall Study|Protocol Violation|2|||
143177670|NCT02549989|516199788|FG000|Overall Study|Adverse Event|4|||
143177671|NCT02549989|516199788|FG000|Overall Study|Death|1|||
143177672|NCT02549989|516199788|FG000|Overall Study|Lack of Efficacy|19|||
143177673|NCT02549989|516199788|FG000|Overall Study|Withdrawal by Subject|3|||
143177674|NCT01333722|516199794|FG000|Overall Study|Lack of Efficacy|0|||
143177675|NCT01333722|516199795|FG001|Overall Study|Lack of Efficacy|2|||
143177676|NCT01333722|516199794|FG000|Overall Study|Withdrawal by Subject|0|||
143177677|NCT01333722|516199795|FG001|Overall Study|Withdrawal by Subject|1|||
143177678|NCT00784368|516199796|FG000|Overall Study|Physician Decision|0|||
143177679|NCT00784368|516199797|FG001|Overall Study|Physician Decision|0|||
143177680|NCT00784368|516199798|FG002|Overall Study|Physician Decision|6|||
143177681|NCT00784368|516199796|FG000|Overall Study|Lack of Efficacy|2|||
143177682|NCT00784368|516199797|FG001|Overall Study|Lack of Efficacy|0|||
143177683|NCT00784368|516199798|FG002|Overall Study|Lack of Efficacy|1|||
143177684|NCT00784368|516199796|FG000|Overall Study|Adverse Event|6|||
143252310|NCT01347580|516478587|FG001|Overall Study|Protocol Violation|7|||
143252311|NCT01347580|516478586|FG000|Overall Study|Lost to Follow-up|3|||
143252312|NCT01347580|516478587|FG001|Overall Study|Lost to Follow-up|1|||
143252313|NCT01347580|516478586|FG000|Overall Study|Had other reason|9|||
143252314|NCT01347580|516478587|FG001|Overall Study|Had other reason|6|||
143252315|NCT01964755|516478590|FG000|Overall Study|Death|2|||
143252316|NCT01410357|516478591|FG000|Overall Study|Death|2|||
143252317|NCT01410357|516478592|FG001|Overall Study|Death|1|||
143252318|NCT01410357|516478591|FG000|Overall Study|Withdrawal by Subject|1|||
143252319|NCT01410357|516478592|FG001|Overall Study|Withdrawal by Subject|2|||
143252320|NCT01410357|516478591|FG000|Overall Study|Lost to Follow-up|23|||
143252321|NCT01410357|516478592|FG001|Overall Study|Lost to Follow-up|21|||
143252322|NCT00538785|516478598|FG000|Overall Study|Death|9|||
143252323|NCT00538785|516478599|FG001|Overall Study|Death|10|||
143252324|NCT00538785|516478598|FG000|Overall Study|Withdrawal of consent|9|||
143252325|NCT00538785|516478599|FG001|Overall Study|Withdrawal of consent|7|||
143252326|NCT00538785|516478598|FG000|Overall Study|Lost to Follow-up|1|||
143252327|NCT00538785|516478599|FG001|Overall Study|Lost to Follow-up|0|||
143252328|NCT04022733|516478600|FG000|Overall Study|conversion to open surgery|3|||
143252329|NCT04022733|516478601|FG001|Overall Study|conversion to open surgery|2|||
143252330|NCT04022733|516478600|FG000|Overall Study|bradycardia|0|||
143252331|NCT04022733|516478601|FG001|Overall Study|bradycardia|1|||
143252332|NCT04224688|516478605|FG000|Overall Study|Withdrawal by Subject|1|||
143252333|NCT04224688|516478606|FG001|Overall Study|Withdrawal by Subject|3|||
143252334|NCT04224688|516478605|FG000|Overall Study|Lack of Efficacy|1|||
143252335|NCT04224688|516478606|FG001|Overall Study|Lack of Efficacy|1|||
143252336|NCT04224688|516478605|FG000|Overall Study|Adverse event, not fatal|0|||
143252337|NCT04224688|516478606|FG001|Overall Study|Adverse event, not fatal|2|||
143177685|NCT00784368|516199797|FG001|Overall Study|Adverse Event|9|||
143177686|NCT00784368|516199798|FG002|Overall Study|Adverse Event|2|||
143252338|NCT04224688|516478605|FG000|Overall Study|COVID-19|0|||
143252339|NCT04224688|516478606|FG001|Overall Study|COVID-19|1|||
143252340|NCT01960907|516478607|FG000|Overall Study|Death|4|||
143252341|NCT01960907|516478608|FG001|Overall Study|Death|3|||
143252342|NCT01960907|516478607|FG000|Overall Study|Withdrawal by Subject|32|||
143102823|NCT01091662|515917968|FG000|Overall Study|Adverse Event|1|||
143102824|NCT01091662|515917969|FG001|Overall Study|Adverse Event|9|||
143177687|NCT00784368|516199796|FG000|Overall Study|Diagnosis of fever|0|||
143177688|NCT00784368|516199797|FG001|Overall Study|Diagnosis of fever|0|||
143177689|NCT00784368|516199798|FG002|Overall Study|Diagnosis of fever|1|||
143177690|NCT00784368|516199796|FG000|Overall Study|Worsening of complications|0|||
143252343|NCT01960907|516478608|FG001|Overall Study|Withdrawal by Subject|42|||
143252344|NCT04784442|516478609|FG000|Overall Study|Adverse Event|1|||
143102825|NCT01091662|515917968|FG000|Overall Study|Physician Decision|1|||
143102826|NCT01091662|515917969|FG001|Overall Study|Physician Decision|1|||
143252345|NCT04784442|516478610|FG001|Overall Study|Adverse Event|0|||
143252346|NCT04784442|516478611|FG002|Overall Study|Adverse Event|2|||
143102827|NCT01091662|515917968|FG000|Overall Study|Withdrawal by Subject|7|||
143102828|NCT01091662|515917969|FG001|Overall Study|Withdrawal by Subject|6|||
143102829|NCT01091662|515917968|FG000|Overall Study|met exit criteria|7|||
143102830|NCT01091662|515917969|FG001|Overall Study|met exit criteria|13|||
143102831|NCT01091662|515917968|FG000|Overall Study|met exclusion criteria|1|||
143102832|NCT01091662|515917969|FG001|Overall Study|met exclusion criteria|0|||
143102833|NCT01091662|515917968|FG000|Overall Study|Lost to Follow-up|0|||
143102834|NCT01091662|515917969|FG001|Overall Study|Lost to Follow-up|1|||
143102835|NCT01091662|515917968|FG000|Overall Study|Pregnancy|0|||
143102836|NCT01091662|515917969|FG001|Overall Study|Pregnancy|1|||
143102837|NCT01091662|515917968|FG000|Overall Study|Protocol Violation|0|||
143102838|NCT01091662|515917969|FG001|Overall Study|Protocol Violation|2|||
143102839|NCT01091662|515917968|FG000|Overall Study|unable to swallow capsule|0|||
143102840|NCT01091662|515917969|FG001|Overall Study|unable to swallow capsule|1|||
143102841|NCT02308540|515917970|FG000|Overall Study|Lost to Follow-up|0|||
143102842|NCT02308540|515917971|FG001|Overall Study|Lost to Follow-up|0|||
143102843|NCT02308540|515917972|FG002|Overall Study|Lost to Follow-up|0|||
143102844|NCT02308540|515917973|FG003|Overall Study|Lost to Follow-up|0|||
143102845|NCT02308540|515917974|FG004|Overall Study|Lost to Follow-up|0|||
143102846|NCT02308540|515917975|FG005|Overall Study|Lost to Follow-up|1|||
143102847|NCT04109391|515917976|FG000|Overall Study|Adverse Event|2|||
143102848|NCT04109391|515917977|FG001|Overall Study|Adverse Event|2|||
143102849|NCT04109391|515917978|FG002|Overall Study|Adverse Event|0|||
143102850|NCT04109391|515917976|FG000|Overall Study|Withdrawal by Subject|2|||
143102851|NCT04109391|515917977|FG001|Overall Study|Withdrawal by Subject|0|||
143102852|NCT04109391|515917978|FG002|Overall Study|Withdrawal by Subject|0|||
143102853|NCT04109391|515917976|FG000|Overall Study|Pregnancy|1|||
143102854|NCT04109391|515917977|FG001|Overall Study|Pregnancy|0|||
143102855|NCT04109391|515917978|FG002|Overall Study|Pregnancy|0|||
143102856|NCT04109391|515917976|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
143102857|NCT04109391|515917977|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
143102858|NCT04109391|515917978|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
143102859|NCT04109391|515917976|FG000|Overall Study|Lost to Follow-up|0|||
143102860|NCT04109391|515917977|FG001|Overall Study|Lost to Follow-up|0|||
143102861|NCT04109391|515917978|FG002|Overall Study|Lost to Follow-up|1|||
143102862|NCT04109391|515917976|FG000|Overall Study|Lack of Efficacy|2|||
143102863|NCT04109391|515917977|FG001|Overall Study|Lack of Efficacy|2|||
143102864|NCT04109391|515917978|FG002|Overall Study|Lack of Efficacy|3|||
143102865|NCT00443079|515917981|FG000|Overall Study|Lost to Follow-up|0|||
143102866|NCT00443079|515917982|FG001|Overall Study|Lost to Follow-up|1|||
143102867|NCT02993250|515917983|FG000|Overall Study|Lost to Follow-up|0|||
143102868|NCT02993250|515917984|FG001|Overall Study|Lost to Follow-up|1|||
143102869|NCT04606394|515917988|FG000|Overall Study|Withdrawal by Subject|3|||
143177691|NCT00784368|516199797|FG001|Overall Study|Worsening of complications|0|||
143177692|NCT00784368|516199798|FG002|Overall Study|Worsening of complications|1|||
143177693|NCT00784368|516199796|FG000|Overall Study|Worsening of symptoms|0|||
143177694|NCT00784368|516199797|FG001|Overall Study|Worsening of symptoms|1|||
143177695|NCT00784368|516199798|FG002|Overall Study|Worsening of symptoms|0|||
143177696|NCT00784368|516199796|FG000|Overall Study|Withdrawal of informed consent|0|||
143177697|NCT00784368|516199797|FG001|Overall Study|Withdrawal of informed consent|1|||
143177698|NCT00784368|516199798|FG002|Overall Study|Withdrawal of informed consent|0|||
143177699|NCT00720356|516199801|FG000|Registration to Study|Determined to have methylated MGMT|67|||
143177700|NCT00720356|516199801|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
143177701|NCT00720356|516199801|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
143177702|NCT00720356|516199801|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
143177703|NCT00720356|516199801|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
143177704|NCT00720356|516199801|FG000|Follow up Until Death|Withdrawal by Subject|1|||
143177705|NCT00720356|516199801|FG000|Follow up Until Death|Alive at last data collection|4|||
143177706|NCT02237001|516199804|FG000|Overall Study|Lost to Follow-up|2|||
143177707|NCT02237001|516199804|FG000|Overall Study|Withdrawal by Subject|1|||
143177708|NCT02237001|516199804|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
143177709|NCT02237001|516199804|FG000|Overall Study|Re-operation|4|||
143102870|NCT04606394|515917988|FG000|Overall Study|Exclusion criteria screen failure|12|||
143177710|NCT02237001|516199804|FG000|Overall Study|Incarceration|1|||
143177711|NCT01713582|516199805|FG000|Overall Study|Disease progression|3|||
143102871|NCT01896128|515917989|FG000|Overall Study|Withdrawal by Subject|3|||
143102872|NCT01896128|515917990|FG001|Overall Study|Withdrawal by Subject|3|||
143102873|NCT02484456|515917992|FG000|Washout Period|Withdrawal by Subject|0|||
143102874|NCT02484456|515917993|FG001|Washout Period|Withdrawal by Subject|1|||
143102875|NCT02484456|515917992|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
143102876|NCT02484456|515917993|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
143252347|NCT04784442|516478612|FG003|Overall Study|Adverse Event|1|||
143252348|NCT04784442|516478609|FG000|Overall Study|Protocol Violation|1|||
143252349|NCT04784442|516478610|FG001|Overall Study|Protocol Violation|0|||
143252350|NCT04784442|516478611|FG002|Overall Study|Protocol Violation|0|||
143252351|NCT04784442|516478612|FG003|Overall Study|Protocol Violation|0|||
143252352|NCT04784442|516478609|FG000|Overall Study|Non-compliance with study drug|1|||
143252353|NCT04784442|516478610|FG001|Overall Study|Non-compliance with study drug|0|||
143252354|NCT04784442|516478611|FG002|Overall Study|Non-compliance with study drug|0|||
143252355|NCT04784442|516478612|FG003|Overall Study|Non-compliance with study drug|0|||
143252356|NCT00486811|516478613|FG000|Overall Study|Adverse Event|28|||
143252357|NCT00486811|516478614|FG001|Overall Study|Adverse Event|60|||
143252358|NCT00486811|516478615|FG002|Overall Study|Adverse Event|135|||
143252359|NCT00486811|516478613|FG000|Overall Study|Lack of Efficacy|34|||
143252360|NCT00486811|516478614|FG001|Overall Study|Lack of Efficacy|14|||
143252361|NCT00486811|516478615|FG002|Overall Study|Lack of Efficacy|7|||
143252362|NCT00486811|516478613|FG000|Overall Study|Lost to Follow-up|4|||
143252363|NCT00486811|516478614|FG001|Overall Study|Lost to Follow-up|6|||
143252364|NCT00486811|516478615|FG002|Overall Study|Lost to Follow-up|4|||
143252365|NCT00486811|516478613|FG000|Overall Study|Withdrawal by Subject|33|||
143252366|NCT00486811|516478614|FG001|Overall Study|Withdrawal by Subject|44|||
143252367|NCT00486811|516478615|FG002|Overall Study|Withdrawal by Subject|58|||
143252368|NCT00486811|516478613|FG000|Overall Study|Study drug non-compliant|5|||
143252369|NCT00486811|516478614|FG001|Overall Study|Study drug non-compliant|6|||
143252370|NCT00486811|516478615|FG002|Overall Study|Study drug non-compliant|3|||
143102877|NCT02484456|515917992|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
143102878|NCT02484456|515917993|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
143102879|NCT02484456|515917992|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
143102880|NCT02484456|515917993|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
143102881|NCT01996254|515917994|FG000|Overall Study|Change in Eligibility|0|||
143102882|NCT01996254|515917995|FG001|Overall Study|Change in Eligibility|2|||
143102883|NCT01996254|515917996|FG002|Overall Study|Change in Eligibility|0|||
143102884|NCT01996254|515917994|FG000|Overall Study|Withdrawal by Subject|0|||
143102885|NCT01996254|515917995|FG001|Overall Study|Withdrawal by Subject|3|||
143102886|NCT01996254|515917996|FG002|Overall Study|Withdrawal by Subject|4|||
143102887|NCT01996254|515917994|FG000|Overall Study|Lost to Follow-up|1|||
143102888|NCT01996254|515917995|FG001|Overall Study|Lost to Follow-up|0|||
143102889|NCT01996254|515917996|FG002|Overall Study|Lost to Follow-up|4|||
143102890|NCT03423173|515917999|FG000|Overall Study|Randomized but not vaccinated|1|||
143367778|NCT00124982|516889440|FG000|Short-term Period|Lost to Follow-up|8|||
143367779|NCT00124982|516889441|FG001|Short-term Period|Lost to Follow-up|5|||
143367780|NCT00124982|516889442|FG002|Short-term Period|Lost to Follow-up|0|||
143367781|NCT00124982|516889440|FG000|Short-term Period|Withdrawal of Consent|7|||
143367782|NCT00124982|516889441|FG001|Short-term Period|Withdrawal of Consent|9|||
143367783|NCT00124982|516889442|FG002|Short-term Period|Withdrawal of Consent|0|||
143367784|NCT00124982|516889440|FG000|Short-term Period|Poor/Non-compliance|3|||
143367785|NCT00124982|516889441|FG001|Short-term Period|Poor/Non-compliance|1|||
143367786|NCT00124982|516889442|FG002|Short-term Period|Poor/Non-compliance|0|||
143367787|NCT00124982|516889440|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
143367788|NCT00124982|516889441|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
143367789|NCT00124982|516889442|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
143367790|NCT00124982|516889440|FG000|Short-term Period|Participant Decision|1|||
143367791|NCT00124982|516889441|FG001|Short-term Period|Participant Decision|0|||
143367792|NCT00124982|516889442|FG002|Short-term Period|Participant Decision|0|||
143367793|NCT00124982|516889440|FG000|Short-term Period|Participant Chose Own Doctor|0|||
143367794|NCT00124982|516889441|FG001|Short-term Period|Participant Chose Own Doctor|1|||
143367795|NCT00124982|516889442|FG002|Short-term Period|Participant Chose Own Doctor|0|||
143367796|NCT00124982|516889440|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
143367797|NCT00124982|516889441|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
143367798|NCT00124982|516889442|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
143367799|NCT00124982|516889440|FG000|Short-term Period|Participant Had Lymphopenia|1|||
143102891|NCT03423173|515918000|FG001|Overall Study|Randomized but not vaccinated|0|||
143102892|NCT03423173|515918001|FG002|Overall Study|Randomized but not vaccinated|2|||
143102893|NCT03423173|515918002|FG003|Overall Study|Randomized but not vaccinated|1|||
143252371|NCT00486811|516478613|FG000|Overall Study|All other|18|||
143252372|NCT00486811|516478614|FG001|Overall Study|All other|11|||
143252373|NCT00486811|516478615|FG002|Overall Study|All other|7|||
143252374|NCT00852371|516478621|FG000|Overall Study|Lost to Follow-up|2|||
143252375|NCT00852371|516478622|FG001|Overall Study|Lost to Follow-up|3|||
143252376|NCT00852371|516478623|FG002|Overall Study|Lost to Follow-up|4|||
143252377|NCT00852371|516478624|FG003|Overall Study|Lost to Follow-up|2|||
143252378|NCT03158285|516478625|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
143252379|NCT03158285|516478626|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
143252380|NCT03158285|516478627|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
143252381|NCT03158285|516478625|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
143252382|NCT03158285|516478626|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
143252383|NCT03158285|516478627|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
143252384|NCT03158285|516478625|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
143252385|NCT03158285|516478626|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
143252386|NCT03158285|516478627|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
143252387|NCT03158285|516478625|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
143252388|NCT03158285|516478626|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
143252389|NCT03158285|516478627|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
143252390|NCT03158285|516478625|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
143252391|NCT03158285|516478626|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
143252392|NCT03158285|516478627|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
143252393|NCT03158285|516478625|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
143252394|NCT03158285|516478626|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
143252395|NCT03158285|516478627|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
143252396|NCT03158285|516478625|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
143252397|NCT03158285|516478626|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
143252398|NCT03158285|516478627|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
143252399|NCT03158285|516478625|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
143252400|NCT03158285|516478626|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
143252401|NCT03158285|516478627|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
143252402|NCT03158285|516478625|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
143252403|NCT03158285|516478626|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
143252404|NCT03158285|516478627|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
143252405|NCT03158285|516478625|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
143252406|NCT03158285|516478626|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
143252407|NCT03158285|516478627|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
143252408|NCT03158285|516478625|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
143252409|NCT03158285|516478626|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
143252410|NCT03158285|516478627|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
143252411|NCT03158285|516478625|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
143252412|NCT03158285|516478626|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
143252413|NCT03158285|516478627|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
143252414|NCT03158285|516478625|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
143252415|NCT03158285|516478626|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
143252416|NCT03158285|516478627|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
143252417|NCT03158285|516478625|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
143252418|NCT03158285|516478626|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
143252419|NCT03158285|516478627|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
143252420|NCT03158285|516478625|FG000|Active Treatment Period: Week 52-100|Death|1|||
143252421|NCT03158285|516478626|FG001|Active Treatment Period: Week 52-100|Death|0|||
143252422|NCT03158285|516478627|FG002|Active Treatment Period: Week 52-100|Death|0|||
143252423|NCT03158285|516478625|FG000|Active Treatment Period: Week 52-100|Other|4|||
143252424|NCT03158285|516478626|FG001|Active Treatment Period: Week 52-100|Other|1|||
143102894|NCT03423173|515917999|FG000|Overall Study|Adverse Event|1|||
143102895|NCT03423173|515918000|FG001|Overall Study|Adverse Event|1|||
143102896|NCT03423173|515918001|FG002|Overall Study|Adverse Event|1|||
143102897|NCT03423173|515918002|FG003|Overall Study|Adverse Event|1|||
143102898|NCT03423173|515917999|FG000|Overall Study|Lost to Follow-up|10|||
143102899|NCT03423173|515918000|FG001|Overall Study|Lost to Follow-up|19|||
143102900|NCT03423173|515918001|FG002|Overall Study|Lost to Follow-up|17|||
143102901|NCT03423173|515918002|FG003|Overall Study|Lost to Follow-up|22|||
143252425|NCT03158285|516478627|FG002|Active Treatment Period: Week 52-100|Other|0|||
143252426|NCT02744040|516478630|FG000|Overall Study|Withdrawal by Subject|3|||
143252427|NCT02744040|516478631|FG001|Overall Study|Withdrawal by Subject|2|||
143252428|NCT02744040|516478632|FG002|Overall Study|Withdrawal by Subject|2|||
143252429|NCT02744040|516478630|FG000|Overall Study|Physician Decision|0|||
143252430|NCT02744040|516478631|FG001|Overall Study|Physician Decision|8|||
143252431|NCT02744040|516478632|FG002|Overall Study|Physician Decision|13|||
143252432|NCT02744040|516478630|FG000|Overall Study|Lost to Follow-up|3|||
143102902|NCT03423173|515917999|FG000|Overall Study|Withdrawal of consent|4|||
143102903|NCT03423173|515918000|FG001|Overall Study|Withdrawal of consent|10|||
143102904|NCT03423173|515918001|FG002|Overall Study|Withdrawal of consent|4|||
143102905|NCT03423173|515918002|FG003|Overall Study|Withdrawal of consent|5|||
143102906|NCT03423173|515917999|FG000|Overall Study|Death|1|||
143102907|NCT03423173|515918000|FG001|Overall Study|Death|0|||
143102908|NCT03423173|515918001|FG002|Overall Study|Death|0|||
143102909|NCT03423173|515918002|FG003|Overall Study|Death|0|||
143102910|NCT03423173|515917999|FG000|Overall Study|Reason not Specified|2|||
143102911|NCT03423173|515918000|FG001|Overall Study|Reason not Specified|5|||
143102912|NCT03423173|515918001|FG002|Overall Study|Reason not Specified|3|||
143102913|NCT03423173|515918002|FG003|Overall Study|Reason not Specified|1|||
143102914|NCT03348930|515918003|FG000|Washout (1 Week)|Lost to Follow-up|1|||
143102915|NCT03348930|515918004|FG001|Washout (1 Week)|Lost to Follow-up|1|||
143102916|NCT01053663|515918005|FG000|Overall Study|Death|2|||
143177712|NCT01713582|516199806|FG001|Overall Study|Disease progression|3|||
143177713|NCT01713582|516199807|FG002|Overall Study|Disease progression|3|||
143177714|NCT01713582|516199808|FG003|Overall Study|Disease progression|2|||
143177715|NCT01713582|516199809|FG004|Overall Study|Disease progression|3|||
143177716|NCT01713582|516199810|FG005|Overall Study|Disease progression|3|||
143177717|NCT01713582|516199811|FG006|Overall Study|Disease progression|3|||
143177718|NCT01713582|516199812|FG007|Overall Study|Disease progression|3|||
143177719|NCT01713582|516199813|FG008|Overall Study|Disease progression|3|||
143177720|NCT01713582|516199814|FG009|Overall Study|Disease progression|11|||
143177721|NCT01713582|516199815|FG010|Overall Study|Disease progression|10|||
143177722|NCT01713582|516199816|FG011|Overall Study|Disease progression|5|||
143177723|NCT01713582|516199817|FG012|Overall Study|Disease progression|3|||
143177724|NCT01713582|516199818|FG013|Overall Study|Disease progression|3|||
143177725|NCT01713582|516199819|FG014|Overall Study|Disease progression|6|||
143177726|NCT01713582|516199820|FG015|Overall Study|Disease progression|6|||
143177727|NCT01713582|516199821|FG016|Overall Study|Disease progression|5|||
143177728|NCT01713582|516199822|FG017|Overall Study|Disease progression|2|||
143177729|NCT01713582|516199823|FG018|Overall Study|Disease progression|3|||
143177730|NCT01713582|516199824|FG019|Overall Study|Disease progression|5|||
143177731|NCT01713582|516199825|FG020|Overall Study|Disease progression|15|||
143177732|NCT01713582|516199805|FG000|Overall Study|Death|0|||
143177733|NCT01713582|516199806|FG001|Overall Study|Death|0|||
143177734|NCT01713582|516199807|FG002|Overall Study|Death|0|||
143177735|NCT01713582|516199808|FG003|Overall Study|Death|1|||
143177736|NCT01713582|516199809|FG004|Overall Study|Death|1|||
143177737|NCT01713582|516199810|FG005|Overall Study|Death|3|||
143177738|NCT01713582|516199811|FG006|Overall Study|Death|3|||
143177739|NCT01713582|516199812|FG007|Overall Study|Death|2|||
143177740|NCT01713582|516199813|FG008|Overall Study|Death|3|||
143177741|NCT01713582|516199814|FG009|Overall Study|Death|4|||
143177742|NCT01713582|516199815|FG010|Overall Study|Death|3|||
143177743|NCT01713582|516199816|FG011|Overall Study|Death|0|||
143177744|NCT01713582|516199817|FG012|Overall Study|Death|0|||
143177745|NCT01713582|516199818|FG013|Overall Study|Death|0|||
143177746|NCT01713582|516199819|FG014|Overall Study|Death|0|||
143177747|NCT01713582|516199820|FG015|Overall Study|Death|0|||
143177748|NCT01713582|516199821|FG016|Overall Study|Death|0|||
143177749|NCT01713582|516199822|FG017|Overall Study|Death|0|||
143177750|NCT01713582|516199823|FG018|Overall Study|Death|0|||
143177751|NCT01713582|516199824|FG019|Overall Study|Death|0|||
143177752|NCT01713582|516199825|FG020|Overall Study|Death|0|||
143252433|NCT02744040|516478631|FG001|Overall Study|Lost to Follow-up|1|||
143252434|NCT02744040|516478632|FG002|Overall Study|Lost to Follow-up|7|||
143252435|NCT01642615|516478633|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
143252436|NCT01642615|516478634|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
143252437|NCT01642615|516478635|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
143252438|NCT01642615|516478633|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
143252439|NCT01642615|516478634|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
143252440|NCT01642615|516478635|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
143102917|NCT01053663|515918005|FG000|Overall Study|Lost to Follow-up|1|||
143102918|NCT01053663|515918005|FG000|Overall Study|Poor IV Access|1|||
143102919|NCT01053663|515918005|FG000|Overall Study|Transferred to Another Hospital|1|||
143102920|NCT01053663|515918005|FG000|Overall Study|Negative Influenza Diagnosis|1|||
143102921|NCT02737930|515918008|FG000|Overall Study|Withdrawal by Subject|0|||
143102922|NCT02737930|515918009|FG001|Overall Study|Withdrawal by Subject|1|||
143102923|NCT02411396|515918012|FG000|Overall Study|Lost to Follow-up|31|||
143102924|NCT02411396|515918012|FG000|Overall Study|Death|10|||
143102925|NCT02071706|515918019|FG000|Overall Study|Adverse Event|1|||
143102926|NCT02071706|515918019|FG000|Overall Study|Withdrawal by Subject|2|||
143102927|NCT01908829|515918020|FG000|Overall Study|Adverse Event|13|||
143102928|NCT01908829|515918021|FG001|Overall Study|Adverse Event|11|||
143102929|NCT01908829|515918022|FG002|Overall Study|Adverse Event|13|||
143102930|NCT01908829|515918020|FG000|Overall Study|Lost to Follow-up|4|||
143102931|NCT01908829|515918021|FG001|Overall Study|Lost to Follow-up|2|||
143252441|NCT01642615|516478633|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
143102932|NCT01908829|515918022|FG002|Overall Study|Lost to Follow-up|1|||
143252442|NCT01642615|516478634|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
143252443|NCT01642615|516478635|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
143102933|NCT01908829|515918020|FG000|Overall Study|Randomized no double-blind drug received|1|||
143102934|NCT01908829|515918021|FG001|Overall Study|Randomized no double-blind drug received|0|||
143177753|NCT01713582|516199805|FG000|Overall Study|Adverse event-related|0|||
143177754|NCT01713582|516199806|FG001|Overall Study|Adverse event-related|0|||
143177755|NCT01713582|516199807|FG002|Overall Study|Adverse event-related|0|||
143177756|NCT01713582|516199808|FG003|Overall Study|Adverse event-related|0|||
143177757|NCT01713582|516199809|FG004|Overall Study|Adverse event-related|0|||
143177758|NCT01713582|516199810|FG005|Overall Study|Adverse event-related|0|||
143177759|NCT01713582|516199811|FG006|Overall Study|Adverse event-related|0|||
143177760|NCT01713582|516199812|FG007|Overall Study|Adverse event-related|0|||
143177761|NCT01713582|516199813|FG008|Overall Study|Adverse event-related|0|||
143177762|NCT01713582|516199814|FG009|Overall Study|Adverse event-related|1|||
143177763|NCT01713582|516199815|FG010|Overall Study|Adverse event-related|1|||
143177764|NCT01713582|516199816|FG011|Overall Study|Adverse event-related|0|||
143177765|NCT01713582|516199817|FG012|Overall Study|Adverse event-related|0|||
143177766|NCT01713582|516199818|FG013|Overall Study|Adverse event-related|0|||
143177767|NCT01713582|516199819|FG014|Overall Study|Adverse event-related|0|||
143177768|NCT01713582|516199820|FG015|Overall Study|Adverse event-related|0|||
143177769|NCT01713582|516199821|FG016|Overall Study|Adverse event-related|0|||
143177770|NCT01713582|516199822|FG017|Overall Study|Adverse event-related|0|||
143177771|NCT01713582|516199823|FG018|Overall Study|Adverse event-related|1|||
143177772|NCT01713582|516199824|FG019|Overall Study|Adverse event-related|0|||
143177773|NCT01713582|516199825|FG020|Overall Study|Adverse event-related|0|||
143177774|NCT01713582|516199805|FG000|Overall Study|Adverse event-unrelated|0|||
143177775|NCT01713582|516199806|FG001|Overall Study|Adverse event-unrelated|0|||
143177776|NCT01713582|516199807|FG002|Overall Study|Adverse event-unrelated|0|||
143177777|NCT01713582|516199808|FG003|Overall Study|Adverse event-unrelated|0|||
143177778|NCT01713582|516199809|FG004|Overall Study|Adverse event-unrelated|0|||
143177779|NCT01713582|516199810|FG005|Overall Study|Adverse event-unrelated|1|||
143177780|NCT01713582|516199811|FG006|Overall Study|Adverse event-unrelated|1|||
143252444|NCT01642615|516478633|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
143252445|NCT01642615|516478634|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
143252446|NCT01642615|516478635|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
143252447|NCT01642615|516478633|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
143252448|NCT01642615|516478634|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
143252449|NCT01642615|516478635|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
143252450|NCT01642615|516478633|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
143252451|NCT01642615|516478634|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
143252452|NCT01642615|516478635|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
143252453|NCT01642615|516478633|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
143252454|NCT01642615|516478634|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
143252455|NCT01642615|516478635|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
143252456|NCT01642615|516478633|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
143252457|NCT01642615|516478634|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
143252458|NCT01642615|516478635|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
143252459|NCT01642615|516478633|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
143252460|NCT01642615|516478634|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
143252461|NCT01642615|516478635|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
143252462|NCT00096356|516478638|FG000|Overall Study|Adverse Event|11|||
143252463|NCT00096356|516478639|FG001|Overall Study|Adverse Event|9|||
143252464|NCT00096356|516478638|FG000|Overall Study|Physician Decision|5|||
143252465|NCT00096356|516478639|FG001|Overall Study|Physician Decision|3|||
143252466|NCT00096356|516478638|FG000|Overall Study|Withdrawal by Subject|17|||
143252467|NCT00096356|516478639|FG001|Overall Study|Withdrawal by Subject|23|||
143252468|NCT00096356|516478638|FG000|Overall Study|Lack of Efficacy|1|||
143252469|NCT00096356|516478639|FG001|Overall Study|Lack of Efficacy|0|||
143252470|NCT00096356|516478638|FG000|Overall Study|multiple reasons|10|||
143252471|NCT00096356|516478639|FG001|Overall Study|multiple reasons|18|||
143252472|NCT01008423|516478640|FG000|Overall Study|Adverse Event|13|||
143252473|NCT01008423|516478641|FG001|Overall Study|Adverse Event|6|||
143252474|NCT01008423|516478640|FG000|Overall Study|Withdrawal by Subject|4|||
143252475|NCT01008423|516478641|FG001|Overall Study|Withdrawal by Subject|7|||
143252476|NCT01008423|516478640|FG000|Overall Study|Lost to Follow-up|0|||
143252477|NCT01008423|516478641|FG001|Overall Study|Lost to Follow-up|2|||
143252478|NCT01008423|516478640|FG000|Overall Study|Low Cortisol|0|||
143252479|NCT01008423|516478641|FG001|Overall Study|Low Cortisol|1|||
143252480|NCT01008423|516478640|FG000|Overall Study|Lack of Efficacy|0|||
143252481|NCT01008423|516478641|FG001|Overall Study|Lack of Efficacy|5|||
143252482|NCT01008423|516478640|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
143252483|NCT01008423|516478641|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
143252484|NCT01008423|516478640|FG000|Overall Study|Personal Conflict|1|||
143252485|NCT01008423|516478641|FG001|Overall Study|Personal Conflict|0|||
143252486|NCT01008423|516478640|FG000|Overall Study|Other|0|||
143252487|NCT01008423|516478641|FG001|Overall Study|Other|1|||
143252488|NCT03288142|516478645|FG000|Overall Study|Lost to Follow-up|22|||
143252489|NCT03288142|516478646|FG001|Overall Study|Lost to Follow-up|15|||
143252490|NCT00402740|516478647|FG000|Overall Study|Withdrawal by Subject|18|||
143252491|NCT00402740|516478647|FG000|Overall Study|Death|50|||
143367800|NCT00124982|516889441|FG001|Short-term Period|Participant Had Lymphopenia|0|||
143367801|NCT00124982|516889442|FG002|Short-term Period|Participant Had Lymphopenia|0|||
143252492|NCT00402740|516478647|FG000|Overall Study|Lost to Follow-up|6|||
143252493|NCT00402740|516478647|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
143252494|NCT00402740|516478647|FG000|Overall Study|Subject disposition unknown.|1|||
143252495|NCT01028300|516478648|FG000|Overall Study|Study Terminated|4|||
143252496|NCT01214395|516478651|FG000|Overall Study|All patients had infection|5|||
143252497|NCT02034409|516478655|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
143252498|NCT02034409|516478656|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
143252499|NCT02034409|516478655|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
143252500|NCT02034409|516478656|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
143252501|NCT02034409|516478655|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
143252502|NCT02034409|516478656|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
143252503|NCT02034409|516478655|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
143252504|NCT02034409|516478656|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
143252505|NCT02034409|516478655|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
143252506|NCT02034409|516478656|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
143252507|NCT02034409|516478655|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
143252508|NCT02034409|516478656|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
143252509|NCT01030666|516478657|FG000|Overall Study|Lost to Follow-up|3|||
143252510|NCT01030666|516478658|FG001|Overall Study|Lost to Follow-up|2|||
143252511|NCT01699867|516478661|FG000|Overall Study|Screening Failure|3|||
143252512|NCT04002908|516478664|FG000|Overall Study|Death|41|||
143252513|NCT04002908|516478665|FG001|Overall Study|Death|0|||
143252514|NCT04002908|516478666|FG002|Overall Study|Death|0|||
143252515|NCT04002908|516478667|FG003|Overall Study|Death|0|||
143252516|NCT04002908|516478664|FG000|Overall Study|Withdrawal by Subject|112|||
143252517|NCT04002908|516478665|FG001|Overall Study|Withdrawal by Subject|0|||
143252518|NCT04002908|516478666|FG002|Overall Study|Withdrawal by Subject|0|||
143252519|NCT04002908|516478667|FG003|Overall Study|Withdrawal by Subject|0|||
143252520|NCT04002908|516478664|FG000|Overall Study|Lost to Follow-up|72|||
143252521|NCT04002908|516478665|FG001|Overall Study|Lost to Follow-up|0|||
143252522|NCT04002908|516478666|FG002|Overall Study|Lost to Follow-up|0|||
143252523|NCT04002908|516478667|FG003|Overall Study|Lost to Follow-up|0|||
143102935|NCT01908829|515918022|FG002|Overall Study|Randomized no double-blind drug received|1|||
143102936|NCT01908829|515918020|FG000|Overall Study|Discontinued (no EoT page)|2|||
143102937|NCT01908829|515918021|FG001|Overall Study|Discontinued (no EoT page)|0|||
143102938|NCT01908829|515918022|FG002|Overall Study|Discontinued (no EoT page)|0|||
143102939|NCT01908829|515918020|FG000|Overall Study|Miscellaneous|0|||
143102940|NCT01908829|515918021|FG001|Overall Study|Miscellaneous|2|||
143252524|NCT04002908|516478664|FG000|Overall Study|Infant died, so mother withdrawn|34|||
143252525|NCT04002908|516478665|FG001|Overall Study|Infant died, so mother withdrawn|0|||
143252526|NCT04002908|516478666|FG002|Overall Study|Infant died, so mother withdrawn|0|||
143252527|NCT04002908|516478667|FG003|Overall Study|Infant died, so mother withdrawn|0|||
143252528|NCT03698591|516478668|FG000|Overall Study|Withdrawal by Subject|2|||
143252529|NCT03698591|516478669|FG001|Overall Study|Withdrawal by Subject|2|||
143252530|NCT03698591|516478668|FG000|Overall Study|Failed drug screen|1|||
143252531|NCT03698591|516478669|FG001|Overall Study|Failed drug screen|1|||
143252532|NCT03698591|516478668|FG000|Overall Study|Failed health screen|0|||
143252533|NCT03698591|516478669|FG001|Overall Study|Failed health screen|1|||
143252534|NCT03698591|516478668|FG000|Overall Study|Ineligible for financial compensation|1|||
143252535|NCT03698591|516478669|FG001|Overall Study|Ineligible for financial compensation|0|||
143252536|NCT03698591|516478668|FG000|Overall Study|Equipment Error|1|||
143252537|NCT03698591|516478669|FG001|Overall Study|Equipment Error|0|||
143252538|NCT03698591|516478668|FG000|Overall Study|Could not establish TMS dosage|0|||
143252539|NCT03698591|516478669|FG001|Overall Study|Could not establish TMS dosage|1|||
143252540|NCT00831493|516478675|FG000|Overall Study|Intractable nausea and vomiting|1|||
143252541|NCT00530504|516478676|FG000|Overall Study|Death|54|||
143252542|NCT00530504|516478676|FG000|Overall Study|Lost to Follow-up|26|||
143252543|NCT00530504|516478676|FG000|Overall Study|Withdrawal by Subject|39|||
143252544|NCT00530504|516478676|FG000|Overall Study|Exited study due to other reasons|33|||
143252545|NCT00006289|516478677|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
143252546|NCT00006289|516478678|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
143252547|NCT00006289|516478677|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
143252548|NCT00006289|516478678|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
143252549|NCT00557856|516478690|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
143252550|NCT00557856|516478691|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
143252551|NCT00557856|516478692|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
143252552|NCT00557856|516478693|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
143252553|NCT00557856|516478694|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
143252554|NCT00557856|516478695|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
143252555|NCT00557856|516478696|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
143252556|NCT00557856|516478697|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
143252557|NCT00557856|516478698|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
143252558|NCT00557856|516478690|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
143252559|NCT00557856|516478691|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
143252560|NCT00557856|516478692|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
143252561|NCT00557856|516478693|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
143252562|NCT00557856|516478694|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
143252563|NCT00557856|516478695|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
143252564|NCT00557856|516478696|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
143252565|NCT00557856|516478697|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
143252566|NCT00557856|516478698|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
143102941|NCT01908829|515918022|FG002|Overall Study|Miscellaneous|0|||
143252567|NCT00557856|516478690|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
143252568|NCT00557856|516478691|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
143252569|NCT00557856|516478692|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
143252570|NCT00557856|516478693|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
143252571|NCT00557856|516478694|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
143252572|NCT00557856|516478695|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
143102942|NCT01908829|515918020|FG000|Overall Study|Protocol Violation|2|||
143102943|NCT01908829|515918021|FG001|Overall Study|Protocol Violation|2|||
143252573|NCT00557856|516478696|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
143252574|NCT00557856|516478697|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
143252575|NCT00557856|516478698|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
143252576|NCT00557856|516478690|FG000|Part 1: Dose Escalation Phase|Other|0|||
143252577|NCT00557856|516478691|FG001|Part 1: Dose Escalation Phase|Other|0|||
143252578|NCT00557856|516478692|FG002|Part 1: Dose Escalation Phase|Other|1|||
143252579|NCT00557856|516478693|FG003|Part 1: Dose Escalation Phase|Other|1|||
143252580|NCT00557856|516478694|FG004|Part 1: Dose Escalation Phase|Other|0|||
143252581|NCT00557856|516478695|FG005|Part 1: Dose Escalation Phase|Other|0|||
143252582|NCT00557856|516478696|FG006|Part 1: Dose Escalation Phase|Other|0|||
143252583|NCT00557856|516478697|FG007|Part 1: Dose Escalation Phase|Other|1|||
143252584|NCT00557856|516478698|FG008|Part 1: Dose Escalation Phase|Other|0|||
143252585|NCT00557856|516478690|FG000|Part 1: Dose Escalation Phase|Death|0|||
143252586|NCT00557856|516478691|FG001|Part 1: Dose Escalation Phase|Death|0|||
143252587|NCT00557856|516478692|FG002|Part 1: Dose Escalation Phase|Death|0|||
143252588|NCT00557856|516478693|FG003|Part 1: Dose Escalation Phase|Death|0|||
143252589|NCT00557856|516478694|FG004|Part 1: Dose Escalation Phase|Death|0|||
143252590|NCT00557856|516478695|FG005|Part 1: Dose Escalation Phase|Death|1|||
143252591|NCT00557856|516478696|FG006|Part 1: Dose Escalation Phase|Death|0|||
143252592|NCT00557856|516478697|FG007|Part 1: Dose Escalation Phase|Death|0|||
143252593|NCT00557856|516478698|FG008|Part 1: Dose Escalation Phase|Death|0|||
143252594|NCT00557856|516478690|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
143252595|NCT00557856|516478691|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
143252596|NCT00557856|516478692|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
143252597|NCT00557856|516478693|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
143252598|NCT00557856|516478694|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
143252599|NCT00557856|516478695|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
143252600|NCT00557856|516478696|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
143252601|NCT00557856|516478697|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
143252602|NCT00557856|516478698|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
143252603|NCT00557856|516478690|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
143252604|NCT00557856|516478691|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
143252605|NCT00557856|516478692|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
143252606|NCT00557856|516478693|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
143252607|NCT00557856|516478694|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
143252608|NCT00557856|516478695|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
143252609|NCT00557856|516478696|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
143252610|NCT00557856|516478697|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
143252611|NCT00557856|516478698|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
143252612|NCT00557856|516478690|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
143252613|NCT00557856|516478691|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
143252614|NCT00557856|516478692|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
143252615|NCT00557856|516478693|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
143252616|NCT00557856|516478694|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
143252617|NCT00557856|516478695|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
143252618|NCT00557856|516478696|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
143252619|NCT00557856|516478697|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
143252620|NCT00557856|516478698|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
143252621|NCT00557856|516478690|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
143252622|NCT00557856|516478691|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
143252623|NCT00557856|516478692|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
143252624|NCT00557856|516478693|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
143252625|NCT00557856|516478694|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
143252626|NCT00557856|516478695|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
143252627|NCT00557856|516478696|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
143252628|NCT00557856|516478697|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
143252629|NCT00557856|516478698|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
143252630|NCT00557856|516478690|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
143252631|NCT00557856|516478691|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
143252632|NCT00557856|516478692|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
143367802|NCT00124982|516889440|FG000|Long-term Period|Death|0|||
143367803|NCT00124982|516889441|FG001|Long-term Period|Death|0|||
143102944|NCT01908829|515918022|FG002|Overall Study|Protocol Violation|0|||
143102945|NCT01908829|515918020|FG000|Overall Study|Lack of Efficacy|1|||
143102946|NCT01908829|515918021|FG001|Overall Study|Lack of Efficacy|3|||
143102947|NCT01908829|515918022|FG002|Overall Study|Lack of Efficacy|2|||
143102948|NCT01908829|515918020|FG000|Overall Study|Withdrawal by Subject|26|||
143102949|NCT01908829|515918021|FG001|Overall Study|Withdrawal by Subject|29|||
143102950|NCT01908829|515918022|FG002|Overall Study|Withdrawal by Subject|22|||
143252633|NCT00557856|516478693|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
143252634|NCT00557856|516478694|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
143252635|NCT00557856|516478695|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
143252636|NCT00557856|516478696|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
143252637|NCT00557856|516478697|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
143252638|NCT00557856|516478698|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
143252639|NCT00557856|516478690|FG000|Part 2: Exploratory Phase|Other|0|||
143252640|NCT00557856|516478691|FG001|Part 2: Exploratory Phase|Other|0|||
143252641|NCT00557856|516478692|FG002|Part 2: Exploratory Phase|Other|0|||
143252642|NCT00557856|516478693|FG003|Part 2: Exploratory Phase|Other|0|||
143252643|NCT00557856|516478694|FG004|Part 2: Exploratory Phase|Other|0|||
143252644|NCT00557856|516478695|FG005|Part 2: Exploratory Phase|Other|0|||
143252645|NCT00557856|516478696|FG006|Part 2: Exploratory Phase|Other|0|||
143102951|NCT02247440|515918023|FG000|Overall Study|Withdrawal by Subject|1|||
143102952|NCT02247440|515918023|FG000|Overall Study|Lack of Efficacy|3|||
143102953|NCT00403481|515918025|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
143102954|NCT00403481|515918025|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
143102955|NCT00403481|515918025|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
143102956|NCT00403481|515918025|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
143102957|NCT00403481|515918025|FG000|Olm 40 mg|Adverse Event|2|||
143102958|NCT00403481|515918025|FG000|Olm 40 mg|Protocol Violation|1|||
143102959|NCT00403481|515918025|FG000|Olm 40 mg|Withdrawal by Subject|1|||
143102960|NCT00403481|515918025|FG000|Olm 40 mg|Other|1|||
143102961|NCT00403481|515918025|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
143102962|NCT00403481|515918025|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
143102963|NCT00403481|515918025|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
143102964|NCT00403481|515918025|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
143252646|NCT00557856|516478697|FG007|Part 2: Exploratory Phase|Other|0|||
143252647|NCT00557856|516478698|FG008|Part 2: Exploratory Phase|Other|1|||
143252648|NCT00557856|516478690|FG000|Part 2: Exploratory Phase|Death|0|||
143252649|NCT00557856|516478691|FG001|Part 2: Exploratory Phase|Death|0|||
143252650|NCT00557856|516478692|FG002|Part 2: Exploratory Phase|Death|0|||
143252651|NCT00557856|516478693|FG003|Part 2: Exploratory Phase|Death|0|||
143252652|NCT00557856|516478694|FG004|Part 2: Exploratory Phase|Death|0|||
143252653|NCT00557856|516478695|FG005|Part 2: Exploratory Phase|Death|0|||
143252654|NCT00557856|516478696|FG006|Part 2: Exploratory Phase|Death|0|||
143252655|NCT00557856|516478697|FG007|Part 2: Exploratory Phase|Death|0|||
143252656|NCT00557856|516478698|FG008|Part 2: Exploratory Phase|Death|2|||
143252657|NCT00557856|516478690|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
143252658|NCT00557856|516478691|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
143252659|NCT00557856|516478692|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
143252660|NCT00557856|516478693|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
143252661|NCT00557856|516478694|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
143252662|NCT00557856|516478695|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
143252663|NCT00557856|516478696|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
143252664|NCT00557856|516478697|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
143252665|NCT00557856|516478698|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
143252666|NCT05092360|516478699|FG000|Overall Study|Withdrawal by Subject|21|||
143252667|NCT05092360|516478700|FG001|Overall Study|Withdrawal by Subject|4|||
143252668|NCT05092360|516478701|FG002|Overall Study|Withdrawal by Subject|9|||
143252669|NCT05092360|516478702|FG003|Overall Study|Withdrawal by Subject|26|||
143252670|NCT05092360|516478699|FG000|Overall Study|Death|97|||
143252671|NCT05092360|516478700|FG001|Overall Study|Death|14|||
143252672|NCT05092360|516478701|FG002|Overall Study|Death|31|||
143252673|NCT05092360|516478702|FG003|Overall Study|Death|101|||
143252674|NCT05092360|516478699|FG000|Overall Study|Lost to Follow-up|1|||
143252675|NCT05092360|516478700|FG001|Overall Study|Lost to Follow-up|2|||
143252676|NCT05092360|516478701|FG002|Overall Study|Lost to Follow-up|2|||
143252677|NCT05092360|516478702|FG003|Overall Study|Lost to Follow-up|2|||
143252678|NCT05092360|516478699|FG000|Overall Study|Study terminated by sponsor|65|||
143252679|NCT05092360|516478700|FG001|Overall Study|Study terminated by sponsor|7|||
143252680|NCT05092360|516478701|FG002|Overall Study|Study terminated by sponsor|13|||
143252681|NCT05092360|516478702|FG003|Overall Study|Study terminated by sponsor|61|||
143252682|NCT01675167|516478703|FG000|Open-label Titration Phase|Adverse Event|81|||
143252683|NCT01675167|516478704|FG001|Open-label Titration Phase|Adverse Event|0|||
143252684|NCT01675167|516478705|FG002|Open-label Titration Phase|Adverse Event|0|||
143252685|NCT01675167|516478703|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
143252686|NCT01675167|516478704|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
143252687|NCT01675167|516478705|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
143252688|NCT01675167|516478703|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
143252689|NCT01675167|516478704|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
143252690|NCT01675167|516478705|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
143102965|NCT00403481|515918025|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
143102966|NCT00403481|515918025|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
143252691|NCT01675167|516478703|FG000|Open-label Titration Phase|Protocol Violation|43|||
143252692|NCT01675167|516478704|FG001|Open-label Titration Phase|Protocol Violation|0|||
143252693|NCT01675167|516478705|FG002|Open-label Titration Phase|Protocol Violation|0|||
143252694|NCT01675167|516478703|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
143252695|NCT01675167|516478704|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
143252696|NCT01675167|516478705|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
143252697|NCT01675167|516478703|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
143252698|NCT01675167|516478704|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
143252699|NCT01675167|516478705|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
143252700|NCT01675167|516478703|FG000|Open-label Titration Phase|Other|55|||
143252701|NCT01675167|516478704|FG001|Open-label Titration Phase|Other|0|||
143252702|NCT01675167|516478705|FG002|Open-label Titration Phase|Other|0|||
143252703|NCT01675167|516478703|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
143252704|NCT01675167|516478704|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
143252705|NCT01675167|516478705|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
143252706|NCT01675167|516478703|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
143252707|NCT01675167|516478704|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
143252708|NCT01675167|516478705|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
143252709|NCT01675167|516478703|FG000|Double-blind Treatment Phase|Adverse Event|0|||
143252710|NCT01675167|516478704|FG001|Double-blind Treatment Phase|Adverse Event|5|||
143252711|NCT01675167|516478705|FG002|Double-blind Treatment Phase|Adverse Event|13|||
143252712|NCT01675167|516478703|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
143252713|NCT01675167|516478704|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
143252714|NCT01675167|516478705|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
143252715|NCT01675167|516478703|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
143252716|NCT01675167|516478704|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
143252717|NCT01675167|516478705|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
143252718|NCT01675167|516478703|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
143252719|NCT01675167|516478704|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
143252720|NCT01675167|516478705|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
143252721|NCT01675167|516478703|FG000|Double-blind Treatment Phase|Other|0|||
143252722|NCT01675167|516478704|FG001|Double-blind Treatment Phase|Other|7|||
143252723|NCT01675167|516478705|FG002|Double-blind Treatment Phase|Other|5|||
143252724|NCT01525225|516478706|FG000|Enrollment|No longer met study criteria|1|||
143252725|NCT01525225|516478706|FG000|Enrollment|Other|1|||
143252726|NCT03255083|516478707|FG000|Overall Study|Clinical progression|1|||
143252727|NCT03255083|516478708|FG001|Overall Study|Clinical progression|0|||
143252728|NCT03255083|516478709|FG002|Overall Study|Clinical progression|0|||
143252729|NCT03255083|516478710|FG003|Overall Study|Clinical progression|0|||
143252730|NCT03255083|516478707|FG000|Overall Study|Adverse Event|0|||
143252731|NCT03255083|516478708|FG001|Overall Study|Adverse Event|1|||
143252732|NCT03255083|516478709|FG002|Overall Study|Adverse Event|0|||
143252733|NCT03255083|516478710|FG003|Overall Study|Adverse Event|0|||
143252734|NCT03255083|516478707|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
143252735|NCT03255083|516478708|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
143252736|NCT03255083|516478709|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
143252737|NCT03255083|516478710|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
143252738|NCT03255083|516478707|FG000|Overall Study|Withdrawal by Subject|1|||
143252739|NCT03255083|516478708|FG001|Overall Study|Withdrawal by Subject|1|||
143252740|NCT03255083|516478709|FG002|Overall Study|Withdrawal by Subject|1|||
143252741|NCT03255083|516478710|FG003|Overall Study|Withdrawal by Subject|0|||
143252742|NCT00363545|516478711|FG000|Overall Study|Serious Adverse Event|0|||
143252743|NCT00363545|516478712|FG001|Overall Study|Serious Adverse Event|1|||
143252744|NCT00363545|516478711|FG000|Overall Study|Withdrawal by Subject|12|||
143252745|NCT00363545|516478712|FG001|Overall Study|Withdrawal by Subject|15|||
143252746|NCT00363545|516478711|FG000|Overall Study|Migrated/moved from study area|3|||
143252747|NCT00363545|516478712|FG001|Overall Study|Migrated/moved from study area|6|||
143252748|NCT00363545|516478711|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
143252749|NCT00363545|516478712|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
143252750|NCT00363545|516478711|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
143252751|NCT00363545|516478712|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
143252752|NCT00363545|516478711|FG000|Overall Study|Others|1|||
143252753|NCT00363545|516478712|FG001|Overall Study|Others|0|||
143252754|NCT01457352|516478713|FG000|Period 1|Adverse Event|2|||
143252755|NCT01457352|516478714|FG001|Period 1|Adverse Event|0|||
143252756|NCT01457352|516478713|FG000|Period 1|Withdrawal by Subject|2|||
143252757|NCT01457352|516478714|FG001|Period 1|Withdrawal by Subject|0|||
143252758|NCT01457352|516478713|FG000|Period 1|Physician Decision|2|||
143252759|NCT01457352|516478714|FG001|Period 1|Physician Decision|0|||
143252760|NCT01457352|516478713|FG000|Period 1|MS related disease progression|1|||
143252761|NCT01457352|516478714|FG001|Period 1|MS related disease progression|0|||
143252762|NCT01457352|516478713|FG000|Period 1|Withdrawn|1|||
143252763|NCT01457352|516478714|FG001|Period 1|Withdrawn|0|||
143177781|NCT01713582|516199812|FG007|Overall Study|Adverse event-unrelated|1|||
143177782|NCT01713582|516199813|FG008|Overall Study|Adverse event-unrelated|0|||
143177783|NCT01713582|516199814|FG009|Overall Study|Adverse event-unrelated|0|||
143177784|NCT01713582|516199815|FG010|Overall Study|Adverse event-unrelated|0|||
143177785|NCT01713582|516199816|FG011|Overall Study|Adverse event-unrelated|0|||
143177786|NCT01713582|516199817|FG012|Overall Study|Adverse event-unrelated|0|||
143102967|NCT03340454|515918031|FG000|Overall Study|Lost to Follow-up|0|||
143102968|NCT03340454|515918032|FG001|Overall Study|Lost to Follow-up|4|||
143102969|NCT01464164|515918033|FG000|Overall Study|Screen failure|0|||
143102970|NCT01464164|515918034|FG001|Overall Study|Screen failure|1|||
143102971|NCT01464164|515918035|FG002|Overall Study|Screen failure|2|||
143102972|NCT01464164|515918036|FG003|Overall Study|Screen failure|0|||
143102973|NCT01464164|515918037|FG004|Overall Study|Screen failure|0|||
143102974|NCT01464164|515918038|FG005|Overall Study|Screen failure|0|||
143102975|NCT01464164|515918039|FG006|Overall Study|Screen failure|0|||
143102976|NCT01464164|515918033|FG000|Overall Study|Physician Decision|0|||
143102977|NCT01464164|515918034|FG001|Overall Study|Physician Decision|1|||
143102978|NCT01464164|515918035|FG002|Overall Study|Physician Decision|0|||
143102979|NCT01464164|515918036|FG003|Overall Study|Physician Decision|0|||
143102980|NCT01464164|515918037|FG004|Overall Study|Physician Decision|0|||
143102981|NCT01464164|515918038|FG005|Overall Study|Physician Decision|0|||
143102982|NCT01464164|515918039|FG006|Overall Study|Physician Decision|2|||
143102983|NCT03682848|515918040|FG000|Overall Study|Withdrawal by Subject|2|||
143102984|NCT03682848|515918040|FG000|Overall Study|Site closed|5|||
143102985|NCT03682848|515918040|FG000|Overall Study|Protocol Deviation|1|||
143102986|NCT03682848|515918040|FG000|Overall Study|Adverse Event|1|||
143102987|NCT00454363|515918041|FG000|Overall Study|Adverse Event|1|||
143102988|NCT00454363|515918042|FG001|Overall Study|Adverse Event|2|||
143102989|NCT00454363|515918041|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
143102990|NCT00454363|515918042|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
143102991|NCT01578239|515918043|FG000|Treatment Period|Progressive Disease|19|||
143102992|NCT01578239|515918044|FG001|Treatment Period|Progressive Disease|64|||
143102993|NCT01578239|515918043|FG000|Treatment Period|Physician Decision|17|||
143102994|NCT01578239|515918044|FG001|Treatment Period|Physician Decision|17|||
143102995|NCT01578239|515918043|FG000|Treatment Period|Adverse Event|13|||
143102996|NCT01578239|515918044|FG001|Treatment Period|Adverse Event|10|||
143102997|NCT01578239|515918043|FG000|Treatment Period|Non-compliance|2|||
143102998|NCT01578239|515918044|FG001|Treatment Period|Non-compliance|0|||
143102999|NCT01578239|515918043|FG000|Treatment Period|Withdrawal by Subject|10|||
143103000|NCT01578239|515918044|FG001|Treatment Period|Withdrawal by Subject|9|||
143103001|NCT01578239|515918043|FG000|Treatment Period|Other|6|||
143103002|NCT01578239|515918044|FG001|Treatment Period|Other|1|||
143103003|NCT01578239|515918043|FG000|Long-term Follow-Up Period|Death|69|||
143103004|NCT01578239|515918044|FG001|Long-term Follow-Up Period|Death|64|||
143103005|NCT01578239|515918043|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
143103006|NCT01578239|515918044|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
143103007|NCT01578239|515918043|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
143103008|NCT01578239|515918044|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
143103009|NCT01578239|515918043|FG000|Long-term Follow-Up Period|Other|2|||
143103010|NCT01578239|515918044|FG001|Long-term Follow-Up Period|Other|2|||
143103011|NCT01119859|515918045|FG000|Overall Study|Adverse Event|9|||
143103012|NCT01119859|515918046|FG001|Overall Study|Adverse Event|10|||
143103013|NCT01119859|515918045|FG000|Overall Study|Death|2|||
143103014|NCT01119859|515918046|FG001|Overall Study|Death|0|||
143103015|NCT01119859|515918045|FG000|Overall Study|Insufficient therapeutic response|7|||
143103016|NCT01119859|515918046|FG001|Overall Study|Insufficient therapeutic response|14|||
143103017|NCT01119859|515918045|FG000|Overall Study|Refused treatment|3|||
143103018|NCT01119859|515918046|FG001|Overall Study|Refused treatment|6|||
143103019|NCT01119859|515918045|FG000|Overall Study|Failure to return|3|||
143103020|NCT01119859|515918046|FG001|Overall Study|Failure to return|0|||
143103021|NCT00757042|515918052|FG000|Overall Study|Lost to Follow-up|0|||
143103022|NCT00757042|515918053|FG001|Overall Study|Lost to Follow-up|0|||
143103023|NCT00757042|515918054|FG002|Overall Study|Lost to Follow-up|0|||
143103024|NCT00757042|515918055|FG003|Overall Study|Lost to Follow-up|0|||
143103025|NCT00757042|515918056|FG004|Overall Study|Lost to Follow-up|0|||
143103026|NCT00757042|515918057|FG005|Overall Study|Lost to Follow-up|0|||
143103027|NCT00757042|515918058|FG006|Overall Study|Lost to Follow-up|0|||
143103028|NCT00757042|515918059|FG007|Overall Study|Lost to Follow-up|0|||
143103029|NCT00757042|515918060|FG008|Overall Study|Lost to Follow-up|1|||
143103030|NCT00757042|515918061|FG009|Overall Study|Lost to Follow-up|0|||
143103031|NCT00757042|515918062|FG010|Overall Study|Lost to Follow-up|0|||
143103032|NCT00757042|515918052|FG000|Overall Study|Ineligibility Determined|0|||
143103033|NCT00757042|515918053|FG001|Overall Study|Ineligibility Determined|0|||
143103034|NCT00757042|515918054|FG002|Overall Study|Ineligibility Determined|0|||
143103035|NCT00757042|515918055|FG003|Overall Study|Ineligibility Determined|0|||
143177787|NCT01713582|516199818|FG013|Overall Study|Adverse event-unrelated|1|||
143252764|NCT01457352|516478713|FG000|Period 1|withdrew per sponsor|1|||
143103036|NCT00757042|515918056|FG004|Overall Study|Ineligibility Determined|0|||
143177788|NCT01713582|516199819|FG014|Overall Study|Adverse event-unrelated|1|||
143252765|NCT01457352|516478714|FG001|Period 1|withdrew per sponsor|0|||
143252766|NCT01457352|516478713|FG000|Period 1|Protocol Violation|4|||
143252767|NCT01457352|516478714|FG001|Period 1|Protocol Violation|0|||
143252768|NCT01457352|516478713|FG000|Period 1|Did not meet eligibility criteria|3|||
143252769|NCT01457352|516478714|FG001|Period 1|Did not meet eligibility criteria|0|||
143252770|NCT01457352|516478713|FG000|Period 2|Withdrawal by Subject|23|||
143252771|NCT01457352|516478714|FG001|Period 2|Withdrawal by Subject|0|||
143252772|NCT01457352|516478713|FG000|Period 2|Adverse Event|22|||
143103037|NCT00757042|515918057|FG005|Overall Study|Ineligibility Determined|0|||
143103038|NCT00757042|515918058|FG006|Overall Study|Ineligibility Determined|0|||
143103039|NCT00757042|515918059|FG007|Overall Study|Ineligibility Determined|0|||
143103040|NCT00757042|515918060|FG008|Overall Study|Ineligibility Determined|0|||
143103041|NCT00757042|515918061|FG009|Overall Study|Ineligibility Determined|0|||
143103042|NCT00757042|515918062|FG010|Overall Study|Ineligibility Determined|1|||
143103043|NCT00757042|515918052|FG000|Overall Study|Withdrawal by Subject|0|||
143103044|NCT00757042|515918053|FG001|Overall Study|Withdrawal by Subject|0|||
143103045|NCT00757042|515918054|FG002|Overall Study|Withdrawal by Subject|0|||
143103046|NCT00757042|515918055|FG003|Overall Study|Withdrawal by Subject|0|||
143103047|NCT00757042|515918056|FG004|Overall Study|Withdrawal by Subject|0|||
143103048|NCT00757042|515918057|FG005|Overall Study|Withdrawal by Subject|0|||
143103049|NCT00757042|515918058|FG006|Overall Study|Withdrawal by Subject|0|||
143103050|NCT00757042|515918059|FG007|Overall Study|Withdrawal by Subject|0|||
143103051|NCT00757042|515918060|FG008|Overall Study|Withdrawal by Subject|0|||
143103052|NCT00757042|515918061|FG009|Overall Study|Withdrawal by Subject|1|||
143103053|NCT00757042|515918062|FG010|Overall Study|Withdrawal by Subject|0|||
143103054|NCT01266291|515918065|FG000|Overall Study|Adverse Event|1|||
143103055|NCT03850483|515918068|FG000|Treatment for Stage 1|Adverse Event|1|||
143103056|NCT03850483|515918069|FG001|Treatment for Stage 1|Adverse Event|1|||
143103057|NCT03850483|515918070|FG002|Treatment for Stage 1|Adverse Event|3|||
143103058|NCT03850483|515918071|FG003|Treatment for Stage 1|Adverse Event|0|||
143103059|NCT03850483|515918072|FG004|Treatment for Stage 1|Adverse Event|2|||
143103060|NCT03850483|515918073|FG005|Treatment for Stage 1|Adverse Event|0|||
143252773|NCT01457352|516478714|FG001|Period 2|Adverse Event|0|||
143252774|NCT01457352|516478713|FG000|Period 2|no analysis|10|||
143252775|NCT01457352|516478714|FG001|Period 2|no analysis|0|||
143252776|NCT01457352|516478713|FG000|Period 2|Lack of Efficacy|8|||
143252777|NCT01457352|516478714|FG001|Period 2|Lack of Efficacy|0|||
143252778|NCT01457352|516478713|FG000|Period 2|Protocol Violation|4|||
143252779|NCT01457352|516478714|FG001|Period 2|Protocol Violation|0|||
143252780|NCT01457352|516478713|FG000|Period 2|Sponsor's withdrawal|7|||
143252781|NCT01457352|516478714|FG001|Period 2|Sponsor's withdrawal|0|||
143252782|NCT01457352|516478713|FG000|Period 2|Lost to Follow-up|1|||
143252783|NCT01457352|516478714|FG001|Period 2|Lost to Follow-up|0|||
143252784|NCT01457352|516478713|FG000|Period 2|dose change|1|||
143252785|NCT01457352|516478714|FG001|Period 2|dose change|0|||
143252786|NCT01457352|516478713|FG000|Period 2|Physician Decision|1|||
143252787|NCT01457352|516478714|FG001|Period 2|Physician Decision|0|||
143252788|NCT01457352|516478713|FG000|Period 2|Did not meet eligibility criteria|3|||
143252789|NCT01457352|516478714|FG001|Period 2|Did not meet eligibility criteria|0|||
143252790|NCT01457352|516478713|FG000|Period 3|Adverse Event|1|||
143252791|NCT01457352|516478714|FG001|Period 3|Adverse Event|1|||
143252792|NCT01457352|516478713|FG000|Period 3|Withdrawal by Subject|0|||
143252793|NCT01457352|516478714|FG001|Period 3|Withdrawal by Subject|2|||
143252794|NCT01457352|516478713|FG000|Period 3|incorrect treatment|0|||
143252795|NCT01457352|516478714|FG001|Period 3|incorrect treatment|1|||
143252796|NCT01457352|516478713|FG000|Period 3|Sponsor's withdrawal|0|||
143252797|NCT01457352|516478714|FG001|Period 3|Sponsor's withdrawal|1|||
143103061|NCT03850483|515918074|FG006|Treatment for Stage 1|Adverse Event|2|||
143103062|NCT03850483|515918075|FG007|Treatment for Stage 1|Adverse Event|2|||
143103063|NCT03850483|515918076|FG008|Treatment for Stage 1|Adverse Event|0|||
143103064|NCT03850483|515918077|FG009|Treatment for Stage 1|Adverse Event|0|||
143252798|NCT03952039|516478715|FG000|Overall Study|Adverse Event|22|||
143252799|NCT03952039|516478716|FG001|Overall Study|Adverse Event|8|||
143252800|NCT03952039|516478715|FG000|Overall Study|Withdrawal by Participant|17|||
143252801|NCT03952039|516478716|FG001|Overall Study|Withdrawal by Participant|12|||
143252802|NCT03952039|516478715|FG000|Overall Study|Death|13|||
143252803|NCT03952039|516478716|FG001|Overall Study|Death|6|||
143252804|NCT03952039|516478715|FG000|Overall Study|Lack of Efficacy|12|||
143252805|NCT03952039|516478716|FG001|Overall Study|Lack of Efficacy|2|||
143252806|NCT03952039|516478715|FG000|Overall Study|Physician Decision|9|||
143252807|NCT03952039|516478716|FG001|Overall Study|Physician Decision|3|||
143103065|NCT03850483|515918068|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
143103066|NCT03850483|515918069|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
143103067|NCT03850483|515918070|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
143103068|NCT03850483|515918071|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
143103069|NCT03850483|515918072|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
143252808|NCT03952039|516478715|FG000|Overall Study|Progressive Disease|6|||
143252809|NCT03952039|516478716|FG001|Overall Study|Progressive Disease|4|||
143252810|NCT03952039|516478715|FG000|Overall Study|Other Reasons|12|||
143252811|NCT03952039|516478716|FG001|Overall Study|Other Reasons|4|||
143252812|NCT05009979|516478717|FG000|Overall Study|Withdrawal by Subject|1|||
143252813|NCT04174365|516478718|FG000|Overall Study|Lost to Follow-up|1|||
143252814|NCT04174365|516478719|FG001|Overall Study|Lost to Follow-up|2|||
143252815|NCT04174365|516478718|FG000|Overall Study|Adverse Event|2|||
143252816|NCT04174365|516478719|FG001|Overall Study|Adverse Event|1|||
143252817|NCT04174365|516478718|FG000|Overall Study|Subject Withdrew Consent To Participate|1|||
143252818|NCT04174365|516478719|FG001|Overall Study|Subject Withdrew Consent To Participate|0|||
143252819|NCT04174365|516478718|FG000|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|2|||
143252820|NCT04174365|516478719|FG001|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|1|||
143252821|NCT04174365|516478718|FG000|Overall Study|Protocol Deviation|1|||
143252822|NCT04174365|516478719|FG001|Overall Study|Protocol Deviation|0|||
143252823|NCT04174365|516478718|FG000|Overall Study|Lack of Efficacy|0|||
143252824|NCT04174365|516478719|FG001|Overall Study|Lack of Efficacy|2|||
143252825|NCT04174365|516478718|FG000|Overall Study|Disease Relapse|1|||
143252826|NCT04174365|516478719|FG001|Overall Study|Disease Relapse|0|||
143252827|NCT04174365|516478718|FG000|Overall Study|Reason Not Specified|0|||
143252828|NCT04174365|516478719|FG001|Overall Study|Reason Not Specified|1|||
143252829|NCT03472547|516478720|FG000|Overall Study|Withdrawal by Subject|30|||
143252830|NCT03137069|516480062|FG000|Overall Study|Withdrawal by Subject|1|||
143252831|NCT03137069|516480063|FG001|Overall Study|Withdrawal by Subject|2|||
143252832|NCT03137069|516480064|FG002|Overall Study|Withdrawal by Subject|2|||
143252833|NCT03137069|516480065|FG003|Overall Study|Withdrawal by Subject|2|||
143252834|NCT03137069|516480066|FG004|Overall Study|Withdrawal by Subject|0|||
143252835|NCT03137069|516480067|FG005|Overall Study|Withdrawal by Subject|0|||
143252836|NCT03137069|516480062|FG000|Overall Study|Adverse Event|0|||
143252837|NCT03137069|516480063|FG001|Overall Study|Adverse Event|3|||
143252838|NCT03137069|516480064|FG002|Overall Study|Adverse Event|1|||
143252839|NCT03137069|516480065|FG003|Overall Study|Adverse Event|1|||
143252840|NCT03137069|516480066|FG004|Overall Study|Adverse Event|0|||
143252841|NCT03137069|516480067|FG005|Overall Study|Adverse Event|1|||
143252842|NCT03137069|516480062|FG000|Overall Study|Protocol Violation|0|||
143252843|NCT03137069|516480063|FG001|Overall Study|Protocol Violation|1|||
143252844|NCT03137069|516480064|FG002|Overall Study|Protocol Violation|0|||
143252845|NCT03137069|516480065|FG003|Overall Study|Protocol Violation|1|||
143252846|NCT03137069|516480066|FG004|Overall Study|Protocol Violation|1|||
143252847|NCT03137069|516480067|FG005|Overall Study|Protocol Violation|1|||
143252848|NCT03137069|516480062|FG000|Overall Study|Physician Decision|0|||
143252849|NCT03137069|516480063|FG001|Overall Study|Physician Decision|0|||
143252850|NCT03137069|516480064|FG002|Overall Study|Physician Decision|0|||
143252851|NCT03137069|516480065|FG003|Overall Study|Physician Decision|1|||
143103070|NCT03850483|515918073|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
143103071|NCT03850483|515918074|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
143103072|NCT03850483|515918075|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
143103073|NCT03850483|515918076|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
143103074|NCT03850483|515918077|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
143103075|NCT03850483|515918068|FG000|Treatment for Stage 1|Protocol Violation|1|||
143103076|NCT03850483|515918069|FG001|Treatment for Stage 1|Protocol Violation|0|||
143103077|NCT03850483|515918070|FG002|Treatment for Stage 1|Protocol Violation|0|||
143103078|NCT03850483|515918071|FG003|Treatment for Stage 1|Protocol Violation|0|||
143103079|NCT03850483|515918072|FG004|Treatment for Stage 1|Protocol Violation|0|||
143103080|NCT03850483|515918073|FG005|Treatment for Stage 1|Protocol Violation|0|||
143103081|NCT03850483|515918074|FG006|Treatment for Stage 1|Protocol Violation|1|||
143103082|NCT03850483|515918075|FG007|Treatment for Stage 1|Protocol Violation|0|||
143103083|NCT03850483|515918076|FG008|Treatment for Stage 1|Protocol Violation|0|||
143103084|NCT03850483|515918077|FG009|Treatment for Stage 1|Protocol Violation|0|||
143103085|NCT03850483|515918068|FG000|Treatment for Stage 1|Physician Decision|0|||
143103086|NCT03850483|515918069|FG001|Treatment for Stage 1|Physician Decision|0|||
143103087|NCT03850483|515918070|FG002|Treatment for Stage 1|Physician Decision|0|||
143103088|NCT03850483|515918071|FG003|Treatment for Stage 1|Physician Decision|0|||
143103089|NCT03850483|515918072|FG004|Treatment for Stage 1|Physician Decision|0|||
143103090|NCT03850483|515918073|FG005|Treatment for Stage 1|Physician Decision|1|||
143103091|NCT03850483|515918074|FG006|Treatment for Stage 1|Physician Decision|0|||
143103092|NCT03850483|515918075|FG007|Treatment for Stage 1|Physician Decision|0|||
143103093|NCT03850483|515918076|FG008|Treatment for Stage 1|Physician Decision|0|||
143252852|NCT03137069|516480066|FG004|Overall Study|Physician Decision|0|||
143252853|NCT03137069|516480067|FG005|Overall Study|Physician Decision|0|||
143252854|NCT03137069|516480062|FG000|Overall Study|Study Terminated by Sponsor|0|||
143252855|NCT03137069|516480063|FG001|Overall Study|Study Terminated by Sponsor|0|||
143252856|NCT03137069|516480064|FG002|Overall Study|Study Terminated by Sponsor|0|||
143252857|NCT03137069|516480065|FG003|Overall Study|Study Terminated by Sponsor|0|||
143252858|NCT03137069|516480066|FG004|Overall Study|Study Terminated by Sponsor|1|||
143252859|NCT03137069|516480067|FG005|Overall Study|Study Terminated by Sponsor|0|||
143103094|NCT03850483|515918077|FG009|Treatment for Stage 1|Physician Decision|0|||
143103095|NCT03850483|515918068|FG000|Treatment for Stage 1|Other|0|||
143252860|NCT03137069|516480062|FG000|Overall Study|Data Entry Error|0|||
143252861|NCT03137069|516480063|FG001|Overall Study|Data Entry Error|0|||
143252862|NCT03137069|516480064|FG002|Overall Study|Data Entry Error|0|||
143252863|NCT03137069|516480065|FG003|Overall Study|Data Entry Error|1|||
143252864|NCT03137069|516480066|FG004|Overall Study|Data Entry Error|0|||
143252865|NCT03137069|516480067|FG005|Overall Study|Data Entry Error|0|||
143252866|NCT00336856|516480068|FG000|Overall Study|Withdrawal by Subject|3|||
143252867|NCT00336856|516480068|FG000|Overall Study|Found ineligible at time of analysis|1|||
143252868|NCT02522624|516480070|FG000|Overall Study|Technical failure|1|||
143252869|NCT02522624|516480071|FG001|Overall Study|Technical failure|0|||
143252870|NCT01325337|516480072|FG000|Overall Study|Adverse Event|0|||
143252871|NCT01325337|516480073|FG001|Overall Study|Adverse Event|2|||
143252872|NCT01325337|516480074|FG002|Overall Study|Adverse Event|2|||
143252873|NCT01325337|516480075|FG003|Overall Study|Adverse Event|1|||
143252874|NCT01325337|516480076|FG004|Overall Study|Adverse Event|2|||
143252875|NCT01325337|516480072|FG000|Overall Study|Lost to Follow-up|2|||
143252876|NCT01325337|516480073|FG001|Overall Study|Lost to Follow-up|2|||
143252877|NCT01325337|516480074|FG002|Overall Study|Lost to Follow-up|2|||
143252878|NCT01325337|516480075|FG003|Overall Study|Lost to Follow-up|1|||
143252879|NCT01325337|516480076|FG004|Overall Study|Lost to Follow-up|2|||
143252880|NCT01325337|516480072|FG000|Overall Study|Personal Reasons|2|||
143252881|NCT01325337|516480073|FG001|Overall Study|Personal Reasons|5|||
143252882|NCT01325337|516480074|FG002|Overall Study|Personal Reasons|4|||
143252883|NCT01325337|516480075|FG003|Overall Study|Personal Reasons|8|||
143252884|NCT01325337|516480076|FG004|Overall Study|Personal Reasons|3|||
143252885|NCT01325337|516480072|FG000|Overall Study|Withdrawal by Subject|1|||
143252886|NCT01325337|516480073|FG001|Overall Study|Withdrawal by Subject|0|||
143252887|NCT01325337|516480074|FG002|Overall Study|Withdrawal by Subject|1|||
143252888|NCT01325337|516480075|FG003|Overall Study|Withdrawal by Subject|0|||
143252889|NCT01325337|516480076|FG004|Overall Study|Withdrawal by Subject|1|||
143252890|NCT00843778|516480089|FG000|Overall Study|Adverse Event|15|||
143252891|NCT00843778|516480089|FG000|Overall Study|Lack of Efficacy|14|||
143252892|NCT00843778|516480089|FG000|Overall Study|Loss of efficacy|2|||
143252893|NCT00843778|516480089|FG000|Overall Study|Withdrawal by Subject|4|||
143252894|NCT00369629|516480090|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
143252895|NCT00369629|516480091|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
143252896|NCT00369629|516480092|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
143252897|NCT00369629|516480093|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
143252898|NCT00369629|516480090|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
143252899|NCT00369629|516480091|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
143252900|NCT00369629|516480092|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
143252901|NCT00369629|516480093|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
143252902|NCT00369629|516480090|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
143252903|NCT00369629|516480091|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
143252904|NCT00369629|516480092|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
143252905|NCT00369629|516480093|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
143252906|NCT00369629|516480090|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
143252907|NCT00369629|516480091|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
143252908|NCT00369629|516480092|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
143252909|NCT00369629|516480093|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
143252910|NCT00369629|516480090|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
143252911|NCT00369629|516480091|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
143252912|NCT00369629|516480092|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
143252913|NCT00369629|516480093|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
143252914|NCT00369629|516480090|FG000|Completed 4 More Cycles|Progressive disease|2|||
143252915|NCT00369629|516480091|FG001|Completed 4 More Cycles|Progressive disease|1|||
143252916|NCT00369629|516480092|FG002|Completed 4 More Cycles|Progressive disease|2|||
143252917|NCT00369629|516480093|FG003|Completed 4 More Cycles|Progressive disease|0|||
143252918|NCT00369629|516480090|FG000|Follow up for 1 Year|Death|2|||
143252919|NCT00369629|516480091|FG001|Follow up for 1 Year|Death|1|||
143252920|NCT00369629|516480092|FG002|Follow up for 1 Year|Death|1|||
143252921|NCT00369629|516480093|FG003|Follow up for 1 Year|Death|0|||
143252922|NCT00369629|516480090|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
143252923|NCT00369629|516480091|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
143252924|NCT00369629|516480092|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
143252925|NCT00369629|516480093|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
143252926|NCT00369629|516480090|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
143252927|NCT00369629|516480091|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
143252928|NCT00369629|516480092|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
143252929|NCT00369629|516480093|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
143252930|NCT02600871|516480094|FG000|Overall Study|Lost to Follow-up|13|||
143252931|NCT02600871|516480095|FG001|Overall Study|Lost to Follow-up|10|||
143367804|NCT00124982|516889442|FG002|Long-term Period|Death|1|||
143252932|NCT03338959|516480096|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
143252933|NCT03338959|516480096|FG000|Overall Study|Physician Decision|1|||
143103096|NCT03850483|515918069|FG001|Treatment for Stage 1|Other|0|||
143103097|NCT03850483|515918070|FG002|Treatment for Stage 1|Other|0|||
143103098|NCT03850483|515918071|FG003|Treatment for Stage 1|Other|0|||
143103099|NCT03850483|515918072|FG004|Treatment for Stage 1|Other|2|||
143103100|NCT03850483|515918073|FG005|Treatment for Stage 1|Other|1|||
143103101|NCT03850483|515918074|FG006|Treatment for Stage 1|Other|0|||
143103102|NCT03850483|515918075|FG007|Treatment for Stage 1|Other|0|||
143103103|NCT03850483|515918076|FG008|Treatment for Stage 1|Other|0|||
143103104|NCT03850483|515918077|FG009|Treatment for Stage 1|Other|0|||
143103105|NCT03850483|515918068|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
143103106|NCT03850483|515918069|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
143103107|NCT03850483|515918070|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
143103108|NCT03850483|515918071|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
143103109|NCT03850483|515918072|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
143103110|NCT03850483|515918073|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
143103111|NCT03850483|515918074|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
143103112|NCT03850483|515918075|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
143103113|NCT03850483|515918076|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
143103114|NCT03850483|515918077|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
143103115|NCT03850483|515918068|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
143103116|NCT03850483|515918069|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
143103117|NCT03850483|515918070|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
143103118|NCT03850483|515918071|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
143103119|NCT03850483|515918072|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
143103120|NCT03850483|515918073|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
143103121|NCT03850483|515918074|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
143103122|NCT03850483|515918075|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
143103123|NCT03850483|515918076|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
143103124|NCT03850483|515918077|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
143103125|NCT03850483|515918068|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
143103126|NCT03850483|515918069|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
143103127|NCT03850483|515918070|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
143103128|NCT03850483|515918071|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
143103129|NCT03850483|515918072|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
143103130|NCT03850483|515918073|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
143103131|NCT03850483|515918074|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
143103132|NCT03850483|515918075|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
143103133|NCT03850483|515918076|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
143103134|NCT03850483|515918077|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
143103135|NCT03850483|515918068|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
143103136|NCT03850483|515918069|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
143103137|NCT03850483|515918070|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
143103138|NCT03850483|515918071|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
143103139|NCT03850483|515918072|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
143103140|NCT03850483|515918073|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
143103141|NCT03850483|515918074|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
143103142|NCT03850483|515918075|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
143103143|NCT03850483|515918076|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
143103144|NCT03850483|515918077|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
143103145|NCT03850483|515918068|FG000|Treatment for Stage 1|Death|0|||
143103146|NCT03850483|515918069|FG001|Treatment for Stage 1|Death|0|||
143103147|NCT03850483|515918070|FG002|Treatment for Stage 1|Death|0|||
143103148|NCT03850483|515918071|FG003|Treatment for Stage 1|Death|0|||
143103149|NCT03850483|515918072|FG004|Treatment for Stage 1|Death|0|||
143103150|NCT03850483|515918073|FG005|Treatment for Stage 1|Death|1|||
143103151|NCT03850483|515918074|FG006|Treatment for Stage 1|Death|0|||
143103152|NCT03850483|515918075|FG007|Treatment for Stage 1|Death|0|||
143103153|NCT03850483|515918076|FG008|Treatment for Stage 1|Death|0|||
143103154|NCT03850483|515918077|FG009|Treatment for Stage 1|Death|0|||
143103155|NCT03850483|515918068|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
143103156|NCT03850483|515918069|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
143103157|NCT03850483|515918070|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
143103158|NCT03850483|515918071|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
143103159|NCT03850483|515918072|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
143103160|NCT03850483|515918073|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
143103161|NCT03850483|515918074|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
143252934|NCT01604278|516480101|FG000|Overall Study|Lack of Efficacy|0|||
143252935|NCT01604278|516480102|FG001|Overall Study|Lack of Efficacy|1|||
143252936|NCT01604278|516480101|FG000|Overall Study|Lost to Follow-up|1|||
143252937|NCT01604278|516480102|FG001|Overall Study|Lost to Follow-up|0|||
143252938|NCT01604278|516480101|FG000|Overall Study|Administrative problems|2|||
143252939|NCT01604278|516480102|FG001|Overall Study|Administrative problems|1|||
143252940|NCT01604278|516480101|FG000|Overall Study|Withdrawal by Subject|3|||
143252941|NCT01604278|516480102|FG001|Overall Study|Withdrawal by Subject|3|||
143252942|NCT01604278|516480101|FG000|Overall Study|Adverse Event|3|||
143252943|NCT01604278|516480102|FG001|Overall Study|Adverse Event|5|||
143252944|NCT01604278|516480101|FG000|Overall Study|Protocol Deviation|5|||
143252945|NCT01604278|516480102|FG001|Overall Study|Protocol Deviation|3|||
143252946|NCT00409331|516480103|FG000|Overall Study|Physician Decision|1|||
143252947|NCT02184455|516480104|FG000|Overall Study|Lost to Follow-up|1|||
143252948|NCT00640224|516480106|FG000|Overall Study|Lost to Follow-up|5|||
143252949|NCT00640224|516480107|FG001|Overall Study|Lost to Follow-up|2|||
143252950|NCT00640224|516480108|FG002|Overall Study|Lost to Follow-up|0|||
143252951|NCT00640224|516480109|FG003|Overall Study|Lost to Follow-up|0|||
143252952|NCT00640224|516480106|FG000|Overall Study|Withdrawal by Subject|1|||
143252953|NCT00640224|516480107|FG001|Overall Study|Withdrawal by Subject|0|||
143252954|NCT00640224|516480108|FG002|Overall Study|Withdrawal by Subject|0|||
143252955|NCT00640224|516480109|FG003|Overall Study|Withdrawal by Subject|0|||
143252956|NCT00640224|516480106|FG000|Overall Study|Headaches|0|||
143252957|NCT00640224|516480107|FG001|Overall Study|Headaches|1|||
143252958|NCT00640224|516480108|FG002|Overall Study|Headaches|0|||
143252959|NCT00640224|516480109|FG003|Overall Study|Headaches|0|||
143252960|NCT00422513|516480110|FG000|Overall Study|Lack of Efficacy|4|||
143252961|NCT00422513|516480111|FG001|Overall Study|Lack of Efficacy|5|||
143252962|NCT00422513|516480110|FG000|Overall Study|Protocol Violation|23|||
143252963|NCT00422513|516480111|FG001|Overall Study|Protocol Violation|7|||
143252964|NCT00422513|516480110|FG000|Overall Study|Refused Treatment|4|||
143252965|NCT00422513|516480111|FG001|Overall Study|Refused Treatment|2|||
143252966|NCT00422513|516480110|FG000|Overall Study|Withdrawal by Subject|2|||
143252967|NCT00422513|516480111|FG001|Overall Study|Withdrawal by Subject|1|||
143252968|NCT00422513|516480110|FG000|Overall Study|early termination of the study|67|||
143252969|NCT00422513|516480111|FG001|Overall Study|early termination of the study|80|||
143252970|NCT00422513|516480110|FG000|Overall Study|Adverse Event|4|||
143252971|NCT00422513|516480111|FG001|Overall Study|Adverse Event|4|||
143252972|NCT00422513|516480110|FG000|Overall Study|Death|3|||
143252973|NCT00422513|516480111|FG001|Overall Study|Death|7|||
143252974|NCT03135119|516480112|FG000|Overall Study|Lost to Follow-up|2|||
143252975|NCT03135119|516480113|FG001|Overall Study|Lost to Follow-up|0|||
143252976|NCT03135119|516480112|FG000|Overall Study|Physician Decision|1|||
143252977|NCT03135119|516480113|FG001|Overall Study|Physician Decision|1|||
143252978|NCT03135119|516480112|FG000|Overall Study|COVID-19 Shutdown|2|||
143252979|NCT03135119|516480113|FG001|Overall Study|COVID-19 Shutdown|2|||
143252980|NCT01478048|516480114|FG000|Overall Study|Disease Progression|52|||
143252981|NCT01478048|516480115|FG001|Overall Study|Disease Progression|35|||
143252982|NCT01478048|516480114|FG000|Overall Study|study drug toxicity|11|||
143252983|NCT01478048|516480115|FG001|Overall Study|study drug toxicity|14|||
143252984|NCT01478048|516480114|FG000|Overall Study|Adverse Event|2|||
143252985|NCT01478048|516480115|FG001|Overall Study|Adverse Event|11|||
143252986|NCT01478048|516480114|FG000|Overall Study|subject request to discontinue treatment|3|||
143252987|NCT01478048|516480115|FG001|Overall Study|subject request to discontinue treatment|5|||
143252988|NCT01478048|516480114|FG000|Overall Study|Withdrawal by Subject|2|||
143252989|NCT01478048|516480115|FG001|Overall Study|Withdrawal by Subject|5|||
143252990|NCT01478048|516480114|FG000|Overall Study|non-specified|6|||
143252991|NCT01478048|516480115|FG001|Overall Study|non-specified|4|||
143252992|NCT01478048|516480114|FG000|Overall Study|poor/non-compliance|0|||
143252993|NCT01478048|516480115|FG001|Overall Study|poor/non-compliance|1|||
143252994|NCT01478048|516480114|FG000|Overall Study|no longer meets study criteria|1|||
143252995|NCT01478048|516480115|FG001|Overall Study|no longer meets study criteria|0|||
143252996|NCT04644315|516480120|FG000|Overall Study|Subject withdrawal of consent|1|||
143252997|NCT01561898|516480121|FG000|Overall Study|Withdrawal by Subject|0|||
143252998|NCT01561898|516480122|FG001|Overall Study|Withdrawal by Subject|8|||
143252999|NCT01561898|516480123|FG002|Overall Study|Withdrawal by Subject|12|||
143253000|NCT01561898|516480124|FG003|Overall Study|Withdrawal by Subject|5|||
143253001|NCT01561898|516480121|FG000|Overall Study|Lack of Efficacy|0|||
143253002|NCT01561898|516480122|FG001|Overall Study|Lack of Efficacy|8|||
143253003|NCT01561898|516480123|FG002|Overall Study|Lack of Efficacy|10|||
143367805|NCT00124982|516889440|FG000|Long-term Period|Adverse Event|0|||
143253004|NCT01561898|516480124|FG003|Overall Study|Lack of Efficacy|5|||
143253005|NCT01561898|516480121|FG000|Overall Study|Worsening of complications|0|||
143253006|NCT01561898|516480122|FG001|Overall Study|Worsening of complications|1|||
143253007|NCT01561898|516480123|FG002|Overall Study|Worsening of complications|0|||
143253008|NCT01561898|516480124|FG003|Overall Study|Worsening of complications|0|||
143253009|NCT01561898|516480121|FG000|Overall Study|Lost to Follow-up|0|||
143253010|NCT01561898|516480122|FG001|Overall Study|Lost to Follow-up|0|||
143253011|NCT01561898|516480123|FG002|Overall Study|Lost to Follow-up|1|||
143253012|NCT01561898|516480124|FG003|Overall Study|Lost to Follow-up|0|||
143253013|NCT01561898|516480121|FG000|Overall Study|Adverse Event|1|||
143253014|NCT01561898|516480122|FG001|Overall Study|Adverse Event|19|||
143253015|NCT01561898|516480123|FG002|Overall Study|Adverse Event|14|||
143253016|NCT01561898|516480124|FG003|Overall Study|Adverse Event|9|||
143253017|NCT01561898|516480121|FG000|Overall Study|Physician Decision|1|||
143253018|NCT01561898|516480122|FG001|Overall Study|Physician Decision|5|||
143253019|NCT01561898|516480123|FG002|Overall Study|Physician Decision|7|||
143253020|NCT01561898|516480124|FG003|Overall Study|Physician Decision|1|||
143253021|NCT00331552|516480127|FG000|Period 3: Phase II|Neurological Symptoms|1|||
143253022|NCT00331552|516480128|FG001|Period 3: Phase II|Neurological Symptoms|0|||
143253023|NCT00331552|516480127|FG000|Period 3: Phase II|Severe Nausea|1|||
143253024|NCT00331552|516480128|FG001|Period 3: Phase II|Severe Nausea|0|||
143253025|NCT01445548|516480129|FG000|Overall Study|Adverse Event|1|||
143253026|NCT01883453|516480131|FG000|Overall Study|No episode of common cold|25|||
143253027|NCT01883453|516480132|FG001|Overall Study|No episode of common cold|23|||
143253028|NCT03642132|516480134|FG000|Chemotherapy Period|Adverse Event|1|||
143253029|NCT03642132|516480135|FG001|Chemotherapy Period|Adverse Event|1|||
143253030|NCT03642132|516480136|FG002|Chemotherapy Period|Adverse Event|0|||
143253031|NCT03642132|516480134|FG000|Chemotherapy Period|Physician's decision|4|||
143253032|NCT03642132|516480135|FG001|Chemotherapy Period|Physician's decision|1|||
143253033|NCT03642132|516480136|FG002|Chemotherapy Period|Physician's decision|0|||
143253034|NCT03642132|516480134|FG000|Chemotherapy Period|Progressive disease|0|||
143253035|NCT03642132|516480135|FG001|Chemotherapy Period|Progressive disease|0|||
143253036|NCT03642132|516480136|FG002|Chemotherapy Period|Progressive disease|1|||
143253037|NCT03642132|516480134|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
143253038|NCT03642132|516480135|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
143253039|NCT03642132|516480136|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
143253040|NCT03642132|516480134|FG000|Chemotherapy Period|Other|1|||
143253041|NCT03642132|516480135|FG001|Chemotherapy Period|Other|0|||
143253042|NCT03642132|516480136|FG002|Chemotherapy Period|Other|2|||
143253043|NCT03642132|516480134|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
143253044|NCT03642132|516480135|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
143253045|NCT03642132|516480136|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
143253046|NCT03642132|516480134|FG000|Maintenance Period|Adverse Event|1|||
143253047|NCT03642132|516480135|FG001|Maintenance Period|Adverse Event|2|||
143253048|NCT03642132|516480136|FG002|Maintenance Period|Adverse Event|0|||
143253049|NCT03642132|516480134|FG000|Maintenance Period|Non-compliance with study drug|0|||
143253050|NCT03642132|516480135|FG001|Maintenance Period|Non-compliance with study drug|0|||
143253051|NCT03642132|516480136|FG002|Maintenance Period|Non-compliance with study drug|1|||
143253052|NCT03642132|516480134|FG000|Maintenance Period|Physician's decision|2|||
143253053|NCT03642132|516480135|FG001|Maintenance Period|Physician's decision|2|||
143253054|NCT03642132|516480136|FG002|Maintenance Period|Physician's decision|2|||
143253055|NCT03642132|516480134|FG000|Maintenance Period|Progressive disease|9|||
143253056|NCT03642132|516480135|FG001|Maintenance Period|Progressive disease|3|||
143253057|NCT03642132|516480136|FG002|Maintenance Period|Progressive disease|6|||
143253058|NCT03642132|516480134|FG000|Maintenance Period|Other|0|||
143253059|NCT03642132|516480135|FG001|Maintenance Period|Other|0|||
143253060|NCT03642132|516480136|FG002|Maintenance Period|Other|3|||
143253061|NCT03642132|516480134|FG000|Maintenance Period|Withdrawal by Subject|1|||
143253062|NCT03642132|516480135|FG001|Maintenance Period|Withdrawal by Subject|1|||
143253063|NCT03642132|516480136|FG002|Maintenance Period|Withdrawal by Subject|2|||
143253064|NCT03642132|516480134|FG000|Follow-up Period|Other|0|||
143253065|NCT03642132|516480135|FG001|Follow-up Period|Other|0|||
143253066|NCT03642132|516480136|FG002|Follow-up Period|Other|1|||
143253067|NCT03642132|516480134|FG000|Follow-up Period|Withdrawal by Subject|1|||
143253068|NCT03642132|516480135|FG001|Follow-up Period|Withdrawal by Subject|2|||
143253069|NCT03642132|516480136|FG002|Follow-up Period|Withdrawal by Subject|0|||
143253070|NCT03642132|516480134|FG000|Follow-up Period|Study terminated by sponsor|1|||
143253071|NCT03642132|516480135|FG001|Follow-up Period|Study terminated by sponsor|0|||
143253072|NCT03642132|516480136|FG002|Follow-up Period|Study terminated by sponsor|1|||
143253073|NCT03642132|516480134|FG000|Follow-up Period|Lack of Efficacy|1|||
143253074|NCT03642132|516480135|FG001|Follow-up Period|Lack of Efficacy|0|||
143253075|NCT03642132|516480136|FG002|Follow-up Period|Lack of Efficacy|0|||
143253076|NCT03642132|516480134|FG000|Follow-up Period|Death|1|||
143253077|NCT03642132|516480135|FG001|Follow-up Period|Death|0|||
143253078|NCT03642132|516480136|FG002|Follow-up Period|Death|2|||
143253079|NCT03642132|516480134|FG000|Follow-up Period|Adverse Event|1|||
143253080|NCT03642132|516480135|FG001|Follow-up Period|Adverse Event|0|||
143253081|NCT03642132|516480136|FG002|Follow-up Period|Adverse Event|0|||
143253082|NCT02577887|516480142|FG000|Overall Study|Death|93|||
143253083|NCT02577887|516480142|FG000|Overall Study|Protocol Violation|125|||
143253084|NCT02577887|516480142|FG000|Overall Study|Withdrawal by Subject|80|||
143253085|NCT04074161|516480143|FG000|Overall Study|Withdrawal by Subject|2|||
143253086|NCT04074161|516480144|FG001|Overall Study|Withdrawal by Subject|4|||
143253087|NCT04074161|516480145|FG002|Overall Study|Withdrawal by Subject|1|||
143253088|NCT04074161|516480143|FG000|Overall Study|Lost to Follow-up|4|||
143253089|NCT04074161|516480144|FG001|Overall Study|Lost to Follow-up|5|||
143253090|NCT04074161|516480145|FG002|Overall Study|Lost to Follow-up|3|||
143253091|NCT02208063|516480148|FG000|Overall Study|Death|3|||
143253092|NCT02208063|516480149|FG001|Overall Study|Death|5|||
143253093|NCT02208063|516480148|FG000|Overall Study|Not Specified in report|3|||
143253094|NCT02208063|516480149|FG001|Overall Study|Not Specified in report|4|||
143253095|NCT02208063|516480148|FG000|Overall Study|Withdrawal by Subject|5|||
143253096|NCT02208063|516480149|FG001|Overall Study|Withdrawal by Subject|2|||
143253097|NCT02208063|516480148|FG000|Overall Study|Lost to Follow-up|1|||
143253098|NCT02208063|516480149|FG001|Overall Study|Lost to Follow-up|0|||
143253099|NCT00322621|516480152|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
143253100|NCT00322621|516480153|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
143253101|NCT00322621|516480154|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
143253102|NCT00322621|516480152|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
143253103|NCT00322621|516480153|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
143253104|NCT00322621|516480154|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
143253105|NCT00322621|516480152|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
143253106|NCT00322621|516480153|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
143253107|NCT00322621|516480154|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
143253108|NCT00322621|516480152|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
143253109|NCT00322621|516480153|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
143253110|NCT00322621|516480154|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
143253111|NCT00322621|516480152|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
143253112|NCT00322621|516480153|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
143253113|NCT00322621|516480154|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
143253114|NCT00322621|516480152|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
143253115|NCT00322621|516480153|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
143253116|NCT00322621|516480154|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
143253117|NCT00322621|516480152|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
143253118|NCT00322621|516480153|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
143253119|NCT00322621|516480154|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
143253120|NCT00322621|516480152|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
143253121|NCT00322621|516480153|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
143253122|NCT00322621|516480154|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
143253123|NCT00322621|516480152|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
143103162|NCT03850483|515918075|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
143103163|NCT03850483|515918076|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
143103164|NCT03850483|515918077|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
143253124|NCT00322621|516480153|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
143253125|NCT00322621|516480154|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
143253126|NCT00322621|516480152|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
143253127|NCT00322621|516480153|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
143253128|NCT00322621|516480154|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
143253129|NCT00322621|516480152|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
143253130|NCT00322621|516480153|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
143253131|NCT00322621|516480154|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
143253132|NCT01038869|516480157|FG000|Overall Study|Withdrawal by Subject|1|||
143253133|NCT01038869|516480157|FG000|Overall Study|Lost to Follow-up|6|||
143253134|NCT02238067|516480158|FG000|Overall Study|Not completed survey at Month 6|45|||
143253135|NCT02213133|516480159|FG000|Overall Study|Participant discontinued study therapy|2|||
143253136|NCT02213133|516480160|FG001|Overall Study|Participant discontinued study therapy|0|||
143253137|NCT02213133|516480161|FG002|Overall Study|Participant discontinued study therapy|0|||
143253138|NCT02213133|516480159|FG000|Overall Study|Participant withdrew informed consent|2|||
143253139|NCT02213133|516480160|FG001|Overall Study|Participant withdrew informed consent|1|||
143253140|NCT02213133|516480161|FG002|Overall Study|Participant withdrew informed consent|2|||
143253141|NCT02213133|516480159|FG000|Overall Study|Disease progression|11|||
143253142|NCT02213133|516480160|FG001|Overall Study|Disease progression|2|||
143253143|NCT02213133|516480161|FG002|Overall Study|Disease progression|0|||
143253144|NCT02213133|516480159|FG000|Overall Study|Adverse Event (AE)|1|||
143253145|NCT02213133|516480160|FG001|Overall Study|Adverse Event (AE)|0|||
143367806|NCT00124982|516889441|FG001|Long-term Period|Adverse Event|0|||
143103165|NCT03850483|515918068|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
143103166|NCT03850483|515918069|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
143253146|NCT02213133|516480161|FG002|Overall Study|Adverse Event (AE)|0|||
143253147|NCT02213133|516480159|FG000|Overall Study|Death|16|||
143253148|NCT02213133|516480160|FG001|Overall Study|Death|2|||
143367807|NCT00124982|516889442|FG002|Long-term Period|Adverse Event|17|||
143367808|NCT00124982|516889440|FG000|Long-term Period|Lack of Efficacy|0|||
143367809|NCT00124982|516889441|FG001|Long-term Period|Lack of Efficacy|0|||
143367810|NCT00124982|516889442|FG002|Long-term Period|Lack of Efficacy|46|||
143367811|NCT00124982|516889440|FG000|Long-term Period|Lost to Follow-up|0|||
143367812|NCT00124982|516889441|FG001|Long-term Period|Lost to Follow-up|0|||
143367813|NCT00124982|516889442|FG002|Long-term Period|Lost to Follow-up|4|||
143367814|NCT00124982|516889440|FG000|Long-term Period|Withdrawal by Subject|0|||
143367815|NCT00124982|516889441|FG001|Long-term Period|Withdrawal by Subject|0|||
143177789|NCT01713582|516199820|FG015|Overall Study|Adverse event-unrelated|0|||
143177790|NCT01713582|516199821|FG016|Overall Study|Adverse event-unrelated|0|||
143177791|NCT01713582|516199822|FG017|Overall Study|Adverse event-unrelated|0|||
143177792|NCT01713582|516199823|FG018|Overall Study|Adverse event-unrelated|0|||
143367816|NCT00124982|516889442|FG002|Long-term Period|Withdrawal by Subject|16|||
143367817|NCT00124982|516889440|FG000|Long-term Period|Pregnancy|0|||
143367818|NCT00124982|516889441|FG001|Long-term Period|Pregnancy|0|||
143367819|NCT00124982|516889442|FG002|Long-term Period|Pregnancy|1|||
143367820|NCT00124982|516889440|FG000|Long-term Period|Poor/Non-compliance|0|||
143367821|NCT00124982|516889441|FG001|Long-term Period|Poor/Non-compliance|0|||
143367822|NCT00124982|516889442|FG002|Long-term Period|Poor/Non-compliance|2|||
143177793|NCT01713582|516199824|FG019|Overall Study|Adverse event-unrelated|0|||
143177794|NCT01713582|516199825|FG020|Overall Study|Adverse event-unrelated|0|||
143177795|NCT01713582|516199805|FG000|Overall Study|Withdrawal of consent|0|||
143177796|NCT01713582|516199806|FG001|Overall Study|Withdrawal of consent|0|||
143177797|NCT01713582|516199807|FG002|Overall Study|Withdrawal of consent|1|||
143177798|NCT01713582|516199808|FG003|Overall Study|Withdrawal of consent|0|||
143177799|NCT01713582|516199809|FG004|Overall Study|Withdrawal of consent|0|||
143177800|NCT01713582|516199810|FG005|Overall Study|Withdrawal of consent|1|||
143177801|NCT01713582|516199811|FG006|Overall Study|Withdrawal of consent|0|||
143177802|NCT01713582|516199812|FG007|Overall Study|Withdrawal of consent|0|||
143253149|NCT02213133|516480161|FG002|Overall Study|Death|1|||
143253150|NCT02213133|516480159|FG000|Overall Study|Other|5|||
143253151|NCT02213133|516480160|FG001|Overall Study|Other|0|||
143253152|NCT02213133|516480161|FG002|Overall Study|Other|0|||
143253153|NCT01328444|516480162|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
143253154|NCT01328444|516480163|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
143253155|NCT01328444|516480164|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
143253156|NCT01328444|516480165|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
143253157|NCT01328444|516480166|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
143253158|NCT01328444|516480167|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
143253159|NCT01328444|516480162|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
143253160|NCT01328444|516480163|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
143253161|NCT01328444|516480164|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
143253162|NCT01328444|516480165|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
143253163|NCT01328444|516480166|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
143253164|NCT01328444|516480167|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
143253165|NCT01328444|516480162|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
143253166|NCT01328444|516480163|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
143253167|NCT01328444|516480164|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
143253168|NCT01328444|516480165|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
143253169|NCT01328444|516480166|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
143253170|NCT01328444|516480167|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
143253171|NCT01328444|516480162|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
143253172|NCT01328444|516480163|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
143253173|NCT01328444|516480164|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
143253174|NCT01328444|516480165|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
143253175|NCT01328444|516480166|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
143253176|NCT01328444|516480167|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
143253177|NCT01328444|516480162|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
143253178|NCT01328444|516480163|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
143367823|NCT00124982|516889440|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
143367824|NCT00124982|516889441|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
143177803|NCT01713582|516199813|FG008|Overall Study|Withdrawal of consent|0|||
143177804|NCT01713582|516199814|FG009|Overall Study|Withdrawal of consent|1|||
143177805|NCT01713582|516199815|FG010|Overall Study|Withdrawal of consent|0|||
143253179|NCT01328444|516480164|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
143253180|NCT01328444|516480165|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
143253181|NCT01328444|516480166|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
143253182|NCT01328444|516480167|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
143253183|NCT01328444|516480162|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
143253184|NCT01328444|516480163|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
143253185|NCT01328444|516480164|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
143253186|NCT01328444|516480165|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
143253187|NCT01328444|516480166|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
143253188|NCT01328444|516480167|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
143253189|NCT01328444|516480162|FG000|Washout Period (14 Days)|Adverse Event|1|||
143253190|NCT01328444|516480163|FG001|Washout Period (14 Days)|Adverse Event|1|||
143253191|NCT01328444|516480164|FG002|Washout Period (14 Days)|Adverse Event|0|||
143253192|NCT01328444|516480165|FG003|Washout Period (14 Days)|Adverse Event|1|||
143253193|NCT01328444|516480166|FG004|Washout Period (14 Days)|Adverse Event|1|||
143253194|NCT01328444|516480167|FG005|Washout Period (14 Days)|Adverse Event|2|||
143253195|NCT01328444|516480162|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
143253196|NCT01328444|516480163|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
143253197|NCT01328444|516480164|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
143253198|NCT01328444|516480165|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
143253199|NCT01328444|516480166|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
143253200|NCT01328444|516480167|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
143253201|NCT01328444|516480162|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
143253202|NCT01328444|516480163|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
143253203|NCT01328444|516480164|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
143253204|NCT01328444|516480165|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
143253205|NCT01328444|516480166|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
143253206|NCT01328444|516480167|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
143253207|NCT01328444|516480162|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
143253208|NCT01328444|516480163|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
143253209|NCT01328444|516480164|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
143253210|NCT01328444|516480165|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
143253211|NCT01328444|516480166|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
143253212|NCT01328444|516480167|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
143253213|NCT01328444|516480162|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
143253214|NCT01328444|516480163|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
143253215|NCT01328444|516480164|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
143253216|NCT01328444|516480165|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
143253217|NCT01328444|516480166|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
143253218|NCT01328444|516480167|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
143253219|NCT01328444|516480162|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
143253220|NCT01328444|516480163|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
143253221|NCT01328444|516480164|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
143253222|NCT01328444|516480165|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
143253223|NCT01328444|516480166|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
143253224|NCT01328444|516480167|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
143253225|NCT01328444|516480162|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
143253226|NCT01328444|516480163|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
143253227|NCT01328444|516480164|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
143253228|NCT01328444|516480165|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
143253229|NCT01328444|516480166|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
143253230|NCT01328444|516480167|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
143253231|NCT01328444|516480162|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
143253232|NCT01328444|516480163|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
143253233|NCT01328444|516480164|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
143253234|NCT01328444|516480165|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
143253235|NCT01328444|516480166|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
143367825|NCT00124982|516889442|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
143253236|NCT01328444|516480167|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
143253237|NCT01328444|516480162|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
143253238|NCT01328444|516480163|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
143253239|NCT01328444|516480164|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
143253240|NCT01328444|516480165|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
143253241|NCT01328444|516480166|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
143253242|NCT01328444|516480167|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
143253243|NCT04620798|516480170|FG000|Overall Study|Lost to Follow-up|126|||
143253244|NCT04620798|516480171|FG001|Overall Study|Lost to Follow-up|138|||
143253245|NCT00539188|516480176|FG000|Overall Study|Withdrawal by Subject|1|||
143253246|NCT00539188|516480177|FG001|Overall Study|Withdrawal by Subject|0|||
143253247|NCT00539188|516480176|FG000|Overall Study|Lost to Follow-up|2|||
143253248|NCT00539188|516480177|FG001|Overall Study|Lost to Follow-up|1|||
143253249|NCT02756806|516480179|FG000|Overall Study|Study terminated early|5|||
143253250|NCT00946153|516480185|FG000|Phase 2|Adverse Event|0|||
143253251|NCT00946153|516480186|FG001|Phase 2|Adverse Event|0|||
143253252|NCT00946153|516480187|FG002|Phase 2|Adverse Event|0|||
143253253|NCT00946153|516480188|FG003|Phase 2|Adverse Event|0|||
143253254|NCT00946153|516480189|FG004|Phase 2|Adverse Event|6|||
143253255|NCT00946153|516480185|FG000|Phase 2|Need more reduction of dose|0|||
143253256|NCT00946153|516480186|FG001|Phase 2|Need more reduction of dose|0|||
143253257|NCT00946153|516480187|FG002|Phase 2|Need more reduction of dose|0|||
143253258|NCT00946153|516480188|FG003|Phase 2|Need more reduction of dose|0|||
143253259|NCT00946153|516480189|FG004|Phase 2|Need more reduction of dose|2|||
143253260|NCT00946153|516480185|FG000|Phase 2|Physician Decision|0|||
143253261|NCT00946153|516480186|FG001|Phase 2|Physician Decision|0|||
143253262|NCT00946153|516480187|FG002|Phase 2|Physician Decision|0|||
143253263|NCT00946153|516480188|FG003|Phase 2|Physician Decision|0|||
143253264|NCT00946153|516480189|FG004|Phase 2|Physician Decision|1|||
143253265|NCT00946153|516480185|FG000|Phase 2|14 days washout for recovery due to AE|0|||
143253266|NCT00946153|516480186|FG001|Phase 2|14 days washout for recovery due to AE|0|||
143253267|NCT00946153|516480187|FG002|Phase 2|14 days washout for recovery due to AE|0|||
143253268|NCT00946153|516480188|FG003|Phase 2|14 days washout for recovery due to AE|0|||
143253269|NCT00946153|516480189|FG004|Phase 2|14 days washout for recovery due to AE|4|||
143253270|NCT00934843|516480190|FG000|Overall Study|Protocol Violation|0|||
143253271|NCT00934843|516480191|FG001|Overall Study|Protocol Violation|1|||
143253272|NCT03865316|516481715|FG000|Overall Study|Procedure Cancelled|4|||
143253273|NCT03865316|516481715|FG000|Overall Study|Equipment failure|4|||
143253274|NCT00730028|516481724|FG000|Overall Study|Adverse Event|23|||
143253275|NCT00730028|516481725|FG001|Overall Study|Adverse Event|26|||
143253276|NCT00730028|516481726|FG002|Overall Study|Adverse Event|16|||
143253277|NCT00730028|516481727|FG003|Overall Study|Adverse Event|20|||
143253278|NCT00730028|516481728|FG004|Overall Study|Adverse Event|43|||
143253279|NCT00730028|516481724|FG000|Overall Study|Lost to Follow-up|13|||
143253280|NCT00730028|516481725|FG001|Overall Study|Lost to Follow-up|26|||
143253281|NCT00730028|516481726|FG002|Overall Study|Lost to Follow-up|22|||
143253282|NCT00730028|516481727|FG003|Overall Study|Lost to Follow-up|26|||
143253283|NCT00730028|516481728|FG004|Overall Study|Lost to Follow-up|25|||
143253284|NCT00730028|516481724|FG000|Overall Study|Protocol Violation|6|||
143253285|NCT00730028|516481725|FG001|Overall Study|Protocol Violation|1|||
143253286|NCT00730028|516481726|FG002|Overall Study|Protocol Violation|1|||
143253287|NCT00730028|516481727|FG003|Overall Study|Protocol Violation|2|||
143253288|NCT00730028|516481728|FG004|Overall Study|Protocol Violation|0|||
143253289|NCT00730028|516481724|FG000|Overall Study|Withdrawal by Subject|9|||
143253290|NCT00730028|516481725|FG001|Overall Study|Withdrawal by Subject|5|||
143253291|NCT00730028|516481726|FG002|Overall Study|Withdrawal by Subject|4|||
143253292|NCT00730028|516481727|FG003|Overall Study|Withdrawal by Subject|5|||
143253293|NCT00730028|516481728|FG004|Overall Study|Withdrawal by Subject|9|||
143253294|NCT00730028|516481724|FG000|Overall Study|Physician Decision|3|||
143253295|NCT00730028|516481725|FG001|Overall Study|Physician Decision|3|||
143253296|NCT00730028|516481726|FG002|Overall Study|Physician Decision|2|||
143253297|NCT00730028|516481727|FG003|Overall Study|Physician Decision|3|||
143253298|NCT00730028|516481728|FG004|Overall Study|Physician Decision|2|||
143253299|NCT00730028|516481724|FG000|Overall Study|Treatment Failure|5|||
143253300|NCT00730028|516481725|FG001|Overall Study|Treatment Failure|5|||
143253301|NCT00730028|516481726|FG002|Overall Study|Treatment Failure|0|||
143253302|NCT00730028|516481727|FG003|Overall Study|Treatment Failure|0|||
143253303|NCT00730028|516481728|FG004|Overall Study|Treatment Failure|1|||
143253304|NCT00730028|516481724|FG000|Overall Study|Randomization Error|1|||
143253305|NCT00730028|516481725|FG001|Overall Study|Randomization Error|0|||
143253306|NCT00730028|516481726|FG002|Overall Study|Randomization Error|0|||
143253307|NCT00730028|516481727|FG003|Overall Study|Randomization Error|0|||
143253308|NCT00730028|516481728|FG004|Overall Study|Randomization Error|2|||
143253309|NCT00874939|516481729|FG000|Overall Study|Study terminated|4|||
143253310|NCT02870933|516481730|FG000|Overall Study|Death|2|||
143253311|NCT02870933|516481731|FG001|Overall Study|Death|1|||
143253312|NCT02870933|516481730|FG000|Overall Study|Withdrawal by Subject|0|||
143253313|NCT02870933|516481731|FG001|Overall Study|Withdrawal by Subject|1|||
143253314|NCT01250496|516481734|FG000|Overall Study|Study terminated|124|||
143103167|NCT03850483|515918070|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
143103168|NCT03850483|515918071|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
143103169|NCT03850483|515918072|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
143103170|NCT03850483|515918073|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
143103171|NCT03850483|515918074|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
143103172|NCT03850483|515918075|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
143103173|NCT03850483|515918076|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
143103174|NCT03850483|515918077|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
143103175|NCT03850483|515918068|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
143103176|NCT03850483|515918069|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
143103177|NCT03850483|515918070|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
143103178|NCT03850483|515918071|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
143103179|NCT03850483|515918072|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
143103180|NCT03850483|515918073|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
143103181|NCT03850483|515918074|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
143103182|NCT03850483|515918075|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
143103183|NCT03850483|515918076|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
143103184|NCT03850483|515918077|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
143103185|NCT03850483|515918068|FG000|Follow-up for Stage 1|Physician Decision|0|||
143103186|NCT03850483|515918069|FG001|Follow-up for Stage 1|Physician Decision|0|||
143103187|NCT03850483|515918070|FG002|Follow-up for Stage 1|Physician Decision|0|||
143103188|NCT03850483|515918071|FG003|Follow-up for Stage 1|Physician Decision|0|||
143103189|NCT03850483|515918072|FG004|Follow-up for Stage 1|Physician Decision|1|||
143103190|NCT03850483|515918073|FG005|Follow-up for Stage 1|Physician Decision|0|||
143103191|NCT03850483|515918074|FG006|Follow-up for Stage 1|Physician Decision|1|||
143103192|NCT03850483|515918075|FG007|Follow-up for Stage 1|Physician Decision|0|||
143103193|NCT03850483|515918076|FG008|Follow-up for Stage 1|Physician Decision|0|||
143253315|NCT01250496|516481735|FG001|Overall Study|Study terminated|124|||
143103194|NCT03850483|515918077|FG009|Follow-up for Stage 1|Physician Decision|0|||
143103195|NCT03850483|515918068|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
143103196|NCT03850483|515918069|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
143103197|NCT03850483|515918070|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
143103198|NCT03850483|515918071|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
143103199|NCT03850483|515918072|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
143103200|NCT03850483|515918073|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
143103201|NCT03850483|515918074|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
143103202|NCT03850483|515918075|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
143103203|NCT03850483|515918076|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
143103204|NCT03850483|515918077|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
143103205|NCT03850483|515918068|FG000|Follow-up for Stage 1|Adverse Event|0|||
143103206|NCT03850483|515918069|FG001|Follow-up for Stage 1|Adverse Event|0|||
143103207|NCT03850483|515918070|FG002|Follow-up for Stage 1|Adverse Event|1|||
143103208|NCT03850483|515918071|FG003|Follow-up for Stage 1|Adverse Event|0|||
143103209|NCT03850483|515918072|FG004|Follow-up for Stage 1|Adverse Event|0|||
143103210|NCT03850483|515918073|FG005|Follow-up for Stage 1|Adverse Event|1|||
143103211|NCT03850483|515918074|FG006|Follow-up for Stage 1|Adverse Event|0|||
143103212|NCT03850483|515918075|FG007|Follow-up for Stage 1|Adverse Event|0|||
143103213|NCT03850483|515918076|FG008|Follow-up for Stage 1|Adverse Event|0|||
143103214|NCT03850483|515918077|FG009|Follow-up for Stage 1|Adverse Event|0|||
143103215|NCT03850483|515918068|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
143103216|NCT03850483|515918069|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
143103217|NCT03850483|515918070|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
143103218|NCT03850483|515918071|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
143103219|NCT03850483|515918072|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
143103220|NCT03850483|515918073|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
143103221|NCT03850483|515918074|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
143103222|NCT03850483|515918075|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
143103223|NCT03850483|515918076|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
143103224|NCT03850483|515918077|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
143103225|NCT03850483|515918068|FG000|Follow-up for Stage 1|Other|0|||
143103226|NCT03850483|515918069|FG001|Follow-up for Stage 1|Other|2|||
143103227|NCT03850483|515918070|FG002|Follow-up for Stage 1|Other|0|||
143103228|NCT03850483|515918071|FG003|Follow-up for Stage 1|Other|2|||
143103229|NCT03850483|515918072|FG004|Follow-up for Stage 1|Other|0|||
143103230|NCT03850483|515918073|FG005|Follow-up for Stage 1|Other|1|||
143103231|NCT03850483|515918074|FG006|Follow-up for Stage 1|Other|0|||
143103232|NCT03850483|515918075|FG007|Follow-up for Stage 1|Other|0|||
143103233|NCT03850483|515918076|FG008|Follow-up for Stage 1|Other|0|||
143103234|NCT03850483|515918077|FG009|Follow-up for Stage 1|Other|0|||
143103235|NCT03850483|515918068|FG000|Treatment for Stage 2|Adverse Event|0|||
143103236|NCT03850483|515918069|FG001|Treatment for Stage 2|Adverse Event|0|||
143103237|NCT03850483|515918070|FG002|Treatment for Stage 2|Adverse Event|0|||
143253316|NCT00003590|516481736|FG000|Overall Study|Ineligible Patient|1|||
143253317|NCT00003590|516481736|FG000|Overall Study|Adverse Event|7|||
143253318|NCT00003590|516481736|FG000|Overall Study|Withdrawal by Subject|1|||
143253319|NCT00003590|516481736|FG000|Overall Study|Lack of Efficacy|11|||
143253320|NCT00003590|516481736|FG000|Overall Study|Death|1|||
143253321|NCT00003590|516481736|FG000|Overall Study|Physician Decision|1|||
143253322|NCT01425463|516481742|FG000|Overall Study|Adverse Event|5|||
143253323|NCT01425463|516481743|FG001|Overall Study|Adverse Event|7|||
143253324|NCT01425463|516481742|FG000|Overall Study|Lack of Efficacy|1|||
143253325|NCT01425463|516481743|FG001|Overall Study|Lack of Efficacy|1|||
143253326|NCT01425463|516481742|FG000|Overall Study|Protocol Violation|2|||
143253327|NCT01425463|516481743|FG001|Overall Study|Protocol Violation|2|||
143253328|NCT01425463|516481742|FG000|Overall Study|Lost to Follow-up|5|||
143253329|NCT01425463|516481743|FG001|Overall Study|Lost to Follow-up|2|||
143253330|NCT01425463|516481742|FG000|Overall Study|Withdrawal by Subject|7|||
143253331|NCT01425463|516481743|FG001|Overall Study|Withdrawal by Subject|5|||
143253332|NCT01425463|516481742|FG000|Overall Study|Unknown Reason|4|||
143253333|NCT01425463|516481743|FG001|Overall Study|Unknown Reason|7|||
143253334|NCT01332799|516481745|FG000|Overall Study|Insufficient funding|10|||
143253335|NCT01332799|516481746|FG001|Overall Study|Insufficient funding|10|||
143253336|NCT00668733|516481747|FG000|Overall Study|Lost to Follow-up|2|||
143253337|NCT00668733|516481748|FG001|Overall Study|Lost to Follow-up|3|||
143253338|NCT00668733|516481747|FG000|Overall Study|Withdrawal by Subject|0|||
143253339|NCT00668733|516481748|FG001|Overall Study|Withdrawal by Subject|4|||
143253340|NCT01909791|516481749|FG000|Overall Study|Death|9|||
143253341|NCT01909791|516481750|FG001|Overall Study|Death|8|||
143253342|NCT01909791|516481751|FG002|Overall Study|Death|4|||
143103238|NCT03850483|515918071|FG003|Treatment for Stage 2|Adverse Event|0|||
143103239|NCT03850483|515918072|FG004|Treatment for Stage 2|Adverse Event|0|||
143103240|NCT03850483|515918073|FG005|Treatment for Stage 2|Adverse Event|0|||
143103241|NCT03850483|515918074|FG006|Treatment for Stage 2|Adverse Event|0|||
143103242|NCT03850483|515918075|FG007|Treatment for Stage 2|Adverse Event|0|||
143103243|NCT03850483|515918076|FG008|Treatment for Stage 2|Adverse Event|0|||
143103244|NCT03850483|515918077|FG009|Treatment for Stage 2|Adverse Event|1|||
143103245|NCT03850483|515918068|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
143103246|NCT03850483|515918069|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
143103247|NCT03850483|515918070|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
143103248|NCT03850483|515918071|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
143103249|NCT03850483|515918072|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
143103250|NCT03850483|515918073|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
143103251|NCT03850483|515918074|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
143103252|NCT03850483|515918075|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
143103253|NCT03850483|515918076|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
143103254|NCT03850483|515918077|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
143103255|NCT03850483|515918068|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
143103256|NCT03850483|515918069|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
143253343|NCT01909791|516481749|FG000|Overall Study|Withdrawal by Subject|5|||
143253344|NCT01909791|516481750|FG001|Overall Study|Withdrawal by Subject|9|||
143253345|NCT01909791|516481751|FG002|Overall Study|Withdrawal by Subject|13|||
143253346|NCT01909791|516481749|FG000|Overall Study|Lost to Follow-up|5|||
143253347|NCT01909791|516481750|FG001|Overall Study|Lost to Follow-up|11|||
143253348|NCT01909791|516481751|FG002|Overall Study|Lost to Follow-up|10|||
143253349|NCT01909791|516481749|FG000|Overall Study|Missed Visit|2|||
143103257|NCT03850483|515918070|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
143103258|NCT03850483|515918071|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
143253350|NCT01909791|516481750|FG001|Overall Study|Missed Visit|0|||
143253351|NCT01909791|516481751|FG002|Overall Study|Missed Visit|1|||
143253352|NCT02168387|516481754|FG000|Overall Study|Planned exubation|6|||
143253353|NCT02168387|516481755|FG001|Overall Study|Planned exubation|3|||
143253354|NCT02168387|516481754|FG000|Overall Study|Death|1|||
143253355|NCT02168387|516481755|FG001|Overall Study|Death|0|||
143103259|NCT03850483|515918072|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
143103260|NCT03850483|515918073|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
143103261|NCT03850483|515918074|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
143103262|NCT03850483|515918075|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
143103263|NCT03850483|515918076|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
143103264|NCT03850483|515918077|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
143103265|NCT03850483|515918068|FG000|Treatment for Stage 2|Physician Decision|0|||
143253356|NCT01659554|516481756|FG000|Overall Study|Study Termination|4|||
143253357|NCT01252667|516481762|FG000|Overall Study|Transplant aborted post-conditioning|0|||
143253358|NCT01252667|516481763|FG001|Overall Study|Transplant aborted post-conditioning|0|||
143253359|NCT01252667|516481764|FG002|Overall Study|Transplant aborted post-conditioning|0|||
143253360|NCT01252667|516481765|FG003|Overall Study|Transplant aborted post-conditioning|0|||
143253361|NCT01252667|516481766|FG004|Overall Study|Transplant aborted post-conditioning|0|||
143253362|NCT01252667|516481767|FG005|Overall Study|Transplant aborted post-conditioning|1|||
143253363|NCT03032380|516481768|FG000|Overall Study|Adverse Event|0|||
143253364|NCT03032380|516481769|FG001|Overall Study|Adverse Event|1|||
143253365|NCT03032380|516481768|FG000|Overall Study|Lack of Efficacy|1|||
143103266|NCT03850483|515918069|FG001|Treatment for Stage 2|Physician Decision|0|||
143253366|NCT03032380|516481769|FG001|Overall Study|Lack of Efficacy|0|||
143253367|NCT03032380|516481768|FG000|Overall Study|Withdrawal by Subject|2|||
143253368|NCT03032380|516481769|FG001|Overall Study|Withdrawal by Subject|3|||
143253369|NCT03032380|516481768|FG000|Overall Study|Recovery|0|||
143253370|NCT03032380|516481769|FG001|Overall Study|Recovery|1|||
143253371|NCT03032380|516481768|FG000|Overall Study|Death|39|||
143253372|NCT03032380|516481769|FG001|Overall Study|Death|34|||
143253373|NCT03032380|516481768|FG000|Overall Study|Other - Miscellaneous|0|||
143253374|NCT03032380|516481769|FG001|Overall Study|Other - Miscellaneous|1|||
143253375|NCT01836276|516481770|FG000|Overall Study|Lost to Follow-up|28|||
143253376|NCT01836276|516481771|FG001|Overall Study|Lost to Follow-up|51|||
143253377|NCT00913458|516481772|FG000|Phase 1|Non-Responder|54|||
143253378|NCT00913458|516481773|FG001|Phase 1|Non-Responder|0|||
143253379|NCT00913458|516481774|FG002|Phase 1|Non-Responder|0|||
143253380|NCT00913458|516481775|FG003|Phase 1|Non-Responder|0|||
143253381|NCT00913458|516481776|FG004|Phase 1|Non-Responder|0|||
143253382|NCT00913458|516481777|FG005|Phase 1|Non-Responder|0|||
143253383|NCT00913458|516481778|FG006|Phase 1|Non-Responder|0|||
143253384|NCT00913458|516481772|FG000|Phase 1|Subject Request|17|||
143253385|NCT00913458|516481773|FG001|Phase 1|Subject Request|0|||
143253386|NCT00913458|516481774|FG002|Phase 1|Subject Request|0|||
143253387|NCT00913458|516481775|FG003|Phase 1|Subject Request|0|||
143253388|NCT00913458|516481776|FG004|Phase 1|Subject Request|0|||
143253389|NCT00913458|516481777|FG005|Phase 1|Subject Request|0|||
143253390|NCT00913458|516481778|FG006|Phase 1|Subject Request|0|||
143253391|NCT00913458|516481772|FG000|Phase 1|Adverse Event|20|||
143103267|NCT03850483|515918070|FG002|Treatment for Stage 2|Physician Decision|0|||
143253392|NCT00913458|516481773|FG001|Phase 1|Adverse Event|0|||
143253393|NCT00913458|516481774|FG002|Phase 1|Adverse Event|0|||
143253394|NCT00913458|516481775|FG003|Phase 1|Adverse Event|0|||
143253395|NCT00913458|516481776|FG004|Phase 1|Adverse Event|0|||
143253396|NCT00913458|516481777|FG005|Phase 1|Adverse Event|0|||
143253397|NCT00913458|516481778|FG006|Phase 1|Adverse Event|0|||
143253398|NCT00913458|516481772|FG000|Phase 1|Lost to Follow-up|2|||
143253399|NCT00913458|516481773|FG001|Phase 1|Lost to Follow-up|0|||
143253400|NCT00913458|516481774|FG002|Phase 1|Lost to Follow-up|0|||
143253401|NCT00913458|516481775|FG003|Phase 1|Lost to Follow-up|0|||
143253402|NCT00913458|516481776|FG004|Phase 1|Lost to Follow-up|0|||
143253403|NCT00913458|516481777|FG005|Phase 1|Lost to Follow-up|0|||
143253404|NCT00913458|516481778|FG006|Phase 1|Lost to Follow-up|0|||
143253405|NCT00913458|516481772|FG000|Phase 1|Protocol Violation|10|||
143253406|NCT00913458|516481773|FG001|Phase 1|Protocol Violation|0|||
143253407|NCT00913458|516481774|FG002|Phase 1|Protocol Violation|0|||
143253408|NCT00913458|516481775|FG003|Phase 1|Protocol Violation|0|||
143253409|NCT00913458|516481776|FG004|Phase 1|Protocol Violation|0|||
143253410|NCT00913458|516481777|FG005|Phase 1|Protocol Violation|0|||
143253411|NCT00913458|516481778|FG006|Phase 1|Protocol Violation|0|||
143253412|NCT00913458|516481772|FG000|Phase 1|Sponsor|2|||
143253413|NCT00913458|516481773|FG001|Phase 1|Sponsor|0|||
143253414|NCT00913458|516481774|FG002|Phase 1|Sponsor|0|||
143253415|NCT00913458|516481775|FG003|Phase 1|Sponsor|0|||
143253416|NCT00913458|516481776|FG004|Phase 1|Sponsor|0|||
143253417|NCT00913458|516481777|FG005|Phase 1|Sponsor|0|||
143253418|NCT00913458|516481778|FG006|Phase 1|Sponsor|0|||
143253419|NCT00913458|516481772|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
143253420|NCT00913458|516481773|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
143253421|NCT00913458|516481774|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
143103268|NCT03850483|515918071|FG003|Treatment for Stage 2|Physician Decision|0|||
143253422|NCT00913458|516481775|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
143253423|NCT00913458|516481776|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
143253424|NCT00913458|516481777|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
143253425|NCT00913458|516481778|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
143253426|NCT00913458|516481772|FG000|Phase 2|Non-Responder|0|||
143253427|NCT00913458|516481773|FG001|Phase 2|Non-Responder|5|||
143253428|NCT00913458|516481774|FG002|Phase 2|Non-Responder|7|||
143253429|NCT00913458|516481775|FG003|Phase 2|Non-Responder|12|||
143253430|NCT00913458|516481776|FG004|Phase 2|Non-Responder|0|||
143253431|NCT00913458|516481777|FG005|Phase 2|Non-Responder|0|||
143253432|NCT00913458|516481778|FG006|Phase 2|Non-Responder|0|||
143253433|NCT00913458|516481772|FG000|Phase 2|Subject Request|0|||
143253434|NCT00913458|516481773|FG001|Phase 2|Subject Request|0|||
143253435|NCT00913458|516481774|FG002|Phase 2|Subject Request|1|||
143253436|NCT00913458|516481775|FG003|Phase 2|Subject Request|2|||
143253437|NCT00913458|516481776|FG004|Phase 2|Subject Request|0|||
143253438|NCT00913458|516481777|FG005|Phase 2|Subject Request|0|||
143253439|NCT00913458|516481778|FG006|Phase 2|Subject Request|0|||
143253440|NCT00913458|516481772|FG000|Phase 2|Adverse Event|0|||
143253441|NCT00913458|516481773|FG001|Phase 2|Adverse Event|3|||
143253442|NCT00913458|516481774|FG002|Phase 2|Adverse Event|0|||
143253443|NCT00913458|516481775|FG003|Phase 2|Adverse Event|1|||
143253444|NCT00913458|516481776|FG004|Phase 2|Adverse Event|0|||
143253445|NCT00913458|516481777|FG005|Phase 2|Adverse Event|0|||
143253446|NCT00913458|516481778|FG006|Phase 2|Adverse Event|0|||
143253447|NCT00913458|516481772|FG000|Phase 2|Lost to Follow-up|0|||
143103269|NCT03850483|515918072|FG004|Treatment for Stage 2|Physician Decision|0|||
143103270|NCT03850483|515918073|FG005|Treatment for Stage 2|Physician Decision|0|||
143103271|NCT03850483|515918074|FG006|Treatment for Stage 2|Physician Decision|0|||
143103272|NCT03850483|515918075|FG007|Treatment for Stage 2|Physician Decision|0|||
143103273|NCT03850483|515918076|FG008|Treatment for Stage 2|Physician Decision|0|||
143103274|NCT03850483|515918077|FG009|Treatment for Stage 2|Physician Decision|1|||
143103275|NCT03850483|515918068|FG000|Treatment for Stage 2|Protocol Violation|0|||
143103276|NCT03850483|515918069|FG001|Treatment for Stage 2|Protocol Violation|0|||
143103277|NCT03850483|515918070|FG002|Treatment for Stage 2|Protocol Violation|0|||
143103278|NCT03850483|515918071|FG003|Treatment for Stage 2|Protocol Violation|0|||
143103279|NCT03850483|515918072|FG004|Treatment for Stage 2|Protocol Violation|0|||
143103280|NCT03850483|515918073|FG005|Treatment for Stage 2|Protocol Violation|0|||
143103281|NCT03850483|515918074|FG006|Treatment for Stage 2|Protocol Violation|0|||
143103282|NCT03850483|515918075|FG007|Treatment for Stage 2|Protocol Violation|0|||
143103283|NCT03850483|515918076|FG008|Treatment for Stage 2|Protocol Violation|1|||
143103284|NCT03850483|515918077|FG009|Treatment for Stage 2|Protocol Violation|0|||
143103285|NCT03850483|515918068|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
143103286|NCT03850483|515918069|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
143103287|NCT03850483|515918070|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
143103288|NCT03850483|515918071|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
143103289|NCT03850483|515918072|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
143103290|NCT03850483|515918073|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
143103291|NCT03850483|515918074|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
143103292|NCT03850483|515918075|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
143103293|NCT03850483|515918076|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
143103294|NCT03850483|515918077|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
143103295|NCT03850483|515918068|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
143103296|NCT03850483|515918069|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
143103297|NCT03850483|515918070|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
143103298|NCT03850483|515918071|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
143103299|NCT03850483|515918072|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
143103300|NCT03850483|515918073|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
143103301|NCT03850483|515918074|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
143103302|NCT03850483|515918075|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
143103303|NCT03850483|515918076|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
143103304|NCT03850483|515918077|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
143103305|NCT03850483|515918068|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
143103306|NCT03850483|515918069|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
143103307|NCT03850483|515918070|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
143103308|NCT03850483|515918071|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
143103309|NCT03850483|515918072|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
143103310|NCT03850483|515918073|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
143103311|NCT03850483|515918074|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
143103312|NCT03850483|515918075|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
143103313|NCT03850483|515918076|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
143103314|NCT03850483|515918077|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
143103315|NCT03850483|515918068|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
143103316|NCT03850483|515918069|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
143103317|NCT03850483|515918070|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
143103318|NCT03850483|515918071|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
143103319|NCT03850483|515918072|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
143103320|NCT03850483|515918073|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
143103321|NCT03850483|515918074|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
143103322|NCT03850483|515918075|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
143103323|NCT03850483|515918076|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
143103324|NCT03850483|515918077|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
143103325|NCT03850483|515918068|FG000|Follow-up For Stage 2|Other|0|||
143103326|NCT03850483|515918069|FG001|Follow-up For Stage 2|Other|0|||
143103327|NCT03850483|515918070|FG002|Follow-up For Stage 2|Other|0|||
143103328|NCT03850483|515918071|FG003|Follow-up For Stage 2|Other|0|||
143103329|NCT03850483|515918072|FG004|Follow-up For Stage 2|Other|0|||
143103330|NCT03850483|515918073|FG005|Follow-up For Stage 2|Other|0|||
143103331|NCT03850483|515918074|FG006|Follow-up For Stage 2|Other|0|||
143103332|NCT03850483|515918075|FG007|Follow-up For Stage 2|Other|0|||
143177806|NCT01713582|516199816|FG011|Overall Study|Withdrawal of consent|0|||
143177807|NCT01713582|516199817|FG012|Overall Study|Withdrawal of consent|0|||
143177808|NCT01713582|516199818|FG013|Overall Study|Withdrawal of consent|0|||
143177809|NCT01713582|516199819|FG014|Overall Study|Withdrawal of consent|0|||
143177810|NCT01713582|516199820|FG015|Overall Study|Withdrawal of consent|0|||
143177811|NCT01713582|516199821|FG016|Overall Study|Withdrawal of consent|0|||
143103333|NCT03850483|515918076|FG008|Follow-up For Stage 2|Other|0|||
143177812|NCT01713582|516199822|FG017|Overall Study|Withdrawal of consent|0|||
143253448|NCT00913458|516481773|FG001|Phase 2|Lost to Follow-up|0|||
143253449|NCT00913458|516481774|FG002|Phase 2|Lost to Follow-up|0|||
143253450|NCT00913458|516481775|FG003|Phase 2|Lost to Follow-up|1|||
143253451|NCT00913458|516481776|FG004|Phase 2|Lost to Follow-up|0|||
143253452|NCT00913458|516481777|FG005|Phase 2|Lost to Follow-up|0|||
143253453|NCT00913458|516481778|FG006|Phase 2|Lost to Follow-up|0|||
143253454|NCT00913458|516481772|FG000|Phase 2|Protocol Violation|0|||
143253455|NCT00913458|516481773|FG001|Phase 2|Protocol Violation|2|||
143253456|NCT00913458|516481774|FG002|Phase 2|Protocol Violation|0|||
143253457|NCT00913458|516481775|FG003|Phase 2|Protocol Violation|0|||
143103334|NCT03850483|515918077|FG009|Follow-up For Stage 2|Other|1|||
143103335|NCT04725812|515920204|FG000|Overall Study|Withdrawal by Subject|1|||
143103336|NCT00610155|515920205|FG000|Period 1|Withdrawal by Subject|0|||
143103337|NCT00610155|515920206|FG001|Period 1|Withdrawal by Subject|0|||
143103338|NCT00610155|515920207|FG002|Period 1|Withdrawal by Subject|1|||
143253458|NCT00913458|516481776|FG004|Phase 2|Protocol Violation|0|||
143253459|NCT00913458|516481777|FG005|Phase 2|Protocol Violation|0|||
143253460|NCT00913458|516481778|FG006|Phase 2|Protocol Violation|0|||
143103339|NCT00610155|515920208|FG003|Period 1|Withdrawal by Subject|0|||
143103340|NCT00610155|515920209|FG004|Period 1|Withdrawal by Subject|0|||
143103341|NCT00610155|515920210|FG005|Period 1|Withdrawal by Subject|0|||
143103342|NCT00610155|515920205|FG000|Period 3|Adverse Event|1|||
143103343|NCT00610155|515920206|FG001|Period 3|Adverse Event|0|||
143103344|NCT00610155|515920207|FG002|Period 3|Adverse Event|0|||
143103345|NCT00610155|515920208|FG003|Period 3|Adverse Event|0|||
143103346|NCT00610155|515920209|FG004|Period 3|Adverse Event|0|||
143103347|NCT00610155|515920210|FG005|Period 3|Adverse Event|0|||
143103348|NCT01284348|515920213|FG000|Overall Study|Death|1|||
143103349|NCT01284348|515920214|FG001|Overall Study|Death|1|||
143103350|NCT01284348|515920213|FG000|Overall Study|Withdrew consent|0|||
143103351|NCT01284348|515920214|FG001|Overall Study|Withdrew consent|1|||
143103352|NCT01284348|515920213|FG000|Overall Study|Status not recorded|9|||
143103353|NCT01284348|515920214|FG001|Overall Study|Status not recorded|10|||
143103354|NCT02714595|515920220|FG000|Overall Study|Lost to Follow-up|1|||
143103355|NCT02714595|515920221|FG001|Overall Study|Lost to Follow-up|0|||
143103356|NCT02714595|515920220|FG000|Overall Study|Withdrawal by Subject|1|||
143177813|NCT01713582|516199823|FG018|Overall Study|Withdrawal of consent|1|||
143177814|NCT01713582|516199824|FG019|Overall Study|Withdrawal of consent|0|||
143253461|NCT00913458|516481772|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
143253462|NCT00913458|516481773|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
143253463|NCT00913458|516481774|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
143253464|NCT00913458|516481775|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
143253465|NCT00913458|516481776|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
143253466|NCT00913458|516481777|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
143253467|NCT00913458|516481778|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
143253468|NCT00913458|516481772|FG000|Phase 3|Adverse Event|0|||
143253469|NCT00913458|516481773|FG001|Phase 3|Adverse Event|0|||
143253470|NCT00913458|516481774|FG002|Phase 3|Adverse Event|0|||
143253471|NCT00913458|516481775|FG003|Phase 3|Adverse Event|0|||
143253472|NCT00913458|516481776|FG004|Phase 3|Adverse Event|5|||
143253473|NCT00913458|516481777|FG005|Phase 3|Adverse Event|4|||
143253474|NCT00913458|516481778|FG006|Phase 3|Adverse Event|1|||
143253475|NCT00913458|516481772|FG000|Phase 3|Lost to Follow-up|0|||
143253476|NCT00913458|516481773|FG001|Phase 3|Lost to Follow-up|0|||
143253477|NCT00913458|516481774|FG002|Phase 3|Lost to Follow-up|0|||
143253478|NCT00913458|516481775|FG003|Phase 3|Lost to Follow-up|0|||
143177815|NCT01713582|516199825|FG020|Overall Study|Withdrawal of consent|0|||
143177816|NCT01713582|516199805|FG000|Overall Study|Lack of Efficacy|0|||
143177817|NCT01713582|516199806|FG001|Overall Study|Lack of Efficacy|0|||
143177818|NCT01713582|516199807|FG002|Overall Study|Lack of Efficacy|0|||
143177819|NCT01713582|516199808|FG003|Overall Study|Lack of Efficacy|0|||
143177820|NCT01713582|516199809|FG004|Overall Study|Lack of Efficacy|0|||
143177821|NCT01713582|516199810|FG005|Overall Study|Lack of Efficacy|0|||
143177822|NCT01713582|516199811|FG006|Overall Study|Lack of Efficacy|0|||
143177823|NCT01713582|516199812|FG007|Overall Study|Lack of Efficacy|0|||
143253479|NCT00913458|516481776|FG004|Phase 3|Lost to Follow-up|2|||
143253480|NCT00913458|516481777|FG005|Phase 3|Lost to Follow-up|0|||
143253481|NCT00913458|516481778|FG006|Phase 3|Lost to Follow-up|0|||
143103357|NCT02714595|515920221|FG001|Overall Study|Withdrawal by Subject|2|||
143103358|NCT02714595|515920220|FG000|Overall Study|Lack of Efficacy|0|||
143103359|NCT02714595|515920221|FG001|Overall Study|Lack of Efficacy|1|||
143253482|NCT00913458|516481772|FG000|Phase 3|Non-Responder|0|||
143253483|NCT00913458|516481773|FG001|Phase 3|Non-Responder|0|||
143253484|NCT00913458|516481774|FG002|Phase 3|Non-Responder|0|||
143253485|NCT00913458|516481775|FG003|Phase 3|Non-Responder|0|||
143253486|NCT00913458|516481776|FG004|Phase 3|Non-Responder|0|||
143103360|NCT02714595|515920220|FG000|Overall Study|Death|30|||
143103361|NCT02714595|515920221|FG001|Overall Study|Death|9|||
143177824|NCT01713582|516199813|FG008|Overall Study|Lack of Efficacy|0|||
143177825|NCT01713582|516199814|FG009|Overall Study|Lack of Efficacy|1|||
143253487|NCT00913458|516481777|FG005|Phase 3|Non-Responder|1|||
143253488|NCT00913458|516481778|FG006|Phase 3|Non-Responder|3|||
143253489|NCT00913458|516481772|FG000|Phase 3|Withdrawal by Subject|0|||
143103362|NCT02714595|515920220|FG000|Overall Study|Other-Miscellaneous|0|||
143103363|NCT02714595|515920221|FG001|Overall Study|Other-Miscellaneous|1|||
143103364|NCT02320058|515920225|FG000|Overall Study|Death|25|||
143103365|NCT02320058|515920226|FG001|Overall Study|Death|10|||
143103366|NCT02320058|515920225|FG000|Overall Study|Lost to Follow-up|4|||
143103367|NCT02320058|515920226|FG001|Overall Study|Lost to Follow-up|0|||
143103368|NCT02320058|515920225|FG000|Overall Study|Other reasons|4|||
143103369|NCT02320058|515920226|FG001|Overall Study|Other reasons|1|||
143103370|NCT02320058|515920225|FG000|Overall Study|Withdrawal by Subject|8|||
143103371|NCT02320058|515920226|FG001|Overall Study|Withdrawal by Subject|2|||
143103372|NCT02320058|515920225|FG000|Overall Study|Not reported|1|||
143103373|NCT02320058|515920226|FG001|Overall Study|Not reported|0|||
143103374|NCT01339923|515920227|FG000|Overall Study|Adverse Event|1|||
143103375|NCT01339923|515920228|FG001|Overall Study|Adverse Event|1|||
143103376|NCT01339923|515920229|FG002|Overall Study|Adverse Event|1|||
143103377|NCT01339923|515920230|FG003|Overall Study|Adverse Event|0|||
143103378|NCT01339923|515920231|FG004|Overall Study|Adverse Event|0|||
143103379|NCT01339923|515920232|FG005|Overall Study|Adverse Event|0|||
143103380|NCT01339923|515920233|FG006|Overall Study|Adverse Event|1|||
143103381|NCT01339923|515920227|FG000|Overall Study|Inappropriate Enrollment|1|||
143103382|NCT01339923|515920228|FG001|Overall Study|Inappropriate Enrollment|0|||
143103383|NCT01339923|515920229|FG002|Overall Study|Inappropriate Enrollment|0|||
143103384|NCT01339923|515920230|FG003|Overall Study|Inappropriate Enrollment|0|||
143103385|NCT01339923|515920231|FG004|Overall Study|Inappropriate Enrollment|0|||
143103386|NCT01339923|515920232|FG005|Overall Study|Inappropriate Enrollment|1|||
143103387|NCT01339923|515920233|FG006|Overall Study|Inappropriate Enrollment|0|||
143103388|NCT01339923|515920227|FG000|Overall Study|Lost to Follow-up|4|||
143103389|NCT01339923|515920228|FG001|Overall Study|Lost to Follow-up|4|||
143103390|NCT01339923|515920229|FG002|Overall Study|Lost to Follow-up|0|||
143103391|NCT01339923|515920230|FG003|Overall Study|Lost to Follow-up|3|||
143103392|NCT01339923|515920231|FG004|Overall Study|Lost to Follow-up|1|||
143103393|NCT01339923|515920232|FG005|Overall Study|Lost to Follow-up|1|||
143103394|NCT01339923|515920233|FG006|Overall Study|Lost to Follow-up|5|||
143103395|NCT01339923|515920227|FG000|Overall Study|Protocol Violation|0|||
143103396|NCT01339923|515920228|FG001|Overall Study|Protocol Violation|0|||
143103397|NCT01339923|515920229|FG002|Overall Study|Protocol Violation|0|||
143103398|NCT01339923|515920230|FG003|Overall Study|Protocol Violation|0|||
143103399|NCT01339923|515920231|FG004|Overall Study|Protocol Violation|0|||
143103400|NCT01339923|515920232|FG005|Overall Study|Protocol Violation|3|||
143103401|NCT01339923|515920233|FG006|Overall Study|Protocol Violation|1|||
143103402|NCT01339923|515920227|FG000|Overall Study|Unable to Classify|1|||
143103403|NCT01339923|515920228|FG001|Overall Study|Unable to Classify|0|||
143103404|NCT01339923|515920229|FG002|Overall Study|Unable to Classify|1|||
143103405|NCT01339923|515920230|FG003|Overall Study|Unable to Classify|0|||
143103406|NCT01339923|515920231|FG004|Overall Study|Unable to Classify|0|||
143103407|NCT01339923|515920232|FG005|Overall Study|Unable to Classify|1|||
143103408|NCT01339923|515920233|FG006|Overall Study|Unable to Classify|5|||
143103409|NCT01339923|515920227|FG000|Overall Study|Withdrawal by Subject|7|||
143103410|NCT01339923|515920228|FG001|Overall Study|Withdrawal by Subject|11|||
143103411|NCT01339923|515920229|FG002|Overall Study|Withdrawal by Subject|6|||
143103412|NCT01339923|515920230|FG003|Overall Study|Withdrawal by Subject|1|||
143103413|NCT01339923|515920231|FG004|Overall Study|Withdrawal by Subject|4|||
143103414|NCT01339923|515920232|FG005|Overall Study|Withdrawal by Subject|3|||
143103415|NCT01339923|515920233|FG006|Overall Study|Withdrawal by Subject|2|||
143103416|NCT00661609|515920234|FG000|Overall Study|Adverse Event|4|||
143103417|NCT00661609|515920234|FG000|Overall Study|Death|20|||
143103418|NCT00661609|515920234|FG000|Overall Study|Withdrawal by Subject|2|||
143103419|NCT00661609|515920234|FG000|Overall Study|PI Decision|1|||
143103420|NCT00661609|515920234|FG000|Overall Study|Survival follow up stage discontinued|11|||
143103421|NCT00661609|515920234|FG000|Overall Study|Disease progression|3|||
143103422|NCT01855243|515920237|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
143103423|NCT01855243|515920238|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
143103424|NCT01855243|515920239|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
143103425|NCT00396656|515920240|FG000|First Treatment Period|Withdrawal by Subject|0|||
143103426|NCT00396656|515920241|FG001|First Treatment Period|Withdrawal by Subject|2|||
143103427|NCT00396656|515920240|FG000|Second Treatment Period|Adverse Event|0|||
143103428|NCT00396656|515920241|FG001|Second Treatment Period|Adverse Event|1|||
143103429|NCT00766636|515920244|FG000|Overall Study|Withdrawal by Subject|1|||
143103430|NCT00766636|515920245|FG001|Overall Study|Withdrawal by Subject|1|||
143103431|NCT00766636|515920244|FG000|Overall Study|Incomplete Treatment|0|||
143103432|NCT00766636|515920245|FG001|Overall Study|Incomplete Treatment|1|||
143103433|NCT00766636|515920244|FG000|Overall Study|Adverse Event|1|||
143103434|NCT00766636|515920245|FG001|Overall Study|Adverse Event|0|||
143103435|NCT00766636|515920244|FG000|Overall Study|Disease Progression|1|||
143103436|NCT00766636|515920245|FG001|Overall Study|Disease Progression|0|||
143103437|NCT02477332|515920250|FG000|Overall Study|Adverse Event|0|||
143103438|NCT02477332|515920251|FG001|Overall Study|Adverse Event|1|||
143103439|NCT02477332|515920252|FG002|Overall Study|Adverse Event|1|||
143103440|NCT02477332|515920253|FG003|Overall Study|Adverse Event|2|||
143103441|NCT02477332|515920254|FG004|Overall Study|Adverse Event|1|||
143103442|NCT02477332|515920255|FG005|Overall Study|Adverse Event|2|||
143103443|NCT02477332|515920250|FG000|Overall Study|Lack of Efficacy|1|||
143103444|NCT02477332|515920251|FG001|Overall Study|Lack of Efficacy|2|||
143103445|NCT02477332|515920252|FG002|Overall Study|Lack of Efficacy|1|||
143103446|NCT02477332|515920253|FG003|Overall Study|Lack of Efficacy|2|||
143103447|NCT02477332|515920254|FG004|Overall Study|Lack of Efficacy|1|||
143103448|NCT02477332|515920255|FG005|Overall Study|Lack of Efficacy|1|||
143103449|NCT02477332|515920250|FG000|Overall Study|Non-compliance with study treatment|0|||
143103450|NCT02477332|515920251|FG001|Overall Study|Non-compliance with study treatment|1|||
143103451|NCT02477332|515920252|FG002|Overall Study|Non-compliance with study treatment|2|||
143103452|NCT02477332|515920253|FG003|Overall Study|Non-compliance with study treatment|0|||
143103453|NCT02477332|515920254|FG004|Overall Study|Non-compliance with study treatment|0|||
143103454|NCT02477332|515920255|FG005|Overall Study|Non-compliance with study treatment|0|||
143103455|NCT02477332|515920250|FG000|Overall Study|Pregnancy|0|||
143103456|NCT02477332|515920251|FG001|Overall Study|Pregnancy|0|||
143103457|NCT02477332|515920252|FG002|Overall Study|Pregnancy|0|||
143103458|NCT02477332|515920253|FG003|Overall Study|Pregnancy|1|||
143177826|NCT01713582|516199815|FG010|Overall Study|Lack of Efficacy|2|||
143177827|NCT01713582|516199816|FG011|Overall Study|Lack of Efficacy|0|||
143177828|NCT01713582|516199817|FG012|Overall Study|Lack of Efficacy|0|||
143177829|NCT01713582|516199818|FG013|Overall Study|Lack of Efficacy|0|||
143177830|NCT01713582|516199819|FG014|Overall Study|Lack of Efficacy|0|||
143177831|NCT01713582|516199820|FG015|Overall Study|Lack of Efficacy|0|||
143177832|NCT01713582|516199821|FG016|Overall Study|Lack of Efficacy|0|||
143177833|NCT01713582|516199822|FG017|Overall Study|Lack of Efficacy|0|||
143177834|NCT01713582|516199823|FG018|Overall Study|Lack of Efficacy|0|||
143177835|NCT01713582|516199824|FG019|Overall Study|Lack of Efficacy|0|||
143177836|NCT01713582|516199825|FG020|Overall Study|Lack of Efficacy|0|||
143177837|NCT01713582|516199805|FG000|Overall Study|Withdrawal by Subject|0|||
143177838|NCT01713582|516199806|FG001|Overall Study|Withdrawal by Subject|0|||
143177839|NCT01713582|516199807|FG002|Overall Study|Withdrawal by Subject|0|||
143177840|NCT01713582|516199808|FG003|Overall Study|Withdrawal by Subject|0|||
143177841|NCT01713582|516199809|FG004|Overall Study|Withdrawal by Subject|0|||
143177842|NCT01713582|516199810|FG005|Overall Study|Withdrawal by Subject|0|||
143177843|NCT01713582|516199811|FG006|Overall Study|Withdrawal by Subject|0|||
143177844|NCT01713582|516199812|FG007|Overall Study|Withdrawal by Subject|0|||
143177845|NCT01713582|516199813|FG008|Overall Study|Withdrawal by Subject|0|||
143177846|NCT01713582|516199814|FG009|Overall Study|Withdrawal by Subject|0|||
143177847|NCT01713582|516199815|FG010|Overall Study|Withdrawal by Subject|0|||
143177848|NCT01713582|516199816|FG011|Overall Study|Withdrawal by Subject|0|||
143177849|NCT01713582|516199817|FG012|Overall Study|Withdrawal by Subject|0|||
143177850|NCT01713582|516199818|FG013|Overall Study|Withdrawal by Subject|0|||
143177851|NCT01713582|516199819|FG014|Overall Study|Withdrawal by Subject|0|||
143177852|NCT01713582|516199820|FG015|Overall Study|Withdrawal by Subject|0|||
143177853|NCT01713582|516199821|FG016|Overall Study|Withdrawal by Subject|0|||
143177854|NCT01713582|516199822|FG017|Overall Study|Withdrawal by Subject|1|||
143177855|NCT01713582|516199823|FG018|Overall Study|Withdrawal by Subject|0|||
143177856|NCT01713582|516199824|FG019|Overall Study|Withdrawal by Subject|0|||
143177857|NCT01713582|516199825|FG020|Overall Study|Withdrawal by Subject|0|||
143177858|NCT01713582|516199805|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
143177859|NCT01713582|516199806|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
143177860|NCT01713582|516199807|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
143177861|NCT01713582|516199808|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
143177862|NCT01713582|516199809|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
143177863|NCT01713582|516199810|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
143177864|NCT01713582|516199811|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
143177865|NCT01713582|516199812|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
143177866|NCT01713582|516199813|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
143103459|NCT02477332|515920254|FG004|Overall Study|Pregnancy|0|||
143103460|NCT02477332|515920255|FG005|Overall Study|Pregnancy|0|||
143103461|NCT02477332|515920250|FG000|Overall Study|Protocol Violation|2|||
143177867|NCT01713582|516199814|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
143177868|NCT01713582|516199815|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
143177869|NCT01713582|516199816|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
143253490|NCT00913458|516481773|FG001|Phase 3|Withdrawal by Subject|0|||
143103462|NCT02477332|515920251|FG001|Overall Study|Protocol Violation|0|||
143103463|NCT02477332|515920252|FG002|Overall Study|Protocol Violation|3|||
143103464|NCT02477332|515920253|FG003|Overall Study|Protocol Violation|3|||
143103465|NCT02477332|515920254|FG004|Overall Study|Protocol Violation|1|||
143103466|NCT02477332|515920255|FG005|Overall Study|Protocol Violation|1|||
143177870|NCT01713582|516199817|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
143177871|NCT01713582|516199818|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
143177872|NCT01713582|516199819|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
143177873|NCT01713582|516199820|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
143253491|NCT00913458|516481774|FG002|Phase 3|Withdrawal by Subject|0|||
143253492|NCT00913458|516481775|FG003|Phase 3|Withdrawal by Subject|0|||
143253493|NCT00913458|516481776|FG004|Phase 3|Withdrawal by Subject|1|||
143253494|NCT00913458|516481777|FG005|Phase 3|Withdrawal by Subject|2|||
143253495|NCT00913458|516481778|FG006|Phase 3|Withdrawal by Subject|0|||
143253496|NCT00913458|516481772|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
143253497|NCT00913458|516481773|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
143253498|NCT00913458|516481774|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
143253499|NCT00913458|516481775|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
143253500|NCT00913458|516481776|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
143253501|NCT00913458|516481777|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
143253502|NCT00913458|516481778|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
143253503|NCT02366091|516481779|FG000|Overall Study|Withdrawal by Subject|3|||
143253504|NCT02366091|516481780|FG001|Overall Study|Withdrawal by Subject|7|||
143253505|NCT02366091|516481781|FG002|Overall Study|Withdrawal by Subject|3|||
143253506|NCT02366091|516481782|FG003|Overall Study|Withdrawal by Subject|1|||
143253507|NCT03595618|516481783|FG000|Overall Study|Adverse Event|16|||
143253508|NCT03595618|516481784|FG001|Overall Study|Adverse Event|17|||
143253509|NCT03595618|516481785|FG002|Overall Study|Adverse Event|20|||
143253510|NCT03595618|516481786|FG003|Overall Study|Adverse Event|8|||
143253511|NCT03595618|516481783|FG000|Overall Study|Withdrawal by Subject|12|||
143253512|NCT03595618|516481784|FG001|Overall Study|Withdrawal by Subject|14|||
143253513|NCT03595618|516481785|FG002|Overall Study|Withdrawal by Subject|14|||
143253514|NCT03595618|516481786|FG003|Overall Study|Withdrawal by Subject|10|||
143253515|NCT03595618|516481783|FG000|Overall Study|Lost to Follow-up|6|||
143253516|NCT03595618|516481784|FG001|Overall Study|Lost to Follow-up|4|||
143253517|NCT03595618|516481785|FG002|Overall Study|Lost to Follow-up|5|||
143253518|NCT03595618|516481786|FG003|Overall Study|Lost to Follow-up|6|||
143253519|NCT03595618|516481783|FG000|Overall Study|Protocol Violation|2|||
143253520|NCT03595618|516481784|FG001|Overall Study|Protocol Violation|0|||
143253521|NCT03595618|516481785|FG002|Overall Study|Protocol Violation|6|||
143253522|NCT03595618|516481786|FG003|Overall Study|Protocol Violation|2|||
143253523|NCT03595618|516481783|FG000|Overall Study|Physician Decision|0|||
143253524|NCT03595618|516481784|FG001|Overall Study|Physician Decision|0|||
143253525|NCT03595618|516481785|FG002|Overall Study|Physician Decision|1|||
143253526|NCT03595618|516481786|FG003|Overall Study|Physician Decision|2|||
143103467|NCT02477332|515920250|FG000|Overall Study|Technical problems|0|||
143103468|NCT02477332|515920251|FG001|Overall Study|Technical problems|0|||
143103469|NCT02477332|515920252|FG002|Overall Study|Technical problems|1|||
143103470|NCT02477332|515920253|FG003|Overall Study|Technical problems|0|||
143103471|NCT02477332|515920254|FG004|Overall Study|Technical problems|0|||
143103472|NCT02477332|515920255|FG005|Overall Study|Technical problems|0|||
143103473|NCT02477332|515920250|FG000|Overall Study|Lost to Follow-up|0|||
143103474|NCT02477332|515920251|FG001|Overall Study|Lost to Follow-up|0|||
143253527|NCT03595618|516481783|FG000|Overall Study|Miscellaneous|7|||
143253528|NCT03595618|516481784|FG001|Overall Study|Miscellaneous|5|||
143253529|NCT03595618|516481785|FG002|Overall Study|Miscellaneous|10|||
143103475|NCT02477332|515920252|FG002|Overall Study|Lost to Follow-up|2|||
143103476|NCT02477332|515920253|FG003|Overall Study|Lost to Follow-up|0|||
143103477|NCT02477332|515920254|FG004|Overall Study|Lost to Follow-up|0|||
143103478|NCT02477332|515920255|FG005|Overall Study|Lost to Follow-up|0|||
143103479|NCT02477332|515920250|FG000|Overall Study|Physician Decision|0|||
143103480|NCT02477332|515920251|FG001|Overall Study|Physician Decision|0|||
143103481|NCT02477332|515920252|FG002|Overall Study|Physician Decision|1|||
143103482|NCT02477332|515920253|FG003|Overall Study|Physician Decision|3|||
143253530|NCT03595618|516481786|FG003|Overall Study|Miscellaneous|6|||
143253531|NCT02338232|516481787|FG000|Overall Study|Screen Failure|3|||
143103483|NCT02477332|515920254|FG004|Overall Study|Physician Decision|0|||
143253532|NCT02338232|516481787|FG000|Overall Study|Withdrawal by Subject|6|||
143253533|NCT02338232|516481787|FG000|Overall Study|Adverse Event|2|||
143103484|NCT02477332|515920255|FG005|Overall Study|Physician Decision|1|||
143253534|NCT02279407|516481788|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
143253535|NCT02279407|516481789|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
143253536|NCT02279407|516481790|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
143253537|NCT02279407|516481791|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
143253538|NCT02279407|516481788|FG000|Overall Study|Withdrawal by Subject|1|||
143253539|NCT02279407|516481789|FG001|Overall Study|Withdrawal by Subject|0|||
143253540|NCT02279407|516481790|FG002|Overall Study|Withdrawal by Subject|1|||
143253541|NCT02279407|516481791|FG003|Overall Study|Withdrawal by Subject|1|||
143253542|NCT02279407|516481788|FG000|Overall Study|Adverse Event|1|||
143253543|NCT02279407|516481789|FG001|Overall Study|Adverse Event|1|||
143253544|NCT02279407|516481790|FG002|Overall Study|Adverse Event|2|||
143253545|NCT02279407|516481791|FG003|Overall Study|Adverse Event|0|||
143253546|NCT02500056|516481794|FG000|Overall Study|Lost to Follow-up|3|||
143103485|NCT02477332|515920250|FG000|Overall Study|Withdrawal by Subject|0|||
143103486|NCT02477332|515920251|FG001|Overall Study|Withdrawal by Subject|3|||
143103487|NCT02477332|515920252|FG002|Overall Study|Withdrawal by Subject|1|||
143103488|NCT02477332|515920253|FG003|Overall Study|Withdrawal by Subject|2|||
143253547|NCT02500056|516481795|FG001|Overall Study|Lost to Follow-up|7|||
143253548|NCT02500056|516481794|FG000|Overall Study|Recurrence|1|||
143253549|NCT02500056|516481795|FG001|Overall Study|Recurrence|0|||
143253550|NCT02500056|516481794|FG000|Overall Study|Death|3|||
143253551|NCT02500056|516481795|FG001|Overall Study|Death|1|||
143253552|NCT00864916|516481796|FG000|Overall Study|Lost to Follow-up|4|||
143253553|NCT00864916|516481797|FG001|Overall Study|Lost to Follow-up|4|||
143253554|NCT00864916|516481796|FG000|Overall Study|Protocol Violation|1|||
143253555|NCT00864916|516481797|FG001|Overall Study|Protocol Violation|0|||
143253556|NCT00864916|516481796|FG000|Overall Study|Withdrawal by Subject|1|||
143253557|NCT00864916|516481797|FG001|Overall Study|Withdrawal by Subject|0|||
143253558|NCT03890666|516481798|FG000|Overall Study|Withdrawal by Subject|0|||
143253559|NCT03890666|516481799|FG001|Overall Study|Withdrawal by Subject|1|||
143253560|NCT03890666|516481798|FG000|Overall Study|Protocol deviation|1|||
143253561|NCT03890666|516481799|FG001|Overall Study|Protocol deviation|4|||
143253562|NCT03890666|516481798|FG000|Overall Study|Lost to Follow-up|2|||
143253563|NCT03890666|516481799|FG001|Overall Study|Lost to Follow-up|5|||
143253564|NCT03890666|516481798|FG000|Overall Study|Other than specified|1|||
143253565|NCT03890666|516481799|FG001|Overall Study|Other than specified|8|||
143103489|NCT02477332|515920254|FG004|Overall Study|Withdrawal by Subject|1|||
143103490|NCT02477332|515920255|FG005|Overall Study|Withdrawal by Subject|0|||
143103491|NCT02549287|515920256|FG000|Overall Study|Lost to Follow-up|65|||
143103492|NCT02549287|515920257|FG001|Overall Study|Lost to Follow-up|26|||
143103493|NCT02549287|515920256|FG000|Overall Study|Withdrawal by Subject|15|||
143103494|NCT02549287|515920257|FG001|Overall Study|Withdrawal by Subject|6|||
143103495|NCT03793842|515920258|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
143103496|NCT03793842|515920259|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
143103497|NCT03793842|515920258|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
143103498|NCT03793842|515920259|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
143103499|NCT04657198|515920260|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
143103500|NCT04657198|515920261|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
143103501|NCT04657198|515920262|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
143103502|NCT04087720|515920263|FG000|Overall Study|Withdrawal by Subject|2|||
143103503|NCT04087720|515920263|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
143103504|NCT00427921|515920271|FG000|Overall Study|Adverse Event|26|||
143103505|NCT00427921|515920271|FG000|Overall Study|Withdrawal by Subject|4|||
143103506|NCT00427921|515920271|FG000|Overall Study|Lost to Follow-up|2|||
143103507|NCT00427921|515920271|FG000|Overall Study|Other reason not specified|10|||
143103508|NCT00427921|515920271|FG000|Overall Study|Adverse Event + Hospitalization|1|||
143103509|NCT00427921|515920271|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
143103510|NCT00427921|515920271|FG000|Overall Study|Adverse Event + No Response|1|||
143103511|NCT00427921|515920271|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
143103512|NCT00427921|515920271|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
143103513|NCT00427921|515920271|FG000|Overall Study|Adverse Event + Lost Response|1|||
143103514|NCT00427921|515920271|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
143103515|NCT00427921|515920271|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
143103516|NCT02887248|515920272|FG000|Overall Study|Withdrawal by Subject|1|||
143103517|NCT02887248|515920272|FG000|Overall Study|Adverse Event|1|||
143103518|NCT02887248|515920272|FG000|Overall Study|Progressive Disease|1|||
143103519|NCT00900159|515920273|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
143103520|NCT00900159|515920274|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
143103521|NCT00520533|515920275|FG000|Overall Study|Death|1|||
143103522|NCT00520533|515920275|FG000|Overall Study|Suspension of the study for safety reasons|1|||
143103523|NCT00520533|515920275|FG000|Overall Study|Withdrawal by Subject|1|||
143103524|NCT00520533|515920275|FG000|Overall Study|Physician Decision|1|||
143103525|NCT01166438|515920276|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
143103526|NCT01166438|515920277|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
143103527|NCT01166438|515920276|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
143103528|NCT01166438|515920277|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
143103529|NCT01166438|515920276|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
143103530|NCT01166438|515920277|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
143103531|NCT01166438|515920276|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
143103532|NCT01166438|515920277|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
143103533|NCT01166438|515920276|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
143103534|NCT01166438|515920277|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
143103535|NCT01166438|515920276|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
143253566|NCT01105065|516481801|FG000|Overall Study|Adverse Event|5|||
143253567|NCT01105065|516481801|FG000|Overall Study|Technical Problems|1|||
143367826|NCT00124982|516889440|FG000|Long-term Period|Neurologist Recommendation|0|||
143367827|NCT00124982|516889441|FG001|Long-term Period|Neurologist Recommendation|0|||
143253568|NCT01155011|516481806|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
143253569|NCT01155011|516481807|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
143367828|NCT00124982|516889442|FG002|Long-term Period|Neurologist Recommendation|1|||
143103536|NCT01166438|515920277|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
143103537|NCT01075256|515920278|FG000|Overall Study|Withdrawal by Subject|1|||
143103538|NCT01075256|515920279|FG001|Overall Study|Withdrawal by Subject|0|||
143103539|NCT01075256|515920280|FG002|Overall Study|Withdrawal by Subject|0|||
143253570|NCT01155011|516481806|FG000|Baseline to 6 Months|investigator decision, moved|4|||
143253571|NCT01155011|516481807|FG001|Baseline to 6 Months|investigator decision, moved|5|||
143253572|NCT01155011|516481806|FG000|Baseline to 6 Months|Death|0|||
143253573|NCT01155011|516481807|FG001|Baseline to 6 Months|Death|1|||
143253574|NCT01155011|516481806|FG000|6 to 12 Months|Withdrawal by Subject|8|||
143253575|NCT01155011|516481807|FG001|6 to 12 Months|Withdrawal by Subject|5|||
143253576|NCT01155011|516481806|FG000|6 to 12 Months|Death|1|||
143103540|NCT01377922|515920287|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
143103541|NCT01377922|515920288|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
143103542|NCT03170362|515920289|FG000|Overall Study|Death|2|||
143103543|NCT03170362|515920290|FG001|Overall Study|Death|2|||
143103544|NCT03170362|515920289|FG000|Overall Study|Withdrawal by Subject|23|||
143103545|NCT03170362|515920290|FG001|Overall Study|Withdrawal by Subject|22|||
143103546|NCT03170362|515920289|FG000|Overall Study|Lost to Follow-up|187|||
143103547|NCT03170362|515920290|FG001|Overall Study|Lost to Follow-up|167|||
143103548|NCT04615403|515920291|FG000|Overall Study|Death|1|||
143103549|NCT01972438|515920294|FG000|Baseline-Month 3 Crossover Period|Death|1|||
143177874|NCT01713582|516199821|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
143177875|NCT01713582|516199822|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
143177876|NCT01713582|516199823|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
143177877|NCT01713582|516199824|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
143177878|NCT01713582|516199825|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
143177879|NCT01713582|516199805|FG000|Overall Study|Disease progression and adverse event|0|||
143177880|NCT01713582|516199806|FG001|Overall Study|Disease progression and adverse event|0|||
143177881|NCT01713582|516199807|FG002|Overall Study|Disease progression and adverse event|0|||
143177882|NCT01713582|516199808|FG003|Overall Study|Disease progression and adverse event|0|||
143177883|NCT01713582|516199809|FG004|Overall Study|Disease progression and adverse event|0|||
143177884|NCT01713582|516199810|FG005|Overall Study|Disease progression and adverse event|0|||
143177885|NCT01713582|516199811|FG006|Overall Study|Disease progression and adverse event|0|||
143177886|NCT01713582|516199812|FG007|Overall Study|Disease progression and adverse event|0|||
143177887|NCT01713582|516199813|FG008|Overall Study|Disease progression and adverse event|0|||
143177888|NCT01713582|516199814|FG009|Overall Study|Disease progression and adverse event|0|||
143177889|NCT01713582|516199815|FG010|Overall Study|Disease progression and adverse event|0|||
143177890|NCT01713582|516199816|FG011|Overall Study|Disease progression and adverse event|0|||
143177891|NCT01713582|516199817|FG012|Overall Study|Disease progression and adverse event|0|||
143177892|NCT01713582|516199818|FG013|Overall Study|Disease progression and adverse event|0|||
143177893|NCT01713582|516199819|FG014|Overall Study|Disease progression and adverse event|0|||
143177894|NCT01713582|516199820|FG015|Overall Study|Disease progression and adverse event|0|||
143177895|NCT01713582|516199821|FG016|Overall Study|Disease progression and adverse event|1|||
143177896|NCT01713582|516199822|FG017|Overall Study|Disease progression and adverse event|0|||
143177897|NCT01713582|516199823|FG018|Overall Study|Disease progression and adverse event|0|||
143177898|NCT01713582|516199824|FG019|Overall Study|Disease progression and adverse event|0|||
143177899|NCT01713582|516199825|FG020|Overall Study|Disease progression and adverse event|0|||
143177900|NCT04776161|516199826|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
143177901|NCT04776161|516199827|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
143177902|NCT04776161|516199828|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
143177903|NCT04776161|516199826|FG000|Overall Study|Withdrawal by Subject|1|||
143177904|NCT04776161|516199827|FG001|Overall Study|Withdrawal by Subject|0|||
143177905|NCT04776161|516199828|FG002|Overall Study|Withdrawal by Subject|1|||
143177906|NCT04776161|516199826|FG000|Overall Study|Adverse Event|0|||
143177907|NCT04776161|516199827|FG001|Overall Study|Adverse Event|1|||
143177908|NCT04776161|516199828|FG002|Overall Study|Adverse Event|1|||
143177909|NCT00342628|516199829|FG000|Overall Study|Withdrawal by Subject|19|||
143253577|NCT01155011|516481807|FG001|6 to 12 Months|Death|5|||
143253578|NCT00422084|516481808|FG000|Overall Study|Adverse Event|21|||
143253579|NCT00422084|516481809|FG001|Overall Study|Adverse Event|7|||
143253580|NCT00422084|516481808|FG000|Overall Study|Withdrawal by Subject|12|||
143253581|NCT00422084|516481809|FG001|Overall Study|Withdrawal by Subject|9|||
143253582|NCT00422084|516481808|FG000|Overall Study|Lost to Follow-up|14|||
143253583|NCT00422084|516481809|FG001|Overall Study|Lost to Follow-up|9|||
143253584|NCT00422084|516481808|FG000|Overall Study|Protocol Violation|4|||
143253585|NCT00422084|516481809|FG001|Overall Study|Protocol Violation|1|||
143367829|NCT00630864|516889443|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
143367830|NCT00630864|516889443|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
143367831|NCT01555762|516889444|FG000|Overall Study|No information on Bevacizumab intake|11|||
143103550|NCT01972438|515920295|FG001|Baseline-Month 3 Crossover Period|Death|0|||
143103551|NCT01972438|515920294|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
143177910|NCT00342628|516199830|FG001|Overall Study|Withdrawal by Subject|19|||
143177911|NCT00342628|516199831|FG002|Overall Study|Withdrawal by Subject|18|||
143177912|NCT00342628|516199829|FG000|Overall Study|Death|1|||
143177913|NCT00342628|516199830|FG001|Overall Study|Death|1|||
143177914|NCT00342628|516199831|FG002|Overall Study|Death|0|||
143177915|NCT00342628|516199829|FG000|Overall Study|moved residence|0|||
143177916|NCT00342628|516199830|FG001|Overall Study|moved residence|1|||
143177917|NCT00342628|516199831|FG002|Overall Study|moved residence|1|||
143177918|NCT03427814|516199832|FG000|Overall Study|Withdrawal by Subject|4|||
143177919|NCT03427814|516199833|FG001|Overall Study|Withdrawal by Subject|4|||
143177920|NCT03427814|516199832|FG000|Overall Study|Lost to Follow-up|0|||
143177921|NCT03427814|516199833|FG001|Overall Study|Lost to Follow-up|2|||
143177922|NCT03427814|516199832|FG000|Overall Study|Death|42|||
143177923|NCT03427814|516199833|FG001|Overall Study|Death|31|||
143177924|NCT03427814|516199832|FG000|Overall Study|Sponsor's Decision|1|||
143177925|NCT03427814|516199833|FG001|Overall Study|Sponsor's Decision|0|||
143177926|NCT03427814|516199832|FG000|Overall Study|Investigator's Decision|1|||
143177927|NCT03427814|516199833|FG001|Overall Study|Investigator's Decision|2|||
143177928|NCT03427814|516199832|FG000|Overall Study|Disease progression|1|||
143177929|NCT03427814|516199833|FG001|Overall Study|Disease progression|0|||
143177930|NCT03427814|516199832|FG000|Overall Study|Treatment Completed|0|||
143177931|NCT03427814|516199833|FG001|Overall Study|Treatment Completed|1|||
143177932|NCT03427814|516199832|FG000|Overall Study|Sponsor's Decision to End study|21|||
143177933|NCT03427814|516199833|FG001|Overall Study|Sponsor's Decision to End study|25|||
143177934|NCT03427814|516199832|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
143177935|NCT03427814|516199833|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
143177936|NCT01334554|516199834|FG000|Overall Study|Adverse Event|4|||
143177937|NCT01334554|516199835|FG001|Overall Study|Adverse Event|2|||
143177938|NCT02393859|516199837|FG000|Overall Study|Decision by Sponsor|2|||
143177939|NCT02393859|516199838|FG001|Overall Study|Decision by Sponsor|4|||
143177940|NCT02393859|516199837|FG000|Overall Study|Withdrawal by Subject|11|||
143177941|NCT02393859|516199838|FG001|Overall Study|Withdrawal by Subject|6|||
143177942|NCT02393859|516199837|FG000|Overall Study|Death|27|||
143177943|NCT02393859|516199838|FG001|Overall Study|Death|10|||
143177944|NCT02393859|516199837|FG000|Overall Study|Lost to Follow-up|1|||
143177945|NCT02393859|516199838|FG001|Overall Study|Lost to Follow-up|1|||
143177946|NCT01944020|516199839|FG000|Overall Study|Withdrawal by Subject|5|||
143177947|NCT01944020|516199840|FG001|Overall Study|Withdrawal by Subject|0|||
143177948|NCT01535287|516199841|FG000|Overall Study|drug not prepared in time|5|||
143177949|NCT01535287|516199842|FG001|Overall Study|drug not prepared in time|6|||
143177950|NCT01475721|516199847|FG000|Overall Study|Death|3|||
143177951|NCT01475721|516199848|FG001|Overall Study|Death|6|||
143177952|NCT01475721|516199847|FG000|Overall Study|Withdrawal by Subject|8|||
143177953|NCT01475721|516199848|FG001|Overall Study|Withdrawal by Subject|8|||
143177954|NCT02364037|516199850|FG000|Overall Study|Withdrawal by Subject|7|||
143177955|NCT02364037|516199851|FG001|Overall Study|Withdrawal by Subject|4|||
143177956|NCT02364037|516199850|FG000|Overall Study|Lost to Follow-up|37|||
143177957|NCT02364037|516199851|FG001|Overall Study|Lost to Follow-up|49|||
143177958|NCT01772550|516199852|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
143177959|NCT01772550|516199853|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
143177960|NCT01772550|516199854|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
143177961|NCT01772550|516199852|FG000|Overall Study|Adverse Event|0|||
143177962|NCT01772550|516199853|FG001|Overall Study|Adverse Event|0|||
143177963|NCT01772550|516199854|FG002|Overall Study|Adverse Event|1|||
143177964|NCT00387088|516199855|FG000|Overall Study|Adverse Event|143|||
143177965|NCT00387088|516199856|FG001|Overall Study|Adverse Event|156|||
143177966|NCT00387088|516199855|FG000|Overall Study|Protocol Violation|47|||
143177967|NCT00387088|516199856|FG001|Overall Study|Protocol Violation|35|||
143177968|NCT00387088|516199855|FG000|Overall Study|Withdrawal by Subject|20|||
143177969|NCT00387088|516199856|FG001|Overall Study|Withdrawal by Subject|35|||
143177970|NCT00387088|516199855|FG000|Overall Study|Lack of Efficacy|28|||
143177971|NCT00387088|516199856|FG001|Overall Study|Lack of Efficacy|67|||
143177972|NCT00387088|516199855|FG000|Overall Study|Lost to Follow-up|22|||
143177973|NCT00387088|516199856|FG001|Overall Study|Lost to Follow-up|28|||
143177974|NCT00387088|516199855|FG000|Overall Study|Other|58|||
143177975|NCT00387088|516199856|FG001|Overall Study|Other|52|||
143177976|NCT01639469|516199857|FG000|Overall Study|Death|4|||
143177977|NCT01639469|516199858|FG001|Overall Study|Death|2|||
143367832|NCT01555762|516889444|FG000|Overall Study|Missing start date of infusion|8|||
143177978|NCT01639469|516199857|FG000|Overall Study|Lost to Follow-up|1|||
143177979|NCT01639469|516199858|FG001|Overall Study|Lost to Follow-up|1|||
143177980|NCT00420381|516199859|FG000|Overall Study|Protocol Violation|1|||
143177981|NCT02071771|516199860|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
143177982|NCT02071771|516199861|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
143177983|NCT02071771|516199860|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
143177984|NCT02071771|516199861|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
143177985|NCT02078752|516199862|FG000|Overall Study|Death|0|||
143177986|NCT02078752|516199863|FG001|Overall Study|Death|3|||
143177987|NCT02078752|516199864|FG002|Overall Study|Death|0|||
143103552|NCT01972438|515920295|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
143103553|NCT01972438|515920294|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
143103554|NCT01972438|515920295|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
143103555|NCT01972438|515920294|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
143103556|NCT01972438|515920295|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
143103557|NCT01972438|515920294|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
143103558|NCT01972438|515920295|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
143103559|NCT01972438|515920294|FG000|Months 6-12 Study Period|Death|1|||
143103560|NCT01972438|515920295|FG001|Months 6-12 Study Period|Death|0|||
143103561|NCT01972438|515920294|FG000|Months 6-12 Study Period|Early Study Closure|2|||
143103562|NCT01972438|515920295|FG001|Months 6-12 Study Period|Early Study Closure|2|||
143103563|NCT01972438|515920294|FG000|Post Month 12 Study Period|Early Study Closure|3|||
143103564|NCT01972438|515920295|FG001|Post Month 12 Study Period|Early Study Closure|4|||
143103565|NCT00570063|515920298|FG000|Overall Study|Adverse Event|4|||
143103566|NCT00570063|515920299|FG001|Overall Study|Adverse Event|1|||
143103567|NCT00570063|515920298|FG000|Overall Study|Lack of Efficacy|0|||
143103568|NCT00570063|515920299|FG001|Overall Study|Lack of Efficacy|1|||
143103569|NCT00570063|515920298|FG000|Overall Study|Withdrawal by Subject|4|||
143103570|NCT00570063|515920299|FG001|Overall Study|Withdrawal by Subject|3|||
143103571|NCT00570063|515920298|FG000|Overall Study|Sponsor's Decision|7|||
143103572|NCT00570063|515920299|FG001|Overall Study|Sponsor's Decision|3|||
143103573|NCT00697463|515920300|FG000|Overall Study|Withdrawal by Subject|1|||
143103574|NCT03307252|515920301|FG000|Part 2, Period 1|Treatment not received|0|||
143103575|NCT03307252|515920302|FG001|Part 2, Period 1|Treatment not received|0|||
143103576|NCT03307252|515920303|FG002|Part 2, Period 1|Treatment not received|0|||
143103577|NCT03307252|515920304|FG003|Part 2, Period 1|Treatment not received|0|||
143103578|NCT03307252|515920305|FG004|Part 2, Period 1|Treatment not received|0|||
143103579|NCT03307252|515920306|FG005|Part 2, Period 1|Treatment not received|1|||
143103580|NCT03307252|515920307|FG006|Part 2, Period 1|Treatment not received|0|||
143103581|NCT03307252|515920308|FG007|Part 2, Period 1|Treatment not received|0|||
143103582|NCT03307252|515920309|FG008|Part 2, Period 1|Treatment not received|0|||
143103583|NCT03307252|515920310|FG009|Part 2, Period 1|Treatment not received|0|||
143103584|NCT03307252|515920311|FG010|Part 2, Period 1|Treatment not received|0|||
143103585|NCT03307252|515920301|FG000|Part 2, Period 3|Other than listed|0|||
143103586|NCT03307252|515920302|FG001|Part 2, Period 3|Other than listed|0|||
143103587|NCT03307252|515920303|FG002|Part 2, Period 3|Other than listed|0|||
143103588|NCT03307252|515920304|FG003|Part 2, Period 3|Other than listed|0|||
143103589|NCT03307252|515920305|FG004|Part 2, Period 3|Other than listed|1|||
143103590|NCT03307252|515920306|FG005|Part 2, Period 3|Other than listed|0|||
143103591|NCT03307252|515920307|FG006|Part 2, Period 3|Other than listed|0|||
143103592|NCT03307252|515920308|FG007|Part 2, Period 3|Other than listed|0|||
143103593|NCT03307252|515920309|FG008|Part 2, Period 3|Other than listed|0|||
143103594|NCT03307252|515920310|FG009|Part 2, Period 3|Other than listed|0|||
143103595|NCT03307252|515920311|FG010|Part 2, Period 3|Other than listed|0|||
143103596|NCT03307252|515920301|FG000|Part 2, Period 4|Other than listed|0|||
143103597|NCT03307252|515920302|FG001|Part 2, Period 4|Other than listed|0|||
143103598|NCT03307252|515920303|FG002|Part 2, Period 4|Other than listed|0|||
143103599|NCT03307252|515920304|FG003|Part 2, Period 4|Other than listed|0|||
143103600|NCT03307252|515920305|FG004|Part 2, Period 4|Other than listed|0|||
143103601|NCT03307252|515920306|FG005|Part 2, Period 4|Other than listed|0|||
143103602|NCT03307252|515920307|FG006|Part 2, Period 4|Other than listed|1|||
143103603|NCT03307252|515920308|FG007|Part 2, Period 4|Other than listed|0|||
143103604|NCT03307252|515920309|FG008|Part 2, Period 4|Other than listed|0|||
143103605|NCT03307252|515920310|FG009|Part 2, Period 4|Other than listed|0|||
143103606|NCT03307252|515920311|FG010|Part 2, Period 4|Other than listed|0|||
143103607|NCT03307252|515920301|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
143103608|NCT03307252|515920302|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
143103609|NCT03307252|515920303|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
143103610|NCT03307252|515920304|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
143103611|NCT03307252|515920305|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
143103612|NCT03307252|515920306|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
143103613|NCT03307252|515920307|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
143103614|NCT03307252|515920308|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
143103615|NCT03307252|515920309|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
143103616|NCT03307252|515920310|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
143103617|NCT03307252|515920311|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
143103618|NCT03482453|515920312|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
143103619|NCT03482453|515920313|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
143177988|NCT02078752|516199865|FG003|Overall Study|Death|0|||
143177989|NCT02078752|516199866|FG004|Overall Study|Death|0|||
143177990|NCT02078752|516199867|FG005|Overall Study|Death|1|||
143253586|NCT00422084|516481808|FG000|Overall Study|Lack of Efficacy|40|||
143253587|NCT00422084|516481809|FG001|Overall Study|Lack of Efficacy|42|||
143253588|NCT00422084|516481808|FG000|Overall Study|P. vivax infection|3|||
143253589|NCT00422084|516481809|FG001|Overall Study|P. vivax infection|6|||
143253590|NCT00422084|516481808|FG000|Overall Study|Cyesis|1|||
143253591|NCT00422084|516481809|FG001|Overall Study|Cyesis|0|||
143253592|NCT00422084|516481808|FG000|Overall Study|Withdrawn from study accidentally|1|||
143253593|NCT00422084|516481809|FG001|Overall Study|Withdrawn from study accidentally|0|||
143253594|NCT00422084|516481808|FG000|Overall Study|Non-compliance|1|||
143253595|NCT00422084|516481809|FG001|Overall Study|Non-compliance|0|||
143253596|NCT00422084|516481808|FG000|Overall Study|Re-location|0|||
143253597|NCT00422084|516481809|FG001|Overall Study|Re-location|1|||
143253598|NCT00422084|516481808|FG000|Overall Study|Not defined|1|||
143253599|NCT00422084|516481809|FG001|Overall Study|Not defined|1|||
143253600|NCT03774823|516481812|FG000|Overall Study|Withdrawal by Subject|1|||
143253601|NCT03774823|516481813|FG001|Overall Study|Withdrawal by Subject|1|||
143253602|NCT00958438|516481817|FG000|Overall Study|Protocol Violation|3|||
143253603|NCT00958438|516481818|FG001|Overall Study|Protocol Violation|2|||
143253604|NCT00958438|516481819|FG002|Overall Study|Protocol Violation|2|||
143253605|NCT00958438|516481817|FG000|Overall Study|Withdrawal by Subject|4|||
143253606|NCT00958438|516481818|FG001|Overall Study|Withdrawal by Subject|2|||
143253607|NCT00958438|516481819|FG002|Overall Study|Withdrawal by Subject|1|||
143253608|NCT00958438|516481817|FG000|Overall Study|Adverse Event|0|||
143253609|NCT00958438|516481818|FG001|Overall Study|Adverse Event|3|||
143253610|NCT00958438|516481819|FG002|Overall Study|Adverse Event|0|||
143367833|NCT01555762|516889444|FG000|Overall Study|75 years old or more ticked No|1|||
143367834|NCT01555762|516889444|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
143367835|NCT01555762|516889444|FG000|Overall Study|Death linked to progression of disease|165|||
143367836|NCT01555762|516889444|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
143367837|NCT01555762|516889444|FG000|Overall Study|Investigator's decision|10|||
143367838|NCT01555762|516889444|FG000|Overall Study|Participant not wishing to continue|5|||
143367839|NCT01555762|516889444|FG000|Overall Study|Missing data|1|||
143367840|NCT01555762|516889444|FG000|Overall Study|Death linked to an adverse event|14|||
143367841|NCT01333514|516889445|FG000|Overall Study|Withdrawal by Subject|1|||
143367842|NCT01333514|516889446|FG001|Overall Study|Withdrawal by Subject|0|||
143367843|NCT00819910|516889447|FG000|Overall Study|Adverse Event|0|||
143367844|NCT00819910|516889448|FG001|Overall Study|Adverse Event|0|||
143367845|NCT00819910|516889449|FG002|Overall Study|Adverse Event|2|||
143367846|NCT00819910|516889450|FG003|Overall Study|Adverse Event|1|||
143367847|NCT00819910|516889447|FG000|Overall Study|Withdrawal by Subject|1|||
143367848|NCT00819910|516889448|FG001|Overall Study|Withdrawal by Subject|1|||
143367849|NCT00819910|516889449|FG002|Overall Study|Withdrawal by Subject|1|||
143367850|NCT00819910|516889450|FG003|Overall Study|Withdrawal by Subject|0|||
143367851|NCT00819910|516889447|FG000|Overall Study|Lost to Follow-up|1|||
143367852|NCT00819910|516889448|FG001|Overall Study|Lost to Follow-up|0|||
143367853|NCT00819910|516889449|FG002|Overall Study|Lost to Follow-up|0|||
143367854|NCT00819910|516889450|FG003|Overall Study|Lost to Follow-up|0|||
143367855|NCT00836810|516889453|FG000|Overall Study|New diagnosis|1|||
143367856|NCT00836810|516889454|FG001|Overall Study|New diagnosis|0|||
143367857|NCT03102242|516889456|FG000|Overall Study|Adverse Event|2|||
143367858|NCT01311713|516889457|FG000|Overall Study|Death|0|||
143367859|NCT01311713|516889458|FG001|Overall Study|Death|0|||
143367860|NCT01311713|516889459|FG002|Overall Study|Death|1|||
143367861|NCT01311713|516889460|FG003|Overall Study|Death|1|||
143367862|NCT01311713|516889461|FG004|Overall Study|Death|0|||
143367863|NCT01311713|516889462|FG005|Overall Study|Death|1|||
143367864|NCT01311713|516889463|FG006|Overall Study|Death|0|||
143367865|NCT01311713|516889457|FG000|Overall Study|Adverse Event|0|||
143367866|NCT01311713|516889458|FG001|Overall Study|Adverse Event|1|||
143367867|NCT01311713|516889459|FG002|Overall Study|Adverse Event|0|||
143253611|NCT00958438|516481817|FG000|Overall Study|Physician Decision|1|||
143253612|NCT00958438|516481818|FG001|Overall Study|Physician Decision|0|||
143253613|NCT00958438|516481819|FG002|Overall Study|Physician Decision|1|||
143253614|NCT00958438|516481817|FG000|Overall Study|Other than specified above|2|||
143367868|NCT01311713|516889460|FG003|Overall Study|Adverse Event|2|||
143253615|NCT00958438|516481818|FG001|Overall Study|Other than specified above|3|||
143253616|NCT00958438|516481819|FG002|Overall Study|Other than specified above|2|||
143253617|NCT02788279|516481821|FG000|Overall Study|Death|62|||
143253618|NCT02788279|516481822|FG001|Overall Study|Death|136|||
143253619|NCT02788279|516481823|FG002|Overall Study|Death|72|||
143253620|NCT02788279|516481821|FG000|Overall Study|Withdrawal by Subject|10|||
143253621|NCT02788279|516481822|FG001|Overall Study|Withdrawal by Subject|15|||
143253622|NCT02788279|516481823|FG002|Overall Study|Withdrawal by Subject|5|||
143253623|NCT02788279|516481821|FG000|Overall Study|Lost to Follow-up|0|||
143253624|NCT02788279|516481822|FG001|Overall Study|Lost to Follow-up|3|||
143367869|NCT01311713|516889461|FG004|Overall Study|Adverse Event|0|||
143367870|NCT01311713|516889462|FG005|Overall Study|Adverse Event|0|||
143367871|NCT01311713|516889463|FG006|Overall Study|Adverse Event|2|||
143367872|NCT01311713|516889457|FG000|Overall Study|Withdrawal by Subject|0|||
143253625|NCT02788279|516481823|FG002|Overall Study|Lost to Follow-up|2|||
143253626|NCT02788279|516481821|FG000|Overall Study|Sponsor decision|18|||
143253627|NCT02788279|516481822|FG001|Overall Study|Sponsor decision|29|||
143253628|NCT02788279|516481823|FG002|Overall Study|Sponsor decision|11|||
143253629|NCT02122783|516481829|FG000|Overall Study|Adverse Event|0|||
143177991|NCT02078752|516199868|FG006|Overall Study|Death|0|||
143177992|NCT02078752|516199869|FG007|Overall Study|Death|1|||
143177993|NCT02078752|516199870|FG008|Overall Study|Death|0|||
143177994|NCT02078752|516199871|FG009|Overall Study|Death|4|||
143177995|NCT02078752|516199862|FG000|Overall Study|Lost to Follow-up|1|||
143177996|NCT02078752|516199863|FG001|Overall Study|Lost to Follow-up|0|||
143177997|NCT02078752|516199864|FG002|Overall Study|Lost to Follow-up|0|||
143177998|NCT02078752|516199865|FG003|Overall Study|Lost to Follow-up|1|||
143177999|NCT02078752|516199866|FG004|Overall Study|Lost to Follow-up|0|||
143178000|NCT02078752|516199867|FG005|Overall Study|Lost to Follow-up|0|||
143178001|NCT02078752|516199868|FG006|Overall Study|Lost to Follow-up|0|||
143178002|NCT02078752|516199869|FG007|Overall Study|Lost to Follow-up|0|||
143178003|NCT02078752|516199870|FG008|Overall Study|Lost to Follow-up|0|||
143178004|NCT02078752|516199871|FG009|Overall Study|Lost to Follow-up|0|||
143178005|NCT02078752|516199862|FG000|Overall Study|Withdrawal by Subject|1|||
143178006|NCT02078752|516199863|FG001|Overall Study|Withdrawal by Subject|1|||
143178007|NCT02078752|516199864|FG002|Overall Study|Withdrawal by Subject|1|||
143178008|NCT02078752|516199865|FG003|Overall Study|Withdrawal by Subject|1|||
143178009|NCT02078752|516199866|FG004|Overall Study|Withdrawal by Subject|0|||
143178010|NCT02078752|516199867|FG005|Overall Study|Withdrawal by Subject|3|||
143178011|NCT02078752|516199868|FG006|Overall Study|Withdrawal by Subject|2|||
143178012|NCT02078752|516199869|FG007|Overall Study|Withdrawal by Subject|1|||
143178013|NCT02078752|516199870|FG008|Overall Study|Withdrawal by Subject|0|||
143178014|NCT02078752|516199871|FG009|Overall Study|Withdrawal by Subject|1|||
143178015|NCT02078752|516199862|FG000|Overall Study|Other|0|||
143178016|NCT02078752|516199863|FG001|Overall Study|Other|3|||
143178017|NCT02078752|516199864|FG002|Overall Study|Other|0|||
143178018|NCT02078752|516199865|FG003|Overall Study|Other|0|||
143178019|NCT02078752|516199866|FG004|Overall Study|Other|1|||
143178020|NCT02078752|516199867|FG005|Overall Study|Other|0|||
143178021|NCT02078752|516199868|FG006|Overall Study|Other|0|||
143178022|NCT02078752|516199869|FG007|Overall Study|Other|1|||
143178023|NCT02078752|516199870|FG008|Overall Study|Other|0|||
143178024|NCT02078752|516199871|FG009|Overall Study|Other|0|||
143178025|NCT02078752|516199862|FG000|Overall Study|Study terminated by sponsor|0|||
143178026|NCT02078752|516199863|FG001|Overall Study|Study terminated by sponsor|0|||
143178027|NCT02078752|516199864|FG002|Overall Study|Study terminated by sponsor|0|||
143178028|NCT02078752|516199865|FG003|Overall Study|Study terminated by sponsor|0|||
143178029|NCT02078752|516199866|FG004|Overall Study|Study terminated by sponsor|0|||
143178030|NCT02078752|516199867|FG005|Overall Study|Study terminated by sponsor|0|||
143178031|NCT02078752|516199868|FG006|Overall Study|Study terminated by sponsor|0|||
143178032|NCT02078752|516199869|FG007|Overall Study|Study terminated by sponsor|0|||
143178033|NCT02078752|516199870|FG008|Overall Study|Study terminated by sponsor|0|||
143178034|NCT02078752|516199871|FG009|Overall Study|Study terminated by sponsor|5|||
143178035|NCT02383862|516199876|FG000|3 Month Follow up|Lost to Follow-up|23|||
143178036|NCT02383862|516199877|FG001|3 Month Follow up|Lost to Follow-up|21|||
143178037|NCT01833494|516199878|FG000|Overall Study|Adverse Event|24|||
143178038|NCT01833494|516199878|FG000|Overall Study|Physician Decision|6|||
143178039|NCT01833494|516199878|FG000|Overall Study|Withdrawal by Subject|6|||
143178040|NCT01833494|516199878|FG000|Overall Study|Decrease in serum phosphorus|4|||
143178041|NCT01833494|516199878|FG000|Overall Study|Decrease in serum calcium|4|||
143178042|NCT01833494|516199878|FG000|Overall Study|Increase in serum ferritin|1|||
143178043|NCT01694433|516199883|FG000|Overall Study|Adverse Event|7|||
143178044|NCT01694433|516199884|FG001|Overall Study|Adverse Event|0|||
143178045|NCT01694433|516199883|FG000|Overall Study|Physician Decision|1|||
143178046|NCT01694433|516199884|FG001|Overall Study|Physician Decision|0|||
143178047|NCT01694433|516199883|FG000|Overall Study|Withdrawal by Subject|3|||
143178048|NCT01694433|516199884|FG001|Overall Study|Withdrawal by Subject|4|||
143178049|NCT00374595|516199887|FG000|Overall Study|Death|23|||
143178050|NCT00374595|516199887|FG000|Overall Study|Withdrawal by Subject|39|||
143178051|NCT00374595|516199887|FG000|Overall Study|Lost to Follow-up|3|||
143178052|NCT00374595|516199887|FG000|Overall Study|too much time commitment|1|||
143178053|NCT00374595|516199887|FG000|Overall Study|transfer care to other clinical site|1|||
143178054|NCT00374595|516199887|FG000|Overall Study|relocation|3|||
143178055|NCT03745768|516199888|FG000|Overall Study|discontinued study|2|||
143178056|NCT03745768|516199889|FG001|Overall Study|discontinued study|0|||
143178057|NCT00443118|516199890|FG000|Overall Study|unknown primary outcome|3|||
143253630|NCT02122783|516481830|FG001|Overall Study|Adverse Event|1|||
143178058|NCT00443118|516199891|FG001|Overall Study|unknown primary outcome|1|||
143178059|NCT00443118|516199892|FG002|Overall Study|unknown primary outcome|0|||
143178060|NCT00443118|516199890|FG000|Overall Study|Withdrawal by Subject|1|||
143178061|NCT00443118|516199891|FG001|Overall Study|Withdrawal by Subject|0|||
143178062|NCT00443118|516199892|FG002|Overall Study|Withdrawal by Subject|0|||
143253631|NCT00329849|516481831|FG000|Overall Study|Withdrawal by Subject|6|||
143253632|NCT00329849|516481832|FG001|Overall Study|Withdrawal by Subject|4|||
143253633|NCT03996369|516481833|FG000|Overall Study|Protocol deviation|1|||
143253634|NCT03996369|516481834|FG001|Overall Study|Protocol deviation|1|||
143253635|NCT03996369|516481833|FG000|Overall Study|Physician Decision|4|||
143253636|NCT03996369|516481834|FG001|Overall Study|Physician Decision|2|||
143253637|NCT03996369|516481833|FG000|Overall Study|Participant decision|0|||
143253638|NCT03996369|516481834|FG001|Overall Study|Participant decision|1|||
143253639|NCT03996369|516481833|FG000|Overall Study|Lack of Efficacy|4|||
143253640|NCT03996369|516481834|FG001|Overall Study|Lack of Efficacy|0|||
143253641|NCT03996369|516481833|FG000|Overall Study|Adverse Event|9|||
143253642|NCT03996369|516481834|FG001|Overall Study|Adverse Event|0|||
143253643|NCT03996369|516481833|FG000|Overall Study|Withdrawal by Subject|6|||
143253644|NCT03996369|516481834|FG001|Overall Study|Withdrawal by Subject|8|||
143253645|NCT03996369|516481833|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
143253646|NCT03996369|516481834|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
143253647|NCT03996369|516481833|FG000|Overall Study|Lost to Follow-up|0|||
143253648|NCT03996369|516481834|FG001|Overall Study|Lost to Follow-up|1|||
143253649|NCT00653432|516481840|FG000|Overall Study|Adverse Event|4|||
143253650|NCT00653432|516481841|FG001|Overall Study|Adverse Event|1|||
143253651|NCT00653432|516481840|FG000|Overall Study|Withdrawal by Subject|4|||
143253652|NCT00653432|516481841|FG001|Overall Study|Withdrawal by Subject|5|||
143253653|NCT00653432|516481840|FG000|Overall Study|Lost to Follow-up|7|||
143253654|NCT00653432|516481841|FG001|Overall Study|Lost to Follow-up|6|||
143253655|NCT00653432|516481840|FG000|Overall Study|Use/Need of Con Therapy|2|||
143253656|NCT00653432|516481841|FG001|Overall Study|Use/Need of Con Therapy|1|||
143253657|NCT00653432|516481840|FG000|Overall Study|Other - Reason Not Provided|5|||
143253658|NCT00653432|516481841|FG001|Overall Study|Other - Reason Not Provided|3|||
143253659|NCT05277337|516481842|FG000|Overall Study|Lost to Follow-up|2|||
143253660|NCT05277337|516481843|FG001|Overall Study|Lost to Follow-up|0|||
143253661|NCT05277337|516481842|FG000|Overall Study|Withdrawal by Subject|1|||
143253662|NCT05277337|516481843|FG001|Overall Study|Withdrawal by Subject|0|||
143253663|NCT01782469|516481844|FG000|Overall Study|Lost to Follow-up|1|||
143253664|NCT00357760|516481847|FG000|Overall Study|Disease progression|44|||
143253665|NCT00357760|516481848|FG001|Overall Study|Disease progression|17|||
143253666|NCT00357760|516481847|FG000|Overall Study|Adverse Event|10|||
143253667|NCT00357760|516481848|FG001|Overall Study|Adverse Event|7|||
143253668|NCT00357760|516481847|FG000|Overall Study|Death|0|||
143253669|NCT00357760|516481848|FG001|Overall Study|Death|3|||
143253670|NCT00357760|516481847|FG000|Overall Study|Alternative therapy|1|||
143253671|NCT00357760|516481848|FG001|Overall Study|Alternative therapy|0|||
143253672|NCT00357760|516481847|FG000|Overall Study|Withdrawal by Subject|0|||
143253673|NCT00357760|516481848|FG001|Overall Study|Withdrawal by Subject|2|||
143253674|NCT00357760|516481847|FG000|Overall Study|Never started treatment|2|||
143253675|NCT00357760|516481848|FG001|Overall Study|Never started treatment|1|||
143253676|NCT00357760|516481847|FG000|Overall Study|Ineligible|0|||
143253677|NCT00357760|516481848|FG001|Overall Study|Ineligible|2|||
143253678|NCT00357760|516481847|FG000|Overall Study|Physician Decision|2|||
143253679|NCT00357760|516481848|FG001|Overall Study|Physician Decision|1|||
143253680|NCT00357760|516481847|FG000|Overall Study|Protocol Violation|0|||
143253681|NCT00357760|516481848|FG001|Overall Study|Protocol Violation|1|||
143253682|NCT00357760|516481847|FG000|Overall Study|To receive hospice care|0|||
143253683|NCT00357760|516481848|FG001|Overall Study|To receive hospice care|1|||
143103620|NCT03482453|515920314|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
143103621|NCT03482453|515920315|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
143103622|NCT03482453|515920316|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
143103623|NCT03482453|515920317|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
143103624|NCT03482453|515920318|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
143103625|NCT03482453|515920319|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
143103626|NCT03482453|515920320|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
143103627|NCT03482453|515920321|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
143103628|NCT03482453|515920322|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
143103629|NCT03482453|515920323|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
143103630|NCT02568189|515920324|FG000|Overall Study|Protocol Violation|0|||
143103631|NCT02568189|515920325|FG001|Overall Study|Protocol Violation|0|||
143103632|NCT02568189|515920326|FG002|Overall Study|Protocol Violation|19|||
143103633|NCT02568189|515920327|FG003|Overall Study|Protocol Violation|18|||
143103634|NCT01554527|515920328|FG000|Overall Study|Withdrawal by Subject|1|||
143103635|NCT01554527|515920329|FG001|Overall Study|Withdrawal by Subject|0|||
143103636|NCT01554527|515920330|FG002|Overall Study|Withdrawal by Subject|3|||
143103637|NCT01554527|515920328|FG000|Overall Study|Lost to Follow-up|0|||
143253684|NCT02395172|516481849|FG000|Overall Study|Participants randomized but not treated|3|||
143253685|NCT02395172|516481850|FG001|Overall Study|Participants randomized but not treated|31|||
143253686|NCT00029146|516481853|FG000|Overall Study|Lost to Follow-up|2|||
143253687|NCT00029146|516481854|FG001|Overall Study|Lost to Follow-up|1|||
143103638|NCT01554527|515920329|FG001|Overall Study|Lost to Follow-up|0|||
143103639|NCT01554527|515920330|FG002|Overall Study|Lost to Follow-up|4|||
143103640|NCT01554527|515920328|FG000|Overall Study|Physician Decision|0|||
143103641|NCT01554527|515920329|FG001|Overall Study|Physician Decision|0|||
143103642|NCT01554527|515920330|FG002|Overall Study|Physician Decision|1|||
143253688|NCT00946985|516481855|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
143103643|NCT01052480|515920331|FG000|Overall Study|Lost to Follow-up|3|||
143103644|NCT01052480|515920332|FG001|Overall Study|Lost to Follow-up|3|||
143103645|NCT01052480|515920331|FG000|Overall Study|Protocol Violation|1|||
143103646|NCT01052480|515920332|FG001|Overall Study|Protocol Violation|0|||
143103647|NCT01052480|515920331|FG000|Overall Study|Withdrawal by Subject|3|||
143103648|NCT01052480|515920332|FG001|Overall Study|Withdrawal by Subject|7|||
143103649|NCT01052480|515920331|FG000|Overall Study|Physician Decision|0|||
143103650|NCT01052480|515920332|FG001|Overall Study|Physician Decision|2|||
143103651|NCT01052480|515920331|FG000|Overall Study|Death|1|||
143103652|NCT01052480|515920332|FG001|Overall Study|Death|5|||
143103653|NCT02157376|515920333|FG000|Overall Study|Death|10|||
143103654|NCT02157376|515920334|FG001|Overall Study|Death|4|||
143103655|NCT02157376|515920333|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
143253689|NCT00946985|516481855|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
143253690|NCT00946985|516481855|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
143253691|NCT00946985|516481855|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
143253692|NCT00946985|516481855|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
143253693|NCT00946985|516481855|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
143253694|NCT00946985|516481855|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
143253695|NCT00946985|516481855|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
143253696|NCT00946985|516481855|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
143253697|NCT01590758|516481856|FG000|Overall Study|Withdrawal by Subject|0|||
143253698|NCT01590758|516481857|FG001|Overall Study|Withdrawal by Subject|3|||
143253699|NCT01590758|516481856|FG000|Overall Study|Physician Decision|1|||
143253700|NCT01590758|516481857|FG001|Overall Study|Physician Decision|2|||
143253701|NCT01590758|516481856|FG000|Overall Study|Lost to Follow-up|4|||
143253702|NCT01590758|516481857|FG001|Overall Study|Lost to Follow-up|2|||
143253703|NCT02717832|516481858|FG000|Overall Study|Inability to place IV|3|||
143253704|NCT01144299|516481859|FG000|Overall Study|Lost to Follow-up|1|||
143253705|NCT01144299|516481860|FG001|Overall Study|Lost to Follow-up|0|||
143253706|NCT01144299|516481859|FG000|Overall Study|Withdrawal by Subject|1|||
143253707|NCT01144299|516481860|FG001|Overall Study|Withdrawal by Subject|0|||
143253708|NCT02342418|516481863|FG000|Overall Study|Adverse Event|0|||
143253709|NCT02342418|516481864|FG001|Overall Study|Adverse Event|1|||
143253710|NCT04255394|516481865|FG000|Overall Study|Death|35|||
143253711|NCT04255394|516481866|FG001|Overall Study|Death|25|||
143253712|NCT04255394|516481865|FG000|Overall Study|Device removed|2|||
143253713|NCT04255394|516481866|FG001|Overall Study|Device removed|10|||
143253714|NCT04255394|516481865|FG000|Overall Study|Withdrawal by Subject|9|||
143253715|NCT04255394|516481866|FG001|Overall Study|Withdrawal by Subject|8|||
143253716|NCT04255394|516481865|FG000|Overall Study|Screen Failure/Not treated|12|||
143253717|NCT04255394|516481866|FG001|Overall Study|Screen Failure/Not treated|8|||
143253718|NCT04255394|516481865|FG000|Overall Study|Lost to Follow-up|123|||
143253719|NCT04255394|516481866|FG001|Overall Study|Lost to Follow-up|265|||
143253720|NCT04255394|516481865|FG000|Overall Study|Adverse Event|1|||
143253721|NCT04255394|516481866|FG001|Overall Study|Adverse Event|3|||
143253722|NCT01330017|516483839|FG000|Overall Study|Adverse Event|0|||
143253723|NCT01330017|516483840|FG001|Overall Study|Adverse Event|1|||
143253724|NCT01330017|516483841|FG002|Overall Study|Adverse Event|1|||
143253725|NCT01330017|516483842|FG003|Overall Study|Adverse Event|4|||
143253726|NCT01330017|516483843|FG004|Overall Study|Adverse Event|0|||
143253727|NCT01330017|516483839|FG000|Overall Study|Withdrawal by Subject|0|||
143253728|NCT01330017|516483840|FG001|Overall Study|Withdrawal by Subject|0|||
143253729|NCT01330017|516483841|FG002|Overall Study|Withdrawal by Subject|1|||
143103656|NCT02157376|515920334|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
143103657|NCT02157376|515920333|FG000|Overall Study|Withdrawal by Subject|3|||
143253730|NCT01330017|516483842|FG003|Overall Study|Withdrawal by Subject|0|||
143253731|NCT01330017|516483843|FG004|Overall Study|Withdrawal by Subject|1|||
143253732|NCT01330017|516483839|FG000|Overall Study|Lost to Follow-up|0|||
143253733|NCT01330017|516483840|FG001|Overall Study|Lost to Follow-up|0|||
143253734|NCT01330017|516483841|FG002|Overall Study|Lost to Follow-up|1|||
143253735|NCT01330017|516483842|FG003|Overall Study|Lost to Follow-up|0|||
143253736|NCT01330017|516483843|FG004|Overall Study|Lost to Follow-up|0|||
143253737|NCT01330017|516483839|FG000|Overall Study|Protocol Violation|0|||
143253738|NCT01330017|516483840|FG001|Overall Study|Protocol Violation|0|||
143253739|NCT01330017|516483841|FG002|Overall Study|Protocol Violation|0|||
143253740|NCT01330017|516483842|FG003|Overall Study|Protocol Violation|1|||
143103658|NCT02157376|515920334|FG001|Overall Study|Withdrawal by Subject|8|||
143103659|NCT02157376|515920333|FG000|Overall Study|Not treated|8|||
143103660|NCT02157376|515920334|FG001|Overall Study|Not treated|3|||
143103661|NCT02157376|515920333|FG000|Overall Study|Investigator's misjudgement|1|||
143103662|NCT02157376|515920334|FG001|Overall Study|Investigator's misjudgement|2|||
143103663|NCT00529373|515920341|FG000|Base Study|Adverse Event|525|||
143253741|NCT01330017|516483843|FG004|Overall Study|Protocol Violation|0|||
143103664|NCT00529373|515920342|FG001|Base Study|Adverse Event|470|||
143103665|NCT00529373|515920341|FG000|Base Study|Lack of Efficacy|16|||
143103666|NCT00529373|515920342|FG001|Base Study|Lack of Efficacy|75|||
143103667|NCT00529373|515920341|FG000|Base Study|Lost to Follow-up|221|||
143103668|NCT00529373|515920342|FG001|Base Study|Lost to Follow-up|208|||
143103669|NCT00529373|515920341|FG000|Base Study|Other Protocol Specified Criteria|19|||
143103670|NCT00529373|515920342|FG001|Base Study|Other Protocol Specified Criteria|20|||
143103671|NCT00529373|515920341|FG000|Base Study|Physician Decision|60|||
143103672|NCT00529373|515920342|FG001|Base Study|Physician Decision|52|||
143103673|NCT00529373|515920341|FG000|Base Study|Protocol Violation|48|||
143103674|NCT00529373|515920342|FG001|Base Study|Protocol Violation|38|||
143103675|NCT00529373|515920341|FG000|Base Study|Withdrawal by Subject|1062|||
143103676|NCT00529373|515920342|FG001|Base Study|Withdrawal by Subject|967|||
143103677|NCT00529373|515920341|FG000|Base Study|Did not continue into Extension|1795|||
143103678|NCT00529373|515920342|FG001|Base Study|Did not continue into Extension|2238|||
143103679|NCT00529373|515920341|FG000|First Extension Study|Adverse Event|162|||
143103680|NCT00529373|515920342|FG001|First Extension Study|Adverse Event|142|||
143103681|NCT00529373|515920341|FG000|First Extension Study|Lack of Efficacy|65|||
143103682|NCT00529373|515920342|FG001|First Extension Study|Lack of Efficacy|427|||
143103683|NCT00529373|515920341|FG000|First Extension Study|Lost to Follow-up|41|||
143103684|NCT00529373|515920342|FG001|First Extension Study|Lost to Follow-up|37|||
143103685|NCT00529373|515920341|FG000|First Extension Study|Other|27|||
143103686|NCT00529373|515920342|FG001|First Extension Study|Other|47|||
143103687|NCT00529373|515920341|FG000|First Extension Study|Physician Decision|50|||
143103688|NCT00529373|515920342|FG001|First Extension Study|Physician Decision|45|||
143103689|NCT00529373|515920341|FG000|First Extension Study|Protocol Violation|16|||
143103690|NCT00529373|515920342|FG001|First Extension Study|Protocol Violation|13|||
143103691|NCT00529373|515920341|FG000|First Extension Study|Withdrawal by Subject|296|||
143103692|NCT00529373|515920342|FG001|First Extension Study|Withdrawal by Subject|287|||
143103693|NCT00529373|515920341|FG000|First Extension Study|Disposition record non-existing|0|||
143103694|NCT00529373|515920342|FG001|First Extension Study|Disposition record non-existing|1|||
143103695|NCT00529373|515920341|FG000|First Extension Study|Discontinued after 5 years completion|208|||
143103696|NCT00529373|515920342|FG001|First Extension Study|Discontinued after 5 years completion|346|||
143103697|NCT00529373|515920341|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
143103698|NCT00529373|515920342|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
143103699|NCT00529373|515920341|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
143103700|NCT00529373|515920342|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
143103701|NCT00529373|515920341|FG000|Second Extension Study|Adverse Event|101|||
143178063|NCT03962855|516199896|FG000|Overall Study|Death|0|||
143178064|NCT03962855|516199897|FG001|Overall Study|Death|1|||
143178065|NCT03962855|516199896|FG000|Overall Study|Lost to Follow-up|0|||
143178066|NCT03962855|516199897|FG001|Overall Study|Lost to Follow-up|1|||
143178067|NCT03962855|516199896|FG000|Overall Study|Adverse Event|0|||
143178068|NCT03962855|516199897|FG001|Overall Study|Adverse Event|1|||
143103702|NCT00529373|515920342|FG001|Second Extension Study|Adverse Event|51|||
143103703|NCT00529373|515920341|FG000|Second Extension Study|Lack of Efficacy|7|||
143103704|NCT00529373|515920342|FG001|Second Extension Study|Lack of Efficacy|15|||
143103705|NCT00529373|515920341|FG000|Second Extension Study|Lost to Follow-up|18|||
143178069|NCT03962855|516199896|FG000|Overall Study|Physician Decision|0|||
143253742|NCT01330017|516483839|FG000|Overall Study|Unknown Reason|5|||
143253743|NCT01330017|516483840|FG001|Overall Study|Unknown Reason|3|||
143253744|NCT01330017|516483841|FG002|Overall Study|Unknown Reason|5|||
143253745|NCT01330017|516483842|FG003|Overall Study|Unknown Reason|7|||
143253746|NCT01330017|516483843|FG004|Overall Study|Unknown Reason|2|||
143253747|NCT02043899|516483848|FG000|Overall Study|Adverse Event|3|||
143253748|NCT02043899|516483848|FG000|Overall Study|Physician Decision|1|||
143253749|NCT02043899|516483848|FG000|Overall Study|Withdrawal by Subject|2|||
143253750|NCT02043899|516483848|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
143253751|NCT02043899|516483848|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
143253752|NCT02043899|516483848|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
143253753|NCT02043899|516483848|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
143253754|NCT02043899|516483848|FG000|Overall Study|Treatment delayed|1|||
143253755|NCT03254108|516483849|FG000|Overall Study|Adverse Event|0|||
143253756|NCT03254108|516483850|FG001|Overall Study|Adverse Event|2|||
143253757|NCT03254108|516483851|FG002|Overall Study|Adverse Event|0|||
143253758|NCT03254108|516483852|FG003|Overall Study|Adverse Event|1|||
143253759|NCT03254108|516483853|FG004|Overall Study|Adverse Event|1|||
143253760|NCT03254108|516483849|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
143253761|NCT03254108|516483850|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
143253762|NCT03254108|516483851|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
143253763|NCT03254108|516483852|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
143253764|NCT03254108|516483853|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
143253765|NCT00362180|516483854|FG000|Treated Period|Withdrawal by Subject|1|||
143253766|NCT00362180|516483855|FG001|Treated Period|Withdrawal by Subject|0|||
143253767|NCT00362180|516483856|FG002|Treated Period|Withdrawal by Subject|0|||
143253768|NCT00362180|516483857|FG003|Treated Period|Withdrawal by Subject|0|||
143253769|NCT00362180|516483858|FG004|Treated Period|Withdrawal by Subject|0|||
143253770|NCT00362180|516483859|FG005|Treated Period|Withdrawal by Subject|0|||
143253771|NCT00362180|516483860|FG006|Treated Period|Withdrawal by Subject|0|||
143253772|NCT00362180|516483861|FG007|Treated Period|Withdrawal by Subject|0|||
143253773|NCT00362180|516483862|FG008|Treated Period|Withdrawal by Subject|0|||
143253774|NCT00362180|516483854|FG000|Treated Period|Adverse Event|0|||
143253775|NCT00362180|516483855|FG001|Treated Period|Adverse Event|0|||
143253776|NCT00362180|516483856|FG002|Treated Period|Adverse Event|0|||
143253777|NCT00362180|516483857|FG003|Treated Period|Adverse Event|0|||
143253778|NCT00362180|516483858|FG004|Treated Period|Adverse Event|0|||
143253779|NCT00362180|516483859|FG005|Treated Period|Adverse Event|1|||
143253780|NCT00362180|516483860|FG006|Treated Period|Adverse Event|0|||
143253781|NCT00362180|516483861|FG007|Treated Period|Adverse Event|1|||
143253782|NCT00362180|516483862|FG008|Treated Period|Adverse Event|0|||
143253783|NCT01106092|516483863|FG000|Overall Study|Withdrawal by Subject|0|||
143253784|NCT01106092|516483864|FG001|Overall Study|Withdrawal by Subject|0|||
143253785|NCT01106092|516483865|FG002|Overall Study|Withdrawal by Subject|0|||
143253786|NCT01106092|516483866|FG003|Overall Study|Withdrawal by Subject|1|||
143253787|NCT02434471|516483869|FG000|Overall Study|Physician Decision|9|||
143253788|NCT04839562|516483874|FG000|Overall Study|Withdrawal by Subject|0|||
143253789|NCT04839562|516483875|FG001|Overall Study|Withdrawal by Subject|1|||
143253790|NCT04839562|516483874|FG000|Overall Study|Physician Decision|0|||
143253791|NCT04839562|516483875|FG001|Overall Study|Physician Decision|1|||
143253792|NCT01236547|516483876|FG000|Overall Study|Protocol Violation|0|||
143253793|NCT01236547|516483877|FG001|Overall Study|Protocol Violation|1|||
143253794|NCT01236547|516483878|FG002|Overall Study|Protocol Violation|1|||
143253795|NCT01236547|516483879|FG003|Overall Study|Protocol Violation|6|||
143253796|NCT01236547|516483880|FG004|Overall Study|Protocol Violation|12|||
143253797|NCT01328366|516483887|FG000|Overall Study|Death|1|||
143103706|NCT00529373|515920342|FG001|Second Extension Study|Lost to Follow-up|12|||
143103707|NCT00529373|515920341|FG000|Second Extension Study|Other|7|||
143103708|NCT00529373|515920342|FG001|Second Extension Study|Other|12|||
143253798|NCT01328366|516483887|FG000|Overall Study|Withdrawal by Subject|2|||
143253799|NCT01328366|516483887|FG000|Overall Study|Lost to Follow-up|7|||
143103709|NCT00529373|515920341|FG000|Second Extension Study|Physician Decision|63|||
143103710|NCT00529373|515920342|FG001|Second Extension Study|Physician Decision|26|||
143103711|NCT00529373|515920341|FG000|Second Extension Study|Protocol Violation|2|||
143253800|NCT00910624|516483888|FG000|Treatment Phase|Adverse Event|2|||
143253801|NCT00910624|516483889|FG001|Treatment Phase|Adverse Event|6|||
143253802|NCT00910624|516483890|FG002|Treatment Phase|Adverse Event|6|||
143253803|NCT00910624|516483891|FG003|Treatment Phase|Adverse Event|0|||
143253804|NCT00910624|516483888|FG000|Treatment Phase|Treatment Failure|23|||
143253805|NCT00910624|516483889|FG001|Treatment Phase|Treatment Failure|10|||
143253806|NCT00910624|516483890|FG002|Treatment Phase|Treatment Failure|0|||
143253807|NCT00910624|516483891|FG003|Treatment Phase|Treatment Failure|0|||
143253808|NCT00910624|516483888|FG000|Treatment Phase|Lost to Follow-up|0|||
143253809|NCT00910624|516483889|FG001|Treatment Phase|Lost to Follow-up|0|||
143103712|NCT00529373|515920342|FG001|Second Extension Study|Protocol Violation|1|||
143253810|NCT00910624|516483890|FG002|Treatment Phase|Lost to Follow-up|1|||
143253811|NCT00910624|516483891|FG003|Treatment Phase|Lost to Follow-up|0|||
143253812|NCT00910624|516483888|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
143253813|NCT00910624|516483889|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
143253814|NCT00910624|516483890|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
143253815|NCT00910624|516483891|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
143253816|NCT00910624|516483888|FG000|Treatment Phase|Withdrawal by Subject|2|||
143253817|NCT00910624|516483889|FG001|Treatment Phase|Withdrawal by Subject|1|||
143253818|NCT00910624|516483890|FG002|Treatment Phase|Withdrawal by Subject|0|||
143253819|NCT00910624|516483891|FG003|Treatment Phase|Withdrawal by Subject|0|||
143253820|NCT00910624|516483888|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
143253821|NCT00910624|516483889|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
143253822|NCT00910624|516483890|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
143253823|NCT00910624|516483891|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
143253824|NCT00910624|516483888|FG000|Follow-Up Phase|Adverse Event|0|||
143253825|NCT00910624|516483889|FG001|Follow-Up Phase|Adverse Event|0|||
143253826|NCT00910624|516483890|FG002|Follow-Up Phase|Adverse Event|1|||
143103713|NCT00529373|515920341|FG000|Second Extension Study|Withdrawal by Subject|97|||
143103714|NCT00529373|515920342|FG001|Second Extension Study|Withdrawal by Subject|75|||
143103715|NCT00529373|515920341|FG000|Second Extension Study|Status Missing|5|||
143103716|NCT00529373|515920342|FG001|Second Extension Study|Status Missing|5|||
143253827|NCT00910624|516483891|FG003|Follow-Up Phase|Adverse Event|0|||
143253828|NCT00910624|516483888|FG000|Follow-Up Phase|Lost to Follow-up|3|||
143253829|NCT00910624|516483889|FG001|Follow-Up Phase|Lost to Follow-up|1|||
143253830|NCT00910624|516483890|FG002|Follow-Up Phase|Lost to Follow-up|2|||
143253831|NCT00910624|516483891|FG003|Follow-Up Phase|Lost to Follow-up|0|||
143253832|NCT00910624|516483888|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
143253833|NCT00910624|516483889|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
143253834|NCT00910624|516483890|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
143253835|NCT00910624|516483891|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
143253836|NCT00910624|516483888|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
143253837|NCT00910624|516483889|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
143253838|NCT00910624|516483890|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
143253839|NCT00910624|516483891|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
143253840|NCT00910624|516483888|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
143253841|NCT00910624|516483889|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
143253842|NCT00910624|516483890|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
143253843|NCT00910624|516483891|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
143253844|NCT00910624|516483888|FG000|Follow-Up Phase|Administrative|0|||
143253845|NCT00910624|516483889|FG001|Follow-Up Phase|Administrative|1|||
143253846|NCT00910624|516483890|FG002|Follow-Up Phase|Administrative|1|||
143253847|NCT00910624|516483891|FG003|Follow-Up Phase|Administrative|0|||
143253848|NCT01122264|516483892|FG000|Overall Study|Adverse Event|6|||
143253849|NCT01122264|516483893|FG001|Overall Study|Adverse Event|5|||
143253850|NCT01122264|516483894|FG002|Overall Study|Adverse Event|7|||
143253851|NCT01122264|516483892|FG000|Overall Study|Death|1|||
143253852|NCT01122264|516483893|FG001|Overall Study|Death|0|||
143253853|NCT01122264|516483894|FG002|Overall Study|Death|0|||
143253854|NCT01122264|516483892|FG000|Overall Study|Lost to Follow-up|5|||
143253855|NCT01122264|516483893|FG001|Overall Study|Lost to Follow-up|9|||
143253856|NCT01122264|516483894|FG002|Overall Study|Lost to Follow-up|13|||
143253857|NCT01122264|516483892|FG000|Overall Study|Entry Criteria Not Met|1|||
143253858|NCT01122264|516483893|FG001|Overall Study|Entry Criteria Not Met|0|||
143253859|NCT01122264|516483894|FG002|Overall Study|Entry Criteria Not Met|0|||
143253860|NCT01122264|516483892|FG000|Overall Study|Protocol Violation|7|||
143253861|NCT01122264|516483893|FG001|Overall Study|Protocol Violation|7|||
143103717|NCT01074268|515920343|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
143103718|NCT01074268|515920344|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
143103719|NCT01074268|515920343|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
143103720|NCT01074268|515920344|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
143103721|NCT01074268|515920343|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
143103722|NCT01074268|515920344|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
143103723|NCT01074268|515920343|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
143103724|NCT01074268|515920344|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
143103725|NCT01074268|515920343|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
143103726|NCT01074268|515920344|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
143103727|NCT01074268|515920343|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
143103728|NCT01074268|515920344|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
143103729|NCT01074268|515920343|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
143103730|NCT01074268|515920344|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
143103731|NCT01074268|515920343|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
143103732|NCT01074268|515920344|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
143103733|NCT01074268|515920343|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
143103734|NCT01074268|515920344|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
143103735|NCT04200651|515920349|FG000|Overall Study|Moved to another country during follow-up|2|||
143103736|NCT04200651|515920350|FG001|Overall Study|Moved to another country during follow-up|2|||
143103737|NCT04200651|515920349|FG000|Overall Study|Lost to Follow-up|1|||
143103738|NCT04200651|515920350|FG001|Overall Study|Lost to Follow-up|3|||
143103739|NCT01134939|515920354|FG000|Overall Study|Adverse Event|9|||
143103740|NCT01134939|515920355|FG001|Overall Study|Adverse Event|3|||
143103741|NCT01134939|515920356|FG002|Overall Study|Adverse Event|4|||
143103742|NCT01134939|515920357|FG003|Overall Study|Adverse Event|5|||
143103743|NCT01134939|515920358|FG004|Overall Study|Adverse Event|5|||
143103744|NCT01134939|515920359|FG005|Overall Study|Adverse Event|5|||
143103745|NCT01134939|515920360|FG006|Overall Study|Adverse Event|1|||
143103746|NCT01134939|515920361|FG007|Overall Study|Adverse Event|0|||
143103747|NCT01134939|515920354|FG000|Overall Study|Lack of Efficacy|2|||
143103748|NCT01134939|515920355|FG001|Overall Study|Lack of Efficacy|5|||
143103749|NCT01134939|515920356|FG002|Overall Study|Lack of Efficacy|1|||
143103750|NCT01134939|515920357|FG003|Overall Study|Lack of Efficacy|0|||
143103751|NCT01134939|515920358|FG004|Overall Study|Lack of Efficacy|3|||
143103752|NCT01134939|515920359|FG005|Overall Study|Lack of Efficacy|0|||
143103753|NCT01134939|515920360|FG006|Overall Study|Lack of Efficacy|1|||
143103754|NCT01134939|515920361|FG007|Overall Study|Lack of Efficacy|0|||
143103755|NCT01134939|515920354|FG000|Overall Study|Lost to Follow-up|2|||
143103756|NCT01134939|515920355|FG001|Overall Study|Lost to Follow-up|3|||
143103757|NCT01134939|515920356|FG002|Overall Study|Lost to Follow-up|0|||
143103758|NCT01134939|515920357|FG003|Overall Study|Lost to Follow-up|1|||
143103759|NCT01134939|515920358|FG004|Overall Study|Lost to Follow-up|2|||
143103760|NCT01134939|515920359|FG005|Overall Study|Lost to Follow-up|1|||
143103761|NCT01134939|515920360|FG006|Overall Study|Lost to Follow-up|0|||
143103762|NCT01134939|515920361|FG007|Overall Study|Lost to Follow-up|0|||
143103763|NCT01134939|515920354|FG000|Overall Study|Death|0|||
143103764|NCT01134939|515920355|FG001|Overall Study|Death|1|||
143103765|NCT01134939|515920356|FG002|Overall Study|Death|0|||
143103766|NCT01134939|515920357|FG003|Overall Study|Death|0|||
143103767|NCT01134939|515920358|FG004|Overall Study|Death|0|||
143103768|NCT01134939|515920359|FG005|Overall Study|Death|0|||
143103769|NCT01134939|515920360|FG006|Overall Study|Death|0|||
143103770|NCT01134939|515920361|FG007|Overall Study|Death|0|||
143103771|NCT01134939|515920354|FG000|Overall Study|Termination page not available|4|||
143103772|NCT01134939|515920355|FG001|Overall Study|Termination page not available|6|||
143103773|NCT01134939|515920356|FG002|Overall Study|Termination page not available|5|||
143103774|NCT01134939|515920357|FG003|Overall Study|Termination page not available|8|||
143103775|NCT01134939|515920358|FG004|Overall Study|Termination page not available|0|||
143103776|NCT01134939|515920359|FG005|Overall Study|Termination page not available|3|||
143103777|NCT01134939|515920360|FG006|Overall Study|Termination page not available|7|||
143103778|NCT01134939|515920361|FG007|Overall Study|Termination page not available|0|||
143103779|NCT00733421|515920362|FG000|Overall Study|Withdrawal by Subject|1|||
143103780|NCT00733421|515920363|FG001|Overall Study|Withdrawal by Subject|1|||
143103781|NCT02547220|515920366|FG000|Overall Study|Withdrawal by Subject|1|||
143103782|NCT02547220|515920367|FG001|Overall Study|Withdrawal by Subject|0|||
143103783|NCT02547220|515920366|FG000|Overall Study|Study terminated by sponsor|18|||
143103784|NCT02547220|515920367|FG001|Overall Study|Study terminated by sponsor|20|||
143103785|NCT01029782|515920372|FG000|Overall Study|Lost to Follow-up|2|||
143103786|NCT01029782|515920373|FG001|Overall Study|Lost to Follow-up|2|||
143103787|NCT01029782|515920372|FG000|Overall Study|Diagnosis changed|1|||
143103788|NCT01029782|515920373|FG001|Overall Study|Diagnosis changed|1|||
143103789|NCT01029782|515920372|FG000|Overall Study|Adverse Event|0|||
143103790|NCT01029782|515920373|FG001|Overall Study|Adverse Event|1|||
143103791|NCT01029782|515920372|FG000|Overall Study|Physician Decision|0|||
143103792|NCT01029782|515920373|FG001|Overall Study|Physician Decision|1|||
143103793|NCT01029782|515920372|FG000|Overall Study|Protocol Violation|0|||
143103794|NCT01029782|515920373|FG001|Overall Study|Protocol Violation|2|||
143103795|NCT01029782|515920372|FG000|Overall Study|Withdrawal by Subject|0|||
143103796|NCT01029782|515920373|FG001|Overall Study|Withdrawal by Subject|1|||
143103797|NCT01186692|515920374|FG000|Overall Study|Not Catheterized|11|||
143103798|NCT01186692|515920374|FG000|Overall Study|Futher testing contraindicated implant|19|||
143103799|NCT01186692|515920374|FG000|Overall Study|Adverse Event|2|||
143103800|NCT02195869|515920376|FG000|Overall Study|cGVHD Progression|5|||
143103801|NCT02195869|515920376|FG000|Overall Study|Malignancy Progression/relapse|2|||
143103802|NCT02195869|515920376|FG000|Overall Study|Adverse Event|15|||
143103803|NCT02195869|515920376|FG000|Overall Study|Withdrawal by Subject|7|||
143103804|NCT02195869|515920376|FG000|Overall Study|Physician Decision|4|||
143103805|NCT02195869|515920376|FG000|Overall Study|Study Terminated by Sponsor|7|||
143103806|NCT02195869|515920376|FG000|Overall Study|Noncompliance with study drug|2|||
143103807|NCT03319732|515920377|FG000|Overall Study|Adverse Event|40|||
143103808|NCT03319732|515920377|FG000|Overall Study|Withdrawal by Subject|50|||
143103809|NCT03319732|515920377|FG000|Overall Study|MS relapse|10|||
143103810|NCT03319732|515920377|FG000|Overall Study|reason not specified|5|||
143103811|NCT00789698|515920378|FG000|Overall Study|Lack of Efficacy|10|||
143103812|NCT00789698|515920379|FG001|Overall Study|Lack of Efficacy|4|||
143103813|NCT00789698|515920380|FG002|Overall Study|Lack of Efficacy|5|||
143103814|NCT00789698|515920381|FG003|Overall Study|Lack of Efficacy|18|||
143103815|NCT00789698|515920378|FG000|Overall Study|Adverse Event|5|||
143103816|NCT00789698|515920379|FG001|Overall Study|Adverse Event|5|||
143103817|NCT00789698|515920380|FG002|Overall Study|Adverse Event|3|||
143103818|NCT00789698|515920381|FG003|Overall Study|Adverse Event|4|||
143103819|NCT00789698|515920378|FG000|Overall Study|Lost to Follow-up|5|||
143103820|NCT00789698|515920379|FG001|Overall Study|Lost to Follow-up|5|||
143103821|NCT00789698|515920380|FG002|Overall Study|Lost to Follow-up|2|||
143103822|NCT00789698|515920381|FG003|Overall Study|Lost to Follow-up|9|||
143103823|NCT00789698|515920378|FG000|Overall Study|Protocol Violation|6|||
143103824|NCT00789698|515920379|FG001|Overall Study|Protocol Violation|1|||
143103825|NCT00789698|515920380|FG002|Overall Study|Protocol Violation|2|||
143103826|NCT00789698|515920381|FG003|Overall Study|Protocol Violation|1|||
143103827|NCT00789698|515920378|FG000|Overall Study|Withdrawal by Subject|14|||
143103828|NCT00789698|515920379|FG001|Overall Study|Withdrawal by Subject|15|||
143103829|NCT00789698|515920380|FG002|Overall Study|Withdrawal by Subject|12|||
143103830|NCT00789698|515920381|FG003|Overall Study|Withdrawal by Subject|19|||
143103831|NCT00789698|515920378|FG000|Overall Study|Administrative|0|||
143103832|NCT00789698|515920379|FG001|Overall Study|Administrative|3|||
143103833|NCT00789698|515920380|FG002|Overall Study|Administrative|3|||
143103834|NCT00789698|515920381|FG003|Overall Study|Administrative|1|||
143103835|NCT01870973|515920382|FG000|Overall Study|Lost to Follow-up|10|||
143103836|NCT01870973|515920383|FG001|Overall Study|Lost to Follow-up|3|||
143103837|NCT03232931|515921570|FG000|Overall Study|Physician Decision|1|||
143103838|NCT03232931|515921571|FG001|Overall Study|Physician Decision|1|||
143103839|NCT03232931|515921570|FG000|Overall Study|Withdrawal by Subject|6|||
143103840|NCT03232931|515921571|FG001|Overall Study|Withdrawal by Subject|0|||
143103841|NCT03232931|515921570|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
143178070|NCT03962855|516199897|FG001|Overall Study|Physician Decision|2|||
143103842|NCT03232931|515921571|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
143103843|NCT03232931|515921570|FG000|Overall Study|Parent did not record voice|1|||
143103844|NCT03232931|515921571|FG001|Overall Study|Parent did not record voice|2|||
143103845|NCT03232931|515921570|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
143103846|NCT03232931|515921571|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
143367873|NCT01311713|516889458|FG001|Overall Study|Withdrawal by Subject|1|||
143367874|NCT01311713|516889459|FG002|Overall Study|Withdrawal by Subject|1|||
143367875|NCT01311713|516889460|FG003|Overall Study|Withdrawal by Subject|0|||
143367876|NCT01311713|516889461|FG004|Overall Study|Withdrawal by Subject|0|||
143103847|NCT04925557|515921572|FG000|Overall Study|Study closed|5|||
143103848|NCT04925557|515921573|FG001|Overall Study|Study closed|3|||
143103849|NCT05488470|515921574|FG000|Overall Study|Physician Decision|2|||
143103850|NCT05488470|515921574|FG000|Overall Study|Withdrawal by Subject|1|||
143103851|NCT05488470|515921574|FG000|Overall Study|Death|1|||
143103852|NCT00068393|515921575|FG000|Overall Study|Adverse Event|2|||
143103853|NCT00068393|515921575|FG000|Overall Study|Death|3|||
143103854|NCT00068393|515921575|FG000|Overall Study|Withdrawal by Subject|3|||
143103855|NCT00068393|515921575|FG000|Overall Study|Alternative treatment|1|||
143103856|NCT00068393|515921575|FG000|Overall Study|Quality of life worsening|1|||
143103857|NCT01068730|515921583|FG000|Period 3|Personal reason|1|||
143103858|NCT01068730|515921584|FG001|Period 3|Personal reason|0|||
143103859|NCT01068730|515921585|FG002|Period 3|Personal reason|0|||
143103860|NCT01068730|515921586|FG003|Period 3|Personal reason|0|||
143103861|NCT01068730|515921583|FG000|Period 4|Family emergency|0|||
143103862|NCT01068730|515921584|FG001|Period 4|Family emergency|1|||
143103863|NCT01068730|515921585|FG002|Period 4|Family emergency|0|||
143103864|NCT01068730|515921586|FG003|Period 4|Family emergency|0|||
143103865|NCT03260244|515921588|FG000|Overall Study|Death|19|||
143103866|NCT03260244|515921588|FG000|Overall Study|Lost to Follow-up|60|||
143103867|NCT03260244|515921588|FG000|Overall Study|Withdrawal by Subject|48|||
143103868|NCT03260244|515921588|FG000|Overall Study|Procedure Not Performed|21|||
143103869|NCT03260244|515921588|FG000|Overall Study|Enrollment Criteria Not Met|31|||
143103870|NCT03260244|515921588|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
143103871|NCT03260244|515921588|FG000|Overall Study|Subject Noncompliance|6|||
143103872|NCT03260244|515921588|FG000|Overall Study|No inducible Arrhythmia|2|||
143103873|NCT03260244|515921588|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
143103874|NCT03260244|515921588|FG000|Overall Study|Screen Failure|2|||
143103875|NCT03260244|515921588|FG000|Overall Study|Treated Off Label|69|||
143103876|NCT03260244|515921588|FG000|Overall Study|No Radiofrequency Ablation|14|||
143103877|NCT02285166|515921598|FG000|Overall Study|Case Report Forms Uncollected|564|||
143103878|NCT02285166|515921598|FG000|Overall Study|Protocol Deviation|402|||
143103879|NCT01089608|515921599|FG000|Overall Study|Adverse Event|0|||
143103880|NCT01089608|515921600|FG001|Overall Study|Adverse Event|4|||
143103881|NCT01089608|515921599|FG000|Overall Study|Lost to Follow-up|0|||
143103882|NCT01089608|515921600|FG001|Overall Study|Lost to Follow-up|2|||
143103883|NCT00384839|515921603|FG000|Overall Study|Adverse Event|4|||
143103884|NCT00384839|515921603|FG000|Overall Study|Investigator Request|1|||
143103885|NCT00384839|515921603|FG000|Overall Study|Patient Request|1|||
143103886|NCT00384839|515921603|FG000|Overall Study|Ineligible|2|||
143103887|NCT01421225|515921604|FG000|Overall Study|Withdrawal by Subject|0|||
143103888|NCT01421225|515921605|FG001|Overall Study|Withdrawal by Subject|1|||
143103889|NCT02649439|515921606|FG000|Overall Study|Switched to alternative treatment|6|||
143103890|NCT02649439|515921607|FG001|Overall Study|Switched to alternative treatment|4|||
143103891|NCT02649439|515921606|FG000|Overall Study|Patient decision|1|||
143103892|NCT02649439|515921607|FG001|Overall Study|Patient decision|0|||
143103893|NCT02649439|515921606|FG000|Overall Study|Patient going out of country|1|||
143103894|NCT02649439|515921607|FG001|Overall Study|Patient going out of country|0|||
143103895|NCT02649439|515921606|FG000|Overall Study|To start finasteride|1|||
143103896|NCT02649439|515921607|FG001|Overall Study|To start finasteride|0|||
143103897|NCT02649439|515921606|FG000|Overall Study|Physician Decision|1|||
143103898|NCT02649439|515921607|FG001|Overall Study|Physician Decision|0|||
143103899|NCT02649439|515921606|FG000|Overall Study|Disease progression on study|12|||
143103900|NCT02649439|515921607|FG001|Overall Study|Disease progression on study|13|||
143103901|NCT02649439|515921606|FG000|Overall Study|Refused further treatment|1|||
143103902|NCT02649439|515921607|FG001|Overall Study|Refused further treatment|0|||
143103903|NCT02649439|515921606|FG000|Overall Study|Refused further follow up|2|||
143103904|NCT02649439|515921607|FG001|Overall Study|Refused further follow up|7|||
143103905|NCT02649439|515921606|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
143103906|NCT02649439|515921607|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
143103907|NCT02649439|515921606|FG000|Overall Study|No treatment, per protocol|1|||
143103908|NCT02649439|515921607|FG001|Overall Study|No treatment, per protocol|0|||
143103909|NCT02649439|515921606|FG000|Overall Study|PSA DT makes ineligible|0|||
143103910|NCT02649439|515921607|FG001|Overall Study|PSA DT makes ineligible|1|||
143103911|NCT02649439|515921606|FG000|Overall Study|Rising PSA No Mets|0|||
143103912|NCT02649439|515921607|FG001|Overall Study|Rising PSA No Mets|1|||
143103913|NCT02649439|515921606|FG000|Overall Study|Rising PSA|0|||
143103914|NCT02649439|515921607|FG001|Overall Study|Rising PSA|1|||
143103915|NCT02649439|515921606|FG000|Overall Study|Signed follow up protocol|0|||
143103916|NCT02649439|515921607|FG001|Overall Study|Signed follow up protocol|1|||
143103917|NCT02257489|515921612|FG000|Overall Study|Withdrawal by Subject|0|||
143103918|NCT02257489|515921613|FG001|Overall Study|Withdrawal by Subject|0|||
143103919|NCT02257489|515921614|FG002|Overall Study|Withdrawal by Subject|0|||
143103920|NCT02257489|515921615|FG003|Overall Study|Withdrawal by Subject|1|||
143103921|NCT02257489|515921616|FG004|Overall Study|Withdrawal by Subject|0|||
143103922|NCT02257489|515921617|FG005|Overall Study|Withdrawal by Subject|0|||
143103923|NCT02257489|515921618|FG006|Overall Study|Withdrawal by Subject|0|||
143103924|NCT02257489|515921619|FG007|Overall Study|Withdrawal by Subject|0|||
143103925|NCT02257489|515921620|FG008|Overall Study|Withdrawal by Subject|0|||
143103926|NCT02920008|515921621|FG000|Overall Study|Death|117|||
143103927|NCT02920008|515921622|FG001|Overall Study|Death|127|||
143103928|NCT02920008|515921621|FG000|Overall Study|Withdrawal by Subject|3|||
143103929|NCT02920008|515921622|FG001|Overall Study|Withdrawal by Subject|6|||
143103930|NCT02920008|515921621|FG000|Overall Study|Lost to Follow-up|0|||
143103931|NCT02920008|515921622|FG001|Overall Study|Lost to Follow-up|1|||
143103932|NCT01862250|515921623|FG000|Overall Study|Adverse Event|4|||
143103933|NCT01028014|515921625|FG000|Overall Study|Lost to Follow-up|1|||
143103934|NCT01028014|515921626|FG001|Overall Study|Lost to Follow-up|2|||
143103935|NCT01028014|515921627|FG002|Overall Study|Lost to Follow-up|0|||
143103936|NCT01028014|515921628|FG003|Overall Study|Lost to Follow-up|1|||
143103937|NCT01028014|515921629|FG004|Overall Study|Lost to Follow-up|1|||
143178071|NCT04389866|516199899|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
143178072|NCT04389866|516199900|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
143178073|NCT00600067|516199903|FG000|Overall Study|Adverse Event|0|||
143178074|NCT00600067|516199904|FG001|Overall Study|Adverse Event|1|||
143178075|NCT00600067|516199903|FG000|Overall Study|Lost to Follow-up|2|||
143178076|NCT00600067|516199904|FG001|Overall Study|Lost to Follow-up|3|||
143178077|NCT00600067|516199903|FG000|Overall Study|protocol non-compliance|0|||
143178078|NCT00600067|516199904|FG001|Overall Study|protocol non-compliance|3|||
143178079|NCT00600067|516199903|FG000|Overall Study|Lack of Efficacy|1|||
143178080|NCT00600067|516199904|FG001|Overall Study|Lack of Efficacy|0|||
143178081|NCT00251693|516199909|FG000|Overall Study|Adverse Event|17|||
143178082|NCT00251693|516199910|FG001|Overall Study|Adverse Event|9|||
143178083|NCT00251693|516199911|FG002|Overall Study|Adverse Event|9|||
143178084|NCT00251693|516199909|FG000|Overall Study|Protocol Violation|2|||
143178085|NCT00251693|516199910|FG001|Overall Study|Protocol Violation|0|||
143178086|NCT00251693|516199911|FG002|Overall Study|Protocol Violation|2|||
143178087|NCT00251693|516199909|FG000|Overall Study|Lost to Follow-up|12|||
143178088|NCT00251693|516199910|FG001|Overall Study|Lost to Follow-up|7|||
143178089|NCT00251693|516199911|FG002|Overall Study|Lost to Follow-up|8|||
143178090|NCT00251693|516199909|FG000|Overall Study|Withdrawal by Subject|11|||
143178091|NCT00251693|516199910|FG001|Overall Study|Withdrawal by Subject|17|||
143178092|NCT00251693|516199911|FG002|Overall Study|Withdrawal by Subject|14|||
143178093|NCT00251693|516199909|FG000|Overall Study|Lack of Efficacy|0|||
143178094|NCT00251693|516199910|FG001|Overall Study|Lack of Efficacy|1|||
143178095|NCT00251693|516199911|FG002|Overall Study|Lack of Efficacy|0|||
143178096|NCT00251693|516199909|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
143103938|NCT01028014|515921630|FG005|Overall Study|Lost to Follow-up|2|||
143103939|NCT02423343|515921631|FG000|Overall Study|Withdrawal by Subject|0|||
143103940|NCT02423343|515921632|FG001|Overall Study|Withdrawal by Subject|1|||
143103941|NCT02423343|515921633|FG002|Overall Study|Withdrawal by Subject|0|||
143103942|NCT02423343|515921634|FG003|Overall Study|Withdrawal by Subject|0|||
143178097|NCT00251693|516199910|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
143178098|NCT00251693|516199911|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
143103943|NCT02423343|515921635|FG004|Overall Study|Withdrawal by Subject|0|||
143103944|NCT02423343|515921636|FG005|Overall Study|Withdrawal by Subject|0|||
143103945|NCT02423343|515921631|FG000|Overall Study|Progressive Disease|0|||
143103946|NCT02423343|515921632|FG001|Overall Study|Progressive Disease|0|||
143103947|NCT02423343|515921633|FG002|Overall Study|Progressive Disease|0|||
143103948|NCT02423343|515921634|FG003|Overall Study|Progressive Disease|0|||
143103949|NCT02423343|515921635|FG004|Overall Study|Progressive Disease|2|||
143103950|NCT02423343|515921636|FG005|Overall Study|Progressive Disease|0|||
143103951|NCT02423343|515921631|FG000|Overall Study|Adverse Event|0|||
143103952|NCT02423343|515921632|FG001|Overall Study|Adverse Event|0|||
143103953|NCT02423343|515921633|FG002|Overall Study|Adverse Event|0|||
143103954|NCT02423343|515921634|FG003|Overall Study|Adverse Event|0|||
143103955|NCT02423343|515921635|FG004|Overall Study|Adverse Event|2|||
143103956|NCT02423343|515921636|FG005|Overall Study|Adverse Event|0|||
143103957|NCT02423343|515921631|FG000|Overall Study|Death|0|||
143103958|NCT02423343|515921632|FG001|Overall Study|Death|0|||
143103959|NCT02423343|515921633|FG002|Overall Study|Death|0|||
143103960|NCT02423343|515921634|FG003|Overall Study|Death|0|||
143103961|NCT02423343|515921635|FG004|Overall Study|Death|1|||
143103962|NCT02423343|515921636|FG005|Overall Study|Death|0|||
143103963|NCT01127451|515921637|FG000|Overall Study|Other|2|||
143103964|NCT01127451|515921638|FG001|Overall Study|Other|1|||
143103965|NCT01127451|515921637|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
143103966|NCT01127451|515921638|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
143103967|NCT01127451|515921637|FG000|Overall Study|Death|22|||
143103968|NCT01127451|515921638|FG001|Overall Study|Death|17|||
143103969|NCT01127451|515921637|FG000|Overall Study|Lost to Follow-up|3|||
143103970|NCT01127451|515921638|FG001|Overall Study|Lost to Follow-up|0|||
143103971|NCT01127451|515921637|FG000|Overall Study|Administrative Reason by Sponsor|2|||
143103972|NCT01127451|515921638|FG001|Overall Study|Administrative Reason by Sponsor|2|||
143103973|NCT00090493|515921639|FG000|Overall Study|Physician Decision|2|||
143103974|NCT02111577|515921642|FG000|Overall Study|Protocol Violation|2|||
143103975|NCT02111577|515921643|FG001|Overall Study|Protocol Violation|0|||
143103976|NCT02111577|515921642|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
143103977|NCT02111577|515921643|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
143103978|NCT02111577|515921642|FG000|Overall Study|Failure to produce study treatment|6|||
143103979|NCT02111577|515921643|FG001|Overall Study|Failure to produce study treatment|0|||
143103980|NCT02111577|515921642|FG000|Overall Study|Death|518|||
143103981|NCT02111577|515921643|FG001|Overall Study|Death|254|||
143103982|NCT02111577|515921642|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
143103983|NCT02111577|515921643|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
143103984|NCT02111577|515921642|FG000|Overall Study|Adverse Event|1|||
143103985|NCT02111577|515921643|FG001|Overall Study|Adverse Event|1|||
143103986|NCT02111577|515921642|FG000|Overall Study|Withdrawal by Subject|51|||
143103987|NCT02111577|515921643|FG001|Overall Study|Withdrawal by Subject|23|||
143103988|NCT02111577|515921642|FG000|Overall Study|Disease progression|0|||
143103989|NCT02111577|515921643|FG001|Overall Study|Disease progression|1|||
143103990|NCT02111577|515921642|FG000|Overall Study|Lost to Follow-up|19|||
143103991|NCT02111577|515921643|FG001|Overall Study|Lost to Follow-up|10|||
143103992|NCT00729157|515921644|FG000|Overall Study|Withdrawal by Subject|1|||
143103993|NCT00886743|515921645|FG000|Overall Study|Adverse Event|3|||
143103994|NCT00886743|515921645|FG000|Overall Study|Other|1|||
143103995|NCT02217410|515921646|FG000|Overall Study|Graft Loss|0|||
143103996|NCT02217410|515921647|FG001|Overall Study|Graft Loss|0|||
143103997|NCT02217410|515921648|FG002|Overall Study|Graft Loss|2|||
143103998|NCT02217410|515921646|FG000|Overall Study|Withdrawal by Subject|0|||
143103999|NCT02217410|515921647|FG001|Overall Study|Withdrawal by Subject|0|||
143104000|NCT02217410|515921648|FG002|Overall Study|Withdrawal by Subject|2|||
143104001|NCT02217410|515921646|FG000|Overall Study|Lost to Follow-up|0|||
143104002|NCT02217410|515921647|FG001|Overall Study|Lost to Follow-up|0|||
143104003|NCT02217410|515921648|FG002|Overall Study|Lost to Follow-up|1|||
143104004|NCT02217410|515921646|FG000|Overall Study|Lack of Efficacy|0|||
143104005|NCT02217410|515921647|FG001|Overall Study|Lack of Efficacy|1|||
143104006|NCT02217410|515921648|FG002|Overall Study|Lack of Efficacy|0|||
143104007|NCT02217410|515921646|FG000|Overall Study|Physician Decision|1|||
143104008|NCT02217410|515921647|FG001|Overall Study|Physician Decision|3|||
143104009|NCT02217410|515921648|FG002|Overall Study|Physician Decision|0|||
143178099|NCT00251693|516199909|FG000|Overall Study|Noncompliant|0|||
143104010|NCT02429778|515921650|FG000|Overall Study|Lost to Follow-up|2|||
143104011|NCT02429778|515921651|FG001|Overall Study|Lost to Follow-up|0|||
143104012|NCT02429778|515921650|FG000|Overall Study|Withdrawal by Subject|5|||
143104013|NCT02429778|515921651|FG001|Overall Study|Withdrawal by Subject|0|||
143104014|NCT02475265|515921652|FG000|Overall Study|Physician Decision|1|||
143178100|NCT00251693|516199910|FG001|Overall Study|Noncompliant|0|||
143104015|NCT02475265|515921652|FG000|Overall Study|Withdrawal by Subject|2|||
143104016|NCT00839527|515921655|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
143104017|NCT00839527|515921656|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
143104018|NCT00839527|515921657|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
143178101|NCT00251693|516199911|FG002|Overall Study|Noncompliant|2|||
143253862|NCT01122264|516483894|FG002|Overall Study|Protocol Violation|9|||
143253863|NCT01122264|516483892|FG000|Overall Study|Withdrawal by Subject|6|||
143253864|NCT01122264|516483893|FG001|Overall Study|Withdrawal by Subject|6|||
143253865|NCT01122264|516483894|FG002|Overall Study|Withdrawal by Subject|16|||
143104019|NCT00839527|515921655|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
143104020|NCT00839527|515921656|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
143104021|NCT00839527|515921657|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
143104022|NCT00839527|515921655|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
143104023|NCT00839527|515921656|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
143104024|NCT00839527|515921657|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
143104025|NCT00839527|515921655|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
143104026|NCT00839527|515921656|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
143104027|NCT00839527|515921657|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
143104028|NCT00839527|515921655|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
143104029|NCT00839527|515921656|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
143104030|NCT00839527|515921657|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
143104031|NCT00839527|515921655|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
143104032|NCT00839527|515921656|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
143104033|NCT00839527|515921657|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
143104034|NCT00839527|515921655|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
143104035|NCT00839527|515921656|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
143104036|NCT00839527|515921657|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
143104037|NCT00839527|515921655|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
143104038|NCT00839527|515921656|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
143104039|NCT00839527|515921657|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
143104040|NCT00839527|515921655|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
143104041|NCT00839527|515921656|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
143104042|NCT00839527|515921657|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
143178102|NCT00251693|516199909|FG000|Overall Study|Possible Barrett's esophagus|3|||
143178103|NCT00251693|516199910|FG001|Overall Study|Possible Barrett's esophagus|5|||
143178104|NCT00251693|516199911|FG002|Overall Study|Possible Barrett's esophagus|2|||
143178105|NCT00251693|516199909|FG000|Overall Study|Subject request/subject unavailable|1|||
143178106|NCT00251693|516199910|FG001|Overall Study|Subject request/subject unavailable|2|||
143178107|NCT00251693|516199911|FG002|Overall Study|Subject request/subject unavailable|0|||
143178108|NCT00251693|516199909|FG000|Overall Study|Abnormal laboratory findings|0|||
143178109|NCT00251693|516199910|FG001|Overall Study|Abnormal laboratory findings|0|||
143178110|NCT00251693|516199911|FG002|Overall Study|Abnormal laboratory findings|1|||
143178111|NCT01030822|516199912|FG000|Overall Study|Moved/migrated from study area|6|||
143178112|NCT01030822|516199913|FG001|Overall Study|Moved/migrated from study area|7|||
143178113|NCT01030822|516199914|FG002|Overall Study|Moved/migrated from study area|3|||
143178114|NCT01030822|516199912|FG000|Overall Study|Withdrawal by Subject|16|||
143178115|NCT01030822|516199913|FG001|Overall Study|Withdrawal by Subject|13|||
143178116|NCT01030822|516199914|FG002|Overall Study|Withdrawal by Subject|16|||
143178117|NCT01030822|516199912|FG000|Overall Study|Lost to Follow-up|9|||
143178118|NCT01030822|516199913|FG001|Overall Study|Lost to Follow-up|4|||
143178119|NCT01030822|516199914|FG002|Overall Study|Lost to Follow-up|7|||
143178120|NCT00401843|516199915|FG000|Overall Study|Achieved Complete Response|1|||
143178121|NCT00401843|516199916|FG001|Overall Study|Achieved Complete Response|5|||
143178122|NCT00401843|516199917|FG002|Overall Study|Achieved Complete Response|11|||
143178123|NCT00401843|516199915|FG000|Overall Study|Adverse Event|7|||
143178124|NCT00401843|516199916|FG001|Overall Study|Adverse Event|26|||
143178125|NCT00401843|516199917|FG002|Overall Study|Adverse Event|27|||
143178126|NCT00401843|516199915|FG000|Overall Study|Death|0|||
143178127|NCT00401843|516199916|FG001|Overall Study|Death|8|||
143178128|NCT00401843|516199917|FG002|Overall Study|Death|10|||
143178129|NCT00401843|516199915|FG000|Overall Study|Disease progression|10|||
143178130|NCT00401843|516199916|FG001|Overall Study|Disease progression|60|||
143178131|NCT00401843|516199917|FG002|Overall Study|Disease progression|49|||
143178132|NCT00401843|516199915|FG000|Overall Study|End of Study|1|||
143178133|NCT00401843|516199916|FG001|Overall Study|End of Study|1|||
143178134|NCT00401843|516199917|FG002|Overall Study|End of Study|2|||
143178135|NCT00401843|516199915|FG000|Overall Study|Lost to Follow-up|0|||
143253866|NCT01122264|516483892|FG000|Overall Study|Physician Decision|3|||
143253867|NCT01122264|516483893|FG001|Overall Study|Physician Decision|1|||
143104043|NCT00839527|515921655|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
143178136|NCT00401843|516199916|FG001|Overall Study|Lost to Follow-up|0|||
143178137|NCT00401843|516199917|FG002|Overall Study|Lost to Follow-up|2|||
143178138|NCT00401843|516199915|FG000|Overall Study|Other Unspecified|0|||
143178139|NCT00401843|516199916|FG001|Overall Study|Other Unspecified|3|||
143178140|NCT00401843|516199917|FG002|Overall Study|Other Unspecified|5|||
143178141|NCT00401843|516199915|FG000|Overall Study|Physician Decision|0|||
143178142|NCT00401843|516199916|FG001|Overall Study|Physician Decision|16|||
143253868|NCT01122264|516483894|FG002|Overall Study|Physician Decision|1|||
143253869|NCT01122264|516483892|FG000|Overall Study|Lack of Efficacy|3|||
143253870|NCT01122264|516483893|FG001|Overall Study|Lack of Efficacy|1|||
143253871|NCT01122264|516483894|FG002|Overall Study|Lack of Efficacy|1|||
143253872|NCT04585009|516483895|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
143253873|NCT04585009|516483896|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
143253874|NCT04585009|516483897|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
143253875|NCT04585009|516483898|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
143253876|NCT04585009|516483899|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
143253877|NCT04585009|516483900|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
143253878|NCT04585009|516483901|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
143253879|NCT04585009|516483902|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
143253880|NCT04585009|516483903|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
143253881|NCT04585009|516483904|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
143253882|NCT04585009|516483905|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
143253883|NCT04585009|516483906|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
143253884|NCT04585009|516483895|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
143253885|NCT04585009|516483896|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
143253886|NCT04585009|516483897|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
143253887|NCT04585009|516483898|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
143253888|NCT04585009|516483899|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
143253889|NCT04585009|516483900|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
143253890|NCT04585009|516483901|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
143253891|NCT04585009|516483902|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
143253892|NCT04585009|516483903|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
143253893|NCT04585009|516483904|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
143253894|NCT04585009|516483905|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
143253895|NCT04585009|516483906|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
143253896|NCT04585009|516483895|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
143253897|NCT04585009|516483896|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
143253898|NCT04585009|516483897|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
143253899|NCT04585009|516483898|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
143253900|NCT04585009|516483899|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
143253901|NCT04585009|516483900|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
143253902|NCT04585009|516483901|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
143253903|NCT04585009|516483902|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
143253904|NCT04585009|516483903|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
143253905|NCT04585009|516483904|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
143253906|NCT04585009|516483905|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
143253907|NCT04585009|516483906|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
143253908|NCT04585009|516483895|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
143253909|NCT04585009|516483896|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
143253910|NCT04585009|516483897|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
143104044|NCT00839527|515921656|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
143253911|NCT04585009|516483898|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
143253912|NCT04585009|516483899|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
143253913|NCT04585009|516483900|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
143104045|NCT00839527|515921657|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
143104046|NCT00839527|515921655|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
143104047|NCT00839527|515921656|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
143104048|NCT00839527|515921657|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
143104049|NCT00839527|515921655|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
143104050|NCT00839527|515921656|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
143104051|NCT00839527|515921657|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
143104052|NCT00839527|515921655|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
143104053|NCT00839527|515921656|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
143104054|NCT00839527|515921657|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
143104055|NCT00839527|515921655|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
143104056|NCT00839527|515921656|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
143104057|NCT00839527|515921657|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
143253914|NCT04585009|516483901|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
143104058|NCT00839527|515921655|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
143104059|NCT00839527|515921656|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
143104060|NCT00839527|515921657|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
143104061|NCT00839527|515921655|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
143104062|NCT00839527|515921656|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
143104063|NCT00839527|515921657|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
143104064|NCT00839527|515921655|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
143104065|NCT00839527|515921656|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
143104066|NCT00839527|515921657|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
143104067|NCT00839527|515921655|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
143104068|NCT00839527|515921656|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
143104069|NCT00839527|515921657|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
143104070|NCT00839527|515921655|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
143104071|NCT00839527|515921656|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
143104072|NCT00839527|515921657|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
143104073|NCT00839527|515921655|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
143104074|NCT00839527|515921656|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
143104075|NCT00839527|515921657|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
143104076|NCT00839527|515921655|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
143104077|NCT00839527|515921656|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
143104078|NCT00839527|515921657|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
143104079|NCT00839527|515921655|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
143104080|NCT00839527|515921656|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
143104081|NCT00839527|515921657|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
143104082|NCT00839527|515921655|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
143104083|NCT00839527|515921656|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
143104084|NCT00839527|515921657|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
143104085|NCT00839527|515921655|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
143178143|NCT00401843|516199917|FG002|Overall Study|Physician Decision|10|||
143178144|NCT00401843|516199915|FG000|Overall Study|Protocol Violation|0|||
143178145|NCT00401843|516199916|FG001|Overall Study|Protocol Violation|0|||
143178146|NCT00401843|516199917|FG002|Overall Study|Protocol Violation|1|||
143178147|NCT00401843|516199915|FG000|Overall Study|Withdrawal by Subject|1|||
143178148|NCT00401843|516199916|FG001|Overall Study|Withdrawal by Subject|5|||
143178149|NCT00401843|516199917|FG002|Overall Study|Withdrawal by Subject|5|||
143178150|NCT00401843|516199915|FG000|Overall Study|Withdrawal of consent to study agent|1|||
143178151|NCT00401843|516199916|FG001|Overall Study|Withdrawal of consent to study agent|15|||
143178152|NCT00401843|516199917|FG002|Overall Study|Withdrawal of consent to study agent|17|||
143178153|NCT00401843|516199915|FG000|Overall Study|Randomized but not Treated|0|||
143178154|NCT00401843|516199916|FG001|Overall Study|Randomized but not Treated|2|||
143178155|NCT00401843|516199917|FG002|Overall Study|Randomized but not Treated|3|||
143178156|NCT00401843|516199915|FG000|Overall Study|Received incorrect treatment|0|||
143178157|NCT00401843|516199916|FG001|Overall Study|Received incorrect treatment|3|||
143178158|NCT00401843|516199917|FG002|Overall Study|Received incorrect treatment|0|||
143178159|NCT01932788|516199930|FG000|Overall Study|Protocol Violation|18|||
143178160|NCT01932788|516199931|FG001|Overall Study|Protocol Violation|0|||
143178161|NCT01932788|516199930|FG000|Overall Study|Lost to Follow-up|18|||
143178162|NCT01932788|516199931|FG001|Overall Study|Lost to Follow-up|46|||
143178163|NCT01932788|516199930|FG000|Overall Study|Lack of Efficacy|2|||
143178164|NCT01932788|516199931|FG001|Overall Study|Lack of Efficacy|0|||
143178165|NCT01932788|516199930|FG000|Overall Study|Withdrawal by Subject|0|||
143178166|NCT01932788|516199931|FG001|Overall Study|Withdrawal by Subject|5|||
143178167|NCT00833027|516199932|FG000|Overall Study|Adverse Event|33|||
143178168|NCT00833027|516199932|FG000|Overall Study|Death|1|||
143178169|NCT00833027|516199932|FG000|Overall Study|Lack of Efficacy|12|||
143178170|NCT00833027|516199932|FG000|Overall Study|Lost to Follow-up|24|||
143178171|NCT00833027|516199932|FG000|Overall Study|Protocol Violation|115|||
143178172|NCT00833027|516199932|FG000|Overall Study|Withdrawal by Subject|16|||
143178173|NCT00833027|516199932|FG000|Overall Study|Missing|10|||
143178174|NCT01342094|516199935|FG000|Overall Study|Adverse Event|5|||
143178175|NCT01342094|516199936|FG001|Overall Study|Adverse Event|0|||
143178176|NCT01342094|516199935|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
143178177|NCT01342094|516199936|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
143178178|NCT01342094|516199935|FG000|Overall Study|Withdrawal by Subject|0|||
143178179|NCT01342094|516199936|FG001|Overall Study|Withdrawal by Subject|2|||
143178180|NCT03069716|516199939|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
143178181|NCT03069716|516199940|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
143178182|NCT03069716|516199941|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
143178183|NCT03069716|516199939|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
143104086|NCT00839527|515921656|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
143104087|NCT00839527|515921657|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
143104088|NCT00828568|515921658|FG000|Randomized|Withdrawal by Subject|1|||
143104089|NCT00828568|515921659|FG001|Randomized|Withdrawal by Subject|0|||
143104090|NCT00828568|515921660|FG002|Randomized|Withdrawal by Subject|2|||
143104091|NCT00828568|515921658|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
143104092|NCT00828568|515921659|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
143104093|NCT00828568|515921660|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
143104094|NCT00828568|515921658|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
143104095|NCT00828568|515921659|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
143104096|NCT00828568|515921660|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
143104097|NCT00828568|515921658|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
143104098|NCT00828568|515921659|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
143104099|NCT00828568|515921660|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
143104100|NCT00828568|515921658|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
143104101|NCT00828568|515921659|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
143104102|NCT00828568|515921660|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
143104103|NCT02821754|515921661|FG000|Overall Study|Procedure not required prior to amendment change|13|||
143104104|NCT02821754|515921662|FG001|Overall Study|Procedure not required prior to amendment change|11|||
143104105|NCT02821754|515921663|FG002|Overall Study|Procedure not required prior to amendment change|0|||
143104106|NCT02821754|515921661|FG000|Overall Study|Participant's Clinical status|2|||
143104107|NCT02821754|515921662|FG001|Overall Study|Participant's Clinical status|0|||
143104108|NCT02821754|515921663|FG002|Overall Study|Participant's Clinical status|0|||
143104109|NCT02821754|515921661|FG000|Overall Study|Participant removed for noncompliance|1|||
143104110|NCT02821754|515921662|FG001|Overall Study|Participant removed for noncompliance|0|||
143104111|NCT02821754|515921663|FG002|Overall Study|Participant removed for noncompliance|0|||
143104112|NCT02821754|515921661|FG000|Overall Study|Drug not available.|0|||
143104113|NCT02821754|515921662|FG001|Overall Study|Drug not available.|0|||
143104114|NCT02821754|515921663|FG002|Overall Study|Drug not available.|1|||
143104115|NCT02821754|515921661|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
143178184|NCT03069716|516199940|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
143178185|NCT03069716|516199941|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
143178186|NCT03069716|516199939|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
143178187|NCT03069716|516199940|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
143178188|NCT03069716|516199941|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
143178189|NCT03069716|516199939|FG000|Randomized Treatment|Withdrawal by Subject|0|||
143178190|NCT03069716|516199940|FG001|Randomized Treatment|Withdrawal by Subject|2|||
143178191|NCT03069716|516199941|FG002|Randomized Treatment|Withdrawal by Subject|0|||
143178192|NCT05653700|516199942|FG000|Overall Study|Non Responders|9|||
143178193|NCT05653700|516199943|FG001|Overall Study|Non Responders|0|||
143178194|NCT01985022|516199944|FG000|Overall Study|Lost to Follow-up|0|||
143178195|NCT01985022|516199945|FG001|Overall Study|Lost to Follow-up|1|||
143178196|NCT01985022|516199944|FG000|Overall Study|Protocol Violation|0|||
143178197|NCT01985022|516199945|FG001|Overall Study|Protocol Violation|1|||
143178198|NCT01985022|516199944|FG000|Overall Study|Withdrawal by Subject|4|||
143178199|NCT01985022|516199945|FG001|Overall Study|Withdrawal by Subject|1|||
143178200|NCT04790279|516201496|FG000|Overall Study|Did not meet medication start criteria|27|||
143178201|NCT04790279|516201497|FG001|Overall Study|Did not meet medication start criteria|15|||
143178202|NCT04790279|516201496|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
143178203|NCT04790279|516201497|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
143178204|NCT04790279|516201496|FG000|Overall Study|Protocol Violation|8|||
143178205|NCT04790279|516201497|FG001|Overall Study|Protocol Violation|3|||
143178206|NCT04790279|516201496|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
143178207|NCT04790279|516201497|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
143178208|NCT04472650|516201510|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
143178209|NCT04472650|516201511|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
143178210|NCT02628444|516201514|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
143178211|NCT02628444|516201515|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
143178212|NCT02628444|516201516|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
143178213|NCT02628444|516201517|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
143178214|NCT02628444|516201518|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
143178215|NCT02628444|516201519|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
143178216|NCT02628444|516201520|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
143178217|NCT02628444|516201521|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
143178218|NCT02628444|516201522|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
143104116|NCT02821754|515921662|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
143253915|NCT04585009|516483902|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
143253916|NCT04585009|516483903|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
143104117|NCT02821754|515921663|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
143104118|NCT04185220|515921668|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
143104119|NCT04185220|515921669|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
143104120|NCT04185220|515921668|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
143104121|NCT04185220|515921669|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
143104122|NCT02887183|515921674|FG000|Overall Study|Adverse Event|44|||
143104123|NCT02887183|515921674|FG000|Overall Study|Death|30|||
143104124|NCT02887183|515921674|FG000|Overall Study|Pregnancy|1|||
143104125|NCT02887183|515921674|FG000|Overall Study|Protocol Violation|6|||
143104126|NCT02887183|515921674|FG000|Overall Study|Technical Problems|2|||
143104127|NCT02887183|515921674|FG000|Overall Study|Lost to Follow-up|13|||
143104128|NCT02887183|515921674|FG000|Overall Study|Physician Decision|10|||
143104129|NCT02887183|515921674|FG000|Overall Study|Withdrawal by Subject|35|||
143104130|NCT01031680|515921675|FG000|Overall Study|Adverse Event|8|||
143104131|NCT01031680|515921676|FG001|Overall Study|Adverse Event|3|||
143104132|NCT01031680|515921675|FG000|Overall Study|Lost to Follow-up|2|||
143104133|NCT01031680|515921676|FG001|Overall Study|Lost to Follow-up|10|||
143104134|NCT01031680|515921675|FG000|Overall Study|Withdrawal by Subject|12|||
143104135|NCT01031680|515921676|FG001|Overall Study|Withdrawal by Subject|16|||
143104136|NCT01031680|515921675|FG000|Overall Study|Death|2|||
143104137|NCT01031680|515921676|FG001|Overall Study|Death|1|||
143104138|NCT01031680|515921675|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
143104139|NCT01031680|515921676|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
143104140|NCT01031680|515921675|FG000|Overall Study|Poor/Non-compliance|5|||
143104141|NCT01031680|515921676|FG001|Overall Study|Poor/Non-compliance|6|||
143104142|NCT01031680|515921675|FG000|Overall Study|Safety|1|||
143104143|NCT01031680|515921676|FG001|Overall Study|Safety|0|||
143104144|NCT01031680|515921675|FG000|Overall Study|Incorrect Enrolment|1|||
143104145|NCT01031680|515921676|FG001|Overall Study|Incorrect Enrolment|2|||
143104146|NCT01031680|515921675|FG000|Overall Study|Administrative Reason by Sponsor|0|||
143104147|NCT01031680|515921676|FG001|Overall Study|Administrative Reason by Sponsor|1|||
143104148|NCT01031680|515921675|FG000|Overall Study|Various|0|||
143104149|NCT01031680|515921676|FG001|Overall Study|Various|2|||
143104150|NCT02654977|515921680|FG000|Overall Study|Death|1|||
143104151|NCT02654977|515921680|FG000|Overall Study|Lost to Follow-up|1|||
143104152|NCT02654977|515921680|FG000|Overall Study|Adverse Event|1|||
143104153|NCT02654977|515921680|FG000|Overall Study|Withdrawal by Subject|1|||
143104154|NCT02654977|515921680|FG000|Overall Study|Lack of Efficacy|3|||
143104155|NCT00767455|515921681|FG000|Overall Study|Investigator error|19|||
143104156|NCT02729051|515921684|FG000|Overall Study|Adverse Event|21|||
143104157|NCT02729051|515921685|FG001|Overall Study|Adverse Event|11|||
143104158|NCT02729051|515921684|FG000|Overall Study|Lack of Efficacy|1|||
143104159|NCT02729051|515921685|FG001|Overall Study|Lack of Efficacy|1|||
143104160|NCT02729051|515921684|FG000|Overall Study|Lost to Follow-up|1|||
143104161|NCT02729051|515921685|FG001|Overall Study|Lost to Follow-up|2|||
143104162|NCT02729051|515921684|FG000|Overall Study|Physician Decision|1|||
143104163|NCT02729051|515921685|FG001|Overall Study|Physician Decision|1|||
143104164|NCT02729051|515921684|FG000|Overall Study|Withdrawal by Subject|6|||
143104165|NCT02729051|515921685|FG001|Overall Study|Withdrawal by Subject|17|||
143104166|NCT02702388|515921686|FG000|Overall Study|Disease Progression|18|||
143178219|NCT02628444|516201514|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
143178220|NCT02628444|516201515|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
143178221|NCT02628444|516201516|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
143178222|NCT02628444|516201517|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
143178223|NCT02628444|516201518|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
143178224|NCT02628444|516201519|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
143178225|NCT02628444|516201520|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
143178226|NCT02628444|516201521|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
143178227|NCT02628444|516201522|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
143178228|NCT02628444|516201514|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
143178229|NCT02628444|516201515|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
143178230|NCT02628444|516201516|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
143104167|NCT02702388|515921687|FG001|Overall Study|Disease Progression|25|||
143104168|NCT02702388|515921686|FG000|Overall Study|Withdrawal by Subject|9|||
143104169|NCT02702388|515921687|FG001|Overall Study|Withdrawal by Subject|7|||
143104170|NCT02702388|515921686|FG000|Overall Study|Adverse Event|11|||
143104171|NCT02702388|515921687|FG001|Overall Study|Adverse Event|15|||
143104172|NCT02702388|515921686|FG000|Overall Study|Other|2|||
143253917|NCT04585009|516483904|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
143253918|NCT04585009|516483905|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
143253919|NCT04585009|516483906|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
143253920|NCT04585009|516483895|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
143253921|NCT04585009|516483896|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
143253922|NCT04585009|516483897|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
143253923|NCT04585009|516483898|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
143253924|NCT04585009|516483899|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
143253925|NCT04585009|516483900|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
143253926|NCT04585009|516483901|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
143253927|NCT04585009|516483902|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
143253928|NCT04585009|516483903|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
143253929|NCT04585009|516483904|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
143253930|NCT04585009|516483905|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
143253931|NCT04585009|516483906|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
143253932|NCT04585009|516483895|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
143253933|NCT04585009|516483896|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
143253934|NCT04585009|516483897|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
143253935|NCT04585009|516483898|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
143253936|NCT04585009|516483899|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
143253937|NCT04585009|516483900|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
143253938|NCT04585009|516483901|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
143253939|NCT04585009|516483902|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
143253940|NCT04585009|516483903|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
143253941|NCT04585009|516483904|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
143253942|NCT04585009|516483905|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
143253943|NCT04585009|516483906|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
143253944|NCT00412373|516483915|FG000|Overall Study|Adverse Event|8|||
143253945|NCT00412373|516483916|FG001|Overall Study|Adverse Event|13|||
143253946|NCT00412373|516483915|FG000|Overall Study|Lack of Efficacy|16|||
143253947|NCT00412373|516483916|FG001|Overall Study|Lack of Efficacy|22|||
143253948|NCT00412373|516483915|FG000|Overall Study|Lost to Follow-up|7|||
143253949|NCT00412373|516483916|FG001|Overall Study|Lost to Follow-up|13|||
143253950|NCT00412373|516483915|FG000|Overall Study|Withdrawal by Subject|8|||
143253951|NCT00412373|516483916|FG001|Overall Study|Withdrawal by Subject|27|||
143253952|NCT00412373|516483915|FG000|Overall Study|Other|2|||
143253953|NCT00412373|516483916|FG001|Overall Study|Other|2|||
143253954|NCT02661178|516483928|FG000|Part 1|Protocol Violation|1|||
143253955|NCT02661178|516483929|FG001|Part 1|Protocol Violation|0|||
143253956|NCT02661178|516483930|FG002|Part 1|Protocol Violation|0|||
143253957|NCT02661178|516483931|FG003|Part 1|Protocol Violation|0|||
143253958|NCT02661178|516483932|FG004|Part 1|Protocol Violation|0|||
143253959|NCT02661178|516483933|FG005|Part 1|Protocol Violation|0|||
143253960|NCT02661178|516483934|FG006|Part 1|Protocol Violation|0|||
143253961|NCT02661178|516483935|FG007|Part 1|Protocol Violation|0|||
143253962|NCT02661178|516483936|FG008|Part 1|Protocol Violation|0|||
143253963|NCT02661178|516483937|FG009|Part 1|Protocol Violation|0|||
143253964|NCT02661178|516483938|FG010|Part 1|Protocol Violation|0|||
143253965|NCT02661178|516483939|FG011|Part 1|Protocol Violation|0|||
143253966|NCT02661178|516483940|FG012|Part 1|Protocol Violation|0|||
143253967|NCT02661178|516483941|FG013|Part 1|Protocol Violation|0|||
143253968|NCT02661178|516483942|FG014|Part 1|Protocol Violation|0|||
143253969|NCT03859973|516483943|FG000|Overall Study|Other reason than listed|3|||
143253970|NCT03859973|516483944|FG001|Overall Study|Other reason than listed|2|||
143253971|NCT03859973|516483943|FG000|Overall Study|COVID-19 related, not due to AE|3|||
143253972|NCT03859973|516483944|FG001|Overall Study|COVID-19 related, not due to AE|4|||
143253973|NCT03859973|516483943|FG000|Overall Study|Withdrawal by Subject|8|||
143253974|NCT03859973|516483944|FG001|Overall Study|Withdrawal by Subject|9|||
143253975|NCT03859973|516483943|FG000|Overall Study|Lost to Follow-up|2|||
143253976|NCT03859973|516483944|FG001|Overall Study|Lost to Follow-up|3|||
143253977|NCT03859973|516483943|FG000|Overall Study|Protocol Violation|1|||
143253978|NCT03859973|516483944|FG001|Overall Study|Protocol Violation|3|||
143253979|NCT03859973|516483943|FG000|Overall Study|Adverse Event|3|||
143253980|NCT03859973|516483944|FG001|Overall Study|Adverse Event|5|||
143253981|NCT02855541|516483945|FG000|Overall Study|Change in health status|2|||
143253982|NCT02855541|516483945|FG000|Overall Study|Withdrawal by Subject|2|||
143253983|NCT01242813|516483946|FG000|Overall Study|Lost to Follow-up|2|||
143253984|NCT03337490|516483953|FG000|Overall Study|Withdrawal by Subject|1|||
143253985|NCT03337490|516483954|FG001|Overall Study|Withdrawal by Subject|0|||
143253986|NCT03337490|516483955|FG002|Overall Study|Withdrawal by Subject|0|||
143253987|NCT03337490|516483953|FG000|Overall Study|Lack of Efficacy|10|||
143253988|NCT03337490|516483954|FG001|Overall Study|Lack of Efficacy|12|||
143253989|NCT03337490|516483955|FG002|Overall Study|Lack of Efficacy|35|||
143253990|NCT03337490|516483953|FG000|Overall Study|Physician Decision|0|||
143253991|NCT03337490|516483954|FG001|Overall Study|Physician Decision|1|||
143253992|NCT03337490|516483955|FG002|Overall Study|Physician Decision|0|||
143253993|NCT03337490|516483953|FG000|Overall Study|Lost to Follow-up|0|||
143253994|NCT03337490|516483954|FG001|Overall Study|Lost to Follow-up|1|||
143253995|NCT03337490|516483955|FG002|Overall Study|Lost to Follow-up|0|||
143253996|NCT04493892|516483956|FG000|Overall Study|Withdrawal by Subject|15|||
143253997|NCT03560518|516483957|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
143253998|NCT03560518|516483958|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
143253999|NCT03560518|516483959|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
143254000|NCT03560518|516483957|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
143254001|NCT03560518|516483958|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
143254002|NCT03560518|516483959|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
143254003|NCT03560518|516483957|FG000|Double Blind Treatment Period|Protocol Violation|1|||
143254004|NCT03560518|516483958|FG001|Double Blind Treatment Period|Protocol Violation|2|||
143254005|NCT03560518|516483959|FG002|Double Blind Treatment Period|Protocol Violation|0|||
143254006|NCT03560518|516483957|FG000|Double Blind Treatment Period|Pregnancy|0|||
143254007|NCT03560518|516483958|FG001|Double Blind Treatment Period|Pregnancy|2|||
143254008|NCT03560518|516483959|FG002|Double Blind Treatment Period|Pregnancy|0|||
143254009|NCT03560518|516483957|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
143254010|NCT03560518|516483958|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
143254011|NCT03560518|516483959|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
143254012|NCT03560518|516483957|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
143254013|NCT03560518|516483958|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
143254014|NCT03560518|516483959|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
143254015|NCT03560518|516483957|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
143254016|NCT03560518|516483958|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
143254017|NCT03560518|516483959|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
143254018|NCT03560518|516483957|FG000|Double Blind Treatment Period|Adverse Event|0|||
143254019|NCT03560518|516483958|FG001|Double Blind Treatment Period|Adverse Event|3|||
143254020|NCT03560518|516483959|FG002|Double Blind Treatment Period|Adverse Event|1|||
143254021|NCT01689532|516483960|FG000|Overall Study|Adverse Event|9|||
143254022|NCT01689532|516483961|FG001|Overall Study|Adverse Event|5|||
143254023|NCT01689532|516483960|FG000|Overall Study|Lack of Efficacy|2|||
143254024|NCT01689532|516483961|FG001|Overall Study|Lack of Efficacy|2|||
143254025|NCT01689532|516483960|FG000|Overall Study|Withdrawal by Subject|1|||
143254026|NCT01689532|516483961|FG001|Overall Study|Withdrawal by Subject|2|||
143254027|NCT01689532|516483960|FG000|Overall Study|Physician Decision|2|||
143254028|NCT01689532|516483961|FG001|Overall Study|Physician Decision|0|||
143254029|NCT01363349|516483962|FG000|Overall Study|Adverse Event|6|||
143254030|NCT01363349|516483963|FG001|Overall Study|Adverse Event|7|||
143254031|NCT01363349|516483962|FG000|Overall Study|Lack of Efficacy|3|||
143254032|NCT01363349|516483963|FG001|Overall Study|Lack of Efficacy|10|||
143254033|NCT01363349|516483962|FG000|Overall Study|Non compliance/Protocol deviations|2|||
143104173|NCT02702388|515921687|FG001|Overall Study|Other|4|||
143104174|NCT03225105|515921693|FG000|Overall Study|Withdrawal by Subject|1|||
143104175|NCT03225105|515921694|FG001|Overall Study|Withdrawal by Subject|0|||
143254034|NCT01363349|516483963|FG001|Overall Study|Non compliance/Protocol deviations|2|||
143254035|NCT01363349|516483962|FG000|Overall Study|Withdrawal by Subject|14|||
143254036|NCT01363349|516483963|FG001|Overall Study|Withdrawal by Subject|6|||
143254037|NCT01363349|516483962|FG000|Overall Study|Lost to Follow-up|5|||
143254038|NCT01363349|516483963|FG001|Overall Study|Lost to Follow-up|6|||
143254039|NCT01363349|516483962|FG000|Overall Study|Not reported|36|||
143254040|NCT01363349|516483963|FG001|Overall Study|Not reported|37|||
143254041|NCT01363349|516483962|FG000|Overall Study|missing|1|||
143254042|NCT01363349|516483963|FG001|Overall Study|missing|2|||
143254043|NCT01958489|516483964|FG000|Period 2|Adverse Event|0|||
143254044|NCT01958489|516483965|FG001|Period 2|Adverse Event|1|||
143254045|NCT00917644|516483966|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
143254046|NCT00917644|516483967|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
143254047|NCT00917644|516483966|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
143254048|NCT00917644|516483967|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
143254049|NCT00917644|516483966|FG000|Period 2: Second Intervention|family emergency|1|||
143254050|NCT00917644|516483967|FG001|Period 2: Second Intervention|family emergency|0|||
143254051|NCT04136444|516483971|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
143254052|NCT04136444|516483972|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
143254053|NCT02350764|516483973|FG000|Overall Study|Adverse Event|4|||
143104176|NCT03225105|515921695|FG002|Overall Study|Withdrawal by Subject|0|||
143104177|NCT03225105|515921696|FG003|Overall Study|Withdrawal by Subject|0|||
143104178|NCT03225105|515921693|FG000|Overall Study|Death|0|||
143104179|NCT03225105|515921694|FG001|Overall Study|Death|4|||
143104180|NCT03225105|515921695|FG002|Overall Study|Death|2|||
143104181|NCT03225105|515921696|FG003|Overall Study|Death|0|||
143254054|NCT02350764|516483973|FG000|Overall Study|Death|3|||
143254055|NCT02350764|516483973|FG000|Overall Study|Physician Decision|2|||
143254056|NCT02350764|516483973|FG000|Overall Study|Withdrawal by Subject|2|||
143254057|NCT03241368|516483974|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
143254058|NCT03241368|516483974|FG000|Overall Study|Lost to Follow-up|1|||
143254059|NCT03241368|516483974|FG000|Overall Study|Physician Decision|6|||
143254060|NCT03241368|516483974|FG000|Overall Study|Withdrawal by Subject|6|||
143254061|NCT03241368|516483974|FG000|Overall Study|Protocol Violation|1|||
143254062|NCT01270802|516483975|FG000|Overall Study|Withdrawal by Subject|1|||
143254063|NCT01270802|516483976|FG001|Overall Study|Withdrawal by Subject|0|||
143254064|NCT01270802|516483975|FG000|Overall Study|Adverse Event|1|||
143254065|NCT01270802|516483976|FG001|Overall Study|Adverse Event|0|||
143254066|NCT01270802|516483975|FG000|Overall Study|Lost to Follow-up|0|||
143254067|NCT01270802|516483976|FG001|Overall Study|Lost to Follow-up|1|||
143254068|NCT01224782|516483982|FG000|Overall Study|Lost to Follow-up|177|||
143254069|NCT01224782|516483982|FG000|Overall Study|Withdrawal by Subject|16|||
143254070|NCT01224782|516483982|FG000|Overall Study|Death|14|||
143254071|NCT01224782|516483982|FG000|Overall Study|Improvement|13|||
143254072|NCT01224782|516483982|FG000|Overall Study|Adverse Event|12|||
143254073|NCT01224782|516483982|FG000|Overall Study|Adverse Reaction|11|||
143254074|NCT01224782|516483982|FG000|Overall Study|Noncompliance|10|||
143254075|NCT01224782|516483982|FG000|Overall Study|Other|4|||
143254076|NCT01224782|516483982|FG000|Overall Study|Start of Dialysis|3|||
143254077|NCT01224782|516483982|FG000|Overall Study|Change of Treatment|1|||
143254078|NCT01224782|516483982|FG000|Overall Study|Financial Reasons|1|||
143254079|NCT01224782|516483982|FG000|Overall Study|Deterioration|1|||
143254080|NCT01224782|516483982|FG000|Overall Study|Transplantation|1|||
143254081|NCT00065429|516483983|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
143254082|NCT00065429|516483984|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
143254083|NCT00065429|516483985|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
143254084|NCT00065429|516483986|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
143254085|NCT00065429|516483987|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
143254086|NCT00065429|516483988|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
143254087|NCT00065429|516483989|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
143254088|NCT00065429|516483983|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
143254089|NCT00065429|516483984|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
143254090|NCT00065429|516483985|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
143254091|NCT00065429|516483986|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
143254092|NCT00065429|516483987|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
143104182|NCT03225105|515921693|FG000|Overall Study|Study termination per Sponsor Decision|2|||
143104183|NCT03225105|515921694|FG001|Overall Study|Study termination per Sponsor Decision|0|||
143104184|NCT03225105|515921695|FG002|Overall Study|Study termination per Sponsor Decision|3|||
143104185|NCT03225105|515921696|FG003|Overall Study|Study termination per Sponsor Decision|3|||
143104186|NCT03467217|515923090|FG000|Overall Study|Trial stopped early|5|||
143104187|NCT03467217|515923091|FG001|Overall Study|Trial stopped early|2|||
143104188|NCT03467217|515923090|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
143104189|NCT03467217|515923091|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
143104190|NCT03467217|515923090|FG000|Overall Study|Lost to Follow-up|0|||
143104191|NCT03467217|515923091|FG001|Overall Study|Lost to Follow-up|2|||
143104192|NCT04981470|515923092|FG000|Overall Study|Device failure in all 4 patients|4|||
143104193|NCT05088603|515923095|FG000|Overall Study|Protocol Violation|6|||
143104194|NCT05088603|515923096|FG001|Overall Study|Protocol Violation|1|||
143104195|NCT03233529|515923099|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
143104196|NCT03233529|515923099|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
143104197|NCT00594100|515923105|FG000|Procedure|Technical Failure|9|||
143104198|NCT00594100|515923105|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
143104199|NCT00594100|515923105|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
143104200|NCT00594100|515923105|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
143254093|NCT00065429|516483988|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
143254094|NCT00065429|516483989|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
143254095|NCT00065429|516483983|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
143254096|NCT00065429|516483984|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
143254097|NCT00065429|516483985|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
143254098|NCT00065429|516483986|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
143254099|NCT00065429|516483987|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
143254100|NCT00065429|516483988|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
143254101|NCT00065429|516483989|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
143104201|NCT00956592|515923106|FG000|Overall Study|Protocol Violation|1|||
143104202|NCT00956592|515923107|FG001|Overall Study|Protocol Violation|3|||
143104203|NCT03528369|515923108|FG000|Overall Study|Withdrawal by Subject|2|||
143104204|NCT03528369|515923109|FG001|Overall Study|Withdrawal by Subject|0|||
143104205|NCT03528369|515923110|FG002|Overall Study|Withdrawal by Subject|0|||
143104206|NCT03528369|515923108|FG000|Overall Study|Lost to Follow-up|1|||
143104207|NCT03528369|515923109|FG001|Overall Study|Lost to Follow-up|0|||
143104208|NCT03528369|515923110|FG002|Overall Study|Lost to Follow-up|0|||
143104209|NCT03528369|515923108|FG000|Overall Study|Adverse Event|0|||
143104210|NCT03528369|515923109|FG001|Overall Study|Adverse Event|1|||
143104211|NCT03528369|515923110|FG002|Overall Study|Adverse Event|0|||
143104212|NCT00076752|515923111|FG000|Overall Study|Death|2|||
143104213|NCT00076752|515923111|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
143104214|NCT04696055|515923112|FG000|Overall Study|Adverse Event|10|||
143104215|NCT04696055|515923113|FG001|Overall Study|Adverse Event|2|||
143104216|NCT04696055|515923112|FG000|Overall Study|Death|4|||
143104217|NCT04696055|515923113|FG001|Overall Study|Death|0|||
143104218|NCT04696055|515923112|FG000|Overall Study|Other|7|||
143104219|NCT04696055|515923113|FG001|Overall Study|Other|2|||
143104220|NCT04696055|515923112|FG000|Overall Study|Physician Decision|3|||
143104221|NCT04696055|515923113|FG001|Overall Study|Physician Decision|0|||
143104222|NCT04696055|515923112|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
143104223|NCT04696055|515923113|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
143104224|NCT04696055|515923112|FG000|Overall Study|Progressive Disease - Radiological Progression|42|||
143104225|NCT04696055|515923113|FG001|Overall Study|Progressive Disease - Radiological Progression|20|||
143104226|NCT04696055|515923112|FG000|Overall Study|Subject Decision|1|||
143104227|NCT04696055|515923113|FG001|Overall Study|Subject Decision|2|||
143104228|NCT03969901|515923114|FG000|Overall Study|Withdrawal by parent/guardian|0|||
143104229|NCT03969901|515923115|FG001|Overall Study|Withdrawal by parent/guardian|0|||
143104230|NCT03969901|515923116|FG002|Overall Study|Withdrawal by parent/guardian|0|||
143104231|NCT03969901|515923117|FG003|Overall Study|Withdrawal by parent/guardian|0|||
143104232|NCT03969901|515923118|FG004|Overall Study|Withdrawal by parent/guardian|1|||
143104233|NCT03969901|515923119|FG005|Overall Study|Withdrawal by parent/guardian|0|||
143104234|NCT03969901|515923120|FG006|Overall Study|Withdrawal by parent/guardian|0|||
143104235|NCT03969901|515923121|FG007|Overall Study|Withdrawal by parent/guardian|1|||
143104236|NCT03969901|515923122|FG008|Overall Study|Withdrawal by parent/guardian|1|||
143104237|NCT03969901|515923123|FG009|Overall Study|Withdrawal by parent/guardian|0|||
143104238|NCT00083759|515923128|FG000|Overall Study|Adverse Event|5|||
143104239|NCT00083759|515923129|FG001|Overall Study|Adverse Event|3|||
143104240|NCT00083759|515923128|FG000|Overall Study|Lost to Follow-up|1|||
143104241|NCT00083759|515923129|FG001|Overall Study|Lost to Follow-up|0|||
143104242|NCT00083759|515923128|FG000|Overall Study|Death|1|||
143104243|NCT00083759|515923129|FG001|Overall Study|Death|1|||
143104244|NCT00083759|515923128|FG000|Overall Study|Inadequate Therapeutic Response|32|||
143104245|NCT00083759|515923129|FG001|Overall Study|Inadequate Therapeutic Response|35|||
143104246|NCT00083759|515923128|FG000|Overall Study|Subject Withdrew Consent|2|||
143104247|NCT00083759|515923129|FG001|Overall Study|Subject Withdrew Consent|2|||
143104248|NCT00083759|515923128|FG000|Overall Study|Non-Compliance|1|||
143104249|NCT00083759|515923129|FG001|Overall Study|Non-Compliance|0|||
143104250|NCT00083759|515923128|FG000|Overall Study|Sponsor's Discretion|28|||
143104251|NCT00083759|515923129|FG001|Overall Study|Sponsor's Discretion|29|||
143104252|NCT00083759|515923128|FG000|Overall Study|Other|14|||
143104253|NCT00083759|515923129|FG001|Overall Study|Other|13|||
143104254|NCT02589626|515923132|FG000|Overall Study|Other than the reason specified|1|||
143104255|NCT02589626|515923133|FG001|Overall Study|Other than the reason specified|0|||
143104256|NCT02589626|515923132|FG000|Overall Study|Withdrawal by Subject|1|||
143104257|NCT02589626|515923133|FG001|Overall Study|Withdrawal by Subject|1|||
143104258|NCT02589626|515923132|FG000|Overall Study|Adverse Event|1|||
143104259|NCT02589626|515923133|FG001|Overall Study|Adverse Event|1|||
143104260|NCT03645395|515923134|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
143104261|NCT03645395|515923135|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
143104262|NCT03645395|515923136|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
143104263|NCT03645395|515923137|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
143104264|NCT03645395|515923134|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
143104265|NCT03645395|515923135|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
143104266|NCT03645395|515923136|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
143104267|NCT03645395|515923137|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
143104268|NCT03645395|515923134|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
143104269|NCT03645395|515923135|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
143104270|NCT03645395|515923136|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
143104271|NCT03645395|515923137|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
143104272|NCT03645395|515923134|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
143104273|NCT03645395|515923135|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
143104274|NCT03645395|515923136|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
143178231|NCT02628444|516201517|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
143104275|NCT03645395|515923137|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
143104276|NCT02564900|515923138|FG000|Dose Escalation|Progressive disease per RECIST|2|||
143104277|NCT02564900|515923139|FG001|Dose Escalation|Progressive disease per RECIST|3|||
143104278|NCT02564900|515923140|FG002|Dose Escalation|Progressive disease per RECIST|3|||
143104279|NCT02564900|515923141|FG003|Dose Escalation|Progressive disease per RECIST|3|||
143104280|NCT02564900|515923142|FG004|Dose Escalation|Progressive disease per RECIST|3|||
143104281|NCT02564900|515923143|FG005|Dose Escalation|Progressive disease per RECIST|1|||
143104282|NCT02564900|515923144|FG006|Dose Escalation|Progressive disease per RECIST|0|||
143104283|NCT02564900|515923145|FG007|Dose Escalation|Progressive disease per RECIST|0|||
143104284|NCT02564900|515923146|FG008|Dose Escalation|Progressive disease per RECIST|0|||
143104285|NCT02564900|515923147|FG009|Dose Escalation|Progressive disease per RECIST|0|||
143104286|NCT02564900|515923148|FG010|Dose Escalation|Progressive disease per RECIST|0|||
143104287|NCT02564900|515923149|FG011|Dose Escalation|Progressive disease per RECIST|0|||
143104288|NCT02564900|515923150|FG012|Dose Escalation|Progressive disease per RECIST|0|||
143104289|NCT02564900|515923151|FG013|Dose Escalation|Progressive disease per RECIST|0|||
143104290|NCT02564900|515923152|FG014|Dose Escalation|Progressive disease per RECIST|0|||
143104291|NCT02564900|515923138|FG000|Dose Escalation|Ongoing|1|||
143104292|NCT02564900|515923139|FG001|Dose Escalation|Ongoing|0|||
143104293|NCT02564900|515923140|FG002|Dose Escalation|Ongoing|0|||
143104294|NCT02564900|515923141|FG003|Dose Escalation|Ongoing|2|||
143104295|NCT02564900|515923142|FG004|Dose Escalation|Ongoing|2|||
143104296|NCT02564900|515923143|FG005|Dose Escalation|Ongoing|2|||
143104297|NCT02564900|515923144|FG006|Dose Escalation|Ongoing|0|||
143104298|NCT02564900|515923145|FG007|Dose Escalation|Ongoing|0|||
143104299|NCT02564900|515923146|FG008|Dose Escalation|Ongoing|0|||
143104300|NCT02564900|515923147|FG009|Dose Escalation|Ongoing|0|||
143104301|NCT02564900|515923148|FG010|Dose Escalation|Ongoing|0|||
143104302|NCT02564900|515923149|FG011|Dose Escalation|Ongoing|0|||
143104303|NCT02564900|515923150|FG012|Dose Escalation|Ongoing|0|||
143104304|NCT02564900|515923151|FG013|Dose Escalation|Ongoing|0|||
143104305|NCT02564900|515923152|FG014|Dose Escalation|Ongoing|0|||
143104306|NCT02564900|515923138|FG000|Dose Escalation|Adverse Event|0|||
143104307|NCT02564900|515923139|FG001|Dose Escalation|Adverse Event|0|||
143104308|NCT02564900|515923140|FG002|Dose Escalation|Adverse Event|0|||
143104309|NCT02564900|515923141|FG003|Dose Escalation|Adverse Event|1|||
143104310|NCT02564900|515923142|FG004|Dose Escalation|Adverse Event|1|||
143104311|NCT02564900|515923143|FG005|Dose Escalation|Adverse Event|3|||
143104312|NCT02564900|515923144|FG006|Dose Escalation|Adverse Event|0|||
143104313|NCT02564900|515923145|FG007|Dose Escalation|Adverse Event|0|||
143104314|NCT02564900|515923146|FG008|Dose Escalation|Adverse Event|0|||
143104315|NCT02564900|515923147|FG009|Dose Escalation|Adverse Event|0|||
143104316|NCT02564900|515923148|FG010|Dose Escalation|Adverse Event|0|||
143104317|NCT02564900|515923149|FG011|Dose Escalation|Adverse Event|0|||
143104318|NCT02564900|515923150|FG012|Dose Escalation|Adverse Event|0|||
143104319|NCT02564900|515923151|FG013|Dose Escalation|Adverse Event|0|||
143104320|NCT02564900|515923152|FG014|Dose Escalation|Adverse Event|0|||
143104321|NCT02564900|515923138|FG000|Dose Expansion|Progressive disease per RECIST|0|||
143104322|NCT02564900|515923139|FG001|Dose Expansion|Progressive disease per RECIST|0|||
143104323|NCT02564900|515923140|FG002|Dose Expansion|Progressive disease per RECIST|0|||
143104324|NCT02564900|515923141|FG003|Dose Expansion|Progressive disease per RECIST|0|||
143104325|NCT02564900|515923142|FG004|Dose Expansion|Progressive disease per RECIST|0|||
143104326|NCT02564900|515923143|FG005|Dose Expansion|Progressive disease per RECIST|0|||
143104327|NCT02564900|515923144|FG006|Dose Expansion|Progressive disease per RECIST|19|||
143104328|NCT02564900|515923145|FG007|Dose Expansion|Progressive disease per RECIST|17|||
143104329|NCT02564900|515923146|FG008|Dose Expansion|Progressive disease per RECIST|8|||
143104330|NCT02564900|515923147|FG009|Dose Expansion|Progressive disease per RECIST|16|||
143104331|NCT02564900|515923148|FG010|Dose Expansion|Progressive disease per RECIST|13|||
143104332|NCT02564900|515923149|FG011|Dose Expansion|Progressive disease per RECIST|19|||
143104333|NCT02564900|515923150|FG012|Dose Expansion|Progressive disease per RECIST|10|||
143104334|NCT02564900|515923151|FG013|Dose Expansion|Progressive disease per RECIST|13|||
143104335|NCT02564900|515923152|FG014|Dose Expansion|Progressive disease per RECIST|11|||
143104336|NCT02564900|515923138|FG000|Dose Expansion|Clinical progression|0|||
143367877|NCT01311713|516889462|FG005|Overall Study|Withdrawal by Subject|1|||
143367878|NCT01311713|516889463|FG006|Overall Study|Withdrawal by Subject|2|||
143367879|NCT01311713|516889457|FG000|Overall Study|Disease progression|3|||
143104337|NCT02564900|515923139|FG001|Dose Expansion|Clinical progression|0|||
143104338|NCT02564900|515923140|FG002|Dose Expansion|Clinical progression|0|||
143104339|NCT02564900|515923141|FG003|Dose Expansion|Clinical progression|0|||
143367880|NCT01311713|516889458|FG001|Overall Study|Disease progression|4|||
143104340|NCT02564900|515923142|FG004|Dose Expansion|Clinical progression|0|||
143104341|NCT02564900|515923143|FG005|Dose Expansion|Clinical progression|0|||
143104342|NCT02564900|515923144|FG006|Dose Expansion|Clinical progression|5|||
143104343|NCT02564900|515923145|FG007|Dose Expansion|Clinical progression|12|||
143104344|NCT02564900|515923146|FG008|Dose Expansion|Clinical progression|0|||
143104345|NCT02564900|515923147|FG009|Dose Expansion|Clinical progression|3|||
143104346|NCT02564900|515923148|FG010|Dose Expansion|Clinical progression|2|||
143104347|NCT02564900|515923149|FG011|Dose Expansion|Clinical progression|0|||
143104348|NCT02564900|515923150|FG012|Dose Expansion|Clinical progression|1|||
143104349|NCT02564900|515923151|FG013|Dose Expansion|Clinical progression|3|||
143104350|NCT02564900|515923152|FG014|Dose Expansion|Clinical progression|1|||
143104351|NCT02564900|515923138|FG000|Dose Expansion|Adverse Event|0|||
143104352|NCT02564900|515923139|FG001|Dose Expansion|Adverse Event|0|||
143104353|NCT02564900|515923140|FG002|Dose Expansion|Adverse Event|0|||
143104354|NCT02564900|515923141|FG003|Dose Expansion|Adverse Event|0|||
143104355|NCT02564900|515923142|FG004|Dose Expansion|Adverse Event|0|||
143104356|NCT02564900|515923143|FG005|Dose Expansion|Adverse Event|0|||
143104357|NCT02564900|515923144|FG006|Dose Expansion|Adverse Event|9|||
143104358|NCT02564900|515923145|FG007|Dose Expansion|Adverse Event|22|||
143104359|NCT02564900|515923146|FG008|Dose Expansion|Adverse Event|0|||
143104360|NCT02564900|515923147|FG009|Dose Expansion|Adverse Event|11|||
143104361|NCT02564900|515923148|FG010|Dose Expansion|Adverse Event|0|||
143104362|NCT02564900|515923149|FG011|Dose Expansion|Adverse Event|5|||
143104363|NCT02564900|515923150|FG012|Dose Expansion|Adverse Event|2|||
143104364|NCT02564900|515923151|FG013|Dose Expansion|Adverse Event|2|||
143104365|NCT02564900|515923152|FG014|Dose Expansion|Adverse Event|1|||
143104366|NCT02564900|515923138|FG000|Dose Expansion|Ongoing|0|||
143104367|NCT02564900|515923139|FG001|Dose Expansion|Ongoing|0|||
143104368|NCT02564900|515923140|FG002|Dose Expansion|Ongoing|0|||
143104369|NCT02564900|515923141|FG003|Dose Expansion|Ongoing|0|||
143104370|NCT02564900|515923142|FG004|Dose Expansion|Ongoing|0|||
143104371|NCT02564900|515923143|FG005|Dose Expansion|Ongoing|0|||
143104372|NCT02564900|515923144|FG006|Dose Expansion|Ongoing|9|||
143104373|NCT02564900|515923145|FG007|Dose Expansion|Ongoing|10|||
143104374|NCT02564900|515923146|FG008|Dose Expansion|Ongoing|11|||
143104375|NCT02564900|515923147|FG009|Dose Expansion|Ongoing|3|||
143104376|NCT02564900|515923148|FG010|Dose Expansion|Ongoing|0|||
143104377|NCT02564900|515923149|FG011|Dose Expansion|Ongoing|0|||
143104378|NCT02564900|515923150|FG012|Dose Expansion|Ongoing|4|||
143104379|NCT02564900|515923151|FG013|Dose Expansion|Ongoing|0|||
143104380|NCT02564900|515923152|FG014|Dose Expansion|Ongoing|6|||
143104381|NCT02564900|515923138|FG000|Dose Expansion|Death|0|||
143104382|NCT02564900|515923139|FG001|Dose Expansion|Death|0|||
143104383|NCT02564900|515923140|FG002|Dose Expansion|Death|0|||
143104384|NCT02564900|515923141|FG003|Dose Expansion|Death|0|||
143104385|NCT02564900|515923142|FG004|Dose Expansion|Death|0|||
143104386|NCT02564900|515923143|FG005|Dose Expansion|Death|0|||
143104387|NCT02564900|515923144|FG006|Dose Expansion|Death|1|||
143104388|NCT02564900|515923145|FG007|Dose Expansion|Death|0|||
143104389|NCT02564900|515923146|FG008|Dose Expansion|Death|0|||
143104390|NCT02564900|515923147|FG009|Dose Expansion|Death|0|||
143104391|NCT02564900|515923148|FG010|Dose Expansion|Death|1|||
143104392|NCT02564900|515923149|FG011|Dose Expansion|Death|0|||
143104393|NCT02564900|515923150|FG012|Dose Expansion|Death|1|||
143104394|NCT02564900|515923151|FG013|Dose Expansion|Death|1|||
143104395|NCT02564900|515923152|FG014|Dose Expansion|Death|0|||
143104396|NCT02564900|515923138|FG000|Dose Expansion|Withdrawal by Subject|0|||
143104397|NCT02564900|515923139|FG001|Dose Expansion|Withdrawal by Subject|0|||
143104398|NCT02564900|515923140|FG002|Dose Expansion|Withdrawal by Subject|0|||
143104399|NCT02564900|515923141|FG003|Dose Expansion|Withdrawal by Subject|0|||
143104400|NCT02564900|515923142|FG004|Dose Expansion|Withdrawal by Subject|0|||
143104401|NCT02564900|515923143|FG005|Dose Expansion|Withdrawal by Subject|0|||
143104402|NCT02564900|515923144|FG006|Dose Expansion|Withdrawal by Subject|4|||
143104403|NCT02564900|515923145|FG007|Dose Expansion|Withdrawal by Subject|0|||
143104404|NCT02564900|515923146|FG008|Dose Expansion|Withdrawal by Subject|0|||
143104405|NCT02564900|515923147|FG009|Dose Expansion|Withdrawal by Subject|0|||
143104406|NCT02564900|515923148|FG010|Dose Expansion|Withdrawal by Subject|1|||
143104407|NCT02564900|515923149|FG011|Dose Expansion|Withdrawal by Subject|0|||
143104408|NCT02564900|515923150|FG012|Dose Expansion|Withdrawal by Subject|0|||
143104409|NCT02564900|515923151|FG013|Dose Expansion|Withdrawal by Subject|1|||
143104410|NCT02564900|515923152|FG014|Dose Expansion|Withdrawal by Subject|1|||
143104411|NCT02564900|515923138|FG000|Dose Expansion|Other|0|||
143104412|NCT02564900|515923139|FG001|Dose Expansion|Other|0|||
143104413|NCT02564900|515923140|FG002|Dose Expansion|Other|0|||
143104414|NCT02564900|515923141|FG003|Dose Expansion|Other|0|||
143104415|NCT02564900|515923142|FG004|Dose Expansion|Other|0|||
143104416|NCT02564900|515923143|FG005|Dose Expansion|Other|0|||
143104417|NCT02564900|515923144|FG006|Dose Expansion|Other|1|||
143178232|NCT02628444|516201518|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
143178233|NCT02628444|516201519|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
143178234|NCT02628444|516201520|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
143367881|NCT01311713|516889459|FG002|Overall Study|Disease progression|3|||
143104418|NCT02564900|515923145|FG007|Dose Expansion|Other|0|||
143104419|NCT02564900|515923146|FG008|Dose Expansion|Other|1|||
143104420|NCT02564900|515923147|FG009|Dose Expansion|Other|0|||
143104421|NCT02564900|515923148|FG010|Dose Expansion|Other|0|||
143104422|NCT02564900|515923149|FG011|Dose Expansion|Other|0|||
143104423|NCT02564900|515923150|FG012|Dose Expansion|Other|0|||
143104424|NCT02564900|515923151|FG013|Dose Expansion|Other|0|||
143104425|NCT02564900|515923152|FG014|Dose Expansion|Other|1|||
143104426|NCT02564900|515923138|FG000|Dose Expansion|Did not receive treatment|0|||
143104427|NCT02564900|515923139|FG001|Dose Expansion|Did not receive treatment|0|||
143104428|NCT02564900|515923140|FG002|Dose Expansion|Did not receive treatment|0|||
143104429|NCT02564900|515923141|FG003|Dose Expansion|Did not receive treatment|0|||
143104430|NCT02564900|515923142|FG004|Dose Expansion|Did not receive treatment|0|||
143104431|NCT02564900|515923143|FG005|Dose Expansion|Did not receive treatment|0|||
143104432|NCT02564900|515923144|FG006|Dose Expansion|Did not receive treatment|1|||
143104433|NCT02564900|515923145|FG007|Dose Expansion|Did not receive treatment|1|||
143104434|NCT02564900|515923146|FG008|Dose Expansion|Did not receive treatment|0|||
143104435|NCT02564900|515923147|FG009|Dose Expansion|Did not receive treatment|0|||
143104436|NCT02564900|515923148|FG010|Dose Expansion|Did not receive treatment|0|||
143104437|NCT02564900|515923149|FG011|Dose Expansion|Did not receive treatment|0|||
143104438|NCT02564900|515923150|FG012|Dose Expansion|Did not receive treatment|0|||
143104439|NCT02564900|515923151|FG013|Dose Expansion|Did not receive treatment|0|||
143104440|NCT02564900|515923152|FG014|Dose Expansion|Did not receive treatment|1|||
143104441|NCT00892151|515923153|FG000|Overall Study|Protocol Violation|1|||
143104442|NCT00379080|515923156|FG000|Overall Study|Withdrawal by Subject|0|||
143104443|NCT00379080|515923157|FG001|Overall Study|Withdrawal by Subject|4|||
143104444|NCT00379080|515923158|FG002|Overall Study|Withdrawal by Subject|0|||
143104445|NCT01222520|515923159|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
143104446|NCT01222520|515923160|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
143104447|NCT01222520|515923159|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
143104448|NCT01222520|515923160|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
143104449|NCT01222520|515923159|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
143104450|NCT01222520|515923160|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
143104451|NCT01222520|515923159|FG000|Double-blind Period|Adverse Event|0|||
143104452|NCT01222520|515923160|FG001|Double-blind Period|Adverse Event|1|||
143104453|NCT01222520|515923159|FG000|Double-blind Period|Lack of Efficacy|0|||
143104454|NCT01222520|515923160|FG001|Double-blind Period|Lack of Efficacy|1|||
143104455|NCT01222520|515923159|FG000|Double-blind Period|Study medication stolen|1|||
143104456|NCT01222520|515923160|FG001|Double-blind Period|Study medication stolen|0|||
143104457|NCT04292912|515923161|FG000|Overall Study|Physician Decision|1|||
143104458|NCT04292912|515923161|FG000|Overall Study|Protocol Violation|6|||
143104459|NCT00280397|515923162|FG000|Overall Study|Adverse Event|1|||
143104460|NCT00637000|515923168|FG000|Overall Study|Withdrawal by Subject|4|||
143104461|NCT00637000|515923169|FG001|Overall Study|Withdrawal by Subject|3|||
143104462|NCT02751450|515923170|FG000|Overall Study|Adverse Event|1|||
143104463|NCT02751450|515923171|FG001|Overall Study|Adverse Event|0|||
143104464|NCT01598090|515923172|FG000|Treatment Period|Poor/non-compliance|0|||
143104465|NCT01598090|515923173|FG001|Treatment Period|Poor/non-compliance|2|||
143104466|NCT01598090|515923174|FG002|Treatment Period|Poor/non-compliance|0|||
143104467|NCT01598090|515923172|FG000|Treatment Period|No longer meet study criteria|0|||
143104468|NCT01598090|515923173|FG001|Treatment Period|No longer meet study criteria|1|||
143104469|NCT01598090|515923174|FG002|Treatment Period|No longer meet study criteria|0|||
143104470|NCT01598090|515923172|FG000|Treatment Period|Lack of Efficacy|5|||
143104471|NCT01598090|515923173|FG001|Treatment Period|Lack of Efficacy|14|||
143104472|NCT01598090|515923174|FG002|Treatment Period|Lack of Efficacy|6|||
143104473|NCT01598090|515923172|FG000|Treatment Period|Adverse Event|2|||
143104474|NCT01598090|515923173|FG001|Treatment Period|Adverse Event|33|||
143104475|NCT01598090|515923174|FG002|Treatment Period|Adverse Event|17|||
143104476|NCT01598090|515923172|FG000|Treatment Period|Other reasons|0|||
143104477|NCT01598090|515923173|FG001|Treatment Period|Other reasons|4|||
143104478|NCT01598090|515923174|FG002|Treatment Period|Other reasons|1|||
143104479|NCT01598090|515923172|FG000|Treatment Period|Withdrawal by Subject|3|||
143104480|NCT01598090|515923173|FG001|Treatment Period|Withdrawal by Subject|13|||
143104481|NCT01598090|515923174|FG002|Treatment Period|Withdrawal by Subject|10|||
143104482|NCT01598090|515923172|FG000|Treatment Period|Lost to Follow-up|1|||
143104483|NCT01598090|515923173|FG001|Treatment Period|Lost to Follow-up|5|||
143104484|NCT01598090|515923174|FG002|Treatment Period|Lost to Follow-up|1|||
143104485|NCT01598090|515923172|FG000|Follow-up Period|Death|0|||
143104486|NCT01598090|515923173|FG001|Follow-up Period|Death|1|||
143104487|NCT01598090|515923174|FG002|Follow-up Period|Death|0|||
143104488|NCT01598090|515923172|FG000|Follow-up Period|No longer required per protocol|1|||
143104489|NCT01598090|515923173|FG001|Follow-up Period|No longer required per protocol|3|||
143104490|NCT01598090|515923174|FG002|Follow-up Period|No longer required per protocol|2|||
143104491|NCT01598090|515923172|FG000|Follow-up Period|Not reported|0|||
143104492|NCT01598090|515923173|FG001|Follow-up Period|Not reported|10|||
143104493|NCT01598090|515923174|FG002|Follow-up Period|Not reported|4|||
143104494|NCT01598090|515923172|FG000|Follow-up Period|Withdrawal by Subject|0|||
143104495|NCT01598090|515923173|FG001|Follow-up Period|Withdrawal by Subject|3|||
143104496|NCT01598090|515923174|FG002|Follow-up Period|Withdrawal by Subject|2|||
143104497|NCT01598090|515923172|FG000|Follow-up Period|Other reasons|2|||
143104498|NCT01598090|515923173|FG001|Follow-up Period|Other reasons|8|||
143104499|NCT01598090|515923174|FG002|Follow-up Period|Other reasons|8|||
143104500|NCT01598090|515923172|FG000|Follow-up Period|Lost to Follow-up|2|||
143104501|NCT01598090|515923173|FG001|Follow-up Period|Lost to Follow-up|10|||
143104502|NCT01598090|515923174|FG002|Follow-up Period|Lost to Follow-up|12|||
143104503|NCT00765336|515923175|FG000|Overall Study|Protocol Violation|4|||
143104504|NCT00765336|515923176|FG001|Overall Study|Protocol Violation|2|||
143104505|NCT00765336|515923175|FG000|Overall Study|Withdrawal by Subject|6|||
143104506|NCT00765336|515923176|FG001|Overall Study|Withdrawal by Subject|4|||
143104507|NCT00765336|515923175|FG000|Overall Study|Lost to Follow-up|7|||
143104508|NCT00765336|515923176|FG001|Overall Study|Lost to Follow-up|9|||
143104509|NCT00765336|515923175|FG000|Overall Study|Adverse Event|2|||
143104510|NCT00765336|515923176|FG001|Overall Study|Adverse Event|1|||
143104511|NCT00478777|515923177|FG000|Overall Study|Adverse Event|29|||
143104512|NCT00478777|515923177|FG000|Overall Study|Lack of Efficacy|23|||
143104513|NCT00478777|515923177|FG000|Overall Study|Withdrawal by Subject|4|||
143104514|NCT00478777|515923177|FG000|Overall Study|Death|3|||
143104515|NCT00478777|515923177|FG000|Overall Study|Protocol Violation|3|||
143104516|NCT00478777|515923177|FG000|Overall Study|Lost to Follow-up|3|||
143104517|NCT00478777|515923177|FG000|Overall Study|Physician Decision|1|||
143104518|NCT00478777|515923177|FG000|Overall Study|Intolerance of therapy|1|||
143104519|NCT00478777|515923177|FG000|Overall Study|Lack of compliance|1|||
143104520|NCT00478777|515923177|FG000|Overall Study|Lymphocytes infusion|1|||
143104521|NCT00478777|515923177|FG000|Overall Study|End of therapy|2|||
143104522|NCT00478777|515923177|FG000|Overall Study|Not treated with lenalidomide|6|||
143104523|NCT04105218|515923178|FG000|Overall Study|Withdrawal by Subject|3|||
143104524|NCT04105218|515923179|FG001|Overall Study|Withdrawal by Subject|2|||
143104525|NCT04105218|515923178|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
143104526|NCT04105218|515923179|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
143104527|NCT04105218|515923178|FG000|Overall Study|Failed screening tests|2|||
143104528|NCT04105218|515923179|FG001|Overall Study|Failed screening tests|1|||
143104529|NCT02858583|515923182|FG000|Overall Study|Declined consent|1|||
143104530|NCT02858583|515923183|FG001|Overall Study|Declined consent|1|||
143104531|NCT01218087|515923185|FG000|Overall Study|Death|2|||
143104532|NCT01218087|515923186|FG001|Overall Study|Death|1|||
143104533|NCT01218087|515923185|FG000|Overall Study|Withdrawal by Subject|5|||
143104534|NCT01218087|515923186|FG001|Overall Study|Withdrawal by Subject|0|||
143104535|NCT01218087|515923185|FG000|Overall Study|Transferred|8|||
143104536|NCT01218087|515923186|FG001|Overall Study|Transferred|5|||
143104537|NCT01323387|515923192|FG000|Overall Study|Withdrawal by Subject|41|||
143104538|NCT01323387|515923192|FG000|Overall Study|Radiographic Data Unavailable|1|||
143104539|NCT01323387|515923192|FG000|Overall Study|Revision|14|||
143104540|NCT01323387|515923192|FG000|Overall Study|Protocol Violation|12|||
143104541|NCT01323387|515923192|FG000|Overall Study|Randomized but Never Treated|16|||
143104542|NCT00603473|515923198|FG000|Overall Study|Adverse Event|4|||
143104543|NCT00603473|515923198|FG000|Overall Study|Lack of Efficacy|4|||
143104544|NCT00603473|515923198|FG000|Overall Study|Protocol Violation|1|||
143104545|NCT00550043|515923201|FG000|Overall Study|Adverse Event|0|||
143178235|NCT02628444|516201521|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
143104546|NCT00550043|515923202|FG001|Overall Study|Adverse Event|0|||
143178236|NCT02628444|516201522|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
143178237|NCT02628444|516201514|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
143104547|NCT00550043|515923203|FG002|Overall Study|Adverse Event|0|||
143104548|NCT00550043|515923204|FG003|Overall Study|Adverse Event|1|||
143104549|NCT00550043|515923205|FG004|Overall Study|Adverse Event|1|||
143104550|NCT00550043|515923201|FG000|Overall Study|Subject Withdrew Consent|0|||
143104551|NCT00550043|515923202|FG001|Overall Study|Subject Withdrew Consent|2|||
143104552|NCT00550043|515923203|FG002|Overall Study|Subject Withdrew Consent|1|||
143104553|NCT00550043|515923204|FG003|Overall Study|Subject Withdrew Consent|0|||
143104554|NCT00550043|515923205|FG004|Overall Study|Subject Withdrew Consent|0|||
143104555|NCT00550043|515923201|FG000|Overall Study|Other Reasons- Unspecified|0|||
143104556|NCT00550043|515923202|FG001|Overall Study|Other Reasons- Unspecified|1|||
143104557|NCT00550043|515923203|FG002|Overall Study|Other Reasons- Unspecified|0|||
143104558|NCT00550043|515923204|FG003|Overall Study|Other Reasons- Unspecified|1|||
143104559|NCT00550043|515923205|FG004|Overall Study|Other Reasons- Unspecified|0|||
143104560|NCT03478644|515923206|FG000|Phase 2|Withdrawal by Subject|2|||
143104561|NCT03478644|515923207|FG001|Phase 2|Withdrawal by Subject|1|||
143104562|NCT03478644|515923206|FG000|Phase 2|Lost to Follow-up|1|||
143104563|NCT03478644|515923207|FG001|Phase 2|Lost to Follow-up|0|||
143104564|NCT02073929|515923208|FG000|Overall Study|Lost to Follow-up|2|||
143104565|NCT02073929|515923209|FG001|Overall Study|Lost to Follow-up|1|||
143104566|NCT02073929|515923208|FG000|Overall Study|Adverse Event|2|||
143104567|NCT02073929|515923209|FG001|Overall Study|Adverse Event|1|||
143104568|NCT02073929|515923208|FG000|Overall Study|Withdrawal by Subject|0|||
143104569|NCT02073929|515923209|FG001|Overall Study|Withdrawal by Subject|1|||
143104570|NCT01483027|515923210|FG000|Overall Study|Administrative Reasons|2|||
143104571|NCT01483027|515923211|FG001|Overall Study|Administrative Reasons|1|||
143104572|NCT01483027|515923210|FG000|Overall Study|Withdrawal by Subject|21|||
143104573|NCT01483027|515923211|FG001|Overall Study|Withdrawal by Subject|32|||
143104574|NCT01483027|515923210|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
143104575|NCT01483027|515923211|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
143104576|NCT01483027|515923210|FG000|Overall Study|Lost to Follow-up|1|||
143104577|NCT01483027|515923211|FG001|Overall Study|Lost to Follow-up|1|||
143104578|NCT01483027|515923210|FG000|Overall Study|Adverse Event|0|||
143104579|NCT01483027|515923211|FG001|Overall Study|Adverse Event|1|||
143104580|NCT01483027|515923210|FG000|Overall Study|Withdrawal by Subject|0|||
143104581|NCT01483027|515923211|FG001|Overall Study|Withdrawal by Subject|1|||
143104582|NCT00596817|515923214|FG000|Open-label Period|Adverse Event|0|||
143104583|NCT00596817|515923215|FG001|Open-label Period|Adverse Event|49|||
143104584|NCT00596817|515923214|FG000|Open-label Period|Lack of Efficacy|0|||
143104585|NCT00596817|515923215|FG001|Open-label Period|Lack of Efficacy|33|||
143104586|NCT00596817|515923214|FG000|Open-label Period|Other Reasons|0|||
143104587|NCT00596817|515923215|FG001|Open-label Period|Other Reasons|65|||
143104588|NCT00596817|515923214|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
143104589|NCT00596817|515923215|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
143104590|NCT00596817|515923214|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
143104591|NCT00596817|515923215|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
143104592|NCT00596817|515923214|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
143104593|NCT00596817|515923215|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
143104594|NCT00596817|515923214|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
143104595|NCT00596817|515923215|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
143104596|NCT00596817|515923214|FG000|Double-blind Period|Adverse Event|5|||
143104597|NCT00596817|515923215|FG001|Double-blind Period|Adverse Event|16|||
143104598|NCT00596817|515923214|FG000|Double-blind Period|Lack of Efficacy|52|||
143104599|NCT00596817|515923215|FG001|Double-blind Period|Lack of Efficacy|28|||
143104600|NCT00596817|515923214|FG000|Double-blind Period|Non-compliance With Study Product|3|||
143104601|NCT00596817|515923215|FG001|Double-blind Period|Non-compliance With Study Product|4|||
143104602|NCT00596817|515923214|FG000|Double-blind Period|Protocol Violation|11|||
143104603|NCT00596817|515923215|FG001|Double-blind Period|Protocol Violation|8|||
143104604|NCT00596817|515923214|FG000|Double-blind Period|Withdrawal of Consent|7|||
143104605|NCT00596817|515923215|FG001|Double-blind Period|Withdrawal of Consent|3|||
143104606|NCT00596817|515923214|FG000|Double-blind Period|Lost to Follow-up|0|||
143104607|NCT00596817|515923215|FG001|Double-blind Period|Lost to Follow-up|2|||
143104608|NCT00596817|515923214|FG000|Double-blind Period|Other Reasons|10|||
143104609|NCT00596817|515923215|FG001|Double-blind Period|Other Reasons|18|||
143104610|NCT01314872|515923218|FG000|Treatment Period 1|Protocol Violation|2|||
143104611|NCT01314872|515923219|FG001|Treatment Period 1|Protocol Violation|1|||
143104612|NCT01314872|515923220|FG002|Treatment Period 1|Protocol Violation|1|||
143104613|NCT01314872|515923221|FG003|Treatment Period 1|Protocol Violation|0|||
143104614|NCT01314872|515923222|FG004|Treatment Period 1|Protocol Violation|1|||
143178238|NCT02628444|516201515|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
143178239|NCT02628444|516201516|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
143178240|NCT02628444|516201517|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
143104615|NCT01314872|515923223|FG005|Treatment Period 1|Protocol Violation|0|||
143104616|NCT01314872|515923224|FG006|Treatment Period 1|Protocol Violation|0|||
143104617|NCT01314872|515923225|FG007|Treatment Period 1|Protocol Violation|0|||
143178241|NCT02628444|516201518|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
143178242|NCT02628444|516201519|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
143178243|NCT02628444|516201520|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
143178244|NCT02628444|516201521|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
143104618|NCT01314872|515923226|FG008|Treatment Period 1|Protocol Violation|0|||
143104619|NCT01314872|515923227|FG009|Treatment Period 1|Protocol Violation|1|||
143104620|NCT01314872|515923228|FG010|Treatment Period 1|Protocol Violation|1|||
143104621|NCT01314872|515923229|FG011|Treatment Period 1|Protocol Violation|0|||
143104622|NCT01314872|515923230|FG012|Treatment Period 1|Protocol Violation|0|||
143104623|NCT01314872|515923231|FG013|Treatment Period 1|Protocol Violation|0|||
143104624|NCT01314872|515923232|FG014|Treatment Period 1|Protocol Violation|0|||
143104625|NCT01314872|515923218|FG000|Treatment Period 1|Physician Decision|0|||
143104626|NCT01314872|515923219|FG001|Treatment Period 1|Physician Decision|1|||
143104627|NCT01314872|515923220|FG002|Treatment Period 1|Physician Decision|0|||
143104628|NCT01314872|515923221|FG003|Treatment Period 1|Physician Decision|1|||
143104629|NCT01314872|515923222|FG004|Treatment Period 1|Physician Decision|0|||
143104630|NCT01314872|515923223|FG005|Treatment Period 1|Physician Decision|0|||
143104631|NCT01314872|515923224|FG006|Treatment Period 1|Physician Decision|0|||
143104632|NCT01314872|515923225|FG007|Treatment Period 1|Physician Decision|0|||
143104633|NCT01314872|515923226|FG008|Treatment Period 1|Physician Decision|0|||
143104634|NCT01314872|515923227|FG009|Treatment Period 1|Physician Decision|1|||
143104635|NCT01314872|515923228|FG010|Treatment Period 1|Physician Decision|0|||
143104636|NCT01314872|515923229|FG011|Treatment Period 1|Physician Decision|0|||
143104637|NCT01314872|515923230|FG012|Treatment Period 1|Physician Decision|0|||
143104638|NCT01314872|515923231|FG013|Treatment Period 1|Physician Decision|0|||
143104639|NCT01314872|515923232|FG014|Treatment Period 1|Physician Decision|0|||
143104640|NCT01314872|515923218|FG000|Treatment Period 1|Lack of Efficacy|1|||
143104641|NCT01314872|515923219|FG001|Treatment Period 1|Lack of Efficacy|0|||
143104642|NCT01314872|515923220|FG002|Treatment Period 1|Lack of Efficacy|0|||
143104643|NCT01314872|515923221|FG003|Treatment Period 1|Lack of Efficacy|0|||
143104644|NCT01314872|515923222|FG004|Treatment Period 1|Lack of Efficacy|0|||
143104645|NCT01314872|515923223|FG005|Treatment Period 1|Lack of Efficacy|1|||
143104646|NCT01314872|515923224|FG006|Treatment Period 1|Lack of Efficacy|0|||
143104647|NCT01314872|515923225|FG007|Treatment Period 1|Lack of Efficacy|2|||
143104648|NCT01314872|515923226|FG008|Treatment Period 1|Lack of Efficacy|0|||
143104649|NCT01314872|515923227|FG009|Treatment Period 1|Lack of Efficacy|0|||
143104650|NCT01314872|515923228|FG010|Treatment Period 1|Lack of Efficacy|0|||
143104651|NCT01314872|515923229|FG011|Treatment Period 1|Lack of Efficacy|0|||
143104652|NCT01314872|515923230|FG012|Treatment Period 1|Lack of Efficacy|0|||
143104653|NCT01314872|515923231|FG013|Treatment Period 1|Lack of Efficacy|0|||
143104654|NCT01314872|515923232|FG014|Treatment Period 1|Lack of Efficacy|0|||
143104655|NCT01314872|515923218|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
143104656|NCT01314872|515923219|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
143104657|NCT01314872|515923220|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
143104658|NCT01314872|515923221|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
143104659|NCT01314872|515923222|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
143104660|NCT01314872|515923223|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
143104661|NCT01314872|515923224|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
143104662|NCT01314872|515923225|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
143104663|NCT01314872|515923226|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
143104664|NCT01314872|515923227|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
143104665|NCT01314872|515923228|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
143104666|NCT01314872|515923229|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
143178245|NCT02628444|516201522|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
143178246|NCT02628444|516201514|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
143178247|NCT02628444|516201515|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
143178248|NCT02628444|516201516|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
143178249|NCT02628444|516201517|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
143178250|NCT02628444|516201518|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
143178251|NCT02628444|516201519|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
143178252|NCT02628444|516201520|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
143178253|NCT02628444|516201521|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
143178254|NCT02628444|516201522|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
143178255|NCT02628444|516201514|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
143178256|NCT02628444|516201515|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
143178257|NCT02628444|516201516|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
143178258|NCT02628444|516201517|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
143178259|NCT02628444|516201518|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
143178260|NCT02628444|516201519|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
143178261|NCT02628444|516201520|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
143178262|NCT02628444|516201521|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
143178263|NCT02628444|516201522|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
143104667|NCT01314872|515923230|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
143104668|NCT01314872|515923231|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
143178264|NCT02628444|516201514|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
143178265|NCT02628444|516201515|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
143178266|NCT02628444|516201516|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
143178267|NCT02628444|516201517|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
143178268|NCT02628444|516201518|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
143178269|NCT02628444|516201519|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
143178270|NCT02628444|516201520|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
143178271|NCT02628444|516201521|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
143178272|NCT02628444|516201522|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
143178273|NCT02628444|516201514|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
143178274|NCT02628444|516201515|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
143178275|NCT02628444|516201516|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
143178276|NCT02628444|516201517|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
143178277|NCT02628444|516201518|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
143178278|NCT02628444|516201519|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
143178279|NCT02628444|516201520|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
143178280|NCT02628444|516201521|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
143178281|NCT02628444|516201522|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
143178282|NCT02628444|516201514|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
143178283|NCT02628444|516201515|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
143178284|NCT02628444|516201516|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
143178285|NCT02628444|516201517|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
143178286|NCT02628444|516201518|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
143178287|NCT02628444|516201519|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
143178288|NCT02628444|516201520|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
143178289|NCT02628444|516201521|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
143178290|NCT02628444|516201522|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
143178291|NCT02628444|516201514|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
143178292|NCT02628444|516201515|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
143178293|NCT02628444|516201516|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
143178294|NCT02628444|516201517|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
143178295|NCT02628444|516201518|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
143178296|NCT02628444|516201519|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
143178297|NCT02628444|516201520|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
143178298|NCT02628444|516201521|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
143178299|NCT02628444|516201522|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
143178300|NCT02079909|516201523|FG000|Overall Study|Adverse Event|23|||
143178301|NCT02079909|516201524|FG001|Overall Study|Adverse Event|23|||
143178302|NCT02079909|516201525|FG002|Overall Study|Adverse Event|7|||
143178303|NCT02079909|516201523|FG000|Overall Study|Withdrawal by Subject|9|||
143178304|NCT02079909|516201524|FG001|Overall Study|Withdrawal by Subject|17|||
143178305|NCT02079909|516201525|FG002|Overall Study|Withdrawal by Subject|4|||
143254102|NCT00065429|516483983|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
143254103|NCT00065429|516483984|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
143254104|NCT00065429|516483985|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
143104669|NCT01314872|515923232|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
143104670|NCT01314872|515923218|FG000|Treatment Period 1|Withdrawal by Subject|3|||
143104671|NCT01314872|515923219|FG001|Treatment Period 1|Withdrawal by Subject|1|||
143104672|NCT01314872|515923220|FG002|Treatment Period 1|Withdrawal by Subject|0|||
143104673|NCT01314872|515923221|FG003|Treatment Period 1|Withdrawal by Subject|2|||
143104674|NCT01314872|515923222|FG004|Treatment Period 1|Withdrawal by Subject|3|||
143104675|NCT01314872|515923223|FG005|Treatment Period 1|Withdrawal by Subject|1|||
143104676|NCT01314872|515923224|FG006|Treatment Period 1|Withdrawal by Subject|3|||
143104677|NCT01314872|515923225|FG007|Treatment Period 1|Withdrawal by Subject|2|||
143104678|NCT01314872|515923226|FG008|Treatment Period 1|Withdrawal by Subject|2|||
143104679|NCT01314872|515923227|FG009|Treatment Period 1|Withdrawal by Subject|2|||
143104680|NCT01314872|515923228|FG010|Treatment Period 1|Withdrawal by Subject|1|||
143104681|NCT01314872|515923229|FG011|Treatment Period 1|Withdrawal by Subject|0|||
143104682|NCT01314872|515923230|FG012|Treatment Period 1|Withdrawal by Subject|0|||
143104683|NCT01314872|515923231|FG013|Treatment Period 1|Withdrawal by Subject|0|||
143104684|NCT01314872|515923232|FG014|Treatment Period 1|Withdrawal by Subject|0|||
143104685|NCT01314872|515923218|FG000|Treatment Period 1|Lost to Follow-up|0|||
143254105|NCT00065429|516483986|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
143254106|NCT00065429|516483987|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
143104686|NCT01314872|515923219|FG001|Treatment Period 1|Lost to Follow-up|1|||
143104687|NCT01314872|515923220|FG002|Treatment Period 1|Lost to Follow-up|2|||
143104688|NCT01314872|515923221|FG003|Treatment Period 1|Lost to Follow-up|2|||
143104689|NCT01314872|515923222|FG004|Treatment Period 1|Lost to Follow-up|1|||
143104690|NCT01314872|515923223|FG005|Treatment Period 1|Lost to Follow-up|1|||
143104691|NCT01314872|515923224|FG006|Treatment Period 1|Lost to Follow-up|1|||
143104692|NCT01314872|515923225|FG007|Treatment Period 1|Lost to Follow-up|1|||
143104693|NCT01314872|515923226|FG008|Treatment Period 1|Lost to Follow-up|1|||
143104694|NCT01314872|515923227|FG009|Treatment Period 1|Lost to Follow-up|0|||
143104695|NCT01314872|515923228|FG010|Treatment Period 1|Lost to Follow-up|0|||
143104696|NCT01314872|515923229|FG011|Treatment Period 1|Lost to Follow-up|0|||
143104697|NCT01314872|515923230|FG012|Treatment Period 1|Lost to Follow-up|0|||
143104698|NCT01314872|515923231|FG013|Treatment Period 1|Lost to Follow-up|0|||
143104699|NCT01314872|515923232|FG014|Treatment Period 1|Lost to Follow-up|0|||
143104700|NCT01314872|515923218|FG000|Period 2|Protocol Violation|0|||
143104701|NCT01314872|515923219|FG001|Period 2|Protocol Violation|0|||
143104702|NCT01314872|515923220|FG002|Period 2|Protocol Violation|0|||
143104703|NCT01314872|515923221|FG003|Period 2|Protocol Violation|0|||
143104704|NCT01314872|515923222|FG004|Period 2|Protocol Violation|0|||
143254107|NCT00065429|516483988|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
143254108|NCT00065429|516483989|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
143104705|NCT01314872|515923223|FG005|Period 2|Protocol Violation|0|||
143104706|NCT01314872|515923224|FG006|Period 2|Protocol Violation|0|||
143104707|NCT01314872|515923225|FG007|Period 2|Protocol Violation|0|||
143104708|NCT01314872|515923226|FG008|Period 2|Protocol Violation|0|||
143104709|NCT01314872|515923227|FG009|Period 2|Protocol Violation|0|||
143104710|NCT01314872|515923228|FG010|Period 2|Protocol Violation|0|||
143104711|NCT01314872|515923229|FG011|Period 2|Protocol Violation|3|||
143104712|NCT01314872|515923230|FG012|Period 2|Protocol Violation|3|||
143104713|NCT01314872|515923231|FG013|Period 2|Protocol Violation|2|||
143104714|NCT01314872|515923232|FG014|Period 2|Protocol Violation|0|||
143104715|NCT01314872|515923218|FG000|Period 2|Non-compliance with study drug|0|||
143104716|NCT01314872|515923219|FG001|Period 2|Non-compliance with study drug|0|||
143104717|NCT01314872|515923220|FG002|Period 2|Non-compliance with study drug|0|||
143104718|NCT01314872|515923221|FG003|Period 2|Non-compliance with study drug|0|||
143104719|NCT01314872|515923222|FG004|Period 2|Non-compliance with study drug|0|||
143104720|NCT01314872|515923223|FG005|Period 2|Non-compliance with study drug|0|||
143104721|NCT01314872|515923224|FG006|Period 2|Non-compliance with study drug|0|||
143104722|NCT01314872|515923225|FG007|Period 2|Non-compliance with study drug|0|||
143104723|NCT01314872|515923226|FG008|Period 2|Non-compliance with study drug|0|||
143104724|NCT01314872|515923227|FG009|Period 2|Non-compliance with study drug|0|||
143104725|NCT01314872|515923228|FG010|Period 2|Non-compliance with study drug|0|||
143104726|NCT01314872|515923229|FG011|Period 2|Non-compliance with study drug|3|||
143104727|NCT01314872|515923230|FG012|Period 2|Non-compliance with study drug|3|||
143104728|NCT01314872|515923231|FG013|Period 2|Non-compliance with study drug|1|||
143104729|NCT01314872|515923232|FG014|Period 2|Non-compliance with study drug|2|||
143104730|NCT01314872|515923218|FG000|Period 2|Lack of Efficacy|0|||
143104731|NCT01314872|515923219|FG001|Period 2|Lack of Efficacy|0|||
143104732|NCT01314872|515923220|FG002|Period 2|Lack of Efficacy|0|||
143104733|NCT01314872|515923221|FG003|Period 2|Lack of Efficacy|0|||
143104734|NCT01314872|515923222|FG004|Period 2|Lack of Efficacy|0|||
143104735|NCT01314872|515923223|FG005|Period 2|Lack of Efficacy|0|||
143104736|NCT01314872|515923224|FG006|Period 2|Lack of Efficacy|0|||
143104737|NCT01314872|515923225|FG007|Period 2|Lack of Efficacy|0|||
143104738|NCT01314872|515923226|FG008|Period 2|Lack of Efficacy|0|||
143104739|NCT01314872|515923227|FG009|Period 2|Lack of Efficacy|0|||
143104740|NCT01314872|515923228|FG010|Period 2|Lack of Efficacy|0|||
143104741|NCT01314872|515923229|FG011|Period 2|Lack of Efficacy|7|||
143104742|NCT01314872|515923230|FG012|Period 2|Lack of Efficacy|12|||
143104743|NCT01314872|515923231|FG013|Period 2|Lack of Efficacy|9|||
143104744|NCT01314872|515923232|FG014|Period 2|Lack of Efficacy|2|||
143104745|NCT01314872|515923218|FG000|Period 2|Pregnancy|0|||
143104746|NCT01314872|515923219|FG001|Period 2|Pregnancy|0|||
143104747|NCT01314872|515923220|FG002|Period 2|Pregnancy|0|||
143104748|NCT01314872|515923221|FG003|Period 2|Pregnancy|0|||
143254109|NCT00065429|516483983|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
143254110|NCT00065429|516483984|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
143104749|NCT01314872|515923222|FG004|Period 2|Pregnancy|0|||
143104750|NCT01314872|515923223|FG005|Period 2|Pregnancy|0|||
143254111|NCT00065429|516483985|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
143254112|NCT00065429|516483986|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
143254113|NCT00065429|516483987|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
143104751|NCT01314872|515923224|FG006|Period 2|Pregnancy|0|||
143104752|NCT01314872|515923225|FG007|Period 2|Pregnancy|0|||
143104753|NCT01314872|515923226|FG008|Period 2|Pregnancy|0|||
143104754|NCT01314872|515923227|FG009|Period 2|Pregnancy|0|||
143104755|NCT01314872|515923228|FG010|Period 2|Pregnancy|0|||
143104756|NCT01314872|515923229|FG011|Period 2|Pregnancy|0|||
143104757|NCT01314872|515923230|FG012|Period 2|Pregnancy|0|||
143254114|NCT00065429|516483988|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
143104758|NCT01314872|515923231|FG013|Period 2|Pregnancy|0|||
143104759|NCT01314872|515923232|FG014|Period 2|Pregnancy|1|||
143104760|NCT01314872|515923218|FG000|Period 2|Study terminated by Sponsor|0|||
143104761|NCT01314872|515923219|FG001|Period 2|Study terminated by Sponsor|0|||
143104762|NCT01314872|515923220|FG002|Period 2|Study terminated by Sponsor|0|||
143104763|NCT01314872|515923221|FG003|Period 2|Study terminated by Sponsor|0|||
143104764|NCT01314872|515923222|FG004|Period 2|Study terminated by Sponsor|0|||
143104765|NCT01314872|515923223|FG005|Period 2|Study terminated by Sponsor|0|||
143104766|NCT01314872|515923224|FG006|Period 2|Study terminated by Sponsor|0|||
143104767|NCT01314872|515923225|FG007|Period 2|Study terminated by Sponsor|0|||
143104768|NCT01314872|515923226|FG008|Period 2|Study terminated by Sponsor|0|||
143104769|NCT01314872|515923227|FG009|Period 2|Study terminated by Sponsor|0|||
143104770|NCT01314872|515923228|FG010|Period 2|Study terminated by Sponsor|0|||
143104771|NCT01314872|515923229|FG011|Period 2|Study terminated by Sponsor|2|||
143104772|NCT01314872|515923230|FG012|Period 2|Study terminated by Sponsor|2|||
143104773|NCT01314872|515923231|FG013|Period 2|Study terminated by Sponsor|3|||
143104774|NCT01314872|515923232|FG014|Period 2|Study terminated by Sponsor|0|||
143104775|NCT01314872|515923218|FG000|Period 2|Adverse event, non-fatal|0|||
143104776|NCT01314872|515923219|FG001|Period 2|Adverse event, non-fatal|0|||
143104777|NCT01314872|515923220|FG002|Period 2|Adverse event, non-fatal|0|||
143104778|NCT01314872|515923221|FG003|Period 2|Adverse event, non-fatal|0|||
143104779|NCT01314872|515923222|FG004|Period 2|Adverse event, non-fatal|0|||
143104780|NCT01314872|515923223|FG005|Period 2|Adverse event, non-fatal|0|||
143104781|NCT01314872|515923224|FG006|Period 2|Adverse event, non-fatal|0|||
143104782|NCT01314872|515923225|FG007|Period 2|Adverse event, non-fatal|0|||
143104783|NCT01314872|515923226|FG008|Period 2|Adverse event, non-fatal|0|||
143104784|NCT01314872|515923227|FG009|Period 2|Adverse event, non-fatal|0|||
143104785|NCT01314872|515923228|FG010|Period 2|Adverse event, non-fatal|0|||
143104786|NCT01314872|515923229|FG011|Period 2|Adverse event, non-fatal|13|||
143104787|NCT01314872|515923230|FG012|Period 2|Adverse event, non-fatal|16|||
143104788|NCT01314872|515923231|FG013|Period 2|Adverse event, non-fatal|24|||
143104789|NCT01314872|515923232|FG014|Period 2|Adverse event, non-fatal|9|||
143104790|NCT01314872|515923218|FG000|Period 2|Withdrawal by Subject|0|||
143104791|NCT01314872|515923219|FG001|Period 2|Withdrawal by Subject|0|||
143104792|NCT01314872|515923220|FG002|Period 2|Withdrawal by Subject|0|||
143104793|NCT01314872|515923221|FG003|Period 2|Withdrawal by Subject|0|||
143104794|NCT01314872|515923222|FG004|Period 2|Withdrawal by Subject|0|||
143104795|NCT01314872|515923223|FG005|Period 2|Withdrawal by Subject|0|||
143104796|NCT01314872|515923224|FG006|Period 2|Withdrawal by Subject|0|||
143104797|NCT01314872|515923225|FG007|Period 2|Withdrawal by Subject|0|||
143104798|NCT01314872|515923226|FG008|Period 2|Withdrawal by Subject|0|||
143104799|NCT01314872|515923227|FG009|Period 2|Withdrawal by Subject|0|||
143104800|NCT01314872|515923228|FG010|Period 2|Withdrawal by Subject|0|||
143104801|NCT01314872|515923229|FG011|Period 2|Withdrawal by Subject|14|||
143104802|NCT01314872|515923230|FG012|Period 2|Withdrawal by Subject|17|||
143104803|NCT01314872|515923231|FG013|Period 2|Withdrawal by Subject|12|||
143104804|NCT01314872|515923232|FG014|Period 2|Withdrawal by Subject|4|||
143104805|NCT01314872|515923218|FG000|Period 2|Lost to Follow-up|0|||
143104806|NCT01314872|515923219|FG001|Period 2|Lost to Follow-up|0|||
143104807|NCT01314872|515923220|FG002|Period 2|Lost to Follow-up|0|||
143104808|NCT01314872|515923221|FG003|Period 2|Lost to Follow-up|0|||
143104809|NCT01314872|515923222|FG004|Period 2|Lost to Follow-up|0|||
143254115|NCT00065429|516483989|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
143254116|NCT00065429|516483983|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
143254117|NCT00065429|516483984|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
143254118|NCT00065429|516483985|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
143254119|NCT00065429|516483986|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
143254120|NCT00065429|516483987|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
143104810|NCT01314872|515923223|FG005|Period 2|Lost to Follow-up|0|||
143104811|NCT01314872|515923224|FG006|Period 2|Lost to Follow-up|0|||
143104812|NCT01314872|515923225|FG007|Period 2|Lost to Follow-up|0|||
143104813|NCT01314872|515923226|FG008|Period 2|Lost to Follow-up|0|||
143104814|NCT01314872|515923227|FG009|Period 2|Lost to Follow-up|0|||
143104815|NCT01314872|515923228|FG010|Period 2|Lost to Follow-up|0|||
143104816|NCT01314872|515923229|FG011|Period 2|Lost to Follow-up|6|||
143104817|NCT01314872|515923230|FG012|Period 2|Lost to Follow-up|7|||
143104818|NCT01314872|515923231|FG013|Period 2|Lost to Follow-up|2|||
143104819|NCT01314872|515923232|FG014|Period 2|Lost to Follow-up|6|||
143104820|NCT01190410|515925082|FG000|Overall Study|Adverse Event|0|||
143104821|NCT01190410|515925083|FG001|Overall Study|Adverse Event|3|||
143104822|NCT01190410|515925082|FG000|Overall Study|Lack of Efficacy|0|||
143104823|NCT01190410|515925083|FG001|Overall Study|Lack of Efficacy|2|||
143104824|NCT01190410|515925082|FG000|Overall Study|Withdrawal by Subject|0|||
143104825|NCT01190410|515925083|FG001|Overall Study|Withdrawal by Subject|2|||
143104826|NCT01190410|515925082|FG000|Overall Study|Administrative decision|1|||
143104827|NCT01190410|515925083|FG001|Overall Study|Administrative decision|0|||
143104828|NCT01190410|515925082|FG000|Overall Study|PI discretion|0|||
143104829|NCT01190410|515925083|FG001|Overall Study|PI discretion|2|||
143104830|NCT01399047|515925084|FG000|Overall Study|Withdrawal by Subject|0|||
143104831|NCT01399047|515925085|FG001|Overall Study|Withdrawal by Subject|1|||
143104832|NCT03652636|515925093|FG000|Overall Study|Withdrawal by Subject|7|||
143104833|NCT03300505|515925095|FG000|Overall Study|Death|0|||
143104834|NCT03300505|515925096|FG001|Overall Study|Death|1|||
143104835|NCT03300505|515925097|FG002|Overall Study|Death|0|||
143104836|NCT03300505|515925095|FG000|Overall Study|Withdrawal by Subject|0|||
143104837|NCT03300505|515925096|FG001|Overall Study|Withdrawal by Subject|1|||
143104838|NCT03300505|515925097|FG002|Overall Study|Withdrawal by Subject|1|||
143104839|NCT03300505|515925095|FG000|Overall Study|Sponsor Termination|0|||
143104840|NCT03300505|515925096|FG001|Overall Study|Sponsor Termination|1|||
143104841|NCT03300505|515925097|FG002|Overall Study|Sponsor Termination|0|||
143104842|NCT03300505|515925095|FG000|Overall Study|Adverse Event|0|||
143104843|NCT03300505|515925096|FG001|Overall Study|Adverse Event|0|||
143104844|NCT03300505|515925097|FG002|Overall Study|Adverse Event|2|||
143104845|NCT05119595|515925098|FG000|Overall Study|Death|1|||
143104846|NCT05119595|515925098|FG000|Overall Study|Lost to Follow-up|7|||
143104847|NCT03806933|515925101|FG000|Main Period|Physician Decision|0|||
143104848|NCT03806933|515925102|FG001|Main Period|Physician Decision|0|||
143104849|NCT03806933|515925103|FG002|Main Period|Physician Decision|0|||
143104850|NCT03806933|515925104|FG003|Main Period|Physician Decision|1|||
143104851|NCT03806933|515925101|FG000|Main Period|Pregnancy|0|||
143104852|NCT03806933|515925102|FG001|Main Period|Pregnancy|0|||
143104853|NCT03806933|515925103|FG002|Main Period|Pregnancy|1|||
143104854|NCT03806933|515925104|FG003|Main Period|Pregnancy|0|||
143104855|NCT03806933|515925101|FG000|Main Period|Withdrawal by Subject|2|||
143104856|NCT03806933|515925102|FG001|Main Period|Withdrawal by Subject|1|||
143104857|NCT03806933|515925103|FG002|Main Period|Withdrawal by Subject|1|||
143104858|NCT03806933|515925104|FG003|Main Period|Withdrawal by Subject|2|||
143104859|NCT03806933|515925101|FG000|Main Period|Lost to Follow-up|2|||
143104860|NCT03806933|515925102|FG001|Main Period|Lost to Follow-up|2|||
143104861|NCT03806933|515925103|FG002|Main Period|Lost to Follow-up|0|||
143104862|NCT03806933|515925104|FG003|Main Period|Lost to Follow-up|0|||
143104863|NCT03806933|515925101|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
143104864|NCT03806933|515925102|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
143104865|NCT03806933|515925103|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
143104866|NCT03806933|515925104|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
143104867|NCT01736397|515925106|FG000|Overall Study|Lack of Efficacy|1|||
143104868|NCT01736397|515925107|FG001|Overall Study|Lack of Efficacy|11|||
143104869|NCT01736397|515925106|FG000|Overall Study|Withdrawal by Subject|6|||
143104870|NCT01736397|515925107|FG001|Overall Study|Withdrawal by Subject|5|||
143104871|NCT01736397|515925106|FG000|Overall Study|Lost to Follow-up|0|||
143104872|NCT01736397|515925107|FG001|Overall Study|Lost to Follow-up|1|||
143104873|NCT01736397|515925106|FG000|Overall Study|Adverse Event|6|||
143104874|NCT01736397|515925107|FG001|Overall Study|Adverse Event|3|||
143104875|NCT01736397|515925106|FG000|Overall Study|Not stated|1|||
143104876|NCT01736397|515925107|FG001|Overall Study|Not stated|4|||
143104877|NCT01868438|515925108|FG000|First Intervention|Withdrawal by Subject|5|||
143104878|NCT01868438|515925109|FG001|First Intervention|Withdrawal by Subject|1|||
143104879|NCT01868438|515925108|FG000|First Intervention|Lost to Follow-up|2|||
143104880|NCT01868438|515925109|FG001|First Intervention|Lost to Follow-up|3|||
143104881|NCT01868438|515925108|FG000|First Intervention|Meeting the non-redosing criteria|0|||
143104882|NCT01868438|515925109|FG001|First Intervention|Meeting the non-redosing criteria|1|||
143104883|NCT01868438|515925108|FG000|Second Intervention|Adverse Event|3|||
143104884|NCT01868438|515925109|FG001|Second Intervention|Adverse Event|3|||
143104885|NCT02162719|515925110|FG000|Overall Study|Death|41|||
143104886|NCT02162719|515925111|FG001|Overall Study|Death|46|||
143104887|NCT02162719|515925110|FG000|Overall Study|Lost to Follow-up|1|||
143104888|NCT02162719|515925111|FG001|Overall Study|Lost to Follow-up|3|||
143104889|NCT02162719|515925110|FG000|Overall Study|Disease Progression|2|||
143104890|NCT02162719|515925111|FG001|Overall Study|Disease Progression|1|||
143104891|NCT02162719|515925110|FG000|Overall Study|Withdrawal by Subject|8|||
143104892|NCT02162719|515925111|FG001|Overall Study|Withdrawal by Subject|2|||
143104893|NCT02162719|515925110|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
143104894|NCT02162719|515925111|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
143104895|NCT00394836|515925117|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
143104896|NCT00394836|515925118|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
143104897|NCT00394836|515925117|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
143104898|NCT00394836|515925118|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
143104899|NCT00394836|515925117|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
143104900|NCT00394836|515925118|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
143104901|NCT00394836|515925117|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
143104902|NCT00394836|515925118|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
143104903|NCT00394836|515925117|FG000|Teatment or Follow-up Phase|Death|0|||
143104904|NCT00394836|515925118|FG001|Teatment or Follow-up Phase|Death|1|||
143104905|NCT00394836|515925117|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
143104906|NCT00394836|515925118|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
143104907|NCT00394836|515925117|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
143104908|NCT00394836|515925118|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
143104909|NCT00394836|515925117|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
143104910|NCT00394836|515925118|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
143104911|NCT00394836|515925117|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
143104912|NCT00394836|515925118|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
143104913|NCT00394836|515925117|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
143104914|NCT00394836|515925118|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
143104915|NCT00394836|515925117|FG000|Teatment or Follow-up Phase|Non compliance|0|||
143104916|NCT00394836|515925118|FG001|Teatment or Follow-up Phase|Non compliance|1|||
143104917|NCT00394836|515925117|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
143104918|NCT00394836|515925118|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
143104919|NCT00394836|515925117|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
143104920|NCT00394836|515925118|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
143104921|NCT00394836|515925117|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
143104922|NCT00394836|515925118|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
143104923|NCT00394836|515925117|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
143104924|NCT00394836|515925118|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
143104925|NCT04411810|515925120|FG000|Overall Study|Screen failure|1|||
143104926|NCT04411810|515925120|FG000|Overall Study|Withdrawal by Subject|1|||
143104927|NCT01920958|515925121|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
143104928|NCT02028767|515925122|FG000|Treatment Period 2|Non compliant with protocol|1|||
143104929|NCT02028767|515925123|FG001|Treatment Period 2|Non compliant with protocol|0|||
143104930|NCT02028767|515925122|FG000|Treatment Period 2|Reason other than those specified above|1|||
143104931|NCT02028767|515925123|FG001|Treatment Period 2|Reason other than those specified above|0|||
143104932|NCT03192306|515925126|FG000|Overall Study|Did not treat cold sore during study|149|||
143104933|NCT03192306|515925127|FG001|Overall Study|Did not treat cold sore during study|143|||
143104934|NCT03192306|515925126|FG000|Overall Study|Withdrawal by Subject|1|||
143104935|NCT03192306|515925127|FG001|Overall Study|Withdrawal by Subject|1|||
143104936|NCT03192306|515925126|FG000|Overall Study|Lost to Follow-up|1|||
143104937|NCT03192306|515925127|FG001|Overall Study|Lost to Follow-up|0|||
143104938|NCT03192306|515925126|FG000|Overall Study|Protocol Violation|1|||
143104939|NCT03192306|515925127|FG001|Overall Study|Protocol Violation|1|||
143104940|NCT03575793|515925139|FG000|Overall Study|Withdrawal by Subject|0|||
143104941|NCT03575793|515925140|FG001|Overall Study|Withdrawal by Subject|1|||
143104942|NCT03575793|515925139|FG000|Overall Study|Never Treated|0|||
143104943|NCT03575793|515925140|FG001|Overall Study|Never Treated|2|||
143104944|NCT01250873|515925141|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
143104945|NCT01250873|515925141|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
143104946|NCT00930774|515925147|FG000|Overall Study|Withdrawal by Subject|1|||
143104947|NCT00930774|515925148|FG001|Overall Study|Withdrawal by Subject|9|||
143104948|NCT00930774|515925149|FG002|Overall Study|Withdrawal by Subject|2|||
143104949|NCT00930774|515925150|FG003|Overall Study|Withdrawal by Subject|0|||
143104950|NCT03200704|515925151|FG000|Overall Study|Withdrawal by Subject|1|||
143104951|NCT00654875|515925152|FG000|Overall Study|Adverse Event|5|||
143104952|NCT00654875|515925153|FG001|Overall Study|Adverse Event|5|||
143104953|NCT00654875|515925152|FG000|Overall Study|Withdrawal by Subject|4|||
143104954|NCT00654875|515925153|FG001|Overall Study|Withdrawal by Subject|4|||
143104955|NCT00654875|515925152|FG000|Overall Study|Protocol Violation|3|||
143104956|NCT00654875|515925153|FG001|Overall Study|Protocol Violation|3|||
143104957|NCT00654875|515925152|FG000|Overall Study|Lack of Efficacy|2|||
143104958|NCT00654875|515925153|FG001|Overall Study|Lack of Efficacy|2|||
143104959|NCT00654875|515925152|FG000|Overall Study|Lost to Follow-up|1|||
143104960|NCT00654875|515925153|FG001|Overall Study|Lost to Follow-up|3|||
143104961|NCT00654875|515925152|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
143104962|NCT00654875|515925153|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
143104963|NCT00654875|515925152|FG000|Overall Study|Administrative Problems|1|||
143104964|NCT00654875|515925153|FG001|Overall Study|Administrative Problems|0|||
143104965|NCT02042950|515925156|FG000|Overall Study|Progressive Disease|4|||
143104966|NCT01014988|515925160|FG000|Overall Study|Adverse Event|20|||
143104967|NCT01014988|515925161|FG001|Overall Study|Adverse Event|0|||
143104968|NCT01014988|515925162|FG002|Overall Study|Adverse Event|1|||
143104969|NCT01014988|515925163|FG003|Overall Study|Adverse Event|0|||
143104970|NCT01014988|515925164|FG004|Overall Study|Adverse Event|1|||
143104971|NCT01014988|515925165|FG005|Overall Study|Adverse Event|3|||
143104972|NCT01014988|515925160|FG000|Overall Study|Lost to Follow-up|1|||
143104973|NCT01014988|515925161|FG001|Overall Study|Lost to Follow-up|0|||
143104974|NCT01014988|515925162|FG002|Overall Study|Lost to Follow-up|1|||
143104975|NCT01014988|515925163|FG003|Overall Study|Lost to Follow-up|0|||
143104976|NCT01014988|515925164|FG004|Overall Study|Lost to Follow-up|0|||
143104977|NCT01014988|515925165|FG005|Overall Study|Lost to Follow-up|0|||
143104978|NCT01014988|515925160|FG000|Overall Study|Physician Decision|1|||
143104979|NCT01014988|515925161|FG001|Overall Study|Physician Decision|0|||
143104980|NCT01014988|515925162|FG002|Overall Study|Physician Decision|0|||
143104981|NCT01014988|515925163|FG003|Overall Study|Physician Decision|0|||
143104982|NCT01014988|515925164|FG004|Overall Study|Physician Decision|0|||
143104983|NCT01014988|515925165|FG005|Overall Study|Physician Decision|0|||
143104984|NCT01014988|515925160|FG000|Overall Study|Withdrawal by Subject|1|||
143104985|NCT01014988|515925161|FG001|Overall Study|Withdrawal by Subject|0|||
143104986|NCT01014988|515925162|FG002|Overall Study|Withdrawal by Subject|0|||
143104987|NCT01014988|515925163|FG003|Overall Study|Withdrawal by Subject|0|||
143104988|NCT01014988|515925164|FG004|Overall Study|Withdrawal by Subject|0|||
143104989|NCT01014988|515925165|FG005|Overall Study|Withdrawal by Subject|0|||
143104990|NCT00626821|515925176|FG000|Overall Study|Adverse Event|44|||
143104991|NCT00626821|515925176|FG000|Overall Study|Protocol Violation|33|||
143104992|NCT00626821|515925176|FG000|Overall Study|Withdrawal by Subject|10|||
143104993|NCT00626821|515925176|FG000|Overall Study|Physician Decision|9|||
143104994|NCT00626821|515925176|FG000|Overall Study|Product dysfunction|21|||
143104995|NCT00626821|515925176|FG000|Overall Study|other/unknown reason|104|||
143104996|NCT01940887|515925177|FG000|Year 1|Protocol Violation|0|||
143104997|NCT01940887|515925178|FG001|Year 1|Protocol Violation|1|||
143104998|NCT01940887|515925177|FG000|Year 1|Physician Decision|7|||
143104999|NCT01940887|515925178|FG001|Year 1|Physician Decision|3|||
143105000|NCT01940887|515925177|FG000|Year 1|Death|5|||
143105001|NCT01940887|515925178|FG001|Year 1|Death|3|||
143105002|NCT01940887|515925177|FG000|Year 1|Adverse Event|7|||
143105003|NCT01940887|515925178|FG001|Year 1|Adverse Event|6|||
143105004|NCT01940887|515925177|FG000|Year 1|Withdrawal by Subject|18|||
143105005|NCT01940887|515925178|FG001|Year 1|Withdrawal by Subject|9|||
143105006|NCT01940887|515925177|FG000|Year 1|Lost to Follow-up|2|||
143105007|NCT01940887|515925178|FG001|Year 1|Lost to Follow-up|1|||
143105008|NCT01940887|515925177|FG000|Year 2|Physician Decision|8|||
143105009|NCT01940887|515925178|FG001|Year 2|Physician Decision|1|||
143105010|NCT01940887|515925177|FG000|Year 2|Death|0|||
143105011|NCT01940887|515925178|FG001|Year 2|Death|2|||
143105012|NCT01940887|515925177|FG000|Year 2|Sponsor Decision, early termination|192|||
143105013|NCT01940887|515925178|FG001|Year 2|Sponsor Decision, early termination|203|||
143105014|NCT01940887|515925177|FG000|Year 2|Adverse Event|8|||
143105015|NCT01940887|515925178|FG001|Year 2|Adverse Event|2|||
143105016|NCT01940887|515925177|FG000|Year 2|Withdrawal by Subject|8|||
143105017|NCT01940887|515925178|FG001|Year 2|Withdrawal by Subject|8|||
143105018|NCT01940887|515925177|FG000|Year 2|Lost to Follow-up|1|||
143105019|NCT01940887|515925178|FG001|Year 2|Lost to Follow-up|6|||
143105020|NCT03521115|515925179|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
143105021|NCT03521115|515925180|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
143105022|NCT03521115|515925179|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
143105023|NCT03521115|515925180|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
143105024|NCT01981954|515925183|FG000|Titration Period|Protocol Deviation|1|||
143105025|NCT01981954|515925183|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
143105026|NCT04590586|515925184|FG000|Overall Study|Death|7|||
143178306|NCT02079909|516201523|FG000|Overall Study|Lost to Follow-up|2|||
143178307|NCT02079909|516201524|FG001|Overall Study|Lost to Follow-up|3|||
143178308|NCT02079909|516201525|FG002|Overall Study|Lost to Follow-up|1|||
143178309|NCT02079909|516201523|FG000|Overall Study|Death|2|||
143105027|NCT04590586|515925185|FG001|Overall Study|Death|1|||
143105028|NCT04590586|515925186|FG002|Overall Study|Death|37|||
143105029|NCT04590586|515925187|FG003|Overall Study|Death|34|||
143178310|NCT02079909|516201524|FG001|Overall Study|Death|2|||
143178311|NCT02079909|516201525|FG002|Overall Study|Death|0|||
143178312|NCT02079909|516201523|FG000|Overall Study|Lack of Efficacy|0|||
143178313|NCT02079909|516201524|FG001|Overall Study|Lack of Efficacy|0|||
143178314|NCT02079909|516201525|FG002|Overall Study|Lack of Efficacy|1|||
143178315|NCT02079909|516201523|FG000|Overall Study|Protocol Violation|0|||
143105030|NCT04590586|515925188|FG004|Overall Study|Death|19|||
143105031|NCT04590586|515925189|FG005|Overall Study|Death|3|||
143105032|NCT04590586|515925184|FG000|Overall Study|Lost to Follow-up|3|||
143105033|NCT04590586|515925185|FG001|Overall Study|Lost to Follow-up|0|||
143105034|NCT04590586|515925186|FG002|Overall Study|Lost to Follow-up|11|||
143105035|NCT04590586|515925187|FG003|Overall Study|Lost to Follow-up|11|||
143178316|NCT02079909|516201524|FG001|Overall Study|Protocol Violation|1|||
143178317|NCT02079909|516201525|FG002|Overall Study|Protocol Violation|1|||
143105036|NCT04590586|515925188|FG004|Overall Study|Lost to Follow-up|6|||
143105037|NCT04590586|515925189|FG005|Overall Study|Lost to Follow-up|0|||
143105038|NCT04590586|515925184|FG000|Overall Study|Withdrawal by Subject|0|||
143105039|NCT04590586|515925185|FG001|Overall Study|Withdrawal by Subject|0|||
143105040|NCT04590586|515925186|FG002|Overall Study|Withdrawal by Subject|6|||
143105041|NCT04590586|515925187|FG003|Overall Study|Withdrawal by Subject|0|||
143105042|NCT04590586|515925188|FG004|Overall Study|Withdrawal by Subject|3|||
143178318|NCT02079909|516201523|FG000|Overall Study|Physician Decision|0|||
143105043|NCT04590586|515925189|FG005|Overall Study|Withdrawal by Subject|0|||
143105044|NCT04590586|515925184|FG000|Overall Study|Other|3|||
143105045|NCT04590586|515925185|FG001|Overall Study|Other|0|||
143105046|NCT04590586|515925186|FG002|Overall Study|Other|1|||
143105047|NCT04590586|515925187|FG003|Overall Study|Other|1|||
143105048|NCT04590586|515925188|FG004|Overall Study|Other|2|||
143105049|NCT04590586|515925189|FG005|Overall Study|Other|1|||
143105050|NCT03063086|515925190|FG000|Overall Study|technical problems|1|||
143105051|NCT03063086|515925191|FG001|Overall Study|technical problems|0|||
143105052|NCT03063086|515925192|FG002|Overall Study|technical problems|0|||
143105053|NCT03063086|515925193|FG003|Overall Study|technical problems|0|||
143105054|NCT03063086|515925194|FG004|Overall Study|technical problems|0|||
143105055|NCT03063086|515925195|FG005|Overall Study|technical problems|0|||
143105056|NCT03063086|515925190|FG000|Overall Study|Adverse Event|1|||
143105057|NCT03063086|515925191|FG001|Overall Study|Adverse Event|1|||
143105058|NCT03063086|515925192|FG002|Overall Study|Adverse Event|1|||
143105059|NCT03063086|515925193|FG003|Overall Study|Adverse Event|1|||
143105060|NCT03063086|515925194|FG004|Overall Study|Adverse Event|0|||
143105061|NCT03063086|515925195|FG005|Overall Study|Adverse Event|0|||
143105062|NCT03063086|515925190|FG000|Overall Study|subject/guardian decision|1|||
143105063|NCT03063086|515925191|FG001|Overall Study|subject/guardian decision|0|||
143105064|NCT03063086|515925192|FG002|Overall Study|subject/guardian decision|0|||
143105065|NCT03063086|515925193|FG003|Overall Study|subject/guardian decision|0|||
143105066|NCT03063086|515925194|FG004|Overall Study|subject/guardian decision|0|||
143105067|NCT03063086|515925195|FG005|Overall Study|subject/guardian decision|0|||
143105068|NCT03063086|515925190|FG000|Overall Study|Non-compliance with study treatment|0|||
143105069|NCT03063086|515925191|FG001|Overall Study|Non-compliance with study treatment|0|||
143105070|NCT03063086|515925192|FG002|Overall Study|Non-compliance with study treatment|0|||
143105071|NCT03063086|515925193|FG003|Overall Study|Non-compliance with study treatment|1|||
143105072|NCT03063086|515925194|FG004|Overall Study|Non-compliance with study treatment|0|||
143105073|NCT03063086|515925195|FG005|Overall Study|Non-compliance with study treatment|1|||
143105074|NCT03063086|515925190|FG000|Overall Study|Physician Decision|0|||
143105075|NCT03063086|515925191|FG001|Overall Study|Physician Decision|0|||
143105076|NCT03063086|515925192|FG002|Overall Study|Physician Decision|0|||
143105077|NCT03063086|515925193|FG003|Overall Study|Physician Decision|1|||
143105078|NCT03063086|515925194|FG004|Overall Study|Physician Decision|0|||
143105079|NCT03063086|515925195|FG005|Overall Study|Physician Decision|0|||
143105080|NCT01290679|515925196|FG000|Overall Study|Adverse Event|2|||
143105081|NCT01290679|515925197|FG001|Overall Study|Adverse Event|0|||
143105082|NCT01290679|515925196|FG000|Overall Study|Lost to Follow-up|8|||
143105083|NCT01290679|515925197|FG001|Overall Study|Lost to Follow-up|10|||
143105084|NCT01290679|515925196|FG000|Overall Study|Protocol Violation|0|||
143105085|NCT01290679|515925197|FG001|Overall Study|Protocol Violation|1|||
143105086|NCT01290679|515925196|FG000|Overall Study|Withdrawal by Subject|6|||
143105087|NCT01290679|515925197|FG001|Overall Study|Withdrawal by Subject|5|||
143105088|NCT01290679|515925196|FG000|Overall Study|Subject Entered Another Trial|0|||
143105089|NCT01290679|515925197|FG001|Overall Study|Subject Entered Another Trial|5|||
143105090|NCT00562302|515925198|FG000|Overall Study|Lost to Follow-up|3|||
143105091|NCT00562302|515925199|FG001|Overall Study|Lost to Follow-up|3|||
143105092|NCT00562302|515925198|FG000|Overall Study|Adverse Event|0|||
143105093|NCT00562302|515925199|FG001|Overall Study|Adverse Event|6|||
143105094|NCT00562302|515925198|FG000|Overall Study|Non-compliance|1|||
143105095|NCT00562302|515925199|FG001|Overall Study|Non-compliance|2|||
143105096|NCT00562302|515925198|FG000|Overall Study|Withdrawal by Subject|7|||
143105097|NCT00562302|515925199|FG001|Overall Study|Withdrawal by Subject|8|||
143105098|NCT00562302|515925198|FG000|Overall Study|Death|1|||
143105099|NCT00562302|515925199|FG001|Overall Study|Death|2|||
143105100|NCT00562302|515925198|FG000|Overall Study|Lung resection prior to study completion|7|||
143105101|NCT00562302|515925199|FG001|Overall Study|Lung resection prior to study completion|7|||
143105102|NCT00562302|515925198|FG000|Overall Study|Not stated|1|||
143105103|NCT00562302|515925199|FG001|Overall Study|Not stated|4|||
143105104|NCT04791319|515925200|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
143105105|NCT04791319|515925201|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
143105106|NCT04791319|515925202|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
143105107|NCT04791319|515925203|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
143105108|NCT04791319|515925204|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
143105109|NCT04791319|515925205|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
143105110|NCT04791319|515925206|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
143178319|NCT02079909|516201524|FG001|Overall Study|Physician Decision|1|||
143178320|NCT02079909|516201525|FG002|Overall Study|Physician Decision|1|||
143178321|NCT02079909|516201523|FG000|Overall Study|Relocation etc.|2|||
143105111|NCT04791319|515925207|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
143105112|NCT04791319|515925208|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
143105113|NCT04791319|515925209|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
143105114|NCT04791319|515925210|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
143105115|NCT04791319|515925200|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
143178322|NCT02079909|516201524|FG001|Overall Study|Relocation etc.|2|||
143178323|NCT02079909|516201525|FG002|Overall Study|Relocation etc.|3|||
143178324|NCT03846427|516201528|FG000|Overall Study|Death|13|||
143178325|NCT03846427|516201528|FG000|Overall Study|Withdrawal by Subject|3|||
143178326|NCT03846427|516201528|FG000|Overall Study|Physician Decision|1|||
143178327|NCT01979614|516201529|FG000|Overall Study|Adverse Event|1|||
143178328|NCT01979614|516201530|FG001|Overall Study|Adverse Event|1|||
143178329|NCT00551031|516201531|FG000|Overall Study|Adverse Event|0|||
143105116|NCT04791319|515925201|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
143105117|NCT04791319|515925202|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
143105118|NCT04791319|515925203|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
143105119|NCT04791319|515925204|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
143105120|NCT04791319|515925205|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
143105121|NCT04791319|515925206|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
143105122|NCT04791319|515925207|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
143105123|NCT04791319|515925208|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
143105124|NCT04791319|515925209|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
143105125|NCT04791319|515925210|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
143105126|NCT04791319|515925200|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
143178330|NCT00551031|516201532|FG001|Overall Study|Adverse Event|1|||
143105127|NCT04791319|515925201|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
143105128|NCT04791319|515925202|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
143105129|NCT04791319|515925203|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
143105130|NCT04791319|515925204|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
143105131|NCT04791319|515925205|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
143105132|NCT04791319|515925206|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
143105133|NCT04791319|515925207|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
143105134|NCT04791319|515925208|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
143105135|NCT04791319|515925209|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
143105136|NCT04791319|515925210|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
143105137|NCT04791319|515925200|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
143105138|NCT04791319|515925201|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
143105139|NCT04791319|515925202|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
143178331|NCT00551031|516201533|FG002|Overall Study|Adverse Event|0|||
143178332|NCT00551031|516201534|FG003|Overall Study|Adverse Event|0|||
143178333|NCT00551031|516201535|FG004|Overall Study|Adverse Event|0|||
143178334|NCT00551031|516201531|FG000|Overall Study|Protocol Violation|1|||
143178335|NCT00551031|516201532|FG001|Overall Study|Protocol Violation|1|||
143178336|NCT00551031|516201533|FG002|Overall Study|Protocol Violation|0|||
143178337|NCT00551031|516201534|FG003|Overall Study|Protocol Violation|0|||
143178338|NCT00551031|516201535|FG004|Overall Study|Protocol Violation|0|||
143178339|NCT00551031|516201531|FG000|Overall Study|Lost to Follow-up|0|||
143367882|NCT01311713|516889460|FG003|Overall Study|Disease progression|2|||
143367883|NCT01311713|516889461|FG004|Overall Study|Disease progression|4|||
143367884|NCT01311713|516889462|FG005|Overall Study|Disease progression|4|||
143105140|NCT04791319|515925203|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
143105141|NCT04791319|515925204|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
143105142|NCT04791319|515925205|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
143105143|NCT04791319|515925206|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
143105144|NCT04791319|515925207|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
143105145|NCT04791319|515925208|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
143105146|NCT04791319|515925209|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
143105147|NCT04791319|515925210|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
143105148|NCT04791319|515925200|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
143105149|NCT04791319|515925201|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
143105150|NCT04791319|515925202|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
143178340|NCT00551031|516201532|FG001|Overall Study|Lost to Follow-up|1|||
143178341|NCT00551031|516201533|FG002|Overall Study|Lost to Follow-up|0|||
143178342|NCT00551031|516201534|FG003|Overall Study|Lost to Follow-up|1|||
143178343|NCT00551031|516201535|FG004|Overall Study|Lost to Follow-up|1|||
143178344|NCT00551031|516201531|FG000|Overall Study|Withdrawal by Subject|0|||
143178345|NCT00551031|516201532|FG001|Overall Study|Withdrawal by Subject|4|||
143178346|NCT00551031|516201533|FG002|Overall Study|Withdrawal by Subject|1|||
143367885|NCT01311713|516889463|FG006|Overall Study|Disease progression|5|||
143105151|NCT04791319|515925203|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
143105152|NCT04791319|515925204|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
143105153|NCT04791319|515925205|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
143105154|NCT04791319|515925206|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
143105155|NCT04791319|515925207|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
143105156|NCT04791319|515925208|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
143105157|NCT04791319|515925209|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
143105158|NCT04791319|515925210|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
143105159|NCT04791319|515925200|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
143105160|NCT04791319|515925201|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
143105161|NCT04791319|515925202|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
143105162|NCT04791319|515925203|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
143105163|NCT04791319|515925204|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
143105164|NCT04791319|515925205|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
143105165|NCT04791319|515925206|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
143105166|NCT04791319|515925207|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
143105167|NCT04791319|515925208|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
143105168|NCT04791319|515925209|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
143105169|NCT04791319|515925210|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
143105170|NCT04791319|515925200|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
143105171|NCT04791319|515925201|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
143105172|NCT04791319|515925202|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
143105173|NCT04791319|515925203|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
143105174|NCT04791319|515925204|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
143105175|NCT04791319|515925205|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
143105176|NCT04791319|515925206|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
143105177|NCT04791319|515925207|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
143105178|NCT04791319|515925208|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
143105179|NCT04791319|515925209|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
143105180|NCT04791319|515925210|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
143105181|NCT04791319|515925200|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
143105182|NCT04791319|515925201|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
143105183|NCT04791319|515925202|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
143105184|NCT04791319|515925203|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
143105185|NCT04791319|515925204|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
143105186|NCT04791319|515925205|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
143105187|NCT04791319|515925206|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
143105188|NCT04791319|515925207|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
143105189|NCT04791319|515925208|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
143105190|NCT04791319|515925209|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
143105191|NCT04791319|515925210|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
143105192|NCT04791319|515925200|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
143105193|NCT04791319|515925201|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
143105194|NCT04791319|515925202|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
143105195|NCT04791319|515925203|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
143105196|NCT04791319|515925204|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
143105197|NCT04791319|515925205|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
143105198|NCT04791319|515925206|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
143105199|NCT04791319|515925207|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
143105200|NCT04791319|515925208|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
143105201|NCT04791319|515925209|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
143105202|NCT04791319|515925210|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
143105203|NCT02587598|515925211|FG000|Overall Study|Death|4|||
143105204|NCT02587598|515925212|FG001|Overall Study|Death|8|||
143105205|NCT02587598|515925213|FG002|Overall Study|Death|4|||
143105206|NCT02587598|515925214|FG003|Overall Study|Death|16|||
143105207|NCT02587598|515925215|FG004|Overall Study|Death|9|||
143105208|NCT02587598|515925216|FG005|Overall Study|Death|4|||
143105209|NCT02587598|515925217|FG006|Overall Study|Death|6|||
143105210|NCT02587598|515925218|FG007|Overall Study|Death|7|||
143105211|NCT02587598|515925219|FG008|Overall Study|Death|9|||
143105212|NCT02587598|515925220|FG009|Overall Study|Death|1|||
143105213|NCT02587598|515925221|FG010|Overall Study|Death|3|||
143105214|NCT02587598|515925211|FG000|Overall Study|Study Terminated by the Sponsor|0|||
143105215|NCT02587598|515925212|FG001|Overall Study|Study Terminated by the Sponsor|1|||
143105216|NCT02587598|515925213|FG002|Overall Study|Study Terminated by the Sponsor|0|||
143105217|NCT02587598|515925214|FG003|Overall Study|Study Terminated by the Sponsor|3|||
143105218|NCT02587598|515925215|FG004|Overall Study|Study Terminated by the Sponsor|0|||
143178347|NCT00551031|516201534|FG003|Overall Study|Withdrawal by Subject|2|||
143178348|NCT00551031|516201535|FG004|Overall Study|Withdrawal by Subject|0|||
143178349|NCT00551031|516201531|FG000|Overall Study|Serious Adverse Event|0|||
143178350|NCT00551031|516201532|FG001|Overall Study|Serious Adverse Event|2|||
143178351|NCT00551031|516201533|FG002|Overall Study|Serious Adverse Event|1|||
143178352|NCT00551031|516201534|FG003|Overall Study|Serious Adverse Event|0|||
143178353|NCT00551031|516201535|FG004|Overall Study|Serious Adverse Event|0|||
143178354|NCT00551031|516201531|FG000|Overall Study|Did not receive vaccine|1|||
143178355|NCT00551031|516201532|FG001|Overall Study|Did not receive vaccine|2|||
143178356|NCT00551031|516201533|FG002|Overall Study|Did not receive vaccine|0|||
143178357|NCT00551031|516201534|FG003|Overall Study|Did not receive vaccine|0|||
143178358|NCT00551031|516201535|FG004|Overall Study|Did not receive vaccine|0|||
143178359|NCT01048242|516201542|FG000|Overall Study|See study flow chart|4|||
143178360|NCT01048242|516201543|FG001|Overall Study|See study flow chart|2|||
143178361|NCT00559104|516201544|FG000|Overall Study|Lack of Efficacy|9|||
143178362|NCT00559104|516201545|FG001|Overall Study|Lack of Efficacy|0|||
143178363|NCT00841776|516201546|FG000|Overall Study|Lack of Efficacy|0|||
143178364|NCT00841776|516201547|FG001|Overall Study|Lack of Efficacy|1|||
143178365|NCT00841776|516201546|FG000|Overall Study|Lost to Follow-up|2|||
143178366|NCT00841776|516201547|FG001|Overall Study|Lost to Follow-up|1|||
143178367|NCT00841776|516201546|FG000|Overall Study|Withdrawal by Subject|0|||
143178368|NCT00841776|516201547|FG001|Overall Study|Withdrawal by Subject|1|||
143178369|NCT04567524|516201548|FG000|Overall Study|Adverse Event|1|||
143178370|NCT04567524|516201549|FG001|Overall Study|Adverse Event|1|||
143178371|NCT04567524|516201550|FG002|Overall Study|Adverse Event|0|||
143178372|NCT04567524|516201551|FG003|Overall Study|Adverse Event|0|||
143178373|NCT04567524|516201548|FG000|Overall Study|Withdrawal by Subject|2|||
143178374|NCT04567524|516201549|FG001|Overall Study|Withdrawal by Subject|0|||
143178375|NCT04567524|516201550|FG002|Overall Study|Withdrawal by Subject|0|||
143178376|NCT04567524|516201551|FG003|Overall Study|Withdrawal by Subject|1|||
143178377|NCT00592631|516201552|FG000|Overall Study|Lost to Follow-up|0|||
143178378|NCT00592631|516201553|FG001|Overall Study|Lost to Follow-up|2|||
143178379|NCT00347932|516201555|FG000|Overall Study|Adverse Event|4|||
143178380|NCT00347932|516201556|FG001|Overall Study|Adverse Event|5|||
143178381|NCT00347932|516201555|FG000|Overall Study|Lack of Efficacy|3|||
143178382|NCT00347932|516201556|FG001|Overall Study|Lack of Efficacy|14|||
143178383|NCT00347932|516201555|FG000|Overall Study|Lost to Follow-up|10|||
143178384|NCT00347932|516201556|FG001|Overall Study|Lost to Follow-up|9|||
143178385|NCT00347932|516201555|FG000|Overall Study|Withdrawal by Subject|10|||
143178386|NCT00347932|516201556|FG001|Overall Study|Withdrawal by Subject|16|||
143178387|NCT00347932|516201555|FG000|Overall Study|Did not meet inclusion criteria|4|||
143105219|NCT02587598|515925216|FG005|Overall Study|Study Terminated by the Sponsor|1|||
143105220|NCT02587598|515925217|FG006|Overall Study|Study Terminated by the Sponsor|0|||
143105221|NCT02587598|515925218|FG007|Overall Study|Study Terminated by the Sponsor|0|||
143367886|NCT01311713|516889457|FG000|Overall Study|Lost to Follow-up|0|||
143367887|NCT01311713|516889458|FG001|Overall Study|Lost to Follow-up|0|||
143254121|NCT00065429|516483988|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
143254122|NCT00065429|516483989|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
143254123|NCT00065429|516483983|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
143254124|NCT00065429|516483984|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
143254125|NCT00065429|516483985|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
143254126|NCT00065429|516483986|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
143254127|NCT00065429|516483987|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
143254128|NCT00065429|516483988|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
143254129|NCT00065429|516483989|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
143254130|NCT00441116|516483993|FG000|Overall Study|Adverse Event|1|||
143254131|NCT00441116|516483994|FG001|Overall Study|Adverse Event|1|||
143254132|NCT00441116|516483993|FG000|Overall Study|Withdrawal by Subject|1|||
143254133|NCT00441116|516483994|FG001|Overall Study|Withdrawal by Subject|0|||
143254134|NCT00441116|516483993|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
143254135|NCT00441116|516483994|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
143254136|NCT02925338|516483995|FG000|Overall Study|Death|0|||
143254137|NCT02925338|516483996|FG001|Overall Study|Death|2|||
143254138|NCT02925338|516483997|FG002|Overall Study|Death|1|||
143254139|NCT02925338|516483998|FG003|Overall Study|Death|0|||
143254140|NCT02925338|516483999|FG004|Overall Study|Death|0|||
143254141|NCT02925338|516483995|FG000|Overall Study|Lost to Follow-up|30|||
143254142|NCT02925338|516483996|FG001|Overall Study|Lost to Follow-up|10|||
143254143|NCT02925338|516483997|FG002|Overall Study|Lost to Follow-up|1|||
143105222|NCT02587598|515925219|FG008|Overall Study|Study Terminated by the Sponsor|0|||
143254144|NCT02925338|516483998|FG003|Overall Study|Lost to Follow-up|16|||
143254145|NCT02925338|516483999|FG004|Overall Study|Lost to Follow-up|3|||
143254146|NCT02925338|516483995|FG000|Overall Study|Withdrawal by Subject|3|||
143254147|NCT02925338|516483996|FG001|Overall Study|Withdrawal by Subject|0|||
143367888|NCT01311713|516889459|FG002|Overall Study|Lost to Follow-up|1|||
143105223|NCT02587598|515925220|FG009|Overall Study|Study Terminated by the Sponsor|1|||
143105224|NCT02587598|515925221|FG010|Overall Study|Study Terminated by the Sponsor|6|||
143105225|NCT02587598|515925211|FG000|Overall Study|Reason for study withdrawal not specified|0|||
143105226|NCT02587598|515925212|FG001|Overall Study|Reason for study withdrawal not specified|1|||
143105227|NCT02587598|515925213|FG002|Overall Study|Reason for study withdrawal not specified|0|||
143105228|NCT02587598|515925214|FG003|Overall Study|Reason for study withdrawal not specified|0|||
143105229|NCT02587598|515925215|FG004|Overall Study|Reason for study withdrawal not specified|0|||
143105230|NCT02587598|515925216|FG005|Overall Study|Reason for study withdrawal not specified|0|||
143105231|NCT02587598|515925217|FG006|Overall Study|Reason for study withdrawal not specified|0|||
143105232|NCT02587598|515925218|FG007|Overall Study|Reason for study withdrawal not specified|0|||
143105233|NCT02587598|515925219|FG008|Overall Study|Reason for study withdrawal not specified|0|||
143105234|NCT02587598|515925220|FG009|Overall Study|Reason for study withdrawal not specified|0|||
143105235|NCT02587598|515925221|FG010|Overall Study|Reason for study withdrawal not specified|0|||
143105236|NCT02587598|515925211|FG000|Overall Study|Withdrawal by Subject|0|||
143105237|NCT02587598|515925212|FG001|Overall Study|Withdrawal by Subject|1|||
143105238|NCT02587598|515925213|FG002|Overall Study|Withdrawal by Subject|0|||
143105239|NCT02587598|515925214|FG003|Overall Study|Withdrawal by Subject|2|||
143105240|NCT02587598|515925215|FG004|Overall Study|Withdrawal by Subject|3|||
143105241|NCT02587598|515925216|FG005|Overall Study|Withdrawal by Subject|1|||
143105242|NCT02587598|515925217|FG006|Overall Study|Withdrawal by Subject|0|||
143105243|NCT02587598|515925218|FG007|Overall Study|Withdrawal by Subject|0|||
143105244|NCT02587598|515925219|FG008|Overall Study|Withdrawal by Subject|0|||
143105245|NCT02587598|515925220|FG009|Overall Study|Withdrawal by Subject|1|||
143105246|NCT02587598|515925221|FG010|Overall Study|Withdrawal by Subject|2|||
143105247|NCT02587598|515925211|FG000|Overall Study|Physician Decision|0|||
143105248|NCT02587598|515925212|FG001|Overall Study|Physician Decision|0|||
143105249|NCT02587598|515925213|FG002|Overall Study|Physician Decision|0|||
143105250|NCT02587598|515925214|FG003|Overall Study|Physician Decision|0|||
143105251|NCT02587598|515925215|FG004|Overall Study|Physician Decision|0|||
143105252|NCT02587598|515925216|FG005|Overall Study|Physician Decision|0|||
143105253|NCT02587598|515925217|FG006|Overall Study|Physician Decision|0|||
143105254|NCT02587598|515925218|FG007|Overall Study|Physician Decision|0|||
143105255|NCT02587598|515925219|FG008|Overall Study|Physician Decision|0|||
143105256|NCT02587598|515925220|FG009|Overall Study|Physician Decision|0|||
143105257|NCT02587598|515925221|FG010|Overall Study|Physician Decision|3|||
143105258|NCT01704651|515925228|FG000|Overall Study|Pre-op withdrawal by subject|1|||
143105259|NCT01704651|515925229|FG001|Overall Study|Pre-op withdrawal by subject|1|||
143105260|NCT01704651|515925228|FG000|Overall Study|Pre-op change in treatment plan|1|||
143105261|NCT01704651|515925229|FG001|Overall Study|Pre-op change in treatment plan|4|||
143105262|NCT01704651|515925228|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
143105263|NCT01704651|515925229|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
143105264|NCT01704651|515925228|FG000|Overall Study|Post-op did not have laparotomy|2|||
143105265|NCT01704651|515925229|FG001|Overall Study|Post-op did not have laparotomy|1|||
143105266|NCT03474731|515925232|FG000|Overall Study|Withdrawal by Subject|36|||
143105267|NCT03474731|515925233|FG001|Overall Study|Withdrawal by Subject|29|||
143105268|NCT03474731|515925234|FG002|Overall Study|Withdrawal by Subject|11|||
143105269|NCT03474731|515925235|FG003|Overall Study|Withdrawal by Subject|27|||
143105270|NCT03474731|515925232|FG000|Overall Study|COVID|0|||
143105271|NCT03474731|515925233|FG001|Overall Study|COVID|23|||
143105272|NCT03474731|515925234|FG002|Overall Study|COVID|0|||
143105273|NCT03474731|515925235|FG003|Overall Study|COVID|0|||
143105274|NCT03474731|515925232|FG000|Overall Study|Participant moved from area|1|||
143105275|NCT03474731|515925233|FG001|Overall Study|Participant moved from area|0|||
143105276|NCT03474731|515925234|FG002|Overall Study|Participant moved from area|0|||
143105277|NCT03474731|515925235|FG003|Overall Study|Participant moved from area|0|||
143105278|NCT03474731|515925232|FG000|Overall Study|Lost to Follow-up|11|||
143105279|NCT03474731|515925233|FG001|Overall Study|Lost to Follow-up|3|||
143105280|NCT03474731|515925234|FG002|Overall Study|Lost to Follow-up|18|||
143105281|NCT03474731|515925235|FG003|Overall Study|Lost to Follow-up|17|||
143178388|NCT00347932|516201556|FG001|Overall Study|Did not meet inclusion criteria|8|||
143178389|NCT04512001|516201557|FG000|Week 0 to Week 24|Adverse Event|14|||
143178390|NCT04512001|516201558|FG001|Week 0 to Week 24|Adverse Event|10|||
143178391|NCT04512001|516201559|FG002|Week 0 to Week 24|Adverse Event|0|||
143178392|NCT04512001|516201560|FG003|Week 0 to Week 24|Adverse Event|0|||
143105282|NCT03474731|515925232|FG000|Overall Study|Death|0|||
143105283|NCT03474731|515925233|FG001|Overall Study|Death|1|||
143105284|NCT03474731|515925234|FG002|Overall Study|Death|0|||
143105285|NCT03474731|515925235|FG003|Overall Study|Death|0|||
143105286|NCT03474731|515925232|FG000|Overall Study|Participant Removed|0|||
143105287|NCT03474731|515925233|FG001|Overall Study|Participant Removed|0|||
143105288|NCT03474731|515925234|FG002|Overall Study|Participant Removed|0|||
143105289|NCT03474731|515925235|FG003|Overall Study|Participant Removed|1|||
143105290|NCT03502070|515925239|FG000|Overall Study|Withdrawal by Subject|1|||
143105291|NCT03502070|515925239|FG000|Overall Study|Screen Failure|1|||
143105292|NCT00552396|515925247|FG000|Overall Study|protocol withdrawal criteria|3|||
143105293|NCT00552396|515925248|FG001|Overall Study|protocol withdrawal criteria|3|||
143105294|NCT00552396|515925249|FG002|Overall Study|protocol withdrawal criteria|3|||
143105295|NCT00552396|515925250|FG003|Overall Study|protocol withdrawal criteria|6|||
143105296|NCT00552396|515925251|FG004|Overall Study|protocol withdrawal criteria|3|||
143105297|NCT00552396|515925252|FG005|Overall Study|protocol withdrawal criteria|3|||
143105298|NCT00552396|515925253|FG006|Overall Study|protocol withdrawal criteria|9|||
143105299|NCT02553499|515925254|FG000|Overall Study|Adverse Event|0|||
143105300|NCT02553499|515925255|FG001|Overall Study|Adverse Event|0|||
143105301|NCT02553499|515925256|FG002|Overall Study|Adverse Event|0|||
143105302|NCT02553499|515925257|FG003|Overall Study|Adverse Event|0|||
143105303|NCT02553499|515925258|FG004|Overall Study|Adverse Event|0|||
143105304|NCT02553499|515925259|FG005|Overall Study|Adverse Event|0|||
143105305|NCT02553499|515925260|FG006|Overall Study|Adverse Event|1|||
143178393|NCT04512001|516201561|FG004|Week 0 to Week 24|Adverse Event|0|||
143178394|NCT04512001|516201557|FG000|Week 0 to Week 24|Death|0|||
143178395|NCT04512001|516201558|FG001|Week 0 to Week 24|Death|2|||
143178396|NCT04512001|516201559|FG002|Week 0 to Week 24|Death|0|||
143178397|NCT04512001|516201560|FG003|Week 0 to Week 24|Death|0|||
143178398|NCT04512001|516201561|FG004|Week 0 to Week 24|Death|0|||
143178399|NCT04512001|516201557|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
143178400|NCT04512001|516201558|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
143178401|NCT04512001|516201559|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
143178402|NCT04512001|516201560|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
143178403|NCT04512001|516201561|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
143178404|NCT04512001|516201557|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
143178405|NCT04512001|516201558|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
143254148|NCT02925338|516483997|FG002|Overall Study|Withdrawal by Subject|3|||
143105306|NCT02553499|515925261|FG007|Overall Study|Adverse Event|1|||
143105307|NCT02553499|515925262|FG008|Overall Study|Adverse Event|0|||
143254149|NCT02925338|516483998|FG003|Overall Study|Withdrawal by Subject|2|||
143254150|NCT02925338|516483999|FG004|Overall Study|Withdrawal by Subject|2|||
143254151|NCT02925338|516483995|FG000|Overall Study|Missing|38|||
143254152|NCT02925338|516483996|FG001|Overall Study|Missing|27|||
143254153|NCT02925338|516483997|FG002|Overall Study|Missing|0|||
143254154|NCT02925338|516483998|FG003|Overall Study|Missing|3|||
143254155|NCT02925338|516483999|FG004|Overall Study|Missing|2|||
143254156|NCT02925338|516483995|FG000|Overall Study|Participant's Decision|11|||
143254157|NCT02925338|516483996|FG001|Overall Study|Participant's Decision|7|||
143254158|NCT02925338|516483997|FG002|Overall Study|Participant's Decision|3|||
143254159|NCT02925338|516483998|FG003|Overall Study|Participant's Decision|8|||
143254160|NCT02925338|516483999|FG004|Overall Study|Participant's Decision|1|||
143254161|NCT02925338|516483995|FG000|Overall Study|Treatment Discontinuation|144|||
143254162|NCT02925338|516483996|FG001|Overall Study|Treatment Discontinuation|65|||
143254163|NCT02925338|516483997|FG002|Overall Study|Treatment Discontinuation|56|||
143254164|NCT02925338|516483998|FG003|Overall Study|Treatment Discontinuation|131|||
143254165|NCT02925338|516483999|FG004|Overall Study|Treatment Discontinuation|22|||
143254166|NCT00832624|516484000|FG000|Overall Study|Study Terminated|10|||
143254167|NCT00548184|516484003|FG000|Overall Study|Adverse Event|3|||
143254168|NCT00548184|516484003|FG000|Overall Study|took other drug|1|||
143254169|NCT00548184|516484003|FG000|Overall Study|Found Her2 negative|1|||
143254170|NCT01546623|516484007|FG000|Overall Study|Adverse Event|2|||
143254171|NCT01546623|516484008|FG001|Overall Study|Adverse Event|3|||
143254172|NCT01546623|516484007|FG000|Overall Study|Major Protocol Deviation|1|||
143254173|NCT01546623|516484008|FG001|Overall Study|Major Protocol Deviation|1|||
143254174|NCT01546623|516484007|FG000|Overall Study|High Prostate specific antigen|2|||
143254175|NCT01546623|516484008|FG001|Overall Study|High Prostate specific antigen|1|||
143254176|NCT01546623|516484007|FG000|Overall Study|Did Not Receive Study Drug|1|||
143254177|NCT01546623|516484008|FG001|Overall Study|Did Not Receive Study Drug|1|||
143254178|NCT04525885|516484009|FG000|Overall Study|Screen Failure|1|||
143254179|NCT04525885|516484010|FG001|Overall Study|Screen Failure|0|||
143254180|NCT04525885|516484011|FG002|Overall Study|Screen Failure|0|||
143105308|NCT02553499|515925263|FG009|Overall Study|Adverse Event|0|||
143254181|NCT04525885|516484009|FG000|Overall Study|Withdrawal by Subject|14|||
143254182|NCT04525885|516484010|FG001|Overall Study|Withdrawal by Subject|6|||
143254183|NCT04525885|516484011|FG002|Overall Study|Withdrawal by Subject|20|||
143254184|NCT04525885|516484009|FG000|Overall Study|Physician Decision|1|||
143178406|NCT04512001|516201559|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
143105309|NCT02553499|515925264|FG010|Overall Study|Adverse Event|0|||
143105310|NCT02553499|515925265|FG011|Overall Study|Adverse Event|0|||
143105311|NCT02553499|515925266|FG012|Overall Study|Adverse Event|0|||
143105312|NCT02553499|515925267|FG013|Overall Study|Adverse Event|1|||
143105313|NCT02553499|515925254|FG000|Overall Study|Death|0|||
143105314|NCT02553499|515925255|FG001|Overall Study|Death|1|||
143105315|NCT02553499|515925256|FG002|Overall Study|Death|1|||
143105316|NCT02553499|515925257|FG003|Overall Study|Death|0|||
143105317|NCT02553499|515925258|FG004|Overall Study|Death|1|||
143254185|NCT04525885|516484010|FG001|Overall Study|Physician Decision|0|||
143254186|NCT04525885|516484011|FG002|Overall Study|Physician Decision|1|||
143254187|NCT00978757|516484017|FG000|Overall Study|Physician Decision|1|||
143254188|NCT00978757|516484018|FG001|Overall Study|Physician Decision|3|||
143254189|NCT01700387|516484020|FG000|Overall Study|Withdrawal by Subject|1|||
143254190|NCT01700387|516484021|FG001|Overall Study|Withdrawal by Subject|2|||
143254191|NCT01700387|516484020|FG000|Overall Study|Adverse Event|1|||
143254192|NCT01700387|516484021|FG001|Overall Study|Adverse Event|1|||
143254193|NCT01700387|516484020|FG000|Overall Study|Lost to Follow-up|2|||
143254194|NCT01700387|516484021|FG001|Overall Study|Lost to Follow-up|1|||
143254195|NCT01185353|516484022|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
143254196|NCT01185353|516484023|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
143254197|NCT01185353|516484024|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
143254198|NCT01185353|516484025|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
143254199|NCT01185353|516484026|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
143254200|NCT01185353|516484027|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
143254201|NCT01185353|516484028|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
143254202|NCT01185353|516484029|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
143254203|NCT01185353|516484030|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
143254204|NCT01185353|516484031|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
143254205|NCT01185353|516484022|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
143254206|NCT01185353|516484023|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
143254207|NCT01185353|516484024|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
143254208|NCT01185353|516484025|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
143254209|NCT01185353|516484026|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
143254210|NCT01185353|516484027|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
143254211|NCT01185353|516484028|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
143254212|NCT01185353|516484029|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
143254213|NCT01185353|516484030|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
143254214|NCT01185353|516484031|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
143254215|NCT01185353|516484022|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
143254216|NCT01185353|516484023|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
143254217|NCT01185353|516484024|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
143254218|NCT01185353|516484025|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
143254219|NCT01185353|516484026|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
143254220|NCT01185353|516484027|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
143254221|NCT01185353|516484028|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
143254222|NCT01185353|516484029|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
143254223|NCT01185353|516484030|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
143254224|NCT01185353|516484031|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
143254225|NCT01185353|516484022|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
143254226|NCT01185353|516484023|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
143254227|NCT01185353|516484024|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
143254228|NCT01185353|516484025|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
143254229|NCT01185353|516484026|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
143254230|NCT01185353|516484027|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
143254231|NCT01185353|516484028|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
143254232|NCT01185353|516484029|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
143254233|NCT01185353|516484030|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
143254234|NCT01185353|516484031|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
143254235|NCT01185353|516484022|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
143254236|NCT01185353|516484023|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
143254237|NCT01185353|516484024|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
143254238|NCT01185353|516484025|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
143254239|NCT01185353|516484026|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
143254240|NCT01185353|516484027|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
143254241|NCT01185353|516484028|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
143254242|NCT01185353|516484029|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
143254243|NCT01185353|516484030|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
143254244|NCT01185353|516484031|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
143254245|NCT01185353|516484022|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
143254246|NCT01185353|516484023|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
143254247|NCT01185353|516484024|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
143254248|NCT01185353|516484025|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
143367889|NCT01311713|516889460|FG003|Overall Study|Lost to Follow-up|0|||
143254249|NCT01185353|516484026|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
143254250|NCT01185353|516484027|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
143254251|NCT01185353|516484028|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
143254252|NCT01185353|516484029|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
143254253|NCT01185353|516484030|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
143254254|NCT01185353|516484031|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
143105318|NCT02553499|515925259|FG005|Overall Study|Death|2|||
143105319|NCT02553499|515925260|FG006|Overall Study|Death|0|||
143105320|NCT02553499|515925261|FG007|Overall Study|Death|0|||
143105321|NCT02553499|515925262|FG008|Overall Study|Death|0|||
143105322|NCT02553499|515925263|FG009|Overall Study|Death|0|||
143105323|NCT02553499|515925264|FG010|Overall Study|Death|1|||
143105324|NCT02553499|515925265|FG011|Overall Study|Death|0|||
143105325|NCT02553499|515925266|FG012|Overall Study|Death|0|||
143178407|NCT04512001|516201560|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
143178408|NCT04512001|516201561|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
143178409|NCT04512001|516201557|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
143178410|NCT04512001|516201558|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
143105326|NCT02553499|515925267|FG013|Overall Study|Death|0|||
143105327|NCT02553499|515925254|FG000|Overall Study|Lost to Follow-up|0|||
143254255|NCT01185353|516484022|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
143254256|NCT01185353|516484023|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
143254257|NCT01185353|516484024|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
143254258|NCT01185353|516484025|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
143254259|NCT01185353|516484026|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
143254260|NCT01185353|516484027|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
143254261|NCT01185353|516484028|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
143254262|NCT01185353|516484029|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
143254263|NCT01185353|516484030|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
143254264|NCT01185353|516484031|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
143254265|NCT01185353|516484022|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
143254266|NCT01185353|516484023|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
143254267|NCT01185353|516484024|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
143254268|NCT01185353|516484025|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
143254269|NCT01185353|516484026|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
143254270|NCT01185353|516484027|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
143254271|NCT01185353|516484028|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
143254272|NCT01185353|516484029|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
143254273|NCT01185353|516484030|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
143254274|NCT01185353|516484031|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
143254275|NCT01185353|516484022|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
143254276|NCT01185353|516484023|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
143254277|NCT01185353|516484024|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
143254278|NCT01185353|516484025|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
143254279|NCT01185353|516484026|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
143254280|NCT01185353|516484027|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
143254281|NCT01185353|516484028|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
143254282|NCT01185353|516484029|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
143254283|NCT01185353|516484030|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
143254284|NCT01185353|516484031|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
143254285|NCT01185353|516484022|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
143254286|NCT01185353|516484023|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
143254287|NCT01185353|516484024|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
143254288|NCT01185353|516484025|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
143254289|NCT01185353|516484026|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
143254290|NCT01185353|516484027|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
143254291|NCT01185353|516484028|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
143254292|NCT01185353|516484029|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
143254293|NCT01185353|516484030|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
143254294|NCT01185353|516484031|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
143254295|NCT01185353|516484022|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
143254296|NCT01185353|516484023|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
143254297|NCT01185353|516484024|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
143254298|NCT01185353|516484025|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
143254299|NCT01185353|516484026|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
143254300|NCT01185353|516484027|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
143254301|NCT01185353|516484028|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
143254302|NCT01185353|516484029|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
143254303|NCT01185353|516484030|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
143254304|NCT01185353|516484031|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
143254305|NCT01185353|516484022|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
143254306|NCT01185353|516484023|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
143254307|NCT01185353|516484024|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
143254308|NCT01185353|516484025|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
143254309|NCT01185353|516484026|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
143254310|NCT01185353|516484027|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
143254311|NCT01185353|516484028|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
143254312|NCT01185353|516484029|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
143254313|NCT01185353|516484030|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
143254314|NCT01185353|516484031|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
143254315|NCT01185353|516484022|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
143254316|NCT01185353|516484023|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
143254317|NCT01185353|516484024|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
143254318|NCT01185353|516484025|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
143254319|NCT01185353|516484026|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
143254320|NCT01185353|516484027|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
143254321|NCT01185353|516484028|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
143254322|NCT01185353|516484029|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
143105328|NCT02553499|515925255|FG001|Overall Study|Lost to Follow-up|0|||
143105329|NCT02553499|515925256|FG002|Overall Study|Lost to Follow-up|0|||
143105330|NCT02553499|515925257|FG003|Overall Study|Lost to Follow-up|0|||
143105331|NCT02553499|515925258|FG004|Overall Study|Lost to Follow-up|0|||
143105332|NCT02553499|515925259|FG005|Overall Study|Lost to Follow-up|0|||
143105333|NCT02553499|515925260|FG006|Overall Study|Lost to Follow-up|1|||
143254323|NCT01185353|516484030|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
143254324|NCT01185353|516484031|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
143254325|NCT01185353|516484022|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
143254326|NCT01185353|516484023|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
143254327|NCT01185353|516484024|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
143254328|NCT01185353|516484025|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
143254329|NCT01185353|516484026|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
143254330|NCT01185353|516484027|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
143254331|NCT01185353|516484028|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
143254332|NCT01185353|516484029|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
143254333|NCT01185353|516484030|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
143254334|NCT01185353|516484031|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
143254335|NCT01185353|516484022|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
143254336|NCT01185353|516484023|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
143254337|NCT01185353|516484024|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
143254338|NCT01185353|516484025|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
143254339|NCT01185353|516484026|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
143254340|NCT01185353|516484027|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
143254341|NCT01185353|516484028|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
143254342|NCT01185353|516484029|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
143254343|NCT01185353|516484030|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
143254344|NCT01185353|516484031|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
143254345|NCT01185353|516484022|FG000|Part C (Weeks 24 Through 76)|Death|0|||
143254346|NCT01185353|516484023|FG001|Part C (Weeks 24 Through 76)|Death|0|||
143254347|NCT01185353|516484024|FG002|Part C (Weeks 24 Through 76)|Death|0|||
143254348|NCT01185353|516484025|FG003|Part C (Weeks 24 Through 76)|Death|0|||
143254349|NCT01185353|516484026|FG004|Part C (Weeks 24 Through 76)|Death|0|||
143254350|NCT01185353|516484027|FG005|Part C (Weeks 24 Through 76)|Death|0|||
143254351|NCT01185353|516484028|FG006|Part C (Weeks 24 Through 76)|Death|0|||
143254352|NCT01185353|516484029|FG007|Part C (Weeks 24 Through 76)|Death|0|||
143254353|NCT01185353|516484030|FG008|Part C (Weeks 24 Through 76)|Death|0|||
143254354|NCT01185353|516484031|FG009|Part C (Weeks 24 Through 76)|Death|1|||
143254355|NCT01185353|516484022|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
143254356|NCT01185353|516484023|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
143254357|NCT01185353|516484024|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
143254358|NCT01185353|516484025|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
143254359|NCT01185353|516484026|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
143254360|NCT01185353|516484027|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
143254361|NCT01185353|516484028|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
143254362|NCT01185353|516484029|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
143254363|NCT01185353|516484030|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
143254364|NCT01185353|516484031|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
143254365|NCT01185353|516484022|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
143254366|NCT01185353|516484023|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
143254367|NCT01185353|516484024|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
143254368|NCT01185353|516484025|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
143105334|NCT02553499|515925261|FG007|Overall Study|Lost to Follow-up|0|||
143105335|NCT02553499|515925262|FG008|Overall Study|Lost to Follow-up|0|||
143105336|NCT02553499|515925263|FG009|Overall Study|Lost to Follow-up|0|||
143105337|NCT02553499|515925264|FG010|Overall Study|Lost to Follow-up|0|||
143105338|NCT02553499|515925265|FG011|Overall Study|Lost to Follow-up|0|||
143105339|NCT02553499|515925266|FG012|Overall Study|Lost to Follow-up|0|||
143105340|NCT02553499|515925267|FG013|Overall Study|Lost to Follow-up|0|||
143105341|NCT02553499|515925254|FG000|Overall Study|Physician Decision|0|||
143105342|NCT02553499|515925255|FG001|Overall Study|Physician Decision|1|||
143105343|NCT02553499|515925256|FG002|Overall Study|Physician Decision|1|||
143105344|NCT02553499|515925257|FG003|Overall Study|Physician Decision|0|||
143105345|NCT02553499|515925258|FG004|Overall Study|Physician Decision|1|||
143105346|NCT02553499|515925259|FG005|Overall Study|Physician Decision|0|||
143105347|NCT02553499|515925260|FG006|Overall Study|Physician Decision|0|||
143178411|NCT04512001|516201559|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
143105348|NCT02553499|515925261|FG007|Overall Study|Physician Decision|1|||
143105349|NCT02553499|515925262|FG008|Overall Study|Physician Decision|1|||
143105350|NCT02553499|515925263|FG009|Overall Study|Physician Decision|2|||
143178412|NCT04512001|516201560|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
143178413|NCT04512001|516201561|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
143178414|NCT04512001|516201557|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
143178415|NCT04512001|516201558|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
143178416|NCT04512001|516201559|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
143178417|NCT04512001|516201560|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
143178418|NCT04512001|516201561|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
143178419|NCT04512001|516201557|FG000|Week 24 to Week 63|Adverse Event|0|||
143178420|NCT04512001|516201558|FG001|Week 24 to Week 63|Adverse Event|0|||
143178421|NCT04512001|516201559|FG002|Week 24 to Week 63|Adverse Event|13|||
143178422|NCT04512001|516201560|FG003|Week 24 to Week 63|Adverse Event|8|||
143178423|NCT04512001|516201561|FG004|Week 24 to Week 63|Adverse Event|6|||
143178424|NCT04512001|516201557|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
143178425|NCT04512001|516201558|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
143178426|NCT04512001|516201559|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
143178427|NCT04512001|516201560|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
143178428|NCT04512001|516201561|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
143178429|NCT04512001|516201557|FG000|Week 24 to Week 63|Death|0|||
143178430|NCT04512001|516201558|FG001|Week 24 to Week 63|Death|0|||
143178431|NCT04512001|516201559|FG002|Week 24 to Week 63|Death|0|||
143178432|NCT04512001|516201560|FG003|Week 24 to Week 63|Death|1|||
143178433|NCT04512001|516201561|FG004|Week 24 to Week 63|Death|1|||
143178434|NCT04512001|516201557|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
143178435|NCT04512001|516201558|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
143178436|NCT04512001|516201559|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
143178437|NCT04512001|516201560|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
143178438|NCT04512001|516201561|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
143178439|NCT04512001|516201557|FG000|Week 24 to Week 63|Miscellaneous|0|||
143178440|NCT04512001|516201558|FG001|Week 24 to Week 63|Miscellaneous|0|||
143178441|NCT04512001|516201559|FG002|Week 24 to Week 63|Miscellaneous|3|||
143178442|NCT04512001|516201560|FG003|Week 24 to Week 63|Miscellaneous|2|||
143178443|NCT04512001|516201561|FG004|Week 24 to Week 63|Miscellaneous|1|||
143254369|NCT01185353|516484026|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
143254370|NCT01185353|516484027|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
143254371|NCT01185353|516484028|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
143254372|NCT01185353|516484029|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
143254373|NCT01185353|516484030|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
143254374|NCT01185353|516484031|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
143254375|NCT01185353|516484022|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
143254376|NCT01185353|516484023|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
143254377|NCT01185353|516484024|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
143254378|NCT01185353|516484025|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
143254379|NCT01185353|516484026|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
143254380|NCT01185353|516484027|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
143254381|NCT01185353|516484028|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
143254382|NCT01185353|516484029|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
143254383|NCT01185353|516484030|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
143254384|NCT01185353|516484031|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
143254385|NCT01185353|516484022|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
143254386|NCT01185353|516484023|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
143254387|NCT01185353|516484024|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
143254388|NCT01185353|516484025|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
143254389|NCT01185353|516484026|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
143254390|NCT01185353|516484027|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
143254391|NCT01185353|516484028|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
143254392|NCT01185353|516484029|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
143254393|NCT01185353|516484030|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
143254394|NCT01185353|516484031|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
143254395|NCT01185353|516484022|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
143254396|NCT01185353|516484023|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
143254397|NCT01185353|516484024|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
143254398|NCT01185353|516484025|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
143254399|NCT01185353|516484026|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
143254400|NCT01185353|516484027|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
143254401|NCT01185353|516484028|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
143254402|NCT01185353|516484029|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
143254403|NCT01185353|516484030|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
143254404|NCT01185353|516484031|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
143254405|NCT01185353|516484022|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
143254406|NCT01185353|516484023|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
143254407|NCT01185353|516484024|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
143254408|NCT01185353|516484025|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
143254409|NCT01185353|516484026|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
143254410|NCT01185353|516484027|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
143254411|NCT01185353|516484028|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
143254412|NCT01185353|516484029|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
143254413|NCT01185353|516484030|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
143254414|NCT01185353|516484031|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
143254415|NCT02270944|516484035|FG000|Overall Study|Lost to Follow-up|9|||
143254416|NCT02270944|516484036|FG001|Overall Study|Lost to Follow-up|4|||
143254417|NCT02270944|516484035|FG000|Overall Study|Withdrawal by Subject|2|||
143254418|NCT02270944|516484036|FG001|Overall Study|Withdrawal by Subject|1|||
143254419|NCT01182844|516484039|FG000|Overall Study|Withdrawal by Subject|0|||
143254420|NCT01182844|516484040|FG001|Overall Study|Withdrawal by Subject|2|||
143254421|NCT01221272|516486076|FG000|Period 1|Adverse Event|2|||
143254422|NCT01221272|516486077|FG001|Period 1|Adverse Event|0|||
143254423|NCT01221272|516486076|FG000|Period 1|Consent Withdrawal|0|||
143254424|NCT01221272|516486077|FG001|Period 1|Consent Withdrawal|1|||
143254425|NCT01221272|516486076|FG000|Period 1|Significant Dosing Noncompliance|0|||
143254426|NCT01221272|516486077|FG001|Period 1|Significant Dosing Noncompliance|1|||
143254427|NCT01221272|516486076|FG000|Period 2|Adverse Event|0|||
143254428|NCT01221272|516486077|FG001|Period 2|Adverse Event|2|||
143254429|NCT01771809|516486078|FG000|Overall Study|Adverse Event|4|||
143254430|NCT01771809|516486079|FG001|Overall Study|Adverse Event|12|||
143254431|NCT01771809|516486078|FG000|Overall Study|Protocol Violation|0|||
143254432|NCT01771809|516486079|FG001|Overall Study|Protocol Violation|1|||
143254433|NCT01771809|516486078|FG000|Overall Study|Withdrawal by Subject|34|||
143254434|NCT01771809|516486079|FG001|Overall Study|Withdrawal by Subject|42|||
143254435|NCT01771809|516486078|FG000|Overall Study|Lost to Follow-up|1|||
143254436|NCT01771809|516486079|FG001|Overall Study|Lost to Follow-up|3|||
143254437|NCT01771809|516486078|FG000|Overall Study|Other (Insufficient clinical response)|22|||
143254438|NCT01771809|516486079|FG001|Overall Study|Other (Insufficient clinical response)|20|||
143254439|NCT01771809|516486078|FG000|Overall Study|Death|1|||
143254440|NCT01771809|516486079|FG001|Overall Study|Death|0|||
143254441|NCT01771809|516486078|FG000|Overall Study|Other (other)|9|||
143254442|NCT01771809|516486079|FG001|Overall Study|Other (other)|5|||
143254443|NCT01012219|516486082|FG000|Period 1|Withdrawal by Subject|1|||
143254444|NCT01012219|516486082|FG000|Period 2|Withdrawal by Subject|1|||
143254445|NCT01444092|516486083|FG000|Overall Study|Adverse Event|8|||
143254446|NCT01444092|516486083|FG000|Overall Study|Protocol Violation|1|||
143254447|NCT01444092|516486083|FG000|Overall Study|Withdrawal by Subject|1|||
143254448|NCT01444092|516486083|FG000|Overall Study|Other Eligibility criteria|7|||
143254449|NCT03005873|516486084|FG000|Overall Study|Prohibited medication use post radnomization|1|||
143254450|NCT03005873|516486085|FG001|Overall Study|Prohibited medication use post radnomization|1|||
143254451|NCT03005873|516486086|FG002|Overall Study|Prohibited medication use post radnomization|1|||
143254452|NCT03005873|516486084|FG000|Overall Study|Withdrew consent|0|||
143254453|NCT03005873|516486085|FG001|Overall Study|Withdrew consent|1|||
143254454|NCT03005873|516486086|FG002|Overall Study|Withdrew consent|2|||
143254455|NCT03005873|516486084|FG000|Overall Study|Lost to Follow-up|0|||
143254456|NCT03005873|516486085|FG001|Overall Study|Lost to Follow-up|1|||
143254457|NCT03005873|516486086|FG002|Overall Study|Lost to Follow-up|0|||
143254458|NCT03005873|516486084|FG000|Overall Study|Ineligible post randomization|0|||
143254459|NCT03005873|516486085|FG001|Overall Study|Ineligible post randomization|0|||
143254460|NCT03005873|516486086|FG002|Overall Study|Ineligible post randomization|1|||
143254461|NCT00097981|516486087|FG000|Overall Study|Adverse Event|31|||
143254462|NCT00097981|516486088|FG001|Overall Study|Adverse Event|44|||
143254463|NCT00097981|516486087|FG000|Overall Study|Withdrawal by Subject|10|||
143254464|NCT00097981|516486088|FG001|Overall Study|Withdrawal by Subject|8|||
143254465|NCT00097981|516486087|FG000|Overall Study|Protocol Violation|1|||
143254466|NCT00097981|516486088|FG001|Overall Study|Protocol Violation|1|||
143105351|NCT02553499|515925264|FG010|Overall Study|Physician Decision|1|||
143105352|NCT02553499|515925265|FG011|Overall Study|Physician Decision|3|||
143105353|NCT02553499|515925266|FG012|Overall Study|Physician Decision|1|||
143105354|NCT02553499|515925267|FG013|Overall Study|Physician Decision|0|||
143105355|NCT02553499|515925254|FG000|Overall Study|Progressive Disease|0|||
143105356|NCT02553499|515925255|FG001|Overall Study|Progressive Disease|0|||
143105357|NCT02553499|515925256|FG002|Overall Study|Progressive Disease|0|||
143105358|NCT02553499|515925257|FG003|Overall Study|Progressive Disease|2|||
143254467|NCT00097981|516486087|FG000|Overall Study|Death|2|||
143105359|NCT02553499|515925258|FG004|Overall Study|Progressive Disease|1|||
143254468|NCT00097981|516486088|FG001|Overall Study|Death|4|||
143254469|NCT00097981|516486087|FG000|Overall Study|Physician Decision|7|||
143254470|NCT00097981|516486088|FG001|Overall Study|Physician Decision|1|||
143254471|NCT00097981|516486087|FG000|Overall Study|Disease Progression|8|||
143254472|NCT00097981|516486088|FG001|Overall Study|Disease Progression|2|||
143254473|NCT00097981|516486087|FG000|Overall Study|Transplant planned|28|||
143254474|NCT00097981|516486088|FG001|Overall Study|Transplant planned|27|||
143105360|NCT02553499|515925259|FG005|Overall Study|Progressive Disease|1|||
143105361|NCT02553499|515925260|FG006|Overall Study|Progressive Disease|1|||
143105362|NCT02553499|515925261|FG007|Overall Study|Progressive Disease|0|||
143105363|NCT02553499|515925262|FG008|Overall Study|Progressive Disease|0|||
143105364|NCT02553499|515925263|FG009|Overall Study|Progressive Disease|1|||
143105365|NCT02553499|515925264|FG010|Overall Study|Progressive Disease|0|||
143105366|NCT02553499|515925265|FG011|Overall Study|Progressive Disease|0|||
143254475|NCT00097981|516486087|FG000|Overall Study|Other|19|||
143254476|NCT00097981|516486088|FG001|Overall Study|Other|13|||
143254477|NCT01713933|516486089|FG000|Overall Study|Lost to Follow-up|2|||
143254478|NCT01713933|516486089|FG000|Overall Study|Withdrawal by Subject|3|||
143254479|NCT01713933|516486089|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
143254480|NCT01009840|516486092|FG000|Overall Study|Lost to Follow-up|1|||
143254481|NCT01009840|516486092|FG000|Overall Study|Adverse Event|4|||
143254482|NCT01009840|516486092|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
143254483|NCT01009840|516486092|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
143254484|NCT01009840|516486092|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
143254485|NCT01104376|516486095|FG000|Overall Study|Withdrawal by Subject|15|||
143254486|NCT01104376|516486095|FG000|Overall Study|Consented but excluded after labs|13|||
143254487|NCT00797966|516486096|FG000|Phase A|Lost to Follow-up|0|||
143178444|NCT02776683|516201562|FG000|Pre-switch Period|Protocol Violation|1|||
143178445|NCT02776683|516201563|FG001|Pre-switch Period|Protocol Violation|0|||
143178446|NCT02776683|516201562|FG000|Pre-switch Period|Adverse Event|21|||
143178447|NCT02776683|516201563|FG001|Pre-switch Period|Adverse Event|0|||
143178448|NCT02776683|516201562|FG000|Pre-switch Period|Withdrawal by Subject|9|||
143178449|NCT02776683|516201563|FG001|Pre-switch Period|Withdrawal by Subject|0|||
143178450|NCT02776683|516201562|FG000|Pre-switch Period|Physician Decision|7|||
143178451|NCT02776683|516201563|FG001|Pre-switch Period|Physician Decision|0|||
143178452|NCT02776683|516201562|FG000|Pre-switch Period|Progressive disease|39|||
143178453|NCT02776683|516201563|FG001|Pre-switch Period|Progressive disease|0|||
143178454|NCT02776683|516201562|FG000|Pre-switch Period|Other than listed|3|||
143178455|NCT02776683|516201563|FG001|Pre-switch Period|Other than listed|0|||
143178456|NCT02776683|516201562|FG000|Post-switch Period|Adverse Event|0|||
143178457|NCT02776683|516201563|FG001|Post-switch Period|Adverse Event|3|||
143178458|NCT02776683|516201562|FG000|Post-switch Period|Withdrawal by Subject|0|||
143178459|NCT02776683|516201563|FG001|Post-switch Period|Withdrawal by Subject|2|||
143178460|NCT02776683|516201562|FG000|Post-switch Period|Physician Decision|0|||
143178461|NCT02776683|516201563|FG001|Post-switch Period|Physician Decision|3|||
143178462|NCT02776683|516201562|FG000|Post-switch Period|Progressive disease|0|||
143178463|NCT02776683|516201563|FG001|Post-switch Period|Progressive disease|20|||
143178464|NCT02776683|516201562|FG000|Post-switch Period|Other than listed|0|||
143178465|NCT02776683|516201563|FG001|Post-switch Period|Other than listed|15|||
143178466|NCT03389308|516201566|FG000|Overall Study|Withdrawal by Subject|5|||
143178467|NCT03389308|516201566|FG000|Overall Study|Lost to Follow-up|3|||
143178468|NCT03389308|516201566|FG000|Overall Study|Adverse Event|2|||
143178469|NCT03389308|516201566|FG000|Overall Study|Sponsor Request|2|||
143178470|NCT01664247|516201571|FG000|Overall Study|Adverse Event|5|||
143178471|NCT01664247|516201572|FG001|Overall Study|Adverse Event|3|||
143178472|NCT01664247|516201571|FG000|Overall Study|Protocol Violation|3|||
143178473|NCT01664247|516201572|FG001|Overall Study|Protocol Violation|5|||
143178474|NCT01664247|516201571|FG000|Overall Study|Withdrawal Criteria|1|||
143178475|NCT01664247|516201572|FG001|Overall Study|Withdrawal Criteria|4|||
143178476|NCT01664247|516201571|FG000|Overall Study|Unclassified|5|||
143178477|NCT01664247|516201572|FG001|Overall Study|Unclassified|29|||
143178478|NCT00400517|516201575|FG000|Overall Study|Withdrawal by Subject|1|||
143178479|NCT00400517|516201575|FG000|Overall Study|Physician Decision|1|||
143178480|NCT01023217|516201576|FG000|Overall Study|Withdrawal by Subject|1|||
143178481|NCT01023217|516201577|FG001|Overall Study|Withdrawal by Subject|0|||
143178482|NCT01106157|516201578|FG000|Overall Study|Withdrawal by Subject|1|||
143178483|NCT01106157|516201579|FG001|Overall Study|Withdrawal by Subject|0|||
143178484|NCT02298868|516201583|FG000|Overall Study|Adverse Event|1|||
143178485|NCT02298868|516201583|FG000|Overall Study|Death|1|||
143178486|NCT02298868|516201583|FG000|Overall Study|Patient underwent transplant|1|||
143178487|NCT01000506|516201584|FG000|Overall Study|Adverse Event|6|||
143178488|NCT01000506|516201585|FG001|Overall Study|Adverse Event|5|||
143178489|NCT01000506|516201586|FG002|Overall Study|Adverse Event|8|||
143178490|NCT01000506|516201587|FG003|Overall Study|Adverse Event|9|||
143178491|NCT01000506|516201584|FG000|Overall Study|Lack of Efficacy|8|||
143178492|NCT01000506|516201585|FG001|Overall Study|Lack of Efficacy|6|||
143178493|NCT01000506|516201586|FG002|Overall Study|Lack of Efficacy|4|||
143178494|NCT01000506|516201587|FG003|Overall Study|Lack of Efficacy|4|||
143178495|NCT01000506|516201584|FG000|Overall Study|Protocol Violation|1|||
143178496|NCT01000506|516201585|FG001|Overall Study|Protocol Violation|1|||
143178497|NCT01000506|516201586|FG002|Overall Study|Protocol Violation|0|||
143178498|NCT01000506|516201587|FG003|Overall Study|Protocol Violation|0|||
143178499|NCT01000506|516201584|FG000|Overall Study|Lost to Follow-up|1|||
143178500|NCT01000506|516201585|FG001|Overall Study|Lost to Follow-up|1|||
143178501|NCT01000506|516201586|FG002|Overall Study|Lost to Follow-up|4|||
143178502|NCT01000506|516201587|FG003|Overall Study|Lost to Follow-up|0|||
143178503|NCT01000506|516201584|FG000|Overall Study|Physician Decision|1|||
143178504|NCT01000506|516201585|FG001|Overall Study|Physician Decision|3|||
143178505|NCT01000506|516201586|FG002|Overall Study|Physician Decision|3|||
143178506|NCT01000506|516201587|FG003|Overall Study|Physician Decision|3|||
143178507|NCT01000506|516201584|FG000|Overall Study|Withdrawal by Subject|11|||
143178508|NCT01000506|516201585|FG001|Overall Study|Withdrawal by Subject|8|||
143178509|NCT01000506|516201586|FG002|Overall Study|Withdrawal by Subject|2|||
143178510|NCT01000506|516201587|FG003|Overall Study|Withdrawal by Subject|7|||
143178511|NCT03064074|516201588|FG000|Overall Study|Physician Decision|0|||
143178512|NCT03064074|516201589|FG001|Overall Study|Physician Decision|0|||
143178513|NCT03064074|516201590|FG002|Overall Study|Physician Decision|0|||
143178514|NCT03064074|516201591|FG003|Overall Study|Physician Decision|1|||
143178515|NCT02141672|516201592|FG000|Overall Study|Adverse Event|0|||
143178516|NCT02141672|516201593|FG001|Overall Study|Adverse Event|1|||
143178517|NCT02141672|516201594|FG002|Overall Study|Adverse Event|0|||
143178518|NCT02141672|516201592|FG000|Overall Study|Death|10|||
143178519|NCT02141672|516201593|FG001|Overall Study|Death|2|||
143178520|NCT02141672|516201594|FG002|Overall Study|Death|1|||
143178521|NCT02141672|516201592|FG000|Overall Study|Lack of Efficacy|0|||
143178522|NCT02141672|516201593|FG001|Overall Study|Lack of Efficacy|0|||
143178523|NCT02141672|516201594|FG002|Overall Study|Lack of Efficacy|2|||
143178524|NCT02141672|516201592|FG000|Overall Study|Lost to Follow-up|1|||
143178525|NCT02141672|516201593|FG001|Overall Study|Lost to Follow-up|1|||
143178526|NCT02141672|516201594|FG002|Overall Study|Lost to Follow-up|3|||
143254488|NCT00797966|516486097|FG001|Phase A|Lost to Follow-up|0|||
143254489|NCT00797966|516486098|FG002|Phase A|Lost to Follow-up|0|||
143254490|NCT00797966|516486099|FG003|Phase A|Lost to Follow-up|0|||
143254491|NCT00797966|516486100|FG004|Phase A|Lost to Follow-up|33|||
143254492|NCT00797966|516486101|FG005|Phase A|Lost to Follow-up|0|||
143254493|NCT00797966|516486096|FG000|Phase A|Adverse Event|0|||
143254494|NCT00797966|516486097|FG001|Phase A|Adverse Event|0|||
143254495|NCT00797966|516486098|FG002|Phase A|Adverse Event|0|||
143254496|NCT00797966|516486099|FG003|Phase A|Adverse Event|0|||
143254497|NCT00797966|516486100|FG004|Phase A|Adverse Event|46|||
143254498|NCT00797966|516486101|FG005|Phase A|Adverse Event|0|||
143254499|NCT00797966|516486096|FG000|Phase A|Met withdrawal criteria|0|||
143254500|NCT00797966|516486097|FG001|Phase A|Met withdrawal criteria|0|||
143254501|NCT00797966|516486098|FG002|Phase A|Met withdrawal criteria|0|||
143254502|NCT00797966|516486099|FG003|Phase A|Met withdrawal criteria|0|||
143254503|NCT00797966|516486100|FG004|Phase A|Met withdrawal criteria|4|||
143254504|NCT00797966|516486101|FG005|Phase A|Met withdrawal criteria|0|||
143254505|NCT00797966|516486096|FG000|Phase A|Physician Decision|0|||
143254506|NCT00797966|516486097|FG001|Phase A|Physician Decision|0|||
143254507|NCT00797966|516486098|FG002|Phase A|Physician Decision|0|||
143254508|NCT00797966|516486099|FG003|Phase A|Physician Decision|0|||
143254509|NCT00797966|516486100|FG004|Phase A|Physician Decision|13|||
143254510|NCT00797966|516486101|FG005|Phase A|Physician Decision|0|||
143254511|NCT00797966|516486096|FG000|Phase A|Withdrawal by Subject|0|||
143254512|NCT00797966|516486097|FG001|Phase A|Withdrawal by Subject|0|||
143254513|NCT00797966|516486098|FG002|Phase A|Withdrawal by Subject|0|||
143254514|NCT00797966|516486099|FG003|Phase A|Withdrawal by Subject|0|||
143254515|NCT00797966|516486100|FG004|Phase A|Withdrawal by Subject|33|||
143254516|NCT00797966|516486101|FG005|Phase A|Withdrawal by Subject|0|||
143254517|NCT00797966|516486096|FG000|Phase A|Protocol deviation|0|||
143254518|NCT00797966|516486097|FG001|Phase A|Protocol deviation|0|||
143254519|NCT00797966|516486098|FG002|Phase A|Protocol deviation|0|||
143254520|NCT00797966|516486099|FG003|Phase A|Protocol deviation|0|||
143254521|NCT00797966|516486100|FG004|Phase A|Protocol deviation|56|||
143254522|NCT00797966|516486101|FG005|Phase A|Protocol deviation|0|||
143254523|NCT00797966|516486096|FG000|Phase B|Lost to Follow-up|0|||
143254524|NCT00797966|516486097|FG001|Phase B|Lost to Follow-up|1|||
143254525|NCT00797966|516486098|FG002|Phase B|Lost to Follow-up|3|||
143254526|NCT00797966|516486099|FG003|Phase B|Lost to Follow-up|0|||
143254527|NCT00797966|516486100|FG004|Phase B|Lost to Follow-up|0|||
143254528|NCT00797966|516486101|FG005|Phase B|Lost to Follow-up|0|||
143254529|NCT00797966|516486096|FG000|Phase B|Adverse Event|2|||
143254530|NCT00797966|516486097|FG001|Phase B|Adverse Event|1|||
143254531|NCT00797966|516486098|FG002|Phase B|Adverse Event|3|||
143254532|NCT00797966|516486099|FG003|Phase B|Adverse Event|1|||
143254533|NCT00797966|516486100|FG004|Phase B|Adverse Event|0|||
143254534|NCT00797966|516486101|FG005|Phase B|Adverse Event|0|||
143254535|NCT00797966|516486096|FG000|Phase B|Met Withdrawal Criteria|3|||
143254536|NCT00797966|516486097|FG001|Phase B|Met Withdrawal Criteria|3|||
143254537|NCT00797966|516486098|FG002|Phase B|Met Withdrawal Criteria|6|||
143254538|NCT00797966|516486099|FG003|Phase B|Met Withdrawal Criteria|1|||
143254539|NCT00797966|516486100|FG004|Phase B|Met Withdrawal Criteria|0|||
143254540|NCT00797966|516486101|FG005|Phase B|Met Withdrawal Criteria|0|||
143254541|NCT00797966|516486096|FG000|Phase B|Physician Decision|1|||
143254542|NCT00797966|516486097|FG001|Phase B|Physician Decision|0|||
143254543|NCT00797966|516486098|FG002|Phase B|Physician Decision|3|||
143254544|NCT00797966|516486099|FG003|Phase B|Physician Decision|1|||
143254545|NCT00797966|516486100|FG004|Phase B|Physician Decision|0|||
143254546|NCT00797966|516486101|FG005|Phase B|Physician Decision|0|||
143254547|NCT00797966|516486096|FG000|Phase B|Withdrawal by Subject|1|||
143254548|NCT00797966|516486097|FG001|Phase B|Withdrawal by Subject|4|||
143254549|NCT00797966|516486098|FG002|Phase B|Withdrawal by Subject|3|||
143254550|NCT00797966|516486099|FG003|Phase B|Withdrawal by Subject|3|||
143254551|NCT00797966|516486100|FG004|Phase B|Withdrawal by Subject|0|||
143254552|NCT00797966|516486101|FG005|Phase B|Withdrawal by Subject|0|||
143254553|NCT00797966|516486096|FG000|Phase B|Protocol Deviation|4|||
143254554|NCT00797966|516486097|FG001|Phase B|Protocol Deviation|8|||
143254555|NCT00797966|516486098|FG002|Phase B|Protocol Deviation|2|||
143254556|NCT00797966|516486099|FG003|Phase B|Protocol Deviation|6|||
143254557|NCT00797966|516486100|FG004|Phase B|Protocol Deviation|0|||
143254558|NCT00797966|516486101|FG005|Phase B|Protocol Deviation|0|||
143254559|NCT00797966|516486096|FG000|Phase B|Lack of Efficacy|0|||
143254560|NCT00797966|516486097|FG001|Phase B|Lack of Efficacy|1|||
143254561|NCT00797966|516486098|FG002|Phase B|Lack of Efficacy|1|||
143254562|NCT00797966|516486099|FG003|Phase B|Lack of Efficacy|4|||
143254563|NCT00797966|516486100|FG004|Phase B|Lack of Efficacy|0|||
143254564|NCT00797966|516486101|FG005|Phase B|Lack of Efficacy|0|||
143254565|NCT00797966|516486096|FG000|Phase A+|Lost to Follow-up|0|||
143254566|NCT00797966|516486097|FG001|Phase A+|Lost to Follow-up|0|||
143254567|NCT00797966|516486098|FG002|Phase A+|Lost to Follow-up|0|||
143254568|NCT00797966|516486099|FG003|Phase A+|Lost to Follow-up|0|||
143254569|NCT00797966|516486100|FG004|Phase A+|Lost to Follow-up|0|||
143254570|NCT00797966|516486101|FG005|Phase A+|Lost to Follow-up|9|||
143254571|NCT00797966|516486096|FG000|Phase A+|Met withdrawal criteria|0|||
143254572|NCT00797966|516486097|FG001|Phase A+|Met withdrawal criteria|0|||
143254573|NCT00797966|516486098|FG002|Phase A+|Met withdrawal criteria|0|||
143254574|NCT00797966|516486099|FG003|Phase A+|Met withdrawal criteria|0|||
143254575|NCT00797966|516486100|FG004|Phase A+|Met withdrawal criteria|0|||
143254576|NCT00797966|516486101|FG005|Phase A+|Met withdrawal criteria|5|||
143254577|NCT00797966|516486096|FG000|Phase A+|Withdrawal by Subject|0|||
143254578|NCT00797966|516486097|FG001|Phase A+|Withdrawal by Subject|0|||
143254579|NCT00797966|516486098|FG002|Phase A+|Withdrawal by Subject|0|||
143254580|NCT00797966|516486099|FG003|Phase A+|Withdrawal by Subject|0|||
143254581|NCT00797966|516486100|FG004|Phase A+|Withdrawal by Subject|0|||
143254582|NCT00797966|516486101|FG005|Phase A+|Withdrawal by Subject|6|||
143254583|NCT00797966|516486096|FG000|Phase A+|Adverse Event|0|||
143254584|NCT00797966|516486097|FG001|Phase A+|Adverse Event|0|||
143254585|NCT00797966|516486098|FG002|Phase A+|Adverse Event|0|||
143254586|NCT00797966|516486099|FG003|Phase A+|Adverse Event|0|||
143254587|NCT00797966|516486100|FG004|Phase A+|Adverse Event|0|||
143254588|NCT00797966|516486101|FG005|Phase A+|Adverse Event|4|||
143254589|NCT00797966|516486096|FG000|Phase A+|Protocol deviation|0|||
143254590|NCT00797966|516486097|FG001|Phase A+|Protocol deviation|0|||
143254591|NCT00797966|516486098|FG002|Phase A+|Protocol deviation|0|||
143254592|NCT00797966|516486099|FG003|Phase A+|Protocol deviation|0|||
143254593|NCT00797966|516486100|FG004|Phase A+|Protocol deviation|0|||
143254594|NCT00797966|516486101|FG005|Phase A+|Protocol deviation|4|||
143254595|NCT01002820|516486107|FG000|Overall Study|Adverse Event|1|||
143254596|NCT01002820|516486107|FG000|Overall Study|Withdrawal by Subject|2|||
143254597|NCT01002820|516486107|FG000|Overall Study|Lack of Efficacy|1|||
143254598|NCT01673347|516486108|FG000|Overall Study|failure of allograft|7|||
143254599|NCT00895011|516486114|FG000|Overall Study|Withdrawal by Subject|14|||
143254600|NCT00895011|516486115|FG001|Overall Study|Withdrawal by Subject|7|||
143254601|NCT00895011|516486116|FG002|Overall Study|Withdrawal by Subject|2|||
143254602|NCT00895011|516486114|FG000|Overall Study|Lost to Follow-up|5|||
143254603|NCT00895011|516486115|FG001|Overall Study|Lost to Follow-up|4|||
143254604|NCT00895011|516486116|FG002|Overall Study|Lost to Follow-up|1|||
143254605|NCT00895011|516486114|FG000|Overall Study|Protocol Violation|3|||
143254606|NCT00895011|516486115|FG001|Overall Study|Protocol Violation|1|||
143254607|NCT00895011|516486116|FG002|Overall Study|Protocol Violation|3|||
143254608|NCT00895011|516486114|FG000|Overall Study|Adverse Event|1|||
143254609|NCT00895011|516486115|FG001|Overall Study|Adverse Event|2|||
143254610|NCT00895011|516486116|FG002|Overall Study|Adverse Event|2|||
143254611|NCT00895011|516486114|FG000|Overall Study|schedule conflict|1|||
143254612|NCT00895011|516486115|FG001|Overall Study|schedule conflict|0|||
143254613|NCT00895011|516486116|FG002|Overall Study|schedule conflict|0|||
143254614|NCT01579812|516486118|FG000|Overall Study|Ineligible after treatment start|40|||
143254615|NCT01579812|516486118|FG000|Overall Study|Patient choice|3|||
143254616|NCT01579812|516486118|FG000|Overall Study|Noncompliance|3|||
143254617|NCT01579812|516486118|FG000|Overall Study|Withdrawal by Subject|6|||
143254618|NCT01133990|516486120|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
143254619|NCT01133990|516486121|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
143254620|NCT01133990|516486122|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
143254621|NCT01133990|516486123|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
143254622|NCT01133990|516486124|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
143254623|NCT01133990|516486125|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
143254624|NCT01133990|516486120|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
143254625|NCT01133990|516486121|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
143254626|NCT01133990|516486122|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
143254627|NCT01133990|516486123|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
143254628|NCT01133990|516486124|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
143254629|NCT01133990|516486125|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
143254630|NCT01133990|516486120|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
143254631|NCT01133990|516486121|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
143254632|NCT01133990|516486122|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
143254633|NCT01133990|516486123|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
143254634|NCT01133990|516486124|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
143254635|NCT01133990|516486125|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
143254636|NCT01133990|516486120|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
143254637|NCT01133990|516486121|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
143254638|NCT01133990|516486122|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
143254639|NCT01133990|516486123|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
143254640|NCT01133990|516486124|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
143254641|NCT01133990|516486125|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
143254642|NCT02282345|516486127|FG000|Overall Study|Progression|0|||
143254643|NCT02282345|516486128|FG001|Overall Study|Progression|1|||
143254644|NCT02683746|516486129|FG000|Overall Study|Adverse Event|3|||
143254645|NCT02683746|516486130|FG001|Overall Study|Adverse Event|2|||
143254646|NCT02683746|516486129|FG000|Overall Study|Lost to Follow-up|5|||
143105367|NCT02553499|515925266|FG012|Overall Study|Progressive Disease|2|||
143254647|NCT02683746|516486130|FG001|Overall Study|Lost to Follow-up|6|||
143254648|NCT02683746|516486129|FG000|Overall Study|Withdrawal by Subject|6|||
143254649|NCT02683746|516486130|FG001|Overall Study|Withdrawal by Subject|5|||
143254650|NCT02683746|516486129|FG000|Overall Study|Physician Decision|2|||
143254651|NCT02683746|516486130|FG001|Overall Study|Physician Decision|1|||
143254652|NCT04987944|516486135|FG000|Overall Study|Adverse Event|0|||
143254653|NCT04987944|516486136|FG001|Overall Study|Adverse Event|1|||
143254654|NCT04987944|516486135|FG000|Overall Study|Withdrawal by Subject|0|||
143254655|NCT04987944|516486136|FG001|Overall Study|Withdrawal by Subject|1|||
143254656|NCT04905498|516486141|FG000|Overall Study|Lost to Follow-up|0|||
143254657|NCT04905498|516486142|FG001|Overall Study|Lost to Follow-up|2|||
143254658|NCT04905498|516486141|FG000|Overall Study|COVID lockdown|1|||
143254659|NCT04905498|516486142|FG001|Overall Study|COVID lockdown|0|||
143254660|NCT01119937|516486151|FG000|Overall Study|Adverse Event|11|||
143254661|NCT01119937|516486152|FG001|Overall Study|Adverse Event|5|||
143254662|NCT01119937|516486151|FG000|Overall Study|Protocol deviation|3|||
143254663|NCT01119937|516486152|FG001|Overall Study|Protocol deviation|1|||
143254664|NCT01119937|516486151|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
143254665|NCT01119937|516486152|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
143254666|NCT01119937|516486151|FG000|Overall Study|Withdrawal by Subject|2|||
143254667|NCT01119937|516486152|FG001|Overall Study|Withdrawal by Subject|1|||
143254668|NCT03316911|516486153|FG000|Overall Study|Lost to Follow-up|33|||
143254669|NCT03316911|516486154|FG001|Overall Study|Lost to Follow-up|29|||
143254670|NCT01073462|516486158|FG000|Overall Study|Death|14|||
143254671|NCT01073462|516486158|FG000|Overall Study|Kidney transplant|10|||
143254672|NCT01073462|516486158|FG000|Overall Study|Low parathyroid hormone levels|8|||
143254673|NCT01073462|516486158|FG000|Overall Study|Serious adverse event|2|||
143254674|NCT01073462|516486158|FG000|Overall Study|Lost to Follow-up|7|||
143254675|NCT03554486|516486159|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
143254676|NCT03554486|516486160|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
143254677|NCT03554486|516486161|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
143254678|NCT03554486|516486159|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
143254679|NCT03554486|516486160|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
143254680|NCT03554486|516486161|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
143367890|NCT01311713|516889461|FG004|Overall Study|Lost to Follow-up|0|||
143254681|NCT03554486|516486159|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
143254682|NCT03554486|516486160|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
143367891|NCT01311713|516889462|FG005|Overall Study|Lost to Follow-up|0|||
143254683|NCT03554486|516486161|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
143254684|NCT02509117|516486165|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
143178527|NCT02141672|516201592|FG000|Overall Study|Physician Decision|1|||
143178528|NCT02141672|516201593|FG001|Overall Study|Physician Decision|2|||
143254685|NCT02509117|516486166|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
143254686|NCT02509117|516486167|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
143367892|NCT01311713|516889463|FG006|Overall Study|Lost to Follow-up|0|||
143178529|NCT02141672|516201594|FG002|Overall Study|Physician Decision|5|||
143105368|NCT02553499|515925267|FG013|Overall Study|Progressive Disease|1|||
143105369|NCT02553499|515925254|FG000|Overall Study|Study Terminated by Sponsor|0|||
143254687|NCT02509117|516486168|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
143254688|NCT02509117|516486169|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
143254689|NCT02509117|516486170|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
143254690|NCT02509117|516486171|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
143254691|NCT02509117|516486172|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
143254692|NCT02509117|516486173|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
143254693|NCT02509117|516486174|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
143254694|NCT02509117|516486165|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
143254695|NCT02509117|516486166|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
143254696|NCT02509117|516486167|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
143254697|NCT02509117|516486168|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
143254698|NCT02509117|516486169|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
143254699|NCT02509117|516486170|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
143254700|NCT02509117|516486171|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
143254701|NCT02509117|516486172|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
143254702|NCT02509117|516486173|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
143254703|NCT02509117|516486174|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
143254704|NCT02509117|516486165|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
143254705|NCT02509117|516486166|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
143254706|NCT02509117|516486167|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
143254707|NCT02509117|516486168|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
143254708|NCT02509117|516486169|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
143254709|NCT02509117|516486170|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
143254710|NCT02509117|516486171|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
143254711|NCT02509117|516486172|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
143254712|NCT02509117|516486173|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
143254713|NCT02509117|516486174|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
143254714|NCT00636363|516486175|FG000|Overall Study|Conjunctivitis|0|||
143254715|NCT00636363|516486176|FG001|Overall Study|Conjunctivitis|0|||
143254716|NCT00636363|516486177|FG002|Overall Study|Conjunctivitis|1|||
143254717|NCT00636363|516486175|FG000|Overall Study|Adverse Event|0|||
143254718|NCT00636363|516486176|FG001|Overall Study|Adverse Event|0|||
143254719|NCT00636363|516486177|FG002|Overall Study|Adverse Event|1|||
143254720|NCT00636363|516486175|FG000|Overall Study|Positive slit lamp finding|0|||
143254721|NCT00636363|516486176|FG001|Overall Study|Positive slit lamp finding|2|||
143254722|NCT00636363|516486177|FG002|Overall Study|Positive slit lamp finding|1|||
143254723|NCT00636363|516486175|FG000|Overall Study|Study related symptoms/complaints|8|||
143254724|NCT00636363|516486176|FG001|Overall Study|Study related symptoms/complaints|7|||
143254725|NCT00636363|516486177|FG002|Overall Study|Study related symptoms/complaints|4|||
143254726|NCT00636363|516486175|FG000|Overall Study|Met ineligibility criteria|0|||
143254727|NCT00636363|516486176|FG001|Overall Study|Met ineligibility criteria|0|||
143254728|NCT00636363|516486177|FG002|Overall Study|Met ineligibility criteria|3|||
143254729|NCT00636363|516486175|FG000|Overall Study|Missed > 1 visit|0|||
143254730|NCT00636363|516486176|FG001|Overall Study|Missed > 1 visit|1|||
143254731|NCT00636363|516486177|FG002|Overall Study|Missed > 1 visit|3|||
143254732|NCT00636363|516486175|FG000|Overall Study|Lack of motivation|1|||
143254733|NCT00636363|516486176|FG001|Overall Study|Lack of motivation|0|||
143254734|NCT00636363|516486177|FG002|Overall Study|Lack of motivation|1|||
143254735|NCT00636363|516486175|FG000|Overall Study|Protocol Violation|0|||
143254736|NCT00636363|516486176|FG001|Overall Study|Protocol Violation|3|||
143254737|NCT00636363|516486177|FG002|Overall Study|Protocol Violation|0|||
143254738|NCT00636363|516486175|FG000|Overall Study|Lost to Follow-up|3|||
143254739|NCT00636363|516486176|FG001|Overall Study|Lost to Follow-up|4|||
143254740|NCT00636363|516486177|FG002|Overall Study|Lost to Follow-up|2|||
143254741|NCT00636363|516486175|FG000|Overall Study|Withdrawal by Subject|1|||
143254742|NCT00636363|516486176|FG001|Overall Study|Withdrawal by Subject|3|||
143254743|NCT00636363|516486177|FG002|Overall Study|Withdrawal by Subject|2|||
143254744|NCT00280748|516486178|FG000|Overall Study|Decline in performance|3|||
143254745|NCT00280748|516486178|FG000|Overall Study|Extra-cranial disease progression|1|||
143254746|NCT01765218|516486179|FG000|Overall Study|Protocol Violation|1|||
143254747|NCT01765218|516486180|FG001|Overall Study|Protocol Violation|2|||
143254748|NCT02730793|516486188|FG000|Overall Study|Physician Decision|0|||
143254749|NCT02730793|516486189|FG001|Overall Study|Physician Decision|1|||
143254750|NCT02730793|516486188|FG000|Overall Study|Withdrawal by Subject|0|||
143254751|NCT02730793|516486189|FG001|Overall Study|Withdrawal by Subject|1|||
143254752|NCT02365233|516486190|FG000|Overall Study|IRB withheld the data|1|||
143254753|NCT02365233|516486191|FG001|Overall Study|IRB withheld the data|2|||
143254754|NCT02365233|516486192|FG002|Overall Study|IRB withheld the data|2|||
143254755|NCT01806662|516486196|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
143254756|NCT01806662|516486197|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
143254757|NCT01806662|516486196|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
143254758|NCT01806662|516486197|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
143254759|NCT01806662|516486196|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
143254760|NCT01806662|516486197|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
143254761|NCT01806662|516486196|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
143254762|NCT01806662|516486197|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
143254763|NCT00043550|516486198|FG000|Overall Study|Withdrawal by Subject|22|||
143254764|NCT00043550|516486199|FG001|Overall Study|Withdrawal by Subject|12|||
143254765|NCT00043550|516486200|FG002|Overall Study|Withdrawal by Subject|20|||
143254766|NCT00995566|516486203|FG000|Overall Study|Adverse Event|2|||
143254767|NCT00995566|516486203|FG000|Overall Study|Early study termination|52|||
143254768|NCT00710762|516486206|FG000|Overall Study|Progressive disease|27|||
143254769|NCT00710762|516486207|FG001|Overall Study|Progressive disease|30|||
143254770|NCT00710762|516486206|FG000|Overall Study|Adverse Event other disease worsening|2|||
143254771|NCT00710762|516486207|FG001|Overall Study|Adverse Event other disease worsening|1|||
143254772|NCT00710762|516486206|FG000|Overall Study|Other Adverse Event|7|||
143254773|NCT00710762|516486207|FG001|Overall Study|Other Adverse Event|7|||
143254774|NCT00710762|516486206|FG000|Overall Study|Lost to Follow-up|1|||
143254775|NCT00710762|516486207|FG001|Overall Study|Lost to Follow-up|0|||
143254776|NCT00710762|516486206|FG000|Overall Study|Reason other than listed above|2|||
143254777|NCT00710762|516486207|FG001|Overall Study|Reason other than listed above|2|||
143254778|NCT01375075|516486208|FG000|Overall Study|Adverse Event|0|||
143254779|NCT01375075|516486209|FG001|Overall Study|Adverse Event|0|||
143254780|NCT01375075|516486210|FG002|Overall Study|Adverse Event|3|||
143254781|NCT01375075|516486211|FG003|Overall Study|Adverse Event|1|||
143254782|NCT01375075|516486212|FG004|Overall Study|Adverse Event|0|||
143254783|NCT01375075|516486213|FG005|Overall Study|Adverse Event|1|||
143254784|NCT01375075|516486208|FG000|Overall Study|Entry Criterion Not Met|1|||
143178530|NCT02141672|516201592|FG000|Overall Study|Protocol Violation|0|||
143254785|NCT01375075|516486209|FG001|Overall Study|Entry Criterion Not Met|0|||
143178531|NCT02141672|516201593|FG001|Overall Study|Protocol Violation|0|||
143178532|NCT02141672|516201594|FG002|Overall Study|Protocol Violation|1|||
143178533|NCT02141672|516201592|FG000|Overall Study|Withdrawal by Subject|3|||
143178534|NCT02141672|516201593|FG001|Overall Study|Withdrawal by Subject|2|||
143178535|NCT02141672|516201594|FG002|Overall Study|Withdrawal by Subject|5|||
143178536|NCT02141672|516201592|FG000|Overall Study|refused to follow-up|1|||
143178537|NCT02141672|516201593|FG001|Overall Study|refused to follow-up|0|||
143178538|NCT02141672|516201594|FG002|Overall Study|refused to follow-up|1|||
143254786|NCT01375075|516486210|FG002|Overall Study|Entry Criterion Not Met|0|||
143254787|NCT01375075|516486211|FG003|Overall Study|Entry Criterion Not Met|0|||
143254788|NCT01375075|516486212|FG004|Overall Study|Entry Criterion Not Met|0|||
143254789|NCT01375075|516486213|FG005|Overall Study|Entry Criterion Not Met|1|||
143254790|NCT01375075|516486208|FG000|Overall Study|Withdrawal by Subject|0|||
143105370|NCT02553499|515925255|FG001|Overall Study|Study Terminated by Sponsor|0|||
143105371|NCT02553499|515925256|FG002|Overall Study|Study Terminated by Sponsor|0|||
143105372|NCT02553499|515925257|FG003|Overall Study|Study Terminated by Sponsor|0|||
143105373|NCT02553499|515925258|FG004|Overall Study|Study Terminated by Sponsor|0|||
143105374|NCT02553499|515925259|FG005|Overall Study|Study Terminated by Sponsor|0|||
143105375|NCT02553499|515925260|FG006|Overall Study|Study Terminated by Sponsor|0|||
143105376|NCT02553499|515925261|FG007|Overall Study|Study Terminated by Sponsor|0|||
143105377|NCT02553499|515925262|FG008|Overall Study|Study Terminated by Sponsor|1|||
143105378|NCT02553499|515925263|FG009|Overall Study|Study Terminated by Sponsor|0|||
143105379|NCT02553499|515925264|FG010|Overall Study|Study Terminated by Sponsor|0|||
143105380|NCT02553499|515925265|FG011|Overall Study|Study Terminated by Sponsor|0|||
143105381|NCT02553499|515925266|FG012|Overall Study|Study Terminated by Sponsor|0|||
143105382|NCT02553499|515925267|FG013|Overall Study|Study Terminated by Sponsor|0|||
143105383|NCT02553499|515925254|FG000|Overall Study|Withdrawal by Subject|2|||
143105384|NCT02553499|515925255|FG001|Overall Study|Withdrawal by Subject|0|||
143105385|NCT02553499|515925256|FG002|Overall Study|Withdrawal by Subject|0|||
143105386|NCT02553499|515925257|FG003|Overall Study|Withdrawal by Subject|0|||
143254791|NCT01375075|516486209|FG001|Overall Study|Withdrawal by Subject|1|||
143105387|NCT02553499|515925258|FG004|Overall Study|Withdrawal by Subject|0|||
143105388|NCT02553499|515925259|FG005|Overall Study|Withdrawal by Subject|0|||
143105389|NCT02553499|515925260|FG006|Overall Study|Withdrawal by Subject|0|||
143105390|NCT02553499|515925261|FG007|Overall Study|Withdrawal by Subject|1|||
143105391|NCT02553499|515925262|FG008|Overall Study|Withdrawal by Subject|1|||
143105392|NCT02553499|515925263|FG009|Overall Study|Withdrawal by Subject|0|||
143105393|NCT02553499|515925264|FG010|Overall Study|Withdrawal by Subject|1|||
143105394|NCT02553499|515925265|FG011|Overall Study|Withdrawal by Subject|0|||
143105395|NCT02553499|515925266|FG012|Overall Study|Withdrawal by Subject|0|||
143105396|NCT02553499|515925267|FG013|Overall Study|Withdrawal by Subject|0|||
143105397|NCT00679029|515926480|FG000|Overall Study|Adverse Event|3|||
143105398|NCT00679029|515926480|FG000|Overall Study|Withdrawal by Subject|1|||
143105399|NCT00679029|515926480|FG000|Overall Study|Lost to Follow-up|1|||
143105400|NCT01283334|515926485|FG000|Overall Study|Withdrawal by Subject|1|||
143105401|NCT01283334|515926485|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
143105402|NCT01283334|515926485|FG000|Overall Study|Adverse Event|4|||
143105403|NCT01283334|515926485|FG000|Overall Study|Physician Decision|1|||
143105404|NCT00784238|515926486|FG000|Overall Study|Adverse Event|14|||
143105405|NCT00784238|515926486|FG000|Overall Study|Death|2|||
143105406|NCT00784238|515926486|FG000|Overall Study|Lack of Efficacy|33|||
143105407|NCT00784238|515926486|FG000|Overall Study|Lost to Follow-up|29|||
143105408|NCT00784238|515926486|FG000|Overall Study|Pregnancy|1|||
143105409|NCT00784238|515926486|FG000|Overall Study|Withdrawal by Subject|26|||
143105410|NCT00784238|515926486|FG000|Overall Study|Other|14|||
143105411|NCT00078767|515926487|FG000|Overall Study|Withdrawal by Subject|1|||
143105412|NCT00078767|515926488|FG001|Overall Study|Withdrawal by Subject|1|||
143105413|NCT00809471|515926489|FG000|Overall Study|Protocol non-compliance|15|||
143105414|NCT00809471|515926490|FG001|Overall Study|Protocol non-compliance|15|||
143105415|NCT00809471|515926491|FG002|Overall Study|Protocol non-compliance|6|||
143105416|NCT00809471|515926489|FG000|Overall Study|Lost to Follow-up|4|||
143105417|NCT00809471|515926490|FG001|Overall Study|Lost to Follow-up|2|||
143105418|NCT00809471|515926491|FG002|Overall Study|Lost to Follow-up|9|||
143105419|NCT00809471|515926489|FG000|Overall Study|Adverse Event|0|||
143105420|NCT00809471|515926490|FG001|Overall Study|Adverse Event|2|||
143105421|NCT00809471|515926491|FG002|Overall Study|Adverse Event|2|||
143105422|NCT00809471|515926489|FG000|Overall Study|Requirement for restricted medication|1|||
143105423|NCT00809471|515926490|FG001|Overall Study|Requirement for restricted medication|1|||
143105424|NCT00809471|515926491|FG002|Overall Study|Requirement for restricted medication|0|||
143105425|NCT01177293|515926492|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
143105426|NCT01177293|515926493|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
143105427|NCT03555565|515926494|FG000|Overall Study|Case Report Forms Uncollected|2|||
143105428|NCT03555565|515926494|FG000|Overall Study|Protocol Deviation|13|||
143105429|NCT01289639|515926496|FG000|Overall Study|Lost to Follow-up|1|||
143105430|NCT01289639|515926497|FG001|Overall Study|Lost to Follow-up|0|||
143105431|NCT01289639|515926498|FG002|Overall Study|Lost to Follow-up|0|||
143105432|NCT02780713|515926499|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
143105433|NCT02780713|515926500|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
143105434|NCT02780713|515926501|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
143105435|NCT02780713|515926502|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
143105436|NCT02780713|515926503|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
143105437|NCT01931475|515926504|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
143105438|NCT01931475|515926505|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
143105439|NCT01931475|515926504|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
143105440|NCT01931475|515926505|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
143105441|NCT01931475|515926504|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
143105442|NCT01931475|515926505|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
143105443|NCT01931475|515926504|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
143105444|NCT01931475|515926505|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
143105445|NCT01931475|515926504|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
143105446|NCT01931475|515926505|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
143105447|NCT01931475|515926504|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
143105448|NCT01931475|515926505|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
143105449|NCT01931475|515926504|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
143105450|NCT01931475|515926505|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
143105451|NCT01931475|515926504|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
143105452|NCT01931475|515926505|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
143105453|NCT01931475|515926504|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
143105454|NCT01931475|515926505|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
143105455|NCT01931475|515926504|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
143105456|NCT01931475|515926505|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
143105457|NCT01931475|515926504|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
143105458|NCT01931475|515926505|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
143105459|NCT05338502|515926506|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
143105460|NCT05338502|515926507|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
143105461|NCT05338502|515926508|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
143105462|NCT05338502|515926506|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
143105463|NCT05338502|515926507|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
143105464|NCT05338502|515926508|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
143105465|NCT03436693|515926510|FG000|Overall Study|Adverse Event|22|||
143105466|NCT03436693|515926511|FG001|Overall Study|Adverse Event|10|||
143105467|NCT03436693|515926510|FG000|Overall Study|Physician Decision|3|||
143105468|NCT03436693|515926511|FG001|Overall Study|Physician Decision|3|||
143105469|NCT03436693|515926510|FG000|Overall Study|Withdrawal by Subject|4|||
143105470|NCT03436693|515926511|FG001|Overall Study|Withdrawal by Subject|13|||
143105471|NCT03436693|515926510|FG000|Overall Study|Progressive Disease|1|||
143105472|NCT03436693|515926511|FG001|Overall Study|Progressive Disease|1|||
143105473|NCT04967885|515926512|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
143105474|NCT04967885|515926513|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
143105475|NCT04967885|515926512|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
143105476|NCT04967885|515926513|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
143105477|NCT04967885|515926512|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
143105478|NCT04967885|515926513|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
143105479|NCT04967885|515926512|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
143105480|NCT04967885|515926513|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
143105481|NCT04967885|515926512|FG000|EMI-II Intervention|Lost to Follow-up|14|||
143105482|NCT04967885|515926513|FG001|EMI-II Intervention|Lost to Follow-up|10|||
143105483|NCT01683266|515926514|FG000|Overall Study|Adverse Event|5|||
143105484|NCT01683266|515926515|FG001|Overall Study|Adverse Event|4|||
143105485|NCT01683266|515926514|FG000|Overall Study|Lack of Efficacy|5|||
143105486|NCT01683266|515926515|FG001|Overall Study|Lack of Efficacy|2|||
143105487|NCT01683266|515926514|FG000|Overall Study|Protocol Violation|13|||
143105488|NCT01683266|515926515|FG001|Overall Study|Protocol Violation|6|||
143105489|NCT01683266|515926514|FG000|Overall Study|Personal Reason|17|||
143105490|NCT01683266|515926515|FG001|Overall Study|Personal Reason|25|||
143105491|NCT01683266|515926514|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
143105492|NCT01683266|515926515|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
143105493|NCT01683266|515926514|FG000|Overall Study|Lost to Follow-up|5|||
143105494|NCT01683266|515926515|FG001|Overall Study|Lost to Follow-up|0|||
143105495|NCT01683266|515926514|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
143105496|NCT01683266|515926515|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
143105497|NCT01683266|515926514|FG000|Overall Study|Nonserious Hypoglycemia|0|||
143105498|NCT01683266|515926515|FG001|Overall Study|Nonserious Hypoglycemia|3|||
143105499|NCT01683266|515926514|FG000|Overall Study|Perceived Lack of Efficacy|1|||
143105500|NCT01683266|515926515|FG001|Overall Study|Perceived Lack of Efficacy|1|||
143105501|NCT01683266|515926514|FG000|Overall Study|Possibly Hypoglycemia|1|||
143105502|NCT01683266|515926515|FG001|Overall Study|Possibly Hypoglycemia|0|||
143105503|NCT01683266|515926514|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
143105504|NCT01683266|515926515|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
143105505|NCT03655470|515926516|FG000|Overall Study|Lost to Follow-up|6|||
143178539|NCT01118780|516201595|FG000|Overall Study|Adverse Event|15|||
143178540|NCT01118780|516201596|FG001|Overall Study|Adverse Event|15|||
143178541|NCT01118780|516201595|FG000|Overall Study|Death|1|||
143178542|NCT01118780|516201596|FG001|Overall Study|Death|0|||
143178543|NCT01118780|516201595|FG000|Overall Study|Lack of Efficacy|2|||
143178544|NCT01118780|516201596|FG001|Overall Study|Lack of Efficacy|6|||
143178545|NCT01118780|516201595|FG000|Overall Study|Physician Decision|2|||
143178546|NCT01118780|516201596|FG001|Overall Study|Physician Decision|0|||
143178547|NCT01118780|516201595|FG000|Overall Study|Protocol Violation|3|||
143178548|NCT01118780|516201596|FG001|Overall Study|Protocol Violation|6|||
143178549|NCT01118780|516201595|FG000|Overall Study|Withdrawal by Subject|13|||
143178550|NCT01118780|516201596|FG001|Overall Study|Withdrawal by Subject|8|||
143178551|NCT00532844|516201597|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
143178552|NCT00532844|516201598|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
143178553|NCT00532844|516201597|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
143178554|NCT00532844|516201598|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
143178555|NCT00532844|516201597|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
143178556|NCT00532844|516201598|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
143178557|NCT00532844|516201597|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
143178558|NCT00532844|516201598|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
143178559|NCT00532844|516201597|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
143178560|NCT00532844|516201598|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
143178561|NCT03637491|516201599|FG000|Overall Study|Death|9|||
143178562|NCT03637491|516201600|FG001|Overall Study|Death|9|||
143178563|NCT03637491|516201601|FG002|Overall Study|Death|5|||
143178564|NCT03637491|516201602|FG003|Overall Study|Death|3|||
143178565|NCT03637491|516201599|FG000|Overall Study|Lost to Follow-up|0|||
143178566|NCT03637491|516201600|FG001|Overall Study|Lost to Follow-up|1|||
143178567|NCT03637491|516201601|FG002|Overall Study|Lost to Follow-up|0|||
143178568|NCT03637491|516201602|FG003|Overall Study|Lost to Follow-up|1|||
143178569|NCT03637491|516201599|FG000|Overall Study|Study Terminated By Sponsor|0|||
143178570|NCT03637491|516201600|FG001|Overall Study|Study Terminated By Sponsor|2|||
143178571|NCT03637491|516201601|FG002|Overall Study|Study Terminated By Sponsor|1|||
143178572|NCT03637491|516201602|FG003|Overall Study|Study Terminated By Sponsor|0|||
143178573|NCT03637491|516201599|FG000|Overall Study|Withdrawal by Subject|1|||
143178574|NCT03637491|516201600|FG001|Overall Study|Withdrawal by Subject|0|||
143105506|NCT03655470|515926517|FG001|Overall Study|Lost to Follow-up|7|||
143367893|NCT01311713|516889457|FG000|Overall Study|Stopped taking study medication|0|||
143367894|NCT01311713|516889458|FG001|Overall Study|Stopped taking study medication|0|||
143254792|NCT01375075|516486210|FG002|Overall Study|Withdrawal by Subject|0|||
143254793|NCT01375075|516486211|FG003|Overall Study|Withdrawal by Subject|0|||
143254794|NCT01375075|516486212|FG004|Overall Study|Withdrawal by Subject|0|||
143254795|NCT01375075|516486213|FG005|Overall Study|Withdrawal by Subject|1|||
143254796|NCT03678870|516486214|FG000|Overall Study|prescribed non- protocol medications|10|||
143254797|NCT03678870|516486215|FG001|Overall Study|prescribed non- protocol medications|6|||
143254798|NCT03678870|516486214|FG000|Overall Study|Lost to Follow-up|3|||
143254799|NCT03678870|516486215|FG001|Overall Study|Lost to Follow-up|2|||
143254800|NCT03104816|516486217|FG000|Overall Study|Lack of Efficacy|0|||
143254801|NCT03104816|516486218|FG001|Overall Study|Lack of Efficacy|2|||
143254802|NCT03104816|516486219|FG002|Overall Study|Lack of Efficacy|0|||
143254803|NCT03104816|516486217|FG000|Overall Study|Protocol Violation|2|||
143254804|NCT03104816|516486218|FG001|Overall Study|Protocol Violation|0|||
143254805|NCT03104816|516486219|FG002|Overall Study|Protocol Violation|2|||
143254806|NCT03612856|516486220|FG000|Pre-dose Period|Physician Decision|0|||
143254807|NCT03612856|516486221|FG001|Pre-dose Period|Physician Decision|1|||
143254808|NCT03612856|516486222|FG002|Pre-dose Period|Physician Decision|1|||
143254809|NCT03612856|516486220|FG000|Pre-dose Period|Withdrawal by Subject|0|||
143254810|NCT03612856|516486221|FG001|Pre-dose Period|Withdrawal by Subject|1|||
143254811|NCT03612856|516486222|FG002|Pre-dose Period|Withdrawal by Subject|0|||
143254812|NCT01576159|516486223|FG000|Overall Study|Withdrawal by Subject|0|||
143254813|NCT01576159|516486224|FG001|Overall Study|Withdrawal by Subject|1|||
143254814|NCT01576159|516486225|FG002|Overall Study|Withdrawal by Subject|0|||
143254815|NCT01576159|516486226|FG003|Overall Study|Withdrawal by Subject|0|||
143254816|NCT01576159|516486223|FG000|Overall Study|Physician Decision|0|||
143254817|NCT01576159|516486224|FG001|Overall Study|Physician Decision|0|||
143254818|NCT01576159|516486225|FG002|Overall Study|Physician Decision|1|||
143254819|NCT01576159|516486226|FG003|Overall Study|Physician Decision|0|||
143254820|NCT01576159|516486223|FG000|Overall Study|Lost to Follow-up|0|||
143254821|NCT01576159|516486224|FG001|Overall Study|Lost to Follow-up|0|||
143254822|NCT01576159|516486225|FG002|Overall Study|Lost to Follow-up|0|||
143254823|NCT01576159|516486226|FG003|Overall Study|Lost to Follow-up|1|||
143254824|NCT01576159|516486223|FG000|Overall Study|Protocol Violation|1|||
143254825|NCT01576159|516486224|FG001|Overall Study|Protocol Violation|0|||
143254826|NCT01576159|516486225|FG002|Overall Study|Protocol Violation|0|||
143254827|NCT01576159|516486226|FG003|Overall Study|Protocol Violation|0|||
143254828|NCT01181986|516486227|FG000|Phase 1|Lost to Follow-up|0|||
143254829|NCT01181986|516486228|FG001|Phase 1|Lost to Follow-up|1|||
143254830|NCT01181986|516486229|FG002|Phase 1|Lost to Follow-up|1|||
143254831|NCT01181986|516486227|FG000|Phase 1|Adverse Event|0|||
143254832|NCT01181986|516486228|FG001|Phase 1|Adverse Event|0|||
143254833|NCT01181986|516486229|FG002|Phase 1|Adverse Event|1|||
143254834|NCT01181986|516486227|FG000|Phase 1|Protocol Violation|1|||
143254835|NCT01181986|516486228|FG001|Phase 1|Protocol Violation|0|||
143254836|NCT01181986|516486229|FG002|Phase 1|Protocol Violation|0|||
143254837|NCT01181986|516486227|FG000|Phase 2|Adverse Event|0|||
143254838|NCT01181986|516486228|FG001|Phase 2|Adverse Event|3|||
143254839|NCT01181986|516486229|FG002|Phase 2|Adverse Event|0|||
143254840|NCT01181986|516486227|FG000|Phase 2|Medical condition|0|||
143254841|NCT01181986|516486228|FG001|Phase 2|Medical condition|1|||
143254842|NCT01181986|516486229|FG002|Phase 2|Medical condition|0|||
143254843|NCT01011309|516486230|FG000|Overall Study|Adverse Event|2|||
143254844|NCT01011309|516486231|FG001|Overall Study|Adverse Event|1|||
143254845|NCT01011309|516486232|FG002|Overall Study|Adverse Event|2|||
143254846|NCT01011309|516486230|FG000|Overall Study|Lack of Efficacy|0|||
143254847|NCT01011309|516486231|FG001|Overall Study|Lack of Efficacy|1|||
143254848|NCT01011309|516486232|FG002|Overall Study|Lack of Efficacy|0|||
143254849|NCT01011309|516486230|FG000|Overall Study|Protocol Violation|0|||
143254850|NCT01011309|516486231|FG001|Overall Study|Protocol Violation|1|||
143254851|NCT01011309|516486232|FG002|Overall Study|Protocol Violation|3|||
143254852|NCT01454778|516486237|FG000|Overall Study|Lost to Follow-up|2|||
143254853|NCT01454778|516486237|FG000|Overall Study|Death|1|||
143254854|NCT00348881|516486238|FG000|Overall Study|Lost to Follow-up|12|||
143254855|NCT00348881|516486239|FG001|Overall Study|Lost to Follow-up|6|||
143254856|NCT00348881|516486238|FG000|Overall Study|Withdrawal by Subject|3|||
143254857|NCT00348881|516486239|FG001|Overall Study|Withdrawal by Subject|4|||
143254858|NCT00348881|516486238|FG000|Overall Study|Adverse Event|2|||
143254859|NCT00348881|516486239|FG001|Overall Study|Adverse Event|0|||
143254860|NCT00348881|516486238|FG000|Overall Study|Serious Adverse Event|0|||
143254861|NCT00348881|516486239|FG001|Overall Study|Serious Adverse Event|2|||
143254862|NCT01227629|516486241|FG000|Overall Study|Adverse Event|2|||
143254863|NCT01227629|516486242|FG001|Overall Study|Adverse Event|2|||
143254864|NCT01227629|516486243|FG002|Overall Study|Adverse Event|1|||
143254865|NCT01227629|516486244|FG003|Overall Study|Adverse Event|6|||
143254866|NCT01227629|516486245|FG004|Overall Study|Adverse Event|1|||
143254867|NCT01227629|516486246|FG005|Overall Study|Adverse Event|1|||
143254868|NCT01227629|516486247|FG006|Overall Study|Adverse Event|6|||
143254869|NCT01227629|516486248|FG007|Overall Study|Adverse Event|6|||
143254870|NCT01227629|516486249|FG008|Overall Study|Adverse Event|4|||
143254871|NCT01227629|516486250|FG009|Overall Study|Adverse Event|0|||
143254872|NCT01227629|516486241|FG000|Overall Study|Protocol Violation|0|||
143254873|NCT01227629|516486242|FG001|Overall Study|Protocol Violation|0|||
143254874|NCT01227629|516486243|FG002|Overall Study|Protocol Violation|0|||
143254875|NCT01227629|516486244|FG003|Overall Study|Protocol Violation|1|||
143254876|NCT01227629|516486245|FG004|Overall Study|Protocol Violation|0|||
143254877|NCT01227629|516486246|FG005|Overall Study|Protocol Violation|0|||
143254878|NCT01227629|516486247|FG006|Overall Study|Protocol Violation|0|||
143254879|NCT01227629|516486248|FG007|Overall Study|Protocol Violation|0|||
143254880|NCT01227629|516486249|FG008|Overall Study|Protocol Violation|0|||
143254881|NCT01227629|516486250|FG009|Overall Study|Protocol Violation|0|||
143254882|NCT01227629|516486241|FG000|Overall Study|Lost to Follow-up|0|||
143254883|NCT01227629|516486242|FG001|Overall Study|Lost to Follow-up|0|||
143254884|NCT01227629|516486243|FG002|Overall Study|Lost to Follow-up|0|||
143254885|NCT01227629|516486244|FG003|Overall Study|Lost to Follow-up|0|||
143254886|NCT01227629|516486245|FG004|Overall Study|Lost to Follow-up|1|||
143254887|NCT01227629|516486246|FG005|Overall Study|Lost to Follow-up|0|||
143254888|NCT01227629|516486247|FG006|Overall Study|Lost to Follow-up|0|||
143254889|NCT01227629|516486248|FG007|Overall Study|Lost to Follow-up|0|||
143254890|NCT01227629|516486249|FG008|Overall Study|Lost to Follow-up|0|||
143254891|NCT01227629|516486250|FG009|Overall Study|Lost to Follow-up|0|||
143254892|NCT01227629|516486241|FG000|Overall Study|Withdrawal by Subject|0|||
143254893|NCT01227629|516486242|FG001|Overall Study|Withdrawal by Subject|0|||
143254894|NCT01227629|516486243|FG002|Overall Study|Withdrawal by Subject|0|||
143254895|NCT01227629|516486244|FG003|Overall Study|Withdrawal by Subject|0|||
143254896|NCT01227629|516486245|FG004|Overall Study|Withdrawal by Subject|0|||
143254897|NCT01227629|516486246|FG005|Overall Study|Withdrawal by Subject|0|||
143254898|NCT01227629|516486247|FG006|Overall Study|Withdrawal by Subject|2|||
143254899|NCT01227629|516486248|FG007|Overall Study|Withdrawal by Subject|0|||
143254900|NCT01227629|516486249|FG008|Overall Study|Withdrawal by Subject|0|||
143254901|NCT01227629|516486250|FG009|Overall Study|Withdrawal by Subject|1|||
143254902|NCT01227629|516486241|FG000|Overall Study|Other|0|||
143254903|NCT01227629|516486242|FG001|Overall Study|Other|0|||
143254904|NCT01227629|516486243|FG002|Overall Study|Other|0|||
143254905|NCT01227629|516486244|FG003|Overall Study|Other|1|||
143254906|NCT01227629|516486245|FG004|Overall Study|Other|0|||
143254907|NCT01227629|516486246|FG005|Overall Study|Other|0|||
143254908|NCT01227629|516486247|FG006|Overall Study|Other|0|||
143254909|NCT01227629|516486248|FG007|Overall Study|Other|0|||
143254910|NCT01227629|516486249|FG008|Overall Study|Other|2|||
143254911|NCT01227629|516486250|FG009|Overall Study|Other|1|||
143105507|NCT01893281|515926527|FG000|Overall Study|Adverse Event|1|||
143105508|NCT01893281|515926527|FG000|Overall Study|Protocol Violation|1|||
143105509|NCT01893281|515926527|FG000|Overall Study|Withdrawal by Subject|1|||
143105510|NCT05481125|515926528|FG000|Overall Study|Adverse Event|1|||
143105511|NCT05481125|515926529|FG001|Overall Study|Adverse Event|0|||
143254912|NCT03976648|516486261|FG000|Overall Study|Adverse Event|0|||
143254913|NCT03976648|516486262|FG001|Overall Study|Adverse Event|2|||
143254914|NCT03976648|516486261|FG000|Overall Study|Study terminated by sponsor|21|||
143254915|NCT03976648|516486262|FG001|Overall Study|Study terminated by sponsor|8|||
143254916|NCT00881868|516486263|FG000|Overall Study|Adverse Event|0|||
143254917|NCT00881868|516486264|FG001|Overall Study|Adverse Event|1|||
143254918|NCT00881868|516486263|FG000|Overall Study|Lost to Follow-up|2|||
143254919|NCT00881868|516486264|FG001|Overall Study|Lost to Follow-up|1|||
143254920|NCT00881868|516486263|FG000|Overall Study|Physician Decision|4|||
143254921|NCT00881868|516486264|FG001|Overall Study|Physician Decision|0|||
143254922|NCT00881868|516486263|FG000|Overall Study|Protocol Violation|2|||
143254923|NCT00881868|516486264|FG001|Overall Study|Protocol Violation|0|||
143254924|NCT01981551|516486265|FG000|Overall Study|Refused further treatment|8|||
143254925|NCT01981551|516486265|FG000|Overall Study|Adverse Event|1|||
143254926|NCT00960570|516486266|FG000|21 Day Washout Period|Adverse Event|1|||
143254927|NCT00960570|516486266|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
143254928|NCT00960570|516486266|FG000|1 Day Period Between Dosing|Adverse Event|2|||
143254929|NCT00960570|516486266|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
143254930|NCT02880956|516486269|FG000|Overall Study|Adverse Event|3|||
143254931|NCT02880956|516486270|FG001|Overall Study|Adverse Event|6|||
143254932|NCT02880956|516486271|FG002|Overall Study|Adverse Event|5|||
143254933|NCT02880956|516486272|FG003|Overall Study|Adverse Event|4|||
143254934|NCT02880956|516486269|FG000|Overall Study|Withdrawal by Subject|9|||
143254935|NCT02880956|516486270|FG001|Overall Study|Withdrawal by Subject|4|||
143254936|NCT02880956|516486271|FG002|Overall Study|Withdrawal by Subject|6|||
143254937|NCT02880956|516486272|FG003|Overall Study|Withdrawal by Subject|11|||
143254938|NCT02880956|516486269|FG000|Overall Study|Lost to Follow-up|0|||
143254939|NCT02880956|516486270|FG001|Overall Study|Lost to Follow-up|1|||
143254940|NCT02880956|516486271|FG002|Overall Study|Lost to Follow-up|0|||
143254941|NCT02880956|516486272|FG003|Overall Study|Lost to Follow-up|0|||
143254942|NCT02880956|516486269|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
143254943|NCT02880956|516486270|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
143254944|NCT02880956|516486271|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
143254945|NCT02880956|516486272|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
143254946|NCT02880956|516486269|FG000|Overall Study|Other, Not Specified|4|||
143254947|NCT02880956|516486270|FG001|Overall Study|Other, Not Specified|2|||
143254948|NCT02880956|516486271|FG002|Overall Study|Other, Not Specified|0|||
143254949|NCT02880956|516486272|FG003|Overall Study|Other, Not Specified|3|||
143254950|NCT00003472|516487994|FG000|Overall Study|Not evaluable|3|||
143254951|NCT01350544|516487995|FG000|Overall Study|Administrative Withdrawal|0|||
143254952|NCT01350544|516487996|FG001|Overall Study|Administrative Withdrawal|1|||
143254953|NCT01350544|516487995|FG000|Overall Study|Death|1|||
143254954|NCT01350544|516487996|FG001|Overall Study|Death|2|||
143254955|NCT01350544|516487995|FG000|Overall Study|Moved out of LA County|2|||
143254956|NCT01350544|516487996|FG001|Overall Study|Moved out of LA County|2|||
143254957|NCT01350544|516487995|FG000|Overall Study|Medical Issues|1|||
143254958|NCT01350544|516487996|FG001|Overall Study|Medical Issues|1|||
143254959|NCT01350544|516487995|FG000|Overall Study|Withdrawal by Subject|0|||
143254960|NCT01350544|516487996|FG001|Overall Study|Withdrawal by Subject|1|||
143254961|NCT01350544|516487995|FG000|Overall Study|Incarceration|1|||
143254962|NCT01350544|516487996|FG001|Overall Study|Incarceration|0|||
143254963|NCT01350544|516487995|FG000|Overall Study|Lost to Follow-up|18|||
143254964|NCT01350544|516487996|FG001|Overall Study|Lost to Follow-up|15|||
143254965|NCT00275821|516488000|FG000|Overall Study|Adverse Event|4|||
143254966|NCT00275821|516488001|FG001|Overall Study|Adverse Event|12|||
143254967|NCT00275821|516488002|FG002|Overall Study|Adverse Event|5|||
143254968|NCT00275821|516488000|FG000|Overall Study|Administrative problems|3|||
143254969|NCT00275821|516488001|FG001|Overall Study|Administrative problems|4|||
143254970|NCT00275821|516488002|FG002|Overall Study|Administrative problems|4|||
143254971|NCT00275821|516488000|FG000|Overall Study|Withdrawal by Subject|0|||
143254972|NCT00275821|516488001|FG001|Overall Study|Withdrawal by Subject|2|||
143254973|NCT00275821|516488002|FG002|Overall Study|Withdrawal by Subject|1|||
143254974|NCT00275821|516488000|FG000|Overall Study|Lost to Follow-up|0|||
143254975|NCT00275821|516488001|FG001|Overall Study|Lost to Follow-up|1|||
143254976|NCT00275821|516488002|FG002|Overall Study|Lost to Follow-up|1|||
143254977|NCT00275821|516488000|FG000|Overall Study|Death|0|||
143254978|NCT00275821|516488001|FG001|Overall Study|Death|2|||
143254979|NCT00275821|516488002|FG002|Overall Study|Death|1|||
143254980|NCT00275821|516488000|FG000|Overall Study|Lack of Efficacy|2|||
143254981|NCT00275821|516488001|FG001|Overall Study|Lack of Efficacy|1|||
143254982|NCT00275821|516488002|FG002|Overall Study|Lack of Efficacy|0|||
143254983|NCT00275821|516488000|FG000|Overall Study|Protocol Violation|5|||
143254984|NCT00275821|516488001|FG001|Overall Study|Protocol Violation|1|||
143254985|NCT00275821|516488002|FG002|Overall Study|Protocol Violation|0|||
143254986|NCT01185301|516488004|FG000|Overall Study|Adverse Event|3|||
143254987|NCT01185301|516488005|FG001|Overall Study|Adverse Event|0|||
143254988|NCT01185301|516488006|FG002|Overall Study|Adverse Event|2|||
143254989|NCT01185301|516488007|FG003|Overall Study|Adverse Event|3|||
143254990|NCT01185301|516488004|FG000|Overall Study|Withdrawal by Subject|7|||
143254991|NCT01185301|516488005|FG001|Overall Study|Withdrawal by Subject|5|||
143254992|NCT01185301|516488006|FG002|Overall Study|Withdrawal by Subject|2|||
143254993|NCT01185301|516488007|FG003|Overall Study|Withdrawal by Subject|3|||
143254994|NCT01185301|516488004|FG000|Overall Study|Lost to Follow-up|2|||
143254995|NCT01185301|516488005|FG001|Overall Study|Lost to Follow-up|0|||
143254996|NCT01185301|516488006|FG002|Overall Study|Lost to Follow-up|0|||
143254997|NCT01185301|516488007|FG003|Overall Study|Lost to Follow-up|1|||
143254998|NCT01185301|516488004|FG000|Overall Study|Other Reason|3|||
143254999|NCT01185301|516488005|FG001|Overall Study|Other Reason|2|||
143255000|NCT01185301|516488006|FG002|Overall Study|Other Reason|2|||
143105512|NCT05481125|515926528|FG000|Overall Study|Lost to Follow-up|0|||
143105513|NCT05481125|515926529|FG001|Overall Study|Lost to Follow-up|1|||
143105514|NCT05481125|515926528|FG000|Overall Study|Withdrawal by Subject|0|||
143105515|NCT05481125|515926529|FG001|Overall Study|Withdrawal by Subject|1|||
143105516|NCT02244463|515926530|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
143105517|NCT02244463|515926531|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
143105518|NCT02244463|515926532|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
143105519|NCT02244463|515926533|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
143105520|NCT02244463|515926534|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
143105521|NCT02244463|515926535|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
143105522|NCT02244463|515926530|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
143105523|NCT02244463|515926531|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
143105524|NCT02244463|515926532|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
143105525|NCT02244463|515926533|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
143105526|NCT02244463|515926534|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
143105527|NCT02244463|515926535|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
143105528|NCT02244463|515926530|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
143105529|NCT02244463|515926531|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
143105530|NCT02244463|515926532|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
143105531|NCT02244463|515926533|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
143105532|NCT02244463|515926534|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
143105533|NCT02244463|515926535|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
143105534|NCT02244463|515926530|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
143105535|NCT02244463|515926531|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
143105536|NCT02244463|515926532|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
143105537|NCT02244463|515926533|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
143105538|NCT02244463|515926534|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
143105539|NCT02244463|515926535|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
143105540|NCT02244463|515926530|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
143105541|NCT02244463|515926531|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
143105542|NCT02244463|515926532|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
143105543|NCT02244463|515926533|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
143105544|NCT02244463|515926534|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
143105545|NCT02244463|515926535|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
143105546|NCT02244463|515926530|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
143105547|NCT02244463|515926531|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
143105548|NCT02244463|515926532|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
143105549|NCT02244463|515926533|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
143105550|NCT02244463|515926534|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
143105551|NCT02244463|515926535|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
143105552|NCT02244463|515926530|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
143105553|NCT02244463|515926531|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
143105554|NCT02244463|515926532|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
143105555|NCT02244463|515926533|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
143105556|NCT02244463|515926534|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
143105557|NCT02244463|515926535|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
143105558|NCT02244463|515926530|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
143105559|NCT02244463|515926531|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
143105560|NCT02244463|515926532|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
143105561|NCT02244463|515926533|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
143367895|NCT01311713|516889459|FG002|Overall Study|Stopped taking study medication|0|||
143105562|NCT02244463|515926534|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
143255001|NCT01185301|516488007|FG003|Overall Study|Other Reason|2|||
143255002|NCT02946931|516488015|FG000|Overall Study|Did not require collection of CRFs|588|||
143255003|NCT02946931|516488015|FG000|Overall Study|Other than listed|37|||
143255004|NCT02946931|516488015|FG000|Overall Study|Discharge from hospital|118|||
143255005|NCT02946931|516488015|FG000|Overall Study|Adverse Event|81|||
143255006|NCT02946931|516488015|FG000|Overall Study|CRFs not valid|1|||
143255007|NCT02946931|516488015|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
143255008|NCT00869778|516488016|FG000|Overall Study|Adverse Event|2|||
143255009|NCT00869778|516488017|FG001|Overall Study|Adverse Event|0|||
143105563|NCT02244463|515926535|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
143105564|NCT02244463|515926530|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
143105565|NCT02244463|515926531|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
143105566|NCT02244463|515926532|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
143105567|NCT02244463|515926533|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
143255010|NCT00869778|516488018|FG002|Overall Study|Adverse Event|0|||
143255011|NCT00869778|516488016|FG000|Overall Study|Withdrawal by Subject|3|||
143255012|NCT00869778|516488017|FG001|Overall Study|Withdrawal by Subject|4|||
143367896|NCT01311713|516889460|FG003|Overall Study|Stopped taking study medication|1|||
143367897|NCT01311713|516889461|FG004|Overall Study|Stopped taking study medication|1|||
143367898|NCT01311713|516889462|FG005|Overall Study|Stopped taking study medication|0|||
143367899|NCT01311713|516889463|FG006|Overall Study|Stopped taking study medication|0|||
143367900|NCT01311713|516889457|FG000|Overall Study|Enrolled but not treated|0|||
143105568|NCT02244463|515926534|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
143105569|NCT02244463|515926535|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
143105570|NCT02244463|515926530|FG000|Period 5: Phase II|Disease Progression|0|||
143105571|NCT02244463|515926531|FG001|Period 5: Phase II|Disease Progression|0|||
143105572|NCT02244463|515926532|FG002|Period 5: Phase II|Disease Progression|0|||
143105573|NCT02244463|515926533|FG003|Period 5: Phase II|Disease Progression|0|||
143105574|NCT02244463|515926534|FG004|Period 5: Phase II|Disease Progression|10|||
143105575|NCT02244463|515926535|FG005|Period 5: Phase II|Disease Progression|11|||
143105576|NCT02244463|515926530|FG000|Period 5: Phase II|Physician Decision|0|||
143105577|NCT02244463|515926531|FG001|Period 5: Phase II|Physician Decision|0|||
143105578|NCT02244463|515926532|FG002|Period 5: Phase II|Physician Decision|0|||
143367901|NCT01311713|516889458|FG001|Overall Study|Enrolled but not treated|0|||
143367902|NCT01311713|516889459|FG002|Overall Study|Enrolled but not treated|1|||
143367903|NCT01311713|516889460|FG003|Overall Study|Enrolled but not treated|0|||
143367904|NCT01311713|516889461|FG004|Overall Study|Enrolled but not treated|0|||
143367905|NCT01311713|516889462|FG005|Overall Study|Enrolled but not treated|0|||
143367906|NCT01311713|516889463|FG006|Overall Study|Enrolled but not treated|0|||
143367907|NCT01311713|516889457|FG000|Overall Study|Other than specified|0|||
143367908|NCT01311713|516889458|FG001|Overall Study|Other than specified|1|||
143367909|NCT01311713|516889459|FG002|Overall Study|Other than specified|2|||
143367910|NCT01311713|516889460|FG003|Overall Study|Other than specified|0|||
143367911|NCT01311713|516889461|FG004|Overall Study|Other than specified|0|||
143367912|NCT01311713|516889462|FG005|Overall Study|Other than specified|0|||
143367913|NCT01311713|516889463|FG006|Overall Study|Other than specified|0|||
143367914|NCT01772719|516889468|FG000|Overall Study|Withdrawal by Subject|3|||
143367915|NCT01772719|516889468|FG000|Overall Study|Adverse Event|2|||
143367916|NCT01772719|516889468|FG000|Overall Study|Protocol Violation|1|||
143367917|NCT01772719|516889468|FG000|Overall Study|Lost to Follow-up|1|||
143367918|NCT05273801|516889469|FG000|Overall Study|Physician Decision|1|||
143367919|NCT00943605|516890826|FG000|Overall Study|Study termination|30|||
143367920|NCT00943605|516890827|FG001|Overall Study|Study termination|30|||
143367921|NCT04148937|516890828|FG000|Overall Study|Withdrawal by Subject|0|||
143367922|NCT04148937|516890829|FG001|Overall Study|Withdrawal by Subject|0|||
143367923|NCT04148937|516890830|FG002|Overall Study|Withdrawal by Subject|0|||
143367924|NCT04148937|516890831|FG003|Overall Study|Withdrawal by Subject|1|||
143367925|NCT04148937|516890832|FG004|Overall Study|Withdrawal by Subject|0|||
143367926|NCT04148937|516890833|FG005|Overall Study|Withdrawal by Subject|1|||
143367927|NCT04148937|516890834|FG006|Overall Study|Withdrawal by Subject|1|||
143367928|NCT04148937|516890835|FG007|Overall Study|Withdrawal by Subject|0|||
143367929|NCT04148937|516890828|FG000|Overall Study|Lost to Follow-up|0|||
143367930|NCT04148937|516890829|FG001|Overall Study|Lost to Follow-up|0|||
143367931|NCT04148937|516890830|FG002|Overall Study|Lost to Follow-up|1|||
143367932|NCT04148937|516890831|FG003|Overall Study|Lost to Follow-up|0|||
143367933|NCT04148937|516890832|FG004|Overall Study|Lost to Follow-up|0|||
143367934|NCT04148937|516890833|FG005|Overall Study|Lost to Follow-up|2|||
143367935|NCT04148937|516890834|FG006|Overall Study|Lost to Follow-up|0|||
143255013|NCT00869778|516488018|FG002|Overall Study|Withdrawal by Subject|5|||
143255014|NCT00869778|516488016|FG000|Overall Study|Pregnancy|1|||
143255015|NCT00869778|516488017|FG001|Overall Study|Pregnancy|0|||
143255016|NCT00869778|516488018|FG002|Overall Study|Pregnancy|0|||
143255017|NCT00869778|516488016|FG000|Overall Study|Protocol Violation|5|||
143255018|NCT00869778|516488017|FG001|Overall Study|Protocol Violation|3|||
143255019|NCT00869778|516488018|FG002|Overall Study|Protocol Violation|5|||
143255020|NCT00869778|516488016|FG000|Overall Study|Unblinding|1|||
143255021|NCT00869778|516488017|FG001|Overall Study|Unblinding|0|||
143255022|NCT00869778|516488018|FG002|Overall Study|Unblinding|0|||
143255023|NCT03339297|516488019|FG000|Overall Study|Relapse of Hematologic Disease|1|||
143255024|NCT03339297|516488020|FG001|Overall Study|Relapse of Hematologic Disease|0|||
143255025|NCT03339297|516488019|FG000|Overall Study|Death|10|||
143367936|NCT04148937|516890835|FG007|Overall Study|Lost to Follow-up|0|||
143105579|NCT02244463|515926533|FG003|Period 5: Phase II|Physician Decision|0|||
143105580|NCT02244463|515926534|FG004|Period 5: Phase II|Physician Decision|3|||
143105581|NCT02244463|515926535|FG005|Period 5: Phase II|Physician Decision|2|||
143105582|NCT02244463|515926530|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
143105583|NCT02244463|515926531|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
143255026|NCT03339297|516488020|FG001|Overall Study|Death|7|||
143255027|NCT03339297|516488019|FG000|Overall Study|Hepatic Candidosis|1|||
143255028|NCT03339297|516488020|FG001|Overall Study|Hepatic Candidosis|0|||
143367937|NCT00918957|516890836|FG000|Overall Study|Adverse Event|2|||
143367938|NCT00918957|516890837|FG001|Overall Study|Adverse Event|0|||
143367939|NCT00918957|516890836|FG000|Overall Study|Withdrawal by Subject|1|||
143367940|NCT00918957|516890837|FG001|Overall Study|Withdrawal by Subject|0|||
143105584|NCT02244463|515926532|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
143105585|NCT02244463|515926533|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
143105586|NCT02244463|515926534|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
143105587|NCT02244463|515926535|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
143105588|NCT02244463|515926530|FG000|Period 5: Phase II|Intercurrent Illness|0|||
143105589|NCT02244463|515926531|FG001|Period 5: Phase II|Intercurrent Illness|0|||
143105590|NCT02244463|515926532|FG002|Period 5: Phase II|Intercurrent Illness|0|||
143105591|NCT02244463|515926533|FG003|Period 5: Phase II|Intercurrent Illness|0|||
143105592|NCT02244463|515926534|FG004|Period 5: Phase II|Intercurrent Illness|2|||
143105593|NCT02244463|515926535|FG005|Period 5: Phase II|Intercurrent Illness|0|||
143105594|NCT02244463|515926530|FG000|Period 5: Phase II|Adverse Event|0|||
143105595|NCT02244463|515926531|FG001|Period 5: Phase II|Adverse Event|0|||
143105596|NCT02244463|515926532|FG002|Period 5: Phase II|Adverse Event|0|||
143105597|NCT02244463|515926533|FG003|Period 5: Phase II|Adverse Event|0|||
143105598|NCT02244463|515926534|FG004|Period 5: Phase II|Adverse Event|0|||
143105599|NCT02244463|515926535|FG005|Period 5: Phase II|Adverse Event|2|||
143105600|NCT02244463|515926530|FG000|Period 5: Phase II|Still On treatment|0|||
143105601|NCT02244463|515926531|FG001|Period 5: Phase II|Still On treatment|0|||
143105602|NCT02244463|515926532|FG002|Period 5: Phase II|Still On treatment|0|||
143105603|NCT02244463|515926533|FG003|Period 5: Phase II|Still On treatment|0|||
143105604|NCT02244463|515926534|FG004|Period 5: Phase II|Still On treatment|0|||
143178575|NCT03637491|516201601|FG002|Overall Study|Withdrawal by Subject|1|||
143105605|NCT02244463|515926535|FG005|Period 5: Phase II|Still On treatment|3|||
143105606|NCT01769508|515926536|FG000|Overall Study|Death|3|||
143105607|NCT01769508|515926536|FG000|Overall Study|Withdrawal by Subject|1|||
143105608|NCT01769508|515926536|FG000|Overall Study|Adverse Event|1|||
143105609|NCT01769508|515926536|FG000|Overall Study|Lost to Follow-up|1|||
143105610|NCT03615144|515926540|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
143105611|NCT03615144|515926541|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
143105612|NCT00355147|515926542|FG000|Overall Study|Lost to Follow-up|10|||
143105613|NCT00355147|515926543|FG001|Overall Study|Lost to Follow-up|8|||
143105614|NCT00355147|515926542|FG000|Overall Study|Withdrawal by Subject|8|||
143105615|NCT00355147|515926543|FG001|Overall Study|Withdrawal by Subject|12|||
143105616|NCT03557931|515926548|FG000|Overall Study|Adverse Event|4|||
143105617|NCT03557931|515926549|FG001|Overall Study|Adverse Event|6|||
143255029|NCT03339297|516488019|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
143255030|NCT03339297|516488020|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
143255031|NCT03339297|516488019|FG000|Overall Study|Consent Withdrawn by Participant|3|||
143255032|NCT03339297|516488020|FG001|Overall Study|Consent Withdrawn by Participant|3|||
143255033|NCT03339297|516488019|FG000|Overall Study|Disease Relapse|2|||
143255034|NCT03339297|516488020|FG001|Overall Study|Disease Relapse|0|||
143255035|NCT03339297|516488019|FG000|Overall Study|Physician Decision|1|||
143255036|NCT03339297|516488020|FG001|Overall Study|Physician Decision|1|||
143255037|NCT03339297|516488019|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
143255038|NCT03339297|516488020|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
143255039|NCT03339297|516488019|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
143255040|NCT03339297|516488020|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
143255041|NCT03339297|516488019|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
143255042|NCT03339297|516488020|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
143255043|NCT03339297|516488019|FG000|Overall Study|Adverse Event, Non-fatal|1|||
143255044|NCT03339297|516488020|FG001|Overall Study|Adverse Event, Non-fatal|0|||
143255045|NCT03339297|516488019|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
143105618|NCT03557931|515926550|FG002|Overall Study|Adverse Event|1|||
143105619|NCT03557931|515926548|FG000|Overall Study|Lost to Follow-up|4|||
143105620|NCT03557931|515926549|FG001|Overall Study|Lost to Follow-up|4|||
143105621|NCT03557931|515926550|FG002|Overall Study|Lost to Follow-up|1|||
143255046|NCT03339297|516488020|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
143105622|NCT03557931|515926548|FG000|Overall Study|Protocol Violation|1|||
143255047|NCT03339297|516488019|FG000|Overall Study|Patient Was Not Eligible|1|||
143255048|NCT03339297|516488020|FG001|Overall Study|Patient Was Not Eligible|0|||
143367941|NCT04464421|516890838|FG000|Overall Study|Lost to Follow-up|2|||
143367942|NCT04464421|516890839|FG001|Overall Study|Lost to Follow-up|2|||
143367943|NCT01956669|516890840|FG000|Overall Study|Disease Progression|12|||
143105623|NCT03557931|515926549|FG001|Overall Study|Protocol Violation|4|||
143105624|NCT03557931|515926550|FG002|Overall Study|Protocol Violation|1|||
143105625|NCT03557931|515926548|FG000|Overall Study|Withdrawal by Subject|14|||
143367944|NCT01956669|516890841|FG001|Overall Study|Disease Progression|7|||
143105626|NCT03557931|515926549|FG001|Overall Study|Withdrawal by Subject|0|||
143105627|NCT03557931|515926550|FG002|Overall Study|Withdrawal by Subject|7|||
143105628|NCT03557931|515926548|FG000|Overall Study|Miscellaneous|8|||
143105629|NCT03557931|515926549|FG001|Overall Study|Miscellaneous|5|||
143105630|NCT03557931|515926550|FG002|Overall Study|Miscellaneous|3|||
143105631|NCT03315286|515926551|FG000|Overall Study|Lost to Follow-up|0|||
143105632|NCT03315286|515926552|FG001|Overall Study|Lost to Follow-up|3|||
143105633|NCT03315286|515926551|FG000|Overall Study|Withdrawal by Subject|1|||
143105634|NCT03315286|515926552|FG001|Overall Study|Withdrawal by Subject|0|||
143105635|NCT03315286|515926551|FG000|Overall Study|Protocol Violation|0|||
143105636|NCT03315286|515926552|FG001|Overall Study|Protocol Violation|1|||
143105637|NCT00791661|515926554|FG000|7 Day Wash-out|Adverse Event|0|||
143105638|NCT00791661|515926555|FG001|7 Day Wash-out|Adverse Event|0|||
143105639|NCT00791661|515926556|FG002|7 Day Wash-out|Adverse Event|1|||
143105640|NCT00791661|515926554|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
143105641|NCT00791661|515926555|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
143105642|NCT00791661|515926556|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
143105643|NCT03605862|515926557|FG000|Overall Study|Withdrawal by Subject|12|||
143105644|NCT03605862|515926558|FG001|Overall Study|Withdrawal by Subject|9|||
143105645|NCT03605862|515926557|FG000|Overall Study|Adverse Event|2|||
143105646|NCT03605862|515926558|FG001|Overall Study|Adverse Event|1|||
143105647|NCT03605862|515926557|FG000|Overall Study|Physician Decision|3|||
143105648|NCT03605862|515926558|FG001|Overall Study|Physician Decision|1|||
143105649|NCT03605862|515926557|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
143105650|NCT03605862|515926558|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
143105651|NCT00679289|515926559|FG000|Overall Study|Progressive disease|4|||
143105652|NCT00679289|515926560|FG001|Overall Study|Progressive disease|5|||
143105653|NCT00679289|515926561|FG002|Overall Study|Progressive disease|18|||
143105654|NCT00679289|515926559|FG000|Overall Study|Withdrawal by Subject|0|||
143255049|NCT04740905|516488032|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
143255050|NCT04740905|516488033|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
143255051|NCT04740905|516488032|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
143255052|NCT04740905|516488033|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
143255053|NCT04740905|516488032|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
143255054|NCT04740905|516488033|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
143255055|NCT04740905|516488032|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
143255056|NCT04740905|516488033|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
143105655|NCT00679289|515926560|FG001|Overall Study|Withdrawal by Subject|1|||
143105656|NCT00679289|515926561|FG002|Overall Study|Withdrawal by Subject|1|||
143105657|NCT00679289|515926559|FG000|Overall Study|Adverse Event|0|||
143255057|NCT04740905|516488032|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
143255058|NCT04740905|516488033|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
143255059|NCT04740905|516488032|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
143255060|NCT04740905|516488033|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
143105658|NCT00679289|515926560|FG001|Overall Study|Adverse Event|0|||
143105659|NCT00679289|515926561|FG002|Overall Study|Adverse Event|3|||
143105660|NCT00679289|515926559|FG000|Overall Study|Physician Decision|1|||
143105661|NCT00679289|515926560|FG001|Overall Study|Physician Decision|0|||
143105662|NCT00679289|515926561|FG002|Overall Study|Physician Decision|1|||
143105663|NCT00937040|515926562|FG000|Overall Study|Adverse Event|5|||
143105664|NCT00937040|515926563|FG001|Overall Study|Adverse Event|8|||
143255061|NCT04740905|516488032|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
143255062|NCT04740905|516488033|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
143255063|NCT04740905|516488032|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
143255064|NCT04740905|516488033|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
143255065|NCT04740905|516488032|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
143255066|NCT04740905|516488033|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
143255067|NCT04740905|516488032|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
143255068|NCT04740905|516488033|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
143255069|NCT04740905|516488032|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
143255070|NCT04740905|516488033|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
143255071|NCT04740905|516488032|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
143255072|NCT04740905|516488033|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
143255073|NCT04740905|516488032|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
143255074|NCT04740905|516488033|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
143255075|NCT04740905|516488032|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
143255076|NCT04740905|516488033|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
143255077|NCT01566214|516488034|FG000|Overall Study|Lost to Follow-up|3|||
143255078|NCT01566214|516488035|FG001|Overall Study|Lost to Follow-up|0|||
143255079|NCT03051620|516488036|FG000|Overall Study|Lost to Follow-up|6|||
143255080|NCT03051620|516488036|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
143255081|NCT00393510|516488038|FG000|Overall Study|Physician Decision|3|||
143255082|NCT00393510|516488039|FG001|Overall Study|Physician Decision|9|||
143255083|NCT01534182|516488042|FG000|Overall Study|Administrative problems|1|||
143255084|NCT01534182|516488043|FG001|Overall Study|Administrative problems|0|||
143255085|NCT01534182|516488042|FG000|Overall Study|Withdrawal by Subject|4|||
143255086|NCT01534182|516488043|FG001|Overall Study|Withdrawal by Subject|7|||
143255087|NCT01534182|516488042|FG000|Overall Study|Adverse Event|7|||
143255088|NCT01534182|516488043|FG001|Overall Study|Adverse Event|3|||
143255089|NCT03077087|516488044|FG000|Overall Study|Physician Decision|2|||
143255090|NCT00770146|516488045|FG000|Treatment Period|Withdrawal by Subject|6|||
143255091|NCT00770146|516488046|FG001|Treatment Period|Withdrawal by Subject|13|||
143255092|NCT00770146|516488045|FG000|Treatment Period|Adverse Event|2|||
143255093|NCT00770146|516488046|FG001|Treatment Period|Adverse Event|26|||
143255094|NCT00770146|516488045|FG000|Treatment Period|Other|1|||
143255095|NCT00770146|516488046|FG001|Treatment Period|Other|5|||
143255096|NCT00770146|516488045|FG000|Treatment Period|Protocol non-compliance|0|||
143255097|NCT00770146|516488046|FG001|Treatment Period|Protocol non-compliance|1|||
143255098|NCT00770146|516488045|FG000|Follow-up Period|Withdrawal by Subject|7|||
143255099|NCT00770146|516488046|FG001|Follow-up Period|Withdrawal by Subject|13|||
143255100|NCT00770146|516488045|FG000|Follow-up Period|Adverse Event|0|||
143255101|NCT00770146|516488046|FG001|Follow-up Period|Adverse Event|2|||
143255102|NCT00770146|516488045|FG000|Follow-up Period|Other|4|||
143255103|NCT00770146|516488046|FG001|Follow-up Period|Other|5|||
143255104|NCT02412488|516488049|FG000|Overall Study|Lost to Follow-up|10|||
143255105|NCT02412488|516488049|FG000|Overall Study|Withdrawal by Subject|5|||
143255106|NCT02412488|516488049|FG000|Overall Study|Physician Decision|1|||
143255107|NCT02412488|516488049|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
143255108|NCT02412488|516488049|FG000|Overall Study|Reveal LINQ explant|1|||
143255109|NCT01989468|516488050|FG000|Overall Study|Adverse Event|10|||
143255110|NCT01989468|516488051|FG001|Overall Study|Adverse Event|15|||
143255111|NCT01989468|516488052|FG002|Overall Study|Adverse Event|4|||
143255112|NCT01989468|516488053|FG003|Overall Study|Adverse Event|5|||
143255113|NCT01989468|516488054|FG004|Overall Study|Adverse Event|4|||
143255114|NCT01989468|516488050|FG000|Overall Study|Lack of Efficacy|11|||
143255115|NCT01989468|516488051|FG001|Overall Study|Lack of Efficacy|11|||
143255116|NCT01989468|516488052|FG002|Overall Study|Lack of Efficacy|7|||
143105665|NCT00937040|515926562|FG000|Overall Study|Lost to Follow-up|12|||
143105666|NCT00937040|515926563|FG001|Overall Study|Lost to Follow-up|12|||
143255117|NCT01989468|516488053|FG003|Overall Study|Lack of Efficacy|4|||
143255118|NCT01989468|516488054|FG004|Overall Study|Lack of Efficacy|2|||
143367945|NCT01956669|516890842|FG002|Overall Study|Disease Progression|7|||
143105667|NCT00937040|515926562|FG000|Overall Study|Protocol Violation|3|||
143255119|NCT01989468|516488050|FG000|Overall Study|Lost to Follow-up|5|||
143255120|NCT01989468|516488051|FG001|Overall Study|Lost to Follow-up|2|||
143255121|NCT01989468|516488052|FG002|Overall Study|Lost to Follow-up|0|||
143255122|NCT01989468|516488053|FG003|Overall Study|Lost to Follow-up|1|||
143255123|NCT01989468|516488054|FG004|Overall Study|Lost to Follow-up|1|||
143255124|NCT01989468|516488050|FG000|Overall Study|Physician Decision|4|||
143255125|NCT01989468|516488051|FG001|Overall Study|Physician Decision|1|||
143255126|NCT01989468|516488052|FG002|Overall Study|Physician Decision|0|||
143105668|NCT00937040|515926563|FG001|Overall Study|Protocol Violation|0|||
143105669|NCT00937040|515926562|FG000|Overall Study|Withdrawal by Subject|13|||
143105670|NCT00937040|515926563|FG001|Overall Study|Withdrawal by Subject|7|||
143105671|NCT00937040|515926562|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
143105672|NCT00937040|515926563|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
143105673|NCT00937040|515926562|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
143105674|NCT00937040|515926563|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
143105675|NCT00634803|515926566|FG000|Overall Study|Lost to Follow-up|6|||
143105676|NCT00634803|515926567|FG001|Overall Study|Lost to Follow-up|7|||
143105677|NCT00634803|515926568|FG002|Overall Study|Lost to Follow-up|7|||
143105678|NCT00364923|515926569|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
143105679|NCT00364923|515926569|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
143105680|NCT01355575|515926577|FG000|Overall Study|Withdrawal by Subject|2|||
143105681|NCT00582608|515926586|FG000|Overall Study|Not Treated|7|||
143178576|NCT03637491|516201602|FG003|Overall Study|Withdrawal by Subject|2|||
143178577|NCT02185534|516201606|FG000|First Period|Withdrawal by Subject|0|||
143178578|NCT02185534|516201607|FG001|First Period|Withdrawal by Subject|0|||
143178579|NCT02185534|516201608|FG002|First Period|Withdrawal by Subject|0|||
143178580|NCT02185534|516201609|FG003|First Period|Withdrawal by Subject|1|||
143178581|NCT02185534|516201610|FG004|First Period|Withdrawal by Subject|0|||
143178582|NCT02185534|516201611|FG005|First Period|Withdrawal by Subject|0|||
143178583|NCT02185534|516201606|FG000|First Washout Period|Withdrawal by Subject|1|||
143178584|NCT02185534|516201607|FG001|First Washout Period|Withdrawal by Subject|0|||
143178585|NCT02185534|516201608|FG002|First Washout Period|Withdrawal by Subject|0|||
143178586|NCT02185534|516201609|FG003|First Washout Period|Withdrawal by Subject|0|||
143178587|NCT02185534|516201610|FG004|First Washout Period|Withdrawal by Subject|1|||
143178588|NCT02185534|516201611|FG005|First Washout Period|Withdrawal by Subject|0|||
143178589|NCT02185534|516201606|FG000|First Washout Period|Protocol Violation|0|||
143178590|NCT02185534|516201607|FG001|First Washout Period|Protocol Violation|0|||
143178591|NCT02185534|516201608|FG002|First Washout Period|Protocol Violation|0|||
143178592|NCT02185534|516201609|FG003|First Washout Period|Protocol Violation|0|||
143178593|NCT02185534|516201610|FG004|First Washout Period|Protocol Violation|0|||
143178594|NCT02185534|516201611|FG005|First Washout Period|Protocol Violation|1|||
143178595|NCT04940130|516201614|FG000|Overall Study|Travel|1|||
143178596|NCT04940130|516201615|FG001|Overall Study|Travel|0|||
143178597|NCT04940130|516201616|FG002|Overall Study|Travel|2|||
143178598|NCT04940130|516201614|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
143178599|NCT04940130|516201615|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
143178600|NCT04940130|516201616|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
143178601|NCT04940130|516201614|FG000|Overall Study|Adverse Event|0|||
143178602|NCT04940130|516201615|FG001|Overall Study|Adverse Event|0|||
143178603|NCT04940130|516201616|FG002|Overall Study|Adverse Event|2|||
143178604|NCT04940130|516201614|FG000|Overall Study|Disease progression/treatment failure|0|||
143178605|NCT04940130|516201615|FG001|Overall Study|Disease progression/treatment failure|0|||
143178606|NCT04940130|516201616|FG002|Overall Study|Disease progression/treatment failure|1|||
143178607|NCT04940130|516201614|FG000|Overall Study|Participant refusal|0|||
143178608|NCT04940130|516201615|FG001|Overall Study|Participant refusal|0|||
143178609|NCT04940130|516201616|FG002|Overall Study|Participant refusal|1|||
143178610|NCT02240121|516201617|FG000|Overall Study|Protocol Violation|1|||
143178611|NCT02240121|516201618|FG001|Overall Study|Protocol Violation|2|||
143178612|NCT02240121|516201617|FG000|Overall Study|Physician Decision|0|||
143178613|NCT02240121|516201618|FG001|Overall Study|Physician Decision|1|||
143178614|NCT02240121|516201617|FG000|Overall Study|Change in protocol interpretation|1|||
143178615|NCT02240121|516201618|FG001|Overall Study|Change in protocol interpretation|0|||
143178616|NCT02240121|516201617|FG000|Overall Study|Lack of Efficacy|2|||
143178617|NCT02240121|516201618|FG001|Overall Study|Lack of Efficacy|3|||
143178618|NCT02240121|516201617|FG000|Overall Study|Site closed|1|||
143178619|NCT02240121|516201618|FG001|Overall Study|Site closed|1|||
143178620|NCT02240121|516201617|FG000|Overall Study|Pregnancy|1|||
143178621|NCT02240121|516201618|FG001|Overall Study|Pregnancy|0|||
143178622|NCT02240121|516201617|FG000|Overall Study|Adverse Event|2|||
143178623|NCT02240121|516201618|FG001|Overall Study|Adverse Event|4|||
143178624|NCT02240121|516201617|FG000|Overall Study|Withdrawal by Subject|6|||
143178625|NCT02240121|516201618|FG001|Overall Study|Withdrawal by Subject|2|||
143178626|NCT02240121|516201617|FG000|Overall Study|Lost to Follow-up|3|||
143178627|NCT02240121|516201618|FG001|Overall Study|Lost to Follow-up|4|||
143178628|NCT02240121|516201617|FG000|Overall Study|Other than specified|1|||
143178629|NCT02240121|516201618|FG001|Overall Study|Other than specified|3|||
143178630|NCT01925768|516201621|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
143178631|NCT01925768|516201622|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
143178632|NCT01925768|516201621|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
143178633|NCT01925768|516201622|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
143178634|NCT01925768|516201621|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
143178635|NCT01925768|516201622|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
143367946|NCT01956669|516890843|FG003|Overall Study|Disease Progression|8|||
143367947|NCT01956669|516890844|FG004|Overall Study|Disease Progression|4|||
143367948|NCT01956669|516890845|FG005|Overall Study|Disease Progression|3|||
143367949|NCT01956669|516890846|FG006|Overall Study|Disease Progression|5|||
143367950|NCT01956669|516890840|FG000|Overall Study|Adverse Event|0|||
143367951|NCT01956669|516890841|FG001|Overall Study|Adverse Event|2|||
143367952|NCT01956669|516890842|FG002|Overall Study|Adverse Event|2|||
143255127|NCT01989468|516488053|FG003|Overall Study|Physician Decision|1|||
143255128|NCT01989468|516488054|FG004|Overall Study|Physician Decision|0|||
143255129|NCT01989468|516488050|FG000|Overall Study|Pregnancy|0|||
143255130|NCT01989468|516488051|FG001|Overall Study|Pregnancy|1|||
143255131|NCT01989468|516488052|FG002|Overall Study|Pregnancy|0|||
143255132|NCT01989468|516488053|FG003|Overall Study|Pregnancy|0|||
143255133|NCT01989468|516488054|FG004|Overall Study|Pregnancy|0|||
143255134|NCT01989468|516488050|FG000|Overall Study|Technical Problems|3|||
143255135|NCT01989468|516488051|FG001|Overall Study|Technical Problems|1|||
143255136|NCT01989468|516488052|FG002|Overall Study|Technical Problems|3|||
143255137|NCT01989468|516488053|FG003|Overall Study|Technical Problems|1|||
143255138|NCT01989468|516488054|FG004|Overall Study|Technical Problems|0|||
143255139|NCT01989468|516488050|FG000|Overall Study|Subject Guardian Decision|11|||
143255140|NCT01989468|516488051|FG001|Overall Study|Subject Guardian Decision|6|||
143255141|NCT01989468|516488052|FG002|Overall Study|Subject Guardian Decision|4|||
143255142|NCT01989468|516488053|FG003|Overall Study|Subject Guardian Decision|4|||
143255143|NCT01989468|516488054|FG004|Overall Study|Subject Guardian Decision|1|||
143255144|NCT01989468|516488050|FG000|Overall Study|Death|3|||
143255145|NCT01989468|516488051|FG001|Overall Study|Death|0|||
143255146|NCT01989468|516488052|FG002|Overall Study|Death|1|||
143255147|NCT01989468|516488053|FG003|Overall Study|Death|0|||
143255148|NCT01989468|516488054|FG004|Overall Study|Death|0|||
143255149|NCT00674154|516488058|FG000|Overall Study|Withdrawal by Subject|3|||
143255150|NCT00674154|516488059|FG001|Overall Study|Withdrawal by Subject|1|||
143255151|NCT00674154|516488058|FG000|Overall Study|Did not want parathyroidectomy|0|||
143255152|NCT00674154|516488059|FG001|Overall Study|Did not want parathyroidectomy|2|||
143255153|NCT03222492|516488060|FG000|Overall Study|Withdrawal by Subject|0|||
143255154|NCT03222492|516488061|FG001|Overall Study|Withdrawal by Subject|0|||
143255155|NCT03222492|516488062|FG002|Overall Study|Withdrawal by Subject|1|||
143255156|NCT03222492|516488063|FG003|Overall Study|Withdrawal by Subject|0|||
143255157|NCT03222492|516488060|FG000|Overall Study|COVID-19 related|0|||
143255158|NCT03222492|516488061|FG001|Overall Study|COVID-19 related|0|||
143255159|NCT03222492|516488062|FG002|Overall Study|COVID-19 related|1|||
143255160|NCT03222492|516488063|FG003|Overall Study|COVID-19 related|0|||
143255161|NCT00816023|516488064|FG000|Overall Study|Lost to Follow-up|1|||
143255162|NCT00816023|516488065|FG001|Overall Study|Lost to Follow-up|1|||
143255163|NCT00816023|516488066|FG002|Overall Study|Lost to Follow-up|0|||
143255164|NCT00816023|516488067|FG003|Overall Study|Lost to Follow-up|0|||
143255165|NCT00816023|516488064|FG000|Overall Study|Withdrawal by Subject|1|||
143255166|NCT00816023|516488065|FG001|Overall Study|Withdrawal by Subject|0|||
143255167|NCT00816023|516488066|FG002|Overall Study|Withdrawal by Subject|0|||
143255168|NCT00816023|516488067|FG003|Overall Study|Withdrawal by Subject|0|||
143255169|NCT00816023|516488064|FG000|Overall Study|Physician Decision|0|||
143255170|NCT00816023|516488065|FG001|Overall Study|Physician Decision|0|||
143255171|NCT00816023|516488066|FG002|Overall Study|Physician Decision|1|||
143255172|NCT00816023|516488067|FG003|Overall Study|Physician Decision|0|||
143255173|NCT00816023|516488064|FG000|Overall Study|assessments complete prior to window|1|||
143255174|NCT00816023|516488065|FG001|Overall Study|assessments complete prior to window|1|||
143255175|NCT00816023|516488066|FG002|Overall Study|assessments complete prior to window|2|||
143255176|NCT00816023|516488067|FG003|Overall Study|assessments complete prior to window|1|||
143255177|NCT00816023|516488064|FG000|Overall Study|Randomized Not Treated|6|||
143255178|NCT00816023|516488065|FG001|Overall Study|Randomized Not Treated|4|||
143255179|NCT00816023|516488066|FG002|Overall Study|Randomized Not Treated|6|||
143255180|NCT00816023|516488067|FG003|Overall Study|Randomized Not Treated|11|||
143255181|NCT01525901|516488068|FG000|Period 2: 12 Weeks|Adverse Event|0|||
143255182|NCT01525901|516488069|FG001|Period 2: 12 Weeks|Adverse Event|1|||
143255183|NCT01525901|516488070|FG002|Period 2: 12 Weeks|Adverse Event|0|||
143255184|NCT01525901|516488071|FG003|Period 2: 12 Weeks|Adverse Event|0|||
143255185|NCT02025556|516488072|FG000|Overall Study|Adverse Event|0|||
143255186|NCT02025556|516488073|FG001|Overall Study|Adverse Event|4|||
143255187|NCT02025556|516488074|FG002|Overall Study|Adverse Event|2|||
143255188|NCT02025556|516488072|FG000|Overall Study|Lack of Efficacy|2|||
143255189|NCT02025556|516488073|FG001|Overall Study|Lack of Efficacy|1|||
143255190|NCT02025556|516488074|FG002|Overall Study|Lack of Efficacy|0|||
143255191|NCT02025556|516488072|FG000|Overall Study|Protocol Violation|2|||
143255192|NCT02025556|516488073|FG001|Overall Study|Protocol Violation|1|||
143255193|NCT02025556|516488074|FG002|Overall Study|Protocol Violation|0|||
143255194|NCT02025556|516488072|FG000|Overall Study|Withdrawal by Subject|0|||
143255195|NCT02025556|516488073|FG001|Overall Study|Withdrawal by Subject|3|||
143255196|NCT02025556|516488074|FG002|Overall Study|Withdrawal by Subject|6|||
143367953|NCT01956669|516890843|FG003|Overall Study|Adverse Event|1|||
143105682|NCT00582608|515926586|FG000|Overall Study|Patient Ineligible|1|||
143105683|NCT00582608|515926586|FG000|Overall Study|Lack of accrual|4|||
143105684|NCT01732640|515926587|FG000|Overall Study|Adverse Event|0|||
143105685|NCT01732640|515926588|FG001|Overall Study|Adverse Event|1|||
143105686|NCT01732640|515926587|FG000|Overall Study|Death|0|||
143105687|NCT01732640|515926588|FG001|Overall Study|Death|1|||
143105688|NCT00504725|515928143|FG000|Overall Study|Protocol Violation|1|||
143105689|NCT00504725|515928144|FG001|Overall Study|Protocol Violation|0|||
143105690|NCT01435018|515928145|FG000|Overall Study|Death|37|||
143105691|NCT01435018|515928146|FG001|Overall Study|Death|18|||
143105692|NCT01435018|515928147|FG002|Overall Study|Death|25|||
143105693|NCT01435018|515928145|FG000|Overall Study|Site is closing|4|||
143105694|NCT01435018|515928146|FG001|Overall Study|Site is closing|9|||
143105695|NCT01435018|515928147|FG002|Overall Study|Site is closing|7|||
143105696|NCT01435018|515928145|FG000|Overall Study|Withdrew consent|0|||
143105697|NCT01435018|515928146|FG001|Overall Study|Withdrew consent|3|||
143105698|NCT01435018|515928147|FG002|Overall Study|Withdrew consent|1|||
143105699|NCT01435018|515928145|FG000|Overall Study|Not willing to adhere to requirements|0|||
143105700|NCT01435018|515928146|FG001|Overall Study|Not willing to adhere to requirements|2|||
143105701|NCT01435018|515928147|FG002|Overall Study|Not willing to adhere to requirements|3|||
143105702|NCT01435018|515928145|FG000|Overall Study|Not able to get to clinic|2|||
143105703|NCT01435018|515928146|FG001|Overall Study|Not able to get to clinic|0|||
143105704|NCT01435018|515928147|FG002|Overall Study|Not able to get to clinic|2|||
143105705|NCT01435018|515928145|FG000|Overall Study|Severe debilitation, unable to continue|0|||
143105706|NCT01435018|515928146|FG001|Overall Study|Severe debilitation, unable to continue|0|||
143105707|NCT01435018|515928147|FG002|Overall Study|Severe debilitation, unable to continue|1|||
143105708|NCT01435018|515928145|FG000|Overall Study|Unable to contact participant/parent|1|||
143105709|NCT01435018|515928146|FG001|Overall Study|Unable to contact participant/parent|1|||
143105710|NCT01435018|515928147|FG002|Overall Study|Unable to contact participant/parent|1|||
143105711|NCT01435018|515928145|FG000|Overall Study|Enrollment Violation|0|||
143105712|NCT01435018|515928146|FG001|Overall Study|Enrollment Violation|1|||
143105713|NCT01435018|515928147|FG002|Overall Study|Enrollment Violation|0|||
143105714|NCT01435018|515928145|FG000|Overall Study|Never started chemotherapy|3|||
143105715|NCT01435018|515928146|FG001|Overall Study|Never started chemotherapy|0|||
143105716|NCT01435018|515928147|FG002|Overall Study|Never started chemotherapy|1|||
143105717|NCT00769067|515928148|FG000|Overall Study|Death|89|||
143105718|NCT00769067|515928149|FG001|Overall Study|Death|86|||
143255197|NCT02025556|516488072|FG000|Overall Study|Lost to Follow-up|2|||
143255198|NCT02025556|516488073|FG001|Overall Study|Lost to Follow-up|4|||
143105719|NCT00769067|515928148|FG000|Overall Study|Lost to Follow-up|3|||
143105720|NCT00769067|515928149|FG001|Overall Study|Lost to Follow-up|1|||
143255199|NCT02025556|516488074|FG002|Overall Study|Lost to Follow-up|0|||
143255200|NCT02025556|516488072|FG000|Overall Study|Reason not reported|0|||
143178636|NCT01925768|516201621|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
143178637|NCT01925768|516201622|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
143255201|NCT02025556|516488073|FG001|Overall Study|Reason not reported|0|||
143178638|NCT01925768|516201621|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
143178639|NCT01925768|516201622|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
143178640|NCT01925768|516201621|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
143178641|NCT01925768|516201622|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
143178642|NCT01925768|516201621|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
143178643|NCT01925768|516201622|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
143178644|NCT01925768|516201621|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
143178645|NCT01925768|516201622|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
143178646|NCT01925768|516201621|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
143178647|NCT01925768|516201622|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
143178648|NCT01925768|516201621|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
143178649|NCT01925768|516201622|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
143178650|NCT01925768|516201621|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
143178651|NCT01925768|516201622|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
143178652|NCT04571060|516201640|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
143178653|NCT04571060|516201641|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
143178654|NCT04571060|516201640|FG000|Overall Study|Never treated migraine|47|||
143178655|NCT04571060|516201641|FG001|Overall Study|Never treated migraine|36|||
143178656|NCT04571060|516201640|FG000|Overall Study|Protocol Violation|4|||
143178657|NCT04571060|516201641|FG001|Overall Study|Protocol Violation|2|||
143178658|NCT04571060|516201640|FG000|Overall Study|Withdrawal by Subject|6|||
143178659|NCT04571060|516201641|FG001|Overall Study|Withdrawal by Subject|2|||
143178660|NCT04571060|516201640|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
143178661|NCT04571060|516201641|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
143178662|NCT01508910|516201644|FG000|Treatment|Death|2|||
143178663|NCT01508910|516201645|FG001|Treatment|Death|3|||
143178664|NCT01508910|516201646|FG002|Treatment|Death|2|||
143178665|NCT01508910|516201647|FG003|Treatment|Death|0|||
143178666|NCT01508910|516201644|FG000|Treatment|Lost to Follow-up|0|||
143178667|NCT01508910|516201645|FG001|Treatment|Lost to Follow-up|0|||
143178668|NCT01508910|516201646|FG002|Treatment|Lost to Follow-up|2|||
143178669|NCT01508910|516201647|FG003|Treatment|Lost to Follow-up|1|||
143178670|NCT01508910|516201644|FG000|Treatment|Withdrawal by Subject|0|||
143178671|NCT01508910|516201645|FG001|Treatment|Withdrawal by Subject|1|||
143178672|NCT01508910|516201646|FG002|Treatment|Withdrawal by Subject|6|||
143178673|NCT01508910|516201647|FG003|Treatment|Withdrawal by Subject|1|||
143178674|NCT01508910|516201644|FG000|Treatment|Sponsor Decision|0|||
143178675|NCT01508910|516201645|FG001|Treatment|Sponsor Decision|0|||
143178676|NCT01508910|516201646|FG002|Treatment|Sponsor Decision|0|||
143178677|NCT01508910|516201647|FG003|Treatment|Sponsor Decision|1|||
143178678|NCT04819113|516201649|FG000|Overall Study|Withdrawal by parent/guardian|3|||
143178679|NCT04819113|516201649|FG000|Overall Study|Lost to Follow-up|1|||
143178680|NCT04819113|516201649|FG000|Overall Study|Withdrawn before vaccination|2|||
143178681|NCT02806414|516201652|FG000|Overall Study|Lost to Follow-up|2|||
143178682|NCT02573948|516201659|FG000|Longitudinal Cohort|Death|9|||
143178683|NCT02573948|516201659|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
143178684|NCT02573948|516201659|FG000|Longitudinal Cohort|Incarcerated|25|||
143178685|NCT01673126|516201660|FG000|Overall Study|change of diagnosis|4|||
143178686|NCT01673126|516201661|FG001|Overall Study|change of diagnosis|3|||
143178687|NCT01913327|516201666|FG000|Overall Study|Withdrawal by Subject|0|||
143178688|NCT01913327|516201667|FG001|Overall Study|Withdrawal by Subject|1|||
143178689|NCT00678288|516203572|FG000|Overall Study|Adverse Event|0|||
143178690|NCT00678288|516203573|FG001|Overall Study|Adverse Event|2|||
143178691|NCT00678288|516203572|FG000|Overall Study|Withdrawal by Subject|1|||
143178692|NCT00678288|516203573|FG001|Overall Study|Withdrawal by Subject|1|||
143178693|NCT00678288|516203572|FG000|Overall Study|Study terminated by the sponsor|2|||
143178694|NCT00678288|516203573|FG001|Overall Study|Study terminated by the sponsor|0|||
143178695|NCT00678288|516203572|FG000|Overall Study|Not compliant with study medication|0|||
143178696|NCT00678288|516203573|FG001|Overall Study|Not compliant with study medication|1|||
143178697|NCT00678288|516203572|FG000|Overall Study|Switch to commercial drug|0|||
143178698|NCT00678288|516203573|FG001|Overall Study|Switch to commercial drug|1|||
143178699|NCT00678288|516203572|FG000|Overall Study|Reason not reported|1|||
143178700|NCT00678288|516203573|FG001|Overall Study|Reason not reported|0|||
143178701|NCT00678288|516203572|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
143178702|NCT00678288|516203573|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
143178703|NCT00628446|516203576|FG000|Overall Study|Lost to Follow-up|3|||
143178704|NCT00628446|516203576|FG000|Overall Study|Withdrawal by Subject|1|||
143178705|NCT00628446|516203576|FG000|Overall Study|Protocol Violation|3|||
143178706|NCT00682929|516203577|FG000|Overall Study|Adverse Event|4|||
143178707|NCT00682929|516203578|FG001|Overall Study|Adverse Event|1|||
143178708|NCT00682929|516203579|FG002|Overall Study|Adverse Event|1|||
143178709|NCT00682929|516203577|FG000|Overall Study|Withdrawal by Subject|1|||
143178710|NCT00682929|516203578|FG001|Overall Study|Withdrawal by Subject|2|||
143255202|NCT02025556|516488074|FG002|Overall Study|Reason not reported|1|||
143255203|NCT02486627|516488075|FG000|Overall Study|Death|1|||
143255204|NCT02486627|516488076|FG001|Overall Study|Death|0|||
143255205|NCT02486627|516488075|FG000|Overall Study|Other Unspecified|0|||
143255206|NCT02486627|516488076|FG001|Overall Study|Other Unspecified|2|||
143255207|NCT02486627|516488075|FG000|Overall Study|Consent Withdrawn by Participant|4|||
143255208|NCT02486627|516488076|FG001|Overall Study|Consent Withdrawn by Participant|3|||
143255209|NCT02486627|516488075|FG000|Overall Study|Significant Participant Noncompliance|1|||
143255210|NCT02486627|516488076|FG001|Overall Study|Significant Participant Noncompliance|1|||
143255211|NCT02486627|516488075|FG000|Overall Study|Lost to Follow-up|1|||
143255212|NCT02486627|516488076|FG001|Overall Study|Lost to Follow-up|3|||
143255213|NCT00627445|516488077|FG000|Overall Study|Adverse Event|3|||
143255214|NCT00627445|516488078|FG001|Overall Study|Adverse Event|3|||
143255215|NCT00627445|516488077|FG000|Overall Study|Lack of Efficacy|0|||
143255216|NCT00627445|516488078|FG001|Overall Study|Lack of Efficacy|1|||
143255217|NCT00627445|516488077|FG000|Overall Study|Other|6|||
143255218|NCT00627445|516488078|FG001|Overall Study|Other|8|||
143255219|NCT01238588|516488080|FG000|Overall Study|Withdrawal by Subject|1|||
143255220|NCT01238588|516488080|FG000|Overall Study|Physician Decision|2|||
143255221|NCT05395091|516488085|FG000|Baseline to Month 12|Adverse Event|7|||
143255222|NCT05395091|516488086|FG001|Baseline to Month 12|Adverse Event|2|||
143255223|NCT05395091|516488087|FG002|Baseline to Month 12|Adverse Event|0|||
143255224|NCT05395091|516488085|FG000|Baseline to Month 12|Death|3|||
143255225|NCT05395091|516488086|FG001|Baseline to Month 12|Death|1|||
143255226|NCT05395091|516488087|FG002|Baseline to Month 12|Death|0|||
143255227|NCT05395091|516488085|FG000|Baseline to Month 12|Withdrawal by Subject|11|||
143255228|NCT05395091|516488086|FG001|Baseline to Month 12|Withdrawal by Subject|16|||
143255229|NCT05395091|516488087|FG002|Baseline to Month 12|Withdrawal by Subject|0|||
143255230|NCT05395091|516488085|FG000|Baseline to Month 12|Protocol Violation|2|||
143255231|NCT05395091|516488086|FG001|Baseline to Month 12|Protocol Violation|3|||
143255232|NCT05395091|516488087|FG002|Baseline to Month 12|Protocol Violation|0|||
143255233|NCT05395091|516488085|FG000|Baseline to Month 12|Physician Decision|1|||
143255234|NCT05395091|516488086|FG001|Baseline to Month 12|Physician Decision|0|||
143255235|NCT05395091|516488087|FG002|Baseline to Month 12|Physician Decision|0|||
143255236|NCT05395091|516488085|FG000|Month 12 to Month 18|Death|1|||
143105721|NCT00769067|515928148|FG000|Overall Study|Study terminated by sponsor|1|||
143255237|NCT05395091|516488086|FG001|Month 12 to Month 18|Death|0|||
143255238|NCT05395091|516488087|FG002|Month 12 to Month 18|Death|0|||
143255239|NCT05395091|516488085|FG000|Month 12 to Month 18|Withdrawal by Subject|3|||
143255240|NCT05395091|516488086|FG001|Month 12 to Month 18|Withdrawal by Subject|2|||
143255241|NCT05395091|516488087|FG002|Month 12 to Month 18|Withdrawal by Subject|1|||
143255242|NCT05395091|516488085|FG000|Month 12 to Month 18|Lost to Follow-up|1|||
143255243|NCT05395091|516488086|FG001|Month 12 to Month 18|Lost to Follow-up|0|||
143255244|NCT05395091|516488087|FG002|Month 12 to Month 18|Lost to Follow-up|1|||
143255245|NCT05395091|516488085|FG000|Month 12 to Month 18|Other reasons|0|||
143255246|NCT05395091|516488086|FG001|Month 12 to Month 18|Other reasons|0|||
143255247|NCT05395091|516488087|FG002|Month 12 to Month 18|Other reasons|1|||
143255248|NCT01915303|516488091|FG000|Core Phase|Adverse Event|7|||
143255249|NCT01915303|516488091|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
143255250|NCT01915303|516488091|FG000|Core Phase|Death|2|||
143255251|NCT01915303|516488091|FG000|Core Phase|Protocol Violation|2|||
143255252|NCT01915303|516488091|FG000|Core Phase|Abnormal lab value|1|||
143255253|NCT01915303|516488091|FG000|Core Phase|Withdrawal by Subject|1|||
143255254|NCT01915303|516488091|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
143255255|NCT01915303|516488091|FG000|Extension Phase|Withdrawal by Subject|4|||
143255256|NCT01915303|516488091|FG000|Extension Phase|Adverse Event|3|||
143255257|NCT01915303|516488091|FG000|Extension Phase|Death|1|||
143255258|NCT01915303|516488091|FG000|Extension Phase|Protocol Violation|1|||
143255259|NCT02431260|516488099|FG000|Overall Study|Subject Decision|0|||
143255260|NCT02431260|516488100|FG001|Overall Study|Subject Decision|1|||
143255261|NCT02431260|516488101|FG002|Overall Study|Subject Decision|1|||
143255262|NCT02431260|516488102|FG003|Overall Study|Subject Decision|0|||
143255263|NCT02431260|516488103|FG004|Overall Study|Subject Decision|0|||
143255264|NCT02431260|516488104|FG005|Overall Study|Subject Decision|0|||
143255265|NCT02431260|516488105|FG006|Overall Study|Subject Decision|0|||
143255266|NCT02431260|516488106|FG007|Overall Study|Subject Decision|0|||
143255267|NCT02431260|516488107|FG008|Overall Study|Subject Decision|1|||
143255268|NCT02431260|516488108|FG009|Overall Study|Subject Decision|1|||
143255269|NCT02431260|516488109|FG010|Overall Study|Subject Decision|0|||
143255270|NCT02431260|516488110|FG011|Overall Study|Subject Decision|1|||
143255271|NCT02431260|516488111|FG012|Overall Study|Subject Decision|0|||
143255272|NCT02431260|516488112|FG013|Overall Study|Subject Decision|0|||
143255273|NCT02431260|516488099|FG000|Overall Study|Death|4|||
143255274|NCT02431260|516488100|FG001|Overall Study|Death|4|||
143255275|NCT02431260|516488101|FG002|Overall Study|Death|3|||
143255276|NCT02431260|516488102|FG003|Overall Study|Death|4|||
143255277|NCT02431260|516488103|FG004|Overall Study|Death|2|||
143255278|NCT02431260|516488104|FG005|Overall Study|Death|2|||
143255279|NCT02431260|516488105|FG006|Overall Study|Death|3|||
143255280|NCT02431260|516488106|FG007|Overall Study|Death|1|||
143255281|NCT02431260|516488107|FG008|Overall Study|Death|6|||
143255282|NCT02431260|516488108|FG009|Overall Study|Death|6|||
143255283|NCT02431260|516488109|FG010|Overall Study|Death|3|||
143255284|NCT02431260|516488110|FG011|Overall Study|Death|2|||
143255285|NCT02431260|516488111|FG012|Overall Study|Death|5|||
143255286|NCT02431260|516488112|FG013|Overall Study|Death|1|||
143255287|NCT02431260|516488099|FG000|Overall Study|Lost to Follow-up|0|||
143255288|NCT02431260|516488100|FG001|Overall Study|Lost to Follow-up|0|||
143255289|NCT02431260|516488101|FG002|Overall Study|Lost to Follow-up|0|||
143255290|NCT02431260|516488102|FG003|Overall Study|Lost to Follow-up|0|||
143255291|NCT02431260|516488103|FG004|Overall Study|Lost to Follow-up|0|||
143255292|NCT02431260|516488104|FG005|Overall Study|Lost to Follow-up|1|||
143255293|NCT02431260|516488105|FG006|Overall Study|Lost to Follow-up|0|||
143255294|NCT02431260|516488106|FG007|Overall Study|Lost to Follow-up|0|||
143255295|NCT02431260|516488107|FG008|Overall Study|Lost to Follow-up|0|||
143255296|NCT02431260|516488108|FG009|Overall Study|Lost to Follow-up|0|||
143255297|NCT02431260|516488109|FG010|Overall Study|Lost to Follow-up|0|||
143255298|NCT02431260|516488110|FG011|Overall Study|Lost to Follow-up|0|||
143255299|NCT02431260|516488111|FG012|Overall Study|Lost to Follow-up|0|||
143255300|NCT02431260|516488112|FG013|Overall Study|Lost to Follow-up|0|||
143255301|NCT02431260|516488099|FG000|Overall Study|Study Terminated by the Sponsor|0|||
143255302|NCT02431260|516488100|FG001|Overall Study|Study Terminated by the Sponsor|0|||
143255303|NCT02431260|516488101|FG002|Overall Study|Study Terminated by the Sponsor|2|||
143255304|NCT02431260|516488102|FG003|Overall Study|Study Terminated by the Sponsor|1|||
143255305|NCT02431260|516488103|FG004|Overall Study|Study Terminated by the Sponsor|1|||
143255306|NCT02431260|516488104|FG005|Overall Study|Study Terminated by the Sponsor|0|||
143255307|NCT02431260|516488105|FG006|Overall Study|Study Terminated by the Sponsor|1|||
143255308|NCT02431260|516488106|FG007|Overall Study|Study Terminated by the Sponsor|2|||
143255309|NCT02431260|516488107|FG008|Overall Study|Study Terminated by the Sponsor|1|||
143255310|NCT02431260|516488108|FG009|Overall Study|Study Terminated by the Sponsor|1|||
143255311|NCT02431260|516488109|FG010|Overall Study|Study Terminated by the Sponsor|1|||
143255312|NCT02431260|516488110|FG011|Overall Study|Study Terminated by the Sponsor|0|||
143255313|NCT02431260|516488111|FG012|Overall Study|Study Terminated by the Sponsor|4|||
143255314|NCT02431260|516488112|FG013|Overall Study|Study Terminated by the Sponsor|0|||
143255315|NCT02431260|516488099|FG000|Overall Study|Physician Decision|0|||
143255316|NCT02431260|516488100|FG001|Overall Study|Physician Decision|0|||
143178711|NCT00682929|516203579|FG002|Overall Study|Withdrawal by Subject|1|||
143255317|NCT02431260|516488101|FG002|Overall Study|Physician Decision|0|||
143255318|NCT02431260|516488102|FG003|Overall Study|Physician Decision|0|||
143255319|NCT02431260|516488103|FG004|Overall Study|Physician Decision|0|||
143255320|NCT02431260|516488104|FG005|Overall Study|Physician Decision|1|||
143255321|NCT02431260|516488105|FG006|Overall Study|Physician Decision|0|||
143255322|NCT02431260|516488106|FG007|Overall Study|Physician Decision|0|||
143255323|NCT02431260|516488107|FG008|Overall Study|Physician Decision|0|||
143255324|NCT02431260|516488108|FG009|Overall Study|Physician Decision|0|||
143255325|NCT02431260|516488109|FG010|Overall Study|Physician Decision|0|||
143255326|NCT02431260|516488110|FG011|Overall Study|Physician Decision|0|||
143255327|NCT02431260|516488111|FG012|Overall Study|Physician Decision|0|||
143255328|NCT02431260|516488112|FG013|Overall Study|Physician Decision|0|||
143255329|NCT02431260|516488099|FG000|Overall Study|Other Unspecified|0|||
143255330|NCT02431260|516488100|FG001|Overall Study|Other Unspecified|0|||
143255331|NCT02431260|516488101|FG002|Overall Study|Other Unspecified|0|||
143255332|NCT02431260|516488102|FG003|Overall Study|Other Unspecified|0|||
143255333|NCT02431260|516488103|FG004|Overall Study|Other Unspecified|0|||
143255334|NCT02431260|516488104|FG005|Overall Study|Other Unspecified|0|||
143255335|NCT02431260|516488105|FG006|Overall Study|Other Unspecified|0|||
143255336|NCT02431260|516488106|FG007|Overall Study|Other Unspecified|0|||
143255337|NCT02431260|516488107|FG008|Overall Study|Other Unspecified|0|||
143255338|NCT02431260|516488108|FG009|Overall Study|Other Unspecified|0|||
143255339|NCT02431260|516488109|FG010|Overall Study|Other Unspecified|0|||
143255340|NCT02431260|516488110|FG011|Overall Study|Other Unspecified|1|||
143255341|NCT02431260|516488111|FG012|Overall Study|Other Unspecified|1|||
143255342|NCT02431260|516488112|FG013|Overall Study|Other Unspecified|0|||
143255343|NCT00439738|516488114|FG000|Overall Study|Withdrawal by Subject|16|||
143255344|NCT00439738|516488115|FG001|Overall Study|Withdrawal by Subject|13|||
143255345|NCT00439738|516488114|FG000|Overall Study|Adverse Event|6|||
143255346|NCT00439738|516488115|FG001|Overall Study|Adverse Event|4|||
143255347|NCT00439738|516488114|FG000|Overall Study|Lost to Follow-up|5|||
143255348|NCT00439738|516488115|FG001|Overall Study|Lost to Follow-up|6|||
143255349|NCT00439738|516488114|FG000|Overall Study|Protocol Violation|6|||
143255350|NCT00439738|516488115|FG001|Overall Study|Protocol Violation|3|||
143255351|NCT00439738|516488114|FG000|Overall Study|Lack of Efficacy|2|||
143255352|NCT00439738|516488115|FG001|Overall Study|Lack of Efficacy|2|||
143255353|NCT00439738|516488114|FG000|Overall Study|Abnormal Lab Values|1|||
143255354|NCT00439738|516488115|FG001|Overall Study|Abnormal Lab Values|0|||
143255355|NCT00781885|516488116|FG000|Overall Study|Physician Decision|1|||
143255356|NCT02576145|516488117|FG000|Overall Study|Adverse Event|1|||
143255357|NCT02576145|516488118|FG001|Overall Study|Adverse Event|0|||
143255358|NCT02576145|516488117|FG000|Overall Study|Withdrawal by Subject|1|||
143255359|NCT02576145|516488118|FG001|Overall Study|Withdrawal by Subject|0|||
143255360|NCT02576145|516488117|FG000|Overall Study|Acute rejection|1|||
143255361|NCT02576145|516488118|FG001|Overall Study|Acute rejection|0|||
143255362|NCT02576145|516488117|FG000|Overall Study|Tetanus Titers Decreased|0|||
143255363|NCT02576145|516488118|FG001|Overall Study|Tetanus Titers Decreased|1|||
143255364|NCT01227824|516488119|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
143255365|NCT01227824|516488120|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
143255366|NCT01227824|516488121|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
143255367|NCT01227824|516488119|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
143255368|NCT01227824|516488120|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
143255369|NCT01227824|516488121|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
143255370|NCT01227824|516488119|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
143255371|NCT01227824|516488120|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
143255372|NCT01227824|516488121|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
143255373|NCT01227824|516488119|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
143255374|NCT01227824|516488120|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
143255375|NCT01227824|516488121|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
143255376|NCT01227824|516488119|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
143255377|NCT01227824|516488120|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
143255378|NCT01227824|516488121|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
143255379|NCT01227824|516488119|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
143255380|NCT01227824|516488120|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
143255381|NCT01227824|516488121|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
143255382|NCT01227824|516488119|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
143255383|NCT01227824|516488120|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
143255384|NCT01227824|516488121|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
143255385|NCT01227824|516488119|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
143255386|NCT01227824|516488120|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
143255387|NCT01227824|516488121|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
143255388|NCT01227824|516488119|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
143255389|NCT01227824|516488120|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
143255390|NCT01227824|516488121|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
143255391|NCT01227824|516488119|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
143255392|NCT01227824|516488120|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
143255393|NCT01227824|516488121|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
143255394|NCT01227824|516488119|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
143255395|NCT01227824|516488120|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
143255396|NCT01227824|516488121|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
143255397|NCT01227824|516488119|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
143255398|NCT01227824|516488120|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
143255399|NCT01227824|516488121|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
143255400|NCT01227824|516488119|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
143255401|NCT01227824|516488120|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
143255402|NCT01227824|516488121|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
143255403|NCT01227824|516488119|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
143367954|NCT01956669|516890844|FG004|Overall Study|Adverse Event|0|||
143255404|NCT01227824|516488120|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
143255405|NCT01227824|516488121|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
143255406|NCT01227824|516488119|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
143255407|NCT01227824|516488120|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
143255408|NCT01227824|516488121|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
143255409|NCT01755026|516488122|FG000|Overall Study|Adverse Event|1|||
143255410|NCT01755026|516488123|FG001|Overall Study|Adverse Event|0|||
143255411|NCT01755026|516488122|FG000|Overall Study|Withdrawal by Subject|1|||
143255412|NCT01755026|516488123|FG001|Overall Study|Withdrawal by Subject|1|||
143255413|NCT00392379|516488126|FG000|Overall Study|Withdrawal by Subject|17|||
143255414|NCT00392379|516488127|FG001|Overall Study|Withdrawal by Subject|28|||
143255415|NCT00392379|516488126|FG000|Overall Study|Lost to Follow-up|4|||
143255416|NCT00392379|516488127|FG001|Overall Study|Lost to Follow-up|9|||
143255417|NCT00392379|516488126|FG000|Overall Study|Adverse Event|1|||
143255418|NCT00392379|516488127|FG001|Overall Study|Adverse Event|1|||
143255419|NCT01978938|516488129|FG000|Overall Study|Lost to Follow-up|12|||
143255420|NCT01978938|516488130|FG001|Overall Study|Lost to Follow-up|6|||
143255421|NCT01978938|516488129|FG000|Overall Study|Withdrawal by Subject|8|||
143255422|NCT01978938|516488130|FG001|Overall Study|Withdrawal by Subject|4|||
143255423|NCT01978938|516488129|FG000|Overall Study|Adverse Event, non-fatal|2|||
143255424|NCT01978938|516488130|FG001|Overall Study|Adverse Event, non-fatal|1|||
143255425|NCT01978938|516488129|FG000|Overall Study|Participant noncompliance|1|||
143255426|NCT01978938|516488130|FG001|Overall Study|Participant noncompliance|1|||
143255427|NCT01978938|516488129|FG000|Overall Study|Did not meet inclusion criteria|0|||
143255428|NCT01978938|516488130|FG001|Overall Study|Did not meet inclusion criteria|1|||
143255429|NCT01978938|516488129|FG000|Overall Study|Previously scheduled procedure|0|||
143255430|NCT01978938|516488130|FG001|Overall Study|Previously scheduled procedure|1|||
143255431|NCT01155167|516488138|FG000|Overall Study|Insufficient ultrasound data|2|||
143255432|NCT01155167|516488139|FG001|Overall Study|Insufficient ultrasound data|0|||
143255433|NCT01155167|516488138|FG000|Overall Study|Access site changed to femoral artery|1|||
143255434|NCT01155167|516488139|FG001|Overall Study|Access site changed to femoral artery|0|||
143255435|NCT01451437|516488140|FG000|Overall Study|Adverse Event|0|||
143255436|NCT01451437|516488141|FG001|Overall Study|Adverse Event|0|||
143255437|NCT01451437|516488142|FG002|Overall Study|Adverse Event|0|||
143255438|NCT01451437|516488143|FG003|Overall Study|Adverse Event|0|||
143255439|NCT01451437|516488144|FG004|Overall Study|Adverse Event|0|||
143255440|NCT01451437|516488145|FG005|Overall Study|Adverse Event|1|||
143255441|NCT01451437|516488146|FG006|Overall Study|Adverse Event|1|||
143255442|NCT01451437|516488147|FG007|Overall Study|Adverse Event|2|||
143255443|NCT01451437|516488148|FG008|Overall Study|Adverse Event|1|||
143255444|NCT01451437|516488140|FG000|Overall Study|Physician Decision|1|||
143255445|NCT01451437|516488141|FG001|Overall Study|Physician Decision|1|||
143367955|NCT01956669|516890845|FG005|Overall Study|Adverse Event|0|||
143255446|NCT01451437|516488142|FG002|Overall Study|Physician Decision|2|||
143255447|NCT01451437|516488143|FG003|Overall Study|Physician Decision|0|||
143255448|NCT01451437|516488144|FG004|Overall Study|Physician Decision|0|||
143255449|NCT01451437|516488145|FG005|Overall Study|Physician Decision|0|||
143255450|NCT01451437|516488146|FG006|Overall Study|Physician Decision|0|||
143255451|NCT01451437|516488147|FG007|Overall Study|Physician Decision|0|||
143255452|NCT01451437|516488148|FG008|Overall Study|Physician Decision|0|||
143255453|NCT01451437|516488140|FG000|Overall Study|Disease Progression|0|||
143255454|NCT01451437|516488141|FG001|Overall Study|Disease Progression|0|||
143255455|NCT01451437|516488142|FG002|Overall Study|Disease Progression|1|||
143255456|NCT01451437|516488143|FG003|Overall Study|Disease Progression|1|||
143255457|NCT01451437|516488144|FG004|Overall Study|Disease Progression|3|||
143255458|NCT01451437|516488145|FG005|Overall Study|Disease Progression|2|||
143255459|NCT01451437|516488146|FG006|Overall Study|Disease Progression|3|||
143255460|NCT01451437|516488147|FG007|Overall Study|Disease Progression|1|||
143255461|NCT01451437|516488148|FG008|Overall Study|Disease Progression|3|||
143255462|NCT01451437|516488140|FG000|Overall Study|Protocol Violation|0|||
143255463|NCT01451437|516488141|FG001|Overall Study|Protocol Violation|0|||
143255464|NCT01451437|516488142|FG002|Overall Study|Protocol Violation|0|||
143255465|NCT01451437|516488143|FG003|Overall Study|Protocol Violation|0|||
143255466|NCT01451437|516488144|FG004|Overall Study|Protocol Violation|0|||
143255467|NCT01451437|516488145|FG005|Overall Study|Protocol Violation|0|||
143255468|NCT01451437|516488146|FG006|Overall Study|Protocol Violation|1|||
143255469|NCT01451437|516488147|FG007|Overall Study|Protocol Violation|0|||
143255470|NCT01451437|516488148|FG008|Overall Study|Protocol Violation|0|||
143255471|NCT01451437|516488140|FG000|Overall Study|Withdrawal by Subject|0|||
143255472|NCT01451437|516488141|FG001|Overall Study|Withdrawal by Subject|0|||
143255473|NCT01451437|516488142|FG002|Overall Study|Withdrawal by Subject|0|||
143255474|NCT01451437|516488143|FG003|Overall Study|Withdrawal by Subject|0|||
143255475|NCT01451437|516488144|FG004|Overall Study|Withdrawal by Subject|1|||
143255476|NCT01451437|516488145|FG005|Overall Study|Withdrawal by Subject|0|||
143255477|NCT01451437|516488146|FG006|Overall Study|Withdrawal by Subject|1|||
143255478|NCT01451437|516488147|FG007|Overall Study|Withdrawal by Subject|0|||
143255479|NCT01451437|516488148|FG008|Overall Study|Withdrawal by Subject|0|||
143255480|NCT02081859|516488149|FG000|Overall Study|No fertilization|2|||
143255481|NCT02081859|516488150|FG001|Overall Study|No fertilization|2|||
143255482|NCT02081859|516488149|FG000|Overall Study|No sperm|1|||
143255483|NCT02081859|516488150|FG001|Overall Study|No sperm|0|||
143255484|NCT02081859|516488149|FG000|Overall Study|Unanticipated freeze all cycle|2|||
143255485|NCT02081859|516488150|FG001|Overall Study|Unanticipated freeze all cycle|6|||
143255486|NCT02081859|516488149|FG000|Overall Study|< 4 embryos|27|||
143255487|NCT02081859|516488150|FG001|Overall Study|< 4 embryos|23|||
143255488|NCT02081859|516488149|FG000|Overall Study|Other reasons|2|||
143255489|NCT02081859|516488150|FG001|Overall Study|Other reasons|0|||
143255490|NCT00576420|516490543|FG000|Overall Study|Death|0|||
143255491|NCT00576420|516490544|FG001|Overall Study|Death|0|||
143255492|NCT00576420|516490545|FG002|Overall Study|Death|1|||
143255493|NCT01340872|516490547|FG000|Double-blind Phase|Adverse Event|6|||
143255494|NCT01340872|516490548|FG001|Double-blind Phase|Adverse Event|4|||
143255495|NCT01340872|516490549|FG002|Double-blind Phase|Adverse Event|0|||
143255496|NCT01340872|516490550|FG003|Double-blind Phase|Adverse Event|0|||
143255497|NCT01340872|516490547|FG000|Double-blind Phase|Withdrawal by Subject|3|||
143255498|NCT01340872|516490548|FG001|Double-blind Phase|Withdrawal by Subject|5|||
143255499|NCT01340872|516490549|FG002|Double-blind Phase|Withdrawal by Subject|0|||
143255500|NCT01340872|516490550|FG003|Double-blind Phase|Withdrawal by Subject|0|||
143255501|NCT01340872|516490547|FG000|Double-blind Phase|Lost to Follow-up|0|||
143255502|NCT01340872|516490548|FG001|Double-blind Phase|Lost to Follow-up|1|||
143255503|NCT01340872|516490549|FG002|Double-blind Phase|Lost to Follow-up|0|||
143255504|NCT01340872|516490550|FG003|Double-blind Phase|Lost to Follow-up|0|||
143255505|NCT01340872|516490547|FG000|Double-blind Phase|Protocol Violation|0|||
143255506|NCT01340872|516490548|FG001|Double-blind Phase|Protocol Violation|1|||
143255507|NCT01340872|516490549|FG002|Double-blind Phase|Protocol Violation|0|||
143255508|NCT01340872|516490550|FG003|Double-blind Phase|Protocol Violation|0|||
143255509|NCT01340872|516490547|FG000|Open-label Phase|Physician Decision|0|||
143255510|NCT01340872|516490548|FG001|Open-label Phase|Physician Decision|0|||
143255511|NCT01340872|516490549|FG002|Open-label Phase|Physician Decision|2|||
143255512|NCT01340872|516490550|FG003|Open-label Phase|Physician Decision|1|||
143255513|NCT01340872|516490547|FG000|Open-label Phase|Pregnancy|0|||
143255514|NCT01340872|516490548|FG001|Open-label Phase|Pregnancy|0|||
143255515|NCT01340872|516490549|FG002|Open-label Phase|Pregnancy|1|||
143255516|NCT01340872|516490550|FG003|Open-label Phase|Pregnancy|0|||
143105722|NCT00769067|515928149|FG001|Overall Study|Study terminated by sponsor|3|||
143105723|NCT00769067|515928148|FG000|Overall Study|Other|1|||
143105724|NCT00769067|515928149|FG001|Overall Study|Other|3|||
143105725|NCT00769067|515928148|FG000|Overall Study|Withdrawal by Subject|0|||
143105726|NCT00769067|515928149|FG001|Overall Study|Withdrawal by Subject|1|||
143105727|NCT00972816|515928152|FG000|Overall Study|Adverse Event|0|||
143105728|NCT00972816|515928153|FG001|Overall Study|Adverse Event|0|||
143105729|NCT00972816|515928154|FG002|Overall Study|Adverse Event|1|||
143105730|NCT00972816|515928155|FG003|Overall Study|Adverse Event|0|||
143105731|NCT00972816|515928156|FG004|Overall Study|Adverse Event|0|||
143105732|NCT00972816|515928157|FG005|Overall Study|Adverse Event|0|||
143105733|NCT00972816|515928158|FG006|Overall Study|Adverse Event|0|||
143105734|NCT00972816|515928159|FG007|Overall Study|Adverse Event|0|||
143105735|NCT00972816|515928152|FG000|Overall Study|Withdrawal by Subject|4|||
143105736|NCT00972816|515928153|FG001|Overall Study|Withdrawal by Subject|2|||
143105737|NCT00972816|515928154|FG002|Overall Study|Withdrawal by Subject|1|||
143105738|NCT00972816|515928155|FG003|Overall Study|Withdrawal by Subject|3|||
143105739|NCT00972816|515928156|FG004|Overall Study|Withdrawal by Subject|0|||
143105740|NCT00972816|515928157|FG005|Overall Study|Withdrawal by Subject|1|||
143105741|NCT00972816|515928158|FG006|Overall Study|Withdrawal by Subject|1|||
143105742|NCT00972816|515928159|FG007|Overall Study|Withdrawal by Subject|2|||
143105743|NCT00972816|515928152|FG000|Overall Study|Lost to Follow-up|11|||
143105744|NCT00972816|515928153|FG001|Overall Study|Lost to Follow-up|9|||
143105745|NCT00972816|515928154|FG002|Overall Study|Lost to Follow-up|7|||
143105746|NCT00972816|515928155|FG003|Overall Study|Lost to Follow-up|5|||
143105747|NCT00972816|515928156|FG004|Overall Study|Lost to Follow-up|11|||
143105748|NCT00972816|515928157|FG005|Overall Study|Lost to Follow-up|10|||
143105749|NCT00972816|515928158|FG006|Overall Study|Lost to Follow-up|7|||
143105750|NCT00972816|515928159|FG007|Overall Study|Lost to Follow-up|7|||
143105751|NCT00972816|515928152|FG000|Overall Study|Inappropriate enrolment|0|||
143105752|NCT00972816|515928153|FG001|Overall Study|Inappropriate enrolment|0|||
143105753|NCT00972816|515928154|FG002|Overall Study|Inappropriate enrolment|0|||
143255517|NCT01340872|516490547|FG000|Open-label Phase|Adverse Event|0|||
143255518|NCT01340872|516490548|FG001|Open-label Phase|Adverse Event|0|||
143255519|NCT01340872|516490549|FG002|Open-label Phase|Adverse Event|8|||
143255520|NCT01340872|516490550|FG003|Open-label Phase|Adverse Event|4|||
143105754|NCT00972816|515928155|FG003|Overall Study|Inappropriate enrolment|0|||
143105755|NCT00972816|515928156|FG004|Overall Study|Inappropriate enrolment|0|||
143105756|NCT00972816|515928157|FG005|Overall Study|Inappropriate enrolment|0|||
143255521|NCT01340872|516490547|FG000|Open-label Phase|Withdrawal by Subject|0|||
143105757|NCT00972816|515928158|FG006|Overall Study|Inappropriate enrolment|2|||
143105758|NCT00972816|515928159|FG007|Overall Study|Inappropriate enrolment|0|||
143105759|NCT00972816|515928152|FG000|Overall Study|Unable to classify|2|||
143105760|NCT00972816|515928153|FG001|Overall Study|Unable to classify|0|||
143105761|NCT00972816|515928154|FG002|Overall Study|Unable to classify|0|||
143105762|NCT00972816|515928155|FG003|Overall Study|Unable to classify|0|||
143255522|NCT01340872|516490548|FG001|Open-label Phase|Withdrawal by Subject|0|||
143255523|NCT01340872|516490549|FG002|Open-label Phase|Withdrawal by Subject|1|||
143255524|NCT01340872|516490550|FG003|Open-label Phase|Withdrawal by Subject|6|||
143255525|NCT01340872|516490547|FG000|Open-label Phase|Worsening of IBD|0|||
143255526|NCT01340872|516490548|FG001|Open-label Phase|Worsening of IBD|0|||
143255527|NCT01340872|516490549|FG002|Open-label Phase|Worsening of IBD|1|||
143255528|NCT01340872|516490550|FG003|Open-label Phase|Worsening of IBD|0|||
143255529|NCT02656680|516490553|FG000|Overall Study|Lost to Follow-up|0|||
143255530|NCT02656680|516490554|FG001|Overall Study|Lost to Follow-up|1|||
143255531|NCT02656680|516490555|FG002|Overall Study|Lost to Follow-up|7|||
143255532|NCT02276027|516490560|FG000|Overall Study|Death|1|||
143255533|NCT02276027|516490561|FG001|Overall Study|Death|0|||
143255534|NCT02276027|516490562|FG002|Overall Study|Death|0|||
143255535|NCT02276027|516490563|FG003|Overall Study|Death|2|||
143255536|NCT02276027|516490560|FG000|Overall Study|Physician Decision|0|||
143255537|NCT02276027|516490561|FG001|Overall Study|Physician Decision|0|||
143255538|NCT02276027|516490562|FG002|Overall Study|Physician Decision|0|||
143255539|NCT02276027|516490563|FG003|Overall Study|Physician Decision|1|||
143255540|NCT02276027|516490560|FG000|Overall Study|Progressive disease|1|||
143255541|NCT02276027|516490561|FG001|Overall Study|Progressive disease|13|||
143255542|NCT02276027|516490562|FG002|Overall Study|Progressive disease|12|||
143255543|NCT02276027|516490563|FG003|Overall Study|Progressive disease|14|||
143255544|NCT02276027|516490560|FG000|Overall Study|Subject/guardian decision|0|||
143255545|NCT02276027|516490561|FG001|Overall Study|Subject/guardian decision|1|||
143255546|NCT02276027|516490562|FG002|Overall Study|Subject/guardian decision|0|||
143255547|NCT02276027|516490563|FG003|Overall Study|Subject/guardian decision|3|||
143255548|NCT02276027|516490560|FG000|Overall Study|Adverse Event|0|||
143255549|NCT02276027|516490561|FG001|Overall Study|Adverse Event|2|||
143255550|NCT02276027|516490562|FG002|Overall Study|Adverse Event|8|||
143255551|NCT02276027|516490563|FG003|Overall Study|Adverse Event|2|||
143255552|NCT03224598|516490564|FG000|Overall Study|Lost to Follow-up|0|||
143255553|NCT03224598|516490565|FG001|Overall Study|Lost to Follow-up|2|||
143255554|NCT03224598|516490566|FG002|Overall Study|Lost to Follow-up|0|||
143255555|NCT03224598|516490564|FG000|Overall Study|Other|0|||
143255556|NCT03224598|516490565|FG001|Overall Study|Other|1|||
143255557|NCT03224598|516490566|FG002|Overall Study|Other|0|||
143255558|NCT01246466|516490568|FG000|Overall Study|Death|1|||
143255559|NCT01246466|516490568|FG000|Overall Study|Withdrawal by Subject|1|||
143255560|NCT00877773|516490569|FG000|Overall Study|Disease Progression|44|||
143255561|NCT02446171|516490576|FG000|Overall Study|Withdrawal by Subject|0|||
143255562|NCT02446171|516490577|FG001|Overall Study|Withdrawal by Subject|0|||
143255563|NCT02446171|516490578|FG002|Overall Study|Withdrawal by Subject|2|||
143255564|NCT02446171|516490579|FG003|Overall Study|Withdrawal by Subject|0|||
143255565|NCT01142089|516490580|FG000|Overall Study|Physician Decision|1|||
143255566|NCT01142089|516490581|FG001|Overall Study|Physician Decision|0|||
143255567|NCT01142089|516490580|FG000|Overall Study|Withdrawal by Subject|1|||
143255568|NCT01142089|516490581|FG001|Overall Study|Withdrawal by Subject|2|||
143255569|NCT01142089|516490580|FG000|Overall Study|Use of prohibited medications|0|||
143255570|NCT01142089|516490581|FG001|Overall Study|Use of prohibited medications|1|||
143255571|NCT01142089|516490580|FG000|Overall Study|Noncompliance with study procedures|2|||
143255572|NCT01142089|516490581|FG001|Overall Study|Noncompliance with study procedures|1|||
143255573|NCT01142089|516490580|FG000|Overall Study|Patient required rescue medication|8|||
143255574|NCT01142089|516490581|FG001|Overall Study|Patient required rescue medication|17|||
143255575|NCT03328182|516490584|FG000|Overall Study|Withdrawal by Subject|1|||
143105763|NCT00972816|515928156|FG004|Overall Study|Unable to classify|1|||
143105764|NCT00972816|515928157|FG005|Overall Study|Unable to classify|0|||
143255576|NCT03328182|516490584|FG000|Overall Study|Protocol Violation|2|||
143255577|NCT03328182|516490584|FG000|Overall Study|No Product Evaluated|1|||
143255578|NCT01489111|516490585|FG000|Overall Study|Withdrawal criterion|1|||
143255579|NCT00603590|516490588|FG000|Overall Study|Did not attend study clinic|39|||
143255580|NCT00603590|516490589|FG001|Overall Study|Did not attend study clinic|30|||
143255581|NCT00603590|516490588|FG000|Overall Study|Refused blood test|5|||
143255582|NCT00603590|516490589|FG001|Overall Study|Refused blood test|1|||
143255583|NCT00603590|516490588|FG000|Overall Study|Patient discontinued study drug|22|||
143255584|NCT00603590|516490589|FG001|Overall Study|Patient discontinued study drug|15|||
143105765|NCT00972816|515928158|FG006|Overall Study|Unable to classify|0|||
143105766|NCT00972816|515928159|FG007|Overall Study|Unable to classify|0|||
143255585|NCT00603590|516490588|FG000|Overall Study|Adverse Event|2|||
143255586|NCT00603590|516490589|FG001|Overall Study|Adverse Event|0|||
143255587|NCT00603590|516490588|FG000|Overall Study|Lost to Follow-up|8|||
143255588|NCT00603590|516490589|FG001|Overall Study|Lost to Follow-up|4|||
143255589|NCT00603590|516490588|FG000|Overall Study|Cardiovascular event|0|||
143255590|NCT00603590|516490589|FG001|Overall Study|Cardiovascular event|1|||
143105767|NCT00593684|515928160|FG000|Overall Study|Death|2|||
143105768|NCT00593684|515928161|FG001|Overall Study|Death|1|||
143105769|NCT03625466|515928162|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
143105770|NCT03625466|515928163|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
143105771|NCT03625466|515928164|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
143105772|NCT03625466|515928162|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
143105773|NCT03625466|515928163|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
143105774|NCT03625466|515928164|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
143105775|NCT03625466|515928162|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
143105776|NCT03625466|515928163|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
143105777|NCT03625466|515928164|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
143105778|NCT00831311|515928166|FG000|Overall Study|Definitive Contraindication|3|||
143105779|NCT00831311|515928167|FG001|Overall Study|Definitive Contraindication|3|||
143105780|NCT00831311|515928166|FG000|Overall Study|Lost to Follow-up|3|||
143105781|NCT00831311|515928167|FG001|Overall Study|Lost to Follow-up|0|||
143105782|NCT00831311|515928166|FG000|Overall Study|Physician Decision|0|||
143105783|NCT00831311|515928167|FG001|Overall Study|Physician Decision|1|||
143105784|NCT00831311|515928166|FG000|Overall Study|Withdrawal by Subject|6|||
143105785|NCT00831311|515928167|FG001|Overall Study|Withdrawal by Subject|4|||
143105786|NCT03214380|515928173|FG000|Lead-in|Adverse Event|3|||
143105787|NCT03214380|515928174|FG001|Lead-in|Adverse Event|0|||
143105788|NCT03214380|515928175|FG002|Lead-in|Adverse Event|0|||
143105789|NCT03214380|515928176|FG003|Lead-in|Adverse Event|1|||
143105790|NCT03214380|515928177|FG004|Lead-in|Adverse Event|0|||
143105791|NCT03214380|515928178|FG005|Lead-in|Adverse Event|0|||
143105792|NCT03214380|515928173|FG000|Lead-in|Lost to Follow-up|4|||
143178712|NCT00682929|516203577|FG000|Overall Study|dosing compliance < 80%|0|||
143178713|NCT00682929|516203578|FG001|Overall Study|dosing compliance < 80%|2|||
143178714|NCT00682929|516203579|FG002|Overall Study|dosing compliance < 80%|0|||
143178715|NCT00682929|516203577|FG000|Overall Study|lag in DEA renewal|1|||
143105793|NCT03214380|515928174|FG001|Lead-in|Lost to Follow-up|0|||
143105794|NCT03214380|515928175|FG002|Lead-in|Lost to Follow-up|0|||
143105795|NCT03214380|515928176|FG003|Lead-in|Lost to Follow-up|1|||
143178716|NCT00682929|516203578|FG001|Overall Study|lag in DEA renewal|0|||
143178717|NCT00682929|516203579|FG002|Overall Study|lag in DEA renewal|0|||
143105796|NCT03214380|515928177|FG004|Lead-in|Lost to Follow-up|0|||
143105797|NCT03214380|515928178|FG005|Lead-in|Lost to Follow-up|0|||
143105798|NCT03214380|515928173|FG000|Lead-in|Eligibility Criteria|3|||
143105799|NCT03214380|515928174|FG001|Lead-in|Eligibility Criteria|0|||
143105800|NCT03214380|515928175|FG002|Lead-in|Eligibility Criteria|0|||
143105801|NCT03214380|515928176|FG003|Lead-in|Eligibility Criteria|0|||
143105802|NCT03214380|515928177|FG004|Lead-in|Eligibility Criteria|0|||
143105803|NCT03214380|515928178|FG005|Lead-in|Eligibility Criteria|0|||
143105804|NCT03214380|515928173|FG000|Lead-in|Physician Decision|6|||
143105805|NCT03214380|515928174|FG001|Lead-in|Physician Decision|0|||
143105806|NCT03214380|515928175|FG002|Lead-in|Physician Decision|0|||
143105807|NCT03214380|515928176|FG003|Lead-in|Physician Decision|0|||
143105808|NCT03214380|515928177|FG004|Lead-in|Physician Decision|0|||
143105809|NCT03214380|515928178|FG005|Lead-in|Physician Decision|0|||
143105810|NCT03214380|515928173|FG000|Lead-in|Protocol Deviation|7|||
143105811|NCT03214380|515928174|FG001|Lead-in|Protocol Deviation|0|||
143105812|NCT03214380|515928175|FG002|Lead-in|Protocol Deviation|0|||
143105813|NCT03214380|515928176|FG003|Lead-in|Protocol Deviation|3|||
143105814|NCT03214380|515928177|FG004|Lead-in|Protocol Deviation|0|||
143105815|NCT03214380|515928178|FG005|Lead-in|Protocol Deviation|0|||
143105816|NCT03214380|515928173|FG000|Lead-in|Withdrawal by Subject|41|||
143105817|NCT03214380|515928174|FG001|Lead-in|Withdrawal by Subject|0|||
143105818|NCT03214380|515928175|FG002|Lead-in|Withdrawal by Subject|0|||
143105819|NCT03214380|515928176|FG003|Lead-in|Withdrawal by Subject|14|||
143105820|NCT03214380|515928177|FG004|Lead-in|Withdrawal by Subject|0|||
143105821|NCT03214380|515928178|FG005|Lead-in|Withdrawal by Subject|0|||
143105822|NCT03214380|515928173|FG000|Lead-in|Family Emergency|1|||
143105823|NCT03214380|515928174|FG001|Lead-in|Family Emergency|0|||
143105824|NCT03214380|515928175|FG002|Lead-in|Family Emergency|0|||
143105825|NCT03214380|515928176|FG003|Lead-in|Family Emergency|0|||
143105826|NCT03214380|515928177|FG004|Lead-in|Family Emergency|0|||
143105827|NCT03214380|515928178|FG005|Lead-in|Family Emergency|0|||
143105828|NCT03214380|515928173|FG000|Lead-in|Natural Disaster|9|||
143105829|NCT03214380|515928174|FG001|Lead-in|Natural Disaster|0|||
143105830|NCT03214380|515928175|FG002|Lead-in|Natural Disaster|0|||
143105831|NCT03214380|515928176|FG003|Lead-in|Natural Disaster|0|||
143105832|NCT03214380|515928177|FG004|Lead-in|Natural Disaster|0|||
143105833|NCT03214380|515928178|FG005|Lead-in|Natural Disaster|0|||
143105834|NCT03214380|515928173|FG000|Lead-in|Non Compliance|1|||
143105835|NCT03214380|515928174|FG001|Lead-in|Non Compliance|0|||
143105836|NCT03214380|515928175|FG002|Lead-in|Non Compliance|0|||
143105837|NCT03214380|515928176|FG003|Lead-in|Non Compliance|0|||
143105838|NCT03214380|515928177|FG004|Lead-in|Non Compliance|0|||
143105839|NCT03214380|515928178|FG005|Lead-in|Non Compliance|0|||
143105840|NCT03214380|515928173|FG000|Lead-in|Participant Schedule|2|||
143105841|NCT03214380|515928174|FG001|Lead-in|Participant Schedule|0|||
143105842|NCT03214380|515928175|FG002|Lead-in|Participant Schedule|0|||
143105843|NCT03214380|515928176|FG003|Lead-in|Participant Schedule|0|||
143105844|NCT03214380|515928177|FG004|Lead-in|Participant Schedule|0|||
143105845|NCT03214380|515928178|FG005|Lead-in|Participant Schedule|0|||
143105846|NCT03214380|515928173|FG000|Treatment Period|Adverse Event|0|||
143105847|NCT03214380|515928174|FG001|Treatment Period|Adverse Event|1|||
143105848|NCT03214380|515928175|FG002|Treatment Period|Adverse Event|1|||
143105849|NCT03214380|515928176|FG003|Treatment Period|Adverse Event|0|||
143105850|NCT03214380|515928177|FG004|Treatment Period|Adverse Event|1|||
143105851|NCT03214380|515928178|FG005|Treatment Period|Adverse Event|0|||
143105852|NCT03214380|515928173|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
143105853|NCT03214380|515928174|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
143105854|NCT03214380|515928175|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
143105855|NCT03214380|515928176|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
143105856|NCT03214380|515928177|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
143105857|NCT03214380|515928178|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
143105858|NCT03214380|515928173|FG000|Treatment Period|Withdrawal by Subject|0|||
143105859|NCT03214380|515928174|FG001|Treatment Period|Withdrawal by Subject|10|||
143105860|NCT03214380|515928175|FG002|Treatment Period|Withdrawal by Subject|8|||
143105861|NCT03214380|515928176|FG003|Treatment Period|Withdrawal by Subject|0|||
143105862|NCT03214380|515928177|FG004|Treatment Period|Withdrawal by Subject|7|||
143105863|NCT03214380|515928178|FG005|Treatment Period|Withdrawal by Subject|11|||
143105864|NCT03214380|515928173|FG000|Treatment Period|Death|0|||
143105865|NCT03214380|515928174|FG001|Treatment Period|Death|1|||
143105866|NCT03214380|515928175|FG002|Treatment Period|Death|2|||
143105867|NCT03214380|515928176|FG003|Treatment Period|Death|0|||
143105868|NCT03214380|515928177|FG004|Treatment Period|Death|0|||
143105869|NCT03214380|515928178|FG005|Treatment Period|Death|0|||
143105870|NCT03214380|515928173|FG000|Treatment Period|Lost to Follow-up|0|||
143105871|NCT03214380|515928174|FG001|Treatment Period|Lost to Follow-up|6|||
143105872|NCT03214380|515928175|FG002|Treatment Period|Lost to Follow-up|3|||
143105873|NCT03214380|515928176|FG003|Treatment Period|Lost to Follow-up|0|||
143105874|NCT03214380|515928177|FG004|Treatment Period|Lost to Follow-up|0|||
143105875|NCT03214380|515928178|FG005|Treatment Period|Lost to Follow-up|0|||
143105876|NCT03214380|515928173|FG000|Treatment Period|Participant schedule|0|||
143105877|NCT03214380|515928174|FG001|Treatment Period|Participant schedule|0|||
143105878|NCT03214380|515928175|FG002|Treatment Period|Participant schedule|1|||
143105879|NCT03214380|515928176|FG003|Treatment Period|Participant schedule|0|||
143105880|NCT03214380|515928177|FG004|Treatment Period|Participant schedule|0|||
143105881|NCT03214380|515928178|FG005|Treatment Period|Participant schedule|0|||
143105882|NCT03214380|515928173|FG000|Treatment Period|Treatment Interruption|0|||
143105883|NCT03214380|515928174|FG001|Treatment Period|Treatment Interruption|0|||
143105884|NCT03214380|515928175|FG002|Treatment Period|Treatment Interruption|1|||
143105885|NCT03214380|515928176|FG003|Treatment Period|Treatment Interruption|0|||
143105886|NCT03214380|515928177|FG004|Treatment Period|Treatment Interruption|0|||
143105887|NCT03214380|515928178|FG005|Treatment Period|Treatment Interruption|0|||
143105888|NCT01905553|515928185|FG000|Period 2|Adverse Event|1|||
143105889|NCT01905553|515928186|FG001|Period 2|Adverse Event|0|||
143105890|NCT02656290|515928194|FG000|Overall Study|Lost to Follow-up|1|||
143105891|NCT02656290|515928194|FG000|Overall Study|Reintervention|3|||
143105892|NCT01608087|515928195|FG000|Overall Study|Lost to Follow-up|0|||
143105893|NCT01608087|515928196|FG001|Overall Study|Lost to Follow-up|1|||
143105894|NCT01608087|515928197|FG002|Overall Study|Lost to Follow-up|0|||
143105895|NCT01608087|515928195|FG000|Overall Study|Other Reason|0|||
143105896|NCT01608087|515928196|FG001|Overall Study|Other Reason|1|||
143105897|NCT01608087|515928197|FG002|Overall Study|Other Reason|0|||
143105898|NCT03692325|515928198|FG000|Overall Study|Adverse Event|2|||
143105899|NCT03692325|515928198|FG000|Overall Study|Progression/Recurrence|2|||
143105900|NCT00748189|515928199|FG000|Overall Study|Death|99|||
143105901|NCT00748189|515928200|FG001|Overall Study|Death|84|||
143105902|NCT00748189|515928199|FG000|Overall Study|Withdrawal by Subject|23|||
143105903|NCT00748189|515928200|FG001|Overall Study|Withdrawal by Subject|29|||
143105904|NCT00748189|515928199|FG000|Overall Study|Physician Decision|16|||
143105905|NCT00748189|515928200|FG001|Overall Study|Physician Decision|5|||
143105906|NCT00748189|515928199|FG000|Overall Study|Lost to Follow-up|8|||
143105907|NCT00748189|515928200|FG001|Overall Study|Lost to Follow-up|15|||
143367956|NCT01956669|516890846|FG006|Overall Study|Adverse Event|0|||
143367957|NCT01956669|516890840|FG000|Overall Study|Physician Decision|0|||
143105908|NCT00748189|515928199|FG000|Overall Study|Study terminated by Sponsor|70|||
143105909|NCT00748189|515928200|FG001|Overall Study|Study terminated by Sponsor|79|||
143105910|NCT04481191|515928201|FG000|Overall Study|Withdrawn by parent/guardian|15|||
143105911|NCT04481191|515928202|FG001|Overall Study|Withdrawn by parent/guardian|10|||
143105912|NCT00546117|515928203|FG000|Overall Study|Withdrawal by Subject|3|||
143105913|NCT00546117|515928204|FG001|Overall Study|Withdrawal by Subject|0|||
143105914|NCT00546117|515928203|FG000|Overall Study|Inability to schedule follow-up visit|1|||
143105915|NCT00546117|515928204|FG001|Overall Study|Inability to schedule follow-up visit|0|||
143105916|NCT01560234|515928207|FG000|Overall Study|Lost to Follow-up|3|||
143105917|NCT01560234|515928208|FG001|Overall Study|Lost to Follow-up|0|||
143105918|NCT01560234|515928209|FG002|Overall Study|Lost to Follow-up|1|||
143105919|NCT01560234|515928210|FG003|Overall Study|Lost to Follow-up|0|||
143105920|NCT01560234|515928211|FG004|Overall Study|Lost to Follow-up|0|||
143105921|NCT01560234|515928212|FG005|Overall Study|Lost to Follow-up|2|||
143105922|NCT01560234|515928213|FG006|Overall Study|Lost to Follow-up|0|||
143105923|NCT01560234|515928214|FG007|Overall Study|Lost to Follow-up|2|||
143105924|NCT02278939|515928217|FG000|Overall Study|lack of time|1|||
143105925|NCT02278939|515928218|FG001|Overall Study|lack of time|0|||
143105926|NCT02278939|515928217|FG000|Overall Study|Lost to Follow-up|1|||
143105927|NCT02278939|515928218|FG001|Overall Study|Lost to Follow-up|1|||
143105928|NCT02278939|515928217|FG000|Overall Study|death in family|1|||
143105929|NCT02278939|515928218|FG001|Overall Study|death in family|0|||
143105930|NCT02278939|515928217|FG000|Overall Study|family emergency unable to commit|2|||
143105931|NCT02278939|515928218|FG001|Overall Study|family emergency unable to commit|0|||
143105932|NCT01062113|515928221|FG000|Overall Study|Adverse Event|1|||
143105933|NCT01062113|515928222|FG001|Overall Study|Adverse Event|0|||
143105934|NCT01062113|515928223|FG002|Overall Study|Adverse Event|0|||
143105935|NCT01062113|515928221|FG000|Overall Study|Lack of Efficacy|38|||
143105936|NCT01062113|515928222|FG001|Overall Study|Lack of Efficacy|22|||
143105937|NCT01062113|515928223|FG002|Overall Study|Lack of Efficacy|31|||
143105938|NCT01062113|515928221|FG000|Overall Study|Withdrawal by Subject|1|||
143105939|NCT01062113|515928222|FG001|Overall Study|Withdrawal by Subject|0|||
143105940|NCT01062113|515928223|FG002|Overall Study|Withdrawal by Subject|0|||
143105941|NCT00526669|515928224|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
143105942|NCT00526669|515928225|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
143105943|NCT00526669|515928224|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
143105944|NCT00526669|515928225|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
143105945|NCT00526669|515928224|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
143105946|NCT00526669|515928225|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
143105947|NCT00526669|515928224|FG000|Combined Treatment Phase|Death|0|||
143105948|NCT00526669|515928225|FG001|Combined Treatment Phase|Death|2|||
143105949|NCT01435460|515928233|FG000|Overall Study|Adverse Event|2|||
143105950|NCT01435460|515928234|FG001|Overall Study|Adverse Event|1|||
143105951|NCT01435460|515928233|FG000|Overall Study|Lost to Follow-up|6|||
143105952|NCT01435460|515928234|FG001|Overall Study|Lost to Follow-up|1|||
143105953|NCT01435460|515928233|FG000|Overall Study|Withdrawal by Subject|1|||
143105954|NCT01435460|515928234|FG001|Overall Study|Withdrawal by Subject|3|||
143105955|NCT01435460|515928233|FG000|Overall Study|Protocol Violation|0|||
143105956|NCT01435460|515928234|FG001|Overall Study|Protocol Violation|1|||
143105957|NCT01435460|515928233|FG000|Overall Study|Did not meet eligibility criteria|2|||
143105958|NCT01435460|515928234|FG001|Overall Study|Did not meet eligibility criteria|0|||
143105959|NCT01706939|515928235|FG000|Pre Randomization|Screen Failure|1|||
143105960|NCT01706939|515928236|FG001|Pre Randomization|Screen Failure|0|||
143105961|NCT01706939|515928237|FG002|Pre Randomization|Screen Failure|0|||
143105962|NCT01706939|515928235|FG000|Pre Randomization|Ineligible for Randomization|1|||
143105963|NCT01706939|515928236|FG001|Pre Randomization|Ineligible for Randomization|0|||
143105964|NCT01706939|515928237|FG002|Pre Randomization|Ineligible for Randomization|0|||
143105965|NCT01706939|515928235|FG000|Pre Randomization|Withdrawal by Subject|1|||
143105966|NCT01706939|515928236|FG001|Pre Randomization|Withdrawal by Subject|0|||
143105967|NCT01706939|515928237|FG002|Pre Randomization|Withdrawal by Subject|0|||
143105968|NCT01706939|515928235|FG000|Randomization|Insufficient QoL survey compliance|0|||
143105969|NCT01706939|515928236|FG001|Randomization|Insufficient QoL survey compliance|1|||
143105970|NCT01706939|515928237|FG002|Randomization|Insufficient QoL survey compliance|1|||
143105971|NCT01706939|515928235|FG000|Randomization|Progression of disease|0|||
143105972|NCT01706939|515928236|FG001|Randomization|Progression of disease|2|||
143105973|NCT01706939|515928237|FG002|Randomization|Progression of disease|1|||
143105974|NCT01046903|515928238|FG000|Overall Study|Lost to Follow-up|16|||
143105975|NCT01046903|515928238|FG000|Overall Study|Adverse Event|4|||
143105976|NCT01046903|515928238|FG000|Overall Study|Withdrawal by Subject|3|||
143105977|NCT01046903|515928238|FG000|Overall Study|Other|5|||
143105978|NCT01894100|515928239|FG000|Overall Study|Lost to Follow-up|0|||
143105979|NCT01894100|515928240|FG001|Overall Study|Lost to Follow-up|1|||
143105980|NCT01894100|515928239|FG000|Overall Study|Withdrawal by Subject|3|||
143105981|NCT01894100|515928240|FG001|Overall Study|Withdrawal by Subject|0|||
143105982|NCT01582178|515928245|FG000|Overall Study|Physician Decision|6|||
143105983|NCT01582178|515928246|FG001|Overall Study|Physician Decision|5|||
143105984|NCT01726270|515928247|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
143105985|NCT01726270|515928247|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
143105986|NCT01726270|515928247|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
143105987|NCT01726270|515928247|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
143105988|NCT01726270|515928247|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
143105989|NCT01726270|515928247|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
143105990|NCT04013672|515928249|FG000|Overall Study|Withdrawal by Subject|3|||
143105991|NCT04013672|515928250|FG001|Overall Study|Withdrawal by Subject|0|||
143105992|NCT04013672|515928249|FG000|Overall Study|Death|1|||
143105993|NCT04013672|515928250|FG001|Overall Study|Death|0|||
143105994|NCT04013672|515928249|FG000|Overall Study|Physician Decision|5|||
143105995|NCT04013672|515928250|FG001|Overall Study|Physician Decision|0|||
143105996|NCT04152837|515928258|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
143105997|NCT04152837|515928258|FG000|Maintenance Period|Adverse Event|1|||
143105998|NCT04152837|515928258|FG000|Maintenance Period|Withdrawal by Subject|1|||
143105999|NCT04152837|515928258|FG000|Maintenance Period|Sponsor Termination of Study|2|||
143106000|NCT00586820|515928259|FG000|Overall Study|Unsuccessful PCI|1|||
143106001|NCT00586820|515928260|FG001|Overall Study|Unsuccessful PCI|0|||
143106002|NCT04463251|515928261|FG000|Overall Study|Death|1|||
143106003|NCT04463251|515928262|FG001|Overall Study|Death|0|||
143106004|NCT04463251|515928263|FG002|Overall Study|Death|1|||
143106005|NCT04463251|515928261|FG000|Overall Study|Adverse Event|0|||
143106006|NCT04463251|515928262|FG001|Overall Study|Adverse Event|1|||
143106007|NCT04463251|515928263|FG002|Overall Study|Adverse Event|0|||
143106008|NCT04463251|515928261|FG000|Overall Study|Lost to Follow-up|0|||
143106009|NCT04463251|515928262|FG001|Overall Study|Lost to Follow-up|1|||
143106010|NCT04463251|515928263|FG002|Overall Study|Lost to Follow-up|0|||
143106011|NCT04463251|515928261|FG000|Overall Study|Withdrawal by Subject|0|||
143106012|NCT04463251|515928262|FG001|Overall Study|Withdrawal by Subject|2|||
143106013|NCT04463251|515928263|FG002|Overall Study|Withdrawal by Subject|2|||
143106014|NCT00101166|515928266|FG000|Overall Study|progressive disease|10|||
143106015|NCT00686829|515928273|FG000|Overall Study|Adverse Event|5|||
143106016|NCT00686829|515928273|FG000|Overall Study|Lack of Efficacy|6|||
143106017|NCT00686829|515928273|FG000|Overall Study|Lost to Follow-up|4|||
143106018|NCT00686829|515928273|FG000|Overall Study|Withdrawal by Subject|14|||
143106019|NCT00686829|515928273|FG000|Overall Study|Protocol Violation|3|||
143106020|NCT00686829|515928273|FG000|Overall Study|Sponsor discontinued VCV|47|||
143106021|NCT01827267|515928274|FG000|Overall Study|Did not receive study drug|1|||
143106022|NCT01827267|515928275|FG001|Overall Study|Did not receive study drug|1|||
143106023|NCT01827267|515928274|FG000|Overall Study|Physician Decision|1|||
143106024|NCT01827267|515928275|FG001|Overall Study|Physician Decision|0|||
143106025|NCT01827267|515928274|FG000|Overall Study|Disease Progression|1|||
143106026|NCT01827267|515928275|FG001|Overall Study|Disease Progression|1|||
143106027|NCT01827267|515928274|FG000|Overall Study|Sponsor Discontinued Study|2|||
143106028|NCT01827267|515928275|FG001|Overall Study|Sponsor Discontinued Study|8|||
143106029|NCT01827267|515928274|FG000|Overall Study|Still on study|0|||
143106030|NCT01827267|515928275|FG001|Overall Study|Still on study|2|||
143106031|NCT03070002|515928278|FG000|Follow up for 2 Years|Death|1|||
143106032|NCT00712543|515928281|FG000|Day 8-14|Lost to Follow-up|0|||
143106033|NCT00712543|515928282|FG001|Day 8-14|Lost to Follow-up|2|||
143106034|NCT04740827|515928292|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
143106035|NCT04740827|515928293|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
143106036|NCT04740827|515928292|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
143106037|NCT04740827|515928293|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
143106038|NCT04740827|515928292|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
143106039|NCT04740827|515928293|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
143106040|NCT04740827|515928292|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
143106041|NCT04740827|515928293|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
143106042|NCT04740827|515928292|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
143106043|NCT04740827|515928293|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
143106044|NCT04740827|515928292|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
143106045|NCT04740827|515928293|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
143178718|NCT00456755|516203584|FG000|Overall Study|Lost to Follow-up|2|||
143106046|NCT02147158|515928294|FG000|Treatment Course 1|Adverse Event|1|||
143106047|NCT02147158|515928295|FG001|Treatment Course 1|Adverse Event|4|||
143106048|NCT02147158|515928296|FG002|Treatment Course 1|Adverse Event|3|||
143106049|NCT02147158|515928297|FG003|Treatment Course 1|Adverse Event|4|||
143106050|NCT02147158|515928298|FG004|Treatment Course 1|Adverse Event|1|||
143106051|NCT02147158|515928299|FG005|Treatment Course 1|Adverse Event|2|||
143106052|NCT02147158|515928294|FG000|Treatment Course 1|Lost to Follow-up|2|||
143106053|NCT02147158|515928295|FG001|Treatment Course 1|Lost to Follow-up|4|||
143106054|NCT02147158|515928296|FG002|Treatment Course 1|Lost to Follow-up|3|||
143106055|NCT02147158|515928297|FG003|Treatment Course 1|Lost to Follow-up|3|||
143106056|NCT02147158|515928298|FG004|Treatment Course 1|Lost to Follow-up|2|||
143106057|NCT02147158|515928299|FG005|Treatment Course 1|Lost to Follow-up|4|||
143178719|NCT00456755|516203585|FG001|Overall Study|Lost to Follow-up|1|||
143178720|NCT04072835|516203589|FG000|Overall Study|Overall trial ended|603|||
143178721|NCT04072835|516203589|FG000|Overall Study|Ablation|97|||
143178722|NCT04072835|516203589|FG000|Overall Study|Withdrawal of consent|66|||
143106058|NCT02147158|515928294|FG000|Treatment Course 1|Protocol Violation|0|||
143106059|NCT02147158|515928295|FG001|Treatment Course 1|Protocol Violation|0|||
143106060|NCT02147158|515928296|FG002|Treatment Course 1|Protocol Violation|1|||
143106061|NCT02147158|515928297|FG003|Treatment Course 1|Protocol Violation|1|||
143178723|NCT04072835|516203589|FG000|Overall Study|Physician Decision|50|||
143106062|NCT02147158|515928298|FG004|Treatment Course 1|Protocol Violation|0|||
143106063|NCT02147158|515928299|FG005|Treatment Course 1|Protocol Violation|0|||
143106064|NCT02147158|515928294|FG000|Treatment Course 1|Withdrawal of Consent|1|||
143106065|NCT02147158|515928295|FG001|Treatment Course 1|Withdrawal of Consent|1|||
143106066|NCT02147158|515928296|FG002|Treatment Course 1|Withdrawal of Consent|1|||
143106067|NCT02147158|515928297|FG003|Treatment Course 1|Withdrawal of Consent|5|||
143106068|NCT02147158|515928298|FG004|Treatment Course 1|Withdrawal of Consent|3|||
143106069|NCT02147158|515928299|FG005|Treatment Course 1|Withdrawal of Consent|2|||
143106070|NCT02147158|515928294|FG000|Off-Treatment Interval 1|Adverse Event|1|||
143106071|NCT02147158|515928295|FG001|Off-Treatment Interval 1|Adverse Event|0|||
143106072|NCT02147158|515928296|FG002|Off-Treatment Interval 1|Adverse Event|0|||
143106073|NCT02147158|515928297|FG003|Off-Treatment Interval 1|Adverse Event|1|||
143106074|NCT02147158|515928298|FG004|Off-Treatment Interval 1|Adverse Event|0|||
143106075|NCT02147158|515928299|FG005|Off-Treatment Interval 1|Adverse Event|0|||
143106076|NCT02147158|515928294|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
143106077|NCT02147158|515928295|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
143106078|NCT02147158|515928296|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
143106079|NCT02147158|515928297|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
143106080|NCT02147158|515928298|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
143106081|NCT02147158|515928299|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
143106082|NCT02147158|515928294|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
143106083|NCT02147158|515928295|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
143106084|NCT02147158|515928296|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
143106085|NCT02147158|515928297|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
143106086|NCT02147158|515928298|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
143106087|NCT02147158|515928299|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
143106088|NCT02147158|515928294|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
143106089|NCT02147158|515928295|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
143106090|NCT02147158|515928296|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
143106091|NCT02147158|515928297|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
143106092|NCT02147158|515928298|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
143106093|NCT02147158|515928299|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
143106094|NCT02147158|515928294|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
143106095|NCT02147158|515928295|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
143106096|NCT02147158|515928296|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
143106097|NCT02147158|515928297|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
143106098|NCT02147158|515928298|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
143106099|NCT02147158|515928299|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
143106100|NCT02147158|515928294|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
143106101|NCT02147158|515928295|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
143106102|NCT02147158|515928296|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
143106103|NCT02147158|515928297|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
143106104|NCT02147158|515928298|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
143106105|NCT02147158|515928299|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
143106106|NCT02147158|515928294|FG000|Treatment Course 2|Adverse Event|0|||
143178724|NCT04072835|516203589|FG000|Overall Study|Lost to Follow-up|39|||
143178725|NCT04072835|516203589|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
143178726|NCT04072835|516203589|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
143178727|NCT04072835|516203589|FG000|Overall Study|Adverse Event|25|||
143178728|NCT04072835|516203589|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
143178729|NCT04072835|516203589|FG000|Overall Study|Death|11|||
143106107|NCT02147158|515928295|FG001|Treatment Course 2|Adverse Event|4|||
143106108|NCT02147158|515928296|FG002|Treatment Course 2|Adverse Event|2|||
143106109|NCT02147158|515928297|FG003|Treatment Course 2|Adverse Event|1|||
143106110|NCT02147158|515928298|FG004|Treatment Course 2|Adverse Event|0|||
143106111|NCT02147158|515928299|FG005|Treatment Course 2|Adverse Event|1|||
143106112|NCT02147158|515928294|FG000|Treatment Course 2|Withdrawal of Consent|0|||
143106113|NCT02147158|515928295|FG001|Treatment Course 2|Withdrawal of Consent|1|||
143106114|NCT02147158|515928296|FG002|Treatment Course 2|Withdrawal of Consent|2|||
143106115|NCT02147158|515928297|FG003|Treatment Course 2|Withdrawal of Consent|3|||
143106116|NCT02147158|515928298|FG004|Treatment Course 2|Withdrawal of Consent|0|||
143106117|NCT02147158|515928299|FG005|Treatment Course 2|Withdrawal of Consent|0|||
143106118|NCT02147158|515928294|FG000|Treatment Course 2|Lost to Follow-up|1|||
143106119|NCT02147158|515928295|FG001|Treatment Course 2|Lost to Follow-up|0|||
143106120|NCT02147158|515928296|FG002|Treatment Course 2|Lost to Follow-up|1|||
143178730|NCT04072835|516203589|FG000|Overall Study|Participant felt the drug did not work|8|||
143106121|NCT02147158|515928297|FG003|Treatment Course 2|Lost to Follow-up|1|||
143106122|NCT02147158|515928298|FG004|Treatment Course 2|Lost to Follow-up|0|||
143106123|NCT02147158|515928299|FG005|Treatment Course 2|Lost to Follow-up|1|||
143106124|NCT02147158|515928294|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
143106125|NCT02147158|515928295|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
143106126|NCT02147158|515928296|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
143106127|NCT02147158|515928297|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
143106128|NCT02147158|515928298|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
143106129|NCT02147158|515928299|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
143106130|NCT02147158|515928294|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
143106131|NCT02147158|515928295|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
143106132|NCT02147158|515928296|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
143106133|NCT02147158|515928297|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
143106134|NCT02147158|515928298|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
143106135|NCT02147158|515928299|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
143106136|NCT02147158|515928294|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
143106137|NCT02147158|515928295|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
143106138|NCT02147158|515928296|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
143106139|NCT02147158|515928297|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
143106140|NCT02147158|515928298|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
143106141|NCT02147158|515928299|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
143106142|NCT02147158|515928294|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
143106143|NCT02147158|515928295|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
143106144|NCT02147158|515928296|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
143106145|NCT02147158|515928297|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
143106146|NCT02147158|515928298|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
143106147|NCT02147158|515928299|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
143106148|NCT02147158|515928294|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
143106149|NCT02147158|515928295|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
143106150|NCT02147158|515928296|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
143106151|NCT02147158|515928297|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
143106152|NCT02147158|515928298|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
143106153|NCT02147158|515928299|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
143106154|NCT04520997|515928303|FG000|Overall Study|Lost to Follow-up|1|||
143106155|NCT04520997|515928304|FG001|Overall Study|Lost to Follow-up|1|||
143106156|NCT04520997|515928303|FG000|Overall Study|Withdrawal by Subject|1|||
143106157|NCT04520997|515928304|FG001|Overall Study|Withdrawal by Subject|0|||
143106158|NCT04520997|515928303|FG000|Overall Study|Not Treated|0|||
143106159|NCT04520997|515928304|FG001|Overall Study|Not Treated|1|||
143106160|NCT02981082|515928305|FG000|Overall Study|Withdrawal by Subject|2|||
143106161|NCT02981082|515928306|FG001|Overall Study|Withdrawal by Subject|0|||
143106162|NCT02981082|515928305|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
143106163|NCT02981082|515928306|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
143106164|NCT02981082|515928305|FG000|Overall Study|Adverse Event|0|||
143106165|NCT02981082|515928306|FG001|Overall Study|Adverse Event|1|||
143106166|NCT03689374|515928307|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
143106167|NCT03689374|515928308|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
143106168|NCT03689374|515928309|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
143106169|NCT03689374|515928307|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
143106170|NCT03689374|515928308|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
143106171|NCT03689374|515928309|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
143106172|NCT03689374|515928307|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
143106173|NCT03689374|515928308|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
143106174|NCT03689374|515928309|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
143106175|NCT03689374|515928307|FG000|Treatment Period (Week 0 to 52)|Death|0|||
143106176|NCT03689374|515928308|FG001|Treatment Period (Week 0 to 52)|Death|11|||
143106177|NCT03689374|515928309|FG002|Treatment Period (Week 0 to 52)|Death|1|||
143106178|NCT05367973|515928310|FG000|Overall Study|Adverse Event|0|||
143106179|NCT05367973|515928311|FG001|Overall Study|Adverse Event|2|||
143106180|NCT01082211|515928312|FG000|Overall Study|Protocol Violation|4|||
143106181|NCT01082211|515928312|FG000|Overall Study|No protocol treatment received|3|||
143106182|NCT01806961|515931755|FG000|Overall Study|sponsor decision|16|||
143106183|NCT00160706|515931758|FG000|Overall Study|Adverse Event|53|||
143106184|NCT00160706|515931758|FG000|Overall Study|Adverse Event and Other Reason|105|||
143106185|NCT00160706|515931758|FG000|Overall Study|Protocol Violation|3|||
143106186|NCT00160706|515931758|FG000|Overall Study|Withdrawal by Subject|41|||
143106187|NCT00160706|515931758|FG000|Overall Study|Withdrawal by Subject and Other|12|||
143106188|NCT00160706|515931758|FG000|Overall Study|Physician Decision|10|||
143106189|NCT00160706|515931758|FG000|Overall Study|Physician Decision and Other|3|||
143106190|NCT00160706|515931758|FG000|Overall Study|Lost to Follow-up|4|||
143106191|NCT00160706|515931758|FG000|Overall Study|Lost to Follow-up and Other|1|||
143106192|NCT00160706|515931758|FG000|Overall Study|Lack of Efficacy|42|||
143106193|NCT00160706|515931758|FG000|Overall Study|Lack of Efficacy and Other|1|||
143106194|NCT00160706|515931758|FG000|Overall Study|Other Reason|11|||
143106195|NCT00664859|515931764|FG000|Overall Study|Adverse Event|2|||
143106196|NCT00664859|515931765|FG001|Overall Study|Adverse Event|1|||
143106197|NCT00664859|515931766|FG002|Overall Study|Adverse Event|3|||
143106198|NCT00664859|515931764|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
143106199|NCT00664859|515931765|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
143106200|NCT00664859|515931766|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
143106201|NCT00664859|515931764|FG000|Overall Study|Noncompliance with protocol|1|||
143106202|NCT00664859|515931765|FG001|Overall Study|Noncompliance with protocol|0|||
143106203|NCT00664859|515931766|FG002|Overall Study|Noncompliance with protocol|4|||
143106204|NCT00664859|515931764|FG000|Overall Study|Laboratory abnormality|2|||
143106205|NCT00664859|515931765|FG001|Overall Study|Laboratory abnormality|1|||
143106206|NCT00664859|515931766|FG002|Overall Study|Laboratory abnormality|4|||
143106207|NCT00664859|515931764|FG000|Overall Study|Withdrawal by Subject|4|||
143106208|NCT00664859|515931765|FG001|Overall Study|Withdrawal by Subject|1|||
143106209|NCT00664859|515931766|FG002|Overall Study|Withdrawal by Subject|3|||
143106210|NCT00664859|515931764|FG000|Overall Study|Lost to Follow-up|2|||
143106211|NCT00664859|515931765|FG001|Overall Study|Lost to Follow-up|2|||
143106212|NCT00664859|515931766|FG002|Overall Study|Lost to Follow-up|1|||
143106213|NCT00664859|515931764|FG000|Overall Study|Other|0|||
143106214|NCT00664859|515931765|FG001|Overall Study|Other|1|||
143106215|NCT00664859|515931766|FG002|Overall Study|Other|2|||
143106216|NCT01943851|515931767|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
143106217|NCT01943851|515931768|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
143106218|NCT01943851|515931769|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
143106219|NCT01943851|515931770|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
143106220|NCT01943851|515931771|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
143367958|NCT01956669|516890841|FG001|Overall Study|Physician Decision|2|||
143106221|NCT01943851|515931772|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
143106222|NCT01943851|515931773|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
143106223|NCT01943851|515931774|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
143106224|NCT01943851|515931775|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
143106225|NCT01943851|515931776|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
143255591|NCT01430754|516490590|FG000|Run-In Phase|Circadian Period Ineligible|24|||
143255592|NCT01430754|516490591|FG001|Run-In Phase|Circadian Period Ineligible|0|||
143255593|NCT01430754|516490590|FG000|Run-In Phase|Protocol Violation|6|||
143255594|NCT01430754|516490591|FG001|Run-In Phase|Protocol Violation|0|||
143255595|NCT01430754|516490590|FG000|Run-In Phase|Adverse Event|2|||
143255596|NCT01430754|516490591|FG001|Run-In Phase|Adverse Event|0|||
143255597|NCT01430754|516490590|FG000|Run-In Phase|Other|2|||
143255598|NCT01430754|516490591|FG001|Run-In Phase|Other|0|||
143255599|NCT01430754|516490590|FG000|Run-In Phase|Withdrawal by Subject|2|||
143255600|NCT01430754|516490591|FG001|Run-In Phase|Withdrawal by Subject|0|||
143255601|NCT01430754|516490590|FG000|Run-In Phase|Lost to Follow-up|1|||
143255602|NCT01430754|516490591|FG001|Run-In Phase|Lost to Follow-up|0|||
143255603|NCT03085914|516490592|FG000|Overall Study|Death|6|||
143255604|NCT03085914|516490593|FG001|Overall Study|Death|6|||
143255605|NCT03085914|516490594|FG002|Overall Study|Death|4|||
143255606|NCT03085914|516490595|FG003|Overall Study|Death|1|||
143255607|NCT03085914|516490596|FG004|Overall Study|Death|5|||
143255608|NCT03085914|516490597|FG005|Overall Study|Death|2|||
143255609|NCT03085914|516490598|FG006|Overall Study|Death|2|||
143255610|NCT03085914|516490592|FG000|Overall Study|Withdrawal by Subject|1|||
143255611|NCT03085914|516490593|FG001|Overall Study|Withdrawal by Subject|1|||
143255612|NCT03085914|516490594|FG002|Overall Study|Withdrawal by Subject|2|||
143255613|NCT03085914|516490595|FG003|Overall Study|Withdrawal by Subject|2|||
143255614|NCT03085914|516490596|FG004|Overall Study|Withdrawal by Subject|2|||
143255615|NCT03085914|516490597|FG005|Overall Study|Withdrawal by Subject|0|||
143255616|NCT03085914|516490598|FG006|Overall Study|Withdrawal by Subject|1|||
143255617|NCT03085914|516490592|FG000|Overall Study|Lost to Follow-up|0|||
143255618|NCT03085914|516490593|FG001|Overall Study|Lost to Follow-up|0|||
143255619|NCT03085914|516490594|FG002|Overall Study|Lost to Follow-up|1|||
143255620|NCT03085914|516490595|FG003|Overall Study|Lost to Follow-up|0|||
143255621|NCT03085914|516490596|FG004|Overall Study|Lost to Follow-up|0|||
143255622|NCT03085914|516490597|FG005|Overall Study|Lost to Follow-up|1|||
143106226|NCT01943851|515931777|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
143106227|NCT01943851|515931778|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
143106228|NCT01943851|515931779|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
143106229|NCT01943851|515931780|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
143106230|NCT01943851|515931781|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
143106231|NCT01943851|515931782|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
143255623|NCT03085914|516490598|FG006|Overall Study|Lost to Follow-up|1|||
143255624|NCT03085914|516490592|FG000|Overall Study|Reason was not specified,|2|||
143255625|NCT03085914|516490593|FG001|Overall Study|Reason was not specified,|2|||
143255626|NCT03085914|516490594|FG002|Overall Study|Reason was not specified,|2|||
143255627|NCT03085914|516490595|FG003|Overall Study|Reason was not specified,|3|||
143106232|NCT01943851|515931783|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
143106233|NCT01943851|515931784|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
143106234|NCT01943851|515931767|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
143106235|NCT01943851|515931768|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
143106236|NCT01943851|515931769|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
143106237|NCT01943851|515931770|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
143106238|NCT01943851|515931771|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
143106239|NCT01943851|515931772|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
143106240|NCT01943851|515931773|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
143106241|NCT01943851|515931774|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
143106242|NCT01943851|515931775|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
143106243|NCT01943851|515931776|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
143106244|NCT01943851|515931777|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
143106245|NCT01943851|515931778|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
143106246|NCT01943851|515931779|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
143106247|NCT01943851|515931780|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
143255628|NCT03085914|516490596|FG004|Overall Study|Reason was not specified,|3|||
143255629|NCT03085914|516490597|FG005|Overall Study|Reason was not specified,|3|||
143255630|NCT03085914|516490598|FG006|Overall Study|Reason was not specified,|6|||
143255631|NCT03085914|516490592|FG000|Overall Study|Progressive Disease|0|||
143255632|NCT03085914|516490593|FG001|Overall Study|Progressive Disease|0|||
143255633|NCT03085914|516490594|FG002|Overall Study|Progressive Disease|2|||
143255634|NCT03085914|516490595|FG003|Overall Study|Progressive Disease|2|||
143255635|NCT03085914|516490596|FG004|Overall Study|Progressive Disease|1|||
143255636|NCT03085914|516490597|FG005|Overall Study|Progressive Disease|1|||
143255637|NCT03085914|516490598|FG006|Overall Study|Progressive Disease|1|||
143255638|NCT03085914|516490592|FG000|Overall Study|Study Terminated by the Sponsor|0|||
143255639|NCT03085914|516490593|FG001|Overall Study|Study Terminated by the Sponsor|0|||
143255640|NCT03085914|516490594|FG002|Overall Study|Study Terminated by the Sponsor|0|||
143255641|NCT03085914|516490595|FG003|Overall Study|Study Terminated by the Sponsor|1|||
143255642|NCT03085914|516490596|FG004|Overall Study|Study Terminated by the Sponsor|2|||
143255643|NCT03085914|516490597|FG005|Overall Study|Study Terminated by the Sponsor|1|||
143255644|NCT03085914|516490598|FG006|Overall Study|Study Terminated by the Sponsor|0|||
143255645|NCT00701662|516490599|FG000|Overall Study|Lack of Efficacy|1|||
143255646|NCT00159822|516490600|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
143255647|NCT00159822|516490600|FG000|Voriconazole Treatment Period|Adverse Event|9|||
143255648|NCT00159822|516490600|FG000|Voriconazole Treatment Period|Death|4|||
143255649|NCT00159822|516490600|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
143255650|NCT00159822|516490600|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
143255651|NCT00159822|516490600|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
143255652|NCT00159822|516490600|FG000|Post-treatment Follow-up Period|Death|1|||
143255653|NCT00159822|516490600|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
143255654|NCT00159822|516490600|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
143255655|NCT04575597|516490601|FG000|Overall Study|Death|0|||
143255656|NCT04575597|516490602|FG001|Overall Study|Death|0|||
143255657|NCT04575597|516490603|FG002|Overall Study|Death|0|||
143255658|NCT04575597|516490604|FG003|Overall Study|Death|1|||
143255659|NCT04575597|516490605|FG004|Overall Study|Death|3|||
143255660|NCT04575597|516490606|FG005|Overall Study|Death|14|||
143255661|NCT04575597|516490601|FG000|Overall Study|Lost to Follow-up|2|||
143255662|NCT04575597|516490602|FG001|Overall Study|Lost to Follow-up|1|||
143255663|NCT04575597|516490603|FG002|Overall Study|Lost to Follow-up|1|||
143255664|NCT04575597|516490604|FG003|Overall Study|Lost to Follow-up|2|||
143255665|NCT04575597|516490605|FG004|Overall Study|Lost to Follow-up|10|||
143255666|NCT04575597|516490606|FG005|Overall Study|Lost to Follow-up|8|||
143255667|NCT04575597|516490601|FG000|Overall Study|Withdrawal by Subject|2|||
143255668|NCT04575597|516490602|FG001|Overall Study|Withdrawal by Subject|2|||
143255669|NCT04575597|516490603|FG002|Overall Study|Withdrawal by Subject|4|||
143255670|NCT04575597|516490604|FG003|Overall Study|Withdrawal by Subject|2|||
143255671|NCT04575597|516490605|FG004|Overall Study|Withdrawal by Subject|25|||
143255672|NCT04575597|516490606|FG005|Overall Study|Withdrawal by Subject|28|||
143106248|NCT01943851|515931781|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
143255673|NCT04575597|516490601|FG000|Overall Study|Not Recorded|0|||
143255674|NCT04575597|516490602|FG001|Overall Study|Not Recorded|0|||
143255675|NCT04575597|516490603|FG002|Overall Study|Not Recorded|0|||
143255676|NCT04575597|516490604|FG003|Overall Study|Not Recorded|0|||
143255677|NCT04575597|516490605|FG004|Overall Study|Not Recorded|0|||
143255678|NCT04575597|516490606|FG005|Overall Study|Not Recorded|2|||
143255679|NCT04575597|516490601|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
143255680|NCT04575597|516490602|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
143255681|NCT04575597|516490603|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
143255682|NCT04575597|516490604|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
143255683|NCT04575597|516490605|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
143106249|NCT01943851|515931782|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
143106250|NCT01943851|515931783|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
143106251|NCT01943851|515931784|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
143106252|NCT01943851|515931767|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
143106253|NCT01943851|515931768|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
143106254|NCT01943851|515931769|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
143106255|NCT01943851|515931770|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
143106256|NCT01943851|515931771|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
143106257|NCT01943851|515931772|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
143106258|NCT01943851|515931773|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
143106259|NCT01943851|515931774|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
143106260|NCT01943851|515931775|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
143106261|NCT01943851|515931776|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
143106262|NCT01943851|515931777|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
143106263|NCT01943851|515931778|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
143106264|NCT01943851|515931779|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
143106265|NCT01943851|515931780|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
143106266|NCT01943851|515931781|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
143106267|NCT01943851|515931782|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
143106268|NCT01943851|515931783|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
143106269|NCT01943851|515931784|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
143106270|NCT01943851|515931767|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
143106271|NCT01943851|515931768|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
143106272|NCT01943851|515931769|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
143106273|NCT01943851|515931770|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
143106274|NCT01943851|515931771|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
143106275|NCT01943851|515931772|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
143106276|NCT01943851|515931773|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
143106277|NCT01943851|515931774|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
143106278|NCT01943851|515931775|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
143106279|NCT01943851|515931776|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
143106280|NCT01943851|515931777|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
143106281|NCT01943851|515931778|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
143106282|NCT01943851|515931779|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
143106283|NCT01943851|515931780|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
143106284|NCT01943851|515931781|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
143106285|NCT01943851|515931782|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
143106286|NCT01943851|515931783|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
143106287|NCT01943851|515931784|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
143106288|NCT01943851|515931767|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
143106289|NCT01943851|515931768|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
143106290|NCT01943851|515931769|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
143106291|NCT01943851|515931770|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
143106292|NCT01943851|515931771|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
143106293|NCT01943851|515931772|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
143106294|NCT01943851|515931773|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
143106295|NCT01943851|515931774|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
143106296|NCT01943851|515931775|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
143106297|NCT01943851|515931776|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
143106298|NCT01943851|515931777|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
143106299|NCT01943851|515931778|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
143106300|NCT01943851|515931779|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
143106301|NCT01943851|515931780|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
143106302|NCT01943851|515931781|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
143106303|NCT01943851|515931782|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
143106304|NCT01943851|515931783|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
143178731|NCT04072835|516203589|FG000|Overall Study|Participant tolerability|5|||
143178732|NCT04072835|516203589|FG000|Overall Study|Missing|5|||
143178733|NCT04072835|516203589|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
143178734|NCT04072835|516203589|FG000|Overall Study|Pregnancy|3|||
143178735|NCT00399568|516203590|FG000|Overall Study|Adverse Event|1|||
143178736|NCT00399568|516203591|FG001|Overall Study|Adverse Event|2|||
143106305|NCT01943851|515931784|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
143106306|NCT00425061|515931792|FG000|Overall Study|Adverse Event|1|||
143106307|NCT00425061|515931793|FG001|Overall Study|Adverse Event|0|||
143106308|NCT00425061|515931794|FG002|Overall Study|Adverse Event|0|||
143106309|NCT00425061|515931795|FG003|Overall Study|Adverse Event|2|||
143106310|NCT00425061|515931796|FG004|Overall Study|Adverse Event|2|||
143106311|NCT00425061|515931797|FG005|Overall Study|Adverse Event|0|||
143106312|NCT00425061|515931798|FG006|Overall Study|Adverse Event|0|||
143106313|NCT00425061|515931792|FG000|Overall Study|Lost to Follow-up|0|||
143106314|NCT00425061|515931793|FG001|Overall Study|Lost to Follow-up|1|||
143106315|NCT00425061|515931794|FG002|Overall Study|Lost to Follow-up|0|||
143106316|NCT00425061|515931795|FG003|Overall Study|Lost to Follow-up|0|||
143106317|NCT00425061|515931796|FG004|Overall Study|Lost to Follow-up|0|||
143106318|NCT00425061|515931797|FG005|Overall Study|Lost to Follow-up|0|||
143106319|NCT00425061|515931798|FG006|Overall Study|Lost to Follow-up|0|||
143106320|NCT00425061|515931792|FG000|Overall Study|Protocol Violation|1|||
143106321|NCT00425061|515931793|FG001|Overall Study|Protocol Violation|0|||
143106322|NCT00425061|515931794|FG002|Overall Study|Protocol Violation|0|||
143106323|NCT00425061|515931795|FG003|Overall Study|Protocol Violation|0|||
143106324|NCT00425061|515931796|FG004|Overall Study|Protocol Violation|0|||
143106325|NCT00425061|515931797|FG005|Overall Study|Protocol Violation|0|||
143106326|NCT00425061|515931798|FG006|Overall Study|Protocol Violation|0|||
143106327|NCT00425061|515931792|FG000|Overall Study|Withdrawal by Subject|0|||
143106328|NCT00425061|515931793|FG001|Overall Study|Withdrawal by Subject|1|||
143106329|NCT00425061|515931794|FG002|Overall Study|Withdrawal by Subject|0|||
143106330|NCT00425061|515931795|FG003|Overall Study|Withdrawal by Subject|0|||
143106331|NCT00425061|515931796|FG004|Overall Study|Withdrawal by Subject|1|||
143106332|NCT00425061|515931797|FG005|Overall Study|Withdrawal by Subject|0|||
143106333|NCT00425061|515931798|FG006|Overall Study|Withdrawal by Subject|3|||
143106334|NCT00425061|515931792|FG000|Overall Study|Sponsor's request|0|||
143106335|NCT00425061|515931793|FG001|Overall Study|Sponsor's request|0|||
143106336|NCT00425061|515931794|FG002|Overall Study|Sponsor's request|0|||
143106337|NCT00425061|515931795|FG003|Overall Study|Sponsor's request|0|||
143106338|NCT00425061|515931796|FG004|Overall Study|Sponsor's request|19|||
143106339|NCT00425061|515931797|FG005|Overall Study|Sponsor's request|4|||
143106340|NCT00425061|515931798|FG006|Overall Study|Sponsor's request|15|||
143106341|NCT00425061|515931792|FG000|Overall Study|Physician Decision|0|||
143106342|NCT00425061|515931793|FG001|Overall Study|Physician Decision|0|||
143106343|NCT00425061|515931794|FG002|Overall Study|Physician Decision|0|||
143106344|NCT00425061|515931795|FG003|Overall Study|Physician Decision|0|||
143106345|NCT00425061|515931796|FG004|Overall Study|Physician Decision|1|||
143106346|NCT00425061|515931797|FG005|Overall Study|Physician Decision|0|||
143106347|NCT00425061|515931798|FG006|Overall Study|Physician Decision|0|||
143106348|NCT00425061|515931792|FG000|Overall Study|Other|0|||
143106349|NCT00425061|515931793|FG001|Overall Study|Other|0|||
143106350|NCT00425061|515931794|FG002|Overall Study|Other|0|||
143106351|NCT00425061|515931795|FG003|Overall Study|Other|0|||
143106352|NCT00425061|515931796|FG004|Overall Study|Other|3|||
143106353|NCT00425061|515931797|FG005|Overall Study|Other|0|||
143106354|NCT00425061|515931798|FG006|Overall Study|Other|1|||
143106355|NCT01680861|515931799|FG000|Early Post-transplant Period|Protocol Violation|1|||
143106356|NCT01680861|515931800|FG001|Early Post-transplant Period|Protocol Violation|1|||
143106357|NCT01011465|515931803|FG000|Overall Study|Withdrawal by Subject|2|||
143106358|NCT01011465|515931804|FG001|Overall Study|Withdrawal by Subject|1|||
143106359|NCT01011465|515931805|FG002|Overall Study|Withdrawal by Subject|0|||
143106360|NCT01011465|515931806|FG003|Overall Study|Withdrawal by Subject|0|||
143106361|NCT01011465|515931807|FG004|Overall Study|Withdrawal by Subject|1|||
143106362|NCT01011465|515931808|FG005|Overall Study|Withdrawal by Subject|0|||
143106363|NCT01011465|515931809|FG006|Overall Study|Withdrawal by Subject|1|||
143106364|NCT01011465|515931810|FG007|Overall Study|Withdrawal by Subject|0|||
143106365|NCT00723008|515931811|FG000|Enrollment|Lost to Follow-up|1|||
143106366|NCT00723008|515931812|FG001|Enrollment|Lost to Follow-up|0|||
143106367|NCT00723008|515931811|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
143255684|NCT04575597|516490606|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
143106368|NCT00723008|515931812|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
143106369|NCT00723008|515931811|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
143106370|NCT00723008|515931812|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
143106371|NCT00723008|515931811|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
143106372|NCT00723008|515931812|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
143106373|NCT00723008|515931811|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
143106374|NCT00723008|515931812|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
143106375|NCT00723008|515931811|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
143106376|NCT00723008|515931812|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
143106377|NCT05835011|515931813|FG000|Overall Study|Study Terminated by the Sponsor|1|||
143255685|NCT02353143|516490607|FG000|Overall Study|Withdrawal by Subject|1|||
143106378|NCT05835011|515931813|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
143106379|NCT04720911|515931816|FG000|Overall Study|Withdrawal by Subject|0|||
143106380|NCT04720911|515931817|FG001|Overall Study|Withdrawal by Subject|1|||
143106381|NCT04720911|515931818|FG002|Overall Study|Withdrawal by Subject|0|||
143106382|NCT00090220|515931819|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
143106383|NCT00090220|515931820|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
143106384|NCT00090220|515931821|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
143106385|NCT00090220|515931822|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
143106386|NCT00090220|515931823|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
143106387|NCT00090220|515931824|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
143106388|NCT00090220|515931819|FG000|Base Study Vaccination Period|Adverse Event|6|||
143106389|NCT00090220|515931820|FG001|Base Study Vaccination Period|Adverse Event|1|||
143106390|NCT00090220|515931821|FG002|Base Study Vaccination Period|Adverse Event|0|||
143106391|NCT00090220|515931822|FG003|Base Study Vaccination Period|Adverse Event|0|||
143106392|NCT00090220|515931823|FG004|Base Study Vaccination Period|Adverse Event|0|||
143106393|NCT00090220|515931824|FG005|Base Study Vaccination Period|Adverse Event|0|||
143106394|NCT00090220|515931819|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
143106395|NCT00090220|515931820|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
143106396|NCT00090220|515931821|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
143106397|NCT00090220|515931822|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
143106398|NCT00090220|515931823|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
143106399|NCT00090220|515931824|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
143106400|NCT00090220|515931819|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
143106401|NCT00090220|515931820|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
143106402|NCT00090220|515931821|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
143106403|NCT00090220|515931822|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
143106404|NCT00090220|515931823|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
143106405|NCT00090220|515931824|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
143106406|NCT00090220|515931819|FG000|Base Study Vaccination Period|Patient Moved|6|||
143106407|NCT00090220|515931820|FG001|Base Study Vaccination Period|Patient Moved|2|||
143106408|NCT00090220|515931821|FG002|Base Study Vaccination Period|Patient Moved|0|||
143106409|NCT00090220|515931822|FG003|Base Study Vaccination Period|Patient Moved|0|||
143106410|NCT00090220|515931823|FG004|Base Study Vaccination Period|Patient Moved|0|||
143106411|NCT00090220|515931824|FG005|Base Study Vaccination Period|Patient Moved|0|||
143106412|NCT00090220|515931819|FG000|Base Study Vaccination Period|Other|4|||
143106413|NCT00090220|515931820|FG001|Base Study Vaccination Period|Other|4|||
143106414|NCT00090220|515931821|FG002|Base Study Vaccination Period|Other|0|||
143106415|NCT00090220|515931822|FG003|Base Study Vaccination Period|Other|0|||
143106416|NCT00090220|515931823|FG004|Base Study Vaccination Period|Other|0|||
143106417|NCT00090220|515931824|FG005|Base Study Vaccination Period|Other|0|||
143106418|NCT00090220|515931819|FG000|Base Study Follow-up Period|Adverse Event|6|||
143106419|NCT00090220|515931820|FG001|Base Study Follow-up Period|Adverse Event|1|||
143106420|NCT00090220|515931821|FG002|Base Study Follow-up Period|Adverse Event|0|||
143106421|NCT00090220|515931822|FG003|Base Study Follow-up Period|Adverse Event|0|||
143106422|NCT00090220|515931823|FG004|Base Study Follow-up Period|Adverse Event|0|||
143106423|NCT00090220|515931824|FG005|Base Study Follow-up Period|Adverse Event|0|||
143106424|NCT00090220|515931819|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
143106425|NCT00090220|515931820|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
143106426|NCT00090220|515931821|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
143106427|NCT00090220|515931822|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
143106428|NCT00090220|515931823|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
143106429|NCT00090220|515931824|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
143106430|NCT00090220|515931819|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
143106431|NCT00090220|515931820|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
143106432|NCT00090220|515931821|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
143106433|NCT00090220|515931822|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
143255686|NCT02353143|516490608|FG001|Overall Study|Withdrawal by Subject|0|||
143255687|NCT02353143|516490609|FG002|Overall Study|Withdrawal by Subject|0|||
143255688|NCT02353143|516490610|FG003|Overall Study|Withdrawal by Subject|0|||
143255689|NCT02353143|516490611|FG004|Overall Study|Withdrawal by Subject|1|||
143255690|NCT02353143|516490612|FG005|Overall Study|Withdrawal by Subject|0|||
143255691|NCT02353143|516490613|FG006|Overall Study|Withdrawal by Subject|0|||
143106434|NCT00090220|515931823|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
143106435|NCT00090220|515931824|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
143106436|NCT00090220|515931819|FG000|Base Study Follow-up Period|Patient Moved|20|||
143106437|NCT00090220|515931820|FG001|Base Study Follow-up Period|Patient Moved|28|||
143106438|NCT00090220|515931821|FG002|Base Study Follow-up Period|Patient Moved|0|||
143106439|NCT00090220|515931822|FG003|Base Study Follow-up Period|Patient Moved|0|||
143255692|NCT02353143|516490614|FG007|Overall Study|Withdrawal by Subject|1|||
143255693|NCT02353143|516490615|FG008|Overall Study|Withdrawal by Subject|1|||
143106440|NCT00090220|515931823|FG004|Base Study Follow-up Period|Patient Moved|0|||
143106441|NCT00090220|515931824|FG005|Base Study Follow-up Period|Patient Moved|0|||
143106442|NCT00090220|515931819|FG000|Base Study Follow-up Period|Other|19|||
143106443|NCT00090220|515931820|FG001|Base Study Follow-up Period|Other|21|||
143106444|NCT00090220|515931821|FG002|Base Study Follow-up Period|Other|0|||
143106445|NCT00090220|515931822|FG003|Base Study Follow-up Period|Other|0|||
143106446|NCT00090220|515931823|FG004|Base Study Follow-up Period|Other|0|||
143106447|NCT00090220|515931824|FG005|Base Study Follow-up Period|Other|0|||
143106448|NCT00090220|515931819|FG000|Extension 1 (EXT1)|Adverse Event|0|||
143106449|NCT00090220|515931820|FG001|Extension 1 (EXT1)|Adverse Event|0|||
143106450|NCT00090220|515931821|FG002|Extension 1 (EXT1)|Adverse Event|4|||
143106451|NCT00090220|515931822|FG003|Extension 1 (EXT1)|Adverse Event|0|||
143106452|NCT00090220|515931823|FG004|Extension 1 (EXT1)|Adverse Event|0|||
143106453|NCT00090220|515931824|FG005|Extension 1 (EXT1)|Adverse Event|0|||
143106454|NCT00090220|515931819|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
143106455|NCT00090220|515931820|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
143106456|NCT00090220|515931821|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
143106457|NCT00090220|515931822|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
143106458|NCT00090220|515931823|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
143106459|NCT00090220|515931824|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
143106460|NCT00090220|515931819|FG000|Extension 1 (EXT1)|Moved|0|||
143106461|NCT00090220|515931820|FG001|Extension 1 (EXT1)|Moved|0|||
143106462|NCT00090220|515931821|FG002|Extension 1 (EXT1)|Moved|2|||
143106463|NCT00090220|515931822|FG003|Extension 1 (EXT1)|Moved|1|||
143106464|NCT00090220|515931823|FG004|Extension 1 (EXT1)|Moved|0|||
143106465|NCT00090220|515931824|FG005|Extension 1 (EXT1)|Moved|0|||
143106466|NCT00090220|515931819|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
143106467|NCT00090220|515931820|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
143106468|NCT00090220|515931821|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
143106469|NCT00090220|515931822|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
143106470|NCT00090220|515931823|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
143106471|NCT00090220|515931824|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
143106472|NCT00090220|515931819|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
143106473|NCT00090220|515931820|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
143106474|NCT00090220|515931821|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
143178737|NCT00399568|516203590|FG000|Overall Study|Withdrawal by Subject|7|||
143178738|NCT00399568|516203591|FG001|Overall Study|Withdrawal by Subject|3|||
143178739|NCT00399568|516203590|FG000|Overall Study|Protocol non-compliance|2|||
143178740|NCT00399568|516203591|FG001|Overall Study|Protocol non-compliance|2|||
143178741|NCT00399568|516203590|FG000|Overall Study|Lost to Follow-up|2|||
143178742|NCT00399568|516203591|FG001|Overall Study|Lost to Follow-up|2|||
143178743|NCT03432494|516203600|FG000|Overall Study|Death|1|||
143178744|NCT03432494|516203600|FG000|Overall Study|Noncompliance|1|||
143178745|NCT00856635|516203601|FG000|Overall Study|Lost to Follow-up|2|||
143178746|NCT00856635|516203602|FG001|Overall Study|Lost to Follow-up|5|||
143178747|NCT00856635|516203601|FG000|Overall Study|Pregnancy|1|||
143178748|NCT00856635|516203602|FG001|Overall Study|Pregnancy|0|||
143178749|NCT00856635|516203601|FG000|Overall Study|Withdrawal by Subject|3|||
143178750|NCT00856635|516203602|FG001|Overall Study|Withdrawal by Subject|1|||
143178751|NCT00856635|516203601|FG000|Overall Study|Serious Adverse Event|1|||
143178752|NCT00856635|516203602|FG001|Overall Study|Serious Adverse Event|0|||
143178753|NCT00856635|516203601|FG000|Overall Study|Other|1|||
143178754|NCT00856635|516203602|FG001|Overall Study|Other|0|||
143106475|NCT00090220|515931822|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
143106476|NCT00090220|515931823|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
143106477|NCT00090220|515931824|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
143106478|NCT00090220|515931819|FG000|Extension 1 (EXT1)|Other reason|0|||
143106479|NCT00090220|515931820|FG001|Extension 1 (EXT1)|Other reason|0|||
143106480|NCT00090220|515931821|FG002|Extension 1 (EXT1)|Other reason|2|||
143106481|NCT00090220|515931822|FG003|Extension 1 (EXT1)|Other reason|0|||
143106482|NCT00090220|515931823|FG004|Extension 1 (EXT1)|Other reason|0|||
143106483|NCT00090220|515931824|FG005|Extension 1 (EXT1)|Other reason|0|||
143106484|NCT00090220|515931819|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
143106485|NCT00090220|515931820|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
143106486|NCT00090220|515931821|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
143106487|NCT00090220|515931822|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
143178755|NCT00856635|516203601|FG000|Overall Study|Discontinued at Randomization|2|||
143178756|NCT00856635|516203602|FG001|Overall Study|Discontinued at Randomization|2|||
143178757|NCT01244035|516203603|FG000|Part 1: Period 1|Adverse Event|0|||
143178758|NCT01244035|516203604|FG001|Part 1: Period 1|Adverse Event|0|||
143106488|NCT00090220|515931823|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
143106489|NCT00090220|515931824|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
143106490|NCT00090220|515931819|FG000|Long-term Follow-up (EXT2)|Death|0|||
143106491|NCT00090220|515931820|FG001|Long-term Follow-up (EXT2)|Death|0|||
143106492|NCT00090220|515931821|FG002|Long-term Follow-up (EXT2)|Death|0|||
143106493|NCT00090220|515931822|FG003|Long-term Follow-up (EXT2)|Death|0|||
143106494|NCT00090220|515931823|FG004|Long-term Follow-up (EXT2)|Death|1|||
143106495|NCT00090220|515931824|FG005|Long-term Follow-up (EXT2)|Death|1|||
143178759|NCT01244035|516203605|FG002|Part 1: Period 1|Adverse Event|0|||
143178760|NCT01244035|516203606|FG003|Part 1: Period 1|Adverse Event|0|||
143178761|NCT01244035|516203607|FG004|Part 1: Period 1|Adverse Event|0|||
143178762|NCT01244035|516203608|FG005|Part 1: Period 1|Adverse Event|1|||
143178763|NCT01244035|516203603|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
143178764|NCT01244035|516203604|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
143178765|NCT01244035|516203605|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
143178766|NCT01244035|516203606|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
143178767|NCT01244035|516203607|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
143178768|NCT01244035|516203608|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
143178769|NCT01244035|516203603|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
143255694|NCT02353143|516490607|FG000|Overall Study|Lack of Efficacy|2|||
143106496|NCT00090220|515931819|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
143106497|NCT00090220|515931820|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
143106498|NCT00090220|515931821|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
143178770|NCT01244035|516203604|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
143255695|NCT02353143|516490608|FG001|Overall Study|Lack of Efficacy|1|||
143255696|NCT02353143|516490609|FG002|Overall Study|Lack of Efficacy|2|||
143106499|NCT00090220|515931822|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
143106500|NCT00090220|515931823|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
143106501|NCT00090220|515931824|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
143106502|NCT00090220|515931819|FG000|Long-term Follow-up (EXT2)|Other|0|||
143106503|NCT00090220|515931820|FG001|Long-term Follow-up (EXT2)|Other|0|||
143106504|NCT00090220|515931821|FG002|Long-term Follow-up (EXT2)|Other|0|||
143106505|NCT00090220|515931822|FG003|Long-term Follow-up (EXT2)|Other|0|||
143106506|NCT00090220|515931823|FG004|Long-term Follow-up (EXT2)|Other|1|||
143106507|NCT00090220|515931824|FG005|Long-term Follow-up (EXT2)|Other|0|||
143106508|NCT00941863|515931825|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
143106509|NCT00941863|515931826|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
143106510|NCT00941863|515931827|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
143106511|NCT00941863|515931828|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
143106512|NCT00941863|515931829|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
143106513|NCT00941863|515931825|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
143106514|NCT00941863|515931826|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
143106515|NCT00941863|515931827|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
143106516|NCT00941863|515931828|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
143106517|NCT00941863|515931829|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
143106518|NCT00941863|515931825|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
143106519|NCT00941863|515931826|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
143106520|NCT00941863|515931827|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
143106521|NCT00941863|515931828|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
143106522|NCT00941863|515931829|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
143106523|NCT00941863|515931825|FG000|Until Primary Completion Date (PCD)|Death|0|||
143106524|NCT00941863|515931826|FG001|Until Primary Completion Date (PCD)|Death|0|||
143106525|NCT00941863|515931827|FG002|Until Primary Completion Date (PCD)|Death|1|||
143106526|NCT00941863|515931828|FG003|Until Primary Completion Date (PCD)|Death|2|||
143106527|NCT00941863|515931829|FG004|Until Primary Completion Date (PCD)|Death|7|||
143106528|NCT00941863|515931825|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
143106529|NCT00941863|515931826|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
143106530|NCT00941863|515931827|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
143106531|NCT00941863|515931828|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
143106532|NCT00941863|515931829|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
143106533|NCT00941863|515931825|FG000|Continued After PCD|Withdrawal by Subject|0|||
143106534|NCT00941863|515931826|FG001|Continued After PCD|Withdrawal by Subject|0|||
143106535|NCT00941863|515931827|FG002|Continued After PCD|Withdrawal by Subject|0|||
143106536|NCT00941863|515931828|FG003|Continued After PCD|Withdrawal by Subject|0|||
143106537|NCT00941863|515931829|FG004|Continued After PCD|Withdrawal by Subject|1|||
143106538|NCT00941863|515931825|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
143106539|NCT00941863|515931826|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
143106540|NCT00941863|515931827|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
143106541|NCT00941863|515931828|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
143106542|NCT00941863|515931829|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
143106543|NCT01867710|515931835|FG000|Overall Study|Death|25|||
143106544|NCT01867710|515931836|FG001|Overall Study|Death|15|||
143106545|NCT01867710|515931837|FG002|Overall Study|Death|27|||
143106546|NCT01867710|515931838|FG003|Overall Study|Death|20|||
143106547|NCT01867710|515931835|FG000|Overall Study|Lost to Follow-up|3|||
143255697|NCT02353143|516490610|FG003|Overall Study|Lack of Efficacy|4|||
143106548|NCT01867710|515931836|FG001|Overall Study|Lost to Follow-up|4|||
143106549|NCT01867710|515931837|FG002|Overall Study|Lost to Follow-up|3|||
143106550|NCT01867710|515931838|FG003|Overall Study|Lost to Follow-up|2|||
143106551|NCT01867710|515931835|FG000|Overall Study|Withdrawal of consent|2|||
143106552|NCT01867710|515931836|FG001|Overall Study|Withdrawal of consent|5|||
143106553|NCT01867710|515931837|FG002|Overall Study|Withdrawal of consent|1|||
143106554|NCT01867710|515931838|FG003|Overall Study|Withdrawal of consent|2|||
143106555|NCT01867710|515931835|FG000|Overall Study|Study Terminated by Sponsor|9|||
143106556|NCT01867710|515931836|FG001|Overall Study|Study Terminated by Sponsor|13|||
143106557|NCT01867710|515931837|FG002|Overall Study|Study Terminated by Sponsor|8|||
143106558|NCT01867710|515931838|FG003|Overall Study|Study Terminated by Sponsor|16|||
143106559|NCT01867710|515931835|FG000|Overall Study|Biochemical progression|0|||
143106560|NCT01867710|515931836|FG001|Overall Study|Biochemical progression|1|||
143106561|NCT01867710|515931837|FG002|Overall Study|Biochemical progression|0|||
143106562|NCT01867710|515931838|FG003|Overall Study|Biochemical progression|0|||
143106563|NCT01867710|515931835|FG000|Overall Study|Clinical progression|0|||
143106564|NCT01867710|515931836|FG001|Overall Study|Clinical progression|0|||
143106565|NCT01867710|515931837|FG002|Overall Study|Clinical progression|1|||
143106566|NCT01867710|515931838|FG003|Overall Study|Clinical progression|0|||
143255698|NCT02353143|516490611|FG004|Overall Study|Lack of Efficacy|13|||
143255699|NCT02353143|516490612|FG005|Overall Study|Lack of Efficacy|2|||
143255700|NCT02353143|516490613|FG006|Overall Study|Lack of Efficacy|2|||
143255701|NCT02353143|516490614|FG007|Overall Study|Lack of Efficacy|2|||
143255702|NCT02353143|516490615|FG008|Overall Study|Lack of Efficacy|1|||
143255703|NCT02353143|516490607|FG000|Overall Study|reason not specified|1|||
143255704|NCT02353143|516490608|FG001|Overall Study|reason not specified|2|||
143255705|NCT02353143|516490609|FG002|Overall Study|reason not specified|0|||
143255706|NCT02353143|516490610|FG003|Overall Study|reason not specified|0|||
143255707|NCT02353143|516490611|FG004|Overall Study|reason not specified|6|||
143255708|NCT02353143|516490612|FG005|Overall Study|reason not specified|1|||
143255709|NCT02353143|516490613|FG006|Overall Study|reason not specified|0|||
143255710|NCT02353143|516490614|FG007|Overall Study|reason not specified|3|||
143255711|NCT02353143|516490615|FG008|Overall Study|reason not specified|1|||
143255712|NCT02353143|516490607|FG000|Overall Study|Physician Decision|0|||
143255713|NCT02353143|516490608|FG001|Overall Study|Physician Decision|4|||
143255714|NCT02353143|516490609|FG002|Overall Study|Physician Decision|2|||
143255715|NCT02353143|516490610|FG003|Overall Study|Physician Decision|3|||
143255716|NCT02353143|516490611|FG004|Overall Study|Physician Decision|4|||
143255717|NCT02353143|516490612|FG005|Overall Study|Physician Decision|0|||
143255718|NCT02353143|516490613|FG006|Overall Study|Physician Decision|1|||
143255719|NCT02353143|516490614|FG007|Overall Study|Physician Decision|2|||
143255720|NCT02353143|516490615|FG008|Overall Study|Physician Decision|0|||
143255721|NCT02353143|516490607|FG000|Overall Study|Adverse Event|0|||
143255722|NCT02353143|516490608|FG001|Overall Study|Adverse Event|0|||
143255723|NCT02353143|516490609|FG002|Overall Study|Adverse Event|1|||
143255724|NCT02353143|516490610|FG003|Overall Study|Adverse Event|0|||
143255725|NCT02353143|516490611|FG004|Overall Study|Adverse Event|1|||
143255726|NCT02353143|516490612|FG005|Overall Study|Adverse Event|1|||
143255727|NCT02353143|516490613|FG006|Overall Study|Adverse Event|0|||
143255728|NCT02353143|516490614|FG007|Overall Study|Adverse Event|0|||
143255729|NCT02353143|516490615|FG008|Overall Study|Adverse Event|0|||
143255730|NCT02353143|516490607|FG000|Overall Study|patient receiving other treatment for AML|0|||
143255731|NCT02353143|516490608|FG001|Overall Study|patient receiving other treatment for AML|0|||
143255732|NCT02353143|516490609|FG002|Overall Study|patient receiving other treatment for AML|1|||
143106567|NCT01867710|515931835|FG000|Overall Study|Disease progression|1|||
143106568|NCT01867710|515931836|FG001|Overall Study|Disease progression|0|||
143106569|NCT01867710|515931837|FG002|Overall Study|Disease progression|0|||
143106570|NCT01867710|515931838|FG003|Overall Study|Disease progression|0|||
143106571|NCT01867710|515931835|FG000|Overall Study|Patient decision|0|||
143106572|NCT01867710|515931836|FG001|Overall Study|Patient decision|0|||
143106573|NCT01867710|515931837|FG002|Overall Study|Patient decision|0|||
143106574|NCT01867710|515931838|FG003|Overall Study|Patient decision|1|||
143106575|NCT01867710|515931835|FG000|Overall Study|Patient to follow subsequent treatment|0|||
143106576|NCT01867710|515931836|FG001|Overall Study|Patient to follow subsequent treatment|1|||
143106577|NCT01867710|515931837|FG002|Overall Study|Patient to follow subsequent treatment|0|||
143106578|NCT01867710|515931838|FG003|Overall Study|Patient to follow subsequent treatment|0|||
143106579|NCT01867710|515931835|FG000|Overall Study|Progressive disease|1|||
143106580|NCT01867710|515931836|FG001|Overall Study|Progressive disease|0|||
143106581|NCT01867710|515931837|FG002|Overall Study|Progressive disease|0|||
143106582|NCT01867710|515931838|FG003|Overall Study|Progressive disease|0|||
143106583|NCT01867710|515931835|FG000|Overall Study|Protocol Violation|0|||
143106584|NCT01867710|515931836|FG001|Overall Study|Protocol Violation|0|||
143106585|NCT01867710|515931837|FG002|Overall Study|Protocol Violation|0|||
143255733|NCT02353143|516490610|FG003|Overall Study|patient receiving other treatment for AML|0|||
143255734|NCT02353143|516490611|FG004|Overall Study|patient receiving other treatment for AML|0|||
143255735|NCT02353143|516490612|FG005|Overall Study|patient receiving other treatment for AML|0|||
143255736|NCT02353143|516490613|FG006|Overall Study|patient receiving other treatment for AML|0|||
143255737|NCT02353143|516490614|FG007|Overall Study|patient receiving other treatment for AML|0|||
143255738|NCT02353143|516490615|FG008|Overall Study|patient receiving other treatment for AML|0|||
143255739|NCT02353143|516490607|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
143255740|NCT02353143|516490608|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
143255741|NCT02353143|516490609|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
143255742|NCT02353143|516490610|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
143255743|NCT02353143|516490611|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
143255744|NCT02353143|516490612|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
143255745|NCT02353143|516490613|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
143255746|NCT02353143|516490614|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
143255747|NCT02353143|516490615|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
143106586|NCT01867710|515931838|FG003|Overall Study|Protocol Violation|1|||
143106587|NCT01867710|515931835|FG000|Overall Study|PSA-progression|0|||
143106588|NCT01867710|515931836|FG001|Overall Study|PSA-progression|1|||
143106589|NCT01867710|515931837|FG002|Overall Study|PSA-progression|0|||
143255748|NCT02095132|516490616|FG000|Overall Study|Adverse Event|0|||
143255749|NCT02095132|516490617|FG001|Overall Study|Adverse Event|0|||
143255750|NCT02095132|516490618|FG002|Overall Study|Adverse Event|0|||
143106590|NCT01867710|515931838|FG003|Overall Study|PSA-progression|0|||
143106591|NCT01867710|515931835|FG000|Overall Study|Study medication no longer effective|0|||
143106592|NCT01867710|515931836|FG001|Overall Study|Study medication no longer effective|1|||
143106593|NCT01867710|515931837|FG002|Overall Study|Study medication no longer effective|0|||
143106594|NCT01867710|515931838|FG003|Overall Study|Study medication no longer effective|0|||
143106595|NCT01471340|515931839|FG000|Overall Study|Death|5|||
143106596|NCT01471340|515931840|FG001|Overall Study|Death|4|||
143106597|NCT01471340|515931839|FG000|Overall Study|Lost to Follow-up|0|||
143106598|NCT01471340|515931840|FG001|Overall Study|Lost to Follow-up|1|||
143106599|NCT01471340|515931839|FG000|Overall Study|Investigational site closure|0|||
143106600|NCT01471340|515931840|FG001|Overall Study|Investigational site closure|1|||
143106601|NCT01471340|515931839|FG000|Overall Study|Invalid informed consent|1|||
143106602|NCT01471340|515931840|FG001|Overall Study|Invalid informed consent|0|||
143106603|NCT00968981|515931841|FG000|Overall Study|Adverse Event|2|||
143106604|NCT00968981|515931842|FG001|Overall Study|Adverse Event|0|||
143106605|NCT00968981|515931843|FG002|Overall Study|Adverse Event|0|||
143106606|NCT00968981|515931841|FG000|Overall Study|Disease Progression|14|||
143106607|NCT00968981|515931842|FG001|Overall Study|Disease Progression|16|||
143106608|NCT00968981|515931843|FG002|Overall Study|Disease Progression|13|||
143106609|NCT00968981|515931841|FG000|Overall Study|Lost to Follow-up|0|||
143106610|NCT00968981|515931842|FG001|Overall Study|Lost to Follow-up|0|||
143106611|NCT00968981|515931843|FG002|Overall Study|Lost to Follow-up|1|||
143106612|NCT00968981|515931841|FG000|Overall Study|Physician Decision|5|||
143106613|NCT00968981|515931842|FG001|Overall Study|Physician Decision|3|||
143106614|NCT00968981|515931843|FG002|Overall Study|Physician Decision|5|||
143106615|NCT00968981|515931841|FG000|Overall Study|Withdrawal by Subject|1|||
143106616|NCT00968981|515931842|FG001|Overall Study|Withdrawal by Subject|3|||
143106617|NCT00968981|515931843|FG002|Overall Study|Withdrawal by Subject|3|||
143106618|NCT03499899|515931847|FG000|Overall Study|Adverse Event|2|||
143106619|NCT03499899|515931848|FG001|Overall Study|Adverse Event|3|||
143106620|NCT03499899|515931849|FG002|Overall Study|Adverse Event|3|||
143106621|NCT03499899|515931847|FG000|Overall Study|Death|0|||
143106622|NCT03499899|515931848|FG001|Overall Study|Death|0|||
143106623|NCT03499899|515931849|FG002|Overall Study|Death|1|||
143106624|NCT03499899|515931847|FG000|Overall Study|Physician Decision|3|||
143106625|NCT03499899|515931848|FG001|Overall Study|Physician Decision|6|||
143106626|NCT03499899|515931849|FG002|Overall Study|Physician Decision|6|||
143106627|NCT03499899|515931847|FG000|Overall Study|Progressive disease|15|||
143106628|NCT03499899|515931848|FG001|Overall Study|Progressive disease|23|||
143106629|NCT03499899|515931849|FG002|Overall Study|Progressive disease|23|||
143106630|NCT03499899|515931847|FG000|Overall Study|Patient decision|0|||
143106631|NCT03499899|515931848|FG001|Overall Study|Patient decision|1|||
143106632|NCT03499899|515931849|FG002|Overall Study|Patient decision|1|||
143106633|NCT03499899|515931847|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
143106634|NCT03499899|515931848|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
143106635|NCT03499899|515931849|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
143106636|NCT01609543|515931854|FG000|Overall Study|Disease Progression|28|||
143106637|NCT01609543|515931854|FG000|Overall Study|Adverse Event|5|||
143106638|NCT01609543|515931854|FG000|Overall Study|Withdrawal by Subject|1|||
143106639|NCT01609543|515931854|FG000|Overall Study|Protocol Violation|1|||
143106640|NCT01609543|515931854|FG000|Overall Study|Death|7|||
143106641|NCT02218736|515931855|FG000|Overall Study|Withdrawal by Subject|10|||
143106642|NCT02218736|515931856|FG001|Overall Study|Withdrawal by Subject|9|||
143106643|NCT02218736|515931855|FG000|Overall Study|Protocol Violation|2|||
143106644|NCT02218736|515931856|FG001|Overall Study|Protocol Violation|0|||
143106645|NCT03702010|515931861|FG000|Follow-up (30days)|Lack of Efficacy|2|||
143106646|NCT03702010|515931862|FG001|Follow-up (30days)|Lack of Efficacy|2|||
143255751|NCT02095132|516490619|FG003|Overall Study|Adverse Event|0|||
143255752|NCT02095132|516490620|FG004|Overall Study|Adverse Event|1|||
143255753|NCT02095132|516490621|FG005|Overall Study|Adverse Event|0|||
143106647|NCT01254318|515931863|FG000|Overall Study|Lost to Follow-up|5|||
143106648|NCT01254318|515931863|FG000|Overall Study|Death|47|||
143106649|NCT04016779|515931874|FG000|Overall Study|Adverse Event|9|||
143106650|NCT04016779|515931875|FG001|Overall Study|Adverse Event|17|||
143106651|NCT04016779|515931874|FG000|Overall Study|Lack of Efficacy|4|||
143106652|NCT04016779|515931875|FG001|Overall Study|Lack of Efficacy|1|||
143106653|NCT04016779|515931874|FG000|Overall Study|Lost to Follow-up|5|||
143255754|NCT02095132|516490622|FG006|Overall Study|Adverse Event|1|||
143106654|NCT04016779|515931875|FG001|Overall Study|Lost to Follow-up|14|||
143255755|NCT02095132|516490623|FG007|Overall Study|Adverse Event|0|||
143106655|NCT04016779|515931874|FG000|Overall Study|Physician Decision|1|||
143106656|NCT04016779|515931875|FG001|Overall Study|Physician Decision|3|||
143106657|NCT04016779|515931874|FG000|Overall Study|Withdrawal by Subject|6|||
143255756|NCT02095132|516490624|FG008|Overall Study|Adverse Event|0|||
143106658|NCT04016779|515931875|FG001|Overall Study|Withdrawal by Subject|8|||
143106659|NCT04016779|515931874|FG000|Overall Study|Non-compliance with Study Drug|2|||
143106660|NCT04016779|515931875|FG001|Overall Study|Non-compliance with Study Drug|3|||
143255757|NCT02095132|516490616|FG000|Overall Study|Death|0|||
143367959|NCT01956669|516890842|FG002|Overall Study|Physician Decision|0|||
143367960|NCT01956669|516890843|FG003|Overall Study|Physician Decision|0|||
143367961|NCT01956669|516890844|FG004|Overall Study|Physician Decision|0|||
143106661|NCT04016779|515931874|FG000|Overall Study|Other, Multiple categories|17|||
143106662|NCT04016779|515931875|FG001|Overall Study|Other, Multiple categories|17|||
143106663|NCT02295020|515931876|FG000|Overall Study|Adverse Event|0|||
143106664|NCT02295020|515931877|FG001|Overall Study|Adverse Event|1|||
143106665|NCT02295020|515931876|FG000|Overall Study|Withdrawal by Subject|3|||
143106666|NCT02295020|515931877|FG001|Overall Study|Withdrawal by Subject|2|||
143106667|NCT01137110|515931878|FG000|Overall Study|Protocol Violation|1|||
143106668|NCT01137110|515931879|FG001|Overall Study|Protocol Violation|0|||
143106669|NCT02394340|515931888|FG000|Overall Study|Failed drug screen test|1|||
143106670|NCT02394340|515931888|FG000|Overall Study|Adverse Event|1|||
143106671|NCT02828124|515931889|FG000|Overall Study|Disease Progression|1|||
143106672|NCT02828124|515931890|FG001|Overall Study|Disease Progression|2|||
143106673|NCT02828124|515931891|FG002|Overall Study|Disease Progression|1|||
143106674|NCT02828124|515931892|FG003|Overall Study|Disease Progression|4|||
143106675|NCT02828124|515931889|FG000|Overall Study|AE Unrelated to Study Drug|0|||
143106676|NCT02828124|515931890|FG001|Overall Study|AE Unrelated to Study Drug|0|||
143106677|NCT02828124|515931891|FG002|Overall Study|AE Unrelated to Study Drug|0|||
143106678|NCT02828124|515931892|FG003|Overall Study|AE Unrelated to Study Drug|1|||
143106679|NCT02828124|515931889|FG000|Overall Study|Subject Withdrew Consent|0|||
143106680|NCT02828124|515931890|FG001|Overall Study|Subject Withdrew Consent|0|||
143106681|NCT02828124|515931891|FG002|Overall Study|Subject Withdrew Consent|0|||
143106682|NCT02828124|515931892|FG003|Overall Study|Subject Withdrew Consent|1|||
143106683|NCT00747474|515931893|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
143106684|NCT00747474|515931894|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
143106685|NCT00747474|515931895|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
143106686|NCT00747474|515931896|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
143106687|NCT00747474|515931897|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
143106688|NCT00747474|515931898|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
143178771|NCT01244035|516203605|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
143178772|NCT01244035|516203606|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
143178773|NCT01244035|516203607|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
143178774|NCT01244035|516203608|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
143178775|NCT01244035|516203603|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
143178776|NCT01244035|516203604|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
143178777|NCT01244035|516203605|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
143178778|NCT01244035|516203606|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
143178779|NCT01244035|516203607|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
143178780|NCT01244035|516203608|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
143178781|NCT01244035|516203603|FG000|Part 1: Period 3|Adverse Event|0|||
143178782|NCT01244035|516203604|FG001|Part 1: Period 3|Adverse Event|0|||
143178783|NCT01244035|516203605|FG002|Part 1: Period 3|Adverse Event|0|||
143178784|NCT01244035|516203606|FG003|Part 1: Period 3|Adverse Event|0|||
143178785|NCT01244035|516203607|FG004|Part 1: Period 3|Adverse Event|0|||
143178786|NCT01244035|516203608|FG005|Part 1: Period 3|Adverse Event|1|||
143178787|NCT01244035|516203603|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
143178788|NCT01244035|516203604|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
143178789|NCT01244035|516203605|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
143178790|NCT01244035|516203606|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
143178791|NCT01244035|516203607|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
143178792|NCT01244035|516203608|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
143178793|NCT01244035|516203603|FG000|Part 1: Period 3|Protocol Deviation|0|||
143178794|NCT01244035|516203604|FG001|Part 1: Period 3|Protocol Deviation|1|||
143178795|NCT01244035|516203605|FG002|Part 1: Period 3|Protocol Deviation|0|||
143178796|NCT01244035|516203606|FG003|Part 1: Period 3|Protocol Deviation|0|||
143178797|NCT01244035|516203607|FG004|Part 1: Period 3|Protocol Deviation|0|||
143178798|NCT01244035|516203608|FG005|Part 1: Period 3|Protocol Deviation|0|||
143178799|NCT03688919|516203609|FG000|Overall Study|Lost to Follow-up|2|||
143178800|NCT03688919|516203610|FG001|Overall Study|Lost to Follow-up|1|||
143178801|NCT03688919|516203609|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
143106689|NCT00747474|515931899|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
143106690|NCT00747474|515931900|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
143106691|NCT00747474|515931901|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
143178802|NCT03688919|516203610|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
143178803|NCT03198767|516203612|FG000|Overall Study|Protocol Violation|0|||
143178804|NCT03198767|516203613|FG001|Overall Study|Protocol Violation|0|||
143178805|NCT03198767|516203614|FG002|Overall Study|Protocol Violation|0|||
143178806|NCT03198767|516203615|FG003|Overall Study|Protocol Violation|6|||
143367962|NCT01956669|516890845|FG005|Overall Study|Physician Decision|1|||
143255758|NCT02095132|516490617|FG001|Overall Study|Death|0|||
143255759|NCT02095132|516490618|FG002|Overall Study|Death|0|||
143255760|NCT02095132|516490619|FG003|Overall Study|Death|0|||
143255761|NCT02095132|516490620|FG004|Overall Study|Death|0|||
143255762|NCT02095132|516490621|FG005|Overall Study|Death|0|||
143255763|NCT02095132|516490622|FG006|Overall Study|Death|1|||
143106692|NCT00747474|515931902|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
143106693|NCT00747474|515931903|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
143106694|NCT00747474|515931904|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
143106695|NCT02829723|515931906|FG000|Overall Study|Adverse Event|0|||
143106696|NCT02829723|515931907|FG001|Overall Study|Adverse Event|0|||
143106697|NCT02829723|515931908|FG002|Overall Study|Adverse Event|1|||
143106698|NCT02829723|515931909|FG003|Overall Study|Adverse Event|1|||
143106699|NCT02829723|515931910|FG004|Overall Study|Adverse Event|0|||
143106700|NCT02829723|515931911|FG005|Overall Study|Adverse Event|0|||
143106701|NCT02829723|515931912|FG006|Overall Study|Adverse Event|0|||
143106702|NCT02829723|515931913|FG007|Overall Study|Adverse Event|1|||
143106703|NCT02829723|515931914|FG008|Overall Study|Adverse Event|0|||
143106704|NCT02829723|515931915|FG009|Overall Study|Adverse Event|0|||
143106705|NCT02829723|515931916|FG010|Overall Study|Adverse Event|0|||
143106706|NCT02829723|515931917|FG011|Overall Study|Adverse Event|0|||
143106707|NCT02829723|515931918|FG012|Overall Study|Adverse Event|0|||
143106708|NCT02829723|515931919|FG013|Overall Study|Adverse Event|0|||
143106709|NCT02829723|515931920|FG014|Overall Study|Adverse Event|1|||
143106710|NCT02829723|515931921|FG015|Overall Study|Adverse Event|1|||
143106711|NCT02829723|515931922|FG016|Overall Study|Adverse Event|1|||
143106712|NCT02829723|515931923|FG017|Overall Study|Adverse Event|2|||
143106713|NCT02829723|515931924|FG018|Overall Study|Adverse Event|1|||
143106714|NCT02829723|515931925|FG019|Overall Study|Adverse Event|1|||
143106715|NCT02829723|515931926|FG020|Overall Study|Adverse Event|3|||
143106716|NCT02829723|515931927|FG021|Overall Study|Adverse Event|0|||
143106717|NCT02829723|515931928|FG022|Overall Study|Adverse Event|0|||
143106718|NCT02829723|515931929|FG023|Overall Study|Adverse Event|1|||
143106719|NCT02829723|515931930|FG024|Overall Study|Adverse Event|1|||
143106720|NCT02829723|515931931|FG025|Overall Study|Adverse Event|3|||
143106721|NCT02829723|515931932|FG026|Overall Study|Adverse Event|5|||
143106722|NCT02829723|515931906|FG000|Overall Study|Death|1|||
143106723|NCT02829723|515931907|FG001|Overall Study|Death|0|||
143106724|NCT02829723|515931908|FG002|Overall Study|Death|1|||
143106725|NCT02829723|515931909|FG003|Overall Study|Death|1|||
143106726|NCT02829723|515931910|FG004|Overall Study|Death|0|||
143106727|NCT02829723|515931911|FG005|Overall Study|Death|0|||
143106728|NCT02829723|515931912|FG006|Overall Study|Death|2|||
143106729|NCT02829723|515931913|FG007|Overall Study|Death|0|||
143106730|NCT02829723|515931914|FG008|Overall Study|Death|1|||
143106731|NCT02829723|515931915|FG009|Overall Study|Death|0|||
143106732|NCT02829723|515931916|FG010|Overall Study|Death|0|||
143106733|NCT02829723|515931917|FG011|Overall Study|Death|0|||
143106734|NCT02829723|515931918|FG012|Overall Study|Death|2|||
143106735|NCT02829723|515931919|FG013|Overall Study|Death|1|||
143106736|NCT02829723|515931920|FG014|Overall Study|Death|0|||
143106737|NCT02829723|515931921|FG015|Overall Study|Death|0|||
143106738|NCT02829723|515931922|FG016|Overall Study|Death|0|||
143106739|NCT02829723|515931923|FG017|Overall Study|Death|0|||
143106740|NCT02829723|515931924|FG018|Overall Study|Death|0|||
143106741|NCT02829723|515931925|FG019|Overall Study|Death|0|||
143106742|NCT02829723|515931926|FG020|Overall Study|Death|0|||
143106743|NCT02829723|515931927|FG021|Overall Study|Death|2|||
143106744|NCT02829723|515931928|FG022|Overall Study|Death|0|||
143106745|NCT02829723|515931929|FG023|Overall Study|Death|0|||
143106746|NCT02829723|515931930|FG024|Overall Study|Death|0|||
143106747|NCT02829723|515931931|FG025|Overall Study|Death|1|||
143106748|NCT02829723|515931932|FG026|Overall Study|Death|2|||
143255764|NCT02095132|516490623|FG007|Overall Study|Death|0|||
143367963|NCT01956669|516890846|FG006|Overall Study|Physician Decision|0|||
143106749|NCT02829723|515931906|FG000|Overall Study|Physician Decision|0|||
143106750|NCT02829723|515931907|FG001|Overall Study|Physician Decision|0|||
143106751|NCT02829723|515931908|FG002|Overall Study|Physician Decision|0|||
143106752|NCT02829723|515931909|FG003|Overall Study|Physician Decision|0|||
143106753|NCT02829723|515931910|FG004|Overall Study|Physician Decision|0|||
143255765|NCT02095132|516490624|FG008|Overall Study|Death|0|||
143255766|NCT02095132|516490616|FG000|Overall Study|Lack of Efficacy|3|||
143106754|NCT02829723|515931911|FG005|Overall Study|Physician Decision|0|||
143106755|NCT02829723|515931912|FG006|Overall Study|Physician Decision|0|||
143106756|NCT02829723|515931913|FG007|Overall Study|Physician Decision|0|||
143106757|NCT02829723|515931914|FG008|Overall Study|Physician Decision|0|||
143255767|NCT02095132|516490617|FG001|Overall Study|Lack of Efficacy|5|||
143106758|NCT02829723|515931915|FG009|Overall Study|Physician Decision|1|||
143106759|NCT02829723|515931916|FG010|Overall Study|Physician Decision|1|||
143106760|NCT02829723|515931917|FG011|Overall Study|Physician Decision|0|||
143106761|NCT02829723|515931918|FG012|Overall Study|Physician Decision|0|||
143255768|NCT02095132|516490618|FG002|Overall Study|Lack of Efficacy|2|||
143255769|NCT02095132|516490619|FG003|Overall Study|Lack of Efficacy|8|||
143255770|NCT02095132|516490620|FG004|Overall Study|Lack of Efficacy|3|||
143255771|NCT02095132|516490621|FG005|Overall Study|Lack of Efficacy|6|||
143255772|NCT02095132|516490622|FG006|Overall Study|Lack of Efficacy|10|||
143255773|NCT02095132|516490623|FG007|Overall Study|Lack of Efficacy|9|||
143255774|NCT02095132|516490624|FG008|Overall Study|Lack of Efficacy|8|||
143255775|NCT02095132|516490616|FG000|Overall Study|Physician Decision|1|||
143255776|NCT02095132|516490617|FG001|Overall Study|Physician Decision|0|||
143255777|NCT02095132|516490618|FG002|Overall Study|Physician Decision|0|||
143255778|NCT02095132|516490619|FG003|Overall Study|Physician Decision|0|||
143255779|NCT02095132|516490620|FG004|Overall Study|Physician Decision|0|||
143255780|NCT02095132|516490621|FG005|Overall Study|Physician Decision|0|||
143255781|NCT02095132|516490622|FG006|Overall Study|Physician Decision|1|||
143255782|NCT02095132|516490623|FG007|Overall Study|Physician Decision|0|||
143255783|NCT02095132|516490624|FG008|Overall Study|Physician Decision|2|||
143255784|NCT02095132|516490616|FG000|Overall Study|Withdrawal by Subject|0|||
143255785|NCT02095132|516490617|FG001|Overall Study|Withdrawal by Subject|0|||
143255786|NCT02095132|516490618|FG002|Overall Study|Withdrawal by Subject|2|||
143255787|NCT02095132|516490619|FG003|Overall Study|Withdrawal by Subject|2|||
143255788|NCT02095132|516490620|FG004|Overall Study|Withdrawal by Subject|3|||
143255789|NCT02095132|516490621|FG005|Overall Study|Withdrawal by Subject|0|||
143255790|NCT02095132|516490622|FG006|Overall Study|Withdrawal by Subject|5|||
143255791|NCT02095132|516490623|FG007|Overall Study|Withdrawal by Subject|0|||
143255792|NCT02095132|516490624|FG008|Overall Study|Withdrawal by Subject|0|||
143255793|NCT00409175|516490625|FG000|Overall Study|Adverse Event|4|||
143255794|NCT00409175|516490626|FG001|Overall Study|Adverse Event|3|||
143255795|NCT00409175|516490625|FG000|Overall Study|Withdrawal by Subject|1|||
143255796|NCT00409175|516490626|FG001|Overall Study|Withdrawal by Subject|2|||
143255797|NCT00409175|516490625|FG000|Overall Study|Negative genotype|0|||
143255798|NCT00409175|516490626|FG001|Overall Study|Negative genotype|1|||
143255799|NCT00409175|516490625|FG000|Overall Study|Liver transplantation|13|||
143255800|NCT00409175|516490626|FG001|Overall Study|Liver transplantation|13|||
143255801|NCT02108262|516490629|FG000|Overall Study|Non-compliance|0|||
143255802|NCT02108262|516490630|FG001|Overall Study|Non-compliance|2|||
143255803|NCT02108262|516490631|FG002|Overall Study|Non-compliance|1|||
143255804|NCT02108262|516490632|FG003|Overall Study|Non-compliance|1|||
143255805|NCT02108262|516490629|FG000|Overall Study|Randomized by error/screen failure|0|||
143255806|NCT02108262|516490630|FG001|Overall Study|Randomized by error/screen failure|0|||
143255807|NCT02108262|516490631|FG002|Overall Study|Randomized by error/screen failure|1|||
143255808|NCT02108262|516490632|FG003|Overall Study|Randomized by error/screen failure|0|||
143255809|NCT02108262|516490629|FG000|Overall Study|Distance to center|0|||
143255810|NCT02108262|516490630|FG001|Overall Study|Distance to center|1|||
143255811|NCT02108262|516490631|FG002|Overall Study|Distance to center|1|||
143255812|NCT02108262|516490632|FG003|Overall Study|Distance to center|0|||
143255813|NCT02108262|516490629|FG000|Overall Study|Adverse Event|0|||
143255814|NCT02108262|516490630|FG001|Overall Study|Adverse Event|11|||
143255815|NCT02108262|516490631|FG002|Overall Study|Adverse Event|6|||
143255816|NCT02108262|516490632|FG003|Overall Study|Adverse Event|12|||
143255817|NCT02108262|516490629|FG000|Overall Study|Death|0|||
143255818|NCT02108262|516490630|FG001|Overall Study|Death|2|||
143255819|NCT02108262|516490631|FG002|Overall Study|Death|2|||
143255820|NCT02108262|516490632|FG003|Overall Study|Death|1|||
143255821|NCT02108262|516490629|FG000|Overall Study|Lost to Follow-up|0|||
143255822|NCT02108262|516490630|FG001|Overall Study|Lost to Follow-up|0|||
143255823|NCT02108262|516490631|FG002|Overall Study|Lost to Follow-up|1|||
143255824|NCT02108262|516490632|FG003|Overall Study|Lost to Follow-up|0|||
143255825|NCT02108262|516490629|FG000|Overall Study|Physician Decision|0|||
143255826|NCT02108262|516490630|FG001|Overall Study|Physician Decision|0|||
143255827|NCT02108262|516490631|FG002|Overall Study|Physician Decision|2|||
143255828|NCT02108262|516490632|FG003|Overall Study|Physician Decision|0|||
143255829|NCT02108262|516490629|FG000|Overall Study|Withdrawal by Subject|0|||
143255830|NCT02108262|516490630|FG001|Overall Study|Withdrawal by Subject|7|||
143255831|NCT02108262|516490631|FG002|Overall Study|Withdrawal by Subject|3|||
143255832|NCT02108262|516490632|FG003|Overall Study|Withdrawal by Subject|4|||
143255833|NCT02108262|516490629|FG000|Overall Study|Due to key hepatic values|0|||
143255834|NCT02108262|516490630|FG001|Overall Study|Due to key hepatic values|1|||
143255835|NCT02108262|516490631|FG002|Overall Study|Due to key hepatic values|0|||
143255836|NCT02108262|516490632|FG003|Overall Study|Due to key hepatic values|0|||
143255837|NCT02108262|516490629|FG000|Overall Study|Unable to contact patient|0|||
143255838|NCT02108262|516490630|FG001|Overall Study|Unable to contact patient|3|||
143255839|NCT02108262|516490631|FG002|Overall Study|Unable to contact patient|1|||
143255840|NCT02108262|516490632|FG003|Overall Study|Unable to contact patient|2|||
143255841|NCT02108262|516490629|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
143255842|NCT02108262|516490630|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
143255843|NCT02108262|516490631|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
143255844|NCT02108262|516490632|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
143255845|NCT02108262|516490629|FG000|Overall Study|Patient did not want another infusion|0|||
143255846|NCT02108262|516490630|FG001|Overall Study|Patient did not want another infusion|3|||
143255847|NCT02108262|516490631|FG002|Overall Study|Patient did not want another infusion|3|||
143255848|NCT02108262|516490632|FG003|Overall Study|Patient did not want another infusion|2|||
143255849|NCT02108262|516490629|FG000|Overall Study|Vacation|0|||
143255850|NCT02108262|516490630|FG001|Overall Study|Vacation|1|||
143255851|NCT02108262|516490631|FG002|Overall Study|Vacation|0|||
143255852|NCT02108262|516490632|FG003|Overall Study|Vacation|0|||
143255853|NCT02108262|516490629|FG000|Overall Study|Patient decision|0|||
143106762|NCT02829723|515931919|FG013|Overall Study|Physician Decision|1|||
143106763|NCT02829723|515931920|FG014|Overall Study|Physician Decision|0|||
143106764|NCT02829723|515931921|FG015|Overall Study|Physician Decision|0|||
143106765|NCT02829723|515931922|FG016|Overall Study|Physician Decision|2|||
143106766|NCT02829723|515931923|FG017|Overall Study|Physician Decision|0|||
143106767|NCT02829723|515931924|FG018|Overall Study|Physician Decision|0|||
143106768|NCT02829723|515931925|FG019|Overall Study|Physician Decision|0|||
143106769|NCT02829723|515931926|FG020|Overall Study|Physician Decision|0|||
143106770|NCT02829723|515931927|FG021|Overall Study|Physician Decision|0|||
143255854|NCT02108262|516490630|FG001|Overall Study|Patient decision|7|||
143255855|NCT02108262|516490631|FG002|Overall Study|Patient decision|9|||
143255856|NCT02108262|516490632|FG003|Overall Study|Patient decision|14|||
143255857|NCT02108262|516490629|FG000|Overall Study|Missed IV due to pharmacy error|0|||
143255858|NCT02108262|516490630|FG001|Overall Study|Missed IV due to pharmacy error|0|||
143255859|NCT02108262|516490631|FG002|Overall Study|Missed IV due to pharmacy error|1|||
143255860|NCT02108262|516490632|FG003|Overall Study|Missed IV due to pharmacy error|0|||
143255861|NCT00247611|516490639|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
143255862|NCT00247611|516490640|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
143106771|NCT02829723|515931928|FG022|Overall Study|Physician Decision|1|||
143255863|NCT00247611|516490639|FG000|Baselined|Completed baseline only|9|||
143255864|NCT00247611|516490640|FG001|Baselined|Completed baseline only|8|||
143255865|NCT01509053|516490641|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
143255866|NCT01509053|516490641|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
143255867|NCT01509053|516490641|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
143106772|NCT02829723|515931929|FG023|Overall Study|Physician Decision|1|||
143106773|NCT02829723|515931930|FG024|Overall Study|Physician Decision|1|||
143106774|NCT02829723|515931931|FG025|Overall Study|Physician Decision|1|||
143367964|NCT01956669|516890840|FG000|Overall Study|Withdrawal by Subject|0|||
143367965|NCT01956669|516890841|FG001|Overall Study|Withdrawal by Subject|0|||
143367966|NCT01956669|516890842|FG002|Overall Study|Withdrawal by Subject|1|||
143255868|NCT01509053|516490641|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
143255869|NCT01509053|516490641|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
143255870|NCT01509053|516490641|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
143255871|NCT00796991|516490643|FG000|Overall Study|Adverse Event|0|||
143255872|NCT00796991|516490644|FG001|Overall Study|Adverse Event|0|||
143255873|NCT00796991|516490645|FG002|Overall Study|Adverse Event|1|||
143255874|NCT00796991|516490643|FG000|Overall Study|Death|2|||
143255875|NCT00796991|516490644|FG001|Overall Study|Death|0|||
143255876|NCT00796991|516490645|FG002|Overall Study|Death|0|||
143255877|NCT00796991|516490643|FG000|Overall Study|Disease Progression|10|||
143255878|NCT00796991|516490644|FG001|Overall Study|Disease Progression|9|||
143255879|NCT00796991|516490645|FG002|Overall Study|Disease Progression|7|||
143255880|NCT00796991|516490643|FG000|Overall Study|Study Drug Toxicity|3|||
143255881|NCT00796991|516490644|FG001|Overall Study|Study Drug Toxicity|3|||
143255882|NCT00796991|516490645|FG002|Overall Study|Study Drug Toxicity|5|||
143255883|NCT00796991|516490643|FG000|Overall Study|Withdrawal by Subject|0|||
143255884|NCT00796991|516490644|FG001|Overall Study|Withdrawal by Subject|0|||
143255885|NCT00796991|516490645|FG002|Overall Study|Withdrawal by Subject|1|||
143255886|NCT00313781|516490646|FG000|Before Crossover|Death|22|||
143255887|NCT00313781|516490647|FG001|Before Crossover|Death|8|||
143255888|NCT00313781|516490648|FG002|Before Crossover|Death|0|||
143255889|NCT00313781|516490646|FG000|Before Crossover|Lost to Follow-up|0|||
143106775|NCT02829723|515931932|FG026|Overall Study|Physician Decision|3|||
143106776|NCT02829723|515931906|FG000|Overall Study|Progressive disease|4|||
143106777|NCT02829723|515931907|FG001|Overall Study|Progressive disease|6|||
143106778|NCT02829723|515931908|FG002|Overall Study|Progressive disease|3|||
143106779|NCT02829723|515931909|FG003|Overall Study|Progressive disease|3|||
143106780|NCT02829723|515931910|FG004|Overall Study|Progressive disease|3|||
143106781|NCT02829723|515931911|FG005|Overall Study|Progressive disease|5|||
143106782|NCT02829723|515931912|FG006|Overall Study|Progressive disease|4|||
143106783|NCT02829723|515931913|FG007|Overall Study|Progressive disease|6|||
143106784|NCT02829723|515931914|FG008|Overall Study|Progressive disease|8|||
143106785|NCT02829723|515931915|FG009|Overall Study|Progressive disease|4|||
143106786|NCT02829723|515931916|FG010|Overall Study|Progressive disease|9|||
143106787|NCT02829723|515931917|FG011|Overall Study|Progressive disease|0|||
143106788|NCT02829723|515931918|FG012|Overall Study|Progressive disease|3|||
143106789|NCT02829723|515931919|FG013|Overall Study|Progressive disease|4|||
143106790|NCT02829723|515931920|FG014|Overall Study|Progressive disease|2|||
143106791|NCT02829723|515931921|FG015|Overall Study|Progressive disease|4|||
143106792|NCT02829723|515931922|FG016|Overall Study|Progressive disease|5|||
143106793|NCT02829723|515931923|FG017|Overall Study|Progressive disease|3|||
143106794|NCT02829723|515931924|FG018|Overall Study|Progressive disease|4|||
143106795|NCT02829723|515931925|FG019|Overall Study|Progressive disease|4|||
143106796|NCT02829723|515931926|FG020|Overall Study|Progressive disease|7|||
143106797|NCT02829723|515931927|FG021|Overall Study|Progressive disease|6|||
143106798|NCT02829723|515931928|FG022|Overall Study|Progressive disease|3|||
143106799|NCT02829723|515931929|FG023|Overall Study|Progressive disease|3|||
143106800|NCT02829723|515931930|FG024|Overall Study|Progressive disease|3|||
143178807|NCT03198767|516203616|FG004|Overall Study|Protocol Violation|0|||
143178808|NCT03198767|516203617|FG005|Overall Study|Protocol Violation|0|||
143178809|NCT03198767|516203618|FG006|Overall Study|Protocol Violation|0|||
143178810|NCT00570323|516203619|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
143178811|NCT00570323|516203620|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
143178812|NCT00570323|516203619|FG000|Started Treatment After Randomization|Protocol Violation|1|||
143178813|NCT00570323|516203620|FG001|Started Treatment After Randomization|Protocol Violation|0|||
143178814|NCT00570323|516203619|FG000|Started Treatment After Randomization|Physician Decision|1|||
143178815|NCT00570323|516203620|FG001|Started Treatment After Randomization|Physician Decision|0|||
143178816|NCT00570323|516203619|FG000|Complete Study After Start|Lost to Follow-up|0|||
143178817|NCT00570323|516203620|FG001|Complete Study After Start|Lost to Follow-up|1|||
143178818|NCT00570323|516203619|FG000|Complete Study After Start|Withdrawal by Subject|2|||
143178819|NCT00570323|516203620|FG001|Complete Study After Start|Withdrawal by Subject|0|||
143255890|NCT00313781|516490647|FG001|Before Crossover|Lost to Follow-up|3|||
143255891|NCT00313781|516490648|FG002|Before Crossover|Lost to Follow-up|0|||
143255892|NCT00313781|516490646|FG000|Before Crossover|Withdrawal by Subject|3|||
143106801|NCT02829723|515931931|FG025|Overall Study|Progressive disease|16|||
143106802|NCT02829723|515931932|FG026|Overall Study|Progressive disease|10|||
143106803|NCT02829723|515931906|FG000|Overall Study|Subject/guardian decision|0|||
143106804|NCT02829723|515931907|FG001|Overall Study|Subject/guardian decision|1|||
143178820|NCT00570323|516203619|FG000|Complete Study After Start|Physician Decision|1|||
143178821|NCT00570323|516203620|FG001|Complete Study After Start|Physician Decision|0|||
143178822|NCT02639247|516203621|FG000|Overall Study|Lost to Follow-up|2|||
143178823|NCT02639247|516203622|FG001|Overall Study|Lost to Follow-up|1|||
143178824|NCT02639247|516203621|FG000|Overall Study|Death|2|||
143178825|NCT02639247|516203622|FG001|Overall Study|Death|0|||
143178826|NCT02639247|516203621|FG000|Overall Study|Withdrew Consent|0|||
143178827|NCT02639247|516203622|FG001|Overall Study|Withdrew Consent|1|||
143178828|NCT02639247|516203621|FG000|Overall Study|Protocol Violation|1|||
143178829|NCT02639247|516203622|FG001|Overall Study|Protocol Violation|0|||
143178830|NCT00413660|516203623|FG000|Up To Week 12|Adverse Event|1|||
143178831|NCT00413660|516203624|FG001|Up To Week 12|Adverse Event|3|||
143178832|NCT00413660|516203625|FG002|Up To Week 12|Adverse Event|1|||
143178833|NCT00413660|516203626|FG003|Up To Week 12|Adverse Event|4|||
143178834|NCT00413660|516203627|FG004|Up To Week 12|Adverse Event|6|||
143178835|NCT00413660|516203628|FG005|Up To Week 12|Adverse Event|4|||
143178836|NCT00413660|516203629|FG006|Up To Week 12|Adverse Event|1|||
143178837|NCT00413660|516203630|FG007|Up To Week 12|Adverse Event|0|||
143255893|NCT00313781|516490647|FG001|Before Crossover|Withdrawal by Subject|1|||
143255894|NCT00313781|516490648|FG002|Before Crossover|Withdrawal by Subject|0|||
143255895|NCT00313781|516490646|FG000|Before Crossover|Other|45|||
143255896|NCT00313781|516490647|FG001|Before Crossover|Other|30|||
143255897|NCT00313781|516490648|FG002|Before Crossover|Other|0|||
143255898|NCT00313781|516490646|FG000|Before Crossover|Crossover|0|||
143255899|NCT00313781|516490647|FG001|Before Crossover|Crossover|37|||
143255900|NCT00313781|516490648|FG002|Before Crossover|Crossover|0|||
143255901|NCT00313781|516490646|FG000|Before Crossover|Randomized, not treated|5|||
143255902|NCT00313781|516490647|FG001|Before Crossover|Randomized, not treated|0|||
143255903|NCT00313781|516490648|FG002|Before Crossover|Randomized, not treated|0|||
143255904|NCT00313781|516490646|FG000|After Crossover|Death|0|||
143255905|NCT00313781|516490647|FG001|After Crossover|Death|0|||
143255906|NCT00313781|516490648|FG002|After Crossover|Death|6|||
143255907|NCT00313781|516490646|FG000|After Crossover|Withdrawal by Subject|0|||
143255908|NCT00313781|516490647|FG001|After Crossover|Withdrawal by Subject|0|||
143255909|NCT00313781|516490648|FG002|After Crossover|Withdrawal by Subject|3|||
143255910|NCT00313781|516490646|FG000|After Crossover|Other|0|||
143255911|NCT00313781|516490647|FG001|After Crossover|Other|0|||
143255912|NCT00313781|516490648|FG002|After Crossover|Other|18|||
143255913|NCT03567343|516490649|FG000|Overall Study|Lost to Follow-up|2|||
143255914|NCT03567343|516490650|FG001|Overall Study|Lost to Follow-up|1|||
143255915|NCT03567343|516490649|FG000|Overall Study|No longer eligible|2|||
143255916|NCT03567343|516490650|FG001|Overall Study|No longer eligible|1|||
143255917|NCT03567343|516490649|FG000|Overall Study|Adverse Event|1|||
143255918|NCT03567343|516490650|FG001|Overall Study|Adverse Event|0|||
143255919|NCT03567343|516490649|FG000|Overall Study|Protocol Violation|1|||
143255920|NCT03567343|516490650|FG001|Overall Study|Protocol Violation|1|||
143255921|NCT01433250|516490651|FG000|Overall Study|Protocol Violation|0|||
143255922|NCT01433250|516490652|FG001|Overall Study|Protocol Violation|1|||
143255923|NCT01433250|516490651|FG000|Overall Study|Withdrawal by Subject|3|||
143255924|NCT01433250|516490652|FG001|Overall Study|Withdrawal by Subject|2|||
143255925|NCT03148691|516490653|FG000|Overall Study|Protocol Violation|1|||
143255926|NCT03148691|516490654|FG001|Overall Study|Protocol Violation|2|||
143178838|NCT00413660|516203631|FG008|Up To Week 12|Adverse Event|0|||
143178839|NCT00413660|516203632|FG009|Up To Week 12|Adverse Event|0|||
143178840|NCT00413660|516203633|FG010|Up To Week 12|Adverse Event|0|||
143178841|NCT00413660|516203623|FG000|Up To Week 12|Lack of Efficacy|2|||
143178842|NCT00413660|516203624|FG001|Up To Week 12|Lack of Efficacy|0|||
143178843|NCT00413660|516203625|FG002|Up To Week 12|Lack of Efficacy|0|||
143178844|NCT00413660|516203626|FG003|Up To Week 12|Lack of Efficacy|0|||
143255927|NCT03148691|516490655|FG002|Overall Study|Protocol Violation|7|||
143255928|NCT03148691|516490653|FG000|Overall Study|Lost to Follow-up|0|||
143255929|NCT03148691|516490654|FG001|Overall Study|Lost to Follow-up|0|||
143255930|NCT03148691|516490655|FG002|Overall Study|Lost to Follow-up|1|||
143255931|NCT03148691|516490653|FG000|Overall Study|Other|1|||
143255932|NCT03148691|516490654|FG001|Overall Study|Other|0|||
143255933|NCT03148691|516490655|FG002|Overall Study|Other|0|||
143255934|NCT03148691|516490653|FG000|Overall Study|Withdrawal by Subject|1|||
143255935|NCT03148691|516490654|FG001|Overall Study|Withdrawal by Subject|0|||
143255936|NCT03148691|516490655|FG002|Overall Study|Withdrawal by Subject|0|||
143255937|NCT00171834|516490656|FG000|Overall Study|Adverse Event|2|||
143255938|NCT00171834|516490657|FG001|Overall Study|Adverse Event|1|||
143255939|NCT00171834|516490658|FG002|Overall Study|Adverse Event|3|||
143255940|NCT00171834|516490659|FG003|Overall Study|Adverse Event|2|||
143255941|NCT00171834|516490660|FG004|Overall Study|Adverse Event|2|||
143255942|NCT00171834|516490661|FG005|Overall Study|Adverse Event|15|||
143255943|NCT00171834|516490662|FG006|Overall Study|Adverse Event|1|||
143178845|NCT00413660|516203627|FG004|Up To Week 12|Lack of Efficacy|0|||
143178846|NCT00413660|516203628|FG005|Up To Week 12|Lack of Efficacy|0|||
143178847|NCT00413660|516203629|FG006|Up To Week 12|Lack of Efficacy|5|||
143178848|NCT00413660|516203630|FG007|Up To Week 12|Lack of Efficacy|0|||
143178849|NCT00413660|516203631|FG008|Up To Week 12|Lack of Efficacy|0|||
143255944|NCT00171834|516490656|FG000|Overall Study|Withdrawal by Subject|0|||
143255945|NCT00171834|516490657|FG001|Overall Study|Withdrawal by Subject|2|||
143255946|NCT00171834|516490658|FG002|Overall Study|Withdrawal by Subject|0|||
143255947|NCT00171834|516490659|FG003|Overall Study|Withdrawal by Subject|1|||
143255948|NCT00171834|516490660|FG004|Overall Study|Withdrawal by Subject|1|||
143255949|NCT00171834|516490661|FG005|Overall Study|Withdrawal by Subject|1|||
143255950|NCT00171834|516490662|FG006|Overall Study|Withdrawal by Subject|0|||
143255951|NCT00171834|516490656|FG000|Overall Study|Death from study indication|0|||
143255952|NCT00171834|516490657|FG001|Overall Study|Death from study indication|1|||
143178850|NCT00413660|516203632|FG009|Up To Week 12|Lack of Efficacy|0|||
143255953|NCT00171834|516490658|FG002|Overall Study|Death from study indication|0|||
143255954|NCT00171834|516490659|FG003|Overall Study|Death from study indication|0|||
143255955|NCT00171834|516490660|FG004|Overall Study|Death from study indication|1|||
143255956|NCT00171834|516490661|FG005|Overall Study|Death from study indication|0|||
143255957|NCT00171834|516490662|FG006|Overall Study|Death from study indication|0|||
143255958|NCT00171834|516490656|FG000|Overall Study|Disease Progression|4|||
143255959|NCT00171834|516490657|FG001|Overall Study|Disease Progression|8|||
143255960|NCT00171834|516490658|FG002|Overall Study|Disease Progression|8|||
143255961|NCT00171834|516490659|FG003|Overall Study|Disease Progression|9|||
143255962|NCT00171834|516490660|FG004|Overall Study|Disease Progression|2|||
143255963|NCT00171834|516490661|FG005|Overall Study|Disease Progression|18|||
143255964|NCT00171834|516490662|FG006|Overall Study|Disease Progression|3|||
143255965|NCT00171834|516490656|FG000|Overall Study|Treatment Duration Completed|0|||
143255966|NCT00171834|516490657|FG001|Overall Study|Treatment Duration Completed|0|||
143255967|NCT00171834|516490658|FG002|Overall Study|Treatment Duration Completed|1|||
143255968|NCT00171834|516490659|FG003|Overall Study|Treatment Duration Completed|0|||
143255969|NCT00171834|516490660|FG004|Overall Study|Treatment Duration Completed|2|||
143255970|NCT00171834|516490661|FG005|Overall Study|Treatment Duration Completed|1|||
143255971|NCT00171834|516490662|FG006|Overall Study|Treatment Duration Completed|0|||
143255972|NCT00834080|516490663|FG000|Overall Study|Adverse Event|7|||
143178851|NCT00413660|516203633|FG010|Up To Week 12|Lack of Efficacy|0|||
143178852|NCT00413660|516203623|FG000|Up To Week 12|Lost to Follow-up|0|||
143178853|NCT00413660|516203624|FG001|Up To Week 12|Lost to Follow-up|1|||
143178854|NCT00413660|516203625|FG002|Up To Week 12|Lost to Follow-up|0|||
143178855|NCT00413660|516203626|FG003|Up To Week 12|Lost to Follow-up|0|||
143178856|NCT00413660|516203627|FG004|Up To Week 12|Lost to Follow-up|1|||
143178857|NCT00413660|516203628|FG005|Up To Week 12|Lost to Follow-up|0|||
143178858|NCT00413660|516203629|FG006|Up To Week 12|Lost to Follow-up|0|||
143178859|NCT00413660|516203630|FG007|Up To Week 12|Lost to Follow-up|0|||
143178860|NCT00413660|516203631|FG008|Up To Week 12|Lost to Follow-up|0|||
143178861|NCT00413660|516203632|FG009|Up To Week 12|Lost to Follow-up|0|||
143178862|NCT00413660|516203633|FG010|Up To Week 12|Lost to Follow-up|0|||
143178863|NCT00413660|516203623|FG000|Up To Week 12|Withdrawal by Subject|0|||
143178864|NCT00413660|516203624|FG001|Up To Week 12|Withdrawal by Subject|2|||
143178865|NCT00413660|516203625|FG002|Up To Week 12|Withdrawal by Subject|0|||
143178866|NCT00413660|516203626|FG003|Up To Week 12|Withdrawal by Subject|2|||
143178867|NCT00413660|516203627|FG004|Up To Week 12|Withdrawal by Subject|0|||
143178868|NCT00413660|516203628|FG005|Up To Week 12|Withdrawal by Subject|2|||
143178869|NCT00413660|516203629|FG006|Up To Week 12|Withdrawal by Subject|2|||
143178870|NCT00413660|516203630|FG007|Up To Week 12|Withdrawal by Subject|0|||
143178871|NCT00413660|516203631|FG008|Up To Week 12|Withdrawal by Subject|0|||
143178872|NCT00413660|516203632|FG009|Up To Week 12|Withdrawal by Subject|0|||
143178873|NCT00413660|516203633|FG010|Up To Week 12|Withdrawal by Subject|0|||
143178874|NCT00413660|516203623|FG000|Up To Week 12|Randomized, Not Treated|1|||
143178875|NCT00413660|516203624|FG001|Up To Week 12|Randomized, Not Treated|0|||
143178876|NCT00413660|516203625|FG002|Up To Week 12|Randomized, Not Treated|0|||
143178877|NCT00413660|516203626|FG003|Up To Week 12|Randomized, Not Treated|1|||
143178878|NCT00413660|516203627|FG004|Up To Week 12|Randomized, Not Treated|0|||
143178879|NCT00413660|516203628|FG005|Up To Week 12|Randomized, Not Treated|0|||
143178880|NCT00413660|516203629|FG006|Up To Week 12|Randomized, Not Treated|0|||
143178881|NCT00413660|516203630|FG007|Up To Week 12|Randomized, Not Treated|0|||
143178882|NCT00413660|516203631|FG008|Up To Week 12|Randomized, Not Treated|0|||
143255973|NCT00834080|516490663|FG000|Overall Study|Lost to Follow-up|7|||
143178883|NCT00413660|516203632|FG009|Up To Week 12|Randomized, Not Treated|0|||
143178884|NCT00413660|516203633|FG010|Up To Week 12|Randomized, Not Treated|0|||
143178885|NCT00413660|516203623|FG000|Up To Week 12|Other|3|||
143178886|NCT00413660|516203624|FG001|Up To Week 12|Other|1|||
143178887|NCT00413660|516203625|FG002|Up To Week 12|Other|6|||
143178888|NCT00413660|516203626|FG003|Up To Week 12|Other|1|||
143178889|NCT00413660|516203627|FG004|Up To Week 12|Other|2|||
143178890|NCT00413660|516203628|FG005|Up To Week 12|Other|4|||
143178891|NCT00413660|516203629|FG006|Up To Week 12|Other|3|||
143178892|NCT00413660|516203630|FG007|Up To Week 12|Other|0|||
143178893|NCT00413660|516203631|FG008|Up To Week 12|Other|0|||
143178894|NCT00413660|516203632|FG009|Up To Week 12|Other|0|||
143178895|NCT00413660|516203633|FG010|Up To Week 12|Other|0|||
143178896|NCT00413660|516203623|FG000|Post Week 12|Adverse Event|2|||
143178897|NCT00413660|516203624|FG001|Post Week 12|Adverse Event|0|||
143255974|NCT00834080|516490663|FG000|Overall Study|Withdrawal by Subject|5|||
143255975|NCT00834080|516490663|FG000|Overall Study|Other - Pregnancy|1|||
143255976|NCT00834080|516490663|FG000|Overall Study|Other - False positive tests of the UDS|1|||
143106805|NCT02829723|515931908|FG002|Overall Study|Subject/guardian decision|0|||
143255977|NCT00834080|516490663|FG000|Overall Study|Physician Decision|1|||
143255978|NCT00834080|516490663|FG000|Overall Study|Subject Relocated|1|||
143255979|NCT04345367|516490667|FG000|Overall Study|Other|3|||
143255980|NCT04345367|516490668|FG001|Overall Study|Other|4|||
143255981|NCT04345367|516490667|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
143255982|NCT04345367|516490668|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
143255983|NCT04345367|516490667|FG000|Overall Study|Withdrawal by Subject|11|||
143255984|NCT04345367|516490668|FG001|Overall Study|Withdrawal by Subject|11|||
143255985|NCT04345367|516490667|FG000|Overall Study|Protocol Violation|4|||
143255986|NCT04345367|516490668|FG001|Overall Study|Protocol Violation|3|||
143255987|NCT04345367|516490667|FG000|Overall Study|Lost to Follow-up|2|||
143255988|NCT04345367|516490668|FG001|Overall Study|Lost to Follow-up|4|||
143255989|NCT04345367|516490667|FG000|Overall Study|Lack of Efficacy|2|||
143255990|NCT04345367|516490668|FG001|Overall Study|Lack of Efficacy|0|||
143255991|NCT04345367|516490667|FG000|Overall Study|Death|2|||
143255992|NCT04345367|516490668|FG001|Overall Study|Death|0|||
143255993|NCT04345367|516490667|FG000|Overall Study|Adverse Event|10|||
143255994|NCT04345367|516490668|FG001|Overall Study|Adverse Event|9|||
143255995|NCT00796523|516490669|FG000|Overall Study|Lost to Follow-up|9|||
143255996|NCT00796523|516490670|FG001|Overall Study|Lost to Follow-up|7|||
143255997|NCT01917656|516490675|FG000|Overall Study|Adverse Event|11|||
143255998|NCT01917656|516490676|FG001|Overall Study|Adverse Event|0|||
143255999|NCT01917656|516490675|FG000|Overall Study|Withdrawal criteria|8|||
143256000|NCT01917656|516490676|FG001|Overall Study|Withdrawal criteria|14|||
143256001|NCT01917656|516490675|FG000|Overall Study|Unclassified|0|||
143256002|NCT01917656|516490676|FG001|Overall Study|Unclassified|3|||
143256003|NCT01917656|516490675|FG000|Overall Study|Withdrawal by Subject|4|||
143256004|NCT01917656|516490676|FG001|Overall Study|Withdrawal by Subject|3|||
143256005|NCT01917656|516490675|FG000|Overall Study|Lost to Follow-up|3|||
143256006|NCT01917656|516490676|FG001|Overall Study|Lost to Follow-up|4|||
143256007|NCT02285062|516490677|FG000|Pre-Treatment Period|Protocol Violation|0|||
143256008|NCT02285062|516490678|FG001|Pre-Treatment Period|Protocol Violation|2|||
143256009|NCT02285062|516490677|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
143256010|NCT02285062|516490678|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
143256011|NCT02015221|516490679|FG000|Overall Study|Withdrawal by Subject|8|||
143256012|NCT02015221|516490680|FG001|Overall Study|Withdrawal by Subject|6|||
143256013|NCT02015221|516490679|FG000|Overall Study|Lost to Follow-up|1|||
143256014|NCT02015221|516490680|FG001|Overall Study|Lost to Follow-up|0|||
143256015|NCT03709576|516490681|FG000|Overall Study|progression prior to enrollment|1|||
143256016|NCT03041129|516490687|FG000|Overall Study|Withdrawal by Subject|2|||
143256017|NCT03041129|516490688|FG001|Overall Study|Withdrawal by Subject|0|||
143256018|NCT03041129|516490689|FG002|Overall Study|Withdrawal by Subject|0|||
143256019|NCT03041129|516490690|FG003|Overall Study|Withdrawal by Subject|0|||
143256020|NCT00510653|516490693|FG000|Overall Study|Withdrawal by Subject|8|||
143256021|NCT00510653|516490693|FG000|Overall Study|Monetary|3|||
143256022|NCT00483756|516490696|FG000|Overall Study|Death|2|||
143256023|NCT00483756|516490697|FG001|Overall Study|Death|0|||
143256024|NCT00483756|516490698|FG002|Overall Study|Death|1|||
143256025|NCT00483756|516490696|FG000|Overall Study|Adverse Event|19|||
143256026|NCT00483756|516490697|FG001|Overall Study|Adverse Event|38|||
143256027|NCT00483756|516490698|FG002|Overall Study|Adverse Event|40|||
143256028|NCT00483756|516490696|FG000|Overall Study|Lack of Efficacy|1|||
143256029|NCT00483756|516490697|FG001|Overall Study|Lack of Efficacy|0|||
143256030|NCT00483756|516490698|FG002|Overall Study|Lack of Efficacy|0|||
143256031|NCT00483756|516490696|FG000|Overall Study|Lost to Follow-up|3|||
143256032|NCT00483756|516490697|FG001|Overall Study|Lost to Follow-up|1|||
143256033|NCT00483756|516490698|FG002|Overall Study|Lost to Follow-up|0|||
143256034|NCT00483756|516490696|FG000|Overall Study|Withdrawal by Subject|5|||
143256035|NCT00483756|516490697|FG001|Overall Study|Withdrawal by Subject|3|||
143256036|NCT00483756|516490698|FG002|Overall Study|Withdrawal by Subject|4|||
143256037|NCT00483756|516490696|FG000|Overall Study|Other|2|||
143256038|NCT00483756|516490697|FG001|Overall Study|Other|4|||
143256039|NCT00483756|516490698|FG002|Overall Study|Other|3|||
143256040|NCT00483756|516490696|FG000|Overall Study|Randomized, Not Treated|1|||
143256041|NCT00483756|516490697|FG001|Overall Study|Randomized, Not Treated|4|||
143106806|NCT02829723|515931909|FG003|Overall Study|Subject/guardian decision|1|||
143106807|NCT02829723|515931910|FG004|Overall Study|Subject/guardian decision|0|||
143256042|NCT00483756|516490698|FG002|Overall Study|Randomized, Not Treated|4|||
143256043|NCT00436501|516490699|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
143256044|NCT00436501|516490700|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
143256045|NCT00436501|516490699|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
143256046|NCT00436501|516490700|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
143256047|NCT00495040|516490701|FG000|Overall Study|Withdrawal by Subject|3|||
143256048|NCT00621621|516490702|FG000|Overall Study|Subjects were exited at EP study|30|||
143256049|NCT00621621|516490703|FG001|Overall Study|Subjects were exited at EP study|0|||
143256050|NCT00906971|516490704|FG000|Overall Study|Withdrawal by Subject|8|||
143256051|NCT00906971|516490705|FG001|Overall Study|Withdrawal by Subject|2|||
143256052|NCT00906971|516490704|FG000|Overall Study|Lost to Follow-up|0|||
143256053|NCT00906971|516490705|FG001|Overall Study|Lost to Follow-up|1|||
143256054|NCT00821509|516490706|FG000|Overall Study|Withdrawal by Subject|12|||
143256055|NCT00821509|516490707|FG001|Overall Study|Withdrawal by Subject|11|||
143256056|NCT00821509|516490708|FG002|Overall Study|Withdrawal by Subject|34|||
143256057|NCT00807573|516490709|FG000|Overall Study|Withdrawal by Subject|1|||
143256058|NCT00807573|516490709|FG000|Overall Study|Adverse Event|1|||
143256059|NCT01551420|516490710|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
143256060|NCT01551420|516490711|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
143256061|NCT01551420|516490710|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
143256062|NCT01551420|516490711|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
143256063|NCT01551420|516490710|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
143256064|NCT01551420|516490711|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
143256065|NCT01551420|516490710|FG000|Screened for Part B Eligibility|Declined participation|8|||
143256066|NCT01551420|516490711|FG001|Screened for Part B Eligibility|Declined participation|1|||
143106808|NCT02829723|515931911|FG005|Overall Study|Subject/guardian decision|0|||
143256067|NCT01551420|516490710|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
143256068|NCT01551420|516490711|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
143256069|NCT01551420|516490710|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
143256070|NCT01551420|516490711|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
143256071|NCT01551420|516490710|FG000|Home Use (Part B)|Withdrawal by staff|0|||
143256072|NCT01551420|516490711|FG001|Home Use (Part B)|Withdrawal by staff|1|||
143256073|NCT00169442|516490712|FG000|Overall Study|Withdrawal by Subject|0|||
143256074|NCT00169442|516490713|FG001|Overall Study|Withdrawal by Subject|0|||
143256075|NCT00169442|516490714|FG002|Overall Study|Withdrawal by Subject|1|||
143256076|NCT00169442|516490715|FG003|Overall Study|Withdrawal by Subject|0|||
143256077|NCT00169442|516490716|FG004|Overall Study|Withdrawal by Subject|0|||
143256078|NCT00169442|516490717|FG005|Overall Study|Withdrawal by Subject|0|||
143256079|NCT00169442|516490712|FG000|Overall Study|Migrated/moved from study area|0|||
143256080|NCT00169442|516490713|FG001|Overall Study|Migrated/moved from study area|0|||
143256081|NCT00169442|516490714|FG002|Overall Study|Migrated/moved from study area|0|||
143256082|NCT00169442|516490715|FG003|Overall Study|Migrated/moved from study area|0|||
143106809|NCT02829723|515931912|FG006|Overall Study|Subject/guardian decision|0|||
143106810|NCT02829723|515931913|FG007|Overall Study|Subject/guardian decision|1|||
143106811|NCT02829723|515931914|FG008|Overall Study|Subject/guardian decision|0|||
143106812|NCT02829723|515931915|FG009|Overall Study|Subject/guardian decision|0|||
143106813|NCT02829723|515931916|FG010|Overall Study|Subject/guardian decision|0|||
143106814|NCT02829723|515931917|FG011|Overall Study|Subject/guardian decision|0|||
143106815|NCT02829723|515931918|FG012|Overall Study|Subject/guardian decision|0|||
143106816|NCT02829723|515931919|FG013|Overall Study|Subject/guardian decision|0|||
143106817|NCT02829723|515931920|FG014|Overall Study|Subject/guardian decision|1|||
143106818|NCT02829723|515931921|FG015|Overall Study|Subject/guardian decision|0|||
143106819|NCT02829723|515931922|FG016|Overall Study|Subject/guardian decision|1|||
143106820|NCT02829723|515931923|FG017|Overall Study|Subject/guardian decision|0|||
143106821|NCT02829723|515931924|FG018|Overall Study|Subject/guardian decision|1|||
143106822|NCT02829723|515931925|FG019|Overall Study|Subject/guardian decision|0|||
143106823|NCT02829723|515931926|FG020|Overall Study|Subject/guardian decision|1|||
143106824|NCT02829723|515931927|FG021|Overall Study|Subject/guardian decision|0|||
143106825|NCT02829723|515931928|FG022|Overall Study|Subject/guardian decision|0|||
143106826|NCT02829723|515931929|FG023|Overall Study|Subject/guardian decision|1|||
143106827|NCT02829723|515931930|FG024|Overall Study|Subject/guardian decision|0|||
143106828|NCT02829723|515931931|FG025|Overall Study|Subject/guardian decision|1|||
143106829|NCT02829723|515931932|FG026|Overall Study|Subject/guardian decision|1|||
143106830|NCT02829723|515931906|FG000|Overall Study|Study terminated by sponsor|0|||
143256083|NCT00169442|516490716|FG004|Overall Study|Migrated/moved from study area|0|||
143256084|NCT00169442|516490717|FG005|Overall Study|Migrated/moved from study area|2|||
143256085|NCT00169442|516490712|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
143256086|NCT00169442|516490713|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
143256087|NCT00169442|516490714|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
143256088|NCT00169442|516490715|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
143106831|NCT02829723|515931907|FG001|Overall Study|Study terminated by sponsor|0|||
143106832|NCT02829723|515931908|FG002|Overall Study|Study terminated by sponsor|0|||
143106833|NCT02829723|515931909|FG003|Overall Study|Study terminated by sponsor|0|||
143256089|NCT00169442|516490716|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
143256090|NCT00169442|516490717|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
143256091|NCT00169442|516490712|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
143256092|NCT00169442|516490713|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
143256093|NCT00169442|516490714|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
143256094|NCT00169442|516490715|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
143256095|NCT00169442|516490716|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
143256096|NCT00169442|516490717|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
143256097|NCT00311584|516490718|FG000|Overall Study|Death|1|||
143256098|NCT00311584|516490719|FG001|Overall Study|Death|0|||
143256099|NCT00311584|516490718|FG000|Overall Study|Lack of Efficacy|12|||
143256100|NCT00311584|516490719|FG001|Overall Study|Lack of Efficacy|15|||
143256101|NCT00311584|516490718|FG000|Overall Study|Physician Decision|4|||
143256102|NCT00311584|516490719|FG001|Overall Study|Physician Decision|5|||
143256103|NCT00311584|516490718|FG000|Overall Study|Withdrawal by Subject|1|||
143256104|NCT00311584|516490719|FG001|Overall Study|Withdrawal by Subject|1|||
143106834|NCT02829723|515931910|FG004|Overall Study|Study terminated by sponsor|0|||
143106835|NCT02829723|515931911|FG005|Overall Study|Study terminated by sponsor|0|||
143106836|NCT02829723|515931912|FG006|Overall Study|Study terminated by sponsor|0|||
143106837|NCT02829723|515931913|FG007|Overall Study|Study terminated by sponsor|0|||
143106838|NCT02829723|515931914|FG008|Overall Study|Study terminated by sponsor|0|||
143106839|NCT02829723|515931915|FG009|Overall Study|Study terminated by sponsor|0|||
143106840|NCT02829723|515931916|FG010|Overall Study|Study terminated by sponsor|0|||
143106841|NCT02829723|515931917|FG011|Overall Study|Study terminated by sponsor|0|||
143106842|NCT02829723|515931918|FG012|Overall Study|Study terminated by sponsor|0|||
143106843|NCT02829723|515931919|FG013|Overall Study|Study terminated by sponsor|0|||
143106844|NCT02829723|515931920|FG014|Overall Study|Study terminated by sponsor|0|||
143106845|NCT02829723|515931921|FG015|Overall Study|Study terminated by sponsor|0|||
143106846|NCT02829723|515931922|FG016|Overall Study|Study terminated by sponsor|0|||
143106847|NCT02829723|515931923|FG017|Overall Study|Study terminated by sponsor|0|||
143106848|NCT02829723|515931924|FG018|Overall Study|Study terminated by sponsor|0|||
143106849|NCT02829723|515931925|FG019|Overall Study|Study terminated by sponsor|0|||
143106850|NCT02829723|515931926|FG020|Overall Study|Study terminated by sponsor|0|||
143106851|NCT02829723|515931927|FG021|Overall Study|Study terminated by sponsor|1|||
143106852|NCT02829723|515931928|FG022|Overall Study|Study terminated by sponsor|0|||
143106853|NCT02829723|515931929|FG023|Overall Study|Study terminated by sponsor|0|||
143106854|NCT02829723|515931930|FG024|Overall Study|Study terminated by sponsor|0|||
143106855|NCT02829723|515931931|FG025|Overall Study|Study terminated by sponsor|0|||
143106856|NCT02829723|515931932|FG026|Overall Study|Study terminated by sponsor|0|||
143106857|NCT02989649|515931933|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
143106858|NCT02989649|515931933|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
143106859|NCT02989649|515931933|FG000|Overall Study|Lost For Observation During Study|3|||
143106860|NCT02989649|515931933|FG000|Overall Study|Reason Not Specified|13|||
143106861|NCT00256854|515931934|FG000|Overall Study|Withdrawal by Subject|2|||
143106862|NCT00256854|515931935|FG001|Overall Study|Withdrawal by Subject|3|||
143106863|NCT00256854|515931936|FG002|Overall Study|Withdrawal by Subject|0|||
143178898|NCT00413660|516203625|FG002|Post Week 12|Adverse Event|2|||
143178899|NCT00413660|516203626|FG003|Post Week 12|Adverse Event|1|||
143178900|NCT00413660|516203627|FG004|Post Week 12|Adverse Event|4|||
143178901|NCT00413660|516203628|FG005|Post Week 12|Adverse Event|2|||
143178902|NCT00413660|516203629|FG006|Post Week 12|Adverse Event|2|||
143178903|NCT00413660|516203630|FG007|Post Week 12|Adverse Event|0|||
143178904|NCT00413660|516203631|FG008|Post Week 12|Adverse Event|0|||
143178905|NCT00413660|516203632|FG009|Post Week 12|Adverse Event|0|||
143178906|NCT00413660|516203633|FG010|Post Week 12|Adverse Event|0|||
143178907|NCT00413660|516203623|FG000|Post Week 12|Lack of Efficacy|0|||
143178908|NCT00413660|516203624|FG001|Post Week 12|Lack of Efficacy|0|||
143178909|NCT00413660|516203625|FG002|Post Week 12|Lack of Efficacy|1|||
143178910|NCT00413660|516203626|FG003|Post Week 12|Lack of Efficacy|0|||
143178911|NCT00413660|516203627|FG004|Post Week 12|Lack of Efficacy|0|||
143178912|NCT00413660|516203628|FG005|Post Week 12|Lack of Efficacy|0|||
143178913|NCT00413660|516203629|FG006|Post Week 12|Lack of Efficacy|0|||
143178914|NCT00413660|516203630|FG007|Post Week 12|Lack of Efficacy|0|||
143178915|NCT00413660|516203631|FG008|Post Week 12|Lack of Efficacy|0|||
143178916|NCT00413660|516203632|FG009|Post Week 12|Lack of Efficacy|1|||
143106864|NCT00256854|515931937|FG003|Overall Study|Withdrawal by Subject|0|||
143106865|NCT00256854|515931938|FG004|Overall Study|Withdrawal by Subject|0|||
143178917|NCT00413660|516203633|FG010|Post Week 12|Lack of Efficacy|0|||
143178918|NCT00413660|516203623|FG000|Post Week 12|Lost to Follow-up|0|||
143178919|NCT00413660|516203624|FG001|Post Week 12|Lost to Follow-up|1|||
143178920|NCT00413660|516203625|FG002|Post Week 12|Lost to Follow-up|1|||
143178921|NCT00413660|516203626|FG003|Post Week 12|Lost to Follow-up|0|||
143178922|NCT00413660|516203627|FG004|Post Week 12|Lost to Follow-up|0|||
143256105|NCT00311584|516490718|FG000|Overall Study|ineligible|2|||
143256106|NCT00311584|516490719|FG001|Overall Study|ineligible|2|||
143256107|NCT03073733|516490720|FG000|Overall Study|Lost to Follow-up|1|||
143106866|NCT00256854|515931939|FG005|Overall Study|Withdrawal by Subject|0|||
143106867|NCT00256854|515931934|FG000|Overall Study|Lack of Efficacy|1|||
143106868|NCT00256854|515931935|FG001|Overall Study|Lack of Efficacy|0|||
143106869|NCT00256854|515931936|FG002|Overall Study|Lack of Efficacy|0|||
143106870|NCT00256854|515931937|FG003|Overall Study|Lack of Efficacy|0|||
143106871|NCT00256854|515931938|FG004|Overall Study|Lack of Efficacy|0|||
143106872|NCT00256854|515931939|FG005|Overall Study|Lack of Efficacy|0|||
143106873|NCT00256854|515931934|FG000|Overall Study|Protocol Violation|0|||
143106874|NCT00256854|515931935|FG001|Overall Study|Protocol Violation|1|||
143106875|NCT00256854|515931936|FG002|Overall Study|Protocol Violation|1|||
143106876|NCT00256854|515931937|FG003|Overall Study|Protocol Violation|1|||
143106877|NCT00256854|515931938|FG004|Overall Study|Protocol Violation|0|||
143106878|NCT00256854|515931939|FG005|Overall Study|Protocol Violation|0|||
143106879|NCT00256854|515931934|FG000|Overall Study|Adverse Event|0|||
143106880|NCT00256854|515931935|FG001|Overall Study|Adverse Event|0|||
143106881|NCT00256854|515931936|FG002|Overall Study|Adverse Event|2|||
143106882|NCT00256854|515931937|FG003|Overall Study|Adverse Event|2|||
143106883|NCT00256854|515931938|FG004|Overall Study|Adverse Event|0|||
143106884|NCT00256854|515931939|FG005|Overall Study|Adverse Event|1|||
143106885|NCT00256854|515931934|FG000|Overall Study|Not compliant with the study drug|0|||
143106886|NCT00256854|515931935|FG001|Overall Study|Not compliant with the study drug|0|||
143106887|NCT00256854|515931936|FG002|Overall Study|Not compliant with the study drug|0|||
143106888|NCT00256854|515931937|FG003|Overall Study|Not compliant with the study drug|0|||
143106889|NCT00256854|515931938|FG004|Overall Study|Not compliant with the study drug|1|||
143106890|NCT00256854|515931939|FG005|Overall Study|Not compliant with the study drug|0|||
143106891|NCT02353442|515931940|FG000|Overall Study|Withdrawal by Subject|3|||
143106892|NCT02353442|515931941|FG001|Overall Study|Withdrawal by Subject|4|||
143106893|NCT06586788|515931943|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
143106894|NCT03514485|515931944|FG000|Overall Study|Lost to Follow-up|5|||
143106895|NCT03514485|515931945|FG001|Overall Study|Lost to Follow-up|3|||
143106896|NCT03514485|515931946|FG002|Overall Study|Lost to Follow-up|2|||
143106897|NCT03514485|515931947|FG003|Overall Study|Lost to Follow-up|0|||
143106898|NCT03514485|515931948|FG004|Overall Study|Lost to Follow-up|1|||
143106899|NCT03514485|515931949|FG005|Overall Study|Lost to Follow-up|4|||
143106900|NCT03514485|515931944|FG000|Overall Study|Withdrawal by Subject|0|||
143106901|NCT03514485|515931945|FG001|Overall Study|Withdrawal by Subject|1|||
143106902|NCT03514485|515931946|FG002|Overall Study|Withdrawal by Subject|3|||
143106903|NCT03514485|515931947|FG003|Overall Study|Withdrawal by Subject|1|||
143106904|NCT03514485|515931948|FG004|Overall Study|Withdrawal by Subject|2|||
143106905|NCT03514485|515931949|FG005|Overall Study|Withdrawal by Subject|1|||
143106906|NCT03075891|515931950|FG000|Overall Study|Withdrawal by Subject|3|||
143106907|NCT03075891|515931951|FG001|Overall Study|Withdrawal by Subject|6|||
143106908|NCT03075891|515931950|FG000|Overall Study|Lost to Follow-up|1|||
143106909|NCT03075891|515931951|FG001|Overall Study|Lost to Follow-up|0|||
143106910|NCT03075891|515931950|FG000|Overall Study|Pregnancy|3|||
143106911|NCT03075891|515931951|FG001|Overall Study|Pregnancy|1|||
143106912|NCT03075891|515931950|FG000|Overall Study|visits not performed (no time)|1|||
143106913|NCT03075891|515931951|FG001|Overall Study|visits not performed (no time)|0|||
143106914|NCT03075891|515931950|FG000|Overall Study|Drug abuse relapse issue|0|||
143106915|NCT03075891|515931951|FG001|Overall Study|Drug abuse relapse issue|1|||
143106916|NCT03075891|515931950|FG000|Overall Study|Participant requiring study withdrawal|0|||
143106917|NCT03075891|515931951|FG001|Overall Study|Participant requiring study withdrawal|1|||
143106918|NCT03075891|515931950|FG000|Overall Study|Adverse event, non-fatal|1|||
143106919|NCT03075891|515931951|FG001|Overall Study|Adverse event, non-fatal|4|||
143106920|NCT02004886|515931952|FG000|Overall Study|Adverse Event|0|||
143106921|NCT02004886|515931953|FG001|Overall Study|Adverse Event|1|||
143106922|NCT02004886|515931954|FG002|Overall Study|Adverse Event|0|||
143106923|NCT02004886|515931955|FG003|Overall Study|Adverse Event|0|||
143106924|NCT02004886|515931952|FG000|Overall Study|Unable to attend future visits|1|||
143106925|NCT02004886|515931953|FG001|Overall Study|Unable to attend future visits|0|||
143256108|NCT03073733|516490721|FG001|Overall Study|Lost to Follow-up|0|||
143256109|NCT03073733|516490722|FG002|Overall Study|Lost to Follow-up|0|||
143256110|NCT03073733|516490720|FG000|Overall Study|Physician Decision|0|||
143256111|NCT03073733|516490721|FG001|Overall Study|Physician Decision|1|||
143106926|NCT02004886|515931954|FG002|Overall Study|Unable to attend future visits|0|||
143106927|NCT02004886|515931955|FG003|Overall Study|Unable to attend future visits|0|||
143106928|NCT00638443|515931956|FG000|First Intervention|Adverse Event|2|||
143106929|NCT00638443|515931957|FG001|First Intervention|Adverse Event|1|||
143106930|NCT00179673|515931958|FG000|Overall Study|Adverse Event|7|||
143106931|NCT00179673|515931958|FG000|Overall Study|Lack of Efficacy|15|||
143106932|NCT00179673|515931958|FG000|Overall Study|Withdrawal by Subject|3|||
143106933|NCT00179673|515931958|FG000|Overall Study|Death|4|||
143106934|NCT00179673|515931958|FG000|Overall Study|Other Observations and options|14|||
143106935|NCT02387957|515931959|FG000|Overall Study|The study was discontinued|21|||
143106936|NCT02387957|515931960|FG001|Overall Study|The study was discontinued|21|||
143256112|NCT03073733|516490722|FG002|Overall Study|Physician Decision|0|||
143106937|NCT02387957|515931961|FG002|Overall Study|The study was discontinued|20|||
143256113|NCT03073733|516490720|FG000|Overall Study|Withdrawal by Subject|0|||
143256114|NCT03073733|516490721|FG001|Overall Study|Withdrawal by Subject|0|||
143106938|NCT02294396|515931962|FG000|Overall Study|Adverse Event|26|||
143106939|NCT02294396|515931963|FG001|Overall Study|Adverse Event|25|||
143106940|NCT02294396|515931964|FG002|Overall Study|Adverse Event|21|||
143106941|NCT02294396|515931965|FG003|Overall Study|Adverse Event|24|||
143106942|NCT02294396|515931962|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
143106943|NCT02294396|515931963|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
143106944|NCT02294396|515931964|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
143106945|NCT02294396|515931965|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
143106946|NCT02294396|515931962|FG000|Overall Study|Withdrawal by Subject|8|||
143106947|NCT02294396|515931963|FG001|Overall Study|Withdrawal by Subject|6|||
143106948|NCT02294396|515931964|FG002|Overall Study|Withdrawal by Subject|6|||
143106949|NCT02294396|515931965|FG003|Overall Study|Withdrawal by Subject|8|||
143106950|NCT02294396|515931962|FG000|Overall Study|Lost to Follow-up|0|||
143106951|NCT02294396|515931963|FG001|Overall Study|Lost to Follow-up|0|||
143106952|NCT02294396|515931964|FG002|Overall Study|Lost to Follow-up|1|||
143106953|NCT02294396|515931965|FG003|Overall Study|Lost to Follow-up|1|||
143106954|NCT02294396|515931962|FG000|Overall Study|Protocol Deviation|3|||
143106955|NCT02294396|515931963|FG001|Overall Study|Protocol Deviation|2|||
143106956|NCT02294396|515931964|FG002|Overall Study|Protocol Deviation|2|||
143106957|NCT02294396|515931965|FG003|Overall Study|Protocol Deviation|1|||
143106958|NCT02294396|515931962|FG000|Overall Study|Miscellaneous|2|||
143106959|NCT02294396|515931963|FG001|Overall Study|Miscellaneous|0|||
143106960|NCT02294396|515931964|FG002|Overall Study|Miscellaneous|5|||
143106961|NCT02294396|515931965|FG003|Overall Study|Miscellaneous|2|||
143106962|NCT02438826|515931969|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
143106963|NCT02438826|515931970|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
143106964|NCT02438826|515931971|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
143106965|NCT02438826|515931972|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
143106966|NCT02438826|515931969|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
143106967|NCT02438826|515931970|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
143178923|NCT00413660|516203628|FG005|Post Week 12|Lost to Follow-up|0|||
143178924|NCT00413660|516203629|FG006|Post Week 12|Lost to Follow-up|0|||
143178925|NCT00413660|516203630|FG007|Post Week 12|Lost to Follow-up|0|||
143178926|NCT00413660|516203631|FG008|Post Week 12|Lost to Follow-up|0|||
143178927|NCT00413660|516203632|FG009|Post Week 12|Lost to Follow-up|0|||
143178928|NCT00413660|516203633|FG010|Post Week 12|Lost to Follow-up|0|||
143178929|NCT00413660|516203623|FG000|Post Week 12|Withdrawal by Subject|0|||
143178930|NCT00413660|516203624|FG001|Post Week 12|Withdrawal by Subject|1|||
143178931|NCT00413660|516203625|FG002|Post Week 12|Withdrawal by Subject|1|||
143178932|NCT00413660|516203626|FG003|Post Week 12|Withdrawal by Subject|0|||
143178933|NCT00413660|516203627|FG004|Post Week 12|Withdrawal by Subject|1|||
143178934|NCT00413660|516203628|FG005|Post Week 12|Withdrawal by Subject|0|||
143178935|NCT00413660|516203629|FG006|Post Week 12|Withdrawal by Subject|0|||
143178936|NCT00413660|516203630|FG007|Post Week 12|Withdrawal by Subject|0|||
143178937|NCT00413660|516203631|FG008|Post Week 12|Withdrawal by Subject|0|||
143178938|NCT00413660|516203632|FG009|Post Week 12|Withdrawal by Subject|0|||
143178939|NCT00413660|516203633|FG010|Post Week 12|Withdrawal by Subject|1|||
143178940|NCT00413660|516203623|FG000|Post Week 12|Other|1|||
143178941|NCT00413660|516203624|FG001|Post Week 12|Other|2|||
143178942|NCT00413660|516203625|FG002|Post Week 12|Other|3|||
143178943|NCT00413660|516203626|FG003|Post Week 12|Other|0|||
143178944|NCT00413660|516203627|FG004|Post Week 12|Other|1|||
143178945|NCT00413660|516203628|FG005|Post Week 12|Other|1|||
143178946|NCT00413660|516203629|FG006|Post Week 12|Other|1|||
143178947|NCT00413660|516203630|FG007|Post Week 12|Other|0|||
143178948|NCT00413660|516203631|FG008|Post Week 12|Other|0|||
143178949|NCT00413660|516203632|FG009|Post Week 12|Other|0|||
143178950|NCT00413660|516203633|FG010|Post Week 12|Other|0|||
143106968|NCT02438826|515931971|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
143106969|NCT02438826|515931972|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
143106970|NCT02438826|515931969|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
143106971|NCT02438826|515931970|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
143178951|NCT01791517|516203636|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
143178952|NCT01791517|516203637|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
143178953|NCT01791517|516203638|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
143178954|NCT01791517|516203639|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
143178955|NCT01791517|516203640|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
143178956|NCT01791517|516203641|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
143178957|NCT01791517|516203642|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
143178958|NCT01791517|516203643|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
143178959|NCT01791517|516203644|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
143178960|NCT01791517|516203645|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
143178961|NCT01791517|516203646|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
143178962|NCT01791517|516203647|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
143256115|NCT03073733|516490722|FG002|Overall Study|Withdrawal by Subject|1|||
143106972|NCT02438826|515931971|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
143106973|NCT02438826|515931972|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
143106974|NCT02438826|515931969|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
143106975|NCT02438826|515931970|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
143106976|NCT02438826|515931971|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
143106977|NCT02438826|515931972|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
143106978|NCT02438826|515931969|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
143106979|NCT02438826|515931970|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
143106980|NCT02438826|515931971|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
143106981|NCT02438826|515931972|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
143106982|NCT02438826|515931969|FG000|Open-Label Treatment Phase|Adverse Event|11|||
143106983|NCT02438826|515931970|FG001|Open-Label Treatment Phase|Adverse Event|6|||
143106984|NCT02438826|515931971|FG002|Open-Label Treatment Phase|Adverse Event|0|||
143106985|NCT02438826|515931972|FG003|Open-Label Treatment Phase|Adverse Event|0|||
143106986|NCT02438826|515931969|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
143106987|NCT02438826|515931970|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
143106988|NCT02438826|515931971|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
143106989|NCT02438826|515931972|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
143106990|NCT02438826|515931969|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
143106991|NCT02438826|515931970|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
143106992|NCT02438826|515931971|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
143106993|NCT02438826|515931972|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
143106994|NCT02438826|515931969|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
143106995|NCT02438826|515931970|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
143106996|NCT02438826|515931971|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
143106997|NCT02438826|515931972|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
143106998|NCT02438826|515931969|FG000|Post-Treatment Phase|Adverse Event|3|||
143106999|NCT02438826|515931970|FG001|Post-Treatment Phase|Adverse Event|0|||
143107000|NCT02438826|515931971|FG002|Post-Treatment Phase|Adverse Event|0|||
143107001|NCT02438826|515931972|FG003|Post-Treatment Phase|Adverse Event|0|||
143107002|NCT02438826|515931969|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
143107003|NCT02438826|515931970|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
143107004|NCT02438826|515931971|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
143107005|NCT02438826|515931972|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
143107006|NCT02438826|515931969|FG000|Post-Treatment Phase|Physician Decision|1|||
143107007|NCT02438826|515931970|FG001|Post-Treatment Phase|Physician Decision|0|||
143107008|NCT02438826|515931971|FG002|Post-Treatment Phase|Physician Decision|0|||
143107009|NCT02438826|515931972|FG003|Post-Treatment Phase|Physician Decision|0|||
143107010|NCT02438826|515931969|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
143107011|NCT02438826|515931970|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
143107012|NCT02438826|515931971|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
143107013|NCT02438826|515931972|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
143107014|NCT01094301|515931979|FG000|Trial Stage|Withdrawal by Subject|1|||
143107015|NCT01094301|515931979|FG000|Implant Stage|Adverse Event|1|||
143107016|NCT01094301|515931979|FG000|Implant Stage|Protocol Violation|1|||
143107017|NCT01094301|515931979|FG000|Implant Stage|Withdrawal by Subject|2|||
143107018|NCT01094301|515931979|FG000|Implant Stage|No return of pain|4|||
143107019|NCT00430573|515931980|FG000|Overall Study|Withdrawal by Subject|5|||
143107020|NCT04999163|515931984|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
143107021|NCT04999163|515931985|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
143107022|NCT04999163|515931984|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
143107023|NCT04999163|515931985|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
143107024|NCT04999163|515931984|FG000|Overall Study|Withdrawal by Subject|1|||
143107025|NCT04999163|515931985|FG001|Overall Study|Withdrawal by Subject|0|||
143107026|NCT00378508|515933749|FG000|Overall Study|Withdrawal by Subject|1|||
143107027|NCT00378508|515933750|FG001|Overall Study|Withdrawal by Subject|3|||
143107028|NCT00378508|515933749|FG000|Overall Study|Lost to Follow-up|1|||
143107029|NCT00378508|515933750|FG001|Overall Study|Lost to Follow-up|0|||
143107030|NCT01106677|515933751|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
143107031|NCT01106677|515933752|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
143107032|NCT01106677|515933753|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
143107033|NCT01106677|515933754|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
143107034|NCT01106677|515933751|FG000|Core Period: Baseline to Week 26|Death|0|||
143107035|NCT01106677|515933752|FG001|Core Period: Baseline to Week 26|Death|0|||
143107036|NCT01106677|515933753|FG002|Core Period: Baseline to Week 26|Death|1|||
143107037|NCT01106677|515933754|FG003|Core Period: Baseline to Week 26|Death|0|||
143107038|NCT01106677|515933751|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
143107039|NCT01106677|515933752|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
143107040|NCT01106677|515933753|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
143107041|NCT01106677|515933754|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
143107042|NCT01106677|515933751|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
143107043|NCT01106677|515933752|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
143107044|NCT01106677|515933753|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
143107045|NCT01106677|515933754|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
143107046|NCT01106677|515933751|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
143107047|NCT01106677|515933752|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
143107048|NCT01106677|515933753|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
143107049|NCT01106677|515933754|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
143107050|NCT01106677|515933751|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
143107051|NCT01106677|515933752|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
143107052|NCT01106677|515933753|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
143107053|NCT01106677|515933754|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
143107054|NCT01106677|515933751|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
143107055|NCT01106677|515933752|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
143107056|NCT01106677|515933753|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
143107057|NCT01106677|515933754|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
143107058|NCT01106677|515933751|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
143107059|NCT01106677|515933752|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
143107060|NCT01106677|515933753|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
143107061|NCT01106677|515933754|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
143107062|NCT01106677|515933751|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
143107063|NCT01106677|515933752|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
143107064|NCT01106677|515933753|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
143107065|NCT01106677|515933754|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
143107066|NCT01106677|515933751|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
143107067|NCT01106677|515933752|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
143107068|NCT01106677|515933753|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
143107069|NCT01106677|515933754|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
143107070|NCT01106677|515933751|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
143107071|NCT01106677|515933752|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
143107072|NCT01106677|515933753|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
143107073|NCT01106677|515933754|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
143107074|NCT01106677|515933751|FG000|Core Period: Baseline to Week 26|Other|8|||
143107075|NCT01106677|515933752|FG001|Core Period: Baseline to Week 26|Other|14|||
143107076|NCT01106677|515933753|FG002|Core Period: Baseline to Week 26|Other|8|||
143107077|NCT01106677|515933754|FG003|Core Period: Baseline to Week 26|Other|23|||
143107078|NCT01106677|515933751|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
143107079|NCT01106677|515933752|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
143107080|NCT01106677|515933753|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
143107081|NCT01106677|515933754|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
143107082|NCT01106677|515933751|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
143107083|NCT01106677|515933752|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
143107084|NCT01106677|515933753|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
143107085|NCT01106677|515933754|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
143107086|NCT01106677|515933751|FG000|Extension Period: Week 26 to Week 52|Death|0|||
143107087|NCT01106677|515933752|FG001|Extension Period: Week 26 to Week 52|Death|0|||
143107088|NCT01106677|515933753|FG002|Extension Period: Week 26 to Week 52|Death|0|||
143107089|NCT01106677|515933754|FG003|Extension Period: Week 26 to Week 52|Death|1|||
143107090|NCT01106677|515933751|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
143107091|NCT01106677|515933752|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
143107092|NCT01106677|515933753|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
143107093|NCT01106677|515933754|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
143107094|NCT01106677|515933751|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
143107095|NCT01106677|515933752|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
143107096|NCT01106677|515933753|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
143107097|NCT01106677|515933754|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
143107098|NCT01106677|515933751|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
143256116|NCT00835731|516490723|FG000|Overall Study|Withdrawal by Subject|1|||
143256117|NCT00835731|516490724|FG001|Overall Study|Withdrawal by Subject|0|||
143107099|NCT01106677|515933752|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
143107100|NCT01106677|515933753|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
143107101|NCT01106677|515933754|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
143107102|NCT01106677|515933751|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
143107103|NCT01106677|515933752|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
143256118|NCT00835731|516490723|FG000|Overall Study|Physician Decision|1|||
143256119|NCT00835731|516490724|FG001|Overall Study|Physician Decision|1|||
143256120|NCT04966910|516492558|FG000|Baseline|Participant did not complete measure|0|||
143256121|NCT04966910|516492559|FG001|Baseline|Participant did not complete measure|0|||
143256122|NCT04966910|516492560|FG002|Baseline|Participant did not complete measure|1|||
143256123|NCT04966910|516492561|FG003|Baseline|Participant did not complete measure|0|||
143256124|NCT04966910|516492558|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
143256125|NCT04966910|516492559|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
143256126|NCT04966910|516492560|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
143256127|NCT04966910|516492561|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
143107104|NCT01106677|515933753|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
143107105|NCT01106677|515933754|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
143107106|NCT01106677|515933751|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
143107107|NCT01106677|515933752|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
143107108|NCT01106677|515933753|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
143107109|NCT01106677|515933754|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
143107110|NCT01106677|515933751|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
143107111|NCT01106677|515933752|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
143107112|NCT01106677|515933753|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
143107113|NCT01106677|515933754|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
143107114|NCT01106677|515933751|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
143107115|NCT01106677|515933752|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
143107116|NCT01106677|515933753|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
143107117|NCT01106677|515933754|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
143107118|NCT01106677|515933751|FG000|Extension Period: Week 26 to Week 52|Other|6|||
143107119|NCT01106677|515933752|FG001|Extension Period: Week 26 to Week 52|Other|5|||
143107120|NCT01106677|515933753|FG002|Extension Period: Week 26 to Week 52|Other|8|||
143107121|NCT01106677|515933754|FG003|Extension Period: Week 26 to Week 52|Other|5|||
143107122|NCT02817516|515933757|FG000|Overall Study|Other|0|||
143107123|NCT02817516|515933758|FG001|Overall Study|Other|0|||
143107124|NCT02817516|515933759|FG002|Overall Study|Other|1|||
143107125|NCT02817516|515933760|FG003|Overall Study|Other|0|||
143107126|NCT00348595|515933761|FG000|Overall Study|Adverse Event|5|||
143107127|NCT00348595|515933762|FG001|Overall Study|Adverse Event|8|||
143107128|NCT04429555|515933769|FG000|Overall Study|Death|0|||
143107129|NCT04429555|515933770|FG001|Overall Study|Death|2|||
143107130|NCT04429555|515933769|FG000|Overall Study|Other|2|||
143107131|NCT04429555|515933770|FG001|Overall Study|Other|0|||
143107132|NCT04470544|515933771|FG000|Overall Study|Withdrawal by Subject|4|||
143107133|NCT04470544|515933772|FG001|Overall Study|Withdrawal by Subject|6|||
143107134|NCT00712881|515933776|FG000|Overall Study|Adverse Event|3|||
143107135|NCT00712881|515933777|FG001|Overall Study|Adverse Event|3|||
143107136|NCT00712881|515933776|FG000|Overall Study|Withdrawal by Subject|1|||
143107137|NCT00712881|515933777|FG001|Overall Study|Withdrawal by Subject|1|||
143107138|NCT00712881|515933776|FG000|Overall Study|Disease Progression|2|||
143107139|NCT00712881|515933777|FG001|Overall Study|Disease Progression|1|||
143107140|NCT00712881|515933776|FG000|Overall Study|Lost to Follow-up|1|||
143107141|NCT00712881|515933777|FG001|Overall Study|Lost to Follow-up|1|||
143107142|NCT00712881|515933776|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
143107143|NCT00712881|515933777|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
143107144|NCT00712881|515933776|FG000|Overall Study|Protocol Violation|1|||
143107145|NCT00712881|515933777|FG001|Overall Study|Protocol Violation|1|||
143107146|NCT00712881|515933776|FG000|Overall Study|Randomized but not treated|1|||
143107147|NCT00712881|515933777|FG001|Overall Study|Randomized but not treated|0|||
143107148|NCT05113979|515933780|FG000|Overall Study|Death|2|||
143107149|NCT05113979|515933780|FG000|Overall Study|Lost to Follow-up|1|||
143107150|NCT03990571|515933787|FG000|Overall Study|Withdrawal by Subject|1|||
143107151|NCT03990571|515933787|FG000|Overall Study|Insurance Issues|3|||
143107152|NCT03990571|515933787|FG000|Overall Study|Covid Restrictions|2|||
143107153|NCT02691936|515933793|FG000|Overall Study|Withdrawal by Subject|2|||
143107154|NCT02691936|515933794|FG001|Overall Study|Withdrawal by Subject|5|||
143107155|NCT01878084|515933795|FG000|Overall Study|Physician Decision|2|||
143107156|NCT01876784|515933796|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
143107157|NCT01876784|515933797|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
143107158|NCT01876784|515933796|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
143107159|NCT01876784|515933797|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
143107160|NCT01876784|515933796|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
143107161|NCT01876784|515933797|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
143107162|NCT01876784|515933796|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
143107163|NCT01876784|515933797|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
143256128|NCT04966910|516492558|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
143256129|NCT04966910|516492559|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
143256130|NCT04966910|516492560|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
143256131|NCT04966910|516492561|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
143107164|NCT01876784|515933796|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
143107165|NCT01876784|515933797|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
143107166|NCT01876784|515933796|FG000|Randomized Treatment Period (40 Months)|Death|1|||
143107167|NCT01876784|515933797|FG001|Randomized Treatment Period (40 Months)|Death|0|||
143107168|NCT01876784|515933796|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
143107169|NCT01876784|515933797|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
143107170|NCT01876784|515933796|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
143107171|NCT01876784|515933797|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
143107172|NCT01876784|515933796|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
143107173|NCT01876784|515933797|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
143107174|NCT01876784|515933796|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
143107175|NCT01876784|515933797|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
143107176|NCT01876784|515933796|FG000|Open-label Period (31 Months)|Adverse Event|2|||
143107177|NCT01876784|515933797|FG001|Open-label Period (31 Months)|Adverse Event|6|||
143107178|NCT01876784|515933796|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
143107179|NCT01876784|515933797|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
143107180|NCT01876784|515933796|FG000|Open-label Period (31 Months)|Progressive disease|4|||
143107181|NCT01876784|515933797|FG001|Open-label Period (31 Months)|Progressive disease|35|||
143107182|NCT01876784|515933796|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
143107183|NCT01876784|515933797|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
143107184|NCT01876784|515933796|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
143107185|NCT01876784|515933797|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
143107186|NCT01876784|515933796|FG000|Open-label Period (31 Months)|Death|0|||
143107187|NCT01876784|515933797|FG001|Open-label Period (31 Months)|Death|1|||
143107188|NCT01876784|515933796|FG000|Open-label Period (31 Months)|Other than specified above|9|||
143107189|NCT01876784|515933797|FG001|Open-label Period (31 Months)|Other than specified above|18|||
143107190|NCT01194531|515933799|FG000|Overall Study|Withdrawal by Subject|1|||
143107191|NCT01194531|515933800|FG001|Overall Study|Withdrawal by Subject|0|||
143107192|NCT01194531|515933799|FG000|Overall Study|Protocol Violation|4|||
143107193|NCT01194531|515933800|FG001|Overall Study|Protocol Violation|1|||
143107194|NCT01194531|515933799|FG000|Overall Study|Physician Decision|0|||
143107195|NCT01194531|515933800|FG001|Overall Study|Physician Decision|2|||
143107196|NCT03891862|515933801|FG000|Open-label Period|Adverse Event|2|||
143107197|NCT03891862|515933802|FG001|Open-label Period|Adverse Event|0|||
143107198|NCT03891862|515933803|FG002|Open-label Period|Adverse Event|0|||
143107199|NCT03891862|515933801|FG000|Open-label Period|Protocol Violation|5|||
143107200|NCT03891862|515933802|FG001|Open-label Period|Protocol Violation|0|||
143107201|NCT03891862|515933803|FG002|Open-label Period|Protocol Violation|0|||
143107202|NCT03891862|515933801|FG000|Open-label Period|Withdrawal by Subject|6|||
143107203|NCT03891862|515933802|FG001|Open-label Period|Withdrawal by Subject|0|||
143107204|NCT03891862|515933803|FG002|Open-label Period|Withdrawal by Subject|0|||
143107205|NCT03891862|515933801|FG000|Open-label Period|Death|1|||
143107206|NCT03891862|515933802|FG001|Open-label Period|Death|0|||
143107207|NCT03891862|515933803|FG002|Open-label Period|Death|0|||
143107208|NCT03891862|515933801|FG000|Open-label Period|Lost to Follow-up|2|||
143107209|NCT03891862|515933802|FG001|Open-label Period|Lost to Follow-up|0|||
143107210|NCT03891862|515933803|FG002|Open-label Period|Lost to Follow-up|0|||
143107211|NCT03891862|515933801|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
143107212|NCT03891862|515933802|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
143107213|NCT03891862|515933803|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
143107214|NCT03891862|515933801|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
143107215|NCT03891862|515933802|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
143107216|NCT03891862|515933803|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
143107217|NCT03891862|515933801|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
143107218|NCT03891862|515933802|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
143107219|NCT03891862|515933803|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
143107220|NCT03891862|515933801|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
143107221|NCT03891862|515933802|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
143107222|NCT03891862|515933803|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
143107223|NCT05239494|515933804|FG000|Overall Study|Lost to Follow-up|1|||
143107224|NCT01053962|515933805|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
143107225|NCT01053962|515933806|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
143107226|NCT01053962|515933807|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
143107227|NCT01053962|515933808|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
143107228|NCT01053962|515933809|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
143107229|NCT01053962|515933805|FG000|Pretreatment Period|Venipuncture Failure|0|||
143107230|NCT01053962|515933806|FG001|Pretreatment Period|Venipuncture Failure|0|||
143107231|NCT01053962|515933807|FG002|Pretreatment Period|Venipuncture Failure|1|||
143107232|NCT01053962|515933808|FG003|Pretreatment Period|Venipuncture Failure|0|||
143107233|NCT01053962|515933809|FG004|Pretreatment Period|Venipuncture Failure|0|||
143107234|NCT01053962|515933805|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
143107235|NCT01053962|515933806|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
143107236|NCT01053962|515933807|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
143107237|NCT01053962|515933808|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
143107238|NCT01053962|515933809|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
143107239|NCT01053962|515933805|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
143107240|NCT01053962|515933806|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
143107241|NCT01053962|515933807|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
143107242|NCT01053962|515933808|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
143107243|NCT01053962|515933809|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
143107244|NCT01053962|515933805|FG000|Treatment Period|Lack of Efficacy|0|||
143107245|NCT01053962|515933806|FG001|Treatment Period|Lack of Efficacy|0|||
143107246|NCT01053962|515933807|FG002|Treatment Period|Lack of Efficacy|0|||
143107247|NCT01053962|515933808|FG003|Treatment Period|Lack of Efficacy|0|||
143107248|NCT01053962|515933809|FG004|Treatment Period|Lack of Efficacy|1|||
143107249|NCT01053962|515933805|FG000|Treatment Period|Adverse Event|0|||
143107250|NCT01053962|515933806|FG001|Treatment Period|Adverse Event|0|||
143107251|NCT01053962|515933807|FG002|Treatment Period|Adverse Event|0|||
143107252|NCT01053962|515933808|FG003|Treatment Period|Adverse Event|0|||
143107253|NCT01053962|515933809|FG004|Treatment Period|Adverse Event|1|||
143107254|NCT01053962|515933805|FG000|Treatment Period|Withdrawal by Subject|0|||
143107255|NCT01053962|515933806|FG001|Treatment Period|Withdrawal by Subject|0|||
143107256|NCT01053962|515933807|FG002|Treatment Period|Withdrawal by Subject|0|||
143107257|NCT01053962|515933808|FG003|Treatment Period|Withdrawal by Subject|0|||
143107258|NCT01053962|515933809|FG004|Treatment Period|Withdrawal by Subject|1|||
143107259|NCT01053962|515933805|FG000|Treatment Period|Noncompliance with protocol|1|||
143107260|NCT01053962|515933806|FG001|Treatment Period|Noncompliance with protocol|0|||
143107261|NCT01053962|515933807|FG002|Treatment Period|Noncompliance with protocol|0|||
143107262|NCT01053962|515933808|FG003|Treatment Period|Noncompliance with protocol|0|||
143107263|NCT01053962|515933809|FG004|Treatment Period|Noncompliance with protocol|0|||
143107264|NCT02892422|515933812|FG000|Overall Study|Enrolled not treated|4|||
143107265|NCT02892422|515933812|FG000|Overall Study|Adverse Event|38|||
143107266|NCT02892422|515933812|FG000|Overall Study|Lack of Efficacy|32|||
143107267|NCT02892422|515933812|FG000|Overall Study|Non-compliance with study drug|11|||
143107268|NCT02892422|515933812|FG000|Overall Study|Protocol Violation|4|||
143107269|NCT02892422|515933812|FG000|Overall Study|Withdrawal by Subject|56|||
143107270|NCT02892422|515933812|FG000|Overall Study|Lost to Follow-up|5|||
143107271|NCT02892422|515933812|FG000|Overall Study|sponsor information 16159A results|21|||
143107272|NCT02892422|515933812|FG000|Overall Study|withdrawal of consent|13|||
143107273|NCT02892422|515933812|FG000|Overall Study|exclusion criteria met|3|||
143107274|NCT02892422|515933812|FG000|Overall Study|moving elsewhere|4|||
143107275|NCT02892422|515933812|FG000|Overall Study|non-compliance|10|||
143107276|NCT02892422|515933812|FG000|Overall Study|patient legally incapable|1|||
143107277|NCT02892422|515933812|FG000|Overall Study|patient decision|7|||
143107278|NCT02892422|515933812|FG000|Overall Study|Investigator decision|1|||
143107279|NCT03089697|515933813|FG000|Overall Study|Adverse Event|1|||
143107280|NCT03089697|515933814|FG001|Overall Study|Adverse Event|2|||
143107281|NCT03089697|515933813|FG000|Overall Study|Withdrawal by Subject|1|||
143107282|NCT03089697|515933814|FG001|Overall Study|Withdrawal by Subject|0|||
143107283|NCT04603482|515933826|FG000|Overall Study|Lost to Follow-up|15|||
143107284|NCT04603482|515933827|FG001|Overall Study|Lost to Follow-up|15|||
143107285|NCT04603482|515933828|FG002|Overall Study|Lost to Follow-up|15|||
143107286|NCT01054196|515933832|FG000|Overall Study|Physician Decision|0|||
143107287|NCT01054196|515933833|FG001|Overall Study|Physician Decision|0|||
143107288|NCT01054196|515933834|FG002|Overall Study|Physician Decision|0|||
143107289|NCT01054196|515933835|FG003|Overall Study|Physician Decision|1|||
143256132|NCT04966910|516492558|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
143256133|NCT04966910|516492559|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
143256134|NCT04966910|516492560|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
143107290|NCT01054196|515933836|FG004|Overall Study|Physician Decision|0|||
143107291|NCT01054196|515933837|FG005|Overall Study|Physician Decision|0|||
143107292|NCT01054196|515933838|FG006|Overall Study|Physician Decision|1|||
143256135|NCT04966910|516492561|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
143256136|NCT02882152|516492565|FG000|Overall Study|Lost to Follow-up|1|||
143107293|NCT00492648|515933840|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
143107294|NCT00492648|515933841|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
143107295|NCT03382834|515933842|FG000|Step 1|Lost to Follow-up|0|||
143107296|NCT03382834|515933843|FG001|Step 1|Lost to Follow-up|1|||
143107297|NCT03382834|515933842|FG000|Step 2|Death|1|||
143107298|NCT03382834|515933843|FG001|Step 2|Death|0|||
143107299|NCT03382834|515933842|FG000|Step 2|Lost to Follow-up|2|||
143107300|NCT03382834|515933843|FG001|Step 2|Lost to Follow-up|2|||
143256137|NCT02882152|516492566|FG001|Overall Study|Lost to Follow-up|0|||
143107301|NCT03382834|515933842|FG000|Step 2|Site Terminated by Sponsor|1|||
143107302|NCT03382834|515933843|FG001|Step 2|Site Terminated by Sponsor|0|||
143107303|NCT02949843|515933844|FG000|Overall Study|Withdrawal by Subject|0|||
143107304|NCT02949843|515933845|FG001|Overall Study|Withdrawal by Subject|1|||
143107305|NCT02949843|515933846|FG002|Overall Study|Withdrawal by Subject|1|||
143107306|NCT02120833|515933847|FG000|Overall Study|Adverse Event|1|||
143107307|NCT02120833|515933848|FG001|Overall Study|Adverse Event|0|||
143107308|NCT02120833|515933847|FG000|Overall Study|Withdrawal by Subject|2|||
143107309|NCT02120833|515933848|FG001|Overall Study|Withdrawal by Subject|0|||
143107310|NCT02120833|515933847|FG000|Overall Study|Lost to Follow-up|1|||
143107311|NCT02120833|515933848|FG001|Overall Study|Lost to Follow-up|1|||
143107312|NCT03613649|515933849|FG000|Second Treatment|Lost to Follow-up|0|||
143107313|NCT03613649|515933850|FG001|Second Treatment|Lost to Follow-up|0|||
143107314|NCT03613649|515933851|FG002|Second Treatment|Lost to Follow-up|1|||
143107315|NCT03613649|515933852|FG003|Second Treatment|Lost to Follow-up|0|||
143107316|NCT03613649|515933853|FG004|Second Treatment|Lost to Follow-up|0|||
143107317|NCT03613649|515933854|FG005|Second Treatment|Lost to Follow-up|0|||
143107318|NCT03613649|515933855|FG006|Second Treatment|Lost to Follow-up|0|||
143107319|NCT03613649|515933856|FG007|Second Treatment|Lost to Follow-up|0|||
143107320|NCT03613649|515933857|FG008|Second Treatment|Lost to Follow-up|0|||
143107321|NCT03613649|515933858|FG009|Second Treatment|Lost to Follow-up|0|||
143107322|NCT03613649|515933859|FG010|Second Treatment|Lost to Follow-up|0|||
143107323|NCT03613649|515933860|FG011|Second Treatment|Lost to Follow-up|0|||
143107324|NCT03613649|515933849|FG000|Second Treatment|Withdrawal by Subject|0|||
143107325|NCT03613649|515933850|FG001|Second Treatment|Withdrawal by Subject|0|||
143107326|NCT03613649|515933851|FG002|Second Treatment|Withdrawal by Subject|0|||
143107327|NCT03613649|515933852|FG003|Second Treatment|Withdrawal by Subject|0|||
143107328|NCT03613649|515933853|FG004|Second Treatment|Withdrawal by Subject|1|||
143107329|NCT03613649|515933854|FG005|Second Treatment|Withdrawal by Subject|0|||
143107330|NCT03613649|515933855|FG006|Second Treatment|Withdrawal by Subject|0|||
143107331|NCT03613649|515933856|FG007|Second Treatment|Withdrawal by Subject|0|||
143107332|NCT03613649|515933857|FG008|Second Treatment|Withdrawal by Subject|0|||
143107333|NCT03613649|515933858|FG009|Second Treatment|Withdrawal by Subject|0|||
143107334|NCT03613649|515933859|FG010|Second Treatment|Withdrawal by Subject|0|||
143107335|NCT03613649|515933860|FG011|Second Treatment|Withdrawal by Subject|0|||
143107336|NCT03613649|515933849|FG000|Third Treatment|Lost to Follow-up|0|||
143107337|NCT03613649|515933850|FG001|Third Treatment|Lost to Follow-up|0|||
143107338|NCT03613649|515933851|FG002|Third Treatment|Lost to Follow-up|0|||
143107339|NCT03613649|515933852|FG003|Third Treatment|Lost to Follow-up|0|||
143107340|NCT03613649|515933853|FG004|Third Treatment|Lost to Follow-up|1|||
143107341|NCT03613649|515933854|FG005|Third Treatment|Lost to Follow-up|0|||
143107342|NCT03613649|515933855|FG006|Third Treatment|Lost to Follow-up|0|||
143107343|NCT03613649|515933856|FG007|Third Treatment|Lost to Follow-up|0|||
143107344|NCT03613649|515933857|FG008|Third Treatment|Lost to Follow-up|0|||
143107345|NCT03613649|515933858|FG009|Third Treatment|Lost to Follow-up|0|||
143107346|NCT03613649|515933859|FG010|Third Treatment|Lost to Follow-up|0|||
143107347|NCT03613649|515933860|FG011|Third Treatment|Lost to Follow-up|1|||
143107348|NCT03613649|515933849|FG000|Third Treatment|Protocol Violation|0|||
143107349|NCT03613649|515933850|FG001|Third Treatment|Protocol Violation|0|||
143178963|NCT01791517|516203636|FG000|Phase I: Period 1|Adverse Event|0|||
143178964|NCT01791517|516203637|FG001|Phase I: Period 1|Adverse Event|0|||
143178965|NCT01791517|516203638|FG002|Phase I: Period 1|Adverse Event|1|||
143178966|NCT01791517|516203639|FG003|Phase I: Period 1|Adverse Event|1|||
143178967|NCT01791517|516203640|FG004|Phase I: Period 1|Adverse Event|0|||
143178968|NCT01791517|516203641|FG005|Phase I: Period 1|Adverse Event|0|||
143178969|NCT01791517|516203642|FG006|Phase I: Period 1|Adverse Event|0|||
143107350|NCT03613649|515933851|FG002|Third Treatment|Protocol Violation|0|||
143107351|NCT03613649|515933852|FG003|Third Treatment|Protocol Violation|0|||
143107352|NCT03613649|515933853|FG004|Third Treatment|Protocol Violation|0|||
143107353|NCT03613649|515933854|FG005|Third Treatment|Protocol Violation|0|||
143107354|NCT03613649|515933855|FG006|Third Treatment|Protocol Violation|1|||
143107355|NCT03613649|515933856|FG007|Third Treatment|Protocol Violation|0|||
143107356|NCT03613649|515933857|FG008|Third Treatment|Protocol Violation|0|||
143107357|NCT03613649|515933858|FG009|Third Treatment|Protocol Violation|0|||
143107358|NCT03613649|515933859|FG010|Third Treatment|Protocol Violation|0|||
143107359|NCT03613649|515933860|FG011|Third Treatment|Protocol Violation|1|||
143107360|NCT03613649|515933849|FG000|Fourth Treatment|Protocol Violation|1|||
143107361|NCT03613649|515933850|FG001|Fourth Treatment|Protocol Violation|0|||
143107362|NCT03613649|515933851|FG002|Fourth Treatment|Protocol Violation|0|||
143107363|NCT03613649|515933852|FG003|Fourth Treatment|Protocol Violation|0|||
143107364|NCT03613649|515933853|FG004|Fourth Treatment|Protocol Violation|1|||
143107365|NCT03613649|515933854|FG005|Fourth Treatment|Protocol Violation|0|||
143107366|NCT03613649|515933855|FG006|Fourth Treatment|Protocol Violation|0|||
143107367|NCT03613649|515933856|FG007|Fourth Treatment|Protocol Violation|0|||
143107368|NCT03613649|515933857|FG008|Fourth Treatment|Protocol Violation|0|||
143107369|NCT03613649|515933858|FG009|Fourth Treatment|Protocol Violation|0|||
143107370|NCT03613649|515933859|FG010|Fourth Treatment|Protocol Violation|0|||
143178970|NCT01791517|516203643|FG007|Phase I: Period 1|Adverse Event|0|||
143107371|NCT03613649|515933860|FG011|Fourth Treatment|Protocol Violation|0|||
143107372|NCT03613649|515933849|FG000|Fourth Treatment|Physician Decision|0|||
143107373|NCT03613649|515933850|FG001|Fourth Treatment|Physician Decision|0|||
143107374|NCT03613649|515933851|FG002|Fourth Treatment|Physician Decision|0|||
143107375|NCT03613649|515933852|FG003|Fourth Treatment|Physician Decision|0|||
143107376|NCT03613649|515933853|FG004|Fourth Treatment|Physician Decision|0|||
143107377|NCT03613649|515933854|FG005|Fourth Treatment|Physician Decision|0|||
143107378|NCT03613649|515933855|FG006|Fourth Treatment|Physician Decision|1|||
143107379|NCT03613649|515933856|FG007|Fourth Treatment|Physician Decision|0|||
143107380|NCT03613649|515933857|FG008|Fourth Treatment|Physician Decision|0|||
143107381|NCT03613649|515933858|FG009|Fourth Treatment|Physician Decision|0|||
143107382|NCT03613649|515933859|FG010|Fourth Treatment|Physician Decision|0|||
143107383|NCT03613649|515933860|FG011|Fourth Treatment|Physician Decision|0|||
143107384|NCT00675428|515933861|FG000|Overall Study|Disease Progression|2|||
143107385|NCT00675428|515933862|FG001|Overall Study|Disease Progression|2|||
143107386|NCT00675428|515933861|FG000|Overall Study|No Disease Response After Cycle 6|0|||
143107387|NCT00675428|515933862|FG001|Overall Study|No Disease Response After Cycle 6|1|||
143107388|NCT00675428|515933861|FG000|Overall Study|Physician Decision|1|||
143107389|NCT00675428|515933862|FG001|Overall Study|Physician Decision|0|||
143107390|NCT01500187|515933864|FG000|Overall Study|Lost to Follow-up|6|||
143107391|NCT01500187|515933865|FG001|Overall Study|Lost to Follow-up|0|||
143107392|NCT01343277|515933878|FG000|Overall Study|Other|3|||
143107393|NCT01343277|515933879|FG001|Overall Study|Other|3|||
143107394|NCT01343277|515933878|FG000|Overall Study|Withdrawal by Subject|18|||
143107395|NCT01343277|515933879|FG001|Overall Study|Withdrawal by Subject|13|||
143107396|NCT01343277|515933878|FG000|Overall Study|Physician Decision|1|||
143107397|NCT01343277|515933879|FG001|Overall Study|Physician Decision|2|||
143107398|NCT01343277|515933878|FG000|Overall Study|Death|10|||
143107399|NCT01343277|515933879|FG001|Overall Study|Death|1|||
143107400|NCT01343277|515933878|FG000|Overall Study|Adverse Event|67|||
143107401|NCT01343277|515933879|FG001|Overall Study|Adverse Event|13|||
143107402|NCT01343277|515933878|FG000|Overall Study|Disease progression|270|||
143107403|NCT01343277|515933879|FG001|Overall Study|Disease progression|138|||
143107404|NCT01343277|515933878|FG000|Overall Study|Randomized not treated|6|||
143107405|NCT01343277|515933879|FG001|Overall Study|Randomized not treated|21|||
143107406|NCT01343277|515933878|FG000|Overall Study|Treatment ongoing|8|||
143107407|NCT01343277|515933879|FG001|Overall Study|Treatment ongoing|2|||
143107408|NCT01343277|515933878|FG000|Overall Study|Subsequent anticancer therapy|1|||
143107409|NCT01343277|515933879|FG001|Overall Study|Subsequent anticancer therapy|0|||
143107410|NCT00135512|515933880|FG000|Overall Study|Adverse Event|56|||
143107411|NCT00135512|515933880|FG000|Overall Study|Lack of Efficacy|25|||
143107412|NCT00135512|515933880|FG000|Overall Study|Other|42|||
143107413|NCT05020665|515933883|FG000|Overall Study|Study terminated by Sponsor|5|||
143107414|NCT05020665|515933884|FG001|Overall Study|Study terminated by Sponsor|4|||
143107415|NCT05020665|515933883|FG000|Overall Study|Death|2|||
143107416|NCT05020665|515933884|FG001|Overall Study|Death|1|||
143107417|NCT05020665|515933883|FG000|Overall Study|Physician Decision|0|||
143107418|NCT05020665|515933884|FG001|Overall Study|Physician Decision|1|||
143107419|NCT05020665|515933883|FG000|Overall Study|Withdrawal by Subject|0|||
143107420|NCT05020665|515933884|FG001|Overall Study|Withdrawal by Subject|1|||
143107421|NCT05020665|515933883|FG000|Overall Study|Reason not specified|1|||
143107422|NCT05020665|515933884|FG001|Overall Study|Reason not specified|0|||
143107423|NCT01868022|515933885|FG000|Overall Study|Withdrawal by Subject|0|||
143107424|NCT01868022|515933886|FG001|Overall Study|Withdrawal by Subject|0|||
143107425|NCT01868022|515933887|FG002|Overall Study|Withdrawal by Subject|1|||
143107426|NCT01868022|515933888|FG003|Overall Study|Withdrawal by Subject|1|||
143178971|NCT01791517|516203644|FG008|Phase I: Period 1|Adverse Event|0|||
143178972|NCT01791517|516203645|FG009|Phase I: Period 1|Adverse Event|0|||
143178973|NCT01791517|516203646|FG010|Phase I: Period 1|Adverse Event|0|||
143178974|NCT01791517|516203647|FG011|Phase I: Period 1|Adverse Event|0|||
143178975|NCT01791517|516203636|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
143178976|NCT01791517|516203637|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
143178977|NCT01791517|516203638|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
143178978|NCT01791517|516203639|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
143107427|NCT01868022|515933889|FG004|Overall Study|Withdrawal by Subject|0|||
143107428|NCT01868022|515933890|FG005|Overall Study|Withdrawal by Subject|0|||
143107429|NCT01868022|515933891|FG006|Overall Study|Withdrawal by Subject|0|||
143178979|NCT01791517|516203640|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
143107430|NCT01868022|515933892|FG007|Overall Study|Withdrawal by Subject|1|||
143107431|NCT01868022|515933893|FG008|Overall Study|Withdrawal by Subject|0|||
143107432|NCT01868022|515933885|FG000|Overall Study|Adverse Event|0|||
143107433|NCT01868022|515933886|FG001|Overall Study|Adverse Event|0|||
143107434|NCT01868022|515933887|FG002|Overall Study|Adverse Event|0|||
143107435|NCT01868022|515933888|FG003|Overall Study|Adverse Event|0|||
143107436|NCT01868022|515933889|FG004|Overall Study|Adverse Event|2|||
143107437|NCT01868022|515933890|FG005|Overall Study|Adverse Event|0|||
143107438|NCT01868022|515933891|FG006|Overall Study|Adverse Event|0|||
143107439|NCT01868022|515933892|FG007|Overall Study|Adverse Event|2|||
143256138|NCT05338671|516492569|FG000|Overall Study|Lost to Follow-up|2|||
143256139|NCT05338671|516492570|FG001|Overall Study|Lost to Follow-up|2|||
143256140|NCT05338671|516492569|FG000|Overall Study|Root canal completed in a single visit|1|||
143107440|NCT01868022|515933893|FG008|Overall Study|Adverse Event|2|||
143107441|NCT01868022|515933885|FG000|Overall Study|Physician Decision|0|||
143107442|NCT01868022|515933886|FG001|Overall Study|Physician Decision|0|||
143107443|NCT01868022|515933887|FG002|Overall Study|Physician Decision|0|||
143107444|NCT01868022|515933888|FG003|Overall Study|Physician Decision|0|||
143107445|NCT01868022|515933889|FG004|Overall Study|Physician Decision|0|||
143107446|NCT01868022|515933890|FG005|Overall Study|Physician Decision|1|||
143107447|NCT01868022|515933891|FG006|Overall Study|Physician Decision|0|||
143107448|NCT01868022|515933892|FG007|Overall Study|Physician Decision|2|||
143107449|NCT01868022|515933893|FG008|Overall Study|Physician Decision|0|||
143107450|NCT01868022|515933885|FG000|Overall Study|Study closed/terminated|0|||
143107451|NCT01868022|515933886|FG001|Overall Study|Study closed/terminated|0|||
143107452|NCT01868022|515933887|FG002|Overall Study|Study closed/terminated|0|||
143107453|NCT01868022|515933888|FG003|Overall Study|Study closed/terminated|0|||
143107454|NCT01868022|515933889|FG004|Overall Study|Study closed/terminated|0|||
143107455|NCT01868022|515933890|FG005|Overall Study|Study closed/terminated|0|||
143107456|NCT01868022|515933891|FG006|Overall Study|Study closed/terminated|0|||
143107457|NCT01868022|515933892|FG007|Overall Study|Study closed/terminated|1|||
143107458|NCT01868022|515933893|FG008|Overall Study|Study closed/terminated|0|||
143107459|NCT01868022|515933885|FG000|Overall Study|Ongoing|0|||
143107460|NCT01868022|515933886|FG001|Overall Study|Ongoing|0|||
143107461|NCT01868022|515933887|FG002|Overall Study|Ongoing|0|||
143107462|NCT01868022|515933888|FG003|Overall Study|Ongoing|0|||
143107463|NCT01868022|515933889|FG004|Overall Study|Ongoing|0|||
143107464|NCT01868022|515933890|FG005|Overall Study|Ongoing|0|||
143107465|NCT01868022|515933891|FG006|Overall Study|Ongoing|0|||
143107466|NCT01868022|515933892|FG007|Overall Study|Ongoing|3|||
143107467|NCT01868022|515933893|FG008|Overall Study|Ongoing|0|||
143107468|NCT00022698|515933894|FG000|Overall Study|Adverse Event|5|||
143107469|NCT00022698|515933895|FG001|Overall Study|Adverse Event|9|||
143107470|NCT00022698|515933894|FG000|Overall Study|Death|0|||
143107471|NCT00022698|515933895|FG001|Overall Study|Death|2|||
143107472|NCT00022698|515933894|FG000|Overall Study|Failure to return|0|||
143107473|NCT00022698|515933895|FG001|Overall Study|Failure to return|1|||
143107474|NCT00022698|515933894|FG000|Overall Study|Refused treatment|0|||
143107475|NCT00022698|515933895|FG001|Overall Study|Refused treatment|2|||
143107476|NCT00022698|515933894|FG000|Overall Study|Insufficient therapeutic response|2|||
143107477|NCT00022698|515933895|FG001|Overall Study|Insufficient therapeutic response|14|||
143107478|NCT00022698|515933894|FG000|Overall Study|Administrative /other|1|||
143107479|NCT00022698|515933895|FG001|Overall Study|Administrative /other|7|||
143107480|NCT01628198|515933896|FG000|Overall Study|Lost to Follow-up|7|||
143107481|NCT01628198|515933896|FG000|Overall Study|Withdrawal by Subject|10|||
143107482|NCT01628198|515933896|FG000|Overall Study|Screen failure|1|||
143107483|NCT02504827|515933898|FG000|Overall Study|Could not produce sputum|1|||
143107484|NCT01743560|515933899|FG000|Overall Study|Disease progression|26|||
143107485|NCT01743560|515933899|FG000|Overall Study|Adverse Event|8|||
143107486|NCT01743560|515933899|FG000|Overall Study|Death|3|||
143107487|NCT01743560|515933899|FG000|Overall Study|Withdrawal by Subject|2|||
143107488|NCT01743560|515933899|FG000|Overall Study|Protocol Violation|1|||
143107489|NCT01743560|515933899|FG000|Overall Study|>1 dose of study drug|3|||
143107490|NCT03386994|515933900|FG000|Overall Study|Lung transplant|1|||
143107491|NCT03386994|515933900|FG000|Overall Study|Adverse Event|14|||
143107492|NCT03386994|515933900|FG000|Overall Study|Lost to Follow-up|4|||
143107493|NCT03386994|515933900|FG000|Overall Study|Withdrawal by Subject|3|||
143107494|NCT03386994|515933900|FG000|Overall Study|Death|16|||
143256141|NCT05338671|516492570|FG001|Overall Study|Root canal completed in a single visit|0|||
143107495|NCT03425396|515933904|FG000|Overall Study|Lost to Follow-up|2|||
143107496|NCT03425396|515933905|FG001|Overall Study|Lost to Follow-up|5|||
143107497|NCT03425396|515933906|FG002|Overall Study|Lost to Follow-up|2|||
143107498|NCT03425396|515933907|FG003|Overall Study|Lost to Follow-up|0|||
143107499|NCT03425396|515933908|FG004|Overall Study|Lost to Follow-up|0|||
143256142|NCT01369329|516492573|FG000|Overall Study|Withdrawal by Subject|8|||
143256143|NCT01369329|516492574|FG001|Overall Study|Withdrawal by Subject|6|||
143107500|NCT03425396|515933904|FG000|Overall Study|Withdrawal by Subject|0|||
143107501|NCT03425396|515933905|FG001|Overall Study|Withdrawal by Subject|1|||
143107502|NCT03425396|515933906|FG002|Overall Study|Withdrawal by Subject|0|||
143107503|NCT03425396|515933907|FG003|Overall Study|Withdrawal by Subject|1|||
143107504|NCT03425396|515933908|FG004|Overall Study|Withdrawal by Subject|0|||
143107505|NCT03425396|515933904|FG000|Overall Study|Other|0|||
143107506|NCT03425396|515933905|FG001|Overall Study|Other|1|||
143107507|NCT03425396|515933906|FG002|Overall Study|Other|1|||
143107508|NCT03425396|515933907|FG003|Overall Study|Other|0|||
143107509|NCT03425396|515933908|FG004|Overall Study|Other|1|||
143107510|NCT03512210|515933911|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
143107511|NCT03512210|515933911|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
143107512|NCT03512210|515933911|FG000|Step 2:Post-MINMON|Death|2|||
143107513|NCT03512210|515933911|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
143178980|NCT01791517|516203641|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
143178981|NCT01791517|516203642|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
143178982|NCT01791517|516203643|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
143178983|NCT01791517|516203644|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
143178984|NCT01791517|516203645|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
143178985|NCT01791517|516203646|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
143178986|NCT01791517|516203647|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
143178987|NCT01791517|516203636|FG000|Phase I: Period 1|Protocol Violation|0|||
143178988|NCT01791517|516203637|FG001|Phase I: Period 1|Protocol Violation|1|||
143178989|NCT01791517|516203638|FG002|Phase I: Period 1|Protocol Violation|0|||
143178990|NCT01791517|516203639|FG003|Phase I: Period 1|Protocol Violation|0|||
143178991|NCT01791517|516203640|FG004|Phase I: Period 1|Protocol Violation|0|||
143178992|NCT01791517|516203641|FG005|Phase I: Period 1|Protocol Violation|0|||
143178993|NCT01791517|516203642|FG006|Phase I: Period 1|Protocol Violation|0|||
143178994|NCT01791517|516203643|FG007|Phase I: Period 1|Protocol Violation|0|||
143178995|NCT01791517|516203644|FG008|Phase I: Period 1|Protocol Violation|0|||
143178996|NCT01791517|516203645|FG009|Phase I: Period 1|Protocol Violation|0|||
143178997|NCT01791517|516203646|FG010|Phase I: Period 1|Protocol Violation|0|||
143178998|NCT01791517|516203647|FG011|Phase I: Period 1|Protocol Violation|0|||
143178999|NCT01791517|516203636|FG000|Phase I: Period 1|Lost to Follow-up|0|||
143179000|NCT01791517|516203637|FG001|Phase I: Period 1|Lost to Follow-up|0|||
143179001|NCT01791517|516203638|FG002|Phase I: Period 1|Lost to Follow-up|0|||
143179002|NCT01791517|516203639|FG003|Phase I: Period 1|Lost to Follow-up|1|||
143179003|NCT01791517|516203640|FG004|Phase I: Period 1|Lost to Follow-up|0|||
143179004|NCT01791517|516203641|FG005|Phase I: Period 1|Lost to Follow-up|0|||
143179005|NCT01791517|516203642|FG006|Phase I: Period 1|Lost to Follow-up|1|||
143179006|NCT01791517|516203643|FG007|Phase I: Period 1|Lost to Follow-up|0|||
143179007|NCT01791517|516203644|FG008|Phase I: Period 1|Lost to Follow-up|1|||
143179008|NCT01791517|516203645|FG009|Phase I: Period 1|Lost to Follow-up|1|||
143179009|NCT01791517|516203646|FG010|Phase I: Period 1|Lost to Follow-up|0|||
143179010|NCT01791517|516203647|FG011|Phase I: Period 1|Lost to Follow-up|0|||
143179011|NCT01791517|516203636|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
143179012|NCT01791517|516203637|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
143179013|NCT01791517|516203638|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
143179014|NCT01791517|516203639|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
143179015|NCT01791517|516203640|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
143179016|NCT01791517|516203641|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
143179017|NCT01791517|516203642|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
143179018|NCT01791517|516203643|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
143179019|NCT01791517|516203644|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
143179020|NCT01791517|516203645|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
143179021|NCT01791517|516203646|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
143179022|NCT01791517|516203647|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
143179023|NCT01791517|516203636|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
143179024|NCT01791517|516203637|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
143179025|NCT01791517|516203638|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
143179026|NCT01791517|516203639|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
143179027|NCT01791517|516203640|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
143179028|NCT01791517|516203641|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
143179029|NCT01791517|516203642|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
143179030|NCT01791517|516203643|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
143179031|NCT01791517|516203644|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
143179032|NCT01791517|516203645|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
143179033|NCT01791517|516203646|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
143179034|NCT01791517|516203647|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
143179035|NCT01791517|516203636|FG000|Phase I: Period 2|Protocol Violation|0|||
143179036|NCT01791517|516203637|FG001|Phase I: Period 2|Protocol Violation|0|||
143179037|NCT01791517|516203638|FG002|Phase I: Period 2|Protocol Violation|0|||
143179038|NCT01791517|516203639|FG003|Phase I: Period 2|Protocol Violation|1|||
143179039|NCT01791517|516203640|FG004|Phase I: Period 2|Protocol Violation|0|||
143179040|NCT01791517|516203641|FG005|Phase I: Period 2|Protocol Violation|0|||
143179041|NCT01791517|516203642|FG006|Phase I: Period 2|Protocol Violation|0|||
143179042|NCT01791517|516203643|FG007|Phase I: Period 2|Protocol Violation|0|||
143256144|NCT01369329|516492575|FG002|Overall Study|Withdrawal by Subject|10|||
143179043|NCT01791517|516203644|FG008|Phase I: Period 2|Protocol Violation|0|||
143256145|NCT01369329|516492573|FG000|Overall Study|Lost to Follow-up|2|||
143256146|NCT01369329|516492574|FG001|Overall Study|Lost to Follow-up|2|||
143256147|NCT01369329|516492575|FG002|Overall Study|Lost to Follow-up|2|||
143256148|NCT01369329|516492573|FG000|Overall Study|Other|2|||
143256149|NCT01369329|516492574|FG001|Overall Study|Other|3|||
143179044|NCT01791517|516203645|FG009|Phase I: Period 2|Protocol Violation|0|||
143179045|NCT01791517|516203646|FG010|Phase I: Period 2|Protocol Violation|0|||
143179046|NCT01791517|516203647|FG011|Phase I: Period 2|Protocol Violation|0|||
143179047|NCT01791517|516203636|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
143256150|NCT01369329|516492575|FG002|Overall Study|Other|2|||
143107514|NCT03512210|515933911|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
143107515|NCT01672710|515933914|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
143107516|NCT01672710|515933915|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
143107517|NCT01672710|515933914|FG000|3 Month Follow up|Lost to Follow-up|2|||
143107518|NCT01672710|515933915|FG001|3 Month Follow up|Lost to Follow-up|3|||
143107519|NCT01672710|515933914|FG000|3 Month Follow up|follow up due after termination date|4|||
143107520|NCT01672710|515933915|FG001|3 Month Follow up|follow up due after termination date|1|||
143107521|NCT02122887|515933916|FG000|Overall Study|Withdrawal by Subject|20|||
143107522|NCT02122887|515933917|FG001|Overall Study|Withdrawal by Subject|2|||
143107523|NCT03875092|515935553|FG000|Overall Study|Adverse Event|2|||
143107524|NCT03875092|515935554|FG001|Overall Study|Adverse Event|5|||
143107525|NCT03875092|515935553|FG000|Overall Study|Death|44|||
143107526|NCT03875092|515935554|FG001|Overall Study|Death|51|||
143107527|NCT03875092|515935553|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
143107528|NCT03875092|515935554|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
143107529|NCT00636194|515935555|FG000|Overall Study|Study related symptoms and complaints|1|||
143107530|NCT00636194|515935556|FG001|Overall Study|Study related symptoms and complaints|0|||
143107531|NCT00636194|515935555|FG000|Overall Study|Protocol Violation|2|||
143107532|NCT00636194|515935556|FG001|Overall Study|Protocol Violation|0|||
143107533|NCT02163226|515935557|FG000|Overall Study|Death|2|||
143107534|NCT02163226|515935558|FG001|Overall Study|Death|1|||
143107535|NCT02163226|515935557|FG000|Overall Study|Withdrawal by Subject|5|||
143107536|NCT02163226|515935558|FG001|Overall Study|Withdrawal by Subject|2|||
143107537|NCT02163226|515935557|FG000|Overall Study|Returned home, local radiotherapy|3|||
143107538|NCT02163226|515935558|FG001|Overall Study|Returned home, local radiotherapy|0|||
143107539|NCT02163226|515935557|FG000|Overall Study|Repeat imaging showed no disease|2|||
143107540|NCT02163226|515935558|FG001|Overall Study|Repeat imaging showed no disease|0|||
143107541|NCT02163226|515935557|FG000|Overall Study|Incomplete radiotherapy|3|||
143107542|NCT02163226|515935558|FG001|Overall Study|Incomplete radiotherapy|0|||
143107543|NCT02163226|515935557|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
143107544|NCT02163226|515935558|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
143107545|NCT02163226|515935557|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
143107546|NCT02163226|515935558|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
143107547|NCT02163226|515935557|FG000|Overall Study|ineligible|0|||
143107548|NCT02163226|515935558|FG001|Overall Study|ineligible|3|||
143107549|NCT05318092|515935559|FG000|Overall Study|Lost to Follow-up|3|||
143107550|NCT05318092|515935559|FG000|Overall Study|Withdrawal by Subject|1|||
143107551|NCT03854370|515935560|FG000|Overall Study|samples not collected|1|||
143107552|NCT03854370|515935561|FG001|Overall Study|samples not collected|1|||
143107553|NCT03854370|515935562|FG002|Overall Study|samples not collected|1|||
143107554|NCT03854370|515935563|FG003|Overall Study|samples not collected|1|||
143107555|NCT01300338|515935572|FG000|Overall Study|Lost to Follow-up|5|||
143107556|NCT01300338|515935573|FG001|Overall Study|Lost to Follow-up|0|||
143107557|NCT02461524|515935574|FG000|Overall Study|Death|16|||
143107558|NCT02461524|515935574|FG000|Overall Study|Withdrawal by Subject|4|||
143107559|NCT02461524|515935574|FG000|Overall Study|Device Explanted|5|||
143107560|NCT02461524|515935574|FG000|Overall Study|Missed Visit|6|||
143107561|NCT00330343|515935575|FG000|Overall Study|Lost to Follow-up|5|||
143107562|NCT00281632|515935576|FG000|Overall Study|Adverse Event|7|||
143107563|NCT00281632|515935576|FG000|Overall Study|Withdrawal by Subject|2|||
143107564|NCT00281632|515935576|FG000|Overall Study|Disease Progression|22|||
143107565|NCT00281632|515935576|FG000|Overall Study|Death|1|||
143107566|NCT00281632|515935576|FG000|Overall Study|Physician Decision|1|||
143107567|NCT00281632|515935576|FG000|Overall Study|Ongoing|3|||
143107568|NCT02980341|515935577|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
143107569|NCT02980341|515935578|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
143107570|NCT02980341|515935579|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
143107571|NCT02980341|515935580|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
143107572|NCT02980341|515935581|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
143107573|NCT02980341|515935582|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
143256151|NCT01215916|516492576|FG000|Overall Study|Progressive Disease|0|||
143256152|NCT01215916|516492577|FG001|Overall Study|Progressive Disease|2|||
143107574|NCT02980341|515935583|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
143107575|NCT02980341|515935584|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
143107576|NCT02980341|515935585|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
143107577|NCT02980341|515935586|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
143256153|NCT01215916|516492578|FG002|Overall Study|Progressive Disease|1|||
143256154|NCT01215916|516492579|FG003|Overall Study|Progressive Disease|2|||
143107578|NCT02980341|515935587|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
143107579|NCT02980341|515935577|FG000|Dose Escalation|Clinical progression|0|||
143107580|NCT02980341|515935578|FG001|Dose Escalation|Clinical progression|0|||
143107581|NCT02980341|515935579|FG002|Dose Escalation|Clinical progression|2|||
143107582|NCT02980341|515935580|FG003|Dose Escalation|Clinical progression|1|||
143256155|NCT01215916|516492580|FG004|Overall Study|Progressive Disease|5|||
143256156|NCT01215916|516492581|FG005|Overall Study|Progressive Disease|4|||
143256157|NCT01215916|516492582|FG006|Overall Study|Progressive Disease|5|||
143256158|NCT01215916|516492583|FG007|Overall Study|Progressive Disease|3|||
143107583|NCT02980341|515935581|FG004|Dose Escalation|Clinical progression|0|||
143107584|NCT02980341|515935582|FG005|Dose Escalation|Clinical progression|0|||
143107585|NCT02980341|515935583|FG006|Dose Escalation|Clinical progression|0|||
143107586|NCT02980341|515935584|FG007|Dose Escalation|Clinical progression|0|||
143107587|NCT02980341|515935585|FG008|Dose Escalation|Clinical progression|0|||
143107588|NCT02980341|515935586|FG009|Dose Escalation|Clinical progression|0|||
143107589|NCT02980341|515935587|FG010|Dose Escalation|Clinical progression|0|||
143107590|NCT02980341|515935577|FG000|Dose Escalation|Adverse Event|0|||
143107591|NCT02980341|515935578|FG001|Dose Escalation|Adverse Event|0|||
143107592|NCT02980341|515935579|FG002|Dose Escalation|Adverse Event|1|||
143107593|NCT02980341|515935580|FG003|Dose Escalation|Adverse Event|2|||
143107594|NCT02980341|515935581|FG004|Dose Escalation|Adverse Event|2|||
143107595|NCT02980341|515935582|FG005|Dose Escalation|Adverse Event|0|||
143107596|NCT02980341|515935583|FG006|Dose Escalation|Adverse Event|0|||
143107597|NCT02980341|515935584|FG007|Dose Escalation|Adverse Event|0|||
143107598|NCT02980341|515935585|FG008|Dose Escalation|Adverse Event|0|||
143107599|NCT02980341|515935586|FG009|Dose Escalation|Adverse Event|0|||
143107600|NCT02980341|515935587|FG010|Dose Escalation|Adverse Event|0|||
143107601|NCT02980341|515935577|FG000|Dose Escalation|Withdrawal by Subject|0|||
143107602|NCT02980341|515935578|FG001|Dose Escalation|Withdrawal by Subject|0|||
143107603|NCT02980341|515935579|FG002|Dose Escalation|Withdrawal by Subject|1|||
143107604|NCT02980341|515935580|FG003|Dose Escalation|Withdrawal by Subject|0|||
143107605|NCT02980341|515935581|FG004|Dose Escalation|Withdrawal by Subject|0|||
143107606|NCT02980341|515935582|FG005|Dose Escalation|Withdrawal by Subject|0|||
143107607|NCT02980341|515935583|FG006|Dose Escalation|Withdrawal by Subject|0|||
143107608|NCT02980341|515935584|FG007|Dose Escalation|Withdrawal by Subject|0|||
143107609|NCT02980341|515935585|FG008|Dose Escalation|Withdrawal by Subject|0|||
143107610|NCT02980341|515935586|FG009|Dose Escalation|Withdrawal by Subject|0|||
143107611|NCT02980341|515935587|FG010|Dose Escalation|Withdrawal by Subject|0|||
143107612|NCT02980341|515935577|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
143107613|NCT02980341|515935578|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
143107614|NCT02980341|515935579|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
143107615|NCT02980341|515935580|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
143107616|NCT02980341|515935581|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
143107617|NCT02980341|515935582|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
143107618|NCT02980341|515935583|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
143107619|NCT02980341|515935584|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
143107620|NCT02980341|515935585|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
143107621|NCT02980341|515935586|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
143107622|NCT02980341|515935587|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
143107623|NCT02980341|515935577|FG000|Dose Escalation|Due to investigator's decision|0|||
143107624|NCT02980341|515935578|FG001|Dose Escalation|Due to investigator's decision|0|||
143107625|NCT02980341|515935579|FG002|Dose Escalation|Due to investigator's decision|0|||
143107626|NCT02980341|515935580|FG003|Dose Escalation|Due to investigator's decision|0|||
143107627|NCT02980341|515935581|FG004|Dose Escalation|Due to investigator's decision|1|||
143107628|NCT02980341|515935582|FG005|Dose Escalation|Due to investigator's decision|0|||
143107629|NCT02980341|515935583|FG006|Dose Escalation|Due to investigator's decision|0|||
143179048|NCT01791517|516203637|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
143179049|NCT01791517|516203638|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
143179050|NCT01791517|516203639|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
143179051|NCT01791517|516203640|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
143179052|NCT01791517|516203641|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
143179053|NCT01791517|516203642|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
143179054|NCT01791517|516203643|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
143179055|NCT01791517|516203644|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
143179056|NCT01791517|516203645|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
143179057|NCT01791517|516203646|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
143179058|NCT01791517|516203647|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
143179059|NCT01791517|516203636|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
143179060|NCT01791517|516203637|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
143179061|NCT01791517|516203638|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
143179062|NCT01791517|516203639|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
143256159|NCT01215916|516492584|FG008|Overall Study|Progressive Disease|1|||
143256160|NCT01215916|516492576|FG000|Overall Study|Adverse Event|1|||
143107630|NCT02980341|515935584|FG007|Dose Escalation|Due to investigator's decision|0|||
143107631|NCT02980341|515935585|FG008|Dose Escalation|Due to investigator's decision|0|||
143107632|NCT02980341|515935586|FG009|Dose Escalation|Due to investigator's decision|0|||
143107633|NCT02980341|515935587|FG010|Dose Escalation|Due to investigator's decision|0|||
143179063|NCT01791517|516203640|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
143179064|NCT01791517|516203641|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
143179065|NCT01791517|516203642|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
143179066|NCT01791517|516203643|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
143179067|NCT01791517|516203644|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
143179068|NCT01791517|516203645|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
143179069|NCT01791517|516203646|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
143179070|NCT01791517|516203647|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
143179071|NCT01791517|516203636|FG000|Phase I: Period 2|Lens Discomfort|0|||
143179072|NCT01791517|516203637|FG001|Phase I: Period 2|Lens Discomfort|0|||
143179073|NCT01791517|516203638|FG002|Phase I: Period 2|Lens Discomfort|0|||
143179074|NCT01791517|516203639|FG003|Phase I: Period 2|Lens Discomfort|0|||
143179075|NCT01791517|516203640|FG004|Phase I: Period 2|Lens Discomfort|0|||
143179076|NCT01791517|516203641|FG005|Phase I: Period 2|Lens Discomfort|1|||
143179077|NCT01791517|516203642|FG006|Phase I: Period 2|Lens Discomfort|0|||
143179078|NCT01791517|516203643|FG007|Phase I: Period 2|Lens Discomfort|0|||
143179079|NCT01791517|516203644|FG008|Phase I: Period 2|Lens Discomfort|0|||
143179080|NCT01791517|516203645|FG009|Phase I: Period 2|Lens Discomfort|0|||
143179081|NCT01791517|516203646|FG010|Phase I: Period 2|Lens Discomfort|0|||
143179082|NCT01791517|516203647|FG011|Phase I: Period 2|Lens Discomfort|0|||
143179083|NCT01791517|516203636|FG000|Phase I: Period 2|Lost to Follow-up|0|||
143179084|NCT01791517|516203637|FG001|Phase I: Period 2|Lost to Follow-up|3|||
143179085|NCT01791517|516203638|FG002|Phase I: Period 2|Lost to Follow-up|2|||
143179086|NCT01791517|516203639|FG003|Phase I: Period 2|Lost to Follow-up|0|||
143179087|NCT01791517|516203640|FG004|Phase I: Period 2|Lost to Follow-up|0|||
143179088|NCT01791517|516203641|FG005|Phase I: Period 2|Lost to Follow-up|0|||
143179089|NCT01791517|516203642|FG006|Phase I: Period 2|Lost to Follow-up|0|||
143179090|NCT01791517|516203643|FG007|Phase I: Period 2|Lost to Follow-up|0|||
143179091|NCT01791517|516203644|FG008|Phase I: Period 2|Lost to Follow-up|0|||
143256161|NCT01215916|516492577|FG001|Overall Study|Adverse Event|1|||
143256162|NCT01215916|516492578|FG002|Overall Study|Adverse Event|0|||
143256163|NCT01215916|516492579|FG003|Overall Study|Adverse Event|1|||
143256164|NCT01215916|516492580|FG004|Overall Study|Adverse Event|0|||
143256165|NCT01215916|516492581|FG005|Overall Study|Adverse Event|0|||
143256166|NCT01215916|516492582|FG006|Overall Study|Adverse Event|3|||
143256167|NCT01215916|516492583|FG007|Overall Study|Adverse Event|0|||
143256168|NCT01215916|516492584|FG008|Overall Study|Adverse Event|0|||
143256169|NCT01215916|516492576|FG000|Overall Study|Withdrawal by Subject|0|||
143256170|NCT01215916|516492577|FG001|Overall Study|Withdrawal by Subject|1|||
143256171|NCT01215916|516492578|FG002|Overall Study|Withdrawal by Subject|1|||
143256172|NCT01215916|516492579|FG003|Overall Study|Withdrawal by Subject|2|||
143256173|NCT01215916|516492580|FG004|Overall Study|Withdrawal by Subject|0|||
143256174|NCT01215916|516492581|FG005|Overall Study|Withdrawal by Subject|0|||
143256175|NCT01215916|516492582|FG006|Overall Study|Withdrawal by Subject|1|||
143256176|NCT01215916|516492583|FG007|Overall Study|Withdrawal by Subject|0|||
143256177|NCT01215916|516492584|FG008|Overall Study|Withdrawal by Subject|0|||
143256178|NCT01215916|516492576|FG000|Overall Study|Death|0|||
143256179|NCT01215916|516492577|FG001|Overall Study|Death|1|||
143256180|NCT01215916|516492578|FG002|Overall Study|Death|0|||
143256181|NCT01215916|516492579|FG003|Overall Study|Death|0|||
143256182|NCT01215916|516492580|FG004|Overall Study|Death|1|||
143256183|NCT01215916|516492581|FG005|Overall Study|Death|0|||
143256184|NCT01215916|516492582|FG006|Overall Study|Death|0|||
143256185|NCT01215916|516492583|FG007|Overall Study|Death|0|||
143256186|NCT01215916|516492584|FG008|Overall Study|Death|1|||
143256187|NCT01215916|516492576|FG000|Overall Study|Physician Decision|0|||
143256188|NCT01215916|516492577|FG001|Overall Study|Physician Decision|0|||
143256189|NCT01215916|516492578|FG002|Overall Study|Physician Decision|1|||
143256190|NCT01215916|516492579|FG003|Overall Study|Physician Decision|1|||
143256191|NCT01215916|516492580|FG004|Overall Study|Physician Decision|0|||
143256192|NCT01215916|516492581|FG005|Overall Study|Physician Decision|0|||
143256193|NCT01215916|516492582|FG006|Overall Study|Physician Decision|0|||
143256194|NCT01215916|516492583|FG007|Overall Study|Physician Decision|0|||
143256195|NCT01215916|516492584|FG008|Overall Study|Physician Decision|0|||
143256196|NCT01029405|516492585|FG000|Overall Study|Withdrawal by Subject|0|||
143256197|NCT01029405|516492586|FG001|Overall Study|Withdrawal by Subject|1|||
143256198|NCT01029405|516492587|FG002|Overall Study|Withdrawal by Subject|2|||
143256199|NCT01029405|516492588|FG003|Overall Study|Withdrawal by Subject|0|||
143256200|NCT01029405|516492585|FG000|Overall Study|Protocol Violation|0|||
143256201|NCT01029405|516492586|FG001|Overall Study|Protocol Violation|0|||
143256202|NCT01029405|516492587|FG002|Overall Study|Protocol Violation|0|||
143256203|NCT01029405|516492588|FG003|Overall Study|Protocol Violation|1|||
143256204|NCT01029405|516492585|FG000|Overall Study|Adverse Event|0|||
143179092|NCT01791517|516203645|FG009|Phase I: Period 2|Lost to Follow-up|0|||
143179093|NCT01791517|516203646|FG010|Phase I: Period 2|Lost to Follow-up|0|||
143179094|NCT01791517|516203647|FG011|Phase I: Period 2|Lost to Follow-up|0|||
143256205|NCT01029405|516492586|FG001|Overall Study|Adverse Event|0|||
143256206|NCT01029405|516492587|FG002|Overall Study|Adverse Event|1|||
143256207|NCT01029405|516492588|FG003|Overall Study|Adverse Event|1|||
143256208|NCT01029405|516492585|FG000|Overall Study|Lost to Follow-up|2|||
143107634|NCT02980341|515935577|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
143107635|NCT02980341|515935578|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
143107636|NCT02980341|515935579|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
143367967|NCT01956669|516890843|FG003|Overall Study|Withdrawal by Subject|1|||
143367968|NCT01956669|516890844|FG004|Overall Study|Withdrawal by Subject|0|||
143367969|NCT01956669|516890845|FG005|Overall Study|Withdrawal by Subject|0|||
143367970|NCT01956669|516890846|FG006|Overall Study|Withdrawal by Subject|1|||
143367971|NCT01908634|516890849|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
143367972|NCT01908634|516890849|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
143256209|NCT01029405|516492586|FG001|Overall Study|Lost to Follow-up|1|||
143256210|NCT01029405|516492587|FG002|Overall Study|Lost to Follow-up|1|||
143256211|NCT01029405|516492588|FG003|Overall Study|Lost to Follow-up|2|||
143256212|NCT01029405|516492585|FG000|Overall Study|Other|0|||
143107637|NCT02980341|515935580|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
143107638|NCT02980341|515935581|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
143107639|NCT02980341|515935582|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
143107640|NCT02980341|515935583|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
143107641|NCT02980341|515935584|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
143107642|NCT02980341|515935585|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
143107643|NCT02980341|515935586|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
143107644|NCT02980341|515935587|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
143107645|NCT02980341|515935577|FG000|Dose Finding|Adverse Event|0|||
143107646|NCT02980341|515935578|FG001|Dose Finding|Adverse Event|0|||
143107647|NCT02980341|515935579|FG002|Dose Finding|Adverse Event|0|||
143107648|NCT02980341|515935580|FG003|Dose Finding|Adverse Event|0|||
143107649|NCT02980341|515935581|FG004|Dose Finding|Adverse Event|0|||
143107650|NCT02980341|515935582|FG005|Dose Finding|Adverse Event|3|||
143107651|NCT02980341|515935583|FG006|Dose Finding|Adverse Event|0|||
143107652|NCT02980341|515935584|FG007|Dose Finding|Adverse Event|0|||
143256213|NCT01029405|516492586|FG001|Overall Study|Other|1|||
143256214|NCT01029405|516492587|FG002|Overall Study|Other|0|||
143256215|NCT01029405|516492588|FG003|Overall Study|Other|1|||
143256216|NCT04449029|516492589|FG000|Overall Study|Adverse Event|0|||
143256217|NCT04449029|516492590|FG001|Overall Study|Adverse Event|1|||
143256218|NCT04449029|516492591|FG002|Overall Study|Adverse Event|1|||
143256219|NCT04449029|516492592|FG003|Overall Study|Adverse Event|0|||
143256220|NCT04449029|516492593|FG004|Overall Study|Adverse Event|1|||
143256221|NCT04449029|516492594|FG005|Overall Study|Adverse Event|0|||
143256222|NCT04449029|516492595|FG006|Overall Study|Adverse Event|1|||
143256223|NCT04449029|516492596|FG007|Overall Study|Adverse Event|0|||
143256224|NCT04449029|516492589|FG000|Overall Study|Lost to Follow-up|0|||
143256225|NCT04449029|516492590|FG001|Overall Study|Lost to Follow-up|1|||
143256226|NCT04449029|516492591|FG002|Overall Study|Lost to Follow-up|0|||
143256227|NCT04449029|516492592|FG003|Overall Study|Lost to Follow-up|0|||
143256228|NCT04449029|516492593|FG004|Overall Study|Lost to Follow-up|0|||
143256229|NCT04449029|516492594|FG005|Overall Study|Lost to Follow-up|0|||
143256230|NCT04449029|516492595|FG006|Overall Study|Lost to Follow-up|0|||
143256231|NCT04449029|516492596|FG007|Overall Study|Lost to Follow-up|0|||
143107653|NCT02980341|515935585|FG008|Dose Finding|Adverse Event|0|||
143107654|NCT02980341|515935586|FG009|Dose Finding|Adverse Event|0|||
143179095|NCT01791517|516203636|FG000|Phase I: Period 3|Lens Discomfort|0|||
143179096|NCT01791517|516203637|FG001|Phase I: Period 3|Lens Discomfort|0|||
143179097|NCT01791517|516203638|FG002|Phase I: Period 3|Lens Discomfort|0|||
143179098|NCT01791517|516203639|FG003|Phase I: Period 3|Lens Discomfort|0|||
143179099|NCT01791517|516203640|FG004|Phase I: Period 3|Lens Discomfort|0|||
143179100|NCT01791517|516203641|FG005|Phase I: Period 3|Lens Discomfort|0|||
143179101|NCT01791517|516203642|FG006|Phase I: Period 3|Lens Discomfort|0|||
143179102|NCT01791517|516203643|FG007|Phase I: Period 3|Lens Discomfort|0|||
143179103|NCT01791517|516203644|FG008|Phase I: Period 3|Lens Discomfort|0|||
143179104|NCT01791517|516203645|FG009|Phase I: Period 3|Lens Discomfort|0|||
143179105|NCT01791517|516203646|FG010|Phase I: Period 3|Lens Discomfort|0|||
143256232|NCT04449029|516492589|FG000|Overall Study|Protocol Violation|0|||
143256233|NCT04449029|516492590|FG001|Overall Study|Protocol Violation|1|||
143179106|NCT01791517|516203647|FG011|Phase I: Period 3|Lens Discomfort|1|||
143179107|NCT01791517|516203636|FG000|Phase I: Period 3|Lost to Follow-up|0|||
143179108|NCT01791517|516203637|FG001|Phase I: Period 3|Lost to Follow-up|1|||
143179109|NCT01791517|516203638|FG002|Phase I: Period 3|Lost to Follow-up|0|||
143256234|NCT04449029|516492591|FG002|Overall Study|Protocol Violation|0|||
143256235|NCT04449029|516492592|FG003|Overall Study|Protocol Violation|0|||
143367973|NCT00930813|516890850|FG000|Overall Study|Death|4|||
143107655|NCT02980341|515935587|FG010|Dose Finding|Adverse Event|0|||
143107656|NCT02980341|515935577|FG000|Dose Finding|Withdrawal by Subject|0|||
143107657|NCT02980341|515935578|FG001|Dose Finding|Withdrawal by Subject|0|||
143256236|NCT04449029|516492593|FG004|Overall Study|Protocol Violation|0|||
143179110|NCT01791517|516203639|FG003|Phase I: Period 3|Lost to Follow-up|0|||
143256237|NCT04449029|516492594|FG005|Overall Study|Protocol Violation|0|||
143256238|NCT04449029|516492595|FG006|Overall Study|Protocol Violation|0|||
143256239|NCT04449029|516492596|FG007|Overall Study|Protocol Violation|0|||
143256240|NCT04449029|516492589|FG000|Overall Study|Physician Decision|0|||
143256241|NCT04449029|516492590|FG001|Overall Study|Physician Decision|0|||
143179111|NCT01791517|516203640|FG004|Phase I: Period 3|Lost to Follow-up|1|||
143256242|NCT04449029|516492591|FG002|Overall Study|Physician Decision|0|||
143179112|NCT01791517|516203641|FG005|Phase I: Period 3|Lost to Follow-up|0|||
143256243|NCT04449029|516492592|FG003|Overall Study|Physician Decision|0|||
143256244|NCT04449029|516492593|FG004|Overall Study|Physician Decision|0|||
143179113|NCT01791517|516203642|FG006|Phase I: Period 3|Lost to Follow-up|0|||
143179114|NCT01791517|516203643|FG007|Phase I: Period 3|Lost to Follow-up|0|||
143179115|NCT01791517|516203644|FG008|Phase I: Period 3|Lost to Follow-up|0|||
143179116|NCT01791517|516203645|FG009|Phase I: Period 3|Lost to Follow-up|0|||
143179117|NCT01791517|516203646|FG010|Phase I: Period 3|Lost to Follow-up|0|||
143179118|NCT01791517|516203647|FG011|Phase I: Period 3|Lost to Follow-up|0|||
143179119|NCT01791517|516203636|FG000|Phase I: Period 3|Adverse Event|0|||
143179120|NCT01791517|516203637|FG001|Phase I: Period 3|Adverse Event|0|||
143179121|NCT01791517|516203638|FG002|Phase I: Period 3|Adverse Event|0|||
143179122|NCT01791517|516203639|FG003|Phase I: Period 3|Adverse Event|1|||
143179123|NCT01791517|516203640|FG004|Phase I: Period 3|Adverse Event|0|||
143179124|NCT01791517|516203641|FG005|Phase I: Period 3|Adverse Event|0|||
143179125|NCT01791517|516203642|FG006|Phase I: Period 3|Adverse Event|0|||
143179126|NCT01791517|516203643|FG007|Phase I: Period 3|Adverse Event|0|||
143179127|NCT01791517|516203644|FG008|Phase I: Period 3|Adverse Event|0|||
143179128|NCT01791517|516203645|FG009|Phase I: Period 3|Adverse Event|0|||
143179129|NCT01791517|516203646|FG010|Phase I: Period 3|Adverse Event|0|||
143179130|NCT01791517|516203647|FG011|Phase I: Period 3|Adverse Event|0|||
143179131|NCT01791517|516203636|FG000|Phase II|Lost to Follow-up|1|||
143179132|NCT01791517|516203637|FG001|Phase II|Lost to Follow-up|0|||
143179133|NCT01791517|516203638|FG002|Phase II|Lost to Follow-up|1|||
143179134|NCT01791517|516203639|FG003|Phase II|Lost to Follow-up|0|||
143179135|NCT01791517|516203640|FG004|Phase II|Lost to Follow-up|1|||
143179136|NCT01791517|516203641|FG005|Phase II|Lost to Follow-up|2|||
143179137|NCT01791517|516203642|FG006|Phase II|Lost to Follow-up|0|||
143179138|NCT01791517|516203643|FG007|Phase II|Lost to Follow-up|1|||
143179139|NCT01791517|516203644|FG008|Phase II|Lost to Follow-up|1|||
143179140|NCT01791517|516203645|FG009|Phase II|Lost to Follow-up|1|||
143179141|NCT01791517|516203646|FG010|Phase II|Lost to Follow-up|0|||
143256245|NCT04449029|516492594|FG005|Overall Study|Physician Decision|1|||
143179142|NCT01791517|516203647|FG011|Phase II|Lost to Follow-up|0|||
143256246|NCT04449029|516492595|FG006|Overall Study|Physician Decision|0|||
143256247|NCT04449029|516492596|FG007|Overall Study|Physician Decision|0|||
143179143|NCT01791517|516203636|FG000|Phase II|Withdrawal by Subject|1|||
143179144|NCT01791517|516203637|FG001|Phase II|Withdrawal by Subject|0|||
143179145|NCT01791517|516203638|FG002|Phase II|Withdrawal by Subject|0|||
143179146|NCT01791517|516203639|FG003|Phase II|Withdrawal by Subject|0|||
143179147|NCT01791517|516203640|FG004|Phase II|Withdrawal by Subject|0|||
143179148|NCT01791517|516203641|FG005|Phase II|Withdrawal by Subject|2|||
143256248|NCT04449029|516492589|FG000|Overall Study|Withdrawal by Subject|3|||
143256249|NCT04449029|516492590|FG001|Overall Study|Withdrawal by Subject|0|||
143256250|NCT04449029|516492591|FG002|Overall Study|Withdrawal by Subject|1|||
143256251|NCT04449029|516492592|FG003|Overall Study|Withdrawal by Subject|1|||
143107658|NCT02980341|515935579|FG002|Dose Finding|Withdrawal by Subject|0|||
143107659|NCT02980341|515935580|FG003|Dose Finding|Withdrawal by Subject|0|||
143107660|NCT02980341|515935581|FG004|Dose Finding|Withdrawal by Subject|0|||
143107661|NCT02980341|515935582|FG005|Dose Finding|Withdrawal by Subject|1|||
143107662|NCT02980341|515935583|FG006|Dose Finding|Withdrawal by Subject|1|||
143107663|NCT02980341|515935584|FG007|Dose Finding|Withdrawal by Subject|0|||
143107664|NCT02980341|515935585|FG008|Dose Finding|Withdrawal by Subject|0|||
143107665|NCT02980341|515935586|FG009|Dose Finding|Withdrawal by Subject|0|||
143107666|NCT02980341|515935587|FG010|Dose Finding|Withdrawal by Subject|0|||
143107667|NCT02980341|515935577|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
143107668|NCT02980341|515935578|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
143107669|NCT02980341|515935579|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
143107670|NCT02980341|515935580|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
143107671|NCT02980341|515935581|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
143107672|NCT02980341|515935582|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
143107673|NCT02980341|515935583|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
143107674|NCT02980341|515935584|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
143107675|NCT02980341|515935585|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
143107676|NCT02980341|515935586|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
143179149|NCT01791517|516203642|FG006|Phase II|Withdrawal by Subject|0|||
143179150|NCT01791517|516203643|FG007|Phase II|Withdrawal by Subject|1|||
143179151|NCT01791517|516203644|FG008|Phase II|Withdrawal by Subject|0|||
143179152|NCT01791517|516203645|FG009|Phase II|Withdrawal by Subject|0|||
143179153|NCT01791517|516203646|FG010|Phase II|Withdrawal by Subject|1|||
143179154|NCT01791517|516203647|FG011|Phase II|Withdrawal by Subject|0|||
143179155|NCT01791517|516203636|FG000|Phase II|Lack of Efficacy|0|||
143179156|NCT01791517|516203637|FG001|Phase II|Lack of Efficacy|0|||
143179157|NCT01791517|516203638|FG002|Phase II|Lack of Efficacy|0|||
143179158|NCT01791517|516203639|FG003|Phase II|Lack of Efficacy|0|||
143179159|NCT01791517|516203640|FG004|Phase II|Lack of Efficacy|1|||
143179160|NCT01791517|516203641|FG005|Phase II|Lack of Efficacy|0|||
143179161|NCT01791517|516203642|FG006|Phase II|Lack of Efficacy|0|||
143179162|NCT01791517|516203643|FG007|Phase II|Lack of Efficacy|0|||
143179163|NCT01791517|516203644|FG008|Phase II|Lack of Efficacy|0|||
143179164|NCT01791517|516203645|FG009|Phase II|Lack of Efficacy|0|||
143179165|NCT01791517|516203646|FG010|Phase II|Lack of Efficacy|0|||
143179166|NCT01791517|516203647|FG011|Phase II|Lack of Efficacy|0|||
143179167|NCT01791517|516203636|FG000|Phase II|Adverse Event|0|||
143179168|NCT01791517|516203637|FG001|Phase II|Adverse Event|0|||
143179169|NCT01791517|516203638|FG002|Phase II|Adverse Event|0|||
143179170|NCT01791517|516203639|FG003|Phase II|Adverse Event|0|||
143179171|NCT01791517|516203640|FG004|Phase II|Adverse Event|0|||
143179172|NCT01791517|516203641|FG005|Phase II|Adverse Event|0|||
143179173|NCT01791517|516203642|FG006|Phase II|Adverse Event|2|||
143179174|NCT01791517|516203643|FG007|Phase II|Adverse Event|1|||
143179175|NCT01791517|516203644|FG008|Phase II|Adverse Event|0|||
143179176|NCT01791517|516203645|FG009|Phase II|Adverse Event|1|||
143179177|NCT01791517|516203646|FG010|Phase II|Adverse Event|0|||
143179178|NCT01791517|516203647|FG011|Phase II|Adverse Event|0|||
143179179|NCT01791517|516203636|FG000|Phase II|Lens Handling Difficulties|0|||
143179180|NCT01791517|516203637|FG001|Phase II|Lens Handling Difficulties|0|||
143179181|NCT01791517|516203638|FG002|Phase II|Lens Handling Difficulties|0|||
143179182|NCT01791517|516203639|FG003|Phase II|Lens Handling Difficulties|0|||
143179183|NCT01791517|516203640|FG004|Phase II|Lens Handling Difficulties|0|||
143179184|NCT01791517|516203641|FG005|Phase II|Lens Handling Difficulties|0|||
143179185|NCT01791517|516203642|FG006|Phase II|Lens Handling Difficulties|0|||
143179186|NCT01791517|516203643|FG007|Phase II|Lens Handling Difficulties|0|||
143179187|NCT01791517|516203644|FG008|Phase II|Lens Handling Difficulties|1|||
143179188|NCT01791517|516203645|FG009|Phase II|Lens Handling Difficulties|0|||
143179189|NCT01791517|516203646|FG010|Phase II|Lens Handling Difficulties|0|||
143179190|NCT01791517|516203647|FG011|Phase II|Lens Handling Difficulties|0|||
143179191|NCT01791517|516203636|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
143179192|NCT01791517|516203637|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
143179193|NCT01791517|516203638|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
143179194|NCT01791517|516203639|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
143179195|NCT01791517|516203640|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
143179196|NCT01791517|516203641|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
143179197|NCT01791517|516203642|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
143179198|NCT01791517|516203643|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
143179199|NCT01791517|516203644|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
143107677|NCT02980341|515935587|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
143179200|NCT01791517|516203645|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
143179201|NCT01791517|516203646|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
143179202|NCT01791517|516203647|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
143256252|NCT04449029|516492593|FG004|Overall Study|Withdrawal by Subject|5|||
143107678|NCT02980341|515935577|FG000|Dose Expansion|Clinical progression|0|||
143107679|NCT02980341|515935578|FG001|Dose Expansion|Clinical progression|0|||
143107680|NCT02980341|515935579|FG002|Dose Expansion|Clinical progression|0|||
143107681|NCT02980341|515935580|FG003|Dose Expansion|Clinical progression|0|||
143107682|NCT02980341|515935581|FG004|Dose Expansion|Clinical progression|0|||
143107683|NCT02980341|515935582|FG005|Dose Expansion|Clinical progression|0|||
143107684|NCT02980341|515935583|FG006|Dose Expansion|Clinical progression|0|||
143107685|NCT02980341|515935584|FG007|Dose Expansion|Clinical progression|4|||
143107686|NCT02980341|515935585|FG008|Dose Expansion|Clinical progression|3|||
143107687|NCT02980341|515935586|FG009|Dose Expansion|Clinical progression|1|||
143107688|NCT02980341|515935587|FG010|Dose Expansion|Clinical progression|4|||
143107689|NCT02980341|515935577|FG000|Dose Expansion|Adverse Event|0|||
143107690|NCT02980341|515935578|FG001|Dose Expansion|Adverse Event|0|||
143107691|NCT02980341|515935579|FG002|Dose Expansion|Adverse Event|0|||
143107692|NCT02980341|515935580|FG003|Dose Expansion|Adverse Event|0|||
143107693|NCT02980341|515935581|FG004|Dose Expansion|Adverse Event|0|||
143107694|NCT02980341|515935582|FG005|Dose Expansion|Adverse Event|0|||
143107695|NCT02980341|515935583|FG006|Dose Expansion|Adverse Event|0|||
143107696|NCT02980341|515935584|FG007|Dose Expansion|Adverse Event|3|||
143107697|NCT02980341|515935585|FG008|Dose Expansion|Adverse Event|0|||
143107698|NCT02980341|515935586|FG009|Dose Expansion|Adverse Event|1|||
143107699|NCT02980341|515935587|FG010|Dose Expansion|Adverse Event|3|||
143107700|NCT02980341|515935577|FG000|Dose Expansion|Death|0|||
143107701|NCT02980341|515935578|FG001|Dose Expansion|Death|0|||
143107702|NCT02980341|515935579|FG002|Dose Expansion|Death|0|||
143107703|NCT02980341|515935580|FG003|Dose Expansion|Death|0|||
143107704|NCT02980341|515935581|FG004|Dose Expansion|Death|0|||
143107705|NCT02980341|515935582|FG005|Dose Expansion|Death|0|||
143107706|NCT02980341|515935583|FG006|Dose Expansion|Death|0|||
143107707|NCT02980341|515935584|FG007|Dose Expansion|Death|0|||
143107708|NCT02980341|515935585|FG008|Dose Expansion|Death|2|||
143107709|NCT02980341|515935586|FG009|Dose Expansion|Death|1|||
143107710|NCT02980341|515935587|FG010|Dose Expansion|Death|0|||
143107711|NCT02980341|515935577|FG000|Dose Expansion|Withdrawal by Subject|0|||
143107712|NCT02980341|515935578|FG001|Dose Expansion|Withdrawal by Subject|0|||
143107713|NCT02980341|515935579|FG002|Dose Expansion|Withdrawal by Subject|0|||
143107714|NCT02980341|515935580|FG003|Dose Expansion|Withdrawal by Subject|0|||
143107715|NCT02980341|515935581|FG004|Dose Expansion|Withdrawal by Subject|0|||
143107716|NCT02980341|515935582|FG005|Dose Expansion|Withdrawal by Subject|0|||
143107717|NCT02980341|515935583|FG006|Dose Expansion|Withdrawal by Subject|0|||
143107718|NCT02980341|515935584|FG007|Dose Expansion|Withdrawal by Subject|2|||
143107719|NCT02980341|515935585|FG008|Dose Expansion|Withdrawal by Subject|0|||
143107720|NCT02980341|515935586|FG009|Dose Expansion|Withdrawal by Subject|1|||
143107721|NCT02980341|515935587|FG010|Dose Expansion|Withdrawal by Subject|0|||
143107722|NCT02980341|515935577|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
143107723|NCT02980341|515935578|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
143107724|NCT02980341|515935579|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
143107725|NCT02980341|515935580|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
143107726|NCT02980341|515935581|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
143256253|NCT04449029|516492594|FG005|Overall Study|Withdrawal by Subject|1|||
143256254|NCT04449029|516492595|FG006|Overall Study|Withdrawal by Subject|4|||
143107727|NCT02980341|515935582|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
143107728|NCT02980341|515935583|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
143107729|NCT02980341|515935584|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
143107730|NCT02980341|515935585|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
143107731|NCT02980341|515935586|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
143117371|NCT01313221|515971827|FG001|Overall Study|Withdrawal by Subject|3|||
143117372|NCT01313221|515971828|FG002|Overall Study|Withdrawal by Subject|5|||
143117373|NCT01313221|515971826|FG000|Overall Study|Requirement for alternative therapy|0|||
143117374|NCT01313221|515971827|FG001|Overall Study|Requirement for alternative therapy|1|||
143117375|NCT01313221|515971828|FG002|Overall Study|Requirement for alternative therapy|1|||
143117376|NCT01313221|515971826|FG000|Overall Study|Lost to Follow-up|6|||
143117377|NCT01313221|515971827|FG001|Overall Study|Lost to Follow-up|3|||
143117378|NCT01313221|515971828|FG002|Overall Study|Lost to Follow-up|1|||
143117379|NCT01313221|515971826|FG000|Overall Study|Other|1|||
143117380|NCT01313221|515971827|FG001|Overall Study|Other|0|||
143117381|NCT01313221|515971828|FG002|Overall Study|Other|0|||
143117382|NCT01313221|515971826|FG000|Overall Study|Adverse Event|0|||
143117383|NCT01313221|515971827|FG001|Overall Study|Adverse Event|0|||
143117384|NCT01313221|515971828|FG002|Overall Study|Adverse Event|7|||
143117385|NCT01313221|515971826|FG000|Overall Study|Disease progression|0|||
143117386|NCT01313221|515971827|FG001|Overall Study|Disease progression|0|||
143117387|NCT01313221|515971828|FG002|Overall Study|Disease progression|2|||
143107732|NCT02980341|515935587|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
143107733|NCT02980341|515935577|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
143107734|NCT02980341|515935578|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
143107735|NCT02980341|515935579|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
143107736|NCT02980341|515935580|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
143107737|NCT02980341|515935581|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
143107738|NCT02980341|515935582|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
143107739|NCT02980341|515935583|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
143107740|NCT02980341|515935584|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
143107741|NCT02980341|515935585|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
143107742|NCT02980341|515935586|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
143107743|NCT02980341|515935587|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
143107744|NCT02980341|515935577|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
143107745|NCT02980341|515935578|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
143107746|NCT02980341|515935579|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
143107747|NCT02980341|515935580|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
143107748|NCT02980341|515935581|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
143107749|NCT02980341|515935582|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
143107750|NCT02980341|515935583|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
143107751|NCT02980341|515935584|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
143107752|NCT02980341|515935585|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
143107753|NCT02980341|515935586|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
143107754|NCT02980341|515935587|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
143107755|NCT02980341|515935577|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
143107756|NCT02980341|515935578|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
143107757|NCT02980341|515935579|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
143107758|NCT02980341|515935580|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
143107759|NCT02980341|515935581|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
143107760|NCT02980341|515935582|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
143107761|NCT02980341|515935583|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
143107762|NCT02980341|515935584|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
143107763|NCT02980341|515935585|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
143107764|NCT02980341|515935586|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
143107765|NCT02980341|515935587|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
143107766|NCT00749684|515935590|FG000|Overall Study|Death|1|||
143107767|NCT00749684|515935590|FG000|Overall Study|Adverse Event|27|||
143107768|NCT00749684|515935590|FG000|Overall Study|Participant's Wish|10|||
143107769|NCT00749684|515935590|FG000|Overall Study|Not Documented|1|||
143107770|NCT00749684|515935590|FG000|Overall Study|Progressive Desease|31|||
143107771|NCT00749684|515935590|FG000|Overall Study|Therapy according to protocol + AE|2|||
143107772|NCT00749684|515935590|FG000|Overall Study|AE+discontinuation on participants wish|1|||
143107773|NCT00749684|515935590|FG000|Overall Study|Missing|9|||
143107774|NCT03696108|515935591|FG000|Overall Study|Physician Decision|1|||
143107775|NCT03696108|515935592|FG001|Overall Study|Physician Decision|0|||
143107776|NCT03696108|515935591|FG000|Overall Study|Withdrawal by Subject|3|||
143107777|NCT03696108|515935592|FG001|Overall Study|Withdrawal by Subject|6|||
143107778|NCT00282113|515935593|FG000|Overall Study|Removed at parents request|1|||
143107779|NCT00282113|515935594|FG001|Overall Study|Removed at parents request|0|||
143107780|NCT00282113|515935595|FG002|Overall Study|Removed at parents request|0|||
143107781|NCT02693171|515935596|FG000|Overall Study|Adverse Event|1|||
143107782|NCT02693171|515935596|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
143107783|NCT03429244|515935597|FG000|Overall Study|Withdrawal by Subject|2|||
143107784|NCT03429244|515935598|FG001|Overall Study|Withdrawal by Subject|1|||
143107785|NCT03429244|515935599|FG002|Overall Study|Withdrawal by Subject|1|||
143107786|NCT00750139|515935600|FG000|Overall Study|Adverse Event|1|||
143107787|NCT00750139|515935601|FG001|Overall Study|Adverse Event|2|||
143107788|NCT00750139|515935602|FG002|Overall Study|Adverse Event|0|||
143107789|NCT00750139|515935603|FG003|Overall Study|Adverse Event|1|||
143107790|NCT00750139|515935600|FG000|Overall Study|Lost to Follow-up|17|||
143179203|NCT01791517|516203636|FG000|Phase II|Pre-Existing Ocular Issue|0|||
143179204|NCT01791517|516203637|FG001|Phase II|Pre-Existing Ocular Issue|0|||
143107791|NCT00750139|515935601|FG001|Overall Study|Lost to Follow-up|12|||
143179205|NCT01791517|516203638|FG002|Phase II|Pre-Existing Ocular Issue|0|||
143367974|NCT00930813|516890851|FG001|Overall Study|Death|5|||
143256255|NCT04449029|516492596|FG007|Overall Study|Withdrawal by Subject|0|||
143256256|NCT05027971|516492604|FG000|Overall Study|Physician Decision|7|||
143256257|NCT05027971|516492605|FG001|Overall Study|Physician Decision|3|||
143107792|NCT00750139|515935602|FG002|Overall Study|Lost to Follow-up|15|||
143107793|NCT00750139|515935603|FG003|Overall Study|Lost to Follow-up|6|||
143256258|NCT05027971|516492604|FG000|Overall Study|Lost to Follow-up|1|||
143256259|NCT05027971|516492605|FG001|Overall Study|Lost to Follow-up|1|||
143107794|NCT00750139|515935600|FG000|Overall Study|Withdrawal by Subject|3|||
143107795|NCT00750139|515935601|FG001|Overall Study|Withdrawal by Subject|2|||
143107796|NCT00750139|515935602|FG002|Overall Study|Withdrawal by Subject|6|||
143107797|NCT00750139|515935603|FG003|Overall Study|Withdrawal by Subject|2|||
143107798|NCT00750139|515935600|FG000|Overall Study|Physician Decision|1|||
143107799|NCT00750139|515935601|FG001|Overall Study|Physician Decision|1|||
143107800|NCT00750139|515935602|FG002|Overall Study|Physician Decision|0|||
143107801|NCT00750139|515935603|FG003|Overall Study|Physician Decision|0|||
143107802|NCT00750139|515935600|FG000|Overall Study|Non-compliance|1|||
143107803|NCT00750139|515935601|FG001|Overall Study|Non-compliance|0|||
143107804|NCT00750139|515935602|FG002|Overall Study|Non-compliance|1|||
143107805|NCT00750139|515935603|FG003|Overall Study|Non-compliance|3|||
143107806|NCT00750139|515935600|FG000|Overall Study|Termination by sponsor|4|||
143107807|NCT00750139|515935601|FG001|Overall Study|Termination by sponsor|0|||
143107808|NCT00750139|515935602|FG002|Overall Study|Termination by sponsor|0|||
143107809|NCT00750139|515935603|FG003|Overall Study|Termination by sponsor|1|||
143107810|NCT00750139|515935600|FG000|Overall Study|Non-specific|62|||
143107811|NCT00750139|515935601|FG001|Overall Study|Non-specific|42|||
143107812|NCT00750139|515935602|FG002|Overall Study|Non-specific|79|||
143256260|NCT05027971|516492604|FG000|Overall Study|Withdrawal by Subject|0|||
143256261|NCT05027971|516492605|FG001|Overall Study|Withdrawal by Subject|2|||
143107813|NCT00750139|515935603|FG003|Overall Study|Non-specific|33|||
143256262|NCT05027971|516492604|FG000|Overall Study|Non-study fiber used.|0|||
143107814|NCT00595517|515935604|FG000|Overall Study|Adverse Event|6|||
143256263|NCT05027971|516492605|FG001|Overall Study|Non-study fiber used.|1|||
143256264|NCT05027971|516492604|FG000|Overall Study|Protocol Violation|0|||
143256265|NCT05027971|516492605|FG001|Overall Study|Protocol Violation|2|||
143107815|NCT00595517|515935604|FG000|Overall Study|Withdrawal by Subject|4|||
143107816|NCT00595517|515935604|FG000|Overall Study|Protocol Violation|2|||
143107817|NCT00595517|515935604|FG000|Overall Study|Recurrence of ulcer|5|||
143107818|NCT00595517|515935604|FG000|Overall Study|usage of prohibited treatment|1|||
143256266|NCT02112045|516492609|FG000|Overall Study|Withdrawal by Subject|1|||
143256267|NCT02112045|516492610|FG001|Overall Study|Withdrawal by Subject|0|||
143256268|NCT00321646|516492611|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
143256269|NCT00321646|516492611|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
143256270|NCT00321646|516492611|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
143107819|NCT00595517|515935604|FG000|Overall Study|No intention to attend regularly|1|||
143107820|NCT01167881|515935605|FG000|Overall Study|Adverse Event|47|||
143107821|NCT01167881|515935606|FG001|Overall Study|Adverse Event|51|||
143107822|NCT01167881|515935605|FG000|Overall Study|Lack of Efficacy|4|||
143107823|NCT01167881|515935606|FG001|Overall Study|Lack of Efficacy|7|||
143256271|NCT02694757|516492613|FG000|Overall Study|Lack of Efficacy|3|||
143256272|NCT00095147|516492614|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
143256273|NCT00095147|516492615|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
143256274|NCT00095147|516492616|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
143256275|NCT00095147|516492617|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
143256276|NCT00095147|516492618|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
143256277|NCT00095147|516492614|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
143256278|NCT00095147|516492615|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
143256279|NCT00095147|516492616|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
143256280|NCT00095147|516492617|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
143256281|NCT00095147|516492618|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
143256282|NCT00095147|516492614|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
143256283|NCT00095147|516492615|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
143256284|NCT00095147|516492616|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
143256285|NCT00095147|516492617|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
143256286|NCT00095147|516492618|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
143256287|NCT00095147|516492614|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
143256288|NCT00095147|516492615|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
143256289|NCT00095147|516492616|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
143256290|NCT00095147|516492617|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
143256291|NCT00095147|516492618|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
143256292|NCT00095147|516492614|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
143256293|NCT00095147|516492615|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
143256294|NCT00095147|516492616|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
143256295|NCT00095147|516492617|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
143256296|NCT00095147|516492618|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
143256297|NCT00095147|516492614|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
143256298|NCT00095147|516492615|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
143256299|NCT00095147|516492616|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
143256300|NCT00095147|516492617|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
143256301|NCT00095147|516492618|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
143256302|NCT00095147|516492614|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
143256303|NCT00095147|516492615|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
143256304|NCT00095147|516492616|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
143256305|NCT00095147|516492617|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
143256306|NCT00095147|516492618|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
143256307|NCT00095147|516492614|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
143256308|NCT00095147|516492615|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
143256309|NCT00095147|516492616|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
143256310|NCT00095147|516492617|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
143256311|NCT00095147|516492618|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
143256312|NCT00095147|516492614|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
143107824|NCT01167881|515935605|FG000|Overall Study|Non compliant with protocol|9|||
143107825|NCT01167881|515935606|FG001|Overall Study|Non compliant with protocol|18|||
143107826|NCT01167881|515935605|FG000|Overall Study|Lost to Follow-up|19|||
143107827|NCT01167881|515935606|FG001|Overall Study|Lost to Follow-up|20|||
143256313|NCT00095147|516492615|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
143256314|NCT00095147|516492616|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
143256315|NCT00095147|516492617|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
143256316|NCT00095147|516492618|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
143256317|NCT00095147|516492614|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
143256318|NCT00095147|516492615|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
143256319|NCT00095147|516492616|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
143256320|NCT00095147|516492617|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
143256321|NCT00095147|516492618|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
143107828|NCT01167881|515935605|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
143107829|NCT01167881|515935606|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
143107830|NCT01167881|515935605|FG000|Overall Study|Not treated|4|||
143107831|NCT01167881|515935606|FG001|Overall Study|Not treated|0|||
143107832|NCT01167881|515935605|FG000|Overall Study|Other not defined above|31|||
143107833|NCT01167881|515935606|FG001|Overall Study|Other not defined above|55|||
143107834|NCT01992653|515935607|FG000|Overall Study|Death|0|||
143107835|NCT01992653|515935608|FG001|Overall Study|Death|0|||
143107836|NCT01992653|515935609|FG002|Overall Study|Death|1|||
143107837|NCT01992653|515935610|FG003|Overall Study|Death|0|||
143107838|NCT01992653|515935611|FG004|Overall Study|Death|1|||
143107839|NCT01992653|515935612|FG005|Overall Study|Death|0|||
143107840|NCT01992653|515935613|FG006|Overall Study|Death|4|||
143107841|NCT01992653|515935614|FG007|Overall Study|Death|2|||
143107842|NCT01992653|515935607|FG000|Overall Study|Lost to Follow-up|0|||
143107843|NCT01992653|515935608|FG001|Overall Study|Lost to Follow-up|0|||
143107844|NCT01992653|515935609|FG002|Overall Study|Lost to Follow-up|0|||
143107845|NCT01992653|515935610|FG003|Overall Study|Lost to Follow-up|0|||
143107846|NCT01992653|515935611|FG004|Overall Study|Lost to Follow-up|0|||
143107847|NCT01992653|515935612|FG005|Overall Study|Lost to Follow-up|0|||
143107848|NCT01992653|515935613|FG006|Overall Study|Lost to Follow-up|0|||
143107849|NCT01992653|515935614|FG007|Overall Study|Lost to Follow-up|1|||
143107850|NCT01992653|515935607|FG000|Overall Study|Study Completed|0|||
143107851|NCT01992653|515935608|FG001|Overall Study|Study Completed|0|||
143107852|NCT01992653|515935609|FG002|Overall Study|Study Completed|0|||
143107853|NCT01992653|515935610|FG003|Overall Study|Study Completed|0|||
143107854|NCT01992653|515935611|FG004|Overall Study|Study Completed|0|||
143107855|NCT01992653|515935612|FG005|Overall Study|Study Completed|0|||
143107856|NCT01992653|515935613|FG006|Overall Study|Study Completed|0|||
143107857|NCT01992653|515935614|FG007|Overall Study|Study Completed|1|||
143107858|NCT01992653|515935607|FG000|Overall Study|Disease Progression|0|||
143107859|NCT01992653|515935608|FG001|Overall Study|Disease Progression|0|||
143107860|NCT01992653|515935609|FG002|Overall Study|Disease Progression|0|||
143107861|NCT01992653|515935610|FG003|Overall Study|Disease Progression|0|||
143107862|NCT01992653|515935611|FG004|Overall Study|Disease Progression|0|||
143107863|NCT01992653|515935612|FG005|Overall Study|Disease Progression|0|||
143107864|NCT01992653|515935613|FG006|Overall Study|Disease Progression|4|||
143107865|NCT01992653|515935614|FG007|Overall Study|Disease Progression|0|||
143107866|NCT00977314|515935615|FG000|Overall Study|Withdrawal by Subject|1|||
143107867|NCT00977314|515935616|FG001|Overall Study|Withdrawal by Subject|0|||
143107868|NCT00977314|515935615|FG000|Overall Study|Physician Decision|1|||
143107869|NCT00977314|515935616|FG001|Overall Study|Physician Decision|0|||
143107870|NCT02107859|515935619|FG000|Overall Study|Withdrawal by Subject|14|||
143107871|NCT02107859|515935619|FG000|Overall Study|Adverse Event|3|||
143107872|NCT02107859|515935619|FG000|Overall Study|Study closure|41|||
143107873|NCT02107859|515935619|FG000|Overall Study|Other than specified|3|||
143107874|NCT02235077|515935625|FG000|Overall Study|Death|5|||
143107875|NCT02235077|515935626|FG001|Overall Study|Death|7|||
143107876|NCT02235077|515935625|FG000|Overall Study|Lost to Follow-up|5|||
143107877|NCT02235077|515935626|FG001|Overall Study|Lost to Follow-up|6|||
143107878|NCT02235077|515935625|FG000|Overall Study|Withdrawal by Subject|8|||
143107879|NCT02235077|515935626|FG001|Overall Study|Withdrawal by Subject|5|||
143107880|NCT02235077|515935625|FG000|Overall Study|Physician Decision|0|||
143107881|NCT02235077|515935626|FG001|Overall Study|Physician Decision|1|||
143107882|NCT03852628|515935627|FG000|Overall Study|Lost to Follow-up|7|||
143107883|NCT03852628|515935628|FG001|Overall Study|Lost to Follow-up|6|||
143107884|NCT03852628|515935627|FG000|Overall Study|Lack of Efficacy|6|||
143179206|NCT01791517|516203639|FG003|Phase II|Pre-Existing Ocular Issue|0|||
143179207|NCT01791517|516203640|FG004|Phase II|Pre-Existing Ocular Issue|0|||
143179208|NCT01791517|516203641|FG005|Phase II|Pre-Existing Ocular Issue|0|||
143179209|NCT01791517|516203642|FG006|Phase II|Pre-Existing Ocular Issue|0|||
143179210|NCT01791517|516203643|FG007|Phase II|Pre-Existing Ocular Issue|0|||
143179211|NCT01791517|516203644|FG008|Phase II|Pre-Existing Ocular Issue|0|||
143179212|NCT01791517|516203645|FG009|Phase II|Pre-Existing Ocular Issue|0|||
143179213|NCT01791517|516203646|FG010|Phase II|Pre-Existing Ocular Issue|0|||
143179214|NCT01791517|516203647|FG011|Phase II|Pre-Existing Ocular Issue|1|||
143179215|NCT03230318|516203651|FG000|Overall Study|Radiographic disease progression|72|||
143107885|NCT03852628|515935628|FG001|Overall Study|Lack of Efficacy|6|||
143107886|NCT03887442|515935632|FG000|Overall Study|Adverse Event|1|||
143107887|NCT03887442|515935633|FG001|Overall Study|Adverse Event|0|||
143107888|NCT00556933|515935634|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
143107889|NCT00556933|515935635|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
143107890|NCT00556933|515935636|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
143107891|NCT00556933|515935637|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
143107892|NCT00556933|515935634|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
143107893|NCT00556933|515935635|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
143107894|NCT00556933|515935636|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
143107895|NCT00556933|515935637|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
143107896|NCT00556933|515935634|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
143107897|NCT00556933|515935635|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
143107898|NCT00556933|515935636|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
143107899|NCT00556933|515935637|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
143107900|NCT00556933|515935634|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
143107901|NCT00556933|515935635|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
143107902|NCT00556933|515935636|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
143107903|NCT00556933|515935637|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
143107904|NCT00556933|515935634|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
143107905|NCT00556933|515935635|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
143107906|NCT00556933|515935636|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
143107907|NCT00556933|515935637|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
143107908|NCT00556933|515935634|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
143107909|NCT00556933|515935635|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
143107910|NCT00556933|515935636|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
143107911|NCT00556933|515935637|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
143107912|NCT00556933|515935634|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
143107913|NCT00556933|515935635|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
143107914|NCT00556933|515935636|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
143107915|NCT00556933|515935637|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
143107916|NCT00556933|515935634|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
143107917|NCT00556933|515935635|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
143107918|NCT00556933|515935636|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
143107919|NCT00556933|515935637|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
143107920|NCT00556933|515935634|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
143107921|NCT00556933|515935635|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
143107922|NCT00556933|515935636|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
143107923|NCT00556933|515935637|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
143107924|NCT00556933|515935634|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
143107925|NCT00556933|515935635|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
143107926|NCT00556933|515935636|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
143107927|NCT00556933|515935637|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
143107928|NCT00556933|515935634|FG000|CNI Withdrawal vs. Minimization|Death|0|||
143107929|NCT00556933|515935635|FG001|CNI Withdrawal vs. Minimization|Death|0|||
143107930|NCT00556933|515935636|FG002|CNI Withdrawal vs. Minimization|Death|0|||
143107931|NCT00556933|515935637|FG003|CNI Withdrawal vs. Minimization|Death|1|||
143107932|NCT01668173|515935644|FG000|Overall Study|Adverse Event|3|||
143107933|NCT01668173|515935644|FG000|Overall Study|Trial suspension|4|||
143107934|NCT01295827|515935647|FG000|Overall Study|Adverse Event|1|||
143107935|NCT01295827|515935648|FG001|Overall Study|Adverse Event|2|||
143107936|NCT01295827|515935649|FG002|Overall Study|Adverse Event|2|||
143107937|NCT01295827|515935650|FG003|Overall Study|Adverse Event|1|||
143107938|NCT01295827|515935651|FG004|Overall Study|Adverse Event|1|||
143107939|NCT01295827|515935652|FG005|Overall Study|Adverse Event|4|||
143107940|NCT01295827|515935653|FG006|Overall Study|Adverse Event|15|||
143107941|NCT01295827|515935654|FG007|Overall Study|Adverse Event|49|||
143107942|NCT01295827|515935655|FG008|Overall Study|Adverse Event|22|||
143107943|NCT01295827|515935656|FG009|Overall Study|Adverse Event|7|||
143107944|NCT01295827|515935657|FG010|Overall Study|Adverse Event|50|||
143107945|NCT01295827|515935658|FG011|Overall Study|Adverse Event|21|||
143107946|NCT01295827|515935659|FG012|Overall Study|Adverse Event|0|||
143107947|NCT01295827|515935660|FG013|Overall Study|Adverse Event|0|||
143107948|NCT01295827|515935661|FG014|Overall Study|Adverse Event|0|||
143107949|NCT01295827|515935647|FG000|Overall Study|Lost to Follow-up|0|||
143107950|NCT01295827|515935648|FG001|Overall Study|Lost to Follow-up|0|||
143107951|NCT01295827|515935649|FG002|Overall Study|Lost to Follow-up|3|||
143107952|NCT01295827|515935650|FG003|Overall Study|Lost to Follow-up|0|||
143107953|NCT01295827|515935651|FG004|Overall Study|Lost to Follow-up|1|||
143107954|NCT01295827|515935652|FG005|Overall Study|Lost to Follow-up|0|||
143107955|NCT01295827|515935653|FG006|Overall Study|Lost to Follow-up|4|||
143107956|NCT01295827|515935654|FG007|Overall Study|Lost to Follow-up|8|||
143107957|NCT01295827|515935655|FG008|Overall Study|Lost to Follow-up|7|||
143107958|NCT01295827|515935656|FG009|Overall Study|Lost to Follow-up|4|||
143107959|NCT01295827|515935657|FG010|Overall Study|Lost to Follow-up|7|||
143107960|NCT01295827|515935658|FG011|Overall Study|Lost to Follow-up|3|||
143256322|NCT00095147|516492614|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
143256323|NCT00095147|516492615|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
143107961|NCT01295827|515935659|FG012|Overall Study|Lost to Follow-up|0|||
143107962|NCT01295827|515935660|FG013|Overall Study|Lost to Follow-up|0|||
143107963|NCT01295827|515935661|FG014|Overall Study|Lost to Follow-up|0|||
143107964|NCT01295827|515935647|FG000|Overall Study|Not Reported|0|||
143107965|NCT01295827|515935648|FG001|Overall Study|Not Reported|0|||
143107966|NCT01295827|515935649|FG002|Overall Study|Not Reported|0|||
143107967|NCT01295827|515935650|FG003|Overall Study|Not Reported|1|||
143107968|NCT01295827|515935651|FG004|Overall Study|Not Reported|0|||
143256324|NCT00095147|516492616|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
143256325|NCT00095147|516492617|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
143107969|NCT01295827|515935652|FG005|Overall Study|Not Reported|0|||
143107970|NCT01295827|515935653|FG006|Overall Study|Not Reported|24|||
143107971|NCT01295827|515935654|FG007|Overall Study|Not Reported|58|||
143107972|NCT01295827|515935655|FG008|Overall Study|Not Reported|41|||
143107973|NCT01295827|515935656|FG009|Overall Study|Not Reported|2|||
143107974|NCT01295827|515935657|FG010|Overall Study|Not Reported|23|||
143107975|NCT01295827|515935658|FG011|Overall Study|Not Reported|13|||
143107976|NCT01295827|515935659|FG012|Overall Study|Not Reported|0|||
143107977|NCT01295827|515935660|FG013|Overall Study|Not Reported|0|||
143107978|NCT01295827|515935661|FG014|Overall Study|Not Reported|0|||
143107979|NCT01295827|515935647|FG000|Overall Study|Progressive Disease|2|||
143107980|NCT01295827|515935648|FG001|Overall Study|Progressive Disease|1|||
143107981|NCT01295827|515935649|FG002|Overall Study|Progressive Disease|5|||
143107982|NCT01295827|515935650|FG003|Overall Study|Progressive Disease|2|||
143107983|NCT01295827|515935651|FG004|Overall Study|Progressive Disease|0|||
143107984|NCT01295827|515935652|FG005|Overall Study|Progressive Disease|1|||
143107985|NCT01295827|515935653|FG006|Overall Study|Progressive Disease|87|||
143107986|NCT01295827|515935654|FG007|Overall Study|Progressive Disease|144|||
143107987|NCT01295827|515935655|FG008|Overall Study|Progressive Disease|85|||
143107988|NCT01295827|515935656|FG009|Overall Study|Progressive Disease|40|||
143107989|NCT01295827|515935657|FG010|Overall Study|Progressive Disease|175|||
143107990|NCT01295827|515935658|FG011|Overall Study|Progressive Disease|136|||
143107991|NCT01295827|515935659|FG012|Overall Study|Progressive Disease|0|||
143107992|NCT01295827|515935660|FG013|Overall Study|Progressive Disease|0|||
143107993|NCT01295827|515935661|FG014|Overall Study|Progressive Disease|0|||
143107994|NCT01295827|515935647|FG000|Overall Study|Screen Failure|0|||
143107995|NCT01295827|515935648|FG001|Overall Study|Screen Failure|0|||
143107996|NCT01295827|515935649|FG002|Overall Study|Screen Failure|0|||
143107997|NCT01295827|515935650|FG003|Overall Study|Screen Failure|0|||
143107998|NCT01295827|515935651|FG004|Overall Study|Screen Failure|0|||
143107999|NCT01295827|515935652|FG005|Overall Study|Screen Failure|0|||
143108000|NCT01295827|515935653|FG006|Overall Study|Screen Failure|2|||
143108001|NCT01295827|515935654|FG007|Overall Study|Screen Failure|2|||
143108002|NCT01295827|515935655|FG008|Overall Study|Screen Failure|2|||
143108003|NCT01295827|515935656|FG009|Overall Study|Screen Failure|0|||
143108004|NCT01295827|515935657|FG010|Overall Study|Screen Failure|1|||
143108005|NCT01295827|515935658|FG011|Overall Study|Screen Failure|0|||
143108006|NCT01295827|515935659|FG012|Overall Study|Screen Failure|0|||
143108007|NCT01295827|515935660|FG013|Overall Study|Screen Failure|0|||
143108008|NCT01295827|515935661|FG014|Overall Study|Screen Failure|0|||
143108009|NCT01295827|515935647|FG000|Overall Study|Withdrawal by Subject|1|||
143108010|NCT01295827|515935648|FG001|Overall Study|Withdrawal by Subject|0|||
143108011|NCT01295827|515935649|FG002|Overall Study|Withdrawal by Subject|2|||
143256326|NCT00095147|516492618|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
143256327|NCT00095147|516492614|FG000|Long-term Extension Period|Death|0|||
143256328|NCT00095147|516492615|FG001|Long-term Extension Period|Death|0|||
143256329|NCT00095147|516492616|FG002|Long-term Extension Period|Death|0|||
143256330|NCT00095147|516492617|FG003|Long-term Extension Period|Death|0|||
143256331|NCT00095147|516492618|FG004|Long-term Extension Period|Death|3|||
143256332|NCT00095147|516492614|FG000|Long-term Extension Period|Adverse Event|0|||
143256333|NCT00095147|516492615|FG001|Long-term Extension Period|Adverse Event|0|||
143256334|NCT00095147|516492616|FG002|Long-term Extension Period|Adverse Event|0|||
143256335|NCT00095147|516492617|FG003|Long-term Extension Period|Adverse Event|0|||
143256336|NCT00095147|516492618|FG004|Long-term Extension Period|Adverse Event|11|||
143256337|NCT00095147|516492614|FG000|Long-term Extension Period|Lack of Efficacy|0|||
143108012|NCT01295827|515935650|FG003|Overall Study|Withdrawal by Subject|0|||
143108013|NCT01295827|515935651|FG004|Overall Study|Withdrawal by Subject|0|||
143108014|NCT01295827|515935652|FG005|Overall Study|Withdrawal by Subject|1|||
143108015|NCT01295827|515935653|FG006|Overall Study|Withdrawal by Subject|13|||
143108016|NCT01295827|515935654|FG007|Overall Study|Withdrawal by Subject|35|||
143108017|NCT01295827|515935655|FG008|Overall Study|Withdrawal by Subject|11|||
143108018|NCT01295827|515935656|FG009|Overall Study|Withdrawal by Subject|2|||
143108019|NCT01295827|515935657|FG010|Overall Study|Withdrawal by Subject|18|||
143108020|NCT01295827|515935658|FG011|Overall Study|Withdrawal by Subject|13|||
143108021|NCT01295827|515935659|FG012|Overall Study|Withdrawal by Subject|0|||
143108022|NCT01295827|515935660|FG013|Overall Study|Withdrawal by Subject|0|||
143108023|NCT01295827|515935661|FG014|Overall Study|Withdrawal by Subject|0|||
143108024|NCT01295827|515935647|FG000|Overall Study|Other|0|||
143108025|NCT01295827|515935648|FG001|Overall Study|Other|0|||
143108026|NCT01295827|515935649|FG002|Overall Study|Other|0|||
143108027|NCT01295827|515935650|FG003|Overall Study|Other|0|||
143256338|NCT00095147|516492615|FG001|Long-term Extension Period|Lack of Efficacy|0|||
143256339|NCT00095147|516492616|FG002|Long-term Extension Period|Lack of Efficacy|0|||
143108028|NCT01295827|515935651|FG004|Overall Study|Other|0|||
143108029|NCT01295827|515935652|FG005|Overall Study|Other|0|||
143108030|NCT01295827|515935653|FG006|Overall Study|Other|1|||
143108031|NCT01295827|515935654|FG007|Overall Study|Other|1|||
143108032|NCT01295827|515935655|FG008|Overall Study|Other|1|||
143108033|NCT01295827|515935656|FG009|Overall Study|Other|0|||
143108034|NCT01295827|515935657|FG010|Overall Study|Other|2|||
143108035|NCT01295827|515935658|FG011|Overall Study|Other|0|||
143108036|NCT01295827|515935659|FG012|Overall Study|Other|0|||
143108037|NCT01295827|515935660|FG013|Overall Study|Other|0|||
143108038|NCT01295827|515935661|FG014|Overall Study|Other|0|||
143108039|NCT00072280|515935662|FG000|Treatment|Found ineligible|1|||
143108040|NCT00072280|515935663|FG001|Treatment|Found ineligible|2|||
143108041|NCT00072280|515935662|FG000|Follow-up|Early termination of study|2|||
143108042|NCT00072280|515935663|FG001|Follow-up|Early termination of study|2|||
143108043|NCT00746564|515935664|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
143108044|NCT00877487|515935669|FG000|Open-label Treatment Phase|Adverse Event|1|||
143108045|NCT00877487|515935670|FG001|Open-label Treatment Phase|Adverse Event|0|||
143108046|NCT00877487|515935669|FG000|Open-label Treatment Phase|Protocol Violation|3|||
143108047|NCT00877487|515935670|FG001|Open-label Treatment Phase|Protocol Violation|0|||
143108048|NCT00877487|515935669|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
143108049|NCT00877487|515935670|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
143108050|NCT00877487|515935669|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
143108051|NCT00877487|515935670|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
143108052|NCT00877487|515935669|FG000|Open-label Treatment Phase|Out of country for business|1|||
143108053|NCT00877487|515935670|FG001|Open-label Treatment Phase|Out of country for business|0|||
143108054|NCT00877487|515935669|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
143108055|NCT00877487|515935670|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
143108056|NCT00877487|515935669|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
143108057|NCT00877487|515935670|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
143108058|NCT00877487|515935669|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
143108059|NCT00877487|515935670|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
143108060|NCT00877487|515935669|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
143108061|NCT00877487|515935670|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
143108062|NCT01516008|515935671|FG000|Overall Study|Adverse Event|0|||
143108063|NCT01516008|515935672|FG001|Overall Study|Adverse Event|2|||
143108064|NCT01516008|515935673|FG002|Overall Study|Adverse Event|7|||
143108065|NCT01516008|515935671|FG000|Overall Study|Lack of Efficacy|44|||
143108066|NCT01516008|515935672|FG001|Overall Study|Lack of Efficacy|14|||
143108067|NCT01516008|515935673|FG002|Overall Study|Lack of Efficacy|10|||
143108068|NCT01516008|515935671|FG000|Overall Study|Protocol Violation|1|||
143108069|NCT01516008|515935672|FG001|Overall Study|Protocol Violation|0|||
143108070|NCT01516008|515935673|FG002|Overall Study|Protocol Violation|0|||
143108071|NCT01516008|515935671|FG000|Overall Study|Reason not specified|0|||
143108072|NCT01516008|515935672|FG001|Overall Study|Reason not specified|0|||
143179216|NCT03230318|516203652|FG001|Overall Study|Radiographic disease progression|19|||
143179217|NCT03230318|516203651|FG000|Overall Study|Clinical progression|17|||
143179218|NCT03230318|516203652|FG001|Overall Study|Clinical progression|7|||
143179219|NCT03230318|516203651|FG000|Overall Study|Adverse Event|5|||
143179220|NCT03230318|516203652|FG001|Overall Study|Adverse Event|3|||
143256340|NCT00095147|516492617|FG003|Long-term Extension Period|Lack of Efficacy|0|||
143256341|NCT00095147|516492618|FG004|Long-term Extension Period|Lack of Efficacy|9|||
143256342|NCT00095147|516492614|FG000|Long-term Extension Period|Lost to Follow-up|0|||
143256343|NCT00095147|516492615|FG001|Long-term Extension Period|Lost to Follow-up|0|||
143179221|NCT03230318|516203651|FG000|Overall Study|Physician Decision|2|||
143179222|NCT03230318|516203652|FG001|Overall Study|Physician Decision|3|||
143179223|NCT03230318|516203651|FG000|Overall Study|Death|3|||
143179224|NCT03230318|516203652|FG001|Overall Study|Death|2|||
143179225|NCT03230318|516203651|FG000|Overall Study|Lost to Follow-up|1|||
143256344|NCT00095147|516492616|FG002|Long-term Extension Period|Lost to Follow-up|0|||
143108073|NCT01516008|515935673|FG002|Overall Study|Reason not specified|1|||
143108074|NCT01217476|515935674|FG000|Overall Study|Adverse Event|6|||
143108075|NCT01217476|515935675|FG001|Overall Study|Adverse Event|1|||
143108076|NCT01217476|515935674|FG000|Overall Study|Physician Decision|0|||
143108077|NCT01217476|515935675|FG001|Overall Study|Physician Decision|1|||
143108078|NCT01217476|515935674|FG000|Overall Study|Withdrawal by Subject|3|||
143108079|NCT01217476|515935675|FG001|Overall Study|Withdrawal by Subject|3|||
143179226|NCT03230318|516203652|FG001|Overall Study|Lost to Follow-up|0|||
143179227|NCT03230318|516203651|FG000|Overall Study|Withdrawal by Subject|1|||
143179228|NCT03230318|516203652|FG001|Overall Study|Withdrawal by Subject|3|||
143179229|NCT03230318|516203651|FG000|Overall Study|Other|3|||
143179230|NCT03230318|516203652|FG001|Overall Study|Other|7|||
143179231|NCT04011735|516203653|FG000|Overall Study|Withdrawal by Subject|1|||
143256345|NCT00095147|516492617|FG003|Long-term Extension Period|Lost to Follow-up|0|||
143367975|NCT00930813|516890850|FG000|Overall Study|Withdrawal by Subject|2|||
143367976|NCT00930813|516890851|FG001|Overall Study|Withdrawal by Subject|5|||
143108080|NCT01217476|515935674|FG000|Overall Study|Surgery on the Target Limb|0|||
143108081|NCT01217476|515935675|FG001|Overall Study|Surgery on the Target Limb|2|||
143108082|NCT01217476|515935674|FG000|Overall Study|Protocol Deviation|1|||
143108083|NCT01217476|515935675|FG001|Overall Study|Protocol Deviation|0|||
143108084|NCT01217476|515935674|FG000|Overall Study|Other|2|||
143108085|NCT01217476|515935675|FG001|Overall Study|Other|0|||
143108086|NCT03033602|515935678|FG000|Overall Study|Withdrawal by Subject|11|||
143108087|NCT03033602|515935679|FG001|Overall Study|Withdrawal by Subject|21|||
143108088|NCT03033602|515935678|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
143108089|NCT03033602|515935679|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
143108090|NCT01441765|515935680|FG000|Overall Study|Death|1|||
143108091|NCT01441765|515935681|FG001|Overall Study|Death|0|||
143108092|NCT00940823|515935682|FG000|Overall Study|Death|8|||
143108093|NCT00940823|515935683|FG001|Overall Study|Death|12|||
143108094|NCT00940823|515935682|FG000|Overall Study|Lost to Follow-up|27|||
143108095|NCT00940823|515935683|FG001|Overall Study|Lost to Follow-up|20|||
143108096|NCT00813813|515935686|FG000|Overall Study|Withdrawal by Subject|1|||
143108097|NCT00813813|515935687|FG001|Overall Study|Withdrawal by Subject|1|||
143108098|NCT00813813|515935686|FG000|Overall Study|Lost to Follow-up|2|||
143108099|NCT00813813|515935687|FG001|Overall Study|Lost to Follow-up|7|||
143108100|NCT00813813|515935686|FG000|Overall Study|Other|0|||
143108101|NCT00813813|515935687|FG001|Overall Study|Other|1|||
143108102|NCT00986921|515935688|FG000|Overall Study|Physician Decision|1|||
143108103|NCT00986921|515935689|FG001|Overall Study|Physician Decision|0|||
143108104|NCT04445714|515935690|FG000|Overall Study|Discontinuation of the study|14|||
143108105|NCT04445714|515935690|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
143108106|NCT04445714|515935690|FG000|Overall Study|Withdrawal of Informed Consent|8|||
143108107|NCT02805660|515935691|FG000|Overall Study|Death|5|||
143108108|NCT02805660|515935692|FG001|Overall Study|Death|2|||
143108109|NCT02805660|515935693|FG002|Overall Study|Death|9|||
143108110|NCT02805660|515935694|FG003|Overall Study|Death|5|||
143108111|NCT02805660|515935695|FG004|Overall Study|Death|0|||
143108112|NCT02805660|515935696|FG005|Overall Study|Death|14|||
143108113|NCT02805660|515935697|FG006|Overall Study|Death|12|||
143108114|NCT02805660|515935691|FG000|Overall Study|Lost to Follow-up|0|||
143108115|NCT02805660|515935692|FG001|Overall Study|Lost to Follow-up|1|||
143108116|NCT02805660|515935693|FG002|Overall Study|Lost to Follow-up|1|||
143108117|NCT02805660|515935694|FG003|Overall Study|Lost to Follow-up|2|||
143108118|NCT02805660|515935695|FG004|Overall Study|Lost to Follow-up|0|||
143108119|NCT02805660|515935696|FG005|Overall Study|Lost to Follow-up|0|||
143108120|NCT02805660|515935697|FG006|Overall Study|Lost to Follow-up|0|||
143108121|NCT02805660|515935691|FG000|Overall Study|Withdrawal by Subject|0|||
143108122|NCT02805660|515935692|FG001|Overall Study|Withdrawal by Subject|0|||
143108123|NCT02805660|515935693|FG002|Overall Study|Withdrawal by Subject|0|||
143108124|NCT02805660|515935694|FG003|Overall Study|Withdrawal by Subject|3|||
143108125|NCT02805660|515935695|FG004|Overall Study|Withdrawal by Subject|1|||
143108126|NCT02805660|515935696|FG005|Overall Study|Withdrawal by Subject|0|||
143108127|NCT02805660|515935697|FG006|Overall Study|Withdrawal by Subject|2|||
143108128|NCT02805660|515935691|FG000|Overall Study|Study terminated by Sponsor|0|||
143108129|NCT02805660|515935692|FG001|Overall Study|Study terminated by Sponsor|0|||
143108130|NCT02805660|515935693|FG002|Overall Study|Study terminated by Sponsor|1|||
143108131|NCT02805660|515935694|FG003|Overall Study|Study terminated by Sponsor|4|||
143108132|NCT02805660|515935695|FG004|Overall Study|Study terminated by Sponsor|2|||
143108133|NCT02805660|515935696|FG005|Overall Study|Study terminated by Sponsor|3|||
143108134|NCT02805660|515935697|FG006|Overall Study|Study terminated by Sponsor|1|||
143108135|NCT02805660|515935691|FG000|Overall Study|Miscellaneous|0|||
143108136|NCT02805660|515935692|FG001|Overall Study|Miscellaneous|1|||
143108137|NCT02805660|515935693|FG002|Overall Study|Miscellaneous|0|||
143108138|NCT02805660|515935694|FG003|Overall Study|Miscellaneous|4|||
143108139|NCT02805660|515935695|FG004|Overall Study|Miscellaneous|0|||
143108140|NCT02805660|515935696|FG005|Overall Study|Miscellaneous|6|||
143108141|NCT02805660|515935697|FG006|Overall Study|Miscellaneous|4|||
143108142|NCT02778074|515935698|FG000|Overall Study|Lost to Follow-up|7|||
143108143|NCT02778074|515935699|FG001|Overall Study|Lost to Follow-up|10|||
143108144|NCT01684943|515935700|FG000|Overall Study|Inadequate Venous Access|3|||
143108145|NCT01684943|515935701|FG001|Overall Study|Inadequate Venous Access|0|||
143108146|NCT01684943|515935702|FG002|Overall Study|Inadequate Venous Access|0|||
143108147|NCT01684943|515935700|FG000|Overall Study|Principal Investigator Determination|1|||
143108148|NCT01684943|515935701|FG001|Overall Study|Principal Investigator Determination|0|||
143108149|NCT01684943|515935702|FG002|Overall Study|Principal Investigator Determination|0|||
143108150|NCT01684943|515935700|FG000|Overall Study|Excluded from Analysis|1|||
143108151|NCT01684943|515935701|FG001|Overall Study|Excluded from Analysis|1|||
143108152|NCT01684943|515935702|FG002|Overall Study|Excluded from Analysis|1|||
143108153|NCT01684943|515935700|FG000|Overall Study|Lost to Follow-up|3|||
143108154|NCT01684943|515935701|FG001|Overall Study|Lost to Follow-up|0|||
143108155|NCT01684943|515935702|FG002|Overall Study|Lost to Follow-up|0|||
143256346|NCT00095147|516492618|FG004|Long-term Extension Period|Lost to Follow-up|6|||
143256347|NCT00095147|516492614|FG000|Long-term Extension Period|Withdrawal of consent|0|||
143256348|NCT00095147|516492615|FG001|Long-term Extension Period|Withdrawal of consent|0|||
143256349|NCT00095147|516492616|FG002|Long-term Extension Period|Withdrawal of consent|0|||
143256350|NCT00095147|516492617|FG003|Long-term Extension Period|Withdrawal of consent|0|||
143256351|NCT00095147|516492618|FG004|Long-term Extension Period|Withdrawal of consent|12|||
143256352|NCT00095147|516492614|FG000|Long-term Extension Period|Pregnancy|0|||
143256353|NCT00095147|516492615|FG001|Long-term Extension Period|Pregnancy|0|||
143256354|NCT00095147|516492616|FG002|Long-term Extension Period|Pregnancy|0|||
143256355|NCT00095147|516492617|FG003|Long-term Extension Period|Pregnancy|0|||
143256356|NCT00095147|516492618|FG004|Long-term Extension Period|Pregnancy|1|||
143256357|NCT00095147|516492614|FG000|Long-term Extension Period|No longer meets study criteria|0|||
143256358|NCT00095147|516492615|FG001|Long-term Extension Period|No longer meets study criteria|0|||
143256359|NCT00095147|516492616|FG002|Long-term Extension Period|No longer meets study criteria|0|||
143256360|NCT00095147|516492617|FG003|Long-term Extension Period|No longer meets study criteria|0|||
143256361|NCT00095147|516492618|FG004|Long-term Extension Period|No longer meets study criteria|1|||
143256362|NCT00095147|516492614|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
143256363|NCT00095147|516492615|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
143256364|NCT00095147|516492616|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
143256365|NCT00095147|516492617|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
143256366|NCT00095147|516492618|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
143256367|NCT00095147|516492614|FG000|Long-term Extension Period|Leaving country|0|||
143256368|NCT00095147|516492615|FG001|Long-term Extension Period|Leaving country|0|||
143256369|NCT00095147|516492616|FG002|Long-term Extension Period|Leaving country|0|||
143256370|NCT00095147|516492617|FG003|Long-term Extension Period|Leaving country|0|||
143256371|NCT00095147|516492618|FG004|Long-term Extension Period|Leaving country|1|||
143256372|NCT02395302|516492619|FG000|Overall Study|Screen Failure|3|||
143256373|NCT02395302|516492619|FG000|Overall Study|Run In Failure|7|||
143256374|NCT02395302|516492619|FG000|Overall Study|Withdrawal by Subject|2|||
143256375|NCT02395302|516492619|FG000|Overall Study|Physician Decision|2|||
143256376|NCT02650921|516492620|FG000|Overall Study|Withdrawal by Subject|4|||
143256377|NCT02650921|516492620|FG000|Overall Study|Lost to Follow-up|2|||
143256378|NCT02650921|516492620|FG000|Overall Study|Adverse Event|1|||
143256379|NCT02650921|516492620|FG000|Overall Study|Due to Medical Condition|1|||
143256380|NCT00783302|516492621|FG000|Overall Study|Lost to Follow-up|17|||
143256381|NCT00783302|516492621|FG000|Overall Study|Technical Problems|11|||
143256382|NCT00783302|516492621|FG000|Overall Study|Protocol Violation|3|||
143256383|NCT00783302|516492621|FG000|Overall Study|Physician Decision|1|||
143256384|NCT00783302|516492621|FG000|Overall Study|Withdrawal by Subject|3|||
143256385|NCT01087788|516492622|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
143256386|NCT01087788|516492623|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
143256387|NCT01087788|516492624|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
143256388|NCT01087788|516492622|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
143256389|NCT01087788|516492623|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
143256390|NCT01087788|516492624|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
143256391|NCT01087788|516492622|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
143256392|NCT01087788|516492623|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
143108156|NCT01684943|515935700|FG000|Overall Study|Planning Pregnancy|1|||
143108157|NCT01684943|515935701|FG001|Overall Study|Planning Pregnancy|0|||
143108158|NCT01684943|515935702|FG002|Overall Study|Planning Pregnancy|0|||
143108159|NCT00199797|515937577|FG000|Overall Study|Progressive Disease|1|||
143108160|NCT00199797|515937577|FG000|Overall Study|Adverse Event|1|||
143108161|NCT00199797|515937577|FG000|Overall Study|Physician Decision|1|||
143108162|NCT04250350|515937578|FG000|Overall Study|Withdrawal by Subject|13|||
143108163|NCT04250350|515937578|FG000|Overall Study|Lost to Follow-up|8|||
143108164|NCT04250350|515937578|FG000|Overall Study|Adverse Event|5|||
143108165|NCT04250350|515937578|FG000|Overall Study|Lack of Efficacy|4|||
143108166|NCT04250350|515937578|FG000|Overall Study|Physician Decision|1|||
143108167|NCT04250350|515937578|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
143108168|NCT02836236|515937579|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
143108169|NCT02836236|515937580|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
143108170|NCT02836236|515937581|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
143108171|NCT02836236|515937582|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
143108172|NCT02836236|515937579|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
143108173|NCT02836236|515937580|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
143108174|NCT02836236|515937581|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
143256393|NCT01087788|516492624|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
143256394|NCT01087788|516492622|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
143256395|NCT01087788|516492623|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
143256396|NCT01087788|516492624|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
143256397|NCT01087788|516492622|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
143256398|NCT01087788|516492623|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
143108175|NCT02836236|515937582|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
143108176|NCT02836236|515937579|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
143108177|NCT02836236|515937580|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
143108178|NCT02836236|515937581|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
143108179|NCT02836236|515937582|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
143108180|NCT02836236|515937579|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
143108181|NCT02836236|515937580|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
143108182|NCT02836236|515937581|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
143108183|NCT02836236|515937582|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
143108184|NCT02836236|515937579|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
143108185|NCT02836236|515937580|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
143108186|NCT02836236|515937581|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
143108187|NCT02836236|515937582|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
143108188|NCT02836236|515937579|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
143108189|NCT02836236|515937580|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
143108190|NCT02836236|515937581|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
143108191|NCT02836236|515937582|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
143108192|NCT02836236|515937579|FG000|Open-Label TAF Treatment Phase|Death|0|||
143108193|NCT02836236|515937580|FG001|Open-Label TAF Treatment Phase|Death|0|||
143108194|NCT02836236|515937581|FG002|Open-Label TAF Treatment Phase|Death|1|||
143108195|NCT02836236|515937582|FG003|Open-Label TAF Treatment Phase|Death|1|||
143108196|NCT02836236|515937579|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
143108197|NCT02836236|515937580|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
143108198|NCT02836236|515937581|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
143108199|NCT02836236|515937582|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
143108200|NCT03937908|515937584|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
143108201|NCT03937908|515937585|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
143108202|NCT03205761|515937586|FG000|Overall Study|Withdrawal by Subject|1|||
143108203|NCT03205761|515937586|FG000|Overall Study|Progressive Disease|10|||
143108204|NCT04114357|515937588|FG000|Baseline-Randomization|Adverse Event|2|||
143108205|NCT04114357|515937589|FG001|Baseline-Randomization|Adverse Event|1|||
143108206|NCT04114357|515937588|FG000|Baseline-Randomization|Lost to Follow-up|1|||
143108207|NCT04114357|515937589|FG001|Baseline-Randomization|Lost to Follow-up|1|||
143108208|NCT04114357|515937588|FG000|Cross-over|Adverse Event|0|||
143108209|NCT04114357|515937589|FG001|Cross-over|Adverse Event|1|||
143108210|NCT00477750|515937590|FG000|Overall Study|Currently Receiving Treatment|11|||
143108211|NCT03558152|515937592|FG000|Overall Study|Adverse Event|0|||
143108212|NCT03558152|515937593|FG001|Overall Study|Adverse Event|0|||
143108213|NCT03558152|515937594|FG002|Overall Study|Adverse Event|1|||
143108214|NCT03558152|515937595|FG003|Overall Study|Adverse Event|1|||
143108215|NCT03558152|515937596|FG004|Overall Study|Adverse Event|2|||
143108216|NCT03558152|515937597|FG005|Overall Study|Adverse Event|1|||
143108217|NCT03558152|515937598|FG006|Overall Study|Adverse Event|1|||
143108218|NCT03558152|515937599|FG007|Overall Study|Adverse Event|0|||
143108219|NCT03558152|515937592|FG000|Overall Study|Death|0|||
143108220|NCT03558152|515937593|FG001|Overall Study|Death|0|||
143108221|NCT03558152|515937594|FG002|Overall Study|Death|0|||
143108222|NCT03558152|515937595|FG003|Overall Study|Death|0|||
143108223|NCT03558152|515937596|FG004|Overall Study|Death|1|||
143108224|NCT03558152|515937597|FG005|Overall Study|Death|0|||
143108225|NCT03558152|515937598|FG006|Overall Study|Death|0|||
143108226|NCT03558152|515937599|FG007|Overall Study|Death|0|||
143256399|NCT01087788|516492624|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
143108227|NCT03558152|515937592|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
143108228|NCT03558152|515937593|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
143108229|NCT03558152|515937594|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
143108230|NCT03558152|515937595|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
143108231|NCT03558152|515937596|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
143108232|NCT03558152|515937597|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
143117388|NCT01313221|515971826|FG000|Overall Study|Physician Decision|0|||
143256400|NCT01087788|516492622|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
143256401|NCT01087788|516492623|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
143256402|NCT01087788|516492624|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
143256403|NCT01087788|516492622|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
143256404|NCT01087788|516492623|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
143256405|NCT01087788|516492624|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
143256406|NCT01087788|516492622|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
143256407|NCT01087788|516492623|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
143256408|NCT01087788|516492624|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
143256409|NCT01087788|516492622|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
143256410|NCT01087788|516492623|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
143256411|NCT01087788|516492624|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
143256412|NCT01087788|516492622|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
143256413|NCT01087788|516492623|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
143256414|NCT01087788|516492624|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
143256415|NCT01087788|516492622|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
143256416|NCT01087788|516492623|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
143256417|NCT01087788|516492624|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
143256418|NCT01087788|516492622|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
143256419|NCT01087788|516492623|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
143256420|NCT01087788|516492624|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
143256421|NCT01087788|516492622|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
143256422|NCT01087788|516492623|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
143256423|NCT01087788|516492624|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
143256424|NCT01087788|516492622|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
143256425|NCT01087788|516492623|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
143256426|NCT01087788|516492624|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
143256427|NCT01087788|516492622|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
143256428|NCT01087788|516492623|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
143256429|NCT01087788|516492624|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
143256430|NCT01087788|516492622|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
143256431|NCT01087788|516492623|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
143256432|NCT01087788|516492624|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
143256433|NCT01087788|516492622|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
143256434|NCT01087788|516492623|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
143256435|NCT01087788|516492624|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
143256436|NCT01087788|516492622|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
143256437|NCT01087788|516492623|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
143256438|NCT01087788|516492624|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
143256439|NCT01087788|516492622|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
143256440|NCT01087788|516492623|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
143256441|NCT01087788|516492624|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
143256442|NCT01087788|516492622|FG000|24-weeks Dose-blind Period|Patient moved|0|||
143256443|NCT01087788|516492623|FG001|24-weeks Dose-blind Period|Patient moved|0|||
143256444|NCT01087788|516492624|FG002|24-weeks Dose-blind Period|Patient moved|1|||
143256445|NCT01087788|516492622|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
143256446|NCT01087788|516492623|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
143256447|NCT01087788|516492624|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
143256448|NCT01087788|516492622|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
143256449|NCT01087788|516492623|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
143256450|NCT01087788|516492624|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
143256451|NCT01087788|516492622|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
143256452|NCT01087788|516492623|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
143256453|NCT01087788|516492624|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
143256454|NCT01087788|516492622|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
143256455|NCT01087788|516492623|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
143256456|NCT01087788|516492624|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
143256457|NCT01087788|516492622|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
143256458|NCT01087788|516492623|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
143256459|NCT01087788|516492624|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
143256460|NCT01087788|516492622|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
143256461|NCT01087788|516492623|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
143256462|NCT01087788|516492624|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
143256463|NCT01087788|516492622|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
143256464|NCT01087788|516492623|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
143256465|NCT01087788|516492624|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
143256466|NCT01087788|516492622|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
143256467|NCT01087788|516492623|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
143256468|NCT01087788|516492624|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
143256469|NCT01087788|516492622|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
143256470|NCT01087788|516492623|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
143256471|NCT01087788|516492624|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
143256472|NCT01087788|516492622|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
143256473|NCT01087788|516492623|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
143256474|NCT01087788|516492624|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
143256475|NCT01087788|516492622|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
143256476|NCT01087788|516492623|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
143256477|NCT01087788|516492624|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
143256478|NCT01087788|516492622|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
143256479|NCT01087788|516492623|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
143256480|NCT01087788|516492624|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
143256481|NCT01087788|516492622|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
143256482|NCT01087788|516492623|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
143256483|NCT01087788|516492624|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
143256484|NCT04604132|516492625|FG000|Overall Study|Adverse Event|2|||
143256485|NCT04604132|516492626|FG001|Overall Study|Adverse Event|0|||
143256486|NCT04604132|516492627|FG002|Overall Study|Adverse Event|0|||
143256487|NCT04604132|516492628|FG003|Overall Study|Adverse Event|1|||
143256488|NCT04604132|516492629|FG004|Overall Study|Adverse Event|2|||
143256489|NCT04604132|516492625|FG000|Overall Study|Study terminated by sponsor|0|||
143256490|NCT04604132|516492626|FG001|Overall Study|Study terminated by sponsor|0|||
143256491|NCT04604132|516492627|FG002|Overall Study|Study terminated by sponsor|0|||
143256492|NCT04604132|516492628|FG003|Overall Study|Study terminated by sponsor|0|||
143256493|NCT04604132|516492629|FG004|Overall Study|Study terminated by sponsor|1|||
143256494|NCT04604132|516492625|FG000|Overall Study|Progressive disease: Clinical progression|0|||
143256495|NCT04604132|516492626|FG001|Overall Study|Progressive disease: Clinical progression|0|||
143256496|NCT04604132|516492627|FG002|Overall Study|Progressive disease: Clinical progression|1|||
143256497|NCT04604132|516492628|FG003|Overall Study|Progressive disease: Clinical progression|0|||
143256498|NCT04604132|516492629|FG004|Overall Study|Progressive disease: Clinical progression|0|||
143256499|NCT04604132|516492625|FG000|Overall Study|Progressive disease: Radiological progression|8|||
143256500|NCT04604132|516492626|FG001|Overall Study|Progressive disease: Radiological progression|7|||
143256501|NCT04604132|516492627|FG002|Overall Study|Progressive disease: Radiological progression|10|||
143256502|NCT04604132|516492628|FG003|Overall Study|Progressive disease: Radiological progression|4|||
143256503|NCT04604132|516492629|FG004|Overall Study|Progressive disease: Radiological progression|3|||
143256504|NCT04604132|516492625|FG000|Overall Study|Death|3|||
143256505|NCT04604132|516492626|FG001|Overall Study|Death|1|||
143256506|NCT04604132|516492627|FG002|Overall Study|Death|2|||
143256507|NCT04604132|516492628|FG003|Overall Study|Death|1|||
143256508|NCT04604132|516492629|FG004|Overall Study|Death|0|||
143256509|NCT00952380|516492630|FG000|Overall Study|Other|0|||
143256510|NCT00952380|516492631|FG001|Overall Study|Other|0|||
143256511|NCT00952380|516492632|FG002|Overall Study|Other|0|||
143256512|NCT00952380|516492633|FG003|Overall Study|Other|0|||
143256513|NCT00952380|516492634|FG004|Overall Study|Other|1|||
143256514|NCT00952380|516492630|FG000|Overall Study|Withdrawal by Subject|0|||
143256515|NCT00952380|516492631|FG001|Overall Study|Withdrawal by Subject|0|||
143256516|NCT00952380|516492632|FG002|Overall Study|Withdrawal by Subject|1|||
143256517|NCT00952380|516492633|FG003|Overall Study|Withdrawal by Subject|0|||
143256518|NCT00952380|516492634|FG004|Overall Study|Withdrawal by Subject|2|||
143256519|NCT00952380|516492630|FG000|Overall Study|Adverse Event|0|||
143256520|NCT00952380|516492631|FG001|Overall Study|Adverse Event|1|||
143256521|NCT00952380|516492632|FG002|Overall Study|Adverse Event|0|||
143256522|NCT00952380|516492633|FG003|Overall Study|Adverse Event|0|||
143256523|NCT00952380|516492634|FG004|Overall Study|Adverse Event|3|||
143256524|NCT00952380|516492630|FG000|Overall Study|Physician Decision|0|||
143256525|NCT00952380|516492631|FG001|Overall Study|Physician Decision|0|||
143256526|NCT00952380|516492632|FG002|Overall Study|Physician Decision|1|||
143256527|NCT00952380|516492633|FG003|Overall Study|Physician Decision|2|||
143256528|NCT00952380|516492634|FG004|Overall Study|Physician Decision|0|||
143256529|NCT00952380|516492630|FG000|Overall Study|Non-compliant to protocol|0|||
143256530|NCT00952380|516492631|FG001|Overall Study|Non-compliant to protocol|0|||
143256531|NCT00952380|516492632|FG002|Overall Study|Non-compliant to protocol|0|||
143256532|NCT00952380|516492633|FG003|Overall Study|Non-compliant to protocol|1|||
143256533|NCT00952380|516492634|FG004|Overall Study|Non-compliant to protocol|0|||
143256534|NCT00160667|516492635|FG000|Overall Study|Adverse Event|3|||
143256535|NCT00160667|516492636|FG001|Overall Study|Adverse Event|1|||
143256536|NCT00160667|516492637|FG002|Overall Study|Adverse Event|4|||
143256537|NCT00160667|516492635|FG000|Overall Study|Withdrawal by Subject|2|||
143256538|NCT00160667|516492636|FG001|Overall Study|Withdrawal by Subject|0|||
143256539|NCT00160667|516492637|FG002|Overall Study|Withdrawal by Subject|1|||
143256540|NCT00160667|516492635|FG000|Overall Study|Lack of Efficacy|0|||
143256541|NCT00160667|516492636|FG001|Overall Study|Lack of Efficacy|1|||
143256542|NCT00160667|516492637|FG002|Overall Study|Lack of Efficacy|0|||
143256543|NCT00160667|516492635|FG000|Overall Study|Protocol Violation|0|||
143256544|NCT00160667|516492636|FG001|Overall Study|Protocol Violation|1|||
143256545|NCT00160667|516492637|FG002|Overall Study|Protocol Violation|0|||
143256546|NCT00160667|516492635|FG000|Overall Study|Patient decision|0|||
143256547|NCT00160667|516492636|FG001|Overall Study|Patient decision|0|||
143256548|NCT00160667|516492637|FG002|Overall Study|Patient decision|1|||
143256549|NCT00534313|516492641|FG000|Short-term Period|Adverse Event|1|||
143256550|NCT00534313|516492642|FG001|Short-term Period|Adverse Event|2|||
143256551|NCT00534313|516492643|FG002|Short-term Period|Adverse Event|1|||
143256552|NCT00534313|516492644|FG003|Short-term Period|Adverse Event|3|||
143256553|NCT00534313|516492641|FG000|Short-term Period|Lack of Efficacy|3|||
143256554|NCT00534313|516492642|FG001|Short-term Period|Lack of Efficacy|4|||
143256555|NCT00534313|516492643|FG002|Short-term Period|Lack of Efficacy|0|||
143256556|NCT00534313|516492644|FG003|Short-term Period|Lack of Efficacy|3|||
143108233|NCT03558152|515937598|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
143108234|NCT03558152|515937599|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
143108235|NCT03558152|515937592|FG000|Overall Study|Miscalculation in mmcs|0|||
143108236|NCT03558152|515937593|FG001|Overall Study|Miscalculation in mmcs|0|||
143256557|NCT00534313|516492641|FG000|Short-term Period|Participant not meeting study criteria|0|||
143256558|NCT00534313|516492642|FG001|Short-term Period|Participant not meeting study criteria|0|||
143108237|NCT03558152|515937594|FG002|Overall Study|Miscalculation in mmcs|0|||
143108238|NCT03558152|515937595|FG003|Overall Study|Miscalculation in mmcs|0|||
143108239|NCT03558152|515937596|FG004|Overall Study|Miscalculation in mmcs|0|||
143108240|NCT03558152|515937597|FG005|Overall Study|Miscalculation in mmcs|0|||
143108241|NCT03558152|515937598|FG006|Overall Study|Miscalculation in mmcs|1|||
143108242|NCT03558152|515937599|FG007|Overall Study|Miscalculation in mmcs|0|||
143108243|NCT03558152|515937592|FG000|Overall Study|Mistake in calculation|0|||
143256559|NCT00534313|516492643|FG002|Short-term Period|Participant not meeting study criteria|0|||
143256560|NCT00534313|516492644|FG003|Short-term Period|Participant not meeting study criteria|1|||
143256561|NCT00534313|516492641|FG000|Short-term Period|Participant withdrew consent|2|||
143256562|NCT00534313|516492642|FG001|Short-term Period|Participant withdrew consent|0|||
143256563|NCT00534313|516492643|FG002|Short-term Period|Participant withdrew consent|0|||
143256564|NCT00534313|516492644|FG003|Short-term Period|Participant withdrew consent|2|||
143256565|NCT00534313|516492641|FG000|Short-term Period|Pregnancy|0|||
143256566|NCT00534313|516492642|FG001|Short-term Period|Pregnancy|0|||
143256567|NCT00534313|516492643|FG002|Short-term Period|Pregnancy|1|||
143256568|NCT00534313|516492644|FG003|Short-term Period|Pregnancy|0|||
143256569|NCT00534313|516492641|FG000|Long-term Period|Adverse Event|2|||
143256570|NCT00534313|516492642|FG001|Long-term Period|Adverse Event|1|||
143256571|NCT00534313|516492643|FG002|Long-term Period|Adverse Event|0|||
143256572|NCT00534313|516492644|FG003|Long-term Period|Adverse Event|1|||
143256573|NCT00534313|516492641|FG000|Long-term Period|Lack of Efficacy|14|||
143256574|NCT00534313|516492642|FG001|Long-term Period|Lack of Efficacy|10|||
143256575|NCT00534313|516492643|FG002|Long-term Period|Lack of Efficacy|14|||
143256576|NCT00534313|516492644|FG003|Long-term Period|Lack of Efficacy|12|||
143256577|NCT00534313|516492641|FG000|Long-term Period|Lost to Follow-up|1|||
143256578|NCT00534313|516492642|FG001|Long-term Period|Lost to Follow-up|2|||
143256579|NCT00534313|516492643|FG002|Long-term Period|Lost to Follow-up|0|||
143256580|NCT00534313|516492644|FG003|Long-term Period|Lost to Follow-up|0|||
143256581|NCT00534313|516492641|FG000|Long-term Period|Withdrawal by Subject|2|||
143256582|NCT00534313|516492642|FG001|Long-term Period|Withdrawal by Subject|2|||
143256583|NCT00534313|516492643|FG002|Long-term Period|Withdrawal by Subject|0|||
143256584|NCT00534313|516492644|FG003|Long-term Period|Withdrawal by Subject|0|||
143256585|NCT00534313|516492641|FG000|Long-term Period|No longer meets study criteria|0|||
143256586|NCT00534313|516492642|FG001|Long-term Period|No longer meets study criteria|1|||
143256587|NCT00534313|516492643|FG002|Long-term Period|No longer meets study criteria|0|||
143256588|NCT00534313|516492644|FG003|Long-term Period|No longer meets study criteria|0|||
143256589|NCT00534313|516492641|FG000|Long-term Period|Poor compliance/noncompliance|0|||
143256590|NCT00534313|516492642|FG001|Long-term Period|Poor compliance/noncompliance|1|||
143256591|NCT00534313|516492643|FG002|Long-term Period|Poor compliance/noncompliance|1|||
143256592|NCT00534313|516492644|FG003|Long-term Period|Poor compliance/noncompliance|0|||
143256593|NCT00534313|516492641|FG000|Long-term Period|Administrative reason by sponsor|17|||
143256594|NCT00534313|516492642|FG001|Long-term Period|Administrative reason by sponsor|15|||
143256595|NCT00534313|516492643|FG002|Long-term Period|Administrative reason by sponsor|26|||
143256596|NCT00534313|516492644|FG003|Long-term Period|Administrative reason by sponsor|18|||
143256597|NCT00534313|516492641|FG000|Long-term Period|Other|1|||
143256598|NCT00534313|516492642|FG001|Long-term Period|Other|2|||
143256599|NCT00534313|516492643|FG002|Long-term Period|Other|2|||
143256600|NCT00534313|516492644|FG003|Long-term Period|Other|2|||
143256601|NCT00927940|516492645|FG000|Overall Study|Death|1|||
143256602|NCT03007888|516492646|FG000|First Intervention (14 Days)|Adverse Event|1|||
143256603|NCT03007888|516492647|FG001|First Intervention (14 Days)|Adverse Event|0|||
143256604|NCT00827931|516492649|FG000|Overall Study|Death|3|||
143256605|NCT00827931|516492650|FG001|Overall Study|Death|5|||
143108244|NCT03558152|515937593|FG001|Overall Study|Mistake in calculation|0|||
143108245|NCT03558152|515937594|FG002|Overall Study|Mistake in calculation|0|||
143108246|NCT03558152|515937595|FG003|Overall Study|Mistake in calculation|1|||
143108247|NCT03558152|515937596|FG004|Overall Study|Mistake in calculation|0|||
143108248|NCT03558152|515937597|FG005|Overall Study|Mistake in calculation|0|||
143108249|NCT03558152|515937598|FG006|Overall Study|Mistake in calculation|0|||
143108250|NCT03558152|515937599|FG007|Overall Study|Mistake in calculation|0|||
143108251|NCT03558152|515937592|FG000|Overall Study|Mistake in evaluation of disease status|0|||
143108252|NCT03558152|515937593|FG001|Overall Study|Mistake in evaluation of disease status|0|||
143108253|NCT03558152|515937594|FG002|Overall Study|Mistake in evaluation of disease status|0|||
143108254|NCT03558152|515937595|FG003|Overall Study|Mistake in evaluation of disease status|0|||
143108255|NCT03558152|515937596|FG004|Overall Study|Mistake in evaluation of disease status|0|||
143108256|NCT03558152|515937597|FG005|Overall Study|Mistake in evaluation of disease status|0|||
143108257|NCT03558152|515937598|FG006|Overall Study|Mistake in evaluation of disease status|0|||
143108258|NCT03558152|515937599|FG007|Overall Study|Mistake in evaluation of disease status|1|||
143108259|NCT03558152|515937592|FG000|Overall Study|Physician Decision|0|||
143108260|NCT03558152|515937593|FG001|Overall Study|Physician Decision|0|||
143108261|NCT03558152|515937594|FG002|Overall Study|Physician Decision|0|||
143108262|NCT03558152|515937595|FG003|Overall Study|Physician Decision|0|||
143108263|NCT03558152|515937596|FG004|Overall Study|Physician Decision|0|||
143108264|NCT03558152|515937597|FG005|Overall Study|Physician Decision|0|||
143108265|NCT03558152|515937598|FG006|Overall Study|Physician Decision|1|||
143108266|NCT03558152|515937599|FG007|Overall Study|Physician Decision|0|||
143108267|NCT03558152|515937592|FG000|Overall Study|Withdrawal by Subject|2|||
143108268|NCT03558152|515937593|FG001|Overall Study|Withdrawal by Subject|3|||
143108269|NCT03558152|515937594|FG002|Overall Study|Withdrawal by Subject|2|||
143108270|NCT03558152|515937595|FG003|Overall Study|Withdrawal by Subject|1|||
143108271|NCT03558152|515937596|FG004|Overall Study|Withdrawal by Subject|1|||
143108272|NCT03558152|515937597|FG005|Overall Study|Withdrawal by Subject|1|||
143108273|NCT03558152|515937598|FG006|Overall Study|Withdrawal by Subject|3|||
143108274|NCT03558152|515937599|FG007|Overall Study|Withdrawal by Subject|2|||
143108275|NCT03558152|515937592|FG000|Overall Study|Lack of Efficacy|11|||
143108276|NCT03558152|515937593|FG001|Overall Study|Lack of Efficacy|11|||
143108277|NCT03558152|515937594|FG002|Overall Study|Lack of Efficacy|10|||
143108278|NCT03558152|515937595|FG003|Overall Study|Lack of Efficacy|11|||
143108279|NCT03558152|515937596|FG004|Overall Study|Lack of Efficacy|14|||
143108280|NCT03558152|515937597|FG005|Overall Study|Lack of Efficacy|12|||
143108281|NCT03558152|515937598|FG006|Overall Study|Lack of Efficacy|14|||
143108282|NCT03558152|515937599|FG007|Overall Study|Lack of Efficacy|13|||
143108283|NCT03558152|515937592|FG000|Overall Study|Protocol Violation|1|||
143108284|NCT03558152|515937593|FG001|Overall Study|Protocol Violation|1|||
143108285|NCT03558152|515937594|FG002|Overall Study|Protocol Violation|0|||
143108286|NCT03558152|515937595|FG003|Overall Study|Protocol Violation|1|||
143108287|NCT03558152|515937596|FG004|Overall Study|Protocol Violation|1|||
143108288|NCT03558152|515937597|FG005|Overall Study|Protocol Violation|0|||
143108289|NCT03558152|515937598|FG006|Overall Study|Protocol Violation|2|||
143108290|NCT03558152|515937599|FG007|Overall Study|Protocol Violation|0|||
143108291|NCT03693612|515937600|FG000|Overall Study|Lost to Follow-up|0|||
143108292|NCT03693612|515937601|FG001|Overall Study|Lost to Follow-up|0|||
143108293|NCT03693612|515937602|FG002|Overall Study|Lost to Follow-up|0|||
143108294|NCT03693612|515937603|FG003|Overall Study|Lost to Follow-up|0|||
143108295|NCT03693612|515937604|FG004|Overall Study|Lost to Follow-up|1|||
143108296|NCT03693612|515937605|FG005|Overall Study|Lost to Follow-up|0|||
143108297|NCT03693612|515937606|FG006|Overall Study|Lost to Follow-up|0|||
143108298|NCT03693612|515937600|FG000|Overall Study|Withdrawal by Subject|0|||
143108299|NCT03693612|515937601|FG001|Overall Study|Withdrawal by Subject|0|||
143108300|NCT03693612|515937602|FG002|Overall Study|Withdrawal by Subject|1|||
143108301|NCT03693612|515937603|FG003|Overall Study|Withdrawal by Subject|0|||
143108302|NCT03693612|515937604|FG004|Overall Study|Withdrawal by Subject|2|||
143108303|NCT03693612|515937605|FG005|Overall Study|Withdrawal by Subject|0|||
143108304|NCT03693612|515937606|FG006|Overall Study|Withdrawal by Subject|0|||
143108305|NCT03693612|515937600|FG000|Overall Study|Study Terminated by Sponsor|0|||
143108306|NCT03693612|515937601|FG001|Overall Study|Study Terminated by Sponsor|1|||
143108307|NCT03693612|515937602|FG002|Overall Study|Study Terminated by Sponsor|0|||
143108308|NCT03693612|515937603|FG003|Overall Study|Study Terminated by Sponsor|0|||
143108309|NCT03693612|515937604|FG004|Overall Study|Study Terminated by Sponsor|3|||
143108310|NCT03693612|515937605|FG005|Overall Study|Study Terminated by Sponsor|0|||
143108311|NCT03693612|515937606|FG006|Overall Study|Study Terminated by Sponsor|0|||
143108312|NCT04434469|515937607|FG000|Overall Study|Death|2|||
143108313|NCT04434469|515937608|FG001|Overall Study|Death|3|||
143108314|NCT04434469|515937609|FG002|Overall Study|Death|2|||
143108315|NCT04434469|515937610|FG003|Overall Study|Death|2|||
143108316|NCT04434469|515937611|FG004|Overall Study|Death|2|||
143108317|NCT04434469|515937612|FG005|Overall Study|Death|0|||
143108318|NCT04434469|515937607|FG000|Overall Study|Lost to Follow-up|0|||
143108319|NCT04434469|515937608|FG001|Overall Study|Lost to Follow-up|0|||
143108320|NCT04434469|515937609|FG002|Overall Study|Lost to Follow-up|0|||
143108321|NCT04434469|515937610|FG003|Overall Study|Lost to Follow-up|1|||
143108322|NCT04434469|515937611|FG004|Overall Study|Lost to Follow-up|1|||
143108323|NCT04434469|515937612|FG005|Overall Study|Lost to Follow-up|0|||
143108324|NCT04434469|515937607|FG000|Overall Study|Study terminated by sponsor|1|||
143108325|NCT04434469|515937608|FG001|Overall Study|Study terminated by sponsor|1|||
143108326|NCT04434469|515937609|FG002|Overall Study|Study terminated by sponsor|1|||
143108327|NCT04434469|515937610|FG003|Overall Study|Study terminated by sponsor|2|||
143108328|NCT04434469|515937611|FG004|Overall Study|Study terminated by sponsor|3|||
143108329|NCT04434469|515937612|FG005|Overall Study|Study terminated by sponsor|3|||
143108330|NCT04434469|515937607|FG000|Overall Study|Withdrawal by Subject|0|||
143108331|NCT04434469|515937608|FG001|Overall Study|Withdrawal by Subject|0|||
143108332|NCT04434469|515937609|FG002|Overall Study|Withdrawal by Subject|1|||
143108333|NCT04434469|515937610|FG003|Overall Study|Withdrawal by Subject|0|||
143108334|NCT04434469|515937611|FG004|Overall Study|Withdrawal by Subject|0|||
143108335|NCT04434469|515937612|FG005|Overall Study|Withdrawal by Subject|0|||
143108336|NCT01669174|515937613|FG000|Overall Study|Subject withdrew consent|2|||
143108337|NCT01669174|515937614|FG001|Overall Study|Subject withdrew consent|2|||
143108338|NCT01669174|515937613|FG000|Overall Study|Lost to Follow-up|1|||
143108339|NCT01669174|515937614|FG001|Overall Study|Lost to Follow-up|0|||
143108340|NCT01669174|515937613|FG000|Overall Study|Adverse Event|2|||
143108341|NCT01669174|515937614|FG001|Overall Study|Adverse Event|2|||
143108342|NCT01669174|515937613|FG000|Overall Study|Administrative problems|1|||
143108343|NCT01669174|515937614|FG001|Overall Study|Administrative problems|2|||
143108344|NCT01953601|515937615|FG000|Part 1 (Base Study)|Adverse Event|24|||
143108345|NCT01953601|515937616|FG001|Part 1 (Base Study)|Adverse Event|37|||
143108346|NCT01953601|515937617|FG002|Part 1 (Base Study)|Adverse Event|15|||
143108347|NCT01953601|515937615|FG000|Part 1 (Base Study)|Death|2|||
143108348|NCT01953601|515937616|FG001|Part 1 (Base Study)|Death|0|||
143108349|NCT01953601|515937617|FG002|Part 1 (Base Study)|Death|3|||
143108350|NCT01953601|515937615|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
143108351|NCT01953601|515937616|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
143108352|NCT01953601|515937617|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
143108353|NCT01953601|515937615|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
143108354|NCT01953601|515937616|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
143108355|NCT01953601|515937617|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
143108356|NCT01953601|515937615|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
143108357|NCT01953601|515937616|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
143108358|NCT01953601|515937617|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
143108359|NCT01953601|515937615|FG000|Part 1 (Base Study)|Physician Decision|3|||
143108360|NCT01953601|515937616|FG001|Part 1 (Base Study)|Physician Decision|7|||
143108361|NCT01953601|515937617|FG002|Part 1 (Base Study)|Physician Decision|4|||
143108362|NCT01953601|515937615|FG000|Part 1 (Base Study)|Screen failure|1|||
143108363|NCT01953601|515937616|FG001|Part 1 (Base Study)|Screen failure|0|||
143108364|NCT01953601|515937617|FG002|Part 1 (Base Study)|Screen failure|1|||
143108365|NCT01953601|515937615|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
143108366|NCT01953601|515937616|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
143108367|NCT01953601|515937617|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
143108368|NCT01953601|515937615|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
143108369|NCT01953601|515937616|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
143179232|NCT04011735|516203654|FG001|Overall Study|Withdrawal by Subject|0|||
143179233|NCT04011735|516203655|FG002|Overall Study|Withdrawal by Subject|1|||
143179234|NCT04011735|516203653|FG000|Overall Study|Met exclusion criteria after study entry|0|||
143179235|NCT04011735|516203654|FG001|Overall Study|Met exclusion criteria after study entry|1|||
143179236|NCT04011735|516203655|FG002|Overall Study|Met exclusion criteria after study entry|0|||
143179237|NCT02457247|516203665|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
143179238|NCT02457247|516203666|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
143179239|NCT02457247|516203667|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
143179240|NCT02457247|516203668|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
143179241|NCT02457247|516203665|FG000|Period 1|Significant Protocol Deviation|1|||
143179242|NCT02457247|516203666|FG001|Period 1|Significant Protocol Deviation|1|||
143179243|NCT02457247|516203667|FG002|Period 1|Significant Protocol Deviation|0|||
143367977|NCT00930813|516890850|FG000|Overall Study|Lost to Follow-up|2|||
143108370|NCT01953601|515937617|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
143108371|NCT01953601|515937615|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
143108372|NCT01953601|515937616|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
143108373|NCT01953601|515937617|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
143108374|NCT01953601|515937615|FG000|Part 1 (Base Study)|Subject moved|2|||
143108375|NCT01953601|515937616|FG001|Part 1 (Base Study)|Subject moved|2|||
143108376|NCT01953601|515937617|FG002|Part 1 (Base Study)|Subject moved|1|||
143108377|NCT01953601|515937615|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
143108378|NCT01953601|515937616|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
143108379|NCT01953601|515937617|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
143108380|NCT01953601|515937615|FG000|Part 2 (Extension Study)|Adverse Event|1|||
143108381|NCT01953601|515937616|FG001|Part 2 (Extension Study)|Adverse Event|1|||
143108382|NCT01953601|515937617|FG002|Part 2 (Extension Study)|Adverse Event|10|||
143108383|NCT01953601|515937615|FG000|Part 2 (Extension Study)|Death|0|||
143108384|NCT01953601|515937616|FG001|Part 2 (Extension Study)|Death|3|||
143108385|NCT01953601|515937617|FG002|Part 2 (Extension Study)|Death|0|||
143108386|NCT01953601|515937615|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
143108387|NCT01953601|515937616|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
143108388|NCT01953601|515937617|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
143108389|NCT01953601|515937615|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
143108390|NCT01953601|515937616|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
143108391|NCT01953601|515937617|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
143108392|NCT01953601|515937615|FG000|Part 2 (Extension Study)|Physician Decision|2|||
143108393|NCT01953601|515937616|FG001|Part 2 (Extension Study)|Physician Decision|0|||
143108394|NCT01953601|515937617|FG002|Part 2 (Extension Study)|Physician Decision|2|||
143108395|NCT01953601|515937615|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
143108396|NCT01953601|515937616|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
143108397|NCT01953601|515937617|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
143256606|NCT00827931|516492649|FG000|Overall Study|Adverse Event|1|||
143256607|NCT00827931|516492650|FG001|Overall Study|Adverse Event|0|||
143256608|NCT00827931|516492649|FG000|Overall Study|Lost to Follow-up|1|||
143256609|NCT00827931|516492650|FG001|Overall Study|Lost to Follow-up|0|||
143256610|NCT00827931|516492649|FG000|Overall Study|Withdrawal by Subject|0|||
143108398|NCT01953601|515937615|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
143108399|NCT01953601|515937616|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
143108400|NCT01953601|515937617|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
143108401|NCT01953601|515937615|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
143108402|NCT01953601|515937616|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
143179244|NCT02457247|516203668|FG003|Period 1|Significant Protocol Deviation|0|||
143256611|NCT00827931|516492650|FG001|Overall Study|Withdrawal by Subject|1|||
143179245|NCT02457247|516203665|FG000|Period 1|Voluntary Withdrawal|1|||
143256612|NCT00827931|516492649|FG000|Overall Study|Other|1|||
143256613|NCT00827931|516492650|FG001|Overall Study|Other|0|||
143256614|NCT01306929|516492651|FG000|Overall Study|Withdrawal by Subject|23|||
143256615|NCT01306929|516492651|FG000|Overall Study|Adverse Event|21|||
143256616|NCT01306929|516492651|FG000|Overall Study|Physician Decision|13|||
143256617|NCT01306929|516492651|FG000|Overall Study|Death|8|||
143256618|NCT01306929|516492651|FG000|Overall Study|Withdrawal by parent/guardian|5|||
143256619|NCT01306929|516492651|FG000|Overall Study|Protocol Violation|3|||
143256620|NCT01306929|516492651|FG000|Overall Study|Non-compliance with study drug|2|||
143256621|NCT01306929|516492651|FG000|Overall Study|Lost to Follow-up|2|||
143256622|NCT01306929|516492651|FG000|Overall Study|Various|17|||
143256623|NCT00492063|516492652|FG000|Overall Study|Death|0|||
143256624|NCT00492063|516492653|FG001|Overall Study|Death|0|||
143256625|NCT00492063|516492654|FG002|Overall Study|Death|1|||
143256626|NCT00492063|516492655|FG003|Overall Study|Death|2|||
143256627|NCT00492063|516492652|FG000|Overall Study|Withdrawal by Subject|4|||
143256628|NCT00492063|516492653|FG001|Overall Study|Withdrawal by Subject|3|||
143256629|NCT00492063|516492654|FG002|Overall Study|Withdrawal by Subject|5|||
143256630|NCT00492063|516492655|FG003|Overall Study|Withdrawal by Subject|4|||
143256631|NCT00492063|516492652|FG000|Overall Study|Lost to Follow-up|6|||
143256632|NCT00492063|516492653|FG001|Overall Study|Lost to Follow-up|11|||
143108403|NCT01953601|515937617|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
143108404|NCT01953601|515937615|FG000|Part 2 (Extension Study)|Subject moved|0|||
143108405|NCT01953601|515937616|FG001|Part 2 (Extension Study)|Subject moved|0|||
143179246|NCT02457247|516203666|FG001|Period 1|Voluntary Withdrawal|0|||
143179247|NCT02457247|516203667|FG002|Period 1|Voluntary Withdrawal|0|||
143179248|NCT02457247|516203668|FG003|Period 1|Voluntary Withdrawal|0|||
143179249|NCT02457247|516203665|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
143179250|NCT02457247|516203666|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
143179251|NCT02457247|516203667|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
143179252|NCT02457247|516203668|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
143179253|NCT02457247|516203665|FG000|Period 2|Significant Protocol Deviation|1|||
143108406|NCT01953601|515937617|FG002|Part 2 (Extension Study)|Subject moved|1|||
143108407|NCT01953601|515937615|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
143179254|NCT02457247|516203666|FG001|Period 2|Significant Protocol Deviation|0|||
143256633|NCT00492063|516492654|FG002|Overall Study|Lost to Follow-up|5|||
143256634|NCT00492063|516492655|FG003|Overall Study|Lost to Follow-up|3|||
143256635|NCT00492063|516492652|FG000|Overall Study|Protocol Violation|0|||
143256636|NCT00492063|516492653|FG001|Overall Study|Protocol Violation|0|||
143256637|NCT00492063|516492654|FG002|Overall Study|Protocol Violation|0|||
143256638|NCT00492063|516492655|FG003|Overall Study|Protocol Violation|1|||
143256639|NCT01870076|516492656|FG000|Overall Study|Withdrawal by Subject|1|||
143256640|NCT01870076|516492657|FG001|Overall Study|Withdrawal by Subject|0|||
143256641|NCT01870076|516492658|FG002|Overall Study|Withdrawal by Subject|1|||
143108408|NCT01953601|515937616|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
143108409|NCT01953601|515937617|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
143108410|NCT00723255|515937622|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
143108411|NCT00723255|515937622|FG000|Overall Study|Ineligible: Second primary|1|||
143108412|NCT00723255|515937622|FG000|Overall Study|Ineligible: Wrong Primary|2|||
143108413|NCT00614523|515937623|FG000|Overall Study|Adverse Event|4|||
143108414|NCT00614523|515937624|FG001|Overall Study|Adverse Event|20|||
143108415|NCT00614523|515937623|FG000|Overall Study|Death|5|||
143108416|NCT00614523|515937624|FG001|Overall Study|Death|8|||
143108417|NCT00614523|515937623|FG000|Overall Study|Lack of Efficacy|9|||
143108418|NCT00614523|515937624|FG001|Overall Study|Lack of Efficacy|11|||
143108419|NCT00614523|515937623|FG000|Overall Study|Lost to Follow-up|0|||
143108420|NCT00614523|515937624|FG001|Overall Study|Lost to Follow-up|1|||
143108421|NCT00614523|515937623|FG000|Overall Study|Protocol Violation|3|||
143108422|NCT00614523|515937624|FG001|Overall Study|Protocol Violation|2|||
143108423|NCT00614523|515937623|FG000|Overall Study|Withdrawal by Subject|12|||
143108424|NCT00614523|515937624|FG001|Overall Study|Withdrawal by Subject|22|||
143108425|NCT00614523|515937623|FG000|Overall Study|Other|6|||
143108426|NCT00614523|515937624|FG001|Overall Study|Other|11|||
143108427|NCT00614523|515937623|FG000|Overall Study|Ineligibility Determined|1|||
143108428|NCT00614523|515937624|FG001|Overall Study|Ineligibility Determined|2|||
143108429|NCT00614523|515937623|FG000|Overall Study|Disease Progression|0|||
143108430|NCT00614523|515937624|FG001|Overall Study|Disease Progression|8|||
143108431|NCT00614523|515937623|FG000|Overall Study|Administrative Decision|23|||
143108432|NCT00614523|515937624|FG001|Overall Study|Administrative Decision|46|||
143108433|NCT03962790|515937625|FG000|Period 1|Adverse Event|0|||
143108434|NCT03962790|515937626|FG001|Period 1|Adverse Event|1|||
143256642|NCT01870076|516492659|FG003|Overall Study|Withdrawal by Subject|0|||
143256643|NCT00890045|516492662|FG000|Overall Study|Death|0|||
143108435|NCT03962790|515937625|FG000|Period 1|Failed to meet all eligibility criteria|1|||
143108436|NCT03962790|515937626|FG001|Period 1|Failed to meet all eligibility criteria|1|||
143108437|NCT03962790|515937625|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
143108438|NCT03962790|515937626|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
143108439|NCT03962790|515937625|FG000|Period 1|Withdrawal by Subject|1|||
143108440|NCT03962790|515937626|FG001|Period 1|Withdrawal by Subject|0|||
143108441|NCT00452673|515937635|FG000|Dose Escalation Period|Disease Progression|6|||
143108442|NCT00452673|515937636|FG001|Dose Escalation Period|Disease Progression|6|||
143108443|NCT00452673|515937637|FG002|Dose Escalation Period|Disease Progression|2|||
143108444|NCT00452673|515937638|FG003|Dose Escalation Period|Disease Progression|6|||
143108445|NCT00452673|515937639|FG004|Dose Escalation Period|Disease Progression|0|||
143108446|NCT00452673|515937635|FG000|Dose Escalation Period|study drug toxicity|1|||
143108447|NCT00452673|515937636|FG001|Dose Escalation Period|study drug toxicity|3|||
143108448|NCT00452673|515937637|FG002|Dose Escalation Period|study drug toxicity|3|||
143108449|NCT00452673|515937638|FG003|Dose Escalation Period|study drug toxicity|1|||
143108450|NCT00452673|515937639|FG004|Dose Escalation Period|study drug toxicity|0|||
143108451|NCT00452673|515937635|FG000|Dose Escalation Period|Other|0|||
143108452|NCT00452673|515937636|FG001|Dose Escalation Period|Other|0|||
143108453|NCT00452673|515937637|FG002|Dose Escalation Period|Other|1|||
143108454|NCT00452673|515937638|FG003|Dose Escalation Period|Other|0|||
143108455|NCT00452673|515937639|FG004|Dose Escalation Period|Other|0|||
143108456|NCT00452673|515937635|FG000|Dose Escalation Period|Adverse Event|0|||
143108457|NCT00452673|515937636|FG001|Dose Escalation Period|Adverse Event|0|||
143108458|NCT00452673|515937637|FG002|Dose Escalation Period|Adverse Event|0|||
143108459|NCT00452673|515937638|FG003|Dose Escalation Period|Adverse Event|1|||
143108460|NCT00452673|515937639|FG004|Dose Escalation Period|Adverse Event|0|||
143108461|NCT00452673|515937635|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
143108462|NCT00452673|515937636|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
143108463|NCT00452673|515937637|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
143108464|NCT00452673|515937638|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
143108465|NCT00452673|515937639|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
143108466|NCT00452673|515937635|FG000|Dose Expansion Period|Disease Progression|0|||
143108467|NCT00452673|515937636|FG001|Dose Expansion Period|Disease Progression|0|||
143108468|NCT00452673|515937637|FG002|Dose Expansion Period|Disease Progression|0|||
143108469|NCT00452673|515937638|FG003|Dose Expansion Period|Disease Progression|0|||
143108470|NCT00452673|515937639|FG004|Dose Expansion Period|Disease Progression|19|||
143108471|NCT00452673|515937635|FG000|Dose Expansion Period|Other|0|||
143108472|NCT00452673|515937636|FG001|Dose Expansion Period|Other|0|||
143108473|NCT00452673|515937637|FG002|Dose Expansion Period|Other|0|||
143108474|NCT00452673|515937638|FG003|Dose Expansion Period|Other|0|||
143108475|NCT00452673|515937639|FG004|Dose Expansion Period|Other|2|||
143108476|NCT00843037|515937644|FG000|Overall Study|Lost to Follow-up|1|||
143108477|NCT04984278|515937645|FG000|Period 1|Withdrawal by Subject|1|||
143108478|NCT04984278|515937646|FG001|Period 1|Withdrawal by Subject|0|||
143108479|NCT04984278|515937645|FG000|Period 1|Other|0|||
143256644|NCT00890045|516492663|FG001|Overall Study|Death|1|||
143256645|NCT00890045|516492662|FG000|Overall Study|Did not receive HeRO Graft|0|||
143256646|NCT00890045|516492663|FG001|Overall Study|Did not receive HeRO Graft|2|||
143256647|NCT00890045|516492662|FG000|Overall Study|Lost to Follow-up|5|||
143256648|NCT00890045|516492663|FG001|Overall Study|Lost to Follow-up|7|||
143256649|NCT01947855|516492664|FG000|Overall Study|Withdrawal by Subject|1|||
143256650|NCT01947855|516492665|FG001|Overall Study|Withdrawal by Subject|0|||
143256651|NCT01947855|516492666|FG002|Overall Study|Withdrawal by Subject|0|||
143256652|NCT02282293|516492673|FG000|Overall Study|Lost to Follow-up|2|||
143256653|NCT02282293|516492674|FG001|Overall Study|Lost to Follow-up|2|||
143256654|NCT02282293|516492673|FG000|Overall Study|Unable to comply with study procedures|1|||
143256655|NCT02282293|516492674|FG001|Overall Study|Unable to comply with study procedures|0|||
143256656|NCT02282293|516492673|FG000|Overall Study|Moved out of study area|0|||
143256657|NCT02282293|516492674|FG001|Overall Study|Moved out of study area|1|||
143256658|NCT00608569|516492675|FG000|Overall Study|Death|4|||
143256659|NCT00608569|516492676|FG001|Overall Study|Death|3|||
143256660|NCT00608569|516492675|FG000|Overall Study|Lost to Follow-up|4|||
143256661|NCT00608569|516492676|FG001|Overall Study|Lost to Follow-up|5|||
143256662|NCT00608569|516492675|FG000|Overall Study|Withdrawal by Subject|1|||
143256663|NCT00608569|516492676|FG001|Overall Study|Withdrawal by Subject|0|||
143256664|NCT00608569|516492675|FG000|Overall Study|Adverse Event|1|||
143256665|NCT00608569|516492676|FG001|Overall Study|Adverse Event|0|||
143256666|NCT00608569|516492675|FG000|Overall Study|Unable to adhere with study requirements|0|||
143256667|NCT00608569|516492676|FG001|Overall Study|Unable to adhere with study requirements|1|||
143256668|NCT03011892|516492677|FG000|Double Blind (DB) Period|Adverse Event|0|||
143256669|NCT03011892|516492678|FG001|Double Blind (DB) Period|Adverse Event|1|||
143256670|NCT03011892|516492679|FG002|Double Blind (DB) Period|Adverse Event|1|||
143256671|NCT03011892|516492680|FG003|Double Blind (DB) Period|Adverse Event|0|||
143256672|NCT03011892|516492681|FG004|Double Blind (DB) Period|Adverse Event|0|||
143256673|NCT03011892|516492682|FG005|Double Blind (DB) Period|Adverse Event|0|||
143256674|NCT03011892|516492683|FG006|Double Blind (DB) Period|Adverse Event|0|||
143256675|NCT03011892|516492684|FG007|Double Blind (DB) Period|Adverse Event|0|||
143256676|NCT03011892|516492685|FG008|Double Blind (DB) Period|Adverse Event|0|||
143256677|NCT03011892|516492686|FG009|Double Blind (DB) Period|Adverse Event|0|||
143256678|NCT03011892|516492687|FG010|Double Blind (DB) Period|Adverse Event|0|||
143256679|NCT03011892|516492688|FG011|Double Blind (DB) Period|Adverse Event|0|||
143256680|NCT03011892|516492677|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
143256681|NCT03011892|516492678|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
143256682|NCT03011892|516492679|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
143256683|NCT03011892|516492680|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
143256684|NCT03011892|516492681|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
143256685|NCT03011892|516492682|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
143256686|NCT03011892|516492683|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
143256687|NCT03011892|516492684|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
143256688|NCT03011892|516492685|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
143256689|NCT03011892|516492686|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
143256690|NCT03011892|516492687|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
143256691|NCT03011892|516492688|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
143256692|NCT03011892|516492677|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
143256693|NCT03011892|516492678|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
143256694|NCT03011892|516492679|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
143256695|NCT03011892|516492680|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
143256696|NCT03011892|516492681|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
143256697|NCT03011892|516492682|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
143256698|NCT03011892|516492683|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
143256699|NCT03011892|516492684|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
143256700|NCT03011892|516492685|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
143256701|NCT03011892|516492686|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
143256702|NCT03011892|516492687|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
143256703|NCT03011892|516492688|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
143256704|NCT03011892|516492677|FG000|Double Blind (DB) Period|Other|1|||
143256705|NCT03011892|516492678|FG001|Double Blind (DB) Period|Other|1|||
143256706|NCT03011892|516492679|FG002|Double Blind (DB) Period|Other|1|||
143256707|NCT03011892|516492680|FG003|Double Blind (DB) Period|Other|0|||
143256708|NCT03011892|516492681|FG004|Double Blind (DB) Period|Other|1|||
143256709|NCT03011892|516492682|FG005|Double Blind (DB) Period|Other|0|||
143256710|NCT03011892|516492683|FG006|Double Blind (DB) Period|Other|0|||
143256711|NCT03011892|516492684|FG007|Double Blind (DB) Period|Other|0|||
143256712|NCT03011892|516492685|FG008|Double Blind (DB) Period|Other|0|||
143256713|NCT03011892|516492686|FG009|Double Blind (DB) Period|Other|0|||
143256714|NCT03011892|516492687|FG010|Double Blind (DB) Period|Other|0|||
143256715|NCT03011892|516492688|FG011|Double Blind (DB) Period|Other|0|||
143256716|NCT03011892|516492677|FG000|Double Blind (DB) Period|Physician Decision|1|||
143256717|NCT03011892|516492678|FG001|Double Blind (DB) Period|Physician Decision|0|||
143256718|NCT03011892|516492679|FG002|Double Blind (DB) Period|Physician Decision|1|||
143256719|NCT03011892|516492680|FG003|Double Blind (DB) Period|Physician Decision|0|||
143256720|NCT03011892|516492681|FG004|Double Blind (DB) Period|Physician Decision|0|||
143256721|NCT03011892|516492682|FG005|Double Blind (DB) Period|Physician Decision|0|||
143256722|NCT03011892|516492683|FG006|Double Blind (DB) Period|Physician Decision|0|||
143256723|NCT03011892|516492684|FG007|Double Blind (DB) Period|Physician Decision|0|||
143256724|NCT03011892|516492685|FG008|Double Blind (DB) Period|Physician Decision|0|||
143256725|NCT03011892|516492686|FG009|Double Blind (DB) Period|Physician Decision|0|||
143256726|NCT03011892|516492687|FG010|Double Blind (DB) Period|Physician Decision|0|||
143256727|NCT03011892|516492688|FG011|Double Blind (DB) Period|Physician Decision|0|||
143256728|NCT03011892|516492677|FG000|Double Blind (DB) Period|Pregnancy|0|||
143256729|NCT03011892|516492678|FG001|Double Blind (DB) Period|Pregnancy|0|||
143256730|NCT03011892|516492679|FG002|Double Blind (DB) Period|Pregnancy|0|||
143256731|NCT03011892|516492680|FG003|Double Blind (DB) Period|Pregnancy|0|||
143256732|NCT03011892|516492681|FG004|Double Blind (DB) Period|Pregnancy|1|||
143256733|NCT03011892|516492682|FG005|Double Blind (DB) Period|Pregnancy|0|||
143256734|NCT03011892|516492683|FG006|Double Blind (DB) Period|Pregnancy|0|||
143256735|NCT03011892|516492684|FG007|Double Blind (DB) Period|Pregnancy|0|||
143256736|NCT03011892|516492685|FG008|Double Blind (DB) Period|Pregnancy|0|||
143256737|NCT03011892|516492686|FG009|Double Blind (DB) Period|Pregnancy|0|||
143256738|NCT03011892|516492687|FG010|Double Blind (DB) Period|Pregnancy|0|||
143256739|NCT03011892|516492688|FG011|Double Blind (DB) Period|Pregnancy|0|||
143256740|NCT03011892|516492677|FG000|Double Blind (DB) Period|Protocol Violation|1|||
143256741|NCT03011892|516492678|FG001|Double Blind (DB) Period|Protocol Violation|0|||
143256742|NCT03011892|516492679|FG002|Double Blind (DB) Period|Protocol Violation|0|||
143256743|NCT03011892|516492680|FG003|Double Blind (DB) Period|Protocol Violation|0|||
143256744|NCT03011892|516492681|FG004|Double Blind (DB) Period|Protocol Violation|0|||
143256745|NCT03011892|516492682|FG005|Double Blind (DB) Period|Protocol Violation|0|||
143256746|NCT03011892|516492683|FG006|Double Blind (DB) Period|Protocol Violation|0|||
143256747|NCT03011892|516492684|FG007|Double Blind (DB) Period|Protocol Violation|0|||
143256748|NCT03011892|516492685|FG008|Double Blind (DB) Period|Protocol Violation|0|||
143256749|NCT03011892|516492686|FG009|Double Blind (DB) Period|Protocol Violation|0|||
143256750|NCT03011892|516492687|FG010|Double Blind (DB) Period|Protocol Violation|0|||
143256751|NCT03011892|516492688|FG011|Double Blind (DB) Period|Protocol Violation|0|||
143256752|NCT03011892|516492677|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
143256753|NCT03011892|516492678|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
143256754|NCT03011892|516492679|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
143256755|NCT03011892|516492680|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
143256756|NCT03011892|516492681|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
143256757|NCT03011892|516492682|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
143256758|NCT03011892|516492683|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
143256759|NCT03011892|516492684|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
143256760|NCT03011892|516492685|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
143256761|NCT03011892|516492686|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
143256762|NCT03011892|516492687|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
143256763|NCT03011892|516492688|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
143256764|NCT03011892|516492677|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
143256765|NCT03011892|516492678|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
143256766|NCT03011892|516492679|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
143256767|NCT03011892|516492680|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
143256768|NCT03011892|516492681|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
143256769|NCT03011892|516492682|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
143256770|NCT03011892|516492683|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
143256771|NCT03011892|516492684|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
143256772|NCT03011892|516492685|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
143256773|NCT03011892|516492686|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
143256774|NCT03011892|516492687|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
143256775|NCT03011892|516492688|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
143256776|NCT03011892|516492677|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
143256777|NCT03011892|516492678|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
143256778|NCT03011892|516492679|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
143256779|NCT03011892|516492680|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
143256780|NCT03011892|516492681|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
143256781|NCT03011892|516492682|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
143256782|NCT03011892|516492683|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
143256783|NCT03011892|516492684|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
143256784|NCT03011892|516492685|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
143256785|NCT03011892|516492686|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
143256786|NCT03011892|516492687|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
143256787|NCT03011892|516492688|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
143256788|NCT03011892|516492677|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
143256789|NCT03011892|516492678|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
143256790|NCT03011892|516492679|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
143256791|NCT03011892|516492680|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
143256792|NCT03011892|516492681|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
143256793|NCT03011892|516492682|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
143256794|NCT03011892|516492683|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
143256795|NCT03011892|516492684|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
143256796|NCT03011892|516492685|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
143256797|NCT03011892|516492686|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
143256798|NCT03011892|516492687|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
143256799|NCT03011892|516492688|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
143256800|NCT03011892|516492677|FG000|Open Label (OL) Period|Reason not specified|0|||
143256801|NCT03011892|516492678|FG001|Open Label (OL) Period|Reason not specified|0|||
143256802|NCT03011892|516492679|FG002|Open Label (OL) Period|Reason not specified|0|||
143256803|NCT03011892|516492680|FG003|Open Label (OL) Period|Reason not specified|0|||
143256804|NCT03011892|516492681|FG004|Open Label (OL) Period|Reason not specified|0|||
143256805|NCT03011892|516492682|FG005|Open Label (OL) Period|Reason not specified|0|||
143256806|NCT03011892|516492683|FG006|Open Label (OL) Period|Reason not specified|0|||
143256807|NCT03011892|516492684|FG007|Open Label (OL) Period|Reason not specified|1|||
143256808|NCT03011892|516492685|FG008|Open Label (OL) Period|Reason not specified|0|||
143256809|NCT03011892|516492686|FG009|Open Label (OL) Period|Reason not specified|0|||
143256810|NCT03011892|516492687|FG010|Open Label (OL) Period|Reason not specified|0|||
143256811|NCT03011892|516492688|FG011|Open Label (OL) Period|Reason not specified|0|||
143367978|NCT00930813|516890851|FG001|Overall Study|Lost to Follow-up|4|||
143367979|NCT01072357|516890852|FG000|Overall Study|Lost to Follow-up|0|||
143367980|NCT01072357|516890853|FG001|Overall Study|Lost to Follow-up|1|||
143108480|NCT04984278|515937646|FG001|Period 1|Other|1|||
143108481|NCT04984278|515937645|FG000|Period 2|Adverse Event|1|||
143108482|NCT04984278|515937646|FG001|Period 2|Adverse Event|0|||
143108483|NCT04984278|515937645|FG000|Period 2|Other|0|||
143108484|NCT04984278|515937646|FG001|Period 2|Other|1|||
143108485|NCT03535194|515937647|FG000|Induction Period|Adverse Event|2|||
143108486|NCT03535194|515937648|FG001|Induction Period|Adverse Event|2|||
143108487|NCT03535194|515937649|FG002|Induction Period|Adverse Event|1|||
143108488|NCT03535194|515937650|FG003|Induction Period|Adverse Event|3|||
143108489|NCT03535194|515937651|FG004|Induction Period|Adverse Event|0|||
143108490|NCT03535194|515937647|FG000|Induction Period|Death|0|||
143108491|NCT03535194|515937648|FG001|Induction Period|Death|1|||
143108492|NCT03535194|515937649|FG002|Induction Period|Death|0|||
143108493|NCT03535194|515937650|FG003|Induction Period|Death|0|||
143108494|NCT03535194|515937651|FG004|Induction Period|Death|0|||
143108495|NCT03535194|515937647|FG000|Induction Period|Lack of Efficacy|1|||
143108496|NCT03535194|515937648|FG001|Induction Period|Lack of Efficacy|3|||
143108497|NCT03535194|515937649|FG002|Induction Period|Lack of Efficacy|2|||
143108498|NCT03535194|515937650|FG003|Induction Period|Lack of Efficacy|2|||
143108499|NCT03535194|515937651|FG004|Induction Period|Lack of Efficacy|0|||
143108500|NCT03535194|515937647|FG000|Induction Period|Lost to Follow-up|3|||
143108501|NCT03535194|515937648|FG001|Induction Period|Lost to Follow-up|5|||
143108502|NCT03535194|515937649|FG002|Induction Period|Lost to Follow-up|2|||
143108503|NCT03535194|515937650|FG003|Induction Period|Lost to Follow-up|3|||
143108504|NCT03535194|515937651|FG004|Induction Period|Lost to Follow-up|0|||
143108505|NCT03535194|515937647|FG000|Induction Period|Physician Decision|1|||
143108506|NCT03535194|515937648|FG001|Induction Period|Physician Decision|1|||
143108507|NCT03535194|515937649|FG002|Induction Period|Physician Decision|0|||
143108508|NCT03535194|515937650|FG003|Induction Period|Physician Decision|0|||
143108509|NCT03535194|515937651|FG004|Induction Period|Physician Decision|0|||
143108510|NCT03535194|515937647|FG000|Induction Period|Protocol Violation|1|||
143108511|NCT03535194|515937648|FG001|Induction Period|Protocol Violation|0|||
143108512|NCT03535194|515937649|FG002|Induction Period|Protocol Violation|0|||
143108513|NCT03535194|515937650|FG003|Induction Period|Protocol Violation|1|||
143367981|NCT01048788|516890854|FG000|Overall Study|Adverse Event|5|||
143108514|NCT03535194|515937651|FG004|Induction Period|Protocol Violation|0|||
143108515|NCT03535194|515937647|FG000|Induction Period|Screen Failure|0|||
143108516|NCT03535194|515937648|FG001|Induction Period|Screen Failure|1|||
143108517|NCT03535194|515937649|FG002|Induction Period|Screen Failure|0|||
143108518|NCT03535194|515937650|FG003|Induction Period|Screen Failure|0|||
143256812|NCT02312687|516492696|FG000|Overall Study|Other, Not Specified|1|||
143256813|NCT00384111|516492697|FG000|Overall Study|Disease Progression|3|||
143367982|NCT01048788|516890855|FG001|Overall Study|Adverse Event|1|||
143367983|NCT01048788|516890856|FG002|Overall Study|Adverse Event|1|||
143108519|NCT03535194|515937651|FG004|Induction Period|Screen Failure|0|||
143108520|NCT03535194|515937647|FG000|Induction Period|Withdrawal by Subject|3|||
143108521|NCT03535194|515937648|FG001|Induction Period|Withdrawal by Subject|4|||
143108522|NCT03535194|515937649|FG002|Induction Period|Withdrawal by Subject|3|||
143108523|NCT03535194|515937650|FG003|Induction Period|Withdrawal by Subject|2|||
143108524|NCT03535194|515937651|FG004|Induction Period|Withdrawal by Subject|0|||
143108525|NCT03535194|515937647|FG000|Maintenance Period|Adverse Event|6|||
143108526|NCT03535194|515937648|FG001|Maintenance Period|Adverse Event|5|||
143108527|NCT03535194|515937649|FG002|Maintenance Period|Adverse Event|1|||
143256814|NCT00384111|516492697|FG000|Overall Study|Adverse Event|1|||
143256815|NCT00384111|516492697|FG000|Overall Study|Investigator Decision|3|||
143256816|NCT00384111|516492697|FG000|Overall Study|Study Terminated by the Sponsor|19|||
143256817|NCT00545129|516492698|FG000|Overall Study|Lack of Efficacy|2|||
143256818|NCT00545129|516492699|FG001|Overall Study|Lack of Efficacy|5|||
143256819|NCT00545129|516492698|FG000|Overall Study|Death|2|||
143256820|NCT00545129|516492699|FG001|Overall Study|Death|1|||
143256821|NCT00545129|516492698|FG000|Overall Study|Adverse Event|1|||
143256822|NCT00545129|516492699|FG001|Overall Study|Adverse Event|1|||
143256823|NCT00545129|516492698|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
143256824|NCT00545129|516492699|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
143256825|NCT00545129|516492698|FG000|Overall Study|Other|3|||
143256826|NCT00545129|516492699|FG001|Overall Study|Other|3|||
143256827|NCT01426789|516492700|FG000|Part 1|Protocol deviation|0|||
143256828|NCT01426789|516492701|FG001|Part 1|Protocol deviation|1|||
143256829|NCT01426789|516492702|FG002|Part 1|Protocol deviation|0|||
143256830|NCT01426789|516492703|FG003|Part 1|Protocol deviation|0|||
143108528|NCT03535194|515937650|FG003|Maintenance Period|Adverse Event|11|||
143108529|NCT03535194|515937651|FG004|Maintenance Period|Adverse Event|4|||
143108530|NCT03535194|515937647|FG000|Maintenance Period|Lack of Efficacy|3|||
143108531|NCT03535194|515937648|FG001|Maintenance Period|Lack of Efficacy|2|||
143108532|NCT03535194|515937649|FG002|Maintenance Period|Lack of Efficacy|5|||
143108533|NCT03535194|515937650|FG003|Maintenance Period|Lack of Efficacy|9|||
143108534|NCT03535194|515937651|FG004|Maintenance Period|Lack of Efficacy|0|||
143108535|NCT03535194|515937647|FG000|Maintenance Period|Lost to Follow-up|4|||
143108536|NCT03535194|515937648|FG001|Maintenance Period|Lost to Follow-up|2|||
143108537|NCT03535194|515937649|FG002|Maintenance Period|Lost to Follow-up|1|||
143108538|NCT03535194|515937650|FG003|Maintenance Period|Lost to Follow-up|5|||
143108539|NCT03535194|515937651|FG004|Maintenance Period|Lost to Follow-up|2|||
143108540|NCT03535194|515937647|FG000|Maintenance Period|Other|1|||
143108541|NCT03535194|515937648|FG001|Maintenance Period|Other|2|||
143108542|NCT03535194|515937649|FG002|Maintenance Period|Other|0|||
143108543|NCT03535194|515937650|FG003|Maintenance Period|Other|0|||
143108544|NCT03535194|515937651|FG004|Maintenance Period|Other|0|||
143108545|NCT03535194|515937647|FG000|Maintenance Period|Physician Decision|1|||
143108546|NCT03535194|515937648|FG001|Maintenance Period|Physician Decision|2|||
143108547|NCT03535194|515937649|FG002|Maintenance Period|Physician Decision|0|||
143108548|NCT03535194|515937650|FG003|Maintenance Period|Physician Decision|2|||
143108549|NCT03535194|515937651|FG004|Maintenance Period|Physician Decision|0|||
143108550|NCT03535194|515937647|FG000|Maintenance Period|Pregnancy|0|||
143108551|NCT03535194|515937648|FG001|Maintenance Period|Pregnancy|0|||
143108552|NCT03535194|515937649|FG002|Maintenance Period|Pregnancy|0|||
143108553|NCT03535194|515937650|FG003|Maintenance Period|Pregnancy|2|||
143108554|NCT03535194|515937651|FG004|Maintenance Period|Pregnancy|0|||
143108555|NCT03535194|515937647|FG000|Maintenance Period|Protocol Violation|0|||
143108556|NCT03535194|515937648|FG001|Maintenance Period|Protocol Violation|1|||
143108557|NCT03535194|515937649|FG002|Maintenance Period|Protocol Violation|0|||
143108558|NCT03535194|515937650|FG003|Maintenance Period|Protocol Violation|0|||
143108559|NCT03535194|515937651|FG004|Maintenance Period|Protocol Violation|0|||
143108560|NCT03535194|515937647|FG000|Maintenance Period|Withdrawal by Subject|7|||
143108561|NCT03535194|515937648|FG001|Maintenance Period|Withdrawal by Subject|2|||
143108562|NCT03535194|515937649|FG002|Maintenance Period|Withdrawal by Subject|1|||
143108563|NCT03535194|515937650|FG003|Maintenance Period|Withdrawal by Subject|8|||
143108564|NCT03535194|515937651|FG004|Maintenance Period|Withdrawal by Subject|0|||
143108565|NCT03535194|515937647|FG000|Post-Treatment Followup Period|Adverse Event|4|||
143108566|NCT03535194|515937648|FG001|Post-Treatment Followup Period|Adverse Event|5|||
143108567|NCT03535194|515937649|FG002|Post-Treatment Followup Period|Adverse Event|1|||
143108568|NCT03535194|515937650|FG003|Post-Treatment Followup Period|Adverse Event|8|||
143108569|NCT03535194|515937651|FG004|Post-Treatment Followup Period|Adverse Event|0|||
143108570|NCT03535194|515937647|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
143108571|NCT03535194|515937648|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
143108572|NCT03535194|515937649|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
143108573|NCT03535194|515937650|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
143108574|NCT03535194|515937651|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
143108575|NCT03535194|515937647|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
143256831|NCT01426789|516492704|FG004|Part 1|Protocol deviation|0|||
143256832|NCT01426789|516492705|FG005|Part 1|Protocol deviation|0|||
143256833|NCT01426789|516492700|FG000|Part 1|Lost to Follow-up|1|||
143108576|NCT03535194|515937648|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
143108577|NCT03535194|515937649|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
143108578|NCT03535194|515937650|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
143108579|NCT03535194|515937651|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
143108580|NCT03535194|515937647|FG000|Post-Treatment Followup Period|Other|1|||
143108581|NCT03535194|515937648|FG001|Post-Treatment Followup Period|Other|0|||
143108582|NCT03535194|515937649|FG002|Post-Treatment Followup Period|Other|0|||
143256834|NCT01426789|516492701|FG001|Part 1|Lost to Follow-up|2|||
143256835|NCT01426789|516492702|FG002|Part 1|Lost to Follow-up|0|||
143256836|NCT01426789|516492703|FG003|Part 1|Lost to Follow-up|0|||
143256837|NCT01426789|516492704|FG004|Part 1|Lost to Follow-up|0|||
143256838|NCT01426789|516492705|FG005|Part 1|Lost to Follow-up|0|||
143256839|NCT01426789|516492700|FG000|Part 1|Lack of Efficacy|2|||
143256840|NCT01426789|516492701|FG001|Part 1|Lack of Efficacy|1|||
143256841|NCT01426789|516492702|FG002|Part 1|Lack of Efficacy|0|||
143256842|NCT01426789|516492703|FG003|Part 1|Lack of Efficacy|0|||
143256843|NCT01426789|516492704|FG004|Part 1|Lack of Efficacy|0|||
143256844|NCT01426789|516492705|FG005|Part 1|Lack of Efficacy|0|||
143256845|NCT01426789|516492700|FG000|Part 1|Adverse Event|3|||
143256846|NCT01426789|516492701|FG001|Part 1|Adverse Event|0|||
143256847|NCT01426789|516492702|FG002|Part 1|Adverse Event|0|||
143256848|NCT01426789|516492703|FG003|Part 1|Adverse Event|0|||
143256849|NCT01426789|516492704|FG004|Part 1|Adverse Event|0|||
143256850|NCT01426789|516492705|FG005|Part 1|Adverse Event|0|||
143256851|NCT01426789|516492700|FG000|Part 2|Protocol deviation|0|||
143256852|NCT01426789|516492701|FG001|Part 2|Protocol deviation|0|||
143256853|NCT01426789|516492702|FG002|Part 2|Protocol deviation|1|||
143256854|NCT01426789|516492703|FG003|Part 2|Protocol deviation|0|||
143256855|NCT01426789|516492704|FG004|Part 2|Protocol deviation|0|||
143256856|NCT01426789|516492705|FG005|Part 2|Protocol deviation|0|||
143256857|NCT01426789|516492700|FG000|Part 2|Death|0|||
143256858|NCT01426789|516492701|FG001|Part 2|Death|0|||
143256859|NCT01426789|516492702|FG002|Part 2|Death|1|||
143256860|NCT01426789|516492703|FG003|Part 2|Death|0|||
143256861|NCT01426789|516492704|FG004|Part 2|Death|1|||
143256862|NCT01426789|516492705|FG005|Part 2|Death|0|||
143256863|NCT01426789|516492700|FG000|Part 2|Administrative problems|0|||
143256864|NCT01426789|516492701|FG001|Part 2|Administrative problems|0|||
143256865|NCT01426789|516492702|FG002|Part 2|Administrative problems|2|||
143108583|NCT03535194|515937650|FG003|Post-Treatment Followup Period|Other|5|||
143108584|NCT03535194|515937651|FG004|Post-Treatment Followup Period|Other|0|||
143108585|NCT03535194|515937647|FG000|Post-Treatment Followup Period|Physician Decision|0|||
143108586|NCT03535194|515937648|FG001|Post-Treatment Followup Period|Physician Decision|2|||
143108587|NCT03535194|515937649|FG002|Post-Treatment Followup Period|Physician Decision|1|||
143108588|NCT03535194|515937650|FG003|Post-Treatment Followup Period|Physician Decision|1|||
143108589|NCT03535194|515937651|FG004|Post-Treatment Followup Period|Physician Decision|0|||
143108590|NCT03535194|515937647|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
143108591|NCT03535194|515937648|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
143108592|NCT03535194|515937649|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
143108593|NCT03535194|515937650|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
143108594|NCT03535194|515937651|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
143108595|NCT03991299|515937654|FG000|Overall Study|Study closed, sponsor decision|3|||
143108596|NCT03991299|515937654|FG000|Overall Study|Withdrawal by Subject|1|||
143108597|NCT04304235|515937655|FG000|Overall Study|incomplete triage data|0|||
143108598|NCT04304235|515937656|FG001|Overall Study|incomplete triage data|69|||
143108599|NCT04304235|515937657|FG002|Overall Study|incomplete triage data|0|||
143108600|NCT04304235|515937658|FG003|Overall Study|incomplete triage data|0|||
143108601|NCT04304235|515937659|FG004|Overall Study|incomplete triage data|289|||
143108602|NCT04304235|515937660|FG005|Overall Study|incomplete triage data|123|||
143108603|NCT04304235|515937661|FG006|Overall Study|incomplete triage data|65|||
143108604|NCT01482065|515937662|FG000|Overall Study|Withdrawal by Subject|0|||
143108605|NCT01482065|515937663|FG001|Overall Study|Withdrawal by Subject|1|||
143108606|NCT01942486|515937664|FG000|Overall Study|Lost to Follow-up|27|||
143108607|NCT03728426|515937665|FG000|Overall Study|Death|3|||
143108608|NCT00231114|515937668|FG000|Randomized|Withdrawal by Subject|6|||
143108609|NCT00231114|515937669|FG001|Randomized|Withdrawal by Subject|3|||
143108610|NCT00231114|515937668|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
143108611|NCT00231114|515937669|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
143108612|NCT00231114|515937668|FG000|Post-Treatment Period|Lost to Follow-up|6|||
143108613|NCT00231114|515937669|FG001|Post-Treatment Period|Lost to Follow-up|1|||
143108614|NCT00231114|515937668|FG000|Post-Treatment Period|Physician Decision|1|||
143108615|NCT00231114|515937669|FG001|Post-Treatment Period|Physician Decision|0|||
143108616|NCT00231114|515937668|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
143108617|NCT00231114|515937669|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
143256866|NCT01426789|516492703|FG003|Part 2|Administrative problems|0|||
143256867|NCT01426789|516492704|FG004|Part 2|Administrative problems|1|||
143256868|NCT01426789|516492705|FG005|Part 2|Administrative problems|0|||
143256869|NCT01426789|516492700|FG000|Part 2|Lost to Follow-up|0|||
143108618|NCT02703272|515937670|FG000|Overall Study|Death|4|||
143256870|NCT01426789|516492701|FG001|Part 2|Lost to Follow-up|0|||
143256871|NCT01426789|516492702|FG002|Part 2|Lost to Follow-up|4|||
143256872|NCT01426789|516492703|FG003|Part 2|Lost to Follow-up|0|||
143256873|NCT01426789|516492704|FG004|Part 2|Lost to Follow-up|1|||
143256874|NCT01426789|516492705|FG005|Part 2|Lost to Follow-up|0|||
143256875|NCT01426789|516492700|FG000|Part 2|Withdrawal by Subject|0|||
143256876|NCT01426789|516492701|FG001|Part 2|Withdrawal by Subject|0|||
143256877|NCT01426789|516492702|FG002|Part 2|Withdrawal by Subject|0|||
143108619|NCT02703272|515937671|FG001|Overall Study|Death|9|||
143108620|NCT02703272|515937672|FG002|Overall Study|Death|19|||
143108621|NCT02703272|515937673|FG003|Overall Study|Death|10|||
143108622|NCT02703272|515937670|FG000|Overall Study|Withdrawal by Subject|0|||
143108623|NCT02703272|515937671|FG001|Overall Study|Withdrawal by Subject|0|||
143108624|NCT02703272|515937672|FG002|Overall Study|Withdrawal by Subject|4|||
143108625|NCT02703272|515937673|FG003|Overall Study|Withdrawal by Subject|2|||
143108626|NCT02703272|515937670|FG000|Overall Study|Study Terminated by Sponsor|6|||
143108627|NCT02703272|515937671|FG001|Overall Study|Study Terminated by Sponsor|1|||
143108628|NCT02703272|515937672|FG002|Overall Study|Study Terminated by Sponsor|12|||
143108629|NCT02703272|515937673|FG003|Overall Study|Study Terminated by Sponsor|4|||
143108630|NCT02703272|515937670|FG000|Overall Study|Other|1|||
143108631|NCT02703272|515937671|FG001|Overall Study|Other|0|||
143108632|NCT02703272|515937672|FG002|Overall Study|Other|0|||
143108633|NCT02703272|515937673|FG003|Overall Study|Other|0|||
143108634|NCT02048826|515937674|FG000|Overall Study|Withdrawal by Subject|1|||
143108635|NCT02048826|515937675|FG001|Overall Study|Withdrawal by Subject|0|||
143108636|NCT02005692|515937676|FG000|Overall Study|Protocol Violation|1|||
143256878|NCT01426789|516492703|FG003|Part 2|Withdrawal by Subject|1|||
143256879|NCT01426789|516492704|FG004|Part 2|Withdrawal by Subject|2|||
143256880|NCT01426789|516492705|FG005|Part 2|Withdrawal by Subject|0|||
143256881|NCT01426789|516492700|FG000|Part 2|Lack of Efficacy|0|||
143256882|NCT01426789|516492701|FG001|Part 2|Lack of Efficacy|0|||
143256883|NCT01426789|516492702|FG002|Part 2|Lack of Efficacy|5|||
143256884|NCT01426789|516492703|FG003|Part 2|Lack of Efficacy|0|||
143256885|NCT01426789|516492704|FG004|Part 2|Lack of Efficacy|2|||
143256886|NCT01426789|516492705|FG005|Part 2|Lack of Efficacy|0|||
143256887|NCT01426789|516492700|FG000|Part 2|Adverse Event|0|||
143256888|NCT01426789|516492701|FG001|Part 2|Adverse Event|0|||
143256889|NCT01426789|516492702|FG002|Part 2|Adverse Event|2|||
143256890|NCT01426789|516492703|FG003|Part 2|Adverse Event|0|||
143256891|NCT01426789|516492704|FG004|Part 2|Adverse Event|1|||
143256892|NCT01426789|516492705|FG005|Part 2|Adverse Event|0|||
143256893|NCT04054947|516492706|FG000|Overall Study|Withdrawal by Subject|1|||
143256894|NCT04054947|516492707|FG001|Overall Study|Withdrawal by Subject|0|||
143256895|NCT04054947|516492706|FG000|Overall Study|Lost to Follow-up|2|||
143256896|NCT04054947|516492707|FG001|Overall Study|Lost to Follow-up|5|||
143256897|NCT04463069|516492710|FG000|Overall Study|Withdrawal by Subject|2|||
143256898|NCT04463069|516492711|FG001|Overall Study|Withdrawal by Subject|10|||
143256899|NCT04463069|516492710|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
143256900|NCT04463069|516492711|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
143256901|NCT01159431|516492714|FG000|Overall Study|Adverse Event|1|||
143256902|NCT01159431|516492715|FG001|Overall Study|Adverse Event|2|||
143256903|NCT01159431|516492714|FG000|Overall Study|non-compliance|1|||
143256904|NCT01159431|516492715|FG001|Overall Study|non-compliance|1|||
143256905|NCT01159431|516492714|FG000|Overall Study|Lack of Efficacy|0|||
143256906|NCT01159431|516492715|FG001|Overall Study|Lack of Efficacy|3|||
143256907|NCT03720652|516492716|FG000|Overall Study|Withdrawal by Subject|2|||
143256908|NCT03720652|516492717|FG001|Overall Study|Withdrawal by Subject|7|||
143256909|NCT03720652|516492716|FG000|Overall Study|Lost to Follow-up|0|||
143256910|NCT03720652|516492717|FG001|Overall Study|Lost to Follow-up|4|||
143256911|NCT00534599|516492719|FG000|Overall Study|Adverse Event|25|||
143256912|NCT00534599|516492720|FG001|Overall Study|Adverse Event|4|||
143256913|NCT00534599|516492719|FG000|Overall Study|Incorrect enrollment|2|||
143256914|NCT00534599|516492720|FG001|Overall Study|Incorrect enrollment|1|||
143256915|NCT00534599|516492719|FG000|Overall Study|Mis-randomization|2|||
143256916|NCT00534599|516492720|FG001|Overall Study|Mis-randomization|2|||
143256917|NCT00534599|516492719|FG000|Overall Study|Developed study-specific d/c criteria|5|||
143256918|NCT00534599|516492720|FG001|Overall Study|Developed study-specific d/c criteria|0|||
143256919|NCT00534599|516492719|FG000|Overall Study|Lack of Efficacy|0|||
143256920|NCT00534599|516492720|FG001|Overall Study|Lack of Efficacy|1|||
143256921|NCT00534599|516492719|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
143256922|NCT00534599|516492720|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
143256923|NCT00534599|516492719|FG000|Overall Study|Protocol Violation|1|||
143256924|NCT00534599|516492720|FG001|Overall Study|Protocol Violation|3|||
143256925|NCT00534599|516492719|FG000|Overall Study|Lost to Follow-up|11|||
143256926|NCT00534599|516492720|FG001|Overall Study|Lost to Follow-up|14|||
143256927|NCT00534599|516492719|FG000|Overall Study|Withdrawal by Subject|4|||
143256928|NCT00534599|516492720|FG001|Overall Study|Withdrawal by Subject|6|||
143256929|NCT00534599|516492719|FG000|Overall Study|Other|7|||
143256930|NCT00534599|516492720|FG001|Overall Study|Other|0|||
143256931|NCT03645434|516492723|FG000|Period 1|Adverse Event|0|||
143256932|NCT03645434|516492724|FG001|Period 1|Adverse Event|0|||
143256933|NCT03645434|516492725|FG002|Period 1|Adverse Event|0|||
143256934|NCT03645434|516492726|FG003|Period 1|Adverse Event|1|||
143256935|NCT03645434|516492727|FG004|Period 1|Adverse Event|0|||
143256936|NCT03645434|516492728|FG005|Period 1|Adverse Event|0|||
143256937|NCT03645434|516492723|FG000|Period 1|COPD exacerbation|0|||
143256938|NCT03645434|516492724|FG001|Period 1|COPD exacerbation|0|||
143256939|NCT03645434|516492725|FG002|Period 1|COPD exacerbation|0|||
143256940|NCT03645434|516492726|FG003|Period 1|COPD exacerbation|0|||
143108637|NCT02005692|515937676|FG000|Overall Study|Withdrawal by Subject|1|||
143108638|NCT02005692|515937676|FG000|Overall Study|Discharged earlier than anticipated|5|||
143256941|NCT03645434|516492727|FG004|Period 1|COPD exacerbation|1|||
143256942|NCT03645434|516492728|FG005|Period 1|COPD exacerbation|0|||
143256943|NCT00167778|516492729|FG000|Overall Study|Withdrawal by Subject|1|||
143256944|NCT02654717|516492730|FG000|Overall Study|Adverse Event|2|||
143256945|NCT02654717|516492731|FG001|Overall Study|Adverse Event|2|||
143256946|NCT02654717|516492730|FG000|Overall Study|Protocol Violation|1|||
143256947|NCT02654717|516492731|FG001|Overall Study|Protocol Violation|2|||
143256948|NCT02654717|516492730|FG000|Overall Study|Withdrawal by Subject|0|||
143256949|NCT02654717|516492731|FG001|Overall Study|Withdrawal by Subject|1|||
143256950|NCT02654717|516492730|FG000|Overall Study|Non-permitted medication|3|||
143256951|NCT02654717|516492731|FG001|Overall Study|Non-permitted medication|0|||
143256952|NCT03658876|516493913|FG000|Overall Study|Protocol Violation|3|||
143256953|NCT03658876|516493914|FG001|Overall Study|Protocol Violation|2|||
143256954|NCT03658876|516493913|FG000|Overall Study|Withdrawal by Subject|2|||
143108639|NCT01194999|515937677|FG000|Overall Study|Lost to Follow-up|17|||
143108640|NCT02222545|515937680|FG000|Overall Study|Adverse Event|1|||
143108641|NCT02222545|515937681|FG001|Overall Study|Adverse Event|0|||
143108642|NCT02222545|515937682|FG002|Overall Study|Adverse Event|2|||
143108643|NCT02222545|515937680|FG000|Overall Study|Death|0|||
143108644|NCT02222545|515937681|FG001|Overall Study|Death|0|||
143108645|NCT02222545|515937682|FG002|Overall Study|Death|9|||
143108646|NCT02222545|515937680|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
143108647|NCT02222545|515937681|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
143108648|NCT02222545|515937682|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
143108649|NCT02222545|515937680|FG000|Overall Study|Withdrawal by Subject|0|||
143108650|NCT02222545|515937681|FG001|Overall Study|Withdrawal by Subject|0|||
143108651|NCT02222545|515937682|FG002|Overall Study|Withdrawal by Subject|3|||
143108652|NCT02222545|515937680|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
143108653|NCT02222545|515937681|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
143108654|NCT02222545|515937682|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
143108655|NCT00537316|515937684|FG000|Part 1|Adverse Event|7|||
143108656|NCT00537316|515937685|FG001|Part 1|Adverse Event|11|||
143108657|NCT00537316|515937686|FG002|Part 1|Adverse Event|8|||
143108658|NCT00537316|515937687|FG003|Part 1|Adverse Event|0|||
143108659|NCT00537316|515937688|FG004|Part 1|Adverse Event|0|||
143108660|NCT00537316|515937689|FG005|Part 1|Adverse Event|0|||
143108661|NCT00537316|515937690|FG006|Part 1|Adverse Event|0|||
143108662|NCT00537316|515937684|FG000|Part 1|Protocol defined clinical event|1|||
143108663|NCT00537316|515937685|FG001|Part 1|Protocol defined clinical event|0|||
143108664|NCT00537316|515937686|FG002|Part 1|Protocol defined clinical event|0|||
143108665|NCT00537316|515937687|FG003|Part 1|Protocol defined clinical event|0|||
143108666|NCT00537316|515937688|FG004|Part 1|Protocol defined clinical event|0|||
143179255|NCT02457247|516203667|FG002|Period 2|Significant Protocol Deviation|0|||
143179256|NCT02457247|516203668|FG003|Period 2|Significant Protocol Deviation|0|||
143179257|NCT02457247|516203665|FG000|Period 2|Lost to Follow-up|0|||
143179258|NCT02457247|516203666|FG001|Period 2|Lost to Follow-up|1|||
143179259|NCT02457247|516203667|FG002|Period 2|Lost to Follow-up|0|||
143179260|NCT02457247|516203668|FG003|Period 2|Lost to Follow-up|0|||
143179261|NCT02457247|516203665|FG000|Period 2|Voluntary Withdrawal|1|||
143179262|NCT02457247|516203666|FG001|Period 2|Voluntary Withdrawal|1|||
143179263|NCT02457247|516203667|FG002|Period 2|Voluntary Withdrawal|0|||
143179264|NCT02457247|516203668|FG003|Period 2|Voluntary Withdrawal|0|||
143179265|NCT00739310|516203669|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
143179266|NCT00739310|516203669|FG000|Overall Study|Withdrawal by Subject|1|||
143179267|NCT00739310|516203669|FG000|Overall Study|Lost to Follow-up|2|||
143179268|NCT02954887|516203670|FG000|Overall Study|Withdrawal by Subject|3|||
143179269|NCT02954887|516203670|FG000|Overall Study|Lack of Efficacy|3|||
143179270|NCT02954887|516203670|FG000|Overall Study|Other|1|||
143179271|NCT01061385|516203671|FG000|Overall Study|Lost to Follow-up|1|||
143179272|NCT01061385|516203672|FG001|Overall Study|Lost to Follow-up|0|||
143179273|NCT01061385|516203671|FG000|Overall Study|subject decision not related to AE|0|||
143256955|NCT03658876|516493914|FG001|Overall Study|Withdrawal by Subject|0|||
143256956|NCT03658876|516493913|FG000|Overall Study|Death|0|||
143256957|NCT03658876|516493914|FG001|Overall Study|Death|1|||
143256958|NCT03658876|516493913|FG000|Overall Study|Intercurrent illness|6|||
143256959|NCT03658876|516493914|FG001|Overall Study|Intercurrent illness|4|||
143256960|NCT03658876|516493913|FG000|Overall Study|Transplantation/other operation|1|||
143256961|NCT03658876|516493914|FG001|Overall Study|Transplantation/other operation|5|||
143256962|NCT02616146|516493915|FG000|Overall Study|Adverse Event|64|||
143256963|NCT02616146|516493916|FG001|Overall Study|Adverse Event|24|||
143256964|NCT02616146|516493915|FG000|Overall Study|Lost to Follow-up|23|||
143256965|NCT02616146|516493916|FG001|Overall Study|Lost to Follow-up|13|||
143256966|NCT02616146|516493915|FG000|Overall Study|Non-compliance with study protocol|2|||
143256967|NCT02616146|516493916|FG001|Overall Study|Non-compliance with study protocol|0|||
143256968|NCT02616146|516493915|FG000|Overall Study|Non-compliance with study drug|4|||
143256969|NCT02616146|516493916|FG001|Overall Study|Non-compliance with study drug|2|||
143256970|NCT02616146|516493915|FG000|Overall Study|Pregnancy|2|||
143256971|NCT02616146|516493916|FG001|Overall Study|Pregnancy|2|||
143256972|NCT02616146|516493915|FG000|Overall Study|Pregnancy wish|3|||
143108667|NCT00537316|515937689|FG005|Part 1|Protocol defined clinical event|0|||
143179274|NCT01061385|516203672|FG001|Overall Study|subject decision not related to AE|1|||
143179275|NCT01492088|516203673|FG000|Overall Study|Withdrawal by Patient|0|||
143179276|NCT01492088|516203674|FG001|Overall Study|Withdrawal by Patient|2|||
143108668|NCT00537316|515937690|FG006|Part 1|Protocol defined clinical event|0|||
143179277|NCT01492088|516203675|FG002|Overall Study|Withdrawal by Patient|0|||
143367984|NCT01048788|516890854|FG000|Overall Study|Lack of Efficacy|0|||
143367985|NCT01048788|516890855|FG001|Overall Study|Lack of Efficacy|0|||
143367986|NCT01048788|516890856|FG002|Overall Study|Lack of Efficacy|1|||
143256973|NCT02616146|516493916|FG001|Overall Study|Pregnancy wish|0|||
143256974|NCT02616146|516493915|FG000|Overall Study|Protocol Violation|6|||
143256975|NCT02616146|516493916|FG001|Overall Study|Protocol Violation|3|||
143108669|NCT00537316|515937684|FG000|Part 1|Lost to Follow-up|1|||
143108670|NCT00537316|515937685|FG001|Part 1|Lost to Follow-up|0|||
143108671|NCT00537316|515937686|FG002|Part 1|Lost to Follow-up|0|||
143108672|NCT00537316|515937687|FG003|Part 1|Lost to Follow-up|0|||
143108673|NCT00537316|515937688|FG004|Part 1|Lost to Follow-up|0|||
143108674|NCT00537316|515937689|FG005|Part 1|Lost to Follow-up|0|||
143108675|NCT00537316|515937690|FG006|Part 1|Lost to Follow-up|0|||
143108676|NCT00537316|515937684|FG000|Part 1|Withdrawal by Subject|3|||
143108677|NCT00537316|515937685|FG001|Part 1|Withdrawal by Subject|8|||
143108678|NCT00537316|515937686|FG002|Part 1|Withdrawal by Subject|4|||
143108679|NCT00537316|515937687|FG003|Part 1|Withdrawal by Subject|0|||
143108680|NCT00537316|515937688|FG004|Part 1|Withdrawal by Subject|0|||
143108681|NCT00537316|515937689|FG005|Part 1|Withdrawal by Subject|0|||
143108682|NCT00537316|515937690|FG006|Part 1|Withdrawal by Subject|0|||
143108683|NCT00537316|515937684|FG000|Part 1|Protocol Violation|1|||
143108684|NCT00537316|515937685|FG001|Part 1|Protocol Violation|5|||
143108685|NCT00537316|515937686|FG002|Part 1|Protocol Violation|1|||
143108686|NCT00537316|515937687|FG003|Part 1|Protocol Violation|0|||
143108687|NCT00537316|515937688|FG004|Part 1|Protocol Violation|0|||
143108688|NCT00537316|515937689|FG005|Part 1|Protocol Violation|0|||
143108689|NCT00537316|515937690|FG006|Part 1|Protocol Violation|0|||
143108690|NCT00537316|515937684|FG000|Part 1|Did not meet protocol eligibility|1|||
143108691|NCT00537316|515937685|FG001|Part 1|Did not meet protocol eligibility|3|||
143108692|NCT00537316|515937686|FG002|Part 1|Did not meet protocol eligibility|2|||
143108693|NCT00537316|515937687|FG003|Part 1|Did not meet protocol eligibility|0|||
143108694|NCT00537316|515937688|FG004|Part 1|Did not meet protocol eligibility|0|||
143108695|NCT00537316|515937689|FG005|Part 1|Did not meet protocol eligibility|0|||
143108696|NCT00537316|515937690|FG006|Part 1|Did not meet protocol eligibility|0|||
143108697|NCT00537316|515937684|FG000|Part 1|Administrative|0|||
143108698|NCT00537316|515937685|FG001|Part 1|Administrative|0|||
143108699|NCT00537316|515937686|FG002|Part 1|Administrative|2|||
143108700|NCT00537316|515937687|FG003|Part 1|Administrative|0|||
143108701|NCT00537316|515937688|FG004|Part 1|Administrative|0|||
143108702|NCT00537316|515937689|FG005|Part 1|Administrative|0|||
143108703|NCT00537316|515937690|FG006|Part 1|Administrative|0|||
143108704|NCT00537316|515937684|FG000|Part 2|Never entered follow-up|0|||
143108705|NCT00537316|515937685|FG001|Part 2|Never entered follow-up|0|||
143108706|NCT00537316|515937686|FG002|Part 2|Never entered follow-up|0|||
143108707|NCT00537316|515937687|FG003|Part 2|Never entered follow-up|0|||
143108708|NCT00537316|515937688|FG004|Part 2|Never entered follow-up|0|||
143108709|NCT00537316|515937689|FG005|Part 2|Never entered follow-up|0|||
143108710|NCT00537316|515937690|FG006|Part 2|Never entered follow-up|1|||
143108711|NCT00537316|515937684|FG000|Part 2|Adverse Event|4|||
143108712|NCT00537316|515937685|FG001|Part 2|Adverse Event|0|||
143108713|NCT00537316|515937686|FG002|Part 2|Adverse Event|2|||
143108714|NCT00537316|515937687|FG003|Part 2|Adverse Event|0|||
143108715|NCT00537316|515937688|FG004|Part 2|Adverse Event|0|||
143108716|NCT00537316|515937689|FG005|Part 2|Adverse Event|0|||
143256976|NCT02616146|516493915|FG000|Overall Study|Study terminated by sponsor|1372|||
143256977|NCT02616146|516493916|FG001|Overall Study|Study terminated by sponsor|432|||
143256978|NCT02616146|516493915|FG000|Overall Study|Participant moved|4|||
143367987|NCT01048788|516890854|FG000|Overall Study|Withdrawal by Subject|0|||
143367988|NCT01048788|516890855|FG001|Overall Study|Withdrawal by Subject|1|||
143256979|NCT02616146|516493916|FG001|Overall Study|Participant moved|3|||
143256980|NCT02616146|516493915|FG000|Overall Study|Withdrawal by Subject|30|||
143256981|NCT02616146|516493916|FG001|Overall Study|Withdrawal by Subject|24|||
143256982|NCT02616146|516493915|FG000|Overall Study|Physician Decision|2|||
143256983|NCT02616146|516493916|FG001|Overall Study|Physician Decision|1|||
143256984|NCT03039621|516493917|FG000|Overall Study|Violation of inclusion criteria|3|||
143256985|NCT03039621|516493918|FG001|Overall Study|Violation of inclusion criteria|2|||
143108717|NCT00537316|515937690|FG006|Part 2|Adverse Event|0|||
143108718|NCT00537316|515937684|FG000|Part 2|Lost to Follow-up|1|||
143108719|NCT00537316|515937685|FG001|Part 2|Lost to Follow-up|0|||
143108720|NCT00537316|515937686|FG002|Part 2|Lost to Follow-up|2|||
143108721|NCT00537316|515937687|FG003|Part 2|Lost to Follow-up|0|||
143108722|NCT00537316|515937688|FG004|Part 2|Lost to Follow-up|0|||
143108723|NCT00537316|515937689|FG005|Part 2|Lost to Follow-up|0|||
143108724|NCT00537316|515937690|FG006|Part 2|Lost to Follow-up|0|||
143108725|NCT00537316|515937684|FG000|Part 2|Withdrawal by Subject|5|||
143108726|NCT00537316|515937685|FG001|Part 2|Withdrawal by Subject|1|||
143108727|NCT00537316|515937686|FG002|Part 2|Withdrawal by Subject|4|||
143108728|NCT00537316|515937687|FG003|Part 2|Withdrawal by Subject|0|||
143108729|NCT00537316|515937688|FG004|Part 2|Withdrawal by Subject|0|||
143108730|NCT00537316|515937689|FG005|Part 2|Withdrawal by Subject|0|||
143108731|NCT00537316|515937690|FG006|Part 2|Withdrawal by Subject|0|||
143108732|NCT00537316|515937684|FG000|Part 2|Administrative|16|||
143367989|NCT01048788|516890856|FG002|Overall Study|Withdrawal by Subject|0|||
143108733|NCT00537316|515937685|FG001|Part 2|Administrative|8|||
143108734|NCT00537316|515937686|FG002|Part 2|Administrative|24|||
143108735|NCT00537316|515937687|FG003|Part 2|Administrative|3|||
143108736|NCT00537316|515937688|FG004|Part 2|Administrative|1|||
143108737|NCT00537316|515937689|FG005|Part 2|Administrative|4|||
143108738|NCT00537316|515937690|FG006|Part 2|Administrative|1|||
143108739|NCT02651155|515937691|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
143108740|NCT02651155|515937692|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
143108741|NCT02651155|515937691|FG000|Overall Study|Voluntary Withdrawal|5|||
143108742|NCT02651155|515937692|FG001|Overall Study|Voluntary Withdrawal|0|||
143108743|NCT04533412|515937693|FG000|Overall Study|Withdrawal by Subject|1|||
143108744|NCT04533412|515937694|FG001|Overall Study|Withdrawal by Subject|1|||
143108745|NCT04533412|515937693|FG000|Overall Study|Lost to Follow-up|1|||
143108746|NCT04533412|515937694|FG001|Overall Study|Lost to Follow-up|4|||
143108747|NCT03452488|515937696|FG000|Overall Study|Adverse Event|4|||
143108748|NCT03452488|515937697|FG001|Overall Study|Adverse Event|6|||
143108749|NCT03452488|515937698|FG002|Overall Study|Adverse Event|1|||
143179278|NCT01492088|516203673|FG000|Overall Study|Death|1|||
143179279|NCT01492088|516203674|FG001|Overall Study|Death|6|||
143179280|NCT01492088|516203675|FG002|Overall Study|Death|2|||
143179281|NCT01492088|516203673|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
143179282|NCT01492088|516203674|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
143179283|NCT01492088|516203675|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
143179284|NCT01492088|516203673|FG000|Overall Study|Alive at Last Follow-up|0|||
143179285|NCT01492088|516203674|FG001|Overall Study|Alive at Last Follow-up|6|||
143179286|NCT01492088|516203675|FG002|Overall Study|Alive at Last Follow-up|11|||
143179287|NCT02803203|516203676|FG000|Overall Study|Adverse Event|4|||
143179288|NCT02803203|516203676|FG000|Overall Study|Death|4|||
143179289|NCT02803203|516203676|FG000|Overall Study|Progressive disease|29|||
143179290|NCT02803203|516203676|FG000|Overall Study|Withdrawal by Subject|8|||
143179291|NCT02803203|516203676|FG000|Overall Study|Complete resection of target disease|2|||
143367990|NCT01131494|516890857|FG000|Overall Study|Withdrawal by Subject|2|||
143367991|NCT02145182|516890859|FG000|Overall Study|Adverse Event|4|||
143367992|NCT02145182|516890860|FG001|Overall Study|Adverse Event|1|||
143367993|NCT02145182|516890859|FG000|Overall Study|Death|7|||
143367994|NCT02145182|516890860|FG001|Overall Study|Death|7|||
143367995|NCT02145182|516890859|FG000|Overall Study|Lost to Follow-up|2|||
143367996|NCT02145182|516890860|FG001|Overall Study|Lost to Follow-up|2|||
143367997|NCT02145182|516890859|FG000|Overall Study|Pre-transplant Withdrawal|0|||
143367998|NCT02145182|516890860|FG001|Overall Study|Pre-transplant Withdrawal|2|||
143367999|NCT02145182|516890859|FG000|Overall Study|Withdrawal by Subject|5|||
143368000|NCT02145182|516890860|FG001|Overall Study|Withdrawal by Subject|4|||
143368001|NCT01196988|516890862|FG000|Overall Study|Adverse Event|1|||
143368002|NCT01196988|516890863|FG001|Overall Study|Adverse Event|2|||
143368003|NCT01196988|516890864|FG002|Overall Study|Adverse Event|0|||
143368004|NCT01196988|516890865|FG003|Overall Study|Adverse Event|0|||
143368005|NCT01196988|516890862|FG000|Overall Study|Withdrawal by Subject|5|||
143368006|NCT01196988|516890863|FG001|Overall Study|Withdrawal by Subject|1|||
143368007|NCT01196988|516890864|FG002|Overall Study|Withdrawal by Subject|4|||
143368008|NCT01196988|516890865|FG003|Overall Study|Withdrawal by Subject|0|||
143368009|NCT01196988|516890862|FG000|Overall Study|Lost to Follow-up|16|||
143368010|NCT01196988|516890863|FG001|Overall Study|Lost to Follow-up|29|||
143368011|NCT01196988|516890864|FG002|Overall Study|Lost to Follow-up|21|||
143368012|NCT01196988|516890865|FG003|Overall Study|Lost to Follow-up|1|||
143108750|NCT03452488|515937696|FG000|Overall Study|Death|0|||
143108751|NCT03452488|515937697|FG001|Overall Study|Death|0|||
143108752|NCT03452488|515937698|FG002|Overall Study|Death|1|||
143108753|NCT03452488|515937696|FG000|Overall Study|Lost to Follow-up|1|||
143108754|NCT03452488|515937697|FG001|Overall Study|Lost to Follow-up|2|||
143179292|NCT02803203|516203676|FG000|Overall Study|Switched to commercial Osi|1|||
143179293|NCT02803203|516203676|FG000|Overall Study|Participant moved away|1|||
143179294|NCT02379052|516203677|FG000|Overall Study|Protocol Violation|0|||
143368013|NCT01196988|516890862|FG000|Overall Study|Other|2|||
143368014|NCT01196988|516890863|FG001|Overall Study|Other|0|||
143368015|NCT01196988|516890864|FG002|Overall Study|Other|0|||
143108755|NCT03452488|515937698|FG002|Overall Study|Lost to Follow-up|0|||
143108756|NCT03452488|515937696|FG000|Overall Study|PI Decision|1|||
143108757|NCT03452488|515937697|FG001|Overall Study|PI Decision|0|||
143368016|NCT01196988|516890865|FG003|Overall Study|Other|0|||
143368017|NCT00588666|516890866|FG000|Overall Study|Adverse Event|4|||
143368018|NCT03999554|516890869|FG000|Overall Study|Lost to Follow-up|4|||
143256986|NCT03039621|516493917|FG000|Overall Study|Non-compliance with protocol requirement|4|||
143256987|NCT03039621|516493918|FG001|Overall Study|Non-compliance with protocol requirement|5|||
143108758|NCT03452488|515937698|FG002|Overall Study|PI Decision|0|||
143108759|NCT03452488|515937696|FG000|Overall Study|Withdrew consent|4|||
143108760|NCT03452488|515937697|FG001|Overall Study|Withdrew consent|2|||
143108761|NCT03452488|515937698|FG002|Overall Study|Withdrew consent|2|||
143108762|NCT03452488|515937696|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
143108763|NCT03452488|515937697|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
143108764|NCT03452488|515937698|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
143108765|NCT03452488|515937696|FG000|Overall Study|Other|0|||
143108766|NCT03452488|515937697|FG001|Overall Study|Other|2|||
143108767|NCT03452488|515937698|FG002|Overall Study|Other|2|||
143108768|NCT03261674|515937699|FG000|Overall Study|Lost to Follow-up|6|||
143108769|NCT03261674|515937700|FG001|Overall Study|Lost to Follow-up|7|||
143108770|NCT03261674|515937699|FG000|Overall Study|Protocol Violation|1|||
143108771|NCT03261674|515937700|FG001|Overall Study|Protocol Violation|4|||
143108772|NCT03261674|515937699|FG000|Overall Study|Withdrawal by Subject|1|||
143108773|NCT03261674|515937700|FG001|Overall Study|Withdrawal by Subject|4|||
143108774|NCT03261674|515937699|FG000|Overall Study|Physician Decision|1|||
143108775|NCT03261674|515937700|FG001|Overall Study|Physician Decision|0|||
143256988|NCT03039621|516493917|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
143256989|NCT03039621|516493918|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
143256990|NCT03039621|516493917|FG000|Overall Study|Violation of non-inclusion criteria|1|||
143256991|NCT03039621|516493918|FG001|Overall Study|Violation of non-inclusion criteria|2|||
143256992|NCT01258998|516493921|FG000|Overall Study|Ineligible|1|||
143256993|NCT01143389|516493922|FG000|Overall Study|Lost to Follow-up|26|||
143256994|NCT01143389|516493923|FG001|Overall Study|Lost to Follow-up|25|||
143256995|NCT00002931|516493925|FG000|Overall Study|rapidly progressing disease during|2|||
143256996|NCT02907892|516493930|FG000|Overall Study|Lost to Follow-up|27|||
143256997|NCT02907892|516493931|FG001|Overall Study|Lost to Follow-up|40|||
143256998|NCT01974765|516493932|FG000|Overall Study|Withdrawal by Subject|1|||
143256999|NCT01974765|516493932|FG000|Overall Study|Death|1|||
143257000|NCT01974765|516493932|FG000|Overall Study|Adverse Event|2|||
143257001|NCT04531462|516493935|FG000|Overall Study|Withdrawal by Subject|3|||
143257002|NCT04531462|516493936|FG001|Overall Study|Withdrawal by Subject|1|||
143257003|NCT04531462|516493935|FG000|Overall Study|Adverse Event|3|||
143257004|NCT04531462|516493936|FG001|Overall Study|Adverse Event|3|||
143257005|NCT00504582|516493937|FG000|Overall Study|Lost to Follow-up|1|||
143257006|NCT00504582|516493938|FG001|Overall Study|Lost to Follow-up|0|||
143257007|NCT00504582|516493939|FG002|Overall Study|Lost to Follow-up|0|||
143257008|NCT00348933|516493942|FG000|Overall Study|Withdrawal by Subject|10|||
143257009|NCT00348933|516493942|FG000|Overall Study|Lost to Follow-up|6|||
143108776|NCT03226769|515937701|FG000|Overall Study|Withdrawal by Subject|0|||
143257010|NCT00348933|516493942|FG000|Overall Study|Protocol Violation|2|||
143257011|NCT00348933|516493942|FG000|Overall Study|Adverse Event|7|||
143257012|NCT01757691|516493947|FG000|Overall Study|Administrative problems|2|||
143257013|NCT01757691|516493948|FG001|Overall Study|Administrative problems|0|||
143257014|NCT00883688|516493949|FG000|Overall Study|Ineligible|2|||
143257015|NCT00464490|516493950|FG000|Overall Study|Physician Decision|11|||
143108777|NCT03226769|515937702|FG001|Overall Study|Withdrawal by Subject|1|||
143108778|NCT02640677|515937705|FG000|Overall Study|Lost to Follow-up|1|||
143257016|NCT00464490|516493951|FG001|Overall Study|Physician Decision|11|||
143257017|NCT03188042|516493952|FG000|Overall Study|Withdrawal by Subject|1|||
143257018|NCT03188042|516493953|FG001|Overall Study|Withdrawal by Subject|1|||
143257019|NCT03860935|516493960|FG000|Overall Study|Withdrawal of Consent|15|||
143257020|NCT03860935|516493961|FG001|Overall Study|Withdrawal of Consent|6|||
143257021|NCT03860935|516493960|FG000|Overall Study|Death|75|||
143257022|NCT03860935|516493961|FG001|Overall Study|Death|51|||
143257023|NCT03086967|516493962|FG000|Overall Study|Screen Failure|2|||
143257024|NCT03086967|516493963|FG001|Overall Study|Screen Failure|2|||
143257025|NCT01475071|516493970|FG000|Overall Study|Physician Decision|1|||
143257026|NCT01475071|516493970|FG000|Overall Study|Withdrawal by Subject|6|||
143257027|NCT01475071|516493970|FG000|Overall Study|Lost to Follow-up|1|||
143108779|NCT02640677|515937705|FG000|Overall Study|Withdrawal by Subject|1|||
143108780|NCT03489707|515937716|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
143108781|NCT03489707|515937717|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
143257028|NCT04461600|516493972|FG000|Overall Study|Death|6|||
143257029|NCT04461600|516493973|FG001|Overall Study|Death|5|||
143257030|NCT04461600|516493972|FG000|Overall Study|Withdrawal by Subject|0|||
143257031|NCT04461600|516493973|FG001|Overall Study|Withdrawal by Subject|1|||
143257032|NCT00704522|516493977|FG000|Overall Study|Lack of Efficacy|65|||
143257033|NCT00704522|516493978|FG001|Overall Study|Lack of Efficacy|17|||
143257034|NCT00704522|516493977|FG000|Overall Study|Failure to appear again at hospital|56|||
143257035|NCT00704522|516493978|FG001|Overall Study|Failure to appear again at hospital|10|||
143257036|NCT00704522|516493977|FG000|Overall Study|Withdrawal by Subject|17|||
143257037|NCT00704522|516493978|FG001|Overall Study|Withdrawal by Subject|8|||
143257038|NCT00704522|516493977|FG000|Overall Study|Adverse Event|9|||
143108782|NCT03489707|515937716|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
143108783|NCT03489707|515937717|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
143108784|NCT00519428|515937718|FG000|Overall Study|Adverse Event|5|||
143108785|NCT00519428|515937719|FG001|Overall Study|Adverse Event|2|||
143108786|NCT00519428|515937720|FG002|Overall Study|Adverse Event|10|||
143108787|NCT00519428|515937718|FG000|Overall Study|Lost to Follow-up|7|||
143108788|NCT00519428|515937719|FG001|Overall Study|Lost to Follow-up|7|||
143108789|NCT00519428|515937720|FG002|Overall Study|Lost to Follow-up|6|||
143108790|NCT00519428|515937718|FG000|Overall Study|Withdrawal by Subject|8|||
143108791|NCT00519428|515937719|FG001|Overall Study|Withdrawal by Subject|3|||
143108792|NCT00519428|515937720|FG002|Overall Study|Withdrawal by Subject|7|||
143108793|NCT00519428|515937718|FG000|Overall Study|unstated|1|||
143108794|NCT00519428|515937719|FG001|Overall Study|unstated|3|||
143108795|NCT00519428|515937720|FG002|Overall Study|unstated|2|||
143108796|NCT04064411|515937721|FG000|Overall Study|Adverse Event|29|||
143108797|NCT04064411|515937722|FG001|Overall Study|Adverse Event|19|||
143108798|NCT04064411|515937721|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
143108799|NCT04064411|515937722|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
143108800|NCT04064411|515937721|FG000|Overall Study|Protocol Deviation|0|||
143108801|NCT04064411|515937722|FG001|Overall Study|Protocol Deviation|2|||
143108802|NCT04064411|515937721|FG000|Overall Study|Withdrawal by Subject|25|||
143108803|NCT04064411|515937722|FG001|Overall Study|Withdrawal by Subject|29|||
143108804|NCT04064411|515937721|FG000|Overall Study|Lost to Follow-up|5|||
143108805|NCT04064411|515937722|FG001|Overall Study|Lost to Follow-up|2|||
143108806|NCT04064411|515937721|FG000|Overall Study|Other than Specified|4|||
143108807|NCT04064411|515937722|FG001|Overall Study|Other than Specified|1|||
143108808|NCT04064411|515937721|FG000|Overall Study|Death|1|||
143108809|NCT04064411|515937722|FG001|Overall Study|Death|0|||
143108810|NCT03395184|515937723|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
143108811|NCT03395184|515937724|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
143108812|NCT03395184|515937725|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
143108813|NCT03395184|515937726|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
143108814|NCT03395184|515937727|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
143108815|NCT03395184|515937728|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
143108816|NCT03395184|515937729|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
143108817|NCT03395184|515937723|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
143108818|NCT03395184|515937724|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
143108819|NCT03395184|515937725|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
143108820|NCT03395184|515937726|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
143108821|NCT03395184|515937727|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
143108822|NCT03395184|515937728|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
143108823|NCT03395184|515937729|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
143108824|NCT03395184|515937723|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
143108825|NCT03395184|515937724|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
143108826|NCT03395184|515937725|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
143108827|NCT03395184|515937726|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
143117389|NCT01313221|515971827|FG001|Overall Study|Physician Decision|0|||
143257039|NCT00704522|516493978|FG001|Overall Study|Adverse Event|1|||
143257040|NCT00704522|516493977|FG000|Overall Study|Undefined causes|9|||
143257041|NCT00704522|516493978|FG001|Overall Study|Undefined causes|7|||
143257042|NCT00704522|516493977|FG000|Overall Study|No information on therapy end|27|||
143257043|NCT00704522|516493978|FG001|Overall Study|No information on therapy end|2|||
143257044|NCT00992589|516493979|FG000|Open-Label Phase|Adverse Event|4|||
143257045|NCT00992589|516493980|FG001|Open-Label Phase|Adverse Event|0|||
143257046|NCT00992589|516493981|FG002|Open-Label Phase|Adverse Event|0|||
143257047|NCT00992589|516493982|FG003|Open-Label Phase|Adverse Event|0|||
143257048|NCT00992589|516493979|FG000|Open-Label Phase|Withdrawal by Subject|20|||
143257049|NCT00992589|516493980|FG001|Open-Label Phase|Withdrawal by Subject|0|||
143257050|NCT00992589|516493981|FG002|Open-Label Phase|Withdrawal by Subject|0|||
143257051|NCT00992589|516493982|FG003|Open-Label Phase|Withdrawal by Subject|0|||
143257052|NCT00992589|516493979|FG000|Open-Label Phase|Lost to Follow-up|1|||
143257053|NCT00992589|516493980|FG001|Open-Label Phase|Lost to Follow-up|0|||
143257054|NCT00992589|516493981|FG002|Open-Label Phase|Lost to Follow-up|0|||
143257055|NCT00992589|516493982|FG003|Open-Label Phase|Lost to Follow-up|0|||
143257056|NCT00992589|516493979|FG000|Open-Label Phase|Protocol Violation|3|||
143257057|NCT00992589|516493980|FG001|Open-Label Phase|Protocol Violation|0|||
143257058|NCT00992589|516493981|FG002|Open-Label Phase|Protocol Violation|0|||
143257059|NCT00992589|516493982|FG003|Open-Label Phase|Protocol Violation|0|||
143257060|NCT00992589|516493979|FG000|Open-Label Phase|Physician Decision|4|||
143257061|NCT00992589|516493980|FG001|Open-Label Phase|Physician Decision|0|||
143108828|NCT03395184|515937727|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
143108829|NCT03395184|515937728|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
143108830|NCT03395184|515937729|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
143257062|NCT00992589|516493981|FG002|Open-Label Phase|Physician Decision|0|||
143257063|NCT00992589|516493982|FG003|Open-Label Phase|Physician Decision|0|||
143108831|NCT03395184|515937723|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
143108832|NCT03395184|515937724|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
143108833|NCT03395184|515937725|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
143108834|NCT03395184|515937726|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
143108835|NCT03395184|515937727|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
143108836|NCT03395184|515937728|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
143108837|NCT03395184|515937729|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
143108838|NCT03395184|515937723|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
143108839|NCT03395184|515937724|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
143108840|NCT03395184|515937725|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
143108841|NCT03395184|515937726|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
143108842|NCT03395184|515937727|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
143108843|NCT03395184|515937728|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
143108844|NCT03395184|515937729|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
143108845|NCT03395184|515937723|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
143108846|NCT03395184|515937724|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
143257064|NCT00992589|516493979|FG000|Open-Label Phase|Other|45|||
143257065|NCT00992589|516493980|FG001|Open-Label Phase|Other|0|||
143257066|NCT00992589|516493981|FG002|Open-Label Phase|Other|0|||
143257067|NCT00992589|516493982|FG003|Open-Label Phase|Other|0|||
143257068|NCT00992589|516493979|FG000|Double-Blind Phase|Adverse Event|0|||
143257069|NCT00992589|516493980|FG001|Double-Blind Phase|Adverse Event|6|||
143257070|NCT00992589|516493981|FG002|Double-Blind Phase|Adverse Event|2|||
143257071|NCT00992589|516493982|FG003|Double-Blind Phase|Adverse Event|3|||
143257072|NCT00992589|516493979|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
143257073|NCT00992589|516493980|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
143257074|NCT00992589|516493981|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
143257075|NCT00992589|516493982|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
143257076|NCT00992589|516493979|FG000|Double-Blind Phase|Lost to Follow-up|0|||
143257077|NCT00992589|516493980|FG001|Double-Blind Phase|Lost to Follow-up|0|||
143257078|NCT00992589|516493981|FG002|Double-Blind Phase|Lost to Follow-up|0|||
143257079|NCT00992589|516493982|FG003|Double-Blind Phase|Lost to Follow-up|2|||
143257080|NCT00992589|516493979|FG000|Double-Blind Phase|Other|0|||
143257081|NCT00992589|516493980|FG001|Double-Blind Phase|Other|1|||
143257082|NCT00992589|516493981|FG002|Double-Blind Phase|Other|6|||
143257083|NCT00992589|516493982|FG003|Double-Blind Phase|Other|3|||
143257084|NCT00045942|516493983|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
143257085|NCT00045942|516493984|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
143257086|NCT00045942|516493985|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
143257087|NCT00045942|516493986|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
143257088|NCT00045942|516493987|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
143257089|NCT00045942|516493988|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
143257090|NCT00045942|516493989|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
143257091|NCT00045942|516493990|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
143257092|NCT00045942|516493991|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
143257093|NCT00045942|516493983|FG000|PKC412A2104 (Core)|Adverse Event|5|||
143257094|NCT00045942|516493984|FG001|PKC412A2104 (Core)|Adverse Event|0|||
143257095|NCT00045942|516493985|FG002|PKC412A2104 (Core)|Adverse Event|0|||
143257096|NCT00045942|516493986|FG003|PKC412A2104 (Core)|Adverse Event|0|||
143257097|NCT00045942|516493987|FG004|PKC412A2104 (Core)|Adverse Event|0|||
143257098|NCT00045942|516493988|FG005|PKC412A2104 (Core)|Adverse Event|0|||
143257099|NCT00045942|516493989|FG006|PKC412A2104 (Core)|Adverse Event|0|||
143108847|NCT03395184|515937725|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
143108848|NCT03395184|515937726|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
143108849|NCT03395184|515937727|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
143257100|NCT00045942|516493990|FG007|PKC412A2104 (Core)|Adverse Event|0|||
143257101|NCT00045942|516493991|FG008|PKC412A2104 (Core)|Adverse Event|0|||
143108850|NCT03395184|515937728|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
143108851|NCT03395184|515937729|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
143108852|NCT03395184|515937723|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
143108853|NCT03395184|515937724|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
143108854|NCT03395184|515937725|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
143257102|NCT00045942|516493983|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
143257103|NCT00045942|516493984|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
143257104|NCT00045942|516493985|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
143257105|NCT00045942|516493986|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
143257106|NCT00045942|516493987|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
143108855|NCT03395184|515937726|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
143257107|NCT00045942|516493988|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
143257108|NCT00045942|516493989|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
143179295|NCT02379052|516203678|FG001|Overall Study|Protocol Violation|1|||
143179296|NCT02379052|516203677|FG000|Overall Study|Adverse Event|0|||
143179297|NCT02379052|516203678|FG001|Overall Study|Adverse Event|1|||
143179298|NCT02379052|516203677|FG000|Overall Study|Physician Decision|1|||
143179299|NCT02379052|516203678|FG001|Overall Study|Physician Decision|1|||
143179300|NCT02379052|516203677|FG000|Overall Study|Withdrawal by Subject|2|||
143179301|NCT02379052|516203678|FG001|Overall Study|Withdrawal by Subject|0|||
143179302|NCT02379052|516203677|FG000|Overall Study|Lost to Follow-up|2|||
143179303|NCT02379052|516203678|FG001|Overall Study|Lost to Follow-up|1|||
143179304|NCT02379052|516203677|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
143179305|NCT02379052|516203678|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
143179306|NCT02379052|516203677|FG000|Overall Study|Subject was Incarcerated|0|||
143179307|NCT02379052|516203678|FG001|Overall Study|Subject was Incarcerated|1|||
143179308|NCT00127855|516203679|FG000|Primary Vaccination Course|Adverse Event|0|||
143179309|NCT00127855|516203680|FG001|Primary Vaccination Course|Adverse Event|0|||
143179310|NCT00127855|516203681|FG002|Primary Vaccination Course|Adverse Event|1|||
143179311|NCT00127855|516203682|FG003|Primary Vaccination Course|Adverse Event|0|||
143179312|NCT00127855|516203683|FG004|Primary Vaccination Course|Adverse Event|0|||
143179313|NCT00127855|516203679|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
143179314|NCT00127855|516203680|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
143179315|NCT00127855|516203681|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
143179316|NCT00127855|516203682|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
143108856|NCT03395184|515937727|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
143108857|NCT03395184|515937728|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
143257109|NCT00045942|516493990|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
143368019|NCT03999554|516890870|FG001|Overall Study|Lost to Follow-up|5|||
143368020|NCT03999554|516890871|FG002|Overall Study|Lost to Follow-up|4|||
143368021|NCT03999554|516890872|FG003|Overall Study|Lost to Follow-up|5|||
143368022|NCT03999554|516890873|FG004|Overall Study|Lost to Follow-up|8|||
143368023|NCT03999554|516890869|FG000|Overall Study|Protocol Violation|0|||
143368024|NCT03999554|516890870|FG001|Overall Study|Protocol Violation|0|||
143368025|NCT03999554|516890871|FG002|Overall Study|Protocol Violation|5|||
143368026|NCT03999554|516890872|FG003|Overall Study|Protocol Violation|0|||
143368027|NCT03999554|516890873|FG004|Overall Study|Protocol Violation|0|||
143368028|NCT03999554|516890869|FG000|Overall Study|Pregnancy|0|||
143368029|NCT03999554|516890870|FG001|Overall Study|Pregnancy|0|||
143368030|NCT03999554|516890871|FG002|Overall Study|Pregnancy|1|||
143368031|NCT03999554|516890872|FG003|Overall Study|Pregnancy|0|||
143368032|NCT03999554|516890873|FG004|Overall Study|Pregnancy|0|||
143368033|NCT03999554|516890869|FG000|Overall Study|Withdrawal by Subject|2|||
143368034|NCT03999554|516890870|FG001|Overall Study|Withdrawal by Subject|2|||
143368035|NCT03999554|516890871|FG002|Overall Study|Withdrawal by Subject|2|||
143368036|NCT03999554|516890872|FG003|Overall Study|Withdrawal by Subject|1|||
143368037|NCT03999554|516890873|FG004|Overall Study|Withdrawal by Subject|1|||
143368038|NCT03999554|516890869|FG000|Overall Study|failure to comply with protocol requirements|0|||
143368039|NCT03999554|516890870|FG001|Overall Study|failure to comply with protocol requirements|0|||
143368040|NCT03999554|516890871|FG002|Overall Study|failure to comply with protocol requirements|0|||
143368041|NCT03999554|516890872|FG003|Overall Study|failure to comply with protocol requirements|1|||
143368042|NCT03999554|516890873|FG004|Overall Study|failure to comply with protocol requirements|0|||
143368043|NCT02274493|516890874|FG000|Overall Study|Withdrawal by Subject|1|||
143368044|NCT00558363|516890875|FG000|Overall Study|Physician Decision|18|||
143257110|NCT00045942|516493991|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
143257111|NCT00045942|516493983|FG000|PKC412A2104 (Core)|Death|1|||
143257112|NCT00045942|516493984|FG001|PKC412A2104 (Core)|Death|0|||
143257113|NCT00045942|516493985|FG002|PKC412A2104 (Core)|Death|0|||
143257114|NCT00045942|516493986|FG003|PKC412A2104 (Core)|Death|0|||
143257115|NCT00045942|516493987|FG004|PKC412A2104 (Core)|Death|0|||
143257116|NCT00045942|516493988|FG005|PKC412A2104 (Core)|Death|0|||
143257117|NCT00045942|516493989|FG006|PKC412A2104 (Core)|Death|0|||
143257118|NCT00045942|516493990|FG007|PKC412A2104 (Core)|Death|0|||
143257119|NCT00045942|516493991|FG008|PKC412A2104 (Core)|Death|0|||
143257120|NCT00045942|516493983|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
143257121|NCT00045942|516493984|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
143257122|NCT00045942|516493985|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
143257123|NCT00045942|516493986|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
143257124|NCT00045942|516493987|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
143257125|NCT00045942|516493988|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
143257126|NCT00045942|516493989|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
143257127|NCT00045942|516493990|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
143257128|NCT00045942|516493991|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
143257129|NCT00045942|516493983|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
143257130|NCT00045942|516493984|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
143257131|NCT00045942|516493985|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
143257132|NCT00045942|516493986|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
143257133|NCT00045942|516493987|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
143257134|NCT00045942|516493988|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
143257135|NCT00045942|516493989|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
143257136|NCT00045942|516493990|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
143257137|NCT00045942|516493991|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
143257138|NCT00045942|516493983|FG000|PKC412A2104E1|Lack of Efficacy|0|||
143257139|NCT00045942|516493984|FG001|PKC412A2104E1|Lack of Efficacy|11|||
143257140|NCT00045942|516493985|FG002|PKC412A2104E1|Lack of Efficacy|11|||
143257141|NCT00045942|516493986|FG003|PKC412A2104E1|Lack of Efficacy|23|||
143257142|NCT00045942|516493987|FG004|PKC412A2104E1|Lack of Efficacy|17|||
143257143|NCT00045942|516493988|FG005|PKC412A2104E1|Lack of Efficacy|0|||
143257144|NCT00045942|516493989|FG006|PKC412A2104E1|Lack of Efficacy|0|||
143257145|NCT00045942|516493990|FG007|PKC412A2104E1|Lack of Efficacy|0|||
143368045|NCT00558363|516890876|FG001|Overall Study|Physician Decision|4|||
143368046|NCT00558363|516890875|FG000|Overall Study|Withdrawal by Subject|11|||
143368047|NCT00558363|516890876|FG001|Overall Study|Withdrawal by Subject|4|||
143368048|NCT00558363|516890875|FG000|Overall Study|Adverse Event|5|||
143368049|NCT00558363|516890876|FG001|Overall Study|Adverse Event|5|||
143108858|NCT03395184|515937729|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
143257146|NCT00045942|516493991|FG008|PKC412A2104E1|Lack of Efficacy|0|||
143257147|NCT00045942|516493983|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
143257148|NCT00045942|516493984|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
143257149|NCT00045942|516493985|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
143257150|NCT00045942|516493986|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
143257151|NCT00045942|516493987|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
143257152|NCT00045942|516493988|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
143108859|NCT03395184|515937723|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
143108860|NCT03395184|515937724|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
143108861|NCT03395184|515937725|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
143108862|NCT03395184|515937726|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
143108863|NCT03395184|515937727|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
143108864|NCT03395184|515937728|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
143108865|NCT03395184|515937729|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
143108866|NCT03395184|515937723|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
143108867|NCT03395184|515937724|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
143108868|NCT03395184|515937725|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
143108869|NCT03395184|515937726|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
143108870|NCT03395184|515937727|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
143108871|NCT03395184|515937728|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
143108872|NCT03395184|515937729|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
143108873|NCT03395184|515937723|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
143108874|NCT03395184|515937724|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
143108875|NCT03395184|515937725|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
143108876|NCT03395184|515937726|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
143108877|NCT03395184|515937727|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
143108878|NCT03395184|515937728|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
143108879|NCT03395184|515937729|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
143257153|NCT00045942|516493989|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
143368050|NCT00558363|516890875|FG000|Overall Study|Lack of Efficacy|2|||
143368051|NCT00558363|516890876|FG001|Overall Study|Lack of Efficacy|2|||
143257154|NCT00045942|516493990|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
143257155|NCT00045942|516493991|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
143257156|NCT00045942|516493983|FG000|PKC412A2104E1|Adverse Event|0|||
143257157|NCT00045942|516493984|FG001|PKC412A2104E1|Adverse Event|1|||
143257158|NCT00045942|516493985|FG002|PKC412A2104E1|Adverse Event|1|||
143257159|NCT00045942|516493986|FG003|PKC412A2104E1|Adverse Event|3|||
143257160|NCT00045942|516493987|FG004|PKC412A2104E1|Adverse Event|6|||
143257161|NCT00045942|516493988|FG005|PKC412A2104E1|Adverse Event|0|||
143257162|NCT00045942|516493989|FG006|PKC412A2104E1|Adverse Event|0|||
143257163|NCT00045942|516493990|FG007|PKC412A2104E1|Adverse Event|0|||
143257164|NCT00045942|516493991|FG008|PKC412A2104E1|Adverse Event|0|||
143257165|NCT00045942|516493983|FG000|PKC412A2104E1|Death|0|||
143257166|NCT00045942|516493984|FG001|PKC412A2104E1|Death|4|||
143257167|NCT00045942|516493985|FG002|PKC412A2104E1|Death|1|||
143257168|NCT00045942|516493986|FG003|PKC412A2104E1|Death|1|||
143257169|NCT00045942|516493987|FG004|PKC412A2104E1|Death|1|||
143257170|NCT00045942|516493988|FG005|PKC412A2104E1|Death|0|||
143257171|NCT00045942|516493989|FG006|PKC412A2104E1|Death|0|||
143257172|NCT00045942|516493990|FG007|PKC412A2104E1|Death|0|||
143257173|NCT00045942|516493991|FG008|PKC412A2104E1|Death|0|||
143257174|NCT00045942|516493983|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
143257175|NCT00045942|516493984|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
143257176|NCT00045942|516493985|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
143257177|NCT00045942|516493986|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
143257178|NCT00045942|516493987|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
143257179|NCT00045942|516493988|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
143257180|NCT00045942|516493989|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
143257181|NCT00045942|516493990|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
143257182|NCT00045942|516493991|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
143257183|NCT00045942|516493983|FG000|PKC412A2104E2|Lost to Follow-up|0|||
143257184|NCT00045942|516493984|FG001|PKC412A2104E2|Lost to Follow-up|0|||
143257185|NCT00045942|516493985|FG002|PKC412A2104E2|Lost to Follow-up|0|||
143257186|NCT00045942|516493986|FG003|PKC412A2104E2|Lost to Follow-up|0|||
143257187|NCT00045942|516493987|FG004|PKC412A2104E2|Lost to Follow-up|0|||
143257188|NCT00045942|516493988|FG005|PKC412A2104E2|Lost to Follow-up|0|||
143257189|NCT00045942|516493989|FG006|PKC412A2104E2|Lost to Follow-up|0|||
143257190|NCT00045942|516493990|FG007|PKC412A2104E2|Lost to Follow-up|3|||
143257191|NCT00045942|516493991|FG008|PKC412A2104E2|Lost to Follow-up|0|||
143257192|NCT00045942|516493983|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
143257193|NCT00045942|516493984|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
143257194|NCT00045942|516493985|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
143257195|NCT00045942|516493986|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
143257196|NCT00045942|516493987|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
143257197|NCT00045942|516493988|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
143108880|NCT03395184|515937723|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
143108881|NCT03395184|515937724|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
143108882|NCT03395184|515937725|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
143257198|NCT00045942|516493989|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
143257199|NCT00045942|516493990|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
143257200|NCT00045942|516493991|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
143257201|NCT00045942|516493983|FG000|PKC412A2104E2|Lack of Efficacy|0|||
143108883|NCT03395184|515937726|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
143108884|NCT03395184|515937727|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
143108885|NCT03395184|515937728|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
143108886|NCT03395184|515937729|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
143108887|NCT03395184|515937723|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
143108888|NCT03395184|515937724|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
143108889|NCT03395184|515937725|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
143108890|NCT03395184|515937726|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
143108891|NCT03395184|515937727|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
143108892|NCT03395184|515937728|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
143108893|NCT03395184|515937729|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
143108894|NCT01817582|515937730|FG000|Overall Study|Withdrawal by Subject|0|||
143108895|NCT01817582|515937731|FG001|Overall Study|Withdrawal by Subject|1|||
143108896|NCT01817582|515937732|FG002|Overall Study|Withdrawal by Subject|0|||
143108897|NCT01817582|515937730|FG000|Overall Study|Participant revealed masked treatment|1|||
143108898|NCT01817582|515937731|FG001|Overall Study|Participant revealed masked treatment|0|||
143108899|NCT01817582|515937732|FG002|Overall Study|Participant revealed masked treatment|0|||
143108900|NCT01817582|515937730|FG000|Overall Study|Randomized but exclusion criteria met|1|||
143108901|NCT01817582|515937731|FG001|Overall Study|Randomized but exclusion criteria met|0|||
143108902|NCT01817582|515937732|FG002|Overall Study|Randomized but exclusion criteria met|0|||
143108903|NCT03963232|515937735|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
143108904|NCT03963232|515937736|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
143108905|NCT03963232|515937735|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
143108906|NCT03963232|515937736|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
143108907|NCT03963232|515937735|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
143108908|NCT03963232|515937736|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
143108909|NCT03963232|515937735|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
143108910|NCT03963232|515937736|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
143108911|NCT03963232|515937735|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
143108912|NCT03963232|515937736|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
143108913|NCT03963232|515937735|FG000|Open-Label Treatment Phase|Adverse Event|1|||
143108914|NCT03963232|515937736|FG001|Open-Label Treatment Phase|Adverse Event|2|||
143108915|NCT03963232|515937735|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
143108916|NCT03963232|515937736|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
143108917|NCT03963232|515937735|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
143108918|NCT03963232|515937736|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
143108919|NCT03963232|515937735|FG000|Open-Label Treatment Phase|Pregnancy|1|||
143108920|NCT03963232|515937736|FG001|Open-Label Treatment Phase|Pregnancy|0|||
143108921|NCT03963232|515937735|FG000|Follow-up Phase|Withdrawal by Subject|7|||
143108922|NCT03963232|515937736|FG001|Follow-up Phase|Withdrawal by Subject|5|||
143108923|NCT03963232|515937735|FG000|Follow-up Phase|Protocol Violation|0|||
143108924|NCT03963232|515937736|FG001|Follow-up Phase|Protocol Violation|2|||
143108925|NCT03963232|515937735|FG000|Follow-up Phase|Adverse Event|0|||
143108926|NCT03963232|515937736|FG001|Follow-up Phase|Adverse Event|1|||
143108927|NCT03963232|515937735|FG000|Follow-up Phase|Lost to Follow-up|0|||
143108928|NCT03963232|515937736|FG001|Follow-up Phase|Lost to Follow-up|1|||
143108929|NCT00356135|515937737|FG000|Overall Study|Protocol Violation|1|||
143108930|NCT00356135|515937738|FG001|Overall Study|Protocol Violation|0|||
143108931|NCT00356135|515937739|FG002|Overall Study|Protocol Violation|0|||
143108932|NCT00356135|515937737|FG000|Overall Study|Adverse Event|1|||
143108933|NCT00356135|515937738|FG001|Overall Study|Adverse Event|0|||
143108934|NCT00356135|515937739|FG002|Overall Study|Adverse Event|0|||
143108935|NCT00356135|515937737|FG000|Overall Study|Lost to Follow-up|0|||
143108936|NCT00356135|515937738|FG001|Overall Study|Lost to Follow-up|0|||
143108937|NCT00356135|515937739|FG002|Overall Study|Lost to Follow-up|1|||
143108938|NCT00356135|515937737|FG000|Overall Study|Physician Decision|1|||
143108939|NCT00356135|515937738|FG001|Overall Study|Physician Decision|1|||
143108940|NCT00356135|515937739|FG002|Overall Study|Physician Decision|1|||
143108941|NCT00356135|515937737|FG000|Overall Study|Subject non-compliance|1|||
143108942|NCT00356135|515937738|FG001|Overall Study|Subject non-compliance|1|||
143108943|NCT00356135|515937739|FG002|Overall Study|Subject non-compliance|3|||
143108944|NCT03617770|515937740|FG000|Overall Study|Lost to Follow-up|1|||
143108945|NCT03617770|515937741|FG001|Overall Study|Lost to Follow-up|0|||
143108946|NCT03725761|515937743|FG000|Overall Study|still on study|1|||
143108947|NCT00688701|515939705|FG000|Overall Study|Adverse Event|1|||
143368052|NCT00558363|516890875|FG000|Overall Study|Protocol Violation|2|||
143368053|NCT00558363|516890876|FG001|Overall Study|Protocol Violation|1|||
143368054|NCT00558363|516890875|FG000|Overall Study|Lost to Follow-up|0|||
143368055|NCT00558363|516890876|FG001|Overall Study|Lost to Follow-up|1|||
143368056|NCT00558363|516890875|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
143368057|NCT00558363|516890876|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
143257202|NCT00045942|516493984|FG001|PKC412A2104E2|Lack of Efficacy|0|||
143257203|NCT00045942|516493985|FG002|PKC412A2104E2|Lack of Efficacy|0|||
143257204|NCT00045942|516493986|FG003|PKC412A2104E2|Lack of Efficacy|0|||
143257205|NCT00045942|516493987|FG004|PKC412A2104E2|Lack of Efficacy|0|||
143257206|NCT00045942|516493988|FG005|PKC412A2104E2|Lack of Efficacy|3|||
143257207|NCT00045942|516493989|FG006|PKC412A2104E2|Lack of Efficacy|2|||
143257208|NCT00045942|516493990|FG007|PKC412A2104E2|Lack of Efficacy|2|||
143257209|NCT00045942|516493991|FG008|PKC412A2104E2|Lack of Efficacy|6|||
143257210|NCT00045942|516493983|FG000|PKC412A2104E2|Adverse Event|0|||
143257211|NCT00045942|516493984|FG001|PKC412A2104E2|Adverse Event|0|||
143257212|NCT00045942|516493985|FG002|PKC412A2104E2|Adverse Event|0|||
143257213|NCT00045942|516493986|FG003|PKC412A2104E2|Adverse Event|0|||
143257214|NCT00045942|516493987|FG004|PKC412A2104E2|Adverse Event|0|||
143257215|NCT00045942|516493988|FG005|PKC412A2104E2|Adverse Event|4|||
143257216|NCT00045942|516493989|FG006|PKC412A2104E2|Adverse Event|3|||
143257217|NCT00045942|516493990|FG007|PKC412A2104E2|Adverse Event|1|||
143257218|NCT00045942|516493991|FG008|PKC412A2104E2|Adverse Event|0|||
143368058|NCT00558363|516890875|FG000|Overall Study|Randomized in Error|1|||
143368059|NCT00558363|516890876|FG001|Overall Study|Randomized in Error|2|||
143257219|NCT00045942|516493983|FG000|PKC412A2104E2|Death|0|||
143257220|NCT00045942|516493984|FG001|PKC412A2104E2|Death|0|||
143257221|NCT00045942|516493985|FG002|PKC412A2104E2|Death|0|||
143257222|NCT00045942|516493986|FG003|PKC412A2104E2|Death|0|||
143257223|NCT00045942|516493987|FG004|PKC412A2104E2|Death|0|||
143257224|NCT00045942|516493988|FG005|PKC412A2104E2|Death|1|||
143257225|NCT00045942|516493989|FG006|PKC412A2104E2|Death|2|||
143257226|NCT00045942|516493990|FG007|PKC412A2104E2|Death|0|||
143257227|NCT00045942|516493991|FG008|PKC412A2104E2|Death|0|||
143257228|NCT01101308|516493992|FG000|Period 1|Adverse Event|2|||
143257229|NCT01101308|516493993|FG001|Period 1|Adverse Event|1|||
143257230|NCT01101308|516493992|FG000|Period 1|Positive for cotinine|1|||
143257231|NCT01101308|516493993|FG001|Period 1|Positive for cotinine|0|||
143257232|NCT00711516|516493995|FG000|Overall Study|Adverse Event|1|||
143257233|NCT00711516|516493996|FG001|Overall Study|Adverse Event|1|||
143257234|NCT00711516|516493995|FG000|Overall Study|Withdrawal by Subject|0|||
143368060|NCT00558363|516890875|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
143257235|NCT00711516|516493996|FG001|Overall Study|Withdrawal by Subject|1|||
143257236|NCT00711516|516493995|FG000|Overall Study|Protocol Violation|0|||
143257237|NCT00711516|516493996|FG001|Overall Study|Protocol Violation|1|||
143257238|NCT01895361|516493998|FG000|Overall Study|Adverse Event|1|||
143257239|NCT01895361|516493999|FG001|Overall Study|Adverse Event|1|||
143257240|NCT01895361|516494000|FG002|Overall Study|Adverse Event|3|||
143257241|NCT01895361|516493998|FG000|Overall Study|Death|2|||
143368061|NCT00558363|516890876|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
143368062|NCT03102710|516890877|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
143257242|NCT01895361|516493999|FG001|Overall Study|Death|1|||
143257243|NCT01895361|516494000|FG002|Overall Study|Death|2|||
143257244|NCT01895361|516493998|FG000|Overall Study|Lost to Follow-up|4|||
143257245|NCT01895361|516493999|FG001|Overall Study|Lost to Follow-up|4|||
143257246|NCT01895361|516494000|FG002|Overall Study|Lost to Follow-up|6|||
143257247|NCT01895361|516493998|FG000|Overall Study|Non-compliance with study|1|||
143257248|NCT01895361|516493999|FG001|Overall Study|Non-compliance with study|3|||
143257249|NCT01895361|516494000|FG002|Overall Study|Non-compliance with study|1|||
143257250|NCT01895361|516493998|FG000|Overall Study|Physician Decision|2|||
143257251|NCT01895361|516493999|FG001|Overall Study|Physician Decision|2|||
143257252|NCT01895361|516494000|FG002|Overall Study|Physician Decision|2|||
143257253|NCT01895361|516493998|FG000|Overall Study|Withdrawal by Subject|7|||
143257254|NCT01895361|516493999|FG001|Overall Study|Withdrawal by Subject|6|||
143257255|NCT01895361|516494000|FG002|Overall Study|Withdrawal by Subject|6|||
143257256|NCT01895361|516493998|FG000|Overall Study|Lack of Efficacy|0|||
143257257|NCT01895361|516493999|FG001|Overall Study|Lack of Efficacy|1|||
143257258|NCT01895361|516494000|FG002|Overall Study|Lack of Efficacy|0|||
143257259|NCT01895361|516493998|FG000|Overall Study|Reasons different from categories above|7|||
143257260|NCT01895361|516493999|FG001|Overall Study|Reasons different from categories above|3|||
143257261|NCT01895361|516494000|FG002|Overall Study|Reasons different from categories above|4|||
143257262|NCT01209832|516494004|FG000|Period 1|Sponsor Decision and was not dosed|1|||
143257263|NCT01209832|516494004|FG000|Period 2|Sponsor Decision|1|||
143257264|NCT01860846|516494005|FG000|Overall Study|Lost to Follow-up|33|||
143257265|NCT05463198|516494006|FG000|Overall Study|Withdrawal by Subject|19|||
143257266|NCT05463198|516494006|FG000|Overall Study|Procedure Notes Missing|18|||
143257267|NCT01381562|516494009|FG000|Overall Study|Adverse Event|0|||
143257268|NCT01381562|516494010|FG001|Overall Study|Adverse Event|1|||
143257269|NCT01381562|516494011|FG002|Overall Study|Adverse Event|0|||
143257270|NCT02660138|516494012|FG000|Overall Study|Adverse Event|0|||
143257271|NCT02660138|516494013|FG001|Overall Study|Adverse Event|3|||
143257272|NCT02660138|516494014|FG002|Overall Study|Adverse Event|2|||
143257273|NCT02660138|516494012|FG000|Overall Study|Lack of Efficacy|1|||
143257274|NCT02660138|516494013|FG001|Overall Study|Lack of Efficacy|2|||
143257275|NCT02660138|516494014|FG002|Overall Study|Lack of Efficacy|1|||
143257276|NCT02660138|516494012|FG000|Overall Study|Withdrawal by Subject|7|||
143257277|NCT02660138|516494013|FG001|Overall Study|Withdrawal by Subject|6|||
143257278|NCT02660138|516494014|FG002|Overall Study|Withdrawal by Subject|6|||
143257279|NCT02660138|516494012|FG000|Overall Study|Lost to Follow-up|4|||
143257280|NCT02660138|516494013|FG001|Overall Study|Lost to Follow-up|4|||
143257281|NCT02660138|516494014|FG002|Overall Study|Lost to Follow-up|1|||
143257282|NCT02660138|516494012|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
143257283|NCT02660138|516494013|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
143257284|NCT02660138|516494014|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
143257285|NCT02660138|516494012|FG000|Overall Study|Other|1|||
143257286|NCT02660138|516494013|FG001|Overall Study|Other|1|||
143257287|NCT02660138|516494014|FG002|Overall Study|Other|0|||
143257288|NCT02660138|516494012|FG000|Overall Study|Not treated|0|||
143257289|NCT02660138|516494013|FG001|Overall Study|Not treated|1|||
143257290|NCT02660138|516494014|FG002|Overall Study|Not treated|0|||
143257291|NCT00899353|516494019|FG000|Overall Study|Adverse Event|2|||
143257292|NCT00899353|516494019|FG000|Overall Study|Lost to Follow-up|1|||
143257293|NCT00899353|516494019|FG000|Overall Study|Withdrawal by Subject|2|||
143108948|NCT00688701|515939706|FG001|Overall Study|Adverse Event|0|||
143108949|NCT00688701|515939707|FG002|Overall Study|Adverse Event|5|||
143108950|NCT00688701|515939708|FG003|Overall Study|Adverse Event|3|||
143108951|NCT00688701|515939705|FG000|Overall Study|Lack of Efficacy|0|||
143108952|NCT00688701|515939706|FG001|Overall Study|Lack of Efficacy|1|||
143108953|NCT00688701|515939707|FG002|Overall Study|Lack of Efficacy|0|||
143108954|NCT00688701|515939708|FG003|Overall Study|Lack of Efficacy|0|||
143108955|NCT00688701|515939705|FG000|Overall Study|Withdrawal by Subject|3|||
143108956|NCT00688701|515939706|FG001|Overall Study|Withdrawal by Subject|3|||
143108957|NCT00688701|515939707|FG002|Overall Study|Withdrawal by Subject|4|||
143108958|NCT00688701|515939708|FG003|Overall Study|Withdrawal by Subject|8|||
143108959|NCT00688701|515939705|FG000|Overall Study|Poor compliance to protocol|0|||
143108960|NCT00688701|515939706|FG001|Overall Study|Poor compliance to protocol|1|||
143108961|NCT00688701|515939707|FG002|Overall Study|Poor compliance to protocol|1|||
143108962|NCT00688701|515939708|FG003|Overall Study|Poor compliance to protocol|0|||
143108963|NCT01275755|515939714|FG000|Double-blind Treatment Period|Adverse Event|0|||
143108964|NCT01275755|515939715|FG001|Double-blind Treatment Period|Adverse Event|2|||
143108965|NCT01275755|515939714|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
143108966|NCT01275755|515939715|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
143108967|NCT01275755|515939714|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
143108968|NCT01275755|515939715|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
143108969|NCT01275755|515939714|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
143108970|NCT01275755|515939715|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
143108971|NCT04420585|515939716|FG000|Overall Study|Adverse Event|1|||
143108972|NCT04420585|515939716|FG000|Overall Study|Never initiated medication|2|||
143108973|NCT00601172|515939717|FG000|Overall Study|Adverse Event|43|||
143108974|NCT00601172|515939718|FG001|Overall Study|Adverse Event|32|||
143108975|NCT00601172|515939717|FG000|Overall Study|Lack of Efficacy|11|||
143108976|NCT00601172|515939718|FG001|Overall Study|Lack of Efficacy|12|||
143108977|NCT00601172|515939717|FG000|Overall Study|Protocol Violation|2|||
143108978|NCT00601172|515939718|FG001|Overall Study|Protocol Violation|5|||
143108979|NCT00601172|515939717|FG000|Overall Study|Lost to Follow-up|4|||
143108980|NCT00601172|515939718|FG001|Overall Study|Lost to Follow-up|3|||
143108981|NCT00601172|515939717|FG000|Overall Study|Physician Decision|27|||
143108982|NCT00601172|515939718|FG001|Overall Study|Physician Decision|28|||
143108983|NCT00601172|515939717|FG000|Overall Study|Withdrawal by Subject|35|||
143108984|NCT00601172|515939718|FG001|Overall Study|Withdrawal by Subject|27|||
143108985|NCT00601172|515939717|FG000|Overall Study|Did not meet continuation criteria|19|||
143108986|NCT00601172|515939718|FG001|Overall Study|Did not meet continuation criteria|20|||
143108987|NCT03917472|515939722|FG000|Overall Study|Physician Decision|4|||
143108988|NCT03917472|515939723|FG001|Overall Study|Physician Decision|0|||
143257294|NCT01284491|516494025|FG000|Overall Study|Study termination|13|||
143257295|NCT01894568|516494040|FG000|Overall Study|Adverse Event|2|||
143257296|NCT01894568|516494041|FG001|Overall Study|Adverse Event|3|||
143257297|NCT01894568|516494040|FG000|Overall Study|Protocol required discontinuation|2|||
143257298|NCT01894568|516494041|FG001|Overall Study|Protocol required discontinuation|1|||
143257299|NCT01894568|516494040|FG000|Overall Study|Withdrawal by Subject|5|||
143257300|NCT01894568|516494041|FG001|Overall Study|Withdrawal by Subject|5|||
143257301|NCT01894568|516494040|FG000|Overall Study|Physician Decision|1|||
143257302|NCT01894568|516494041|FG001|Overall Study|Physician Decision|0|||
143257303|NCT01894568|516494040|FG000|Overall Study|Lost to Follow-up|0|||
143257304|NCT01894568|516494041|FG001|Overall Study|Lost to Follow-up|1|||
143257305|NCT02055365|516495751|FG000|Overall Study|Prematurely Withdrawn|1|||
143257306|NCT00336583|516495753|FG000|Overall Study|Lost to Follow-up|1|||
143257307|NCT00336583|516495753|FG000|Overall Study|Death|1|||
143257308|NCT01264081|516495754|FG000|Participants Screened|Screening failures|30|||
143257309|NCT01264081|516495754|FG000|Started Treatment|Withdrawal by Subject|1|||
143257310|NCT01264081|516495754|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
143257311|NCT02716896|516495755|FG000|Overall Study|Physician Decision|0|||
143257312|NCT02716896|516495756|FG001|Overall Study|Physician Decision|1|||
143108989|NCT03917472|515939722|FG000|Overall Study|Adverse Event|3|||
143108990|NCT03917472|515939723|FG001|Overall Study|Adverse Event|1|||
143108991|NCT03917472|515939722|FG000|Overall Study|Death|7|||
143108992|NCT03917472|515939723|FG001|Overall Study|Death|5|||
143108993|NCT03917472|515939722|FG000|Overall Study|Withdrawal by Subject|11|||
143108994|NCT03917472|515939723|FG001|Overall Study|Withdrawal by Subject|4|||
143108995|NCT03917472|515939722|FG000|Overall Study|Lost to Follow-up|10|||
143108996|NCT03917472|515939723|FG001|Overall Study|Lost to Follow-up|5|||
143108997|NCT01154296|515939732|FG000|Randomization and Intervention|Decided to decline|1|||
143108998|NCT01154296|515939733|FG001|Randomization and Intervention|Decided to decline|1|||
143108999|NCT01154296|515939732|FG000|Randomization and Intervention|Declined by staff|1|||
143109000|NCT01154296|515939733|FG001|Randomization and Intervention|Declined by staff|0|||
143257313|NCT01727700|516495757|FG000|Overall Study|Adverse Event|0|||
143257314|NCT01727700|516495758|FG001|Overall Study|Adverse Event|7|||
143257315|NCT01727700|516495759|FG002|Overall Study|Adverse Event|1|||
143257316|NCT01727700|516495757|FG000|Overall Study|Particpant withdrew consent|0|||
143109001|NCT01154296|515939732|FG000|Randomization and Intervention|Did not return|1|||
143109002|NCT01154296|515939733|FG001|Randomization and Intervention|Did not return|0|||
143109003|NCT01154296|515939732|FG000|Randomization and Intervention|Left before test|0|||
143109004|NCT01154296|515939733|FG001|Randomization and Intervention|Left before test|1|||
143109005|NCT01154296|515939732|FG000|Randomization and Intervention|Left clinic early|2|||
143109006|NCT01154296|515939733|FG001|Randomization and Intervention|Left clinic early|0|||
143109007|NCT01154296|515939732|FG000|6-month Follow-up|Lost contact|269|||
143109008|NCT01154296|515939733|FG001|6-month Follow-up|Lost contact|275|||
143109009|NCT01154296|515939732|FG000|6-month Follow-up|Incarcerated|37|||
143109010|NCT01154296|515939733|FG001|6-month Follow-up|Incarcerated|32|||
143109011|NCT01154296|515939732|FG000|6-month Follow-up|Withdrew consent|14|||
143109012|NCT01154296|515939733|FG001|6-month Follow-up|Withdrew consent|15|||
143109013|NCT01154296|515939732|FG000|6-month Follow-up|Death|3|||
143109014|NCT01154296|515939733|FG001|6-month Follow-up|Death|2|||
143109015|NCT01154296|515939732|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
143109016|NCT01154296|515939733|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
143109017|NCT04310397|515939734|FG000|Overall Study|Lack of Efficacy|3|||
143109018|NCT04310397|515939734|FG000|Overall Study|Withdrawal by Subject|1|||
143109019|NCT01936181|515939740|FG000|Randomised, Double-blind|Adverse Event|27|||
143109020|NCT01936181|515939741|FG001|Randomised, Double-blind|Adverse Event|21|||
143109021|NCT01936181|515939742|FG002|Randomised, Double-blind|Adverse Event|0|||
143109022|NCT01936181|515939743|FG003|Randomised, Double-blind|Adverse Event|0|||
143109023|NCT01936181|515939740|FG000|Randomised, Double-blind|Protocol Violation|1|||
143109024|NCT01936181|515939741|FG001|Randomised, Double-blind|Protocol Violation|5|||
143109025|NCT01936181|515939742|FG002|Randomised, Double-blind|Protocol Violation|0|||
143109026|NCT01936181|515939743|FG003|Randomised, Double-blind|Protocol Violation|0|||
143109027|NCT01936181|515939740|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
143109028|NCT01936181|515939741|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
143109029|NCT01936181|515939742|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
143109030|NCT01936181|515939743|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
143109031|NCT01936181|515939740|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
143109032|NCT01936181|515939741|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
143109033|NCT01936181|515939742|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
143109034|NCT01936181|515939743|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
143109035|NCT01936181|515939740|FG000|Randomised, Double-blind|Pregnancy|0|||
143109036|NCT01936181|515939741|FG001|Randomised, Double-blind|Pregnancy|1|||
143109037|NCT01936181|515939742|FG002|Randomised, Double-blind|Pregnancy|0|||
143109038|NCT01936181|515939743|FG003|Randomised, Double-blind|Pregnancy|0|||
143109039|NCT01936181|515939740|FG000|Randomised, Double-blind|Physician Decision|4|||
143109040|NCT01936181|515939741|FG001|Randomised, Double-blind|Physician Decision|4|||
143109041|NCT01936181|515939742|FG002|Randomised, Double-blind|Physician Decision|0|||
143109042|NCT01936181|515939743|FG003|Randomised, Double-blind|Physician Decision|0|||
143109043|NCT01936181|515939740|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
143109044|NCT01936181|515939741|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
143109045|NCT01936181|515939742|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
143109046|NCT01936181|515939743|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
143109047|NCT01936181|515939740|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
143109048|NCT01936181|515939741|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
143109049|NCT01936181|515939742|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
143109050|NCT01936181|515939743|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
143109051|NCT01936181|515939740|FG000|Transition-extension|Adverse Event|3|||
143109052|NCT01936181|515939741|FG001|Transition-extension|Adverse Event|0|||
143109053|NCT01936181|515939742|FG002|Transition-extension|Adverse Event|3|||
143109054|NCT01936181|515939743|FG003|Transition-extension|Adverse Event|1|||
143109055|NCT01936181|515939740|FG000|Transition-extension|Lost to Follow-up|3|||
143109056|NCT01936181|515939741|FG001|Transition-extension|Lost to Follow-up|0|||
143109057|NCT01936181|515939742|FG002|Transition-extension|Lost to Follow-up|1|||
143109058|NCT01936181|515939743|FG003|Transition-extension|Lost to Follow-up|2|||
143109059|NCT01936181|515939740|FG000|Transition-extension|Physician Decision|2|||
143109060|NCT01936181|515939741|FG001|Transition-extension|Physician Decision|0|||
143109061|NCT01936181|515939742|FG002|Transition-extension|Physician Decision|0|||
143109062|NCT01936181|515939743|FG003|Transition-extension|Physician Decision|1|||
143109063|NCT01936181|515939740|FG000|Transition-extension|Withdrawal by Subject|7|||
143109064|NCT01936181|515939741|FG001|Transition-extension|Withdrawal by Subject|0|||
143109065|NCT01936181|515939742|FG002|Transition-extension|Withdrawal by Subject|2|||
143179317|NCT00127855|516203683|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
143179318|NCT00127855|516203679|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
143179319|NCT00127855|516203680|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
143179320|NCT00127855|516203681|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
143179321|NCT00127855|516203682|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
143179322|NCT00127855|516203683|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
143179323|NCT00127855|516203679|FG000|Primary Vaccination Course|Other|0|||
143109066|NCT01936181|515939743|FG003|Transition-extension|Withdrawal by Subject|1|||
143109067|NCT03320850|515939746|FG000|Overall Study|Lost to Follow-up|0|||
143109068|NCT03320850|515939747|FG001|Overall Study|Lost to Follow-up|0|||
143109069|NCT03320850|515939748|FG002|Overall Study|Lost to Follow-up|0|||
143109070|NCT03320850|515939749|FG003|Overall Study|Lost to Follow-up|0|||
143109071|NCT03320850|515939750|FG004|Overall Study|Lost to Follow-up|1|||
143109072|NCT03320850|515939751|FG005|Overall Study|Lost to Follow-up|2|||
143109073|NCT03320850|515939752|FG006|Overall Study|Lost to Follow-up|2|||
143109074|NCT03320850|515939753|FG007|Overall Study|Lost to Follow-up|0|||
143109075|NCT03320850|515939754|FG008|Overall Study|Lost to Follow-up|6|||
143109076|NCT03320850|515939755|FG009|Overall Study|Lost to Follow-up|4|||
143109077|NCT03320850|515939746|FG000|Overall Study|Withdrawal by Subject|0|||
143109078|NCT03320850|515939747|FG001|Overall Study|Withdrawal by Subject|0|||
143109079|NCT03320850|515939748|FG002|Overall Study|Withdrawal by Subject|0|||
143109080|NCT03320850|515939749|FG003|Overall Study|Withdrawal by Subject|0|||
143109081|NCT03320850|515939750|FG004|Overall Study|Withdrawal by Subject|1|||
143109082|NCT03320850|515939751|FG005|Overall Study|Withdrawal by Subject|2|||
143109083|NCT03320850|515939752|FG006|Overall Study|Withdrawal by Subject|4|||
143109084|NCT03320850|515939753|FG007|Overall Study|Withdrawal by Subject|5|||
143109085|NCT03320850|515939754|FG008|Overall Study|Withdrawal by Subject|2|||
143109086|NCT03320850|515939755|FG009|Overall Study|Withdrawal by Subject|1|||
143109087|NCT03320850|515939746|FG000|Overall Study|Lack of Efficacy|0|||
143109088|NCT03320850|515939747|FG001|Overall Study|Lack of Efficacy|0|||
143109089|NCT03320850|515939748|FG002|Overall Study|Lack of Efficacy|0|||
143109090|NCT03320850|515939749|FG003|Overall Study|Lack of Efficacy|1|||
143109091|NCT03320850|515939750|FG004|Overall Study|Lack of Efficacy|0|||
143109092|NCT03320850|515939751|FG005|Overall Study|Lack of Efficacy|1|||
143109093|NCT03320850|515939752|FG006|Overall Study|Lack of Efficacy|0|||
143109094|NCT03320850|515939753|FG007|Overall Study|Lack of Efficacy|2|||
143109095|NCT03320850|515939754|FG008|Overall Study|Lack of Efficacy|0|||
143109096|NCT03320850|515939755|FG009|Overall Study|Lack of Efficacy|3|||
143109097|NCT03320850|515939746|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
143109098|NCT03320850|515939747|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
143109099|NCT03320850|515939748|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
143109100|NCT03320850|515939749|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
143109101|NCT03320850|515939750|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
143109102|NCT03320850|515939751|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
143109103|NCT03320850|515939752|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
143109104|NCT03320850|515939753|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
143109105|NCT03320850|515939754|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
143109106|NCT03320850|515939755|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
143109107|NCT03320850|515939746|FG000|Overall Study|Adverse Event|0|||
143109108|NCT03320850|515939747|FG001|Overall Study|Adverse Event|0|||
143109109|NCT03320850|515939748|FG002|Overall Study|Adverse Event|0|||
143109110|NCT03320850|515939749|FG003|Overall Study|Adverse Event|0|||
143109111|NCT03320850|515939750|FG004|Overall Study|Adverse Event|0|||
143109112|NCT03320850|515939751|FG005|Overall Study|Adverse Event|2|||
143109113|NCT03320850|515939752|FG006|Overall Study|Adverse Event|1|||
143109114|NCT03320850|515939753|FG007|Overall Study|Adverse Event|0|||
143109115|NCT03320850|515939754|FG008|Overall Study|Adverse Event|2|||
143109116|NCT03320850|515939755|FG009|Overall Study|Adverse Event|0|||
143109117|NCT03320850|515939746|FG000|Overall Study|Reason Not Specified|0|||
143109118|NCT03320850|515939747|FG001|Overall Study|Reason Not Specified|0|||
143109119|NCT03320850|515939748|FG002|Overall Study|Reason Not Specified|0|||
143109120|NCT03320850|515939749|FG003|Overall Study|Reason Not Specified|0|||
143109121|NCT03320850|515939750|FG004|Overall Study|Reason Not Specified|0|||
143109122|NCT03320850|515939751|FG005|Overall Study|Reason Not Specified|1|||
143109123|NCT03320850|515939752|FG006|Overall Study|Reason Not Specified|0|||
143109124|NCT03320850|515939753|FG007|Overall Study|Reason Not Specified|0|||
143109125|NCT03320850|515939754|FG008|Overall Study|Reason Not Specified|0|||
143109126|NCT03320850|515939755|FG009|Overall Study|Reason Not Specified|1|||
143109127|NCT04598451|515939756|FG000|Overall Study|Adverse Event|3|||
143109128|NCT04598451|515939757|FG001|Overall Study|Adverse Event|2|||
143109129|NCT04598451|515939756|FG000|Overall Study|Withdrawal by Subject|3|||
143109130|NCT04598451|515939757|FG001|Overall Study|Withdrawal by Subject|7|||
143109131|NCT04598451|515939756|FG000|Overall Study|Lost to Follow-up|2|||
143109132|NCT04598451|515939757|FG001|Overall Study|Lost to Follow-up|0|||
143109133|NCT04598451|515939756|FG000|Overall Study|Physician Decision|4|||
143257317|NCT01727700|516495758|FG001|Overall Study|Particpant withdrew consent|3|||
143109134|NCT04598451|515939757|FG001|Overall Study|Physician Decision|1|||
143109135|NCT04598451|515939756|FG000|Overall Study|Requires Prohibited Medication|1|||
143109136|NCT04598451|515939757|FG001|Overall Study|Requires Prohibited Medication|0|||
143109137|NCT04598451|515939756|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
143109138|NCT04598451|515939757|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
143109139|NCT02653170|515939758|FG000|Overall Study|Withdrawal by Subject|3|||
143117390|NCT01313221|515971828|FG002|Overall Study|Physician Decision|2|||
143257318|NCT01727700|516495759|FG002|Overall Study|Particpant withdrew consent|1|||
143257319|NCT01727700|516495757|FG000|Overall Study|Protocol Violation|2|||
143257320|NCT01727700|516495758|FG001|Overall Study|Protocol Violation|0|||
143257321|NCT01727700|516495759|FG002|Overall Study|Protocol Violation|0|||
143257322|NCT02054481|516495760|FG000|Overall Study|Adverse Event|1|||
143257323|NCT02054481|516495761|FG001|Overall Study|Adverse Event|1|||
143257324|NCT02054481|516495762|FG002|Overall Study|Adverse Event|0|||
143257325|NCT02054481|516495763|FG003|Overall Study|Adverse Event|1|||
143257326|NCT02054481|516495760|FG000|Overall Study|Lost to Follow-up|1|||
143257327|NCT02054481|516495761|FG001|Overall Study|Lost to Follow-up|0|||
143257328|NCT02054481|516495762|FG002|Overall Study|Lost to Follow-up|0|||
143257329|NCT02054481|516495763|FG003|Overall Study|Lost to Follow-up|0|||
143257330|NCT02054481|516495760|FG000|Overall Study|Other reason|2|||
143257331|NCT02054481|516495761|FG001|Overall Study|Other reason|1|||
143257332|NCT02054481|516495762|FG002|Overall Study|Other reason|2|||
143257333|NCT02054481|516495763|FG003|Overall Study|Other reason|0|||
143257334|NCT02320903|516495764|FG000|Overall Study|Withdrawal by Subject|0|||
143257335|NCT02320903|516495765|FG001|Overall Study|Withdrawal by Subject|9|||
143257336|NCT02320903|516495766|FG002|Overall Study|Withdrawal by Subject|9|||
143257337|NCT02320903|516495764|FG000|Overall Study|Exited therapy; no longer eligible|8|||
143257338|NCT02320903|516495765|FG001|Overall Study|Exited therapy; no longer eligible|2|||
143257339|NCT02320903|516495766|FG002|Overall Study|Exited therapy; no longer eligible|2|||
143257340|NCT02320903|516495764|FG000|Overall Study|Lost to Follow-up|0|||
143257341|NCT02320903|516495765|FG001|Overall Study|Lost to Follow-up|5|||
143257342|NCT02320903|516495766|FG002|Overall Study|Lost to Follow-up|5|||
143257343|NCT02278471|516495769|FG000|Overall Study|Lost to Follow-up|6|||
143257344|NCT02278471|516495770|FG001|Overall Study|Lost to Follow-up|15|||
143257345|NCT02278471|516495769|FG000|Overall Study|Death|2|||
143257346|NCT02278471|516495770|FG001|Overall Study|Death|2|||
143257347|NCT02278471|516495769|FG000|Overall Study|Withdrawal by Subject|0|||
143257348|NCT02278471|516495770|FG001|Overall Study|Withdrawal by Subject|3|||
143257349|NCT00640835|516495771|FG000|Overall Study|Adverse Event|5|||
143257350|NCT00640835|516495772|FG001|Overall Study|Adverse Event|3|||
143257351|NCT00640835|516495771|FG000|Overall Study|Withdrawal by Subject|12|||
143257352|NCT00640835|516495772|FG001|Overall Study|Withdrawal by Subject|14|||
143257353|NCT00640835|516495771|FG000|Overall Study|Physician Decision|10|||
143257354|NCT00640835|516495772|FG001|Overall Study|Physician Decision|14|||
143257355|NCT00640835|516495771|FG000|Overall Study|Sponsor's Decision|11|||
143257356|NCT00640835|516495772|FG001|Overall Study|Sponsor's Decision|7|||
143257357|NCT00640835|516495771|FG000|Overall Study|Protocol Violation|2|||
143257358|NCT00640835|516495772|FG001|Overall Study|Protocol Violation|2|||
143257359|NCT00640835|516495771|FG000|Overall Study|Lost to Follow-up|17|||
143257360|NCT00640835|516495772|FG001|Overall Study|Lost to Follow-up|13|||
143257361|NCT00640835|516495771|FG000|Overall Study|Other Reason|19|||
143257362|NCT00640835|516495772|FG001|Overall Study|Other Reason|4|||
143257363|NCT01437995|516495773|FG000|Overall Study|Lost to Follow-up|11|||
143257364|NCT01437995|516495774|FG001|Overall Study|Lost to Follow-up|18|||
143257365|NCT01437995|516495775|FG002|Overall Study|Lost to Follow-up|20|||
143257366|NCT03874429|516495776|FG000|Overall Study|Adverse Event|2|||
143257367|NCT03874429|516495777|FG001|Overall Study|Adverse Event|2|||
143257368|NCT03874429|516495776|FG000|Overall Study|Lack of Efficacy|0|||
143257369|NCT03874429|516495777|FG001|Overall Study|Lack of Efficacy|1|||
143257370|NCT03874429|516495776|FG000|Overall Study|Covid-19 pandemic|4|||
143257371|NCT03874429|516495777|FG001|Overall Study|Covid-19 pandemic|2|||
143257372|NCT00775203|516495778|FG000|Overall Study|Adverse Event|25|||
143257373|NCT00775203|516495779|FG001|Overall Study|Adverse Event|6|||
143368063|NCT03102710|516890878|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
143257374|NCT00775203|516495778|FG000|Overall Study|Lack of Efficacy|8|||
143257375|NCT00775203|516495779|FG001|Overall Study|Lack of Efficacy|9|||
143257376|NCT00775203|516495778|FG000|Overall Study|Withdrawal by Subject|11|||
143257377|NCT00775203|516495779|FG001|Overall Study|Withdrawal by Subject|9|||
143257378|NCT00775203|516495778|FG000|Overall Study|Lost to Follow-up|11|||
143257379|NCT00775203|516495779|FG001|Overall Study|Lost to Follow-up|15|||
143257380|NCT00775203|516495778|FG000|Overall Study|Administrative reason|2|||
143257381|NCT00775203|516495779|FG001|Overall Study|Administrative reason|0|||
143257382|NCT00775203|516495778|FG000|Overall Study|Noncompliance|4|||
143257383|NCT00775203|516495779|FG001|Overall Study|Noncompliance|2|||
143368064|NCT03102710|516890879|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
143368065|NCT03102710|516890877|FG000|Overall Study|Technical issues during final MRI scan|0|||
143368066|NCT03102710|516890878|FG001|Overall Study|Technical issues during final MRI scan|1|||
143368067|NCT03102710|516890879|FG002|Overall Study|Technical issues during final MRI scan|0|||
143368068|NCT03102710|516890877|FG000|Overall Study|Nausea during MRI scan|0|||
143368069|NCT03102710|516890878|FG001|Overall Study|Nausea during MRI scan|1|||
143368070|NCT03102710|516890879|FG002|Overall Study|Nausea during MRI scan|0|||
143368071|NCT03102710|516890877|FG000|Overall Study|Subject unable to attend final session|0|||
143368072|NCT03102710|516890878|FG001|Overall Study|Subject unable to attend final session|1|||
143368073|NCT03102710|516890879|FG002|Overall Study|Subject unable to attend final session|0|||
143368074|NCT04012853|516890880|FG000|Overall Study|Withdrawal by Subject|1|||
143368075|NCT04012853|516890881|FG001|Overall Study|Withdrawal by Subject|1|||
143368076|NCT04012853|516890880|FG000|Overall Study|Protocol Violation|1|||
143368077|NCT04012853|516890881|FG001|Overall Study|Protocol Violation|0|||
143368078|NCT04012853|516890880|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
143368079|NCT04012853|516890881|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
143368080|NCT04304534|516890882|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
143368081|NCT04304534|516890883|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
143257384|NCT00775203|516495778|FG000|Overall Study|Protocol Violation|0|||
143257385|NCT00775203|516495779|FG001|Overall Study|Protocol Violation|1|||
143257386|NCT00775203|516495778|FG000|Overall Study|Entered other study|1|||
143257387|NCT00775203|516495779|FG001|Overall Study|Entered other study|0|||
143257388|NCT00775203|516495778|FG000|Overall Study|Physician Decision|0|||
143257389|NCT00775203|516495779|FG001|Overall Study|Physician Decision|1|||
143257390|NCT04896229|516495781|FG000|Overall Study|Lost to Follow-up|113|||
143257391|NCT04896229|516495782|FG001|Overall Study|Lost to Follow-up|113|||
143368082|NCT04304534|516890884|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
143368083|NCT04304534|516890885|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
143368084|NCT04304534|516890882|FG000|Overall Study|Non-Compliance with study drug|0|||
143368085|NCT04304534|516890883|FG001|Overall Study|Non-Compliance with study drug|1|||
143368086|NCT04304534|516890884|FG002|Overall Study|Non-Compliance with study drug|1|||
143109140|NCT02653170|515939759|FG001|Overall Study|Withdrawal by Subject|8|||
143109141|NCT02653170|515939760|FG002|Overall Study|Withdrawal by Subject|3|||
143109142|NCT02653170|515939758|FG000|Overall Study|withdrawn by study team|2|||
143109143|NCT02653170|515939759|FG001|Overall Study|withdrawn by study team|4|||
143109144|NCT02653170|515939760|FG002|Overall Study|withdrawn by study team|5|||
143109145|NCT02653170|515939758|FG000|Overall Study|Lost to Follow-up|12|||
143109146|NCT02653170|515939759|FG001|Overall Study|Lost to Follow-up|4|||
143109147|NCT02653170|515939760|FG002|Overall Study|Lost to Follow-up|10|||
143109148|NCT02086448|515939761|FG000|Overall Study|Withdrawal by Subject|1|||
143257392|NCT04418661|516495783|FG000|Overall Study|Adverse Event|0|||
143368087|NCT04304534|516890885|FG003|Overall Study|Non-Compliance with study drug|1|||
143368088|NCT04304534|516890882|FG000|Overall Study|Lost to Follow-up|0|||
143257393|NCT04418661|516495784|FG001|Overall Study|Adverse Event|1|||
143368089|NCT04304534|516890883|FG001|Overall Study|Lost to Follow-up|1|||
143368090|NCT04304534|516890884|FG002|Overall Study|Lost to Follow-up|2|||
143368091|NCT04304534|516890885|FG003|Overall Study|Lost to Follow-up|3|||
143368092|NCT04304534|516890882|FG000|Overall Study|Unspecific|4|||
143368093|NCT04304534|516890883|FG001|Overall Study|Unspecific|2|||
143368094|NCT04304534|516890884|FG002|Overall Study|Unspecific|2|||
143368095|NCT04304534|516890885|FG003|Overall Study|Unspecific|2|||
143368096|NCT04304534|516890882|FG000|Overall Study|Technical Problems|2|||
143368097|NCT04304534|516890883|FG001|Overall Study|Technical Problems|2|||
143368098|NCT04304534|516890884|FG002|Overall Study|Technical Problems|3|||
143368099|NCT04304534|516890885|FG003|Overall Study|Technical Problems|4|||
143368100|NCT04304534|516890882|FG000|Overall Study|Death|7|||
143179324|NCT00127855|516203680|FG001|Primary Vaccination Course|Other|0|||
143368101|NCT04304534|516890883|FG001|Overall Study|Death|2|||
143179325|NCT00127855|516203681|FG002|Primary Vaccination Course|Other|0|||
143179326|NCT00127855|516203682|FG003|Primary Vaccination Course|Other|0|||
143179327|NCT00127855|516203683|FG004|Primary Vaccination Course|Other|1|||
143179328|NCT02343302|516203684|FG000|Overall Study|Physician Decision|1|||
143179329|NCT02343302|516203685|FG001|Overall Study|Physician Decision|1|||
143179330|NCT01887717|516203686|FG000|Overall Study|Withdrawal by Subject|1|||
143179331|NCT01887717|516203687|FG001|Overall Study|Withdrawal by Subject|7|||
143179332|NCT01887717|516203686|FG000|Overall Study|Physician Decision|0|||
143179333|NCT01887717|516203687|FG001|Overall Study|Physician Decision|2|||
143179334|NCT01887717|516203686|FG000|Overall Study|Administrative reasons|5|||
143179335|NCT01887717|516203687|FG001|Overall Study|Administrative reasons|2|||
143179336|NCT02655887|516203688|FG000|Overall Study|Lost to Follow-up|3|||
143179337|NCT02655887|516203688|FG000|Overall Study|Death|4|||
143179338|NCT02655887|516203688|FG000|Overall Study|Withdrawal by Subject|3|||
143179339|NCT02655887|516203688|FG000|Overall Study|Missed 12-month follow-up visit|4|||
143179340|NCT02834819|516203689|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
143179341|NCT02834819|516203690|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
143179342|NCT04245709|516203691|FG000|Overall Study|Adverse Event|13|||
143179343|NCT04245709|516203691|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
143179344|NCT00889707|516203692|FG000|Overall Study|Adverse Event|1|||
143179345|NCT00889707|516203693|FG001|Overall Study|Adverse Event|0|||
143179346|NCT00889707|516203692|FG000|Overall Study|Withdrawal by Subject|4|||
143179347|NCT00889707|516203693|FG001|Overall Study|Withdrawal by Subject|3|||
143179348|NCT00889707|516203692|FG000|Overall Study|Lost to Follow-up|0|||
143179349|NCT00889707|516203693|FG001|Overall Study|Lost to Follow-up|2|||
143179350|NCT00889707|516203692|FG000|Overall Study|Lack of Efficacy|2|||
143179351|NCT00889707|516203693|FG001|Overall Study|Lack of Efficacy|5|||
143179352|NCT02389465|516203694|FG000|Overall Study|Lost to Follow-up|1|||
143179353|NCT02389465|516203695|FG001|Overall Study|Lost to Follow-up|3|||
143179354|NCT02389465|516203696|FG002|Overall Study|Lost to Follow-up|3|||
143179355|NCT02389465|516203697|FG003|Overall Study|Lost to Follow-up|0|||
143179356|NCT02389465|516203694|FG000|Overall Study|Physician Decision|0|||
143179357|NCT02389465|516203695|FG001|Overall Study|Physician Decision|0|||
143179358|NCT02389465|516203696|FG002|Overall Study|Physician Decision|0|||
143179359|NCT02389465|516203697|FG003|Overall Study|Physician Decision|1|||
143179360|NCT02389465|516203694|FG000|Overall Study|Withdrawal by Subject|0|||
143179361|NCT02389465|516203695|FG001|Overall Study|Withdrawal by Subject|1|||
143179362|NCT02389465|516203696|FG002|Overall Study|Withdrawal by Subject|2|||
143179363|NCT02389465|516203697|FG003|Overall Study|Withdrawal by Subject|2|||
143179364|NCT04419467|516203698|FG000|Overall Study|Not treated with IP|0|||
143179365|NCT04419467|516203699|FG001|Overall Study|Not treated with IP|0|||
143179366|NCT04419467|516203700|FG002|Overall Study|Not treated with IP|2|||
143179367|NCT04419467|516203698|FG000|Overall Study|Adverse Event|0|||
143179368|NCT04419467|516203699|FG001|Overall Study|Adverse Event|2|||
143179369|NCT04419467|516203700|FG002|Overall Study|Adverse Event|0|||
143179370|NCT04419467|516203698|FG000|Overall Study|Death|1|||
143179371|NCT04419467|516203699|FG001|Overall Study|Death|0|||
143179372|NCT04419467|516203700|FG002|Overall Study|Death|0|||
143179373|NCT04419467|516203698|FG000|Overall Study|Lost to Follow-up|0|||
143179374|NCT04419467|516203699|FG001|Overall Study|Lost to Follow-up|1|||
143179375|NCT04419467|516203700|FG002|Overall Study|Lost to Follow-up|2|||
143179376|NCT04419467|516203698|FG000|Overall Study|Withdrawal by Subject|0|||
143179377|NCT04419467|516203699|FG001|Overall Study|Withdrawal by Subject|0|||
143179378|NCT04419467|516203700|FG002|Overall Study|Withdrawal by Subject|4|||
143179379|NCT04419467|516203698|FG000|Overall Study|Pandemic related|0|||
143179380|NCT04419467|516203699|FG001|Overall Study|Pandemic related|0|||
143179381|NCT04419467|516203700|FG002|Overall Study|Pandemic related|1|||
143368102|NCT04304534|516890884|FG002|Overall Study|Death|4|||
143179382|NCT04419467|516203698|FG000|Overall Study|Reason not known|1|||
143179383|NCT04419467|516203699|FG001|Overall Study|Reason not known|0|||
143179384|NCT04419467|516203700|FG002|Overall Study|Reason not known|0|||
143179385|NCT00003631|516203702|FG000|Overall Study|Patient not treated|1|||
143368103|NCT04304534|516890885|FG003|Overall Study|Death|3|||
143109149|NCT02086448|515939762|FG001|Overall Study|Withdrawal by Subject|0|||
143109150|NCT02086448|515939763|FG002|Overall Study|Withdrawal by Subject|0|||
143109151|NCT02086448|515939764|FG003|Overall Study|Withdrawal by Subject|2|||
143109152|NCT00976820|515939769|FG000|Overall Study|Lost to Follow-up|5|||
143109153|NCT00976820|515939770|FG001|Overall Study|Lost to Follow-up|16|||
143109154|NCT00976820|515939771|FG002|Overall Study|Lost to Follow-up|2|||
143109155|NCT00976820|515939772|FG003|Overall Study|Lost to Follow-up|3|||
143109156|NCT00976820|515939769|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
143109157|NCT00976820|515939770|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
143109158|NCT00976820|515939771|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
143109159|NCT00976820|515939772|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
143109160|NCT00976820|515939769|FG000|Overall Study|Withdrawal by Subject|2|||
143109161|NCT00976820|515939770|FG001|Overall Study|Withdrawal by Subject|4|||
143109162|NCT00976820|515939771|FG002|Overall Study|Withdrawal by Subject|1|||
143109163|NCT00976820|515939772|FG003|Overall Study|Withdrawal by Subject|4|||
143109164|NCT00507819|515939775|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
143109165|NCT00507819|515939776|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
143109166|NCT00631410|515939781|FG000|Overall Study|Adverse Event|1|||
143109167|NCT00631410|515939782|FG001|Overall Study|Adverse Event|3|||
143109168|NCT00631410|515939781|FG000|Overall Study|Objective Progression or Relapse|4|||
143109169|NCT00631410|515939782|FG001|Overall Study|Objective Progression or Relapse|3|||
143109170|NCT00631410|515939781|FG000|Overall Study|Surgery|1|||
143109171|NCT00631410|515939782|FG001|Overall Study|Surgery|0|||
143109172|NCT00782184|515939789|FG000|Overall Study|Adverse Event|1|||
143109173|NCT00782184|515939790|FG001|Overall Study|Adverse Event|2|||
143109174|NCT00782184|515939789|FG000|Overall Study|Protocol Violation|0|||
143109175|NCT00782184|515939790|FG001|Overall Study|Protocol Violation|1|||
143109176|NCT00782184|515939789|FG000|Overall Study|Withdrawal by Subject|3|||
143109177|NCT00782184|515939790|FG001|Overall Study|Withdrawal by Subject|2|||
143109178|NCT01075646|515939794|FG000|Overall Study|Lost to Follow-up|4|||
143109179|NCT01075646|515939795|FG001|Overall Study|Lost to Follow-up|3|||
143109180|NCT01075646|515939796|FG002|Overall Study|Lost to Follow-up|1|||
143109181|NCT01075646|515939797|FG003|Overall Study|Lost to Follow-up|2|||
143109182|NCT01676896|515939798|FG000|Overall Study|Withdrawal by Subject|12|||
143109183|NCT01676896|515939799|FG001|Overall Study|Withdrawal by Subject|7|||
143109184|NCT01676896|515939800|FG002|Overall Study|Withdrawal by Subject|19|||
143109185|NCT01647516|515939801|FG000|Induction Period (IP)|Physician Decision|2|||
143109186|NCT01647516|515939802|FG001|Induction Period (IP)|Physician Decision|0|||
143109187|NCT01647516|515939803|FG002|Induction Period (IP)|Physician Decision|0|||
143109188|NCT01647516|515939804|FG003|Induction Period (IP)|Physician Decision|0|||
143109189|NCT01647516|515939805|FG004|Induction Period (IP)|Physician Decision|0|||
143109190|NCT01647516|515939806|FG005|Induction Period (IP)|Physician Decision|0|||
143109191|NCT01647516|515939801|FG000|Induction Period (IP)|Adverse Event|1|||
143109192|NCT01647516|515939802|FG001|Induction Period (IP)|Adverse Event|2|||
143109193|NCT01647516|515939803|FG002|Induction Period (IP)|Adverse Event|0|||
143109194|NCT01647516|515939804|FG003|Induction Period (IP)|Adverse Event|0|||
143109195|NCT01647516|515939805|FG004|Induction Period (IP)|Adverse Event|0|||
143109196|NCT01647516|515939806|FG005|Induction Period (IP)|Adverse Event|0|||
143109197|NCT01647516|515939801|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
143109198|NCT01647516|515939802|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
143109199|NCT01647516|515939803|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
143109200|NCT01647516|515939804|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
143109201|NCT01647516|515939805|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
143109202|NCT01647516|515939806|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
143109203|NCT01647516|515939801|FG000|Induction Period (IP)|Participant Choice|0|||
143109204|NCT01647516|515939802|FG001|Induction Period (IP)|Participant Choice|0|||
143368104|NCT04304534|516890882|FG000|Overall Study|Withdrawal by Subject|7|||
143368105|NCT04304534|516890883|FG001|Overall Study|Withdrawal by Subject|2|||
143368106|NCT04304534|516890884|FG002|Overall Study|Withdrawal by Subject|7|||
143368107|NCT04304534|516890885|FG003|Overall Study|Withdrawal by Subject|4|||
143368108|NCT04304534|516890882|FG000|Overall Study|Physician Decision|4|||
143109205|NCT01647516|515939803|FG002|Induction Period (IP)|Participant Choice|1|||
143109206|NCT01647516|515939804|FG003|Induction Period (IP)|Participant Choice|0|||
143109207|NCT01647516|515939805|FG004|Induction Period (IP)|Participant Choice|0|||
143109208|NCT01647516|515939806|FG005|Induction Period (IP)|Participant Choice|0|||
143109209|NCT01647516|515939801|FG000|Induction Period (IP)|Lack of Efficacy|1|||
143109210|NCT01647516|515939802|FG001|Induction Period (IP)|Lack of Efficacy|0|||
143368109|NCT04304534|516890883|FG001|Overall Study|Physician Decision|9|||
143368110|NCT04304534|516890884|FG002|Overall Study|Physician Decision|9|||
143109211|NCT01647516|515939803|FG002|Induction Period (IP)|Lack of Efficacy|0|||
143368111|NCT04304534|516890885|FG003|Overall Study|Physician Decision|5|||
143109212|NCT01647516|515939804|FG003|Induction Period (IP)|Lack of Efficacy|0|||
143109213|NCT01647516|515939805|FG004|Induction Period (IP)|Lack of Efficacy|0|||
143109214|NCT01647516|515939806|FG005|Induction Period (IP)|Lack of Efficacy|0|||
143368112|NCT04304534|516890882|FG000|Overall Study|Subject Decision|34|||
143368113|NCT04304534|516890883|FG001|Overall Study|Subject Decision|25|||
143109215|NCT01647516|515939801|FG000|Induction Period (IP)|No study drug received|1|||
143109216|NCT01647516|515939802|FG001|Induction Period (IP)|No study drug received|1|||
143109217|NCT01647516|515939803|FG002|Induction Period (IP)|No study drug received|0|||
143109218|NCT01647516|515939804|FG003|Induction Period (IP)|No study drug received|0|||
143109219|NCT01647516|515939805|FG004|Induction Period (IP)|No study drug received|0|||
143109220|NCT01647516|515939806|FG005|Induction Period (IP)|No study drug received|0|||
143109221|NCT01647516|515939801|FG000|Maintenance Period (MP)|Adverse Event|2|||
143109222|NCT01647516|515939802|FG001|Maintenance Period (MP)|Adverse Event|1|||
143109223|NCT01647516|515939803|FG002|Maintenance Period (MP)|Adverse Event|0|||
143109224|NCT01647516|515939804|FG003|Maintenance Period (MP)|Adverse Event|0|||
143109225|NCT01647516|515939805|FG004|Maintenance Period (MP)|Adverse Event|0|||
143109226|NCT01647516|515939806|FG005|Maintenance Period (MP)|Adverse Event|0|||
143109227|NCT01647516|515939801|FG000|Maintenance Period (MP)|Non-compliance|1|||
143109228|NCT01647516|515939802|FG001|Maintenance Period (MP)|Non-compliance|0|||
143109229|NCT01647516|515939803|FG002|Maintenance Period (MP)|Non-compliance|0|||
143109230|NCT01647516|515939804|FG003|Maintenance Period (MP)|Non-compliance|0|||
143109231|NCT01647516|515939805|FG004|Maintenance Period (MP)|Non-compliance|0|||
143109232|NCT01647516|515939806|FG005|Maintenance Period (MP)|Non-compliance|0|||
143109233|NCT01647516|515939801|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
143109234|NCT01647516|515939802|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
143109235|NCT01647516|515939803|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
143109236|NCT01647516|515939804|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
143109237|NCT01647516|515939805|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
143109238|NCT01647516|515939806|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
143109239|NCT01647516|515939801|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
143109240|NCT01647516|515939802|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
143109241|NCT01647516|515939803|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
143109242|NCT01647516|515939804|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
143109243|NCT01647516|515939805|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
143109244|NCT01647516|515939806|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
143109245|NCT01647516|515939801|FG000|Open-Label Period|Adverse Event|0|||
143109246|NCT01647516|515939802|FG001|Open-Label Period|Adverse Event|0|||
143109247|NCT01647516|515939803|FG002|Open-Label Period|Adverse Event|0|||
143109248|NCT01647516|515939804|FG003|Open-Label Period|Adverse Event|5|||
143109249|NCT01647516|515939805|FG004|Open-Label Period|Adverse Event|6|||
143109250|NCT01647516|515939806|FG005|Open-Label Period|Adverse Event|3|||
143109251|NCT01647516|515939801|FG000|Open-Label Period|Pregnancy|0|||
143109252|NCT01647516|515939802|FG001|Open-Label Period|Pregnancy|0|||
143109253|NCT01647516|515939803|FG002|Open-Label Period|Pregnancy|0|||
143109254|NCT01647516|515939804|FG003|Open-Label Period|Pregnancy|0|||
143109255|NCT01647516|515939805|FG004|Open-Label Period|Pregnancy|0|||
143109256|NCT01647516|515939806|FG005|Open-Label Period|Pregnancy|1|||
143368114|NCT04304534|516890884|FG002|Overall Study|Subject Decision|25|||
143109257|NCT01647516|515939801|FG000|Open-Label Period|Non-compliance|0|||
143109258|NCT01647516|515939802|FG001|Open-Label Period|Non-compliance|0|||
143109259|NCT01647516|515939803|FG002|Open-Label Period|Non-compliance|0|||
143109260|NCT01647516|515939804|FG003|Open-Label Period|Non-compliance|1|||
143109261|NCT01647516|515939805|FG004|Open-Label Period|Non-compliance|0|||
143109262|NCT01647516|515939806|FG005|Open-Label Period|Non-compliance|1|||
143109263|NCT01647516|515939801|FG000|Open-Label Period|Physician Decision|0|||
143109264|NCT01647516|515939802|FG001|Open-Label Period|Physician Decision|0|||
143109265|NCT01647516|515939803|FG002|Open-Label Period|Physician Decision|0|||
143109266|NCT01647516|515939804|FG003|Open-Label Period|Physician Decision|1|||
143109267|NCT01647516|515939805|FG004|Open-Label Period|Physician Decision|1|||
143109268|NCT01647516|515939806|FG005|Open-Label Period|Physician Decision|0|||
143109269|NCT01647516|515939801|FG000|Open-Label Period|Withdrawal by Subject|0|||
143109270|NCT01647516|515939802|FG001|Open-Label Period|Withdrawal by Subject|0|||
143109271|NCT01647516|515939803|FG002|Open-Label Period|Withdrawal by Subject|0|||
143109272|NCT01647516|515939804|FG003|Open-Label Period|Withdrawal by Subject|9|||
143109273|NCT01647516|515939805|FG004|Open-Label Period|Withdrawal by Subject|11|||
143109274|NCT01647516|515939806|FG005|Open-Label Period|Withdrawal by Subject|6|||
143109275|NCT01647516|515939801|FG000|Open-Label Period|Lost to Follow-up|0|||
143109276|NCT01647516|515939802|FG001|Open-Label Period|Lost to Follow-up|0|||
143109277|NCT01647516|515939803|FG002|Open-Label Period|Lost to Follow-up|0|||
143109278|NCT01647516|515939804|FG003|Open-Label Period|Lost to Follow-up|1|||
143109279|NCT01647516|515939805|FG004|Open-Label Period|Lost to Follow-up|0|||
143109280|NCT01647516|515939806|FG005|Open-Label Period|Lost to Follow-up|1|||
143109281|NCT01647516|515939801|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
143109282|NCT01647516|515939802|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
143109283|NCT01647516|515939803|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
143109284|NCT01647516|515939804|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
143109285|NCT01647516|515939805|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
143109286|NCT01647516|515939806|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
143109287|NCT01647516|515939801|FG000|Open-Label Period|Lack of Efficacy|0|||
143109288|NCT01647516|515939802|FG001|Open-Label Period|Lack of Efficacy|0|||
143109289|NCT01647516|515939803|FG002|Open-Label Period|Lack of Efficacy|0|||
143109290|NCT01647516|515939804|FG003|Open-Label Period|Lack of Efficacy|7|||
143109291|NCT01647516|515939805|FG004|Open-Label Period|Lack of Efficacy|9|||
143109292|NCT01647516|515939806|FG005|Open-Label Period|Lack of Efficacy|10|||
143109293|NCT01647516|515939801|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
143109294|NCT01647516|515939802|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
143109295|NCT01647516|515939803|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
143109296|NCT01647516|515939804|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
143109297|NCT01647516|515939805|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
143109298|NCT01647516|515939806|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
143109299|NCT01647516|515939801|FG000|Open-Label Period|No completion / discontinuation visit|0|||
143109300|NCT01647516|515939802|FG001|Open-Label Period|No completion / discontinuation visit|0|||
143109301|NCT01647516|515939803|FG002|Open-Label Period|No completion / discontinuation visit|0|||
143109302|NCT01647516|515939804|FG003|Open-Label Period|No completion / discontinuation visit|0|||
143109303|NCT01647516|515939805|FG004|Open-Label Period|No completion / discontinuation visit|2|||
143109304|NCT01647516|515939806|FG005|Open-Label Period|No completion / discontinuation visit|1|||
143109305|NCT01613222|515939809|FG000|Overall Study|Physician Decision|1|||
143109306|NCT01613222|515939809|FG000|Overall Study|Unable to place arterial line|1|||
143109307|NCT01613222|515939809|FG000|Overall Study|Reused disposable sensors|10|||
143109308|NCT01895608|515939810|FG000|Overall Study|change in health status|0|||
143117391|NCT01313221|515971826|FG000|Overall Study|Pregnancy|0|||
143257394|NCT04418661|516495785|FG002|Overall Study|Adverse Event|5|||
143257395|NCT04418661|516495786|FG003|Overall Study|Adverse Event|3|||
143257396|NCT04418661|516495787|FG004|Overall Study|Adverse Event|0|||
143257397|NCT04418661|516495788|FG005|Overall Study|Adverse Event|2|||
143257398|NCT04418661|516495783|FG000|Overall Study|Progressive disease|4|||
143257399|NCT04418661|516495784|FG001|Overall Study|Progressive disease|11|||
143257400|NCT04418661|516495785|FG002|Overall Study|Progressive disease|6|||
143257401|NCT04418661|516495786|FG003|Overall Study|Progressive disease|11|||
143257402|NCT04418661|516495787|FG004|Overall Study|Progressive disease|1|||
143257403|NCT04418661|516495788|FG005|Overall Study|Progressive disease|12|||
143257404|NCT04418661|516495783|FG000|Overall Study|Withdrawal by Subject|0|||
143257405|NCT04418661|516495784|FG001|Overall Study|Withdrawal by Subject|1|||
143257406|NCT04418661|516495785|FG002|Overall Study|Withdrawal by Subject|0|||
143257407|NCT04418661|516495786|FG003|Overall Study|Withdrawal by Subject|1|||
143257408|NCT04418661|516495787|FG004|Overall Study|Withdrawal by Subject|0|||
143257409|NCT04418661|516495788|FG005|Overall Study|Withdrawal by Subject|0|||
143257410|NCT04418661|516495783|FG000|Overall Study|Other|0|||
143368115|NCT04304534|516890885|FG003|Overall Study|Subject Decision|26|||
143257411|NCT04418661|516495784|FG001|Overall Study|Other|0|||
143368116|NCT04304534|516890882|FG000|Overall Study|Adverse Event|35|||
143109309|NCT01895608|515939811|FG001|Overall Study|change in health status|1|||
143109310|NCT01895608|515939812|FG002|Overall Study|change in health status|1|||
143109311|NCT01895608|515939813|FG003|Overall Study|change in health status|0|||
143109312|NCT01895608|515939810|FG000|Overall Study|Withdrawal by Subject|0|||
143109313|NCT01895608|515939811|FG001|Overall Study|Withdrawal by Subject|0|||
143109314|NCT01895608|515939812|FG002|Overall Study|Withdrawal by Subject|2|||
143109315|NCT01895608|515939813|FG003|Overall Study|Withdrawal by Subject|0|||
143109316|NCT03505593|515939814|FG000|Overall Study|Withdrawal by Subject|1|||
143109317|NCT03505593|515939814|FG000|Overall Study|Died before procedure|1|||
143109318|NCT03505593|515939814|FG000|Overall Study|Anatomical abnormality|1|||
143109319|NCT03505593|515939814|FG000|Overall Study|Unable to pass through esophagus|1|||
143109320|NCT03505593|515939814|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
143109321|NCT04143594|515939816|FG000|Overall Study|Withdrew consent|3|||
143109322|NCT04143594|515939817|FG001|Overall Study|Withdrew consent|10|||
143109323|NCT04143594|515939818|FG002|Overall Study|Withdrew consent|3|||
143109324|NCT04143594|515939819|FG003|Overall Study|Withdrew consent|1|||
143109325|NCT04143594|515939816|FG000|Overall Study|Lost to Follow-up|3|||
143109326|NCT04143594|515939817|FG001|Overall Study|Lost to Follow-up|5|||
143109327|NCT04143594|515939818|FG002|Overall Study|Lost to Follow-up|11|||
143109328|NCT04143594|515939819|FG003|Overall Study|Lost to Follow-up|0|||
143109329|NCT04143594|515939816|FG000|Overall Study|Investigator's discretion|2|||
143109330|NCT04143594|515939817|FG001|Overall Study|Investigator's discretion|2|||
143109331|NCT04143594|515939818|FG002|Overall Study|Investigator's discretion|0|||
143109332|NCT04143594|515939819|FG003|Overall Study|Investigator's discretion|0|||
143109333|NCT04143594|515939816|FG000|Overall Study|Randomized but never treated|0|||
143109334|NCT04143594|515939817|FG001|Overall Study|Randomized but never treated|0|||
143109335|NCT04143594|515939818|FG002|Overall Study|Randomized but never treated|0|||
143109336|NCT04143594|515939819|FG003|Overall Study|Randomized but never treated|1|||
143109337|NCT04143594|515939816|FG000|Overall Study|Death|1|||
143109338|NCT04143594|515939817|FG001|Overall Study|Death|0|||
143109339|NCT04143594|515939818|FG002|Overall Study|Death|1|||
143109340|NCT04143594|515939819|FG003|Overall Study|Death|0|||
143109341|NCT04143594|515939816|FG000|Overall Study|Adverse Event|1|||
143109342|NCT04143594|515939817|FG001|Overall Study|Adverse Event|0|||
143109343|NCT04143594|515939818|FG002|Overall Study|Adverse Event|0|||
143109344|NCT04143594|515939819|FG003|Overall Study|Adverse Event|0|||
143109345|NCT04143594|515939816|FG000|Overall Study|Pregnancy|0|||
143109346|NCT04143594|515939817|FG001|Overall Study|Pregnancy|0|||
143109347|NCT04143594|515939818|FG002|Overall Study|Pregnancy|1|||
143109348|NCT04143594|515939819|FG003|Overall Study|Pregnancy|0|||
143109349|NCT04143594|515939816|FG000|Overall Study|Lack of Efficacy|1|||
143109350|NCT04143594|515939817|FG001|Overall Study|Lack of Efficacy|1|||
143109351|NCT04143594|515939818|FG002|Overall Study|Lack of Efficacy|0|||
143109352|NCT04143594|515939819|FG003|Overall Study|Lack of Efficacy|0|||
143109353|NCT03155178|515939820|FG000|Overall Study|Did not meet treatment day baseline|7|||
143109354|NCT03155178|515939821|FG001|Overall Study|Did not meet treatment day baseline|7|||
143109355|NCT03155178|515939822|FG002|Overall Study|Did not meet treatment day baseline|7|||
143109356|NCT03155178|515939823|FG003|Overall Study|Did not meet treatment day baseline|7|||
143109357|NCT01023256|515939824|FG000|Overall Study|Protocol Violation|2|||
143109358|NCT01023256|515939825|FG001|Overall Study|Protocol Violation|3|||
143109359|NCT01023256|515939826|FG002|Overall Study|Protocol Violation|0|||
143109360|NCT01023256|515939827|FG003|Overall Study|Protocol Violation|0|||
143109361|NCT01023256|515939824|FG000|Overall Study|Randomized but not treated|1|||
143109362|NCT01023256|515939825|FG001|Overall Study|Randomized but not treated|0|||
143109363|NCT01023256|515939826|FG002|Overall Study|Randomized but not treated|1|||
143109364|NCT01023256|515939827|FG003|Overall Study|Randomized but not treated|0|||
143109365|NCT01023256|515939824|FG000|Overall Study|Other|1|||
143109366|NCT01023256|515939825|FG001|Overall Study|Other|0|||
143109367|NCT01023256|515939826|FG002|Overall Study|Other|0|||
143109368|NCT01023256|515939827|FG003|Overall Study|Other|2|||
143109369|NCT01023256|515939824|FG000|Overall Study|Adverse Event|0|||
143109370|NCT01023256|515939825|FG001|Overall Study|Adverse Event|0|||
143109371|NCT01023256|515939826|FG002|Overall Study|Adverse Event|0|||
143109372|NCT01023256|515939827|FG003|Overall Study|Adverse Event|1|||
143109373|NCT01023256|515939824|FG000|Overall Study|Withdrawal by Subject|0|||
143109374|NCT01023256|515939825|FG001|Overall Study|Withdrawal by Subject|0|||
143109375|NCT01023256|515939826|FG002|Overall Study|Withdrawal by Subject|0|||
143109376|NCT01023256|515939827|FG003|Overall Study|Withdrawal by Subject|2|||
143109377|NCT04323306|515939828|FG000|Overall Study|Physician Decision|1|||
143109378|NCT04323306|515939829|FG001|Overall Study|Physician Decision|0|||
143109379|NCT04323306|515939830|FG002|Overall Study|Physician Decision|0|||
143109380|NCT04323306|515939831|FG003|Overall Study|Physician Decision|0|||
143109381|NCT04323306|515939832|FG004|Overall Study|Physician Decision|0|||
143109382|NCT04323306|515939833|FG005|Overall Study|Physician Decision|0|||
143109383|NCT04323306|515939834|FG006|Overall Study|Physician Decision|0|||
143109384|NCT04323306|515939835|FG007|Overall Study|Physician Decision|0|||
143109385|NCT04323306|515939836|FG008|Overall Study|Physician Decision|0|||
143109386|NCT04323306|515939828|FG000|Overall Study|Withdrawal by Subject|0|||
143109387|NCT04323306|515939829|FG001|Overall Study|Withdrawal by Subject|0|||
143109388|NCT04323306|515939830|FG002|Overall Study|Withdrawal by Subject|0|||
143109389|NCT04323306|515939831|FG003|Overall Study|Withdrawal by Subject|0|||
143109390|NCT04323306|515939832|FG004|Overall Study|Withdrawal by Subject|0|||
143109391|NCT04323306|515939833|FG005|Overall Study|Withdrawal by Subject|1|||
143109392|NCT04323306|515939834|FG006|Overall Study|Withdrawal by Subject|3|||
143109393|NCT04323306|515939835|FG007|Overall Study|Withdrawal by Subject|0|||
143109394|NCT04323306|515939836|FG008|Overall Study|Withdrawal by Subject|1|||
143109395|NCT01869699|515939839|FG000|Overall Study|Withdrawal by Subject|1|||
143109396|NCT01869699|515939840|FG001|Overall Study|Withdrawal by Subject|0|||
143109397|NCT01322035|515939841|FG000|Overall Study|Lost to Follow-up|8|||
143109398|NCT01322035|515939842|FG001|Overall Study|Lost to Follow-up|3|||
143109399|NCT00727844|515939843|FG000|Initial Randomization|Physician Decision|2|||
143109400|NCT00727844|515939844|FG001|Initial Randomization|Physician Decision|0|||
143109401|NCT00727844|515939845|FG002|Initial Randomization|Physician Decision|0|||
143109402|NCT00727844|515939846|FG003|Initial Randomization|Physician Decision|0|||
143109403|NCT00732758|515939847|FG000|Overall Study|Lost to Follow-up|8|||
143109404|NCT00732758|515939848|FG001|Overall Study|Lost to Follow-up|16|||
143109405|NCT00373958|515939849|FG000|Infant Series|Withdrawal by Subject|13|||
143109406|NCT00373958|515939850|FG001|Infant Series|Withdrawal by Subject|15|||
143109407|NCT00373958|515939849|FG000|Infant Series|Failed to return|8|||
143109408|NCT00373958|515939850|FG001|Infant Series|Failed to return|13|||
143109409|NCT00373958|515939849|FG000|Infant Series|Lost to Follow-up|6|||
143109410|NCT00373958|515939850|FG001|Infant Series|Lost to Follow-up|5|||
143109411|NCT00373958|515939849|FG000|Infant Series|Protocol Violation|3|||
143109412|NCT00373958|515939850|FG001|Infant Series|Protocol Violation|7|||
143109413|NCT00373958|515939849|FG000|Infant Series|Lost Kaiser coverage|4|||
143109414|NCT00373958|515939850|FG001|Infant Series|Lost Kaiser coverage|0|||
143109415|NCT00373958|515939849|FG000|Infant Series|Child relocated|1|||
143109416|NCT00373958|515939850|FG001|Infant Series|Child relocated|0|||
143109417|NCT00373958|515939849|FG000|Infant Series|Consent was not received|1|||
143109418|NCT00373958|515939850|FG001|Infant Series|Consent was not received|0|||
143109419|NCT00373958|515939849|FG000|Infant Series|Adverse Event|3|||
143109420|NCT00373958|515939850|FG001|Infant Series|Adverse Event|1|||
143109421|NCT00373958|515939849|FG000|Infant Series|Physician Decision|1|||
143109422|NCT00373958|515939850|FG001|Infant Series|Physician Decision|1|||
143109423|NCT00373958|515939849|FG000|Toddler Dose|Lost to Follow-up|5|||
143109424|NCT00373958|515939850|FG001|Toddler Dose|Lost to Follow-up|8|||
143109425|NCT00373958|515939849|FG000|Toddler Dose|Withdrawal by Subject|2|||
143109426|NCT00373958|515939850|FG001|Toddler Dose|Withdrawal by Subject|2|||
143109427|NCT00373958|515939849|FG000|Toddler Dose|Failed to return|1|||
143109428|NCT00373958|515939850|FG001|Toddler Dose|Failed to return|2|||
143109429|NCT00373958|515939849|FG000|Toddler Dose|Protocol Violation|0|||
143109430|NCT00373958|515939850|FG001|Toddler Dose|Protocol Violation|1|||
143109431|NCT00373958|515939849|FG000|Toddler Dose|Withdrawn after infant series|22|||
143109432|NCT00373958|515939850|FG001|Toddler Dose|Withdrawn after infant series|25|||
143109433|NCT01552915|515939851|FG000|Overall Study|Adverse Event|3|||
143109434|NCT01552915|515939852|FG001|Overall Study|Adverse Event|14|||
143109435|NCT01552915|515939853|FG002|Overall Study|Adverse Event|3|||
143109436|NCT01552915|515939851|FG000|Overall Study|Lost to Follow-up|4|||
143109437|NCT01552915|515939852|FG001|Overall Study|Lost to Follow-up|6|||
143109438|NCT01552915|515939853|FG002|Overall Study|Lost to Follow-up|5|||
143109439|NCT01552915|515939851|FG000|Overall Study|Withdrawal by Subject|6|||
143109440|NCT01552915|515939852|FG001|Overall Study|Withdrawal by Subject|4|||
143257412|NCT04418661|516495785|FG002|Overall Study|Other|1|||
143257413|NCT04418661|516495786|FG003|Overall Study|Other|3|||
143257414|NCT04418661|516495787|FG004|Overall Study|Other|0|||
143257415|NCT04418661|516495788|FG005|Overall Study|Other|1|||
143257416|NCT00635024|516495791|FG000|Overall Study|Adverse Event|1|||
143257417|NCT00329901|516495792|FG000|Overall Study|Withdrawal by Subject|4|||
143257418|NCT00329901|516495793|FG001|Overall Study|Withdrawal by Subject|3|||
143257419|NCT00329901|516495794|FG002|Overall Study|Withdrawal by Subject|2|||
143257420|NCT00329901|516495792|FG000|Overall Study|Lost to Follow-up|2|||
143257421|NCT00329901|516495793|FG001|Overall Study|Lost to Follow-up|0|||
143109441|NCT01552915|515939853|FG002|Overall Study|Withdrawal by Subject|5|||
143109442|NCT01552915|515939851|FG000|Overall Study|Protocol Violation|0|||
143109443|NCT01552915|515939852|FG001|Overall Study|Protocol Violation|4|||
143109444|NCT01552915|515939853|FG002|Overall Study|Protocol Violation|4|||
143109445|NCT01552915|515939851|FG000|Overall Study|Lack of Efficacy|8|||
143109446|NCT01552915|515939852|FG001|Overall Study|Lack of Efficacy|1|||
143109447|NCT01552915|515939853|FG002|Overall Study|Lack of Efficacy|4|||
143109448|NCT01552915|515939851|FG000|Overall Study|Other|2|||
143109449|NCT01552915|515939852|FG001|Overall Study|Other|0|||
143109450|NCT01552915|515939853|FG002|Overall Study|Other|6|||
143109451|NCT04240457|515939856|FG000|Overall Study|Lost to Follow-up|5|||
143257422|NCT00329901|516495794|FG002|Overall Study|Lost to Follow-up|1|||
143257423|NCT00329901|516495792|FG000|Overall Study|Protocol Violation|1|||
143257424|NCT00329901|516495793|FG001|Overall Study|Protocol Violation|0|||
143109452|NCT04240457|515939857|FG001|Overall Study|Lost to Follow-up|1|||
143109453|NCT00319592|515939862|FG000|Overall Study|Protocol Violation|1|||
143109454|NCT00319592|515939863|FG001|Overall Study|Protocol Violation|0|||
143109455|NCT00319592|515939862|FG000|Overall Study|Physician Decision|0|||
143109456|NCT00319592|515939863|FG001|Overall Study|Physician Decision|1|||
143109457|NCT01820572|515939870|FG000|Randomization|Not Treated|2|||
143109458|NCT01820572|515939871|FG001|Randomization|Not Treated|1|||
143109459|NCT01820572|515939870|FG000|Treatment Period|Adverse Event|12|||
143109460|NCT01820572|515939871|FG001|Treatment Period|Adverse Event|7|||
143109461|NCT01820572|515939870|FG000|Treatment Period|Death|3|||
143109462|NCT01820572|515939871|FG001|Treatment Period|Death|3|||
143109463|NCT01820572|515939870|FG000|Treatment Period|Lack of Efficacy|1|||
143109464|NCT01820572|515939871|FG001|Treatment Period|Lack of Efficacy|0|||
143109465|NCT01820572|515939870|FG000|Treatment Period|poor/non compliance|0|||
143109466|NCT01820572|515939871|FG001|Treatment Period|poor/non compliance|3|||
143109467|NCT01820572|515939870|FG000|Treatment Period|request to discontinue|6|||
143109468|NCT01820572|515939871|FG001|Treatment Period|request to discontinue|11|||
143109469|NCT01820572|515939870|FG000|Treatment Period|No longer meets study criteria|3|||
143109470|NCT01820572|515939871|FG001|Treatment Period|No longer meets study criteria|10|||
143109471|NCT01820572|515939870|FG000|Treatment Period|withdrew consent|1|||
143109472|NCT01820572|515939871|FG001|Treatment Period|withdrew consent|2|||
143109473|NCT00658775|515939872|FG000|Overall Study|Adverse Event|4|||
143109474|NCT00658775|515939873|FG001|Overall Study|Adverse Event|6|||
143109475|NCT00658775|515939872|FG000|Overall Study|Lost to Follow-up|17|||
143109476|NCT00658775|515939873|FG001|Overall Study|Lost to Follow-up|18|||
143109477|NCT00658775|515939872|FG000|Overall Study|Withdrawal by Subject|6|||
143109478|NCT00658775|515939873|FG001|Overall Study|Withdrawal by Subject|4|||
143109479|NCT00658775|515939872|FG000|Overall Study|Withdrawal of consent|8|||
143109480|NCT00658775|515939873|FG001|Overall Study|Withdrawal of consent|7|||
143109481|NCT00658775|515939872|FG000|Overall Study|Other|7|||
143109482|NCT00658775|515939873|FG001|Overall Study|Other|8|||
143109483|NCT04439214|515939876|FG000|Overall Study|Adverse Event|13|||
143109484|NCT04439214|515939876|FG000|Overall Study|Disease progression|16|||
143109485|NCT04439214|515939876|FG000|Overall Study|Death|1|||
143109486|NCT04439214|515939876|FG000|Overall Study|Withdrawal by Subject|2|||
143109487|NCT04439214|515939876|FG000|Overall Study|Declining health|1|||
143109488|NCT04439214|515939876|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
143109489|NCT04439214|515939876|FG000|Overall Study|Ineligible|5|||
143109490|NCT02964208|515939877|FG000|Overall Study|Death|103|||
143109491|NCT02964208|515939877|FG000|Overall Study|Withdrawal by Subject|6|||
143109492|NCT02964208|515939877|FG000|Overall Study|Lost to Follow-up|6|||
143109493|NCT02964208|515939877|FG000|Overall Study|Unsuccessful Procedure|5|||
143109494|NCT02964208|515939877|FG000|Overall Study|Device Explant|1|||
143109495|NCT02964208|515939877|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
143109496|NCT00957268|515939882|FG000|Overall Study|Voluntary Withdrawal|0|||
143109497|NCT00957268|515939883|FG001|Overall Study|Voluntary Withdrawal|0|||
143109498|NCT00957268|515939884|FG002|Overall Study|Voluntary Withdrawal|1|||
143109499|NCT00957268|515939885|FG003|Overall Study|Voluntary Withdrawal|0|||
143109500|NCT00957268|515939886|FG004|Overall Study|Voluntary Withdrawal|0|||
143109501|NCT01758731|515939888|FG000|Overall Study|Physician Decision|1|||
143109502|NCT02396420|515939894|FG000|Overall Study|Death|1|||
143257425|NCT00329901|516495794|FG002|Overall Study|Protocol Violation|1|||
143257426|NCT00329901|516495792|FG000|Overall Study|Unable to classify|2|||
143257427|NCT00329901|516495793|FG001|Overall Study|Unable to classify|2|||
143257428|NCT00329901|516495794|FG002|Overall Study|Unable to classify|0|||
143257429|NCT02142387|516495795|FG000|Overall Study|<19 years old|49|||
143257430|NCT02142387|516495796|FG001|Overall Study|<19 years old|326|||
143257431|NCT02142387|516495795|FG000|Overall Study|non-cardiac etiology|504|||
143257432|NCT02142387|516495796|FG001|Overall Study|non-cardiac etiology|3431|||
143257433|NCT02142387|516495795|FG000|Overall Study|CPR not performed|74|||
143109503|NCT01493284|515939895|FG000|Overall Study|Death|29|||
143109504|NCT01493284|515939895|FG000|Overall Study|Withdrawal by Subject|32|||
143257434|NCT02142387|516495796|FG001|Overall Study|CPR not performed|473|||
143257435|NCT02142387|516495795|FG000|Overall Study|witnessed by paramedic|139|||
143109505|NCT00325156|515939896|FG000|Overall Study|Protocol Violation|8|||
143109506|NCT00325156|515939896|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
143109507|NCT00325156|515939896|FG000|Overall Study|Migrated/moved from study area|12|||
143109508|NCT00325156|515939896|FG000|Overall Study|Adverse event, non-fatal|3|||
143109509|NCT00325156|515939896|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
143109510|NCT00325156|515939896|FG000|Overall Study|Other|1|||
143109511|NCT00325156|515939896|FG000|Overall Study|Withdrawal by Subject|31|||
143109512|NCT05270395|515939897|FG000|Overall Study|Lost to Follow-up|2|||
143257436|NCT02142387|516495796|FG001|Overall Study|witnessed by paramedic|917|||
143109513|NCT05270395|515939898|FG001|Overall Study|Lost to Follow-up|2|||
143109514|NCT05270395|515939897|FG000|Overall Study|Death|1|||
143257437|NCT02142387|516495795|FG000|Overall Study|incomplete data|1|||
143257438|NCT02142387|516495796|FG001|Overall Study|incomplete data|9|||
143257439|NCT02142387|516495795|FG000|Overall Study|occurred not at home|298|||
143257440|NCT02142387|516495796|FG001|Overall Study|occurred not at home|2474|||
143257441|NCT02984943|516495797|FG000|Overall Study|Withdrawal by Subject|3|||
143257442|NCT02984943|516495797|FG000|Overall Study|Physician Decision|1|||
143257443|NCT01268579|516495803|FG000|Overall Study|Adverse Event|1|||
143257444|NCT01268579|516495803|FG000|Overall Study|Withdrawal by Subject|2|||
143109515|NCT05270395|515939898|FG001|Overall Study|Death|2|||
143109516|NCT05270395|515939897|FG000|Overall Study|Study Team Withdrew|1|||
143109517|NCT05270395|515939898|FG001|Overall Study|Study Team Withdrew|0|||
143109518|NCT01397786|515942032|FG000|Phase A|Lost to Follow-up|0|||
143109519|NCT01397786|515942033|FG001|Phase A|Lost to Follow-up|0|||
143109520|NCT01397786|515942034|FG002|Phase A|Lost to Follow-up|6|||
143109521|NCT01397786|515942032|FG000|Phase A|Adverse Event|0|||
143109522|NCT01397786|515942033|FG001|Phase A|Adverse Event|0|||
143109523|NCT01397786|515942034|FG002|Phase A|Adverse Event|8|||
143109524|NCT01397786|515942032|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
143109525|NCT01397786|515942033|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
143257445|NCT02692651|516495804|FG000|Study Treatment|Death|7|||
143257446|NCT02692651|516495805|FG001|Study Treatment|Death|3|||
143257447|NCT02692651|516495804|FG000|Study Treatment|comfort care|1|||
143257448|NCT02692651|516495805|FG001|Study Treatment|comfort care|1|||
143257449|NCT02692651|516495804|FG000|Study Treatment|Protocol violation per treating team preference|8|||
143109526|NCT01397786|515942034|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
143109527|NCT01397786|515942032|FG000|Phase A|Physician Decision|0|||
143109528|NCT01397786|515942033|FG001|Phase A|Physician Decision|0|||
143109529|NCT01397786|515942034|FG002|Phase A|Physician Decision|1|||
143109530|NCT01397786|515942032|FG000|Phase A|Withdrawal by Subject|0|||
143109531|NCT01397786|515942033|FG001|Phase A|Withdrawal by Subject|0|||
143109532|NCT01397786|515942034|FG002|Phase A|Withdrawal by Subject|5|||
143109533|NCT01397786|515942032|FG000|Phase A|Lack of Efficacy|0|||
143109534|NCT01397786|515942033|FG001|Phase A|Lack of Efficacy|0|||
143109535|NCT01397786|515942034|FG002|Phase A|Lack of Efficacy|1|||
143109536|NCT01397786|515942032|FG000|Phase B|Lost to Follow-up|22|||
143109537|NCT01397786|515942033|FG001|Phase B|Lost to Follow-up|12|||
143109538|NCT01397786|515942034|FG002|Phase B|Lost to Follow-up|22|||
143109539|NCT01397786|515942032|FG000|Phase B|Adverse Event|109|||
143109540|NCT01397786|515942033|FG001|Phase B|Adverse Event|23|||
143109541|NCT01397786|515942034|FG002|Phase B|Adverse Event|27|||
143109542|NCT01397786|515942032|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
143109543|NCT01397786|515942033|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
143109544|NCT01397786|515942034|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
143109545|NCT01397786|515942032|FG000|Phase B|Physician Decision|9|||
143109546|NCT01397786|515942033|FG001|Phase B|Physician Decision|1|||
143109547|NCT01397786|515942034|FG002|Phase B|Physician Decision|3|||
143109548|NCT01397786|515942032|FG000|Phase B|Withdrawal by Subject|102|||
143257450|NCT02692651|516495805|FG001|Study Treatment|Protocol violation per treating team preference|6|||
143257451|NCT02692651|516495804|FG000|Post Study Treatment Follow-up|Death|4|||
143257452|NCT02692651|516495805|FG001|Post Study Treatment Follow-up|Death|4|||
143257453|NCT02480712|516495806|FG000|Overall Study|Enrolled but Never Treated|1|||
143257454|NCT02480712|516495806|FG000|Overall Study|Lost to Follow-up|5|||
143257455|NCT02480712|516495806|FG000|Overall Study|Withdrew Consent|3|||
143257456|NCT02480712|516495806|FG000|Overall Study|Death|1|||
143257457|NCT02480712|516495806|FG000|Overall Study|Lack of Efficacy|1|||
143257458|NCT00466687|516495809|FG000|Overall Study|Adverse Event|1|||
143257459|NCT00466687|516495809|FG000|Overall Study|Other complicating illness|3|||
143257460|NCT00466687|516495809|FG000|Overall Study|Withdrawal by Subject|1|||
143257461|NCT00466687|516495809|FG000|Overall Study|Disease progression|29|||
143257462|NCT03459690|516495814|FG000|Overall Study|Lost to Follow-up|0|||
143257463|NCT03459690|516495815|FG001|Overall Study|Lost to Follow-up|1|||
143257464|NCT03459690|516495814|FG000|Overall Study|Withdrawal by Subject|1|||
143109549|NCT01397786|515942033|FG001|Phase B|Withdrawal by Subject|45|||
143109550|NCT01397786|515942034|FG002|Phase B|Withdrawal by Subject|30|||
143109551|NCT01397786|515942032|FG000|Phase B|Protocol Deviation|1|||
143109552|NCT01397786|515942033|FG001|Phase B|Protocol Deviation|2|||
143109553|NCT01397786|515942034|FG002|Phase B|Protocol Deviation|4|||
143257465|NCT03459690|516495815|FG001|Overall Study|Withdrawal by Subject|1|||
143257466|NCT02586506|516495816|FG000|Overall Study|Protocol Violation|6|||
143257467|NCT02586506|516495816|FG000|Overall Study|Lost to Follow-up|1|||
143109554|NCT01397786|515942032|FG000|Phase B|Lack of Efficacy|22|||
143109555|NCT01397786|515942033|FG001|Phase B|Lack of Efficacy|7|||
143109556|NCT01397786|515942034|FG002|Phase B|Lack of Efficacy|14|||
143109557|NCT00784550|515942038|FG000|Overall Study|Adverse Event|12|||
143109558|NCT00784550|515942039|FG001|Overall Study|Adverse Event|10|||
143109559|NCT00784550|515942038|FG000|Overall Study|Lack of Efficacy|0|||
143109560|NCT00784550|515942039|FG001|Overall Study|Lack of Efficacy|1|||
143257468|NCT02586506|516495816|FG000|Overall Study|Other Reason|2|||
143257469|NCT02536404|516495824|FG000|Overall Study|Adverse Event|5|||
143109561|NCT00784550|515942038|FG000|Overall Study|Protocol Violation|10|||
143109562|NCT00784550|515942039|FG001|Overall Study|Protocol Violation|10|||
143109563|NCT00784550|515942038|FG000|Overall Study|Lost to Follow-up|8|||
143109564|NCT00784550|515942039|FG001|Overall Study|Lost to Follow-up|5|||
143109565|NCT00784550|515942038|FG000|Overall Study|Physician Decision|2|||
143109566|NCT00784550|515942039|FG001|Overall Study|Physician Decision|3|||
143109567|NCT00784550|515942038|FG000|Overall Study|Withdrawal by Subject|4|||
143109568|NCT00784550|515942039|FG001|Overall Study|Withdrawal by Subject|13|||
143109569|NCT00174967|515942040|FG000|Overall Study|Adverse Event|1|||
143109570|NCT00174967|515942041|FG001|Overall Study|Adverse Event|2|||
143109571|NCT00174967|515942042|FG002|Overall Study|Adverse Event|2|||
143109572|NCT00174967|515942043|FG003|Overall Study|Adverse Event|1|||
143109573|NCT00174967|515942040|FG000|Overall Study|Gout Flare|0|||
143109574|NCT00174967|515942041|FG001|Overall Study|Gout Flare|0|||
143109575|NCT00174967|515942042|FG002|Overall Study|Gout Flare|0|||
143109576|NCT00174967|515942043|FG003|Overall Study|Gout Flare|1|||
143109577|NCT00174967|515942040|FG000|Overall Study|Other|0|||
143109578|NCT00174967|515942041|FG001|Overall Study|Other|1|||
143109579|NCT00174967|515942042|FG002|Overall Study|Other|0|||
143109580|NCT00174967|515942043|FG003|Overall Study|Other|0|||
143109581|NCT00970632|515942047|FG000|Overall Study|Adverse Event|2|||
143109582|NCT00970632|515942048|FG001|Overall Study|Adverse Event|2|||
143109583|NCT00970632|515942049|FG002|Overall Study|Adverse Event|1|||
143109584|NCT00970632|515942047|FG000|Overall Study|Lack of Efficacy|3|||
143109585|NCT00970632|515942048|FG001|Overall Study|Lack of Efficacy|0|||
143109586|NCT00970632|515942049|FG002|Overall Study|Lack of Efficacy|0|||
143109587|NCT00970632|515942047|FG000|Overall Study|Lost to Follow-up|3|||
143109588|NCT00970632|515942048|FG001|Overall Study|Lost to Follow-up|0|||
143109589|NCT00970632|515942049|FG002|Overall Study|Lost to Follow-up|2|||
143109590|NCT00970632|515942047|FG000|Overall Study|Protocol Violation|8|||
143109591|NCT00970632|515942048|FG001|Overall Study|Protocol Violation|5|||
143109592|NCT00970632|515942049|FG002|Overall Study|Protocol Violation|8|||
143109593|NCT00970632|515942047|FG000|Overall Study|Withdrawal by Subject|7|||
143109594|NCT00970632|515942048|FG001|Overall Study|Withdrawal by Subject|6|||
143109595|NCT00970632|515942049|FG002|Overall Study|Withdrawal by Subject|4|||
143109596|NCT00970632|515942047|FG000|Overall Study|Entry criteria not met|0|||
143109597|NCT00970632|515942048|FG001|Overall Study|Entry criteria not met|2|||
143109598|NCT00970632|515942049|FG002|Overall Study|Entry criteria not met|2|||
143109599|NCT00970632|515942047|FG000|Overall Study|Sponsor decision|1|||
143109600|NCT00970632|515942048|FG001|Overall Study|Sponsor decision|0|||
143109601|NCT00970632|515942049|FG002|Overall Study|Sponsor decision|1|||
143109602|NCT00900757|515942050|FG000|Overall Study|screen failure|19|||
143109603|NCT01286168|515942055|FG000|Overall Study|Withdrawal by Subject|1|||
143109604|NCT01286168|515942055|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
143109605|NCT01424514|515942056|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
143109606|NCT01424514|515942057|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
143109607|NCT01424514|515942056|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
143109608|NCT01424514|515942057|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
143109609|NCT02487771|515942060|FG000|Overall Study|Lost to Follow-up|2|||
143109610|NCT02487771|515942061|FG001|Overall Study|Lost to Follow-up|3|||
143109611|NCT02487771|515942060|FG000|Overall Study|Moved out of area|5|||
143109612|NCT02487771|515942061|FG001|Overall Study|Moved out of area|6|||
143109613|NCT02487771|515942060|FG000|Overall Study|Withdrawal by Subject|3|||
143109614|NCT02487771|515942061|FG001|Overall Study|Withdrawal by Subject|5|||
143109615|NCT02002533|515942062|FG000|Overall Study|Withdrawal by Subject|6|||
143109616|NCT02002533|515942063|FG001|Overall Study|Withdrawal by Subject|13|||
143109617|NCT02002533|515942062|FG000|Overall Study|Protocol Violation|0|||
143109618|NCT02002533|515942063|FG001|Overall Study|Protocol Violation|1|||
143257470|NCT02536404|516495825|FG001|Overall Study|Adverse Event|0|||
143257471|NCT02536404|516495824|FG000|Overall Study|Withdrawal by Subject|4|||
143257472|NCT02536404|516495825|FG001|Overall Study|Withdrawal by Subject|1|||
143257473|NCT02536404|516495824|FG000|Overall Study|Physician Decision|10|||
143109619|NCT02002533|515942062|FG000|Overall Study|Adverse Event|0|||
143109620|NCT02002533|515942063|FG001|Overall Study|Adverse Event|3|||
143109621|NCT02002533|515942062|FG000|Overall Study|Lost to Follow-up|0|||
143109622|NCT02002533|515942063|FG001|Overall Study|Lost to Follow-up|1|||
143257474|NCT02536404|516495825|FG001|Overall Study|Physician Decision|0|||
143109623|NCT00381238|515942071|FG000|Overall Study|Adverse Event|3|||
143109624|NCT00381238|515942071|FG000|Overall Study|Protocol Violation|1|||
143109625|NCT00381238|515942071|FG000|Overall Study|Withdrawal by Subject|4|||
143109626|NCT00381238|515942071|FG000|Overall Study|Lack of Efficacy|2|||
143109627|NCT00381238|515942071|FG000|Overall Study|Withdrew by physician|1|||
143109628|NCT00381238|515942071|FG000|Overall Study|Disease progression|1|||
143109629|NCT00401544|515942081|FG000|Overall Study|Adverse Event|5|||
143109630|NCT00401544|515942082|FG001|Overall Study|Adverse Event|1|||
143109631|NCT00401544|515942083|FG002|Overall Study|Adverse Event|1|||
143109632|NCT00401544|515942084|FG003|Overall Study|Adverse Event|1|||
143109633|NCT00401544|515942081|FG000|Overall Study|Death|3|||
143109634|NCT00401544|515942082|FG001|Overall Study|Death|6|||
143109635|NCT00401544|515942083|FG002|Overall Study|Death|2|||
143109636|NCT00401544|515942084|FG003|Overall Study|Death|5|||
143109637|NCT00401544|515942081|FG000|Overall Study|Lost to Follow-up|2|||
143109638|NCT00401544|515942082|FG001|Overall Study|Lost to Follow-up|0|||
143109639|NCT00401544|515942083|FG002|Overall Study|Lost to Follow-up|1|||
143109640|NCT00401544|515942084|FG003|Overall Study|Lost to Follow-up|1|||
143109641|NCT00401544|515942081|FG000|Overall Study|Withdrawal by Subject|7|||
143109642|NCT00401544|515942082|FG001|Overall Study|Withdrawal by Subject|6|||
143109643|NCT00401544|515942083|FG002|Overall Study|Withdrawal by Subject|6|||
143109644|NCT00401544|515942084|FG003|Overall Study|Withdrawal by Subject|5|||
143109645|NCT00401544|515942081|FG000|Overall Study|Physician Decision|1|||
143109646|NCT00401544|515942082|FG001|Overall Study|Physician Decision|3|||
143109647|NCT00401544|515942083|FG002|Overall Study|Physician Decision|0|||
143109648|NCT00401544|515942084|FG003|Overall Study|Physician Decision|0|||
143109649|NCT00401544|515942081|FG000|Overall Study|Ineligibility determined|0|||
143109650|NCT00401544|515942082|FG001|Overall Study|Ineligibility determined|1|||
143109651|NCT00401544|515942083|FG002|Overall Study|Ineligibility determined|0|||
143257475|NCT02536404|516495824|FG000|Overall Study|Sponsor decision|1|||
143257476|NCT02536404|516495825|FG001|Overall Study|Sponsor decision|0|||
143257477|NCT02158364|516495826|FG000|Overall Study|Case report forms uncollected|10|||
143257478|NCT02158364|516495826|FG000|Overall Study|Protocol Deviation|50|||
143257479|NCT04381988|516495829|FG000|Overall Study|The study was terminated|4|||
143257480|NCT04381988|516495830|FG001|Overall Study|The study was terminated|0|||
143257481|NCT01944839|516495831|FG000|Overall Study|Physician Decision|2|||
143257482|NCT01944839|516495832|FG001|Overall Study|Physician Decision|2|||
143257483|NCT01944839|516495831|FG000|Overall Study|Protocol Violation|0|||
143257484|NCT01944839|516495832|FG001|Overall Study|Protocol Violation|1|||
143257485|NCT01944839|516495831|FG000|Overall Study|Adverse Event|10|||
143257486|NCT01944839|516495832|FG001|Overall Study|Adverse Event|5|||
143257487|NCT01944839|516495831|FG000|Overall Study|Withdrawal by Subject|9|||
143257488|NCT01944839|516495832|FG001|Overall Study|Withdrawal by Subject|17|||
143257489|NCT01944839|516495831|FG000|Overall Study|Lost to Follow-up|1|||
143257490|NCT01944839|516495832|FG001|Overall Study|Lost to Follow-up|0|||
143257491|NCT01944839|516495831|FG000|Overall Study|Subject non-compliance|0|||
143257492|NCT01944839|516495832|FG001|Overall Study|Subject non-compliance|3|||
143257493|NCT01107379|516495836|FG000|Overall Study|Withdrawal by Subject|18|||
143257494|NCT01107379|516495836|FG000|Overall Study|Lost to Follow-up|3|||
143257495|NCT00609362|516495837|FG000|Overall Study|Withdrawal by Subject|2|||
143257496|NCT00609362|516495838|FG001|Overall Study|Withdrawal by Subject|1|||
143257497|NCT00609362|516495837|FG000|Overall Study|Adverse Event|1|||
143257498|NCT00609362|516495838|FG001|Overall Study|Adverse Event|0|||
143257499|NCT04559529|516495839|FG000|First Intervention (1 Day)|Adverse Event|0|||
143257500|NCT04559529|516495840|FG001|First Intervention (1 Day)|Adverse Event|0|||
143257501|NCT04559529|516495841|FG002|First Intervention (1 Day)|Adverse Event|0|||
143257502|NCT04559529|516495842|FG003|First Intervention (1 Day)|Adverse Event|1|||
143257503|NCT04559529|516495839|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
143257504|NCT04559529|516495840|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
143257505|NCT04559529|516495841|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
143257506|NCT04559529|516495842|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
143257507|NCT04559529|516495839|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
143257508|NCT04559529|516495840|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
143257509|NCT04559529|516495841|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
143257510|NCT04559529|516495842|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
143257511|NCT05093790|516495843|FG000|Overall Study|Failure to meet continuation criteria|0|||
143257512|NCT05093790|516495844|FG001|Overall Study|Failure to meet continuation criteria|0|||
143257513|NCT05093790|516495845|FG002|Overall Study|Failure to meet continuation criteria|1|||
143257514|NCT05093790|516495846|FG003|Overall Study|Failure to meet continuation criteria|0|||
143257515|NCT05093790|516495843|FG000|Overall Study|Adverse Event|1|||
143257516|NCT05093790|516495844|FG001|Overall Study|Adverse Event|0|||
143109652|NCT00401544|515942084|FG003|Overall Study|Ineligibility determined|2|||
143109653|NCT00401544|515942081|FG000|Overall Study|Disease progression|0|||
143109654|NCT00401544|515942082|FG001|Overall Study|Disease progression|1|||
143109655|NCT00401544|515942083|FG002|Overall Study|Disease progression|0|||
143109656|NCT00401544|515942084|FG003|Overall Study|Disease progression|0|||
143109657|NCT00401544|515942081|FG000|Overall Study|Other|0|||
143109658|NCT00401544|515942082|FG001|Overall Study|Other|0|||
143109659|NCT00401544|515942083|FG002|Overall Study|Other|2|||
143109660|NCT00401544|515942084|FG003|Overall Study|Other|2|||
143109661|NCT05139303|515942095|FG000|Overall Study|Lost to Follow-up|3|||
143109662|NCT05139303|515942096|FG001|Overall Study|Lost to Follow-up|0|||
143109663|NCT05139303|515942095|FG000|Overall Study|Adverse Event|1|||
143109664|NCT05139303|515942096|FG001|Overall Study|Adverse Event|0|||
143257517|NCT05093790|516495845|FG002|Overall Study|Adverse Event|0|||
143257518|NCT05093790|516495846|FG003|Overall Study|Adverse Event|0|||
143257519|NCT00924170|516495847|FG000|Overall Study|Refused further treatment|0|||
143368117|NCT04304534|516890883|FG001|Overall Study|Adverse Event|40|||
143257520|NCT00924170|516495848|FG001|Overall Study|Refused further treatment|1|||
143257521|NCT00924170|516495847|FG000|Overall Study|Physician Decision|0|||
143257522|NCT00924170|516495848|FG001|Overall Study|Physician Decision|1|||
143257523|NCT00924170|516495847|FG000|Overall Study|Progressive disease|3|||
143109665|NCT01489254|515942097|FG000|Double-blind Part|Adverse Event|7|||
143109666|NCT01489254|515942098|FG001|Double-blind Part|Adverse Event|2|||
143109667|NCT01489254|515942099|FG002|Double-blind Part|Adverse Event|2|||
143109668|NCT01489254|515942100|FG003|Double-blind Part|Adverse Event|0|||
143109669|NCT01489254|515942097|FG000|Double-blind Part|Pregnancy|1|||
143109670|NCT01489254|515942098|FG001|Double-blind Part|Pregnancy|3|||
143109671|NCT01489254|515942099|FG002|Double-blind Part|Pregnancy|0|||
143109672|NCT01489254|515942100|FG003|Double-blind Part|Pregnancy|0|||
143109673|NCT01489254|515942097|FG000|Double-blind Part|Withdrawal by Subject|12|||
143109674|NCT01489254|515942098|FG001|Double-blind Part|Withdrawal by Subject|20|||
143109675|NCT01489254|515942099|FG002|Double-blind Part|Withdrawal by Subject|1|||
143109676|NCT01489254|515942100|FG003|Double-blind Part|Withdrawal by Subject|0|||
143109677|NCT01489254|515942097|FG000|Double-blind Part|Lost to Follow-up|1|||
143109678|NCT01489254|515942098|FG001|Double-blind Part|Lost to Follow-up|2|||
143109679|NCT01489254|515942099|FG002|Double-blind Part|Lost to Follow-up|0|||
143109680|NCT01489254|515942100|FG003|Double-blind Part|Lost to Follow-up|0|||
143109681|NCT01489254|515942097|FG000|Double-blind Part|Other reasons for not completing study|4|||
143109682|NCT01489254|515942098|FG001|Double-blind Part|Other reasons for not completing study|6|||
143109683|NCT01489254|515942099|FG002|Double-blind Part|Other reasons for not completing study|0|||
143109684|NCT01489254|515942100|FG003|Double-blind Part|Other reasons for not completing study|0|||
143109685|NCT01489254|515942097|FG000|Open-label Extension Part|Adverse Event|0|||
143109686|NCT01489254|515942098|FG001|Open-label Extension Part|Adverse Event|0|||
143109687|NCT01489254|515942099|FG002|Open-label Extension Part|Adverse Event|0|||
143109688|NCT01489254|515942100|FG003|Open-label Extension Part|Adverse Event|10|||
143109689|NCT01489254|515942097|FG000|Open-label Extension Part|Pregnancy|0|||
143109690|NCT01489254|515942098|FG001|Open-label Extension Part|Pregnancy|0|||
143109691|NCT01489254|515942099|FG002|Open-label Extension Part|Pregnancy|0|||
143109692|NCT01489254|515942100|FG003|Open-label Extension Part|Pregnancy|3|||
143109693|NCT01489254|515942097|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
143109694|NCT01489254|515942098|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
143109695|NCT01489254|515942099|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
143109696|NCT01489254|515942100|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
143109697|NCT01489254|515942097|FG000|Open-label Extension Part|Protocol Violation|0|||
143109698|NCT01489254|515942098|FG001|Open-label Extension Part|Protocol Violation|0|||
143109699|NCT01489254|515942099|FG002|Open-label Extension Part|Protocol Violation|0|||
143109700|NCT01489254|515942100|FG003|Open-label Extension Part|Protocol Violation|1|||
143109701|NCT01489254|515942097|FG000|Open-label Extension Part|Lost to Follow-up|0|||
143109702|NCT01489254|515942098|FG001|Open-label Extension Part|Lost to Follow-up|0|||
143109703|NCT01489254|515942099|FG002|Open-label Extension Part|Lost to Follow-up|0|||
143109704|NCT01489254|515942100|FG003|Open-label Extension Part|Lost to Follow-up|9|||
143109705|NCT01489254|515942097|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
143109706|NCT01489254|515942098|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
143109707|NCT01489254|515942099|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
143109708|NCT01489254|515942100|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
143109709|NCT04507256|515942101|FG000|Overall Study|Withdrawal by Subject|1|||
143109710|NCT04507256|515942102|FG001|Overall Study|Withdrawal by Subject|0|||
143109711|NCT04507256|515942103|FG002|Overall Study|Withdrawal by Subject|0|||
143109712|NCT04507256|515942104|FG003|Overall Study|Withdrawal by Subject|1|||
143109713|NCT04507256|515942105|FG004|Overall Study|Withdrawal by Subject|0|||
143109714|NCT04507256|515942106|FG005|Overall Study|Withdrawal by Subject|0|||
143109715|NCT00890084|515942113|FG000|Overall Study|Adverse Event|16|||
143109716|NCT00890084|515942113|FG000|Overall Study|Lost to Follow-up|126|||
143109717|NCT03614078|515942114|FG000|Overall Study|Withdrawal by Subject|2|||
143109718|NCT03614078|515942115|FG001|Overall Study|Withdrawal by Subject|2|||
143257524|NCT00924170|516495848|FG001|Overall Study|Progressive disease|6|||
143257525|NCT00924170|516495847|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
143109719|NCT03614078|515942116|FG002|Overall Study|Withdrawal by Subject|3|||
143109720|NCT03614078|515942114|FG000|Overall Study|Participant Did Not Return for Visit|0|||
143109721|NCT03614078|515942115|FG001|Overall Study|Participant Did Not Return for Visit|1|||
143109722|NCT03614078|515942116|FG002|Overall Study|Participant Did Not Return for Visit|0|||
143109723|NCT03614078|515942114|FG000|Overall Study|High Neutrophils|0|||
143109724|NCT03614078|515942115|FG001|Overall Study|High Neutrophils|0|||
143109725|NCT03614078|515942116|FG002|Overall Study|High Neutrophils|2|||
143109726|NCT03614078|515942114|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
143109727|NCT03614078|515942115|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
143109728|NCT03614078|515942116|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
143109729|NCT03614078|515942114|FG000|Overall Study|Exacerbation of Psoriasis|0|||
143257526|NCT00924170|516495848|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
143257527|NCT00924170|516495847|FG000|Overall Study|Death|1|||
143368118|NCT04304534|516890884|FG002|Overall Study|Adverse Event|39|||
143368119|NCT04304534|516890885|FG003|Overall Study|Adverse Event|44|||
143368120|NCT01313182|516890886|FG000|Overall Study|Protocol Violation|66|||
143368121|NCT01313182|516890887|FG001|Overall Study|Protocol Violation|92|||
143368122|NCT01695317|516890888|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
143368123|NCT01695317|516890889|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
143368124|NCT01695317|516890888|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
143368125|NCT01695317|516890889|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
143368126|NCT00464672|516890890|FG000|Overall Study|withdrawal of consent|0|||
143368127|NCT00464672|516890891|FG001|Overall Study|withdrawal of consent|0|||
143368128|NCT00464672|516890892|FG002|Overall Study|withdrawal of consent|0|||
143368129|NCT00464672|516890893|FG003|Overall Study|withdrawal of consent|1|||
143368130|NCT00464672|516890894|FG004|Overall Study|withdrawal of consent|9|||
143368131|NCT00464672|516890895|FG005|Overall Study|withdrawal of consent|4|||
143368132|NCT00464672|516890890|FG000|Overall Study|Lost to Follow-up|25|||
143368133|NCT00464672|516890891|FG001|Overall Study|Lost to Follow-up|10|||
143368134|NCT00464672|516890892|FG002|Overall Study|Lost to Follow-up|0|||
143368135|NCT00464672|516890893|FG003|Overall Study|Lost to Follow-up|0|||
143368136|NCT00464672|516890894|FG004|Overall Study|Lost to Follow-up|1|||
143368137|NCT00464672|516890895|FG005|Overall Study|Lost to Follow-up|0|||
143368138|NCT03055767|516890896|FG000|Open-Label Period|Lost to Follow-up|0|||
143368139|NCT03055767|516890897|FG001|Open-Label Period|Lost to Follow-up|0|||
143368140|NCT03055767|516890898|FG002|Open-Label Period|Lost to Follow-up|2|||
143368141|NCT03055767|516890899|FG003|Open-Label Period|Lost to Follow-up|0|||
143368142|NCT03055767|516890896|FG000|Open-Label Period|Withdrawal by Subject|0|||
143368143|NCT03055767|516890897|FG001|Open-Label Period|Withdrawal by Subject|0|||
143368144|NCT03055767|516890898|FG002|Open-Label Period|Withdrawal by Subject|0|||
143257528|NCT00924170|516495848|FG001|Overall Study|Death|0|||
143257529|NCT04098224|516495851|FG000|Overall Study|Adverse Event|1|||
143257530|NCT04098224|516495852|FG001|Overall Study|Adverse Event|0|||
143257531|NCT04098224|516495851|FG000|Overall Study|Physician Decision|1|||
143257532|NCT04098224|516495852|FG001|Overall Study|Physician Decision|0|||
143257533|NCT04098224|516495851|FG000|Overall Study|Patient not required enteral feeding|1|||
143257534|NCT04098224|516495852|FG001|Overall Study|Patient not required enteral feeding|0|||
143257535|NCT04098224|516495851|FG000|Overall Study|Patient failure nasogastric tube|1|||
143257536|NCT04098224|516495852|FG001|Overall Study|Patient failure nasogastric tube|0|||
143257537|NCT04098224|516495851|FG000|Overall Study|Patient early extubation|1|||
143368145|NCT03055767|516890899|FG003|Open-Label Period|Withdrawal by Subject|1|||
143368146|NCT02759731|516890902|FG000|Overall Study|Did not complete treatment.|8|||
143368147|NCT00015457|516890908|FG000|First Intervention|Adverse Event|0|||
143368148|NCT00015457|516890909|FG001|First Intervention|Adverse Event|2|||
143368149|NCT00015457|516890908|FG000|First Intervention|Lack of Efficacy|0|||
143368150|NCT00015457|516890909|FG001|First Intervention|Lack of Efficacy|1|||
143368151|NCT00015457|516890908|FG000|Second Intervention|Withdrawal by Subject|1|||
143368152|NCT00015457|516890909|FG001|Second Intervention|Withdrawal by Subject|0|||
143368153|NCT01710514|516890915|FG000|Overall Study|Adverse Event|6|||
143368154|NCT01710514|516890916|FG001|Overall Study|Adverse Event|7|||
143368155|NCT01710514|516890915|FG000|Overall Study|Withdrawal by Subject|1|||
143368156|NCT01710514|516890916|FG001|Overall Study|Withdrawal by Subject|0|||
143368157|NCT04044664|516890917|FG000|Stage 1|Adverse Event|3|||
143368158|NCT04044664|516890918|FG001|Stage 1|Adverse Event|3|||
143368159|NCT04044664|516890919|FG002|Stage 1|Adverse Event|1|||
143368160|NCT04044664|516890917|FG000|Stage 1|Lost to Follow-up|3|||
143368161|NCT04044664|516890918|FG001|Stage 1|Lost to Follow-up|2|||
143109730|NCT03614078|515942115|FG001|Overall Study|Exacerbation of Psoriasis|1|||
143109731|NCT03614078|515942116|FG002|Overall Study|Exacerbation of Psoriasis|0|||
143109732|NCT03614078|515942114|FG000|Overall Study|Adverse Event|0|||
143109733|NCT03614078|515942115|FG001|Overall Study|Adverse Event|2|||
143109734|NCT03614078|515942116|FG002|Overall Study|Adverse Event|0|||
143257538|NCT04098224|516495852|FG001|Overall Study|Patient early extubation|3|||
143109735|NCT03614078|515942114|FG000|Overall Study|Dizziness and Rash|0|||
143109736|NCT03614078|515942115|FG001|Overall Study|Dizziness and Rash|1|||
143109737|NCT03614078|515942116|FG002|Overall Study|Dizziness and Rash|0|||
143257539|NCT01203852|516495856|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
143109738|NCT00308087|515942119|FG000|Overall Study|Progressive Disease|19|||
143257540|NCT01203852|516495856|FG000|Washout 2 Weeks|Physician Decision|46|||
143257541|NCT01587898|516495859|FG000|Overall Study|Adverse Event|1|||
143368162|NCT04044664|516890919|FG002|Stage 1|Lost to Follow-up|2|||
143368163|NCT04044664|516890917|FG000|Stage 1|Withdrawal by Subject|9|||
143368164|NCT04044664|516890918|FG001|Stage 1|Withdrawal by Subject|1|||
143368165|NCT04044664|516890919|FG002|Stage 1|Withdrawal by Subject|0|||
143368166|NCT04044664|516890917|FG000|Stage 1|noncompliance, personal reason|2|||
143368167|NCT04044664|516890918|FG001|Stage 1|noncompliance, personal reason|0|||
143368168|NCT04044664|516890919|FG002|Stage 1|noncompliance, personal reason|0|||
143368169|NCT04044664|516890917|FG000|Stage 1|randomization error|0|||
143368170|NCT04044664|516890918|FG001|Stage 1|randomization error|1|||
143368171|NCT04044664|516890919|FG002|Stage 1|randomization error|0|||
143368172|NCT04044664|516890917|FG000|Stage 2|Adverse Event|2|||
143109739|NCT00308087|515942120|FG001|Overall Study|Progressive Disease|21|||
143109740|NCT00308087|515942119|FG000|Overall Study|Study Closure|11|||
143109741|NCT00308087|515942120|FG001|Overall Study|Study Closure|12|||
143109742|NCT00308087|515942119|FG000|Overall Study|Withdrawal by Subject|2|||
143109743|NCT00308087|515942120|FG001|Overall Study|Withdrawal by Subject|1|||
143109744|NCT00308087|515942119|FG000|Overall Study|Other|4|||
143109745|NCT00308087|515942120|FG001|Overall Study|Other|3|||
143109746|NCT01899742|515942123|FG000|Overall Study|Adverse Event|5|||
143109747|NCT01899742|515942124|FG001|Overall Study|Adverse Event|4|||
143109748|NCT01899742|515942123|FG000|Overall Study|Lack of Efficacy|1|||
143109749|NCT01899742|515942124|FG001|Overall Study|Lack of Efficacy|5|||
143109750|NCT01899742|515942123|FG000|Overall Study|Protocol Violation|2|||
143109751|NCT01899742|515942124|FG001|Overall Study|Protocol Violation|2|||
143109752|NCT01899742|515942123|FG000|Overall Study|Withdrawal by Subject|9|||
143109753|NCT01899742|515942124|FG001|Overall Study|Withdrawal by Subject|5|||
143109754|NCT00089778|515942126|FG000|Overall Study|Protocol Violation|0|||
143109755|NCT00089778|515942127|FG001|Overall Study|Protocol Violation|0|||
143109756|NCT00089778|515942128|FG002|Overall Study|Protocol Violation|1|||
143109757|NCT02677038|515942131|FG000|Overall Study|Physician Decision|1|||
143109758|NCT02677038|515942131|FG000|Overall Study|Withdrawal by Subject|1|||
143109759|NCT04712019|515942132|FG000|Overall Study|Withdrawal by Subject|2|||
143109760|NCT04712019|515942133|FG001|Overall Study|Withdrawal by Subject|2|||
143109761|NCT04712019|515942132|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
143109762|NCT04712019|515942133|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
143109763|NCT01646021|515942134|FG000|Overall Study|Death|77|||
143109764|NCT01646021|515942135|FG001|Overall Study|Death|83|||
143109765|NCT01646021|515942134|FG000|Overall Study|Study Terminated by Sponsor|50|||
143109766|NCT01646021|515942135|FG001|Overall Study|Study Terminated by Sponsor|41|||
143109767|NCT01646021|515942134|FG000|Overall Study|Lost to Follow-up|2|||
143109768|NCT01646021|515942135|FG001|Overall Study|Lost to Follow-up|2|||
143109769|NCT01646021|515942134|FG000|Overall Study|Withdrawal by Subject|10|||
143109770|NCT01646021|515942135|FG001|Overall Study|Withdrawal by Subject|15|||
143109771|NCT05129137|515942141|FG000|Second Period|Adverse Event|1|||
143109772|NCT05129137|515942142|FG001|Second Period|Adverse Event|0|||
143109773|NCT05129137|515942143|FG002|Second Period|Adverse Event|0|||
143109774|NCT05129137|515942144|FG003|Second Period|Adverse Event|0|||
143109775|NCT05129137|515942141|FG000|Second Period|Protocol Violation|0|||
143109776|NCT05129137|515942142|FG001|Second Period|Protocol Violation|0|||
143109777|NCT05129137|515942143|FG002|Second Period|Protocol Violation|0|||
143109778|NCT05129137|515942144|FG003|Second Period|Protocol Violation|1|||
143109779|NCT05129137|515942141|FG000|Third Period|Protocol Violation|0|||
143109780|NCT05129137|515942142|FG001|Third Period|Protocol Violation|0|||
143109781|NCT05129137|515942143|FG002|Third Period|Protocol Violation|0|||
143109782|NCT05129137|515942144|FG003|Third Period|Protocol Violation|1|||
143109783|NCT05129137|515942141|FG000|Forth Period|Protocol Violation|0|||
143109784|NCT05129137|515942142|FG001|Forth Period|Protocol Violation|1|||
143109785|NCT05129137|515942143|FG002|Forth Period|Protocol Violation|0|||
143109786|NCT05129137|515942144|FG003|Forth Period|Protocol Violation|0|||
143109787|NCT05129137|515942141|FG000|Forth Period|Withdrawal by Subject|0|||
143109788|NCT05129137|515942142|FG001|Forth Period|Withdrawal by Subject|0|||
143109789|NCT05129137|515942143|FG002|Forth Period|Withdrawal by Subject|1|||
143109790|NCT05129137|515942144|FG003|Forth Period|Withdrawal by Subject|0|||
143109791|NCT01475851|515942149|FG000|Overall Study|Protocol defined stopping criteria|1|||
143109792|NCT01475851|515942150|FG001|Overall Study|Protocol defined stopping criteria|0|||
143109793|NCT02447497|515942153|FG000|Overall Study|Did not meet treatment day baseline.|6|||
143109794|NCT02447497|515942154|FG001|Overall Study|Did not meet treatment day baseline.|5|||
143109795|NCT02447497|515942155|FG002|Overall Study|Did not meet treatment day baseline.|2|||
143109796|NCT02447497|515942156|FG003|Overall Study|Did not meet treatment day baseline.|2|||
143109797|NCT02447497|515942153|FG000|Overall Study|Dressing was compromised|0|||
143109798|NCT02447497|515942154|FG001|Overall Study|Dressing was compromised|1|||
143109799|NCT02447497|515942155|FG002|Overall Study|Dressing was compromised|0|||
143109800|NCT02447497|515942156|FG003|Overall Study|Dressing was compromised|0|||
143109801|NCT00844480|515942158|FG000|Overall Study|Withdrawal by Subject|2|||
143109802|NCT00844480|515942159|FG001|Overall Study|Withdrawal by Subject|3|||
143109803|NCT02858180|515942160|FG000|Overall Study|Lost to Follow-up|0|||
143109804|NCT02858180|515942161|FG001|Overall Study|Lost to Follow-up|2|||
143109805|NCT04553471|515942163|FG000|Overall Study|Did not start treatment on protocol|3|||
143109806|NCT04553471|515942163|FG000|Overall Study|Death|1|||
143109807|NCT01340027|515942164|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
143109808|NCT01340027|515942165|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
143257542|NCT01587898|516495860|FG001|Overall Study|Adverse Event|1|||
143109809|NCT01340027|515942166|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
143109810|NCT01340027|515942167|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
143109811|NCT01340027|515942168|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
143109812|NCT01340027|515942169|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
143257543|NCT01587898|516495861|FG002|Overall Study|Adverse Event|0|||
143109813|NCT01340027|515942170|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
143109814|NCT01340027|515942171|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
143109815|NCT01340027|515942172|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
143109816|NCT01340027|515942173|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
143109817|NCT01340027|515942174|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
143109818|NCT01340027|515942175|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
143109819|NCT01340027|515942164|FG000|Overall Study|Adverse Event|0|||
143109820|NCT01340027|515942165|FG001|Overall Study|Adverse Event|1|||
143109821|NCT01340027|515942166|FG002|Overall Study|Adverse Event|2|||
143109822|NCT01340027|515942167|FG003|Overall Study|Adverse Event|0|||
143109823|NCT01340027|515942168|FG004|Overall Study|Adverse Event|1|||
143109824|NCT01340027|515942169|FG005|Overall Study|Adverse Event|2|||
143109825|NCT01340027|515942170|FG006|Overall Study|Adverse Event|2|||
143109826|NCT01340027|515942171|FG007|Overall Study|Adverse Event|1|||
143109827|NCT01340027|515942172|FG008|Overall Study|Adverse Event|4|||
143109828|NCT01340027|515942173|FG009|Overall Study|Adverse Event|1|||
143109829|NCT01340027|515942174|FG010|Overall Study|Adverse Event|1|||
143109830|NCT01340027|515942175|FG011|Overall Study|Adverse Event|3|||
143109831|NCT01340027|515942164|FG000|Overall Study|Lack of Efficacy|0|||
143109832|NCT01340027|515942165|FG001|Overall Study|Lack of Efficacy|0|||
143109833|NCT01340027|515942166|FG002|Overall Study|Lack of Efficacy|0|||
143109834|NCT01340027|515942167|FG003|Overall Study|Lack of Efficacy|0|||
143109835|NCT01340027|515942168|FG004|Overall Study|Lack of Efficacy|0|||
143109836|NCT01340027|515942169|FG005|Overall Study|Lack of Efficacy|0|||
143109837|NCT01340027|515942170|FG006|Overall Study|Lack of Efficacy|1|||
143109838|NCT01340027|515942171|FG007|Overall Study|Lack of Efficacy|1|||
143109839|NCT01340027|515942172|FG008|Overall Study|Lack of Efficacy|1|||
143109840|NCT01340027|515942173|FG009|Overall Study|Lack of Efficacy|0|||
143109841|NCT01340027|515942174|FG010|Overall Study|Lack of Efficacy|0|||
143109842|NCT01340027|515942175|FG011|Overall Study|Lack of Efficacy|0|||
143109843|NCT01340027|515942164|FG000|Overall Study|Lost to Follow-up|0|||
143109844|NCT01340027|515942165|FG001|Overall Study|Lost to Follow-up|1|||
143109845|NCT01340027|515942166|FG002|Overall Study|Lost to Follow-up|0|||
143109846|NCT01340027|515942167|FG003|Overall Study|Lost to Follow-up|0|||
143109847|NCT01340027|515942168|FG004|Overall Study|Lost to Follow-up|0|||
143109848|NCT01340027|515942169|FG005|Overall Study|Lost to Follow-up|0|||
143109849|NCT01340027|515942170|FG006|Overall Study|Lost to Follow-up|1|||
143109850|NCT01340027|515942171|FG007|Overall Study|Lost to Follow-up|0|||
143109851|NCT01340027|515942172|FG008|Overall Study|Lost to Follow-up|0|||
143109852|NCT01340027|515942173|FG009|Overall Study|Lost to Follow-up|1|||
143109853|NCT01340027|515942174|FG010|Overall Study|Lost to Follow-up|0|||
143368173|NCT04044664|516890918|FG001|Stage 2|Adverse Event|0|||
143109854|NCT01340027|515942175|FG011|Overall Study|Lost to Follow-up|0|||
143109855|NCT01340027|515942164|FG000|Overall Study|Protocol Violation|1|||
143109856|NCT01340027|515942165|FG001|Overall Study|Protocol Violation|2|||
143109857|NCT01340027|515942166|FG002|Overall Study|Protocol Violation|0|||
143109858|NCT01340027|515942167|FG003|Overall Study|Protocol Violation|0|||
143109859|NCT01340027|515942168|FG004|Overall Study|Protocol Violation|6|||
143109860|NCT01340027|515942169|FG005|Overall Study|Protocol Violation|0|||
143109861|NCT01340027|515942170|FG006|Overall Study|Protocol Violation|0|||
143109862|NCT01340027|515942171|FG007|Overall Study|Protocol Violation|1|||
143109863|NCT01340027|515942172|FG008|Overall Study|Protocol Violation|2|||
143109864|NCT01340027|515942173|FG009|Overall Study|Protocol Violation|2|||
143109865|NCT01340027|515942174|FG010|Overall Study|Protocol Violation|0|||
143109866|NCT01340027|515942175|FG011|Overall Study|Protocol Violation|0|||
143109867|NCT01340027|515942164|FG000|Overall Study|Withdrawal by Subject|4|||
143109868|NCT01340027|515942165|FG001|Overall Study|Withdrawal by Subject|3|||
143109869|NCT01340027|515942166|FG002|Overall Study|Withdrawal by Subject|1|||
143109870|NCT01340027|515942167|FG003|Overall Study|Withdrawal by Subject|3|||
143109871|NCT01340027|515942168|FG004|Overall Study|Withdrawal by Subject|3|||
143109872|NCT01340027|515942169|FG005|Overall Study|Withdrawal by Subject|2|||
143109873|NCT01340027|515942170|FG006|Overall Study|Withdrawal by Subject|3|||
143109874|NCT01340027|515942171|FG007|Overall Study|Withdrawal by Subject|4|||
143109875|NCT01340027|515942172|FG008|Overall Study|Withdrawal by Subject|1|||
143109876|NCT01340027|515942173|FG009|Overall Study|Withdrawal by Subject|2|||
143109877|NCT01340027|515942174|FG010|Overall Study|Withdrawal by Subject|0|||
143109878|NCT01340027|515942175|FG011|Overall Study|Withdrawal by Subject|1|||
143109879|NCT01340027|515942164|FG000|Overall Study|Miscellaneous|0|||
143109880|NCT01340027|515942165|FG001|Overall Study|Miscellaneous|0|||
143109881|NCT01340027|515942166|FG002|Overall Study|Miscellaneous|0|||
143109882|NCT01340027|515942167|FG003|Overall Study|Miscellaneous|1|||
143109883|NCT01340027|515942168|FG004|Overall Study|Miscellaneous|0|||
143109884|NCT01340027|515942169|FG005|Overall Study|Miscellaneous|0|||
143109885|NCT01340027|515942170|FG006|Overall Study|Miscellaneous|0|||
143109886|NCT01340027|515942171|FG007|Overall Study|Miscellaneous|0|||
143368174|NCT04044664|516890919|FG002|Stage 2|Adverse Event|0|||
143109887|NCT01340027|515942172|FG008|Overall Study|Miscellaneous|0|||
143109888|NCT01340027|515942173|FG009|Overall Study|Miscellaneous|0|||
143368175|NCT04044664|516890917|FG000|Stage 2|Lost to Follow-up|3|||
143368176|NCT04044664|516890918|FG001|Stage 2|Lost to Follow-up|2|||
143368177|NCT04044664|516890919|FG002|Stage 2|Lost to Follow-up|1|||
143368178|NCT04044664|516890917|FG000|Stage 2|Withdrawal by Subject|3|||
143368179|NCT04044664|516890918|FG001|Stage 2|Withdrawal by Subject|0|||
143368180|NCT04044664|516890919|FG002|Stage 2|Withdrawal by Subject|0|||
143368181|NCT04044664|516890917|FG000|Stage 2|protocol deviation|1|||
143368182|NCT04044664|516890918|FG001|Stage 2|protocol deviation|0|||
143368183|NCT04044664|516890919|FG002|Stage 2|protocol deviation|0|||
143368184|NCT03736785|516890923|FG000|Overall Study|Adverse Event|1|||
143368185|NCT03736785|516890924|FG001|Overall Study|Adverse Event|1|||
143368186|NCT03736785|516890925|FG002|Overall Study|Adverse Event|1|||
143368187|NCT03736785|516890923|FG000|Overall Study|Death|1|||
143368188|NCT03736785|516890924|FG001|Overall Study|Death|0|||
143368189|NCT03736785|516890925|FG002|Overall Study|Death|1|||
143368190|NCT03736785|516890923|FG000|Overall Study|Lost to Follow-up|0|||
143368191|NCT03736785|516890924|FG001|Overall Study|Lost to Follow-up|2|||
143368192|NCT03736785|516890925|FG002|Overall Study|Lost to Follow-up|3|||
143368193|NCT03736785|516890923|FG000|Overall Study|Non compliance with study drug|1|||
143368194|NCT03736785|516890924|FG001|Overall Study|Non compliance with study drug|1|||
143368195|NCT03736785|516890925|FG002|Overall Study|Non compliance with study drug|0|||
143368196|NCT03736785|516890923|FG000|Overall Study|Physician Decision|0|||
143368197|NCT03736785|516890924|FG001|Overall Study|Physician Decision|1|||
143368198|NCT03736785|516890925|FG002|Overall Study|Physician Decision|1|||
143368199|NCT03736785|516890923|FG000|Overall Study|Protocol Violation|1|||
143368200|NCT03736785|516890924|FG001|Overall Study|Protocol Violation|4|||
143368201|NCT03736785|516890925|FG002|Overall Study|Protocol Violation|3|||
143368202|NCT03736785|516890923|FG000|Overall Study|Sponsor Decision|1|||
143368203|NCT03736785|516890924|FG001|Overall Study|Sponsor Decision|0|||
143368204|NCT03736785|516890925|FG002|Overall Study|Sponsor Decision|0|||
143368205|NCT03736785|516890923|FG000|Overall Study|Unknown/Missing data|3|||
143368206|NCT03736785|516890924|FG001|Overall Study|Unknown/Missing data|2|||
143368207|NCT03736785|516890925|FG002|Overall Study|Unknown/Missing data|1|||
143368208|NCT03736785|516890923|FG000|Overall Study|Withdrawal by Subject|9|||
143368209|NCT03736785|516890924|FG001|Overall Study|Withdrawal by Subject|6|||
143368210|NCT03736785|516890925|FG002|Overall Study|Withdrawal by Subject|4|||
143368211|NCT01744691|516890928|FG000|Overall Study|Progressive Disease|18|||
143368212|NCT01744691|516890928|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
143368213|NCT01744691|516890928|FG000|Overall Study|Withdrawal of consent for treatment|3|||
143368214|NCT01744691|516890928|FG000|Overall Study|Physician Decision|4|||
143368215|NCT04588480|516890929|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
143368216|NCT04588480|516890930|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
143368217|NCT04588480|516890931|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
143368218|NCT04588480|516890929|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
143368219|NCT04588480|516890930|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
143368220|NCT04588480|516890931|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
143368221|NCT05196737|516890944|FG000|Non-intervention Week|Lost to Follow-up|2|||
143368222|NCT05196737|516890944|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
143368223|NCT03722446|516890945|FG000|Overall Study|Protocol Violation|15|||
143368224|NCT03722446|516890946|FG001|Overall Study|Protocol Violation|2|||
143368225|NCT00871429|516890951|FG000|Overall Study|Lost to Follow-up|6|||
143368226|NCT00871429|516890951|FG000|Overall Study|Withdrawal by Subject|17|||
143368227|NCT00871429|516890951|FG000|Overall Study|Questionnaire not completed|1|||
143368228|NCT02908464|516890952|FG000|Overall Study|Withdrawal by Subject|2|||
143368229|NCT02908464|516890953|FG001|Overall Study|Withdrawal by Subject|1|||
143368230|NCT02908464|516890952|FG000|Overall Study|Found ineligible after randomization|0|||
143368231|NCT02908464|516890953|FG001|Overall Study|Found ineligible after randomization|2|||
143368232|NCT00477412|516890954|FG000|Overall Study|Death|0|||
143257544|NCT01587898|516495862|FG003|Overall Study|Adverse Event|0|||
143257545|NCT01587898|516495859|FG000|Overall Study|Protocol Violation|0|||
143257546|NCT01587898|516495860|FG001|Overall Study|Protocol Violation|2|||
143257547|NCT01587898|516495861|FG002|Overall Study|Protocol Violation|1|||
143257548|NCT01587898|516495862|FG003|Overall Study|Protocol Violation|1|||
143257549|NCT01587898|516495859|FG000|Overall Study|Lost to Follow-up|0|||
143257550|NCT01587898|516495860|FG001|Overall Study|Lost to Follow-up|0|||
143257551|NCT01587898|516495861|FG002|Overall Study|Lost to Follow-up|0|||
143368233|NCT00477412|516890955|FG001|Overall Study|Death|0|||
143368234|NCT00477412|516890956|FG002|Overall Study|Death|0|||
143257552|NCT01587898|516495862|FG003|Overall Study|Lost to Follow-up|1|||
143257553|NCT01587898|516495859|FG000|Overall Study|Withdrawal by Subject|2|||
143368235|NCT00477412|516890957|FG003|Overall Study|Death|4|||
143368236|NCT00477412|516890954|FG000|Overall Study|Lost to Follow-up|0|||
143368237|NCT00477412|516890955|FG001|Overall Study|Lost to Follow-up|0|||
143368238|NCT00477412|516890956|FG002|Overall Study|Lost to Follow-up|0|||
143368239|NCT00477412|516890957|FG003|Overall Study|Lost to Follow-up|1|||
143368240|NCT00477412|516890954|FG000|Overall Study|Withdrawal by Subject|0|||
143368241|NCT00477412|516890955|FG001|Overall Study|Withdrawal by Subject|0|||
143368242|NCT00477412|516890956|FG002|Overall Study|Withdrawal by Subject|0|||
143179386|NCT00003631|516203703|FG001|Overall Study|Patient not treated|0|||
143179387|NCT00003631|516203704|FG002|Overall Study|Patient not treated|1|||
143179388|NCT00003631|516203702|FG000|Overall Study|Protocol Violation|1|||
143179389|NCT00003631|516203703|FG001|Overall Study|Protocol Violation|0|||
143179390|NCT00003631|516203704|FG002|Overall Study|Protocol Violation|0|||
143179391|NCT00003631|516203702|FG000|Overall Study|Adverse Event|1|||
143179392|NCT00003631|516203703|FG001|Overall Study|Adverse Event|1|||
143179393|NCT00003631|516203704|FG002|Overall Study|Adverse Event|5|||
143179394|NCT00003631|516203702|FG000|Overall Study|Death|0|||
143179395|NCT00003631|516203703|FG001|Overall Study|Death|0|||
143179396|NCT00003631|516203704|FG002|Overall Study|Death|1|||
143179397|NCT00003631|516203702|FG000|Overall Study|Evaluable for toxicity only|0|||
143179398|NCT00003631|516203703|FG001|Overall Study|Evaluable for toxicity only|0|||
143179399|NCT00003631|516203704|FG002|Overall Study|Evaluable for toxicity only|2|||
143179400|NCT00087698|516203710|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
143179401|NCT00087698|516203710|FG000|Overall Study|Death from Other Causes|3|||
143179402|NCT00087698|516203710|FG000|Overall Study|Adverse Event|4|||
143179403|NCT00087698|516203710|FG000|Overall Study|Withdrawal by Subject|4|||
143179404|NCT00087698|516203710|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
143179405|NCT00087698|516203710|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
143179406|NCT00087698|516203710|FG000|Overall Study|Clinical Relapse|1|||
143179407|NCT00087698|516203710|FG000|Overall Study|Death from Study Disease|2|||
143179408|NCT00087698|516203710|FG000|Overall Study|Death from Study Drug Toxicity|2|||
143179409|NCT00087698|516203710|FG000|Overall Study|Protocol Violation|1|||
143179410|NCT01220401|516203711|FG000|Overall Study|Withdrawal by Subject|2|||
143257554|NCT01587898|516495860|FG001|Overall Study|Withdrawal by Subject|1|||
143257555|NCT01587898|516495861|FG002|Overall Study|Withdrawal by Subject|0|||
143179411|NCT01220401|516203711|FG000|Overall Study|Protocol Violation|1|||
143179412|NCT03192137|516203715|FG000|Overall Study|Adverse Event|10|||
143179413|NCT03192137|516203716|FG001|Overall Study|Adverse Event|11|||
143179414|NCT03192137|516203715|FG000|Overall Study|Physician Decision|1|||
143179415|NCT03192137|516203716|FG001|Overall Study|Physician Decision|0|||
143179416|NCT03192137|516203715|FG000|Overall Study|Lack of Efficacy|20|||
143179417|NCT03192137|516203716|FG001|Overall Study|Lack of Efficacy|37|||
143179418|NCT03192137|516203715|FG000|Overall Study|Withdrawal by Subject|3|||
143179419|NCT03192137|516203716|FG001|Overall Study|Withdrawal by Subject|3|||
143179420|NCT03192137|516203715|FG000|Overall Study|Protocol Violation|4|||
143179421|NCT03192137|516203716|FG001|Overall Study|Protocol Violation|3|||
143179422|NCT03192137|516203715|FG000|Overall Study|Surgery Cancelled|4|||
143179423|NCT03192137|516203716|FG001|Overall Study|Surgery Cancelled|1|||
143179424|NCT03192137|516203715|FG000|Overall Study|Other - Various Administrative Reasons|8|||
143179425|NCT03192137|516203716|FG001|Overall Study|Other - Various Administrative Reasons|3|||
143179426|NCT02737501|516203719|FG000|Randomized Phase|Died|41|||
143179427|NCT02737501|516203720|FG001|Randomized Phase|Died|29|||
143179428|NCT02737501|516203721|FG002|Randomized Phase|Died|0|||
143179429|NCT02737501|516203719|FG000|Randomized Phase|Withdrawal by Subject|16|||
143179430|NCT02737501|516203720|FG001|Randomized Phase|Withdrawal by Subject|6|||
143257556|NCT01587898|516495862|FG003|Overall Study|Withdrawal by Subject|0|||
143257557|NCT01587898|516495859|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
143257558|NCT01587898|516495860|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
143257559|NCT01587898|516495861|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
143257560|NCT01587898|516495862|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
143257561|NCT01738477|516495863|FG000|Overall Study|Lost to Follow-up|1|||
143257562|NCT01738477|516495864|FG001|Overall Study|Lost to Follow-up|4|||
143257563|NCT00502203|516495865|FG000|Overall Study|Inevaluable|1|||
143257564|NCT01903252|516495868|FG000|Double-Blind Induction|Adverse Event|20|||
143257565|NCT01903252|516495869|FG001|Double-Blind Induction|Adverse Event|18|||
143257566|NCT01903252|516495870|FG002|Double-Blind Induction|Adverse Event|0|||
143257567|NCT01903252|516495871|FG003|Double-Blind Induction|Adverse Event|0|||
143257568|NCT01903252|516495872|FG004|Double-Blind Induction|Adverse Event|0|||
143257569|NCT01903252|516495873|FG005|Double-Blind Induction|Adverse Event|0|||
143257570|NCT01903252|516495868|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
143257571|NCT01903252|516495869|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
143257572|NCT01903252|516495870|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
143257573|NCT01903252|516495871|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
143257574|NCT01903252|516495872|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
143257575|NCT01903252|516495873|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
143257576|NCT01903252|516495868|FG000|Double-Blind Induction|Physician Decision|2|||
143257577|NCT01903252|516495869|FG001|Double-Blind Induction|Physician Decision|3|||
143257578|NCT01903252|516495870|FG002|Double-Blind Induction|Physician Decision|0|||
143179431|NCT02737501|516203721|FG002|Randomized Phase|Withdrawal by Subject|0|||
143179432|NCT02737501|516203719|FG000|Randomized Phase|Lost to Follow-up|0|||
143179433|NCT02737501|516203720|FG001|Randomized Phase|Lost to Follow-up|1|||
143179434|NCT02737501|516203721|FG002|Randomized Phase|Lost to Follow-up|0|||
143179435|NCT02737501|516203719|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
143179436|NCT02737501|516203720|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
143109889|NCT01340027|515942174|FG010|Overall Study|Miscellaneous|1|||
143109890|NCT01340027|515942175|FG011|Overall Study|Miscellaneous|0|||
143109891|NCT00833482|515942176|FG000|Days 11-20|Adverse Event|0|||
143109892|NCT00833482|515942177|FG001|Days 11-20|Adverse Event|2|||
143109893|NCT00833482|515942178|FG002|Days 11-20|Adverse Event|0|||
143109894|NCT00833482|515942179|FG003|Days 11-20|Adverse Event|0|||
143109895|NCT00833482|515942180|FG004|Days 11-20|Adverse Event|0|||
143109896|NCT00833482|515942181|FG005|Days 11-20|Adverse Event|0|||
143109897|NCT00833482|515942176|FG000|Days 11-20|Withdrawal by Subject|0|||
143109898|NCT00833482|515942177|FG001|Days 11-20|Withdrawal by Subject|1|||
143109899|NCT00833482|515942178|FG002|Days 11-20|Withdrawal by Subject|0|||
143109900|NCT00833482|515942179|FG003|Days 11-20|Withdrawal by Subject|0|||
143109901|NCT00833482|515942180|FG004|Days 11-20|Withdrawal by Subject|0|||
143109902|NCT00833482|515942181|FG005|Days 11-20|Withdrawal by Subject|0|||
143109903|NCT00833482|515942176|FG000|Days 21-30|Adverse Event|0|||
143109904|NCT00833482|515942177|FG001|Days 21-30|Adverse Event|0|||
143109905|NCT00833482|515942178|FG002|Days 21-30|Adverse Event|1|||
143109906|NCT00833482|515942179|FG003|Days 21-30|Adverse Event|0|||
143109907|NCT00833482|515942180|FG004|Days 21-30|Adverse Event|0|||
143109908|NCT00833482|515942181|FG005|Days 21-30|Adverse Event|0|||
143109909|NCT00833482|515942176|FG000|Days 21-30|Withdrawal by Subject|0|||
143109910|NCT00833482|515942177|FG001|Days 21-30|Withdrawal by Subject|0|||
143109911|NCT00833482|515942178|FG002|Days 21-30|Withdrawal by Subject|0|||
143109912|NCT00833482|515942179|FG003|Days 21-30|Withdrawal by Subject|0|||
143109913|NCT00833482|515942180|FG004|Days 21-30|Withdrawal by Subject|1|||
143109914|NCT00833482|515942181|FG005|Days 21-30|Withdrawal by Subject|0|||
143109915|NCT02572076|515942182|FG000|Overall Study|Protocol Violation|1|||
143109916|NCT02272842|515942185|FG000|Overall Study|Lost to Follow-up|8|||
143109917|NCT02272842|515942186|FG001|Overall Study|Lost to Follow-up|8|||
143109918|NCT02272842|515942185|FG000|Overall Study|Withdrawal by Subject|8|||
143109919|NCT02272842|515942186|FG001|Overall Study|Withdrawal by Subject|2|||
143109920|NCT01273623|515942190|FG000|Overall Study|did not meet IVUS criteria|29|||
143109921|NCT03053063|515942204|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
143109922|NCT03053063|515942205|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
143109923|NCT03053063|515942206|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
143109924|NCT03053063|515942207|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
143109925|NCT03053063|515942204|FG000|Randomized Phase|Withdrew consent|8|||
143109926|NCT03053063|515942205|FG001|Randomized Phase|Withdrew consent|11|||
143109927|NCT03053063|515942206|FG002|Randomized Phase|Withdrew consent|5|||
143109928|NCT03053063|515942207|FG003|Randomized Phase|Withdrew consent|0|||
143109929|NCT03053063|515942204|FG000|Randomized Phase|Investigator's Discretion|8|||
143109930|NCT03053063|515942205|FG001|Randomized Phase|Investigator's Discretion|6|||
143109931|NCT03053063|515942206|FG002|Randomized Phase|Investigator's Discretion|2|||
143109932|NCT03053063|515942207|FG003|Randomized Phase|Investigator's Discretion|0|||
143109933|NCT03053063|515942204|FG000|Randomized Phase|Lost to Follow-up|3|||
143109934|NCT03053063|515942205|FG001|Randomized Phase|Lost to Follow-up|5|||
143109935|NCT03053063|515942206|FG002|Randomized Phase|Lost to Follow-up|1|||
143109936|NCT03053063|515942207|FG003|Randomized Phase|Lost to Follow-up|0|||
143109937|NCT03053063|515942204|FG000|Randomized Phase|Adverse Event|0|||
143109938|NCT03053063|515942205|FG001|Randomized Phase|Adverse Event|1|||
143109939|NCT03053063|515942206|FG002|Randomized Phase|Adverse Event|0|||
143109940|NCT03053063|515942207|FG003|Randomized Phase|Adverse Event|0|||
143109941|NCT03053063|515942204|FG000|Randomized Phase|Randomized but Never Treated|1|||
143109942|NCT03053063|515942205|FG001|Randomized Phase|Randomized but Never Treated|3|||
143109943|NCT03053063|515942206|FG002|Randomized Phase|Randomized but Never Treated|2|||
143109944|NCT03053063|515942207|FG003|Randomized Phase|Randomized but Never Treated|0|||
143109945|NCT03053063|515942204|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
143109946|NCT03053063|515942205|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
143109947|NCT03053063|515942206|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
143109948|NCT03053063|515942207|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
143109949|NCT03053063|515942204|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
143109950|NCT03053063|515942205|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
143109951|NCT03053063|515942206|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
143109952|NCT03053063|515942207|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
143109953|NCT03053063|515942204|FG000|Open-Label Phase|Death|0|||
143109954|NCT03053063|515942205|FG001|Open-Label Phase|Death|0|||
143109955|NCT03053063|515942206|FG002|Open-Label Phase|Death|0|||
143257579|NCT01903252|516495871|FG003|Double-Blind Induction|Physician Decision|0|||
143257580|NCT01903252|516495872|FG004|Double-Blind Induction|Physician Decision|0|||
143257581|NCT01903252|516495873|FG005|Double-Blind Induction|Physician Decision|0|||
143257582|NCT01903252|516495868|FG000|Double-Blind Induction|non-compliance,|7|||
143257583|NCT01903252|516495869|FG001|Double-Blind Induction|non-compliance,|7|||
143257584|NCT01903252|516495870|FG002|Double-Blind Induction|non-compliance,|0|||
143257585|NCT01903252|516495871|FG003|Double-Blind Induction|non-compliance,|0|||
143257586|NCT01903252|516495872|FG004|Double-Blind Induction|non-compliance,|0|||
143109956|NCT03053063|515942207|FG003|Open-Label Phase|Death|2|||
143109957|NCT03053063|515942204|FG000|Open-Label Phase|Investigator's discretion|0|||
143109958|NCT03053063|515942205|FG001|Open-Label Phase|Investigator's discretion|0|||
143109959|NCT03053063|515942206|FG002|Open-Label Phase|Investigator's discretion|0|||
143109960|NCT03053063|515942207|FG003|Open-Label Phase|Investigator's discretion|2|||
143109961|NCT01970475|515942209|FG000|Overall Study|Withdrawal by Subject|11|||
143109962|NCT01970475|515942210|FG001|Overall Study|Withdrawal by Subject|6|||
143109963|NCT01970475|515942209|FG000|Overall Study|Adverse Event|7|||
143109964|NCT01970475|515942210|FG001|Overall Study|Adverse Event|3|||
143109965|NCT01970475|515942209|FG000|Overall Study|Lost to Follow-up|2|||
143109966|NCT01970475|515942210|FG001|Overall Study|Lost to Follow-up|2|||
143109967|NCT01970475|515942209|FG000|Overall Study|Protocol Violation|1|||
143109968|NCT01970475|515942210|FG001|Overall Study|Protocol Violation|0|||
143109969|NCT05033262|515942221|FG000|Overall Study|Lost to Follow-up|1|||
143109970|NCT05033262|515942222|FG001|Overall Study|Lost to Follow-up|0|||
143109971|NCT05033262|515942223|FG002|Overall Study|Lost to Follow-up|0|||
143109972|NCT05033262|515942224|FG003|Overall Study|Lost to Follow-up|1|||
143109973|NCT03634033|515944570|FG000|Overall Study|Did not have a post-assessment|384|||
143109974|NCT03634033|515944571|FG001|Overall Study|Did not have a post-assessment|291|||
143109975|NCT03634033|515944572|FG002|Overall Study|Did not have a post-assessment|114|||
143109976|NCT03634033|515944573|FG003|Overall Study|Did not have a post-assessment|161|||
143109977|NCT03634033|515944574|FG004|Overall Study|Did not have a post-assessment|5|||
143109978|NCT03634033|515944575|FG005|Overall Study|Did not have a post-assessment|0|||
143109979|NCT03634033|515944576|FG006|Overall Study|Did not have a post-assessment|0|||
143109980|NCT03634033|515944570|FG000|Overall Study|Death|0|||
143109981|NCT03634033|515944571|FG001|Overall Study|Death|0|||
143109982|NCT03634033|515944572|FG002|Overall Study|Death|0|||
143109983|NCT03634033|515944573|FG003|Overall Study|Death|0|||
143109984|NCT03634033|515944574|FG004|Overall Study|Death|0|||
143109985|NCT03634033|515944575|FG005|Overall Study|Death|7|||
143109986|NCT03634033|515944576|FG006|Overall Study|Death|7|||
143109987|NCT03634033|515944570|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
143109988|NCT03634033|515944571|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
143109989|NCT03634033|515944572|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
143109990|NCT03634033|515944573|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
143109991|NCT03634033|515944574|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
143109992|NCT03634033|515944575|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
143109993|NCT03634033|515944576|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
143109994|NCT03634033|515944570|FG000|Overall Study|Lost to Follow-up|0|||
143109995|NCT03634033|515944571|FG001|Overall Study|Lost to Follow-up|0|||
143109996|NCT03634033|515944572|FG002|Overall Study|Lost to Follow-up|0|||
143109997|NCT03634033|515944573|FG003|Overall Study|Lost to Follow-up|0|||
143109998|NCT03634033|515944574|FG004|Overall Study|Lost to Follow-up|0|||
143109999|NCT03634033|515944575|FG005|Overall Study|Lost to Follow-up|1|||
143110000|NCT03634033|515944576|FG006|Overall Study|Lost to Follow-up|2|||
143110001|NCT03634033|515944570|FG000|Overall Study|Withdrawal by Subject|0|||
143110002|NCT03634033|515944571|FG001|Overall Study|Withdrawal by Subject|0|||
143110003|NCT03634033|515944572|FG002|Overall Study|Withdrawal by Subject|0|||
143110004|NCT03634033|515944573|FG003|Overall Study|Withdrawal by Subject|0|||
143110005|NCT03634033|515944574|FG004|Overall Study|Withdrawal by Subject|0|||
143110006|NCT03634033|515944575|FG005|Overall Study|Withdrawal by Subject|0|||
143110007|NCT03634033|515944576|FG006|Overall Study|Withdrawal by Subject|1|||
143110008|NCT06366087|515944577|FG000|Overall Study|Withdrawal by Subject|0|||
143110009|NCT06366087|515944578|FG001|Overall Study|Withdrawal by Subject|1|||
143110010|NCT00860249|515944584|FG000|Overall Study|trial was terminated prior to completion|21|||
143110011|NCT00860249|515944585|FG001|Overall Study|trial was terminated prior to completion|18|||
143110012|NCT00860249|515944586|FG002|Overall Study|trial was terminated prior to completion|21|||
143110013|NCT00743288|515944587|FG000|Overall Study|Adverse Event|1|||
143110014|NCT00743288|515944588|FG001|Overall Study|Adverse Event|1|||
143110015|NCT00743288|515944589|FG002|Overall Study|Adverse Event|2|||
143110016|NCT00743288|515944590|FG003|Overall Study|Adverse Event|2|||
143110017|NCT00743288|515944591|FG004|Overall Study|Adverse Event|1|||
143110018|NCT00743288|515944592|FG005|Overall Study|Adverse Event|1|||
143110019|NCT00743288|515944593|FG006|Overall Study|Adverse Event|2|||
143110020|NCT00743288|515944587|FG000|Overall Study|Withdrawal by Subject|0|||
143110021|NCT00743288|515944588|FG001|Overall Study|Withdrawal by Subject|0|||
143110022|NCT00743288|515944589|FG002|Overall Study|Withdrawal by Subject|1|||
143110023|NCT00743288|515944590|FG003|Overall Study|Withdrawal by Subject|0|||
143257587|NCT01903252|516495873|FG005|Double-Blind Induction|non-compliance,|0|||
143257588|NCT01903252|516495868|FG000|Extended Induction, Open-Label|Adverse Event|0|||
143257589|NCT01903252|516495869|FG001|Extended Induction, Open-Label|Adverse Event|0|||
143257590|NCT01903252|516495870|FG002|Extended Induction, Open-Label|Adverse Event|17|||
143257591|NCT01903252|516495871|FG003|Extended Induction, Open-Label|Adverse Event|0|||
143257592|NCT01903252|516495872|FG004|Extended Induction, Open-Label|Adverse Event|0|||
143110024|NCT00743288|515944591|FG004|Overall Study|Withdrawal by Subject|0|||
143110025|NCT00743288|515944592|FG005|Overall Study|Withdrawal by Subject|1|||
143110026|NCT00743288|515944593|FG006|Overall Study|Withdrawal by Subject|1|||
143110027|NCT00743288|515944587|FG000|Overall Study|Progressive disease (PD)|2|||
143368243|NCT00477412|516890957|FG003|Overall Study|Withdrawal by Subject|2|||
143368244|NCT00477412|516890954|FG000|Overall Study|Second Malignancy|0|||
143368245|NCT00477412|516890955|FG001|Overall Study|Second Malignancy|0|||
143368246|NCT00477412|516890956|FG002|Overall Study|Second Malignancy|0|||
143368247|NCT00477412|516890957|FG003|Overall Study|Second Malignancy|1|||
143368248|NCT00477412|516890954|FG000|Overall Study|Adverse Event|1|||
143368249|NCT00477412|516890955|FG001|Overall Study|Adverse Event|0|||
143368250|NCT00477412|516890956|FG002|Overall Study|Adverse Event|1|||
143368251|NCT00477412|516890957|FG003|Overall Study|Adverse Event|0|||
143368252|NCT02931396|516890959|FG000|Overall Study|Lost to Follow-up|3|||
143368253|NCT02931396|516890960|FG001|Overall Study|Lost to Follow-up|0|||
143368254|NCT02931396|516890959|FG000|Overall Study|Withdrawal by Subject|2|||
143368255|NCT02931396|516890960|FG001|Overall Study|Withdrawal by Subject|0|||
143110028|NCT00743288|515944588|FG001|Overall Study|Progressive disease (PD)|0|||
143110029|NCT00743288|515944589|FG002|Overall Study|Progressive disease (PD)|1|||
143110030|NCT00743288|515944590|FG003|Overall Study|Progressive disease (PD)|4|||
143110031|NCT00743288|515944591|FG004|Overall Study|Progressive disease (PD)|5|||
143110032|NCT00743288|515944592|FG005|Overall Study|Progressive disease (PD)|3|||
143110033|NCT00743288|515944593|FG006|Overall Study|Progressive disease (PD)|6|||
143110034|NCT00743288|515944587|FG000|Overall Study|Worsening of condition (Not PD)|0|||
143110035|NCT00743288|515944588|FG001|Overall Study|Worsening of condition (Not PD)|2|||
143110036|NCT00743288|515944589|FG002|Overall Study|Worsening of condition (Not PD)|1|||
143110037|NCT00743288|515944590|FG003|Overall Study|Worsening of condition (Not PD)|1|||
143110038|NCT00743288|515944591|FG004|Overall Study|Worsening of condition (Not PD)|0|||
143110039|NCT00743288|515944592|FG005|Overall Study|Worsening of condition (Not PD)|0|||
143110040|NCT00743288|515944593|FG006|Overall Study|Worsening of condition (Not PD)|0|||
143110041|NCT05903924|515944594|FG000|Overall Study|Lost to Follow-up|1|||
143110042|NCT05903924|515944595|FG001|Overall Study|Lost to Follow-up|0|||
143110043|NCT05903924|515944596|FG002|Overall Study|Lost to Follow-up|0|||
143110044|NCT02706886|515944605|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
143110045|NCT02706886|515944606|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
143110046|NCT02706886|515944607|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
143110047|NCT02706886|515944608|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
143110048|NCT02706886|515944609|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
143110049|NCT02706886|515944610|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
143110050|NCT02706886|515944611|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
143110051|NCT02706886|515944612|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
143110052|NCT02706886|515944613|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
143110053|NCT02759055|515944614|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
143110054|NCT02759055|515944615|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
143110055|NCT04934189|515944616|FG000|Overall Study|Lost to Follow-up|4|||
143110056|NCT04934189|515944616|FG000|Overall Study|Withdrawal by Subject|17|||
143110057|NCT01871402|515944627|FG000|Overall Study|Lost to Follow-up|1|||
143110058|NCT01871402|515944628|FG001|Overall Study|Lost to Follow-up|0|||
143110059|NCT01871402|515944627|FG000|Overall Study|Withdrawal by Subject|0|||
143110060|NCT01871402|515944628|FG001|Overall Study|Withdrawal by Subject|2|||
143110061|NCT01871402|515944627|FG000|Overall Study|Non-compliance|0|||
143110062|NCT01871402|515944628|FG001|Overall Study|Non-compliance|1|||
143110063|NCT04594941|515944629|FG000|Overall Study|Other|0|||
143110064|NCT04594941|515944630|FG001|Overall Study|Other|3|||
143110065|NCT04594941|515944631|FG002|Overall Study|Other|1|||
143110066|NCT04594941|515944632|FG003|Overall Study|Other|0|||
143110067|NCT01895270|515944635|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
143110068|NCT01895270|515944636|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
143110069|NCT01895270|515944635|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
143110070|NCT01895270|515944636|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
143110071|NCT01895270|515944635|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
143110072|NCT01895270|515944636|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
143110073|NCT01895270|515944635|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
143110074|NCT01895270|515944636|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
143110075|NCT01895270|515944635|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
143368256|NCT05460663|516890961|FG000|Overall Study|Withdrawal by Subject|2|||
143110076|NCT01895270|515944636|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
143110077|NCT01895270|515944635|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
143368257|NCT05460663|516890962|FG001|Overall Study|Withdrawal by Subject|5|||
143110078|NCT01895270|515944636|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
143110079|NCT01895270|515944635|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
143110080|NCT01895270|515944636|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
143110081|NCT02091375|515944637|FG000|Overall Study|Adverse Event|8|||
143110082|NCT02091375|515944638|FG001|Overall Study|Adverse Event|1|||
143368258|NCT03068468|516892633|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
143368259|NCT03068468|516892634|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
143110083|NCT02091375|515944637|FG000|Overall Study|Lost to Follow-up|0|||
143110084|NCT02091375|515944638|FG001|Overall Study|Lost to Follow-up|1|||
143110085|NCT02091375|515944637|FG000|Overall Study|Withdrawal by Subject|0|||
143110086|NCT02091375|515944638|FG001|Overall Study|Withdrawal by Subject|1|||
143110087|NCT02091375|515944637|FG000|Overall Study|Withdrawn by the investigator|1|||
143110088|NCT02091375|515944638|FG001|Overall Study|Withdrawn by the investigator|0|||
143110089|NCT02682823|515944639|FG000|Overall Study|Withdrawal by Subject|0|||
143110090|NCT02682823|515944640|FG001|Overall Study|Withdrawal by Subject|0|||
143110091|NCT02682823|515944641|FG002|Overall Study|Withdrawal by Subject|1|||
143110092|NCT02682823|515944642|FG003|Overall Study|Withdrawal by Subject|0|||
143110093|NCT02682823|515944643|FG004|Overall Study|Withdrawal by Subject|1|||
143110094|NCT02682823|515944639|FG000|Overall Study|Protocol Deviation|0|||
143110095|NCT02682823|515944640|FG001|Overall Study|Protocol Deviation|1|||
143110096|NCT02682823|515944641|FG002|Overall Study|Protocol Deviation|0|||
143110097|NCT02682823|515944642|FG003|Overall Study|Protocol Deviation|0|||
143110098|NCT02682823|515944643|FG004|Overall Study|Protocol Deviation|0|||
143110099|NCT02682823|515944639|FG000|Overall Study|Adverse Event|0|||
143110100|NCT02682823|515944640|FG001|Overall Study|Adverse Event|0|||
143110101|NCT02682823|515944641|FG002|Overall Study|Adverse Event|0|||
143110102|NCT02682823|515944642|FG003|Overall Study|Adverse Event|1|||
143110103|NCT02682823|515944643|FG004|Overall Study|Adverse Event|0|||
143110104|NCT03781583|515944644|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
143110105|NCT03781583|515944645|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
143110106|NCT03781583|515944646|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
143110107|NCT03781583|515944647|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
143110108|NCT03781583|515944644|FG000|Overall Study|Technology did not work for that person in that environment|1|||
143110109|NCT03781583|515944645|FG001|Overall Study|Technology did not work for that person in that environment|0|||
143110110|NCT03781583|515944646|FG002|Overall Study|Technology did not work for that person in that environment|0|||
143110111|NCT03781583|515944647|FG003|Overall Study|Technology did not work for that person in that environment|0|||
143110112|NCT03781583|515944644|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
143110113|NCT03781583|515944645|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
143110114|NCT03781583|515944646|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
143110115|NCT03781583|515944647|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
143110116|NCT03781583|515944644|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
143110117|NCT03781583|515944645|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
143110118|NCT03781583|515944646|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
143110119|NCT03781583|515944647|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
143110120|NCT01938430|515944648|FG000|Overall Study|Randomized but Not Treated|0|||
143110121|NCT01938430|515944649|FG001|Overall Study|Randomized but Not Treated|0|||
143110122|NCT01938430|515944650|FG002|Overall Study|Randomized but Not Treated|0|||
143110123|NCT01938430|515944651|FG003|Overall Study|Randomized but Not Treated|0|||
143110124|NCT01938430|515944652|FG004|Overall Study|Randomized but Not Treated|0|||
143110125|NCT01938430|515944653|FG005|Overall Study|Randomized but Not Treated|0|||
143110126|NCT01938430|515944654|FG006|Overall Study|Randomized but Not Treated|0|||
143110127|NCT01938430|515944655|FG007|Overall Study|Randomized but Not Treated|0|||
143110128|NCT01938430|515944656|FG008|Overall Study|Randomized but Not Treated|0|||
143110129|NCT01938430|515944657|FG009|Overall Study|Randomized but Not Treated|0|||
143110130|NCT01938430|515944658|FG010|Overall Study|Randomized but Not Treated|1|||
143110131|NCT01938430|515944659|FG011|Overall Study|Randomized but Not Treated|0|||
143110132|NCT01938430|515944660|FG012|Overall Study|Randomized but Not Treated|0|||
143110133|NCT01938430|515944661|FG013|Overall Study|Randomized but Not Treated|1|||
143110134|NCT01938430|515944648|FG000|Overall Study|Adverse Event|0|||
143110135|NCT01938430|515944649|FG001|Overall Study|Adverse Event|0|||
143110136|NCT01938430|515944650|FG002|Overall Study|Adverse Event|0|||
143110137|NCT01938430|515944651|FG003|Overall Study|Adverse Event|0|||
143110138|NCT01938430|515944652|FG004|Overall Study|Adverse Event|0|||
143110139|NCT01938430|515944653|FG005|Overall Study|Adverse Event|0|||
143110140|NCT01938430|515944654|FG006|Overall Study|Adverse Event|1|||
143110141|NCT01938430|515944655|FG007|Overall Study|Adverse Event|0|||
143110142|NCT01938430|515944656|FG008|Overall Study|Adverse Event|0|||
143110143|NCT01938430|515944657|FG009|Overall Study|Adverse Event|0|||
143110144|NCT01938430|515944658|FG010|Overall Study|Adverse Event|0|||
143110145|NCT01938430|515944659|FG011|Overall Study|Adverse Event|0|||
143110146|NCT01938430|515944660|FG012|Overall Study|Adverse Event|0|||
143110147|NCT01938430|515944661|FG013|Overall Study|Adverse Event|0|||
143110148|NCT01938430|515944648|FG000|Overall Study|Death|1|||
143257593|NCT01903252|516495873|FG005|Extended Induction, Open-Label|Adverse Event|0|||
143257594|NCT01903252|516495868|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
143257595|NCT01903252|516495869|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
143257596|NCT01903252|516495870|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
143110149|NCT01938430|515944649|FG001|Overall Study|Death|2|||
143110150|NCT01938430|515944650|FG002|Overall Study|Death|2|||
143110151|NCT01938430|515944651|FG003|Overall Study|Death|1|||
143110152|NCT01938430|515944652|FG004|Overall Study|Death|0|||
143110153|NCT01938430|515944653|FG005|Overall Study|Death|0|||
143110154|NCT01938430|515944654|FG006|Overall Study|Death|1|||
143110155|NCT01938430|515944655|FG007|Overall Study|Death|1|||
143110156|NCT01938430|515944656|FG008|Overall Study|Death|2|||
143110157|NCT01938430|515944657|FG009|Overall Study|Death|3|||
143110158|NCT01938430|515944658|FG010|Overall Study|Death|0|||
143110159|NCT01938430|515944659|FG011|Overall Study|Death|0|||
143110160|NCT01938430|515944660|FG012|Overall Study|Death|0|||
143257597|NCT01903252|516495871|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
143257598|NCT01903252|516495872|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
143257599|NCT01903252|516495873|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
143257600|NCT01903252|516495868|FG000|Extended Induction, Open-Label|Physician Decision|0|||
143257601|NCT01903252|516495869|FG001|Extended Induction, Open-Label|Physician Decision|0|||
143257602|NCT01903252|516495870|FG002|Extended Induction, Open-Label|Physician Decision|1|||
143257603|NCT01903252|516495871|FG003|Extended Induction, Open-Label|Physician Decision|0|||
143257604|NCT01903252|516495872|FG004|Extended Induction, Open-Label|Physician Decision|0|||
143257605|NCT01903252|516495873|FG005|Extended Induction, Open-Label|Physician Decision|0|||
143257606|NCT01903252|516495868|FG000|Maintenance, Open-Label|Adverse Event|0|||
143257607|NCT01903252|516495869|FG001|Maintenance, Open-Label|Adverse Event|0|||
143257608|NCT01903252|516495870|FG002|Maintenance, Open-Label|Adverse Event|0|||
143257609|NCT01903252|516495871|FG003|Maintenance, Open-Label|Adverse Event|3|||
143257610|NCT01903252|516495872|FG004|Maintenance, Open-Label|Adverse Event|9|||
143257611|NCT01903252|516495873|FG005|Maintenance, Open-Label|Adverse Event|14|||
143257612|NCT01903252|516495868|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
143257613|NCT01903252|516495869|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
143257614|NCT01903252|516495870|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
143257615|NCT01903252|516495871|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
143257616|NCT01903252|516495872|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
143257617|NCT01903252|516495873|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
143257618|NCT01903252|516495868|FG000|Maintenance, Open-Label|Other|0|||
143257619|NCT01903252|516495869|FG001|Maintenance, Open-Label|Other|0|||
143257620|NCT01903252|516495870|FG002|Maintenance, Open-Label|Other|0|||
143257621|NCT01903252|516495871|FG003|Maintenance, Open-Label|Other|2|||
143257622|NCT01903252|516495872|FG004|Maintenance, Open-Label|Other|6|||
143257623|NCT01903252|516495873|FG005|Maintenance, Open-Label|Other|2|||
143257624|NCT02437110|516495874|FG000|Screening|Lost to Follow-up|3|||
143257625|NCT02437110|516495874|FG000|Screening|Physician Decision|1|||
143257626|NCT02437110|516495874|FG000|ART|Adverse Event|3|||
143257627|NCT02437110|516495874|FG000|ART|Protocol Violation|3|||
143257628|NCT02437110|516495874|FG000|ART|Withdrawal by Subject|4|||
143257629|NCT02437110|516495874|FG000|ART|Lost to follow-up prior to start of intervention|1|||
143110161|NCT01938430|515944661|FG013|Overall Study|Death|0|||
143110162|NCT01938430|515944648|FG000|Overall Study|Investigator's Discretion|0|||
143110163|NCT01938430|515944649|FG001|Overall Study|Investigator's Discretion|0|||
143110164|NCT01938430|515944650|FG002|Overall Study|Investigator's Discretion|1|||
143110165|NCT01938430|515944651|FG003|Overall Study|Investigator's Discretion|0|||
143110166|NCT01938430|515944652|FG004|Overall Study|Investigator's Discretion|0|||
143257630|NCT02437110|516495874|FG000|ART|Physician decision prior to start of intervention|2|||
143257631|NCT02437110|516495874|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
143257632|NCT02437110|516495874|FG000|Post-ART|Lost to Follow-up|3|||
143257633|NCT02437110|516495874|FG000|Post-ART|Protocol Violation|4|||
143257634|NCT02437110|516495874|FG000|Post-ART|Withdrawal by Subject|3|||
143257635|NCT00308581|516495875|FG000|Induction Phase|Adverse Event|0|||
143257636|NCT00308581|516495876|FG001|Induction Phase|Adverse Event|0|||
143257637|NCT00308581|516495877|FG002|Induction Phase|Adverse Event|37|||
143257638|NCT00308581|516495875|FG000|Induction Phase|Lack of Efficacy|0|||
143257639|NCT00308581|516495876|FG001|Induction Phase|Lack of Efficacy|0|||
143257640|NCT00308581|516495877|FG002|Induction Phase|Lack of Efficacy|121|||
143257641|NCT00308581|516495875|FG000|Induction Phase|Withdrawal by Subject|0|||
143257642|NCT00308581|516495876|FG001|Induction Phase|Withdrawal by Subject|0|||
143257643|NCT00308581|516495877|FG002|Induction Phase|Withdrawal by Subject|5|||
143257644|NCT00308581|516495875|FG000|Induction Phase|Unknown reason|0|||
143257645|NCT00308581|516495876|FG001|Induction Phase|Unknown reason|0|||
143368260|NCT03068468|516892635|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
143368261|NCT03068468|516892636|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
143257646|NCT00308581|516495877|FG002|Induction Phase|Unknown reason|3|||
143257647|NCT00308581|516495875|FG000|Randomized Maintenance Phase|Adverse Event|10|||
143257648|NCT00308581|516495876|FG001|Randomized Maintenance Phase|Adverse Event|17|||
143257649|NCT00308581|516495877|FG002|Randomized Maintenance Phase|Adverse Event|0|||
143110167|NCT01938430|515944653|FG005|Overall Study|Investigator's Discretion|0|||
143257650|NCT00308581|516495875|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
143110168|NCT01938430|515944654|FG006|Overall Study|Investigator's Discretion|0|||
143110169|NCT01938430|515944655|FG007|Overall Study|Investigator's Discretion|0|||
143110170|NCT01938430|515944656|FG008|Overall Study|Investigator's Discretion|0|||
143110171|NCT01938430|515944657|FG009|Overall Study|Investigator's Discretion|0|||
143110172|NCT01938430|515944658|FG010|Overall Study|Investigator's Discretion|0|||
143110173|NCT01938430|515944659|FG011|Overall Study|Investigator's Discretion|0|||
143110174|NCT01938430|515944660|FG012|Overall Study|Investigator's Discretion|0|||
143110175|NCT01938430|515944661|FG013|Overall Study|Investigator's Discretion|0|||
143110176|NCT01938430|515944648|FG000|Overall Study|Lack of Efficacy|3|||
143110177|NCT01938430|515944649|FG001|Overall Study|Lack of Efficacy|1|||
143110178|NCT01938430|515944650|FG002|Overall Study|Lack of Efficacy|1|||
143110179|NCT01938430|515944651|FG003|Overall Study|Lack of Efficacy|1|||
143110180|NCT01938430|515944652|FG004|Overall Study|Lack of Efficacy|0|||
143110181|NCT01938430|515944653|FG005|Overall Study|Lack of Efficacy|0|||
143110182|NCT01938430|515944654|FG006|Overall Study|Lack of Efficacy|0|||
143110183|NCT01938430|515944655|FG007|Overall Study|Lack of Efficacy|0|||
143110184|NCT01938430|515944656|FG008|Overall Study|Lack of Efficacy|1|||
143110185|NCT01938430|515944657|FG009|Overall Study|Lack of Efficacy|0|||
143110186|NCT01938430|515944658|FG010|Overall Study|Lack of Efficacy|2|||
143110187|NCT01938430|515944659|FG011|Overall Study|Lack of Efficacy|1|||
143110188|NCT01938430|515944660|FG012|Overall Study|Lack of Efficacy|0|||
143110189|NCT01938430|515944661|FG013|Overall Study|Lack of Efficacy|0|||
143110190|NCT01938430|515944648|FG000|Overall Study|Lost to Follow-up|0|||
143110191|NCT01938430|515944649|FG001|Overall Study|Lost to Follow-up|0|||
143110192|NCT01938430|515944650|FG002|Overall Study|Lost to Follow-up|1|||
143110193|NCT01938430|515944651|FG003|Overall Study|Lost to Follow-up|0|||
143110194|NCT01938430|515944652|FG004|Overall Study|Lost to Follow-up|0|||
143110195|NCT01938430|515944653|FG005|Overall Study|Lost to Follow-up|1|||
143110196|NCT01938430|515944654|FG006|Overall Study|Lost to Follow-up|0|||
143110197|NCT01938430|515944655|FG007|Overall Study|Lost to Follow-up|0|||
143110198|NCT01938430|515944656|FG008|Overall Study|Lost to Follow-up|0|||
143110199|NCT01938430|515944657|FG009|Overall Study|Lost to Follow-up|0|||
143110200|NCT01938430|515944658|FG010|Overall Study|Lost to Follow-up|0|||
143110201|NCT01938430|515944659|FG011|Overall Study|Lost to Follow-up|0|||
143110202|NCT01938430|515944660|FG012|Overall Study|Lost to Follow-up|0|||
143110203|NCT01938430|515944661|FG013|Overall Study|Lost to Follow-up|0|||
143110204|NCT01938430|515944648|FG000|Overall Study|Withdrew Consent|0|||
143110205|NCT01938430|515944649|FG001|Overall Study|Withdrew Consent|0|||
143110206|NCT01938430|515944650|FG002|Overall Study|Withdrew Consent|0|||
143110207|NCT01938430|515944651|FG003|Overall Study|Withdrew Consent|0|||
143110208|NCT01938430|515944652|FG004|Overall Study|Withdrew Consent|0|||
143110209|NCT01938430|515944653|FG005|Overall Study|Withdrew Consent|0|||
143110210|NCT01938430|515944654|FG006|Overall Study|Withdrew Consent|0|||
143110211|NCT01938430|515944655|FG007|Overall Study|Withdrew Consent|0|||
143110212|NCT01938430|515944656|FG008|Overall Study|Withdrew Consent|1|||
143110213|NCT01938430|515944657|FG009|Overall Study|Withdrew Consent|0|||
143110214|NCT01938430|515944658|FG010|Overall Study|Withdrew Consent|0|||
143110215|NCT01938430|515944659|FG011|Overall Study|Withdrew Consent|0|||
143110216|NCT01938430|515944660|FG012|Overall Study|Withdrew Consent|0|||
143110217|NCT01938430|515944661|FG013|Overall Study|Withdrew Consent|0|||
143110218|NCT03875482|515944662|FG000|Overall Study|Adverse Event|0|||
143110219|NCT03875482|515944663|FG001|Overall Study|Adverse Event|1|||
143110220|NCT03875482|515944662|FG000|Overall Study|Withdrew consent|5|||
143368262|NCT03068468|516892633|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
143368263|NCT03068468|516892634|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
143110221|NCT03875482|515944663|FG001|Overall Study|Withdrew consent|6|||
143110222|NCT03875482|515944662|FG000|Overall Study|Lost to Follow-up|8|||
143110223|NCT03875482|515944663|FG001|Overall Study|Lost to Follow-up|2|||
143110224|NCT03875482|515944662|FG000|Overall Study|Lack of Efficacy|0|||
143110225|NCT03875482|515944663|FG001|Overall Study|Lack of Efficacy|11|||
143110226|NCT02045862|515944664|FG000|Overall Study|Death|0|||
143110227|NCT02045862|515944665|FG001|Overall Study|Death|0|||
143110228|NCT02045862|515944666|FG002|Overall Study|Death|1|||
143110229|NCT02045862|515944664|FG000|Overall Study|Miscellaneous|5|||
143110230|NCT02045862|515944665|FG001|Overall Study|Miscellaneous|0|||
143110231|NCT02045862|515944666|FG002|Overall Study|Miscellaneous|8|||
143110232|NCT02045862|515944664|FG000|Overall Study|Withdrawal by Patient|18|||
143110233|NCT02045862|515944665|FG001|Overall Study|Withdrawal by Patient|27|||
143110234|NCT02045862|515944666|FG002|Overall Study|Withdrawal by Patient|57|||
143110235|NCT02045862|515944664|FG000|Overall Study|Protocol Violation|0|||
143110236|NCT02045862|515944665|FG001|Overall Study|Protocol Violation|0|||
143110237|NCT02045862|515944666|FG002|Overall Study|Protocol Violation|6|||
143110238|NCT02045862|515944664|FG000|Overall Study|Lack of Efficacy|8|||
143110239|NCT02045862|515944665|FG001|Overall Study|Lack of Efficacy|4|||
143110240|NCT02045862|515944666|FG002|Overall Study|Lack of Efficacy|13|||
143110241|NCT02045862|515944664|FG000|Overall Study|Randomized but not Received Study Drug|0|||
143110242|NCT02045862|515944665|FG001|Overall Study|Randomized but not Received Study Drug|2|||
143110243|NCT02045862|515944666|FG002|Overall Study|Randomized but not Received Study Drug|8|||
143110244|NCT02045862|515944664|FG000|Overall Study|Adverse Event|7|||
143110245|NCT02045862|515944665|FG001|Overall Study|Adverse Event|5|||
143110246|NCT02045862|515944666|FG002|Overall Study|Adverse Event|27|||
143110247|NCT02045862|515944664|FG000|Overall Study|Lost to Follow-up|1|||
143110248|NCT02045862|515944665|FG001|Overall Study|Lost to Follow-up|2|||
143110249|NCT02045862|515944666|FG002|Overall Study|Lost to Follow-up|6|||
143110250|NCT00623935|515944667|FG000|Overall Study|Death|1|||
143110251|NCT00623935|515944667|FG000|Overall Study|Patient Declined Transplant|1|||
143110252|NCT01730534|515944670|FG000|Overall Study|Withdrawal by Subject|97|||
143110253|NCT01730534|515944671|FG001|Overall Study|Withdrawal by Subject|127|||
143110254|NCT01730534|515944670|FG000|Overall Study|Lost to Follow-up|12|||
143110255|NCT01730534|515944671|FG001|Overall Study|Lost to Follow-up|18|||
143110256|NCT04964544|515944677|FG000|Overall Study|Screen failure or other uncategorised|10|||
143257651|NCT00308581|516495876|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
143257652|NCT00308581|516495877|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
143257653|NCT00308581|516495875|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
143257654|NCT00308581|516495876|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
143257655|NCT00308581|516495877|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
143257656|NCT00308581|516495875|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
143257657|NCT00308581|516495876|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
143257658|NCT00308581|516495877|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
143257659|NCT00308581|516495875|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
143257660|NCT00308581|516495876|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
143257661|NCT00308581|516495877|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
143257662|NCT00308581|516495875|FG000|Randomized Maintenance Phase|Unknown reason|3|||
143257663|NCT00308581|516495876|FG001|Randomized Maintenance Phase|Unknown reason|0|||
143257664|NCT00308581|516495877|FG002|Randomized Maintenance Phase|Unknown reason|0|||
143257665|NCT03400956|516495880|FG000|Treatment Period 1|Adverse Event|0|||
143257666|NCT03400956|516495881|FG001|Treatment Period 1|Adverse Event|1|||
143257667|NCT03400956|516495882|FG002|Treatment Period 1|Adverse Event|0|||
143257668|NCT03400956|516495880|FG000|Treatment Period 1|Lost to Follow-up|0|||
143257669|NCT03400956|516495881|FG001|Treatment Period 1|Lost to Follow-up|0|||
143257670|NCT03400956|516495882|FG002|Treatment Period 1|Lost to Follow-up|1|||
143257671|NCT03400956|516495880|FG000|Treatment Period 1|Protocol Violation|0|||
143257672|NCT03400956|516495881|FG001|Treatment Period 1|Protocol Violation|2|||
143257673|NCT03400956|516495882|FG002|Treatment Period 1|Protocol Violation|0|||
143257674|NCT03400956|516495880|FG000|Treatment Period 1|Study terminated by sponsor|3|||
143257675|NCT03400956|516495881|FG001|Treatment Period 1|Study terminated by sponsor|1|||
143257676|NCT03400956|516495882|FG002|Treatment Period 1|Study terminated by sponsor|1|||
143257677|NCT03400956|516495880|FG000|Treatment Period 1|Withdrawal by Subject|0|||
143257678|NCT03400956|516495881|FG001|Treatment Period 1|Withdrawal by Subject|2|||
143257679|NCT03400956|516495882|FG002|Treatment Period 1|Withdrawal by Subject|4|||
143257680|NCT03400956|516495880|FG000|Treatment Period 1|Other|1|||
143257681|NCT03400956|516495881|FG001|Treatment Period 1|Other|2|||
143257682|NCT03400956|516495882|FG002|Treatment Period 1|Other|3|||
143257683|NCT03400956|516495880|FG000|Post-treatment Period 1|Adverse Event|0|||
143257684|NCT03400956|516495881|FG001|Post-treatment Period 1|Adverse Event|0|||
143257685|NCT03400956|516495882|FG002|Post-treatment Period 1|Adverse Event|1|||
143257686|NCT03400956|516495880|FG000|Post-treatment Period 1|Physician Decision|2|||
143257687|NCT03400956|516495881|FG001|Post-treatment Period 1|Physician Decision|3|||
143257688|NCT03400956|516495882|FG002|Post-treatment Period 1|Physician Decision|0|||
143257689|NCT03400956|516495880|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
143257690|NCT03400956|516495881|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
143257691|NCT03400956|516495882|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
143257692|NCT03400956|516495880|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
143257693|NCT03400956|516495881|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
143257694|NCT03400956|516495882|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
143257695|NCT03400956|516495880|FG000|Post-treatment Period 1|Other|4|||
143257696|NCT03400956|516495881|FG001|Post-treatment Period 1|Other|3|||
143257697|NCT03400956|516495882|FG002|Post-treatment Period 1|Other|4|||
143257698|NCT03400956|516495880|FG000|Treatment Period 2|Adverse Event|2|||
143257699|NCT03400956|516495881|FG001|Treatment Period 2|Adverse Event|1|||
143257700|NCT03400956|516495882|FG002|Treatment Period 2|Adverse Event|1|||
143257701|NCT03400956|516495880|FG000|Treatment Period 2|Lost to Follow-up|1|||
143110257|NCT04964544|515944677|FG000|Overall Study|Physician Decision|4|||
143110258|NCT04964544|515944677|FG000|Overall Study|Lost to Follow-up|9|||
143110259|NCT04964544|515944677|FG000|Overall Study|Withdrawal by Subject|18|||
143110260|NCT04964544|515944677|FG000|Overall Study|Death|1|||
143110261|NCT02855359|515944680|FG000|Overall Study|Death|2|||
143110262|NCT02855359|515944681|FG001|Overall Study|Death|2|||
143110263|NCT02855359|515944682|FG002|Overall Study|Death|0|||
143110264|NCT02855359|515944683|FG003|Overall Study|Death|0|||
143110265|NCT02855359|515944680|FG000|Overall Study|Study Termination by Sponsor|9|||
143257702|NCT03400956|516495881|FG001|Treatment Period 2|Lost to Follow-up|1|||
143257703|NCT03400956|516495882|FG002|Treatment Period 2|Lost to Follow-up|0|||
143110266|NCT02855359|515944681|FG001|Overall Study|Study Termination by Sponsor|11|||
143257704|NCT03400956|516495880|FG000|Treatment Period 2|Withdrawal by Subject|0|||
143110267|NCT02855359|515944682|FG002|Overall Study|Study Termination by Sponsor|0|||
143257705|NCT03400956|516495881|FG001|Treatment Period 2|Withdrawal by Subject|0|||
143257706|NCT03400956|516495882|FG002|Treatment Period 2|Withdrawal by Subject|3|||
143257707|NCT03400956|516495880|FG000|Treatment Period 2|Other|1|||
143257708|NCT03400956|516495881|FG001|Treatment Period 2|Other|1|||
143257709|NCT03400956|516495882|FG002|Treatment Period 2|Other|0|||
143257710|NCT03400956|516495880|FG000|Follow-up Period|Withdrawal by Subject|0|||
143257711|NCT03400956|516495881|FG001|Follow-up Period|Withdrawal by Subject|0|||
143257712|NCT03400956|516495882|FG002|Follow-up Period|Withdrawal by Subject|1|||
143257713|NCT03400956|516495880|FG000|Follow-up Period|Other|0|||
143257714|NCT03400956|516495881|FG001|Follow-up Period|Other|0|||
143257715|NCT03400956|516495882|FG002|Follow-up Period|Other|1|||
143257716|NCT03044574|516495888|FG000|Overall Study|Lost to Follow-up|37|||
143257717|NCT03044574|516495889|FG001|Overall Study|Lost to Follow-up|45|||
143257718|NCT00592774|516495893|FG000|Overall Study|Adverse Event|5|||
143257719|NCT00592774|516495894|FG001|Overall Study|Adverse Event|19|||
143257720|NCT00592774|516495895|FG002|Overall Study|Adverse Event|2|||
143257721|NCT00592774|516495896|FG003|Overall Study|Adverse Event|14|||
143257722|NCT00592774|516495897|FG004|Overall Study|Adverse Event|8|||
143257723|NCT00592774|516495893|FG000|Overall Study|Protocol Violation|0|||
143257724|NCT00592774|516495894|FG001|Overall Study|Protocol Violation|1|||
143257725|NCT00592774|516495895|FG002|Overall Study|Protocol Violation|0|||
143257726|NCT00592774|516495896|FG003|Overall Study|Protocol Violation|0|||
143257727|NCT00592774|516495897|FG004|Overall Study|Protocol Violation|1|||
143257728|NCT00592774|516495893|FG000|Overall Study|Withdrawal by Subject|3|||
143257729|NCT00592774|516495894|FG001|Overall Study|Withdrawal by Subject|7|||
143257730|NCT00592774|516495895|FG002|Overall Study|Withdrawal by Subject|0|||
143257731|NCT00592774|516495896|FG003|Overall Study|Withdrawal by Subject|0|||
143257732|NCT00592774|516495897|FG004|Overall Study|Withdrawal by Subject|0|||
143257733|NCT00592774|516495893|FG000|Overall Study|Lack of Efficacy|3|||
143257734|NCT00592774|516495894|FG001|Overall Study|Lack of Efficacy|3|||
143257735|NCT00592774|516495895|FG002|Overall Study|Lack of Efficacy|0|||
143257736|NCT00592774|516495896|FG003|Overall Study|Lack of Efficacy|0|||
143257737|NCT00592774|516495897|FG004|Overall Study|Lack of Efficacy|2|||
143257738|NCT00592774|516495893|FG000|Overall Study|Physician Decision|0|||
143257739|NCT00592774|516495894|FG001|Overall Study|Physician Decision|1|||
143257740|NCT00592774|516495895|FG002|Overall Study|Physician Decision|1|||
143257741|NCT00592774|516495896|FG003|Overall Study|Physician Decision|0|||
143257742|NCT00592774|516495897|FG004|Overall Study|Physician Decision|1|||
143257743|NCT00592774|516495893|FG000|Overall Study|Other|0|||
143257744|NCT00592774|516495894|FG001|Overall Study|Other|1|||
143257745|NCT00592774|516495895|FG002|Overall Study|Other|1|||
143257746|NCT00592774|516495896|FG003|Overall Study|Other|0|||
143257747|NCT00592774|516495897|FG004|Overall Study|Other|2|||
143257748|NCT01892384|516495898|FG000|Overall Study|Withdrawal by Subject|1|||
143257749|NCT01892384|516495899|FG001|Overall Study|Withdrawal by Subject|1|||
143257750|NCT01892384|516495900|FG002|Overall Study|Withdrawal by Subject|0|||
143257751|NCT01892384|516495901|FG003|Overall Study|Withdrawal by Subject|0|||
143257752|NCT01924429|516495905|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
143257753|NCT01924429|516495906|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
143257754|NCT01514370|516495910|FG000|Overall Study|Protocol Violation|2|||
143257755|NCT01514370|516495911|FG001|Overall Study|Protocol Violation|3|||
143257756|NCT01514370|516495910|FG000|Overall Study|Lost to Follow-up|0|||
143257757|NCT01514370|516495911|FG001|Overall Study|Lost to Follow-up|2|||
143257758|NCT01514370|516495910|FG000|Overall Study|Withdrawal by Subject|2|||
143257759|NCT01514370|516495911|FG001|Overall Study|Withdrawal by Subject|1|||
143257760|NCT01514370|516495910|FG000|Overall Study|Adverse Event|1|||
143257761|NCT01514370|516495911|FG001|Overall Study|Adverse Event|3|||
143257762|NCT01514370|516495910|FG000|Overall Study|Other|6|||
143257763|NCT01514370|516495911|FG001|Overall Study|Other|7|||
143257764|NCT00604214|516495914|FG000|Baseline to Day 28|Death|223|||
143257765|NCT00604214|516495915|FG001|Baseline to Day 28|Death|202|||
143257766|NCT00604214|516495914|FG000|Baseline to Day 28|Lost to Follow-up|2|||
143257767|NCT00604214|516495915|FG001|Baseline to Day 28|Lost to Follow-up|4|||
143257768|NCT00604214|516495914|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
143257769|NCT00604214|516495915|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
143257770|NCT00604214|516495914|FG000|Day 29 to Day 90|Death|64|||
143257771|NCT00604214|516495915|FG001|Day 29 to Day 90|Death|67|||
143257772|NCT00604214|516495914|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
143257773|NCT00604214|516495915|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
143257774|NCT00604214|516495914|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
143257775|NCT00604214|516495915|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
143257776|NCT00604214|516495914|FG000|Day 91 to Day 180|Death|19|||
143257777|NCT00604214|516495915|FG001|Day 91 to Day 180|Death|23|||
143257778|NCT00604214|516495914|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
143257779|NCT00604214|516495915|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
143257780|NCT00604214|516495914|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
143257781|NCT00604214|516495915|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
143257782|NCT03603509|516497455|FG000|Overall Study|Lost to Follow-up|3|||
143257783|NCT03603509|516497456|FG001|Overall Study|Lost to Follow-up|4|||
143257784|NCT01527357|516497458|FG000|Overall Study|Death|8|||
143257785|NCT01527357|516497459|FG001|Overall Study|Death|2|||
143257786|NCT01527357|516497458|FG000|Overall Study|Lost to Follow-up|6|||
143257787|NCT01527357|516497459|FG001|Overall Study|Lost to Follow-up|4|||
143257788|NCT01527357|516497458|FG000|Overall Study|Withdrew Consent|1|||
143257789|NCT01527357|516497459|FG001|Overall Study|Withdrew Consent|1|||
143257790|NCT01527357|516497458|FG000|Overall Study|Non-compliance|0|||
143257791|NCT01527357|516497459|FG001|Overall Study|Non-compliance|1|||
143257792|NCT01527357|516497458|FG000|Overall Study|No Day 29 Visit|0|||
143257793|NCT01527357|516497459|FG001|Overall Study|No Day 29 Visit|1|||
143110268|NCT02855359|515944683|FG003|Overall Study|Study Termination by Sponsor|0|||
143110269|NCT02833844|515944684|FG000|Double-Blind Period|Withdrawal by Subject|2|||
143110270|NCT02833844|515944685|FG001|Double-Blind Period|Withdrawal by Subject|3|||
143110271|NCT02833844|515944684|FG000|Double-Blind Period|Protocol Violation|0|||
143110272|NCT02833844|515944685|FG001|Double-Blind Period|Protocol Violation|4|||
143110273|NCT02833844|515944684|FG000|Open-Label Period|Death|0|||
143110274|NCT02833844|515944685|FG001|Open-Label Period|Death|2|||
143110275|NCT02833844|515944684|FG000|Open-Label Period|Lost to Follow-up|1|||
143110276|NCT02833844|515944685|FG001|Open-Label Period|Lost to Follow-up|0|||
143110277|NCT02833844|515944684|FG000|Open-Label Period|Withdrawal by Subject|1|||
143110278|NCT02833844|515944685|FG001|Open-Label Period|Withdrawal by Subject|0|||
143110279|NCT00834639|515944686|FG000|Second Intervention|Physician Decision|0|||
143110280|NCT00834639|515944687|FG001|Second Intervention|Physician Decision|2|||
143110281|NCT00614120|515944691|FG000|Overall Study|Adverse Event|9|||
143110282|NCT00614120|515944692|FG001|Overall Study|Adverse Event|22|||
143110283|NCT00614120|515944693|FG002|Overall Study|Adverse Event|30|||
143110284|NCT00614120|515944694|FG003|Overall Study|Adverse Event|3|||
143110285|NCT00614120|515944691|FG000|Overall Study|Lack of Efficacy|3|||
143110286|NCT00614120|515944692|FG001|Overall Study|Lack of Efficacy|3|||
143110287|NCT00614120|515944693|FG002|Overall Study|Lack of Efficacy|2|||
143110288|NCT00614120|515944694|FG003|Overall Study|Lack of Efficacy|2|||
143110289|NCT00614120|515944691|FG000|Overall Study|Protocol Violation|2|||
143257794|NCT01527357|516497458|FG000|Overall Study|Did Not Receive Treatment|2|||
143257795|NCT01527357|516497459|FG001|Overall Study|Did Not Receive Treatment|0|||
143257796|NCT00910247|516497460|FG000|Overall Study|Adverse Event|15|||
143257797|NCT00910247|516497460|FG000|Overall Study|Death|2|||
143257798|NCT00910247|516497460|FG000|Overall Study|Lost to Follow-up|10|||
143257799|NCT00910247|516497460|FG000|Overall Study|Physician Decision|3|||
143257800|NCT00910247|516497460|FG000|Overall Study|Protocol Violation|10|||
143257801|NCT00910247|516497460|FG000|Overall Study|Withdrawal by Subject|25|||
143257802|NCT00910247|516497460|FG000|Overall Study|Not collected|4|||
143257803|NCT00773383|516497464|FG000|Overall Study|Adverse Event|4|||
143257804|NCT00773383|516497464|FG000|Overall Study|Death|1|||
143110290|NCT00614120|515944692|FG001|Overall Study|Protocol Violation|5|||
143110291|NCT00614120|515944693|FG002|Overall Study|Protocol Violation|3|||
143110292|NCT00614120|515944694|FG003|Overall Study|Protocol Violation|1|||
143110293|NCT00614120|515944691|FG000|Overall Study|Withdrawal criteria|1|||
143110294|NCT00614120|515944692|FG001|Overall Study|Withdrawal criteria|0|||
143110295|NCT00614120|515944693|FG002|Overall Study|Withdrawal criteria|0|||
143110296|NCT00614120|515944694|FG003|Overall Study|Withdrawal criteria|0|||
143110297|NCT00614120|515944691|FG000|Overall Study|Withdrawal by Subject|9|||
143110298|NCT00614120|515944692|FG001|Overall Study|Withdrawal by Subject|10|||
143110299|NCT00614120|515944693|FG002|Overall Study|Withdrawal by Subject|16|||
143110300|NCT00614120|515944694|FG003|Overall Study|Withdrawal by Subject|3|||
143110301|NCT00614120|515944691|FG000|Overall Study|Did not meet trial criteria|0|||
143110302|NCT00614120|515944692|FG001|Overall Study|Did not meet trial criteria|1|||
143110303|NCT00614120|515944693|FG002|Overall Study|Did not meet trial criteria|1|||
143110304|NCT00614120|515944694|FG003|Overall Study|Did not meet trial criteria|1|||
143110305|NCT00614120|515944691|FG000|Overall Study|hCG positive (not pregnant)|0|||
143110306|NCT00614120|515944692|FG001|Overall Study|hCG positive (not pregnant)|0|||
143110307|NCT00614120|515944693|FG002|Overall Study|hCG positive (not pregnant)|1|||
143110308|NCT00614120|515944694|FG003|Overall Study|hCG positive (not pregnant)|0|||
143110309|NCT00614120|515944691|FG000|Overall Study|Hypoglycaemia|0|||
143110310|NCT00614120|515944692|FG001|Overall Study|Hypoglycaemia|0|||
143110311|NCT00614120|515944693|FG002|Overall Study|Hypoglycaemia|0|||
143110312|NCT00614120|515944694|FG003|Overall Study|Hypoglycaemia|1|||
143110313|NCT00614120|515944691|FG000|Overall Study|Lack of trial product|3|||
143110314|NCT00614120|515944692|FG001|Overall Study|Lack of trial product|3|||
143110315|NCT00614120|515944693|FG002|Overall Study|Lack of trial product|2|||
143110316|NCT00614120|515944694|FG003|Overall Study|Lack of trial product|0|||
143110317|NCT00614120|515944691|FG000|Overall Study|Late syphilis, latent|1|||
143110318|NCT00614120|515944692|FG001|Overall Study|Late syphilis, latent|0|||
143110319|NCT00614120|515944693|FG002|Overall Study|Late syphilis, latent|0|||
143110320|NCT00614120|515944694|FG003|Overall Study|Late syphilis, latent|0|||
143110321|NCT00614120|515944691|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
143110322|NCT00614120|515944692|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
143110323|NCT00614120|515944693|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
143110324|NCT00614120|515944694|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
143110325|NCT00614120|515944691|FG000|Overall Study|Lost to Follow-up|1|||
143110326|NCT00614120|515944692|FG001|Overall Study|Lost to Follow-up|2|||
143110327|NCT00614120|515944693|FG002|Overall Study|Lost to Follow-up|3|||
143110328|NCT00614120|515944694|FG003|Overall Study|Lost to Follow-up|4|||
143110329|NCT01154088|515944695|FG000|Overall Study|Lost to Follow-up|4|||
143110330|NCT01154088|515944696|FG001|Overall Study|Lost to Follow-up|6|||
143110331|NCT01154088|515944697|FG002|Overall Study|Lost to Follow-up|7|||
143110332|NCT01084668|515944698|FG000|Overall Study|Lack of Efficacy|5|||
143110333|NCT01084668|515944698|FG000|Overall Study|Withdrawal by Subject|2|||
143110334|NCT01084668|515944698|FG000|Overall Study|Pregnancy|1|||
143110335|NCT01084668|515944698|FG000|Overall Study|Non-compliance|1|||
143110336|NCT05178641|515944699|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
143110337|NCT05178641|515944700|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
143110338|NCT05178641|515944699|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
143110339|NCT05178641|515944700|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
143110340|NCT00108485|515944702|FG000|Overall Study|Withdrawal by Subject|3|||
143110341|NCT00108485|515944703|FG001|Overall Study|Withdrawal by Subject|0|||
143110342|NCT00108485|515944702|FG000|Overall Study|Lost to Follow-up|0|||
143110343|NCT00108485|515944703|FG001|Overall Study|Lost to Follow-up|2|||
143110344|NCT01867294|515944708|FG000|Overall Study|Withdrawal by Subject|1|||
143110345|NCT01867294|515944709|FG001|Overall Study|Withdrawal by Subject|1|||
143110346|NCT01867294|515944710|FG002|Overall Study|Withdrawal by Subject|0|||
143110347|NCT01867294|515944711|FG003|Overall Study|Withdrawal by Subject|0|||
143110348|NCT02017912|515944712|FG000|Overall Study|Withdrawal by Subject|2|||
143110349|NCT02017912|515944713|FG001|Overall Study|Withdrawal by Subject|1|||
143110350|NCT02017912|515944712|FG000|Overall Study|miscellaneous|1|||
143110351|NCT02017912|515944713|FG001|Overall Study|miscellaneous|1|||
143110352|NCT03640481|515944714|FG000|Overall Study|Death|14|||
143110353|NCT03640481|515944715|FG001|Overall Study|Death|14|||
143110354|NCT03640481|515944716|FG002|Overall Study|Death|0|||
143110355|NCT03640481|515944717|FG003|Overall Study|Death|0|||
143110356|NCT03640481|515944714|FG000|Overall Study|Lost to Follow-up|2|||
143110357|NCT03640481|515944715|FG001|Overall Study|Lost to Follow-up|0|||
143110358|NCT03640481|515944716|FG002|Overall Study|Lost to Follow-up|0|||
143110359|NCT03640481|515944717|FG003|Overall Study|Lost to Follow-up|0|||
143110360|NCT03640481|515944714|FG000|Overall Study|Site terminated by sponsor|1|||
143110361|NCT03640481|515944715|FG001|Overall Study|Site terminated by sponsor|3|||
143110362|NCT03640481|515944716|FG002|Overall Study|Site terminated by sponsor|0|||
143110363|NCT03640481|515944717|FG003|Overall Study|Site terminated by sponsor|0|||
143110364|NCT03640481|515944714|FG000|Overall Study|Study terminated by sponsor|29|||
143110365|NCT03640481|515944715|FG001|Overall Study|Study terminated by sponsor|42|||
143368264|NCT03068468|516892635|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
143368265|NCT03068468|516892636|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
143368266|NCT03068468|516892633|FG000|Placebo-Controlled Period|Adverse Event|16|||
143368267|NCT03068468|516892634|FG001|Placebo-Controlled Period|Adverse Event|21|||
143368268|NCT03068468|516892635|FG002|Placebo-Controlled Period|Adverse Event|0|||
143368269|NCT03068468|516892636|FG003|Placebo-Controlled Period|Adverse Event|0|||
143368270|NCT03068468|516892633|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
143368271|NCT03068468|516892634|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
143368272|NCT03068468|516892635|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
143368273|NCT03068468|516892636|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
143368274|NCT03068468|516892633|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
143368275|NCT03068468|516892634|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
143368276|NCT03068468|516892635|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
143368277|NCT03068468|516892636|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
143368278|NCT03068468|516892633|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
143368279|NCT03068468|516892634|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
143368280|NCT03068468|516892635|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
143368281|NCT03068468|516892636|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
143368282|NCT03068468|516892633|FG000|Placebo-Controlled Period|Death|0|||
143368283|NCT03068468|516892634|FG001|Placebo-Controlled Period|Death|1|||
143368284|NCT03068468|516892635|FG002|Placebo-Controlled Period|Death|0|||
143368285|NCT03068468|516892636|FG003|Placebo-Controlled Period|Death|0|||
143368286|NCT03068468|516892633|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
143368287|NCT03068468|516892634|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
143368288|NCT03068468|516892635|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
143110366|NCT03640481|515944716|FG002|Overall Study|Study terminated by sponsor|1|||
143110367|NCT03640481|515944717|FG003|Overall Study|Study terminated by sponsor|0|||
143110368|NCT03640481|515944714|FG000|Overall Study|Withdrawal by Subject|5|||
143110369|NCT03640481|515944715|FG001|Overall Study|Withdrawal by Subject|4|||
143110370|NCT03640481|515944716|FG002|Overall Study|Withdrawal by Subject|0|||
143110371|NCT03640481|515944717|FG003|Overall Study|Withdrawal by Subject|1|||
143110372|NCT03640481|515944714|FG000|Overall Study|Other|26|||
143110373|NCT03640481|515944715|FG001|Overall Study|Other|12|||
143110374|NCT03640481|515944716|FG002|Overall Study|Other|1|||
143110375|NCT03640481|515944717|FG003|Overall Study|Other|0|||
143110376|NCT03640481|515944714|FG000|Overall Study|Randomized, but not treated|1|||
143110377|NCT03640481|515944715|FG001|Overall Study|Randomized, but not treated|3|||
143110378|NCT03640481|515944716|FG002|Overall Study|Randomized, but not treated|0|||
143110379|NCT03640481|515944717|FG003|Overall Study|Randomized, but not treated|0|||
143110380|NCT00979420|515944721|FG000|Overall Study|Adverse Event|1|||
143110381|NCT00979420|515944722|FG001|Overall Study|Adverse Event|0|||
143110382|NCT00979420|515944723|FG002|Overall Study|Adverse Event|0|||
143110383|NCT00979420|515944724|FG003|Overall Study|Adverse Event|0|||
143110384|NCT00979420|515944721|FG000|Overall Study|Lack of Efficacy|3|||
143110385|NCT00979420|515944722|FG001|Overall Study|Lack of Efficacy|0|||
143110386|NCT00979420|515944723|FG002|Overall Study|Lack of Efficacy|1|||
143110387|NCT00979420|515944724|FG003|Overall Study|Lack of Efficacy|1|||
143110388|NCT00979420|515944721|FG000|Overall Study|Other reasons not related to Viramune|3|||
143110389|NCT00979420|515944722|FG001|Overall Study|Other reasons not related to Viramune|0|||
143110390|NCT00979420|515944723|FG002|Overall Study|Other reasons not related to Viramune|0|||
143110391|NCT00979420|515944724|FG003|Overall Study|Other reasons not related to Viramune|1|||
143110392|NCT01618019|515944726|FG000|Overall Study|Withdrawal by Subject|14|||
143110393|NCT01618019|515944727|FG001|Overall Study|Withdrawal by Subject|14|||
143110394|NCT04021121|515944732|FG000|Overall Study|Death|3|||
143110395|NCT04021121|515944733|FG001|Overall Study|Death|3|||
143110396|NCT04021121|515944734|FG002|Overall Study|Death|5|||
143110397|NCT04021121|515944735|FG003|Overall Study|Death|4|||
143110398|NCT02288091|515944736|FG000|Overall Study|Lost to Follow-up|1|||
143110399|NCT02288091|515944736|FG000|Overall Study|Screen fail|7|||
143110400|NCT03843632|515944742|FG000|Overall Study|Withdrawal by Subject|1|||
143110401|NCT03843632|515944743|FG001|Overall Study|Withdrawal by Subject|0|||
143110402|NCT03843632|515944744|FG002|Overall Study|Withdrawal by Subject|0|||
143368289|NCT03068468|516892636|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
143110403|NCT03843632|515944745|FG003|Overall Study|Withdrawal by Subject|0|||
143110404|NCT03403751|515944746|FG000|Overall Study|Death|5|||
143110405|NCT03403751|515944747|FG001|Overall Study|Death|6|||
143110406|NCT03403751|515944746|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
143110407|NCT03403751|515944747|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
143110408|NCT05036668|515944750|FG000|Overall Study|lost to follow Up|0|||
143110409|NCT05036668|515944751|FG001|Overall Study|lost to follow Up|0|||
143110410|NCT05036668|515944752|FG002|Overall Study|lost to follow Up|1|||
143110411|NCT00387010|515944753|FG000|Dose Titration Period|Adverse Event|12|||
143110412|NCT00387010|515944753|FG000|Dose Titration Period|Lack of Efficacy|5|||
143368290|NCT03068468|516892633|FG000|Open-Label Extension Period|Adverse Event|0|||
143117392|NCT01313221|515971827|FG001|Overall Study|Pregnancy|0|||
143257805|NCT00773383|516497464|FG000|Overall Study|Progression of Disease|23|||
143257806|NCT00773383|516497464|FG000|Overall Study|Other|2|||
143110413|NCT00387010|515944753|FG000|Dose Titration Period|Withdrawal by Subject|3|||
143110414|NCT00387010|515944753|FG000|Dose Titration Period|Protocol Violation|1|||
143110415|NCT00387010|515944753|FG000|Dose Titration Period|Lost to Follow-up|2|||
143110416|NCT00387010|515944753|FG000|Dose Titration Period|Noncompliance with study medication|8|||
143110417|NCT00387010|515944753|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
143110418|NCT00387010|515944753|FG000|Treatment Period|Adverse Event|4|||
143110419|NCT00387010|515944753|FG000|Treatment Period|Withdrawal by Subject|1|||
143110420|NCT00387010|515944753|FG000|Treatment Period|Noncompliance with study medication|2|||
143110421|NCT00387010|515944753|FG000|Treatment Period|Noncompliance with study procedures|3|||
143110422|NCT00387010|515944753|FG000|Treatment Period|Participant reported study drug stolen|1|||
143110423|NCT00520481|515944754|FG000|Overall Study|Adverse Event|4|||
143110424|NCT00520481|515944755|FG001|Overall Study|Adverse Event|1|||
143110425|NCT00520481|515944754|FG000|Overall Study|Withdrawal by Subject|3|||
143110426|NCT00520481|515944755|FG001|Overall Study|Withdrawal by Subject|0|||
143110427|NCT01931956|515944765|FG000|Overall Study|Death|42|||
143110428|NCT01931956|515944766|FG001|Overall Study|Death|7|||
143110429|NCT01931956|515944767|FG002|Overall Study|Death|379|||
143110430|NCT01931956|515944768|FG003|Overall Study|Death|96|||
143110431|NCT01931956|515944765|FG000|Overall Study|Withdrawal by Subject|5|||
143110432|NCT01931956|515944766|FG001|Overall Study|Withdrawal by Subject|0|||
143110433|NCT01931956|515944767|FG002|Overall Study|Withdrawal by Subject|70|||
143110434|NCT01931956|515944768|FG003|Overall Study|Withdrawal by Subject|30|||
143110435|NCT01931956|515944765|FG000|Overall Study|Lost to Follow-up|2|||
143110436|NCT01931956|515944766|FG001|Overall Study|Lost to Follow-up|0|||
143110437|NCT01931956|515944767|FG002|Overall Study|Lost to Follow-up|11|||
143110438|NCT01931956|515944768|FG003|Overall Study|Lost to Follow-up|7|||
143110439|NCT01931956|515944765|FG000|Overall Study|Expected|2|||
143110440|NCT01931956|515944766|FG001|Overall Study|Expected|0|||
143110441|NCT01931956|515944767|FG002|Overall Study|Expected|6|||
143110442|NCT01931956|515944768|FG003|Overall Study|Expected|0|||
143110443|NCT01931956|515944765|FG000|Overall Study|Not due|0|||
143110444|NCT01931956|515944766|FG001|Overall Study|Not due|0|||
143110445|NCT01931956|515944767|FG002|Overall Study|Not due|21|||
143110446|NCT01931956|515944768|FG003|Overall Study|Not due|0|||
143110447|NCT02841280|515944769|FG000|Overall Study|Adverse Event|2|||
143110448|NCT02841280|515944770|FG001|Overall Study|Adverse Event|1|||
143110449|NCT02841280|515944769|FG000|Overall Study|Death|1|||
143110450|NCT02841280|515944770|FG001|Overall Study|Death|0|||
143110451|NCT02841280|515944769|FG000|Overall Study|Lost to Follow-up|2|||
143110452|NCT02841280|515944770|FG001|Overall Study|Lost to Follow-up|2|||
143110453|NCT02841280|515944769|FG000|Overall Study|Withdrawal by Subject|7|||
143110454|NCT02841280|515944770|FG001|Overall Study|Withdrawal by Subject|3|||
143110455|NCT02841280|515944769|FG000|Overall Study|Stop Point: BP above threshold|2|||
143110456|NCT02841280|515944770|FG001|Overall Study|Stop Point: BP above threshold|0|||
143110457|NCT02496091|515944772|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
143110458|NCT02031640|515946280|FG000|Screening Period|Adverse Event|1|||
143110459|NCT02031640|515946281|FG001|Screening Period|Adverse Event|0|||
143110460|NCT02031640|515946282|FG002|Screening Period|Adverse Event|0|||
143110461|NCT02031640|515946283|FG003|Screening Period|Adverse Event|0|||
143110462|NCT02031640|515946284|FG004|Screening Period|Adverse Event|0|||
143110463|NCT02031640|515946285|FG005|Screening Period|Adverse Event|0|||
143110464|NCT02031640|515946280|FG000|Screening Period|Withdrawal by Subject|29|||
143110465|NCT02031640|515946281|FG001|Screening Period|Withdrawal by Subject|0|||
143110466|NCT02031640|515946282|FG002|Screening Period|Withdrawal by Subject|0|||
143110467|NCT02031640|515946283|FG003|Screening Period|Withdrawal by Subject|0|||
143110468|NCT02031640|515946284|FG004|Screening Period|Withdrawal by Subject|0|||
143110469|NCT02031640|515946285|FG005|Screening Period|Withdrawal by Subject|0|||
143110470|NCT02031640|515946280|FG000|Screening Period|Inclusion criteria not met|312|||
143179437|NCT02737501|516203721|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
143179438|NCT02737501|516203719|FG000|Randomized Phase|Reason not Specified|1|||
143179439|NCT02737501|516203720|FG001|Randomized Phase|Reason not Specified|1|||
143179440|NCT02737501|516203721|FG002|Randomized Phase|Reason not Specified|0|||
143179441|NCT02737501|516203719|FG000|Randomized Phase|Never Treated|1|||
143179442|NCT02737501|516203720|FG001|Randomized Phase|Never Treated|1|||
143179443|NCT02737501|516203721|FG002|Randomized Phase|Never Treated|0|||
143179444|NCT02737501|516203719|FG000|Crossover Phase|Died|0|||
143257807|NCT00773383|516497464|FG000|Overall Study|No study dose received|1|||
143110471|NCT02031640|515946281|FG001|Screening Period|Inclusion criteria not met|0|||
143257808|NCT03384693|516497465|FG000|Overall Study|Adverse Event|3|||
143110472|NCT02031640|515946282|FG002|Screening Period|Inclusion criteria not met|0|||
143110473|NCT02031640|515946283|FG003|Screening Period|Inclusion criteria not met|0|||
143110474|NCT02031640|515946284|FG004|Screening Period|Inclusion criteria not met|0|||
143179445|NCT02737501|516203720|FG001|Crossover Phase|Died|0|||
143179446|NCT02737501|516203721|FG002|Crossover Phase|Died|22|||
143257809|NCT02519855|516497466|FG000|Overall Study|Adverse Event|0|||
143257810|NCT02519855|516497467|FG001|Overall Study|Adverse Event|1|||
143110475|NCT02031640|515946285|FG005|Screening Period|Inclusion criteria not met|0|||
143110476|NCT02031640|515946280|FG000|Screening Period|Exclusion criteria met|30|||
143110477|NCT02031640|515946281|FG001|Screening Period|Exclusion criteria met|0|||
143110478|NCT02031640|515946282|FG002|Screening Period|Exclusion criteria met|0|||
143110479|NCT02031640|515946283|FG003|Screening Period|Exclusion criteria met|0|||
143110480|NCT02031640|515946284|FG004|Screening Period|Exclusion criteria met|0|||
143110481|NCT02031640|515946285|FG005|Screening Period|Exclusion criteria met|0|||
143110482|NCT02031640|515946280|FG000|Screening Period|Lost to Follow-up|14|||
143110483|NCT02031640|515946281|FG001|Screening Period|Lost to Follow-up|0|||
143110484|NCT02031640|515946282|FG002|Screening Period|Lost to Follow-up|0|||
143110485|NCT02031640|515946283|FG003|Screening Period|Lost to Follow-up|0|||
143110486|NCT02031640|515946284|FG004|Screening Period|Lost to Follow-up|0|||
143110487|NCT02031640|515946285|FG005|Screening Period|Lost to Follow-up|0|||
143110488|NCT02031640|515946280|FG000|Screening Period|Enrollment closed|26|||
143110489|NCT02031640|515946281|FG001|Screening Period|Enrollment closed|0|||
143110490|NCT02031640|515946282|FG002|Screening Period|Enrollment closed|0|||
143110491|NCT02031640|515946283|FG003|Screening Period|Enrollment closed|0|||
143110492|NCT02031640|515946284|FG004|Screening Period|Enrollment closed|0|||
143110493|NCT02031640|515946285|FG005|Screening Period|Enrollment closed|0|||
143110494|NCT02031640|515946280|FG000|Run-In Period|Adverse Event|4|||
143110495|NCT02031640|515946281|FG001|Run-In Period|Adverse Event|0|||
143110496|NCT02031640|515946282|FG002|Run-In Period|Adverse Event|0|||
143110497|NCT02031640|515946283|FG003|Run-In Period|Adverse Event|0|||
143110498|NCT02031640|515946284|FG004|Run-In Period|Adverse Event|0|||
143110499|NCT02031640|515946285|FG005|Run-In Period|Adverse Event|0|||
143110500|NCT02031640|515946280|FG000|Run-In Period|Withdrawal by Subject|17|||
143110501|NCT02031640|515946281|FG001|Run-In Period|Withdrawal by Subject|0|||
143110502|NCT02031640|515946282|FG002|Run-In Period|Withdrawal by Subject|0|||
143110503|NCT02031640|515946283|FG003|Run-In Period|Withdrawal by Subject|0|||
143110504|NCT02031640|515946284|FG004|Run-In Period|Withdrawal by Subject|0|||
143110505|NCT02031640|515946285|FG005|Run-In Period|Withdrawal by Subject|0|||
143110506|NCT02031640|515946280|FG000|Run-In Period|Inclusion criteria not met|38|||
143110507|NCT02031640|515946281|FG001|Run-In Period|Inclusion criteria not met|0|||
143110508|NCT02031640|515946282|FG002|Run-In Period|Inclusion criteria not met|0|||
143110509|NCT02031640|515946283|FG003|Run-In Period|Inclusion criteria not met|0|||
143110510|NCT02031640|515946284|FG004|Run-In Period|Inclusion criteria not met|0|||
143110511|NCT02031640|515946285|FG005|Run-In Period|Inclusion criteria not met|0|||
143179447|NCT02737501|516203719|FG000|Crossover Phase|Withdrew Consent|0|||
143179448|NCT02737501|516203720|FG001|Crossover Phase|Withdrew Consent|0|||
143179449|NCT02737501|516203721|FG002|Crossover Phase|Withdrew Consent|9|||
143179450|NCT02737501|516203719|FG000|Crossover Phase|Physician Decision|0|||
143179451|NCT02737501|516203720|FG001|Crossover Phase|Physician Decision|0|||
143179452|NCT02737501|516203721|FG002|Crossover Phase|Physician Decision|1|||
143179453|NCT02737501|516203719|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
143179454|NCT02737501|516203720|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
143179455|NCT02737501|516203721|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
143179456|NCT01261975|516203722|FG000|Overall Study|Surgical complication|1|||
143179457|NCT00437268|516203725|FG000|Overall Study|Adverse Event|1|||
143179458|NCT00437268|516203726|FG001|Overall Study|Adverse Event|1|||
143179459|NCT00437268|516203725|FG000|Overall Study|Withdrawal by Subject|2|||
143179460|NCT00437268|516203726|FG001|Overall Study|Withdrawal by Subject|2|||
143179461|NCT00437268|516203725|FG000|Overall Study|Progressive disease|9|||
143179462|NCT00437268|516203726|FG001|Overall Study|Progressive disease|9|||
143179463|NCT00437268|516203725|FG000|Overall Study|Physician Decision|1|||
143179464|NCT00437268|516203726|FG001|Overall Study|Physician Decision|0|||
143179465|NCT00437268|516203725|FG000|Overall Study|Death|0|||
143179466|NCT00437268|516203726|FG001|Overall Study|Death|1|||
143179467|NCT00444925|516203731|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
143179468|NCT00444925|516203732|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
143179469|NCT00444925|516203733|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
143110512|NCT02031640|515946280|FG000|Run-In Period|Exclusion criteria met|8|||
143110513|NCT02031640|515946281|FG001|Run-In Period|Exclusion criteria met|0|||
143110514|NCT02031640|515946282|FG002|Run-In Period|Exclusion criteria met|0|||
143110515|NCT02031640|515946283|FG003|Run-In Period|Exclusion criteria met|0|||
143110516|NCT02031640|515946284|FG004|Run-In Period|Exclusion criteria met|0|||
143110517|NCT02031640|515946285|FG005|Run-In Period|Exclusion criteria met|0|||
143110518|NCT02031640|515946280|FG000|Run-In Period|Randomization criteria not met|85|||
143110519|NCT02031640|515946281|FG001|Run-In Period|Randomization criteria not met|0|||
143110520|NCT02031640|515946282|FG002|Run-In Period|Randomization criteria not met|0|||
143179470|NCT00444925|516203731|FG000|Double-blind Treatment Period|Death|2|||
143179471|NCT00444925|516203732|FG001|Double-blind Treatment Period|Death|0|||
143179472|NCT00444925|516203733|FG002|Double-blind Treatment Period|Death|0|||
143179473|NCT00444925|516203731|FG000|Double-blind Treatment Period|Adverse Event|6|||
143179474|NCT00444925|516203732|FG001|Double-blind Treatment Period|Adverse Event|28|||
143110521|NCT02031640|515946283|FG003|Run-In Period|Randomization criteria not met|0|||
143110522|NCT02031640|515946284|FG004|Run-In Period|Randomization criteria not met|0|||
143110523|NCT02031640|515946285|FG005|Run-In Period|Randomization criteria not met|0|||
143110524|NCT02031640|515946280|FG000|Run-In Period|Various administrative reasons|17|||
143110525|NCT02031640|515946281|FG001|Run-In Period|Various administrative reasons|0|||
143110526|NCT02031640|515946282|FG002|Run-In Period|Various administrative reasons|0|||
143110527|NCT02031640|515946283|FG003|Run-In Period|Various administrative reasons|0|||
143110528|NCT02031640|515946284|FG004|Run-In Period|Various administrative reasons|0|||
143257811|NCT02519855|516497466|FG000|Overall Study|Lost to Follow-up|3|||
143110529|NCT02031640|515946285|FG005|Run-In Period|Various administrative reasons|0|||
143110530|NCT02031640|515946280|FG000|Double-blind Treatment Period|Protocol deviation|0|||
143110531|NCT02031640|515946281|FG001|Double-blind Treatment Period|Protocol deviation|2|||
143110532|NCT02031640|515946282|FG002|Double-blind Treatment Period|Protocol deviation|0|||
143110533|NCT02031640|515946283|FG003|Double-blind Treatment Period|Protocol deviation|1|||
143110534|NCT02031640|515946284|FG004|Double-blind Treatment Period|Protocol deviation|3|||
143110535|NCT02031640|515946285|FG005|Double-blind Treatment Period|Protocol deviation|1|||
143110536|NCT02031640|515946280|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
143110537|NCT02031640|515946281|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
143110538|NCT02031640|515946282|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
143110539|NCT02031640|515946283|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
143110540|NCT02031640|515946284|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
143110541|NCT02031640|515946285|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
143110542|NCT02031640|515946280|FG000|Double-blind Treatment Period|Non-compliance|0|||
143110543|NCT02031640|515946281|FG001|Double-blind Treatment Period|Non-compliance|1|||
143110544|NCT02031640|515946282|FG002|Double-blind Treatment Period|Non-compliance|0|||
143110545|NCT02031640|515946283|FG003|Double-blind Treatment Period|Non-compliance|1|||
143110546|NCT02031640|515946284|FG004|Double-blind Treatment Period|Non-compliance|1|||
143110547|NCT02031640|515946285|FG005|Double-blind Treatment Period|Non-compliance|0|||
143110548|NCT02031640|515946280|FG000|Double-blind Treatment Period|Adverse Event|0|||
143110549|NCT02031640|515946281|FG001|Double-blind Treatment Period|Adverse Event|0|||
143110550|NCT02031640|515946282|FG002|Double-blind Treatment Period|Adverse Event|0|||
143110551|NCT02031640|515946283|FG003|Double-blind Treatment Period|Adverse Event|2|||
143110552|NCT02031640|515946284|FG004|Double-blind Treatment Period|Adverse Event|0|||
143110553|NCT02031640|515946285|FG005|Double-blind Treatment Period|Adverse Event|0|||
143110554|NCT02031640|515946280|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
143110555|NCT02031640|515946281|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
143110556|NCT02031640|515946282|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
143110557|NCT02031640|515946283|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
143110558|NCT02031640|515946284|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
143110559|NCT02031640|515946285|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
143110560|NCT02031640|515946280|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
143110561|NCT02031640|515946281|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
143110562|NCT02031640|515946282|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
143110563|NCT02031640|515946283|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
143110564|NCT02031640|515946284|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
143110565|NCT02031640|515946285|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
143110566|NCT05896527|515946291|FG000|Overall Study|Withdrawal by Subject|11|||
143110567|NCT05896527|515946292|FG001|Overall Study|Withdrawal by Subject|10|||
143110568|NCT05896527|515946293|FG002|Overall Study|Withdrawal by Subject|4|||
143110569|NCT05896527|515946294|FG003|Overall Study|Withdrawal by Subject|3|||
143110570|NCT05896527|515946295|FG004|Overall Study|Withdrawal by Subject|2|||
143110571|NCT05896527|515946291|FG000|Overall Study|Lost to Follow-up|0|||
143110572|NCT05896527|515946292|FG001|Overall Study|Lost to Follow-up|2|||
143110573|NCT05896527|515946293|FG002|Overall Study|Lost to Follow-up|2|||
143110574|NCT05896527|515946294|FG003|Overall Study|Lost to Follow-up|2|||
143110575|NCT05896527|515946295|FG004|Overall Study|Lost to Follow-up|1|||
143110576|NCT05896527|515946291|FG000|Overall Study|Significant protocol noncompliance|0|||
143110577|NCT05896527|515946292|FG001|Overall Study|Significant protocol noncompliance|1|||
143110578|NCT05896527|515946293|FG002|Overall Study|Significant protocol noncompliance|0|||
143110579|NCT05896527|515946294|FG003|Overall Study|Significant protocol noncompliance|0|||
143110580|NCT05896527|515946295|FG004|Overall Study|Significant protocol noncompliance|0|||
143110581|NCT05896527|515946291|FG000|Overall Study|Eligibility criteria not met|1|||
143257812|NCT02519855|516497467|FG001|Overall Study|Lost to Follow-up|3|||
143257813|NCT00003830|516497483|FG000|Overall Study|No follow up data|3|||
143257814|NCT00003830|516497484|FG001|Overall Study|No follow up data|0|||
143257815|NCT00003830|516497483|FG000|Overall Study|Sentinel node positive patients|829|||
143257816|NCT00003830|516497484|FG001|Overall Study|Sentinel node positive patients|793|||
143257817|NCT03811093|516497485|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
143257818|NCT03811093|516497486|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
143257819|NCT03811093|516497485|FG000|Overall Study|Unable to measure body fat percentage|2|||
143257820|NCT03811093|516497486|FG001|Overall Study|Unable to measure body fat percentage|0|||
143110582|NCT05896527|515946292|FG001|Overall Study|Eligibility criteria not met|0|||
143110583|NCT05896527|515946293|FG002|Overall Study|Eligibility criteria not met|0|||
143110584|NCT05896527|515946294|FG003|Overall Study|Eligibility criteria not met|0|||
143110585|NCT05896527|515946295|FG004|Overall Study|Eligibility criteria not met|0|||
143110586|NCT05896527|515946291|FG000|Overall Study|Sponsor's decision|0|||
143110587|NCT05896527|515946292|FG001|Overall Study|Sponsor's decision|0|||
143110588|NCT05896527|515946293|FG002|Overall Study|Sponsor's decision|0|||
143110589|NCT05896527|515946294|FG003|Overall Study|Sponsor's decision|1|||
143110590|NCT05896527|515946295|FG004|Overall Study|Sponsor's decision|0|||
143110591|NCT05896527|515946291|FG000|Overall Study|Investigator's decision|0|||
143110592|NCT05896527|515946292|FG001|Overall Study|Investigator's decision|1|||
143110593|NCT05896527|515946293|FG002|Overall Study|Investigator's decision|0|||
143110594|NCT05896527|515946294|FG003|Overall Study|Investigator's decision|0|||
143110595|NCT05896527|515946295|FG004|Overall Study|Investigator's decision|0|||
143110596|NCT05896527|515946291|FG000|Overall Study|Pregnancy of his partner|0|||
143110597|NCT05896527|515946292|FG001|Overall Study|Pregnancy of his partner|0|||
143110598|NCT05896527|515946293|FG002|Overall Study|Pregnancy of his partner|0|||
143110599|NCT05896527|515946294|FG003|Overall Study|Pregnancy of his partner|1|||
143110600|NCT05896527|515946295|FG004|Overall Study|Pregnancy of his partner|0|||
143110601|NCT03085238|515946296|FG000|Overall Study|Adverse Event|2|||
143110602|NCT03085238|515946296|FG000|Overall Study|Death|2|||
143110603|NCT01279070|515946297|FG000|Overall Study|Withdrawal by Subject|2|||
143257821|NCT01095094|516497488|FG000|Overall Study|Withdrawal by Subject|1|||
143110604|NCT01279070|515946298|FG001|Overall Study|Withdrawal by Subject|3|||
143110605|NCT01279070|515946297|FG000|Overall Study|Acute exacerbation|3|||
143110606|NCT01279070|515946298|FG001|Overall Study|Acute exacerbation|1|||
143110607|NCT01741792|515946299|FG000|Overall Study|Death|6|||
143110608|NCT01741792|515946300|FG001|Overall Study|Death|1|||
143110609|NCT01741792|515946301|FG002|Overall Study|Death|12|||
143110610|NCT00761280|515946302|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
143110611|NCT00761280|515946303|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
143110612|NCT00761280|515946302|FG000|Randomization to First Dose|Sponsor decision|1|||
143110613|NCT00761280|515946303|FG001|Randomization to First Dose|Sponsor decision|0|||
143110614|NCT00761280|515946302|FG000|Randomization to First Dose|Other|1|||
143110615|NCT00761280|515946303|FG001|Randomization to First Dose|Other|0|||
143110616|NCT00761280|515946302|FG000|First Dose to End of Study|End of trial|5|||
143110617|NCT00761280|515946303|FG001|First Dose to End of Study|End of trial|5|||
143110618|NCT00761280|515946302|FG000|First Dose to End of Study|Progressive disease|5|||
143110619|NCT00761280|515946303|FG001|First Dose to End of Study|Progressive disease|3|||
143110620|NCT00761280|515946302|FG000|First Dose to End of Study|Sponsor decision|1|||
143110621|NCT00761280|515946303|FG001|First Dose to End of Study|Sponsor decision|2|||
143110622|NCT00761280|515946302|FG000|First Dose to End of Study|Death|1|||
143110623|NCT00761280|515946303|FG001|First Dose to End of Study|Death|0|||
143110624|NCT00761280|515946302|FG000|First Dose to End of Study|Lost to Follow-up|0|||
143110625|NCT00761280|515946303|FG001|First Dose to End of Study|Lost to Follow-up|1|||
143110626|NCT02691013|515946307|FG000|Overall Study|Withdrawal by Subject|3|||
143110627|NCT02691013|515946308|FG001|Overall Study|Withdrawal by Subject|0|||
143110628|NCT02738879|515946309|FG000|Overall Study|Adverse Event|1|||
143110629|NCT02738879|515946310|FG001|Overall Study|Adverse Event|1|||
143110630|NCT02738879|515946309|FG000|Overall Study|Death|0|||
143110631|NCT02738879|515946310|FG001|Overall Study|Death|2|||
143110632|NCT02738879|515946309|FG000|Overall Study|Lost to Follow-up|1|||
143110633|NCT02738879|515946310|FG001|Overall Study|Lost to Follow-up|5|||
143110634|NCT02738879|515946309|FG000|Overall Study|Protocol Violation|1|||
143110635|NCT02738879|515946310|FG001|Overall Study|Protocol Violation|3|||
143110636|NCT02738879|515946309|FG000|Overall Study|Physician Decision|3|||
143110637|NCT02738879|515946310|FG001|Overall Study|Physician Decision|4|||
143110638|NCT02738879|515946309|FG000|Overall Study|Pregnancy|0|||
143110639|NCT02738879|515946310|FG001|Overall Study|Pregnancy|1|||
143110640|NCT02738879|515946309|FG000|Overall Study|Screen Failure|1|||
143257822|NCT01095094|516497488|FG000|Overall Study|Death|1|||
143110641|NCT02738879|515946310|FG001|Overall Study|Screen Failure|2|||
143110642|NCT02738879|515946309|FG000|Overall Study|Site Discontinued Study Participation|1|||
143110643|NCT02738879|515946310|FG001|Overall Study|Site Discontinued Study Participation|0|||
143110644|NCT02738879|515946309|FG000|Overall Study|Withdrawal by Subject|5|||
143110645|NCT02738879|515946310|FG001|Overall Study|Withdrawal by Subject|7|||
143110646|NCT01438294|515946311|FG000|Overall Study|Lost to Follow-up|3|||
143110647|NCT01438294|515946312|FG001|Overall Study|Lost to Follow-up|7|||
143110648|NCT02256982|515946313|FG000|Overall Study|Disease Progression|0|||
143110649|NCT02256982|515946314|FG001|Overall Study|Disease Progression|1|||
143110650|NCT02822573|515946318|FG000|Overall Study|Lost to Follow-up|5|||
143110651|NCT02822573|515946319|FG001|Overall Study|Lost to Follow-up|3|||
143110652|NCT02822573|515946318|FG000|Overall Study|Physician Decision|1|||
143110653|NCT02822573|515946319|FG001|Overall Study|Physician Decision|1|||
143257823|NCT01095094|516497488|FG000|Overall Study|Physician Decision|1|||
143257824|NCT05347147|516497489|FG000|Overall Study|Lost to Follow-up|0|||
143257825|NCT05347147|516497490|FG001|Overall Study|Lost to Follow-up|1|||
143179475|NCT00444925|516203733|FG002|Double-blind Treatment Period|Adverse Event|44|||
143179476|NCT00444925|516203731|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
143179477|NCT00444925|516203732|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
143179478|NCT00444925|516203733|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
143179479|NCT00444925|516203731|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
143179480|NCT00444925|516203732|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
143257826|NCT05347147|516497489|FG000|Overall Study|Sponsor request|3|||
143179481|NCT00444925|516203733|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
143179482|NCT00444925|516203731|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
143179483|NCT00444925|516203732|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
143179484|NCT00444925|516203733|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
143179485|NCT00444925|516203731|FG000|Double-blind Treatment Period|Other|7|||
143179486|NCT00444925|516203732|FG001|Double-blind Treatment Period|Other|7|||
143179487|NCT00444925|516203733|FG002|Double-blind Treatment Period|Other|12|||
143257827|NCT05347147|516497490|FG001|Overall Study|Sponsor request|3|||
143257828|NCT05347147|516497489|FG000|Overall Study|Study termination|2|||
143257829|NCT05347147|516497490|FG001|Overall Study|Study termination|1|||
143257830|NCT03565367|516497491|FG000|Overall Study|No scan due to technical issues|4|||
143257831|NCT03565367|516497492|FG001|Overall Study|No scan due to technical issues|0|||
143257832|NCT03699475|516497496|FG000|Overall Study|Death|1|||
143257833|NCT00137839|516497497|FG000|Overall Study|Adverse Event|7|||
143257834|NCT00137839|516497497|FG000|Overall Study|Physician Decision|7|||
143257835|NCT00137839|516497497|FG000|Overall Study|Death|8|||
143257836|NCT00137839|516497497|FG000|Overall Study|Disease Progression|60|||
143257837|NCT00137839|516497497|FG000|Overall Study|Not Start Treatment|1|||
143257838|NCT00137839|516497497|FG000|Overall Study|Prolonged Treatment Delay|1|||
143257839|NCT00528970|516497498|FG000|Overall Study|Adverse Event|6|||
143257840|NCT00528970|516497499|FG001|Overall Study|Adverse Event|8|||
143257841|NCT00528970|516497500|FG002|Overall Study|Adverse Event|5|||
143257842|NCT00528970|516497498|FG000|Overall Study|Lost to Follow-up|0|||
143257843|NCT00528970|516497499|FG001|Overall Study|Lost to Follow-up|0|||
143257844|NCT00528970|516497500|FG002|Overall Study|Lost to Follow-up|1|||
143257845|NCT00528970|516497498|FG000|Overall Study|Other than specified|2|||
143257846|NCT00528970|516497499|FG001|Overall Study|Other than specified|3|||
143257847|NCT00528970|516497500|FG002|Overall Study|Other than specified|3|||
143257848|NCT00528970|516497498|FG000|Overall Study|Protocol Violation|2|||
143257849|NCT00528970|516497499|FG001|Overall Study|Protocol Violation|1|||
143257850|NCT00528970|516497500|FG002|Overall Study|Protocol Violation|4|||
143257851|NCT00528970|516497498|FG000|Overall Study|Lack of Efficacy|0|||
143257852|NCT00528970|516497499|FG001|Overall Study|Lack of Efficacy|0|||
143257853|NCT00528970|516497500|FG002|Overall Study|Lack of Efficacy|1|||
143257854|NCT00528970|516497498|FG000|Overall Study|Withdrawal by Subject|4|||
143257855|NCT00528970|516497499|FG001|Overall Study|Withdrawal by Subject|3|||
143257856|NCT00528970|516497500|FG002|Overall Study|Withdrawal by Subject|5|||
143257857|NCT00528970|516497498|FG000|Overall Study|Randomized but not treated|0|||
143257858|NCT00528970|516497499|FG001|Overall Study|Randomized but not treated|0|||
143257859|NCT00528970|516497500|FG002|Overall Study|Randomized but not treated|1|||
143257860|NCT01122394|516497508|FG000|Overall Study|Withdrawal by Subject|1|||
143257861|NCT01122394|516497509|FG001|Overall Study|Withdrawal by Subject|1|||
143257862|NCT01122394|516497508|FG000|Overall Study|Lost to Follow-up|2|||
143257863|NCT01122394|516497509|FG001|Overall Study|Lost to Follow-up|2|||
143257864|NCT01122394|516497508|FG000|Overall Study|Adverse Event|0|||
143257865|NCT01122394|516497509|FG001|Overall Study|Adverse Event|1|||
143257866|NCT03739242|516497510|FG000|Overall Study|Withdrawal by Subject|1|||
143257867|NCT03739242|516497511|FG001|Overall Study|Withdrawal by Subject|1|||
143257868|NCT03739242|516497510|FG000|Overall Study|Protocol Violation|0|||
143257869|NCT03739242|516497511|FG001|Overall Study|Protocol Violation|1|||
143257870|NCT02446743|516497512|FG000|Overall Study|Withdrawal by Subject|1|||
143257871|NCT02446743|516497513|FG001|Overall Study|Withdrawal by Subject|1|||
143257872|NCT02446743|516497512|FG000|Overall Study|Lost to Follow-up|1|||
143257873|NCT02446743|516497513|FG001|Overall Study|Lost to Follow-up|0|||
143257874|NCT02446743|516497512|FG000|Overall Study|Adverse Event|1|||
143257875|NCT02446743|516497513|FG001|Overall Study|Adverse Event|1|||
143179488|NCT00786422|516203734|FG000|Rivaroxaban Treatment|Death|2|||
143179489|NCT00786422|516203734|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
143179490|NCT00786422|516203734|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
143179491|NCT00786422|516203734|FG000|Rivaroxaban Treatment|Physician Decision|1|||
143179492|NCT00786422|516203734|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
143257876|NCT02446743|516497512|FG000|Overall Study|Other|2|||
143257877|NCT02446743|516497513|FG001|Overall Study|Other|3|||
143257878|NCT00039871|516497514|FG000|Overall Study|Adverse Event|165|||
143257879|NCT00039871|516497514|FG000|Overall Study|Lost to Follow-up|18|||
143257880|NCT00039871|516497514|FG000|Overall Study|Protocol Violation|24|||
143257881|NCT00039871|516497514|FG000|Overall Study|Withdrawal by Subject|97|||
143257882|NCT00039871|516497514|FG000|Overall Study|Did not meet eligibility criteria|11|||
143257883|NCT00039871|516497514|FG000|Overall Study|Administrative|1|||
143257884|NCT00039871|516497514|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
143257885|NCT00039871|516497514|FG000|Overall Study|Never entered follow-up|7|||
143257886|NCT03361176|516497515|FG000|Overall Study|Lost to Follow-up|1|||
143257887|NCT03361176|516497516|FG001|Overall Study|Lost to Follow-up|2|||
143257888|NCT03361176|516497515|FG000|Overall Study|Adverse Event|0|||
143257889|NCT03361176|516497516|FG001|Overall Study|Adverse Event|2|||
143257890|NCT03361176|516497515|FG000|Overall Study|Withdrawal by Subject|0|||
143257891|NCT03361176|516497516|FG001|Overall Study|Withdrawal by Subject|1|||
143257892|NCT02478398|516497517|FG000|Overall Study|Adverse Event|20|||
143257893|NCT02478398|516497518|FG001|Overall Study|Adverse Event|5|||
143257894|NCT02478398|516497517|FG000|Overall Study|Lost to Follow-up|5|||
143257895|NCT02478398|516497518|FG001|Overall Study|Lost to Follow-up|4|||
143257896|NCT02478398|516497517|FG000|Overall Study|Non-Compliance With Study Drug|5|||
143257897|NCT02478398|516497518|FG001|Overall Study|Non-Compliance With Study Drug|1|||
143257898|NCT02478398|516497517|FG000|Overall Study|Protocol Violation|3|||
143257899|NCT02478398|516497518|FG001|Overall Study|Protocol Violation|1|||
143257900|NCT02478398|516497517|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
143257901|NCT02478398|516497518|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
143257902|NCT02478398|516497517|FG000|Overall Study|Withdrawal By Participant|10|||
143257903|NCT02478398|516497518|FG001|Overall Study|Withdrawal By Participant|4|||
143257904|NCT01752036|516497519|FG000|Overall Study|Death|2|||
143257905|NCT02230527|516497520|FG000|Overall Study|Withdrawal by Subject|1|||
143257906|NCT02230527|516497521|FG001|Overall Study|Withdrawal by Subject|1|||
143257907|NCT02230527|516497520|FG000|Overall Study|Death|1|||
143257908|NCT02230527|516497521|FG001|Overall Study|Death|0|||
143257909|NCT02230527|516497520|FG000|Overall Study|Lost to Follow-up|2|||
143257910|NCT02230527|516497521|FG001|Overall Study|Lost to Follow-up|1|||
143257911|NCT02230527|516497520|FG000|Overall Study|Other|1|||
143257912|NCT02230527|516497521|FG001|Overall Study|Other|0|||
143257913|NCT01011478|516497522|FG000|Overall Study|No follow up data|12|||
143257914|NCT01011478|516497523|FG001|Overall Study|No follow up data|7|||
143257915|NCT04618770|516497524|FG000|Overall Study|Censored from Analysis|12|||
143257916|NCT04618770|516497524|FG000|Overall Study|Early Termination|25|||
143257917|NCT04456673|516497525|FG000|Overall Study|Adverse Event|7|||
143257918|NCT04456673|516497526|FG001|Overall Study|Adverse Event|14|||
143257919|NCT04456673|516497525|FG000|Overall Study|Poor compliance to protocol|1|||
143257920|NCT04456673|516497526|FG001|Overall Study|Poor compliance to protocol|0|||
143257921|NCT04456673|516497525|FG000|Overall Study|Withdrawal by Subject|31|||
143257922|NCT04456673|516497526|FG001|Overall Study|Withdrawal by Subject|23|||
143257923|NCT04456673|516497525|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|4|||
143257924|NCT04456673|516497526|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|5|||
143257925|NCT04391049|516497527|FG000|Overall Study|Protocol Violation|1|||
143257926|NCT04395001|516497528|FG000|Overall Study|Lost to Follow-up|8|||
143257927|NCT04395001|516497529|FG001|Overall Study|Lost to Follow-up|9|||
143257928|NCT04395001|516497530|FG002|Overall Study|Lost to Follow-up|5|||
143257929|NCT04395001|516497528|FG000|Overall Study|Withdrawal by Subject|3|||
143257930|NCT04395001|516497529|FG001|Overall Study|Withdrawal by Subject|1|||
143257931|NCT04395001|516497530|FG002|Overall Study|Withdrawal by Subject|3|||
143257932|NCT04395001|516497528|FG000|Overall Study|missed appointment|7|||
143257933|NCT04395001|516497529|FG001|Overall Study|missed appointment|4|||
143257934|NCT04395001|516497530|FG002|Overall Study|missed appointment|1|||
143257935|NCT02239120|516497538|FG000|Overall Study|Death|56|||
143257936|NCT02239120|516497539|FG001|Overall Study|Death|58|||
143257937|NCT02239120|516497538|FG000|Overall Study|Lost to Follow-up|19|||
143257938|NCT02239120|516497539|FG001|Overall Study|Lost to Follow-up|14|||
143257939|NCT00046891|516497540|FG000|Overall Study|Cancels|5|||
143257940|NCT00046891|516497541|FG001|Overall Study|Cancels|9|||
143257941|NCT00046891|516497540|FG000|Overall Study|Ineligible|1|||
143257942|NCT00046891|516497541|FG001|Overall Study|Ineligible|1|||
143257943|NCT00046891|516497540|FG000|Overall Study|Withdrawal by Subject|18|||
143257944|NCT00046891|516497541|FG001|Overall Study|Withdrawal by Subject|15|||
143257945|NCT00046891|516497540|FG000|Overall Study|Adverse Event|5|||
143257946|NCT00046891|516497541|FG001|Overall Study|Adverse Event|5|||
143257947|NCT00420641|516497544|FG000|Overall Study|Adverse Event|3|||
143257948|NCT00420641|516497545|FG001|Overall Study|Adverse Event|25|||
143257949|NCT00420641|516497546|FG002|Overall Study|Adverse Event|10|||
143257950|NCT00420641|516497544|FG000|Overall Study|Lost to Follow-up|2|||
143257951|NCT00420641|516497545|FG001|Overall Study|Lost to Follow-up|4|||
143257952|NCT00420641|516497546|FG002|Overall Study|Lost to Follow-up|2|||
143257953|NCT00420641|516497544|FG000|Overall Study|Protocol Violation|8|||
143257954|NCT00420641|516497545|FG001|Overall Study|Protocol Violation|8|||
143257955|NCT00420641|516497546|FG002|Overall Study|Protocol Violation|7|||
143257956|NCT00420641|516497544|FG000|Overall Study|Withdrawal by Subject|15|||
143257957|NCT00420641|516497545|FG001|Overall Study|Withdrawal by Subject|21|||
143257958|NCT00420641|516497546|FG002|Overall Study|Withdrawal by Subject|14|||
143257959|NCT00420641|516497544|FG000|Overall Study|Lack of Efficacy|6|||
143257960|NCT00420641|516497545|FG001|Overall Study|Lack of Efficacy|5|||
143110654|NCT02822573|515946318|FG000|Overall Study|Withdrawal by Subject|9|||
143110655|NCT02822573|515946319|FG001|Overall Study|Withdrawal by Subject|5|||
143110656|NCT02822573|515946318|FG000|Overall Study|Protocol Violation|6|||
143110657|NCT02822573|515946319|FG001|Overall Study|Protocol Violation|4|||
143110658|NCT02822573|515946318|FG000|Overall Study|Too sick or ill|2|||
143110659|NCT02822573|515946319|FG001|Overall Study|Too sick or ill|1|||
143110660|NCT02822573|515946318|FG000|Overall Study|Disease Progression|1|||
143110661|NCT02822573|515946319|FG001|Overall Study|Disease Progression|1|||
143110662|NCT02822573|515946318|FG000|Overall Study|No reason given|6|||
143110663|NCT02822573|515946319|FG001|Overall Study|No reason given|4|||
143110664|NCT02662764|515946320|FG000|Overall Study|Adverse Event|6|||
143110665|NCT02662764|515946320|FG000|Overall Study|Lack of Efficacy|8|||
143110666|NCT02662764|515946320|FG000|Overall Study|Protocol Violation|1|||
143110667|NCT02662764|515946320|FG000|Overall Study|Withdrawal by Subject|5|||
143110668|NCT02662764|515946320|FG000|Overall Study|Device failure|4|||
143110669|NCT02662764|515946320|FG000|Overall Study|Patient changed treatment|1|||
143110670|NCT02662764|515946320|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
143110671|NCT01044290|515946321|FG000|Follow-up 1|Death|3|||
143110672|NCT01044290|515946322|FG001|Follow-up 1|Death|3|||
143110673|NCT01044290|515946323|FG002|Follow-up 1|Death|1|||
143110674|NCT01044290|515946321|FG000|Follow-up 1|Withdrawal by Subject|2|||
143110675|NCT01044290|515946322|FG001|Follow-up 1|Withdrawal by Subject|2|||
143110676|NCT01044290|515946323|FG002|Follow-up 1|Withdrawal by Subject|0|||
143110677|NCT01044290|515946321|FG000|Follow-Up 2|Death|0|||
143110678|NCT01044290|515946322|FG001|Follow-Up 2|Death|1|||
143110679|NCT01044290|515946323|FG002|Follow-Up 2|Death|1|||
143110680|NCT01044290|515946321|FG000|Follow-Up 2|Withdrawal by Subject|0|||
143110681|NCT01044290|515946322|FG001|Follow-Up 2|Withdrawal by Subject|1|||
143110682|NCT01044290|515946323|FG002|Follow-Up 2|Withdrawal by Subject|1|||
143110683|NCT01967706|515946332|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
143110684|NCT01967706|515946333|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
143110685|NCT01967706|515946334|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
143110686|NCT01967706|515946335|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
143110687|NCT02777970|515946336|FG000|Overall Study|Lost to Follow-up|0|||
143110688|NCT02777970|515946337|FG001|Overall Study|Lost to Follow-up|1|||
143110689|NCT02777970|515946338|FG002|Overall Study|Lost to Follow-up|0|||
143110690|NCT02777970|515946336|FG000|Overall Study|Protocol Violation|1|||
143110691|NCT02777970|515946337|FG001|Overall Study|Protocol Violation|0|||
143110692|NCT02777970|515946338|FG002|Overall Study|Protocol Violation|0|||
143110693|NCT02347891|515946344|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
143110694|NCT02347891|515946345|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
143110695|NCT02347891|515946344|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
143110696|NCT02347891|515946345|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
143110697|NCT05845567|515946346|FG000|Overall Study|Withdrawal by Subject|1|||
143110698|NCT02541669|515946347|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
143110699|NCT02541669|515946348|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
143110700|NCT02541669|515946349|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
143110701|NCT02541669|515946350|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
143110702|NCT02541669|515946351|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
143110703|NCT04739722|515946352|FG000|Overall Study|Lost to Follow-up|5301|||
143110704|NCT04739722|515946352|FG000|Overall Study|Withdrawal by Subject|42|||
143110705|NCT04739722|515946352|FG000|Overall Study|Non Average-risk|1157|||
143110706|NCT00725608|515946353|FG000|Overall Study|Lost to Follow-up|60|||
143110707|NCT00725608|515946353|FG000|Overall Study|Adverse Event|14|||
143110708|NCT00725608|515946353|FG000|Overall Study|Individual reasons|86|||
143110709|NCT00725608|515946353|FG000|Overall Study|Other|7|||
143110710|NCT03047720|515946354|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
143110711|NCT03047720|515946355|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
143110712|NCT01104246|515946358|FG000|Overall Study|Withdrawal by Subject|1|||
143110713|NCT01104246|515946358|FG000|Overall Study|did not meet inclusion criteria|4|||
143110714|NCT01083186|515946360|FG000|Overall Study|Lost to Follow-up|48|||
143110715|NCT01083186|515946360|FG000|Overall Study|Consent Withdrawal|7|||
143110716|NCT01083186|515946360|FG000|Overall Study|Death|3|||
143110717|NCT01083186|515946360|FG000|Overall Study|Adverse Event|3|||
143110718|NCT01083186|515946360|FG000|Overall Study|Lack of Efficacy|2|||
143110719|NCT01083186|515946360|FG000|Overall Study|Hemodialysis Initiation|28|||
143110720|NCT01083186|515946360|FG000|Overall Study|Administrative Reasons|2|||
143110721|NCT01083186|515946360|FG000|Overall Study|Non-compliance to Study Treatment|1|||
143110722|NCT00278148|515946366|FG000|Phase II - Expansion Phase|Disease progression|0|||
143110723|NCT00278148|515946367|FG001|Phase II - Expansion Phase|Disease progression|0|||
143110724|NCT00278148|515946368|FG002|Phase II - Expansion Phase|Disease progression|4|||
143110725|NCT00278148|515946366|FG000|Phase II - Expansion Phase|Adverse Event|0|||
143110726|NCT00278148|515946367|FG001|Phase II - Expansion Phase|Adverse Event|0|||
143110727|NCT00278148|515946368|FG002|Phase II - Expansion Phase|Adverse Event|2|||
143110728|NCT03419598|515946369|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
143110729|NCT02474589|515946370|FG000|Overall Study|Adverse Event|6|||
143110730|NCT02474589|515946371|FG001|Overall Study|Adverse Event|2|||
143110731|NCT02474589|515946370|FG000|Overall Study|Lost to Follow-up|6|||
143110732|NCT02474589|515946371|FG001|Overall Study|Lost to Follow-up|1|||
143110733|NCT02474589|515946370|FG000|Overall Study|Protocol Violation|4|||
143110734|NCT02474589|515946371|FG001|Overall Study|Protocol Violation|1|||
143110735|NCT02474589|515946370|FG000|Overall Study|Withdrawal by Subject|4|||
143110736|NCT02474589|515946371|FG001|Overall Study|Withdrawal by Subject|0|||
143110737|NCT02474589|515946370|FG000|Overall Study|Inability to complete study procedures|5|||
143110738|NCT02474589|515946371|FG001|Overall Study|Inability to complete study procedures|1|||
143110739|NCT01740128|515946372|FG000|Overall Study|Pregnancy|0|||
143110740|NCT01740128|515946373|FG001|Overall Study|Pregnancy|1|||
143110741|NCT01740128|515946372|FG000|Overall Study|Protocol Violation|1|||
143110742|NCT01740128|515946373|FG001|Overall Study|Protocol Violation|2|||
143110743|NCT01740128|515946372|FG000|Overall Study|Lost to Follow-up|2|||
143110744|NCT01740128|515946373|FG001|Overall Study|Lost to Follow-up|2|||
143110745|NCT01740128|515946372|FG000|Overall Study|Withdrawal by Subject|1|||
143110746|NCT01740128|515946373|FG001|Overall Study|Withdrawal by Subject|0|||
143110747|NCT01740128|515946372|FG000|Overall Study|Insufficient protocol compliance|2|||
143110748|NCT01740128|515946373|FG001|Overall Study|Insufficient protocol compliance|2|||
143110749|NCT00380081|515946376|FG000|Overall Study|Withdrawal by Subject|0|||
143110750|NCT00380081|515946377|FG001|Overall Study|Withdrawal by Subject|0|||
143110751|NCT00380081|515946378|FG002|Overall Study|Withdrawal by Subject|0|||
143110752|NCT00380081|515946379|FG003|Overall Study|Withdrawal by Subject|0|||
143110753|NCT00380081|515946380|FG004|Overall Study|Withdrawal by Subject|1|||
143110754|NCT00380081|515946381|FG005|Overall Study|Withdrawal by Subject|0|||
143110755|NCT00380081|515946376|FG000|Overall Study|Family Emergency|0|||
143110756|NCT00380081|515946377|FG001|Overall Study|Family Emergency|0|||
143110757|NCT00380081|515946378|FG002|Overall Study|Family Emergency|0|||
143110758|NCT00380081|515946379|FG003|Overall Study|Family Emergency|0|||
143110759|NCT00380081|515946380|FG004|Overall Study|Family Emergency|0|||
143110760|NCT00380081|515946381|FG005|Overall Study|Family Emergency|1|||
143110761|NCT02658734|515946382|FG000|Overall Study|Adverse Event|2|||
143110762|NCT02658734|515946382|FG000|Overall Study|Death|4|||
143110763|NCT02658734|515946382|FG000|Overall Study|Lost to Follow-up|7|||
143110764|NCT02658734|515946382|FG000|Overall Study|Withdrawal of Consent|16|||
143110765|NCT02658734|515946382|FG000|Overall Study|Disease Progression|28|||
143110766|NCT00459706|515946384|FG000|Overall Study|Adverse Event|19|||
143110767|NCT00459706|515946385|FG001|Overall Study|Adverse Event|13|||
143110768|NCT00459706|515946384|FG000|Overall Study|Withdrawal by Subject|1|||
143110769|NCT00459706|515946385|FG001|Overall Study|Withdrawal by Subject|6|||
143110770|NCT00459706|515946384|FG000|Overall Study|Physician Decision|2|||
143110771|NCT00459706|515946385|FG001|Overall Study|Physician Decision|0|||
143110772|NCT00459706|515946384|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
143110773|NCT00459706|515946385|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
143110774|NCT00459706|515946384|FG000|Overall Study|Protocol Violation|2|||
143110775|NCT00459706|515946385|FG001|Overall Study|Protocol Violation|1|||
143110776|NCT00459706|515946384|FG000|Overall Study|Failed to Return|1|||
143110777|NCT00459706|515946385|FG001|Overall Study|Failed to Return|0|||
143110778|NCT00459706|515946384|FG000|Overall Study|Other|0|||
143110779|NCT00459706|515946385|FG001|Overall Study|Other|1|||
143110780|NCT00189306|515946386|FG000|Treatment Period|Withdrawal by Subject|2|||
143110781|NCT00189306|515946386|FG000|Treatment Period|Adverse Event|2|||
143110782|NCT00189306|515946386|FG000|Treatment Period|Protocol Violation|1|||
143110783|NCT00189306|515946386|FG000|Posttreatment Period|Death|1|||
143110784|NCT00189306|515946386|FG000|Posttreatment Period|Withdrawal by Subject|2|||
143110785|NCT00189306|515946386|FG000|Posttreatment Period|Noncompliance|1|||
143110786|NCT00189306|515946386|FG000|Posttreatment Period|Target lesion excised|1|||
143179493|NCT00786422|516203734|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
143179494|NCT00786422|516203734|FG000|Rivaroxaban Treatment|Adverse Event|2|||
143179495|NCT00786422|516203734|FG000|Follow-up Period|Death|1|||
143179496|NCT00786422|516203734|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
143179497|NCT00810277|516205608|FG000|Overall Study|Adverse Event|1|||
143179498|NCT00532129|516205611|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
143179499|NCT00532129|516205611|FG000|Treatment Period|Physician Decision|15|||
143179500|NCT00532129|516205611|FG000|Treatment Period|Disease progression|3|||
143110787|NCT00189306|515946386|FG000|Posttreatment Period|Protocol Violation|1|||
143110788|NCT00189306|515946386|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
143110789|NCT00189306|515946386|FG000|Posttreatment Period|Local skin reaction/sign|1|||
143110790|NCT00189306|515946386|FG000|Long-Term Follow-up|Adverse Event|2|||
143110791|NCT00189306|515946386|FG000|Long-Term Follow-up|Death|4|||
143179501|NCT00532129|516205611|FG000|Treatment Period|Protocol Violation|1|||
143179502|NCT00532129|516205611|FG000|Treatment Period|Other|5|||
143179503|NCT00532129|516205611|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
143179504|NCT00532129|516205611|FG000|Follow-up Period|Disease progression|57|||
143110792|NCT00189306|515946386|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
143110793|NCT00189306|515946386|FG000|Long-Term Follow-up|Intercurrent disease|2|||
143110794|NCT00189306|515946386|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
143110795|NCT00189306|515946386|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
143110796|NCT04569968|515946387|FG000|Overall Study|Lost to Follow-up|2|||
143110797|NCT04569968|515946388|FG001|Overall Study|Lost to Follow-up|5|||
143110798|NCT04569968|515946387|FG000|Overall Study|Story of head and/or neck surgery|2|||
143110799|NCT04569968|515946388|FG001|Overall Study|Story of head and/or neck surgery|2|||
143110800|NCT04569968|515946387|FG000|Overall Study|Time of stroke onset|8|||
143110801|NCT04569968|515946388|FG001|Overall Study|Time of stroke onset|7|||
143110802|NCT04569968|515946387|FG000|Overall Study|Type of strokr|12|||
143110803|NCT04569968|515946388|FG001|Overall Study|Type of strokr|8|||
143110804|NCT04569968|515946387|FG000|Overall Study|Cooperation|8|||
143110805|NCT04569968|515946388|FG001|Overall Study|Cooperation|8|||
143110806|NCT04569968|515946387|FG000|Overall Study|Age interval|17|||
143110807|NCT04569968|515946388|FG001|Overall Study|Age interval|6|||
143110808|NCT04569968|515946387|FG000|Overall Study|Denial of participation to the study|0|||
143110809|NCT04569968|515946388|FG001|Overall Study|Denial of participation to the study|3|||
143110810|NCT04569968|515946387|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
143110811|NCT04569968|515946388|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
143110812|NCT04569968|515946387|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
143110813|NCT04569968|515946388|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
143110814|NCT04569968|515946387|FG000|Overall Study|Quarantine|1|||
143110815|NCT04569968|515946388|FG001|Overall Study|Quarantine|0|||
143110816|NCT04569968|515946387|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
143110817|NCT04569968|515946388|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
143110818|NCT04569968|515946387|FG000|Overall Study|Repetitive stroke|8|||
143110819|NCT04569968|515946388|FG001|Overall Study|Repetitive stroke|0|||
143110820|NCT04569968|515946387|FG000|Overall Study|Insufficient mastication|1|||
143110821|NCT04569968|515946388|FG001|Overall Study|Insufficient mastication|0|||
143110822|NCT04569968|515946387|FG000|Overall Study|Infection|1|||
143110823|NCT04569968|515946388|FG001|Overall Study|Infection|0|||
143110824|NCT00423189|515946393|FG000|Overall Study|Death|0|||
143110825|NCT00423189|515946394|FG001|Overall Study|Death|1|||
143110826|NCT00423189|515946395|FG002|Overall Study|Death|0|||
143110827|NCT00574249|515946404|FG000|Overall Study|Adverse Event|6|||
143110828|NCT00574249|515946405|FG001|Overall Study|Adverse Event|18|||
143110829|NCT00574249|515946404|FG000|Overall Study|Lack of Efficacy|5|||
143110830|NCT00574249|515946405|FG001|Overall Study|Lack of Efficacy|3|||
143110831|NCT00574249|515946404|FG000|Overall Study|Lost to Follow-up|4|||
143110832|NCT00574249|515946405|FG001|Overall Study|Lost to Follow-up|3|||
143110833|NCT00574249|515946404|FG000|Overall Study|Protocol Violation|5|||
143110834|NCT00574249|515946405|FG001|Overall Study|Protocol Violation|2|||
143110835|NCT00574249|515946404|FG000|Overall Study|History of carcinoma|1|||
143110836|NCT00574249|515946405|FG001|Overall Study|History of carcinoma|0|||
143110837|NCT00574249|515946404|FG000|Overall Study|Withdrawal by Subject|3|||
143110838|NCT00574249|515946405|FG001|Overall Study|Withdrawal by Subject|0|||
143110839|NCT00574249|515946404|FG000|Overall Study|Physician Decision|1|||
143110840|NCT00574249|515946405|FG001|Overall Study|Physician Decision|0|||
143110841|NCT00574249|515946404|FG000|Overall Study|Pregnancy|1|||
143110842|NCT00574249|515946405|FG001|Overall Study|Pregnancy|0|||
143110843|NCT00574249|515946404|FG000|Overall Study|Excluded by company|0|||
143110844|NCT00574249|515946405|FG001|Overall Study|Excluded by company|1|||
143110845|NCT00574249|515946404|FG000|Overall Study|PPD test taken twice|0|||
143110846|NCT00574249|515946405|FG001|Overall Study|PPD test taken twice|1|||
143110847|NCT03197870|515946406|FG000|Overall Study|Adverse Event|9|||
143110848|NCT03197870|515946407|FG001|Overall Study|Adverse Event|4|||
143110849|NCT03197870|515946408|FG002|Overall Study|Adverse Event|6|||
143110850|NCT03197870|515946406|FG000|Overall Study|Withdrawal by Subject|2|||
143110851|NCT03197870|515946407|FG001|Overall Study|Withdrawal by Subject|3|||
143110852|NCT03197870|515946408|FG002|Overall Study|Withdrawal by Subject|0|||
143110853|NCT03197870|515946406|FG000|Overall Study|Lost to Follow-up|2|||
143110854|NCT03197870|515946407|FG001|Overall Study|Lost to Follow-up|2|||
143110855|NCT03197870|515946408|FG002|Overall Study|Lost to Follow-up|0|||
143110856|NCT03197870|515946406|FG000|Overall Study|data not available|1|||
143110857|NCT03197870|515946407|FG001|Overall Study|data not available|1|||
143110858|NCT03197870|515946408|FG002|Overall Study|data not available|0|||
143110859|NCT01542034|515946409|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
143110860|NCT01542034|515946410|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
143110861|NCT01542034|515946409|FG000|Overall Study|Administrative decision|0|||
143110862|NCT01542034|515946410|FG001|Overall Study|Administrative decision|3|||
143110863|NCT01542034|515946409|FG000|Overall Study|Subject Noncompliance|1|||
143110864|NCT01542034|515946410|FG001|Overall Study|Subject Noncompliance|0|||
143110865|NCT01542034|515946409|FG000|Overall Study|Adverse Event|2|||
143110866|NCT01542034|515946410|FG001|Overall Study|Adverse Event|2|||
143110867|NCT01542034|515946409|FG000|Overall Study|Lost to Follow-up|7|||
143110868|NCT01542034|515946410|FG001|Overall Study|Lost to Follow-up|6|||
143110869|NCT01508130|515946411|FG000|Overall Study|Adverse Event|81|||
143110870|NCT01508130|515946412|FG001|Overall Study|Adverse Event|28|||
143110871|NCT01508130|515946411|FG000|Overall Study|Death|3|||
143257961|NCT00420641|516497546|FG002|Overall Study|Lack of Efficacy|4|||
143110872|NCT01508130|515946412|FG001|Overall Study|Death|1|||
143110873|NCT01508130|515946411|FG000|Overall Study|Protocol Violation|2|||
143110874|NCT01508130|515946412|FG001|Overall Study|Protocol Violation|0|||
143110875|NCT01508130|515946411|FG000|Overall Study|Lost to Follow-up|25|||
143110876|NCT01508130|515946412|FG001|Overall Study|Lost to Follow-up|2|||
143110877|NCT01508130|515946411|FG000|Overall Study|Withdrawal by Subject|3|||
143110878|NCT01508130|515946412|FG001|Overall Study|Withdrawal by Subject|3|||
143110879|NCT01508130|515946411|FG000|Overall Study|Subject's substantial non-compliance|25|||
143110880|NCT01508130|515946412|FG001|Overall Study|Subject's substantial non-compliance|9|||
143110881|NCT01508130|515946411|FG000|Overall Study|Insufficient therapeutic response|74|||
143110882|NCT01508130|515946412|FG001|Overall Study|Insufficient therapeutic response|23|||
143110883|NCT01508130|515946411|FG000|Overall Study|Administrative|14|||
143110884|NCT01508130|515946412|FG001|Overall Study|Administrative|3|||
143110885|NCT01680159|515946413|FG000|Screening Period|Not meet criteria for dose-up period|7|||
143110886|NCT01680159|515946413|FG000|Increased Dose Period|Adverse Event|6|||
143110887|NCT01680159|515946413|FG000|Increased Dose Period|Withdrawal by Subject|2|||
143110888|NCT02783729|515946414|FG000|Overall Study|Lack of Efficacy|1|||
143110889|NCT02783729|515946415|FG001|Overall Study|Lack of Efficacy|0|||
143110890|NCT02783729|515946416|FG002|Overall Study|Lack of Efficacy|0|||
143110891|NCT02783729|515946417|FG003|Overall Study|Lack of Efficacy|0|||
143110892|NCT02783729|515946414|FG000|Overall Study|Adverse Event|2|||
143110893|NCT02783729|515946415|FG001|Overall Study|Adverse Event|6|||
143110894|NCT02783729|515946416|FG002|Overall Study|Adverse Event|2|||
143110895|NCT02783729|515946417|FG003|Overall Study|Adverse Event|3|||
143110896|NCT02783729|515946414|FG000|Overall Study|Other|1|||
143110897|NCT02783729|515946415|FG001|Overall Study|Other|6|||
143110898|NCT02783729|515946416|FG002|Overall Study|Other|2|||
143110899|NCT02783729|515946417|FG003|Overall Study|Other|3|||
143110900|NCT02783729|515946414|FG000|Overall Study|Withdrawal by Subject|2|||
143110901|NCT02783729|515946415|FG001|Overall Study|Withdrawal by Subject|3|||
143110902|NCT02783729|515946416|FG002|Overall Study|Withdrawal by Subject|1|||
143110903|NCT02783729|515946417|FG003|Overall Study|Withdrawal by Subject|2|||
143110904|NCT02783729|515946414|FG000|Overall Study|Participant's choice|2|||
143110905|NCT02783729|515946415|FG001|Overall Study|Participant's choice|1|||
143110906|NCT02783729|515946416|FG002|Overall Study|Participant's choice|2|||
143110907|NCT02783729|515946417|FG003|Overall Study|Participant's choice|1|||
143110908|NCT02783729|515946414|FG000|Overall Study|Lost to Follow-up|2|||
143110909|NCT02783729|515946415|FG001|Overall Study|Lost to Follow-up|1|||
143110910|NCT02783729|515946416|FG002|Overall Study|Lost to Follow-up|1|||
143110911|NCT02783729|515946417|FG003|Overall Study|Lost to Follow-up|0|||
143110912|NCT03055494|515948329|FG000|Overall Study|Lost to Follow-up|6|||
143110913|NCT03055494|515948330|FG001|Overall Study|Lost to Follow-up|0|||
143110914|NCT03055494|515948329|FG000|Overall Study|Physician Decision|2|||
143110915|NCT03055494|515948330|FG001|Overall Study|Physician Decision|0|||
143110916|NCT03055494|515948329|FG000|Overall Study|Withdrawal by Subject|1|||
143110917|NCT03055494|515948330|FG001|Overall Study|Withdrawal by Subject|0|||
143110918|NCT03055494|515948329|FG000|Overall Study|Adverse Event|0|||
143110919|NCT03055494|515948330|FG001|Overall Study|Adverse Event|1|||
143110920|NCT03055494|515948329|FG000|Overall Study|Non-compliance with study treatment|1|||
143110921|NCT03055494|515948330|FG001|Overall Study|Non-compliance with study treatment|0|||
143110922|NCT04488419|515948331|FG000|Safety Population, >=1 Dose Administered|Adverse Event|10|||
143110923|NCT04488419|515948332|FG001|Safety Population, >=1 Dose Administered|Adverse Event|22|||
143110924|NCT04488419|515948333|FG002|Safety Population, >=1 Dose Administered|Adverse Event|18|||
143110925|NCT04488419|515948331|FG000|Safety Population, >=1 Dose Administered|Withdrawal by Subject|3|||
143110926|NCT04488419|515948332|FG001|Safety Population, >=1 Dose Administered|Withdrawal by Subject|6|||
143110927|NCT04488419|515948333|FG002|Safety Population, >=1 Dose Administered|Withdrawal by Subject|1|||
143110928|NCT04488419|515948331|FG000|Safety Population, >=1 Dose Administered|Lost to Follow-up|0|||
143110929|NCT04488419|515948332|FG001|Safety Population, >=1 Dose Administered|Lost to Follow-up|3|||
143110930|NCT04488419|515948333|FG002|Safety Population, >=1 Dose Administered|Lost to Follow-up|2|||
143110931|NCT04488419|515948331|FG000|Safety Population, >=1 Dose Administered|Protocol Violation|2|||
143110932|NCT04488419|515948332|FG001|Safety Population, >=1 Dose Administered|Protocol Violation|1|||
143110933|NCT04488419|515948333|FG002|Safety Population, >=1 Dose Administered|Protocol Violation|0|||
143110934|NCT04488419|515948331|FG000|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
143110935|NCT04488419|515948332|FG001|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
143110936|NCT04488419|515948333|FG002|Safety Population, >=1 Dose Administered|Lack of Efficacy|0|||
143110937|NCT04488419|515948331|FG000|Safety Population, >=1 Dose Administered|Physician Decision|0|||
143110938|NCT04488419|515948332|FG001|Safety Population, >=1 Dose Administered|Physician Decision|1|||
143110939|NCT04488419|515948333|FG002|Safety Population, >=1 Dose Administered|Physician Decision|0|||
143110940|NCT04488419|515948331|FG000|Safety Population, >=1 Dose Administered|Undetermined|15|||
143110941|NCT04488419|515948332|FG001|Safety Population, >=1 Dose Administered|Undetermined|9|||
143110942|NCT04488419|515948333|FG002|Safety Population, >=1 Dose Administered|Undetermined|5|||
143110943|NCT04488419|515948331|FG000|Safety Population, >=1 Dose Administered|>1 Reason|4|||
143110944|NCT04488419|515948332|FG001|Safety Population, >=1 Dose Administered|>1 Reason|7|||
143368291|NCT03068468|516892634|FG001|Open-Label Extension Period|Adverse Event|0|||
143368292|NCT03068468|516892635|FG002|Open-Label Extension Period|Adverse Event|13|||
143368293|NCT03068468|516892636|FG003|Open-Label Extension Period|Adverse Event|17|||
143368294|NCT03068468|516892633|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
143368295|NCT03068468|516892634|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
143368296|NCT03068468|516892635|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
143368297|NCT03068468|516892636|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
143368298|NCT03068468|516892633|FG000|Open-Label Extension Period|Death|0|||
143368299|NCT03068468|516892634|FG001|Open-Label Extension Period|Death|0|||
143257962|NCT00420641|516497544|FG000|Overall Study|Non-compliance|7|||
143257963|NCT00420641|516497545|FG001|Overall Study|Non-compliance|5|||
143257964|NCT00420641|516497546|FG002|Overall Study|Non-compliance|4|||
143257965|NCT00420641|516497544|FG000|Overall Study|Other|4|||
143257966|NCT00420641|516497545|FG001|Overall Study|Other|4|||
143257967|NCT00420641|516497546|FG002|Overall Study|Other|3|||
143257968|NCT02048241|516497553|FG000|Overall Study|Withdrawal by Subject|0|||
143257969|NCT02048241|516497554|FG001|Overall Study|Withdrawal by Subject|1|||
143257970|NCT03985878|516497555|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
143257971|NCT03985878|516497555|FG000|Overall Study|Study Terminated by Sponsor|12|||
143257972|NCT03985878|516497555|FG000|Overall Study|Withdrawal by Subject|1|||
143257973|NCT01606878|516497557|FG000|Overall Study|Adverse Event|1|||
143110945|NCT04488419|515948333|FG002|Safety Population, >=1 Dose Administered|>1 Reason|12|||
143110946|NCT04488419|515948331|FG000|Primary Analysis Population|Adverse Event|6|||
143110947|NCT04488419|515948332|FG001|Primary Analysis Population|Adverse Event|9|||
143110948|NCT04488419|515948333|FG002|Primary Analysis Population|Adverse Event|0|||
143110949|NCT04488419|515948331|FG000|Primary Analysis Population|Withdrawal by Subject|0|||
143110950|NCT04488419|515948332|FG001|Primary Analysis Population|Withdrawal by Subject|4|||
143110951|NCT04488419|515948333|FG002|Primary Analysis Population|Withdrawal by Subject|0|||
143110952|NCT04488419|515948331|FG000|Primary Analysis Population|Protocol Violation|1|||
143110953|NCT04488419|515948332|FG001|Primary Analysis Population|Protocol Violation|1|||
143110954|NCT04488419|515948333|FG002|Primary Analysis Population|Protocol Violation|0|||
143110955|NCT04488419|515948331|FG000|Primary Analysis Population|Undetermined|7|||
143110956|NCT04488419|515948332|FG001|Primary Analysis Population|Undetermined|3|||
143110957|NCT04488419|515948333|FG002|Primary Analysis Population|Undetermined|0|||
143110958|NCT04488419|515948331|FG000|Primary Analysis Population|>1 Reason|2|||
143110959|NCT04488419|515948332|FG001|Primary Analysis Population|>1 Reason|4|||
143110960|NCT04488419|515948333|FG002|Primary Analysis Population|>1 Reason|0|||
143110961|NCT04338269|515948334|FG000|Overall Study|Death|86|||
143110962|NCT04338269|515948335|FG001|Overall Study|Death|89|||
143110963|NCT04338269|515948334|FG000|Overall Study|Lost to Follow-up|1|||
143110964|NCT04338269|515948335|FG001|Overall Study|Lost to Follow-up|2|||
143110965|NCT04338269|515948334|FG000|Overall Study|Physician Decision|1|||
143110966|NCT04338269|515948335|FG001|Overall Study|Physician Decision|0|||
143257974|NCT01606878|516497558|FG001|Overall Study|Adverse Event|1|||
143257975|NCT01606878|516497559|FG002|Overall Study|Adverse Event|0|||
143257976|NCT01606878|516497560|FG003|Overall Study|Adverse Event|0|||
143257977|NCT01606878|516497561|FG004|Overall Study|Adverse Event|0|||
143257978|NCT01606878|516497562|FG005|Overall Study|Adverse Event|0|||
143257979|NCT01606878|516497563|FG006|Overall Study|Adverse Event|1|||
143257980|NCT01606878|516497564|FG007|Overall Study|Adverse Event|0|||
143257981|NCT01606878|516497565|FG008|Overall Study|Adverse Event|1|||
143257982|NCT01606878|516497566|FG009|Overall Study|Adverse Event|3|||
143257983|NCT01606878|516497567|FG010|Overall Study|Adverse Event|0|||
143257984|NCT01606878|516497557|FG000|Overall Study|Lack of Efficacy|1|||
143110967|NCT04338269|515948334|FG000|Overall Study|Withdrawal by Subject|14|||
143110968|NCT04338269|515948335|FG001|Overall Study|Withdrawal by Subject|11|||
143110969|NCT03339726|515948336|FG000|Overall Study|Withdrawal by Subject|1|||
143110970|NCT03339726|515948337|FG001|Overall Study|Withdrawal by Subject|0|||
143110971|NCT03339726|515948338|FG002|Overall Study|Withdrawal by Subject|0|||
143110972|NCT03339726|515948336|FG000|Overall Study|Lost to Follow-up|0|||
143110973|NCT03339726|515948337|FG001|Overall Study|Lost to Follow-up|1|||
143110974|NCT03339726|515948338|FG002|Overall Study|Lost to Follow-up|0|||
143110975|NCT04166591|515948341|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
143110976|NCT04166591|515948342|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
143110977|NCT04166591|515948343|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
143110978|NCT04166591|515948344|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
143257985|NCT01606878|516497558|FG001|Overall Study|Lack of Efficacy|1|||
143368300|NCT03068468|516892635|FG002|Open-Label Extension Period|Death|0|||
143368301|NCT03068468|516892636|FG003|Open-Label Extension Period|Death|1|||
143368302|NCT03068468|516892633|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
143257986|NCT01606878|516497559|FG002|Overall Study|Lack of Efficacy|1|||
143110979|NCT04166591|515948341|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
143110980|NCT04166591|515948342|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
143257987|NCT01606878|516497560|FG003|Overall Study|Lack of Efficacy|2|||
143110981|NCT04166591|515948343|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
143110982|NCT04166591|515948344|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
143257988|NCT01606878|516497561|FG004|Overall Study|Lack of Efficacy|1|||
143257989|NCT01606878|516497562|FG005|Overall Study|Lack of Efficacy|2|||
143257990|NCT01606878|516497563|FG006|Overall Study|Lack of Efficacy|1|||
143257991|NCT01606878|516497564|FG007|Overall Study|Lack of Efficacy|2|||
143257992|NCT01606878|516497565|FG008|Overall Study|Lack of Efficacy|2|||
143257993|NCT01606878|516497566|FG009|Overall Study|Lack of Efficacy|0|||
143257994|NCT01606878|516497567|FG010|Overall Study|Lack of Efficacy|1|||
143110983|NCT03030989|515948345|FG000|Overall Study|Fever|2|||
143110984|NCT03030989|515948346|FG001|Overall Study|Fever|2|||
143110985|NCT03030989|515948345|FG000|Overall Study|Rash|2|||
143110986|NCT03030989|515948346|FG001|Overall Study|Rash|1|||
143110987|NCT03030989|515948345|FG000|Overall Study|Fatigue/Overwhelmed|1|||
143110988|NCT03030989|515948346|FG001|Overall Study|Fatigue/Overwhelmed|5|||
143110989|NCT03030989|515948345|FG000|Overall Study|Positive Blood Cultures|2|||
143110990|NCT03030989|515948346|FG001|Overall Study|Positive Blood Cultures|1|||
143110991|NCT03030989|515948345|FG000|Overall Study|Line Removed|0|||
143110992|NCT03030989|515948346|FG001|Overall Study|Line Removed|2|||
143110993|NCT03030989|515948345|FG000|Overall Study|No longer interested|5|||
143110994|NCT03030989|515948346|FG001|Overall Study|No longer interested|3|||
143110995|NCT02730377|515948347|FG000|Overall Study|Other|5|||
143110996|NCT02730377|515948348|FG001|Overall Study|Other|4|||
143110997|NCT02730377|515948347|FG000|Overall Study|Death|1|||
143110998|NCT02730377|515948348|FG001|Overall Study|Death|8|||
143110999|NCT02730377|515948347|FG000|Overall Study|Inadequate glycaemic control|368|||
143111000|NCT02730377|515948348|FG001|Overall Study|Inadequate glycaemic control|473|||
143111001|NCT02730377|515948347|FG000|Overall Study|Adverse Event|79|||
143111002|NCT02730377|515948348|FG001|Overall Study|Adverse Event|41|||
143111003|NCT02730377|515948347|FG000|Overall Study|Protocol Violation|23|||
143111004|NCT02730377|515948348|FG001|Overall Study|Protocol Violation|30|||
143111005|NCT02730377|515948347|FG000|Overall Study|Lack of Efficacy|4|||
143111006|NCT02730377|515948348|FG001|Overall Study|Lack of Efficacy|13|||
143111007|NCT02730377|515948347|FG000|Overall Study|Pregnancy|0|||
143111008|NCT02730377|515948348|FG001|Overall Study|Pregnancy|1|||
143111009|NCT02730377|515948347|FG000|Overall Study|Withdrawal by Subject|45|||
143111010|NCT02730377|515948348|FG001|Overall Study|Withdrawal by Subject|42|||
143111011|NCT02730377|515948347|FG000|Overall Study|Lost to Follow-up|25|||
143111012|NCT02730377|515948348|FG001|Overall Study|Lost to Follow-up|21|||
143111013|NCT02203851|515948349|FG000|Overall Study|Lost to Follow-up|4|||
143111014|NCT02203851|515948349|FG000|Overall Study|Withdrawal by Subject|6|||
143111015|NCT02203851|515948349|FG000|Overall Study|Other|1|||
143111016|NCT02143791|515948354|FG000|Enrolled|Withdrawal by Subject|4|||
143111017|NCT02143791|515948354|FG000|Trial Stimulation|Lack of Efficacy|21|||
143111018|NCT02143791|515948354|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
143111019|NCT02143791|515948354|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
143111020|NCT02143791|515948354|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
143111021|NCT02143791|515948354|FG000|Any Programming (3-6 Months)|Missing Data|1|||
143111022|NCT02143791|515948354|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
143111023|NCT02091960|515948357|FG000|Overall Study|Death|7|||
143111024|NCT02091960|515948357|FG000|Overall Study|Withdrawal by Subject|1|||
143111025|NCT02091960|515948357|FG000|Overall Study|Miscellaneous Reasons|37|||
143111026|NCT02424630|515948358|FG000|Overall Study|No rotator cuff tear|1|||
143257995|NCT01606878|516497557|FG000|Overall Study|Physician Decision|1|||
143257996|NCT01606878|516497558|FG001|Overall Study|Physician Decision|0|||
143257997|NCT01606878|516497559|FG002|Overall Study|Physician Decision|2|||
143257998|NCT01606878|516497560|FG003|Overall Study|Physician Decision|1|||
143111027|NCT02424630|515948359|FG001|Overall Study|No rotator cuff tear|2|||
143111028|NCT02424630|515948358|FG000|Overall Study|Open procedure|0|||
143111029|NCT02424630|515948359|FG001|Overall Study|Open procedure|1|||
143111030|NCT00070018|515948366|FG000|Overall Study|Adverse Event|2|||
143111031|NCT00070018|515948366|FG000|Overall Study|Lack of Efficacy|1|||
143111032|NCT00070018|515948366|FG000|Overall Study|Withdrawal by Subject|1|||
143111033|NCT02939716|515948367|FG000|Overall Study|scanner failure|0|||
143257999|NCT01606878|516497561|FG004|Overall Study|Physician Decision|1|||
143258000|NCT01606878|516497562|FG005|Overall Study|Physician Decision|1|||
143258001|NCT01606878|516497563|FG006|Overall Study|Physician Decision|2|||
143111034|NCT02939716|515948368|FG001|Overall Study|scanner failure|0|||
143111035|NCT02939716|515948369|FG002|Overall Study|scanner failure|0|||
143111036|NCT02939716|515948370|FG003|Overall Study|scanner failure|1|||
143111037|NCT02939716|515948371|FG004|Overall Study|scanner failure|1|||
143111038|NCT02939716|515948372|FG005|Overall Study|scanner failure|1|||
143111039|NCT00985959|515948373|FG000|Overall Study|Adverse Event|0|||
143258002|NCT01606878|516497564|FG007|Overall Study|Physician Decision|0|||
143258003|NCT01606878|516497565|FG008|Overall Study|Physician Decision|1|||
143258004|NCT01606878|516497566|FG009|Overall Study|Physician Decision|0|||
143258005|NCT01606878|516497567|FG010|Overall Study|Physician Decision|0|||
143111040|NCT00985959|515948374|FG001|Overall Study|Adverse Event|0|||
143111041|NCT00985959|515948375|FG002|Overall Study|Adverse Event|19|||
143111042|NCT00985959|515948373|FG000|Overall Study|Withdrawal by Subject|0|||
143111043|NCT00985959|515948374|FG001|Overall Study|Withdrawal by Subject|0|||
143258006|NCT01606878|516497557|FG000|Overall Study|Withdrawal by Subject|3|||
143111044|NCT00985959|515948375|FG002|Overall Study|Withdrawal by Subject|8|||
143111045|NCT00985959|515948373|FG000|Overall Study|Progressive disease|1|||
143111046|NCT00985959|515948374|FG001|Overall Study|Progressive disease|2|||
143111047|NCT00985959|515948375|FG002|Overall Study|Progressive disease|8|||
143111048|NCT00985959|515948373|FG000|Overall Study|Unrecovered toxicity|0|||
143111049|NCT00985959|515948374|FG001|Overall Study|Unrecovered toxicity|0|||
143111050|NCT00985959|515948375|FG002|Overall Study|Unrecovered toxicity|7|||
143111051|NCT00985959|515948373|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
143111052|NCT00985959|515948374|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
143111053|NCT00985959|515948375|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
143111054|NCT00985959|515948373|FG000|Overall Study|Complete response observed over 2 cycles|0|||
143111055|NCT00985959|515948374|FG001|Overall Study|Complete response observed over 2 cycles|1|||
143111056|NCT00985959|515948375|FG002|Overall Study|Complete response observed over 2 cycles|4|||
143111057|NCT00985959|515948373|FG000|Overall Study|Other|0|||
143111058|NCT00985959|515948374|FG001|Overall Study|Other|0|||
143111059|NCT00985959|515948375|FG002|Overall Study|Other|11|||
143111060|NCT01252563|515948383|FG000|Overall Study|Contract Deviation|41|||
143111061|NCT01252563|515948383|FG000|Overall Study|Centralized Registration Deviation|30|||
143111062|NCT01252563|515948383|FG000|Overall Study|Lost to Follow-up|161|||
143111063|NCT01252563|515948383|FG000|Overall Study|No visit after first day of treatment|194|||
143111064|NCT01252563|515948383|FG000|Overall Study|No drug administration|6|||
143111065|NCT01866657|515948384|FG000|Overall Study|Surgery canceled|2|||
143111066|NCT01866657|515948385|FG001|Overall Study|Surgery canceled|0|||
143111067|NCT00978250|515948397|FG000|Overall Study|Late determination of ineligibility|0|||
143111068|NCT00978250|515948398|FG001|Overall Study|Late determination of ineligibility|1|||
143111069|NCT00978250|515948399|FG002|Overall Study|Late determination of ineligibility|0|||
143111070|NCT00978250|515948400|FG003|Overall Study|Late determination of ineligibility|1|||
143111071|NCT00381043|515948403|FG000|Overall Study|Lost to Follow-up|8|||
143111072|NCT00381043|515948404|FG001|Overall Study|Lost to Follow-up|6|||
143111073|NCT00381043|515948403|FG000|Overall Study|Withdrawal by Subject|3|||
143111074|NCT00381043|515948404|FG001|Overall Study|Withdrawal by Subject|1|||
143111075|NCT00381043|515948403|FG000|Overall Study|wanted more care|0|||
143111076|NCT00381043|515948404|FG001|Overall Study|wanted more care|1|||
143111077|NCT00381043|515948403|FG000|Overall Study|incarcerated|1|||
143111078|NCT00381043|515948404|FG001|Overall Study|incarcerated|0|||
143111079|NCT00471718|515948405|FG000|Overall Study|Adverse Event|3|||
143111080|NCT00471718|515948405|FG000|Overall Study|other complicating disease|1|||
143111081|NCT00471718|515948405|FG000|Overall Study|disease progression|22|||
143111082|NCT00471718|515948405|FG000|Overall Study|Withdrawal by Subject|1|||
143111083|NCT02880865|515948408|FG000|Overall Study|Adverse Event|1|||
143111084|NCT02880865|515948409|FG001|Overall Study|Adverse Event|0|||
143111085|NCT02880865|515948408|FG000|Overall Study|Withdrawal by Subject|0|||
143111086|NCT02880865|515948409|FG001|Overall Study|Withdrawal by Subject|2|||
143111087|NCT02880865|515948408|FG000|Overall Study|Physician Decision|0|||
143111088|NCT02880865|515948409|FG001|Overall Study|Physician Decision|1|||
143111089|NCT03045276|515948412|FG000|Intervention Phase|Withdrawal by Subject|7|||
143111090|NCT03045276|515948413|FG001|Intervention Phase|Withdrawal by Subject|2|||
143111091|NCT03045276|515948414|FG002|Intervention Phase|Withdrawal by Subject|3|||
143111092|NCT03045276|515948415|FG003|Intervention Phase|Withdrawal by Subject|7|||
143111093|NCT03045276|515948412|FG000|Intervention Phase|Developed exclusionary criteria|3|||
143111094|NCT03045276|515948413|FG001|Intervention Phase|Developed exclusionary criteria|3|||
143111095|NCT03045276|515948414|FG002|Intervention Phase|Developed exclusionary criteria|0|||
143111096|NCT03045276|515948415|FG003|Intervention Phase|Developed exclusionary criteria|0|||
143111097|NCT03045276|515948412|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
143111098|NCT03045276|515948413|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
143111099|NCT03045276|515948414|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
143111100|NCT03045276|515948415|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
143111101|NCT03045276|515948412|FG000|Follow-Up Phase|Lost to Follow-up|0|||
143111102|NCT03045276|515948413|FG001|Follow-Up Phase|Lost to Follow-up|1|||
143111103|NCT03045276|515948414|FG002|Follow-Up Phase|Lost to Follow-up|0|||
143111104|NCT03045276|515948415|FG003|Follow-Up Phase|Lost to Follow-up|1|||
143111105|NCT03045276|515948412|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
143258007|NCT01606878|516497558|FG001|Overall Study|Withdrawal by Subject|2|||
143258008|NCT01606878|516497559|FG002|Overall Study|Withdrawal by Subject|2|||
143258009|NCT01606878|516497560|FG003|Overall Study|Withdrawal by Subject|0|||
143258010|NCT01606878|516497561|FG004|Overall Study|Withdrawal by Subject|1|||
143111106|NCT03045276|515948413|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
143111107|NCT03045276|515948414|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
143111108|NCT03045276|515948415|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
143111109|NCT01446237|515948416|FG000|Overall Study|Adverse Event|1|||
143111110|NCT01446237|515948416|FG000|Overall Study|Lost to Follow-up|2|||
143258011|NCT01606878|516497562|FG005|Overall Study|Withdrawal by Subject|1|||
143111111|NCT01446237|515948416|FG000|Overall Study|Withdrawal by Subject|7|||
143111112|NCT02294175|515948417|FG000|Overall Study|Withdrawal by Subject|1|||
143111113|NCT02294175|515948418|FG001|Overall Study|Withdrawal by Subject|2|||
143111114|NCT02294175|515948417|FG000|Overall Study|pt taking excluded medication|3|||
143111115|NCT02294175|515948418|FG001|Overall Study|pt taking excluded medication|1|||
143111116|NCT02294175|515948417|FG000|Overall Study|Protocol Violation|1|||
143111117|NCT02294175|515948418|FG001|Overall Study|Protocol Violation|0|||
143111118|NCT02294175|515948417|FG000|Overall Study|Lost to Follow-up|0|||
143111119|NCT02294175|515948418|FG001|Overall Study|Lost to Follow-up|1|||
143111120|NCT02294175|515948417|FG000|Overall Study|wound healed|0|||
143111121|NCT02294175|515948418|FG001|Overall Study|wound healed|2|||
143111122|NCT02847494|515948419|FG000|Overall Study|Lost to Follow-up|8|||
143111123|NCT02847494|515948420|FG001|Overall Study|Lost to Follow-up|5|||
143111124|NCT01901653|515948423|FG000|Overall Study|Death|2|||
143111125|NCT01901653|515948424|FG001|Overall Study|Death|1|||
143111126|NCT01901653|515948425|FG002|Overall Study|Death|8|||
143111127|NCT01901653|515948426|FG003|Overall Study|Death|3|||
143111128|NCT01901653|515948427|FG004|Overall Study|Death|2|||
143111129|NCT01901653|515948428|FG005|Overall Study|Death|2|||
143111130|NCT01901653|515948429|FG006|Overall Study|Death|6|||
143111131|NCT01901653|515948430|FG007|Overall Study|Death|9|||
143111132|NCT01901653|515948431|FG008|Overall Study|Death|1|||
143111133|NCT01901653|515948432|FG009|Overall Study|Death|16|||
143111134|NCT01901653|515948433|FG010|Overall Study|Death|2|||
143111135|NCT01901653|515948434|FG011|Overall Study|Death|15|||
143111136|NCT01901653|515948435|FG012|Overall Study|Death|4|||
143111137|NCT01901653|515948423|FG000|Overall Study|Lost to Follow-up|1|||
143111138|NCT01901653|515948424|FG001|Overall Study|Lost to Follow-up|0|||
143111139|NCT01901653|515948425|FG002|Overall Study|Lost to Follow-up|2|||
143111140|NCT01901653|515948426|FG003|Overall Study|Lost to Follow-up|0|||
143111141|NCT01901653|515948427|FG004|Overall Study|Lost to Follow-up|0|||
143111142|NCT01901653|515948428|FG005|Overall Study|Lost to Follow-up|1|||
143111143|NCT01901653|515948429|FG006|Overall Study|Lost to Follow-up|0|||
143111144|NCT01901653|515948430|FG007|Overall Study|Lost to Follow-up|1|||
143111145|NCT01901653|515948431|FG008|Overall Study|Lost to Follow-up|0|||
143111146|NCT01901653|515948432|FG009|Overall Study|Lost to Follow-up|0|||
143111147|NCT01901653|515948433|FG010|Overall Study|Lost to Follow-up|0|||
143111148|NCT01901653|515948434|FG011|Overall Study|Lost to Follow-up|0|||
143111149|NCT01901653|515948435|FG012|Overall Study|Lost to Follow-up|0|||
143111150|NCT01901653|515948423|FG000|Overall Study|Withdrawal by Subject|0|||
143111151|NCT01901653|515948424|FG001|Overall Study|Withdrawal by Subject|0|||
143111152|NCT01901653|515948425|FG002|Overall Study|Withdrawal by Subject|0|||
143111153|NCT01901653|515948426|FG003|Overall Study|Withdrawal by Subject|0|||
143111154|NCT01901653|515948427|FG004|Overall Study|Withdrawal by Subject|0|||
143111155|NCT01901653|515948428|FG005|Overall Study|Withdrawal by Subject|0|||
143111156|NCT01901653|515948429|FG006|Overall Study|Withdrawal by Subject|1|||
143111157|NCT01901653|515948430|FG007|Overall Study|Withdrawal by Subject|0|||
143111158|NCT01901653|515948431|FG008|Overall Study|Withdrawal by Subject|0|||
143111159|NCT01901653|515948432|FG009|Overall Study|Withdrawal by Subject|0|||
143111160|NCT01901653|515948433|FG010|Overall Study|Withdrawal by Subject|0|||
143111161|NCT01901653|515948434|FG011|Overall Study|Withdrawal by Subject|0|||
143111162|NCT01901653|515948435|FG012|Overall Study|Withdrawal by Subject|0|||
143111163|NCT01901653|515948423|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
143111164|NCT01901653|515948424|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
143111165|NCT01901653|515948425|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
143111166|NCT01901653|515948426|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
143111167|NCT01901653|515948427|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
143179505|NCT00532129|516205611|FG000|Follow-up Period|Lost to Follow-up|1|||
143179506|NCT00532129|516205611|FG000|Follow-up Period|Other|6|||
143179507|NCT04551898|516205612|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
143179508|NCT04551898|516205613|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
143179509|NCT04551898|516205614|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
143179510|NCT04551898|516205615|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
143179511|NCT04551898|516205612|FG000|Overall Study|Withdrawal by Subject|5|||
143179512|NCT04551898|516205613|FG001|Overall Study|Withdrawal by Subject|1|||
143258012|NCT01606878|516497563|FG006|Overall Study|Withdrawal by Subject|2|||
143258013|NCT01606878|516497564|FG007|Overall Study|Withdrawal by Subject|1|||
143111168|NCT01901653|515948428|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
143179513|NCT04551898|516205614|FG002|Overall Study|Withdrawal by Subject|2|||
143179514|NCT04551898|516205615|FG003|Overall Study|Withdrawal by Subject|2|||
143179515|NCT04551898|516205612|FG000|Overall Study|Lost to Follow-up|2|||
143258014|NCT01606878|516497565|FG008|Overall Study|Withdrawal by Subject|2|||
143111169|NCT01901653|515948429|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
143111170|NCT01901653|515948430|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
143111171|NCT01901653|515948431|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
143111172|NCT01901653|515948432|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
143111173|NCT01901653|515948433|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
143111174|NCT01901653|515948434|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
143258015|NCT01606878|516497566|FG009|Overall Study|Withdrawal by Subject|0|||
143111175|NCT01901653|515948435|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
143111176|NCT02727777|515948438|FG000|Overall Study|Screen Failure|2|||
143111177|NCT02727777|515948439|FG001|Overall Study|Screen Failure|0|||
143111178|NCT02727777|515948440|FG002|Overall Study|Screen Failure|0|||
143111179|NCT02727777|515948438|FG000|Overall Study|Progressive disease|2|||
143111180|NCT02727777|515948439|FG001|Overall Study|Progressive disease|0|||
143111181|NCT02727777|515948440|FG002|Overall Study|Progressive disease|0|||
143111182|NCT01738503|515948441|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
143111183|NCT01738503|515948442|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
143111184|NCT01738503|515948443|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
143111185|NCT01738503|515948444|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
143111186|NCT01738503|515948445|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
143111187|NCT01738503|515948446|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
143111188|NCT01738503|515948447|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
143111189|NCT01738503|515948441|FG000|Treatment Period|Adverse Event|0|||
143111190|NCT01738503|515948442|FG001|Treatment Period|Adverse Event|1|||
143111191|NCT01738503|515948443|FG002|Treatment Period|Adverse Event|0|||
143111192|NCT01738503|515948444|FG003|Treatment Period|Adverse Event|1|||
143111193|NCT01738503|515948445|FG004|Treatment Period|Adverse Event|2|||
143111194|NCT01738503|515948446|FG005|Treatment Period|Adverse Event|2|||
143111195|NCT01738503|515948447|FG006|Treatment Period|Adverse Event|2|||
143111196|NCT01738503|515948441|FG000|Treatment Period|Lost to Follow-up|0|||
143111197|NCT01738503|515948442|FG001|Treatment Period|Lost to Follow-up|0|||
143111198|NCT01738503|515948443|FG002|Treatment Period|Lost to Follow-up|3|||
143111199|NCT01738503|515948444|FG003|Treatment Period|Lost to Follow-up|4|||
143111200|NCT01738503|515948445|FG004|Treatment Period|Lost to Follow-up|1|||
143111201|NCT01738503|515948446|FG005|Treatment Period|Lost to Follow-up|1|||
143111202|NCT01738503|515948447|FG006|Treatment Period|Lost to Follow-up|5|||
143111203|NCT01738503|515948441|FG000|Treatment Period|Withdrawal by Subject|0|||
143111204|NCT01738503|515948442|FG001|Treatment Period|Withdrawal by Subject|1|||
143111205|NCT01738503|515948443|FG002|Treatment Period|Withdrawal by Subject|0|||
143111206|NCT01738503|515948444|FG003|Treatment Period|Withdrawal by Subject|1|||
143111207|NCT01738503|515948445|FG004|Treatment Period|Withdrawal by Subject|1|||
143111208|NCT01738503|515948446|FG005|Treatment Period|Withdrawal by Subject|1|||
143111209|NCT01738503|515948447|FG006|Treatment Period|Withdrawal by Subject|1|||
143111210|NCT01738503|515948441|FG000|Treatment Period|Protocol Violation|0|||
143111211|NCT01738503|515948442|FG001|Treatment Period|Protocol Violation|3|||
143111212|NCT01738503|515948443|FG002|Treatment Period|Protocol Violation|1|||
143111213|NCT01738503|515948444|FG003|Treatment Period|Protocol Violation|0|||
143111214|NCT01738503|515948445|FG004|Treatment Period|Protocol Violation|4|||
143111215|NCT01738503|515948446|FG005|Treatment Period|Protocol Violation|2|||
143111216|NCT01738503|515948447|FG006|Treatment Period|Protocol Violation|0|||
143111217|NCT01738503|515948441|FG000|Treatment Period|Other|0|||
143111218|NCT01738503|515948442|FG001|Treatment Period|Other|0|||
143111219|NCT01738503|515948443|FG002|Treatment Period|Other|1|||
143111220|NCT01738503|515948444|FG003|Treatment Period|Other|0|||
143111221|NCT01738503|515948445|FG004|Treatment Period|Other|0|||
143111222|NCT01738503|515948446|FG005|Treatment Period|Other|0|||
143111223|NCT01738503|515948447|FG006|Treatment Period|Other|0|||
143111224|NCT01738503|515948441|FG000|PET Imaging Sub-study|Adverse Event|0|||
143111225|NCT01738503|515948442|FG001|PET Imaging Sub-study|Adverse Event|0|||
143111226|NCT01738503|515948443|FG002|PET Imaging Sub-study|Adverse Event|0|||
143111227|NCT01738503|515948444|FG003|PET Imaging Sub-study|Adverse Event|0|||
143111228|NCT01738503|515948445|FG004|PET Imaging Sub-study|Adverse Event|0|||
143111229|NCT01738503|515948446|FG005|PET Imaging Sub-study|Adverse Event|1|||
143111230|NCT01738503|515948447|FG006|PET Imaging Sub-study|Adverse Event|0|||
143111231|NCT01738503|515948441|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
143111232|NCT01738503|515948442|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
143111233|NCT01738503|515948443|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
143111234|NCT01738503|515948444|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
143111235|NCT01738503|515948445|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
143111236|NCT01738503|515948446|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
143111237|NCT01738503|515948447|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
143111238|NCT04696354|515948448|FG000|Overall Study|Study termination|6|||
143111239|NCT04696354|515948449|FG001|Overall Study|Study termination|6|||
143111240|NCT03005327|515948450|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
143111241|NCT03005327|515948451|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
143111242|NCT03005327|515948452|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
143111243|NCT03005327|515948453|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
143111244|NCT03005327|515948450|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
143111245|NCT03005327|515948451|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
143111246|NCT03005327|515948452|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
143179516|NCT04551898|516205613|FG001|Overall Study|Lost to Follow-up|1|||
143179517|NCT04551898|516205614|FG002|Overall Study|Lost to Follow-up|2|||
143179518|NCT04551898|516205615|FG003|Overall Study|Lost to Follow-up|2|||
143111247|NCT03005327|515948453|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
143111248|NCT04687072|515948454|FG000|Overall Study|Adverse Event|2|||
143111249|NCT04687072|515948455|FG001|Overall Study|Adverse Event|0|||
143111250|NCT04687072|515948454|FG000|Overall Study|Death|1|||
143111251|NCT04687072|515948455|FG001|Overall Study|Death|0|||
143111252|NCT04687072|515948454|FG000|Overall Study|Lack of Efficacy|2|||
143111253|NCT04687072|515948455|FG001|Overall Study|Lack of Efficacy|1|||
143111254|NCT04687072|515948454|FG000|Overall Study|Physician Decision|1|||
143111255|NCT04687072|515948455|FG001|Overall Study|Physician Decision|0|||
143111256|NCT04687072|515948454|FG000|Overall Study|Pregnancy|1|||
143111257|NCT04687072|515948455|FG001|Overall Study|Pregnancy|0|||
143111258|NCT04687072|515948454|FG000|Overall Study|Requires Prohibited Medication|2|||
143111259|NCT04687072|515948455|FG001|Overall Study|Requires Prohibited Medication|0|||
143111260|NCT04687072|515948454|FG000|Overall Study|Withdrawal of Consent|11|||
143111261|NCT04687072|515948455|FG001|Overall Study|Withdrawal of Consent|6|||
143111262|NCT04687072|515948454|FG000|Overall Study|Miscellaneous|4|||
143111263|NCT04687072|515948455|FG001|Overall Study|Miscellaneous|1|||
143111264|NCT02600845|515948460|FG000|Overall Study|Reason Not Specified|3|||
143111265|NCT02600845|515948460|FG000|Overall Study|Non-compliance with Study Procedures|10|||
143111266|NCT02600845|515948460|FG000|Overall Study|Consent Withdrawal|5|||
143111267|NCT00965341|515948463|FG000|Overall Study|Withdrew consent|1|||
143111268|NCT00965341|515948464|FG001|Overall Study|Withdrew consent|5|||
143111269|NCT00965341|515948463|FG000|Overall Study|Lost to Follow-up|1|||
143111270|NCT00965341|515948464|FG001|Overall Study|Lost to Follow-up|0|||
143111271|NCT00965341|515948463|FG000|Overall Study|Transportation issues|4|||
143111272|NCT00965341|515948464|FG001|Overall Study|Transportation issues|3|||
143111273|NCT00960986|515948470|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
143111274|NCT00960986|515948471|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
143111275|NCT00960986|515948472|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
143111276|NCT00960986|515948473|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
143111277|NCT00960986|515948470|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
143111278|NCT00960986|515948471|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
143111279|NCT00960986|515948472|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
143111280|NCT00960986|515948473|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
143111281|NCT00960986|515948470|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
143111282|NCT00960986|515948471|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
143111283|NCT00960986|515948472|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
143111284|NCT00960986|515948473|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
143111285|NCT00960986|515948470|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
143111286|NCT00960986|515948471|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
143111287|NCT00960986|515948472|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
143111288|NCT00960986|515948473|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
143111289|NCT00960986|515948470|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
143111290|NCT00960986|515948471|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
143111291|NCT00960986|515948472|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
143111292|NCT00960986|515948473|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
143111293|NCT00960986|515948470|FG000|Period 3 (7-week Therapy Period)|Death|0|||
143111294|NCT00960986|515948471|FG001|Period 3 (7-week Therapy Period)|Death|0|||
143111295|NCT00960986|515948472|FG002|Period 3 (7-week Therapy Period)|Death|1|||
143111296|NCT00960986|515948473|FG003|Period 3 (7-week Therapy Period)|Death|0|||
143111297|NCT00960986|515948470|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
143111298|NCT00960986|515948471|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
143111299|NCT00960986|515948472|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
143111300|NCT00960986|515948473|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
143111301|NCT00960986|515948470|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
143111302|NCT00960986|515948471|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
143179519|NCT04551898|516205612|FG000|Overall Study|Death|1|||
143179520|NCT04551898|516205613|FG001|Overall Study|Death|0|||
143179521|NCT04551898|516205614|FG002|Overall Study|Death|0|||
143179522|NCT04551898|516205615|FG003|Overall Study|Death|0|||
143179523|NCT04551898|516205612|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
143179524|NCT04551898|516205613|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
143179525|NCT04551898|516205614|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
143179526|NCT04551898|516205615|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
143179527|NCT02477527|516205616|FG000|Overall Study|Lost to Follow-up|2|||
143179528|NCT02477527|516205616|FG000|Overall Study|Withdrawal by Subject|1|||
143111303|NCT00960986|515948472|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
143111304|NCT00960986|515948473|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
143111305|NCT00960986|515948470|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
143111306|NCT00960986|515948471|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
143111307|NCT00960986|515948472|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
143111308|NCT00960986|515948473|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
143111309|NCT00960986|515948470|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
143111310|NCT00960986|515948471|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
143111311|NCT00960986|515948472|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
143111312|NCT00960986|515948473|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
143111313|NCT01984892|515948474|FG000|Overall Study|Progressive disease|7|||
143111314|NCT04464720|515948475|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
143111315|NCT04413552|515948477|FG000|Overall Study|Adverse Event|0|||
143111316|NCT04413552|515948478|FG001|Overall Study|Adverse Event|0|||
143111317|NCT04413552|515948479|FG002|Overall Study|Adverse Event|0|||
143111318|NCT04413552|515948480|FG003|Overall Study|Adverse Event|0|||
143111319|NCT04413552|515948481|FG004|Overall Study|Adverse Event|0|||
143111320|NCT04413552|515948482|FG005|Overall Study|Adverse Event|0|||
143111321|NCT04413552|515948483|FG006|Overall Study|Adverse Event|1|||
143111322|NCT04413552|515948484|FG007|Overall Study|Adverse Event|0|||
143111323|NCT04413552|515948485|FG008|Overall Study|Adverse Event|0|||
143111324|NCT04413552|515948486|FG009|Overall Study|Adverse Event|0|||
143111325|NCT01794793|515948489|FG000|Treatment Period|Withdrawal by Subject|24|||
143111326|NCT01794793|515948489|FG000|Treatment Period|Lack of Efficacy|22|||
143111327|NCT01794793|515948489|FG000|Treatment Period|Adverse Event|17|||
143111328|NCT01794793|515948489|FG000|Treatment Period|Physician Decision|14|||
143111329|NCT01794793|515948489|FG000|Treatment Period|Lost to Follow-up|7|||
143111330|NCT01794793|515948489|FG000|Treatment Period|Death|6|||
143111331|NCT01794793|515948489|FG000|Treatment Period|Protocol Violation|5|||
143111332|NCT01794793|515948489|FG000|Treatment Period|administrative problem|3|||
143111333|NCT01794793|515948489|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
143111334|NCT01794793|515948489|FG000|Post-treatment Follow-up|Adverse Event|8|||
143111335|NCT01794793|515948489|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
143111336|NCT01794793|515948489|FG000|Post-treatment Follow-up|administrative problem|5|||
143111337|NCT01794793|515948489|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
143111338|NCT01794793|515948489|FG000|Post-treatment Follow-up|Protocol Violation|3|||
143111339|NCT02234596|515948490|FG000|Overall Study|Participant not treated|2|||
143111340|NCT04852679|515948493|FG000|Main Intervention Period|Withdrawal by Subject|3|||
143111341|NCT04852679|515948493|FG000|Main Intervention Period|Adverse Event|1|||
143111342|NCT04852679|515948493|FG000|Main Intervention Period|Progressive Disease|16|||
143111343|NCT04852679|515948493|FG000|Main Intervention Period|Refused study visit|1|||
143111344|NCT04852679|515948493|FG000|Independent Injection Period|Missed study visit|1|||
143111345|NCT03960021|515950322|FG000|Overall Study|did not undergo the 2 radiofrequency ablations.|3|||
143111346|NCT04161079|515950323|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
143111347|NCT02515994|515950324|FG000|Overall Study|Protocol Violation|3|||
143111348|NCT02515994|515950325|FG001|Overall Study|Protocol Violation|5|||
143111349|NCT02515994|515950324|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
143111350|NCT02515994|515950325|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
143111351|NCT02515994|515950324|FG000|Overall Study|Adverse Event|3|||
143111352|NCT02515994|515950325|FG001|Overall Study|Adverse Event|1|||
143111353|NCT02515994|515950324|FG000|Overall Study|Withdrawal by Subject|2|||
143111354|NCT02515994|515950325|FG001|Overall Study|Withdrawal by Subject|0|||
143111355|NCT03391232|515950328|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
143111356|NCT03391232|515950329|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
143111357|NCT03391232|515950328|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
143111358|NCT03391232|515950329|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
143111359|NCT02637895|515950330|FG000|Overall Study|Lost to Follow-up|4|||
143111360|NCT02637895|515950331|FG001|Overall Study|Lost to Follow-up|0|||
143111361|NCT02637895|515950330|FG000|Overall Study|Protocol Violation|0|||
143111362|NCT02637895|515950331|FG001|Overall Study|Protocol Violation|1|||
143111363|NCT02637895|515950330|FG000|Overall Study|Lack of Efficacy|1|||
143111364|NCT02637895|515950331|FG001|Overall Study|Lack of Efficacy|0|||
143111365|NCT02637895|515950330|FG000|Overall Study|Withdrawal by Subject|1|||
143111366|NCT02637895|515950331|FG001|Overall Study|Withdrawal by Subject|1|||
143111367|NCT02637895|515950330|FG000|Overall Study|Abnormal baseline lab|0|||
143111368|NCT02637895|515950331|FG001|Overall Study|Abnormal baseline lab|1|||
143111369|NCT01346189|515950335|FG000|Overall Study|Withdrawal by Subject|7|||
143111370|NCT01346189|515950336|FG001|Overall Study|Withdrawal by Subject|5|||
143111371|NCT01346189|515950337|FG002|Overall Study|Withdrawal by Subject|3|||
143111372|NCT01346189|515950338|FG003|Overall Study|Withdrawal by Subject|5|||
143111373|NCT01346189|515950335|FG000|Overall Study|Physician Decision|4|||
143111374|NCT01346189|515950336|FG001|Overall Study|Physician Decision|0|||
143111375|NCT01346189|515950337|FG002|Overall Study|Physician Decision|0|||
143111376|NCT01346189|515950338|FG003|Overall Study|Physician Decision|0|||
143111377|NCT01346189|515950335|FG000|Overall Study|Moved|3|||
143111378|NCT01346189|515950336|FG001|Overall Study|Moved|0|||
143111379|NCT01346189|515950337|FG002|Overall Study|Moved|4|||
143111380|NCT01346189|515950338|FG003|Overall Study|Moved|0|||
143111381|NCT01346189|515950335|FG000|Overall Study|Other|2|||
143258016|NCT01606878|516497567|FG010|Overall Study|Withdrawal by Subject|2|||
143111382|NCT01346189|515950336|FG001|Overall Study|Other|4|||
143111383|NCT01346189|515950337|FG002|Overall Study|Other|7|||
143111384|NCT01346189|515950338|FG003|Overall Study|Other|3|||
143111385|NCT01346189|515950335|FG000|Overall Study|Death|0|||
143111386|NCT01346189|515950336|FG001|Overall Study|Death|3|||
143111387|NCT01346189|515950337|FG002|Overall Study|Death|0|||
143111388|NCT01346189|515950338|FG003|Overall Study|Death|0|||
143111389|NCT01346189|515950335|FG000|Overall Study|Non-health system primary care physician|0|||
143111390|NCT01346189|515950336|FG001|Overall Study|Non-health system primary care physician|5|||
143111391|NCT01346189|515950337|FG002|Overall Study|Non-health system primary care physician|0|||
143111392|NCT01346189|515950338|FG003|Overall Study|Non-health system primary care physician|0|||
143111393|NCT01346189|515950335|FG000|Overall Study|Travel|0|||
143111394|NCT01346189|515950336|FG001|Overall Study|Travel|0|||
143111395|NCT01346189|515950337|FG002|Overall Study|Travel|0|||
143111396|NCT01346189|515950338|FG003|Overall Study|Travel|3|||
143111397|NCT00759785|515950348|FG000|Overall Study|Participant sample not evaluable|11|||
143111398|NCT00759785|515950349|FG001|Overall Study|Participant sample not evaluable|2|||
143111399|NCT00759785|515950348|FG000|Overall Study|Participant sample lost|0|||
143111400|NCT00759785|515950349|FG001|Overall Study|Participant sample lost|1|||
143111401|NCT00759785|515950348|FG000|Overall Study|Protocol Violation|1|||
143111402|NCT00759785|515950349|FG001|Overall Study|Protocol Violation|0|||
143111403|NCT00759785|515950348|FG000|Overall Study|Physician Decision|0|||
143111404|NCT00759785|515950349|FG001|Overall Study|Physician Decision|1|||
143111405|NCT00759785|515950348|FG000|Overall Study|Withdrawal by Subject|0|||
143111406|NCT00759785|515950349|FG001|Overall Study|Withdrawal by Subject|1|||
143111407|NCT00177307|515950350|FG000|Overall Study|Withdrawal by Subject|1|||
143111408|NCT03671564|515950354|FG000|Overall Study|Progressive Disease|3|||
143111409|NCT03671564|515950355|FG001|Overall Study|Progressive Disease|5|||
143111410|NCT03671564|515950356|FG002|Overall Study|Progressive Disease|3|||
143111411|NCT03671564|515950354|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
143111412|NCT03671564|515950355|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
143111413|NCT03671564|515950356|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
143111414|NCT03671564|515950354|FG000|Overall Study|Withdrawal by Subject|1|||
143111415|NCT03671564|515950355|FG001|Overall Study|Withdrawal by Subject|1|||
143111416|NCT03671564|515950356|FG002|Overall Study|Withdrawal by Subject|0|||
143111417|NCT04521621|515950357|FG000|Overall Study|Death|17|||
143111418|NCT04521621|515950358|FG001|Overall Study|Death|8|||
143111419|NCT04521621|515950359|FG002|Overall Study|Death|8|||
143111420|NCT04521621|515950360|FG003|Overall Study|Death|5|||
143111421|NCT04521621|515950361|FG004|Overall Study|Death|2|||
143111422|NCT04521621|515950362|FG005|Overall Study|Death|7|||
143111423|NCT04521621|515950363|FG006|Overall Study|Death|0|||
143111424|NCT04521621|515950364|FG007|Overall Study|Death|0|||
143111425|NCT04521621|515950357|FG000|Overall Study|Study Terminated by Sponsor|4|||
143111426|NCT04521621|515950358|FG001|Overall Study|Study Terminated by Sponsor|6|||
143111427|NCT04521621|515950359|FG002|Overall Study|Study Terminated by Sponsor|8|||
143111428|NCT04521621|515950360|FG003|Overall Study|Study Terminated by Sponsor|0|||
143111429|NCT04521621|515950361|FG004|Overall Study|Study Terminated by Sponsor|1|||
143111430|NCT04521621|515950362|FG005|Overall Study|Study Terminated by Sponsor|7|||
143111431|NCT04521621|515950363|FG006|Overall Study|Study Terminated by Sponsor|0|||
143111432|NCT04521621|515950364|FG007|Overall Study|Study Terminated by Sponsor|0|||
143111433|NCT04521621|515950357|FG000|Overall Study|Withdrawal by Subject|0|||
143111434|NCT04521621|515950358|FG001|Overall Study|Withdrawal by Subject|0|||
143111435|NCT04521621|515950359|FG002|Overall Study|Withdrawal by Subject|1|||
143111436|NCT04521621|515950360|FG003|Overall Study|Withdrawal by Subject|1|||
143111437|NCT04521621|515950361|FG004|Overall Study|Withdrawal by Subject|0|||
143111438|NCT04521621|515950362|FG005|Overall Study|Withdrawal by Subject|0|||
143111439|NCT04521621|515950363|FG006|Overall Study|Withdrawal by Subject|0|||
143111440|NCT04521621|515950364|FG007|Overall Study|Withdrawal by Subject|0|||
143258017|NCT03353740|516497569|FG000|Overall Study|Images for these participants not viable|52|||
143111441|NCT04521621|515950357|FG000|Overall Study|Allocated in error without study intervention|1|||
143111442|NCT04521621|515950358|FG001|Overall Study|Allocated in error without study intervention|0|||
143111443|NCT04521621|515950359|FG002|Overall Study|Allocated in error without study intervention|0|||
143111444|NCT04521621|515950360|FG003|Overall Study|Allocated in error without study intervention|0|||
143258018|NCT00129311|516497571|FG000|Overall Study|Withdrawal by Subject|12|||
143258019|NCT00129311|516497572|FG001|Overall Study|Withdrawal by Subject|19|||
143111445|NCT04521621|515950361|FG004|Overall Study|Allocated in error without study intervention|0|||
143111446|NCT04521621|515950362|FG005|Overall Study|Allocated in error without study intervention|0|||
143111447|NCT04521621|515950363|FG006|Overall Study|Allocated in error without study intervention|0|||
143111448|NCT04521621|515950364|FG007|Overall Study|Allocated in error without study intervention|0|||
143111449|NCT01282164|515950365|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
143111450|NCT01282164|515950366|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
143111451|NCT01968707|515950374|FG000|Overall Study|Did not meet treatment day baseline|49|||
143258020|NCT02232880|516497573|FG000|Overall Study|study stopped prior to randomization|1|||
143111452|NCT01968707|515950375|FG001|Overall Study|Did not meet treatment day baseline|12|||
143111453|NCT01968707|515950376|FG002|Overall Study|Did not meet treatment day baseline|41|||
143111454|NCT01968707|515950377|FG003|Overall Study|Did not meet treatment day baseline|44|||
143111455|NCT01968707|515950378|FG004|Overall Study|Did not meet treatment day baseline|36|||
143111456|NCT01968707|515950379|FG005|Overall Study|Did not meet treatment day baseline|11|||
143111457|NCT01968707|515950380|FG006|Overall Study|Did not meet treatment day baseline|34|||
143111458|NCT01968707|515950381|FG007|Overall Study|Did not meet treatment day baseline|35|||
143111459|NCT01185509|515950382|FG000|Overall Study|Progression/Relapse|9|||
143111460|NCT01185509|515950383|FG001|Overall Study|Progression/Relapse|15|||
143111461|NCT01185509|515950382|FG000|Overall Study|Physician Decision|2|||
143111462|NCT01185509|515950383|FG001|Overall Study|Physician Decision|2|||
143111463|NCT01185509|515950382|FG000|Overall Study|Withdrawal by Subject|0|||
143111464|NCT01185509|515950383|FG001|Overall Study|Withdrawal by Subject|1|||
143111465|NCT01185509|515950382|FG000|Overall Study|Death|0|||
143111466|NCT01185509|515950383|FG001|Overall Study|Death|1|||
143111467|NCT01185509|515950382|FG000|Overall Study|Intercurrent Illness|0|||
143111468|NCT01185509|515950383|FG001|Overall Study|Intercurrent Illness|1|||
143111469|NCT03729570|515950395|FG000|Overall Study|Lost to Follow-up|16|||
143111470|NCT03729570|515950396|FG001|Overall Study|Lost to Follow-up|20|||
143111471|NCT03729570|515950395|FG000|Overall Study|Seroconversion|5|||
143111472|NCT03729570|515950396|FG001|Overall Study|Seroconversion|0|||
143111473|NCT03729570|515950395|FG000|Overall Study|Moved out of the city|1|||
143111474|NCT03729570|515950396|FG001|Overall Study|Moved out of the city|0|||
143111475|NCT03729570|515950395|FG000|Overall Study|Time Conflict|1|||
143111476|NCT03729570|515950396|FG001|Overall Study|Time Conflict|0|||
143111477|NCT03729570|515950395|FG000|Overall Study|Time Commitment|2|||
143111478|NCT03729570|515950396|FG001|Overall Study|Time Commitment|0|||
143111479|NCT03729570|515950395|FG000|Overall Study|Bad Experience|0|||
143111480|NCT03729570|515950396|FG001|Overall Study|Bad Experience|1|||
143111481|NCT03729570|515950395|FG000|Overall Study|No reason provided|2|||
143111482|NCT03729570|515950396|FG001|Overall Study|No reason provided|1|||
143111483|NCT03729570|515950395|FG000|Overall Study|Family Conflict|0|||
143111484|NCT03729570|515950396|FG001|Overall Study|Family Conflict|1|||
143111485|NCT03729570|515950395|FG000|Overall Study|Did not want to continue taking medications|0|||
143111486|NCT03729570|515950396|FG001|Overall Study|Did not want to continue taking medications|1|||
143111487|NCT03729570|515950395|FG000|Overall Study|Found another PrEP provider|1|||
143111488|NCT03729570|515950396|FG001|Overall Study|Found another PrEP provider|0|||
143111489|NCT03729570|515950395|FG000|Overall Study|Did not enjoy being in the control group|0|||
143111490|NCT03729570|515950396|FG001|Overall Study|Did not enjoy being in the control group|1|||
143111491|NCT02062944|515950397|FG000|Overall Study|Lost to Follow-up|1|||
143111492|NCT02062944|515950397|FG000|Overall Study|New hemotological disorder identified|1|||
143111493|NCT02062944|515950397|FG000|Overall Study|Uncontrolled Hypertension|1|||
143111494|NCT02062944|515950397|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
143111495|NCT02122770|515950399|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
143111496|NCT02122770|515950400|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
143111497|NCT02122770|515950401|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
143111498|NCT02122770|515950402|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
143111499|NCT02122770|515950403|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
143111500|NCT02122770|515950404|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
143111501|NCT02122770|515950399|FG000|Part A: Drug-drug Interaction 2|Other|0|||
143111502|NCT02122770|515950400|FG001|Part A: Drug-drug Interaction 2|Other|0|||
143111503|NCT02122770|515950401|FG002|Part A: Drug-drug Interaction 2|Other|1|||
143111504|NCT02122770|515950402|FG003|Part A: Drug-drug Interaction 2|Other|0|||
143111505|NCT02122770|515950403|FG004|Part A: Drug-drug Interaction 2|Other|0|||
143111506|NCT02122770|515950404|FG005|Part A: Drug-drug Interaction 2|Other|0|||
143179529|NCT02477527|516205616|FG000|Overall Study|Screen Failure|3|||
143179530|NCT01147393|516205617|FG000|Dose Level 1|Dose limiting Toxicity|2|||
143179531|NCT01147393|516205617|FG000|Dose Level -1|Dose Limited Toxicity|1|||
143179532|NCT04263766|516205626|FG000|Overall Study|Withdrawal by Subject|6|||
143179533|NCT04263766|516205627|FG001|Overall Study|Withdrawal by Subject|4|||
143179534|NCT04263766|516205626|FG000|Overall Study|Lack of Efficacy|1|||
143179535|NCT04263766|516205627|FG001|Overall Study|Lack of Efficacy|3|||
143179536|NCT01891396|516205629|FG000|Overall Study|Withdrawal by Subject|4|||
143179537|NCT01891396|516205630|FG001|Overall Study|Withdrawal by Subject|4|||
143179538|NCT01891396|516205631|FG002|Overall Study|Withdrawal by Subject|3|||
143179539|NCT01891396|516205629|FG000|Overall Study|Lost to Follow-up|0|||
143179540|NCT01891396|516205630|FG001|Overall Study|Lost to Follow-up|1|||
143179541|NCT01891396|516205631|FG002|Overall Study|Lost to Follow-up|0|||
143111507|NCT02122770|515950399|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
143111508|NCT02122770|515950400|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
143111509|NCT02122770|515950401|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
143179542|NCT03462758|516205632|FG000|Overall Study|Chose no or other method of contraception|20|||
143179543|NCT03462758|516205633|FG001|Overall Study|Chose no or other method of contraception|23|||
143258021|NCT04085367|516498708|FG000|Overall Study|Adverse Event|1|||
143258022|NCT04085367|516498709|FG001|Overall Study|Adverse Event|1|||
143111510|NCT02122770|515950402|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
143111511|NCT02122770|515950403|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
143111512|NCT02122770|515950404|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
143111513|NCT02122770|515950399|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
143111514|NCT02122770|515950400|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
143111515|NCT02122770|515950401|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
143111516|NCT02122770|515950402|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
143111517|NCT02122770|515950403|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
143111518|NCT02122770|515950404|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
143111519|NCT02122770|515950399|FG000|Part B: Standard of Care|Adverse Event|0|||
143111520|NCT02122770|515950400|FG001|Part B: Standard of Care|Adverse Event|0|||
143111521|NCT02122770|515950401|FG002|Part B: Standard of Care|Adverse Event|0|||
143111522|NCT02122770|515950402|FG003|Part B: Standard of Care|Adverse Event|0|||
143111523|NCT02122770|515950403|FG004|Part B: Standard of Care|Adverse Event|4|||
143111524|NCT02122770|515950404|FG005|Part B: Standard of Care|Adverse Event|1|||
143111525|NCT02122770|515950399|FG000|Part B: Standard of Care|Other|0|||
143111526|NCT02122770|515950400|FG001|Part B: Standard of Care|Other|0|||
143111527|NCT02122770|515950401|FG002|Part B: Standard of Care|Other|0|||
143111528|NCT02122770|515950402|FG003|Part B: Standard of Care|Other|0|||
143111529|NCT02122770|515950403|FG004|Part B: Standard of Care|Other|0|||
143111530|NCT02122770|515950404|FG005|Part B: Standard of Care|Other|2|||
143111531|NCT02122770|515950399|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
143111532|NCT02122770|515950400|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
143111533|NCT02122770|515950401|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
143111534|NCT02122770|515950402|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
143111535|NCT02122770|515950403|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
143111536|NCT02122770|515950404|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
143111537|NCT02122770|515950399|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
143111538|NCT02122770|515950400|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
143111539|NCT02122770|515950401|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
143111540|NCT02122770|515950402|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
143111541|NCT02122770|515950403|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
143111542|NCT02122770|515950404|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
143111543|NCT02122770|515950399|FG000|Part B: Standard of Care|Progressive Disease|0|||
143111544|NCT02122770|515950400|FG001|Part B: Standard of Care|Progressive Disease|0|||
143111545|NCT02122770|515950401|FG002|Part B: Standard of Care|Progressive Disease|0|||
143111546|NCT02122770|515950402|FG003|Part B: Standard of Care|Progressive Disease|0|||
143111547|NCT02122770|515950403|FG004|Part B: Standard of Care|Progressive Disease|10|||
143111548|NCT02122770|515950404|FG005|Part B: Standard of Care|Progressive Disease|8|||
143111549|NCT02083185|515950405|FG000|Overall Study|Lost to Follow-up|0|||
143111550|NCT02083185|515950406|FG001|Overall Study|Lost to Follow-up|3|||
143111551|NCT02083185|515950407|FG002|Overall Study|Lost to Follow-up|0|||
143111552|NCT02083185|515950405|FG000|Overall Study|Withdrawal by Subject|9|||
143111553|NCT02083185|515950406|FG001|Overall Study|Withdrawal by Subject|15|||
143111554|NCT02083185|515950407|FG002|Overall Study|Withdrawal by Subject|1|||
143111555|NCT02083185|515950405|FG000|Overall Study|Death|2|||
143111556|NCT02083185|515950406|FG001|Overall Study|Death|2|||
143111557|NCT02083185|515950407|FG002|Overall Study|Death|1|||
143111558|NCT02083185|515950405|FG000|Overall Study|Reason not Specified|9|||
143111559|NCT02083185|515950406|FG001|Overall Study|Reason not Specified|6|||
143111560|NCT02083185|515950407|FG002|Overall Study|Reason not Specified|5|||
143111561|NCT02083185|515950405|FG000|Overall Study|Study Terminated by Sponsor|0|||
143111562|NCT02083185|515950406|FG001|Overall Study|Study Terminated by Sponsor|1|||
143111563|NCT02083185|515950407|FG002|Overall Study|Study Terminated by Sponsor|0|||
143111564|NCT02083185|515950405|FG000|Overall Study|Did not Receive Study Drug|0|||
143111565|NCT02083185|515950406|FG001|Overall Study|Did not Receive Study Drug|2|||
143111566|NCT02083185|515950407|FG002|Overall Study|Did not Receive Study Drug|0|||
143111567|NCT01041976|515950408|FG000|Overall Study|Withdrawal by Subject|3|||
143111568|NCT01041976|515950409|FG001|Overall Study|Withdrawal by Subject|0|||
143111569|NCT01041976|515950408|FG000|Overall Study|Incarceration|2|||
143111570|NCT01041976|515950409|FG001|Overall Study|Incarceration|0|||
143111571|NCT01041976|515950408|FG000|Overall Study|Death|0|||
143111572|NCT01041976|515950409|FG001|Overall Study|Death|4|||
143111573|NCT02231879|515950410|FG000|Overall Study|Adverse Event|2|||
143179544|NCT03462758|516205632|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
143111574|NCT02231879|515950411|FG001|Overall Study|Adverse Event|1|||
143111575|NCT02231879|515950410|FG000|Overall Study|Lack of Efficacy|0|||
143111576|NCT02231879|515950411|FG001|Overall Study|Lack of Efficacy|1|||
143111577|NCT00535847|515950412|FG000|Overall Study|Adverse Event|5|||
143111578|NCT00535847|515950413|FG001|Overall Study|Adverse Event|3|||
143111579|NCT00535847|515950414|FG002|Overall Study|Adverse Event|2|||
143111580|NCT00535847|515950412|FG000|Overall Study|Non compliance|1|||
143111581|NCT00535847|515950413|FG001|Overall Study|Non compliance|1|||
143179545|NCT03462758|516205633|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
143111582|NCT00535847|515950414|FG002|Overall Study|Non compliance|0|||
143111583|NCT00535847|515950412|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
143111584|NCT00535847|515950413|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
143111585|NCT00535847|515950414|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
143111586|NCT01546168|515950415|FG000|Overall Study|Lost to Follow-up|1|||
143111587|NCT01546168|515950416|FG001|Overall Study|Lost to Follow-up|0|||
143111588|NCT01546168|515950415|FG000|Overall Study|Withdrawal by Subject|1|||
143111589|NCT01546168|515950416|FG001|Overall Study|Withdrawal by Subject|0|||
143111590|NCT01546168|515950415|FG000|Overall Study|ineligible after signing consent|2|||
143111591|NCT01546168|515950416|FG001|Overall Study|ineligible after signing consent|0|||
143111592|NCT02370667|515950417|FG000|Overall Study|Lost to Follow-up|0|||
143111593|NCT02370667|515950418|FG001|Overall Study|Lost to Follow-up|1|||
143111594|NCT02370667|515950419|FG002|Overall Study|Lost to Follow-up|0|||
143111595|NCT02850016|515950420|FG000|Overall Study|Withdrawal by Subject|1|||
143111596|NCT02850016|515950421|FG001|Overall Study|Withdrawal by Subject|2|||
143111597|NCT01258075|515950425|FG000|Overall Study|Adverse Event|8|||
143111598|NCT01258075|515950426|FG001|Overall Study|Adverse Event|3|||
143111599|NCT01258075|515950425|FG000|Overall Study|Lost to Follow-up|11|||
143111600|NCT01258075|515950426|FG001|Overall Study|Lost to Follow-up|6|||
143111601|NCT01258075|515950425|FG000|Overall Study|Withdrawal by Subject|10|||
143111602|NCT01258075|515950426|FG001|Overall Study|Withdrawal by Subject|7|||
143111603|NCT01258075|515950425|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
143111604|NCT01258075|515950426|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
143111605|NCT01258075|515950425|FG000|Overall Study|Other|12|||
143111606|NCT01258075|515950426|FG001|Overall Study|Other|5|||
143111607|NCT00976209|515950429|FG000|Treatment Period 1|Protocol Violation|1|||
143111608|NCT00976209|515950430|FG001|Treatment Period 1|Protocol Violation|0|||
143111609|NCT00976209|515950429|FG000|Treatment Period 1|Lost to Follow-up|2|||
143111610|NCT00976209|515950430|FG001|Treatment Period 1|Lost to Follow-up|0|||
143111611|NCT00976209|515950429|FG000|Treatment Period 1|Other|0|||
143111612|NCT00976209|515950430|FG001|Treatment Period 1|Other|1|||
143111613|NCT00976209|515950429|FG000|Wash-out Period|Adverse Event|1|||
143111614|NCT00976209|515950430|FG001|Wash-out Period|Adverse Event|2|||
143111615|NCT00976209|515950429|FG000|Wash-out Period|Lost to Follow-up|1|||
143111616|NCT00976209|515950430|FG001|Wash-out Period|Lost to Follow-up|0|||
143111617|NCT00976209|515950429|FG000|Wash-out Period|Protocol Violation|1|||
143111618|NCT00976209|515950430|FG001|Wash-out Period|Protocol Violation|0|||
143111619|NCT00976209|515950429|FG000|Wash-out Period|Other|1|||
143111620|NCT00976209|515950430|FG001|Wash-out Period|Other|0|||
143111621|NCT00976209|515950429|FG000|Treatment Period 2|Withdrawal by Subject|0|||
143111622|NCT00976209|515950430|FG001|Treatment Period 2|Withdrawal by Subject|1|||
143111623|NCT00976209|515950429|FG000|Treatment Period 2|Lost to Follow-up|0|||
143111624|NCT00976209|515950430|FG001|Treatment Period 2|Lost to Follow-up|1|||
143111625|NCT02612610|515950431|FG000|Overall Study|Withdrawal by Subject|1|||
143111626|NCT02612610|515950432|FG001|Overall Study|Withdrawal by Subject|1|||
143111627|NCT02612610|515950433|FG002|Overall Study|Withdrawal by Subject|0|||
143111628|NCT02612610|515950434|FG003|Overall Study|Withdrawal by Subject|2|||
143111629|NCT02612610|515950431|FG000|Overall Study|Adverse Event|2|||
143179546|NCT03462758|516205632|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
143179547|NCT03462758|516205633|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
143179548|NCT03462758|516205632|FG000|Overall Study|Medical contraindication|2|||
143179549|NCT03462758|516205633|FG001|Overall Study|Medical contraindication|2|||
143179550|NCT03462758|516205632|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
143179551|NCT03462758|516205633|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
143179552|NCT02820844|516205634|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
143179553|NCT02820844|516205635|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
143179554|NCT02820844|516205636|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
143179555|NCT02820844|516205637|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
143179556|NCT02820844|516205638|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
143179557|NCT02820844|516205639|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
143179558|NCT02820844|516205634|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
143179559|NCT02820844|516205635|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
143179560|NCT02820844|516205636|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
143179561|NCT02820844|516205637|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
143179562|NCT02820844|516205638|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
143111630|NCT02612610|515950432|FG001|Overall Study|Adverse Event|2|||
143111631|NCT02612610|515950433|FG002|Overall Study|Adverse Event|3|||
143111632|NCT02612610|515950434|FG003|Overall Study|Adverse Event|10|||
143111633|NCT02612610|515950431|FG000|Overall Study|Lost to Follow-up|0|||
143111634|NCT02612610|515950432|FG001|Overall Study|Lost to Follow-up|1|||
143111635|NCT02612610|515950433|FG002|Overall Study|Lost to Follow-up|0|||
143111636|NCT02612610|515950434|FG003|Overall Study|Lost to Follow-up|0|||
143111637|NCT02612610|515950431|FG000|Overall Study|Protocol Violation|0|||
143111638|NCT02612610|515950432|FG001|Overall Study|Protocol Violation|1|||
143111639|NCT02612610|515950433|FG002|Overall Study|Protocol Violation|1|||
143111640|NCT02612610|515950434|FG003|Overall Study|Protocol Violation|0|||
143111641|NCT02612610|515950431|FG000|Overall Study|Lack of Efficacy|1|||
143111642|NCT02612610|515950432|FG001|Overall Study|Lack of Efficacy|2|||
143111643|NCT02612610|515950433|FG002|Overall Study|Lack of Efficacy|0|||
143111644|NCT02612610|515950434|FG003|Overall Study|Lack of Efficacy|1|||
143111645|NCT02612610|515950431|FG000|Overall Study|Physician Decision|0|||
143111646|NCT02612610|515950432|FG001|Overall Study|Physician Decision|1|||
143111647|NCT02612610|515950433|FG002|Overall Study|Physician Decision|0|||
143111648|NCT02612610|515950434|FG003|Overall Study|Physician Decision|0|||
143111649|NCT02612610|515950431|FG000|Overall Study|Noncompliance|1|||
143111650|NCT02612610|515950432|FG001|Overall Study|Noncompliance|0|||
143111651|NCT02612610|515950433|FG002|Overall Study|Noncompliance|0|||
143111652|NCT02612610|515950434|FG003|Overall Study|Noncompliance|0|||
143111653|NCT02612610|515950431|FG000|Overall Study|Cough Improvement|0|||
143111654|NCT02612610|515950432|FG001|Overall Study|Cough Improvement|0|||
143111655|NCT02612610|515950433|FG002|Overall Study|Cough Improvement|1|||
143111656|NCT02612610|515950434|FG003|Overall Study|Cough Improvement|0|||
143111657|NCT01801280|515950435|FG000|Period 1|Withdrawal by Subject|0|||
143111658|NCT01801280|515950436|FG001|Period 1|Withdrawal by Subject|1|||
143258023|NCT04085367|516498708|FG000|Overall Study|Withdrawal by Subject|13|||
143258024|NCT04085367|516498709|FG001|Overall Study|Withdrawal by Subject|4|||
143258025|NCT04085367|516498708|FG000|Overall Study|Lost to Follow-up|3|||
143258026|NCT04085367|516498709|FG001|Overall Study|Lost to Follow-up|1|||
143258027|NCT04085367|516498708|FG000|Overall Study|Other unspecified|2|||
143258028|NCT04085367|516498709|FG001|Overall Study|Other unspecified|1|||
143258029|NCT04085367|516498708|FG000|Overall Study|Status Unknown|1|||
143258030|NCT04085367|516498709|FG001|Overall Study|Status Unknown|1|||
143258031|NCT00130442|516498712|FG000|Overall Study|Withdrawal by Subject|0|||
143258032|NCT00130442|516498713|FG001|Overall Study|Withdrawal by Subject|1|||
143258033|NCT00130442|516498712|FG000|Overall Study|did not meet criteria|1|||
143258034|NCT00130442|516498713|FG001|Overall Study|did not meet criteria|1|||
143368303|NCT03068468|516892634|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
143258035|NCT00814333|516498714|FG000|Enrollment|Lost to Follow-up|1|||
143111659|NCT01801280|515950437|FG002|Period 1|Withdrawal by Subject|0|||
143111660|NCT01801280|515950438|FG003|Period 1|Withdrawal by Subject|0|||
143111661|NCT01801280|515950435|FG000|Period 2|Withdrawal by Subject|1|||
143111662|NCT01801280|515950436|FG001|Period 2|Withdrawal by Subject|0|||
143111663|NCT01801280|515950437|FG002|Period 2|Withdrawal by Subject|0|||
143111664|NCT01801280|515950438|FG003|Period 2|Withdrawal by Subject|0|||
143111665|NCT01801280|515950435|FG000|Period 4|Protocol Violation|0|||
143111666|NCT01801280|515950436|FG001|Period 4|Protocol Violation|0|||
143111667|NCT01801280|515950437|FG002|Period 4|Protocol Violation|1|||
143111668|NCT01801280|515950438|FG003|Period 4|Protocol Violation|0|||
143111669|NCT00176644|515950439|FG000|Overall Study|Withdrawal by Subject|1|||
143111670|NCT03973918|515950440|FG000|Overall Study|Adverse Event|0|||
143111671|NCT03973918|515950441|FG001|Overall Study|Adverse Event|0|||
143111672|NCT03973918|515950442|FG002|Overall Study|Adverse Event|0|||
143111673|NCT03973918|515950443|FG003|Overall Study|Adverse Event|1|||
143111674|NCT03973918|515950440|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
143111675|NCT03973918|515950441|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
143111676|NCT03973918|515950442|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
143111677|NCT03973918|515950443|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
143111678|NCT02951533|515950447|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
143111679|NCT02951533|515950448|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
143111680|NCT02951533|515950449|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
143111681|NCT02951533|515950447|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
143111682|NCT02951533|515950448|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
143111683|NCT02951533|515950449|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
143111684|NCT02951533|515950447|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
143111685|NCT02951533|515950448|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
143111686|NCT02951533|515950449|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
143111687|NCT02951533|515950447|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
143111688|NCT02951533|515950448|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
143111689|NCT02951533|515950449|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
143111690|NCT02951533|515950447|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
143111691|NCT02951533|515950448|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
143111692|NCT02951533|515950449|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
143258036|NCT00814333|516498715|FG001|Enrollment|Lost to Follow-up|0|||
143111693|NCT02951533|515950447|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
143111694|NCT02951533|515950448|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
143111695|NCT02951533|515950449|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
143111696|NCT02951533|515950447|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
143368304|NCT03068468|516892635|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
143111697|NCT02951533|515950448|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
143111698|NCT02951533|515950449|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
143111699|NCT02951533|515950447|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
143111700|NCT02951533|515950448|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
143111701|NCT02951533|515950449|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
143111702|NCT02951533|515950447|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
143111703|NCT02951533|515950448|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
143111704|NCT02951533|515950449|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
143111705|NCT02951533|515950447|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
143111706|NCT02951533|515950448|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
143111707|NCT02951533|515950449|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
143111708|NCT02951533|515950447|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
143111709|NCT02951533|515950448|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
143111710|NCT02951533|515950449|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
143111711|NCT02029989|515950450|FG000|Overall Study|Withdrawal by Subject|1|||
143111712|NCT02029989|515950451|FG001|Overall Study|Withdrawal by Subject|0|||
143111713|NCT02029989|515950450|FG000|Overall Study|Withdrawal: Fear of needles|1|||
143111714|NCT02029989|515950451|FG001|Overall Study|Withdrawal: Fear of needles|0|||
143111715|NCT02029989|515950450|FG000|Overall Study|Change of location|2|||
143111716|NCT02029989|515950451|FG001|Overall Study|Change of location|3|||
143111717|NCT02029989|515950450|FG000|Overall Study|Physician Decision|2|||
143111718|NCT02029989|515950451|FG001|Overall Study|Physician Decision|0|||
143111719|NCT02029989|515950450|FG000|Overall Study|Lost to Follow-up|9|||
143111720|NCT02029989|515950451|FG001|Overall Study|Lost to Follow-up|7|||
143111721|NCT02029989|515950450|FG000|Overall Study|Death|0|||
143111722|NCT02029989|515950451|FG001|Overall Study|Death|1|||
143111723|NCT02029989|515950450|FG000|Overall Study|Protocol Violation|1|||
143111724|NCT02029989|515950451|FG001|Overall Study|Protocol Violation|0|||
143111725|NCT04351373|515950452|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
143111726|NCT01123941|515950459|FG000|Overall Study|Lost to Follow-up|2|||
143111727|NCT01123941|515950460|FG001|Overall Study|Lost to Follow-up|1|||
143111728|NCT06011161|515950465|FG000|Overall Study|Withdrawal by Subject|2|||
143111729|NCT06011161|515950465|FG000|Overall Study|Lost to Follow-up|5|||
143111730|NCT03099694|515950466|FG000|Overall Study|Withdrawal by Subject|11|||
143111731|NCT03099694|515950467|FG001|Overall Study|Withdrawal by Subject|13|||
143111732|NCT03099694|515950466|FG000|Overall Study|Lost to Follow-up|9|||
143111733|NCT03099694|515950467|FG001|Overall Study|Lost to Follow-up|5|||
143111734|NCT03379753|515950475|FG000|Overall Study|Withdrawal by Subject|2|||
143111735|NCT03379753|515950476|FG001|Overall Study|Withdrawal by Subject|1|||
143111736|NCT03379753|515950475|FG000|Overall Study|not having correct procedure|1|||
143111737|NCT03379753|515950476|FG001|Overall Study|not having correct procedure|2|||
143111738|NCT03379753|515950475|FG000|Overall Study|No primary outcome|12|||
143111739|NCT03379753|515950476|FG001|Overall Study|No primary outcome|22|||
143111740|NCT02091986|515950481|FG000|Overall Study|7 rand in error 1 patient decision|2|||
143111741|NCT02091986|515950482|FG001|Overall Study|7 rand in error 1 patient decision|3|||
143111742|NCT02091986|515950483|FG002|Overall Study|7 rand in error 1 patient decision|3|||
143111743|NCT02091986|515950481|FG000|Overall Study|Lost to Follow-up|1|||
143111744|NCT02091986|515950482|FG001|Overall Study|Lost to Follow-up|0|||
143111745|NCT02091986|515950483|FG002|Overall Study|Lost to Follow-up|0|||
143111746|NCT02091986|515950481|FG000|Overall Study|Withdrawal by Subject|4|||
143111747|NCT02091986|515950482|FG001|Overall Study|Withdrawal by Subject|8|||
143111748|NCT02091986|515950483|FG002|Overall Study|Withdrawal by Subject|3|||
143111749|NCT02091986|515950481|FG000|Overall Study|Adverse Event|0|||
143111750|NCT02091986|515950482|FG001|Overall Study|Adverse Event|0|||
143111751|NCT02091986|515950483|FG002|Overall Study|Adverse Event|2|||
143111752|NCT00915876|515950484|FG000|Overall Study|Adverse Event|0|||
143111753|NCT00915876|515950485|FG001|Overall Study|Adverse Event|1|||
143111754|NCT04545567|515950487|FG000|Overall Study|tested positive for SARS-co-V2|1|||
143111755|NCT04545567|515950488|FG001|Overall Study|tested positive for SARS-co-V2|1|||
143111756|NCT04545567|515950487|FG000|Overall Study|Withdrawal by Subject|0|||
143111757|NCT04545567|515950488|FG001|Overall Study|Withdrawal by Subject|1|||
143111758|NCT03626363|515950491|FG000|Overall Study|Protocol Violation|4|||
143111759|NCT03626363|515950492|FG001|Overall Study|Protocol Violation|0|||
143258037|NCT02233946|516498716|FG000|Baseline|Withdrawal by Subject|2|||
143258038|NCT02233946|516498717|FG001|Baseline|Withdrawal by Subject|0|||
143258039|NCT02233946|516498716|FG000|3-months Follow-up|Lost to Follow-up|53|||
143258040|NCT02233946|516498717|FG001|3-months Follow-up|Lost to Follow-up|29|||
143258041|NCT02233946|516498716|FG000|6-months Follow-up|Lost to Follow-up|21|||
143258042|NCT02233946|516498717|FG001|6-months Follow-up|Lost to Follow-up|2|||
143258043|NCT02233946|516498716|FG000|9-month Follow-up|Lost to Follow-up|20|||
143258044|NCT02233946|516498717|FG001|9-month Follow-up|Lost to Follow-up|11|||
143111760|NCT03626363|515950491|FG000|Overall Study|Lost to Follow-up|5|||
143111761|NCT03626363|515950492|FG001|Overall Study|Lost to Follow-up|7|||
143258045|NCT02233946|516498716|FG000|12-month Follow-up|Lost to Follow-up|28|||
143258046|NCT02233946|516498717|FG001|12-month Follow-up|Lost to Follow-up|11|||
143111762|NCT00533702|515950493|FG000|Overall Study|Withdrawal by Subject|3|||
143111763|NCT00533702|515950494|FG001|Overall Study|Withdrawal by Subject|1|||
143111764|NCT00533702|515950493|FG000|Overall Study|Found ineligible after randomization|2|||
143111765|NCT00533702|515950494|FG001|Overall Study|Found ineligible after randomization|1|||
143111766|NCT01294696|515950495|FG000|Overall Study|Screening failures|7|||
143111767|NCT01294696|515950495|FG000|Overall Study|Protocol Violation|8|||
143111768|NCT01294696|515950495|FG000|Overall Study|Missing BPI Response|7|||
143111769|NCT01294696|515950495|FG000|Overall Study|Site closure|52|||
143111770|NCT02017717|515951878|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
143111771|NCT02017717|515951879|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
143111772|NCT02017717|515951880|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
143111773|NCT02017717|515951881|FG003|Before Treatment Period|Adverse Event unrelated to study drug|0|||
143111774|NCT02017717|515951882|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
143111775|NCT02017717|515951883|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
143111776|NCT02017717|515951884|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
143111777|NCT02017717|515951885|FG007|Before Treatment Period|Adverse Event unrelated to study drug|1|||
143111778|NCT02017717|515951886|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
143111779|NCT02017717|515951878|FG000|Before Treatment Period|Participant request to stop therapy|0|||
143111780|NCT02017717|515951879|FG001|Before Treatment Period|Participant request to stop therapy|0|||
143111781|NCT02017717|515951880|FG002|Before Treatment Period|Participant request to stop therapy|0|||
143111782|NCT02017717|515951881|FG003|Before Treatment Period|Participant request to stop therapy|0|||
143111783|NCT02017717|515951882|FG004|Before Treatment Period|Participant request to stop therapy|0|||
143111784|NCT02017717|515951883|FG005|Before Treatment Period|Participant request to stop therapy|0|||
143111785|NCT02017717|515951884|FG006|Before Treatment Period|Participant request to stop therapy|0|||
143111786|NCT02017717|515951885|FG007|Before Treatment Period|Participant request to stop therapy|0|||
143111787|NCT02017717|515951886|FG008|Before Treatment Period|Participant request to stop therapy|5|||
143111788|NCT02017717|515951878|FG000|Before Treatment Period|Participant withdrew consent|0|||
143111789|NCT02017717|515951879|FG001|Before Treatment Period|Participant withdrew consent|0|||
143111790|NCT02017717|515951880|FG002|Before Treatment Period|Participant withdrew consent|0|||
143111791|NCT02017717|515951881|FG003|Before Treatment Period|Participant withdrew consent|0|||
143111792|NCT02017717|515951882|FG004|Before Treatment Period|Participant withdrew consent|0|||
143111793|NCT02017717|515951883|FG005|Before Treatment Period|Participant withdrew consent|0|||
143111794|NCT02017717|515951884|FG006|Before Treatment Period|Participant withdrew consent|2|||
143111795|NCT02017717|515951885|FG007|Before Treatment Period|Participant withdrew consent|0|||
143111796|NCT02017717|515951886|FG008|Before Treatment Period|Participant withdrew consent|11|||
143111797|NCT02017717|515951878|FG000|Before Treatment Period|Lost to Follow-up|0|||
143111798|NCT02017717|515951879|FG001|Before Treatment Period|Lost to Follow-up|0|||
143111799|NCT02017717|515951880|FG002|Before Treatment Period|Lost to Follow-up|0|||
143111800|NCT02017717|515951881|FG003|Before Treatment Period|Lost to Follow-up|0|||
143111801|NCT02017717|515951882|FG004|Before Treatment Period|Lost to Follow-up|0|||
143111802|NCT02017717|515951883|FG005|Before Treatment Period|Lost to Follow-up|0|||
143111803|NCT02017717|515951884|FG006|Before Treatment Period|Lost to Follow-up|0|||
143111804|NCT02017717|515951885|FG007|Before Treatment Period|Lost to Follow-up|0|||
143111805|NCT02017717|515951886|FG008|Before Treatment Period|Lost to Follow-up|1|||
143111806|NCT02017717|515951878|FG000|Before Treatment Period|Participant no longer met criteria|0|||
143111807|NCT02017717|515951879|FG001|Before Treatment Period|Participant no longer met criteria|0|||
143111808|NCT02017717|515951880|FG002|Before Treatment Period|Participant no longer met criteria|0|||
143111809|NCT02017717|515951881|FG003|Before Treatment Period|Participant no longer met criteria|0|||
143111810|NCT02017717|515951882|FG004|Before Treatment Period|Participant no longer met criteria|0|||
143111811|NCT02017717|515951883|FG005|Before Treatment Period|Participant no longer met criteria|1|||
143111812|NCT02017717|515951884|FG006|Before Treatment Period|Participant no longer met criteria|0|||
143111813|NCT02017717|515951885|FG007|Before Treatment Period|Participant no longer met criteria|1|||
143111814|NCT02017717|515951886|FG008|Before Treatment Period|Participant no longer met criteria|2|||
143111815|NCT02017717|515951878|FG000|Before Treatment Period|other reason|0|||
143111816|NCT02017717|515951879|FG001|Before Treatment Period|other reason|0|||
143111817|NCT02017717|515951880|FG002|Before Treatment Period|other reason|0|||
143111818|NCT02017717|515951881|FG003|Before Treatment Period|other reason|0|||
143111819|NCT02017717|515951882|FG004|Before Treatment Period|other reason|0|||
143111820|NCT02017717|515951883|FG005|Before Treatment Period|other reason|0|||
143111821|NCT02017717|515951884|FG006|Before Treatment Period|other reason|0|||
143111822|NCT02017717|515951885|FG007|Before Treatment Period|other reason|0|||
143111823|NCT02017717|515951886|FG008|Before Treatment Period|other reason|1|||
143111824|NCT02017717|515951878|FG000|Treatment Period|Disease progression|7|||
143111825|NCT02017717|515951879|FG001|Treatment Period|Disease progression|9|||
143111826|NCT02017717|515951880|FG002|Treatment Period|Disease progression|12|||
143179563|NCT02820844|516205639|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
143179564|NCT02820844|516205634|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
143179565|NCT02820844|516205635|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
143368305|NCT03068468|516892636|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
143368306|NCT03068468|516892633|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
143368307|NCT03068468|516892634|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
143111827|NCT02017717|515951881|FG003|Treatment Period|Disease progression|20|||
143111828|NCT02017717|515951882|FG004|Treatment Period|Disease progression|26|||
143179566|NCT02820844|516205636|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
143179567|NCT02820844|516205637|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
143179568|NCT02820844|516205638|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
143179569|NCT02820844|516205639|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
143179570|NCT02820844|516205634|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
143179571|NCT02820844|516205635|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
143179572|NCT02820844|516205636|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
143179573|NCT02820844|516205637|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
143111829|NCT02017717|515951883|FG005|Treatment Period|Disease progression|16|||
143111830|NCT02017717|515951884|FG006|Treatment Period|Disease progression|22|||
143111831|NCT02017717|515951885|FG007|Treatment Period|Disease progression|165|||
143111832|NCT02017717|515951886|FG008|Treatment Period|Disease progression|135|||
143111833|NCT02017717|515951878|FG000|Treatment Period|Study drug toxicity|3|||
143111834|NCT02017717|515951879|FG001|Treatment Period|Study drug toxicity|0|||
143111835|NCT02017717|515951880|FG002|Treatment Period|Study drug toxicity|1|||
143111836|NCT02017717|515951881|FG003|Treatment Period|Study drug toxicity|4|||
143111837|NCT02017717|515951882|FG004|Treatment Period|Study drug toxicity|4|||
143111838|NCT02017717|515951883|FG005|Treatment Period|Study drug toxicity|5|||
143111839|NCT02017717|515951884|FG006|Treatment Period|Study drug toxicity|3|||
143111840|NCT02017717|515951885|FG007|Treatment Period|Study drug toxicity|7|||
143111841|NCT02017717|515951886|FG008|Treatment Period|Study drug toxicity|11|||
143111842|NCT02017717|515951878|FG000|Treatment Period|Death|0|||
143179574|NCT02820844|516205638|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
143179575|NCT02820844|516205639|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
143179576|NCT02820844|516205634|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
143179577|NCT02820844|516205635|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
143179578|NCT02820844|516205636|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
143179579|NCT02820844|516205637|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
143179580|NCT02820844|516205638|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
143179581|NCT02820844|516205639|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
143179582|NCT02820844|516205634|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
143179583|NCT02820844|516205635|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
143179584|NCT02820844|516205636|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
143179585|NCT02820844|516205637|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
143179586|NCT02820844|516205638|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
143179587|NCT02820844|516205639|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
143179588|NCT02820844|516205634|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
143179589|NCT02820844|516205635|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
143179590|NCT02820844|516205636|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
143179591|NCT02820844|516205637|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
143179592|NCT02820844|516205638|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
143179593|NCT02820844|516205639|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
143179594|NCT02820844|516205634|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
143179595|NCT02820844|516205635|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
143179596|NCT02820844|516205636|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
143179597|NCT02820844|516205637|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
143179598|NCT02820844|516205638|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
143179599|NCT02820844|516205639|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
143179600|NCT02820844|516205634|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
143179601|NCT02820844|516205635|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
143179602|NCT02820844|516205636|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
143179603|NCT02820844|516205637|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
143179604|NCT02820844|516205638|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
143179605|NCT02820844|516205639|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
143179606|NCT02820844|516205634|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
143179607|NCT02820844|516205635|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
143179608|NCT02820844|516205636|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
143179609|NCT02820844|516205637|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
143179610|NCT02820844|516205638|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
143179611|NCT02820844|516205639|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
143368308|NCT03068468|516892635|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
143368309|NCT03068468|516892636|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
143368310|NCT03068468|516892633|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
143368311|NCT03068468|516892634|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
143368312|NCT03068468|516892635|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
143368313|NCT03068468|516892636|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
143368314|NCT03068468|516892633|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
143368315|NCT03068468|516892634|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
143368316|NCT03068468|516892635|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
143368317|NCT03068468|516892636|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
143368318|NCT03068468|516892633|FG000|Open-Label Extension Period|Reason not Specified|0|||
143368319|NCT03068468|516892634|FG001|Open-Label Extension Period|Reason not Specified|0|||
143368320|NCT03068468|516892635|FG002|Open-Label Extension Period|Reason not Specified|1|||
143368321|NCT03068468|516892636|FG003|Open-Label Extension Period|Reason not Specified|4|||
143368322|NCT00739102|516892637|FG000|Overall Study|Death|5|||
143368323|NCT00739102|516892637|FG000|Overall Study|Withdrawal by Subject|10|||
143368324|NCT01062126|516892639|FG000|Overall Study|Death|209|||
143368325|NCT01062126|516892639|FG000|Overall Study|All Withdrawals|324|||
143368326|NCT01510912|516892642|FG000|Overall Study|Adverse Event|99|||
143368327|NCT01510912|516892642|FG000|Overall Study|Lack of Efficacy|12|||
143368328|NCT01510912|516892642|FG000|Overall Study|Non-compliance with trial drug|23|||
143368329|NCT01510912|516892642|FG000|Overall Study|Withdrawal by Subject|49|||
143368330|NCT01510912|516892642|FG000|Overall Study|Physician Decision|1|||
143368331|NCT01510912|516892642|FG000|Overall Study|Protocol Violation|27|||
143368332|NCT01510912|516892642|FG000|Overall Study|Lost to Follow-up|26|||
143368333|NCT01510912|516892642|FG000|Overall Study|Other, including joint replacement|5|||
143368334|NCT00349908|516892643|FG000|Overall Study|Withdrawal by Subject|0|||
143368335|NCT00349908|516892644|FG001|Overall Study|Withdrawal by Subject|4|||
143368336|NCT01259102|516892645|FG000|Overall Study|Adverse Event|1|||
143368337|NCT01259102|516892646|FG001|Overall Study|Adverse Event|0|||
143368338|NCT01259102|516892647|FG002|Overall Study|Adverse Event|1|||
143368339|NCT01259102|516892648|FG003|Overall Study|Adverse Event|1|||
143368340|NCT01259102|516892649|FG004|Overall Study|Adverse Event|0|||
143368341|NCT01259102|516892645|FG000|Overall Study|Other|0|||
143368342|NCT01259102|516892646|FG001|Overall Study|Other|0|||
143368343|NCT01259102|516892647|FG002|Overall Study|Other|1|||
143368344|NCT01259102|516892648|FG003|Overall Study|Other|1|||
143368345|NCT01259102|516892649|FG004|Overall Study|Other|1|||
143368346|NCT05790408|516892650|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
143368347|NCT01064817|516892651|FG000|Study Completion|Physician Decision|1|||
143368348|NCT01064817|516892652|FG001|Study Completion|Physician Decision|0|||
143368349|NCT01064817|516892651|FG000|Study Completion|Withdrawal by Subject|1|||
143368350|NCT01064817|516892652|FG001|Study Completion|Withdrawal by Subject|0|||
143368351|NCT01466881|516892654|FG000|Overall Study|Ineligible|5|||
143368352|NCT01466881|516892654|FG000|Overall Study|Adverse Event|6|||
143368353|NCT01466881|516892654|FG000|Overall Study|Progression/relapse|20|||
143368354|NCT01466881|516892654|FG000|Overall Study|Death|4|||
143368355|NCT01466881|516892654|FG000|Overall Study|Other reason not protocol specified|5|||
143368356|NCT00606580|516892655|FG000|Overall Study|Lost to Follow-up|1|||
143368357|NCT00606580|516892656|FG001|Overall Study|Lost to Follow-up|1|||
143368358|NCT00606580|516892657|FG002|Overall Study|Lost to Follow-up|4|||
143179612|NCT02266147|516205641|FG000|PART 1: Dose Escalation|Physician Decision|0|||
143179613|NCT02266147|516205642|FG001|PART 1: Dose Escalation|Physician Decision|0|||
143179614|NCT02266147|516205643|FG002|PART 1: Dose Escalation|Physician Decision|1|||
143179615|NCT02266147|516205644|FG003|PART 1: Dose Escalation|Physician Decision|0|||
143179616|NCT02266147|516205641|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
143179617|NCT02266147|516205642|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
143179618|NCT02266147|516205643|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
143368359|NCT00606580|516892655|FG000|Overall Study|Clinical failures|1|||
143368360|NCT00606580|516892656|FG001|Overall Study|Clinical failures|0|||
143368361|NCT00606580|516892657|FG002|Overall Study|Clinical failures|12|||
143368362|NCT00606580|516892655|FG000|Overall Study|Withdrawal by investigator|0|||
143368363|NCT00606580|516892656|FG001|Overall Study|Withdrawal by investigator|1|||
143368364|NCT00606580|516892657|FG002|Overall Study|Withdrawal by investigator|6|||
143368365|NCT00606580|516892655|FG000|Overall Study|Withdrawal by Subject|0|||
143368366|NCT00606580|516892656|FG001|Overall Study|Withdrawal by Subject|1|||
143368367|NCT00606580|516892657|FG002|Overall Study|Withdrawal by Subject|0|||
143368368|NCT01101165|516892658|FG000|Period 1|Adverse Event|1|||
143368369|NCT01101165|516892659|FG001|Period 1|Adverse Event|2|||
143368370|NCT01101165|516892658|FG000|Period 1|Withdrawal by Subject|0|||
143368371|NCT01101165|516892659|FG001|Period 1|Withdrawal by Subject|2|||
143179619|NCT02266147|516205644|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
143111843|NCT02017717|515951879|FG001|Treatment Period|Death|0|||
143111844|NCT02017717|515951880|FG002|Treatment Period|Death|1|||
143111845|NCT02017717|515951881|FG003|Treatment Period|Death|0|||
143111846|NCT02017717|515951882|FG004|Treatment Period|Death|0|||
143111847|NCT02017717|515951883|FG005|Treatment Period|Death|2|||
143111848|NCT02017717|515951884|FG006|Treatment Period|Death|0|||
143111849|NCT02017717|515951885|FG007|Treatment Period|Death|0|||
143111850|NCT02017717|515951886|FG008|Treatment Period|Death|0|||
143111851|NCT02017717|515951878|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
143111852|NCT02017717|515951879|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
143111853|NCT02017717|515951880|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
143111854|NCT02017717|515951881|FG003|Treatment Period|Adverse event unrelated to study drug|0|||
143111855|NCT02017717|515951882|FG004|Treatment Period|Adverse event unrelated to study drug|0|||
143111856|NCT02017717|515951883|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
143111857|NCT02017717|515951884|FG006|Treatment Period|Adverse event unrelated to study drug|1|||
143111858|NCT02017717|515951885|FG007|Treatment Period|Adverse event unrelated to study drug|4|||
143111859|NCT02017717|515951886|FG008|Treatment Period|Adverse event unrelated to study drug|5|||
143111860|NCT02017717|515951878|FG000|Treatment Period|Participant request to stop therapy|0|||
143111861|NCT02017717|515951879|FG001|Treatment Period|Participant request to stop therapy|0|||
143111862|NCT02017717|515951880|FG002|Treatment Period|Participant request to stop therapy|3|||
143111863|NCT02017717|515951881|FG003|Treatment Period|Participant request to stop therapy|6|||
143111864|NCT02017717|515951882|FG004|Treatment Period|Participant request to stop therapy|0|||
143111865|NCT02017717|515951883|FG005|Treatment Period|Participant request to stop therapy|2|||
143111866|NCT02017717|515951884|FG006|Treatment Period|Participant request to stop therapy|1|||
143111867|NCT02017717|515951885|FG007|Treatment Period|Participant request to stop therapy|4|||
143111868|NCT02017717|515951886|FG008|Treatment Period|Participant request to stop therapy|7|||
143111869|NCT02017717|515951878|FG000|Treatment Period|Participant withdrew consent|0|||
143111870|NCT02017717|515951879|FG001|Treatment Period|Participant withdrew consent|0|||
143111871|NCT02017717|515951880|FG002|Treatment Period|Participant withdrew consent|1|||
143111872|NCT02017717|515951881|FG003|Treatment Period|Participant withdrew consent|0|||
143111873|NCT02017717|515951882|FG004|Treatment Period|Participant withdrew consent|0|||
143111874|NCT02017717|515951883|FG005|Treatment Period|Participant withdrew consent|2|||
143111875|NCT02017717|515951884|FG006|Treatment Period|Participant withdrew consent|0|||
143111876|NCT02017717|515951885|FG007|Treatment Period|Participant withdrew consent|1|||
143111877|NCT02017717|515951886|FG008|Treatment Period|Participant withdrew consent|4|||
143111878|NCT02017717|515951878|FG000|Treatment Period|Participant no longer met criteria|0|||
143111879|NCT02017717|515951879|FG001|Treatment Period|Participant no longer met criteria|0|||
143111880|NCT02017717|515951880|FG002|Treatment Period|Participant no longer met criteria|0|||
143111881|NCT02017717|515951881|FG003|Treatment Period|Participant no longer met criteria|0|||
143111882|NCT02017717|515951882|FG004|Treatment Period|Participant no longer met criteria|0|||
143111883|NCT02017717|515951883|FG005|Treatment Period|Participant no longer met criteria|0|||
143111884|NCT02017717|515951884|FG006|Treatment Period|Participant no longer met criteria|0|||
143111885|NCT02017717|515951885|FG007|Treatment Period|Participant no longer met criteria|0|||
143111886|NCT02017717|515951886|FG008|Treatment Period|Participant no longer met criteria|1|||
143111887|NCT02017717|515951878|FG000|Treatment Period|Other reasons|0|||
143111888|NCT02017717|515951879|FG001|Treatment Period|Other reasons|0|||
143111889|NCT02017717|515951880|FG002|Treatment Period|Other reasons|0|||
143111890|NCT02017717|515951881|FG003|Treatment Period|Other reasons|1|||
143111891|NCT02017717|515951882|FG004|Treatment Period|Other reasons|0|||
143111892|NCT02017717|515951883|FG005|Treatment Period|Other reasons|1|||
143111893|NCT02017717|515951884|FG006|Treatment Period|Other reasons|1|||
143111894|NCT02017717|515951885|FG007|Treatment Period|Other reasons|1|||
143111895|NCT02017717|515951886|FG008|Treatment Period|Other reasons|1|||
143111896|NCT02017717|515951878|FG000|Treatment Period|Maximum clinical benefit|0|||
143111897|NCT02017717|515951879|FG001|Treatment Period|Maximum clinical benefit|0|||
143111898|NCT02017717|515951880|FG002|Treatment Period|Maximum clinical benefit|0|||
143179620|NCT02266147|516205641|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
143179621|NCT02266147|516205642|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
143179622|NCT02266147|516205643|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
143179623|NCT02266147|516205644|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
143179624|NCT02266147|516205641|FG000|PART 1: Dose Escalation|Other|1|||
143179625|NCT02266147|516205642|FG001|PART 1: Dose Escalation|Other|1|||
143179626|NCT02266147|516205643|FG002|PART 1: Dose Escalation|Other|0|||
143179627|NCT02266147|516205644|FG003|PART 1: Dose Escalation|Other|0|||
143111899|NCT02017717|515951881|FG003|Treatment Period|Maximum clinical benefit|0|||
143111900|NCT02017717|515951882|FG004|Treatment Period|Maximum clinical benefit|0|||
143111901|NCT02017717|515951883|FG005|Treatment Period|Maximum clinical benefit|0|||
143111902|NCT02017717|515951884|FG006|Treatment Period|Maximum clinical benefit|0|||
143111903|NCT02017717|515951885|FG007|Treatment Period|Maximum clinical benefit|0|||
143111904|NCT02017717|515951886|FG008|Treatment Period|Maximum clinical benefit|1|||
143111905|NCT02017717|515951878|FG000|Treatment Period|Not reported|0|||
143179628|NCT02266147|516205641|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
143258047|NCT01879579|516498720|FG000|Overall Study|Phone incompatible with texting platform|3|||
143258048|NCT01879579|516498721|FG001|Overall Study|Phone incompatible with texting platform|0|||
143258049|NCT01879579|516498720|FG000|Overall Study|Did not enroll in texting platform|1|||
143258050|NCT01879579|516498721|FG001|Overall Study|Did not enroll in texting platform|0|||
143258051|NCT01879579|516498720|FG000|Overall Study|Did not initiate insulin treatment|1|||
143258052|NCT01879579|516498721|FG001|Overall Study|Did not initiate insulin treatment|0|||
143258053|NCT01879579|516498720|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
143111906|NCT02017717|515951879|FG001|Treatment Period|Not reported|1|||
143111907|NCT02017717|515951880|FG002|Treatment Period|Not reported|0|||
143111908|NCT02017717|515951881|FG003|Treatment Period|Not reported|0|||
143111909|NCT02017717|515951882|FG004|Treatment Period|Not reported|0|||
143111910|NCT02017717|515951883|FG005|Treatment Period|Not reported|0|||
143111911|NCT02017717|515951884|FG006|Treatment Period|Not reported|0|||
143111912|NCT02017717|515951885|FG007|Treatment Period|Not reported|0|||
143111913|NCT02017717|515951886|FG008|Treatment Period|Not reported|0|||
143111914|NCT04045132|515951887|FG000|Overall Study|Lost to Follow-up|3|||
143111915|NCT04045132|515951888|FG001|Overall Study|Lost to Follow-up|6|||
143111916|NCT01632150|515951889|FG000|Overall Study|Disease progression|27|||
143258054|NCT01879579|516498721|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
143258055|NCT01879579|516498720|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
143258056|NCT01879579|516498721|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
143258057|NCT02927067|516498722|FG000|Overall Study|Withdrawn Consent|20|||
143111917|NCT01632150|515951889|FG000|Overall Study|Study drug toxicity|1|||
143111918|NCT01632150|515951889|FG000|Overall Study|Unrelated adverse event|7|||
143111919|NCT01632150|515951889|FG000|Overall Study|Withdrawal by Subject|2|||
143111920|NCT01632150|515951889|FG000|Overall Study|Patient underwent autologous transplant|1|||
143111921|NCT01632150|515951889|FG000|Overall Study|Moved to compassionate program|2|||
143111922|NCT02879994|515951890|FG000|Overall Study|off treatment early|7|||
143111923|NCT02879994|515951890|FG000|Overall Study|Adverse Event|2|||
143111924|NCT02879994|515951890|FG000|Overall Study|Death|2|||
143111925|NCT03408444|515951896|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
143111926|NCT03408444|515951897|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
143111927|NCT03408444|515951898|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
143111928|NCT03408444|515951899|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
143111929|NCT03408444|515951896|FG000|Overall Study|Lens Discomfort|0|||
143111930|NCT03408444|515951897|FG001|Overall Study|Lens Discomfort|1|||
143111931|NCT03408444|515951898|FG002|Overall Study|Lens Discomfort|0|||
143111932|NCT03408444|515951899|FG003|Overall Study|Lens Discomfort|0|||
143258058|NCT02927067|516498723|FG001|Overall Study|Withdrawn Consent|12|||
143258059|NCT02927067|516498722|FG000|Overall Study|Death|18|||
143258060|NCT02927067|516498723|FG001|Overall Study|Death|31|||
143258061|NCT02927067|516498722|FG000|Overall Study|Adverse Event|13|||
143258062|NCT02927067|516498723|FG001|Overall Study|Adverse Event|10|||
143258063|NCT02927067|516498722|FG000|Overall Study|Noncompliance|5|||
143258064|NCT02927067|516498723|FG001|Overall Study|Noncompliance|2|||
143258065|NCT02927067|516498722|FG000|Overall Study|Reason not Specified|4|||
143258066|NCT02927067|516498723|FG001|Overall Study|Reason not Specified|6|||
143258067|NCT02292784|516498726|FG000|Overall Study|Lost to Follow-up|1|||
143258068|NCT02292784|516498727|FG001|Overall Study|Lost to Follow-up|17|||
143258069|NCT02292784|516498728|FG002|Overall Study|Lost to Follow-up|18|||
143258070|NCT02292784|516498726|FG000|Overall Study|Withdrawal by Subject|0|||
143258071|NCT02292784|516498727|FG001|Overall Study|Withdrawal by Subject|3|||
143258072|NCT02292784|516498728|FG002|Overall Study|Withdrawal by Subject|3|||
143258073|NCT00134784|516498729|FG000|Overall Study|Withdrawal by Subject|2|||
143258074|NCT00134784|516498730|FG001|Overall Study|Withdrawal by Subject|2|||
143258075|NCT00134784|516498731|FG002|Overall Study|Withdrawal by Subject|2|||
143258076|NCT00134784|516498732|FG003|Overall Study|Withdrawal by Subject|1|||
143258077|NCT00779259|516498735|FG000|Quinine Alone|Adverse Event|2|||
143258078|NCT03490981|516498736|FG000|Overall Study|Lost to Follow-up|1|||
143258079|NCT03490981|516498737|FG001|Overall Study|Lost to Follow-up|2|||
143258080|NCT00290407|516498738|FG000|Overall Study|Physician Decision|2|||
143258081|NCT01925989|516498749|FG000|Period 1|Sponsor Decision|1|||
143258082|NCT01925989|516498750|FG001|Period 1|Sponsor Decision|1|||
143111933|NCT03408444|515951896|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
143111934|NCT03408444|515951897|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
143111935|NCT03408444|515951898|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
143111936|NCT03408444|515951899|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
143111937|NCT03408444|515951896|FG000|Overall Study|Withdrawal by Subject|0|||
143117393|NCT01313221|515971828|FG002|Overall Study|Pregnancy|2|||
143258083|NCT01925989|516498751|FG002|Period 1|Sponsor Decision|0|||
143258084|NCT01925989|516498749|FG000|Period 1|Withdrawal by Subject|0|||
143258085|NCT01925989|516498750|FG001|Period 1|Withdrawal by Subject|1|||
143258086|NCT01925989|516498751|FG002|Period 1|Withdrawal by Subject|0|||
143258087|NCT02496676|516498752|FG000|Phase 1 - Period 1|Adverse Event|0|||
143111938|NCT03408444|515951897|FG001|Overall Study|Withdrawal by Subject|2|||
143111939|NCT03408444|515951898|FG002|Overall Study|Withdrawal by Subject|3|||
143111940|NCT03408444|515951899|FG003|Overall Study|Withdrawal by Subject|0|||
143111941|NCT03408444|515951896|FG000|Overall Study|Lost to Follow-up|0|||
143111942|NCT03408444|515951897|FG001|Overall Study|Lost to Follow-up|0|||
143111943|NCT03408444|515951898|FG002|Overall Study|Lost to Follow-up|1|||
143111944|NCT03408444|515951899|FG003|Overall Study|Lost to Follow-up|0|||
143111945|NCT03408444|515951896|FG000|Overall Study|Adverse Event|0|||
143111946|NCT03408444|515951897|FG001|Overall Study|Adverse Event|0|||
143111947|NCT03408444|515951898|FG002|Overall Study|Adverse Event|0|||
143111948|NCT03408444|515951899|FG003|Overall Study|Adverse Event|1|||
143111949|NCT03408444|515951896|FG000|Overall Study|Lens Handling Difficulties|0|||
143111950|NCT03408444|515951897|FG001|Overall Study|Lens Handling Difficulties|0|||
143111951|NCT03408444|515951898|FG002|Overall Study|Lens Handling Difficulties|1|||
143111952|NCT03408444|515951899|FG003|Overall Study|Lens Handling Difficulties|0|||
143111953|NCT03408444|515951896|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
143111954|NCT03408444|515951897|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
143111955|NCT03408444|515951898|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
143111956|NCT03408444|515951899|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
143111957|NCT04984681|515951900|FG000|Overall Study|Lost to Follow-up|3|||
143111958|NCT04984681|515951901|FG001|Overall Study|Lost to Follow-up|1|||
143258088|NCT02496676|516498753|FG001|Phase 1 - Period 1|Adverse Event|1|||
143258089|NCT02496676|516498752|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
143258090|NCT02496676|516498753|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
143111959|NCT01214252|515951902|FG000|Overall Study|Not eligible per protocol|82|||
143111960|NCT04327661|515951903|FG000|Overall Study|Withdrawal by Subject|1|||
143111961|NCT04327661|515951904|FG001|Overall Study|Withdrawal by Subject|0|||
143111962|NCT04327661|515951905|FG002|Overall Study|Withdrawal by Subject|0|||
143111963|NCT01995175|515951912|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
143111964|NCT01995175|515951912|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
143111965|NCT01995175|515951912|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
143111966|NCT01995175|515951912|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
143111967|NCT01995175|515951912|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
143111968|NCT01995175|515951912|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
143111969|NCT01995175|515951912|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
143111970|NCT01995175|515951912|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
143111971|NCT01995175|515951912|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
143111972|NCT01877551|515951913|FG000|Overall Study|Physician Decision|0|||
143111973|NCT01877551|515951914|FG001|Overall Study|Physician Decision|1|||
143111974|NCT00984061|515951915|FG000|Clarithromycin Alone|Protocol Violation|1|||
143111975|NCT02111785|515951919|FG000|Overall Study|Death|0|||
143111976|NCT02111785|515951920|FG001|Overall Study|Death|1|||
143111977|NCT02111785|515951921|FG002|Overall Study|Death|0|||
143111978|NCT02111785|515951922|FG003|Overall Study|Death|0|||
143111979|NCT00738881|515951925|FG000|Overall Study|Withdrawal by Subject|0|||
143111980|NCT00738881|515951926|FG001|Overall Study|Withdrawal by Subject|2|||
143111981|NCT00348790|515951927|FG000|Completed Treatment|Withdrawal by Subject|4|||
143111982|NCT00348790|515951927|FG000|Completed Treatment|Disease progression|14|||
143111983|NCT00348790|515951927|FG000|Completed Treatment|Adverse Event|4|||
143111984|NCT00348790|515951927|FG000|Completed Treatment|Required surgery|2|||
143111985|NCT00348790|515951927|FG000|Completed Treatment|Unable to travel to study site|1|||
143111986|NCT03409107|515951928|FG000|Overall Study|Withdrawal by Subject|4|||
143111987|NCT03409107|515951929|FG001|Overall Study|Withdrawal by Subject|2|||
143111988|NCT03409107|515951928|FG000|Overall Study|Physician Decision|1|||
143111989|NCT03409107|515951929|FG001|Overall Study|Physician Decision|0|||
143111990|NCT03409107|515951928|FG000|Overall Study|Lost to Follow-up|7|||
143111991|NCT03409107|515951929|FG001|Overall Study|Lost to Follow-up|2|||
143111992|NCT03409107|515951928|FG000|Overall Study|Adverse Event|5|||
143111993|NCT03409107|515951929|FG001|Overall Study|Adverse Event|3|||
143111994|NCT03687372|515951930|FG000|Overall Study|Lost to Follow-up|12|||
143111995|NCT03687372|515951931|FG001|Overall Study|Lost to Follow-up|21|||
143111996|NCT03687372|515951930|FG000|Overall Study|Withdrawal by Subject|4|||
143111997|NCT03687372|515951931|FG001|Overall Study|Withdrawal by Subject|17|||
143111998|NCT03687372|515951930|FG000|Overall Study|Investigator Decision|1|||
143111999|NCT03687372|515951931|FG001|Overall Study|Investigator Decision|1|||
143112000|NCT00878969|515951935|FG000|Overall Study|Physician Decision|5|||
143112001|NCT00878969|515951936|FG001|Overall Study|Physician Decision|3|||
143112002|NCT00878969|515951937|FG002|Overall Study|Physician Decision|2|||
143112003|NCT00878969|515951935|FG000|Overall Study|Withdrawal by Subject|1|||
143112004|NCT00878969|515951936|FG001|Overall Study|Withdrawal by Subject|6|||
143112005|NCT00878969|515951937|FG002|Overall Study|Withdrawal by Subject|3|||
143112006|NCT00878969|515951935|FG000|Overall Study|kidney transplant|2|||
143112007|NCT00878969|515951936|FG001|Overall Study|kidney transplant|3|||
143112008|NCT00878969|515951937|FG002|Overall Study|kidney transplant|2|||
143258091|NCT02514473|516498758|FG000|Overall Study|Adverse Event|0|||
143179629|NCT02266147|516205642|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
143179630|NCT02266147|516205643|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
143179631|NCT02266147|516205644|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
143179632|NCT02266147|516205641|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
143179633|NCT02266147|516205642|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
143179634|NCT02266147|516205643|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
143179635|NCT02266147|516205644|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
143179636|NCT00573391|516205645|FG000|Overall Study|study stopped|2|||
143179637|NCT00573391|516205646|FG001|Overall Study|study stopped|2|||
143179638|NCT00573391|516205645|FG000|Overall Study|Death|1|||
143179639|NCT00573391|516205646|FG001|Overall Study|Death|0|||
143179640|NCT03896477|516205647|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
143179641|NCT03896477|516205648|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
143179642|NCT03896477|516205649|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
143179643|NCT03896477|516205647|FG000|Overall Study|Parent Requested Withdrawal|8|||
143179644|NCT03896477|516205648|FG001|Overall Study|Parent Requested Withdrawal|12|||
143179645|NCT03896477|516205649|FG002|Overall Study|Parent Requested Withdrawal|9|||
143179646|NCT03896477|516205647|FG000|Overall Study|Adverse Event|0|||
143179647|NCT03896477|516205648|FG001|Overall Study|Adverse Event|0|||
143179648|NCT03896477|516205649|FG002|Overall Study|Adverse Event|1|||
143258092|NCT02514473|516498759|FG001|Overall Study|Adverse Event|2|||
143258093|NCT02514473|516498758|FG000|Overall Study|Withdrawal by Subject|2|||
143258094|NCT02514473|516498759|FG001|Overall Study|Withdrawal by Subject|1|||
143258095|NCT02514473|516498758|FG000|Overall Study|Lost to Follow-up|0|||
143258096|NCT02514473|516498759|FG001|Overall Study|Lost to Follow-up|1|||
143258097|NCT02514473|516498758|FG000|Overall Study|Other|1|||
143258098|NCT02514473|516498759|FG001|Overall Study|Other|1|||
143258099|NCT00548405|516498760|FG000|Overall Study|Adverse Event|6|||
143258100|NCT00548405|516498761|FG001|Overall Study|Adverse Event|2|||
143258101|NCT00548405|516498762|FG002|Overall Study|Adverse Event|0|||
143258102|NCT00548405|516498760|FG000|Overall Study|Lack of Efficacy|6|||
143258103|NCT00548405|516498761|FG001|Overall Study|Lack of Efficacy|0|||
143258104|NCT00548405|516498762|FG002|Overall Study|Lack of Efficacy|0|||
143258105|NCT00548405|516498760|FG000|Overall Study|Physician Decision|3|||
143258106|NCT00548405|516498761|FG001|Overall Study|Physician Decision|4|||
143258107|NCT00548405|516498762|FG002|Overall Study|Physician Decision|1|||
143258108|NCT00548405|516498760|FG000|Overall Study|Pregnancy|1|||
143258109|NCT00548405|516498761|FG001|Overall Study|Pregnancy|0|||
143258110|NCT00548405|516498762|FG002|Overall Study|Pregnancy|0|||
143258111|NCT00548405|516498760|FG000|Overall Study|Protocol Violation|1|||
143258112|NCT00548405|516498761|FG001|Overall Study|Protocol Violation|0|||
143258113|NCT00548405|516498762|FG002|Overall Study|Protocol Violation|0|||
143258114|NCT00548405|516498760|FG000|Overall Study|Withdrawal by Subject|36|||
143258115|NCT00548405|516498761|FG001|Overall Study|Withdrawal by Subject|12|||
143258116|NCT00548405|516498762|FG002|Overall Study|Withdrawal by Subject|5|||
143258117|NCT00548405|516498760|FG000|Overall Study|Lost to Follow-up|1|||
143258118|NCT00548405|516498761|FG001|Overall Study|Lost to Follow-up|1|||
143258119|NCT00548405|516498762|FG002|Overall Study|Lost to Follow-up|2|||
143258120|NCT00548405|516498760|FG000|Overall Study|Death|0|||
143258121|NCT00548405|516498761|FG001|Overall Study|Death|1|||
143258122|NCT00548405|516498762|FG002|Overall Study|Death|1|||
143258123|NCT00548405|516498760|FG000|Overall Study|Sponsor decision|1|||
143258124|NCT00548405|516498761|FG001|Overall Study|Sponsor decision|0|||
143258125|NCT00548405|516498762|FG002|Overall Study|Sponsor decision|0|||
143258126|NCT00548405|516498760|FG000|Overall Study|Randomized but not treated|1|||
143258127|NCT00548405|516498761|FG001|Overall Study|Randomized but not treated|0|||
143258128|NCT00548405|516498762|FG002|Overall Study|Randomized but not treated|0|||
143179649|NCT03896477|516205647|FG000|Overall Study|Death|1|||
143179650|NCT03896477|516205648|FG001|Overall Study|Death|0|||
143258129|NCT01624870|516498764|FG000|Overall Study|Death|19|||
143258130|NCT01624870|516498764|FG000|Overall Study|Withdrawal by Subject|1|||
143258131|NCT01624870|516498764|FG000|Overall Study|CoreValve not implanted|6|||
143258132|NCT01624870|516498764|FG000|Overall Study|Lost to follow up|1|||
143258133|NCT02217527|516498766|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
143258134|NCT02217527|516498767|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
143179651|NCT03896477|516205649|FG002|Overall Study|Death|0|||
143179652|NCT03896477|516205647|FG000|Overall Study|Other|5|||
143258135|NCT02217527|516498766|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
143368372|NCT01101165|516892658|FG000|Period 1|Positive Drug Screen|0|||
143368373|NCT01101165|516892659|FG001|Period 1|Positive Drug Screen|1|||
143368374|NCT01101165|516892658|FG000|Period 1|Lost to Follow-up|1|||
143368375|NCT01101165|516892659|FG001|Period 1|Lost to Follow-up|0|||
143368376|NCT01101165|516892658|FG000|Period 2|Withdrawal by Subject|3|||
143368377|NCT01101165|516892659|FG001|Period 2|Withdrawal by Subject|1|||
143368378|NCT01101165|516892658|FG000|Period 2|Adverse Event|1|||
143368379|NCT01101165|516892659|FG001|Period 2|Adverse Event|0|||
143368380|NCT04580303|516892660|FG000|Overall Study|Adverse Event|0|||
143368381|NCT04580303|516892661|FG001|Overall Study|Adverse Event|1|||
143368382|NCT04580303|516892662|FG002|Overall Study|Adverse Event|0|||
143368383|NCT04580303|516892663|FG003|Overall Study|Adverse Event|0|||
143368384|NCT04580303|516892660|FG000|Overall Study|Withdrawal by Subject|0|||
143368385|NCT04580303|516892661|FG001|Overall Study|Withdrawal by Subject|0|||
143368386|NCT04580303|516892662|FG002|Overall Study|Withdrawal by Subject|1|||
143368387|NCT04580303|516892663|FG003|Overall Study|Withdrawal by Subject|0|||
143368388|NCT00927823|516892667|FG000|Continuous Dosing Period|Death|0|||
143368389|NCT00927823|516892668|FG001|Continuous Dosing Period|Death|0|||
143368390|NCT00927823|516892669|FG002|Continuous Dosing Period|Death|6|||
143368391|NCT00927823|516892670|FG003|Continuous Dosing Period|Death|0|||
143368392|NCT00927823|516892667|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
143368393|NCT00927823|516892668|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
143368394|NCT00927823|516892669|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
143368395|NCT00927823|516892670|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
143368396|NCT00927823|516892667|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
143368397|NCT00927823|516892668|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
143368398|NCT00927823|516892669|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
143258136|NCT02217527|516498767|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
143258137|NCT02582684|516498768|FG000|Overall Study|Unable to contact subject/parent|4|||
143258138|NCT02582684|516498768|FG000|Overall Study|Subject not able to get to clinic|10|||
143258139|NCT02582684|516498768|FG000|Overall Study|Subject withdrew consent|1|||
143258140|NCT02582684|516498768|FG000|Overall Study|Found to be ineligible after enrollment|2|||
143112009|NCT00878969|515951935|FG000|Overall Study|Adverse Event|3|||
143112010|NCT00878969|515951936|FG001|Overall Study|Adverse Event|1|||
143112011|NCT00878969|515951937|FG002|Overall Study|Adverse Event|2|||
143112012|NCT00878969|515951935|FG000|Overall Study|Lost to Follow-up|2|||
143112013|NCT00878969|515951936|FG001|Overall Study|Lost to Follow-up|1|||
143258141|NCT01878149|516498769|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
143258142|NCT01878149|516498770|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
143258143|NCT04672252|516498773|FG000|Overall Study|Protocol Violation|1|||
143258144|NCT04672252|516498774|FG001|Overall Study|Protocol Violation|0|||
143258145|NCT01302834|516498783|FG000|Overall Study|Protocol Violation|17|||
143258146|NCT01302834|516498784|FG001|Overall Study|Protocol Violation|23|||
143258147|NCT01302834|516498783|FG000|Overall Study|HIV positive|1|||
143258148|NCT01302834|516498784|FG001|Overall Study|HIV positive|3|||
143258149|NCT00899392|516498785|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
143258150|NCT00899392|516498786|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
143258151|NCT03735238|516498787|FG000|Overall Study|Did not want to participate in research|3|||
143258152|NCT03735238|516498787|FG000|Overall Study|Time constraints, patient preference or percieved burden of survey completion|26|||
143258153|NCT01431638|516498788|FG000|Overall Study|Adverse Event|1|||
143258154|NCT01431638|516498789|FG001|Overall Study|Adverse Event|3|||
143258155|NCT01431638|516498790|FG002|Overall Study|Adverse Event|1|||
143258156|NCT01431638|516498788|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
143258157|NCT01431638|516498789|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
143258158|NCT01431638|516498790|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
143258159|NCT01431638|516498788|FG000|Overall Study|Participants condition no longer requires study drug|0|||
143258160|NCT01431638|516498789|FG001|Overall Study|Participants condition no longer requires study drug|1|||
143258161|NCT01431638|516498790|FG002|Overall Study|Participants condition no longer requires study drug|0|||
143258162|NCT01431638|516498788|FG000|Overall Study|Participant withdrew consent|14|||
143258163|NCT01431638|516498789|FG001|Overall Study|Participant withdrew consent|5|||
143258164|NCT01431638|516498790|FG002|Overall Study|Participant withdrew consent|8|||
143112014|NCT00878969|515951937|FG002|Overall Study|Lost to Follow-up|0|||
143112015|NCT00878969|515951935|FG000|Overall Study|Protocol Violation|2|||
143258165|NCT01431638|516498788|FG000|Overall Study|Lost to Follow-up|7|||
143258166|NCT01431638|516498789|FG001|Overall Study|Lost to Follow-up|9|||
143258167|NCT01431638|516498790|FG002|Overall Study|Lost to Follow-up|7|||
143258168|NCT01431638|516498788|FG000|Overall Study|Administrative problems|1|||
143368399|NCT00927823|516892670|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
143368400|NCT00927823|516892667|FG000|Continuous Dosing Period|Other|1|||
143368401|NCT00927823|516892668|FG001|Continuous Dosing Period|Other|2|||
143368402|NCT00927823|516892669|FG002|Continuous Dosing Period|Other|9|||
143258169|NCT01431638|516498789|FG001|Overall Study|Administrative problems|4|||
143258170|NCT01431638|516498790|FG002|Overall Study|Administrative problems|6|||
143258171|NCT01431638|516498788|FG000|Overall Study|Death|1|||
143368403|NCT00927823|516892670|FG003|Continuous Dosing Period|Other|3|||
143258172|NCT01431638|516498789|FG001|Overall Study|Death|0|||
143258173|NCT01431638|516498790|FG002|Overall Study|Death|0|||
143258174|NCT01431638|516498788|FG000|Overall Study|Protocol deviation|1|||
143258175|NCT01431638|516498789|FG001|Overall Study|Protocol deviation|1|||
143258176|NCT01431638|516498790|FG002|Overall Study|Protocol deviation|4|||
143258177|NCT01431638|516498788|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
143258178|NCT01431638|516498789|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
143258179|NCT01431638|516498790|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
143258180|NCT01261780|516498791|FG000|Overall Study|Withdrawal by Subject|1|||
143258181|NCT01261780|516498792|FG001|Overall Study|Withdrawal by Subject|0|||
143258182|NCT01261780|516498791|FG000|Overall Study|Event not related to subject|1|||
143258183|NCT01261780|516498792|FG001|Overall Study|Event not related to subject|2|||
143258184|NCT01239732|516498793|FG000|Overall Study|Termination of study per protocol|667|||
143258185|NCT01239732|516498793|FG000|Overall Study|Death|226|||
143258186|NCT01239732|516498793|FG000|Overall Study|Withdrawal by Subject|87|||
143258187|NCT01239732|516498793|FG000|Overall Study|Adverse Event|6|||
143258188|NCT01239732|516498793|FG000|Overall Study|Protocol Violation|3|||
143258189|NCT01239732|516498793|FG000|Overall Study|Participant non compliance|5|||
143258190|NCT01239732|516498793|FG000|Overall Study|Study termination by sponsor|2|||
143258191|NCT01239732|516498793|FG000|Overall Study|Investigator's decision|4|||
143258192|NCT01239732|516498793|FG000|Overall Study|Treatment failure|2|||
143258193|NCT01239732|516498793|FG000|Overall Study|Other|19|||
143258194|NCT04658940|516498800|FG000|Overall Study|Withdrawal by Subject|1|||
143258195|NCT01700439|516498801|FG000|Overall Study|Lost to Follow-up|47|||
143258196|NCT01700439|516498801|FG000|Overall Study|Withdrawal by Subject|183|||
143258197|NCT01700439|516498801|FG000|Overall Study|Death|186|||
143258198|NCT02518464|516498802|FG000|Overall Study|Adverse Event|2|||
143258199|NCT01829243|516498809|FG000|First Intervention|Screen Failure|4|||
143258200|NCT01829243|516498810|FG001|First Intervention|Screen Failure|2|||
143258201|NCT00053898|516498815|FG000|Overall Study|No follow-up data from any source|9|||
143258202|NCT00053898|516498816|FG001|Overall Study|No follow-up data from any source|12|||
143258203|NCT00053898|516498815|FG000|Overall Study|Follow-up from telephone contact only|5|||
143258204|NCT00053898|516498816|FG001|Overall Study|Follow-up from telephone contact only|1|||
143258205|NCT00266877|516498817|FG000|Overall Study|Death|1|||
143258206|NCT00266877|516498818|FG001|Overall Study|Death|1|||
143258207|NCT00266877|516498819|FG002|Overall Study|Death|1|||
143258208|NCT00266877|516498817|FG000|Overall Study|Adverse Event|6|||
143258209|NCT00266877|516498818|FG001|Overall Study|Adverse Event|4|||
143258210|NCT00266877|516498819|FG002|Overall Study|Adverse Event|1|||
143112016|NCT00878969|515951936|FG001|Overall Study|Protocol Violation|0|||
143112017|NCT00878969|515951937|FG002|Overall Study|Protocol Violation|0|||
143112018|NCT00878969|515951935|FG000|Overall Study|Death|0|||
143112019|NCT00878969|515951936|FG001|Overall Study|Death|0|||
143112020|NCT00878969|515951937|FG002|Overall Study|Death|2|||
143112021|NCT00878969|515951935|FG000|Overall Study|Pregnancy|0|||
143112022|NCT00878969|515951936|FG001|Overall Study|Pregnancy|1|||
143112023|NCT00878969|515951937|FG002|Overall Study|Pregnancy|0|||
143112024|NCT00655733|515951938|FG000|Overall Study|Lost to Follow-up|2|||
143112025|NCT00655733|515951939|FG001|Overall Study|Lost to Follow-up|2|||
143112026|NCT00655733|515951938|FG000|Overall Study|Adverse Event|2|||
143112027|NCT00655733|515951939|FG001|Overall Study|Adverse Event|2|||
143112028|NCT00655733|515951938|FG000|Overall Study|Withdrawal by Subject|3|||
143112029|NCT00655733|515951939|FG001|Overall Study|Withdrawal by Subject|3|||
143112030|NCT00655733|515951938|FG000|Overall Study|Physician Decision|0|||
143112031|NCT00655733|515951939|FG001|Overall Study|Physician Decision|1|||
143112032|NCT02035748|515951943|FG000|Overall Study|Adverse Event|5|||
143112033|NCT02035748|515951943|FG000|Overall Study|Death|3|||
143112034|NCT02035748|515951943|FG000|Overall Study|Lost to Follow-up|2|||
143112035|NCT02035748|515951943|FG000|Overall Study|Physician Decision|3|||
143112036|NCT02035748|515951943|FG000|Overall Study|Withdrawal by Subject|6|||
143112037|NCT02035748|515951943|FG000|Overall Study|Progressive Disease|1|||
143112038|NCT01088243|515951944|FG000|Overall Study|Adverse Event|1|||
143112039|NCT01088243|515951945|FG001|Overall Study|Adverse Event|0|||
143112040|NCT05007041|515951948|FG000|Overall Study|Missing Diary Entries|0|||
143112041|NCT05007041|515951949|FG001|Overall Study|Missing Diary Entries|1|||
143112042|NCT00705718|515951950|FG000|Overall Study|Death|6|||
143112043|NCT00705718|515951951|FG001|Overall Study|Death|6|||
143112044|NCT00705718|515951950|FG000|Overall Study|Not due for Visit|0|||
143258211|NCT00266877|516498817|FG000|Overall Study|Physician Decision|2|||
143258212|NCT00266877|516498818|FG001|Overall Study|Physician Decision|1|||
143258213|NCT00266877|516498819|FG002|Overall Study|Physician Decision|1|||
143258214|NCT00266877|516498817|FG000|Overall Study|Withdrawal by Subject|3|||
143258215|NCT00266877|516498818|FG001|Overall Study|Withdrawal by Subject|1|||
143258216|NCT00266877|516498819|FG002|Overall Study|Withdrawal by Subject|1|||
143112045|NCT00705718|515951951|FG001|Overall Study|Not due for Visit|12|||
143112046|NCT00705718|515951950|FG000|Overall Study|Follow up not done|1|||
143258217|NCT00266877|516498817|FG000|Overall Study|Disease Progression|72|||
143258218|NCT00266877|516498818|FG001|Overall Study|Disease Progression|37|||
143258219|NCT00266877|516498819|FG002|Overall Study|Disease Progression|23|||
143258220|NCT00266877|516498817|FG000|Overall Study|Symptomatic Deterioration|6|||
143258221|NCT00266877|516498818|FG001|Overall Study|Symptomatic Deterioration|3|||
143258222|NCT00266877|516498819|FG002|Overall Study|Symptomatic Deterioration|1|||
143112047|NCT00705718|515951951|FG001|Overall Study|Follow up not done|4|||
143112048|NCT01459718|515951952|FG000|Overall Study|Physician Decision|1|||
143112049|NCT01459718|515951952|FG000|Overall Study|Lost to Follow-up|1|||
143112050|NCT01459718|515951952|FG000|Overall Study|Adverse Event|1|||
143112051|NCT04416737|515951953|FG000|Week 1 (First Injection)|Physician Decision|0|||
143112052|NCT04416737|515951954|FG001|Week 1 (First Injection)|Physician Decision|1|||
143112053|NCT04489381|515951964|FG000|Overall Study|Lost to Follow-up|2|||
143112054|NCT04489381|515951965|FG001|Overall Study|Lost to Follow-up|3|||
143112055|NCT04489381|515951964|FG000|Overall Study|Withdrawal by Subject|1|||
143112056|NCT04489381|515951965|FG001|Overall Study|Withdrawal by Subject|0|||
143112057|NCT03199612|515951970|FG000|Overall Study|Adverse Event|1|||
143112058|NCT03199612|515951971|FG001|Overall Study|Adverse Event|0|||
143112059|NCT02543892|515951972|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
143112060|NCT02543892|515951973|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
143112061|NCT02543892|515951974|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
143112062|NCT02543892|515951975|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
143112063|NCT02543892|515951976|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
143112064|NCT02543892|515951977|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
143112065|NCT02543892|515951978|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
143112066|NCT02543892|515951979|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
143112067|NCT02543892|515951972|FG000|Received Vaccination 2|Physician Decision|0|||
143112068|NCT02543892|515951973|FG001|Received Vaccination 2|Physician Decision|0|||
143112069|NCT02543892|515951974|FG002|Received Vaccination 2|Physician Decision|0|||
143112070|NCT02543892|515951975|FG003|Received Vaccination 2|Physician Decision|0|||
143112071|NCT02543892|515951976|FG004|Received Vaccination 2|Physician Decision|0|||
143112072|NCT02543892|515951977|FG005|Received Vaccination 2|Physician Decision|1|||
143112073|NCT02543892|515951978|FG006|Received Vaccination 2|Physician Decision|0|||
143112074|NCT02543892|515951979|FG007|Received Vaccination 2|Physician Decision|0|||
143112075|NCT02543892|515951972|FG000|Received Vaccination 2|Adverse Event|0|||
143112076|NCT02543892|515951973|FG001|Received Vaccination 2|Adverse Event|1|||
143112077|NCT02543892|515951974|FG002|Received Vaccination 2|Adverse Event|0|||
143112078|NCT02543892|515951975|FG003|Received Vaccination 2|Adverse Event|0|||
143112079|NCT02543892|515951976|FG004|Received Vaccination 2|Adverse Event|0|||
143112080|NCT02543892|515951977|FG005|Received Vaccination 2|Adverse Event|0|||
143112081|NCT02543892|515951978|FG006|Received Vaccination 2|Adverse Event|0|||
143112082|NCT02543892|515951979|FG007|Received Vaccination 2|Adverse Event|0|||
143112083|NCT02543892|515951972|FG000|Had Immunology Data|Withdrawal by Subject|0|||
143112084|NCT02543892|515951973|FG001|Had Immunology Data|Withdrawal by Subject|0|||
143112085|NCT02543892|515951974|FG002|Had Immunology Data|Withdrawal by Subject|0|||
143112086|NCT02543892|515951975|FG003|Had Immunology Data|Withdrawal by Subject|0|||
143112087|NCT02543892|515951976|FG004|Had Immunology Data|Withdrawal by Subject|0|||
143112088|NCT02543892|515951977|FG005|Had Immunology Data|Withdrawal by Subject|0|||
143179653|NCT03896477|516205648|FG001|Overall Study|Other|6|||
143179654|NCT03896477|516205649|FG002|Overall Study|Other|7|||
143179655|NCT03896477|516205647|FG000|Overall Study|Lost to Follow-up|2|||
143179656|NCT03896477|516205648|FG001|Overall Study|Lost to Follow-up|1|||
143179657|NCT03896477|516205649|FG002|Overall Study|Lost to Follow-up|1|||
143179658|NCT02651116|516205650|FG000|Overall Study|Adverse Event|0|||
143179659|NCT02651116|516205651|FG001|Overall Study|Adverse Event|1|||
143179660|NCT02651116|516205650|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
143179661|NCT02651116|516205651|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
143179662|NCT00041470|516205659|FG000|Overall Study|Loss of Funding|38|||
143179663|NCT01459666|516205660|FG000|Overall Study|PI left institution|5|||
143179664|NCT01459666|516205661|FG001|Overall Study|PI left institution|4|||
143179665|NCT00533429|516205662|FG000|Overall Study|Adverse Event|3|||
143179666|NCT00533429|516205663|FG001|Overall Study|Adverse Event|1|||
143179667|NCT00533429|516205662|FG000|Overall Study|Death|1|||
143179668|NCT00533429|516205663|FG001|Overall Study|Death|0|||
143179669|NCT00533429|516205662|FG000|Overall Study|Withdrawal by Subject|2|||
143179670|NCT00533429|516205663|FG001|Overall Study|Withdrawal by Subject|0|||
143112089|NCT02543892|515951978|FG006|Had Immunology Data|Withdrawal by Subject|1|||
143112090|NCT02543892|515951979|FG007|Had Immunology Data|Withdrawal by Subject|0|||
143112091|NCT00526331|515951980|FG000|Overall Study|Sponsor Termination|55|||
143112092|NCT01043705|515951983|FG000|Overall Study|Death|28|||
143112093|NCT01043705|515951984|FG001|Overall Study|Death|60|||
143112094|NCT01043705|515951985|FG002|Overall Study|Death|26|||
143112095|NCT01043705|515951983|FG000|Overall Study|Lost to Follow-up|27|||
143112096|NCT01043705|515951984|FG001|Overall Study|Lost to Follow-up|12|||
143112097|NCT01043705|515951985|FG002|Overall Study|Lost to Follow-up|0|||
143258223|NCT00266877|516498817|FG000|Overall Study|Hospitalization|1|||
143179671|NCT00533429|516205662|FG000|Overall Study|Progressive Disease|12|||
143179672|NCT00533429|516205663|FG001|Overall Study|Progressive Disease|13|||
143179673|NCT00533429|516205662|FG000|Overall Study|Symptomatic deterioration|1|||
143179674|NCT00533429|516205663|FG001|Overall Study|Symptomatic deterioration|2|||
143179675|NCT02948582|516205676|FG000|Washout Period 1|Adverse Event|0|||
143179676|NCT02948582|516205677|FG001|Washout Period 1|Adverse Event|2|||
143179677|NCT02948582|516205678|FG002|Washout Period 1|Adverse Event|0|||
143179678|NCT02948582|516205679|FG003|Washout Period 1|Adverse Event|0|||
143179679|NCT02948582|516205680|FG004|Washout Period 1|Adverse Event|0|||
143179680|NCT02948582|516205681|FG005|Washout Period 1|Adverse Event|0|||
143179681|NCT02948582|516205676|FG000|Washout Period 1|Protocol Violation|0|||
143179682|NCT02948582|516205677|FG001|Washout Period 1|Protocol Violation|0|||
143179683|NCT02948582|516205678|FG002|Washout Period 1|Protocol Violation|0|||
143179684|NCT02948582|516205679|FG003|Washout Period 1|Protocol Violation|0|||
143179685|NCT02948582|516205680|FG004|Washout Period 1|Protocol Violation|0|||
143179686|NCT02948582|516205681|FG005|Washout Period 1|Protocol Violation|1|||
143179687|NCT02948582|516205676|FG000|Washout Period 2|Adverse Event|0|||
143179688|NCT02948582|516205677|FG001|Washout Period 2|Adverse Event|1|||
143179689|NCT02948582|516205678|FG002|Washout Period 2|Adverse Event|0|||
143179690|NCT02948582|516205679|FG003|Washout Period 2|Adverse Event|0|||
143179691|NCT02948582|516205680|FG004|Washout Period 2|Adverse Event|0|||
143179692|NCT02948582|516205681|FG005|Washout Period 2|Adverse Event|0|||
143179693|NCT02948582|516205676|FG000|Washout Period 2|personal reasons|0|||
143179694|NCT02948582|516205677|FG001|Washout Period 2|personal reasons|0|||
143179695|NCT02948582|516205678|FG002|Washout Period 2|personal reasons|0|||
143179696|NCT02948582|516205679|FG003|Washout Period 2|personal reasons|1|||
143179697|NCT02948582|516205680|FG004|Washout Period 2|personal reasons|0|||
143179698|NCT02948582|516205681|FG005|Washout Period 2|personal reasons|0|||
143179699|NCT02948582|516205676|FG000|Washout Period 4|Adverse Event|1|||
143179700|NCT02948582|516205677|FG001|Washout Period 4|Adverse Event|0|||
143179701|NCT02948582|516205678|FG002|Washout Period 4|Adverse Event|1|||
143179702|NCT02948582|516205679|FG003|Washout Period 4|Adverse Event|0|||
143179703|NCT02948582|516205680|FG004|Washout Period 4|Adverse Event|0|||
143179704|NCT02948582|516205681|FG005|Washout Period 4|Adverse Event|0|||
143179705|NCT02041299|516205682|FG000|Overall Study|Adverse Event|9|||
143368404|NCT01456936|516892678|FG000|Overall Study|Other reason|41|||
143368405|NCT01456936|516892679|FG001|Overall Study|Other reason|30|||
143368406|NCT01456936|516892680|FG002|Overall Study|Other reason|36|||
143179706|NCT02041299|516205683|FG001|Overall Study|Adverse Event|3|||
143179707|NCT02041299|516205682|FG000|Overall Study|Lost to Follow-up|4|||
143179708|NCT02041299|516205683|FG001|Overall Study|Lost to Follow-up|1|||
143179709|NCT02041299|516205682|FG000|Overall Study|Physician Decision|1|||
143179710|NCT02041299|516205683|FG001|Overall Study|Physician Decision|1|||
143179711|NCT02041299|516205682|FG000|Overall Study|Withdrawal by Subject|13|||
143179712|NCT02041299|516205683|FG001|Overall Study|Withdrawal by Subject|7|||
143179713|NCT02041299|516205682|FG000|Overall Study|Protocol Violation|11|||
143179714|NCT02041299|516205683|FG001|Overall Study|Protocol Violation|4|||
143179715|NCT02041299|516205682|FG000|Overall Study|Termination of the study|7|||
143179716|NCT02041299|516205683|FG001|Overall Study|Termination of the study|3|||
143179717|NCT02041299|516205682|FG000|Overall Study|Required bone marrow transplant|0|||
143179718|NCT02041299|516205683|FG001|Overall Study|Required bone marrow transplant|1|||
143179719|NCT02041299|516205682|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
143179720|NCT02041299|516205683|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
143179721|NCT00846846|516205684|FG000|Overall Study|Death|56|||
143179722|NCT00846846|516205684|FG000|Overall Study|Withdrawal by Subject|19|||
143179723|NCT04339413|516205685|FG000|Overall Study|Reason Not Specified|2|||
143179724|NCT04339413|516205686|FG001|Overall Study|Reason Not Specified|7|||
143179725|NCT04339413|516205685|FG000|Overall Study|Study Terminated by Sponsor|30|||
143179726|NCT04339413|516205686|FG001|Overall Study|Study Terminated by Sponsor|33|||
143179727|NCT04339413|516205685|FG000|Overall Study|Progressive Disease|9|||
143179728|NCT04339413|516205686|FG001|Overall Study|Progressive Disease|6|||
143179729|NCT04339413|516205685|FG000|Overall Study|Withdrawal by Subject|9|||
143179730|NCT04339413|516205686|FG001|Overall Study|Withdrawal by Subject|10|||
143179731|NCT04339413|516205685|FG000|Overall Study|Physician Decision|3|||
143368407|NCT01456936|516892681|FG003|Overall Study|Other reason|33|||
143368408|NCT01456936|516892678|FG000|Overall Study|No longer meets eligibility criteria|4|||
143368409|NCT01456936|516892679|FG001|Overall Study|No longer meets eligibility criteria|8|||
143179732|NCT04339413|516205686|FG001|Overall Study|Physician Decision|1|||
143179733|NCT04339413|516205685|FG000|Overall Study|Death|2|||
143179734|NCT04339413|516205686|FG001|Overall Study|Death|0|||
143179735|NCT04339413|516205685|FG000|Overall Study|Adverse Event|3|||
143179736|NCT04339413|516205686|FG001|Overall Study|Adverse Event|0|||
143179737|NCT00442416|516205692|FG000|Overall Study|Adverse Event|4|||
143179738|NCT00442416|516205693|FG001|Overall Study|Adverse Event|1|||
143179739|NCT00442416|516205692|FG000|Overall Study|Death|1|||
143179740|NCT00442416|516205693|FG001|Overall Study|Death|0|||
143179741|NCT00442416|516205692|FG000|Overall Study|Lack of Efficacy|2|||
143179742|NCT00442416|516205693|FG001|Overall Study|Lack of Efficacy|0|||
143179743|NCT00442416|516205692|FG000|Overall Study|Protocol Violation|2|||
143179744|NCT00442416|516205693|FG001|Overall Study|Protocol Violation|3|||
143112098|NCT01043705|515951983|FG000|Overall Study|Multiple Reasons|4|||
143112099|NCT01043705|515951984|FG001|Overall Study|Multiple Reasons|7|||
143112100|NCT01043705|515951985|FG002|Overall Study|Multiple Reasons|0|||
143112101|NCT01043705|515951983|FG000|Overall Study|Protocol Violation|2|||
143112102|NCT01043705|515951984|FG001|Overall Study|Protocol Violation|1|||
143112103|NCT01043705|515951985|FG002|Overall Study|Protocol Violation|0|||
143112104|NCT01043705|515951983|FG000|Overall Study|Withdrawal by Subject|8|||
143112105|NCT01043705|515951984|FG001|Overall Study|Withdrawal by Subject|6|||
143112106|NCT01043705|515951985|FG002|Overall Study|Withdrawal by Subject|0|||
143112107|NCT01043705|515951983|FG000|Overall Study|Site Closure|8|||
143112108|NCT01043705|515951984|FG001|Overall Study|Site Closure|0|||
143112109|NCT01043705|515951985|FG002|Overall Study|Site Closure|0|||
143112110|NCT01043705|515951983|FG000|Overall Study|Subsequent Procedure|9|||
143112111|NCT01043705|515951984|FG001|Overall Study|Subsequent Procedure|24|||
143112112|NCT01043705|515951985|FG002|Overall Study|Subsequent Procedure|29|||
143112113|NCT01043705|515951983|FG000|Overall Study|Adverse Event|0|||
143112114|NCT01043705|515951984|FG001|Overall Study|Adverse Event|2|||
143112115|NCT01043705|515951985|FG002|Overall Study|Adverse Event|0|||
143112116|NCT01043705|515951983|FG000|Overall Study|Screen Fail|21|||
143112117|NCT01043705|515951984|FG001|Overall Study|Screen Fail|0|||
143112118|NCT01043705|515951985|FG002|Overall Study|Screen Fail|0|||
143112119|NCT01043705|515951983|FG000|Overall Study|Other|0|||
143112120|NCT01043705|515951984|FG001|Overall Study|Other|19|||
143112121|NCT01043705|515951985|FG002|Overall Study|Other|25|||
143112122|NCT00581542|515951986|FG000|Overall Study|they met an exclusion criteria|2|||
143112123|NCT00581542|515951987|FG001|Overall Study|they met an exclusion criteria|2|||
143112124|NCT00581542|515951986|FG000|Overall Study|Lost to Follow-up|9|||
143112125|NCT00581542|515951987|FG001|Overall Study|Lost to Follow-up|21|||
143112126|NCT01880086|515951990|FG000|Overall Study|Lost to Follow-up|1|||
143179745|NCT00442416|516205692|FG000|Overall Study|Withdrew consent|1|||
143179746|NCT00442416|516205693|FG001|Overall Study|Withdrew consent|2|||
143179747|NCT00442416|516205692|FG000|Overall Study|Administrative/Other|27|||
143179748|NCT00442416|516205693|FG001|Overall Study|Administrative/Other|33|||
143179749|NCT01853462|516205694|FG000|Overall Study|Withdrawal by Subject|1|||
143179750|NCT01853462|516205695|FG001|Overall Study|Withdrawal by Subject|1|||
143179751|NCT03943290|516205699|FG000|Overall Study|Sponsor Terminated Study|6|||
143179752|NCT03943290|516205700|FG001|Overall Study|Sponsor Terminated Study|1|||
143179753|NCT03943290|516205701|FG002|Overall Study|Sponsor Terminated Study|11|||
143179754|NCT03943290|516205702|FG003|Overall Study|Sponsor Terminated Study|6|||
143179755|NCT03943290|516205703|FG004|Overall Study|Sponsor Terminated Study|7|||
143179756|NCT03943290|516205704|FG005|Overall Study|Sponsor Terminated Study|6|||
143179757|NCT03943290|516205705|FG006|Overall Study|Sponsor Terminated Study|6|||
143179758|NCT03943290|516205706|FG007|Overall Study|Sponsor Terminated Study|7|||
143179759|NCT03943290|516205707|FG008|Overall Study|Sponsor Terminated Study|8|||
143179760|NCT03943290|516205699|FG000|Overall Study|Lost to Follow-up|1|||
143179761|NCT03943290|516205700|FG001|Overall Study|Lost to Follow-up|0|||
143179762|NCT03943290|516205701|FG002|Overall Study|Lost to Follow-up|1|||
143179763|NCT03943290|516205702|FG003|Overall Study|Lost to Follow-up|0|||
143179764|NCT03943290|516205703|FG004|Overall Study|Lost to Follow-up|0|||
143179765|NCT03943290|516205704|FG005|Overall Study|Lost to Follow-up|0|||
143179766|NCT03943290|516205705|FG006|Overall Study|Lost to Follow-up|0|||
143179767|NCT03943290|516205706|FG007|Overall Study|Lost to Follow-up|1|||
143179768|NCT03943290|516205707|FG008|Overall Study|Lost to Follow-up|0|||
143179769|NCT03943290|516205699|FG000|Overall Study|Withdrawal by Subject|0|||
143179770|NCT03943290|516205700|FG001|Overall Study|Withdrawal by Subject|0|||
143179771|NCT03943290|516205701|FG002|Overall Study|Withdrawal by Subject|1|||
143179772|NCT03943290|516205702|FG003|Overall Study|Withdrawal by Subject|0|||
143179773|NCT03943290|516205703|FG004|Overall Study|Withdrawal by Subject|0|||
143179774|NCT03943290|516205704|FG005|Overall Study|Withdrawal by Subject|0|||
143179775|NCT03943290|516205705|FG006|Overall Study|Withdrawal by Subject|0|||
143179776|NCT03943290|516205706|FG007|Overall Study|Withdrawal by Subject|0|||
143179777|NCT03943290|516205707|FG008|Overall Study|Withdrawal by Subject|0|||
143179778|NCT04179305|516205709|FG000|Overall Study|Death|1|||
143179779|NCT04179305|516205710|FG001|Overall Study|Death|1|||
143179780|NCT04179305|516205711|FG002|Overall Study|Death|0|||
143179781|NCT04179305|516205712|FG003|Overall Study|Death|0|||
143179782|NCT04179305|516205709|FG000|Overall Study|Lost to Follow-up|1|||
143179783|NCT04179305|516205710|FG001|Overall Study|Lost to Follow-up|1|||
143179784|NCT04179305|516205711|FG002|Overall Study|Lost to Follow-up|0|||
143179785|NCT04179305|516205712|FG003|Overall Study|Lost to Follow-up|0|||
143112127|NCT01880086|515951991|FG001|Overall Study|Lost to Follow-up|1|||
143112128|NCT05174949|515951992|FG000|Overall Study|Physician Decision|1|||
143112129|NCT05174949|515951993|FG001|Overall Study|Physician Decision|2|||
143112130|NCT05174949|515951994|FG002|Overall Study|Physician Decision|0|||
143112131|NCT05174949|515951995|FG003|Overall Study|Physician Decision|1|||
143112132|NCT05174949|515951996|FG004|Overall Study|Physician Decision|0|||
143112133|NCT05174949|515951997|FG005|Overall Study|Physician Decision|0|||
143179786|NCT04179305|516205709|FG000|Overall Study|Withdrawal by Subject|0|||
143179787|NCT04179305|516205710|FG001|Overall Study|Withdrawal by Subject|1|||
143258224|NCT00266877|516498818|FG001|Overall Study|Hospitalization|0|||
143258225|NCT00266877|516498819|FG002|Overall Study|Hospitalization|0|||
143112134|NCT05174949|515951992|FG000|Overall Study|Withdrawal by Subject|0|||
143112135|NCT05174949|515951993|FG001|Overall Study|Withdrawal by Subject|1|||
143112136|NCT05174949|515951994|FG002|Overall Study|Withdrawal by Subject|0|||
143258226|NCT00266877|516498817|FG000|Overall Study|Concomitant Radiotherapy|0|||
143258227|NCT00266877|516498818|FG001|Overall Study|Concomitant Radiotherapy|1|||
143258228|NCT00266877|516498819|FG002|Overall Study|Concomitant Radiotherapy|0|||
143258229|NCT01077375|516498824|FG000|Overall Study|Adverse Event|2|||
143258230|NCT01077375|516498825|FG001|Overall Study|Adverse Event|15|||
143258231|NCT01077375|516498824|FG000|Overall Study|Lack of Efficacy|6|||
143258232|NCT01077375|516498825|FG001|Overall Study|Lack of Efficacy|8|||
143258233|NCT01077375|516498824|FG000|Overall Study|Withdrawal by Subject|0|||
143258234|NCT01077375|516498825|FG001|Overall Study|Withdrawal by Subject|6|||
143258235|NCT01077375|516498824|FG000|Overall Study|Lost to Follow-up|2|||
143258236|NCT01077375|516498825|FG001|Overall Study|Lost to Follow-up|5|||
143258237|NCT01077375|516498824|FG000|Overall Study|Other Reason|0|||
143258238|NCT01077375|516498825|FG001|Overall Study|Other Reason|1|||
143258239|NCT00853970|516498835|FG000|Overall Study|Withdrawal by Subject|2|||
143258240|NCT00853970|516498836|FG001|Overall Study|Withdrawal by Subject|1|||
143258241|NCT00853970|516498835|FG000|Overall Study|Cancelled surgery|4|||
143258242|NCT00853970|516498836|FG001|Overall Study|Cancelled surgery|2|||
143258243|NCT02919969|516500522|FG000|Overall Study|Lack of Efficacy|22|||
143258244|NCT02919969|516500522|FG000|Overall Study|Death|4|||
143258245|NCT02919969|516500522|FG000|Overall Study|Physician Decision|3|||
143258246|NCT02919969|516500522|FG000|Overall Study|Withdrawal by Subject|2|||
143258247|NCT03621475|516500523|FG000|Overall Study|No longer required restraints at initiation|0|||
143258248|NCT03621475|516500524|FG001|Overall Study|No longer required restraints at initiation|1|||
143258249|NCT01842633|516500525|FG000|Overall Study|Screen Failure|1|||
143258250|NCT01842633|516500526|FG001|Overall Study|Screen Failure|0|||
143258251|NCT01842633|516500527|FG002|Overall Study|Screen Failure|0|||
143112137|NCT05174949|515951995|FG003|Overall Study|Withdrawal by Subject|0|||
143112138|NCT05174949|515951996|FG004|Overall Study|Withdrawal by Subject|0|||
143112139|NCT05174949|515951997|FG005|Overall Study|Withdrawal by Subject|0|||
143112140|NCT05174949|515951992|FG000|Overall Study|Lost to Follow-up|0|||
143112141|NCT05174949|515951993|FG001|Overall Study|Lost to Follow-up|0|||
143179788|NCT04179305|516205711|FG002|Overall Study|Withdrawal by Subject|0|||
143179789|NCT04179305|516205712|FG003|Overall Study|Withdrawal by Subject|0|||
143179790|NCT04179305|516205709|FG000|Overall Study|Did not have scan|1|||
143179791|NCT04179305|516205710|FG001|Overall Study|Did not have scan|0|||
143179792|NCT04179305|516205711|FG002|Overall Study|Did not have scan|0|||
143258252|NCT01842633|516500525|FG000|Overall Study|Adverse Event|1|||
143258253|NCT01842633|516500526|FG001|Overall Study|Adverse Event|1|||
143258254|NCT01842633|516500527|FG002|Overall Study|Adverse Event|0|||
143258255|NCT01842633|516500525|FG000|Overall Study|Withdrawal by Subject|0|||
143258256|NCT01842633|516500526|FG001|Overall Study|Withdrawal by Subject|1|||
143258257|NCT01842633|516500527|FG002|Overall Study|Withdrawal by Subject|0|||
143258258|NCT01842633|516500525|FG000|Overall Study|Technical issues|1|||
143258259|NCT01842633|516500526|FG001|Overall Study|Technical issues|0|||
143258260|NCT01842633|516500527|FG002|Overall Study|Technical issues|0|||
143258261|NCT00706849|516500533|FG000|Treatment Period|Adverse Event|0|||
143258262|NCT00706849|516500534|FG001|Treatment Period|Adverse Event|9|||
143258263|NCT00706849|516500533|FG000|Treatment Period|Other|0|||
143258264|NCT00706849|516500534|FG001|Treatment Period|Other|1|||
143258265|NCT00706849|516500533|FG000|Follow-up Period|Withdrawal by Subject|0|||
143258266|NCT00706849|516500534|FG001|Follow-up Period|Withdrawal by Subject|2|||
143258267|NCT00706849|516500533|FG000|Follow-up Period|Protocol non-compliance|0|||
143258268|NCT00706849|516500534|FG001|Follow-up Period|Protocol non-compliance|1|||
143179793|NCT04179305|516205712|FG003|Overall Study|Did not have scan|0|||
143258269|NCT02616601|516500535|FG000|Overall Study|Withdrawal by Subject|4|||
143258270|NCT02616601|516500536|FG001|Overall Study|Withdrawal by Subject|4|||
143258271|NCT02616601|516500537|FG002|Overall Study|Withdrawal by Subject|3|||
143258272|NCT02616601|516500535|FG000|Overall Study|Adverse Event|2|||
143258273|NCT02616601|516500536|FG001|Overall Study|Adverse Event|0|||
143258274|NCT02616601|516500537|FG002|Overall Study|Adverse Event|2|||
143179794|NCT04179305|516205709|FG000|Overall Study|In hospice care|3|||
143179795|NCT04179305|516205710|FG001|Overall Study|In hospice care|0|||
143179796|NCT04179305|516205711|FG002|Overall Study|In hospice care|0|||
143112142|NCT05174949|515951994|FG002|Overall Study|Lost to Follow-up|0|||
143112143|NCT05174949|515951995|FG003|Overall Study|Lost to Follow-up|1|||
143112144|NCT05174949|515951996|FG004|Overall Study|Lost to Follow-up|0|||
143112145|NCT05174949|515951997|FG005|Overall Study|Lost to Follow-up|0|||
143179797|NCT04179305|516205712|FG003|Overall Study|In hospice care|0|||
143258275|NCT02616601|516500535|FG000|Overall Study|Death|1|||
143258276|NCT02616601|516500536|FG001|Overall Study|Death|0|||
143258277|NCT02616601|516500537|FG002|Overall Study|Death|0|||
143258278|NCT02616601|516500535|FG000|Overall Study|Lost to Follow-up|1|||
143112146|NCT05083923|515952005|FG000|Overall Study|Adverse Event|2|||
143258279|NCT02616601|516500536|FG001|Overall Study|Lost to Follow-up|0|||
143258280|NCT02616601|516500537|FG002|Overall Study|Lost to Follow-up|1|||
143258281|NCT02616601|516500535|FG000|Overall Study|Non-Compliance with Test Article|1|||
143258282|NCT02616601|516500536|FG001|Overall Study|Non-Compliance with Test Article|0|||
143258283|NCT02616601|516500537|FG002|Overall Study|Non-Compliance with Test Article|1|||
143258284|NCT03718299|516500538|FG000|Overall Study|Adverse Event|1|||
143258285|NCT03718299|516500538|FG000|Overall Study|Withdrawal by Subject|6|||
143258286|NCT03718299|516500538|FG000|Overall Study|Physician Decision|2|||
143258287|NCT03718299|516500538|FG000|Overall Study|Lost to Follow-up|1|||
143258288|NCT04389970|516500539|FG000|Overall Study|Lost to Follow-up|1|||
143258289|NCT01343823|516500540|FG000|Overall Study|Study Terminated|1|||
143258290|NCT01343823|516500541|FG001|Overall Study|Study Terminated|0|||
143258291|NCT01343823|516500542|FG002|Overall Study|Study Terminated|0|||
143258292|NCT01343823|516500543|FG003|Overall Study|Study Terminated|1|||
143258293|NCT01343823|516500540|FG000|Overall Study|Withdrawal by Subject|1|||
143258294|NCT01343823|516500541|FG001|Overall Study|Withdrawal by Subject|0|||
143258295|NCT01343823|516500542|FG002|Overall Study|Withdrawal by Subject|0|||
143258296|NCT01343823|516500543|FG003|Overall Study|Withdrawal by Subject|0|||
143258297|NCT00923364|516500546|FG000|Overall Study|Death|3|||
143112147|NCT05083923|515952006|FG001|Overall Study|Adverse Event|0|||
143112148|NCT05083923|515952005|FG000|Overall Study|Lack of Efficacy|1|||
143112149|NCT05083923|515952006|FG001|Overall Study|Lack of Efficacy|3|||
143112150|NCT05083923|515952005|FG000|Overall Study|Withdrawal by Subject|2|||
143112151|NCT05083923|515952006|FG001|Overall Study|Withdrawal by Subject|6|||
143112152|NCT05083923|515952005|FG000|Overall Study|Reason Not Specified|0|||
143112153|NCT05083923|515952006|FG001|Overall Study|Reason Not Specified|1|||
143112154|NCT00430352|515952007|FG000|Overall Study|Disease progression|58|||
143112155|NCT00430352|515952007|FG000|Overall Study|Withdrawal by Subject|11|||
143112156|NCT00430352|515952007|FG000|Overall Study|Adverse Event|16|||
143112157|NCT00430352|515952007|FG000|Overall Study|Death|5|||
143112158|NCT00430352|515952007|FG000|Overall Study|Other|48|||
143112159|NCT00347919|515952008|FG000|Overall Study|Lost to Follow-up|11|||
143112160|NCT00347919|515952009|FG001|Overall Study|Lost to Follow-up|13|||
143112161|NCT00347919|515952010|FG002|Overall Study|Lost to Follow-up|0|||
143112162|NCT00347919|515952008|FG000|Overall Study|Withdrawal by Subject|6|||
143112163|NCT00347919|515952009|FG001|Overall Study|Withdrawal by Subject|8|||
143112164|NCT00347919|515952010|FG002|Overall Study|Withdrawal by Subject|0|||
143112165|NCT00347919|515952008|FG000|Overall Study|Physician Decision|1|||
143112166|NCT00347919|515952009|FG001|Overall Study|Physician Decision|1|||
143112167|NCT00347919|515952010|FG002|Overall Study|Physician Decision|0|||
143112168|NCT00347919|515952008|FG000|Overall Study|Sponsor terminated study|15|||
143112169|NCT00347919|515952009|FG001|Overall Study|Sponsor terminated study|10|||
143112170|NCT00347919|515952010|FG002|Overall Study|Sponsor terminated study|16|||
143112171|NCT00347919|515952008|FG000|Overall Study|Death|35|||
143112172|NCT00347919|515952009|FG001|Overall Study|Death|42|||
143112173|NCT00347919|515952010|FG002|Overall Study|Death|19|||
143112174|NCT00347919|515952008|FG000|Overall Study|Par. Started Other Treatment|1|||
143112175|NCT00347919|515952009|FG001|Overall Study|Par. Started Other Treatment|1|||
143112176|NCT00347919|515952010|FG002|Overall Study|Par. Started Other Treatment|1|||
143112177|NCT00347919|515952008|FG000|Overall Study|Missing|2|||
143112178|NCT00347919|515952009|FG001|Overall Study|Missing|1|||
143112179|NCT00347919|515952010|FG002|Overall Study|Missing|2|||
143112180|NCT01597375|515952011|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
143112181|NCT01597375|515952012|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
143258298|NCT00923364|516500547|FG001|Overall Study|Death|0|||
143258299|NCT00923364|516500546|FG000|Overall Study|Did not go to transplant|1|||
143258300|NCT00923364|516500547|FG001|Overall Study|Did not go to transplant|0|||
143258301|NCT01397825|516500548|FG000|Overall Study|Progressive Disease|10|||
143258302|NCT01397825|516500549|FG001|Overall Study|Progressive Disease|3|||
143258303|NCT01397825|516500550|FG002|Overall Study|Progressive Disease|11|||
143258304|NCT01397825|516500551|FG003|Overall Study|Progressive Disease|1|||
143258305|NCT01397825|516500552|FG004|Overall Study|Progressive Disease|0|||
143258306|NCT01397825|516500548|FG000|Overall Study|Symptomatic Deterioration|2|||
143368410|NCT01456936|516892680|FG002|Overall Study|No longer meets eligibility criteria|6|||
143112182|NCT01597375|515952011|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
143112183|NCT01597375|515952012|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
143112184|NCT01597375|515952011|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
143112185|NCT01597375|515952012|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
143258307|NCT01397825|516500549|FG001|Overall Study|Symptomatic Deterioration|0|||
143258308|NCT01397825|516500550|FG002|Overall Study|Symptomatic Deterioration|4|||
143258309|NCT01397825|516500551|FG003|Overall Study|Symptomatic Deterioration|0|||
143258310|NCT01397825|516500552|FG004|Overall Study|Symptomatic Deterioration|0|||
143258311|NCT01397825|516500548|FG000|Overall Study|Adverse Event|0|||
143258312|NCT01397825|516500549|FG001|Overall Study|Adverse Event|1|||
143258313|NCT01397825|516500550|FG002|Overall Study|Adverse Event|5|||
143258314|NCT01397825|516500551|FG003|Overall Study|Adverse Event|1|||
143112186|NCT01597375|515952011|FG000|Washout (2 Weeks)|Adverse Event|1|||
143112187|NCT01597375|515952012|FG001|Washout (2 Weeks)|Adverse Event|0|||
143258315|NCT01397825|516500552|FG004|Overall Study|Adverse Event|0|||
143258316|NCT01397825|516500548|FG000|Overall Study|Withdrawal by Subject|1|||
143258317|NCT01397825|516500549|FG001|Overall Study|Withdrawal by Subject|0|||
143258318|NCT01397825|516500550|FG002|Overall Study|Withdrawal by Subject|5|||
143258319|NCT01397825|516500551|FG003|Overall Study|Withdrawal by Subject|1|||
143258320|NCT01397825|516500552|FG004|Overall Study|Withdrawal by Subject|0|||
143258321|NCT01931670|516500554|FG000|Treatment Period|Exclusionary Medication Received|1|||
143112188|NCT01597375|515952011|FG000|Second Intervention|Failed to react at both Aspirin|1|||
143112189|NCT01597375|515952012|FG001|Second Intervention|Failed to react at both Aspirin|1|||
143112190|NCT02225366|515952013|FG000|Overall Study|Lack of Efficacy|1|||
143112191|NCT02225366|515952014|FG001|Overall Study|Lack of Efficacy|0|||
143112192|NCT00794040|515952039|FG000|Overall Study|Withdrawal by Subject|3|||
143112193|NCT00794040|515952040|FG001|Overall Study|Withdrawal by Subject|4|||
143112194|NCT00794040|515952039|FG000|Overall Study|Physician Decision|0|||
143112195|NCT00794040|515952040|FG001|Overall Study|Physician Decision|1|||
143112196|NCT01263782|515952041|FG000|Overall Study|Death|0|||
143112197|NCT01263782|515952042|FG001|Overall Study|Death|0|||
143112198|NCT01263782|515952043|FG002|Overall Study|Death|1|||
143112199|NCT01263782|515952044|FG003|Overall Study|Death|0|||
143112200|NCT01263782|515952041|FG000|Overall Study|Progressive disease|0|||
143112201|NCT01263782|515952042|FG001|Overall Study|Progressive disease|0|||
143112202|NCT01263782|515952043|FG002|Overall Study|Progressive disease|0|||
143112203|NCT01263782|515952044|FG003|Overall Study|Progressive disease|1|||
143112204|NCT01263782|515952041|FG000|Overall Study|Too early|0|||
143112205|NCT01263782|515952042|FG001|Overall Study|Too early|0|||
143112206|NCT01263782|515952043|FG002|Overall Study|Too early|1|||
143112207|NCT01263782|515952044|FG003|Overall Study|Too early|0|||
143112208|NCT01263782|515952041|FG000|Overall Study|Inevaluable|0|||
143112209|NCT01263782|515952042|FG001|Overall Study|Inevaluable|0|||
143112210|NCT01263782|515952043|FG002|Overall Study|Inevaluable|1|||
143112211|NCT01263782|515952044|FG003|Overall Study|Inevaluable|0|||
143112212|NCT02419612|515952046|FG000|Short-term Treatment Period|Adverse Event|1|||
143112213|NCT02419612|515952047|FG001|Short-term Treatment Period|Adverse Event|1|||
143112214|NCT02419612|515952046|FG000|Short-term Treatment Period|Death|0|||
143112215|NCT02419612|515952047|FG001|Short-term Treatment Period|Death|2|||
143112216|NCT02419612|515952046|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
143112217|NCT02419612|515952047|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
143112218|NCT02419612|515952046|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
143112219|NCT02419612|515952047|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
143112220|NCT02419612|515952046|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
143112221|NCT02419612|515952047|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
143112222|NCT02419612|515952046|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
143112223|NCT02419612|515952047|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
143112224|NCT02419612|515952046|FG000|Short-term Treatment Period|Worsening of liver function|0|||
143112225|NCT02419612|515952047|FG001|Short-term Treatment Period|Worsening of liver function|1|||
143112226|NCT02419612|515952046|FG000|Short-term Treatment Period|Subject moved out of state|0|||
143112227|NCT02419612|515952047|FG001|Short-term Treatment Period|Subject moved out of state|1|||
143112228|NCT02419612|515952046|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
143112229|NCT02419612|515952047|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
143112230|NCT02419612|515952046|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
143112231|NCT02419612|515952047|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
143112232|NCT02419612|515952046|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
143112233|NCT02419612|515952047|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
143112234|NCT02419612|515952046|FG000|Long-term Treatment Period|Death|0|||
143112235|NCT02419612|515952047|FG001|Long-term Treatment Period|Death|1|||
143112236|NCT02419612|515952046|FG000|Long-term Treatment Period|Adverse Event|0|||
143112237|NCT02419612|515952047|FG001|Long-term Treatment Period|Adverse Event|5|||
143112238|NCT02419612|515952046|FG000|Long-term Treatment Period|Other|4|||
143112239|NCT02419612|515952047|FG001|Long-term Treatment Period|Other|4|||
143112240|NCT02419612|515952046|FG000|Long-term Treatment Period|Subject Decision|2|||
143112241|NCT02419612|515952047|FG001|Long-term Treatment Period|Subject Decision|4|||
143112242|NCT02419612|515952046|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
143112243|NCT02419612|515952047|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
143112244|NCT01095978|515952048|FG000|Overall Study|Did not take Klacid SR|2|||
143112245|NCT01095978|515952048|FG000|Overall Study|Adverse Event|1|||
143112246|NCT03197467|515953700|FG000|Overall Study|Withdrawal by Subject|1|||
143112247|NCT03666533|515953702|FG000|Overall Study|Lost to Follow-up|2|||
143112248|NCT03666533|515953703|FG001|Overall Study|Lost to Follow-up|2|||
143112249|NCT05091346|515953704|FG000|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
143112250|NCT05091346|515953705|FG001|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
143112251|NCT05091346|515953706|FG002|Overall Study|Survival follow-up ceased/discontinued by sponsor|7|||
143112252|NCT05091346|515953707|FG003|Overall Study|Survival follow-up ceased/discontinued by sponsor|10|||
143258322|NCT01931670|516500555|FG001|Treatment Period|Exclusionary Medication Received|1|||
143258323|NCT01931670|516500556|FG002|Treatment Period|Exclusionary Medication Received|1|||
143112253|NCT05091346|515953708|FG004|Overall Study|Survival follow-up ceased/discontinued by sponsor|4|||
143112254|NCT05091346|515953704|FG000|Overall Study|Death|6|||
143112255|NCT05091346|515953705|FG001|Overall Study|Death|5|||
143112256|NCT05091346|515953706|FG002|Overall Study|Death|8|||
143112257|NCT05091346|515953707|FG003|Overall Study|Death|16|||
143112258|NCT05091346|515953708|FG004|Overall Study|Death|26|||
143112259|NCT05091346|515953704|FG000|Overall Study|Lost to Follow-up|0|||
143112260|NCT05091346|515953705|FG001|Overall Study|Lost to Follow-up|0|||
143112261|NCT05091346|515953706|FG002|Overall Study|Lost to Follow-up|0|||
143112262|NCT05091346|515953707|FG003|Overall Study|Lost to Follow-up|1|||
143112263|NCT05091346|515953708|FG004|Overall Study|Lost to Follow-up|0|||
143112264|NCT05091346|515953704|FG000|Overall Study|Withdrawal by Subject|0|||
143112265|NCT05091346|515953705|FG001|Overall Study|Withdrawal by Subject|1|||
143112266|NCT05091346|515953706|FG002|Overall Study|Withdrawal by Subject|2|||
143112267|NCT05091346|515953707|FG003|Overall Study|Withdrawal by Subject|2|||
143112268|NCT05091346|515953708|FG004|Overall Study|Withdrawal by Subject|1|||
143112269|NCT00197002|515953709|FG000|Overall Study|Adverse Event|0|||
143112270|NCT00197002|515953710|FG001|Overall Study|Adverse Event|1|||
143112271|NCT00197002|515953711|FG002|Overall Study|Adverse Event|0|||
143112272|NCT00197002|515953709|FG000|Overall Study|Protocol Violation|1|||
143112273|NCT00197002|515953710|FG001|Overall Study|Protocol Violation|0|||
143112274|NCT00197002|515953711|FG002|Overall Study|Protocol Violation|2|||
143112275|NCT00197002|515953709|FG000|Overall Study|Withdrawal by Subject|9|||
143112276|NCT00197002|515953710|FG001|Overall Study|Withdrawal by Subject|5|||
143112277|NCT00197002|515953711|FG002|Overall Study|Withdrawal by Subject|7|||
143112278|NCT00197002|515953709|FG000|Overall Study|Migrated/moved from study area|3|||
143112279|NCT00197002|515953710|FG001|Overall Study|Migrated/moved from study area|5|||
143112280|NCT00197002|515953711|FG002|Overall Study|Migrated/moved from study area|1|||
143112281|NCT00197002|515953709|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
143112282|NCT00197002|515953710|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
143112283|NCT00197002|515953711|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
143112284|NCT00197002|515953709|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
143112285|NCT00197002|515953710|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
143112286|NCT00197002|515953711|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
143112287|NCT00197002|515953709|FG000|Overall Study|Others|3|||
143112288|NCT00197002|515953710|FG001|Overall Study|Others|1|||
143112289|NCT00197002|515953711|FG002|Overall Study|Others|1|||
143112290|NCT05376241|515953712|FG000|Overall Study|did not meet eligibility criteria after consenting|22|||
143112291|NCT05376241|515953712|FG000|Overall Study|103 did not complete the survey|103|||
143112292|NCT05376241|515953712|FG000|Overall Study|17 failed 2 attention check questions|17|||
143112293|NCT03036098|515953713|FG000|Pre-Treatment|Other Reasons|1|||
143112294|NCT03036098|515953714|FG001|Pre-Treatment|Other Reasons|2|||
143112295|NCT03036098|515953715|FG002|Pre-Treatment|Other Reasons|0|||
143112296|NCT03036098|515953716|FG003|Pre-Treatment|Other Reasons|5|||
143112297|NCT03036098|515953713|FG000|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
143112298|NCT03036098|515953714|FG001|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
143112299|NCT03036098|515953715|FG002|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
143112300|NCT03036098|515953716|FG003|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
143112301|NCT03036098|515953713|FG000|Pre-Treatment|Withdrawal by Subject|1|||
143112302|NCT03036098|515953714|FG001|Pre-Treatment|Withdrawal by Subject|14|||
143112303|NCT03036098|515953715|FG002|Pre-Treatment|Withdrawal by Subject|0|||
143112304|NCT03036098|515953716|FG003|Pre-Treatment|Withdrawal by Subject|5|||
143112305|NCT03036098|515953713|FG000|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
143112306|NCT03036098|515953714|FG001|Pre-Treatment|Participant Request to Discontinue Study Treatment|3|||
143112307|NCT03036098|515953715|FG002|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
143112308|NCT03036098|515953716|FG003|Pre-Treatment|Participant Request to Discontinue Study Treatment|1|||
143112309|NCT03036098|515953713|FG000|Treatment|Disease Progression|130|||
143112310|NCT03036098|515953714|FG001|Treatment|Disease Progression|77|||
143112311|NCT03036098|515953715|FG002|Treatment|Disease Progression|168|||
143112312|NCT03036098|515953716|FG003|Treatment|Disease Progression|50|||
143112313|NCT03036098|515953713|FG000|Treatment|Study Drug Toxicity|95|||
143112314|NCT03036098|515953714|FG001|Treatment|Study Drug Toxicity|45|||
143112315|NCT03036098|515953715|FG002|Treatment|Study Drug Toxicity|26|||
143112316|NCT03036098|515953716|FG003|Treatment|Study Drug Toxicity|22|||
143112317|NCT03036098|515953713|FG000|Treatment|Death|9|||
143112318|NCT03036098|515953714|FG001|Treatment|Death|3|||
143112319|NCT03036098|515953715|FG002|Treatment|Death|1|||
143112320|NCT03036098|515953716|FG003|Treatment|Death|2|||
143112321|NCT03036098|515953713|FG000|Treatment|Adverse Event Unrelated to Study Drug|18|||
143117394|NCT02864316|515971833|FG000|Overall Study|Progressive Disease|2|||
143117395|NCT02864316|515971834|FG001|Overall Study|Progressive Disease|1|||
143117396|NCT02864316|515971833|FG000|Overall Study|Adverse Event|0|||
143117397|NCT02864316|515971834|FG001|Overall Study|Adverse Event|1|||
143117398|NCT05459558|515971835|FG000|Overall Study|Adverse Event|1|||
143117399|NCT05459558|515971836|FG001|Overall Study|Adverse Event|0|||
143117400|NCT05459558|515971837|FG002|Overall Study|Adverse Event|0|||
143112322|NCT03036098|515953714|FG001|Treatment|Adverse Event Unrelated to Study Drug|15|||
143112323|NCT03036098|515953715|FG002|Treatment|Adverse Event Unrelated to Study Drug|10|||
143112324|NCT03036098|515953716|FG003|Treatment|Adverse Event Unrelated to Study Drug|14|||
143112325|NCT03036098|515953713|FG000|Treatment|Participant Request to Discontinue Study Treatment|6|||
143112326|NCT03036098|515953714|FG001|Treatment|Participant Request to Discontinue Study Treatment|18|||
143112327|NCT03036098|515953715|FG002|Treatment|Participant Request to Discontinue Study Treatment|15|||
143112328|NCT03036098|515953716|FG003|Treatment|Participant Request to Discontinue Study Treatment|18|||
143112329|NCT03036098|515953713|FG000|Treatment|Withdrawal by Subject|2|||
143112330|NCT03036098|515953714|FG001|Treatment|Withdrawal by Subject|9|||
143112331|NCT03036098|515953715|FG002|Treatment|Withdrawal by Subject|2|||
143112332|NCT03036098|515953716|FG003|Treatment|Withdrawal by Subject|4|||
143112333|NCT03036098|515953713|FG000|Treatment|Maximum Clinical Benefit|6|||
143112334|NCT03036098|515953714|FG001|Treatment|Maximum Clinical Benefit|1|||
143112335|NCT03036098|515953715|FG002|Treatment|Maximum Clinical Benefit|6|||
143112336|NCT03036098|515953716|FG003|Treatment|Maximum Clinical Benefit|10|||
143112337|NCT03036098|515953713|FG000|Treatment|Poor/Non Compliance|1|||
143112338|NCT03036098|515953714|FG001|Treatment|Poor/Non Compliance|2|||
143112339|NCT03036098|515953715|FG002|Treatment|Poor/Non Compliance|0|||
143112340|NCT03036098|515953716|FG003|Treatment|Poor/Non Compliance|1|||
143112341|NCT03036098|515953713|FG000|Treatment|Participant No Longer Meets Study Criteria|0|||
143112342|NCT03036098|515953714|FG001|Treatment|Participant No Longer Meets Study Criteria|1|||
143112343|NCT03036098|515953715|FG002|Treatment|Participant No Longer Meets Study Criteria|1|||
143112344|NCT03036098|515953716|FG003|Treatment|Participant No Longer Meets Study Criteria|1|||
143112345|NCT03036098|515953713|FG000|Treatment|Administrative Reason by Sponsor|1|||
143112346|NCT03036098|515953714|FG001|Treatment|Administrative Reason by Sponsor|0|||
143112347|NCT03036098|515953715|FG002|Treatment|Administrative Reason by Sponsor|2|||
143112348|NCT03036098|515953716|FG003|Treatment|Administrative Reason by Sponsor|1|||
143112349|NCT03036098|515953713|FG000|Treatment|Other Reasons|31|||
143112350|NCT03036098|515953714|FG001|Treatment|Other Reasons|5|||
143112351|NCT03036098|515953715|FG002|Treatment|Other Reasons|21|||
143112352|NCT03036098|515953716|FG003|Treatment|Other Reasons|8|||
143112353|NCT03036098|515953713|FG000|Treatment|Ongoing Treatment|0|||
143112354|NCT03036098|515953714|FG001|Treatment|Ongoing Treatment|0|||
143112355|NCT03036098|515953715|FG002|Treatment|Ongoing Treatment|23|||
143112356|NCT03036098|515953716|FG003|Treatment|Ongoing Treatment|0|||
143112357|NCT04035434|515953720|FG000|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
143112358|NCT04035434|515953721|FG001|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
143112359|NCT04035434|515953722|FG002|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
143112360|NCT04035434|515953723|FG003|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|2|||
143112361|NCT04035434|515953724|FG004|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
143112362|NCT04035434|515953725|FG005|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
143112363|NCT04035434|515953726|FG006|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
143112364|NCT04035434|515953727|FG007|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
143112365|NCT04035434|515953728|FG008|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
143112366|NCT04035434|515953729|FG009|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
143112367|NCT04035434|515953730|FG010|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
143112368|NCT04035434|515953731|FG011|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
143112369|NCT04035434|515953732|FG012|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
143112370|NCT04035434|515953720|FG000|Dose Escalation Phase (Up to 5 Years)|Death|3|||
143112371|NCT04035434|515953721|FG001|Dose Escalation Phase (Up to 5 Years)|Death|1|||
143112372|NCT04035434|515953722|FG002|Dose Escalation Phase (Up to 5 Years)|Death|4|||
143112373|NCT04035434|515953723|FG003|Dose Escalation Phase (Up to 5 Years)|Death|3|||
143112374|NCT04035434|515953724|FG004|Dose Escalation Phase (Up to 5 Years)|Death|8|||
143112375|NCT04035434|515953725|FG005|Dose Escalation Phase (Up to 5 Years)|Death|3|||
143112376|NCT04035434|515953726|FG006|Dose Escalation Phase (Up to 5 Years)|Death|0|||
143112377|NCT04035434|515953727|FG007|Dose Escalation Phase (Up to 5 Years)|Death|1|||
143112378|NCT04035434|515953728|FG008|Dose Escalation Phase (Up to 5 Years)|Death|3|||
143112379|NCT04035434|515953729|FG009|Dose Escalation Phase (Up to 5 Years)|Death|4|||
143179798|NCT00003869|516205715|FG000|Overall Study|Adverse Event|14|||
143179799|NCT00003869|516205716|FG001|Overall Study|Adverse Event|3|||
143112380|NCT04035434|515953730|FG010|Dose Escalation Phase (Up to 5 Years)|Death|3|||
143112381|NCT04035434|515953731|FG011|Dose Escalation Phase (Up to 5 Years)|Death|2|||
143112382|NCT04035434|515953732|FG012|Dose Escalation Phase (Up to 5 Years)|Death|1|||
143112383|NCT04035434|515953720|FG000|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
143112384|NCT04035434|515953721|FG001|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
143112385|NCT04035434|515953722|FG002|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
143112386|NCT04035434|515953723|FG003|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
143112387|NCT04035434|515953724|FG004|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
143179800|NCT00003869|516205715|FG000|Overall Study|Withdrawal by Subject|21|||
143179801|NCT00003869|516205716|FG001|Overall Study|Withdrawal by Subject|3|||
143179802|NCT00003869|516205715|FG000|Overall Study|Death|1|||
143179803|NCT00003869|516205716|FG001|Overall Study|Death|2|||
143179804|NCT00003869|516205715|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
143179805|NCT00003869|516205716|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
143179806|NCT01964378|516205717|FG000|Overall Study|Disc. due to death before first dosing|0|||
143179807|NCT01964378|516205718|FG001|Overall Study|Disc. due to death before first dosing|1|||
143179808|NCT01964378|516205717|FG000|Overall Study|Disc. due to AE before first dosing|1|||
143179809|NCT01964378|516205718|FG001|Overall Study|Disc. due to AE before first dosing|0|||
143179810|NCT01964378|516205717|FG000|Overall Study|Death|3|||
143179811|NCT01964378|516205718|FG001|Overall Study|Death|2|||
143179812|NCT01964378|516205717|FG000|Overall Study|Adverse Event|12|||
143179813|NCT01964378|516205718|FG001|Overall Study|Adverse Event|5|||
143179814|NCT01964378|516205717|FG000|Overall Study|Lack of Efficacy|0|||
143179815|NCT01964378|516205718|FG001|Overall Study|Lack of Efficacy|1|||
143179816|NCT01964378|516205717|FG000|Overall Study|Protocol Violation|0|||
143179817|NCT01964378|516205718|FG001|Overall Study|Protocol Violation|1|||
143179818|NCT01964378|516205717|FG000|Overall Study|Lost to Follow-up|0|||
143179819|NCT01964378|516205718|FG001|Overall Study|Lost to Follow-up|1|||
143179820|NCT01964378|516205717|FG000|Overall Study|Withdrawal by Subject|7|||
143179821|NCT01964378|516205718|FG001|Overall Study|Withdrawal by Subject|5|||
143179822|NCT01964378|516205717|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
143179823|NCT01964378|516205718|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
143179824|NCT01964378|516205717|FG000|Overall Study|Other|1|||
143179825|NCT01964378|516205718|FG001|Overall Study|Other|2|||
143179826|NCT00326599|516205719|FG000|Overall Study|Withdrawal by Subject|1|||
143179827|NCT00326599|516205720|FG001|Overall Study|Withdrawal by Subject|0|||
143179828|NCT00326599|516205721|FG002|Overall Study|Withdrawal by Subject|5|||
143179829|NCT00326599|516205722|FG003|Overall Study|Withdrawal by Subject|2|||
143179830|NCT00326599|516205719|FG000|Overall Study|Adverse Event|1|||
143179831|NCT00326599|516205720|FG001|Overall Study|Adverse Event|0|||
143179832|NCT00326599|516205721|FG002|Overall Study|Adverse Event|32|||
143179833|NCT00326599|516205722|FG003|Overall Study|Adverse Event|3|||
143179834|NCT00326599|516205719|FG000|Overall Study|Disease Progression|3|||
143179835|NCT00326599|516205720|FG001|Overall Study|Disease Progression|1|||
143179836|NCT00326599|516205721|FG002|Overall Study|Disease Progression|13|||
143179837|NCT00326599|516205722|FG003|Overall Study|Disease Progression|11|||
143179838|NCT00326599|516205719|FG000|Overall Study|Alternate Treatment|1|||
143179839|NCT00326599|516205720|FG001|Overall Study|Alternate Treatment|0|||
143179840|NCT00326599|516205721|FG002|Overall Study|Alternate Treatment|0|||
143179841|NCT00326599|516205722|FG003|Overall Study|Alternate Treatment|0|||
143179842|NCT00326599|516205719|FG000|Overall Study|Death|0|||
143179843|NCT00326599|516205720|FG001|Overall Study|Death|0|||
143179844|NCT00326599|516205721|FG002|Overall Study|Death|1|||
143179845|NCT00326599|516205722|FG003|Overall Study|Death|2|||
143179846|NCT00326599|516205719|FG000|Overall Study|Other Unspecified Reason|0|||
143179847|NCT00326599|516205720|FG001|Overall Study|Other Unspecified Reason|0|||
143179848|NCT00326599|516205721|FG002|Overall Study|Other Unspecified Reason|2|||
143179849|NCT00326599|516205722|FG003|Overall Study|Other Unspecified Reason|1|||
143179850|NCT03364231|516205723|FG000|Overall Study|Adverse Event|1|||
143179851|NCT03364231|516205724|FG001|Overall Study|Adverse Event|4|||
143179852|NCT03364231|516205723|FG000|Overall Study|Death|1|||
143179853|NCT03364231|516205724|FG001|Overall Study|Death|0|||
143179854|NCT03364231|516205723|FG000|Overall Study|Investigator Decision|2|||
143179855|NCT03364231|516205724|FG001|Overall Study|Investigator Decision|2|||
143179856|NCT03364231|516205723|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
143179857|NCT03364231|516205724|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
143179858|NCT03364231|516205723|FG000|Overall Study|Withdrawal of Subject Consent|1|||
143179859|NCT03364231|516205724|FG001|Overall Study|Withdrawal of Subject Consent|0|||
143179860|NCT03364231|516205723|FG000|Overall Study|Reason Not Specified|1|||
143179861|NCT03364231|516205724|FG001|Overall Study|Reason Not Specified|0|||
143179862|NCT03364231|516205723|FG000|Overall Study|Disease Progression|0|||
143179863|NCT03364231|516205724|FG001|Overall Study|Disease Progression|6|||
143179864|NCT03386435|516205725|FG000|Overall Study|Protocol Violation|5|||
143179865|NCT03386435|516205726|FG001|Overall Study|Protocol Violation|7|||
143179866|NCT04068922|516205727|FG000|Overall Study|Lost to Follow-up|5|||
143179867|NCT04068922|516205727|FG000|Overall Study|Withdrawal by Subject|7|||
143179868|NCT04068922|516205727|FG000|Overall Study|Adverse Event|1|||
143179869|NCT00625586|516205728|FG000|Overall Study|Adverse Event|1|||
143179870|NCT00625586|516205728|FG000|Overall Study|Progressive disease|1|||
143179871|NCT03542266|516205729|FG000|Treatment Phase|Withdrawal by Subject|1|||
143179872|NCT03542266|516205729|FG000|Treatment Phase|Adverse Event|1|||
143179873|NCT03542266|516205729|FG000|Treatment Phase|PD|1|||
143179874|NCT01162473|516205741|FG000|Overall Study|Adverse Event|2|||
143179875|NCT01162473|516205742|FG001|Overall Study|Adverse Event|1|||
143179876|NCT01162473|516205741|FG000|Overall Study|Withdrawal by Subject|0|||
143179877|NCT01162473|516205742|FG001|Overall Study|Withdrawal by Subject|4|||
143179878|NCT00657267|516205751|FG000|Overall Study|Progressive disease|45|||
143112388|NCT04035434|515953725|FG005|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
143112389|NCT04035434|515953726|FG006|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
143112390|NCT04035434|515953727|FG007|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
143112391|NCT04035434|515953728|FG008|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
143112392|NCT04035434|515953729|FG009|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
143112393|NCT04035434|515953730|FG010|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
143112394|NCT04035434|515953731|FG011|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
143112395|NCT04035434|515953732|FG012|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|6|||
143112396|NCT04035434|515953720|FG000|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
143112397|NCT04035434|515953721|FG001|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
143112398|NCT04035434|515953722|FG002|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
143112399|NCT04035434|515953723|FG003|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|1|||
143112400|NCT04035434|515953724|FG004|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
143112401|NCT04035434|515953725|FG005|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
143112402|NCT04035434|515953726|FG006|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
143112403|NCT04035434|515953727|FG007|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
143112404|NCT04035434|515953728|FG008|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
143112405|NCT04035434|515953729|FG009|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
143112406|NCT04035434|515953730|FG010|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
143112407|NCT04035434|515953731|FG011|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
143112408|NCT04035434|515953732|FG012|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
143112409|NCT04035434|515953720|FG000|Dose Expansion Phase (Up to 5 Years)|Death|0|||
143112410|NCT04035434|515953721|FG001|Dose Expansion Phase (Up to 5 Years)|Death|0|||
143112411|NCT04035434|515953722|FG002|Dose Expansion Phase (Up to 5 Years)|Death|0|||
143112412|NCT04035434|515953723|FG003|Dose Expansion Phase (Up to 5 Years)|Death|0|||
143112413|NCT04035434|515953724|FG004|Dose Expansion Phase (Up to 5 Years)|Death|0|||
143112414|NCT04035434|515953725|FG005|Dose Expansion Phase (Up to 5 Years)|Death|14|||
143112415|NCT04035434|515953726|FG006|Dose Expansion Phase (Up to 5 Years)|Death|3|||
143112416|NCT04035434|515953727|FG007|Dose Expansion Phase (Up to 5 Years)|Death|0|||
143112417|NCT04035434|515953728|FG008|Dose Expansion Phase (Up to 5 Years)|Death|0|||
143112418|NCT04035434|515953729|FG009|Dose Expansion Phase (Up to 5 Years)|Death|0|||
143112419|NCT04035434|515953730|FG010|Dose Expansion Phase (Up to 5 Years)|Death|0|||
143112420|NCT04035434|515953731|FG011|Dose Expansion Phase (Up to 5 Years)|Death|0|||
143112421|NCT04035434|515953732|FG012|Dose Expansion Phase (Up to 5 Years)|Death|0|||
143112422|NCT04035434|515953720|FG000|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
143112423|NCT04035434|515953721|FG001|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
143112424|NCT04035434|515953722|FG002|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
143112425|NCT04035434|515953723|FG003|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
143112426|NCT04035434|515953724|FG004|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
143112427|NCT04035434|515953725|FG005|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
143112428|NCT04035434|515953726|FG006|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
143112429|NCT04035434|515953727|FG007|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
143112430|NCT04035434|515953728|FG008|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
143112431|NCT04035434|515953729|FG009|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
143112432|NCT04035434|515953730|FG010|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
143112433|NCT04035434|515953731|FG011|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
143112434|NCT04035434|515953732|FG012|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
143112435|NCT04035434|515953720|FG000|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
143112436|NCT04035434|515953721|FG001|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
143112437|NCT04035434|515953722|FG002|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
143112438|NCT04035434|515953723|FG003|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
143112439|NCT04035434|515953724|FG004|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
143112440|NCT04035434|515953725|FG005|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|8|||
143112441|NCT04035434|515953726|FG006|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|4|||
143112442|NCT04035434|515953727|FG007|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
143112443|NCT04035434|515953728|FG008|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
143112444|NCT04035434|515953729|FG009|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
143112445|NCT04035434|515953730|FG010|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
143112446|NCT04035434|515953731|FG011|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
143112447|NCT04035434|515953732|FG012|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
143112448|NCT01668966|515953737|FG000|Overall Study|Withdrawal by Subject|1|||
143112449|NCT01668966|515953737|FG000|Overall Study|Death|1|||
143112450|NCT01668966|515953737|FG000|Overall Study|Not treated|2|||
143112451|NCT00916344|515953738|FG000|Overall Study|Death|2|||
143112452|NCT00916344|515953738|FG000|Overall Study|ICD upgrade|1|||
143112453|NCT00916344|515953738|FG000|Overall Study|Drop-out|5|||
143112454|NCT03602391|515953745|FG000|Overall Study|COVID-19|7|||
143112455|NCT03602391|515953746|FG001|Overall Study|COVID-19|6|||
143112456|NCT02954653|515953756|FG000|Overall Study|Death|3|||
143112457|NCT02954653|515953757|FG001|Overall Study|Death|1|||
143112458|NCT02954653|515953758|FG002|Overall Study|Death|0|||
143112459|NCT02954653|515953759|FG003|Overall Study|Death|0|||
143112460|NCT02954653|515953760|FG004|Overall Study|Death|0|||
143112461|NCT02954653|515953761|FG005|Overall Study|Death|0|||
143112462|NCT02954653|515953762|FG006|Overall Study|Death|0|||
143112463|NCT02954653|515953763|FG007|Overall Study|Death|0|||
143112464|NCT02954653|515953764|FG008|Overall Study|Death|0|||
143112465|NCT02954653|515953756|FG000|Overall Study|Randomized but did not receive treatment|1|||
143112466|NCT02954653|515953757|FG001|Overall Study|Randomized but did not receive treatment|0|||
143112467|NCT02954653|515953758|FG002|Overall Study|Randomized but did not receive treatment|0|||
143112468|NCT02954653|515953759|FG003|Overall Study|Randomized but did not receive treatment|0|||
143112469|NCT02954653|515953760|FG004|Overall Study|Randomized but did not receive treatment|0|||
143112470|NCT02954653|515953761|FG005|Overall Study|Randomized but did not receive treatment|0|||
143112471|NCT02954653|515953762|FG006|Overall Study|Randomized but did not receive treatment|0|||
143112472|NCT02954653|515953763|FG007|Overall Study|Randomized but did not receive treatment|0|||
143112473|NCT02954653|515953764|FG008|Overall Study|Randomized but did not receive treatment|0|||
143112474|NCT02954653|515953756|FG000|Overall Study|Started another anti-cancer therapy|0|||
143112475|NCT02954653|515953757|FG001|Overall Study|Started another anti-cancer therapy|1|||
143112476|NCT02954653|515953758|FG002|Overall Study|Started another anti-cancer therapy|0|||
143112477|NCT02954653|515953759|FG003|Overall Study|Started another anti-cancer therapy|0|||
143112478|NCT02954653|515953760|FG004|Overall Study|Started another anti-cancer therapy|0|||
143112479|NCT02954653|515953761|FG005|Overall Study|Started another anti-cancer therapy|0|||
143112480|NCT02954653|515953762|FG006|Overall Study|Started another anti-cancer therapy|0|||
143112481|NCT02954653|515953763|FG007|Overall Study|Started another anti-cancer therapy|0|||
143112482|NCT02954653|515953764|FG008|Overall Study|Started another anti-cancer therapy|0|||
143112483|NCT02954653|515953756|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
143112484|NCT02954653|515953757|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
143112485|NCT02954653|515953758|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
143112486|NCT02954653|515953759|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
143112487|NCT02954653|515953760|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
143112488|NCT02954653|515953761|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
143112489|NCT02954653|515953762|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
143112490|NCT02954653|515953763|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
143112491|NCT02954653|515953764|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
143112492|NCT03054064|515953765|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
143112493|NCT03054064|515953765|FG000|Overall Study|Investigator Decision|2|||
143112494|NCT03054064|515953765|FG000|Overall Study|Bladder Issue|1|||
143112495|NCT03054064|515953765|FG000|Overall Study|High Blood Pressure|1|||
143112496|NCT03054064|515953765|FG000|Overall Study|Change in Status|1|||
143112497|NCT00767039|515953770|FG000|Overall Study|Death|5|||
143112498|NCT00767039|515953771|FG001|Overall Study|Death|2|||
143112499|NCT01826370|515953772|FG000|Overall Study|Protocol Violation|6|||
143112500|NCT01826370|515953772|FG000|Overall Study|Lost to Follow-up|12|||
143112501|NCT01826370|515953772|FG000|Overall Study|Other reason not defined above|2|||
143112502|NCT01472757|515953773|FG000|Overall Study|Withdrawal by Subject|1|||
143258324|NCT01931670|516500554|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
143258325|NCT01931670|516500555|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
143258326|NCT01931670|516500556|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
143258327|NCT01931670|516500554|FG000|Treatment Period|Subject Noncompliant|4|||
143112503|NCT01472757|515953774|FG001|Overall Study|Withdrawal by Subject|2|||
143112504|NCT01472757|515953775|FG002|Overall Study|Withdrawal by Subject|2|||
143112505|NCT01472757|515953776|FG003|Overall Study|Withdrawal by Subject|0|||
143112506|NCT01472757|515953773|FG000|Overall Study|Asthma exacerbation|4|||
143112507|NCT01472757|515953774|FG001|Overall Study|Asthma exacerbation|1|||
143112508|NCT01472757|515953775|FG002|Overall Study|Asthma exacerbation|2|||
143112509|NCT01472757|515953776|FG003|Overall Study|Asthma exacerbation|1|||
143112510|NCT01472757|515953773|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
143112511|NCT01472757|515953774|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
143112512|NCT01472757|515953775|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
143112513|NCT01472757|515953776|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
143112514|NCT01472757|515953773|FG000|Overall Study|Protocol Violation|3|||
143112515|NCT01472757|515953774|FG001|Overall Study|Protocol Violation|2|||
143112516|NCT01472757|515953775|FG002|Overall Study|Protocol Violation|4|||
143112517|NCT01472757|515953776|FG003|Overall Study|Protocol Violation|4|||
143112518|NCT01472757|515953773|FG000|Overall Study|Other reasons|1|||
143112519|NCT01472757|515953774|FG001|Overall Study|Other reasons|0|||
143112520|NCT01472757|515953775|FG002|Overall Study|Other reasons|2|||
143112521|NCT01472757|515953776|FG003|Overall Study|Other reasons|2|||
143112522|NCT00081731|515953781|FG000|Overall Study|scientific integrity issue|8|||
143112523|NCT00081731|515953782|FG001|Overall Study|scientific integrity issue|8|||
143112524|NCT00785213|515953783|FG000|Quinine Sulfate Alone|Adverse Event|4|||
143112525|NCT00785213|515953783|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
143112526|NCT01259375|515953784|FG000|Overall Study|Adverse Event|1|||
143112527|NCT00478699|515953787|FG000|Overall Study|Inclusion Error|1|||
143112528|NCT00478699|515953788|FG001|Overall Study|Inclusion Error|7|||
143112529|NCT00478699|515953787|FG000|Overall Study|Not receive study treatment|6|||
143112530|NCT00478699|515953788|FG001|Overall Study|Not receive study treatment|30|||
143112531|NCT01546571|515953789|FG000|Overall Study|Adverse Event|1|||
143112532|NCT01546571|515953790|FG001|Overall Study|Adverse Event|0|||
143112533|NCT01546571|515953791|FG002|Overall Study|Adverse Event|0|||
143112534|NCT01546571|515953792|FG003|Overall Study|Adverse Event|1|||
143112535|NCT01546571|515953793|FG004|Overall Study|Adverse Event|0|||
143112536|NCT01546571|515953789|FG000|Overall Study|assigned placebo in Part A|0|||
143112537|NCT01546571|515953790|FG001|Overall Study|assigned placebo in Part A|0|||
143112538|NCT01546571|515953791|FG002|Overall Study|assigned placebo in Part A|22|||
143112539|NCT01546571|515953792|FG003|Overall Study|assigned placebo in Part A|0|||
143112540|NCT01546571|515953793|FG004|Overall Study|assigned placebo in Part A|0|||
143112541|NCT01546571|515953789|FG000|Overall Study|Death|0|||
143112542|NCT01546571|515953790|FG001|Overall Study|Death|1|||
143112543|NCT01546571|515953791|FG002|Overall Study|Death|0|||
143112544|NCT01546571|515953792|FG003|Overall Study|Death|0|||
143112545|NCT01546571|515953793|FG004|Overall Study|Death|0|||
143112546|NCT01546571|515953789|FG000|Overall Study|Lost to Follow-up|0|||
143112547|NCT01546571|515953790|FG001|Overall Study|Lost to Follow-up|0|||
143112548|NCT01546571|515953791|FG002|Overall Study|Lost to Follow-up|2|||
143112549|NCT01546571|515953792|FG003|Overall Study|Lost to Follow-up|2|||
143112550|NCT01546571|515953793|FG004|Overall Study|Lost to Follow-up|3|||
143112551|NCT01546571|515953789|FG000|Overall Study|Pregnancy|0|||
143112552|NCT01546571|515953790|FG001|Overall Study|Pregnancy|0|||
143112553|NCT01546571|515953791|FG002|Overall Study|Pregnancy|0|||
143112554|NCT01546571|515953792|FG003|Overall Study|Pregnancy|1|||
143112555|NCT01546571|515953793|FG004|Overall Study|Pregnancy|0|||
143112556|NCT01546571|515953789|FG000|Overall Study|Disease Progression|20|||
143112557|NCT01546571|515953790|FG001|Overall Study|Disease Progression|18|||
143112558|NCT01546571|515953791|FG002|Overall Study|Disease Progression|15|||
143112559|NCT01546571|515953792|FG003|Overall Study|Disease Progression|73|||
143112560|NCT01546571|515953793|FG004|Overall Study|Disease Progression|37|||
143112561|NCT01546571|515953789|FG000|Overall Study|Withdrawal by Subject|1|||
143112562|NCT01546571|515953790|FG001|Overall Study|Withdrawal by Subject|2|||
143112563|NCT01546571|515953791|FG002|Overall Study|Withdrawal by Subject|4|||
143112564|NCT01546571|515953792|FG003|Overall Study|Withdrawal by Subject|9|||
143112565|NCT01546571|515953793|FG004|Overall Study|Withdrawal by Subject|2|||
143112566|NCT01546571|515953789|FG000|Overall Study|Intercurrent Illness|1|||
143112567|NCT01546571|515953790|FG001|Overall Study|Intercurrent Illness|2|||
143112568|NCT01546571|515953791|FG002|Overall Study|Intercurrent Illness|0|||
143112569|NCT01546571|515953792|FG003|Overall Study|Intercurrent Illness|0|||
143112570|NCT01546571|515953793|FG004|Overall Study|Intercurrent Illness|0|||
143112571|NCT01546571|515953789|FG000|Overall Study|Other Cancers|0|||
143112572|NCT01546571|515953790|FG001|Overall Study|Other Cancers|0|||
143112573|NCT01546571|515953791|FG002|Overall Study|Other Cancers|0|||
143112574|NCT01546571|515953792|FG003|Overall Study|Other Cancers|3|||
143112575|NCT01546571|515953793|FG004|Overall Study|Other Cancers|1|||
143112576|NCT01546571|515953789|FG000|Overall Study|Other|0|||
143112577|NCT01546571|515953790|FG001|Overall Study|Other|0|||
143112578|NCT01546571|515953791|FG002|Overall Study|Other|3|||
143112579|NCT01546571|515953792|FG003|Overall Study|Other|0|||
143112580|NCT01546571|515953793|FG004|Overall Study|Other|0|||
143112581|NCT04601103|515953795|FG000|Overall Study|Needed crown & cleaning|0|||
143112582|NCT04601103|515953796|FG001|Overall Study|Needed crown & cleaning|0|||
143112583|NCT04601103|515953797|FG002|Overall Study|Needed crown & cleaning|1|||
143112584|NCT04601103|515953795|FG000|Overall Study|study was terminated|18|||
143112585|NCT04601103|515953796|FG001|Overall Study|study was terminated|18|||
143112586|NCT04601103|515953797|FG002|Overall Study|study was terminated|16|||
143112587|NCT01537068|515953800|FG000|Overall Study|Lost to Follow-up|2|||
143179879|NCT00657267|516205751|FG000|Overall Study|Adverse Event|9|||
143112588|NCT01537068|515953801|FG001|Overall Study|Lost to Follow-up|1|||
143112589|NCT01537068|515953800|FG000|Overall Study|Adverse Event|0|||
143112590|NCT01537068|515953801|FG001|Overall Study|Adverse Event|1|||
143112591|NCT01537068|515953800|FG000|Overall Study|Withdrawal by Subject|1|||
143179880|NCT01070979|516205752|FG000|Overall Study|Adverse Event|2|||
143112592|NCT01537068|515953801|FG001|Overall Study|Withdrawal by Subject|1|||
143112593|NCT01537068|515953800|FG000|Overall Study|Lack of Efficacy|1|||
143112594|NCT01537068|515953801|FG001|Overall Study|Lack of Efficacy|0|||
143112595|NCT02291601|515953802|FG000|Abdomen|Did not qualify|333|||
143112596|NCT02291601|515953803|FG001|Abdomen|Did not qualify|54|||
143112597|NCT02291601|515953804|FG002|Abdomen|Did not qualify|339|||
143112598|NCT02291601|515953802|FG000|Groin|Did not qualify|183|||
143112599|NCT02291601|515953803|FG001|Groin|Did not qualify|30|||
143112600|NCT02291601|515953804|FG002|Groin|Did not qualify|177|||
143112601|NCT04017832|515953811|FG000|Overall Study|Withdrawal by Subject|13|||
143112602|NCT04017832|515953812|FG001|Overall Study|Withdrawal by Subject|12|||
143112603|NCT04017832|515953813|FG002|Overall Study|Withdrawal by Subject|21|||
143112604|NCT04017832|515953814|FG003|Overall Study|Withdrawal by Subject|7|||
143112605|NCT04017832|515953811|FG000|Overall Study|Lost to Follow-up|0|||
143112606|NCT04017832|515953812|FG001|Overall Study|Lost to Follow-up|3|||
143112607|NCT04017832|515953813|FG002|Overall Study|Lost to Follow-up|3|||
143112608|NCT04017832|515953814|FG003|Overall Study|Lost to Follow-up|1|||
143112609|NCT04017832|515953811|FG000|Overall Study|Physician Decision|1|||
143112610|NCT04017832|515953812|FG001|Overall Study|Physician Decision|1|||
143112611|NCT04017832|515953813|FG002|Overall Study|Physician Decision|1|||
143112612|NCT04017832|515953814|FG003|Overall Study|Physician Decision|1|||
143112613|NCT04017832|515953811|FG000|Overall Study|Death|2|||
143112614|NCT04017832|515953812|FG001|Overall Study|Death|2|||
143112615|NCT04017832|515953813|FG002|Overall Study|Death|1|||
143112616|NCT04017832|515953814|FG003|Overall Study|Death|0|||
143112617|NCT01419080|515953817|FG000|Overall Study|Withdrawal by Subject|75|||
143112618|NCT01419080|515953817|FG000|Overall Study|Death|30|||
143112619|NCT01419080|515953817|FG000|Overall Study|Lost to Follow-up|23|||
143112620|NCT01419080|515953817|FG000|Overall Study|Too Ill|3|||
143112621|NCT02375555|515953818|FG000|Induction Period|Adverse Event|7|||
143112622|NCT02375555|515953818|FG000|Induction Period|Withdrawal by Subject|2|||
143112623|NCT02375555|515953818|FG000|Induction Period|Other|1|||
143112624|NCT02375555|515953818|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
143112625|NCT02375555|515953818|FG000|Maintenance Period|Adverse Event|2|||
143112626|NCT02375555|515953818|FG000|Maintenance Period|Withdrawal by Subject|4|||
143112627|NCT02375555|515953818|FG000|Maintenance Period|Death|1|||
143112628|NCT02375555|515953818|FG000|Maintenance Period|Disease Progression|5|||
143112629|NCT02375555|515953818|FG000|Maintenance Period|Patient Non-compliance|1|||
143112630|NCT02375555|515953818|FG000|Maintenance Period|Still on maintenance|16|||
143112631|NCT02548351|515953828|FG000|Overall Study|Withdrawal by Subject|149|||
143112632|NCT02548351|515953829|FG001|Overall Study|Withdrawal by Subject|154|||
143112633|NCT02548351|515953830|FG002|Overall Study|Withdrawal by Subject|152|||
143112634|NCT02548351|515953828|FG000|Overall Study|Death|11|||
143112635|NCT02548351|515953829|FG001|Overall Study|Death|15|||
143112636|NCT02548351|515953830|FG002|Overall Study|Death|12|||
143112637|NCT02548351|515953828|FG000|Overall Study|Adverse Event|22|||
143112638|NCT02548351|515953829|FG001|Overall Study|Adverse Event|56|||
143112639|NCT02548351|515953830|FG002|Overall Study|Adverse Event|36|||
143112640|NCT02548351|515953828|FG000|Overall Study|Study Terminated by Sponsor|549|||
143112641|NCT02548351|515953829|FG001|Overall Study|Study Terminated by Sponsor|509|||
143112642|NCT02548351|515953830|FG002|Overall Study|Study Terminated by Sponsor|528|||
143112643|NCT02548351|515953828|FG000|Overall Study|Site Closure|14|||
143112644|NCT02548351|515953829|FG001|Overall Study|Site Closure|5|||
143112645|NCT02548351|515953830|FG002|Overall Study|Site Closure|7|||
143112646|NCT02548351|515953828|FG000|Overall Study|Non-compliance with Study Drug|4|||
143112647|NCT02548351|515953829|FG001|Overall Study|Non-compliance with Study Drug|2|||
143112648|NCT02548351|515953830|FG002|Overall Study|Non-compliance with Study Drug|0|||
143112649|NCT02548351|515953828|FG000|Overall Study|Protocol Violation|2|||
143112650|NCT02548351|515953829|FG001|Overall Study|Protocol Violation|1|||
143112651|NCT02548351|515953830|FG002|Overall Study|Protocol Violation|2|||
143112652|NCT02548351|515953828|FG000|Overall Study|Physician Decision|11|||
143112653|NCT02548351|515953829|FG001|Overall Study|Physician Decision|18|||
143112654|NCT02548351|515953830|FG002|Overall Study|Physician Decision|11|||
143368411|NCT01456936|516892681|FG003|Overall Study|No longer meets eligibility criteria|5|||
143368412|NCT01456936|516892678|FG000|Overall Study|Protocol Violation|4|||
143368413|NCT01456936|516892679|FG001|Overall Study|Protocol Violation|2|||
143368414|NCT01456936|516892680|FG002|Overall Study|Protocol Violation|5|||
143368415|NCT01456936|516892681|FG003|Overall Study|Protocol Violation|5|||
143368416|NCT01456936|516892678|FG000|Overall Study|Pregnancy|1|||
143112655|NCT02548351|515953828|FG000|Overall Study|Lost to Follow-up|43|||
143112656|NCT02548351|515953829|FG001|Overall Study|Lost to Follow-up|50|||
143112657|NCT02548351|515953830|FG002|Overall Study|Lost to Follow-up|57|||
143112658|NCT02548351|515953828|FG000|Overall Study|Other|19|||
143112659|NCT02548351|515953829|FG001|Overall Study|Other|16|||
143112660|NCT02548351|515953830|FG002|Overall Study|Other|20|||
143112661|NCT02548351|515953828|FG000|Overall Study|Missing|1|||
143112662|NCT02548351|515953829|FG001|Overall Study|Missing|1|||
143112663|NCT02548351|515953830|FG002|Overall Study|Missing|0|||
143112664|NCT01744184|515953831|FG000|Overall Study|Adverse Event|1|||
143112665|NCT01744184|515953832|FG001|Overall Study|Adverse Event|0|||
143368417|NCT01456936|516892679|FG001|Overall Study|Pregnancy|0|||
143368418|NCT01456936|516892680|FG002|Overall Study|Pregnancy|0|||
143368419|NCT01456936|516892681|FG003|Overall Study|Pregnancy|1|||
143112666|NCT01744184|515953831|FG000|Overall Study|Withdrawal by Subject|0|||
143112667|NCT01744184|515953832|FG001|Overall Study|Withdrawal by Subject|1|||
143112668|NCT00125242|515953837|FG000|Overall Study|did not qualify|7|||
143112669|NCT00125242|515953838|FG001|Overall Study|did not qualify|2|||
143112670|NCT01664949|515953841|FG000|Overall Study|Adverse Event|11|||
143112671|NCT01664949|515953842|FG001|Overall Study|Adverse Event|12|||
143112672|NCT01664949|515953841|FG000|Overall Study|Lack of Efficacy|1|||
143112673|NCT01664949|515953842|FG001|Overall Study|Lack of Efficacy|1|||
143112674|NCT01664949|515953841|FG000|Overall Study|Lost to Follow-up|1|||
143112675|NCT01664949|515953842|FG001|Overall Study|Lost to Follow-up|2|||
143112676|NCT01664949|515953841|FG000|Overall Study|Personal Reasons|3|||
143112677|NCT01664949|515953842|FG001|Overall Study|Personal Reasons|4|||
143112678|NCT01664949|515953841|FG000|Overall Study|Protocol Violation|5|||
143112679|NCT01664949|515953842|FG001|Overall Study|Protocol Violation|5|||
143112680|NCT01664949|515953841|FG000|Overall Study|Other Miscellaneous Reasons|3|||
143112681|NCT01664949|515953842|FG001|Overall Study|Other Miscellaneous Reasons|1|||
143112682|NCT02537431|515953844|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
143112683|NCT03003494|515953845|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
143112684|NCT05238025|515953848|FG000|Overall Study|Adverse Event|2|||
143112685|NCT05238025|515953849|FG001|Overall Study|Adverse Event|2|||
143112686|NCT05238025|515953848|FG000|Overall Study|Lost to Follow-up|334|||
143112687|NCT05238025|515953849|FG001|Overall Study|Lost to Follow-up|339|||
143112688|NCT05238025|515953848|FG000|Overall Study|Withdrawal by Subject|203|||
143112689|NCT05238025|515953849|FG001|Overall Study|Withdrawal by Subject|222|||
143112690|NCT05238025|515953848|FG000|Overall Study|Physician Decision|20|||
143112691|NCT05238025|515953849|FG001|Overall Study|Physician Decision|8|||
143112692|NCT05238025|515953848|FG000|Overall Study|Protocol Violation|6|||
143112693|NCT05238025|515953849|FG001|Overall Study|Protocol Violation|2|||
143112694|NCT05238025|515953848|FG000|Overall Study|Death|38|||
143112695|NCT05238025|515953849|FG001|Overall Study|Death|32|||
143112696|NCT05238025|515953848|FG000|Overall Study|Study terminated by Sponsor|6358|||
143112697|NCT05238025|515953849|FG001|Overall Study|Study terminated by Sponsor|6358|||
143112698|NCT05238025|515953848|FG000|Overall Study|Other Reason|669|||
143112699|NCT05238025|515953849|FG001|Overall Study|Other Reason|690|||
143112700|NCT02278120|515953858|FG000|Treatment Period|Progressive disease|234|||
143258328|NCT01931670|516500555|FG001|Treatment Period|Subject Noncompliant|9|||
143258329|NCT01931670|516500556|FG002|Treatment Period|Subject Noncompliant|5|||
143258330|NCT01931670|516500554|FG000|Treatment Period|Adverse Event|19|||
143258331|NCT01931670|516500555|FG001|Treatment Period|Adverse Event|8|||
143258332|NCT01931670|516500556|FG002|Treatment Period|Adverse Event|21|||
143258333|NCT01931670|516500554|FG000|Treatment Period|Lack of Efficacy|11|||
143258334|NCT01931670|516500555|FG001|Treatment Period|Lack of Efficacy|2|||
143258335|NCT01931670|516500556|FG002|Treatment Period|Lack of Efficacy|2|||
143258336|NCT01931670|516500554|FG000|Treatment Period|Pregnancy|7|||
143258337|NCT01931670|516500555|FG001|Treatment Period|Pregnancy|2|||
143258338|NCT01931670|516500556|FG002|Treatment Period|Pregnancy|0|||
143258339|NCT01931670|516500554|FG000|Treatment Period|Other|8|||
143258340|NCT01931670|516500555|FG001|Treatment Period|Other|7|||
143258341|NCT01931670|516500556|FG002|Treatment Period|Other|2|||
143258342|NCT01931670|516500554|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
143258343|NCT01931670|516500555|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
143258344|NCT01931670|516500556|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
143258345|NCT01931670|516500554|FG000|Treatment Period|Lost to Follow-up|19|||
143258346|NCT01931670|516500555|FG001|Treatment Period|Lost to Follow-up|5|||
143258347|NCT01931670|516500556|FG002|Treatment Period|Lost to Follow-up|7|||
143258348|NCT01931670|516500554|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
143258349|NCT01931670|516500555|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
143258350|NCT01931670|516500556|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
143258351|NCT01931670|516500554|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
143258352|NCT01931670|516500555|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
143258353|NCT01931670|516500556|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
143258354|NCT01931670|516500554|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
143258355|NCT01931670|516500555|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
143258356|NCT01931670|516500556|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
143258357|NCT01931670|516500554|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
143112701|NCT02278120|515953859|FG001|Treatment Period|Progressive disease|260|||
143112702|NCT02278120|515953858|FG000|Treatment Period|Subject/guardian decision|23|||
143258358|NCT01931670|516500555|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
143112703|NCT02278120|515953859|FG001|Treatment Period|Subject/guardian decision|20|||
143112704|NCT02278120|515953858|FG000|Treatment Period|Adverse Event|16|||
143112705|NCT02278120|515953859|FG001|Treatment Period|Adverse Event|14|||
143112706|NCT02278120|515953858|FG000|Treatment Period|Physician Decision|14|||
143258359|NCT01931670|516500556|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
143258360|NCT01931670|516500554|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
143112707|NCT02278120|515953859|FG001|Treatment Period|Physician Decision|27|||
143179881|NCT01070979|516205753|FG001|Overall Study|Adverse Event|3|||
143179882|NCT01070979|516205754|FG002|Overall Study|Adverse Event|3|||
143179883|NCT01070979|516205752|FG000|Overall Study|Lost to Follow-up|2|||
143179884|NCT01070979|516205753|FG001|Overall Study|Lost to Follow-up|1|||
143179885|NCT01070979|516205754|FG002|Overall Study|Lost to Follow-up|1|||
143179886|NCT01070979|516205752|FG000|Overall Study|Protocol Violation|0|||
143179887|NCT01070979|516205753|FG001|Overall Study|Protocol Violation|2|||
143179888|NCT01070979|516205754|FG002|Overall Study|Protocol Violation|6|||
143112708|NCT02278120|515953858|FG000|Treatment Period|Death|3|||
143112709|NCT02278120|515953859|FG001|Treatment Period|Death|3|||
143112710|NCT02278120|515953858|FG000|Treatment Period|Lost to Follow-up|2|||
143112711|NCT02278120|515953859|FG001|Treatment Period|Lost to Follow-up|0|||
143112712|NCT02278120|515953858|FG000|Treatment Period|Protocol deviation|0|||
143112713|NCT02278120|515953859|FG001|Treatment Period|Protocol deviation|2|||
143112714|NCT02278120|515953858|FG000|Treatment Period|Study terminated as per protocol|43|||
143112715|NCT02278120|515953859|FG001|Treatment Period|Study terminated as per protocol|11|||
143112716|NCT02278120|515953858|FG000|Post-treatment Efficacy Follow-up|Death|0|||
143112717|NCT02278120|515953859|FG001|Post-treatment Efficacy Follow-up|Death|1|||
143112718|NCT02278120|515953858|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
143112719|NCT02278120|515953859|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
143112720|NCT02278120|515953858|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
143112721|NCT02278120|515953859|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
143112722|NCT02278120|515953858|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
143112723|NCT02278120|515953859|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
143112724|NCT02278120|515953858|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
143112725|NCT02278120|515953859|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
143112726|NCT03197324|515953860|FG000|Overall Study|Adverse Event|0|||
143112727|NCT03197324|515953861|FG001|Overall Study|Adverse Event|1|||
143112728|NCT02417961|515956293|FG000|Overall Study|Adverse Event|1|||
143112729|NCT02417961|515956293|FG000|Overall Study|Lost to Follow-up|1|||
143112730|NCT02417961|515956293|FG000|Overall Study|Withdrawal by Subject|2|||
143112731|NCT05079750|515956294|FG000|Overall Study|Lost to Follow-up|0|||
143112732|NCT05079750|515956295|FG001|Overall Study|Lost to Follow-up|0|||
143112733|NCT05079750|515956296|FG002|Overall Study|Lost to Follow-up|1|||
143112734|NCT03569293|515956297|FG000|Overall Study|Adverse Event|4|||
143112735|NCT03569293|515956298|FG001|Overall Study|Adverse Event|1|||
143112736|NCT03569293|515956299|FG002|Overall Study|Adverse Event|5|||
143112737|NCT03569293|515956300|FG003|Overall Study|Adverse Event|1|||
143112738|NCT03569293|515956301|FG004|Overall Study|Adverse Event|0|||
143112739|NCT03569293|515956302|FG005|Overall Study|Adverse Event|0|||
143112740|NCT03569293|515956297|FG000|Overall Study|Withdrawal by Subject|16|||
143112741|NCT03569293|515956298|FG001|Overall Study|Withdrawal by Subject|2|||
143112742|NCT03569293|515956299|FG002|Overall Study|Withdrawal by Subject|4|||
143112743|NCT03569293|515956300|FG003|Overall Study|Withdrawal by Subject|1|||
143112744|NCT03569293|515956301|FG004|Overall Study|Withdrawal by Subject|0|||
143112745|NCT03569293|515956302|FG005|Overall Study|Withdrawal by Subject|0|||
143112746|NCT03569293|515956297|FG000|Overall Study|Lost to Follow-up|1|||
143112747|NCT03569293|515956298|FG001|Overall Study|Lost to Follow-up|3|||
143112748|NCT03569293|515956299|FG002|Overall Study|Lost to Follow-up|1|||
143112749|NCT03569293|515956300|FG003|Overall Study|Lost to Follow-up|1|||
143112750|NCT03569293|515956301|FG004|Overall Study|Lost to Follow-up|0|||
143179889|NCT01070979|516205752|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
143179890|NCT01070979|516205753|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
143179891|NCT01070979|516205754|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
143179892|NCT01070979|516205752|FG000|Overall Study|Withdrawal by Subject|3|||
143179893|NCT01070979|516205753|FG001|Overall Study|Withdrawal by Subject|1|||
143179894|NCT01070979|516205754|FG002|Overall Study|Withdrawal by Subject|1|||
143179895|NCT01070979|516205752|FG000|Overall Study|No study drug taken|0|||
143179896|NCT01070979|516205753|FG001|Overall Study|No study drug taken|1|||
143179897|NCT01070979|516205754|FG002|Overall Study|No study drug taken|0|||
143179898|NCT00142792|516205755|FG000|Overall Study|Death|0|||
143179899|NCT00142792|516205756|FG001|Overall Study|Death|0|||
143179900|NCT00142792|516205757|FG002|Overall Study|Death|1|||
143179901|NCT00142792|516205755|FG000|Overall Study|Withdrawal by Subject|3|||
143179902|NCT00142792|516205756|FG001|Overall Study|Withdrawal by Subject|2|||
143179903|NCT00142792|516205757|FG002|Overall Study|Withdrawal by Subject|3|||
143259586|NCT00913692|516505793|FG000|Screening (4 Months)|Physician Decision|3|||
143112751|NCT03569293|515956302|FG005|Overall Study|Lost to Follow-up|0|||
143112752|NCT03569293|515956297|FG000|Overall Study|Other|8|||
143112753|NCT03569293|515956298|FG001|Overall Study|Other|2|||
143112754|NCT03569293|515956299|FG002|Overall Study|Other|1|||
143112755|NCT03569293|515956300|FG003|Overall Study|Other|1|||
143112756|NCT03569293|515956301|FG004|Overall Study|Other|0|||
143112757|NCT03569293|515956302|FG005|Overall Study|Other|0|||
143112758|NCT03569293|515956297|FG000|Overall Study|Ongoing at Time of Analysis|8|||
143112759|NCT03569293|515956298|FG001|Overall Study|Ongoing at Time of Analysis|1|||
143179904|NCT00142792|516205755|FG000|Overall Study|Lost to Follow-up|8|||
143112760|NCT03569293|515956299|FG002|Overall Study|Ongoing at Time of Analysis|3|||
143112761|NCT03569293|515956300|FG003|Overall Study|Ongoing at Time of Analysis|0|||
143112762|NCT03569293|515956301|FG004|Overall Study|Ongoing at Time of Analysis|0|||
143112763|NCT03569293|515956302|FG005|Overall Study|Ongoing at Time of Analysis|0|||
143112764|NCT05072106|515956313|FG000|Overall Study|Progressive disease|3|||
143112765|NCT05072106|515956314|FG001|Overall Study|Progressive disease|3|||
143112766|NCT05072106|515956313|FG000|Overall Study|Compassionate use|3|||
143112767|NCT05072106|515956314|FG001|Overall Study|Compassionate use|1|||
143112768|NCT05072106|515956313|FG000|Overall Study|Withdrawal by Subject|1|||
143112769|NCT05072106|515956314|FG001|Overall Study|Withdrawal by Subject|0|||
143112770|NCT03839459|515956315|FG000|Overall Study|Withdrawal by Subject|2|||
143112771|NCT03839459|515956315|FG000|Overall Study|progression of disease|3|||
143112772|NCT04240886|515956326|FG000|Treatment Phase|Death|4|||
143112773|NCT04240886|515956326|FG000|Treatment Phase|Discontinuation by Subject|1|||
143112774|NCT04240886|515956326|FG000|Treatment Phase|Adverse Event|5|||
143112775|NCT04240886|515956326|FG000|Follow-up Phase|Withdrawal by Subject|1|||
143112776|NCT04240886|515956326|FG000|Follow-up Phase|Discontinuation by Subject|1|||
143112777|NCT04240886|515956326|FG000|Follow-up Phase|Death|2|||
143112778|NCT02276053|515956329|FG000|Overall Study|Death|2|||
143112779|NCT02276053|515956329|FG000|Overall Study|Adverse Event|5|||
143112780|NCT02276053|515956329|FG000|Overall Study|Lack of Efficacy|2|||
143112781|NCT02276053|515956329|FG000|Overall Study|Withdrawal by Subject|1|||
143112782|NCT02276053|515956329|FG000|Overall Study|Patient does not meet selection criteria|3|||
143112783|NCT02276053|515956329|FG000|Overall Study|Patient needs to increase baseline AED|1|||
143112784|NCT01632904|515956330|FG000|Overall Study|Adverse Event|4|||
143112785|NCT01632904|515956331|FG001|Overall Study|Adverse Event|1|||
143112786|NCT01632904|515956330|FG000|Overall Study|Physician Decision|0|||
143112787|NCT01632904|515956331|FG001|Overall Study|Physician Decision|1|||
143112788|NCT01632904|515956330|FG000|Overall Study|Subject decision|3|||
143112789|NCT01632904|515956331|FG001|Overall Study|Subject decision|2|||
143112790|NCT01632904|515956330|FG000|Overall Study|Disease Progression|0|||
143112791|NCT01632904|515956331|FG001|Overall Study|Disease Progression|1|||
143112792|NCT01632904|515956330|FG000|Overall Study|Reason for discontinuation not available|0|||
143112793|NCT01632904|515956331|FG001|Overall Study|Reason for discontinuation not available|1|||
143112794|NCT04743804|515956332|FG000|Overall Study|Other|1|||
143112795|NCT04743804|515956333|FG001|Overall Study|Other|0|||
143112796|NCT04743804|515956332|FG000|Overall Study|Withdrawal by Subject|0|||
143112797|NCT04743804|515956333|FG001|Overall Study|Withdrawal by Subject|1|||
143112798|NCT04743804|515956332|FG000|Overall Study|Study Terminated by Sponsor|1|||
143112799|NCT04743804|515956333|FG001|Overall Study|Study Terminated by Sponsor|4|||
143112800|NCT04743804|515956332|FG000|Overall Study|Physician Decision|0|||
143112801|NCT04743804|515956333|FG001|Overall Study|Physician Decision|1|||
143112802|NCT04743804|515956332|FG000|Overall Study|Death|3|||
143112803|NCT04743804|515956333|FG001|Overall Study|Death|0|||
143112804|NCT01944670|515956339|FG000|Overall Study|Lost to Follow-up|2|||
143112805|NCT04542499|515956351|FG000|Overall Study|Adverse Event|23|||
143112806|NCT04542499|515956352|FG001|Overall Study|Adverse Event|43|||
143112807|NCT04542499|515956351|FG000|Overall Study|Lack of Efficacy|5|||
143112808|NCT04542499|515956352|FG001|Overall Study|Lack of Efficacy|2|||
143112809|NCT04542499|515956351|FG000|Overall Study|Lost to Follow-up|3|||
143112810|NCT04542499|515956352|FG001|Overall Study|Lost to Follow-up|4|||
143112811|NCT04542499|515956351|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
143112812|NCT04542499|515956352|FG001|Overall Study|Failure to Meet Continuation Criteria|1|||
143112813|NCT04542499|515956351|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
143112814|NCT04542499|515956352|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
143112815|NCT04542499|515956351|FG000|Overall Study|Non-Compliance with Study Drug|0|||
143112816|NCT04542499|515956352|FG001|Overall Study|Non-Compliance with Study Drug|2|||
143112817|NCT04542499|515956351|FG000|Overall Study|Physician Decision|0|||
143112818|NCT04542499|515956352|FG001|Overall Study|Physician Decision|1|||
143112819|NCT04542499|515956351|FG000|Overall Study|Site Terminated by Sponsor|3|||
143112820|NCT04542499|515956352|FG001|Overall Study|Site Terminated by Sponsor|5|||
143112821|NCT04542499|515956351|FG000|Overall Study|Withdrawal by Subject|12|||
143112822|NCT04542499|515956352|FG001|Overall Study|Withdrawal by Subject|33|||
143258361|NCT01931670|516500555|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
143112823|NCT04542499|515956351|FG000|Overall Study|Other|2|||
143112824|NCT04542499|515956352|FG001|Overall Study|Other|2|||
143112825|NCT04488497|515956355|FG000|Randomization/Baseline Assessment|Lost to Follow-up|2|||
143112826|NCT04488497|515956356|FG001|Randomization/Baseline Assessment|Lost to Follow-up|3|||
143112827|NCT04488497|515956355|FG000|Intervention|Physician Decision|2|||
143112828|NCT04488497|515956356|FG001|Intervention|Physician Decision|1|||
143112829|NCT04488497|515956355|FG000|Intervention|Withdrawal by Subject|5|||
143112830|NCT04488497|515956356|FG001|Intervention|Withdrawal by Subject|6|||
143112831|NCT04488497|515956355|FG000|Intervention|Lost to Follow-up|2|||
143112832|NCT04488497|515956356|FG001|Intervention|Lost to Follow-up|0|||
143112833|NCT04488497|515956355|FG000|1-Week Post-Intervention Data Collection|Lost to Follow-up|0|||
143112834|NCT04488497|515956356|FG001|1-Week Post-Intervention Data Collection|Lost to Follow-up|2|||
143258362|NCT01931670|516500556|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
143258363|NCT01931670|516500554|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
143112835|NCT04488497|515956355|FG000|3-Months Post-Intervention|Lost to Follow-up|0|||
143112836|NCT04488497|515956356|FG001|3-Months Post-Intervention|Lost to Follow-up|2|||
143112837|NCT04063657|515956362|FG000|Overall Study|Lost to Follow-up|1|||
143112838|NCT04063657|515956363|FG001|Overall Study|Lost to Follow-up|0|||
143112839|NCT04430738|515956364|FG000|Phase 1: Dose Escalation|Death|1|||
143112840|NCT04430738|515956365|FG001|Phase 1: Dose Escalation|Death|4|||
143112841|NCT04430738|515956366|FG002|Phase 1: Dose Escalation|Death|4|||
143112842|NCT04430738|515956367|FG003|Phase 1: Dose Escalation|Death|1|||
143112843|NCT04430738|515956368|FG004|Phase 1: Dose Escalation|Death|6|||
143112844|NCT04430738|515956369|FG005|Phase 1: Dose Escalation|Death|0|||
143112845|NCT04430738|515956364|FG000|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
143112846|NCT04430738|515956365|FG001|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
143112847|NCT04430738|515956366|FG002|Phase 1: Dose Escalation|Participation terminated by sponsor|3|||
143112848|NCT04430738|515956367|FG003|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
143112849|NCT04430738|515956368|FG004|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
143112850|NCT04430738|515956369|FG005|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
143112851|NCT04430738|515956364|FG000|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
143112852|NCT04430738|515956365|FG001|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
143112853|NCT04430738|515956366|FG002|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
143112854|NCT04430738|515956367|FG003|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
143112855|NCT04430738|515956368|FG004|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
143112856|NCT04430738|515956369|FG005|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
143112857|NCT04430738|515956364|FG000|Phase 1: Dose Escalation|Other|1|||
143112858|NCT04430738|515956365|FG001|Phase 1: Dose Escalation|Other|0|||
143112859|NCT04430738|515956366|FG002|Phase 1: Dose Escalation|Other|0|||
143112860|NCT04430738|515956367|FG003|Phase 1: Dose Escalation|Other|0|||
143112861|NCT04430738|515956368|FG004|Phase 1: Dose Escalation|Other|0|||
143112862|NCT04430738|515956369|FG005|Phase 1: Dose Escalation|Other|0|||
143112863|NCT04430738|515956364|FG000|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
143112864|NCT04430738|515956365|FG001|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
143112865|NCT04430738|515956366|FG002|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
143112866|NCT04430738|515956367|FG003|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
143112867|NCT04430738|515956368|FG004|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
143112868|NCT04430738|515956369|FG005|Phase 1: Dose Expansion|Participation terminated by sponsor|3|||
143112869|NCT04430738|515956364|FG000|Phase 1: Dose Expansion|Continuing to LTEP|0|||
143112870|NCT04430738|515956365|FG001|Phase 1: Dose Expansion|Continuing to LTEP|0|||
143112871|NCT04430738|515956366|FG002|Phase 1: Dose Expansion|Continuing to LTEP|0|||
143112872|NCT04430738|515956367|FG003|Phase 1: Dose Expansion|Continuing to LTEP|0|||
143112873|NCT04430738|515956368|FG004|Phase 1: Dose Expansion|Continuing to LTEP|0|||
143112874|NCT04430738|515956369|FG005|Phase 1: Dose Expansion|Continuing to LTEP|2|||
143112875|NCT04777201|515956379|FG000|Main Study|Withdrawal by Subject|19|||
143112876|NCT04777201|515956380|FG001|Main Study|Withdrawal by Subject|27|||
143112877|NCT04777201|515956381|FG002|Main Study|Withdrawal by Subject|0|||
143112878|NCT04777201|515956379|FG000|Main Study|Death|13|||
143112879|NCT04777201|515956380|FG001|Main Study|Death|27|||
143112880|NCT04777201|515956381|FG002|Main Study|Death|0|||
143112881|NCT04777201|515956379|FG000|Main Study|Subject missed the safety follow-up visit|9|||
143112882|NCT04777201|515956380|FG001|Main Study|Subject missed the safety follow-up visit|10|||
143112883|NCT04777201|515956381|FG002|Main Study|Subject missed the safety follow-up visit|0|||
143112884|NCT04777201|515956379|FG000|Main Study|Physician Decision|8|||
143112885|NCT04777201|515956380|FG001|Main Study|Physician Decision|10|||
143112886|NCT04777201|515956381|FG002|Main Study|Physician Decision|0|||
143112887|NCT04777201|515956379|FG000|Main Study|Adverse Event|8|||
143112888|NCT04777201|515956380|FG001|Main Study|Adverse Event|8|||
143112889|NCT04777201|515956381|FG002|Main Study|Adverse Event|0|||
143112890|NCT04777201|515956379|FG000|Main Study|Lost to Follow-up|9|||
143112891|NCT04777201|515956380|FG001|Main Study|Lost to Follow-up|4|||
143112892|NCT04777201|515956381|FG002|Main Study|Lost to Follow-up|0|||
143112893|NCT04777201|515956379|FG000|Main Study|Reason not specified|3|||
143112894|NCT04777201|515956380|FG001|Main Study|Reason not specified|3|||
143112895|NCT04777201|515956381|FG002|Main Study|Reason not specified|0|||
143112896|NCT04777201|515956379|FG000|Main Study|Lack of Efficacy|1|||
143112897|NCT04777201|515956380|FG001|Main Study|Lack of Efficacy|1|||
143112898|NCT04777201|515956381|FG002|Main Study|Lack of Efficacy|0|||
143112899|NCT04777201|515956379|FG000|Main Study|Protocol Violation|1|||
143112900|NCT04777201|515956380|FG001|Main Study|Protocol Violation|0|||
143112901|NCT04777201|515956381|FG002|Main Study|Protocol Violation|0|||
143112902|NCT04777201|515956379|FG000|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
143112903|NCT04777201|515956380|FG001|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
143112904|NCT04777201|515956381|FG002|Substudy (Concurrent With Main Study)|Withdrawal by Subject|4|||
143258364|NCT01931670|516500555|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
143258365|NCT01931670|516500556|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
143258366|NCT00976508|516500558|FG000|Overall Study|Death|7|||
143258367|NCT00976508|516500559|FG001|Overall Study|Death|1|||
143112905|NCT04777201|515956379|FG000|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
143112906|NCT04777201|515956380|FG001|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
143112907|NCT04777201|515956381|FG002|Substudy (Concurrent With Main Study)|Prohibited Medication|2|||
143112908|NCT04777201|515956379|FG000|Substudy (Concurrent With Main Study)|Adverse Event|0|||
143112909|NCT04777201|515956380|FG001|Substudy (Concurrent With Main Study)|Adverse Event|0|||
143112910|NCT04777201|515956381|FG002|Substudy (Concurrent With Main Study)|Adverse Event|1|||
143112911|NCT04777201|515956379|FG000|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
143112912|NCT04777201|515956380|FG001|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
143112913|NCT04777201|515956381|FG002|Substudy (Concurrent With Main Study)|Cataract Surgery|1|||
143112914|NCT04777201|515956379|FG000|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
143112915|NCT04777201|515956380|FG001|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
143112916|NCT04777201|515956381|FG002|Substudy (Concurrent With Main Study)|Lost to Follow-up|1|||
143112917|NCT04777201|515956379|FG000|Substudy (Concurrent With Main Study)|Physician Decision|0|||
143112918|NCT04777201|515956380|FG001|Substudy (Concurrent With Main Study)|Physician Decision|0|||
143112919|NCT04777201|515956381|FG002|Substudy (Concurrent With Main Study)|Physician Decision|1|||
143112920|NCT02659514|515956386|FG000|Overall Study|Adverse Event|3|||
143112921|NCT02659514|515956387|FG001|Overall Study|Adverse Event|12|||
143112922|NCT02659514|515956386|FG000|Overall Study|Disease Progression|23|||
143112923|NCT02659514|515956387|FG001|Overall Study|Disease Progression|13|||
143112924|NCT02659514|515956386|FG000|Overall Study|Withdrawal by Subject|0|||
143112925|NCT02659514|515956387|FG001|Overall Study|Withdrawal by Subject|4|||
143112926|NCT02659514|515956386|FG000|Overall Study|Lost to Follow-up|0|||
143112927|NCT02659514|515956387|FG001|Overall Study|Lost to Follow-up|1|||
143112928|NCT02659514|515956386|FG000|Overall Study|Death|6|||
143112929|NCT02659514|515956387|FG001|Overall Study|Death|1|||
143112930|NCT02659514|515956386|FG000|Overall Study|Reason Unspecified|0|||
143112931|NCT02659514|515956387|FG001|Overall Study|Reason Unspecified|3|||
143112932|NCT02275780|515956390|FG000|Base Study: 96 Weeks|Adverse Event|6|||
143112933|NCT02275780|515956391|FG001|Base Study: 96 Weeks|Adverse Event|14|||
143112934|NCT02275780|515956390|FG000|Base Study: 96 Weeks|Death|3|||
143112935|NCT02275780|515956391|FG001|Base Study: 96 Weeks|Death|1|||
143112936|NCT02275780|515956390|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
143112937|NCT02275780|515956391|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
143112938|NCT02275780|515956390|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
143112939|NCT02275780|515956391|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
143112940|NCT02275780|515956390|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
143112941|NCT02275780|515956391|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
143112942|NCT02275780|515956390|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
143112943|NCT02275780|515956391|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
143112944|NCT02275780|515956390|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
143112945|NCT02275780|515956391|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
143112946|NCT02275780|515956390|FG000|Base Study: 96 Weeks|Physician Decision|2|||
143112947|NCT02275780|515956391|FG001|Base Study: 96 Weeks|Physician Decision|4|||
143258368|NCT00976508|516500558|FG000|Overall Study|Lost to Follow-up|1|||
143258369|NCT00976508|516500559|FG001|Overall Study|Lost to Follow-up|0|||
143258370|NCT00976508|516500558|FG000|Overall Study|Withdrawal by Subject|1|||
143258371|NCT00976508|516500559|FG001|Overall Study|Withdrawal by Subject|0|||
143258372|NCT00976508|516500558|FG000|Overall Study|Disease Progression|4|||
143258373|NCT00976508|516500559|FG001|Overall Study|Disease Progression|4|||
143258374|NCT00976508|516500558|FG000|Overall Study|Subject Enrolled in Hospice|1|||
143112948|NCT02275780|515956390|FG000|Base Study: 96 Weeks|Pregnancy|2|||
143112949|NCT02275780|515956391|FG001|Base Study: 96 Weeks|Pregnancy|1|||
143112950|NCT02275780|515956390|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
143112951|NCT02275780|515956391|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
143112952|NCT02275780|515956390|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
143112953|NCT02275780|515956391|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
143112954|NCT02275780|515956390|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
143112955|NCT02275780|515956391|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
143112956|NCT02275780|515956390|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
143112957|NCT02275780|515956391|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
143112958|NCT02275780|515956390|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
143112959|NCT02275780|515956391|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
143258375|NCT00976508|516500559|FG001|Overall Study|Subject Enrolled in Hospice|0|||
143258376|NCT00976508|516500558|FG000|Overall Study|Terminated by the Sponsor|0|||
143258377|NCT00976508|516500559|FG001|Overall Study|Terminated by the Sponsor|1|||
143112960|NCT02275780|515956390|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
143112961|NCT02275780|515956391|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
143112962|NCT02275780|515956390|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
143112963|NCT02275780|515956391|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
143112964|NCT02275780|515956390|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
143112965|NCT02275780|515956391|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
143112966|NCT02275780|515956390|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
143112967|NCT02275780|515956391|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
143112968|NCT02275780|515956390|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
143112969|NCT02275780|515956391|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
143112970|NCT02275780|515956390|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
143112971|NCT02275780|515956391|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
143112972|NCT02275780|515956390|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
143112973|NCT02275780|515956391|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
143112974|NCT02275780|515956390|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
143112975|NCT02275780|515956391|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
143112976|NCT02275780|515956390|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
143112977|NCT02275780|515956391|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
143112978|NCT02275780|515956390|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
143112979|NCT02275780|515956391|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
143112980|NCT02275780|515956390|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
143112981|NCT02275780|515956391|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
143112982|NCT02275780|515956390|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
143112983|NCT02275780|515956391|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
143112984|NCT02275780|515956390|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
143112985|NCT02275780|515956391|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
143112986|NCT02275780|515956390|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
143112987|NCT02275780|515956391|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
143112988|NCT02275780|515956390|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
143112989|NCT02275780|515956391|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
143112990|NCT02275780|515956390|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
143112991|NCT02275780|515956391|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
143112992|NCT02275780|515956390|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
143258378|NCT04352127|516500560|FG000|Overall Study|Unable to obtain readings|4|||
143258379|NCT04352127|516500561|FG001|Overall Study|Unable to obtain readings|1|||
143258380|NCT01992159|516500562|FG000|Overall Study|Withdrawal by Subject|4|||
143258381|NCT01992159|516500563|FG001|Overall Study|Withdrawal by Subject|7|||
143258382|NCT01992159|516500564|FG002|Overall Study|Withdrawal by Subject|0|||
143258383|NCT01992159|516500565|FG003|Overall Study|Withdrawal by Subject|3|||
143258384|NCT01992159|516500562|FG000|Overall Study|Adverse Event|0|||
143258385|NCT01992159|516500563|FG001|Overall Study|Adverse Event|1|||
143258386|NCT01992159|516500564|FG002|Overall Study|Adverse Event|0|||
143258387|NCT01992159|516500565|FG003|Overall Study|Adverse Event|1|||
143258388|NCT01992159|516500562|FG000|Overall Study|Death|0|||
143258389|NCT01992159|516500563|FG001|Overall Study|Death|0|||
143258390|NCT01992159|516500564|FG002|Overall Study|Death|1|||
143258391|NCT01992159|516500565|FG003|Overall Study|Death|0|||
143258392|NCT03023046|516500569|FG000|Overall Study|Withdrawal by Subject|1|||
143258393|NCT01205581|516500570|FG000|Overall Study|Withdrawal by Subject|1|||
143258394|NCT01205581|516500571|FG001|Overall Study|Withdrawal by Subject|0|||
143258395|NCT01205581|516500572|FG002|Overall Study|Withdrawal by Subject|0|||
143258396|NCT01205581|516500573|FG003|Overall Study|Withdrawal by Subject|0|||
143112993|NCT02275780|515956391|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
143112994|NCT01054300|515956392|FG000|Period 1|Adverse Event|1|||
143112995|NCT01054300|515956393|FG001|Period 1|Adverse Event|0|||
143112996|NCT01054300|515956394|FG002|Period 1|Adverse Event|0|||
143112997|NCT01054300|515956395|FG003|Period 1|Adverse Event|0|||
143112998|NCT01054300|515956392|FG000|Period 2|Withdrawal by Subject|0|||
143112999|NCT01054300|515956393|FG001|Period 2|Withdrawal by Subject|0|||
143113000|NCT01054300|515956394|FG002|Period 2|Withdrawal by Subject|1|||
143258397|NCT01205581|516500574|FG004|Overall Study|Withdrawal by Subject|0|||
143258398|NCT01205581|516500575|FG005|Overall Study|Withdrawal by Subject|0|||
143258399|NCT01236118|516500576|FG000|Overall Study|Adverse Event|2|||
143258400|NCT01236118|516500577|FG001|Overall Study|Adverse Event|0|||
143258401|NCT01236118|516500578|FG002|Overall Study|Adverse Event|2|||
143258402|NCT01236118|516500576|FG000|Overall Study|Physician Decision|0|||
143258403|NCT01236118|516500577|FG001|Overall Study|Physician Decision|1|||
143258404|NCT01236118|516500578|FG002|Overall Study|Physician Decision|0|||
143258405|NCT01236118|516500576|FG000|Overall Study|Withdrawal by Subject|0|||
143258406|NCT01236118|516500577|FG001|Overall Study|Withdrawal by Subject|0|||
143258407|NCT01236118|516500578|FG002|Overall Study|Withdrawal by Subject|1|||
143258408|NCT04535167|516500579|FG000|Treatment|Adverse Event|0|||
143258409|NCT04535167|516500580|FG001|Treatment|Adverse Event|0|||
143179905|NCT00142792|516205756|FG001|Overall Study|Lost to Follow-up|11|||
143179906|NCT00142792|516205757|FG002|Overall Study|Lost to Follow-up|7|||
143179907|NCT00142792|516205755|FG000|Overall Study|No category|1|||
143179908|NCT00142792|516205756|FG001|Overall Study|No category|2|||
143179909|NCT00142792|516205757|FG002|Overall Study|No category|1|||
143179910|NCT03484429|516205759|FG000|Overall Study|Withdrawal by Subject|1|||
143179911|NCT03484429|516205760|FG001|Overall Study|Withdrawal by Subject|0|||
143179912|NCT03484429|516205759|FG000|Overall Study|Adverse Event|2|||
143179913|NCT03484429|516205760|FG001|Overall Study|Adverse Event|0|||
143179914|NCT04466384|516205761|FG000|First Phase|Protocol Violation|1|||
143179915|NCT04466384|516205762|FG001|First Phase|Protocol Violation|0|||
143179916|NCT04466384|516205761|FG000|First Phase|Missing data|1|||
143179917|NCT04466384|516205762|FG001|First Phase|Missing data|0|||
143179918|NCT04466384|516205761|FG000|Cross Over Phase|Physician Decision|1|||
143179919|NCT04466384|516205762|FG001|Cross Over Phase|Physician Decision|0|||
143179920|NCT04466384|516205761|FG000|Cross Over Phase|Withdrawal by Subject|0|||
143179921|NCT04466384|516205762|FG001|Cross Over Phase|Withdrawal by Subject|1|||
143179922|NCT04162470|516205765|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
143179923|NCT04570384|516205766|FG000|Overall Study|Adverse Event|2|||
143179924|NCT04570384|516205767|FG001|Overall Study|Adverse Event|1|||
143179925|NCT04570384|516205766|FG000|Overall Study|Death|2|||
143179926|NCT04570384|516205767|FG001|Overall Study|Death|5|||
143179927|NCT04570384|516205766|FG000|Overall Study|Lost to Follow-up|1|||
143179928|NCT04570384|516205767|FG001|Overall Study|Lost to Follow-up|0|||
143179929|NCT04570384|516205766|FG000|Overall Study|Other|1|||
143179930|NCT04570384|516205767|FG001|Overall Study|Other|0|||
143179931|NCT04570384|516205766|FG000|Overall Study|Protocol Violation|0|||
143179932|NCT04570384|516205767|FG001|Overall Study|Protocol Violation|1|||
143179933|NCT04570384|516205766|FG000|Overall Study|Sponsor Decision|1|||
143179934|NCT04570384|516205767|FG001|Overall Study|Sponsor Decision|0|||
143179935|NCT04570384|516205766|FG000|Overall Study|Withdrawal by Subject|4|||
143179936|NCT04570384|516205767|FG001|Overall Study|Withdrawal by Subject|2|||
143179937|NCT04749745|516205769|FG000|Overall Study|Withdrawal by Subject|1|||
143179938|NCT04749745|516205770|FG001|Overall Study|Withdrawal by Subject|0|||
143179939|NCT01365455|516205773|FG000|Induction Period|Adverse Event|5|||
143179940|NCT01365455|516205774|FG001|Induction Period|Adverse Event|3|||
143179941|NCT01365455|516205775|FG002|Induction Period|Adverse Event|4|||
143179942|NCT01365455|516205776|FG003|Induction Period|Adverse Event|0|||
143179943|NCT01365455|516205777|FG004|Induction Period|Adverse Event|0|||
143179944|NCT01365455|516205773|FG000|Induction Period|Lack of Efficacy|1|||
143179945|NCT01365455|516205774|FG001|Induction Period|Lack of Efficacy|1|||
143179946|NCT01365455|516205775|FG002|Induction Period|Lack of Efficacy|0|||
143179947|NCT01365455|516205776|FG003|Induction Period|Lack of Efficacy|0|||
143179948|NCT01365455|516205777|FG004|Induction Period|Lack of Efficacy|0|||
143179949|NCT01365455|516205773|FG000|Induction Period|Pregnancy|0|||
143179950|NCT01365455|516205774|FG001|Induction Period|Pregnancy|1|||
143179951|NCT01365455|516205775|FG002|Induction Period|Pregnancy|0|||
143179952|NCT01365455|516205776|FG003|Induction Period|Pregnancy|0|||
143179953|NCT01365455|516205777|FG004|Induction Period|Pregnancy|0|||
143179954|NCT01365455|516205773|FG000|Induction Period|Protocol deviation|0|||
143179955|NCT01365455|516205774|FG001|Induction Period|Protocol deviation|1|||
143179956|NCT01365455|516205775|FG002|Induction Period|Protocol deviation|1|||
143179957|NCT01365455|516205776|FG003|Induction Period|Protocol deviation|0|||
143179958|NCT01365455|516205777|FG004|Induction Period|Protocol deviation|0|||
143179959|NCT01365455|516205773|FG000|Induction Period|Subject/guardian decision|9|||
143179960|NCT01365455|516205774|FG001|Induction Period|Subject/guardian decision|1|||
143179961|NCT01365455|516205775|FG002|Induction Period|Subject/guardian decision|8|||
143179962|NCT01365455|516205776|FG003|Induction Period|Subject/guardian decision|0|||
143179963|NCT01365455|516205777|FG004|Induction Period|Subject/guardian decision|0|||
143179964|NCT01365455|516205773|FG000|Induction Period|Lost to Follow-up|0|||
143179965|NCT01365455|516205774|FG001|Induction Period|Lost to Follow-up|0|||
143179966|NCT01365455|516205775|FG002|Induction Period|Lost to Follow-up|3|||
143179967|NCT01365455|516205776|FG003|Induction Period|Lost to Follow-up|0|||
143179968|NCT01365455|516205777|FG004|Induction Period|Lost to Follow-up|0|||
143179969|NCT01365455|516205773|FG000|Maintenance Period|Adverse Event|12|||
143179970|NCT01365455|516205774|FG001|Maintenance Period|Adverse Event|5|||
143179971|NCT01365455|516205775|FG002|Maintenance Period|Adverse Event|1|||
143179972|NCT01365455|516205776|FG003|Maintenance Period|Adverse Event|2|||
143179973|NCT01365455|516205777|FG004|Maintenance Period|Adverse Event|4|||
143179974|NCT01365455|516205773|FG000|Maintenance Period|Lack of Efficacy|10|||
143179975|NCT01365455|516205774|FG001|Maintenance Period|Lack of Efficacy|2|||
143179976|NCT01365455|516205775|FG002|Maintenance Period|Lack of Efficacy|0|||
143179977|NCT01365455|516205776|FG003|Maintenance Period|Lack of Efficacy|2|||
143179978|NCT01365455|516205777|FG004|Maintenance Period|Lack of Efficacy|2|||
143179979|NCT01365455|516205773|FG000|Maintenance Period|Lost to Follow-up|2|||
143179980|NCT01365455|516205774|FG001|Maintenance Period|Lost to Follow-up|4|||
143179981|NCT01365455|516205775|FG002|Maintenance Period|Lost to Follow-up|0|||
143179982|NCT01365455|516205776|FG003|Maintenance Period|Lost to Follow-up|0|||
143179983|NCT01365455|516205777|FG004|Maintenance Period|Lost to Follow-up|3|||
143258410|NCT04535167|516500581|FG002|Treatment|Adverse Event|0|||
143258411|NCT04535167|516500582|FG003|Treatment|Adverse Event|0|||
143258412|NCT04535167|516500583|FG004|Treatment|Adverse Event|0|||
143258413|NCT04535167|516500584|FG005|Treatment|Adverse Event|0|||
143258414|NCT04535167|516500585|FG006|Treatment|Adverse Event|1|||
143258415|NCT04535167|516500579|FG000|Follow-Up|Death|0|||
143258416|NCT04535167|516500580|FG001|Follow-Up|Death|0|||
143258417|NCT04535167|516500581|FG002|Follow-Up|Death|0|||
143258418|NCT04535167|516500582|FG003|Follow-Up|Death|0|||
143258419|NCT04535167|516500583|FG004|Follow-Up|Death|0|||
143258420|NCT04535167|516500584|FG005|Follow-Up|Death|0|||
143258421|NCT04535167|516500585|FG006|Follow-Up|Death|1|||
143258422|NCT04535167|516500579|FG000|Follow-Up|Lost to Follow-up|0|||
143258423|NCT04535167|516500580|FG001|Follow-Up|Lost to Follow-up|0|||
143258424|NCT04535167|516500581|FG002|Follow-Up|Lost to Follow-up|0|||
143258425|NCT04535167|516500582|FG003|Follow-Up|Lost to Follow-up|1|||
143258426|NCT04535167|516500583|FG004|Follow-Up|Lost to Follow-up|0|||
143258427|NCT04535167|516500584|FG005|Follow-Up|Lost to Follow-up|0|||
143258428|NCT04535167|516500585|FG006|Follow-Up|Lost to Follow-up|0|||
143258429|NCT00075270|516500586|FG000|Overall Study|Withdrawal by Subject|28|||
143258430|NCT00075270|516500587|FG001|Overall Study|Withdrawal by Subject|21|||
143258431|NCT00075270|516500586|FG000|Overall Study|Lost to Follow-up|25|||
143258432|NCT00075270|516500587|FG001|Overall Study|Lost to Follow-up|28|||
143258433|NCT00075270|516500586|FG000|Overall Study|Protocol Violation|0|||
143258434|NCT00075270|516500587|FG001|Overall Study|Protocol Violation|2|||
143258435|NCT00075270|516500586|FG000|Overall Study|Death|198|||
143258436|NCT00075270|516500587|FG001|Overall Study|Death|215|||
143258437|NCT00075270|516500586|FG000|Overall Study|Other/Unknown|9|||
143258438|NCT00075270|516500587|FG001|Overall Study|Other/Unknown|5|||
143258439|NCT00075270|516500586|FG000|Overall Study|Missing|26|||
143258440|NCT00075270|516500587|FG001|Overall Study|Missing|13|||
143258441|NCT02160002|516500588|FG000|Overall Study|Withdrawal by Subject|2|||
143258442|NCT02160002|516500589|FG001|Overall Study|Withdrawal by Subject|1|||
143258443|NCT00713310|516500594|FG000|Overall Study|Adverse Event|5|||
143258444|NCT00713310|516500595|FG001|Overall Study|Adverse Event|2|||
143258445|NCT00713310|516500594|FG000|Overall Study|Lack of Efficacy|0|||
143258446|NCT00713310|516500595|FG001|Overall Study|Lack of Efficacy|2|||
143258447|NCT00713310|516500594|FG000|Overall Study|Withdrawal by Subject|0|||
143258448|NCT00713310|516500595|FG001|Overall Study|Withdrawal by Subject|2|||
143258449|NCT05508074|516500598|FG000|Overall Study|Death|2|||
143258450|NCT05508074|516500599|FG001|Overall Study|Death|5|||
143258451|NCT05508074|516500598|FG000|Overall Study|Withdrawal by Subject|1|||
143258452|NCT05508074|516500599|FG001|Overall Study|Withdrawal by Subject|2|||
143258453|NCT05508074|516500598|FG000|Overall Study|Adverse Event|0|||
143258454|NCT05508074|516500599|FG001|Overall Study|Adverse Event|1|||
143258455|NCT05508074|516500598|FG000|Overall Study|Physician Decision|0|||
143258456|NCT05508074|516500599|FG001|Overall Study|Physician Decision|1|||
143258457|NCT05508074|516500598|FG000|Overall Study|wrongly randomized|0|||
143258458|NCT05508074|516500599|FG001|Overall Study|wrongly randomized|1|||
143258459|NCT05508074|516500598|FG000|Overall Study|non-compliance|0|||
143258460|NCT05508074|516500599|FG001|Overall Study|non-compliance|1|||
143258461|NCT05028361|516500600|FG000|Overall Study|Withdrawal by Subject|1|||
143258462|NCT05028361|516500601|FG001|Overall Study|Withdrawal by Subject|0|||
143258463|NCT01993836|516500604|FG000|Overall Study|Surgery Cancelled|3|||
143258464|NCT01993836|516500605|FG001|Overall Study|Surgery Cancelled|0|||
143258465|NCT01993836|516500606|FG002|Overall Study|Surgery Cancelled|0|||
143258466|NCT01993836|516500604|FG000|Overall Study|Physician Decision|2|||
143258467|NCT01993836|516500605|FG001|Overall Study|Physician Decision|1|||
143258468|NCT01993836|516500606|FG002|Overall Study|Physician Decision|0|||
143258469|NCT01993836|516500604|FG000|Overall Study|Death|0|||
143258470|NCT01993836|516500605|FG001|Overall Study|Death|2|||
143258471|NCT01993836|516500606|FG002|Overall Study|Death|0|||
143258472|NCT01993836|516500604|FG000|Overall Study|Withdrawal by Subject|12|||
143258473|NCT01993836|516500605|FG001|Overall Study|Withdrawal by Subject|10|||
143258474|NCT01993836|516500606|FG002|Overall Study|Withdrawal by Subject|5|||
143258475|NCT00686634|516500610|FG000|Overall Study|Protocol Violation|6|||
143258476|NCT02047318|516500613|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
143258477|NCT02047318|516500613|FG000|Core Study Period|Adverse Event|1|||
143258478|NCT02047318|516500613|FG000|Core Study Period|Withdrawal by caregiver|3|||
143258479|NCT02047318|516500613|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
143258480|NCT02296138|516500614|FG000|Overall Study|Adverse Event|348|||
143258481|NCT02296138|516500615|FG001|Overall Study|Adverse Event|259|||
143258482|NCT02296138|516500614|FG000|Overall Study|Lack of Efficacy|59|||
143258483|NCT02296138|516500615|FG001|Overall Study|Lack of Efficacy|37|||
143258484|NCT02296138|516500614|FG000|Overall Study|Protocol Violation|35|||
143258485|NCT02296138|516500615|FG001|Overall Study|Protocol Violation|36|||
143258486|NCT02296138|516500614|FG000|Overall Study|Lost to Follow-up|9|||
143258487|NCT02296138|516500615|FG001|Overall Study|Lost to Follow-up|12|||
143258488|NCT02296138|516500614|FG000|Overall Study|Withdrawal by Subject|184|||
143258489|NCT02296138|516500615|FG001|Overall Study|Withdrawal by Subject|131|||
143258490|NCT02296138|516500614|FG000|Overall Study|Not Treated|1|||
143258491|NCT02296138|516500615|FG001|Overall Study|Not Treated|1|||
143113001|NCT01054300|515956395|FG003|Period 2|Withdrawal by Subject|0|||
143113002|NCT04186806|515956399|FG000|Period 1: 7 Days|Adverse Event|1|||
143113003|NCT04186806|515956400|FG001|Period 1: 7 Days|Adverse Event|0|||
143113004|NCT00597506|515956401|FG000|Overall Study|Subject is being followed for survival|1|||
143258492|NCT02296138|516500614|FG000|Overall Study|Patients with data irregularities|10|||
143258493|NCT02296138|516500615|FG001|Overall Study|Patients with data irregularities|11|||
143258494|NCT02296138|516500614|FG000|Overall Study|Other than specified|15|||
143258495|NCT02296138|516500615|FG001|Overall Study|Other than specified|13|||
143258496|NCT01653132|516500616|FG000|First Intervention|Protocol Violation|1|||
143258497|NCT01653132|516500617|FG001|First Intervention|Protocol Violation|0|||
143258498|NCT02677324|516500618|FG000|Overall Study|Disease Progression|6|||
143258499|NCT02677324|516500618|FG000|Overall Study|Inability to Swallow pills|1|||
143258500|NCT02677324|516500618|FG000|Overall Study|Non-compliance|1|||
143258501|NCT02677324|516500618|FG000|Overall Study|Lack of Efficacy|1|||
143258502|NCT02677324|516500618|FG000|Overall Study|Medical insurance coverage|1|||
143258503|NCT02677324|516500618|FG000|Overall Study|Adverse Event|1|||
143258504|NCT02677324|516500618|FG000|Overall Study|IgM Myeloma diagnosis|1|||
143258505|NCT00761150|516500621|FG000|Open-label Period|Adverse Event|36|||
143258506|NCT00761150|516500622|FG001|Open-label Period|Adverse Event|0|||
143258507|NCT00761150|516500623|FG002|Open-label Period|Adverse Event|0|||
143258508|NCT00761150|516500621|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
143258509|NCT00761150|516500622|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
143258510|NCT00761150|516500623|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
143258511|NCT00761150|516500621|FG000|Open-label Period|Lost to Follow-up|7|||
143258512|NCT00761150|516500622|FG001|Open-label Period|Lost to Follow-up|0|||
143258513|NCT00761150|516500623|FG002|Open-label Period|Lost to Follow-up|0|||
143258514|NCT00761150|516500621|FG000|Open-label Period|Lack of Efficacy|4|||
143113005|NCT01629823|515956403|FG000|Trial Period|Missed visit|11|||
143113006|NCT01629823|515956404|FG001|Trial Period|Missed visit|9|||
143113007|NCT01629823|515956405|FG002|Trial Period|Missed visit|8|||
143113008|NCT01629823|515956403|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
143113009|NCT01629823|515956404|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
143113010|NCT01629823|515956405|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
143113011|NCT01629823|515956403|FG000|Trial Period|Pregnancy|1|||
143113012|NCT01629823|515956404|FG001|Trial Period|Pregnancy|0|||
143113013|NCT01629823|515956405|FG002|Trial Period|Pregnancy|0|||
143113014|NCT01629823|515956403|FG000|Trial Period|Adverse Event|0|||
143113015|NCT01629823|515956404|FG001|Trial Period|Adverse Event|1|||
143113016|NCT01629823|515956405|FG002|Trial Period|Adverse Event|0|||
143113017|NCT01629823|515956403|FG000|Trial Period|Out-of-window visit|0|||
143113018|NCT01629823|515956404|FG001|Trial Period|Out-of-window visit|2|||
143113019|NCT01629823|515956405|FG002|Trial Period|Out-of-window visit|0|||
143113020|NCT01629823|515956403|FG000|Trial Period|Failed to hold medication|0|||
143113021|NCT01629823|515956404|FG001|Trial Period|Failed to hold medication|0|||
143113022|NCT01629823|515956405|FG002|Trial Period|Failed to hold medication|1|||
143113023|NCT01629823|515956403|FG000|Washout Period|Safety|2|||
143113024|NCT01629823|515956404|FG001|Washout Period|Safety|5|||
143113025|NCT01629823|515956405|FG002|Washout Period|Safety|0|||
143113026|NCT01629823|515956403|FG000|Washout Period|Pregnancy|1|||
143113027|NCT01629823|515956404|FG001|Washout Period|Pregnancy|0|||
143113028|NCT01629823|515956405|FG002|Washout Period|Pregnancy|0|||
143113029|NCT01629823|515956403|FG000|Washout Period|Protocol Violation|0|||
143113030|NCT01629823|515956404|FG001|Washout Period|Protocol Violation|1|||
143113031|NCT01629823|515956405|FG002|Washout Period|Protocol Violation|0|||
143113032|NCT01500213|515956406|FG000|Overall Study|Adverse Event|35|||
143113033|NCT01500213|515956407|FG001|Overall Study|Adverse Event|35|||
143113034|NCT01500213|515956406|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
143113035|NCT01500213|515956407|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
143113036|NCT01500213|515956406|FG000|Overall Study|Withdrawal by Subject|28|||
143113037|NCT01500213|515956407|FG001|Overall Study|Withdrawal by Subject|37|||
143113038|NCT01500213|515956406|FG000|Overall Study|Death|7|||
143113039|NCT01500213|515956407|FG001|Overall Study|Death|3|||
143113040|NCT01500213|515956406|FG000|Overall Study|Disease Progression|13|||
143113041|NCT01500213|515956407|FG001|Overall Study|Disease Progression|21|||
143113042|NCT01500213|515956406|FG000|Overall Study|Protocol Violation|19|||
143113043|NCT01500213|515956407|FG001|Overall Study|Protocol Violation|19|||
143113044|NCT01500213|515956406|FG000|Overall Study|Physician Decision|12|||
143113045|NCT01500213|515956407|FG001|Overall Study|Physician Decision|10|||
143113046|NCT01500213|515956406|FG000|Overall Study|Lack of Efficacy|9|||
143113047|NCT01500213|515956407|FG001|Overall Study|Lack of Efficacy|7|||
143113048|NCT01500213|515956406|FG000|Overall Study|Lost to Follow-up|3|||
143113049|NCT01500213|515956407|FG001|Overall Study|Lost to Follow-up|6|||
143113050|NCT01500213|515956406|FG000|Overall Study|Other Reasons|7|||
143258515|NCT00761150|516500622|FG001|Open-label Period|Lack of Efficacy|0|||
143258516|NCT00761150|516500623|FG002|Open-label Period|Lack of Efficacy|0|||
143258517|NCT00761150|516500621|FG000|Open-label Period|Withdrawal by Subject|5|||
143258518|NCT00761150|516500622|FG001|Open-label Period|Withdrawal by Subject|0|||
143258519|NCT00761150|516500623|FG002|Open-label Period|Withdrawal by Subject|0|||
143113051|NCT01500213|515956407|FG001|Overall Study|Other Reasons|5|||
143113052|NCT02386345|515956408|FG000|Overall Study|Not treated|14|||
143113053|NCT02386345|515956408|FG000|Overall Study|Lost to Follow-up|1|||
143113054|NCT02386345|515956408|FG000|Overall Study|Adverse Event|5|||
143113055|NCT02386345|515956408|FG000|Overall Study|Repeat Procedure|10|||
143113056|NCT02386345|515956408|FG000|Overall Study|Did not complete 12-month follow-up|72|||
143113057|NCT02258542|515956409|FG000|Overall Study|eg. not made to the visit|7|||
143113058|NCT02258542|515956410|FG001|Overall Study|eg. not made to the visit|4|||
143113059|NCT02258542|515956411|FG002|Overall Study|eg. not made to the visit|0|||
143113060|NCT02258542|515956412|FG003|Overall Study|eg. not made to the visit|1|||
143113061|NCT02258542|515956409|FG000|Overall Study|study specific discount. criteria|1|||
143113062|NCT02258542|515956410|FG001|Overall Study|study specific discount. criteria|1|||
143113063|NCT02258542|515956411|FG002|Overall Study|study specific discount. criteria|0|||
143113064|NCT02258542|515956412|FG003|Overall Study|study specific discount. criteria|0|||
143113065|NCT02258542|515956409|FG000|Overall Study|Withdrawal by Subject|20|||
143113066|NCT02258542|515956410|FG001|Overall Study|Withdrawal by Subject|20|||
143113067|NCT02258542|515956411|FG002|Overall Study|Withdrawal by Subject|7|||
143113068|NCT02258542|515956412|FG003|Overall Study|Withdrawal by Subject|1|||
143113069|NCT02258542|515956409|FG000|Overall Study|Lost to Follow-up|5|||
143113070|NCT02258542|515956410|FG001|Overall Study|Lost to Follow-up|12|||
143113071|NCT02258542|515956411|FG002|Overall Study|Lost to Follow-up|1|||
143113072|NCT02258542|515956412|FG003|Overall Study|Lost to Follow-up|2|||
143113073|NCT02258542|515956409|FG000|Overall Study|Death|5|||
143113074|NCT02258542|515956410|FG001|Overall Study|Death|4|||
143113075|NCT02258542|515956411|FG002|Overall Study|Death|0|||
143113076|NCT02258542|515956412|FG003|Overall Study|Death|1|||
143113077|NCT02258542|515956409|FG000|Overall Study|Adverse Event|3|||
143113078|NCT02258542|515956410|FG001|Overall Study|Adverse Event|4|||
143113079|NCT02258542|515956411|FG002|Overall Study|Adverse Event|0|||
143113080|NCT02258542|515956412|FG003|Overall Study|Adverse Event|0|||
143113081|NCT02258542|515956409|FG000|Overall Study|Protocol Violation|1|||
143113082|NCT02258542|515956410|FG001|Overall Study|Protocol Violation|2|||
143113083|NCT02258542|515956411|FG002|Overall Study|Protocol Violation|0|||
143113084|NCT02258542|515956412|FG003|Overall Study|Protocol Violation|0|||
143113085|NCT02258542|515956409|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
143113086|NCT02258542|515956410|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
143113087|NCT02258542|515956411|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
143113088|NCT02258542|515956412|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
143113089|NCT00656851|515956420|FG000|Overall Study|Withdrawal by Subject|0|||
143113090|NCT00656851|515956421|FG001|Overall Study|Withdrawal by Subject|4|||
143113091|NCT04713592|515956424|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
143113092|NCT04713592|515956425|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
143113093|NCT04713592|515956426|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
143113094|NCT04713592|515956427|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
143113095|NCT04713592|515956424|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
143113096|NCT04713592|515956425|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
143113097|NCT04713592|515956426|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
143179984|NCT01365455|516205773|FG000|Maintenance Period|Non-compliance with study treatment|0|||
143179985|NCT01365455|516205774|FG001|Maintenance Period|Non-compliance with study treatment|0|||
143179986|NCT01365455|516205775|FG002|Maintenance Period|Non-compliance with study treatment|0|||
143179987|NCT01365455|516205776|FG003|Maintenance Period|Non-compliance with study treatment|1|||
143179988|NCT01365455|516205777|FG004|Maintenance Period|Non-compliance with study treatment|0|||
143179989|NCT01365455|516205773|FG000|Maintenance Period|Physician Decision|0|||
143179990|NCT01365455|516205774|FG001|Maintenance Period|Physician Decision|1|||
143179991|NCT01365455|516205775|FG002|Maintenance Period|Physician Decision|0|||
143179992|NCT01365455|516205776|FG003|Maintenance Period|Physician Decision|0|||
143179993|NCT01365455|516205777|FG004|Maintenance Period|Physician Decision|1|||
143179994|NCT01365455|516205773|FG000|Maintenance Period|Pregnancy|0|||
143179995|NCT01365455|516205774|FG001|Maintenance Period|Pregnancy|4|||
143179996|NCT01365455|516205775|FG002|Maintenance Period|Pregnancy|0|||
143179997|NCT01365455|516205776|FG003|Maintenance Period|Pregnancy|0|||
143179998|NCT01365455|516205777|FG004|Maintenance Period|Pregnancy|2|||
143179999|NCT01365455|516205773|FG000|Maintenance Period|Protocol deviation|1|||
143180000|NCT01365455|516205774|FG001|Maintenance Period|Protocol deviation|1|||
143180001|NCT01365455|516205775|FG002|Maintenance Period|Protocol deviation|0|||
143180002|NCT01365455|516205776|FG003|Maintenance Period|Protocol deviation|0|||
143180003|NCT01365455|516205777|FG004|Maintenance Period|Protocol deviation|0|||
143180004|NCT01365455|516205773|FG000|Maintenance Period|Subject/guardian decision|4|||
143180005|NCT01365455|516205774|FG001|Maintenance Period|Subject/guardian decision|6|||
143180006|NCT01365455|516205775|FG002|Maintenance Period|Subject/guardian decision|2|||
143180007|NCT01365455|516205776|FG003|Maintenance Period|Subject/guardian decision|4|||
143180008|NCT01365455|516205777|FG004|Maintenance Period|Subject/guardian decision|1|||
143180009|NCT03965403|516205778|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
143258520|NCT00761150|516500621|FG000|Open-label Period|Noncompliance|2|||
143258521|NCT00761150|516500622|FG001|Open-label Period|Noncompliance|0|||
143258522|NCT00761150|516500623|FG002|Open-label Period|Noncompliance|0|||
143258523|NCT00761150|516500621|FG000|Open-label Period|Other|5|||
143258524|NCT00761150|516500622|FG001|Open-label Period|Other|0|||
143258525|NCT00761150|516500623|FG002|Open-label Period|Other|0|||
143258526|NCT00761150|516500621|FG000|Double-blind Period|Lack of Efficacy|0|||
143258527|NCT00761150|516500622|FG001|Double-blind Period|Lack of Efficacy|2|||
143258528|NCT00761150|516500623|FG002|Double-blind Period|Lack of Efficacy|19|||
143258529|NCT00761150|516500621|FG000|Double-blind Period|Adverse Event|0|||
143258530|NCT00761150|516500622|FG001|Double-blind Period|Adverse Event|3|||
143258531|NCT00761150|516500623|FG002|Double-blind Period|Adverse Event|3|||
143258532|NCT00761150|516500621|FG000|Double-blind Period|Withdrawal by Subject|0|||
143258533|NCT00761150|516500622|FG001|Double-blind Period|Withdrawal by Subject|3|||
143258534|NCT00761150|516500623|FG002|Double-blind Period|Withdrawal by Subject|2|||
143258535|NCT00761150|516500621|FG000|Double-blind Period|Lost to Follow-up|0|||
143258536|NCT00761150|516500622|FG001|Double-blind Period|Lost to Follow-up|2|||
143258537|NCT00761150|516500623|FG002|Double-blind Period|Lost to Follow-up|1|||
143258538|NCT00761150|516500621|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
143258539|NCT00761150|516500622|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
143258540|NCT00761150|516500623|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
143258541|NCT00761150|516500621|FG000|Double-blind Period|Noncompliance|0|||
143258542|NCT00761150|516500622|FG001|Double-blind Period|Noncompliance|1|||
143258543|NCT00761150|516500623|FG002|Double-blind Period|Noncompliance|0|||
143258544|NCT00761150|516500621|FG000|Double-blind Period|Other|0|||
143258545|NCT00761150|516500622|FG001|Double-blind Period|Other|3|||
143258546|NCT00761150|516500623|FG002|Double-blind Period|Other|3|||
143258547|NCT03312751|516500624|FG000|Overall Study|Death|7|||
143258548|NCT03312751|516500625|FG001|Overall Study|Death|9|||
143258549|NCT03312751|516500624|FG000|Overall Study|Study discontinuation due to other reason|0|||
143258550|NCT03312751|516500625|FG001|Overall Study|Study discontinuation due to other reason|1|||
143258551|NCT00282464|516500626|FG000|Overall Study|Adverse Event|26|||
143258552|NCT00282464|516500627|FG001|Overall Study|Adverse Event|20|||
143258553|NCT00282464|516500626|FG000|Overall Study|Lack of Efficacy|8|||
143258554|NCT00282464|516500627|FG001|Overall Study|Lack of Efficacy|8|||
143258555|NCT00282464|516500626|FG000|Overall Study|Lost to Follow-up|10|||
143258556|NCT00282464|516500627|FG001|Overall Study|Lost to Follow-up|10|||
143258557|NCT00282464|516500626|FG000|Overall Study|Withdrawal by Subject|24|||
143258558|NCT00282464|516500627|FG001|Overall Study|Withdrawal by Subject|10|||
143258559|NCT00282464|516500626|FG000|Overall Study|laboratory abnormality|1|||
143258560|NCT00282464|516500627|FG001|Overall Study|laboratory abnormality|2|||
143258561|NCT00282464|516500626|FG000|Overall Study|Protocol Violation|0|||
143258562|NCT00282464|516500627|FG001|Overall Study|Protocol Violation|7|||
143258563|NCT00282464|516500626|FG000|Overall Study|Patient moved|1|||
143258564|NCT00282464|516500627|FG001|Overall Study|Patient moved|0|||
143258565|NCT00282464|516500626|FG000|Overall Study|patient non-compliant|3|||
143258566|NCT00282464|516500627|FG001|Overall Study|patient non-compliant|0|||
143258567|NCT00282464|516500626|FG000|Overall Study|patient no show|0|||
143258568|NCT00282464|516500627|FG001|Overall Study|patient no show|1|||
143258569|NCT00282464|516500626|FG000|Overall Study|patient incarcerated|0|||
143258570|NCT00282464|516500627|FG001|Overall Study|patient incarcerated|1|||
143258571|NCT00282464|516500626|FG000|Overall Study|family crisis|0|||
143258572|NCT00282464|516500627|FG001|Overall Study|family crisis|1|||
143258573|NCT00282464|516500626|FG000|Overall Study|dispensed wrong kit|0|||
143258574|NCT00282464|516500627|FG001|Overall Study|dispensed wrong kit|1|||
143258575|NCT00282464|516500626|FG000|Overall Study|dropped due to missed visits|0|||
143258576|NCT00282464|516500627|FG001|Overall Study|dropped due to missed visits|1|||
143258577|NCT00475423|516500628|FG000|Overall Study|Protocol Violation|5|||
143258578|NCT00475423|516500628|FG000|Overall Study|Adverse Event|4|||
143258579|NCT00475423|516500628|FG000|Overall Study|Withdrawal by Subject|6|||
143258580|NCT00475423|516500628|FG000|Overall Study|Lack of Efficacy|8|||
143258581|NCT00475423|516500628|FG000|Overall Study|Death|1|||
143258582|NCT00475423|516500628|FG000|Overall Study|Reason not specified|1|||
143258583|NCT00475423|516500628|FG000|Overall Study|Lost to Follow-up|7|||
143258584|NCT01214174|516500629|FG000|Overall Study|Withdrawal by Subject|0|||
143258585|NCT01214174|516500630|FG001|Overall Study|Withdrawal by Subject|0|||
143258586|NCT01214174|516500631|FG002|Overall Study|Withdrawal by Subject|1|||
143258587|NCT00868517|516500635|FG000|Overall Study|Withdrawal by Subject|3|||
143258588|NCT00868517|516500636|FG001|Overall Study|Withdrawal by Subject|3|||
143258589|NCT00868517|516500637|FG002|Overall Study|Withdrawal by Subject|2|||
143258590|NCT00868517|516500635|FG000|Overall Study|Protocol Violation|1|||
143258591|NCT00868517|516500636|FG001|Overall Study|Protocol Violation|1|||
143258592|NCT00868517|516500637|FG002|Overall Study|Protocol Violation|0|||
143258593|NCT02815280|516500642|FG000|Double-Blind Phase|Adverse Event|1|||
143258594|NCT02815280|516500643|FG001|Double-Blind Phase|Adverse Event|1|||
143258595|NCT02815280|516500642|FG000|Double-Blind Phase|Lost to Follow-up|10|||
143258596|NCT02815280|516500643|FG001|Double-Blind Phase|Lost to Follow-up|9|||
143258597|NCT02815280|516500642|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
143258598|NCT02815280|516500643|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
143180010|NCT03145064|516206912|FG000|Overall Study|Death|24|||
143180011|NCT03145064|516206912|FG000|Overall Study|Lost to Follow-up|3|||
143180012|NCT03145064|516206912|FG000|Overall Study|Withdrawal by Subject|6|||
143180013|NCT03145064|516206912|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
143180014|NCT03145064|516206912|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
143180015|NCT01396187|516206913|FG000|Overall Study|Adverse Event|0|||
143180016|NCT01396187|516206914|FG001|Overall Study|Adverse Event|1|||
143180017|NCT01396187|516206915|FG002|Overall Study|Adverse Event|0|||
143180018|NCT01396187|516206916|FG003|Overall Study|Adverse Event|0|||
143180019|NCT01396187|516206917|FG004|Overall Study|Adverse Event|0|||
143180020|NCT01396187|516206913|FG000|Overall Study|Withdrawal by Subject|0|||
143180021|NCT01396187|516206914|FG001|Overall Study|Withdrawal by Subject|1|||
143180022|NCT01396187|516206915|FG002|Overall Study|Withdrawal by Subject|1|||
143180023|NCT01396187|516206916|FG003|Overall Study|Withdrawal by Subject|0|||
143180024|NCT01396187|516206917|FG004|Overall Study|Withdrawal by Subject|0|||
143180025|NCT01396187|516206913|FG000|Overall Study|Other|1|||
143180026|NCT01396187|516206914|FG001|Overall Study|Other|1|||
143180027|NCT01396187|516206915|FG002|Overall Study|Other|0|||
143180028|NCT01396187|516206916|FG003|Overall Study|Other|0|||
143180029|NCT01396187|516206917|FG004|Overall Study|Other|1|||
143180030|NCT01898286|516206918|FG000|Overall Study|Withdrawal by Subject|1|||
143180031|NCT01898286|516206918|FG000|Overall Study|Protocol Violation|1|||
143180032|NCT01898286|516206918|FG000|Overall Study|Lost to Follow-up|1|||
143180033|NCT02257242|516206919|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
143180034|NCT02257242|516206920|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
143180035|NCT02257242|516206921|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
143180036|NCT02257242|516206922|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
143180037|NCT02257242|516206923|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
143180038|NCT02257242|516206924|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
143180039|NCT02257242|516206925|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
143180040|NCT02257242|516206926|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
143180041|NCT02257242|516206927|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
143180042|NCT02964273|516206934|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
143180043|NCT02964273|516206935|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
143180044|NCT02964273|516206936|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
143180045|NCT02964273|516206937|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
143180046|NCT02964273|516206934|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
143180047|NCT02964273|516206935|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
143180048|NCT02964273|516206936|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
143180049|NCT02964273|516206937|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
143180050|NCT02964273|516206934|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
143180051|NCT02964273|516206935|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
143180052|NCT02964273|516206936|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
143180053|NCT02964273|516206937|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
143180054|NCT02964273|516206934|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
143180055|NCT02964273|516206935|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
143180056|NCT02964273|516206936|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
143180057|NCT02964273|516206937|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
143180058|NCT02964273|516206934|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
143180059|NCT02964273|516206935|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
143180060|NCT02964273|516206936|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
143180061|NCT02964273|516206937|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
143180062|NCT02964273|516206934|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
143180063|NCT02964273|516206935|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
143180064|NCT02964273|516206936|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
143180065|NCT02964273|516206937|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
143180066|NCT01453036|516206938|FG000|Overall Study|Lost to Follow-up|26|||
143180067|NCT01453036|516206939|FG001|Overall Study|Lost to Follow-up|115|||
143180068|NCT01453036|516206940|FG002|Overall Study|Lost to Follow-up|31|||
143180069|NCT01336712|516206941|FG000|Overall Study|Death|2|||
143180070|NCT01336712|516206941|FG000|Overall Study|Lack of Efficacy|1|||
143180071|NCT02848092|516206944|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
143258599|NCT02815280|516500642|FG000|Double-Blind Phase|Protocol Violation|2|||
143258600|NCT02815280|516500643|FG001|Double-Blind Phase|Protocol Violation|2|||
143259587|NCT00913692|516505793|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
143113098|NCT04713592|515956427|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
143113099|NCT04713592|515956424|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
143113100|NCT04713592|515956425|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
143113101|NCT04713592|515956426|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
143113102|NCT04713592|515956427|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
143113103|NCT04713592|515956424|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
143113104|NCT04713592|515956425|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
143113105|NCT04713592|515956426|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
143113106|NCT04713592|515956427|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
143113107|NCT04713592|515956424|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
143113108|NCT04713592|515956425|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
143113109|NCT04713592|515956426|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
143113110|NCT04713592|515956427|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
143113111|NCT04713592|515956424|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
143113112|NCT04713592|515956425|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
143113113|NCT04713592|515956426|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
143113114|NCT04713592|515956427|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
143113115|NCT04713592|515956424|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
143113116|NCT04713592|515956425|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
143113117|NCT04713592|515956426|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
143180072|NCT02848092|516206945|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
143180073|NCT02848092|516206944|FG000|1-month Post-training Follow-up|Adverse Event|2|||
143180074|NCT02848092|516206945|FG001|1-month Post-training Follow-up|Adverse Event|1|||
143180075|NCT02848092|516206944|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
143180076|NCT02848092|516206945|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
143180077|NCT02848092|516206944|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
143180078|NCT02848092|516206945|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
143180079|NCT02848092|516206944|FG000|1-month Post-training Follow-up|fatigue|0|||
143180080|NCT02848092|516206945|FG001|1-month Post-training Follow-up|fatigue|1|||
143180081|NCT02848092|516206944|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
143180082|NCT02848092|516206945|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
143180083|NCT02848092|516206944|FG000|6-month Post-training Follow-up|Adverse Event|1|||
143180084|NCT02848092|516206945|FG001|6-month Post-training Follow-up|Adverse Event|1|||
143180085|NCT02848092|516206944|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
143180086|NCT02848092|516206945|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
143180087|NCT02848092|516206944|FG000|6-month Post-training Follow-up|frustrated with task|1|||
143180088|NCT02848092|516206945|FG001|6-month Post-training Follow-up|frustrated with task|0|||
143180089|NCT02848092|516206944|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
143180090|NCT02848092|516206945|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
143180091|NCT02848092|516206944|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
143180092|NCT02848092|516206945|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
143180093|NCT01645735|516206948|FG000|Overall Study|Physician Decision|2|||
143180094|NCT01645735|516206949|FG001|Overall Study|Physician Decision|0|||
143180095|NCT01645735|516206948|FG000|Overall Study|Withdrawal by Subject|1|||
143180096|NCT01645735|516206949|FG001|Overall Study|Withdrawal by Subject|0|||
143180097|NCT01645735|516206948|FG000|Overall Study|Protocol Violation|1|||
143180098|NCT01645735|516206949|FG001|Overall Study|Protocol Violation|0|||
143180099|NCT01645735|516206948|FG000|Overall Study|Adverse Event|0|||
143180100|NCT01645735|516206949|FG001|Overall Study|Adverse Event|1|||
143180101|NCT00589797|516206952|FG000|Overall Study|Death|1|||
143180102|NCT00589797|516206953|FG001|Overall Study|Death|0|||
143180103|NCT00589797|516206952|FG000|Overall Study|Lost to Follow-up|12|||
143180104|NCT00589797|516206953|FG001|Overall Study|Lost to Follow-up|9|||
143180105|NCT00589797|516206952|FG000|Overall Study|Physician Decision|8|||
143180106|NCT00589797|516206953|FG001|Overall Study|Physician Decision|3|||
143180107|NCT00589797|516206952|FG000|Overall Study|Withdrawal by Subject|6|||
143180108|NCT00589797|516206953|FG001|Overall Study|Withdrawal by Subject|5|||
143180109|NCT00589797|516206952|FG000|Overall Study|Non-Randomized Training Subjects|46|||
143180110|NCT00589797|516206953|FG001|Overall Study|Non-Randomized Training Subjects|6|||
143180111|NCT02831855|516206955|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
143180112|NCT02831855|516206956|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
143180113|NCT02831855|516206957|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
143180114|NCT02831855|516206955|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
143180115|NCT02831855|516206956|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
143180116|NCT02831855|516206957|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
143180117|NCT02831855|516206955|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
143180118|NCT02831855|516206956|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
143258601|NCT02815280|516500642|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
143258602|NCT02815280|516500643|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
143258603|NCT02815280|516500642|FG000|Open-Label Phase|Adverse Event|2|||
143258604|NCT02815280|516500643|FG001|Open-Label Phase|Adverse Event|3|||
143258605|NCT02815280|516500642|FG000|Open-Label Phase|Lost to Follow-up|18|||
143258606|NCT02815280|516500643|FG001|Open-Label Phase|Lost to Follow-up|9|||
143258607|NCT02815280|516500642|FG000|Open-Label Phase|Withdrawal by Subject|33|||
143258608|NCT02815280|516500643|FG001|Open-Label Phase|Withdrawal by Subject|18|||
143258609|NCT02815280|516500642|FG000|Open-Label Phase|Protocol Violation|3|||
143258610|NCT02815280|516500643|FG001|Open-Label Phase|Protocol Violation|0|||
143258611|NCT02815280|516500642|FG000|Open-Label Phase|Administrative|26|||
143258612|NCT02815280|516500643|FG001|Open-Label Phase|Administrative|12|||
143258613|NCT02815280|516500642|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
143258614|NCT02815280|516500643|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
143258615|NCT03485495|516500652|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
143258616|NCT03485495|516500653|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
143258617|NCT01009281|516500654|FG000|Overall Study|Administrative problems|7|||
143258618|NCT03562767|516500657|FG000|Overall Study|Physician Decision|2|||
143258619|NCT03562767|516500658|FG001|Overall Study|Physician Decision|0|||
143258620|NCT03562767|516500659|FG002|Overall Study|Physician Decision|0|||
143258621|NCT03562767|516500657|FG000|Overall Study|Logistic Reason|1|||
143258622|NCT03562767|516500658|FG001|Overall Study|Logistic Reason|3|||
143258623|NCT03562767|516500659|FG002|Overall Study|Logistic Reason|0|||
143258624|NCT00814801|516500661|FG000|Overall Study|Adverse Event|15|||
143258625|NCT00814801|516500662|FG001|Overall Study|Adverse Event|16|||
143258626|NCT00814801|516500663|FG002|Overall Study|Adverse Event|19|||
143258627|NCT00814801|516500661|FG000|Overall Study|Withdrawal by Subject|9|||
143258628|NCT00814801|516500662|FG001|Overall Study|Withdrawal by Subject|11|||
143258629|NCT00814801|516500663|FG002|Overall Study|Withdrawal by Subject|14|||
143258630|NCT00814801|516500661|FG000|Overall Study|Inappropriate as a subject|1|||
143258631|NCT00814801|516500662|FG001|Overall Study|Inappropriate as a subject|1|||
143258632|NCT00814801|516500663|FG002|Overall Study|Inappropriate as a subject|1|||
143258633|NCT00814801|516500661|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
143258634|NCT00814801|516500662|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
143258635|NCT00814801|516500663|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
143258636|NCT00814801|516500661|FG000|Overall Study|Missing or change of caregiver|6|||
143258637|NCT00814801|516500662|FG001|Overall Study|Missing or change of caregiver|2|||
143258638|NCT00814801|516500663|FG002|Overall Study|Missing or change of caregiver|4|||
143258639|NCT00814801|516500661|FG000|Overall Study|Non-compliance|0|||
143258640|NCT00814801|516500662|FG001|Overall Study|Non-compliance|1|||
143258641|NCT00814801|516500663|FG002|Overall Study|Non-compliance|1|||
143258642|NCT00814801|516500661|FG000|Overall Study|Other|2|||
143258643|NCT00814801|516500662|FG001|Overall Study|Other|6|||
143258644|NCT00814801|516500663|FG002|Overall Study|Other|4|||
143258645|NCT02486718|516500664|FG000|Enrollment Phase|Death|19|||
143258646|NCT02486718|516500665|FG001|Enrollment Phase|Death|0|||
143258647|NCT02486718|516500666|FG002|Enrollment Phase|Death|0|||
143258648|NCT02486718|516500664|FG000|Enrollment Phase|Symptomatic deterioration|1|||
143258649|NCT02486718|516500665|FG001|Enrollment Phase|Symptomatic deterioration|0|||
143258650|NCT02486718|516500666|FG002|Enrollment Phase|Symptomatic deterioration|0|||
143258651|NCT02486718|516500664|FG000|Enrollment Phase|Withdrawal by Subject|86|||
143258652|NCT02486718|516500665|FG001|Enrollment Phase|Withdrawal by Subject|0|||
143258653|NCT02486718|516500666|FG002|Enrollment Phase|Withdrawal by Subject|0|||
143258654|NCT02486718|516500664|FG000|Enrollment Phase|Protocol Violation|18|||
143258655|NCT02486718|516500665|FG001|Enrollment Phase|Protocol Violation|0|||
143258656|NCT02486718|516500666|FG002|Enrollment Phase|Protocol Violation|0|||
143258657|NCT02486718|516500664|FG000|Enrollment Phase|Physician Decision|18|||
143258658|NCT02486718|516500665|FG001|Enrollment Phase|Physician Decision|0|||
143258659|NCT02486718|516500666|FG002|Enrollment Phase|Physician Decision|0|||
143258660|NCT02486718|516500664|FG000|Enrollment Phase|Reason not provided|41|||
143258661|NCT02486718|516500665|FG001|Enrollment Phase|Reason not provided|0|||
143258662|NCT02486718|516500666|FG002|Enrollment Phase|Reason not provided|0|||
143258663|NCT02486718|516500664|FG000|Enrollment Phase|Disease relapse|54|||
143258664|NCT02486718|516500665|FG001|Enrollment Phase|Disease relapse|0|||
143258665|NCT02486718|516500666|FG002|Enrollment Phase|Disease relapse|0|||
143368420|NCT01456936|516892678|FG000|Overall Study|Insufficient clinical response|4|||
143258666|NCT02486718|516500664|FG000|Enrollment Phase|Lost to Follow-up|4|||
143258667|NCT02486718|516500665|FG001|Enrollment Phase|Lost to Follow-up|0|||
143258668|NCT02486718|516500666|FG002|Enrollment Phase|Lost to Follow-up|0|||
143258669|NCT02486718|516500664|FG000|Enrollment Phase|Adverse Event|34|||
143258670|NCT02486718|516500665|FG001|Enrollment Phase|Adverse Event|0|||
143258671|NCT02486718|516500666|FG002|Enrollment Phase|Adverse Event|0|||
143258672|NCT02486718|516500664|FG000|Randomized Phase|Withdrawal by Subject|0|||
143258673|NCT02486718|516500665|FG001|Randomized Phase|Withdrawal by Subject|44|||
143258674|NCT02486718|516500666|FG002|Randomized Phase|Withdrawal by Subject|47|||
143258675|NCT02486718|516500664|FG000|Randomized Phase|Protocol Violation|0|||
143258676|NCT02486718|516500665|FG001|Randomized Phase|Protocol Violation|2|||
143258677|NCT02486718|516500666|FG002|Randomized Phase|Protocol Violation|0|||
143258678|NCT02486718|516500664|FG000|Randomized Phase|Physician Decision|0|||
143258679|NCT02486718|516500665|FG001|Randomized Phase|Physician Decision|0|||
143113118|NCT04713592|515956427|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
143113119|NCT01190267|515956430|FG000|Overall Study|Adverse Event|10|||
143113120|NCT01190267|515956431|FG001|Overall Study|Adverse Event|0|||
143113121|NCT01190267|515956430|FG000|Overall Study|Treatment Failure|8|||
143113122|NCT01190267|515956431|FG001|Overall Study|Treatment Failure|2|||
143113123|NCT01190267|515956430|FG000|Overall Study|Lost to Follow-up|2|||
143113124|NCT01190267|515956431|FG001|Overall Study|Lost to Follow-up|0|||
143113125|NCT01190267|515956430|FG000|Overall Study|Withdrawal by Subject|13|||
143113126|NCT01190267|515956431|FG001|Overall Study|Withdrawal by Subject|1|||
143113127|NCT01190267|515956430|FG000|Overall Study|Protocol Violation|8|||
143113128|NCT01190267|515956431|FG001|Overall Study|Protocol Violation|1|||
143113129|NCT00742508|515956434|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
143113130|NCT00742508|515956435|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
143113131|NCT00742508|515956434|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
143113132|NCT00742508|515956435|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
143113133|NCT00742508|515956434|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
143113134|NCT00742508|515956435|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
143258680|NCT02486718|516500666|FG002|Randomized Phase|Physician Decision|3|||
143258681|NCT02486718|516500664|FG000|Randomized Phase|Lost to Follow-up|0|||
143258682|NCT02486718|516500665|FG001|Randomized Phase|Lost to Follow-up|5|||
143258683|NCT02486718|516500666|FG002|Randomized Phase|Lost to Follow-up|11|||
143258684|NCT02486718|516500664|FG000|Randomized Phase|Disease Relapse|0|||
143258685|NCT02486718|516500665|FG001|Randomized Phase|Disease Relapse|1|||
143258686|NCT02486718|516500666|FG002|Randomized Phase|Disease Relapse|0|||
143258687|NCT02486718|516500664|FG000|Randomized Phase|Death|0|||
143258688|NCT02486718|516500665|FG001|Randomized Phase|Death|154|||
143258689|NCT02486718|516500666|FG002|Randomized Phase|Death|155|||
143258690|NCT02486718|516500664|FG000|Randomized Phase|Ongoing|0|||
143258691|NCT02486718|516500665|FG001|Randomized Phase|Ongoing|301|||
143258692|NCT02486718|516500666|FG002|Randomized Phase|Ongoing|282|||
143258693|NCT02520089|516500667|FG000|Overall Study|Lost to Follow-up|3|||
143258694|NCT02520089|516500668|FG001|Overall Study|Lost to Follow-up|4|||
143258695|NCT02216812|516500671|FG000|Overall Study|Lost to Follow-up|10|||
143258696|NCT02216812|516500672|FG001|Overall Study|Lost to Follow-up|5|||
143258697|NCT00527488|516500673|FG000|Overall Study|Withdrawn prior to dosing|0|||
143258698|NCT00527488|516500674|FG001|Overall Study|Withdrawn prior to dosing|1|||
143258699|NCT00527488|516500675|FG002|Overall Study|Withdrawn prior to dosing|1|||
143258700|NCT00527488|516500676|FG003|Overall Study|Withdrawn prior to dosing|0|||
143258701|NCT02545543|516500677|FG000|Overall Study|Lost to Follow-up|67|||
143258702|NCT02545543|516500678|FG001|Overall Study|Lost to Follow-up|25|||
143258703|NCT02545543|516500677|FG000|Overall Study|Physician Decision|3|||
143258704|NCT02545543|516500678|FG001|Overall Study|Physician Decision|0|||
143258705|NCT02545543|516500677|FG000|Overall Study|Withdrawal by Subject|9|||
143258706|NCT02545543|516500678|FG001|Overall Study|Withdrawal by Subject|8|||
143258707|NCT02545543|516500677|FG000|Overall Study|Noncomplaince|1|||
143258708|NCT02545543|516500678|FG001|Overall Study|Noncomplaince|0|||
143368421|NCT01456936|516892679|FG001|Overall Study|Insufficient clinical response|4|||
143368422|NCT01456936|516892680|FG002|Overall Study|Insufficient clinical response|14|||
143368423|NCT01456936|516892681|FG003|Overall Study|Insufficient clinical response|13|||
143368424|NCT01456936|516892678|FG000|Overall Study|No longer willing to participate|195|||
143368425|NCT01456936|516892679|FG001|Overall Study|No longer willing to participate|218|||
143368426|NCT01456936|516892680|FG002|Overall Study|No longer willing to participate|224|||
143368427|NCT01456936|516892681|FG003|Overall Study|No longer willing to participate|248|||
143368428|NCT01456936|516892678|FG000|Overall Study|Lost to Follow-up|135|||
143113135|NCT00742508|515956434|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
143258709|NCT02545543|516500677|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
143368429|NCT01456936|516892679|FG001|Overall Study|Lost to Follow-up|126|||
143368430|NCT01456936|516892680|FG002|Overall Study|Lost to Follow-up|144|||
143113136|NCT00742508|515956435|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
143113137|NCT00742508|515956434|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
143258710|NCT02545543|516500678|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
143258711|NCT02829944|516500682|FG000|Overall Study|Physician Decision|0|||
143258712|NCT02829944|516500683|FG001|Overall Study|Physician Decision|1|||
143258713|NCT02829944|516500682|FG000|Overall Study|Screen Failure|2|||
143258714|NCT02829944|516500683|FG001|Overall Study|Screen Failure|2|||
143258715|NCT02829944|516500682|FG000|Overall Study|Inadequate Neuraxial Block|1|||
143368431|NCT01456936|516892681|FG003|Overall Study|Lost to Follow-up|127|||
143258716|NCT02829944|516500683|FG001|Overall Study|Inadequate Neuraxial Block|1|||
143113138|NCT00742508|515956435|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
143258717|NCT02829944|516500682|FG000|Overall Study|Withdrawal by Subject|2|||
143258718|NCT02829944|516500683|FG001|Overall Study|Withdrawal by Subject|1|||
143113139|NCT01382225|515956436|FG000|Overall Study|Adverse Event|3|||
143113140|NCT01382225|515956437|FG001|Overall Study|Adverse Event|2|||
143113141|NCT01382225|515956436|FG000|Overall Study|Protocol Violation|2|||
143113142|NCT01382225|515956437|FG001|Overall Study|Protocol Violation|1|||
143258719|NCT02829944|516500682|FG000|Overall Study|Catheter Displacement|1|||
143258720|NCT02829944|516500683|FG001|Overall Study|Catheter Displacement|0|||
143258721|NCT02829944|516500682|FG000|Overall Study|Catheter broke|0|||
143258722|NCT02829944|516500683|FG001|Overall Study|Catheter broke|1|||
143258723|NCT02829944|516500682|FG000|Overall Study|Staff unavailable|0|||
143258724|NCT02829944|516500683|FG001|Overall Study|Staff unavailable|1|||
143258725|NCT04268823|516500684|FG000|Overall Study|Adverse Event|1|||
143258726|NCT04268823|516500685|FG001|Overall Study|Adverse Event|0|||
143258727|NCT04268823|516500684|FG000|Overall Study|Participant Decision|1|||
143258728|NCT04268823|516500685|FG001|Overall Study|Participant Decision|0|||
143259588|NCT00913692|516505793|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
143259589|NCT00400153|516505796|FG000|Overall Study|AE due to study disease worsening|14|||
143259590|NCT00400153|516505797|FG001|Overall Study|AE due to study disease worsening|19|||
143259591|NCT00400153|516505798|FG002|Overall Study|AE due to study disease worsening|20|||
143259592|NCT00400153|516505796|FG000|Overall Study|AE due to other disease worsening|2|||
143259593|NCT00400153|516505797|FG001|Overall Study|AE due to other disease worsening|1|||
143259594|NCT00400153|516505798|FG002|Overall Study|AE due to other disease worsening|0|||
143259595|NCT00400153|516505796|FG000|Overall Study|AE due to other condition|3|||
143259596|NCT00400153|516505797|FG001|Overall Study|AE due to other condition|14|||
143259597|NCT00400153|516505798|FG002|Overall Study|AE due to other condition|15|||
143259598|NCT00400153|516505796|FG000|Overall Study|Protocol Violation|7|||
143259599|NCT00400153|516505797|FG001|Overall Study|Protocol Violation|4|||
143259600|NCT00400153|516505798|FG002|Overall Study|Protocol Violation|9|||
143113143|NCT01382225|515956436|FG000|Overall Study|Subject Withdrew Consent|5|||
143113144|NCT01382225|515956437|FG001|Overall Study|Subject Withdrew Consent|2|||
143113145|NCT01382225|515956436|FG000|Overall Study|Other|4|||
143113146|NCT01382225|515956437|FG001|Overall Study|Other|2|||
143113147|NCT02484651|515956441|FG000|Overall Study|Patients' data files were corrupted.|1|||
143113148|NCT02484651|515956442|FG001|Overall Study|Patients' data files were corrupted.|1|||
143113149|NCT02484651|515956441|FG000|Overall Study|BIS monitoring failed.|1|||
143113150|NCT02484651|515956442|FG001|Overall Study|BIS monitoring failed.|1|||
143113151|NCT02484651|515956441|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
143113152|NCT02484651|515956442|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
143113153|NCT04972968|515956443|FG000|Overall Study|Adverse Event|3|||
143113154|NCT04972968|515956444|FG001|Overall Study|Adverse Event|1|||
143113155|NCT04972968|515956445|FG002|Overall Study|Adverse Event|1|||
143113156|NCT04972968|515956446|FG003|Overall Study|Adverse Event|7|||
143113157|NCT04972968|515956443|FG000|Overall Study|Lack of Efficacy|2|||
143113158|NCT04972968|515956444|FG001|Overall Study|Lack of Efficacy|1|||
143113159|NCT04972968|515956445|FG002|Overall Study|Lack of Efficacy|0|||
143113160|NCT04972968|515956446|FG003|Overall Study|Lack of Efficacy|0|||
143113161|NCT04972968|515956443|FG000|Overall Study|Withdrawal by Subject|7|||
143113162|NCT04972968|515956444|FG001|Overall Study|Withdrawal by Subject|4|||
143113163|NCT04972968|515956445|FG002|Overall Study|Withdrawal by Subject|3|||
143113164|NCT04972968|515956446|FG003|Overall Study|Withdrawal by Subject|2|||
143113165|NCT04972968|515956443|FG000|Overall Study|Study Terminated by Sponsor|25|||
143113166|NCT04972968|515956444|FG001|Overall Study|Study Terminated by Sponsor|28|||
143113167|NCT04972968|515956445|FG002|Overall Study|Study Terminated by Sponsor|32|||
143113168|NCT04972968|515956446|FG003|Overall Study|Study Terminated by Sponsor|27|||
143259601|NCT00400153|516505796|FG000|Overall Study|Lost to Follow-up|2|||
143113169|NCT04972968|515956443|FG000|Overall Study|Other|1|||
143113170|NCT04972968|515956444|FG001|Overall Study|Other|0|||
143113171|NCT04972968|515956445|FG002|Overall Study|Other|1|||
143113172|NCT04972968|515956446|FG003|Overall Study|Other|1|||
143113173|NCT03649178|515956447|FG000|Overall Study|Adverse Event|1|||
143259602|NCT00400153|516505797|FG001|Overall Study|Lost to Follow-up|1|||
143259603|NCT00400153|516505798|FG002|Overall Study|Lost to Follow-up|4|||
143259604|NCT00400153|516505796|FG000|Overall Study|Withdrawal by Subject|12|||
143113174|NCT03649178|515956448|FG001|Overall Study|Adverse Event|2|||
143113175|NCT03649178|515956447|FG000|Overall Study|Withdrawal by Subject|0|||
143259605|NCT00400153|516505797|FG001|Overall Study|Withdrawal by Subject|11|||
143259606|NCT00400153|516505798|FG002|Overall Study|Withdrawal by Subject|10|||
143259607|NCT00400153|516505796|FG000|Overall Study|Other reasons - not mentioned above|8|||
143259608|NCT00400153|516505797|FG001|Overall Study|Other reasons - not mentioned above|5|||
143368432|NCT01456936|516892678|FG000|Overall Study|Medication error|0|||
143113176|NCT03649178|515956448|FG001|Overall Study|Withdrawal by Subject|2|||
143113177|NCT03649178|515956447|FG000|Overall Study|COVID regulation required halt in protocol|1|||
143113178|NCT03649178|515956448|FG001|Overall Study|COVID regulation required halt in protocol|0|||
143113179|NCT03814720|515956453|FG000|Overall Study|Lost to Follow-up|0|||
143113180|NCT03814720|515956454|FG001|Overall Study|Lost to Follow-up|1|||
143113181|NCT03814720|515956455|FG002|Overall Study|Lost to Follow-up|0|||
143113182|NCT03814720|515956456|FG003|Overall Study|Lost to Follow-up|0|||
143113183|NCT03814720|515956457|FG004|Overall Study|Lost to Follow-up|0|||
143113184|NCT02135107|515956458|FG000|Treatment Period|Withdrawal by Subject|11|||
143113185|NCT02135107|515956459|FG001|Treatment Period|Withdrawal by Subject|0|||
143113186|NCT02135107|515956460|FG002|Treatment Period|Withdrawal by Subject|0|||
143113187|NCT02135107|515956461|FG003|Treatment Period|Withdrawal by Subject|0|||
143113188|NCT02135107|515956458|FG000|Treatment Period|Adverse Event|5|||
143113189|NCT02135107|515956459|FG001|Treatment Period|Adverse Event|2|||
143113190|NCT02135107|515956460|FG002|Treatment Period|Adverse Event|0|||
143113191|NCT02135107|515956461|FG003|Treatment Period|Adverse Event|0|||
143113192|NCT02135107|515956458|FG000|Treatment Period|Pregnancy|1|||
143113193|NCT02135107|515956459|FG001|Treatment Period|Pregnancy|0|||
143113194|NCT02135107|515956460|FG002|Treatment Period|Pregnancy|0|||
143113195|NCT02135107|515956461|FG003|Treatment Period|Pregnancy|0|||
143113196|NCT02135107|515956458|FG000|Treatment Period|Other|115|||
143113197|NCT02135107|515956459|FG001|Treatment Period|Other|24|||
143113198|NCT02135107|515956460|FG002|Treatment Period|Other|0|||
143113199|NCT02135107|515956461|FG003|Treatment Period|Other|0|||
143113200|NCT02135107|515956458|FG000|Maintenance Therapy Period|Adverse Event|0|||
143113201|NCT02135107|515956459|FG001|Maintenance Therapy Period|Adverse Event|0|||
143113202|NCT02135107|515956460|FG002|Maintenance Therapy Period|Adverse Event|3|||
143113203|NCT02135107|515956461|FG003|Maintenance Therapy Period|Adverse Event|7|||
143113204|NCT02135107|515956458|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
143113205|NCT02135107|515956459|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
143113206|NCT02135107|515956460|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
143113207|NCT02135107|515956461|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
143113208|NCT02135107|515956458|FG000|Maintenance Therapy Period|Pregnancy|0|||
143113209|NCT02135107|515956459|FG001|Maintenance Therapy Period|Pregnancy|0|||
143113210|NCT02135107|515956460|FG002|Maintenance Therapy Period|Pregnancy|0|||
143113211|NCT02135107|515956461|FG003|Maintenance Therapy Period|Pregnancy|1|||
143113212|NCT02135107|515956458|FG000|Maintenance Therapy Period|Other|0|||
143113213|NCT02135107|515956459|FG001|Maintenance Therapy Period|Other|0|||
143113214|NCT02135107|515956460|FG002|Maintenance Therapy Period|Other|7|||
143113215|NCT02135107|515956461|FG003|Maintenance Therapy Period|Other|8|||
143113216|NCT00102531|515956465|FG000|Overall Study|Adverse Event|0|||
143113217|NCT00102531|515956466|FG001|Overall Study|Adverse Event|1|||
143113218|NCT00102531|515956465|FG000|Overall Study|Disease Progression|5|||
143113219|NCT00102531|515956466|FG001|Overall Study|Disease Progression|9|||
143113220|NCT00102531|515956465|FG000|Overall Study|Physician Decision|0|||
143113221|NCT00102531|515956466|FG001|Overall Study|Physician Decision|1|||
143113222|NCT01077739|515956468|FG000|Overall Study|Premature withdrawal|1|||
143113223|NCT01077739|515956469|FG001|Overall Study|Premature withdrawal|3|||
143113224|NCT01077739|515956468|FG000|Overall Study|Withdrawal by Subject|1|||
143113225|NCT01077739|515956469|FG001|Overall Study|Withdrawal by Subject|0|||
143113226|NCT01077739|515956468|FG000|Overall Study|Death|0|||
143113227|NCT01077739|515956469|FG001|Overall Study|Death|3|||
143113228|NCT01077739|515956468|FG000|Overall Study|Unacceptable toxicity|1|||
143113229|NCT01077739|515956469|FG001|Overall Study|Unacceptable toxicity|2|||
143113230|NCT01077739|515956468|FG000|Overall Study|Other|2|||
143113231|NCT01077739|515956469|FG001|Overall Study|Other|2|||
143113232|NCT00877071|515956470|FG000|Overall Study|disease progression|2|||
143113233|NCT05723328|515956471|FG000|Overall Study|Investigator's Decision|5|||
143113234|NCT05723328|515956472|FG001|Overall Study|Investigator's Decision|2|||
143113235|NCT00954512|515956474|FG000|Overall Study|Withdrawal by Subject|0|||
143113236|NCT00954512|515956475|FG001|Overall Study|Withdrawal by Subject|0|||
143113237|NCT00954512|515956476|FG002|Overall Study|Withdrawal by Subject|0|||
143113238|NCT00954512|515956477|FG003|Overall Study|Withdrawal by Subject|0|||
143113239|NCT00954512|515956478|FG004|Overall Study|Withdrawal by Subject|0|||
143113240|NCT00954512|515956479|FG005|Overall Study|Withdrawal by Subject|1|||
143113241|NCT00954512|515956474|FG000|Overall Study|Adverse Event|0|||
143113242|NCT00954512|515956475|FG001|Overall Study|Adverse Event|0|||
143113243|NCT00954512|515956476|FG002|Overall Study|Adverse Event|0|||
143113244|NCT00954512|515956477|FG003|Overall Study|Adverse Event|0|||
143113245|NCT00954512|515956478|FG004|Overall Study|Adverse Event|1|||
143113246|NCT00954512|515956479|FG005|Overall Study|Adverse Event|2|||
143113247|NCT00954512|515956474|FG000|Overall Study|Physician Decision|0|||
143113248|NCT00954512|515956475|FG001|Overall Study|Physician Decision|1|||
143113249|NCT00954512|515956476|FG002|Overall Study|Physician Decision|0|||
143113250|NCT00954512|515956477|FG003|Overall Study|Physician Decision|1|||
143113251|NCT00954512|515956478|FG004|Overall Study|Physician Decision|0|||
143113252|NCT00954512|515956479|FG005|Overall Study|Physician Decision|0|||
143113253|NCT00954512|515956474|FG000|Overall Study|Symptomatic Deterioration|0|||
143113254|NCT00954512|515956475|FG001|Overall Study|Symptomatic Deterioration|1|||
143113255|NCT00954512|515956476|FG002|Overall Study|Symptomatic Deterioration|0|||
143113256|NCT00954512|515956477|FG003|Overall Study|Symptomatic Deterioration|0|||
143113257|NCT00954512|515956478|FG004|Overall Study|Symptomatic Deterioration|2|||
143113258|NCT00954512|515956479|FG005|Overall Study|Symptomatic Deterioration|0|||
143113259|NCT00954512|515956474|FG000|Overall Study|Progression of Disease|2|||
143117401|NCT05459558|515971835|FG000|Overall Study|Scheduling issue|0|||
143113260|NCT00954512|515956475|FG001|Overall Study|Progression of Disease|1|||
143113261|NCT00954512|515956476|FG002|Overall Study|Progression of Disease|0|||
143113262|NCT00954512|515956477|FG003|Overall Study|Progression of Disease|1|||
143113263|NCT00954512|515956478|FG004|Overall Study|Progression of Disease|1|||
143113264|NCT00954512|515956479|FG005|Overall Study|Progression of Disease|1|||
143113265|NCT03495154|515956480|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
143113266|NCT03495154|515956480|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
143113267|NCT03495154|515956480|FG000|Overall Study|Screen Failures During Surgery|6|||
143113268|NCT03495154|515956480|FG000|Overall Study|Death|2|||
143113269|NCT03495154|515956480|FG000|Overall Study|Lost to Follow-up|16|||
143113270|NCT03495154|515956480|FG000|Overall Study|Withdrawal by Subject|2|||
143113271|NCT03495154|515956480|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
143113272|NCT05685732|515956481|FG000|Overall Study|Withdrawal by Subject|2|||
143113273|NCT05685732|515956482|FG001|Overall Study|Withdrawal by Subject|0|||
143113274|NCT05685732|515956483|FG002|Overall Study|Withdrawal by Subject|2|||
143113275|NCT05685732|515956484|FG003|Overall Study|Withdrawal by Subject|3|||
143113276|NCT05685732|515956481|FG000|Overall Study|Protocol Violation|1|||
143113277|NCT05685732|515956482|FG001|Overall Study|Protocol Violation|2|||
143113278|NCT05685732|515956483|FG002|Overall Study|Protocol Violation|4|||
143113279|NCT05685732|515956484|FG003|Overall Study|Protocol Violation|1|||
143113280|NCT05685732|515956481|FG000|Overall Study|Lost to Follow-up|5|||
143113281|NCT05685732|515956482|FG001|Overall Study|Lost to Follow-up|1|||
143113282|NCT05685732|515956483|FG002|Overall Study|Lost to Follow-up|3|||
143113283|NCT05685732|515956484|FG003|Overall Study|Lost to Follow-up|1|||
143113284|NCT05685732|515956481|FG000|Overall Study|Adverse Event|2|||
143113285|NCT05685732|515956482|FG001|Overall Study|Adverse Event|1|||
143113286|NCT05685732|515956483|FG002|Overall Study|Adverse Event|0|||
143113287|NCT05685732|515956484|FG003|Overall Study|Adverse Event|0|||
143180119|NCT02831855|516206957|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
143180120|NCT02831855|516206955|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
143180121|NCT02831855|516206956|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
143180122|NCT02831855|516206957|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
143180123|NCT02831855|516206955|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
143180124|NCT02831855|516206956|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
143180125|NCT02831855|516206957|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
143180126|NCT02831855|516206955|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
143180127|NCT02831855|516206956|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
143180128|NCT02831855|516206957|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
143180129|NCT02831855|516206955|FG000|Open Label Phase (24 Weeks)|Other|4|||
143180130|NCT02831855|516206956|FG001|Open Label Phase (24 Weeks)|Other|0|||
143180131|NCT02831855|516206957|FG002|Open Label Phase (24 Weeks)|Other|0|||
143180132|NCT02831855|516206955|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
143180133|NCT02831855|516206956|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
143180134|NCT02831855|516206957|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
143180135|NCT02831855|516206955|FG000|Double Blind Phase (24 Weeks)|Death|0|||
143180136|NCT02831855|516206956|FG001|Double Blind Phase (24 Weeks)|Death|0|||
143180137|NCT02831855|516206957|FG002|Double Blind Phase (24 Weeks)|Death|2|||
143180138|NCT02831855|516206955|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
143180139|NCT02831855|516206956|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
143180140|NCT02831855|516206957|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
143180141|NCT02831855|516206955|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
143180142|NCT02831855|516206956|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
143180143|NCT02831855|516206957|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
143180144|NCT02831855|516206955|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
143180145|NCT02831855|516206956|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
143180146|NCT02831855|516206957|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
143180147|NCT02831855|516206955|FG000|Double Blind Phase (24 Weeks)|Other|0|||
143180148|NCT02831855|516206956|FG001|Double Blind Phase (24 Weeks)|Other|2|||
143180149|NCT02831855|516206957|FG002|Double Blind Phase (24 Weeks)|Other|5|||
143180150|NCT02831855|516206955|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
143180151|NCT02831855|516206956|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
143180152|NCT02831855|516206957|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
143180153|NCT02831855|516206955|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
143180154|NCT02831855|516206956|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
143180155|NCT02831855|516206957|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
143180156|NCT02831855|516206955|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
143180157|NCT02831855|516206956|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
143113288|NCT05685732|515956481|FG000|Overall Study|Physician Decision|1|||
143113289|NCT05685732|515956482|FG001|Overall Study|Physician Decision|0|||
143113290|NCT05685732|515956483|FG002|Overall Study|Physician Decision|0|||
143113291|NCT05685732|515956484|FG003|Overall Study|Physician Decision|0|||
143113292|NCT02640404|515956485|FG000|Overall Study|Protocol Violation|1|||
143113293|NCT02640404|515956486|FG001|Overall Study|Protocol Violation|0|||
143113294|NCT02640404|515956485|FG000|Overall Study|Withdrawal by Subject|1|||
143113295|NCT02640404|515956486|FG001|Overall Study|Withdrawal by Subject|0|||
143113296|NCT04908202|515956488|FG000|Pre-Treatment Period|OTHER REASONS|3|||
143113297|NCT04908202|515956489|FG001|Pre-Treatment Period|OTHER REASONS|1|||
143113298|NCT04908202|515956490|FG002|Pre-Treatment Period|OTHER REASONS|0|||
143113299|NCT04908202|515956491|FG003|Pre-Treatment Period|OTHER REASONS|0|||
143113300|NCT04908202|515956488|FG000|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|1|||
143113301|NCT04908202|515956489|FG001|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
143113302|NCT04908202|515956490|FG002|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
143113303|NCT04908202|515956491|FG003|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
143113304|NCT04908202|515956488|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|1|||
143113305|NCT04908202|515956489|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
143113306|NCT04908202|515956490|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
143113307|NCT04908202|515956491|FG003|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
143113308|NCT04908202|515956488|FG000|Placebo-Controlled Treatment Period|Adverse Event|8|||
143113309|NCT04908202|515956489|FG001|Placebo-Controlled Treatment Period|Adverse Event|6|||
143113310|NCT04908202|515956490|FG002|Placebo-Controlled Treatment Period|Adverse Event|0|||
143113311|NCT04908202|515956491|FG003|Placebo-Controlled Treatment Period|Adverse Event|0|||
143113312|NCT04908202|515956488|FG000|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
143113313|NCT04908202|515956489|FG001|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
143113314|NCT04908202|515956490|FG002|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
143113315|NCT04908202|515956491|FG003|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
143113316|NCT04908202|515956488|FG000|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|4|||
143113317|NCT04908202|515956489|FG001|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|10|||
143113318|NCT04908202|515956490|FG002|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
143113319|NCT04908202|515956491|FG003|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
143113320|NCT04908202|515956488|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
143113321|NCT04908202|515956489|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
143113322|NCT04908202|515956490|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
143113323|NCT04908202|515956491|FG003|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
143113324|NCT04908202|515956488|FG000|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
143180158|NCT02831855|516206957|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
143180159|NCT02236572|516206958|FG000|Overall Study|Withdrawal by Subject|1|||
143180160|NCT02236572|516206958|FG000|Overall Study|Protocol Violation|1|||
143180161|NCT02236572|516206958|FG000|Overall Study|Lost to Follow-up|1|||
143180162|NCT01057693|516206959|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
143180163|NCT01057693|516206960|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
143180164|NCT01057693|516206961|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
143180165|NCT01057693|516206959|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
143180166|NCT01057693|516206960|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
143180167|NCT01057693|516206961|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
143180168|NCT01057693|516206959|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
143180169|NCT01057693|516206960|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
143180170|NCT01057693|516206961|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
143180171|NCT01057693|516206959|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
143180172|NCT01057693|516206960|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
143180173|NCT01057693|516206961|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
143180174|NCT01057693|516206959|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
143180175|NCT01057693|516206960|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
143180176|NCT01057693|516206961|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
143180177|NCT01057693|516206959|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
143180178|NCT01057693|516206960|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
143180179|NCT01057693|516206961|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
143180180|NCT01057693|516206959|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
143180181|NCT01057693|516206960|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
143180182|NCT01057693|516206961|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
143180183|NCT01057693|516206959|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
143180184|NCT01057693|516206960|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
143180185|NCT01057693|516206961|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
143180186|NCT01057693|516206959|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
143180187|NCT01057693|516206960|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
143180188|NCT01057693|516206961|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
143180189|NCT01057693|516206959|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
143180190|NCT01057693|516206960|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
143258729|NCT01099709|516501968|FG000|Period 1|Withdrawal by Subject|0|||
143258730|NCT01099709|516501969|FG001|Period 1|Withdrawal by Subject|1|||
143113325|NCT04908202|515956489|FG001|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
143113326|NCT04908202|515956490|FG002|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
143113327|NCT04908202|515956491|FG003|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
143113328|NCT04908202|515956488|FG000|Placebo-Controlled Treatment Period|Other reasons|8|||
143113329|NCT04908202|515956489|FG001|Placebo-Controlled Treatment Period|Other reasons|4|||
143113330|NCT04908202|515956490|FG002|Placebo-Controlled Treatment Period|Other reasons|0|||
143113331|NCT04908202|515956491|FG003|Placebo-Controlled Treatment Period|Other reasons|0|||
143113332|NCT04908202|515956488|FG000|Active Treatment Period|OTHER REASONS|0|||
143113333|NCT04908202|515956489|FG001|Active Treatment Period|OTHER REASONS|0|||
143113334|NCT04908202|515956490|FG002|Active Treatment Period|OTHER REASONS|1|||
143113335|NCT04908202|515956491|FG003|Active Treatment Period|OTHER REASONS|3|||
143113336|NCT04908202|515956488|FG000|Active Treatment Period|Lack of Efficacy|0|||
143113337|NCT04908202|515956489|FG001|Active Treatment Period|Lack of Efficacy|0|||
143113338|NCT04908202|515956490|FG002|Active Treatment Period|Lack of Efficacy|4|||
143113339|NCT04908202|515956491|FG003|Active Treatment Period|Lack of Efficacy|5|||
143113340|NCT04908202|515956488|FG000|Active Treatment Period|Adverse Event|0|||
143113341|NCT04908202|515956489|FG001|Active Treatment Period|Adverse Event|0|||
143113342|NCT04908202|515956490|FG002|Active Treatment Period|Adverse Event|5|||
143113343|NCT04908202|515956491|FG003|Active Treatment Period|Adverse Event|8|||
143113344|NCT04908202|515956488|FG000|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
143113345|NCT04908202|515956489|FG001|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
143113346|NCT04908202|515956490|FG002|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
143113347|NCT04908202|515956491|FG003|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
143113348|NCT04908202|515956488|FG000|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
143113349|NCT04908202|515956489|FG001|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
143180191|NCT01057693|516206961|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
143180192|NCT01057693|516206959|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
143180193|NCT01057693|516206960|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
143180194|NCT01057693|516206961|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
143180195|NCT01057693|516206959|FG000|Between Single-Blind and Double-Blind|Other|6|||
143180196|NCT01057693|516206960|FG001|Between Single-Blind and Double-Blind|Other|0|||
143180197|NCT01057693|516206961|FG002|Between Single-Blind and Double-Blind|Other|0|||
143180198|NCT01057693|516206959|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
143180199|NCT01057693|516206960|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
143180200|NCT01057693|516206961|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
143258731|NCT01099709|516501968|FG000|Period 1|Positive cotinine test|0|||
143258732|NCT01099709|516501969|FG001|Period 1|Positive cotinine test|1|||
143180201|NCT01057693|516206959|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
143180202|NCT01057693|516206960|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
143180203|NCT01057693|516206961|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
143180204|NCT01057693|516206959|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
143258733|NCT01099709|516501968|FG000|Period 1|Adverse Event|1|||
143258734|NCT01099709|516501969|FG001|Period 1|Adverse Event|0|||
143258735|NCT03468543|516501972|FG000|Overall Study|Protocol stopping rules met|3|||
143258736|NCT04179890|516501973|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
143258737|NCT04179890|516501974|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
143113350|NCT04908202|515956490|FG002|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|8|||
143113351|NCT04908202|515956491|FG003|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|11|||
143113352|NCT04908202|515956488|FG000|Active Treatment Period|Lost to Follow-up|0|||
143113353|NCT04908202|515956489|FG001|Active Treatment Period|Lost to Follow-up|0|||
143113354|NCT04908202|515956490|FG002|Active Treatment Period|Lost to Follow-up|2|||
143113355|NCT04908202|515956491|FG003|Active Treatment Period|Lost to Follow-up|2|||
143113356|NCT04908202|515956488|FG000|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
143113357|NCT04908202|515956489|FG001|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
143113358|NCT04908202|515956490|FG002|Active Treatment Period|POOR/NON-COMPLIANCE|1|||
143259609|NCT00400153|516505798|FG002|Overall Study|Other reasons - not mentioned above|3|||
143259610|NCT00327470|516505805|FG000|Overall Study|Randomized, but not treated|0|||
143259611|NCT00327470|516505806|FG001|Overall Study|Randomized, but not treated|2|||
143259612|NCT00327470|516505805|FG000|Overall Study|Adverse Event|9|||
143259613|NCT00327470|516505806|FG001|Overall Study|Adverse Event|14|||
143259614|NCT00327470|516505805|FG000|Overall Study|Lack of Efficacy|7|||
143259615|NCT00327470|516505806|FG001|Overall Study|Lack of Efficacy|19|||
143259616|NCT00327470|516505805|FG000|Overall Study|Other|5|||
143259617|NCT00327470|516505806|FG001|Overall Study|Other|9|||
143259618|NCT00327470|516505805|FG000|Overall Study|Lost to Follow-up|1|||
143259619|NCT00327470|516505806|FG001|Overall Study|Lost to Follow-up|3|||
143259620|NCT00327470|516505805|FG000|Overall Study|Withdrawal by Subject|6|||
143259621|NCT00327470|516505806|FG001|Overall Study|Withdrawal by Subject|12|||
143259622|NCT00327470|516505805|FG000|Overall Study|Death|1|||
143259623|NCT00327470|516505806|FG001|Overall Study|Death|4|||
143113359|NCT04908202|515956491|FG003|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
143113360|NCT04908202|515956488|FG000|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
143113361|NCT04908202|515956489|FG001|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
143113362|NCT04908202|515956490|FG002|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
143113363|NCT04908202|515956491|FG003|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
143113364|NCT04908202|515956488|FG000|Active Treatment Period|ONGOING Treatment|0|||
143113365|NCT04908202|515956489|FG001|Active Treatment Period|ONGOING Treatment|0|||
143113366|NCT04908202|515956490|FG002|Active Treatment Period|ONGOING Treatment|117|||
143113367|NCT04908202|515956491|FG003|Active Treatment Period|ONGOING Treatment|114|||
143113368|NCT05397171|515956492|FG000|Overall Study|Death|2|||
143113369|NCT05397171|515956493|FG001|Overall Study|Death|3|||
143113370|NCT05397171|515956494|FG002|Overall Study|Death|3|||
143113371|NCT05397171|515956492|FG000|Overall Study|Study Terminated By Sponsor|1|||
143113372|NCT05397171|515956493|FG001|Overall Study|Study Terminated By Sponsor|2|||
143113373|NCT05397171|515956494|FG002|Overall Study|Study Terminated By Sponsor|3|||
143113374|NCT05397171|515956492|FG000|Overall Study|Withdrawal by Subject|0|||
143113375|NCT05397171|515956493|FG001|Overall Study|Withdrawal by Subject|1|||
143113376|NCT05397171|515956494|FG002|Overall Study|Withdrawal by Subject|1|||
143113377|NCT02100670|515956495|FG000|Overall Study|Adverse Event|10|||
143113378|NCT02100670|515956496|FG001|Overall Study|Adverse Event|3|||
143113379|NCT02100670|515956497|FG002|Overall Study|Adverse Event|3|||
143113380|NCT02100670|515956498|FG003|Overall Study|Adverse Event|0|||
143113381|NCT02100670|515956495|FG000|Overall Study|Lost to Follow-up|1|||
143113382|NCT02100670|515956496|FG001|Overall Study|Lost to Follow-up|0|||
143113383|NCT02100670|515956497|FG002|Overall Study|Lost to Follow-up|0|||
143113384|NCT02100670|515956498|FG003|Overall Study|Lost to Follow-up|0|||
143113385|NCT02100670|515956495|FG000|Overall Study|Protocol Violation|0|||
143113386|NCT02100670|515956496|FG001|Overall Study|Protocol Violation|1|||
143113387|NCT02100670|515956497|FG002|Overall Study|Protocol Violation|0|||
143113388|NCT02100670|515956498|FG003|Overall Study|Protocol Violation|1|||
143113389|NCT02100670|515956495|FG000|Overall Study|Withdrawal of Consent|0|||
143113390|NCT02100670|515956496|FG001|Overall Study|Withdrawal of Consent|1|||
143113391|NCT02100670|515956497|FG002|Overall Study|Withdrawal of Consent|1|||
143113392|NCT02100670|515956498|FG003|Overall Study|Withdrawal of Consent|0|||
143113393|NCT02100670|515956495|FG000|Overall Study|No swelling no pain|1|||
143113394|NCT02100670|515956496|FG001|Overall Study|No swelling no pain|0|||
143113395|NCT02100670|515956497|FG002|Overall Study|No swelling no pain|0|||
143113396|NCT02100670|515956498|FG003|Overall Study|No swelling no pain|0|||
143113397|NCT02100670|515956495|FG000|Overall Study|Poor Efficacy|0|||
143113398|NCT02100670|515956496|FG001|Overall Study|Poor Efficacy|1|||
143113399|NCT02100670|515956497|FG002|Overall Study|Poor Efficacy|0|||
143113400|NCT02100670|515956498|FG003|Overall Study|Poor Efficacy|0|||
143113401|NCT02100670|515956495|FG000|Overall Study|Physician Decision|0|||
143113402|NCT02100670|515956496|FG001|Overall Study|Physician Decision|1|||
143113403|NCT02100670|515956497|FG002|Overall Study|Physician Decision|0|||
143113404|NCT02100670|515956498|FG003|Overall Study|Physician Decision|0|||
143113405|NCT02100670|515956495|FG000|Overall Study|Withdrawal by Subject|1|||
143113406|NCT02100670|515956496|FG001|Overall Study|Withdrawal by Subject|0|||
143113407|NCT02100670|515956497|FG002|Overall Study|Withdrawal by Subject|0|||
143113408|NCT02100670|515956498|FG003|Overall Study|Withdrawal by Subject|0|||
143113409|NCT01390428|515958268|FG000|Overall Study|Elective Surgery|0|||
143113410|NCT01390428|515958269|FG001|Overall Study|Elective Surgery|0|||
143113411|NCT01390428|515958270|FG002|Overall Study|Elective Surgery|0|||
143113412|NCT01390428|515958271|FG003|Overall Study|Elective Surgery|0|||
143113413|NCT01390428|515958272|FG004|Overall Study|Elective Surgery|1|||
143113414|NCT01390428|515958273|FG005|Overall Study|Elective Surgery|0|||
143180205|NCT01057693|516206960|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
143180206|NCT01057693|516206961|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
143180207|NCT01057693|516206959|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
143180208|NCT01057693|516206960|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
143180209|NCT01057693|516206961|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
143180210|NCT01057693|516206959|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
143180211|NCT01057693|516206960|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
143180212|NCT01057693|516206961|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
143258738|NCT04179890|516501973|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
143258739|NCT04179890|516501974|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
143113415|NCT01390428|515958268|FG000|Overall Study|Withdrawal by Subject|0|||
143113416|NCT01390428|515958269|FG001|Overall Study|Withdrawal by Subject|0|||
143113417|NCT01390428|515958270|FG002|Overall Study|Withdrawal by Subject|1|||
143113418|NCT01390428|515958271|FG003|Overall Study|Withdrawal by Subject|0|||
143113419|NCT01390428|515958272|FG004|Overall Study|Withdrawal by Subject|0|||
143113420|NCT01390428|515958273|FG005|Overall Study|Withdrawal by Subject|0|||
143113421|NCT05897827|515958276|FG000|Overall Study|Lost to Follow-up|33|||
143113422|NCT05897827|515958277|FG001|Overall Study|Lost to Follow-up|14|||
143113423|NCT05897827|515958276|FG000|Overall Study|Withdrawal by Subject|1|||
143113424|NCT05897827|515958277|FG001|Overall Study|Withdrawal by Subject|1|||
143113425|NCT02059434|515958280|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
143113426|NCT02059434|515958281|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
143113427|NCT02059434|515958282|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
143113428|NCT02059434|515958283|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
143113429|NCT02059434|515958284|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
143113430|NCT02059434|515958285|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
143113431|NCT02059434|515958286|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
143113432|NCT02059434|515958287|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
143113433|NCT02059434|515958288|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
143113434|NCT02059434|515958280|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
143113435|NCT02059434|515958281|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
143113436|NCT02059434|515958282|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
143113437|NCT02059434|515958283|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
143113438|NCT02059434|515958284|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
143113439|NCT02059434|515958285|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
143113440|NCT02059434|515958286|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
143113441|NCT02059434|515958287|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
143113442|NCT02059434|515958288|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
143113443|NCT02059434|515958280|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
143113444|NCT02059434|515958281|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
143113445|NCT02059434|515958282|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
143113446|NCT02059434|515958283|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
143113447|NCT02059434|515958284|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
143113448|NCT02059434|515958285|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
143113449|NCT02059434|515958286|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
143113450|NCT02059434|515958287|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
143113451|NCT02059434|515958288|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
143113452|NCT02059434|515958280|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
143113453|NCT02059434|515958281|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
143113454|NCT02059434|515958282|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
143113455|NCT02059434|515958283|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
143113456|NCT02059434|515958284|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
143113457|NCT02059434|515958285|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
143113458|NCT02059434|515958286|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
143113459|NCT02059434|515958287|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
143113460|NCT02059434|515958288|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
143113461|NCT02059434|515958280|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
143113462|NCT02059434|515958281|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
143113463|NCT02059434|515958282|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
143113464|NCT02059434|515958283|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
143113465|NCT02059434|515958284|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
143113466|NCT02059434|515958285|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
143113467|NCT02059434|515958286|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
143113468|NCT02059434|515958287|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
143113469|NCT02059434|515958288|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
143113470|NCT03201874|515958293|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
143113471|NCT03201874|515958294|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
143113472|NCT03201874|515958293|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
143113473|NCT03201874|515958294|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
143113474|NCT02907593|515958295|FG000|Overall Study|Withdrawal by Subject|0|||
143258740|NCT04179890|516501973|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
143258741|NCT04179890|516501974|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
143258742|NCT04179890|516501973|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
143258743|NCT04179890|516501974|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
143258744|NCT04179890|516501973|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
143258745|NCT04179890|516501974|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
143258746|NCT04179890|516501973|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
143258747|NCT04179890|516501974|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
143258748|NCT04179890|516501973|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
143258749|NCT04179890|516501974|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
143258750|NCT04179890|516501973|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
143258751|NCT04179890|516501974|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
143113475|NCT02907593|515958296|FG001|Overall Study|Withdrawal by Subject|0|||
143113476|NCT02907593|515958297|FG002|Overall Study|Withdrawal by Subject|1|||
143113477|NCT02907593|515958298|FG003|Overall Study|Withdrawal by Subject|0|||
143113478|NCT05562934|515958299|FG000|Overall Study|Adverse Event|0|||
143113479|NCT05562934|515958300|FG001|Overall Study|Adverse Event|2|||
143113480|NCT05562934|515958301|FG002|Overall Study|Adverse Event|0|||
143113481|NCT05562934|515958302|FG003|Overall Study|Adverse Event|0|||
143113482|NCT05562934|515958303|FG004|Overall Study|Adverse Event|2|||
143113483|NCT05562934|515958299|FG000|Overall Study|Lost to Follow-up|0|||
143113484|NCT05562934|515958300|FG001|Overall Study|Lost to Follow-up|0|||
143113485|NCT05562934|515958301|FG002|Overall Study|Lost to Follow-up|0|||
143113486|NCT05562934|515958302|FG003|Overall Study|Lost to Follow-up|0|||
143113487|NCT05562934|515958303|FG004|Overall Study|Lost to Follow-up|1|||
143113488|NCT05562934|515958299|FG000|Overall Study|Protocol Violation|0|||
143113489|NCT05562934|515958300|FG001|Overall Study|Protocol Violation|0|||
143113490|NCT05562934|515958301|FG002|Overall Study|Protocol Violation|0|||
143113491|NCT05562934|515958302|FG003|Overall Study|Protocol Violation|1|||
143113492|NCT05562934|515958303|FG004|Overall Study|Protocol Violation|1|||
143113493|NCT05562934|515958299|FG000|Overall Study|Withdrawal by Subject|0|||
143113494|NCT05562934|515958300|FG001|Overall Study|Withdrawal by Subject|0|||
143113495|NCT05562934|515958301|FG002|Overall Study|Withdrawal by Subject|1|||
143113496|NCT05562934|515958302|FG003|Overall Study|Withdrawal by Subject|1|||
143113497|NCT05562934|515958303|FG004|Overall Study|Withdrawal by Subject|0|||
143113498|NCT05741346|515958304|FG000|Overall Study|Withdrawn due to termination of study|28|||
143113499|NCT04982575|515958310|FG000|Overall Study|Withdrawal by Subject|2|||
143113500|NCT04982575|515958311|FG001|Overall Study|Withdrawal by Subject|0|||
143113501|NCT04982575|515958312|FG002|Overall Study|Withdrawal by Subject|2|||
143113502|NCT04322539|515958317|FG000|Overall Study|Adverse Event|2|||
143113503|NCT04322539|515958318|FG001|Overall Study|Adverse Event|0|||
143113504|NCT04322539|515958317|FG000|Overall Study|Death|411|||
143113505|NCT04322539|515958318|FG001|Overall Study|Death|203|||
143113506|NCT04322539|515958317|FG000|Overall Study|Lost to Follow-up|3|||
143113507|NCT04322539|515958318|FG001|Overall Study|Lost to Follow-up|1|||
143113508|NCT04322539|515958317|FG000|Overall Study|Withdrawal of consent|14|||
143113509|NCT04322539|515958318|FG001|Overall Study|Withdrawal of consent|8|||
143113510|NCT04322539|515958317|FG000|Overall Study|Radiological Disease Progression|6|||
143113511|NCT04322539|515958318|FG001|Overall Study|Radiological Disease Progression|0|||
143113512|NCT04322539|515958317|FG000|Overall Study|Sponsor Decision|19|||
143113513|NCT04322539|515958318|FG001|Overall Study|Sponsor Decision|14|||
143113514|NCT04322539|515958317|FG000|Overall Study|Other|6|||
143113515|NCT04322539|515958318|FG001|Overall Study|Other|4|||
143113516|NCT03617861|515958319|FG000|Second Intervention (1 Day)|Adverse Event|0|||
143113517|NCT03617861|515958320|FG001|Second Intervention (1 Day)|Adverse Event|0|||
143113518|NCT03617861|515958321|FG002|Second Intervention (1 Day)|Adverse Event|1|||
143113519|NCT03617861|515958322|FG003|Second Intervention (1 Day)|Adverse Event|0|||
143113520|NCT01702532|515958323|FG000|Overall Study|Adverse Event|0|||
143113521|NCT01702532|515958324|FG001|Overall Study|Adverse Event|1|||
143113522|NCT00623597|515958325|FG000|Overall Study|Failed to return|1|||
143113523|NCT00623597|515958326|FG001|Overall Study|Failed to return|0|||
143113524|NCT03226678|515958332|FG000|Part A (Core Study Phase)|Adverse Event|0|||
143113525|NCT03226678|515958333|FG001|Part A (Core Study Phase)|Adverse Event|1|||
143113526|NCT03226678|515958334|FG002|Part A (Core Study Phase)|Adverse Event|0|||
143113527|NCT03226678|515958335|FG003|Part A (Core Study Phase)|Adverse Event|0|||
143113528|NCT03226678|515958336|FG004|Part A (Core Study Phase)|Adverse Event|0|||
143113529|NCT03226678|515958337|FG005|Part A (Core Study Phase)|Adverse Event|0|||
143113530|NCT03226678|515958332|FG000|Part A (Core Study Phase)|Death|0|||
143113531|NCT03226678|515958333|FG001|Part A (Core Study Phase)|Death|0|||
143113532|NCT03226678|515958334|FG002|Part A (Core Study Phase)|Death|1|||
143113533|NCT03226678|515958335|FG003|Part A (Core Study Phase)|Death|0|||
143113534|NCT03226678|515958336|FG004|Part A (Core Study Phase)|Death|0|||
143113535|NCT03226678|515958337|FG005|Part A (Core Study Phase)|Death|0|||
143113536|NCT03226678|515958332|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
143113537|NCT03226678|515958333|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
143113538|NCT03226678|515958334|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
143113539|NCT03226678|515958335|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
143113540|NCT03226678|515958336|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
143113541|NCT03226678|515958337|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
143113542|NCT03226678|515958332|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
143113543|NCT03226678|515958333|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
143113544|NCT03226678|515958334|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
143113545|NCT03226678|515958335|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
143113546|NCT03226678|515958336|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
143113547|NCT03226678|515958337|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
143113548|NCT03226678|515958332|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
143113549|NCT03226678|515958333|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
143113550|NCT03226678|515958334|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
143368433|NCT01456936|516892679|FG001|Overall Study|Medication error|1|||
143368434|NCT01456936|516892680|FG002|Overall Study|Medication error|0|||
143368435|NCT01456936|516892681|FG003|Overall Study|Medication error|1|||
143368436|NCT01456936|516892678|FG000|Overall Study|Adverse event (study drug)|25|||
143368437|NCT01456936|516892679|FG001|Overall Study|Adverse event (study drug)|21|||
143368438|NCT01456936|516892680|FG002|Overall Study|Adverse event (study drug)|26|||
143368439|NCT01456936|516892681|FG003|Overall Study|Adverse event (study drug)|17|||
143368440|NCT01456936|516892678|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
143368441|NCT01456936|516892679|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
143368442|NCT01456936|516892680|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
143368443|NCT01456936|516892681|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
143368444|NCT01456936|516892678|FG000|Overall Study|Death|0|||
143368445|NCT01456936|516892679|FG001|Overall Study|Death|3|||
143368446|NCT01456936|516892680|FG002|Overall Study|Death|1|||
143368447|NCT01456936|516892681|FG003|Overall Study|Death|3|||
143368448|NCT01456936|516892678|FG000|Overall Study|Randomized but not treated|21|||
143368449|NCT01456936|516892679|FG001|Overall Study|Randomized but not treated|28|||
143368450|NCT01456936|516892680|FG002|Overall Study|Randomized but not treated|16|||
143368451|NCT01456936|516892681|FG003|Overall Study|Randomized but not treated|21|||
143368452|NCT00906698|516892682|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
143368453|NCT00906698|516892683|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
143368454|NCT00906698|516892684|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
143368455|NCT00906698|516892685|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
143368456|NCT00906698|516892686|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
143368457|NCT00906698|516892687|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
143368458|NCT00906698|516892682|FG000|Overall Study|Adverse Event|0|||
143368459|NCT00906698|516892683|FG001|Overall Study|Adverse Event|0|||
143368460|NCT00906698|516892684|FG002|Overall Study|Adverse Event|2|||
143368461|NCT00906698|516892685|FG003|Overall Study|Adverse Event|0|||
143368462|NCT00906698|516892686|FG004|Overall Study|Adverse Event|4|||
143368463|NCT00906698|516892687|FG005|Overall Study|Adverse Event|1|||
143368464|NCT00906698|516892682|FG000|Overall Study|Disease progression|3|||
143368465|NCT00906698|516892683|FG001|Overall Study|Disease progression|12|||
143368466|NCT00906698|516892684|FG002|Overall Study|Disease progression|4|||
143368467|NCT00906698|516892685|FG003|Overall Study|Disease progression|4|||
143368468|NCT00906698|516892686|FG004|Overall Study|Disease progression|12|||
143368469|NCT00906698|516892687|FG005|Overall Study|Disease progression|4|||
143368470|NCT00906698|516892682|FG000|Overall Study|Withdrawal by Subject|0|||
143368471|NCT00906698|516892683|FG001|Overall Study|Withdrawal by Subject|0|||
143368472|NCT00906698|516892684|FG002|Overall Study|Withdrawal by Subject|0|||
143368473|NCT00906698|516892685|FG003|Overall Study|Withdrawal by Subject|0|||
143368474|NCT00906698|516892686|FG004|Overall Study|Withdrawal by Subject|1|||
143113551|NCT03226678|515958335|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
143113552|NCT03226678|515958336|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
143113553|NCT03226678|515958337|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
143113554|NCT03226678|515958332|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
143113555|NCT03226678|515958333|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
143113556|NCT03226678|515958334|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
143113557|NCT03226678|515958335|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
143113558|NCT03226678|515958336|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
143113559|NCT03226678|515958337|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
143113560|NCT03226678|515958332|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
143113561|NCT03226678|515958333|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
143113562|NCT03226678|515958334|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
143368475|NCT00906698|516892687|FG005|Overall Study|Withdrawal by Subject|0|||
143113563|NCT03226678|515958335|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
143368476|NCT00906698|516892682|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
143368477|NCT00906698|516892683|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
143368478|NCT00906698|516892684|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
143368479|NCT00906698|516892685|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
143368480|NCT00906698|516892686|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
143368481|NCT00906698|516892687|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
143368482|NCT01250002|516892688|FG000|Overall Study|Change to open surgical procedure|4|||
143368483|NCT01250002|516892689|FG001|Overall Study|Change to open surgical procedure|3|||
143368484|NCT02317705|516892690|FG000|Overall Study|Withdrawal by Subject|3|||
143368485|NCT02317705|516892690|FG000|Overall Study|Physician Decision|1|||
143368486|NCT02317705|516892690|FG000|Overall Study|Drug not usable|1|||
143368487|NCT01878890|516892698|FG000|Overall Study|Protocol Violation|0|||
143368488|NCT01878890|516892699|FG001|Overall Study|Protocol Violation|1|||
143368489|NCT01878890|516892700|FG002|Overall Study|Protocol Violation|0|||
143368490|NCT01878890|516892701|FG003|Overall Study|Protocol Violation|0|||
143368491|NCT03404843|516892704|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
143368492|NCT03404843|516892705|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
143368493|NCT02701361|516892707|FG000|Overall Study|Lost to Follow-up|5|||
143113564|NCT03226678|515958336|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
143113565|NCT03226678|515958337|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
143113566|NCT03226678|515958332|FG000|Part B (Long-Term Extension Phase)|Death|0|||
143113567|NCT03226678|515958333|FG001|Part B (Long-Term Extension Phase)|Death|0|||
143113568|NCT03226678|515958334|FG002|Part B (Long-Term Extension Phase)|Death|0|||
143113569|NCT03226678|515958335|FG003|Part B (Long-Term Extension Phase)|Death|0|||
143113570|NCT03226678|515958336|FG004|Part B (Long-Term Extension Phase)|Death|0|||
143113571|NCT03226678|515958337|FG005|Part B (Long-Term Extension Phase)|Death|1|||
143113572|NCT03226678|515958332|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
143113573|NCT03226678|515958333|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
143113574|NCT03226678|515958334|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
143113575|NCT03226678|515958335|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
143113576|NCT03226678|515958336|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
143113577|NCT03226678|515958337|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
143113578|NCT03226678|515958332|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
143113579|NCT03226678|515958333|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
143113580|NCT03226678|515958334|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
143180213|NCT01057693|516206959|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
143180214|NCT01057693|516206960|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
143180215|NCT01057693|516206961|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
143180216|NCT01057693|516206959|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
143180217|NCT01057693|516206960|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
143258752|NCT04179890|516501973|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
143258753|NCT04179890|516501974|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
143258754|NCT00978432|516501976|FG000|Overall Study|Withdrawal by Subject|0|||
143258755|NCT00978432|516501977|FG001|Overall Study|Withdrawal by Subject|0|||
143258756|NCT00978432|516501978|FG002|Overall Study|Withdrawal by Subject|1|||
143258757|NCT00978432|516501976|FG000|Overall Study|Lack of Efficacy|1|||
143258758|NCT00978432|516501977|FG001|Overall Study|Lack of Efficacy|1|||
143258759|NCT00978432|516501978|FG002|Overall Study|Lack of Efficacy|3|||
143258760|NCT00978432|516501976|FG000|Overall Study|Adverse Event|2|||
143258761|NCT00978432|516501977|FG001|Overall Study|Adverse Event|0|||
143258762|NCT00978432|516501978|FG002|Overall Study|Adverse Event|1|||
143258763|NCT02579928|516501979|FG000|Overall Study|Withdrawal by Subject|1|||
143258764|NCT02579928|516501980|FG001|Overall Study|Withdrawal by Subject|0|||
143258765|NCT02311582|516501985|FG000|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
143258766|NCT02311582|516501986|FG001|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
143258767|NCT02311582|516501987|FG002|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
143258768|NCT02311582|516501988|FG003|Overall Study|Was enrolled but did not receive any MK-3475 treatment|6|||
143258769|NCT02311582|516501989|FG004|Overall Study|Was enrolled but did not receive any MK-3475 treatment|4|||
143258770|NCT03404960|516501991|FG000|Overall Study|Adverse Event|0|||
143258771|NCT03404960|516501992|FG001|Overall Study|Adverse Event|2|||
143113581|NCT03226678|515958335|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
143113582|NCT03226678|515958336|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
143180218|NCT01057693|516206961|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
143180219|NCT02413996|516206962|FG000|Overall Study|not comfortable with the intervention|9|||
143180220|NCT02413996|516206963|FG001|Overall Study|not comfortable with the intervention|2|||
143180221|NCT00590967|516206967|FG000|Overall Study|Withdrawal by Subject|1|||
143180222|NCT00590967|516206968|FG001|Overall Study|Withdrawal by Subject|1|||
143180223|NCT00590967|516206967|FG000|Overall Study|Ineligible|1|||
143180224|NCT00590967|516206968|FG001|Overall Study|Ineligible|0|||
143180225|NCT00590967|516206967|FG000|Overall Study|Poor performance status|0|||
143180226|NCT00590967|516206968|FG001|Overall Study|Poor performance status|1|||
143180227|NCT00590967|516206967|FG000|Overall Study|Non-compliant|0|||
143180228|NCT00590967|516206968|FG001|Overall Study|Non-compliant|2|||
143180229|NCT00590967|516206967|FG000|Overall Study|Did not sign consent form|0|||
143180230|NCT00590967|516206968|FG001|Overall Study|Did not sign consent form|1|||
143180231|NCT00590967|516206967|FG000|Overall Study|Did not receive chemo per protocol|1|||
143180232|NCT00590967|516206968|FG001|Overall Study|Did not receive chemo per protocol|0|||
143180233|NCT01881789|516206969|FG000|Overall Study|Withdrawal by Subject|0|||
143180234|NCT01881789|516206970|FG001|Overall Study|Withdrawal by Subject|2|||
143180235|NCT01881789|516206971|FG002|Overall Study|Withdrawal by Subject|1|||
143258772|NCT03404960|516501991|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
143113583|NCT03226678|515958337|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
143180236|NCT01881789|516206972|FG003|Overall Study|Withdrawal by Subject|0|||
143180237|NCT01881789|516206973|FG004|Overall Study|Withdrawal by Subject|1|||
143180238|NCT01881789|516206974|FG005|Overall Study|Withdrawal by Subject|1|||
143258773|NCT03404960|516501992|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
143258774|NCT03404960|516501991|FG000|Overall Study|Bowel obstruction|0|||
143113584|NCT03226678|515958332|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
143113585|NCT03226678|515958333|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
143258775|NCT03404960|516501992|FG001|Overall Study|Bowel obstruction|1|||
143258776|NCT03404960|516501991|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
143113586|NCT03226678|515958334|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
143113587|NCT03226678|515958335|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
143113588|NCT03226678|515958336|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
143113589|NCT03226678|515958337|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
143113590|NCT01473394|515958340|FG000|Overall Study|Adverse Event|13|||
143113591|NCT01473394|515958341|FG001|Overall Study|Adverse Event|16|||
143113592|NCT01473394|515958340|FG000|Overall Study|Insufficient Therapeutic Response|4|||
143113593|NCT01473394|515958341|FG001|Overall Study|Insufficient Therapeutic Response|1|||
143113594|NCT01473394|515958340|FG000|Overall Study|Protocol Violation|7|||
143113595|NCT01473394|515958341|FG001|Overall Study|Protocol Violation|5|||
143113596|NCT01473394|515958340|FG000|Overall Study|Withdrew Consent|12|||
143113597|NCT01473394|515958341|FG001|Overall Study|Withdrew Consent|10|||
143113598|NCT01473394|515958340|FG000|Overall Study|Lost to Follow-up|9|||
143113599|NCT01473394|515958341|FG001|Overall Study|Lost to Follow-up|11|||
143113600|NCT00552032|515958342|FG000|Overall Study|Withdrawal by Subject|2|||
143113601|NCT00552032|515958343|FG001|Overall Study|Withdrawal by Subject|2|||
143113602|NCT00552032|515958342|FG000|Overall Study|Protocol Violation|7|||
143113603|NCT00552032|515958343|FG001|Overall Study|Protocol Violation|12|||
143113604|NCT00552032|515958342|FG000|Overall Study|Lost to Follow-up|8|||
143113605|NCT00552032|515958343|FG001|Overall Study|Lost to Follow-up|5|||
143258777|NCT03404960|516501992|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
143258778|NCT04972630|516501993|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
143258779|NCT04972630|516501994|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
143258780|NCT04972630|516501995|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
143258781|NCT00246571|516501998|FG000|Overall Study|Adverse Event|7|||
143258782|NCT00246571|516501999|FG001|Overall Study|Adverse Event|0|||
143258783|NCT00246571|516501998|FG000|Overall Study|Protocol Violation|0|||
143258784|NCT00246571|516501999|FG001|Overall Study|Protocol Violation|1|||
143258785|NCT00246571|516501998|FG000|Overall Study|Withdrawal by Subject|2|||
143258786|NCT00246571|516501999|FG001|Overall Study|Withdrawal by Subject|3|||
143113606|NCT00345878|515958344|FG000|Overall Study|Adverse Event|1|||
143113607|NCT00345878|515958345|FG001|Overall Study|Adverse Event|0|||
143113608|NCT00345878|515958344|FG000|Overall Study|Lost to Follow-up|2|||
143113609|NCT00345878|515958345|FG001|Overall Study|Lost to Follow-up|1|||
143113610|NCT00345878|515958344|FG000|Overall Study|Other|1|||
143113611|NCT00345878|515958345|FG001|Overall Study|Other|0|||
143113612|NCT01349322|515958346|FG000|Overall Study|Protocol Violation|45|||
143113613|NCT01349322|515958347|FG001|Overall Study|Protocol Violation|47|||
143180239|NCT01881789|516206969|FG000|Overall Study|Study Terminated by Sponsor|0|||
143258787|NCT00246571|516501998|FG000|Overall Study|Lack of Efficacy|84|||
143258788|NCT00246571|516501999|FG001|Overall Study|Lack of Efficacy|21|||
143258789|NCT00246571|516501998|FG000|Overall Study|Death|17|||
143258790|NCT00246571|516501999|FG001|Overall Study|Death|3|||
143258791|NCT00246571|516501998|FG000|Overall Study|Sponsor|0|||
143258792|NCT00246571|516501999|FG001|Overall Study|Sponsor|1|||
143258793|NCT00246571|516501998|FG000|Overall Study|Did not meet entrance criteria|2|||
143258794|NCT00246571|516501999|FG001|Overall Study|Did not meet entrance criteria|1|||
143180240|NCT01881789|516206970|FG001|Overall Study|Study Terminated by Sponsor|0|||
143180241|NCT01881789|516206971|FG002|Overall Study|Study Terminated by Sponsor|0|||
143180242|NCT01881789|516206972|FG003|Overall Study|Study Terminated by Sponsor|0|||
143180243|NCT01881789|516206973|FG004|Overall Study|Study Terminated by Sponsor|0|||
143180244|NCT01881789|516206974|FG005|Overall Study|Study Terminated by Sponsor|1|||
143180245|NCT01881789|516206969|FG000|Overall Study|Other|3|||
143180246|NCT01881789|516206970|FG001|Overall Study|Other|5|||
143180247|NCT01881789|516206971|FG002|Overall Study|Other|2|||
143180248|NCT01881789|516206972|FG003|Overall Study|Other|3|||
143258795|NCT00246571|516501998|FG000|Overall Study|Laboratory abnormalities|1|||
143258796|NCT00246571|516501999|FG001|Overall Study|Laboratory abnormalities|0|||
143258797|NCT00246571|516501998|FG000|Overall Study|Crossover participants|0|||
143258798|NCT00246571|516501999|FG001|Overall Study|Crossover participants|74|||
143258799|NCT03422627|516502000|FG000|Overall Study|Protocol-specified Criteria|1|||
143113614|NCT04076059|515958356|FG000|Double Blind Phase|Progressive disease|22|||
143113615|NCT04076059|515958357|FG001|Double Blind Phase|Progressive disease|26|||
143180249|NCT01881789|516206973|FG004|Overall Study|Other|1|||
143180250|NCT01881789|516206974|FG005|Overall Study|Other|1|||
143180251|NCT00920556|516206977|FG000|Overall Study|Adverse Event|16|||
143180252|NCT00920556|516206977|FG000|Overall Study|Physician Decision|7|||
143180253|NCT00920556|516206977|FG000|Overall Study|Withdrawal by Subject|1|||
143258800|NCT03422627|516502001|FG001|Overall Study|Protocol-specified Criteria|1|||
143113616|NCT04076059|515958358|FG002|Double Blind Phase|Progressive disease|0|||
143113617|NCT04076059|515958356|FG000|Double Blind Phase|Withdrawal by Subject|4|||
143180254|NCT01299389|516206978|FG000|Double-blind|Adverse Event|45|||
143368494|NCT02701361|516892708|FG001|Overall Study|Lost to Follow-up|2|||
143368495|NCT02701361|516892709|FG002|Overall Study|Lost to Follow-up|1|||
143368496|NCT02701361|516892707|FG000|Overall Study|Withdrawal by Subject|4|||
143368497|NCT02701361|516892708|FG001|Overall Study|Withdrawal by Subject|0|||
143368498|NCT02701361|516892709|FG002|Overall Study|Withdrawal by Subject|0|||
143113618|NCT04076059|515958357|FG001|Double Blind Phase|Withdrawal by Subject|11|||
143113619|NCT04076059|515958358|FG002|Double Blind Phase|Withdrawal by Subject|0|||
143113620|NCT04076059|515958356|FG000|Double Blind Phase|Death|1|||
143113621|NCT04076059|515958357|FG001|Double Blind Phase|Death|1|||
143113622|NCT04076059|515958358|FG002|Double Blind Phase|Death|0|||
143113623|NCT04076059|515958356|FG000|Double Blind Phase|Lost to Follow-up|1|||
143113624|NCT04076059|515958357|FG001|Double Blind Phase|Lost to Follow-up|0|||
143113625|NCT04076059|515958358|FG002|Double Blind Phase|Lost to Follow-up|0|||
143368499|NCT02701361|516892707|FG000|Overall Study|timed out in rehab center|0|||
143368500|NCT02701361|516892708|FG001|Overall Study|timed out in rehab center|1|||
143368501|NCT02701361|516892709|FG002|Overall Study|timed out in rehab center|0|||
143368502|NCT02701361|516892707|FG000|Overall Study|incarceration|0|||
143368503|NCT02701361|516892708|FG001|Overall Study|incarceration|0|||
143368504|NCT02701361|516892709|FG002|Overall Study|incarceration|1|||
143368505|NCT02430532|516892716|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
143368506|NCT02430532|516892717|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
143368507|NCT02430532|516892716|FG000|Overall Study|Consent Withdrawn|0|||
143368508|NCT02430532|516892717|FG001|Overall Study|Consent Withdrawn|2|||
143368509|NCT02430532|516892716|FG000|Overall Study|Adverse Event|0|||
143368510|NCT02430532|516892717|FG001|Overall Study|Adverse Event|1|||
143368511|NCT00290732|516892718|FG000|Overall Study|Inability to instill drug intraductally.|0|||
143368512|NCT00290732|516892719|FG001|Overall Study|Inability to instill drug intraductally.|1|||
143368513|NCT00290732|516892720|FG002|Overall Study|Inability to instill drug intraductally.|1|||
143368514|NCT00290732|516892721|FG003|Overall Study|Inability to instill drug intraductally.|0|||
143368515|NCT00290732|516892722|FG004|Overall Study|Inability to instill drug intraductally.|0|||
143368516|NCT00502593|516892723|FG000|Overall Study|Withdrawn unspecified reason|1|||
143368517|NCT00502593|516892724|FG001|Overall Study|Withdrawn unspecified reason|1|||
143368518|NCT00502593|516892725|FG002|Overall Study|Withdrawn unspecified reason|3|||
143113626|NCT04076059|515958356|FG000|Double Blind Phase|Adverse Event|5|||
143113627|NCT04076059|515958357|FG001|Double Blind Phase|Adverse Event|1|||
143368519|NCT00502593|516892726|FG003|Overall Study|Withdrawn unspecified reason|1|||
143368520|NCT00502593|516892727|FG004|Overall Study|Withdrawn unspecified reason|2|||
143368521|NCT00502593|516892728|FG005|Overall Study|Withdrawn unspecified reason|0|||
143368522|NCT00502593|516892729|FG006|Overall Study|Withdrawn unspecified reason|2|||
143368523|NCT00502593|516892730|FG007|Overall Study|Withdrawn unspecified reason|0|||
143368524|NCT00502593|516892731|FG008|Overall Study|Withdrawn unspecified reason|0|||
143368525|NCT00502593|516892732|FG009|Overall Study|Withdrawn unspecified reason|0|||
143368526|NCT00502593|516892733|FG010|Overall Study|Withdrawn unspecified reason|0|||
143368527|NCT00502593|516892734|FG011|Overall Study|Withdrawn unspecified reason|0|||
143113628|NCT04076059|515958358|FG002|Double Blind Phase|Adverse Event|0|||
143113629|NCT04076059|515958356|FG000|Double Blind Phase|Ongoing Participants|82|||
143113630|NCT04076059|515958357|FG001|Double Blind Phase|Ongoing Participants|18|||
143113631|NCT04076059|515958358|FG002|Double Blind Phase|Ongoing Participants|0|||
143113632|NCT04076059|515958356|FG000|Double Blind Phase|Miscellaneous|3|||
143113633|NCT04076059|515958357|FG001|Double Blind Phase|Miscellaneous|1|||
143113634|NCT04076059|515958358|FG002|Double Blind Phase|Miscellaneous|0|||
143113635|NCT04076059|515958356|FG000|Double Blind Phase|Protocol Deviation|1|||
143113636|NCT04076059|515958357|FG001|Double Blind Phase|Protocol Deviation|1|||
143113637|NCT04076059|515958358|FG002|Double Blind Phase|Protocol Deviation|0|||
143113638|NCT04076059|515958356|FG000|Double Blind Phase|Did not take study drug|1|||
143113639|NCT04076059|515958357|FG001|Double Blind Phase|Did not take study drug|1|||
143258801|NCT03422627|516502002|FG002|Overall Study|Protocol-specified Criteria|0|||
143258802|NCT03422627|516502003|FG003|Overall Study|Protocol-specified Criteria|0|||
143258803|NCT03422627|516502004|FG004|Overall Study|Protocol-specified Criteria|2|||
143258804|NCT03422627|516502000|FG000|Overall Study|Requirement for Alternative Therapy|1|||
143258805|NCT03422627|516502001|FG001|Overall Study|Requirement for Alternative Therapy|1|||
143258806|NCT03422627|516502002|FG002|Overall Study|Requirement for Alternative Therapy|2|||
143258807|NCT03422627|516502003|FG003|Overall Study|Requirement for Alternative Therapy|0|||
143258808|NCT03422627|516502004|FG004|Overall Study|Requirement for Alternative Therapy|0|||
143258809|NCT03422627|516502000|FG000|Overall Study|Disease Progression|1|||
143258810|NCT03422627|516502001|FG001|Overall Study|Disease Progression|0|||
143258811|NCT03422627|516502002|FG002|Overall Study|Disease Progression|1|||
143258812|NCT03422627|516502003|FG003|Overall Study|Disease Progression|2|||
143258813|NCT03422627|516502004|FG004|Overall Study|Disease Progression|0|||
143258814|NCT03422627|516502000|FG000|Overall Study|Adverse Event|2|||
143113640|NCT04076059|515958358|FG002|Double Blind Phase|Did not take study drug|0|||
143113641|NCT04076059|515958356|FG000|Open Label Phase|Progressive disease|0|||
143113642|NCT04076059|515958357|FG001|Open Label Phase|Progressive disease|0|||
143258815|NCT03422627|516502001|FG001|Overall Study|Adverse Event|1|||
143368528|NCT00502593|516892723|FG000|Overall Study|Withdrawal by Subject|0|||
143368529|NCT00502593|516892724|FG001|Overall Study|Withdrawal by Subject|0|||
143368530|NCT00502593|516892725|FG002|Overall Study|Withdrawal by Subject|6|||
143368531|NCT00502593|516892726|FG003|Overall Study|Withdrawal by Subject|2|||
143368532|NCT00502593|516892727|FG004|Overall Study|Withdrawal by Subject|2|||
143368533|NCT00502593|516892728|FG005|Overall Study|Withdrawal by Subject|0|||
143368534|NCT00502593|516892729|FG006|Overall Study|Withdrawal by Subject|3|||
143368535|NCT00502593|516892730|FG007|Overall Study|Withdrawal by Subject|0|||
143368536|NCT00502593|516892731|FG008|Overall Study|Withdrawal by Subject|3|||
143368537|NCT00502593|516892732|FG009|Overall Study|Withdrawal by Subject|0|||
143368538|NCT00502593|516892733|FG010|Overall Study|Withdrawal by Subject|1|||
143368539|NCT00502593|516892734|FG011|Overall Study|Withdrawal by Subject|0|||
143368540|NCT00502593|516892723|FG000|Overall Study|Lost to Follow-up|2|||
143368541|NCT00502593|516892724|FG001|Overall Study|Lost to Follow-up|1|||
143368542|NCT00502593|516892725|FG002|Overall Study|Lost to Follow-up|1|||
143258816|NCT03422627|516502002|FG002|Overall Study|Adverse Event|0|||
143258817|NCT03422627|516502003|FG003|Overall Study|Adverse Event|0|||
143258818|NCT03422627|516502004|FG004|Overall Study|Adverse Event|2|||
143258819|NCT03422627|516502000|FG000|Overall Study|Ineligibility Determined|0|||
143258820|NCT03422627|516502001|FG001|Overall Study|Ineligibility Determined|1|||
143258821|NCT03422627|516502002|FG002|Overall Study|Ineligibility Determined|0|||
143258822|NCT03422627|516502003|FG003|Overall Study|Ineligibility Determined|0|||
143258823|NCT03422627|516502004|FG004|Overall Study|Ineligibility Determined|0|||
143258824|NCT03422627|516502000|FG000|Overall Study|Death|0|||
143258825|NCT03422627|516502001|FG001|Overall Study|Death|1|||
143258826|NCT03422627|516502002|FG002|Overall Study|Death|1|||
143258827|NCT03422627|516502003|FG003|Overall Study|Death|0|||
143258828|NCT03422627|516502004|FG004|Overall Study|Death|0|||
143258829|NCT03422627|516502000|FG000|Overall Study|Withdrawal by Subject|0|||
143258830|NCT03422627|516502001|FG001|Overall Study|Withdrawal by Subject|0|||
143258831|NCT03422627|516502002|FG002|Overall Study|Withdrawal by Subject|0|||
143258832|NCT03422627|516502003|FG003|Overall Study|Withdrawal by Subject|1|||
143258833|NCT03422627|516502004|FG004|Overall Study|Withdrawal by Subject|0|||
143258834|NCT04251156|516502008|FG000|Overall Study|Lost to Follow-up|1|||
143258835|NCT04251156|516502009|FG001|Overall Study|Lost to Follow-up|1|||
143258836|NCT04251156|516502008|FG000|Overall Study|Withdrawal by Subject|4|||
143258837|NCT04251156|516502009|FG001|Overall Study|Withdrawal by Subject|4|||
143258838|NCT02455557|516502010|FG000|Overall Study|Withdrawal by Subject|2|||
143258839|NCT00807027|516502011|FG000|Overall Study|Withdrawal by Subject|13|||
143258840|NCT00807027|516502012|FG001|Overall Study|Withdrawal by Subject|14|||
143258841|NCT00807027|516502011|FG000|Overall Study|Protocol Violation|1|||
143258842|NCT00807027|516502012|FG001|Overall Study|Protocol Violation|1|||
143258843|NCT00807027|516502011|FG000|Overall Study|Adverse Event|2|||
143258844|NCT00807027|516502012|FG001|Overall Study|Adverse Event|2|||
143258845|NCT04656275|516502013|FG000|Overall Study|Study terminated by sponsor|2|||
143258846|NCT04656275|516502014|FG001|Overall Study|Study terminated by sponsor|4|||
143258847|NCT01129024|516502016|FG000|Overall Study|Physician Decision|5|||
143258848|NCT01129024|516502016|FG000|Overall Study|Study Terminated by Sponsor|8|||
143258849|NCT01129024|516502016|FG000|Overall Study|Withdrawal by Subject|2|||
143258850|NCT01129024|516502016|FG000|Overall Study|Lack of Efficacy|3|||
143258851|NCT01129024|516502016|FG000|Overall Study|Needed a Platelet Transfusion|1|||
143258852|NCT00934648|516502019|FG000|Overall Study|Failure to return|8|||
143258853|NCT00934648|516502019|FG000|Overall Study|Withdrawal by Subject|1|||
143258854|NCT00924781|516502022|FG000|Overall Study|Study terminated by sponsor|12|||
143258855|NCT00924781|516502023|FG001|Overall Study|Study terminated by sponsor|10|||
143258856|NCT02106923|516502024|FG000|Overall Study|Protocol Violation|0|||
143258857|NCT02106923|516502025|FG001|Overall Study|Protocol Violation|0|||
143258858|NCT02106923|516502026|FG002|Overall Study|Protocol Violation|0|||
143258859|NCT02106923|516502027|FG003|Overall Study|Protocol Violation|0|||
143258860|NCT02106923|516502028|FG004|Overall Study|Protocol Violation|0|||
143258861|NCT02106923|516502029|FG005|Overall Study|Protocol Violation|1|||
143368543|NCT00502593|516892726|FG003|Overall Study|Lost to Follow-up|1|||
143368544|NCT00502593|516892727|FG004|Overall Study|Lost to Follow-up|0|||
143258862|NCT01323920|516502030|FG000|Overall Study|Death|5|||
143258863|NCT01323920|516502030|FG000|Overall Study|Withdrawal by Subject|1|||
143258864|NCT03915860|516502032|FG000|Overall Study|Adverse Event|3|||
143368545|NCT00502593|516892728|FG005|Overall Study|Lost to Follow-up|0|||
143368546|NCT00502593|516892729|FG006|Overall Study|Lost to Follow-up|0|||
143258865|NCT03915860|516502032|FG000|Overall Study|Withdrawal by Subject|6|||
143258866|NCT03915860|516502032|FG000|Overall Study|Lost to Follow-up|2|||
143258867|NCT03915860|516502032|FG000|Overall Study|Other than specified|3|||
143258868|NCT03901456|516502033|FG000|Overall Study|Withdrawal by Subject|0|||
143258869|NCT03901456|516502034|FG001|Overall Study|Withdrawal by Subject|0|||
143258870|NCT03901456|516502035|FG002|Overall Study|Withdrawal by Subject|1|||
143258871|NCT03901456|516502033|FG000|Overall Study|Lost to Follow-up|0|||
143258872|NCT03901456|516502034|FG001|Overall Study|Lost to Follow-up|1|||
143368547|NCT00502593|516892730|FG007|Overall Study|Lost to Follow-up|0|||
143368548|NCT00502593|516892731|FG008|Overall Study|Lost to Follow-up|3|||
143368549|NCT00502593|516892732|FG009|Overall Study|Lost to Follow-up|0|||
143113643|NCT04076059|515958358|FG002|Open Label Phase|Progressive disease|7|||
143113644|NCT04076059|515958356|FG000|Open Label Phase|Withdrawal by Subject|0|||
143113645|NCT04076059|515958357|FG001|Open Label Phase|Withdrawal by Subject|0|||
143113646|NCT04076059|515958358|FG002|Open Label Phase|Withdrawal by Subject|3|||
143113647|NCT04076059|515958356|FG000|Open Label Phase|Death|0|||
143113648|NCT04076059|515958357|FG001|Open Label Phase|Death|0|||
143113649|NCT04076059|515958358|FG002|Open Label Phase|Death|2|||
143113650|NCT04076059|515958356|FG000|Open Label Phase|Ongoing Participants|0|||
143113651|NCT04076059|515958357|FG001|Open Label Phase|Ongoing Participants|0|||
143113652|NCT04076059|515958358|FG002|Open Label Phase|Ongoing Participants|11|||
143113653|NCT02677896|515958359|FG000|Double Blind Period (up to 35 Months)|Death|117|||
143113654|NCT02677896|515958360|FG001|Double Blind Period (up to 35 Months)|Death|197|||
143180255|NCT01299389|516206979|FG001|Double-blind|Adverse Event|27|||
143180256|NCT01299389|516206980|FG002|Double-blind|Adverse Event|0|||
143180257|NCT01299389|516206981|FG003|Double-blind|Adverse Event|0|||
143180258|NCT01299389|516206978|FG000|Double-blind|Lack of Efficacy|45|||
143180259|NCT01299389|516206979|FG001|Double-blind|Lack of Efficacy|21|||
143180260|NCT01299389|516206980|FG002|Double-blind|Lack of Efficacy|0|||
143180261|NCT01299389|516206981|FG003|Double-blind|Lack of Efficacy|0|||
143180262|NCT01299389|516206978|FG000|Double-blind|Lost to Follow-up|2|||
143180263|NCT01299389|516206979|FG001|Double-blind|Lost to Follow-up|1|||
143180264|NCT01299389|516206980|FG002|Double-blind|Lost to Follow-up|0|||
143180265|NCT01299389|516206981|FG003|Double-blind|Lost to Follow-up|0|||
143180266|NCT01299389|516206978|FG000|Double-blind|Withdrawal by Subject|16|||
143180267|NCT01299389|516206979|FG001|Double-blind|Withdrawal by Subject|13|||
143180268|NCT01299389|516206980|FG002|Double-blind|Withdrawal by Subject|0|||
143180269|NCT01299389|516206981|FG003|Double-blind|Withdrawal by Subject|0|||
143180270|NCT01299389|516206978|FG000|Double-blind|Other|1|||
143180271|NCT01299389|516206979|FG001|Double-blind|Other|1|||
143180272|NCT01299389|516206980|FG002|Double-blind|Other|0|||
143180273|NCT01299389|516206981|FG003|Double-blind|Other|0|||
143180274|NCT01299389|516206978|FG000|Double-blind|"fail to meet study population criteria"|0|||
143180275|NCT01299389|516206979|FG001|Double-blind|"fail to meet study population criteria"|1|||
143180276|NCT01299389|516206980|FG002|Double-blind|"fail to meet study population criteria"|0|||
143180277|NCT01299389|516206981|FG003|Double-blind|"fail to meet study population criteria"|0|||
143180278|NCT01299389|516206978|FG000|Post-observational|Other|0|||
143180279|NCT01299389|516206979|FG001|Post-observational|Other|0|||
143180280|NCT01299389|516206980|FG002|Post-observational|Other|12|||
143180281|NCT01299389|516206981|FG003|Post-observational|Other|6|||
143180282|NCT03465722|516206982|FG000|Overall Study|Withdrawal by Subject|21|||
143180283|NCT03465722|516206983|FG001|Overall Study|Withdrawal by Subject|14|||
143180284|NCT03465722|516206982|FG000|Overall Study|Death|89|||
143180285|NCT03465722|516206983|FG001|Overall Study|Death|87|||
143180286|NCT03465722|516206982|FG000|Overall Study|Lost to Follow-up|5|||
143180287|NCT03465722|516206983|FG001|Overall Study|Lost to Follow-up|3|||
143180288|NCT03465722|516206982|FG000|Overall Study|Administrative/Other|33|||
143180289|NCT03465722|516206983|FG001|Overall Study|Administrative/Other|32|||
143180290|NCT03465722|516206982|FG000|Overall Study|Not treated|1|||
143180291|NCT03465722|516206983|FG001|Overall Study|Not treated|2|||
143180292|NCT03465722|516206982|FG000|Overall Study|Sponsor decision|91|||
143180293|NCT03465722|516206983|FG001|Overall Study|Sponsor decision|98|||
143180294|NCT01635998|516206984|FG000|Overall Study|Death|1|||
143180295|NCT01635998|516206985|FG001|Overall Study|Death|1|||
143180296|NCT01635998|516206984|FG000|Overall Study|Lost to Follow-up|2|||
143180297|NCT01635998|516206985|FG001|Overall Study|Lost to Follow-up|1|||
143180298|NCT01635998|516206984|FG000|Overall Study|Withdrawal by Subject|1|||
143180299|NCT01635998|516206985|FG001|Overall Study|Withdrawal by Subject|5|||
143180300|NCT00955474|516206990|FG000|Overall Study|Physician Decision|7|||
143180301|NCT00955474|516206991|FG001|Overall Study|Physician Decision|5|||
143180302|NCT02012218|516206995|FG000|Overall Study|Withdrawal by Subject|1|||
143180303|NCT02012218|516206996|FG001|Overall Study|Withdrawal by Subject|0|||
143180304|NCT02012218|516206997|FG002|Overall Study|Withdrawal by Subject|1|||
143180305|NCT02012218|516206998|FG003|Overall Study|Withdrawal by Subject|1|||
143180306|NCT02012218|516206999|FG004|Overall Study|Withdrawal by Subject|1|||
143180307|NCT02012218|516206995|FG000|Overall Study|Adverse Event|1|||
143180308|NCT02012218|516206996|FG001|Overall Study|Adverse Event|0|||
143180309|NCT02012218|516206997|FG002|Overall Study|Adverse Event|0|||
143180310|NCT02012218|516206998|FG003|Overall Study|Adverse Event|1|||
143180311|NCT02012218|516206999|FG004|Overall Study|Adverse Event|0|||
143180312|NCT02012218|516206995|FG000|Overall Study|Lost to Follow-up|0|||
143180313|NCT02012218|516206996|FG001|Overall Study|Lost to Follow-up|1|||
143180314|NCT02012218|516206997|FG002|Overall Study|Lost to Follow-up|1|||
143180315|NCT02012218|516206998|FG003|Overall Study|Lost to Follow-up|0|||
143180316|NCT02012218|516206999|FG004|Overall Study|Lost to Follow-up|0|||
143180317|NCT02012218|516206995|FG000|Overall Study|Protocol Specified|1|||
143180318|NCT02012218|516206996|FG001|Overall Study|Protocol Specified|0|||
143180319|NCT02012218|516206997|FG002|Overall Study|Protocol Specified|0|||
143180320|NCT02012218|516206998|FG003|Overall Study|Protocol Specified|0|||
143368550|NCT00502593|516892733|FG010|Overall Study|Lost to Follow-up|1|||
143368551|NCT00502593|516892734|FG011|Overall Study|Lost to Follow-up|0|||
143368552|NCT00843193|516892735|FG000|Overall Study|Adverse Event|2|||
143368553|NCT00843193|516892736|FG001|Overall Study|Adverse Event|4|||
143368554|NCT00843193|516892735|FG000|Overall Study|Lack of Efficacy|1|||
143368555|NCT00843193|516892736|FG001|Overall Study|Lack of Efficacy|1|||
143368556|NCT00843193|516892735|FG000|Overall Study|Protocol Violation|1|||
143368557|NCT00843193|516892736|FG001|Overall Study|Protocol Violation|2|||
143368558|NCT00843193|516892735|FG000|Overall Study|Lost to Follow-up|1|||
143368559|NCT00843193|516892736|FG001|Overall Study|Lost to Follow-up|0|||
143368560|NCT00843193|516892735|FG000|Overall Study|Physician Decision|0|||
143368561|NCT00843193|516892736|FG001|Overall Study|Physician Decision|1|||
143368562|NCT00843193|516892735|FG000|Overall Study|Withdrawal by Subject|3|||
143368563|NCT00843193|516892736|FG001|Overall Study|Withdrawal by Subject|3|||
143113655|NCT02677896|515958359|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
143113656|NCT02677896|515958360|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|15|||
143113657|NCT02677896|515958359|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
143113658|NCT02677896|515958360|FG001|Double Blind Period (up to 35 Months)|Progressive disease|6|||
143368564|NCT00542386|516892737|FG000|Overall Study|Adverse Event|1|||
143368565|NCT00542386|516892738|FG001|Overall Study|Adverse Event|7|||
143368566|NCT00542386|516892739|FG002|Overall Study|Adverse Event|7|||
143113659|NCT02677896|515958359|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
143113660|NCT02677896|515958360|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|71|||
143113661|NCT02677896|515958359|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|30|||
143113662|NCT02677896|515958360|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|99|||
143113663|NCT02677896|515958359|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|370|||
143113664|NCT02677896|515958360|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|182|||
143113665|NCT02677896|515958359|FG000|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|1|||
143113666|NCT02677896|515958360|FG001|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|4|||
143368567|NCT00542386|516892740|FG003|Overall Study|Adverse Event|8|||
143368568|NCT00542386|516892741|FG004|Overall Study|Adverse Event|13|||
143368569|NCT00542386|516892742|FG005|Overall Study|Adverse Event|4|||
143113667|NCT02677896|515958359|FG000|Double Blind Period (up to 35 Months)|Randomized, Not Treated|0|||
143113668|NCT02677896|515958360|FG001|Double Blind Period (up to 35 Months)|Randomized, Not Treated|2|||
143113669|NCT02677896|515958359|FG000|Open-Label Extension (Approx. 66 Months)|Death|73|||
143113670|NCT02677896|515958360|FG001|Open-Label Extension (Approx. 66 Months)|Death|26|||
143113671|NCT02677896|515958359|FG000|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|8|||
143113672|NCT02677896|515958360|FG001|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|3|||
143113673|NCT02677896|515958359|FG000|Open-Label Extension (Approx. 66 Months)|Progressive disease|22|||
143113674|NCT02677896|515958360|FG001|Open-Label Extension (Approx. 66 Months)|Progressive disease|10|||
143113675|NCT02677896|515958359|FG000|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|16|||
143113676|NCT02677896|515958360|FG001|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|13|||
143113677|NCT02677896|515958359|FG000|Open-Label Extension (Approx. 66 Months)|Miscellaneous|241|||
143113678|NCT02677896|515958360|FG001|Open-Label Extension (Approx. 66 Months)|Miscellaneous|125|||
143113679|NCT02677896|515958359|FG000|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|10|||
143113680|NCT02677896|515958360|FG001|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|5|||
143113681|NCT01097421|515958365|FG000|Overall Study|Adverse Event|8|||
143113682|NCT01097421|515958365|FG000|Overall Study|Protocol Violation|2|||
143113683|NCT01097421|515958365|FG000|Overall Study|Lost to Follow-up|1|||
143113684|NCT01097421|515958365|FG000|Overall Study|Withdrawal by Subject|3|||
143113685|NCT01120249|515958368|FG000|Overall Study|No protocol treatment received|21|||
143113686|NCT01120249|515958369|FG001|Overall Study|No protocol treatment received|15|||
143113687|NCT01120249|515958368|FG000|Overall Study|Disease recurrence|107|||
143113688|NCT01120249|515958369|FG001|Overall Study|Disease recurrence|57|||
143113689|NCT01120249|515958368|FG000|Overall Study|Death|1|||
143113690|NCT01120249|515958369|FG001|Overall Study|Death|0|||
143113691|NCT01120249|515958368|FG000|Overall Study|Adverse Event|40|||
143113692|NCT01120249|515958369|FG001|Overall Study|Adverse Event|276|||
143113693|NCT01120249|515958368|FG000|Overall Study|Participant refusal|34|||
143113694|NCT01120249|515958369|FG001|Overall Study|Participant refusal|42|||
143113695|NCT01120249|515958368|FG000|Overall Study|Other reasons, not protocol specified|29|||
143113696|NCT01120249|515958369|FG001|Overall Study|Other reasons, not protocol specified|22|||
143113697|NCT01701193|515958370|FG000|Overall Study|Withdrawal by Subject|2|||
143113698|NCT01701193|515958371|FG001|Overall Study|Withdrawal by Subject|2|||
143113699|NCT01701193|515958372|FG002|Overall Study|Withdrawal by Subject|1|||
143113700|NCT01701193|515958373|FG003|Overall Study|Withdrawal by Subject|2|||
143113701|NCT01701193|515958370|FG000|Overall Study|Adverse Event|1|||
143113702|NCT01701193|515958371|FG001|Overall Study|Adverse Event|0|||
143368570|NCT00542386|516892737|FG000|Overall Study|Death|0|||
143368571|NCT00542386|516892738|FG001|Overall Study|Death|0|||
143368572|NCT00542386|516892739|FG002|Overall Study|Death|1|||
143368573|NCT00542386|516892740|FG003|Overall Study|Death|2|||
143368574|NCT00542386|516892741|FG004|Overall Study|Death|1|||
143258873|NCT03901456|516502035|FG002|Overall Study|Lost to Follow-up|0|||
143258874|NCT03836001|516502038|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
143258875|NCT03836001|516502039|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
143258876|NCT03836001|516502040|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
143258877|NCT03836001|516502038|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
143258878|NCT03836001|516502039|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
143258879|NCT03836001|516502040|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
143258880|NCT03836001|516502038|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
143258881|NCT03836001|516502039|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
143258882|NCT03836001|516502040|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
143258883|NCT03836001|516502038|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
143258884|NCT03836001|516502039|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
143258885|NCT03836001|516502040|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
143258886|NCT01642732|516502041|FG000|Overall Study|Withdrawal by Subject|1|||
143258887|NCT00402233|516502044|FG000|Overall Study|Adverse Event|1|||
143258888|NCT00402233|516502045|FG001|Overall Study|Adverse Event|7|||
143258889|NCT00402233|516502046|FG002|Overall Study|Adverse Event|9|||
143258890|NCT00402233|516502047|FG003|Overall Study|Adverse Event|9|||
143258891|NCT00402233|516502044|FG000|Overall Study|Protocol Violation|0|||
143258892|NCT00402233|516502045|FG001|Overall Study|Protocol Violation|1|||
143258893|NCT00402233|516502046|FG002|Overall Study|Protocol Violation|0|||
143258894|NCT00402233|516502047|FG003|Overall Study|Protocol Violation|0|||
143258895|NCT00402233|516502044|FG000|Overall Study|Withdrawal by Subject|2|||
143258896|NCT00402233|516502045|FG001|Overall Study|Withdrawal by Subject|1|||
143258897|NCT00402233|516502046|FG002|Overall Study|Withdrawal by Subject|2|||
143258898|NCT00402233|516502047|FG003|Overall Study|Withdrawal by Subject|2|||
143258899|NCT00402233|516502044|FG000|Overall Study|Worsening of disease under study|2|||
143258900|NCT00402233|516502045|FG001|Overall Study|Worsening of disease under study|0|||
143258901|NCT00402233|516502046|FG002|Overall Study|Worsening of disease under study|0|||
143258902|NCT00402233|516502047|FG003|Overall Study|Worsening of disease under study|0|||
143258903|NCT00402233|516502044|FG000|Overall Study|Worsening of other pre-existing disease|0|||
143258904|NCT00402233|516502045|FG001|Overall Study|Worsening of other pre-existing disease|1|||
143258905|NCT00402233|516502046|FG002|Overall Study|Worsening of other pre-existing disease|0|||
143258906|NCT00402233|516502047|FG003|Overall Study|Worsening of other pre-existing disease|0|||
143258907|NCT00938886|516502048|FG000|Overall Study|Death|0|||
143258908|NCT00938886|516502049|FG001|Overall Study|Death|1|||
143258909|NCT00938886|516502048|FG000|Overall Study|Withdrawal by Subject|4|||
143258910|NCT00938886|516502049|FG001|Overall Study|Withdrawal by Subject|7|||
143258911|NCT00938886|516502048|FG000|Overall Study|Lost to Follow-up|3|||
143258912|NCT00938886|516502049|FG001|Overall Study|Lost to Follow-up|2|||
143258913|NCT03579602|516502050|FG000|Overall Study|Subject unable to receive study drug|0|||
143258914|NCT03579602|516502051|FG001|Overall Study|Subject unable to receive study drug|2|||
143258915|NCT03579602|516502050|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
143258916|NCT03579602|516502051|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
143258917|NCT01120067|516502054|FG000|Overall Study|Lost to Follow-up|3|||
143258918|NCT01120067|516502055|FG001|Overall Study|Lost to Follow-up|1|||
143258919|NCT01120067|516502054|FG000|Overall Study|fail to engage >3 sessions|2|||
143258920|NCT01120067|516502055|FG001|Overall Study|fail to engage >3 sessions|0|||
143258921|NCT03021564|516502061|FG000|Overall Study|Death|84|||
143258922|NCT03021564|516502062|FG001|Overall Study|Death|466|||
143258923|NCT03021564|516502061|FG000|Overall Study|Lost to Follow-up|0|||
143258924|NCT03021564|516502062|FG001|Overall Study|Lost to Follow-up|2|||
143258925|NCT02889562|516502063|FG000|Overall Study|Physician Decision|0|||
143258926|NCT02889562|516502064|FG001|Overall Study|Physician Decision|1|||
143113703|NCT01701193|515958372|FG002|Overall Study|Adverse Event|0|||
143113704|NCT01701193|515958373|FG003|Overall Study|Adverse Event|0|||
143113705|NCT01482962|515958374|FG000|Overall Study|Progressive Disease|65|||
143113706|NCT01482962|515958375|FG001|Overall Study|Progressive Disease|53|||
143113707|NCT01482962|515958374|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
143113708|NCT01482962|515958375|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
143113709|NCT01482962|515958374|FG000|Overall Study|Adverse Event|18|||
143113710|NCT01482962|515958375|FG001|Overall Study|Adverse Event|22|||
143113711|NCT01482962|515958374|FG000|Overall Study|Withdrawal by Participant|8|||
143113712|NCT01482962|515958375|FG001|Overall Study|Withdrawal by Participant|13|||
143113713|NCT01482962|515958374|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
143258927|NCT02889562|516502063|FG000|Overall Study|Withdrawal by Subject|0|||
143258928|NCT02889562|516502064|FG001|Overall Study|Withdrawal by Subject|1|||
143258929|NCT01470989|516502067|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
143258930|NCT01470989|516502068|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
143258931|NCT01470989|516502067|FG000|Overall Study|Adverse Event|2|||
143258932|NCT01470989|516502068|FG001|Overall Study|Adverse Event|5|||
143113714|NCT01482962|515958375|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
143113715|NCT01482962|515958374|FG000|Overall Study|Other Reason|1|||
143259624|NCT04738318|516505807|FG000|Overall Study|Protocol Violation|1|||
143113716|NCT01482962|515958375|FG001|Overall Study|Other Reason|5|||
143113717|NCT01482962|515958374|FG000|Overall Study|Study Terminated by Sponsor|5|||
143113718|NCT01482962|515958375|FG001|Overall Study|Study Terminated by Sponsor|2|||
143113719|NCT01482962|515958374|FG000|Overall Study|Did not Receive Study Drug|1|||
143113720|NCT01482962|515958375|FG001|Overall Study|Did not Receive Study Drug|6|||
143113721|NCT02407457|515958376|FG000|1 Month|Death|3|||
143113722|NCT02407457|515958377|FG001|1 Month|Death|0|||
143113723|NCT02407457|515958376|FG000|1 Month|Lost to Follow-up|1|||
143113724|NCT02407457|515958377|FG001|1 Month|Lost to Follow-up|1|||
143113725|NCT02407457|515958376|FG000|1 Month|missed visit|2|||
143113726|NCT02407457|515958377|FG001|1 Month|missed visit|5|||
143113727|NCT02407457|515958376|FG000|6-Month|Death|2|||
143113728|NCT02407457|515958377|FG001|6-Month|Death|8|||
143113729|NCT02407457|515958376|FG000|6-Month|Lost to Follow-up|2|||
143113730|NCT02407457|515958377|FG001|6-Month|Lost to Follow-up|2|||
143113731|NCT02407457|515958376|FG000|6-Month|missed visit|16|||
143113732|NCT02407457|515958377|FG001|6-Month|missed visit|14|||
143113733|NCT02407457|515958376|FG000|6-Month|Open Repair|0|||
143113734|NCT02407457|515958377|FG001|6-Month|Open Repair|1|||
143113735|NCT02407457|515958376|FG000|1 Year|Death|6|||
143113736|NCT02407457|515958377|FG001|1 Year|Death|11|||
143113737|NCT02407457|515958376|FG000|1 Year|Lost to Follow-up|3|||
143113738|NCT02407457|515958377|FG001|1 Year|Lost to Follow-up|2|||
143113739|NCT02407457|515958376|FG000|1 Year|Missed Visit|24|||
143113740|NCT02407457|515958377|FG001|1 Year|Missed Visit|14|||
143113741|NCT02407457|515958376|FG000|1 Year|Open Repair|0|||
143113742|NCT02407457|515958377|FG001|1 Year|Open Repair|1|||
143113743|NCT02407457|515958376|FG000|2-year|Death|14|||
143113744|NCT02407457|515958377|FG001|2-year|Death|8|||
143113745|NCT02407457|515958376|FG000|2-year|Lost to Follow-up|7|||
143113746|NCT02407457|515958377|FG001|2-year|Lost to Follow-up|10|||
143113747|NCT02407457|515958376|FG000|2-year|Missed Visit|13|||
143113748|NCT02407457|515958377|FG001|2-year|Missed Visit|15|||
143113749|NCT02407457|515958376|FG000|2-year|Open Repair|0|||
143113750|NCT02407457|515958377|FG001|2-year|Open Repair|2|||
143113751|NCT02407457|515958376|FG000|3-year|Death|11|||
143113752|NCT02407457|515958377|FG001|3-year|Death|10|||
143113753|NCT02407457|515958376|FG000|3-year|Lost to Follow-up|9|||
143113754|NCT02407457|515958377|FG001|3-year|Lost to Follow-up|10|||
143113755|NCT02407457|515958376|FG000|3-year|Missed Visit|19|||
143113756|NCT02407457|515958377|FG001|3-year|Missed Visit|16|||
143258933|NCT01470989|516502067|FG000|Overall Study|Abnormal laboratory value|1|||
143258934|NCT01470989|516502068|FG001|Overall Study|Abnormal laboratory value|1|||
143258935|NCT01470989|516502067|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
143258936|NCT01470989|516502068|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
143258937|NCT01470989|516502067|FG000|Overall Study|Withdrawal by Subject|19|||
143258938|NCT01470989|516502068|FG001|Overall Study|Withdrawal by Subject|17|||
143258939|NCT01470989|516502067|FG000|Overall Study|Lost to Follow-up|18|||
143258940|NCT01470989|516502068|FG001|Overall Study|Lost to Follow-up|13|||
143258941|NCT01470989|516502067|FG000|Overall Study|Administrative problems|2|||
143258942|NCT01470989|516502068|FG001|Overall Study|Administrative problems|4|||
143258943|NCT01470989|516502067|FG000|Overall Study|Death|2|||
143258944|NCT01470989|516502068|FG001|Overall Study|Death|2|||
143258945|NCT01470989|516502067|FG000|Overall Study|Protocol deviation|1|||
143258946|NCT01470989|516502068|FG001|Overall Study|Protocol deviation|2|||
143258947|NCT00969280|516502069|FG000|Overall Study|Protocol Violation|2|||
143258948|NCT00969280|516502070|FG001|Overall Study|Protocol Violation|1|||
143258949|NCT00969280|516502069|FG000|Overall Study|Withdrawal by Subject|0|||
143258950|NCT00969280|516502070|FG001|Overall Study|Withdrawal by Subject|1|||
143258951|NCT00969280|516502069|FG000|Overall Study|infection of influenza A(H1N1)|0|||
143258952|NCT00969280|516502070|FG001|Overall Study|infection of influenza A(H1N1)|1|||
143258953|NCT00821327|516502071|FG000|Overall Study|Adverse Event|13|||
143258954|NCT00821327|516502071|FG000|Overall Study|Patient Request|1|||
143258955|NCT00821327|516502071|FG000|Overall Study|Investigator Request|2|||
143258956|NCT00821327|516502071|FG000|Overall Study|Sponsor Request|1|||
143258957|NCT00821327|516502071|FG000|Overall Study|Disease Progression|13|||
143258958|NCT00821327|516502071|FG000|Overall Study|Other/Unknown|5|||
143258959|NCT02119676|516502072|FG000|Overall Study|Adverse Event|9|||
143258960|NCT02119676|516502073|FG001|Overall Study|Adverse Event|17|||
143258961|NCT02119676|516502074|FG002|Overall Study|Adverse Event|10|||
143258962|NCT02119676|516502075|FG003|Overall Study|Adverse Event|10|||
143258963|NCT02119676|516502072|FG000|Overall Study|Disease progression|53|||
143258964|NCT02119676|516502073|FG001|Overall Study|Disease progression|55|||
143258965|NCT02119676|516502074|FG002|Overall Study|Disease progression|68|||
143113757|NCT02407457|515958376|FG000|4-year|Death|18|||
143113758|NCT02407457|515958377|FG001|4-year|Death|10|||
143113759|NCT02407457|515958376|FG000|4-year|Lost to Follow-up|10|||
143113760|NCT02407457|515958377|FG001|4-year|Lost to Follow-up|12|||
143113761|NCT02407457|515958376|FG000|4-year|Missed Visit|18|||
143113762|NCT02407457|515958377|FG001|4-year|Missed Visit|16|||
143113763|NCT02407457|515958376|FG000|5-year|Death|10|||
143113764|NCT02407457|515958377|FG001|5-year|Death|3|||
143258966|NCT02119676|516502075|FG003|Overall Study|Disease progression|73|||
143258967|NCT02119676|516502072|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
143113765|NCT02407457|515958376|FG000|5-year|Lost to Follow-up|22|||
143113766|NCT02407457|515958377|FG001|5-year|Lost to Follow-up|13|||
143113767|NCT02407457|515958376|FG000|5-year|Missed Visit|9|||
143113768|NCT02407457|515958377|FG001|5-year|Missed Visit|1|||
143113769|NCT03536949|515958378|FG000|Overall Study|Adverse Event|4|||
143113770|NCT03536949|515958379|FG001|Overall Study|Adverse Event|0|||
143113771|NCT03536949|515958378|FG000|Overall Study|Lost to Follow-up|2|||
143113772|NCT03536949|515958379|FG001|Overall Study|Lost to Follow-up|1|||
143258968|NCT02119676|516502073|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
143258969|NCT02119676|516502074|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
143258970|NCT02119676|516502075|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
143258971|NCT02119676|516502072|FG000|Overall Study|Physician Decision|4|||
143258972|NCT02119676|516502073|FG001|Overall Study|Physician Decision|2|||
143258973|NCT02119676|516502074|FG002|Overall Study|Physician Decision|3|||
143258974|NCT02119676|516502075|FG003|Overall Study|Physician Decision|2|||
143258975|NCT02119676|516502072|FG000|Overall Study|Death|9|||
143258976|NCT02119676|516502073|FG001|Overall Study|Death|3|||
143258977|NCT02119676|516502074|FG002|Overall Study|Death|2|||
143258978|NCT02119676|516502075|FG003|Overall Study|Death|1|||
143258979|NCT02119676|516502072|FG000|Overall Study|Noncompliance|0|||
143258980|NCT02119676|516502073|FG001|Overall Study|Noncompliance|1|||
143113773|NCT03536949|515958378|FG000|Overall Study|Withdrawal by Subject|6|||
143113774|NCT03536949|515958379|FG001|Overall Study|Withdrawal by Subject|0|||
143113775|NCT03536949|515958378|FG000|Overall Study|Non-compliance|2|||
143113776|NCT03536949|515958379|FG001|Overall Study|Non-compliance|1|||
143258981|NCT02119676|516502074|FG002|Overall Study|Noncompliance|0|||
143258982|NCT02119676|516502075|FG003|Overall Study|Noncompliance|0|||
143113777|NCT06137703|515958381|FG000|Overall Study|Other|0|||
143113778|NCT06137703|515958382|FG001|Overall Study|Other|1|||
143113779|NCT06137703|515958383|FG002|Overall Study|Other|0|||
143113780|NCT06137703|515958384|FG003|Overall Study|Other|0|||
143113781|NCT06137703|515958381|FG000|Overall Study|Adverse Event|0|||
143113782|NCT06137703|515958382|FG001|Overall Study|Adverse Event|0|||
143113783|NCT06137703|515958383|FG002|Overall Study|Adverse Event|1|||
143113784|NCT06137703|515958384|FG003|Overall Study|Adverse Event|0|||
143113785|NCT04329091|515958387|FG000|Overall Study|Physician Decision|5|||
143113786|NCT00741091|515958390|FG000|Overall Study|Death|13|||
143113787|NCT00741091|515958390|FG000|Overall Study|Lost to Follow-up|16|||
143113788|NCT00741091|515958390|FG000|Overall Study|Withdrawal by Subject|6|||
143113789|NCT00741091|515958390|FG000|Overall Study|Missed Visit|22|||
143113790|NCT01801358|515958391|FG000|Overall Study|Adverse Event|0|||
143113791|NCT01801358|515958392|FG001|Overall Study|Adverse Event|2|||
143113792|NCT01801358|515958393|FG002|Overall Study|Adverse Event|1|||
143113793|NCT01801358|515958394|FG003|Overall Study|Adverse Event|0|||
143113794|NCT01801358|515958395|FG004|Overall Study|Adverse Event|0|||
143113795|NCT01801358|515958396|FG005|Overall Study|Adverse Event|1|||
143113796|NCT01801358|515958391|FG000|Overall Study|Physician Decision|0|||
143113797|NCT01801358|515958392|FG001|Overall Study|Physician Decision|0|||
143113798|NCT01801358|515958393|FG002|Overall Study|Physician Decision|1|||
143113799|NCT01801358|515958394|FG003|Overall Study|Physician Decision|0|||
143113800|NCT01801358|515958395|FG004|Overall Study|Physician Decision|0|||
143113801|NCT01801358|515958396|FG005|Overall Study|Physician Decision|0|||
143113802|NCT01801358|515958391|FG000|Overall Study|Progressive Disease|6|||
143113803|NCT01801358|515958392|FG001|Overall Study|Progressive Disease|4|||
143113804|NCT01801358|515958393|FG002|Overall Study|Progressive Disease|4|||
143113805|NCT01801358|515958394|FG003|Overall Study|Progressive Disease|5|||
143113806|NCT01801358|515958395|FG004|Overall Study|Progressive Disease|6|||
143113807|NCT01801358|515958396|FG005|Overall Study|Progressive Disease|5|||
143113808|NCT01801358|515958391|FG000|Overall Study|Withdrawal by Subject|0|||
143113809|NCT01801358|515958392|FG001|Overall Study|Withdrawal by Subject|0|||
143113810|NCT01801358|515958393|FG002|Overall Study|Withdrawal by Subject|0|||
143113811|NCT01801358|515958394|FG003|Overall Study|Withdrawal by Subject|1|||
143113812|NCT01801358|515958395|FG004|Overall Study|Withdrawal by Subject|0|||
143113813|NCT01801358|515958396|FG005|Overall Study|Withdrawal by Subject|2|||
143113814|NCT03787303|515958397|FG000|Overall Study|Death|1|||
143113815|NCT03787303|515958397|FG000|Overall Study|Premature Termination of Study|1|||
143113816|NCT01527487|515958398|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
143113817|NCT01527487|515958399|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
143113818|NCT01527487|515958398|FG000|Overall Study|Disease Progression|4|||
143113819|NCT01527487|515958399|FG001|Overall Study|Disease Progression|1|||
143113820|NCT01527487|515958398|FG000|Overall Study|Adverse Event|1|||
143113821|NCT01527487|515958399|FG001|Overall Study|Adverse Event|1|||
143113822|NCT01527487|515958398|FG000|Overall Study|Death|0|||
143113823|NCT01527487|515958399|FG001|Overall Study|Death|1|||
143113824|NCT01210495|515958402|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
143258983|NCT02119676|516502072|FG000|Overall Study|Lost to Follow-up|0|||
143258984|NCT02119676|516502073|FG001|Overall Study|Lost to Follow-up|0|||
143113825|NCT01210495|515958403|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
143113826|NCT01210495|515958404|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
143117402|NCT05459558|515971836|FG001|Overall Study|Scheduling issue|1|||
143113827|NCT01210495|515958405|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
143368575|NCT00542386|516892742|FG005|Overall Study|Death|2|||
143368576|NCT00542386|516892737|FG000|Overall Study|Lack of Efficacy|32|||
143368577|NCT00542386|516892738|FG001|Overall Study|Lack of Efficacy|12|||
143368578|NCT00542386|516892739|FG002|Overall Study|Lack of Efficacy|10|||
143368579|NCT00542386|516892740|FG003|Overall Study|Lack of Efficacy|13|||
143368580|NCT00542386|516892741|FG004|Overall Study|Lack of Efficacy|7|||
143368581|NCT00542386|516892742|FG005|Overall Study|Lack of Efficacy|31|||
143368582|NCT00542386|516892737|FG000|Overall Study|Physician Decision|1|||
143368583|NCT00542386|516892738|FG001|Overall Study|Physician Decision|0|||
143368584|NCT00542386|516892739|FG002|Overall Study|Physician Decision|0|||
143368585|NCT00542386|516892740|FG003|Overall Study|Physician Decision|1|||
143368586|NCT00542386|516892741|FG004|Overall Study|Physician Decision|0|||
143368587|NCT00542386|516892742|FG005|Overall Study|Physician Decision|0|||
143368588|NCT00542386|516892737|FG000|Overall Study|Protocol Violation|0|||
143368589|NCT00542386|516892738|FG001|Overall Study|Protocol Violation|0|||
143368590|NCT00542386|516892739|FG002|Overall Study|Protocol Violation|1|||
143368591|NCT00542386|516892740|FG003|Overall Study|Protocol Violation|0|||
143368592|NCT00542386|516892741|FG004|Overall Study|Protocol Violation|0|||
143368593|NCT00542386|516892742|FG005|Overall Study|Protocol Violation|4|||
143368594|NCT00542386|516892737|FG000|Overall Study|Withdrawal by Subject|5|||
143368595|NCT00542386|516892738|FG001|Overall Study|Withdrawal by Subject|8|||
143368596|NCT00542386|516892739|FG002|Overall Study|Withdrawal by Subject|10|||
143368597|NCT00542386|516892740|FG003|Overall Study|Withdrawal by Subject|11|||
143368598|NCT00542386|516892741|FG004|Overall Study|Withdrawal by Subject|15|||
143368599|NCT00542386|516892742|FG005|Overall Study|Withdrawal by Subject|7|||
143368600|NCT00542386|516892737|FG000|Overall Study|Other Reasons|4|||
143368601|NCT00542386|516892738|FG001|Overall Study|Other Reasons|1|||
143368602|NCT00542386|516892739|FG002|Overall Study|Other Reasons|4|||
143368603|NCT00542386|516892740|FG003|Overall Study|Other Reasons|3|||
143368604|NCT00542386|516892741|FG004|Overall Study|Other Reasons|4|||
143368605|NCT00542386|516892742|FG005|Overall Study|Other Reasons|2|||
143368606|NCT00880906|516892743|FG000|Overall Study|Lost to Follow-up|0|||
143368607|NCT00880906|516892744|FG001|Overall Study|Lost to Follow-up|1|||
143368608|NCT00880906|516892743|FG000|Overall Study|Did not meet criteria following patholog|12|||
143368609|NCT00880906|516892744|FG001|Overall Study|Did not meet criteria following patholog|6|||
143368610|NCT00544440|516892745|FG000|Overall Study|Other|1|||
143368611|NCT00544440|516892745|FG000|Overall Study|Adverse Event|1|||
143368612|NCT00544440|516892745|FG000|Overall Study|Withdrawal by Subject|2|||
143368613|NCT00544440|516892745|FG000|Overall Study|Subject Non-compliance|1|||
143368614|NCT00544440|516892745|FG000|Overall Study|Progressive Disease|47|||
143368615|NCT00544440|516892745|FG000|Overall Study|Other|5|||
143368616|NCT05824351|516892748|FG000|Overall Study|Adverse Event|6|||
143368617|NCT00828945|516892749|FG000|Overall Study|Death|4|||
143368618|NCT00828945|516892749|FG000|Overall Study|Participant was missing|1|||
143113828|NCT01210495|515958402|FG000|Overall Study|Death|14|||
143113829|NCT01210495|515958403|FG001|Overall Study|Death|7|||
143368619|NCT00828945|516892749|FG000|Overall Study|Other|36|||
143368620|NCT01543685|516892752|FG000|Overall Study|Lack of Efficacy|1|||
143368621|NCT01543685|516892753|FG001|Overall Study|Lack of Efficacy|2|||
143113830|NCT01210495|515958404|FG002|Overall Study|Death|112|||
143113831|NCT01210495|515958405|FG003|Overall Study|Death|54|||
143113832|NCT01210495|515958402|FG000|Overall Study|Study Terminated by Sponsor|0|||
143113833|NCT01210495|515958403|FG001|Overall Study|Study Terminated by Sponsor|0|||
143113834|NCT01210495|515958404|FG002|Overall Study|Study Terminated by Sponsor|4|||
143113835|NCT01210495|515958405|FG003|Overall Study|Study Terminated by Sponsor|11|||
143113836|NCT01210495|515958402|FG000|Overall Study|Lost to Follow-up|0|||
143113837|NCT01210495|515958403|FG001|Overall Study|Lost to Follow-up|0|||
143113838|NCT01210495|515958404|FG002|Overall Study|Lost to Follow-up|1|||
143113839|NCT01210495|515958405|FG003|Overall Study|Lost to Follow-up|1|||
143113840|NCT01210495|515958402|FG000|Overall Study|Other unspecified|0|||
143113841|NCT01210495|515958403|FG001|Overall Study|Other unspecified|0|||
143113842|NCT01210495|515958404|FG002|Overall Study|Other unspecified|6|||
143113843|NCT01210495|515958405|FG003|Overall Study|Other unspecified|0|||
143113844|NCT00723190|515958407|FG000|Overall Study|Withdrawal by Subject|45|||
143113845|NCT00723190|515958407|FG000|Overall Study|Lost to Follow-up|37|||
143113846|NCT00723190|515958407|FG000|Overall Study|Adverse Event|18|||
143113847|NCT00723190|515958407|FG000|Overall Study|Lack of Efficacy|16|||
143113848|NCT00723190|515958407|FG000|Overall Study|Protocol Violation|15|||
143113849|NCT00723190|515958407|FG000|Overall Study|Other-Premature Discontinuation|9|||
143368622|NCT01543685|516892754|FG002|Overall Study|Lack of Efficacy|2|||
143368623|NCT01543685|516892755|FG003|Overall Study|Lack of Efficacy|0|||
143113850|NCT00723190|515958407|FG000|Overall Study|Other-Not included in safety population|2|||
143113851|NCT00454818|515958410|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
143113852|NCT00454818|515958411|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
143368624|NCT01543685|516892756|FG004|Overall Study|Lack of Efficacy|2|||
143368625|NCT01543685|516892752|FG000|Overall Study|Adverse Event|2|||
143368626|NCT01543685|516892753|FG001|Overall Study|Adverse Event|1|||
143368627|NCT01543685|516892754|FG002|Overall Study|Adverse Event|0|||
143368628|NCT01543685|516892755|FG003|Overall Study|Adverse Event|0|||
143368629|NCT01543685|516892756|FG004|Overall Study|Adverse Event|2|||
143368630|NCT02163915|516892759|FG000|Overall Study|Withdrawal by Subject|2|||
143368631|NCT02163915|516892760|FG001|Overall Study|Withdrawal by Subject|0|||
143368632|NCT02163915|516892761|FG002|Overall Study|Withdrawal by Subject|2|||
143368633|NCT02163915|516892762|FG003|Overall Study|Withdrawal by Subject|2|||
143368634|NCT02163915|516892763|FG004|Overall Study|Withdrawal by Subject|2|||
143368635|NCT02163915|516892759|FG000|Overall Study|Study termination|1|||
143368636|NCT02163915|516892760|FG001|Overall Study|Study termination|0|||
143368637|NCT02163915|516892761|FG002|Overall Study|Study termination|0|||
143368638|NCT02163915|516892762|FG003|Overall Study|Study termination|0|||
143368639|NCT02163915|516892763|FG004|Overall Study|Study termination|2|||
143368640|NCT02163915|516892759|FG000|Overall Study|Physician Decision|0|||
143368641|NCT02163915|516892760|FG001|Overall Study|Physician Decision|0|||
143368642|NCT02163915|516892761|FG002|Overall Study|Physician Decision|0|||
143368643|NCT02163915|516892762|FG003|Overall Study|Physician Decision|1|||
143368644|NCT02163915|516892763|FG004|Overall Study|Physician Decision|0|||
143368645|NCT03227757|516894493|FG000|Overall Study|Death|25|||
143368646|NCT03227757|516894493|FG000|Overall Study|Withdrawal|10|||
143368647|NCT03227757|516894493|FG000|Overall Study|Missed visits|1|||
143368648|NCT03227757|516894493|FG000|Overall Study|Lost to Follow-up|2|||
143368649|NCT01645111|516894495|FG000|Overall Study|Did not require Clevidipine|15|||
143368650|NCT01875250|516894497|FG000|Overall Study|Adverse Event|2|||
143368651|NCT01875250|516894498|FG001|Overall Study|Adverse Event|0|||
143368652|NCT00482729|516894499|FG000|Overall Study|Adverse Event|29|||
143368653|NCT00482729|516894500|FG001|Overall Study|Adverse Event|33|||
143368654|NCT00482729|516894499|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
143368655|NCT00482729|516894500|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
143368656|NCT00482729|516894499|FG000|Overall Study|Hyperglycemia Criteria|7|||
143368657|NCT00482729|516894500|FG001|Overall Study|Hyperglycemia Criteria|5|||
143368658|NCT00482729|516894499|FG000|Overall Study|Lack of Efficacy|4|||
143368659|NCT00482729|516894500|FG001|Overall Study|Lack of Efficacy|16|||
143368660|NCT00482729|516894499|FG000|Overall Study|Lost to Follow-up|86|||
143368661|NCT00482729|516894500|FG001|Overall Study|Lost to Follow-up|66|||
143368662|NCT00482729|516894499|FG000|Overall Study|Physician Decision|10|||
143368663|NCT00482729|516894500|FG001|Overall Study|Physician Decision|7|||
143368664|NCT00482729|516894499|FG000|Overall Study|Pregnancy|4|||
143368665|NCT00482729|516894500|FG001|Overall Study|Pregnancy|2|||
143368666|NCT00482729|516894499|FG000|Overall Study|Protocol Violation|10|||
143368667|NCT00482729|516894500|FG001|Overall Study|Protocol Violation|18|||
143368668|NCT00482729|516894499|FG000|Overall Study|Withdrawal by Subject|67|||
143368669|NCT00482729|516894500|FG001|Overall Study|Withdrawal by Subject|69|||
143368670|NCT03140176|516894501|FG000|Overall Study|Reason missing|23|||
143368671|NCT03140176|516894501|FG000|Overall Study|Death|33|||
143368672|NCT03140176|516894501|FG000|Overall Study|Disease progression|1|||
143368673|NCT03140176|516894501|FG000|Overall Study|Physician Decision|1|||
143368674|NCT03140176|516894501|FG000|Overall Study|Withdrawal by Subject|1|||
143368675|NCT03140176|516894501|FG000|Overall Study|Lost to Follow-up|15|||
143368676|NCT03784963|516894503|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
143368677|NCT03784963|516894504|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
143368678|NCT03784963|516894505|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
143368679|NCT03784963|516894506|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
143368680|NCT02030028|516894507|FG000|Overall Study|Withdrawal by Subject|4|||
143368681|NCT02030028|516894507|FG000|Overall Study|lack of transportation|1|||
143368682|NCT00661778|516894508|FG000|Overall Study|Disease Progression|23|||
143368683|NCT00661778|516894508|FG000|Overall Study|Adverse Event|18|||
143368684|NCT00661778|516894508|FG000|Overall Study|Reason not Specified|6|||
143368685|NCT00661778|516894508|FG000|Overall Study|Protocol Violation|2|||
143368686|NCT00661778|516894508|FG000|Overall Study|Withdrawal of Consent|1|||
143368687|NCT01090024|516894513|FG000|Period 1|Met exclusion criteria|0|||
143368688|NCT01090024|516894514|FG001|Period 1|Met exclusion criteria|0|||
143368689|NCT01090024|516894515|FG002|Period 1|Met exclusion criteria|0|||
143368690|NCT01090024|516894516|FG003|Period 1|Met exclusion criteria|0|||
143368691|NCT01090024|516894517|FG004|Period 1|Met exclusion criteria|0|||
143368692|NCT01090024|516894518|FG005|Period 1|Met exclusion criteria|0|||
143368693|NCT01090024|516894519|FG006|Period 1|Met exclusion criteria|0|||
143368694|NCT01090024|516894520|FG007|Period 1|Met exclusion criteria|0|||
143368695|NCT01090024|516894521|FG008|Period 1|Met exclusion criteria|0|||
143368696|NCT01090024|516894522|FG009|Period 1|Met exclusion criteria|0|||
143368697|NCT01090024|516894523|FG010|Period 1|Met exclusion criteria|0|||
143368698|NCT01090024|516894524|FG011|Period 1|Met exclusion criteria|0|||
143368699|NCT01090024|516894525|FG012|Period 1|Met exclusion criteria|0|||
143368700|NCT01090024|516894526|FG013|Period 1|Met exclusion criteria|0|||
143368701|NCT01090024|516894527|FG014|Period 1|Met exclusion criteria|1|||
143368702|NCT01090024|516894528|FG015|Period 1|Met exclusion criteria|0|||
143258985|NCT02119676|516502074|FG002|Overall Study|Lost to Follow-up|1|||
143258986|NCT02119676|516502075|FG003|Overall Study|Lost to Follow-up|0|||
143258987|NCT02119676|516502072|FG000|Overall Study|Protocol deviation|0|||
143258988|NCT02119676|516502073|FG001|Overall Study|Protocol deviation|0|||
143258989|NCT02119676|516502074|FG002|Overall Study|Protocol deviation|1|||
143258990|NCT02119676|516502075|FG003|Overall Study|Protocol deviation|0|||
143258991|NCT02119676|516502072|FG000|Overall Study|Other, unspecified|2|||
143258992|NCT02119676|516502073|FG001|Overall Study|Other, unspecified|1|||
143258993|NCT02119676|516502074|FG002|Overall Study|Other, unspecified|3|||
143258994|NCT02119676|516502075|FG003|Overall Study|Other, unspecified|4|||
143258995|NCT02119676|516502072|FG000|Overall Study|Did not receive study med|2|||
143258996|NCT02119676|516502073|FG001|Overall Study|Did not receive study med|2|||
143258997|NCT02119676|516502074|FG002|Overall Study|Did not receive study med|4|||
143258998|NCT02119676|516502075|FG003|Overall Study|Did not receive study med|5|||
143258999|NCT00217464|516502076|FG000|Overall Study|Progression|15|||
143259000|NCT00217464|516502076|FG000|Overall Study|Other|2|||
143259001|NCT01089361|516502077|FG000|Overall Study|Death|1|||
143259002|NCT01089361|516502078|FG001|Overall Study|Death|0|||
143259003|NCT00278915|516502081|FG000|Overall Study|Disease progression|1|||
143259004|NCT01007253|516502082|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
143259005|NCT01007253|516502083|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
143259006|NCT01007253|516502084|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
143259007|NCT01007253|516502085|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
143259008|NCT04675151|516502090|FG000|Overall Study|Protocol Violation|1|||
143259009|NCT04675151|516502091|FG001|Overall Study|Protocol Violation|0|||
143259010|NCT04675151|516502092|FG002|Overall Study|Protocol Violation|0|||
143259011|NCT04675151|516502093|FG003|Overall Study|Protocol Violation|1|||
143259012|NCT04035486|516502094|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
143259013|NCT04035486|516502095|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
143259014|NCT04035486|516502096|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
143259015|NCT04035486|516502097|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
143259016|NCT04035486|516502094|FG000|Overall Study|Death|6|||
143259017|NCT04035486|516502095|FG001|Overall Study|Death|3|||
143259018|NCT04035486|516502096|FG002|Overall Study|Death|70|||
143259019|NCT04035486|516502097|FG003|Overall Study|Death|77|||
143259020|NCT04035486|516502094|FG000|Overall Study|Screen Failure|0|||
143259021|NCT04035486|516502095|FG001|Overall Study|Screen Failure|0|||
143259022|NCT04035486|516502096|FG002|Overall Study|Screen Failure|1|||
143259023|NCT04035486|516502097|FG003|Overall Study|Screen Failure|1|||
143259024|NCT04035486|516502094|FG000|Overall Study|Withdrawal by Subject|1|||
143259025|NCT04035486|516502095|FG001|Overall Study|Withdrawal by Subject|1|||
143259026|NCT04035486|516502096|FG002|Overall Study|Withdrawal by Subject|11|||
143259027|NCT04035486|516502097|FG003|Overall Study|Withdrawal by Subject|9|||
143259028|NCT01730937|516502098|FG000|Overall Study|Protocol Violation|5|||
143259029|NCT01730937|516502099|FG001|Overall Study|Protocol Violation|11|||
143259030|NCT03947684|516502100|FG000|Overall Study|Lost to Follow-up|13|||
143259031|NCT03947684|516502101|FG001|Overall Study|Lost to Follow-up|5|||
143259032|NCT03947684|516502102|FG002|Overall Study|Lost to Follow-up|1|||
143259033|NCT03947684|516502100|FG000|Overall Study|Withdrawal by Subject|11|||
143259034|NCT03947684|516502101|FG001|Overall Study|Withdrawal by Subject|4|||
143259035|NCT03947684|516502102|FG002|Overall Study|Withdrawal by Subject|0|||
143259036|NCT03947684|516502100|FG000|Overall Study|Physician Decision|1|||
143259037|NCT03947684|516502101|FG001|Overall Study|Physician Decision|0|||
143259038|NCT03947684|516502102|FG002|Overall Study|Physician Decision|0|||
143259039|NCT03947684|516502100|FG000|Overall Study|Lack of adherence to study protocol|2|||
143259040|NCT03947684|516502101|FG001|Overall Study|Lack of adherence to study protocol|0|||
143259041|NCT03947684|516502102|FG002|Overall Study|Lack of adherence to study protocol|0|||
143259042|NCT03875235|516502103|FG000|Overall Study|Ongoing study treatment|63|||
143259043|NCT03875235|516502104|FG001|Overall Study|Ongoing study treatment|20|||
143259044|NCT03875235|516502103|FG000|Overall Study|Off treatment|77|||
143259045|NCT03875235|516502104|FG001|Overall Study|Off treatment|91|||
143259046|NCT03875235|516502103|FG000|Overall Study|Withdrawal by Subject|3|||
143259047|NCT03875235|516502104|FG001|Overall Study|Withdrawal by Subject|10|||
143259048|NCT03875235|516502103|FG000|Overall Study|Death|198|||
143259049|NCT03875235|516502104|FG001|Overall Study|Death|223|||
143259050|NCT01395784|516502107|FG000|Overall Study|Lost to Follow-up|7|||
143259051|NCT01395784|516502107|FG000|Overall Study|Withdrawal by Subject|3|||
143259052|NCT01395784|516502107|FG000|Overall Study|Physician Decision|5|||
143259053|NCT00622739|516503724|FG000|Overall Study|Physician Decision|1|||
143259054|NCT00622739|516503725|FG001|Overall Study|Physician Decision|0|||
143259055|NCT00622739|516503724|FG000|Overall Study|Adverse Event|1|||
143259056|NCT00622739|516503725|FG001|Overall Study|Adverse Event|2|||
143259057|NCT00622739|516503724|FG000|Overall Study|Lack of Efficacy|0|||
143259058|NCT00622739|516503725|FG001|Overall Study|Lack of Efficacy|2|||
143259059|NCT00622739|516503724|FG000|Overall Study|Withdrawal by Subject|0|||
143259060|NCT00622739|516503725|FG001|Overall Study|Withdrawal by Subject|1|||
143259061|NCT00622739|516503724|FG000|Overall Study|Lost to Follow-up|0|||
143259062|NCT00622739|516503725|FG001|Overall Study|Lost to Follow-up|1|||
143259063|NCT02093351|516503726|FG000|Part A|Adverse Event|0|||
143113853|NCT00454818|515958412|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
143113854|NCT00454818|515958413|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
143113855|NCT00454818|515958414|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
143113856|NCT00454818|515958410|FG000|Phase I: Open-label Dose-escalation|Death|0|||
143113857|NCT00454818|515958411|FG001|Phase I: Open-label Dose-escalation|Death|1|||
143113858|NCT00454818|515958412|FG002|Phase I: Open-label Dose-escalation|Death|0|||
143113859|NCT00454818|515958413|FG003|Phase I: Open-label Dose-escalation|Death|0|||
143113860|NCT00454818|515958414|FG004|Phase I: Open-label Dose-escalation|Death|0|||
143113861|NCT00454818|515958410|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
143113862|NCT00454818|515958411|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
143113863|NCT00454818|515958412|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
143113864|NCT00454818|515958413|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
143113865|NCT00454818|515958414|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
143113866|NCT00454818|515958410|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
143113867|NCT00454818|515958411|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
143113868|NCT00454818|515958412|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
143113869|NCT00454818|515958413|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
143113870|NCT00454818|515958414|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
143113871|NCT00454818|515958410|FG000|Phase 2: Randomized Double-blind|Death|0|||
143113872|NCT00454818|515958411|FG001|Phase 2: Randomized Double-blind|Death|1|||
143113873|NCT00454818|515958412|FG002|Phase 2: Randomized Double-blind|Death|0|||
143113874|NCT00454818|515958413|FG003|Phase 2: Randomized Double-blind|Death|0|||
143113875|NCT00454818|515958414|FG004|Phase 2: Randomized Double-blind|Death|1|||
143113876|NCT00454818|515958410|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
143113877|NCT00454818|515958411|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
143113878|NCT00454818|515958412|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
143113879|NCT00454818|515958413|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
143113880|NCT00454818|515958414|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
143113881|NCT00454818|515958410|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
143113882|NCT00454818|515958411|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
143113883|NCT00454818|515958412|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
143113884|NCT00454818|515958413|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
143113885|NCT00454818|515958414|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
143113886|NCT01384019|515958415|FG000|Overall Study|Withdrawal by Subject|3|||
143113887|NCT01384019|515958416|FG001|Overall Study|Withdrawal by Subject|0|||
143113888|NCT01384019|515958415|FG000|Overall Study|Death|1|||
143113889|NCT01384019|515958416|FG001|Overall Study|Death|0|||
143113890|NCT01384019|515958415|FG000|Overall Study|MRI refusal|6|||
143113891|NCT01384019|515958416|FG001|Overall Study|MRI refusal|6|||
143113892|NCT03332628|515958420|FG000|Overall Study|Physician Decision|2|||
143113893|NCT02505334|515958423|FG000|Main Treatment Period|Adverse Event|3|||
143113894|NCT02505334|515958424|FG001|Main Treatment Period|Adverse Event|3|||
143113895|NCT02505334|515958423|FG000|Main Treatment Period|Lack of Efficacy|7|||
143113896|NCT02505334|515958424|FG001|Main Treatment Period|Lack of Efficacy|17|||
143113897|NCT02505334|515958423|FG000|Main Treatment Period|Protocol Violation|0|||
143113898|NCT02505334|515958424|FG001|Main Treatment Period|Protocol Violation|1|||
143113899|NCT02505334|515958423|FG000|Main Treatment Period|Withdrawal by Subject|1|||
143113900|NCT02505334|515958424|FG001|Main Treatment Period|Withdrawal by Subject|8|||
143113901|NCT02505334|515958423|FG000|Main Treatment Period|Unclassified|4|||
143113902|NCT02505334|515958424|FG001|Main Treatment Period|Unclassified|10|||
143113903|NCT02505334|515958423|FG000|Extension Treatment Period|Adverse Event|5|||
143113904|NCT02505334|515958424|FG001|Extension Treatment Period|Adverse Event|0|||
143113905|NCT02505334|515958423|FG000|Extension Treatment Period|Lack of Efficacy|4|||
143113906|NCT02505334|515958424|FG001|Extension Treatment Period|Lack of Efficacy|0|||
143113907|NCT02505334|515958423|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
143113908|NCT02505334|515958424|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
143113909|NCT02505334|515958423|FG000|Extension Treatment Period|Unclassified|3|||
143113910|NCT02505334|515958424|FG001|Extension Treatment Period|Unclassified|0|||
143113911|NCT00525902|515958427|FG000|Overall Study|Lack of Efficacy|1|||
143113912|NCT01004406|515959686|FG000|Overall Study|Withdrawal by Subject|2|||
143113913|NCT01004406|515959687|FG001|Overall Study|Withdrawal by Subject|0|||
143113914|NCT01004406|515959686|FG000|Overall Study|Lost to Follow-up|1|||
143113915|NCT01004406|515959687|FG001|Overall Study|Lost to Follow-up|0|||
143113916|NCT02928770|515959688|FG000|Overall Study|Withdrawal by Subject|2|||
143113917|NCT05128773|515959689|FG000|Overall Study|Sponsor decision to terminate study|3|||
143113918|NCT04697056|515959690|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
143117403|NCT05459558|515971837|FG002|Overall Study|Scheduling issue|3|||
143259064|NCT02093351|516503727|FG001|Part A|Adverse Event|1|||
143259065|NCT02093351|516503728|FG002|Part A|Adverse Event|1|||
143259066|NCT02093351|516503729|FG003|Part A|Adverse Event|0|||
143259067|NCT02093351|516503726|FG000|Part A|Condition under investigation worsened|2|||
143259068|NCT02093351|516503727|FG001|Part A|Condition under investigation worsened|0|||
143259069|NCT02093351|516503728|FG002|Part A|Condition under investigation worsened|2|||
143259070|NCT02093351|516503729|FG003|Part A|Condition under investigation worsened|0|||
143259071|NCT02093351|516503726|FG000|Part A|Death|0|||
143259072|NCT02093351|516503727|FG001|Part A|Death|1|||
143259073|NCT02093351|516503728|FG002|Part A|Death|0|||
143259074|NCT02093351|516503729|FG003|Part A|Death|0|||
143259075|NCT02093351|516503726|FG000|Part B|Patient decision|0|||
143259076|NCT02093351|516503727|FG001|Part B|Patient decision|0|||
143259077|NCT02093351|516503728|FG002|Part B|Patient decision|0|||
143259078|NCT02093351|516503729|FG003|Part B|Patient decision|3|||
143259079|NCT02093351|516503726|FG000|Part B|Disease progression|0|||
143259080|NCT02093351|516503727|FG001|Part B|Disease progression|0|||
143113919|NCT04697056|515959691|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
143113920|NCT02339155|515959696|FG000|Overall Study|Adverse Event|0|||
143113921|NCT02339155|515959697|FG001|Overall Study|Adverse Event|6|||
143113922|NCT02339155|515959696|FG000|Overall Study|Death|1|||
143259081|NCT02093351|516503728|FG002|Part B|Disease progression|0|||
143113923|NCT02339155|515959697|FG001|Overall Study|Death|1|||
143113924|NCT02339155|515959696|FG000|Overall Study|Lost to Follow-up|8|||
143113925|NCT02339155|515959697|FG001|Overall Study|Lost to Follow-up|9|||
143113926|NCT02339155|515959696|FG000|Overall Study|Physician Decision|2|||
143113927|NCT02339155|515959697|FG001|Overall Study|Physician Decision|1|||
143113928|NCT02339155|515959696|FG000|Overall Study|Withdrawal by Subject|4|||
143113929|NCT02339155|515959697|FG001|Overall Study|Withdrawal by Subject|4|||
143113930|NCT03427268|515959698|FG000|Overall Study|Progressive disease|25|||
143113931|NCT03427268|515959698|FG000|Overall Study|Never treated|2|||
143113932|NCT03427268|515959698|FG000|Overall Study|Compassionate use|1|||
143113933|NCT03427268|515959698|FG000|Overall Study|Withdrawal by Subject|1|||
143259082|NCT02093351|516503729|FG003|Part B|Disease progression|4|||
143259083|NCT02093351|516503726|FG000|Part B|Complete response|0|||
143259084|NCT02093351|516503727|FG001|Part B|Complete response|0|||
143259085|NCT02093351|516503728|FG002|Part B|Complete response|0|||
143259086|NCT02093351|516503729|FG003|Part B|Complete response|1|||
143259087|NCT02093351|516503726|FG000|Part B|Adverse event + disease progression|0|||
143259088|NCT02093351|516503727|FG001|Part B|Adverse event + disease progression|0|||
143259089|NCT02093351|516503728|FG002|Part B|Adverse event + disease progression|0|||
143259090|NCT02093351|516503729|FG003|Part B|Adverse event + disease progression|1|||
143259091|NCT02093351|516503726|FG000|Part B|Lack of therapeutic response|0|||
143259092|NCT02093351|516503727|FG001|Part B|Lack of therapeutic response|0|||
143259093|NCT02093351|516503728|FG002|Part B|Lack of therapeutic response|0|||
143259094|NCT02093351|516503729|FG003|Part B|Lack of therapeutic response|12|||
143259095|NCT02093351|516503726|FG000|Part B|Condition under investigation worsened|0|||
143259096|NCT02093351|516503727|FG001|Part B|Condition under investigation worsened|0|||
143259097|NCT02093351|516503728|FG002|Part B|Condition under investigation worsened|0|||
143259098|NCT02093351|516503729|FG003|Part B|Condition under investigation worsened|39|||
143259099|NCT02093351|516503726|FG000|Part B|Adverse Event|0|||
143259100|NCT02093351|516503727|FG001|Part B|Adverse Event|0|||
143259101|NCT02093351|516503728|FG002|Part B|Adverse Event|0|||
143259102|NCT02093351|516503729|FG003|Part B|Adverse Event|2|||
143259103|NCT02093351|516503726|FG000|Part B|Death|0|||
143259104|NCT02093351|516503727|FG001|Part B|Death|0|||
143259105|NCT02093351|516503728|FG002|Part B|Death|0|||
143259106|NCT02093351|516503729|FG003|Part B|Death|1|||
143259107|NCT01611454|516503734|FG000|Overall Study|Lack of Efficacy|18|||
143259108|NCT01611454|516503735|FG001|Overall Study|Lack of Efficacy|10|||
143259109|NCT00920907|516503737|FG000|Induction Period|Adverse Event|0|||
143259110|NCT00920907|516503738|FG001|Induction Period|Adverse Event|2|||
143259111|NCT00920907|516503737|FG000|Induction Period|Death|1|||
143259112|NCT00920907|516503738|FG001|Induction Period|Death|1|||
143259113|NCT00920907|516503737|FG000|Induction Period|Disease Progression|12|||
143259114|NCT00920907|516503738|FG001|Induction Period|Disease Progression|11|||
143259115|NCT00920907|516503737|FG000|Induction Period|Study Drug Toxicity|8|||
143259116|NCT00920907|516503738|FG001|Induction Period|Study Drug Toxicity|6|||
143259117|NCT00920907|516503737|FG000|Induction Period|No longer meets study criteria|0|||
143259118|NCT00920907|516503738|FG001|Induction Period|No longer meets study criteria|1|||
143259119|NCT00920907|516503737|FG000|Induction Period|Withdrawal by Subject|1|||
143259120|NCT00920907|516503738|FG001|Induction Period|Withdrawal by Subject|1|||
143113934|NCT03427268|515959698|FG000|Overall Study|Adverse Event|3|||
143113935|NCT01643798|515959702|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
143113936|NCT01643798|515959703|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
143259121|NCT00920907|516503737|FG000|Maintenance Period|Disease Progression|3|||
143259122|NCT00920907|516503738|FG001|Maintenance Period|Disease Progression|7|||
143259123|NCT00920907|516503737|FG000|Maintenance Period|Administrative (study closure)|7|||
143259124|NCT00920907|516503738|FG001|Maintenance Period|Administrative (study closure)|2|||
143113937|NCT04495816|515959705|FG000|Overall Study|Lost to Follow-up|10|||
143113938|NCT04495816|515959706|FG001|Overall Study|Lost to Follow-up|4|||
143113939|NCT04495816|515959705|FG000|Overall Study|Withdrawal by Subject|3|||
143113940|NCT04495816|515959706|FG001|Overall Study|Withdrawal by Subject|5|||
143113941|NCT03181503|515959707|FG000|Overall Study|Adverse Event|2|||
143113942|NCT03181503|515959708|FG001|Overall Study|Adverse Event|2|||
143113943|NCT03181503|515959707|FG000|Overall Study|Protocol Violation|1|||
143259125|NCT00920907|516503737|FG000|Maintenance Period|Study Drug Toxicity|0|||
143259126|NCT00920907|516503738|FG001|Maintenance Period|Study Drug Toxicity|2|||
143259127|NCT00920907|516503737|FG000|Maintenance Period|Death|1|||
143259128|NCT00920907|516503738|FG001|Maintenance Period|Death|1|||
143259129|NCT00920907|516503737|FG000|Maintenance Period|Withdrawal by Subject|1|||
143259130|NCT00920907|516503738|FG001|Maintenance Period|Withdrawal by Subject|0|||
143259131|NCT00920907|516503737|FG000|Maintenance Period|Adverse Event|0|||
143259132|NCT00920907|516503738|FG001|Maintenance Period|Adverse Event|1|||
143259133|NCT01275339|516503739|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
143259134|NCT01275339|516503740|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
143259135|NCT01275339|516503741|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
143259136|NCT01275339|516503742|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
143259137|NCT01275339|516503739|FG000|Overall Study|Withdrawal by Subject|0|||
143259138|NCT01275339|516503740|FG001|Overall Study|Withdrawal by Subject|0|||
143259139|NCT01275339|516503741|FG002|Overall Study|Withdrawal by Subject|1|||
143259140|NCT01275339|516503742|FG003|Overall Study|Withdrawal by Subject|0|||
143259141|NCT03123185|516503743|FG000|Overall Study|Withdrawal by Subject|0|||
143259142|NCT03123185|516503744|FG001|Overall Study|Withdrawal by Subject|0|||
143259143|NCT03123185|516503745|FG002|Overall Study|Withdrawal by Subject|0|||
143259144|NCT03123185|516503746|FG003|Overall Study|Withdrawal by Subject|0|||
143259145|NCT03123185|516503747|FG004|Overall Study|Withdrawal by Subject|0|||
143259146|NCT03123185|516503748|FG005|Overall Study|Withdrawal by Subject|0|||
143259147|NCT03123185|516503749|FG006|Overall Study|Withdrawal by Subject|0|||
143259148|NCT03123185|516503750|FG007|Overall Study|Withdrawal by Subject|0|||
143259149|NCT03123185|516503751|FG008|Overall Study|Withdrawal by Subject|0|||
143259150|NCT03123185|516503752|FG009|Overall Study|Withdrawal by Subject|0|||
143259151|NCT03123185|516503753|FG010|Overall Study|Withdrawal by Subject|0|||
143259152|NCT03123185|516503754|FG011|Overall Study|Withdrawal by Subject|0|||
143259153|NCT03123185|516503755|FG012|Overall Study|Withdrawal by Subject|1|||
143259154|NCT03123185|516503756|FG013|Overall Study|Withdrawal by Subject|0|||
143259155|NCT00718081|516503757|FG000|Overall Study|Adverse Event|0|||
143259156|NCT00718081|516503758|FG001|Overall Study|Adverse Event|1|||
143259157|NCT00718081|516503759|FG002|Overall Study|Adverse Event|0|||
143259158|NCT00718081|516503757|FG000|Overall Study|Lack of Efficacy|7|||
143259159|NCT00718081|516503758|FG001|Overall Study|Lack of Efficacy|3|||
143259160|NCT00718081|516503759|FG002|Overall Study|Lack of Efficacy|21|||
143259161|NCT00815516|516503760|FG000|Overall Study|Death|3|||
143259162|NCT00815516|516503761|FG001|Overall Study|Death|1|||
143259163|NCT00815516|516503760|FG000|Overall Study|Physician Decision|1|||
143259164|NCT00815516|516503761|FG001|Overall Study|Physician Decision|0|||
143259165|NCT00470158|516503769|FG000|Overall Study|Death|0|||
143259166|NCT00470158|516503770|FG001|Overall Study|Death|0|||
143259167|NCT00470158|516503771|FG002|Overall Study|Death|0|||
143259168|NCT00470158|516503772|FG003|Overall Study|Death|0|||
143259169|NCT00470158|516503773|FG004|Overall Study|Death|2|||
143259170|NCT00470158|516503769|FG000|Overall Study|Lost to Follow-up|7|||
143259171|NCT00470158|516503770|FG001|Overall Study|Lost to Follow-up|8|||
143259172|NCT00470158|516503771|FG002|Overall Study|Lost to Follow-up|8|||
143259173|NCT00470158|516503772|FG003|Overall Study|Lost to Follow-up|5|||
143259174|NCT00470158|516503773|FG004|Overall Study|Lost to Follow-up|4|||
143259175|NCT00470158|516503769|FG000|Overall Study|Protocol Violation|1|||
143259176|NCT00470158|516503770|FG001|Overall Study|Protocol Violation|0|||
143113944|NCT03181503|515959708|FG001|Overall Study|Protocol Violation|0|||
143113945|NCT03181503|515959707|FG000|Overall Study|Withdrawal by Subject|3|||
143113946|NCT03181503|515959708|FG001|Overall Study|Withdrawal by Subject|0|||
143113947|NCT03181503|515959707|FG000|Overall Study|Lost to Follow-up|1|||
143259177|NCT00470158|516503771|FG002|Overall Study|Protocol Violation|0|||
143259178|NCT00470158|516503772|FG003|Overall Study|Protocol Violation|0|||
143259179|NCT00470158|516503773|FG004|Overall Study|Protocol Violation|0|||
143259180|NCT01249118|516503774|FG000|First Washout Period|Physician Decision|0|||
143259181|NCT01249118|516503775|FG001|First Washout Period|Physician Decision|1|||
143259182|NCT01249118|516503776|FG002|First Washout Period|Physician Decision|0|||
143259183|NCT00880685|516503777|FG000|Memantine 10mg|Lost to Follow-up|2|||
143368703|NCT01090024|516894529|FG016|Period 1|Met exclusion criteria|0|||
143113948|NCT03181503|515959708|FG001|Overall Study|Lost to Follow-up|1|||
143113949|NCT01892085|515959709|FG000|Overall Study|Death|4|||
143259184|NCT00880685|516503777|FG000|Memantine 20mg|Withdrawal by Subject|1|||
143259185|NCT02195687|516503778|FG000|Overall Study|Personal Reasons|1|||
143259186|NCT02195687|516503779|FG001|Overall Study|Personal Reasons|1|||
143259187|NCT02195687|516503778|FG000|Overall Study|Lost to Follow-up|4|||
143259188|NCT02195687|516503779|FG001|Overall Study|Lost to Follow-up|1|||
143259189|NCT02361580|516503780|FG000|Overall Study|Lost to Follow-up|6|||
143259190|NCT02361580|516503781|FG001|Overall Study|Lost to Follow-up|3|||
143259191|NCT04369924|516503782|FG000|Overall Study|Lost to Follow-up|302|||
143259192|NCT04369924|516503783|FG001|Overall Study|Lost to Follow-up|339|||
143259193|NCT00708201|516503784|FG000|Overall Study|Adverse Event|4|||
143259194|NCT00708201|516503785|FG001|Overall Study|Adverse Event|4|||
143259195|NCT00708201|516503784|FG000|Overall Study|Withdrawal by Subject|1|||
143259196|NCT00708201|516503785|FG001|Overall Study|Withdrawal by Subject|1|||
143259197|NCT00708201|516503784|FG000|Overall Study|Lost to Follow-up|2|||
143259198|NCT00708201|516503785|FG001|Overall Study|Lost to Follow-up|0|||
143259199|NCT00708201|516503784|FG000|Overall Study|Protocol Violation|0|||
143259200|NCT00708201|516503785|FG001|Overall Study|Protocol Violation|1|||
143259201|NCT03828370|516503786|FG000|3 Month Follow-up|Lost to Follow-up|4|||
143259202|NCT03828370|516503787|FG001|3 Month Follow-up|Lost to Follow-up|12|||
143259203|NCT03828370|516503786|FG000|9 Month Follow up|Lost to Follow-up|12|||
143259204|NCT03828370|516503787|FG001|9 Month Follow up|Lost to Follow-up|20|||
143259205|NCT00761748|516503788|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
143259206|NCT00761748|516503789|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
143259207|NCT00761748|516503788|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
143259208|NCT00761748|516503789|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
143259209|NCT01857310|516503790|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
143259210|NCT01857310|516503791|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
143259211|NCT02554279|516503792|FG000|Overall Study|Adverse Event|2|||
143259212|NCT02554279|516503793|FG001|Overall Study|Adverse Event|5|||
143259213|NCT02554279|516503792|FG000|Overall Study|Lost to Follow-up|3|||
143259214|NCT02554279|516503793|FG001|Overall Study|Lost to Follow-up|2|||
143259215|NCT02554279|516503792|FG000|Overall Study|Withdrawal by Subject|6|||
143259216|NCT02554279|516503793|FG001|Overall Study|Withdrawal by Subject|4|||
143259217|NCT02554279|516503792|FG000|Overall Study|Protocol Violation|2|||
143259218|NCT02554279|516503793|FG001|Overall Study|Protocol Violation|1|||
143259219|NCT02554279|516503792|FG000|Overall Study|Other reason|19|||
143259220|NCT02554279|516503793|FG001|Overall Study|Other reason|6|||
143259221|NCT00812487|516503794|FG000|Overall Study|Lost to Follow-up|2|||
143368704|NCT01090024|516894530|FG017|Period 1|Met exclusion criteria|0|||
143368705|NCT01090024|516894513|FG000|Period 1|Adverse Event|0|||
143368706|NCT01090024|516894514|FG001|Period 1|Adverse Event|0|||
143259222|NCT00812487|516503795|FG001|Overall Study|Lost to Follow-up|0|||
143259223|NCT00812487|516503794|FG000|Overall Study|Withdrawal by Subject|3|||
143368707|NCT01090024|516894515|FG002|Period 1|Adverse Event|0|||
143368708|NCT01090024|516894516|FG003|Period 1|Adverse Event|0|||
143368709|NCT01090024|516894517|FG004|Period 1|Adverse Event|0|||
143259224|NCT00812487|516503795|FG001|Overall Study|Withdrawal by Subject|2|||
143259225|NCT00812487|516503794|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
143259226|NCT00812487|516503795|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
143259227|NCT00812487|516503794|FG000|Overall Study|Protocol Violation|0|||
143259228|NCT00812487|516503795|FG001|Overall Study|Protocol Violation|1|||
143259229|NCT00998764|516503796|FG000|Overall Study|Lack of Efficacy|3|||
143259230|NCT00998764|516503797|FG001|Overall Study|Lack of Efficacy|6|||
143259231|NCT00998764|516503796|FG000|Overall Study|Adverse Event|17|||
143259232|NCT00998764|516503797|FG001|Overall Study|Adverse Event|12|||
143259233|NCT00998764|516503796|FG000|Overall Study|Withdrawal by Subject|19|||
143259234|NCT00998764|516503797|FG001|Overall Study|Withdrawal by Subject|25|||
143259235|NCT00998764|516503796|FG000|Overall Study|Physician Decision|3|||
143259236|NCT00998764|516503797|FG001|Overall Study|Physician Decision|3|||
143259237|NCT00998764|516503796|FG000|Overall Study|Death|3|||
143259238|NCT00998764|516503797|FG001|Overall Study|Death|1|||
143259239|NCT00998764|516503796|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
143259240|NCT00998764|516503797|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
143259241|NCT00998764|516503796|FG000|Overall Study|Protocol Violation|0|||
143259242|NCT00998764|516503797|FG001|Overall Study|Protocol Violation|1|||
143259243|NCT00998764|516503796|FG000|Overall Study|Failed to Return|1|||
143259244|NCT00998764|516503797|FG001|Overall Study|Failed to Return|1|||
143259245|NCT00998764|516503796|FG000|Overall Study|Lost to Follow-up|1|||
143259246|NCT00998764|516503797|FG001|Overall Study|Lost to Follow-up|1|||
143259247|NCT00998764|516503796|FG000|Overall Study|Loss of Caregiver|0|||
143259248|NCT00998764|516503797|FG001|Overall Study|Loss of Caregiver|3|||
143259249|NCT00998764|516503796|FG000|Overall Study|Other|4|||
143259250|NCT00998764|516503797|FG001|Overall Study|Other|4|||
143259251|NCT00998764|516503796|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
143259252|NCT00998764|516503797|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
143259253|NCT04761627|516503800|FG000|Run-in Period|Death|1|||
143368710|NCT01090024|516894518|FG005|Period 1|Adverse Event|0|||
143368711|NCT01090024|516894519|FG006|Period 1|Adverse Event|0|||
143259254|NCT04761627|516503801|FG001|Run-in Period|Death|0|||
143113950|NCT01892085|515959710|FG001|Overall Study|Death|1|||
143113951|NCT01892085|515959711|FG002|Overall Study|Death|3|||
143259255|NCT04761627|516503802|FG002|Run-in Period|Death|0|||
143259256|NCT04761627|516503800|FG000|Run-in Period|Required alternative therapy|2|||
143259257|NCT04761627|516503801|FG001|Run-in Period|Required alternative therapy|0|||
143113952|NCT01892085|515959709|FG000|Overall Study|Withdrawal by Subject|2|||
143113953|NCT01892085|515959710|FG001|Overall Study|Withdrawal by Subject|0|||
143113954|NCT01892085|515959711|FG002|Overall Study|Withdrawal by Subject|2|||
143113955|NCT01549041|515959712|FG000|Overall Study|Lack of Efficacy|2|||
143113956|NCT01549041|515959713|FG001|Overall Study|Lack of Efficacy|4|||
143113957|NCT01549041|515959712|FG000|Overall Study|Adverse Event|0|||
143113958|NCT01549041|515959713|FG001|Overall Study|Adverse Event|4|||
143113959|NCT00628095|515959716|FG000|Overall Study|Adverse Event|5|||
143113960|NCT00628095|515959717|FG001|Overall Study|Adverse Event|3|||
143113961|NCT00628095|515959716|FG000|Overall Study|Lack of Efficacy|0|||
143113962|NCT00628095|515959717|FG001|Overall Study|Lack of Efficacy|3|||
143113963|NCT00628095|515959716|FG000|Overall Study|Withdrawal by Subject|2|||
143113964|NCT00628095|515959717|FG001|Overall Study|Withdrawal by Subject|0|||
143113965|NCT00628095|515959716|FG000|Overall Study|Other|0|||
143113966|NCT00628095|515959717|FG001|Overall Study|Other|1|||
143113967|NCT03235115|515959718|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
143113968|NCT03235115|515959719|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
143113969|NCT03235115|515959720|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
143113970|NCT03235115|515959721|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
143113971|NCT03235115|515959722|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
143113972|NCT03235115|515959723|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
143113973|NCT02003963|515959726|FG000|Overall Study|Lost to Follow-up|2|||
143113974|NCT02003963|515959727|FG001|Overall Study|Lost to Follow-up|1|||
143113975|NCT05020366|515959728|FG000|Overall Study|Lost to Follow-up|2|||
143113976|NCT05020366|515959729|FG001|Overall Study|Lost to Follow-up|0|||
143113977|NCT05020366|515959728|FG000|Overall Study|Withdrawal by Subject|2|||
143113978|NCT05020366|515959729|FG001|Overall Study|Withdrawal by Subject|0|||
143113979|NCT04050124|515959732|FG000|Overall Study|Death|1|||
143113980|NCT04050124|515959733|FG001|Overall Study|Death|0|||
143113981|NCT04442269|515959737|FG000|Overall Study|Adverse Event|1|||
143113982|NCT04442269|515959738|FG001|Overall Study|Adverse Event|0|||
143113983|NCT04442269|515959737|FG000|Overall Study|Death|0|||
143113984|NCT04442269|515959738|FG001|Overall Study|Death|1|||
143259258|NCT04761627|516503802|FG002|Run-in Period|Required alternative therapy|0|||
143259259|NCT04761627|516503800|FG000|Run-in Period|Lost to Follow-up|2|||
143259260|NCT04761627|516503801|FG001|Run-in Period|Lost to Follow-up|0|||
143259261|NCT04761627|516503802|FG002|Run-in Period|Lost to Follow-up|0|||
143259262|NCT04761627|516503800|FG000|Run-in Period|Protocol Violation|3|||
143259263|NCT04761627|516503801|FG001|Run-in Period|Protocol Violation|0|||
143259264|NCT04761627|516503802|FG002|Run-in Period|Protocol Violation|0|||
143259265|NCT04761627|516503800|FG000|Run-in Period|Abnormal liver function|1|||
143113985|NCT04442269|515959737|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
143113986|NCT04442269|515959738|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
143113987|NCT04442269|515959737|FG000|Overall Study|Lost to Follow-up|1|||
143113988|NCT04442269|515959738|FG001|Overall Study|Lost to Follow-up|0|||
143113989|NCT04442269|515959737|FG000|Overall Study|Withdrawal by Subject|3|||
143259266|NCT04761627|516503801|FG001|Run-in Period|Abnormal liver function|0|||
143113990|NCT04442269|515959738|FG001|Overall Study|Withdrawal by Subject|2|||
143113991|NCT04442269|515959737|FG000|Overall Study|Protocol Deviation|0|||
143113992|NCT04442269|515959738|FG001|Overall Study|Protocol Deviation|1|||
143113993|NCT04442269|515959737|FG000|Overall Study|Travel Limitations|1|||
143113994|NCT04442269|515959738|FG001|Overall Study|Travel Limitations|1|||
143113995|NCT03802565|515959739|FG000|Overall Study|Adverse Event|0|||
143113996|NCT03802565|515959740|FG001|Overall Study|Adverse Event|1|||
143113997|NCT03802565|515959741|FG002|Overall Study|Adverse Event|2|||
143113998|NCT03802565|515959742|FG003|Overall Study|Adverse Event|1|||
143113999|NCT03802565|515959743|FG004|Overall Study|Adverse Event|1|||
143114000|NCT03802565|515959739|FG000|Overall Study|Withdrawal by Subject|2|||
143114001|NCT03802565|515959740|FG001|Overall Study|Withdrawal by Subject|2|||
143114002|NCT03802565|515959741|FG002|Overall Study|Withdrawal by Subject|2|||
143114003|NCT03802565|515959742|FG003|Overall Study|Withdrawal by Subject|0|||
143114004|NCT03802565|515959743|FG004|Overall Study|Withdrawal by Subject|1|||
143114005|NCT03802565|515959739|FG000|Overall Study|Protocol Violation|2|||
143114006|NCT03802565|515959740|FG001|Overall Study|Protocol Violation|1|||
143114007|NCT03802565|515959741|FG002|Overall Study|Protocol Violation|4|||
143114008|NCT03802565|515959742|FG003|Overall Study|Protocol Violation|5|||
143114009|NCT03802565|515959743|FG004|Overall Study|Protocol Violation|1|||
143114010|NCT03802565|515959739|FG000|Overall Study|Lost to Follow-up|0|||
143114011|NCT03802565|515959740|FG001|Overall Study|Lost to Follow-up|0|||
143114012|NCT03802565|515959741|FG002|Overall Study|Lost to Follow-up|1|||
143114013|NCT03802565|515959742|FG003|Overall Study|Lost to Follow-up|0|||
143114014|NCT03802565|515959743|FG004|Overall Study|Lost to Follow-up|0|||
143114015|NCT03802565|515959739|FG000|Overall Study|Subjects Related to Each Other|1|||
143114016|NCT03802565|515959740|FG001|Overall Study|Subjects Related to Each Other|0|||
143114017|NCT03802565|515959741|FG002|Overall Study|Subjects Related to Each Other|0|||
143114018|NCT03802565|515959742|FG003|Overall Study|Subjects Related to Each Other|2|||
143114019|NCT03802565|515959743|FG004|Overall Study|Subjects Related to Each Other|1|||
143114020|NCT03802565|515959739|FG000|Overall Study|Elevated Enzymes|0|||
143114021|NCT03802565|515959740|FG001|Overall Study|Elevated Enzymes|0|||
143180321|NCT02012218|516206999|FG004|Overall Study|Protocol Specified|0|||
143180322|NCT02012218|516206995|FG000|Overall Study|Protocol Deviation|1|||
143180323|NCT02012218|516206996|FG001|Overall Study|Protocol Deviation|0|||
143180324|NCT02012218|516206997|FG002|Overall Study|Protocol Deviation|0|||
143180325|NCT02012218|516206998|FG003|Overall Study|Protocol Deviation|0|||
143180326|NCT02012218|516206999|FG004|Overall Study|Protocol Deviation|0|||
143180327|NCT04872569|516207000|FG000|Overall Study|Withdrawal by Subject|2|||
143180328|NCT02382991|516207003|FG000|Overall Study|Adverse Event|1|||
143180329|NCT02382991|516207004|FG001|Overall Study|Adverse Event|2|||
143180330|NCT02382991|516207003|FG000|Overall Study|Lost to Follow-up|1|||
143180331|NCT02382991|516207004|FG001|Overall Study|Lost to Follow-up|0|||
143180332|NCT02382991|516207003|FG000|Overall Study|Withdrawal by Subject|0|||
143180333|NCT02382991|516207004|FG001|Overall Study|Withdrawal by Subject|1|||
143180334|NCT02268383|516207008|FG000|Overall Study|Death|12|||
143180335|NCT02268383|516207008|FG000|Overall Study|Lost to Follow-up|2|||
143180336|NCT02268383|516207008|FG000|Overall Study|Withdrawal by Subject|9|||
143180337|NCT02268383|516207008|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
143180338|NCT02268383|516207008|FG000|Overall Study|Protocol deviation|3|||
143180339|NCT02268383|516207008|FG000|Overall Study|Sponsor decision|22|||
143180340|NCT02268383|516207008|FG000|Overall Study|Not reported|12|||
143180341|NCT03382912|516207009|FG000|Overall Study|Physician Decision|0|||
143180342|NCT03382912|516207010|FG001|Overall Study|Physician Decision|1|||
143180343|NCT03382912|516207009|FG000|Overall Study|Sponsor Decision|6|||
143180344|NCT03382912|516207010|FG001|Overall Study|Sponsor Decision|6|||
143180345|NCT03382912|516207009|FG000|Overall Study|Withdrawal by Subject|0|||
143180346|NCT03382912|516207010|FG001|Overall Study|Withdrawal by Subject|5|||
143114022|NCT03802565|515959741|FG002|Overall Study|Elevated Enzymes|0|||
143114023|NCT03802565|515959742|FG003|Overall Study|Elevated Enzymes|0|||
143180347|NCT00326001|516207011|FG000|Overall Study|Adverse Event|4|||
143180348|NCT00326001|516207012|FG001|Overall Study|Adverse Event|5|||
143259267|NCT04761627|516503802|FG002|Run-in Period|Abnormal liver function|0|||
143259268|NCT04761627|516503800|FG000|Run-in Period|Adverse Event|6|||
143259269|NCT04761627|516503801|FG001|Run-in Period|Adverse Event|0|||
143259270|NCT04761627|516503802|FG002|Run-in Period|Adverse Event|0|||
143259271|NCT04761627|516503800|FG000|Run-in Period|Withdrawal by Subject|7|||
143259272|NCT04761627|516503801|FG001|Run-in Period|Withdrawal by Subject|0|||
143259273|NCT04761627|516503802|FG002|Run-in Period|Withdrawal by Subject|0|||
143259274|NCT04761627|516503800|FG000|Run-in Period|Did not meet PASI 50|15|||
143259275|NCT04761627|516503801|FG001|Run-in Period|Did not meet PASI 50|0|||
143259276|NCT04761627|516503802|FG002|Run-in Period|Did not meet PASI 50|0|||
143259277|NCT04761627|516503800|FG000|Run-in Period|Study site closure|2|||
143259278|NCT04761627|516503801|FG001|Run-in Period|Study site closure|0|||
143259279|NCT04761627|516503802|FG002|Run-in Period|Study site closure|0|||
143259280|NCT04761627|516503800|FG000|Run-in Period|Pregnancy|2|||
143259281|NCT04761627|516503801|FG001|Run-in Period|Pregnancy|0|||
143259282|NCT04761627|516503802|FG002|Run-in Period|Pregnancy|0|||
143259283|NCT04761627|516503800|FG000|Post-randomization Period|Military service|0|||
143259284|NCT04761627|516503801|FG001|Post-randomization Period|Military service|1|||
143259285|NCT04761627|516503802|FG002|Post-randomization Period|Military service|0|||
143259286|NCT04761627|516503800|FG000|Post-randomization Period|Adverse Event|0|||
143259287|NCT04761627|516503801|FG001|Post-randomization Period|Adverse Event|4|||
143259288|NCT04761627|516503802|FG002|Post-randomization Period|Adverse Event|2|||
143259289|NCT04761627|516503800|FG000|Post-randomization Period|Lost to Follow-up|0|||
143259290|NCT04761627|516503801|FG001|Post-randomization Period|Lost to Follow-up|6|||
143259291|NCT04761627|516503802|FG002|Post-randomization Period|Lost to Follow-up|6|||
143259292|NCT04761627|516503800|FG000|Post-randomization Period|Withdrawal by Subject|0|||
143259293|NCT04761627|516503801|FG001|Post-randomization Period|Withdrawal by Subject|7|||
143259294|NCT04761627|516503802|FG002|Post-randomization Period|Withdrawal by Subject|6|||
143259295|NCT04761627|516503800|FG000|Post-randomization Period|Pregnancy|0|||
143259296|NCT04761627|516503801|FG001|Post-randomization Period|Pregnancy|0|||
143259297|NCT04761627|516503802|FG002|Post-randomization Period|Pregnancy|1|||
143259298|NCT04761627|516503800|FG000|Post-randomization Period|Study site closure|0|||
143259299|NCT04761627|516503801|FG001|Post-randomization Period|Study site closure|0|||
143259300|NCT04761627|516503802|FG002|Post-randomization Period|Study site closure|1|||
143259301|NCT04761627|516503800|FG000|Post-randomization Period|Family planning|0|||
143259302|NCT04761627|516503801|FG001|Post-randomization Period|Family planning|1|||
143259303|NCT04761627|516503802|FG002|Post-randomization Period|Family planning|0|||
143259304|NCT01933789|516503803|FG000|Overall Study|Death|0|||
143259305|NCT01933789|516503804|FG001|Overall Study|Death|0|||
143259306|NCT01933789|516503805|FG002|Overall Study|Death|0|||
143259307|NCT01933789|516503806|FG003|Overall Study|Death|0|||
143259308|NCT01933789|516503807|FG004|Overall Study|Death|21|||
143259309|NCT01933789|516503808|FG005|Overall Study|Death|32|||
143259310|NCT01933789|516503809|FG006|Overall Study|Death|0|||
143259311|NCT01933789|516503810|FG007|Overall Study|Death|0|||
143259312|NCT01933789|516503811|FG008|Overall Study|Death|0|||
143259313|NCT01933789|516503803|FG000|Overall Study|Lost to Follow-up|0|||
143259314|NCT01933789|516503804|FG001|Overall Study|Lost to Follow-up|0|||
143259315|NCT01933789|516503805|FG002|Overall Study|Lost to Follow-up|0|||
143259316|NCT01933789|516503806|FG003|Overall Study|Lost to Follow-up|1|||
143259317|NCT01933789|516503807|FG004|Overall Study|Lost to Follow-up|8|||
143259318|NCT01933789|516503808|FG005|Overall Study|Lost to Follow-up|9|||
143259319|NCT01933789|516503809|FG006|Overall Study|Lost to Follow-up|1|||
143259320|NCT01933789|516503810|FG007|Overall Study|Lost to Follow-up|4|||
143259321|NCT01933789|516503811|FG008|Overall Study|Lost to Follow-up|0|||
143259322|NCT01933789|516503803|FG000|Overall Study|Withdrawal by Subject|2|||
143259323|NCT01933789|516503804|FG001|Overall Study|Withdrawal by Subject|1|||
143259324|NCT01933789|516503805|FG002|Overall Study|Withdrawal by Subject|0|||
143259325|NCT01933789|516503806|FG003|Overall Study|Withdrawal by Subject|0|||
143259326|NCT01933789|516503807|FG004|Overall Study|Withdrawal by Subject|17|||
143259327|NCT01933789|516503808|FG005|Overall Study|Withdrawal by Subject|16|||
143259328|NCT01933789|516503809|FG006|Overall Study|Withdrawal by Subject|1|||
143259329|NCT01933789|516503810|FG007|Overall Study|Withdrawal by Subject|4|||
143259330|NCT01933789|516503811|FG008|Overall Study|Withdrawal by Subject|0|||
143180349|NCT00326001|516207011|FG000|Overall Study|Physician Decision|3|||
143180350|NCT00326001|516207012|FG001|Overall Study|Physician Decision|3|||
143114024|NCT03802565|515959743|FG004|Overall Study|Elevated Enzymes|2|||
143114025|NCT04326439|515959747|FG000|Overall Study|Withdrawal by Subject|1|||
143180351|NCT03265145|516207013|FG000|Overall Study|Protocol Violation|2|||
143114026|NCT04326439|515959748|FG001|Overall Study|Withdrawal by Subject|0|||
143114027|NCT04326439|515959747|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
143114028|NCT04326439|515959748|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
143114029|NCT04326439|515959747|FG000|Overall Study|Relapse after Induction 2|0|||
143114030|NCT04326439|515959748|FG001|Overall Study|Relapse after Induction 2|1|||
143114031|NCT04326439|515959747|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
143114032|NCT04326439|515959748|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
143114033|NCT03932331|515959752|FG000|Overall Study|Death|0|||
143114034|NCT03932331|515959753|FG001|Overall Study|Death|7|||
143114035|NCT03932331|515959754|FG002|Overall Study|Death|2|||
143114036|NCT03932331|515959752|FG000|Overall Study|Withdrawal by Subject|0|||
143114037|NCT03932331|515959753|FG001|Overall Study|Withdrawal by Subject|3|||
143114038|NCT03932331|515959754|FG002|Overall Study|Withdrawal by Subject|0|||
143114039|NCT03932331|515959752|FG000|Overall Study|Meet the point of final analysis for this cohort|8|||
143114040|NCT03932331|515959753|FG001|Overall Study|Meet the point of final analysis for this cohort|23|||
143114041|NCT03932331|515959754|FG002|Overall Study|Meet the point of final analysis for this cohort|0|||
143114042|NCT03932331|515959752|FG000|Overall Study|Progressive disease|3|||
143114043|NCT03932331|515959753|FG001|Overall Study|Progressive disease|0|||
143114044|NCT03932331|515959754|FG002|Overall Study|Progressive disease|0|||
143114045|NCT03932331|515959752|FG000|Overall Study|Lung infection|1|||
143114046|NCT03932331|515959753|FG001|Overall Study|Lung infection|0|||
143114047|NCT03932331|515959754|FG002|Overall Study|Lung infection|0|||
143114048|NCT03932331|515959752|FG000|Overall Study|Other|0|||
143114049|NCT03932331|515959753|FG001|Overall Study|Other|0|||
143114050|NCT03932331|515959754|FG002|Overall Study|Other|58|||
143114051|NCT01032239|515959755|FG000|Overall Study|Lost to Follow-up|3|||
143114052|NCT01032239|515959756|FG001|Overall Study|Lost to Follow-up|2|||
143114053|NCT01032239|515959755|FG000|Overall Study|Withdrawal by Subject|2|||
143114054|NCT01032239|515959756|FG001|Overall Study|Withdrawal by Subject|3|||
143114055|NCT01032239|515959755|FG000|Overall Study|Death|1|||
143114056|NCT01032239|515959756|FG001|Overall Study|Death|0|||
143114057|NCT01032239|515959755|FG000|Overall Study|Protocol Violation|1|||
143114058|NCT01032239|515959756|FG001|Overall Study|Protocol Violation|0|||
143114059|NCT01940900|515959757|FG000|Overall Study|Physician Decision|4|||
143114060|NCT01940900|515959758|FG001|Overall Study|Physician Decision|0|||
143114061|NCT01940900|515959757|FG000|Overall Study|Adverse Event|10|||
143114062|NCT01940900|515959758|FG001|Overall Study|Adverse Event|15|||
143114063|NCT01940900|515959757|FG000|Overall Study|Withdrawal by Subject|11|||
143114064|NCT01940900|515959758|FG001|Overall Study|Withdrawal by Subject|15|||
143114065|NCT01940900|515959757|FG000|Overall Study|Lost to Follow-up|1|||
143114066|NCT01940900|515959758|FG001|Overall Study|Lost to Follow-up|0|||
143114067|NCT01940900|515959757|FG000|Overall Study|Sponsor Decision|1|||
143114068|NCT01940900|515959758|FG001|Overall Study|Sponsor Decision|0|||
143114069|NCT01940900|515959757|FG000|Overall Study|subject non-compliance|1|||
143114070|NCT01940900|515959758|FG001|Overall Study|subject non-compliance|1|||
143114071|NCT01940900|515959757|FG000|Overall Study|other|1|||
143114072|NCT01940900|515959758|FG001|Overall Study|other|0|||
143114073|NCT03782298|515959759|FG000|Overall Study|Protocol Deviation|4|||
143114074|NCT02431806|515959760|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
143114075|NCT02431806|515959761|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
143114076|NCT02431806|515959762|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
143114077|NCT02431806|515959763|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
143114078|NCT02431806|515959760|FG000|Double-blind Treatment Period|Adverse Event|4|||
143114079|NCT02431806|515959761|FG001|Double-blind Treatment Period|Adverse Event|7|||
143114080|NCT02431806|515959762|FG002|Double-blind Treatment Period|Adverse Event|11|||
143114081|NCT02431806|515959763|FG003|Double-blind Treatment Period|Adverse Event|7|||
143114082|NCT02431806|515959760|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
143114083|NCT02431806|515959761|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
143114084|NCT02431806|515959762|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
143114085|NCT02431806|515959763|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
143114086|NCT02431806|515959760|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
143114087|NCT02431806|515959761|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
143114088|NCT02431806|515959762|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
143114089|NCT02431806|515959763|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
143114090|NCT02431806|515959760|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
143114091|NCT02431806|515959761|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
143114092|NCT02431806|515959762|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
143114093|NCT02431806|515959763|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
143180352|NCT03265145|516207014|FG001|Overall Study|Protocol Violation|0|||
143180353|NCT03265145|516207013|FG000|Overall Study|Adverse Event|1|||
143180354|NCT03265145|516207014|FG001|Overall Study|Adverse Event|0|||
143180355|NCT03265145|516207013|FG000|Overall Study|Withdrawal by Subject|23|||
143180356|NCT03265145|516207014|FG001|Overall Study|Withdrawal by Subject|19|||
143180357|NCT03265145|516207013|FG000|Overall Study|Death|12|||
143180358|NCT03265145|516207014|FG001|Overall Study|Death|12|||
143180359|NCT03265145|516207013|FG000|Overall Study|Lost to Follow-up|13|||
143180360|NCT03265145|516207014|FG001|Overall Study|Lost to Follow-up|9|||
143180361|NCT03265145|516207013|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
143180362|NCT03265145|516207014|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
143180363|NCT03265145|516207013|FG000|Overall Study|Switched back to previous medication|1|||
143180364|NCT03265145|516207014|FG001|Overall Study|Switched back to previous medication|0|||
143180365|NCT03265145|516207013|FG000|Overall Study|Did not want to take medication|1|||
143180366|NCT03265145|516207014|FG001|Overall Study|Did not want to take medication|0|||
143180367|NCT03265145|516207013|FG000|Overall Study|Subject could not afford medication|0|||
143180368|NCT03265145|516207014|FG001|Overall Study|Subject could not afford medication|1|||
143180369|NCT03265145|516207013|FG000|Overall Study|Site closed|2|||
143180370|NCT03265145|516207014|FG001|Overall Study|Site closed|3|||
143180371|NCT03265145|516207013|FG000|Overall Study|Incorrectly randomized|16|||
143180372|NCT03265145|516207014|FG001|Overall Study|Incorrectly randomized|6|||
143180373|NCT03265145|516207013|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
143180374|NCT03265145|516207014|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
143180375|NCT03265145|516207013|FG000|Overall Study|Physician Decision|0|||
143180376|NCT03265145|516207014|FG001|Overall Study|Physician Decision|3|||
143180377|NCT03265145|516207013|FG000|Overall Study|Subject transferred to another facility|0|||
143180378|NCT03265145|516207014|FG001|Overall Study|Subject transferred to another facility|1|||
143180379|NCT05005273|516207015|FG000|Overall Study|Study Terminated|1|||
143180380|NCT05005273|516207016|FG001|Overall Study|Study Terminated|0|||
143180381|NCT04409834|516207017|FG000|Overall Study|Death|55|||
143180382|NCT04409834|516207018|FG001|Overall Study|Death|62|||
143180383|NCT02112656|516207019|FG000|Overall Study|Death|78|||
143180384|NCT02112656|516207020|FG001|Overall Study|Death|82|||
143180385|NCT02112656|516207019|FG000|Overall Study|Withdrawal by Subject|9|||
143180386|NCT02112656|516207020|FG001|Overall Study|Withdrawal by Subject|11|||
143180387|NCT02112656|516207019|FG000|Overall Study|Lost to Follow-up|2|||
143180388|NCT02112656|516207020|FG001|Overall Study|Lost to Follow-up|4|||
143180389|NCT02112656|516207019|FG000|Overall Study|Noncompliance|1|||
143180390|NCT02112656|516207020|FG001|Overall Study|Noncompliance|2|||
143180391|NCT03941483|516207021|FG000|Overall Study|Miscellaneous|2|||
143180392|NCT03941483|516207022|FG001|Overall Study|Miscellaneous|3|||
143180393|NCT03941483|516207023|FG002|Overall Study|Miscellaneous|0|||
143180394|NCT03941483|516207021|FG000|Overall Study|Study Terminated by Sponsor|1|||
143180395|NCT03941483|516207022|FG001|Overall Study|Study Terminated by Sponsor|0|||
143180396|NCT03941483|516207023|FG002|Overall Study|Study Terminated by Sponsor|0|||
143180397|NCT03941483|516207021|FG000|Overall Study|Withdrawal by Subject|1|||
143180398|NCT03941483|516207022|FG001|Overall Study|Withdrawal by Subject|4|||
143180399|NCT03941483|516207023|FG002|Overall Study|Withdrawal by Subject|1|||
143180400|NCT03941483|516207021|FG000|Overall Study|Lost to Follow-up|2|||
143259331|NCT01933789|516503803|FG000|Overall Study|Became Ineligible|4|||
143180401|NCT03941483|516207022|FG001|Overall Study|Lost to Follow-up|1|||
143368712|NCT01090024|516894520|FG007|Period 1|Adverse Event|0|||
143368713|NCT01090024|516894521|FG008|Period 1|Adverse Event|0|||
143368714|NCT01090024|516894522|FG009|Period 1|Adverse Event|1|||
143368715|NCT01090024|516894523|FG010|Period 1|Adverse Event|0|||
143368716|NCT01090024|516894524|FG011|Period 1|Adverse Event|1|||
143368717|NCT01090024|516894525|FG012|Period 1|Adverse Event|0|||
143368718|NCT01090024|516894526|FG013|Period 1|Adverse Event|0|||
143368719|NCT01090024|516894527|FG014|Period 1|Adverse Event|0|||
143368720|NCT01090024|516894528|FG015|Period 1|Adverse Event|0|||
143368721|NCT01090024|516894529|FG016|Period 1|Adverse Event|0|||
143368722|NCT01090024|516894530|FG017|Period 1|Adverse Event|1|||
143368723|NCT01090024|516894513|FG000|Period 1|Withdrawal by Subject|0|||
143368724|NCT01090024|516894514|FG001|Period 1|Withdrawal by Subject|0|||
143368725|NCT01090024|516894515|FG002|Period 1|Withdrawal by Subject|0|||
143368726|NCT01090024|516894516|FG003|Period 1|Withdrawal by Subject|1|||
143368727|NCT01090024|516894517|FG004|Period 1|Withdrawal by Subject|0|||
143368728|NCT01090024|516894518|FG005|Period 1|Withdrawal by Subject|0|||
143368729|NCT01090024|516894519|FG006|Period 1|Withdrawal by Subject|0|||
143368730|NCT01090024|516894520|FG007|Period 1|Withdrawal by Subject|0|||
143368731|NCT01090024|516894521|FG008|Period 1|Withdrawal by Subject|0|||
143368732|NCT01090024|516894522|FG009|Period 1|Withdrawal by Subject|0|||
143368733|NCT01090024|516894523|FG010|Period 1|Withdrawal by Subject|0|||
143368734|NCT01090024|516894524|FG011|Period 1|Withdrawal by Subject|0|||
143368735|NCT01090024|516894525|FG012|Period 1|Withdrawal by Subject|0|||
143368736|NCT01090024|516894526|FG013|Period 1|Withdrawal by Subject|0|||
143368737|NCT01090024|516894527|FG014|Period 1|Withdrawal by Subject|0|||
143368738|NCT01090024|516894528|FG015|Period 1|Withdrawal by Subject|0|||
143368739|NCT01090024|516894529|FG016|Period 1|Withdrawal by Subject|0|||
143368740|NCT01090024|516894530|FG017|Period 1|Withdrawal by Subject|0|||
143368741|NCT01090024|516894513|FG000|Period 1|Lost to Follow-up|0|||
143368742|NCT01090024|516894514|FG001|Period 1|Lost to Follow-up|1|||
143368743|NCT01090024|516894515|FG002|Period 1|Lost to Follow-up|0|||
143368744|NCT01090024|516894516|FG003|Period 1|Lost to Follow-up|0|||
143368745|NCT01090024|516894517|FG004|Period 1|Lost to Follow-up|0|||
143368746|NCT01090024|516894518|FG005|Period 1|Lost to Follow-up|0|||
143368747|NCT01090024|516894519|FG006|Period 1|Lost to Follow-up|0|||
143368748|NCT01090024|516894520|FG007|Period 1|Lost to Follow-up|0|||
143368749|NCT01090024|516894521|FG008|Period 1|Lost to Follow-up|0|||
143368750|NCT01090024|516894522|FG009|Period 1|Lost to Follow-up|0|||
143368751|NCT01090024|516894523|FG010|Period 1|Lost to Follow-up|0|||
143368752|NCT01090024|516894524|FG011|Period 1|Lost to Follow-up|0|||
143368753|NCT01090024|516894525|FG012|Period 1|Lost to Follow-up|0|||
143368754|NCT01090024|516894526|FG013|Period 1|Lost to Follow-up|0|||
143368755|NCT01090024|516894527|FG014|Period 1|Lost to Follow-up|0|||
143180402|NCT03941483|516207023|FG002|Overall Study|Lost to Follow-up|8|||
143368756|NCT01090024|516894528|FG015|Period 1|Lost to Follow-up|0|||
143368757|NCT01090024|516894529|FG016|Period 1|Lost to Follow-up|0|||
143368758|NCT01090024|516894530|FG017|Period 1|Lost to Follow-up|0|||
143368759|NCT01090024|516894513|FG000|Period 2|Lost to Follow-up|0|||
143368760|NCT01090024|516894514|FG001|Period 2|Lost to Follow-up|0|||
143368761|NCT01090024|516894515|FG002|Period 2|Lost to Follow-up|0|||
143368762|NCT01090024|516894516|FG003|Period 2|Lost to Follow-up|1|||
143114094|NCT02431806|515959760|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
143114095|NCT02431806|515959761|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
143114096|NCT02431806|515959762|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
143114097|NCT02431806|515959763|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
143114098|NCT02431806|515959760|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
143114099|NCT02431806|515959761|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
143114100|NCT02431806|515959762|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
143114101|NCT02431806|515959763|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
143114102|NCT01797081|515959764|FG000|Overall Study|Adverse Event|1|||
143114103|NCT01797081|515959765|FG001|Overall Study|Adverse Event|0|||
143114104|NCT01797081|515959766|FG002|Overall Study|Adverse Event|1|||
143114105|NCT01797081|515959767|FG003|Overall Study|Adverse Event|0|||
143114106|NCT01797081|515959764|FG000|Overall Study|Pregnancy|1|||
143114107|NCT01797081|515959765|FG001|Overall Study|Pregnancy|0|||
143114108|NCT01797081|515959766|FG002|Overall Study|Pregnancy|0|||
143114109|NCT01797081|515959767|FG003|Overall Study|Pregnancy|0|||
143114110|NCT01797081|515959764|FG000|Overall Study|Personal Reasons|12|||
143114111|NCT01797081|515959765|FG001|Overall Study|Personal Reasons|4|||
143114112|NCT01797081|515959766|FG002|Overall Study|Personal Reasons|4|||
143114113|NCT01797081|515959767|FG003|Overall Study|Personal Reasons|8|||
143114114|NCT01797081|515959764|FG000|Overall Study|Protocol Violation|0|||
143114115|NCT01797081|515959765|FG001|Overall Study|Protocol Violation|0|||
143114116|NCT01797081|515959766|FG002|Overall Study|Protocol Violation|0|||
143114117|NCT01797081|515959767|FG003|Overall Study|Protocol Violation|1|||
143114118|NCT05513703|515959771|FG000|Overall Study|Death|4|||
143114119|NCT05513703|515959771|FG000|Overall Study|Study terminated by sponsor|5|||
143114120|NCT01793688|515959775|FG000|Overall Study|Protocol Violation|2|||
143114121|NCT01698879|515959778|FG000|Overall Study|Withdrawal by Subject|1|||
143114122|NCT01698879|515959779|FG001|Overall Study|Withdrawal by Subject|0|||
143114123|NCT01698879|515959780|FG002|Overall Study|Withdrawal by Subject|0|||
143114124|NCT04450407|515959782|FG000|Overall Study|Withdrawal by Subject|10|||
143114125|NCT04450407|515959783|FG001|Overall Study|Withdrawal by Subject|1|||
143114126|NCT04450407|515959784|FG002|Overall Study|Withdrawal by Subject|4|||
143114127|NCT04450407|515959782|FG000|Overall Study|Adverse Event|0|||
143114128|NCT04450407|515959783|FG001|Overall Study|Adverse Event|0|||
143114129|NCT04450407|515959784|FG002|Overall Study|Adverse Event|1|||
143114130|NCT04450407|515959782|FG000|Overall Study|Lost to Follow-up|1|||
143114131|NCT04450407|515959783|FG001|Overall Study|Lost to Follow-up|0|||
143114132|NCT04450407|515959784|FG002|Overall Study|Lost to Follow-up|0|||
143114133|NCT04450407|515959782|FG000|Overall Study|Physician Decision|0|||
143114134|NCT04450407|515959783|FG001|Overall Study|Physician Decision|0|||
143114135|NCT04450407|515959784|FG002|Overall Study|Physician Decision|1|||
143114136|NCT04450407|515959782|FG000|Overall Study|Pregnancy|1|||
143180403|NCT03941483|516207021|FG000|Overall Study|Death|3|||
143114137|NCT04450407|515959783|FG001|Overall Study|Pregnancy|0|||
143114138|NCT04450407|515959784|FG002|Overall Study|Pregnancy|0|||
143114139|NCT04450407|515959782|FG000|Overall Study|Protocol Violation|2|||
143114140|NCT04450407|515959783|FG001|Overall Study|Protocol Violation|0|||
143114141|NCT04450407|515959784|FG002|Overall Study|Protocol Violation|0|||
143114142|NCT04450407|515959782|FG000|Overall Study|Investigational site terminated by sponsor|3|||
143114143|NCT04450407|515959783|FG001|Overall Study|Investigational site terminated by sponsor|0|||
143114144|NCT04450407|515959784|FG002|Overall Study|Investigational site terminated by sponsor|2|||
143114145|NCT00191282|515959788|FG000|Overall Study|Adverse Event|5|||
143114146|NCT00191282|515959789|FG001|Overall Study|Adverse Event|6|||
143368763|NCT01090024|516894517|FG004|Period 2|Lost to Follow-up|0|||
143368764|NCT01090024|516894518|FG005|Period 2|Lost to Follow-up|0|||
143368765|NCT01090024|516894519|FG006|Period 2|Lost to Follow-up|0|||
143368766|NCT01090024|516894520|FG007|Period 2|Lost to Follow-up|0|||
143368767|NCT01090024|516894521|FG008|Period 2|Lost to Follow-up|0|||
143368768|NCT01090024|516894522|FG009|Period 2|Lost to Follow-up|0|||
143368769|NCT01090024|516894523|FG010|Period 2|Lost to Follow-up|0|||
143368770|NCT01090024|516894524|FG011|Period 2|Lost to Follow-up|0|||
143368771|NCT01090024|516894525|FG012|Period 2|Lost to Follow-up|0|||
143368772|NCT01090024|516894526|FG013|Period 2|Lost to Follow-up|0|||
143368773|NCT01090024|516894527|FG014|Period 2|Lost to Follow-up|0|||
143368774|NCT01090024|516894528|FG015|Period 2|Lost to Follow-up|0|||
143368775|NCT01090024|516894529|FG016|Period 2|Lost to Follow-up|0|||
143368776|NCT01090024|516894530|FG017|Period 2|Lost to Follow-up|0|||
143368777|NCT01090024|516894513|FG000|Period 2|Adverse Event|1|||
143368778|NCT01090024|516894514|FG001|Period 2|Adverse Event|0|||
143368779|NCT01090024|516894515|FG002|Period 2|Adverse Event|0|||
143368780|NCT01090024|516894516|FG003|Period 2|Adverse Event|0|||
143368781|NCT01090024|516894517|FG004|Period 2|Adverse Event|0|||
143368782|NCT01090024|516894518|FG005|Period 2|Adverse Event|0|||
143368783|NCT01090024|516894519|FG006|Period 2|Adverse Event|0|||
143368784|NCT01090024|516894520|FG007|Period 2|Adverse Event|0|||
143368785|NCT01090024|516894521|FG008|Period 2|Adverse Event|0|||
143368786|NCT01090024|516894522|FG009|Period 2|Adverse Event|0|||
143368787|NCT01090024|516894523|FG010|Period 2|Adverse Event|0|||
143368788|NCT01090024|516894524|FG011|Period 2|Adverse Event|0|||
143368789|NCT01090024|516894525|FG012|Period 2|Adverse Event|0|||
143368790|NCT01090024|516894526|FG013|Period 2|Adverse Event|0|||
143368791|NCT01090024|516894527|FG014|Period 2|Adverse Event|0|||
143368792|NCT01090024|516894528|FG015|Period 2|Adverse Event|0|||
143368793|NCT01090024|516894529|FG016|Period 2|Adverse Event|0|||
143368794|NCT01090024|516894530|FG017|Period 2|Adverse Event|0|||
143368795|NCT01090024|516894513|FG000|Period 3|Withdrawal by Subject|0|||
143368796|NCT01090024|516894514|FG001|Period 3|Withdrawal by Subject|0|||
143368797|NCT01090024|516894515|FG002|Period 3|Withdrawal by Subject|0|||
143368798|NCT01090024|516894516|FG003|Period 3|Withdrawal by Subject|0|||
143368799|NCT01090024|516894517|FG004|Period 3|Withdrawal by Subject|0|||
143368800|NCT01090024|516894518|FG005|Period 3|Withdrawal by Subject|0|||
143368801|NCT01090024|516894519|FG006|Period 3|Withdrawal by Subject|0|||
143368802|NCT01090024|516894520|FG007|Period 3|Withdrawal by Subject|0|||
143368803|NCT01090024|516894521|FG008|Period 3|Withdrawal by Subject|0|||
143368804|NCT01090024|516894522|FG009|Period 3|Withdrawal by Subject|0|||
143368805|NCT01090024|516894523|FG010|Period 3|Withdrawal by Subject|0|||
143368806|NCT01090024|516894524|FG011|Period 3|Withdrawal by Subject|0|||
143368807|NCT01090024|516894525|FG012|Period 3|Withdrawal by Subject|0|||
143368808|NCT01090024|516894526|FG013|Period 3|Withdrawal by Subject|0|||
143368809|NCT01090024|516894527|FG014|Period 3|Withdrawal by Subject|0|||
143368810|NCT01090024|516894528|FG015|Period 3|Withdrawal by Subject|1|||
143368811|NCT01090024|516894529|FG016|Period 3|Withdrawal by Subject|0|||
143368812|NCT01090024|516894530|FG017|Period 3|Withdrawal by Subject|0|||
143368813|NCT01090024|516894513|FG000|Period 3|Protocol Violation|0|||
143368814|NCT01090024|516894514|FG001|Period 3|Protocol Violation|0|||
143368815|NCT01090024|516894515|FG002|Period 3|Protocol Violation|0|||
143368816|NCT01090024|516894516|FG003|Period 3|Protocol Violation|0|||
143368817|NCT01090024|516894517|FG004|Period 3|Protocol Violation|0|||
143368818|NCT01090024|516894518|FG005|Period 3|Protocol Violation|0|||
143368819|NCT01090024|516894519|FG006|Period 3|Protocol Violation|0|||
143368820|NCT01090024|516894520|FG007|Period 3|Protocol Violation|0|||
143368821|NCT01090024|516894521|FG008|Period 3|Protocol Violation|1|||
143368822|NCT01090024|516894522|FG009|Period 3|Protocol Violation|0|||
143368823|NCT01090024|516894523|FG010|Period 3|Protocol Violation|0|||
143368824|NCT01090024|516894524|FG011|Period 3|Protocol Violation|0|||
143368825|NCT01090024|516894525|FG012|Period 3|Protocol Violation|0|||
143114147|NCT00191282|515959788|FG000|Overall Study|Death|51|||
143114148|NCT00191282|515959789|FG001|Overall Study|Death|51|||
143114149|NCT00191282|515959788|FG000|Overall Study|Lack of Efficacy|11|||
143114150|NCT00191282|515959789|FG001|Overall Study|Lack of Efficacy|6|||
143114151|NCT00191282|515959788|FG000|Overall Study|Noncompliance|14|||
143114152|NCT00191282|515959789|FG001|Overall Study|Noncompliance|17|||
143114153|NCT00191282|515959788|FG000|Overall Study|Patient moved|11|||
143114154|NCT00191282|515959789|FG001|Overall Study|Patient moved|14|||
143180404|NCT03941483|516207022|FG001|Overall Study|Death|2|||
143180405|NCT03941483|516207023|FG002|Overall Study|Death|6|||
143180406|NCT03154476|516207026|FG000|Overall Study|Lost to Follow-up|4|||
143180407|NCT03154476|516207027|FG001|Overall Study|Lost to Follow-up|4|||
143180408|NCT03816176|516207028|FG000|Overall Study|Miscellaneous|5|||
143368826|NCT01090024|516894526|FG013|Period 3|Protocol Violation|0|||
143368827|NCT01090024|516894527|FG014|Period 3|Protocol Violation|0|||
143368828|NCT01090024|516894528|FG015|Period 3|Protocol Violation|0|||
143368829|NCT01090024|516894529|FG016|Period 3|Protocol Violation|0|||
143368830|NCT01090024|516894530|FG017|Period 3|Protocol Violation|0|||
143368831|NCT01090024|516894513|FG000|Period 3|Adverse Event|0|||
143368832|NCT01090024|516894514|FG001|Period 3|Adverse Event|0|||
143180409|NCT03816176|516207028|FG000|Overall Study|Lack of Efficacy|4|||
143180410|NCT03816176|516207028|FG000|Overall Study|Adverse Event|3|||
143368833|NCT01090024|516894515|FG002|Period 3|Adverse Event|0|||
143368834|NCT01090024|516894516|FG003|Period 3|Adverse Event|0|||
143368835|NCT01090024|516894517|FG004|Period 3|Adverse Event|0|||
143368836|NCT01090024|516894518|FG005|Period 3|Adverse Event|1|||
143368837|NCT01090024|516894519|FG006|Period 3|Adverse Event|0|||
143368838|NCT01090024|516894520|FG007|Period 3|Adverse Event|0|||
143368839|NCT01090024|516894521|FG008|Period 3|Adverse Event|0|||
143368840|NCT01090024|516894522|FG009|Period 3|Adverse Event|0|||
143368841|NCT01090024|516894523|FG010|Period 3|Adverse Event|0|||
143368842|NCT01090024|516894524|FG011|Period 3|Adverse Event|0|||
143368843|NCT01090024|516894525|FG012|Period 3|Adverse Event|0|||
143368844|NCT01090024|516894526|FG013|Period 3|Adverse Event|0|||
143259332|NCT01933789|516503804|FG001|Overall Study|Became Ineligible|0|||
143259333|NCT01933789|516503805|FG002|Overall Study|Became Ineligible|0|||
143259334|NCT01933789|516503806|FG003|Overall Study|Became Ineligible|0|||
143259335|NCT01933789|516503807|FG004|Overall Study|Became Ineligible|13|||
143259336|NCT01933789|516503808|FG005|Overall Study|Became Ineligible|10|||
143259337|NCT01933789|516503809|FG006|Overall Study|Became Ineligible|13|||
143259338|NCT01933789|516503810|FG007|Overall Study|Became Ineligible|6|||
143259339|NCT01933789|516503811|FG008|Overall Study|Became Ineligible|0|||
143259340|NCT01117792|516503812|FG000|Overall Study|Death|1|||
143259341|NCT01117792|516503812|FG000|Overall Study|Adverse Event|3|||
143259342|NCT05867342|516503813|FG000|Overall Study|Investigator Decision|3|||
143259343|NCT05867342|516503814|FG001|Overall Study|Investigator Decision|3|||
143259344|NCT00723203|516503815|FG000|Overall Study|Withdrawal by Subject|3|||
143259345|NCT05442775|516503816|FG000|Overall Study|Trial terminated|61|||
143259346|NCT05442775|516503816|FG000|Overall Study|Lack of Efficacy|4|||
143259347|NCT05442775|516503816|FG000|Overall Study|Withdrawal by Subject|4|||
143259348|NCT05442775|516503816|FG000|Overall Study|Death|1|||
143259349|NCT05442775|516503816|FG000|Overall Study|Participant removed at Sponsor request|1|||
143259350|NCT00274924|516503820|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
143259351|NCT00274924|516503821|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
143259352|NCT00274924|516503822|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
143259353|NCT00274924|516503820|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
143259354|NCT00274924|516503821|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
143259355|NCT00274924|516503822|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
143259356|NCT00274924|516503820|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
143259357|NCT00274924|516503821|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
143259358|NCT00274924|516503822|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
143259359|NCT00274924|516503820|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
143259360|NCT00274924|516503821|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
143259361|NCT00274924|516503822|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
143259362|NCT00274924|516503820|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
143259363|NCT00274924|516503821|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
143259364|NCT00274924|516503822|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
143259365|NCT00274924|516503820|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
143259366|NCT00274924|516503821|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
143259367|NCT00274924|516503822|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
143259368|NCT00274924|516503820|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
143259369|NCT00274924|516503821|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
143259370|NCT00274924|516503822|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
143259371|NCT00274924|516503820|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
143259372|NCT00274924|516503821|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
143259373|NCT00274924|516503822|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
143259374|NCT00274924|516503820|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
143259375|NCT00274924|516503821|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
143259376|NCT00274924|516503822|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
143259377|NCT00274924|516503820|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
143259378|NCT00274924|516503821|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
143259379|NCT00274924|516503822|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
143259380|NCT00274924|516503820|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
143259381|NCT00274924|516503821|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
143259382|NCT00274924|516503822|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
143259383|NCT00274924|516503820|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
143259384|NCT00274924|516503821|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
143259385|NCT00274924|516503822|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
143259386|NCT00274924|516503820|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
143259387|NCT00274924|516503821|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
143259388|NCT00274924|516503822|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
143259389|NCT02963831|516503824|FG000|Overall Study|Progressive Disease|3|||
143259390|NCT02963831|516503825|FG001|Overall Study|Progressive Disease|3|||
143259391|NCT02963831|516503826|FG002|Overall Study|Progressive Disease|16|||
143259392|NCT02963831|516503827|FG003|Overall Study|Progressive Disease|27|||
143259393|NCT02963831|516503824|FG000|Overall Study|Withdrawal by Subject|1|||
143259394|NCT02963831|516503825|FG001|Overall Study|Withdrawal by Subject|0|||
143259395|NCT02963831|516503826|FG002|Overall Study|Withdrawal by Subject|2|||
143259396|NCT02963831|516503827|FG003|Overall Study|Withdrawal by Subject|4|||
143259397|NCT02963831|516503824|FG000|Overall Study|Adverse Event|0|||
143259398|NCT02963831|516503825|FG001|Overall Study|Adverse Event|1|||
143259399|NCT02963831|516503826|FG002|Overall Study|Adverse Event|1|||
143259400|NCT02963831|516503827|FG003|Overall Study|Adverse Event|2|||
143259401|NCT02963831|516503824|FG000|Overall Study|Death|0|||
143259402|NCT02963831|516503825|FG001|Overall Study|Death|0|||
143259403|NCT02963831|516503826|FG002|Overall Study|Death|0|||
143259404|NCT02963831|516503827|FG003|Overall Study|Death|2|||
143259405|NCT01966432|516503828|FG000|Overall Study|Lost to Follow-up|3|||
143259406|NCT01966432|516503829|FG001|Overall Study|Lost to Follow-up|2|||
143259407|NCT01966432|516503830|FG002|Overall Study|Lost to Follow-up|5|||
143259408|NCT01966432|516503828|FG000|Overall Study|Withdrawal by Subject|1|||
143259409|NCT01966432|516503829|FG001|Overall Study|Withdrawal by Subject|3|||
143259410|NCT01966432|516503830|FG002|Overall Study|Withdrawal by Subject|0|||
143259411|NCT01966432|516503828|FG000|Overall Study|Subject Incarcerated|0|||
143259412|NCT01966432|516503829|FG001|Overall Study|Subject Incarcerated|0|||
143259413|NCT01966432|516503830|FG002|Overall Study|Subject Incarcerated|1|||
143259414|NCT01966432|516503828|FG000|Overall Study|SBIRT program ended|1|||
143259415|NCT01966432|516503829|FG001|Overall Study|SBIRT program ended|8|||
143259416|NCT01966432|516503830|FG002|Overall Study|SBIRT program ended|20|||
143259417|NCT01055496|516503831|FG000|Overall Study|Withdrawal by Subject|2|||
143259418|NCT01055496|516503832|FG001|Overall Study|Withdrawal by Subject|4|||
143259419|NCT01055496|516503831|FG000|Overall Study|Death|13|||
143259420|NCT01055496|516503832|FG001|Overall Study|Death|23|||
143259421|NCT01055496|516503831|FG000|Overall Study|Lost to Follow-up|0|||
143259422|NCT01055496|516503832|FG001|Overall Study|Lost to Follow-up|2|||
143259423|NCT01055496|516503831|FG000|Overall Study|Other - Unspecified|0|||
143259424|NCT01055496|516503832|FG001|Overall Study|Other - Unspecified|1|||
143259425|NCT00584740|516503833|FG000|Overall Study|Adverse Event|1|||
143259426|NCT00584740|516503834|FG001|Overall Study|Adverse Event|1|||
143259427|NCT00584740|516503833|FG000|Overall Study|Lack of Efficacy|8|||
143259428|NCT00584740|516503834|FG001|Overall Study|Lack of Efficacy|2|||
143259429|NCT00584740|516503833|FG000|Overall Study|Withdrawal by Subject|3|||
143259430|NCT00584740|516503834|FG001|Overall Study|Withdrawal by Subject|2|||
143259431|NCT00584740|516503833|FG000|Overall Study|Lost to Follow-up|0|||
143259432|NCT00584740|516503834|FG001|Overall Study|Lost to Follow-up|1|||
143259433|NCT01673282|516503838|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
143259434|NCT01673282|516503839|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
143259435|NCT01673282|516503838|FG000|Overall Study|Lack of Efficacy|9|||
143114155|NCT00191282|515959788|FG000|Overall Study|Withdrawal by Subject|59|||
143114156|NCT00191282|515959789|FG001|Overall Study|Withdrawal by Subject|44|||
143114157|NCT00191282|515959788|FG000|Overall Study|Physician Decision|18|||
143114158|NCT00191282|515959789|FG001|Overall Study|Physician Decision|15|||
143114159|NCT00191282|515959788|FG000|Overall Study|Protocol entry criteria not met|14|||
143114160|NCT00191282|515959789|FG001|Overall Study|Protocol entry criteria not met|9|||
143114161|NCT00191282|515959788|FG000|Overall Study|Protocol Violation|9|||
143114162|NCT00191282|515959789|FG001|Overall Study|Protocol Violation|12|||
143114163|NCT00191282|515959788|FG000|Overall Study|Severity of outcome|2|||
143114164|NCT00191282|515959789|FG001|Overall Study|Severity of outcome|5|||
143114165|NCT00191282|515959788|FG000|Overall Study|Sponsor's decision|2|||
143114166|NCT00191282|515959789|FG001|Overall Study|Sponsor's decision|2|||
143180411|NCT03718325|516208791|FG000|Overall Study|Externalized leads were removed independent of the research protocol|2|||
143180412|NCT03718325|516208792|FG001|Overall Study|Externalized leads were removed independent of the research protocol|0|||
143180413|NCT03718325|516208793|FG002|Overall Study|Externalized leads were removed independent of the research protocol|0|||
143180414|NCT03718325|516208791|FG000|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|1|||
143180415|NCT03718325|516208792|FG001|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
143180416|NCT03718325|516208793|FG002|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
143180417|NCT04245449|516208794|FG000|Overall Study|COVID shutdown|7|||
143180418|NCT03073525|516208795|FG000|Overall Study|Withdrawal by Subject|0|||
143180419|NCT03073525|516208796|FG001|Overall Study|Withdrawal by Subject|0|||
143180420|NCT03073525|516208797|FG002|Overall Study|Withdrawal by Subject|3|||
143180421|NCT01976299|516208798|FG000|Overall Study|Withdrawal by Subject|3|||
143180422|NCT01976299|516208799|FG001|Overall Study|Withdrawal by Subject|1|||
143180423|NCT01976299|516208798|FG000|Overall Study|Death|4|||
143180424|NCT01976299|516208799|FG001|Overall Study|Death|2|||
143180425|NCT01976299|516208798|FG000|Overall Study|Lost to Follow-up|7|||
143180426|NCT01976299|516208799|FG001|Overall Study|Lost to Follow-up|1|||
143180427|NCT01976299|516208798|FG000|Overall Study|See clarification above in comments|9|||
143180428|NCT01976299|516208799|FG001|Overall Study|See clarification above in comments|2|||
143180429|NCT03692403|516208800|FG000|Overall Study|Withdrawal by Subject|1|||
143180430|NCT03692403|516208801|FG001|Overall Study|Withdrawal by Subject|0|||
143180431|NCT03692403|516208802|FG002|Overall Study|Withdrawal by Subject|1|||
143180432|NCT03692403|516208803|FG003|Overall Study|Withdrawal by Subject|0|||
143180433|NCT03692403|516208800|FG000|Overall Study|Adverse Event|0|||
143180434|NCT03692403|516208801|FG001|Overall Study|Adverse Event|0|||
143180435|NCT03692403|516208802|FG002|Overall Study|Adverse Event|0|||
143180436|NCT03692403|516208803|FG003|Overall Study|Adverse Event|1|||
143180437|NCT03692403|516208800|FG000|Overall Study|Pregnancy|0|||
143180438|NCT03692403|516208801|FG001|Overall Study|Pregnancy|1|||
143180439|NCT03692403|516208802|FG002|Overall Study|Pregnancy|0|||
143180440|NCT03692403|516208803|FG003|Overall Study|Pregnancy|0|||
143180441|NCT03692403|516208800|FG000|Overall Study|Other|0|||
143180442|NCT03692403|516208801|FG001|Overall Study|Other|0|||
143180443|NCT03692403|516208802|FG002|Overall Study|Other|1|||
143180444|NCT03692403|516208803|FG003|Overall Study|Other|0|||
143180445|NCT02479880|516208810|FG000|Overall Study|Study Terminated by Sponsor|13|||
143180446|NCT02479880|516208811|FG001|Overall Study|Study Terminated by Sponsor|12|||
143180447|NCT02479880|516208810|FG000|Overall Study|Pregnancy|0|||
143180448|NCT02479880|516208811|FG001|Overall Study|Pregnancy|1|||
143180449|NCT00355368|516208812|FG000|Overall Study|Protocol Violation|8|||
143180450|NCT00355368|516208813|FG001|Overall Study|Protocol Violation|7|||
143180451|NCT00355368|516208812|FG000|Overall Study|cardiac arrest prior to intubation|2|||
143180452|NCT00355368|516208813|FG001|Overall Study|cardiac arrest prior to intubation|2|||
143180453|NCT01349673|516208814|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
143259436|NCT01673282|516503839|FG001|Overall Study|Lack of Efficacy|2|||
143259437|NCT01673282|516503838|FG000|Overall Study|Lost to Follow-up|11|||
143259438|NCT01673282|516503839|FG001|Overall Study|Lost to Follow-up|10|||
143259439|NCT01673282|516503838|FG000|Overall Study|Withdrawal by Subject|3|||
143180454|NCT01349673|516208814|FG000|Overall Study|No Longer Qualified For Study|1|||
143180455|NCT01349673|516208814|FG000|Overall Study|Site Closure|10|||
143180456|NCT01349673|516208814|FG000|Overall Study|Withdrawal by Subject|21|||
143180457|NCT01349673|516208814|FG000|Overall Study|Lost to Follow-up|6|||
143180458|NCT01349673|516208814|FG000|Overall Study|Adverse Event|17|||
143180459|NCT01349673|516208814|FG000|Overall Study|Study Terminated By Sponsor|50|||
143180460|NCT01349673|516208814|FG000|Overall Study|Lack of Efficacy|8|||
143180461|NCT03801928|516208817|FG000|Overall Study|Adverse Event|1|||
143180462|NCT03801928|516208818|FG001|Overall Study|Adverse Event|0|||
143180463|NCT03801928|516208819|FG002|Overall Study|Adverse Event|1|||
143180464|NCT03801928|516208820|FG003|Overall Study|Adverse Event|2|||
143180465|NCT03801928|516208821|FG004|Overall Study|Adverse Event|0|||
143180466|NCT03801928|516208822|FG005|Overall Study|Adverse Event|2|||
143180467|NCT03801928|516208817|FG000|Overall Study|Lack of Efficacy|0|||
143180468|NCT03801928|516208818|FG001|Overall Study|Lack of Efficacy|0|||
143180469|NCT03801928|516208819|FG002|Overall Study|Lack of Efficacy|1|||
143259440|NCT01673282|516503839|FG001|Overall Study|Withdrawal by Subject|3|||
143259441|NCT01673282|516503838|FG000|Overall Study|Other|1|||
143259442|NCT01673282|516503839|FG001|Overall Study|Other|6|||
143259443|NCT02915874|516503842|FG000|Overall Study|Lost to Follow-up|5|||
143259444|NCT02915874|516503843|FG001|Overall Study|Lost to Follow-up|4|||
143259445|NCT02915874|516503842|FG000|Overall Study|Withdrawal by Subject|1|||
143259446|NCT02915874|516503843|FG001|Overall Study|Withdrawal by Subject|1|||
143259447|NCT02915874|516503842|FG000|Overall Study|Started New Anxiety Medication|0|||
143180470|NCT03801928|516208820|FG003|Overall Study|Lack of Efficacy|0|||
143180471|NCT03801928|516208821|FG004|Overall Study|Lack of Efficacy|0|||
143259448|NCT02915874|516503843|FG001|Overall Study|Started New Anxiety Medication|1|||
143259449|NCT04391569|516503845|FG000|Overall Study|Death|15|||
143259450|NCT04391569|516503846|FG001|Overall Study|Death|10|||
143259451|NCT04391569|516503845|FG000|Overall Study|Withdrawal by Subject|1|||
143259452|NCT04391569|516503846|FG001|Overall Study|Withdrawal by Subject|0|||
143259453|NCT04391569|516503845|FG000|Overall Study|Lost to Follow-up|3|||
143259454|NCT04391569|516503846|FG001|Overall Study|Lost to Follow-up|2|||
143259455|NCT04391569|516503845|FG000|Overall Study|Lack of Efficacy|0|||
143259456|NCT04391569|516503846|FG001|Overall Study|Lack of Efficacy|1|||
143259457|NCT04391569|516503845|FG000|Overall Study|Participant discharged to hospice facility|0|||
143259458|NCT04391569|516503846|FG001|Overall Study|Participant discharged to hospice facility|1|||
143259459|NCT04391569|516503845|FG000|Overall Study|Participant family decision|1|||
143368845|NCT01090024|516894527|FG014|Period 3|Adverse Event|0|||
143368846|NCT01090024|516894528|FG015|Period 3|Adverse Event|0|||
143368847|NCT01090024|516894529|FG016|Period 3|Adverse Event|0|||
143368848|NCT01090024|516894530|FG017|Period 3|Adverse Event|0|||
143368849|NCT00149630|516894531|FG000|Overall Study|Incarceration|2|||
143368850|NCT00149630|516894532|FG001|Overall Study|Incarceration|0|||
143368851|NCT00149630|516894531|FG000|Overall Study|Treatment Programs|4|||
143368852|NCT00149630|516894532|FG001|Overall Study|Treatment Programs|5|||
143368853|NCT00149630|516894531|FG000|Overall Study|Adverse Event|2|||
143368854|NCT00149630|516894532|FG001|Overall Study|Adverse Event|0|||
143368855|NCT00777556|516894534|FG000|Overall Study|Inappropriate self-selection|34|||
143368856|NCT00777556|516894534|FG000|Overall Study|Dispensed but did not use product|12|||
143368857|NCT00777556|516894534|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
143368858|NCT05298111|516894536|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
143368859|NCT05298111|516894537|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
143368860|NCT01249092|516894542|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
143368861|NCT01249092|516894542|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
143368862|NCT02380742|516894543|FG000|Overall Study|Withdrawal by Subject|1|||
143259460|NCT04391569|516503846|FG001|Overall Study|Participant family decision|0|||
143259461|NCT04391569|516503845|FG000|Overall Study|Participant discharged prematurely|1|||
143259462|NCT04391569|516503846|FG001|Overall Study|Participant discharged prematurely|0|||
143259463|NCT01150474|516503852|FG000|Overall Study|Withdrawal by Subject|5|||
143259464|NCT01150474|516503853|FG001|Overall Study|Withdrawal by Subject|2|||
143259465|NCT01150474|516503852|FG000|Overall Study|Cancer found|1|||
143259466|NCT01150474|516503853|FG001|Overall Study|Cancer found|0|||
143259467|NCT01150474|516503852|FG000|Overall Study|Multiple Studies|0|||
143259468|NCT01150474|516503853|FG001|Overall Study|Multiple Studies|1|||
143259469|NCT01150474|516503852|FG000|Overall Study|Rectotomy|1|||
143368863|NCT02380742|516894544|FG001|Overall Study|Withdrawal by Subject|0|||
143368864|NCT00151996|516894548|FG000|Overall Study|Adverse Event|3|||
143368865|NCT00151996|516894549|FG001|Overall Study|Adverse Event|2|||
143368866|NCT00151996|516894548|FG000|Overall Study|Withdrawal by Subject|1|||
143368867|NCT00151996|516894549|FG001|Overall Study|Withdrawal by Subject|1|||
143368868|NCT00151996|516894548|FG000|Overall Study|Protocol Violation|1|||
143259470|NCT01150474|516503853|FG001|Overall Study|Rectotomy|0|||
143259471|NCT01150474|516503852|FG000|Overall Study|Drug did not arrive in time|1|||
143180472|NCT03801928|516208822|FG005|Overall Study|Lack of Efficacy|0|||
143180473|NCT03801928|516208817|FG000|Overall Study|Lost to Follow-up|5|||
143180474|NCT03801928|516208818|FG001|Overall Study|Lost to Follow-up|1|||
143180475|NCT03801928|516208819|FG002|Overall Study|Lost to Follow-up|1|||
143180476|NCT03801928|516208820|FG003|Overall Study|Lost to Follow-up|4|||
143180477|NCT03801928|516208821|FG004|Overall Study|Lost to Follow-up|4|||
143180478|NCT03801928|516208822|FG005|Overall Study|Lost to Follow-up|2|||
143180479|NCT03801928|516208817|FG000|Overall Study|Withdrawal by Subject|0|||
143180480|NCT03801928|516208818|FG001|Overall Study|Withdrawal by Subject|0|||
143180481|NCT03801928|516208819|FG002|Overall Study|Withdrawal by Subject|2|||
143180482|NCT03801928|516208820|FG003|Overall Study|Withdrawal by Subject|1|||
143180483|NCT03801928|516208821|FG004|Overall Study|Withdrawal by Subject|0|||
143180484|NCT03801928|516208822|FG005|Overall Study|Withdrawal by Subject|0|||
143180485|NCT03801928|516208817|FG000|Overall Study|Other|0|||
143180486|NCT03801928|516208818|FG001|Overall Study|Other|2|||
143180487|NCT03801928|516208819|FG002|Overall Study|Other|0|||
143180488|NCT03801928|516208820|FG003|Overall Study|Other|1|||
143180489|NCT03801928|516208821|FG004|Overall Study|Other|0|||
143180490|NCT03801928|516208822|FG005|Overall Study|Other|1|||
143180491|NCT02370368|516208825|FG000|Overall Study|Adverse Event|1|||
143180492|NCT02370368|516208826|FG001|Overall Study|Adverse Event|2|||
143180493|NCT02370368|516208825|FG000|Overall Study|Withdrawal by Subject|5|||
143180494|NCT02370368|516208826|FG001|Overall Study|Withdrawal by Subject|4|||
143180495|NCT00564733|516208831|FG000|Overall Study|Withdrawal by Subject|4|||
143180496|NCT00564733|516208831|FG000|Overall Study|Ineligible|5|||
143180497|NCT01484496|516208834|FG000|Period 1|Protocol Violation|3|||
143180498|NCT01484496|516208835|FG001|Period 1|Protocol Violation|4|||
143180499|NCT01484496|516208836|FG002|Period 1|Protocol Violation|0|||
143180500|NCT01484496|516208837|FG003|Period 1|Protocol Violation|0|||
143180501|NCT01484496|516208834|FG000|Period 1|Physician Decision|5|||
143180502|NCT01484496|516208835|FG001|Period 1|Physician Decision|1|||
143180503|NCT01484496|516208836|FG002|Period 1|Physician Decision|0|||
143180504|NCT01484496|516208837|FG003|Period 1|Physician Decision|0|||
143180505|NCT01484496|516208834|FG000|Period 1|Lack of Efficacy|10|||
143180506|NCT01484496|516208835|FG001|Period 1|Lack of Efficacy|15|||
143180507|NCT01484496|516208836|FG002|Period 1|Lack of Efficacy|0|||
143180508|NCT01484496|516208837|FG003|Period 1|Lack of Efficacy|0|||
143180509|NCT01484496|516208834|FG000|Period 1|Adverse Event|25|||
143180510|NCT01484496|516208835|FG001|Period 1|Adverse Event|40|||
143180511|NCT01484496|516208836|FG002|Period 1|Adverse Event|0|||
143180512|NCT01484496|516208837|FG003|Period 1|Adverse Event|0|||
143180513|NCT01484496|516208834|FG000|Period 1|Withdrawal by Subject|15|||
143180514|NCT01484496|516208835|FG001|Period 1|Withdrawal by Subject|12|||
143180515|NCT01484496|516208836|FG002|Period 1|Withdrawal by Subject|0|||
143180516|NCT01484496|516208837|FG003|Period 1|Withdrawal by Subject|0|||
143180517|NCT01484496|516208834|FG000|Period 1|Lost to Follow-up|2|||
143180518|NCT01484496|516208835|FG001|Period 1|Lost to Follow-up|6|||
143180519|NCT01484496|516208836|FG002|Period 1|Lost to Follow-up|0|||
143180520|NCT01484496|516208837|FG003|Period 1|Lost to Follow-up|0|||
143180521|NCT01484496|516208834|FG000|Period 1|Positive Pregnancy|1|||
143180522|NCT01484496|516208835|FG001|Period 1|Positive Pregnancy|6|||
143180523|NCT01484496|516208836|FG002|Period 1|Positive Pregnancy|0|||
143180524|NCT01484496|516208837|FG003|Period 1|Positive Pregnancy|0|||
143180525|NCT01484496|516208834|FG000|Period 1|Treatment Failure|3|||
143180526|NCT01484496|516208835|FG001|Period 1|Treatment Failure|6|||
143180527|NCT01484496|516208836|FG002|Period 1|Treatment Failure|0|||
143180528|NCT01484496|516208837|FG003|Period 1|Treatment Failure|0|||
143180529|NCT01484496|516208834|FG000|Period 1|Lack of Compliance|2|||
143180530|NCT01484496|516208835|FG001|Period 1|Lack of Compliance|1|||
143180531|NCT01484496|516208836|FG002|Period 1|Lack of Compliance|0|||
143180532|NCT01484496|516208837|FG003|Period 1|Lack of Compliance|0|||
143180533|NCT01484496|516208834|FG000|Period 1|Unable to Visit Site|0|||
143180534|NCT01484496|516208835|FG001|Period 1|Unable to Visit Site|2|||
143180535|NCT01484496|516208836|FG002|Period 1|Unable to Visit Site|0|||
143180536|NCT01484496|516208837|FG003|Period 1|Unable to Visit Site|0|||
143180537|NCT01484496|516208834|FG000|Period 2|Lack of Efficacy|0|||
143180538|NCT01484496|516208835|FG001|Period 2|Lack of Efficacy|0|||
143180539|NCT01484496|516208836|FG002|Period 2|Lack of Efficacy|1|||
143180540|NCT01484496|516208837|FG003|Period 2|Lack of Efficacy|3|||
143180541|NCT01484496|516208834|FG000|Period 2|Adverse Event|0|||
143180542|NCT01484496|516208835|FG001|Period 2|Adverse Event|0|||
143180543|NCT01484496|516208836|FG002|Period 2|Adverse Event|5|||
143114167|NCT00191282|515959788|FG000|Overall Study|Lost to Follow-up|24|||
143114168|NCT00191282|515959789|FG001|Overall Study|Lost to Follow-up|31|||
143114169|NCT04756154|515959792|FG000|Overall Study|Did not meet treatment day baseline|30|||
143114170|NCT04756154|515959793|FG001|Overall Study|Did not meet treatment day baseline|28|||
143114171|NCT04756154|515959794|FG002|Overall Study|Did not meet treatment day baseline|7|||
143114172|NCT04756154|515959792|FG000|Overall Study|Did not return for final sample collection|1|||
143114173|NCT04756154|515959793|FG001|Overall Study|Did not return for final sample collection|1|||
143180544|NCT01484496|516208837|FG003|Period 2|Adverse Event|13|||
143180545|NCT01484496|516208834|FG000|Period 2|Other|0|||
143180546|NCT01484496|516208835|FG001|Period 2|Other|0|||
143180547|NCT01484496|516208836|FG002|Period 2|Other|9|||
143180548|NCT01484496|516208837|FG003|Period 2|Other|6|||
143180549|NCT00506779|516208838|FG000|Overall Study|Withdrawal by Subject|1|||
143180550|NCT00506779|516208839|FG001|Overall Study|Withdrawal by Subject|0|||
143180551|NCT00506779|516208840|FG002|Overall Study|Withdrawal by Subject|1|||
143180552|NCT00506779|516208841|FG003|Overall Study|Withdrawal by Subject|0|||
143180553|NCT00506779|516208838|FG000|Overall Study|Adverse Event|0|||
143180554|NCT00506779|516208839|FG001|Overall Study|Adverse Event|1|||
143180555|NCT00506779|516208840|FG002|Overall Study|Adverse Event|1|||
143180556|NCT00506779|516208841|FG003|Overall Study|Adverse Event|1|||
143180557|NCT01456130|516208844|FG000|Overall Study|Adverse Event|4|||
143180558|NCT01456130|516208844|FG000|Overall Study|Voluntary Withdrawal|1|||
143180559|NCT01456130|516208844|FG000|Overall Study|Lack of Efficacy|4|||
143180560|NCT01456130|516208844|FG000|Overall Study|Other|1|||
143180561|NCT04908683|516208847|FG000|Overall Study|Failure to meet continuation criteria|34|||
143180562|NCT04908683|516208848|FG001|Overall Study|Failure to meet continuation criteria|22|||
143180563|NCT04908683|516208847|FG000|Overall Study|Initiated prohibited medication|3|||
143180564|NCT04908683|516208848|FG001|Overall Study|Initiated prohibited medication|0|||
143180565|NCT04908683|516208847|FG000|Overall Study|Randomized by mistake|1|||
143180566|NCT04908683|516208848|FG001|Overall Study|Randomized by mistake|0|||
143180567|NCT04908683|516208847|FG000|Overall Study|Lost to Follow-up|679|||
143180568|NCT04908683|516208848|FG001|Overall Study|Lost to Follow-up|341|||
143180569|NCT04908683|516208847|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
143180570|NCT04908683|516208848|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
143180571|NCT04908683|516208847|FG000|Overall Study|Physician Decision|44|||
143180572|NCT04908683|516208848|FG001|Overall Study|Physician Decision|35|||
143180573|NCT04908683|516208847|FG000|Overall Study|Technical problems|12|||
143180574|NCT04908683|516208848|FG001|Overall Study|Technical problems|9|||
143180575|NCT04908683|516208847|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
143180576|NCT04908683|516208848|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
143180577|NCT04908683|516208847|FG000|Overall Study|Protocol Violation|2|||
143180578|NCT04908683|516208848|FG001|Overall Study|Protocol Violation|0|||
143180579|NCT04908683|516208847|FG000|Overall Study|Withdrawal by Subject|1188|||
143180580|NCT04908683|516208848|FG001|Overall Study|Withdrawal by Subject|570|||
143180581|NCT04908683|516208847|FG000|Overall Study|Site Closure by Sponsor|6|||
143180582|NCT04908683|516208848|FG001|Overall Study|Site Closure by Sponsor|3|||
143180583|NCT04908683|516208847|FG000|Overall Study|Adverse Event|21|||
143180584|NCT04908683|516208848|FG001|Overall Study|Adverse Event|11|||
143180585|NCT04908683|516208847|FG000|Overall Study|Death|101|||
143180586|NCT04908683|516208848|FG001|Overall Study|Death|61|||
143180587|NCT04908683|516208847|FG000|Overall Study|Sponsor's decision|14398|||
143180588|NCT04908683|516208848|FG001|Overall Study|Sponsor's decision|7205|||
143180589|NCT04908683|516208847|FG000|Overall Study|Other|92|||
143180590|NCT04908683|516208848|FG001|Overall Study|Other|50|||
143180591|NCT04908683|516208847|FG000|Overall Study|Randomized not vaccinated|108|||
143180592|NCT04908683|516208848|FG001|Overall Study|Randomized not vaccinated|52|||
143180593|NCT01773967|516208849|FG000|Overall Study|Lost to Follow-up|15|||
143180594|NCT01773967|516208850|FG001|Overall Study|Lost to Follow-up|13|||
143180595|NCT01135459|516208851|FG000|Overall Study|Adverse Event|8|||
143180596|NCT01135459|516208852|FG001|Overall Study|Adverse Event|10|||
143180597|NCT01135459|516208851|FG000|Overall Study|Lack of Efficacy|3|||
143180598|NCT01135459|516208852|FG001|Overall Study|Lack of Efficacy|1|||
143180599|NCT01135459|516208851|FG000|Overall Study|Withdrawal by Subject|2|||
143180600|NCT01135459|516208852|FG001|Overall Study|Withdrawal by Subject|3|||
143180601|NCT01135459|516208851|FG000|Overall Study|Protocol Violation|5|||
143180602|NCT01135459|516208852|FG001|Overall Study|Protocol Violation|3|||
143180603|NCT01135459|516208851|FG000|Overall Study|Lost to Follow-up|2|||
143180604|NCT01135459|516208852|FG001|Overall Study|Lost to Follow-up|1|||
143180605|NCT01135459|516208851|FG000|Overall Study|Non-compliance to study procedures|0|||
143180606|NCT01135459|516208852|FG001|Overall Study|Non-compliance to study procedures|1|||
143180607|NCT01135459|516208851|FG000|Overall Study|Other than specified|1|||
143180608|NCT01135459|516208852|FG001|Overall Study|Other than specified|1|||
143180609|NCT01766037|516208853|FG000|Overall Study|Adverse Event|1|||
143180610|NCT01766037|516208854|FG001|Overall Study|Adverse Event|0|||
143180611|NCT01766037|516208853|FG000|Overall Study|Lack of Efficacy|1|||
143180612|NCT01766037|516208854|FG001|Overall Study|Lack of Efficacy|0|||
143180613|NCT01766037|516208853|FG000|Overall Study|Lost to Follow-up|0|||
143180614|NCT01766037|516208854|FG001|Overall Study|Lost to Follow-up|10|||
143180615|NCT01766037|516208853|FG000|Overall Study|Physician Decision|0|||
143180616|NCT01766037|516208854|FG001|Overall Study|Physician Decision|1|||
143180617|NCT01766037|516208853|FG000|Overall Study|Withdrawal by Subject|18|||
143180618|NCT01766037|516208854|FG001|Overall Study|Withdrawal by Subject|16|||
143180619|NCT01766037|516208853|FG000|Overall Study|Moved from area|5|||
143180620|NCT01766037|516208854|FG001|Overall Study|Moved from area|0|||
143180621|NCT01766037|516208853|FG000|Overall Study|medical - unrelated|1|||
143180622|NCT01766037|516208854|FG001|Overall Study|medical - unrelated|2|||
143180623|NCT01766037|516208853|FG000|Overall Study|nausea / discomfort|3|||
143259472|NCT01150474|516503853|FG001|Overall Study|Drug did not arrive in time|0|||
143180624|NCT01766037|516208854|FG001|Overall Study|nausea / discomfort|0|||
143180625|NCT00090779|516208855|FG000|Step 1|Withdrawal by Subject|4|||
143180626|NCT00090779|516208856|FG001|Step 1|Withdrawal by Subject|2|||
143180627|NCT00090779|516208855|FG000|Step 1|Lost to Follow-up|3|||
143259473|NCT01150474|516503852|FG000|Overall Study|Drug not administered|1|||
143180628|NCT00090779|516208856|FG001|Step 1|Lost to Follow-up|2|||
143180629|NCT00090779|516208855|FG000|Step 1|Death|0|||
143180630|NCT00090779|516208856|FG001|Step 1|Death|2|||
143180631|NCT00090779|516208855|FG000|Step 1|Physician Decision|1|||
143180632|NCT00090779|516208856|FG001|Step 1|Physician Decision|0|||
143180633|NCT00090779|516208855|FG000|Step 1|Pregnancy|1|||
143180634|NCT00090779|516208856|FG001|Step 1|Pregnancy|0|||
143180635|NCT00090779|516208855|FG000|Step 1|Non-compliance to study requirements|0|||
143180636|NCT00090779|516208856|FG001|Step 1|Non-compliance to study requirements|1|||
143180637|NCT00090779|516208855|FG000|Step 1|Subject relocated|2|||
143180638|NCT00090779|516208856|FG001|Step 1|Subject relocated|8|||
143180639|NCT00090779|516208855|FG000|Step 2|Off study per study closure|6|||
143180640|NCT00090779|516208856|FG001|Step 2|Off study per study closure|16|||
143180641|NCT00090779|516208855|FG000|Step 2|Subject relocated|0|||
143180642|NCT00090779|516208856|FG001|Step 2|Subject relocated|1|||
143180643|NCT00090779|516208855|FG000|Step 2|Non-compliance to study requirements|0|||
143180644|NCT00090779|516208856|FG001|Step 2|Non-compliance to study requirements|1|||
143180645|NCT00090779|516208855|FG000|Step 3|Initiation of ART and off extended study|3|||
143180646|NCT00090779|516208856|FG001|Step 3|Initiation of ART and off extended study|2|||
143180647|NCT00090779|516208855|FG000|Step 3|Off extended study due to study closure|4|||
143180648|NCT00090779|516208856|FG001|Step 3|Off extended study due to study closure|3|||
143180649|NCT04860869|516208857|FG000|Overall Study|Withdrawal by Subject|1|||
143180650|NCT04860869|516208858|FG001|Overall Study|Withdrawal by Subject|0|||
143180651|NCT03810014|516208864|FG000|Overall Study|Pregnancy|2|||
143180652|NCT03810014|516208865|FG001|Overall Study|Pregnancy|2|||
143180653|NCT03810014|516208866|FG002|Overall Study|Pregnancy|0|||
143180654|NCT03810014|516208867|FG003|Overall Study|Pregnancy|2|||
143180655|NCT01151020|516208868|FG000|Overall Study|Death|25|||
143180656|NCT01151020|516208868|FG000|Overall Study|Conversion to open repair|1|||
143180657|NCT01151020|516208868|FG000|Overall Study|Lost to Follow-up|4|||
143180658|NCT01151020|516208868|FG000|Overall Study|Withdrawal by Subject|22|||
143180659|NCT01151020|516208868|FG000|Overall Study|Patients did not receive the device|2|||
143180660|NCT03606486|516208869|FG000|Overall Study|Unable to collect sample|5|||
143180661|NCT01737762|516208876|FG000|Overall Study|Adverse Event|2|||
143180662|NCT01737762|516208877|FG001|Overall Study|Adverse Event|2|||
143180663|NCT01737762|516208876|FG000|Overall Study|Lost to Follow-up|1|||
143180664|NCT01737762|516208877|FG001|Overall Study|Lost to Follow-up|0|||
143180665|NCT01737762|516208876|FG000|Overall Study|Withdrawal by Subject|2|||
143180666|NCT01737762|516208877|FG001|Overall Study|Withdrawal by Subject|2|||
143180667|NCT01737762|516208876|FG000|Overall Study|Progressive disease|1|||
143180668|NCT01737762|516208877|FG001|Overall Study|Progressive disease|2|||
143180669|NCT01737762|516208876|FG000|Overall Study|Physician Decision|1|||
143180670|NCT01737762|516208877|FG001|Overall Study|Physician Decision|1|||
143180671|NCT01737762|516208876|FG000|Overall Study|Moved from area|2|||
143180672|NCT01737762|516208877|FG001|Overall Study|Moved from area|1|||
143180673|NCT01737762|516208876|FG000|Overall Study|Trial termination|11|||
143180674|NCT01737762|516208877|FG001|Overall Study|Trial termination|9|||
143180675|NCT00503425|516208878|FG000|Overall Study|Participant files lost|6|||
143180676|NCT00503425|516208878|FG000|Overall Study|Adverse Event|5|||
143180677|NCT00503425|516208878|FG000|Overall Study|Lack of Efficacy|25|||
143180678|NCT00503425|516208878|FG000|Overall Study|Withdrawal by Subject|8|||
143180679|NCT00503425|516208878|FG000|Overall Study|Lost to Follow-up|3|||
143180680|NCT00503425|516208878|FG000|Overall Study|Death|3|||
143180681|NCT00503425|516208878|FG000|Overall Study|Missing Data/Unknown|4|||
143180682|NCT02148263|516208879|FG000|Overall Study|Withdrawal by Subject|3|||
143180683|NCT02148263|516208880|FG001|Overall Study|Withdrawal by Subject|2|||
143180684|NCT02503085|516208881|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
143180685|NCT02503085|516208882|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
143180686|NCT02503085|516208883|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
143180687|NCT02503085|516208884|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
143180688|NCT01144416|516208888|FG000|Intervention Period|Adverse Event|5|||
143180689|NCT01144416|516208889|FG001|Intervention Period|Adverse Event|6|||
143180690|NCT01144416|516208888|FG000|Intervention Period|Insufficient ovarian response|11|||
143180691|NCT01144416|516208889|FG001|Intervention Period|Insufficient ovarian response|17|||
143180692|NCT01144416|516208888|FG000|Intervention Period|Risk of OHSS|0|||
143180693|NCT01144416|516208889|FG001|Intervention Period|Risk of OHSS|1|||
143180694|NCT01144416|516208888|FG000|Intervention Period|Too high ovarian response|4|||
143180695|NCT01144416|516208889|FG001|Intervention Period|Too high ovarian response|2|||
143180696|NCT01144416|516208888|FG000|Intervention Period|No/too few/bad oocytes|7|||
143180697|NCT01144416|516208889|FG001|Intervention Period|No/too few/bad oocytes|5|||
143180698|NCT01144416|516208888|FG000|Intervention Period|No or abnormal fertilization|25|||
143180699|NCT01144416|516208889|FG001|Intervention Period|No or abnormal fertilization|10|||
143180700|NCT01144416|516208888|FG000|Intervention Period|No/too few/bad quality embryos|3|||
143180701|NCT01144416|516208889|FG001|Intervention Period|No/too few/bad quality embryos|3|||
143180702|NCT01144416|516208888|FG000|Intervention Period|Other|7|||
143180703|NCT01144416|516208889|FG001|Intervention Period|Other|5|||
143180704|NCT02534883|516208890|FG000|Overall Study|Early Termination|8|||
143180705|NCT02534883|516208891|FG001|Overall Study|Early Termination|3|||
143180706|NCT03328832|516208892|FG000|Overall Study|Lost to Follow-up|0|||
143180707|NCT03328832|516208893|FG001|Overall Study|Lost to Follow-up|1|||
143180708|NCT00943761|516208898|FG000|Overall Study|Lost to Follow-up|2|||
143180709|NCT00943761|516208899|FG001|Overall Study|Lost to Follow-up|0|||
143180710|NCT00943761|516208898|FG000|Overall Study|Withdrawal by Subject|2|||
143180711|NCT00943761|516208899|FG001|Overall Study|Withdrawal by Subject|1|||
143180712|NCT00714948|516208902|FG000|Overall Study|Adverse Event|2|||
143180713|NCT02708680|516208903|FG000|Overall Study|Withdrawal by Subject|4|||
143180714|NCT02708680|516208904|FG001|Overall Study|Withdrawal by Subject|12|||
143259474|NCT01150474|516503853|FG001|Overall Study|Drug not administered|0|||
143259475|NCT01150474|516503852|FG000|Overall Study|Surgery Changed|1|||
143259476|NCT01150474|516503853|FG001|Overall Study|Surgery Changed|0|||
143259477|NCT00459979|516503854|FG000|Overall Study|Withdrawal by Subject|1|||
143259478|NCT00459979|516503854|FG000|Overall Study|Protocol Violation|1|||
143259479|NCT00219544|516503855|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
143259480|NCT00219544|516503856|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
143259481|NCT00219544|516503855|FG000|Single Blind Treatment Period|Adverse Event|9|||
143259482|NCT00219544|516503856|FG001|Single Blind Treatment Period|Adverse Event|0|||
143259483|NCT00219544|516503855|FG000|Single Blind Treatment Period|Protocol Violation|4|||
143259484|NCT00219544|516503856|FG001|Single Blind Treatment Period|Protocol Violation|0|||
143259485|NCT00219544|516503855|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
143259486|NCT00219544|516503856|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
143259487|NCT00219544|516503855|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
143259488|NCT00219544|516503856|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
143114174|NCT04756154|515959794|FG002|Overall Study|Did not return for final sample collection|0|||
143114175|NCT01790828|515959795|FG000|Overall Study|Other|34|||
143114176|NCT03589976|515959796|FG000|Overall Study|Death|5|||
143114177|NCT03589976|515959797|FG001|Overall Study|Death|1|||
143114178|NCT03589976|515959796|FG000|Overall Study|Adverse Event|5|||
143114179|NCT03589976|515959797|FG001|Overall Study|Adverse Event|1|||
143114180|NCT03589976|515959796|FG000|Overall Study|Withdrawal by Subject|4|||
143114181|NCT03589976|515959797|FG001|Overall Study|Withdrawal by Subject|1|||
143114182|NCT03589976|515959796|FG000|Overall Study|Lost to Follow-up|1|||
143114183|NCT03589976|515959797|FG001|Overall Study|Lost to Follow-up|0|||
143114184|NCT03589976|515959796|FG000|Overall Study|Other|4|||
143114185|NCT03589976|515959797|FG001|Overall Study|Other|3|||
143114186|NCT02089334|515959798|FG000|Overall Study|Withdrawal by Subject|0|||
143114187|NCT02089334|515959799|FG001|Overall Study|Withdrawal by Subject|0|||
143114188|NCT02089334|515959800|FG002|Overall Study|Withdrawal by Subject|0|||
143114189|NCT02089334|515959801|FG003|Overall Study|Withdrawal by Subject|2|||
143114190|NCT02089334|515959798|FG000|Overall Study|Adverse Event|0|||
143114191|NCT02089334|515959799|FG001|Overall Study|Adverse Event|0|||
143114192|NCT02089334|515959800|FG002|Overall Study|Adverse Event|0|||
143114193|NCT02089334|515959801|FG003|Overall Study|Adverse Event|2|||
143114194|NCT02089334|515959798|FG000|Overall Study|Progressive disease|0|||
143114195|NCT02089334|515959799|FG001|Overall Study|Progressive disease|0|||
143114196|NCT02089334|515959800|FG002|Overall Study|Progressive disease|0|||
143114197|NCT02089334|515959801|FG003|Overall Study|Progressive disease|2|||
143114198|NCT02089334|515959798|FG000|Overall Study|Physician Decision|0|||
143114199|NCT02089334|515959799|FG001|Overall Study|Physician Decision|0|||
143114200|NCT02089334|515959800|FG002|Overall Study|Physician Decision|1|||
143114201|NCT02089334|515959801|FG003|Overall Study|Physician Decision|1|||
143114202|NCT04778059|515959802|FG000|Overall Study|Death|2|||
143114203|NCT04778059|515959803|FG001|Overall Study|Death|2|||
143114204|NCT04778059|515959804|FG002|Overall Study|Death|1|||
143114205|NCT04778059|515959805|FG003|Overall Study|Death|1|||
143114206|NCT04778059|515959806|FG004|Overall Study|Death|1|||
143114207|NCT04778059|515959802|FG000|Overall Study|Lost to Follow-up|0|||
143114208|NCT04778059|515959803|FG001|Overall Study|Lost to Follow-up|0|||
143114209|NCT04778059|515959804|FG002|Overall Study|Lost to Follow-up|0|||
143114210|NCT04778059|515959805|FG003|Overall Study|Lost to Follow-up|0|||
143114211|NCT04778059|515959806|FG004|Overall Study|Lost to Follow-up|1|||
143114212|NCT04778059|515959802|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
143114213|NCT04778059|515959803|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
143114214|NCT04778059|515959804|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
143114215|NCT04778059|515959805|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
143114216|NCT04778059|515959806|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
143114217|NCT02832375|515959807|FG000|Overall Study|Lost to Follow-up|1|||
143114218|NCT02832375|515959808|FG001|Overall Study|Lost to Follow-up|0|||
143114219|NCT02832375|515959807|FG000|Overall Study|Withdrawal of Consent|1|||
143259489|NCT00219544|516503855|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
143259490|NCT00219544|516503856|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
143114220|NCT02832375|515959808|FG001|Overall Study|Withdrawal of Consent|0|||
143114221|NCT00514904|515959814|FG000|Overall Study|Withdrawal by Subject|3|||
143114222|NCT00514904|515959815|FG001|Overall Study|Withdrawal by Subject|2|||
143114223|NCT00514904|515959814|FG000|Overall Study|Lost to Follow-up|21|||
143114224|NCT00514904|515959815|FG001|Overall Study|Lost to Follow-up|3|||
143114225|NCT02637713|515959819|FG000|Overall Study|Screen Failure|2|||
143114226|NCT04814368|515959820|FG000|Overall Study|Study Terminated by Sponsor|0|||
143114227|NCT04814368|515959821|FG001|Overall Study|Study Terminated by Sponsor|3|||
143114228|NCT04814368|515959822|FG002|Overall Study|Study Terminated by Sponsor|0|||
143114229|NCT04814368|515959823|FG003|Overall Study|Study Terminated by Sponsor|2|||
143114230|NCT04814368|515959820|FG000|Overall Study|Subject Decision|1|||
143114231|NCT04814368|515959821|FG001|Overall Study|Subject Decision|2|||
143114232|NCT04814368|515959822|FG002|Overall Study|Subject Decision|0|||
143114233|NCT04814368|515959823|FG003|Overall Study|Subject Decision|0|||
143114234|NCT01173055|515959824|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
143114235|NCT01173055|515959825|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
143114236|NCT01173055|515959824|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
143114237|NCT01173055|515959825|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
143114238|NCT02294461|515959826|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
143114239|NCT02294461|515959827|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
143114240|NCT02294461|515959828|FG002|Double-blind Period (up to 29.4 Months)|Death|0|||
143114241|NCT02294461|515959826|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
143114242|NCT02294461|515959827|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
143114243|NCT02294461|515959828|FG002|Double-blind Period (up to 29.4 Months)|Miscellaneous|0|||
143114244|NCT02294461|515959826|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
143114245|NCT02294461|515959827|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
143114246|NCT02294461|515959828|FG002|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|0|||
143114247|NCT02294461|515959826|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
143114248|NCT02294461|515959827|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
143114249|NCT02294461|515959828|FG002|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
143114250|NCT02294461|515959826|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
143114251|NCT02294461|515959827|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
143114252|NCT02294461|515959828|FG002|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
143114253|NCT02294461|515959826|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
143114254|NCT02294461|515959827|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
143114255|NCT02294461|515959828|FG002|Double-blind Period (up to 29.4 Months)|Progressive Disease|0|||
143114256|NCT02294461|515959826|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
143114257|NCT02294461|515959827|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
143114258|NCT02294461|515959828|FG002|Double-blind Period (up to 29.4 Months)|Adverse Event|0|||
143114259|NCT02294461|515959826|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|28|||
143114260|NCT02294461|515959827|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|0|||
143114261|NCT02294461|515959828|FG002|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
143114262|NCT02294461|515959826|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|19|||
143114263|NCT02294461|515959827|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|0|||
143114264|NCT02294461|515959828|FG002|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|10|||
143114265|NCT02294461|515959826|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
143114266|NCT02294461|515959827|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
143114267|NCT02294461|515959828|FG002|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
143114268|NCT02294461|515959826|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|4|||
143114269|NCT02294461|515959827|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|0|||
143114270|NCT02294461|515959828|FG002|Open-label Period (up to 54.3 Months)|Lost to Follow-up|2|||
143114271|NCT02294461|515959826|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|20|||
143114272|NCT02294461|515959827|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|0|||
143114273|NCT02294461|515959828|FG002|Open-label Period (up to 54.3 Months)|Progressive Disease|12|||
143114274|NCT02294461|515959826|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
143114275|NCT02294461|515959827|FG001|Open-label Period (up to 54.3 Months)|Death|0|||
143114276|NCT02294461|515959828|FG002|Open-label Period (up to 54.3 Months)|Death|5|||
143114277|NCT02294461|515959826|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
143114278|NCT02294461|515959827|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|0|||
143114279|NCT02294461|515959828|FG002|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
143114280|NCT01752634|515961009|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
143114281|NCT01752634|515961010|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
143114282|NCT01752634|515961011|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
143114283|NCT01752634|515961012|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
143114284|NCT01752634|515961013|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
143114285|NCT01752634|515961014|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
143114286|NCT01752634|515961009|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
143114287|NCT01752634|515961010|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
143114288|NCT01752634|515961011|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
143114289|NCT01752634|515961012|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
143180715|NCT02708680|516208905|FG002|Overall Study|Withdrawal by Subject|12|||
143180716|NCT02708680|516208903|FG000|Overall Study|Death|4|||
143180717|NCT02708680|516208904|FG001|Overall Study|Death|19|||
143180718|NCT02708680|516208905|FG002|Overall Study|Death|21|||
143180719|NCT02708680|516208903|FG000|Overall Study|Lost to Follow-up|0|||
143180720|NCT02708680|516208904|FG001|Overall Study|Lost to Follow-up|3|||
143180721|NCT02708680|516208905|FG002|Overall Study|Lost to Follow-up|3|||
143180722|NCT02708680|516208903|FG000|Overall Study|Study Terminated By Sponsor|0|||
143180723|NCT02708680|516208904|FG001|Overall Study|Study Terminated By Sponsor|5|||
143180724|NCT02708680|516208905|FG002|Overall Study|Study Terminated By Sponsor|4|||
143180725|NCT02708680|516208903|FG000|Overall Study|Other than Specified|0|||
143180726|NCT02708680|516208904|FG001|Overall Study|Other than Specified|0|||
143180727|NCT02708680|516208905|FG002|Overall Study|Other than Specified|1|||
143180728|NCT02708680|516208903|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
143180729|NCT02708680|516208904|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
143180730|NCT02708680|516208905|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
143180731|NCT01342926|516208906|FG000|Overall Study|Adverse Event|5|||
143180732|NCT01342926|516208907|FG001|Overall Study|Adverse Event|8|||
143180733|NCT01342926|516208908|FG002|Overall Study|Adverse Event|10|||
143180734|NCT01342926|516208909|FG003|Overall Study|Adverse Event|7|||
143180735|NCT01342926|516208906|FG000|Overall Study|Lost to Follow-up|0|||
143180736|NCT01342926|516208907|FG001|Overall Study|Lost to Follow-up|1|||
143180737|NCT01342926|516208908|FG002|Overall Study|Lost to Follow-up|1|||
143180738|NCT01342926|516208909|FG003|Overall Study|Lost to Follow-up|0|||
143180739|NCT01342926|516208906|FG000|Overall Study|Investigator Discretion|2|||
143180740|NCT01342926|516208907|FG001|Overall Study|Investigator Discretion|2|||
143180741|NCT01342926|516208908|FG002|Overall Study|Investigator Discretion|0|||
143180742|NCT01342926|516208909|FG003|Overall Study|Investigator Discretion|0|||
143180743|NCT01342926|516208906|FG000|Overall Study|Withdrawal by Subject|2|||
143180744|NCT01342926|516208907|FG001|Overall Study|Withdrawal by Subject|4|||
143180745|NCT01342926|516208908|FG002|Overall Study|Withdrawal by Subject|3|||
143180746|NCT01342926|516208909|FG003|Overall Study|Withdrawal by Subject|5|||
143180747|NCT01837680|516208910|FG000|Overall Study|Lost to Follow-up|2|||
143259491|NCT05214573|516503857|FG000|Overall Study|Physician Decision|5924|||
143259492|NCT05214573|516503858|FG001|Overall Study|Physician Decision|0|||
143259493|NCT02207946|516503861|FG000|Overall Study|Lost to Follow-up|1|||
143259494|NCT02207946|516503862|FG001|Overall Study|Lost to Follow-up|0|||
143259495|NCT02207946|516503861|FG000|Overall Study|Adverse Event|0|||
143259496|NCT02207946|516503862|FG001|Overall Study|Adverse Event|1|||
143259497|NCT01006603|516503871|FG000|Overall Study|Withdrawal by Subject|17|||
143259498|NCT01006603|516503872|FG001|Overall Study|Withdrawal by Subject|19|||
143180748|NCT01837680|516208911|FG001|Overall Study|Lost to Follow-up|2|||
143180749|NCT01837680|516208910|FG000|Overall Study|lack of insurance|0|||
143180750|NCT01837680|516208911|FG001|Overall Study|lack of insurance|2|||
143180751|NCT01837680|516208910|FG000|Overall Study|allergic reaction|6|||
143180752|NCT01837680|516208911|FG001|Overall Study|allergic reaction|0|||
143180753|NCT01837680|516208910|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
143180754|NCT01837680|516208911|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
143180755|NCT03008070|516208912|FG000|Overall Study|Adverse Event|3|||
143180756|NCT03008070|516208913|FG001|Overall Study|Adverse Event|3|||
143180757|NCT03008070|516208914|FG002|Overall Study|Adverse Event|3|||
143180758|NCT03008070|516208912|FG000|Overall Study|Lost to Follow-up|1|||
143259499|NCT01006603|516503871|FG000|Overall Study|Lost to Follow-up|0|||
143259500|NCT01006603|516503872|FG001|Overall Study|Lost to Follow-up|1|||
143180759|NCT03008070|516208913|FG001|Overall Study|Lost to Follow-up|1|||
143180760|NCT03008070|516208914|FG002|Overall Study|Lost to Follow-up|0|||
143180761|NCT03008070|516208912|FG000|Overall Study|Non compliance|0|||
143180762|NCT03008070|516208913|FG001|Overall Study|Non compliance|1|||
143259501|NCT01006603|516503871|FG000|Overall Study|Safety reason|1|||
143259502|NCT01006603|516503872|FG001|Overall Study|Safety reason|1|||
143180763|NCT03008070|516208914|FG002|Overall Study|Non compliance|1|||
143180764|NCT03008070|516208912|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
143368869|NCT00151996|516894549|FG001|Overall Study|Protocol Violation|2|||
143368870|NCT00151996|516894548|FG000|Overall Study|Sponsor's decision|0|||
143368871|NCT00151996|516894549|FG001|Overall Study|Sponsor's decision|2|||
143368872|NCT01729819|516894550|FG000|Overall Study|Adverse Event|2|||
143368873|NCT01729819|516894551|FG001|Overall Study|Adverse Event|4|||
143368874|NCT01729819|516894550|FG000|Overall Study|Lack of Efficacy|1|||
143368875|NCT01729819|516894551|FG001|Overall Study|Lack of Efficacy|0|||
143368876|NCT01729819|516894550|FG000|Overall Study|Lost to Follow-up|2|||
143368877|NCT01729819|516894551|FG001|Overall Study|Lost to Follow-up|0|||
143368878|NCT01729819|516894550|FG000|Overall Study|Other reason|1|||
143368879|NCT01729819|516894551|FG001|Overall Study|Other reason|0|||
143368880|NCT01729819|516894550|FG000|Overall Study|Protocol Violation|0|||
143368881|NCT01729819|516894551|FG001|Overall Study|Protocol Violation|1|||
143368882|NCT01729819|516894550|FG000|Overall Study|Withdrawal by Subject|0|||
143368883|NCT01729819|516894551|FG001|Overall Study|Withdrawal by Subject|2|||
143368884|NCT02987543|516894554|FG000|Overall Study|Ongoing study at data cut off|49|||
143368885|NCT02987543|516894555|FG001|Overall Study|Ongoing study at data cut off|21|||
143368886|NCT02987543|516894556|FG002|Overall Study|Ongoing study at data cut off|19|||
143368887|NCT02987543|516894557|FG003|Overall Study|Ongoing study at data cut off|12|||
143368888|NCT02987543|516894554|FG000|Overall Study|Death|88|||
143368889|NCT02987543|516894555|FG001|Overall Study|Death|54|||
143368890|NCT02987543|516894556|FG002|Overall Study|Death|67|||
143368891|NCT02987543|516894557|FG003|Overall Study|Death|28|||
143368892|NCT02987543|516894554|FG000|Overall Study|Lost to Follow-up|3|||
143368893|NCT02987543|516894555|FG001|Overall Study|Lost to Follow-up|0|||
143368894|NCT02987543|516894556|FG002|Overall Study|Lost to Follow-up|1|||
143368895|NCT02987543|516894557|FG003|Overall Study|Lost to Follow-up|0|||
143368896|NCT02987543|516894554|FG000|Overall Study|Screen failure|0|||
143368897|NCT02987543|516894555|FG001|Overall Study|Screen failure|0|||
143368898|NCT02987543|516894556|FG002|Overall Study|Screen failure|0|||
143368899|NCT02987543|516894557|FG003|Overall Study|Screen failure|1|||
143368900|NCT02987543|516894554|FG000|Overall Study|Withdrawal by Subject|21|||
143368901|NCT02987543|516894555|FG001|Overall Study|Withdrawal by Subject|7|||
143368902|NCT02987543|516894556|FG002|Overall Study|Withdrawal by Subject|7|||
143368903|NCT02987543|516894557|FG003|Overall Study|Withdrawal by Subject|6|||
143368904|NCT02987543|516894554|FG000|Overall Study|Study terminated by sponsor|1|||
143368905|NCT02987543|516894555|FG001|Overall Study|Study terminated by sponsor|0|||
143368906|NCT02987543|516894556|FG002|Overall Study|Study terminated by sponsor|0|||
143368907|NCT02987543|516894557|FG003|Overall Study|Study terminated by sponsor|0|||
143368908|NCT02987543|516894554|FG000|Overall Study|Investigator decision|0|||
143368909|NCT02987543|516894555|FG001|Overall Study|Investigator decision|1|||
143368910|NCT02987543|516894556|FG002|Overall Study|Investigator decision|0|||
143368911|NCT02987543|516894557|FG003|Overall Study|Investigator decision|0|||
143368912|NCT02987543|516894554|FG000|Overall Study|Disease progression|0|||
143368913|NCT02987543|516894555|FG001|Overall Study|Disease progression|0|||
143368914|NCT02987543|516894556|FG002|Overall Study|Disease progression|0|||
143368915|NCT02987543|516894557|FG003|Overall Study|Disease progression|1|||
143368916|NCT02001623|516894558|FG000|Overall Study|Disease Progression|2|||
143368917|NCT02001623|516894559|FG001|Overall Study|Disease Progression|2|||
143368918|NCT02001623|516894560|FG002|Overall Study|Disease Progression|3|||
143114290|NCT01752634|515961013|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
143114291|NCT01752634|515961014|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
143114292|NCT01752634|515961009|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
143114293|NCT01752634|515961010|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
143114294|NCT01752634|515961011|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
143114295|NCT01752634|515961012|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
143114296|NCT01752634|515961013|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
143114297|NCT01752634|515961014|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
143114298|NCT01752634|515961009|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
143114299|NCT01752634|515961010|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
143114300|NCT01752634|515961011|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
143114301|NCT01752634|515961012|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
143114302|NCT01752634|515961013|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
143114303|NCT01752634|515961014|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
143114304|NCT01752634|515961009|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
143114305|NCT01752634|515961010|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
143114306|NCT01752634|515961011|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
143114307|NCT01752634|515961012|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
143114308|NCT01752634|515961013|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
143114309|NCT01752634|515961014|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
143114310|NCT01752634|515961009|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
143114311|NCT01752634|515961010|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
143114312|NCT01752634|515961011|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
143368919|NCT02001623|516894561|FG003|Overall Study|Disease Progression|2|||
143114313|NCT01752634|515961012|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
143114314|NCT01752634|515961013|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
143180765|NCT03008070|516208913|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
143180766|NCT03008070|516208914|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
143180767|NCT03008070|516208912|FG000|Overall Study|Withdrawal by Subject|2|||
143180768|NCT03008070|516208913|FG001|Overall Study|Withdrawal by Subject|0|||
143180769|NCT03008070|516208914|FG002|Overall Study|Withdrawal by Subject|1|||
143180770|NCT03008070|516208912|FG000|Overall Study|Use of prohibited drug|0|||
143180771|NCT03008070|516208913|FG001|Overall Study|Use of prohibited drug|0|||
143180772|NCT03008070|516208914|FG002|Overall Study|Use of prohibited drug|2|||
143180773|NCT03761056|516208918|FG000|Overall Study|Death|8|||
143180774|NCT03761056|516208918|FG000|Overall Study|Enrolled but never treated|2|||
143180775|NCT03761056|516208918|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
143180776|NCT03761056|516208918|FG000|Overall Study|Investigator decision|1|||
143180777|NCT00996658|516208919|FG000|Overall Study|Adverse Event|2|||
143180778|NCT00996658|516208920|FG001|Overall Study|Adverse Event|5|||
143180779|NCT00996658|516208919|FG000|Overall Study|Protocol Violation|0|||
143180780|NCT00996658|516208920|FG001|Overall Study|Protocol Violation|1|||
143180781|NCT00996658|516208919|FG000|Overall Study|Lost to Follow-up|2|||
143180782|NCT00996658|516208920|FG001|Overall Study|Lost to Follow-up|5|||
143180783|NCT00996658|516208919|FG000|Overall Study|Non-compliance issues|3|||
143180784|NCT00996658|516208920|FG001|Overall Study|Non-compliance issues|3|||
143180785|NCT00996658|516208919|FG000|Overall Study|Other|9|||
143180786|NCT00996658|516208920|FG001|Overall Study|Other|7|||
143180787|NCT02685826|516208923|FG000|Overall Study|Adverse Event|2|||
143180788|NCT02685826|516208924|FG001|Overall Study|Adverse Event|0|||
143180789|NCT02685826|516208925|FG002|Overall Study|Adverse Event|1|||
143180790|NCT02685826|516208923|FG000|Overall Study|Progressive Disease|2|||
143180791|NCT02685826|516208924|FG001|Overall Study|Progressive Disease|1|||
143180792|NCT02685826|516208925|FG002|Overall Study|Progressive Disease|0|||
143180793|NCT02685826|516208923|FG000|Overall Study|Withdrawal by Subject|2|||
143180794|NCT02685826|516208924|FG001|Overall Study|Withdrawal by Subject|0|||
143180795|NCT02685826|516208925|FG002|Overall Study|Withdrawal by Subject|0|||
143180796|NCT02685826|516208923|FG000|Overall Study|Full Clinical Hold by FDA|19|||
143180797|NCT02685826|516208924|FG001|Overall Study|Full Clinical Hold by FDA|9|||
143180798|NCT02685826|516208925|FG002|Overall Study|Full Clinical Hold by FDA|20|||
143180799|NCT04267926|516210361|FG000|Overall Study|abnormal labs. No longer eligible|0|||
143180800|NCT04267926|516210362|FG001|Overall Study|abnormal labs. No longer eligible|0|||
143180801|NCT04267926|516210363|FG002|Overall Study|abnormal labs. No longer eligible|1|||
143180802|NCT04267926|516210361|FG000|Overall Study|Iron infusion for fatigue. No longer eligible for study.|1|||
143180803|NCT04267926|516210362|FG001|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
143180804|NCT04267926|516210363|FG002|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
143180805|NCT00972023|516210366|FG000|Overall Study|Withdrawal by Subject|1|||
143180806|NCT02489318|516210367|FG000|Randomized|Withdrawal by Subject|0|||
143180807|NCT02489318|516210368|FG001|Randomized|Withdrawal by Subject|1|||
143180808|NCT02489318|516210367|FG000|Treated|Adverse Event|19|||
143180809|NCT02489318|516210368|FG001|Treated|Adverse Event|62|||
143180810|NCT02489318|516210367|FG000|Treated|Death|13|||
143180811|NCT02489318|516210368|FG001|Treated|Death|11|||
143180812|NCT02489318|516210367|FG000|Treated|Physician Decision|4|||
143180813|NCT02489318|516210368|FG001|Treated|Physician Decision|6|||
143180814|NCT02489318|516210367|FG000|Treated|Protocol Violation|1|||
143180815|NCT02489318|516210368|FG001|Treated|Protocol Violation|2|||
143180816|NCT02489318|516210367|FG000|Treated|Withdrawal by Subject|37|||
143180817|NCT02489318|516210368|FG001|Treated|Withdrawal by Subject|36|||
143180818|NCT02489318|516210367|FG000|Treated|Other: Progressive Disease|245|||
143180819|NCT02489318|516210368|FG001|Treated|Other: Progressive Disease|138|||
143180820|NCT02489318|516210367|FG000|Treated|Other|0|||
143180821|NCT02489318|516210368|FG001|Treated|Other|2|||
143180822|NCT02489318|516210367|FG000|Treated|Ongoing|0|||
143180823|NCT02489318|516210368|FG001|Treated|Ongoing|267|||
143180824|NCT02595879|516210369|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
143259503|NCT01006603|516503871|FG000|Overall Study|Protocol Violation|1|||
143259504|NCT01006603|516503872|FG001|Overall Study|Protocol Violation|3|||
143259505|NCT01006603|516503871|FG000|Overall Study|Incorrect enrolment|0|||
143259506|NCT01006603|516503872|FG001|Overall Study|Incorrect enrolment|2|||
143180825|NCT02595879|516210370|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
143259507|NCT01006603|516503871|FG000|Overall Study|Adverse Event|15|||
143259508|NCT01006603|516503872|FG001|Overall Study|Adverse Event|7|||
143180826|NCT05554146|516210371|FG000|Overall Study|Adverse Event|0|||
143180827|NCT05554146|516210372|FG001|Overall Study|Adverse Event|1|||
143180828|NCT05554146|516210373|FG002|Overall Study|Adverse Event|0|||
143180829|NCT05554146|516210374|FG003|Overall Study|Adverse Event|0|||
143180830|NCT05554146|516210371|FG000|Overall Study|Protocol Violation|0|||
143180831|NCT05554146|516210372|FG001|Overall Study|Protocol Violation|1|||
143180832|NCT05554146|516210373|FG002|Overall Study|Protocol Violation|0|||
143180833|NCT05554146|516210374|FG003|Overall Study|Protocol Violation|0|||
143259509|NCT01006603|516503871|FG000|Overall Study|Death|1|||
143259510|NCT01006603|516503872|FG001|Overall Study|Death|1|||
143259511|NCT01006603|516503871|FG000|Overall Study|Study specific discontinuation criteria|33|||
143180834|NCT05554146|516210371|FG000|Overall Study|No longer interested in participating|0|||
143180835|NCT05554146|516210372|FG001|Overall Study|No longer interested in participating|0|||
143180836|NCT05554146|516210373|FG002|Overall Study|No longer interested in participating|1|||
143180837|NCT05554146|516210374|FG003|Overall Study|No longer interested in participating|0|||
143180838|NCT05554146|516210371|FG000|Overall Study|Lost to Follow-up|1|||
143180839|NCT05554146|516210372|FG001|Overall Study|Lost to Follow-up|0|||
143180840|NCT05554146|516210373|FG002|Overall Study|Lost to Follow-up|0|||
143180841|NCT05554146|516210374|FG003|Overall Study|Lost to Follow-up|0|||
143180842|NCT04988295|516210375|FG000|Overall Study|Withdrawal by Subject|9|||
143180843|NCT04988295|516210376|FG001|Overall Study|Withdrawal by Subject|29|||
143180844|NCT04988295|516210377|FG002|Overall Study|Withdrawal by Subject|6|||
143180845|NCT04988295|516210378|FG003|Overall Study|Withdrawal by Subject|0|||
143180846|NCT04988295|516210375|FG000|Overall Study|Lost to Follow-up|1|||
143180847|NCT04988295|516210376|FG001|Overall Study|Lost to Follow-up|0|||
143180848|NCT04988295|516210377|FG002|Overall Study|Lost to Follow-up|0|||
143180849|NCT04988295|516210378|FG003|Overall Study|Lost to Follow-up|0|||
143180850|NCT04988295|516210375|FG000|Overall Study|Study participation ongoing|186|||
143180851|NCT04988295|516210376|FG001|Overall Study|Study participation ongoing|169|||
143180852|NCT04988295|516210377|FG002|Overall Study|Study participation ongoing|99|||
143114315|NCT01752634|515961014|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
143114316|NCT01752634|515961009|FG000|Week 24 to Week 260|Physician Decision|1|||
143114317|NCT01752634|515961010|FG001|Week 24 to Week 260|Physician Decision|2|||
143114318|NCT01752634|515961011|FG002|Week 24 to Week 260|Physician Decision|4|||
143114319|NCT01752634|515961012|FG003|Week 24 to Week 260|Physician Decision|2|||
143114320|NCT01752634|515961013|FG004|Week 24 to Week 260|Physician Decision|1|||
143114321|NCT01752634|515961014|FG005|Week 24 to Week 260|Physician Decision|0|||
143114322|NCT01752634|515961009|FG000|Week 24 to Week 260|Death|0|||
143114323|NCT01752634|515961010|FG001|Week 24 to Week 260|Death|1|||
143114324|NCT01752634|515961011|FG002|Week 24 to Week 260|Death|0|||
143114325|NCT01752634|515961012|FG003|Week 24 to Week 260|Death|0|||
143114326|NCT01752634|515961013|FG004|Week 24 to Week 260|Death|0|||
143114327|NCT01752634|515961014|FG005|Week 24 to Week 260|Death|0|||
143114328|NCT01752634|515961009|FG000|Week 24 to Week 260|Pregnancy|0|||
143114329|NCT01752634|515961010|FG001|Week 24 to Week 260|Pregnancy|0|||
143114330|NCT01752634|515961011|FG002|Week 24 to Week 260|Pregnancy|1|||
143114331|NCT01752634|515961012|FG003|Week 24 to Week 260|Pregnancy|0|||
143114332|NCT01752634|515961013|FG004|Week 24 to Week 260|Pregnancy|0|||
143114333|NCT01752634|515961014|FG005|Week 24 to Week 260|Pregnancy|0|||
143114334|NCT01752634|515961009|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
143114335|NCT01752634|515961010|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
143114336|NCT01752634|515961011|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
143114337|NCT01752634|515961012|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
143114338|NCT01752634|515961013|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
143114339|NCT01752634|515961014|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
143114340|NCT01752634|515961009|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
143114341|NCT01752634|515961010|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
143114342|NCT01752634|515961011|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
143114343|NCT01752634|515961012|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
143114344|NCT01752634|515961013|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
143114345|NCT01752634|515961014|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
143114346|NCT01752634|515961009|FG000|Week 24 to Week 260|Adverse Event|4|||
143114347|NCT01752634|515961010|FG001|Week 24 to Week 260|Adverse Event|8|||
143114348|NCT01752634|515961011|FG002|Week 24 to Week 260|Adverse Event|8|||
143114349|NCT01752634|515961012|FG003|Week 24 to Week 260|Adverse Event|4|||
143114350|NCT01752634|515961013|FG004|Week 24 to Week 260|Adverse Event|2|||
143114351|NCT01752634|515961014|FG005|Week 24 to Week 260|Adverse Event|0|||
143114352|NCT04250714|515961024|FG000|Overall Study|Treatment - withdrawal by subject|14|||
143114353|NCT04250714|515961024|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
143114354|NCT04250714|515961024|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
143114355|NCT04250714|515961024|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
143114356|NCT04250714|515961024|FG000|Overall Study|Treatment - Death|1|||
143114357|NCT04250714|515961024|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
143114358|NCT04250714|515961024|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
143114359|NCT04250714|515961024|FG000|Overall Study|Attempt|2|||
143114360|NCT04250714|515961024|FG000|Overall Study|Intent|7|||
143114361|NCT05906836|515961025|FG000|Overall Study|Unwilling to Make Travel Arrangements|1|||
143114362|NCT05906836|515961025|FG000|Overall Study|Lost to Follow-up|1|||
143114363|NCT01451164|515961026|FG000|Overall Study|Adverse Event|19|||
143114364|NCT01451164|515961027|FG001|Overall Study|Adverse Event|12|||
143114365|NCT01451164|515961028|FG002|Overall Study|Adverse Event|18|||
143114366|NCT01451164|515961029|FG003|Overall Study|Adverse Event|21|||
143114367|NCT01451164|515961026|FG000|Overall Study|Withdrawal Criteria|1|||
143114368|NCT01451164|515961027|FG001|Overall Study|Withdrawal Criteria|1|||
143114369|NCT01451164|515961028|FG002|Overall Study|Withdrawal Criteria|1|||
143114370|NCT01451164|515961029|FG003|Overall Study|Withdrawal Criteria|1|||
143114371|NCT01451164|515961026|FG000|Overall Study|Physician Decision|2|||
143114372|NCT01451164|515961027|FG001|Overall Study|Physician Decision|0|||
143114373|NCT01451164|515961028|FG002|Overall Study|Physician Decision|1|||
143114374|NCT01451164|515961029|FG003|Overall Study|Physician Decision|0|||
143114375|NCT01451164|515961026|FG000|Overall Study|Withdrawal by Subject|14|||
143114376|NCT01451164|515961027|FG001|Overall Study|Withdrawal by Subject|11|||
143114377|NCT01451164|515961028|FG002|Overall Study|Withdrawal by Subject|16|||
143114378|NCT01451164|515961029|FG003|Overall Study|Withdrawal by Subject|17|||
143114379|NCT01451164|515961026|FG000|Overall Study|Protocol Violation|0|||
143114380|NCT01451164|515961027|FG001|Overall Study|Protocol Violation|1|||
143180853|NCT04988295|516210378|FG003|Overall Study|Study participation ongoing|119|||
143180854|NCT01306643|516210381|FG000|Overall Study|Adverse Event|5|||
143114381|NCT01451164|515961028|FG002|Overall Study|Protocol Violation|0|||
143114382|NCT01451164|515961029|FG003|Overall Study|Protocol Violation|0|||
143114383|NCT01451164|515961026|FG000|Overall Study|Lack of Efficacy|7|||
143114384|NCT01451164|515961027|FG001|Overall Study|Lack of Efficacy|9|||
143114385|NCT01451164|515961028|FG002|Overall Study|Lack of Efficacy|9|||
143114386|NCT01451164|515961029|FG003|Overall Study|Lack of Efficacy|7|||
143114387|NCT01846221|515961030|FG000|Overall Study|Catheter Failure|2|||
143114388|NCT01846221|515961031|FG001|Overall Study|Catheter Failure|0|||
143114389|NCT01846221|515961030|FG000|Overall Study|Age Exclusion|1|||
143114390|NCT01846221|515961031|FG001|Overall Study|Age Exclusion|0|||
143114391|NCT04599933|515961032|FG000|Overall Study|Adverse Event|4|||
143114392|NCT04599933|515961033|FG001|Overall Study|Adverse Event|1|||
143114393|NCT04599933|515961032|FG000|Overall Study|Withdrawal by Subject|4|||
143114394|NCT04599933|515961033|FG001|Overall Study|Withdrawal by Subject|2|||
143114395|NCT04599933|515961032|FG000|Overall Study|Lost to Follow-up|0|||
143114396|NCT04599933|515961033|FG001|Overall Study|Lost to Follow-up|1|||
143114397|NCT04599933|515961032|FG000|Overall Study|Physician Decision|0|||
143114398|NCT04599933|515961033|FG001|Overall Study|Physician Decision|1|||
143114399|NCT04599933|515961032|FG000|Overall Study|Screen Failure|1|||
143114400|NCT04599933|515961033|FG001|Overall Study|Screen Failure|2|||
143114401|NCT04392167|515961040|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
143114402|NCT02963558|515961041|FG000|Overall Study|Withdrawn by investigator|1|||
143114403|NCT02963558|515961042|FG001|Overall Study|Withdrawn by investigator|0|||
143114404|NCT02963558|515961041|FG000|Overall Study|Withdrawal by Subject|0|||
143114405|NCT02963558|515961042|FG001|Overall Study|Withdrawal by Subject|1|||
143114406|NCT02045732|515961047|FG000|Overall Study|At the discretion of the investigator|1|||
143114407|NCT02045732|515961048|FG001|Overall Study|At the discretion of the investigator|1|||
143114408|NCT00473824|515961049|FG000|Overall Study|Virologic Breakthrough|1|||
143114409|NCT00473824|515961050|FG001|Overall Study|Virologic Breakthrough|0|||
143114410|NCT00473824|515961049|FG000|Overall Study|Adverse Event|1|||
143114411|NCT00473824|515961050|FG001|Overall Study|Adverse Event|0|||
143114412|NCT00473824|515961049|FG000|Overall Study|Death|1|||
143114413|NCT00473824|515961050|FG001|Overall Study|Death|0|||
143114414|NCT00473824|515961049|FG000|Overall Study|Lost to Follow-up|1|||
143114415|NCT00473824|515961050|FG001|Overall Study|Lost to Follow-up|0|||
143114416|NCT00473824|515961049|FG000|Overall Study|Withdrawal by physician|1|||
143114417|NCT00473824|515961050|FG001|Overall Study|Withdrawal by physician|0|||
143114418|NCT02560623|515961051|FG000|Overall Study|Unable to swallow sponge|0|||
143114419|NCT02560623|515961052|FG001|Overall Study|Unable to swallow sponge|1|||
143114420|NCT02560623|515961053|FG002|Overall Study|Unable to swallow sponge|0|||
143114421|NCT02560623|515961054|FG003|Overall Study|Unable to swallow sponge|0|||
143114422|NCT02560623|515961051|FG000|Overall Study|Intervention prior to sponge administration|0|||
143114423|NCT02560623|515961052|FG001|Overall Study|Intervention prior to sponge administration|1|||
143114424|NCT02560623|515961053|FG002|Overall Study|Intervention prior to sponge administration|0|||
143114425|NCT02560623|515961054|FG003|Overall Study|Intervention prior to sponge administration|0|||
143114426|NCT05014815|515961055|FG000|Overall Study|Death|63|||
143114427|NCT05014815|515961056|FG001|Overall Study|Death|70|||
143114428|NCT05014815|515961055|FG000|Overall Study|Withdrawal by Subject|10|||
143114429|NCT05014815|515961056|FG001|Overall Study|Withdrawal by Subject|10|||
143114430|NCT05014815|515961055|FG000|Overall Study|Lost to Follow-up|4|||
143114431|NCT05014815|515961056|FG001|Overall Study|Lost to Follow-up|2|||
143114432|NCT05014815|515961055|FG000|Overall Study|Physician Decision|2|||
143114433|NCT05014815|515961056|FG001|Overall Study|Physician Decision|4|||
143114434|NCT04247880|515961057|FG000|Overall Study|Lost to Follow-up|24|||
143114435|NCT04247880|515961058|FG001|Overall Study|Lost to Follow-up|17|||
143114436|NCT04247880|515961057|FG000|Overall Study|Withdrawal by Subject|3|||
143114437|NCT04247880|515961058|FG001|Overall Study|Withdrawal by Subject|0|||
143114438|NCT06303167|515961059|FG000|Overall Study|Ineligible|1|||
143114439|NCT06303167|515961059|FG000|Overall Study|Never start protocol therapy|2|||
143114440|NCT06303167|515961059|FG000|Overall Study|Disease progression|16|||
143114441|NCT03385304|515961060|FG000|Overall Study|Death|19|||
143114442|NCT03385304|515961061|FG001|Overall Study|Death|7|||
143114443|NCT03385304|515961060|FG000|Overall Study|Lost to Follow-up|17|||
143114444|NCT03385304|515961061|FG001|Overall Study|Lost to Follow-up|14|||
143114445|NCT03385304|515961060|FG000|Overall Study|Withdrawal by Subject|3|||
143114446|NCT03385304|515961061|FG001|Overall Study|Withdrawal by Subject|2|||
143114447|NCT03385304|515961060|FG000|Overall Study|Incarceration|2|||
143114448|NCT03385304|515961061|FG001|Overall Study|Incarceration|3|||
143114449|NCT02720744|515961062|FG000|Overall Study|Protocol Violation|0|||
143114450|NCT02720744|515961063|FG001|Overall Study|Protocol Violation|2|||
143114451|NCT02720744|515961062|FG000|Overall Study|Pregnancy|2|||
143114452|NCT02720744|515961063|FG001|Overall Study|Pregnancy|0|||
143114453|NCT02720744|515961062|FG000|Overall Study|Lack of Efficacy|2|||
143114454|NCT02720744|515961063|FG001|Overall Study|Lack of Efficacy|8|||
143114455|NCT02720744|515961062|FG000|Overall Study|Adverse Event|21|||
143114456|NCT02720744|515961063|FG001|Overall Study|Adverse Event|3|||
143114457|NCT02720744|515961062|FG000|Overall Study|Withdrawal by Subject|11|||
143114458|NCT02720744|515961063|FG001|Overall Study|Withdrawal by Subject|11|||
143114459|NCT02720744|515961062|FG000|Overall Study|Lost to follow up|2|||
143114460|NCT02720744|515961063|FG001|Overall Study|Lost to follow up|0|||
143114461|NCT02720744|515961062|FG000|Overall Study|Non Compliance with Investigational Product|0|||
143114462|NCT02720744|515961063|FG001|Overall Study|Non Compliance with Investigational Product|1|||
143114463|NCT02720744|515961062|FG000|Overall Study|Excluded Concomitant Medication|0|||
143114464|NCT02720744|515961063|FG001|Overall Study|Excluded Concomitant Medication|1|||
143114465|NCT02052596|515961074|FG000|Active Phase|Adverse Event|3|||
143180855|NCT01306643|516210381|FG000|Overall Study|Disease Progression|7|||
143180856|NCT01306643|516210381|FG000|Overall Study|Other: Change in Eligibility Status|1|||
143180857|NCT01665911|516210386|FG000|Overall Study|Protocol Violation|4|||
143180858|NCT01665911|516210386|FG000|Overall Study|Withdrawal by Subject|1|||
143180859|NCT01665911|516210386|FG000|Overall Study|Adverse Event|1|||
143180860|NCT02763059|516210387|FG000|Overall Study|Lost to Follow-up|4|||
143180861|NCT02763059|516210388|FG001|Overall Study|Lost to Follow-up|1|||
143180862|NCT02763059|516210389|FG002|Overall Study|Lost to Follow-up|6|||
143180863|NCT02763059|516210387|FG000|Overall Study|Withdrawal by Subject|1|||
143180864|NCT02763059|516210388|FG001|Overall Study|Withdrawal by Subject|0|||
143180865|NCT02763059|516210389|FG002|Overall Study|Withdrawal by Subject|3|||
143180866|NCT01724216|516210390|FG000|Overall Study|Scan was not completed|1|||
143180867|NCT04024436|516210391|FG000|Overall Study|Death|10|||
143180868|NCT04024436|516210392|FG001|Overall Study|Death|14|||
143180869|NCT04024436|516210393|FG002|Overall Study|Death|2|||
143180870|NCT04024436|516210394|FG003|Overall Study|Death|7|||
143180871|NCT04024436|516210391|FG000|Overall Study|Loss to follow up|1|||
143180872|NCT04024436|516210392|FG001|Overall Study|Loss to follow up|0|||
143180873|NCT04024436|516210393|FG002|Overall Study|Loss to follow up|0|||
143180874|NCT04024436|516210394|FG003|Overall Study|Loss to follow up|1|||
143180875|NCT04024436|516210391|FG000|Overall Study|Withdrawal of consent|2|||
143180876|NCT04024436|516210392|FG001|Overall Study|Withdrawal of consent|0|||
143180877|NCT04024436|516210393|FG002|Overall Study|Withdrawal of consent|0|||
143180878|NCT04024436|516210394|FG003|Overall Study|Withdrawal of consent|1|||
143180879|NCT04024436|516210391|FG000|Overall Study|Study termination by sponsor|4|||
143180880|NCT04024436|516210392|FG001|Overall Study|Study termination by sponsor|6|||
143180881|NCT04024436|516210393|FG002|Overall Study|Study termination by sponsor|2|||
143180882|NCT04024436|516210394|FG003|Overall Study|Study termination by sponsor|11|||
143180883|NCT04024436|516210391|FG000|Overall Study|Reason Not Specified|0|||
143114466|NCT02052596|515961075|FG001|Active Phase|Adverse Event|2|||
143114467|NCT02052596|515961074|FG000|Active Phase|Lost to Follow-up|8|||
143114468|NCT02052596|515961075|FG001|Active Phase|Lost to Follow-up|11|||
143114469|NCT02052596|515961074|FG000|Active Phase|Protocol Violation|1|||
143114470|NCT02052596|515961075|FG001|Active Phase|Protocol Violation|2|||
143114471|NCT02052596|515961074|FG000|Active Phase|Withdrawal by Subject|3|||
143114472|NCT02052596|515961075|FG001|Active Phase|Withdrawal by Subject|4|||
143114473|NCT02052596|515961074|FG000|Active Phase|Enrolled in error|1|||
143114474|NCT02052596|515961075|FG001|Active Phase|Enrolled in error|0|||
143114475|NCT02052596|515961074|FG000|Active Phase|Lost due to Crohn's disease|0|||
143180884|NCT04024436|516210392|FG001|Overall Study|Reason Not Specified|1|||
143180885|NCT04024436|516210393|FG002|Overall Study|Reason Not Specified|0|||
143259512|NCT01006603|516503872|FG001|Overall Study|Study specific discontinuation criteria|34|||
143259513|NCT01006603|516503871|FG000|Overall Study|Other|3|||
143180886|NCT04024436|516210394|FG003|Overall Study|Reason Not Specified|2|||
143180887|NCT00540592|516210396|FG000|Overall Study|Adverse Event|0|||
143180888|NCT00540592|516210397|FG001|Overall Study|Adverse Event|1|||
143180889|NCT00540592|516210398|FG002|Overall Study|Adverse Event|0|||
143180890|NCT00540592|516210399|FG003|Overall Study|Adverse Event|0|||
143180891|NCT00540592|516210400|FG004|Overall Study|Adverse Event|1|||
143180892|NCT00540592|516210401|FG005|Overall Study|Adverse Event|0|||
143180893|NCT00540592|516210402|FG006|Overall Study|Adverse Event|0|||
143180894|NCT00540592|516210403|FG007|Overall Study|Adverse Event|1|||
143180895|NCT00540592|516210404|FG008|Overall Study|Adverse Event|1|||
143180896|NCT00540592|516210405|FG009|Overall Study|Adverse Event|2|||
143180897|NCT00540592|516210396|FG000|Overall Study|Lost to Follow-up|2|||
143180898|NCT00540592|516210397|FG001|Overall Study|Lost to Follow-up|0|||
143180899|NCT00540592|516210398|FG002|Overall Study|Lost to Follow-up|0|||
143180900|NCT00540592|516210399|FG003|Overall Study|Lost to Follow-up|0|||
143180901|NCT00540592|516210400|FG004|Overall Study|Lost to Follow-up|0|||
143180902|NCT00540592|516210401|FG005|Overall Study|Lost to Follow-up|0|||
143180903|NCT00540592|516210402|FG006|Overall Study|Lost to Follow-up|0|||
143180904|NCT00540592|516210403|FG007|Overall Study|Lost to Follow-up|0|||
143180905|NCT00540592|516210404|FG008|Overall Study|Lost to Follow-up|0|||
143180906|NCT00540592|516210405|FG009|Overall Study|Lost to Follow-up|0|||
143180907|NCT00540592|516210396|FG000|Overall Study|Withdrawal by Subject|0|||
143180908|NCT00540592|516210397|FG001|Overall Study|Withdrawal by Subject|0|||
143180909|NCT00540592|516210398|FG002|Overall Study|Withdrawal by Subject|1|||
143180910|NCT00540592|516210399|FG003|Overall Study|Withdrawal by Subject|1|||
143180911|NCT00540592|516210400|FG004|Overall Study|Withdrawal by Subject|0|||
143180912|NCT00540592|516210401|FG005|Overall Study|Withdrawal by Subject|0|||
143180913|NCT00540592|516210402|FG006|Overall Study|Withdrawal by Subject|0|||
143180914|NCT00540592|516210403|FG007|Overall Study|Withdrawal by Subject|0|||
143180915|NCT00540592|516210404|FG008|Overall Study|Withdrawal by Subject|0|||
143180916|NCT00540592|516210405|FG009|Overall Study|Withdrawal by Subject|0|||
143180917|NCT03369665|516210409|FG000|Overall Study|Adverse Event|3|||
143180918|NCT03369665|516210409|FG000|Overall Study|Lost to Follow-up|7|||
143180919|NCT03369665|516210409|FG000|Overall Study|Withdrawal by Subject|15|||
143180920|NCT03369665|516210409|FG000|Overall Study|Progression Disease|2|||
143180921|NCT03369665|516210409|FG000|Overall Study|Not classified|3|||
143180922|NCT05197049|516210410|FG000|Overall Study|Death|0|||
143180923|NCT05197049|516210411|FG001|Overall Study|Death|1|||
143180924|NCT05197049|516210412|FG002|Overall Study|Death|0|||
143180925|NCT05197049|516210410|FG000|Overall Study|Lost to Follow-up|3|||
143180926|NCT05197049|516210411|FG001|Overall Study|Lost to Follow-up|1|||
143180927|NCT05197049|516210412|FG002|Overall Study|Lost to Follow-up|0|||
143180928|NCT05197049|516210410|FG000|Overall Study|Withdrawal by Subject|15|||
143180929|NCT05197049|516210411|FG001|Overall Study|Withdrawal by Subject|3|||
143180930|NCT05197049|516210412|FG002|Overall Study|Withdrawal by Subject|1|||
143180931|NCT05197049|516210410|FG000|Overall Study|GCP non-compliance|1|||
143180932|NCT05197049|516210411|FG001|Overall Study|GCP non-compliance|2|||
143180933|NCT05197049|516210412|FG002|Overall Study|GCP non-compliance|0|||
143180934|NCT02688192|516210413|FG000|Overall Study|Lost to Follow-up|11|||
143180935|NCT02688192|516210414|FG001|Overall Study|Lost to Follow-up|5|||
143180936|NCT02688192|516210413|FG000|Overall Study|Physician Decision|1|||
143180937|NCT02688192|516210414|FG001|Overall Study|Physician Decision|0|||
143180938|NCT00075764|516210415|FG000|Overall Study|Adverse Event|5|||
143180939|NCT00075764|516210416|FG001|Overall Study|Adverse Event|12|||
143259514|NCT01006603|516503872|FG001|Overall Study|Other|7|||
143259515|NCT05772702|516503880|FG000|Overall Study|Adverse Event|1|||
143259516|NCT00884377|516505744|FG000|Overall Study|Withdrawal by Subject|1|||
143259517|NCT00884377|516505745|FG001|Overall Study|Withdrawal by Subject|0|||
143259518|NCT00884377|516505744|FG000|Overall Study|Could not confirm diagnosis|1|||
143259519|NCT00884377|516505745|FG001|Overall Study|Could not confirm diagnosis|0|||
143259520|NCT00884377|516505744|FG000|Overall Study|Physician Decision|0|||
143259521|NCT00884377|516505745|FG001|Overall Study|Physician Decision|1|||
143259522|NCT02003365|516505746|FG000|Overall Study|Lost to Follow-up|0|||
143259523|NCT02003365|516505747|FG001|Overall Study|Lost to Follow-up|0|||
143259524|NCT02003365|516505748|FG002|Overall Study|Lost to Follow-up|1|||
143259525|NCT00625742|516505749|FG000|Overall Study|Disease Progression|2|||
143259526|NCT00625742|516505749|FG000|Overall Study|Withdrawal by Subject|1|||
143180940|NCT00075764|516210415|FG000|Overall Study|Death|4|||
143180941|NCT00075764|516210416|FG001|Overall Study|Death|8|||
143180942|NCT00075764|516210415|FG000|Overall Study|Withdrawal by Subject|28|||
143180943|NCT00075764|516210416|FG001|Overall Study|Withdrawal by Subject|18|||
143180944|NCT00075764|516210415|FG000|Overall Study|Progression|269|||
143180945|NCT00075764|516210416|FG001|Overall Study|Progression|274|||
143259527|NCT00625742|516505749|FG000|Overall Study|Adverse Event|4|||
143180946|NCT00075764|516210415|FG000|Overall Study|Still on treatment|8|||
143180947|NCT00075764|516210416|FG001|Overall Study|Still on treatment|15|||
143180948|NCT00075764|516210415|FG000|Overall Study|Delinquent|4|||
143180949|NCT00075764|516210416|FG001|Overall Study|Delinquent|2|||
143180950|NCT00075764|516210415|FG000|Overall Study|Not protocol specified|27|||
143180951|NCT00075764|516210416|FG001|Overall Study|Not protocol specified|19|||
143180952|NCT00075764|516210415|FG000|Overall Study|Under review|0|||
143180953|NCT00075764|516210416|FG001|Overall Study|Under review|1|||
143180954|NCT02817594|516210420|FG000|Overall Study|Withdrawal by Subject|1|||
143180955|NCT02817594|516210420|FG000|Overall Study|Other|1|||
143180956|NCT02817594|516210420|FG000|Overall Study|Did Not Receive Treatment|1|||
143180957|NCT02010593|516210421|FG000|Overall Study|Lost to Follow-up|1|||
143180958|NCT02010593|516210422|FG001|Overall Study|Lost to Follow-up|0|||
143180959|NCT02010593|516210421|FG000|Overall Study|Physician Decision|1|||
143180960|NCT02010593|516210422|FG001|Overall Study|Physician Decision|0|||
143180961|NCT02010593|516210421|FG000|Overall Study|Unable to adhere to visit schedule|0|||
143180962|NCT02010593|516210422|FG001|Overall Study|Unable to adhere to visit schedule|2|||
143180963|NCT00709319|516210425|FG000|Overall Study|Death|4|||
143180964|NCT00709319|516210425|FG000|Overall Study|Withdrawal by Subject|2|||
143180965|NCT00579553|516210429|FG000|Overall Study|Lost to Follow-up|16|||
143180966|NCT00579553|516210430|FG001|Overall Study|Lost to Follow-up|13|||
143180967|NCT05384834|516210437|FG000|Overall Study|Lost to Follow-up|43|||
143180968|NCT05384834|516210437|FG000|Overall Study|Withdrawal by Subject|5|||
143180969|NCT01775553|516210438|FG000|Overall Study|Adverse Event|1|||
143180970|NCT01775553|516210438|FG000|Overall Study|Disease Progression|12|||
143180971|NCT03748641|516210439|FG000|Overall Study|Ongoing|155|||
143180972|NCT03748641|516210440|FG001|Overall Study|Ongoing|148|||
143180973|NCT03748641|516210441|FG002|Overall Study|Ongoing|66|||
143180974|NCT03748641|516210442|FG003|Overall Study|Ongoing|79|||
143180975|NCT03748641|516210443|FG004|Overall Study|Ongoing|84|||
143180976|NCT03748641|516210439|FG000|Overall Study|Death|54|||
143180977|NCT03748641|516210440|FG001|Overall Study|Death|59|||
143180978|NCT03748641|516210441|FG002|Overall Study|Death|51|||
143180979|NCT03748641|516210442|FG003|Overall Study|Death|42|||
143180980|NCT03748641|516210443|FG004|Overall Study|Death|9|||
143180981|NCT03748641|516210439|FG000|Overall Study|Lost to Follow-up|0|||
143180982|NCT03748641|516210440|FG001|Overall Study|Lost to Follow-up|2|||
143180983|NCT03748641|516210441|FG002|Overall Study|Lost to Follow-up|1|||
143180984|NCT03748641|516210442|FG003|Overall Study|Lost to Follow-up|0|||
143180985|NCT03748641|516210443|FG004|Overall Study|Lost to Follow-up|0|||
143180986|NCT03748641|516210439|FG000|Overall Study|Withdrawal by Subject|3|||
143180987|NCT03748641|516210440|FG001|Overall Study|Withdrawal by Subject|2|||
143180988|NCT03748641|516210441|FG002|Overall Study|Withdrawal by Subject|5|||
143180989|NCT03748641|516210442|FG003|Overall Study|Withdrawal by Subject|3|||
143180990|NCT03748641|516210443|FG004|Overall Study|Withdrawal by Subject|2|||
143180991|NCT04834726|516210444|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
143180992|NCT04834726|516210445|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
143180993|NCT04834726|516210446|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
143180994|NCT04834726|516210447|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
143180995|NCT04834726|516210448|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
143180996|NCT04834726|516210449|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
143180997|NCT04834726|516210450|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
143180998|NCT04834726|516210451|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
143180999|NCT04834726|516210452|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
143181000|NCT00124072|516210454|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
143181001|NCT00124072|516210455|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
143181002|NCT00124072|516210456|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
143181003|NCT00124072|516210457|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
143181004|NCT00124072|516210454|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
143181005|NCT00124072|516210455|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
143181006|NCT00124072|516210456|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
143181007|NCT00124072|516210457|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
143181008|NCT00124072|516210454|FG000|Overall Study|Death|499|||
143181009|NCT00124072|516210455|FG001|Overall Study|Death|484|||
143181010|NCT00124072|516210456|FG002|Overall Study|Death|471|||
143181011|NCT00124072|516210457|FG003|Overall Study|Death|480|||
143181012|NCT00886769|516210458|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
143181013|NCT00886769|516210459|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
143181014|NCT00414076|516210460|FG000|Overall Study|Progression|1|||
143181015|NCT00414076|516210461|FG001|Overall Study|Progression|2|||
143181016|NCT00414076|516210460|FG000|Overall Study|Withdrawal by Subject|1|||
143181017|NCT00414076|516210461|FG001|Overall Study|Withdrawal by Subject|3|||
143181018|NCT00414076|516210460|FG000|Overall Study|Adverse Event|1|||
143181019|NCT00414076|516210461|FG001|Overall Study|Adverse Event|0|||
143181020|NCT00778336|516210462|FG000|Index Procedure-Discharge|Death|6|||
143181021|NCT00778336|516210463|FG001|Index Procedure-Discharge|Death|3|||
143114476|NCT02052596|515961075|FG001|Active Phase|Lost due to Crohn's disease|1|||
143114477|NCT02052596|515961074|FG000|Safety Phase|Adverse Event|6|||
143114478|NCT02052596|515961075|FG001|Safety Phase|Adverse Event|3|||
143114479|NCT02052596|515961074|FG000|Safety Phase|Lost to Follow-up|11|||
143114480|NCT02052596|515961075|FG001|Safety Phase|Lost to Follow-up|18|||
143114481|NCT02052596|515961074|FG000|Safety Phase|Protocol Violation|1|||
143114482|NCT02052596|515961075|FG001|Safety Phase|Protocol Violation|2|||
143114483|NCT02052596|515961074|FG000|Safety Phase|Withdrawal by Subject|8|||
143114484|NCT02052596|515961075|FG001|Safety Phase|Withdrawal by Subject|11|||
143114485|NCT02052596|515961074|FG000|Safety Phase|Enrolled in error|1|||
143114486|NCT02052596|515961075|FG001|Safety Phase|Enrolled in error|0|||
143114487|NCT02052596|515961074|FG000|Safety Phase|Lost due to Crohn's disease|0|||
143114488|NCT02052596|515961075|FG001|Safety Phase|Lost due to Crohn's disease|1|||
143114489|NCT00558896|515961076|FG000|Overall Study|Adverse Event|1|||
143114490|NCT00558896|515961077|FG001|Overall Study|Adverse Event|1|||
143114491|NCT00558896|515961078|FG002|Overall Study|Adverse Event|1|||
143114492|NCT00558896|515961079|FG003|Overall Study|Adverse Event|3|||
143114493|NCT00558896|515961080|FG004|Overall Study|Adverse Event|4|||
143114494|NCT00558896|515961081|FG005|Overall Study|Adverse Event|10|||
143114495|NCT00558896|515961082|FG006|Overall Study|Adverse Event|3|||
143114496|NCT00558896|515961076|FG000|Overall Study|Death|3|||
143114497|NCT00558896|515961077|FG001|Overall Study|Death|0|||
143114498|NCT00558896|515961078|FG002|Overall Study|Death|2|||
143114499|NCT00558896|515961079|FG003|Overall Study|Death|3|||
143114500|NCT00558896|515961080|FG004|Overall Study|Death|2|||
143114501|NCT00558896|515961081|FG005|Overall Study|Death|2|||
143114502|NCT00558896|515961082|FG006|Overall Study|Death|6|||
143114503|NCT00558896|515961076|FG000|Overall Study|Withdrawal by Subject|2|||
143114504|NCT00558896|515961077|FG001|Overall Study|Withdrawal by Subject|1|||
143114505|NCT00558896|515961078|FG002|Overall Study|Withdrawal by Subject|1|||
143114506|NCT00558896|515961079|FG003|Overall Study|Withdrawal by Subject|1|||
143114507|NCT00558896|515961080|FG004|Overall Study|Withdrawal by Subject|1|||
143114508|NCT00558896|515961081|FG005|Overall Study|Withdrawal by Subject|5|||
143114509|NCT00558896|515961082|FG006|Overall Study|Withdrawal by Subject|5|||
143114510|NCT00558896|515961076|FG000|Overall Study|Alternative Treatment|2|||
143114511|NCT00558896|515961077|FG001|Overall Study|Alternative Treatment|2|||
143114512|NCT00558896|515961078|FG002|Overall Study|Alternative Treatment|0|||
143114513|NCT00558896|515961079|FG003|Overall Study|Alternative Treatment|2|||
143114514|NCT00558896|515961080|FG004|Overall Study|Alternative Treatment|6|||
143114515|NCT00558896|515961081|FG005|Overall Study|Alternative Treatment|7|||
143114516|NCT00558896|515961082|FG006|Overall Study|Alternative Treatment|1|||
143114517|NCT00558896|515961076|FG000|Overall Study|Physician discretion|3|||
143114518|NCT00558896|515961077|FG001|Overall Study|Physician discretion|2|||
143114519|NCT00558896|515961078|FG002|Overall Study|Physician discretion|1|||
143114520|NCT00558896|515961079|FG003|Overall Study|Physician discretion|2|||
143114521|NCT00558896|515961080|FG004|Overall Study|Physician discretion|1|||
143114522|NCT00558896|515961081|FG005|Overall Study|Physician discretion|3|||
143114523|NCT00558896|515961082|FG006|Overall Study|Physician discretion|3|||
143114524|NCT00558896|515961076|FG000|Overall Study|Continues on treatment|10|||
143114525|NCT00558896|515961077|FG001|Overall Study|Continues on treatment|1|||
143114526|NCT00558896|515961078|FG002|Overall Study|Continues on treatment|0|||
143114527|NCT00558896|515961079|FG003|Overall Study|Continues on treatment|1|||
143114528|NCT00558896|515961080|FG004|Overall Study|Continues on treatment|9|||
143114529|NCT00558896|515961081|FG005|Overall Study|Continues on treatment|25|||
143114530|NCT00558896|515961082|FG006|Overall Study|Continues on treatment|6|||
143114531|NCT00250458|515961084|FG000|Overall Study|Lost to Follow-up|4|||
143114532|NCT00250458|515961085|FG001|Overall Study|Lost to Follow-up|2|||
143114533|NCT00250458|515961084|FG000|Overall Study|Protocol Violation|0|||
143114534|NCT00250458|515961085|FG001|Overall Study|Protocol Violation|1|||
143114535|NCT00250458|515961084|FG000|Overall Study|Withdrawal by Subject|4|||
143114536|NCT00250458|515961085|FG001|Overall Study|Withdrawal by Subject|2|||
143114537|NCT00250458|515961084|FG000|Overall Study|Lack of Migraine Attack|20|||
143114538|NCT00250458|515961085|FG001|Overall Study|Lack of Migraine Attack|9|||
143114539|NCT00250458|515961084|FG000|Overall Study|Qualifying migraine but did not treat|3|||
143114540|NCT00250458|515961085|FG001|Overall Study|Qualifying migraine but did not treat|3|||
143114541|NCT00250458|515961084|FG000|Overall Study|Other|1|||
143114542|NCT00250458|515961085|FG001|Overall Study|Other|0|||
143114543|NCT01199822|515961092|FG000|Overall Study|Investigator discontinued therapy|0|||
143114544|NCT01199822|515961093|FG001|Overall Study|Investigator discontinued therapy|1|||
143181022|NCT00778336|516210464|FG002|Index Procedure-Discharge|Death|2|||
143181023|NCT00778336|516210465|FG003|Index Procedure-Discharge|Death|0|||
143181024|NCT00778336|516210462|FG000|3 Month Follow Up|Lost to Follow-up|15|||
143181025|NCT00778336|516210463|FG001|3 Month Follow Up|Lost to Follow-up|20|||
143181026|NCT00778336|516210464|FG002|3 Month Follow Up|Lost to Follow-up|3|||
143181027|NCT00778336|516210465|FG003|3 Month Follow Up|Lost to Follow-up|0|||
143181028|NCT00778336|516210462|FG000|3 Month Follow Up|Death|8|||
143181029|NCT00778336|516210463|FG001|3 Month Follow Up|Death|3|||
143181030|NCT00778336|516210464|FG002|3 Month Follow Up|Death|2|||
143181031|NCT00778336|516210465|FG003|3 Month Follow Up|Death|0|||
143181032|NCT04417257|516210468|FG000|Pilot Phase 2|Adverse Event|2|||
143181033|NCT04417257|516210469|FG001|Pilot Phase 2|Adverse Event|0|||
143181034|NCT04417257|516210468|FG000|Pilot Phase 2|Death|14|||
143181035|NCT04417257|516210469|FG001|Pilot Phase 2|Death|11|||
143181036|NCT04417257|516210468|FG000|Pilot Phase 2|Lost to Follow-up|3|||
143181037|NCT04417257|516210469|FG001|Pilot Phase 2|Lost to Follow-up|5|||
143181038|NCT04417257|516210468|FG000|Pilot Phase 2|Withdrawal by Subject|7|||
143181039|NCT04417257|516210469|FG001|Pilot Phase 2|Withdrawal by Subject|6|||
143181040|NCT04417257|516210468|FG000|Pilot Phase 2|Hepatic impairment|1|||
143181041|NCT04417257|516210469|FG001|Pilot Phase 2|Hepatic impairment|0|||
143181042|NCT04417257|516210468|FG000|Pilot Phase 2|Unblinding|1|||
143181043|NCT04417257|516210469|FG001|Pilot Phase 2|Unblinding|0|||
143181044|NCT04417257|516210468|FG000|Pilot Phase 2|All other|0|||
143181045|NCT04417257|516210469|FG001|Pilot Phase 2|All other|2|||
143181046|NCT04417257|516210468|FG000|Phase 3 Extension|Death|3|||
143181047|NCT04417257|516210469|FG001|Phase 3 Extension|Death|1|||
143181048|NCT04417257|516210468|FG000|Phase 3 Extension|Lost to Follow-up|4|||
143181049|NCT04417257|516210469|FG001|Phase 3 Extension|Lost to Follow-up|2|||
143181050|NCT04417257|516210468|FG000|Phase 3 Extension|Patient withdrawal|2|||
143181051|NCT04417257|516210469|FG001|Phase 3 Extension|Patient withdrawal|2|||
143181052|NCT04417257|516210468|FG000|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|3|||
143181053|NCT04417257|516210469|FG001|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|1|||
143181054|NCT04951622|516210470|FG000|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|7|||
143181055|NCT04951622|516210471|FG001|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|5|||
143181056|NCT04951622|516210472|FG002|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
143181057|NCT04951622|516210473|FG003|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
143181058|NCT04951622|516210474|FG004|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
143181059|NCT04951622|516210470|FG000|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
143181060|NCT04951622|516210471|FG001|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
143181061|NCT04951622|516210472|FG002|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
143181062|NCT04951622|516210473|FG003|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
143181063|NCT04951622|516210474|FG004|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
143181064|NCT04951622|516210470|FG000|DB Phase: Day 1 (Week 0) to Week 24|Death|2|||
143181065|NCT04951622|516210471|FG001|DB Phase: Day 1 (Week 0) to Week 24|Death|1|||
143181066|NCT04951622|516210472|FG002|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
143181067|NCT04951622|516210473|FG003|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
143181068|NCT04951622|516210474|FG004|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
143181069|NCT04951622|516210470|FG000|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
143181070|NCT04951622|516210471|FG001|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|1|||
143181071|NCT04951622|516210472|FG002|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
143181072|NCT04951622|516210473|FG003|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
143181073|NCT04951622|516210474|FG004|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
143181074|NCT04951622|516210470|FG000|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
143181075|NCT04951622|516210471|FG001|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
143181076|NCT04951622|516210472|FG002|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
143181077|NCT04951622|516210473|FG003|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
143181078|NCT04951622|516210474|FG004|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
143181079|NCT04951622|516210470|FG000|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
143181080|NCT04951622|516210471|FG001|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|1|||
143181081|NCT04951622|516210472|FG002|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
143259528|NCT00625742|516505749|FG000|Overall Study|Lost to Follow-up|4|||
143259529|NCT00625742|516505749|FG000|Overall Study|Ineligible|1|||
143259530|NCT00371761|516505752|FG000|Overall Study|Adverse Event|1|||
143114545|NCT01199822|515961094|FG002|Overall Study|Investigator discontinued therapy|0|||
143114546|NCT00480493|515961095|FG000|Overall Study|moved|2|||
143114547|NCT00480493|515961096|FG001|Overall Study|moved|7|||
143114548|NCT04027075|515961097|FG000|Overall Study|Lost to Follow-up|41|||
143114549|NCT04027075|515961098|FG001|Overall Study|Lost to Follow-up|22|||
143114550|NCT02844907|515961099|FG000|With Dexamethasone|No IV access|1|||
143114551|NCT00550862|515961100|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
143114552|NCT00550862|515961101|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
143114553|NCT00550862|515961102|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
143114554|NCT00550862|515961103|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
143114555|NCT00550862|515961104|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
143114556|NCT00550862|515961100|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
143114557|NCT00550862|515961101|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
143114558|NCT00550862|515961102|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
143114559|NCT00550862|515961103|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
143114560|NCT00550862|515961104|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
143114561|NCT00550862|515961100|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
143114562|NCT00550862|515961101|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
143114563|NCT00550862|515961102|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
143114564|NCT00550862|515961103|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
143114565|NCT00550862|515961104|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
143114566|NCT00550862|515961100|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
143114567|NCT00550862|515961101|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
143114568|NCT00550862|515961102|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
143114569|NCT00550862|515961103|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
143114570|NCT00550862|515961104|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
143114571|NCT00550862|515961100|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
143114572|NCT00550862|515961101|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
143114573|NCT00550862|515961102|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
143114574|NCT00550862|515961103|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
143114575|NCT00550862|515961104|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
143114576|NCT00550862|515961100|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
143114577|NCT00550862|515961101|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
143181082|NCT04951622|516210473|FG003|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
143181083|NCT04951622|516210474|FG004|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
143181084|NCT04951622|516210470|FG000|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|2|||
143181085|NCT04951622|516210471|FG001|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
143181086|NCT04951622|516210472|FG002|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
143181087|NCT04951622|516210473|FG003|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
143181088|NCT04951622|516210474|FG004|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
143181089|NCT04951622|516210470|FG000|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|1|||
143181090|NCT04951622|516210471|FG001|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
143181091|NCT04951622|516210472|FG002|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
143181092|NCT04951622|516210473|FG003|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
143181093|NCT04951622|516210474|FG004|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
143181094|NCT04951622|516210470|FG000|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|1|||
143181095|NCT04951622|516210471|FG001|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
143181096|NCT04951622|516210472|FG002|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
143181097|NCT04951622|516210473|FG003|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
143181098|NCT04951622|516210474|FG004|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
143181099|NCT04951622|516210470|FG000|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
143181100|NCT04951622|516210471|FG001|DB Phase: Day 1 (Week 0) to Week 24|Other|1|||
143181101|NCT04951622|516210472|FG002|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
143181102|NCT04951622|516210473|FG003|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
143181103|NCT04951622|516210474|FG004|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
143181104|NCT04951622|516210470|FG000|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|1|||
143181105|NCT04951622|516210471|FG001|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
143181106|NCT04951622|516210472|FG002|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
143368920|NCT02001623|516894562|FG004|Overall Study|Disease Progression|3|||
143181107|NCT04951622|516210473|FG003|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
143114578|NCT00550862|515961102|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
143114579|NCT00550862|515961103|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
143114580|NCT00550862|515961104|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
143114581|NCT00550862|515961100|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
143114582|NCT00550862|515961101|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
143114583|NCT00550862|515961102|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
143114584|NCT00550862|515961103|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
143114585|NCT00550862|515961104|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
143114586|NCT00550862|515961100|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
143114587|NCT00550862|515961101|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
143114588|NCT00550862|515961102|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
143114589|NCT00550862|515961103|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
143114590|NCT00550862|515961104|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
143114591|NCT00550862|515961100|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
143114592|NCT00550862|515961101|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
143114593|NCT00550862|515961102|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
143114594|NCT00550862|515961103|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
143114595|NCT00550862|515961104|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
143114596|NCT00550862|515961100|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
143114597|NCT00550862|515961101|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
143114598|NCT00550862|515961102|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
143114599|NCT00550862|515961103|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
143114600|NCT00550862|515961104|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
143114601|NCT00455520|515961106|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
143114602|NCT00455520|515961107|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
143114603|NCT00455520|515961106|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
143114604|NCT00455520|515961107|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
143114605|NCT00455520|515961106|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
143114606|NCT00455520|515961107|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
143114607|NCT00455520|515961106|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
143114608|NCT00455520|515961107|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
143114609|NCT00455520|515961106|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
143114610|NCT00455520|515961107|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
143114611|NCT00455520|515961106|FG000|Open Label Tapentadol Extended Release|All other|33|||
143114612|NCT00455520|515961107|FG001|Open Label Tapentadol Extended Release|All other|0|||
143114613|NCT00455520|515961106|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
143114614|NCT00455520|515961107|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
143114615|NCT00455520|515961106|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
143114616|NCT00455520|515961107|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
143114617|NCT00455520|515961106|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
143114618|NCT00455520|515961107|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
143114619|NCT00455520|515961106|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
143114620|NCT00455520|515961107|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
143114621|NCT00455520|515961106|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
143114622|NCT00455520|515961107|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
143114623|NCT00455520|515961106|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
143181108|NCT04951622|516210474|FG004|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
143181109|NCT04951622|516210470|FG000|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
143181110|NCT04951622|516210471|FG001|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|1|||
143181111|NCT04951622|516210472|FG002|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
143114624|NCT00455520|515961107|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
143181112|NCT04951622|516210473|FG003|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
143181113|NCT04951622|516210474|FG004|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
143181114|NCT04951622|516210470|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
143181115|NCT04951622|516210471|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
143181116|NCT04951622|516210472|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|5|||
143259531|NCT00371761|516505753|FG001|Overall Study|Adverse Event|1|||
143114625|NCT01472965|515961112|FG000|Overall Study|Withdrawal by Subject|1|||
143114626|NCT01472965|515961113|FG001|Overall Study|Withdrawal by Subject|0|||
143114627|NCT00986986|515961114|FG000|Overall Study|Lost to Follow-up|0|||
143114628|NCT00986986|515961115|FG001|Overall Study|Lost to Follow-up|1|||
143114629|NCT00474045|515961116|FG000|Overall Study|Adverse Event|18|||
143114630|NCT00474045|515961117|FG001|Overall Study|Adverse Event|8|||
143114631|NCT00474045|515961116|FG000|Overall Study|Unclassified|1|||
143114632|NCT00474045|515961117|FG001|Overall Study|Unclassified|3|||
143114633|NCT00474045|515961116|FG000|Overall Study|Lack of Efficacy|0|||
143114634|NCT00474045|515961117|FG001|Overall Study|Lack of Efficacy|9|||
143114635|NCT00474045|515961116|FG000|Overall Study|Lost to Follow-up|1|||
143114636|NCT00474045|515961117|FG001|Overall Study|Lost to Follow-up|1|||
143114637|NCT00474045|515961116|FG000|Overall Study|Protocol Violation|10|||
143114638|NCT00474045|515961117|FG001|Overall Study|Protocol Violation|12|||
143114639|NCT00474045|515961116|FG000|Overall Study|Withdrawal by Subject|16|||
143114640|NCT00474045|515961117|FG001|Overall Study|Withdrawal by Subject|18|||
143114641|NCT00474045|515961116|FG000|Overall Study|Withdrawal criteria|60|||
143114642|NCT00474045|515961117|FG001|Overall Study|Withdrawal criteria|50|||
143114643|NCT02009397|515961120|FG000|Overall Study|Protocol Violation|6|||
143114644|NCT02009397|515961120|FG000|Overall Study|Death|8|||
143114645|NCT02009397|515961120|FG000|Overall Study|Lost to Follow-up|6|||
143114646|NCT01966068|515961122|FG000|Overall Study|Withdrawal by Subject|57|||
143114647|NCT01966068|515961122|FG000|Overall Study|Lost to Follow-up|81|||
143114648|NCT00808639|515961123|FG000|Overall Study|Disease progression before surgery.|1|||
143114649|NCT03430895|515961124|FG000|Overall Study|Not Treated|2|||
143114650|NCT01317797|515961125|FG000|Overall Study|Other|0|||
143114651|NCT01317797|515961126|FG001|Overall Study|Other|1|||
143181117|NCT04951622|516210473|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
143259532|NCT00371761|516505752|FG000|Overall Study|Withdrawal by Subject|1|||
143114652|NCT01317797|515961127|FG002|Overall Study|Other|0|||
143114653|NCT01317797|515961125|FG000|Overall Study|Withdrawal of Patient|0|||
143259533|NCT00371761|516505753|FG001|Overall Study|Withdrawal by Subject|3|||
143259534|NCT00371761|516505752|FG000|Overall Study|Investigator Judgment|2|||
143259535|NCT00371761|516505753|FG001|Overall Study|Investigator Judgment|3|||
143114654|NCT01317797|515961126|FG001|Overall Study|Withdrawal of Patient|0|||
143114655|NCT01317797|515961127|FG002|Overall Study|Withdrawal of Patient|1|||
143114656|NCT01645891|515961128|FG000|Overall Study|Adverse Event|6|||
143114657|NCT01645891|515961129|FG001|Overall Study|Adverse Event|10|||
143114658|NCT01645891|515961128|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
143114659|NCT01645891|515961129|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
143114660|NCT01645891|515961128|FG000|Overall Study|Withdrawal by Subject|3|||
143114661|NCT01645891|515961129|FG001|Overall Study|Withdrawal by Subject|3|||
143114662|NCT01645891|515961128|FG000|Overall Study|Protocol Violation|4|||
143114663|NCT01645891|515961129|FG001|Overall Study|Protocol Violation|0|||
143114664|NCT01645891|515961128|FG000|Overall Study|Lost to Follow-up|4|||
143114665|NCT01645891|515961129|FG001|Overall Study|Lost to Follow-up|1|||
143114666|NCT01645891|515961128|FG000|Overall Study|Death|0|||
143114667|NCT01645891|515961129|FG001|Overall Study|Death|2|||
143114668|NCT01037127|515961133|FG000|Overall Study|Lost to Follow-up|2|||
143114669|NCT01037127|515961134|FG001|Overall Study|Lost to Follow-up|4|||
143114670|NCT01037127|515961133|FG000|Overall Study|Physician Decision|1|||
143114671|NCT01037127|515961134|FG001|Overall Study|Physician Decision|0|||
143114672|NCT01037127|515961133|FG000|Overall Study|Study Closed Terminated|2|||
143114673|NCT01037127|515961134|FG001|Overall Study|Study Closed Terminated|17|||
143114674|NCT04253782|515961139|FG000|Overall Study|Death|2|||
143114675|NCT04253782|515961140|FG001|Overall Study|Death|0|||
143114676|NCT03721835|515961141|FG000|Overall Study|Participant not able to return|1|||
143114677|NCT03721835|515961141|FG000|Overall Study|Lost to Follow-up|1|||
143114678|NCT03721835|515961141|FG000|Overall Study|Revision of the components of the study device|2|||
143114679|NCT03721835|515961141|FG000|Overall Study|Sponsor terminated study|6|||
143114680|NCT03721835|515961141|FG000|Overall Study|Death|1|||
143114681|NCT03721835|515961141|FG000|Overall Study|Sponsor decision|1|||
143114682|NCT01250171|515962380|FG000|Overall Study|Administrative reasons|1|||
143259536|NCT00371761|516505752|FG000|Overall Study|Study termination|4|||
143114683|NCT01250171|515962381|FG001|Overall Study|Administrative reasons|0|||
143114684|NCT01250171|515962382|FG002|Overall Study|Administrative reasons|0|||
143114685|NCT01573767|515962383|FG000|Overall Study|Adverse Event|0|||
143114686|NCT01573767|515962384|FG001|Overall Study|Adverse Event|1|||
143114687|NCT01573767|515962385|FG002|Overall Study|Adverse Event|0|||
143114688|NCT01573767|515962386|FG003|Overall Study|Adverse Event|1|||
143114689|NCT01573767|515962383|FG000|Overall Study|Lack of Efficacy|18|||
143114690|NCT01573767|515962384|FG001|Overall Study|Lack of Efficacy|15|||
143114691|NCT01573767|515962385|FG002|Overall Study|Lack of Efficacy|12|||
143114692|NCT01573767|515962386|FG003|Overall Study|Lack of Efficacy|17|||
143114693|NCT01573767|515962383|FG000|Overall Study|Protocol Violation|3|||
143114694|NCT01573767|515962384|FG001|Overall Study|Protocol Violation|1|||
143114695|NCT01573767|515962385|FG002|Overall Study|Protocol Violation|1|||
143114696|NCT01573767|515962386|FG003|Overall Study|Protocol Violation|3|||
143114697|NCT01573767|515962383|FG000|Overall Study|Lost to Follow-up|0|||
143114698|NCT01573767|515962384|FG001|Overall Study|Lost to Follow-up|1|||
143114699|NCT01573767|515962385|FG002|Overall Study|Lost to Follow-up|1|||
143114700|NCT01573767|515962386|FG003|Overall Study|Lost to Follow-up|1|||
143114701|NCT01573767|515962383|FG000|Overall Study|Physician Decision|1|||
143114702|NCT01573767|515962384|FG001|Overall Study|Physician Decision|2|||
143114703|NCT01573767|515962385|FG002|Overall Study|Physician Decision|0|||
143114704|NCT01573767|515962386|FG003|Overall Study|Physician Decision|2|||
143114705|NCT01573767|515962383|FG000|Overall Study|Withdrawal by Subject|0|||
143114706|NCT01573767|515962384|FG001|Overall Study|Withdrawal by Subject|1|||
143114707|NCT01573767|515962385|FG002|Overall Study|Withdrawal by Subject|0|||
143114708|NCT01573767|515962386|FG003|Overall Study|Withdrawal by Subject|0|||
143114709|NCT03117881|515962387|FG000|Baseline|Withdrawal by Subject|21|||
143114710|NCT03117881|515962388|FG001|Baseline|Withdrawal by Subject|10|||
143114711|NCT03117881|515962389|FG002|Baseline|Withdrawal by Subject|0|||
143114712|NCT03117881|515962387|FG000|Baseline|Lost to Follow-up|22|||
143114713|NCT03117881|515962388|FG001|Baseline|Lost to Follow-up|25|||
143114714|NCT03117881|515962389|FG002|Baseline|Lost to Follow-up|0|||
143114715|NCT03117881|515962387|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
143114716|NCT03117881|515962388|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
143114717|NCT03117881|515962389|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
143114718|NCT03117881|515962387|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
143114719|NCT03117881|515962388|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
143114720|NCT03117881|515962389|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
143114721|NCT03117881|515962387|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
143114722|NCT03117881|515962388|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
143114723|NCT03117881|515962389|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
143114724|NCT03117881|515962387|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
143114725|NCT03117881|515962388|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
143114726|NCT03117881|515962389|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
143114727|NCT03117881|515962387|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
143114728|NCT03117881|515962388|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
143114729|NCT03117881|515962389|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
143114730|NCT03117881|515962387|FG000|6-Month Follow-Up|Did not complete test|53|||
143114731|NCT03117881|515962388|FG001|6-Month Follow-Up|Did not complete test|25|||
143114732|NCT03117881|515962389|FG002|6-Month Follow-Up|Did not complete test|7|||
143114733|NCT03117881|515962387|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
143114734|NCT03117881|515962388|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
143114735|NCT03117881|515962389|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
143114736|NCT03117881|515962387|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
143114737|NCT03117881|515962388|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
143114738|NCT03117881|515962389|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
143114739|NCT03117881|515962387|FG000|12-Month Follow-Up|Did not complete test|40|||
143114740|NCT03117881|515962388|FG001|12-Month Follow-Up|Did not complete test|0|||
143114741|NCT03117881|515962389|FG002|12-Month Follow-Up|Did not complete test|0|||
143114742|NCT01027897|515962390|FG000|Overall Study|Protocol Violation|1|||
143114743|NCT01027897|515962390|FG000|Overall Study|Withdrawal by Subject|1|||
143114744|NCT01911780|515962391|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
143114745|NCT01911780|515962392|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
143114746|NCT01911780|515962391|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
143114747|NCT01911780|515962392|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
143114748|NCT01911780|515962391|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
143114749|NCT01911780|515962392|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
143114750|NCT01911780|515962391|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
143114751|NCT01911780|515962392|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
143114752|NCT01911780|515962391|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
143114753|NCT01911780|515962392|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
143114754|NCT01911780|515962391|FG000|Extension Period (52 Weeks)|Personal reason|1|||
143114755|NCT01911780|515962392|FG001|Extension Period (52 Weeks)|Personal reason|1|||
143114756|NCT03488225|515962393|FG000|Overall Study|Off Protocol Therapy|2|||
143114757|NCT03488225|515962393|FG000|Overall Study|Stem Cell Transplant|2|||
143114758|NCT00955968|515962397|FG000|Overall Study|Death|2|||
143114759|NCT00955968|515962398|FG001|Overall Study|Death|4|||
143114760|NCT00955968|515962397|FG000|Overall Study|Withdrawal by Subject|35|||
143114761|NCT00955968|515962398|FG001|Overall Study|Withdrawal by Subject|31|||
143114762|NCT00955968|515962397|FG000|Overall Study|Lost to Follow-up|45|||
143114763|NCT00955968|515962398|FG001|Overall Study|Lost to Follow-up|39|||
143114764|NCT00955968|515962397|FG000|Overall Study|Site closed|55|||
143259537|NCT00371761|516505753|FG001|Overall Study|Study termination|3|||
143114765|NCT00955968|515962398|FG001|Overall Study|Site closed|52|||
143114766|NCT05020899|515962399|FG000|8 Week Follow-up|Lost to Follow-up|3|||
143114767|NCT05020899|515962400|FG001|8 Week Follow-up|Lost to Follow-up|6|||
143114768|NCT05020899|515962399|FG000|12 Week Follow-up|Lost to Follow-up|1|||
143114769|NCT05020899|515962400|FG001|12 Week Follow-up|Lost to Follow-up|0|||
143114770|NCT05020899|515962399|FG000|12 Week Follow-up|Death|0|||
143114771|NCT05020899|515962400|FG001|12 Week Follow-up|Death|1|||
143114772|NCT01068626|515962403|FG000|Overall Study|Adverse Event|3|||
143114773|NCT01068626|515962404|FG001|Overall Study|Adverse Event|0|||
143114774|NCT01068626|515962403|FG000|Overall Study|Withdrawal by Subject|0|||
143114775|NCT01068626|515962404|FG001|Overall Study|Withdrawal by Subject|2|||
143114776|NCT01785849|515962405|FG000|Overall Study|Death|7|||
143181118|NCT04951622|516210474|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|2|||
143181119|NCT04951622|516210470|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
143181120|NCT04951622|516210471|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
143181121|NCT04951622|516210472|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
143181122|NCT04951622|516210473|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
143181123|NCT04951622|516210474|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
143181124|NCT04951622|516210470|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
143181125|NCT04951622|516210471|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
143181126|NCT04951622|516210472|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
143181127|NCT04951622|516210473|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|5|||
143181128|NCT04951622|516210474|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
143181129|NCT04951622|516210470|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
143181130|NCT04951622|516210471|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
143181131|NCT04951622|516210472|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|3|||
143181132|NCT04951622|516210473|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|7|||
143181133|NCT04951622|516210474|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
143181134|NCT04951622|516210470|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
143181135|NCT04951622|516210471|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
143181136|NCT04951622|516210472|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|1|||
143181137|NCT04951622|516210473|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
143181138|NCT04951622|516210474|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
143181139|NCT04951622|516210470|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
143181140|NCT04951622|516210471|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
143181141|NCT04951622|516210472|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
143259538|NCT05040971|516505760|FG000|Overall Study|Withdrawal by Subject|0|||
143259539|NCT05040971|516505761|FG001|Overall Study|Withdrawal by Subject|2|||
143259540|NCT05040971|516505760|FG000|Overall Study|Lost to Follow-up|8|||
143259541|NCT05040971|516505761|FG001|Overall Study|Lost to Follow-up|3|||
143114777|NCT01785849|515962406|FG001|Overall Study|Death|9|||
143114778|NCT01785849|515962405|FG000|Overall Study|Protocol Specified Criteria|29|||
143114779|NCT01785849|515962406|FG001|Overall Study|Protocol Specified Criteria|1|||
143114780|NCT01785849|515962405|FG000|Overall Study|Withdrawal by Subject|15|||
143114781|NCT01785849|515962406|FG001|Overall Study|Withdrawal by Subject|12|||
143114782|NCT01785849|515962405|FG000|Overall Study|Sponsor Decision|0|||
143114783|NCT01785849|515962406|FG001|Overall Study|Sponsor Decision|1|||
143114784|NCT01785849|515962405|FG000|Overall Study|Lost to Follow-up|10|||
143114785|NCT01785849|515962406|FG001|Overall Study|Lost to Follow-up|11|||
143114786|NCT00204477|515962407|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
143114787|NCT00204477|515962408|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
143114788|NCT00204477|515962407|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
143114789|NCT00204477|515962408|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
143114790|NCT00150800|515962409|FG000|Overall Study|Adverse Event|89|||
143114791|NCT00150800|515962409|FG000|Overall Study|Death|18|||
143114792|NCT00150800|515962409|FG000|Overall Study|Lack of Efficacy|166|||
143114793|NCT00150800|515962409|FG000|Overall Study|Lost to Follow-up|58|||
143114794|NCT00150800|515962409|FG000|Overall Study|Subject's choice|90|||
143114795|NCT00150800|515962409|FG000|Overall Study|No compliance|18|||
143114796|NCT00150800|515962409|FG000|Overall Study|IP misshandling|1|||
143114797|NCT00150800|515962409|FG000|Overall Study|Site closure|24|||
143114798|NCT00150800|515962409|FG000|Overall Study|Protocol non-adherence|2|||
143114799|NCT00150800|515962409|FG000|Overall Study|Nobody to accompany patient|1|||
143114800|NCT00150800|515962409|FG000|Overall Study|Distance too long for patient|1|||
143114801|NCT00150800|515962409|FG000|Overall Study|Neurosurgery|2|||
143114802|NCT00150800|515962409|FG000|Overall Study|BRV monotherapy|1|||
143114803|NCT00150800|515962409|FG000|Overall Study|Visit refusal|3|||
143114804|NCT00150800|515962409|FG000|Overall Study|Sponsor's request|2|||
143114805|NCT00150800|515962409|FG000|Overall Study|Generalized Epilepsy|1|||
143114806|NCT00150800|515962409|FG000|Overall Study|Moved from area/country|8|||
143114807|NCT00150800|515962409|FG000|Overall Study|PI retiring|2|||
143114808|NCT00150800|515962409|FG000|Overall Study|PI leaving site|2|||
143114809|NCT00150800|515962409|FG000|Overall Study|Patient insurance|1|||
143114810|NCT00150800|515962409|FG000|Overall Study|Surgical intervention|4|||
143114811|NCT00150800|515962409|FG000|Overall Study|Pregnancy planned|1|||
143114812|NCT00150800|515962409|FG000|Overall Study|PI discontinuation request|1|||
143114813|NCT00710684|515962419|FG000|Overall Study|Adverse Event|11|||
143114814|NCT00710684|515962420|FG001|Overall Study|Adverse Event|19|||
143114815|NCT00710684|515962421|FG002|Overall Study|Adverse Event|16|||
143114816|NCT00710684|515962419|FG000|Overall Study|Lack of Efficacy|4|||
143114817|NCT00710684|515962420|FG001|Overall Study|Lack of Efficacy|3|||
143114818|NCT00710684|515962421|FG002|Overall Study|Lack of Efficacy|5|||
143114819|NCT00710684|515962419|FG000|Overall Study|Protocol Violation|5|||
143114820|NCT00710684|515962420|FG001|Overall Study|Protocol Violation|5|||
143114821|NCT00710684|515962421|FG002|Overall Study|Protocol Violation|5|||
143114822|NCT00710684|515962419|FG000|Overall Study|Lost to Follow-up|4|||
143114823|NCT00710684|515962420|FG001|Overall Study|Lost to Follow-up|6|||
143114824|NCT00710684|515962421|FG002|Overall Study|Lost to Follow-up|7|||
143114825|NCT00710684|515962419|FG000|Overall Study|Physician Decision|0|||
143114826|NCT00710684|515962420|FG001|Overall Study|Physician Decision|2|||
143114827|NCT00710684|515962421|FG002|Overall Study|Physician Decision|4|||
143114828|NCT00710684|515962419|FG000|Overall Study|Withdrawal by Subject|24|||
143114829|NCT00710684|515962420|FG001|Overall Study|Withdrawal by Subject|18|||
143114830|NCT00710684|515962421|FG002|Overall Study|Withdrawal by Subject|11|||
143114831|NCT00710684|515962419|FG000|Overall Study|Missing|1|||
143114832|NCT00710684|515962420|FG001|Overall Study|Missing|0|||
143114833|NCT00710684|515962421|FG002|Overall Study|Missing|0|||
143114834|NCT00710684|515962419|FG000|Overall Study|Did not continue after week 24|25|||
143114835|NCT00710684|515962420|FG001|Overall Study|Did not continue after week 24|21|||
143114836|NCT00710684|515962421|FG002|Overall Study|Did not continue after week 24|16|||
143114837|NCT00084318|515962424|FG000|Overall Study|Withdrawal by Subject|5|||
143114838|NCT00084318|515962425|FG001|Overall Study|Withdrawal by Subject|2|||
143114839|NCT00084318|515962424|FG000|Overall Study|Protocol Violation|15|||
143114840|NCT00084318|515962425|FG001|Overall Study|Protocol Violation|11|||
143114841|NCT00084318|515962424|FG000|Overall Study|No protocol treatment|2|||
143114842|NCT00084318|515962425|FG001|Overall Study|No protocol treatment|0|||
143114843|NCT00138073|515962431|FG000|Overall Study|lack of resources|55|||
143114844|NCT03026530|515962432|FG000|Overall Study|Lost to Follow-up|19|||
143114845|NCT03026530|515962433|FG001|Overall Study|Lost to Follow-up|24|||
143114846|NCT03026530|515962432|FG000|Overall Study|Protocol Violation|2|||
143114847|NCT03026530|515962433|FG001|Overall Study|Protocol Violation|5|||
143114848|NCT03301740|515962434|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
143114849|NCT03301740|515962435|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
143259542|NCT05040971|516505760|FG000|Overall Study|Death|2|||
143259543|NCT05040971|516505761|FG001|Overall Study|Death|0|||
143259544|NCT03025035|516505767|FG000|Overall Study|Death|2|||
143368921|NCT02001623|516894563|FG005|Overall Study|Disease Progression|2|||
143368922|NCT02001623|516894564|FG006|Overall Study|Disease Progression|3|||
143259625|NCT04738318|516505808|FG001|Overall Study|Protocol Violation|0|||
143259545|NCT03025035|516505767|FG000|Overall Study|Disease progression and was taken off study. Only received pembrolizumab & is not evaluable.|1|||
143259546|NCT02720094|516505771|FG000|Overall Study|Ongoing|2210|||
143259547|NCT02720094|516505772|FG001|Overall Study|Ongoing|2203|||
143259548|NCT02720094|516505771|FG000|Overall Study|Scheduled exit visit/end of study|2|||
143259549|NCT02720094|516505772|FG001|Overall Study|Scheduled exit visit/end of study|1|||
143369037|NCT02001623|516894559|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
143369038|NCT02001623|516894560|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
143369039|NCT02001623|516894561|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
143369040|NCT02001623|516894562|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
143369041|NCT02001623|516894563|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
143369042|NCT02001623|516894564|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
143369043|NCT02001623|516894565|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
143369044|NCT02001623|516894566|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
143369045|NCT02001623|516894567|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
143369046|NCT02001623|516894568|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
143369047|NCT02001623|516894569|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
143369048|NCT02001623|516894570|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
143369049|NCT02001623|516894571|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
143369050|NCT02001623|516894572|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
143369051|NCT01063036|516894577|FG000|Participants Treated With Study Drug|Adverse Event|1|||
143181482|NCT02891226|516211765|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
143181483|NCT02891226|516211766|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
143181484|NCT02891226|516211767|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
143181485|NCT02891226|516211768|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
143181486|NCT02891226|516211769|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
143181487|NCT02891226|516211770|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
143181488|NCT02891226|516211771|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
143181489|NCT02891226|516211772|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
143181490|NCT02891226|516211773|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
143181491|NCT02891226|516211774|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
143181492|NCT02891226|516211775|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
143181493|NCT02891226|516211760|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
143181494|NCT02891226|516211761|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
143181495|NCT02891226|516211762|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
143181496|NCT02891226|516211763|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
143181497|NCT02891226|516211764|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
143181498|NCT02891226|516211765|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
143259679|NCT01163032|516505836|FG001|Open Label Extension Phase|Adverse Event|0|||
143259680|NCT01163032|516505837|FG002|Open Label Extension Phase|Adverse Event|3|||
143259681|NCT01163032|516505835|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
143259682|NCT01163032|516505836|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
143259683|NCT01163032|516505837|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
143259684|NCT01163032|516505835|FG000|Open Label Extension Phase|Protocol Violation|0|||
143259685|NCT01163032|516505836|FG001|Open Label Extension Phase|Protocol Violation|0|||
143259686|NCT01163032|516505837|FG002|Open Label Extension Phase|Protocol Violation|1|||
143259687|NCT01163032|516505835|FG000|Open Label Extension Phase|Study Termination|0|||
143259688|NCT01163032|516505836|FG001|Open Label Extension Phase|Study Termination|0|||
143259689|NCT01163032|516505837|FG002|Open Label Extension Phase|Study Termination|7|||
143259690|NCT01163032|516505835|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
143259691|NCT01163032|516505836|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
143259692|NCT01163032|516505837|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
143259693|NCT02751931|516505838|FG000|Overall Study|Adverse Event|3|||
143259694|NCT02751931|516505839|FG001|Overall Study|Adverse Event|0|||
143259695|NCT02751931|516505838|FG000|Overall Study|Other: Miscelleneous|10|||
143259696|NCT02751931|516505839|FG001|Overall Study|Other: Miscelleneous|8|||
143259697|NCT03473548|516505842|FG000|Overall Study|Did not attempt HST testing|3|||
143259698|NCT03473548|516505843|FG001|Overall Study|Did not attempt HST testing|0|||
143259699|NCT01037088|516505844|FG000|Overall Study|Withdrawal by Subject|3|||
143259700|NCT01585584|516505853|FG000|Overall Study|Lack of Efficacy|1|||
143259701|NCT01585584|516505853|FG000|Overall Study|Withdrawal by Subject|1|||
143259702|NCT01585584|516505853|FG000|Overall Study|Physician Decision|2|||
143259703|NCT01958827|516505854|FG000|Overall Study|Adverse Event|3|||
143259704|NCT01958827|516505854|FG000|Overall Study|Lack of Efficacy|6|||
143259705|NCT01958827|516505854|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
143259706|NCT03036800|516505855|FG000|Overall Study|Protocol Violation|1|||
143259707|NCT03036800|516505856|FG001|Overall Study|Protocol Violation|0|||
143259708|NCT03036800|516505855|FG000|Overall Study|Non-compliance|1|||
143259709|NCT03036800|516505856|FG001|Overall Study|Non-compliance|0|||
143181499|NCT02891226|516211766|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
143181500|NCT02891226|516211767|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
143181501|NCT02891226|516211768|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
143181502|NCT02891226|516211769|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
143181503|NCT02891226|516211770|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
143181504|NCT02891226|516211771|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
143181505|NCT02891226|516211772|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
143181506|NCT02891226|516211773|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
143181507|NCT02891226|516211774|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
143181508|NCT02891226|516211775|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
143181509|NCT02891226|516211760|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
143181510|NCT02891226|516211761|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
143181511|NCT02891226|516211762|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
143181512|NCT02891226|516211763|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
143259710|NCT03036800|516505855|FG000|Overall Study|Lost to Follow-up|1|||
143259711|NCT03036800|516505856|FG001|Overall Study|Lost to Follow-up|0|||
143259712|NCT03036800|516505855|FG000|Overall Study|Death|1|||
143259713|NCT03036800|516505856|FG001|Overall Study|Death|0|||
143259714|NCT03036800|516505855|FG000|Overall Study|Tolerance|5|||
143259715|NCT03036800|516505856|FG001|Overall Study|Tolerance|0|||
143259716|NCT03036800|516505855|FG000|Overall Study|Unknown/no reason given|50|||
143259717|NCT03036800|516505856|FG001|Overall Study|Unknown/no reason given|39|||
143259718|NCT01077154|516505861|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
143259719|NCT01077154|516505862|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
143259720|NCT01077154|516505861|FG000|Overall Study|Withdrawal by Subject|369|||
143259721|NCT01077154|516505862|FG001|Overall Study|Withdrawal by Subject|385|||
143259722|NCT01077154|516505861|FG000|Overall Study|Death|215|||
143259723|NCT01077154|516505862|FG001|Overall Study|Death|214|||
143259724|NCT01077154|516505861|FG000|Overall Study|Lost to Follow-up|43|||
143259725|NCT01077154|516505862|FG001|Overall Study|Lost to Follow-up|35|||
143259726|NCT01077154|516505861|FG000|Overall Study|Noncompliance|22|||
143259727|NCT01077154|516505862|FG001|Overall Study|Noncompliance|20|||
143259728|NCT01077154|516505861|FG000|Overall Study|Disease Progression|18|||
143259729|NCT01077154|516505862|FG001|Overall Study|Disease Progression|20|||
143259730|NCT01077154|516505861|FG000|Overall Study|Ineligibility Determined|10|||
143259731|NCT01077154|516505862|FG001|Overall Study|Ineligibility Determined|14|||
143259732|NCT01077154|516505861|FG000|Overall Study|Other|14|||
143259733|NCT01077154|516505862|FG001|Overall Study|Other|11|||
143259734|NCT01077154|516505861|FG000|Overall Study|Adverse Event|9|||
143259735|NCT01077154|516505862|FG001|Overall Study|Adverse Event|9|||
143259736|NCT01077154|516505861|FG000|Overall Study|Administrative Decision|1|||
143259737|NCT01077154|516505862|FG001|Overall Study|Administrative Decision|6|||
143259738|NCT01077154|516505861|FG000|Overall Study|Protocol Deviation|1|||
143259739|NCT01077154|516505862|FG001|Overall Study|Protocol Deviation|0|||
143259740|NCT05985980|516505863|FG000|Overall Study|Withdrawal by Subject|1|||
143259741|NCT05985980|516505863|FG000|Overall Study|Withdrawal by Subject|1|||
143259742|NCT05985980|516505863|FG000|Overall Study|Withdrawal by Subject|1|||
143259743|NCT05985980|516505863|FG000|Overall Study|Withdrawal by Subject|1|||
143181513|NCT02891226|516211764|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
143259744|NCT00811642|516505864|FG000|Overall Study|Adverse Event|3|||
143259745|NCT00811642|516505864|FG000|Overall Study|Protocol Violation|1|||
143259746|NCT00811642|516505864|FG000|Overall Study|Death|2|||
143259747|NCT00811642|516505864|FG000|Overall Study|Withdrawal by Subject|7|||
143259748|NCT00811642|516505864|FG000|Overall Study|Cumulative use of antifungal agent|2|||
143259749|NCT02361346|516505865|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
143259750|NCT02361346|516505866|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
143259751|NCT02361346|516505867|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
143369052|NCT01063036|516894577|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
143369053|NCT01063036|516894577|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
143369054|NCT01063036|516894577|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
143369055|NCT01063036|516894577|FG000|Participants Treated With Study Drug|Pregnancy|1|||
143369056|NCT01063036|516894577|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
143369057|NCT01063036|516894577|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
143369058|NCT01063036|516894577|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
143369059|NCT02814643|516894578|FG000|Overall Study|Lost to Follow-up|0|||
143369060|NCT02814643|516894579|FG001|Overall Study|Lost to Follow-up|1|||
143369061|NCT02814643|516894578|FG000|Overall Study|Withdrawal by Subject|1|||
143369062|NCT02814643|516894579|FG001|Overall Study|Withdrawal by Subject|2|||
143259752|NCT02361346|516505868|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
143259753|NCT02361346|516505869|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
143259754|NCT02361346|516505870|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
143259755|NCT02361346|516505871|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
143259756|NCT02361346|516505872|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
143259757|NCT02361346|516505873|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
143259758|NCT02361346|516505865|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
143259759|NCT02361346|516505866|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
143259760|NCT02361346|516505867|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
143259761|NCT02361346|516505868|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
143259762|NCT02361346|516505869|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
143259763|NCT02361346|516505870|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
143259764|NCT02361346|516505871|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
143259765|NCT02361346|516505872|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
143259766|NCT02361346|516505873|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
143259767|NCT02361346|516505865|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
143259768|NCT02361346|516505866|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
143259769|NCT02361346|516505867|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
143369063|NCT01280591|516894580|FG000|Overall Study|Withdrawal by Subject|0|||
143369064|NCT01280591|516894581|FG001|Overall Study|Withdrawal by Subject|0|||
143369065|NCT01280591|516894582|FG002|Overall Study|Withdrawal by Subject|0|||
143369066|NCT01280591|516894583|FG003|Overall Study|Withdrawal by Subject|2|||
143369067|NCT01280591|516894580|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
143369068|NCT01280591|516894581|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
143369069|NCT01280591|516894582|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
143369070|NCT01280591|516894583|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
143369071|NCT01883492|516894585|FG000|Overall Study|Lost to Follow-up|3|||
143369072|NCT01883492|516894586|FG001|Overall Study|Lost to Follow-up|4|||
143369073|NCT01883492|516894585|FG000|Overall Study|Surgery on contra-lateral hip|0|||
143369074|NCT01883492|516894586|FG001|Overall Study|Surgery on contra-lateral hip|1|||
143369075|NCT01883492|516894585|FG000|Overall Study|Poor X-ray quality|7|||
143369076|NCT01883492|516894586|FG001|Overall Study|Poor X-ray quality|4|||
143369077|NCT01883492|516894585|FG000|Overall Study|Withdrawal by Subject|1|||
143369078|NCT01883492|516894586|FG001|Overall Study|Withdrawal by Subject|0|||
143369079|NCT01883492|516894585|FG000|Overall Study|inappropriate implant used|1|||
143369080|NCT01883492|516894586|FG001|Overall Study|inappropriate implant used|1|||
143369081|NCT01883492|516894585|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
143369082|NCT01883492|516894586|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
143369083|NCT03357341|516894587|FG000|Overall Study|Withdrawal by Subject|3|||
143369084|NCT03357341|516894588|FG001|Overall Study|Withdrawal by Subject|6|||
143369085|NCT03357341|516894587|FG000|Overall Study|Lost to Follow-up|4|||
143369086|NCT03357341|516894588|FG001|Overall Study|Lost to Follow-up|5|||
143369087|NCT03357341|516894587|FG000|Overall Study|Death|0|||
143369088|NCT03357341|516894588|FG001|Overall Study|Death|1|||
143369089|NCT00957229|516894590|FG000|Study Start|Adverse Event|0|||
143369090|NCT00957229|516894591|FG001|Study Start|Adverse Event|3|||
143369091|NCT00957229|516894590|FG000|Study Start|Disease Progression|1|||
143369092|NCT00957229|516894591|FG001|Study Start|Disease Progression|0|||
143369093|NCT00957229|516894590|FG000|Reallocated to or Continued Vismodegib|Death|1|||
143369094|NCT00957229|516894591|FG001|Reallocated to or Continued Vismodegib|Death|1|||
143369095|NCT00957229|516894590|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
143369096|NCT00957229|516894591|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
143369097|NCT00828672|516894592|FG000|Study Treatment|Lost to Follow-up|1|||
143369098|NCT00828672|516894593|FG001|Study Treatment|Lost to Follow-up|0|||
143369099|NCT00828672|516894592|FG000|Study Treatment|Adverse Event|0|||
143369100|NCT00828672|516894593|FG001|Study Treatment|Adverse Event|1|||
143369101|NCT00828672|516894592|FG000|Study Treatment|Complete response, no surgery|1|||
143369102|NCT00828672|516894593|FG001|Study Treatment|Complete response, no surgery|1|||
143369103|NCT00828672|516894592|FG000|Post-surgery (<30 Days)|No central review materials|0|||
143369104|NCT00828672|516894593|FG001|Post-surgery (<30 Days)|No central review materials|1|||
143369105|NCT03095508|516894594|FG000|Overall Study|Adverse Event|0|||
143369106|NCT03095508|516894595|FG001|Overall Study|Adverse Event|1|||
143369107|NCT00853827|516894598|FG000|Single Blind Period (1 Week)|Other|4|||
143369108|NCT00853827|516894599|FG001|Single Blind Period (1 Week)|Other|0|||
143369109|NCT00853827|516894598|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
143369110|NCT00853827|516894599|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
143369111|NCT00853827|516894598|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
143369112|NCT00853827|516894599|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
143369113|NCT00853827|516894598|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
143369114|NCT00853827|516894599|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
143369115|NCT00853827|516894598|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
143369116|NCT00853827|516894599|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
143369117|NCT00853827|516894598|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
143369118|NCT00853827|516894599|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
143369119|NCT00853827|516894598|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
143369120|NCT00853827|516894599|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
143369121|NCT00853827|516894598|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
143369122|NCT00853827|516894599|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
143369123|NCT00853827|516894598|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
143369124|NCT00853827|516894599|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
143369125|NCT00853827|516894598|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
143369126|NCT00853827|516894599|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
143369127|NCT00853827|516894598|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
143369128|NCT00853827|516894599|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
143369129|NCT00853827|516894598|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
143369130|NCT00853827|516894599|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
143369131|NCT00853827|516894598|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
143369132|NCT00853827|516894599|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
143369133|NCT00853827|516894598|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
143369134|NCT00853827|516894599|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
143369135|NCT00853827|516894598|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
143259770|NCT02361346|516505868|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
143259771|NCT02361346|516505869|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
143259772|NCT02361346|516505870|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
143259773|NCT02361346|516505871|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
143259774|NCT02361346|516505872|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
143259775|NCT02361346|516505873|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
143259776|NCT02361346|516505865|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
143259777|NCT02361346|516505866|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
143259778|NCT02361346|516505867|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
143259779|NCT02361346|516505868|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
143259780|NCT02361346|516505869|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
143259781|NCT02361346|516505870|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
143259782|NCT02361346|516505871|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
143259783|NCT02361346|516505872|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
143259784|NCT02361346|516505873|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
143181514|NCT02891226|516211765|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
143181515|NCT02891226|516211766|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
143181516|NCT02891226|516211767|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
143181517|NCT02891226|516211768|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
143181518|NCT02891226|516211769|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
143181519|NCT02891226|516211770|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
143181520|NCT02891226|516211771|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
143181521|NCT02891226|516211772|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
143181522|NCT02891226|516211773|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
143181523|NCT02891226|516211774|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
143181524|NCT02891226|516211775|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
143181525|NCT02891226|516211760|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
143181526|NCT02891226|516211761|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
143181527|NCT02891226|516211762|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
143181528|NCT02891226|516211763|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
143181529|NCT02891226|516211764|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
143181530|NCT02891226|516211765|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
143181531|NCT02891226|516211766|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
143181532|NCT02891226|516211767|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
143181533|NCT02891226|516211768|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
143181534|NCT02891226|516211769|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
143181535|NCT02891226|516211770|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
143181536|NCT02891226|516211771|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
143181537|NCT02891226|516211772|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
143181538|NCT02891226|516211773|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
143259785|NCT02361346|516505865|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
143259786|NCT02361346|516505866|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
143181539|NCT02891226|516211774|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
143181540|NCT02891226|516211775|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
143181541|NCT02891226|516211760|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
143181542|NCT02891226|516211761|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
143181543|NCT02891226|516211762|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
143369136|NCT00853827|516894599|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
143369137|NCT00853827|516894598|FG000|Double Blind Period (103 Weeks)|Death|1|||
143181544|NCT02891226|516211763|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
143369138|NCT00853827|516894599|FG001|Double Blind Period (103 Weeks)|Death|6|||
143369139|NCT01460342|516894601|FG000|Overall Study|Adverse Event|5|||
143369140|NCT01460342|516894602|FG001|Overall Study|Adverse Event|4|||
143369141|NCT01460342|516894601|FG000|Overall Study|Lost to Follow-up|1|||
143369142|NCT01460342|516894602|FG001|Overall Study|Lost to Follow-up|2|||
143369143|NCT01460342|516894601|FG000|Overall Study|Protocol Violation|0|||
143369144|NCT01460342|516894602|FG001|Overall Study|Protocol Violation|1|||
143369145|NCT01460342|516894601|FG000|Overall Study|Withdrawal by Subject|3|||
143369146|NCT01460342|516894602|FG001|Overall Study|Withdrawal by Subject|4|||
143369147|NCT01460342|516894601|FG000|Overall Study|Physician Decision|1|||
143369148|NCT01460342|516894602|FG001|Overall Study|Physician Decision|3|||
143369149|NCT01460342|516894601|FG000|Overall Study|Lack of Efficacy|1|||
143369150|NCT01460342|516894602|FG001|Overall Study|Lack of Efficacy|0|||
143369151|NCT00591838|516894603|FG000|Overall Study|Withdrawal by Subject|0|||
143369152|NCT00591838|516894604|FG001|Overall Study|Withdrawal by Subject|0|||
143369153|NCT00591838|516894605|FG002|Overall Study|Withdrawal by Subject|0|||
143369154|NCT00591838|516894606|FG003|Overall Study|Withdrawal by Subject|1|||
143369155|NCT00591838|516894607|FG004|Overall Study|Withdrawal by Subject|0|||
143369156|NCT02982213|516894609|FG000|Overall Study|Did not complete follow up questionnaire|5|||
143369157|NCT02982213|516894610|FG001|Overall Study|Did not complete follow up questionnaire|1|||
143369158|NCT01549652|516894611|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
143369159|NCT01549652|516894612|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
143369160|NCT01549652|516894613|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
143369161|NCT01549652|516894614|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
143369162|NCT01549652|516894611|FG000|Overall Study|Study Drug Titration Failure|5|||
143369163|NCT01549652|516894612|FG001|Overall Study|Study Drug Titration Failure|6|||
143369164|NCT01549652|516894613|FG002|Overall Study|Study Drug Titration Failure|0|||
143369165|NCT01549652|516894614|FG003|Overall Study|Study Drug Titration Failure|0|||
143369166|NCT01549652|516894611|FG000|Overall Study|Withdrawal Effect|0|||
143369167|NCT01549652|516894612|FG001|Overall Study|Withdrawal Effect|2|||
143369168|NCT01549652|516894613|FG002|Overall Study|Withdrawal Effect|0|||
143369169|NCT01549652|516894614|FG003|Overall Study|Withdrawal Effect|0|||
143369170|NCT01549652|516894611|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
143369171|NCT01549652|516894612|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
143369172|NCT01549652|516894613|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
143369173|NCT01549652|516894614|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
143369174|NCT01549652|516894611|FG000|Overall Study|Problem with Infusion|1|||
143369175|NCT01549652|516894612|FG001|Overall Study|Problem with Infusion|0|||
143369176|NCT01549652|516894613|FG002|Overall Study|Problem with Infusion|0|||
143369177|NCT01549652|516894614|FG003|Overall Study|Problem with Infusion|0|||
143369178|NCT01549652|516894611|FG000|Overall Study|Titration Non-Compliance|1|||
143369179|NCT01549652|516894612|FG001|Overall Study|Titration Non-Compliance|3|||
143369180|NCT01549652|516894613|FG002|Overall Study|Titration Non-Compliance|4|||
143369181|NCT01549652|516894614|FG003|Overall Study|Titration Non-Compliance|5|||
143181545|NCT02891226|516211764|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
143181546|NCT02891226|516211765|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
143181547|NCT02891226|516211766|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
143181548|NCT02891226|516211767|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
143181549|NCT02891226|516211768|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
143181550|NCT02891226|516211769|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
143181551|NCT02891226|516211770|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
143181552|NCT02891226|516211771|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
143181553|NCT02891226|516211772|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
143181554|NCT02891226|516211773|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
143181555|NCT02891226|516211774|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
143181556|NCT02891226|516211775|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
143181557|NCT02891226|516211760|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
143181558|NCT02891226|516211761|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
143181559|NCT02891226|516211762|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
143181560|NCT02891226|516211763|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
143181561|NCT02891226|516211764|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
143181562|NCT02891226|516211765|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
143181563|NCT02891226|516211766|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
143181564|NCT02891226|516211767|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
143181565|NCT02891226|516211768|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
143259787|NCT02361346|516505867|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
143259788|NCT02361346|516505868|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
143259789|NCT02361346|516505869|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
143259790|NCT02361346|516505870|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
143259791|NCT02361346|516505871|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
143259792|NCT02361346|516505872|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
143259793|NCT02361346|516505873|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
143259794|NCT02361346|516505865|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
143259795|NCT02361346|516505866|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
143259796|NCT02361346|516505867|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
143259797|NCT02361346|516505868|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
143369182|NCT01549652|516894611|FG000|Overall Study|Titration Side Effects|0|||
143369183|NCT01549652|516894612|FG001|Overall Study|Titration Side Effects|0|||
143369184|NCT01549652|516894613|FG002|Overall Study|Titration Side Effects|6|||
143369185|NCT01549652|516894614|FG003|Overall Study|Titration Side Effects|3|||
143369186|NCT01549652|516894611|FG000|Overall Study|Withdrawal by Subject|0|||
143369187|NCT01549652|516894612|FG001|Overall Study|Withdrawal by Subject|0|||
143369188|NCT01549652|516894613|FG002|Overall Study|Withdrawal by Subject|5|||
143369189|NCT01549652|516894614|FG003|Overall Study|Withdrawal by Subject|3|||
143369190|NCT02512042|516894615|FG000|Overall Study|Adverse Event|0|||
143369191|NCT02512042|516894616|FG001|Overall Study|Adverse Event|4|||
143369192|NCT02512042|516894615|FG000|Overall Study|Withdrawal by Subject|6|||
143181566|NCT02891226|516211769|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
143181567|NCT02891226|516211770|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
143181568|NCT02891226|516211771|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
143181569|NCT02891226|516211772|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
143181570|NCT02891226|516211773|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
143181571|NCT02891226|516211774|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
143181572|NCT02891226|516211775|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
143181573|NCT02891226|516211760|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
143181574|NCT02891226|516211761|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
143181575|NCT02891226|516211762|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
143181576|NCT02891226|516211763|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
143181577|NCT02891226|516211764|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
143181578|NCT02891226|516211765|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
143181579|NCT02891226|516211766|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
143181580|NCT02891226|516211767|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
143181581|NCT02891226|516211768|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
143181582|NCT02891226|516211769|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
143181583|NCT02891226|516211770|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
143181584|NCT02891226|516211771|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
143181585|NCT02891226|516211772|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
143181586|NCT02891226|516211773|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
143181587|NCT02891226|516211774|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
143181588|NCT02891226|516211775|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
143181589|NCT02891226|516211760|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
143181590|NCT02891226|516211761|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
143181591|NCT02891226|516211762|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
143181592|NCT02891226|516211763|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
143181593|NCT02891226|516211764|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
143181594|NCT02891226|516211765|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
143181595|NCT02891226|516211766|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
143181596|NCT02891226|516211767|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
143181597|NCT02891226|516211768|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
143181598|NCT02891226|516211769|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
143181599|NCT02891226|516211770|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
143181600|NCT02891226|516211771|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
143181601|NCT02891226|516211772|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
143259798|NCT02361346|516505869|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
143259799|NCT02361346|516505870|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
143259800|NCT02361346|516505871|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
143259801|NCT02361346|516505872|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
143259802|NCT02361346|516505873|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
143259803|NCT01163318|516505874|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
143259804|NCT01163318|516505874|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
143259805|NCT01163318|516505874|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
143259806|NCT01163318|516505874|FG000|Overall Study|Participants Without Case Report Form|7|||
143259807|NCT01163318|516505874|FG000|Overall Study|Multiple Reasons Per Participant|224|||
143259808|NCT03587727|516505879|FG000|Overall Study|10 did not complete either of the pre-op MMTT or post-op MMTT.|10|||
143259809|NCT03587727|516505879|FG000|Overall Study|4 completed the pre-op MMTT but did not complete the post-op MMTT.|4|||
143259810|NCT04102189|516505880|FG000|Overall Study|Withdrawal by Subject|1|||
143259811|NCT04102189|516505881|FG001|Overall Study|Withdrawal by Subject|2|||
143259812|NCT04102189|516505880|FG000|Overall Study|Withdrawal by parent/guardian|0|||
143259813|NCT04102189|516505881|FG001|Overall Study|Withdrawal by parent/guardian|1|||
143259814|NCT04102189|516505880|FG000|Overall Study|Lost to Follow-up|1|||
143259815|NCT04102189|516505881|FG001|Overall Study|Lost to Follow-up|0|||
143259816|NCT03576274|516505882|FG000|Overall Study|Lost to Follow-up|3|||
143369193|NCT02512042|516894616|FG001|Overall Study|Withdrawal by Subject|6|||
143369194|NCT02512042|516894615|FG000|Overall Study|Non-compliance with study drug|1|||
143369195|NCT02512042|516894616|FG001|Overall Study|Non-compliance with study drug|2|||
143369196|NCT02512042|516894615|FG000|Overall Study|Lost to Follow-up|5|||
143369197|NCT02512042|516894616|FG001|Overall Study|Lost to Follow-up|2|||
143369198|NCT02512042|516894615|FG000|Overall Study|Other|11|||
143369199|NCT02512042|516894616|FG001|Overall Study|Other|11|||
143369200|NCT04163458|516894621|FG000|Overall Study|Protocol Deviation|7|||
143369201|NCT04163458|516894622|FG001|Overall Study|Protocol Deviation|13|||
143369202|NCT04163458|516894621|FG000|Overall Study|Adverse Event|5|||
143369203|NCT04163458|516894622|FG001|Overall Study|Adverse Event|8|||
143369204|NCT04163458|516894621|FG000|Overall Study|Due to COVID-19 pandemic|4|||
143369205|NCT04163458|516894622|FG001|Overall Study|Due to COVID-19 pandemic|2|||
143369206|NCT04163458|516894621|FG000|Overall Study|Participant withdrew consent|2|||
143369207|NCT04163458|516894622|FG001|Overall Study|Participant withdrew consent|3|||
143369208|NCT04163458|516894621|FG000|Overall Study|Randomization failure|2|||
143369209|NCT04163458|516894622|FG001|Overall Study|Randomization failure|2|||
143369210|NCT04163458|516894621|FG000|Overall Study|Other|4|||
143369211|NCT04163458|516894622|FG001|Overall Study|Other|2|||
143369212|NCT00835380|516894628|FG000|Overall Study|Withdrawal by Subject|2|||
143369213|NCT03247543|516894629|FG000|Overall Study|Adverse Event|3|||
143369214|NCT03247543|516894630|FG001|Overall Study|Adverse Event|6|||
143369215|NCT03247543|516894631|FG002|Overall Study|Adverse Event|4|||
143369216|NCT03247543|516894629|FG000|Overall Study|Lost to Follow-up|10|||
143369217|NCT03247543|516894630|FG001|Overall Study|Lost to Follow-up|7|||
143369218|NCT03247543|516894631|FG002|Overall Study|Lost to Follow-up|8|||
143369219|NCT03247543|516894629|FG000|Overall Study|Consent withdrawn by caregiver|2|||
143369220|NCT03247543|516894630|FG001|Overall Study|Consent withdrawn by caregiver|2|||
143369221|NCT03247543|516894631|FG002|Overall Study|Consent withdrawn by caregiver|9|||
143369222|NCT03247543|516894629|FG000|Overall Study|Withdrawal by Subject|0|||
143369223|NCT03247543|516894630|FG001|Overall Study|Withdrawal by Subject|0|||
143181602|NCT02891226|516211773|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
143181603|NCT02891226|516211774|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
143181604|NCT02891226|516211775|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
143181605|NCT02891226|516211760|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
143181606|NCT02891226|516211761|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
143181607|NCT02891226|516211762|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
143181608|NCT02891226|516211763|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
143181609|NCT02891226|516211764|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
143181610|NCT02891226|516211765|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
143181611|NCT02891226|516211766|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
143181612|NCT02891226|516211767|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
143181613|NCT02891226|516211768|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
143181614|NCT02891226|516211769|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
143181615|NCT02891226|516211770|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
143181616|NCT02891226|516211771|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
143181617|NCT02891226|516211772|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
143181618|NCT02891226|516211773|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
143181619|NCT02891226|516211774|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
143181620|NCT02891226|516211775|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
143181621|NCT02891226|516211760|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
143181622|NCT02891226|516211761|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
143181623|NCT02891226|516211762|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
143181624|NCT02891226|516211763|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
143181625|NCT02891226|516211764|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
143181626|NCT02891226|516211765|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
143181627|NCT02891226|516211766|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
143181628|NCT02891226|516211767|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
143181629|NCT02891226|516211768|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
143181630|NCT02891226|516211769|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
143181631|NCT02891226|516211770|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
143181632|NCT02891226|516211771|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
143181633|NCT02891226|516211772|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
143259817|NCT03576274|516505883|FG001|Overall Study|Lost to Follow-up|2|||
143259818|NCT03576274|516505884|FG002|Overall Study|Lost to Follow-up|3|||
143259819|NCT03576274|516505885|FG003|Overall Study|Lost to Follow-up|1|||
143259820|NCT03576274|516505886|FG004|Overall Study|Lost to Follow-up|3|||
143259821|NCT03576274|516505882|FG000|Overall Study|Withdrawal by Subject|5|||
143259822|NCT03576274|516505883|FG001|Overall Study|Withdrawal by Subject|3|||
143259823|NCT03576274|516505884|FG002|Overall Study|Withdrawal by Subject|2|||
143259824|NCT03576274|516505885|FG003|Overall Study|Withdrawal by Subject|8|||
143259825|NCT03576274|516505886|FG004|Overall Study|Withdrawal by Subject|6|||
143259826|NCT00562627|516507142|FG000|Overall Study|Protocol Violation|1|||
143259827|NCT00562627|516507143|FG001|Overall Study|Protocol Violation|1|||
143259828|NCT00562627|516507144|FG002|Overall Study|Protocol Violation|1|||
143259829|NCT03387150|516507148|FG000|Overall Study|Withdrawal by Subject|3|||
143181634|NCT02891226|516211773|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
143181635|NCT02891226|516211774|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
143181636|NCT02891226|516211775|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
143181637|NCT02891226|516211760|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
143181638|NCT02891226|516211761|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
143181639|NCT02891226|516211762|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
143181640|NCT02891226|516211763|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
143181641|NCT02891226|516211764|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
143181642|NCT02891226|516211765|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
143181643|NCT02891226|516211766|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
143181644|NCT02891226|516211767|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
143181645|NCT02891226|516211768|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
143181646|NCT02891226|516211769|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
143181647|NCT02891226|516211770|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
143181648|NCT02891226|516211771|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
143181649|NCT02891226|516211772|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
143181650|NCT02891226|516211773|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
143181651|NCT02891226|516211774|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
143181652|NCT02891226|516211775|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
143181653|NCT02891226|516211760|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
143181654|NCT02891226|516211761|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
143181655|NCT02891226|516211762|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
143181656|NCT02891226|516211763|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
143181657|NCT02891226|516211764|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
143181658|NCT02891226|516211765|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
143181659|NCT02891226|516211766|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
143181660|NCT02891226|516211767|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
143181661|NCT02891226|516211768|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
143181662|NCT02891226|516211769|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
143181663|NCT02891226|516211770|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
143181664|NCT02891226|516211771|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
143181665|NCT02891226|516211772|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
143181666|NCT02891226|516211773|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
143181667|NCT02891226|516211774|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
143181668|NCT02891226|516211775|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
143181669|NCT02891226|516211760|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
143181670|NCT02891226|516211761|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
143181671|NCT02891226|516211762|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
143181672|NCT02891226|516211763|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
143181673|NCT02891226|516211764|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
143181674|NCT02891226|516211765|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
143181675|NCT02891226|516211766|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
143181676|NCT02891226|516211767|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
143181677|NCT02891226|516211768|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
143181678|NCT02891226|516211769|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
143181679|NCT02891226|516211770|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
143181680|NCT02891226|516211771|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
143181681|NCT02891226|516211772|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
143181682|NCT02891226|516211773|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
143181683|NCT02891226|516211774|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
143181684|NCT02891226|516211775|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
143181685|NCT02891226|516211760|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
143181686|NCT02891226|516211761|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
143181687|NCT02891226|516211762|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
143181688|NCT02891226|516211763|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
143181689|NCT02891226|516211764|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
143181690|NCT02891226|516211765|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
143181691|NCT02891226|516211766|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
143181692|NCT02891226|516211767|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
143181693|NCT02891226|516211768|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
143181694|NCT02891226|516211769|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
143181695|NCT02891226|516211770|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
143181696|NCT02891226|516211771|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
143181697|NCT02891226|516211772|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
143181698|NCT02891226|516211773|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
143181699|NCT02891226|516211774|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
143181700|NCT02891226|516211775|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
143181701|NCT02891226|516211760|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
143181702|NCT02891226|516211761|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
143181703|NCT02891226|516211762|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
143181704|NCT02891226|516211763|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
143181705|NCT02891226|516211764|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
143181706|NCT02891226|516211765|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
143181707|NCT02891226|516211766|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
143181708|NCT02891226|516211767|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
143181709|NCT02891226|516211768|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
143181710|NCT02891226|516211769|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
143181711|NCT02891226|516211770|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
143181712|NCT02891226|516211771|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
143181713|NCT02891226|516211772|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
143181714|NCT02891226|516211773|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
143181715|NCT02891226|516211774|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
143181716|NCT02891226|516211775|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
143181717|NCT02891226|516211760|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
143181718|NCT02891226|516211761|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
143181719|NCT02891226|516211762|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
143181720|NCT02891226|516211763|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
143181721|NCT02891226|516211764|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
143181722|NCT02891226|516211765|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
143181723|NCT02891226|516211766|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
143181724|NCT02891226|516211767|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
143181725|NCT02891226|516211768|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
143181726|NCT02891226|516211769|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
143181727|NCT02891226|516211770|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
143181728|NCT02891226|516211771|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
143181729|NCT02891226|516211772|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
143181730|NCT02891226|516211773|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
143181731|NCT02891226|516211774|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
143181732|NCT02891226|516211775|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
143181733|NCT02891226|516211760|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
143181734|NCT02891226|516211761|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
143181735|NCT02891226|516211762|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
143181736|NCT02891226|516211763|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
143181737|NCT02891226|516211764|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
143181738|NCT02891226|516211765|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
143181739|NCT02891226|516211766|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
143181740|NCT02891226|516211767|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
143181741|NCT02891226|516211768|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
143181742|NCT02891226|516211769|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
143181743|NCT02891226|516211770|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
143181744|NCT02891226|516211771|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
143181745|NCT02891226|516211772|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
143115002|NCT02326298|515962467|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
143115003|NCT02326298|515962468|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
143115004|NCT02326298|515962469|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
143115005|NCT02326298|515962470|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
143115006|NCT02326298|515962471|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
143115007|NCT02326298|515962458|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
143115008|NCT02326298|515962459|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
143115009|NCT02326298|515962460|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
143181746|NCT02891226|516211773|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
143181747|NCT02891226|516211774|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
143181748|NCT02891226|516211775|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
143181749|NCT02891226|516211760|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
143181750|NCT02891226|516211761|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
143181751|NCT02891226|516211762|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
143181752|NCT02891226|516211763|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
143181753|NCT02891226|516211764|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
143181754|NCT02891226|516211765|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
143115010|NCT02326298|515962461|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
143259830|NCT03387150|516507149|FG001|Overall Study|Withdrawal by Subject|0|||
143259831|NCT03387150|516507150|FG002|Overall Study|Withdrawal by Subject|3|||
143259832|NCT03387150|516507151|FG003|Overall Study|Withdrawal by Subject|4|||
143259833|NCT03387150|516507152|FG004|Overall Study|Withdrawal by Subject|1|||
143259834|NCT03387150|516507153|FG005|Overall Study|Withdrawal by Subject|2|||
143259835|NCT03387150|516507154|FG006|Overall Study|Withdrawal by Subject|0|||
143259836|NCT03387150|516507148|FG000|Overall Study|Lost to Follow-up|3|||
143259837|NCT03387150|516507149|FG001|Overall Study|Lost to Follow-up|2|||
143259838|NCT03387150|516507150|FG002|Overall Study|Lost to Follow-up|2|||
143259839|NCT03387150|516507151|FG003|Overall Study|Lost to Follow-up|3|||
143259840|NCT03387150|516507152|FG004|Overall Study|Lost to Follow-up|3|||
143259841|NCT03387150|516507153|FG005|Overall Study|Lost to Follow-up|3|||
143259842|NCT03387150|516507154|FG006|Overall Study|Lost to Follow-up|0|||
143259843|NCT03387150|516507148|FG000|Overall Study|Participant unable to adhere to visit|0|||
143259844|NCT03387150|516507149|FG001|Overall Study|Participant unable to adhere to visit|1|||
143259845|NCT03387150|516507150|FG002|Overall Study|Participant unable to adhere to visit|0|||
143259846|NCT03387150|516507151|FG003|Overall Study|Participant unable to adhere to visit|0|||
143259847|NCT03387150|516507152|FG004|Overall Study|Participant unable to adhere to visit|2|||
143259848|NCT03387150|516507153|FG005|Overall Study|Participant unable to adhere to visit|2|||
143259849|NCT03387150|516507154|FG006|Overall Study|Participant unable to adhere to visit|0|||
143259850|NCT03269552|516507155|FG000|Overall Study|Adverse Event|2|||
143259851|NCT02186301|516507156|FG000|Overall Study|Progressive Disease|7|||
143259852|NCT02186301|516507157|FG001|Overall Study|Progressive Disease|22|||
143259853|NCT02186301|516507158|FG002|Overall Study|Progressive Disease|27|||
143259854|NCT02186301|516507156|FG000|Overall Study|Adverse Event|5|||
143259855|NCT02186301|516507157|FG001|Overall Study|Adverse Event|5|||
143259856|NCT02186301|516507158|FG002|Overall Study|Adverse Event|5|||
143259857|NCT02186301|516507156|FG000|Overall Study|Death|1|||
143259858|NCT02186301|516507157|FG001|Overall Study|Death|0|||
143259859|NCT02186301|516507158|FG002|Overall Study|Death|0|||
143259860|NCT02186301|516507156|FG000|Overall Study|Withdrawal by Subject|5|||
143259861|NCT02186301|516507157|FG001|Overall Study|Withdrawal by Subject|1|||
143259862|NCT02186301|516507158|FG002|Overall Study|Withdrawal by Subject|3|||
143259863|NCT02186301|516507156|FG000|Overall Study|Physician Decision|1|||
143259864|NCT02186301|516507157|FG001|Overall Study|Physician Decision|0|||
143259865|NCT02186301|516507158|FG002|Overall Study|Physician Decision|1|||
143259866|NCT02186301|516507156|FG000|Overall Study|Study Terminated by Sponsor|1|||
143259867|NCT02186301|516507157|FG001|Overall Study|Study Terminated by Sponsor|0|||
143259868|NCT02186301|516507158|FG002|Overall Study|Study Terminated by Sponsor|11|||
143259869|NCT02186301|516507156|FG000|Overall Study|Protocol Deviation|0|||
143259870|NCT02186301|516507157|FG001|Overall Study|Protocol Deviation|2|||
143259871|NCT02186301|516507158|FG002|Overall Study|Protocol Deviation|0|||
143259872|NCT02186301|516507156|FG000|Overall Study|Missing|0|||
143259873|NCT02186301|516507157|FG001|Overall Study|Missing|0|||
143259874|NCT02186301|516507158|FG002|Overall Study|Missing|2|||
143259875|NCT02186301|516507156|FG000|Overall Study|Other|0|||
143259876|NCT02186301|516507157|FG001|Overall Study|Other|0|||
143259877|NCT02186301|516507158|FG002|Overall Study|Other|1|||
143259878|NCT03560739|516507160|FG000|Overall Study|Adverse Event|0|||
143259879|NCT03560739|516507161|FG001|Overall Study|Adverse Event|1|||
143259880|NCT03560739|516507162|FG002|Overall Study|Adverse Event|0|||
143259881|NCT03560739|516507163|FG003|Overall Study|Adverse Event|0|||
143259882|NCT03505671|516507167|FG000|Overall Study|Withdrawal by Subject|2|||
143259883|NCT03505671|516507168|FG001|Overall Study|Withdrawal by Subject|1|||
143259884|NCT03505671|516507167|FG000|Overall Study|Lost to Follow-up|1|||
143259885|NCT03505671|516507168|FG001|Overall Study|Lost to Follow-up|0|||
143259886|NCT04393298|516507169|FG000|Overall Study|Adverse Event|0|||
143259887|NCT04393298|516507170|FG001|Overall Study|Adverse Event|0|||
143259888|NCT04393298|516507171|FG002|Overall Study|Adverse Event|0|||
143259889|NCT04393298|516507172|FG003|Overall Study|Adverse Event|0|||
143259890|NCT04393298|516507173|FG004|Overall Study|Adverse Event|1|||
143259891|NCT04393298|516507174|FG005|Overall Study|Adverse Event|0|||
143259892|NCT04393298|516507175|FG006|Overall Study|Adverse Event|0|||
143259893|NCT04393298|516507176|FG007|Overall Study|Adverse Event|0|||
143259894|NCT04393298|516507177|FG008|Overall Study|Adverse Event|2|||
143259895|NCT04393298|516507178|FG009|Overall Study|Adverse Event|0|||
143259896|NCT04393298|516507179|FG010|Overall Study|Adverse Event|0|||
143259897|NCT04393298|516507180|FG011|Overall Study|Adverse Event|0|||
143259898|NCT04393298|516507181|FG012|Overall Study|Adverse Event|1|||
143259899|NCT04393298|516507182|FG013|Overall Study|Adverse Event|1|||
143259900|NCT04393298|516507183|FG014|Overall Study|Adverse Event|0|||
143259901|NCT04393298|516507169|FG000|Overall Study|Consent withdrawn by participant, not due to AE|0|||
143259902|NCT04393298|516507170|FG001|Overall Study|Consent withdrawn by participant, not due to AE|0|||
143259903|NCT04393298|516507171|FG002|Overall Study|Consent withdrawn by participant, not due to AE|1|||
143259904|NCT04393298|516507172|FG003|Overall Study|Consent withdrawn by participant, not due to AE|0|||
143259905|NCT04393298|516507173|FG004|Overall Study|Consent withdrawn by participant, not due to AE|0|||
143259906|NCT04393298|516507174|FG005|Overall Study|Consent withdrawn by participant, not due to AE|0|||
143259907|NCT04393298|516507175|FG006|Overall Study|Consent withdrawn by participant, not due to AE|0|||
143259908|NCT04393298|516507176|FG007|Overall Study|Consent withdrawn by participant, not due to AE|0|||
143259909|NCT04393298|516507177|FG008|Overall Study|Consent withdrawn by participant, not due to AE|0|||
143259910|NCT04393298|516507178|FG009|Overall Study|Consent withdrawn by participant, not due to AE|0|||
143259911|NCT04393298|516507179|FG010|Overall Study|Consent withdrawn by participant, not due to AE|0|||
143259912|NCT04393298|516507180|FG011|Overall Study|Consent withdrawn by participant, not due to AE|0|||
143259913|NCT04393298|516507181|FG012|Overall Study|Consent withdrawn by participant, not due to AE|0|||
143259914|NCT04393298|516507182|FG013|Overall Study|Consent withdrawn by participant, not due to AE|0|||
143259915|NCT04393298|516507183|FG014|Overall Study|Consent withdrawn by participant, not due to AE|3|||
143259916|NCT04393298|516507169|FG000|Overall Study|Lack of Efficacy|0|||
143259917|NCT04393298|516507170|FG001|Overall Study|Lack of Efficacy|0|||
143259918|NCT04393298|516507171|FG002|Overall Study|Lack of Efficacy|0|||
143259919|NCT04393298|516507172|FG003|Overall Study|Lack of Efficacy|0|||
143259920|NCT04393298|516507173|FG004|Overall Study|Lack of Efficacy|0|||
143259921|NCT04393298|516507174|FG005|Overall Study|Lack of Efficacy|0|||
143259922|NCT04393298|516507175|FG006|Overall Study|Lack of Efficacy|0|||
143181755|NCT02891226|516211766|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
143181756|NCT02891226|516211767|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
143181757|NCT02891226|516211768|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
143181758|NCT02891226|516211769|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
143181759|NCT02891226|516211770|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
143181760|NCT02891226|516211771|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
143181761|NCT02891226|516211772|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
143181762|NCT02891226|516211773|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
143181763|NCT02891226|516211774|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
143181764|NCT02891226|516211775|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
143181765|NCT02891226|516211760|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
143181766|NCT02891226|516211761|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
143181767|NCT02891226|516211762|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
143181768|NCT02891226|516211763|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
143181769|NCT02891226|516211764|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
143181770|NCT02891226|516211765|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
143181771|NCT02891226|516211766|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
143181772|NCT02891226|516211767|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
143181773|NCT02891226|516211768|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
143181774|NCT02891226|516211769|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
143181775|NCT02891226|516211770|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
143181776|NCT02891226|516211771|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
143181777|NCT02891226|516211772|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
143181778|NCT02891226|516211773|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
143181779|NCT02891226|516211774|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
143181780|NCT02891226|516211775|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
143181781|NCT02891226|516211760|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
143181782|NCT02891226|516211761|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
143181783|NCT02891226|516211762|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
143181784|NCT02891226|516211763|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
143181785|NCT02891226|516211764|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
143181786|NCT02891226|516211765|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
143181787|NCT02891226|516211766|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
143181788|NCT02891226|516211767|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
143369224|NCT03247543|516894631|FG002|Overall Study|Withdrawal by Subject|1|||
143369225|NCT03247543|516894629|FG000|Overall Study|Failure to Follow study procedures|1|||
143369226|NCT03247543|516894630|FG001|Overall Study|Failure to Follow study procedures|3|||
143369227|NCT03247543|516894631|FG002|Overall Study|Failure to Follow study procedures|1|||
143369228|NCT03247543|516894629|FG000|Overall Study|Lack of Efficacy|1|||
143369229|NCT03247543|516894630|FG001|Overall Study|Lack of Efficacy|0|||
143369230|NCT03247543|516894631|FG002|Overall Study|Lack of Efficacy|0|||
143369231|NCT03247543|516894629|FG000|Overall Study|Non-compliance with study visits|0|||
143369232|NCT03247543|516894630|FG001|Overall Study|Non-compliance with study visits|1|||
143369233|NCT03247543|516894631|FG002|Overall Study|Non-compliance with study visits|0|||
143369234|NCT02059980|516894635|FG000|Overall Study|Lost to Follow-up|2|||
143369235|NCT02059980|516894636|FG001|Overall Study|Lost to Follow-up|1|||
143369236|NCT01104415|516894637|FG000|Core Phase|Consent withdrawn by subjects|1|||
143369237|NCT01104415|516894638|FG001|Core Phase|Consent withdrawn by subjects|0|||
143369238|NCT01104415|516894637|FG000|Extension Period|Progressive disease|0|||
143369239|NCT01104415|516894638|FG001|Extension Period|Progressive disease|4|||
143369240|NCT01104415|516894637|FG000|Extension Period|Death|0|||
143369241|NCT01104415|516894638|FG001|Extension Period|Death|1|||
143369242|NCT01104415|516894637|FG000|Extension Period|Physician Decision|0|||
143369243|NCT01104415|516894638|FG001|Extension Period|Physician Decision|1|||
143369244|NCT01104415|516894637|FG000|Extension Period|Transition to Study LX1606.302|0|||
143369245|NCT01104415|516894638|FG001|Extension Period|Transition to Study LX1606.302|4|||
143369246|NCT01104415|516894637|FG000|Extension Period|Heart surgery/feeling miserable|0|||
143369247|NCT01104415|516894638|FG001|Extension Period|Heart surgery/feeling miserable|1|||
143369248|NCT00988637|516894641|FG000|Overall Study|Lost to Follow-up|2|||
143369249|NCT00988637|516894642|FG001|Overall Study|Lost to Follow-up|1|||
143369250|NCT00988637|516894641|FG000|Overall Study|Withdrawal by Subject|1|||
143181789|NCT02891226|516211768|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
143181790|NCT02891226|516211769|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
143369251|NCT00988637|516894642|FG001|Overall Study|Withdrawal by Subject|1|||
143369252|NCT00988637|516894641|FG000|Overall Study|non-compliance with study drug|0|||
143369253|NCT00988637|516894642|FG001|Overall Study|non-compliance with study drug|1|||
143369254|NCT01582945|516894643|FG000|Overall Study|Intolerable side-effects|1|||
143181791|NCT02891226|516211770|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
143181792|NCT02891226|516211771|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
143181793|NCT02891226|516211772|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
143181794|NCT02891226|516211773|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
143181795|NCT02891226|516211774|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
143181796|NCT02891226|516211775|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
143181797|NCT02891226|516211760|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
143181798|NCT02891226|516211761|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
143181799|NCT02891226|516211762|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
143181800|NCT02891226|516211763|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
143181801|NCT02891226|516211764|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
143181802|NCT02891226|516211765|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
143181803|NCT02891226|516211766|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
143181804|NCT02891226|516211767|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
143181805|NCT02891226|516211768|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
143181806|NCT02891226|516211769|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
143181807|NCT02891226|516211770|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
143181808|NCT02891226|516211771|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
143181809|NCT02891226|516211772|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
143181810|NCT02891226|516211773|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
143181811|NCT02891226|516211774|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
143181812|NCT02891226|516211775|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
143181813|NCT02891226|516211760|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
143181814|NCT02891226|516211761|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
143181815|NCT02891226|516211762|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
143181816|NCT02891226|516211763|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
143181817|NCT02891226|516211764|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
143181818|NCT02891226|516211765|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
143181819|NCT02891226|516211766|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
143181820|NCT02891226|516211767|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
143181821|NCT02891226|516211768|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
143181822|NCT02891226|516211769|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
143181823|NCT02891226|516211770|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
143181824|NCT02891226|516211771|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
143181825|NCT02891226|516211772|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
143181826|NCT02891226|516211773|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
143181827|NCT02891226|516211774|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
143181828|NCT02891226|516211775|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
143181829|NCT02891226|516211760|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
143181830|NCT02891226|516211761|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
143181831|NCT02891226|516211762|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
143181832|NCT02891226|516211763|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
143181833|NCT02891226|516211764|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
143181834|NCT02891226|516211765|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
143181835|NCT02891226|516211766|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
143181836|NCT02891226|516211767|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
143181837|NCT02891226|516211768|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
143181838|NCT02891226|516211769|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
143181839|NCT02891226|516211770|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
143181840|NCT02891226|516211771|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
143181841|NCT02891226|516211772|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
143181842|NCT02891226|516211773|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
143181843|NCT02891226|516211774|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
143181844|NCT02891226|516211775|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
143181845|NCT02891226|516211760|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
143181846|NCT02891226|516211761|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
143181847|NCT02891226|516211762|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
143181848|NCT02891226|516211763|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
143181849|NCT02891226|516211764|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
143181850|NCT02891226|516211765|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
143181851|NCT02891226|516211766|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
143181852|NCT02891226|516211767|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
143181853|NCT02891226|516211768|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
143181854|NCT02891226|516211769|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
143181855|NCT02891226|516211770|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
143181856|NCT02891226|516211771|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
143369255|NCT01582945|516894643|FG000|Overall Study|Scheduling conflicts|1|||
143369256|NCT01726023|516894644|FG000|Overall Study|Death|1|||
143369257|NCT01726023|516894645|FG001|Overall Study|Death|1|||
143369258|NCT01726023|516894644|FG000|Overall Study|Lost to Follow-up|5|||
143369259|NCT01726023|516894645|FG001|Overall Study|Lost to Follow-up|10|||
143181857|NCT02891226|516211772|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
143181858|NCT02891226|516211773|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
143181859|NCT02891226|516211774|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
143181860|NCT02891226|516211775|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
143181861|NCT02891226|516211760|FG000|Follow-up Period|Withdrawal by Subject|0|||
143181862|NCT02891226|516211761|FG001|Follow-up Period|Withdrawal by Subject|0|||
143181863|NCT02891226|516211762|FG002|Follow-up Period|Withdrawal by Subject|0|||
143181864|NCT02891226|516211763|FG003|Follow-up Period|Withdrawal by Subject|0|||
143181865|NCT02891226|516211764|FG004|Follow-up Period|Withdrawal by Subject|0|||
143181866|NCT02891226|516211765|FG005|Follow-up Period|Withdrawal by Subject|0|||
143181867|NCT02891226|516211766|FG006|Follow-up Period|Withdrawal by Subject|0|||
143181868|NCT02891226|516211767|FG007|Follow-up Period|Withdrawal by Subject|0|||
143181869|NCT02891226|516211768|FG008|Follow-up Period|Withdrawal by Subject|0|||
143181870|NCT02891226|516211769|FG009|Follow-up Period|Withdrawal by Subject|0|||
143181871|NCT02891226|516211770|FG010|Follow-up Period|Withdrawal by Subject|0|||
143181872|NCT02891226|516211771|FG011|Follow-up Period|Withdrawal by Subject|1|||
143181873|NCT02891226|516211772|FG012|Follow-up Period|Withdrawal by Subject|0|||
143181874|NCT02891226|516211773|FG013|Follow-up Period|Withdrawal by Subject|0|||
143181875|NCT02891226|516211774|FG014|Follow-up Period|Withdrawal by Subject|1|||
143181876|NCT02891226|516211775|FG015|Follow-up Period|Withdrawal by Subject|1|||
143181877|NCT01445847|516211776|FG000|Overall Study|Protocol Violation|13|||
143181878|NCT01445847|516211777|FG001|Overall Study|Protocol Violation|14|||
143181879|NCT01445847|516211776|FG000|Overall Study|Missed Data|1|||
143181880|NCT01445847|516211777|FG001|Overall Study|Missed Data|0|||
143181881|NCT00145626|516211778|FG000|Overall Study|Did not have NK infusions|2|||
143181882|NCT00145626|516211778|FG000|Overall Study|Turned 2 years old before treatment|1|||
143181883|NCT00145626|516211778|FG000|Overall Study|Death|1|||
143181884|NCT00145626|516211778|FG000|Overall Study|Withdrawal by Subject|1|||
143181885|NCT03381287|516211779|FG000|Overall Study|Withdrawal by Subject|0|||
143181886|NCT03381287|516211780|FG001|Overall Study|Withdrawal by Subject|1|||
143181887|NCT03381287|516211781|FG002|Overall Study|Withdrawal by Subject|0|||
143181888|NCT03381287|516211782|FG003|Overall Study|Withdrawal by Subject|0|||
143181889|NCT03381287|516211779|FG000|Overall Study|Adverse Event|0|||
143181890|NCT03381287|516211780|FG001|Overall Study|Adverse Event|0|||
143181891|NCT03381287|516211781|FG002|Overall Study|Adverse Event|0|||
143181892|NCT03381287|516211782|FG003|Overall Study|Adverse Event|1|||
143181893|NCT03381287|516211779|FG000|Overall Study|Physician Decision|0|||
143181894|NCT03381287|516211780|FG001|Overall Study|Physician Decision|0|||
143181895|NCT03381287|516211781|FG002|Overall Study|Physician Decision|0|||
143181896|NCT03381287|516211782|FG003|Overall Study|Physician Decision|1|||
143181897|NCT04487080|516211785|FG000|Overall Study|Withdrawal by Subject|19|||
143181898|NCT04487080|516211786|FG001|Overall Study|Withdrawal by Subject|18|||
143181899|NCT04487080|516211787|FG002|Overall Study|Withdrawal by Subject|13|||
143181900|NCT04487080|516211785|FG000|Overall Study|Lost to Follow-up|3|||
143181901|NCT04487080|516211786|FG001|Overall Study|Lost to Follow-up|1|||
143181902|NCT04487080|516211787|FG002|Overall Study|Lost to Follow-up|0|||
143181903|NCT04487080|516211785|FG000|Overall Study|Ongoing|313|||
143181904|NCT04487080|516211786|FG001|Overall Study|Ongoing|297|||
143181905|NCT04487080|516211787|FG002|Overall Study|Ongoing|149|||
143369260|NCT01726023|516894644|FG000|Overall Study|Other Eligibility criteria|7|||
143181906|NCT02842086|516211792|FG000|Overall Study|Randomized but Never Treated|6|||
143181907|NCT02842086|516211793|FG001|Overall Study|Randomized but Never Treated|6|||
143181908|NCT02842086|516211792|FG000|Overall Study|Still in Double-Blind Phase|7|||
143181909|NCT02842086|516211793|FG001|Overall Study|Still in Double-Blind Phase|3|||
143181910|NCT02842086|516211792|FG000|Overall Study|Adverse Event|18|||
143181911|NCT02842086|516211793|FG001|Overall Study|Adverse Event|20|||
143259923|NCT04393298|516507176|FG007|Overall Study|Lack of Efficacy|0|||
143259924|NCT04393298|516507177|FG008|Overall Study|Lack of Efficacy|0|||
143259925|NCT04393298|516507178|FG009|Overall Study|Lack of Efficacy|0|||
143259926|NCT04393298|516507179|FG010|Overall Study|Lack of Efficacy|0|||
143259927|NCT04393298|516507180|FG011|Overall Study|Lack of Efficacy|0|||
143181912|NCT02842086|516211792|FG000|Overall Study|Death|3|||
143181913|NCT02842086|516211793|FG001|Overall Study|Death|3|||
143181914|NCT02842086|516211792|FG000|Overall Study|Investigator's Discretion|9|||
143259928|NCT04393298|516507181|FG012|Overall Study|Lack of Efficacy|0|||
143259929|NCT04393298|516507182|FG013|Overall Study|Lack of Efficacy|0|||
143259930|NCT04393298|516507183|FG014|Overall Study|Lack of Efficacy|1|||
143181915|NCT02842086|516211793|FG001|Overall Study|Investigator's Discretion|13|||
143259931|NCT04393298|516507169|FG000|Overall Study|Progression|1|||
143259932|NCT04393298|516507170|FG001|Overall Study|Progression|0|||
143181916|NCT02842086|516211792|FG000|Overall Study|Non-Compliance with Study Drug|9|||
143181917|NCT02842086|516211793|FG001|Overall Study|Non-Compliance with Study Drug|8|||
143181918|NCT02842086|516211792|FG000|Overall Study|Protocol Violation|8|||
143181919|NCT02842086|516211793|FG001|Overall Study|Protocol Violation|4|||
143181920|NCT02842086|516211792|FG000|Overall Study|Withdrew Consent|205|||
143181921|NCT02842086|516211793|FG001|Overall Study|Withdrew Consent|194|||
143369261|NCT01726023|516894645|FG001|Overall Study|Other Eligibility criteria|7|||
143369262|NCT01726023|516894644|FG000|Overall Study|Withdrawal by Subject|16|||
143369263|NCT01726023|516894645|FG001|Overall Study|Withdrawal by Subject|8|||
143369264|NCT04536077|516894649|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
143369265|NCT04536077|516894650|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
143369266|NCT04536077|516894649|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
143369267|NCT04536077|516894650|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
143369268|NCT04550039|516894655|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
143369269|NCT04550039|516894656|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
143369270|NCT04550039|516894655|FG000|Overall Study|patient self-withdrew from study|0|||
143369271|NCT04550039|516894656|FG001|Overall Study|patient self-withdrew from study|1|||
143181922|NCT02842086|516211792|FG000|Overall Study|Lost to Follow-up|274|||
143181923|NCT02842086|516211793|FG001|Overall Study|Lost to Follow-up|236|||
143181924|NCT02842086|516211792|FG000|Overall Study|HIV-1 Infection|5|||
143181925|NCT02842086|516211793|FG001|Overall Study|HIV-1 Infection|6|||
143181926|NCT03451851|516211794|FG000|PCP: Week 0 -16|Adverse Event|1|||
143181927|NCT03451851|516211795|FG001|PCP: Week 0 -16|Adverse Event|0|||
143181928|NCT03451851|516211796|FG002|PCP: Week 0 -16|Adverse Event|0|||
143181929|NCT03451851|516211797|FG003|PCP: Week 0 -16|Adverse Event|0|||
143181930|NCT03451851|516211798|FG004|PCP: Week 0 -16|Adverse Event|0|||
143181931|NCT03451851|516211799|FG005|PCP: Week 0 -16|Adverse Event|0|||
143181932|NCT03451851|516211800|FG006|PCP: Week 0 -16|Adverse Event|1|||
143181933|NCT03451851|516211801|FG007|PCP: Week 0 -16|Adverse Event|0|||
143181934|NCT03451851|516211794|FG000|PCP: Week 0 -16|Withdrawal by Subject|0|||
143181935|NCT03451851|516211795|FG001|PCP: Week 0 -16|Withdrawal by Subject|0|||
143181936|NCT03451851|516211796|FG002|PCP: Week 0 -16|Withdrawal by Subject|1|||
143181937|NCT03451851|516211797|FG003|PCP: Week 0 -16|Withdrawal by Subject|0|||
143181938|NCT03451851|516211798|FG004|PCP: Week 0 -16|Withdrawal by Subject|0|||
143181939|NCT03451851|516211799|FG005|PCP: Week 0 -16|Withdrawal by Subject|0|||
143181940|NCT03451851|516211800|FG006|PCP: Week 0 -16|Withdrawal by Subject|0|||
143181941|NCT03451851|516211801|FG007|PCP: Week 0 -16|Withdrawal by Subject|0|||
143181942|NCT03451851|516211794|FG000|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
143369272|NCT02824432|516894659|FG000|Overall Study|Major Protocol Deviation|1|||
143369273|NCT02824432|516894660|FG001|Overall Study|Major Protocol Deviation|0|||
143369274|NCT00708097|516894661|FG000|Period 1|Protocol Violation|0|||
143369275|NCT00708097|516894662|FG001|Period 1|Protocol Violation|1|||
143369276|NCT00708097|516894663|FG002|Period 1|Protocol Violation|0|||
143369277|NCT00708097|516894664|FG003|Period 1|Protocol Violation|2|||
143369278|NCT00708097|516894665|FG004|Period 1|Protocol Violation|0|||
143369279|NCT00708097|516894661|FG000|Period 1|Other Reason|0|||
143369280|NCT00708097|516894662|FG001|Period 1|Other Reason|0|||
143369281|NCT00708097|516894663|FG002|Period 1|Other Reason|0|||
143369282|NCT00708097|516894664|FG003|Period 1|Other Reason|0|||
143369283|NCT00708097|516894665|FG004|Period 1|Other Reason|1|||
143369284|NCT00708097|516894661|FG000|Period 2|Protocol Violation|0|||
143369285|NCT00708097|516894662|FG001|Period 2|Protocol Violation|1|||
143369286|NCT00708097|516894663|FG002|Period 2|Protocol Violation|1|||
143369287|NCT00708097|516894664|FG003|Period 2|Protocol Violation|1|||
143181943|NCT03451851|516211795|FG001|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
143181944|NCT03451851|516211796|FG002|PCP: Week 0 -16|Withdrawal by Parent/Guardian|2|||
143181945|NCT03451851|516211797|FG003|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
143181946|NCT03451851|516211798|FG004|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
143181947|NCT03451851|516211799|FG005|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
143181948|NCT03451851|516211800|FG006|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
143181949|NCT03451851|516211801|FG007|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
143181950|NCT03451851|516211794|FG000|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
143181951|NCT03451851|516211795|FG001|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
143181952|NCT03451851|516211796|FG002|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
143369288|NCT00708097|516894665|FG004|Period 2|Protocol Violation|0|||
143369289|NCT04257058|516896038|FG000|Overall Study|Lost to Follow-up|31|||
143369290|NCT01144468|516896039|FG000|Overall Study|Lost to Follow-up|4|||
143181953|NCT03451851|516211797|FG003|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
143181954|NCT03451851|516211798|FG004|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|3|||
143181955|NCT03451851|516211799|FG005|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|1|||
143181956|NCT03451851|516211800|FG006|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
143369291|NCT01144468|516896040|FG001|Overall Study|Lost to Follow-up|7|||
143115011|NCT02326298|515962462|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
143115012|NCT02326298|515962463|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
143115013|NCT02326298|515962464|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
143115014|NCT02326298|515962465|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
143115015|NCT02326298|515962466|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
143115016|NCT02326298|515962467|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
143115017|NCT02326298|515962468|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
143115018|NCT02326298|515962469|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
143115019|NCT02326298|515962470|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
143115020|NCT02326298|515962471|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
143115021|NCT02326298|515962458|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
143115022|NCT02326298|515962459|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
143115023|NCT02326298|515962460|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
143115024|NCT02326298|515962461|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
143115025|NCT02326298|515962462|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
143115026|NCT02326298|515962463|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
143115027|NCT02326298|515962464|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
143115028|NCT02326298|515962465|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
143115029|NCT02326298|515962466|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
143115030|NCT02326298|515962467|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
143115031|NCT02326298|515962468|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
143115032|NCT02326298|515962469|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
143115033|NCT02326298|515962470|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
143115034|NCT02326298|515962471|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
143115035|NCT02326298|515962458|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143115036|NCT02326298|515962459|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143115037|NCT02326298|515962460|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143115038|NCT02326298|515962461|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143115039|NCT02326298|515962462|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143115040|NCT02326298|515962463|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143115041|NCT02326298|515962464|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
143115042|NCT02326298|515962465|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
143115043|NCT02326298|515962466|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143115044|NCT02326298|515962467|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143115045|NCT02326298|515962468|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143115046|NCT02326298|515962469|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143115047|NCT02326298|515962470|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143115048|NCT02326298|515962471|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143115049|NCT02326298|515962458|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143115050|NCT02326298|515962459|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143115051|NCT02326298|515962460|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143115052|NCT02326298|515962461|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143115053|NCT02326298|515962462|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143115054|NCT02326298|515962463|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143115055|NCT02326298|515962464|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143115056|NCT02326298|515962465|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
143115057|NCT02326298|515962466|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143115058|NCT02326298|515962467|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143115059|NCT02326298|515962468|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143115060|NCT02326298|515962469|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143115061|NCT02326298|515962470|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143115062|NCT02326298|515962471|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143115063|NCT02326298|515962458|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
143181957|NCT03451851|516211801|FG007|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
143181958|NCT03451851|516211794|FG000|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
143181959|NCT03451851|516211795|FG001|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
143181960|NCT03451851|516211796|FG002|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
143181961|NCT03451851|516211797|FG003|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
143181962|NCT03451851|516211798|FG004|Withdrawal and Retreament: Week 16-52|Other Unspecified|1|||
143181963|NCT03451851|516211799|FG005|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
143181964|NCT03451851|516211800|FG006|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
143181965|NCT03451851|516211801|FG007|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
143181966|NCT03451851|516211794|FG000|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
143181967|NCT03451851|516211795|FG001|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
143181968|NCT03451851|516211796|FG002|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
143181969|NCT03451851|516211797|FG003|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
143181970|NCT03451851|516211798|FG004|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|2|||
143181971|NCT03451851|516211799|FG005|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
143181972|NCT03451851|516211800|FG006|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
143181973|NCT03451851|516211801|FG007|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
143181974|NCT03581292|516211802|FG000|Overall Study|Physician Decision|9|||
143181975|NCT03581292|516211803|FG001|Overall Study|Physician Decision|5|||
143181976|NCT03581292|516211802|FG000|Overall Study|Withdrawal by Subject|3|||
143181977|NCT03581292|516211803|FG001|Overall Study|Withdrawal by Subject|0|||
143181978|NCT03581292|516211802|FG000|Overall Study|Withdrawal before Therapy Start|1|||
143181979|NCT03581292|516211803|FG001|Overall Study|Withdrawal before Therapy Start|0|||
143181980|NCT07214935|516211804|FG000|Overall Study|Adverse Event|1|||
143181981|NCT07214935|516211805|FG001|Overall Study|Adverse Event|1|||
143181982|NCT07214935|516211806|FG002|Overall Study|Adverse Event|1|||
143181983|NCT07214935|516211807|FG003|Overall Study|Adverse Event|0|||
143181984|NCT07214935|516211804|FG000|Overall Study|Lost to Follow-up|0|||
143181985|NCT07214935|516211805|FG001|Overall Study|Lost to Follow-up|1|||
143181986|NCT07214935|516211806|FG002|Overall Study|Lost to Follow-up|0|||
143181987|NCT07214935|516211807|FG003|Overall Study|Lost to Follow-up|0|||
143181988|NCT07214935|516211804|FG000|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|1|||
143181989|NCT07214935|516211805|FG001|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
143181990|NCT07214935|516211806|FG002|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
143181991|NCT07214935|516211807|FG003|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
143181992|NCT07214935|516211804|FG000|Overall Study|Participant discontinued prior to first dosing|0|||
143181993|NCT07214935|516211805|FG001|Overall Study|Participant discontinued prior to first dosing|0|||
143181994|NCT07214935|516211806|FG002|Overall Study|Participant discontinued prior to first dosing|0|||
143181995|NCT07214935|516211807|FG003|Overall Study|Participant discontinued prior to first dosing|1|||
143181996|NCT01650831|516212863|FG000|Overall Study|Screen failure|1|||
143181997|NCT02522429|516212864|FG000|Overall Study|Lost to Follow-up|8|||
143181998|NCT02522429|516212864|FG000|Overall Study|Adverse Event|2|||
143181999|NCT02522429|516212864|FG000|Overall Study|Death|1|||
143182000|NCT02522429|516212864|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
143182001|NCT00600106|516212865|FG000|Overall Study|Withdrawal by Subject|1|||
143182002|NCT00600106|516212866|FG001|Overall Study|Withdrawal by Subject|1|||
143259933|NCT04393298|516507171|FG002|Overall Study|Progression|0|||
143259934|NCT04393298|516507172|FG003|Overall Study|Progression|0|||
143182003|NCT02840253|516212879|FG000|Overall Study|Unsuccessful block|4|||
143182004|NCT00460655|516212884|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
143259935|NCT04393298|516507173|FG004|Overall Study|Progression|0|||
143259936|NCT04393298|516507174|FG005|Overall Study|Progression|0|||
143259937|NCT04393298|516507175|FG006|Overall Study|Progression|0|||
143259938|NCT04393298|516507176|FG007|Overall Study|Progression|0|||
143182005|NCT00460655|516212885|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
143182006|NCT00460655|516212886|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
143182007|NCT00460655|516212887|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
143182008|NCT00460655|516212884|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
143182009|NCT00460655|516212885|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
143182010|NCT00460655|516212886|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
143182011|NCT00460655|516212887|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
143182012|NCT00460655|516212884|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
143182013|NCT00460655|516212885|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
143182014|NCT00460655|516212886|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
143182015|NCT00460655|516212887|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
143182016|NCT00460655|516212884|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
143182017|NCT00460655|516212885|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
143182018|NCT00460655|516212886|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
143182019|NCT00460655|516212887|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
143182020|NCT00460655|516212884|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
143182021|NCT00460655|516212885|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
143182022|NCT00460655|516212886|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
143182023|NCT00460655|516212887|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
143182024|NCT00460655|516212884|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
143182025|NCT00460655|516212885|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
143182026|NCT00460655|516212886|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
143182027|NCT00460655|516212887|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
143182028|NCT02168101|516212888|FG000|Overall Study|Death|2|||
143182029|NCT02168101|516212889|FG001|Overall Study|Death|2|||
143182030|NCT02168101|516212890|FG002|Overall Study|Death|1|||
143182031|NCT05507567|516212891|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
143182032|NCT05507567|516212892|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
143182033|NCT05507567|516212893|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
143182034|NCT05507567|516212891|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
143182035|NCT05507567|516212892|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
143182036|NCT05507567|516212893|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
143182037|NCT05507567|516212891|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
143182038|NCT05507567|516212892|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
143182039|NCT05507567|516212893|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
143182040|NCT05507567|516212891|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
143182041|NCT05507567|516212892|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
143182042|NCT05507567|516212893|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
143182043|NCT01722994|516212896|FG000|Overall Study|Missing data|25|||
143182044|NCT01722994|516212897|FG001|Overall Study|Missing data|17|||
143182045|NCT01194219|516212903|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
143182046|NCT01194219|516212904|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
143182047|NCT01194219|516212905|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
143369292|NCT01144468|516896039|FG000|Overall Study|Adverse Event|3|||
143115064|NCT02326298|515962459|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
143115065|NCT02326298|515962460|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
143117110|NCT02470403|515970027|FG002|Overall Study|Subject/guardian decision|0|||
143259939|NCT04393298|516507177|FG008|Overall Study|Progression|0|||
143259940|NCT04393298|516507178|FG009|Overall Study|Progression|0|||
143115066|NCT02326298|515962461|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
143259941|NCT04393298|516507179|FG010|Overall Study|Progression|1|||
143259942|NCT04393298|516507180|FG011|Overall Study|Progression|1|||
143182048|NCT01194219|516212906|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
143182049|NCT01194219|516212907|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
143182050|NCT01194219|516212908|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
143182051|NCT01194219|516212909|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
143182052|NCT01194219|516212910|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
143182053|NCT01194219|516212911|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
143182054|NCT01194219|516212912|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
143182055|NCT01194219|516212903|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
143182056|NCT01194219|516212904|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
143182057|NCT01194219|516212905|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
143182058|NCT01194219|516212906|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
143182059|NCT01194219|516212907|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
143182060|NCT01194219|516212908|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
143182061|NCT01194219|516212909|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
143182062|NCT01194219|516212910|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
143182063|NCT01194219|516212911|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
143182064|NCT01194219|516212912|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
143182065|NCT01194219|516212903|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
143182066|NCT01194219|516212904|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
143182067|NCT01194219|516212905|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
143182068|NCT01194219|516212906|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
143182069|NCT01194219|516212907|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
143182070|NCT01194219|516212908|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
143182071|NCT01194219|516212909|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
143182072|NCT01194219|516212910|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
143182073|NCT01194219|516212911|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
143182074|NCT01194219|516212912|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
143182075|NCT01194219|516212903|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
143182076|NCT01194219|516212904|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
143182077|NCT01194219|516212905|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
143182078|NCT01194219|516212906|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
143182079|NCT01194219|516212907|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
143182080|NCT01194219|516212908|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
143182081|NCT01194219|516212909|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
143182082|NCT01194219|516212910|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
143182083|NCT01194219|516212911|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
143182084|NCT01194219|516212912|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
143182085|NCT01194219|516212903|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
143182086|NCT01194219|516212904|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
143182087|NCT01194219|516212905|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
143182088|NCT01194219|516212906|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
143182089|NCT01194219|516212907|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
143182090|NCT01194219|516212908|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
143182091|NCT01194219|516212909|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
143182092|NCT01194219|516212910|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
143182093|NCT01194219|516212911|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
143182094|NCT01194219|516212912|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
143182095|NCT01194219|516212903|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
143182096|NCT01194219|516212904|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
143182097|NCT01194219|516212905|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
143182098|NCT01194219|516212906|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
143182099|NCT01194219|516212907|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
143182100|NCT01194219|516212908|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
143182101|NCT01194219|516212909|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
143182102|NCT01194219|516212910|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
143182103|NCT01194219|516212911|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
143259943|NCT04393298|516507181|FG012|Overall Study|Progression|0|||
143259944|NCT04393298|516507182|FG013|Overall Study|Progression|0|||
143259945|NCT04393298|516507183|FG014|Overall Study|Progression|0|||
143259946|NCT04393298|516507169|FG000|Overall Study|Passed Away on The 30 Oct 2020|1|||
143259947|NCT04393298|516507170|FG001|Overall Study|Passed Away on The 30 Oct 2020|0|||
143259948|NCT04393298|516507171|FG002|Overall Study|Passed Away on The 30 Oct 2020|0|||
143259949|NCT04393298|516507172|FG003|Overall Study|Passed Away on The 30 Oct 2020|0|||
143259950|NCT04393298|516507173|FG004|Overall Study|Passed Away on The 30 Oct 2020|0|||
143259951|NCT04393298|516507174|FG005|Overall Study|Passed Away on The 30 Oct 2020|0|||
143259952|NCT04393298|516507175|FG006|Overall Study|Passed Away on The 30 Oct 2020|0|||
143259953|NCT04393298|516507176|FG007|Overall Study|Passed Away on The 30 Oct 2020|0|||
143259954|NCT04393298|516507177|FG008|Overall Study|Passed Away on The 30 Oct 2020|0|||
143259955|NCT04393298|516507178|FG009|Overall Study|Passed Away on The 30 Oct 2020|0|||
143259956|NCT04393298|516507179|FG010|Overall Study|Passed Away on The 30 Oct 2020|0|||
143259957|NCT04393298|516507180|FG011|Overall Study|Passed Away on The 30 Oct 2020|0|||
143259958|NCT04393298|516507181|FG012|Overall Study|Passed Away on The 30 Oct 2020|0|||
143259959|NCT04393298|516507182|FG013|Overall Study|Passed Away on The 30 Oct 2020|0|||
143259960|NCT04393298|516507183|FG014|Overall Study|Passed Away on The 30 Oct 2020|0|||
143259961|NCT04393298|516507169|FG000|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
143259962|NCT04393298|516507170|FG001|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|1|||
143259963|NCT04393298|516507171|FG002|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
143259964|NCT04393298|516507172|FG003|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
143259965|NCT04393298|516507173|FG004|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
143259966|NCT04393298|516507174|FG005|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
143259967|NCT04393298|516507175|FG006|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
143259968|NCT04393298|516507176|FG007|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
143259969|NCT04393298|516507177|FG008|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
143259970|NCT04393298|516507178|FG009|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
143259971|NCT04393298|516507179|FG010|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
143259972|NCT04393298|516507180|FG011|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
143259973|NCT04393298|516507181|FG012|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
143259974|NCT04393298|516507182|FG013|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
143259975|NCT04393298|516507183|FG014|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
143259976|NCT04393298|516507169|FG000|Overall Study|Clinical Progression|0|||
143115067|NCT02326298|515962462|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
143115068|NCT02326298|515962463|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
143115069|NCT02326298|515962464|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
143115070|NCT02326298|515962465|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
143115071|NCT02326298|515962466|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
143115072|NCT02326298|515962467|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
143115073|NCT02326298|515962468|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
143115074|NCT02326298|515962469|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
143115075|NCT02326298|515962470|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
143115076|NCT02326298|515962471|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
143115077|NCT02326298|515962458|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
143115078|NCT02326298|515962459|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
143115079|NCT02326298|515962460|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
143115080|NCT02326298|515962461|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
143115081|NCT02326298|515962462|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
143115082|NCT02326298|515962463|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
143115083|NCT02326298|515962464|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
143115084|NCT02326298|515962465|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
143115085|NCT02326298|515962466|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
143115086|NCT02326298|515962467|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
143115087|NCT02326298|515962468|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
143115088|NCT02326298|515962469|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
143115089|NCT02326298|515962470|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
143115090|NCT02326298|515962471|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
143115091|NCT02326298|515962458|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
143115092|NCT02326298|515962459|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
143115093|NCT02326298|515962460|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
143115094|NCT02326298|515962461|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
143115095|NCT02326298|515962462|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
143115096|NCT02326298|515962463|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
143115097|NCT02326298|515962464|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
143115098|NCT02326298|515962465|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
143115099|NCT02326298|515962466|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
143115100|NCT02326298|515962467|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
143115101|NCT02326298|515962468|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
143115102|NCT02326298|515962469|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
143115103|NCT02326298|515962470|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
143115104|NCT02326298|515962471|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
143259977|NCT04393298|516507170|FG001|Overall Study|Clinical Progression|2|||
143259978|NCT04393298|516507171|FG002|Overall Study|Clinical Progression|0|||
143259979|NCT04393298|516507172|FG003|Overall Study|Clinical Progression|0|||
143259980|NCT04393298|516507173|FG004|Overall Study|Clinical Progression|0|||
143259981|NCT04393298|516507174|FG005|Overall Study|Clinical Progression|0|||
143182104|NCT01194219|516212912|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
143182105|NCT01194219|516212903|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
143182106|NCT01194219|516212904|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
143182107|NCT01194219|516212905|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
143182108|NCT01194219|516212906|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
143182109|NCT01194219|516212907|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
143259982|NCT04393298|516507175|FG006|Overall Study|Clinical Progression|0|||
143259983|NCT04393298|516507176|FG007|Overall Study|Clinical Progression|0|||
143259984|NCT04393298|516507177|FG008|Overall Study|Clinical Progression|0|||
143182110|NCT01194219|516212908|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
143259985|NCT04393298|516507178|FG009|Overall Study|Clinical Progression|0|||
143259986|NCT04393298|516507179|FG010|Overall Study|Clinical Progression|0|||
143259987|NCT04393298|516507180|FG011|Overall Study|Clinical Progression|0|||
143259988|NCT04393298|516507181|FG012|Overall Study|Clinical Progression|0|||
143259989|NCT04393298|516507182|FG013|Overall Study|Clinical Progression|0|||
143259990|NCT04393298|516507183|FG014|Overall Study|Clinical Progression|0|||
143259991|NCT04393298|516507169|FG000|Overall Study|Disease Progression|0|||
143259992|NCT04393298|516507170|FG001|Overall Study|Disease Progression|1|||
143259993|NCT04393298|516507171|FG002|Overall Study|Disease Progression|0|||
143259994|NCT04393298|516507172|FG003|Overall Study|Disease Progression|0|||
143259995|NCT04393298|516507173|FG004|Overall Study|Disease Progression|0|||
143259996|NCT04393298|516507174|FG005|Overall Study|Disease Progression|3|||
143259997|NCT04393298|516507175|FG006|Overall Study|Disease Progression|2|||
143259998|NCT04393298|516507176|FG007|Overall Study|Disease Progression|1|||
143369293|NCT01144468|516896040|FG001|Overall Study|Adverse Event|2|||
143369294|NCT01144468|516896039|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
143369295|NCT01144468|516896040|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
143369296|NCT02960659|516896041|FG000|Overall Study|Withdrawal by Subject|1|||
143369297|NCT02960659|516896042|FG001|Overall Study|Withdrawal by Subject|0|||
143369298|NCT02960659|516896041|FG000|Overall Study|Poor compliance|0|||
143369299|NCT02960659|516896042|FG001|Overall Study|Poor compliance|1|||
143369300|NCT04199728|516896046|FG000|Overall Study|Adverse Event|1|||
143369301|NCT04199728|516896047|FG001|Overall Study|Adverse Event|0|||
143369302|NCT04199728|516896046|FG000|Overall Study|Withdrawal by Subject|8|||
143369303|NCT04199728|516896047|FG001|Overall Study|Withdrawal by Subject|3|||
143369304|NCT04199728|516896046|FG000|Overall Study|Screen fail after consent|0|||
143369305|NCT04199728|516896047|FG001|Overall Study|Screen fail after consent|1|||
143369306|NCT04199728|516896046|FG000|Overall Study|Early withdraw criteria met|0|||
143369307|NCT04199728|516896047|FG001|Overall Study|Early withdraw criteria met|1|||
143369308|NCT04199728|516896046|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
143369309|NCT04199728|516896047|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
143369310|NCT01331824|516896054|FG000|Overall Study|Adverse Event|2|||
143369311|NCT01331824|516896054|FG000|Overall Study|Death|1|||
143369312|NCT01331824|516896054|FG000|Overall Study|Disease Progression|9|||
143369313|NCT01331824|516896054|FG000|Overall Study|Withdrawal by Subject|1|||
143369314|NCT01091454|516896055|FG000|Overall Study|Ineligible|1|||
143369315|NCT03179787|516896059|FG000|Overall Study|Lost to Follow-up|15|||
143369316|NCT03179787|516896059|FG000|Overall Study|Case report failures|2|||
143369317|NCT03179787|516896059|FG000|Overall Study|Treatment not administered|1|||
143369318|NCT00567879|516896064|FG000|Overall Study|Adverse Event|2|||
143369319|NCT00567879|516896065|FG001|Overall Study|Adverse Event|0|||
143369320|NCT00567879|516896066|FG002|Overall Study|Adverse Event|1|||
143369321|NCT00567879|516896067|FG003|Overall Study|Adverse Event|0|||
143369322|NCT00567879|516896068|FG004|Overall Study|Adverse Event|1|||
143369323|NCT00567879|516896069|FG005|Overall Study|Adverse Event|0|||
143369324|NCT00567879|516896064|FG000|Overall Study|Abnormal test procedure(s)|0|||
143115105|NCT02326298|515962458|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143115106|NCT02326298|515962459|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143115107|NCT02326298|515962460|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143115108|NCT02326298|515962461|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143115109|NCT02326298|515962462|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143115110|NCT02326298|515962463|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143115111|NCT02326298|515962464|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143115112|NCT02326298|515962465|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143115113|NCT02326298|515962466|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143115114|NCT02326298|515962467|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143115115|NCT02326298|515962468|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143115116|NCT02326298|515962469|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
143115117|NCT02326298|515962470|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
143115118|NCT02326298|515962471|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143115119|NCT02326298|515962458|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
143115120|NCT02326298|515962459|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
143115121|NCT02326298|515962460|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
143115122|NCT02326298|515962461|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
143115123|NCT02326298|515962462|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
143115124|NCT02326298|515962463|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
143259999|NCT04393298|516507177|FG008|Overall Study|Disease Progression|2|||
143260000|NCT04393298|516507178|FG009|Overall Study|Disease Progression|1|||
143369325|NCT00567879|516896065|FG001|Overall Study|Abnormal test procedure(s)|0|||
143369326|NCT00567879|516896066|FG002|Overall Study|Abnormal test procedure(s)|1|||
143369327|NCT00567879|516896067|FG003|Overall Study|Abnormal test procedure(s)|0|||
143369328|NCT00567879|516896068|FG004|Overall Study|Abnormal test procedure(s)|0|||
143260001|NCT04393298|516507179|FG010|Overall Study|Disease Progression|0|||
143369329|NCT00567879|516896069|FG005|Overall Study|Abnormal test procedure(s)|0|||
143182111|NCT01194219|516212909|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
143182112|NCT01194219|516212910|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
143182113|NCT01194219|516212911|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
143182114|NCT01194219|516212912|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
143182115|NCT01194219|516212903|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
143182116|NCT01194219|516212904|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
143182117|NCT01194219|516212905|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
143182118|NCT01194219|516212906|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
143182119|NCT01194219|516212907|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
143182120|NCT01194219|516212908|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
143182121|NCT01194219|516212909|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
143182122|NCT01194219|516212910|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
143182123|NCT01194219|516212911|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
143182124|NCT01194219|516212912|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
143182125|NCT01194219|516212903|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
143182126|NCT01194219|516212904|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
143182127|NCT01194219|516212905|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
143182128|NCT01194219|516212906|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
143182129|NCT01194219|516212907|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
143182130|NCT01194219|516212908|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
143182131|NCT01194219|516212909|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
143182132|NCT01194219|516212910|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
143182133|NCT01194219|516212911|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
143182134|NCT01194219|516212912|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
143182135|NCT01194219|516212903|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
143182136|NCT01194219|516212904|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
143182137|NCT01194219|516212905|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
143182138|NCT01194219|516212906|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
143182139|NCT01194219|516212907|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
143182140|NCT01194219|516212908|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
143260002|NCT04393298|516507180|FG011|Overall Study|Disease Progression|3|||
143115125|NCT02326298|515962464|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
143115126|NCT02326298|515962465|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
143115127|NCT02326298|515962466|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
143115128|NCT02326298|515962467|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
143115129|NCT02326298|515962468|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
143115130|NCT02326298|515962469|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
143115131|NCT02326298|515962470|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
143115132|NCT02326298|515962471|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
143115133|NCT02326298|515962458|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143115134|NCT02326298|515962459|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143115135|NCT02326298|515962460|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143115136|NCT02326298|515962461|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143115137|NCT02326298|515962462|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143115138|NCT02326298|515962463|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143115139|NCT02326298|515962464|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143115140|NCT02326298|515962465|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143115141|NCT02326298|515962466|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143115142|NCT02326298|515962467|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143115143|NCT02326298|515962468|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143115144|NCT02326298|515962469|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
143115145|NCT02326298|515962470|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
143115146|NCT02326298|515962471|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
143115147|NCT02326298|515962458|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
143115148|NCT02326298|515962459|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
143260003|NCT04393298|516507181|FG012|Overall Study|Disease Progression|0|||
143182141|NCT01194219|516212909|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
143182142|NCT01194219|516212910|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
143182143|NCT01194219|516212911|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
143182144|NCT01194219|516212912|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
143182145|NCT01194219|516212903|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
143182146|NCT01194219|516212904|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
143182147|NCT01194219|516212905|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
143182148|NCT01194219|516212906|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
143182149|NCT01194219|516212907|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
143182150|NCT01194219|516212908|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
143182151|NCT01194219|516212909|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
143182152|NCT01194219|516212910|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
143182153|NCT01194219|516212911|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
143182154|NCT01194219|516212912|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
143182155|NCT01194219|516212903|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
143182156|NCT01194219|516212904|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
143182157|NCT01194219|516212905|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
143182158|NCT01194219|516212906|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
143182159|NCT01194219|516212907|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
143182160|NCT01194219|516212908|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
143182161|NCT01194219|516212909|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
143182162|NCT01194219|516212910|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
143182163|NCT01194219|516212911|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
143182164|NCT01194219|516212912|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
143182165|NCT01194219|516212903|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
143182166|NCT01194219|516212904|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
143182167|NCT01194219|516212905|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
143182168|NCT01194219|516212906|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
143182169|NCT01194219|516212907|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
143182170|NCT01194219|516212908|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
143182171|NCT01194219|516212909|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
143182172|NCT01194219|516212910|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
143182173|NCT01194219|516212911|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
143182174|NCT01194219|516212912|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
143182175|NCT01194219|516212903|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
143182176|NCT01194219|516212904|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
143182177|NCT01194219|516212905|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
143182178|NCT01194219|516212906|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
143182179|NCT01194219|516212907|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
143182180|NCT01194219|516212908|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
143182181|NCT01194219|516212909|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
143182182|NCT01194219|516212910|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
143182183|NCT01194219|516212911|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
143182184|NCT01194219|516212912|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
143182185|NCT01194219|516212903|FG000|Maintenance Phase Weeks16-32|Other|0|||
143182186|NCT01194219|516212904|FG001|Maintenance Phase Weeks16-32|Other|0|||
143182187|NCT01194219|516212905|FG002|Maintenance Phase Weeks16-32|Other|2|||
143182188|NCT01194219|516212906|FG003|Maintenance Phase Weeks16-32|Other|1|||
143182189|NCT01194219|516212907|FG004|Maintenance Phase Weeks16-32|Other|0|||
143260004|NCT04393298|516507182|FG013|Overall Study|Disease Progression|0|||
143260005|NCT04393298|516507183|FG014|Overall Study|Disease Progression|1|||
143260006|NCT04393298|516507169|FG000|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
143260007|NCT04393298|516507170|FG001|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
143260008|NCT04393298|516507171|FG002|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|1|||
143260009|NCT04393298|516507172|FG003|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
143260010|NCT04393298|516507173|FG004|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
143260011|NCT04393298|516507174|FG005|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
143260012|NCT04393298|516507175|FG006|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
143260013|NCT04393298|516507176|FG007|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
143260014|NCT04393298|516507177|FG008|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
143260015|NCT04393298|516507178|FG009|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
143260016|NCT04393298|516507179|FG010|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
143260017|NCT04393298|516507180|FG011|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
143260018|NCT04393298|516507181|FG012|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
143260019|NCT04393298|516507182|FG013|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
143260020|NCT04393298|516507183|FG014|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
143260021|NCT04393298|516507169|FG000|Overall Study|Further Deterioration Noted at Clinic review|0|||
143260022|NCT04393298|516507170|FG001|Overall Study|Further Deterioration Noted at Clinic review|0|||
143260023|NCT04393298|516507171|FG002|Overall Study|Further Deterioration Noted at Clinic review|1|||
143260024|NCT04393298|516507172|FG003|Overall Study|Further Deterioration Noted at Clinic review|0|||
143260025|NCT04393298|516507173|FG004|Overall Study|Further Deterioration Noted at Clinic review|0|||
143260026|NCT04393298|516507174|FG005|Overall Study|Further Deterioration Noted at Clinic review|0|||
143260027|NCT04393298|516507175|FG006|Overall Study|Further Deterioration Noted at Clinic review|0|||
143260028|NCT04393298|516507176|FG007|Overall Study|Further Deterioration Noted at Clinic review|0|||
143260029|NCT04393298|516507177|FG008|Overall Study|Further Deterioration Noted at Clinic review|0|||
143260030|NCT04393298|516507178|FG009|Overall Study|Further Deterioration Noted at Clinic review|0|||
143260031|NCT04393298|516507179|FG010|Overall Study|Further Deterioration Noted at Clinic review|0|||
143260032|NCT04393298|516507180|FG011|Overall Study|Further Deterioration Noted at Clinic review|0|||
143260033|NCT04393298|516507181|FG012|Overall Study|Further Deterioration Noted at Clinic review|0|||
143260034|NCT04393298|516507182|FG013|Overall Study|Further Deterioration Noted at Clinic review|0|||
143260035|NCT04393298|516507183|FG014|Overall Study|Further Deterioration Noted at Clinic review|0|||
143260036|NCT04393298|516507169|FG000|Overall Study|Progressive Disease (PD)|0|||
143260037|NCT04393298|516507170|FG001|Overall Study|Progressive Disease (PD)|0|||
143260038|NCT04393298|516507171|FG002|Overall Study|Progressive Disease (PD)|0|||
143260039|NCT04393298|516507172|FG003|Overall Study|Progressive Disease (PD)|3|||
143260040|NCT04393298|516507173|FG004|Overall Study|Progressive Disease (PD)|0|||
143260041|NCT04393298|516507174|FG005|Overall Study|Progressive Disease (PD)|0|||
143260042|NCT04393298|516507175|FG006|Overall Study|Progressive Disease (PD)|0|||
143260043|NCT04393298|516507176|FG007|Overall Study|Progressive Disease (PD)|0|||
143260044|NCT04393298|516507177|FG008|Overall Study|Progressive Disease (PD)|0|||
143260045|NCT04393298|516507178|FG009|Overall Study|Progressive Disease (PD)|0|||
143260046|NCT04393298|516507179|FG010|Overall Study|Progressive Disease (PD)|0|||
143260047|NCT04393298|516507180|FG011|Overall Study|Progressive Disease (PD)|0|||
143260048|NCT04393298|516507181|FG012|Overall Study|Progressive Disease (PD)|0|||
143182190|NCT01194219|516212908|FG005|Maintenance Phase Weeks16-32|Other|0|||
143182191|NCT01194219|516212909|FG006|Maintenance Phase Weeks16-32|Other|0|||
143182192|NCT01194219|516212910|FG007|Maintenance Phase Weeks16-32|Other|0|||
143182193|NCT01194219|516212911|FG008|Maintenance Phase Weeks16-32|Other|0|||
143182194|NCT01194219|516212912|FG009|Maintenance Phase Weeks16-32|Other|0|||
143182195|NCT01194219|516212903|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
143182196|NCT01194219|516212904|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
143182197|NCT01194219|516212905|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
143182198|NCT01194219|516212906|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
143182199|NCT01194219|516212907|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
143182200|NCT01194219|516212908|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
143182201|NCT01194219|516212909|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
143182202|NCT01194219|516212910|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
143182203|NCT01194219|516212911|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
143182204|NCT01194219|516212912|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
143182205|NCT01194219|516212903|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
143182206|NCT01194219|516212904|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
143182207|NCT01194219|516212905|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
143182208|NCT01194219|516212906|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
143182209|NCT01194219|516212907|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
143182210|NCT01194219|516212908|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
143182211|NCT01194219|516212909|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
143182212|NCT01194219|516212910|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
143182213|NCT01194219|516212911|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
143182214|NCT01194219|516212912|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
143182215|NCT01194219|516212903|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
143182216|NCT01194219|516212904|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
143182217|NCT01194219|516212905|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
143182218|NCT01194219|516212906|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
143182219|NCT01194219|516212907|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
143182220|NCT01194219|516212908|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
143182221|NCT01194219|516212909|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
143182222|NCT01194219|516212910|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
143182223|NCT01194219|516212911|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
143182224|NCT01194219|516212912|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
143182225|NCT01194219|516212903|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
143182226|NCT01194219|516212904|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
143182227|NCT01194219|516212905|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
143182228|NCT01194219|516212906|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
143182229|NCT01194219|516212907|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
143182230|NCT01194219|516212908|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
143182231|NCT01194219|516212909|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
143182232|NCT01194219|516212910|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
143182233|NCT01194219|516212911|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
143182234|NCT01194219|516212912|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
143182235|NCT01194219|516212903|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
143182236|NCT01194219|516212904|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
143182237|NCT01194219|516212905|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
143182238|NCT01194219|516212906|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
143182239|NCT01194219|516212907|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
143182240|NCT01194219|516212908|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
143182241|NCT01194219|516212909|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
143182242|NCT01194219|516212910|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
143182243|NCT01194219|516212911|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
143182244|NCT01194219|516212912|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
143182245|NCT01194219|516212903|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
143182246|NCT01194219|516212904|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
143182247|NCT01194219|516212905|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
143182248|NCT01194219|516212906|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
143182249|NCT01194219|516212907|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
143182250|NCT01194219|516212908|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
143182251|NCT01194219|516212909|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
143182252|NCT01194219|516212910|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
143182253|NCT01194219|516212911|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
143182254|NCT01194219|516212912|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
143182255|NCT01194219|516212903|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
143182256|NCT01194219|516212904|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
143182257|NCT01194219|516212905|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
143182258|NCT01194219|516212906|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
143182259|NCT01194219|516212907|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
143182260|NCT01194219|516212908|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
143182261|NCT01194219|516212909|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
143182262|NCT01194219|516212910|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
143182263|NCT01194219|516212911|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
143182264|NCT01194219|516212912|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
143182265|NCT01194219|516212903|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
143182266|NCT01194219|516212904|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
143182267|NCT01194219|516212905|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
143182268|NCT01194219|516212906|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
143182269|NCT01194219|516212907|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
143182270|NCT01194219|516212908|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
143182271|NCT01194219|516212909|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
143182272|NCT01194219|516212910|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
143182273|NCT01194219|516212911|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
143182274|NCT01194219|516212912|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
143182275|NCT01194219|516212903|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
143182276|NCT01194219|516212904|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
143182277|NCT01194219|516212905|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
143182278|NCT01194219|516212906|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
143182279|NCT01194219|516212907|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
143182280|NCT01194219|516212908|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
143182281|NCT01194219|516212909|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
143182282|NCT01194219|516212910|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
143182283|NCT01194219|516212911|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
143182284|NCT01194219|516212912|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
143182285|NCT01194219|516212903|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
143182286|NCT01194219|516212904|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
143182287|NCT01194219|516212905|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
143182288|NCT01194219|516212906|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
143182289|NCT01194219|516212907|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
143182290|NCT01194219|516212908|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
143182291|NCT01194219|516212909|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
143182292|NCT01194219|516212910|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
143182293|NCT01194219|516212911|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
143182294|NCT01194219|516212912|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
143182295|NCT01194219|516212903|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
143182296|NCT01194219|516212904|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
143182297|NCT01194219|516212905|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
143182298|NCT01194219|516212906|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
143182299|NCT01194219|516212907|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
143182300|NCT01194219|516212908|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
143182301|NCT01194219|516212909|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
143182302|NCT01194219|516212910|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
143182303|NCT01194219|516212911|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
143182304|NCT01194219|516212912|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
143182305|NCT01194219|516212903|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
143182306|NCT01194219|516212904|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
143182307|NCT01194219|516212905|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
143182308|NCT01194219|516212906|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
143182309|NCT01194219|516212907|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
143260049|NCT04393298|516507182|FG013|Overall Study|Progressive Disease (PD)|0|||
143260050|NCT04393298|516507183|FG014|Overall Study|Progressive Disease (PD)|0|||
143260051|NCT04393298|516507169|FG000|Overall Study|Started a New Cancer Treatment|0|||
143260052|NCT04393298|516507170|FG001|Overall Study|Started a New Cancer Treatment|0|||
143260053|NCT04393298|516507171|FG002|Overall Study|Started a New Cancer Treatment|0|||
143260054|NCT04393298|516507172|FG003|Overall Study|Started a New Cancer Treatment|0|||
143260055|NCT04393298|516507173|FG004|Overall Study|Started a New Cancer Treatment|1|||
143260056|NCT04393298|516507174|FG005|Overall Study|Started a New Cancer Treatment|0|||
143260057|NCT04393298|516507175|FG006|Overall Study|Started a New Cancer Treatment|0|||
143260058|NCT04393298|516507176|FG007|Overall Study|Started a New Cancer Treatment|0|||
143260059|NCT04393298|516507177|FG008|Overall Study|Started a New Cancer Treatment|0|||
143260060|NCT04393298|516507178|FG009|Overall Study|Started a New Cancer Treatment|0|||
143260061|NCT04393298|516507179|FG010|Overall Study|Started a New Cancer Treatment|0|||
143260062|NCT04393298|516507180|FG011|Overall Study|Started a New Cancer Treatment|0|||
143260063|NCT04393298|516507181|FG012|Overall Study|Started a New Cancer Treatment|0|||
143260064|NCT04393298|516507182|FG013|Overall Study|Started a New Cancer Treatment|0|||
143260065|NCT04393298|516507183|FG014|Overall Study|Started a New Cancer Treatment|0|||
143260066|NCT04393298|516507169|FG000|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
143369330|NCT00567879|516896064|FG000|Overall Study|Withdrawal by Subject|0|||
143369331|NCT00567879|516896065|FG001|Overall Study|Withdrawal by Subject|0|||
143369332|NCT00567879|516896066|FG002|Overall Study|Withdrawal by Subject|3|||
143182310|NCT01194219|516212908|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
143182311|NCT01194219|516212909|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
143182312|NCT01194219|516212910|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
143182313|NCT01194219|516212911|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
143182314|NCT01194219|516212912|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
143182315|NCT01194219|516212903|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
143182316|NCT01194219|516212904|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
143182317|NCT01194219|516212905|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
143182318|NCT01194219|516212906|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
143182319|NCT01194219|516212907|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
143182320|NCT01194219|516212908|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
143182321|NCT01194219|516212909|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
143182322|NCT01194219|516212910|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
143182323|NCT01194219|516212911|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
143182324|NCT01194219|516212912|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
143182325|NCT01194219|516212903|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
143182326|NCT01194219|516212904|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
143182327|NCT01194219|516212905|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
143182328|NCT01194219|516212906|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
143182329|NCT01194219|516212907|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
143182330|NCT01194219|516212908|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
143182331|NCT01194219|516212909|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
143182332|NCT01194219|516212910|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
143182333|NCT01194219|516212911|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
143182334|NCT01194219|516212912|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
143182335|NCT01194219|516212903|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
143369333|NCT00567879|516896067|FG003|Overall Study|Withdrawal by Subject|1|||
143182336|NCT01194219|516212904|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
143182337|NCT01194219|516212905|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
143182338|NCT01194219|516212906|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
143260067|NCT04393298|516507170|FG001|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
143260068|NCT04393298|516507171|FG002|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
143260069|NCT04393298|516507172|FG003|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
143182339|NCT01194219|516212907|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
143182340|NCT01194219|516212908|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
143182341|NCT01194219|516212909|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
143182342|NCT01194219|516212910|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
143182343|NCT01194219|516212911|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
143182344|NCT01194219|516212912|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
143182345|NCT01672879|516212913|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
143182346|NCT01672879|516212914|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
143182347|NCT01672879|516212915|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
143182348|NCT01672879|516212913|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
143182349|NCT01672879|516212914|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
143182350|NCT01672879|516212915|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
143182351|NCT01672879|516212913|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
143182352|NCT01672879|516212914|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
143182353|NCT01672879|516212915|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
143182354|NCT01672879|516212913|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
143182355|NCT01672879|516212914|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
143182356|NCT01672879|516212915|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
143182357|NCT01672879|516212913|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
143182358|NCT01672879|516212914|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
143182359|NCT01672879|516212915|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
143182360|NCT01672879|516212913|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
143182361|NCT01672879|516212914|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
143182362|NCT01672879|516212915|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
143182363|NCT01672879|516212913|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
143182364|NCT01672879|516212914|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
143182365|NCT01672879|516212915|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
143182366|NCT01672879|516212913|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
143182367|NCT01672879|516212914|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
143182368|NCT01672879|516212915|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
143182369|NCT01672879|516212913|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
143182370|NCT01672879|516212914|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
143182371|NCT01672879|516212915|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
143182372|NCT01672879|516212913|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
143182373|NCT01672879|516212914|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
143182374|NCT01672879|516212915|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
143182375|NCT01672879|516212913|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
143182376|NCT01672879|516212914|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
143182377|NCT01672879|516212915|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
143182378|NCT01672879|516212913|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
143182379|NCT01672879|516212914|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
143182380|NCT01672879|516212915|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
143182381|NCT01672879|516212913|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
143182382|NCT01672879|516212914|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
143182383|NCT01672879|516212915|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
143182384|NCT03951766|516212920|FG000|Treatment Phase|Lost to Follow-up|1|||
143182385|NCT03951766|516212920|FG000|Follow-up Phase|Lost to Follow-up|10|||
143182386|NCT01871545|516212921|FG000|Overall Study|Death|2|||
143182387|NCT01871545|516212922|FG001|Overall Study|Death|0|||
143182388|NCT01871545|516212921|FG000|Overall Study|Lack of Efficacy|11|||
143182389|NCT01871545|516212922|FG001|Overall Study|Lack of Efficacy|2|||
143260070|NCT04393298|516507173|FG004|Overall Study|Sponsor decision- sepsis (treatment delay)|1|||
143182390|NCT01871545|516212921|FG000|Overall Study|Physician Decision|4|||
143182391|NCT01871545|516212922|FG001|Overall Study|Physician Decision|0|||
143182392|NCT01871545|516212921|FG000|Overall Study|Withdrawal by Subject|0|||
143182393|NCT01871545|516212922|FG001|Overall Study|Withdrawal by Subject|1|||
143182394|NCT01523743|516212923|FG000|Period 1|Adverse Event|1|||
143182395|NCT01523743|516212924|FG001|Period 1|Adverse Event|0|||
143182396|NCT01523743|516212923|FG000|Period 1|Withdrawal by Subject|6|||
143182397|NCT01523743|516212924|FG001|Period 1|Withdrawal by Subject|2|||
143182398|NCT01523743|516212923|FG000|Period 1|Lost to Follow-up|1|||
143182399|NCT01523743|516212924|FG001|Period 1|Lost to Follow-up|0|||
143182400|NCT01523743|516212923|FG000|Period 1|Lack of Efficacy|1|||
143182401|NCT01523743|516212924|FG001|Period 1|Lack of Efficacy|0|||
143182402|NCT01523743|516212923|FG000|Period 1|Felt unable to empty bladder|1|||
143182403|NCT01523743|516212924|FG001|Period 1|Felt unable to empty bladder|0|||
143182404|NCT01523743|516212923|FG000|Period 2|Withdrawal by Subject|0|||
143182405|NCT01523743|516212924|FG001|Period 2|Withdrawal by Subject|2|||
143182406|NCT01523743|516212923|FG000|Period 2|Adverse Event|1|||
143182407|NCT01523743|516212924|FG001|Period 2|Adverse Event|0|||
143182408|NCT01071954|516212925|FG000|Overall Study|Noncompliance|4|||
143182409|NCT01071954|516212925|FG000|Overall Study|Adverse Event|1|||
143182410|NCT01071954|516212925|FG000|Overall Study|Withdrawal by Subject|11|||
143182411|NCT01071954|516212925|FG000|Overall Study|Requirement for Alternative Therapy|5|||
143182412|NCT01071954|516212925|FG000|Overall Study|Administrative Decision|5|||
143182413|NCT01071954|516212925|FG000|Overall Study|Protocol Specified Criteria|1|||
143182414|NCT01152788|516212927|FG000|Overall Study|Withdrawal by Subject|0|||
143182415|NCT01152788|516212928|FG001|Overall Study|Withdrawal by Subject|3|||
143182416|NCT01152788|516212927|FG000|Overall Study|No treatment|0|||
143182417|NCT01152788|516212928|FG001|Overall Study|No treatment|1|||
143182418|NCT01282866|516212930|FG000|Overall Study|Adverse Event|1|||
143182419|NCT03782064|516212931|FG000|Overall Study|Lack of Efficacy|2|||
143182420|NCT03782064|516212931|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
143182421|NCT00049257|516212932|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
143182422|NCT00049257|516212932|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
143182423|NCT00049257|516212932|FG000|Carboplatin, Paclitaxel|Death|2|||
143182424|NCT00049257|516212932|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
143182425|NCT04721158|516212933|FG000|Overall Study|Lost to Follow-up|4|||
143182426|NCT04721158|516212933|FG000|Overall Study|Device did not connect|1|||
143182427|NCT01890265|516212937|FG000|Overall Study|Other (Unspecified reason)|0|||
143182428|NCT01890265|516212938|FG001|Overall Study|Other (Unspecified reason)|1|||
143182429|NCT01890265|516212939|FG002|Overall Study|Other (Unspecified reason)|0|||
143182430|NCT01890265|516212940|FG003|Overall Study|Other (Unspecified reason)|0|||
143182431|NCT01890265|516212941|FG004|Overall Study|Other (Unspecified reason)|0|||
143182432|NCT01890265|516212942|FG005|Overall Study|Other (Unspecified reason)|0|||
143182433|NCT01890265|516212937|FG000|Overall Study|Progressive disease|6|||
143182434|NCT01890265|516212938|FG001|Overall Study|Progressive disease|6|||
143182435|NCT01890265|516212939|FG002|Overall Study|Progressive disease|0|||
143182436|NCT01890265|516212940|FG003|Overall Study|Progressive disease|0|||
143182437|NCT01890265|516212941|FG004|Overall Study|Progressive disease|0|||
143182438|NCT01890265|516212942|FG005|Overall Study|Progressive disease|0|||
143182439|NCT01890265|516212937|FG000|Overall Study|Adverse Event|2|||
143182440|NCT01890265|516212938|FG001|Overall Study|Adverse Event|1|||
143182441|NCT01890265|516212939|FG002|Overall Study|Adverse Event|0|||
143182442|NCT01890265|516212940|FG003|Overall Study|Adverse Event|0|||
143182443|NCT01890265|516212941|FG004|Overall Study|Adverse Event|0|||
143182444|NCT01890265|516212942|FG005|Overall Study|Adverse Event|0|||
143182445|NCT01890265|516212937|FG000|Overall Study|Death|2|||
143182446|NCT01890265|516212938|FG001|Overall Study|Death|3|||
143182447|NCT01890265|516212939|FG002|Overall Study|Death|1|||
143182448|NCT01890265|516212940|FG003|Overall Study|Death|0|||
143182449|NCT01890265|516212941|FG004|Overall Study|Death|0|||
143182450|NCT01890265|516212942|FG005|Overall Study|Death|0|||
143182451|NCT01890265|516212937|FG000|Overall Study|Withdrawal by Subject|0|||
143182452|NCT01890265|516212938|FG001|Overall Study|Withdrawal by Subject|2|||
143182453|NCT01890265|516212939|FG002|Overall Study|Withdrawal by Subject|3|||
143182454|NCT01890265|516212940|FG003|Overall Study|Withdrawal by Subject|0|||
143182455|NCT01890265|516212941|FG004|Overall Study|Withdrawal by Subject|2|||
143182456|NCT01890265|516212942|FG005|Overall Study|Withdrawal by Subject|0|||
143182457|NCT03666988|516212945|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
143182458|NCT03666988|516212946|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
143182459|NCT03666988|516212947|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
143182460|NCT03666988|516212948|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
143182461|NCT03666988|516212949|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
143182462|NCT03666988|516212950|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
143182463|NCT03666988|516212945|FG000|Part 1 (Up to 28 Months)|Other|0|||
143182464|NCT03666988|516212946|FG001|Part 1 (Up to 28 Months)|Other|1|||
143182465|NCT03666988|516212947|FG002|Part 1 (Up to 28 Months)|Other|1|||
143182466|NCT03666988|516212948|FG003|Part 1 (Up to 28 Months)|Other|0|||
143182467|NCT03666988|516212949|FG004|Part 1 (Up to 28 Months)|Other|0|||
143182468|NCT03666988|516212950|FG005|Part 1 (Up to 28 Months)|Other|0|||
143182469|NCT03666988|516212945|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
143182470|NCT03666988|516212946|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
143182471|NCT03666988|516212947|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
143182472|NCT03666988|516212948|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
143182473|NCT03666988|516212949|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
143182474|NCT03666988|516212950|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
143182475|NCT03666988|516212945|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
143182476|NCT03666988|516212946|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
143182477|NCT03666988|516212947|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
143182478|NCT03666988|516212948|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
143182479|NCT03666988|516212949|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
143182480|NCT03666988|516212950|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
143182481|NCT03666988|516212945|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
143182482|NCT03666988|516212946|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
143182483|NCT03666988|516212947|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
143182484|NCT03666988|516212948|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
143182485|NCT03666988|516212949|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
143182486|NCT03666988|516212950|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
143182487|NCT05588440|516212951|FG000|Overall Study|Sponsor Decision|2|||
143182488|NCT05588440|516212952|FG001|Overall Study|Sponsor Decision|0|||
143182489|NCT05588440|516212953|FG002|Overall Study|Sponsor Decision|1|||
143182490|NCT05588440|516212951|FG000|Overall Study|Death|1|||
143182491|NCT05588440|516212952|FG001|Overall Study|Death|1|||
143182492|NCT05588440|516212953|FG002|Overall Study|Death|1|||
143182493|NCT05588440|516212951|FG000|Overall Study|Screen Fail|0|||
143182494|NCT05588440|516212952|FG001|Overall Study|Screen Fail|1|||
143182495|NCT05588440|516212953|FG002|Overall Study|Screen Fail|1|||
143182496|NCT05588440|516212951|FG000|Overall Study|Withdrawal by Subject|0|||
143182497|NCT05588440|516212952|FG001|Overall Study|Withdrawal by Subject|0|||
143182498|NCT05588440|516212953|FG002|Overall Study|Withdrawal by Subject|1|||
143182499|NCT03929913|516212954|FG000|Overall Study|Death|4|||
143182500|NCT03929913|516212954|FG000|Overall Study|Lost to Follow-up|1|||
143182501|NCT03929913|516212954|FG000|Overall Study|Failed Procedure|2|||
143182502|NCT01402869|516212955|FG000|Overall Study|Required Tooth Extraction|0|||
143182503|NCT01402869|516212956|FG001|Overall Study|Required Tooth Extraction|0|||
143182504|NCT01402869|516212957|FG002|Overall Study|Required Tooth Extraction|1|||
143182505|NCT01392573|516212960|FG000|Overall Study|Adverse Event|1|||
143182506|NCT01392573|516212961|FG001|Overall Study|Adverse Event|3|||
143182507|NCT01392573|516212960|FG000|Overall Study|Lack of Efficacy|1|||
143182508|NCT01392573|516212961|FG001|Overall Study|Lack of Efficacy|2|||
143182509|NCT01392573|516212960|FG000|Overall Study|Protocol Violation|0|||
143182510|NCT01392573|516212961|FG001|Overall Study|Protocol Violation|2|||
143182511|NCT01392573|516212960|FG000|Overall Study|Withdrawal Criteria|13|||
143182512|NCT01392573|516212961|FG001|Overall Study|Withdrawal Criteria|15|||
143182513|NCT01392573|516212960|FG000|Overall Study|Site closure|8|||
143182514|NCT01392573|516212961|FG001|Overall Study|Site closure|7|||
143182515|NCT01392573|516212960|FG000|Overall Study|Unclassified|9|||
143182516|NCT01392573|516212961|FG001|Overall Study|Unclassified|6|||
143182517|NCT00100802|516212962|FG000|Overall Study|Adverse Event|9|||
143182518|NCT00100802|516212962|FG000|Overall Study|Death|1|||
143182519|NCT00100802|516212962|FG000|Overall Study|Lack of Efficacy|47|||
143182520|NCT00100802|516212962|FG000|Overall Study|Physician Decision|5|||
143182521|NCT00100802|516212962|FG000|Overall Study|Protocol Violation|1|||
143182522|NCT00100802|516212962|FG000|Overall Study|Withdrawal by Subject|5|||
143182523|NCT00100802|516212962|FG000|Overall Study|Ineligible|12|||
143182524|NCT00436436|516212963|FG000|Overall Study|Progression|4|||
143182525|NCT00436436|516212963|FG000|Overall Study|Adverse Event|2|||
143182526|NCT00436436|516212963|FG000|Overall Study|Death|6|||
143369334|NCT00567879|516896068|FG004|Overall Study|Withdrawal by Subject|0|||
143369335|NCT00567879|516896069|FG005|Overall Study|Withdrawal by Subject|0|||
143369336|NCT00567879|516896064|FG000|Overall Study|New cancer therapy|0|||
143369337|NCT00567879|516896065|FG001|Overall Study|New cancer therapy|0|||
143369338|NCT00567879|516896066|FG002|Overall Study|New cancer therapy|1|||
143369339|NCT00567879|516896067|FG003|Overall Study|New cancer therapy|0|||
143369340|NCT00567879|516896068|FG004|Overall Study|New cancer therapy|0|||
143369341|NCT00567879|516896069|FG005|Overall Study|New cancer therapy|0|||
143182527|NCT02454530|516212964|FG000|Overall Study|Other|8|||
143182528|NCT02454530|516212965|FG001|Overall Study|Other|13|||
143182529|NCT02454530|516212964|FG000|Overall Study|Missing information|56|||
143182530|NCT02454530|516212965|FG001|Overall Study|Missing information|69|||
143182531|NCT02454530|516212964|FG000|Overall Study|Death|2|||
143182532|NCT02454530|516212965|FG001|Overall Study|Death|41|||
143369342|NCT00567879|516896064|FG000|Overall Study|Disease progression|5|||
143369343|NCT00567879|516896065|FG001|Overall Study|Disease progression|7|||
143369344|NCT00567879|516896066|FG002|Overall Study|Disease progression|15|||
143182533|NCT02454530|516212964|FG000|Overall Study|Lost to Follow-up|4|||
143182534|NCT02454530|516212965|FG001|Overall Study|Lost to Follow-up|4|||
143182535|NCT00200967|516212972|FG000|First Treatment Period|Withdrawal by Subject|5|||
143182536|NCT00200967|516212973|FG001|First Treatment Period|Withdrawal by Subject|1|||
143182537|NCT00200967|516212972|FG000|First Treatment Period|Pregnancy|1|||
143182538|NCT00200967|516212973|FG001|First Treatment Period|Pregnancy|0|||
143182539|NCT00200967|516212972|FG000|Wash-out Period|Lost to Follow-up|0|||
143182540|NCT00200967|516212973|FG001|Wash-out Period|Lost to Follow-up|1|||
143182541|NCT00200967|516212972|FG000|Second Treatment Period|Withdrawal by Subject|1|||
143182542|NCT00200967|516212973|FG001|Second Treatment Period|Withdrawal by Subject|2|||
143182543|NCT00200967|516212972|FG000|Run-out Period|Lost to Follow-up|1|||
143182544|NCT00200967|516212973|FG001|Run-out Period|Lost to Follow-up|0|||
143182545|NCT00928187|516212977|FG000|Overall Study|Death|1|||
143182546|NCT00928187|516212978|FG001|Overall Study|Death|2|||
143182547|NCT00928187|516212979|FG002|Overall Study|Death|3|||
143182548|NCT00928187|516212977|FG000|Overall Study|Lost to Follow-up|1|||
143182549|NCT00928187|516212978|FG001|Overall Study|Lost to Follow-up|2|||
143182550|NCT00928187|516212979|FG002|Overall Study|Lost to Follow-up|1|||
143182551|NCT00928187|516212977|FG000|Overall Study|Withdrawal by Subject|0|||
143182552|NCT00928187|516212978|FG001|Overall Study|Withdrawal by Subject|1|||
143182553|NCT00928187|516212979|FG002|Overall Study|Withdrawal by Subject|1|||
143182554|NCT00928187|516212977|FG000|Overall Study|Protocol Violation|0|||
143182555|NCT00928187|516212978|FG001|Overall Study|Protocol Violation|1|||
143182556|NCT00928187|516212979|FG002|Overall Study|Protocol Violation|0|||
143182557|NCT02524145|516212983|FG000|Overall Study|Withdrawal by Subject|2|||
143182558|NCT02524145|516212984|FG001|Overall Study|Withdrawal by Subject|2|||
143182559|NCT02524145|516212985|FG002|Overall Study|Withdrawal by Subject|3|||
143182560|NCT01127607|516214777|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
143182561|NCT01127607|516214778|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
143182562|NCT01127607|516214777|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
143182563|NCT01127607|516214778|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
143182564|NCT03640325|516214779|FG000|Overall Study|Withdrawal by Subject|4|||
143182565|NCT03640325|516214780|FG001|Overall Study|Withdrawal by Subject|1|||
143182566|NCT03640325|516214781|FG002|Overall Study|Withdrawal by Subject|0|||
143182567|NCT03640325|516214779|FG000|Overall Study|Lost to Follow-up|4|||
143182568|NCT03640325|516214780|FG001|Overall Study|Lost to Follow-up|5|||
143182569|NCT03640325|516214781|FG002|Overall Study|Lost to Follow-up|21|||
143182570|NCT03640325|516214779|FG000|Overall Study|Death|5|||
143182571|NCT03640325|516214780|FG001|Overall Study|Death|5|||
143182572|NCT03640325|516214781|FG002|Overall Study|Death|0|||
143182573|NCT03493451|516214782|FG000|Overall Study|Death|11|||
143182574|NCT03493451|516214783|FG001|Overall Study|Death|26|||
143182575|NCT03493451|516214784|FG002|Overall Study|Death|3|||
143182576|NCT03493451|516214782|FG000|Overall Study|Lost to Follow-up|1|||
143182577|NCT03493451|516214783|FG001|Overall Study|Lost to Follow-up|4|||
143182578|NCT03493451|516214784|FG002|Overall Study|Lost to Follow-up|1|||
143182579|NCT03493451|516214782|FG000|Overall Study|Withdrawal by Subject|1|||
143182580|NCT03493451|516214783|FG001|Overall Study|Withdrawal by Subject|1|||
143182581|NCT03493451|516214784|FG002|Overall Study|Withdrawal by Subject|2|||
143182582|NCT03493451|516214782|FG000|Overall Study|Progressive Disease|1|||
143182583|NCT03493451|516214783|FG001|Overall Study|Progressive Disease|0|||
143182584|NCT03493451|516214784|FG002|Overall Study|Progressive Disease|0|||
143182585|NCT03493451|516214782|FG000|Overall Study|Transferred to long term extension study|8|||
143182586|NCT03493451|516214783|FG001|Overall Study|Transferred to long term extension study|13|||
143182587|NCT03493451|516214784|FG002|Overall Study|Transferred to long term extension study|5|||
143182588|NCT01133756|516214788|FG000|Overall Study|Adverse Event|1|||
143182589|NCT01133756|516214789|FG001|Overall Study|Adverse Event|2|||
143182590|NCT01133756|516214790|FG002|Overall Study|Adverse Event|1|||
143182591|NCT01133756|516214788|FG000|Overall Study|Investigator Decision|1|||
143182592|NCT01133756|516214789|FG001|Overall Study|Investigator Decision|0|||
143182593|NCT01133756|516214790|FG002|Overall Study|Investigator Decision|0|||
143182594|NCT01133756|516214788|FG000|Overall Study|Withdrawal by Subject|0|||
143182595|NCT01133756|516214789|FG001|Overall Study|Withdrawal by Subject|1|||
143182596|NCT01133756|516214790|FG002|Overall Study|Withdrawal by Subject|0|||
143182597|NCT01133756|516214788|FG000|Overall Study|Progression of Disease|0|||
143182598|NCT01133756|516214789|FG001|Overall Study|Progression of Disease|0|||
143182599|NCT01133756|516214790|FG002|Overall Study|Progression of Disease|1|||
143182600|NCT01566149|516214791|FG000|Overall Study|Adverse Event|0|||
143182601|NCT01566149|516214792|FG001|Overall Study|Adverse Event|1|||
143182602|NCT01566149|516214791|FG000|Overall Study|Non-compliance with study medication|2|||
143182603|NCT01566149|516214792|FG001|Overall Study|Non-compliance with study medication|0|||
143182604|NCT01566149|516214791|FG000|Overall Study|Protocol Violation|0|||
143182605|NCT01566149|516214792|FG001|Overall Study|Protocol Violation|1|||
143182606|NCT01566149|516214791|FG000|Overall Study|Withdrawal by Subject|1|||
143182607|NCT01566149|516214792|FG001|Overall Study|Withdrawal by Subject|0|||
143182608|NCT01693250|516214806|FG000|Overall Study|Lost to Follow-up|2|||
143182609|NCT01693250|516214807|FG001|Overall Study|Lost to Follow-up|2|||
143182610|NCT02297815|516214813|FG000|Overall Study|Lost to Follow-up|236|||
143182611|NCT02297815|516214814|FG001|Overall Study|Lost to Follow-up|140|||
143182612|NCT00620373|516214815|FG000|Overall Study|Unverified cancer status|33|||
143182613|NCT01897727|516214816|FG000|Overall Study|Exclusion: central sleep apnea|0|||
143182614|NCT01897727|516214817|FG001|Overall Study|Exclusion: central sleep apnea|1|||
143182615|NCT02013778|516214823|FG000|Overall Study|Death|4|||
143182616|NCT02013778|516214823|FG000|Overall Study|Withdrawal by Subject|1|||
143182617|NCT02013778|516214823|FG000|Overall Study|Physician Decision|1|||
143182618|NCT02013778|516214823|FG000|Overall Study|Adverse Event|1|||
143182619|NCT00293813|516214824|FG000|Overall Study|Physician Decision|0|||
143182620|NCT00293813|516214825|FG001|Overall Study|Physician Decision|1|||
143182621|NCT00293813|516214826|FG002|Overall Study|Physician Decision|0|||
143182622|NCT00293813|516214824|FG000|Overall Study|Adverse Event|3|||
143182623|NCT00293813|516214825|FG001|Overall Study|Adverse Event|1|||
143182624|NCT00293813|516214826|FG002|Overall Study|Adverse Event|1|||
143182625|NCT00293813|516214824|FG000|Overall Study|Withdrawal by Subject|7|||
143182626|NCT00293813|516214825|FG001|Overall Study|Withdrawal by Subject|4|||
143182627|NCT00293813|516214826|FG002|Overall Study|Withdrawal by Subject|4|||
143182628|NCT00293813|516214824|FG000|Overall Study|Lost to Follow-up|3|||
143182629|NCT00293813|516214825|FG001|Overall Study|Lost to Follow-up|2|||
143182630|NCT00293813|516214826|FG002|Overall Study|Lost to Follow-up|3|||
143182631|NCT00293813|516214824|FG000|Overall Study|Noncompliance|0|||
143182632|NCT00293813|516214825|FG001|Overall Study|Noncompliance|1|||
143182633|NCT00293813|516214826|FG002|Overall Study|Noncompliance|0|||
143182634|NCT02197572|516214827|FG000|Overall Study|Progressive Disease|28|||
143182635|NCT02197572|516214827|FG000|Overall Study|Withdrawal by Subject|9|||
143182636|NCT02197572|516214827|FG000|Overall Study|Adverse Event|3|||
143182637|NCT02197572|516214827|FG000|Overall Study|Reason Not Specified|4|||
143182638|NCT01465386|516214829|FG000|Overall Study|Lack of Efficacy|3|||
143182639|NCT01465386|516214829|FG000|Overall Study|Adverse Event|1|||
143182640|NCT01279044|516214830|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
143182641|NCT01279044|516214831|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
143182642|NCT01279044|516214832|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
143182643|NCT01279044|516214830|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
143182644|NCT01279044|516214831|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
143182645|NCT01279044|516214832|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
143182646|NCT01279044|516214830|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
143182647|NCT01279044|516214831|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
143182648|NCT01279044|516214832|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
143182649|NCT01408277|516214834|FG000|Overall Study|Adverse Event|3|||
143182650|NCT01408277|516214835|FG001|Overall Study|Adverse Event|4|||
143182651|NCT01408277|516214834|FG000|Overall Study|Lost to Follow-up|1|||
143182652|NCT01408277|516214835|FG001|Overall Study|Lost to Follow-up|0|||
143182653|NCT01408277|516214834|FG000|Overall Study|Withdrawal by Subject|2|||
143260071|NCT04393298|516507174|FG005|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
143260072|NCT04393298|516507175|FG006|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
143182654|NCT01408277|516214835|FG001|Overall Study|Withdrawal by Subject|0|||
143182655|NCT01408277|516214834|FG000|Overall Study|Protocol Violation|2|||
143182656|NCT01408277|516214835|FG001|Overall Study|Protocol Violation|0|||
143182657|NCT03783962|516214836|FG000|Overall Study|Lost to Follow-up|3|||
143182658|NCT03783962|516214837|FG001|Overall Study|Lost to Follow-up|6|||
143182659|NCT03783962|516214836|FG000|Overall Study|Protocol Violation|0|||
143182660|NCT03783962|516214837|FG001|Overall Study|Protocol Violation|1|||
143182661|NCT03458325|516214838|FG000|Overall Study|Withdrawal by Subject|1|||
143182662|NCT03650413|516214839|FG000|Overall Study|Adverse Event|1|||
143182663|NCT03650413|516214839|FG000|Overall Study|Lack of Efficacy|17|||
143182664|NCT03650413|516214839|FG000|Overall Study|Other|9|||
143182665|NCT03650413|516214839|FG000|Overall Study|Physician Decision|2|||
143182666|NCT03650413|516214839|FG000|Overall Study|Study Terminated By Sponsor|16|||
143182667|NCT03650413|516214839|FG000|Overall Study|Withdrawal by Subject|16|||
143182668|NCT01973231|516214840|FG000|Overall Study|Protocol Violation|1|||
143182669|NCT01973231|516214841|FG001|Overall Study|Protocol Violation|1|||
143182670|NCT01973231|516214840|FG000|Overall Study|Lost to Follow-up|1|||
143182671|NCT01973231|516214841|FG001|Overall Study|Lost to Follow-up|1|||
143182672|NCT01973231|516214840|FG000|Overall Study|unclassified|2|||
143182673|NCT01973231|516214841|FG001|Overall Study|unclassified|1|||
143182674|NCT01973231|516214840|FG000|Overall Study|Withdrawal by Subject|7|||
143182675|NCT01973231|516214841|FG001|Overall Study|Withdrawal by Subject|9|||
143182676|NCT01643408|516214842|FG000|Overall Study|Adverse Event|12|||
143182677|NCT01643408|516214842|FG000|Overall Study|Other|2|||
143182678|NCT03726658|516214846|FG000|Overall Study|Lost to Follow-up|0|||
143182679|NCT03726658|516214847|FG001|Overall Study|Lost to Follow-up|0|||
143182680|NCT03726658|516214848|FG002|Overall Study|Lost to Follow-up|2|||
143182681|NCT03726658|516214849|FG003|Overall Study|Lost to Follow-up|0|||
143182682|NCT03726658|516214850|FG004|Overall Study|Lost to Follow-up|0|||
143182683|NCT03726658|516214851|FG005|Overall Study|Lost to Follow-up|1|||
143182684|NCT03726658|516214852|FG006|Overall Study|Lost to Follow-up|1|||
143182685|NCT03726658|516214846|FG000|Overall Study|Withdrawal by Subject|1|||
143182686|NCT03726658|516214847|FG001|Overall Study|Withdrawal by Subject|0|||
143182687|NCT03726658|516214848|FG002|Overall Study|Withdrawal by Subject|0|||
143182688|NCT03726658|516214849|FG003|Overall Study|Withdrawal by Subject|0|||
143182689|NCT03726658|516214850|FG004|Overall Study|Withdrawal by Subject|6|||
143182690|NCT03726658|516214851|FG005|Overall Study|Withdrawal by Subject|4|||
143182691|NCT03726658|516214852|FG006|Overall Study|Withdrawal by Subject|2|||
143182692|NCT03726658|516214846|FG000|Overall Study|Pregnancy|0|||
143115149|NCT02326298|515962460|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
143115150|NCT02326298|515962461|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
143115151|NCT02326298|515962462|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
143115152|NCT02326298|515962463|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
143115153|NCT02326298|515962464|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
143115154|NCT02326298|515962465|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
143115155|NCT02326298|515962466|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
143115156|NCT02326298|515962467|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
143115157|NCT02326298|515962468|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
143115158|NCT02326298|515962469|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
143115159|NCT02326298|515962470|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
143115160|NCT02326298|515962471|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
143115161|NCT02326298|515962458|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143115162|NCT02326298|515962459|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143115163|NCT02326298|515962460|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143115164|NCT02326298|515962461|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143115165|NCT02326298|515962462|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143115166|NCT02326298|515962463|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143115167|NCT02326298|515962464|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143115168|NCT02326298|515962465|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143182693|NCT03726658|516214847|FG001|Overall Study|Pregnancy|0|||
143260073|NCT04393298|516507176|FG007|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
143260074|NCT04393298|516507177|FG008|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
143260075|NCT04393298|516507178|FG009|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
143260076|NCT04393298|516507179|FG010|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
143260077|NCT04393298|516507180|FG011|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
143260078|NCT04393298|516507181|FG012|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
143260079|NCT04393298|516507182|FG013|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
143260080|NCT04393298|516507183|FG014|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
143260081|NCT04393298|516507169|FG000|Overall Study|Due to symptoms (New Brain Metastases)|0|||
143260082|NCT04393298|516507170|FG001|Overall Study|Due to symptoms (New Brain Metastases)|0|||
143260083|NCT04393298|516507171|FG002|Overall Study|Due to symptoms (New Brain Metastases)|0|||
143260084|NCT04393298|516507172|FG003|Overall Study|Due to symptoms (New Brain Metastases)|0|||
143260085|NCT04393298|516507173|FG004|Overall Study|Due to symptoms (New Brain Metastases)|0|||
143260086|NCT04393298|516507174|FG005|Overall Study|Due to symptoms (New Brain Metastases)|1|||
143260087|NCT04393298|516507175|FG006|Overall Study|Due to symptoms (New Brain Metastases)|0|||
143260088|NCT04393298|516507176|FG007|Overall Study|Due to symptoms (New Brain Metastases)|0|||
143260089|NCT04393298|516507177|FG008|Overall Study|Due to symptoms (New Brain Metastases)|0|||
143260090|NCT04393298|516507178|FG009|Overall Study|Due to symptoms (New Brain Metastases)|0|||
143182694|NCT03726658|516214848|FG002|Overall Study|Pregnancy|0|||
143182695|NCT03726658|516214849|FG003|Overall Study|Pregnancy|0|||
143182696|NCT03726658|516214850|FG004|Overall Study|Pregnancy|0|||
143182697|NCT03726658|516214851|FG005|Overall Study|Pregnancy|0|||
143182698|NCT03726658|516214852|FG006|Overall Study|Pregnancy|1|||
143182699|NCT03726658|516214846|FG000|Overall Study|Not Reported|0|||
143182700|NCT03726658|516214847|FG001|Overall Study|Not Reported|0|||
143182701|NCT03726658|516214848|FG002|Overall Study|Not Reported|0|||
143182702|NCT03726658|516214849|FG003|Overall Study|Not Reported|0|||
143182703|NCT03726658|516214850|FG004|Overall Study|Not Reported|0|||
143182704|NCT03726658|516214851|FG005|Overall Study|Not Reported|0|||
143182705|NCT03726658|516214852|FG006|Overall Study|Not Reported|1|||
143182706|NCT00412958|516214853|FG000|Overall Study|Withdrawal by Subject|3|||
143182707|NCT00412958|516214854|FG001|Overall Study|Withdrawal by Subject|0|||
143182708|NCT00412958|516214855|FG002|Overall Study|Withdrawal by Subject|0|||
143182709|NCT00412958|516214856|FG003|Overall Study|Withdrawal by Subject|1|||
143182710|NCT00412958|516214853|FG000|Overall Study|Adverse Event|0|||
143182711|NCT00412958|516214854|FG001|Overall Study|Adverse Event|1|||
143182712|NCT00412958|516214855|FG002|Overall Study|Adverse Event|0|||
143182713|NCT00412958|516214856|FG003|Overall Study|Adverse Event|0|||
143182714|NCT00412958|516214853|FG000|Overall Study|Lost to Follow-up|0|||
143182715|NCT00412958|516214854|FG001|Overall Study|Lost to Follow-up|1|||
143182716|NCT00412958|516214855|FG002|Overall Study|Lost to Follow-up|0|||
143182717|NCT00412958|516214856|FG003|Overall Study|Lost to Follow-up|0|||
143182718|NCT00412958|516214853|FG000|Overall Study|Death|0|||
143182719|NCT00412958|516214854|FG001|Overall Study|Death|1|||
143182720|NCT00412958|516214855|FG002|Overall Study|Death|0|||
143182721|NCT00412958|516214856|FG003|Overall Study|Death|0|||
143182722|NCT00412958|516214853|FG000|Overall Study|Transport issue|0|||
143260091|NCT04393298|516507179|FG010|Overall Study|Due to symptoms (New Brain Metastases)|0|||
143260092|NCT04393298|516507180|FG011|Overall Study|Due to symptoms (New Brain Metastases)|0|||
143260093|NCT04393298|516507181|FG012|Overall Study|Due to symptoms (New Brain Metastases)|0|||
143260094|NCT04393298|516507182|FG013|Overall Study|Due to symptoms (New Brain Metastases)|0|||
143260095|NCT04393298|516507183|FG014|Overall Study|Due to symptoms (New Brain Metastases)|0|||
143260096|NCT04393298|516507169|FG000|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
143260097|NCT04393298|516507170|FG001|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
143260098|NCT04393298|516507171|FG002|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
143260099|NCT04393298|516507172|FG003|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
143260100|NCT04393298|516507173|FG004|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
143260101|NCT04393298|516507174|FG005|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
143260102|NCT04393298|516507175|FG006|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
143260103|NCT04393298|516507176|FG007|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
143182723|NCT00412958|516214854|FG001|Overall Study|Transport issue|1|||
143182724|NCT00412958|516214855|FG002|Overall Study|Transport issue|0|||
143260104|NCT04393298|516507177|FG008|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
143260105|NCT04393298|516507178|FG009|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
143260106|NCT04393298|516507179|FG010|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
143260107|NCT04393298|516507180|FG011|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
143260108|NCT04393298|516507181|FG012|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
143260109|NCT04393298|516507182|FG013|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
143260110|NCT04393298|516507183|FG014|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
143260111|NCT04393298|516507169|FG000|Overall Study|Death|0|||
143260112|NCT04393298|516507170|FG001|Overall Study|Death|0|||
143260113|NCT04393298|516507171|FG002|Overall Study|Death|0|||
143182725|NCT00412958|516214856|FG003|Overall Study|Transport issue|0|||
143182726|NCT01318135|516214857|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
143182727|NCT01318135|516214858|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
143182728|NCT01318135|516214859|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
143182729|NCT01318135|516214860|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
143182730|NCT01318135|516214861|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
143182731|NCT01318135|516214862|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
143182732|NCT01318135|516214863|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
143182733|NCT01318135|516214864|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
143182734|NCT01318135|516214857|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
143182735|NCT01318135|516214858|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
143182736|NCT01318135|516214859|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
143182737|NCT01318135|516214860|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
143182738|NCT01318135|516214861|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
143182739|NCT01318135|516214862|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
143182740|NCT01318135|516214863|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
143182741|NCT01318135|516214864|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
143182742|NCT01318135|516214857|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
143182743|NCT01318135|516214858|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
143182744|NCT01318135|516214859|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
143182745|NCT01318135|516214860|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
143182746|NCT01318135|516214861|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
143182747|NCT01318135|516214862|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
143182748|NCT01318135|516214863|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
143182749|NCT01318135|516214864|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
143182750|NCT01318135|516214857|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
143182751|NCT01318135|516214858|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
143182752|NCT01318135|516214859|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
143182753|NCT01318135|516214860|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
143182754|NCT01318135|516214861|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
143182755|NCT01318135|516214862|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
143182756|NCT01318135|516214863|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
143182757|NCT01318135|516214864|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
143182758|NCT01318135|516214857|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
143182759|NCT01318135|516214858|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
143182760|NCT01318135|516214859|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
143182761|NCT01318135|516214860|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
143182762|NCT01318135|516214861|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
143182763|NCT01318135|516214862|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
143182764|NCT01318135|516214863|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
143182765|NCT01318135|516214864|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
143182766|NCT01318135|516214857|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
143182767|NCT01318135|516214858|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
143182768|NCT01318135|516214859|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
143182769|NCT01318135|516214860|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
143182770|NCT01318135|516214861|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
143182771|NCT01318135|516214862|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
143182772|NCT01318135|516214863|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
143182773|NCT01318135|516214864|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
143182774|NCT01318135|516214857|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
143182775|NCT01318135|516214858|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
143182776|NCT01318135|516214859|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
143182777|NCT01318135|516214860|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
143182778|NCT01318135|516214861|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
143182779|NCT01318135|516214862|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
143182780|NCT01318135|516214863|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
143182781|NCT01318135|516214864|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
143182782|NCT00363142|516214869|FG000|Overall Study|Adverse Event|2|||
143182783|NCT00363142|516214870|FG001|Overall Study|Adverse Event|0|||
143182784|NCT00363142|516214869|FG000|Overall Study|Lack of Efficacy|0|||
143182785|NCT00363142|516214870|FG001|Overall Study|Lack of Efficacy|1|||
143182786|NCT00363142|516214869|FG000|Overall Study|Lost to Follow-up|1|||
143182787|NCT00363142|516214870|FG001|Overall Study|Lost to Follow-up|0|||
143182788|NCT00363142|516214869|FG000|Overall Study|Non-compliance|1|||
143182789|NCT00363142|516214870|FG001|Overall Study|Non-compliance|1|||
143182790|NCT00363142|516214869|FG000|Overall Study|Withdrawal by Subject|3|||
143182791|NCT00363142|516214870|FG001|Overall Study|Withdrawal by Subject|1|||
143182792|NCT00049322|516214874|FG000|Overall Study|disease burden|0|||
143182793|NCT00049322|516214875|FG001|Overall Study|disease burden|3|||
143182794|NCT00049322|516214874|FG000|Overall Study|Adverse Event|1|||
143182795|NCT00049322|516214875|FG001|Overall Study|Adverse Event|0|||
143182796|NCT00049322|516214874|FG000|Overall Study|refused angio|0|||
143182797|NCT00049322|516214875|FG001|Overall Study|refused angio|3|||
143182798|NCT03994211|516214876|FG000|Core Phase|Adverse Event|0|||
143182799|NCT03994211|516214877|FG001|Core Phase|Adverse Event|1|||
143182800|NCT03994211|516214878|FG002|Core Phase|Adverse Event|0|||
143182801|NCT03994211|516214876|FG000|Extension Phase|Adverse Event|0|||
143182802|NCT03994211|516214877|FG001|Extension Phase|Adverse Event|0|||
143182803|NCT03994211|516214878|FG002|Extension Phase|Adverse Event|1|||
143182804|NCT03994211|516214876|FG000|Extension Phase|Physician Decision|0|||
143182805|NCT03994211|516214877|FG001|Extension Phase|Physician Decision|0|||
143182806|NCT03994211|516214878|FG002|Extension Phase|Physician Decision|1|||
143182807|NCT03994211|516214876|FG000|Extension Phase|Progressive Disease|0|||
143182808|NCT03994211|516214877|FG001|Extension Phase|Progressive Disease|0|||
143182809|NCT03994211|516214878|FG002|Extension Phase|Progressive Disease|20|||
143182810|NCT03994211|516214876|FG000|Extension Phase|Withdrawal by Subject|0|||
143182811|NCT03994211|516214877|FG001|Extension Phase|Withdrawal by Subject|0|||
143182812|NCT03994211|516214878|FG002|Extension Phase|Withdrawal by Subject|2|||
143182813|NCT02625220|516214879|FG000|Overall Study|Adverse Event|2|||
143182814|NCT02625220|516214879|FG000|Overall Study|Lost to Follow-up|2|||
143182815|NCT02625220|516214879|FG000|Overall Study|Protocol Violation|1|||
143182816|NCT02625220|516214879|FG000|Overall Study|Study discontinued at site|2|||
143182817|NCT01140867|516214880|FG000|Overall Study|Adverse Event|22|||
143182818|NCT01140867|516214880|FG000|Overall Study|Lack of Efficacy|3|||
143182819|NCT01140867|516214880|FG000|Overall Study|Lost to Follow-up|2|||
143182820|NCT01140867|516214880|FG000|Overall Study|Withdrawal by Subject|1|||
143182821|NCT01140867|516214880|FG000|Overall Study|Protocol Violation|1|||
143182822|NCT01140867|516214880|FG000|Overall Study|Uncooperative patient|2|||
143182823|NCT01140867|516214880|FG000|Overall Study|Medication Noncompliance|2|||
143182824|NCT01926444|516214881|FG000|Overall Study|Colonoscopy not performed|0|||
143182825|NCT01926444|516214882|FG001|Overall Study|Colonoscopy not performed|0|||
143182826|NCT01926444|516214883|FG002|Overall Study|Colonoscopy not performed|4|||
143182827|NCT01926444|516214884|FG003|Overall Study|Colonoscopy not performed|2|||
143182828|NCT01637584|516214887|FG000|Overall Study|Withdrawal by Subject|1|||
143182829|NCT01637584|516214888|FG001|Overall Study|Withdrawal by Subject|3|||
143182830|NCT00995436|516214889|FG000|Overall Study|Withdrawal by Subject|2|||
143182831|NCT00995436|516214890|FG001|Overall Study|Withdrawal by Subject|5|||
143182832|NCT00995436|516214891|FG002|Overall Study|Withdrawal by Subject|0|||
143182833|NCT00132301|516214892|FG000|Overall Study|Death|7|||
143182834|NCT00132301|516214893|FG001|Overall Study|Death|6|||
143182835|NCT00132301|516214892|FG000|Overall Study|Withdrawal by Subject|5|||
143182836|NCT00132301|516214893|FG001|Overall Study|Withdrawal by Subject|2|||
143182837|NCT00132301|516214892|FG000|Overall Study|Physician Decision|1|||
143182838|NCT00132301|516214893|FG001|Overall Study|Physician Decision|1|||
143182839|NCT00132301|516214892|FG000|Overall Study|Lost to Follow-up|5|||
143182840|NCT00132301|516214893|FG001|Overall Study|Lost to Follow-up|3|||
143182841|NCT00132301|516214892|FG000|Overall Study|Other|1|||
143182842|NCT00132301|516214893|FG001|Overall Study|Other|1|||
143182843|NCT00132301|516214892|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
143182844|NCT00132301|516214893|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
143182845|NCT01232127|516214894|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
143182846|NCT01232127|516214895|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
143182847|NCT01232127|516214896|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
143182848|NCT03035864|516214899|FG000|Treatment Period|Adverse Event|1|||
143182849|NCT03035864|516214900|FG001|Treatment Period|Adverse Event|0|||
143182850|NCT03035864|516214899|FG000|Treatment Period|Other|3|||
143182851|NCT03035864|516214900|FG001|Treatment Period|Other|1|||
143182852|NCT03035864|516214899|FG000|Follow-up Period|Adverse Event|1|||
143182853|NCT03035864|516214900|FG001|Follow-up Period|Adverse Event|0|||
143182854|NCT03035864|516214899|FG000|Follow-up Period|Lost to Follow-up|6|||
143182855|NCT03035864|516214900|FG001|Follow-up Period|Lost to Follow-up|2|||
143182856|NCT03035864|516214899|FG000|Follow-up Period|Physician Decision|1|||
143182857|NCT03035864|516214900|FG001|Follow-up Period|Physician Decision|0|||
143182858|NCT03035864|516214899|FG000|Follow-up Period|Other|3|||
143369345|NCT00567879|516896067|FG003|Overall Study|Disease progression|5|||
143182859|NCT03035864|516214900|FG001|Follow-up Period|Other|2|||
143182860|NCT02720523|516214901|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
143182861|NCT02720523|516214902|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
143182862|NCT02720523|516214903|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
143182863|NCT02720523|516214904|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
143182864|NCT02720523|516214905|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
143182865|NCT02720523|516214906|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
143182866|NCT02720523|516214907|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
143182867|NCT02720523|516214901|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
143182868|NCT02720523|516214902|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
143182869|NCT02720523|516214903|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
143182870|NCT02720523|516214904|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
143182871|NCT02720523|516214905|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
143182872|NCT02720523|516214906|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
143182873|NCT02720523|516214907|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
143182874|NCT02720523|516214901|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
143182875|NCT02720523|516214902|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
143182876|NCT02720523|516214903|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
143182877|NCT02720523|516214904|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
143260114|NCT04393298|516507172|FG003|Overall Study|Death|0|||
143260115|NCT04393298|516507173|FG004|Overall Study|Death|0|||
143260116|NCT04393298|516507174|FG005|Overall Study|Death|1|||
143260117|NCT04393298|516507175|FG006|Overall Study|Death|1|||
143260118|NCT04393298|516507176|FG007|Overall Study|Death|0|||
143260119|NCT04393298|516507177|FG008|Overall Study|Death|1|||
143260120|NCT04393298|516507178|FG009|Overall Study|Death|1|||
143260121|NCT04393298|516507179|FG010|Overall Study|Death|0|||
143369346|NCT00567879|516896068|FG004|Overall Study|Disease progression|11|||
143260122|NCT04393298|516507180|FG011|Overall Study|Death|1|||
143260123|NCT04393298|516507181|FG012|Overall Study|Death|1|||
143260124|NCT04393298|516507182|FG013|Overall Study|Death|0|||
143260125|NCT04393298|516507183|FG014|Overall Study|Death|1|||
143182878|NCT02720523|516214905|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
143182879|NCT02720523|516214906|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
143182880|NCT02720523|516214907|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
143182881|NCT02720523|516214901|FG000|Period 1: Placebo-controlled Period|Other|0|||
143182882|NCT02720523|516214902|FG001|Period 1: Placebo-controlled Period|Other|0|||
143182883|NCT02720523|516214903|FG002|Period 1: Placebo-controlled Period|Other|1|||
143182884|NCT02720523|516214904|FG003|Period 1: Placebo-controlled Period|Other|1|||
143182885|NCT02720523|516214905|FG004|Period 1: Placebo-controlled Period|Other|0|||
143182886|NCT02720523|516214906|FG005|Period 1: Placebo-controlled Period|Other|0|||
143182887|NCT02720523|516214907|FG006|Period 1: Placebo-controlled Period|Other|0|||
143182888|NCT02720523|516214901|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
143182889|NCT02720523|516214902|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
143182890|NCT02720523|516214903|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
143182891|NCT02720523|516214904|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
143182892|NCT02720523|516214905|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
143182893|NCT02720523|516214906|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
143182894|NCT02720523|516214907|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
143182895|NCT02720523|516214901|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
143182896|NCT02720523|516214902|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
143182897|NCT02720523|516214903|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
143182898|NCT02720523|516214904|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
143182899|NCT02720523|516214905|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
143182900|NCT02720523|516214906|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
143182901|NCT02720523|516214907|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
143182902|NCT02720523|516214901|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
143182903|NCT02720523|516214902|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
143182904|NCT02720523|516214903|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
143182905|NCT02720523|516214904|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
143182906|NCT02720523|516214905|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
143182907|NCT02720523|516214906|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
143182908|NCT02720523|516214907|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
143182909|NCT02720523|516214901|FG000|Period 2: Long-term Extension Period|Other|0|||
143182910|NCT02720523|516214902|FG001|Period 2: Long-term Extension Period|Other|0|||
143182911|NCT02720523|516214903|FG002|Period 2: Long-term Extension Period|Other|0|||
143182912|NCT02720523|516214904|FG003|Period 2: Long-term Extension Period|Other|0|||
143182913|NCT02720523|516214905|FG004|Period 2: Long-term Extension Period|Other|2|||
143182914|NCT02720523|516214906|FG005|Period 2: Long-term Extension Period|Other|0|||
143260126|NCT04393298|516507169|FG000|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
143260127|NCT04393298|516507170|FG001|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
143260128|NCT04393298|516507171|FG002|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
143260129|NCT04393298|516507172|FG003|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
143260130|NCT04393298|516507173|FG004|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
143260131|NCT04393298|516507174|FG005|Overall Study|Progressive Disease - New Brain Mets on CT Head|1|||
143260132|NCT04393298|516507175|FG006|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
143260133|NCT04393298|516507176|FG007|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
143260134|NCT04393298|516507177|FG008|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
143369347|NCT00567879|516896069|FG005|Overall Study|Disease progression|3|||
143260135|NCT04393298|516507178|FG009|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
143260136|NCT04393298|516507179|FG010|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
143260137|NCT04393298|516507180|FG011|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
143260138|NCT04393298|516507181|FG012|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
143260139|NCT04393298|516507182|FG013|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
143369348|NCT00377455|516896072|FG000|Overall Study|Withdrawal by Subject|1|||
143182915|NCT02720523|516214907|FG006|Period 2: Long-term Extension Period|Other|3|||
143182916|NCT00577707|516214916|FG000|Overall Study|Withdrawal by Subject|3|||
143182917|NCT03299244|516214917|FG000|Overall Study|Withdrawal by Subject|34|||
143182918|NCT03299244|516214918|FG001|Overall Study|Withdrawal by Subject|29|||
143182919|NCT03299244|516214917|FG000|Overall Study|Decision by Sponsor|4|||
143182920|NCT03299244|516214918|FG001|Overall Study|Decision by Sponsor|5|||
143182921|NCT03299244|516214917|FG000|Overall Study|Death|9|||
143182922|NCT03299244|516214918|FG001|Overall Study|Death|4|||
143182923|NCT03146663|516214921|FG000|Overall Study|Did not receive study treatment|1|||
143182924|NCT03146663|516214922|FG001|Overall Study|Did not receive study treatment|1|||
143182925|NCT01154452|516214929|FG000|Phase Ib|Not Treated|1|||
143182926|NCT01154452|516214930|FG001|Phase Ib|Not Treated|0|||
143182927|NCT01154452|516214931|FG002|Phase Ib|Not Treated|0|||
143182928|NCT01154452|516214932|FG003|Phase Ib|Not Treated|0|||
143182929|NCT01154452|516214929|FG000|Phase Ib|Adverse Event|2|||
143182930|NCT01154452|516214930|FG001|Phase Ib|Adverse Event|1|||
143182931|NCT01154452|516214931|FG002|Phase Ib|Adverse Event|0|||
143182932|NCT01154452|516214932|FG003|Phase Ib|Adverse Event|0|||
143182933|NCT01154452|516214929|FG000|Phase II|Withdrawal by Subject|0|||
143182934|NCT01154452|516214930|FG001|Phase II|Withdrawal by Subject|0|||
143182935|NCT01154452|516214931|FG002|Phase II|Withdrawal by Subject|1|||
143182936|NCT01154452|516214932|FG003|Phase II|Withdrawal by Subject|2|||
143182937|NCT01154452|516214929|FG000|Phase II|Adverse Event|0|||
143182938|NCT01154452|516214930|FG001|Phase II|Adverse Event|0|||
143182939|NCT01154452|516214931|FG002|Phase II|Adverse Event|4|||
143182940|NCT01154452|516214932|FG003|Phase II|Adverse Event|4|||
143182941|NCT00130039|516214937|FG000|Overall Study|Withdrawal by Subject|15|||
143182942|NCT00130039|516214938|FG001|Overall Study|Withdrawal by Subject|11|||
143182943|NCT00130039|516214937|FG000|Overall Study|Lost to Follow-up|3|||
143182944|NCT00130039|516214938|FG001|Overall Study|Lost to Follow-up|1|||
143182945|NCT00130039|516214937|FG000|Overall Study|Adverse Event|4|||
143182946|NCT00130039|516214938|FG001|Overall Study|Adverse Event|2|||
143182947|NCT00130039|516214937|FG000|Overall Study|Physician Decision|3|||
143182948|NCT00130039|516214938|FG001|Overall Study|Physician Decision|0|||
143182949|NCT00130039|516214937|FG000|Overall Study|clinical events without follow up MRI|5|||
143182950|NCT00130039|516214938|FG001|Overall Study|clinical events without follow up MRI|4|||
143182951|NCT01016132|516214939|FG000|Overall Study|Discomfort|1|||
143182952|NCT02709720|516214940|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
143182953|NCT02709720|516214940|FG000|Overall Study|Protocol Violation|1|||
143182954|NCT02709720|516214940|FG000|Overall Study|Not take study medication|1|||
143182955|NCT00325130|516214972|FG000|Overall Study|Lost to Follow-up|6|||
143182956|NCT00325130|516214973|FG001|Overall Study|Lost to Follow-up|14|||
143182957|NCT00325130|516214972|FG000|Overall Study|Withdrawal by Subject|12|||
143182958|NCT00325130|516214973|FG001|Overall Study|Withdrawal by Subject|14|||
143182959|NCT00325130|516214972|FG000|Overall Study|Protocol Deviation|0|||
143182960|NCT00325130|516214973|FG001|Overall Study|Protocol Deviation|1|||
143182961|NCT00325130|516214972|FG000|Overall Study|Moved|0|||
143182962|NCT00325130|516214973|FG001|Overall Study|Moved|1|||
143182963|NCT00325130|516214972|FG000|Overall Study|Patient Discontinued for Other|1|||
143182964|NCT00325130|516214973|FG001|Overall Study|Patient Discontinued for Other|0|||
143182965|NCT00316706|516216727|FG000|Overall Study|Lost to Follow-up|38|||
143182966|NCT00316706|516216728|FG001|Overall Study|Lost to Follow-up|48|||
143182967|NCT00283803|516216729|FG000|Overall Study|Physician Decision|9|||
143182968|NCT00283803|516216729|FG000|Overall Study|Withdrawal by Subject|4|||
143182969|NCT03276728|516216734|FG000|Overall Study|Lost to Follow-up|0|||
143182970|NCT03276728|516216735|FG001|Overall Study|Lost to Follow-up|0|||
143182971|NCT03276728|516216736|FG002|Overall Study|Lost to Follow-up|2|||
143182972|NCT03276728|516216737|FG003|Overall Study|Lost to Follow-up|2|||
143182973|NCT03276728|516216738|FG004|Overall Study|Lost to Follow-up|0|||
143182974|NCT03276728|516216739|FG005|Overall Study|Lost to Follow-up|0|||
143182975|NCT03276728|516216740|FG006|Overall Study|Lost to Follow-up|0|||
143182976|NCT03276728|516216741|FG007|Overall Study|Lost to Follow-up|0|||
143182977|NCT03276728|516216734|FG000|Overall Study|Withdrawal by Subject|0|||
143182978|NCT03276728|516216735|FG001|Overall Study|Withdrawal by Subject|0|||
143182979|NCT03276728|516216736|FG002|Overall Study|Withdrawal by Subject|0|||
143182980|NCT03276728|516216737|FG003|Overall Study|Withdrawal by Subject|3|||
143182981|NCT03276728|516216738|FG004|Overall Study|Withdrawal by Subject|0|||
143182982|NCT03276728|516216739|FG005|Overall Study|Withdrawal by Subject|0|||
143182983|NCT03276728|516216740|FG006|Overall Study|Withdrawal by Subject|0|||
143182984|NCT03276728|516216741|FG007|Overall Study|Withdrawal by Subject|0|||
143182985|NCT03276728|516216734|FG000|Overall Study|Decision by sponsor|0|||
143182986|NCT03276728|516216735|FG001|Overall Study|Decision by sponsor|0|||
143182987|NCT03276728|516216736|FG002|Overall Study|Decision by sponsor|0|||
143182988|NCT03276728|516216737|FG003|Overall Study|Decision by sponsor|0|||
143182989|NCT03276728|516216738|FG004|Overall Study|Decision by sponsor|1|||
143182990|NCT03276728|516216739|FG005|Overall Study|Decision by sponsor|0|||
143182991|NCT03276728|516216740|FG006|Overall Study|Decision by sponsor|2|||
143182992|NCT03276728|516216741|FG007|Overall Study|Decision by sponsor|1|||
143182993|NCT03941873|516216742|FG000|Overall Study|Death|0|||
143182994|NCT03941873|516216743|FG001|Overall Study|Death|12|||
143182995|NCT03941873|516216744|FG002|Overall Study|Death|2|||
143182996|NCT03941873|516216745|FG003|Overall Study|Death|53|||
143182997|NCT03941873|516216742|FG000|Overall Study|Withdrawal by Subject|1|||
143182998|NCT03941873|516216743|FG001|Overall Study|Withdrawal by Subject|1|||
143182999|NCT03941873|516216744|FG002|Overall Study|Withdrawal by Subject|0|||
143183000|NCT03941873|516216745|FG003|Overall Study|Withdrawal by Subject|5|||
143183001|NCT03941873|516216742|FG000|Overall Study|Lost to Follow-up|1|||
143183002|NCT03941873|516216743|FG001|Overall Study|Lost to Follow-up|2|||
143183003|NCT03941873|516216744|FG002|Overall Study|Lost to Follow-up|0|||
143183004|NCT03941873|516216745|FG003|Overall Study|Lost to Follow-up|0|||
143183005|NCT03941873|516216742|FG000|Overall Study|Sponsor Decision|0|||
143183006|NCT03941873|516216743|FG001|Overall Study|Sponsor Decision|6|||
143183007|NCT03941873|516216744|FG002|Overall Study|Sponsor Decision|0|||
143183008|NCT03941873|516216745|FG003|Overall Study|Sponsor Decision|15|||
143183009|NCT02982772|516216748|FG000|Intervention|Lost to Follow-up|19|||
143183010|NCT02982772|516216749|FG001|Intervention|Lost to Follow-up|13|||
143183011|NCT02982772|516216748|FG000|1M Follow-Up|Lost to Follow-up|21|||
143183012|NCT02982772|516216749|FG001|1M Follow-Up|Lost to Follow-up|18|||
143183013|NCT02982772|516216748|FG000|3M Follow-Up|Lost to Follow-up|17|||
143183014|NCT02982772|516216749|FG001|3M Follow-Up|Lost to Follow-up|11|||
143183015|NCT02982772|516216748|FG000|6M Follow-Up|Lost to Follow-up|11|||
143183016|NCT02982772|516216749|FG001|6M Follow-Up|Lost to Follow-up|9|||
143183017|NCT02982772|516216748|FG000|12M Follow-Up|Lost to Follow-up|11|||
143183018|NCT02982772|516216749|FG001|12M Follow-Up|Lost to Follow-up|5|||
143183019|NCT01234480|516216750|FG000|Overall Study|Pregnancy|88|||
143183020|NCT01234480|516216750|FG000|Overall Study|>36/Normal History|50|||
143183021|NCT01234480|516216750|FG000|Overall Study|Age|3|||
143183022|NCT01234480|516216750|FG000|Overall Study|HPV Vaccine History|28|||
143183023|NCT01234480|516216750|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
143183024|NCT01234480|516216750|FG000|Overall Study|Hysterectomy|2|||
143183025|NCT01234480|516216750|FG000|Overall Study|Hysterectomy post enrollment|1|||
143183026|NCT01234480|516216750|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
143183027|NCT01234480|516216750|FG000|Overall Study|Informed Consent Form Violation|30|||
143183028|NCT01234480|516216750|FG000|Overall Study|Incorrect Visit|3|||
143183029|NCT01234480|516216750|FG000|Overall Study|No Florida Lab License|20|||
143183030|NCT01234480|516216750|FG000|Overall Study|Out of Window|42|||
143183031|NCT01234480|516216750|FG000|Overall Study|Sample Processing/Storage|92|||
143183032|NCT01234480|516216750|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
143183033|NCT01234480|516216750|FG000|Overall Study|Site/Subject non-compliance|44|||
143183034|NCT01234480|516216750|FG000|Overall Study|Missing Sample|9|||
143183035|NCT02974140|516216751|FG000|Overall Study|Adverse Event|2|||
143183036|NCT02974140|516216751|FG000|Overall Study|Lost to Follow-up|1|||
143183037|NCT02974140|516216751|FG000|Overall Study|Study Terminated by Sponsor|36|||
143183038|NCT00617084|516216752|FG000|Overall Study|Withdrawal by Subject|5|||
143183039|NCT00617084|516216753|FG001|Overall Study|Withdrawal by Subject|7|||
143183040|NCT00617084|516216752|FG000|Overall Study|Missed 12 Months visit|16|||
143183041|NCT00617084|516216753|FG001|Overall Study|Missed 12 Months visit|19|||
143183042|NCT03370419|516216754|FG000|Overall Study|Lost to Follow-up|16|||
143183043|NCT00662831|516216765|FG000|Overall Study|Death|4|||
143183044|NCT00662831|516216766|FG001|Overall Study|Death|1|||
143183045|NCT00662831|516216765|FG000|Overall Study|Lack of Efficacy|6|||
143183046|NCT00662831|516216766|FG001|Overall Study|Lack of Efficacy|6|||
143183047|NCT00662831|516216765|FG000|Overall Study|Lost to Follow-up|1|||
143183048|NCT00662831|516216766|FG001|Overall Study|Lost to Follow-up|0|||
143183049|NCT00662831|516216765|FG000|Overall Study|Withdrawal by Subject|2|||
143183050|NCT00662831|516216766|FG001|Overall Study|Withdrawal by Subject|1|||
143183051|NCT00662831|516216765|FG000|Overall Study|Other|62|||
143183052|NCT00662831|516216766|FG001|Overall Study|Other|31|||
143183053|NCT00662831|516216765|FG000|Overall Study|Protocol Violation|8|||
143183054|NCT00662831|516216766|FG001|Overall Study|Protocol Violation|4|||
143183055|NCT00662831|516216765|FG000|Overall Study|Adverse Event|23|||
143183056|NCT00662831|516216766|FG001|Overall Study|Adverse Event|16|||
143183057|NCT01061723|516216771|FG000|Overall Study|Adverse Event|0|||
143183058|NCT01061723|516216772|FG001|Overall Study|Adverse Event|2|||
143183059|NCT01061723|516216773|FG002|Overall Study|Adverse Event|5|||
143183060|NCT01061723|516216774|FG003|Overall Study|Adverse Event|5|||
143260140|NCT04393298|516507183|FG014|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
143260141|NCT04393298|516507169|FG000|Overall Study|Progressive Disease and Subsequent Death|0|||
143260142|NCT04393298|516507170|FG001|Overall Study|Progressive Disease and Subsequent Death|0|||
143260143|NCT04393298|516507171|FG002|Overall Study|Progressive Disease and Subsequent Death|0|||
143260144|NCT04393298|516507172|FG003|Overall Study|Progressive Disease and Subsequent Death|0|||
143260145|NCT04393298|516507173|FG004|Overall Study|Progressive Disease and Subsequent Death|0|||
143183061|NCT01061723|516216775|FG004|Overall Study|Adverse Event|2|||
143183062|NCT01061723|516216776|FG005|Overall Study|Adverse Event|6|||
143183063|NCT01061723|516216771|FG000|Overall Study|Lack of Efficacy|2|||
143183064|NCT01061723|516216772|FG001|Overall Study|Lack of Efficacy|3|||
143183065|NCT01061723|516216773|FG002|Overall Study|Lack of Efficacy|4|||
143183066|NCT01061723|516216774|FG003|Overall Study|Lack of Efficacy|2|||
143183067|NCT01061723|516216775|FG004|Overall Study|Lack of Efficacy|1|||
143183068|NCT01061723|516216776|FG005|Overall Study|Lack of Efficacy|1|||
143183069|NCT01061723|516216771|FG000|Overall Study|Randomized but not treated|0|||
143183070|NCT01061723|516216772|FG001|Overall Study|Randomized but not treated|0|||
143183071|NCT01061723|516216773|FG002|Overall Study|Randomized but not treated|0|||
143183072|NCT01061723|516216774|FG003|Overall Study|Randomized but not treated|0|||
143260146|NCT04393298|516507174|FG005|Overall Study|Progressive Disease and Subsequent Death|0|||
143260147|NCT04393298|516507175|FG006|Overall Study|Progressive Disease and Subsequent Death|1|||
143183073|NCT01061723|516216775|FG004|Overall Study|Randomized but not treated|0|||
143183074|NCT01061723|516216776|FG005|Overall Study|Randomized but not treated|1|||
143183075|NCT01061723|516216771|FG000|Overall Study|Other than specified above|2|||
143183076|NCT01061723|516216772|FG001|Overall Study|Other than specified above|1|||
143183077|NCT01061723|516216773|FG002|Overall Study|Other than specified above|1|||
143183078|NCT01061723|516216774|FG003|Overall Study|Other than specified above|1|||
143183079|NCT01061723|516216775|FG004|Overall Study|Other than specified above|0|||
143183080|NCT01061723|516216776|FG005|Overall Study|Other than specified above|1|||
143183081|NCT01734785|516216777|FG000|Open-Label Period|Adverse Event|0|||
143183082|NCT01734785|516216778|FG001|Open-Label Period|Adverse Event|0|||
143183083|NCT01734785|516216779|FG002|Open-Label Period|Adverse Event|0|||
143183084|NCT01734785|516216780|FG003|Open-Label Period|Adverse Event|9|||
143183085|NCT01734785|516216777|FG000|Open-Label Period|Lack of Efficacy|0|||
143183086|NCT01734785|516216778|FG001|Open-Label Period|Lack of Efficacy|0|||
143183087|NCT01734785|516216779|FG002|Open-Label Period|Lack of Efficacy|0|||
143183088|NCT01734785|516216780|FG003|Open-Label Period|Lack of Efficacy|1|||
143183089|NCT01734785|516216777|FG000|Open-Label Period|Protocol Violation|0|||
143183090|NCT01734785|516216778|FG001|Open-Label Period|Protocol Violation|0|||
143183091|NCT01734785|516216779|FG002|Open-Label Period|Protocol Violation|0|||
143183092|NCT01734785|516216780|FG003|Open-Label Period|Protocol Violation|13|||
143183093|NCT01734785|516216777|FG000|Open-Label Period|Lost to Follow-up|0|||
143183094|NCT01734785|516216778|FG001|Open-Label Period|Lost to Follow-up|0|||
143183095|NCT01734785|516216779|FG002|Open-Label Period|Lost to Follow-up|0|||
143183096|NCT01734785|516216780|FG003|Open-Label Period|Lost to Follow-up|14|||
143183097|NCT01734785|516216777|FG000|Open-Label Period|Withdrawal by Subject|0|||
143183098|NCT01734785|516216778|FG001|Open-Label Period|Withdrawal by Subject|0|||
143183099|NCT01734785|516216779|FG002|Open-Label Period|Withdrawal by Subject|0|||
143183100|NCT01734785|516216780|FG003|Open-Label Period|Withdrawal by Subject|12|||
143183101|NCT01734785|516216777|FG000|Open-Label Period|Other Reasons|0|||
143183102|NCT01734785|516216778|FG001|Open-Label Period|Other Reasons|0|||
143183103|NCT01734785|516216779|FG002|Open-Label Period|Other Reasons|0|||
143183104|NCT01734785|516216780|FG003|Open-Label Period|Other Reasons|224|||
143183105|NCT01734785|516216777|FG000|Double-Blind Period|Adverse Event|0|||
143183106|NCT01734785|516216778|FG001|Double-Blind Period|Adverse Event|3|||
143183107|NCT01734785|516216779|FG002|Double-Blind Period|Adverse Event|2|||
143183108|NCT01734785|516216780|FG003|Double-Blind Period|Adverse Event|0|||
143183109|NCT01734785|516216777|FG000|Double-Blind Period|Lack of Efficacy|0|||
143183110|NCT01734785|516216778|FG001|Double-Blind Period|Lack of Efficacy|1|||
143183111|NCT01734785|516216779|FG002|Double-Blind Period|Lack of Efficacy|0|||
143183112|NCT01734785|516216780|FG003|Double-Blind Period|Lack of Efficacy|0|||
143183113|NCT01734785|516216777|FG000|Double-Blind Period|Protocol Violation|0|||
143183114|NCT01734785|516216778|FG001|Double-Blind Period|Protocol Violation|1|||
143183115|NCT01734785|516216779|FG002|Double-Blind Period|Protocol Violation|1|||
143183116|NCT01734785|516216780|FG003|Double-Blind Period|Protocol Violation|0|||
143183117|NCT01734785|516216777|FG000|Double-Blind Period|Lost to Follow-up|2|||
143183118|NCT01734785|516216778|FG001|Double-Blind Period|Lost to Follow-up|4|||
143183119|NCT01734785|516216779|FG002|Double-Blind Period|Lost to Follow-up|2|||
143183120|NCT01734785|516216780|FG003|Double-Blind Period|Lost to Follow-up|0|||
143183121|NCT01734785|516216777|FG000|Double-Blind Period|Withdrawal by Subject|2|||
143183122|NCT01734785|516216778|FG001|Double-Blind Period|Withdrawal by Subject|0|||
143183123|NCT01734785|516216779|FG002|Double-Blind Period|Withdrawal by Subject|0|||
143183124|NCT01734785|516216780|FG003|Double-Blind Period|Withdrawal by Subject|0|||
143183125|NCT01734785|516216777|FG000|Double-Blind Period|Not treated|1|||
143183126|NCT01734785|516216778|FG001|Double-Blind Period|Not treated|0|||
143183127|NCT01734785|516216779|FG002|Double-Blind Period|Not treated|0|||
143183128|NCT01734785|516216780|FG003|Double-Blind Period|Not treated|0|||
143183129|NCT01961297|516216781|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
143183130|NCT01961297|516216782|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
143183131|NCT01582009|516216785|FG000|Overall Study|Withdrawal by Subject|1|||
143183132|NCT01582009|516216785|FG000|Overall Study|Physician Decision|1|||
143183133|NCT01947283|516216788|FG000|Overall Study|Death|1|||
143183134|NCT01947283|516216789|FG001|Overall Study|Death|1|||
143183135|NCT01947283|516216790|FG002|Overall Study|Death|1|||
143183136|NCT01947283|516216791|FG003|Overall Study|Death|0|||
143183137|NCT01947283|516216792|FG004|Overall Study|Death|0|||
143183138|NCT01947283|516216793|FG005|Overall Study|Death|0|||
143183139|NCT01947283|516216794|FG006|Overall Study|Death|0|||
143183140|NCT01947283|516216788|FG000|Overall Study|Lost to Follow-up|4|||
143183141|NCT01947283|516216789|FG001|Overall Study|Lost to Follow-up|6|||
143183142|NCT01947283|516216790|FG002|Overall Study|Lost to Follow-up|5|||
143183143|NCT01947283|516216791|FG003|Overall Study|Lost to Follow-up|5|||
143183144|NCT01947283|516216792|FG004|Overall Study|Lost to Follow-up|0|||
143260148|NCT04393298|516507176|FG007|Overall Study|Progressive Disease and Subsequent Death|0|||
143183145|NCT01947283|516216793|FG005|Overall Study|Lost to Follow-up|2|||
143183146|NCT01947283|516216794|FG006|Overall Study|Lost to Follow-up|5|||
143183147|NCT01947283|516216788|FG000|Overall Study|Withdrawal by Subject|10|||
143183148|NCT01947283|516216789|FG001|Overall Study|Withdrawal by Subject|8|||
143183149|NCT01947283|516216790|FG002|Overall Study|Withdrawal by Subject|4|||
143183150|NCT01947283|516216791|FG003|Overall Study|Withdrawal by Subject|1|||
143183151|NCT01947283|516216792|FG004|Overall Study|Withdrawal by Subject|0|||
143183152|NCT01947283|516216793|FG005|Overall Study|Withdrawal by Subject|0|||
143183153|NCT01947283|516216794|FG006|Overall Study|Withdrawal by Subject|2|||
143183154|NCT01947283|516216788|FG000|Overall Study|No Clinical Recording|12|||
143183155|NCT01947283|516216789|FG001|Overall Study|No Clinical Recording|6|||
143183156|NCT01947283|516216790|FG002|Overall Study|No Clinical Recording|8|||
143183157|NCT01947283|516216791|FG003|Overall Study|No Clinical Recording|10|||
143183158|NCT01947283|516216792|FG004|Overall Study|No Clinical Recording|0|||
143183159|NCT01947283|516216793|FG005|Overall Study|No Clinical Recording|0|||
143183160|NCT01947283|516216794|FG006|Overall Study|No Clinical Recording|0|||
143183161|NCT01947283|516216788|FG000|Overall Study|Non-coding Clinical Recording language|0|||
143183162|NCT01947283|516216789|FG001|Overall Study|Non-coding Clinical Recording language|0|||
143183163|NCT01947283|516216790|FG002|Overall Study|Non-coding Clinical Recording language|0|||
143183164|NCT01947283|516216791|FG003|Overall Study|Non-coding Clinical Recording language|1|||
143183165|NCT01947283|516216792|FG004|Overall Study|Non-coding Clinical Recording language|0|||
143183166|NCT01947283|516216793|FG005|Overall Study|Non-coding Clinical Recording language|0|||
143183167|NCT01947283|516216794|FG006|Overall Study|Non-coding Clinical Recording language|0|||
143183168|NCT01947283|516216788|FG000|Overall Study|Missing Follow-up Assessment|2|||
143183169|NCT01947283|516216789|FG001|Overall Study|Missing Follow-up Assessment|2|||
143183170|NCT01947283|516216790|FG002|Overall Study|Missing Follow-up Assessment|3|||
143183171|NCT01947283|516216791|FG003|Overall Study|Missing Follow-up Assessment|0|||
143183172|NCT01947283|516216792|FG004|Overall Study|Missing Follow-up Assessment|0|||
143183173|NCT01947283|516216793|FG005|Overall Study|Missing Follow-up Assessment|2|||
143183174|NCT01947283|516216794|FG006|Overall Study|Missing Follow-up Assessment|0|||
143183175|NCT01947283|516216788|FG000|Overall Study|No patients were enrolled in study|0|||
143183176|NCT01947283|516216789|FG001|Overall Study|No patients were enrolled in study|0|||
143183177|NCT01947283|516216790|FG002|Overall Study|No patients were enrolled in study|0|||
143183178|NCT01947283|516216791|FG003|Overall Study|No patients were enrolled in study|0|||
143183179|NCT01947283|516216792|FG004|Overall Study|No patients were enrolled in study|0|||
143183180|NCT01947283|516216793|FG005|Overall Study|No patients were enrolled in study|3|||
143183181|NCT01947283|516216794|FG006|Overall Study|No patients were enrolled in study|1|||
143183182|NCT03782259|516216795|FG000|Overall Study|Lost to Follow-up|1|||
143183183|NCT03782259|516216796|FG001|Overall Study|Lost to Follow-up|1|||
143183184|NCT03782259|516216795|FG000|Overall Study|Moved out of state|0|||
143183185|NCT03782259|516216796|FG001|Overall Study|Moved out of state|2|||
143183186|NCT03782259|516216795|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
143183187|NCT03782259|516216796|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
143183188|NCT03782259|516216795|FG000|Overall Study|Subject discontinued intervention|1|||
143183189|NCT03782259|516216796|FG001|Overall Study|Subject discontinued intervention|0|||
143183190|NCT03592771|516216797|FG000|Overall Study|Adverse Event|2|||
143183191|NCT03592771|516216798|FG001|Overall Study|Adverse Event|0|||
143183192|NCT03592771|516216799|FG002|Overall Study|Adverse Event|1|||
143183193|NCT03592771|516216797|FG000|Overall Study|Death|0|||
143183194|NCT03592771|516216798|FG001|Overall Study|Death|1|||
143183195|NCT03592771|516216799|FG002|Overall Study|Death|1|||
143183196|NCT03592771|516216797|FG000|Overall Study|Lost to Follow-up|5|||
143183197|NCT03592771|516216798|FG001|Overall Study|Lost to Follow-up|11|||
143183198|NCT03592771|516216799|FG002|Overall Study|Lost to Follow-up|15|||
143183199|NCT03592771|516216797|FG000|Overall Study|Withdrawal by Subject|0|||
143183200|NCT03592771|516216798|FG001|Overall Study|Withdrawal by Subject|2|||
143183201|NCT03592771|516216799|FG002|Overall Study|Withdrawal by Subject|0|||
143183202|NCT00735553|516216800|FG000|Overall Study|Study prematurely terminated|77|||
143183203|NCT02705105|516216801|FG000|Treatment|Objective Disease Progression|1|||
143183204|NCT02705105|516216802|FG001|Treatment|Objective Disease Progression|50|||
143183205|NCT02705105|516216801|FG000|Treatment|Withdrawal by Subject|3|||
143183206|NCT02705105|516216802|FG001|Treatment|Withdrawal by Subject|5|||
143183207|NCT02705105|516216801|FG000|Treatment|Adverse Event|0|||
143183208|NCT02705105|516216802|FG001|Treatment|Adverse Event|17|||
143183209|NCT02705105|516216801|FG000|Treatment|Clinical Disease Progression|0|||
143183210|NCT02705105|516216802|FG001|Treatment|Clinical Disease Progression|32|||
143183211|NCT02705105|516216801|FG000|Treatment|Physician Decision|0|||
143183212|NCT02705105|516216802|FG001|Treatment|Physician Decision|3|||
143183213|NCT02705105|516216801|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
143183214|NCT02705105|516216802|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
143183215|NCT02705105|516216801|FG000|Follow-Up|Death|3|||
143183216|NCT02705105|516216802|FG001|Follow-Up|Death|68|||
143183217|NCT02705105|516216801|FG000|Follow-Up|Withdrawal by Subject|1|||
143183218|NCT02705105|516216802|FG001|Follow-Up|Withdrawal by Subject|14|||
143183219|NCT02705105|516216801|FG000|Follow-Up|Study Terminated|0|||
143183220|NCT02705105|516216802|FG001|Follow-Up|Study Terminated|26|||
143183221|NCT02705105|516216801|FG000|Follow-Up|Discontinued per Amendment 3|0|||
143183222|NCT02705105|516216802|FG001|Follow-Up|Discontinued per Amendment 3|2|||
143183223|NCT01014767|516216803|FG000|Overall Study|PI left institution, data unavailable|12|||
143183224|NCT01014767|516216804|FG001|Overall Study|PI left institution, data unavailable|1|||
143183225|NCT01014767|516216805|FG002|Overall Study|PI left institution, data unavailable|4|||
143183226|NCT01014767|516216806|FG003|Overall Study|PI left institution, data unavailable|1|||
143183227|NCT00310375|516216810|FG000|Primary Reporting Phase|Adverse Event|28|||
143183228|NCT00310375|516216811|FG001|Primary Reporting Phase|Adverse Event|22|||
143183229|NCT00310375|516216812|FG002|Primary Reporting Phase|Adverse Event|0|||
143183230|NCT00310375|516216810|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
143183231|NCT00310375|516216811|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
143183232|NCT00310375|516216812|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
143183233|NCT00310375|516216810|FG000|Primary Reporting Phase|Pregnancy|2|||
143183234|NCT00310375|516216811|FG001|Primary Reporting Phase|Pregnancy|2|||
143183235|NCT00310375|516216812|FG002|Primary Reporting Phase|Pregnancy|0|||
143183236|NCT00310375|516216810|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
143183237|NCT00310375|516216811|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
143183238|NCT00310375|516216812|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
143183239|NCT00310375|516216810|FG000|Primary Reporting Phase|Protocol Violation|8|||
143183240|NCT00310375|516216811|FG001|Primary Reporting Phase|Protocol Violation|5|||
143183241|NCT00310375|516216812|FG002|Primary Reporting Phase|Protocol Violation|0|||
143183242|NCT00310375|516216810|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
143183243|NCT00310375|516216811|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
143183244|NCT00310375|516216812|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
143183245|NCT00310375|516216810|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
143183246|NCT00310375|516216811|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
143183247|NCT00310375|516216812|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
143183248|NCT00310375|516216810|FG000|Primary Reporting Phase|Physician Decision|5|||
143183249|NCT00310375|516216811|FG001|Primary Reporting Phase|Physician Decision|3|||
143183250|NCT00310375|516216812|FG002|Primary Reporting Phase|Physician Decision|0|||
143183251|NCT00310375|516216810|FG000|Primary Reporting Phase|Request of the sponsor|2|||
143183252|NCT00310375|516216811|FG001|Primary Reporting Phase|Request of the sponsor|2|||
143183253|NCT00310375|516216812|FG002|Primary Reporting Phase|Request of the sponsor|0|||
143183254|NCT00310375|516216810|FG000|Primary Reporting Phase|Failed to return|1|||
143183255|NCT00310375|516216811|FG001|Primary Reporting Phase|Failed to return|3|||
143183256|NCT00310375|516216812|FG002|Primary Reporting Phase|Failed to return|0|||
143183257|NCT00310375|516216810|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
143183258|NCT00310375|516216811|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
143183259|NCT00310375|516216812|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
143183260|NCT00310375|516216810|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
143183261|NCT00310375|516216811|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
143183262|NCT00310375|516216812|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
143183263|NCT00310375|516216810|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
143183264|NCT00310375|516216811|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
143183265|NCT00310375|516216812|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
143183266|NCT00310375|516216810|FG000|Primary Reporting Phase|Site closure|3|||
143183267|NCT00310375|516216811|FG001|Primary Reporting Phase|Site closure|0|||
143183268|NCT00310375|516216812|FG002|Primary Reporting Phase|Site closure|0|||
143183269|NCT00310375|516216810|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
143183270|NCT00310375|516216811|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
143183271|NCT00310375|516216812|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
143183272|NCT00310375|516216810|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
143183273|NCT00310375|516216811|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
143183274|NCT00310375|516216812|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
143183275|NCT00310375|516216810|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
143183276|NCT00310375|516216811|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
143183277|NCT00310375|516216812|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
143183278|NCT00310375|516216810|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
143183279|NCT00310375|516216811|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
143183280|NCT00310375|516216812|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
143183281|NCT00910910|516216813|FG000|Overall Study|Adverse Event|63|||
143183282|NCT00910910|516216814|FG001|Overall Study|Adverse Event|35|||
143183283|NCT00910910|516216813|FG000|Overall Study|PD without histologic change|27|||
143183284|NCT00910910|516216814|FG001|Overall Study|PD without histologic change|23|||
143183285|NCT00910910|516216813|FG000|Overall Study|PD with histologic change|0|||
143183286|NCT00910910|516216814|FG001|Overall Study|PD with histologic change|2|||
143183287|NCT00910910|516216813|FG000|Overall Study|Withdrawal by Subject|7|||
143183288|NCT00910910|516216814|FG001|Overall Study|Withdrawal by Subject|5|||
143183289|NCT00910910|516216813|FG000|Overall Study|Lost to Follow-up|2|||
143183290|NCT00910910|516216814|FG001|Overall Study|Lost to Follow-up|2|||
143183291|NCT00910910|516216813|FG000|Overall Study|Death|9|||
143183292|NCT00910910|516216814|FG001|Overall Study|Death|3|||
143183293|NCT00910910|516216813|FG000|Overall Study|Protocol Violation|2|||
143183294|NCT00910910|516216814|FG001|Overall Study|Protocol Violation|2|||
143183295|NCT00910910|516216813|FG000|Overall Study|Completed 13 cycles of treatment|0|||
143183296|NCT00910910|516216814|FG001|Overall Study|Completed 13 cycles of treatment|118|||
143183297|NCT00910910|516216813|FG000|Overall Study|Other|114|||
143183298|NCT00910910|516216814|FG001|Overall Study|Other|32|||
143183299|NCT00910910|516216813|FG000|Overall Study|Untreated before cycle 1|1|||
143183300|NCT00910910|516216814|FG001|Overall Study|Untreated before cycle 1|2|||
143183301|NCT04830215|516216815|FG000|Overall Study|Adverse Event|6|||
143183302|NCT04830215|516216815|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
143183303|NCT04830215|516216815|FG000|Overall Study|Withdrawal by Subject|3|||
143183304|NCT04830215|516216815|FG000|Overall Study|Protocol Deviation|1|||
143183305|NCT00211172|516216817|FG000|Overall Study|Died or lost health plan eligibility|39|||
143183306|NCT00211172|516216818|FG001|Overall Study|Died or lost health plan eligibility|32|||
143183307|NCT00770562|516216819|FG000|Overall Study|Did not take treatment|1|||
143183308|NCT00770562|516216820|FG001|Overall Study|Did not take treatment|1|||
143183309|NCT00292045|516216824|FG000|Core Study (Through Week 13)|Adverse Event|1|||
143183310|NCT00292045|516216824|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
143183311|NCT04474197|516216825|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
143183312|NCT04474197|516216826|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
143183313|NCT04474197|516216827|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
143183314|NCT04474197|516216828|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
143183315|NCT00606411|516216829|FG000|Overall Study|Adverse Event|1|||
143183316|NCT00606411|516216830|FG001|Overall Study|Adverse Event|2|||
143183317|NCT00606411|516216829|FG000|Overall Study|Lack of Adherence|1|||
143183318|NCT00606411|516216830|FG001|Overall Study|Lack of Adherence|1|||
143183319|NCT00606411|516216829|FG000|Overall Study|Lack of Efficacy|1|||
143183320|NCT00606411|516216830|FG001|Overall Study|Lack of Efficacy|1|||
143183321|NCT00606411|516216829|FG000|Overall Study|Withdrawal by Subject|2|||
143183322|NCT00606411|516216830|FG001|Overall Study|Withdrawal by Subject|0|||
143183323|NCT00606411|516216829|FG000|Overall Study|Lost to Follow-up|1|||
143183324|NCT00606411|516216830|FG001|Overall Study|Lost to Follow-up|2|||
143183325|NCT00606411|516216829|FG000|Overall Study|Move out of state|0|||
143183326|NCT00606411|516216830|FG001|Overall Study|Move out of state|1|||
143183327|NCT02443337|516216832|FG000|Overall Study|Adverse Event|0|||
143183328|NCT02443337|516216833|FG001|Overall Study|Adverse Event|1|||
143183329|NCT02443337|516216832|FG000|Overall Study|Clinical Progressive Disease|3|||
143183330|NCT02443337|516216833|FG001|Overall Study|Clinical Progressive Disease|0|||
143183331|NCT02443337|516216832|FG000|Overall Study|Withdrawal by Subject|2|||
143183332|NCT02443337|516216833|FG001|Overall Study|Withdrawal by Subject|1|||
143183333|NCT00040742|516216834|FG000|Overall Study|Death|0|||
143183334|NCT00040742|516216835|FG001|Overall Study|Death|0|||
143183335|NCT00040742|516216836|FG002|Overall Study|Death|1|||
143183336|NCT00040742|516216837|FG003|Overall Study|Death|0|||
143183337|NCT00040742|516216834|FG000|Overall Study|Adverse Event|15|||
143260149|NCT04393298|516507177|FG008|Overall Study|Progressive Disease and Subsequent Death|0|||
143260150|NCT04393298|516507178|FG009|Overall Study|Progressive Disease and Subsequent Death|0|||
143260151|NCT04393298|516507179|FG010|Overall Study|Progressive Disease and Subsequent Death|0|||
143260152|NCT04393298|516507180|FG011|Overall Study|Progressive Disease and Subsequent Death|0|||
143260153|NCT04393298|516507181|FG012|Overall Study|Progressive Disease and Subsequent Death|0|||
143260154|NCT04393298|516507182|FG013|Overall Study|Progressive Disease and Subsequent Death|0|||
143260155|NCT04393298|516507183|FG014|Overall Study|Progressive Disease and Subsequent Death|0|||
143183338|NCT00040742|516216835|FG001|Overall Study|Adverse Event|16|||
143183339|NCT00040742|516216836|FG002|Overall Study|Adverse Event|21|||
143183340|NCT00040742|516216837|FG003|Overall Study|Adverse Event|9|||
143183341|NCT00040742|516216834|FG000|Overall Study|Withdrawal by Subject|7|||
143183342|NCT00040742|516216835|FG001|Overall Study|Withdrawal by Subject|15|||
143183343|NCT00040742|516216836|FG002|Overall Study|Withdrawal by Subject|10|||
143183344|NCT00040742|516216837|FG003|Overall Study|Withdrawal by Subject|13|||
143183345|NCT00040742|516216834|FG000|Overall Study|Chemotoxicity|4|||
143183346|NCT00040742|516216835|FG001|Overall Study|Chemotoxicity|3|||
143183347|NCT00040742|516216836|FG002|Overall Study|Chemotoxicity|5|||
143183348|NCT00040742|516216837|FG003|Overall Study|Chemotoxicity|2|||
143260156|NCT04393298|516507169|FG000|Overall Study|Patient Passed Away|0|||
143183349|NCT00040742|516216834|FG000|Overall Study|Incomplete Forms|6|||
143183350|NCT00040742|516216835|FG001|Overall Study|Incomplete Forms|10|||
143183351|NCT00040742|516216836|FG002|Overall Study|Incomplete Forms|4|||
143183352|NCT00040742|516216837|FG003|Overall Study|Incomplete Forms|5|||
143183353|NCT00040742|516216834|FG000|Overall Study|Other medical|7|||
143183354|NCT00040742|516216835|FG001|Overall Study|Other medical|5|||
143183355|NCT00040742|516216836|FG002|Overall Study|Other medical|5|||
143183356|NCT00040742|516216837|FG003|Overall Study|Other medical|5|||
143183357|NCT00635349|516216838|FG000|Overall Study|Other|8|||
143183358|NCT00635349|516216839|FG001|Overall Study|Other|6|||
143183359|NCT00635349|516216838|FG000|Overall Study|Protocol Violation|18|||
143183360|NCT00635349|516216839|FG001|Overall Study|Protocol Violation|22|||
143183361|NCT00635349|516216838|FG000|Overall Study|Withdrawal by Subject|3|||
143183362|NCT00635349|516216839|FG001|Overall Study|Withdrawal by Subject|8|||
143183363|NCT00635349|516216838|FG000|Overall Study|Lost to Follow-up|4|||
143183364|NCT00635349|516216839|FG001|Overall Study|Lost to Follow-up|3|||
143183365|NCT00635349|516216838|FG000|Overall Study|Adverse Event|11|||
143183366|NCT00635349|516216839|FG001|Overall Study|Adverse Event|9|||
143183367|NCT00645840|516216840|FG000|Overall Study|Protocol Violation|3|||
143183368|NCT01340664|516216841|FG000|Overall Study|Adverse Event|0|||
143183369|NCT01340664|516216842|FG001|Overall Study|Adverse Event|1|||
143183370|NCT01340664|516216843|FG002|Overall Study|Adverse Event|7|||
143183371|NCT01340664|516216841|FG000|Overall Study|Lost to Follow-up|2|||
143183372|NCT01340664|516216842|FG001|Overall Study|Lost to Follow-up|0|||
143183373|NCT01340664|516216843|FG002|Overall Study|Lost to Follow-up|2|||
143183374|NCT01340664|516216841|FG000|Overall Study|Withdrawal by Subject|2|||
143183375|NCT01340664|516216842|FG001|Overall Study|Withdrawal by Subject|4|||
143183376|NCT01340664|516216843|FG002|Overall Study|Withdrawal by Subject|0|||
143183377|NCT01340664|516216841|FG000|Overall Study|Glycemic withdrawal criteria|2|||
143183378|NCT01340664|516216842|FG001|Overall Study|Glycemic withdrawal criteria|0|||
143183379|NCT01340664|516216843|FG002|Overall Study|Glycemic withdrawal criteria|0|||
143183380|NCT01340664|516216841|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
143183381|NCT01340664|516216842|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
143183382|NCT01340664|516216843|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
143183383|NCT01340664|516216841|FG000|Overall Study|Other|1|||
143183384|NCT01340664|516216842|FG001|Overall Study|Other|2|||
143183385|NCT01340664|516216843|FG002|Overall Study|Other|2|||
143183386|NCT00402324|516216844|FG000|Overall Study|Lost to Follow-up|11|||
143183387|NCT00402324|516216845|FG001|Overall Study|Lost to Follow-up|11|||
143183388|NCT00402324|516216844|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
143183389|NCT00402324|516216845|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
143183390|NCT00402324|516216844|FG000|Overall Study|Protocol Violation|8|||
143183391|NCT00402324|516216845|FG001|Overall Study|Protocol Violation|7|||
143183392|NCT00402324|516216844|FG000|Overall Study|Withdrawal by Subject|5|||
143183393|NCT00402324|516216845|FG001|Overall Study|Withdrawal by Subject|2|||
143183394|NCT00402324|516216844|FG000|Overall Study|Physician Decision|2|||
143183395|NCT00402324|516216845|FG001|Overall Study|Physician Decision|4|||
143183396|NCT00402324|516216844|FG000|Overall Study|Sponsor Decision|4|||
143183397|NCT00402324|516216845|FG001|Overall Study|Sponsor Decision|5|||
143183398|NCT00402324|516216844|FG000|Overall Study|Lack of Efficacy|1|||
143183399|NCT00402324|516216845|FG001|Overall Study|Lack of Efficacy|4|||
143183400|NCT00402324|516216844|FG000|Overall Study|Adverse Event|6|||
143183401|NCT00402324|516216845|FG001|Overall Study|Adverse Event|4|||
143183402|NCT00402324|516216844|FG000|Overall Study|Death|1|||
143183403|NCT00402324|516216845|FG001|Overall Study|Death|0|||
143183404|NCT02997865|516216847|FG000|Overall Study|Death|2|||
143183405|NCT02997865|516216848|FG001|Overall Study|Death|1|||
143260157|NCT04393298|516507170|FG001|Overall Study|Patient Passed Away|0|||
143260158|NCT04393298|516507171|FG002|Overall Study|Patient Passed Away|0|||
143183406|NCT02997865|516216847|FG000|Overall Study|Lost to Follow-up|6|||
143183407|NCT02997865|516216848|FG001|Overall Study|Lost to Follow-up|3|||
143183408|NCT02997865|516216847|FG000|Overall Study|Withdrawal by Subject|5|||
143183409|NCT02997865|516216848|FG001|Overall Study|Withdrawal by Subject|0|||
143183410|NCT01823198|516216849|FG000|Overall Study|Physician Decision|0|||
143183411|NCT01823198|516216850|FG001|Overall Study|Physician Decision|1|||
143183412|NCT01823198|516216851|FG002|Overall Study|Physician Decision|0|||
143183413|NCT01823198|516216852|FG003|Overall Study|Physician Decision|0|||
143183414|NCT01823198|516216853|FG004|Overall Study|Physician Decision|0|||
143183415|NCT01823198|516216854|FG005|Overall Study|Physician Decision|3|||
143183416|NCT01823198|516216855|FG006|Overall Study|Physician Decision|3|||
143183417|NCT01119066|516216856|FG000|Overall Study|Withdrawal by Subject|4|||
143183418|NCT01119066|516216857|FG001|Overall Study|Withdrawal by Subject|6|||
143183419|NCT01119066|516216858|FG002|Overall Study|Withdrawal by Subject|0|||
143183420|NCT01119066|516216859|FG003|Overall Study|Withdrawal by Subject|0|||
143183421|NCT01119066|516216856|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
143183422|NCT01119066|516216857|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
143183423|NCT01119066|516216858|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
143260159|NCT04393298|516507172|FG003|Overall Study|Patient Passed Away|0|||
143183424|NCT01119066|516216859|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
143183425|NCT01119066|516216856|FG000|Overall Study|Relapse identified before transplant|1|||
143183426|NCT01119066|516216857|FG001|Overall Study|Relapse identified before transplant|0|||
143183427|NCT01119066|516216858|FG002|Overall Study|Relapse identified before transplant|0|||
143183428|NCT01119066|516216859|FG003|Overall Study|Relapse identified before transplant|0|||
143183429|NCT01119066|516216856|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
143183430|NCT01119066|516216857|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
143183431|NCT01119066|516216858|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
143183432|NCT01119066|516216859|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
143183433|NCT01119066|516216856|FG000|Overall Study|Relapse identified before transplant|0|||
143183434|NCT01119066|516216857|FG001|Overall Study|Relapse identified before transplant|4|||
143183435|NCT01119066|516216858|FG002|Overall Study|Relapse identified before transplant|0|||
143183436|NCT01119066|516216859|FG003|Overall Study|Relapse identified before transplant|0|||
143183437|NCT01509846|516216862|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
143183438|NCT01509846|516216863|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
143183439|NCT01509846|516216864|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
143183440|NCT01509846|516216865|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
143183441|NCT01509846|516216866|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
143183442|NCT01509846|516216862|FG000|Received Vaccination 2|Illness|0|||
143183443|NCT01509846|516216863|FG001|Received Vaccination 2|Illness|0|||
143183444|NCT01509846|516216864|FG002|Received Vaccination 2|Illness|0|||
143183445|NCT01509846|516216865|FG003|Received Vaccination 2|Illness|0|||
143183446|NCT01509846|516216866|FG004|Received Vaccination 2|Illness|1|||
143183447|NCT01509846|516216862|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
143183448|NCT01509846|516216863|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
143183449|NCT01509846|516216864|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
143183450|NCT01509846|516216865|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
143183451|NCT01509846|516216866|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
143183452|NCT01509846|516216862|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
143183453|NCT01509846|516216863|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
143183454|NCT01509846|516216864|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
143183455|NCT01509846|516216865|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
143183456|NCT01509846|516216866|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
143183457|NCT01509846|516216862|FG000|Received Vaccination 3|Pregnancy|0|||
143183458|NCT01509846|516216863|FG001|Received Vaccination 3|Pregnancy|0|||
143183459|NCT01509846|516216864|FG002|Received Vaccination 3|Pregnancy|0|||
143183460|NCT01509846|516216865|FG003|Received Vaccination 3|Pregnancy|1|||
143183461|NCT01509846|516216866|FG004|Received Vaccination 3|Pregnancy|0|||
143183462|NCT01509846|516216862|FG000|Received Vaccination 3|Lost to Follow-up|0|||
143183463|NCT01509846|516216863|FG001|Received Vaccination 3|Lost to Follow-up|0|||
143183464|NCT01509846|516216864|FG002|Received Vaccination 3|Lost to Follow-up|1|||
143183465|NCT01509846|516216865|FG003|Received Vaccination 3|Lost to Follow-up|0|||
143183466|NCT01509846|516216866|FG004|Received Vaccination 3|Lost to Follow-up|0|||
143183467|NCT00763256|516216868|FG000|Overall Study|Didn't return for appointments|7|||
143183468|NCT00763256|516216869|FG001|Overall Study|Didn't return for appointments|10|||
143183469|NCT02517398|516216886|FG000|Overall Study|Death|2|||
143183470|NCT02517398|516216887|FG001|Overall Study|Death|3|||
143183471|NCT02517398|516216888|FG002|Overall Study|Death|4|||
143183472|NCT02517398|516216889|FG003|Overall Study|Death|2|||
143183473|NCT02517398|516216890|FG004|Overall Study|Death|3|||
143183474|NCT02517398|516216891|FG005|Overall Study|Death|8|||
143183475|NCT02517398|516216892|FG006|Overall Study|Death|3|||
143183476|NCT02517398|516216893|FG007|Overall Study|Death|2|||
143183477|NCT02517398|516216894|FG008|Overall Study|Death|6|||
143183478|NCT02517398|516216895|FG009|Overall Study|Death|24|||
143183479|NCT02517398|516216896|FG010|Overall Study|Death|53|||
143183480|NCT02517398|516216897|FG011|Overall Study|Death|25|||
143183481|NCT02517398|516216898|FG012|Overall Study|Death|73|||
143183482|NCT02517398|516216899|FG013|Overall Study|Death|29|||
143183483|NCT02517398|516216900|FG014|Overall Study|Death|26|||
143183484|NCT02517398|516216901|FG015|Overall Study|Death|23|||
143183485|NCT02517398|516216902|FG016|Overall Study|Death|26|||
143260160|NCT04393298|516507173|FG004|Overall Study|Patient Passed Away|0|||
143260161|NCT04393298|516507174|FG005|Overall Study|Patient Passed Away|0|||
143183486|NCT02517398|516216903|FG017|Overall Study|Death|25|||
143183487|NCT02517398|516216904|FG018|Overall Study|Death|22|||
143183488|NCT02517398|516216905|FG019|Overall Study|Death|7|||
143183489|NCT02517398|516216906|FG020|Overall Study|Death|26|||
143183490|NCT02517398|516216907|FG021|Overall Study|Death|30|||
143183491|NCT02517398|516216908|FG022|Overall Study|Death|20|||
143183492|NCT02517398|516216886|FG000|Overall Study|Other|0|||
143183493|NCT02517398|516216887|FG001|Overall Study|Other|0|||
143183494|NCT02517398|516216888|FG002|Overall Study|Other|0|||
143183495|NCT02517398|516216889|FG003|Overall Study|Other|1|||
143183496|NCT02517398|516216890|FG004|Overall Study|Other|0|||
143183497|NCT02517398|516216891|FG005|Overall Study|Other|0|||
143183498|NCT02517398|516216892|FG006|Overall Study|Other|0|||
143183499|NCT02517398|516216893|FG007|Overall Study|Other|0|||
143183500|NCT02517398|516216894|FG008|Overall Study|Other|0|||
143183501|NCT02517398|516216895|FG009|Overall Study|Other|1|||
143183502|NCT02517398|516216896|FG010|Overall Study|Other|0|||
143183503|NCT02517398|516216897|FG011|Overall Study|Other|0|||
143183504|NCT02517398|516216898|FG012|Overall Study|Other|0|||
143183505|NCT02517398|516216899|FG013|Overall Study|Other|1|||
143183506|NCT02517398|516216900|FG014|Overall Study|Other|0|||
143183507|NCT02517398|516216901|FG015|Overall Study|Other|1|||
143183508|NCT02517398|516216902|FG016|Overall Study|Other|1|||
143183509|NCT02517398|516216903|FG017|Overall Study|Other|0|||
143183510|NCT02517398|516216904|FG018|Overall Study|Other|0|||
143183511|NCT02517398|516216905|FG019|Overall Study|Other|1|||
143183512|NCT02517398|516216906|FG020|Overall Study|Other|0|||
143183513|NCT02517398|516216907|FG021|Overall Study|Other|0|||
143183514|NCT02517398|516216908|FG022|Overall Study|Other|0|||
143183515|NCT02517398|516216886|FG000|Overall Study|Lost to Follow-up|0|||
143183516|NCT02517398|516216887|FG001|Overall Study|Lost to Follow-up|0|||
143183517|NCT02517398|516216888|FG002|Overall Study|Lost to Follow-up|0|||
143183518|NCT02517398|516216889|FG003|Overall Study|Lost to Follow-up|0|||
143183519|NCT02517398|516216890|FG004|Overall Study|Lost to Follow-up|0|||
143183520|NCT02517398|516216891|FG005|Overall Study|Lost to Follow-up|0|||
143183521|NCT02517398|516216892|FG006|Overall Study|Lost to Follow-up|0|||
143183522|NCT02517398|516216893|FG007|Overall Study|Lost to Follow-up|0|||
143183523|NCT02517398|516216894|FG008|Overall Study|Lost to Follow-up|0|||
143183524|NCT02517398|516216895|FG009|Overall Study|Lost to Follow-up|1|||
143183525|NCT02517398|516216896|FG010|Overall Study|Lost to Follow-up|0|||
143183526|NCT02517398|516216897|FG011|Overall Study|Lost to Follow-up|2|||
143183527|NCT02517398|516216898|FG012|Overall Study|Lost to Follow-up|2|||
143183528|NCT02517398|516216899|FG013|Overall Study|Lost to Follow-up|0|||
143183529|NCT02517398|516216900|FG014|Overall Study|Lost to Follow-up|1|||
143183530|NCT02517398|516216901|FG015|Overall Study|Lost to Follow-up|1|||
143183531|NCT02517398|516216902|FG016|Overall Study|Lost to Follow-up|0|||
143183532|NCT02517398|516216903|FG017|Overall Study|Lost to Follow-up|3|||
143183533|NCT02517398|516216904|FG018|Overall Study|Lost to Follow-up|1|||
143183534|NCT02517398|516216905|FG019|Overall Study|Lost to Follow-up|0|||
143183535|NCT02517398|516216906|FG020|Overall Study|Lost to Follow-up|1|||
143183536|NCT02517398|516216907|FG021|Overall Study|Lost to Follow-up|0|||
143183537|NCT02517398|516216908|FG022|Overall Study|Lost to Follow-up|2|||
143183538|NCT02517398|516216886|FG000|Overall Study|Withdrew Consent|0|||
143183539|NCT02517398|516216887|FG001|Overall Study|Withdrew Consent|0|||
143183540|NCT02517398|516216888|FG002|Overall Study|Withdrew Consent|0|||
143183541|NCT02517398|516216889|FG003|Overall Study|Withdrew Consent|0|||
143183542|NCT02517398|516216890|FG004|Overall Study|Withdrew Consent|0|||
143183543|NCT02517398|516216891|FG005|Overall Study|Withdrew Consent|0|||
143183544|NCT02517398|516216892|FG006|Overall Study|Withdrew Consent|1|||
143183545|NCT02517398|516216893|FG007|Overall Study|Withdrew Consent|0|||
143183546|NCT02517398|516216894|FG008|Overall Study|Withdrew Consent|0|||
143183547|NCT02517398|516216895|FG009|Overall Study|Withdrew Consent|2|||
143183548|NCT02517398|516216896|FG010|Overall Study|Withdrew Consent|7|||
143183549|NCT02517398|516216897|FG011|Overall Study|Withdrew Consent|1|||
143183550|NCT02517398|516216898|FG012|Overall Study|Withdrew Consent|5|||
143183551|NCT02517398|516216899|FG013|Overall Study|Withdrew Consent|4|||
143183552|NCT02517398|516216900|FG014|Overall Study|Withdrew Consent|2|||
143183553|NCT02517398|516216901|FG015|Overall Study|Withdrew Consent|5|||
143183554|NCT02517398|516216902|FG016|Overall Study|Withdrew Consent|4|||
143183555|NCT02517398|516216903|FG017|Overall Study|Withdrew Consent|2|||
143183556|NCT02517398|516216904|FG018|Overall Study|Withdrew Consent|3|||
143183557|NCT02517398|516216905|FG019|Overall Study|Withdrew Consent|2|||
143183558|NCT02517398|516216906|FG020|Overall Study|Withdrew Consent|9|||
143260162|NCT04393298|516507175|FG006|Overall Study|Patient Passed Away|0|||
143260163|NCT04393298|516507176|FG007|Overall Study|Patient Passed Away|1|||
143183559|NCT02517398|516216907|FG021|Overall Study|Withdrew Consent|3|||
143183560|NCT02517398|516216908|FG022|Overall Study|Withdrew Consent|1|||
143183561|NCT02131662|516216909|FG000|Overall Study|Protocol Violation|1|||
143183562|NCT02131662|516216910|FG001|Overall Study|Protocol Violation|0|||
143183563|NCT02131662|516216911|FG002|Overall Study|Protocol Violation|0|||
143183564|NCT02131662|516216912|FG003|Overall Study|Protocol Violation|0|||
143183565|NCT02131662|516216913|FG004|Overall Study|Protocol Violation|0|||
143183566|NCT02131662|516216909|FG000|Overall Study|Other|2|||
143183567|NCT02131662|516216910|FG001|Overall Study|Other|4|||
143183568|NCT02131662|516216911|FG002|Overall Study|Other|3|||
143183569|NCT02131662|516216912|FG003|Overall Study|Other|3|||
143183570|NCT02131662|516216913|FG004|Overall Study|Other|4|||
143183571|NCT02131662|516216909|FG000|Overall Study|Adverse Event|0|||
143260164|NCT04393298|516507177|FG008|Overall Study|Patient Passed Away|0|||
143183572|NCT02131662|516216910|FG001|Overall Study|Adverse Event|1|||
143183573|NCT02131662|516216911|FG002|Overall Study|Adverse Event|1|||
143183574|NCT02131662|516216912|FG003|Overall Study|Adverse Event|1|||
143183575|NCT02131662|516216913|FG004|Overall Study|Adverse Event|3|||
143183576|NCT02131662|516216909|FG000|Overall Study|Pregnancy|0|||
143183577|NCT02131662|516216910|FG001|Overall Study|Pregnancy|1|||
143183578|NCT02131662|516216911|FG002|Overall Study|Pregnancy|0|||
143183579|NCT02131662|516216912|FG003|Overall Study|Pregnancy|1|||
143183580|NCT02131662|516216913|FG004|Overall Study|Pregnancy|0|||
143183581|NCT02131662|516216909|FG000|Overall Study|Wish for pregnancy|0|||
143183582|NCT02131662|516216910|FG001|Overall Study|Wish for pregnancy|0|||
143183583|NCT02131662|516216911|FG002|Overall Study|Wish for pregnancy|0|||
143183584|NCT02131662|516216912|FG003|Overall Study|Wish for pregnancy|0|||
143183585|NCT02131662|516216913|FG004|Overall Study|Wish for pregnancy|1|||
143183586|NCT02131662|516216909|FG000|Overall Study|Lack of Efficacy|1|||
143183587|NCT02131662|516216910|FG001|Overall Study|Lack of Efficacy|0|||
143183588|NCT02131662|516216911|FG002|Overall Study|Lack of Efficacy|0|||
143183589|NCT02131662|516216912|FG003|Overall Study|Lack of Efficacy|0|||
143183590|NCT02131662|516216913|FG004|Overall Study|Lack of Efficacy|1|||
143183591|NCT02131662|516216909|FG000|Overall Study|Withdrawal by Subject|1|||
143183592|NCT02131662|516216910|FG001|Overall Study|Withdrawal by Subject|5|||
143183593|NCT02131662|516216911|FG002|Overall Study|Withdrawal by Subject|1|||
143183594|NCT02131662|516216912|FG003|Overall Study|Withdrawal by Subject|5|||
143183595|NCT02131662|516216913|FG004|Overall Study|Withdrawal by Subject|6|||
143183596|NCT02131662|516216909|FG000|Overall Study|Lost to Follow-up|1|||
143183597|NCT02131662|516216910|FG001|Overall Study|Lost to Follow-up|3|||
143183598|NCT02131662|516216911|FG002|Overall Study|Lost to Follow-up|0|||
143183599|NCT02131662|516216912|FG003|Overall Study|Lost to Follow-up|9|||
143183600|NCT02131662|516216913|FG004|Overall Study|Lost to Follow-up|0|||
143183601|NCT02131662|516216909|FG000|Overall Study|Not treated|2|||
143183602|NCT02131662|516216910|FG001|Overall Study|Not treated|0|||
143183603|NCT02131662|516216911|FG002|Overall Study|Not treated|2|||
143183604|NCT02131662|516216912|FG003|Overall Study|Not treated|2|||
143183605|NCT02131662|516216913|FG004|Overall Study|Not treated|3|||
143183606|NCT03554018|516216914|FG000|Overall Study|Lost to Follow-up|3|||
143183607|NCT03554018|516216915|FG001|Overall Study|Lost to Follow-up|7|||
143183608|NCT01928433|516216928|FG000|Overall Study|Adverse Event|5|||
143183609|NCT01928433|516216929|FG001|Overall Study|Adverse Event|2|||
143183610|NCT01928433|516216930|FG002|Overall Study|Adverse Event|5|||
143183611|NCT01928433|516216928|FG000|Overall Study|Protocol Violation|0|||
143183612|NCT01928433|516216929|FG001|Overall Study|Protocol Violation|0|||
143183613|NCT01928433|516216930|FG002|Overall Study|Protocol Violation|2|||
143183614|NCT01928433|516216928|FG000|Overall Study|Lack of Efficacy|5|||
143183615|NCT01928433|516216929|FG001|Overall Study|Lack of Efficacy|4|||
143183616|NCT01928433|516216930|FG002|Overall Study|Lack of Efficacy|4|||
143183617|NCT01928433|516216928|FG000|Overall Study|Withdrawal by Subject|0|||
143183618|NCT01928433|516216929|FG001|Overall Study|Withdrawal by Subject|4|||
143183619|NCT01928433|516216930|FG002|Overall Study|Withdrawal by Subject|0|||
143183620|NCT01928433|516216928|FG000|Overall Study|Negative screening urine culture|7|||
143183621|NCT01928433|516216929|FG001|Overall Study|Negative screening urine culture|6|||
143183622|NCT01928433|516216930|FG002|Overall Study|Negative screening urine culture|10|||
143183623|NCT01928433|516216928|FG000|Overall Study|Lost to Follow-up|0|||
143183624|NCT01928433|516216929|FG001|Overall Study|Lost to Follow-up|2|||
143183625|NCT01928433|516216930|FG002|Overall Study|Lost to Follow-up|3|||
143183626|NCT01928433|516216928|FG000|Overall Study|Other reasons|3|||
143183627|NCT01928433|516216929|FG001|Overall Study|Other reasons|3|||
143183628|NCT01928433|516216930|FG002|Overall Study|Other reasons|4|||
143183629|NCT01198574|516216932|FG000|Overall Study|Resigned from schools|4|||
143183630|NCT01198574|516216933|FG001|Overall Study|Resigned from schools|1|||
143183631|NCT01198574|516216934|FG002|Overall Study|Resigned from schools|1|||
143183632|NCT01198574|516216935|FG003|Overall Study|Resigned from schools|4|||
143183633|NCT00556439|516216936|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
143183634|NCT00556439|516216937|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
143183635|NCT00556439|516216938|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
143183636|NCT00556439|516216939|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
143183637|NCT00556439|516216936|FG000|Study Entry to Week 12|Physician Decision|1|||
143183638|NCT00556439|516216937|FG001|Study Entry to Week 12|Physician Decision|0|||
143183639|NCT00556439|516216938|FG002|Study Entry to Week 12|Physician Decision|0|||
143183640|NCT00556439|516216939|FG003|Study Entry to Week 12|Physician Decision|0|||
143183641|NCT00556439|516216936|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
143183642|NCT00556439|516216937|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
143183643|NCT00556439|516216938|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
143183644|NCT00556439|516216939|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
143183645|NCT00556439|516216936|FG000|Study Entry to Week 12|Recurrent infection|1|||
143183646|NCT00556439|516216937|FG001|Study Entry to Week 12|Recurrent infection|0|||
143183647|NCT00556439|516216938|FG002|Study Entry to Week 12|Recurrent infection|0|||
143183648|NCT00556439|516216939|FG003|Study Entry to Week 12|Recurrent infection|0|||
143183649|NCT00556439|516216936|FG000|Study Entry to Week 12|Malignancy|0|||
143183650|NCT00556439|516216937|FG001|Study Entry to Week 12|Malignancy|0|||
143183651|NCT00556439|516216938|FG002|Study Entry to Week 12|Malignancy|1|||
143183652|NCT00556439|516216939|FG003|Study Entry to Week 12|Malignancy|0|||
143183653|NCT00556439|516216936|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
143183654|NCT00556439|516216937|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
143183655|NCT00556439|516216938|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
143183656|NCT00556439|516216939|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
143183657|NCT00556439|516216936|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
143183658|NCT00556439|516216937|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
143183659|NCT00556439|516216938|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
143183660|NCT00556439|516216939|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
143183661|NCT00556439|516216936|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
143183662|NCT00556439|516216937|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
143183663|NCT00556439|516216938|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
143183664|NCT00556439|516216939|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
143183665|NCT00556439|516216936|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
143183666|NCT00556439|516216937|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
143183667|NCT00556439|516216938|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
143183668|NCT00556439|516216939|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
143183669|NCT02100423|516216940|FG000|Overall Study|Death|1|||
143183670|NCT02100423|516216940|FG000|Overall Study|Withdrawal by Subject|3|||
143183671|NCT02100423|516216940|FG000|Overall Study|Adverse Event|1|||
143183672|NCT02100423|516216940|FG000|Overall Study|Physician Decision|1|||
143183673|NCT05823974|516218752|FG000|Overall Study|Lost to Follow-up|0|||
143183674|NCT05823974|516218753|FG001|Overall Study|Lost to Follow-up|3|||
143183675|NCT05823974|516218754|FG002|Overall Study|Lost to Follow-up|1|||
143183676|NCT05823974|516218755|FG003|Overall Study|Lost to Follow-up|0|||
143183677|NCT05823974|516218756|FG004|Overall Study|Lost to Follow-up|1|||
143183678|NCT05823974|516218757|FG005|Overall Study|Lost to Follow-up|0|||
143183679|NCT05823974|516218758|FG006|Overall Study|Lost to Follow-up|1|||
143183680|NCT05823974|516218759|FG007|Overall Study|Lost to Follow-up|0|||
143183681|NCT05823974|516218760|FG008|Overall Study|Lost to Follow-up|0|||
143183682|NCT05823974|516218761|FG009|Overall Study|Lost to Follow-up|1|||
143183683|NCT05823974|516218762|FG010|Overall Study|Lost to Follow-up|1|||
143183684|NCT05823974|516218763|FG011|Overall Study|Lost to Follow-up|0|||
143183685|NCT05823974|516218764|FG012|Overall Study|Lost to Follow-up|1|||
143183686|NCT05823974|516218765|FG013|Overall Study|Lost to Follow-up|2|||
143183687|NCT05823974|516218766|FG014|Overall Study|Lost to Follow-up|1|||
143183688|NCT05823974|516218767|FG015|Overall Study|Lost to Follow-up|1|||
143183689|NCT05823974|516218768|FG016|Overall Study|Lost to Follow-up|1|||
143183690|NCT05823974|516218769|FG017|Overall Study|Lost to Follow-up|0|||
143183691|NCT05823974|516218770|FG018|Overall Study|Lost to Follow-up|0|||
143183692|NCT05823974|516218771|FG019|Overall Study|Lost to Follow-up|2|||
143183693|NCT05823974|516218772|FG020|Overall Study|Lost to Follow-up|0|||
143183694|NCT05823974|516218752|FG000|Overall Study|Physician Decision|0|||
143183695|NCT05823974|516218753|FG001|Overall Study|Physician Decision|0|||
143183696|NCT05823974|516218754|FG002|Overall Study|Physician Decision|0|||
143183697|NCT05823974|516218755|FG003|Overall Study|Physician Decision|0|||
143183698|NCT05823974|516218756|FG004|Overall Study|Physician Decision|0|||
143183699|NCT05823974|516218757|FG005|Overall Study|Physician Decision|0|||
143183700|NCT05823974|516218758|FG006|Overall Study|Physician Decision|0|||
143369349|NCT02263508|516896073|FG000|Overall Study|Withdrawal by Subject|1|||
143260165|NCT04393298|516507178|FG009|Overall Study|Patient Passed Away|0|||
143260166|NCT04393298|516507179|FG010|Overall Study|Patient Passed Away|0|||
143260167|NCT04393298|516507180|FG011|Overall Study|Patient Passed Away|0|||
143260168|NCT04393298|516507181|FG012|Overall Study|Patient Passed Away|0|||
143260169|NCT04393298|516507182|FG013|Overall Study|Patient Passed Away|0|||
143183701|NCT05823974|516218759|FG007|Overall Study|Physician Decision|0|||
143183702|NCT05823974|516218760|FG008|Overall Study|Physician Decision|0|||
143183703|NCT05823974|516218761|FG009|Overall Study|Physician Decision|0|||
143183704|NCT05823974|516218762|FG010|Overall Study|Physician Decision|0|||
143183705|NCT05823974|516218763|FG011|Overall Study|Physician Decision|0|||
143183706|NCT05823974|516218764|FG012|Overall Study|Physician Decision|0|||
143183707|NCT05823974|516218765|FG013|Overall Study|Physician Decision|0|||
143183708|NCT05823974|516218766|FG014|Overall Study|Physician Decision|0|||
143183709|NCT05823974|516218767|FG015|Overall Study|Physician Decision|1|||
143183710|NCT05823974|516218768|FG016|Overall Study|Physician Decision|0|||
143183711|NCT05823974|516218769|FG017|Overall Study|Physician Decision|1|||
143183712|NCT05823974|516218770|FG018|Overall Study|Physician Decision|1|||
143183713|NCT05823974|516218771|FG019|Overall Study|Physician Decision|0|||
143183714|NCT05823974|516218772|FG020|Overall Study|Physician Decision|0|||
143183715|NCT05823974|516218752|FG000|Overall Study|Withdrawal by Subject|1|||
143183716|NCT05823974|516218753|FG001|Overall Study|Withdrawal by Subject|1|||
143183717|NCT05823974|516218754|FG002|Overall Study|Withdrawal by Subject|2|||
143183718|NCT05823974|516218755|FG003|Overall Study|Withdrawal by Subject|0|||
143183719|NCT05823974|516218756|FG004|Overall Study|Withdrawal by Subject|2|||
143183720|NCT05823974|516218757|FG005|Overall Study|Withdrawal by Subject|3|||
143183721|NCT05823974|516218758|FG006|Overall Study|Withdrawal by Subject|1|||
143183722|NCT05823974|516218759|FG007|Overall Study|Withdrawal by Subject|1|||
143183723|NCT05823974|516218760|FG008|Overall Study|Withdrawal by Subject|2|||
143183724|NCT05823974|516218761|FG009|Overall Study|Withdrawal by Subject|1|||
143183725|NCT05823974|516218762|FG010|Overall Study|Withdrawal by Subject|1|||
143183726|NCT05823974|516218763|FG011|Overall Study|Withdrawal by Subject|0|||
143183727|NCT05823974|516218764|FG012|Overall Study|Withdrawal by Subject|0|||
143183728|NCT05823974|516218765|FG013|Overall Study|Withdrawal by Subject|1|||
143183729|NCT05823974|516218766|FG014|Overall Study|Withdrawal by Subject|1|||
143183730|NCT05823974|516218767|FG015|Overall Study|Withdrawal by Subject|3|||
143183731|NCT05823974|516218768|FG016|Overall Study|Withdrawal by Subject|0|||
143183732|NCT05823974|516218769|FG017|Overall Study|Withdrawal by Subject|2|||
143183733|NCT05823974|516218770|FG018|Overall Study|Withdrawal by Subject|2|||
143183734|NCT05823974|516218771|FG019|Overall Study|Withdrawal by Subject|0|||
143183735|NCT05823974|516218772|FG020|Overall Study|Withdrawal by Subject|1|||
143183736|NCT05823974|516218752|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143183737|NCT05823974|516218753|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143183738|NCT05823974|516218754|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
143183739|NCT05823974|516218755|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143183740|NCT05823974|516218756|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143183741|NCT05823974|516218757|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143183742|NCT05823974|516218758|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143183743|NCT05823974|516218759|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143183744|NCT05823974|516218760|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143183745|NCT05823974|516218761|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143183746|NCT05823974|516218762|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143183747|NCT05823974|516218763|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143183748|NCT05823974|516218764|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143183749|NCT05823974|516218765|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143183750|NCT05823974|516218766|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
143183751|NCT05823974|516218767|FG015|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143183752|NCT05823974|516218768|FG016|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143183753|NCT05823974|516218769|FG017|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143183754|NCT05823974|516218770|FG018|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143183755|NCT05823974|516218771|FG019|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143183756|NCT05823974|516218772|FG020|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143183757|NCT05823974|516218752|FG000|Overall Study|Other|0|||
143183758|NCT05823974|516218753|FG001|Overall Study|Other|1|||
143183759|NCT05823974|516218754|FG002|Overall Study|Other|1|||
143183760|NCT05823974|516218755|FG003|Overall Study|Other|1|||
143183761|NCT05823974|516218756|FG004|Overall Study|Other|0|||
143183762|NCT05823974|516218757|FG005|Overall Study|Other|1|||
143183763|NCT05823974|516218758|FG006|Overall Study|Other|1|||
143183764|NCT05823974|516218759|FG007|Overall Study|Other|1|||
143183765|NCT05823974|516218760|FG008|Overall Study|Other|1|||
143183766|NCT05823974|516218761|FG009|Overall Study|Other|0|||
143183767|NCT05823974|516218762|FG010|Overall Study|Other|0|||
143183768|NCT05823974|516218763|FG011|Overall Study|Other|0|||
143260170|NCT04393298|516507183|FG014|Overall Study|Patient Passed Away|0|||
143369350|NCT02263508|516896074|FG001|Overall Study|Withdrawal by Subject|23|||
143369351|NCT02263508|516896075|FG002|Overall Study|Withdrawal by Subject|17|||
143369352|NCT02263508|516896073|FG000|Overall Study|Sponsor Decision|12|||
143369353|NCT02263508|516896074|FG001|Overall Study|Sponsor Decision|165|||
143115169|NCT02326298|515962466|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143115170|NCT02326298|515962467|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143115171|NCT02326298|515962468|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143115172|NCT02326298|515962469|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
143115173|NCT02326298|515962470|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
143115174|NCT02326298|515962471|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
143115175|NCT01306045|515962472|FG000|Met General Eligibility Criteria|Screen failures|193|||
143115176|NCT01306045|515962473|FG001|Met General Eligibility Criteria|Screen failures|11|||
143115177|NCT01306045|515962474|FG002|Met General Eligibility Criteria|Screen failures|8|||
143115178|NCT03521817|515962481|FG000|Overall Study|Protocol Violation|0|||
143115179|NCT03521817|515962482|FG001|Overall Study|Protocol Violation|1|||
143115180|NCT00778102|515962483|FG000|Overall Study|Adverse Event|8|||
143115181|NCT00778102|515962484|FG001|Overall Study|Adverse Event|5|||
143115182|NCT00778102|515962483|FG000|Overall Study|Death|1|||
143115183|NCT00778102|515962484|FG001|Overall Study|Death|1|||
143115184|NCT00778102|515962483|FG000|Overall Study|Lost to Follow-up|1|||
143115185|NCT00778102|515962484|FG001|Overall Study|Lost to Follow-up|0|||
143115186|NCT00778102|515962483|FG000|Overall Study|Violation of Selection Criteria|1|||
143115187|NCT00778102|515962484|FG001|Overall Study|Violation of Selection Criteria|1|||
143115188|NCT00778102|515962483|FG000|Overall Study|Protocol Violation|0|||
143115189|NCT00778102|515962484|FG001|Overall Study|Protocol Violation|1|||
143115190|NCT00778102|515962483|FG000|Overall Study|Refused Treatment|2|||
143115191|NCT00778102|515962484|FG001|Overall Study|Refused Treatment|3|||
143115192|NCT00778102|515962483|FG000|Overall Study|Withdrawal by Subject|1|||
143115193|NCT00778102|515962484|FG001|Overall Study|Withdrawal by Subject|1|||
143115194|NCT00778102|515962483|FG000|Overall Study|Administrative Reason|7|||
143115195|NCT00778102|515962484|FG001|Overall Study|Administrative Reason|10|||
143115196|NCT01328548|515962485|FG000|Overall Study|Death|3|||
143115197|NCT01328548|515962486|FG001|Overall Study|Death|0|||
143115198|NCT01328548|515962485|FG000|Overall Study|Protocol Violation|1|||
143115199|NCT01328548|515962486|FG001|Overall Study|Protocol Violation|0|||
143115200|NCT03976323|515962489|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
143115201|NCT03976323|515962490|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
143115202|NCT03976323|515962491|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
143115203|NCT03976323|515962489|FG000|Induction Phase|Death|80|||
143115204|NCT03976323|515962490|FG001|Induction Phase|Death|0|||
143115205|NCT03976323|515962491|FG002|Induction Phase|Death|0|||
143115206|NCT03976323|515962489|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
143115207|NCT03976323|515962490|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
143115208|NCT03976323|515962491|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
143115209|NCT03976323|515962489|FG000|Maintenance Phase|Withdrawal by Subject|0|||
143115210|NCT03976323|515962490|FG001|Maintenance Phase|Withdrawal by Subject|9|||
143115211|NCT03976323|515962491|FG002|Maintenance Phase|Withdrawal by Subject|3|||
143115212|NCT03976323|515962489|FG000|Maintenance Phase|Physician Decision|0|||
143115213|NCT03976323|515962490|FG001|Maintenance Phase|Physician Decision|0|||
143115214|NCT03976323|515962491|FG002|Maintenance Phase|Physician Decision|1|||
143115215|NCT03976323|515962489|FG000|Maintenance Phase|Death|0|||
143115216|NCT03976323|515962490|FG001|Maintenance Phase|Death|228|||
143115217|NCT03976323|515962491|FG002|Maintenance Phase|Death|234|||
143115218|NCT04676412|515963858|FG000|Overall Study|Death|28|||
143115219|NCT04676412|515963859|FG001|Overall Study|Death|31|||
143115220|NCT04676412|515963858|FG000|Overall Study|Lost to Follow-up|1|||
143115221|NCT04676412|515963859|FG001|Overall Study|Lost to Follow-up|2|||
143115222|NCT04676412|515963858|FG000|Overall Study|Sponsor Decision|20|||
143115223|NCT04676412|515963859|FG001|Overall Study|Sponsor Decision|23|||
143115224|NCT04676412|515963858|FG000|Overall Study|Withdrawal by Subject|0|||
143115225|NCT04676412|515963859|FG001|Overall Study|Withdrawal by Subject|2|||
143115226|NCT04550832|515963860|FG000|Overall Study|Adverse Event|0|||
143115227|NCT04550832|515963861|FG001|Overall Study|Adverse Event|0|||
143115228|NCT04550832|515963862|FG002|Overall Study|Adverse Event|2|||
143115229|NCT04550832|515963863|FG003|Overall Study|Adverse Event|0|||
143115230|NCT04550832|515963864|FG004|Overall Study|Adverse Event|1|||
143115231|NCT04823130|515963865|FG000|Overall Study|Withdrawal by Subject|2|||
143115232|NCT04823130|515963866|FG001|Overall Study|Withdrawal by Subject|3|||
143115233|NCT04823130|515963865|FG000|Overall Study|Failure to meet inclusion criteria|6|||
143115234|NCT04823130|515963866|FG001|Overall Study|Failure to meet inclusion criteria|4|||
143115235|NCT04823130|515963865|FG000|Overall Study|Other-unspecified|1|||
143115236|NCT04823130|515963866|FG001|Overall Study|Other-unspecified|0|||
143115237|NCT03315455|515963867|FG000|Overall Study|Ongoing in the Study|13|||
143115238|NCT03315455|515963868|FG001|Overall Study|Ongoing in the Study|24|||
143115239|NCT03315455|515963869|FG002|Overall Study|Ongoing in the Study|17|||
143183769|NCT05823974|516218764|FG012|Overall Study|Other|2|||
143183770|NCT05823974|516218765|FG013|Overall Study|Other|1|||
143183771|NCT05823974|516218766|FG014|Overall Study|Other|0|||
143183772|NCT05823974|516218767|FG015|Overall Study|Other|1|||
143183773|NCT05823974|516218768|FG016|Overall Study|Other|0|||
143183774|NCT05823974|516218769|FG017|Overall Study|Other|0|||
143183775|NCT05823974|516218770|FG018|Overall Study|Other|0|||
143183776|NCT05823974|516218771|FG019|Overall Study|Other|0|||
143183777|NCT05823974|516218772|FG020|Overall Study|Other|0|||
143183778|NCT01238991|516218777|FG000|Overall Study|Adverse Event|1|||
143183779|NCT01238991|516218778|FG001|Overall Study|Adverse Event|0|||
143183780|NCT01238991|516218779|FG002|Overall Study|Adverse Event|3|||
143183781|NCT01238991|516218780|FG003|Overall Study|Adverse Event|1|||
143183782|NCT01238991|516218781|FG004|Overall Study|Adverse Event|1|||
143183783|NCT01238991|516218782|FG005|Overall Study|Adverse Event|0|||
143183784|NCT01238991|516218783|FG006|Overall Study|Adverse Event|1|||
143183785|NCT01238991|516218784|FG007|Overall Study|Adverse Event|1|||
143183786|NCT01238991|516218785|FG008|Overall Study|Adverse Event|0|||
143183787|NCT01238991|516218786|FG009|Overall Study|Adverse Event|0|||
143183788|NCT01238991|516218777|FG000|Overall Study|Death|0|||
143183789|NCT01238991|516218778|FG001|Overall Study|Death|0|||
143183790|NCT01238991|516218779|FG002|Overall Study|Death|0|||
143183791|NCT01238991|516218780|FG003|Overall Study|Death|1|||
143183792|NCT01238991|516218781|FG004|Overall Study|Death|0|||
143183793|NCT01238991|516218782|FG005|Overall Study|Death|0|||
143183794|NCT01238991|516218783|FG006|Overall Study|Death|0|||
143183795|NCT01238991|516218784|FG007|Overall Study|Death|0|||
143183796|NCT01238991|516218785|FG008|Overall Study|Death|0|||
143183797|NCT01238991|516218786|FG009|Overall Study|Death|0|||
143183798|NCT01238991|516218777|FG000|Overall Study|Lack of Efficacy|0|||
143183799|NCT01238991|516218778|FG001|Overall Study|Lack of Efficacy|0|||
143183800|NCT01238991|516218779|FG002|Overall Study|Lack of Efficacy|1|||
143183801|NCT01238991|516218780|FG003|Overall Study|Lack of Efficacy|0|||
143183802|NCT01238991|516218781|FG004|Overall Study|Lack of Efficacy|0|||
143183803|NCT01238991|516218782|FG005|Overall Study|Lack of Efficacy|0|||
143183804|NCT01238991|516218783|FG006|Overall Study|Lack of Efficacy|0|||
143183805|NCT01238991|516218784|FG007|Overall Study|Lack of Efficacy|0|||
143183806|NCT01238991|516218785|FG008|Overall Study|Lack of Efficacy|1|||
143183807|NCT01238991|516218786|FG009|Overall Study|Lack of Efficacy|0|||
143183808|NCT01238991|516218777|FG000|Overall Study|Withdrawal by Subject|0|||
143183809|NCT01238991|516218778|FG001|Overall Study|Withdrawal by Subject|0|||
143183810|NCT01238991|516218779|FG002|Overall Study|Withdrawal by Subject|1|||
143183811|NCT01238991|516218780|FG003|Overall Study|Withdrawal by Subject|0|||
143183812|NCT01238991|516218781|FG004|Overall Study|Withdrawal by Subject|0|||
143183813|NCT01238991|516218782|FG005|Overall Study|Withdrawal by Subject|0|||
143183814|NCT01238991|516218783|FG006|Overall Study|Withdrawal by Subject|0|||
143183815|NCT01238991|516218784|FG007|Overall Study|Withdrawal by Subject|0|||
143183816|NCT01238991|516218785|FG008|Overall Study|Withdrawal by Subject|0|||
143183817|NCT01238991|516218786|FG009|Overall Study|Withdrawal by Subject|0|||
143183818|NCT01238991|516218777|FG000|Overall Study|Study Terminated by Sponsor|0|||
143183819|NCT01238991|516218778|FG001|Overall Study|Study Terminated by Sponsor|0|||
143183820|NCT01238991|516218779|FG002|Overall Study|Study Terminated by Sponsor|0|||
143183821|NCT01238991|516218780|FG003|Overall Study|Study Terminated by Sponsor|0|||
143183822|NCT01238991|516218781|FG004|Overall Study|Study Terminated by Sponsor|1|||
143183823|NCT01238991|516218782|FG005|Overall Study|Study Terminated by Sponsor|0|||
143183824|NCT01238991|516218783|FG006|Overall Study|Study Terminated by Sponsor|7|||
143183825|NCT01238991|516218784|FG007|Overall Study|Study Terminated by Sponsor|4|||
143183826|NCT01238991|516218785|FG008|Overall Study|Study Terminated by Sponsor|2|||
143183827|NCT01238991|516218786|FG009|Overall Study|Study Terminated by Sponsor|2|||
143183828|NCT01238991|516218777|FG000|Overall Study|Caregiver's request|0|||
143183829|NCT01238991|516218778|FG001|Overall Study|Caregiver's request|0|||
143183830|NCT01238991|516218779|FG002|Overall Study|Caregiver's request|0|||
143183831|NCT01238991|516218780|FG003|Overall Study|Caregiver's request|0|||
143183832|NCT01238991|516218781|FG004|Overall Study|Caregiver's request|0|||
143183833|NCT01238991|516218782|FG005|Overall Study|Caregiver's request|0|||
143183834|NCT01238991|516218783|FG006|Overall Study|Caregiver's request|0|||
143183835|NCT01238991|516218784|FG007|Overall Study|Caregiver's request|0|||
143183836|NCT01238991|516218785|FG008|Overall Study|Caregiver's request|1|||
143183837|NCT01238991|516218786|FG009|Overall Study|Caregiver's request|0|||
143183838|NCT01238991|516218777|FG000|Overall Study|Admission to a nursing home|1|||
143183839|NCT01238991|516218778|FG001|Overall Study|Admission to a nursing home|0|||
143183840|NCT01238991|516218779|FG002|Overall Study|Admission to a nursing home|1|||
143183841|NCT01238991|516218780|FG003|Overall Study|Admission to a nursing home|0|||
143183842|NCT01238991|516218781|FG004|Overall Study|Admission to a nursing home|0|||
143183843|NCT01238991|516218782|FG005|Overall Study|Admission to a nursing home|0|||
143183844|NCT01238991|516218783|FG006|Overall Study|Admission to a nursing home|0|||
143183845|NCT01238991|516218784|FG007|Overall Study|Admission to a nursing home|0|||
143183846|NCT01238991|516218785|FG008|Overall Study|Admission to a nursing home|0|||
143183847|NCT01238991|516218786|FG009|Overall Study|Admission to a nursing home|0|||
143183848|NCT02222688|516218790|FG000|Overall Study|Withdrawal by Subject|0|||
143183849|NCT02222688|516218791|FG001|Overall Study|Withdrawal by Subject|0|||
143183850|NCT02222688|516218792|FG002|Overall Study|Withdrawal by Subject|0|||
143183851|NCT02222688|516218793|FG003|Overall Study|Withdrawal by Subject|2|||
143183852|NCT02222688|516218794|FG004|Overall Study|Withdrawal by Subject|1|||
143183853|NCT02222688|516218795|FG005|Overall Study|Withdrawal by Subject|0|||
143183854|NCT02222688|516218796|FG006|Overall Study|Withdrawal by Subject|1|||
143183855|NCT02222688|516218790|FG000|Overall Study|Disease progression|1|||
143183856|NCT02222688|516218791|FG001|Overall Study|Disease progression|0|||
143183857|NCT02222688|516218792|FG002|Overall Study|Disease progression|0|||
143183858|NCT02222688|516218793|FG003|Overall Study|Disease progression|0|||
143183859|NCT02222688|516218794|FG004|Overall Study|Disease progression|0|||
143183860|NCT02222688|516218795|FG005|Overall Study|Disease progression|0|||
143183861|NCT02222688|516218796|FG006|Overall Study|Disease progression|0|||
143183862|NCT00294671|516218799|FG000|Overall Study|Lack of Efficacy|11|||
143183863|NCT00294671|516218800|FG001|Overall Study|Lack of Efficacy|23|||
143183864|NCT00294671|516218799|FG000|Overall Study|Liver transplant|7|||
143183865|NCT00294671|516218800|FG001|Overall Study|Liver transplant|9|||
143183866|NCT00294671|516218799|FG000|Overall Study|Drug related adverse event (AE)|4|||
143183867|NCT00294671|516218800|FG001|Overall Study|Drug related adverse event (AE)|2|||
143183868|NCT00294671|516218799|FG000|Overall Study|Non-drug related AE|3|||
143183869|NCT00294671|516218800|FG001|Overall Study|Non-drug related AE|2|||
143183870|NCT00294671|516218799|FG000|Overall Study|Lost to Follow-up|1|||
143183871|NCT00294671|516218800|FG001|Overall Study|Lost to Follow-up|3|||
143183872|NCT00294671|516218799|FG000|Overall Study|Non-compliance|1|||
143183873|NCT00294671|516218800|FG001|Overall Study|Non-compliance|0|||
143183874|NCT00294671|516218799|FG000|Overall Study|Death|0|||
143183875|NCT00294671|516218800|FG001|Overall Study|Death|1|||
143183876|NCT00078806|516218806|FG000|Part 1A|Adverse Event|2|||
143183877|NCT00078806|516218807|FG001|Part 1A|Adverse Event|0|||
143183878|NCT00078806|516218808|FG002|Part 1A|Adverse Event|0|||
143183879|NCT00078806|516218809|FG003|Part 1A|Adverse Event|0|||
143183880|NCT00078806|516218806|FG000|Part 1A|Lack of Efficacy|7|||
143183881|NCT00078806|516218807|FG001|Part 1A|Lack of Efficacy|0|||
143183882|NCT00078806|516218808|FG002|Part 1A|Lack of Efficacy|0|||
143183883|NCT00078806|516218809|FG003|Part 1A|Lack of Efficacy|0|||
143183884|NCT00078806|516218806|FG000|Part 1A|Other|1|||
143183885|NCT00078806|516218807|FG001|Part 1A|Other|0|||
143183886|NCT00078806|516218808|FG002|Part 1A|Other|0|||
143183887|NCT00078806|516218809|FG003|Part 1A|Other|0|||
143183888|NCT00078806|516218806|FG000|Part 1B|Adverse Event|1|||
143183889|NCT00078806|516218807|FG001|Part 1B|Adverse Event|0|||
143183890|NCT00078806|516218808|FG002|Part 1B|Adverse Event|0|||
143183891|NCT00078806|516218809|FG003|Part 1B|Adverse Event|0|||
143183892|NCT00078806|516218806|FG000|Part 1B|Lack of Efficacy|7|||
143183893|NCT00078806|516218807|FG001|Part 1B|Lack of Efficacy|0|||
143183894|NCT00078806|516218808|FG002|Part 1B|Lack of Efficacy|0|||
143183895|NCT00078806|516218809|FG003|Part 1B|Lack of Efficacy|0|||
143183896|NCT00078806|516218806|FG000|Part 2|Adverse Event|0|||
143183897|NCT00078806|516218807|FG001|Part 2|Adverse Event|1|||
143183898|NCT00078806|516218808|FG002|Part 2|Adverse Event|0|||
143183899|NCT00078806|516218809|FG003|Part 2|Adverse Event|0|||
143183900|NCT03308968|516218812|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
143183901|NCT03308968|516218813|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
143183902|NCT03308968|516218814|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
143183903|NCT03308968|516218812|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
143183904|NCT03308968|516218813|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
143183905|NCT03308968|516218814|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
143183906|NCT03308968|516218812|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
143183907|NCT03308968|516218813|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
143183908|NCT03308968|516218814|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
143183909|NCT03308968|516218812|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
143183910|NCT03308968|516218813|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
143183911|NCT03308968|516218814|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
143183912|NCT03308968|516218812|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
143183913|NCT03308968|516218813|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
143183914|NCT03308968|516218814|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
143183915|NCT03308968|516218812|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
143183916|NCT03308968|516218813|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
143183917|NCT03308968|516218814|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
143183918|NCT03308968|516218812|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
143183919|NCT03308968|516218813|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
143183920|NCT03308968|516218814|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
143183921|NCT03308968|516218812|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
143183922|NCT03308968|516218813|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
143183923|NCT03308968|516218814|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
143183924|NCT03308968|516218812|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
143183925|NCT03308968|516218813|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
143183926|NCT03308968|516218814|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
143183927|NCT03308968|516218812|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
143183928|NCT03308968|516218813|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
143183929|NCT03308968|516218814|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
143183930|NCT03308968|516218812|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
143183931|NCT03308968|516218813|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
143183932|NCT03308968|516218814|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
143183933|NCT03308968|516218812|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
143183934|NCT03308968|516218813|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
143183935|NCT03308968|516218814|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
143183936|NCT03308968|516218812|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
143183937|NCT03308968|516218813|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
143183938|NCT03308968|516218814|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
143183939|NCT03308968|516218812|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
143183940|NCT03308968|516218813|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
143183941|NCT03308968|516218814|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
143183942|NCT02482298|516218815|FG000|Overall Study|Withdrawal by Subject|2|||
143183943|NCT02482298|516218816|FG001|Overall Study|Withdrawal by Subject|1|||
143183944|NCT02482298|516218817|FG002|Overall Study|Withdrawal by Subject|2|||
143183945|NCT02482298|516218815|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
143183946|NCT02482298|516218816|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
143183947|NCT02482298|516218817|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
143183948|NCT02482298|516218815|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
143183949|NCT02482298|516218816|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
143183950|NCT02482298|516218817|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
143183951|NCT02482298|516218815|FG000|Overall Study|Lost to Follow-up|0|||
143183952|NCT02482298|516218816|FG001|Overall Study|Lost to Follow-up|1|||
143183953|NCT02482298|516218817|FG002|Overall Study|Lost to Follow-up|0|||
143183954|NCT02140970|516218818|FG000|Overall Study|Lost to Follow-up|1|||
143183955|NCT02140970|516218819|FG001|Overall Study|Lost to Follow-up|2|||
143183956|NCT02140970|516218818|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
143183957|NCT02140970|516218819|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
143183958|NCT02140970|516218818|FG000|Overall Study|Did not meet inclusion criteria|0|||
143260171|NCT04393298|516507169|FG000|Overall Study|Patient Deceased|0|||
143260172|NCT04393298|516507170|FG001|Overall Study|Patient Deceased|0|||
143260173|NCT04393298|516507171|FG002|Overall Study|Patient Deceased|0|||
143260174|NCT04393298|516507172|FG003|Overall Study|Patient Deceased|0|||
143260175|NCT04393298|516507173|FG004|Overall Study|Patient Deceased|0|||
143260176|NCT04393298|516507174|FG005|Overall Study|Patient Deceased|0|||
143260177|NCT04393298|516507175|FG006|Overall Study|Patient Deceased|0|||
143260178|NCT04393298|516507176|FG007|Overall Study|Patient Deceased|1|||
143260179|NCT04393298|516507177|FG008|Overall Study|Patient Deceased|0|||
143260180|NCT04393298|516507178|FG009|Overall Study|Patient Deceased|0|||
143260181|NCT04393298|516507179|FG010|Overall Study|Patient Deceased|0|||
143260182|NCT04393298|516507180|FG011|Overall Study|Patient Deceased|0|||
143260183|NCT04393298|516507181|FG012|Overall Study|Patient Deceased|0|||
143260184|NCT04393298|516507182|FG013|Overall Study|Patient Deceased|0|||
143260185|NCT04393298|516507183|FG014|Overall Study|Patient Deceased|0|||
143115240|NCT03315455|515963870|FG003|Overall Study|Ongoing in the Study|15|||
143115241|NCT03315455|515963867|FG000|Overall Study|Withdrawal by Subject|0|||
143115242|NCT03315455|515963868|FG001|Overall Study|Withdrawal by Subject|1|||
143115243|NCT03315455|515963869|FG002|Overall Study|Withdrawal by Subject|0|||
143115244|NCT03315455|515963870|FG003|Overall Study|Withdrawal by Subject|0|||
143115245|NCT04439357|515963871|FG000|Overall Study|Disease Progression|4|||
143115246|NCT00308750|515963881|FG000|Overall Study|Adverse Event|9|||
143115247|NCT00308750|515963882|FG001|Overall Study|Adverse Event|9|||
143115248|NCT00308750|515963883|FG002|Overall Study|Adverse Event|13|||
143115249|NCT00308750|515963881|FG000|Overall Study|Withdrawal by Subject|6|||
143115250|NCT00308750|515963882|FG001|Overall Study|Withdrawal by Subject|2|||
143115251|NCT00308750|515963883|FG002|Overall Study|Withdrawal by Subject|3|||
143115252|NCT00308750|515963881|FG000|Overall Study|Physician Decision|3|||
143115253|NCT00308750|515963882|FG001|Overall Study|Physician Decision|4|||
143115254|NCT00308750|515963883|FG002|Overall Study|Physician Decision|3|||
143115255|NCT00308750|515963881|FG000|Overall Study|Sponsor Decision|1|||
143115256|NCT00308750|515963882|FG001|Overall Study|Sponsor Decision|0|||
143115257|NCT00308750|515963883|FG002|Overall Study|Sponsor Decision|0|||
143115258|NCT00308750|515963881|FG000|Overall Study|Disease Progression|47|||
143115259|NCT00308750|515963882|FG001|Overall Study|Disease Progression|24|||
143115260|NCT00308750|515963883|FG002|Overall Study|Disease Progression|28|||
143115261|NCT00308750|515963881|FG000|Overall Study|Unrelated Complication|3|||
143115262|NCT00308750|515963882|FG001|Overall Study|Unrelated Complication|0|||
143115263|NCT00308750|515963883|FG002|Overall Study|Unrelated Complication|1|||
143115264|NCT00308750|515963881|FG000|Overall Study|Death|1|||
143115265|NCT00308750|515963882|FG001|Overall Study|Death|0|||
143115266|NCT00308750|515963883|FG002|Overall Study|Death|1|||
143115267|NCT00308750|515963881|FG000|Overall Study|Protocol Violation|1|||
143115268|NCT00308750|515963882|FG001|Overall Study|Protocol Violation|0|||
143115269|NCT00308750|515963883|FG002|Overall Study|Protocol Violation|0|||
143115270|NCT00308750|515963881|FG000|Overall Study|New Primary Disease Identified|1|||
143115271|NCT00308750|515963882|FG001|Overall Study|New Primary Disease Identified|1|||
143115272|NCT00308750|515963883|FG002|Overall Study|New Primary Disease Identified|0|||
143115273|NCT01358578|515963884|FG000|Induction Period|Adverse Event|2|||
143115274|NCT01358578|515963885|FG001|Induction Period|Adverse Event|4|||
143115275|NCT01358578|515963886|FG002|Induction Period|Adverse Event|2|||
143115276|NCT01358578|515963887|FG003|Induction Period|Adverse Event|6|||
143115277|NCT01358578|515963888|FG004|Induction Period|Adverse Event|0|||
143115278|NCT01358578|515963889|FG005|Induction Period|Adverse Event|0|||
143115279|NCT01358578|515963884|FG000|Induction Period|Lack of Efficacy|0|||
143115280|NCT01358578|515963885|FG001|Induction Period|Lack of Efficacy|0|||
143115281|NCT01358578|515963886|FG002|Induction Period|Lack of Efficacy|9|||
143115282|NCT01358578|515963887|FG003|Induction Period|Lack of Efficacy|1|||
143115283|NCT01358578|515963888|FG004|Induction Period|Lack of Efficacy|0|||
143115284|NCT01358578|515963889|FG005|Induction Period|Lack of Efficacy|0|||
143115285|NCT01358578|515963884|FG000|Induction Period|Lost to Follow-up|0|||
143115286|NCT01358578|515963885|FG001|Induction Period|Lost to Follow-up|0|||
143115287|NCT01358578|515963886|FG002|Induction Period|Lost to Follow-up|1|||
143115288|NCT01358578|515963887|FG003|Induction Period|Lost to Follow-up|4|||
143115289|NCT01358578|515963888|FG004|Induction Period|Lost to Follow-up|0|||
143115290|NCT01358578|515963889|FG005|Induction Period|Lost to Follow-up|0|||
143115291|NCT01358578|515963884|FG000|Induction Period|Physician Decision|2|||
143115292|NCT01358578|515963885|FG001|Induction Period|Physician Decision|1|||
143115293|NCT01358578|515963886|FG002|Induction Period|Physician Decision|2|||
143115294|NCT01358578|515963887|FG003|Induction Period|Physician Decision|0|||
143115295|NCT01358578|515963888|FG004|Induction Period|Physician Decision|0|||
143115296|NCT01358578|515963889|FG005|Induction Period|Physician Decision|0|||
143115297|NCT01358578|515963884|FG000|Induction Period|Protocol Deviation|3|||
143115298|NCT01358578|515963885|FG001|Induction Period|Protocol Deviation|5|||
143115299|NCT01358578|515963886|FG002|Induction Period|Protocol Deviation|0|||
143115300|NCT01358578|515963887|FG003|Induction Period|Protocol Deviation|3|||
143115301|NCT01358578|515963888|FG004|Induction Period|Protocol Deviation|0|||
143115302|NCT01358578|515963889|FG005|Induction Period|Protocol Deviation|0|||
143115303|NCT01358578|515963884|FG000|Induction Period|technical problems|0|||
143115304|NCT01358578|515963885|FG001|Induction Period|technical problems|0|||
143115305|NCT01358578|515963886|FG002|Induction Period|technical problems|1|||
143115306|NCT01358578|515963887|FG003|Induction Period|technical problems|1|||
143115307|NCT01358578|515963888|FG004|Induction Period|technical problems|0|||
143115308|NCT01358578|515963889|FG005|Induction Period|technical problems|0|||
143260186|NCT04393298|516507169|FG000|Overall Study|Patient Discharged to Hospice|0|||
143260187|NCT04393298|516507170|FG001|Overall Study|Patient Discharged to Hospice|0|||
143260188|NCT04393298|516507171|FG002|Overall Study|Patient Discharged to Hospice|0|||
143260189|NCT04393298|516507172|FG003|Overall Study|Patient Discharged to Hospice|0|||
143260190|NCT04393298|516507173|FG004|Overall Study|Patient Discharged to Hospice|0|||
143260191|NCT04393298|516507174|FG005|Overall Study|Patient Discharged to Hospice|0|||
143260192|NCT04393298|516507175|FG006|Overall Study|Patient Discharged to Hospice|0|||
143260193|NCT04393298|516507176|FG007|Overall Study|Patient Discharged to Hospice|0|||
143183959|NCT02140970|516218819|FG001|Overall Study|Did not meet inclusion criteria|1|||
143183960|NCT00430989|516218820|FG000|Overall Study|Lost to Follow-up|2|||
143183961|NCT00430989|516218821|FG001|Overall Study|Lost to Follow-up|3|||
143183962|NCT00430989|516218820|FG000|Overall Study|Withdrawal by Subject|15|||
143183963|NCT00430989|516218821|FG001|Overall Study|Withdrawal by Subject|14|||
143183964|NCT00430989|516218820|FG000|Overall Study|Protocol Violation|30|||
143183965|NCT00430989|516218821|FG001|Overall Study|Protocol Violation|37|||
143183966|NCT00430989|516218820|FG000|Overall Study|Not eligible|13|||
143183967|NCT00430989|516218821|FG001|Overall Study|Not eligible|6|||
143183968|NCT03050450|516218822|FG000|Overall Study|Physician Decision|1|||
143183969|NCT03050450|516218823|FG001|Overall Study|Physician Decision|0|||
143183970|NCT03050450|516218824|FG002|Overall Study|Physician Decision|0|||
143183971|NCT03050450|516218825|FG003|Overall Study|Physician Decision|0|||
143260194|NCT04393298|516507177|FG008|Overall Study|Patient Discharged to Hospice|1|||
143260195|NCT04393298|516507178|FG009|Overall Study|Patient Discharged to Hospice|0|||
143260196|NCT04393298|516507179|FG010|Overall Study|Patient Discharged to Hospice|0|||
143260197|NCT04393298|516507180|FG011|Overall Study|Patient Discharged to Hospice|0|||
143260198|NCT04393298|516507181|FG012|Overall Study|Patient Discharged to Hospice|0|||
143260199|NCT04393298|516507182|FG013|Overall Study|Patient Discharged to Hospice|0|||
143260200|NCT04393298|516507183|FG014|Overall Study|Patient Discharged to Hospice|0|||
143260201|NCT04393298|516507169|FG000|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
143260202|NCT04393298|516507170|FG001|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
143260203|NCT04393298|516507171|FG002|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
143260204|NCT04393298|516507172|FG003|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
143260205|NCT04393298|516507173|FG004|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
143260206|NCT04393298|516507174|FG005|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
143260207|NCT04393298|516507175|FG006|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
143260208|NCT04393298|516507176|FG007|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
143260209|NCT04393298|516507177|FG008|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
143260210|NCT04393298|516507178|FG009|Overall Study|Symptomatic Cancer - Unfit to take a call|1|||
143260211|NCT04393298|516507179|FG010|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
143260212|NCT04393298|516507180|FG011|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
143260213|NCT04393298|516507181|FG012|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
143260214|NCT04393298|516507182|FG013|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
143260215|NCT04393298|516507183|FG014|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
143260216|NCT04393298|516507169|FG000|Overall Study|Clinical Progression in Combination with AE|0|||
143260217|NCT04393298|516507170|FG001|Overall Study|Clinical Progression in Combination with AE|0|||
143260218|NCT04393298|516507171|FG002|Overall Study|Clinical Progression in Combination with AE|0|||
143260219|NCT04393298|516507172|FG003|Overall Study|Clinical Progression in Combination with AE|0|||
143260220|NCT04393298|516507173|FG004|Overall Study|Clinical Progression in Combination with AE|0|||
143260221|NCT04393298|516507174|FG005|Overall Study|Clinical Progression in Combination with AE|0|||
143260222|NCT04393298|516507175|FG006|Overall Study|Clinical Progression in Combination with AE|0|||
143260223|NCT04393298|516507176|FG007|Overall Study|Clinical Progression in Combination with AE|0|||
143260224|NCT04393298|516507177|FG008|Overall Study|Clinical Progression in Combination with AE|0|||
143260225|NCT04393298|516507178|FG009|Overall Study|Clinical Progression in Combination with AE|1|||
143260226|NCT04393298|516507179|FG010|Overall Study|Clinical Progression in Combination with AE|0|||
143260227|NCT04393298|516507180|FG011|Overall Study|Clinical Progression in Combination with AE|0|||
143260228|NCT04393298|516507181|FG012|Overall Study|Clinical Progression in Combination with AE|0|||
143260229|NCT04393298|516507182|FG013|Overall Study|Clinical Progression in Combination with AE|0|||
143260230|NCT04393298|516507183|FG014|Overall Study|Clinical Progression in Combination with AE|0|||
143260231|NCT03754972|516507184|FG000|Overall Study|Protocol Violation|25|||
143260232|NCT04062123|516507185|FG000|Overall Study|Withdrawal by Subject|0|||
143260233|NCT04062123|516507186|FG001|Overall Study|Withdrawal by Subject|1|||
143260234|NCT04062123|516507187|FG002|Overall Study|Withdrawal by Subject|0|||
143260235|NCT01634178|516507191|FG000|Treatment Period 1|Adverse Event|0|||
143260236|NCT01634178|516507192|FG001|Treatment Period 1|Adverse Event|1|||
143260237|NCT01634178|516507191|FG000|Treatment Period 2|Adverse Event|1|||
143260238|NCT01634178|516507192|FG001|Treatment Period 2|Adverse Event|0|||
143260239|NCT01721577|516507195|FG000|Overall Study|Lack of Efficacy|1|||
143260240|NCT01721577|516507196|FG001|Overall Study|Lack of Efficacy|0|||
143260241|NCT01721577|516507195|FG000|Overall Study|Death|1|||
143260242|NCT01721577|516507196|FG001|Overall Study|Death|0|||
143260243|NCT01721577|516507195|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
143260244|NCT01721577|516507196|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
143260245|NCT01721577|516507195|FG000|Overall Study|Adverse Event|0|||
143260246|NCT01721577|516507196|FG001|Overall Study|Adverse Event|2|||
143260247|NCT02497976|516507197|FG000|Overall Study|Withdrawal by Subject|2|||
143260248|NCT02497976|516507198|FG001|Overall Study|Withdrawal by Subject|0|||
143260249|NCT02497976|516507197|FG000|Overall Study|Moved out of area|0|||
143260250|NCT02497976|516507198|FG001|Overall Study|Moved out of area|1|||
143260251|NCT01282203|516507199|FG000|Overall Study|Adverse Event|1|||
143260252|NCT00058539|516507202|FG000|Overall Study|Disease progression|24|||
143260253|NCT00058539|516507202|FG000|Overall Study|Adverse Event|3|||
143260254|NCT00058539|516507202|FG000|Overall Study|Withdrawal by Subject|5|||
143260255|NCT00058539|516507202|FG000|Overall Study|Physician Decision|9|||
143260256|NCT00058539|516507202|FG000|Overall Study|Death|1|||
143260257|NCT00740051|516507203|FG000|Overall Study|Lack of Efficacy|2|||
143260258|NCT00740051|516507204|FG001|Overall Study|Lack of Efficacy|5|||
143260259|NCT00740051|516507203|FG000|Overall Study|Adverse Event|1|||
143260260|NCT00740051|516507204|FG001|Overall Study|Adverse Event|4|||
143260261|NCT00740051|516507203|FG000|Overall Study|Protocol Violation|2|||
143260262|NCT00740051|516507204|FG001|Overall Study|Protocol Violation|6|||
143260263|NCT00740051|516507203|FG000|Overall Study|Lost to Follow-up|3|||
143260264|NCT00740051|516507204|FG001|Overall Study|Lost to Follow-up|8|||
143260265|NCT00740051|516507203|FG000|Overall Study|Withdrawal by Subject|6|||
143183972|NCT03050450|516218826|FG004|Overall Study|Physician Decision|0|||
143369354|NCT02263508|516896075|FG002|Overall Study|Sponsor Decision|182|||
143115309|NCT01358578|515963884|FG000|Induction Period|Withdrawal by Subject|5|||
143260266|NCT00740051|516507204|FG001|Overall Study|Withdrawal by Subject|8|||
143260267|NCT00740051|516507203|FG000|Overall Study|Other reason (not specified)|4|||
143260268|NCT00740051|516507204|FG001|Overall Study|Other reason (not specified)|1|||
143260269|NCT01903525|516507207|FG000|Overall Study|Lost to Follow-up|5|||
143260270|NCT01903525|516507208|FG001|Overall Study|Lost to Follow-up|9|||
143260271|NCT01903525|516507207|FG000|Overall Study|Adverse Event|0|||
143260272|NCT01903525|516507208|FG001|Overall Study|Adverse Event|1|||
143260273|NCT03977454|516507209|FG000|Overall Study|immediate postoperative revision|2|||
143260274|NCT03977454|516507210|FG001|Overall Study|immediate postoperative revision|2|||
143260275|NCT00930982|516507211|FG000|Overall Study|Adverse Event|19|||
143260276|NCT00930982|516507212|FG001|Overall Study|Adverse Event|23|||
143260277|NCT00930982|516507211|FG000|Overall Study|Protocol Violation|1|||
143260278|NCT00930982|516507212|FG001|Overall Study|Protocol Violation|5|||
143260279|NCT00930982|516507211|FG000|Overall Study|Withdrawal by Subject|1|||
143260280|NCT00930982|516507212|FG001|Overall Study|Withdrawal by Subject|1|||
143260281|NCT00991952|516507213|FG000|Overall Study|Adverse Event|0|||
143260282|NCT00991952|516507214|FG001|Overall Study|Adverse Event|1|||
143260283|NCT02483533|516507217|FG000|Overall Study|Lack of Efficacy|50|||
143260284|NCT02483533|516507218|FG001|Overall Study|Lack of Efficacy|50|||
143260285|NCT04365257|516507219|FG000|Overall Study|Physician Decision|1|||
143260286|NCT04365257|516507220|FG001|Overall Study|Physician Decision|0|||
143260287|NCT04365257|516507219|FG000|Overall Study|Patient Noncompliance|1|||
143260288|NCT04365257|516507220|FG001|Overall Study|Patient Noncompliance|0|||
143260289|NCT04365257|516507219|FG000|Overall Study|Withdrawal by Subject|0|||
143260290|NCT04365257|516507220|FG001|Overall Study|Withdrawal by Subject|1|||
143260291|NCT00509262|516507223|FG000|Overall Study|Adverse Event|16|||
143260292|NCT00509262|516507224|FG001|Overall Study|Adverse Event|18|||
143260293|NCT00509262|516507223|FG000|Overall Study|Other|2|||
143260294|NCT00509262|516507224|FG001|Overall Study|Other|2|||
143260295|NCT00509262|516507223|FG000|Overall Study|Lack of Efficacy|1|||
143260296|NCT00509262|516507224|FG001|Overall Study|Lack of Efficacy|0|||
143260297|NCT00509262|516507223|FG000|Overall Study|Lost to Follow-up|1|||
143260298|NCT00509262|516507224|FG001|Overall Study|Lost to Follow-up|6|||
143260299|NCT00509262|516507223|FG000|Overall Study|Physician Decision|1|||
143260300|NCT00509262|516507224|FG001|Overall Study|Physician Decision|3|||
143260301|NCT00509262|516507223|FG000|Overall Study|Protocol Violation|2|||
143260302|NCT00509262|516507224|FG001|Overall Study|Protocol Violation|2|||
143260303|NCT00509262|516507223|FG000|Overall Study|Withdrawal by Subject|24|||
143260304|NCT00509262|516507224|FG001|Overall Study|Withdrawal by Subject|11|||
143260305|NCT01589770|516507225|FG000|Overall Study|EGFR <60ml/min|6|||
143260306|NCT01589770|516507226|FG001|Overall Study|EGFR <60ml/min|4|||
143260307|NCT01589770|516507225|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
143260308|NCT01589770|516507226|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
143260309|NCT01853618|516507227|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
143260310|NCT01853618|516507228|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
143260311|NCT01853618|516507229|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
143260312|NCT01853618|516507230|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
143260313|NCT01853618|516507231|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
143260314|NCT01853618|516507227|FG000|Overall Study|Progressive disease|1|||
143260315|NCT01853618|516507228|FG001|Overall Study|Progressive disease|1|||
143260316|NCT01853618|516507229|FG002|Overall Study|Progressive disease|1|||
143260317|NCT01853618|516507230|FG003|Overall Study|Progressive disease|1|||
143260318|NCT01853618|516507231|FG004|Overall Study|Progressive disease|2|||
143260319|NCT01853618|516507227|FG000|Overall Study|Physician Decision|0|||
143260320|NCT01853618|516507228|FG001|Overall Study|Physician Decision|1|||
143260321|NCT01853618|516507229|FG002|Overall Study|Physician Decision|1|||
143260322|NCT01853618|516507230|FG003|Overall Study|Physician Decision|0|||
143260323|NCT01853618|516507231|FG004|Overall Study|Physician Decision|0|||
143260324|NCT01853618|516507227|FG000|Overall Study|Refused further treatment|0|||
143260325|NCT01853618|516507228|FG001|Overall Study|Refused further treatment|0|||
143260326|NCT01853618|516507229|FG002|Overall Study|Refused further treatment|0|||
143260327|NCT01853618|516507230|FG003|Overall Study|Refused further treatment|0|||
143260328|NCT01853618|516507231|FG004|Overall Study|Refused further treatment|1|||
143260329|NCT01658813|516507234|FG000|Overall Study|Disease progression|3|||
143260330|NCT02283177|516507235|FG000|Overall Study|Withdrawal by Subject|1|||
143260331|NCT02283177|516507236|FG001|Overall Study|Withdrawal by Subject|1|||
143260332|NCT01101191|516507237|FG000|Period 1|Withdrawal by Subject|1|||
143369355|NCT02263508|516896073|FG000|Overall Study|Lost to Follow-up|2|||
143369356|NCT02263508|516896074|FG001|Overall Study|Lost to Follow-up|7|||
143369357|NCT02263508|516896075|FG002|Overall Study|Lost to Follow-up|7|||
143260333|NCT01101191|516507238|FG001|Period 1|Withdrawal by Subject|0|||
143260334|NCT01101191|516507237|FG000|Period 1|Adverse Event|1|||
143183973|NCT05069597|516218827|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
143183974|NCT05069597|516218828|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
143183975|NCT04556591|516218830|FG000|Overall Study|Lost to Follow-up|1|||
143183976|NCT04556591|516218831|FG001|Overall Study|Lost to Follow-up|0|||
143183977|NCT04556591|516218830|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
143183978|NCT04556591|516218831|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
143183979|NCT02553928|516218832|FG000|Overall Study|Adverse Event|2|||
143183980|NCT02553928|516218833|FG001|Overall Study|Adverse Event|1|||
143183981|NCT02553928|516218832|FG000|Overall Study|Lost to Follow-up|0|||
143183982|NCT02553928|516218833|FG001|Overall Study|Lost to Follow-up|1|||
143183983|NCT02553928|516218832|FG000|Overall Study|Administrative reason(s)|0|||
143183984|NCT02553928|516218833|FG001|Overall Study|Administrative reason(s)|1|||
143183985|NCT00131352|516218834|FG000|Initial Treatment Period|Adverse Event|1|||
143183986|NCT00131352|516218835|FG001|Initial Treatment Period|Adverse Event|3|||
143183987|NCT00131352|516218834|FG000|Initial Treatment Period|Non-compliant|1|||
143183988|NCT00131352|516218835|FG001|Initial Treatment Period|Non-compliant|2|||
143260335|NCT01101191|516507238|FG001|Period 1|Adverse Event|2|||
143260336|NCT02009384|516507239|FG000|Overall Study|Death|2|||
143260337|NCT00722371|516507240|FG000|Overall Study|Adverse Event|6|||
143260338|NCT00722371|516507241|FG001|Overall Study|Adverse Event|13|||
143260339|NCT00722371|516507242|FG002|Overall Study|Adverse Event|9|||
143260340|NCT00722371|516507243|FG003|Overall Study|Adverse Event|10|||
143260341|NCT00722371|516507244|FG004|Overall Study|Adverse Event|6|||
143260342|NCT00722371|516507245|FG005|Overall Study|Adverse Event|8|||
143260343|NCT00722371|516507246|FG006|Overall Study|Adverse Event|4|||
143260344|NCT00722371|516507240|FG000|Overall Study|Contraindication|0|||
143260345|NCT00722371|516507241|FG001|Overall Study|Contraindication|0|||
143260346|NCT00722371|516507242|FG002|Overall Study|Contraindication|1|||
143260347|NCT00722371|516507243|FG003|Overall Study|Contraindication|0|||
143260348|NCT00722371|516507244|FG004|Overall Study|Contraindication|0|||
143260349|NCT00722371|516507245|FG005|Overall Study|Contraindication|0|||
143260350|NCT00722371|516507246|FG006|Overall Study|Contraindication|0|||
143260351|NCT00722371|516507240|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
143260352|NCT00722371|516507241|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
143260353|NCT00722371|516507242|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
143260354|NCT00722371|516507243|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
143260355|NCT00722371|516507244|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
143260356|NCT00722371|516507245|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
143260357|NCT00722371|516507246|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
143260358|NCT00722371|516507240|FG000|Overall Study|Excluded medication|0|||
143260359|NCT00722371|516507241|FG001|Overall Study|Excluded medication|1|||
143260360|NCT00722371|516507242|FG002|Overall Study|Excluded medication|1|||
143260361|NCT00722371|516507243|FG003|Overall Study|Excluded medication|0|||
143260362|NCT00722371|516507244|FG004|Overall Study|Excluded medication|0|||
143260363|NCT00722371|516507245|FG005|Overall Study|Excluded medication|0|||
143260364|NCT00722371|516507246|FG006|Overall Study|Excluded medication|1|||
143260365|NCT00722371|516507240|FG000|Overall Study|Hyperglycemia|2|||
143260366|NCT00722371|516507241|FG001|Overall Study|Hyperglycemia|6|||
143260367|NCT00722371|516507242|FG002|Overall Study|Hyperglycemia|4|||
143260368|NCT00722371|516507243|FG003|Overall Study|Hyperglycemia|2|||
143260369|NCT00722371|516507244|FG004|Overall Study|Hyperglycemia|5|||
143260370|NCT00722371|516507245|FG005|Overall Study|Hyperglycemia|1|||
143260371|NCT00722371|516507246|FG006|Overall Study|Hyperglycemia|1|||
143260372|NCT00722371|516507240|FG000|Overall Study|Hypoglycemia|1|||
143260373|NCT00722371|516507241|FG001|Overall Study|Hypoglycemia|0|||
143260374|NCT00722371|516507242|FG002|Overall Study|Hypoglycemia|0|||
143260375|NCT00722371|516507243|FG003|Overall Study|Hypoglycemia|0|||
143260376|NCT00722371|516507244|FG004|Overall Study|Hypoglycemia|0|||
143260377|NCT00722371|516507245|FG005|Overall Study|Hypoglycemia|0|||
143260378|NCT00722371|516507246|FG006|Overall Study|Hypoglycemia|0|||
143260379|NCT00722371|516507240|FG000|Overall Study|Lack of Efficacy|4|||
143260380|NCT00722371|516507241|FG001|Overall Study|Lack of Efficacy|6|||
143260381|NCT00722371|516507242|FG002|Overall Study|Lack of Efficacy|6|||
143260382|NCT00722371|516507243|FG003|Overall Study|Lack of Efficacy|6|||
143260383|NCT00722371|516507244|FG004|Overall Study|Lack of Efficacy|2|||
143260384|NCT00722371|516507245|FG005|Overall Study|Lack of Efficacy|3|||
143260385|NCT00722371|516507246|FG006|Overall Study|Lack of Efficacy|0|||
143260386|NCT00722371|516507240|FG000|Overall Study|Lost to Follow-up|11|||
143260387|NCT00722371|516507241|FG001|Overall Study|Lost to Follow-up|14|||
143260388|NCT00722371|516507242|FG002|Overall Study|Lost to Follow-up|21|||
143260389|NCT00722371|516507243|FG003|Overall Study|Lost to Follow-up|13|||
143260390|NCT00722371|516507244|FG004|Overall Study|Lost to Follow-up|8|||
143260391|NCT00722371|516507245|FG005|Overall Study|Lost to Follow-up|16|||
143260392|NCT00722371|516507246|FG006|Overall Study|Lost to Follow-up|13|||
143260393|NCT00722371|516507240|FG000|Overall Study|Physician Decision|5|||
143260394|NCT00722371|516507241|FG001|Overall Study|Physician Decision|2|||
143260395|NCT00722371|516507242|FG002|Overall Study|Physician Decision|2|||
143260396|NCT00722371|516507243|FG003|Overall Study|Physician Decision|5|||
143260397|NCT00722371|516507244|FG004|Overall Study|Physician Decision|2|||
143260398|NCT00722371|516507245|FG005|Overall Study|Physician Decision|3|||
143260399|NCT00722371|516507246|FG006|Overall Study|Physician Decision|4|||
143260400|NCT00722371|516507240|FG000|Overall Study|Pregnancy|1|||
143260401|NCT00722371|516507241|FG001|Overall Study|Pregnancy|1|||
143260402|NCT00722371|516507242|FG002|Overall Study|Pregnancy|0|||
143260403|NCT00722371|516507243|FG003|Overall Study|Pregnancy|0|||
143260404|NCT00722371|516507244|FG004|Overall Study|Pregnancy|0|||
143260405|NCT00722371|516507245|FG005|Overall Study|Pregnancy|1|||
143260406|NCT00722371|516507246|FG006|Overall Study|Pregnancy|0|||
143260407|NCT00722371|516507240|FG000|Overall Study|Protocol Violation|6|||
143260408|NCT00722371|516507241|FG001|Overall Study|Protocol Violation|1|||
143260409|NCT00722371|516507242|FG002|Overall Study|Protocol Violation|0|||
143260410|NCT00722371|516507243|FG003|Overall Study|Protocol Violation|1|||
143260411|NCT00722371|516507244|FG004|Overall Study|Protocol Violation|4|||
143260412|NCT00722371|516507245|FG005|Overall Study|Protocol Violation|2|||
143260413|NCT00722371|516507246|FG006|Overall Study|Protocol Violation|1|||
143260414|NCT00722371|516507240|FG000|Overall Study|Withdrawal by Subject|18|||
143260415|NCT00722371|516507241|FG001|Overall Study|Withdrawal by Subject|27|||
143260416|NCT00722371|516507242|FG002|Overall Study|Withdrawal by Subject|19|||
143260417|NCT00722371|516507243|FG003|Overall Study|Withdrawal by Subject|23|||
143260418|NCT00722371|516507244|FG004|Overall Study|Withdrawal by Subject|19|||
143260419|NCT00722371|516507245|FG005|Overall Study|Withdrawal by Subject|18|||
143260420|NCT00722371|516507246|FG006|Overall Study|Withdrawal by Subject|26|||
143260421|NCT01092832|516507247|FG000|Overall Study|Other|1|||
143260422|NCT01092832|516507248|FG001|Overall Study|Other|0|||
143260423|NCT02674854|516507249|FG000|Overall Study|Adverse Event|17|||
143260424|NCT02674854|516507250|FG001|Overall Study|Adverse Event|15|||
143260425|NCT02674854|516507251|FG002|Overall Study|Adverse Event|5|||
143260426|NCT02674854|516507249|FG000|Overall Study|Withdrawal by Subject|1|||
143260427|NCT02674854|516507250|FG001|Overall Study|Withdrawal by Subject|5|||
143260428|NCT02674854|516507251|FG002|Overall Study|Withdrawal by Subject|4|||
143260429|NCT02674854|516507249|FG000|Overall Study|No-compliant subject|1|||
143260430|NCT02674854|516507250|FG001|Overall Study|No-compliant subject|0|||
143260431|NCT02674854|516507251|FG002|Overall Study|No-compliant subject|1|||
143260432|NCT02674854|516507249|FG000|Overall Study|Lost to Follow-up|1|||
143260433|NCT02674854|516507250|FG001|Overall Study|Lost to Follow-up|0|||
143260434|NCT02674854|516507251|FG002|Overall Study|Lost to Follow-up|2|||
143260435|NCT02674854|516507249|FG000|Overall Study|Lack of Efficacy|0|||
143260436|NCT02674854|516507250|FG001|Overall Study|Lack of Efficacy|3|||
143260437|NCT02674854|516507251|FG002|Overall Study|Lack of Efficacy|0|||
143260438|NCT02674854|516507249|FG000|Overall Study|Disallowed Concurrent Medication|2|||
143260439|NCT02674854|516507250|FG001|Overall Study|Disallowed Concurrent Medication|2|||
143260440|NCT02674854|516507251|FG002|Overall Study|Disallowed Concurrent Medication|0|||
143260441|NCT02674854|516507249|FG000|Overall Study|Protocol Violation|1|||
143260442|NCT02674854|516507250|FG001|Overall Study|Protocol Violation|1|||
143260443|NCT02674854|516507251|FG002|Overall Study|Protocol Violation|2|||
143260444|NCT02674854|516507249|FG000|Overall Study|Death|0|||
143260445|NCT02674854|516507250|FG001|Overall Study|Death|1|||
143260446|NCT02674854|516507251|FG002|Overall Study|Death|0|||
143260447|NCT02674854|516507249|FG000|Overall Study|Subject missed V6.2|1|||
143260448|NCT02674854|516507250|FG001|Overall Study|Subject missed V6.2|0|||
143260449|NCT02674854|516507251|FG002|Overall Study|Subject missed V6.2|0|||
143260450|NCT02635646|516507253|FG000|Overall Study|Lost to Follow-up|24|||
143260451|NCT02635646|516507254|FG001|Overall Study|Lost to Follow-up|25|||
143260452|NCT02635646|516507253|FG000|Overall Study|Pregnancy|1|||
143260453|NCT02635646|516507254|FG001|Overall Study|Pregnancy|1|||
143260454|NCT03761797|516507255|FG000|Overall Study|Changing hospital|11|||
143260455|NCT03761797|516507255|FG000|Overall Study|Improvement/remission|6|||
143260456|NCT03761797|516507255|FG000|Overall Study|Withdrawal by Subject|19|||
143260457|NCT03761797|516507255|FG000|Overall Study|Lost to Follow-up|33|||
143260458|NCT03761797|516507255|FG000|Overall Study|Adverse Event|37|||
143260459|NCT03761797|516507255|FG000|Overall Study|Case report form (CRF) not collected|5|||
143260460|NCT03761797|516507255|FG000|Overall Study|No patient visit after entry|13|||
143260461|NCT03761797|516507255|FG000|Overall Study|Switch to other diabetes medication|10|||
143260462|NCT03761797|516507255|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
143260463|NCT03761797|516507255|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
143260464|NCT03761797|516507255|FG000|Overall Study|Insufficient effectives|2|||
143260465|NCT03761797|516507255|FG000|Overall Study|Excessive alcohol intake|1|||
143260466|NCT00879879|516507260|FG000|Overall Study|Death|1|||
143260467|NCT00879879|516507260|FG000|Overall Study|Withdrawal by Subject|1|||
143260468|NCT00879879|516507260|FG000|Overall Study|Physician Decision|1|||
143260469|NCT00645788|516507263|FG000|Overall Study|Did not receive study drug|1|||
143260470|NCT00645788|516507264|FG001|Overall Study|Did not receive study drug|1|||
143260471|NCT00645788|516507265|FG002|Overall Study|Did not receive study drug|0|||
143260472|NCT00645788|516507266|FG003|Overall Study|Did not receive study drug|0|||
143260473|NCT00645788|516507263|FG000|Overall Study|Adverse Event|4|||
143260474|NCT00645788|516507264|FG001|Overall Study|Adverse Event|9|||
143260475|NCT00645788|516507265|FG002|Overall Study|Adverse Event|5|||
143260476|NCT00645788|516507266|FG003|Overall Study|Adverse Event|3|||
143369358|NCT02263508|516896073|FG000|Overall Study|Death|6|||
143369359|NCT02263508|516896074|FG001|Overall Study|Death|151|||
143369360|NCT02263508|516896075|FG002|Overall Study|Death|140|||
143369361|NCT03265210|516896079|FG000|Overall Study|Withdrawal by Subject|7|||
143369362|NCT03265210|516896080|FG001|Overall Study|Withdrawal by Subject|9|||
143369363|NCT03265210|516896079|FG000|Overall Study|Lost to Follow-up|2|||
143369364|NCT03265210|516896080|FG001|Overall Study|Lost to Follow-up|0|||
143260477|NCT00645788|516507263|FG000|Overall Study|Lost to Follow-up|1|||
143369365|NCT03265210|516896079|FG000|Overall Study|Physician Decision|2|||
143369366|NCT03265210|516896080|FG001|Overall Study|Physician Decision|0|||
143260478|NCT00645788|516507264|FG001|Overall Study|Lost to Follow-up|0|||
143260479|NCT00645788|516507265|FG002|Overall Study|Lost to Follow-up|0|||
143260480|NCT00645788|516507266|FG003|Overall Study|Lost to Follow-up|0|||
143260481|NCT00645788|516507263|FG000|Overall Study|Protocol Violation|1|||
143260482|NCT00645788|516507264|FG001|Overall Study|Protocol Violation|0|||
143260483|NCT00645788|516507265|FG002|Overall Study|Protocol Violation|2|||
143260484|NCT00645788|516507266|FG003|Overall Study|Protocol Violation|0|||
143260485|NCT00645788|516507263|FG000|Overall Study|Withdrawal by Subject|0|||
143260486|NCT00645788|516507264|FG001|Overall Study|Withdrawal by Subject|1|||
143260487|NCT00645788|516507265|FG002|Overall Study|Withdrawal by Subject|0|||
143260488|NCT00645788|516507266|FG003|Overall Study|Withdrawal by Subject|2|||
143260489|NCT00645788|516507263|FG000|Overall Study|Pulmonary exacerbation|13|||
143260490|NCT00645788|516507264|FG001|Overall Study|Pulmonary exacerbation|16|||
143260491|NCT00645788|516507265|FG002|Overall Study|Pulmonary exacerbation|11|||
143260492|NCT00645788|516507266|FG003|Overall Study|Pulmonary exacerbation|9|||
143260493|NCT03149848|516507268|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
143260494|NCT03149848|516507268|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
143260495|NCT00745615|516507270|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
143260496|NCT00745615|516507271|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
143260497|NCT00745615|516507272|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
143260498|NCT00745615|516507273|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
143260499|NCT00745615|516507274|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
143260500|NCT00745615|516507275|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
143260501|NCT00745615|516507270|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
143260502|NCT00745615|516507271|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
143260503|NCT00745615|516507272|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
143260504|NCT00745615|516507273|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
143260505|NCT00745615|516507274|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
143260506|NCT00745615|516507275|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
143260507|NCT00745615|516507270|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
143260508|NCT00745615|516507271|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
143260509|NCT00745615|516507272|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
143260510|NCT00745615|516507273|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
143260511|NCT00745615|516507274|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
143260512|NCT00745615|516507275|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
143260513|NCT00745615|516507270|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
143260514|NCT00745615|516507271|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
143260515|NCT00745615|516507272|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
143260516|NCT00745615|516507273|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
143260517|NCT00745615|516507274|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
143260518|NCT00745615|516507275|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
143260519|NCT00745615|516507270|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
143260520|NCT00745615|516507271|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
143260521|NCT00745615|516507272|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
143260522|NCT00745615|516507273|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
143260523|NCT00745615|516507274|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
143260524|NCT00745615|516507275|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
143260525|NCT00745615|516507270|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
143260526|NCT00745615|516507271|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
143260527|NCT00745615|516507272|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
143260528|NCT00745615|516507273|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
143260529|NCT00745615|516507274|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
143260530|NCT00745615|516507275|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
143260531|NCT00745615|516507270|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
143260532|NCT00745615|516507271|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
143260533|NCT00745615|516507272|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
143260534|NCT00745615|516507273|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
143260535|NCT00745615|516507274|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
143260536|NCT00745615|516507275|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
143260537|NCT00745615|516507270|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
143369367|NCT03265210|516896079|FG000|Overall Study|Adverse Event|1|||
143260538|NCT00745615|516507271|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
143260539|NCT00745615|516507272|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
143369368|NCT03265210|516896080|FG001|Overall Study|Adverse Event|0|||
143260540|NCT00745615|516507273|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
143260541|NCT00745615|516507274|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
143260542|NCT00745615|516507275|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
143260543|NCT00745615|516507270|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
143260544|NCT00745615|516507271|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
143260545|NCT00745615|516507272|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
143260546|NCT00745615|516507273|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
143260547|NCT00745615|516507274|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
143260548|NCT00745615|516507275|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
143260549|NCT00745615|516507270|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
143260550|NCT00745615|516507271|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
143260551|NCT00745615|516507272|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
143260552|NCT00745615|516507273|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
143260553|NCT00745615|516507274|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
143260554|NCT00745615|516507275|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
143260555|NCT00745615|516507270|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
143260556|NCT00745615|516507271|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
143260557|NCT00745615|516507272|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
143260558|NCT00745615|516507273|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
143260559|NCT00745615|516507274|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
143260560|NCT00745615|516507275|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
143260561|NCT00745615|516507270|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
143260562|NCT00745615|516507271|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
143260563|NCT00745615|516507272|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
143260564|NCT00745615|516507273|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
143260565|NCT00745615|516507274|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
143260566|NCT00745615|516507275|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
143260567|NCT00745615|516507270|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
143260568|NCT00745615|516507271|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
143260569|NCT00745615|516507272|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
143260570|NCT00745615|516507273|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
143260571|NCT00745615|516507274|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
143260572|NCT00745615|516507275|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
143260573|NCT00745615|516507270|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
143260574|NCT00745615|516507271|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
143260575|NCT00745615|516507272|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
143260576|NCT00745615|516507273|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
143260577|NCT00745615|516507274|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
143260578|NCT00745615|516507275|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
143260579|NCT01445886|516507278|FG000|Overall Study|Lost to Follow-up|2|||
143260580|NCT01445886|516507278|FG000|Overall Study|Protocol Violation|3|||
143260581|NCT00686998|516507284|FG000|Overall Study|Adverse Event|3|||
143260582|NCT00686998|516507285|FG001|Overall Study|Adverse Event|2|||
143260583|NCT00686998|516507286|FG002|Overall Study|Adverse Event|1|||
143260584|NCT00686998|516507284|FG000|Overall Study|Withdrawal by Subject|2|||
143260585|NCT00686998|516507285|FG001|Overall Study|Withdrawal by Subject|1|||
143260586|NCT00686998|516507286|FG002|Overall Study|Withdrawal by Subject|2|||
143260587|NCT00686998|516507284|FG000|Overall Study|Lack of Efficacy|7|||
143260588|NCT00686998|516507285|FG001|Overall Study|Lack of Efficacy|5|||
143260589|NCT00686998|516507286|FG002|Overall Study|Lack of Efficacy|0|||
143260590|NCT00686998|516507284|FG000|Overall Study|Other|0|||
143260591|NCT00686998|516507285|FG001|Overall Study|Other|0|||
143260592|NCT00686998|516507286|FG002|Overall Study|Other|1|||
143260593|NCT00686998|516507284|FG000|Overall Study|Safety Reasons|1|||
143260594|NCT00686998|516507285|FG001|Overall Study|Safety Reasons|0|||
143260595|NCT00686998|516507286|FG002|Overall Study|Safety Reasons|0|||
143260596|NCT03370276|516507287|FG000|Overall Study|Death|0|||
143260597|NCT03370276|516507288|FG001|Overall Study|Death|2|||
143260598|NCT03370276|516507289|FG002|Overall Study|Death|5|||
143260599|NCT04030026|516507290|FG000|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|0|||
143260600|NCT04030026|516507291|FG001|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|1|||
143260601|NCT04030026|516507290|FG000|Treatment Period 1 (22 Days)|Withdrawal by Participant|1|||
143260602|NCT04030026|516507291|FG001|Treatment Period 1 (22 Days)|Withdrawal by Participant|0|||
143260603|NCT04030026|516507290|FG000|Treatment Period 1 (22 Days)|Protocol Deviation|0|||
143260604|NCT04030026|516507291|FG001|Treatment Period 1 (22 Days)|Protocol Deviation|1|||
143260605|NCT04030026|516507290|FG000|Treatment Period 1 (22 Days)|Physician Decision|1|||
143260606|NCT04030026|516507291|FG001|Treatment Period 1 (22 Days)|Physician Decision|0|||
143260607|NCT04030026|516507290|FG000|Treatment Period 2 (22 Days)|Adverse Event|0|||
143260608|NCT04030026|516507291|FG001|Treatment Period 2 (22 Days)|Adverse Event|6|||
143369369|NCT00686517|516896083|FG000|Treatment|Serious Adverse Event|1|||
143260609|NCT04030026|516507290|FG000|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
143260610|NCT04030026|516507291|FG001|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
143260611|NCT04030026|516507290|FG000|Treatment Period 2 (22 Days)|Withdrawal by Participant|0|||
143260612|NCT04030026|516507291|FG001|Treatment Period 2 (22 Days)|Withdrawal by Participant|2|||
143260613|NCT04854642|516508778|FG000|Overall Study|Adverse Event|1|||
143260614|NCT04854642|516508779|FG001|Overall Study|Adverse Event|2|||
143260615|NCT04854642|516508778|FG000|Overall Study|Withdrawal by Subject|0|||
143260616|NCT04854642|516508779|FG001|Overall Study|Withdrawal by Subject|1|||
143260617|NCT01741012|516508781|FG000|Overall Study|Lost to Follow-up|1|||
143260618|NCT01741012|516508781|FG000|Overall Study|Withdrawal by Subject|2|||
143260619|NCT00997438|516508782|FG000|Overall Study|Blood draw difficulty|2|||
143260620|NCT00997438|516508783|FG001|Overall Study|Blood draw difficulty|0|||
143260621|NCT00997438|516508784|FG002|Overall Study|Blood draw difficulty|1|||
143260622|NCT00997438|516508782|FG000|Overall Study|Withdrawal by Subject|1|||
143260623|NCT00997438|516508783|FG001|Overall Study|Withdrawal by Subject|1|||
143260624|NCT00997438|516508784|FG002|Overall Study|Withdrawal by Subject|0|||
143260625|NCT00997438|516508782|FG000|Overall Study|Exclusion criteria at visit 1|2|||
143260626|NCT00997438|516508783|FG001|Overall Study|Exclusion criteria at visit 1|2|||
143260627|NCT00997438|516508784|FG002|Overall Study|Exclusion criteria at visit 1|3|||
143260628|NCT00095238|516508785|FG000|Overall Study|Lack of Efficacy|9|||
143260629|NCT00095238|516508786|FG001|Overall Study|Lack of Efficacy|9|||
143260630|NCT00095238|516508785|FG000|Overall Study|Adverse Event|331|||
143260631|NCT00095238|516508786|FG001|Overall Study|Adverse Event|287|||
143260632|NCT00095238|516508785|FG000|Overall Study|Subject Withdrew Consent|208|||
143260633|NCT00095238|516508786|FG001|Overall Study|Subject Withdrew Consent|223|||
143260634|NCT00095238|516508785|FG000|Overall Study|Death|154|||
143260635|NCT00095238|516508786|FG001|Overall Study|Death|170|||
143260636|NCT00095238|516508785|FG000|Overall Study|Lost to Follow-up|19|||
143260637|NCT00095238|516508786|FG001|Overall Study|Lost to Follow-up|24|||
143260638|NCT00095238|516508785|FG000|Overall Study|Noncompliance|44|||
143260639|NCT00095238|516508786|FG001|Overall Study|Noncompliance|45|||
143260640|NCT00095238|516508785|FG000|Overall Study|No longer met study criteria|4|||
143260641|NCT00095238|516508786|FG001|Overall Study|No longer met study criteria|5|||
143260642|NCT00095238|516508785|FG000|Overall Study|Study terminated by sponsor|0|||
143260643|NCT00095238|516508786|FG001|Overall Study|Study terminated by sponsor|1|||
143260644|NCT00095238|516508785|FG000|Overall Study|Missing|1|||
143260645|NCT00095238|516508786|FG001|Overall Study|Missing|0|||
143260646|NCT00095238|516508785|FG000|Overall Study|Other Reasons|87|||
143260647|NCT00095238|516508786|FG001|Overall Study|Other Reasons|88|||
143260648|NCT02038829|516508789|FG000|Washout Period 1|Death|0|||
143260649|NCT02038829|516508790|FG001|Washout Period 1|Death|0|||
143260650|NCT02038829|516508791|FG002|Washout Period 1|Death|0|||
143260651|NCT02038829|516508792|FG003|Washout Period 1|Death|0|||
143260652|NCT02038829|516508793|FG004|Washout Period 1|Death|1|||
143260653|NCT02038829|516508794|FG005|Washout Period 1|Death|0|||
143260654|NCT02038829|516508795|FG006|Washout Period 1|Death|0|||
143260655|NCT02038829|516508796|FG007|Washout Period 1|Death|0|||
143260656|NCT02038829|516508797|FG008|Washout Period 1|Death|0|||
143260657|NCT02038829|516508798|FG009|Washout Period 1|Death|0|||
143260658|NCT02038829|516508799|FG010|Washout Period 1|Death|0|||
143260659|NCT02038829|516508800|FG011|Washout Period 1|Death|0|||
143260660|NCT02038829|516508789|FG000|Treatment Period 2|Adverse Event|0|||
143260661|NCT02038829|516508790|FG001|Treatment Period 2|Adverse Event|0|||
143260662|NCT02038829|516508791|FG002|Treatment Period 2|Adverse Event|0|||
143260663|NCT02038829|516508792|FG003|Treatment Period 2|Adverse Event|0|||
143260664|NCT02038829|516508793|FG004|Treatment Period 2|Adverse Event|0|||
143260665|NCT02038829|516508794|FG005|Treatment Period 2|Adverse Event|0|||
143260666|NCT02038829|516508795|FG006|Treatment Period 2|Adverse Event|0|||
143260667|NCT02038829|516508796|FG007|Treatment Period 2|Adverse Event|0|||
143260668|NCT02038829|516508797|FG008|Treatment Period 2|Adverse Event|0|||
143260669|NCT02038829|516508798|FG009|Treatment Period 2|Adverse Event|0|||
143260670|NCT02038829|516508799|FG010|Treatment Period 2|Adverse Event|1|||
143260671|NCT02038829|516508800|FG011|Treatment Period 2|Adverse Event|0|||
143260672|NCT02038829|516508789|FG000|Treatment Period 2|Withdrawal by Subject|1|||
143260673|NCT02038829|516508790|FG001|Treatment Period 2|Withdrawal by Subject|0|||
143260674|NCT02038829|516508791|FG002|Treatment Period 2|Withdrawal by Subject|0|||
143260675|NCT02038829|516508792|FG003|Treatment Period 2|Withdrawal by Subject|0|||
143260676|NCT02038829|516508793|FG004|Treatment Period 2|Withdrawal by Subject|0|||
143260677|NCT02038829|516508794|FG005|Treatment Period 2|Withdrawal by Subject|0|||
143260678|NCT02038829|516508795|FG006|Treatment Period 2|Withdrawal by Subject|0|||
143260679|NCT02038829|516508796|FG007|Treatment Period 2|Withdrawal by Subject|0|||
143260680|NCT02038829|516508797|FG008|Treatment Period 2|Withdrawal by Subject|0|||
143260681|NCT02038829|516508798|FG009|Treatment Period 2|Withdrawal by Subject|0|||
143260682|NCT02038829|516508799|FG010|Treatment Period 2|Withdrawal by Subject|0|||
143260683|NCT02038829|516508800|FG011|Treatment Period 2|Withdrawal by Subject|0|||
143260684|NCT02038829|516508789|FG000|Washout Period 2|Adverse Event|0|||
143260685|NCT02038829|516508790|FG001|Washout Period 2|Adverse Event|0|||
143260686|NCT02038829|516508791|FG002|Washout Period 2|Adverse Event|0|||
143260687|NCT02038829|516508792|FG003|Washout Period 2|Adverse Event|0|||
143260688|NCT02038829|516508793|FG004|Washout Period 2|Adverse Event|0|||
143260689|NCT02038829|516508794|FG005|Washout Period 2|Adverse Event|0|||
143260690|NCT02038829|516508795|FG006|Washout Period 2|Adverse Event|0|||
143260691|NCT02038829|516508796|FG007|Washout Period 2|Adverse Event|0|||
143260692|NCT02038829|516508797|FG008|Washout Period 2|Adverse Event|1|||
143260693|NCT02038829|516508798|FG009|Washout Period 2|Adverse Event|0|||
143260694|NCT02038829|516508799|FG010|Washout Period 2|Adverse Event|0|||
143260695|NCT02038829|516508800|FG011|Washout Period 2|Adverse Event|0|||
143260696|NCT02038829|516508789|FG000|Washout Period 2|Withdrawal by Subject|0|||
143260697|NCT02038829|516508790|FG001|Washout Period 2|Withdrawal by Subject|0|||
143260698|NCT02038829|516508791|FG002|Washout Period 2|Withdrawal by Subject|0|||
143260699|NCT02038829|516508792|FG003|Washout Period 2|Withdrawal by Subject|0|||
143260700|NCT02038829|516508793|FG004|Washout Period 2|Withdrawal by Subject|0|||
143260701|NCT02038829|516508794|FG005|Washout Period 2|Withdrawal by Subject|1|||
143260702|NCT02038829|516508795|FG006|Washout Period 2|Withdrawal by Subject|0|||
143183989|NCT00131352|516218834|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
143183990|NCT00131352|516218835|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
143183991|NCT00131352|516218834|FG000|Initial Treatment Period|Lack of Efficacy|6|||
143183992|NCT00131352|516218835|FG001|Initial Treatment Period|Lack of Efficacy|4|||
143183993|NCT00131352|516218834|FG000|Initial Treatment Period|Other|0|||
143183994|NCT00131352|516218835|FG001|Initial Treatment Period|Other|2|||
143183995|NCT00131352|516218834|FG000|Repeat Treatment Period|Adverse Event|1|||
143183996|NCT00131352|516218835|FG001|Repeat Treatment Period|Adverse Event|0|||
143183997|NCT00131352|516218834|FG000|Repeat Treatment Period|Other|1|||
143183998|NCT00131352|516218835|FG001|Repeat Treatment Period|Other|0|||
143183999|NCT01485796|516218838|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
143184000|NCT01485796|516218838|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
143184001|NCT01485796|516218838|FG000|Period 2: Epoch 2|Adverse Event|3|||
143184002|NCT01485796|516218838|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
143184003|NCT01485796|516218838|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
143184004|NCT01485796|516218838|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
143369370|NCT00686517|516896084|FG001|Treatment|Serious Adverse Event|2|||
143260703|NCT02038829|516508796|FG007|Washout Period 2|Withdrawal by Subject|0|||
143260704|NCT02038829|516508797|FG008|Washout Period 2|Withdrawal by Subject|0|||
143260705|NCT02038829|516508798|FG009|Washout Period 2|Withdrawal by Subject|0|||
143260706|NCT02038829|516508799|FG010|Washout Period 2|Withdrawal by Subject|0|||
143260707|NCT02038829|516508800|FG011|Washout Period 2|Withdrawal by Subject|0|||
143260708|NCT02038829|516508789|FG000|Treatment Period 4|Adverse Event|0|||
143260709|NCT02038829|516508790|FG001|Treatment Period 4|Adverse Event|1|||
143260710|NCT02038829|516508791|FG002|Treatment Period 4|Adverse Event|0|||
143260711|NCT02038829|516508792|FG003|Treatment Period 4|Adverse Event|0|||
143260712|NCT02038829|516508793|FG004|Treatment Period 4|Adverse Event|0|||
143260713|NCT02038829|516508794|FG005|Treatment Period 4|Adverse Event|0|||
143260714|NCT02038829|516508795|FG006|Treatment Period 4|Adverse Event|0|||
143260715|NCT02038829|516508796|FG007|Treatment Period 4|Adverse Event|0|||
143260716|NCT02038829|516508797|FG008|Treatment Period 4|Adverse Event|0|||
143260717|NCT02038829|516508798|FG009|Treatment Period 4|Adverse Event|0|||
143260718|NCT02038829|516508799|FG010|Treatment Period 4|Adverse Event|0|||
143260719|NCT02038829|516508800|FG011|Treatment Period 4|Adverse Event|0|||
143260720|NCT02038829|516508789|FG000|Washout Period 4|Adverse Event|0|||
143260721|NCT02038829|516508790|FG001|Washout Period 4|Adverse Event|0|||
143260722|NCT02038829|516508791|FG002|Washout Period 4|Adverse Event|0|||
143260723|NCT02038829|516508792|FG003|Washout Period 4|Adverse Event|0|||
143260724|NCT02038829|516508793|FG004|Washout Period 4|Adverse Event|0|||
143260725|NCT02038829|516508794|FG005|Washout Period 4|Adverse Event|0|||
143260726|NCT02038829|516508795|FG006|Washout Period 4|Adverse Event|1|||
143260727|NCT02038829|516508796|FG007|Washout Period 4|Adverse Event|0|||
143260728|NCT02038829|516508797|FG008|Washout Period 4|Adverse Event|0|||
143260729|NCT02038829|516508798|FG009|Washout Period 4|Adverse Event|0|||
143260730|NCT02038829|516508799|FG010|Washout Period 4|Adverse Event|0|||
143260731|NCT02038829|516508800|FG011|Washout Period 4|Adverse Event|0|||
143260732|NCT02038829|516508789|FG000|Treatment Period 6|Adverse Event|0|||
143260733|NCT02038829|516508790|FG001|Treatment Period 6|Adverse Event|0|||
143260734|NCT02038829|516508791|FG002|Treatment Period 6|Adverse Event|1|||
143260735|NCT02038829|516508792|FG003|Treatment Period 6|Adverse Event|0|||
143260736|NCT02038829|516508793|FG004|Treatment Period 6|Adverse Event|0|||
143260737|NCT02038829|516508794|FG005|Treatment Period 6|Adverse Event|0|||
143260738|NCT02038829|516508795|FG006|Treatment Period 6|Adverse Event|0|||
143260739|NCT02038829|516508796|FG007|Treatment Period 6|Adverse Event|0|||
143260740|NCT02038829|516508797|FG008|Treatment Period 6|Adverse Event|0|||
143260741|NCT02038829|516508798|FG009|Treatment Period 6|Adverse Event|0|||
143260742|NCT02038829|516508799|FG010|Treatment Period 6|Adverse Event|0|||
143260743|NCT02038829|516508800|FG011|Treatment Period 6|Adverse Event|0|||
143260744|NCT03410823|516508803|FG000|Overall Study|Death|1|||
143260745|NCT03410823|516508803|FG000|Overall Study|Withdrawal by Subject|2|||
143260746|NCT03410823|516508803|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
143184005|NCT01485796|516218838|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
143184006|NCT01485796|516218838|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
143184007|NCT02569476|516218843|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
143184008|NCT02569476|516218843|FG000|Overall Study|Death|33|||
143184009|NCT02569476|516218843|FG000|Overall Study|Withdrawal by Subject|9|||
143184010|NCT02569476|516218843|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
143184011|NCT02569476|516218843|FG000|Overall Study|Palliative care|1|||
143184012|NCT02569476|516218843|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
143184013|NCT02569476|516218843|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
143184014|NCT00703963|516218844|FG000|Overall Study|Withdrawal by Subject|7|||
143184015|NCT00703963|516218845|FG001|Overall Study|Withdrawal by Subject|13|||
143184016|NCT00703963|516218844|FG000|Overall Study|Physician Decision|0|||
143184017|NCT00703963|516218845|FG001|Overall Study|Physician Decision|1|||
143184018|NCT03072043|516218846|FG000|Overall Study|Death|0|||
143184019|NCT03072043|516218847|FG001|Overall Study|Death|0|||
143184020|NCT03072043|516218848|FG002|Overall Study|Death|3|||
143184021|NCT03072043|516218846|FG000|Overall Study|Adverse Event|0|||
143184022|NCT03072043|516218847|FG001|Overall Study|Adverse Event|0|||
143184023|NCT03072043|516218848|FG002|Overall Study|Adverse Event|2|||
143184024|NCT03072043|516218846|FG000|Overall Study|Withdrawal by Subject|0|||
143184025|NCT03072043|516218847|FG001|Overall Study|Withdrawal by Subject|0|||
143184026|NCT03072043|516218848|FG002|Overall Study|Withdrawal by Subject|4|||
143184027|NCT00997984|516218849|FG000|Overall Study|Adverse Event|1|||
143184028|NCT00997984|516218850|FG001|Overall Study|Adverse Event|8|||
143184029|NCT00997984|516218851|FG002|Overall Study|Adverse Event|8|||
143184030|NCT00997984|516218849|FG000|Overall Study|Protocol Violation|1|||
143184031|NCT00997984|516218850|FG001|Overall Study|Protocol Violation|3|||
143184032|NCT00997984|516218851|FG002|Overall Study|Protocol Violation|0|||
143184033|NCT00997984|516218849|FG000|Overall Study|Withdrawal by Subject|6|||
143184034|NCT00997984|516218850|FG001|Overall Study|Withdrawal by Subject|9|||
143184035|NCT00997984|516218851|FG002|Overall Study|Withdrawal by Subject|5|||
143184036|NCT00997984|516218849|FG000|Overall Study|Lost to Follow-up|8|||
143184037|NCT00997984|516218850|FG001|Overall Study|Lost to Follow-up|5|||
143184038|NCT00997984|516218851|FG002|Overall Study|Lost to Follow-up|4|||
143184039|NCT00997984|516218849|FG000|Overall Study|Lack of Efficacy|20|||
143184040|NCT00997984|516218850|FG001|Overall Study|Lack of Efficacy|6|||
143184041|NCT00997984|516218851|FG002|Overall Study|Lack of Efficacy|3|||
143184042|NCT00997984|516218849|FG000|Overall Study|Met exclusion criteria|1|||
143184043|NCT00997984|516218850|FG001|Overall Study|Met exclusion criteria|0|||
143184044|NCT00997984|516218851|FG002|Overall Study|Met exclusion criteria|0|||
143184045|NCT00997984|516218849|FG000|Overall Study|non-compliance|0|||
143184046|NCT00997984|516218850|FG001|Overall Study|non-compliance|2|||
143184047|NCT00997984|516218851|FG002|Overall Study|non-compliance|3|||
143184048|NCT00997984|516218849|FG000|Overall Study|Wrong medication dispensed|0|||
143184049|NCT00997984|516218850|FG001|Overall Study|Wrong medication dispensed|1|||
143184050|NCT00997984|516218851|FG002|Overall Study|Wrong medication dispensed|0|||
143184051|NCT00997984|516218849|FG000|Overall Study|Suicidal ideation|0|||
143184052|NCT00997984|516218850|FG001|Overall Study|Suicidal ideation|0|||
143184053|NCT00997984|516218851|FG002|Overall Study|Suicidal ideation|1|||
143184054|NCT00997984|516218849|FG000|Overall Study|Work schedule|0|||
143184055|NCT00997984|516218850|FG001|Overall Study|Work schedule|0|||
143184056|NCT00997984|516218851|FG002|Overall Study|Work schedule|2|||
143184057|NCT00295646|516218857|FG000|Overall Study|Protocol Violation|18|||
143184058|NCT00295646|516218858|FG001|Overall Study|Protocol Violation|20|||
143184059|NCT00295646|516218859|FG002|Overall Study|Protocol Violation|20|||
143184060|NCT00295646|516218860|FG003|Overall Study|Protocol Violation|18|||
143260747|NCT06460493|516508810|FG000|Overall Study|Withdrawal by Subject|2|||
143184061|NCT00295646|516218857|FG000|Overall Study|Withdrawal by Subject|8|||
143184062|NCT00295646|516218858|FG001|Overall Study|Withdrawal by Subject|9|||
143260748|NCT05128929|516508811|FG000|Overall Study|Adverse Event|0|||
143184063|NCT00295646|516218859|FG002|Overall Study|Withdrawal by Subject|11|||
143184064|NCT00295646|516218860|FG003|Overall Study|Withdrawal by Subject|14|||
143184065|NCT00295646|516218857|FG000|Overall Study|Lost to Follow-up|0|||
143184066|NCT00295646|516218858|FG001|Overall Study|Lost to Follow-up|5|||
143184067|NCT00295646|516218859|FG002|Overall Study|Lost to Follow-up|1|||
143184068|NCT00295646|516218860|FG003|Overall Study|Lost to Follow-up|5|||
143184069|NCT00295646|516218857|FG000|Overall Study|Death|9|||
143184070|NCT00295646|516218858|FG001|Overall Study|Death|7|||
143184071|NCT00295646|516218859|FG002|Overall Study|Death|18|||
143184072|NCT00295646|516218860|FG003|Overall Study|Death|8|||
143184073|NCT02243371|516218861|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
143184074|NCT02243371|516218862|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
143184075|NCT02243371|516218861|FG000|Overall Study|Death (unrelated)|2|||
143184076|NCT02243371|516218862|FG001|Overall Study|Death (unrelated)|4|||
143260749|NCT05128929|516508812|FG001|Overall Study|Adverse Event|1|||
143260750|NCT02987660|516508817|FG000|Overall Study|Study terminated by sponsor|10|||
143260751|NCT02987660|516508818|FG001|Overall Study|Study terminated by sponsor|10|||
143260752|NCT01155479|516508824|FG000|Part I|Adverse Event|13|||
143260753|NCT01155479|516508825|FG001|Part I|Adverse Event|8|||
143260754|NCT01155479|516508826|FG002|Part I|Adverse Event|18|||
143260755|NCT01155479|516508827|FG003|Part I|Adverse Event|7|||
143260756|NCT01155479|516508828|FG004|Part I|Adverse Event|6|||
143260757|NCT01155479|516508824|FG000|Part I|Administrative|2|||
143260758|NCT01155479|516508825|FG001|Part I|Administrative|2|||
143260759|NCT01155479|516508826|FG002|Part I|Administrative|2|||
143260760|NCT01155479|516508827|FG003|Part I|Administrative|0|||
143260761|NCT01155479|516508828|FG004|Part I|Administrative|0|||
143260762|NCT01155479|516508824|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
143260763|NCT01155479|516508825|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
143260764|NCT01155479|516508826|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
143260765|NCT01155479|516508827|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
143260766|NCT01155479|516508828|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
143260767|NCT01155479|516508824|FG000|Part I|Withdrawal by Subject|11|||
143260768|NCT01155479|516508825|FG001|Part I|Withdrawal by Subject|13|||
143260769|NCT01155479|516508826|FG002|Part I|Withdrawal by Subject|8|||
143260770|NCT01155479|516508827|FG003|Part I|Withdrawal by Subject|8|||
143260771|NCT01155479|516508828|FG004|Part I|Withdrawal by Subject|9|||
143260772|NCT01155479|516508824|FG000|Part I|Lost to Follow-up|0|||
143260773|NCT01155479|516508825|FG001|Part I|Lost to Follow-up|0|||
143260774|NCT01155479|516508826|FG002|Part I|Lost to Follow-up|1|||
143260775|NCT01155479|516508827|FG003|Part I|Lost to Follow-up|1|||
143260776|NCT01155479|516508828|FG004|Part I|Lost to Follow-up|0|||
143260777|NCT01155479|516508824|FG000|Part I|Treatment Failure|3|||
143260778|NCT01155479|516508825|FG001|Part I|Treatment Failure|0|||
143260779|NCT01155479|516508826|FG002|Part I|Treatment Failure|3|||
143260780|NCT01155479|516508827|FG003|Part I|Treatment Failure|1|||
143260781|NCT01155479|516508828|FG004|Part I|Treatment Failure|2|||
143260782|NCT01155479|516508824|FG000|Part I|Did Not Receive Treatment|4|||
143260783|NCT01155479|516508825|FG001|Part I|Did Not Receive Treatment|2|||
143260784|NCT01155479|516508826|FG002|Part I|Did Not Receive Treatment|2|||
143260785|NCT01155479|516508827|FG003|Part I|Did Not Receive Treatment|6|||
143260786|NCT01155479|516508828|FG004|Part I|Did Not Receive Treatment|1|||
143260787|NCT01155479|516508824|FG000|Part I|Non-Compliance with Protocol|2|||
143260788|NCT01155479|516508825|FG001|Part I|Non-Compliance with Protocol|1|||
143260789|NCT01155479|516508826|FG002|Part I|Non-Compliance with Protocol|3|||
143260790|NCT01155479|516508827|FG003|Part I|Non-Compliance with Protocol|3|||
143260791|NCT01155479|516508828|FG004|Part I|Non-Compliance with Protocol|2|||
143260792|NCT01155479|516508824|FG000|Part II|Adverse Event|7|||
143260793|NCT01155479|516508825|FG001|Part II|Adverse Event|6|||
143260794|NCT01155479|516508826|FG002|Part II|Adverse Event|8|||
143260795|NCT01155479|516508827|FG003|Part II|Adverse Event|3|||
143260796|NCT01155479|516508828|FG004|Part II|Adverse Event|4|||
143184077|NCT02243371|516218861|FG000|Overall Study|Adverse Event (unrelated)|0|||
143260797|NCT01155479|516508824|FG000|Part II|Administrative|43|||
143260798|NCT01155479|516508825|FG001|Part II|Administrative|49|||
143260799|NCT01155479|516508826|FG002|Part II|Administrative|36|||
143260800|NCT01155479|516508827|FG003|Part II|Administrative|38|||
143260801|NCT01155479|516508828|FG004|Part II|Administrative|46|||
143260802|NCT01155479|516508824|FG000|Part II|Withdrawal by Subject|8|||
143260803|NCT01155479|516508825|FG001|Part II|Withdrawal by Subject|4|||
143260804|NCT01155479|516508826|FG002|Part II|Withdrawal by Subject|12|||
143260805|NCT01155479|516508827|FG003|Part II|Withdrawal by Subject|7|||
143184078|NCT02243371|516218862|FG001|Overall Study|Adverse Event (unrelated)|1|||
143260806|NCT01155479|516508828|FG004|Part II|Withdrawal by Subject|3|||
143260807|NCT01155479|516508824|FG000|Part II|Lost to Follow-up|1|||
143260808|NCT01155479|516508825|FG001|Part II|Lost to Follow-up|0|||
143260809|NCT01155479|516508826|FG002|Part II|Lost to Follow-up|0|||
143369371|NCT00686517|516896085|FG002|Treatment|Serious Adverse Event|1|||
143260810|NCT01155479|516508827|FG003|Part II|Lost to Follow-up|0|||
143260811|NCT01155479|516508828|FG004|Part II|Lost to Follow-up|1|||
143260812|NCT01155479|516508824|FG000|Part II|Treatment Failure|0|||
143260813|NCT01155479|516508825|FG001|Part II|Treatment Failure|1|||
143184079|NCT02243371|516218861|FG000|Overall Study|Lack of Clinical Benefit|0|||
143184080|NCT02243371|516218862|FG001|Overall Study|Lack of Clinical Benefit|1|||
143184081|NCT02243371|516218861|FG000|Overall Study|Withdrawal by Subject|0|||
143184082|NCT02243371|516218862|FG001|Overall Study|Withdrawal by Subject|2|||
143184083|NCT02441101|516218863|FG000|Overall Study|Withdrawal by Subject|1|||
143184084|NCT02441101|516218864|FG001|Overall Study|Withdrawal by Subject|0|||
143184085|NCT02441101|516218863|FG000|Overall Study|Lost to Follow-up|1|||
143184086|NCT02441101|516218864|FG001|Overall Study|Lost to Follow-up|0|||
143184087|NCT02441101|516218863|FG000|Overall Study|PI relocated and study terminated|1|||
143184088|NCT02441101|516218864|FG001|Overall Study|PI relocated and study terminated|0|||
143184089|NCT02528942|516218866|FG000|Overall Study|Did not meet imaging criteria|9|||
143184090|NCT02528942|516218866|FG000|Overall Study|Lost to Follow-up|25|||
143184091|NCT04599803|516218867|FG000|Overall Study|Withdrawal by Subject|5|||
143184092|NCT04599803|516218867|FG000|Overall Study|Lost to Follow-up|26|||
143184093|NCT00881530|516218868|FG000|Overall Study|Adverse Event|5|||
143184094|NCT00881530|516218869|FG001|Overall Study|Adverse Event|1|||
143184095|NCT00881530|516218870|FG002|Overall Study|Adverse Event|1|||
143184096|NCT00881530|516218871|FG003|Overall Study|Adverse Event|4|||
143184097|NCT00881530|516218872|FG004|Overall Study|Adverse Event|10|||
143184098|NCT00881530|516218873|FG005|Overall Study|Adverse Event|2|||
143184099|NCT00881530|516218868|FG000|Overall Study|Lack of Efficacy|1|||
143184100|NCT00881530|516218869|FG001|Overall Study|Lack of Efficacy|0|||
143184101|NCT00881530|516218870|FG002|Overall Study|Lack of Efficacy|0|||
143184102|NCT00881530|516218871|FG003|Overall Study|Lack of Efficacy|0|||
143184103|NCT00881530|516218872|FG004|Overall Study|Lack of Efficacy|1|||
143184104|NCT00881530|516218873|FG005|Overall Study|Lack of Efficacy|1|||
143184105|NCT00881530|516218868|FG000|Overall Study|Not compliant with the protocol|0|||
143184106|NCT00881530|516218869|FG001|Overall Study|Not compliant with the protocol|0|||
143184107|NCT00881530|516218870|FG002|Overall Study|Not compliant with the protocol|0|||
143184108|NCT00881530|516218871|FG003|Overall Study|Not compliant with the protocol|0|||
143184109|NCT00881530|516218872|FG004|Overall Study|Not compliant with the protocol|2|||
143184110|NCT00881530|516218873|FG005|Overall Study|Not compliant with the protocol|0|||
143184111|NCT00881530|516218868|FG000|Overall Study|Lost to Follow-up|0|||
143184112|NCT00881530|516218869|FG001|Overall Study|Lost to Follow-up|1|||
143184113|NCT00881530|516218870|FG002|Overall Study|Lost to Follow-up|1|||
143184114|NCT00881530|516218871|FG003|Overall Study|Lost to Follow-up|3|||
143184115|NCT00881530|516218872|FG004|Overall Study|Lost to Follow-up|1|||
143184116|NCT00881530|516218873|FG005|Overall Study|Lost to Follow-up|0|||
143184117|NCT00881530|516218868|FG000|Overall Study|Refused to continue medication|7|||
143184118|NCT00881530|516218869|FG001|Overall Study|Refused to continue medication|2|||
143184119|NCT00881530|516218870|FG002|Overall Study|Refused to continue medication|1|||
143184120|NCT00881530|516218871|FG003|Overall Study|Refused to continue medication|2|||
143184121|NCT00881530|516218872|FG004|Overall Study|Refused to continue medication|0|||
143184122|NCT00881530|516218873|FG005|Overall Study|Refused to continue medication|0|||
143184123|NCT00881530|516218868|FG000|Overall Study|Other reason not defined above|1|||
143184124|NCT00881530|516218869|FG001|Overall Study|Other reason not defined above|1|||
143184125|NCT00881530|516218870|FG002|Overall Study|Other reason not defined above|2|||
143184126|NCT00881530|516218871|FG003|Overall Study|Other reason not defined above|0|||
143184127|NCT00881530|516218872|FG004|Overall Study|Other reason not defined above|0|||
143184128|NCT00881530|516218873|FG005|Overall Study|Other reason not defined above|2|||
143184129|NCT04396795|516218877|FG000|Month 1|Lost to Follow-up|2|||
143184130|NCT04396795|516218878|FG001|Month 1|Lost to Follow-up|3|||
143184131|NCT04396795|516218877|FG000|Month 3|Lost to Follow-up|1|||
143184132|NCT04396795|516218878|FG001|Month 3|Lost to Follow-up|3|||
143184133|NCT04396795|516218877|FG000|Month 6|Lost to Follow-up|3|||
143184134|NCT04396795|516218878|FG001|Month 6|Lost to Follow-up|3|||
143184135|NCT02366923|516218879|FG000|Overall Study|Withdrawal by Subject|1|||
143184136|NCT02366923|516218879|FG000|Overall Study|Positive Slit Lamp Findings|2|||
143184137|NCT02366923|516218879|FG000|Overall Study|High Astigmatism|3|||
143184138|NCT02725476|516218881|FG000|Overall Study|Physician Decision|2|||
143184139|NCT02725476|516218882|FG001|Overall Study|Physician Decision|0|||
143184140|NCT02725476|516218881|FG000|Overall Study|Adverse Event|1|||
143184141|NCT02725476|516218882|FG001|Overall Study|Adverse Event|1|||
143184142|NCT00289289|516218883|FG000|Overall Study|Withdrawal by Subject|5|||
143184143|NCT00289289|516218884|FG001|Overall Study|Withdrawal by Subject|3|||
143184144|NCT00289289|516218885|FG002|Overall Study|Withdrawal by Subject|15|||
143184145|NCT00289289|516218883|FG000|Overall Study|Lost to Follow-up|1|||
143184146|NCT00289289|516218884|FG001|Overall Study|Lost to Follow-up|0|||
143184147|NCT00289289|516218885|FG002|Overall Study|Lost to Follow-up|1|||
143184148|NCT00289289|516218883|FG000|Overall Study|Death|4|||
143184149|NCT00289289|516218884|FG001|Overall Study|Death|2|||
143184150|NCT00289289|516218885|FG002|Overall Study|Death|5|||
143184151|NCT00289289|516218883|FG000|Overall Study|No implant attempted|0|||
143184152|NCT00289289|516218884|FG001|Overall Study|No implant attempted|0|||
143184153|NCT00289289|516218885|FG002|Overall Study|No implant attempted|1|||
143184154|NCT00289289|516218883|FG000|Overall Study|Physician Decision|1|||
143184155|NCT00289289|516218884|FG001|Overall Study|Physician Decision|0|||
143184156|NCT00289289|516218885|FG002|Overall Study|Physician Decision|6|||
143184157|NCT00289289|516218883|FG000|Overall Study|Non-study device implanted|2|||
143115310|NCT01358578|515963885|FG001|Induction Period|Withdrawal by Subject|5|||
143115311|NCT01358578|515963886|FG002|Induction Period|Withdrawal by Subject|10|||
143115312|NCT01358578|515963887|FG003|Induction Period|Withdrawal by Subject|6|||
143115313|NCT01358578|515963888|FG004|Induction Period|Withdrawal by Subject|0|||
143115314|NCT01358578|515963889|FG005|Induction Period|Withdrawal by Subject|0|||
143115315|NCT01358578|515963884|FG000|Maintenance Period|Adverse Event|2|||
143115316|NCT01358578|515963885|FG001|Maintenance Period|Adverse Event|7|||
143115317|NCT01358578|515963886|FG002|Maintenance Period|Adverse Event|0|||
143115318|NCT01358578|515963887|FG003|Maintenance Period|Adverse Event|6|||
143115319|NCT01358578|515963888|FG004|Maintenance Period|Adverse Event|4|||
143115320|NCT01358578|515963889|FG005|Maintenance Period|Adverse Event|3|||
143115321|NCT01358578|515963884|FG000|Maintenance Period|Lack of Efficacy|10|||
143115322|NCT01358578|515963885|FG001|Maintenance Period|Lack of Efficacy|2|||
143115323|NCT01358578|515963886|FG002|Maintenance Period|Lack of Efficacy|0|||
143115324|NCT01358578|515963887|FG003|Maintenance Period|Lack of Efficacy|11|||
143115325|NCT01358578|515963888|FG004|Maintenance Period|Lack of Efficacy|3|||
143115326|NCT01358578|515963889|FG005|Maintenance Period|Lack of Efficacy|0|||
143115327|NCT01358578|515963884|FG000|Maintenance Period|Lost to Follow-up|4|||
143115328|NCT01358578|515963885|FG001|Maintenance Period|Lost to Follow-up|0|||
143115329|NCT01358578|515963886|FG002|Maintenance Period|Lost to Follow-up|0|||
143115330|NCT01358578|515963887|FG003|Maintenance Period|Lost to Follow-up|5|||
143115331|NCT01358578|515963888|FG004|Maintenance Period|Lost to Follow-up|1|||
143115332|NCT01358578|515963889|FG005|Maintenance Period|Lost to Follow-up|1|||
143115333|NCT01358578|515963884|FG000|Maintenance Period|Non-compliance with study treatment|3|||
143115334|NCT01358578|515963885|FG001|Maintenance Period|Non-compliance with study treatment|1|||
143115335|NCT01358578|515963886|FG002|Maintenance Period|Non-compliance with study treatment|0|||
143115336|NCT01358578|515963887|FG003|Maintenance Period|Non-compliance with study treatment|2|||
143115337|NCT01358578|515963888|FG004|Maintenance Period|Non-compliance with study treatment|1|||
143115338|NCT01358578|515963889|FG005|Maintenance Period|Non-compliance with study treatment|2|||
143115339|NCT01358578|515963884|FG000|Maintenance Period|Physician Decision|0|||
143115340|NCT01358578|515963885|FG001|Maintenance Period|Physician Decision|1|||
143115341|NCT01358578|515963886|FG002|Maintenance Period|Physician Decision|0|||
143115342|NCT01358578|515963887|FG003|Maintenance Period|Physician Decision|1|||
143115343|NCT01358578|515963888|FG004|Maintenance Period|Physician Decision|0|||
143115344|NCT01358578|515963889|FG005|Maintenance Period|Physician Decision|0|||
143115345|NCT01358578|515963884|FG000|Maintenance Period|Pregnancy|1|||
143115346|NCT01358578|515963885|FG001|Maintenance Period|Pregnancy|0|||
143115347|NCT01358578|515963886|FG002|Maintenance Period|Pregnancy|0|||
143115348|NCT01358578|515963887|FG003|Maintenance Period|Pregnancy|0|||
143115349|NCT01358578|515963888|FG004|Maintenance Period|Pregnancy|0|||
143115350|NCT01358578|515963889|FG005|Maintenance Period|Pregnancy|0|||
143115351|NCT01358578|515963884|FG000|Maintenance Period|Protocol deviation|7|||
143115352|NCT01358578|515963885|FG001|Maintenance Period|Protocol deviation|4|||
143115353|NCT01358578|515963886|FG002|Maintenance Period|Protocol deviation|0|||
143115354|NCT01358578|515963887|FG003|Maintenance Period|Protocol deviation|2|||
143115355|NCT01358578|515963888|FG004|Maintenance Period|Protocol deviation|2|||
143115356|NCT01358578|515963889|FG005|Maintenance Period|Protocol deviation|2|||
143115357|NCT01358578|515963884|FG000|Maintenance Period|Withdrawal by Subject|12|||
143115358|NCT01358578|515963885|FG001|Maintenance Period|Withdrawal by Subject|7|||
143115359|NCT01358578|515963886|FG002|Maintenance Period|Withdrawal by Subject|2|||
143115360|NCT01358578|515963887|FG003|Maintenance Period|Withdrawal by Subject|15|||
143115361|NCT01358578|515963888|FG004|Maintenance Period|Withdrawal by Subject|6|||
143115362|NCT01358578|515963889|FG005|Maintenance Period|Withdrawal by Subject|3|||
143115363|NCT01358578|515963884|FG000|Follow-up Period|Adverse Event|1|||
143115364|NCT01358578|515963885|FG001|Follow-up Period|Adverse Event|1|||
143115365|NCT01358578|515963886|FG002|Follow-up Period|Adverse Event|0|||
143115366|NCT01358578|515963887|FG003|Follow-up Period|Adverse Event|0|||
143115367|NCT01358578|515963888|FG004|Follow-up Period|Adverse Event|0|||
143115368|NCT01358578|515963889|FG005|Follow-up Period|Adverse Event|0|||
143115369|NCT01358578|515963884|FG000|Follow-up Period|Lack of Efficacy|3|||
143115370|NCT01358578|515963885|FG001|Follow-up Period|Lack of Efficacy|0|||
143115371|NCT01358578|515963886|FG002|Follow-up Period|Lack of Efficacy|4|||
143115372|NCT01358578|515963887|FG003|Follow-up Period|Lack of Efficacy|1|||
143115373|NCT01358578|515963888|FG004|Follow-up Period|Lack of Efficacy|0|||
143115374|NCT01358578|515963889|FG005|Follow-up Period|Lack of Efficacy|0|||
143115375|NCT01358578|515963884|FG000|Follow-up Period|Lost to Follow-up|0|||
143115376|NCT01358578|515963885|FG001|Follow-up Period|Lost to Follow-up|1|||
143115377|NCT01358578|515963886|FG002|Follow-up Period|Lost to Follow-up|0|||
143115378|NCT01358578|515963887|FG003|Follow-up Period|Lost to Follow-up|4|||
143115379|NCT01358578|515963888|FG004|Follow-up Period|Lost to Follow-up|0|||
143115380|NCT01358578|515963889|FG005|Follow-up Period|Lost to Follow-up|0|||
143115381|NCT01358578|515963884|FG000|Follow-up Period|non- compliance with study treatment|1|||
143115382|NCT01358578|515963885|FG001|Follow-up Period|non- compliance with study treatment|0|||
143115383|NCT01358578|515963886|FG002|Follow-up Period|non- compliance with study treatment|0|||
143115384|NCT01358578|515963887|FG003|Follow-up Period|non- compliance with study treatment|0|||
143260814|NCT01155479|516508826|FG002|Part II|Treatment Failure|2|||
143184158|NCT00289289|516218884|FG001|Overall Study|Non-study device implanted|1|||
143184159|NCT00289289|516218885|FG002|Overall Study|Non-study device implanted|3|||
143184160|NCT00289289|516218883|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
143184161|NCT00289289|516218884|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
143184162|NCT00289289|516218885|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
143184163|NCT00289289|516218883|FG000|Overall Study|Other Exit Reason|6|||
143184164|NCT00289289|516218884|FG001|Overall Study|Other Exit Reason|4|||
143184165|NCT00289289|516218885|FG002|Overall Study|Other Exit Reason|12|||
143184166|NCT01445613|516218886|FG000|30-day Follow-up|Withdrawal by Subject|6|||
143184167|NCT01445613|516218886|FG000|30-day Follow-up|Physician Decision|3|||
143184168|NCT01445613|516218886|FG000|30-day Follow-up|Missed visit|23|||
143184169|NCT01445613|516218886|FG000|30-day Follow-up|Death|3|||
143184170|NCT01445613|516218886|FG000|1-year Follow-up|Withdrawal by Subject|12|||
143184171|NCT01445613|516218886|FG000|1-year Follow-up|Missed visit|29|||
143184172|NCT01445613|516218886|FG000|1-year Follow-up|Lost to Follow-up|2|||
143184173|NCT01445613|516218886|FG000|1-year Follow-up|Death|30|||
143184174|NCT01445613|516218886|FG000|1-year Follow-up|Physician Decision|2|||
143184175|NCT01445613|516218886|FG000|1-year Follow-up|Received a non-study stent|2|||
143184176|NCT00407602|516218887|FG000|Overall Study|Death - unrelated to device|1|||
143184177|NCT00407602|516218887|FG000|Overall Study|Device explanted|5|||
143184178|NCT00407602|516218887|FG000|Overall Study|Withdrawal by Subject|1|||
143184179|NCT00809926|516218888|FG000|Overall Study|Adverse Event|18|||
143184180|NCT00809926|516218889|FG001|Overall Study|Adverse Event|10|||
143184181|NCT00809926|516218888|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
143184182|NCT00809926|516218889|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
143184183|NCT00809926|516218888|FG000|Overall Study|Patient withdrew consent|8|||
143184184|NCT00809926|516218889|FG001|Overall Study|Patient withdrew consent|6|||
143184185|NCT00809926|516218888|FG000|Overall Study|Lost to Follow-up|2|||
143184186|NCT00809926|516218889|FG001|Overall Study|Lost to Follow-up|1|||
143184187|NCT00809926|516218888|FG000|Overall Study|Administrative Problems|0|||
143184188|NCT00809926|516218889|FG001|Overall Study|Administrative Problems|1|||
143184189|NCT00809926|516218888|FG000|Overall Study|Protocol deviation|0|||
143184190|NCT00809926|516218889|FG001|Overall Study|Protocol deviation|2|||
143184191|NCT01740687|516218894|FG000|Overall Study|Lost to Follow-up|11|||
143184192|NCT01740687|516218894|FG000|Overall Study|Withdrawal by Subject|2|||
143184193|NCT01740687|516218894|FG000|Overall Study|other reason|22|||
143184194|NCT01740687|516218894|FG000|Overall Study|treatment not received|2|||
143184195|NCT01963767|516218896|FG000|Overall Study|Withdrawal by Subject|4|||
143184196|NCT01963767|516218897|FG001|Overall Study|Withdrawal by Subject|2|||
143184197|NCT01963767|516218896|FG000|Overall Study|Adverse Event|2|||
143184198|NCT01963767|516218897|FG001|Overall Study|Adverse Event|0|||
143184199|NCT01082081|516218900|FG000|Overall Study|Lost to Follow-up|0|||
143184200|NCT01082081|516218901|FG001|Overall Study|Lost to Follow-up|0|||
143184201|NCT01082081|516218902|FG002|Overall Study|Lost to Follow-up|1|||
143184202|NCT01082081|516218900|FG000|Overall Study|Withdrawal by Subject|0|||
143184203|NCT01082081|516218901|FG001|Overall Study|Withdrawal by Subject|0|||
143184204|NCT01082081|516218902|FG002|Overall Study|Withdrawal by Subject|1|||
143184205|NCT01082081|516218900|FG000|Overall Study|Other Reason|0|||
143184206|NCT01082081|516218901|FG001|Overall Study|Other Reason|1|||
143184207|NCT01082081|516218902|FG002|Overall Study|Other Reason|0|||
143184208|NCT00670930|516218903|FG000|Overall Study|Adminstrative Problem|0|||
143184209|NCT00670930|516218904|FG001|Overall Study|Adminstrative Problem|1|||
143260815|NCT01155479|516508827|FG003|Part II|Treatment Failure|0|||
143260816|NCT01155479|516508828|FG004|Part II|Treatment Failure|1|||
143260817|NCT01155479|516508824|FG000|Part II|Non-Compliance with Protocol|0|||
143260818|NCT01155479|516508825|FG001|Part II|Non-Compliance with Protocol|1|||
143260819|NCT01155479|516508826|FG002|Part II|Non-Compliance with Protocol|0|||
143184210|NCT00670930|516218903|FG000|Overall Study|Lost to Follow-up|1|||
143184211|NCT00670930|516218904|FG001|Overall Study|Lost to Follow-up|0|||
143184212|NCT03159468|516218906|FG000|Overall Study|Withdrawal by Subject|0|||
143184213|NCT03159468|516218907|FG001|Overall Study|Withdrawal by Subject|0|||
143184214|NCT03159468|516218908|FG002|Overall Study|Withdrawal by Subject|3|||
143260820|NCT01155479|516508827|FG003|Part II|Non-Compliance with Protocol|2|||
143184215|NCT03159468|516218909|FG003|Overall Study|Withdrawal by Subject|0|||
143184216|NCT03159468|516218910|FG004|Overall Study|Withdrawal by Subject|0|||
143260821|NCT01155479|516508828|FG004|Part II|Non-Compliance with Protocol|0|||
143260822|NCT02360605|516508829|FG000|Overall Study|Withdrawal by Subject|4|||
143184217|NCT03159468|516218911|FG005|Overall Study|Withdrawal by Subject|0|||
143184218|NCT00958360|516220652|FG000|Overall Study|Withdrawal by Subject|3|||
143184219|NCT00958360|516220653|FG001|Overall Study|Withdrawal by Subject|1|||
143184220|NCT00958360|516220652|FG000|Overall Study|Death|6|||
143184221|NCT00958360|516220653|FG001|Overall Study|Death|7|||
143184222|NCT00958360|516220652|FG000|Overall Study|Physician Decision|2|||
143184223|NCT00958360|516220653|FG001|Overall Study|Physician Decision|1|||
143184224|NCT00958360|516220652|FG000|Overall Study|Lost to Follow-up|0|||
143184225|NCT00958360|516220653|FG001|Overall Study|Lost to Follow-up|1|||
143184226|NCT03015363|516220654|FG000|Overall Study|Physician Decision|14|||
143184227|NCT03015363|516220654|FG000|Overall Study|Withdrawal by Subject|3|||
143260823|NCT02360605|516508830|FG001|Overall Study|Withdrawal by Subject|9|||
143260824|NCT02360605|516508829|FG000|Overall Study|Lost to Follow-up|7|||
143260825|NCT02360605|516508830|FG001|Overall Study|Lost to Follow-up|8|||
143260826|NCT02360605|516508829|FG000|Overall Study|Death|0|||
143260827|NCT02360605|516508830|FG001|Overall Study|Death|1|||
143260828|NCT00470184|516508835|FG000|Overall Study|Not Treated(became ineligible)|4|||
143260829|NCT00470184|516508835|FG000|Overall Study|Not treated (other)|1|||
143260830|NCT00470184|516508835|FG000|Overall Study|disease Progression|4|||
143260831|NCT00470184|516508835|FG000|Overall Study|Adverse Event|3|||
143260832|NCT00470184|516508835|FG000|Overall Study|Withdrawal by Subject|4|||
143260833|NCT00470184|516508835|FG000|Overall Study|other|5|||
143260834|NCT00470184|516508835|FG000|Overall Study|recurrence|1|||
143260835|NCT01001299|516508838|FG000|Overall Study|Insufficient Therapeutic Response|20|||
143260836|NCT01001299|516508838|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
143260837|NCT01001299|516508838|FG000|Overall Study|Death|1|||
143260838|NCT01001299|516508838|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
143260839|NCT01001299|516508838|FG000|Overall Study|Withdrew Consent|1|||
143260840|NCT01923168|516508843|FG000|Overall Study|Protocol Violation|1|||
143260841|NCT01923168|516508844|FG001|Overall Study|Protocol Violation|1|||
143260842|NCT01923168|516508845|FG002|Overall Study|Protocol Violation|0|||
143184228|NCT03107052|516220655|FG000|Overall Study|Adverse Event|6|||
143184229|NCT03107052|516220656|FG001|Overall Study|Adverse Event|1|||
143184230|NCT03107052|516220657|FG002|Overall Study|Adverse Event|2|||
143184231|NCT03107052|516220655|FG000|Overall Study|Withdrawal by Subject|9|||
143184232|NCT03107052|516220656|FG001|Overall Study|Withdrawal by Subject|5|||
143184233|NCT03107052|516220657|FG002|Overall Study|Withdrawal by Subject|8|||
143184234|NCT03107052|516220655|FG000|Overall Study|Protocol Violation|6|||
143184235|NCT03107052|516220656|FG001|Overall Study|Protocol Violation|0|||
143184236|NCT03107052|516220657|FG002|Overall Study|Protocol Violation|3|||
143184237|NCT03107052|516220655|FG000|Overall Study|Lost to Follow-up|4|||
143184238|NCT03107052|516220656|FG001|Overall Study|Lost to Follow-up|0|||
143184239|NCT03107052|516220657|FG002|Overall Study|Lost to Follow-up|1|||
143184240|NCT03107052|516220655|FG000|Overall Study|Lack of Efficacy|23|||
143184241|NCT03107052|516220656|FG001|Overall Study|Lack of Efficacy|7|||
143184242|NCT03107052|516220657|FG002|Overall Study|Lack of Efficacy|4|||
143184243|NCT03107052|516220655|FG000|Overall Study|Other than specified|4|||
143184244|NCT03107052|516220656|FG001|Overall Study|Other than specified|2|||
143184245|NCT03107052|516220657|FG002|Overall Study|Other than specified|0|||
143184246|NCT03107052|516220655|FG000|Overall Study|Study terminated due to futility|67|||
143184247|NCT03107052|516220656|FG001|Overall Study|Study terminated due to futility|31|||
143184248|NCT03107052|516220657|FG002|Overall Study|Study terminated due to futility|23|||
143184249|NCT02263326|516220658|FG000|Overall Study|Lost to Follow-up|1|||
143184250|NCT02263326|516220659|FG001|Overall Study|Lost to Follow-up|1|||
143184251|NCT00500357|516220660|FG000|Overall Study|Death|1|||
143184252|NCT02397915|516220661|FG000|Period 1|Protocol Violation|0|||
143184253|NCT02397915|516220662|FG001|Period 1|Protocol Violation|1|||
143184254|NCT02397915|516220663|FG002|Period 1|Protocol Violation|0|||
143184255|NCT02397915|516220664|FG003|Period 1|Protocol Violation|0|||
143184256|NCT02397915|516220661|FG000|Period 1|Physician Decision|1|||
143184257|NCT02397915|516220662|FG001|Period 1|Physician Decision|0|||
143184258|NCT02397915|516220663|FG002|Period 1|Physician Decision|0|||
143260843|NCT01923168|516508843|FG000|Overall Study|Subject/guardian decision|14|||
143260844|NCT01923168|516508844|FG001|Overall Study|Subject/guardian decision|14|||
143260845|NCT01923168|516508845|FG002|Overall Study|Subject/guardian decision|4|||
143260846|NCT01923168|516508843|FG000|Overall Study|Adverse Event|12|||
143260847|NCT01923168|516508844|FG001|Overall Study|Adverse Event|12|||
143260848|NCT01923168|516508845|FG002|Overall Study|Adverse Event|0|||
143260849|NCT01923168|516508843|FG000|Overall Study|Physician Decision|6|||
143260850|NCT01923168|516508844|FG001|Overall Study|Physician Decision|9|||
143260851|NCT01923168|516508845|FG002|Overall Study|Physician Decision|5|||
143260852|NCT01923168|516508843|FG000|Overall Study|Progressive disease|4|||
143260853|NCT01923168|516508844|FG001|Overall Study|Progressive disease|3|||
143260854|NCT01923168|516508845|FG002|Overall Study|Progressive disease|7|||
143260855|NCT01923168|516508843|FG000|Overall Study|Death|0|||
143260856|NCT01923168|516508844|FG001|Overall Study|Death|0|||
143184259|NCT02397915|516220664|FG003|Period 1|Physician Decision|0|||
143184260|NCT03292874|516220665|FG000|Overall Study|Due to pandemic|5|||
143184261|NCT00566982|516220666|FG000|Overall Study|Adverse Event|6|||
143184262|NCT00566982|516220667|FG001|Overall Study|Adverse Event|48|||
143184263|NCT00566982|516220666|FG000|Overall Study|Withdrawal by Subject|1|||
143184264|NCT00566982|516220667|FG001|Overall Study|Withdrawal by Subject|14|||
143184265|NCT00566982|516220666|FG000|Overall Study|Protocol Violation|1|||
143184266|NCT00566982|516220667|FG001|Overall Study|Protocol Violation|4|||
143184267|NCT00566982|516220666|FG000|Overall Study|Lost to Follow-up|0|||
143184268|NCT00566982|516220667|FG001|Overall Study|Lost to Follow-up|1|||
143184269|NCT00566982|516220666|FG000|Overall Study|Other-family problems & doctor's request|0|||
143184270|NCT00566982|516220667|FG001|Overall Study|Other-family problems & doctor's request|2|||
143184271|NCT00161616|516220668|FG000|Overall Study|Withdrawal by Subject|6|||
143184272|NCT00161616|516220669|FG001|Overall Study|Withdrawal by Subject|5|||
143184273|NCT00161616|516220668|FG000|Overall Study|Physician Decision|1|||
143184274|NCT00161616|516220669|FG001|Overall Study|Physician Decision|0|||
143184275|NCT00161616|516220668|FG000|Overall Study|Death|1|||
143184276|NCT00161616|516220669|FG001|Overall Study|Death|1|||
143184277|NCT00161616|516220668|FG000|Overall Study|Lost to Follow-up|17|||
143184278|NCT00161616|516220669|FG001|Overall Study|Lost to Follow-up|13|||
143184279|NCT00161616|516220668|FG000|Overall Study|Protocol deviation|1|||
143184280|NCT00161616|516220669|FG001|Overall Study|Protocol deviation|0|||
143184281|NCT00336284|516220670|FG000|Overall Study|Death|52|||
143184282|NCT00336284|516220671|FG001|Overall Study|Death|26|||
143184283|NCT00336284|516220670|FG000|Overall Study|Lost to Follow-up|82|||
143184284|NCT00336284|516220671|FG001|Overall Study|Lost to Follow-up|61|||
143184285|NCT00336284|516220670|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
143184286|NCT00336284|516220671|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
143184287|NCT02141633|516220677|FG000|Overall Study|Physician Decision|1|||
143184288|NCT02141633|516220678|FG001|Overall Study|Physician Decision|0|||
143184289|NCT02403817|516220683|FG000|Overall Study|Withdrawal by Subject|5|||
143184290|NCT02403817|516220684|FG001|Overall Study|Withdrawal by Subject|0|||
143184291|NCT01188551|516220685|FG000|Overall Study|Pharmacy issues|1|||
143184292|NCT01188551|516220686|FG001|Overall Study|Pharmacy issues|0|||
143184293|NCT01188551|516220687|FG002|Overall Study|Pharmacy issues|0|||
143184294|NCT01188551|516220688|FG003|Overall Study|Pharmacy issues|0|||
143184295|NCT00391053|516220689|FG000|Overall Study|Serious Adverse Events|1|||
143184296|NCT00391053|516220690|FG001|Overall Study|Serious Adverse Events|0|||
143184297|NCT00391053|516220691|FG002|Overall Study|Serious Adverse Events|1|||
143184298|NCT00391053|516220692|FG003|Overall Study|Serious Adverse Events|4|||
143184299|NCT00391053|516220689|FG000|Overall Study|Protocol Violation|2|||
143184300|NCT00391053|516220690|FG001|Overall Study|Protocol Violation|0|||
143184301|NCT00391053|516220691|FG002|Overall Study|Protocol Violation|0|||
143184302|NCT00391053|516220692|FG003|Overall Study|Protocol Violation|0|||
143184303|NCT00391053|516220689|FG000|Overall Study|Lost to Follow-up|1|||
143184304|NCT00391053|516220690|FG001|Overall Study|Lost to Follow-up|0|||
143184305|NCT00391053|516220691|FG002|Overall Study|Lost to Follow-up|0|||
143184306|NCT00391053|516220692|FG003|Overall Study|Lost to Follow-up|5|||
143184307|NCT00391053|516220689|FG000|Overall Study|Withdrawal by Subject|5|||
143184308|NCT00391053|516220690|FG001|Overall Study|Withdrawal by Subject|1|||
143184309|NCT00391053|516220691|FG002|Overall Study|Withdrawal by Subject|1|||
143184310|NCT00391053|516220692|FG003|Overall Study|Withdrawal by Subject|1|||
143184311|NCT00473889|516220693|FG000|Overall Study|Did not receive study medication|1|||
143184312|NCT00473889|516220694|FG001|Overall Study|Did not receive study medication|4|||
143184313|NCT00473889|516220693|FG000|Overall Study|Adverse Event|30|||
143184314|NCT00473889|516220694|FG001|Overall Study|Adverse Event|17|||
143184315|NCT00473889|516220693|FG000|Overall Study|Protocol Violation|4|||
143184316|NCT00473889|516220694|FG001|Overall Study|Protocol Violation|2|||
143184317|NCT00473889|516220693|FG000|Overall Study|Lack of Efficacy|28|||
143184318|NCT00473889|516220694|FG001|Overall Study|Lack of Efficacy|29|||
143184319|NCT00473889|516220693|FG000|Overall Study|Lost to Follow-up|2|||
143184320|NCT00473889|516220694|FG001|Overall Study|Lost to Follow-up|1|||
143184321|NCT00473889|516220693|FG000|Overall Study|Physician Decision|10|||
143184322|NCT00473889|516220694|FG001|Overall Study|Physician Decision|5|||
143184323|NCT00473889|516220693|FG000|Overall Study|Trial Terminated|3|||
143184324|NCT00473889|516220694|FG001|Overall Study|Trial Terminated|6|||
143184325|NCT00473889|516220693|FG000|Overall Study|Withdrawal by Subject|5|||
143184326|NCT00473889|516220694|FG001|Overall Study|Withdrawal by Subject|0|||
143184327|NCT04908384|516220698|FG000|Overall Study|Lost to Follow-up|4|||
143184328|NCT04908384|516220699|FG001|Overall Study|Lost to Follow-up|4|||
143184329|NCT04908384|516220700|FG002|Overall Study|Lost to Follow-up|0|||
143184330|NCT04908384|516220701|FG003|Overall Study|Lost to Follow-up|0|||
143184331|NCT05002985|516220702|FG000|Overall Study|Withdrawal by Subject|1|||
143184332|NCT02943070|516220703|FG000|Overall Study|Physician Decision|1|||
143184333|NCT02943070|516220703|FG000|Overall Study|Adverse Event|2|||
143184334|NCT02943070|516220703|FG000|Overall Study|Death|2|||
143184335|NCT02943070|516220703|FG000|Overall Study|Withdrawal by Subject|3|||
143184336|NCT02943070|516220703|FG000|Overall Study|Lost to Follow-up|4|||
143184337|NCT02943070|516220703|FG000|Overall Study|Retreatment or TURP|13|||
143184338|NCT02943070|516220703|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
143369372|NCT00686517|516896083|FG000|Treatment|Adverse Event|2|||
143184339|NCT00570778|516220704|FG000|Overall Study|Protocol deviation|2|||
143184340|NCT00570778|516220705|FG001|Overall Study|Protocol deviation|1|||
143184341|NCT00570778|516220706|FG002|Overall Study|Protocol deviation|2|||
143184342|NCT00570778|516220707|FG003|Overall Study|Protocol deviation|2|||
143184343|NCT00570778|516220704|FG000|Overall Study|Adverse Event|0|||
143184344|NCT00570778|516220705|FG001|Overall Study|Adverse Event|1|||
143184345|NCT00570778|516220706|FG002|Overall Study|Adverse Event|4|||
143184346|NCT00570778|516220707|FG003|Overall Study|Adverse Event|1|||
143184347|NCT00570778|516220704|FG000|Overall Study|Subject withdrew consent|0|||
143184348|NCT00570778|516220705|FG001|Overall Study|Subject withdrew consent|1|||
143184349|NCT00570778|516220706|FG002|Overall Study|Subject withdrew consent|0|||
143184350|NCT00570778|516220707|FG003|Overall Study|Subject withdrew consent|1|||
143184351|NCT00570778|516220704|FG000|Overall Study|Abnormal test procedure|1|||
143184352|NCT00570778|516220705|FG001|Overall Study|Abnormal test procedure|0|||
143184353|NCT00570778|516220706|FG002|Overall Study|Abnormal test procedure|0|||
143184354|NCT00570778|516220707|FG003|Overall Study|Abnormal test procedure|0|||
143184355|NCT00570778|516220704|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
143184356|NCT00570778|516220705|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
143184357|NCT00570778|516220706|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
143184358|NCT00570778|516220707|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
143184359|NCT00570778|516220704|FG000|Overall Study|Lost to Follow-up|0|||
143184360|NCT00570778|516220705|FG001|Overall Study|Lost to Follow-up|0|||
143184361|NCT00570778|516220706|FG002|Overall Study|Lost to Follow-up|1|||
143184362|NCT00570778|516220707|FG003|Overall Study|Lost to Follow-up|0|||
143184363|NCT00570778|516220704|FG000|Overall Study|Subject no longer requires study drug|0|||
143184364|NCT00570778|516220705|FG001|Overall Study|Subject no longer requires study drug|1|||
143184365|NCT00570778|516220706|FG002|Overall Study|Subject no longer requires study drug|0|||
143184366|NCT00570778|516220707|FG003|Overall Study|Subject no longer requires study drug|0|||
143184367|NCT03654040|516220708|FG000|Overall Study|Death|1|||
143184368|NCT03654040|516220709|FG001|Overall Study|Death|0|||
143184369|NCT03654040|516220708|FG000|Overall Study|Withdrawal by Subject|1|||
143184370|NCT03654040|516220709|FG001|Overall Study|Withdrawal by Subject|0|||
143184371|NCT03654040|516220708|FG000|Overall Study|Study terminated by sponsor|8|||
143184372|NCT03654040|516220709|FG001|Overall Study|Study terminated by sponsor|2|||
143184373|NCT03654040|516220708|FG000|Overall Study|Failure to initiate study therapy|2|||
143184374|NCT03654040|516220709|FG001|Overall Study|Failure to initiate study therapy|0|||
143184375|NCT03654040|516220708|FG000|Overall Study|Transplanted at another center|2|||
143184376|NCT03654040|516220709|FG001|Overall Study|Transplanted at another center|0|||
143184377|NCT03654040|516220708|FG000|Overall Study|Failure to meet eligibility criteria|14|||
143184378|NCT03654040|516220709|FG001|Overall Study|Failure to meet eligibility criteria|2|||
143184379|NCT03654040|516220708|FG000|Overall Study|No longer transplant candidate|1|||
143184380|NCT03654040|516220709|FG001|Overall Study|No longer transplant candidate|0|||
143184381|NCT03654040|516220708|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
143184382|NCT03654040|516220709|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
143184383|NCT03654040|516220708|FG000|Overall Study|Recipient ineligible|0|||
143184384|NCT03654040|516220709|FG001|Overall Study|Recipient ineligible|2|||
143184385|NCT03654040|516220708|FG000|Overall Study|Received deceased liver|0|||
143184386|NCT03654040|516220709|FG001|Overall Study|Received deceased liver|1|||
143184387|NCT03332173|516220710|FG000|Overall Study|Death|7|||
143184388|NCT03332173|516220710|FG000|Overall Study|Withdrawal by Subject|6|||
143184389|NCT03332173|516220710|FG000|Overall Study|Lost to Follow-up|2|||
143184390|NCT03332173|516220710|FG000|Overall Study|Transferred to long-term extension study|29|||
143184391|NCT00135330|516220711|FG000|Overall Study|Adverse Event|2|||
143184392|NCT00135330|516220712|FG001|Overall Study|Adverse Event|5|||
143184393|NCT00135330|516220713|FG002|Overall Study|Adverse Event|1|||
143184394|NCT00135330|516220711|FG000|Overall Study|Lost to Follow-up|0|||
143184395|NCT00135330|516220712|FG001|Overall Study|Lost to Follow-up|2|||
143184396|NCT00135330|516220713|FG002|Overall Study|Lost to Follow-up|3|||
143184397|NCT00135330|516220711|FG000|Overall Study|Physician Decision|1|||
143184398|NCT00135330|516220712|FG001|Overall Study|Physician Decision|1|||
143184399|NCT00135330|516220713|FG002|Overall Study|Physician Decision|0|||
143184400|NCT00135330|516220711|FG000|Overall Study|Protocol Violation|4|||
143184401|NCT00135330|516220712|FG001|Overall Study|Protocol Violation|3|||
143184402|NCT00135330|516220713|FG002|Overall Study|Protocol Violation|3|||
143184403|NCT00135330|516220711|FG000|Overall Study|Patient Decision|5|||
143184404|NCT00135330|516220712|FG001|Overall Study|Patient Decision|1|||
143184405|NCT00135330|516220713|FG002|Overall Study|Patient Decision|4|||
143184406|NCT00135330|516220711|FG000|Overall Study|Sponsor Decision|0|||
143184407|NCT00135330|516220712|FG001|Overall Study|Sponsor Decision|1|||
143184408|NCT00135330|516220713|FG002|Overall Study|Sponsor Decision|0|||
143184409|NCT02526212|516220714|FG000|Overall Study|Incarceration|1|||
143184410|NCT02526212|516220715|FG001|Overall Study|Incarceration|0|||
143184411|NCT02526212|516220714|FG000|Overall Study|Lost to Follow-up|1|||
143184412|NCT02526212|516220715|FG001|Overall Study|Lost to Follow-up|0|||
143184413|NCT02526212|516220714|FG000|Overall Study|Death|0|||
143184414|NCT02526212|516220715|FG001|Overall Study|Death|1|||
143184415|NCT01390298|516220716|FG000|Overall Study|Death|1|||
143184416|NCT01390298|516220716|FG000|Overall Study|long term ICU admission|1|||
143184417|NCT01390298|516220716|FG000|Overall Study|Withdrawal by Subject|14|||
143260857|NCT01923168|516508845|FG002|Overall Study|Death|1|||
143260858|NCT01609478|516508846|FG000|Overall Study|Adverse Event|3|||
143260859|NCT01609478|516508847|FG001|Overall Study|Adverse Event|1|||
143260860|NCT01609478|516508848|FG002|Overall Study|Adverse Event|5|||
143260861|NCT01609478|516508846|FG000|Overall Study|Protocol Deviation|0|||
143260862|NCT01609478|516508847|FG001|Overall Study|Protocol Deviation|1|||
143260863|NCT01609478|516508848|FG002|Overall Study|Protocol Deviation|1|||
143260864|NCT01609478|516508846|FG000|Overall Study|Non-Compliance with study treatment|1|||
143260865|NCT01609478|516508847|FG001|Overall Study|Non-Compliance with study treatment|0|||
143260866|NCT01609478|516508848|FG002|Overall Study|Non-Compliance with study treatment|0|||
143260867|NCT01609478|516508846|FG000|Overall Study|Physician Decision|1|||
143260868|NCT01609478|516508847|FG001|Overall Study|Physician Decision|0|||
143260869|NCT01609478|516508848|FG002|Overall Study|Physician Decision|1|||
143260870|NCT01609478|516508846|FG000|Overall Study|Withdrawal by Subject|2|||
143260871|NCT01609478|516508847|FG001|Overall Study|Withdrawal by Subject|0|||
143260872|NCT01609478|516508848|FG002|Overall Study|Withdrawal by Subject|2|||
143260873|NCT03116347|516508849|FG000|Overall Study|Withdrawal by Subject|1|||
143260874|NCT03116347|516508850|FG001|Overall Study|Withdrawal by Subject|2|||
143260875|NCT00476047|516508851|FG000|Overall Study|Lost to Follow-up|1|||
143260876|NCT01056380|516508852|FG000|Overall Study|Lost to Follow-up|2|||
143260877|NCT01056380|516508853|FG001|Overall Study|Lost to Follow-up|3|||
143260878|NCT03170232|516508854|FG000|Overall Study|Adverse Event|0|||
143260879|NCT03170232|516508855|FG001|Overall Study|Adverse Event|1|||
143260880|NCT03170232|516508854|FG000|Overall Study|Protocol Violation|0|||
143260881|NCT03170232|516508855|FG001|Overall Study|Protocol Violation|1|||
143260882|NCT03170232|516508854|FG000|Overall Study|Lack of Efficacy|0|||
143260883|NCT03170232|516508855|FG001|Overall Study|Lack of Efficacy|1|||
143260884|NCT03170232|516508854|FG000|Overall Study|Study closed/terminated|26|||
143260885|NCT03170232|516508855|FG001|Overall Study|Study closed/terminated|23|||
143260886|NCT03170232|516508854|FG000|Overall Study|Lost to Follow-up|1|||
143260887|NCT03170232|516508855|FG001|Overall Study|Lost to Follow-up|0|||
143184418|NCT01390298|516220716|FG000|Overall Study|Lost to Follow-up|7|||
143184419|NCT01390298|516220716|FG000|Overall Study|Surgery cancelled|1|||
143184420|NCT02096952|516220717|FG000|Overall Study|Adverse Event|1|||
143184421|NCT00624468|516220718|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
143184422|NCT00624468|516220719|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
143184423|NCT00624468|516220720|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
143184424|NCT00624468|516220721|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
143184425|NCT00624468|516220718|FG000|Double-blind Period|Withdrew Prematurely|1|||
143184426|NCT00624468|516220719|FG001|Double-blind Period|Withdrew Prematurely|1|||
143184427|NCT00624468|516220720|FG002|Double-blind Period|Withdrew Prematurely|0|||
143184428|NCT00624468|516220721|FG003|Double-blind Period|Withdrew Prematurely|0|||
143184429|NCT00624468|516220718|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
143184430|NCT00624468|516220719|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
143184431|NCT00624468|516220720|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
143184432|NCT00624468|516220721|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
143184433|NCT00624468|516220718|FG000|Safety Follow-up (SFU) Period|Other|0|||
143184434|NCT00624468|516220719|FG001|Safety Follow-up (SFU) Period|Other|0|||
143184435|NCT00624468|516220720|FG002|Safety Follow-up (SFU) Period|Other|1|||
143184436|NCT00624468|516220721|FG003|Safety Follow-up (SFU) Period|Other|1|||
143184437|NCT00988052|516220733|FG000|Overall Study|Missing|1|||
143184438|NCT00988052|516220734|FG001|Overall Study|Missing|0|||
143184439|NCT00988052|516220733|FG000|Overall Study|Teva requested subject withdrawal|3|||
143184440|NCT00988052|516220734|FG001|Overall Study|Teva requested subject withdrawal|1|||
143184441|NCT00988052|516220733|FG000|Overall Study|Death|1|||
143260888|NCT03170232|516508854|FG000|Overall Study|Withdrawal by Subject|0|||
143260889|NCT03170232|516508855|FG001|Overall Study|Withdrawal by Subject|1|||
143260890|NCT03882008|516508856|FG000|Overall Study|Withdrawal by Subject|1|||
143260891|NCT03882008|516508856|FG000|Overall Study|Lost to Follow-up|1|||
143260892|NCT00768469|516508857|FG000|Overall Study|Adverse Event|0|||
143260893|NCT00768469|516508858|FG001|Overall Study|Adverse Event|2|||
143184442|NCT00988052|516220734|FG001|Overall Study|Death|3|||
143184443|NCT00988052|516220733|FG000|Overall Study|Protocol Violation|6|||
143184444|NCT00988052|516220734|FG001|Overall Study|Protocol Violation|5|||
143184445|NCT00988052|516220733|FG000|Overall Study|Pregnancy|6|||
143184446|NCT00988052|516220734|FG001|Overall Study|Pregnancy|6|||
143260894|NCT00768469|516508857|FG000|Overall Study|Disease Progression|3|||
143260895|NCT00768469|516508858|FG001|Overall Study|Disease Progression|4|||
143260896|NCT00768469|516508857|FG000|Overall Study|Withdrawal by Subject|0|||
143260897|NCT00768469|516508858|FG001|Overall Study|Withdrawal by Subject|1|||
143260898|NCT02953509|516508863|FG000|Overall Study|Death|1|||
143260899|NCT02953509|516508864|FG001|Overall Study|Death|3|||
143260900|NCT02953509|516508865|FG002|Overall Study|Death|3|||
143260901|NCT02953509|516508866|FG003|Overall Study|Death|4|||
143260902|NCT02953509|516508867|FG004|Overall Study|Death|12|||
143260903|NCT02953509|516508868|FG005|Overall Study|Death|3|||
143260904|NCT02953509|516508869|FG006|Overall Study|Death|25|||
143260905|NCT02953509|516508870|FG007|Overall Study|Death|10|||
143260906|NCT02953509|516508871|FG008|Overall Study|Death|21|||
143260907|NCT02953509|516508872|FG009|Overall Study|Death|20|||
143260908|NCT02953509|516508863|FG000|Overall Study|Reason Not Specified|0|||
143260909|NCT02953509|516508864|FG001|Overall Study|Reason Not Specified|2|||
143260910|NCT02953509|516508865|FG002|Overall Study|Reason Not Specified|8|||
143260911|NCT02953509|516508866|FG003|Overall Study|Reason Not Specified|2|||
143260912|NCT02953509|516508867|FG004|Overall Study|Reason Not Specified|11|||
143260913|NCT02953509|516508868|FG005|Overall Study|Reason Not Specified|4|||
143260914|NCT02953509|516508869|FG006|Overall Study|Reason Not Specified|12|||
143260915|NCT02953509|516508870|FG007|Overall Study|Reason Not Specified|2|||
143260916|NCT02953509|516508871|FG008|Overall Study|Reason Not Specified|7|||
143260917|NCT02953509|516508872|FG009|Overall Study|Reason Not Specified|2|||
143260918|NCT02953509|516508863|FG000|Overall Study|Consent Withdrawn|1|||
143260919|NCT02953509|516508864|FG001|Overall Study|Consent Withdrawn|1|||
143260920|NCT02953509|516508865|FG002|Overall Study|Consent Withdrawn|2|||
143260921|NCT02953509|516508866|FG003|Overall Study|Consent Withdrawn|1|||
143260922|NCT02953509|516508867|FG004|Overall Study|Consent Withdrawn|3|||
143260923|NCT02953509|516508868|FG005|Overall Study|Consent Withdrawn|0|||
143260924|NCT02953509|516508869|FG006|Overall Study|Consent Withdrawn|4|||
143260925|NCT02953509|516508870|FG007|Overall Study|Consent Withdrawn|1|||
143260926|NCT02953509|516508871|FG008|Overall Study|Consent Withdrawn|1|||
143260927|NCT02953509|516508872|FG009|Overall Study|Consent Withdrawn|4|||
143260928|NCT02953509|516508863|FG000|Overall Study|Lost to Follow-up|0|||
143184447|NCT00988052|516220733|FG000|Overall Study|Lack of Efficacy|8|||
143260929|NCT02953509|516508864|FG001|Overall Study|Lost to Follow-up|0|||
143260930|NCT02953509|516508865|FG002|Overall Study|Lost to Follow-up|0|||
143260931|NCT02953509|516508866|FG003|Overall Study|Lost to Follow-up|0|||
143260932|NCT02953509|516508867|FG004|Overall Study|Lost to Follow-up|0|||
143260933|NCT02953509|516508868|FG005|Overall Study|Lost to Follow-up|0|||
143260934|NCT02953509|516508869|FG006|Overall Study|Lost to Follow-up|1|||
143260935|NCT02953509|516508870|FG007|Overall Study|Lost to Follow-up|1|||
143260936|NCT02953509|516508871|FG008|Overall Study|Lost to Follow-up|1|||
143260937|NCT02953509|516508872|FG009|Overall Study|Lost to Follow-up|1|||
143260938|NCT02953509|516508863|FG000|Overall Study|Study terminated by sponsor|1|||
143260939|NCT02953509|516508864|FG001|Overall Study|Study terminated by sponsor|0|||
143260940|NCT02953509|516508865|FG002|Overall Study|Study terminated by sponsor|0|||
143260941|NCT02953509|516508866|FG003|Overall Study|Study terminated by sponsor|0|||
143260942|NCT02953509|516508867|FG004|Overall Study|Study terminated by sponsor|0|||
143260943|NCT02953509|516508868|FG005|Overall Study|Study terminated by sponsor|0|||
143184448|NCT00988052|516220734|FG001|Overall Study|Lack of Efficacy|7|||
143184449|NCT00988052|516220733|FG000|Overall Study|Lost to Follow-up|6|||
143184450|NCT00988052|516220734|FG001|Overall Study|Lost to Follow-up|11|||
143184451|NCT00988052|516220733|FG000|Overall Study|Physician Decision|27|||
143184452|NCT00988052|516220734|FG001|Overall Study|Physician Decision|28|||
143184453|NCT00988052|516220733|FG000|Overall Study|Adverse Event|35|||
143184454|NCT00988052|516220734|FG001|Overall Study|Adverse Event|28|||
143184455|NCT00988052|516220733|FG000|Overall Study|Withdrawal by Subject|90|||
143184456|NCT00988052|516220734|FG001|Overall Study|Withdrawal by Subject|91|||
143184457|NCT00988052|516220733|FG000|Overall Study|Study terminated by sponsor|240|||
143184458|NCT00988052|516220734|FG001|Overall Study|Study terminated by sponsor|236|||
143184459|NCT01434654|516220735|FG000|Overall Study|Withdrawal by Subject|1|||
143184460|NCT01434654|516220736|FG001|Overall Study|Withdrawal by Subject|0|||
143184461|NCT01434654|516220735|FG000|Overall Study|Lost to Follow-up|1|||
143184462|NCT01434654|516220736|FG001|Overall Study|Lost to Follow-up|0|||
143184463|NCT00803361|516220737|FG000|Overall Study|Adverse Event|13|||
143184464|NCT00803361|516220738|FG001|Overall Study|Adverse Event|3|||
143184465|NCT00803361|516220737|FG000|Overall Study|Lack of Efficacy|4|||
143184466|NCT00803361|516220738|FG001|Overall Study|Lack of Efficacy|13|||
143260944|NCT02953509|516508869|FG006|Overall Study|Study terminated by sponsor|1|||
143260945|NCT02953509|516508870|FG007|Overall Study|Study terminated by sponsor|0|||
143184467|NCT00803361|516220737|FG000|Overall Study|Lost to Follow-up|1|||
143184468|NCT00803361|516220738|FG001|Overall Study|Lost to Follow-up|2|||
143184469|NCT00803361|516220737|FG000|Overall Study|Physician Decision|1|||
143260946|NCT02953509|516508871|FG008|Overall Study|Study terminated by sponsor|1|||
143260947|NCT02953509|516508872|FG009|Overall Study|Study terminated by sponsor|1|||
143260948|NCT00484185|516508875|FG000|Overall Study|Lost to Follow-up|44|||
143260949|NCT00484185|516508875|FG000|Overall Study|Other|20|||
143260950|NCT00484185|516508875|FG000|Overall Study|Randomized but not treated|5|||
143260951|NCT00484185|516508875|FG000|Overall Study|Death|2|||
143260952|NCT00725842|516508878|FG000|Overall Study|Lost to Follow-up|19|||
143260953|NCT00725842|516508878|FG000|Overall Study|Death|1|||
143184470|NCT00803361|516220738|FG001|Overall Study|Physician Decision|0|||
143260954|NCT00725842|516508878|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
143260955|NCT00725842|516508878|FG000|Overall Study|Consent date prior to study start date|5|||
143184471|NCT00803361|516220737|FG000|Overall Study|Protocol Violation|2|||
143184472|NCT00803361|516220738|FG001|Overall Study|Protocol Violation|4|||
143184473|NCT00803361|516220737|FG000|Overall Study|Withdrawal by Subject|5|||
143184474|NCT00803361|516220738|FG001|Overall Study|Withdrawal by Subject|6|||
143184475|NCT02446769|516220740|FG000|Screening Period|Screen Failure|11|||
143184476|NCT02446769|516220741|FG001|Screening Period|Screen Failure|0|||
143184477|NCT02446769|516220742|FG002|Screening Period|Screen Failure|0|||
143184478|NCT02446769|516220740|FG000|Study Period|Randomized in Error|0|||
143184479|NCT02446769|516220741|FG001|Study Period|Randomized in Error|2|||
143184480|NCT02446769|516220742|FG002|Study Period|Randomized in Error|0|||
143184481|NCT04482439|516220743|FG000|Overall Study|Lost to Follow-up|1|||
143184482|NCT04482439|516220743|FG000|Overall Study|Unrelated illness|1|||
143184483|NCT01277822|516220746|FG000|Overall Study|Adverse Event|2|||
143184484|NCT01277822|516220747|FG001|Overall Study|Adverse Event|1|||
143184485|NCT01277822|516220746|FG000|Overall Study|Withdrawal by Subject|6|||
143184486|NCT01277822|516220747|FG001|Overall Study|Withdrawal by Subject|7|||
143184487|NCT01277822|516220746|FG000|Overall Study|Physician Decision|1|||
143184488|NCT01277822|516220747|FG001|Overall Study|Physician Decision|1|||
143184489|NCT01277822|516220746|FG000|Overall Study|Protocol Violation|1|||
143184490|NCT01277822|516220747|FG001|Overall Study|Protocol Violation|0|||
143184491|NCT01277822|516220746|FG000|Overall Study|Lost to Follow-up|2|||
143184492|NCT01277822|516220747|FG001|Overall Study|Lost to Follow-up|1|||
143184493|NCT01277822|516220746|FG000|Overall Study|Contraindicated medication used|2|||
143184494|NCT01277822|516220747|FG001|Overall Study|Contraindicated medication used|1|||
143184495|NCT01277822|516220746|FG000|Overall Study|Participant moved|1|||
143184496|NCT01277822|516220747|FG001|Overall Study|Participant moved|0|||
143184497|NCT02923531|516220748|FG000|Overall Study|Adverse Event|4|||
143184498|NCT02923531|516220748|FG000|Overall Study|Clinical Deterioration|1|||
143184499|NCT02923531|516220748|FG000|Overall Study|Disease Progression|3|||
143184500|NCT02923531|516220748|FG000|Overall Study|Study Termination|1|||
143184501|NCT01945996|516220751|FG000|Overall Study|Lost to Follow-up|3|||
143184502|NCT01945996|516220752|FG001|Overall Study|Lost to Follow-up|5|||
143184503|NCT00271856|516220753|FG000|Overall Study|Withdrawal by Subject|1|||
143184504|NCT00271856|516220754|FG001|Overall Study|Withdrawal by Subject|7|||
143184505|NCT00271856|516220753|FG000|Overall Study|Lost to Follow-up|10|||
143184506|NCT00271856|516220754|FG001|Overall Study|Lost to Follow-up|11|||
143184507|NCT03012828|516220755|FG000|Overall Study|Lost to Follow-up|1|||
143184508|NCT03012828|516220756|FG001|Overall Study|Lost to Follow-up|0|||
143184509|NCT03012828|516220757|FG002|Overall Study|Lost to Follow-up|1|||
143184510|NCT03012828|516220758|FG003|Overall Study|Lost to Follow-up|0|||
143184511|NCT03012828|516220759|FG004|Overall Study|Lost to Follow-up|1|||
143184512|NCT03012828|516220760|FG005|Overall Study|Lost to Follow-up|0|||
143184513|NCT03012828|516220755|FG000|Overall Study|Withdrawal by Subject|0|||
143184514|NCT03012828|516220756|FG001|Overall Study|Withdrawal by Subject|0|||
143184515|NCT03012828|516220757|FG002|Overall Study|Withdrawal by Subject|1|||
143184516|NCT03012828|516220758|FG003|Overall Study|Withdrawal by Subject|0|||
143184517|NCT03012828|516220759|FG004|Overall Study|Withdrawal by Subject|0|||
143184518|NCT03012828|516220760|FG005|Overall Study|Withdrawal by Subject|1|||
143184519|NCT03012828|516220755|FG000|Overall Study|Non-compliance with protocol|0|||
143184520|NCT03012828|516220756|FG001|Overall Study|Non-compliance with protocol|0|||
143184521|NCT03012828|516220757|FG002|Overall Study|Non-compliance with protocol|0|||
143184522|NCT03012828|516220758|FG003|Overall Study|Non-compliance with protocol|0|||
143184523|NCT03012828|516220759|FG004|Overall Study|Non-compliance with protocol|1|||
143184524|NCT03012828|516220760|FG005|Overall Study|Non-compliance with protocol|0|||
143184525|NCT03012828|516220755|FG000|Overall Study|Delay to last visit would delay DBL|0|||
143184526|NCT03012828|516220756|FG001|Overall Study|Delay to last visit would delay DBL|0|||
143184527|NCT03012828|516220757|FG002|Overall Study|Delay to last visit would delay DBL|0|||
143184528|NCT03012828|516220758|FG003|Overall Study|Delay to last visit would delay DBL|0|||
143184529|NCT03012828|516220759|FG004|Overall Study|Delay to last visit would delay DBL|0|||
143184530|NCT03012828|516220760|FG005|Overall Study|Delay to last visit would delay DBL|1|||
143184531|NCT03900728|516220761|FG000|Overall Study|No text responses|0|||
143184532|NCT03900728|516220762|FG001|Overall Study|No text responses|0|||
143184533|NCT03900728|516220763|FG002|Overall Study|No text responses|4|||
143184534|NCT02544750|516220764|FG000|Overall Study|Physician Decision|3|||
143184535|NCT02544750|516220765|FG001|Overall Study|Physician Decision|1|||
143184536|NCT02544750|516220764|FG000|Overall Study|Other reasons|69|||
143184537|NCT02544750|516220765|FG001|Overall Study|Other reasons|39|||
143260956|NCT00725842|516508878|FG000|Overall Study|Inclusion criterion not met|1|||
143260957|NCT00725842|516508878|FG000|Overall Study|No Visit 1 data|1|||
143260958|NCT02398227|516508879|FG000|Overall Study|Lost to Follow-up|21|||
143184538|NCT02544750|516220764|FG000|Overall Study|Met withdrawal criteria|2|||
143184539|NCT02544750|516220765|FG001|Overall Study|Met withdrawal criteria|2|||
143184540|NCT02544750|516220764|FG000|Overall Study|Transition To Commercial Product|1|||
143184541|NCT02544750|516220765|FG001|Overall Study|Transition To Commercial Product|0|||
143184542|NCT02544750|516220764|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
143260959|NCT02398227|516508880|FG001|Overall Study|Lost to Follow-up|12|||
143184543|NCT02544750|516220765|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
143184544|NCT02544750|516220764|FG000|Overall Study|Adverse Event|8|||
143184545|NCT02544750|516220765|FG001|Overall Study|Adverse Event|10|||
143184546|NCT02544750|516220764|FG000|Overall Study|Withdrawal by Subject|10|||
143184547|NCT02544750|516220765|FG001|Overall Study|Withdrawal by Subject|4|||
143184548|NCT02544750|516220764|FG000|Overall Study|Lost to Follow-up|1|||
143184549|NCT02544750|516220765|FG001|Overall Study|Lost to Follow-up|0|||
143184550|NCT02484443|516220766|FG000|Overall Study|Lack of Efficacy|28|||
143184551|NCT02484443|516220766|FG000|Overall Study|Physician Decision|2|||
143184552|NCT02484443|516220766|FG000|Overall Study|Ineligible|2|||
143184553|NCT04677543|516220767|FG000|Overall Study|Withdrawal by Subject|4|||
143184554|NCT04677543|516220768|FG001|Overall Study|Withdrawal by Subject|1|||
143184555|NCT04677543|516220767|FG000|Overall Study|Physician Decision|0|||
143184556|NCT04677543|516220768|FG001|Overall Study|Physician Decision|1|||
143184557|NCT04677543|516220767|FG000|Overall Study|Adverse Event|0|||
143184558|NCT04677543|516220768|FG001|Overall Study|Adverse Event|1|||
143184559|NCT02969915|516220769|FG000|Overall Study|Death|104|||
143184560|NCT02969915|516220770|FG001|Overall Study|Death|125|||
143184561|NCT02969915|516220769|FG000|Overall Study|Lost to Follow-up|108|||
143184562|NCT02969915|516220770|FG001|Overall Study|Lost to Follow-up|112|||
143184563|NCT02969915|516220769|FG000|Overall Study|Censored due to COVID-19|481|||
143184564|NCT02969915|516220770|FG001|Overall Study|Censored due to COVID-19|471|||
143184565|NCT02595866|516220771|FG000|Overall Study|Adverse Event|2|||
143184566|NCT02595866|516220772|FG001|Overall Study|Adverse Event|5|||
143184567|NCT02595866|516220771|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
143184568|NCT02595866|516220772|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
143184569|NCT02595866|516220771|FG000|Overall Study|Death|0|||
143184570|NCT02595866|516220772|FG001|Overall Study|Death|1|||
143184571|NCT02595866|516220771|FG000|Overall Study|Incarceration|1|||
143184572|NCT02595866|516220772|FG001|Overall Study|Incarceration|0|||
143184573|NCT02595866|516220771|FG000|Overall Study|Lack of Efficacy|17|||
143184574|NCT02595866|516220772|FG001|Overall Study|Lack of Efficacy|7|||
143184575|NCT02595866|516220771|FG000|Overall Study|Physician Decision|4|||
143184576|NCT02595866|516220772|FG001|Overall Study|Physician Decision|3|||
143184577|NCT02595866|516220771|FG000|Overall Study|Switched to Alternative Treatment|1|||
143184578|NCT02595866|516220772|FG001|Overall Study|Switched to Alternative Treatment|0|||
143184579|NCT02595866|516220771|FG000|Overall Study|Study Terminated|0|||
143184580|NCT02595866|516220772|FG001|Overall Study|Study Terminated|4|||
143184581|NCT02595866|516220771|FG000|Overall Study|Withdrawal by Subject|6|||
143184582|NCT02595866|516220772|FG001|Overall Study|Withdrawal by Subject|1|||
143184583|NCT02520388|516220773|FG000|Overall Study|Physician Decision|1|||
143184584|NCT02520388|516220774|FG001|Overall Study|Physician Decision|0|||
143184585|NCT02520388|516220773|FG000|Overall Study|Subject or parent/guardian request|0|||
143184586|NCT02520388|516220774|FG001|Overall Study|Subject or parent/guardian request|6|||
143184587|NCT02520388|516220773|FG000|Overall Study|Adverse Event|1|||
143184588|NCT02520388|516220774|FG001|Overall Study|Adverse Event|4|||
143184589|NCT02520388|516220773|FG000|Overall Study|Lost to Follow-up|3|||
143184590|NCT02520388|516220774|FG001|Overall Study|Lost to Follow-up|2|||
143184591|NCT02520388|516220773|FG000|Overall Study|Other (reason not defined)|4|||
143184592|NCT02520388|516220774|FG001|Overall Study|Other (reason not defined)|4|||
143184593|NCT01437111|516220775|FG000|Overall Study|Adverse Event|2|||
143184594|NCT01437111|516220775|FG000|Overall Study|Withdrawal by Subject|4|||
143184595|NCT01437111|516220775|FG000|Overall Study|Not reported|5|||
143184596|NCT01437111|516220775|FG000|Overall Study|Physician Decision|1|||
143184597|NCT01437111|516220775|FG000|Overall Study|Lost to Follow-up|5|||
143184598|NCT01437111|516220775|FG000|Overall Study|Protocol Violation|1|||
143184599|NCT02131311|516220777|FG000|Overall Study|Adverse Event|2|||
143184600|NCT02131311|516220777|FG000|Overall Study|Protocol Violation|1|||
143184601|NCT02131311|516220777|FG000|Overall Study|Lost to Follow-up|1|||
143184602|NCT03162796|516220782|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
143184603|NCT03162796|516220783|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
143184604|NCT03162796|516220784|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
143184605|NCT03162796|516220782|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
143184606|NCT03162796|516220783|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
143184607|NCT03162796|516220784|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
143184608|NCT03162796|516220782|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
143184609|NCT03162796|516220783|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
143184610|NCT03162796|516220784|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
143369373|NCT00686517|516896084|FG001|Treatment|Adverse Event|0|||
143184611|NCT03162796|516220782|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
143184612|NCT03162796|516220783|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
143184613|NCT03162796|516220784|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
143184614|NCT03162796|516220782|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
143184615|NCT03162796|516220783|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
143184616|NCT03162796|516220784|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
143184617|NCT03162796|516220782|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
143184618|NCT03162796|516220783|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
143184619|NCT03162796|516220784|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
143184620|NCT03162796|516220782|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
143184621|NCT03162796|516220783|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
143184622|NCT03162796|516220784|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
143184623|NCT03162796|516220782|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
143184624|NCT03162796|516220783|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
143184625|NCT03162796|516220784|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
143184626|NCT03162796|516220782|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
143184627|NCT03162796|516220783|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
143184628|NCT03162796|516220784|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
143184629|NCT03162796|516220782|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
143184630|NCT03162796|516220783|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
143184631|NCT03162796|516220784|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
143184632|NCT03162796|516220782|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
143184633|NCT03162796|516220783|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
143184634|NCT03162796|516220784|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
143184635|NCT02473471|516220785|FG000|Overall Study|poor oral hygiene|2|||
143184636|NCT02473471|516220785|FG000|Overall Study|Lost to Follow-up|1|||
143184637|NCT02342288|516220786|FG000|Overall Study|no protocol anesthesiologist available|3|||
143184638|NCT02342288|516220787|FG001|Overall Study|no protocol anesthesiologist available|2|||
143184639|NCT02342288|516220786|FG000|Overall Study|anesthesia leak in system|1|||
143184640|NCT02342288|516220787|FG001|Overall Study|anesthesia leak in system|0|||
143184641|NCT02342288|516220786|FG000|Overall Study|Withdrawal by Subject|1|||
143184642|NCT02342288|516220787|FG001|Overall Study|Withdrawal by Subject|0|||
143184643|NCT02342288|516220786|FG000|Overall Study|coordinator contaminated with blood|0|||
143184644|NCT02342288|516220787|FG001|Overall Study|coordinator contaminated with blood|1|||
143184645|NCT02342288|516220786|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
143184646|NCT02342288|516220787|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
143184647|NCT02342288|516220786|FG000|Overall Study|coordinator not available|0|||
143184648|NCT02342288|516220787|FG001|Overall Study|coordinator not available|2|||
143184649|NCT02375373|516220793|FG000|Overall Study|Withdrawal by Subject|11|||
143184650|NCT00391430|516220795|FG000|Overall Study|Withdrawal by Subject|3|||
143184651|NCT00391430|516220796|FG001|Overall Study|Withdrawal by Subject|0|||
143184652|NCT00391430|516220797|FG002|Overall Study|Withdrawal by Subject|12|||
143184653|NCT02467192|516220798|FG000|Overall Study|Death|1|||
143184654|NCT02467192|516220798|FG000|Overall Study|revealed to have pneumonia before|2|||
143184655|NCT00431444|516220801|FG000|Overall Study|Protocol Violation|1|||
143184656|NCT00431444|516220802|FG001|Overall Study|Protocol Violation|4|||
143184657|NCT00431444|516220801|FG000|Overall Study|Adverse Event|2|||
143184658|NCT00431444|516220802|FG001|Overall Study|Adverse Event|1|||
143184659|NCT00431444|516220801|FG000|Overall Study|Withdrawal by Subject|1|||
143184660|NCT00431444|516220802|FG001|Overall Study|Withdrawal by Subject|1|||
143184661|NCT00431444|516220801|FG000|Overall Study|Lost to Follow-up|1|||
143184662|NCT00431444|516220802|FG001|Overall Study|Lost to Follow-up|0|||
143184663|NCT00431444|516220801|FG000|Overall Study|Administrative Problems|0|||
143184664|NCT00431444|516220802|FG001|Overall Study|Administrative Problems|1|||
143184665|NCT01603043|516220804|FG000|Overall Study|Study Futility|7|||
143184666|NCT01603043|516220805|FG001|Overall Study|Study Futility|3|||
143184667|NCT03089047|516220806|FG000|Overall Study|Lost to Follow-up|1|||
143184668|NCT03089047|516220807|FG001|Overall Study|Lost to Follow-up|0|||
143184669|NCT03599518|516220808|FG000|Overall Study|Clinical progression|0|||
143184670|NCT03599518|516220809|FG001|Overall Study|Clinical progression|0|||
143184671|NCT03599518|516220810|FG002|Overall Study|Clinical progression|0|||
143369374|NCT00686517|516896085|FG002|Treatment|Adverse Event|0|||
143260960|NCT02398227|516508879|FG000|Overall Study|Withdrawal by Subject|5|||
143260961|NCT02398227|516508880|FG001|Overall Study|Withdrawal by Subject|6|||
143260962|NCT02398227|516508879|FG000|Overall Study|Removed from treatment and dropped out|1|||
143260963|NCT02398227|516508880|FG001|Overall Study|Removed from treatment and dropped out|0|||
143260964|NCT01715129|516508881|FG000|Overall Study|Adverse Event, fatal|1|||
143260965|NCT01715129|516508881|FG000|Overall Study|Lack of Efficacy|3|||
143260966|NCT01715129|516508881|FG000|Overall Study|Protocol Violation|1|||
143260967|NCT01715129|516508881|FG000|Overall Study|Consent Withdrawn|2|||
143260968|NCT01715129|516508881|FG000|Overall Study|Lost to Follow-up|1|||
143260969|NCT01715129|516508881|FG000|Overall Study|Other|1|||
143260970|NCT02793622|516508883|FG000|Overall Study|Lost to Follow-up|31|||
143260971|NCT02793622|516508884|FG001|Overall Study|Lost to Follow-up|19|||
143260972|NCT02793622|516508883|FG000|Overall Study|Withdrawal by Subject|21|||
143260973|NCT02793622|516508884|FG001|Overall Study|Withdrawal by Subject|17|||
143260974|NCT02793622|516508883|FG000|Overall Study|Adverse Event|0|||
143115385|NCT01358578|515963888|FG004|Follow-up Period|non- compliance with study treatment|0|||
143115386|NCT01358578|515963889|FG005|Follow-up Period|non- compliance with study treatment|0|||
143115387|NCT01358578|515963884|FG000|Follow-up Period|Pregnancy|1|||
143115388|NCT01358578|515963885|FG001|Follow-up Period|Pregnancy|0|||
143115389|NCT01358578|515963886|FG002|Follow-up Period|Pregnancy|0|||
143115390|NCT01358578|515963887|FG003|Follow-up Period|Pregnancy|0|||
143115391|NCT01358578|515963888|FG004|Follow-up Period|Pregnancy|0|||
143115392|NCT01358578|515963889|FG005|Follow-up Period|Pregnancy|0|||
143115393|NCT01358578|515963884|FG000|Follow-up Period|Withdrawal by Subject|3|||
143115394|NCT01358578|515963885|FG001|Follow-up Period|Withdrawal by Subject|3|||
143115395|NCT01358578|515963886|FG002|Follow-up Period|Withdrawal by Subject|1|||
143115396|NCT01358578|515963887|FG003|Follow-up Period|Withdrawal by Subject|12|||
143115397|NCT01358578|515963888|FG004|Follow-up Period|Withdrawal by Subject|0|||
143115398|NCT01358578|515963889|FG005|Follow-up Period|Withdrawal by Subject|0|||
143115399|NCT01358578|515963884|FG000|Follow-up Period|Physician Decision|1|||
143115400|NCT01358578|515963885|FG001|Follow-up Period|Physician Decision|1|||
143115401|NCT01358578|515963886|FG002|Follow-up Period|Physician Decision|0|||
143115402|NCT01358578|515963887|FG003|Follow-up Period|Physician Decision|2|||
143115403|NCT01358578|515963888|FG004|Follow-up Period|Physician Decision|0|||
143115404|NCT01358578|515963889|FG005|Follow-up Period|Physician Decision|0|||
143115405|NCT02539134|515963893|FG000|Overall Study|Lost to Follow-up|1|||
143115406|NCT02539134|515963894|FG001|Overall Study|Lost to Follow-up|0|||
143115407|NCT02539134|515963895|FG002|Overall Study|Lost to Follow-up|0|||
143115408|NCT02539134|515963896|FG003|Overall Study|Lost to Follow-up|0|||
143115409|NCT02539134|515963897|FG004|Overall Study|Lost to Follow-up|0|||
143115410|NCT02539134|515963898|FG005|Overall Study|Lost to Follow-up|0|||
143115411|NCT00985426|515963899|FG000|Overall Study|Adverse Event|0|||
143115412|NCT00985426|515963900|FG001|Overall Study|Adverse Event|1|||
143115413|NCT00985426|515963899|FG000|Overall Study|Subject Non-Compliance|3|||
143115414|NCT00985426|515963900|FG001|Overall Study|Subject Non-Compliance|3|||
143115415|NCT00985426|515963899|FG000|Overall Study|Withdrawal by Subject|12|||
143115416|NCT00985426|515963900|FG001|Overall Study|Withdrawal by Subject|16|||
143115417|NCT00985426|515963899|FG000|Overall Study|Lost to Follow-up|8|||
143115418|NCT00985426|515963900|FG001|Overall Study|Lost to Follow-up|10|||
143115419|NCT00985426|515963899|FG000|Overall Study|Death|7|||
143115420|NCT00985426|515963900|FG001|Overall Study|Death|3|||
143115421|NCT00985426|515963899|FG000|Overall Study|Protocol Violation|2|||
143115422|NCT00985426|515963900|FG001|Overall Study|Protocol Violation|0|||
143115423|NCT00985426|515963899|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
143115424|NCT00985426|515963900|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
143115425|NCT01661933|515963902|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
143115426|NCT01661933|515963902|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
143115427|NCT03448939|515963907|FG000|Overall Study|Adverse Event|5|||
143115428|NCT03448939|515963908|FG001|Overall Study|Adverse Event|1|||
143115429|NCT03448939|515963907|FG000|Overall Study|Lost to Follow-up|6|||
143115430|NCT03448939|515963908|FG001|Overall Study|Lost to Follow-up|6|||
143115431|NCT03448939|515963907|FG000|Overall Study|Pregnancy|1|||
143115432|NCT03448939|515963908|FG001|Overall Study|Pregnancy|1|||
143115433|NCT03448939|515963907|FG000|Overall Study|Withdrawal by Subject|9|||
143115434|NCT03448939|515963908|FG001|Overall Study|Withdrawal by Subject|3|||
143115435|NCT04631107|515963911|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
143115436|NCT04631107|515963911|FG000|Second Intervention (1 Night)|Adverse Event|1|||
143115437|NCT04631107|515963911|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
143260975|NCT02793622|516508884|FG001|Overall Study|Adverse Event|1|||
143184672|NCT03599518|516220811|FG003|Overall Study|Clinical progression|0|||
143184673|NCT03599518|516220812|FG004|Overall Study|Clinical progression|1|||
143184674|NCT03599518|516220808|FG000|Overall Study|Adverse Event|0|||
143184675|NCT03599518|516220809|FG001|Overall Study|Adverse Event|0|||
143184676|NCT03599518|516220810|FG002|Overall Study|Adverse Event|0|||
143184677|NCT03599518|516220811|FG003|Overall Study|Adverse Event|0|||
143184678|NCT03599518|516220812|FG004|Overall Study|Adverse Event|1|||
143184679|NCT03599518|516220808|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
143184680|NCT03599518|516220809|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
143184681|NCT03599518|516220810|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
143184682|NCT03599518|516220811|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
143184683|NCT03599518|516220812|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
143184684|NCT03599518|516220808|FG000|Overall Study|Participant withdrawal from study treatment|0|||
143184685|NCT03599518|516220809|FG001|Overall Study|Participant withdrawal from study treatment|0|||
143184686|NCT03599518|516220810|FG002|Overall Study|Participant withdrawal from study treatment|1|||
143184687|NCT03599518|516220811|FG003|Overall Study|Participant withdrawal from study treatment|0|||
143184688|NCT03599518|516220812|FG004|Overall Study|Participant withdrawal from study treatment|0|||
143184689|NCT00912782|516220816|FG000|Overall Study|Death|2|||
143184690|NCT00912782|516220817|FG001|Overall Study|Death|1|||
143184691|NCT00912782|516220816|FG000|Overall Study|Lost to Follow-up|0|||
143184692|NCT00912782|516220817|FG001|Overall Study|Lost to Follow-up|1|||
143184693|NCT00912782|516220816|FG000|Overall Study|Did not receive vascular access type|1|||
143184694|NCT00912782|516220817|FG001|Overall Study|Did not receive vascular access type|2|||
143184695|NCT00912782|516220816|FG000|Overall Study|Relocated before study completion|0|||
143184696|NCT00912782|516220817|FG001|Overall Study|Relocated before study completion|1|||
143184697|NCT03744910|516223091|FG000|Overall Study|Withdrew Consent|1|||
143184698|NCT03744910|516223092|FG001|Overall Study|Withdrew Consent|8|||
143184699|NCT03744910|516223091|FG000|Overall Study|Physician Decision|5|||
143184700|NCT03744910|516223092|FG001|Overall Study|Physician Decision|4|||
143184701|NCT03744910|516223091|FG000|Overall Study|Sponsor Decision (due to study termination)|68|||
143184702|NCT03744910|516223092|FG001|Overall Study|Sponsor Decision (due to study termination)|71|||
143184703|NCT03744910|516223091|FG000|Overall Study|Lost to Follow-up|0|||
143184704|NCT03744910|516223092|FG001|Overall Study|Lost to Follow-up|1|||
143184705|NCT03744910|516223091|FG000|Overall Study|Other-unspecified|4|||
143184706|NCT03744910|516223092|FG001|Overall Study|Other-unspecified|1|||
143184707|NCT02744612|516223093|FG000|Overall Study|Withdrawal by Subject|0|||
143184708|NCT02744612|516223094|FG001|Overall Study|Withdrawal by Subject|2|||
143184709|NCT02712983|516223096|FG000|Treatment Phase|Adverse Event|3|||
143184710|NCT02712983|516223097|FG001|Treatment Phase|Adverse Event|1|||
143184711|NCT02712983|516223098|FG002|Treatment Phase|Adverse Event|1|||
143184712|NCT02712983|516223099|FG003|Treatment Phase|Adverse Event|4|||
143184713|NCT02712983|516223100|FG004|Treatment Phase|Adverse Event|3|||
143184714|NCT02712983|516223101|FG005|Treatment Phase|Adverse Event|0|||
143184715|NCT02712983|516223102|FG006|Treatment Phase|Adverse Event|6|||
143184716|NCT02712983|516223103|FG007|Treatment Phase|Adverse Event|6|||
143184717|NCT02712983|516223104|FG008|Treatment Phase|Adverse Event|1|||
143184718|NCT02712983|516223096|FG000|Treatment Phase|Protocol Deviation|0|||
143184719|NCT02712983|516223097|FG001|Treatment Phase|Protocol Deviation|0|||
143184720|NCT02712983|516223098|FG002|Treatment Phase|Protocol Deviation|0|||
143184721|NCT02712983|516223099|FG003|Treatment Phase|Protocol Deviation|2|||
143184722|NCT02712983|516223100|FG004|Treatment Phase|Protocol Deviation|0|||
143184723|NCT02712983|516223101|FG005|Treatment Phase|Protocol Deviation|0|||
143184724|NCT02712983|516223102|FG006|Treatment Phase|Protocol Deviation|1|||
143184725|NCT02712983|516223103|FG007|Treatment Phase|Protocol Deviation|0|||
143184726|NCT02712983|516223104|FG008|Treatment Phase|Protocol Deviation|0|||
143184727|NCT02712983|516223096|FG000|Treatment Phase|Technical Problems|0|||
143184728|NCT02712983|516223097|FG001|Treatment Phase|Technical Problems|0|||
143184729|NCT02712983|516223098|FG002|Treatment Phase|Technical Problems|0|||
143184730|NCT02712983|516223099|FG003|Treatment Phase|Technical Problems|0|||
143184731|NCT02712983|516223100|FG004|Treatment Phase|Technical Problems|0|||
143184732|NCT02712983|516223101|FG005|Treatment Phase|Technical Problems|0|||
143184733|NCT02712983|516223102|FG006|Treatment Phase|Technical Problems|1|||
143184734|NCT02712983|516223103|FG007|Treatment Phase|Technical Problems|0|||
143184735|NCT02712983|516223104|FG008|Treatment Phase|Technical Problems|0|||
143184736|NCT02712983|516223096|FG000|Treatment Phase|Physician Decision|0|||
143184737|NCT02712983|516223097|FG001|Treatment Phase|Physician Decision|0|||
143184738|NCT02712983|516223098|FG002|Treatment Phase|Physician Decision|0|||
143184739|NCT02712983|516223099|FG003|Treatment Phase|Physician Decision|0|||
143184740|NCT02712983|516223100|FG004|Treatment Phase|Physician Decision|0|||
143184741|NCT02712983|516223101|FG005|Treatment Phase|Physician Decision|0|||
143184742|NCT02712983|516223102|FG006|Treatment Phase|Physician Decision|0|||
143184743|NCT02712983|516223103|FG007|Treatment Phase|Physician Decision|1|||
143184744|NCT02712983|516223104|FG008|Treatment Phase|Physician Decision|1|||
143184745|NCT02712983|516223096|FG000|Treatment Phase|Subject Decision|2|||
143184746|NCT02712983|516223097|FG001|Treatment Phase|Subject Decision|0|||
143184747|NCT02712983|516223098|FG002|Treatment Phase|Subject Decision|0|||
143184748|NCT02712983|516223099|FG003|Treatment Phase|Subject Decision|2|||
143184749|NCT02712983|516223100|FG004|Treatment Phase|Subject Decision|1|||
143184750|NCT02712983|516223101|FG005|Treatment Phase|Subject Decision|0|||
143184751|NCT02712983|516223102|FG006|Treatment Phase|Subject Decision|1|||
143184752|NCT02712983|516223103|FG007|Treatment Phase|Subject Decision|2|||
143184753|NCT02712983|516223104|FG008|Treatment Phase|Subject Decision|0|||
143184754|NCT02712983|516223096|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
143184755|NCT02712983|516223097|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
143184756|NCT02712983|516223098|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
143184757|NCT02712983|516223099|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
143184758|NCT02712983|516223100|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
143184759|NCT02712983|516223101|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
143184760|NCT02712983|516223102|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
143184761|NCT02712983|516223103|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
143184762|NCT02712983|516223104|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
143184763|NCT02712983|516223096|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
143184764|NCT02712983|516223097|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
143184765|NCT02712983|516223098|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
143184766|NCT02712983|516223099|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
143184767|NCT02712983|516223100|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
143184768|NCT02712983|516223101|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
143184769|NCT02712983|516223102|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
143184770|NCT02712983|516223103|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
143184771|NCT02712983|516223104|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
143184772|NCT02712983|516223096|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
143184773|NCT02712983|516223097|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
143184774|NCT02712983|516223098|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
143184775|NCT02712983|516223099|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
143184776|NCT02712983|516223100|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
143184777|NCT02712983|516223101|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
143184778|NCT02712983|516223102|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
143184779|NCT02712983|516223103|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
143184780|NCT02712983|516223104|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
143184781|NCT02220855|516223105|FG000|Overall Study|Adverse Event|8|||
143184782|NCT02220855|516223105|FG000|Overall Study|Disease Progression|5|||
143184783|NCT02220855|516223105|FG000|Overall Study|Withdrawal by Subject|1|||
143184784|NCT03280303|516223106|FG000|Overall Study|Death|505|||
143184785|NCT03280303|516223106|FG000|Overall Study|Study terminated by sponsor|383|||
143184786|NCT03280303|516223106|FG000|Overall Study|Other|148|||
143184787|NCT03280303|516223106|FG000|Overall Study|No longer willing to participate in study|101|||
143184788|NCT03280303|516223106|FG000|Overall Study|Lost to follow up|39|||
143184789|NCT03280303|516223106|FG000|Overall Study|Adverse Event|20|||
143184790|NCT03419897|516223107|FG000|Overall Study|Death|180|||
143184791|NCT03419897|516223107|FG000|Overall Study|Lost to Follow-up|1|||
143184792|NCT03419897|516223107|FG000|Overall Study|Withdrawal by Subject|6|||
143184793|NCT03419897|516223107|FG000|Overall Study|Sponsor Decision|61|||
143184794|NCT03419897|516223107|FG000|Overall Study|Physician Decision|1|||
143184795|NCT01945216|516223110|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
143184796|NCT01945216|516223110|FG000|Overall Study|Protocol Violation|42|||
143184797|NCT01945216|516223110|FG000|Overall Study|CRF not assured by investigators|5|||
143184798|NCT01905943|516223114|FG000|Overall Study|Withdrawal of consent|90|||
143184799|NCT01905943|516223114|FG000|Overall Study|Lost to Follow-up|16|||
143184800|NCT01905943|516223114|FG000|Overall Study|Investigator discretion|7|||
143184801|NCT01905943|516223114|FG000|Overall Study|Death|186|||
143184802|NCT01905943|516223114|FG000|Overall Study|Adverse Event|3|||
143184803|NCT01905943|516223114|FG000|Overall Study|Other|12|||
143184804|NCT02574078|516223115|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
143184805|NCT02574078|516223116|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
143184806|NCT02574078|516223117|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
143260976|NCT02793622|516508883|FG000|Overall Study|Protocol Violation|1|||
143184807|NCT02574078|516223118|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
143184808|NCT02574078|516223119|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
143184809|NCT02574078|516223120|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
143184810|NCT02574078|516223121|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
143184811|NCT02574078|516223122|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
143184812|NCT02574078|516223123|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
143184813|NCT02574078|516223124|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
143184814|NCT02574078|516223125|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
143184815|NCT02574078|516223126|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
143184816|NCT02574078|516223127|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
143184817|NCT02574078|516223115|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
143184818|NCT02574078|516223116|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
143184819|NCT02574078|516223117|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
143184820|NCT02574078|516223118|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
143184821|NCT02574078|516223119|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
143184822|NCT02574078|516223120|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
143184823|NCT02574078|516223121|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
143184824|NCT02574078|516223122|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
143184825|NCT02574078|516223123|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
143184826|NCT02574078|516223124|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
143184827|NCT02574078|516223125|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
143184828|NCT02574078|516223126|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
143184829|NCT02574078|516223127|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
143184830|NCT02574078|516223115|FG000|Pre-Treatment Period|Other reasons|0|||
143184831|NCT02574078|516223116|FG001|Pre-Treatment Period|Other reasons|0|||
143184832|NCT02574078|516223117|FG002|Pre-Treatment Period|Other reasons|0|||
143184833|NCT02574078|516223118|FG003|Pre-Treatment Period|Other reasons|0|||
143184834|NCT02574078|516223119|FG004|Pre-Treatment Period|Other reasons|0|||
143184835|NCT02574078|516223120|FG005|Pre-Treatment Period|Other reasons|0|||
143184836|NCT02574078|516223121|FG006|Pre-Treatment Period|Other reasons|2|||
143184837|NCT02574078|516223122|FG007|Pre-Treatment Period|Other reasons|0|||
143184838|NCT02574078|516223123|FG008|Pre-Treatment Period|Other reasons|0|||
143184839|NCT02574078|516223124|FG009|Pre-Treatment Period|Other reasons|0|||
143184840|NCT02574078|516223125|FG010|Pre-Treatment Period|Other reasons|2|||
143184841|NCT02574078|516223126|FG011|Pre-Treatment Period|Other reasons|0|||
143184842|NCT02574078|516223127|FG012|Pre-Treatment Period|Other reasons|0|||
143184843|NCT02574078|516223115|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
143184844|NCT02574078|516223116|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
143184845|NCT02574078|516223117|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
143184846|NCT02574078|516223118|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
143184847|NCT02574078|516223119|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
143184848|NCT02574078|516223120|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
143184849|NCT02574078|516223121|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
143184850|NCT02574078|516223122|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
143184851|NCT02574078|516223123|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
143184852|NCT02574078|516223124|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
143184853|NCT02574078|516223125|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
143184854|NCT02574078|516223126|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
143184855|NCT02574078|516223127|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
143184856|NCT02574078|516223115|FG000|Treatment Period|Disease progression|6|||
143184857|NCT02574078|516223116|FG001|Treatment Period|Disease progression|4|||
143184858|NCT02574078|516223117|FG002|Treatment Period|Disease progression|7|||
143184859|NCT02574078|516223118|FG003|Treatment Period|Disease progression|18|||
143184860|NCT02574078|516223119|FG004|Treatment Period|Disease progression|16|||
143260977|NCT02793622|516508884|FG001|Overall Study|Protocol Violation|5|||
143184861|NCT02574078|516223120|FG005|Treatment Period|Disease progression|26|||
143184862|NCT02574078|516223121|FG006|Treatment Period|Disease progression|5|||
143184863|NCT02574078|516223122|FG007|Treatment Period|Disease progression|9|||
143184864|NCT02574078|516223123|FG008|Treatment Period|Disease progression|8|||
143184865|NCT02574078|516223124|FG009|Treatment Period|Disease progression|5|||
143184866|NCT02574078|516223125|FG010|Treatment Period|Disease progression|20|||
143184867|NCT02574078|516223126|FG011|Treatment Period|Disease progression|29|||
143184868|NCT02574078|516223127|FG012|Treatment Period|Disease progression|2|||
143184869|NCT02574078|516223115|FG000|Treatment Period|Study drug toxicity|1|||
143184870|NCT02574078|516223116|FG001|Treatment Period|Study drug toxicity|1|||
143184871|NCT02574078|516223117|FG002|Treatment Period|Study drug toxicity|0|||
143184872|NCT02574078|516223118|FG003|Treatment Period|Study drug toxicity|5|||
143184873|NCT02574078|516223119|FG004|Treatment Period|Study drug toxicity|3|||
143184874|NCT02574078|516223120|FG005|Treatment Period|Study drug toxicity|1|||
143184875|NCT02574078|516223121|FG006|Treatment Period|Study drug toxicity|2|||
143184876|NCT02574078|516223122|FG007|Treatment Period|Study drug toxicity|0|||
143184877|NCT02574078|516223123|FG008|Treatment Period|Study drug toxicity|2|||
143184878|NCT02574078|516223124|FG009|Treatment Period|Study drug toxicity|1|||
143184879|NCT02574078|516223125|FG010|Treatment Period|Study drug toxicity|16|||
143184880|NCT02574078|516223126|FG011|Treatment Period|Study drug toxicity|2|||
143184881|NCT02574078|516223127|FG012|Treatment Period|Study drug toxicity|4|||
143184882|NCT02574078|516223115|FG000|Treatment Period|Death|2|||
143184883|NCT02574078|516223116|FG001|Treatment Period|Death|0|||
143184884|NCT02574078|516223117|FG002|Treatment Period|Death|0|||
143184885|NCT02574078|516223118|FG003|Treatment Period|Death|0|||
143184886|NCT02574078|516223119|FG004|Treatment Period|Death|1|||
143184887|NCT02574078|516223120|FG005|Treatment Period|Death|1|||
143184888|NCT02574078|516223121|FG006|Treatment Period|Death|1|||
143184889|NCT02574078|516223122|FG007|Treatment Period|Death|1|||
143184890|NCT02574078|516223123|FG008|Treatment Period|Death|7|||
143184891|NCT02574078|516223124|FG009|Treatment Period|Death|1|||
143184892|NCT02574078|516223125|FG010|Treatment Period|Death|0|||
143184893|NCT02574078|516223126|FG011|Treatment Period|Death|2|||
143184894|NCT02574078|516223127|FG012|Treatment Period|Death|1|||
143184895|NCT02574078|516223115|FG000|Treatment Period|Adverse event unrelated to drug|0|||
143184896|NCT02574078|516223116|FG001|Treatment Period|Adverse event unrelated to drug|0|||
143184897|NCT02574078|516223117|FG002|Treatment Period|Adverse event unrelated to drug|1|||
143184898|NCT02574078|516223118|FG003|Treatment Period|Adverse event unrelated to drug|0|||
143184899|NCT02574078|516223119|FG004|Treatment Period|Adverse event unrelated to drug|2|||
143184900|NCT02574078|516223120|FG005|Treatment Period|Adverse event unrelated to drug|3|||
143184901|NCT02574078|516223121|FG006|Treatment Period|Adverse event unrelated to drug|0|||
143184902|NCT02574078|516223122|FG007|Treatment Period|Adverse event unrelated to drug|0|||
143184903|NCT02574078|516223123|FG008|Treatment Period|Adverse event unrelated to drug|1|||
143184904|NCT02574078|516223124|FG009|Treatment Period|Adverse event unrelated to drug|2|||
143184905|NCT02574078|516223125|FG010|Treatment Period|Adverse event unrelated to drug|4|||
143184906|NCT02574078|516223126|FG011|Treatment Period|Adverse event unrelated to drug|1|||
143184907|NCT02574078|516223127|FG012|Treatment Period|Adverse event unrelated to drug|0|||
143184908|NCT02574078|516223115|FG000|Treatment Period|Administrative reason by Sponsor|0|||
143184909|NCT02574078|516223116|FG001|Treatment Period|Administrative reason by Sponsor|1|||
143184910|NCT02574078|516223117|FG002|Treatment Period|Administrative reason by Sponsor|0|||
143184911|NCT02574078|516223118|FG003|Treatment Period|Administrative reason by Sponsor|0|||
143184912|NCT02574078|516223119|FG004|Treatment Period|Administrative reason by Sponsor|0|||
143184913|NCT02574078|516223120|FG005|Treatment Period|Administrative reason by Sponsor|0|||
143184914|NCT02574078|516223121|FG006|Treatment Period|Administrative reason by Sponsor|1|||
143184915|NCT02574078|516223122|FG007|Treatment Period|Administrative reason by Sponsor|0|||
143184916|NCT02574078|516223123|FG008|Treatment Period|Administrative reason by Sponsor|0|||
143260978|NCT01146860|516508885|FG000|Overall Study|Withdrawal by Subject|0|||
143260979|NCT01146860|516508886|FG001|Overall Study|Withdrawal by Subject|1|||
143260980|NCT01075191|516508888|FG000|Overall Study|Death|1|||
143260981|NCT01075191|516508888|FG000|Overall Study|Intensification|3|||
143260982|NCT01075191|516508888|FG000|Overall Study|Co-morbidities|1|||
143260983|NCT01075191|516508888|FG000|Overall Study|Adverse Event|4|||
143260984|NCT01075191|516508888|FG000|Overall Study|Noncompliance|3|||
143260985|NCT01075191|516508888|FG000|Overall Study|Therapy Break|3|||
143260986|NCT01075191|516508888|FG000|Overall Study|Patient's Wish|2|||
143260987|NCT01075191|516508888|FG000|Overall Study|Unknown Reasons|1|||
143260988|NCT00718237|516508893|FG000|Overall Study|Adverse Event|1|||
143260989|NCT00718237|516508894|FG001|Overall Study|Adverse Event|3|||
143260990|NCT00718237|516508893|FG000|Overall Study|Lost to Follow-up|2|||
143260991|NCT00718237|516508894|FG001|Overall Study|Lost to Follow-up|2|||
143260992|NCT00718237|516508893|FG000|Overall Study|Physician Decision|1|||
143260993|NCT00718237|516508894|FG001|Overall Study|Physician Decision|0|||
143260994|NCT00718237|516508893|FG000|Overall Study|Withdrawal by Subject|9|||
143260995|NCT00718237|516508894|FG001|Overall Study|Withdrawal by Subject|10|||
143260996|NCT02068768|516508895|FG000|Overall Study|Lost to Follow-up|5|||
143184917|NCT02574078|516223124|FG009|Treatment Period|Administrative reason by Sponsor|0|||
143260997|NCT02068768|516508895|FG000|Overall Study|Early Termination by Sponsor|2|||
143260998|NCT01423604|516508899|FG000|Safety Run-In|Adverse Event|3|||
143184918|NCT02574078|516223125|FG010|Treatment Period|Administrative reason by Sponsor|0|||
143184919|NCT02574078|516223126|FG011|Treatment Period|Administrative reason by Sponsor|0|||
143184920|NCT02574078|516223127|FG012|Treatment Period|Administrative reason by Sponsor|3|||
143184921|NCT02574078|516223115|FG000|Treatment Period|Other reasons|1|||
143260999|NCT01423604|516508900|FG001|Safety Run-In|Adverse Event|0|||
143261000|NCT01423604|516508899|FG000|Safety Run-In|Death|1|||
143261001|NCT01423604|516508900|FG001|Safety Run-In|Death|0|||
143261002|NCT01423604|516508899|FG000|Safety Run-In|Physician Decision|1|||
143261003|NCT01423604|516508900|FG001|Safety Run-In|Physician Decision|0|||
143261004|NCT01423604|516508899|FG000|Safety Run-In|Disease progression|3|||
143261005|NCT01423604|516508900|FG001|Safety Run-In|Disease progression|0|||
143261006|NCT01423604|516508899|FG000|Safety Run-In|Patient decision|1|||
143261007|NCT01423604|516508900|FG001|Safety Run-In|Patient decision|0|||
143261008|NCT01423604|516508899|FG000|Randomized|Adverse Event|4|||
143261009|NCT01423604|516508900|FG001|Randomized|Adverse Event|10|||
143261010|NCT01423604|516508899|FG000|Randomized|Death|1|||
143261011|NCT01423604|516508900|FG001|Randomized|Death|0|||
143261012|NCT01423604|516508899|FG000|Randomized|Physician Decision|16|||
143261013|NCT01423604|516508900|FG001|Randomized|Physician Decision|13|||
143261014|NCT01423604|516508899|FG000|Randomized|Other - unspecified|37|||
143261015|NCT01423604|516508900|FG001|Randomized|Other - unspecified|31|||
143261016|NCT01423604|516508899|FG000|Randomized|Patient decision|5|||
143261017|NCT01423604|516508900|FG001|Randomized|Patient decision|9|||
143261018|NCT01233687|516508901|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
143184922|NCT02574078|516223116|FG001|Treatment Period|Other reasons|0|||
143184923|NCT02574078|516223117|FG002|Treatment Period|Other reasons|1|||
143261019|NCT01233687|516508901|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
143261020|NCT01233687|516508901|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
143261021|NCT03324581|516508905|FG000|Overall Study|Adverse Event|18|||
143261022|NCT03324581|516508906|FG001|Overall Study|Adverse Event|11|||
143261023|NCT03324581|516508907|FG002|Overall Study|Adverse Event|7|||
143261024|NCT03324581|516508905|FG000|Overall Study|Lack of Efficacy|0|||
143261025|NCT03324581|516508906|FG001|Overall Study|Lack of Efficacy|1|||
143261026|NCT03324581|516508907|FG002|Overall Study|Lack of Efficacy|0|||
143261027|NCT03324581|516508905|FG000|Overall Study|Lost to Follow-up|5|||
143184924|NCT02574078|516223118|FG003|Treatment Period|Other reasons|3|||
143184925|NCT02574078|516223119|FG004|Treatment Period|Other reasons|3|||
143261028|NCT03324581|516508906|FG001|Overall Study|Lost to Follow-up|3|||
143261029|NCT03324581|516508907|FG002|Overall Study|Lost to Follow-up|6|||
143261030|NCT03324581|516508905|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
143261031|NCT03324581|516508906|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
143261032|NCT03324581|516508907|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
143261033|NCT03324581|516508905|FG000|Overall Study|Physician Decision|0|||
143261034|NCT03324581|516508906|FG001|Overall Study|Physician Decision|1|||
143261035|NCT03324581|516508907|FG002|Overall Study|Physician Decision|2|||
143261036|NCT03324581|516508905|FG000|Overall Study|Protocol Deviation|8|||
143184926|NCT02574078|516223120|FG005|Treatment Period|Other reasons|1|||
143184927|NCT02574078|516223121|FG006|Treatment Period|Other reasons|2|||
143184928|NCT02574078|516223122|FG007|Treatment Period|Other reasons|1|||
143184929|NCT02574078|516223123|FG008|Treatment Period|Other reasons|3|||
143184930|NCT02574078|516223124|FG009|Treatment Period|Other reasons|1|||
143184931|NCT02574078|516223125|FG010|Treatment Period|Other reasons|1|||
143184932|NCT02574078|516223126|FG011|Treatment Period|Other reasons|3|||
143184933|NCT02574078|516223127|FG012|Treatment Period|Other reasons|1|||
143184934|NCT02574078|516223115|FG000|Treatment Period|Participant request to stop drug|0|||
143184935|NCT02574078|516223116|FG001|Treatment Period|Participant request to stop drug|0|||
143184936|NCT02574078|516223117|FG002|Treatment Period|Participant request to stop drug|0|||
143184937|NCT02574078|516223118|FG003|Treatment Period|Participant request to stop drug|2|||
143184938|NCT02574078|516223119|FG004|Treatment Period|Participant request to stop drug|4|||
143184939|NCT02574078|516223120|FG005|Treatment Period|Participant request to stop drug|0|||
143184940|NCT02574078|516223121|FG006|Treatment Period|Participant request to stop drug|1|||
143184941|NCT02574078|516223122|FG007|Treatment Period|Participant request to stop drug|0|||
143184942|NCT02574078|516223123|FG008|Treatment Period|Participant request to stop drug|3|||
143184943|NCT02574078|516223124|FG009|Treatment Period|Participant request to stop drug|2|||
143184944|NCT02574078|516223125|FG010|Treatment Period|Participant request to stop drug|2|||
143184945|NCT02574078|516223126|FG011|Treatment Period|Participant request to stop drug|4|||
143184946|NCT02574078|516223127|FG012|Treatment Period|Participant request to stop drug|1|||
143184947|NCT02574078|516223115|FG000|Treatment Period|Participant withdrew consent|0|||
143184948|NCT02574078|516223116|FG001|Treatment Period|Participant withdrew consent|0|||
143261037|NCT03324581|516508906|FG001|Overall Study|Protocol Deviation|9|||
143261038|NCT03324581|516508907|FG002|Overall Study|Protocol Deviation|4|||
143261039|NCT03324581|516508905|FG000|Overall Study|Withdrawal by Subject|6|||
143261040|NCT03324581|516508906|FG001|Overall Study|Withdrawal by Subject|8|||
143261041|NCT03324581|516508907|FG002|Overall Study|Withdrawal by Subject|6|||
143261042|NCT03324581|516508905|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
143261043|NCT03324581|516508906|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
143261044|NCT03324581|516508907|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
143261045|NCT03783702|516508908|FG000|Overall Study|Lost to Follow-up|6|||
143184949|NCT02574078|516223117|FG002|Treatment Period|Participant withdrew consent|0|||
143184950|NCT02574078|516223118|FG003|Treatment Period|Participant withdrew consent|0|||
143184951|NCT02574078|516223119|FG004|Treatment Period|Participant withdrew consent|1|||
143184952|NCT02574078|516223120|FG005|Treatment Period|Participant withdrew consent|1|||
143184953|NCT02574078|516223121|FG006|Treatment Period|Participant withdrew consent|0|||
143184954|NCT02574078|516223122|FG007|Treatment Period|Participant withdrew consent|1|||
143184955|NCT02574078|516223123|FG008|Treatment Period|Participant withdrew consent|0|||
143184956|NCT02574078|516223124|FG009|Treatment Period|Participant withdrew consent|2|||
143184957|NCT02574078|516223125|FG010|Treatment Period|Participant withdrew consent|1|||
143184958|NCT02574078|516223126|FG011|Treatment Period|Participant withdrew consent|4|||
143184959|NCT02574078|516223127|FG012|Treatment Period|Participant withdrew consent|1|||
143184960|NCT02574078|516223115|FG000|Treatment Period|Participant no longer meets criteria|0|||
143184961|NCT02574078|516223116|FG001|Treatment Period|Participant no longer meets criteria|0|||
143184962|NCT02574078|516223117|FG002|Treatment Period|Participant no longer meets criteria|0|||
143184963|NCT02574078|516223118|FG003|Treatment Period|Participant no longer meets criteria|0|||
143184964|NCT02574078|516223119|FG004|Treatment Period|Participant no longer meets criteria|1|||
143184965|NCT02574078|516223120|FG005|Treatment Period|Participant no longer meets criteria|0|||
143184966|NCT02574078|516223121|FG006|Treatment Period|Participant no longer meets criteria|0|||
143184967|NCT02574078|516223122|FG007|Treatment Period|Participant no longer meets criteria|0|||
143184968|NCT02574078|516223123|FG008|Treatment Period|Participant no longer meets criteria|0|||
143184969|NCT02574078|516223124|FG009|Treatment Period|Participant no longer meets criteria|1|||
143184970|NCT02574078|516223125|FG010|Treatment Period|Participant no longer meets criteria|1|||
143184971|NCT02574078|516223126|FG011|Treatment Period|Participant no longer meets criteria|1|||
143184972|NCT02574078|516223127|FG012|Treatment Period|Participant no longer meets criteria|0|||
143184973|NCT02574078|516223115|FG000|Treatment Period|Lost to Follow-up|0|||
143184974|NCT02574078|516223116|FG001|Treatment Period|Lost to Follow-up|0|||
143184975|NCT02574078|516223117|FG002|Treatment Period|Lost to Follow-up|0|||
143184976|NCT02574078|516223118|FG003|Treatment Period|Lost to Follow-up|0|||
143184977|NCT02574078|516223119|FG004|Treatment Period|Lost to Follow-up|0|||
143184978|NCT02574078|516223120|FG005|Treatment Period|Lost to Follow-up|0|||
143184979|NCT02574078|516223121|FG006|Treatment Period|Lost to Follow-up|0|||
143184980|NCT02574078|516223122|FG007|Treatment Period|Lost to Follow-up|0|||
143184981|NCT02574078|516223123|FG008|Treatment Period|Lost to Follow-up|0|||
143184982|NCT02574078|516223124|FG009|Treatment Period|Lost to Follow-up|1|||
143184983|NCT02574078|516223125|FG010|Treatment Period|Lost to Follow-up|0|||
143184984|NCT02574078|516223126|FG011|Treatment Period|Lost to Follow-up|1|||
143184985|NCT02574078|516223127|FG012|Treatment Period|Lost to Follow-up|0|||
143184986|NCT02574078|516223115|FG000|Treatment Period|Maximum clinical benefit|0|||
143184987|NCT02574078|516223116|FG001|Treatment Period|Maximum clinical benefit|0|||
143184988|NCT02574078|516223117|FG002|Treatment Period|Maximum clinical benefit|0|||
143184989|NCT02574078|516223118|FG003|Treatment Period|Maximum clinical benefit|0|||
143184990|NCT02574078|516223119|FG004|Treatment Period|Maximum clinical benefit|0|||
143184991|NCT02574078|516223120|FG005|Treatment Period|Maximum clinical benefit|0|||
143184992|NCT02574078|516223121|FG006|Treatment Period|Maximum clinical benefit|0|||
143184993|NCT02574078|516223122|FG007|Treatment Period|Maximum clinical benefit|0|||
143184994|NCT02574078|516223123|FG008|Treatment Period|Maximum clinical benefit|0|||
143184995|NCT02574078|516223124|FG009|Treatment Period|Maximum clinical benefit|1|||
143184996|NCT02574078|516223125|FG010|Treatment Period|Maximum clinical benefit|0|||
143184997|NCT02574078|516223126|FG011|Treatment Period|Maximum clinical benefit|0|||
143184998|NCT02574078|516223127|FG012|Treatment Period|Maximum clinical benefit|0|||
143184999|NCT05935878|516223128|FG000|Overall Study|Death|1|||
143185000|NCT05935878|516223129|FG001|Overall Study|Death|2|||
143185001|NCT05935878|516223128|FG000|Overall Study|Withdrawal by Subject|5|||
143185002|NCT05935878|516223129|FG001|Overall Study|Withdrawal by Subject|5|||
143185003|NCT05935878|516223128|FG000|Overall Study|Revision of implant|1|||
143185004|NCT05935878|516223129|FG001|Overall Study|Revision of implant|1|||
143185005|NCT05935878|516223128|FG000|Overall Study|Mobile bearing dislocation|0|||
143185006|NCT05935878|516223129|FG001|Overall Study|Mobile bearing dislocation|1|||
143185007|NCT01893411|516223134|FG000|Overall Study|Protocol Violation|1|||
143185008|NCT01893411|516223135|FG001|Overall Study|Protocol Violation|0|||
143185009|NCT01893411|516223136|FG002|Overall Study|Protocol Violation|0|||
143185010|NCT01893411|516223134|FG000|Overall Study|Physician Decision|1|||
143185011|NCT01893411|516223135|FG001|Overall Study|Physician Decision|1|||
143185012|NCT01893411|516223136|FG002|Overall Study|Physician Decision|2|||
143185013|NCT01893411|516223134|FG000|Overall Study|Lack of Efficacy|2|||
143185014|NCT01893411|516223135|FG001|Overall Study|Lack of Efficacy|1|||
143185015|NCT01893411|516223136|FG002|Overall Study|Lack of Efficacy|0|||
143185016|NCT01893411|516223134|FG000|Overall Study|Other|3|||
143185017|NCT01893411|516223135|FG001|Overall Study|Other|1|||
143185018|NCT01893411|516223136|FG002|Overall Study|Other|3|||
143185019|NCT01893411|516223134|FG000|Overall Study|Adverse Event|1|||
143185020|NCT01893411|516223135|FG001|Overall Study|Adverse Event|0|||
143185021|NCT01893411|516223136|FG002|Overall Study|Adverse Event|0|||
143185022|NCT01893411|516223134|FG000|Overall Study|Withdrawal by Subject|7|||
143185023|NCT01893411|516223135|FG001|Overall Study|Withdrawal by Subject|4|||
143185024|NCT01893411|516223136|FG002|Overall Study|Withdrawal by Subject|3|||
143185025|NCT01893411|516223134|FG000|Overall Study|Lost to Follow-up|2|||
143185026|NCT01893411|516223135|FG001|Overall Study|Lost to Follow-up|0|||
143185027|NCT01893411|516223136|FG002|Overall Study|Lost to Follow-up|1|||
143185028|NCT00368745|516223137|FG000|Double-blind Treatment Period|Adverse Event|6|||
143185029|NCT00368745|516223138|FG001|Double-blind Treatment Period|Adverse Event|6|||
143185030|NCT00368745|516223137|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
143185031|NCT00368745|516223138|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
143185032|NCT00368745|516223137|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
143185033|NCT00368745|516223138|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
143185034|NCT00368745|516223137|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
143185035|NCT00368745|516223138|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
143185036|NCT00368745|516223137|FG000|Double-blind Treatment Period|Other|7|||
143185037|NCT00368745|516223138|FG001|Double-blind Treatment Period|Other|6|||
143185038|NCT00933608|516223140|FG000|Overall Study|Adverse Event|4|||
143185039|NCT00933608|516223141|FG001|Overall Study|Adverse Event|2|||
143185040|NCT00933608|516223140|FG000|Overall Study|Physician Decision|1|||
143185041|NCT00933608|516223141|FG001|Overall Study|Physician Decision|0|||
143185042|NCT02719691|516223144|FG000|Overall Study|Physician Decision|0|||
143185043|NCT02719691|516223145|FG001|Overall Study|Physician Decision|0|||
143185044|NCT02719691|516223146|FG002|Overall Study|Physician Decision|1|||
143185045|NCT02719691|516223147|FG003|Overall Study|Physician Decision|0|||
143185046|NCT02719691|516223148|FG004|Overall Study|Physician Decision|0|||
143185047|NCT02719691|516223149|FG005|Overall Study|Physician Decision|0|||
143185048|NCT02719691|516223150|FG006|Overall Study|Physician Decision|0|||
143185049|NCT02719691|516223144|FG000|Overall Study|Withdrawal by Subject|0|||
143185050|NCT02719691|516223145|FG001|Overall Study|Withdrawal by Subject|0|||
143185051|NCT02719691|516223146|FG002|Overall Study|Withdrawal by Subject|0|||
143185052|NCT02719691|516223147|FG003|Overall Study|Withdrawal by Subject|0|||
143185053|NCT02719691|516223148|FG004|Overall Study|Withdrawal by Subject|0|||
143185054|NCT02719691|516223149|FG005|Overall Study|Withdrawal by Subject|1|||
143185055|NCT02719691|516223150|FG006|Overall Study|Withdrawal by Subject|0|||
143185056|NCT00861757|516223155|FG000|Overall Study|Adverse Event|1|||
143185057|NCT00861757|516223156|FG001|Overall Study|Adverse Event|5|||
143185058|NCT00861757|516223157|FG002|Overall Study|Adverse Event|7|||
143185059|NCT00861757|516223158|FG003|Overall Study|Adverse Event|2|||
143185060|NCT00861757|516223155|FG000|Overall Study|Entry Criteria Not Met|1|||
143185061|NCT00861757|516223156|FG001|Overall Study|Entry Criteria Not Met|2|||
143185062|NCT00861757|516223157|FG002|Overall Study|Entry Criteria Not Met|1|||
143185063|NCT00861757|516223158|FG003|Overall Study|Entry Criteria Not Met|1|||
143185064|NCT00861757|516223155|FG000|Overall Study|Lack of Efficacy|3|||
143185065|NCT00861757|516223156|FG001|Overall Study|Lack of Efficacy|1|||
143261046|NCT03783702|516508909|FG001|Overall Study|Lost to Follow-up|8|||
143261047|NCT03783702|516508908|FG000|Overall Study|Protocol Violation|1|||
143261048|NCT03783702|516508909|FG001|Overall Study|Protocol Violation|3|||
143261049|NCT02274038|516508910|FG000|Overall Study|Death|1|||
143185066|NCT00861757|516223157|FG002|Overall Study|Lack of Efficacy|0|||
143185067|NCT00861757|516223158|FG003|Overall Study|Lack of Efficacy|1|||
143185068|NCT00861757|516223155|FG000|Overall Study|Lost to Follow-up|1|||
143185069|NCT00861757|516223156|FG001|Overall Study|Lost to Follow-up|0|||
143185070|NCT00861757|516223157|FG002|Overall Study|Lost to Follow-up|1|||
143185071|NCT00861757|516223158|FG003|Overall Study|Lost to Follow-up|1|||
143185072|NCT00861757|516223155|FG000|Overall Study|Physician Decision|0|||
143185073|NCT00861757|516223156|FG001|Overall Study|Physician Decision|0|||
143185074|NCT00861757|516223157|FG002|Overall Study|Physician Decision|0|||
143185075|NCT00861757|516223158|FG003|Overall Study|Physician Decision|1|||
143185076|NCT00861757|516223155|FG000|Overall Study|Protocol Violation|2|||
143261050|NCT04473482|516508911|FG000|Overall Study|Death|0|||
143261051|NCT04473482|516508912|FG001|Overall Study|Death|3|||
143185077|NCT00861757|516223156|FG001|Overall Study|Protocol Violation|2|||
143185078|NCT00861757|516223157|FG002|Overall Study|Protocol Violation|4|||
143185079|NCT00861757|516223158|FG003|Overall Study|Protocol Violation|1|||
143261052|NCT04473482|516508911|FG000|Overall Study|Lost to Follow-up|9|||
143185080|NCT00861757|516223155|FG000|Overall Study|Withdrawal by Subject|1|||
143185081|NCT00861757|516223156|FG001|Overall Study|Withdrawal by Subject|5|||
143185082|NCT00861757|516223157|FG002|Overall Study|Withdrawal by Subject|5|||
143185083|NCT00861757|516223158|FG003|Overall Study|Withdrawal by Subject|2|||
143185084|NCT01521923|516223161|FG000|Overall Study|AE, serious fatal|1|||
143261053|NCT04473482|516508912|FG001|Overall Study|Lost to Follow-up|7|||
143185085|NCT01521923|516223162|FG001|Overall Study|AE, serious fatal|0|||
143185086|NCT01521923|516223163|FG002|Overall Study|AE, serious fatal|0|||
143185087|NCT01521923|516223164|FG003|Overall Study|AE, serious fatal|0|||
143185088|NCT01521923|516223161|FG000|Overall Study|SAE, non-fatal|0|||
143185089|NCT01521923|516223162|FG001|Overall Study|SAE, non-fatal|2|||
143185090|NCT01521923|516223163|FG002|Overall Study|SAE, non-fatal|2|||
143185091|NCT01521923|516223164|FG003|Overall Study|SAE, non-fatal|0|||
143185092|NCT01521923|516223161|FG000|Overall Study|AE, non-serious, non-fatal|1|||
143185093|NCT01521923|516223162|FG001|Overall Study|AE, non-serious, non-fatal|3|||
143185094|NCT01521923|516223163|FG002|Overall Study|AE, non-serious, non-fatal|6|||
143185095|NCT01521923|516223164|FG003|Overall Study|AE, non-serious, non-fatal|2|||
143185096|NCT01521923|516223161|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
143185097|NCT01521923|516223162|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
143185098|NCT01521923|516223163|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
143185099|NCT01521923|516223164|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
143185100|NCT01521923|516223161|FG000|Overall Study|Lack of Efficacy|1|||
143185101|NCT01521923|516223162|FG001|Overall Study|Lack of Efficacy|1|||
143185102|NCT01521923|516223163|FG002|Overall Study|Lack of Efficacy|0|||
143185103|NCT01521923|516223164|FG003|Overall Study|Lack of Efficacy|0|||
143185104|NCT01521923|516223161|FG000|Overall Study|Protocol Violation|0|||
143185105|NCT01521923|516223162|FG001|Overall Study|Protocol Violation|0|||
143185106|NCT01521923|516223163|FG002|Overall Study|Protocol Violation|1|||
143185107|NCT01521923|516223164|FG003|Overall Study|Protocol Violation|0|||
143185108|NCT01521923|516223161|FG000|Overall Study|Lost to Follow-up|1|||
143185109|NCT01521923|516223162|FG001|Overall Study|Lost to Follow-up|0|||
143185110|NCT01521923|516223163|FG002|Overall Study|Lost to Follow-up|2|||
143185111|NCT01521923|516223164|FG003|Overall Study|Lost to Follow-up|1|||
143185112|NCT01521923|516223161|FG000|Overall Study|Withdrawal by Subject|1|||
143185113|NCT01521923|516223162|FG001|Overall Study|Withdrawal by Subject|1|||
143185114|NCT01521923|516223163|FG002|Overall Study|Withdrawal by Subject|1|||
143185115|NCT01521923|516223164|FG003|Overall Study|Withdrawal by Subject|2|||
143185116|NCT01521923|516223161|FG000|Overall Study|Other|2|||
143185117|NCT01521923|516223162|FG001|Overall Study|Other|1|||
143185118|NCT01521923|516223163|FG002|Overall Study|Other|3|||
143185119|NCT01521923|516223164|FG003|Overall Study|Other|6|||
143185120|NCT01521923|516223161|FG000|Overall Study|AE, captured in Period 1|0|||
143185121|NCT01521923|516223162|FG001|Overall Study|AE, captured in Period 1|1|||
143185122|NCT01521923|516223163|FG002|Overall Study|AE, captured in Period 1|0|||
143185123|NCT01521923|516223164|FG003|Overall Study|AE, captured in Period 1|1|||
143185124|NCT03037476|516223165|FG000|Overall Study|Lost to Follow-up|63|||
143185125|NCT03037476|516223166|FG001|Overall Study|Lost to Follow-up|46|||
143185126|NCT03053440|516223169|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
143185127|NCT03053440|516223170|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
143185128|NCT03053440|516223169|FG000|Overall Study|Death|18|||
143185129|NCT03053440|516223170|FG001|Overall Study|Death|14|||
143185130|NCT03053440|516223169|FG000|Overall Study|Withdrawal by Subject|9|||
143185131|NCT03053440|516223170|FG001|Overall Study|Withdrawal by Subject|8|||
143185132|NCT03053440|516223169|FG000|Overall Study|Lost to Follow-up|1|||
143185133|NCT03053440|516223170|FG001|Overall Study|Lost to Follow-up|0|||
143185134|NCT03053440|516223169|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
143185135|NCT03053440|516223170|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
143185136|NCT03053440|516223169|FG000|Overall Study|Physician Decision|2|||
143185137|NCT03053440|516223170|FG001|Overall Study|Physician Decision|1|||
143185138|NCT03053440|516223169|FG000|Overall Study|Participant Randomized but died before dosing|1|||
143185139|NCT03053440|516223170|FG001|Overall Study|Participant Randomized but died before dosing|0|||
143185140|NCT00603941|516223175|FG000|Overall Study|Disease progression|6|||
143185141|NCT00603941|516223176|FG001|Overall Study|Disease progression|7|||
143185142|NCT00603941|516223177|FG002|Overall Study|Disease progression|1|||
143185143|NCT00603941|516223175|FG000|Overall Study|Adverse Event|1|||
143185144|NCT00603941|516223176|FG001|Overall Study|Adverse Event|0|||
143369375|NCT00686517|516896083|FG000|Treatment|Poor Protocol Compliance|1|||
143185145|NCT00603941|516223177|FG002|Overall Study|Adverse Event|1|||
143185146|NCT00603941|516223175|FG000|Overall Study|Physician Decision|0|||
143185147|NCT00603941|516223176|FG001|Overall Study|Physician Decision|1|||
143185148|NCT00603941|516223177|FG002|Overall Study|Physician Decision|0|||
143185149|NCT00603941|516223175|FG000|Overall Study|Withdrawal by Subject|0|||
143185150|NCT00603941|516223176|FG001|Overall Study|Withdrawal by Subject|2|||
143185151|NCT00603941|516223177|FG002|Overall Study|Withdrawal by Subject|0|||
143185152|NCT00833469|516223178|FG000|Overall Study|Withdrawal by Subject|1|||
143185153|NCT00833469|516223178|FG000|Overall Study|Lost to Follow-up|1|||
143185154|NCT01642901|516223179|FG000|12-month Follow-up|Withdrawal by Subject|1|||
143185155|NCT01642901|516223180|FG001|12-month Follow-up|Withdrawal by Subject|0|||
143185156|NCT02707965|516223181|FG000|Overall Study|Withdrawal by Subject|0|||
143185157|NCT02707965|516223182|FG001|Overall Study|Withdrawal by Subject|0|||
143185158|NCT02707965|516223183|FG002|Overall Study|Withdrawal by Subject|1|||
143185159|NCT02707965|516223184|FG003|Overall Study|Withdrawal by Subject|0|||
143185160|NCT02707965|516223185|FG004|Overall Study|Withdrawal by Subject|0|||
143185161|NCT02707965|516223186|FG005|Overall Study|Withdrawal by Subject|0|||
143185162|NCT02707965|516223187|FG006|Overall Study|Withdrawal by Subject|0|||
143185163|NCT02707965|516223188|FG007|Overall Study|Withdrawal by Subject|2|||
143185164|NCT02707965|516223189|FG008|Overall Study|Withdrawal by Subject|0|||
143185165|NCT02707965|516223190|FG009|Overall Study|Withdrawal by Subject|0|||
143185166|NCT02707965|516223191|FG010|Overall Study|Withdrawal by Subject|0|||
143185167|NCT02707965|516223192|FG011|Overall Study|Withdrawal by Subject|0|||
143185168|NCT02707965|516223193|FG012|Overall Study|Withdrawal by Subject|0|||
143185169|NCT02707965|516223194|FG013|Overall Study|Withdrawal by Subject|0|||
143185170|NCT02707965|516223195|FG014|Overall Study|Withdrawal by Subject|0|||
143185171|NCT02707965|516223196|FG015|Overall Study|Withdrawal by Subject|0|||
143185172|NCT02707965|516223181|FG000|Overall Study|PI decisions|0|||
143185173|NCT02707965|516223182|FG001|Overall Study|PI decisions|0|||
143185174|NCT02707965|516223183|FG002|Overall Study|PI decisions|0|||
143185175|NCT02707965|516223184|FG003|Overall Study|PI decisions|0|||
143185176|NCT02707965|516223185|FG004|Overall Study|PI decisions|0|||
143185177|NCT02707965|516223186|FG005|Overall Study|PI decisions|0|||
143185178|NCT02707965|516223187|FG006|Overall Study|PI decisions|0|||
143185179|NCT02707965|516223188|FG007|Overall Study|PI decisions|0|||
143185180|NCT02707965|516223189|FG008|Overall Study|PI decisions|0|||
143261054|NCT04473482|516508911|FG000|Overall Study|Withdrawal by Subject|2|||
143261055|NCT04473482|516508912|FG001|Overall Study|Withdrawal by Subject|1|||
143261056|NCT00321893|516508914|FG000|Overall Study|Non-Compliance/Refusal|16|||
143261057|NCT00321893|516508915|FG001|Overall Study|Non-Compliance/Refusal|10|||
143261058|NCT00321893|516508914|FG000|Overall Study|Lost to Follow-up|2|||
143261059|NCT00321893|516508915|FG001|Overall Study|Lost to Follow-up|1|||
143261060|NCT00321893|516508914|FG000|Overall Study|Adverse Event|6|||
143261061|NCT00321893|516508915|FG001|Overall Study|Adverse Event|3|||
143261062|NCT03455764|516508916|FG000|Overall Study|Adverse Event|1|||
143115438|NCT04631107|515963911|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
143115439|NCT01935128|515963918|FG000|Overall Study|Death|1|||
143115440|NCT01935128|515963918|FG000|Overall Study|Adverse Event|6|||
143115441|NCT00096993|515963919|FG000|Overall Study|Death|1|||
143115442|NCT00096993|515963920|FG001|Overall Study|Death|0|||
143115443|NCT00096993|515963919|FG000|Overall Study|Disease progression|56|||
143115444|NCT00096993|515963920|FG001|Overall Study|Disease progression|53|||
143115445|NCT00096993|515963919|FG000|Overall Study|Adverse Event|2|||
143115446|NCT00096993|515963920|FG001|Overall Study|Adverse Event|8|||
143115447|NCT00096993|515963919|FG000|Overall Study|Subject's decision|3|||
143115448|NCT00096993|515963920|FG001|Overall Study|Subject's decision|1|||
143115449|NCT00096993|515963919|FG000|Overall Study|Physician Decision|2|||
143115450|NCT00096993|515963920|FG001|Overall Study|Physician Decision|1|||
143115451|NCT00096993|515963919|FG000|Overall Study|Non-compliance|0|||
143115452|NCT00096993|515963920|FG001|Overall Study|Non-compliance|1|||
143115453|NCT00096993|515963919|FG000|Overall Study|Other unspecified|1|||
143115454|NCT00096993|515963920|FG001|Overall Study|Other unspecified|1|||
143115455|NCT00435487|515963927|FG000|Overall Study|Death|3|||
143115456|NCT00435487|515963928|FG001|Overall Study|Death|4|||
143115457|NCT00435487|515963927|FG000|Overall Study|Adverse Event|0|||
143115458|NCT00435487|515963928|FG001|Overall Study|Adverse Event|3|||
143115459|NCT00435487|515963927|FG000|Overall Study|Lost to Follow-up|2|||
143115460|NCT00435487|515963928|FG001|Overall Study|Lost to Follow-up|2|||
143115461|NCT00435487|515963927|FG000|Overall Study|Other|5|||
143115462|NCT00435487|515963928|FG001|Overall Study|Other|2|||
143115463|NCT00435487|515963927|FG000|Overall Study|Withdrawal by Subject|2|||
143115464|NCT00435487|515963928|FG001|Overall Study|Withdrawal by Subject|1|||
143115465|NCT00435487|515963927|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
143115466|NCT00435487|515963928|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
143115467|NCT00435487|515963927|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
143115468|NCT00435487|515963928|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
143115469|NCT00835679|515963931|FG000|Overall Study|Withdrawal by Subject|1|||
143115470|NCT00835679|515963932|FG001|Overall Study|Withdrawal by Subject|0|||
143115471|NCT00835679|515963933|FG002|Overall Study|Withdrawal by Subject|0|||
143115472|NCT00835679|515963934|FG003|Overall Study|Withdrawal by Subject|0|||
143115473|NCT00483704|515963939|FG000|Randomization|Withdrawal by Subject|19|||
143115474|NCT00483704|515963940|FG001|Randomization|Withdrawal by Subject|28|||
143115475|NCT00483704|515963941|FG002|Randomization|Withdrawal by Subject|18|||
143261063|NCT03455764|516508917|FG001|Overall Study|Adverse Event|0|||
143261064|NCT03455764|516508918|FG002|Overall Study|Adverse Event|0|||
143261065|NCT03455764|516508919|FG003|Overall Study|Adverse Event|0|||
143261066|NCT03455764|516508920|FG004|Overall Study|Adverse Event|0|||
143261067|NCT03455764|516508916|FG000|Overall Study|Disease Progression|4|||
143261068|NCT03455764|516508917|FG001|Overall Study|Disease Progression|0|||
143261069|NCT03455764|516508918|FG002|Overall Study|Disease Progression|0|||
143261070|NCT03455764|516508919|FG003|Overall Study|Disease Progression|0|||
143185181|NCT02707965|516223190|FG009|Overall Study|PI decisions|0|||
143185182|NCT02707965|516223191|FG010|Overall Study|PI decisions|0|||
143185183|NCT02707965|516223192|FG011|Overall Study|PI decisions|0|||
143185184|NCT02707965|516223193|FG012|Overall Study|PI decisions|0|||
143185185|NCT02707965|516223194|FG013|Overall Study|PI decisions|0|||
143185186|NCT02707965|516223195|FG014|Overall Study|PI decisions|2|||
143185187|NCT02707965|516223196|FG015|Overall Study|PI decisions|0|||
143185188|NCT02707965|516223181|FG000|Overall Study|Protocol deviation|1|||
143185189|NCT02707965|516223182|FG001|Overall Study|Protocol deviation|1|||
143185190|NCT02707965|516223183|FG002|Overall Study|Protocol deviation|0|||
143185191|NCT02707965|516223184|FG003|Overall Study|Protocol deviation|0|||
143185192|NCT02707965|516223185|FG004|Overall Study|Protocol deviation|0|||
143185193|NCT02707965|516223186|FG005|Overall Study|Protocol deviation|0|||
143185194|NCT02707965|516223187|FG006|Overall Study|Protocol deviation|0|||
143185195|NCT02707965|516223188|FG007|Overall Study|Protocol deviation|1|||
143185196|NCT02707965|516223189|FG008|Overall Study|Protocol deviation|0|||
143185197|NCT02707965|516223190|FG009|Overall Study|Protocol deviation|0|||
143185198|NCT02707965|516223191|FG010|Overall Study|Protocol deviation|0|||
143185199|NCT02707965|516223192|FG011|Overall Study|Protocol deviation|0|||
143185200|NCT02707965|516223193|FG012|Overall Study|Protocol deviation|0|||
143185201|NCT02707965|516223194|FG013|Overall Study|Protocol deviation|0|||
143185202|NCT02707965|516223195|FG014|Overall Study|Protocol deviation|0|||
143185203|NCT02707965|516223196|FG015|Overall Study|Protocol deviation|0|||
143185204|NCT03520920|516223200|FG000|Overall Study|Death|13|||
143185205|NCT03520920|516223201|FG001|Overall Study|Death|1|||
143185206|NCT03520920|516223202|FG002|Overall Study|Death|0|||
143185207|NCT03520920|516223200|FG000|Overall Study|Withdrawal by Subject|2|||
143185208|NCT03520920|516223201|FG001|Overall Study|Withdrawal by Subject|1|||
143185209|NCT03520920|516223202|FG002|Overall Study|Withdrawal by Subject|0|||
143185210|NCT03520920|516223200|FG000|Overall Study|Study Terminated by the Sponsor|5|||
143185211|NCT03520920|516223201|FG001|Overall Study|Study Terminated by the Sponsor|14|||
143185212|NCT03520920|516223202|FG002|Overall Study|Study Terminated by the Sponsor|5|||
143185213|NCT00405392|516223203|FG000|Overall Study|Adverse Event|15|||
143185214|NCT00405392|516223204|FG001|Overall Study|Adverse Event|14|||
143185215|NCT00405392|516223203|FG000|Overall Study|Did not meet Eligibility criteria|7|||
143185216|NCT00405392|516223204|FG001|Overall Study|Did not meet Eligibility criteria|2|||
143185217|NCT00405392|516223203|FG000|Overall Study|Withdrawal by Subject|4|||
143185218|NCT00405392|516223204|FG001|Overall Study|Withdrawal by Subject|3|||
143185219|NCT00405392|516223203|FG000|Overall Study|Lost to Follow-up|1|||
143185220|NCT00405392|516223204|FG001|Overall Study|Lost to Follow-up|2|||
143185221|NCT00405392|516223203|FG000|Overall Study|Data missing|2|||
143185222|NCT00405392|516223204|FG001|Overall Study|Data missing|0|||
143185223|NCT00405392|516223203|FG000|Overall Study|Non-compliance|0|||
143185224|NCT00405392|516223204|FG001|Overall Study|Non-compliance|1|||
143185225|NCT00405392|516223203|FG000|Overall Study|Other|1|||
143261071|NCT03455764|516508920|FG004|Overall Study|Disease Progression|0|||
143185226|NCT00405392|516223204|FG001|Overall Study|Other|5|||
143185227|NCT03902392|516223205|FG000|Overall Study|Lost to Follow-up|7|||
143261072|NCT03455764|516508916|FG000|Overall Study|On Treatment|1|||
143185228|NCT03902392|516223206|FG001|Overall Study|Lost to Follow-up|7|||
143185229|NCT00244725|516223207|FG000|Overall Study|Lost to Follow-up|3|||
143185230|NCT00244725|516223208|FG001|Overall Study|Lost to Follow-up|4|||
143185231|NCT00244725|516223209|FG002|Overall Study|Lost to Follow-up|9|||
143185232|NCT00244725|516223210|FG003|Overall Study|Lost to Follow-up|2|||
143185233|NCT00244725|516223207|FG000|Overall Study|Withdrawal by Subject|9|||
143185234|NCT00244725|516223208|FG001|Overall Study|Withdrawal by Subject|7|||
143261073|NCT03455764|516508917|FG001|Overall Study|On Treatment|0|||
143185235|NCT00244725|516223209|FG002|Overall Study|Withdrawal by Subject|7|||
143185236|NCT00244725|516223210|FG003|Overall Study|Withdrawal by Subject|8|||
143261074|NCT03455764|516508918|FG002|Overall Study|On Treatment|0|||
143261075|NCT03455764|516508919|FG003|Overall Study|On Treatment|0|||
143261076|NCT03455764|516508920|FG004|Overall Study|On Treatment|0|||
143261077|NCT00570232|516508921|FG000|Overall Study|Adverse Event|10|||
143261078|NCT00570232|516508921|FG000|Overall Study|discontinued due to medical condition|3|||
143261079|NCT00570232|516508921|FG000|Overall Study|discontinued due to recurrence|8|||
143261080|NCT00570232|516508921|FG000|Overall Study|discontinued due to noncompliance|2|||
143261081|NCT01076075|516508922|FG000|Overall Study|Adverse Event|3|||
143261082|NCT01076075|516508923|FG001|Overall Study|Adverse Event|9|||
143261083|NCT01076075|516508922|FG000|Overall Study|Lack of Efficacy|5|||
143261084|NCT01076075|516508923|FG001|Overall Study|Lack of Efficacy|4|||
143261085|NCT01076075|516508922|FG000|Overall Study|Lost to Follow-up|6|||
143261086|NCT01076075|516508923|FG001|Overall Study|Lost to Follow-up|5|||
143261087|NCT01076075|516508922|FG000|Overall Study|other|19|||
143261088|NCT01076075|516508923|FG001|Overall Study|other|9|||
143261089|NCT01076075|516508922|FG000|Overall Study|Protocol Violation|0|||
143185237|NCT00244725|516223207|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
143185238|NCT00244725|516223208|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
143185239|NCT00244725|516223209|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
143185240|NCT00244725|516223210|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
143185241|NCT00244725|516223207|FG000|Overall Study|Physician Decision|3|||
143185242|NCT00244725|516223208|FG001|Overall Study|Physician Decision|0|||
143185243|NCT00244725|516223209|FG002|Overall Study|Physician Decision|1|||
143185244|NCT00244725|516223210|FG003|Overall Study|Physician Decision|2|||
143185245|NCT00244725|516223207|FG000|Overall Study|Adverse Events|3|||
143185246|NCT00244725|516223208|FG001|Overall Study|Adverse Events|1|||
143185247|NCT00244725|516223209|FG002|Overall Study|Adverse Events|4|||
143185248|NCT00244725|516223210|FG003|Overall Study|Adverse Events|4|||
143185249|NCT00244725|516223207|FG000|Overall Study|Withdrwal by participant|1|||
143185250|NCT00244725|516223208|FG001|Overall Study|Withdrwal by participant|0|||
143185251|NCT00244725|516223209|FG002|Overall Study|Withdrwal by participant|0|||
143185252|NCT00244725|516223210|FG003|Overall Study|Withdrwal by participant|1|||
143185253|NCT00244725|516223207|FG000|Overall Study|Liver function test abnormality|2|||
143185254|NCT00244725|516223208|FG001|Overall Study|Liver function test abnormality|0|||
143185255|NCT00244725|516223209|FG002|Overall Study|Liver function test abnormality|0|||
143185256|NCT00244725|516223210|FG003|Overall Study|Liver function test abnormality|1|||
143185257|NCT00244725|516223207|FG000|Overall Study|Sponsor withdrew the participant|1|||
143185258|NCT00244725|516223208|FG001|Overall Study|Sponsor withdrew the participant|0|||
143185259|NCT00244725|516223209|FG002|Overall Study|Sponsor withdrew the participant|0|||
143185260|NCT00244725|516223210|FG003|Overall Study|Sponsor withdrew the participant|1|||
143185261|NCT00244725|516223207|FG000|Overall Study|Mediciation Error|0|||
143185262|NCT00244725|516223208|FG001|Overall Study|Mediciation Error|1|||
143185263|NCT00244725|516223209|FG002|Overall Study|Mediciation Error|0|||
143185264|NCT00244725|516223210|FG003|Overall Study|Mediciation Error|0|||
143185265|NCT00244725|516223207|FG000|Overall Study|Rehab Refused to allow participantion|0|||
143185266|NCT00244725|516223208|FG001|Overall Study|Rehab Refused to allow participantion|1|||
143185267|NCT00244725|516223209|FG002|Overall Study|Rehab Refused to allow participantion|0|||
143185268|NCT00244725|516223210|FG003|Overall Study|Rehab Refused to allow participantion|0|||
143185269|NCT00244725|516223207|FG000|Overall Study|Headache|0|||
143185270|NCT00244725|516223208|FG001|Overall Study|Headache|1|||
143185271|NCT00244725|516223209|FG002|Overall Study|Headache|0|||
143185272|NCT00244725|516223210|FG003|Overall Study|Headache|0|||
143185273|NCT00244725|516223207|FG000|Overall Study|Received prohibited medication|0|||
143185274|NCT00244725|516223208|FG001|Overall Study|Received prohibited medication|1|||
143185275|NCT00244725|516223209|FG002|Overall Study|Received prohibited medication|0|||
143185276|NCT00244725|516223210|FG003|Overall Study|Received prohibited medication|1|||
143185277|NCT00244725|516223207|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
143185278|NCT00244725|516223208|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
143185279|NCT00244725|516223209|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
143185280|NCT00244725|516223210|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
143185281|NCT00244725|516223207|FG000|Overall Study|Administrative reason|0|||
143185282|NCT00244725|516223208|FG001|Overall Study|Administrative reason|0|||
143185283|NCT00244725|516223209|FG002|Overall Study|Administrative reason|1|||
143185284|NCT00244725|516223210|FG003|Overall Study|Administrative reason|0|||
143185285|NCT00244725|516223207|FG000|Overall Study|Vomit|0|||
143185286|NCT00244725|516223208|FG001|Overall Study|Vomit|0|||
143185287|NCT00244725|516223209|FG002|Overall Study|Vomit|1|||
143261090|NCT01076075|516508923|FG001|Overall Study|Protocol Violation|1|||
143261091|NCT01076075|516508922|FG000|Overall Study|Withdrawal by Subject|8|||
143261092|NCT01076075|516508923|FG001|Overall Study|Withdrawal by Subject|19|||
143261093|NCT01986933|516508927|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
143261094|NCT01986933|516508928|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
143185288|NCT00244725|516223210|FG003|Overall Study|Vomit|0|||
143261095|NCT01986933|516508929|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
143185289|NCT00244725|516223207|FG000|Overall Study|Failed to follow-up|0|||
143185290|NCT00244725|516223208|FG001|Overall Study|Failed to follow-up|0|||
143185291|NCT00244725|516223209|FG002|Overall Study|Failed to follow-up|1|||
143185292|NCT00244725|516223210|FG003|Overall Study|Failed to follow-up|1|||
143185293|NCT03799952|516223211|FG000|Overall Study|Program was too easy, discontinued|1|||
143185294|NCT03799952|516223212|FG001|Overall Study|Program was too easy, discontinued|0|||
143185295|NCT03799952|516223211|FG000|Overall Study|Lost to Follow-up|0|||
143185296|NCT03799952|516223212|FG001|Overall Study|Lost to Follow-up|2|||
143185297|NCT03248167|516223213|FG000|Overall Study|Withdrawal by Subject|2|||
143185298|NCT03248167|516223214|FG001|Overall Study|Withdrawal by Subject|2|||
143185299|NCT03248167|516223213|FG000|Overall Study|Physician Decision|0|||
143185300|NCT03248167|516223214|FG001|Overall Study|Physician Decision|1|||
143185301|NCT03248167|516223213|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
143185302|NCT03248167|516223214|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
143185303|NCT03248167|516223213|FG000|Overall Study|Lost to Follow-up|1|||
143185304|NCT03248167|516223214|FG001|Overall Study|Lost to Follow-up|0|||
143185305|NCT02122146|516223215|FG000|Part 1: Dose Escalation|Death|0|||
143185306|NCT02122146|516223216|FG001|Part 1: Dose Escalation|Death|1|||
143185307|NCT02122146|516223217|FG002|Part 1: Dose Escalation|Death|1|||
143185308|NCT02122146|516223218|FG003|Part 1: Dose Escalation|Death|0|||
143185309|NCT02122146|516223219|FG004|Part 1: Dose Escalation|Death|0|||
143185310|NCT02122146|516223220|FG005|Part 1: Dose Escalation|Death|0|||
143185311|NCT02122146|516223221|FG006|Part 1: Dose Escalation|Death|0|||
143185312|NCT02122146|516223222|FG007|Part 1: Dose Escalation|Death|0|||
143185313|NCT02122146|516223215|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
143185314|NCT02122146|516223216|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
143185315|NCT02122146|516223217|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
143185316|NCT02122146|516223218|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
143185317|NCT02122146|516223219|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
143185318|NCT02122146|516223220|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
143185319|NCT02122146|516223221|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
143185320|NCT02122146|516223222|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
143185321|NCT02122146|516223215|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
143185322|NCT02122146|516223216|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
143185323|NCT02122146|516223217|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
143185324|NCT02122146|516223218|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
143185325|NCT02122146|516223219|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
143185326|NCT02122146|516223220|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
143185327|NCT02122146|516223221|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
143185328|NCT02122146|516223222|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
143185329|NCT02122146|516223215|FG000|Part 1: Dose Escalation|Other|1|||
143185330|NCT02122146|516223216|FG001|Part 1: Dose Escalation|Other|0|||
143185331|NCT02122146|516223217|FG002|Part 1: Dose Escalation|Other|0|||
143185332|NCT02122146|516223218|FG003|Part 1: Dose Escalation|Other|0|||
143185333|NCT02122146|516223219|FG004|Part 1: Dose Escalation|Other|0|||
143185334|NCT02122146|516223220|FG005|Part 1: Dose Escalation|Other|1|||
143185335|NCT02122146|516223221|FG006|Part 1: Dose Escalation|Other|1|||
143185336|NCT02122146|516223222|FG007|Part 1: Dose Escalation|Other|2|||
143185337|NCT03472495|516223223|FG000|Overall Study|Treatment no longer indicated|1|||
143185338|NCT03472495|516223224|FG001|Overall Study|Treatment no longer indicated|2|||
143185339|NCT03472495|516223223|FG000|Overall Study|Physician Decision|0|||
143185340|NCT03472495|516223224|FG001|Overall Study|Physician Decision|2|||
143185341|NCT02623205|516223225|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
143185342|NCT02623205|516223226|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
143185343|NCT03082677|516223227|FG000|Overall Study|Not Treated|2|||
143185344|NCT01667133|516223228|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
143185345|NCT01667133|516223229|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
143185346|NCT01667133|516223230|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
143185347|NCT01667133|516223231|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
143185348|NCT01667133|516223232|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
143261096|NCT01986933|516508930|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
143261097|NCT01986933|516508931|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
143261098|NCT01986933|516508927|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
143261099|NCT01986933|516508928|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
143261100|NCT01986933|516508929|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
143185349|NCT01667133|516223233|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
143185350|NCT01667133|516223234|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
143185351|NCT01667133|516223235|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
143185352|NCT01667133|516223236|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
143185353|NCT01667133|516223237|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
143185354|NCT01667133|516223238|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
143185355|NCT01667133|516223239|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
143185356|NCT01667133|516223228|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
143185357|NCT01667133|516223229|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
143185358|NCT01667133|516223230|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
143185359|NCT01667133|516223231|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
143185360|NCT01667133|516223232|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
143185361|NCT01667133|516223233|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
143185362|NCT01667133|516223234|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
143185363|NCT01667133|516223235|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
143185364|NCT01667133|516223236|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
143185365|NCT01667133|516223237|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
143185366|NCT01667133|516223238|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
143185367|NCT01667133|516223239|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
143185368|NCT01667133|516223228|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
143185369|NCT01667133|516223229|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
143185370|NCT01667133|516223230|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
143185371|NCT01667133|516223231|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
143185372|NCT01667133|516223232|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
143185373|NCT01667133|516223233|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
143185374|NCT01667133|516223234|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
143185375|NCT01667133|516223235|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
143185376|NCT01667133|516223236|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
143185377|NCT01667133|516223237|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
143185378|NCT01667133|516223238|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
143185379|NCT01667133|516223239|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
143185380|NCT01667133|516223228|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
143185381|NCT01667133|516223229|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
143185382|NCT01667133|516223230|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
143185383|NCT01667133|516223231|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
143185384|NCT01667133|516223232|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
143185385|NCT01667133|516223233|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
143185386|NCT01667133|516223234|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
143185387|NCT01667133|516223235|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
143185388|NCT01667133|516223236|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
143185389|NCT01667133|516223237|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
143185390|NCT01667133|516223238|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
143185391|NCT01667133|516223239|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
143185392|NCT01667133|516223228|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
143185393|NCT01667133|516223229|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
143185394|NCT01667133|516223230|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
143185395|NCT01667133|516223231|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
143185396|NCT01667133|516223232|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
143185397|NCT01667133|516223233|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
143185398|NCT01667133|516223234|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
143185399|NCT01667133|516223235|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
143185400|NCT01667133|516223236|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
143185401|NCT01667133|516223237|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
143185402|NCT01667133|516223238|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
143185403|NCT01667133|516223239|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
143185404|NCT01667133|516223228|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
143185405|NCT01667133|516223229|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
143185406|NCT01667133|516223230|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
143185407|NCT01667133|516223231|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
143185408|NCT01667133|516223232|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
143185409|NCT01667133|516223233|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
143185410|NCT01667133|516223234|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
143185411|NCT01667133|516223235|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
143185412|NCT01667133|516223236|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
143185413|NCT01667133|516223237|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
143185414|NCT01667133|516223238|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
143185415|NCT01667133|516223239|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
143185416|NCT01667133|516223228|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
143185417|NCT01667133|516223229|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
143185418|NCT01667133|516223230|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
143185419|NCT01667133|516223231|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
143185420|NCT01667133|516223232|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
143185421|NCT01667133|516223233|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
143369376|NCT00686517|516896084|FG001|Treatment|Poor Protocol Compliance|0|||
143185422|NCT01667133|516223234|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
143185423|NCT01667133|516223235|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
143185424|NCT01667133|516223236|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
143369377|NCT00686517|516896085|FG002|Treatment|Poor Protocol Compliance|0|||
143185425|NCT01667133|516223237|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
143185426|NCT01667133|516223238|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
143185427|NCT01667133|516223239|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
143185428|NCT01667133|516223228|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
143185429|NCT01667133|516223229|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
143185430|NCT01667133|516223230|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
143185431|NCT01667133|516223231|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
143185432|NCT01667133|516223232|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
143185433|NCT01667133|516223233|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
143185434|NCT01667133|516223234|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
143185435|NCT01667133|516223235|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
143185436|NCT01667133|516223236|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
143185437|NCT01667133|516223237|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
143185438|NCT01667133|516223238|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
143185439|NCT01667133|516223239|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
143185440|NCT01667133|516223228|FG000|Phase 2: Dose-expansion|Death|0|||
143185441|NCT01667133|516223229|FG001|Phase 2: Dose-expansion|Death|0|||
143185442|NCT01667133|516223230|FG002|Phase 2: Dose-expansion|Death|0|||
143185443|NCT01667133|516223231|FG003|Phase 2: Dose-expansion|Death|0|||
143185444|NCT01667133|516223232|FG004|Phase 2: Dose-expansion|Death|0|||
143185445|NCT01667133|516223233|FG005|Phase 2: Dose-expansion|Death|0|||
143185446|NCT01667133|516223234|FG006|Phase 2: Dose-expansion|Death|0|||
143185447|NCT01667133|516223235|FG007|Phase 2: Dose-expansion|Death|0|||
143185448|NCT01667133|516223236|FG008|Phase 2: Dose-expansion|Death|0|||
143185449|NCT01667133|516223237|FG009|Phase 2: Dose-expansion|Death|1|||
143185450|NCT01667133|516223238|FG010|Phase 2: Dose-expansion|Death|0|||
143185451|NCT01667133|516223239|FG011|Phase 2: Dose-expansion|Death|0|||
143185452|NCT01667133|516223228|FG000|Phase 2: Dose-expansion|Other|0|||
143185453|NCT01667133|516223229|FG001|Phase 2: Dose-expansion|Other|0|||
143185454|NCT01667133|516223230|FG002|Phase 2: Dose-expansion|Other|0|||
143185455|NCT01667133|516223231|FG003|Phase 2: Dose-expansion|Other|0|||
143185456|NCT01667133|516223232|FG004|Phase 2: Dose-expansion|Other|0|||
143185457|NCT01667133|516223233|FG005|Phase 2: Dose-expansion|Other|0|||
143185458|NCT01667133|516223234|FG006|Phase 2: Dose-expansion|Other|0|||
143185459|NCT01667133|516223235|FG007|Phase 2: Dose-expansion|Other|0|||
143185460|NCT01667133|516223236|FG008|Phase 2: Dose-expansion|Other|0|||
143185461|NCT01667133|516223237|FG009|Phase 2: Dose-expansion|Other|0|||
143185462|NCT01667133|516223238|FG010|Phase 2: Dose-expansion|Other|0|||
143185463|NCT01667133|516223239|FG011|Phase 2: Dose-expansion|Other|1|||
143185464|NCT00191945|516223240|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
143185465|NCT00191945|516223241|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
143185466|NCT00191945|516223240|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
143185467|NCT00191945|516223241|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
143185468|NCT00191945|516223240|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
143185469|NCT00191945|516223241|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
143185470|NCT00191945|516223240|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
143185471|NCT00191945|516223241|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
143185472|NCT02455336|516223244|FG000|Overall Study|Withdrawal by Subject|0|||
143185473|NCT02455336|516223245|FG001|Overall Study|Withdrawal by Subject|2|||
143185474|NCT02455336|516223244|FG000|Overall Study|Adverse Event|3|||
143185475|NCT02455336|516223245|FG001|Overall Study|Adverse Event|0|||
143185476|NCT02455336|516223244|FG000|Overall Study|Non-responder to treatment|2|||
143185477|NCT02455336|516223245|FG001|Overall Study|Non-responder to treatment|0|||
143185478|NCT03497039|516223246|FG000|Overall Study|Withdrawal by Subject|1|||
143185479|NCT03497039|516223247|FG001|Overall Study|Withdrawal by Subject|0|||
143185480|NCT03497039|516223246|FG000|Overall Study|Protocol Violation|0|||
143185481|NCT03497039|516223247|FG001|Overall Study|Protocol Violation|1|||
143185482|NCT01451749|516223251|FG000|Overall Study|Protocol Violation|14|||
143185483|NCT01451749|516223252|FG001|Overall Study|Protocol Violation|7|||
143185484|NCT01451749|516223251|FG000|Overall Study|Lost to Follow-up|15|||
143185485|NCT01451749|516223252|FG001|Overall Study|Lost to Follow-up|5|||
143185486|NCT01451749|516223251|FG000|Overall Study|Meet the exclusion criteria,and|1|||
143185487|NCT01451749|516223252|FG001|Overall Study|Meet the exclusion criteria,and|1|||
143185488|NCT01451749|516223251|FG000|Overall Study|Adverse Event|2|||
143185489|NCT01451749|516223252|FG001|Overall Study|Adverse Event|0|||
143185490|NCT01451749|516223251|FG000|Overall Study|Withdrawal by Subject|0|||
143185491|NCT01451749|516223252|FG001|Overall Study|Withdrawal by Subject|1|||
143185492|NCT02311881|516223255|FG000|Overall Study|Did not meet the study criteria|2|||
143185493|NCT02311881|516223256|FG001|Overall Study|Did not meet the study criteria|2|||
143185494|NCT02311881|516223257|FG002|Overall Study|Did not meet the study criteria|0|||
143185495|NCT02311881|516223255|FG000|Overall Study|Adverse Event|7|||
143185496|NCT02311881|516223256|FG001|Overall Study|Adverse Event|15|||
143185497|NCT02311881|516223257|FG002|Overall Study|Adverse Event|8|||
143185498|NCT02311881|516223255|FG000|Overall Study|Lost to Follow-up|3|||
143185499|NCT02311881|516223256|FG001|Overall Study|Lost to Follow-up|3|||
143185500|NCT02311881|516223257|FG002|Overall Study|Lost to Follow-up|2|||
143185501|NCT02311881|516223255|FG000|Overall Study|Protocol Violation|1|||
143185502|NCT02311881|516223256|FG001|Overall Study|Protocol Violation|2|||
143185503|NCT02311881|516223257|FG002|Overall Study|Protocol Violation|3|||
143185504|NCT02311881|516223255|FG000|Overall Study|Withdrawal of consent|14|||
143185505|NCT02311881|516223256|FG001|Overall Study|Withdrawal of consent|16|||
143185506|NCT02311881|516223257|FG002|Overall Study|Withdrawal of consent|17|||
143185507|NCT02311881|516223255|FG000|Overall Study|Other|0|||
143185508|NCT02311881|516223256|FG001|Overall Study|Other|0|||
143185509|NCT02311881|516223257|FG002|Overall Study|Other|1|||
143185510|NCT02311881|516223255|FG000|Overall Study|Lack of Efficacy|1|||
143185511|NCT02311881|516223256|FG001|Overall Study|Lack of Efficacy|2|||
143185512|NCT02311881|516223257|FG002|Overall Study|Lack of Efficacy|0|||
143185513|NCT02311881|516223255|FG000|Overall Study|Subject has border line pregnancy test|1|||
143185514|NCT02311881|516223256|FG001|Overall Study|Subject has border line pregnancy test|0|||
143185515|NCT02311881|516223257|FG002|Overall Study|Subject has border line pregnancy test|0|||
143185516|NCT02311881|516223255|FG000|Overall Study|Withdrawal by Subject|3|||
143185517|NCT02311881|516223256|FG001|Overall Study|Withdrawal by Subject|1|||
143185518|NCT02311881|516223257|FG002|Overall Study|Withdrawal by Subject|4|||
143185519|NCT02311881|516223255|FG000|Overall Study|Sponsor Decision|1|||
143185520|NCT02311881|516223256|FG001|Overall Study|Sponsor Decision|1|||
143185521|NCT02311881|516223257|FG002|Overall Study|Sponsor Decision|1|||
143185522|NCT02311881|516223255|FG000|Overall Study|Protocol Deviation|1|||
143185523|NCT02311881|516223256|FG001|Overall Study|Protocol Deviation|0|||
143185524|NCT02311881|516223257|FG002|Overall Study|Protocol Deviation|0|||
143185525|NCT02311881|516223255|FG000|Overall Study|Non-Compliance|1|||
143185526|NCT02311881|516223256|FG001|Overall Study|Non-Compliance|0|||
143185527|NCT02311881|516223257|FG002|Overall Study|Non-Compliance|2|||
143185528|NCT02311881|516223255|FG000|Overall Study|Physician Decision|0|||
143185529|NCT02311881|516223256|FG001|Overall Study|Physician Decision|0|||
143185530|NCT02311881|516223257|FG002|Overall Study|Physician Decision|1|||
143185531|NCT02311881|516223255|FG000|Overall Study|Medical Monitor Discretion|0|||
143185532|NCT02311881|516223256|FG001|Overall Study|Medical Monitor Discretion|0|||
143185533|NCT02311881|516223257|FG002|Overall Study|Medical Monitor Discretion|1|||
143261101|NCT01986933|516508930|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
143185534|NCT02311881|516223255|FG000|Overall Study|Participant taking another medication|0|||
143185535|NCT02311881|516223256|FG001|Overall Study|Participant taking another medication|0|||
143261102|NCT01986933|516508931|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
143185536|NCT02311881|516223257|FG002|Overall Study|Participant taking another medication|1|||
143185537|NCT02311881|516223255|FG000|Overall Study|Serious Adverse Event|0|||
143185538|NCT02311881|516223256|FG001|Overall Study|Serious Adverse Event|1|||
143185539|NCT02311881|516223257|FG002|Overall Study|Serious Adverse Event|0|||
143185540|NCT00790582|516223262|FG000|Overall Study|Death|14|||
143185541|NCT00790582|516223263|FG001|Overall Study|Death|32|||
143185542|NCT00790582|516223262|FG000|Overall Study|Physician Decision|7|||
143185543|NCT00790582|516223263|FG001|Overall Study|Physician Decision|1|||
143185544|NCT00790582|516223262|FG000|Overall Study|Lost to Follow-up|3|||
143185545|NCT00790582|516223263|FG001|Overall Study|Lost to Follow-up|3|||
143185546|NCT00790582|516223262|FG000|Overall Study|Withdrawal by Subject|7|||
143185547|NCT00790582|516223263|FG001|Overall Study|Withdrawal by Subject|51|||
143185548|NCT01597908|516223266|FG000|Randomized Phase|Death|217|||
143185549|NCT01597908|516223267|FG001|Randomized Phase|Death|238|||
143185550|NCT01597908|516223268|FG002|Randomized Phase|Death|0|||
143185551|NCT01597908|516223266|FG000|Randomized Phase|Sponsor Decision|93|||
143185552|NCT01597908|516223267|FG001|Randomized Phase|Sponsor Decision|39|||
143185553|NCT01597908|516223268|FG002|Randomized Phase|Sponsor Decision|0|||
143185554|NCT01597908|516223266|FG000|Randomized Phase|Lost to Follow-up|9|||
143185555|NCT01597908|516223267|FG001|Randomized Phase|Lost to Follow-up|16|||
143185556|NCT01597908|516223268|FG002|Randomized Phase|Lost to Follow-up|0|||
143185557|NCT01597908|516223266|FG000|Randomized Phase|Physician Decision|6|||
143185558|NCT01597908|516223267|FG001|Randomized Phase|Physician Decision|3|||
143185559|NCT01597908|516223268|FG002|Randomized Phase|Physician Decision|0|||
143185560|NCT01597908|516223266|FG000|Randomized Phase|Withdrawal by Subject|26|||
143185561|NCT01597908|516223267|FG001|Randomized Phase|Withdrawal by Subject|22|||
143185562|NCT01597908|516223268|FG002|Randomized Phase|Withdrawal by Subject|0|||
143185563|NCT01597908|516223266|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
143185564|NCT01597908|516223267|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
143185565|NCT01597908|516223268|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
143185566|NCT01597908|516223266|FG000|Crossover Phase|Death|0|||
143185567|NCT01597908|516223267|FG001|Crossover Phase|Death|0|||
143185568|NCT01597908|516223268|FG002|Crossover Phase|Death|11|||
143185569|NCT01597908|516223266|FG000|Crossover Phase|Withdrawal by Subject|0|||
143261103|NCT01986933|516508927|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
143261104|NCT01986933|516508928|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
143261105|NCT01986933|516508929|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
143261106|NCT01986933|516508930|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
143261107|NCT01986933|516508931|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
143261108|NCT01986933|516508927|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
143261109|NCT01986933|516508928|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
143261110|NCT01986933|516508929|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
143261111|NCT01986933|516508930|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
143261112|NCT01986933|516508931|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
143261113|NCT01986933|516508927|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
143261114|NCT01986933|516508928|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
143261115|NCT01986933|516508929|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
143261116|NCT01986933|516508930|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
143261117|NCT01986933|516508931|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
143261118|NCT01986933|516508927|FG000|Active-to-active (Part B)|Adverse Event|0|||
143261119|NCT01986933|516508928|FG001|Active-to-active (Part B)|Adverse Event|2|||
143261120|NCT01986933|516508929|FG002|Active-to-active (Part B)|Adverse Event|0|||
143261121|NCT01986933|516508930|FG003|Active-to-active (Part B)|Adverse Event|1|||
143369378|NCT00686517|516896083|FG000|Treatment|Protocol Violation|2|||
143369379|NCT00686517|516896084|FG001|Treatment|Protocol Violation|1|||
143369380|NCT00686517|516896085|FG002|Treatment|Protocol Violation|0|||
143369381|NCT01803646|516896086|FG000|Overall Study|Protocol Violation|1|||
143369382|NCT01803646|516896087|FG001|Overall Study|Protocol Violation|0|||
143369383|NCT01803646|516896086|FG000|Overall Study|Adverse Event|1|||
143369384|NCT01803646|516896087|FG001|Overall Study|Adverse Event|1|||
143185570|NCT01597908|516223267|FG001|Crossover Phase|Withdrawal by Subject|0|||
143185571|NCT01597908|516223268|FG002|Crossover Phase|Withdrawal by Subject|3|||
143185572|NCT01597908|516223266|FG000|Crossover Phase|Sponsor Decision|0|||
143369385|NCT01803646|516896086|FG000|Overall Study|Withdrawal by Subject|9|||
143369386|NCT01803646|516896087|FG001|Overall Study|Withdrawal by Subject|6|||
143185573|NCT01597908|516223267|FG001|Crossover Phase|Sponsor Decision|0|||
143185574|NCT01597908|516223268|FG002|Crossover Phase|Sponsor Decision|20|||
143185575|NCT02949024|516223269|FG000|Overall Study|Withdrawal by Subject|0|||
143185576|NCT02949024|516223270|FG001|Overall Study|Withdrawal by Subject|1|||
143185577|NCT01027650|516223271|FG000|Overall Study|Personal Reasons|0|||
143185578|NCT01027650|516223272|FG001|Overall Study|Personal Reasons|0|||
143185579|NCT01027650|516223273|FG002|Overall Study|Personal Reasons|0|||
143185580|NCT01027650|516223274|FG003|Overall Study|Personal Reasons|0|||
143185581|NCT01027650|516223275|FG004|Overall Study|Personal Reasons|2|||
143185582|NCT01027650|516223276|FG005|Overall Study|Personal Reasons|1|||
143185583|NCT01027650|516223277|FG006|Overall Study|Personal Reasons|0|||
143185584|NCT01027650|516223278|FG007|Overall Study|Personal Reasons|0|||
143185585|NCT01027650|516223271|FG000|Overall Study|Lost to Follow-up|0|||
143185586|NCT01027650|516223272|FG001|Overall Study|Lost to Follow-up|0|||
143185587|NCT01027650|516223273|FG002|Overall Study|Lost to Follow-up|0|||
143185588|NCT01027650|516223274|FG003|Overall Study|Lost to Follow-up|0|||
143185589|NCT01027650|516223275|FG004|Overall Study|Lost to Follow-up|0|||
143185590|NCT01027650|516223276|FG005|Overall Study|Lost to Follow-up|0|||
143185591|NCT01027650|516223277|FG006|Overall Study|Lost to Follow-up|1|||
143185592|NCT01027650|516223278|FG007|Overall Study|Lost to Follow-up|0|||
143185593|NCT01027650|516223271|FG000|Overall Study|Lack of Efficacy|0|||
143185594|NCT01027650|516223272|FG001|Overall Study|Lack of Efficacy|0|||
143185595|NCT01027650|516223273|FG002|Overall Study|Lack of Efficacy|0|||
143185596|NCT01027650|516223274|FG003|Overall Study|Lack of Efficacy|0|||
143185597|NCT01027650|516223275|FG004|Overall Study|Lack of Efficacy|0|||
143185598|NCT01027650|516223276|FG005|Overall Study|Lack of Efficacy|1|||
143185599|NCT01027650|516223277|FG006|Overall Study|Lack of Efficacy|0|||
143261122|NCT01986933|516508931|FG004|Active-to-active (Part B)|Adverse Event|3|||
143261123|NCT01986933|516508927|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
143261124|NCT01986933|516508928|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
143261125|NCT01986933|516508929|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
143261126|NCT01986933|516508930|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
143261127|NCT01986933|516508931|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
143261128|NCT01986933|516508927|FG000|Active-to-active (Part B)|Pregnancy|0|||
143261129|NCT01986933|516508928|FG001|Active-to-active (Part B)|Pregnancy|0|||
143261130|NCT01986933|516508929|FG002|Active-to-active (Part B)|Pregnancy|0|||
143261131|NCT01986933|516508930|FG003|Active-to-active (Part B)|Pregnancy|0|||
143261132|NCT01986933|516508931|FG004|Active-to-active (Part B)|Pregnancy|1|||
143261133|NCT01986933|516508927|FG000|Active-to-active (Part B)|Physician Decision|0|||
143261134|NCT01986933|516508928|FG001|Active-to-active (Part B)|Physician Decision|0|||
143261135|NCT01986933|516508929|FG002|Active-to-active (Part B)|Physician Decision|1|||
143261136|NCT01986933|516508930|FG003|Active-to-active (Part B)|Physician Decision|1|||
143261137|NCT01986933|516508931|FG004|Active-to-active (Part B)|Physician Decision|0|||
143261138|NCT01986933|516508927|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
143261139|NCT01986933|516508928|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
143261140|NCT01986933|516508929|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
143261141|NCT01986933|516508930|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
143261142|NCT01986933|516508931|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
143261143|NCT01986933|516508927|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
143261144|NCT01986933|516508928|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
143261145|NCT01986933|516508929|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
143261146|NCT01986933|516508930|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
143261147|NCT01986933|516508931|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
143261148|NCT01986933|516508927|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
143261149|NCT01986933|516508928|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
143261150|NCT01986933|516508929|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
143261151|NCT01986933|516508930|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
143261152|NCT01986933|516508931|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
143261153|NCT01986933|516508927|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
143261154|NCT01986933|516508928|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
143185600|NCT01027650|516223278|FG007|Overall Study|Lack of Efficacy|0|||
143185601|NCT00854724|516225017|FG000|First Intervention|Withdrawal by Subject|1|||
143185602|NCT00854724|516225018|FG001|First Intervention|Withdrawal by Subject|1|||
143185603|NCT00854724|516225017|FG000|Washout|Protocol Violation|1|||
143185604|NCT00854724|516225018|FG001|Washout|Protocol Violation|0|||
143185605|NCT00854724|516225017|FG000|Washout|Withdrawal by Subject|0|||
143185606|NCT00854724|516225018|FG001|Washout|Withdrawal by Subject|1|||
143185607|NCT00854724|516225017|FG000|Second Intervention|Protocol Violation|1|||
143185608|NCT00854724|516225018|FG001|Second Intervention|Protocol Violation|0|||
143185609|NCT00854724|516225017|FG000|Second Intervention|Physician Decision|0|||
143185610|NCT00854724|516225018|FG001|Second Intervention|Physician Decision|1|||
143185611|NCT01498692|516225024|FG000|Overall Study|Death|4|||
143185612|NCT01498692|516225024|FG000|Overall Study|Withdrawal by Subject|1|||
143185613|NCT01498692|516225024|FG000|Overall Study|Missed 12-month visit|3|||
143185614|NCT01701362|516225025|FG000|Overall Study|Adverse events not related to study drug|1|||
143185615|NCT01701362|516225026|FG001|Overall Study|Adverse events not related to study drug|6|||
143185616|NCT01701362|516225025|FG000|Overall Study|Adverse events related to study drug|12|||
143185617|NCT01701362|516225026|FG001|Overall Study|Adverse events related to study drug|10|||
143185618|NCT01701362|516225025|FG000|Overall Study|Protocol Violation|5|||
143185619|NCT01701362|516225026|FG001|Overall Study|Protocol Violation|3|||
143185620|NCT01701362|516225025|FG000|Overall Study|No longer willing to participate|8|||
143185621|NCT01701362|516225026|FG001|Overall Study|No longer willing to participate|14|||
143185622|NCT01701362|516225025|FG000|Overall Study|Lost to Follow-up|6|||
143185623|NCT01701362|516225026|FG001|Overall Study|Lost to Follow-up|9|||
143185624|NCT01701362|516225025|FG000|Overall Study|Insufficient clinical response|6|||
143185625|NCT01701362|516225026|FG001|Overall Study|Insufficient clinical response|6|||
143185626|NCT01701362|516225025|FG000|Overall Study|Death|0|||
143185627|NCT01701362|516225026|FG001|Overall Study|Death|1|||
143185628|NCT01701362|516225025|FG000|Overall Study|Randomized but not treated|1|||
143185629|NCT01701362|516225026|FG001|Overall Study|Randomized but not treated|2|||
143185630|NCT01701362|516225025|FG000|Overall Study|Reasons other than those mentioned above|3|||
143261155|NCT01986933|516508929|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
143261156|NCT01986933|516508930|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
143261157|NCT01986933|516508931|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
143261158|NCT01986933|516508927|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
143261159|NCT01986933|516508928|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
143185631|NCT01701362|516225026|FG001|Overall Study|Reasons other than those mentioned above|5|||
143185632|NCT00249808|516225027|FG000|Overall Study|Other|27|||
143185633|NCT00249808|516225027|FG000|Overall Study|Protocol Violation|3|||
143261160|NCT01986933|516508929|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
143261161|NCT01986933|516508930|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
143261162|NCT01986933|516508931|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
143261163|NCT01986933|516508927|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
143261164|NCT01986933|516508928|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
143261165|NCT01986933|516508929|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
143261166|NCT01986933|516508930|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
143261167|NCT01986933|516508931|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
143261168|NCT01986933|516508927|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
143261169|NCT01986933|516508928|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
143261170|NCT01986933|516508929|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
143261171|NCT01986933|516508930|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
143261172|NCT01986933|516508931|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
143261173|NCT01986933|516508927|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
143261174|NCT01986933|516508928|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
143261175|NCT01986933|516508929|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
143261176|NCT01986933|516508930|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
143261177|NCT01986933|516508931|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
143261178|NCT00523367|516508932|FG000|Overall Study|19 screen failures|19|||
143261179|NCT00523367|516508932|FG000|Overall Study|4 Withdrawn by PI|4|||
143261180|NCT04050371|516510477|FG000|Overall Study|Withdrawal by Subject|1|||
143261181|NCT04050371|516510478|FG001|Overall Study|Withdrawal by Subject|0|||
143261182|NCT01394718|516510483|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
143261183|NCT01394718|516510484|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
143261184|NCT04078178|516510485|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
143261185|NCT04078178|516510486|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
143261186|NCT04078178|516510485|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
143261187|NCT04078178|516510486|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
143261188|NCT04078178|516510485|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
143261189|NCT04078178|516510486|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
143261190|NCT04078178|516510485|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
143261191|NCT04078178|516510486|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
143261192|NCT04078178|516510485|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
143261193|NCT04078178|516510486|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
143261194|NCT04006119|516510487|FG000|Run in Cemiplimab Period|Lack of Efficacy|1|||
143261195|NCT04006119|516510487|FG000|End of Treatment Veledimex|Adverse Event|2|||
143261196|NCT04006119|516510487|FG000|Adjuvant Cemiplimab Period|Lack of Efficacy|28|||
143261197|NCT04006119|516510487|FG000|Adjuvant Cemiplimab Period|Adverse Event|3|||
143261198|NCT04006119|516510487|FG000|Adjuvant Cemiplimab Period|Withdrawal by Subject|4|||
143261199|NCT04006119|516510487|FG000|Adjuvant Cemiplimab Period|Sponsor Study Termination rollover to Compassionate Use|2|||
143261200|NCT04617795|516510488|FG000|Main Study|Lost to Follow-up|1|||
143261201|NCT04617795|516510489|FG001|Main Study|Lost to Follow-up|0|||
143261202|NCT00472459|516510490|FG000|Overall Study|Adverse Event|13|||
143261203|NCT00472459|516510491|FG001|Overall Study|Adverse Event|13|||
143261204|NCT00472459|516510490|FG000|Overall Study|Withdrawal by Subject|5|||
143261205|NCT00472459|516510491|FG001|Overall Study|Withdrawal by Subject|5|||
143261206|NCT00472459|516510490|FG000|Overall Study|Protocol Violation|3|||
143261207|NCT00472459|516510491|FG001|Overall Study|Protocol Violation|3|||
143261208|NCT00472459|516510490|FG000|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
143261209|NCT00472459|516510491|FG001|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
143261210|NCT00472459|516510490|FG000|Overall Study|Lost to Follow-up|1|||
143369387|NCT01803646|516896086|FG000|Overall Study|Randomization error|1|||
143369388|NCT01803646|516896087|FG001|Overall Study|Randomization error|2|||
143185634|NCT00249808|516225027|FG000|Overall Study|Lost to Follow-up|8|||
143185635|NCT00249808|516225027|FG000|Overall Study|Adverse Event|81|||
143185636|NCT00249808|516225027|FG000|Overall Study|Lack of Efficacy|52|||
143185637|NCT00249808|516225027|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
143185638|NCT00711594|516225030|FG000|Overall Study|Progressive disease|2|||
143185639|NCT00711594|516225031|FG001|Overall Study|Progressive disease|2|||
143185640|NCT00711594|516225032|FG002|Overall Study|Progressive disease|6|||
143185641|NCT00711594|516225033|FG003|Overall Study|Progressive disease|44|||
143185642|NCT00711594|516225030|FG000|Overall Study|Other Adverse Event|1|||
143185643|NCT00711594|516225031|FG001|Overall Study|Other Adverse Event|0|||
143261211|NCT00472459|516510491|FG001|Overall Study|Lost to Follow-up|1|||
143261212|NCT04850313|516510492|FG000|Overall Study|Withdrawal by Subject|0|||
143261213|NCT04850313|516510493|FG001|Overall Study|Withdrawal by Subject|1|||
143261214|NCT01547780|516510494|FG000|Baseline PET Scan|Physician Decision|1|||
143261215|NCT01547780|516510495|FG001|Baseline PET Scan|Physician Decision|0|||
143261216|NCT01547780|516510496|FG002|Baseline PET Scan|Physician Decision|1|||
143261217|NCT01547780|516510497|FG003|Baseline PET Scan|Physician Decision|0|||
143261218|NCT01547780|516510494|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
143185644|NCT00711594|516225032|FG002|Overall Study|Other Adverse Event|0|||
143185645|NCT00711594|516225033|FG003|Overall Study|Other Adverse Event|16|||
143185646|NCT00711594|516225030|FG000|Overall Study|Withdrawal by Subject|0|||
143185647|NCT00711594|516225031|FG001|Overall Study|Withdrawal by Subject|1|||
143185648|NCT00711594|516225032|FG002|Overall Study|Withdrawal by Subject|0|||
143185649|NCT00711594|516225033|FG003|Overall Study|Withdrawal by Subject|2|||
143185650|NCT00443872|516225034|FG000|Overall Study|Protocol Violation|7|||
143185651|NCT00443872|516225034|FG000|Overall Study|Lost to Follow-up|2|||
143185652|NCT00443872|516225034|FG000|Overall Study|Adverse Event|8|||
143185653|NCT01709110|516225035|FG000|Overall Study|Adverse Event|56|||
143185654|NCT01709110|516225036|FG001|Overall Study|Adverse Event|48|||
143185655|NCT01709110|516225035|FG000|Overall Study|Death|14|||
143185656|NCT01709110|516225036|FG001|Overall Study|Death|6|||
143185657|NCT01709110|516225035|FG000|Overall Study|Lost to Follow-up|7|||
143185658|NCT01709110|516225036|FG001|Overall Study|Lost to Follow-up|5|||
143185659|NCT01709110|516225035|FG000|Overall Study|Protocol Violation|4|||
143185660|NCT01709110|516225036|FG001|Overall Study|Protocol Violation|6|||
143185661|NCT01709110|516225035|FG000|Overall Study|Withdrawal by Subject|96|||
143185662|NCT01709110|516225036|FG001|Overall Study|Withdrawal by Subject|89|||
143185663|NCT01709110|516225035|FG000|Overall Study|Physician Decision|4|||
143185664|NCT01709110|516225036|FG001|Overall Study|Physician Decision|10|||
143185665|NCT01709110|516225035|FG000|Overall Study|Sponsor Decision|2|||
143185666|NCT01709110|516225036|FG001|Overall Study|Sponsor Decision|2|||
143185667|NCT01709110|516225035|FG000|Overall Study|Lack of Efficacy|1|||
143185668|NCT01709110|516225036|FG001|Overall Study|Lack of Efficacy|1|||
143185669|NCT01709110|516225035|FG000|Overall Study|Caregiver Decision|1|||
143185670|NCT01709110|516225036|FG001|Overall Study|Caregiver Decision|1|||
143185671|NCT02789345|516225037|FG000|Overall Study|Adverse Event|0|||
143261219|NCT01547780|516510495|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
143261220|NCT01547780|516510496|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
143261221|NCT01547780|516510497|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
143261222|NCT01362595|516510501|FG000|Overall Study|Screen failure|10|||
143261223|NCT01362595|516510501|FG000|Overall Study|Withdrawal by Subject|2|||
143261224|NCT00959374|516510502|FG000|Overall Study|Withdrawal by Subject|2|||
143261225|NCT00959374|516510502|FG000|Overall Study|Lost to Follow-up|14|||
143261226|NCT00959374|516510502|FG000|Overall Study|Death|1|||
143261227|NCT00959374|516510502|FG000|Overall Study|Protocol Violation|1|||
143261228|NCT00959374|516510502|FG000|Overall Study|Implant Removed/Not Replaced|4|||
143261229|NCT00959374|516510502|FG000|Overall Study|Physician Decision|1|||
143261230|NCT02448680|516510503|FG000|Overall Study|Physician Decision|1|||
143261231|NCT02448680|516510504|FG001|Overall Study|Physician Decision|1|||
143261232|NCT02448680|516510503|FG000|Overall Study|Withdrawal by Subject|0|||
143261233|NCT02448680|516510504|FG001|Overall Study|Withdrawal by Subject|2|||
143261234|NCT01736657|516510505|FG000|Overall Study|insufficient vascular access|1|||
143261235|NCT03707184|516510514|FG000|Overall Study|Withdrawal by Subject|2|||
143261236|NCT05007717|516510515|FG000|Overall Study|Death|3|||
143261237|NCT05007717|516510516|FG001|Overall Study|Death|2|||
143261238|NCT03553836|516510517|FG000|Overall Study|Ongoing in Study|460|||
143261239|NCT03553836|516510518|FG001|Overall Study|Ongoing in Study|459|||
143261240|NCT03553836|516510517|FG000|Overall Study|Withdrawal by Subject|9|||
143261241|NCT03553836|516510518|FG001|Overall Study|Withdrawal by Subject|10|||
143261242|NCT03553836|516510517|FG000|Overall Study|Lost to Follow-up|1|||
143261243|NCT03553836|516510518|FG001|Overall Study|Lost to Follow-up|3|||
143261244|NCT03553836|516510517|FG000|Overall Study|Death|17|||
143261245|NCT03553836|516510518|FG001|Overall Study|Death|17|||
143261246|NCT04626310|516510520|FG000|Overall Study|4-miss from treatment|6|||
143261247|NCT04626310|516510521|FG001|Overall Study|4-miss from treatment|5|||
143261248|NCT04626310|516510522|FG002|Overall Study|4-miss from treatment|5|||
143261249|NCT04626310|516510520|FG000|Overall Study|Withdrawal by Subject|1|||
143261250|NCT04626310|516510521|FG001|Overall Study|Withdrawal by Subject|0|||
143261251|NCT04626310|516510522|FG002|Overall Study|Withdrawal by Subject|3|||
143261252|NCT02278341|516510523|FG000|Overall Study|Randomized but never received study drug|1|||
143261253|NCT02278341|516510524|FG001|Overall Study|Randomized but never received study drug|1|||
143261254|NCT02278341|516510523|FG000|Overall Study|Adverse Event|3|||
143261255|NCT02278341|516510524|FG001|Overall Study|Adverse Event|0|||
143261256|NCT02278341|516510523|FG000|Overall Study|Death|68|||
143261257|NCT02278341|516510524|FG001|Overall Study|Death|56|||
143261258|NCT02278341|516510523|FG000|Overall Study|Withdrawal by Subject|30|||
143369389|NCT01803646|516896086|FG000|Overall Study|Lost to Follow-up|5|||
143185672|NCT02789345|516225038|FG001|Overall Study|Adverse Event|0|||
143185673|NCT02789345|516225039|FG002|Overall Study|Adverse Event|1|||
143185674|NCT02789345|516225037|FG000|Overall Study|Death|0|||
143261259|NCT02278341|516510524|FG001|Overall Study|Withdrawal by Subject|19|||
143261260|NCT02278341|516510523|FG000|Overall Study|Lost to Follow-up|0|||
143261261|NCT02278341|516510524|FG001|Overall Study|Lost to Follow-up|1|||
143261262|NCT02278341|516510523|FG000|Overall Study|Physician Decision|1|||
143261263|NCT02278341|516510524|FG001|Overall Study|Physician Decision|1|||
143185675|NCT02789345|516225038|FG001|Overall Study|Death|0|||
143185676|NCT02789345|516225039|FG002|Overall Study|Death|1|||
143185677|NCT02789345|516225037|FG000|Overall Study|Physician Decision|2|||
143185678|NCT02789345|516225038|FG001|Overall Study|Physician Decision|0|||
143185679|NCT02789345|516225039|FG002|Overall Study|Physician Decision|1|||
143185680|NCT02789345|516225037|FG000|Overall Study|Progressive Disease|1|||
143185681|NCT02789345|516225038|FG001|Overall Study|Progressive Disease|3|||
143185682|NCT02789345|516225039|FG002|Overall Study|Progressive Disease|14|||
143185683|NCT00485758|516225054|FG000|Overall Study|Adverse Event|102|||
143185684|NCT00485758|516225055|FG001|Overall Study|Adverse Event|31|||
143185685|NCT00485758|516225054|FG000|Overall Study|Death|0|||
143185686|NCT00485758|516225055|FG001|Overall Study|Death|1|||
143185687|NCT00485758|516225054|FG000|Overall Study|Lost to Follow-up|5|||
143185688|NCT00485758|516225055|FG001|Overall Study|Lost to Follow-up|1|||
143185689|NCT00485758|516225054|FG000|Overall Study|Physician Decision|3|||
143185690|NCT00485758|516225055|FG001|Overall Study|Physician Decision|3|||
143185691|NCT00485758|516225054|FG000|Overall Study|Protocol Violation|11|||
143185692|NCT00485758|516225055|FG001|Overall Study|Protocol Violation|2|||
143185693|NCT00485758|516225054|FG000|Overall Study|Withdrawal by Subject|32|||
143185694|NCT00485758|516225055|FG001|Overall Study|Withdrawal by Subject|27|||
143185695|NCT00485758|516225054|FG000|Overall Study|Study Terminated by Sponsor|3|||
143185696|NCT00485758|516225055|FG001|Overall Study|Study Terminated by Sponsor|0|||
143185697|NCT04123093|516225056|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
143185698|NCT04123093|516225057|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
143185699|NCT04123093|516225056|FG000|Phase 2|Physician Decision|0|||
143185700|NCT04123093|516225057|FG001|Phase 2|Physician Decision|1|||
143185701|NCT04123093|516225056|FG000|Phase 2|Withdrawal by Subject|0|||
143185702|NCT04123093|516225057|FG001|Phase 2|Withdrawal by Subject|1|||
143185703|NCT04551963|516225058|FG000|Overall Study|Physician Decision|1|||
143185704|NCT04551963|516225059|FG001|Overall Study|Physician Decision|1|||
143185705|NCT04551963|516225058|FG000|Overall Study|Death|1|||
143185706|NCT04551963|516225059|FG001|Overall Study|Death|0|||
143185707|NCT03379259|516225060|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
143185708|NCT03379259|516225061|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
143185709|NCT03379259|516225062|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
143185710|NCT03379259|516225063|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
143185711|NCT03379259|516225064|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
143185712|NCT03379259|516225065|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
143185713|NCT03379259|516225060|FG000|Overall Study|Death|0|||
143185714|NCT03379259|516225061|FG001|Overall Study|Death|1|||
143185715|NCT03379259|516225062|FG002|Overall Study|Death|2|||
143185716|NCT03379259|516225063|FG003|Overall Study|Death|1|||
143185717|NCT03379259|516225064|FG004|Overall Study|Death|4|||
143185718|NCT03379259|516225065|FG005|Overall Study|Death|2|||
143185719|NCT03379259|516225060|FG000|Overall Study|Withdrawal by Subject|0|||
143185720|NCT03379259|516225061|FG001|Overall Study|Withdrawal by Subject|0|||
143185721|NCT03379259|516225062|FG002|Overall Study|Withdrawal by Subject|1|||
143185722|NCT03379259|516225063|FG003|Overall Study|Withdrawal by Subject|0|||
143185723|NCT03379259|516225064|FG004|Overall Study|Withdrawal by Subject|2|||
143185724|NCT03379259|516225065|FG005|Overall Study|Withdrawal by Subject|0|||
143185725|NCT03379259|516225060|FG000|Overall Study|Study terminated by sponsor|0|||
143185726|NCT03379259|516225061|FG001|Overall Study|Study terminated by sponsor|0|||
143185727|NCT03379259|516225062|FG002|Overall Study|Study terminated by sponsor|0|||
143185728|NCT03379259|516225063|FG003|Overall Study|Study terminated by sponsor|1|||
143185729|NCT03379259|516225064|FG004|Overall Study|Study terminated by sponsor|1|||
143185730|NCT03379259|516225065|FG005|Overall Study|Study terminated by sponsor|4|||
143185731|NCT03379259|516225060|FG000|Overall Study|Disease progression|0|||
143185732|NCT03379259|516225061|FG001|Overall Study|Disease progression|0|||
143185733|NCT03379259|516225062|FG002|Overall Study|Disease progression|0|||
143185734|NCT03379259|516225063|FG003|Overall Study|Disease progression|1|||
143185735|NCT03379259|516225064|FG004|Overall Study|Disease progression|0|||
143185736|NCT03379259|516225065|FG005|Overall Study|Disease progression|1|||
143185737|NCT03379259|516225060|FG000|Overall Study|Lost to Follow-up|0|||
143185738|NCT03379259|516225061|FG001|Overall Study|Lost to Follow-up|0|||
143185739|NCT03379259|516225062|FG002|Overall Study|Lost to Follow-up|0|||
143185740|NCT03379259|516225063|FG003|Overall Study|Lost to Follow-up|0|||
143261264|NCT02278341|516510523|FG000|Overall Study|Miscellaneous|15|||
143185741|NCT03379259|516225064|FG004|Overall Study|Lost to Follow-up|1|||
143185742|NCT03379259|516225065|FG005|Overall Study|Lost to Follow-up|0|||
143185743|NCT03379259|516225060|FG000|Overall Study|Deteriorating condition|0|||
143185744|NCT03379259|516225061|FG001|Overall Study|Deteriorating condition|0|||
143261265|NCT02278341|516510524|FG001|Overall Study|Miscellaneous|14|||
143185745|NCT03379259|516225062|FG002|Overall Study|Deteriorating condition|0|||
143185746|NCT03379259|516225063|FG003|Overall Study|Deteriorating condition|0|||
143261266|NCT04902326|516510525|FG000|Overall Study|Withdrawal by Subject|1|||
143185747|NCT03379259|516225064|FG004|Overall Study|Deteriorating condition|1|||
143185748|NCT03379259|516225065|FG005|Overall Study|Deteriorating condition|0|||
143185749|NCT00984165|516225066|FG000|Overall Study|Death on study|2|||
143369390|NCT01803646|516896087|FG001|Overall Study|Lost to Follow-up|1|||
143185750|NCT00984165|516225067|FG001|Overall Study|Death on study|0|||
143185751|NCT00984165|516225068|FG002|Overall Study|Death on study|0|||
143185752|NCT00984165|516225069|FG003|Overall Study|Death on study|0|||
143185753|NCT00984165|516225066|FG000|Overall Study|Disease progression on study|5|||
143185754|NCT00984165|516225067|FG001|Overall Study|Disease progression on study|1|||
143185755|NCT00984165|516225068|FG002|Overall Study|Disease progression on study|0|||
143185756|NCT00984165|516225069|FG003|Overall Study|Disease progression on study|0|||
143185757|NCT00984165|516225066|FG000|Overall Study|Death of recipient|0|||
143369391|NCT01693614|516896090|FG000|Overall Study|Adverse Event|7|||
143369392|NCT01693614|516896091|FG001|Overall Study|Adverse Event|11|||
143369393|NCT01693614|516896092|FG002|Overall Study|Adverse Event|5|||
143369394|NCT01693614|516896090|FG000|Overall Study|Disease progression|11|||
143369395|NCT01693614|516896091|FG001|Overall Study|Disease progression|8|||
143369396|NCT01693614|516896092|FG002|Overall Study|Disease progression|7|||
143369397|NCT01693614|516896090|FG000|Overall Study|Protocol Violation|5|||
143369398|NCT01693614|516896091|FG001|Overall Study|Protocol Violation|2|||
143185758|NCT00984165|516225067|FG001|Overall Study|Death of recipient|0|||
143185759|NCT00984165|516225068|FG002|Overall Study|Death of recipient|0|||
143185760|NCT00984165|516225069|FG003|Overall Study|Death of recipient|1|||
143185761|NCT00984165|516225066|FG000|Overall Study|New protocol|0|||
143185762|NCT00984165|516225067|FG001|Overall Study|New protocol|0|||
143185763|NCT00984165|516225068|FG002|Overall Study|New protocol|0|||
143185764|NCT00984165|516225069|FG003|Overall Study|New protocol|1|||
143185765|NCT00984165|516225066|FG000|Overall Study|P+/donor pair removed from protocol|0|||
143185766|NCT00984165|516225067|FG001|Overall Study|P+/donor pair removed from protocol|0|||
143185767|NCT00984165|516225068|FG002|Overall Study|P+/donor pair removed from protocol|0|||
143185768|NCT00984165|516225069|FG003|Overall Study|P+/donor pair removed from protocol|1|||
143185769|NCT00984165|516225066|FG000|Overall Study|removed with a pair recipient|0|||
143185770|NCT00984165|516225067|FG001|Overall Study|removed with a pair recipient|0|||
143185771|NCT00984165|516225068|FG002|Overall Study|removed with a pair recipient|0|||
143185772|NCT00984165|516225069|FG003|Overall Study|removed with a pair recipient|1|||
143185773|NCT00383331|516225071|FG000|Overall Study|Protocol Violation|0|||
143185774|NCT00383331|516225072|FG001|Overall Study|Protocol Violation|1|||
143185775|NCT03850093|516225076|FG000|Overall Study|Withdrawal by Subject|1|||
143185776|NCT03850093|516225077|FG001|Overall Study|Withdrawal by Subject|0|||
143185777|NCT03850093|516225078|FG002|Overall Study|Withdrawal by Subject|2|||
143185778|NCT02229825|516225080|FG000|Overall Study|Personal Reasons|0|||
143185779|NCT02229825|516225081|FG001|Overall Study|Personal Reasons|1|||
143185780|NCT02229825|516225080|FG000|Overall Study|Refused continuing medication|7|||
143185781|NCT02229825|516225081|FG001|Overall Study|Refused continuing medication|6|||
143185782|NCT02229825|516225080|FG000|Overall Study|Lost to Follow-up|1|||
143185783|NCT02229825|516225081|FG001|Overall Study|Lost to Follow-up|2|||
143185784|NCT02229825|516225080|FG000|Overall Study|Protocol Violation|1|||
143185785|NCT02229825|516225081|FG001|Overall Study|Protocol Violation|1|||
143185786|NCT02229825|516225080|FG000|Overall Study|Lack of Efficacy|4|||
143185787|NCT02229825|516225081|FG001|Overall Study|Lack of Efficacy|10|||
143185788|NCT02229825|516225080|FG000|Overall Study|Adverse Event|11|||
143185789|NCT02229825|516225081|FG001|Overall Study|Adverse Event|9|||
143185790|NCT02229825|516225080|FG000|Overall Study|Not treated|0|||
143185791|NCT02229825|516225081|FG001|Overall Study|Not treated|1|||
143185792|NCT03226249|516225086|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
143185793|NCT03226249|516225086|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
143185794|NCT03226249|516225086|FG000|Survival Follow-up|Patients still in follow-up.|30|||
143185795|NCT01532921|516225087|FG000|Overall Study|Death|3|||
143185796|NCT01532921|516225087|FG000|Overall Study|Withdrawal by Subject|2|||
143185797|NCT01532921|516225087|FG000|Overall Study|Lost to Follow-up|3|||
143185798|NCT01532921|516225087|FG000|Overall Study|Physician Decision|7|||
143185799|NCT01532921|516225087|FG000|Overall Study|Device was explanted during procedure|1|||
143369399|NCT01693614|516896092|FG002|Overall Study|Protocol Violation|1|||
143369400|NCT01693614|516896090|FG000|Overall Study|Death|1|||
143369401|NCT01693614|516896091|FG001|Overall Study|Death|0|||
143369402|NCT01693614|516896092|FG002|Overall Study|Death|0|||
143369403|NCT01693614|516896090|FG000|Overall Study|Physician Decision|1|||
143185800|NCT01804049|516225088|FG000|Overall Study|Adverse Event|2|||
143185801|NCT01804049|516225089|FG001|Overall Study|Adverse Event|10|||
143185802|NCT01804049|516225088|FG000|Overall Study|Lost to Follow-up|2|||
143185803|NCT01804049|516225089|FG001|Overall Study|Lost to Follow-up|1|||
143185804|NCT01804049|516225088|FG000|Overall Study|Decreased interest/personal|4|||
143185805|NCT01804049|516225089|FG001|Overall Study|Decreased interest/personal|5|||
143185806|NCT01804049|516225088|FG000|Overall Study|Other health concerns|2|||
143185807|NCT01804049|516225089|FG001|Overall Study|Other health concerns|7|||
143185808|NCT01804049|516225088|FG000|Overall Study|Moved out of area|0|||
143185809|NCT01804049|516225089|FG001|Overall Study|Moved out of area|7|||
143369404|NCT01693614|516896091|FG001|Overall Study|Physician Decision|1|||
143369405|NCT01693614|516896092|FG002|Overall Study|Physician Decision|4|||
143115476|NCT00483704|515963939|FG000|Randomization|Protocol Violation|14|||
143115477|NCT00483704|515963940|FG001|Randomization|Protocol Violation|25|||
143115478|NCT00483704|515963941|FG002|Randomization|Protocol Violation|22|||
143115479|NCT00483704|515963939|FG000|Randomization|Lost to Follow-up|14|||
143115480|NCT00483704|515963940|FG001|Randomization|Lost to Follow-up|14|||
143115481|NCT00483704|515963941|FG002|Randomization|Lost to Follow-up|19|||
143115482|NCT00483704|515963939|FG000|Randomization|Pregnancy|1|||
143115483|NCT00483704|515963940|FG001|Randomization|Pregnancy|0|||
143115484|NCT00483704|515963941|FG002|Randomization|Pregnancy|0|||
143115485|NCT00483704|515963939|FG000|Randomization|Physician Decision|2|||
143115486|NCT00483704|515963940|FG001|Randomization|Physician Decision|4|||
143115487|NCT00483704|515963941|FG002|Randomization|Physician Decision|0|||
143115488|NCT00483704|515963939|FG000|Randomization|Progressive disease|0|||
143115489|NCT00483704|515963940|FG001|Randomization|Progressive disease|0|||
143115490|NCT00483704|515963941|FG002|Randomization|Progressive disease|1|||
143115491|NCT00483704|515963939|FG000|Randomization|Lack of qualifying migraines|21|||
143115492|NCT00483704|515963940|FG001|Randomization|Lack of qualifying migraines|25|||
143115493|NCT00483704|515963941|FG002|Randomization|Lack of qualifying migraines|31|||
143115494|NCT00483704|515963939|FG000|Treatment|Lack of qualifying migraines|101|||
143115495|NCT00483704|515963940|FG001|Treatment|Lack of qualifying migraines|99|||
143115496|NCT00483704|515963941|FG002|Treatment|Lack of qualifying migraines|116|||
143115497|NCT00483704|515963939|FG000|Treatment|Adverse Event|3|||
143115498|NCT00483704|515963940|FG001|Treatment|Adverse Event|5|||
143115499|NCT00483704|515963941|FG002|Treatment|Adverse Event|4|||
143115500|NCT00483704|515963939|FG000|Treatment|Withdrawal by Subject|16|||
143115501|NCT00483704|515963940|FG001|Treatment|Withdrawal by Subject|12|||
143115502|NCT00483704|515963941|FG002|Treatment|Withdrawal by Subject|21|||
143115503|NCT00483704|515963939|FG000|Treatment|Protocol Violation|6|||
143115504|NCT00483704|515963940|FG001|Treatment|Protocol Violation|3|||
143115505|NCT00483704|515963941|FG002|Treatment|Protocol Violation|5|||
143115506|NCT00483704|515963939|FG000|Treatment|Lost to Follow-up|2|||
143115507|NCT00483704|515963940|FG001|Treatment|Lost to Follow-up|7|||
143115508|NCT00483704|515963941|FG002|Treatment|Lost to Follow-up|5|||
143115509|NCT00483704|515963939|FG000|Treatment|Lack of Efficacy|1|||
143115510|NCT00483704|515963940|FG001|Treatment|Lack of Efficacy|1|||
143115511|NCT00483704|515963941|FG002|Treatment|Lack of Efficacy|1|||
143115512|NCT00483704|515963939|FG000|Treatment|Pregnancy|0|||
143115513|NCT00483704|515963940|FG001|Treatment|Pregnancy|1|||
143115514|NCT00483704|515963941|FG002|Treatment|Pregnancy|0|||
143115515|NCT00483704|515963939|FG000|Treatment|Physician Decision|0|||
143261267|NCT04902326|516510526|FG001|Overall Study|Withdrawal by Subject|3|||
143261268|NCT04902326|516510527|FG002|Overall Study|Withdrawal by Subject|0|||
143261269|NCT04902326|516510528|FG003|Overall Study|Withdrawal by Subject|1|||
143261270|NCT04902326|516510525|FG000|Overall Study|Lost to Follow-up|14|||
143261271|NCT04902326|516510526|FG001|Overall Study|Lost to Follow-up|14|||
143261272|NCT04902326|516510527|FG002|Overall Study|Lost to Follow-up|14|||
143261273|NCT04902326|516510528|FG003|Overall Study|Lost to Follow-up|6|||
143261274|NCT02604017|516510530|FG000|Overall Study|Withdrew Consent|0|||
143261275|NCT02604017|516510531|FG001|Overall Study|Withdrew Consent|2|||
143261276|NCT02604017|516510530|FG000|Overall Study|Lost to Follow-up|5|||
143115516|NCT00483704|515963940|FG001|Treatment|Physician Decision|1|||
143115517|NCT00483704|515963941|FG002|Treatment|Physician Decision|4|||
143115518|NCT01634659|515963944|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
143115519|NCT01634659|515963945|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
143115520|NCT01634659|515963944|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
143115521|NCT01634659|515963945|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
143115522|NCT03627416|515963946|FG000|Overall Study|Adverse Event|0|||
143115523|NCT03627416|515963947|FG001|Overall Study|Adverse Event|1|||
143115524|NCT02968433|515963948|FG000|Overall Study|Withdrawal by Subject|1|||
143115525|NCT01294371|515963949|FG000|Overall Study|Adverse Event|1|||
143115526|NCT01294371|515963949|FG000|Overall Study|Withdrawal by Subject|12|||
143115527|NCT01294371|515963949|FG000|Overall Study|Lost to Follow-up|6|||
143115528|NCT01294371|515963949|FG000|Overall Study|Administrative Reason|1|||
143115529|NCT01294371|515963949|FG000|Overall Study|Other|14|||
143115530|NCT00875433|515963950|FG000|Overall Study|Progressive disease|41|||
143115531|NCT00875433|515963950|FG000|Overall Study|Other Adverse Event|14|||
143115532|NCT00875433|515963950|FG000|Overall Study|Withdrawal by Subject|2|||
143115533|NCT00875433|515963950|FG000|Overall Study|Other|3|||
143115534|NCT04272606|515963951|FG000|Overall Study|Protocol Violation|1|||
143115535|NCT04272606|515963952|FG001|Overall Study|Protocol Violation|1|||
143115536|NCT04272606|515963951|FG000|Overall Study|Physician Decision|0|||
143115537|NCT04272606|515963952|FG001|Overall Study|Physician Decision|1|||
143261277|NCT02604017|516510531|FG001|Overall Study|Lost to Follow-up|6|||
143261278|NCT02604017|516510530|FG000|Overall Study|Other|1|||
143261279|NCT02604017|516510531|FG001|Overall Study|Other|0|||
143261280|NCT01041495|516510532|FG000|Overall Study|Withdrawal by Subject|2|||
143261281|NCT01041495|516510533|FG001|Overall Study|Withdrawal by Subject|5|||
143261282|NCT01041495|516510532|FG000|Overall Study|Adverse Event|2|||
143115538|NCT00725101|515963953|FG000|Overall Study|Death|3|||
143115539|NCT00725101|515963953|FG000|Overall Study|Lost to Follow-up|353|||
143185810|NCT01804049|516225088|FG000|Overall Study|other MD recommended|1|||
143185811|NCT01804049|516225089|FG001|Overall Study|other MD recommended|1|||
143185812|NCT01804049|516225088|FG000|Overall Study|Enrollment in dual studies|0|||
143185813|NCT01804049|516225089|FG001|Overall Study|Enrollment in dual studies|1|||
143185814|NCT05420961|516225107|FG000|Overall Study|Withdrawal by Subject|2|||
143185815|NCT05420961|516225108|FG001|Overall Study|Withdrawal by Subject|1|||
143185816|NCT05420961|516225109|FG002|Overall Study|Withdrawal by Subject|1|||
143185817|NCT05420961|516225110|FG003|Overall Study|Withdrawal by Subject|0|||
143185818|NCT05420961|516225111|FG004|Overall Study|Withdrawal by Subject|0|||
143185819|NCT05420961|516225107|FG000|Overall Study|Lost to Follow-up|0|||
143185820|NCT05420961|516225108|FG001|Overall Study|Lost to Follow-up|0|||
143185821|NCT05420961|516225109|FG002|Overall Study|Lost to Follow-up|1|||
143185822|NCT05420961|516225110|FG003|Overall Study|Lost to Follow-up|0|||
143185823|NCT05420961|516225111|FG004|Overall Study|Lost to Follow-up|0|||
143185824|NCT05420961|516225107|FG000|Overall Study|Randomized by mistake without study treatment|0|||
143115540|NCT00725101|515963953|FG000|Overall Study|Protocol Violation|1|||
143115541|NCT00725101|515963953|FG000|Overall Study|Withdrawal by Subject|127|||
143115542|NCT00725101|515963953|FG000|Overall Study|not specified/no reason given|11|||
143115543|NCT00819780|515963954|FG000|Overall Study|Did not receive study drug|3|||
143115544|NCT00819780|515963955|FG001|Overall Study|Did not receive study drug|4|||
143115545|NCT00819780|515963954|FG000|Overall Study|Still in treatment|25|||
143115546|NCT00819780|515963955|FG001|Overall Study|Still in treatment|17|||
143115547|NCT03619902|515963956|FG000|Overall Study|Termination of Study by Investigator|1|||
143115548|NCT03619902|515963956|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
143115549|NCT02923245|515963957|FG000|Overall Study|ultrasound order was cancelled|2|||
143115550|NCT02923245|515963958|FG001|Overall Study|ultrasound order was cancelled|1|||
143115551|NCT03191864|515963961|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
143115552|NCT03191864|515963962|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
143115553|NCT03191864|515963963|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
143115554|NCT03191864|515963964|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
143115555|NCT03191864|515963965|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
143115556|NCT03191864|515963966|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
143115557|NCT03191864|515963961|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
143115558|NCT03191864|515963962|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
143115559|NCT03191864|515963963|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
143115560|NCT03191864|515963964|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
143115561|NCT03191864|515963965|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
143115562|NCT03191864|515963966|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
143115563|NCT03191864|515963961|FG000|Baseline Symptom Assessment|Adverse Event|0|||
143115564|NCT03191864|515963962|FG001|Baseline Symptom Assessment|Adverse Event|0|||
143115565|NCT03191864|515963963|FG002|Baseline Symptom Assessment|Adverse Event|0|||
143115566|NCT03191864|515963964|FG003|Baseline Symptom Assessment|Adverse Event|0|||
143115567|NCT03191864|515963965|FG004|Baseline Symptom Assessment|Adverse Event|0|||
143115568|NCT03191864|515963966|FG005|Baseline Symptom Assessment|Adverse Event|2|||
143115569|NCT03191864|515963961|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
143115570|NCT03191864|515963962|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
143115571|NCT03191864|515963963|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
143115572|NCT03191864|515963964|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
143115573|NCT03191864|515963965|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
143115574|NCT03191864|515963966|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
143115575|NCT03191864|515963961|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
143115576|NCT03191864|515963962|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
143115577|NCT03191864|515963963|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
143115578|NCT03191864|515963964|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
143115579|NCT03191864|515963965|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
143115580|NCT03191864|515963966|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
143115581|NCT03191864|515963961|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
143115582|NCT03191864|515963962|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
143115583|NCT03191864|515963963|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
143115584|NCT03191864|515963964|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
143115585|NCT03191864|515963965|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
143185825|NCT05420961|516225108|FG001|Overall Study|Randomized by mistake without study treatment|0|||
143185826|NCT05420961|516225109|FG002|Overall Study|Randomized by mistake without study treatment|1|||
143261283|NCT01041495|516510533|FG001|Overall Study|Adverse Event|1|||
143185827|NCT05420961|516225110|FG003|Overall Study|Randomized by mistake without study treatment|0|||
143185828|NCT05420961|516225111|FG004|Overall Study|Randomized by mistake without study treatment|1|||
143185829|NCT00771927|516225118|FG000|Overall Study|Adverse Event|100|||
143185830|NCT00771927|516225119|FG001|Overall Study|Adverse Event|105|||
143185831|NCT00771927|516225118|FG000|Overall Study|Lack of Efficacy|70|||
143185832|NCT00771927|516225119|FG001|Overall Study|Lack of Efficacy|42|||
143185833|NCT00771927|516225118|FG000|Overall Study|Lost to Follow-up|46|||
143185834|NCT00771927|516225119|FG001|Overall Study|Lost to Follow-up|46|||
143185835|NCT00771927|516225118|FG000|Overall Study|Withdrawal by Subject|16|||
143185836|NCT00771927|516225119|FG001|Overall Study|Withdrawal by Subject|17|||
143185837|NCT00771927|516225118|FG000|Overall Study|Other reason|23|||
143185838|NCT00771927|516225119|FG001|Overall Study|Other reason|27|||
143185839|NCT00255723|516225121|FG000|Overall Study|Adverse Event|1|||
143185840|NCT00255723|516225122|FG001|Overall Study|Adverse Event|1|||
143185841|NCT00255723|516225121|FG000|Overall Study|Death|0|||
143185842|NCT00255723|516225122|FG001|Overall Study|Death|1|||
143185843|NCT00255723|516225121|FG000|Overall Study|Response Data Not Available|1|||
143185844|NCT00255723|516225122|FG001|Overall Study|Response Data Not Available|0|||
143185845|NCT03711370|516225124|FG000|Overall Study|Lost to Follow-up|16|||
143185846|NCT03711370|516225125|FG001|Overall Study|Lost to Follow-up|10|||
143185847|NCT03711370|516225124|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
143185848|NCT03711370|516225125|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
143185849|NCT02063984|516225126|FG000|Overall Study|Lost to Follow-up|6|||
143185850|NCT02063984|516225127|FG001|Overall Study|Lost to Follow-up|5|||
143185851|NCT01169701|516225128|FG000|Overall Study|Lost to Follow-up|1|||
143185852|NCT01169701|516225129|FG001|Overall Study|Lost to Follow-up|1|||
143185853|NCT01169701|516225128|FG000|Overall Study|Withdrawal by Subject|1|||
143185854|NCT01169701|516225129|FG001|Overall Study|Withdrawal by Subject|3|||
143185855|NCT01169701|516225128|FG000|Overall Study|Adverse Event|1|||
143185856|NCT01169701|516225129|FG001|Overall Study|Adverse Event|2|||
143185857|NCT01169701|516225128|FG000|Overall Study|Exclusion criteria|2|||
143185858|NCT01169701|516225129|FG001|Overall Study|Exclusion criteria|0|||
143185859|NCT01169701|516225128|FG000|Overall Study|Death|0|||
143185860|NCT01169701|516225129|FG001|Overall Study|Death|1|||
143185861|NCT01169701|516225128|FG000|Overall Study|Administrative problems|0|||
143185862|NCT01169701|516225129|FG001|Overall Study|Administrative problems|1|||
143185863|NCT01169701|516225128|FG000|Overall Study|Serious adverse event|0|||
143185864|NCT01169701|516225129|FG001|Overall Study|Serious adverse event|1|||
143185865|NCT01169701|516225128|FG000|Overall Study|Sponsor decision|0|||
143185866|NCT01169701|516225129|FG001|Overall Study|Sponsor decision|1|||
143185867|NCT01536561|516225130|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
143185868|NCT01536561|516225130|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
143185869|NCT01536561|516225130|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
143185870|NCT01536561|516225130|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
143185871|NCT01536561|516225130|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
143185872|NCT01536561|516225130|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
143185873|NCT00553436|516225131|FG000|Overall Study|Conversion to another procedure|1|||
143185874|NCT04188834|516225132|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
143185875|NCT01030952|516225133|FG000|Overall Study|Protocol Violation|0|||
143185876|NCT01030952|516225134|FG001|Overall Study|Protocol Violation|1|||
143185877|NCT01030952|516225133|FG000|Overall Study|Informed consent withdrawal|1|||
143185878|NCT01030952|516225134|FG001|Overall Study|Informed consent withdrawal|0|||
143185879|NCT01030952|516225133|FG000|Overall Study|Lost to Follow-up|0|||
143185880|NCT01030952|516225134|FG001|Overall Study|Lost to Follow-up|1|||
143185881|NCT01030952|516225133|FG000|Overall Study|Unexplained|1|||
143185882|NCT01030952|516225134|FG001|Overall Study|Unexplained|1|||
143185883|NCT00958347|516225138|FG000|Overall Study|Death|43|||
143185884|NCT00958347|516225138|FG000|Overall Study|Withdrawal by Subject|23|||
143185885|NCT00958347|516225138|FG000|Overall Study|Lost to Follow-up|15|||
143185886|NCT00958347|516225138|FG000|Overall Study|revision/removal|10|||
143185887|NCT00958347|516225138|FG000|Overall Study|study termination|135|||
143185888|NCT04532294|516225139|FG000|Overall Study|Withdrawal by Subject|0|||
143185889|NCT04532294|516225140|FG001|Overall Study|Withdrawal by Subject|0|||
143185890|NCT04532294|516225141|FG002|Overall Study|Withdrawal by Subject|1|||
143185891|NCT04532294|516225139|FG000|Overall Study|Participants Not Dosed|0|||
143185892|NCT04532294|516225140|FG001|Overall Study|Participants Not Dosed|0|||
143185893|NCT04532294|516225141|FG002|Overall Study|Participants Not Dosed|2|||
143185894|NCT00375505|516225142|FG000|Overall Study|Adverse Event|1|||
143185895|NCT00375505|516225143|FG001|Overall Study|Adverse Event|2|||
143185896|NCT00429182|516225146|FG000|Overall Study|Not evaluable, Disease Progression|2|||
143185897|NCT00429182|516225146|FG000|Overall Study|Not eligible|5|||
143185898|NCT03292640|516225148|FG000|Overall Study|Withdrawal by Subject|17|||
143185899|NCT03292640|516225149|FG001|Overall Study|Withdrawal by Subject|16|||
143185900|NCT03292640|516225148|FG000|Overall Study|Adverse Event|20|||
143185901|NCT03292640|516225149|FG001|Overall Study|Adverse Event|2|||
143185902|NCT03292640|516225148|FG000|Overall Study|Lost to Follow-up|24|||
143185903|NCT03292640|516225149|FG001|Overall Study|Lost to Follow-up|24|||
143185904|NCT05111002|516225150|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
143185905|NCT05111002|516225151|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
143185906|NCT05111002|516225150|FG000|Secondary Outcome|Lost to Follow-up|1|||
143185907|NCT05111002|516225151|FG001|Secondary Outcome|Lost to Follow-up|0|||
143185908|NCT04380753|516225152|FG000|Overall Study|Participants continuing study|4|||
143185909|NCT04380753|516225152|FG000|Overall Study|Death|2|||
143185910|NCT02712996|516225156|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
143185911|NCT02712996|516225157|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
143185912|NCT00972517|516225161|FG000|Overall Study|Adverse Event|0|||
143185913|NCT00972517|516225162|FG001|Overall Study|Adverse Event|0|||
143185914|NCT00972517|516225163|FG002|Overall Study|Adverse Event|0|||
143185915|NCT00972517|516225164|FG003|Overall Study|Adverse Event|1|||
143185916|NCT00972517|516225165|FG004|Overall Study|Adverse Event|0|||
143185917|NCT00972517|516225166|FG005|Overall Study|Adverse Event|0|||
143185918|NCT00972517|516225161|FG000|Overall Study|Withdrawal by Subject|0|||
143185919|NCT00972517|516225162|FG001|Overall Study|Withdrawal by Subject|1|||
143185920|NCT00972517|516225163|FG002|Overall Study|Withdrawal by Subject|0|||
143185921|NCT00972517|516225164|FG003|Overall Study|Withdrawal by Subject|2|||
143185922|NCT00972517|516225165|FG004|Overall Study|Withdrawal by Subject|1|||
143185923|NCT00972517|516225166|FG005|Overall Study|Withdrawal by Subject|0|||
143185924|NCT03306433|516225169|FG000|Overall Study|Lost to Follow-up|3|||
143185925|NCT03306433|516225169|FG000|Overall Study|Patient did not have teeth extracted|1|||
143185926|NCT03306433|516225169|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
143185927|NCT00819156|516225170|FG000|Overall Study|Adverse Event|1|||
143185928|NCT00819156|516225171|FG001|Overall Study|Adverse Event|4|||
143185929|NCT00819156|516225172|FG002|Overall Study|Adverse Event|2|||
143185930|NCT00819156|516225173|FG003|Overall Study|Adverse Event|1|||
143185931|NCT00819156|516225174|FG004|Overall Study|Adverse Event|2|||
143185932|NCT00819156|516225175|FG005|Overall Study|Adverse Event|3|||
143185933|NCT00819156|516225170|FG000|Overall Study|Withdrawal by Subject|0|||
143185934|NCT00819156|516225171|FG001|Overall Study|Withdrawal by Subject|3|||
143185935|NCT00819156|516225172|FG002|Overall Study|Withdrawal by Subject|2|||
143185936|NCT00819156|516225173|FG003|Overall Study|Withdrawal by Subject|0|||
143185937|NCT00819156|516225174|FG004|Overall Study|Withdrawal by Subject|1|||
143185938|NCT00819156|516225175|FG005|Overall Study|Withdrawal by Subject|0|||
143185939|NCT00819156|516225170|FG000|Overall Study|Protocol Violation|1|||
143185940|NCT00819156|516225171|FG001|Overall Study|Protocol Violation|0|||
143185941|NCT00819156|516225172|FG002|Overall Study|Protocol Violation|1|||
143185942|NCT00819156|516225173|FG003|Overall Study|Protocol Violation|0|||
143185943|NCT00819156|516225174|FG004|Overall Study|Protocol Violation|0|||
143185944|NCT00819156|516225175|FG005|Overall Study|Protocol Violation|1|||
143185945|NCT00819156|516225170|FG000|Overall Study|Lost to Follow-up|0|||
143185946|NCT00819156|516225171|FG001|Overall Study|Lost to Follow-up|1|||
143185947|NCT00819156|516225172|FG002|Overall Study|Lost to Follow-up|0|||
143185948|NCT00819156|516225173|FG003|Overall Study|Lost to Follow-up|0|||
143185949|NCT00819156|516225174|FG004|Overall Study|Lost to Follow-up|0|||
143185950|NCT00819156|516225175|FG005|Overall Study|Lost to Follow-up|2|||
143185951|NCT00819156|516225170|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
143185952|NCT00819156|516225171|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
143185953|NCT00819156|516225172|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
143185954|NCT00819156|516225173|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
143185955|NCT00819156|516225174|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
143185956|NCT00819156|516225175|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
143185957|NCT00819156|516225170|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
143185958|NCT00819156|516225171|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
143185959|NCT00819156|516225172|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
143185960|NCT00819156|516225173|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
143185961|NCT00819156|516225174|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
143185962|NCT00819156|516225175|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
143185963|NCT00819156|516225170|FG000|Overall Study|Prostate-specific antigen progression|0|||
143185964|NCT00819156|516225171|FG001|Overall Study|Prostate-specific antigen progression|0|||
143185965|NCT00819156|516225172|FG002|Overall Study|Prostate-specific antigen progression|0|||
143185966|NCT00819156|516225173|FG003|Overall Study|Prostate-specific antigen progression|0|||
143185967|NCT00819156|516225174|FG004|Overall Study|Prostate-specific antigen progression|1|||
143185968|NCT00819156|516225175|FG005|Overall Study|Prostate-specific antigen progression|0|||
143185969|NCT02931838|516225176|FG000|Overall Study|Reason not provided by investigator|1|||
143185970|NCT02931838|516225177|FG001|Overall Study|Reason not provided by investigator|0|||
143185971|NCT02931838|516225178|FG002|Overall Study|Reason not provided by investigator|1|||
143115586|NCT03191864|515963966|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
143115587|NCT03191864|515963961|FG000|Part 1 - Induction|Adverse Event|0|||
143261284|NCT01041495|516510532|FG000|Overall Study|Lost to Follow-up|0|||
143261285|NCT01041495|516510533|FG001|Overall Study|Lost to Follow-up|1|||
143261286|NCT01117051|516510534|FG000|Overall Study|Withdrawal by Subject|5|||
143261287|NCT01117051|516510535|FG001|Overall Study|Withdrawal by Subject|3|||
143261288|NCT01117051|516510534|FG000|Overall Study|Adverse Event|4|||
143261289|NCT01117051|516510535|FG001|Overall Study|Adverse Event|3|||
143261290|NCT01117051|516510534|FG000|Overall Study|Lost to Follow-up|0|||
143261291|NCT01117051|516510535|FG001|Overall Study|Lost to Follow-up|1|||
143261292|NCT01117051|516510534|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
143261293|NCT01117051|516510535|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
143261294|NCT01117051|516510534|FG000|Overall Study|Sponsor's decision|3|||
143115588|NCT03191864|515963962|FG001|Part 1 - Induction|Adverse Event|2|||
143115589|NCT03191864|515963963|FG002|Part 1 - Induction|Adverse Event|0|||
143115590|NCT03191864|515963964|FG003|Part 1 - Induction|Adverse Event|1|||
143115591|NCT03191864|515963965|FG004|Part 1 - Induction|Adverse Event|0|||
143185972|NCT02931838|516225179|FG003|Overall Study|Reason not provided by investigator|0|||
143185973|NCT02931838|516225180|FG004|Overall Study|Reason not provided by investigator|0|||
143185974|NCT02931838|516225181|FG005|Overall Study|Reason not provided by investigator|0|||
143185975|NCT02931838|516225176|FG000|Overall Study|Poor/non-compliance|0|||
143185976|NCT02931838|516225177|FG001|Overall Study|Poor/non-compliance|0|||
143185977|NCT02931838|516225178|FG002|Overall Study|Poor/non-compliance|1|||
143185978|NCT02931838|516225179|FG003|Overall Study|Poor/non-compliance|0|||
143185979|NCT02931838|516225180|FG004|Overall Study|Poor/non-compliance|0|||
143185980|NCT02931838|516225181|FG005|Overall Study|Poor/non-compliance|0|||
143185981|NCT02931838|516225176|FG000|Overall Study|Lack of Efficacy|5|||
143185982|NCT02931838|516225177|FG001|Overall Study|Lack of Efficacy|4|||
143185983|NCT02931838|516225178|FG002|Overall Study|Lack of Efficacy|0|||
143185984|NCT02931838|516225179|FG003|Overall Study|Lack of Efficacy|0|||
143185985|NCT02931838|516225180|FG004|Overall Study|Lack of Efficacy|0|||
143185986|NCT02931838|516225181|FG005|Overall Study|Lack of Efficacy|1|||
143185987|NCT02931838|516225176|FG000|Overall Study|Lost to Follow-up|1|||
143185988|NCT02931838|516225177|FG001|Overall Study|Lost to Follow-up|0|||
143185989|NCT02931838|516225178|FG002|Overall Study|Lost to Follow-up|1|||
143185990|NCT02931838|516225179|FG003|Overall Study|Lost to Follow-up|1|||
143185991|NCT02931838|516225180|FG004|Overall Study|Lost to Follow-up|2|||
143185992|NCT02931838|516225181|FG005|Overall Study|Lost to Follow-up|0|||
143185993|NCT02931838|516225176|FG000|Overall Study|Subject request to discontinue treatment|4|||
143185994|NCT02931838|516225177|FG001|Overall Study|Subject request to discontinue treatment|3|||
143185995|NCT02931838|516225178|FG002|Overall Study|Subject request to discontinue treatment|3|||
143185996|NCT02931838|516225179|FG003|Overall Study|Subject request to discontinue treatment|0|||
143185997|NCT02931838|516225180|FG004|Overall Study|Subject request to discontinue treatment|1|||
143185998|NCT02931838|516225181|FG005|Overall Study|Subject request to discontinue treatment|0|||
143185999|NCT02931838|516225176|FG000|Overall Study|Withdrawal by Subject|1|||
143186000|NCT02931838|516225177|FG001|Overall Study|Withdrawal by Subject|2|||
143186001|NCT02931838|516225178|FG002|Overall Study|Withdrawal by Subject|0|||
143186002|NCT02931838|516225179|FG003|Overall Study|Withdrawal by Subject|1|||
143186003|NCT02931838|516225180|FG004|Overall Study|Withdrawal by Subject|0|||
143186004|NCT02931838|516225181|FG005|Overall Study|Withdrawal by Subject|0|||
143186005|NCT02931838|516225176|FG000|Overall Study|Adverse Event|2|||
143186006|NCT02931838|516225177|FG001|Overall Study|Adverse Event|1|||
143186007|NCT02931838|516225178|FG002|Overall Study|Adverse Event|2|||
143186008|NCT02931838|516225179|FG003|Overall Study|Adverse Event|1|||
143186009|NCT02931838|516225180|FG004|Overall Study|Adverse Event|3|||
143186010|NCT02931838|516225181|FG005|Overall Study|Adverse Event|1|||
143186011|NCT00104728|516225182|FG000|Overall Study|screen failures|19|||
143186012|NCT02709577|516225183|FG000|Overall Study|non-accommodating anatomy|0|||
143186013|NCT02709577|516225184|FG001|Overall Study|non-accommodating anatomy|1|||
143115592|NCT03191864|515963966|FG005|Part 1 - Induction|Adverse Event|2|||
143115593|NCT03191864|515963961|FG000|Part 1 - Induction|Randomized but never dosed|0|||
143186014|NCT02709577|516225185|FG002|Overall Study|non-accommodating anatomy|0|||
143186015|NCT02709577|516225186|FG003|Overall Study|non-accommodating anatomy|0|||
143186016|NCT02709577|516225183|FG000|Overall Study|procedural complication|0|||
143186017|NCT02709577|516225184|FG001|Overall Study|procedural complication|1|||
143186018|NCT02709577|516225185|FG002|Overall Study|procedural complication|0|||
143186019|NCT02709577|516225186|FG003|Overall Study|procedural complication|0|||
143186020|NCT02709577|516225183|FG000|Overall Study|Withdrawal by Subject|2|||
143186021|NCT02709577|516225184|FG001|Overall Study|Withdrawal by Subject|3|||
143186022|NCT02709577|516225185|FG002|Overall Study|Withdrawal by Subject|2|||
143261295|NCT01117051|516510535|FG001|Overall Study|Sponsor's decision|1|||
143261296|NCT01117051|516510534|FG000|Overall Study|Surgical procedure|0|||
143261297|NCT01117051|516510535|FG001|Overall Study|Surgical procedure|1|||
143261298|NCT01117051|516510534|FG000|Overall Study|Randomized by mistake|0|||
143261299|NCT01117051|516510535|FG001|Overall Study|Randomized by mistake|1|||
143261300|NCT01117051|516510534|FG000|Overall Study|Convenience issue|1|||
143261301|NCT01117051|516510535|FG001|Overall Study|Convenience issue|0|||
143261302|NCT03780400|516510539|FG000|Overall Study|Lost to Follow-up|5|||
143261303|NCT03780400|516510539|FG000|Overall Study|Withdrawal by Subject|2|||
143261304|NCT01479985|516510540|FG000|Overall Study|Tablet malfunction, no data saved|1|||
143261305|NCT01479985|516510541|FG001|Overall Study|Tablet malfunction, no data saved|1|||
143261306|NCT01479985|516510540|FG000|Overall Study|No decisional conflict scale responses|0|||
143261307|NCT01479985|516510541|FG001|Overall Study|No decisional conflict scale responses|2|||
143261308|NCT01479985|516510540|FG000|Overall Study|No post-visit survey|5|||
143261309|NCT01479985|516510541|FG001|Overall Study|No post-visit survey|3|||
143261310|NCT01653782|516510542|FG000|Overall Study|Withdrawal by Subject|9|||
143261311|NCT01653782|516510543|FG001|Overall Study|Withdrawal by Subject|15|||
143261312|NCT01653782|516510544|FG002|Overall Study|Withdrawal by Subject|4|||
143261313|NCT01653782|516510542|FG000|Overall Study|Lost to Follow-up|7|||
143261314|NCT01653782|516510543|FG001|Overall Study|Lost to Follow-up|3|||
143261315|NCT01653782|516510544|FG002|Overall Study|Lost to Follow-up|2|||
143261316|NCT01850602|516510550|FG000|Overall Study|Adverse Event|7|||
143261317|NCT01850602|516510551|FG001|Overall Study|Adverse Event|10|||
143261318|NCT01850602|516510550|FG000|Overall Study|Physician Decision|2|||
143261319|NCT01850602|516510551|FG001|Overall Study|Physician Decision|1|||
143261320|NCT01850602|516510550|FG000|Overall Study|Withdrawal by Subject|2|||
143261321|NCT01850602|516510551|FG001|Overall Study|Withdrawal by Subject|4|||
143115594|NCT03191864|515963962|FG001|Part 1 - Induction|Randomized but never dosed|0|||
143115595|NCT03191864|515963963|FG002|Part 1 - Induction|Randomized but never dosed|1|||
143115596|NCT03191864|515963964|FG003|Part 1 - Induction|Randomized but never dosed|0|||
143115597|NCT03191864|515963965|FG004|Part 1 - Induction|Randomized but never dosed|0|||
143115598|NCT03191864|515963966|FG005|Part 1 - Induction|Randomized but never dosed|0|||
143115599|NCT03191864|515963961|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
143115600|NCT03191864|515963962|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
143115601|NCT03191864|515963963|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
143115602|NCT03191864|515963964|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
143115603|NCT03191864|515963965|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
143115604|NCT03191864|515963966|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
143115605|NCT03191864|515963961|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
143115606|NCT03191864|515963962|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
143115607|NCT03191864|515963963|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
143115608|NCT03191864|515963964|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
143115609|NCT03191864|515963965|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
143115610|NCT03191864|515963966|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
143115611|NCT03191864|515963961|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
143115612|NCT03191864|515963962|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
143115613|NCT03191864|515963963|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
143115614|NCT03191864|515963964|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
143115615|NCT03191864|515963965|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
143115616|NCT03191864|515963966|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
143115617|NCT03191864|515963961|FG000|Part 2 - Maintenance|Physician Decision|1|||
143115618|NCT03191864|515963962|FG001|Part 2 - Maintenance|Physician Decision|0|||
143115619|NCT03191864|515963963|FG002|Part 2 - Maintenance|Physician Decision|0|||
143115620|NCT03191864|515963964|FG003|Part 2 - Maintenance|Physician Decision|0|||
143115621|NCT03191864|515963965|FG004|Part 2 - Maintenance|Physician Decision|0|||
143115622|NCT03191864|515963966|FG005|Part 2 - Maintenance|Physician Decision|0|||
143115623|NCT03191864|515963961|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
143115624|NCT03191864|515963962|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
143115625|NCT03191864|515963963|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
143115626|NCT03191864|515963964|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
143115627|NCT03191864|515963965|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
143115628|NCT03191864|515963966|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
143115629|NCT03191864|515963961|FG000|Part 2 - Maintenance|Adverse Event|0|||
143115630|NCT03191864|515963962|FG001|Part 2 - Maintenance|Adverse Event|0|||
143261322|NCT01850602|516510550|FG000|Overall Study|Decrease in serum calcium|2|||
143261323|NCT01850602|516510551|FG001|Overall Study|Decrease in serum calcium|3|||
143261324|NCT01850602|516510550|FG000|Overall Study|Increase in serum ferritin|1|||
143261325|NCT01850602|516510551|FG001|Overall Study|Increase in serum ferritin|0|||
143261326|NCT00367770|516510552|FG000|Overall Study|Adverse Event|1|||
143261327|NCT00367770|516510552|FG000|Overall Study|Withdrawal by Subject|1|||
143261328|NCT00287079|516510553|FG000|Overall Study|Qualifying relapse|12|||
143261329|NCT00287079|516510554|FG001|Overall Study|Qualifying relapse|1|||
143261330|NCT00287079|516510553|FG000|Overall Study|Non-qualifying relapse|1|||
143261331|NCT00287079|516510554|FG001|Overall Study|Non-qualifying relapse|0|||
143261332|NCT00287079|516510553|FG000|Overall Study|Adverse Event|5|||
143261333|NCT00287079|516510554|FG001|Overall Study|Adverse Event|0|||
143186023|NCT02709577|516225186|FG003|Overall Study|Withdrawal by Subject|0|||
143186024|NCT00064259|516226845|FG000|Overall Study|Adverse Event|1|||
143186025|NCT00064259|516226846|FG001|Overall Study|Adverse Event|0|||
143186026|NCT00064259|516226847|FG002|Overall Study|Adverse Event|0|||
143186027|NCT00064259|516226848|FG003|Overall Study|Adverse Event|1|||
143186028|NCT01132651|516226851|FG000|Overall Study|Lost to Follow-up|1|||
143186029|NCT01132651|516226852|FG001|Overall Study|Lost to Follow-up|1|||
143186030|NCT00948857|516226853|FG000|Overall Study|Lost to Follow-up|1|||
143186031|NCT00948857|516226854|FG001|Overall Study|Lost to Follow-up|0|||
143186032|NCT03430843|516226855|FG000|Overall Study|Death|233|||
143186033|NCT03430843|516226856|FG001|Overall Study|Death|233|||
143186034|NCT03430843|516226855|FG000|Overall Study|Sponsor Decision|17|||
143186035|NCT03430843|516226856|FG001|Overall Study|Sponsor Decision|6|||
143186036|NCT03430843|516226855|FG000|Overall Study|Withdrawal by Subject|5|||
143186037|NCT03430843|516226856|FG001|Overall Study|Withdrawal by Subject|14|||
143186038|NCT03430843|516226855|FG000|Overall Study|Lost to Follow-up|1|||
143186039|NCT03430843|516226856|FG001|Overall Study|Lost to Follow-up|3|||
143186040|NCT05360966|516226864|FG000|Overall Study|Adverse Event|5|||
143186041|NCT05360966|516226865|FG001|Overall Study|Adverse Event|5|||
143186042|NCT05360966|516226864|FG000|Overall Study|Withdrawal of Consent|5|||
143186043|NCT05360966|516226865|FG001|Overall Study|Withdrawal of Consent|3|||
143186044|NCT05360966|516226864|FG000|Overall Study|Noncompliance|2|||
143186045|NCT05360966|516226865|FG001|Overall Study|Noncompliance|1|||
143186046|NCT05360966|516226864|FG000|Overall Study|Lost to Follow-up|2|||
143186047|NCT05360966|516226865|FG001|Overall Study|Lost to Follow-up|3|||
143186048|NCT05360966|516226864|FG000|Overall Study|Protocol Deviation|2|||
143186049|NCT05360966|516226865|FG001|Overall Study|Protocol Deviation|1|||
143186050|NCT05360966|516226864|FG000|Overall Study|As specified in the Clinical Study Report|1|||
143186051|NCT05360966|516226865|FG001|Overall Study|As specified in the Clinical Study Report|3|||
143186052|NCT03062280|516226866|FG000|Overall Study|Adverse Event|1|||
143186053|NCT03062280|516226866|FG000|Overall Study|Death|1|||
143186054|NCT03062280|516226866|FG000|Overall Study|Fertility Treatment|2|||
143186055|NCT03062280|516226866|FG000|Overall Study|Physician Decision|2|||
143186056|NCT03062280|516226866|FG000|Overall Study|Pregnancy|5|||
143186057|NCT03062280|516226866|FG000|Overall Study|Withdrawal by Subject|11|||
143186058|NCT05258890|516226868|FG000|Overall Study|Patient withdrawal|6|||
143186059|NCT05258890|516226869|FG001|Overall Study|Patient withdrawal|7|||
143186060|NCT05258890|516226868|FG000|Overall Study|Patient lost to follow-up|10|||
143186061|NCT05258890|516226869|FG001|Overall Study|Patient lost to follow-up|3|||
143186062|NCT05258890|516226868|FG000|Overall Study|Social network member withdrawal|1|||
143186063|NCT05258890|516226869|FG001|Overall Study|Social network member withdrawal|0|||
143186064|NCT05258890|516226868|FG000|Overall Study|Social network member lost to follow-up|5|||
143186065|NCT05258890|516226869|FG001|Overall Study|Social network member lost to follow-up|0|||
143186066|NCT05959447|516226870|FG000|Part 1 (Up to Day 21)|Adverse Event|1|||
143186067|NCT05959447|516226871|FG001|Part 1 (Up to Day 21)|Adverse Event|0|||
143186068|NCT05959447|516226870|FG000|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|9|||
143186069|NCT05959447|516226871|FG001|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|0|||
143186070|NCT05959447|516226870|FG000|Part 2 (Up to Day 22)|Adverse Event|0|||
143186071|NCT05959447|516226871|FG001|Part 2 (Up to Day 22)|Adverse Event|2|||
143186072|NCT05959447|516226870|FG000|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
143186073|NCT05959447|516226871|FG001|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
143186074|NCT04729972|516226873|FG000|Overall Study|Adverse Event|1|||
143186075|NCT00590122|516226874|FG000|Overall Study|swallowed oral dissolving dose|1|||
143186076|NCT00590122|516226875|FG001|Overall Study|swallowed oral dissolving dose|0|||
143186077|NCT01208324|516226876|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
143186078|NCT01208324|516226877|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
143186079|NCT01208324|516226878|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
143186080|NCT01208324|516226879|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
143186081|NCT00700622|516226883|FG000|Overall Study|Adverse Event|4|||
143186082|NCT00700622|516226884|FG001|Overall Study|Adverse Event|0|||
143186083|NCT00700622|516226883|FG000|Overall Study|Lost to Follow-up|0|||
143186084|NCT00700622|516226884|FG001|Overall Study|Lost to Follow-up|1|||
143186085|NCT00700622|516226883|FG000|Overall Study|Physician Decision|2|||
143186086|NCT00700622|516226884|FG001|Overall Study|Physician Decision|1|||
143186087|NCT00700622|516226883|FG000|Overall Study|Protocol Violation|0|||
143186088|NCT00700622|516226884|FG001|Overall Study|Protocol Violation|1|||
143261334|NCT00287079|516510553|FG000|Overall Study|Protocol Violation|1|||
143261335|NCT00287079|516510554|FG001|Overall Study|Protocol Violation|0|||
143186089|NCT00700622|516226883|FG000|Overall Study|Withdrawal by Subject|4|||
143186090|NCT00700622|516226884|FG001|Overall Study|Withdrawal by Subject|1|||
143186091|NCT00700622|516226883|FG000|Overall Study|Other|3|||
143186092|NCT00700622|516226884|FG001|Overall Study|Other|1|||
143186093|NCT02253433|516226885|FG000|Overall Study|Unable to Contact|9|||
143186094|NCT02253433|516226886|FG001|Overall Study|Unable to Contact|16|||
143261336|NCT00287079|516510553|FG000|Overall Study|Other|3|||
143261337|NCT00287079|516510554|FG001|Overall Study|Other|0|||
143115631|NCT03191864|515963963|FG002|Part 2 - Maintenance|Adverse Event|0|||
143115632|NCT03191864|515963964|FG003|Part 2 - Maintenance|Adverse Event|0|||
143115633|NCT03191864|515963965|FG004|Part 2 - Maintenance|Adverse Event|1|||
143115634|NCT03191864|515963966|FG005|Part 2 - Maintenance|Adverse Event|0|||
143115635|NCT03191864|515963961|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
143115636|NCT03191864|515963962|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
143115637|NCT03191864|515963963|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
143115638|NCT03191864|515963964|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
143115639|NCT03191864|515963965|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
143115640|NCT03191864|515963966|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
143115641|NCT03191864|515963961|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
143115642|NCT03191864|515963962|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
143115643|NCT03191864|515963963|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
143115644|NCT03191864|515963964|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
143115645|NCT03191864|515963965|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
143115646|NCT03191864|515963966|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
143115647|NCT05072964|515963967|FG000|Overall Study|Withdrawal by Subject|4|||
143115648|NCT05072964|515963967|FG000|Overall Study|Death|1|||
143115649|NCT04506905|515963971|FG000|Overall Study|Lost to Follow-up|1|||
143115650|NCT04506905|515963972|FG001|Overall Study|Lost to Follow-up|0|||
143115651|NCT04506905|515963973|FG002|Overall Study|Lost to Follow-up|0|||
143115652|NCT04506905|515963974|FG003|Overall Study|Lost to Follow-up|1|||
143115653|NCT04506905|515963975|FG004|Overall Study|Lost to Follow-up|0|||
143115654|NCT04506905|515963976|FG005|Overall Study|Lost to Follow-up|0|||
143115655|NCT04506905|515963977|FG006|Overall Study|Lost to Follow-up|0|||
143115656|NCT04506905|515963978|FG007|Overall Study|Lost to Follow-up|0|||
143186095|NCT02253433|516226885|FG000|Overall Study|Death|1|||
143186096|NCT02253433|516226886|FG001|Overall Study|Death|1|||
143186097|NCT02253433|516226885|FG000|Overall Study|No Longer Interested|3|||
143186098|NCT02253433|516226886|FG001|Overall Study|No Longer Interested|15|||
143186099|NCT02253433|516226885|FG000|Overall Study|Out of Study Area|2|||
143186100|NCT02253433|516226886|FG001|Overall Study|Out of Study Area|7|||
143186101|NCT02253433|516226885|FG000|Overall Study|Uncomfortable with home visitors|0|||
143186102|NCT02253433|516226886|FG001|Overall Study|Uncomfortable with home visitors|3|||
143186103|NCT02253433|516226885|FG000|Overall Study|Unstable Housing/Homeless|0|||
143186104|NCT02253433|516226886|FG001|Overall Study|Unstable Housing/Homeless|7|||
143186105|NCT02253433|516226885|FG000|Overall Study|Too Busy|0|||
143186106|NCT02253433|516226886|FG001|Overall Study|Too Busy|4|||
143186107|NCT02253433|516226885|FG000|Overall Study|Medical or Other Concerns|1|||
143186108|NCT02253433|516226886|FG001|Overall Study|Medical or Other Concerns|2|||
143186109|NCT02836717|516226892|FG000|Test Phase|Lack of Efficacy|14|||
143186110|NCT02836717|516226893|FG001|Test Phase|Lack of Efficacy|8|||
143186111|NCT02836717|516226894|FG002|Test Phase|Lack of Efficacy|0|||
143186112|NCT02836717|516226892|FG000|Study Phase|Adverse Event|2|||
143186113|NCT02836717|516226893|FG001|Study Phase|Adverse Event|0|||
143186114|NCT02836717|516226894|FG002|Study Phase|Adverse Event|0|||
143115657|NCT04506905|515963979|FG008|Overall Study|Lost to Follow-up|0|||
143115658|NCT04506905|515963971|FG000|Overall Study|Withdrawal by Subject|0|||
143115659|NCT04506905|515963972|FG001|Overall Study|Withdrawal by Subject|0|||
143115660|NCT04506905|515963973|FG002|Overall Study|Withdrawal by Subject|0|||
143186115|NCT02836717|516226892|FG000|Study Phase|Lack of Efficacy|8|||
143186116|NCT02836717|516226893|FG001|Study Phase|Lack of Efficacy|6|||
143186117|NCT02836717|516226894|FG002|Study Phase|Lack of Efficacy|1|||
143186118|NCT02836717|516226892|FG000|Study Phase|Withdrawal by Subject|1|||
143186119|NCT02836717|516226893|FG001|Study Phase|Withdrawal by Subject|0|||
143186120|NCT02836717|516226894|FG002|Study Phase|Withdrawal by Subject|0|||
143186121|NCT02836717|516226892|FG000|Study Phase|Death|1|||
143186122|NCT02836717|516226893|FG001|Study Phase|Death|0|||
143261338|NCT03282565|516510555|FG000|Overall Study|COVID-19 Research Shutdown|0|||
143261339|NCT03282565|516510556|FG001|Overall Study|COVID-19 Research Shutdown|2|||
143115661|NCT04506905|515963974|FG003|Overall Study|Withdrawal by Subject|2|||
143115662|NCT04506905|515963975|FG004|Overall Study|Withdrawal by Subject|0|||
143115663|NCT04506905|515963976|FG005|Overall Study|Withdrawal by Subject|0|||
143115664|NCT04506905|515963977|FG006|Overall Study|Withdrawal by Subject|0|||
143186123|NCT02836717|516226894|FG002|Study Phase|Death|0|||
143186124|NCT02836717|516226892|FG000|Study Phase|abdominal surgeries|2|||
143186125|NCT02836717|516226893|FG001|Study Phase|abdominal surgeries|1|||
143186126|NCT02836717|516226894|FG002|Study Phase|abdominal surgeries|0|||
143186127|NCT01309997|516226896|FG000|Overall Study|Adverse Event|1|||
143186128|NCT01309997|516226897|FG001|Overall Study|Adverse Event|0|||
143186129|NCT01309997|516226896|FG000|Overall Study|Death|1|||
143186130|NCT01309997|516226897|FG001|Overall Study|Death|3|||
143186131|NCT01309997|516226896|FG000|Overall Study|Lack of Efficacy|2|||
143186132|NCT01309997|516226897|FG001|Overall Study|Lack of Efficacy|2|||
143186133|NCT01309997|516226896|FG000|Overall Study|Withdrawal by Subject|1|||
143186134|NCT01309997|516226897|FG001|Overall Study|Withdrawal by Subject|1|||
143186135|NCT00282087|516226898|FG000|Overall Study|Death|1|||
143186136|NCT03462641|516226899|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
143186137|NCT03462641|516226900|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
143186138|NCT03462641|516226899|FG000|Visit 2|Withdrawal by Subject|0|||
143186139|NCT03462641|516226900|FG001|Visit 2|Withdrawal by Subject|1|||
143186140|NCT00372619|516226903|FG000|Overall Study|Ineligible|0|||
143186141|NCT00372619|516226904|FG001|Overall Study|Ineligible|0|||
143186142|NCT00372619|516226905|FG002|Overall Study|Ineligible|0|||
143186143|NCT00372619|516226906|FG003|Overall Study|Ineligible|0|||
143186144|NCT00372619|516226907|FG004|Overall Study|Ineligible|0|||
143186145|NCT00372619|516226908|FG005|Overall Study|Ineligible|2|||
143186146|NCT00372619|516226909|FG006|Overall Study|Ineligible|0|||
143186147|NCT00372619|516226903|FG000|Overall Study|Inevaluable|0|||
143186148|NCT00372619|516226904|FG001|Overall Study|Inevaluable|0|||
143186149|NCT00372619|516226905|FG002|Overall Study|Inevaluable|0|||
143186150|NCT00372619|516226906|FG003|Overall Study|Inevaluable|0|||
143186151|NCT00372619|516226907|FG004|Overall Study|Inevaluable|0|||
143186152|NCT00372619|516226908|FG005|Overall Study|Inevaluable|1|||
143186153|NCT00372619|516226909|FG006|Overall Study|Inevaluable|0|||
143186154|NCT00066222|516226910|FG000|Overall Study|No protocol treatment received|1|||
143186155|NCT01703091|516226920|FG000|Overall Study|Adverse Event|5|||
143186156|NCT01703091|516226921|FG001|Overall Study|Adverse Event|3|||
143186157|NCT01703091|516226920|FG000|Overall Study|Physician Decision|2|||
143186158|NCT01703091|516226921|FG001|Overall Study|Physician Decision|1|||
143186159|NCT01703091|516226920|FG000|Overall Study|Withdrawal by Subject|1|||
143186160|NCT01703091|516226921|FG001|Overall Study|Withdrawal by Subject|0|||
143186161|NCT01703091|516226920|FG000|Overall Study|Sponsor Decision|1|||
143186162|NCT01703091|516226921|FG001|Overall Study|Sponsor Decision|0|||
143186163|NCT01901614|516226923|FG000|Overall Study|Adverse Event|0|||
143186164|NCT01901614|516226924|FG001|Overall Study|Adverse Event|1|||
143186165|NCT01901614|516226923|FG000|Overall Study|Lost to Follow-up|1|||
143186166|NCT01901614|516226924|FG001|Overall Study|Lost to Follow-up|0|||
143186167|NCT01901614|516226923|FG000|Overall Study|Screen Fail|1|||
143186168|NCT01901614|516226924|FG001|Overall Study|Screen Fail|0|||
143186169|NCT02201329|516226925|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
143186170|NCT02201329|516226925|FG000|Overall Study|Withdrawal by Subject|2|||
143186171|NCT03629223|516226926|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
143186172|NCT03629223|516226927|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
143186173|NCT03629223|516226928|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
143186174|NCT03629223|516226929|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
143186175|NCT03629223|516226930|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
143186176|NCT03629223|516226931|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
143186177|NCT03629223|516226926|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
143186178|NCT03629223|516226927|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
143186179|NCT03629223|516226928|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
143186180|NCT03629223|516226929|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
143186181|NCT03629223|516226930|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
143186182|NCT03629223|516226931|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
143186183|NCT03629223|516226926|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
143186184|NCT03629223|516226927|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
143186185|NCT03629223|516226928|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
143186186|NCT03629223|516226929|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
143186187|NCT03629223|516226930|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
143186188|NCT03629223|516226931|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
143186189|NCT03629223|516226926|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
143186190|NCT03629223|516226927|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
143186191|NCT03629223|516226928|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
143186192|NCT03629223|516226929|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
143186193|NCT03629223|516226930|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
143186194|NCT03629223|516226931|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
143186195|NCT03629223|516226926|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
143186196|NCT03629223|516226927|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
143186197|NCT03629223|516226928|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
143186198|NCT03629223|516226929|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
143186199|NCT03629223|516226930|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
143186200|NCT03629223|516226931|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
143186201|NCT01262638|516226932|FG000|Overall Study|Adverse Event|3|||
143186202|NCT01262638|516226933|FG001|Overall Study|Adverse Event|4|||
143186203|NCT01262638|516226934|FG002|Overall Study|Adverse Event|3|||
143186204|NCT01262638|516226935|FG003|Overall Study|Adverse Event|4|||
143186205|NCT01262638|516226932|FG000|Overall Study|Protocol Violation|1|||
143186206|NCT01262638|516226933|FG001|Overall Study|Protocol Violation|0|||
143186207|NCT01262638|516226934|FG002|Overall Study|Protocol Violation|0|||
143186208|NCT01262638|516226935|FG003|Overall Study|Protocol Violation|1|||
143186209|NCT01262638|516226932|FG000|Overall Study|Withdrawal by Subject|2|||
143186210|NCT01262638|516226933|FG001|Overall Study|Withdrawal by Subject|1|||
143186211|NCT01262638|516226934|FG002|Overall Study|Withdrawal by Subject|0|||
143186212|NCT01262638|516226935|FG003|Overall Study|Withdrawal by Subject|1|||
143186213|NCT01262638|516226932|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
143186214|NCT01262638|516226933|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
143186215|NCT01262638|516226934|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
143186216|NCT01262638|516226935|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
143186217|NCT01262638|516226932|FG000|Overall Study|Lost to Follow-up|1|||
143186218|NCT01262638|516226933|FG001|Overall Study|Lost to Follow-up|1|||
143186219|NCT01262638|516226934|FG002|Overall Study|Lost to Follow-up|1|||
143186220|NCT01262638|516226935|FG003|Overall Study|Lost to Follow-up|1|||
143186221|NCT01262638|516226932|FG000|Overall Study|Participant Went Out of Town|0|||
143186222|NCT01262638|516226933|FG001|Overall Study|Participant Went Out of Town|0|||
143186223|NCT01262638|516226934|FG002|Overall Study|Participant Went Out of Town|1|||
143186224|NCT01262638|516226935|FG003|Overall Study|Participant Went Out of Town|0|||
143186225|NCT01369199|516226936|FG000|Overall Study|Withdrawal by Subject|1|||
143186226|NCT01369199|516226936|FG000|Overall Study|Lost to Follow-up|2|||
143186227|NCT01071252|516226937|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
143186228|NCT01071252|516226938|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
143115665|NCT04506905|515963978|FG007|Overall Study|Withdrawal by Subject|0|||
143115666|NCT04506905|515963979|FG008|Overall Study|Withdrawal by Subject|0|||
143115667|NCT03800836|515963982|FG000|Overall Study|Other|2|||
143115668|NCT03800836|515963983|FG001|Overall Study|Other|1|||
143115669|NCT03800836|515963984|FG002|Overall Study|Other|0|||
143186229|NCT01071252|516226939|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
143186230|NCT01071252|516226940|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
143186231|NCT01071252|516226941|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
143186232|NCT01071252|516226937|FG000|Overall Study|Withdrawal by Subject|8|||
143186233|NCT01071252|516226938|FG001|Overall Study|Withdrawal by Subject|2|||
143186234|NCT01071252|516226939|FG002|Overall Study|Withdrawal by Subject|1|||
143186235|NCT01071252|516226940|FG003|Overall Study|Withdrawal by Subject|2|||
143186236|NCT01071252|516226941|FG004|Overall Study|Withdrawal by Subject|3|||
143186237|NCT01071252|516226937|FG000|Overall Study|administrative problems|1|||
143186238|NCT01071252|516226938|FG001|Overall Study|administrative problems|1|||
143186239|NCT01071252|516226939|FG002|Overall Study|administrative problems|0|||
143186240|NCT01071252|516226940|FG003|Overall Study|administrative problems|2|||
143186241|NCT01071252|516226941|FG004|Overall Study|administrative problems|1|||
143186242|NCT01071252|516226937|FG000|Overall Study|Lost to Follow-up|1|||
143186243|NCT01071252|516226938|FG001|Overall Study|Lost to Follow-up|0|||
143186244|NCT01071252|516226939|FG002|Overall Study|Lost to Follow-up|1|||
143186245|NCT01071252|516226940|FG003|Overall Study|Lost to Follow-up|2|||
143186246|NCT01071252|516226941|FG004|Overall Study|Lost to Follow-up|0|||
143186247|NCT01071252|516226937|FG000|Overall Study|Adverse Event|1|||
143186248|NCT01071252|516226938|FG001|Overall Study|Adverse Event|1|||
143369406|NCT01693614|516896090|FG000|Overall Study|Withdrawal by subject/guardian|0|||
143115670|NCT03800836|515963985|FG003|Overall Study|Other|2|||
143115671|NCT03800836|515963986|FG004|Overall Study|Other|0|||
143115672|NCT03800836|515963987|FG005|Overall Study|Other|1|||
143115673|NCT03800836|515963982|FG000|Overall Study|Lost to Follow-up|2|||
143186249|NCT01071252|516226939|FG002|Overall Study|Adverse Event|0|||
143186250|NCT01071252|516226940|FG003|Overall Study|Adverse Event|1|||
143186251|NCT01071252|516226941|FG004|Overall Study|Adverse Event|0|||
143186252|NCT01071252|516226937|FG000|Overall Study|Death|0|||
143186253|NCT01071252|516226938|FG001|Overall Study|Death|0|||
143186254|NCT01071252|516226939|FG002|Overall Study|Death|0|||
143186255|NCT01071252|516226940|FG003|Overall Study|Death|0|||
143186256|NCT01071252|516226941|FG004|Overall Study|Death|1|||
143186257|NCT00470262|516226942|FG000|Overall Study|Withdrawal by Subject|2|||
143186258|NCT00470262|516226943|FG001|Overall Study|Withdrawal by Subject|0|||
143186259|NCT01107392|516226951|FG000|Overall Study|Adverse Event|2|||
143115674|NCT03800836|515963983|FG001|Overall Study|Lost to Follow-up|0|||
143115675|NCT03800836|515963984|FG002|Overall Study|Lost to Follow-up|1|||
143115676|NCT03800836|515963985|FG003|Overall Study|Lost to Follow-up|1|||
143115677|NCT03800836|515963986|FG004|Overall Study|Lost to Follow-up|3|||
143186260|NCT01107392|516226952|FG001|Overall Study|Adverse Event|0|||
143186261|NCT01107392|516226951|FG000|Overall Study|Personal Reasons|2|||
143186262|NCT01107392|516226952|FG001|Overall Study|Personal Reasons|3|||
143186263|NCT01107392|516226951|FG000|Overall Study|Administrative decision|1|||
143186264|NCT01107392|516226952|FG001|Overall Study|Administrative decision|0|||
143186265|NCT02689206|516226953|FG000|Overall Study|Adverse Event|0|||
143186266|NCT02689206|516226954|FG001|Overall Study|Adverse Event|0|||
143186267|NCT02689206|516226955|FG002|Overall Study|Adverse Event|1|||
143186268|NCT02689206|516226956|FG003|Overall Study|Adverse Event|0|||
143186269|NCT02689206|516226957|FG004|Overall Study|Adverse Event|2|||
143186270|NCT02689206|516226953|FG000|Overall Study|Protocol Violation|1|||
143186271|NCT02689206|516226954|FG001|Overall Study|Protocol Violation|0|||
143186272|NCT02689206|516226955|FG002|Overall Study|Protocol Violation|0|||
143186273|NCT02689206|516226956|FG003|Overall Study|Protocol Violation|1|||
143186274|NCT02689206|516226957|FG004|Overall Study|Protocol Violation|2|||
143186275|NCT02689206|516226953|FG000|Overall Study|Other: Reached stopping criteria|0|||
143186276|NCT02689206|516226954|FG001|Overall Study|Other: Reached stopping criteria|1|||
143186277|NCT02689206|516226955|FG002|Overall Study|Other: Reached stopping criteria|2|||
143186278|NCT02689206|516226956|FG003|Overall Study|Other: Reached stopping criteria|3|||
143186279|NCT02689206|516226957|FG004|Overall Study|Other: Reached stopping criteria|4|||
143186280|NCT02689206|516226953|FG000|Overall Study|Physician Decision|1|||
143186281|NCT02689206|516226954|FG001|Overall Study|Physician Decision|0|||
143186282|NCT02689206|516226955|FG002|Overall Study|Physician Decision|0|||
143186283|NCT02689206|516226956|FG003|Overall Study|Physician Decision|0|||
143186284|NCT02689206|516226957|FG004|Overall Study|Physician Decision|0|||
143186285|NCT02689206|516226953|FG000|Overall Study|Withdrawal by Subject|1|||
143186286|NCT02689206|516226954|FG001|Overall Study|Withdrawal by Subject|0|||
143186287|NCT02689206|516226955|FG002|Overall Study|Withdrawal by Subject|1|||
143186288|NCT02689206|516226956|FG003|Overall Study|Withdrawal by Subject|0|||
143186289|NCT02689206|516226957|FG004|Overall Study|Withdrawal by Subject|0|||
143186290|NCT02998671|516226958|FG000|Period 1|Study Terminated By Sponsor|2|||
143186291|NCT02998671|516226959|FG001|Period 1|Study Terminated By Sponsor|1|||
143186292|NCT02998671|516226960|FG002|Period 1|Study Terminated By Sponsor|0|||
143186293|NCT02998671|516226961|FG003|Period 1|Study Terminated By Sponsor|0|||
143186294|NCT02998671|516226962|FG004|Period 1|Study Terminated By Sponsor|1|||
143186295|NCT02998671|516226958|FG000|Period 1|Withdrawal by Subject|1|||
143186296|NCT02998671|516226959|FG001|Period 1|Withdrawal by Subject|2|||
143186297|NCT02998671|516226960|FG002|Period 1|Withdrawal by Subject|0|||
143186298|NCT02998671|516226961|FG003|Period 1|Withdrawal by Subject|0|||
143186299|NCT02998671|516226962|FG004|Period 1|Withdrawal by Subject|2|||
143186300|NCT02998671|516226958|FG000|Period 1|Pregnancy|1|||
143186301|NCT02998671|516226959|FG001|Period 1|Pregnancy|0|||
143186302|NCT02998671|516226960|FG002|Period 1|Pregnancy|0|||
143186303|NCT02998671|516226961|FG003|Period 1|Pregnancy|0|||
143186304|NCT02998671|516226962|FG004|Period 1|Pregnancy|0|||
143186305|NCT02998671|516226958|FG000|Period 1|Adverse Event|0|||
143186306|NCT02998671|516226959|FG001|Period 1|Adverse Event|0|||
143186307|NCT02998671|516226960|FG002|Period 1|Adverse Event|0|||
143186308|NCT02998671|516226961|FG003|Period 1|Adverse Event|0|||
143186309|NCT02998671|516226962|FG004|Period 1|Adverse Event|1|||
143186310|NCT02998671|516226958|FG000|Period 2|Adverse Event|0|||
143186311|NCT02998671|516226959|FG001|Period 2|Adverse Event|1|||
143186312|NCT02998671|516226960|FG002|Period 2|Adverse Event|0|||
143186313|NCT02998671|516226961|FG003|Period 2|Adverse Event|0|||
143186314|NCT02998671|516226962|FG004|Period 2|Adverse Event|0|||
143186315|NCT02998671|516226958|FG000|Period 2|Study Terminated By Sponsor|3|||
143186316|NCT02998671|516226959|FG001|Period 2|Study Terminated By Sponsor|5|||
143186317|NCT02998671|516226960|FG002|Period 2|Study Terminated By Sponsor|1|||
143186318|NCT02998671|516226961|FG003|Period 2|Study Terminated By Sponsor|3|||
143186319|NCT02998671|516226962|FG004|Period 2|Study Terminated By Sponsor|0|||
143186320|NCT02998671|516226958|FG000|Period 2|Withdrawal by Subject|0|||
143186321|NCT02998671|516226959|FG001|Period 2|Withdrawal by Subject|1|||
143186322|NCT02998671|516226960|FG002|Period 2|Withdrawal by Subject|0|||
143186323|NCT02998671|516226961|FG003|Period 2|Withdrawal by Subject|0|||
143186324|NCT02998671|516226962|FG004|Period 2|Withdrawal by Subject|0|||
143186325|NCT02998671|516226958|FG000|Period 2|Lost to Follow-up|0|||
143186326|NCT02998671|516226959|FG001|Period 2|Lost to Follow-up|0|||
143186327|NCT02998671|516226960|FG002|Period 2|Lost to Follow-up|0|||
143186328|NCT02998671|516226961|FG003|Period 2|Lost to Follow-up|1|||
143186329|NCT02998671|516226962|FG004|Period 2|Lost to Follow-up|0|||
143186330|NCT01916824|516226965|FG000|Overall Study|Lost to Follow-up|3|||
143186331|NCT01916824|516226966|FG001|Overall Study|Lost to Follow-up|6|||
143186332|NCT01916824|516226965|FG000|Overall Study|Physician Decision|2|||
143186333|NCT01916824|516226966|FG001|Overall Study|Physician Decision|0|||
143186334|NCT01916824|516226965|FG000|Overall Study|Withdrawal by Subject|2|||
143186335|NCT01916824|516226966|FG001|Overall Study|Withdrawal by Subject|3|||
143186336|NCT03835481|516226967|FG000|Double-blind Period|Other not stated below|0|||
143186337|NCT03835481|516226968|FG001|Double-blind Period|Other not stated below|0|||
143186338|NCT03835481|516226969|FG002|Double-blind Period|Other not stated below|0|||
143186339|NCT03835481|516226970|FG003|Double-blind Period|Other not stated below|1|||
143186340|NCT03835481|516226971|FG004|Double-blind Period|Other not stated below|1|||
143186341|NCT03835481|516226967|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
143186342|NCT03835481|516226968|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
143186343|NCT03835481|516226969|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
143186344|NCT03835481|516226970|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
143186345|NCT03835481|516226971|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
143186346|NCT03835481|516226967|FG000|Double-blind Period|Withdrawal by Subject|0|||
143186347|NCT03835481|516226968|FG001|Double-blind Period|Withdrawal by Subject|0|||
143186348|NCT03835481|516226969|FG002|Double-blind Period|Withdrawal by Subject|1|||
143186349|NCT03835481|516226970|FG003|Double-blind Period|Withdrawal by Subject|0|||
143186350|NCT03835481|516226971|FG004|Double-blind Period|Withdrawal by Subject|5|||
143186351|NCT03835481|516226967|FG000|Double-blind Period|Lost to Follow-up|0|||
143186352|NCT03835481|516226968|FG001|Double-blind Period|Lost to Follow-up|0|||
143186353|NCT03835481|516226969|FG002|Double-blind Period|Lost to Follow-up|0|||
143186354|NCT03835481|516226970|FG003|Double-blind Period|Lost to Follow-up|1|||
143186355|NCT03835481|516226971|FG004|Double-blind Period|Lost to Follow-up|0|||
143186356|NCT03835481|516226967|FG000|Double-blind Period|Protocol Violation|0|||
143186357|NCT03835481|516226968|FG001|Double-blind Period|Protocol Violation|2|||
143186358|NCT03835481|516226969|FG002|Double-blind Period|Protocol Violation|0|||
143186359|NCT03835481|516226970|FG003|Double-blind Period|Protocol Violation|1|||
143186360|NCT03835481|516226971|FG004|Double-blind Period|Protocol Violation|0|||
143186361|NCT03835481|516226967|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
143186362|NCT03835481|516226968|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
143186363|NCT03835481|516226969|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
143186364|NCT03835481|516226970|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
143186365|NCT03835481|516226971|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
143186366|NCT03835481|516226967|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
143186367|NCT03835481|516226968|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
143186368|NCT03835481|516226969|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
143186369|NCT03835481|516226970|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
143186370|NCT03835481|516226971|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
143186371|NCT03835481|516226967|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
143186372|NCT03835481|516226968|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
143186373|NCT03835481|516226969|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
143186374|NCT03835481|516226970|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
143186375|NCT03835481|516226971|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
143186376|NCT03835481|516226967|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
143186377|NCT03835481|516226968|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
143186378|NCT03835481|516226969|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
143186379|NCT03835481|516226970|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
143186380|NCT03835481|516226971|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
143186381|NCT03835481|516226967|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
143186382|NCT03835481|516226968|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
143186383|NCT03835481|516226969|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
143186384|NCT03835481|516226970|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
143186385|NCT03835481|516226971|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
143186386|NCT03835481|516226967|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
143186387|NCT03835481|516226968|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
143261340|NCT03282565|516510557|FG002|Overall Study|COVID-19 Research Shutdown|2|||
143186388|NCT03835481|516226969|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
143186389|NCT03835481|516226970|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
143186390|NCT03835481|516226971|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
143186391|NCT01221753|516226978|FG000|Overall Study|Adverse Event|1|||
143186392|NCT03335150|516226979|FG000|Overall Study|Withdrawal by Subject|10|||
143186393|NCT03335150|516226980|FG001|Overall Study|Withdrawal by Subject|4|||
143186394|NCT03335150|516226979|FG000|Overall Study|Adverse Event|0|||
143186395|NCT03335150|516226980|FG001|Overall Study|Adverse Event|1|||
143186396|NCT00861692|516226981|FG000|Overall Study|Death|6|||
143186397|NCT02218697|516226982|FG000|Overall Study|Adverse Event|0|||
143186398|NCT02218697|516226983|FG001|Overall Study|Adverse Event|2|||
143186399|NCT02218697|516226982|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
143186400|NCT02218697|516226983|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
143186401|NCT02218697|516226982|FG000|Overall Study|Withdrawal by Subject|2|||
143186402|NCT02218697|516226983|FG001|Overall Study|Withdrawal by Subject|3|||
143186403|NCT04776720|516226992|FG000|Overall Study|COVID Related|4|||
143186404|NCT04776720|516226993|FG001|Overall Study|COVID Related|2|||
143186405|NCT04776720|516226992|FG000|Overall Study|Adverse Event|2|||
143186406|NCT04776720|516226993|FG001|Overall Study|Adverse Event|0|||
143186407|NCT04776720|516226992|FG000|Overall Study|Serious Adverse Event|0|||
143186408|NCT04776720|516226993|FG001|Overall Study|Serious Adverse Event|1|||
143186409|NCT04776720|516226992|FG000|Overall Study|Too Busy|3|||
143186410|NCT04776720|516226993|FG001|Overall Study|Too Busy|1|||
143186411|NCT04776720|516226992|FG000|Overall Study|Lost to Follow-up|1|||
143186412|NCT04776720|516226993|FG001|Overall Study|Lost to Follow-up|2|||
143186413|NCT04776720|516226992|FG000|Overall Study|Family|2|||
143186414|NCT04776720|516226993|FG001|Overall Study|Family|2|||
143186415|NCT04776720|516226992|FG000|Overall Study|No remote technology access|0|||
143186416|NCT04776720|516226993|FG001|Overall Study|No remote technology access|1|||
143186417|NCT04776720|516226992|FG000|Overall Study|Withdrawal by Subject|1|||
143186418|NCT04776720|516226993|FG001|Overall Study|Withdrawal by Subject|0|||
143186419|NCT04776720|516226992|FG000|Overall Study|Cannot tolerate intervention|1|||
143186420|NCT04776720|516226993|FG001|Overall Study|Cannot tolerate intervention|0|||
143186421|NCT04776720|516226992|FG000|Overall Study|Incomplete outcome data|6|||
143186422|NCT04776720|516226993|FG001|Overall Study|Incomplete outcome data|1|||
143186423|NCT00803595|516226994|FG000|Overall Study|Adverse Event|3|||
143186424|NCT00803595|516226995|FG001|Overall Study|Adverse Event|4|||
143186425|NCT00803595|516226996|FG002|Overall Study|Adverse Event|1|||
143186426|NCT00803595|516226994|FG000|Overall Study|Protocol Violation|7|||
143186427|NCT00803595|516226995|FG001|Overall Study|Protocol Violation|2|||
143186428|NCT00803595|516226996|FG002|Overall Study|Protocol Violation|12|||
143186429|NCT00803595|516226994|FG000|Overall Study|Withdrawal by Subject|5|||
143186430|NCT00803595|516226995|FG001|Overall Study|Withdrawal by Subject|2|||
143186431|NCT00803595|516226996|FG002|Overall Study|Withdrawal by Subject|3|||
143186432|NCT02195700|516226997|FG000|Overall Study|Protocol Violation|0|||
143186433|NCT02195700|516226998|FG001|Overall Study|Protocol Violation|2|||
143186434|NCT02195700|516226997|FG000|Overall Study|Noncompliance|1|||
143186435|NCT02195700|516226998|FG001|Overall Study|Noncompliance|0|||
143186436|NCT02195700|516226997|FG000|Overall Study|Adverse Event|1|||
143186437|NCT02195700|516226998|FG001|Overall Study|Adverse Event|2|||
143186438|NCT02195700|516226997|FG000|Overall Study|Withdrawal by Subject|3|||
143186439|NCT02195700|516226998|FG001|Overall Study|Withdrawal by Subject|2|||
143186440|NCT02195700|516226997|FG000|Overall Study|Lost to Follow-up|1|||
143186441|NCT02195700|516226998|FG001|Overall Study|Lost to Follow-up|1|||
143186442|NCT02701764|516226999|FG000|Overall Study|Lost to Follow-up|0|||
143186443|NCT02701764|516227000|FG001|Overall Study|Lost to Follow-up|1|||
143186444|NCT03110029|516227001|FG000|Overall Study|Withdrawal by Subject|1|||
143186445|NCT03110029|516227002|FG001|Overall Study|Withdrawal by Subject|1|||
143186446|NCT03281629|516227003|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
143186447|NCT03281629|516227004|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
143186448|NCT03281629|516227003|FG000|Overall Study|Death|0|||
143186449|NCT03281629|516227004|FG001|Overall Study|Death|1|||
143186450|NCT03281629|516227003|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
143186451|NCT03281629|516227004|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
143186452|NCT02175277|516227005|FG000|Overall Study|Protocol-specified Criteria|1|||
143186453|NCT01042158|516227006|FG000|Overall Study|Physician Decision|1|||
143186454|NCT01575808|516227007|FG000|Overall Study|Death|2|||
143186455|NCT01575808|516227008|FG001|Overall Study|Death|0|||
143186456|NCT01575808|516227007|FG000|Overall Study|Withdrawal by Subject|1|||
143186457|NCT01575808|516227008|FG001|Overall Study|Withdrawal by Subject|0|||
143186458|NCT05396014|516228768|FG000|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|18|||
143186459|NCT05396014|516228769|FG001|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143186460|NCT05396014|516228770|FG002|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143186461|NCT05396014|516228771|FG003|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143186462|NCT05396014|516228772|FG004|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143115678|NCT03800836|515963987|FG005|Overall Study|Lost to Follow-up|0|||
143115679|NCT03800836|515963982|FG000|Overall Study|Withdrawal by Subject|1|||
143115680|NCT03800836|515963983|FG001|Overall Study|Withdrawal by Subject|0|||
143115681|NCT03800836|515963984|FG002|Overall Study|Withdrawal by Subject|0|||
143115682|NCT03800836|515963985|FG003|Overall Study|Withdrawal by Subject|0|||
143115683|NCT03800836|515963986|FG004|Overall Study|Withdrawal by Subject|0|||
143115684|NCT03800836|515963987|FG005|Overall Study|Withdrawal by Subject|0|||
143115685|NCT03800836|515963982|FG000|Overall Study|Physician Decision|31|||
143115686|NCT03800836|515963983|FG001|Overall Study|Physician Decision|3|||
143115687|NCT03800836|515963984|FG002|Overall Study|Physician Decision|6|||
143115688|NCT03800836|515963985|FG003|Overall Study|Physician Decision|4|||
143115689|NCT03800836|515963986|FG004|Overall Study|Physician Decision|4|||
143115690|NCT03800836|515963987|FG005|Overall Study|Physician Decision|5|||
143115691|NCT03800836|515963982|FG000|Overall Study|Death|34|||
143115692|NCT03800836|515963983|FG001|Overall Study|Death|16|||
143115693|NCT03800836|515963984|FG002|Overall Study|Death|5|||
143115694|NCT03800836|515963985|FG003|Overall Study|Death|5|||
143115695|NCT03800836|515963986|FG004|Overall Study|Death|10|||
143115696|NCT03800836|515963987|FG005|Overall Study|Death|0|||
143115697|NCT03800836|515963982|FG000|Overall Study|Symptomatic Deterioration|1|||
143115698|NCT03800836|515963983|FG001|Overall Study|Symptomatic Deterioration|0|||
143115699|NCT03800836|515963984|FG002|Overall Study|Symptomatic Deterioration|1|||
143115700|NCT03800836|515963985|FG003|Overall Study|Symptomatic Deterioration|0|||
143115701|NCT03800836|515963986|FG004|Overall Study|Symptomatic Deterioration|0|||
143115702|NCT03800836|515963987|FG005|Overall Study|Symptomatic Deterioration|0|||
143115703|NCT02000882|515966298|FG000|Overall Study|Adverse Event|3|||
143115704|NCT02000882|515966298|FG000|Overall Study|Physician Decision|2|||
143115705|NCT02000882|515966298|FG000|Overall Study|Withdrawal by Subject|1|||
143115706|NCT00549601|515966299|FG000|Randomized|Protocol Violation|0|||
143115707|NCT00549601|515966300|FG001|Randomized|Protocol Violation|0|||
143115708|NCT00549601|515966301|FG002|Randomized|Protocol Violation|1|||
143115709|NCT00549601|515966299|FG000|Randomized|Withdrawal by Subject|0|||
143115710|NCT00549601|515966300|FG001|Randomized|Withdrawal by Subject|1|||
143115711|NCT00549601|515966301|FG002|Randomized|Withdrawal by Subject|1|||
143115712|NCT00549601|515966299|FG000|Received Study Drug|Adverse Event|2|||
143115713|NCT00549601|515966300|FG001|Received Study Drug|Adverse Event|5|||
143115714|NCT00549601|515966301|FG002|Received Study Drug|Adverse Event|1|||
143115715|NCT00549601|515966299|FG000|Received Study Drug|Death|0|||
143115716|NCT00549601|515966300|FG001|Received Study Drug|Death|1|||
143115717|NCT00549601|515966301|FG002|Received Study Drug|Death|0|||
143115718|NCT00549601|515966299|FG000|Received Study Drug|Lost to Follow-up|0|||
143115719|NCT00549601|515966300|FG001|Received Study Drug|Lost to Follow-up|1|||
143115720|NCT00549601|515966301|FG002|Received Study Drug|Lost to Follow-up|1|||
143115721|NCT00549601|515966299|FG000|Received Study Drug|Protocol Violation|3|||
143115722|NCT00549601|515966300|FG001|Received Study Drug|Protocol Violation|4|||
143115723|NCT00549601|515966301|FG002|Received Study Drug|Protocol Violation|1|||
143115724|NCT00549601|515966299|FG000|Received Study Drug|Withdrawal by Subject|2|||
143115725|NCT00549601|515966300|FG001|Received Study Drug|Withdrawal by Subject|0|||
143115726|NCT00549601|515966301|FG002|Received Study Drug|Withdrawal by Subject|1|||
143115727|NCT00908596|515966305|FG000|Overall Study|Other reasons|46|||
143115728|NCT00908596|515966306|FG001|Overall Study|Other reasons|6|||
143115729|NCT00908596|515966307|FG002|Overall Study|Other reasons|2|||
143115730|NCT00908596|515966308|FG003|Overall Study|Other reasons|0|||
143115731|NCT00908596|515966305|FG000|Overall Study|Lost to Follow-up|0|||
143115732|NCT00908596|515966306|FG001|Overall Study|Lost to Follow-up|1|||
143115733|NCT00908596|515966307|FG002|Overall Study|Lost to Follow-up|12|||
143115734|NCT00908596|515966308|FG003|Overall Study|Lost to Follow-up|4|||
143115735|NCT00908596|515966305|FG000|Overall Study|Death|0|||
143115736|NCT00908596|515966306|FG001|Overall Study|Death|5|||
143115737|NCT00908596|515966307|FG002|Overall Study|Death|57|||
143115738|NCT00908596|515966308|FG003|Overall Study|Death|32|||
143115739|NCT00908596|515966305|FG000|Overall Study|Protocol Violation|1|||
143115740|NCT00908596|515966306|FG001|Overall Study|Protocol Violation|0|||
143115741|NCT00908596|515966307|FG002|Overall Study|Protocol Violation|0|||
143115742|NCT00908596|515966308|FG003|Overall Study|Protocol Violation|0|||
143115743|NCT00908596|515966305|FG000|Overall Study|Withdrawal by Subject|0|||
143115744|NCT00908596|515966306|FG001|Overall Study|Withdrawal by Subject|1|||
143115745|NCT00908596|515966307|FG002|Overall Study|Withdrawal by Subject|3|||
143369407|NCT01693614|516896091|FG001|Overall Study|Withdrawal by subject/guardian|0|||
143115746|NCT00908596|515966308|FG003|Overall Study|Withdrawal by Subject|1|||
143115747|NCT00224406|515966309|FG000|Overall Study|Re-transplant|0|||
143115748|NCT00224406|515966310|FG001|Overall Study|Re-transplant|2|||
143115749|NCT00224406|515966309|FG000|Overall Study|Death|0|||
143115750|NCT00224406|515966310|FG001|Overall Study|Death|1|||
143115751|NCT00224406|515966309|FG000|Overall Study|Transplant cancelled|0|||
143115752|NCT00224406|515966310|FG001|Overall Study|Transplant cancelled|4|||
143369408|NCT01693614|516896092|FG002|Overall Study|Withdrawal by subject/guardian|2|||
143186463|NCT05396014|516228773|FG005|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143186464|NCT05396014|516228774|FG006|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143186465|NCT05396014|516228775|FG007|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143186466|NCT05396014|516228776|FG008|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143186467|NCT05396014|516228777|FG009|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143186468|NCT05396014|516228778|FG010|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143115753|NCT00224406|515966309|FG000|Overall Study|Drug not delivered|2|||
143115754|NCT00224406|515966310|FG001|Overall Study|Drug not delivered|0|||
143115755|NCT00224406|515966309|FG000|Overall Study|Other|4|||
143115756|NCT00224406|515966310|FG001|Overall Study|Other|0|||
143115757|NCT00224406|515966309|FG000|Overall Study|Transplant cancelled|3|||
143115758|NCT00224406|515966310|FG001|Overall Study|Transplant cancelled|0|||
143115759|NCT01556997|515966313|FG000|Overall Study|Adverse Event|10|||
143115760|NCT01556997|515966314|FG001|Overall Study|Adverse Event|12|||
143115761|NCT01556997|515966315|FG002|Overall Study|Adverse Event|12|||
143115762|NCT01556997|515966313|FG000|Overall Study|Lost to Follow-up|6|||
143115763|NCT01556997|515966314|FG001|Overall Study|Lost to Follow-up|6|||
143115764|NCT01556997|515966315|FG002|Overall Study|Lost to Follow-up|4|||
143115765|NCT01556997|515966313|FG000|Overall Study|Physician Decision|1|||
143115766|NCT01556997|515966314|FG001|Overall Study|Physician Decision|1|||
143115767|NCT01556997|515966315|FG002|Overall Study|Physician Decision|1|||
143115768|NCT01556997|515966313|FG000|Overall Study|Withdrawal by Subject|7|||
143115769|NCT01556997|515966314|FG001|Overall Study|Withdrawal by Subject|6|||
143115770|NCT01556997|515966315|FG002|Overall Study|Withdrawal by Subject|8|||
143115771|NCT01556997|515966313|FG000|Overall Study|Other|2|||
143115772|NCT01556997|515966314|FG001|Overall Study|Other|3|||
143115773|NCT01556997|515966315|FG002|Overall Study|Other|7|||
143115774|NCT02542293|515966321|FG000|Overall Study|Death|367|||
143115775|NCT02542293|515966322|FG001|Overall Study|Death|377|||
143115776|NCT02542293|515966321|FG000|Overall Study|Withdrawal by Subject|8|||
143115777|NCT02542293|515966322|FG001|Overall Study|Withdrawal by Subject|19|||
143115778|NCT03030118|515966323|FG000|Overall Study|Achieved SLE Diagnosis|11|||
143115779|NCT03030118|515966324|FG001|Overall Study|Achieved SLE Diagnosis|10|||
143115780|NCT03030118|515966323|FG000|Overall Study|Adverse Event|1|||
143115781|NCT03030118|515966324|FG001|Overall Study|Adverse Event|1|||
143115782|NCT03030118|515966323|FG000|Overall Study|Pregnancy|2|||
143115783|NCT03030118|515966324|FG001|Overall Study|Pregnancy|2|||
143115784|NCT03030118|515966323|FG000|Overall Study|Lost to Follow-up|5|||
143115785|NCT03030118|515966324|FG001|Overall Study|Lost to Follow-up|6|||
143115786|NCT03030118|515966323|FG000|Overall Study|Concomitant Medications|1|||
143115787|NCT03030118|515966324|FG001|Overall Study|Concomitant Medications|1|||
143115788|NCT03030118|515966323|FG000|Overall Study|Achieved SLE and Concomitant Meds|1|||
143115789|NCT03030118|515966324|FG001|Overall Study|Achieved SLE and Concomitant Meds|0|||
143115790|NCT03030118|515966323|FG000|Overall Study|Other|2|||
143115791|NCT03030118|515966324|FG001|Overall Study|Other|0|||
143115792|NCT03030118|515966323|FG000|Overall Study|Withdrawal by Subject|26|||
143115793|NCT03030118|515966324|FG001|Overall Study|Withdrawal by Subject|21|||
143115794|NCT03030118|515966323|FG000|Overall Study|Protocol Violation|1|||
143115795|NCT03030118|515966324|FG001|Overall Study|Protocol Violation|6|||
143115796|NCT04529850|515966329|FG000|Overall Study|Death|2|||
143115797|NCT04529850|515966329|FG000|Overall Study|Physician Decision|1|||
143115798|NCT04529850|515966329|FG000|Overall Study|Withdrawal by Subject|2|||
143115799|NCT01458951|515966332|FG000|Overall Study|Other|1|||
143115800|NCT01458951|515966333|FG001|Overall Study|Other|0|||
143115801|NCT01458951|515966334|FG002|Overall Study|Other|0|||
143115802|NCT01458951|515966332|FG000|Overall Study|Protocol Violation|5|||
143115803|NCT01458951|515966333|FG001|Overall Study|Protocol Violation|1|||
143115804|NCT01458951|515966334|FG002|Overall Study|Protocol Violation|0|||
143115805|NCT01458951|515966332|FG000|Overall Study|Withdrawal by Subject|2|||
143115806|NCT01458951|515966333|FG001|Overall Study|Withdrawal by Subject|0|||
143115807|NCT01458951|515966334|FG002|Overall Study|Withdrawal by Subject|2|||
143115808|NCT01458951|515966332|FG000|Overall Study|Adverse Event|7|||
143115809|NCT01458951|515966333|FG001|Overall Study|Adverse Event|0|||
143115810|NCT01458951|515966334|FG002|Overall Study|Adverse Event|2|||
143115811|NCT01458951|515966332|FG000|Overall Study|Insufficient Clinical Response|17|||
143115812|NCT01458951|515966333|FG001|Overall Study|Insufficient Clinical Response|0|||
143115813|NCT01458951|515966334|FG002|Overall Study|Insufficient Clinical Response|11|||
143115814|NCT01371877|515966337|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
143115815|NCT01371877|515966338|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
143115816|NCT05932225|515966339|FG000|Overall Study|Lost to Follow-up|0|||
143115817|NCT05932225|515966340|FG001|Overall Study|Lost to Follow-up|1|||
143115818|NCT05932225|515966341|FG002|Overall Study|Lost to Follow-up|0|||
143115819|NCT05932225|515966339|FG000|Overall Study|Withdrawal by Subject|1|||
143115820|NCT05932225|515966340|FG001|Overall Study|Withdrawal by Subject|0|||
143115821|NCT05932225|515966341|FG002|Overall Study|Withdrawal by Subject|0|||
143115822|NCT05932225|515966339|FG000|Overall Study|As detailed in the Clinical Study Report|0|||
143115823|NCT05932225|515966340|FG001|Overall Study|As detailed in the Clinical Study Report|2|||
143115824|NCT05932225|515966341|FG002|Overall Study|As detailed in the Clinical Study Report|0|||
143186469|NCT05396014|516228779|FG011|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143186470|NCT05396014|516228780|FG012|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143186471|NCT05396014|516228781|FG013|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|13|||
143186472|NCT05396014|516228782|FG014|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143186473|NCT05396014|516228783|FG015|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143186474|NCT05396014|516228784|FG016|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143186475|NCT05396014|516228785|FG017|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143186476|NCT05396014|516228786|FG018|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143186477|NCT05396014|516228787|FG019|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143186478|NCT05396014|516228788|FG020|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143186479|NCT05396014|516228789|FG021|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143186480|NCT05396014|516228790|FG022|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143186481|NCT05396014|516228791|FG023|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143186482|NCT05396014|516228792|FG024|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143186483|NCT05396014|516228793|FG025|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143186484|NCT05396014|516228794|FG026|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
143186485|NCT05396014|516228795|FG027|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143186486|NCT05396014|516228796|FG028|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143186487|NCT05396014|516228797|FG029|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143186488|NCT05396014|516228798|FG030|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143186489|NCT05396014|516228799|FG031|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143186490|NCT05396014|516228800|FG032|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143186491|NCT05396014|516228801|FG033|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143186492|NCT05396014|516228802|FG034|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143186493|NCT05396014|516228803|FG035|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143186494|NCT05396014|516228804|FG036|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143186495|NCT05396014|516228805|FG037|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143186496|NCT05396014|516228806|FG038|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143186497|NCT05396014|516228807|FG039|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
143186498|NCT05396014|516228808|FG040|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143186499|NCT05396014|516228809|FG041|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143186500|NCT05396014|516228810|FG042|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
143186501|NCT05396014|516228768|FG000|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|15|||
143186502|NCT05396014|516228769|FG001|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143186503|NCT05396014|516228770|FG002|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143186504|NCT05396014|516228771|FG003|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143186505|NCT05396014|516228772|FG004|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143186506|NCT05396014|516228773|FG005|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143186507|NCT05396014|516228774|FG006|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143186508|NCT05396014|516228775|FG007|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143186509|NCT05396014|516228776|FG008|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143115825|NCT02949908|515966342|FG000|Overall Study|Study termination|2|||
143115826|NCT03605849|515966345|FG000|Overall Study|Adverse Event|20|||
143115827|NCT03605849|515966346|FG001|Overall Study|Adverse Event|21|||
143115828|NCT03605849|515966347|FG002|Overall Study|Adverse Event|29|||
143115829|NCT03605849|515966348|FG003|Overall Study|Adverse Event|11|||
143115830|NCT03605849|515966345|FG000|Overall Study|Lack of Efficacy|4|||
143115831|NCT03605849|515966346|FG001|Overall Study|Lack of Efficacy|7|||
143115832|NCT03605849|515966347|FG002|Overall Study|Lack of Efficacy|9|||
143115833|NCT03605849|515966348|FG003|Overall Study|Lack of Efficacy|2|||
143115834|NCT03605849|515966345|FG000|Overall Study|Lost to Follow-up|8|||
143115835|NCT03605849|515966346|FG001|Overall Study|Lost to Follow-up|8|||
143115836|NCT03605849|515966347|FG002|Overall Study|Lost to Follow-up|14|||
143115837|NCT03605849|515966348|FG003|Overall Study|Lost to Follow-up|11|||
143115838|NCT03605849|515966345|FG000|Overall Study|Non-compliance With IMP|6|||
143115839|NCT03605849|515966346|FG001|Overall Study|Non-compliance With IMP|5|||
143115840|NCT03605849|515966347|FG002|Overall Study|Non-compliance With IMP|2|||
143115841|NCT03605849|515966348|FG003|Overall Study|Non-compliance With IMP|1|||
143115842|NCT03605849|515966345|FG000|Overall Study|Protocol Deviation|1|||
143115843|NCT03605849|515966346|FG001|Overall Study|Protocol Deviation|2|||
143115844|NCT03605849|515966347|FG002|Overall Study|Protocol Deviation|1|||
143115845|NCT03605849|515966348|FG003|Overall Study|Protocol Deviation|3|||
143115846|NCT03605849|515966345|FG000|Overall Study|Withdrawal by Subject|33|||
143115847|NCT03605849|515966346|FG001|Overall Study|Withdrawal by Subject|28|||
143115848|NCT03605849|515966347|FG002|Overall Study|Withdrawal by Subject|30|||
143115849|NCT03605849|515966348|FG003|Overall Study|Withdrawal by Subject|28|||
143115850|NCT03605849|515966345|FG000|Overall Study|Site Terminated by Sponsor|0|||
143115851|NCT03605849|515966346|FG001|Overall Study|Site Terminated by Sponsor|0|||
143115852|NCT03605849|515966347|FG002|Overall Study|Site Terminated by Sponsor|0|||
143115853|NCT03605849|515966348|FG003|Overall Study|Site Terminated by Sponsor|1|||
143115854|NCT03605849|515966345|FG000|Overall Study|Physician Decision|2|||
143115855|NCT03605849|515966346|FG001|Overall Study|Physician Decision|1|||
143115856|NCT03605849|515966347|FG002|Overall Study|Physician Decision|2|||
143115857|NCT03605849|515966348|FG003|Overall Study|Physician Decision|1|||
143115858|NCT03605849|515966345|FG000|Overall Study|Enrolled, but not Treated|2|||
143115859|NCT03605849|515966346|FG001|Overall Study|Enrolled, but not Treated|2|||
143115860|NCT03605849|515966347|FG002|Overall Study|Enrolled, but not Treated|3|||
143115861|NCT03605849|515966348|FG003|Overall Study|Enrolled, but not Treated|2|||
143115862|NCT03605849|515966345|FG000|Overall Study|Other (COVID-19 Related)|0|||
143115863|NCT03605849|515966346|FG001|Overall Study|Other (COVID-19 Related)|1|||
143115864|NCT03605849|515966347|FG002|Overall Study|Other (COVID-19 Related)|1|||
143115865|NCT03605849|515966348|FG003|Overall Study|Other (COVID-19 Related)|0|||
143115866|NCT03605849|515966345|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
143115867|NCT03605849|515966346|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
143115868|NCT03605849|515966347|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
143115869|NCT03605849|515966348|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
143115870|NCT02304380|515966349|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
143115871|NCT02304380|515966350|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
143115872|NCT02304380|515966351|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
143115873|NCT02304380|515966352|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
143115874|NCT02304380|515966353|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
143115875|NCT02304380|515966354|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
143115876|NCT00328094|515966355|FG000|Overall Study|Physician Decision|3|||
143115877|NCT00328094|515966356|FG001|Overall Study|Physician Decision|3|||
143115878|NCT02667626|515966357|FG000|Overall Study|Withdrawal by Subject|0|||
143115879|NCT02667626|515966358|FG001|Overall Study|Withdrawal by Subject|1|||
143115880|NCT02309723|515966359|FG000|Overall Study|Withdrawal by Subject|24|||
143115881|NCT02309723|515966360|FG001|Overall Study|Withdrawal by Subject|23|||
143115882|NCT02309723|515966361|FG002|Overall Study|Withdrawal by Subject|24|||
143115883|NCT01143064|515966362|FG000|Overall Study|Death|109|||
143115884|NCT01143064|515966363|FG001|Overall Study|Death|91|||
143115885|NCT01143064|515966362|FG000|Overall Study|Adverse Event|0|||
143115886|NCT01143064|515966363|FG001|Overall Study|Adverse Event|1|||
143115887|NCT01143064|515966362|FG000|Overall Study|Withdrawal by Subject|7|||
143115888|NCT01143064|515966363|FG001|Overall Study|Withdrawal by Subject|5|||
143115889|NCT01143064|515966362|FG000|Overall Study|Lost to Follow-up|17|||
143115890|NCT01143064|515966363|FG001|Overall Study|Lost to Follow-up|14|||
143186510|NCT05396014|516228777|FG009|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143186511|NCT05396014|516228778|FG010|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143186512|NCT05396014|516228779|FG011|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143186513|NCT05396014|516228780|FG012|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143186514|NCT05396014|516228781|FG013|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
143186515|NCT05396014|516228782|FG014|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143186516|NCT05396014|516228783|FG015|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143261341|NCT00518973|516510558|FG000|Overall Study|Withdrawal by Subject|3|||
143261342|NCT00518973|516510559|FG001|Overall Study|Withdrawal by Subject|2|||
143115891|NCT01143064|515966362|FG000|Overall Study|Physician Decision|0|||
143115892|NCT01143064|515966363|FG001|Overall Study|Physician Decision|4|||
143115893|NCT02453282|515966364|FG000|Overall Study|Death|275|||
143115894|NCT02453282|515966365|FG001|Overall Study|Death|277|||
143115895|NCT02453282|515966366|FG002|Overall Study|Death|296|||
143115896|NCT02453282|515966364|FG000|Overall Study|Lost to Follow-up|1|||
143115897|NCT02453282|515966365|FG001|Overall Study|Lost to Follow-up|0|||
143115898|NCT02453282|515966366|FG002|Overall Study|Lost to Follow-up|2|||
143115899|NCT02453282|515966364|FG000|Overall Study|Withdrawal by Subject|12|||
143115900|NCT02453282|515966365|FG001|Overall Study|Withdrawal by Subject|10|||
143115901|NCT02453282|515966366|FG002|Overall Study|Withdrawal by Subject|11|||
143115902|NCT02453282|515966364|FG000|Overall Study|Participants ongoing at data cut-off|85|||
143115903|NCT02453282|515966365|FG001|Overall Study|Participants ongoing at data cut-off|84|||
143115904|NCT02453282|515966366|FG002|Overall Study|Participants ongoing at data cut-off|62|||
143115905|NCT02453282|515966364|FG000|Overall Study|Other|1|||
143115906|NCT02453282|515966365|FG001|Overall Study|Other|1|||
143115907|NCT02453282|515966366|FG002|Overall Study|Other|1|||
143115908|NCT04258254|515966369|FG000|Overall Study|Withdrawal by Subject|0|||
143115909|NCT04258254|515966370|FG001|Overall Study|Withdrawal by Subject|1|||
143115910|NCT04258254|515966371|FG002|Overall Study|Withdrawal by Subject|0|||
143115911|NCT02255552|515966372|FG000|Overall Study|Participants enrolled into another study|0|||
143115912|NCT02255552|515966373|FG001|Overall Study|Participants enrolled into another study|11|||
143115913|NCT02255552|515966372|FG000|Overall Study|Withdrawal by Subject|1|||
143115914|NCT02255552|515966373|FG001|Overall Study|Withdrawal by Subject|4|||
143115915|NCT01447446|515966374|FG000|Overall Study|Death|6|||
143115916|NCT01447446|515966375|FG001|Overall Study|Death|3|||
143115917|NCT01447446|515966376|FG002|Overall Study|Death|2|||
143115918|NCT01447446|515966377|FG003|Overall Study|Death|1|||
143115919|NCT01447446|515966378|FG004|Overall Study|Death|7|||
143115920|NCT01447446|515966379|FG005|Overall Study|Death|0|||
143115921|NCT01447446|515966374|FG000|Overall Study|Adverse Event|3|||
143115922|NCT01447446|515966375|FG001|Overall Study|Adverse Event|0|||
143115923|NCT01447446|515966376|FG002|Overall Study|Adverse Event|1|||
143115924|NCT01447446|515966377|FG003|Overall Study|Adverse Event|0|||
143115925|NCT01447446|515966378|FG004|Overall Study|Adverse Event|2|||
143115926|NCT01447446|515966379|FG005|Overall Study|Adverse Event|0|||
143115927|NCT01447446|515966374|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
143115928|NCT01447446|515966375|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
143115929|NCT01447446|515966376|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
143115930|NCT01447446|515966377|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
143115931|NCT01447446|515966378|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
143115932|NCT01447446|515966379|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
143115933|NCT01447446|515966374|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
143115934|NCT01447446|515966375|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
143115935|NCT01447446|515966376|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
143261343|NCT03452527|516510560|FG000|Overall Study|Withdrawal by Subject|1|||
143115936|NCT01447446|515966377|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
143115937|NCT01447446|515966378|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
143115938|NCT01447446|515966379|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
143115939|NCT01447446|515966374|FG000|Overall Study|Administrative/Other|34|||
143115940|NCT01447446|515966375|FG001|Overall Study|Administrative/Other|9|||
143115941|NCT01447446|515966376|FG002|Overall Study|Administrative/Other|10|||
143115942|NCT01447446|515966377|FG003|Overall Study|Administrative/Other|2|||
143115943|NCT01447446|515966378|FG004|Overall Study|Administrative/Other|33|||
143115944|NCT01447446|515966379|FG005|Overall Study|Administrative/Other|4|||
143115945|NCT01447446|515966374|FG000|Overall Study|SVR12 Assessment|13|||
143115946|NCT01447446|515966375|FG001|Overall Study|SVR12 Assessment|1|||
143115947|NCT01447446|515966376|FG002|Overall Study|SVR12 Assessment|2|||
143115948|NCT01447446|515966377|FG003|Overall Study|SVR12 Assessment|1|||
143115949|NCT01447446|515966378|FG004|Overall Study|SVR12 Assessment|5|||
143186517|NCT05396014|516228784|FG016|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143186518|NCT05396014|516228785|FG017|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143186519|NCT05396014|516228786|FG018|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143186520|NCT05396014|516228787|FG019|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143186521|NCT05396014|516228788|FG020|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143186522|NCT05396014|516228789|FG021|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143186523|NCT05396014|516228790|FG022|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143186524|NCT05396014|516228791|FG023|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143186525|NCT05396014|516228792|FG024|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143186526|NCT05396014|516228793|FG025|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143115950|NCT01447446|515966379|FG005|Overall Study|SVR12 Assessment|5|||
143186527|NCT05396014|516228794|FG026|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
143186528|NCT05396014|516228795|FG027|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143186529|NCT05396014|516228796|FG028|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143186530|NCT05396014|516228797|FG029|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143186531|NCT05396014|516228798|FG030|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143186532|NCT05396014|516228799|FG031|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143186533|NCT05396014|516228800|FG032|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143186534|NCT05396014|516228801|FG033|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143186535|NCT05396014|516228802|FG034|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143186536|NCT05396014|516228803|FG035|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143115951|NCT01447446|515966374|FG000|Overall Study|New Treatment Started|8|||
143115952|NCT01447446|515966375|FG001|Overall Study|New Treatment Started|2|||
143115953|NCT01447446|515966376|FG002|Overall Study|New Treatment Started|1|||
143115954|NCT01447446|515966377|FG003|Overall Study|New Treatment Started|0|||
143115955|NCT01447446|515966378|FG004|Overall Study|New Treatment Started|2|||
143115956|NCT01447446|515966379|FG005|Overall Study|New Treatment Started|0|||
143115957|NCT01447446|515966374|FG000|Overall Study|Reason not Specified|1|||
143115958|NCT01447446|515966375|FG001|Overall Study|Reason not Specified|1|||
143186537|NCT05396014|516228804|FG036|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143186538|NCT05396014|516228805|FG037|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143115959|NCT01447446|515966376|FG002|Overall Study|Reason not Specified|1|||
143115960|NCT01447446|515966377|FG003|Overall Study|Reason not Specified|1|||
143115961|NCT01447446|515966378|FG004|Overall Study|Reason not Specified|1|||
143115962|NCT01447446|515966379|FG005|Overall Study|Reason not Specified|0|||
143115963|NCT02604550|515966387|FG000|Overall Study|Lost to Follow-up|7|||
143186539|NCT05396014|516228806|FG038|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143186540|NCT05396014|516228807|FG039|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|14|||
143186541|NCT05396014|516228808|FG040|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143186542|NCT05396014|516228809|FG041|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143186543|NCT05396014|516228810|FG042|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
143186544|NCT05396014|516228768|FG000|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
143186545|NCT05396014|516228769|FG001|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143186546|NCT05396014|516228770|FG002|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143186547|NCT05396014|516228771|FG003|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143186548|NCT05396014|516228772|FG004|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143186549|NCT05396014|516228773|FG005|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143186550|NCT05396014|516228774|FG006|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143186551|NCT05396014|516228775|FG007|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143186552|NCT05396014|516228776|FG008|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143186553|NCT05396014|516228777|FG009|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143186554|NCT05396014|516228778|FG010|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143186555|NCT05396014|516228779|FG011|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143186556|NCT05396014|516228780|FG012|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143186557|NCT05396014|516228781|FG013|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
143186558|NCT05396014|516228782|FG014|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143369409|NCT01693614|516896090|FG000|Overall Study|Withdrawal by Subject|1|||
143115964|NCT02604550|515966388|FG001|Overall Study|Lost to Follow-up|6|||
143115965|NCT02604550|515966387|FG000|Overall Study|Withdrawal by Subject|0|||
143115966|NCT02604550|515966388|FG001|Overall Study|Withdrawal by Subject|1|||
143115967|NCT02604550|515966387|FG000|Overall Study|Incomplete data using paper journal|18|||
143115968|NCT02604550|515966388|FG001|Overall Study|Incomplete data using paper journal|19|||
143115969|NCT02609724|515966389|FG000|Overall Study|Death|2|||
143115970|NCT02609724|515966390|FG001|Overall Study|Death|0|||
143115971|NCT02609724|515966391|FG002|Overall Study|Death|1|||
143115972|NCT02609724|515966389|FG000|Overall Study|Withdrawal by Subject|1|||
143115973|NCT02609724|515966390|FG001|Overall Study|Withdrawal by Subject|2|||
143115974|NCT02609724|515966391|FG002|Overall Study|Withdrawal by Subject|3|||
143115975|NCT02609724|515966389|FG000|Overall Study|Illness|2|||
143115976|NCT02609724|515966390|FG001|Overall Study|Illness|1|||
143115977|NCT02609724|515966391|FG002|Overall Study|Illness|0|||
143115978|NCT03077659|515966392|FG000|Overall Study|Withdrawal by Subject|0|||
143115979|NCT03077659|515966393|FG001|Overall Study|Withdrawal by Subject|0|||
143115980|NCT03077659|515966394|FG002|Overall Study|Withdrawal by Subject|1|||
143115981|NCT03747302|515966395|FG000|Overall Study|Withdrawal by Subject|1|||
143115982|NCT03747302|515966396|FG001|Overall Study|Withdrawal by Subject|2|||
143115983|NCT01032070|515966399|FG000|Overall Study|Disease progression|13|||
143115984|NCT01032070|515966400|FG001|Overall Study|Disease progression|8|||
143115985|NCT01032070|515966399|FG000|Overall Study|Medical or ethical reasons|0|||
143115986|NCT01032070|515966400|FG001|Overall Study|Medical or ethical reasons|2|||
143115987|NCT01032070|515966399|FG000|Overall Study|Withdrawal by Subject|0|||
143115988|NCT01032070|515966400|FG001|Overall Study|Withdrawal by Subject|2|||
143115989|NCT02772276|515966401|FG000|Overall Study|Lost to Follow-up|0|||
143115990|NCT02772276|515966402|FG001|Overall Study|Lost to Follow-up|0|||
143115991|NCT02772276|515966403|FG002|Overall Study|Lost to Follow-up|0|||
143115992|NCT02772276|515966404|FG003|Overall Study|Lost to Follow-up|0|||
143115993|NCT02772276|515966405|FG004|Overall Study|Lost to Follow-up|0|||
143115994|NCT02772276|515966406|FG005|Overall Study|Lost to Follow-up|0|||
143115995|NCT02772276|515966407|FG006|Overall Study|Lost to Follow-up|1|||
143115996|NCT02772276|515966408|FG007|Overall Study|Lost to Follow-up|0|||
143115997|NCT02772276|515966409|FG008|Overall Study|Lost to Follow-up|0|||
143115998|NCT02772276|515966410|FG009|Overall Study|Lost to Follow-up|0|||
143115999|NCT02772276|515966411|FG010|Overall Study|Lost to Follow-up|0|||
143116000|NCT02772276|515966412|FG011|Overall Study|Lost to Follow-up|0|||
143116001|NCT02772276|515966413|FG012|Overall Study|Lost to Follow-up|0|||
143186559|NCT05396014|516228783|FG015|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143186560|NCT05396014|516228784|FG016|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143186561|NCT05396014|516228785|FG017|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143186562|NCT05396014|516228786|FG018|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143369410|NCT01693614|516896091|FG001|Overall Study|Withdrawal by Subject|0|||
143369411|NCT01693614|516896092|FG002|Overall Study|Withdrawal by Subject|5|||
143116002|NCT02772276|515966401|FG000|Overall Study|Withdrew consent|0|||
143116003|NCT02772276|515966402|FG001|Overall Study|Withdrew consent|0|||
143116004|NCT02772276|515966403|FG002|Overall Study|Withdrew consent|0|||
143116005|NCT02772276|515966404|FG003|Overall Study|Withdrew consent|0|||
143116006|NCT02772276|515966405|FG004|Overall Study|Withdrew consent|0|||
143116007|NCT02772276|515966406|FG005|Overall Study|Withdrew consent|0|||
143116008|NCT02772276|515966407|FG006|Overall Study|Withdrew consent|0|||
143116009|NCT02772276|515966408|FG007|Overall Study|Withdrew consent|1|||
143116010|NCT02772276|515966409|FG008|Overall Study|Withdrew consent|0|||
143116011|NCT02772276|515966410|FG009|Overall Study|Withdrew consent|0|||
143116012|NCT02772276|515966411|FG010|Overall Study|Withdrew consent|0|||
143116013|NCT02772276|515966412|FG011|Overall Study|Withdrew consent|0|||
143116014|NCT02772276|515966413|FG012|Overall Study|Withdrew consent|0|||
143116015|NCT00033657|515966414|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
143116016|NCT00033657|515966415|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
143116017|NCT00033657|515966414|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
143116018|NCT00033657|515966415|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
143369412|NCT00420316|516896095|FG000|Overall Study|Withdrawal by Subject|0|||
143369413|NCT00420316|516896096|FG001|Overall Study|Withdrawal by Subject|1|||
143369414|NCT00420316|516896095|FG000|Overall Study|Lost to Follow-up|12|||
143116019|NCT00033657|515966414|FG000|Neoadjuvant Chemotherapy|Death|1|||
143186563|NCT05396014|516228787|FG019|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143116020|NCT00033657|515966415|FG001|Neoadjuvant Chemotherapy|Death|1|||
143116021|NCT00033657|515966414|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
143116022|NCT00033657|515966415|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
143116023|NCT00033657|515966414|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
143116024|NCT00033657|515966415|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
143116025|NCT00033657|515966414|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
143116026|NCT00033657|515966415|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
143116027|NCT00033657|515966414|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
143116028|NCT00033657|515966415|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
143116029|NCT00033657|515966414|FG000|Surgical Resection|not complete resection|0|||
143116030|NCT00033657|515966415|FG001|Surgical Resection|not complete resection|3|||
143116031|NCT00033657|515966414|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
143116032|NCT00033657|515966415|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
143116033|NCT00033657|515966414|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
143116034|NCT00033657|515966415|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
143116035|NCT00033657|515966414|FG000|Adjuvant Chemotherapy|Death|2|||
143116036|NCT00033657|515966415|FG001|Adjuvant Chemotherapy|Death|1|||
143116037|NCT00033657|515966414|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
143116038|NCT00033657|515966415|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
143116039|NCT00033657|515966414|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
143116040|NCT00033657|515966415|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
143116041|NCT00033657|515966414|FG000|Adjuvant Chemotherapy|Other|0|||
143116042|NCT00033657|515966415|FG001|Adjuvant Chemotherapy|Other|2|||
143116043|NCT02248974|515966416|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
143116044|NCT02248974|515966417|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
143116045|NCT02248974|515966416|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
143116046|NCT02248974|515966417|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
143116047|NCT02248974|515966416|FG000|1-Day Follow-Up|Enrolled in another study|1|||
143116048|NCT02248974|515966417|FG001|1-Day Follow-Up|Enrolled in another study|0|||
143186564|NCT05396014|516228788|FG020|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143186565|NCT05396014|516228789|FG021|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143186566|NCT05396014|516228790|FG022|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143186567|NCT05396014|516228791|FG023|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143186568|NCT05396014|516228792|FG024|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143116049|NCT02248974|515966416|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
143116050|NCT02248974|515966417|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
143116051|NCT02248974|515966416|FG000|1-Week Follow-Up|Enrolled in another study|1|||
143116052|NCT02248974|515966417|FG001|1-Week Follow-Up|Enrolled in another study|1|||
143116053|NCT02248974|515966416|FG000|1-Week Follow-Up|Transferred to another facility|1|||
143116054|NCT02248974|515966417|FG001|1-Week Follow-Up|Transferred to another facility|0|||
143116055|NCT02248974|515966416|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
143116056|NCT02248974|515966417|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
143116057|NCT02248974|515966416|FG000|1-Week Follow-Up|Death|1|||
143116058|NCT02248974|515966417|FG001|1-Week Follow-Up|Death|1|||
143116059|NCT02248974|515966416|FG000|1-Week Follow-Up|Excluded because of age|0|||
143116060|NCT02248974|515966417|FG001|1-Week Follow-Up|Excluded because of age|1|||
143116061|NCT02248974|515966416|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
143116062|NCT02248974|515966417|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
143116063|NCT02248974|515966416|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
143116064|NCT02248974|515966417|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
143116065|NCT02248974|515966416|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
143116066|NCT02248974|515966417|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
143116067|NCT02248974|515966416|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
143116068|NCT02248974|515966417|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
143116069|NCT02248974|515966416|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
143116070|NCT02248974|515966417|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
143116071|NCT02332239|515966418|FG000|Overall Study|Lost to Follow-up|4|||
143116072|NCT02332239|515966419|FG001|Overall Study|Lost to Follow-up|6|||
143116073|NCT00894790|515966420|FG000|Overall Study|Protocol Violation|0|||
143116074|NCT00894790|515966421|FG001|Overall Study|Protocol Violation|1|||
143116075|NCT00894790|515966420|FG000|Overall Study|Lost to Follow-up|0|||
143116076|NCT00894790|515966421|FG001|Overall Study|Lost to Follow-up|1|||
143116077|NCT00894790|515966420|FG000|Overall Study|Did not meet entrance criteria|1|||
143116078|NCT00894790|515966421|FG001|Overall Study|Did not meet entrance criteria|0|||
143116079|NCT04093492|515966422|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
143116080|NCT04093492|515966423|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
143116081|NCT04093492|515966424|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
143116082|NCT04093492|515966425|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
143116083|NCT04093492|515966422|FG000|25 Weeks Gestational Age (GA)|No response|5|||
143116084|NCT04093492|515966423|FG001|25 Weeks Gestational Age (GA)|No response|5|||
143116085|NCT04093492|515966424|FG002|25 Weeks Gestational Age (GA)|No response|5|||
143116086|NCT04093492|515966425|FG003|25 Weeks Gestational Age (GA)|No response|2|||
143116087|NCT04093492|515966422|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
143116088|NCT04093492|515966423|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
143116089|NCT04093492|515966424|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
143116090|NCT04093492|515966425|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
143116091|NCT04093492|515966422|FG000|30 Weeks GA|Delivered before assessment|1|||
143116092|NCT04093492|515966423|FG001|30 Weeks GA|Delivered before assessment|2|||
143116093|NCT04093492|515966424|FG002|30 Weeks GA|Delivered before assessment|0|||
143116094|NCT04093492|515966425|FG003|30 Weeks GA|Delivered before assessment|0|||
143116095|NCT04093492|515966422|FG000|30 Weeks GA|No response|7|||
143116096|NCT04093492|515966423|FG001|30 Weeks GA|No response|5|||
143116097|NCT04093492|515966424|FG002|30 Weeks GA|No response|5|||
143186569|NCT05396014|516228793|FG025|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143186570|NCT05396014|516228794|FG026|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
143186571|NCT05396014|516228795|FG027|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143186572|NCT05396014|516228796|FG028|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143186573|NCT05396014|516228797|FG029|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143186574|NCT05396014|516228798|FG030|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143186575|NCT05396014|516228799|FG031|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143186576|NCT05396014|516228800|FG032|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143186577|NCT05396014|516228801|FG033|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143186578|NCT05396014|516228802|FG034|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143186579|NCT05396014|516228803|FG035|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143186580|NCT05396014|516228804|FG036|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143186581|NCT05396014|516228805|FG037|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143186582|NCT05396014|516228806|FG038|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143186583|NCT05396014|516228807|FG039|Stage 1 Intervention (Weeks 0-12)|Adverse Event|1|||
143186584|NCT05396014|516228808|FG040|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143186585|NCT05396014|516228809|FG041|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143186586|NCT05396014|516228810|FG042|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
143186587|NCT05396014|516228768|FG000|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186588|NCT05396014|516228769|FG001|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186589|NCT05396014|516228770|FG002|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186590|NCT05396014|516228771|FG003|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186591|NCT05396014|516228772|FG004|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186592|NCT05396014|516228773|FG005|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186593|NCT05396014|516228774|FG006|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186594|NCT05396014|516228775|FG007|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186595|NCT05396014|516228776|FG008|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186596|NCT05396014|516228777|FG009|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186597|NCT05396014|516228778|FG010|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186598|NCT05396014|516228779|FG011|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186599|NCT05396014|516228780|FG012|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186600|NCT05396014|516228781|FG013|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186601|NCT05396014|516228782|FG014|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186602|NCT05396014|516228783|FG015|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186603|NCT05396014|516228784|FG016|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186604|NCT05396014|516228785|FG017|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186605|NCT05396014|516228786|FG018|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186606|NCT05396014|516228787|FG019|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186607|NCT05396014|516228788|FG020|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186608|NCT05396014|516228789|FG021|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186609|NCT05396014|516228790|FG022|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186610|NCT05396014|516228791|FG023|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186611|NCT05396014|516228792|FG024|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186612|NCT05396014|516228793|FG025|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186613|NCT05396014|516228794|FG026|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
143186614|NCT05396014|516228795|FG027|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186615|NCT05396014|516228796|FG028|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186616|NCT05396014|516228797|FG029|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186617|NCT05396014|516228798|FG030|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186618|NCT05396014|516228799|FG031|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143369415|NCT00420316|516896096|FG001|Overall Study|Lost to Follow-up|8|||
143369416|NCT02281318|516896097|FG000|Overall Study|Adverse Event|2|||
143186619|NCT05396014|516228800|FG032|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186620|NCT05396014|516228801|FG033|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186621|NCT05396014|516228802|FG034|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186622|NCT05396014|516228803|FG035|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186623|NCT05396014|516228804|FG036|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186624|NCT05396014|516228805|FG037|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186625|NCT05396014|516228806|FG038|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186626|NCT05396014|516228807|FG039|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
143186627|NCT05396014|516228808|FG040|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186628|NCT05396014|516228809|FG041|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186629|NCT05396014|516228810|FG042|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
143186630|NCT05396014|516228768|FG000|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186631|NCT05396014|516228769|FG001|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186632|NCT05396014|516228770|FG002|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186633|NCT05396014|516228771|FG003|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186634|NCT05396014|516228772|FG004|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186635|NCT05396014|516228773|FG005|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186636|NCT05396014|516228774|FG006|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186637|NCT05396014|516228775|FG007|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186638|NCT05396014|516228776|FG008|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186639|NCT05396014|516228777|FG009|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186640|NCT05396014|516228778|FG010|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186641|NCT05396014|516228779|FG011|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186642|NCT05396014|516228780|FG012|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186643|NCT05396014|516228781|FG013|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186644|NCT05396014|516228782|FG014|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186645|NCT05396014|516228783|FG015|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186646|NCT05396014|516228784|FG016|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186647|NCT05396014|516228785|FG017|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186648|NCT05396014|516228786|FG018|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186649|NCT05396014|516228787|FG019|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186650|NCT05396014|516228788|FG020|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186651|NCT05396014|516228789|FG021|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186652|NCT05396014|516228790|FG022|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186653|NCT05396014|516228791|FG023|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186654|NCT05396014|516228792|FG024|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186655|NCT05396014|516228793|FG025|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186656|NCT05396014|516228794|FG026|Stage 1 Intervention (Weeks 0-12)|Physician Decision|1|||
143186657|NCT05396014|516228795|FG027|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186658|NCT05396014|516228796|FG028|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186659|NCT05396014|516228797|FG029|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186660|NCT05396014|516228798|FG030|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186661|NCT05396014|516228799|FG031|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186662|NCT05396014|516228800|FG032|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186663|NCT05396014|516228801|FG033|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186664|NCT05396014|516228802|FG034|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186665|NCT05396014|516228803|FG035|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143116098|NCT04093492|515966425|FG003|30 Weeks GA|No response|2|||
143116099|NCT04093492|515966422|FG000|30 Weeks GA|Lost to Follow-up|0|||
143116100|NCT04093492|515966423|FG001|30 Weeks GA|Lost to Follow-up|1|||
143116101|NCT04093492|515966424|FG002|30 Weeks GA|Lost to Follow-up|0|||
143116102|NCT04093492|515966425|FG003|30 Weeks GA|Lost to Follow-up|0|||
143116103|NCT04093492|515966422|FG000|34 Weeks GA|Delivered before assessment|6|||
143116104|NCT04093492|515966423|FG001|34 Weeks GA|Delivered before assessment|3|||
143116105|NCT04093492|515966424|FG002|34 Weeks GA|Delivered before assessment|0|||
143116106|NCT04093492|515966425|FG003|34 Weeks GA|Delivered before assessment|0|||
143116107|NCT04093492|515966422|FG000|34 Weeks GA|No response|0|||
143116108|NCT04093492|515966423|FG001|34 Weeks GA|No response|7|||
143116109|NCT04093492|515966424|FG002|34 Weeks GA|No response|5|||
143116110|NCT04093492|515966425|FG003|34 Weeks GA|No response|3|||
143116111|NCT04093492|515966422|FG000|34 Weeks GA|Lost to Follow-up|0|||
143116112|NCT04093492|515966423|FG001|34 Weeks GA|Lost to Follow-up|1|||
143116113|NCT04093492|515966424|FG002|34 Weeks GA|Lost to Follow-up|0|||
143116114|NCT04093492|515966425|FG003|34 Weeks GA|Lost to Follow-up|0|||
143116115|NCT00006305|515966429|FG000|Overall Study|Withdrawal by Subject|17|||
143186666|NCT05396014|516228804|FG036|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186667|NCT05396014|516228805|FG037|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186668|NCT05396014|516228806|FG038|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186669|NCT05396014|516228807|FG039|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186670|NCT05396014|516228808|FG040|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186671|NCT05396014|516228809|FG041|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186672|NCT05396014|516228810|FG042|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
143186673|NCT05396014|516228768|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186674|NCT05396014|516228769|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186675|NCT05396014|516228770|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186676|NCT05396014|516228771|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186677|NCT05396014|516228772|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186678|NCT05396014|516228773|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186679|NCT05396014|516228774|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186680|NCT05396014|516228775|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186681|NCT05396014|516228776|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186682|NCT05396014|516228777|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186683|NCT05396014|516228778|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186684|NCT05396014|516228779|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186685|NCT05396014|516228780|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186686|NCT05396014|516228781|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|1|||
143186687|NCT05396014|516228782|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186688|NCT05396014|516228783|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186689|NCT05396014|516228784|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186690|NCT05396014|516228785|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186691|NCT05396014|516228786|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186692|NCT05396014|516228787|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186693|NCT05396014|516228788|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186694|NCT05396014|516228789|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186695|NCT05396014|516228790|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186696|NCT05396014|516228791|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186697|NCT05396014|516228792|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186698|NCT05396014|516228793|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186699|NCT05396014|516228794|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186700|NCT05396014|516228795|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186701|NCT05396014|516228796|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186702|NCT05396014|516228797|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186703|NCT05396014|516228798|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186704|NCT05396014|516228799|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186705|NCT05396014|516228800|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186706|NCT05396014|516228801|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186707|NCT05396014|516228802|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186708|NCT05396014|516228803|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186709|NCT05396014|516228804|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186710|NCT05396014|516228805|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186711|NCT05396014|516228806|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186712|NCT05396014|516228807|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186713|NCT05396014|516228808|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186714|NCT05396014|516228809|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186715|NCT05396014|516228810|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
143186716|NCT05396014|516228768|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
143186717|NCT05396014|516228769|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186718|NCT05396014|516228770|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186719|NCT05396014|516228771|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186720|NCT05396014|516228772|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186721|NCT05396014|516228773|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186722|NCT05396014|516228774|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186723|NCT05396014|516228775|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186724|NCT05396014|516228776|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186725|NCT05396014|516228777|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186726|NCT05396014|516228778|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143261344|NCT03452527|516510561|FG001|Overall Study|Withdrawal by Subject|1|||
143261345|NCT03452527|516510560|FG000|Overall Study|Study Terminated|2|||
143116116|NCT00006305|515966430|FG001|Overall Study|Withdrawal by Subject|10|||
143116117|NCT00006305|515966431|FG002|Overall Study|Withdrawal by Subject|15|||
143186727|NCT05396014|516228779|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186728|NCT05396014|516228780|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186729|NCT05396014|516228781|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
143186730|NCT05396014|516228782|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186731|NCT05396014|516228783|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186732|NCT05396014|516228784|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186733|NCT05396014|516228785|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186734|NCT05396014|516228786|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186735|NCT05396014|516228787|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186736|NCT05396014|516228788|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186737|NCT05396014|516228789|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186738|NCT05396014|516228790|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186739|NCT05396014|516228791|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186740|NCT05396014|516228792|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186741|NCT05396014|516228793|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186742|NCT05396014|516228794|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186743|NCT05396014|516228795|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186744|NCT05396014|516228796|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186745|NCT05396014|516228797|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186746|NCT05396014|516228798|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186747|NCT05396014|516228799|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186748|NCT05396014|516228800|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186749|NCT05396014|516228801|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186750|NCT05396014|516228802|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186751|NCT05396014|516228803|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186752|NCT05396014|516228804|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186753|NCT05396014|516228805|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186754|NCT05396014|516228806|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186755|NCT05396014|516228807|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|2|||
143186756|NCT05396014|516228808|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186757|NCT05396014|516228809|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186758|NCT05396014|516228810|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
143186759|NCT05396014|516228768|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
143186760|NCT05396014|516228769|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143186761|NCT05396014|516228770|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143186762|NCT05396014|516228771|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143186763|NCT05396014|516228772|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143186764|NCT05396014|516228773|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143186765|NCT05396014|516228774|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143186766|NCT05396014|516228775|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143186767|NCT05396014|516228776|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143186768|NCT05396014|516228777|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143186769|NCT05396014|516228778|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143186770|NCT05396014|516228779|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143186771|NCT05396014|516228780|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143186772|NCT05396014|516228781|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143186773|NCT05396014|516228782|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143186774|NCT05396014|516228783|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143116118|NCT00006305|515966432|FG003|Overall Study|Withdrawal by Subject|14|||
143116119|NCT00662558|515966435|FG000|Overall Study|Adverse Event|21|||
143186775|NCT05396014|516228784|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143186776|NCT05396014|516228785|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143186777|NCT05396014|516228786|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143186778|NCT05396014|516228787|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143116120|NCT00662558|515966436|FG001|Overall Study|Adverse Event|59|||
143116121|NCT00662558|515966435|FG000|Overall Study|Lack of Efficacy|4|||
143116122|NCT00662558|515966436|FG001|Overall Study|Lack of Efficacy|7|||
143116123|NCT00662558|515966435|FG000|Overall Study|Lost to Follow-up|13|||
143116124|NCT00662558|515966436|FG001|Overall Study|Lost to Follow-up|10|||
143116125|NCT00662558|515966435|FG000|Overall Study|Other|9|||
143116126|NCT00662558|515966436|FG001|Overall Study|Other|14|||
143116127|NCT00662558|515966435|FG000|Overall Study|Withdrawal by Subject|7|||
143116128|NCT00662558|515966436|FG001|Overall Study|Withdrawal by Subject|12|||
143116129|NCT00662558|515966435|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
143186779|NCT05396014|516228788|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143186780|NCT05396014|516228789|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143116130|NCT00662558|515966436|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
143116131|NCT00783224|515966439|FG000|Overall Study|Adverse Event|0|||
143116132|NCT00783224|515966440|FG001|Overall Study|Adverse Event|0|||
143116133|NCT00783224|515966441|FG002|Overall Study|Adverse Event|1|||
143116134|NCT00783224|515966442|FG003|Overall Study|Adverse Event|0|||
143116135|NCT00783224|515966439|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
143116136|NCT00783224|515966440|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
143116137|NCT00783224|515966441|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
143116138|NCT00783224|515966442|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
143116139|NCT00783224|515966439|FG000|Overall Study|Inappropriate as a study subject|0|||
143116140|NCT00783224|515966440|FG001|Overall Study|Inappropriate as a study subject|0|||
143116141|NCT00783224|515966441|FG002|Overall Study|Inappropriate as a study subject|0|||
143116142|NCT00783224|515966442|FG003|Overall Study|Inappropriate as a study subject|1|||
143116143|NCT01711619|515966443|FG000|Overall Study|Early study termination|10|||
143116144|NCT01711619|515966444|FG001|Overall Study|Early study termination|14|||
143116145|NCT01711619|515966443|FG000|Overall Study|Withdrawal by Subject|3|||
143116146|NCT01711619|515966444|FG001|Overall Study|Withdrawal by Subject|7|||
143116147|NCT01711619|515966443|FG000|Overall Study|Protocol Violation|2|||
143116148|NCT01711619|515966444|FG001|Overall Study|Protocol Violation|3|||
143116149|NCT01711619|515966443|FG000|Overall Study|Adverse Event|2|||
143116150|NCT01711619|515966444|FG001|Overall Study|Adverse Event|0|||
143116151|NCT01711619|515966443|FG000|Overall Study|Lost to Follow-up|1|||
143116152|NCT01711619|515966444|FG001|Overall Study|Lost to Follow-up|0|||
143116153|NCT00503997|515966455|FG000|Overall Study|disease progression|1|||
143116154|NCT00503997|515966455|FG000|Overall Study|Adverse Event|5|||
143116155|NCT00503997|515966455|FG000|Overall Study|Death|1|||
143116156|NCT00503997|515966455|FG000|Overall Study|Withdrawal by Subject|1|||
143116157|NCT01195844|515966456|FG000|Overall Study|Fecal sample not collected|40|||
143116158|NCT00772005|515966458|FG000|Overall Study|Adverse Event|9|||
143116159|NCT00772005|515966459|FG001|Overall Study|Adverse Event|14|||
143116160|NCT00772005|515966460|FG002|Overall Study|Adverse Event|10|||
143116161|NCT00772005|515966461|FG003|Overall Study|Adverse Event|13|||
143116162|NCT00772005|515966458|FG000|Overall Study|Lack of Efficacy|0|||
143116163|NCT00772005|515966459|FG001|Overall Study|Lack of Efficacy|1|||
143116164|NCT00772005|515966460|FG002|Overall Study|Lack of Efficacy|0|||
143116165|NCT00772005|515966461|FG003|Overall Study|Lack of Efficacy|0|||
143116166|NCT00772005|515966458|FG000|Overall Study|Withdrawal by Subject|3|||
143116167|NCT00772005|515966459|FG001|Overall Study|Withdrawal by Subject|7|||
143116168|NCT00772005|515966460|FG002|Overall Study|Withdrawal by Subject|10|||
143116169|NCT00772005|515966461|FG003|Overall Study|Withdrawal by Subject|2|||
143116170|NCT00772005|515966458|FG000|Overall Study|Protocol Violation|2|||
143116171|NCT00772005|515966459|FG001|Overall Study|Protocol Violation|4|||
143116172|NCT00772005|515966460|FG002|Overall Study|Protocol Violation|1|||
143116173|NCT00772005|515966461|FG003|Overall Study|Protocol Violation|6|||
143116174|NCT00772005|515966458|FG000|Overall Study|Lost to Follow-up|7|||
143116175|NCT00772005|515966459|FG001|Overall Study|Lost to Follow-up|3|||
143116176|NCT00772005|515966460|FG002|Overall Study|Lost to Follow-up|6|||
143116177|NCT00772005|515966461|FG003|Overall Study|Lost to Follow-up|3|||
143116178|NCT00772005|515966458|FG000|Overall Study|Non-compliance with study procedures|1|||
143116179|NCT00772005|515966459|FG001|Overall Study|Non-compliance with study procedures|1|||
143116180|NCT00772005|515966460|FG002|Overall Study|Non-compliance with study procedures|0|||
143116181|NCT00772005|515966461|FG003|Overall Study|Non-compliance with study procedures|1|||
143116182|NCT00772005|515966458|FG000|Overall Study|Non-compliance with drug administration|3|||
143116183|NCT00772005|515966459|FG001|Overall Study|Non-compliance with drug administration|0|||
143116184|NCT00772005|515966460|FG002|Overall Study|Non-compliance with drug administration|1|||
143116185|NCT00772005|515966461|FG003|Overall Study|Non-compliance with drug administration|1|||
143116186|NCT02607280|515968474|FG000|Overall Study|Adverse Event|4|||
143116187|NCT02607280|515968475|FG001|Overall Study|Adverse Event|0|||
143116188|NCT02607280|515968474|FG000|Overall Study|Decrease in CrCl <15|0|||
143116189|NCT02607280|515968475|FG001|Overall Study|Decrease in CrCl <15|1|||
143116190|NCT00590538|515968476|FG000|Overall Study|Study terminated before completed|2|||
143116191|NCT01125813|515968477|FG000|Overall Study|Death|1|||
143116192|NCT01125813|515968477|FG000|Overall Study|Withdrawal by Subject|1|||
143116193|NCT01125813|515968477|FG000|Overall Study|Screen Failures|4|||
143116194|NCT02327013|515968478|FG000|Overall Study|Adverse Event|4|||
143116195|NCT02327013|515968479|FG001|Overall Study|Adverse Event|4|||
143116196|NCT02327013|515968480|FG002|Overall Study|Adverse Event|3|||
143116197|NCT02327013|515968481|FG003|Overall Study|Adverse Event|0|||
143116198|NCT02327013|515968482|FG004|Overall Study|Adverse Event|1|||
143116199|NCT02327013|515968478|FG000|Overall Study|Lack of Efficacy|2|||
143116200|NCT02327013|515968479|FG001|Overall Study|Lack of Efficacy|0|||
143116201|NCT02327013|515968480|FG002|Overall Study|Lack of Efficacy|5|||
143116202|NCT02327013|515968481|FG003|Overall Study|Lack of Efficacy|0|||
143116203|NCT02327013|515968482|FG004|Overall Study|Lack of Efficacy|1|||
143116204|NCT02327013|515968478|FG000|Overall Study|Non-compliance with IMP|1|||
143116205|NCT02327013|515968479|FG001|Overall Study|Non-compliance with IMP|2|||
143116206|NCT02327013|515968480|FG002|Overall Study|Non-compliance with IMP|7|||
143116207|NCT02327013|515968481|FG003|Overall Study|Non-compliance with IMP|0|||
143116208|NCT02327013|515968482|FG004|Overall Study|Non-compliance with IMP|0|||
143116209|NCT02327013|515968478|FG000|Overall Study|Withdrawal of Consent|1|||
143116210|NCT02327013|515968479|FG001|Overall Study|Withdrawal of Consent|0|||
143116211|NCT02327013|515968480|FG002|Overall Study|Withdrawal of Consent|3|||
143116212|NCT02327013|515968481|FG003|Overall Study|Withdrawal of Consent|0|||
143116213|NCT02327013|515968482|FG004|Overall Study|Withdrawal of Consent|0|||
143116214|NCT02327013|515968478|FG000|Overall Study|Lost to Follow-up|2|||
143116215|NCT02327013|515968479|FG001|Overall Study|Lost to Follow-up|4|||
143116216|NCT02327013|515968480|FG002|Overall Study|Lost to Follow-up|5|||
143116217|NCT02327013|515968481|FG003|Overall Study|Lost to Follow-up|0|||
143116218|NCT02327013|515968482|FG004|Overall Study|Lost to Follow-up|0|||
143116219|NCT02327013|515968478|FG000|Overall Study|Administrative or other reason(s)|1|||
143116220|NCT02327013|515968479|FG001|Overall Study|Administrative or other reason(s)|5|||
143116221|NCT02327013|515968480|FG002|Overall Study|Administrative or other reason(s)|11|||
143116222|NCT02327013|515968481|FG003|Overall Study|Administrative or other reason(s)|1|||
143116223|NCT02327013|515968482|FG004|Overall Study|Administrative or other reason(s)|1|||
143116224|NCT02327013|515968478|FG000|Overall Study|Protocol Violation|0|||
143116225|NCT02327013|515968479|FG001|Overall Study|Protocol Violation|0|||
143116226|NCT02327013|515968480|FG002|Overall Study|Protocol Violation|3|||
143116227|NCT02327013|515968481|FG003|Overall Study|Protocol Violation|0|||
143116228|NCT02327013|515968482|FG004|Overall Study|Protocol Violation|1|||
143116229|NCT02327013|515968478|FG000|Overall Study|Withdrawal before treatment|2|||
143116230|NCT02327013|515968479|FG001|Overall Study|Withdrawal before treatment|1|||
143116231|NCT02327013|515968480|FG002|Overall Study|Withdrawal before treatment|5|||
143116232|NCT02327013|515968481|FG003|Overall Study|Withdrawal before treatment|0|||
143116233|NCT02327013|515968482|FG004|Overall Study|Withdrawal before treatment|0|||
143116234|NCT02380859|515968483|FG000|Overall Study|Withdrawal by Subject|2|||
143116235|NCT02380859|515968484|FG001|Overall Study|Withdrawal by Subject|0|||
143116236|NCT01565668|515968485|FG000|Overall Study|Death|2|||
143116237|NCT01565668|515968486|FG001|Overall Study|Death|1|||
143116238|NCT01565668|515968485|FG000|Overall Study|Lack of Efficacy|4|||
143116239|NCT01565668|515968486|FG001|Overall Study|Lack of Efficacy|2|||
143116240|NCT01565668|515968485|FG000|Overall Study|Participant went on Hospice Care|1|||
143116241|NCT01565668|515968486|FG001|Overall Study|Participant went on Hospice Care|0|||
143116242|NCT01565668|515968485|FG000|Overall Study|Adverse Event|6|||
143116243|NCT01565668|515968486|FG001|Overall Study|Adverse Event|1|||
143116244|NCT01565668|515968485|FG000|Overall Study|Randomized, but never received drug|0|||
143116245|NCT01565668|515968486|FG001|Overall Study|Randomized, but never received drug|2|||
143186781|NCT05396014|516228790|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143186782|NCT05396014|516228791|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143186783|NCT05396014|516228792|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143186784|NCT05396014|516228793|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143186785|NCT05396014|516228794|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
143186786|NCT05396014|516228795|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143186787|NCT05396014|516228796|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143186788|NCT05396014|516228797|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143186789|NCT05396014|516228798|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143186790|NCT05396014|516228799|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143186791|NCT05396014|516228800|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143186792|NCT05396014|516228801|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143186793|NCT05396014|516228802|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143186794|NCT05396014|516228803|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143186795|NCT05396014|516228804|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143186796|NCT05396014|516228805|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143186797|NCT05396014|516228806|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143116246|NCT01565668|515968485|FG000|Overall Study|Progressive disease|13|||
143116247|NCT01565668|515968486|FG001|Overall Study|Progressive disease|14|||
143116248|NCT01565668|515968485|FG000|Overall Study|Withdrawal by Subject|1|||
143116249|NCT01565668|515968486|FG001|Overall Study|Withdrawal by Subject|3|||
143116250|NCT01565668|515968485|FG000|Overall Study|HSCT Transplant|11|||
143116251|NCT01565668|515968486|FG001|Overall Study|HSCT Transplant|15|||
143116252|NCT04829331|515968487|FG000|Overall Study|Lost to Follow-up|1|||
143261346|NCT03452527|516510561|FG001|Overall Study|Study Terminated|3|||
143116253|NCT04829331|515968488|FG001|Overall Study|Lost to Follow-up|0|||
143116254|NCT03769675|515968493|FG000|Overall Study|Lost to Follow-up|1|||
143116255|NCT00738062|515968494|FG000|Open Label Treatment|Lack of Efficacy|5|||
143186798|NCT05396014|516228807|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143186799|NCT05396014|516228808|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143186800|NCT05396014|516228809|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143186801|NCT05396014|516228810|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
143186802|NCT05396014|516228768|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186803|NCT05396014|516228769|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186804|NCT05396014|516228770|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186805|NCT05396014|516228771|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186806|NCT05396014|516228772|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186807|NCT05396014|516228773|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186808|NCT05396014|516228774|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186809|NCT05396014|516228775|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186810|NCT05396014|516228776|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186811|NCT05396014|516228777|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186812|NCT05396014|516228778|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186813|NCT05396014|516228779|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186814|NCT05396014|516228780|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186815|NCT05396014|516228781|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|1|||
143116256|NCT00738062|515968495|FG001|Open Label Treatment|Lack of Efficacy|0|||
143116257|NCT00738062|515968496|FG002|Open Label Treatment|Lack of Efficacy|0|||
143116258|NCT00738062|515968494|FG000|Open Label Treatment|Adverse Event|11|||
143116259|NCT00738062|515968495|FG001|Open Label Treatment|Adverse Event|0|||
143116260|NCT00738062|515968496|FG002|Open Label Treatment|Adverse Event|0|||
143116261|NCT00738062|515968494|FG000|Open Label Treatment|Protocol Violation|2|||
143116262|NCT00738062|515968495|FG001|Open Label Treatment|Protocol Violation|0|||
143116263|NCT00738062|515968496|FG002|Open Label Treatment|Protocol Violation|0|||
143116264|NCT00738062|515968494|FG000|Open Label Treatment|Withdrawal by Subject|9|||
143116265|NCT00738062|515968495|FG001|Open Label Treatment|Withdrawal by Subject|0|||
143116266|NCT00738062|515968496|FG002|Open Label Treatment|Withdrawal by Subject|0|||
143116267|NCT00738062|515968494|FG000|Open Label Treatment|Investigator Decision|1|||
143116268|NCT00738062|515968495|FG001|Open Label Treatment|Investigator Decision|0|||
143116269|NCT00738062|515968496|FG002|Open Label Treatment|Investigator Decision|0|||
143116270|NCT00738062|515968494|FG000|Open-Label Extension|Adverse Event|5|||
143116271|NCT00738062|515968495|FG001|Open-Label Extension|Adverse Event|0|||
143116272|NCT00738062|515968496|FG002|Open-Label Extension|Adverse Event|0|||
143116273|NCT00738062|515968494|FG000|Open-Label Extension|Physician Decision|1|||
143116274|NCT00738062|515968495|FG001|Open-Label Extension|Physician Decision|0|||
143116275|NCT00738062|515968496|FG002|Open-Label Extension|Physician Decision|0|||
143116276|NCT00738062|515968494|FG000|Open-Label Extension|Lack of Efficacy|2|||
143116277|NCT00738062|515968495|FG001|Open-Label Extension|Lack of Efficacy|0|||
143116278|NCT00738062|515968496|FG002|Open-Label Extension|Lack of Efficacy|0|||
143116279|NCT00738062|515968494|FG000|Open-Label Extension|Withdrawal by Subject|6|||
143116280|NCT00738062|515968495|FG001|Open-Label Extension|Withdrawal by Subject|0|||
143116281|NCT00738062|515968496|FG002|Open-Label Extension|Withdrawal by Subject|0|||
143116282|NCT00738062|515968494|FG000|Open-Label Extension|Protocol Violation|1|||
143116283|NCT00738062|515968495|FG001|Open-Label Extension|Protocol Violation|0|||
143116284|NCT00738062|515968496|FG002|Open-Label Extension|Protocol Violation|0|||
143116285|NCT00738062|515968494|FG000|Open-Label Extension|Study Terminated|2|||
143116286|NCT00738062|515968495|FG001|Open-Label Extension|Study Terminated|0|||
143116287|NCT00738062|515968496|FG002|Open-Label Extension|Study Terminated|0|||
143116288|NCT00426660|515968497|FG000|Overall Study|Death|14|||
143116289|NCT00426660|515968497|FG000|Overall Study|Adverse Event|23|||
143116290|NCT00426660|515968497|FG000|Overall Study|Insufficient Clinical Response|22|||
143116291|NCT00426660|515968497|FG000|Overall Study|Lost to Follow-up|15|||
143116292|NCT00426660|515968497|FG000|Overall Study|Other|23|||
143186816|NCT05396014|516228782|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186817|NCT05396014|516228783|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186818|NCT05396014|516228784|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186819|NCT05396014|516228785|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186820|NCT05396014|516228786|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186821|NCT05396014|516228787|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143116293|NCT00426660|515968497|FG000|Overall Study|Withdrawal by Subject|18|||
143116294|NCT00426660|515968497|FG000|Overall Study|Protocol Violation|1|||
143116295|NCT00426660|515968497|FG000|Overall Study|Enrolled Not Treated|15|||
143116296|NCT00980174|515968498|FG000|Overall Study|Withdrawal by Subject|1|||
143116297|NCT00980174|515968499|FG001|Overall Study|Withdrawal by Subject|4|||
143116298|NCT00980174|515968498|FG000|Overall Study|Adverse Event|0|||
143116299|NCT00980174|515968499|FG001|Overall Study|Adverse Event|3|||
143186822|NCT05396014|516228788|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186823|NCT05396014|516228789|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186824|NCT05396014|516228790|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186825|NCT05396014|516228791|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143116300|NCT00980174|515968498|FG000|Overall Study|Ineligibility determined|2|||
143116301|NCT00980174|515968499|FG001|Overall Study|Ineligibility determined|1|||
143116302|NCT00980174|515968498|FG000|Overall Study|Death|1|||
143116303|NCT00980174|515968499|FG001|Overall Study|Death|1|||
143116304|NCT00980174|515968498|FG000|Overall Study|Other|0|||
143116305|NCT00980174|515968499|FG001|Overall Study|Other|1|||
143116306|NCT03422159|515968500|FG000|Overall Study|Exclusion due to terminal disease|2|||
143116307|NCT03422159|515968501|FG001|Overall Study|Exclusion due to terminal disease|1|||
143116308|NCT02631070|515968502|FG000|Overall Study|Withdrawal by Subject|35|||
143116309|NCT02631070|515968503|FG001|Overall Study|Withdrawal by Subject|13|||
143116310|NCT02631070|515968502|FG000|Overall Study|Death|45|||
143116311|NCT02631070|515968503|FG001|Overall Study|Death|24|||
143116312|NCT02631070|515968502|FG000|Overall Study|Lost to Follow-up|5|||
143116313|NCT02631070|515968503|FG001|Overall Study|Lost to Follow-up|1|||
143116314|NCT02631070|515968502|FG000|Overall Study|Transition to rollover protocol|52|||
143186826|NCT05396014|516228792|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186827|NCT05396014|516228793|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186828|NCT05396014|516228794|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186829|NCT05396014|516228795|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186830|NCT05396014|516228796|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186831|NCT05396014|516228797|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186832|NCT05396014|516228798|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186833|NCT05396014|516228799|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186834|NCT05396014|516228800|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186835|NCT05396014|516228801|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186836|NCT05396014|516228802|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186837|NCT05396014|516228803|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186838|NCT05396014|516228804|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186839|NCT05396014|516228805|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186840|NCT05396014|516228806|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186841|NCT05396014|516228807|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186842|NCT05396014|516228808|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186843|NCT05396014|516228809|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143186844|NCT05396014|516228810|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
143116315|NCT02631070|515968503|FG001|Overall Study|Transition to rollover protocol|21|||
143116316|NCT02631070|515968502|FG000|Overall Study|Other reasons|12|||
143116317|NCT02631070|515968503|FG001|Overall Study|Other reasons|5|||
143116318|NCT00980018|515968508|FG000|Overall Study|Adverse Event|8|||
143116319|NCT00980018|515968508|FG000|Overall Study|Patient withdrew consent|3|||
143116320|NCT00980018|515968508|FG000|Overall Study|Lost to Follow-up|1|||
143116321|NCT01522235|515968509|FG000|Overall Study|Physician Decision|1|||
143116322|NCT01522235|515968510|FG001|Overall Study|Physician Decision|1|||
143116323|NCT05385224|515968511|FG000|Overall Study|Unable to swallow capsule|2|||
143116324|NCT05385224|515968511|FG000|Overall Study|Withdrawal by Subject|2|||
143116325|NCT05385224|515968511|FG000|Overall Study|Did not meet study criteria|1|||
143116326|NCT00087126|515968515|FG000|Overall Study|Ineligible - second primary|1|||
143369417|NCT02281318|516896098|FG001|Overall Study|Adverse Event|2|||
143116327|NCT00087126|515968515|FG000|Overall Study|Never treated|1|||
143116328|NCT01432275|515968516|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
143116329|NCT01432275|515968517|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
143116330|NCT01432275|515968516|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
143116331|NCT01432275|515968517|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
143116332|NCT01432275|515968516|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
143116333|NCT01432275|515968517|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
143116334|NCT01432275|515968516|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
143116335|NCT01432275|515968517|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
143116336|NCT01432275|515968516|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
143116337|NCT01432275|515968517|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
143116338|NCT01432275|515968516|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
143116339|NCT01432275|515968517|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
143116340|NCT01432275|515968516|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
143116341|NCT01432275|515968517|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
143116342|NCT01432275|515968516|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
143116343|NCT01432275|515968517|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
143116344|NCT01432275|515968516|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
143116345|NCT01432275|515968517|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
143116346|NCT00934856|515968524|FG000|Feasibility Part|Progressive disease|4|||
143116347|NCT00934856|515968525|FG001|Feasibility Part|Progressive disease|4|||
143116348|NCT00934856|515968526|FG002|Feasibility Part|Progressive disease|2|||
143116349|NCT00934856|515968527|FG003|Feasibility Part|Progressive disease|3|||
143116350|NCT00934856|515968528|FG004|Feasibility Part|Progressive disease|0|||
143116351|NCT00934856|515968529|FG005|Feasibility Part|Progressive disease|0|||
143116352|NCT00934856|515968524|FG000|Feasibility Part|Physician Decision|0|||
143116353|NCT00934856|515968525|FG001|Feasibility Part|Physician Decision|0|||
143116354|NCT00934856|515968526|FG002|Feasibility Part|Physician Decision|1|||
143116355|NCT00934856|515968527|FG003|Feasibility Part|Physician Decision|0|||
143116356|NCT00934856|515968528|FG004|Feasibility Part|Physician Decision|0|||
143116357|NCT00934856|515968529|FG005|Feasibility Part|Physician Decision|0|||
143116358|NCT00934856|515968524|FG000|Feasibility Part|Adverse Event|1|||
143116359|NCT00934856|515968525|FG001|Feasibility Part|Adverse Event|1|||
143116360|NCT00934856|515968526|FG002|Feasibility Part|Adverse Event|0|||
143116361|NCT00934856|515968527|FG003|Feasibility Part|Adverse Event|1|||
143116362|NCT00934856|515968528|FG004|Feasibility Part|Adverse Event|0|||
143116363|NCT00934856|515968529|FG005|Feasibility Part|Adverse Event|2|||
143116364|NCT00934856|515968524|FG000|Feasibility Part|Withdrawal by Subject|0|||
143116365|NCT00934856|515968525|FG001|Feasibility Part|Withdrawal by Subject|0|||
143116366|NCT00934856|515968526|FG002|Feasibility Part|Withdrawal by Subject|0|||
143116367|NCT00934856|515968527|FG003|Feasibility Part|Withdrawal by Subject|1|||
143116368|NCT00934856|515968528|FG004|Feasibility Part|Withdrawal by Subject|0|||
143116369|NCT00934856|515968529|FG005|Feasibility Part|Withdrawal by Subject|1|||
143116370|NCT00934856|515968524|FG000|Extension Part|Adverse Event|0|||
143116371|NCT00934856|515968525|FG001|Extension Part|Adverse Event|0|||
143116372|NCT00934856|515968526|FG002|Extension Part|Adverse Event|0|||
143116373|NCT00934856|515968527|FG003|Extension Part|Adverse Event|1|||
143116374|NCT00934856|515968528|FG004|Extension Part|Adverse Event|4|||
143116375|NCT00934856|515968529|FG005|Extension Part|Adverse Event|4|||
143116376|NCT00934856|515968524|FG000|Extension Part|Progressive disease|0|||
143116377|NCT00934856|515968525|FG001|Extension Part|Progressive disease|0|||
143116378|NCT00934856|515968526|FG002|Extension Part|Progressive disease|0|||
143116379|NCT00934856|515968527|FG003|Extension Part|Progressive disease|1|||
143116380|NCT00934856|515968528|FG004|Extension Part|Progressive disease|0|||
143116381|NCT00934856|515968529|FG005|Extension Part|Progressive disease|0|||
143116382|NCT00934856|515968524|FG000|Extension Part|Non-compliance with drug|0|||
143116383|NCT00934856|515968525|FG001|Extension Part|Non-compliance with drug|0|||
143116384|NCT00934856|515968526|FG002|Extension Part|Non-compliance with drug|0|||
143116385|NCT00934856|515968527|FG003|Extension Part|Non-compliance with drug|0|||
143116386|NCT00934856|515968528|FG004|Extension Part|Non-compliance with drug|0|||
143116387|NCT00934856|515968529|FG005|Extension Part|Non-compliance with drug|1|||
143116388|NCT01935700|515968530|FG000|Overall Study|Withdrawal by Subject|1|||
143116389|NCT01935700|515968531|FG001|Overall Study|Withdrawal by Subject|0|||
143116390|NCT01935700|515968530|FG000|Overall Study|Physician Decision|4|||
143116391|NCT01935700|515968531|FG001|Overall Study|Physician Decision|0|||
143116392|NCT01440569|515968532|FG000|Main Study|Enrolled but not treated|1|||
143116393|NCT01440569|515968533|FG001|Main Study|Enrolled but not treated|0|||
143116394|NCT01440569|515968532|FG000|Main Study|Adverse Event|9|||
143116395|NCT01440569|515968533|FG001|Main Study|Adverse Event|0|||
143116396|NCT01440569|515968532|FG000|Main Study|Pregnancy|1|||
143116397|NCT01440569|515968533|FG001|Main Study|Pregnancy|0|||
143186845|NCT05396014|516228768|FG000|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
143116398|NCT01440569|515968532|FG000|Main Study|Investigator's Discretion|1|||
143116399|NCT01440569|515968533|FG001|Main Study|Investigator's Discretion|1|||
143116400|NCT01440569|515968532|FG000|Main Study|Withdrew Consent|7|||
143116401|NCT01440569|515968533|FG001|Main Study|Withdrew Consent|1|||
143116402|NCT01440569|515968532|FG000|Main Study|Lost to Follow-up|13|||
143116403|NCT01440569|515968533|FG001|Main Study|Lost to Follow-up|2|||
143116404|NCT01440569|515968532|FG000|Main Study|Subject Non-Compliance|3|||
143116405|NCT01440569|515968533|FG001|Main Study|Subject Non-Compliance|0|||
143186846|NCT05396014|516228769|FG001|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
143186847|NCT05396014|516228770|FG002|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
143186848|NCT05396014|516228771|FG003|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
143186849|NCT05396014|516228772|FG004|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
143186850|NCT05396014|516228773|FG005|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
143116406|NCT01440569|515968532|FG000|Main Study|Protocol Violation|1|||
143116407|NCT01440569|515968533|FG001|Main Study|Protocol Violation|0|||
143116408|NCT01440569|515968532|FG000|Open-Label Rollover Phase|Adverse Event|3|||
143116409|NCT01440569|515968533|FG001|Open-Label Rollover Phase|Adverse Event|0|||
143116410|NCT01440569|515968532|FG000|Open-Label Rollover Phase|Pregnancy|1|||
143116411|NCT01440569|515968533|FG001|Open-Label Rollover Phase|Pregnancy|0|||
143116412|NCT01440569|515968532|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
143116413|NCT01440569|515968533|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
143116414|NCT01440569|515968532|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
143116415|NCT01440569|515968533|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
143116416|NCT01440569|515968532|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
143116417|NCT01440569|515968533|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
143116418|NCT01440569|515968532|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
143116419|NCT01440569|515968533|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
143116420|NCT01440569|515968532|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
143116421|NCT01440569|515968533|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
143116422|NCT02584959|515968542|FG000|Period 1|Withdrawn from study|3|||
143116423|NCT02584959|515968543|FG001|Period 1|Withdrawn from study|4|||
143116424|NCT02584959|515968544|FG002|Period 1|Withdrawn from study|0|||
143116425|NCT02584959|515968542|FG000|Period 2|Withdrawn from study|6|||
143116426|NCT02584959|515968543|FG001|Period 2|Withdrawn from study|1|||
143116427|NCT02584959|515968544|FG002|Period 2|Withdrawn from study|2|||
143116428|NCT00195494|515968545|FG000|Year 1|Adverse Event|0|||
143116429|NCT00195494|515968546|FG001|Year 1|Adverse Event|0|||
143116430|NCT00195494|515968547|FG002|Year 1|Adverse Event|0|||
143116431|NCT00195494|515968548|FG003|Year 1|Adverse Event|0|||
143116432|NCT00195494|515968549|FG004|Year 1|Adverse Event|34|||
143116433|NCT00195494|515968550|FG005|Year 1|Adverse Event|27|||
143116434|NCT00195494|515968545|FG000|Year 1|System Toxicity|0|||
143116435|NCT00195494|515968546|FG001|Year 1|System Toxicity|0|||
143116436|NCT00195494|515968547|FG002|Year 1|System Toxicity|0|||
143116437|NCT00195494|515968548|FG003|Year 1|System Toxicity|0|||
143116438|NCT00195494|515968549|FG004|Year 1|System Toxicity|0|||
143116439|NCT00195494|515968550|FG005|Year 1|System Toxicity|1|||
143116440|NCT00195494|515968545|FG000|Year 1|Lack of Efficacy|0|||
143116441|NCT00195494|515968546|FG001|Year 1|Lack of Efficacy|0|||
143116442|NCT00195494|515968547|FG002|Year 1|Lack of Efficacy|0|||
143116443|NCT00195494|515968548|FG003|Year 1|Lack of Efficacy|0|||
143116444|NCT00195494|515968549|FG004|Year 1|Lack of Efficacy|24|||
143116445|NCT00195494|515968550|FG005|Year 1|Lack of Efficacy|9|||
143116446|NCT00195494|515968545|FG000|Year 1|Compliance|0|||
143116447|NCT00195494|515968546|FG001|Year 1|Compliance|0|||
143116448|NCT00195494|515968547|FG002|Year 1|Compliance|0|||
143116449|NCT00195494|515968548|FG003|Year 1|Compliance|0|||
143116450|NCT00195494|515968549|FG004|Year 1|Compliance|5|||
143116451|NCT00195494|515968550|FG005|Year 1|Compliance|1|||
143116452|NCT00195494|515968545|FG000|Year 1|Lost to Follow-up|0|||
143116453|NCT00195494|515968546|FG001|Year 1|Lost to Follow-up|0|||
143116454|NCT00195494|515968547|FG002|Year 1|Lost to Follow-up|0|||
143116455|NCT00195494|515968548|FG003|Year 1|Lost to Follow-up|0|||
143116456|NCT00195494|515968549|FG004|Year 1|Lost to Follow-up|1|||
143116457|NCT00195494|515968550|FG005|Year 1|Lost to Follow-up|0|||
143116458|NCT00195494|515968545|FG000|Year 1|Missed >4 consecutive doses|0|||
143116459|NCT00195494|515968546|FG001|Year 1|Missed >4 consecutive doses|0|||
143116460|NCT00195494|515968547|FG002|Year 1|Missed >4 consecutive doses|0|||
143116461|NCT00195494|515968548|FG003|Year 1|Missed >4 consecutive doses|0|||
143116462|NCT00195494|515968549|FG004|Year 1|Missed >4 consecutive doses|3|||
143116463|NCT00195494|515968550|FG005|Year 1|Missed >4 consecutive doses|2|||
143116464|NCT00195494|515968545|FG000|Year 1|Protocol deviation|0|||
143116465|NCT00195494|515968546|FG001|Year 1|Protocol deviation|0|||
143116466|NCT00195494|515968547|FG002|Year 1|Protocol deviation|0|||
143116467|NCT00195494|515968548|FG003|Year 1|Protocol deviation|0|||
143116468|NCT00195494|515968549|FG004|Year 1|Protocol deviation|2|||
143116469|NCT00195494|515968550|FG005|Year 1|Protocol deviation|3|||
143116470|NCT00195494|515968545|FG000|Year 1|Physician Decision|0|||
143116471|NCT00195494|515968546|FG001|Year 1|Physician Decision|0|||
143116472|NCT00195494|515968547|FG002|Year 1|Physician Decision|0|||
143116473|NCT00195494|515968548|FG003|Year 1|Physician Decision|0|||
143116474|NCT00195494|515968549|FG004|Year 1|Physician Decision|1|||
143116475|NCT00195494|515968550|FG005|Year 1|Physician Decision|0|||
143116476|NCT00195494|515968545|FG000|Year 1|Withdrawal by Subject|0|||
143116477|NCT00195494|515968546|FG001|Year 1|Withdrawal by Subject|0|||
143116478|NCT00195494|515968547|FG002|Year 1|Withdrawal by Subject|0|||
143116479|NCT00195494|515968548|FG003|Year 1|Withdrawal by Subject|0|||
143116480|NCT00195494|515968549|FG004|Year 1|Withdrawal by Subject|8|||
143116481|NCT00195494|515968550|FG005|Year 1|Withdrawal by Subject|9|||
143116482|NCT00195494|515968545|FG000|Year 1|Protocol Violation|0|||
143116483|NCT00195494|515968546|FG001|Year 1|Protocol Violation|0|||
143116484|NCT00195494|515968547|FG002|Year 1|Protocol Violation|0|||
143116485|NCT00195494|515968548|FG003|Year 1|Protocol Violation|0|||
143116486|NCT00195494|515968549|FG004|Year 1|Protocol Violation|1|||
143116487|NCT00195494|515968550|FG005|Year 1|Protocol Violation|1|||
143116488|NCT00195494|515968545|FG000|Year 2|Adverse Event|3|||
143116489|NCT00195494|515968546|FG001|Year 2|Adverse Event|7|||
143116490|NCT00195494|515968547|FG002|Year 2|Adverse Event|5|||
143116491|NCT00195494|515968548|FG003|Year 2|Adverse Event|9|||
143116492|NCT00195494|515968549|FG004|Year 2|Adverse Event|0|||
143116493|NCT00195494|515968550|FG005|Year 2|Adverse Event|0|||
143116494|NCT00195494|515968545|FG000|Year 2|Lack of Efficacy|0|||
143116495|NCT00195494|515968546|FG001|Year 2|Lack of Efficacy|1|||
143116496|NCT00195494|515968547|FG002|Year 2|Lack of Efficacy|7|||
143116497|NCT00195494|515968548|FG003|Year 2|Lack of Efficacy|7|||
143116498|NCT00195494|515968549|FG004|Year 2|Lack of Efficacy|0|||
143116499|NCT00195494|515968550|FG005|Year 2|Lack of Efficacy|0|||
143116500|NCT00195494|515968545|FG000|Year 2|Compliance|1|||
143116501|NCT00195494|515968546|FG001|Year 2|Compliance|0|||
143116502|NCT00195494|515968547|FG002|Year 2|Compliance|0|||
143186851|NCT05396014|516228774|FG006|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
143186852|NCT05396014|516228775|FG007|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
143186853|NCT05396014|516228776|FG008|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
143186854|NCT05396014|516228777|FG009|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
143186855|NCT05396014|516228778|FG010|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
143186856|NCT05396014|516228779|FG011|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
143186857|NCT05396014|516228780|FG012|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
143186858|NCT05396014|516228781|FG013|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
143186859|NCT05396014|516228782|FG014|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
143186860|NCT05396014|516228783|FG015|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
143186861|NCT05396014|516228784|FG016|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
143186862|NCT05396014|516228785|FG017|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
143186863|NCT05396014|516228786|FG018|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
143186864|NCT05396014|516228787|FG019|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
143186865|NCT05396014|516228788|FG020|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
143186866|NCT05396014|516228789|FG021|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
143186867|NCT05396014|516228790|FG022|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
143186868|NCT05396014|516228791|FG023|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
143186869|NCT05396014|516228792|FG024|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
143186870|NCT05396014|516228793|FG025|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
143186871|NCT05396014|516228794|FG026|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
143186872|NCT05396014|516228795|FG027|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
143186873|NCT05396014|516228796|FG028|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
143186874|NCT05396014|516228797|FG029|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
143186875|NCT05396014|516228798|FG030|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
143186876|NCT05396014|516228799|FG031|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
143186877|NCT05396014|516228800|FG032|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
143186878|NCT05396014|516228801|FG033|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
143186879|NCT05396014|516228802|FG034|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
143186880|NCT05396014|516228803|FG035|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
143186881|NCT05396014|516228804|FG036|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
143186882|NCT05396014|516228805|FG037|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
143186883|NCT05396014|516228806|FG038|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
143186884|NCT05396014|516228807|FG039|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
143186885|NCT05396014|516228808|FG040|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|3|||
143186886|NCT05396014|516228809|FG041|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
143186887|NCT05396014|516228810|FG042|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
143261347|NCT00582816|516510562|FG000|Overall Study|Engraftment Failure|3|||
143186888|NCT05396014|516228768|FG000|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
143186889|NCT05396014|516228769|FG001|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
143186890|NCT05396014|516228770|FG002|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
143186891|NCT05396014|516228771|FG003|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
143186892|NCT05396014|516228772|FG004|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
143186893|NCT05396014|516228773|FG005|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
143186894|NCT05396014|516228774|FG006|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
143186895|NCT05396014|516228775|FG007|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
143186896|NCT05396014|516228776|FG008|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
143186897|NCT05396014|516228777|FG009|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
143186898|NCT05396014|516228778|FG010|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
143186899|NCT05396014|516228779|FG011|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
143186900|NCT05396014|516228780|FG012|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
143186901|NCT05396014|516228781|FG013|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
143186902|NCT05396014|516228782|FG014|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
143186903|NCT05396014|516228783|FG015|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
143186904|NCT05396014|516228784|FG016|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
143186905|NCT05396014|516228785|FG017|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
143186906|NCT05396014|516228786|FG018|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
143186907|NCT05396014|516228787|FG019|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
143186908|NCT05396014|516228788|FG020|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
143186909|NCT05396014|516228789|FG021|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
143186910|NCT05396014|516228790|FG022|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
143186911|NCT05396014|516228791|FG023|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
143186912|NCT05396014|516228792|FG024|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
143186913|NCT05396014|516228793|FG025|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
143186914|NCT05396014|516228794|FG026|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
143186915|NCT05396014|516228795|FG027|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
143186916|NCT05396014|516228796|FG028|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
143186917|NCT05396014|516228797|FG029|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
143186918|NCT05396014|516228798|FG030|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
143186919|NCT05396014|516228799|FG031|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
143186920|NCT05396014|516228800|FG032|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
143186921|NCT05396014|516228801|FG033|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
143186922|NCT05396014|516228802|FG034|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
143186923|NCT05396014|516228803|FG035|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
143186924|NCT05396014|516228804|FG036|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
143186925|NCT05396014|516228805|FG037|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
143186926|NCT05396014|516228806|FG038|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
143186927|NCT05396014|516228807|FG039|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
143186928|NCT05396014|516228808|FG040|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
143186929|NCT05396014|516228809|FG041|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|3|||
143186930|NCT05396014|516228810|FG042|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
143186931|NCT05396014|516228768|FG000|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186932|NCT05396014|516228769|FG001|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186933|NCT05396014|516228770|FG002|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186934|NCT05396014|516228771|FG003|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186935|NCT05396014|516228772|FG004|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186936|NCT05396014|516228773|FG005|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186937|NCT05396014|516228774|FG006|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186938|NCT05396014|516228775|FG007|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186939|NCT05396014|516228776|FG008|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186940|NCT05396014|516228777|FG009|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186941|NCT05396014|516228778|FG010|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186942|NCT05396014|516228779|FG011|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186943|NCT05396014|516228780|FG012|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186944|NCT05396014|516228781|FG013|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
143186945|NCT05396014|516228782|FG014|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186946|NCT05396014|516228783|FG015|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186947|NCT05396014|516228784|FG016|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186948|NCT05396014|516228785|FG017|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186949|NCT05396014|516228786|FG018|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186950|NCT05396014|516228787|FG019|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186951|NCT05396014|516228788|FG020|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186952|NCT05396014|516228789|FG021|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186953|NCT05396014|516228790|FG022|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186954|NCT05396014|516228791|FG023|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186955|NCT05396014|516228792|FG024|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186956|NCT05396014|516228793|FG025|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186957|NCT05396014|516228794|FG026|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
143186958|NCT05396014|516228795|FG027|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186959|NCT05396014|516228796|FG028|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186960|NCT05396014|516228797|FG029|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186961|NCT05396014|516228798|FG030|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186962|NCT05396014|516228799|FG031|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186963|NCT05396014|516228800|FG032|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186964|NCT05396014|516228801|FG033|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186965|NCT05396014|516228802|FG034|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
143186966|NCT05396014|516228803|FG035|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186967|NCT05396014|516228804|FG036|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186968|NCT05396014|516228805|FG037|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186969|NCT05396014|516228806|FG038|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186970|NCT05396014|516228807|FG039|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186971|NCT05396014|516228808|FG040|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186972|NCT05396014|516228809|FG041|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
143186973|NCT05396014|516228810|FG042|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
143186974|NCT05396014|516228768|FG000|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143186975|NCT05396014|516228769|FG001|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143186976|NCT05396014|516228770|FG002|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143186977|NCT05396014|516228771|FG003|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143186978|NCT05396014|516228772|FG004|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143186979|NCT05396014|516228773|FG005|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143186980|NCT05396014|516228774|FG006|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143186981|NCT05396014|516228775|FG007|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143186982|NCT05396014|516228776|FG008|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143186983|NCT05396014|516228777|FG009|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143186984|NCT05396014|516228778|FG010|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143186985|NCT05396014|516228779|FG011|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143186986|NCT05396014|516228780|FG012|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143186987|NCT05396014|516228781|FG013|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143186988|NCT05396014|516228782|FG014|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143186989|NCT05396014|516228783|FG015|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143186990|NCT05396014|516228784|FG016|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143186991|NCT05396014|516228785|FG017|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143186992|NCT05396014|516228786|FG018|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143186993|NCT05396014|516228787|FG019|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143116503|NCT00195494|515968548|FG003|Year 2|Compliance|2|||
143116504|NCT00195494|515968549|FG004|Year 2|Compliance|0|||
143116505|NCT00195494|515968550|FG005|Year 2|Compliance|0|||
143116506|NCT00195494|515968545|FG000|Year 2|Lost to Follow-up|0|||
143116507|NCT00195494|515968546|FG001|Year 2|Lost to Follow-up|0|||
143116508|NCT00195494|515968547|FG002|Year 2|Lost to Follow-up|1|||
143116509|NCT00195494|515968548|FG003|Year 2|Lost to Follow-up|1|||
143116510|NCT00195494|515968549|FG004|Year 2|Lost to Follow-up|0|||
143116511|NCT00195494|515968550|FG005|Year 2|Lost to Follow-up|0|||
143116512|NCT00195494|515968545|FG000|Year 2|Missed >4 consecutive doses|1|||
143116513|NCT00195494|515968546|FG001|Year 2|Missed >4 consecutive doses|1|||
143116514|NCT00195494|515968547|FG002|Year 2|Missed >4 consecutive doses|1|||
143116515|NCT00195494|515968548|FG003|Year 2|Missed >4 consecutive doses|0|||
143116516|NCT00195494|515968549|FG004|Year 2|Missed >4 consecutive doses|0|||
143116517|NCT00195494|515968550|FG005|Year 2|Missed >4 consecutive doses|0|||
143116518|NCT00195494|515968545|FG000|Year 2|Protocol deviation|0|||
143116519|NCT00195494|515968546|FG001|Year 2|Protocol deviation|1|||
143116520|NCT00195494|515968547|FG002|Year 2|Protocol deviation|0|||
143116521|NCT00195494|515968548|FG003|Year 2|Protocol deviation|0|||
143116522|NCT00195494|515968549|FG004|Year 2|Protocol deviation|0|||
143116523|NCT00195494|515968550|FG005|Year 2|Protocol deviation|0|||
143116524|NCT00195494|515968545|FG000|Year 2|Physician Decision|1|||
143116525|NCT00195494|515968546|FG001|Year 2|Physician Decision|1|||
143116526|NCT00195494|515968547|FG002|Year 2|Physician Decision|0|||
143116527|NCT00195494|515968548|FG003|Year 2|Physician Decision|0|||
143116528|NCT00195494|515968549|FG004|Year 2|Physician Decision|0|||
143116529|NCT00195494|515968550|FG005|Year 2|Physician Decision|0|||
143116530|NCT00195494|515968545|FG000|Year 2|Withdrawal by Subject|1|||
143116531|NCT00195494|515968546|FG001|Year 2|Withdrawal by Subject|5|||
143116532|NCT00195494|515968547|FG002|Year 2|Withdrawal by Subject|4|||
143116533|NCT00195494|515968548|FG003|Year 2|Withdrawal by Subject|3|||
143116534|NCT00195494|515968549|FG004|Year 2|Withdrawal by Subject|0|||
143116535|NCT00195494|515968550|FG005|Year 2|Withdrawal by Subject|0|||
143116536|NCT00195494|515968545|FG000|Year 2|System toxicity|0|||
143116537|NCT00195494|515968546|FG001|Year 2|System toxicity|0|||
143116538|NCT00195494|515968547|FG002|Year 2|System toxicity|0|||
143116539|NCT00195494|515968548|FG003|Year 2|System toxicity|1|||
143116540|NCT00195494|515968549|FG004|Year 2|System toxicity|0|||
143116541|NCT00195494|515968550|FG005|Year 2|System toxicity|0|||
143116542|NCT00513357|515968551|FG000|Overall Study|did not receive allocated placebo|2|||
143116543|NCT00513357|515968552|FG001|Overall Study|did not receive allocated placebo|3|||
143116544|NCT00513357|515968551|FG000|Overall Study|Adverse Event|4|||
143116545|NCT00513357|515968552|FG001|Overall Study|Adverse Event|2|||
143116546|NCT00513357|515968551|FG000|Overall Study|Death|2|||
143116547|NCT00513357|515968552|FG001|Overall Study|Death|0|||
143116548|NCT00513357|515968551|FG000|Overall Study|Withdrawal by Subject|5|||
143116549|NCT00513357|515968552|FG001|Overall Study|Withdrawal by Subject|4|||
143116550|NCT00513357|515968551|FG000|Overall Study|Disease Progression|2|||
143116551|NCT00513357|515968552|FG001|Overall Study|Disease Progression|1|||
143116552|NCT01162122|515968553|FG000|Overall Study|Withdrawal by Subject|52|||
143116553|NCT01162122|515968554|FG001|Overall Study|Withdrawal by Subject|43|||
143116554|NCT01162122|515968553|FG000|Overall Study|Lost to Follow-up|73|||
143116555|NCT01162122|515968554|FG001|Overall Study|Lost to Follow-up|91|||
143116556|NCT01162122|515968553|FG000|Overall Study|Adverse Event|3|||
143116557|NCT01162122|515968554|FG001|Overall Study|Adverse Event|2|||
143116558|NCT01162122|515968553|FG000|Overall Study|Death|51|||
143116559|NCT01162122|515968554|FG001|Overall Study|Death|46|||
143116560|NCT01162122|515968553|FG000|Overall Study|Protocol Violation|2|||
143116561|NCT01162122|515968554|FG001|Overall Study|Protocol Violation|2|||
143116562|NCT01162122|515968553|FG000|Overall Study|Inappropriate enrollment|5|||
143116563|NCT01162122|515968554|FG001|Overall Study|Inappropriate enrollment|4|||
143116564|NCT01162122|515968553|FG000|Overall Study|Administrative reason|1|||
143116565|NCT01162122|515968554|FG001|Overall Study|Administrative reason|1|||
143116566|NCT01162122|515968553|FG000|Overall Study|Unable to classify|3|||
143116567|NCT01162122|515968554|FG001|Overall Study|Unable to classify|7|||
143116568|NCT01162122|515968553|FG000|Overall Study|Missing primary reason|1|||
143116569|NCT01162122|515968554|FG001|Overall Study|Missing primary reason|0|||
143116570|NCT02020512|515968555|FG000|Overall Study|Adverse Event|1|||
143186994|NCT05396014|516228788|FG020|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143186995|NCT05396014|516228789|FG021|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143186996|NCT05396014|516228790|FG022|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143116571|NCT02020512|515968555|FG000|Overall Study|Lost to Follow-up|3|||
143116572|NCT02020512|515968555|FG000|Overall Study|Protocol Violation|4|||
143116573|NCT00926536|515968566|FG000|Overall Study|Physician Decision|1|||
143116574|NCT00926536|515968567|FG001|Overall Study|Physician Decision|2|||
143116575|NCT05087966|515968568|FG000|Overall Study|Lost to Follow-up|1|||
143116576|NCT05087966|515968568|FG000|Overall Study|Withdrawal by Subject|5|||
143116577|NCT01267201|515968569|FG000|First Intervention Period|Withdrawal by Subject|1|||
143116578|NCT01267201|515968570|FG001|First Intervention Period|Withdrawal by Subject|0|||
143116579|NCT01267201|515968571|FG002|First Intervention Period|Withdrawal by Subject|0|||
143116580|NCT01267201|515968572|FG003|First Intervention Period|Withdrawal by Subject|0|||
143186997|NCT05396014|516228791|FG023|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143186998|NCT05396014|516228792|FG024|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143186999|NCT05396014|516228793|FG025|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143187000|NCT05396014|516228794|FG026|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|1|||
143187001|NCT05396014|516228795|FG027|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143187002|NCT05396014|516228796|FG028|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143187003|NCT05396014|516228797|FG029|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143187004|NCT05396014|516228798|FG030|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143187005|NCT05396014|516228799|FG031|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143187006|NCT05396014|516228800|FG032|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143187007|NCT05396014|516228801|FG033|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143187008|NCT05396014|516228802|FG034|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143187009|NCT05396014|516228803|FG035|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143187010|NCT05396014|516228804|FG036|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143187011|NCT05396014|516228805|FG037|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143187012|NCT05396014|516228806|FG038|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143187013|NCT05396014|516228807|FG039|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143187014|NCT05396014|516228808|FG040|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143116581|NCT01267201|515968573|FG004|First Intervention Period|Withdrawal by Subject|0|||
143261348|NCT02129777|516510565|FG000|Double-Blind Period|Adverse Event|0|||
143261349|NCT02129777|516510566|FG001|Double-Blind Period|Adverse Event|0|||
143261350|NCT02129777|516510567|FG002|Double-Blind Period|Adverse Event|0|||
143261351|NCT02129777|516510568|FG003|Double-Blind Period|Adverse Event|0|||
143261352|NCT02129777|516510569|FG004|Double-Blind Period|Adverse Event|1|||
143261353|NCT02129777|516510570|FG005|Double-Blind Period|Adverse Event|0|||
143261354|NCT02129777|516510571|FG006|Double-Blind Period|Adverse Event|0|||
143261355|NCT02129777|516510565|FG000|Double-Blind Period|Lost to Follow-up|1|||
143261356|NCT02129777|516510566|FG001|Double-Blind Period|Lost to Follow-up|1|||
143116582|NCT01267201|515968574|FG005|First Intervention Period|Withdrawal by Subject|0|||
143116583|NCT01267201|515968569|FG000|Second Intervention Period|Withdrawal by Subject|0|||
143116584|NCT01267201|515968570|FG001|Second Intervention Period|Withdrawal by Subject|1|||
143116585|NCT01267201|515968571|FG002|Second Intervention Period|Withdrawal by Subject|0|||
143116586|NCT01267201|515968572|FG003|Second Intervention Period|Withdrawal by Subject|0|||
143116587|NCT01267201|515968573|FG004|Second Intervention Period|Withdrawal by Subject|0|||
143116588|NCT01267201|515968574|FG005|Second Intervention Period|Withdrawal by Subject|0|||
143187015|NCT05396014|516228809|FG041|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143187016|NCT05396014|516228810|FG042|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
143187017|NCT04439539|516228813|FG000|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|1|||
143261357|NCT02129777|516510567|FG002|Double-Blind Period|Lost to Follow-up|1|||
143261358|NCT02129777|516510568|FG003|Double-Blind Period|Lost to Follow-up|2|||
143261359|NCT02129777|516510569|FG004|Double-Blind Period|Lost to Follow-up|0|||
143116589|NCT02124759|515968575|FG000|Overall Study|Withdrawal by Subject|3|||
143187018|NCT04439539|516228814|FG001|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|0|||
143187019|NCT04439539|516228815|FG002|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|2|||
143187020|NCT04439539|516228813|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
143116590|NCT02124759|515968576|FG001|Overall Study|Withdrawal by Subject|1|||
143116591|NCT02124759|515968577|FG002|Overall Study|Withdrawal by Subject|1|||
143116592|NCT02124759|515968575|FG000|Overall Study|Screen Fail|2|||
143116593|NCT02124759|515968576|FG001|Overall Study|Screen Fail|2|||
143116594|NCT02124759|515968577|FG002|Overall Study|Screen Fail|3|||
143116595|NCT03689543|515968580|FG000|Overall Study|Adverse Event|0|||
143116596|NCT03689543|515968581|FG001|Overall Study|Adverse Event|0|||
143116597|NCT03689543|515968582|FG002|Overall Study|Adverse Event|1|||
143116598|NCT00932451|515968583|FG000|Overall Study|Withdrawal by Subject|69|||
143116599|NCT00932451|515968583|FG000|Overall Study|Lost to Follow-up|22|||
143116600|NCT00932451|515968583|FG000|Overall Study|Death|726|||
143116601|NCT00932451|515968583|FG000|Overall Study|Other reasons|5|||
143116602|NCT05619536|515968599|FG000|Overall Study|Withdrawal by Subject|0|||
143116603|NCT05619536|515968600|FG001|Overall Study|Withdrawal by Subject|1|||
143116604|NCT05619536|515968601|FG002|Overall Study|Withdrawal by Subject|0|||
143116605|NCT05619536|515968602|FG003|Overall Study|Withdrawal by Subject|1|||
143116606|NCT05619536|515968599|FG000|Overall Study|Lost to Follow-up|0|||
143116607|NCT05619536|515968600|FG001|Overall Study|Lost to Follow-up|1|||
143116608|NCT05619536|515968601|FG002|Overall Study|Lost to Follow-up|1|||
143116609|NCT05619536|515968602|FG003|Overall Study|Lost to Follow-up|0|||
143116610|NCT00637806|515968603|FG000|Double-blind Phase|Study Discontinued|2|||
143116611|NCT00637806|515968604|FG001|Double-blind Phase|Study Discontinued|0|||
143116612|NCT00637806|515968605|FG002|Double-blind Phase|Study Discontinued|1|||
143116613|NCT00637806|515968606|FG003|Double-blind Phase|Study Discontinued|0|||
143116614|NCT00637806|515968603|FG000|Extension Phase|Study Discontinued|0|||
143116615|NCT00637806|515968604|FG001|Extension Phase|Study Discontinued|0|||
143116616|NCT00637806|515968605|FG002|Extension Phase|Study Discontinued|0|||
143116617|NCT00637806|515968606|FG003|Extension Phase|Study Discontinued|1|||
143116618|NCT01592292|515968607|FG000|Overall Study|Follow-up loss|3|||
143116619|NCT01592292|515968608|FG001|Overall Study|Follow-up loss|3|||
143116620|NCT01592292|515968609|FG002|Overall Study|Follow-up loss|1|||
143116621|NCT01592292|515968610|FG003|Overall Study|Follow-up loss|0|||
143116622|NCT01592292|515968607|FG000|Overall Study|Withdrew consent|2|||
143116623|NCT01592292|515968608|FG001|Overall Study|Withdrew consent|1|||
143116624|NCT01592292|515968609|FG002|Overall Study|Withdrew consent|0|||
143116625|NCT01592292|515968610|FG003|Overall Study|Withdrew consent|0|||
143116626|NCT01592292|515968607|FG000|Overall Study|Other|1|||
143116627|NCT01592292|515968608|FG001|Overall Study|Other|1|||
143116628|NCT01592292|515968609|FG002|Overall Study|Other|2|||
143116629|NCT01592292|515968610|FG003|Overall Study|Other|1|||
143116630|NCT00622336|515968611|FG000|Treatment Phase|Progression of Disease|181|||
143116631|NCT00622336|515968611|FG000|Treatment Phase|Adverse Event|46|||
143116632|NCT00622336|515968611|FG000|Treatment Phase|Other|40|||
143116633|NCT00622336|515968611|FG000|Treatment Phase|Death|14|||
143116634|NCT00622336|515968611|FG000|Treatment Phase|Lack of therapeutic effect|13|||
143116635|NCT00622336|515968611|FG000|Treatment Phase|Withdrawal by Subject|13|||
143116636|NCT00622336|515968611|FG000|Treatment Phase|Lost to Follow-up|2|||
143116637|NCT00622336|515968611|FG000|Extension Phase|Adverse Event|2|||
143116638|NCT00622336|515968611|FG000|Extension Phase|Progressive Disease|6|||
143116639|NCT00622336|515968611|FG000|Extension Phase|Lack of therapeutic effect|2|||
143116640|NCT00622336|515968611|FG000|Extension Phase|Withdrawal by Subject|1|||
143116641|NCT00622336|515968611|FG000|Extension Phase|Lost to Follow-up|1|||
143116642|NCT00622336|515968611|FG000|Extension Phase|Other|9|||
143116643|NCT00948506|515968612|FG000|Overall Study|Withdrawal by Subject|3|||
143116644|NCT00948506|515968613|FG001|Overall Study|Withdrawal by Subject|1|||
143261360|NCT02129777|516510570|FG005|Double-Blind Period|Lost to Follow-up|0|||
143261361|NCT02129777|516510571|FG006|Double-Blind Period|Lost to Follow-up|0|||
143116645|NCT03912428|515968614|FG000|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
143116646|NCT03912428|515968615|FG001|Phase 2: Whole Body PET/CT Scans|Physician Decision|2|||
143116647|NCT03912428|515968616|FG002|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
143116648|NCT03912428|515968617|FG003|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
143116649|NCT03912428|515968614|FG000|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
143116650|NCT03912428|515968615|FG001|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|3|||
143116651|NCT03912428|515968616|FG002|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|1|||
143261362|NCT02129777|516510565|FG000|Double-Blind Period|Withdrawal by Subject|2|||
143261363|NCT02129777|516510566|FG001|Double-Blind Period|Withdrawal by Subject|4|||
143261364|NCT02129777|516510567|FG002|Double-Blind Period|Withdrawal by Subject|3|||
143116652|NCT03912428|515968617|FG003|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
143116653|NCT03912428|515968614|FG000|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
143116654|NCT03912428|515968615|FG001|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
143116655|NCT03912428|515968616|FG002|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
143116656|NCT03912428|515968617|FG003|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|2|||
143116657|NCT03233204|515968618|FG000|Overall Study|Adverse Event|1|||
143116658|NCT03233204|515968618|FG000|Overall Study|Death|1|||
143116659|NCT03233204|515968618|FG000|Overall Study|Withdrawal by Subject|1|||
143116660|NCT03233204|515968618|FG000|Overall Study|Progressive Disease|3|||
143116661|NCT02520427|515968619|FG000|Overall Study|Decision by sponsor|0|||
143116662|NCT02520427|515968620|FG001|Overall Study|Decision by sponsor|0|||
143116663|NCT02520427|515968621|FG002|Overall Study|Decision by sponsor|0|||
143116664|NCT02520427|515968622|FG003|Overall Study|Decision by sponsor|0|||
143116665|NCT02520427|515968623|FG004|Overall Study|Decision by sponsor|0|||
143116666|NCT02520427|515968624|FG005|Overall Study|Decision by sponsor|0|||
143116667|NCT02520427|515968625|FG006|Overall Study|Decision by sponsor|0|||
143116668|NCT02520427|515968626|FG007|Overall Study|Decision by sponsor|0|||
143116669|NCT02520427|515968627|FG008|Overall Study|Decision by sponsor|1|||
143116670|NCT02520427|515968628|FG009|Overall Study|Decision by sponsor|1|||
143116671|NCT02520427|515968629|FG010|Overall Study|Decision by sponsor|0|||
143116672|NCT02520427|515968630|FG011|Overall Study|Decision by sponsor|0|||
143116673|NCT02520427|515968631|FG012|Overall Study|Decision by sponsor|0|||
143116674|NCT02520427|515968632|FG013|Overall Study|Decision by sponsor|0|||
143116675|NCT02520427|515968633|FG014|Overall Study|Decision by sponsor|0|||
143116676|NCT02520427|515968634|FG015|Overall Study|Decision by sponsor|0|||
143116677|NCT02520427|515968635|FG016|Overall Study|Decision by sponsor|0|||
143116678|NCT02520427|515968636|FG017|Overall Study|Decision by sponsor|0|||
143116679|NCT02520427|515968637|FG018|Overall Study|Decision by sponsor|0|||
143116680|NCT02520427|515968638|FG019|Overall Study|Decision by sponsor|0|||
143116681|NCT02520427|515968639|FG020|Overall Study|Decision by sponsor|0|||
143116682|NCT02520427|515968640|FG021|Overall Study|Decision by sponsor|0|||
143116683|NCT02520427|515968641|FG022|Overall Study|Decision by sponsor|0|||
143116684|NCT02520427|515968642|FG023|Overall Study|Decision by sponsor|0|||
143116685|NCT02520427|515968643|FG024|Overall Study|Decision by sponsor|0|||
143261365|NCT02129777|516510568|FG003|Double-Blind Period|Withdrawal by Subject|2|||
143261366|NCT02129777|516510569|FG004|Double-Blind Period|Withdrawal by Subject|3|||
143261367|NCT02129777|516510570|FG005|Double-Blind Period|Withdrawal by Subject|0|||
143261368|NCT02129777|516510571|FG006|Double-Blind Period|Withdrawal by Subject|0|||
143261369|NCT02129777|516510565|FG000|Double-Blind Period|Pregnancy|0|||
143261370|NCT02129777|516510566|FG001|Double-Blind Period|Pregnancy|0|||
143261371|NCT02129777|516510567|FG002|Double-Blind Period|Pregnancy|0|||
143261372|NCT02129777|516510568|FG003|Double-Blind Period|Pregnancy|0|||
143261373|NCT02129777|516510569|FG004|Double-Blind Period|Pregnancy|1|||
143261374|NCT02129777|516510570|FG005|Double-Blind Period|Pregnancy|0|||
143261375|NCT02129777|516510571|FG006|Double-Blind Period|Pregnancy|0|||
143261376|NCT02129777|516510565|FG000|Double-Blind Period|Lack of Efficacy|3|||
143116686|NCT02520427|515968644|FG025|Overall Study|Decision by sponsor|0|||
143116687|NCT02520427|515968619|FG000|Overall Study|Withdrawal by Subject|0|||
143116688|NCT02520427|515968620|FG001|Overall Study|Withdrawal by Subject|0|||
143116689|NCT02520427|515968621|FG002|Overall Study|Withdrawal by Subject|1|||
143116690|NCT02520427|515968622|FG003|Overall Study|Withdrawal by Subject|0|||
143369418|NCT02281318|516896097|FG000|Overall Study|Lack of Efficacy|2|||
143369419|NCT02281318|516896098|FG001|Overall Study|Lack of Efficacy|0|||
143369420|NCT02281318|516896097|FG000|Overall Study|Lost to Follow-up|2|||
143369421|NCT02281318|516896098|FG001|Overall Study|Lost to Follow-up|1|||
143369422|NCT02281318|516896097|FG000|Overall Study|Physician Decision|2|||
143369423|NCT02281318|516896098|FG001|Overall Study|Physician Decision|0|||
143187021|NCT04439539|516228814|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Other|1|||
143187022|NCT04439539|516228815|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
143187023|NCT04439539|516228813|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
143187024|NCT04439539|516228814|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|1|||
143187025|NCT04439539|516228815|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
143369424|NCT02281318|516896097|FG000|Overall Study|Withdrawal by Subject|6|||
143369425|NCT02281318|516896098|FG001|Overall Study|Withdrawal by Subject|2|||
143369426|NCT01368406|516896099|FG000|Overall Study|Lost to Follow-up|8|||
143116691|NCT02520427|515968623|FG004|Overall Study|Withdrawal by Subject|0|||
143116692|NCT02520427|515968624|FG005|Overall Study|Withdrawal by Subject|0|||
143116693|NCT02520427|515968625|FG006|Overall Study|Withdrawal by Subject|0|||
143116694|NCT02520427|515968626|FG007|Overall Study|Withdrawal by Subject|0|||
143116695|NCT02520427|515968627|FG008|Overall Study|Withdrawal by Subject|0|||
143116696|NCT02520427|515968628|FG009|Overall Study|Withdrawal by Subject|0|||
143116697|NCT02520427|515968629|FG010|Overall Study|Withdrawal by Subject|0|||
143116698|NCT02520427|515968630|FG011|Overall Study|Withdrawal by Subject|0|||
143116699|NCT02520427|515968631|FG012|Overall Study|Withdrawal by Subject|1|||
143116700|NCT02520427|515968632|FG013|Overall Study|Withdrawal by Subject|1|||
143116701|NCT02520427|515968633|FG014|Overall Study|Withdrawal by Subject|1|||
143116702|NCT02520427|515968634|FG015|Overall Study|Withdrawal by Subject|0|||
143116703|NCT02520427|515968635|FG016|Overall Study|Withdrawal by Subject|1|||
143116704|NCT02520427|515968636|FG017|Overall Study|Withdrawal by Subject|0|||
143116705|NCT02520427|515968637|FG018|Overall Study|Withdrawal by Subject|0|||
143116706|NCT02520427|515968638|FG019|Overall Study|Withdrawal by Subject|3|||
143116707|NCT02520427|515968639|FG020|Overall Study|Withdrawal by Subject|2|||
143116708|NCT02520427|515968640|FG021|Overall Study|Withdrawal by Subject|0|||
143116709|NCT02520427|515968641|FG022|Overall Study|Withdrawal by Subject|0|||
143116710|NCT02520427|515968642|FG023|Overall Study|Withdrawal by Subject|0|||
143116711|NCT02520427|515968643|FG024|Overall Study|Withdrawal by Subject|0|||
143116712|NCT02520427|515968644|FG025|Overall Study|Withdrawal by Subject|0|||
143116713|NCT02520427|515968619|FG000|Overall Study|Death|1|||
143116714|NCT02520427|515968620|FG001|Overall Study|Death|0|||
143116715|NCT02520427|515968621|FG002|Overall Study|Death|0|||
143116716|NCT02520427|515968622|FG003|Overall Study|Death|0|||
143116717|NCT02520427|515968623|FG004|Overall Study|Death|0|||
143116718|NCT02520427|515968624|FG005|Overall Study|Death|0|||
143116719|NCT02520427|515968625|FG006|Overall Study|Death|0|||
143116720|NCT02520427|515968626|FG007|Overall Study|Death|0|||
143116721|NCT02520427|515968627|FG008|Overall Study|Death|0|||
143116722|NCT02520427|515968628|FG009|Overall Study|Death|0|||
143116723|NCT02520427|515968629|FG010|Overall Study|Death|0|||
143116724|NCT02520427|515968630|FG011|Overall Study|Death|0|||
143116725|NCT02520427|515968631|FG012|Overall Study|Death|0|||
143116726|NCT02520427|515968632|FG013|Overall Study|Death|0|||
143116727|NCT02520427|515968633|FG014|Overall Study|Death|0|||
143116728|NCT02520427|515968634|FG015|Overall Study|Death|0|||
143116729|NCT02520427|515968635|FG016|Overall Study|Death|2|||
143116730|NCT02520427|515968636|FG017|Overall Study|Death|1|||
143116731|NCT02520427|515968637|FG018|Overall Study|Death|3|||
143116732|NCT02520427|515968638|FG019|Overall Study|Death|2|||
143116733|NCT02520427|515968639|FG020|Overall Study|Death|0|||
143116734|NCT02520427|515968640|FG021|Overall Study|Death|0|||
143116735|NCT02520427|515968641|FG022|Overall Study|Death|1|||
143116736|NCT02520427|515968642|FG023|Overall Study|Death|0|||
143116737|NCT02520427|515968643|FG024|Overall Study|Death|1|||
143116738|NCT02520427|515968644|FG025|Overall Study|Death|0|||
143116739|NCT00793624|515968645|FG000|Overall Study|Adverse Event|18|||
143116740|NCT00793624|515968646|FG001|Overall Study|Adverse Event|16|||
143116741|NCT00793624|515968647|FG002|Overall Study|Adverse Event|15|||
143116742|NCT00793624|515968648|FG003|Overall Study|Adverse Event|20|||
143116743|NCT00793624|515968645|FG000|Overall Study|Lost to Follow-up|2|||
143116744|NCT00793624|515968646|FG001|Overall Study|Lost to Follow-up|2|||
143116745|NCT00793624|515968647|FG002|Overall Study|Lost to Follow-up|4|||
143116746|NCT00793624|515968648|FG003|Overall Study|Lost to Follow-up|0|||
143116747|NCT00793624|515968645|FG000|Overall Study|Withdrawal by Subject|20|||
143116748|NCT00793624|515968646|FG001|Overall Study|Withdrawal by Subject|9|||
143116749|NCT00793624|515968647|FG002|Overall Study|Withdrawal by Subject|11|||
143116750|NCT00793624|515968648|FG003|Overall Study|Withdrawal by Subject|14|||
143116751|NCT00793624|515968645|FG000|Overall Study|Lack of Efficacy|9|||
143116752|NCT00793624|515968646|FG001|Overall Study|Lack of Efficacy|2|||
143116753|NCT00793624|515968647|FG002|Overall Study|Lack of Efficacy|1|||
143116754|NCT00793624|515968648|FG003|Overall Study|Lack of Efficacy|3|||
143116755|NCT00793624|515968645|FG000|Overall Study|Non compliance with protocol|2|||
143116756|NCT00793624|515968646|FG001|Overall Study|Non compliance with protocol|3|||
143116757|NCT00793624|515968647|FG002|Overall Study|Non compliance with protocol|2|||
143116758|NCT00793624|515968648|FG003|Overall Study|Non compliance with protocol|3|||
143116759|NCT00793624|515968645|FG000|Overall Study|Other reason not described above|6|||
143116760|NCT00793624|515968646|FG001|Overall Study|Other reason not described above|4|||
143116761|NCT00793624|515968647|FG002|Overall Study|Other reason not described above|6|||
143116762|NCT00793624|515968648|FG003|Overall Study|Other reason not described above|3|||
143116763|NCT02044874|515968650|FG000|Overall Study|Adverse Event|5|||
143116764|NCT02044874|515968651|FG001|Overall Study|Adverse Event|6|||
143116765|NCT02044874|515968652|FG002|Overall Study|Adverse Event|6|||
143116766|NCT02044874|515968650|FG000|Overall Study|Withdrawal by Subject|8|||
143116767|NCT02044874|515968651|FG001|Overall Study|Withdrawal by Subject|16|||
143116768|NCT02044874|515968652|FG002|Overall Study|Withdrawal by Subject|23|||
143116769|NCT02044874|515968650|FG000|Overall Study|Physician Decision|0|||
143116770|NCT02044874|515968651|FG001|Overall Study|Physician Decision|2|||
143116771|NCT02044874|515968652|FG002|Overall Study|Physician Decision|1|||
143116772|NCT02044874|515968650|FG000|Overall Study|Lost to Follow-up|10|||
143116773|NCT02044874|515968651|FG001|Overall Study|Lost to Follow-up|27|||
143116774|NCT02044874|515968652|FG002|Overall Study|Lost to Follow-up|21|||
143116775|NCT02044874|515968650|FG000|Overall Study|Sponsor Decision|0|||
143116776|NCT02044874|515968651|FG001|Overall Study|Sponsor Decision|1|||
143116777|NCT02044874|515968652|FG002|Overall Study|Sponsor Decision|1|||
143116778|NCT02044874|515968650|FG000|Overall Study|Other|7|||
143116779|NCT02044874|515968651|FG001|Overall Study|Other|3|||
143116780|NCT02044874|515968652|FG002|Overall Study|Other|8|||
143116781|NCT02889835|515968653|FG000|Overall Study|Lost to Follow-up|13|||
143116782|NCT02889835|515968654|FG001|Overall Study|Lost to Follow-up|13|||
143116783|NCT02889835|515968655|FG002|Overall Study|Lost to Follow-up|13|||
143116784|NCT02889835|515968653|FG000|Overall Study|Withdrawal by Subject|2|||
143187026|NCT02482428|516228816|FG000|Overall Study|Lost to Follow-up|4|||
143187027|NCT02482428|516228817|FG001|Overall Study|Lost to Follow-up|9|||
143187028|NCT02482428|516228818|FG002|Overall Study|Lost to Follow-up|1|||
143369427|NCT01368406|516896100|FG001|Overall Study|Lost to Follow-up|4|||
143116785|NCT02889835|515968654|FG001|Overall Study|Withdrawal by Subject|2|||
143187029|NCT02482428|516228819|FG003|Overall Study|Lost to Follow-up|2|||
143187030|NCT02482428|516228820|FG004|Overall Study|Lost to Follow-up|4|||
143187031|NCT02482428|516228816|FG000|Overall Study|Physician Decision|0|||
143187032|NCT02482428|516228817|FG001|Overall Study|Physician Decision|0|||
143187033|NCT02482428|516228818|FG002|Overall Study|Physician Decision|0|||
143187034|NCT02482428|516228819|FG003|Overall Study|Physician Decision|0|||
143187035|NCT02482428|516228820|FG004|Overall Study|Physician Decision|1|||
143187036|NCT02482428|516228816|FG000|Overall Study|protocol deviation|1|||
143187037|NCT02482428|516228817|FG001|Overall Study|protocol deviation|1|||
143187038|NCT02482428|516228818|FG002|Overall Study|protocol deviation|0|||
143187039|NCT02482428|516228819|FG003|Overall Study|protocol deviation|0|||
143116786|NCT02889835|515968655|FG002|Overall Study|Withdrawal by Subject|2|||
143116787|NCT02889835|515968653|FG000|Overall Study|Protocol Violation|1|||
143187040|NCT02482428|516228820|FG004|Overall Study|protocol deviation|0|||
143187041|NCT02482428|516228816|FG000|Overall Study|subject/guardian decision|4|||
143187042|NCT02482428|516228817|FG001|Overall Study|subject/guardian decision|2|||
143187043|NCT02482428|516228818|FG002|Overall Study|subject/guardian decision|0|||
143187044|NCT02482428|516228819|FG003|Overall Study|subject/guardian decision|0|||
143187045|NCT02482428|516228820|FG004|Overall Study|subject/guardian decision|2|||
143187046|NCT00516893|516228822|FG000|Overall Study|Lost to Follow-up|4|||
143187047|NCT00516893|516228822|FG000|Overall Study|Adverse Event|3|||
143187048|NCT00516893|516228822|FG000|Overall Study|Withdrawal by Subject|2|||
143187049|NCT00516893|516228822|FG000|Overall Study|Noncompliance|2|||
143187050|NCT00516893|516228822|FG000|Overall Study|Death|1|||
143187051|NCT00516893|516228822|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
143187052|NCT00516893|516228822|FG000|Overall Study|Relocated|1|||
143116788|NCT02889835|515968654|FG001|Overall Study|Protocol Violation|1|||
143116789|NCT02889835|515968655|FG002|Overall Study|Protocol Violation|1|||
143116790|NCT02889835|515968653|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
143116791|NCT02889835|515968654|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
143116792|NCT02889835|515968655|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
143116793|NCT02889835|515968653|FG000|Overall Study|Death|1|||
143116794|NCT02889835|515968654|FG001|Overall Study|Death|1|||
143116795|NCT02889835|515968655|FG002|Overall Study|Death|1|||
143116796|NCT02342548|515968656|FG000|Overall Study|Adverse Event|12|||
143116797|NCT02342548|515968657|FG001|Overall Study|Adverse Event|17|||
143116798|NCT02342548|515968658|FG002|Overall Study|Adverse Event|13|||
143116799|NCT02342548|515968656|FG000|Overall Study|Lost to Follow-up|0|||
143116800|NCT02342548|515968657|FG001|Overall Study|Lost to Follow-up|1|||
143116801|NCT02342548|515968658|FG002|Overall Study|Lost to Follow-up|0|||
143116802|NCT02342548|515968656|FG000|Overall Study|Study terminated by sponsor|20|||
143116803|NCT02342548|515968657|FG001|Overall Study|Study terminated by sponsor|39|||
143116804|NCT02342548|515968658|FG002|Overall Study|Study terminated by sponsor|25|||
143116805|NCT02342548|515968656|FG000|Overall Study|Protocol Violation|0|||
143116806|NCT02342548|515968657|FG001|Overall Study|Protocol Violation|1|||
143116807|NCT02342548|515968658|FG002|Overall Study|Protocol Violation|0|||
143116808|NCT02342548|515968656|FG000|Overall Study|Withdrawal by Subject|1|||
143116809|NCT02342548|515968657|FG001|Overall Study|Withdrawal by Subject|3|||
143116810|NCT02342548|515968658|FG002|Overall Study|Withdrawal by Subject|4|||
143116811|NCT02342548|515968656|FG000|Overall Study|Other|1|||
143116812|NCT02342548|515968657|FG001|Overall Study|Other|1|||
143116813|NCT02342548|515968658|FG002|Overall Study|Other|1|||
143187053|NCT00516893|516228822|FG000|Overall Study|Pregnancy|1|||
143187054|NCT00516893|516228822|FG000|Overall Study|Received Medication From Another Study|1|||
143187055|NCT00301262|516228827|FG000|Double Blind Phase (DB)|Adverse Event|1|||
143187056|NCT00301262|516228828|FG001|Double Blind Phase (DB)|Adverse Event|0|||
143187057|NCT00301262|516228827|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
143187058|NCT00301262|516228828|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
143187059|NCT00301262|516228827|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
143187060|NCT00301262|516228828|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
143187061|NCT00301262|516228827|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
143187062|NCT00301262|516228828|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
143116814|NCT02987972|515968659|FG000|Overall Study|Adverse Event|1|||
143116815|NCT02987972|515968660|FG001|Overall Study|Adverse Event|1|||
143116816|NCT02987972|515968661|FG002|Overall Study|Adverse Event|0|||
143116817|NCT02987972|515968659|FG000|Overall Study|Death|1|||
143116818|NCT02987972|515968660|FG001|Overall Study|Death|0|||
143116819|NCT02987972|515968661|FG002|Overall Study|Death|0|||
143116820|NCT02987972|515968659|FG000|Overall Study|Lack of Efficacy|9|||
143116821|NCT02987972|515968660|FG001|Overall Study|Lack of Efficacy|12|||
143116822|NCT02987972|515968661|FG002|Overall Study|Lack of Efficacy|12|||
143116823|NCT02987972|515968659|FG000|Overall Study|Lost to Follow-up|7|||
143116824|NCT02987972|515968660|FG001|Overall Study|Lost to Follow-up|8|||
143116825|NCT02987972|515968661|FG002|Overall Study|Lost to Follow-up|4|||
143116826|NCT02987972|515968659|FG000|Overall Study|Physician Decision|1|||
143116827|NCT02987972|515968660|FG001|Overall Study|Physician Decision|6|||
143116828|NCT02987972|515968661|FG002|Overall Study|Physician Decision|0|||
143116829|NCT02987972|515968659|FG000|Overall Study|Protocol Violation|2|||
143116830|NCT02987972|515968660|FG001|Overall Study|Protocol Violation|1|||
143116831|NCT02987972|515968661|FG002|Overall Study|Protocol Violation|5|||
143116832|NCT02987972|515968659|FG000|Overall Study|Withdrawal by Subject|22|||
143116833|NCT02987972|515968660|FG001|Overall Study|Withdrawal by Subject|17|||
143116834|NCT02987972|515968661|FG002|Overall Study|Withdrawal by Subject|21|||
143116835|NCT01047332|515968662|FG000|Overall Study|SEMS Obstruction|11|||
143116836|NCT01047332|515968663|FG001|Overall Study|SEMS Obstruction|20|||
143116837|NCT01047332|515968662|FG000|Overall Study|Died Unobstructed|38|||
143116838|NCT01047332|515968663|FG001|Overall Study|Died Unobstructed|41|||
143116839|NCT01047332|515968662|FG000|Overall Study|Lost to Follow-up|8|||
143116840|NCT01047332|515968663|FG001|Overall Study|Lost to Follow-up|3|||
143116841|NCT00073983|515968668|FG000|Overall Study|not evaluable|1|||
143116842|NCT03292458|515969926|FG000|Period 1|Adverse Event|2|||
143116843|NCT03292458|515969927|FG001|Period 1|Adverse Event|0|||
143116844|NCT04643964|515969928|FG000|Overall Study|Lost to Follow-up|55|||
143116845|NCT04643964|515969929|FG001|Overall Study|Lost to Follow-up|59|||
143116846|NCT04643964|515969930|FG002|Overall Study|Lost to Follow-up|54|||
143116847|NCT04643964|515969931|FG003|Overall Study|Lost to Follow-up|129|||
143261377|NCT02129777|516510566|FG001|Double-Blind Period|Lack of Efficacy|1|||
143261378|NCT02129777|516510567|FG002|Double-Blind Period|Lack of Efficacy|0|||
143116848|NCT04643964|515969932|FG004|Overall Study|Lost to Follow-up|48|||
143116849|NCT04643964|515969928|FG000|Overall Study|Failed attention check|1|||
143116850|NCT04643964|515969929|FG001|Overall Study|Failed attention check|8|||
143116851|NCT04643964|515969930|FG002|Overall Study|Failed attention check|2|||
143116852|NCT04643964|515969931|FG003|Overall Study|Failed attention check|14|||
143116853|NCT04643964|515969932|FG004|Overall Study|Failed attention check|11|||
143116854|NCT05940077|515969935|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
143116855|NCT02368210|515969936|FG000|Overall Study|Withdrawal by Subject|1|||
143116856|NCT02368210|515969937|FG001|Overall Study|Withdrawal by Subject|0|||
143116857|NCT02368210|515969936|FG000|Overall Study|Adverse Event|0|||
143116858|NCT02368210|515969937|FG001|Overall Study|Adverse Event|1|||
143116859|NCT00078949|515969938|FG000|Overall Study|No treated|4|||
143116860|NCT00078949|515969939|FG001|Overall Study|No treated|5|||
143116861|NCT00078949|515969940|FG002|Overall Study|No treated|3|||
143116862|NCT00078949|515969941|FG003|Overall Study|No treated|3|||
143116863|NCT01492101|515969942|FG000|Overall Study|Death|323|||
143116864|NCT01492101|515969943|FG001|Overall Study|Death|322|||
143116865|NCT01492101|515969942|FG000|Overall Study|Withdrawal by Subject|14|||
143116866|NCT01492101|515969943|FG001|Overall Study|Withdrawal by Subject|18|||
143116867|NCT01492101|515969942|FG000|Overall Study|Lost to Follow-up|0|||
143116868|NCT01492101|515969943|FG001|Overall Study|Lost to Follow-up|2|||
143116869|NCT00577005|515969944|FG000|Overall Study|Lost to Follow-up|3|||
143116870|NCT00577005|515969945|FG001|Overall Study|Lost to Follow-up|2|||
143116871|NCT00577005|515969944|FG000|Overall Study|Withdrawal by Subject|2|||
143116872|NCT00577005|515969945|FG001|Overall Study|Withdrawal by Subject|1|||
143116873|NCT01004432|515969946|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
143116874|NCT01004432|515969947|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
143116875|NCT01004432|515969948|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
143116876|NCT01004432|515969949|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
143116877|NCT01004432|515969950|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
143116878|NCT01004432|515969946|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
143116879|NCT01004432|515969947|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
143116880|NCT01004432|515969948|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
143116881|NCT01004432|515969949|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
143116882|NCT01004432|515969950|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
143116883|NCT01004432|515969946|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
143116884|NCT01004432|515969947|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
143116885|NCT01004432|515969948|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
143116886|NCT01004432|515969949|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
143116887|NCT01004432|515969950|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
143116888|NCT01004432|515969946|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
143116889|NCT01004432|515969947|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
143116890|NCT01004432|515969948|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
143116891|NCT01004432|515969949|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
143187063|NCT00301262|516228827|FG000|Double Blind Phase (DB)|Other|1|||
143116892|NCT01004432|515969950|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
143116893|NCT01004432|515969946|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
143116894|NCT01004432|515969947|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
143116895|NCT01004432|515969948|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
143116896|NCT01004432|515969949|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
143116897|NCT01004432|515969950|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
143116898|NCT01004432|515969946|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
143116899|NCT01004432|515969947|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
143116900|NCT01004432|515969948|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
143116901|NCT01004432|515969949|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
143116902|NCT01004432|515969950|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
143116903|NCT01004432|515969946|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
143116904|NCT01004432|515969947|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
143116905|NCT01004432|515969948|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
143116906|NCT01004432|515969949|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
143116907|NCT01004432|515969950|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
143116908|NCT01004432|515969946|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
143116909|NCT01004432|515969947|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
143116910|NCT01004432|515969948|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
143116911|NCT01004432|515969949|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
143116912|NCT01004432|515969950|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
143116913|NCT01004432|515969946|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
143116914|NCT01004432|515969947|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
143116915|NCT01004432|515969948|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
143116916|NCT01004432|515969949|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
143116917|NCT01004432|515969950|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
143116918|NCT01004432|515969946|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
143116919|NCT01004432|515969947|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
143116920|NCT01004432|515969948|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
143116921|NCT01004432|515969949|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
143116922|NCT01004432|515969950|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
143116923|NCT01004432|515969946|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
143116924|NCT01004432|515969947|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
143116925|NCT01004432|515969948|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
143116926|NCT01004432|515969949|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
143116927|NCT01004432|515969950|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
143116928|NCT01004432|515969946|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
143116929|NCT01004432|515969947|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
143116930|NCT01004432|515969948|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
143116931|NCT01004432|515969949|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
143116932|NCT01004432|515969950|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
143116933|NCT01004432|515969946|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
143116934|NCT01004432|515969947|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
143116935|NCT01004432|515969948|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
143116936|NCT01004432|515969949|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
143116937|NCT01004432|515969950|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
143116938|NCT01004432|515969946|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
143116939|NCT01004432|515969947|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
143116940|NCT01004432|515969948|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
143116941|NCT01004432|515969949|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
143116942|NCT01004432|515969950|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
143116943|NCT01004432|515969946|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
143116944|NCT01004432|515969947|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
143116945|NCT01004432|515969948|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
143116946|NCT01004432|515969949|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
143116947|NCT01004432|515969950|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
143116948|NCT02696434|515969951|FG000|Overall Study|Adverse Event|3|||
143116949|NCT02696434|515969952|FG001|Overall Study|Adverse Event|1|||
143116950|NCT02696434|515969951|FG000|Overall Study|Lost to Follow-up|5|||
143116951|NCT02696434|515969952|FG001|Overall Study|Lost to Follow-up|4|||
143116952|NCT02696434|515969951|FG000|Overall Study|Withdrawal by Subject|14|||
143116953|NCT02696434|515969952|FG001|Overall Study|Withdrawal by Subject|12|||
143116954|NCT02696434|515969951|FG000|Overall Study|Physician Decision|0|||
143116955|NCT02696434|515969952|FG001|Overall Study|Physician Decision|1|||
143116956|NCT02971800|515969955|FG000|Overall Study|Protocol Violation|1|||
143116957|NCT02971800|515969955|FG000|Overall Study|Withdrawal by Subject|1|||
143116958|NCT02971800|515969955|FG000|Overall Study|Exclusion criteria prior intervention|1|||
143116959|NCT02971800|515969955|FG000|Overall Study|Number evaluable participant already reached|4|||
143116960|NCT01149421|515969957|FG000|Overall Study|Adverse Event|22|||
143116961|NCT01149421|515969958|FG001|Overall Study|Adverse Event|6|||
143116962|NCT01149421|515969959|FG002|Overall Study|Adverse Event|11|||
143116963|NCT01149421|515969957|FG000|Overall Study|Withdrawal by Subject|20|||
143116964|NCT01149421|515969958|FG001|Overall Study|Withdrawal by Subject|12|||
143116965|NCT01149421|515969959|FG002|Overall Study|Withdrawal by Subject|13|||
143116966|NCT01149421|515969957|FG000|Overall Study|Sponsor Decision|0|||
143116967|NCT01149421|515969958|FG001|Overall Study|Sponsor Decision|1|||
143116968|NCT01149421|515969959|FG002|Overall Study|Sponsor Decision|1|||
143116969|NCT01149421|515969957|FG000|Overall Study|Lost to Follow-up|2|||
143116970|NCT01149421|515969958|FG001|Overall Study|Lost to Follow-up|4|||
143116971|NCT01149421|515969959|FG002|Overall Study|Lost to Follow-up|5|||
143116972|NCT01149421|515969957|FG000|Overall Study|Physician Decision|5|||
143116973|NCT01149421|515969958|FG001|Overall Study|Physician Decision|3|||
143116974|NCT01149421|515969959|FG002|Overall Study|Physician Decision|6|||
143116975|NCT01149421|515969957|FG000|Overall Study|Entry Criteria Not Met|1|||
143116976|NCT01149421|515969958|FG001|Overall Study|Entry Criteria Not Met|1|||
143116977|NCT01149421|515969959|FG002|Overall Study|Entry Criteria Not Met|2|||
143116978|NCT01149421|515969957|FG000|Overall Study|Protocol Violation|2|||
143116979|NCT01149421|515969958|FG001|Overall Study|Protocol Violation|2|||
143116980|NCT01149421|515969959|FG002|Overall Study|Protocol Violation|6|||
143116981|NCT03738800|515969963|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
143116982|NCT03738800|515969964|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
143116983|NCT03738800|515969965|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
143116984|NCT03738800|515969963|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
143116985|NCT03738800|515969964|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
143116986|NCT03738800|515969965|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
143116987|NCT03738800|515969963|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
143116988|NCT03738800|515969964|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
143116989|NCT03738800|515969965|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
143116990|NCT02956057|515969967|FG000|Overall Study|Discontinued intervention|14|||
143116991|NCT02956057|515969968|FG001|Overall Study|Discontinued intervention|10|||
143116992|NCT02956057|515969969|FG002|Overall Study|Discontinued intervention|7|||
143116993|NCT02956057|515969970|FG003|Overall Study|Discontinued intervention|14|||
143116994|NCT02956057|515969971|FG004|Overall Study|Discontinued intervention|4|||
143116995|NCT02956057|515969972|FG005|Overall Study|Discontinued intervention|17|||
143116996|NCT02956057|515969967|FG000|Overall Study|Lost to Follow-up|0|||
143116997|NCT02956057|515969968|FG001|Overall Study|Lost to Follow-up|2|||
143116998|NCT02956057|515969969|FG002|Overall Study|Lost to Follow-up|1|||
143116999|NCT02956057|515969970|FG003|Overall Study|Lost to Follow-up|1|||
143117000|NCT02956057|515969971|FG004|Overall Study|Lost to Follow-up|1|||
143117001|NCT02956057|515969972|FG005|Overall Study|Lost to Follow-up|0|||
143117002|NCT00367484|515969975|FG000|Overall Study|Adverse Event|7|||
143117003|NCT00367484|515969975|FG000|Overall Study|Withdrew informed consent|5|||
143117004|NCT00367484|515969975|FG000|Overall Study|Travel to USA|1|||
143117005|NCT00367484|515969975|FG000|Overall Study|Lost to Follow-up|1|||
143117006|NCT00367484|515969975|FG000|Overall Study|Protocol Violation|1|||
143117007|NCT00367484|515969975|FG000|Overall Study|The choice of the patient|1|||
143117008|NCT00367484|515969975|FG000|Overall Study|Lack of Efficacy|1|||
143117009|NCT01404208|515969976|FG000|Overall Study|Discontinued|3|||
143117010|NCT01404208|515969977|FG001|Overall Study|Discontinued|0|||
143117011|NCT00908076|515969978|FG000|Overall Study|Lack of Efficacy|1|||
143117012|NCT00908076|515969979|FG001|Overall Study|Lack of Efficacy|1|||
143117013|NCT02382796|515969980|FG000|Overall Study|Global deterioration of health status|1|||
143117014|NCT02382796|515969980|FG000|Overall Study|Objective progression or relapse|3|||
143117015|NCT02382796|515969980|FG000|Overall Study|Commercial dacomitinib became available|3|||
143117016|NCT04007107|515969991|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
143117017|NCT04007107|515969992|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
143117018|NCT04007107|515969993|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
143117019|NCT04007107|515969994|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
143117020|NCT04526574|515969995|FG000|Overall Study|Protocol Violation|3|||
143117021|NCT04526574|515969996|FG001|Overall Study|Protocol Violation|1|||
143117022|NCT04526574|515969995|FG000|Overall Study|Withdrawal by Subject|12|||
143117023|NCT04526574|515969996|FG001|Overall Study|Withdrawal by Subject|9|||
143117024|NCT04526574|515969995|FG000|Overall Study|Other|1|||
143117025|NCT04526574|515969996|FG001|Overall Study|Other|2|||
143117026|NCT04526574|515969995|FG000|Overall Study|Adverse Event|1|||
143117027|NCT04526574|515969996|FG001|Overall Study|Adverse Event|1|||
143117028|NCT04526574|515969995|FG000|Overall Study|Death|2|||
143117029|NCT04526574|515969996|FG001|Overall Study|Death|3|||
143117030|NCT04526574|515969995|FG000|Overall Study|Lost to Follow-up|9|||
143117031|NCT04526574|515969996|FG001|Overall Study|Lost to Follow-up|9|||
143117032|NCT04526574|515969995|FG000|Overall Study|No longer meets eligibility criteria|8|||
143187064|NCT00301262|516228828|FG001|Double Blind Phase (DB)|Other|4|||
143187065|NCT00301262|516228827|FG000|Open Label Phase (OL)|Adverse Event|1|||
143187066|NCT00301262|516228828|FG001|Open Label Phase (OL)|Adverse Event|0|||
143187067|NCT00301262|516228827|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
143187068|NCT00301262|516228828|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
143187069|NCT00301262|516228827|FG000|Open Label Phase (OL)|Other|2|||
143187070|NCT00301262|516228828|FG001|Open Label Phase (OL)|Other|0|||
143187071|NCT03206970|516228831|FG000|Overall Study|Death|21|||
143187072|NCT03206970|516228831|FG000|Overall Study|Withdrawal by Subject|13|||
143187073|NCT03206970|516228831|FG000|Overall Study|Lost to Follow-up|3|||
143187074|NCT03206970|516228831|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
143187075|NCT04560816|516228835|FG000|Overall Study|Withdrawal by Subject|1|||
143187076|NCT04560816|516228836|FG001|Overall Study|Withdrawal by Subject|1|||
143187077|NCT04560816|516228837|FG002|Overall Study|Withdrawal by Subject|1|||
143187078|NCT04560816|516228838|FG003|Overall Study|Withdrawal by Subject|0|||
143187079|NCT04560816|516228839|FG004|Overall Study|Withdrawal by Subject|3|||
143187080|NCT04560816|516228840|FG005|Overall Study|Withdrawal by Subject|0|||
143187081|NCT04560816|516228835|FG000|Overall Study|Lost to Follow-up|1|||
143187082|NCT04560816|516228836|FG001|Overall Study|Lost to Follow-up|0|||
143187083|NCT04560816|516228837|FG002|Overall Study|Lost to Follow-up|0|||
143117033|NCT04526574|515969996|FG001|Overall Study|No longer meets eligibility criteria|8|||
143117034|NCT04068688|515970002|FG000|Overall Study|Lost to Follow-up|1|||
143117035|NCT04068688|515970003|FG001|Overall Study|Lost to Follow-up|1|||
143187084|NCT04560816|516228838|FG003|Overall Study|Lost to Follow-up|0|||
143187085|NCT04560816|516228839|FG004|Overall Study|Lost to Follow-up|0|||
143187086|NCT04560816|516228840|FG005|Overall Study|Lost to Follow-up|0|||
143187087|NCT04560816|516228835|FG000|Overall Study|Protocol Violation|1|||
143187088|NCT04560816|516228836|FG001|Overall Study|Protocol Violation|0|||
143187089|NCT04560816|516228837|FG002|Overall Study|Protocol Violation|0|||
143117036|NCT04068688|515970004|FG002|Overall Study|Lost to Follow-up|0|||
143117037|NCT04068688|515970005|FG003|Overall Study|Lost to Follow-up|0|||
143117038|NCT04068688|515970006|FG004|Overall Study|Lost to Follow-up|5|||
143117039|NCT04068688|515970007|FG005|Overall Study|Lost to Follow-up|5|||
143187090|NCT04560816|516228838|FG003|Overall Study|Protocol Violation|0|||
143187091|NCT04560816|516228839|FG004|Overall Study|Protocol Violation|0|||
143187092|NCT04560816|516228840|FG005|Overall Study|Protocol Violation|0|||
143187093|NCT00070109|516228845|FG000|Overall Study|Death|1|||
143187094|NCT00070109|516228846|FG001|Overall Study|Death|1|||
143117040|NCT04068688|515970008|FG006|Overall Study|Lost to Follow-up|0|||
143117041|NCT04068688|515970009|FG007|Overall Study|Lost to Follow-up|0|||
143117042|NCT04068688|515970010|FG008|Overall Study|Lost to Follow-up|1|||
143117043|NCT04068688|515970011|FG009|Overall Study|Lost to Follow-up|0|||
143117044|NCT04068688|515970002|FG000|Overall Study|Withdrawal by Subject|1|||
143117045|NCT04068688|515970003|FG001|Overall Study|Withdrawal by Subject|1|||
143117046|NCT04068688|515970004|FG002|Overall Study|Withdrawal by Subject|0|||
143117047|NCT04068688|515970005|FG003|Overall Study|Withdrawal by Subject|0|||
143117048|NCT04068688|515970006|FG004|Overall Study|Withdrawal by Subject|0|||
143187095|NCT00070109|516228847|FG002|Overall Study|Death|0|||
143187096|NCT00070109|516228848|FG003|Overall Study|Death|0|||
143187097|NCT00070109|516228849|FG004|Overall Study|Death|1|||
143187098|NCT00070109|516228845|FG000|Overall Study|Lack of Efficacy|6|||
143187099|NCT00070109|516228846|FG001|Overall Study|Lack of Efficacy|4|||
143187100|NCT00070109|516228847|FG002|Overall Study|Lack of Efficacy|5|||
143187101|NCT00070109|516228848|FG003|Overall Study|Lack of Efficacy|15|||
143187102|NCT00070109|516228849|FG004|Overall Study|Lack of Efficacy|5|||
143187103|NCT00070109|516228845|FG000|Overall Study|Physician Decision|1|||
143187104|NCT00070109|516228846|FG001|Overall Study|Physician Decision|0|||
143187105|NCT00070109|516228847|FG002|Overall Study|Physician Decision|0|||
143187106|NCT00070109|516228848|FG003|Overall Study|Physician Decision|0|||
143187107|NCT00070109|516228849|FG004|Overall Study|Physician Decision|0|||
143187108|NCT00070109|516228845|FG000|Overall Study|Withdrawal by Subject|0|||
143187109|NCT00070109|516228846|FG001|Overall Study|Withdrawal by Subject|1|||
143187110|NCT00070109|516228847|FG002|Overall Study|Withdrawal by Subject|1|||
143187111|NCT00070109|516228848|FG003|Overall Study|Withdrawal by Subject|0|||
143187112|NCT00070109|516228849|FG004|Overall Study|Withdrawal by Subject|0|||
143187113|NCT00070109|516228845|FG000|Overall Study|Adverse Event|0|||
143187114|NCT00070109|516228846|FG001|Overall Study|Adverse Event|0|||
143187115|NCT00070109|516228847|FG002|Overall Study|Adverse Event|2|||
143187116|NCT00070109|516228848|FG003|Overall Study|Adverse Event|4|||
143117049|NCT04068688|515970007|FG005|Overall Study|Withdrawal by Subject|0|||
143117050|NCT04068688|515970008|FG006|Overall Study|Withdrawal by Subject|0|||
143117051|NCT04068688|515970009|FG007|Overall Study|Withdrawal by Subject|0|||
143117052|NCT04068688|515970010|FG008|Overall Study|Withdrawal by Subject|0|||
143117053|NCT04068688|515970011|FG009|Overall Study|Withdrawal by Subject|0|||
143117054|NCT04068688|515970002|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
143117055|NCT04068688|515970003|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
143187117|NCT00070109|516228849|FG004|Overall Study|Adverse Event|2|||
143187118|NCT00070109|516228845|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
143187119|NCT00070109|516228846|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
143187120|NCT00070109|516228847|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
143187121|NCT00070109|516228848|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
143187122|NCT00070109|516228849|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
143187123|NCT00588237|516228850|FG000|Overall Study|Evaluable for toxicity only|3|||
143187124|NCT00588237|516228850|FG000|Overall Study|Patien not treated|1|||
143187125|NCT00716482|516228860|FG000|Overall Study|Lost to Follow-up|6|||
143187126|NCT00716482|516228860|FG000|Overall Study|Inadequate acquisition or analysis|50|||
143187127|NCT00716482|516228860|FG000|Overall Study|no pathology obtained|10|||
143187128|NCT00716482|516228860|FG000|Overall Study|technical/machine error|28|||
143187129|NCT00716482|516228860|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
143187130|NCT03248531|516228861|FG000|Overall Study|Adverse Event|0|||
143187131|NCT03248531|516228862|FG001|Overall Study|Adverse Event|0|||
143187132|NCT03248531|516228863|FG002|Overall Study|Adverse Event|1|||
143187133|NCT03248531|516228861|FG000|Overall Study|Lost to Follow-up|1|||
143187134|NCT03248531|516228862|FG001|Overall Study|Lost to Follow-up|0|||
143187135|NCT03248531|516228863|FG002|Overall Study|Lost to Follow-up|5|||
143187136|NCT03248531|516228861|FG000|Overall Study|Withdrawal by Subject|3|||
143187137|NCT03248531|516228862|FG001|Overall Study|Withdrawal by Subject|3|||
143187138|NCT03248531|516228863|FG002|Overall Study|Withdrawal by Subject|2|||
143187139|NCT03248531|516228861|FG000|Overall Study|Sponsor Request|0|||
143187140|NCT03248531|516228862|FG001|Overall Study|Sponsor Request|2|||
143187141|NCT03248531|516228863|FG002|Overall Study|Sponsor Request|0|||
143187142|NCT04075513|516228864|FG000|Overall Study|Withdrawal by Subject|2|||
143187143|NCT04075513|516228865|FG001|Overall Study|Withdrawal by Subject|2|||
143187144|NCT04075513|516228864|FG000|Overall Study|Lack of Efficacy|1|||
143187145|NCT04075513|516228865|FG001|Overall Study|Lack of Efficacy|0|||
143187146|NCT04075513|516228864|FG000|Overall Study|Lost to Follow-up|4|||
143187147|NCT04075513|516228865|FG001|Overall Study|Lost to Follow-up|2|||
143187148|NCT04075513|516228864|FG000|Overall Study|Switch to insulin pump|1|||
143187149|NCT04075513|516228865|FG001|Overall Study|Switch to insulin pump|0|||
143187150|NCT02550288|516228866|FG000|Overall Study|Adverse Event|0|||
143187151|NCT02550288|516228867|FG001|Overall Study|Adverse Event|1|||
143187152|NCT02550288|516228868|FG002|Overall Study|Adverse Event|0|||
143187153|NCT02550288|516228869|FG003|Overall Study|Adverse Event|0|||
143187154|NCT02550288|516228870|FG004|Overall Study|Adverse Event|0|||
143187155|NCT02550288|516228866|FG000|Overall Study|Physician Decision|0|||
143187156|NCT02550288|516228867|FG001|Overall Study|Physician Decision|0|||
143187157|NCT02550288|516228868|FG002|Overall Study|Physician Decision|0|||
143187158|NCT02550288|516228869|FG003|Overall Study|Physician Decision|1|||
143187159|NCT02550288|516228870|FG004|Overall Study|Physician Decision|0|||
143187160|NCT02550288|516228866|FG000|Overall Study|Protocol Violation|2|||
143187161|NCT02550288|516228867|FG001|Overall Study|Protocol Violation|2|||
143187162|NCT02550288|516228868|FG002|Overall Study|Protocol Violation|1|||
143187163|NCT02550288|516228869|FG003|Overall Study|Protocol Violation|0|||
143187164|NCT02550288|516228870|FG004|Overall Study|Protocol Violation|3|||
143187165|NCT02550288|516228866|FG000|Overall Study|Participant moved|0|||
143187166|NCT02550288|516228867|FG001|Overall Study|Participant moved|0|||
143187167|NCT02550288|516228868|FG002|Overall Study|Participant moved|0|||
143187168|NCT02550288|516228869|FG003|Overall Study|Participant moved|1|||
143187169|NCT02550288|516228870|FG004|Overall Study|Participant moved|0|||
143187170|NCT02550288|516228866|FG000|Overall Study|Withdrawal by Subject|0|||
143187171|NCT02550288|516228867|FG001|Overall Study|Withdrawal by Subject|0|||
143187172|NCT02550288|516228868|FG002|Overall Study|Withdrawal by Subject|0|||
143187173|NCT02550288|516228869|FG003|Overall Study|Withdrawal by Subject|1|||
143187174|NCT02550288|516228870|FG004|Overall Study|Withdrawal by Subject|0|||
143117056|NCT04068688|515970004|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
143117057|NCT04068688|515970005|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
143117058|NCT04068688|515970006|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
143117059|NCT04068688|515970007|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
143117060|NCT04068688|515970008|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
143117061|NCT04068688|515970009|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
143117062|NCT04068688|515970010|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
143117063|NCT04068688|515970011|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
143117064|NCT04679051|515970012|FG000|Overall Study|felt tired after restricted time in bed|3|||
143117065|NCT04679051|515970013|FG001|Overall Study|felt tired after restricted time in bed|0|||
143117066|NCT04679051|515970012|FG000|Overall Study|discomfort with blood pressure cuff|2|||
143117067|NCT04679051|515970013|FG001|Overall Study|discomfort with blood pressure cuff|0|||
143117068|NCT04679051|515970012|FG000|Overall Study|scheduling conflict|1|||
143117069|NCT04679051|515970013|FG001|Overall Study|scheduling conflict|1|||
143117070|NCT04679051|515970012|FG000|Overall Study|Protocol Violation|0|||
143117071|NCT04679051|515970013|FG001|Overall Study|Protocol Violation|4|||
143117072|NCT02554318|515970016|FG000|Overall Study|Withdrawal by Subject|10|||
143117073|NCT02554318|515970017|FG001|Overall Study|Withdrawal by Subject|8|||
143117074|NCT00329641|515970019|FG000|Overall Study|Did not start treatment|1|||
143117075|NCT00329641|515970019|FG000|Overall Study|Not eligible|1|||
143117076|NCT00329641|515970019|FG000|Overall Study|Adverse Event|3|||
143117077|NCT00329641|515970019|FG000|Overall Study|Other reason, not protocol specified|1|||
143117078|NCT00396877|515970021|FG000|Overall Study|Lost to Follow-up|2|||
143117079|NCT00396877|515970022|FG001|Overall Study|Lost to Follow-up|1|||
143117080|NCT00396877|515970021|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
143117081|NCT00396877|515970022|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
143187175|NCT01524224|516228871|FG000|Overall Study|Progressive Disease|1|||
143187176|NCT01524224|516228872|FG001|Overall Study|Progressive Disease|0|||
143187177|NCT01524224|516228873|FG002|Overall Study|Progressive Disease|2|||
143187178|NCT01524224|516228874|FG003|Overall Study|Progressive Disease|1|||
143187179|NCT01524224|516228875|FG004|Overall Study|Progressive Disease|2|||
143369428|NCT01368406|516896099|FG000|Overall Study|Withdrawal by Subject|8|||
143369429|NCT01368406|516896100|FG001|Overall Study|Withdrawal by Subject|4|||
143369430|NCT01368406|516896099|FG000|Overall Study|relapse of the disease|3|||
143369431|NCT01368406|516896100|FG001|Overall Study|relapse of the disease|2|||
143369432|NCT01368406|516896099|FG000|Overall Study|started working|2|||
143369433|NCT01368406|516896100|FG001|Overall Study|started working|3|||
143369434|NCT00001575|516896103|FG000|Overall Study|Screening failures-Ph I portion|22|||
143369435|NCT00001575|516896103|FG000|Overall Study|Withdrawn/deaths|23|||
143369436|NCT03383887|516896104|FG000|Overall Study|Lost to Follow-up|0|||
143369437|NCT03383887|516896105|FG001|Overall Study|Lost to Follow-up|1|||
143369438|NCT00831792|516896106|FG000|Overall Study|Not Eligible|3|||
143369439|NCT00831792|516896106|FG000|Overall Study|Adverse Event|1|||
143369440|NCT00831792|516896106|FG000|Overall Study|Death|1|||
143187180|NCT01524224|516228876|FG005|Overall Study|Progressive Disease|1|||
143369441|NCT00831792|516896106|FG000|Overall Study|Lack of Efficacy|1|||
143369442|NCT01242085|516896114|FG000|Overall Study|Withdrawal by Subject|4|||
143369443|NCT01242085|516896115|FG001|Overall Study|Withdrawal by Subject|2|||
143187181|NCT01524224|516228877|FG006|Overall Study|Progressive Disease|1|||
143187182|NCT01524224|516228878|FG007|Overall Study|Progressive Disease|5|||
143187183|NCT01524224|516228871|FG000|Overall Study|Withdrawal by Subject|2|||
143187184|NCT01524224|516228872|FG001|Overall Study|Withdrawal by Subject|0|||
143187185|NCT01524224|516228873|FG002|Overall Study|Withdrawal by Subject|0|||
143187186|NCT01524224|516228874|FG003|Overall Study|Withdrawal by Subject|0|||
143187187|NCT01524224|516228875|FG004|Overall Study|Withdrawal by Subject|0|||
143187188|NCT01524224|516228876|FG005|Overall Study|Withdrawal by Subject|0|||
143187189|NCT01524224|516228877|FG006|Overall Study|Withdrawal by Subject|2|||
143187190|NCT01524224|516228878|FG007|Overall Study|Withdrawal by Subject|0|||
143187191|NCT01524224|516228871|FG000|Overall Study|Adverse Event|0|||
143187192|NCT01524224|516228872|FG001|Overall Study|Adverse Event|1|||
143187193|NCT01524224|516228873|FG002|Overall Study|Adverse Event|0|||
143187194|NCT01524224|516228874|FG003|Overall Study|Adverse Event|0|||
143187195|NCT01524224|516228875|FG004|Overall Study|Adverse Event|0|||
143187196|NCT01524224|516228876|FG005|Overall Study|Adverse Event|1|||
143187197|NCT01524224|516228877|FG006|Overall Study|Adverse Event|0|||
143187198|NCT01524224|516228878|FG007|Overall Study|Adverse Event|0|||
143187199|NCT01524224|516228871|FG000|Overall Study|Physician Decision|0|||
143187200|NCT01524224|516228872|FG001|Overall Study|Physician Decision|0|||
143187201|NCT01524224|516228873|FG002|Overall Study|Physician Decision|0|||
143187202|NCT01524224|516228874|FG003|Overall Study|Physician Decision|1|||
143187203|NCT01524224|516228875|FG004|Overall Study|Physician Decision|1|||
143187204|NCT01524224|516228876|FG005|Overall Study|Physician Decision|0|||
143187205|NCT01524224|516228877|FG006|Overall Study|Physician Decision|0|||
143187206|NCT01524224|516228878|FG007|Overall Study|Physician Decision|1|||
143187207|NCT01524224|516228871|FG000|Overall Study|Sponsor Decision|0|||
143187208|NCT01524224|516228872|FG001|Overall Study|Sponsor Decision|0|||
143187209|NCT01524224|516228873|FG002|Overall Study|Sponsor Decision|0|||
143187210|NCT01524224|516228874|FG003|Overall Study|Sponsor Decision|0|||
143187211|NCT01524224|516228875|FG004|Overall Study|Sponsor Decision|1|||
143187212|NCT01524224|516228876|FG005|Overall Study|Sponsor Decision|0|||
143187213|NCT01524224|516228877|FG006|Overall Study|Sponsor Decision|0|||
143187214|NCT01524224|516228878|FG007|Overall Study|Sponsor Decision|0|||
143187215|NCT02702609|516228880|FG000|Overall Study|Lost to Follow-up|8|||
143187216|NCT02702609|516228881|FG001|Overall Study|Lost to Follow-up|4|||
143187217|NCT02702609|516228880|FG000|Overall Study|Physician Decision|1|||
143187218|NCT02702609|516228881|FG001|Overall Study|Physician Decision|0|||
143187219|NCT00935493|516228882|FG000|Overall Study|Lost to Follow-up|1|||
143187220|NCT00935493|516228883|FG001|Overall Study|Lost to Follow-up|1|||
143187221|NCT00935493|516228884|FG002|Overall Study|Lost to Follow-up|1|||
143187222|NCT00935493|516228882|FG000|Overall Study|Treatment Discontinued|0|||
143187223|NCT00935493|516228883|FG001|Overall Study|Treatment Discontinued|1|||
143187224|NCT00935493|516228884|FG002|Overall Study|Treatment Discontinued|0|||
143187225|NCT02674464|516228885|FG000|Overall Study|Death|10|||
143187226|NCT02674464|516228886|FG001|Overall Study|Death|21|||
143187227|NCT02674464|516228885|FG000|Overall Study|Withdrawal by Subject|24|||
143187228|NCT02674464|516228886|FG001|Overall Study|Withdrawal by Subject|44|||
143187229|NCT02674464|516228885|FG000|Overall Study|Lost to Follow-up|97|||
143187230|NCT02674464|516228886|FG001|Overall Study|Lost to Follow-up|92|||
143187231|NCT02674464|516228885|FG000|Overall Study|Outside survey window|6|||
143187232|NCT02674464|516228886|FG001|Overall Study|Outside survey window|3|||
143369444|NCT01242085|516896116|FG002|Overall Study|Withdrawal by Subject|0|||
143187233|NCT00783835|516228887|FG000|Overall Study|Adverse Event|3|||
143369445|NCT01242085|516896114|FG000|Overall Study|medically unable to have surgery|4|||
143187234|NCT00783835|516228887|FG000|Overall Study|Medical Criteria|1|||
143187235|NCT00783835|516228887|FG000|Overall Study|Withdrawal by Subject|2|||
143187236|NCT00783835|516228887|FG000|Overall Study|Lost to Follow-up|1|||
143187237|NCT00783835|516228887|FG000|Overall Study|Participant not Adherent|3|||
143187238|NCT01555073|516228888|FG000|Overall Study|Lost to Follow-up|1|||
143187239|NCT01555073|516228889|FG001|Overall Study|Lost to Follow-up|2|||
143187240|NCT01555073|516228890|FG002|Overall Study|Lost to Follow-up|0|||
143187241|NCT01555073|516228891|FG003|Overall Study|Lost to Follow-up|5|||
143187242|NCT01066104|516228894|FG000|Overall Study|Adverse Event|1|||
143187243|NCT01066104|516228895|FG001|Overall Study|Adverse Event|1|||
143187244|NCT01066104|516228894|FG000|Overall Study|Protocol Violation|1|||
143187245|NCT01066104|516228895|FG001|Overall Study|Protocol Violation|0|||
143187246|NCT01970241|516228896|FG000|Overall Study|Withdrawal by Subject|2|||
143187247|NCT01970241|516228897|FG001|Overall Study|Withdrawal by Subject|0|||
143117082|NCT00334802|515970023|FG000|Overall Study|Progressive Disease|2|||
143117083|NCT00334802|515970024|FG001|Overall Study|Progressive Disease|24|||
143117084|NCT00334802|515970023|FG000|Overall Study|Toxicity|1|||
143117085|NCT00334802|515970024|FG001|Overall Study|Toxicity|5|||
143117086|NCT00334802|515970023|FG000|Overall Study|Lack of Efficacy|1|||
143117087|NCT00334802|515970024|FG001|Overall Study|Lack of Efficacy|3|||
143117088|NCT00334802|515970023|FG000|Overall Study|Patient Condition Aggrevated|1|||
143117089|NCT00334802|515970024|FG001|Overall Study|Patient Condition Aggrevated|0|||
143117090|NCT00334802|515970023|FG000|Overall Study|Physician Decision|1|||
143117091|NCT00334802|515970024|FG001|Overall Study|Physician Decision|0|||
143117092|NCT00334802|515970023|FG000|Overall Study|Withdrawal by Subject|0|||
143117093|NCT00334802|515970024|FG001|Overall Study|Withdrawal by Subject|4|||
143117094|NCT00334802|515970023|FG000|Overall Study|Adverse Event|0|||
143117095|NCT00334802|515970024|FG001|Overall Study|Adverse Event|3|||
143117096|NCT00334802|515970023|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
143117097|NCT00334802|515970024|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
143117098|NCT02470403|515970025|FG000|Overall Study|Adverse Event|1|||
143117099|NCT02470403|515970026|FG001|Overall Study|Adverse Event|0|||
143117100|NCT02470403|515970027|FG002|Overall Study|Adverse Event|0|||
143117101|NCT02470403|515970028|FG003|Overall Study|Adverse Event|0|||
143117102|NCT02470403|515970029|FG004|Overall Study|Adverse Event|0|||
143117103|NCT02470403|515970025|FG000|Overall Study|Lost to Follow-up|0|||
143117104|NCT02470403|515970026|FG001|Overall Study|Lost to Follow-up|1|||
143117105|NCT02470403|515970027|FG002|Overall Study|Lost to Follow-up|0|||
143187248|NCT01970241|516228896|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
143187249|NCT01970241|516228897|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
143187250|NCT01001767|516228900|FG000|Overall Study|no baseline study performed|1|||
143187251|NCT01001767|516228901|FG001|Overall Study|no baseline study performed|0|||
143187252|NCT01001767|516228900|FG000|Overall Study|Protocol Violation|1|||
143187253|NCT01001767|516228901|FG001|Overall Study|Protocol Violation|0|||
143187254|NCT01001767|516228900|FG000|Overall Study|Lost to Follow-up|1|||
143187255|NCT01001767|516228901|FG001|Overall Study|Lost to Follow-up|0|||
143187256|NCT01001767|516228900|FG000|Overall Study|Physician Decision|1|||
143187257|NCT01001767|516228901|FG001|Overall Study|Physician Decision|0|||
143187258|NCT02584452|516228902|FG000|Overall Study|Physician Decision|1|||
143187259|NCT02584452|516228903|FG001|Overall Study|Physician Decision|1|||
143187260|NCT02584452|516228902|FG000|Overall Study|Lost to Follow-up|1|||
143187261|NCT02584452|516228903|FG001|Overall Study|Lost to Follow-up|1|||
143187262|NCT00851552|516228904|FG000|Overall Study|Death|2|||
143187263|NCT00851552|516228904|FG000|Overall Study|Adverse Event|1|||
143187264|NCT00851552|516228904|FG000|Overall Study|Disease Progression|4|||
143187265|NCT00177294|516228905|FG000|Overall Study|Withdrawal by Subject|7|||
143187266|NCT00177294|516228906|FG001|Overall Study|Withdrawal by Subject|5|||
143187267|NCT02038946|516228907|FG000|Overall Study|Death|5|||
143187268|NCT02038946|516228907|FG000|Overall Study|Withdrawal by Subject|3|||
143187269|NCT02038946|516228907|FG000|Overall Study|Lost to Follow-up|2|||
143187270|NCT02038946|516228907|FG000|Overall Study|Other reasons|2|||
143187271|NCT01479764|516228910|FG000|Randomized|Adverse Event|1|||
143187272|NCT01479764|516228911|FG001|Randomized|Adverse Event|1|||
143187273|NCT01479764|516228910|FG000|Randomized|Withdrawal by Subject|1|||
143187274|NCT01479764|516228911|FG001|Randomized|Withdrawal by Subject|0|||
143187275|NCT01479764|516228910|FG000|Treated|Lost to Follow-up|0|||
143187276|NCT01479764|516228911|FG001|Treated|Lost to Follow-up|2|||
143187277|NCT00902850|516228912|FG000|Overall Study|Physician Decision|2|||
143187278|NCT00902850|516228913|FG001|Overall Study|Physician Decision|2|||
143117106|NCT02470403|515970028|FG003|Overall Study|Lost to Follow-up|0|||
143117107|NCT02470403|515970029|FG004|Overall Study|Lost to Follow-up|0|||
143117108|NCT02470403|515970025|FG000|Overall Study|Subject/guardian decision|1|||
143117109|NCT02470403|515970026|FG001|Overall Study|Subject/guardian decision|0|||
143187279|NCT00260832|516228914|FG000|Overall Study|Adverse Event|26|||
143187280|NCT00260832|516228915|FG001|Overall Study|Adverse Event|19|||
143187281|NCT00260832|516228914|FG000|Overall Study|Progression|116|||
143187282|NCT00260832|516228915|FG001|Overall Study|Progression|96|||
143187283|NCT00260832|516228914|FG000|Overall Study|Withdrawal by Subject|15|||
143187284|NCT00260832|516228915|FG001|Overall Study|Withdrawal by Subject|17|||
143187285|NCT00260832|516228914|FG000|Overall Study|Physician Decision|15|||
143187286|NCT00260832|516228915|FG001|Overall Study|Physician Decision|9|||
143187287|NCT00260832|516228914|FG000|Overall Study|Death|43|||
143187288|NCT00260832|516228915|FG001|Overall Study|Death|62|||
143187289|NCT00260832|516228914|FG000|Overall Study|Other|10|||
143187290|NCT00260832|516228915|FG001|Overall Study|Other|7|||
143187291|NCT00260832|516228914|FG000|Overall Study|Protocol Violation|3|||
143187292|NCT00260832|516228915|FG001|Overall Study|Protocol Violation|1|||
143369446|NCT01242085|516896115|FG001|Overall Study|medically unable to have surgery|5|||
143187293|NCT03745638|516228918|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
143187294|NCT03745638|516228919|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
143187295|NCT03745638|516228920|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
143187296|NCT03745638|516228921|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
143187297|NCT03745638|516228922|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
143187298|NCT03745638|516228923|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
143187299|NCT03745638|516228924|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
143187300|NCT03745638|516228918|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
143187301|NCT03745638|516228919|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
143187302|NCT03745638|516228920|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
143187303|NCT03745638|516228921|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
143187304|NCT03745638|516228922|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
143187305|NCT03745638|516228923|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
143187306|NCT03745638|516228924|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
143187307|NCT03745638|516228918|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
143187308|NCT03745638|516228919|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
143187309|NCT03745638|516228920|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
143187310|NCT03745638|516228921|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
143187311|NCT03745638|516228922|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
143187312|NCT03745638|516228923|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
143187313|NCT03745638|516228924|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
143369447|NCT01242085|516896116|FG002|Overall Study|medically unable to have surgery|0|||
143187314|NCT03745638|516228918|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
143187315|NCT03745638|516228919|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
143187316|NCT03745638|516228920|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
143187317|NCT03745638|516228921|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
143187318|NCT03745638|516228922|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
143187319|NCT03745638|516228923|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
143187320|NCT03745638|516228924|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
143187321|NCT03745638|516228918|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
143187322|NCT03745638|516228919|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
143187323|NCT03745638|516228920|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
143187324|NCT03745638|516228921|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
143187325|NCT03745638|516228922|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
143187326|NCT03745638|516228923|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
143187327|NCT03745638|516228924|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
143187328|NCT03745638|516228918|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
143187329|NCT03745638|516228919|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
143187330|NCT03745638|516228920|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
143187331|NCT03745638|516228921|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
143187332|NCT03745638|516228922|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
143369448|NCT01178762|516896117|FG000|Overall Study|Lost to Follow-up|15|||
143369449|NCT02322216|516896118|FG000|Overall Study|Adverse Event|1|||
143369450|NCT02322216|516896119|FG001|Overall Study|Adverse Event|0|||
143369451|NCT02322216|516896118|FG000|Overall Study|Withdrawal by Subject|1|||
143369452|NCT02322216|516896119|FG001|Overall Study|Withdrawal by Subject|4|||
143369453|NCT01651949|516896121|FG000|Overall Study|Unknown status|4|||
143187333|NCT03745638|516228923|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
143187334|NCT03745638|516228924|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
143187335|NCT03745638|516228918|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
143187336|NCT03745638|516228919|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
143187337|NCT03745638|516228920|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
143187338|NCT03745638|516228921|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
143187339|NCT03745638|516228922|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
143187340|NCT03745638|516228923|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
143187341|NCT03745638|516228924|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
143187342|NCT03745638|516228918|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
143187343|NCT03745638|516228919|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
143187344|NCT03745638|516228920|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
143187345|NCT03745638|516228921|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
143187346|NCT03745638|516228922|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
143187347|NCT03745638|516228923|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
143187348|NCT03745638|516228924|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
143187349|NCT03745638|516228918|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
143187350|NCT03745638|516228919|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
143187351|NCT03745638|516228920|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
143187352|NCT03745638|516228921|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
143187353|NCT03745638|516228922|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
143187354|NCT03745638|516228923|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
143187355|NCT03745638|516228924|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
143187356|NCT03745638|516228918|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
143187357|NCT03745638|516228919|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
143187358|NCT03745638|516228920|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
143187359|NCT03745638|516228921|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
143187360|NCT03745638|516228922|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
143187361|NCT03745638|516228923|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
143187362|NCT03745638|516228924|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
143187363|NCT03745638|516228918|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
143187364|NCT03745638|516228919|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
143187365|NCT03745638|516228920|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
143187366|NCT03745638|516228921|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
143187367|NCT03745638|516228922|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
143187368|NCT03745638|516228923|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
143187369|NCT03745638|516228924|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
143187370|NCT03745638|516228918|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
143187371|NCT03745638|516228919|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
143187372|NCT03745638|516228920|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
143187373|NCT03745638|516228921|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
143187374|NCT03745638|516228922|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
143187375|NCT03745638|516228923|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
143187376|NCT03745638|516228924|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
143187377|NCT03745638|516228918|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
143187378|NCT03745638|516228919|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
143187379|NCT03745638|516228920|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
143187380|NCT03745638|516228921|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
143187381|NCT03745638|516228922|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
143187382|NCT03745638|516228923|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
143187383|NCT03745638|516228924|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
143187384|NCT03745638|516228918|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
143187385|NCT03745638|516228919|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
143187386|NCT03745638|516228920|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
143187387|NCT03745638|516228921|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
143187388|NCT03745638|516228922|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
143369454|NCT01651949|516896122|FG001|Overall Study|Unknown status|4|||
143369455|NCT01651949|516896123|FG002|Overall Study|Unknown status|0|||
143369456|NCT01651949|516896121|FG000|Overall Study|Lost to Follow-up|30|||
143369457|NCT01651949|516896122|FG001|Overall Study|Lost to Follow-up|56|||
143369458|NCT01651949|516896123|FG002|Overall Study|Lost to Follow-up|20|||
143187389|NCT03745638|516228923|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
143187390|NCT03745638|516228924|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
143187391|NCT03745638|516228918|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
143187392|NCT03745638|516228919|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
143187393|NCT03745638|516228920|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
143187394|NCT03745638|516228921|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
143187395|NCT03745638|516228922|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
143187396|NCT03745638|516228923|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
143187397|NCT03745638|516228924|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
143187398|NCT00976716|516228934|FG000|Overall Study|Adverse Event|1|||
143187399|NCT02146131|516228943|FG000|Overall Study|Physician Decision|61|||
143187400|NCT02146131|516228944|FG001|Overall Study|Physician Decision|56|||
143187401|NCT02567799|516228945|FG000|Concurrent Chemoradiotherapy|Death|1|||
143187402|NCT02567799|516228946|FG001|Concurrent Chemoradiotherapy|Death|0|||
143187403|NCT02567799|516228947|FG002|Concurrent Chemoradiotherapy|Death|0|||
143187404|NCT02567799|516228945|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
143187405|NCT02567799|516228946|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
143187406|NCT02567799|516228947|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
143187407|NCT02567799|516228945|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
143187408|NCT02567799|516228946|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
143187409|NCT02567799|516228947|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
143187410|NCT02567799|516228945|FG000|Follow-up|Death|1|||
143187411|NCT02567799|516228946|FG001|Follow-up|Death|0|||
143187412|NCT02567799|516228947|FG002|Follow-up|Death|1|||
143187413|NCT02567799|516228945|FG000|Follow-up|Progressive Disease|1|||
143187414|NCT02567799|516228946|FG001|Follow-up|Progressive Disease|1|||
143187415|NCT02567799|516228947|FG002|Follow-up|Progressive Disease|3|||
143187416|NCT05356910|516228952|FG000|Overall Study|Lost to Follow-up|10|||
143187417|NCT05356910|516228953|FG001|Overall Study|Lost to Follow-up|19|||
143187418|NCT05356910|516228954|FG002|Overall Study|Lost to Follow-up|0|||
143187419|NCT05356910|516228955|FG003|Overall Study|Lost to Follow-up|0|||
143187420|NCT05356910|516228952|FG000|Overall Study|Withdrawal by Subject|4|||
143187421|NCT05356910|516228953|FG001|Overall Study|Withdrawal by Subject|2|||
143187422|NCT05356910|516228954|FG002|Overall Study|Withdrawal by Subject|0|||
143187423|NCT05356910|516228955|FG003|Overall Study|Withdrawal by Subject|0|||
143187424|NCT01659996|516228957|FG000|Overall Study|Protocol Violation|3|||
143187425|NCT01659996|516228958|FG001|Overall Study|Protocol Violation|3|||
143187426|NCT01659996|516228959|FG002|Overall Study|Protocol Violation|3|||
143187427|NCT01659996|516228957|FG000|Overall Study|Lost to Follow-up|1|||
143187428|NCT01659996|516228958|FG001|Overall Study|Lost to Follow-up|3|||
143187429|NCT01659996|516228959|FG002|Overall Study|Lost to Follow-up|2|||
143187430|NCT01659996|516228957|FG000|Overall Study|Adverse Event|0|||
143187431|NCT01659996|516228958|FG001|Overall Study|Adverse Event|0|||
143187432|NCT01659996|516228959|FG002|Overall Study|Adverse Event|1|||
143187433|NCT01659996|516228957|FG000|Overall Study|Withdrawal by Subject|4|||
143187434|NCT01659996|516228958|FG001|Overall Study|Withdrawal by Subject|1|||
143187435|NCT01659996|516228959|FG002|Overall Study|Withdrawal by Subject|5|||
143187436|NCT01443364|516230561|FG000|Overall Study|Lack of Efficacy|14|||
143187437|NCT01443364|516230561|FG000|Overall Study|Lost to Follow-up|3|||
143187438|NCT01443364|516230561|FG000|Overall Study|Withdrawal by Subject|5|||
143187439|NCT01443364|516230561|FG000|Overall Study|Other Reason|4|||
143187440|NCT01443364|516230561|FG000|Overall Study|SAE, non-fatal|6|||
143187441|NCT01443364|516230561|FG000|Overall Study|AE, non-serious non-fatal|8|||
143187442|NCT01443364|516230561|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
143187443|NCT01519791|516230562|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
143187444|NCT01519791|516230563|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
143187445|NCT01519791|516230562|FG000|Overall Study|Protocol Violation|6|||
143187446|NCT01519791|516230563|FG001|Overall Study|Protocol Violation|19|||
143187447|NCT01519791|516230562|FG000|Overall Study|Other Reason|87|||
143187448|NCT01519791|516230563|FG001|Overall Study|Other Reason|222|||
143187449|NCT01519791|516230562|FG000|Overall Study|subjects randomized in error|2|||
143187450|NCT01519791|516230563|FG001|Overall Study|subjects randomized in error|0|||
143187451|NCT01519791|516230562|FG000|Overall Study|Lack of Efficacy|16|||
143187452|NCT01519791|516230563|FG001|Overall Study|Lack of Efficacy|20|||
143187453|NCT01519791|516230562|FG000|Overall Study|SAE, non-fatal|6|||
143187454|NCT01519791|516230563|FG001|Overall Study|SAE, non-fatal|22|||
143187455|NCT01519791|516230562|FG000|Overall Study|AE, serious fatal|0|||
143187456|NCT01519791|516230563|FG001|Overall Study|AE, serious fatal|1|||
143187457|NCT01519791|516230562|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
143187458|NCT01519791|516230563|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
143187459|NCT01519791|516230562|FG000|Overall Study|AE, non-serious non-fatal|12|||
143187460|NCT01519791|516230563|FG001|Overall Study|AE, non-serious non-fatal|31|||
143187461|NCT01519791|516230562|FG000|Overall Study|Withdrawal by Subject|15|||
143187462|NCT01519791|516230563|FG001|Overall Study|Withdrawal by Subject|37|||
143187463|NCT01519791|516230562|FG000|Overall Study|Lost to Follow-up|6|||
143187464|NCT01519791|516230563|FG001|Overall Study|Lost to Follow-up|14|||
143187465|NCT00459875|516230564|FG000|Overall Study|Ineligible participant|1|||
143187466|NCT00459875|516230564|FG000|Overall Study|Adverse Event|2|||
143187467|NCT03645421|516230565|FG000|Overall Study|Adverse Event|0|||
143187468|NCT03645421|516230566|FG001|Overall Study|Adverse Event|0|||
143187469|NCT03645421|516230567|FG002|Overall Study|Adverse Event|4|||
143261379|NCT02129777|516510568|FG003|Double-Blind Period|Lack of Efficacy|3|||
143261380|NCT02129777|516510569|FG004|Double-Blind Period|Lack of Efficacy|2|||
143261381|NCT02129777|516510570|FG005|Double-Blind Period|Lack of Efficacy|0|||
143261382|NCT02129777|516510571|FG006|Double-Blind Period|Lack of Efficacy|0|||
143261383|NCT02129777|516510565|FG000|Double-Blind Period|Other|1|||
143261384|NCT02129777|516510566|FG001|Double-Blind Period|Other|2|||
143261385|NCT02129777|516510567|FG002|Double-Blind Period|Other|0|||
143261386|NCT02129777|516510568|FG003|Double-Blind Period|Other|0|||
143261387|NCT02129777|516510569|FG004|Double-Blind Period|Other|0|||
143261388|NCT02129777|516510570|FG005|Double-Blind Period|Other|0|||
143261389|NCT02129777|516510571|FG006|Double-Blind Period|Other|0|||
143261390|NCT02129777|516510565|FG000|Open-Label Period|Lack of Efficacy|0|||
143261391|NCT02129777|516510566|FG001|Open-Label Period|Lack of Efficacy|0|||
143261392|NCT02129777|516510567|FG002|Open-Label Period|Lack of Efficacy|0|||
143261393|NCT02129777|516510568|FG003|Open-Label Period|Lack of Efficacy|0|||
143261394|NCT02129777|516510569|FG004|Open-Label Period|Lack of Efficacy|0|||
143261395|NCT02129777|516510570|FG005|Open-Label Period|Lack of Efficacy|0|||
143261396|NCT02129777|516510571|FG006|Open-Label Period|Lack of Efficacy|5|||
143261397|NCT02129777|516510565|FG000|Open-Label Period|Lost to Follow-up|0|||
143261398|NCT02129777|516510566|FG001|Open-Label Period|Lost to Follow-up|0|||
143261399|NCT02129777|516510567|FG002|Open-Label Period|Lost to Follow-up|0|||
143261400|NCT02129777|516510568|FG003|Open-Label Period|Lost to Follow-up|0|||
143261401|NCT02129777|516510569|FG004|Open-Label Period|Lost to Follow-up|0|||
143261402|NCT02129777|516510570|FG005|Open-Label Period|Lost to Follow-up|1|||
143261403|NCT02129777|516510571|FG006|Open-Label Period|Lost to Follow-up|1|||
143261404|NCT02129777|516510565|FG000|Open-Label Period|Withdrawal by Subject|0|||
143261405|NCT02129777|516510566|FG001|Open-Label Period|Withdrawal by Subject|0|||
143261406|NCT02129777|516510567|FG002|Open-Label Period|Withdrawal by Subject|0|||
143261407|NCT02129777|516510568|FG003|Open-Label Period|Withdrawal by Subject|0|||
143261408|NCT02129777|516510569|FG004|Open-Label Period|Withdrawal by Subject|0|||
143261409|NCT02129777|516510570|FG005|Open-Label Period|Withdrawal by Subject|1|||
143261410|NCT02129777|516510571|FG006|Open-Label Period|Withdrawal by Subject|3|||
143261411|NCT02129777|516510565|FG000|Open-Label Period|Study Termination|0|||
143261412|NCT02129777|516510566|FG001|Open-Label Period|Study Termination|0|||
143261413|NCT02129777|516510567|FG002|Open-Label Period|Study Termination|0|||
143261414|NCT02129777|516510568|FG003|Open-Label Period|Study Termination|0|||
143261415|NCT02129777|516510569|FG004|Open-Label Period|Study Termination|0|||
143261416|NCT02129777|516510570|FG005|Open-Label Period|Study Termination|10|||
143261417|NCT02129777|516510571|FG006|Open-Label Period|Study Termination|39|||
143261418|NCT01565499|516510573|FG000|Overall Study|Physician Decision|1|||
143261419|NCT01565499|516510573|FG000|Overall Study|Adverse Event|5|||
143261420|NCT01565499|516510573|FG000|Overall Study|Withdrawal by Subject|2|||
143261421|NCT01255787|516510576|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
143261422|NCT01255787|516510577|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
143261423|NCT01255787|516510578|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
143261424|NCT01255787|516510579|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
143261425|NCT01255787|516510576|FG000|Overall Study|Major Protocol Deviation|1|||
143261426|NCT01255787|516510577|FG001|Overall Study|Major Protocol Deviation|1|||
143261427|NCT01255787|516510578|FG002|Overall Study|Major Protocol Deviation|0|||
143261428|NCT01255787|516510579|FG003|Overall Study|Major Protocol Deviation|4|||
143261429|NCT01255787|516510576|FG000|Overall Study|Lost to Follow-up|1|||
143261430|NCT01255787|516510577|FG001|Overall Study|Lost to Follow-up|2|||
143261431|NCT01255787|516510578|FG002|Overall Study|Lost to Follow-up|4|||
143187470|NCT03645421|516230568|FG003|Overall Study|Adverse Event|1|||
143187471|NCT03645421|516230565|FG000|Overall Study|Withdrawal by patient|0|||
143187472|NCT03645421|516230566|FG001|Overall Study|Withdrawal by patient|0|||
143187473|NCT03645421|516230567|FG002|Overall Study|Withdrawal by patient|0|||
143187474|NCT03645421|516230568|FG003|Overall Study|Withdrawal by patient|3|||
143187475|NCT03645421|516230565|FG000|Overall Study|Study specific withdrawal criteria|0|||
143187476|NCT03645421|516230566|FG001|Overall Study|Study specific withdrawal criteria|0|||
143187477|NCT03645421|516230567|FG002|Overall Study|Study specific withdrawal criteria|1|||
143187478|NCT03645421|516230568|FG003|Overall Study|Study specific withdrawal criteria|0|||
143187479|NCT01995526|516230569|FG000|Overall Study|Physician Decision|1|||
143187480|NCT00375427|516230570|FG000|Overall Study|Adverse Event|21|||
143187481|NCT00375427|516230571|FG001|Overall Study|Adverse Event|27|||
143187482|NCT00375427|516230570|FG000|Overall Study|Abnormal test procedure result(s)|0|||
143187483|NCT00375427|516230571|FG001|Overall Study|Abnormal test procedure result(s)|1|||
143187484|NCT00375427|516230570|FG000|Overall Study|Abnormal laboratory value(s)|1|||
143187485|NCT00375427|516230571|FG001|Overall Study|Abnormal laboratory value(s)|2|||
143187486|NCT00375427|516230570|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
143187487|NCT00375427|516230571|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
143187488|NCT00375427|516230570|FG000|Overall Study|Patient no longer requires study drug|3|||
143187489|NCT00375427|516230571|FG001|Overall Study|Patient no longer requires study drug|7|||
143187490|NCT00375427|516230570|FG000|Overall Study|Protocol Violation|10|||
143187491|NCT00375427|516230571|FG001|Overall Study|Protocol Violation|8|||
143187492|NCT00375427|516230570|FG000|Overall Study|Withdrawal by Subject|9|||
143187493|NCT00375427|516230571|FG001|Overall Study|Withdrawal by Subject|13|||
143187494|NCT00375427|516230570|FG000|Overall Study|Lost to Follow-up|1|||
143187495|NCT00375427|516230571|FG001|Overall Study|Lost to Follow-up|1|||
143187496|NCT00375427|516230570|FG000|Overall Study|Administrative reasons|0|||
143187497|NCT00375427|516230571|FG001|Overall Study|Administrative reasons|1|||
143187498|NCT00375427|516230570|FG000|Overall Study|Death|11|||
143187499|NCT00375427|516230571|FG001|Overall Study|Death|10|||
143187500|NCT03636893|516230578|FG000|Overall Study|Death|0|||
143187501|NCT03636893|516230579|FG001|Overall Study|Death|1|||
143187502|NCT03636893|516230578|FG000|Overall Study|Protocol Violation|0|||
143187503|NCT03636893|516230579|FG001|Overall Study|Protocol Violation|3|||
143187504|NCT03636893|516230578|FG000|Overall Study|Withdrawal by Subject|1|||
143187505|NCT03636893|516230579|FG001|Overall Study|Withdrawal by Subject|2|||
143187506|NCT03636893|516230578|FG000|Overall Study|Refusal to surgery|4|||
143187507|NCT03636893|516230579|FG001|Overall Study|Refusal to surgery|3|||
143187508|NCT03636893|516230578|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
143187509|NCT03636893|516230579|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
143187510|NCT03636893|516230578|FG000|Overall Study|Adverse Event|1|||
143187511|NCT03636893|516230579|FG001|Overall Study|Adverse Event|1|||
143187512|NCT00224120|516230580|FG000|Overall Study|Adverse Event|10|||
143187513|NCT00224120|516230581|FG001|Overall Study|Adverse Event|4|||
143187514|NCT00224120|516230580|FG000|Overall Study|Protocol Violation|1|||
143187515|NCT00224120|516230581|FG001|Overall Study|Protocol Violation|0|||
143187516|NCT00224120|516230580|FG000|Overall Study|Withdrawal by Subject|5|||
143187517|NCT00224120|516230581|FG001|Overall Study|Withdrawal by Subject|10|||
143187518|NCT00224120|516230580|FG000|Overall Study|Lack of Efficacy|0|||
143187519|NCT00224120|516230581|FG001|Overall Study|Lack of Efficacy|2|||
143187520|NCT00224120|516230580|FG000|Overall Study|Lost to Follow-up|2|||
143187521|NCT00224120|516230581|FG001|Overall Study|Lost to Follow-up|3|||
143187522|NCT00224120|516230580|FG000|Overall Study|Other|4|||
143187523|NCT00224120|516230581|FG001|Overall Study|Other|5|||
143187524|NCT00104416|516230582|FG000|Double-Blind Phase|Adverse Event|2|||
143187525|NCT00104416|516230583|FG001|Double-Blind Phase|Adverse Event|1|||
143187526|NCT00104416|516230584|FG002|Double-Blind Phase|Adverse Event|0|||
143187527|NCT00104416|516230585|FG003|Double-Blind Phase|Adverse Event|0|||
143187528|NCT00104416|516230586|FG004|Double-Blind Phase|Adverse Event|0|||
143187529|NCT00104416|516230582|FG000|Double-Blind Phase|Lost to Follow-up|0|||
143187530|NCT00104416|516230583|FG001|Double-Blind Phase|Lost to Follow-up|1|||
143187531|NCT00104416|516230584|FG002|Double-Blind Phase|Lost to Follow-up|0|||
143187532|NCT00104416|516230585|FG003|Double-Blind Phase|Lost to Follow-up|0|||
143187533|NCT00104416|516230586|FG004|Double-Blind Phase|Lost to Follow-up|0|||
143187534|NCT00104416|516230582|FG000|Double-Blind Phase|Protocol Violation|0|||
143187535|NCT00104416|516230583|FG001|Double-Blind Phase|Protocol Violation|1|||
143187536|NCT00104416|516230584|FG002|Double-Blind Phase|Protocol Violation|0|||
143187537|NCT00104416|516230585|FG003|Double-Blind Phase|Protocol Violation|0|||
143187538|NCT00104416|516230586|FG004|Double-Blind Phase|Protocol Violation|0|||
143187539|NCT00104416|516230582|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
143187540|NCT00104416|516230583|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
143187541|NCT00104416|516230584|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
143187542|NCT00104416|516230585|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
143187543|NCT00104416|516230586|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
143187544|NCT00104416|516230582|FG000|Double-Blind Phase|Pregnancy|1|||
143187545|NCT00104416|516230583|FG001|Double-Blind Phase|Pregnancy|0|||
143187546|NCT00104416|516230584|FG002|Double-Blind Phase|Pregnancy|0|||
143187547|NCT00104416|516230585|FG003|Double-Blind Phase|Pregnancy|0|||
143187548|NCT00104416|516230586|FG004|Double-Blind Phase|Pregnancy|0|||
143187549|NCT00104416|516230582|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
143187550|NCT00104416|516230583|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
143187551|NCT00104416|516230584|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
143187552|NCT00104416|516230585|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
143187553|NCT00104416|516230586|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
143187554|NCT00104416|516230582|FG000|Continuation Phase|Adverse Event|0|||
143187555|NCT00104416|516230583|FG001|Continuation Phase|Adverse Event|0|||
143187556|NCT00104416|516230584|FG002|Continuation Phase|Adverse Event|2|||
143187557|NCT00104416|516230585|FG003|Continuation Phase|Adverse Event|0|||
143187558|NCT00104416|516230586|FG004|Continuation Phase|Adverse Event|2|||
143187559|NCT00104416|516230582|FG000|Continuation Phase|Lost to Follow-up|0|||
143187560|NCT00104416|516230583|FG001|Continuation Phase|Lost to Follow-up|0|||
143187561|NCT00104416|516230584|FG002|Continuation Phase|Lost to Follow-up|1|||
143187562|NCT00104416|516230585|FG003|Continuation Phase|Lost to Follow-up|0|||
143187563|NCT00104416|516230586|FG004|Continuation Phase|Lost to Follow-up|1|||
143187564|NCT00104416|516230582|FG000|Continuation Phase|Withdrawal by Subject|0|||
143187565|NCT00104416|516230583|FG001|Continuation Phase|Withdrawal by Subject|0|||
143187566|NCT00104416|516230584|FG002|Continuation Phase|Withdrawal by Subject|2|||
143187567|NCT00104416|516230585|FG003|Continuation Phase|Withdrawal by Subject|1|||
143187568|NCT00104416|516230586|FG004|Continuation Phase|Withdrawal by Subject|1|||
143187569|NCT00104416|516230582|FG000|Continuation Phase|Pregnancy|0|||
143187570|NCT00104416|516230583|FG001|Continuation Phase|Pregnancy|0|||
143187571|NCT00104416|516230584|FG002|Continuation Phase|Pregnancy|1|||
143187572|NCT00104416|516230585|FG003|Continuation Phase|Pregnancy|1|||
143187573|NCT00104416|516230586|FG004|Continuation Phase|Pregnancy|0|||
143187574|NCT00104416|516230582|FG000|Continuation Phase|Non-compliance|0|||
143187575|NCT00104416|516230583|FG001|Continuation Phase|Non-compliance|0|||
143187576|NCT00104416|516230584|FG002|Continuation Phase|Non-compliance|0|||
143187577|NCT00104416|516230585|FG003|Continuation Phase|Non-compliance|0|||
143187578|NCT00104416|516230586|FG004|Continuation Phase|Non-compliance|1|||
143187579|NCT00438360|516230587|FG000|Overall Study|Adverse Event|6|||
143187580|NCT00438360|516230588|FG001|Overall Study|Adverse Event|1|||
143187581|NCT00438360|516230587|FG000|Overall Study|Lack of Efficacy|42|||
143187582|NCT00438360|516230588|FG001|Overall Study|Lack of Efficacy|27|||
143187583|NCT00438360|516230587|FG000|Overall Study|Other|24|||
143187584|NCT00438360|516230588|FG001|Overall Study|Other|15|||
143187585|NCT00758069|516230589|FG000|Overall Study|Lack of Efficacy|0|||
143187586|NCT00758069|516230590|FG001|Overall Study|Lack of Efficacy|0|||
143369459|NCT01651949|516896121|FG000|Overall Study|Protocol Violation|0|||
143369460|NCT01651949|516896122|FG001|Overall Study|Protocol Violation|2|||
143369461|NCT01651949|516896123|FG002|Overall Study|Protocol Violation|1|||
143369462|NCT01651949|516896121|FG000|Overall Study|Physician Decision|0|||
143369463|NCT01651949|516896122|FG001|Overall Study|Physician Decision|2|||
143369464|NCT01651949|516896123|FG002|Overall Study|Physician Decision|0|||
143369465|NCT01651949|516896121|FG000|Overall Study|Adverse Event|0|||
143369466|NCT01651949|516896122|FG001|Overall Study|Adverse Event|2|||
143187587|NCT00758069|516230591|FG002|Overall Study|Lack of Efficacy|1|||
143187588|NCT00758069|516230589|FG000|Overall Study|Incorrect Study Drug|1|||
143187589|NCT00758069|516230590|FG001|Overall Study|Incorrect Study Drug|0|||
143187590|NCT00758069|516230591|FG002|Overall Study|Incorrect Study Drug|0|||
143187591|NCT02684617|516230592|FG000|Overall Study|Adverse Event|1|||
143187592|NCT02684617|516230593|FG001|Overall Study|Adverse Event|0|||
143187593|NCT02684617|516230594|FG002|Overall Study|Adverse Event|1|||
143187594|NCT02684617|516230592|FG000|Overall Study|Death|8|||
143187595|NCT02684617|516230593|FG001|Overall Study|Death|16|||
143187596|NCT02684617|516230594|FG002|Overall Study|Death|28|||
143187597|NCT02684617|516230592|FG000|Overall Study|Withdrawal by Subject|2|||
143187598|NCT02684617|516230593|FG001|Overall Study|Withdrawal by Subject|0|||
143187599|NCT02684617|516230594|FG002|Overall Study|Withdrawal by Subject|4|||
143369467|NCT01651949|516896123|FG002|Overall Study|Adverse Event|1|||
143187600|NCT02684617|516230592|FG000|Overall Study|Screen Failure|1|||
143187601|NCT02684617|516230593|FG001|Overall Study|Screen Failure|0|||
143187602|NCT02684617|516230594|FG002|Overall Study|Screen Failure|2|||
143187603|NCT02684617|516230592|FG000|Overall Study|Study Terminated by Sponsor|6|||
143187604|NCT02684617|516230593|FG001|Overall Study|Study Terminated by Sponsor|1|||
143187605|NCT02684617|516230594|FG002|Overall Study|Study Terminated by Sponsor|5|||
143369468|NCT01651949|516896121|FG000|Overall Study|Screen failure|2|||
143369469|NCT01651949|516896122|FG001|Overall Study|Screen failure|2|||
143187606|NCT03985943|516230595|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
143187607|NCT03985943|516230596|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
143187608|NCT03985943|516230597|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
143187609|NCT03985943|516230598|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
143187610|NCT03985943|516230599|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
143369470|NCT01651949|516896123|FG002|Overall Study|Screen failure|0|||
143261432|NCT01255787|516510579|FG003|Overall Study|Lost to Follow-up|2|||
143261433|NCT01255787|516510576|FG000|Overall Study|Withdrawal of Consent|3|||
143261434|NCT01255787|516510577|FG001|Overall Study|Withdrawal of Consent|9|||
143261435|NCT01255787|516510578|FG002|Overall Study|Withdrawal of Consent|3|||
143187611|NCT03985943|516230600|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
143187612|NCT03985943|516230595|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
143187613|NCT03985943|516230596|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
143187614|NCT03985943|516230597|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
143187615|NCT03985943|516230598|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
143187616|NCT03985943|516230599|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
143187617|NCT03985943|516230600|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
143187618|NCT03985943|516230595|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
143187619|NCT03985943|516230596|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
143187620|NCT03985943|516230597|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
143187621|NCT03985943|516230598|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
143187622|NCT03985943|516230599|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
143187623|NCT03985943|516230600|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
143187624|NCT03985943|516230595|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
143187625|NCT03985943|516230596|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
143187626|NCT03985943|516230597|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
143187627|NCT03985943|516230598|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
143187628|NCT03985943|516230599|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
143187629|NCT03985943|516230600|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
143187630|NCT03985943|516230595|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
143187631|NCT03985943|516230596|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
143187632|NCT03985943|516230597|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
143187633|NCT03985943|516230598|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
143187634|NCT03985943|516230599|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
143187635|NCT03985943|516230600|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
143187636|NCT03985943|516230595|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
143187637|NCT03985943|516230596|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
143187638|NCT03985943|516230597|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
143187639|NCT03985943|516230598|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
143187640|NCT03985943|516230599|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
143187641|NCT03985943|516230600|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
143187642|NCT03985943|516230595|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
143187643|NCT03985943|516230596|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
143187644|NCT03985943|516230597|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
143187645|NCT03985943|516230598|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
143187646|NCT03985943|516230599|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
143187647|NCT03985943|516230600|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
143187648|NCT03985943|516230595|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
143187649|NCT03985943|516230596|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
143187650|NCT03985943|516230597|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
143187651|NCT03985943|516230598|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
143187652|NCT03985943|516230599|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
143187653|NCT03985943|516230600|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
143187654|NCT03985943|516230595|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
143187655|NCT03985943|516230596|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
143187656|NCT03985943|516230597|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
143187657|NCT03985943|516230598|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
143187658|NCT03985943|516230599|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
143187659|NCT03985943|516230600|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
143261436|NCT01255787|516510579|FG003|Overall Study|Withdrawal of Consent|4|||
143261437|NCT01255787|516510576|FG000|Overall Study|Pregnancy|0|||
143261438|NCT01255787|516510577|FG001|Overall Study|Pregnancy|0|||
143261439|NCT01255787|516510578|FG002|Overall Study|Pregnancy|0|||
143261440|NCT01255787|516510579|FG003|Overall Study|Pregnancy|1|||
143261441|NCT01255787|516510576|FG000|Overall Study|Lack of Efficacy|2|||
143261442|NCT01255787|516510577|FG001|Overall Study|Lack of Efficacy|2|||
143369471|NCT01651949|516896121|FG000|Overall Study|Withdrawal by Subject|17|||
143187660|NCT03985943|516230595|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
143187661|NCT03985943|516230596|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
143187662|NCT03985943|516230597|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
143187663|NCT03985943|516230598|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
143187664|NCT03985943|516230599|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
143187665|NCT03985943|516230600|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
143187666|NCT03985943|516230595|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
143187667|NCT03985943|516230596|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
143187668|NCT03985943|516230597|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
143187669|NCT03985943|516230598|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
143187670|NCT03985943|516230599|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
143187671|NCT03985943|516230600|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
143187672|NCT03985943|516230595|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
143187673|NCT03985943|516230596|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
143187674|NCT03985943|516230597|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
143187675|NCT03985943|516230598|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
143187676|NCT03985943|516230599|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
143187677|NCT03985943|516230600|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
143187678|NCT03985943|516230595|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
143187679|NCT03985943|516230596|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
143187680|NCT03985943|516230597|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
143187681|NCT03985943|516230598|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
143187682|NCT03985943|516230599|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
143187683|NCT03985943|516230600|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
143187684|NCT03985943|516230595|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
143187685|NCT03985943|516230596|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
143187686|NCT03985943|516230597|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
143187687|NCT03985943|516230598|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
143187688|NCT03985943|516230599|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
143187689|NCT03985943|516230600|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
143187690|NCT03985943|516230595|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
143187691|NCT03985943|516230596|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
143187692|NCT03985943|516230597|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
143187693|NCT03985943|516230598|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
143187694|NCT03985943|516230599|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
143187695|NCT03985943|516230600|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
143187696|NCT00338286|516230601|FG000|Overall Study|Withdrawal by Subject|50|||
143187697|NCT00338286|516230602|FG001|Overall Study|Withdrawal by Subject|54|||
143187698|NCT00338286|516230601|FG000|Overall Study|Lost to Follow-up|80|||
143187699|NCT00338286|516230602|FG001|Overall Study|Lost to Follow-up|66|||
143187700|NCT00338286|516230601|FG000|Overall Study|Other|103|||
143187701|NCT00338286|516230602|FG001|Overall Study|Other|93|||
143187702|NCT01265563|516230603|FG000|Overall Study|Withdrawal by Subject|0|||
143187703|NCT01265563|516230604|FG001|Overall Study|Withdrawal by Subject|1|||
143187704|NCT01265563|516230605|FG002|Overall Study|Withdrawal by Subject|1|||
143187705|NCT01265563|516230606|FG003|Overall Study|Withdrawal by Subject|0|||
143187706|NCT01265563|516230607|FG004|Overall Study|Withdrawal by Subject|2|||
143187707|NCT03517371|516230610|FG000|Overall Study|Adverse Event|8|||
143187708|NCT03517371|516230611|FG001|Overall Study|Adverse Event|9|||
143187709|NCT03517371|516230610|FG000|Overall Study|Lost to Follow-up|1|||
143187710|NCT03517371|516230611|FG001|Overall Study|Lost to Follow-up|2|||
143187711|NCT03517371|516230610|FG000|Overall Study|Withdrawal by Subject|4|||
143187712|NCT03517371|516230611|FG001|Overall Study|Withdrawal by Subject|4|||
143187713|NCT03517371|516230610|FG000|Overall Study|Not idiopathic Parkinson's disease|0|||
143187714|NCT03517371|516230611|FG001|Overall Study|Not idiopathic Parkinson's disease|3|||
143187715|NCT03517371|516230610|FG000|Overall Study|COVID restrictions|2|||
143187716|NCT03517371|516230611|FG001|Overall Study|COVID restrictions|0|||
143187717|NCT03517371|516230610|FG000|Overall Study|Receiving DBS Surgery|0|||
143187718|NCT03517371|516230611|FG001|Overall Study|Receiving DBS Surgery|1|||
143187719|NCT05411822|516230612|FG000|Overall Study|Withdrawal by Subject|2|||
143187720|NCT05411822|516230613|FG001|Overall Study|Withdrawal by Subject|1|||
143187721|NCT05312697|516230614|FG000|Overall Study|Sponsor Terminated Trial|2|||
143187722|NCT04283656|516230615|FG000|Overall Study|Adverse Event|1|||
143187723|NCT04283656|516230616|FG001|Overall Study|Adverse Event|0|||
143187724|NCT04283656|516230615|FG000|Overall Study|Lost to Follow-up|0|||
143187725|NCT04283656|516230616|FG001|Overall Study|Lost to Follow-up|1|||
143187726|NCT02819297|516230617|FG000|Overall Study|Withdrawal by Subject|25|||
143187727|NCT02819297|516230618|FG001|Overall Study|Withdrawal by Subject|13|||
143187728|NCT02819297|516230617|FG000|Overall Study|Lost to Follow-up|12|||
143187729|NCT02819297|516230618|FG001|Overall Study|Lost to Follow-up|14|||
143369472|NCT01651949|516896122|FG001|Overall Study|Withdrawal by Subject|18|||
143187730|NCT02819297|516230617|FG000|Overall Study|Adverse Event|12|||
143187731|NCT02819297|516230618|FG001|Overall Study|Adverse Event|10|||
143187732|NCT02819297|516230617|FG000|Overall Study|Physician Decision|5|||
143187733|NCT02819297|516230618|FG001|Overall Study|Physician Decision|5|||
143187734|NCT02819297|516230617|FG000|Overall Study|Lack of Efficacy|5|||
143187735|NCT02819297|516230618|FG001|Overall Study|Lack of Efficacy|8|||
143187736|NCT02819297|516230617|FG000|Overall Study|Protocol Violation|1|||
143187737|NCT02819297|516230618|FG001|Overall Study|Protocol Violation|2|||
143187738|NCT02858440|516230619|FG000|Overall Study|Lost to Follow-up|3|||
143187739|NCT02858440|516230619|FG000|Overall Study|Protocol Violation|2|||
143187740|NCT02858440|516230619|FG000|Overall Study|Consent withdrawal|3|||
143187741|NCT02858440|516230619|FG000|Overall Study|Migrated/moved from study area|4|||
143187742|NCT01670279|516230620|FG000|Overall Study|Adverse Event|0|||
143187743|NCT01670279|516230621|FG001|Overall Study|Adverse Event|1|||
143187744|NCT01670279|516230622|FG002|Overall Study|Adverse Event|0|||
143187745|NCT01670279|516230623|FG003|Overall Study|Adverse Event|0|||
143187746|NCT01670279|516230620|FG000|Overall Study|Physician Decision|0|||
143187747|NCT01670279|516230621|FG001|Overall Study|Physician Decision|1|||
143187748|NCT01670279|516230622|FG002|Overall Study|Physician Decision|0|||
143187749|NCT01670279|516230623|FG003|Overall Study|Physician Decision|0|||
143187750|NCT01670279|516230620|FG000|Overall Study|Participant met withdrawal criteria|0|||
143187751|NCT01670279|516230621|FG001|Overall Study|Participant met withdrawal criteria|0|||
143187752|NCT01670279|516230622|FG002|Overall Study|Participant met withdrawal criteria|0|||
143187753|NCT01670279|516230623|FG003|Overall Study|Participant met withdrawal criteria|1|||
143187754|NCT02318368|516230624|FG000|Overall Study|Withdrawal by Subject|2|||
143187755|NCT02318368|516230625|FG001|Overall Study|Withdrawal by Subject|0|||
143187756|NCT02318368|516230624|FG000|Overall Study|Study terminated by the sponsor|5|||
143187757|NCT02318368|516230625|FG001|Overall Study|Study terminated by the sponsor|2|||
143187758|NCT02318368|516230624|FG000|Overall Study|Death|0|||
143187759|NCT02318368|516230625|FG001|Overall Study|Death|1|||
143187760|NCT01534351|516230626|FG000|Overall Study|Study Terminated Early|1|||
143187761|NCT01534351|516230627|FG001|Overall Study|Study Terminated Early|0|||
143187762|NCT01534351|516230628|FG002|Overall Study|Study Terminated Early|0|||
143187763|NCT04660552|516230629|FG000|Overall Study|Withdrawal by Subject|3|||
143187764|NCT04660552|516230630|FG001|Overall Study|Withdrawal by Subject|1|||
143187765|NCT03928418|516230631|FG000|Overall Study|Lost to Follow-up|5|||
143187766|NCT03928418|516230632|FG001|Overall Study|Lost to Follow-up|3|||
143187767|NCT03928418|516230633|FG002|Overall Study|Lost to Follow-up|5|||
143187768|NCT03928418|516230631|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
143187769|NCT03928418|516230632|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
143187770|NCT03928418|516230633|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
143187771|NCT00964002|516230638|FG000|Overall Study|Protocol Violation|8|||
143187772|NCT04004221|516230644|FG000|Overall Study|Death|89|||
143187773|NCT04004221|516230644|FG000|Overall Study|Withdrawal by Subject|5|||
143187774|NCT04004221|516230644|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
143187775|NCT04004221|516230644|FG000|Overall Study|Sponsor Decision|9|||
143187776|NCT04004221|516230644|FG000|Overall Study|Participant refused to enter LTE|1|||
143187777|NCT03423238|516230647|FG000|Overall Study|Lost to Follow-up|1|||
143187778|NCT03423238|516230648|FG001|Overall Study|Lost to Follow-up|0|||
143187779|NCT03423238|516230647|FG000|Overall Study|Withdrawal by Subject|1|||
143187780|NCT03423238|516230648|FG001|Overall Study|Withdrawal by Subject|0|||
143187781|NCT02036580|516230653|FG000|Overall Study|Withdrawal by Subject|0|||
143187782|NCT02036580|516230654|FG001|Overall Study|Withdrawal by Subject|1|||
143187783|NCT02036580|516230655|FG002|Overall Study|Withdrawal by Subject|0|||
143187784|NCT02036580|516230653|FG000|Overall Study|Adverse Event|1|||
143187785|NCT02036580|516230654|FG001|Overall Study|Adverse Event|0|||
143187786|NCT02036580|516230655|FG002|Overall Study|Adverse Event|0|||
143187787|NCT00992056|516230656|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
143187788|NCT00992056|516230657|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
143187789|NCT00992056|516230656|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
143187790|NCT00992056|516230657|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
143187791|NCT01558596|516230658|FG000|Overall Study|Withdrawal by Subject|1|||
143187792|NCT01558596|516230659|FG001|Overall Study|Withdrawal by Subject|0|||
143187793|NCT01558596|516230658|FG000|Overall Study|surgery elsewhere or cancelled|1|||
143187794|NCT01558596|516230659|FG001|Overall Study|surgery elsewhere or cancelled|1|||
143187795|NCT01558596|516230658|FG000|Overall Study|Protocol Violation|1|||
143187796|NCT01558596|516230659|FG001|Overall Study|Protocol Violation|0|||
143187797|NCT01270880|516230661|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
143187798|NCT04222699|516230662|FG000|Overall Study|Lost to Follow-up|2|||
143187799|NCT04552288|516230666|FG000|Overall Study|Death|3|||
143187800|NCT04552288|516230666|FG000|Overall Study|Lost to Follow-up|6|||
143187801|NCT04552288|516230666|FG000|Overall Study|Physician Decision|3|||
143187802|NCT04552288|516230666|FG000|Overall Study|Protocol Violation|9|||
143187803|NCT04552288|516230666|FG000|Overall Study|Withdrawal by Subject|6|||
143187804|NCT04552288|516230666|FG000|Overall Study|Disease progression, Complicated disease, Ineligible|10|||
143187805|NCT03583359|516230667|FG000|Overall Study|Withdrawal by Subject|15|||
143187806|NCT03583359|516230668|FG001|Overall Study|Withdrawal by Subject|6|||
143187807|NCT03583359|516230667|FG000|Overall Study|Lost to Follow-up|12|||
143187808|NCT03583359|516230668|FG001|Overall Study|Lost to Follow-up|3|||
143187809|NCT03583359|516230667|FG000|Overall Study|Adverse Event|0|||
143187810|NCT03583359|516230668|FG001|Overall Study|Adverse Event|1|||
143187811|NCT03583359|516230667|FG000|Overall Study|Protocol Violation|0|||
143187812|NCT03583359|516230668|FG001|Overall Study|Protocol Violation|1|||
143187813|NCT03583359|516230667|FG000|Overall Study|Other|2|||
143187814|NCT03583359|516230668|FG001|Overall Study|Other|1|||
143187815|NCT01831466|516230674|FG000|Overall Study|Protocol Violation|1|||
143187816|NCT01831466|516230675|FG001|Overall Study|Protocol Violation|1|||
143187817|NCT01831466|516230676|FG002|Overall Study|Protocol Violation|2|||
143187818|NCT01831466|516230677|FG003|Overall Study|Protocol Violation|0|||
143187819|NCT01831466|516230678|FG004|Overall Study|Protocol Violation|0|||
143187820|NCT01831466|516230679|FG005|Overall Study|Protocol Violation|1|||
143187821|NCT01831466|516230680|FG006|Overall Study|Protocol Violation|0|||
143187822|NCT01831466|516230681|FG007|Overall Study|Protocol Violation|0|||
143187823|NCT01831466|516230682|FG008|Overall Study|Protocol Violation|0|||
143187824|NCT01831466|516230683|FG009|Overall Study|Protocol Violation|0|||
143187825|NCT01831466|516230684|FG010|Overall Study|Protocol Violation|0|||
143187826|NCT01831466|516230685|FG011|Overall Study|Protocol Violation|0|||
143187827|NCT01831466|516230674|FG000|Overall Study|Other|2|||
143187828|NCT01831466|516230675|FG001|Overall Study|Other|3|||
143187829|NCT01831466|516230676|FG002|Overall Study|Other|2|||
143187830|NCT01831466|516230677|FG003|Overall Study|Other|2|||
143187831|NCT01831466|516230678|FG004|Overall Study|Other|2|||
143187832|NCT01831466|516230679|FG005|Overall Study|Other|1|||
143187833|NCT01831466|516230680|FG006|Overall Study|Other|0|||
143187834|NCT01831466|516230681|FG007|Overall Study|Other|0|||
143187835|NCT01831466|516230682|FG008|Overall Study|Other|0|||
143187836|NCT01831466|516230683|FG009|Overall Study|Other|0|||
143187837|NCT01831466|516230684|FG010|Overall Study|Other|0|||
143187838|NCT01831466|516230685|FG011|Overall Study|Other|0|||
143187839|NCT01831466|516230674|FG000|Overall Study|Non-compliance with study treatment|2|||
143187840|NCT01831466|516230675|FG001|Overall Study|Non-compliance with study treatment|1|||
143187841|NCT01831466|516230676|FG002|Overall Study|Non-compliance with study treatment|1|||
143187842|NCT01831466|516230677|FG003|Overall Study|Non-compliance with study treatment|0|||
143187843|NCT01831466|516230678|FG004|Overall Study|Non-compliance with study treatment|0|||
143187844|NCT01831466|516230679|FG005|Overall Study|Non-compliance with study treatment|1|||
143187845|NCT01831466|516230680|FG006|Overall Study|Non-compliance with study treatment|0|||
143187846|NCT01831466|516230681|FG007|Overall Study|Non-compliance with study treatment|0|||
143187847|NCT01831466|516230682|FG008|Overall Study|Non-compliance with study treatment|0|||
143187848|NCT01831466|516230683|FG009|Overall Study|Non-compliance with study treatment|0|||
143187849|NCT01831466|516230684|FG010|Overall Study|Non-compliance with study treatment|0|||
143187850|NCT01831466|516230685|FG011|Overall Study|Non-compliance with study treatment|0|||
143187851|NCT01831466|516230674|FG000|Overall Study|Death|0|||
143187852|NCT01831466|516230675|FG001|Overall Study|Death|1|||
143187853|NCT01831466|516230676|FG002|Overall Study|Death|0|||
143187854|NCT01831466|516230677|FG003|Overall Study|Death|0|||
143187855|NCT01831466|516230678|FG004|Overall Study|Death|0|||
143187856|NCT01831466|516230679|FG005|Overall Study|Death|0|||
143187857|NCT01831466|516230680|FG006|Overall Study|Death|0|||
143187858|NCT01831466|516230681|FG007|Overall Study|Death|0|||
143187859|NCT01831466|516230682|FG008|Overall Study|Death|0|||
143187860|NCT01831466|516230683|FG009|Overall Study|Death|0|||
143187861|NCT01831466|516230684|FG010|Overall Study|Death|0|||
143187862|NCT01831466|516230685|FG011|Overall Study|Death|0|||
143187863|NCT01831466|516230674|FG000|Overall Study|Withdrawal by Subject|6|||
143187864|NCT01831466|516230675|FG001|Overall Study|Withdrawal by Subject|3|||
143187865|NCT01831466|516230676|FG002|Overall Study|Withdrawal by Subject|3|||
143187866|NCT01831466|516230677|FG003|Overall Study|Withdrawal by Subject|3|||
143187867|NCT01831466|516230678|FG004|Overall Study|Withdrawal by Subject|3|||
143187868|NCT01831466|516230679|FG005|Overall Study|Withdrawal by Subject|5|||
143187869|NCT01831466|516230680|FG006|Overall Study|Withdrawal by Subject|0|||
143187870|NCT01831466|516230681|FG007|Overall Study|Withdrawal by Subject|0|||
143187871|NCT01831466|516230682|FG008|Overall Study|Withdrawal by Subject|0|||
143187872|NCT01831466|516230683|FG009|Overall Study|Withdrawal by Subject|1|||
143187873|NCT01831466|516230684|FG010|Overall Study|Withdrawal by Subject|0|||
143187874|NCT01831466|516230685|FG011|Overall Study|Withdrawal by Subject|1|||
143187875|NCT01831466|516230674|FG000|Overall Study|Lost to Follow-up|0|||
143187876|NCT01831466|516230675|FG001|Overall Study|Lost to Follow-up|1|||
143187877|NCT01831466|516230676|FG002|Overall Study|Lost to Follow-up|4|||
143187878|NCT01831466|516230677|FG003|Overall Study|Lost to Follow-up|2|||
143187879|NCT01831466|516230678|FG004|Overall Study|Lost to Follow-up|0|||
143187880|NCT01831466|516230679|FG005|Overall Study|Lost to Follow-up|3|||
143369473|NCT01651949|516896123|FG002|Overall Study|Withdrawal by Subject|9|||
143369474|NCT01806714|516896124|FG000|Overall Study|No functioning phone number|200|||
143369475|NCT01806714|516896125|FG001|Overall Study|No functioning phone number|170|||
143369476|NCT00678795|516896126|FG000|Overall Study|Adverse Event|7|||
143187881|NCT01831466|516230680|FG006|Overall Study|Lost to Follow-up|0|||
143187882|NCT01831466|516230681|FG007|Overall Study|Lost to Follow-up|0|||
143187883|NCT01831466|516230682|FG008|Overall Study|Lost to Follow-up|0|||
143187884|NCT01831466|516230683|FG009|Overall Study|Lost to Follow-up|1|||
143187885|NCT01831466|516230684|FG010|Overall Study|Lost to Follow-up|0|||
143187886|NCT01831466|516230685|FG011|Overall Study|Lost to Follow-up|1|||
143187887|NCT01831466|516230674|FG000|Overall Study|Lack of Efficacy|5|||
143187888|NCT01831466|516230675|FG001|Overall Study|Lack of Efficacy|8|||
143187889|NCT01831466|516230676|FG002|Overall Study|Lack of Efficacy|7|||
143187890|NCT01831466|516230677|FG003|Overall Study|Lack of Efficacy|6|||
143187891|NCT01831466|516230678|FG004|Overall Study|Lack of Efficacy|9|||
143187892|NCT01831466|516230679|FG005|Overall Study|Lack of Efficacy|8|||
143187893|NCT01831466|516230680|FG006|Overall Study|Lack of Efficacy|1|||
143187894|NCT01831466|516230681|FG007|Overall Study|Lack of Efficacy|1|||
143187895|NCT01831466|516230682|FG008|Overall Study|Lack of Efficacy|2|||
143187896|NCT01831466|516230683|FG009|Overall Study|Lack of Efficacy|2|||
143187897|NCT01831466|516230684|FG010|Overall Study|Lack of Efficacy|2|||
143187898|NCT01831466|516230685|FG011|Overall Study|Lack of Efficacy|0|||
143187899|NCT01831466|516230674|FG000|Overall Study|Adverse Event|0|||
143187900|NCT01831466|516230675|FG001|Overall Study|Adverse Event|0|||
143187901|NCT01831466|516230676|FG002|Overall Study|Adverse Event|4|||
143187902|NCT01831466|516230677|FG003|Overall Study|Adverse Event|6|||
143187903|NCT01831466|516230678|FG004|Overall Study|Adverse Event|3|||
143187904|NCT01831466|516230679|FG005|Overall Study|Adverse Event|7|||
143187905|NCT01831466|516230680|FG006|Overall Study|Adverse Event|0|||
143187906|NCT01831466|516230681|FG007|Overall Study|Adverse Event|1|||
143187907|NCT01831466|516230682|FG008|Overall Study|Adverse Event|1|||
143187908|NCT01831466|516230683|FG009|Overall Study|Adverse Event|1|||
143187909|NCT01831466|516230684|FG010|Overall Study|Adverse Event|0|||
143187910|NCT01831466|516230685|FG011|Overall Study|Adverse Event|2|||
143187911|NCT02798315|516230686|FG000|Overall Study|Failure to return|1|||
143187912|NCT00005947|516230687|FG000|Overall Study|Death|54|||
143187913|NCT00005947|516230688|FG001|Overall Study|Death|40|||
143187914|NCT00005947|516230687|FG000|Overall Study|Patient Refused to Continue|2|||
143187915|NCT00005947|516230688|FG001|Overall Study|Patient Refused to Continue|1|||
143187916|NCT00005947|516230687|FG000|Overall Study|Site Closure|1|||
143187917|NCT00005947|516230688|FG001|Overall Study|Site Closure|0|||
143187918|NCT00703846|516230692|FG000|Overall Study|Adverse Event|8|||
143187919|NCT00703846|516230692|FG000|Overall Study|Lost to Follow-up|55|||
143187920|NCT00703846|516230692|FG000|Overall Study|Lack of Efficacy|15|||
143187921|NCT00703846|516230692|FG000|Overall Study|Noncompliance with Study Treatment|2|||
143187922|NCT00703846|516230692|FG000|Overall Study|Withdrawal by Subject|40|||
143187923|NCT00703846|516230692|FG000|Overall Study|Death|1|||
143187924|NCT00703846|516230692|FG000|Overall Study|Other|14|||
143187925|NCT00703846|516230692|FG000|Overall Study|Did Not Receive Study Drug|2|||
143187926|NCT04601532|516230693|FG000|Overall Study|Lost to Follow-up|1|||
143187927|NCT04601532|516230694|FG001|Overall Study|Lost to Follow-up|2|||
143187928|NCT04601532|516230693|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
143187929|NCT04601532|516230694|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
143187930|NCT02566785|516230696|FG000|Overall Study|Lost to Follow-up|0|||
143187931|NCT02566785|516230697|FG001|Overall Study|Lost to Follow-up|2|||
143187932|NCT02566785|516230696|FG000|Overall Study|Worsening condition|1|||
143187933|NCT02566785|516230697|FG001|Overall Study|Worsening condition|1|||
143187934|NCT00837161|516230700|FG000|Overall Study|refused hysterectomy|2|||
143187935|NCT00451958|516230703|FG000|CS21A (NCT00451958)|Adverse Event|21|||
143187936|NCT00451958|516230704|FG001|CS21A (NCT00451958)|Adverse Event|34|||
143187937|NCT00451958|516230705|FG002|CS21A (NCT00451958)|Adverse Event|14|||
143187938|NCT00451958|516230706|FG003|CS21A (NCT00451958)|Adverse Event|17|||
143369477|NCT00678795|516896127|FG001|Overall Study|Adverse Event|3|||
143187939|NCT00451958|516230707|FG004|CS21A (NCT00451958)|Adverse Event|0|||
143187940|NCT00451958|516230703|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
143187941|NCT00451958|516230704|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
143187942|NCT00451958|516230705|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
143187943|NCT00451958|516230706|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
143187944|NCT00451958|516230707|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
143187945|NCT00451958|516230703|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
143187946|NCT00451958|516230704|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
143187947|NCT00451958|516230705|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
143187948|NCT00451958|516230706|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
143369478|NCT00678795|516896126|FG000|Overall Study|Withdrawal by Subject|3|||
143187949|NCT00451958|516230707|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
143369479|NCT00678795|516896127|FG001|Overall Study|Withdrawal by Subject|0|||
143187950|NCT00451958|516230703|FG000|CS21A (NCT00451958)|Physician Decision|2|||
143187951|NCT00451958|516230704|FG001|CS21A (NCT00451958)|Physician Decision|4|||
143187952|NCT00451958|516230705|FG002|CS21A (NCT00451958)|Physician Decision|4|||
143187953|NCT00451958|516230706|FG003|CS21A (NCT00451958)|Physician Decision|4|||
143187954|NCT00451958|516230707|FG004|CS21A (NCT00451958)|Physician Decision|0|||
143187955|NCT00451958|516230703|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
143187956|NCT00451958|516230704|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
143187957|NCT00451958|516230705|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
143187958|NCT00451958|516230706|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
143187959|NCT00451958|516230707|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
143187960|NCT00451958|516230703|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
143187961|NCT00451958|516230704|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
143187962|NCT00451958|516230705|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
143187963|NCT00451958|516230706|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
143187964|NCT00451958|516230707|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
143187965|NCT03108521|516230711|FG000|Overall Study|Lost to Follow-up|3|||
143187966|NCT03108521|516230712|FG001|Overall Study|Lost to Follow-up|0|||
143187967|NCT03108521|516230711|FG000|Overall Study|Lack of Efficacy|2|||
143187968|NCT03108521|516230712|FG001|Overall Study|Lack of Efficacy|0|||
143187969|NCT03108521|516230711|FG000|Overall Study|Physician Decision|4|||
143187970|NCT03108521|516230712|FG001|Overall Study|Physician Decision|0|||
143187971|NCT03108521|516230711|FG000|Overall Study|Adverse Event|3|||
143187972|NCT03108521|516230712|FG001|Overall Study|Adverse Event|0|||
143187973|NCT00375674|516230719|FG000|Overall Study|Other|26|||
143187974|NCT00375674|516230720|FG001|Overall Study|Other|18|||
143187975|NCT00375674|516230719|FG000|Overall Study|Death|67|||
143187976|NCT00375674|516230720|FG001|Overall Study|Death|76|||
143187977|NCT00375674|516230719|FG000|Overall Study|Participants refused further follow-up|31|||
143187978|NCT00375674|516230720|FG001|Overall Study|Participants refused further follow-up|30|||
143187979|NCT00375674|516230719|FG000|Overall Study|Lost to Follow-up|17|||
143187980|NCT00375674|516230720|FG001|Overall Study|Lost to Follow-up|15|||
143187981|NCT00375674|516230719|FG000|Overall Study|Enrolled but not treated|3|||
143187982|NCT00375674|516230720|FG001|Overall Study|Enrolled but not treated|2|||
143187983|NCT02547038|516232061|FG000|Overall Study|Lost to Follow-up|3|||
143187984|NCT02547038|516232062|FG001|Overall Study|Lost to Follow-up|2|||
143187985|NCT00623233|516232063|FG000|Overall Study|Adverse Event|10|||
143187986|NCT00623233|516232063|FG000|Overall Study|Physician Decision|10|||
143187987|NCT00623233|516232063|FG000|Overall Study|Lost to Follow-up|1|||
143187988|NCT00623233|516232063|FG000|Overall Study|Withdrawal by Subject|3|||
143187989|NCT00559845|516232064|FG000|Overall Study|Withdrew Consent|1|||
143187990|NCT00559845|516232064|FG000|Overall Study|Disease Progression|1|||
143187991|NCT00559845|516232064|FG000|Overall Study|Adverse Event|3|||
143187992|NCT00559845|516232064|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
143187993|NCT00559845|516232064|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
143187994|NCT02150057|516232065|FG000|Overall Study|Lost to Follow-up|6|||
143187995|NCT02150057|516232066|FG001|Overall Study|Lost to Follow-up|4|||
143187996|NCT01558115|516232067|FG000|Overall Study|Withdrawal by Subject|3|||
143187997|NCT01558115|516232067|FG000|Overall Study|Study closed due to poor enrollment|4|||
143187998|NCT01696994|516232068|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
143187999|NCT01696994|516232069|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
143188000|NCT01696994|516232068|FG000|Overall Study|Died Before Randomization|1|||
143188001|NCT01696994|516232069|FG001|Overall Study|Died Before Randomization|2|||
143188002|NCT01696994|516232068|FG000|Overall Study|Died Before ASU (Control)|73|||
143369480|NCT00678795|516896126|FG000|Overall Study|Protocol Violation|0|||
143369481|NCT00678795|516896127|FG001|Overall Study|Protocol Violation|1|||
143188003|NCT01696994|516232069|FG001|Overall Study|Died Before ASU (Control)|0|||
143188004|NCT01696994|516232068|FG000|Overall Study|No Ovaries at Baseline|4807|||
143188005|NCT01696994|516232069|FG001|Overall Study|No Ovaries at Baseline|4851|||
143188006|NCT01696994|516232068|FG000|Overall Study|Refused ASU (Control)|311|||
143188007|NCT01696994|516232069|FG001|Overall Study|Refused ASU (Control)|0|||
143188008|NCT01696994|516232068|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
143188009|NCT01696994|516232069|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
143188010|NCT00576628|516232070|FG000|Overall Study|Adverse Event|11|||
143188011|NCT00576628|516232070|FG000|Overall Study|Death|2|||
143188012|NCT00576628|516232070|FG000|Overall Study|Failure to return|1|||
143188013|NCT00576628|516232070|FG000|Overall Study|Refused Treatment|8|||
143369482|NCT00678795|516896126|FG000|Overall Study|Lost to Follow-up|0|||
143188014|NCT00576628|516232070|FG000|Overall Study|Pregnancy|1|||
143188015|NCT00576628|516232070|FG000|Overall Study|RBC transfusion|1|||
143188016|NCT00576628|516232070|FG000|Overall Study|Progression of Kidney Disease|1|||
143188017|NCT00576628|516232070|FG000|Overall Study|Progression of Renal Failure|1|||
143188018|NCT00576628|516232070|FG000|Overall Study|The patient move into other town|1|||
143188019|NCT00576628|516232070|FG000|Overall Study|Transplantation|1|||
143188020|NCT00576628|516232070|FG000|Overall Study|Dialysis|15|||
143188021|NCT02516982|516232071|FG000|Overall Study|Called in to antenatal appointment|32|||
143188022|NCT02516982|516232072|FG001|Overall Study|Called in to antenatal appointment|35|||
143188023|NCT02516982|516232073|FG002|Overall Study|Called in to antenatal appointment|0|||
143188024|NCT02516982|516232074|FG003|Overall Study|Called in to antenatal appointment|0|||
143188025|NCT02516982|516232071|FG000|Overall Study|Withdrawal by Subject|0|||
143188026|NCT02516982|516232072|FG001|Overall Study|Withdrawal by Subject|0|||
143188027|NCT02516982|516232073|FG002|Overall Study|Withdrawal by Subject|1|||
143188028|NCT02516982|516232074|FG003|Overall Study|Withdrawal by Subject|2|||
143188029|NCT02516982|516232071|FG000|Overall Study|Protocol Violation|0|||
143188030|NCT02516982|516232072|FG001|Overall Study|Protocol Violation|0|||
143188031|NCT02516982|516232073|FG002|Overall Study|Protocol Violation|1|||
143188032|NCT02516982|516232074|FG003|Overall Study|Protocol Violation|1|||
143188033|NCT02516982|516232071|FG000|Overall Study|Did not install the app|0|||
143188034|NCT02516982|516232072|FG001|Overall Study|Did not install the app|0|||
143188035|NCT02516982|516232073|FG002|Overall Study|Did not install the app|46|||
143188036|NCT02516982|516232074|FG003|Overall Study|Did not install the app|47|||
143188037|NCT01951586|516232077|FG000|Overall Study|Death|61|||
143188038|NCT01951586|516232078|FG001|Overall Study|Death|120|||
143188039|NCT01951586|516232077|FG000|Overall Study|Withdrawal by Subject|8|||
143188040|NCT01951586|516232078|FG001|Overall Study|Withdrawal by Subject|17|||
143188041|NCT01951586|516232077|FG000|Overall Study|Lost to Follow-up|0|||
143188042|NCT01951586|516232078|FG001|Overall Study|Lost to Follow-up|1|||
143188043|NCT01951586|516232077|FG000|Overall Study|Sponsor Decision|9|||
143188044|NCT01951586|516232078|FG001|Overall Study|Sponsor Decision|10|||
143188045|NCT00962741|516232079|FG000|Overall Study|Failed to return|3|||
143188046|NCT00962741|516232079|FG000|Overall Study|Lost to Follow-up|2|||
143188047|NCT00962741|516232079|FG000|Overall Study|Withdrawal by Subject|1|||
143188048|NCT00962741|516232079|FG000|Overall Study|Lack of Efficacy|1|||
143188049|NCT00962741|516232079|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
143188050|NCT01977729|516232082|FG000|Overall Study|Study terminated|1|||
143188051|NCT02277691|516232083|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
143188052|NCT02277691|516232083|FG000|Overall Study|Voluntary Withdrawal|7|||
143188053|NCT02277691|516232083|FG000|Overall Study|Lack of Efficacy|5|||
143188054|NCT02277691|516232083|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
143188055|NCT01147250|516232084|FG000|Overall Study|Lost to Follow-up|14|||
143188056|NCT01147250|516232085|FG001|Overall Study|Lost to Follow-up|11|||
143188057|NCT01147250|516232084|FG000|Overall Study|Withdrawal by Subject|83|||
143188058|NCT01147250|516232085|FG001|Overall Study|Withdrawal by Subject|88|||
143188059|NCT01147250|516232084|FG000|Overall Study|Site termination by sponsor|13|||
143188060|NCT01147250|516232085|FG001|Overall Study|Site termination by sponsor|5|||
143188061|NCT01147250|516232084|FG000|Overall Study|Other than specified|0|||
143188062|NCT01147250|516232085|FG001|Overall Study|Other than specified|1|||
143188063|NCT01164891|516232086|FG000|Overall Study|Disease Progression|5|||
143188064|NCT01164891|516232086|FG000|Overall Study|Adverse Event|1|||
143188065|NCT00441142|516232087|FG000|Overall Study|Adverse Event|2|||
143188066|NCT00441142|516232088|FG001|Overall Study|Adverse Event|3|||
143188067|NCT00441142|516232089|FG002|Overall Study|Adverse Event|3|||
143188068|NCT00441142|516232090|FG003|Overall Study|Adverse Event|22|||
143188069|NCT00441142|516232087|FG000|Overall Study|Lack of Efficacy|3|||
143188070|NCT00441142|516232088|FG001|Overall Study|Lack of Efficacy|3|||
143188071|NCT00441142|516232089|FG002|Overall Study|Lack of Efficacy|17|||
143188072|NCT00441142|516232090|FG003|Overall Study|Lack of Efficacy|32|||
143188073|NCT00441142|516232087|FG000|Overall Study|Withdrawal by Subject|0|||
143188074|NCT00441142|516232088|FG001|Overall Study|Withdrawal by Subject|0|||
143188075|NCT00441142|516232089|FG002|Overall Study|Withdrawal by Subject|2|||
143188076|NCT00441142|516232090|FG003|Overall Study|Withdrawal by Subject|10|||
143188077|NCT00441142|516232087|FG000|Overall Study|Patient still receiving active study tx|1|||
143188078|NCT00441142|516232088|FG001|Overall Study|Patient still receiving active study tx|0|||
143188079|NCT00441142|516232089|FG002|Overall Study|Patient still receiving active study tx|0|||
143188080|NCT00441142|516232090|FG003|Overall Study|Patient still receiving active study tx|2|||
143188081|NCT00441142|516232087|FG000|Overall Study|Physician Decision|0|||
143188082|NCT00441142|516232088|FG001|Overall Study|Physician Decision|1|||
143188083|NCT00441142|516232089|FG002|Overall Study|Physician Decision|0|||
143188084|NCT00441142|516232090|FG003|Overall Study|Physician Decision|1|||
143188085|NCT00441142|516232087|FG000|Overall Study|Death|0|||
143188086|NCT00441142|516232088|FG001|Overall Study|Death|0|||
143188087|NCT00441142|516232089|FG002|Overall Study|Death|0|||
143188088|NCT00441142|516232090|FG003|Overall Study|Death|1|||
143188089|NCT04952597|516232091|FG000|Overall Study|Death|12|||
143188090|NCT04952597|516232092|FG001|Overall Study|Death|13|||
143188091|NCT04952597|516232093|FG002|Overall Study|Death|14|||
143188092|NCT04952597|516232091|FG000|Overall Study|Withdrawal by Subject|1|||
143188093|NCT04952597|516232092|FG001|Overall Study|Withdrawal by Subject|0|||
143188094|NCT04952597|516232093|FG002|Overall Study|Withdrawal by Subject|3|||
143188095|NCT04952597|516232091|FG000|Overall Study|Lost to Follow-up|0|||
143188096|NCT04952597|516232092|FG001|Overall Study|Lost to Follow-up|1|||
143188097|NCT04952597|516232093|FG002|Overall Study|Lost to Follow-up|1|||
143188098|NCT02141399|516232097|FG000|Overall Study|Adverse Event|158|||
143188099|NCT02141399|516232097|FG000|Overall Study|Lack of Efficacy|62|||
143188100|NCT02141399|516232097|FG000|Overall Study|Lost to Follow-up|151|||
143188101|NCT02141399|516232097|FG000|Overall Study|Non-compliance with study drug|18|||
143188102|NCT02141399|516232097|FG000|Overall Study|Other|45|||
143188103|NCT02141399|516232097|FG000|Overall Study|Physician Decision|17|||
143188104|NCT02141399|516232097|FG000|Overall Study|Pregnancy|3|||
143188105|NCT02141399|516232097|FG000|Overall Study|Protocol Violation|38|||
143188106|NCT02141399|516232097|FG000|Overall Study|Withdrawal by Subject|238|||
143188107|NCT02141399|516232097|FG000|Overall Study|Failure to meet eligibility criteria|14|||
143188108|NCT04445519|516232098|FG000|Overall Study|Due to adaptive design|3|||
143188109|NCT04445519|516232099|FG001|Overall Study|Due to adaptive design|0|||
143188110|NCT04445519|516232100|FG002|Overall Study|Due to adaptive design|0|||
143188111|NCT04445519|516232098|FG000|Overall Study|Lost to Follow-up|0|||
143188112|NCT04445519|516232099|FG001|Overall Study|Lost to Follow-up|1|||
143188113|NCT04445519|516232100|FG002|Overall Study|Lost to Follow-up|4|||
143188114|NCT04445519|516232098|FG000|Overall Study|Sponsor or IRB Decision|0|||
143188115|NCT04445519|516232099|FG001|Overall Study|Sponsor or IRB Decision|1|||
143188116|NCT04445519|516232100|FG002|Overall Study|Sponsor or IRB Decision|2|||
143188117|NCT04445519|516232098|FG000|Overall Study|Withdrawal by Subject|0|||
143188118|NCT04445519|516232099|FG001|Overall Study|Withdrawal by Subject|3|||
143188119|NCT04445519|516232100|FG002|Overall Study|Withdrawal by Subject|3|||
143188120|NCT04445519|516232098|FG000|Overall Study|Adverse Event|0|||
143188121|NCT04445519|516232099|FG001|Overall Study|Adverse Event|8|||
143188122|NCT04445519|516232100|FG002|Overall Study|Adverse Event|6|||
143188123|NCT04445519|516232098|FG000|Overall Study|Other Reason|0|||
143188124|NCT04445519|516232099|FG001|Overall Study|Other Reason|1|||
143188125|NCT04445519|516232100|FG002|Overall Study|Other Reason|1|||
143188126|NCT04445519|516232098|FG000|Overall Study|Protocol Violation|0|||
143188127|NCT04445519|516232099|FG001|Overall Study|Protocol Violation|0|||
143188128|NCT04445519|516232100|FG002|Overall Study|Protocol Violation|1|||
143188129|NCT01345929|516232101|FG000|Overall Study|Withdrawal by Subject|9|||
143188130|NCT01345929|516232102|FG001|Overall Study|Withdrawal by Subject|8|||
143188131|NCT01345929|516232101|FG000|Overall Study|Lost to Follow-up|9|||
143188132|NCT01345929|516232102|FG001|Overall Study|Lost to Follow-up|9|||
143188133|NCT01345929|516232101|FG000|Overall Study|Adverse Event|0|||
143188134|NCT01345929|516232102|FG001|Overall Study|Adverse Event|1|||
143188135|NCT01345929|516232101|FG000|Overall Study|Didn't meet eligibility criteria|2|||
143188136|NCT01345929|516232102|FG001|Overall Study|Didn't meet eligibility criteria|0|||
143188137|NCT01345929|516232101|FG000|Overall Study|40,000 CFU/ML|1|||
143188138|NCT01345929|516232102|FG001|Overall Study|40,000 CFU/ML|0|||
143188139|NCT01345929|516232101|FG000|Overall Study|Patient withdrawal|0|||
143188140|NCT01345929|516232102|FG001|Overall Study|Patient withdrawal|1|||
143188141|NCT04153981|516232109|FG000|Overall Study|Death|1|||
143188142|NCT04153981|516232109|FG000|Overall Study|Withdrawal by Subject|24|||
143188143|NCT04153981|516232109|FG000|Overall Study|Lost to Follow-up|1|||
143188144|NCT04153981|516232109|FG000|Overall Study|Physician Decision|1|||
143188145|NCT04153981|516232109|FG000|Overall Study|Due to Unavailable Glucometer|1|||
143188146|NCT04153981|516232109|FG000|Overall Study|Covid 19|52|||
143188147|NCT04153981|516232109|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
143188148|NCT04153981|516232109|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
143188149|NCT02091362|516232110|FG000|Period 1|Protocol Violation|1|||
143188150|NCT02091362|516232111|FG001|Period 1|Protocol Violation|0|||
143188151|NCT02091362|516232110|FG000|Period 1|Withdrawal by Subject|2|||
143188152|NCT02091362|516232111|FG001|Period 1|Withdrawal by Subject|3|||
143188153|NCT02091362|516232110|FG000|Period 1|Lost to Follow-up|0|||
143188154|NCT02091362|516232111|FG001|Period 1|Lost to Follow-up|1|||
143188155|NCT02091362|516232110|FG000|Period 1|Adverse Event|2|||
143188156|NCT02091362|516232111|FG001|Period 1|Adverse Event|0|||
143188157|NCT02091362|516232110|FG000|Wash-out|Lost to Follow-up|1|||
143188158|NCT02091362|516232111|FG001|Wash-out|Lost to Follow-up|1|||
143188159|NCT02091362|516232110|FG000|Wash-out|Withdrawal by Subject|0|||
143188160|NCT02091362|516232111|FG001|Wash-out|Withdrawal by Subject|2|||
143188161|NCT02091362|516232110|FG000|Period 2|Adverse Event|1|||
143188162|NCT02091362|516232111|FG001|Period 2|Adverse Event|0|||
143188163|NCT02091362|516232110|FG000|Period 2|Lost to Follow-up|0|||
143188164|NCT02091362|516232111|FG001|Period 2|Lost to Follow-up|1|||
143188165|NCT02091362|516232110|FG000|Period 2|Withdrawal by Subject|1|||
143188166|NCT02091362|516232111|FG001|Period 2|Withdrawal by Subject|1|||
143188167|NCT00690430|516232112|FG000|Core Phase|Abnormal Laboratory value|0|||
143188168|NCT00690430|516232113|FG001|Core Phase|Abnormal Laboratory value|1|||
143188169|NCT00690430|516232114|FG002|Core Phase|Abnormal Laboratory value|0|||
143188170|NCT00690430|516232112|FG000|Core Phase|Adverse Event|5|||
143188171|NCT00690430|516232113|FG001|Core Phase|Adverse Event|1|||
143188172|NCT00690430|516232114|FG002|Core Phase|Adverse Event|0|||
143188173|NCT00690430|516232112|FG000|Core Phase|Death|0|||
143188174|NCT00690430|516232113|FG001|Core Phase|Death|2|||
143188175|NCT00690430|516232114|FG002|Core Phase|Death|0|||
143188176|NCT00690430|516232112|FG000|Core Phase|Protocol Violation|1|||
143188177|NCT00690430|516232113|FG001|Core Phase|Protocol Violation|0|||
143188178|NCT00690430|516232114|FG002|Core Phase|Protocol Violation|0|||
143188179|NCT00690430|516232112|FG000|Core Phase|Withdrawal by Subject|3|||
143188180|NCT00690430|516232113|FG001|Core Phase|Withdrawal by Subject|3|||
143188181|NCT00690430|516232114|FG002|Core Phase|Withdrawal by Subject|0|||
143188182|NCT00690430|516232112|FG000|Core Phase|Subject no longer requires study drug|1|||
143188183|NCT00690430|516232113|FG001|Core Phase|Subject no longer requires study drug|0|||
143188184|NCT00690430|516232114|FG002|Core Phase|Subject no longer requires study drug|0|||
143188185|NCT00690430|516232112|FG000|Core Phase|Lack of Efficacy|8|||
143188186|NCT00690430|516232113|FG001|Core Phase|Lack of Efficacy|10|||
143188187|NCT00690430|516232114|FG002|Core Phase|Lack of Efficacy|0|||
143188188|NCT00690430|516232112|FG000|Core Phase|Administrative Problems|0|||
143188189|NCT00690430|516232113|FG001|Core Phase|Administrative Problems|1|||
143188190|NCT00690430|516232114|FG002|Core Phase|Administrative Problems|0|||
143188191|NCT00690430|516232112|FG000|Core Phase|Early Termination|0|||
143188192|NCT00690430|516232113|FG001|Core Phase|Early Termination|5|||
143188193|NCT00690430|516232114|FG002|Core Phase|Early Termination|0|||
143188194|NCT00690430|516232112|FG000|Extension Phase|Lack of Efficacy|3|||
143188195|NCT00690430|516232113|FG001|Extension Phase|Lack of Efficacy|1|||
143188196|NCT00690430|516232114|FG002|Extension Phase|Lack of Efficacy|4|||
143188197|NCT00690430|516232112|FG000|Extension Phase|Abnormal Lab Values|1|||
143188198|NCT00690430|516232113|FG001|Extension Phase|Abnormal Lab Values|0|||
143188199|NCT00690430|516232114|FG002|Extension Phase|Abnormal Lab Values|0|||
143188200|NCT00690430|516232112|FG000|Extension Phase|Abnormal test procedure results|1|||
143188201|NCT00690430|516232113|FG001|Extension Phase|Abnormal test procedure results|0|||
143188202|NCT00690430|516232114|FG002|Extension Phase|Abnormal test procedure results|0|||
143188203|NCT00690430|516232112|FG000|Extension Phase|Administrative Problems|0|||
143188204|NCT00690430|516232113|FG001|Extension Phase|Administrative Problems|1|||
143188205|NCT00690430|516232114|FG002|Extension Phase|Administrative Problems|1|||
143188206|NCT00690430|516232112|FG000|Extension Phase|Adverse Event|2|||
143369483|NCT00678795|516896127|FG001|Overall Study|Lost to Follow-up|1|||
143369484|NCT00678795|516896126|FG000|Overall Study|Lack of Efficacy|1|||
143369485|NCT00678795|516896127|FG001|Overall Study|Lack of Efficacy|1|||
143188207|NCT00690430|516232113|FG001|Extension Phase|Adverse Event|1|||
143188208|NCT00690430|516232114|FG002|Extension Phase|Adverse Event|2|||
143188209|NCT00690430|516232112|FG000|Extension Phase|Death|1|||
143188210|NCT00690430|516232113|FG001|Extension Phase|Death|1|||
143188211|NCT00690430|516232114|FG002|Extension Phase|Death|1|||
143188212|NCT00690430|516232112|FG000|Extension Phase|Withdrawal by Subject|0|||
143188213|NCT00690430|516232113|FG001|Extension Phase|Withdrawal by Subject|0|||
143188214|NCT00690430|516232114|FG002|Extension Phase|Withdrawal by Subject|2|||
143188215|NCT00690430|516232112|FG000|Extension Phase|Early Termination|10|||
143188216|NCT00690430|516232113|FG001|Extension Phase|Early Termination|1|||
143188217|NCT00690430|516232114|FG002|Extension Phase|Early Termination|3|||
143188218|NCT02125838|516232123|FG000|Overall Study|Lost to Follow-up|4|||
143369486|NCT04107805|516896128|FG000|Overall Study|Adverse Event|0|||
143369487|NCT04107805|516896129|FG001|Overall Study|Adverse Event|0|||
143369488|NCT04107805|516896130|FG002|Overall Study|Adverse Event|0|||
143369489|NCT04107805|516896131|FG003|Overall Study|Adverse Event|1|||
143188219|NCT02125838|516232124|FG001|Overall Study|Lost to Follow-up|4|||
143188220|NCT02565147|516232125|FG000|Overall Study|Withdrawal by Subject|5|||
143188221|NCT02565147|516232126|FG001|Overall Study|Withdrawal by Subject|1|||
143188222|NCT02565147|516232125|FG000|Overall Study|Lost to Follow-up|0|||
143369490|NCT04107805|516896132|FG004|Overall Study|Adverse Event|0|||
143369491|NCT04107805|516896133|FG005|Overall Study|Adverse Event|1|||
143188223|NCT02565147|516232126|FG001|Overall Study|Lost to Follow-up|1|||
143188224|NCT02565147|516232125|FG000|Overall Study|Death|1|||
143188225|NCT02565147|516232126|FG001|Overall Study|Death|1|||
143188226|NCT00787839|516232127|FG000|Overall Study|Failure to have the OGTT was most common|404|||
143188227|NCT00286091|516232128|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
143188228|NCT00286091|516232129|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
143188229|NCT00286091|516232128|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
143188230|NCT00286091|516232129|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
143188231|NCT00286091|516232128|FG000|Double-blind Treatment Phase|Death|58|||
143188232|NCT00286091|516232129|FG001|Double-blind Treatment Phase|Death|65|||
143188233|NCT00286091|516232128|FG000|Double-blind Treatment Phase|Adverse Event|28|||
143188234|NCT00286091|516232129|FG001|Double-blind Treatment Phase|Adverse Event|40|||
143188235|NCT00286091|516232128|FG000|Double-blind Treatment Phase|Disease Progression|22|||
143188236|NCT00286091|516232129|FG001|Double-blind Treatment Phase|Disease Progression|35|||
143188237|NCT00286091|516232128|FG000|Double-blind Treatment Phase|Other|25|||
143188238|NCT00286091|516232129|FG001|Double-blind Treatment Phase|Other|33|||
143188239|NCT00286091|516232128|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
143188240|NCT00286091|516232129|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
143188241|NCT00286091|516232128|FG000|Double-blind Treatment Phase|Noncompliance|8|||
143188242|NCT00286091|516232129|FG001|Double-blind Treatment Phase|Noncompliance|8|||
143188243|NCT00286091|516232128|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
143188244|NCT00286091|516232129|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
143188245|NCT00286091|516232128|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
143188246|NCT00286091|516232129|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
143188247|NCT00286091|516232128|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
143188248|NCT00286091|516232129|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
143188249|NCT00286091|516232128|FG000|Open-label Treatment Phase|Physician Decision|24|||
143188250|NCT00286091|516232129|FG001|Open-label Treatment Phase|Physician Decision|21|||
143188251|NCT00286091|516232128|FG000|Open-label Treatment Phase|Adverse Event|5|||
143188252|NCT00286091|516232129|FG001|Open-label Treatment Phase|Adverse Event|16|||
143188253|NCT00286091|516232128|FG000|Open-label Treatment Phase|Other|11|||
143188254|NCT00286091|516232129|FG001|Open-label Treatment Phase|Other|11|||
143188255|NCT00286091|516232128|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
143188256|NCT00286091|516232129|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
143188257|NCT00286091|516232128|FG000|Open-label Treatment Phase|Death|10|||
143188258|NCT00286091|516232129|FG001|Open-label Treatment Phase|Death|7|||
143188259|NCT00286091|516232128|FG000|Open-label Treatment Phase|Disease Progression|9|||
143188260|NCT00286091|516232129|FG001|Open-label Treatment Phase|Disease Progression|3|||
143188261|NCT00286091|516232128|FG000|Open-label Treatment Phase|Noncompliance|3|||
143188262|NCT00286091|516232129|FG001|Open-label Treatment Phase|Noncompliance|1|||
143188263|NCT00286091|516232128|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
143188264|NCT00286091|516232129|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
143188265|NCT00286091|516232128|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
143188266|NCT00286091|516232129|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
143188267|NCT00286091|516232128|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
143188268|NCT00286091|516232129|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
143188269|NCT02936869|516232132|FG000|Overall Study|Lost to Follow-up|1|||
143188270|NCT02936869|516232133|FG001|Overall Study|Lost to Follow-up|3|||
143188271|NCT02936869|516232132|FG000|Overall Study|Death|0|||
143188272|NCT02936869|516232133|FG001|Overall Study|Death|1|||
143188273|NCT02936869|516232132|FG000|Overall Study|Legal Case|0|||
143188274|NCT02936869|516232133|FG001|Overall Study|Legal Case|1|||
143188275|NCT02936869|516232132|FG000|Overall Study|Protocol Violation|1|||
143188276|NCT02936869|516232133|FG001|Overall Study|Protocol Violation|0|||
143188277|NCT04470050|516232138|FG000|Double-blind Treatment Phase|Adverse Event|0|||
143188278|NCT04470050|516232139|FG001|Double-blind Treatment Phase|Adverse Event|0|||
143188279|NCT04470050|516232140|FG002|Double-blind Treatment Phase|Adverse Event|0|||
143188280|NCT04470050|516232141|FG003|Double-blind Treatment Phase|Adverse Event|1|||
143188281|NCT04470050|516232142|FG004|Double-blind Treatment Phase|Adverse Event|0|||
143188282|NCT04470050|516232143|FG005|Double-blind Treatment Phase|Adverse Event|0|||
143188283|NCT04470050|516232144|FG006|Double-blind Treatment Phase|Adverse Event|0|||
143188284|NCT04470050|516232138|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
143188285|NCT04470050|516232139|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
143188286|NCT04470050|516232140|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
143188287|NCT04470050|516232141|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
143188288|NCT04470050|516232142|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
143188289|NCT04470050|516232143|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
143188290|NCT04470050|516232144|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
143188291|NCT04470050|516232138|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
143188292|NCT04470050|516232139|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
143188293|NCT04470050|516232140|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
143188294|NCT04470050|516232141|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
143188295|NCT04470050|516232142|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
143188296|NCT04470050|516232143|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
143188297|NCT04470050|516232144|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
143188298|NCT03640507|516232145|FG000|Overall Study|Withdrawal by Subject|0|||
143188299|NCT03640507|516232146|FG001|Overall Study|Withdrawal by Subject|0|||
143188300|NCT03640507|516232147|FG002|Overall Study|Withdrawal by Subject|1|||
143188301|NCT03604172|516232148|FG000|Overall Study|Lost to Follow-up|1|||
143188302|NCT03604172|516232149|FG001|Overall Study|Lost to Follow-up|2|||
143188303|NCT00923351|516232150|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
143188304|NCT00923351|516232151|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
143188305|NCT00923351|516232152|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
143188306|NCT01814046|516232162|FG000|Drug Administration|Death due to complications of RSV|1|||
143188307|NCT01814046|516232163|FG001|Drug Administration|Death due to complications of RSV|0|||
143188308|NCT01814046|516232164|FG002|Drug Administration|Death due to complications of RSV|0|||
143188309|NCT00564902|516232165|FG000|Overall Study|Withdrawal by Subject|0|||
143188310|NCT00564902|516232166|FG001|Overall Study|Withdrawal by Subject|3|||
143188311|NCT00564902|516232167|FG002|Overall Study|Withdrawal by Subject|4|||
143188312|NCT00564902|516232165|FG000|Overall Study|Death|1|||
143188313|NCT00564902|516232166|FG001|Overall Study|Death|1|||
143188314|NCT00564902|516232167|FG002|Overall Study|Death|0|||
143188315|NCT02097719|516232171|FG000|Overall Study|Subject Withdrew Consent|1|||
143188316|NCT02097719|516232172|FG001|Overall Study|Subject Withdrew Consent|0|||
143188317|NCT02097719|516232171|FG000|Overall Study|Lost to Follow-up|0|||
143188318|NCT02097719|516232172|FG001|Overall Study|Lost to Follow-up|1|||
143188319|NCT02097719|516232171|FG000|Overall Study|Adverse Event|2|||
143188320|NCT02097719|516232172|FG001|Overall Study|Adverse Event|0|||
143188321|NCT01854775|516232175|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
143188322|NCT01854775|516232176|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
143188323|NCT01854775|516232177|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
143188324|NCT01854775|516232175|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
143188325|NCT01854775|516232176|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
143188326|NCT01854775|516232177|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
143188327|NCT01854775|516232175|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
143188328|NCT01854775|516232176|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
143188329|NCT01854775|516232177|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
143188330|NCT01854775|516232175|FG000|Extension Phase|Pregnancy|3|||
143188331|NCT01854775|516232176|FG001|Extension Phase|Pregnancy|0|||
143188332|NCT01854775|516232177|FG002|Extension Phase|Pregnancy|0|||
143188333|NCT01854775|516232175|FG000|Extension Phase|Investigator's Discretion|1|||
143188334|NCT01854775|516232176|FG001|Extension Phase|Investigator's Discretion|0|||
143188335|NCT01854775|516232177|FG002|Extension Phase|Investigator's Discretion|0|||
143188336|NCT01854775|516232175|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
143188337|NCT01854775|516232176|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
143188338|NCT01854775|516232177|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
143188339|NCT01854775|516232175|FG000|Extension Phase|Lost to Follow-up|2|||
143188340|NCT01854775|516232176|FG001|Extension Phase|Lost to Follow-up|0|||
143188341|NCT01854775|516232177|FG002|Extension Phase|Lost to Follow-up|0|||
143188342|NCT01854775|516232175|FG000|Extension Phase|Still on Study|32|||
143188343|NCT01854775|516232176|FG001|Extension Phase|Still on Study|47|||
143188344|NCT01854775|516232177|FG002|Extension Phase|Still on Study|18|||
143188345|NCT00984594|516232179|FG000|Overall Study|Lost to Follow-up|1|||
143188346|NCT00984594|516232180|FG001|Overall Study|Lost to Follow-up|0|||
143188347|NCT00984594|516232179|FG000|Overall Study|Withdrawal by Subject|0|||
143188348|NCT00984594|516232180|FG001|Overall Study|Withdrawal by Subject|1|||
143188349|NCT03135431|516232181|FG000|Overall Study|Study Surgeon not available|2|||
143188350|NCT03135431|516232182|FG001|Overall Study|Study Surgeon not available|0|||
143188351|NCT02597452|516232183|FG000|Overall Study|testing incomplete|30|||
143188352|NCT03122145|516232186|FG000|Overall Study|Concurrent respiratory disease|3|||
143188353|NCT03122145|516232187|FG001|Overall Study|Concurrent respiratory disease|0|||
143188354|NCT00281099|516232192|FG000|Overall Study|Death|46|||
143188355|NCT00281099|516232193|FG001|Overall Study|Death|57|||
143188356|NCT00281099|516232192|FG000|Overall Study|Lost to Follow-up|10|||
143188357|NCT00281099|516232193|FG001|Overall Study|Lost to Follow-up|19|||
143188358|NCT00281099|516232192|FG000|Overall Study|Withdrawal by Subject|65|||
143188359|NCT00281099|516232193|FG001|Overall Study|Withdrawal by Subject|70|||
143188360|NCT00281099|516232192|FG000|Overall Study|Physician Decision|79|||
143188361|NCT00281099|516232193|FG001|Overall Study|Physician Decision|72|||
143188362|NCT00281099|516232192|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
143188363|NCT00281099|516232193|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
143188364|NCT03206918|516232194|FG000|Overall Study|Death|11|||
143188365|NCT03206918|516232194|FG000|Overall Study|Withdrawal by Subject|5|||
143188366|NCT03206918|516232194|FG000|Overall Study|Study terminated by sponsor|12|||
143188367|NCT03206918|516232194|FG000|Overall Study|Lost to Follow-up|3|||
143188368|NCT03206918|516232194|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
143188369|NCT03823287|516232195|FG000|Overall Study|Withdrawal by Subject|25|||
143188370|NCT03823287|516232196|FG001|Overall Study|Withdrawal by Subject|17|||
143188371|NCT03823287|516232195|FG000|Overall Study|Death|13|||
143188372|NCT03823287|516232196|FG001|Overall Study|Death|7|||
143188373|NCT03823287|516232195|FG000|Overall Study|Lost to Follow-up|7|||
143188374|NCT03823287|516232196|FG001|Overall Study|Lost to Follow-up|8|||
143188375|NCT03823287|516232195|FG000|Overall Study|Adverse Event|6|||
143188376|NCT03823287|516232196|FG001|Overall Study|Adverse Event|8|||
143188377|NCT03823287|516232195|FG000|Overall Study|Physician Decision|5|||
143188378|NCT03823287|516232196|FG001|Overall Study|Physician Decision|2|||
143188379|NCT03823287|516232195|FG000|Overall Study|Lack of Efficacy|2|||
143188380|NCT03823287|516232196|FG001|Overall Study|Lack of Efficacy|0|||
143188381|NCT03823287|516232195|FG000|Overall Study|Other|2|||
143188382|NCT03823287|516232196|FG001|Overall Study|Other|4|||
143188383|NCT01059864|516232201|FG000|Open-Label Run-In Phase|Adverse Event|7|||
143188384|NCT01059864|516232202|FG001|Open-Label Run-In Phase|Adverse Event|0|||
143188385|NCT01059864|516232203|FG002|Open-Label Run-In Phase|Adverse Event|0|||
143188386|NCT01059864|516232201|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
143188387|NCT01059864|516232202|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
143188388|NCT01059864|516232203|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
143188389|NCT01059864|516232201|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
143188390|NCT01059864|516232202|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
143188391|NCT01059864|516232203|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
143188392|NCT01059864|516232201|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
143188393|NCT01059864|516232202|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
143188394|NCT01059864|516232203|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
143188395|NCT01059864|516232201|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
143188396|NCT01059864|516232202|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
143188397|NCT01059864|516232203|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
143188398|NCT01059864|516232201|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
143188399|NCT01059864|516232202|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
143188400|NCT01059864|516232203|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
143188401|NCT01271010|516234542|FG000|Overall Study|Reason not specified|11|||
143188402|NCT01271010|516234542|FG000|Overall Study|Start of new CLL therapy|1|||
143188403|NCT01271010|516234542|FG000|Overall Study|Protocol Violation|1|||
143188404|NCT01271010|516234542|FG000|Overall Study|Death|2|||
143188405|NCT01271010|516234542|FG000|Overall Study|Progression and relapse of disease|1|||
143188406|NCT01271010|516234542|FG000|Overall Study|Withdrawal by Subject|18|||
143188407|NCT01271010|516234542|FG000|Overall Study|Disease progression|27|||
143188408|NCT02109432|516234543|FG000|Overall Study|Withdrawal by Subject|1|||
143188409|NCT02908685|516234550|FG000|Part 1 OLE|Withdrawal by Subject|0|||
143188410|NCT02908685|516234551|FG001|Part 1 OLE|Withdrawal by Subject|0|||
143188411|NCT02908685|516234552|FG002|Part 1 OLE|Withdrawal by Subject|0|||
143188412|NCT02908685|516234553|FG003|Part 1 OLE|Withdrawal by Subject|0|||
143188413|NCT02908685|516234554|FG004|Part 1 OLE|Withdrawal by Subject|0|||
143188414|NCT02908685|516234555|FG005|Part 1 OLE|Withdrawal by Subject|0|||
143188415|NCT02908685|516234556|FG006|Part 1 OLE|Withdrawal by Subject|0|||
143188416|NCT02908685|516234557|FG007|Part 1 OLE|Withdrawal by Subject|0|||
143188417|NCT02908685|516234558|FG008|Part 1 OLE|Withdrawal by Subject|0|||
143188418|NCT02908685|516234559|FG009|Part 1 OLE|Withdrawal by Subject|0|||
143188419|NCT02908685|516234560|FG010|Part 1 OLE|Withdrawal by Subject|2|||
143188420|NCT02908685|516234561|FG011|Part 1 OLE|Withdrawal by Subject|1|||
143188421|NCT02908685|516234562|FG012|Part 1 OLE|Withdrawal by Subject|0|||
143188422|NCT02908685|516234563|FG013|Part 1 OLE|Withdrawal by Subject|0|||
143188423|NCT02908685|516234550|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
143188424|NCT02908685|516234551|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
143188425|NCT02908685|516234552|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
143188426|NCT02908685|516234553|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
143188427|NCT02908685|516234554|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
143188428|NCT02908685|516234555|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
143188429|NCT02908685|516234556|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
143188430|NCT02908685|516234557|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
143188431|NCT02908685|516234558|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
143188432|NCT02908685|516234559|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
143188433|NCT02908685|516234560|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
143188434|NCT02908685|516234561|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
143188435|NCT02908685|516234562|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
143188436|NCT02908685|516234563|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
143188437|NCT02908685|516234550|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
143188438|NCT02908685|516234551|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
143188439|NCT02908685|516234552|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
143188440|NCT02908685|516234553|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
143188441|NCT02908685|516234554|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
143188442|NCT02908685|516234555|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
143188443|NCT02908685|516234556|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
143188444|NCT02908685|516234557|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
143188445|NCT02908685|516234558|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
143188446|NCT02908685|516234559|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
143188447|NCT02908685|516234560|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
143188448|NCT02908685|516234561|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
143261443|NCT01255787|516510578|FG002|Overall Study|Lack of Efficacy|2|||
143188449|NCT02908685|516234562|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
143188450|NCT02908685|516234563|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
143188451|NCT02908685|516234550|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
143188452|NCT02908685|516234551|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
143188453|NCT02908685|516234552|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
143188454|NCT02908685|516234553|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
143188455|NCT02908685|516234554|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
143188456|NCT02908685|516234555|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
143188457|NCT02908685|516234556|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
143188458|NCT02908685|516234557|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
143188459|NCT02908685|516234558|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
143188460|NCT02908685|516234559|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
143188461|NCT02908685|516234560|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
143188462|NCT02908685|516234561|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
143188463|NCT02908685|516234562|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
143188464|NCT02908685|516234563|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
143188465|NCT02908685|516234550|FG000|Part 2 OLE: > Month 24|Death|0|||
143188466|NCT02908685|516234551|FG001|Part 2 OLE: > Month 24|Death|0|||
143188467|NCT02908685|516234552|FG002|Part 2 OLE: > Month 24|Death|0|||
143188468|NCT02908685|516234553|FG003|Part 2 OLE: > Month 24|Death|0|||
143188469|NCT02908685|516234554|FG004|Part 2 OLE: > Month 24|Death|0|||
143188470|NCT02908685|516234555|FG005|Part 2 OLE: > Month 24|Death|0|||
143188471|NCT02908685|516234556|FG006|Part 2 OLE: > Month 24|Death|0|||
143188472|NCT02908685|516234557|FG007|Part 2 OLE: > Month 24|Death|0|||
143188473|NCT02908685|516234558|FG008|Part 2 OLE: > Month 24|Death|0|||
143188474|NCT02908685|516234559|FG009|Part 2 OLE: > Month 24|Death|0|||
143188475|NCT02908685|516234560|FG010|Part 2 OLE: > Month 24|Death|0|||
143188476|NCT02908685|516234561|FG011|Part 2 OLE: > Month 24|Death|0|||
143188477|NCT02908685|516234562|FG012|Part 2 OLE: > Month 24|Death|1|||
143188478|NCT02908685|516234563|FG013|Part 2 OLE: > Month 24|Death|0|||
143188479|NCT02908685|516234550|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
143188480|NCT02908685|516234551|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
143188481|NCT02908685|516234552|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
143188482|NCT02908685|516234553|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
143188483|NCT02908685|516234554|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
143188484|NCT02908685|516234555|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
143188485|NCT02908685|516234556|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
143188486|NCT02908685|516234557|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
143188487|NCT02908685|516234558|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
143188488|NCT02908685|516234559|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
143188489|NCT02908685|516234560|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
143188490|NCT02908685|516234561|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
143188491|NCT02908685|516234562|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
143188492|NCT02908685|516234563|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
143188493|NCT02908685|516234550|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
143188494|NCT02908685|516234551|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
143188495|NCT02908685|516234552|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
143188496|NCT02908685|516234553|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
143188497|NCT02908685|516234554|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
143188498|NCT02908685|516234555|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
143188499|NCT02908685|516234556|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
143188500|NCT02908685|516234557|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
143188501|NCT02908685|516234558|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
143188502|NCT02908685|516234559|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
143188503|NCT02908685|516234560|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
143188504|NCT02908685|516234561|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
143188505|NCT02908685|516234562|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
143188506|NCT02908685|516234563|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
143188507|NCT02954406|516234564|FG000|Overall Study|Adverse Event|0|||
143188508|NCT02954406|516234565|FG001|Overall Study|Adverse Event|1|||
143369492|NCT04107805|516896134|FG006|Overall Study|Adverse Event|0|||
143369493|NCT04107805|516896135|FG007|Overall Study|Adverse Event|0|||
143188509|NCT02954406|516234566|FG002|Overall Study|Adverse Event|0|||
143188510|NCT02954406|516234567|FG003|Overall Study|Adverse Event|0|||
143369494|NCT04107805|516896136|FG008|Overall Study|Adverse Event|1|||
143369495|NCT01191086|516896141|FG000|Overall Study|Adverse Event|20|||
143188511|NCT02954406|516234568|FG004|Overall Study|Adverse Event|1|||
143188512|NCT02954406|516234569|FG005|Overall Study|Adverse Event|0|||
143188513|NCT02954406|516234570|FG006|Overall Study|Adverse Event|0|||
143188514|NCT02954406|516234571|FG007|Overall Study|Adverse Event|0|||
143188515|NCT02954406|516234572|FG008|Overall Study|Adverse Event|1|||
143188516|NCT02954406|516234573|FG009|Overall Study|Adverse Event|1|||
143188517|NCT02954406|516234574|FG010|Overall Study|Adverse Event|0|||
143369496|NCT01191086|516896141|FG000|Overall Study|Lack of Efficacy|10|||
143188518|NCT02954406|516234564|FG000|Overall Study|Progressive Disease|3|||
143188519|NCT02954406|516234565|FG001|Overall Study|Progressive Disease|4|||
143188520|NCT02954406|516234566|FG002|Overall Study|Progressive Disease|3|||
143188521|NCT02954406|516234567|FG003|Overall Study|Progressive Disease|4|||
143188522|NCT02954406|516234568|FG004|Overall Study|Progressive Disease|3|||
143188523|NCT02954406|516234569|FG005|Overall Study|Progressive Disease|3|||
143188524|NCT02954406|516234570|FG006|Overall Study|Progressive Disease|2|||
143188525|NCT02954406|516234571|FG007|Overall Study|Progressive Disease|2|||
143188526|NCT02954406|516234572|FG008|Overall Study|Progressive Disease|1|||
143188527|NCT02954406|516234573|FG009|Overall Study|Progressive Disease|1|||
143188528|NCT02954406|516234574|FG010|Overall Study|Progressive Disease|0|||
143188529|NCT02954406|516234564|FG000|Overall Study|Symptomatic Deterioration|0|||
143188530|NCT02954406|516234565|FG001|Overall Study|Symptomatic Deterioration|1|||
143188531|NCT02954406|516234566|FG002|Overall Study|Symptomatic Deterioration|0|||
143188532|NCT02954406|516234567|FG003|Overall Study|Symptomatic Deterioration|0|||
143188533|NCT02954406|516234568|FG004|Overall Study|Symptomatic Deterioration|0|||
143188534|NCT02954406|516234569|FG005|Overall Study|Symptomatic Deterioration|0|||
143188535|NCT02954406|516234570|FG006|Overall Study|Symptomatic Deterioration|0|||
143188536|NCT02954406|516234571|FG007|Overall Study|Symptomatic Deterioration|0|||
143188537|NCT02954406|516234572|FG008|Overall Study|Symptomatic Deterioration|0|||
143188538|NCT02954406|516234573|FG009|Overall Study|Symptomatic Deterioration|0|||
143188539|NCT02954406|516234574|FG010|Overall Study|Symptomatic Deterioration|0|||
143188540|NCT02954406|516234564|FG000|Overall Study|Death|0|||
143188541|NCT02954406|516234565|FG001|Overall Study|Death|0|||
143188542|NCT02954406|516234566|FG002|Overall Study|Death|0|||
143188543|NCT02954406|516234567|FG003|Overall Study|Death|0|||
143188544|NCT02954406|516234568|FG004|Overall Study|Death|1|||
143188545|NCT02954406|516234569|FG005|Overall Study|Death|0|||
143188546|NCT02954406|516234570|FG006|Overall Study|Death|0|||
143188547|NCT02954406|516234571|FG007|Overall Study|Death|0|||
143369497|NCT01191086|516896141|FG000|Overall Study|Lost to Follow-up|4|||
143188548|NCT02954406|516234572|FG008|Overall Study|Death|1|||
143188549|NCT02954406|516234573|FG009|Overall Study|Death|1|||
143188550|NCT02954406|516234574|FG010|Overall Study|Death|0|||
143188551|NCT02954406|516234564|FG000|Overall Study|Reason Not Specified|0|||
143188552|NCT02954406|516234565|FG001|Overall Study|Reason Not Specified|0|||
143188553|NCT02954406|516234566|FG002|Overall Study|Reason Not Specified|3|||
143188554|NCT02954406|516234567|FG003|Overall Study|Reason Not Specified|2|||
143188555|NCT02954406|516234568|FG004|Overall Study|Reason Not Specified|2|||
143188556|NCT02954406|516234569|FG005|Overall Study|Reason Not Specified|0|||
143188557|NCT02954406|516234570|FG006|Overall Study|Reason Not Specified|1|||
143188558|NCT02954406|516234571|FG007|Overall Study|Reason Not Specified|0|||
143188559|NCT02954406|516234572|FG008|Overall Study|Reason Not Specified|1|||
143188560|NCT02954406|516234573|FG009|Overall Study|Reason Not Specified|0|||
143188561|NCT02954406|516234574|FG010|Overall Study|Reason Not Specified|0|||
143188562|NCT00782171|516234576|FG000|Overall Study|Lost to Follow-up|2|||
143188563|NCT00782171|516234577|FG001|Overall Study|Lost to Follow-up|2|||
143188564|NCT00782171|516234576|FG000|Overall Study|Withdrawal by Subject|2|||
143188565|NCT00782171|516234577|FG001|Overall Study|Withdrawal by Subject|1|||
143188566|NCT00782171|516234576|FG000|Overall Study|complications|3|||
143188567|NCT00782171|516234577|FG001|Overall Study|complications|1|||
143188568|NCT00782171|516234576|FG000|Overall Study|others|7|||
143188569|NCT00782171|516234577|FG001|Overall Study|others|9|||
143188570|NCT00782171|516234576|FG000|Overall Study|not eligible|8|||
143188571|NCT00782171|516234577|FG001|Overall Study|not eligible|6|||
143188572|NCT01691014|516234578|FG000|Overall Study|Premature Termination|1|||
143188573|NCT01691014|516234579|FG001|Overall Study|Premature Termination|6|||
143188574|NCT01691014|516234580|FG002|Overall Study|Premature Termination|0|||
143188575|NCT01691014|516234581|FG003|Overall Study|Premature Termination|3|||
143188576|NCT01691014|516234578|FG000|Overall Study|Other|0|||
143188577|NCT01691014|516234579|FG001|Overall Study|Other|0|||
143188578|NCT01691014|516234580|FG002|Overall Study|Other|2|||
143188579|NCT01691014|516234581|FG003|Overall Study|Other|0|||
143188580|NCT01691014|516234578|FG000|Overall Study|Withdrawal by Subject|0|||
143188581|NCT01691014|516234579|FG001|Overall Study|Withdrawal by Subject|1|||
143188582|NCT01691014|516234580|FG002|Overall Study|Withdrawal by Subject|1|||
143188583|NCT01691014|516234581|FG003|Overall Study|Withdrawal by Subject|1|||
143188584|NCT01691014|516234578|FG000|Overall Study|Adverse Event|0|||
143188585|NCT01691014|516234579|FG001|Overall Study|Adverse Event|5|||
143188586|NCT01691014|516234580|FG002|Overall Study|Adverse Event|1|||
143188587|NCT01691014|516234581|FG003|Overall Study|Adverse Event|1|||
143188588|NCT01691014|516234578|FG000|Overall Study|Lack of Efficacy|2|||
143188589|NCT01691014|516234579|FG001|Overall Study|Lack of Efficacy|3|||
143188590|NCT01691014|516234580|FG002|Overall Study|Lack of Efficacy|7|||
143188591|NCT01691014|516234581|FG003|Overall Study|Lack of Efficacy|0|||
143188592|NCT03372551|516234582|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
143188593|NCT03372551|516234583|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
143188594|NCT03522246|516234590|FG000|Overall Study|Ongoing in Long-Term Follow-up (Alive)|184|||
143188595|NCT03522246|516234591|FG001|Overall Study|Ongoing in Long-Term Follow-up (Alive)|194|||
143188596|NCT03522246|516234592|FG002|Overall Study|Ongoing in Long-Term Follow-up (Alive)|46|||
143188597|NCT03522246|516234593|FG003|Overall Study|Ongoing in Long-Term Follow-up (Alive)|45|||
143188598|NCT03522246|516234594|FG004|Overall Study|Ongoing in Long-Term Follow-up (Alive)|0|||
143188599|NCT04299308|516234595|FG000|Overall Study|Withdrawal by Subject|1|||
143188600|NCT04299308|516234596|FG001|Overall Study|Withdrawal by Subject|0|||
143188601|NCT04299308|516234595|FG000|Overall Study|issue with PET image (1)|1|||
143188602|NCT04299308|516234596|FG001|Overall Study|issue with PET image (1)|0|||
143188603|NCT00814580|516234597|FG000|Overall Study|Adverse Event|6|||
143188604|NCT00814580|516234598|FG001|Overall Study|Adverse Event|15|||
143188605|NCT00814580|516234597|FG000|Overall Study|Lack of Efficacy|18|||
143188606|NCT00814580|516234598|FG001|Overall Study|Lack of Efficacy|25|||
143188607|NCT00814580|516234597|FG000|Overall Study|Protocol Violation|2|||
143188608|NCT00814580|516234598|FG001|Overall Study|Protocol Violation|0|||
143188609|NCT00814580|516234597|FG000|Overall Study|Withdrawal by Subject|2|||
143188610|NCT00814580|516234598|FG001|Overall Study|Withdrawal by Subject|2|||
143188611|NCT00814580|516234597|FG000|Overall Study|Other|1|||
143188612|NCT00814580|516234598|FG001|Overall Study|Other|3|||
143188613|NCT00814580|516234597|FG000|Overall Study|Did Not Take Drug|2|||
143188614|NCT00814580|516234598|FG001|Overall Study|Did Not Take Drug|2|||
143188615|NCT02920528|516234601|FG000|Overall Study|Incomplete Data|1|||
143188616|NCT02920528|516234602|FG001|Overall Study|Incomplete Data|1|||
143188617|NCT02920528|516234603|FG002|Overall Study|Incomplete Data|1|||
143188618|NCT02920528|516234601|FG000|Overall Study|Adverse Event|0|||
143188619|NCT02920528|516234602|FG001|Overall Study|Adverse Event|0|||
143188620|NCT02920528|516234603|FG002|Overall Study|Adverse Event|3|||
143188621|NCT02920528|516234601|FG000|Overall Study|Did not meet inclusion criteria|2|||
143188622|NCT02920528|516234602|FG001|Overall Study|Did not meet inclusion criteria|0|||
143188623|NCT02920528|516234603|FG002|Overall Study|Did not meet inclusion criteria|1|||
143188624|NCT01340625|516234604|FG000|First Intervention|Adverse Event|1|||
143188625|NCT01340625|516234605|FG001|First Intervention|Adverse Event|0|||
143188626|NCT01340625|516234604|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
143188627|NCT01340625|516234605|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
143188628|NCT05924165|516234606|FG000|Overall Study|Physician Decision|2|||
143188629|NCT05924165|516234607|FG001|Overall Study|Physician Decision|3|||
143188630|NCT05160415|516234608|FG000|Overall Study|Withdrawal by Subject|3|||
143188631|NCT04308239|516234615|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
143188632|NCT04308239|516234616|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
143188633|NCT04308239|516234615|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
143188634|NCT04308239|516234616|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
143188635|NCT04308239|516234615|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
143188636|NCT04308239|516234616|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
143188637|NCT04308239|516234615|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
143188638|NCT04308239|516234616|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
143188639|NCT01986231|516234617|FG000|Overall Study|Adverse Event|1|||
143188640|NCT00489424|516234620|FG000|Overall Study|Adverse Event|3|||
143188641|NCT00489424|516234621|FG001|Overall Study|Adverse Event|3|||
143188642|NCT00489424|516234622|FG002|Overall Study|Adverse Event|4|||
143188643|NCT00489424|516234620|FG000|Overall Study|Lack of Efficacy|1|||
143188644|NCT00489424|516234621|FG001|Overall Study|Lack of Efficacy|0|||
143188645|NCT00489424|516234622|FG002|Overall Study|Lack of Efficacy|0|||
143188646|NCT00489424|516234620|FG000|Overall Study|Administrative problems|0|||
143188647|NCT00489424|516234621|FG001|Overall Study|Administrative problems|2|||
143188648|NCT00489424|516234622|FG002|Overall Study|Administrative problems|1|||
143188649|NCT01436656|516234623|FG000|Dose Escalation|Death|1|||
143188650|NCT01436656|516234624|FG001|Dose Escalation|Death|3|||
143188651|NCT01436656|516234625|FG002|Dose Escalation|Death|1|||
143188652|NCT01436656|516234626|FG003|Dose Escalation|Death|0|||
143188653|NCT01436656|516234627|FG004|Dose Escalation|Death|2|||
143188654|NCT01436656|516234628|FG005|Dose Escalation|Death|1|||
143188655|NCT01436656|516234629|FG006|Dose Escalation|Death|1|||
143188656|NCT01436656|516234630|FG007|Dose Escalation|Death|1|||
143188657|NCT01436656|516234631|FG008|Dose Escalation|Death|1|||
143188658|NCT01436656|516234632|FG009|Dose Escalation|Death|0|||
143188659|NCT01436656|516234633|FG010|Dose Escalation|Death|0|||
143188660|NCT01436656|516234634|FG011|Dose Escalation|Death|0|||
143188661|NCT01436656|516234635|FG012|Dose Escalation|Death|0|||
143188662|NCT01436656|516234636|FG013|Dose Escalation|Death|0|||
143188663|NCT01436656|516234637|FG014|Dose Escalation|Death|0|||
143261444|NCT01255787|516510579|FG003|Overall Study|Lack of Efficacy|2|||
143261445|NCT01255787|516510576|FG000|Overall Study|Noncompliance with Study Drug|3|||
143261446|NCT01255787|516510577|FG001|Overall Study|Noncompliance with Study Drug|1|||
143261447|NCT01255787|516510578|FG002|Overall Study|Noncompliance with Study Drug|0|||
143261448|NCT01255787|516510579|FG003|Overall Study|Noncompliance with Study Drug|0|||
143261449|NCT04966741|516510581|FG000|Overall Study|Lost to Follow-up|1|||
143261450|NCT04966741|516510582|FG001|Overall Study|Lost to Follow-up|0|||
143261451|NCT01582854|516510585|FG000|Overall Study|Death|8|||
143188664|NCT01436656|516234638|FG015|Dose Escalation|Death|0|||
143188665|NCT01436656|516234639|FG016|Dose Escalation|Death|0|||
143188666|NCT01436656|516234640|FG017|Dose Escalation|Death|0|||
143188667|NCT01436656|516234623|FG000|Dose Escalation|Protocol Violation|0|||
143188668|NCT01436656|516234624|FG001|Dose Escalation|Protocol Violation|0|||
143188669|NCT01436656|516234625|FG002|Dose Escalation|Protocol Violation|0|||
143188670|NCT01436656|516234626|FG003|Dose Escalation|Protocol Violation|0|||
143188671|NCT01436656|516234627|FG004|Dose Escalation|Protocol Violation|0|||
143188672|NCT01436656|516234628|FG005|Dose Escalation|Protocol Violation|1|||
143188673|NCT01436656|516234629|FG006|Dose Escalation|Protocol Violation|0|||
143188674|NCT01436656|516234630|FG007|Dose Escalation|Protocol Violation|0|||
143188675|NCT01436656|516234631|FG008|Dose Escalation|Protocol Violation|0|||
143188676|NCT01436656|516234632|FG009|Dose Escalation|Protocol Violation|0|||
143188677|NCT01436656|516234633|FG010|Dose Escalation|Protocol Violation|0|||
143188678|NCT01436656|516234634|FG011|Dose Escalation|Protocol Violation|0|||
143188679|NCT01436656|516234635|FG012|Dose Escalation|Protocol Violation|0|||
143261452|NCT01582854|516510586|FG001|Overall Study|Death|5|||
143369498|NCT01191086|516896141|FG000|Overall Study|Physician Decision|2|||
143188680|NCT01436656|516234636|FG013|Dose Escalation|Protocol Violation|0|||
143188681|NCT01436656|516234637|FG014|Dose Escalation|Protocol Violation|0|||
143188682|NCT01436656|516234638|FG015|Dose Escalation|Protocol Violation|0|||
143188683|NCT01436656|516234639|FG016|Dose Escalation|Protocol Violation|0|||
143188684|NCT01436656|516234640|FG017|Dose Escalation|Protocol Violation|0|||
143188685|NCT01436656|516234623|FG000|Dose Escalation|Withdrawal by Subject|0|||
143188686|NCT01436656|516234624|FG001|Dose Escalation|Withdrawal by Subject|0|||
143188687|NCT01436656|516234625|FG002|Dose Escalation|Withdrawal by Subject|0|||
143188688|NCT01436656|516234626|FG003|Dose Escalation|Withdrawal by Subject|0|||
143188689|NCT01436656|516234627|FG004|Dose Escalation|Withdrawal by Subject|1|||
143188690|NCT01436656|516234628|FG005|Dose Escalation|Withdrawal by Subject|0|||
143369499|NCT01191086|516896141|FG000|Overall Study|Withdrawal by Subject|24|||
143188691|NCT01436656|516234629|FG006|Dose Escalation|Withdrawal by Subject|0|||
143188692|NCT01436656|516234630|FG007|Dose Escalation|Withdrawal by Subject|2|||
143188693|NCT01436656|516234631|FG008|Dose Escalation|Withdrawal by Subject|0|||
143188694|NCT01436656|516234632|FG009|Dose Escalation|Withdrawal by Subject|1|||
143188695|NCT01436656|516234633|FG010|Dose Escalation|Withdrawal by Subject|1|||
143188696|NCT01436656|516234634|FG011|Dose Escalation|Withdrawal by Subject|0|||
143188697|NCT01436656|516234635|FG012|Dose Escalation|Withdrawal by Subject|0|||
143188698|NCT01436656|516234636|FG013|Dose Escalation|Withdrawal by Subject|0|||
143188699|NCT01436656|516234637|FG014|Dose Escalation|Withdrawal by Subject|0|||
143188700|NCT01436656|516234638|FG015|Dose Escalation|Withdrawal by Subject|0|||
143188701|NCT01436656|516234639|FG016|Dose Escalation|Withdrawal by Subject|0|||
143188702|NCT01436656|516234640|FG017|Dose Escalation|Withdrawal by Subject|0|||
143188703|NCT01436656|516234623|FG000|Dose Escalation|Administrative problems|0|||
143188704|NCT01436656|516234624|FG001|Dose Escalation|Administrative problems|1|||
143188705|NCT01436656|516234625|FG002|Dose Escalation|Administrative problems|0|||
143188706|NCT01436656|516234626|FG003|Dose Escalation|Administrative problems|0|||
143188707|NCT01436656|516234627|FG004|Dose Escalation|Administrative problems|0|||
143188708|NCT01436656|516234628|FG005|Dose Escalation|Administrative problems|0|||
143188709|NCT01436656|516234629|FG006|Dose Escalation|Administrative problems|0|||
143188710|NCT01436656|516234630|FG007|Dose Escalation|Administrative problems|0|||
143188711|NCT01436656|516234631|FG008|Dose Escalation|Administrative problems|0|||
143188712|NCT01436656|516234632|FG009|Dose Escalation|Administrative problems|0|||
143188713|NCT01436656|516234633|FG010|Dose Escalation|Administrative problems|0|||
143188714|NCT01436656|516234634|FG011|Dose Escalation|Administrative problems|0|||
143188715|NCT01436656|516234635|FG012|Dose Escalation|Administrative problems|0|||
143188716|NCT01436656|516234636|FG013|Dose Escalation|Administrative problems|0|||
143188717|NCT01436656|516234637|FG014|Dose Escalation|Administrative problems|0|||
143188718|NCT01436656|516234638|FG015|Dose Escalation|Administrative problems|0|||
143261453|NCT01582854|516510585|FG000|Overall Study|Adverse Event|2|||
143261454|NCT01582854|516510586|FG001|Overall Study|Adverse Event|3|||
143188719|NCT01436656|516234639|FG016|Dose Escalation|Administrative problems|0|||
143188720|NCT01436656|516234640|FG017|Dose Escalation|Administrative problems|0|||
143188721|NCT01436656|516234623|FG000|Dose Escalation|Lost to Follow-up|1|||
143188722|NCT01436656|516234624|FG001|Dose Escalation|Lost to Follow-up|0|||
143188723|NCT01436656|516234625|FG002|Dose Escalation|Lost to Follow-up|0|||
143188724|NCT01436656|516234626|FG003|Dose Escalation|Lost to Follow-up|0|||
143261455|NCT01582854|516510585|FG000|Overall Study|Withdrawal by Participant|8|||
143188725|NCT01436656|516234627|FG004|Dose Escalation|Lost to Follow-up|1|||
143188726|NCT01436656|516234628|FG005|Dose Escalation|Lost to Follow-up|0|||
143188727|NCT01436656|516234629|FG006|Dose Escalation|Lost to Follow-up|0|||
143188728|NCT01436656|516234630|FG007|Dose Escalation|Lost to Follow-up|0|||
143188729|NCT01436656|516234631|FG008|Dose Escalation|Lost to Follow-up|0|||
143188730|NCT01436656|516234632|FG009|Dose Escalation|Lost to Follow-up|0|||
143188731|NCT01436656|516234633|FG010|Dose Escalation|Lost to Follow-up|0|||
143188732|NCT01436656|516234634|FG011|Dose Escalation|Lost to Follow-up|0|||
143188733|NCT01436656|516234635|FG012|Dose Escalation|Lost to Follow-up|0|||
143188734|NCT01436656|516234636|FG013|Dose Escalation|Lost to Follow-up|0|||
143188735|NCT01436656|516234637|FG014|Dose Escalation|Lost to Follow-up|0|||
143188736|NCT01436656|516234638|FG015|Dose Escalation|Lost to Follow-up|0|||
143188737|NCT01436656|516234639|FG016|Dose Escalation|Lost to Follow-up|0|||
143188738|NCT01436656|516234640|FG017|Dose Escalation|Lost to Follow-up|0|||
143188739|NCT01436656|516234623|FG000|Dose Escalation|New anti-cancer therapy|1|||
143188740|NCT01436656|516234624|FG001|Dose Escalation|New anti-cancer therapy|0|||
143188741|NCT01436656|516234625|FG002|Dose Escalation|New anti-cancer therapy|0|||
143188742|NCT01436656|516234626|FG003|Dose Escalation|New anti-cancer therapy|0|||
143188743|NCT01436656|516234627|FG004|Dose Escalation|New anti-cancer therapy|0|||
143188744|NCT01436656|516234628|FG005|Dose Escalation|New anti-cancer therapy|0|||
143188745|NCT01436656|516234629|FG006|Dose Escalation|New anti-cancer therapy|0|||
143188746|NCT01436656|516234630|FG007|Dose Escalation|New anti-cancer therapy|0|||
143188747|NCT01436656|516234631|FG008|Dose Escalation|New anti-cancer therapy|1|||
143188748|NCT01436656|516234632|FG009|Dose Escalation|New anti-cancer therapy|1|||
143188749|NCT01436656|516234633|FG010|Dose Escalation|New anti-cancer therapy|0|||
143188750|NCT01436656|516234634|FG011|Dose Escalation|New anti-cancer therapy|0|||
143188751|NCT01436656|516234635|FG012|Dose Escalation|New anti-cancer therapy|0|||
143188752|NCT01436656|516234636|FG013|Dose Escalation|New anti-cancer therapy|0|||
143188753|NCT01436656|516234637|FG014|Dose Escalation|New anti-cancer therapy|0|||
143188754|NCT01436656|516234638|FG015|Dose Escalation|New anti-cancer therapy|0|||
143188755|NCT01436656|516234639|FG016|Dose Escalation|New anti-cancer therapy|0|||
143188756|NCT01436656|516234640|FG017|Dose Escalation|New anti-cancer therapy|0|||
143188757|NCT01436656|516234623|FG000|Dose Expansion|Adverse Event|0|||
143188758|NCT01436656|516234624|FG001|Dose Expansion|Adverse Event|0|||
143188759|NCT01436656|516234625|FG002|Dose Expansion|Adverse Event|0|||
143188760|NCT01436656|516234626|FG003|Dose Expansion|Adverse Event|0|||
143188761|NCT01436656|516234627|FG004|Dose Expansion|Adverse Event|0|||
143188762|NCT01436656|516234628|FG005|Dose Expansion|Adverse Event|0|||
143188763|NCT01436656|516234629|FG006|Dose Expansion|Adverse Event|0|||
143188764|NCT01436656|516234630|FG007|Dose Expansion|Adverse Event|0|||
143188765|NCT01436656|516234631|FG008|Dose Expansion|Adverse Event|0|||
143188766|NCT01436656|516234632|FG009|Dose Expansion|Adverse Event|0|||
143188767|NCT01436656|516234633|FG010|Dose Expansion|Adverse Event|0|||
143188768|NCT01436656|516234634|FG011|Dose Expansion|Adverse Event|1|||
143188769|NCT01436656|516234635|FG012|Dose Expansion|Adverse Event|0|||
143188770|NCT01436656|516234636|FG013|Dose Expansion|Adverse Event|0|||
143188771|NCT01436656|516234637|FG014|Dose Expansion|Adverse Event|0|||
143188772|NCT01436656|516234638|FG015|Dose Expansion|Adverse Event|0|||
143188773|NCT01436656|516234639|FG016|Dose Expansion|Adverse Event|0|||
143188774|NCT01436656|516234640|FG017|Dose Expansion|Adverse Event|0|||
143188775|NCT01436656|516234623|FG000|Dose Expansion|Withdrawal by Subject|0|||
143188776|NCT01436656|516234624|FG001|Dose Expansion|Withdrawal by Subject|0|||
143188777|NCT01436656|516234625|FG002|Dose Expansion|Withdrawal by Subject|0|||
143188778|NCT01436656|516234626|FG003|Dose Expansion|Withdrawal by Subject|0|||
143188779|NCT01436656|516234627|FG004|Dose Expansion|Withdrawal by Subject|0|||
143188780|NCT01436656|516234628|FG005|Dose Expansion|Withdrawal by Subject|0|||
143188781|NCT01436656|516234629|FG006|Dose Expansion|Withdrawal by Subject|0|||
143188782|NCT01436656|516234630|FG007|Dose Expansion|Withdrawal by Subject|0|||
143188783|NCT01436656|516234631|FG008|Dose Expansion|Withdrawal by Subject|0|||
143188784|NCT01436656|516234632|FG009|Dose Expansion|Withdrawal by Subject|0|||
143188785|NCT01436656|516234633|FG010|Dose Expansion|Withdrawal by Subject|0|||
143188786|NCT01436656|516234634|FG011|Dose Expansion|Withdrawal by Subject|1|||
143188787|NCT01436656|516234635|FG012|Dose Expansion|Withdrawal by Subject|3|||
143188788|NCT01436656|516234636|FG013|Dose Expansion|Withdrawal by Subject|1|||
143188789|NCT01436656|516234637|FG014|Dose Expansion|Withdrawal by Subject|2|||
143188790|NCT01436656|516234638|FG015|Dose Expansion|Withdrawal by Subject|0|||
143188791|NCT01436656|516234639|FG016|Dose Expansion|Withdrawal by Subject|1|||
143188792|NCT01436656|516234640|FG017|Dose Expansion|Withdrawal by Subject|1|||
143188793|NCT01436656|516234623|FG000|Dose Expansion|Death|0|||
143188794|NCT01436656|516234624|FG001|Dose Expansion|Death|0|||
143188795|NCT01436656|516234625|FG002|Dose Expansion|Death|0|||
143188796|NCT01436656|516234626|FG003|Dose Expansion|Death|0|||
143188797|NCT01436656|516234627|FG004|Dose Expansion|Death|0|||
143188798|NCT01436656|516234628|FG005|Dose Expansion|Death|0|||
143188799|NCT01436656|516234629|FG006|Dose Expansion|Death|0|||
143188800|NCT01436656|516234630|FG007|Dose Expansion|Death|0|||
143188801|NCT01436656|516234631|FG008|Dose Expansion|Death|0|||
143188802|NCT01436656|516234632|FG009|Dose Expansion|Death|0|||
143188803|NCT01436656|516234633|FG010|Dose Expansion|Death|0|||
143188804|NCT01436656|516234634|FG011|Dose Expansion|Death|0|||
143188805|NCT01436656|516234635|FG012|Dose Expansion|Death|1|||
143188806|NCT01436656|516234636|FG013|Dose Expansion|Death|0|||
143188807|NCT01436656|516234637|FG014|Dose Expansion|Death|3|||
143188808|NCT01436656|516234638|FG015|Dose Expansion|Death|0|||
143188809|NCT01436656|516234639|FG016|Dose Expansion|Death|3|||
143188810|NCT01436656|516234640|FG017|Dose Expansion|Death|3|||
143188811|NCT01436656|516234623|FG000|Dose Expansion|Lost to Follow-up|0|||
143188812|NCT01436656|516234624|FG001|Dose Expansion|Lost to Follow-up|0|||
143188813|NCT01436656|516234625|FG002|Dose Expansion|Lost to Follow-up|0|||
143188814|NCT01436656|516234626|FG003|Dose Expansion|Lost to Follow-up|0|||
143188815|NCT01436656|516234627|FG004|Dose Expansion|Lost to Follow-up|0|||
143188816|NCT01436656|516234628|FG005|Dose Expansion|Lost to Follow-up|0|||
143188817|NCT01436656|516234629|FG006|Dose Expansion|Lost to Follow-up|0|||
143188818|NCT01436656|516234630|FG007|Dose Expansion|Lost to Follow-up|0|||
143188819|NCT01436656|516234631|FG008|Dose Expansion|Lost to Follow-up|0|||
143188820|NCT01436656|516234632|FG009|Dose Expansion|Lost to Follow-up|0|||
143188821|NCT01436656|516234633|FG010|Dose Expansion|Lost to Follow-up|0|||
143188822|NCT01436656|516234634|FG011|Dose Expansion|Lost to Follow-up|0|||
143188823|NCT01436656|516234635|FG012|Dose Expansion|Lost to Follow-up|0|||
143188824|NCT01436656|516234636|FG013|Dose Expansion|Lost to Follow-up|0|||
143188825|NCT01436656|516234637|FG014|Dose Expansion|Lost to Follow-up|0|||
143188826|NCT01436656|516234638|FG015|Dose Expansion|Lost to Follow-up|0|||
143188827|NCT01436656|516234639|FG016|Dose Expansion|Lost to Follow-up|0|||
143188828|NCT01436656|516234640|FG017|Dose Expansion|Lost to Follow-up|3|||
143188829|NCT01436656|516234623|FG000|Dose Expansion|Disease progression|0|||
143188830|NCT01436656|516234624|FG001|Dose Expansion|Disease progression|0|||
143188831|NCT01436656|516234625|FG002|Dose Expansion|Disease progression|0|||
143188832|NCT01436656|516234626|FG003|Dose Expansion|Disease progression|0|||
143188833|NCT01436656|516234627|FG004|Dose Expansion|Disease progression|0|||
143188834|NCT01436656|516234628|FG005|Dose Expansion|Disease progression|0|||
143188835|NCT01436656|516234629|FG006|Dose Expansion|Disease progression|0|||
143188836|NCT01436656|516234630|FG007|Dose Expansion|Disease progression|0|||
143188837|NCT01436656|516234631|FG008|Dose Expansion|Disease progression|0|||
143188838|NCT01436656|516234632|FG009|Dose Expansion|Disease progression|0|||
143188839|NCT01436656|516234633|FG010|Dose Expansion|Disease progression|0|||
143188840|NCT01436656|516234634|FG011|Dose Expansion|Disease progression|3|||
143188841|NCT01436656|516234635|FG012|Dose Expansion|Disease progression|1|||
143188842|NCT01436656|516234636|FG013|Dose Expansion|Disease progression|0|||
143188843|NCT01436656|516234637|FG014|Dose Expansion|Disease progression|1|||
143188844|NCT01436656|516234638|FG015|Dose Expansion|Disease progression|0|||
143188845|NCT01436656|516234639|FG016|Dose Expansion|Disease progression|0|||
143188846|NCT01436656|516234640|FG017|Dose Expansion|Disease progression|1|||
143188847|NCT01436656|516234623|FG000|Dose Expansion|New cancer therapy|0|||
143188848|NCT01436656|516234624|FG001|Dose Expansion|New cancer therapy|0|||
143188849|NCT01436656|516234625|FG002|Dose Expansion|New cancer therapy|0|||
143188850|NCT01436656|516234626|FG003|Dose Expansion|New cancer therapy|0|||
143188851|NCT01436656|516234627|FG004|Dose Expansion|New cancer therapy|0|||
143188852|NCT01436656|516234628|FG005|Dose Expansion|New cancer therapy|0|||
143188853|NCT01436656|516234629|FG006|Dose Expansion|New cancer therapy|0|||
143188854|NCT01436656|516234630|FG007|Dose Expansion|New cancer therapy|0|||
143188855|NCT01436656|516234631|FG008|Dose Expansion|New cancer therapy|0|||
143188856|NCT01436656|516234632|FG009|Dose Expansion|New cancer therapy|0|||
143188857|NCT01436656|516234633|FG010|Dose Expansion|New cancer therapy|0|||
143188858|NCT01436656|516234634|FG011|Dose Expansion|New cancer therapy|1|||
143188859|NCT01436656|516234635|FG012|Dose Expansion|New cancer therapy|1|||
143188860|NCT01436656|516234636|FG013|Dose Expansion|New cancer therapy|0|||
143188861|NCT01436656|516234637|FG014|Dose Expansion|New cancer therapy|2|||
143188862|NCT01436656|516234638|FG015|Dose Expansion|New cancer therapy|0|||
143188863|NCT01436656|516234639|FG016|Dose Expansion|New cancer therapy|0|||
143188864|NCT01436656|516234640|FG017|Dose Expansion|New cancer therapy|0|||
143188865|NCT02120781|516234650|FG000|Overall Study|Physician Decision|2|||
143188866|NCT02120781|516234651|FG001|Overall Study|Physician Decision|0|||
143188867|NCT02120781|516234650|FG000|Overall Study|Completion not documented|2|||
143188868|NCT02120781|516234651|FG001|Overall Study|Completion not documented|1|||
143188869|NCT00654745|516234654|FG000|Overall Study|Adverse Event|12|||
143188870|NCT00654745|516234654|FG000|Overall Study|Lost to Follow-up|7|||
143188871|NCT00654745|516234654|FG000|Overall Study|Protocol Violation|11|||
143188872|NCT00654745|516234654|FG000|Overall Study|Withdrawal by Subject|10|||
143188873|NCT00654745|516234654|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
143188874|NCT00748618|516234655|FG000|Overall Study|Adverse Event|1|||
143188875|NCT00748618|516234656|FG001|Overall Study|Adverse Event|0|||
143188876|NCT00466947|516234657|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
143188877|NCT00466947|516234658|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
143188878|NCT00466947|516234657|FG000|Study End Analysis Period|Adverse Event|35|||
143188879|NCT00466947|516234658|FG001|Study End Analysis Period|Adverse Event|43|||
143188880|NCT00466947|516234657|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
143188881|NCT00466947|516234658|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
143188882|NCT00466947|516234657|FG000|Study End Analysis Period|Physician Decision|29|||
143188883|NCT00466947|516234658|FG001|Study End Analysis Period|Physician Decision|29|||
143188884|NCT00466947|516234657|FG000|Study End Analysis Period|Protocol Violation|9|||
143188885|NCT00466947|516234658|FG001|Study End Analysis Period|Protocol Violation|17|||
143188886|NCT00466947|516234657|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
143188887|NCT00466947|516234658|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
143188888|NCT00466947|516234657|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
143188889|NCT00466947|516234658|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
143188890|NCT00466947|516234657|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
143188891|NCT00466947|516234658|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
143188892|NCT00466947|516234657|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
143188893|NCT00466947|516234658|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
143188894|NCT03286543|516234661|FG000|Consented|Screen failure before randomization|2|||
143188895|NCT03286543|516234662|FG001|Consented|Screen failure before randomization|0|||
143188896|NCT03286543|516234663|FG002|Consented|Screen failure before randomization|0|||
143188897|NCT03286543|516234661|FG000|Consented|Screen failure before enrollment|4|||
143188898|NCT03286543|516234662|FG001|Consented|Screen failure before enrollment|0|||
143188899|NCT03286543|516234663|FG002|Consented|Screen failure before enrollment|0|||
143188900|NCT03286543|516234661|FG000|Consented|TKA cancelled after enrollment|1|||
143188901|NCT03286543|516234662|FG001|Consented|TKA cancelled after enrollment|0|||
143188902|NCT03286543|516234663|FG002|Consented|TKA cancelled after enrollment|0|||
143188903|NCT03286543|516234661|FG000|Consented|Withdrawn from study|12|||
143188904|NCT03286543|516234662|FG001|Consented|Withdrawn from study|0|||
143188905|NCT03286543|516234663|FG002|Consented|Withdrawn from study|0|||
143188906|NCT03286543|516234661|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
143188907|NCT03286543|516234662|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
143188908|NCT03286543|516234663|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
143188909|NCT03286543|516234661|FG000|Study Enrollment|Withdrawn from study|0|||
143188910|NCT03286543|516234662|FG001|Study Enrollment|Withdrawn from study|6|||
143188911|NCT03286543|516234663|FG002|Study Enrollment|Withdrawn from study|6|||
143188912|NCT00022763|516234671|FG000|Overall Study|Adverse Event|1|||
143188913|NCT00022763|516234672|FG001|Overall Study|Adverse Event|2|||
143188914|NCT00022763|516234671|FG000|Overall Study|Injection Site Reactions|0|||
143188915|NCT00022763|516234672|FG001|Overall Study|Injection Site Reactions|2|||
143188916|NCT00022763|516234671|FG000|Overall Study|Death|0|||
143188917|NCT00022763|516234672|FG001|Overall Study|Death|1|||
143188918|NCT00022763|516234671|FG000|Overall Study|Lost to Follow-up|0|||
143188919|NCT00022763|516234672|FG001|Overall Study|Lost to Follow-up|3|||
143188920|NCT00022763|516234671|FG000|Overall Study|Withdrawal by Subject|4|||
143188921|NCT00022763|516234672|FG001|Overall Study|Withdrawal by Subject|7|||
143188922|NCT00022763|516234671|FG000|Overall Study|Insufficient Therapy|1|||
143188923|NCT00022763|516234672|FG001|Overall Study|Insufficient Therapy|0|||
143188924|NCT00022763|516234671|FG000|Overall Study|Admin|3|||
143188925|NCT00022763|516234672|FG001|Overall Study|Admin|2|||
143188926|NCT04908865|516234673|FG000|Overall Study|Adverse Event|2|||
143188927|NCT04908865|516234673|FG000|Overall Study|Lack of Efficacy|5|||
143188928|NCT04908865|516234673|FG000|Overall Study|Lost to Follow-up|1|||
143188929|NCT00335738|516234686|FG000|Overall Study|Physician Decision|6|||
143188930|NCT00335738|516234687|FG001|Overall Study|Physician Decision|0|||
143188931|NCT00335738|516234686|FG000|Overall Study|Withdrawal by Subject|2|||
143188932|NCT00335738|516234687|FG001|Overall Study|Withdrawal by Subject|0|||
143188933|NCT00335738|516234686|FG000|Overall Study|Ineligible|3|||
143188934|NCT00335738|516234687|FG001|Overall Study|Ineligible|4|||
143188935|NCT00506454|516234688|FG000|Overall Study|Withdrawal by Subject|1|||
143188936|NCT00506454|516234689|FG001|Overall Study|Withdrawal by Subject|1|||
143188937|NCT03098433|516234692|FG000|Overall Study|Withdrawal by Subject|10|||
143188938|NCT01104545|516234693|FG000|Overall Study|Adverse Event|0|||
143188939|NCT01104545|516234694|FG001|Overall Study|Adverse Event|1|||
143188940|NCT01104545|516234695|FG002|Overall Study|Adverse Event|2|||
143188941|NCT02676895|516234696|FG000|Overall Study|Administrative reason|1|||
143188942|NCT02676895|516234697|FG001|Overall Study|Administrative reason|0|||
143188943|NCT02676895|516234698|FG002|Overall Study|Administrative reason|0|||
143188944|NCT02676895|516234696|FG000|Overall Study|Protocol Violation|1|||
143188945|NCT02676895|516234697|FG001|Overall Study|Protocol Violation|0|||
143188946|NCT02676895|516234698|FG002|Overall Study|Protocol Violation|0|||
143188947|NCT02676895|516234696|FG000|Overall Study|Adverse Event|0|||
143188948|NCT02676895|516234697|FG001|Overall Study|Adverse Event|3|||
143188949|NCT02676895|516234698|FG002|Overall Study|Adverse Event|1|||
143188950|NCT02676895|516234696|FG000|Overall Study|Lost to Follow-up|0|||
143188951|NCT02676895|516234697|FG001|Overall Study|Lost to Follow-up|0|||
143188952|NCT02676895|516234698|FG002|Overall Study|Lost to Follow-up|1|||
143188953|NCT02676895|516234696|FG000|Overall Study|Withdrawal by Subject|0|||
143188954|NCT02676895|516234697|FG001|Overall Study|Withdrawal by Subject|0|||
143188955|NCT02676895|516234698|FG002|Overall Study|Withdrawal by Subject|1|||
143188956|NCT00395486|516234702|FG000|Overall Study|Adverse Event|1|||
143188957|NCT00395486|516234703|FG001|Overall Study|Adverse Event|2|||
143188958|NCT00395486|516234702|FG000|Overall Study|Withdrawal by Subject|5|||
143188959|NCT00395486|516234703|FG001|Overall Study|Withdrawal by Subject|2|||
143188960|NCT00395486|516234702|FG000|Overall Study|Lost to Follow-up|0|||
143188961|NCT00395486|516234703|FG001|Overall Study|Lost to Follow-up|1|||
143188962|NCT01076205|516234704|FG000|Overall Study|Adverse Drug Reaction|299|||
143188963|NCT01076205|516234704|FG000|Overall Study|Lack of Effectiveness|1423|||
143188964|NCT01076205|516234704|FG000|Overall Study|Other Reason|1075|||
143188965|NCT01076205|516234704|FG000|Overall Study|Unknown Reason|71|||
143188966|NCT01076205|516234704|FG000|Overall Study|Lost to Follow-up|3151|||
143188967|NCT02993822|516234709|FG000|Overall Study|Lack of Efficacy|1|||
143188968|NCT02993822|516234710|FG001|Overall Study|Lack of Efficacy|1|||
143188969|NCT02993822|516234711|FG002|Overall Study|Lack of Efficacy|0|||
143188970|NCT02993822|516234712|FG003|Overall Study|Lack of Efficacy|0|||
143188971|NCT02993822|516234709|FG000|Overall Study|Protocol Violation|1|||
143188972|NCT02993822|516234710|FG001|Overall Study|Protocol Violation|0|||
143188973|NCT02993822|516234711|FG002|Overall Study|Protocol Violation|0|||
143188974|NCT02993822|516234712|FG003|Overall Study|Protocol Violation|0|||
143188975|NCT02993822|516234709|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
143188976|NCT02993822|516234710|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
143188977|NCT02993822|516234711|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
143188978|NCT02993822|516234712|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
143188979|NCT02993822|516234709|FG000|Overall Study|Adverse Event|3|||
143188980|NCT02993822|516234710|FG001|Overall Study|Adverse Event|1|||
143188981|NCT02993822|516234711|FG002|Overall Study|Adverse Event|7|||
143188982|NCT02993822|516234712|FG003|Overall Study|Adverse Event|0|||
143188983|NCT02993822|516234709|FG000|Overall Study|Withdrawal by Subject|4|||
143188984|NCT02993822|516234710|FG001|Overall Study|Withdrawal by Subject|2|||
143188985|NCT02993822|516234711|FG002|Overall Study|Withdrawal by Subject|2|||
143188986|NCT02993822|516234712|FG003|Overall Study|Withdrawal by Subject|3|||
143188987|NCT02993822|516234709|FG000|Overall Study|Lost to Follow-up|1|||
143188988|NCT02993822|516234710|FG001|Overall Study|Lost to Follow-up|0|||
143188989|NCT02993822|516234711|FG002|Overall Study|Lost to Follow-up|1|||
143188990|NCT02993822|516234712|FG003|Overall Study|Lost to Follow-up|0|||
143188991|NCT02443116|516234715|FG000|Part 1|Adverse Event|2|||
143188992|NCT02443116|516234716|FG001|Part 1|Adverse Event|3|||
143188993|NCT02443116|516234717|FG002|Part 1|Adverse Event|0|||
143188994|NCT02443116|516234718|FG003|Part 1|Adverse Event|0|||
143188995|NCT02443116|516234719|FG004|Part 1|Adverse Event|0|||
143188996|NCT02443116|516234720|FG005|Part 1|Adverse Event|0|||
143188997|NCT02443116|516234721|FG006|Part 1|Adverse Event|0|||
143188998|NCT02443116|516234722|FG007|Part 1|Adverse Event|0|||
143188999|NCT02443116|516234723|FG008|Part 1|Adverse Event|0|||
143189000|NCT02443116|516234715|FG000|Part 1|Withdrew informed consent|0|||
143189001|NCT02443116|516234716|FG001|Part 1|Withdrew informed consent|1|||
143189002|NCT02443116|516234717|FG002|Part 1|Withdrew informed consent|0|||
143189003|NCT02443116|516234718|FG003|Part 1|Withdrew informed consent|0|||
143189004|NCT02443116|516234719|FG004|Part 1|Withdrew informed consent|0|||
143189005|NCT02443116|516234720|FG005|Part 1|Withdrew informed consent|0|||
143189006|NCT02443116|516234721|FG006|Part 1|Withdrew informed consent|0|||
143189007|NCT02443116|516234722|FG007|Part 1|Withdrew informed consent|0|||
143189008|NCT02443116|516234723|FG008|Part 1|Withdrew informed consent|0|||
143189009|NCT02443116|516234715|FG000|Part 1|Lost to Follow-up|0|||
143189010|NCT02443116|516234716|FG001|Part 1|Lost to Follow-up|0|||
143189011|NCT02443116|516234717|FG002|Part 1|Lost to Follow-up|2|||
143189012|NCT02443116|516234718|FG003|Part 1|Lost to Follow-up|0|||
143189013|NCT02443116|516234719|FG004|Part 1|Lost to Follow-up|0|||
143189014|NCT02443116|516234720|FG005|Part 1|Lost to Follow-up|0|||
143189015|NCT02443116|516234721|FG006|Part 1|Lost to Follow-up|0|||
143189016|NCT02443116|516234722|FG007|Part 1|Lost to Follow-up|0|||
143189017|NCT02443116|516234723|FG008|Part 1|Lost to Follow-up|0|||
143189018|NCT02443116|516234715|FG000|Part 1|Participant moved out of state|0|||
143189019|NCT02443116|516234716|FG001|Part 1|Participant moved out of state|0|||
143189020|NCT02443116|516234717|FG002|Part 1|Participant moved out of state|1|||
143189021|NCT02443116|516234718|FG003|Part 1|Participant moved out of state|0|||
143189022|NCT02443116|516234719|FG004|Part 1|Participant moved out of state|0|||
143189023|NCT02443116|516234720|FG005|Part 1|Participant moved out of state|0|||
143189024|NCT02443116|516234721|FG006|Part 1|Participant moved out of state|0|||
143189025|NCT02443116|516234722|FG007|Part 1|Participant moved out of state|0|||
143189026|NCT02443116|516234723|FG008|Part 1|Participant moved out of state|0|||
143189027|NCT02443116|516234715|FG000|Part 1|Participant enrolled in another clinical trial|0|||
143189028|NCT02443116|516234716|FG001|Part 1|Participant enrolled in another clinical trial|0|||
143189029|NCT02443116|516234717|FG002|Part 1|Participant enrolled in another clinical trial|1|||
143189030|NCT02443116|516234718|FG003|Part 1|Participant enrolled in another clinical trial|0|||
143189031|NCT02443116|516234719|FG004|Part 1|Participant enrolled in another clinical trial|0|||
143189032|NCT02443116|516234720|FG005|Part 1|Participant enrolled in another clinical trial|0|||
143189033|NCT02443116|516234721|FG006|Part 1|Participant enrolled in another clinical trial|0|||
143189034|NCT02443116|516234722|FG007|Part 1|Participant enrolled in another clinical trial|0|||
143189035|NCT02443116|516234723|FG008|Part 1|Participant enrolled in another clinical trial|0|||
143189036|NCT02443116|516234715|FG000|Part 2|Adverse Event|0|||
143189037|NCT02443116|516234716|FG001|Part 2|Adverse Event|0|||
143189038|NCT02443116|516234717|FG002|Part 2|Adverse Event|0|||
143189039|NCT02443116|516234718|FG003|Part 2|Adverse Event|0|||
143189040|NCT02443116|516234719|FG004|Part 2|Adverse Event|1|||
143189041|NCT02443116|516234720|FG005|Part 2|Adverse Event|1|||
143189042|NCT02443116|516234721|FG006|Part 2|Adverse Event|2|||
143189043|NCT02443116|516234722|FG007|Part 2|Adverse Event|0|||
143189044|NCT02443116|516234723|FG008|Part 2|Adverse Event|0|||
143189045|NCT02443116|516234715|FG000|Part 2|Withdrew informed consent|0|||
143189046|NCT02443116|516234716|FG001|Part 2|Withdrew informed consent|0|||
143189047|NCT02443116|516234717|FG002|Part 2|Withdrew informed consent|0|||
143189048|NCT02443116|516234718|FG003|Part 2|Withdrew informed consent|0|||
143189049|NCT02443116|516234719|FG004|Part 2|Withdrew informed consent|0|||
143189050|NCT02443116|516234720|FG005|Part 2|Withdrew informed consent|1|||
143189051|NCT02443116|516234721|FG006|Part 2|Withdrew informed consent|1|||
143189052|NCT02443116|516234722|FG007|Part 2|Withdrew informed consent|0|||
143189053|NCT02443116|516234723|FG008|Part 2|Withdrew informed consent|0|||
143189054|NCT02443116|516234715|FG000|Part 2|Inability to comply with protocol|0|||
143189055|NCT02443116|516234716|FG001|Part 2|Inability to comply with protocol|0|||
143189056|NCT02443116|516234717|FG002|Part 2|Inability to comply with protocol|0|||
143189057|NCT02443116|516234718|FG003|Part 2|Inability to comply with protocol|1|||
143189058|NCT02443116|516234719|FG004|Part 2|Inability to comply with protocol|0|||
143189059|NCT02443116|516234720|FG005|Part 2|Inability to comply with protocol|0|||
143189060|NCT02443116|516234721|FG006|Part 2|Inability to comply with protocol|0|||
143189061|NCT02443116|516234722|FG007|Part 2|Inability to comply with protocol|0|||
143189062|NCT02443116|516234723|FG008|Part 2|Inability to comply with protocol|0|||
143189063|NCT02443116|516234715|FG000|Part 2|Lost to Follow-up|0|||
143189064|NCT02443116|516234716|FG001|Part 2|Lost to Follow-up|0|||
143189065|NCT02443116|516234717|FG002|Part 2|Lost to Follow-up|0|||
143189066|NCT02443116|516234718|FG003|Part 2|Lost to Follow-up|1|||
143189067|NCT02443116|516234719|FG004|Part 2|Lost to Follow-up|0|||
143189068|NCT02443116|516234720|FG005|Part 2|Lost to Follow-up|0|||
143189069|NCT02443116|516234721|FG006|Part 2|Lost to Follow-up|0|||
143189070|NCT02443116|516234722|FG007|Part 2|Lost to Follow-up|0|||
143189071|NCT02443116|516234723|FG008|Part 2|Lost to Follow-up|0|||
143189072|NCT02443116|516234715|FG000|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
143189073|NCT02443116|516234716|FG001|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
143189074|NCT02443116|516234717|FG002|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
143189075|NCT02443116|516234718|FG003|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
143189076|NCT02443116|516234719|FG004|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
143189077|NCT02443116|516234720|FG005|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|1|||
143189078|NCT02443116|516234721|FG006|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
143189079|NCT02443116|516234722|FG007|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
143189080|NCT02443116|516234723|FG008|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
143189081|NCT02443116|516234715|FG000|Part 3|Adverse Event|0|||
143189082|NCT02443116|516234716|FG001|Part 3|Adverse Event|0|||
143189083|NCT02443116|516234717|FG002|Part 3|Adverse Event|0|||
143189084|NCT02443116|516234718|FG003|Part 3|Adverse Event|0|||
143189085|NCT02443116|516234719|FG004|Part 3|Adverse Event|0|||
143189086|NCT02443116|516234720|FG005|Part 3|Adverse Event|0|||
143189087|NCT02443116|516234721|FG006|Part 3|Adverse Event|0|||
143189088|NCT02443116|516234722|FG007|Part 3|Adverse Event|0|||
143189089|NCT02443116|516234723|FG008|Part 3|Adverse Event|1|||
143189090|NCT02443116|516234715|FG000|Part 3|Withdrew informed consent|0|||
143189091|NCT02443116|516234716|FG001|Part 3|Withdrew informed consent|0|||
143189092|NCT02443116|516234717|FG002|Part 3|Withdrew informed consent|0|||
143189093|NCT02443116|516234718|FG003|Part 3|Withdrew informed consent|0|||
143189094|NCT02443116|516234719|FG004|Part 3|Withdrew informed consent|0|||
143189095|NCT02443116|516234720|FG005|Part 3|Withdrew informed consent|0|||
143189096|NCT02443116|516234721|FG006|Part 3|Withdrew informed consent|0|||
143189097|NCT02443116|516234722|FG007|Part 3|Withdrew informed consent|3|||
143189098|NCT02443116|516234723|FG008|Part 3|Withdrew informed consent|2|||
143189099|NCT02443116|516234715|FG000|Part 3|Lost to Follow-up|0|||
143189100|NCT02443116|516234716|FG001|Part 3|Lost to Follow-up|0|||
143189101|NCT02443116|516234717|FG002|Part 3|Lost to Follow-up|0|||
143189102|NCT02443116|516234718|FG003|Part 3|Lost to Follow-up|0|||
143189103|NCT02443116|516234719|FG004|Part 3|Lost to Follow-up|0|||
143189104|NCT02443116|516234720|FG005|Part 3|Lost to Follow-up|0|||
143189105|NCT02443116|516234721|FG006|Part 3|Lost to Follow-up|0|||
143189106|NCT02443116|516234722|FG007|Part 3|Lost to Follow-up|1|||
143189107|NCT02443116|516234723|FG008|Part 3|Lost to Follow-up|2|||
143189108|NCT04295759|516234724|FG000|Overall Study|Lack of Efficacy|9|||
143189109|NCT04295759|516234724|FG000|Overall Study|Death|1|||
143189110|NCT04295759|516234724|FG000|Overall Study|Withdrawal by Subject|2|||
143189111|NCT04295759|516234724|FG000|Overall Study|Deemed ineligible|1|||
143189112|NCT01696981|516234725|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
143189113|NCT01696981|516234726|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
143189114|NCT01696981|516234725|FG000|Overall Study|Died Before Randomization|3|||
143189115|NCT01696981|516234726|FG001|Overall Study|Died Before Randomization|8|||
143189116|NCT01696981|516234725|FG000|Overall Study|Died Before ASU (Control)|278|||
143189117|NCT01696981|516234726|FG001|Overall Study|Died Before ASU (Control)|0|||
143189118|NCT01696981|516234725|FG000|Overall Study|Refused ASU (Control)|920|||
143189119|NCT01696981|516234726|FG001|Overall Study|Refused ASU (Control)|0|||
143189120|NCT01696981|516234725|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
143189121|NCT01696981|516234726|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
143189122|NCT00465972|516234729|FG000|Overall Study|Withdrawal by Subject|2|||
143189123|NCT00465972|516234730|FG001|Overall Study|Withdrawal by Subject|1|||
143189124|NCT02095873|516234731|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
143189125|NCT02095873|516234732|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
143189126|NCT02095873|516234731|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
143189127|NCT02095873|516234732|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
143189128|NCT02095873|516234731|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
143189129|NCT02095873|516234732|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
143189130|NCT00851890|516234733|FG000|Overall Study|Lost to Follow-up|0|||
143189131|NCT00851890|516234734|FG001|Overall Study|Lost to Follow-up|1|||
143189132|NCT00851890|516234735|FG002|Overall Study|Lost to Follow-up|0|||
143189133|NCT00851890|516234736|FG003|Overall Study|Lost to Follow-up|1|||
143189134|NCT06899737|516234743|FG000|Overall Study|Lost to Follow-up|19|||
143189135|NCT06899737|516234744|FG001|Overall Study|Lost to Follow-up|7|||
143189136|NCT01170273|516234746|FG000|Overall Study|Lost to Follow-up|6|||
143189137|NCT01170273|516234747|FG001|Overall Study|Lost to Follow-up|8|||
143189138|NCT01170273|516234746|FG000|Overall Study|Protocol Violation|1|||
143189139|NCT01170273|516234747|FG001|Overall Study|Protocol Violation|0|||
143189140|NCT01170273|516234746|FG000|Overall Study|Death|1|||
143189141|NCT01170273|516234747|FG001|Overall Study|Death|0|||
143189142|NCT01170273|516234746|FG000|Overall Study|Adverse Event|0|||
143189143|NCT01170273|516234747|FG001|Overall Study|Adverse Event|1|||
143189144|NCT00334737|516234748|FG000|Hospital Phase|Death|1|||
143189145|NCT00334737|516234749|FG001|Hospital Phase|Death|2|||
143189146|NCT00334737|516234750|FG002|Hospital Phase|Death|3|||
143189147|NCT00334737|516234748|FG000|Hospital Phase|Withdrawal by Subject|0|||
143189148|NCT00334737|516234749|FG001|Hospital Phase|Withdrawal by Subject|0|||
143189149|NCT00334737|516234750|FG002|Hospital Phase|Withdrawal by Subject|1|||
143189150|NCT00334737|516234748|FG000|Hospital Phase|Did not receive study drug|1|||
143189151|NCT00334737|516234749|FG001|Hospital Phase|Did not receive study drug|0|||
143189152|NCT00334737|516234750|FG002|Hospital Phase|Did not receive study drug|0|||
143189153|NCT00334737|516234748|FG000|Follow up Phase|Lost to Follow-up|5|||
143189154|NCT00334737|516234749|FG001|Follow up Phase|Lost to Follow-up|3|||
143189155|NCT00334737|516234750|FG002|Follow up Phase|Lost to Follow-up|6|||
143189156|NCT02316353|516234751|FG000|Overall Study|Pregnancy|1|||
143189157|NCT02316353|516234752|FG001|Overall Study|Pregnancy|3|||
143189158|NCT02316353|516234751|FG000|Overall Study|Adverse Event|1|||
143189159|NCT02316353|516234752|FG001|Overall Study|Adverse Event|3|||
143189160|NCT02316353|516234751|FG000|Overall Study|Withdrawal by Subject|6|||
143189161|NCT02316353|516234752|FG001|Overall Study|Withdrawal by Subject|2|||
143189162|NCT00875485|516236425|FG000|Challenge Dose Epoch|Pregnancy|1|||
143189163|NCT00875485|516236426|FG001|Challenge Dose Epoch|Pregnancy|0|||
143189164|NCT01631747|516236427|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
143189165|NCT01631747|516236428|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
143189166|NCT01631747|516236427|FG000|Live Birth|Pregnancy Termination|1|||
143189167|NCT01631747|516236428|FG001|Live Birth|Pregnancy Termination|0|||
143189168|NCT01631747|516236427|FG000|Live Birth|MIscarriage|2|||
143189169|NCT01631747|516236428|FG001|Live Birth|MIscarriage|0|||
143189170|NCT01631747|516236427|FG000|Live Birth|Stillbirth|1|||
143189171|NCT01631747|516236428|FG001|Live Birth|Stillbirth|1|||
143189172|NCT01631747|516236427|FG000|One Year Infant Outcomes|Patient Refused|13|||
143189173|NCT01631747|516236428|FG001|One Year Infant Outcomes|Patient Refused|9|||
143189174|NCT01456195|516236429|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
143189175|NCT01456195|516236430|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
143189176|NCT01456195|516236431|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
143189177|NCT01456195|516236429|FG000|Overall Study|Lost to Follow-up|3|||
143189178|NCT01456195|516236430|FG001|Overall Study|Lost to Follow-up|1|||
143189179|NCT01456195|516236431|FG002|Overall Study|Lost to Follow-up|3|||
143189180|NCT01456195|516236429|FG000|Overall Study|Voluntary Withdrawal|5|||
143189181|NCT01456195|516236430|FG001|Overall Study|Voluntary Withdrawal|3|||
143189182|NCT01456195|516236431|FG002|Overall Study|Voluntary Withdrawal|7|||
143189183|NCT01456195|516236429|FG000|Overall Study|Lack of Efficacy|0|||
143189184|NCT01456195|516236430|FG001|Overall Study|Lack of Efficacy|1|||
143189185|NCT01456195|516236431|FG002|Overall Study|Lack of Efficacy|0|||
143189186|NCT01456195|516236429|FG000|Overall Study|Other Reasons|2|||
143189187|NCT01456195|516236430|FG001|Overall Study|Other Reasons|1|||
143189188|NCT01456195|516236431|FG002|Overall Study|Other Reasons|3|||
143189189|NCT04683029|516236432|FG000|Main Study: Week 0-Week 60|Withdrawal by Subject|1|||
143189190|NCT04683029|516236433|FG001|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
143189191|NCT04683029|516236434|FG002|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
143189192|NCT04683029|516236435|FG003|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
143189193|NCT04683029|516236432|FG000|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
143189194|NCT04683029|516236433|FG001|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
143189195|NCT04683029|516236434|FG002|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
143189196|NCT04683029|516236435|FG003|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|2|||
143189197|NCT04683029|516236432|FG000|Long-term Extension(LTE):Week52-Week 112|Death|0|||
143189198|NCT04683029|516236433|FG001|Long-term Extension(LTE):Week52-Week 112|Death|0|||
143189199|NCT04683029|516236434|FG002|Long-term Extension(LTE):Week52-Week 112|Death|1|||
143189200|NCT04683029|516236435|FG003|Long-term Extension(LTE):Week52-Week 112|Death|0|||
143189201|NCT00066703|516236438|FG000|Overall Study|Adverse Event|80|||
143189202|NCT00066703|516236439|FG001|Overall Study|Adverse Event|111|||
143189203|NCT00066703|516236438|FG000|Overall Study|Death|3|||
143189204|NCT00066703|516236439|FG001|Overall Study|Death|0|||
143189205|NCT00066703|516236438|FG000|Overall Study|Lack of Efficacy|114|||
143189206|NCT00066703|516236439|FG001|Overall Study|Lack of Efficacy|69|||
143189207|NCT00066703|516236438|FG000|Overall Study|Lost to Follow-up|31|||
143189208|NCT00066703|516236439|FG001|Overall Study|Lost to Follow-up|28|||
143189209|NCT00066703|516236438|FG000|Overall Study|Withdrawal by Subject|38|||
143189210|NCT00066703|516236439|FG001|Overall Study|Withdrawal by Subject|63|||
143189211|NCT00066703|516236438|FG000|Overall Study|Treatment ongoing|346|||
143189212|NCT00066703|516236439|FG001|Overall Study|Treatment ongoing|311|||
143189213|NCT01696968|516236440|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
143189214|NCT01696968|516236441|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
143189215|NCT01696968|516236440|FG000|Overall Study|Died Before Randomization|3|||
143189216|NCT01696968|516236441|FG001|Overall Study|Died Before Randomization|8|||
143189217|NCT01696968|516236440|FG000|Overall Study|Died Before ASU (Control)|278|||
143189218|NCT01696968|516236441|FG001|Overall Study|Died Before ASU (Control)|0|||
143189219|NCT01696968|516236440|FG000|Overall Study|Refused ASU (Control)|920|||
143189220|NCT01696968|516236441|FG001|Overall Study|Refused ASU (Control)|0|||
143189221|NCT01696968|516236440|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
143189222|NCT01696968|516236441|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
143189223|NCT03727646|516236442|FG000|Overall Study|Adverse Event|1|||
143189224|NCT03727646|516236443|FG001|Overall Study|Adverse Event|0|||
143189225|NCT04753658|516236446|FG000|Overall Study|Progressive disease|7|||
143189226|NCT04753658|516236446|FG000|Overall Study|Other|7|||
143189227|NCT04753658|516236446|FG000|Overall Study|Adverse Event|1|||
143189228|NCT05659719|516236447|FG000|Overall Study|At sponsor's request|0|||
143189229|NCT05659719|516236448|FG001|Overall Study|At sponsor's request|0|||
143189230|NCT05659719|516236449|FG002|Overall Study|At sponsor's request|0|||
143189231|NCT05659719|516236450|FG003|Overall Study|At sponsor's request|95|||
143189232|NCT05659719|516236447|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
143189233|NCT05659719|516236448|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
143189234|NCT05659719|516236449|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
143189235|NCT05659719|516236450|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
143189236|NCT05659719|516236447|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
143189237|NCT05659719|516236448|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
143189238|NCT05659719|516236449|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
143189239|NCT05659719|516236450|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
143261456|NCT01582854|516510586|FG001|Overall Study|Withdrawal by Participant|11|||
143261457|NCT01582854|516510585|FG000|Overall Study|Lost to Follow-up|1|||
143189240|NCT05659719|516236447|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
143189241|NCT05659719|516236448|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
143189242|NCT05659719|516236449|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
143189243|NCT05659719|516236450|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
143189244|NCT05659719|516236447|FG000|Overall Study|Lost to Follow-up|0|||
143189245|NCT05659719|516236448|FG001|Overall Study|Lost to Follow-up|0|||
143189246|NCT05659719|516236449|FG002|Overall Study|Lost to Follow-up|0|||
143189247|NCT05659719|516236450|FG003|Overall Study|Lost to Follow-up|2|||
143189248|NCT05659719|516236447|FG000|Overall Study|Moved to another observational study|0|||
143189249|NCT05659719|516236448|FG001|Overall Study|Moved to another observational study|0|||
143189250|NCT05659719|516236449|FG002|Overall Study|Moved to another observational study|0|||
143189251|NCT05659719|516236450|FG003|Overall Study|Moved to another observational study|1|||
143189252|NCT05659719|516236447|FG000|Overall Study|The child was enrolled in an interventional study|0|||
143189253|NCT05659719|516236448|FG001|Overall Study|The child was enrolled in an interventional study|0|||
143189254|NCT05659719|516236449|FG002|Overall Study|The child was enrolled in an interventional study|0|||
143189255|NCT05659719|516236450|FG003|Overall Study|The child was enrolled in an interventional study|55|||
143189256|NCT05659719|516236447|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
143189257|NCT05659719|516236448|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
143189258|NCT05659719|516236449|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
143189259|NCT05659719|516236450|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
143189260|NCT05659719|516236447|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
143189261|NCT05659719|516236448|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
143189262|NCT05659719|516236449|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
143189263|NCT05659719|516236450|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
143189264|NCT01681186|516236457|FG000|Washout Period From Second Intervention|Adverse Event|0|||
143189265|NCT01681186|516236458|FG001|Washout Period From Second Intervention|Adverse Event|0|||
143189266|NCT01681186|516236459|FG002|Washout Period From Second Intervention|Adverse Event|0|||
143189267|NCT01681186|516236460|FG003|Washout Period From Second Intervention|Adverse Event|0|||
143189268|NCT01681186|516236461|FG004|Washout Period From Second Intervention|Adverse Event|0|||
143189269|NCT01681186|516236462|FG005|Washout Period From Second Intervention|Adverse Event|0|||
143189270|NCT01681186|516236463|FG006|Washout Period From Second Intervention|Adverse Event|1|||
143189271|NCT01681186|516236464|FG007|Washout Period From Second Intervention|Adverse Event|0|||
143189272|NCT01681186|516236457|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
143189273|NCT01681186|516236458|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
143189274|NCT01681186|516236459|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
143189275|NCT01681186|516236460|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
143189276|NCT01681186|516236461|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
143189277|NCT01681186|516236462|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
143189278|NCT01681186|516236463|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
143189279|NCT01681186|516236464|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
143189280|NCT01681186|516236457|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
143189281|NCT01681186|516236458|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
143189282|NCT01681186|516236459|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
143189283|NCT01681186|516236460|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
143189284|NCT01681186|516236461|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
143189285|NCT01681186|516236462|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
143189286|NCT01681186|516236463|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
143189287|NCT01681186|516236464|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
143189288|NCT01681186|516236457|FG000|Fourth Intervention|Protocol Violation|0|||
143189289|NCT01681186|516236458|FG001|Fourth Intervention|Protocol Violation|0|||
143189290|NCT01681186|516236459|FG002|Fourth Intervention|Protocol Violation|0|||
143189291|NCT01681186|516236460|FG003|Fourth Intervention|Protocol Violation|0|||
143189292|NCT01681186|516236461|FG004|Fourth Intervention|Protocol Violation|0|||
143189293|NCT01681186|516236462|FG005|Fourth Intervention|Protocol Violation|0|||
143189294|NCT01681186|516236463|FG006|Fourth Intervention|Protocol Violation|0|||
143189295|NCT01681186|516236464|FG007|Fourth Intervention|Protocol Violation|1|||
143189296|NCT03470194|516236473|FG000|Overall Study|Lost to Follow-up|11|||
143189297|NCT03470194|516236474|FG001|Overall Study|Lost to Follow-up|17|||
143189298|NCT01822899|516236475|FG000|Overall Study|Adverse Event|6|||
143189299|NCT01822899|516236476|FG001|Overall Study|Adverse Event|5|||
143189300|NCT01822899|516236475|FG000|Overall Study|Lack of Efficacy|6|||
143189301|NCT01822899|516236476|FG001|Overall Study|Lack of Efficacy|3|||
143189302|NCT01822899|516236475|FG000|Overall Study|Protocol Violation|6|||
143189303|NCT01822899|516236476|FG001|Overall Study|Protocol Violation|3|||
143189304|NCT01822899|516236475|FG000|Overall Study|Lost to Follow-up|1|||
143189305|NCT01822899|516236476|FG001|Overall Study|Lost to Follow-up|0|||
143189306|NCT01822899|516236475|FG000|Overall Study|Withdrawal by Subject|5|||
143189307|NCT01822899|516236476|FG001|Overall Study|Withdrawal by Subject|7|||
143189308|NCT05332392|516236477|FG000|Overall Study|Did not meet inclusion criteria|25|||
143189309|NCT05332392|516236477|FG000|Overall Study|Principal Investigator's decision|17|||
143189310|NCT05332392|516236477|FG000|Overall Study|Adverse Event|1|||
143189311|NCT05332392|516236477|FG000|Overall Study|Subject's decision|1|||
143189312|NCT01268046|516236478|FG000|Overall Study|Withdrawal by Subject|1|||
143189313|NCT01268046|516236479|FG001|Overall Study|Withdrawal by Subject|0|||
143189314|NCT01268046|516236480|FG002|Overall Study|Withdrawal by Subject|0|||
143189315|NCT01268046|516236481|FG003|Overall Study|Withdrawal by Subject|1|||
143189316|NCT01268046|516236478|FG000|Overall Study|Lost to Follow-up|0|||
143189317|NCT01268046|516236479|FG001|Overall Study|Lost to Follow-up|0|||
143189318|NCT01268046|516236480|FG002|Overall Study|Lost to Follow-up|1|||
143189319|NCT01268046|516236481|FG003|Overall Study|Lost to Follow-up|0|||
143189320|NCT02314156|516236482|FG000|Overall Study|Adverse Event|1|||
143189321|NCT02314156|516236483|FG001|Overall Study|Adverse Event|0|||
143189322|NCT02314156|516236482|FG000|Overall Study|Withdrawal by Subject|1|||
143189323|NCT02314156|516236483|FG001|Overall Study|Withdrawal by Subject|0|||
143189324|NCT01450696|516236484|FG000|Overall Study|Never Treated|1|||
143189325|NCT01450696|516236485|FG001|Overall Study|Never Treated|1|||
143189326|NCT01450696|516236484|FG000|Overall Study|Death|77|||
143189327|NCT01450696|516236485|FG001|Overall Study|Death|84|||
143189328|NCT01450696|516236484|FG000|Overall Study|Lost to Follow-up|3|||
143189329|NCT01450696|516236485|FG001|Overall Study|Lost to Follow-up|3|||
143189330|NCT01450696|516236484|FG000|Overall Study|Non-Compliance|1|||
143189331|NCT01450696|516236485|FG001|Overall Study|Non-Compliance|0|||
143189332|NCT01450696|516236484|FG000|Overall Study|Withdrawal by Subject|13|||
143189333|NCT01450696|516236485|FG001|Overall Study|Withdrawal by Subject|2|||
143189334|NCT01450696|516236484|FG000|Overall Study|Study Terminated by Sponsor|53|||
143189335|NCT01450696|516236485|FG001|Overall Study|Study Terminated by Sponsor|58|||
143369500|NCT01191086|516896141|FG000|Overall Study|Discontinuation criterion met|1|||
143369501|NCT01191086|516896141|FG000|Overall Study|Other|1|||
143369502|NCT02057718|516896144|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
143369503|NCT02057718|516896145|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
143189336|NCT03818607|516236486|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
143189337|NCT03818607|516236487|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
143369504|NCT02057718|516896144|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
143369505|NCT02057718|516896145|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
143369506|NCT02057718|516896144|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
143369507|NCT02057718|516896145|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
143369508|NCT02057718|516896144|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
143369509|NCT02057718|516896145|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
143369510|NCT02057718|516896144|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
143369511|NCT02057718|516896145|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
143369512|NCT02057718|516896144|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
143369513|NCT02057718|516896145|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
143369514|NCT02057718|516896144|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
143369515|NCT02057718|516896145|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
143369516|NCT02057718|516896144|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
143369517|NCT02057718|516896145|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
143189338|NCT03818607|516236486|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
143189339|NCT03818607|516236487|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
143189340|NCT03818607|516236486|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
143189341|NCT03818607|516236487|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
143189342|NCT05059301|516236490|FG000|Overall Study|Adverse Event|0|||
143189343|NCT05059301|516236491|FG001|Overall Study|Adverse Event|2|||
143189344|NCT05059301|516236492|FG002|Overall Study|Adverse Event|2|||
143189345|NCT05059301|516236490|FG000|Overall Study|Lost to Follow-up|2|||
143189346|NCT05059301|516236491|FG001|Overall Study|Lost to Follow-up|3|||
143189347|NCT05059301|516236492|FG002|Overall Study|Lost to Follow-up|3|||
143369518|NCT02057718|516896144|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
143189348|NCT00853242|516236493|FG000|Overall Study|Adverse Event|0|||
143369519|NCT02057718|516896145|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
143189349|NCT00853242|516236494|FG001|Overall Study|Adverse Event|1|||
143189350|NCT00853242|516236495|FG002|Overall Study|Adverse Event|1|||
143369520|NCT02057718|516896144|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
143189351|NCT00853242|516236496|FG003|Overall Study|Adverse Event|0|||
143189352|NCT00853242|516236497|FG004|Overall Study|Adverse Event|3|||
143189353|NCT00853242|516236498|FG005|Overall Study|Adverse Event|1|||
143261458|NCT01582854|516510586|FG001|Overall Study|Lost to Follow-up|2|||
143261459|NCT01582854|516510585|FG000|Overall Study|Physician Decision|0|||
143189354|NCT00853242|516236499|FG006|Overall Study|Adverse Event|1|||
143189355|NCT00853242|516236493|FG000|Overall Study|Noncompliant|0|||
143189356|NCT00853242|516236494|FG001|Overall Study|Noncompliant|0|||
143189357|NCT00853242|516236495|FG002|Overall Study|Noncompliant|0|||
143189358|NCT00853242|516236496|FG003|Overall Study|Noncompliant|0|||
143189359|NCT00853242|516236497|FG004|Overall Study|Noncompliant|1|||
143189360|NCT00853242|516236498|FG005|Overall Study|Noncompliant|0|||
143189361|NCT00853242|516236499|FG006|Overall Study|Noncompliant|0|||
143189362|NCT00853242|516236493|FG000|Overall Study|Withdrawal by Subject|1|||
143189363|NCT00853242|516236494|FG001|Overall Study|Withdrawal by Subject|2|||
143189364|NCT00853242|516236495|FG002|Overall Study|Withdrawal by Subject|0|||
143189365|NCT00853242|516236496|FG003|Overall Study|Withdrawal by Subject|4|||
143189366|NCT00853242|516236497|FG004|Overall Study|Withdrawal by Subject|0|||
143189367|NCT00853242|516236498|FG005|Overall Study|Withdrawal by Subject|0|||
143189368|NCT00853242|516236499|FG006|Overall Study|Withdrawal by Subject|2|||
143189369|NCT00853242|516236493|FG000|Overall Study|Other|2|||
143189370|NCT00853242|516236494|FG001|Overall Study|Other|0|||
143189371|NCT00853242|516236495|FG002|Overall Study|Other|2|||
143189372|NCT00853242|516236496|FG003|Overall Study|Other|0|||
143189373|NCT00853242|516236497|FG004|Overall Study|Other|0|||
143189374|NCT00853242|516236498|FG005|Overall Study|Other|1|||
143189375|NCT00853242|516236499|FG006|Overall Study|Other|2|||
143189376|NCT05730335|516236500|FG000|Overall Study|Lost to Follow-up|8|||
143189377|NCT05730335|516236500|FG000|Overall Study|Withdrawal by Subject|6|||
143189378|NCT03249909|516236507|FG000|Overall Study|Withdrawal by Subject|3|||
143189379|NCT03249909|516236508|FG001|Overall Study|Withdrawal by Subject|0|||
143189380|NCT03249909|516236509|FG002|Overall Study|Withdrawal by Subject|0|||
143189381|NCT03249909|516236507|FG000|Overall Study|Adverse Event|3|||
143189382|NCT03249909|516236508|FG001|Overall Study|Adverse Event|0|||
143189383|NCT03249909|516236509|FG002|Overall Study|Adverse Event|0|||
143189384|NCT03249909|516236507|FG000|Overall Study|Lost to Follow-up|0|||
143189385|NCT03249909|516236508|FG001|Overall Study|Lost to Follow-up|1|||
143189386|NCT03249909|516236509|FG002|Overall Study|Lost to Follow-up|0|||
143189387|NCT00606034|516236510|FG000|Overall Study|incarceration|1|||
143189388|NCT05286658|516236512|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
143189389|NCT05286658|516236512|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
143189390|NCT01205061|516236515|FG000|Overall Study|Adverse Event|4|||
143189391|NCT01205061|516236515|FG000|Overall Study|Withdrawal by Subject|11|||
143189392|NCT01205061|516236515|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
143189393|NCT01205061|516236515|FG000|Overall Study|Lost to Follow-up|9|||
143189394|NCT01205061|516236515|FG000|Overall Study|Other|1|||
143189395|NCT04026009|516236516|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
143189396|NCT04026009|516236517|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
143189397|NCT04026009|516236518|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
143189398|NCT04026009|516236519|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
143189399|NCT04026009|516236520|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
143189400|NCT04026009|516236516|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
143189401|NCT04026009|516236517|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
143189402|NCT04026009|516236518|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
143189403|NCT04026009|516236519|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
143189404|NCT04026009|516236520|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
143189405|NCT00615719|516236523|FG000|Overall Study|Physician Decision|5|||
143189406|NCT03748706|516236524|FG000|Overall Study|Lost to Follow-up|1|||
143189407|NCT00842153|516236527|FG000|Overall Study|Adverse Event|0|||
143189408|NCT00842153|516236528|FG001|Overall Study|Adverse Event|1|||
143189409|NCT00842153|516236527|FG000|Overall Study|Lost to Follow-up|1|||
143189410|NCT00842153|516236528|FG001|Overall Study|Lost to Follow-up|2|||
143189411|NCT01355679|516236530|FG000|Overall Study|benign tumor types found at biopsy|2|||
143189412|NCT02027311|516236531|FG000|Overall Study|Protocol Violation|3|||
143189413|NCT02027311|516236532|FG001|Overall Study|Protocol Violation|2|||
143189414|NCT05319600|516236533|FG000|Overall Study|Withdrawal by Subject|1|||
143189415|NCT05319600|516236534|FG001|Overall Study|Withdrawal by Subject|0|||
143189416|NCT05319600|516236533|FG000|Overall Study|Lost to Follow-up|0|||
143189417|NCT05319600|516236534|FG001|Overall Study|Lost to Follow-up|4|||
143261460|NCT01582854|516510586|FG001|Overall Study|Physician Decision|1|||
143189418|NCT03028129|516236541|FG000|Overall Study|Adverse Event|13|||
143189419|NCT03028129|516236542|FG001|Overall Study|Adverse Event|2|||
143189420|NCT03028129|516236541|FG000|Overall Study|Lost to Follow-up|50|||
143189421|NCT03028129|516236542|FG001|Overall Study|Lost to Follow-up|38|||
143189422|NCT03028129|516236541|FG000|Overall Study|Physician Decision|0|||
143189423|NCT03028129|516236542|FG001|Overall Study|Physician Decision|1|||
143189424|NCT03028129|516236541|FG000|Overall Study|Protocol Violation|1|||
143189425|NCT03028129|516236542|FG001|Overall Study|Protocol Violation|1|||
143189426|NCT03028129|516236541|FG000|Overall Study|Withdrawal by Subject|62|||
143189427|NCT03028129|516236542|FG001|Overall Study|Withdrawal by Subject|45|||
143189428|NCT00182078|516236543|FG000|Overall Study|Withdrawal by Subject|1|||
143189429|NCT00182078|516236544|FG001|Overall Study|Withdrawal by Subject|0|||
143189430|NCT01939977|516236545|FG000|Overall Study|Adverse Event|4|||
143189431|NCT01939977|516236546|FG001|Overall Study|Adverse Event|3|||
143189432|NCT01939977|516236545|FG000|Overall Study|Lack of Efficacy|3|||
143189433|NCT01939977|516236546|FG001|Overall Study|Lack of Efficacy|0|||
143189434|NCT01939977|516236545|FG000|Overall Study|Physician Decision|1|||
143189435|NCT01939977|516236546|FG001|Overall Study|Physician Decision|1|||
143189436|NCT01939977|516236545|FG000|Overall Study|Withdrawal by Subject|0|||
143189437|NCT01939977|516236546|FG001|Overall Study|Withdrawal by Subject|2|||
143189438|NCT01939977|516236545|FG000|Overall Study|Did not meet inclusion criteria|1|||
143189439|NCT01939977|516236546|FG001|Overall Study|Did not meet inclusion criteria|0|||
143189440|NCT01939977|516236545|FG000|Overall Study|Did not receive study medication|0|||
143189441|NCT01939977|516236546|FG001|Overall Study|Did not receive study medication|1|||
143189442|NCT01262560|516236556|FG000|Overall Study|Protocol Violation|0|||
143189443|NCT01262560|516236557|FG001|Overall Study|Protocol Violation|1|||
143189444|NCT01262560|516236558|FG002|Overall Study|Protocol Violation|2|||
143189445|NCT02470585|516236563|FG000|Overall Study|Death|224|||
143189446|NCT02470585|516236564|FG001|Overall Study|Death|227|||
143189447|NCT02470585|516236565|FG002|Overall Study|Death|199|||
143189448|NCT02470585|516236563|FG000|Overall Study|Withdrew consent|21|||
143189449|NCT02470585|516236564|FG001|Overall Study|Withdrew consent|22|||
143189450|NCT02470585|516236565|FG002|Overall Study|Withdrew consent|31|||
143189451|NCT02470585|516236563|FG000|Overall Study|Lost to Follow-up|8|||
143189452|NCT02470585|516236564|FG001|Overall Study|Lost to Follow-up|15|||
143189453|NCT02470585|516236565|FG002|Overall Study|Lost to Follow-up|13|||
143189454|NCT02470585|516236563|FG000|Overall Study|Sponsor discontinued study|117|||
143189455|NCT02470585|516236564|FG001|Overall Study|Sponsor discontinued study|110|||
143189456|NCT02470585|516236565|FG002|Overall Study|Sponsor discontinued study|122|||
143189457|NCT02470585|516236563|FG000|Overall Study|Other, not specified|5|||
143189458|NCT02470585|516236564|FG001|Overall Study|Other, not specified|7|||
143189459|NCT02470585|516236565|FG002|Overall Study|Other, not specified|14|||
143189460|NCT02470585|516236563|FG000|Overall Study|Missing due to site non-compliance|0|||
143189461|NCT02470585|516236564|FG001|Overall Study|Missing due to site non-compliance|2|||
143189462|NCT02470585|516236565|FG002|Overall Study|Missing due to site non-compliance|3|||
143189463|NCT00349349|516236566|FG000|Overall Study|Adverse Event|5|||
143189464|NCT00349349|516236567|FG001|Overall Study|Adverse Event|6|||
143189465|NCT00349349|516236568|FG002|Overall Study|Adverse Event|2|||
143189466|NCT00349349|516236566|FG000|Overall Study|Withdrawal by Subject|5|||
143189467|NCT00349349|516236567|FG001|Overall Study|Withdrawal by Subject|2|||
143189468|NCT00349349|516236568|FG002|Overall Study|Withdrawal by Subject|1|||
143189469|NCT00349349|516236566|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
143189470|NCT00349349|516236567|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
143189471|NCT00349349|516236568|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
143189472|NCT00349349|516236566|FG000|Overall Study|Death|13|||
143189473|NCT00349349|516236567|FG001|Overall Study|Death|10|||
143189474|NCT00349349|516236568|FG002|Overall Study|Death|1|||
143189475|NCT00349349|516236566|FG000|Overall Study|Other Treatment Selected|2|||
143189476|NCT00349349|516236567|FG001|Overall Study|Other Treatment Selected|0|||
143189477|NCT00349349|516236568|FG002|Overall Study|Other Treatment Selected|0|||
143189478|NCT00349349|516236566|FG000|Overall Study|Participant Reduced General Condition|0|||
143189479|NCT00349349|516236567|FG001|Overall Study|Participant Reduced General Condition|1|||
143189480|NCT00349349|516236568|FG002|Overall Study|Participant Reduced General Condition|0|||
143189481|NCT00349349|516236566|FG000|Overall Study|Physician Decision|1|||
143189482|NCT00349349|516236567|FG001|Overall Study|Physician Decision|2|||
143189483|NCT00349349|516236568|FG002|Overall Study|Physician Decision|1|||
143189484|NCT00349349|516236566|FG000|Overall Study|No Response|0|||
143189485|NCT00349349|516236567|FG001|Overall Study|No Response|3|||
143189486|NCT00349349|516236568|FG002|Overall Study|No Response|0|||
143189487|NCT00349349|516236566|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
143189488|NCT00349349|516236567|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
143189489|NCT00349349|516236568|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
143189490|NCT00792740|516236576|FG000|Overall Study|Disease Worsening|3|||
143189491|NCT00792740|516236577|FG001|Overall Study|Disease Worsening|2|||
143189492|NCT00792740|516236576|FG000|Overall Study|Personal Reason|1|||
143189493|NCT00792740|516236577|FG001|Overall Study|Personal Reason|0|||
143189494|NCT00792740|516236576|FG000|Overall Study|Adverse Event|1|||
143189495|NCT00792740|516236577|FG001|Overall Study|Adverse Event|3|||
143189496|NCT00792740|516236576|FG000|Overall Study|Patient's withdrawal of consent|0|||
143189497|NCT00792740|516236577|FG001|Overall Study|Patient's withdrawal of consent|1|||
143189498|NCT00792740|516236576|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
143189499|NCT00792740|516236577|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
143189500|NCT00792740|516236576|FG000|Overall Study|Other reasons|0|||
143189501|NCT00792740|516236577|FG001|Overall Study|Other reasons|1|||
143189502|NCT01063062|516236578|FG000|Overall Study|Patient withdrew consent|0|||
143189503|NCT01063062|516236579|FG001|Overall Study|Patient withdrew consent|1|||
143189504|NCT01063062|516236578|FG000|Overall Study|Adverse Event|2|||
143189505|NCT01063062|516236579|FG001|Overall Study|Adverse Event|4|||
143189506|NCT01063062|516236578|FG000|Overall Study|Protocol Violation|5|||
143189507|NCT01063062|516236579|FG001|Overall Study|Protocol Violation|4|||
143189508|NCT01063062|516236578|FG000|Overall Study|Investigator's request|1|||
143189509|NCT01063062|516236579|FG001|Overall Study|Investigator's request|0|||
143189510|NCT01063062|516236578|FG000|Overall Study|Lost to Follow-up|0|||
143189511|NCT01063062|516236579|FG001|Overall Study|Lost to Follow-up|2|||
143189512|NCT01063062|516236578|FG000|Overall Study|Miscellaneous reason|0|||
143189513|NCT01063062|516236579|FG001|Overall Study|Miscellaneous reason|1|||
143189514|NCT02015481|516236580|FG000|Overall Study|Death|1|||
143189515|NCT01352221|516236581|FG000|Double-blind Phase|Adverse Event|6|||
143189516|NCT01352221|516236582|FG001|Double-blind Phase|Adverse Event|4|||
143189517|NCT01352221|516236583|FG002|Double-blind Phase|Adverse Event|0|||
143189518|NCT01352221|516236584|FG003|Double-blind Phase|Adverse Event|0|||
143189519|NCT01352221|516236581|FG000|Double-blind Phase|Withdrawal by Subject|3|||
143189520|NCT01352221|516236582|FG001|Double-blind Phase|Withdrawal by Subject|5|||
143189521|NCT01352221|516236583|FG002|Double-blind Phase|Withdrawal by Subject|0|||
143189522|NCT01352221|516236584|FG003|Double-blind Phase|Withdrawal by Subject|0|||
143189523|NCT01352221|516236581|FG000|Double-blind Phase|Lost to Follow-up|0|||
143189524|NCT01352221|516236582|FG001|Double-blind Phase|Lost to Follow-up|1|||
143189525|NCT01352221|516236583|FG002|Double-blind Phase|Lost to Follow-up|0|||
143189526|NCT01352221|516236584|FG003|Double-blind Phase|Lost to Follow-up|0|||
143189527|NCT01352221|516236581|FG000|Double-blind Phase|Protocol Violation|0|||
143189528|NCT01352221|516236582|FG001|Double-blind Phase|Protocol Violation|1|||
143189529|NCT01352221|516236583|FG002|Double-blind Phase|Protocol Violation|0|||
143189530|NCT01352221|516236584|FG003|Double-blind Phase|Protocol Violation|0|||
143189531|NCT01352221|516236581|FG000|Open-label Phase|Physician Decision|0|||
143189532|NCT01352221|516236582|FG001|Open-label Phase|Physician Decision|0|||
143189533|NCT01352221|516236583|FG002|Open-label Phase|Physician Decision|2|||
143189534|NCT01352221|516236584|FG003|Open-label Phase|Physician Decision|1|||
143189535|NCT01352221|516236581|FG000|Open-label Phase|Pregnancy|0|||
143189536|NCT01352221|516236582|FG001|Open-label Phase|Pregnancy|0|||
143189537|NCT01352221|516236583|FG002|Open-label Phase|Pregnancy|1|||
143189538|NCT01352221|516236584|FG003|Open-label Phase|Pregnancy|0|||
143189539|NCT01352221|516236581|FG000|Open-label Phase|Adverse Event|0|||
143189540|NCT01352221|516236582|FG001|Open-label Phase|Adverse Event|0|||
143189541|NCT01352221|516236583|FG002|Open-label Phase|Adverse Event|8|||
143189542|NCT01352221|516236584|FG003|Open-label Phase|Adverse Event|4|||
143189543|NCT01352221|516236581|FG000|Open-label Phase|Withdrawal by Subject|0|||
143189544|NCT01352221|516236582|FG001|Open-label Phase|Withdrawal by Subject|0|||
143189545|NCT01352221|516236583|FG002|Open-label Phase|Withdrawal by Subject|1|||
143189546|NCT01352221|516236584|FG003|Open-label Phase|Withdrawal by Subject|6|||
143189547|NCT01352221|516236581|FG000|Open-label Phase|Worsening of IBD|0|||
143189548|NCT01352221|516236582|FG001|Open-label Phase|Worsening of IBD|0|||
143189549|NCT01352221|516236583|FG002|Open-label Phase|Worsening of IBD|1|||
143189550|NCT01352221|516236584|FG003|Open-label Phase|Worsening of IBD|0|||
143189551|NCT02016716|516236585|FG000|Overall Study|Withdrawal by Subject|5|||
143189552|NCT02016716|516236586|FG001|Overall Study|Withdrawal by Subject|5|||
143189553|NCT02016716|516236587|FG002|Overall Study|Withdrawal by Subject|5|||
143189554|NCT02016716|516236585|FG000|Overall Study|Protocol-specified Criteria|0|||
143189555|NCT02016716|516236586|FG001|Overall Study|Protocol-specified Criteria|1|||
143189556|NCT02016716|516236587|FG002|Overall Study|Protocol-specified Criteria|0|||
143189557|NCT02016716|516236585|FG000|Overall Study|Lost to Follow-up|1|||
143189558|NCT02016716|516236586|FG001|Overall Study|Lost to Follow-up|2|||
143189559|NCT02016716|516236587|FG002|Overall Study|Lost to Follow-up|1|||
143189560|NCT00107900|516236590|FG000|Overall Study|Adverse Event|3|||
143189561|NCT00107900|516236591|FG001|Overall Study|Adverse Event|2|||
143189562|NCT00107900|516236592|FG002|Overall Study|Adverse Event|10|||
143189563|NCT00107900|516236593|FG003|Overall Study|Adverse Event|3|||
143189564|NCT00107900|516236594|FG004|Overall Study|Adverse Event|5|||
143189565|NCT00107900|516236595|FG005|Overall Study|Adverse Event|3|||
143189566|NCT00107900|516236590|FG000|Overall Study|Death|0|||
143189567|NCT00107900|516236591|FG001|Overall Study|Death|0|||
143189568|NCT00107900|516236592|FG002|Overall Study|Death|0|||
143189569|NCT00107900|516236593|FG003|Overall Study|Death|0|||
143189570|NCT00107900|516236594|FG004|Overall Study|Death|1|||
143189571|NCT00107900|516236595|FG005|Overall Study|Death|0|||
143189572|NCT00107900|516236590|FG000|Overall Study|Lost to Follow-up|4|||
143189573|NCT00107900|516236591|FG001|Overall Study|Lost to Follow-up|1|||
143189574|NCT00107900|516236592|FG002|Overall Study|Lost to Follow-up|3|||
143189575|NCT00107900|516236593|FG003|Overall Study|Lost to Follow-up|2|||
143189576|NCT00107900|516236594|FG004|Overall Study|Lost to Follow-up|5|||
143189577|NCT00107900|516236595|FG005|Overall Study|Lost to Follow-up|5|||
143189578|NCT00107900|516236590|FG000|Overall Study|Protocol Violation|1|||
143189579|NCT00107900|516236591|FG001|Overall Study|Protocol Violation|0|||
143189580|NCT00107900|516236592|FG002|Overall Study|Protocol Violation|5|||
143189581|NCT00107900|516236593|FG003|Overall Study|Protocol Violation|5|||
143189582|NCT00107900|516236594|FG004|Overall Study|Protocol Violation|7|||
143189583|NCT00107900|516236595|FG005|Overall Study|Protocol Violation|0|||
143189584|NCT00107900|516236590|FG000|Overall Study|Withdrawal by Subject|1|||
143189585|NCT00107900|516236591|FG001|Overall Study|Withdrawal by Subject|0|||
143189586|NCT00107900|516236592|FG002|Overall Study|Withdrawal by Subject|5|||
143189587|NCT00107900|516236593|FG003|Overall Study|Withdrawal by Subject|0|||
143189588|NCT00107900|516236594|FG004|Overall Study|Withdrawal by Subject|1|||
143189589|NCT00107900|516236595|FG005|Overall Study|Withdrawal by Subject|1|||
143189590|NCT00107900|516236590|FG000|Overall Study|Administrative Reasons|1|||
143189591|NCT00107900|516236591|FG001|Overall Study|Administrative Reasons|0|||
143189592|NCT00107900|516236592|FG002|Overall Study|Administrative Reasons|2|||
143189593|NCT00107900|516236593|FG003|Overall Study|Administrative Reasons|2|||
143189594|NCT00107900|516236594|FG004|Overall Study|Administrative Reasons|2|||
143189595|NCT00107900|516236595|FG005|Overall Study|Administrative Reasons|0|||
143189596|NCT02147197|516236599|FG000|Overall Study|Adverse Event|1|||
143189597|NCT02147197|516236600|FG001|Overall Study|Adverse Event|0|||
143189598|NCT02147197|516236601|FG002|Overall Study|Adverse Event|0|||
143189599|NCT02147197|516236599|FG000|Overall Study|Withdrawal of Consent|4|||
143189600|NCT02147197|516236600|FG001|Overall Study|Withdrawal of Consent|3|||
143189601|NCT02147197|516236601|FG002|Overall Study|Withdrawal of Consent|2|||
143189602|NCT02147197|516236599|FG000|Overall Study|Lost to Follow-up|2|||
143189603|NCT02147197|516236600|FG001|Overall Study|Lost to Follow-up|3|||
143189604|NCT02147197|516236601|FG002|Overall Study|Lost to Follow-up|1|||
143189605|NCT02147197|516236599|FG000|Overall Study|Protocol Violation|1|||
143189606|NCT02147197|516236600|FG001|Overall Study|Protocol Violation|0|||
143189607|NCT02147197|516236601|FG002|Overall Study|Protocol Violation|3|||
143189608|NCT02147197|516236599|FG000|Overall Study|Other Miscellaneous Reasons|1|||
143189609|NCT02147197|516236600|FG001|Overall Study|Other Miscellaneous Reasons|0|||
143189610|NCT02147197|516236601|FG002|Overall Study|Other Miscellaneous Reasons|3|||
143189611|NCT04848220|516238175|FG000|Overall Study|Unable to proceed to study procedure|0|||
143189612|NCT04848220|516238176|FG001|Overall Study|Unable to proceed to study procedure|1|||
143189613|NCT04848220|516238177|FG002|Overall Study|Unable to proceed to study procedure|0|||
143189614|NCT04848220|516238175|FG000|Overall Study|Fractional flow not significant|0|||
143189615|NCT04848220|516238176|FG001|Overall Study|Fractional flow not significant|1|||
143189616|NCT04848220|516238177|FG002|Overall Study|Fractional flow not significant|0|||
143189617|NCT02923830|516238178|FG000|Overall Study|Physician Decision|13|||
143189618|NCT02923830|516238179|FG001|Overall Study|Physician Decision|15|||
143189619|NCT00394251|516238197|FG000|Overall Study|Adverse Event|7|||
143189620|NCT00394251|516238198|FG001|Overall Study|Adverse Event|5|||
143189621|NCT00394251|516238197|FG000|Overall Study|Unacceptable Toxicity|20|||
143189622|NCT00394251|516238198|FG001|Overall Study|Unacceptable Toxicity|18|||
143189623|NCT00394251|516238197|FG000|Overall Study|Physician Decision|1|||
143189624|NCT00394251|516238198|FG001|Overall Study|Physician Decision|1|||
143189625|NCT00394251|516238197|FG000|Overall Study|Protocol Violation|0|||
143189626|NCT00394251|516238198|FG001|Overall Study|Protocol Violation|1|||
143189627|NCT00394251|516238197|FG000|Overall Study|Withdrawal by Subject|7|||
143189628|NCT00394251|516238198|FG001|Overall Study|Withdrawal by Subject|11|||
143189629|NCT00394251|516238197|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
143189630|NCT00394251|516238198|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
143189631|NCT05791565|516238199|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
143189632|NCT05791565|516238200|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
143189633|NCT04644276|516238201|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
143189634|NCT04644276|516238202|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
143189635|NCT04644276|516238203|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
143189636|NCT00705250|516238204|FG000|Overall Study|Withdrawal by Subject|1|||
143189637|NCT00705250|516238204|FG000|Overall Study|Patient died in car accident|1|||
143189638|NCT00880269|516238205|FG000|Overall Study|Protocol Violation|1|||
143189639|NCT00880269|516238206|FG001|Overall Study|Protocol Violation|0|||
143189640|NCT00880269|516238205|FG000|Overall Study|Disease Progression|13|||
143189641|NCT00880269|516238206|FG001|Overall Study|Disease Progression|11|||
143189642|NCT00880269|516238205|FG000|Overall Study|New Cancer Therapy|1|||
143189643|NCT00880269|516238206|FG001|Overall Study|New Cancer Therapy|0|||
143189644|NCT00880269|516238205|FG000|Overall Study|Death|4|||
143189645|NCT00880269|516238206|FG001|Overall Study|Death|2|||
143189646|NCT00880269|516238205|FG000|Overall Study|Lost to Follow-up|0|||
143189647|NCT00880269|516238206|FG001|Overall Study|Lost to Follow-up|1|||
143189648|NCT00880269|516238205|FG000|Overall Study|Withdrawal by Subject|3|||
143189649|NCT00880269|516238206|FG001|Overall Study|Withdrawal by Subject|4|||
143189650|NCT00880269|516238205|FG000|Overall Study|Adverse Event|10|||
143189651|NCT00880269|516238206|FG001|Overall Study|Adverse Event|9|||
143189652|NCT01406938|516238207|FG000|Induction Period|Subject/guardian decision|6|||
143189653|NCT01406938|516238208|FG001|Induction Period|Subject/guardian decision|8|||
143189654|NCT01406938|516238209|FG002|Induction Period|Subject/guardian decision|0|||
143189655|NCT01406938|516238210|FG003|Induction Period|Subject/guardian decision|0|||
143189656|NCT01406938|516238211|FG004|Induction Period|Subject/guardian decision|0|||
143189657|NCT01406938|516238212|FG005|Induction Period|Subject/guardian decision|0|||
143189658|NCT01406938|516238207|FG000|Induction Period|Protocol deviation|1|||
143189659|NCT01406938|516238208|FG001|Induction Period|Protocol deviation|0|||
143189660|NCT01406938|516238209|FG002|Induction Period|Protocol deviation|0|||
143189661|NCT01406938|516238210|FG003|Induction Period|Protocol deviation|0|||
143189662|NCT01406938|516238211|FG004|Induction Period|Protocol deviation|0|||
143189663|NCT01406938|516238212|FG005|Induction Period|Protocol deviation|0|||
143189664|NCT01406938|516238207|FG000|Induction Period|Adverse Event|8|||
143189665|NCT01406938|516238208|FG001|Induction Period|Adverse Event|9|||
143189666|NCT01406938|516238209|FG002|Induction Period|Adverse Event|0|||
143189667|NCT01406938|516238210|FG003|Induction Period|Adverse Event|0|||
143189668|NCT01406938|516238211|FG004|Induction Period|Adverse Event|0|||
143189669|NCT01406938|516238212|FG005|Induction Period|Adverse Event|0|||
143189670|NCT01406938|516238207|FG000|Induction Period|Lack of Efficacy|1|||
143189671|NCT01406938|516238208|FG001|Induction Period|Lack of Efficacy|0|||
143189672|NCT01406938|516238209|FG002|Induction Period|Lack of Efficacy|0|||
143189673|NCT01406938|516238210|FG003|Induction Period|Lack of Efficacy|0|||
143189674|NCT01406938|516238211|FG004|Induction Period|Lack of Efficacy|0|||
143189675|NCT01406938|516238212|FG005|Induction Period|Lack of Efficacy|0|||
143189676|NCT01406938|516238207|FG000|Induction Period|Lost to Follow-up|2|||
143189677|NCT01406938|516238208|FG001|Induction Period|Lost to Follow-up|3|||
143189678|NCT01406938|516238209|FG002|Induction Period|Lost to Follow-up|0|||
143189679|NCT01406938|516238210|FG003|Induction Period|Lost to Follow-up|0|||
143189680|NCT01406938|516238211|FG004|Induction Period|Lost to Follow-up|0|||
143189681|NCT01406938|516238212|FG005|Induction Period|Lost to Follow-up|0|||
143189682|NCT01406938|516238207|FG000|Maintenance Period|Adverse Event|0|||
143189683|NCT01406938|516238208|FG001|Maintenance Period|Adverse Event|0|||
143189684|NCT01406938|516238209|FG002|Maintenance Period|Adverse Event|2|||
143189685|NCT01406938|516238210|FG003|Maintenance Period|Adverse Event|8|||
143189686|NCT01406938|516238211|FG004|Maintenance Period|Adverse Event|4|||
143189687|NCT01406938|516238212|FG005|Maintenance Period|Adverse Event|2|||
143189688|NCT01406938|516238207|FG000|Maintenance Period|Death|0|||
143189689|NCT01406938|516238208|FG001|Maintenance Period|Death|0|||
143189690|NCT01406938|516238209|FG002|Maintenance Period|Death|0|||
143189691|NCT01406938|516238210|FG003|Maintenance Period|Death|0|||
143189692|NCT01406938|516238211|FG004|Maintenance Period|Death|1|||
143189693|NCT01406938|516238212|FG005|Maintenance Period|Death|0|||
143189694|NCT01406938|516238207|FG000|Maintenance Period|Subject/guardian decision|0|||
143189695|NCT01406938|516238208|FG001|Maintenance Period|Subject/guardian decision|0|||
143369521|NCT02057718|516896145|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
143189696|NCT01406938|516238209|FG002|Maintenance Period|Subject/guardian decision|11|||
143189697|NCT01406938|516238210|FG003|Maintenance Period|Subject/guardian decision|7|||
143189698|NCT01406938|516238211|FG004|Maintenance Period|Subject/guardian decision|10|||
143189699|NCT01406938|516238212|FG005|Maintenance Period|Subject/guardian decision|7|||
143189700|NCT01406938|516238207|FG000|Maintenance Period|Protocol Violation|0|||
143189701|NCT01406938|516238208|FG001|Maintenance Period|Protocol Violation|0|||
143189702|NCT01406938|516238209|FG002|Maintenance Period|Protocol Violation|2|||
143189703|NCT01406938|516238210|FG003|Maintenance Period|Protocol Violation|2|||
143189704|NCT01406938|516238211|FG004|Maintenance Period|Protocol Violation|2|||
143189705|NCT01406938|516238212|FG005|Maintenance Period|Protocol Violation|2|||
143189706|NCT01406938|516238207|FG000|Maintenance Period|Pregnancy|0|||
143189707|NCT01406938|516238208|FG001|Maintenance Period|Pregnancy|0|||
143189708|NCT01406938|516238209|FG002|Maintenance Period|Pregnancy|0|||
143189709|NCT01406938|516238210|FG003|Maintenance Period|Pregnancy|0|||
143189710|NCT01406938|516238211|FG004|Maintenance Period|Pregnancy|1|||
143189711|NCT01406938|516238212|FG005|Maintenance Period|Pregnancy|0|||
143189712|NCT01406938|516238207|FG000|Maintenance Period|Lost to Follow-up|0|||
143189713|NCT01406938|516238208|FG001|Maintenance Period|Lost to Follow-up|0|||
143189714|NCT01406938|516238209|FG002|Maintenance Period|Lost to Follow-up|0|||
143189715|NCT01406938|516238210|FG003|Maintenance Period|Lost to Follow-up|0|||
143189716|NCT01406938|516238211|FG004|Maintenance Period|Lost to Follow-up|4|||
143189717|NCT01406938|516238212|FG005|Maintenance Period|Lost to Follow-up|0|||
143189718|NCT01406938|516238207|FG000|Maintenance Period|Lack of Efficacy|0|||
143189719|NCT01406938|516238208|FG001|Maintenance Period|Lack of Efficacy|0|||
143189720|NCT01406938|516238209|FG002|Maintenance Period|Lack of Efficacy|2|||
143189721|NCT01406938|516238210|FG003|Maintenance Period|Lack of Efficacy|1|||
143189722|NCT01406938|516238211|FG004|Maintenance Period|Lack of Efficacy|3|||
143189723|NCT01406938|516238212|FG005|Maintenance Period|Lack of Efficacy|5|||
143189724|NCT01406938|516238207|FG000|Follow up|Lack of Efficacy|3|||
143189725|NCT01406938|516238208|FG001|Follow up|Lack of Efficacy|2|||
143189726|NCT01406938|516238209|FG002|Follow up|Lack of Efficacy|1|||
143189727|NCT01406938|516238210|FG003|Follow up|Lack of Efficacy|0|||
143189728|NCT01406938|516238211|FG004|Follow up|Lack of Efficacy|0|||
143189729|NCT01406938|516238212|FG005|Follow up|Lack of Efficacy|0|||
143189730|NCT01406938|516238207|FG000|Follow up|Patient/guardian decision|4|||
143189731|NCT01406938|516238208|FG001|Follow up|Patient/guardian decision|2|||
143189732|NCT01406938|516238209|FG002|Follow up|Patient/guardian decision|4|||
143189733|NCT01406938|516238210|FG003|Follow up|Patient/guardian decision|2|||
143189734|NCT01406938|516238211|FG004|Follow up|Patient/guardian decision|4|||
143189735|NCT01406938|516238212|FG005|Follow up|Patient/guardian decision|1|||
143189736|NCT01406938|516238207|FG000|Follow up|Protocol Violation|0|||
143189737|NCT01406938|516238208|FG001|Follow up|Protocol Violation|0|||
143189738|NCT01406938|516238209|FG002|Follow up|Protocol Violation|1|||
143189739|NCT01406938|516238210|FG003|Follow up|Protocol Violation|0|||
143189740|NCT01406938|516238211|FG004|Follow up|Protocol Violation|0|||
143189741|NCT01406938|516238212|FG005|Follow up|Protocol Violation|0|||
143189742|NCT01406938|516238207|FG000|Follow up|Physician Decision|0|||
143189743|NCT01406938|516238208|FG001|Follow up|Physician Decision|0|||
143189744|NCT01406938|516238209|FG002|Follow up|Physician Decision|2|||
143189745|NCT01406938|516238210|FG003|Follow up|Physician Decision|0|||
143189746|NCT01406938|516238211|FG004|Follow up|Physician Decision|3|||
143261461|NCT01582854|516510585|FG000|Overall Study|Recurrent Stroke|13|||
143261462|NCT01582854|516510586|FG001|Overall Study|Recurrent Stroke|8|||
143261463|NCT01582854|516510585|FG000|Overall Study|Disallowed Concomitant Medication|3|||
143261464|NCT01582854|516510586|FG001|Overall Study|Disallowed Concomitant Medication|2|||
143261465|NCT01582854|516510585|FG000|Overall Study|Carotid or Neurosurgery|0|||
143189747|NCT01406938|516238212|FG005|Follow up|Physician Decision|1|||
143189748|NCT01406938|516238207|FG000|Follow up|Lost to Follow-up|1|||
143189749|NCT01406938|516238208|FG001|Follow up|Lost to Follow-up|1|||
143189750|NCT01406938|516238209|FG002|Follow up|Lost to Follow-up|0|||
143189751|NCT01406938|516238210|FG003|Follow up|Lost to Follow-up|1|||
143189752|NCT01406938|516238211|FG004|Follow up|Lost to Follow-up|2|||
143189753|NCT01406938|516238212|FG005|Follow up|Lost to Follow-up|1|||
143189754|NCT01576146|516238213|FG000|Extension Period 1|Adverse Event|2|||
143189755|NCT01576146|516238213|FG000|Extension Period 1|Death|2|||
143189756|NCT01576146|516238213|FG000|Extension Period 1|Physician Decision|2|||
143261466|NCT01582854|516510586|FG001|Overall Study|Carotid or Neurosurgery|1|||
143189757|NCT01576146|516238213|FG000|Extension Period 1|Withdrawal by Subject|1|||
143189758|NCT01576146|516238213|FG000|Extension Period 1|Lost to Follow-up|1|||
143189759|NCT01576146|516238213|FG000|Extension Period 1|Parathyroidectomy|1|||
143189760|NCT01576146|516238213|FG000|Extension Period 1|Renal Transplant|1|||
143189761|NCT01576146|516238213|FG000|Extension Period 2|Sponsor Decision|13|||
143261467|NCT01582854|516510585|FG000|Overall Study|General Anaesthesia|0|||
143261468|NCT01582854|516510586|FG001|Overall Study|General Anaesthesia|1|||
143189762|NCT01576146|516238213|FG000|Extension Period 2|Death|1|||
143189763|NCT01576146|516238213|FG000|Extension Period 2|Adverse Event|1|||
143189764|NCT01576146|516238213|FG000|Extension Period 2|Renal Transplant|1|||
143189765|NCT01576146|516238213|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
143189766|NCT01667224|516238218|FG000|Overall Study|Withdrawal by Subject|3|||
143189767|NCT01667224|516238219|FG001|Overall Study|Withdrawal by Subject|1|||
143189768|NCT01667224|516238218|FG000|Overall Study|Protocol Violation|1|||
143189769|NCT01667224|516238219|FG001|Overall Study|Protocol Violation|1|||
143189770|NCT00316225|516238220|FG000|Overall Study|Adverse Event|2|||
143189771|NCT00316225|516238220|FG000|Overall Study|Physician Decision|3|||
143189772|NCT00316225|516238220|FG000|Overall Study|Progressive Disease|15|||
143189773|NCT00316225|516238220|FG000|Overall Study|Withdrawal by Subject|3|||
143261469|NCT01582854|516510585|FG000|Overall Study|Other Miscellaneous Reason|1|||
143261470|NCT01582854|516510586|FG001|Overall Study|Other Miscellaneous Reason|0|||
143261471|NCT04068896|516510587|FG000|Overall Study|Adverse Event|2|||
143261472|NCT04068896|516510588|FG001|Overall Study|Adverse Event|0|||
143261473|NCT04068896|516510589|FG002|Overall Study|Adverse Event|1|||
143261474|NCT04068896|516510590|FG003|Overall Study|Adverse Event|0|||
143261475|NCT04068896|516510591|FG004|Overall Study|Adverse Event|0|||
143261476|NCT04068896|516510592|FG005|Overall Study|Adverse Event|0|||
143261477|NCT04068896|516510587|FG000|Overall Study|Death|3|||
143261478|NCT04068896|516510588|FG001|Overall Study|Death|1|||
143261479|NCT04068896|516510589|FG002|Overall Study|Death|3|||
143261480|NCT04068896|516510590|FG003|Overall Study|Death|19|||
143189774|NCT00316225|516238220|FG000|Overall Study|Death|2|||
143189775|NCT01814878|516238221|FG000|Overall Study|Adverse Event|16|||
143189776|NCT01814878|516238222|FG001|Overall Study|Adverse Event|5|||
143189777|NCT01814878|516238221|FG000|Overall Study|Withdrawal by Subject|20|||
143189778|NCT01814878|516238222|FG001|Overall Study|Withdrawal by Subject|16|||
143189779|NCT01814878|516238221|FG000|Overall Study|Protocol Violation|5|||
143189780|NCT01814878|516238222|FG001|Overall Study|Protocol Violation|5|||
143189781|NCT01814878|516238221|FG000|Overall Study|Physician Decision|3|||
143189782|NCT01814878|516238222|FG001|Overall Study|Physician Decision|1|||
143189783|NCT01814878|516238221|FG000|Overall Study|Screening failure (drop-out)|0|||
143189784|NCT01814878|516238222|FG001|Overall Study|Screening failure (drop-out)|3|||
143189785|NCT01814878|516238221|FG000|Overall Study|Other|2|||
143189786|NCT01814878|516238222|FG001|Overall Study|Other|0|||
143189787|NCT01811485|516238223|FG000|Overall Study|Adverse Event|1|||
143189788|NCT01811485|516238224|FG001|Overall Study|Adverse Event|3|||
143189789|NCT01811485|516238225|FG002|Overall Study|Adverse Event|2|||
143189790|NCT01811485|516238223|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
143189791|NCT01811485|516238224|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
143189792|NCT01811485|516238225|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
143189793|NCT01811485|516238223|FG000|Overall Study|Administrative problems|1|||
143189794|NCT01811485|516238224|FG001|Overall Study|Administrative problems|0|||
143189795|NCT01811485|516238225|FG002|Overall Study|Administrative problems|0|||
143189796|NCT01811485|516238223|FG000|Overall Study|Protocol Deviation|0|||
143189797|NCT01811485|516238224|FG001|Overall Study|Protocol Deviation|1|||
143189798|NCT01811485|516238225|FG002|Overall Study|Protocol Deviation|0|||
143189799|NCT01545934|516238226|FG000|Overall Study|Withdrawal by Subject|4|||
143189800|NCT01545934|516238227|FG001|Overall Study|Withdrawal by Subject|3|||
143189801|NCT01545934|516238226|FG000|Overall Study|Lost to Follow-up|1|||
143189802|NCT01545934|516238227|FG001|Overall Study|Lost to Follow-up|0|||
143189803|NCT03654404|516238228|FG000|Overall Study|Death|1|||
143189804|NCT03654404|516238228|FG000|Overall Study|Lost to Follow-up|2|||
143189805|NCT03654404|516238228|FG000|Overall Study|Withdrawal by Subject|5|||
143189806|NCT02003638|516238233|FG000|Overall Study|Withdrawal by Subject|1|||
143189807|NCT02003638|516238234|FG001|Overall Study|Withdrawal by Subject|0|||
143189808|NCT03299881|516238235|FG000|Overall Study|Study Termination|17|||
143189809|NCT03299881|516238236|FG001|Overall Study|Study Termination|13|||
143261481|NCT04068896|516510591|FG004|Overall Study|Death|17|||
143189810|NCT00878254|516238237|FG000|Overall Study|Physician Decision|1|||
143189811|NCT00878254|516238237|FG000|Overall Study|Death|1|||
143189812|NCT00878254|516238237|FG000|Overall Study|Withdrawal by Subject|1|||
143189813|NCT00194077|516238241|FG000|Overall Study|Lack of Efficacy|22|||
143189814|NCT00194077|516238242|FG001|Overall Study|Lack of Efficacy|29|||
143189815|NCT00194077|516238241|FG000|Overall Study|Study nonadherence|1|||
143189816|NCT00194077|516238242|FG001|Overall Study|Study nonadherence|0|||
143189817|NCT00194077|516238241|FG000|Overall Study|Withdrawal by Subject|1|||
143189818|NCT00194077|516238242|FG001|Overall Study|Withdrawal by Subject|1|||
143261482|NCT04068896|516510592|FG005|Overall Study|Death|0|||
143189819|NCT00759876|516238244|FG000|Overall Study|Sponsor terminated study early|36|||
143189820|NCT02957747|516238246|FG000|Overall Study|Withdrawal by Subject|0|||
143189821|NCT02957747|516238247|FG001|Overall Study|Withdrawal by Subject|3|||
143189822|NCT02957747|516238246|FG000|Overall Study|Lost to Follow-up|10|||
143189823|NCT02957747|516238247|FG001|Overall Study|Lost to Follow-up|5|||
143189824|NCT01035463|516238250|FG000|Overall Study|Adverse Event|0|||
143189825|NCT01035463|516238251|FG001|Overall Study|Adverse Event|0|||
143189826|NCT01035463|516238252|FG002|Overall Study|Adverse Event|4|||
143189827|NCT01035463|516238253|FG003|Overall Study|Adverse Event|1|||
143189828|NCT01035463|516238254|FG004|Overall Study|Adverse Event|5|||
143189829|NCT01035463|516238255|FG005|Overall Study|Adverse Event|7|||
143261483|NCT04068896|516510587|FG000|Overall Study|Physician Decision|0|||
143189830|NCT01035463|516238250|FG000|Overall Study|Withdrawal by Subject|0|||
143189831|NCT01035463|516238251|FG001|Overall Study|Withdrawal by Subject|2|||
143189832|NCT01035463|516238252|FG002|Overall Study|Withdrawal by Subject|1|||
143189833|NCT01035463|516238253|FG003|Overall Study|Withdrawal by Subject|0|||
143189834|NCT01035463|516238254|FG004|Overall Study|Withdrawal by Subject|1|||
143189835|NCT01035463|516238255|FG005|Overall Study|Withdrawal by Subject|4|||
143189836|NCT01035463|516238250|FG000|Overall Study|Disease progression|0|||
143189837|NCT01035463|516238251|FG001|Overall Study|Disease progression|0|||
143189838|NCT01035463|516238252|FG002|Overall Study|Disease progression|0|||
143189839|NCT01035463|516238253|FG003|Overall Study|Disease progression|0|||
143189840|NCT01035463|516238254|FG004|Overall Study|Disease progression|0|||
143189841|NCT01035463|516238255|FG005|Overall Study|Disease progression|3|||
143189842|NCT01035463|516238250|FG000|Overall Study|Other Malignancy|0|||
143189843|NCT01035463|516238251|FG001|Overall Study|Other Malignancy|0|||
143189844|NCT01035463|516238252|FG002|Overall Study|Other Malignancy|0|||
143189845|NCT01035463|516238253|FG003|Overall Study|Other Malignancy|0|||
143189846|NCT01035463|516238254|FG004|Overall Study|Other Malignancy|0|||
143189847|NCT01035463|516238255|FG005|Overall Study|Other Malignancy|2|||
143189848|NCT01035463|516238250|FG000|Overall Study|Other|0|||
143189849|NCT01035463|516238251|FG001|Overall Study|Other|0|||
143189850|NCT01035463|516238252|FG002|Overall Study|Other|0|||
143189851|NCT01035463|516238253|FG003|Overall Study|Other|1|||
143189852|NCT01035463|516238254|FG004|Overall Study|Other|0|||
143189853|NCT01035463|516238255|FG005|Overall Study|Other|2|||
143189854|NCT01257230|516238256|FG000|Overall Study|Not Treated|0|||
143189855|NCT01257230|516238257|FG001|Overall Study|Not Treated|0|||
143189856|NCT01257230|516238258|FG002|Overall Study|Not Treated|1|||
143189857|NCT01257230|516238256|FG000|Overall Study|Adverse Event|2|||
143189858|NCT01257230|516238257|FG001|Overall Study|Adverse Event|0|||
143189859|NCT01257230|516238258|FG002|Overall Study|Adverse Event|0|||
143189860|NCT01257230|516238256|FG000|Overall Study|Lack of Efficacy|0|||
143189861|NCT01257230|516238257|FG001|Overall Study|Lack of Efficacy|1|||
143189862|NCT01257230|516238258|FG002|Overall Study|Lack of Efficacy|0|||
143189863|NCT01257230|516238256|FG000|Overall Study|Protocol Violation|3|||
143189864|NCT01257230|516238257|FG001|Overall Study|Protocol Violation|0|||
143189865|NCT01257230|516238258|FG002|Overall Study|Protocol Violation|1|||
143189866|NCT01257230|516238256|FG000|Overall Study|Withdrawal by Subject|0|||
143189867|NCT01257230|516238257|FG001|Overall Study|Withdrawal by Subject|4|||
143189868|NCT01257230|516238258|FG002|Overall Study|Withdrawal by Subject|1|||
143189869|NCT01257230|516238256|FG000|Overall Study|Other reason not defined above|1|||
143189870|NCT01257230|516238257|FG001|Overall Study|Other reason not defined above|5|||
143189871|NCT01257230|516238258|FG002|Overall Study|Other reason not defined above|3|||
143189872|NCT00765037|516238261|FG000|Overall Study|Lost to Follow-up|5|||
143189873|NCT00765037|516238261|FG000|Overall Study|Adverse Event|1|||
143189874|NCT01988662|516238266|FG000|Overall Study|Subject/guardian decision|1|||
143189875|NCT01988662|516238267|FG001|Overall Study|Subject/guardian decision|1|||
143261484|NCT04068896|516510588|FG001|Overall Study|Physician Decision|0|||
143261485|NCT04068896|516510589|FG002|Overall Study|Physician Decision|0|||
143261486|NCT04068896|516510590|FG003|Overall Study|Physician Decision|1|||
143261487|NCT04068896|516510591|FG004|Overall Study|Physician Decision|0|||
143261488|NCT04068896|516510592|FG005|Overall Study|Physician Decision|0|||
143189876|NCT01988662|516238266|FG000|Overall Study|Adverse Event|3|||
143189877|NCT01988662|516238267|FG001|Overall Study|Adverse Event|1|||
143189878|NCT00002540|516238269|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
143189879|NCT00002540|516238270|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
143189880|NCT00002540|516238269|FG000|Overall Study|Died Before Randomization|2|||
143189881|NCT00002540|516238270|FG001|Overall Study|Died Before Randomization|6|||
143189882|NCT00002540|516238269|FG000|Overall Study|Died Before ASU (Control)|202|||
143189883|NCT00002540|516238270|FG001|Overall Study|Died Before ASU (Control)|0|||
143189884|NCT00002540|516238269|FG000|Overall Study|Refused ASU (Control)|597|||
143189885|NCT00002540|516238270|FG001|Overall Study|Refused ASU (Control)|0|||
143189886|NCT00002540|516238269|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
143189887|NCT00002540|516238270|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
143189888|NCT01864148|516238271|FG000|Overall Study|Other|2|||
143261489|NCT04068896|516510587|FG000|Overall Study|progressive disease|3|||
143261490|NCT04068896|516510588|FG001|Overall Study|progressive disease|5|||
143261491|NCT04068896|516510589|FG002|Overall Study|progressive disease|3|||
143261492|NCT04068896|516510590|FG003|Overall Study|progressive disease|2|||
143261493|NCT04068896|516510591|FG004|Overall Study|progressive disease|1|||
143261494|NCT04068896|516510592|FG005|Overall Study|progressive disease|2|||
143261495|NCT04068896|516510587|FG000|Overall Study|Study terminated by sponsor|0|||
143261496|NCT04068896|516510588|FG001|Overall Study|Study terminated by sponsor|0|||
143261497|NCT04068896|516510589|FG002|Overall Study|Study terminated by sponsor|1|||
143261498|NCT04068896|516510590|FG003|Overall Study|Study terminated by sponsor|2|||
143261499|NCT04068896|516510591|FG004|Overall Study|Study terminated by sponsor|1|||
143261500|NCT04068896|516510592|FG005|Overall Study|Study terminated by sponsor|4|||
143189889|NCT01864148|516238272|FG001|Overall Study|Other|1|||
143189890|NCT01864148|516238273|FG002|Overall Study|Other|1|||
143189891|NCT01864148|516238274|FG003|Overall Study|Other|3|||
143189892|NCT01864148|516238275|FG004|Overall Study|Other|1|||
143189893|NCT01864148|516238271|FG000|Overall Study|Death|0|||
143189894|NCT01864148|516238272|FG001|Overall Study|Death|0|||
143189895|NCT01864148|516238273|FG002|Overall Study|Death|0|||
143189896|NCT01864148|516238274|FG003|Overall Study|Death|1|||
143189897|NCT01864148|516238275|FG004|Overall Study|Death|0|||
143189898|NCT01864148|516238271|FG000|Overall Study|Investigator Decision|5|||
143189899|NCT01864148|516238272|FG001|Overall Study|Investigator Decision|0|||
143189900|NCT01864148|516238273|FG002|Overall Study|Investigator Decision|0|||
143189901|NCT01864148|516238274|FG003|Overall Study|Investigator Decision|4|||
143189902|NCT01864148|516238275|FG004|Overall Study|Investigator Decision|6|||
143189903|NCT01864148|516238271|FG000|Overall Study|Withdrawal by Subject|9|||
143189904|NCT01864148|516238272|FG001|Overall Study|Withdrawal by Subject|2|||
143189905|NCT01864148|516238273|FG002|Overall Study|Withdrawal by Subject|6|||
143189906|NCT01864148|516238274|FG003|Overall Study|Withdrawal by Subject|8|||
143189907|NCT01864148|516238275|FG004|Overall Study|Withdrawal by Subject|8|||
143189908|NCT01864148|516238271|FG000|Overall Study|Lost to Follow-up|0|||
143189909|NCT01864148|516238272|FG001|Overall Study|Lost to Follow-up|0|||
143189910|NCT01864148|516238273|FG002|Overall Study|Lost to Follow-up|0|||
143189911|NCT01864148|516238274|FG003|Overall Study|Lost to Follow-up|2|||
143189912|NCT01864148|516238275|FG004|Overall Study|Lost to Follow-up|1|||
143189913|NCT01864148|516238271|FG000|Overall Study|Adverse Event|4|||
143189914|NCT01864148|516238272|FG001|Overall Study|Adverse Event|2|||
143189915|NCT01864148|516238273|FG002|Overall Study|Adverse Event|4|||
143189916|NCT01864148|516238274|FG003|Overall Study|Adverse Event|7|||
143189917|NCT01864148|516238275|FG004|Overall Study|Adverse Event|7|||
143189918|NCT01864148|516238271|FG000|Overall Study|Not Dosed|0|||
143189919|NCT01864148|516238272|FG001|Overall Study|Not Dosed|0|||
143261501|NCT04068896|516510587|FG000|Overall Study|Protocol Violation|0|||
143261502|NCT04068896|516510588|FG001|Overall Study|Protocol Violation|0|||
143261503|NCT04068896|516510589|FG002|Overall Study|Protocol Violation|0|||
143261504|NCT04068896|516510590|FG003|Overall Study|Protocol Violation|1|||
143189920|NCT01864148|516238273|FG002|Overall Study|Not Dosed|0|||
143189921|NCT01864148|516238274|FG003|Overall Study|Not Dosed|1|||
143189922|NCT01864148|516238275|FG004|Overall Study|Not Dosed|0|||
143189923|NCT03490292|516238276|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
143189924|NCT03490292|516238277|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
143189925|NCT03490292|516238276|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
143189926|NCT03490292|516238277|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
143189927|NCT03490292|516238276|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
143261505|NCT04068896|516510591|FG004|Overall Study|Protocol Violation|0|||
143189928|NCT03490292|516238277|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
143189929|NCT03490292|516238276|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
143189930|NCT03490292|516238277|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
143189931|NCT03490292|516238276|FG000|1 Year Follow Up Post Last Dose|Death|1|||
143189932|NCT03490292|516238277|FG001|1 Year Follow Up Post Last Dose|Death|1|||
143189933|NCT02466425|516238280|FG000|Overall Study|Adverse Event|3|||
143189934|NCT02466425|516238281|FG001|Overall Study|Adverse Event|11|||
143189935|NCT02466425|516238280|FG000|Overall Study|Lack of Efficacy|4|||
143189936|NCT02466425|516238281|FG001|Overall Study|Lack of Efficacy|1|||
143189937|NCT02466425|516238280|FG000|Overall Study|Lost to Follow-up|3|||
143189938|NCT02466425|516238281|FG001|Overall Study|Lost to Follow-up|0|||
143189939|NCT02466425|516238280|FG000|Overall Study|Protocol Violation|1|||
143189940|NCT02466425|516238281|FG001|Overall Study|Protocol Violation|0|||
143189941|NCT02466425|516238280|FG000|Overall Study|Withdrawal by Subject|0|||
143189942|NCT02466425|516238281|FG001|Overall Study|Withdrawal by Subject|1|||
143189943|NCT02466425|516238280|FG000|Overall Study|Other|1|||
143189944|NCT02466425|516238281|FG001|Overall Study|Other|3|||
143189945|NCT02466425|516238280|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
143189946|NCT02466425|516238281|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
143189947|NCT00582712|516238284|FG000|Overall Study|Adverse Event|1|||
143189948|NCT00582712|516238284|FG000|Overall Study|Lack of Efficacy|1|||
143189949|NCT00582712|516238284|FG000|Overall Study|Withdrawal by Subject|1|||
143189950|NCT00582712|516238284|FG000|Overall Study|Complicating disease requiring treatment|1|||
143189951|NCT01732510|516238285|FG000|Overall Study|Adverse Event|0|||
143189952|NCT01732510|516238286|FG001|Overall Study|Adverse Event|1|||
143189953|NCT01732510|516238287|FG002|Overall Study|Adverse Event|1|||
143189954|NCT01732510|516238288|FG003|Overall Study|Adverse Event|0|||
143189955|NCT01732510|516238289|FG004|Overall Study|Adverse Event|0|||
143189956|NCT01732510|516238290|FG005|Overall Study|Adverse Event|0|||
143189957|NCT01732510|516238291|FG006|Overall Study|Adverse Event|1|||
143189958|NCT01732510|516238285|FG000|Overall Study|Protocol Violation|0|||
143189959|NCT01732510|516238286|FG001|Overall Study|Protocol Violation|0|||
143189960|NCT01732510|516238287|FG002|Overall Study|Protocol Violation|0|||
143189961|NCT01732510|516238288|FG003|Overall Study|Protocol Violation|1|||
143189962|NCT01732510|516238289|FG004|Overall Study|Protocol Violation|0|||
143189963|NCT01732510|516238290|FG005|Overall Study|Protocol Violation|0|||
143189964|NCT01732510|516238291|FG006|Overall Study|Protocol Violation|0|||
143189965|NCT01732510|516238285|FG000|Overall Study|Withdrawal by Subject|1|||
143189966|NCT01732510|516238286|FG001|Overall Study|Withdrawal by Subject|3|||
143189967|NCT01732510|516238287|FG002|Overall Study|Withdrawal by Subject|2|||
143189968|NCT01732510|516238288|FG003|Overall Study|Withdrawal by Subject|1|||
143189969|NCT01732510|516238289|FG004|Overall Study|Withdrawal by Subject|5|||
143189970|NCT01732510|516238290|FG005|Overall Study|Withdrawal by Subject|0|||
143189971|NCT01732510|516238291|FG006|Overall Study|Withdrawal by Subject|1|||
143189972|NCT01732510|516238285|FG000|Overall Study|Lost to Follow-up|0|||
143189973|NCT01732510|516238286|FG001|Overall Study|Lost to Follow-up|0|||
143189974|NCT01732510|516238287|FG002|Overall Study|Lost to Follow-up|1|||
143189975|NCT01732510|516238288|FG003|Overall Study|Lost to Follow-up|1|||
143189976|NCT01732510|516238289|FG004|Overall Study|Lost to Follow-up|0|||
143369522|NCT02057718|516896144|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
143189977|NCT01732510|516238290|FG005|Overall Study|Lost to Follow-up|1|||
143189978|NCT01732510|516238291|FG006|Overall Study|Lost to Follow-up|0|||
143189979|NCT01732510|516238285|FG000|Overall Study|Physician Decision|0|||
143189980|NCT01732510|516238286|FG001|Overall Study|Physician Decision|1|||
143189981|NCT01732510|516238287|FG002|Overall Study|Physician Decision|0|||
143189982|NCT01732510|516238288|FG003|Overall Study|Physician Decision|0|||
143189983|NCT01732510|516238289|FG004|Overall Study|Physician Decision|0|||
143189984|NCT01732510|516238290|FG005|Overall Study|Physician Decision|0|||
143189985|NCT01732510|516238291|FG006|Overall Study|Physician Decision|0|||
143189986|NCT01732510|516238285|FG000|Overall Study|Pregnancy|0|||
143189987|NCT01732510|516238286|FG001|Overall Study|Pregnancy|0|||
143189988|NCT01732510|516238287|FG002|Overall Study|Pregnancy|0|||
143189989|NCT01732510|516238288|FG003|Overall Study|Pregnancy|1|||
143189990|NCT01732510|516238289|FG004|Overall Study|Pregnancy|0|||
143189991|NCT01732510|516238290|FG005|Overall Study|Pregnancy|0|||
143189992|NCT01732510|516238291|FG006|Overall Study|Pregnancy|0|||
143189993|NCT01732510|516238285|FG000|Overall Study|Study Terminated By Sponsor|0|||
143189994|NCT01732510|516238286|FG001|Overall Study|Study Terminated By Sponsor|0|||
143189995|NCT01732510|516238287|FG002|Overall Study|Study Terminated By Sponsor|0|||
143189996|NCT01732510|516238288|FG003|Overall Study|Study Terminated By Sponsor|1|||
143189997|NCT01732510|516238289|FG004|Overall Study|Study Terminated By Sponsor|0|||
143189998|NCT01732510|516238290|FG005|Overall Study|Study Terminated By Sponsor|12|||
143189999|NCT01732510|516238291|FG006|Overall Study|Study Terminated By Sponsor|6|||
143190000|NCT01814397|516238292|FG000|Overall Study|Adverse Event|7|||
143190001|NCT01814397|516238292|FG000|Overall Study|Withdrawal by Subject|7|||
143190002|NCT00244933|516238294|FG000|Overall Study|Not response evaluable|2|||
143190003|NCT03403361|516238296|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
143190004|NCT03213938|516238297|FG000|Overall Study|Lost to Follow-up|4|||
143190005|NCT03213938|516238298|FG001|Overall Study|Lost to Follow-up|3|||
143190006|NCT03213938|516238297|FG000|Overall Study|Lack of Efficacy|1|||
143190007|NCT03213938|516238298|FG001|Overall Study|Lack of Efficacy|0|||
143190008|NCT03213938|516238297|FG000|Overall Study|Decline to participate|5|||
143190009|NCT03213938|516238298|FG001|Overall Study|Decline to participate|4|||
143190010|NCT03213938|516238297|FG000|Overall Study|Without reason|4|||
143190011|NCT03213938|516238298|FG001|Overall Study|Without reason|5|||
143190012|NCT04238481|516238299|FG000|Overall Study|Miscellaneous|0|||
143190013|NCT04238481|516238300|FG001|Overall Study|Miscellaneous|1|||
143190014|NCT04238481|516238301|FG002|Overall Study|Miscellaneous|0|||
143190015|NCT04238481|516238302|FG003|Overall Study|Miscellaneous|0|||
143190016|NCT00350870|516238303|FG000|Overall Study|Withdrawal by Subject|21|||
143190017|NCT00350870|516238304|FG001|Overall Study|Withdrawal by Subject|17|||
143190018|NCT00350870|516238305|FG002|Overall Study|Withdrawal by Subject|15|||
143190019|NCT00350870|516238306|FG003|Overall Study|Withdrawal by Subject|14|||
143190020|NCT00350870|516238303|FG000|Overall Study|Physician Decision|1|||
143190021|NCT00350870|516238304|FG001|Overall Study|Physician Decision|0|||
143190022|NCT00350870|516238305|FG002|Overall Study|Physician Decision|1|||
143190023|NCT00350870|516238306|FG003|Overall Study|Physician Decision|1|||
143190024|NCT00349921|516238307|FG000|First Spinal Injection|Physician Decision|1|||
143190025|NCT00349921|516238308|FG001|First Spinal Injection|Physician Decision|0|||
143190026|NCT00349921|516238309|FG002|First Spinal Injection|Physician Decision|0|||
143190027|NCT00349921|516238310|FG003|First Spinal Injection|Physician Decision|0|||
143190028|NCT00349921|516238307|FG000|First Spinal Injection|Adverse Event|0|||
143190029|NCT00349921|516238308|FG001|First Spinal Injection|Adverse Event|0|||
143190030|NCT00349921|516238309|FG002|First Spinal Injection|Adverse Event|1|||
143190031|NCT00349921|516238310|FG003|First Spinal Injection|Adverse Event|0|||
143190032|NCT01932372|516238311|FG000|Overall Study|Not meeting eligibility criteria|33|||
143190033|NCT01932372|516238312|FG001|Overall Study|Not meeting eligibility criteria|179|||
143190034|NCT01917929|516238317|FG000|Overall Study|Death|8|||
143190035|NCT01917929|516238317|FG000|Overall Study|Lost to Follow-up|19|||
143190036|NCT01917929|516238317|FG000|Overall Study|Withdrawal by Subject|33|||
143190037|NCT01917929|516238317|FG000|Overall Study|Adverse Event|6|||
143190038|NCT01917929|516238317|FG000|Overall Study|Investigative Site Terminated|35|||
143190039|NCT01917929|516238317|FG000|Overall Study|Censored because study device not implanted|6|||
143190040|NCT01917929|516238317|FG000|Overall Study|Censored because surgery not performed|3|||
143190041|NCT01917929|516238317|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
143190042|NCT01917929|516238317|FG000|Overall Study|Sponsor terminated study|175|||
143190043|NCT00673231|516238318|FG000|Overall Study|Withdrawal by Subject|14|||
143190044|NCT00673231|516238319|FG001|Overall Study|Withdrawal by Subject|10|||
143190045|NCT00673231|516238320|FG002|Overall Study|Withdrawal by Subject|8|||
143190046|NCT00673231|516238321|FG003|Overall Study|Withdrawal by Subject|6|||
143190047|NCT00673231|516238318|FG000|Overall Study|Adverse Event|6|||
143190048|NCT00673231|516238319|FG001|Overall Study|Adverse Event|5|||
143190049|NCT00673231|516238320|FG002|Overall Study|Adverse Event|9|||
143190050|NCT00673231|516238321|FG003|Overall Study|Adverse Event|6|||
143190051|NCT00673231|516238318|FG000|Overall Study|Lost to Follow-up|1|||
143190052|NCT00673231|516238319|FG001|Overall Study|Lost to Follow-up|2|||
143190053|NCT00673231|516238320|FG002|Overall Study|Lost to Follow-up|1|||
143190054|NCT00673231|516238321|FG003|Overall Study|Lost to Follow-up|2|||
143190055|NCT00673231|516238318|FG000|Overall Study|Death|0|||
143190056|NCT00673231|516238319|FG001|Overall Study|Death|0|||
143190057|NCT00673231|516238320|FG002|Overall Study|Death|1|||
143190058|NCT00673231|516238321|FG003|Overall Study|Death|0|||
143190059|NCT00673231|516238318|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
143190060|NCT00673231|516238319|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
143190061|NCT00673231|516238320|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
143190062|NCT00673231|516238321|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
143190063|NCT03594747|516238325|FG000|Overall Study|Death|78|||
143190064|NCT03594747|516238326|FG001|Overall Study|Death|86|||
143190065|NCT03594747|516238327|FG002|Overall Study|Death|87|||
143190066|NCT03594747|516238325|FG000|Overall Study|Withdrawal by Subject|5|||
143190067|NCT03594747|516238326|FG001|Overall Study|Withdrawal by Subject|2|||
143190068|NCT03594747|516238327|FG002|Overall Study|Withdrawal by Subject|11|||
143190069|NCT03594747|516238325|FG000|Overall Study|Lost to Follow-up|4|||
143190070|NCT03594747|516238326|FG001|Overall Study|Lost to Follow-up|1|||
143190071|NCT03594747|516238327|FG002|Overall Study|Lost to Follow-up|1|||
143190072|NCT03594747|516238325|FG000|Overall Study|Physician Decision|0|||
143190073|NCT03594747|516238326|FG001|Overall Study|Physician Decision|1|||
143190074|NCT03594747|516238327|FG002|Overall Study|Physician Decision|0|||
143190075|NCT03594747|516238325|FG000|Overall Study|Sponsor decision|23|||
143190076|NCT03594747|516238326|FG001|Overall Study|Sponsor decision|17|||
143190077|NCT03594747|516238327|FG002|Overall Study|Sponsor decision|16|||
143190078|NCT03594747|516238325|FG000|Overall Study|Did not meet inclusion criteria|0|||
143190079|NCT03594747|516238326|FG001|Overall Study|Did not meet inclusion criteria|0|||
143190080|NCT03594747|516238327|FG002|Overall Study|Did not meet inclusion criteria|1|||
143190081|NCT03594747|516238325|FG000|Overall Study|Transfer to long term extension study|10|||
143190082|NCT03594747|516238326|FG001|Overall Study|Transfer to long term extension study|12|||
143190083|NCT03594747|516238327|FG002|Overall Study|Transfer to long term extension study|5|||
143190084|NCT03028415|516238328|FG000|Overall Study|Lost to Follow-up|6|||
143190085|NCT03028415|516238329|FG001|Overall Study|Lost to Follow-up|3|||
143190086|NCT03028415|516238328|FG000|Overall Study|Withdrawal by Subject|1|||
143190087|NCT03028415|516238329|FG001|Overall Study|Withdrawal by Subject|0|||
143190088|NCT03028415|516238328|FG000|Overall Study|Discontinued due to COVID-19|1|||
143190089|NCT03028415|516238329|FG001|Overall Study|Discontinued due to COVID-19|0|||
143190090|NCT02907216|516238330|FG000|Overall Study|No benefit to be obtained by continuing|0|||
143190091|NCT02907216|516238331|FG001|Overall Study|No benefit to be obtained by continuing|1|||
143190092|NCT02907216|516238330|FG000|Overall Study|Withdrawal by Subject|1|||
143190093|NCT02907216|516238331|FG001|Overall Study|Withdrawal by Subject|0|||
143190094|NCT01108731|516238333|FG000|Overall Study|Withdrawal by Subject|1|||
143190095|NCT01108731|516238334|FG001|Overall Study|Withdrawal by Subject|1|||
143190096|NCT01108731|516238333|FG000|Overall Study|Adverse Event|3|||
143190097|NCT01108731|516238334|FG001|Overall Study|Adverse Event|3|||
143190098|NCT02485639|516238339|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
143190099|NCT02485639|516238339|FG000|Overall Study|Early termination|4|||
143190100|NCT02485639|516238339|FG000|Overall Study|Withdrawal by Subject|4|||
143190101|NCT01673854|516238341|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
143190102|NCT01673854|516238341|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
143190103|NCT01673854|516238341|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
143190104|NCT01673854|516238341|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
143190105|NCT01673854|516238341|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
143369523|NCT02057718|516896145|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
143190106|NCT01673854|516238341|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
143190107|NCT01673854|516238341|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
143190108|NCT01673854|516238341|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
143190109|NCT01673854|516238341|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
143190110|NCT01673854|516238341|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
143190111|NCT01673854|516238341|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
143190112|NCT01673854|516238341|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
143190113|NCT00830375|516238344|FG000|Overall Study|Lost to Follow-up|1|||
143190114|NCT01700959|516238345|FG000|Overall Study|Adverse Event|0|||
143190115|NCT01700959|516238346|FG001|Overall Study|Adverse Event|1|||
143190116|NCT01700959|516238347|FG002|Overall Study|Adverse Event|1|||
143190117|NCT01700959|516238348|FG003|Overall Study|Adverse Event|2|||
143190118|NCT01700959|516238349|FG004|Overall Study|Adverse Event|0|||
143190119|NCT01700959|516238350|FG005|Overall Study|Adverse Event|2|||
143190120|NCT01700959|516238345|FG000|Overall Study|Withdrawal by Subject|15|||
143190121|NCT01700959|516238346|FG001|Overall Study|Withdrawal by Subject|9|||
143190122|NCT01700959|516238347|FG002|Overall Study|Withdrawal by Subject|12|||
143190123|NCT01700959|516238348|FG003|Overall Study|Withdrawal by Subject|11|||
143190124|NCT01700959|516238349|FG004|Overall Study|Withdrawal by Subject|8|||
143190125|NCT01700959|516238350|FG005|Overall Study|Withdrawal by Subject|12|||
143190126|NCT01700959|516238345|FG000|Overall Study|Ineligible|2|||
143190127|NCT01700959|516238346|FG001|Overall Study|Ineligible|1|||
143190128|NCT01700959|516238347|FG002|Overall Study|Ineligible|2|||
143190129|NCT01700959|516238348|FG003|Overall Study|Ineligible|0|||
143190130|NCT01700959|516238349|FG004|Overall Study|Ineligible|0|||
143190131|NCT01700959|516238350|FG005|Overall Study|Ineligible|1|||
143190132|NCT01700959|516238345|FG000|Overall Study|Noncompliant|9|||
143190133|NCT01700959|516238346|FG001|Overall Study|Noncompliant|9|||
143190134|NCT01700959|516238347|FG002|Overall Study|Noncompliant|17|||
143190135|NCT01700959|516238348|FG003|Overall Study|Noncompliant|18|||
143190136|NCT01700959|516238349|FG004|Overall Study|Noncompliant|15|||
143190137|NCT01700959|516238350|FG005|Overall Study|Noncompliant|9|||
143190138|NCT01700959|516238345|FG000|Overall Study|Side effects|1|||
143190139|NCT01700959|516238346|FG001|Overall Study|Side effects|4|||
143190140|NCT01700959|516238347|FG002|Overall Study|Side effects|8|||
143190141|NCT01700959|516238348|FG003|Overall Study|Side effects|4|||
143190142|NCT01700959|516238349|FG004|Overall Study|Side effects|4|||
143190143|NCT01700959|516238350|FG005|Overall Study|Side effects|1|||
143190144|NCT05897242|516240743|FG000|Overall Study|Lost to Follow-up|6|||
143190145|NCT05897242|516240744|FG001|Overall Study|Lost to Follow-up|1|||
143190146|NCT05897242|516240743|FG000|Overall Study|Incomplete|1|||
143190147|NCT05897242|516240744|FG001|Overall Study|Incomplete|0|||
143190148|NCT05897242|516240743|FG000|Overall Study|Withdrawal by Subject|1|||
143190149|NCT05897242|516240744|FG001|Overall Study|Withdrawal by Subject|0|||
143190150|NCT00809835|516240745|FG000|Overall Study|Lost to Follow-up|7|||
143190151|NCT00809835|516240746|FG001|Overall Study|Lost to Follow-up|6|||
143190152|NCT00809835|516240747|FG002|Overall Study|Lost to Follow-up|10|||
143190153|NCT00809835|516240748|FG003|Overall Study|Lost to Follow-up|2|||
143190154|NCT00809835|516240745|FG000|Overall Study|Withdrawal by Subject|1|||
143190155|NCT00809835|516240746|FG001|Overall Study|Withdrawal by Subject|1|||
143190156|NCT00809835|516240747|FG002|Overall Study|Withdrawal by Subject|1|||
143190157|NCT00809835|516240748|FG003|Overall Study|Withdrawal by Subject|0|||
143190158|NCT02582814|516240749|FG000|Overall Study|Study-specific withdrawal criteria|1|||
143190159|NCT02582814|516240750|FG001|Overall Study|Study-specific withdrawal criteria|0|||
143190160|NCT02582814|516240749|FG000|Overall Study|Withdrawal by Subject|4|||
143190161|NCT02582814|516240750|FG001|Overall Study|Withdrawal by Subject|3|||
143190162|NCT02582814|516240749|FG000|Overall Study|Adverse Event|4|||
143190163|NCT02582814|516240750|FG001|Overall Study|Adverse Event|4|||
143190164|NCT03530995|516240751|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
143369524|NCT00197015|516896146|FG000|Overall Study|Adverse Event|3|||
143190165|NCT03530995|516240752|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
143190166|NCT03530995|516240751|FG000|Part 1 Period 3|Protocol Violation|1|||
143369525|NCT00197015|516896147|FG001|Overall Study|Adverse Event|0|||
143190167|NCT03530995|516240752|FG001|Part 1 Period 3|Protocol Violation|0|||
143190168|NCT03530995|516240751|FG000|Part 1 Period 4|Physician Decision|1|||
143190169|NCT03530995|516240752|FG001|Part 1 Period 4|Physician Decision|0|||
143190170|NCT03530995|516240751|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
143190171|NCT03530995|516240752|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
143190172|NCT01751906|516240756|FG000|Overall Study|Lost to Follow-up|151|||
143190173|NCT01751906|516240757|FG001|Overall Study|Lost to Follow-up|68|||
143369526|NCT00197015|516896148|FG002|Overall Study|Adverse Event|1|||
143369527|NCT00197015|516896146|FG000|Overall Study|Protocol Violation|0|||
143369528|NCT00197015|516896147|FG001|Overall Study|Protocol Violation|3|||
143190174|NCT01751906|516240756|FG000|Overall Study|Withdrawal by Subject|22|||
143190175|NCT01751906|516240757|FG001|Overall Study|Withdrawal by Subject|18|||
143190176|NCT01751906|516240756|FG000|Overall Study|Physician Decision|5|||
143190177|NCT01751906|516240757|FG001|Overall Study|Physician Decision|2|||
143190178|NCT01751906|516240756|FG000|Overall Study|Death|84|||
143190179|NCT01751906|516240757|FG001|Overall Study|Death|43|||
143190180|NCT01751906|516240756|FG000|Overall Study|Denied on premises for follow-up by law|1|||
143190181|NCT01751906|516240757|FG001|Overall Study|Denied on premises for follow-up by law|0|||
143190182|NCT01110330|516240758|FG000|Overall Study|Adverse Event|0|||
143190183|NCT01110330|516240759|FG001|Overall Study|Adverse Event|4|||
143190184|NCT01110330|516240760|FG002|Overall Study|Adverse Event|3|||
143190185|NCT01110330|516240758|FG000|Overall Study|Lack of Efficacy|3|||
143190186|NCT01110330|516240759|FG001|Overall Study|Lack of Efficacy|1|||
143190187|NCT01110330|516240760|FG002|Overall Study|Lack of Efficacy|1|||
143190188|NCT01110330|516240758|FG000|Overall Study|Lost to Follow-up|9|||
143190189|NCT01110330|516240759|FG001|Overall Study|Lost to Follow-up|10|||
143190190|NCT01110330|516240760|FG002|Overall Study|Lost to Follow-up|15|||
143190191|NCT01110330|516240758|FG000|Overall Study|Physician Decision|0|||
143190192|NCT01110330|516240759|FG001|Overall Study|Physician Decision|1|||
143190193|NCT01110330|516240760|FG002|Overall Study|Physician Decision|0|||
143190194|NCT01110330|516240758|FG000|Overall Study|Protocol Violation|2|||
143190195|NCT01110330|516240759|FG001|Overall Study|Protocol Violation|0|||
143190196|NCT01110330|516240760|FG002|Overall Study|Protocol Violation|4|||
143190197|NCT01110330|516240758|FG000|Overall Study|Withdrawal by Subject|0|||
143190198|NCT01110330|516240759|FG001|Overall Study|Withdrawal by Subject|6|||
143190199|NCT01110330|516240760|FG002|Overall Study|Withdrawal by Subject|2|||
143190200|NCT01110330|516240758|FG000|Overall Study|Other|1|||
143190201|NCT01110330|516240759|FG001|Overall Study|Other|1|||
143190202|NCT01110330|516240760|FG002|Overall Study|Other|1|||
143190203|NCT02557100|516240761|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
143190204|NCT02557100|516240762|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
143190205|NCT02557100|516240763|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
143190206|NCT02557100|516240761|FG000|Single Blind Treatment Period|Death|0|||
143190207|NCT02557100|516240762|FG001|Single Blind Treatment Period|Death|1|||
143190208|NCT02557100|516240763|FG002|Single Blind Treatment Period|Death|0|||
143190209|NCT02557100|516240761|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
143190210|NCT02557100|516240762|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
143190211|NCT02557100|516240763|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
143369529|NCT00197015|516896148|FG002|Overall Study|Protocol Violation|3|||
143369530|NCT00197015|516896146|FG000|Overall Study|Withdrawal by Subject|17|||
143369531|NCT00197015|516896147|FG001|Overall Study|Withdrawal by Subject|37|||
143190212|NCT02557100|516240761|FG000|Single Blind Treatment Period|Adverse Event|0|||
143190213|NCT02557100|516240762|FG001|Single Blind Treatment Period|Adverse Event|1|||
143190214|NCT02557100|516240763|FG002|Single Blind Treatment Period|Adverse Event|0|||
143190215|NCT02557100|516240761|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
143190216|NCT02557100|516240762|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
143190217|NCT02557100|516240763|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
143190218|NCT02557100|516240761|FG000|Cumulative Abatacept Period|Other Reasons|0|||
143190219|NCT02557100|516240762|FG001|Cumulative Abatacept Period|Other Reasons|0|||
143190220|NCT02557100|516240763|FG002|Cumulative Abatacept Period|Other Reasons|1|||
143190221|NCT02557100|516240761|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
143190222|NCT02557100|516240762|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
143190223|NCT02557100|516240763|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
143190224|NCT02557100|516240761|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
143190225|NCT02557100|516240762|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
143190226|NCT02557100|516240763|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
143190227|NCT00510718|516240764|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
143190228|NCT00510718|516240765|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
143190229|NCT00510718|516240764|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
143190230|NCT00510718|516240765|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
143190231|NCT00510718|516240764|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
143190232|NCT00510718|516240765|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
143190233|NCT00510718|516240764|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
143369532|NCT00197015|516896148|FG002|Overall Study|Withdrawal by Subject|34|||
143190234|NCT00510718|516240765|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
143190235|NCT00510718|516240764|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
143190236|NCT00510718|516240765|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
143190237|NCT00510718|516240764|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
143190238|NCT00510718|516240765|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
143190239|NCT02388165|516240766|FG000|Overall Study|Study terminated by sponsor|5|||
143190240|NCT02388165|516240767|FG001|Overall Study|Study terminated by sponsor|5|||
143190241|NCT02388165|516240766|FG000|Overall Study|Other|11|||
143190242|NCT02388165|516240767|FG001|Overall Study|Other|13|||
143190243|NCT02388165|516240766|FG000|Overall Study|No longer meet eligibility criteria|40|||
143190244|NCT02388165|516240767|FG001|Overall Study|No longer meet eligibility criteria|43|||
143190245|NCT02388165|516240766|FG000|Overall Study|Withdrawal of consent|31|||
143190246|NCT02388165|516240767|FG001|Overall Study|Withdrawal of consent|32|||
143190247|NCT02388165|516240766|FG000|Overall Study|Lost to Follow-up|19|||
143190248|NCT02388165|516240767|FG001|Overall Study|Lost to Follow-up|20|||
143190249|NCT02388165|516240766|FG000|Overall Study|Death|13|||
143190250|NCT02388165|516240767|FG001|Overall Study|Death|10|||
143190251|NCT02388165|516240766|FG000|Overall Study|Adverse Event|3|||
143190252|NCT02388165|516240767|FG001|Overall Study|Adverse Event|5|||
143190253|NCT02388165|516240766|FG000|Overall Study|Did not meet entrance criteria|5|||
143190254|NCT02388165|516240767|FG001|Overall Study|Did not meet entrance criteria|2|||
143190255|NCT01474772|516240772|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
143190256|NCT01474772|516240773|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
143190257|NCT01474772|516240772|FG000|Period 1|AE not Related to Study Drug|1|||
143190258|NCT01474772|516240773|FG001|Period 1|AE not Related to Study Drug|0|||
143190259|NCT01474772|516240772|FG000|Period 1|Withdrawal by Subject|3|||
143261506|NCT04068896|516510592|FG005|Overall Study|Protocol Violation|0|||
143190260|NCT01474772|516240773|FG001|Period 1|Withdrawal by Subject|1|||
143190261|NCT01474772|516240772|FG000|Period 1|Lost to Follow-up|1|||
143190262|NCT01474772|516240773|FG001|Period 1|Lost to Follow-up|0|||
143190263|NCT01474772|516240772|FG000|Period 1|Reason not Specified|1|||
143190264|NCT01474772|516240773|FG001|Period 1|Reason not Specified|1|||
143190265|NCT01474772|516240772|FG000|Washout|AE not Related to Study Drug|2|||
143190266|NCT01474772|516240773|FG001|Washout|AE not Related to Study Drug|0|||
143190267|NCT01474772|516240772|FG000|Washout|Withdrawal by Subject|1|||
143190268|NCT01474772|516240773|FG001|Washout|Withdrawal by Subject|0|||
143190269|NCT01474772|516240772|FG000|Washout|Lost to Follow-up|0|||
143190270|NCT01474772|516240773|FG001|Washout|Lost to Follow-up|1|||
143190271|NCT01474772|516240772|FG000|Washout|Reason not Specified|0|||
143190272|NCT01474772|516240773|FG001|Washout|Reason not Specified|1|||
143190273|NCT01474772|516240772|FG000|Period 2|Death|0|||
143190274|NCT01474772|516240773|FG001|Period 2|Death|1|||
143190275|NCT01474772|516240772|FG000|Period 2|AE Related to Study Drug|0|||
143190276|NCT01474772|516240773|FG001|Period 2|AE Related to Study Drug|1|||
143190277|NCT01474772|516240772|FG000|Period 2|AE not Related to Study Drug|4|||
143190278|NCT01474772|516240773|FG001|Period 2|AE not Related to Study Drug|1|||
143190279|NCT01474772|516240772|FG000|Period 2|Lack of Efficacy|1|||
143190280|NCT01474772|516240773|FG001|Period 2|Lack of Efficacy|0|||
143190281|NCT01474772|516240772|FG000|Period 2|Withdrawal by Subject|3|||
143190282|NCT01474772|516240773|FG001|Period 2|Withdrawal by Subject|4|||
143190283|NCT01474772|516240772|FG000|Period 2|Lost to Follow-up|1|||
143190284|NCT01474772|516240773|FG001|Period 2|Lost to Follow-up|1|||
143190285|NCT01474772|516240772|FG000|Period 2|Reason not Specified|0|||
143190286|NCT01474772|516240773|FG001|Period 2|Reason not Specified|2|||
143190287|NCT01474772|516240772|FG000|Follow-up|AE not Related to Study Drug|0|||
143190288|NCT01474772|516240773|FG001|Follow-up|AE not Related to Study Drug|1|||
143190289|NCT03195660|516240774|FG000|Overall Study|The study was terminated|2|||
143190290|NCT03367403|516240775|FG000|Overall Study|Adverse Event|20|||
143190291|NCT03367403|516240776|FG001|Overall Study|Adverse Event|6|||
143190292|NCT03367403|516240777|FG002|Overall Study|Adverse Event|2|||
143190293|NCT03367403|516240775|FG000|Overall Study|Withdrawal by Subject|12|||
143190294|NCT03367403|516240776|FG001|Overall Study|Withdrawal by Subject|13|||
143190295|NCT03367403|516240777|FG002|Overall Study|Withdrawal by Subject|1|||
143261507|NCT04068896|516510587|FG000|Overall Study|Withdrawal by Subject|0|||
143190296|NCT03367403|516240775|FG000|Overall Study|Death|1|||
143190297|NCT03367403|516240776|FG001|Overall Study|Death|2|||
143190298|NCT03367403|516240777|FG002|Overall Study|Death|0|||
143190299|NCT03367403|516240775|FG000|Overall Study|Physician Decision|0|||
143190300|NCT03367403|516240776|FG001|Overall Study|Physician Decision|1|||
143190301|NCT03367403|516240777|FG002|Overall Study|Physician Decision|0|||
143190302|NCT03367403|516240775|FG000|Overall Study|Protocol Violation|1|||
143190303|NCT03367403|516240776|FG001|Overall Study|Protocol Violation|1|||
143190304|NCT03367403|516240777|FG002|Overall Study|Protocol Violation|0|||
143190305|NCT03367403|516240775|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
143190306|NCT03367403|516240776|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
143190307|NCT03367403|516240777|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
143190308|NCT03367403|516240775|FG000|Overall Study|COVID-19|3|||
143190309|NCT03367403|516240776|FG001|Overall Study|COVID-19|6|||
143369533|NCT00197015|516896146|FG000|Overall Study|Lost to Follow-up|28|||
143190310|NCT03367403|516240777|FG002|Overall Study|COVID-19|0|||
143190311|NCT03367403|516240775|FG000|Overall Study|Abuse of Alcohol Intake|0|||
143190312|NCT03367403|516240776|FG001|Overall Study|Abuse of Alcohol Intake|1|||
143190313|NCT03367403|516240777|FG002|Overall Study|Abuse of Alcohol Intake|0|||
143190314|NCT03367403|516240775|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
143190315|NCT03367403|516240776|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
143190316|NCT03367403|516240777|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
143190317|NCT02321319|516240778|FG000|Overall Study|Product discontinued|5|||
143190318|NCT01126268|516240779|FG000|Overall Study|Adverse Event|1|||
143190319|NCT00610857|516240786|FG000|Overall Study|Not evaluable for response|2|||
143190320|NCT01626118|516240789|FG000|Overall Study|Lack of Efficacy|1|||
143190321|NCT01626118|516240790|FG001|Overall Study|Lack of Efficacy|0|||
143190322|NCT01626118|516240791|FG002|Overall Study|Lack of Efficacy|1|||
143190323|NCT01626118|516240792|FG003|Overall Study|Lack of Efficacy|3|||
143190324|NCT01626118|516240789|FG000|Overall Study|Lost to Follow-up|1|||
143190325|NCT01626118|516240790|FG001|Overall Study|Lost to Follow-up|0|||
143190326|NCT01626118|516240791|FG002|Overall Study|Lost to Follow-up|0|||
143190327|NCT01626118|516240792|FG003|Overall Study|Lost to Follow-up|0|||
143190328|NCT01626118|516240789|FG000|Overall Study|Adverse Event|0|||
143190329|NCT01626118|516240790|FG001|Overall Study|Adverse Event|1|||
143190330|NCT01626118|516240791|FG002|Overall Study|Adverse Event|1|||
143190331|NCT01626118|516240792|FG003|Overall Study|Adverse Event|0|||
143190332|NCT01626118|516240789|FG000|Overall Study|Investigator Decision|0|||
143190333|NCT01626118|516240790|FG001|Overall Study|Investigator Decision|1|||
143190334|NCT01626118|516240791|FG002|Overall Study|Investigator Decision|0|||
143190335|NCT01626118|516240792|FG003|Overall Study|Investigator Decision|0|||
143190336|NCT00888329|516240793|FG000|Overall Study|Physician Decision|6|||
143190337|NCT00888329|516240794|FG001|Overall Study|Physician Decision|9|||
143190338|NCT02151903|516240795|FG000|Overall Study|Withdrawal by Subject|1|||
143190339|NCT02151903|516240796|FG001|Overall Study|Withdrawal by Subject|0|||
143190340|NCT02151903|516240795|FG000|Overall Study|Progressive disease|2|||
143190341|NCT02151903|516240796|FG001|Overall Study|Progressive disease|1|||
143190342|NCT00778375|516240798|FG000|Overall Study|Ineligible|3|||
143190343|NCT06003777|516240800|FG000|Period 1|Adverse Event|0|||
143190344|NCT06003777|516240801|FG001|Period 1|Adverse Event|0|||
143190345|NCT06003777|516240802|FG002|Period 1|Adverse Event|1|||
143190346|NCT06003777|516240803|FG003|Period 1|Adverse Event|0|||
143190347|NCT06003777|516240804|FG004|Period 1|Adverse Event|0|||
143190348|NCT06003777|516240805|FG005|Period 1|Adverse Event|0|||
143190349|NCT06003777|516240806|FG006|Period 1|Adverse Event|0|||
143190350|NCT06003777|516240807|FG007|Period 1|Adverse Event|0|||
143190351|NCT06003777|516240808|FG008|Period 1|Adverse Event|0|||
143190352|NCT06003777|516240809|FG009|Period 1|Adverse Event|0|||
143190353|NCT06003777|516240810|FG010|Period 1|Adverse Event|0|||
143190354|NCT06003777|516240811|FG011|Period 1|Adverse Event|0|||
143190355|NCT06003777|516240800|FG000|Period 1|Withdrawal by Subject|0|||
143190356|NCT06003777|516240801|FG001|Period 1|Withdrawal by Subject|0|||
143190357|NCT06003777|516240802|FG002|Period 1|Withdrawal by Subject|0|||
143190358|NCT06003777|516240803|FG003|Period 1|Withdrawal by Subject|0|||
143190359|NCT06003777|516240804|FG004|Period 1|Withdrawal by Subject|1|||
143190360|NCT06003777|516240805|FG005|Period 1|Withdrawal by Subject|0|||
143190361|NCT06003777|516240806|FG006|Period 1|Withdrawal by Subject|0|||
143190362|NCT06003777|516240807|FG007|Period 1|Withdrawal by Subject|0|||
143190363|NCT06003777|516240808|FG008|Period 1|Withdrawal by Subject|0|||
143190364|NCT06003777|516240809|FG009|Period 1|Withdrawal by Subject|0|||
143190365|NCT06003777|516240810|FG010|Period 1|Withdrawal by Subject|0|||
143190366|NCT06003777|516240811|FG011|Period 1|Withdrawal by Subject|0|||
143190367|NCT06003777|516240800|FG000|Period 2|Withdrawal by Subject|0|||
143190368|NCT06003777|516240801|FG001|Period 2|Withdrawal by Subject|0|||
143190369|NCT06003777|516240802|FG002|Period 2|Withdrawal by Subject|0|||
143190370|NCT06003777|516240803|FG003|Period 2|Withdrawal by Subject|0|||
143190371|NCT06003777|516240804|FG004|Period 2|Withdrawal by Subject|0|||
143190372|NCT06003777|516240805|FG005|Period 2|Withdrawal by Subject|0|||
143190373|NCT06003777|516240806|FG006|Period 2|Withdrawal by Subject|0|||
143190374|NCT06003777|516240807|FG007|Period 2|Withdrawal by Subject|0|||
143190375|NCT06003777|516240808|FG008|Period 2|Withdrawal by Subject|1|||
143190376|NCT06003777|516240809|FG009|Period 2|Withdrawal by Subject|0|||
143190377|NCT06003777|516240810|FG010|Period 2|Withdrawal by Subject|0|||
143190378|NCT06003777|516240811|FG011|Period 2|Withdrawal by Subject|0|||
143190379|NCT06003777|516240800|FG000|Period 3|Adverse Event|0|||
143190380|NCT06003777|516240801|FG001|Period 3|Adverse Event|0|||
143190381|NCT06003777|516240802|FG002|Period 3|Adverse Event|0|||
143190382|NCT06003777|516240803|FG003|Period 3|Adverse Event|0|||
143190383|NCT06003777|516240804|FG004|Period 3|Adverse Event|0|||
143190384|NCT06003777|516240805|FG005|Period 3|Adverse Event|0|||
143190385|NCT06003777|516240806|FG006|Period 3|Adverse Event|1|||
143190386|NCT06003777|516240807|FG007|Period 3|Adverse Event|0|||
143190387|NCT06003777|516240808|FG008|Period 3|Adverse Event|0|||
143190388|NCT06003777|516240809|FG009|Period 3|Adverse Event|0|||
143190389|NCT06003777|516240810|FG010|Period 3|Adverse Event|0|||
143190390|NCT06003777|516240811|FG011|Period 3|Adverse Event|0|||
143190391|NCT06003777|516240800|FG000|Period 4|No longer met eligibility criteria|0|||
143190392|NCT06003777|516240801|FG001|Period 4|No longer met eligibility criteria|0|||
143190393|NCT06003777|516240802|FG002|Period 4|No longer met eligibility criteria|1|||
143190394|NCT06003777|516240803|FG003|Period 4|No longer met eligibility criteria|0|||
143190395|NCT06003777|516240804|FG004|Period 4|No longer met eligibility criteria|0|||
143190396|NCT06003777|516240805|FG005|Period 4|No longer met eligibility criteria|0|||
143190397|NCT06003777|516240806|FG006|Period 4|No longer met eligibility criteria|0|||
143190398|NCT06003777|516240807|FG007|Period 4|No longer met eligibility criteria|0|||
143190399|NCT06003777|516240808|FG008|Period 4|No longer met eligibility criteria|0|||
143190400|NCT06003777|516240809|FG009|Period 4|No longer met eligibility criteria|0|||
143190401|NCT06003777|516240810|FG010|Period 4|No longer met eligibility criteria|0|||
143190402|NCT06003777|516240811|FG011|Period 4|No longer met eligibility criteria|0|||
143190403|NCT06003777|516240800|FG000|Period 4|Withdrawal by Subject|0|||
143190404|NCT06003777|516240801|FG001|Period 4|Withdrawal by Subject|1|||
143190405|NCT06003777|516240802|FG002|Period 4|Withdrawal by Subject|0|||
143190406|NCT06003777|516240803|FG003|Period 4|Withdrawal by Subject|0|||
143190407|NCT06003777|516240804|FG004|Period 4|Withdrawal by Subject|0|||
143190408|NCT06003777|516240805|FG005|Period 4|Withdrawal by Subject|0|||
143190409|NCT06003777|516240806|FG006|Period 4|Withdrawal by Subject|0|||
143190410|NCT06003777|516240807|FG007|Period 4|Withdrawal by Subject|0|||
143190411|NCT06003777|516240808|FG008|Period 4|Withdrawal by Subject|0|||
143190412|NCT06003777|516240809|FG009|Period 4|Withdrawal by Subject|0|||
143190413|NCT06003777|516240810|FG010|Period 4|Withdrawal by Subject|0|||
143190414|NCT06003777|516240811|FG011|Period 4|Withdrawal by Subject|0|||
143190415|NCT00904670|516240812|FG000|Open Label Phase|Withdrawal by Subject|2|||
143190416|NCT00904670|516240813|FG001|Open Label Phase|Withdrawal by Subject|0|||
143190417|NCT00904670|516240812|FG000|Open Label Phase|Adverse Event|2|||
143190418|NCT00904670|516240813|FG001|Open Label Phase|Adverse Event|0|||
143190419|NCT00904670|516240812|FG000|Open Label Phase|Lack of Efficacy|1|||
143190420|NCT00904670|516240813|FG001|Open Label Phase|Lack of Efficacy|0|||
143190421|NCT00904670|516240812|FG000|Open Label Phase|Lost to Follow-up|1|||
143190422|NCT00904670|516240813|FG001|Open Label Phase|Lost to Follow-up|0|||
143190423|NCT01721486|516240818|FG000|Overall Study|Protocol Violation|1|||
143190424|NCT01721486|516240819|FG001|Overall Study|Protocol Violation|0|||
143190425|NCT01721486|516240818|FG000|Overall Study|Physician Decision|0|||
143190426|NCT01721486|516240819|FG001|Overall Study|Physician Decision|1|||
143190427|NCT05141175|516240820|FG000|Overall Study|Withdrawal by Subject|1|||
143190428|NCT01901289|516240821|FG000|Overall Study|Death|32|||
143190429|NCT01901289|516240821|FG000|Overall Study|Lost to Follow-up|16|||
143190430|NCT01901289|516240821|FG000|Overall Study|Withdrawal by Subject|35|||
143190431|NCT01901289|516240821|FG000|Overall Study|Other type of endpoint met|2|||
143190432|NCT01813058|516240826|FG000|Overall Study|Withdrawal by Subject|5|||
143190433|NCT01813058|516240827|FG001|Overall Study|Withdrawal by Subject|4|||
143190434|NCT03585764|516240828|FG000|Overall Study|Death|3|||
143190435|NCT03585764|516240829|FG001|Overall Study|Death|2|||
143190436|NCT03585764|516240830|FG002|Overall Study|Death|3|||
143190437|NCT03585764|516240831|FG003|Overall Study|Death|0|||
143190438|NCT03585764|516240828|FG000|Overall Study|Lost to Follow-up|0|||
143190439|NCT03585764|516240829|FG001|Overall Study|Lost to Follow-up|1|||
143190440|NCT03585764|516240830|FG002|Overall Study|Lost to Follow-up|0|||
143190441|NCT03585764|516240831|FG003|Overall Study|Lost to Follow-up|0|||
143190442|NCT03585764|516240828|FG000|Overall Study|Physician Decision|0|||
143190443|NCT03585764|516240829|FG001|Overall Study|Physician Decision|0|||
143190444|NCT03585764|516240830|FG002|Overall Study|Physician Decision|2|||
143190445|NCT03585764|516240831|FG003|Overall Study|Physician Decision|0|||
143190446|NCT01581021|516240832|FG000|Overall Study|Lost to Follow-up|4|||
143190447|NCT01581021|516240833|FG001|Overall Study|Lost to Follow-up|6|||
143190448|NCT01581021|516240832|FG000|Overall Study|More than 2 hooks in thoracic|3|||
143190449|NCT01581021|516240833|FG001|Overall Study|More than 2 hooks in thoracic|0|||
143190450|NCT01581021|516240832|FG000|Overall Study|Neuromuscular|2|||
143190451|NCT01581021|516240833|FG001|Overall Study|Neuromuscular|1|||
143190452|NCT01581021|516240832|FG000|Overall Study|Not Randomized|1|||
143190453|NCT01581021|516240833|FG001|Overall Study|Not Randomized|2|||
143190454|NCT01581021|516240832|FG000|Overall Study|Lenke 6 Classification|0|||
143190455|NCT01581021|516240833|FG001|Overall Study|Lenke 6 Classification|1|||
143190456|NCT01581021|516240832|FG000|Overall Study|Lack of Efficacy|0|||
143190457|NCT01581021|516240833|FG001|Overall Study|Lack of Efficacy|1|||
143190458|NCT00054327|516240836|FG000|Overall Study|Engraftment failure|1|||
143190459|NCT00054327|516240837|FG001|Overall Study|Engraftment failure|0|||
143190460|NCT00054327|516240838|FG002|Overall Study|Engraftment failure|0|||
143190461|NCT00054327|516240839|FG003|Overall Study|Engraftment failure|0|||
143190462|NCT00054327|516240840|FG004|Overall Study|Engraftment failure|0|||
143190463|NCT00054327|516240841|FG005|Overall Study|Engraftment failure|0|||
143190464|NCT00613327|516240845|FG000|Overall Study|Adverse Event|38|||
143190465|NCT00613327|516240845|FG000|Overall Study|Lost to Follow-up|8|||
143190466|NCT00613327|516240845|FG000|Overall Study|Withdrawal by Subject|6|||
143190467|NCT00613327|516240845|FG000|Overall Study|Protocol Violation|2|||
143190468|NCT00613327|516240845|FG000|Overall Study|Other|47|||
143190469|NCT00344318|516240846|FG000|Overall Study|Adverse Event|0|||
143190470|NCT00344318|516240847|FG001|Overall Study|Adverse Event|3|||
143190471|NCT00344318|516240848|FG002|Overall Study|Adverse Event|0|||
143190472|NCT00344318|516240849|FG003|Overall Study|Adverse Event|1|||
143190473|NCT00344318|516240846|FG000|Overall Study|Withdrawal by Subject|2|||
143190474|NCT00344318|516240847|FG001|Overall Study|Withdrawal by Subject|2|||
143190475|NCT00344318|516240848|FG002|Overall Study|Withdrawal by Subject|0|||
143190476|NCT00344318|516240849|FG003|Overall Study|Withdrawal by Subject|2|||
143190477|NCT00344318|516240846|FG000|Overall Study|Lost to Follow-up|2|||
143190478|NCT00344318|516240847|FG001|Overall Study|Lost to Follow-up|0|||
143190479|NCT00344318|516240848|FG002|Overall Study|Lost to Follow-up|1|||
143190480|NCT00344318|516240849|FG003|Overall Study|Lost to Follow-up|0|||
143190481|NCT01606176|516240859|FG000|Overall Study|Adverse Event|2|||
143190482|NCT01606176|516240860|FG001|Overall Study|Adverse Event|3|||
143190483|NCT01606176|516240859|FG000|Overall Study|Disease progression|1|||
143190484|NCT01606176|516240860|FG001|Overall Study|Disease progression|0|||
143190485|NCT01606176|516240859|FG000|Overall Study|Withdrawal by Subject|1|||
143190486|NCT01606176|516240860|FG001|Overall Study|Withdrawal by Subject|0|||
143190487|NCT00361231|516240861|FG000|Overall Study|Physician Decision|3|||
143190488|NCT00361231|516240861|FG000|Overall Study|Symptomatic deterioration|5|||
143190489|NCT00361231|516240861|FG000|Overall Study|Radiographic disease progression|16|||
143190490|NCT00361231|516240861|FG000|Overall Study|Withdrawal by Subject|4|||
143190491|NCT00361231|516240861|FG000|Overall Study|Adverse Event|6|||
143190492|NCT00313144|516240864|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
143190493|NCT00313144|516240864|FG000|Overall Study|Death|7|||
143190494|NCT00313144|516240864|FG000|Overall Study|Lost to Follow-up|5|||
143190495|NCT00313144|516240864|FG000|Overall Study|Withdrawal by Subject|4|||
143190496|NCT00313144|516240864|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
143190497|NCT00313144|516240864|FG000|Overall Study|Physician Decision|4|||
143190498|NCT00313144|516240864|FG000|Overall Study|Adverse event - transient|5|||
143190499|NCT00313144|516240864|FG000|Overall Study|Liver transplant|1|||
143190500|NCT00313144|516240864|FG000|Overall Study|Insurance (homecare provider) change|1|||
143190501|NCT00313144|516240864|FG000|Overall Study|Change to different product|1|||
143190502|NCT00313144|516240864|FG000|Overall Study|Due to termination of the study|66|||
143190503|NCT04731298|516240867|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
143190504|NCT04731298|516240868|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
143190505|NCT01208961|516240869|FG000|High-Fat Period III|Protocol Violation|1|||
143190506|NCT01208961|516240870|FG001|High-Fat Period III|Protocol Violation|0|||
143190507|NCT02487654|516240872|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
143190508|NCT02487654|516240873|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
143190509|NCT02487654|516240872|FG000|Overall Study|Withdrawal by Subject|3|||
143190510|NCT02487654|516240873|FG001|Overall Study|Withdrawal by Subject|7|||
143190511|NCT02152371|516240874|FG000|Overall Study|Adverse Event|6|||
143190512|NCT02152371|516240875|FG001|Overall Study|Adverse Event|2|||
143190513|NCT02152371|516240874|FG000|Overall Study|Withdrawal by Subject|3|||
143190514|NCT02152371|516240875|FG001|Overall Study|Withdrawal by Subject|7|||
143190515|NCT02152371|516240874|FG000|Overall Study|Protocol Violation|2|||
143190516|NCT02152371|516240875|FG001|Overall Study|Protocol Violation|3|||
143190517|NCT02152371|516240874|FG000|Overall Study|Lost to Follow-up|1|||
143190518|NCT02152371|516240875|FG001|Overall Study|Lost to Follow-up|0|||
143190519|NCT02152371|516240874|FG000|Overall Study|Lack of Efficacy|0|||
143190520|NCT02152371|516240875|FG001|Overall Study|Lack of Efficacy|1|||
143190521|NCT02152371|516240874|FG000|Overall Study|Physician Decision|0|||
143190522|NCT02152371|516240875|FG001|Overall Study|Physician Decision|2|||
143190523|NCT02152371|516240874|FG000|Overall Study|Reason Not Given|0|||
143190524|NCT02152371|516240875|FG001|Overall Study|Reason Not Given|1|||
143190525|NCT05285644|516240876|FG000|Overall Study|Adverse Event|3|||
143190526|NCT05285644|516240877|FG001|Overall Study|Adverse Event|3|||
143190527|NCT05285644|516240876|FG000|Overall Study|Withdrawal of Consent|2|||
143190528|NCT05285644|516240877|FG001|Overall Study|Withdrawal of Consent|5|||
143190529|NCT05285644|516240876|FG000|Overall Study|Noncompliance|0|||
143190530|NCT05285644|516240877|FG001|Overall Study|Noncompliance|4|||
143190531|NCT05285644|516240876|FG000|Overall Study|Lost to Follow-up|4|||
143190532|NCT05285644|516240877|FG001|Overall Study|Lost to Follow-up|6|||
143190533|NCT05285644|516240876|FG000|Overall Study|Disallowed Concurrent Medication|1|||
143190534|NCT05285644|516240877|FG001|Overall Study|Disallowed Concurrent Medication|1|||
143190535|NCT05285644|516240876|FG000|Overall Study|Investigator Decision|2|||
143190536|NCT05285644|516240877|FG001|Overall Study|Investigator Decision|0|||
143190537|NCT05285644|516240876|FG000|Overall Study|Protocol Deviation|1|||
143190538|NCT05285644|516240877|FG001|Overall Study|Protocol Deviation|0|||
143369534|NCT00197015|516896147|FG001|Overall Study|Lost to Follow-up|46|||
143369535|NCT00197015|516896148|FG002|Overall Study|Lost to Follow-up|37|||
143369536|NCT00197015|516896146|FG000|Overall Study|Other|2|||
143369537|NCT00197015|516896147|FG001|Overall Study|Other|3|||
143369538|NCT00197015|516896148|FG002|Overall Study|Other|2|||
143369539|NCT04511650|516896151|FG000|Overall Study|Lost to Follow-up|1|||
143369540|NCT04511650|516896152|FG001|Overall Study|Lost to Follow-up|0|||
143369541|NCT04511650|516896153|FG002|Overall Study|Lost to Follow-up|0|||
143369542|NCT04511650|516896151|FG000|Overall Study|Withdrawal by Subject|1|||
143369543|NCT04511650|516896152|FG001|Overall Study|Withdrawal by Subject|0|||
143369544|NCT04511650|516896153|FG002|Overall Study|Withdrawal by Subject|0|||
143369545|NCT04511650|516896151|FG000|Overall Study|reason not provided|0|||
143369546|NCT04511650|516896152|FG001|Overall Study|reason not provided|0|||
143369547|NCT04511650|516896153|FG002|Overall Study|reason not provided|1|||
143369548|NCT04511650|516896151|FG000|Overall Study|Death|1|||
143369549|NCT04511650|516896152|FG001|Overall Study|Death|1|||
143369550|NCT04511650|516896153|FG002|Overall Study|Death|1|||
143369551|NCT00608907|516896158|FG000|Overall Study|Adverse Event|6|||
143369552|NCT00608907|516896159|FG001|Overall Study|Adverse Event|0|||
143369553|NCT00608907|516896160|FG002|Overall Study|Adverse Event|1|||
143369554|NCT00608907|516896158|FG000|Overall Study|Death|1|||
143369555|NCT00608907|516896159|FG001|Overall Study|Death|0|||
143369556|NCT00608907|516896160|FG002|Overall Study|Death|0|||
143369557|NCT00608907|516896158|FG000|Overall Study|Withdrawal by Subject|4|||
143369558|NCT00608907|516896159|FG001|Overall Study|Withdrawal by Subject|0|||
143369559|NCT00608907|516896160|FG002|Overall Study|Withdrawal by Subject|0|||
143190539|NCT05285644|516240876|FG000|Overall Study|As specified in the Clinical Study Report|7|||
143190540|NCT05285644|516240877|FG001|Overall Study|As specified in the Clinical Study Report|3|||
143190541|NCT02952313|516240878|FG000|Primary Endpoint|Lost to Follow-up|4|||
143190542|NCT02952313|516240878|FG000|Primary Endpoint|Withdrawal by Subject|1|||
143190543|NCT02952313|516240878|FG000|Primary Endpoint|Lack of Efficacy|1|||
143190544|NCT02952313|516240878|FG000|Primary Endpoint|Missed visit|1|||
143190545|NCT02952313|516240878|FG000|Long-term Follow-up|Lost to Follow-up|12|||
143190546|NCT02952313|516240878|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
143190547|NCT02952313|516240878|FG000|Long-term Follow-up|Lack of Efficacy|6|||
143190548|NCT02952313|516240878|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
143190549|NCT02952313|516240878|FG000|Long-term Follow-up|Physician Decision|1|||
143190550|NCT02952313|516240878|FG000|Long-term Follow-up|Death|1|||
143190551|NCT04382586|516240879|FG000|Overall Study|Death|3|||
143190552|NCT04382586|516240880|FG001|Overall Study|Death|4|||
143190553|NCT04382586|516240879|FG000|Overall Study|Lost to Follow-up|11|||
143190554|NCT04382586|516240880|FG001|Overall Study|Lost to Follow-up|8|||
143190555|NCT04382586|516240879|FG000|Overall Study|Withdrawal by Subject|3|||
143190556|NCT04382586|516240880|FG001|Overall Study|Withdrawal by Subject|1|||
143190557|NCT04382586|516240879|FG000|Overall Study|Physician Decision|0|||
143190558|NCT04382586|516240880|FG001|Overall Study|Physician Decision|3|||
143190559|NCT00079391|516240881|FG000|Overall Study|Withdrawal by Subject|1|||
143190560|NCT03479541|516240882|FG000|Early and Late Physical Therapy|Lost to Follow-up|2|||
143190561|NCT03479541|516240883|FG001|Early and Late Physical Therapy|Lost to Follow-up|18|||
143190562|NCT03479541|516240884|FG002|Early and Late Physical Therapy|Lost to Follow-up|0|||
143190563|NCT03479541|516240885|FG003|Early and Late Physical Therapy|Lost to Follow-up|0|||
143369560|NCT00608907|516896158|FG000|Overall Study|Progressive Disease|1|||
143369561|NCT00608907|516896159|FG001|Overall Study|Progressive Disease|0|||
143369562|NCT00608907|516896160|FG002|Overall Study|Progressive Disease|0|||
143369563|NCT00906035|516896162|FG000|Overall Study|Withdrawal by Subject|2|||
143369564|NCT00906035|516896163|FG001|Overall Study|Withdrawal by Subject|3|||
143369565|NCT00906035|516896164|FG002|Overall Study|Withdrawal by Subject|0|||
143369566|NCT03058991|516896167|FG000|Overall Study|Lost to Follow-up|17|||
143369567|NCT03058991|516896168|FG001|Overall Study|Lost to Follow-up|12|||
143369568|NCT03058991|516896169|FG002|Overall Study|Lost to Follow-up|12|||
143369569|NCT03058991|516896167|FG000|Overall Study|Withdrawal by Subject|1|||
143369570|NCT03058991|516896168|FG001|Overall Study|Withdrawal by Subject|0|||
143369571|NCT03058991|516896169|FG002|Overall Study|Withdrawal by Subject|0|||
143369572|NCT01689519|516896170|FG000|Intent to Treat|Death|157|||
143369573|NCT01689519|516896171|FG001|Intent to Treat|Death|167|||
143369574|NCT01689519|516896170|FG000|Intent to Treat|Lost to Follow-up|4|||
143369575|NCT01689519|516896171|FG001|Intent to Treat|Lost to Follow-up|8|||
143369576|NCT01689519|516896170|FG000|Intent to Treat|Other|2|||
143369577|NCT01689519|516896171|FG001|Intent to Treat|Other|4|||
143369578|NCT01689519|516896170|FG000|Intent to Treat|Physician Decision|4|||
143369579|NCT01689519|516896171|FG001|Intent to Treat|Physician Decision|1|||
143190564|NCT03479541|516240882|FG000|Early and Late Physical Therapy|Withdrawal by Subject|15|||
143190565|NCT03479541|516240883|FG001|Early and Late Physical Therapy|Withdrawal by Subject|32|||
143369580|NCT01689519|516896170|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
143369581|NCT01689519|516896171|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
143369582|NCT01689519|516896170|FG000|Intent to Treat|Withdrawal by Subject|21|||
143369583|NCT01689519|516896171|FG001|Intent to Treat|Withdrawal by Subject|20|||
143190566|NCT03479541|516240884|FG002|Early and Late Physical Therapy|Withdrawal by Subject|0|||
143190567|NCT03479541|516240885|FG003|Early and Late Physical Therapy|Withdrawal by Subject|0|||
143190568|NCT03479541|516240882|FG000|Early and Late Physical Therapy|Early Termination - PI Decision|2|||
143190569|NCT03479541|516240883|FG001|Early and Late Physical Therapy|Early Termination - PI Decision|8|||
143190570|NCT03479541|516240884|FG002|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
143190571|NCT03479541|516240885|FG003|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
143190572|NCT03479541|516240882|FG000|Home Monitoring|Lost to Follow-up|0|||
143190573|NCT03479541|516240883|FG001|Home Monitoring|Lost to Follow-up|0|||
143190574|NCT03479541|516240884|FG002|Home Monitoring|Lost to Follow-up|8|||
143190575|NCT03479541|516240885|FG003|Home Monitoring|Lost to Follow-up|12|||
143190576|NCT03479541|516240882|FG000|Home Monitoring|Withdrawal by Subject|0|||
143190577|NCT03479541|516240883|FG001|Home Monitoring|Withdrawal by Subject|0|||
143190578|NCT03479541|516240884|FG002|Home Monitoring|Withdrawal by Subject|17|||
143190579|NCT03479541|516240885|FG003|Home Monitoring|Withdrawal by Subject|30|||
143190580|NCT03479541|516240882|FG000|Home Monitoring|Early Termination - PI Decision|0|||
143190581|NCT03479541|516240883|FG001|Home Monitoring|Early Termination - PI Decision|0|||
143190582|NCT03479541|516240884|FG002|Home Monitoring|Early Termination - PI Decision|4|||
143190583|NCT03479541|516240885|FG003|Home Monitoring|Early Termination - PI Decision|6|||
143190584|NCT00583752|516240886|FG000|Overall Study|Lost to Follow-up|5|||
143190585|NCT00583752|516240887|FG001|Overall Study|Lost to Follow-up|5|||
143190586|NCT01331837|516240888|FG000|Overall Study|Death|30|||
143190587|NCT01331837|516240889|FG001|Overall Study|Death|34|||
143190588|NCT01331837|516240888|FG000|Overall Study|Lost to Follow-up|3|||
143190589|NCT01331837|516240889|FG001|Overall Study|Lost to Follow-up|1|||
143190590|NCT01331837|516240888|FG000|Overall Study|Info not recorded|10|||
143190591|NCT01331837|516240889|FG001|Overall Study|Info not recorded|16|||
143190592|NCT01331837|516240888|FG000|Overall Study|Withdrawal by Subject|13|||
143190593|NCT01331837|516240889|FG001|Overall Study|Withdrawal by Subject|16|||
143190594|NCT02640625|516243899|FG000|Overall Study|Adverse Event|1|||
143190595|NCT00511433|516243900|FG000|Overall Study|Adverse Event|5|||
143190596|NCT00511433|516243901|FG001|Overall Study|Adverse Event|0|||
143190597|NCT00511433|516243900|FG000|Overall Study|Other Reason|1|||
143190598|NCT00511433|516243901|FG001|Overall Study|Other Reason|1|||
143190599|NCT01380535|516243902|FG000|Overall Study|Adverse Event|3|||
143190600|NCT01380535|516243903|FG001|Overall Study|Adverse Event|3|||
143190601|NCT01380535|516243902|FG000|Overall Study|Death|3|||
143190602|NCT01380535|516243903|FG001|Overall Study|Death|0|||
143190603|NCT01380535|516243902|FG000|Overall Study|Study site closed|0|||
143190604|NCT01380535|516243903|FG001|Overall Study|Study site closed|5|||
143190605|NCT01380535|516243902|FG000|Overall Study|Withdrawal by Subject|1|||
143190606|NCT01380535|516243903|FG001|Overall Study|Withdrawal by Subject|2|||
143190607|NCT01380535|516243902|FG000|Overall Study|Protocol Violation|0|||
143190608|NCT01380535|516243903|FG001|Overall Study|Protocol Violation|2|||
143190609|NCT01380535|516243902|FG000|Overall Study|Lack of Efficacy|0|||
143190610|NCT01380535|516243903|FG001|Overall Study|Lack of Efficacy|3|||
143190611|NCT02370537|516243904|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
143190612|NCT02370537|516243905|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
143190613|NCT02370537|516243906|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
143190614|NCT02370537|516243904|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
143190615|NCT02370537|516243905|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
143190616|NCT02370537|516243906|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
143190617|NCT02370537|516243904|FG000|Part B|Not randomised to receive treatment|1|||
143261508|NCT04068896|516510588|FG001|Overall Study|Withdrawal by Subject|3|||
143190618|NCT02370537|516243905|FG001|Part B|Not randomised to receive treatment|2|||
143190619|NCT02370537|516243906|FG002|Part B|Not randomised to receive treatment|259|||
143190620|NCT02370537|516243904|FG000|Part B|Withdrawal by Subject|0|||
143190621|NCT02370537|516243905|FG001|Part B|Withdrawal by Subject|1|||
143190622|NCT02370537|516243906|FG002|Part B|Withdrawal by Subject|0|||
143190623|NCT03100539|516243913|FG000|Overall Study|Lost to Follow-up|60|||
143190624|NCT03100539|516243914|FG001|Overall Study|Lost to Follow-up|54|||
143190625|NCT03100539|516243915|FG002|Overall Study|Lost to Follow-up|17|||
143190626|NCT03100539|516243913|FG000|Overall Study|Uncollected|8|||
143190627|NCT03100539|516243914|FG001|Overall Study|Uncollected|8|||
143190628|NCT03100539|516243915|FG002|Overall Study|Uncollected|0|||
143190629|NCT03100539|516243913|FG000|Overall Study|Ally Health|0|||
143190630|NCT03100539|516243914|FG001|Overall Study|Ally Health|0|||
143190631|NCT03100539|516243915|FG002|Overall Study|Ally Health|3|||
143190632|NCT03100539|516243913|FG000|Overall Study|Disinterest|0|||
143190633|NCT03100539|516243914|FG001|Overall Study|Disinterest|0|||
143190634|NCT03100539|516243915|FG002|Overall Study|Disinterest|22|||
143190635|NCT03100539|516243913|FG000|Overall Study|Veteran Health|0|||
143190636|NCT03100539|516243914|FG001|Overall Study|Veteran Health|0|||
143190637|NCT03100539|516243915|FG002|Overall Study|Veteran Health|8|||
143190638|NCT03100539|516243913|FG000|Overall Study|Moved|0|||
143190639|NCT03100539|516243914|FG001|Overall Study|Moved|0|||
143190640|NCT03100539|516243915|FG002|Overall Study|Moved|1|||
143190641|NCT03100539|516243913|FG000|Overall Study|Scheduling Conflicts|0|||
143190642|NCT03100539|516243914|FG001|Overall Study|Scheduling Conflicts|0|||
143190643|NCT03100539|516243915|FG002|Overall Study|Scheduling Conflicts|12|||
143190644|NCT02242435|516243929|FG000|Overall Study|Lost to Follow-up|3|||
143190645|NCT02242435|516243930|FG001|Overall Study|Lost to Follow-up|4|||
143190646|NCT02242435|516243929|FG000|Overall Study|Adverse Event|3|||
143190647|NCT02242435|516243930|FG001|Overall Study|Adverse Event|2|||
143190648|NCT02242435|516243929|FG000|Overall Study|Withdrawal by Subject|13|||
143190649|NCT02242435|516243930|FG001|Overall Study|Withdrawal by Subject|8|||
143190650|NCT02242435|516243929|FG000|Overall Study|Death|0|||
143190651|NCT02242435|516243930|FG001|Overall Study|Death|1|||
143190652|NCT02242435|516243929|FG000|Overall Study|Protocol Violation|1|||
143190653|NCT02242435|516243930|FG001|Overall Study|Protocol Violation|0|||
143190654|NCT02242435|516243929|FG000|Overall Study|Physician Decision|0|||
143190655|NCT02242435|516243930|FG001|Overall Study|Physician Decision|1|||
143190656|NCT03895086|516243934|FG000|Overall Study|Early termination study|1|||
143190657|NCT03895086|516243935|FG001|Overall Study|Early termination study|0|||
143190658|NCT02513485|516243947|FG000|Overall Study|Adverse Event|1|||
143190659|NCT02513485|516243948|FG001|Overall Study|Adverse Event|0|||
143190660|NCT00420004|516243958|FG000|Overall Study|Adverse Event|4|||
143369584|NCT01689519|516896170|FG000|Safety Population|Death|158|||
143190661|NCT00420004|516243959|FG001|Overall Study|Adverse Event|1|||
143190662|NCT00420004|516243960|FG002|Overall Study|Adverse Event|1|||
143190663|NCT00420004|516243958|FG000|Overall Study|Lack of Efficacy|5|||
143190664|NCT00420004|516243959|FG001|Overall Study|Lack of Efficacy|4|||
143190665|NCT00420004|516243960|FG002|Overall Study|Lack of Efficacy|1|||
143190666|NCT00420004|516243958|FG000|Overall Study|Lost to Follow-up|31|||
143190667|NCT00420004|516243959|FG001|Overall Study|Lost to Follow-up|12|||
143190668|NCT00420004|516243960|FG002|Overall Study|Lost to Follow-up|10|||
143190669|NCT00420004|516243958|FG000|Overall Study|Entry Criteria Not Met|0|||
143190670|NCT00420004|516243959|FG001|Overall Study|Entry Criteria Not Met|1|||
143190671|NCT00420004|516243960|FG002|Overall Study|Entry Criteria Not Met|0|||
143190672|NCT00420004|516243958|FG000|Overall Study|Physician Decision|14|||
143190673|NCT00420004|516243959|FG001|Overall Study|Physician Decision|4|||
143190674|NCT00420004|516243960|FG002|Overall Study|Physician Decision|2|||
143190675|NCT00420004|516243958|FG000|Overall Study|Protocol Violation|5|||
143190676|NCT00420004|516243959|FG001|Overall Study|Protocol Violation|4|||
143190677|NCT00420004|516243960|FG002|Overall Study|Protocol Violation|3|||
143190678|NCT00420004|516243958|FG000|Overall Study|Withdrawal by Subject|67|||
143190679|NCT00420004|516243959|FG001|Overall Study|Withdrawal by Subject|42|||
143190680|NCT00420004|516243960|FG002|Overall Study|Withdrawal by Subject|14|||
143190681|NCT00420004|516243958|FG000|Overall Study|Sponsor Decision|3|||
143190682|NCT00420004|516243959|FG001|Overall Study|Sponsor Decision|3|||
143190683|NCT00420004|516243960|FG002|Overall Study|Sponsor Decision|1|||
143190684|NCT03215758|516243966|FG000|Overall Study|Technical Problems|1|||
143190685|NCT03215758|516243967|FG001|Overall Study|Technical Problems|0|||
143190686|NCT03215758|516243966|FG000|Overall Study|Protocol deviation|0|||
143190687|NCT03215758|516243967|FG001|Overall Study|Protocol deviation|1|||
143190688|NCT03215758|516243966|FG000|Overall Study|Physician Decision|0|||
143190689|NCT03215758|516243967|FG001|Overall Study|Physician Decision|1|||
143190690|NCT03215758|516243966|FG000|Overall Study|Death|0|||
143190691|NCT03215758|516243967|FG001|Overall Study|Death|1|||
143190692|NCT03215758|516243966|FG000|Overall Study|Adverse Event|1|||
143190693|NCT03215758|516243967|FG001|Overall Study|Adverse Event|2|||
143190694|NCT03215758|516243966|FG000|Overall Study|Subject/Guardian Decision|3|||
143369585|NCT01689519|516896171|FG001|Safety Population|Death|165|||
143190695|NCT03215758|516243967|FG001|Overall Study|Subject/Guardian Decision|3|||
143190696|NCT04115748|516243968|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
143190697|NCT04115748|516243969|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
143190698|NCT04115748|516243970|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
143190699|NCT04115748|516243971|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
143190700|NCT04115748|516243972|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
143190701|NCT04115748|516243973|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
143190702|NCT04115748|516243974|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
143190703|NCT04115748|516243975|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
143190704|NCT04115748|516243976|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
143190705|NCT04115748|516243977|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
143190706|NCT04115748|516243968|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
143190707|NCT04115748|516243969|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
143190708|NCT04115748|516243970|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
143190709|NCT04115748|516243971|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
143190710|NCT04115748|516243972|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
143190711|NCT04115748|516243973|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
143190712|NCT04115748|516243974|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
143190713|NCT04115748|516243975|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
143190714|NCT04115748|516243976|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
143190715|NCT04115748|516243977|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
143190716|NCT04115748|516243968|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
143190717|NCT04115748|516243969|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
143190718|NCT04115748|516243970|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
143190719|NCT04115748|516243971|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
143190720|NCT04115748|516243972|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
143190721|NCT04115748|516243973|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
143190722|NCT04115748|516243974|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
143190723|NCT04115748|516243975|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
143190724|NCT04115748|516243976|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
143190725|NCT04115748|516243977|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
143190726|NCT04115748|516243968|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
143190727|NCT04115748|516243969|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
143190728|NCT04115748|516243970|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
143190729|NCT04115748|516243971|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
143190730|NCT04115748|516243972|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
143190731|NCT04115748|516243973|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
143190732|NCT04115748|516243974|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
143190733|NCT04115748|516243975|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
143190734|NCT04115748|516243976|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
143190735|NCT04115748|516243977|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
143190736|NCT00713349|516243978|FG000|Overall Study|Protocol Violation|1|||
143190737|NCT03764631|516243979|FG000|Overall Study|Personal Reasons|3|||
143190738|NCT03764631|516243980|FG001|Overall Study|Personal Reasons|2|||
143190739|NCT03764631|516243979|FG000|Overall Study|Switching Therapy|3|||
143190740|NCT03764631|516243980|FG001|Overall Study|Switching Therapy|3|||
143190741|NCT03764631|516243979|FG000|Overall Study|Adverse Event|0|||
143190742|NCT03764631|516243980|FG001|Overall Study|Adverse Event|1|||
143190743|NCT03764631|516243979|FG000|Overall Study|Lost to Follow-up|33|||
143190744|NCT03764631|516243980|FG001|Overall Study|Lost to Follow-up|41|||
143190745|NCT03764631|516243979|FG000|Overall Study|No data as study site was closed|2|||
143190746|NCT03764631|516243980|FG001|Overall Study|No data as study site was closed|6|||
143190747|NCT01200407|516243981|FG000|Overall Study|Lost to Follow-up|56|||
143190748|NCT01200407|516243981|FG000|Overall Study|Adverse Event|3|||
143190749|NCT01200407|516243981|FG000|Overall Study|Withdrawal by Subject|4|||
143190750|NCT01200407|516243981|FG000|Overall Study|Other|19|||
143190751|NCT02752633|516243984|FG000|Overall Study|Withdrawal by Subject|1|||
143190752|NCT02846389|516243985|FG000|Overall Study|Withdrawal by Subject|1|||
143190753|NCT02846389|516243986|FG001|Overall Study|Withdrawal by Subject|1|||
143190754|NCT01843673|516243987|FG000|Overall Study|Lack of Efficacy|2|||
143190755|NCT01843673|516243987|FG000|Overall Study|Withdrawal by Subject|4|||
143190756|NCT02249091|516243988|FG000|Overall Study|Lack of Efficacy|8|||
143190757|NCT02249091|516243989|FG001|Overall Study|Lack of Efficacy|3|||
143190758|NCT02249091|516243988|FG000|Overall Study|Physician Decision|4|||
143190759|NCT02249091|516243989|FG001|Overall Study|Physician Decision|1|||
143190760|NCT02249091|516243988|FG000|Overall Study|Withdrawal by Subject|2|||
143190761|NCT02249091|516243989|FG001|Overall Study|Withdrawal by Subject|2|||
143190762|NCT02249091|516243988|FG000|Overall Study|Death|3|||
143190763|NCT02249091|516243989|FG001|Overall Study|Death|4|||
143190764|NCT02249091|516243988|FG000|Overall Study|Adverse Event|1|||
143190765|NCT02249091|516243989|FG001|Overall Study|Adverse Event|0|||
143190766|NCT02249091|516243988|FG000|Overall Study|Stable disease with following SCT|0|||
143190767|NCT02249091|516243989|FG001|Overall Study|Stable disease with following SCT|1|||
143190768|NCT02249091|516243988|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
143190769|NCT02249091|516243989|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
143190770|NCT02249091|516243988|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
143190771|NCT02249091|516243989|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
143190772|NCT02249091|516243988|FG000|Overall Study|Refractory AML|1|||
143190773|NCT02249091|516243989|FG001|Overall Study|Refractory AML|1|||
143190774|NCT03275246|516243990|FG000|Overall Study|Protocol Violation|5|||
143190775|NCT03275246|516243990|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
143190776|NCT00433966|516243993|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
143190777|NCT00433966|516243994|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
143190778|NCT00433966|516243995|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
143190779|NCT00433966|516243996|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
143190780|NCT00433966|516243993|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
143190781|NCT00433966|516243994|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
143190782|NCT00433966|516243995|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
143190783|NCT00433966|516243996|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
143190784|NCT00433966|516243993|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
143190785|NCT00433966|516243994|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
143190786|NCT00433966|516243995|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
143190787|NCT00433966|516243996|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
143190788|NCT00433966|516243993|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
143190789|NCT00433966|516243994|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
143190790|NCT00433966|516243995|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
143190791|NCT00433966|516243996|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
143190792|NCT00433966|516243993|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
143190793|NCT00433966|516243994|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
143190794|NCT00433966|516243995|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
143190795|NCT00433966|516243996|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
143190796|NCT03497975|516243998|FG000|Overall Study|Withdrew Consent|34|||
143190797|NCT03497975|516243999|FG001|Overall Study|Withdrew Consent|35|||
143190798|NCT03497975|516243998|FG000|Overall Study|Lost to Follow-up|7|||
143190799|NCT03497975|516243999|FG001|Overall Study|Lost to Follow-up|7|||
143190800|NCT03497975|516243998|FG000|Overall Study|Physician Decision|4|||
143190801|NCT03497975|516243999|FG001|Overall Study|Physician Decision|5|||
143190802|NCT03497975|516243998|FG000|Overall Study|Discontinued|42|||
143190803|NCT03497975|516243999|FG001|Overall Study|Discontinued|39|||
143190804|NCT03497975|516243998|FG000|Overall Study|Reason Not Specified|15|||
143190805|NCT03497975|516243999|FG001|Overall Study|Reason Not Specified|14|||
143190806|NCT01296711|516244000|FG000|Overall Study|Adverse Event|3|||
143190807|NCT01296711|516244001|FG001|Overall Study|Adverse Event|1|||
143190808|NCT01296711|516244002|FG002|Overall Study|Adverse Event|4|||
143190809|NCT01296711|516244003|FG003|Overall Study|Adverse Event|3|||
143190810|NCT01296711|516244004|FG004|Overall Study|Adverse Event|1|||
143190811|NCT01296711|516244005|FG005|Overall Study|Adverse Event|6|||
143190812|NCT01296711|516244006|FG006|Overall Study|Adverse Event|11|||
143190813|NCT01296711|516244007|FG007|Overall Study|Adverse Event|3|||
143190814|NCT01296711|516244000|FG000|Overall Study|Lack of Efficacy|1|||
143190815|NCT01296711|516244001|FG001|Overall Study|Lack of Efficacy|4|||
143190816|NCT01296711|516244002|FG002|Overall Study|Lack of Efficacy|1|||
143190817|NCT01296711|516244003|FG003|Overall Study|Lack of Efficacy|1|||
143190818|NCT01296711|516244004|FG004|Overall Study|Lack of Efficacy|1|||
143190819|NCT01296711|516244005|FG005|Overall Study|Lack of Efficacy|0|||
143190820|NCT01296711|516244006|FG006|Overall Study|Lack of Efficacy|2|||
143190821|NCT01296711|516244007|FG007|Overall Study|Lack of Efficacy|3|||
143190822|NCT01296711|516244000|FG000|Overall Study|Lost to Follow-up|0|||
143190823|NCT01296711|516244001|FG001|Overall Study|Lost to Follow-up|0|||
143190824|NCT01296711|516244002|FG002|Overall Study|Lost to Follow-up|1|||
143190825|NCT01296711|516244003|FG003|Overall Study|Lost to Follow-up|1|||
143190826|NCT01296711|516244004|FG004|Overall Study|Lost to Follow-up|2|||
143190827|NCT01296711|516244005|FG005|Overall Study|Lost to Follow-up|0|||
143190828|NCT01296711|516244006|FG006|Overall Study|Lost to Follow-up|4|||
143190829|NCT01296711|516244007|FG007|Overall Study|Lost to Follow-up|2|||
143190830|NCT01296711|516244000|FG000|Overall Study|Protocol Violation|0|||
143190831|NCT01296711|516244001|FG001|Overall Study|Protocol Violation|0|||
143190832|NCT01296711|516244002|FG002|Overall Study|Protocol Violation|0|||
143190833|NCT01296711|516244003|FG003|Overall Study|Protocol Violation|1|||
143190834|NCT01296711|516244004|FG004|Overall Study|Protocol Violation|1|||
143190835|NCT01296711|516244005|FG005|Overall Study|Protocol Violation|0|||
143190836|NCT01296711|516244006|FG006|Overall Study|Protocol Violation|0|||
143190837|NCT01296711|516244007|FG007|Overall Study|Protocol Violation|0|||
143190838|NCT01296711|516244000|FG000|Overall Study|Withdrawal by Subject|4|||
143190839|NCT01296711|516244001|FG001|Overall Study|Withdrawal by Subject|2|||
143190840|NCT01296711|516244002|FG002|Overall Study|Withdrawal by Subject|2|||
143190841|NCT01296711|516244003|FG003|Overall Study|Withdrawal by Subject|1|||
143190842|NCT01296711|516244004|FG004|Overall Study|Withdrawal by Subject|1|||
143190843|NCT01296711|516244005|FG005|Overall Study|Withdrawal by Subject|1|||
143190844|NCT01296711|516244006|FG006|Overall Study|Withdrawal by Subject|2|||
143190845|NCT01296711|516244007|FG007|Overall Study|Withdrawal by Subject|1|||
143190846|NCT01296711|516244000|FG000|Overall Study|Study termination|8|||
143190847|NCT01296711|516244001|FG001|Overall Study|Study termination|1|||
143190848|NCT01296711|516244002|FG002|Overall Study|Study termination|5|||
143190849|NCT01296711|516244003|FG003|Overall Study|Study termination|4|||
143190850|NCT01296711|516244004|FG004|Overall Study|Study termination|4|||
143190851|NCT01296711|516244005|FG005|Overall Study|Study termination|4|||
143190852|NCT01296711|516244006|FG006|Overall Study|Study termination|8|||
143190853|NCT01296711|516244007|FG007|Overall Study|Study termination|10|||
143190854|NCT01296711|516244000|FG000|Overall Study|Continued elevated liver enzymes|0|||
143190855|NCT01296711|516244001|FG001|Overall Study|Continued elevated liver enzymes|0|||
143190856|NCT01296711|516244002|FG002|Overall Study|Continued elevated liver enzymes|0|||
143190857|NCT01296711|516244003|FG003|Overall Study|Continued elevated liver enzymes|1|||
143190858|NCT01296711|516244004|FG004|Overall Study|Continued elevated liver enzymes|0|||
143190859|NCT01296711|516244005|FG005|Overall Study|Continued elevated liver enzymes|0|||
143190860|NCT01296711|516244006|FG006|Overall Study|Continued elevated liver enzymes|0|||
143190861|NCT01296711|516244007|FG007|Overall Study|Continued elevated liver enzymes|0|||
143190862|NCT01296711|516244000|FG000|Overall Study|Methotrexate discontinued|0|||
143190863|NCT01296711|516244001|FG001|Overall Study|Methotrexate discontinued|0|||
143190864|NCT01296711|516244002|FG002|Overall Study|Methotrexate discontinued|0|||
143190865|NCT01296711|516244003|FG003|Overall Study|Methotrexate discontinued|1|||
143190866|NCT01296711|516244004|FG004|Overall Study|Methotrexate discontinued|0|||
143190867|NCT01296711|516244005|FG005|Overall Study|Methotrexate discontinued|0|||
143190868|NCT01296711|516244006|FG006|Overall Study|Methotrexate discontinued|0|||
143190869|NCT01296711|516244007|FG007|Overall Study|Methotrexate discontinued|0|||
143190870|NCT01296711|516244000|FG000|Overall Study|Investigator discretion|0|||
143190871|NCT01296711|516244001|FG001|Overall Study|Investigator discretion|0|||
143190872|NCT01296711|516244002|FG002|Overall Study|Investigator discretion|0|||
143190873|NCT01296711|516244003|FG003|Overall Study|Investigator discretion|0|||
143190874|NCT01296711|516244004|FG004|Overall Study|Investigator discretion|0|||
143190875|NCT01296711|516244005|FG005|Overall Study|Investigator discretion|0|||
143190876|NCT01296711|516244006|FG006|Overall Study|Investigator discretion|1|||
143190877|NCT01296711|516244007|FG007|Overall Study|Investigator discretion|0|||
143190878|NCT01296711|516244000|FG000|Overall Study|Other|0|||
143190879|NCT01296711|516244001|FG001|Overall Study|Other|0|||
143190880|NCT01296711|516244002|FG002|Overall Study|Other|0|||
143190881|NCT01296711|516244003|FG003|Overall Study|Other|0|||
143190882|NCT01296711|516244004|FG004|Overall Study|Other|0|||
143190883|NCT01296711|516244005|FG005|Overall Study|Other|0|||
143190884|NCT01296711|516244006|FG006|Overall Study|Other|1|||
143190885|NCT01296711|516244007|FG007|Overall Study|Other|0|||
143190886|NCT01296711|516244000|FG000|Overall Study|Required restricted steroid injections|0|||
143190887|NCT01296711|516244001|FG001|Overall Study|Required restricted steroid injections|0|||
143190888|NCT01296711|516244002|FG002|Overall Study|Required restricted steroid injections|0|||
143369586|NCT01689519|516896170|FG000|Safety Population|Lost to Follow-up|4|||
143369587|NCT01689519|516896171|FG001|Safety Population|Lost to Follow-up|8|||
143369588|NCT01689519|516896170|FG000|Safety Population|Other|2|||
143369589|NCT01689519|516896171|FG001|Safety Population|Other|4|||
143190889|NCT01296711|516244003|FG003|Overall Study|Required restricted steroid injections|0|||
143190890|NCT01296711|516244004|FG004|Overall Study|Required restricted steroid injections|0|||
143190891|NCT01296711|516244005|FG005|Overall Study|Required restricted steroid injections|0|||
143190892|NCT01296711|516244006|FG006|Overall Study|Required restricted steroid injections|1|||
143190893|NCT01296711|516244007|FG007|Overall Study|Required restricted steroid injections|0|||
143369590|NCT01689519|516896170|FG000|Safety Population|Physician Decision|4|||
143190894|NCT01296711|516244000|FG000|Overall Study|Ongoing missed appointments|0|||
143190895|NCT01296711|516244001|FG001|Overall Study|Ongoing missed appointments|0|||
143190896|NCT01296711|516244002|FG002|Overall Study|Ongoing missed appointments|0|||
143369591|NCT01689519|516896171|FG001|Safety Population|Physician Decision|1|||
143369592|NCT01689519|516896170|FG000|Safety Population|Study Terminated By Sponsor|60|||
143369593|NCT01689519|516896171|FG001|Safety Population|Study Terminated By Sponsor|47|||
143190897|NCT01296711|516244003|FG003|Overall Study|Ongoing missed appointments|0|||
143369594|NCT01689519|516896170|FG000|Safety Population|Withdrawal by Subject|20|||
143190898|NCT01296711|516244004|FG004|Overall Study|Ongoing missed appointments|0|||
143190899|NCT01296711|516244005|FG005|Overall Study|Ongoing missed appointments|0|||
143190900|NCT01296711|516244006|FG006|Overall Study|Ongoing missed appointments|1|||
143190901|NCT01296711|516244007|FG007|Overall Study|Ongoing missed appointments|0|||
143190902|NCT01296711|516244000|FG000|Overall Study|Failure to comply with visits|0|||
143190903|NCT01296711|516244001|FG001|Overall Study|Failure to comply with visits|0|||
143190904|NCT01296711|516244002|FG002|Overall Study|Failure to comply with visits|0|||
143190905|NCT01296711|516244003|FG003|Overall Study|Failure to comply with visits|0|||
143190906|NCT01296711|516244004|FG004|Overall Study|Failure to comply with visits|0|||
143190907|NCT01296711|516244005|FG005|Overall Study|Failure to comply with visits|0|||
143190908|NCT01296711|516244006|FG006|Overall Study|Failure to comply with visits|0|||
143190909|NCT01296711|516244007|FG007|Overall Study|Failure to comply with visits|1|||
143190910|NCT01296711|516244000|FG000|Overall Study|Patient decision due to transport|0|||
143190911|NCT01296711|516244001|FG001|Overall Study|Patient decision due to transport|0|||
143190912|NCT01296711|516244002|FG002|Overall Study|Patient decision due to transport|0|||
143190913|NCT01296711|516244003|FG003|Overall Study|Patient decision due to transport|0|||
143190914|NCT01296711|516244004|FG004|Overall Study|Patient decision due to transport|0|||
143190915|NCT01296711|516244005|FG005|Overall Study|Patient decision due to transport|0|||
143190916|NCT01296711|516244006|FG006|Overall Study|Patient decision due to transport|0|||
143190917|NCT01296711|516244007|FG007|Overall Study|Patient decision due to transport|1|||
143190918|NCT00923975|516244011|FG000|Overall Study|Did not meet inclusion criteria|1|||
143190919|NCT01005316|516244014|FG000|Overall Study|Adverse Event|0|||
143190920|NCT01005316|516244015|FG001|Overall Study|Adverse Event|0|||
143190921|NCT01005316|516244016|FG002|Overall Study|Adverse Event|0|||
143190922|NCT01005316|516244017|FG003|Overall Study|Adverse Event|1|||
143190923|NCT01005316|516244014|FG000|Overall Study|Death|20|||
143190924|NCT01005316|516244015|FG001|Overall Study|Death|5|||
143190925|NCT01005316|516244016|FG002|Overall Study|Death|1|||
143190926|NCT01005316|516244017|FG003|Overall Study|Death|15|||
143190927|NCT01005316|516244014|FG000|Overall Study|Study Termination|5|||
143190928|NCT01005316|516244015|FG001|Overall Study|Study Termination|63|||
143190929|NCT01005316|516244016|FG002|Overall Study|Study Termination|9|||
143190930|NCT01005316|516244017|FG003|Overall Study|Study Termination|85|||
143190931|NCT01005316|516244014|FG000|Overall Study|Lost to Follow-up|1|||
143190932|NCT01005316|516244015|FG001|Overall Study|Lost to Follow-up|3|||
143190933|NCT01005316|516244016|FG002|Overall Study|Lost to Follow-up|0|||
143190934|NCT01005316|516244017|FG003|Overall Study|Lost to Follow-up|2|||
143190935|NCT01005316|516244014|FG000|Overall Study|Physician Decision|6|||
143190936|NCT01005316|516244015|FG001|Overall Study|Physician Decision|0|||
143190937|NCT01005316|516244016|FG002|Overall Study|Physician Decision|0|||
143190938|NCT01005316|516244017|FG003|Overall Study|Physician Decision|0|||
143190939|NCT01005316|516244014|FG000|Overall Study|Sponsor Decision|6|||
143190940|NCT01005316|516244015|FG001|Overall Study|Sponsor Decision|3|||
143190941|NCT01005316|516244016|FG002|Overall Study|Sponsor Decision|0|||
143190942|NCT01005316|516244017|FG003|Overall Study|Sponsor Decision|0|||
143190943|NCT01005316|516244014|FG000|Overall Study|Withdrawal by Subject|1|||
143190944|NCT01005316|516244015|FG001|Overall Study|Withdrawal by Subject|1|||
143190945|NCT01005316|516244016|FG002|Overall Study|Withdrawal by Subject|0|||
143190946|NCT01005316|516244017|FG003|Overall Study|Withdrawal by Subject|2|||
143190947|NCT01005316|516244014|FG000|Overall Study|Consented to Another Study|2|||
143190948|NCT01005316|516244015|FG001|Overall Study|Consented to Another Study|0|||
143190949|NCT01005316|516244016|FG002|Overall Study|Consented to Another Study|0|||
143190950|NCT01005316|516244017|FG003|Overall Study|Consented to Another Study|0|||
143190951|NCT01005316|516244014|FG000|Overall Study|Delisted|8|||
143190952|NCT01005316|516244015|FG001|Overall Study|Delisted|0|||
143190953|NCT01005316|516244016|FG002|Overall Study|Delisted|0|||
143190954|NCT01005316|516244017|FG003|Overall Study|Delisted|0|||
143190955|NCT01005316|516244014|FG000|Overall Study|Transferred Care|1|||
143190956|NCT01005316|516244015|FG001|Overall Study|Transferred Care|0|||
143190957|NCT01005316|516244016|FG002|Overall Study|Transferred Care|1|||
143190958|NCT01005316|516244017|FG003|Overall Study|Transferred Care|3|||
143190959|NCT01005316|516244014|FG000|Overall Study|Retransplanted|0|||
143190960|NCT01005316|516244015|FG001|Overall Study|Retransplanted|1|||
143190961|NCT01005316|516244016|FG002|Overall Study|Retransplanted|0|||
143190962|NCT01005316|516244017|FG003|Overall Study|Retransplanted|0|||
143190963|NCT00632827|516244018|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
143190964|NCT00632827|516244018|FG000|Overall Study|Death|2|||
143190965|NCT00632827|516244018|FG000|Overall Study|Adverse Event|5|||
143190966|NCT00632827|516244018|FG000|Overall Study|Lost to Follow-up|1|||
143190967|NCT02516098|516244021|FG000|Period 1|Protocol Violation|1|||
143190968|NCT02516098|516244022|FG001|Period 1|Protocol Violation|0|||
143190969|NCT02516098|516244021|FG000|Washout After Period 1|Adverse Event|0|||
143190970|NCT02516098|516244022|FG001|Washout After Period 1|Adverse Event|1|||
143190971|NCT02516098|516244021|FG000|Period 2|Withdrawal by Subject|0|||
143190972|NCT02516098|516244022|FG001|Period 2|Withdrawal by Subject|1|||
143190973|NCT01092780|516244023|FG000|Washout Period 1|Adverse Event|0|||
143190974|NCT01092780|516244024|FG001|Washout Period 1|Adverse Event|1|||
143190975|NCT01092780|516244025|FG002|Washout Period 1|Adverse Event|0|||
143190976|NCT01092780|516244026|FG003|Washout Period 1|Adverse Event|0|||
143190977|NCT01092780|516244023|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
143190978|NCT01092780|516244024|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
143190979|NCT01092780|516244025|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
143190980|NCT01092780|516244026|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
143190981|NCT01092780|516244023|FG000|Washout Period 2|Adverse Event|0|||
143190982|NCT01092780|516244024|FG001|Washout Period 2|Adverse Event|1|||
143190983|NCT01092780|516244025|FG002|Washout Period 2|Adverse Event|1|||
143190984|NCT01092780|516244026|FG003|Washout Period 2|Adverse Event|0|||
143190985|NCT01734395|516244027|FG000|Overall Study|Other|65|||
143190986|NCT01734395|516244027|FG000|Overall Study|Lost to Follow-up|287|||
143190987|NCT01734395|516244027|FG000|Overall Study|Lack of Efficacy|5|||
143190988|NCT01734395|516244027|FG000|Overall Study|Adverse Event|40|||
143190989|NCT01734395|516244027|FG000|Overall Study|Withdrawal by Subject|10|||
143190990|NCT01734395|516244027|FG000|Overall Study|Missing the reasons for not completed|3|||
143190991|NCT02300558|516244035|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
143190992|NCT02300558|516244035|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
143190993|NCT02300558|516244035|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
143190994|NCT02300558|516244035|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
143190995|NCT04826094|516244036|FG000|Overall Study|Lost to Follow-up|2|||
143190996|NCT04826094|516244037|FG001|Overall Study|Lost to Follow-up|1|||
143190997|NCT04826094|516244038|FG002|Overall Study|Lost to Follow-up|0|||
143190998|NCT04826094|516244039|FG003|Overall Study|Lost to Follow-up|0|||
143190999|NCT04826094|516244040|FG004|Overall Study|Lost to Follow-up|1|||
143191000|NCT04826094|516244041|FG005|Overall Study|Lost to Follow-up|3|||
143191001|NCT04826094|516244042|FG006|Overall Study|Lost to Follow-up|1|||
143191002|NCT04826094|516244043|FG007|Overall Study|Lost to Follow-up|1|||
143191003|NCT04826094|516244036|FG000|Overall Study|Participant withdrew consent|1|||
143191004|NCT04826094|516244037|FG001|Overall Study|Participant withdrew consent|0|||
143191005|NCT04826094|516244038|FG002|Overall Study|Participant withdrew consent|0|||
143191006|NCT04826094|516244039|FG003|Overall Study|Participant withdrew consent|1|||
143191007|NCT04826094|516244040|FG004|Overall Study|Participant withdrew consent|1|||
143191008|NCT04826094|516244041|FG005|Overall Study|Participant withdrew consent|1|||
143191009|NCT04826094|516244042|FG006|Overall Study|Participant withdrew consent|0|||
143191010|NCT04826094|516244043|FG007|Overall Study|Participant withdrew consent|1|||
143191011|NCT04826094|516244036|FG000|Overall Study|Non-adherence (protocol deviation)|0|||
143191012|NCT04826094|516244037|FG001|Overall Study|Non-adherence (protocol deviation)|0|||
143191013|NCT04826094|516244038|FG002|Overall Study|Non-adherence (protocol deviation)|0|||
143191014|NCT04826094|516244039|FG003|Overall Study|Non-adherence (protocol deviation)|0|||
143191015|NCT04826094|516244040|FG004|Overall Study|Non-adherence (protocol deviation)|0|||
143191016|NCT04826094|516244041|FG005|Overall Study|Non-adherence (protocol deviation)|0|||
143191017|NCT04826094|516244042|FG006|Overall Study|Non-adherence (protocol deviation)|1|||
143191018|NCT04826094|516244043|FG007|Overall Study|Non-adherence (protocol deviation)|0|||
143191019|NCT04826094|516244036|FG000|Overall Study|Withdrawn by Investigator|0|||
143191020|NCT04826094|516244037|FG001|Overall Study|Withdrawn by Investigator|0|||
143191021|NCT04826094|516244038|FG002|Overall Study|Withdrawn by Investigator|0|||
143191022|NCT04826094|516244039|FG003|Overall Study|Withdrawn by Investigator|0|||
143191023|NCT04826094|516244040|FG004|Overall Study|Withdrawn by Investigator|0|||
143191024|NCT04826094|516244041|FG005|Overall Study|Withdrawn by Investigator|1|||
143191025|NCT04826094|516244042|FG006|Overall Study|Withdrawn by Investigator|0|||
143191026|NCT04826094|516244043|FG007|Overall Study|Withdrawn by Investigator|1|||
143191027|NCT04826094|516244036|FG000|Overall Study|Other: Moved from area|1|||
143191028|NCT04826094|516244037|FG001|Overall Study|Other: Moved from area|1|||
143191029|NCT04826094|516244038|FG002|Overall Study|Other: Moved from area|1|||
143191030|NCT04826094|516244039|FG003|Overall Study|Other: Moved from area|0|||
143191031|NCT04826094|516244040|FG004|Overall Study|Other: Moved from area|0|||
143191032|NCT04826094|516244041|FG005|Overall Study|Other: Moved from area|0|||
143191033|NCT04826094|516244042|FG006|Overall Study|Other: Moved from area|0|||
143191034|NCT04826094|516244043|FG007|Overall Study|Other: Moved from area|0|||
143191035|NCT04826094|516244036|FG000|Overall Study|Other: Declined|0|||
143191036|NCT04826094|516244037|FG001|Overall Study|Other: Declined|0|||
143191037|NCT04826094|516244038|FG002|Overall Study|Other: Declined|0|||
143191038|NCT04826094|516244039|FG003|Overall Study|Other: Declined|0|||
143191039|NCT04826094|516244040|FG004|Overall Study|Other: Declined|1|||
143191040|NCT04826094|516244041|FG005|Overall Study|Other: Declined|0|||
143191041|NCT04826094|516244042|FG006|Overall Study|Other: Declined|0|||
143191042|NCT04826094|516244043|FG007|Overall Study|Other: Declined|0|||
143191043|NCT04826094|516244036|FG000|Overall Study|Other: Vaccine not administered|0|||
143191044|NCT04826094|516244037|FG001|Overall Study|Other: Vaccine not administered|0|||
143191045|NCT04826094|516244038|FG002|Overall Study|Other: Vaccine not administered|1|||
143191046|NCT04826094|516244039|FG003|Overall Study|Other: Vaccine not administered|0|||
143191047|NCT04826094|516244040|FG004|Overall Study|Other: Vaccine not administered|0|||
143191048|NCT04826094|516244041|FG005|Overall Study|Other: Vaccine not administered|1|||
143191049|NCT04826094|516244042|FG006|Overall Study|Other: Vaccine not administered|1|||
143191050|NCT04826094|516244043|FG007|Overall Study|Other: Vaccine not administered|3|||
143191051|NCT01500252|516244044|FG000|Overall Study|Death|4|||
143191052|NCT01500252|516244045|FG001|Overall Study|Death|2|||
143191053|NCT01500252|516244044|FG000|Overall Study|Lost to Follow-up|5|||
143191054|NCT01500252|516244045|FG001|Overall Study|Lost to Follow-up|4|||
143191055|NCT01421303|516244046|FG000|Overall Study|Lost to Follow-up|13|||
143191056|NCT01421303|516244046|FG000|Overall Study|Non compliance with study procedure|1|||
143191057|NCT01421303|516244046|FG000|Overall Study|Other|7|||
143191058|NCT01421303|516244046|FG000|Overall Study|Withdrawal by Subject|1|||
143191059|NCT02120300|516244047|FG000|Overall Study|Enrolled but Never Treated|2|||
143191060|NCT02120300|516244048|FG001|Overall Study|Enrolled but Never Treated|0|||
143191061|NCT02120300|516244049|FG002|Overall Study|Enrolled but Never Treated|0|||
143191062|NCT02120300|516244050|FG003|Overall Study|Enrolled but Never Treated|0|||
143191063|NCT02120300|516244047|FG000|Overall Study|Lack of Efficacy|0|||
143191064|NCT02120300|516244048|FG001|Overall Study|Lack of Efficacy|0|||
143191065|NCT02120300|516244049|FG002|Overall Study|Lack of Efficacy|0|||
143191066|NCT02120300|516244050|FG003|Overall Study|Lack of Efficacy|1|||
143191067|NCT02120300|516244047|FG000|Overall Study|Lost to Follow-up|1|||
143191068|NCT02120300|516244048|FG001|Overall Study|Lost to Follow-up|0|||
143191069|NCT02120300|516244049|FG002|Overall Study|Lost to Follow-up|0|||
143191070|NCT02120300|516244050|FG003|Overall Study|Lost to Follow-up|0|||
143191071|NCT00700882|516244051|FG000|Overall Study|Never received treatment|6|||
143191072|NCT00700882|516244051|FG000|Overall Study|Ineligible|2|||
143191073|NCT00700882|516244051|FG000|Overall Study|No KIT mutation|51|||
143191074|NCT01832493|516244052|FG000|Overall Study|Physician Decision|2|||
143191075|NCT01832493|516244052|FG000|Overall Study|Protocol Violation|4|||
143191076|NCT01832493|516244052|FG000|Overall Study|Unable to place LV lead|2|||
143191077|NCT00656058|516244053|FG000|Overall Study|Withdrawal by Subject|2|||
143191078|NCT00656058|516244053|FG000|Overall Study|Withdrawal by Subject|4|||
143191079|NCT00404755|516244054|FG000|Phase I (Bupropion)|Adverse Event|3|||
143191080|NCT00404755|516244054|FG000|Phase I (Bupropion)|Other|1|||
143191081|NCT00404755|516244054|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
143191082|NCT04700540|516244055|FG000|Overall Study|Withdrawal by Subject|12|||
143191083|NCT04700540|516244056|FG001|Overall Study|Withdrawal by Subject|8|||
143191084|NCT04700540|516244055|FG000|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|28|||
143191085|NCT04700540|516244056|FG001|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|0|||
143191086|NCT02265536|516244057|FG000|Overall Study|Adverse Event|1|||
143191087|NCT02265536|516244058|FG001|Overall Study|Adverse Event|0|||
143191088|NCT02265536|516244059|FG002|Overall Study|Adverse Event|0|||
143191089|NCT02265536|516244060|FG003|Overall Study|Adverse Event|0|||
143191090|NCT02265536|516244061|FG004|Overall Study|Adverse Event|1|||
143191091|NCT02265536|516244062|FG005|Overall Study|Adverse Event|0|||
143191092|NCT02265536|516244057|FG000|Overall Study|Physician Decision|0|||
143191093|NCT02265536|516244058|FG001|Overall Study|Physician Decision|0|||
143191094|NCT02265536|516244059|FG002|Overall Study|Physician Decision|0|||
143191095|NCT02265536|516244060|FG003|Overall Study|Physician Decision|0|||
143191096|NCT02265536|516244061|FG004|Overall Study|Physician Decision|2|||
143191097|NCT02265536|516244062|FG005|Overall Study|Physician Decision|0|||
143191098|NCT02265536|516244057|FG000|Overall Study|Withdrawal by Subject|0|||
143191099|NCT02265536|516244058|FG001|Overall Study|Withdrawal by Subject|3|||
143191100|NCT02265536|516244059|FG002|Overall Study|Withdrawal by Subject|0|||
143191101|NCT02265536|516244060|FG003|Overall Study|Withdrawal by Subject|0|||
143191102|NCT02265536|516244061|FG004|Overall Study|Withdrawal by Subject|0|||
143191103|NCT02265536|516244062|FG005|Overall Study|Withdrawal by Subject|0|||
143191104|NCT02241733|516244065|FG000|Overall Study|Lost to Follow-up|9|||
143191105|NCT02241733|516244066|FG001|Overall Study|Lost to Follow-up|4|||
143191106|NCT02241733|516244065|FG000|Overall Study|Physician Decision|6|||
143191107|NCT02241733|516244066|FG001|Overall Study|Physician Decision|2|||
143191108|NCT02241733|516244065|FG000|Overall Study|Withdrawal by Subject|0|||
143191109|NCT02241733|516244066|FG001|Overall Study|Withdrawal by Subject|2|||
143191110|NCT02241733|516244065|FG000|Overall Study|Death|0|||
143191111|NCT02241733|516244066|FG001|Overall Study|Death|2|||
143191112|NCT01866111|516244067|FG000|Double-blind Period of Study YKP3089C017|Adverse Event|5|||
143191113|NCT01866111|516244068|FG001|Double-blind Period of Study YKP3089C017|Adverse Event|12|||
143191114|NCT01866111|516244069|FG002|Double-blind Period of Study YKP3089C017|Adverse Event|15|||
143191115|NCT01866111|516244070|FG003|Double-blind Period of Study YKP3089C017|Adverse Event|23|||
143191116|NCT01866111|516244067|FG000|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|5|||
143191117|NCT01866111|516244068|FG001|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|0|||
143191118|NCT01866111|516244069|FG002|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|4|||
143191119|NCT01866111|516244070|FG003|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|3|||
143191120|NCT01866111|516244067|FG000|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
143191121|NCT01866111|516244068|FG001|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
143191122|NCT01866111|516244069|FG002|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
143191123|NCT01866111|516244070|FG003|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
143191124|NCT01866111|516244067|FG000|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
143191125|NCT01866111|516244068|FG001|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
143191126|NCT01866111|516244069|FG002|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
143191127|NCT01866111|516244070|FG003|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
143191128|NCT01866111|516244067|FG000|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
143191129|NCT01866111|516244068|FG001|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
143191130|NCT01866111|516244069|FG002|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
143191131|NCT01866111|516244070|FG003|Double-blind Period of Study YKP3089C017|Lost to Follow-up|1|||
143191132|NCT01866111|516244067|FG000|Double-blind Period of Study YKP3089C017|Pregnancy|1|||
143191133|NCT01866111|516244068|FG001|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
143191134|NCT01866111|516244069|FG002|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
143191135|NCT01866111|516244070|FG003|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
143191136|NCT01866111|516244067|FG000|Double-blind Period of Study YKP3089C017|Reason Unknown|3|||
143191137|NCT01866111|516244068|FG001|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
143191138|NCT01866111|516244069|FG002|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
143191139|NCT01866111|516244070|FG003|Double-blind Period of Study YKP3089C017|Reason Unknown|1|||
143191140|NCT01866111|516244067|FG000|Open-label Extension Study YKP3089C017|Adverse Event|9|||
143191141|NCT01866111|516244068|FG001|Open-label Extension Study YKP3089C017|Adverse Event|6|||
143191142|NCT01866111|516244069|FG002|Open-label Extension Study YKP3089C017|Adverse Event|6|||
143191143|NCT01866111|516244070|FG003|Open-label Extension Study YKP3089C017|Adverse Event|7|||
143191144|NCT01866111|516244067|FG000|Open-label Extension Study YKP3089C017|Withdrawal by Subject|16|||
143191145|NCT01866111|516244068|FG001|Open-label Extension Study YKP3089C017|Withdrawal by Subject|7|||
143191146|NCT01866111|516244069|FG002|Open-label Extension Study YKP3089C017|Withdrawal by Subject|9|||
143191147|NCT01866111|516244070|FG003|Open-label Extension Study YKP3089C017|Withdrawal by Subject|3|||
143191148|NCT01866111|516244067|FG000|Open-label Extension Study YKP3089C017|Protocol Violation|1|||
143191149|NCT01866111|516244068|FG001|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
143191150|NCT01866111|516244069|FG002|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
143191151|NCT01866111|516244070|FG003|Open-label Extension Study YKP3089C017|Protocol Violation|2|||
143191152|NCT01866111|516244067|FG000|Open-label Extension Study YKP3089C017|Lost to Follow-up|2|||
143191153|NCT01866111|516244068|FG001|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
143191154|NCT01866111|516244069|FG002|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
143191155|NCT01866111|516244070|FG003|Open-label Extension Study YKP3089C017|Lost to Follow-up|3|||
143191156|NCT01866111|516244067|FG000|Open-label Extension Study YKP3089C017|Death|1|||
143191157|NCT01866111|516244068|FG001|Open-label Extension Study YKP3089C017|Death|1|||
143191158|NCT01866111|516244069|FG002|Open-label Extension Study YKP3089C017|Death|3|||
143191159|NCT01866111|516244070|FG003|Open-label Extension Study YKP3089C017|Death|2|||
143191160|NCT01866111|516244067|FG000|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|30|||
143191161|NCT01866111|516244068|FG001|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|39|||
143191162|NCT01866111|516244069|FG002|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|28|||
143191163|NCT01866111|516244070|FG003|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|32|||
143191164|NCT01866111|516244067|FG000|Open-label Extension Study YKP3089C017|Lack of Efficacy|13|||
143191165|NCT01866111|516244068|FG001|Open-label Extension Study YKP3089C017|Lack of Efficacy|17|||
143191166|NCT01866111|516244069|FG002|Open-label Extension Study YKP3089C017|Lack of Efficacy|23|||
143191167|NCT01866111|516244070|FG003|Open-label Extension Study YKP3089C017|Lack of Efficacy|14|||
143191168|NCT01866111|516244067|FG000|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
143191169|NCT01866111|516244068|FG001|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
143191170|NCT01866111|516244069|FG002|Open-label Extension Study YKP3089C017|Reason Unknown|1|||
143191171|NCT01866111|516244070|FG003|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
143191172|NCT01252186|516244071|FG000|Overall Study|Adverse Event|9|||
143191173|NCT01252186|516244072|FG001|Overall Study|Adverse Event|6|||
143191174|NCT01252186|516244073|FG002|Overall Study|Adverse Event|8|||
143191175|NCT01252186|516244071|FG000|Overall Study|Withdrawal by Subject|2|||
143191176|NCT01252186|516244072|FG001|Overall Study|Withdrawal by Subject|5|||
143191177|NCT01252186|516244073|FG002|Overall Study|Withdrawal by Subject|2|||
143191178|NCT01252186|516244071|FG000|Overall Study|Physician Decision|0|||
143191179|NCT01252186|516244072|FG001|Overall Study|Physician Decision|0|||
143191180|NCT01252186|516244073|FG002|Overall Study|Physician Decision|1|||
143191181|NCT01252186|516244071|FG000|Overall Study|Non-compliance|0|||
143191182|NCT01252186|516244072|FG001|Overall Study|Non-compliance|3|||
143191183|NCT01252186|516244073|FG002|Overall Study|Non-compliance|4|||
143191184|NCT01252186|516244071|FG000|Overall Study|Protocol Violation|0|||
143191185|NCT01252186|516244072|FG001|Overall Study|Protocol Violation|0|||
143191186|NCT01252186|516244073|FG002|Overall Study|Protocol Violation|1|||
143191187|NCT01252186|516244071|FG000|Overall Study|Pregnancy|2|||
143191188|NCT01252186|516244072|FG001|Overall Study|Pregnancy|2|||
143191189|NCT01252186|516244073|FG002|Overall Study|Pregnancy|0|||
143191190|NCT01252186|516244071|FG000|Overall Study|Sponsor Request|2|||
143191191|NCT01252186|516244072|FG001|Overall Study|Sponsor Request|1|||
143191192|NCT01252186|516244073|FG002|Overall Study|Sponsor Request|0|||
143191193|NCT01252186|516244071|FG000|Overall Study|Lost to Follow-up|10|||
143191194|NCT01252186|516244072|FG001|Overall Study|Lost to Follow-up|10|||
143191195|NCT01252186|516244073|FG002|Overall Study|Lost to Follow-up|11|||
143191196|NCT01252186|516244071|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
143191197|NCT01252186|516244072|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
143191198|NCT01252186|516244073|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
143191199|NCT02791516|516244074|FG000|Overall Study|Withdrawal by Subject|1|||
143191200|NCT02791516|516244075|FG001|Overall Study|Withdrawal by Subject|1|||
143191201|NCT04283994|516244076|FG000|Overall Study|Death|11|||
143191202|NCT04283994|516244077|FG001|Overall Study|Death|20|||
143191203|NCT04283994|516244078|FG002|Overall Study|Death|11|||
143191204|NCT04283994|516244079|FG003|Overall Study|Death|0|||
143191205|NCT04283994|516244080|FG004|Overall Study|Death|0|||
143191206|NCT04283994|516244081|FG005|Overall Study|Death|0|||
143191207|NCT04283994|516244082|FG006|Overall Study|Death|0|||
143191208|NCT04283994|516244076|FG000|Overall Study|Withdrawal by Subject|16|||
143191209|NCT04283994|516244077|FG001|Overall Study|Withdrawal by Subject|4|||
143191210|NCT04283994|516244078|FG002|Overall Study|Withdrawal by Subject|6|||
143191211|NCT04283994|516244079|FG003|Overall Study|Withdrawal by Subject|1|||
143191212|NCT04283994|516244080|FG004|Overall Study|Withdrawal by Subject|0|||
143191213|NCT04283994|516244081|FG005|Overall Study|Withdrawal by Subject|1|||
143191214|NCT04283994|516244082|FG006|Overall Study|Withdrawal by Subject|0|||
143191215|NCT03763656|516244083|FG000|Overall Study|Physician Decision|1|||
143191216|NCT03763656|516244083|FG000|Overall Study|Protocol Violation|1|||
143191217|NCT03763656|516244083|FG000|Overall Study|Withdrawal by Subject|7|||
143191218|NCT00882583|516245909|FG000|Overall Study|Physician Decision|1|||
143191219|NCT00882583|516245910|FG001|Overall Study|Physician Decision|0|||
143191220|NCT00882583|516245909|FG000|Overall Study|Adverse Event|0|||
143191221|NCT00882583|516245910|FG001|Overall Study|Adverse Event|1|||
143191222|NCT02596958|516245911|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
143191223|NCT02596958|516245911|FG000|Overall Study|Cancer Progression|441|||
143191224|NCT02596958|516245911|FG000|Overall Study|Death From Cancer|112|||
143191225|NCT02596958|516245911|FG000|Overall Study|Death From Other Cause|33|||
143191226|NCT02596958|516245911|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
143191227|NCT02596958|516245911|FG000|Overall Study|Administrative Reasons/Other|231|||
143191228|NCT02596958|516245911|FG000|Overall Study|Lost to Follow-up|33|||
143191229|NCT02596958|516245911|FG000|Overall Study|Missing|32|||
143191230|NCT02596958|516245911|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
143191231|NCT03596047|516245912|FG000|Overall Study|Withdrawal by Subject|7|||
143191232|NCT03596047|516245913|FG001|Overall Study|Withdrawal by Subject|4|||
143191233|NCT03596047|516245912|FG000|Overall Study|Lost to Follow-up|0|||
143191234|NCT03596047|516245913|FG001|Overall Study|Lost to Follow-up|2|||
143191235|NCT00837265|516245917|FG000|Pilot Phase|Withdrawal by Subject|0|||
143191236|NCT00837265|516245918|FG001|Pilot Phase|Withdrawal by Subject|2|||
143191237|NCT00837265|516245919|FG002|Pilot Phase|Withdrawal by Subject|3|||
143191238|NCT00837265|516245920|FG003|Pilot Phase|Withdrawal by Subject|2|||
143191239|NCT00837265|516245921|FG004|Pilot Phase|Withdrawal by Subject|0|||
143191240|NCT00837265|516245922|FG005|Pilot Phase|Withdrawal by Subject|0|||
143191241|NCT00837265|516245923|FG006|Pilot Phase|Withdrawal by Subject|0|||
143191242|NCT00837265|516245917|FG000|Pilot Phase|Decision of the investigator|2|||
143191243|NCT00837265|516245918|FG001|Pilot Phase|Decision of the investigator|1|||
143191244|NCT00837265|516245919|FG002|Pilot Phase|Decision of the investigator|0|||
143191245|NCT00837265|516245920|FG003|Pilot Phase|Decision of the investigator|0|||
143191246|NCT00837265|516245921|FG004|Pilot Phase|Decision of the investigator|0|||
143191247|NCT00837265|516245922|FG005|Pilot Phase|Decision of the investigator|0|||
143191248|NCT00837265|516245923|FG006|Pilot Phase|Decision of the investigator|0|||
143191249|NCT00837265|516245917|FG000|Pilot Phase|Adverse Event|1|||
143191250|NCT00837265|516245918|FG001|Pilot Phase|Adverse Event|0|||
143191251|NCT00837265|516245919|FG002|Pilot Phase|Adverse Event|0|||
143191252|NCT00837265|516245920|FG003|Pilot Phase|Adverse Event|0|||
143191253|NCT00837265|516245921|FG004|Pilot Phase|Adverse Event|0|||
143191254|NCT00837265|516245922|FG005|Pilot Phase|Adverse Event|0|||
143191255|NCT00837265|516245923|FG006|Pilot Phase|Adverse Event|0|||
143191256|NCT00837265|516245917|FG000|Pilot Phase|Disease progression|0|||
143191257|NCT00837265|516245918|FG001|Pilot Phase|Disease progression|0|||
143191258|NCT00837265|516245919|FG002|Pilot Phase|Disease progression|0|||
143191259|NCT00837265|516245920|FG003|Pilot Phase|Disease progression|1|||
143191260|NCT00837265|516245921|FG004|Pilot Phase|Disease progression|0|||
143191261|NCT00837265|516245922|FG005|Pilot Phase|Disease progression|0|||
143191262|NCT00837265|516245923|FG006|Pilot Phase|Disease progression|0|||
143191263|NCT00837265|516245917|FG000|Pilot Phase|Participant left the city|0|||
143191264|NCT00837265|516245918|FG001|Pilot Phase|Participant left the city|0|||
143191265|NCT00837265|516245919|FG002|Pilot Phase|Participant left the city|0|||
143191266|NCT00837265|516245920|FG003|Pilot Phase|Participant left the city|1|||
143191267|NCT00837265|516245921|FG004|Pilot Phase|Participant left the city|0|||
143191268|NCT00837265|516245922|FG005|Pilot Phase|Participant left the city|0|||
143191269|NCT00837265|516245923|FG006|Pilot Phase|Participant left the city|0|||
143191270|NCT00837265|516245917|FG000|Main Phase|Withdrawal by Subject|0|||
143191271|NCT00837265|516245918|FG001|Main Phase|Withdrawal by Subject|0|||
143191272|NCT00837265|516245919|FG002|Main Phase|Withdrawal by Subject|0|||
143191273|NCT00837265|516245920|FG003|Main Phase|Withdrawal by Subject|0|||
143191274|NCT00837265|516245921|FG004|Main Phase|Withdrawal by Subject|4|||
143191275|NCT00837265|516245922|FG005|Main Phase|Withdrawal by Subject|2|||
143191276|NCT00837265|516245923|FG006|Main Phase|Withdrawal by Subject|1|||
143191277|NCT00837265|516245917|FG000|Main Phase|Decision of the investigator|0|||
143191278|NCT00837265|516245918|FG001|Main Phase|Decision of the investigator|0|||
143191279|NCT00837265|516245919|FG002|Main Phase|Decision of the investigator|0|||
143191280|NCT00837265|516245920|FG003|Main Phase|Decision of the investigator|0|||
143191281|NCT00837265|516245921|FG004|Main Phase|Decision of the investigator|0|||
143191282|NCT00837265|516245922|FG005|Main Phase|Decision of the investigator|2|||
143191283|NCT00837265|516245923|FG006|Main Phase|Decision of the investigator|1|||
143191284|NCT00837265|516245917|FG000|Main Phase|Adverse Event|0|||
143191285|NCT00837265|516245918|FG001|Main Phase|Adverse Event|0|||
143191286|NCT00837265|516245919|FG002|Main Phase|Adverse Event|0|||
143191287|NCT00837265|516245920|FG003|Main Phase|Adverse Event|0|||
143191288|NCT00837265|516245921|FG004|Main Phase|Adverse Event|0|||
143191289|NCT00837265|516245922|FG005|Main Phase|Adverse Event|1|||
143191290|NCT00837265|516245923|FG006|Main Phase|Adverse Event|0|||
143191291|NCT00837265|516245917|FG000|Main Phase|Death|0|||
143191292|NCT00837265|516245918|FG001|Main Phase|Death|0|||
143191293|NCT00837265|516245919|FG002|Main Phase|Death|0|||
143191294|NCT00837265|516245920|FG003|Main Phase|Death|0|||
143191295|NCT00837265|516245921|FG004|Main Phase|Death|2|||
143191296|NCT00837265|516245922|FG005|Main Phase|Death|0|||
143191297|NCT00837265|516245923|FG006|Main Phase|Death|1|||
143191298|NCT00837265|516245917|FG000|Main Phase|Lost to Follow-up|0|||
143261509|NCT04068896|516510589|FG002|Overall Study|Withdrawal by Subject|0|||
143261510|NCT04068896|516510590|FG003|Overall Study|Withdrawal by Subject|2|||
143261511|NCT04068896|516510591|FG004|Overall Study|Withdrawal by Subject|1|||
143261512|NCT04068896|516510592|FG005|Overall Study|Withdrawal by Subject|0|||
143261513|NCT04068896|516510587|FG000|Overall Study|Symptomatic deterioration|2|||
143191299|NCT00837265|516245918|FG001|Main Phase|Lost to Follow-up|0|||
143191300|NCT00837265|516245919|FG002|Main Phase|Lost to Follow-up|0|||
143191301|NCT00837265|516245920|FG003|Main Phase|Lost to Follow-up|0|||
143191302|NCT00837265|516245921|FG004|Main Phase|Lost to Follow-up|1|||
143191303|NCT00837265|516245922|FG005|Main Phase|Lost to Follow-up|0|||
143191304|NCT00837265|516245923|FG006|Main Phase|Lost to Follow-up|0|||
143191305|NCT00837265|516245917|FG000|Main Phase|Principal investigator resignation|0|||
143191306|NCT00837265|516245918|FG001|Main Phase|Principal investigator resignation|0|||
143191307|NCT00837265|516245919|FG002|Main Phase|Principal investigator resignation|0|||
143191308|NCT00837265|516245920|FG003|Main Phase|Principal investigator resignation|0|||
143191309|NCT00837265|516245921|FG004|Main Phase|Principal investigator resignation|2|||
143191310|NCT00837265|516245922|FG005|Main Phase|Principal investigator resignation|0|||
143191311|NCT00837265|516245923|FG006|Main Phase|Principal investigator resignation|0|||
143191312|NCT00837265|516245917|FG000|Main Phase|Participant's personal reason|0|||
143191313|NCT00837265|516245918|FG001|Main Phase|Participant's personal reason|0|||
143191314|NCT00837265|516245919|FG002|Main Phase|Participant's personal reason|0|||
143191315|NCT00837265|516245920|FG003|Main Phase|Participant's personal reason|0|||
143191316|NCT00837265|516245921|FG004|Main Phase|Participant's personal reason|1|||
143191317|NCT00837265|516245922|FG005|Main Phase|Participant's personal reason|0|||
143191318|NCT00837265|516245923|FG006|Main Phase|Participant's personal reason|0|||
143191319|NCT00733291|516245925|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
143191320|NCT00733291|516245926|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
143191321|NCT00733291|516245927|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
143191322|NCT00733291|516245928|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
143191323|NCT02759107|516245929|FG000|Overall Study|Adverse Event|0|||
143191324|NCT02759107|516245930|FG001|Overall Study|Adverse Event|0|||
143191325|NCT02759107|516245931|FG002|Overall Study|Adverse Event|0|||
143191326|NCT02759107|516245932|FG003|Overall Study|Adverse Event|0|||
143191327|NCT02759107|516245933|FG004|Overall Study|Adverse Event|0|||
143191328|NCT02759107|516245934|FG005|Overall Study|Adverse Event|0|||
143191329|NCT02759107|516245935|FG006|Overall Study|Adverse Event|0|||
143191330|NCT02759107|516245936|FG007|Overall Study|Adverse Event|0|||
143191331|NCT02759107|516245937|FG008|Overall Study|Adverse Event|0|||
143191332|NCT02759107|516245938|FG009|Overall Study|Adverse Event|0|||
143191333|NCT02759107|516245939|FG010|Overall Study|Adverse Event|0|||
143191334|NCT02759107|516245940|FG011|Overall Study|Adverse Event|0|||
143191335|NCT02759107|516245941|FG012|Overall Study|Adverse Event|2|||
143191336|NCT02759107|516245942|FG013|Overall Study|Adverse Event|0|||
143191337|NCT02759107|516245943|FG014|Overall Study|Adverse Event|0|||
143191338|NCT02759107|516245944|FG015|Overall Study|Adverse Event|1|||
143191339|NCT02759107|516245945|FG016|Overall Study|Adverse Event|0|||
143191340|NCT02759107|516245946|FG017|Overall Study|Adverse Event|2|||
143191341|NCT02759107|516245929|FG000|Overall Study|Scheduling Conflict|0|||
143191342|NCT02759107|516245930|FG001|Overall Study|Scheduling Conflict|0|||
143191343|NCT02759107|516245931|FG002|Overall Study|Scheduling Conflict|0|||
143191344|NCT02759107|516245932|FG003|Overall Study|Scheduling Conflict|0|||
143191345|NCT02759107|516245933|FG004|Overall Study|Scheduling Conflict|0|||
143191346|NCT02759107|516245934|FG005|Overall Study|Scheduling Conflict|0|||
143191347|NCT02759107|516245935|FG006|Overall Study|Scheduling Conflict|0|||
143191348|NCT02759107|516245936|FG007|Overall Study|Scheduling Conflict|0|||
143191349|NCT02759107|516245937|FG008|Overall Study|Scheduling Conflict|0|||
143191350|NCT02759107|516245938|FG009|Overall Study|Scheduling Conflict|1|||
143191351|NCT02759107|516245939|FG010|Overall Study|Scheduling Conflict|0|||
143191352|NCT02759107|516245940|FG011|Overall Study|Scheduling Conflict|0|||
143191353|NCT02759107|516245941|FG012|Overall Study|Scheduling Conflict|0|||
143191354|NCT02759107|516245942|FG013|Overall Study|Scheduling Conflict|0|||
143191355|NCT02759107|516245943|FG014|Overall Study|Scheduling Conflict|0|||
143191356|NCT02759107|516245944|FG015|Overall Study|Scheduling Conflict|0|||
143191357|NCT02759107|516245945|FG016|Overall Study|Scheduling Conflict|0|||
143191358|NCT02759107|516245946|FG017|Overall Study|Scheduling Conflict|0|||
143191359|NCT03350035|516245949|FG000|Overall Study|Lack of Efficacy|2|||
143191360|NCT03350035|516245950|FG001|Overall Study|Lack of Efficacy|0|||
143191361|NCT03350035|516245951|FG002|Overall Study|Lack of Efficacy|0|||
143191362|NCT03350035|516245949|FG000|Overall Study|Subject discharged to hospice|0|||
143191363|NCT03350035|516245950|FG001|Overall Study|Subject discharged to hospice|0|||
143191364|NCT03350035|516245951|FG002|Overall Study|Subject discharged to hospice|1|||
143191365|NCT01289353|516245952|FG000|Overall Study|Lost to Follow-up|2|||
143191366|NCT01549886|516245953|FG000|Overall Study|Sponsor's decision|2|||
143191367|NCT01549886|516245954|FG001|Overall Study|Sponsor's decision|3|||
143191368|NCT02226562|516245955|FG000|Overall Study|Lost to Follow-up|0|||
143191369|NCT02226562|516245956|FG001|Overall Study|Lost to Follow-up|1|||
143191370|NCT02974855|516245961|FG000|Overall Study|Adverse Event|0|||
143191371|NCT02974855|516245962|FG001|Overall Study|Adverse Event|1|||
143191372|NCT02974855|516245963|FG002|Overall Study|Adverse Event|0|||
143191373|NCT02974855|516245964|FG003|Overall Study|Adverse Event|1|||
143191374|NCT02570152|516245966|FG000|Overall Study|Protocol Violation|2|||
143191375|NCT02570152|516245966|FG000|Overall Study|Migrated/moved from study area|13|||
143191376|NCT00758264|516245969|FG000|Active Phase|Withdrawal by Subject|0|||
143261514|NCT04068896|516510588|FG001|Overall Study|Symptomatic deterioration|0|||
143261515|NCT04068896|516510589|FG002|Overall Study|Symptomatic deterioration|0|||
143261516|NCT04068896|516510590|FG003|Overall Study|Symptomatic deterioration|0|||
143261517|NCT04068896|516510591|FG004|Overall Study|Symptomatic deterioration|0|||
143261518|NCT04068896|516510592|FG005|Overall Study|Symptomatic deterioration|0|||
143261519|NCT00459056|516510593|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
143261520|NCT00459056|516510594|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
143261521|NCT02522871|516510595|FG000|Overall Study|Protocol Violation|1|||
143261522|NCT02522871|516510596|FG001|Overall Study|Protocol Violation|4|||
143191377|NCT00758264|516245970|FG001|Active Phase|Withdrawal by Subject|0|||
143191378|NCT00758264|516245971|FG002|Active Phase|Withdrawal by Subject|1|||
143191379|NCT00758264|516245969|FG000|Active Phase|Lost to Follow-up|1|||
143191380|NCT00758264|516245970|FG001|Active Phase|Lost to Follow-up|0|||
143191381|NCT00758264|516245971|FG002|Active Phase|Lost to Follow-up|0|||
143191382|NCT00758264|516245969|FG000|Active Phase|Other|0|||
143261523|NCT02522871|516510595|FG000|Overall Study|Treated without randomization|1|||
143261524|NCT02522871|516510596|FG001|Overall Study|Treated without randomization|0|||
143261525|NCT02522871|516510595|FG000|Overall Study|Death|9|||
143261526|NCT02522871|516510596|FG001|Overall Study|Death|9|||
143261527|NCT02522871|516510595|FG000|Overall Study|Died in operating room prior to transplant|0|||
143261528|NCT02522871|516510596|FG001|Overall Study|Died in operating room prior to transplant|1|||
143261529|NCT01222403|516510597|FG000|Overall Study|Inappropriate enrollment|0|||
143261530|NCT01222403|516510598|FG001|Overall Study|Inappropriate enrollment|2|||
143191383|NCT00758264|516245970|FG001|Active Phase|Other|0|||
143191384|NCT00758264|516245971|FG002|Active Phase|Other|4|||
143191385|NCT03425006|516245972|FG000|Overall Study|Withdrawal by Subject|1|||
143191386|NCT03425006|516245972|FG000|Overall Study|Physician Decision|1|||
143191387|NCT03425006|516245972|FG000|Overall Study|Death|1|||
143191388|NCT01177553|516245973|FG000|Overall Study|babies not yet 6 months of age|1|||
143191389|NCT01177553|516245974|FG001|Overall Study|babies not yet 6 months of age|0|||
143191390|NCT03831191|516245980|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
143191391|NCT03831191|516245981|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
143191392|NCT03831191|516245982|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
143191393|NCT03831191|516245983|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
143191394|NCT03831191|516245984|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
143191395|NCT03831191|516245985|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
143191396|NCT03831191|516245986|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
143191397|NCT03831191|516245987|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
143191398|NCT03831191|516245988|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
143191399|NCT03831191|516245989|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
143191400|NCT03831191|516245990|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
143191401|NCT03831191|516245991|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
143191402|NCT03831191|516245992|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
143191403|NCT03831191|516245993|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
143191404|NCT03831191|516245994|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
143191405|NCT03831191|516245980|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
143191406|NCT03831191|516245981|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
143191407|NCT03831191|516245982|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
143191408|NCT03831191|516245983|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
143191409|NCT03831191|516245984|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
143191410|NCT03831191|516245985|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
143191411|NCT03831191|516245986|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
143191412|NCT03831191|516245987|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
143191413|NCT03831191|516245988|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
143191414|NCT03831191|516245989|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
143191415|NCT03831191|516245990|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
143191416|NCT03831191|516245991|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
143191417|NCT03831191|516245992|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
143261531|NCT01262352|516510601|FG000|Period 1|Illness after randomization|1|||
143261532|NCT01262352|516510602|FG001|Period 1|Illness after randomization|0|||
143261533|NCT01262352|516510601|FG000|Washout|Adverse Event|1|||
143191418|NCT03831191|516245993|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
143261534|NCT01262352|516510602|FG001|Washout|Adverse Event|1|||
143191419|NCT03831191|516245994|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
143191420|NCT03831191|516245980|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
143191421|NCT03831191|516245981|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
143261535|NCT01262352|516510601|FG000|Washout|Extended Washout|0|||
143261536|NCT01262352|516510602|FG001|Washout|Extended Washout|1|||
143261537|NCT01185834|516510603|FG000|Overall Study|Lost to Follow-up|2|||
143191422|NCT03831191|516245982|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
143191423|NCT03831191|516245983|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
143191424|NCT03831191|516245984|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
143191425|NCT03831191|516245985|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
143191426|NCT03831191|516245986|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
143191427|NCT03831191|516245987|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
143191428|NCT03831191|516245988|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
143191429|NCT03831191|516245989|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
143191430|NCT03831191|516245990|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
143191431|NCT03831191|516245991|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
143191432|NCT03831191|516245992|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
143191433|NCT03831191|516245993|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
143191434|NCT03831191|516245994|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
143191435|NCT03831191|516245980|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
143191436|NCT03831191|516245981|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
143191437|NCT03831191|516245982|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
143191438|NCT03831191|516245983|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
143191439|NCT03831191|516245984|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
143191440|NCT03831191|516245985|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
143191441|NCT03831191|516245986|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
143191442|NCT03831191|516245987|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
143191443|NCT03831191|516245988|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
143191444|NCT03831191|516245989|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
143191445|NCT03831191|516245990|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
143191446|NCT03831191|516245991|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
143191447|NCT03831191|516245992|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
143191448|NCT03831191|516245993|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
143191449|NCT03831191|516245994|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
143191450|NCT03831191|516245980|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
143191451|NCT03831191|516245981|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
143191452|NCT03831191|516245982|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
143191453|NCT03831191|516245983|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
143191454|NCT03831191|516245984|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
143191455|NCT03831191|516245985|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
143191456|NCT03831191|516245986|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
143191457|NCT03831191|516245987|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
143191458|NCT03831191|516245988|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
143191459|NCT03831191|516245989|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
143191460|NCT03831191|516245990|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
143191461|NCT03831191|516245991|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
143191462|NCT03831191|516245992|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
143191463|NCT03831191|516245993|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
143191464|NCT03831191|516245994|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
143191465|NCT03831191|516245980|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
143191466|NCT03831191|516245981|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
143191467|NCT03831191|516245982|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
143191468|NCT03831191|516245983|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
143191469|NCT03831191|516245984|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
143191470|NCT03831191|516245985|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
143191471|NCT03831191|516245986|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
143191472|NCT03831191|516245987|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
143191473|NCT03831191|516245988|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
143191474|NCT03831191|516245989|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
143191475|NCT03831191|516245990|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
143191476|NCT03831191|516245991|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
143191477|NCT03831191|516245992|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
143191478|NCT03831191|516245993|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
143191479|NCT03831191|516245994|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
143191480|NCT03831191|516245980|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
143191481|NCT03831191|516245981|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
143191482|NCT03831191|516245982|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
143191483|NCT03831191|516245983|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
143191484|NCT03831191|516245984|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
143191485|NCT03831191|516245985|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
143191486|NCT03831191|516245986|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
143191487|NCT03831191|516245987|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
143261538|NCT01185834|516510603|FG000|Overall Study|Discomfort|4|||
143191488|NCT03831191|516245988|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
143191489|NCT03831191|516245989|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
143261539|NCT01185834|516510603|FG000|Overall Study|Biomicroscopy|4|||
143191490|NCT03831191|516245990|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
143191491|NCT03831191|516245991|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
143191492|NCT03831191|516245992|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
143191493|NCT03831191|516245993|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
143191494|NCT03831191|516245994|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
143191495|NCT03831191|516245980|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
143191496|NCT03831191|516245981|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
143191497|NCT03831191|516245982|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
143191498|NCT03831191|516245983|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
143191499|NCT03831191|516245984|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
143191500|NCT03831191|516245985|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
143191501|NCT03831191|516245986|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
143191502|NCT03831191|516245987|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
143191503|NCT03831191|516245988|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
143191504|NCT03831191|516245989|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
143191505|NCT03831191|516245990|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
143191506|NCT03831191|516245991|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
143191507|NCT03831191|516245992|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
143191508|NCT03831191|516245993|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
143191509|NCT03831191|516245994|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
143191510|NCT03831191|516245980|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
143191511|NCT03831191|516245981|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
143191512|NCT03831191|516245982|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
143191513|NCT03831191|516245983|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
143191514|NCT03831191|516245984|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
143191515|NCT03831191|516245985|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
143191516|NCT03831191|516245986|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
143191517|NCT03831191|516245987|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
143191518|NCT03831191|516245988|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
143191519|NCT03831191|516245989|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
143191520|NCT03831191|516245990|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
143191521|NCT03831191|516245991|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
143191522|NCT03831191|516245992|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
143191523|NCT03831191|516245993|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
143191524|NCT03831191|516245994|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
143191525|NCT03831191|516245980|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
143191526|NCT03831191|516245981|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
143191527|NCT03831191|516245982|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
143191528|NCT03831191|516245983|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
143191529|NCT03831191|516245984|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
143191530|NCT03831191|516245985|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
143191531|NCT03831191|516245986|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
143191532|NCT03831191|516245987|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
143191533|NCT03831191|516245988|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
143191534|NCT03831191|516245989|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
143191535|NCT03831191|516245990|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
143191536|NCT03831191|516245991|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
143191537|NCT03831191|516245992|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
143191538|NCT03831191|516245993|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
143191539|NCT03831191|516245994|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
143191540|NCT03070171|516245995|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
143191541|NCT03070171|516245996|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
143191542|NCT03070171|516245995|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
143191543|NCT03070171|516245996|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
143191544|NCT01471028|516245997|FG000|VTI-208|Adverse Event|39|||
143191545|NCT01471028|516245998|FG001|VTI-208|Adverse Event|41|||
143191546|NCT01471028|516245997|FG000|VTI-208|Withdrawal by Subject|0|||
143191547|NCT01471028|516245998|FG001|VTI-208|Withdrawal by Subject|2|||
143191548|NCT01471028|516245997|FG000|VTI-208|Lost to Follow-up|1|||
143191549|NCT01471028|516245998|FG001|VTI-208|Lost to Follow-up|1|||
143191550|NCT01471028|516245997|FG000|VTI-208E|Death|7|||
143191551|NCT01471028|516245998|FG001|VTI-208E|Death|10|||
143191552|NCT01471028|516245997|FG000|VTI-208E|Withdrawal by Subject|1|||
143261540|NCT01185834|516510603|FG000|Overall Study|Time/Job Conflict|2|||
143191553|NCT01471028|516245998|FG001|VTI-208E|Withdrawal by Subject|0|||
143191554|NCT01471028|516245997|FG000|VTI-208E|Lost to Follow-up|0|||
143191555|NCT01471028|516245998|FG001|VTI-208E|Lost to Follow-up|2|||
143191556|NCT00695955|516245999|FG000|Cohort 1|Adverse Event|26|||
143191557|NCT00695955|516245999|FG000|Cohort 1|Protocol Violation|2|||
143191558|NCT00695955|516245999|FG000|Cohort 1|Lost to Follow-up|30|||
143191559|NCT00695955|516245999|FG000|Cohort 1|Withdrawal by Subject|25|||
143191560|NCT00695955|516245999|FG000|Cohort 1|Lack of Efficacy|3|||
143191561|NCT00695955|516245999|FG000|Cohort 1|Other|16|||
143191562|NCT00695955|516245999|FG000|Cohort 2|Adverse Event|24|||
143191563|NCT00695955|516245999|FG000|Cohort 2|Protocol Violation|5|||
143191564|NCT00695955|516245999|FG000|Cohort 2|Lost to Follow-up|38|||
143191565|NCT00695955|516245999|FG000|Cohort 2|Withdrawal by Subject|28|||
143191566|NCT00695955|516245999|FG000|Cohort 2|Lack of Efficacy|4|||
143191567|NCT00695955|516245999|FG000|Cohort 2|Other|5|||
143191568|NCT01106651|516246005|FG000|Overall Study|Adverse Event|17|||
143191569|NCT01106651|516246006|FG001|Overall Study|Adverse Event|9|||
143191570|NCT01106651|516246007|FG002|Overall Study|Adverse Event|23|||
143191571|NCT01106651|516246005|FG000|Overall Study|Lost to Follow-up|8|||
143191572|NCT01106651|516246006|FG001|Overall Study|Lost to Follow-up|2|||
143191573|NCT01106651|516246007|FG002|Overall Study|Lost to Follow-up|6|||
143191574|NCT01106651|516246005|FG000|Overall Study|Physician Decision|4|||
143191575|NCT01106651|516246006|FG001|Overall Study|Physician Decision|3|||
143191576|NCT01106651|516246007|FG002|Overall Study|Physician Decision|1|||
143191577|NCT01106651|516246005|FG000|Overall Study|Protocol Violation|1|||
143191578|NCT01106651|516246006|FG001|Overall Study|Protocol Violation|2|||
143191579|NCT01106651|516246007|FG002|Overall Study|Protocol Violation|1|||
143191580|NCT01106651|516246005|FG000|Overall Study|Withdrawal by Subject|14|||
143191581|NCT01106651|516246006|FG001|Overall Study|Withdrawal by Subject|7|||
143191582|NCT01106651|516246007|FG002|Overall Study|Withdrawal by Subject|4|||
143191583|NCT01106651|516246005|FG000|Overall Study|Noncompliance with study drug|1|||
143191584|NCT01106651|516246006|FG001|Overall Study|Noncompliance with study drug|0|||
143191585|NCT01106651|516246007|FG002|Overall Study|Noncompliance with study drug|2|||
143191586|NCT01106651|516246005|FG000|Overall Study|Other|34|||
143191587|NCT01106651|516246006|FG001|Overall Study|Other|31|||
143191588|NCT01106651|516246007|FG002|Overall Study|Other|21|||
143191589|NCT01106651|516246005|FG000|Overall Study|Death|0|||
143191590|NCT01106651|516246006|FG001|Overall Study|Death|3|||
143191591|NCT01106651|516246007|FG002|Overall Study|Death|0|||
143191592|NCT03768089|516246008|FG000|Part A|Lost to Follow-up|0|||
143191593|NCT03768089|516246009|FG001|Part A|Lost to Follow-up|0|||
143191594|NCT03768089|516246010|FG002|Part A|Lost to Follow-up|0|||
143191595|NCT03768089|516246011|FG003|Part A|Lost to Follow-up|0|||
143191596|NCT03768089|516246012|FG004|Part A|Lost to Follow-up|1|||
143191597|NCT03768089|516246013|FG005|Part A|Lost to Follow-up|0|||
143191598|NCT03768089|516246014|FG006|Part A|Lost to Follow-up|0|||
143191599|NCT03768089|516246015|FG007|Part A|Lost to Follow-up|0|||
143191600|NCT03768089|516246016|FG008|Part A|Lost to Follow-up|0|||
143191601|NCT03768089|516246017|FG009|Part A|Lost to Follow-up|0|||
143191602|NCT03768089|516246018|FG010|Part A|Lost to Follow-up|0|||
143191603|NCT03768089|516246019|FG011|Part A|Lost to Follow-up|0|||
143191604|NCT03768089|516246020|FG012|Part A|Lost to Follow-up|0|||
143191605|NCT03768089|516246021|FG013|Part A|Lost to Follow-up|0|||
143191606|NCT03768089|516246022|FG014|Part A|Lost to Follow-up|0|||
143191607|NCT03768089|516246023|FG015|Part A|Lost to Follow-up|0|||
143191608|NCT03768089|516246024|FG016|Part A|Lost to Follow-up|0|||
143191609|NCT03768089|516246025|FG017|Part A|Lost to Follow-up|0|||
143191610|NCT03768089|516246008|FG000|Part C|Randomized, Never Dosed|0|||
143191611|NCT03768089|516246009|FG001|Part C|Randomized, Never Dosed|0|||
143191612|NCT03768089|516246010|FG002|Part C|Randomized, Never Dosed|0|||
143191613|NCT03768089|516246011|FG003|Part C|Randomized, Never Dosed|0|||
143191614|NCT03768089|516246012|FG004|Part C|Randomized, Never Dosed|0|||
143191615|NCT03768089|516246013|FG005|Part C|Randomized, Never Dosed|0|||
143191616|NCT03768089|516246014|FG006|Part C|Randomized, Never Dosed|0|||
143191617|NCT03768089|516246015|FG007|Part C|Randomized, Never Dosed|0|||
143191618|NCT03768089|516246016|FG008|Part C|Randomized, Never Dosed|0|||
143191619|NCT03768089|516246017|FG009|Part C|Randomized, Never Dosed|0|||
143191620|NCT03768089|516246018|FG010|Part C|Randomized, Never Dosed|0|||
143191621|NCT03768089|516246019|FG011|Part C|Randomized, Never Dosed|0|||
143191622|NCT03768089|516246020|FG012|Part C|Randomized, Never Dosed|0|||
143191623|NCT03768089|516246021|FG013|Part C|Randomized, Never Dosed|0|||
143191624|NCT03768089|516246022|FG014|Part C|Randomized, Never Dosed|1|||
143191625|NCT03768089|516246023|FG015|Part C|Randomized, Never Dosed|0|||
143191626|NCT03768089|516246024|FG016|Part C|Randomized, Never Dosed|0|||
143191627|NCT03768089|516246025|FG017|Part C|Randomized, Never Dosed|0|||
143191628|NCT02135029|516246026|FG000|Overall Study|Adverse Event|2|||
143191629|NCT02135029|516246027|FG001|Overall Study|Adverse Event|2|||
143191630|NCT02135029|516246028|FG002|Overall Study|Adverse Event|2|||
143191631|NCT02135029|516246026|FG000|Overall Study|Lost to Follow-up|0|||
143191632|NCT02135029|516246027|FG001|Overall Study|Lost to Follow-up|1|||
143191633|NCT02135029|516246028|FG002|Overall Study|Lost to Follow-up|0|||
143369595|NCT01689519|516896171|FG001|Safety Population|Withdrawal by Subject|20|||
143191634|NCT02135029|516246026|FG000|Overall Study|Withdrawal by Subject|2|||
143191635|NCT02135029|516246027|FG001|Overall Study|Withdrawal by Subject|0|||
143191636|NCT02135029|516246028|FG002|Overall Study|Withdrawal by Subject|1|||
143191637|NCT02135029|516246026|FG000|Overall Study|Other|0|||
143191638|NCT02135029|516246027|FG001|Overall Study|Other|1|||
143191639|NCT02135029|516246028|FG002|Overall Study|Other|0|||
143191640|NCT02135029|516246026|FG000|Overall Study|Death|0|||
143191641|NCT02135029|516246027|FG001|Overall Study|Death|1|||
143191642|NCT02135029|516246028|FG002|Overall Study|Death|0|||
143191643|NCT00712725|516246031|FG000|Overall Study|Adverse Event|1|||
143191644|NCT00712725|516246032|FG001|Overall Study|Adverse Event|0|||
143191645|NCT00712725|516246033|FG002|Overall Study|Adverse Event|0|||
143191646|NCT00712725|516246034|FG003|Overall Study|Adverse Event|1|||
143191647|NCT00712725|516246035|FG004|Overall Study|Adverse Event|0|||
143191648|NCT00712725|516246036|FG005|Overall Study|Adverse Event|0|||
143191649|NCT00712725|516246037|FG006|Overall Study|Adverse Event|0|||
143191650|NCT00712725|516246038|FG007|Overall Study|Adverse Event|0|||
143191651|NCT00712725|516246031|FG000|Overall Study|Lost to Follow-up|3|||
143191652|NCT00712725|516246032|FG001|Overall Study|Lost to Follow-up|2|||
143191653|NCT00712725|516246033|FG002|Overall Study|Lost to Follow-up|1|||
143191654|NCT00712725|516246034|FG003|Overall Study|Lost to Follow-up|1|||
143191655|NCT00712725|516246035|FG004|Overall Study|Lost to Follow-up|2|||
143191656|NCT00712725|516246036|FG005|Overall Study|Lost to Follow-up|2|||
143191657|NCT00712725|516246037|FG006|Overall Study|Lost to Follow-up|3|||
143191658|NCT00712725|516246038|FG007|Overall Study|Lost to Follow-up|1|||
143191659|NCT00712725|516246031|FG000|Overall Study|Physician Decision|2|||
143191660|NCT00712725|516246032|FG001|Overall Study|Physician Decision|0|||
143191661|NCT00712725|516246033|FG002|Overall Study|Physician Decision|0|||
143191662|NCT00712725|516246034|FG003|Overall Study|Physician Decision|0|||
143191663|NCT00712725|516246035|FG004|Overall Study|Physician Decision|1|||
143191664|NCT00712725|516246036|FG005|Overall Study|Physician Decision|0|||
143191665|NCT00712725|516246037|FG006|Overall Study|Physician Decision|2|||
143191666|NCT00712725|516246038|FG007|Overall Study|Physician Decision|0|||
143191667|NCT00712725|516246031|FG000|Overall Study|Pregnancy|0|||
143191668|NCT00712725|516246032|FG001|Overall Study|Pregnancy|1|||
143191669|NCT00712725|516246033|FG002|Overall Study|Pregnancy|0|||
143191670|NCT00712725|516246034|FG003|Overall Study|Pregnancy|0|||
143191671|NCT00712725|516246035|FG004|Overall Study|Pregnancy|1|||
143191672|NCT00712725|516246036|FG005|Overall Study|Pregnancy|0|||
143191673|NCT00712725|516246037|FG006|Overall Study|Pregnancy|2|||
143191674|NCT00712725|516246038|FG007|Overall Study|Pregnancy|0|||
143191675|NCT00712725|516246031|FG000|Overall Study|Protocol Violation|2|||
143191676|NCT00712725|516246032|FG001|Overall Study|Protocol Violation|0|||
143191677|NCT00712725|516246033|FG002|Overall Study|Protocol Violation|1|||
143191678|NCT00712725|516246034|FG003|Overall Study|Protocol Violation|3|||
143191679|NCT00712725|516246035|FG004|Overall Study|Protocol Violation|2|||
143191680|NCT00712725|516246036|FG005|Overall Study|Protocol Violation|0|||
143191681|NCT00712725|516246037|FG006|Overall Study|Protocol Violation|1|||
143191682|NCT00712725|516246038|FG007|Overall Study|Protocol Violation|1|||
143191683|NCT00712725|516246031|FG000|Overall Study|Withdrawal by Subject|2|||
143191684|NCT00712725|516246032|FG001|Overall Study|Withdrawal by Subject|1|||
143191685|NCT00712725|516246033|FG002|Overall Study|Withdrawal by Subject|1|||
143191686|NCT00712725|516246034|FG003|Overall Study|Withdrawal by Subject|2|||
143191687|NCT00712725|516246035|FG004|Overall Study|Withdrawal by Subject|1|||
143191688|NCT00712725|516246036|FG005|Overall Study|Withdrawal by Subject|1|||
143191689|NCT00712725|516246037|FG006|Overall Study|Withdrawal by Subject|1|||
143191690|NCT00712725|516246038|FG007|Overall Study|Withdrawal by Subject|2|||
143191691|NCT00712725|516246031|FG000|Overall Study|Lack of Qualifying Event|16|||
143191692|NCT00712725|516246032|FG001|Overall Study|Lack of Qualifying Event|2|||
143191693|NCT00712725|516246033|FG002|Overall Study|Lack of Qualifying Event|6|||
143191694|NCT00712725|516246034|FG003|Overall Study|Lack of Qualifying Event|8|||
143191695|NCT00712725|516246035|FG004|Overall Study|Lack of Qualifying Event|11|||
143191696|NCT00712725|516246036|FG005|Overall Study|Lack of Qualifying Event|13|||
143191697|NCT00712725|516246037|FG006|Overall Study|Lack of Qualifying Event|11|||
143191698|NCT00712725|516246038|FG007|Overall Study|Lack of Qualifying Event|6|||
143191699|NCT00712725|516246031|FG000|Overall Study|Protocol Specified Criteria|3|||
143191700|NCT00712725|516246032|FG001|Overall Study|Protocol Specified Criteria|0|||
143191701|NCT00712725|516246033|FG002|Overall Study|Protocol Specified Criteria|1|||
143191702|NCT00712725|516246034|FG003|Overall Study|Protocol Specified Criteria|2|||
143191703|NCT00712725|516246035|FG004|Overall Study|Protocol Specified Criteria|1|||
143191704|NCT00712725|516246036|FG005|Overall Study|Protocol Specified Criteria|0|||
143191705|NCT00712725|516246037|FG006|Overall Study|Protocol Specified Criteria|2|||
143191706|NCT00712725|516246038|FG007|Overall Study|Protocol Specified Criteria|1|||
143191707|NCT03466099|516246039|FG000|Overall Study|Adverse Event|1|||
143191708|NCT03466099|516246040|FG001|Overall Study|Adverse Event|1|||
143191709|NCT03466099|516246041|FG002|Overall Study|Adverse Event|1|||
143191710|NCT03466099|516246039|FG000|Overall Study|Withdrawal by Subject|2|||
143191711|NCT03466099|516246040|FG001|Overall Study|Withdrawal by Subject|3|||
143191712|NCT03466099|516246041|FG002|Overall Study|Withdrawal by Subject|1|||
143191713|NCT03466099|516246039|FG000|Overall Study|Use of rescue medication|8|||
143191714|NCT03466099|516246040|FG001|Overall Study|Use of rescue medication|9|||
143369596|NCT03396913|516896179|FG000|Overall Study|Lost to Follow-up|0|||
143191715|NCT03466099|516246041|FG002|Overall Study|Use of rescue medication|13|||
143191716|NCT03466099|516246039|FG000|Overall Study|Rescued without meeting criteria|4|||
143191717|NCT03466099|516246040|FG001|Overall Study|Rescued without meeting criteria|1|||
143191718|NCT03466099|516246041|FG002|Overall Study|Rescued without meeting criteria|1|||
143191719|NCT03466099|516246039|FG000|Overall Study|Subject compliance|2|||
143191720|NCT03466099|516246040|FG001|Overall Study|Subject compliance|0|||
143191721|NCT03466099|516246041|FG002|Overall Study|Subject compliance|0|||
143191722|NCT03466099|516246039|FG000|Overall Study|Worsening disease|0|||
143191723|NCT03466099|516246040|FG001|Overall Study|Worsening disease|0|||
143191724|NCT03466099|516246041|FG002|Overall Study|Worsening disease|1|||
143191725|NCT04590404|516246044|FG000|Overall Study|Death|16|||
143191726|NCT04590404|516246045|FG001|Overall Study|Death|17|||
143191727|NCT04590404|516246044|FG000|Overall Study|Withdrawal by Subject|7|||
143191728|NCT04590404|516246045|FG001|Overall Study|Withdrawal by Subject|2|||
143191729|NCT01923363|516246050|FG000|Overall Study|Protocol Violation|1|||
143191730|NCT00290771|516246053|FG000|Overall Study|Disease progression|95|||
143191731|NCT00290771|516246054|FG001|Overall Study|Disease progression|73|||
143191732|NCT00290771|516246053|FG000|Overall Study|Death|11|||
143191733|NCT00290771|516246054|FG001|Overall Study|Death|10|||
143191734|NCT00290771|516246053|FG000|Overall Study|Adverse Event|12|||
143191735|NCT00290771|516246054|FG001|Overall Study|Adverse Event|6|||
143191736|NCT00290771|516246053|FG000|Overall Study|Withdrawal by Subject|5|||
143191737|NCT00290771|516246054|FG001|Overall Study|Withdrawal by Subject|6|||
143191738|NCT00290771|516246053|FG000|Overall Study|Administrative problems|2|||
143191739|NCT00290771|516246054|FG001|Overall Study|Administrative problems|1|||
143191740|NCT00290771|516246053|FG000|Overall Study|Protocol Violation|2|||
143191741|NCT00290771|516246054|FG001|Overall Study|Protocol Violation|0|||
143191742|NCT00290771|516246053|FG000|Overall Study|Lost to Follow-up|0|||
143191743|NCT00290771|516246054|FG001|Overall Study|Lost to Follow-up|1|||
143191744|NCT04154293|516246057|FG000|Overall Study|Withdrawal by Subject|2|||
143191745|NCT04154293|516246058|FG001|Overall Study|Withdrawal by Subject|3|||
143191746|NCT04154293|516246059|FG002|Overall Study|Withdrawal by Subject|1|||
143191747|NCT04154293|516246057|FG000|Overall Study|Physician Decision|0|||
143191748|NCT04154293|516246058|FG001|Overall Study|Physician Decision|0|||
143191749|NCT04154293|516246059|FG002|Overall Study|Physician Decision|1|||
143191750|NCT06359028|516246061|FG000|Overall Study|Adverse Event|1|||
143191751|NCT06359028|516246062|FG001|Overall Study|Adverse Event|0|||
143191752|NCT06359028|516246061|FG000|Overall Study|Withdrawal by Subject|1|||
143191753|NCT06359028|516246062|FG001|Overall Study|Withdrawal by Subject|0|||
143191754|NCT04113018|516246070|FG000|Overall Study|Death|2|||
143191755|NCT04113018|516246070|FG000|Overall Study|Lost to Follow-up|1|||
143191756|NCT04113018|516246070|FG000|Overall Study|Still On Study (on study treatment)|24|||
143191757|NCT04113018|516246070|FG000|Overall Study|Still On Study (in follow up)|12|||
143191758|NCT03802630|516246071|FG000|Overall Study|Study terminated by sponsor|130|||
143191759|NCT03802630|516246072|FG001|Overall Study|Study terminated by sponsor|134|||
143191760|NCT03802630|516246071|FG000|Overall Study|Subject decision|16|||
143191761|NCT03802630|516246072|FG001|Overall Study|Subject decision|9|||
143191762|NCT03802630|516246071|FG000|Overall Study|Adverse Event|3|||
143191763|NCT03802630|516246072|FG001|Overall Study|Adverse Event|1|||
143191764|NCT03802630|516246071|FG000|Overall Study|Lost to Follow-up|2|||
143191765|NCT03802630|516246072|FG001|Overall Study|Lost to Follow-up|2|||
143191766|NCT03802630|516246071|FG000|Overall Study|Physician Decision|2|||
143191767|NCT03802630|516246072|FG001|Overall Study|Physician Decision|0|||
143191768|NCT03802630|516246071|FG000|Overall Study|Death|0|||
143191769|NCT03802630|516246072|FG001|Overall Study|Death|2|||
143191770|NCT00157196|516246073|FG000|Overall Study|Ongoing at data cut-off|9|||
143191771|NCT05005013|516246076|FG000|Overall Study|Withdrawal by Subject|5|||
143191772|NCT05005013|516246077|FG001|Overall Study|Withdrawal by Subject|1|||
143191773|NCT05005013|516246076|FG000|Overall Study|Lost to Follow-up|3|||
143191774|NCT05005013|516246077|FG001|Overall Study|Lost to Follow-up|1|||
143191775|NCT05005013|516246076|FG000|Overall Study|Ineligibility|1|||
143191776|NCT05005013|516246077|FG001|Overall Study|Ineligibility|1|||
143191777|NCT02059499|516246078|FG000|Upto Week 20|Lost to Follow-up|2|||
143191778|NCT02059499|516246079|FG001|Upto Week 20|Lost to Follow-up|6|||
143191779|NCT02059499|516246080|FG002|Upto Week 20|Lost to Follow-up|0|||
143261541|NCT01185834|516510603|FG000|Overall Study|Early exit - Site error|2|||
143261542|NCT03189381|516510604|FG000|Overall Study|Death|1|||
143261543|NCT03189381|516510605|FG001|Overall Study|Death|0|||
143191780|NCT02059499|516246078|FG000|Upto Week 20|Treatment completed per protocol criteria|0|||
143191781|NCT02059499|516246079|FG001|Upto Week 20|Treatment completed per protocol criteria|2|||
143191782|NCT02059499|516246080|FG002|Upto Week 20|Treatment completed per protocol criteria|0|||
143191783|NCT02059499|516246078|FG000|Upto Week 20|Withdrawal by Subject|1|||
143191784|NCT02059499|516246079|FG001|Upto Week 20|Withdrawal by Subject|1|||
143191785|NCT02059499|516246080|FG002|Upto Week 20|Withdrawal by Subject|0|||
143191786|NCT02059499|516246078|FG000|Upto Week 20|No treatment per protocol criteria|0|||
143191787|NCT02059499|516246079|FG001|Upto Week 20|No treatment per protocol criteria|0|||
143191788|NCT02059499|516246080|FG002|Upto Week 20|No treatment per protocol criteria|5|||
143191789|NCT02059499|516246078|FG000|Post-week 20|Treatment not as per protocol criteria|3|||
143191790|NCT02059499|516246079|FG001|Post-week 20|Treatment not as per protocol criteria|4|||
143191791|NCT02059499|516246080|FG002|Post-week 20|Treatment not as per protocol criteria|9|||
143369597|NCT03396913|516896180|FG001|Overall Study|Lost to Follow-up|6|||
143191792|NCT02059499|516246078|FG000|Post-week 20|Lost to Follow-up|0|||
143191793|NCT02059499|516246079|FG001|Post-week 20|Lost to Follow-up|2|||
143191794|NCT02059499|516246080|FG002|Post-week 20|Lost to Follow-up|0|||
143191795|NCT02059499|516246078|FG000|Post-week 20|Withdrawal by Subject|0|||
143191796|NCT02059499|516246079|FG001|Post-week 20|Withdrawal by Subject|1|||
143191797|NCT02059499|516246080|FG002|Post-week 20|Withdrawal by Subject|0|||
143191798|NCT02059499|516246078|FG000|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
143191799|NCT02059499|516246079|FG001|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|3|||
143191800|NCT02059499|516246080|FG002|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
143191801|NCT02248649|516246081|FG000|Overall Study|Death|7|||
143191802|NCT02248649|516246082|FG001|Overall Study|Death|11|||
143191803|NCT02248649|516246081|FG000|Overall Study|Lost to Follow-up|14|||
143191804|NCT02248649|516246082|FG001|Overall Study|Lost to Follow-up|10|||
143191805|NCT02524275|516246083|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
143191806|NCT01439971|516246084|FG000|Overall Study|Required number in cohort dosed|0|||
143191807|NCT01439971|516246085|FG001|Overall Study|Required number in cohort dosed|1|||
143191808|NCT01439971|516246086|FG002|Overall Study|Required number in cohort dosed|2|||
143191809|NCT01439971|516246087|FG003|Overall Study|Required number in cohort dosed|0|||
143191810|NCT01439971|516246088|FG004|Overall Study|Required number in cohort dosed|1|||
143191811|NCT02628600|516246092|FG000|Overall Study|Death|2|||
143191812|NCT02628600|516246093|FG001|Overall Study|Death|1|||
143191813|NCT02628600|516246092|FG000|Overall Study|Adverse Event|3|||
143191814|NCT02628600|516246093|FG001|Overall Study|Adverse Event|20|||
143191815|NCT02628600|516246092|FG000|Overall Study|Protocol Violation|0|||
143191816|NCT02628600|516246093|FG001|Overall Study|Protocol Violation|1|||
143191817|NCT02628600|516246092|FG000|Overall Study|Lack of Efficacy|2|||
143191818|NCT02628600|516246093|FG001|Overall Study|Lack of Efficacy|0|||
143191819|NCT02628600|516246092|FG000|Overall Study|Withdrawal by Subject|13|||
143191820|NCT02628600|516246093|FG001|Overall Study|Withdrawal by Subject|8|||
143191821|NCT02628600|516246092|FG000|Overall Study|Lost to Follow-up|1|||
143191822|NCT02628600|516246093|FG001|Overall Study|Lost to Follow-up|0|||
143191823|NCT02628600|516246092|FG000|Overall Study|Physician Decision|2|||
143191824|NCT02628600|516246093|FG001|Overall Study|Physician Decision|2|||
143191825|NCT02628600|516246092|FG000|Overall Study|Other not specified|1|||
143191826|NCT02628600|516246093|FG001|Overall Study|Other not specified|0|||
143191827|NCT01221623|516246100|FG000|Overall Study|Withdrawal by Subject|19|||
143191828|NCT01221623|516246101|FG001|Overall Study|Withdrawal by Subject|8|||
143191829|NCT01221623|516246100|FG000|Overall Study|Lost to Follow-up|7|||
143191830|NCT01221623|516246101|FG001|Overall Study|Lost to Follow-up|1|||
143191831|NCT01221623|516246100|FG000|Overall Study|Adverse Event|6|||
143191832|NCT01221623|516246101|FG001|Overall Study|Adverse Event|3|||
143191833|NCT01221623|516246100|FG000|Overall Study|Death|1|||
143191834|NCT01221623|516246101|FG001|Overall Study|Death|0|||
143191835|NCT01221623|516246100|FG000|Overall Study|Other|5|||
143191836|NCT01221623|516246101|FG001|Overall Study|Other|2|||
143191837|NCT00780143|516246102|FG000|Overall Study|Progressive disease|1|||
143191838|NCT00780143|516246102|FG000|Overall Study|Toxicity|1|||
143191839|NCT00780143|516246102|FG000|Overall Study|Adverse Event|1|||
143191840|NCT03724981|516247369|FG000|First Device|Protocol Violation|1|||
143191841|NCT03724981|516247370|FG001|First Device|Protocol Violation|1|||
143191842|NCT00197145|516247371|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
143191843|NCT00197145|516247372|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
143191844|NCT00197145|516247371|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
143191845|NCT00197145|516247372|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
143191846|NCT00197145|516247371|FG000|Period 1: Randomized Treatment Phase|Other|2|||
143191847|NCT00197145|516247372|FG001|Period 1: Randomized Treatment Phase|Other|2|||
143191848|NCT00197145|516247371|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
143191849|NCT00197145|516247372|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
143191850|NCT00197145|516247371|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
143191851|NCT00197145|516247372|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
143191852|NCT00197145|516247371|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
143191853|NCT00197145|516247372|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
143191854|NCT00197145|516247371|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
143191855|NCT00197145|516247372|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
143191856|NCT00197145|516247371|FG000|Period 2 : Open Label Phase|Other|1|||
143191857|NCT00197145|516247372|FG001|Period 2 : Open Label Phase|Other|0|||
143191858|NCT00790868|516247373|FG000|Overall Study|Withdrawal by Subject|4|||
143191859|NCT00790868|516247374|FG001|Overall Study|Withdrawal by Subject|5|||
143191860|NCT00790868|516247373|FG000|Overall Study|Lost to Follow-up|2|||
143191861|NCT00790868|516247374|FG001|Overall Study|Lost to Follow-up|12|||
143191862|NCT02578680|516247377|FG000|Overall Study|Death|329|||
143191863|NCT02578680|516247378|FG001|Overall Study|Death|181|||
143191864|NCT02578680|516247377|FG000|Overall Study|Lost to Follow-up|3|||
143191865|NCT02578680|516247378|FG001|Overall Study|Lost to Follow-up|1|||
143191866|NCT02578680|516247377|FG000|Overall Study|Physician Decision|0|||
143191867|NCT02578680|516247378|FG001|Overall Study|Physician Decision|1|||
143191868|NCT02578680|516247377|FG000|Overall Study|Protocol Violation|1|||
143191869|NCT02578680|516247378|FG001|Overall Study|Protocol Violation|1|||
143191870|NCT02578680|516247377|FG000|Overall Study|Sponsor Decision|64|||
143191871|NCT02578680|516247378|FG001|Overall Study|Sponsor Decision|13|||
143191872|NCT02578680|516247377|FG000|Overall Study|Withdrawal by Subject|13|||
143191873|NCT02578680|516247378|FG001|Overall Study|Withdrawal by Subject|9|||
143191874|NCT00306293|516247380|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
143191875|NCT00306293|516247381|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
143191876|NCT00306293|516247380|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
143191877|NCT00306293|516247381|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
143191878|NCT00306293|516247380|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
143191879|NCT00306293|516247381|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
143191880|NCT00306293|516247380|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
143191881|NCT00306293|516247381|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
143191882|NCT00306293|516247380|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
143191883|NCT00306293|516247381|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
143191884|NCT00306293|516247380|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
143191885|NCT00306293|516247381|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
143191886|NCT00306293|516247380|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
143191887|NCT00306293|516247381|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
143191888|NCT00306293|516247380|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
143191889|NCT00306293|516247381|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
143191890|NCT01089413|516247387|FG000|Overall Study|Lost to Follow-up|1|||
143191891|NCT01089413|516247387|FG000|Overall Study|Progressive Disease|93|||
143191892|NCT01089413|516247387|FG000|Overall Study|Participant Withdrew Consent|1|||
143191893|NCT01089413|516247387|FG000|Overall Study|Unacceptable Toxicity|12|||
143191894|NCT01089413|516247387|FG000|Overall Study|Death|10|||
143191895|NCT01089413|516247387|FG000|Overall Study|Metastasectomy|13|||
143191896|NCT01089413|516247387|FG000|Overall Study|Other|71|||
143191897|NCT02526524|516247388|FG000|Overall Study|Withdrawal by Subject|3|||
143191898|NCT02526524|516247389|FG001|Overall Study|Withdrawal by Subject|3|||
143191899|NCT02526524|516247390|FG002|Overall Study|Withdrawal by Subject|6|||
143191900|NCT02526524|516247391|FG003|Overall Study|Withdrawal by Subject|1|||
143191901|NCT02526524|516247392|FG004|Overall Study|Withdrawal by Subject|9|||
143191902|NCT02526524|516247393|FG005|Overall Study|Withdrawal by Subject|5|||
143191903|NCT02526524|516247388|FG000|Overall Study|Adverse Event|3|||
143191904|NCT02526524|516247389|FG001|Overall Study|Adverse Event|2|||
143191905|NCT02526524|516247390|FG002|Overall Study|Adverse Event|4|||
143191906|NCT02526524|516247391|FG003|Overall Study|Adverse Event|2|||
143191907|NCT02526524|516247392|FG004|Overall Study|Adverse Event|6|||
143191908|NCT02526524|516247393|FG005|Overall Study|Adverse Event|8|||
143191909|NCT02526524|516247388|FG000|Overall Study|Lost to Follow-up|2|||
143191910|NCT02526524|516247389|FG001|Overall Study|Lost to Follow-up|3|||
143191911|NCT02526524|516247390|FG002|Overall Study|Lost to Follow-up|8|||
143191912|NCT02526524|516247391|FG003|Overall Study|Lost to Follow-up|1|||
143191913|NCT02526524|516247392|FG004|Overall Study|Lost to Follow-up|2|||
143191914|NCT02526524|516247393|FG005|Overall Study|Lost to Follow-up|5|||
143191915|NCT02526524|516247388|FG000|Overall Study|Protocol Violation|3|||
143191916|NCT02526524|516247389|FG001|Overall Study|Protocol Violation|1|||
143191917|NCT02526524|516247390|FG002|Overall Study|Protocol Violation|5|||
143191918|NCT02526524|516247391|FG003|Overall Study|Protocol Violation|3|||
143191919|NCT02526524|516247392|FG004|Overall Study|Protocol Violation|4|||
143191920|NCT02526524|516247393|FG005|Overall Study|Protocol Violation|3|||
143191921|NCT02526524|516247388|FG000|Overall Study|Loss of Glucose Control|0|||
143191922|NCT02526524|516247389|FG001|Overall Study|Loss of Glucose Control|0|||
143191923|NCT02526524|516247390|FG002|Overall Study|Loss of Glucose Control|3|||
143191924|NCT02526524|516247391|FG003|Overall Study|Loss of Glucose Control|0|||
143191925|NCT02526524|516247392|FG004|Overall Study|Loss of Glucose Control|2|||
143191926|NCT02526524|516247393|FG005|Overall Study|Loss of Glucose Control|0|||
143191927|NCT02526524|516247388|FG000|Overall Study|Physician Decision|0|||
143191928|NCT02526524|516247389|FG001|Overall Study|Physician Decision|0|||
143191929|NCT02526524|516247390|FG002|Overall Study|Physician Decision|0|||
143191930|NCT02526524|516247391|FG003|Overall Study|Physician Decision|0|||
143191931|NCT02526524|516247392|FG004|Overall Study|Physician Decision|1|||
143191932|NCT02526524|516247393|FG005|Overall Study|Physician Decision|0|||
143191933|NCT02526524|516247388|FG000|Overall Study|Sponsor Decision|1|||
143191934|NCT02526524|516247389|FG001|Overall Study|Sponsor Decision|0|||
143191935|NCT02526524|516247390|FG002|Overall Study|Sponsor Decision|0|||
143191936|NCT02526524|516247391|FG003|Overall Study|Sponsor Decision|0|||
143191937|NCT02526524|516247392|FG004|Overall Study|Sponsor Decision|0|||
143191938|NCT02526524|516247393|FG005|Overall Study|Sponsor Decision|0|||
143191939|NCT00470093|516247398|FG000|Overall Study|Adverse Event|2|||
143261544|NCT01975831|516510606|FG000|Overall Study|Adverse Event|1|||
143261545|NCT01975831|516510607|FG001|Overall Study|Adverse Event|2|||
143261546|NCT01975831|516510608|FG002|Overall Study|Adverse Event|2|||
143191940|NCT01610557|516247401|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
143191941|NCT01610557|516247402|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
143191942|NCT01610557|516247403|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
143191943|NCT01610557|516247404|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
143191944|NCT01610557|516247405|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
143191945|NCT01610557|516247401|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
143191946|NCT01610557|516247402|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
143191947|NCT01610557|516247403|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
143191948|NCT01610557|516247404|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
143191949|NCT01610557|516247405|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
143191950|NCT00473668|516247406|FG000|Overall Study|Withdrawal by Subject|0|||
143191951|NCT00473668|516247407|FG001|Overall Study|Withdrawal by Subject|2|||
143191952|NCT00473668|516247408|FG002|Overall Study|Withdrawal by Subject|0|||
143191953|NCT00473668|516247406|FG000|Overall Study|Migrated/moved from study area|3|||
143191954|NCT00473668|516247407|FG001|Overall Study|Migrated/moved from study area|2|||
143191955|NCT00473668|516247408|FG002|Overall Study|Migrated/moved from study area|0|||
143191956|NCT00473668|516247406|FG000|Overall Study|Lost to Follow-up|0|||
143191957|NCT00473668|516247407|FG001|Overall Study|Lost to Follow-up|4|||
143191958|NCT00473668|516247408|FG002|Overall Study|Lost to Follow-up|6|||
143191959|NCT00473668|516247406|FG000|Overall Study|Other|2|||
143191960|NCT00473668|516247407|FG001|Overall Study|Other|3|||
143191961|NCT00473668|516247408|FG002|Overall Study|Other|4|||
143191962|NCT02039219|516247409|FG000|Treatment|Withdrawal by Subject|1|||
143191963|NCT02039219|516247410|FG001|Treatment|Withdrawal by Subject|0|||
143191964|NCT02039219|516247409|FG000|Treatment|Adverse Event|0|||
143191965|NCT02039219|516247410|FG001|Treatment|Adverse Event|1|||
143191966|NCT02039219|516247409|FG000|Treatment|Physician Decision|1|||
143191967|NCT02039219|516247410|FG001|Treatment|Physician Decision|0|||
143191968|NCT02039219|516247409|FG000|Treatment|Lost to Follow-up|0|||
143191969|NCT02039219|516247410|FG001|Treatment|Lost to Follow-up|1|||
143191970|NCT02039219|516247409|FG000|Treatment|Protocol Violation|1|||
143191971|NCT02039219|516247410|FG001|Treatment|Protocol Violation|0|||
143191972|NCT02039219|516247409|FG000|Treatment|Death|1|||
143191973|NCT02039219|516247410|FG001|Treatment|Death|0|||
143191974|NCT02039219|516247409|FG000|Follow up|Adverse Event|0|||
143191975|NCT02039219|516247410|FG001|Follow up|Adverse Event|1|||
143191976|NCT04569136|516247411|FG000|Overall Study|Lost to Follow-up|2|||
143191977|NCT04569136|516247412|FG001|Overall Study|Lost to Follow-up|0|||
143191978|NCT04569136|516247413|FG002|Overall Study|Lost to Follow-up|1|||
143191979|NCT00129701|516247415|FG000|Overall Study|Withdrawal by Subject|33|||
143191980|NCT01466660|516247416|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
143191981|NCT01466660|516247417|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
143191982|NCT01466660|516247416|FG000|Overall Study|Worsening of underlying cancer disease|5|||
143191983|NCT01466660|516247417|FG001|Overall Study|Worsening of underlying cancer disease|2|||
143191984|NCT01466660|516247416|FG000|Overall Study|Other adverse event|19|||
143191985|NCT01466660|516247417|FG001|Overall Study|Other adverse event|18|||
143191986|NCT01466660|516247416|FG000|Overall Study|Protocol Violation|2|||
143191987|NCT01466660|516247417|FG001|Overall Study|Protocol Violation|1|||
143191988|NCT01466660|516247416|FG000|Overall Study|Refused continuation of trial medication|4|||
143191989|NCT01466660|516247417|FG001|Overall Study|Refused continuation of trial medication|3|||
143191990|NCT01466660|516247416|FG000|Overall Study|Other reason not defined above|10|||
143191991|NCT01466660|516247417|FG001|Overall Study|Other reason not defined above|8|||
143191992|NCT00006164|516247418|FG000|Overall Study|Withdrew or lost to follow-up|70|||
143191993|NCT00006164|516247419|FG001|Overall Study|Withdrew or lost to follow-up|81|||
143191994|NCT02750345|516247420|FG000|Intervention 1|Adverse Event|0|||
143191995|NCT02750345|516247421|FG001|Intervention 1|Adverse Event|0|||
143191996|NCT02750345|516247422|FG002|Intervention 1|Adverse Event|0|||
143191997|NCT02750345|516247423|FG003|Intervention 1|Adverse Event|0|||
143191998|NCT02750345|516247424|FG004|Intervention 1|Adverse Event|1|||
143191999|NCT02750345|516247425|FG005|Intervention 1|Adverse Event|0|||
143192000|NCT00633074|516247426|FG000|Overall Study|Adverse Event|1|||
143192001|NCT00633074|516247427|FG001|Overall Study|Adverse Event|0|||
143192002|NCT00223808|516247428|FG000|Overall Study|<5 hrs therapy before discharge|3|||
143192003|NCT00223808|516247429|FG001|Overall Study|<5 hrs therapy before discharge|5|||
143192004|NCT00223808|516247430|FG002|Overall Study|<5 hrs therapy before discharge|5|||
143192005|NCT03931382|516247433|FG000|Overall Study|Equipment malfunction|2|||
143192006|NCT03931382|516247434|FG001|Overall Study|Equipment malfunction|0|||
143192007|NCT03931382|516247435|FG002|Overall Study|Equipment malfunction|2|||
143192008|NCT03931382|516247433|FG000|Overall Study|Withdrawal by Subject|0|||
143192009|NCT03931382|516247434|FG001|Overall Study|Withdrawal by Subject|1|||
143192010|NCT03931382|516247435|FG002|Overall Study|Withdrawal by Subject|0|||
143192011|NCT01054560|516247438|FG000|Overall Study|Death|10|||
143192012|NCT01054560|516247439|FG001|Overall Study|Death|21|||
143192013|NCT01054560|516247438|FG000|Overall Study|Lost to Follow-up|2|||
143192014|NCT01054560|516247439|FG001|Overall Study|Lost to Follow-up|5|||
143261547|NCT01975831|516510609|FG003|Overall Study|Adverse Event|0|||
143192015|NCT01054560|516247438|FG000|Overall Study|Withdrawal by Subject|0|||
143192016|NCT01054560|516247439|FG001|Overall Study|Withdrawal by Subject|2|||
143192017|NCT01054560|516247438|FG000|Overall Study|Physician Decision|1|||
143192018|NCT01054560|516247439|FG001|Overall Study|Physician Decision|0|||
143192019|NCT04154605|516247444|FG000|Overall Study|Procedure Canceled|1|||
143192020|NCT04154605|516247445|FG001|Overall Study|Procedure Canceled|1|||
143192021|NCT04154605|516247444|FG000|Overall Study|Missed follow up|1|||
143192022|NCT04154605|516247445|FG001|Overall Study|Missed follow up|1|||
143192023|NCT04154605|516247444|FG000|Overall Study|Withdrawal by Subject|1|||
143192024|NCT04154605|516247445|FG001|Overall Study|Withdrawal by Subject|0|||
143192025|NCT00675441|516247446|FG000|Overall Study|Withdrawal by Subject|2|||
143192026|NCT00675441|516247446|FG000|Overall Study|Death|1|||
143192027|NCT03525600|516247447|FG000|Overall Study|Adverse Event|9|||
143192028|NCT03525600|516247448|FG001|Overall Study|Adverse Event|6|||
143192029|NCT03525600|516247449|FG002|Overall Study|Adverse Event|5|||
143192030|NCT03525600|516247450|FG003|Overall Study|Adverse Event|3|||
143192031|NCT03525600|516247447|FG000|Overall Study|Lost to Follow-up|2|||
143192032|NCT03525600|516247448|FG001|Overall Study|Lost to Follow-up|4|||
143192033|NCT03525600|516247449|FG002|Overall Study|Lost to Follow-up|4|||
143192034|NCT03525600|516247450|FG003|Overall Study|Lost to Follow-up|0|||
143192035|NCT03525600|516247447|FG000|Overall Study|Physician Decision|1|||
143192036|NCT03525600|516247448|FG001|Overall Study|Physician Decision|0|||
143192037|NCT03525600|516247449|FG002|Overall Study|Physician Decision|2|||
143192038|NCT03525600|516247450|FG003|Overall Study|Physician Decision|0|||
143192039|NCT03525600|516247447|FG000|Overall Study|Consent withdrawal|36|||
143192040|NCT03525600|516247448|FG001|Overall Study|Consent withdrawal|20|||
143192041|NCT03525600|516247449|FG002|Overall Study|Consent withdrawal|6|||
143192042|NCT03525600|516247450|FG003|Overall Study|Consent withdrawal|13|||
143192043|NCT03525600|516247447|FG000|Overall Study|Death|7|||
143192044|NCT03525600|516247448|FG001|Overall Study|Death|6|||
143192045|NCT03525600|516247449|FG002|Overall Study|Death|4|||
143192046|NCT03525600|516247450|FG003|Overall Study|Death|3|||
143192047|NCT03525600|516247447|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
143192048|NCT03525600|516247448|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
143192049|NCT03525600|516247449|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
143192050|NCT03525600|516247450|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
143192051|NCT03525600|516247447|FG000|Overall Study|Other|0|||
143192052|NCT03525600|516247448|FG001|Overall Study|Other|1|||
143192053|NCT03525600|516247449|FG002|Overall Study|Other|0|||
143192054|NCT03525600|516247450|FG003|Overall Study|Other|0|||
143192055|NCT01818258|516247451|FG000|Overall Study|Death|3|||
143192056|NCT01818258|516247452|FG001|Overall Study|Death|0|||
143192057|NCT01818258|516247451|FG000|Overall Study|Withdrawal by Subject|0|||
143192058|NCT01818258|516247452|FG001|Overall Study|Withdrawal by Subject|1|||
143192059|NCT01818258|516247451|FG000|Overall Study|Lost to Follow-up|0|||
143192060|NCT01818258|516247452|FG001|Overall Study|Lost to Follow-up|1|||
143192061|NCT01818258|516247451|FG000|Overall Study|Unable to Travel to Clinic|0|||
143192062|NCT01818258|516247452|FG001|Overall Study|Unable to Travel to Clinic|1|||
143192063|NCT02099344|516247453|FG000|Overall Study|Physician Decision|1|||
143192064|NCT02099344|516247454|FG001|Overall Study|Physician Decision|0|||
143192065|NCT05145322|516247459|FG000|Overall Study|Lost to Follow-up|4|||
143192066|NCT05145322|516247460|FG001|Overall Study|Lost to Follow-up|5|||
143192067|NCT03194568|516247461|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
143192068|NCT03515551|516247464|FG000|Overall Study|Death|4|||
143192069|NCT03515551|516247465|FG001|Overall Study|Death|1|||
143192070|NCT03515551|516247466|FG002|Overall Study|Death|2|||
143192071|NCT03515551|516247467|FG003|Overall Study|Death|2|||
143192072|NCT03515551|516247468|FG004|Overall Study|Death|2|||
143192073|NCT03515551|516247469|FG005|Overall Study|Death|4|||
143192074|NCT03515551|516247470|FG006|Overall Study|Death|1|||
143192075|NCT03515551|516247464|FG000|Overall Study|Lost to Follow-up|0|||
143192076|NCT03515551|516247465|FG001|Overall Study|Lost to Follow-up|0|||
143192077|NCT03515551|516247466|FG002|Overall Study|Lost to Follow-up|1|||
143192078|NCT03515551|516247467|FG003|Overall Study|Lost to Follow-up|0|||
143192079|NCT03515551|516247468|FG004|Overall Study|Lost to Follow-up|0|||
143192080|NCT03515551|516247469|FG005|Overall Study|Lost to Follow-up|0|||
143192081|NCT03515551|516247470|FG006|Overall Study|Lost to Follow-up|0|||
143192082|NCT03515551|516247464|FG000|Overall Study|Withdrawal by Subject|0|||
143192083|NCT03515551|516247465|FG001|Overall Study|Withdrawal by Subject|1|||
143192084|NCT03515551|516247466|FG002|Overall Study|Withdrawal by Subject|0|||
143192085|NCT03515551|516247467|FG003|Overall Study|Withdrawal by Subject|0|||
143261548|NCT01975831|516510610|FG004|Overall Study|Adverse Event|1|||
143192086|NCT03515551|516247468|FG004|Overall Study|Withdrawal by Subject|0|||
143192087|NCT03515551|516247469|FG005|Overall Study|Withdrawal by Subject|0|||
143192088|NCT03515551|516247470|FG006|Overall Study|Withdrawal by Subject|1|||
143192089|NCT03515551|516247464|FG000|Overall Study|Study ended by sponsor|0|||
143192090|NCT03515551|516247465|FG001|Overall Study|Study ended by sponsor|0|||
143192091|NCT03515551|516247466|FG002|Overall Study|Study ended by sponsor|2|||
143261549|NCT01975831|516510611|FG005|Overall Study|Adverse Event|1|||
143192092|NCT03515551|516247467|FG003|Overall Study|Study ended by sponsor|1|||
143192093|NCT03515551|516247468|FG004|Overall Study|Study ended by sponsor|3|||
143192094|NCT03515551|516247469|FG005|Overall Study|Study ended by sponsor|0|||
143192095|NCT03515551|516247470|FG006|Overall Study|Study ended by sponsor|3|||
143192096|NCT03515551|516247464|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
143192097|NCT03515551|516247465|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
143192098|NCT03515551|516247466|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
143192099|NCT03515551|516247467|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
143192100|NCT03515551|516247468|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
143192101|NCT03515551|516247469|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
143192102|NCT03515551|516247470|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
143192103|NCT00920387|516247478|FG000|Stage 1|Adverse Event|1|||
143192104|NCT00920387|516247479|FG001|Stage 1|Adverse Event|0|||
143192105|NCT00920387|516247480|FG002|Stage 1|Adverse Event|0|||
143192106|NCT04210245|516247490|FG000|Overall Study|Adverse Event|0|||
143192107|NCT04210245|516247491|FG001|Overall Study|Adverse Event|3|||
143192108|NCT04210245|516247492|FG002|Overall Study|Adverse Event|6|||
143192109|NCT04210245|516247493|FG003|Overall Study|Adverse Event|0|||
143192110|NCT04210245|516247490|FG000|Overall Study|Withdrawal by Subject|0|||
143192111|NCT04210245|516247491|FG001|Overall Study|Withdrawal by Subject|1|||
143192112|NCT04210245|516247492|FG002|Overall Study|Withdrawal by Subject|4|||
143192113|NCT04210245|516247493|FG003|Overall Study|Withdrawal by Subject|4|||
143192114|NCT04210245|516247490|FG000|Overall Study|Lost to Follow-up|0|||
143192115|NCT04210245|516247491|FG001|Overall Study|Lost to Follow-up|1|||
143192116|NCT04210245|516247492|FG002|Overall Study|Lost to Follow-up|1|||
143192117|NCT04210245|516247493|FG003|Overall Study|Lost to Follow-up|1|||
143192118|NCT04210245|516247490|FG000|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
143192119|NCT04210245|516247491|FG001|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
143192120|NCT04210245|516247492|FG002|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
143192121|NCT04210245|516247493|FG003|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|2|||
143192122|NCT06099223|516247494|FG000|Overall Study|Preoperative surveys missed|0|||
143192123|NCT06099223|516247495|FG001|Overall Study|Preoperative surveys missed|1|||
143192124|NCT04621240|516247501|FG000|Overall Study|Withdrawal by Subject|36|||
143192125|NCT00661726|516247503|FG000|Overall Study|Adverse Event|1|||
143192126|NCT02644096|516247504|FG000|Overall Study|Withdrawal by Subject|28|||
143192127|NCT02644096|516247505|FG001|Overall Study|Withdrawal by Subject|25|||
143192128|NCT00322452|516247506|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
143192129|NCT00322452|516247507|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
143192130|NCT00322452|516247506|FG000|Overall Study|Lost to Follow-up|5|||
143192131|NCT00322452|516247507|FG001|Overall Study|Lost to Follow-up|2|||
143192132|NCT00322452|516247506|FG000|Overall Study|Withdrawal by Subject|19|||
143192133|NCT00322452|516247507|FG001|Overall Study|Withdrawal by Subject|46|||
143192134|NCT00322452|516247506|FG000|Overall Study|Death|223|||
143192135|NCT00322452|516247507|FG001|Overall Study|Death|227|||
143192136|NCT00526656|516247508|FG000|Overall Study|Death|1|||
143192137|NCT00526656|516247508|FG000|Overall Study|Refused surgery|1|||
143192138|NCT04091581|516247509|FG000|Overall Study|Lost to Follow-up|0|||
143192139|NCT04091581|516247510|FG001|Overall Study|Lost to Follow-up|1|||
143192140|NCT02438384|516247511|FG000|Overall Study|Lost to Follow-up|8|||
143192141|NCT02438384|516247512|FG001|Overall Study|Lost to Follow-up|6|||
143192142|NCT02438384|516247513|FG002|Overall Study|Lost to Follow-up|4|||
143192143|NCT03319953|516247514|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
143192144|NCT03319953|516247515|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
143192145|NCT03319953|516247516|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
143192146|NCT03319953|516247517|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
143192147|NCT03319953|516247514|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
143192148|NCT03319953|516247515|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
143192149|NCT03319953|516247516|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
143192150|NCT03319953|516247517|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
143192151|NCT01795495|516247519|FG000|Overall Study|Protocol Violation|1|||
143192152|NCT01795495|516247520|FG001|Overall Study|Protocol Violation|0|||
143192153|NCT01795495|516247521|FG002|Overall Study|Protocol Violation|1|||
143192154|NCT01795495|516247519|FG000|Overall Study|Physician Decision|0|||
143192155|NCT01795495|516247520|FG001|Overall Study|Physician Decision|0|||
143192156|NCT01795495|516247521|FG002|Overall Study|Physician Decision|1|||
143192157|NCT03315793|516247522|FG000|Overall Study|Adverse Event|4|||
143192158|NCT03315793|516247523|FG001|Overall Study|Adverse Event|2|||
143192159|NCT03315793|516247522|FG000|Overall Study|Protocol Deviation|1|||
143192160|NCT03315793|516247523|FG001|Overall Study|Protocol Deviation|0|||
143192161|NCT03315793|516247522|FG000|Overall Study|Difficult for regular visit|0|||
143192162|NCT03315793|516247523|FG001|Overall Study|Difficult for regular visit|1|||
143192163|NCT01579565|516249294|FG000|Randomized|Adverse Event|1|||
143192164|NCT01579565|516249295|FG001|Randomized|Adverse Event|3|||
143192165|NCT01579565|516249294|FG000|Randomized|Withdrawal by Subject|3|||
143192166|NCT01579565|516249295|FG001|Randomized|Withdrawal by Subject|0|||
143192167|NCT01579565|516249294|FG000|Randomized|inadequate preoperative pupil dilation|0|||
143192168|NCT01579565|516249295|FG001|Randomized|inadequate preoperative pupil dilation|1|||
143192169|NCT01579565|516249294|FG000|Randomized|prohibited preoperative eating|1|||
143192170|NCT01579565|516249295|FG001|Randomized|prohibited preoperative eating|0|||
143192171|NCT01579565|516249294|FG000|Randomized|prohibited preoperative medication|0|||
143192172|NCT01579565|516249295|FG001|Randomized|prohibited preoperative medication|1|||
143192173|NCT01579565|516249294|FG000|Treated|Physician Decision|0|||
143192174|NCT01579565|516249295|FG001|Treated|Physician Decision|1|||
143192175|NCT01579565|516249294|FG000|Treated|Lost to Follow-up|2|||
143192176|NCT01579565|516249295|FG001|Treated|Lost to Follow-up|1|||
143192177|NCT01579565|516249294|FG000|Treated|declined to return for final visit|0|||
143192178|NCT01579565|516249295|FG001|Treated|declined to return for final visit|1|||
143192179|NCT02791191|516249296|FG000|Overall Study|Adverse Event|2|||
143192180|NCT02791191|516249297|FG001|Overall Study|Adverse Event|4|||
143192181|NCT02791191|516249298|FG002|Overall Study|Adverse Event|5|||
143192182|NCT02791191|516249296|FG000|Overall Study|Lack of Efficacy|0|||
143192183|NCT02791191|516249297|FG001|Overall Study|Lack of Efficacy|1|||
143192184|NCT02791191|516249298|FG002|Overall Study|Lack of Efficacy|0|||
143192185|NCT02791191|516249296|FG000|Overall Study|Study Drug Non-Compliance|0|||
143192186|NCT02791191|516249297|FG001|Overall Study|Study Drug Non-Compliance|2|||
143192187|NCT02791191|516249298|FG002|Overall Study|Study Drug Non-Compliance|0|||
143192188|NCT02791191|516249296|FG000|Overall Study|Site Closed by Sponsor|1|||
143192189|NCT02791191|516249297|FG001|Overall Study|Site Closed by Sponsor|1|||
143192190|NCT02791191|516249298|FG002|Overall Study|Site Closed by Sponsor|3|||
143192191|NCT02791191|516249296|FG000|Overall Study|Progressive Disease|1|||
143192192|NCT02791191|516249297|FG001|Overall Study|Progressive Disease|0|||
143192193|NCT02791191|516249298|FG002|Overall Study|Progressive Disease|0|||
143192194|NCT02791191|516249296|FG000|Overall Study|Study Terminated by Sponsor|29|||
143192195|NCT02791191|516249297|FG001|Overall Study|Study Terminated by Sponsor|101|||
143192196|NCT02791191|516249298|FG002|Overall Study|Study Terminated by Sponsor|109|||
143192197|NCT02791191|516249296|FG000|Overall Study|Withdrawal by Subject|3|||
143192198|NCT02791191|516249297|FG001|Overall Study|Withdrawal by Subject|1|||
143192199|NCT02791191|516249298|FG002|Overall Study|Withdrawal by Subject|3|||
143192200|NCT02791191|516249296|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
143192201|NCT02791191|516249297|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
143192202|NCT02791191|516249298|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
143192203|NCT00185380|516249299|FG000|Overall Study|Adverse Event|41|||
143192204|NCT00185380|516249300|FG001|Overall Study|Adverse Event|43|||
143192205|NCT00185380|516249301|FG002|Overall Study|Adverse Event|48|||
143192206|NCT00185380|516249299|FG000|Overall Study|Lost to Follow-up|0|||
143192207|NCT00185380|516249300|FG001|Overall Study|Lost to Follow-up|4|||
143192208|NCT00185380|516249301|FG002|Overall Study|Lost to Follow-up|3|||
143192209|NCT00185380|516249299|FG000|Overall Study|Pregnancy|1|||
143192210|NCT00185380|516249300|FG001|Overall Study|Pregnancy|4|||
143192211|NCT00185380|516249301|FG002|Overall Study|Pregnancy|0|||
143192212|NCT00185380|516249299|FG000|Overall Study|Protocol Violation|2|||
143192213|NCT00185380|516249300|FG001|Overall Study|Protocol Violation|2|||
143192214|NCT00185380|516249301|FG002|Overall Study|Protocol Violation|1|||
143192215|NCT00185380|516249299|FG000|Overall Study|Withdrawal by Subject|1|||
143192216|NCT00185380|516249300|FG001|Overall Study|Withdrawal by Subject|2|||
143192217|NCT00185380|516249301|FG002|Overall Study|Withdrawal by Subject|0|||
143192218|NCT00185380|516249299|FG000|Overall Study|Failed insertion|1|||
143192219|NCT00185380|516249300|FG001|Overall Study|Failed insertion|1|||
143192220|NCT00185380|516249301|FG002|Overall Study|Failed insertion|2|||
143192221|NCT00185380|516249299|FG000|Overall Study|Planned pregnancy|9|||
143192222|NCT00185380|516249300|FG001|Overall Study|Planned pregnancy|12|||
143192223|NCT00185380|516249301|FG002|Overall Study|Planned pregnancy|12|||
143192224|NCT00185380|516249299|FG000|Overall Study|No need for contraception|3|||
143192225|NCT00185380|516249300|FG001|Overall Study|No need for contraception|3|||
143192226|NCT00185380|516249301|FG002|Overall Study|No need for contraception|3|||
143192227|NCT00185380|516249299|FG000|Overall Study|Could not attend visits|2|||
143192228|NCT00185380|516249300|FG001|Overall Study|Could not attend visits|0|||
143192229|NCT00185380|516249301|FG002|Overall Study|Could not attend visits|4|||
143192230|NCT00185380|516249299|FG000|Overall Study|personal reason|6|||
143192231|NCT00185380|516249300|FG001|Overall Study|personal reason|1|||
143369598|NCT00462943|516896181|FG000|Overall Study|Failure to achieve a response|5|||
143192232|NCT00185380|516249301|FG002|Overall Study|personal reason|1|||
143192233|NCT00218634|516249302|FG000|Overall Study|Lost to Follow-up|8|||
143192234|NCT00218634|516249303|FG001|Overall Study|Lost to Follow-up|15|||
143192235|NCT00734604|516249304|FG000|Overall Study|Adverse Event|0|||
143192236|NCT00734604|516249305|FG001|Overall Study|Adverse Event|2|||
143192237|NCT00734604|516249306|FG002|Overall Study|Adverse Event|0|||
143192238|NCT00734604|516249307|FG003|Overall Study|Adverse Event|2|||
143192239|NCT00734604|516249308|FG004|Overall Study|Adverse Event|1|||
143192240|NCT00734604|516249309|FG005|Overall Study|Adverse Event|1|||
143192241|NCT00734604|516249304|FG000|Overall Study|Serious Adverse Event|1|||
143192242|NCT00734604|516249305|FG001|Overall Study|Serious Adverse Event|0|||
143192243|NCT00734604|516249306|FG002|Overall Study|Serious Adverse Event|1|||
143192244|NCT00734604|516249307|FG003|Overall Study|Serious Adverse Event|2|||
143192245|NCT00734604|516249308|FG004|Overall Study|Serious Adverse Event|0|||
143192246|NCT00734604|516249309|FG005|Overall Study|Serious Adverse Event|1|||
143192247|NCT00734604|516249304|FG000|Overall Study|Lost to Follow-up|1|||
143192248|NCT00734604|516249305|FG001|Overall Study|Lost to Follow-up|2|||
143192249|NCT00734604|516249306|FG002|Overall Study|Lost to Follow-up|2|||
143192250|NCT00734604|516249307|FG003|Overall Study|Lost to Follow-up|4|||
143192251|NCT00734604|516249308|FG004|Overall Study|Lost to Follow-up|2|||
143192252|NCT00734604|516249309|FG005|Overall Study|Lost to Follow-up|3|||
143192253|NCT00734604|516249304|FG000|Overall Study|Physician Decision|0|||
143192254|NCT00734604|516249305|FG001|Overall Study|Physician Decision|1|||
143192255|NCT00734604|516249306|FG002|Overall Study|Physician Decision|1|||
143192256|NCT00734604|516249307|FG003|Overall Study|Physician Decision|0|||
143192257|NCT00734604|516249308|FG004|Overall Study|Physician Decision|0|||
143192258|NCT00734604|516249309|FG005|Overall Study|Physician Decision|0|||
143192259|NCT00734604|516249304|FG000|Overall Study|Protocol Violation|0|||
143192260|NCT00734604|516249305|FG001|Overall Study|Protocol Violation|2|||
143192261|NCT00734604|516249306|FG002|Overall Study|Protocol Violation|0|||
143192262|NCT00734604|516249307|FG003|Overall Study|Protocol Violation|0|||
143192263|NCT00734604|516249308|FG004|Overall Study|Protocol Violation|1|||
143192264|NCT00734604|516249309|FG005|Overall Study|Protocol Violation|0|||
143192265|NCT00734604|516249304|FG000|Overall Study|Sponsor Decision|1|||
143192266|NCT00734604|516249305|FG001|Overall Study|Sponsor Decision|2|||
143192267|NCT00734604|516249306|FG002|Overall Study|Sponsor Decision|1|||
143192268|NCT00734604|516249307|FG003|Overall Study|Sponsor Decision|0|||
143192269|NCT00734604|516249308|FG004|Overall Study|Sponsor Decision|2|||
143192270|NCT00734604|516249309|FG005|Overall Study|Sponsor Decision|0|||
143192271|NCT00734604|516249304|FG000|Overall Study|Withdrawal by Subject|0|||
143192272|NCT00734604|516249305|FG001|Overall Study|Withdrawal by Subject|2|||
143192273|NCT00734604|516249306|FG002|Overall Study|Withdrawal by Subject|0|||
143192274|NCT00734604|516249307|FG003|Overall Study|Withdrawal by Subject|1|||
143192275|NCT00734604|516249308|FG004|Overall Study|Withdrawal by Subject|2|||
143192276|NCT00734604|516249309|FG005|Overall Study|Withdrawal by Subject|1|||
143192277|NCT00734604|516249304|FG000|Overall Study|Lack of Efficacy|0|||
143192278|NCT00734604|516249305|FG001|Overall Study|Lack of Efficacy|1|||
143192279|NCT00734604|516249306|FG002|Overall Study|Lack of Efficacy|1|||
143192280|NCT00734604|516249307|FG003|Overall Study|Lack of Efficacy|0|||
143192281|NCT00734604|516249308|FG004|Overall Study|Lack of Efficacy|0|||
143192282|NCT00734604|516249309|FG005|Overall Study|Lack of Efficacy|0|||
143192283|NCT02589665|516249310|FG000|Induction Period|Did not receive drug|0|||
143192284|NCT02589665|516249311|FG001|Induction Period|Did not receive drug|0|||
143192285|NCT02589665|516249312|FG002|Induction Period|Did not receive drug|0|||
143192286|NCT02589665|516249313|FG003|Induction Period|Did not receive drug|1|||
143192287|NCT02589665|516249314|FG004|Induction Period|Did not receive drug|0|||
143192288|NCT02589665|516249315|FG005|Induction Period|Did not receive drug|0|||
143192289|NCT02589665|516249316|FG006|Induction Period|Did not receive drug|0|||
143192290|NCT02589665|516249317|FG007|Induction Period|Did not receive drug|0|||
143192291|NCT02589665|516249318|FG008|Induction Period|Did not receive drug|0|||
143192292|NCT02589665|516249319|FG009|Induction Period|Did not receive drug|0|||
143192293|NCT02589665|516249310|FG000|Induction Period|Adverse Event|3|||
143192294|NCT02589665|516249311|FG001|Induction Period|Adverse Event|0|||
143192295|NCT02589665|516249312|FG002|Induction Period|Adverse Event|2|||
143192296|NCT02589665|516249313|FG003|Induction Period|Adverse Event|2|||
143192297|NCT02589665|516249314|FG004|Induction Period|Adverse Event|0|||
143192298|NCT02589665|516249315|FG005|Induction Period|Adverse Event|0|||
143192299|NCT02589665|516249316|FG006|Induction Period|Adverse Event|0|||
143192300|NCT02589665|516249317|FG007|Induction Period|Adverse Event|0|||
143192301|NCT02589665|516249318|FG008|Induction Period|Adverse Event|0|||
143192302|NCT02589665|516249319|FG009|Induction Period|Adverse Event|0|||
143192303|NCT02589665|516249310|FG000|Induction Period|Withdrawal by Subject|0|||
143192304|NCT02589665|516249311|FG001|Induction Period|Withdrawal by Subject|1|||
143192305|NCT02589665|516249312|FG002|Induction Period|Withdrawal by Subject|0|||
143192306|NCT02589665|516249313|FG003|Induction Period|Withdrawal by Subject|1|||
143192307|NCT02589665|516249314|FG004|Induction Period|Withdrawal by Subject|0|||
143192308|NCT02589665|516249315|FG005|Induction Period|Withdrawal by Subject|0|||
143192309|NCT02589665|516249316|FG006|Induction Period|Withdrawal by Subject|0|||
143192310|NCT02589665|516249317|FG007|Induction Period|Withdrawal by Subject|0|||
143192311|NCT02589665|516249318|FG008|Induction Period|Withdrawal by Subject|0|||
143192312|NCT02589665|516249319|FG009|Induction Period|Withdrawal by Subject|0|||
143192313|NCT02589665|516249310|FG000|Induction Period|Protocol Violation|0|||
143192314|NCT02589665|516249311|FG001|Induction Period|Protocol Violation|1|||
143192315|NCT02589665|516249312|FG002|Induction Period|Protocol Violation|0|||
143192316|NCT02589665|516249313|FG003|Induction Period|Protocol Violation|0|||
143192317|NCT02589665|516249314|FG004|Induction Period|Protocol Violation|0|||
143192318|NCT02589665|516249315|FG005|Induction Period|Protocol Violation|0|||
143192319|NCT02589665|516249316|FG006|Induction Period|Protocol Violation|0|||
143192320|NCT02589665|516249317|FG007|Induction Period|Protocol Violation|0|||
143192321|NCT02589665|516249318|FG008|Induction Period|Protocol Violation|0|||
143192322|NCT02589665|516249319|FG009|Induction Period|Protocol Violation|0|||
143192323|NCT02589665|516249310|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
143192324|NCT02589665|516249311|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
143192325|NCT02589665|516249312|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
143192326|NCT02589665|516249313|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
143192327|NCT02589665|516249314|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
143192328|NCT02589665|516249315|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
143192329|NCT02589665|516249316|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
143192330|NCT02589665|516249317|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
143192331|NCT02589665|516249318|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
143192332|NCT02589665|516249319|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
143192333|NCT02589665|516249310|FG000|Maintenance Period|Withdrawal by Subject|0|||
143192334|NCT02589665|516249311|FG001|Maintenance Period|Withdrawal by Subject|0|||
143192335|NCT02589665|516249312|FG002|Maintenance Period|Withdrawal by Subject|0|||
143192336|NCT02589665|516249313|FG003|Maintenance Period|Withdrawal by Subject|0|||
143192337|NCT02589665|516249314|FG004|Maintenance Period|Withdrawal by Subject|4|||
143192338|NCT02589665|516249315|FG005|Maintenance Period|Withdrawal by Subject|2|||
143192339|NCT02589665|516249316|FG006|Maintenance Period|Withdrawal by Subject|4|||
143192340|NCT02589665|516249317|FG007|Maintenance Period|Withdrawal by Subject|0|||
143192341|NCT02589665|516249318|FG008|Maintenance Period|Withdrawal by Subject|0|||
143192342|NCT02589665|516249319|FG009|Maintenance Period|Withdrawal by Subject|0|||
143192343|NCT02589665|516249310|FG000|Maintenance Period|Lack of Efficacy|0|||
143192344|NCT02589665|516249311|FG001|Maintenance Period|Lack of Efficacy|0|||
143192345|NCT02589665|516249312|FG002|Maintenance Period|Lack of Efficacy|0|||
143192346|NCT02589665|516249313|FG003|Maintenance Period|Lack of Efficacy|0|||
143192347|NCT02589665|516249314|FG004|Maintenance Period|Lack of Efficacy|2|||
143192348|NCT02589665|516249315|FG005|Maintenance Period|Lack of Efficacy|1|||
143192349|NCT02589665|516249316|FG006|Maintenance Period|Lack of Efficacy|0|||
143192350|NCT02589665|516249317|FG007|Maintenance Period|Lack of Efficacy|0|||
143192351|NCT02589665|516249318|FG008|Maintenance Period|Lack of Efficacy|0|||
143192352|NCT02589665|516249319|FG009|Maintenance Period|Lack of Efficacy|0|||
143192353|NCT02589665|516249310|FG000|Maintenance Period|Adverse Event|0|||
143192354|NCT02589665|516249311|FG001|Maintenance Period|Adverse Event|0|||
143192355|NCT02589665|516249312|FG002|Maintenance Period|Adverse Event|0|||
143192356|NCT02589665|516249313|FG003|Maintenance Period|Adverse Event|0|||
143192357|NCT02589665|516249314|FG004|Maintenance Period|Adverse Event|0|||
143192358|NCT02589665|516249315|FG005|Maintenance Period|Adverse Event|0|||
143192359|NCT02589665|516249316|FG006|Maintenance Period|Adverse Event|2|||
143192360|NCT02589665|516249317|FG007|Maintenance Period|Adverse Event|0|||
143192361|NCT02589665|516249318|FG008|Maintenance Period|Adverse Event|0|||
143192362|NCT02589665|516249319|FG009|Maintenance Period|Adverse Event|0|||
143192363|NCT02589665|516249310|FG000|Maintenance Period|Lost to Follow-up|0|||
143192364|NCT02589665|516249311|FG001|Maintenance Period|Lost to Follow-up|0|||
143192365|NCT02589665|516249312|FG002|Maintenance Period|Lost to Follow-up|0|||
143192366|NCT02589665|516249313|FG003|Maintenance Period|Lost to Follow-up|0|||
143192367|NCT02589665|516249314|FG004|Maintenance Period|Lost to Follow-up|0|||
143192368|NCT02589665|516249315|FG005|Maintenance Period|Lost to Follow-up|1|||
143192369|NCT02589665|516249316|FG006|Maintenance Period|Lost to Follow-up|0|||
143192370|NCT02589665|516249317|FG007|Maintenance Period|Lost to Follow-up|0|||
143192371|NCT02589665|516249318|FG008|Maintenance Period|Lost to Follow-up|0|||
143192372|NCT02589665|516249319|FG009|Maintenance Period|Lost to Follow-up|0|||
143192373|NCT02589665|516249310|FG000|Maintenance Period|Physician Decision|0|||
143192374|NCT02589665|516249311|FG001|Maintenance Period|Physician Decision|0|||
143192375|NCT02589665|516249312|FG002|Maintenance Period|Physician Decision|0|||
143192376|NCT02589665|516249313|FG003|Maintenance Period|Physician Decision|0|||
143192377|NCT02589665|516249314|FG004|Maintenance Period|Physician Decision|0|||
143192378|NCT02589665|516249315|FG005|Maintenance Period|Physician Decision|1|||
143192379|NCT02589665|516249316|FG006|Maintenance Period|Physician Decision|0|||
143192380|NCT02589665|516249317|FG007|Maintenance Period|Physician Decision|0|||
143192381|NCT02589665|516249318|FG008|Maintenance Period|Physician Decision|0|||
143192382|NCT02589665|516249319|FG009|Maintenance Period|Physician Decision|0|||
143192383|NCT02589665|516249310|FG000|Maintenance Period|Reason Not Collected|0|||
143192384|NCT02589665|516249311|FG001|Maintenance Period|Reason Not Collected|0|||
143192385|NCT02589665|516249312|FG002|Maintenance Period|Reason Not Collected|0|||
143192386|NCT02589665|516249313|FG003|Maintenance Period|Reason Not Collected|0|||
143192387|NCT02589665|516249314|FG004|Maintenance Period|Reason Not Collected|0|||
143192388|NCT02589665|516249315|FG005|Maintenance Period|Reason Not Collected|1|||
143192389|NCT02589665|516249316|FG006|Maintenance Period|Reason Not Collected|1|||
143192390|NCT02589665|516249317|FG007|Maintenance Period|Reason Not Collected|0|||
143192391|NCT02589665|516249318|FG008|Maintenance Period|Reason Not Collected|0|||
143192392|NCT02589665|516249319|FG009|Maintenance Period|Reason Not Collected|0|||
143192393|NCT02589665|516249310|FG000|Induction Extension Period|Adverse Event|0|||
143192394|NCT02589665|516249311|FG001|Induction Extension Period|Adverse Event|0|||
143192395|NCT02589665|516249312|FG002|Induction Extension Period|Adverse Event|0|||
143192396|NCT02589665|516249313|FG003|Induction Extension Period|Adverse Event|0|||
143192397|NCT02589665|516249314|FG004|Induction Extension Period|Adverse Event|0|||
143192398|NCT02589665|516249315|FG005|Induction Extension Period|Adverse Event|0|||
143192399|NCT02589665|516249316|FG006|Induction Extension Period|Adverse Event|0|||
143192400|NCT02589665|516249317|FG007|Induction Extension Period|Adverse Event|0|||
143192401|NCT02589665|516249318|FG008|Induction Extension Period|Adverse Event|4|||
143192402|NCT02589665|516249319|FG009|Induction Extension Period|Adverse Event|0|||
143192403|NCT02589665|516249310|FG000|Induction Extension Period|Lack of Efficacy|0|||
143192404|NCT02589665|516249311|FG001|Induction Extension Period|Lack of Efficacy|0|||
143192405|NCT02589665|516249312|FG002|Induction Extension Period|Lack of Efficacy|0|||
143192406|NCT02589665|516249313|FG003|Induction Extension Period|Lack of Efficacy|0|||
143192407|NCT02589665|516249314|FG004|Induction Extension Period|Lack of Efficacy|0|||
143192408|NCT02589665|516249315|FG005|Induction Extension Period|Lack of Efficacy|0|||
143192409|NCT02589665|516249316|FG006|Induction Extension Period|Lack of Efficacy|0|||
143192410|NCT02589665|516249317|FG007|Induction Extension Period|Lack of Efficacy|0|||
143192411|NCT02589665|516249318|FG008|Induction Extension Period|Lack of Efficacy|3|||
143192412|NCT02589665|516249319|FG009|Induction Extension Period|Lack of Efficacy|0|||
143192413|NCT02589665|516249310|FG000|Induction Extension Period|Withdrawal by Subject|0|||
143192414|NCT02589665|516249311|FG001|Induction Extension Period|Withdrawal by Subject|0|||
143192415|NCT02589665|516249312|FG002|Induction Extension Period|Withdrawal by Subject|0|||
143192416|NCT02589665|516249313|FG003|Induction Extension Period|Withdrawal by Subject|0|||
143192417|NCT02589665|516249314|FG004|Induction Extension Period|Withdrawal by Subject|0|||
143192418|NCT02589665|516249315|FG005|Induction Extension Period|Withdrawal by Subject|0|||
143192419|NCT02589665|516249316|FG006|Induction Extension Period|Withdrawal by Subject|0|||
143192420|NCT02589665|516249317|FG007|Induction Extension Period|Withdrawal by Subject|2|||
143192421|NCT02589665|516249318|FG008|Induction Extension Period|Withdrawal by Subject|3|||
143192422|NCT02589665|516249319|FG009|Induction Extension Period|Withdrawal by Subject|0|||
143192423|NCT02589665|516249310|FG000|Induction Extension Period|Physician Decision|0|||
143192424|NCT02589665|516249311|FG001|Induction Extension Period|Physician Decision|0|||
143192425|NCT02589665|516249312|FG002|Induction Extension Period|Physician Decision|0|||
143192426|NCT02589665|516249313|FG003|Induction Extension Period|Physician Decision|0|||
143192427|NCT02589665|516249314|FG004|Induction Extension Period|Physician Decision|0|||
143192428|NCT02589665|516249315|FG005|Induction Extension Period|Physician Decision|0|||
143192429|NCT02589665|516249316|FG006|Induction Extension Period|Physician Decision|0|||
143192430|NCT02589665|516249317|FG007|Induction Extension Period|Physician Decision|0|||
143192431|NCT02589665|516249318|FG008|Induction Extension Period|Physician Decision|1|||
143192432|NCT02589665|516249319|FG009|Induction Extension Period|Physician Decision|0|||
143192433|NCT02589665|516249310|FG000|Induction Extension Period|Reason Not Collected|0|||
143192434|NCT02589665|516249311|FG001|Induction Extension Period|Reason Not Collected|0|||
143192435|NCT02589665|516249312|FG002|Induction Extension Period|Reason Not Collected|0|||
143192436|NCT02589665|516249313|FG003|Induction Extension Period|Reason Not Collected|0|||
143192437|NCT02589665|516249314|FG004|Induction Extension Period|Reason Not Collected|0|||
143192438|NCT02589665|516249315|FG005|Induction Extension Period|Reason Not Collected|0|||
143192439|NCT02589665|516249316|FG006|Induction Extension Period|Reason Not Collected|0|||
143192440|NCT02589665|516249317|FG007|Induction Extension Period|Reason Not Collected|0|||
143192441|NCT02589665|516249318|FG008|Induction Extension Period|Reason Not Collected|1|||
143192442|NCT02589665|516249319|FG009|Induction Extension Period|Reason Not Collected|0|||
143192443|NCT02589665|516249310|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
143192444|NCT02589665|516249311|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
143192445|NCT02589665|516249312|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
143192446|NCT02589665|516249313|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
143192447|NCT02589665|516249314|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
143192448|NCT02589665|516249315|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
143192449|NCT02589665|516249316|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
143192450|NCT02589665|516249317|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
143192451|NCT02589665|516249318|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
143192452|NCT02589665|516249319|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
143192453|NCT02589665|516249310|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
143192454|NCT02589665|516249311|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
143192455|NCT02589665|516249312|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
143192456|NCT02589665|516249313|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
143192457|NCT02589665|516249314|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
143192458|NCT02589665|516249315|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
143192459|NCT02589665|516249316|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
143192460|NCT02589665|516249317|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
143192461|NCT02589665|516249318|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
143192462|NCT02589665|516249319|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
143192463|NCT02589665|516249310|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
143192464|NCT02589665|516249311|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
143192465|NCT02589665|516249312|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
143192466|NCT02589665|516249313|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
143192467|NCT02589665|516249314|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
143192468|NCT02589665|516249315|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
143192469|NCT02589665|516249316|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
143192470|NCT02589665|516249317|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
143192471|NCT02589665|516249318|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
143192472|NCT02589665|516249319|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
143192473|NCT02589665|516249310|FG000|Maintenance Extension Period|Adverse Event|0|||
143192474|NCT02589665|516249311|FG001|Maintenance Extension Period|Adverse Event|0|||
143192475|NCT02589665|516249312|FG002|Maintenance Extension Period|Adverse Event|0|||
143192476|NCT02589665|516249313|FG003|Maintenance Extension Period|Adverse Event|0|||
143192477|NCT02589665|516249314|FG004|Maintenance Extension Period|Adverse Event|0|||
143192478|NCT02589665|516249315|FG005|Maintenance Extension Period|Adverse Event|0|||
143192479|NCT02589665|516249316|FG006|Maintenance Extension Period|Adverse Event|0|||
143192480|NCT02589665|516249317|FG007|Maintenance Extension Period|Adverse Event|0|||
143192481|NCT02589665|516249318|FG008|Maintenance Extension Period|Adverse Event|0|||
143192482|NCT02589665|516249319|FG009|Maintenance Extension Period|Adverse Event|2|||
143192483|NCT02589665|516249310|FG000|Maintenance Extension Period|Non-responder|0|||
143192484|NCT02589665|516249311|FG001|Maintenance Extension Period|Non-responder|0|||
143192485|NCT02589665|516249312|FG002|Maintenance Extension Period|Non-responder|0|||
143192486|NCT02589665|516249313|FG003|Maintenance Extension Period|Non-responder|0|||
143192487|NCT02589665|516249314|FG004|Maintenance Extension Period|Non-responder|0|||
143192488|NCT02589665|516249315|FG005|Maintenance Extension Period|Non-responder|0|||
143192489|NCT02589665|516249316|FG006|Maintenance Extension Period|Non-responder|0|||
143192490|NCT02589665|516249317|FG007|Maintenance Extension Period|Non-responder|0|||
143192491|NCT02589665|516249318|FG008|Maintenance Extension Period|Non-responder|0|||
143192492|NCT02589665|516249319|FG009|Maintenance Extension Period|Non-responder|1|||
143192493|NCT00978380|516249320|FG000|Overall Study|Protocol Violation|2|||
143192494|NCT00978380|516249320|FG000|Overall Study|Withdrawal criteria|9|||
143192495|NCT00978380|516249320|FG000|Overall Study|Unclassified|8|||
143192496|NCT02199314|516249323|FG000|Overall Study|Withdrawal by Subject|6|||
143192497|NCT02199314|516249323|FG000|Overall Study|Physician Decision|10|||
143192498|NCT00176488|516249324|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
143192499|NCT00327015|516249325|FG000|Overall Study|Lack of Efficacy|18|||
143192500|NCT00327015|516249326|FG001|Overall Study|Lack of Efficacy|18|||
143192501|NCT00327015|516249327|FG002|Overall Study|Lack of Efficacy|35|||
143192502|NCT00327015|516249328|FG003|Overall Study|Lack of Efficacy|29|||
143192503|NCT00327015|516249325|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
143192504|NCT00327015|516249326|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
143192505|NCT00327015|516249327|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
143192506|NCT00327015|516249328|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
143192507|NCT00327015|516249325|FG000|Overall Study|Lost to Follow-up|22|||
143192508|NCT00327015|516249326|FG001|Overall Study|Lost to Follow-up|23|||
143192509|NCT00327015|516249327|FG002|Overall Study|Lost to Follow-up|29|||
143192510|NCT00327015|516249328|FG003|Overall Study|Lost to Follow-up|22|||
143192511|NCT00327015|516249325|FG000|Overall Study|Adverse Event|14|||
143192512|NCT00327015|516249326|FG001|Overall Study|Adverse Event|10|||
143192513|NCT00327015|516249327|FG002|Overall Study|Adverse Event|14|||
143192514|NCT00327015|516249328|FG003|Overall Study|Adverse Event|14|||
143192515|NCT00327015|516249325|FG000|Overall Study|Subject no longer meets study criteria|4|||
143192516|NCT00327015|516249326|FG001|Overall Study|Subject no longer meets study criteria|2|||
143192517|NCT00327015|516249327|FG002|Overall Study|Subject no longer meets study criteria|8|||
143192518|NCT00327015|516249328|FG003|Overall Study|Subject no longer meets study criteria|7|||
143192519|NCT00327015|516249325|FG000|Overall Study|Poor/Noncompliance|11|||
143192520|NCT00327015|516249326|FG001|Overall Study|Poor/Noncompliance|8|||
143192521|NCT00327015|516249327|FG002|Overall Study|Poor/Noncompliance|4|||
143192522|NCT00327015|516249328|FG003|Overall Study|Poor/Noncompliance|5|||
143192523|NCT00327015|516249325|FG000|Overall Study|Physician Decision|0|||
143192524|NCT00327015|516249326|FG001|Overall Study|Physician Decision|1|||
143192525|NCT00327015|516249327|FG002|Overall Study|Physician Decision|3|||
143192526|NCT00327015|516249328|FG003|Overall Study|Physician Decision|2|||
143192527|NCT00327015|516249325|FG000|Overall Study|Death|1|||
143192528|NCT00327015|516249326|FG001|Overall Study|Death|2|||
143192529|NCT00327015|516249327|FG002|Overall Study|Death|2|||
143192530|NCT00327015|516249328|FG003|Overall Study|Death|3|||
143192531|NCT00327015|516249325|FG000|Overall Study|Pregnancy|0|||
143192532|NCT00327015|516249326|FG001|Overall Study|Pregnancy|2|||
143192533|NCT00327015|516249327|FG002|Overall Study|Pregnancy|1|||
143192534|NCT00327015|516249328|FG003|Overall Study|Pregnancy|1|||
143192535|NCT00327015|516249325|FG000|Overall Study|Administrative Reason by Sponsor|1|||
143192536|NCT00327015|516249326|FG001|Overall Study|Administrative Reason by Sponsor|2|||
143192537|NCT00327015|516249327|FG002|Overall Study|Administrative Reason by Sponsor|2|||
143192538|NCT00327015|516249328|FG003|Overall Study|Administrative Reason by Sponsor|1|||
143192539|NCT02650804|516249329|FG000|Overall Study|Adverse Event|3|||
143192540|NCT02650804|516249330|FG001|Overall Study|Adverse Event|2|||
143192541|NCT02650804|516249329|FG000|Overall Study|Death|1|||
143192542|NCT02650804|516249330|FG001|Overall Study|Death|2|||
143192543|NCT02650804|516249329|FG000|Overall Study|Progressive Disease|7|||
143192544|NCT02650804|516249330|FG001|Overall Study|Progressive Disease|10|||
143192545|NCT02650804|516249329|FG000|Overall Study|Physician Decision|0|||
143192546|NCT02650804|516249330|FG001|Overall Study|Physician Decision|2|||
143192547|NCT02650804|516249329|FG000|Overall Study|Withdrawal by Subject|1|||
143192548|NCT02650804|516249330|FG001|Overall Study|Withdrawal by Subject|4|||
143192549|NCT02650804|516249329|FG000|Overall Study|Symptomatic deterioration|5|||
143192550|NCT02650804|516249330|FG001|Overall Study|Symptomatic deterioration|7|||
143192551|NCT02650804|516249329|FG000|Overall Study|Protocol Violation|0|||
143192552|NCT02650804|516249330|FG001|Overall Study|Protocol Violation|1|||
143192553|NCT01159171|516249331|FG000|Overall Study|Adverse Event|11|||
143192554|NCT01159171|516249331|FG000|Overall Study|Progression of Disease|28|||
143192555|NCT01159171|516249331|FG000|Overall Study|Protocol Violation|1|||
143192556|NCT01159171|516249331|FG000|Overall Study|Need for Surgery|5|||
143192557|NCT01159171|516249331|FG000|Overall Study|Medical Decision|4|||
143192558|NCT01159171|516249331|FG000|Overall Study|Death|1|||
143192559|NCT01892436|516249334|FG000|Overall Study|Withdrawal by Subject|8|||
143192560|NCT01892436|516249335|FG001|Overall Study|Withdrawal by Subject|15|||
143192561|NCT01892436|516249336|FG002|Overall Study|Withdrawal by Subject|4|||
143192562|NCT01892436|516249337|FG003|Overall Study|Withdrawal by Subject|4|||
143192563|NCT01892436|516249334|FG000|Overall Study|Death|1|||
143192564|NCT01892436|516249335|FG001|Overall Study|Death|1|||
143192565|NCT01892436|516249336|FG002|Overall Study|Death|0|||
143192566|NCT01892436|516249337|FG003|Overall Study|Death|0|||
143192567|NCT01892436|516249334|FG000|Overall Study|Physician Decision|2|||
143192568|NCT01892436|516249335|FG001|Overall Study|Physician Decision|1|||
143192569|NCT01892436|516249336|FG002|Overall Study|Physician Decision|0|||
143192570|NCT01892436|516249337|FG003|Overall Study|Physician Decision|1|||
143192571|NCT01892436|516249334|FG000|Overall Study|Pregnancy|0|||
143192572|NCT01892436|516249335|FG001|Overall Study|Pregnancy|2|||
143192573|NCT01892436|516249336|FG002|Overall Study|Pregnancy|1|||
143192574|NCT01892436|516249337|FG003|Overall Study|Pregnancy|0|||
143192575|NCT01892436|516249334|FG000|Overall Study|Technical problems|2|||
143192576|NCT01892436|516249335|FG001|Overall Study|Technical problems|1|||
143192577|NCT01892436|516249336|FG002|Overall Study|Technical problems|1|||
143192578|NCT01892436|516249337|FG003|Overall Study|Technical problems|1|||
143192579|NCT01892436|516249334|FG000|Overall Study|Lack of Efficacy|1|||
143192580|NCT01892436|516249335|FG001|Overall Study|Lack of Efficacy|2|||
143192581|NCT01892436|516249336|FG002|Overall Study|Lack of Efficacy|2|||
143192582|NCT01892436|516249337|FG003|Overall Study|Lack of Efficacy|2|||
143192583|NCT01892436|516249334|FG000|Overall Study|Lost to Follow-up|1|||
143192584|NCT01892436|516249335|FG001|Overall Study|Lost to Follow-up|1|||
143192585|NCT01892436|516249336|FG002|Overall Study|Lost to Follow-up|1|||
143192586|NCT01892436|516249337|FG003|Overall Study|Lost to Follow-up|3|||
143192587|NCT01892436|516249334|FG000|Overall Study|non-compliance with treatment|1|||
143192588|NCT01892436|516249335|FG001|Overall Study|non-compliance with treatment|0|||
143192589|NCT01892436|516249336|FG002|Overall Study|non-compliance with treatment|0|||
143192590|NCT01892436|516249337|FG003|Overall Study|non-compliance with treatment|0|||
143192591|NCT01892436|516249334|FG000|Overall Study|Adverse Event|7|||
143192592|NCT01892436|516249335|FG001|Overall Study|Adverse Event|6|||
143192593|NCT01892436|516249336|FG002|Overall Study|Adverse Event|2|||
143192594|NCT01892436|516249337|FG003|Overall Study|Adverse Event|3|||
143192595|NCT00664560|516249338|FG000|Overall Study|Adverse Event|19|||
143192596|NCT00664560|516249339|FG001|Overall Study|Adverse Event|16|||
143192597|NCT00664560|516249340|FG002|Overall Study|Adverse Event|7|||
143192598|NCT00664560|516249338|FG000|Overall Study|Withdrawal by Subject|9|||
143192599|NCT00664560|516249339|FG001|Overall Study|Withdrawal by Subject|13|||
143192600|NCT00664560|516249340|FG002|Overall Study|Withdrawal by Subject|7|||
143192601|NCT00664560|516249338|FG000|Overall Study|Lost to Follow-up|0|||
143192602|NCT00664560|516249339|FG001|Overall Study|Lost to Follow-up|2|||
143192603|NCT00664560|516249340|FG002|Overall Study|Lost to Follow-up|0|||
143192604|NCT00664560|516249338|FG000|Overall Study|Other|11|||
143192605|NCT00664560|516249339|FG001|Overall Study|Other|4|||
143192606|NCT00664560|516249340|FG002|Overall Study|Other|5|||
143192607|NCT02650128|516249341|FG000|Overall Study|Death|2|||
143192608|NCT00365105|516249344|FG000|Overall Study|Protocol Violation|5|||
143192609|NCT00365105|516249345|FG001|Overall Study|Protocol Violation|8|||
143192610|NCT00191724|516249346|FG000|Overall Study|Adverse Event|0|||
143192611|NCT00191724|516249347|FG001|Overall Study|Adverse Event|0|||
143192612|NCT00191724|516249348|FG002|Overall Study|Adverse Event|1|||
143192613|NCT00191724|516249349|FG003|Overall Study|Adverse Event|0|||
143192614|NCT00191724|516249350|FG004|Overall Study|Adverse Event|0|||
143192615|NCT00191724|516249346|FG000|Overall Study|Lost to Follow-up|1|||
143192616|NCT00191724|516249347|FG001|Overall Study|Lost to Follow-up|1|||
143192617|NCT00191724|516249348|FG002|Overall Study|Lost to Follow-up|0|||
143192618|NCT00191724|516249349|FG003|Overall Study|Lost to Follow-up|2|||
143192619|NCT00191724|516249350|FG004|Overall Study|Lost to Follow-up|3|||
143192620|NCT00191724|516249346|FG000|Overall Study|Withdrawal by Subject|0|||
143192621|NCT00191724|516249347|FG001|Overall Study|Withdrawal by Subject|0|||
143192622|NCT00191724|516249348|FG002|Overall Study|Withdrawal by Subject|0|||
143192623|NCT00191724|516249349|FG003|Overall Study|Withdrawal by Subject|1|||
143192624|NCT00191724|516249350|FG004|Overall Study|Withdrawal by Subject|0|||
143192625|NCT00608023|516249351|FG000|Overall Study|Withdrawal by Subject|8|||
143192626|NCT00608023|516249352|FG001|Overall Study|Withdrawal by Subject|10|||
143192627|NCT00608023|516249353|FG002|Overall Study|Withdrawal by Subject|7|||
143192628|NCT00608023|516249351|FG000|Overall Study|Adverse Event|1|||
143192629|NCT00608023|516249352|FG001|Overall Study|Adverse Event|4|||
143192630|NCT00608023|516249353|FG002|Overall Study|Adverse Event|5|||
143192631|NCT00608023|516249351|FG000|Overall Study|Lost to Follow-up|2|||
143192632|NCT00608023|516249352|FG001|Overall Study|Lost to Follow-up|2|||
143192633|NCT00608023|516249353|FG002|Overall Study|Lost to Follow-up|1|||
143192634|NCT00608023|516249351|FG000|Overall Study|Protocol Violation|1|||
143192635|NCT00608023|516249352|FG001|Overall Study|Protocol Violation|3|||
143192636|NCT00608023|516249353|FG002|Overall Study|Protocol Violation|1|||
143192637|NCT00608023|516249351|FG000|Overall Study|Unknown reason|0|||
143192638|NCT00608023|516249352|FG001|Overall Study|Unknown reason|3|||
143192639|NCT00608023|516249353|FG002|Overall Study|Unknown reason|0|||
143192640|NCT05260073|516249354|FG000|Overall Study|Physician Decision|1|||
143192641|NCT05260073|516249354|FG000|Overall Study|Withdrawal by Subject|6|||
143192642|NCT05260073|516249354|FG000|Overall Study|Lost to Follow-up|14|||
143192643|NCT03458910|516249355|FG000|Overall Study|Withdrawal by Subject|7|||
143192644|NCT03458910|516249356|FG001|Overall Study|Withdrawal by Subject|8|||
143192645|NCT03458910|516249357|FG002|Overall Study|Withdrawal by Subject|6|||
143192646|NCT03458910|516249358|FG003|Overall Study|Withdrawal by Subject|4|||
143192647|NCT03458910|516249355|FG000|Overall Study|Study halted due to risk of catching COVID-19|0|||
143192648|NCT03458910|516249356|FG001|Overall Study|Study halted due to risk of catching COVID-19|0|||
143192649|NCT03458910|516249357|FG002|Overall Study|Study halted due to risk of catching COVID-19|3|||
143192650|NCT03458910|516249358|FG003|Overall Study|Study halted due to risk of catching COVID-19|3|||
143192651|NCT00152477|516249368|FG000|Chemotherapy Period|Adverse Event|9|||
143192652|NCT00152477|516249369|FG001|Chemotherapy Period|Adverse Event|4|||
143192653|NCT00152477|516249370|FG002|Chemotherapy Period|Adverse Event|5|||
143192654|NCT00152477|516249368|FG000|Chemotherapy Period|Death|1|||
143192655|NCT00152477|516249369|FG001|Chemotherapy Period|Death|3|||
143192656|NCT00152477|516249370|FG002|Chemotherapy Period|Death|3|||
143192657|NCT00152477|516249368|FG000|Chemotherapy Period|Lack of Efficacy|4|||
143192658|NCT00152477|516249369|FG001|Chemotherapy Period|Lack of Efficacy|5|||
143192659|NCT00152477|516249370|FG002|Chemotherapy Period|Lack of Efficacy|6|||
143192660|NCT00152477|516249368|FG000|Chemotherapy Period|Lost to Follow-up|1|||
143192661|NCT00152477|516249369|FG001|Chemotherapy Period|Lost to Follow-up|0|||
143192662|NCT00152477|516249370|FG002|Chemotherapy Period|Lost to Follow-up|1|||
143192663|NCT00152477|516249368|FG000|Chemotherapy Period|Protocol Violation|1|||
143192664|NCT00152477|516249369|FG001|Chemotherapy Period|Protocol Violation|1|||
143192665|NCT00152477|516249370|FG002|Chemotherapy Period|Protocol Violation|0|||
143192666|NCT00152477|516249368|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
143192667|NCT00152477|516249369|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
143192668|NCT00152477|516249370|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
143192669|NCT00152477|516249368|FG000|Chemotherapy Period|Progression of Disease|6|||
143192670|NCT00152477|516249369|FG001|Chemotherapy Period|Progression of Disease|8|||
143192671|NCT00152477|516249370|FG002|Chemotherapy Period|Progression of Disease|4|||
143192672|NCT00152477|516249368|FG000|Chemotherapy Period|Investigator decision|0|||
143192673|NCT00152477|516249369|FG001|Chemotherapy Period|Investigator decision|0|||
143192674|NCT00152477|516249370|FG002|Chemotherapy Period|Investigator decision|1|||
143192675|NCT00152477|516249368|FG000|Chemotherapy Period|Patient condition worsened|1|||
143192676|NCT00152477|516249369|FG001|Chemotherapy Period|Patient condition worsened|0|||
143192677|NCT00152477|516249370|FG002|Chemotherapy Period|Patient condition worsened|0|||
143192678|NCT00152477|516249368|FG000|Monotherapy Period|Adverse Event|1|||
143192679|NCT00152477|516249369|FG001|Monotherapy Period|Adverse Event|0|||
143192680|NCT00152477|516249370|FG002|Monotherapy Period|Adverse Event|5|||
143192681|NCT00152477|516249368|FG000|Monotherapy Period|Death|2|||
143192682|NCT00152477|516249369|FG001|Monotherapy Period|Death|0|||
143192683|NCT00152477|516249370|FG002|Monotherapy Period|Death|1|||
143192684|NCT00152477|516249368|FG000|Monotherapy Period|Lack of Efficacy|7|||
143192685|NCT00152477|516249369|FG001|Monotherapy Period|Lack of Efficacy|16|||
143192686|NCT00152477|516249370|FG002|Monotherapy Period|Lack of Efficacy|10|||
143192687|NCT00152477|516249368|FG000|Monotherapy Period|Protocol Violation|0|||
143192688|NCT00152477|516249369|FG001|Monotherapy Period|Protocol Violation|1|||
143192689|NCT00152477|516249370|FG002|Monotherapy Period|Protocol Violation|0|||
143192690|NCT00152477|516249368|FG000|Monotherapy Period|Withdrawal by Subject|0|||
143192691|NCT00152477|516249369|FG001|Monotherapy Period|Withdrawal by Subject|0|||
143261550|NCT01975831|516510612|FG006|Overall Study|Adverse Event|3|||
143192692|NCT00152477|516249370|FG002|Monotherapy Period|Withdrawal by Subject|4|||
143192693|NCT00152477|516249368|FG000|Monotherapy Period|Progression of Disease|5|||
143192694|NCT00152477|516249369|FG001|Monotherapy Period|Progression of Disease|11|||
143192695|NCT00152477|516249370|FG002|Monotherapy Period|Progression of Disease|12|||
143192696|NCT00152477|516249368|FG000|Monotherapy Period|Patient decision|0|||
143192697|NCT00152477|516249369|FG001|Monotherapy Period|Patient decision|1|||
143192698|NCT00152477|516249370|FG002|Monotherapy Period|Patient decision|1|||
143192699|NCT00152477|516249368|FG000|Monotherapy Period|Study personel decision|0|||
143192700|NCT00152477|516249369|FG001|Monotherapy Period|Study personel decision|0|||
143192701|NCT00152477|516249370|FG002|Monotherapy Period|Study personel decision|1|||
143192702|NCT00425698|516249371|FG000|Overall Study|Adverse Event|3|||
143192703|NCT00425698|516249372|FG001|Overall Study|Adverse Event|1|||
143192704|NCT00425698|516249371|FG000|Overall Study|Withdrawal by Subject|0|||
143192705|NCT00425698|516249372|FG001|Overall Study|Withdrawal by Subject|1|||
143192706|NCT03905265|516249380|FG000|Overall Study|Withdrawal by Subject|1|||
143192707|NCT03905265|516249381|FG001|Overall Study|Withdrawal by Subject|1|||
143192708|NCT03905265|516249382|FG002|Overall Study|Withdrawal by Subject|0|||
143192709|NCT03905265|516249383|FG003|Overall Study|Withdrawal by Subject|0|||
143192710|NCT01328535|516249384|FG000|Overall Study|Ineligible|1|||
143192711|NCT00960011|516249385|FG000|Overall Study|Death|5|||
143192712|NCT00960011|516249386|FG001|Overall Study|Death|0|||
143192713|NCT00960011|516249385|FG000|Overall Study|Lost to Follow-up|6|||
143192714|NCT00960011|516249386|FG001|Overall Study|Lost to Follow-up|2|||
143192715|NCT01082874|516249392|FG000|Overall Study|Lost to Follow-up|10|||
143192716|NCT01082874|516249393|FG001|Overall Study|Lost to Follow-up|10|||
143192717|NCT01082874|516249394|FG002|Overall Study|Lost to Follow-up|6|||
143192718|NCT01082874|516249395|FG003|Overall Study|Lost to Follow-up|10|||
143192719|NCT01082874|516249392|FG000|Overall Study|Withdrawal by Subject|1|||
143192720|NCT01082874|516249393|FG001|Overall Study|Withdrawal by Subject|2|||
143192721|NCT01082874|516249394|FG002|Overall Study|Withdrawal by Subject|5|||
143192722|NCT01082874|516249395|FG003|Overall Study|Withdrawal by Subject|3|||
143192723|NCT00939029|516249396|FG000|Overall Study|Withdrawal by Subject|3|||
143192724|NCT00939029|516249397|FG001|Overall Study|Withdrawal by Subject|7|||
143192725|NCT00939029|516249396|FG000|Overall Study|Lost to Follow-up|3|||
143192726|NCT00939029|516249397|FG001|Overall Study|Lost to Follow-up|4|||
143192727|NCT00939029|516249396|FG000|Overall Study|Adverse Event|0|||
143192728|NCT00939029|516249397|FG001|Overall Study|Adverse Event|1|||
143192729|NCT03832322|516249398|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
143192730|NCT03832322|516249399|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
143192731|NCT03703817|516249411|FG000|Overall Study|Not meeting eligibility criteria|7|||
143192732|NCT03703817|516249412|FG001|Overall Study|Not meeting eligibility criteria|4|||
143192733|NCT05129449|516249413|FG000|Overall Study|Protocol Violation|1|||
143192734|NCT00616018|516249420|FG000|Overall Study|Protocol Violation|3|||
143192735|NCT03718884|516249421|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
143192736|NCT03718884|516249422|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
143192737|NCT03718884|516249421|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
143192738|NCT03718884|516249422|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
143192739|NCT02839720|516249424|FG000|Overall Study|Adverse Event|2|||
143192740|NCT02839720|516249424|FG000|Overall Study|Non-compliance|2|||
143192741|NCT02839720|516249424|FG000|Overall Study|Intercurrent Illness|1|||
143192742|NCT02839720|516249424|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
143192743|NCT05248997|516249425|FG000|Overall Study|Lost to Follow-up|1|||
143192744|NCT05248997|516249426|FG001|Overall Study|Lost to Follow-up|1|||
143192745|NCT05248997|516249425|FG000|Overall Study|Randomized but not treated|32|||
143192746|NCT05248997|516249426|FG001|Overall Study|Randomized but not treated|25|||
143192747|NCT03255967|516249429|FG000|Overall Study|Adverse Event|26|||
143192748|NCT03255967|516249430|FG001|Overall Study|Adverse Event|30|||
143192749|NCT03255967|516249429|FG000|Overall Study|Withdrawal by Subject|6|||
143192750|NCT03255967|516249430|FG001|Overall Study|Withdrawal by Subject|6|||
143192751|NCT03255967|516249429|FG000|Overall Study|Schedule conflict|6|||
143192752|NCT03255967|516249430|FG001|Overall Study|Schedule conflict|4|||
143192753|NCT03255967|516249429|FG000|Overall Study|POA did not sign consent form|2|||
143192754|NCT03255967|516249430|FG001|Overall Study|POA did not sign consent form|0|||
143192755|NCT01202188|516249433|FG000|Overall Study|Protocol deviation|14|||
143192756|NCT01202188|516249434|FG001|Overall Study|Protocol deviation|8|||
143192757|NCT01202188|516249435|FG002|Overall Study|Protocol deviation|12|||
143192758|NCT01202188|516249436|FG003|Overall Study|Protocol deviation|10|||
143192759|NCT01202188|516249437|FG004|Overall Study|Protocol deviation|11|||
143192760|NCT01202188|516249433|FG000|Overall Study|Subject withdrew consent|12|||
143192761|NCT01202188|516249434|FG001|Overall Study|Subject withdrew consent|13|||
143192762|NCT01202188|516249435|FG002|Overall Study|Subject withdrew consent|22|||
143192763|NCT01202188|516249436|FG003|Overall Study|Subject withdrew consent|11|||
143192764|NCT01202188|516249437|FG004|Overall Study|Subject withdrew consent|13|||
143192765|NCT01202188|516249433|FG000|Overall Study|Adverse Event|5|||
143192766|NCT01202188|516249434|FG001|Overall Study|Adverse Event|23|||
143192767|NCT01202188|516249435|FG002|Overall Study|Adverse Event|13|||
143192768|NCT01202188|516249436|FG003|Overall Study|Adverse Event|10|||
143192769|NCT01202188|516249437|FG004|Overall Study|Adverse Event|10|||
143192770|NCT01202188|516249433|FG000|Overall Study|Administrative problems|3|||
143192771|NCT01202188|516249434|FG001|Overall Study|Administrative problems|2|||
143192772|NCT01202188|516249435|FG002|Overall Study|Administrative problems|1|||
143192773|NCT01202188|516249436|FG003|Overall Study|Administrative problems|1|||
143192774|NCT01202188|516249437|FG004|Overall Study|Administrative problems|2|||
143192775|NCT01202188|516249433|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
143192776|NCT01202188|516249434|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
143192777|NCT01202188|516249435|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
143192778|NCT01202188|516249436|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
143192779|NCT01202188|516249437|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
143192780|NCT01202188|516249433|FG000|Overall Study|Lost to Follow-up|1|||
143192781|NCT01202188|516249434|FG001|Overall Study|Lost to Follow-up|1|||
143192782|NCT01202188|516249435|FG002|Overall Study|Lost to Follow-up|0|||
143192783|NCT01202188|516249436|FG003|Overall Study|Lost to Follow-up|4|||
143192784|NCT01202188|516249437|FG004|Overall Study|Lost to Follow-up|1|||
143192785|NCT01202188|516249433|FG000|Overall Study|Death|1|||
143192786|NCT01202188|516249434|FG001|Overall Study|Death|1|||
143192787|NCT01202188|516249435|FG002|Overall Study|Death|1|||
143192788|NCT01202188|516249436|FG003|Overall Study|Death|1|||
143192789|NCT01202188|516249437|FG004|Overall Study|Death|0|||
143192790|NCT01202188|516249433|FG000|Overall Study|Abnormal test procedure result (s)|0|||
143192791|NCT01202188|516249434|FG001|Overall Study|Abnormal test procedure result (s)|0|||
143192792|NCT01202188|516249435|FG002|Overall Study|Abnormal test procedure result (s)|2|||
143192793|NCT01202188|516249436|FG003|Overall Study|Abnormal test procedure result (s)|0|||
143192794|NCT01202188|516249437|FG004|Overall Study|Abnormal test procedure result (s)|0|||
143192795|NCT00487942|516249438|FG000|Overall Study|Adverse Event|1|||
143192796|NCT00487942|516249439|FG001|Overall Study|Adverse Event|1|||
143192797|NCT00487942|516249440|FG002|Overall Study|Adverse Event|1|||
143192798|NCT00487942|516249441|FG003|Overall Study|Adverse Event|1|||
143192799|NCT00487942|516249438|FG000|Overall Study|Lost to Follow-up|1|||
143192800|NCT00487942|516249439|FG001|Overall Study|Lost to Follow-up|0|||
143192801|NCT00487942|516249440|FG002|Overall Study|Lost to Follow-up|0|||
143192802|NCT00487942|516249441|FG003|Overall Study|Lost to Follow-up|1|||
143192803|NCT00487942|516249438|FG000|Overall Study|Protocol Violation|1|||
143192804|NCT00487942|516249439|FG001|Overall Study|Protocol Violation|1|||
143192805|NCT00487942|516249440|FG002|Overall Study|Protocol Violation|0|||
143192806|NCT00487942|516249441|FG003|Overall Study|Protocol Violation|0|||
143192807|NCT00487942|516249438|FG000|Overall Study|Withdrawal by Subject|0|||
143192808|NCT00487942|516249439|FG001|Overall Study|Withdrawal by Subject|1|||
143192809|NCT00487942|516249440|FG002|Overall Study|Withdrawal by Subject|2|||
143192810|NCT00487942|516249441|FG003|Overall Study|Withdrawal by Subject|0|||
143192811|NCT00211757|516249442|FG000|Overall Study|Withdrawal by Subject|1|||
143192812|NCT00211757|516249443|FG001|Overall Study|Withdrawal by Subject|1|||
143192813|NCT00211757|516249442|FG000|Overall Study|Lack of Efficacy|0|||
143192814|NCT00211757|516249443|FG001|Overall Study|Lack of Efficacy|1|||
143192815|NCT00082368|516249446|FG000|Overall Study|Not treated-pt had poor IV access|1|||
143192816|NCT02461290|516249447|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
143192817|NCT02461290|516249447|FG000|Overall Study|Lost to Follow-up|3|||
143192818|NCT01457014|516249448|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
143192819|NCT01457014|516249449|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
143192820|NCT01457014|516249450|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
143192821|NCT01457014|516249451|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
143192822|NCT01457014|516249448|FG000|First Night|Withdrawal by Subject|3|||
143192823|NCT01457014|516249449|FG001|First Night|Withdrawal by Subject|0|||
143192824|NCT01457014|516249450|FG002|First Night|Withdrawal by Subject|0|||
143192825|NCT01457014|516249451|FG003|First Night|Withdrawal by Subject|0|||
143192826|NCT04027049|516249452|FG000|Overall Study|Withdrawn by family|1|||
143192827|NCT04027049|516249453|FG001|Overall Study|Withdrawn by family|0|||
143192828|NCT04027049|516249452|FG000|Overall Study|Participant safety|1|||
143192829|NCT04027049|516249453|FG001|Overall Study|Participant safety|0|||
143192830|NCT02013206|516251373|FG000|Overall Study|Progressive disease (PD)|14|||
143192831|NCT02013206|516251374|FG001|Overall Study|Progressive disease (PD)|17|||
143192832|NCT02013206|516251373|FG000|Overall Study|Symptomatic deterioration|3|||
143192833|NCT02013206|516251374|FG001|Overall Study|Symptomatic deterioration|1|||
143192834|NCT02013206|516251373|FG000|Overall Study|Adverse Event|1|||
143192835|NCT02013206|516251374|FG001|Overall Study|Adverse Event|0|||
143192836|NCT02013206|516251373|FG000|Overall Study|Patient refusal|2|||
143192837|NCT02013206|516251374|FG001|Overall Study|Patient refusal|0|||
143192838|NCT02013206|516251373|FG000|Overall Study|Patient non-compliance|1|||
143192839|NCT02013206|516251374|FG001|Overall Study|Patient non-compliance|0|||
143192840|NCT02013206|516251373|FG000|Overall Study|Death|1|||
143192841|NCT02013206|516251374|FG001|Overall Study|Death|2|||
143192842|NCT02013206|516251373|FG000|Overall Study|Other reasons off treatment|5|||
143192843|NCT02013206|516251374|FG001|Overall Study|Other reasons off treatment|2|||
143192844|NCT02867813|516251378|FG000|Overall Study|Withdrawal by Subject|57|||
143192845|NCT02867813|516251379|FG001|Overall Study|Withdrawal by Subject|56|||
143192846|NCT02867813|516251378|FG000|Overall Study|Decision by Sponsor|7|||
143192847|NCT02867813|516251379|FG001|Overall Study|Decision by Sponsor|7|||
143192848|NCT02867813|516251378|FG000|Overall Study|Lost to Follow-up|91|||
143192849|NCT02867813|516251379|FG001|Overall Study|Lost to Follow-up|78|||
143192850|NCT02867813|516251378|FG000|Overall Study|Missing|2|||
143192851|NCT02867813|516251379|FG001|Overall Study|Missing|1|||
143192852|NCT02867813|516251378|FG000|Overall Study|Death|294|||
143192853|NCT02867813|516251379|FG001|Overall Study|Death|268|||
143192854|NCT02290691|516251383|FG000|Overall Study|Noncompliance|0|||
143192855|NCT02290691|516251384|FG001|Overall Study|Noncompliance|1|||
143192856|NCT02290691|516251383|FG000|Overall Study|Withdrawal by Subject|1|||
143192857|NCT02290691|516251384|FG001|Overall Study|Withdrawal by Subject|1|||
143192858|NCT02290691|516251383|FG000|Overall Study|Lost to Follow-up|7|||
143192859|NCT02290691|516251384|FG001|Overall Study|Lost to Follow-up|7|||
143192860|NCT01044745|516251386|FG000|Overall Study|Ineiligible|2|||
143192861|NCT01461928|516251389|FG000|Induction (up to 8 Months)|Adverse Event|76|||
143192862|NCT01461928|516251390|FG001|Induction (up to 8 Months)|Adverse Event|0|||
143192863|NCT01461928|516251391|FG002|Induction (up to 8 Months)|Adverse Event|0|||
143192864|NCT01461928|516251389|FG000|Induction (up to 8 Months)|Death|3|||
143192865|NCT01461928|516251390|FG001|Induction (up to 8 Months)|Death|0|||
143192866|NCT01461928|516251391|FG002|Induction (up to 8 Months)|Death|0|||
143192867|NCT01461928|516251389|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
143192868|NCT01461928|516251390|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
143192869|NCT01461928|516251391|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
143192870|NCT01461928|516251389|FG000|Induction (up to 8 Months)|Physician Decision|9|||
143192871|NCT01461928|516251390|FG001|Induction (up to 8 Months)|Physician Decision|0|||
143192872|NCT01461928|516251391|FG002|Induction (up to 8 Months)|Physician Decision|0|||
143192873|NCT01461928|516251389|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
143192874|NCT01461928|516251390|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
143192875|NCT01461928|516251391|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
143192876|NCT01461928|516251389|FG000|Induction (up to 8 Months)|Disease progression|45|||
143192877|NCT01461928|516251390|FG001|Induction (up to 8 Months)|Disease progression|0|||
143192878|NCT01461928|516251391|FG002|Induction (up to 8 Months)|Disease progression|0|||
143192879|NCT01461928|516251389|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
143192880|NCT01461928|516251390|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
143192881|NCT01461928|516251391|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
143192882|NCT01461928|516251389|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
143192883|NCT01461928|516251390|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
143192884|NCT01461928|516251391|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
143192885|NCT01461928|516251389|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
143192886|NCT01461928|516251390|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
143192887|NCT01461928|516251391|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
143192888|NCT01461928|516251389|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
143192889|NCT01461928|516251390|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
143192890|NCT01461928|516251391|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
143192891|NCT01461928|516251389|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
143192892|NCT01461928|516251390|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
143192893|NCT01461928|516251391|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
143192894|NCT01461928|516251389|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
143192895|NCT01461928|516251390|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
143192896|NCT01461928|516251391|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
143192897|NCT01461928|516251389|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
143192898|NCT01461928|516251390|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
143192899|NCT01461928|516251391|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
143192900|NCT01461928|516251389|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
143192901|NCT01461928|516251390|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
143192902|NCT01461928|516251391|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
143192903|NCT01461928|516251389|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
143192904|NCT01461928|516251390|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
143192905|NCT01461928|516251391|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
143192906|NCT01461928|516251389|FG000|Induction (up to 8 Months)|Promotor request|1|||
143192907|NCT01461928|516251390|FG001|Induction (up to 8 Months)|Promotor request|0|||
143192908|NCT01461928|516251391|FG002|Induction (up to 8 Months)|Promotor request|0|||
143192909|NCT01461928|516251389|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
143192910|NCT01461928|516251390|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
143192911|NCT01461928|516251391|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
143192912|NCT01461928|516251389|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
143192913|NCT01461928|516251390|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
143261551|NCT01975831|516510613|FG007|Overall Study|Adverse Event|4|||
143192914|NCT01461928|516251391|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
143192915|NCT01461928|516251389|FG000|Maintenance I (24 Months)|Death|3|||
143192916|NCT01461928|516251390|FG001|Maintenance I (24 Months)|Death|0|||
143192917|NCT01461928|516251391|FG002|Maintenance I (24 Months)|Death|0|||
143192918|NCT01461928|516251389|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
143192919|NCT01461928|516251390|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
143192920|NCT01461928|516251391|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
143192921|NCT01461928|516251389|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
143192922|NCT01461928|516251390|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
143192923|NCT01461928|516251391|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
143192924|NCT01461928|516251389|FG000|Maintenance I (24 Months)|Diseases progression|91|||
143192925|NCT01461928|516251390|FG001|Maintenance I (24 Months)|Diseases progression|0|||
143192926|NCT01461928|516251391|FG002|Maintenance I (24 Months)|Diseases progression|0|||
143192927|NCT01461928|516251389|FG000|Maintenance I (24 Months)|Adverse Event|70|||
143192928|NCT01461928|516251390|FG001|Maintenance I (24 Months)|Adverse Event|0|||
143192929|NCT01461928|516251391|FG002|Maintenance I (24 Months)|Adverse Event|0|||
143192930|NCT01461928|516251389|FG000|Maintenance I (24 Months)|Physician Decision|9|||
143192931|NCT01461928|516251390|FG001|Maintenance I (24 Months)|Physician Decision|0|||
143192932|NCT01461928|516251391|FG002|Maintenance I (24 Months)|Physician Decision|0|||
143192933|NCT01461928|516251389|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
143192934|NCT01461928|516251390|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
143192935|NCT01461928|516251391|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
143369599|NCT00462943|516896182|FG001|Overall Study|Failure to achieve a response|5|||
143369600|NCT00462943|516896183|FG002|Overall Study|Failure to achieve a response|1|||
143369601|NCT00462943|516896181|FG000|Overall Study|Adverse Event|6|||
143369602|NCT00462943|516896182|FG001|Overall Study|Adverse Event|4|||
143369603|NCT00462943|516896183|FG002|Overall Study|Adverse Event|1|||
143369604|NCT00462943|516896181|FG000|Overall Study|Protocol Violation|1|||
143369605|NCT00462943|516896182|FG001|Overall Study|Protocol Violation|0|||
143369606|NCT00462943|516896183|FG002|Overall Study|Protocol Violation|0|||
143369607|NCT00462943|516896181|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
143369608|NCT00462943|516896182|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
143369609|NCT00462943|516896183|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
143369610|NCT00462943|516896181|FG000|Overall Study|Disease Progression|15|||
143369611|NCT00462943|516896182|FG001|Overall Study|Disease Progression|15|||
143369612|NCT00462943|516896183|FG002|Overall Study|Disease Progression|9|||
143369613|NCT00462943|516896181|FG000|Overall Study|Death|5|||
143369614|NCT00462943|516896182|FG001|Overall Study|Death|2|||
143369615|NCT00462943|516896183|FG002|Overall Study|Death|7|||
143369616|NCT00462943|516896181|FG000|Overall Study|Stem Cell Transplant|1|||
143369617|NCT00462943|516896182|FG001|Overall Study|Stem Cell Transplant|1|||
143369618|NCT00462943|516896183|FG002|Overall Study|Stem Cell Transplant|0|||
143369619|NCT00462943|516896181|FG000|Overall Study|Bone Marrow Transplant|1|||
143369620|NCT00462943|516896182|FG001|Overall Study|Bone Marrow Transplant|0|||
143369621|NCT00462943|516896183|FG002|Overall Study|Bone Marrow Transplant|0|||
143369622|NCT00462943|516896181|FG000|Overall Study|Required Lymphocyte Infusion|1|||
143369623|NCT00462943|516896182|FG001|Overall Study|Required Lymphocyte Infusion|0|||
143369624|NCT00462943|516896183|FG002|Overall Study|Required Lymphocyte Infusion|0|||
143369625|NCT00462943|516896181|FG000|Overall Study|Transplant - not specified|1|||
143192936|NCT01461928|516251389|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
143192937|NCT01461928|516251390|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
143192938|NCT01461928|516251391|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
143192939|NCT01461928|516251389|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
143192940|NCT01461928|516251390|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
143192941|NCT01461928|516251391|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
143192942|NCT01461928|516251389|FG000|Maintenance I (24 Months)|Not compliant|1|||
143192943|NCT01461928|516251390|FG001|Maintenance I (24 Months)|Not compliant|0|||
143192944|NCT01461928|516251391|FG002|Maintenance I (24 Months)|Not compliant|0|||
143192945|NCT01461928|516251389|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
143192946|NCT01461928|516251390|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
143369626|NCT00462943|516896182|FG001|Overall Study|Transplant - not specified|0|||
143369627|NCT00462943|516896183|FG002|Overall Study|Transplant - not specified|1|||
143369628|NCT00462943|516896181|FG000|Overall Study|Physician Decision|1|||
143369629|NCT00462943|516896182|FG001|Overall Study|Physician Decision|0|||
143369630|NCT00462943|516896183|FG002|Overall Study|Physician Decision|0|||
143369631|NCT00462943|516896181|FG000|Overall Study|Withdrawal by Subject|0|||
143369632|NCT00462943|516896182|FG001|Overall Study|Withdrawal by Subject|1|||
143369633|NCT00462943|516896183|FG002|Overall Study|Withdrawal by Subject|0|||
143369634|NCT02698241|516896184|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
143369635|NCT02698241|516896184|FG000|Overall Study|Screening not met|7|||
143369636|NCT02698241|516896184|FG000|Overall Study|Withdrawal by Subject|7|||
143369637|NCT02698241|516896184|FG000|Overall Study|Physician Decision|2|||
143369638|NCT02698241|516896184|FG000|Overall Study|Subject underwent system modification|2|||
143192947|NCT01461928|516251391|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
143192948|NCT01461928|516251389|FG000|Maintenance II (15 Months)|Adverse Event|0|||
143192949|NCT01461928|516251390|FG001|Maintenance II (15 Months)|Adverse Event|2|||
143192950|NCT01461928|516251391|FG002|Maintenance II (15 Months)|Adverse Event|0|||
143192951|NCT01461928|516251389|FG000|Maintenance II (15 Months)|Death|0|||
143192952|NCT01461928|516251390|FG001|Maintenance II (15 Months)|Death|10|||
143192953|NCT01461928|516251391|FG002|Maintenance II (15 Months)|Death|8|||
143192954|NCT01461928|516251389|FG000|Maintenance II (15 Months)|Physician Decision|0|||
143192955|NCT01461928|516251390|FG001|Maintenance II (15 Months)|Physician Decision|0|||
143192956|NCT01461928|516251391|FG002|Maintenance II (15 Months)|Physician Decision|4|||
143192957|NCT01461928|516251389|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
143192958|NCT01461928|516251390|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
143192959|NCT01461928|516251391|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
143192960|NCT01461928|516251389|FG000|Maintenance II (15 Months)|Moved to another town|0|||
143192961|NCT01461928|516251390|FG001|Maintenance II (15 Months)|Moved to another town|1|||
143192962|NCT01461928|516251391|FG002|Maintenance II (15 Months)|Moved to another town|0|||
143192963|NCT01461928|516251389|FG000|Maintenance II (15 Months)|Disease progression|0|||
143192964|NCT01461928|516251390|FG001|Maintenance II (15 Months)|Disease progression|0|||
143192965|NCT01461928|516251391|FG002|Maintenance II (15 Months)|Disease progression|3|||
143192966|NCT01461928|516251389|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
143192967|NCT01461928|516251390|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
143192968|NCT01461928|516251391|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
143192969|NCT01461928|516251389|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
143192970|NCT01461928|516251390|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
143192971|NCT01461928|516251391|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
143192972|NCT01461928|516251389|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
143192973|NCT01461928|516251390|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
143192974|NCT01461928|516251391|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
143192975|NCT01461928|516251389|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
143192976|NCT01461928|516251390|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
143192977|NCT01461928|516251391|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
143192978|NCT01461928|516251389|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
143192979|NCT01461928|516251390|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
143192980|NCT01461928|516251391|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
143192981|NCT00591149|516251397|FG000|Overall Study|Adverse Event|4|||
143192982|NCT00591149|516251397|FG000|Overall Study|Withdrawal by Subject|1|||
143192983|NCT02456636|516251398|FG000|Overall Study|Death|0|||
143192984|NCT02456636|516251399|FG001|Overall Study|Death|3|||
143192985|NCT02456636|516251400|FG002|Overall Study|Death|0|||
143192986|NCT02456636|516251398|FG000|Overall Study|Pregnancy|1|||
143192987|NCT02456636|516251399|FG001|Overall Study|Pregnancy|3|||
143192988|NCT02456636|516251400|FG002|Overall Study|Pregnancy|5|||
143192989|NCT02456636|516251398|FG000|Overall Study|Physician Decision|4|||
143192990|NCT02456636|516251399|FG001|Overall Study|Physician Decision|5|||
143192991|NCT02456636|516251400|FG002|Overall Study|Physician Decision|4|||
143192992|NCT02456636|516251398|FG000|Overall Study|Withdrawal by Subject|13|||
143192993|NCT02456636|516251399|FG001|Overall Study|Withdrawal by Subject|14|||
143192994|NCT02456636|516251400|FG002|Overall Study|Withdrawal by Subject|16|||
143192995|NCT02456636|516251398|FG000|Overall Study|Lost to Follow-up|50|||
143192996|NCT02456636|516251399|FG001|Overall Study|Lost to Follow-up|44|||
143192997|NCT02456636|516251400|FG002|Overall Study|Lost to Follow-up|50|||
143192998|NCT02379221|516251401|FG000|Overall Study|Lost to Follow-up|1|||
143192999|NCT02019108|516251402|FG000|Overall Study|Lost to Follow-up|5|||
143193000|NCT02019108|516251403|FG001|Overall Study|Lost to Follow-up|7|||
143193001|NCT00519376|516251406|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
143193002|NCT00519376|516251407|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
143193003|NCT00519376|516251408|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
143193004|NCT00519376|516251409|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
143193005|NCT00519376|516251410|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
143193006|NCT00519376|516251411|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
143193007|NCT00519376|516251412|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
143193008|NCT00519376|516251413|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
143193009|NCT00519376|516251414|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
143193010|NCT00519376|516251415|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
143193011|NCT00519376|516251416|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
143193012|NCT00519376|516251417|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
143193013|NCT00519376|516251418|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
143193014|NCT00519376|516251419|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
143193015|NCT00519376|516251420|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
143261552|NCT01975831|516510614|FG008|Overall Study|Adverse Event|1|||
143193016|NCT00519376|516251421|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
143193017|NCT00519376|516251406|FG000|Treatment Period 4|Lost to Follow-up|0|||
143193018|NCT00519376|516251407|FG001|Treatment Period 4|Lost to Follow-up|0|||
143193019|NCT00519376|516251408|FG002|Treatment Period 4|Lost to Follow-up|1|||
143193020|NCT00519376|516251409|FG003|Treatment Period 4|Lost to Follow-up|0|||
143193021|NCT00519376|516251410|FG004|Treatment Period 4|Lost to Follow-up|0|||
143193022|NCT00519376|516251411|FG005|Treatment Period 4|Lost to Follow-up|0|||
143193023|NCT00519376|516251412|FG006|Treatment Period 4|Lost to Follow-up|0|||
143193024|NCT00519376|516251413|FG007|Treatment Period 4|Lost to Follow-up|0|||
143193025|NCT00519376|516251414|FG008|Treatment Period 4|Lost to Follow-up|0|||
143193026|NCT00519376|516251415|FG009|Treatment Period 4|Lost to Follow-up|0|||
143193027|NCT00519376|516251416|FG010|Treatment Period 4|Lost to Follow-up|0|||
143193028|NCT00519376|516251417|FG011|Treatment Period 4|Lost to Follow-up|0|||
143193029|NCT00519376|516251418|FG012|Treatment Period 4|Lost to Follow-up|0|||
143193030|NCT00519376|516251419|FG013|Treatment Period 4|Lost to Follow-up|0|||
143193031|NCT00519376|516251420|FG014|Treatment Period 4|Lost to Follow-up|0|||
143193032|NCT00519376|516251421|FG015|Treatment Period 4|Lost to Follow-up|0|||
143193033|NCT03576066|516251427|FG000|Overall Study|Noncompliance with study drug|0|||
143193034|NCT03576066|516251428|FG001|Overall Study|Noncompliance with study drug|1|||
143193035|NCT06422364|516251431|FG000|Overall Study|Withdrawn due to study closure|0|||
143193036|NCT06422364|516251432|FG001|Overall Study|Withdrawn due to study closure|2|||
143193037|NCT05275010|516251434|FG000|Overall Study|Reason Not Specified|4|||
143193038|NCT05275010|516251435|FG001|Overall Study|Reason Not Specified|1|||
143193039|NCT05275010|516251434|FG000|Overall Study|Withdrawal by Subject|1|||
143193040|NCT05275010|516251435|FG001|Overall Study|Withdrawal by Subject|0|||
143193041|NCT05275010|516251434|FG000|Overall Study|Lost to Follow-up|0|||
143193042|NCT05275010|516251435|FG001|Overall Study|Lost to Follow-up|1|||
143193043|NCT06004895|516251438|FG000|Overall Study|Development of a stye in the upper left eyelid detected at the second visit|1|||
143193044|NCT06004895|516251438|FG000|Overall Study|Prescribed with corticosteroid eyedrops by their eye care clinician following the baseline visit|1|||
143193045|NCT04484649|516251439|FG000|Overall Study|Lost to Follow-up|2|||
143193046|NCT04484649|516251440|FG001|Overall Study|Lost to Follow-up|1|||
143193047|NCT04484649|516251439|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
143193048|NCT04484649|516251440|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
143193049|NCT01463696|516251444|FG000|Overall Study|Adverse Event|0|||
143193050|NCT01463696|516251445|FG001|Overall Study|Adverse Event|1|||
143193051|NCT01463696|516251446|FG002|Overall Study|Adverse Event|0|||
143193052|NCT01463696|516251447|FG003|Overall Study|Adverse Event|2|||
143193053|NCT01463696|516251448|FG004|Overall Study|Adverse Event|0|||
143193054|NCT01463696|516251449|FG005|Overall Study|Adverse Event|1|||
143193055|NCT01463696|516251450|FG006|Overall Study|Adverse Event|3|||
143193056|NCT01463696|516251451|FG007|Overall Study|Adverse Event|2|||
143193057|NCT01463696|516251444|FG000|Overall Study|Lost to Follow-up|0|||
143193058|NCT01463696|516251445|FG001|Overall Study|Lost to Follow-up|0|||
143193059|NCT01463696|516251446|FG002|Overall Study|Lost to Follow-up|1|||
143193060|NCT01463696|516251447|FG003|Overall Study|Lost to Follow-up|0|||
143193061|NCT01463696|516251448|FG004|Overall Study|Lost to Follow-up|0|||
143193062|NCT01463696|516251449|FG005|Overall Study|Lost to Follow-up|0|||
143193063|NCT01463696|516251450|FG006|Overall Study|Lost to Follow-up|0|||
143193064|NCT01463696|516251451|FG007|Overall Study|Lost to Follow-up|0|||
143193065|NCT01463696|516251444|FG000|Overall Study|Progressive Disease|0|||
143193066|NCT01463696|516251445|FG001|Overall Study|Progressive Disease|1|||
143193067|NCT01463696|516251446|FG002|Overall Study|Progressive Disease|0|||
143193068|NCT01463696|516251447|FG003|Overall Study|Progressive Disease|1|||
143193069|NCT01463696|516251448|FG004|Overall Study|Progressive Disease|0|||
143193070|NCT01463696|516251449|FG005|Overall Study|Progressive Disease|1|||
143193071|NCT01463696|516251450|FG006|Overall Study|Progressive Disease|4|||
143193072|NCT01463696|516251451|FG007|Overall Study|Progressive Disease|2|||
143193073|NCT01463696|516251444|FG000|Overall Study|Withdrawal by Subject|0|||
143193074|NCT01463696|516251445|FG001|Overall Study|Withdrawal by Subject|0|||
143193075|NCT01463696|516251446|FG002|Overall Study|Withdrawal by Subject|0|||
143193076|NCT01463696|516251447|FG003|Overall Study|Withdrawal by Subject|1|||
143193077|NCT01463696|516251448|FG004|Overall Study|Withdrawal by Subject|1|||
143193078|NCT01463696|516251449|FG005|Overall Study|Withdrawal by Subject|1|||
143193079|NCT01463696|516251450|FG006|Overall Study|Withdrawal by Subject|2|||
143193080|NCT01463696|516251451|FG007|Overall Study|Withdrawal by Subject|0|||
143193081|NCT01463696|516251444|FG000|Overall Study|Not Treated|0|||
143193082|NCT01463696|516251445|FG001|Overall Study|Not Treated|0|||
143193083|NCT01463696|516251446|FG002|Overall Study|Not Treated|0|||
143193084|NCT01463696|516251447|FG003|Overall Study|Not Treated|0|||
143193085|NCT01463696|516251448|FG004|Overall Study|Not Treated|0|||
143193086|NCT01463696|516251449|FG005|Overall Study|Not Treated|0|||
143193087|NCT01463696|516251450|FG006|Overall Study|Not Treated|1|||
143193088|NCT01463696|516251451|FG007|Overall Study|Not Treated|0|||
143193089|NCT00967694|516251457|FG000|Overall Study|Withdrawal by Subject|6|||
143193090|NCT04417218|516251458|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
143193091|NCT04417218|516251459|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
143193092|NCT00873041|516251460|FG000|Core Study|Adverse Event|2|||
143193093|NCT00873041|516251461|FG001|Core Study|Adverse Event|3|||
143193094|NCT00873041|516251462|FG002|Core Study|Adverse Event|1|||
143193095|NCT00873041|516251460|FG000|Core Study|Withdrawal by Subject|1|||
143193096|NCT00873041|516251461|FG001|Core Study|Withdrawal by Subject|2|||
143193097|NCT00873041|516251462|FG002|Core Study|Withdrawal by Subject|2|||
143193098|NCT00873041|516251460|FG000|Core Study|Lost to Follow-up|3|||
143193099|NCT00873041|516251461|FG001|Core Study|Lost to Follow-up|1|||
143193100|NCT00873041|516251462|FG002|Core Study|Lost to Follow-up|0|||
143193101|NCT00873041|516251460|FG000|Core Study|Abnormal laboratory value|0|||
143193102|NCT00873041|516251461|FG001|Core Study|Abnormal laboratory value|0|||
143193103|NCT00873041|516251462|FG002|Core Study|Abnormal laboratory value|1|||
143193104|NCT00873041|516251460|FG000|Core Study|Protocol deviation|1|||
143193105|NCT00873041|516251461|FG001|Core Study|Protocol deviation|0|||
143193106|NCT00873041|516251462|FG002|Core Study|Protocol deviation|1|||
143193107|NCT00873041|516251460|FG000|Extension Study|Adverse Event|1|||
143193108|NCT00873041|516251461|FG001|Extension Study|Adverse Event|0|||
143193109|NCT00873041|516251462|FG002|Extension Study|Adverse Event|1|||
143193110|NCT00873041|516251460|FG000|Extension Study|Administrative reasons|0|||
143193111|NCT00873041|516251461|FG001|Extension Study|Administrative reasons|0|||
143193112|NCT00873041|516251462|FG002|Extension Study|Administrative reasons|1|||
143193113|NCT00313313|516251465|FG000|Overall Study|Lack of Efficacy|14|||
143193114|NCT00313313|516251466|FG001|Overall Study|Lack of Efficacy|9|||
143193115|NCT00313313|516251467|FG002|Overall Study|Lack of Efficacy|20|||
143193116|NCT00313313|516251465|FG000|Overall Study|Withdrawal of consent by subject|18|||
143193117|NCT00313313|516251466|FG001|Overall Study|Withdrawal of consent by subject|17|||
143193118|NCT00313313|516251467|FG002|Overall Study|Withdrawal of consent by subject|31|||
143193119|NCT00313313|516251465|FG000|Overall Study|Lost to Follow-up|10|||
143193120|NCT00313313|516251466|FG001|Overall Study|Lost to Follow-up|7|||
143193121|NCT00313313|516251467|FG002|Overall Study|Lost to Follow-up|9|||
143193122|NCT00313313|516251465|FG000|Overall Study|Adverse Event|15|||
143193123|NCT00313313|516251466|FG001|Overall Study|Adverse Event|16|||
143193124|NCT00313313|516251467|FG002|Overall Study|Adverse Event|12|||
143193125|NCT00313313|516251465|FG000|Overall Study|Physician Decision|2|||
143193126|NCT00313313|516251466|FG001|Overall Study|Physician Decision|6|||
143193127|NCT00313313|516251467|FG002|Overall Study|Physician Decision|4|||
143193128|NCT00313313|516251465|FG000|Overall Study|Poor/Noncompliance|3|||
143193129|NCT00313313|516251466|FG001|Overall Study|Poor/Noncompliance|6|||
143193130|NCT00313313|516251467|FG002|Overall Study|Poor/Noncompliance|2|||
143193131|NCT00313313|516251465|FG000|Overall Study|Pregnancy|1|||
143193132|NCT00313313|516251466|FG001|Overall Study|Pregnancy|2|||
143193133|NCT00313313|516251467|FG002|Overall Study|Pregnancy|0|||
143193134|NCT00313313|516251465|FG000|Overall Study|Death|0|||
143193135|NCT00313313|516251466|FG001|Overall Study|Death|0|||
143193136|NCT00313313|516251467|FG002|Overall Study|Death|2|||
143193137|NCT00313313|516251465|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
143193138|NCT00313313|516251466|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
143193139|NCT00313313|516251467|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
143193140|NCT03655054|516251469|FG000|Overall Study|Lost to Follow-up|1|||
143193141|NCT03888235|516251473|FG000|Overall Study|Lost to Follow-up|1|||
143193142|NCT03888235|516251474|FG001|Overall Study|Lost to Follow-up|1|||
143193143|NCT03888235|516251475|FG002|Overall Study|Lost to Follow-up|0|||
143193144|NCT03305419|516251492|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
143193145|NCT03305419|516251493|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
143193146|NCT03305419|516251494|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
143193147|NCT03305419|516251495|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
143193148|NCT03305419|516251496|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
143193149|NCT03305419|516251497|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
143193150|NCT03305419|516251498|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
143193151|NCT03305419|516251499|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
143193152|NCT03305419|516251492|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
143193153|NCT03305419|516251493|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
143193154|NCT03305419|516251494|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
143193155|NCT03305419|516251495|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
143193156|NCT03305419|516251496|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
143261553|NCT01975831|516510606|FG000|Overall Study|Death|1|||
143193157|NCT03305419|516251497|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
143193158|NCT03305419|516251498|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
143193159|NCT03305419|516251499|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
143193160|NCT03305419|516251492|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
143193161|NCT03305419|516251493|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
143193162|NCT03305419|516251494|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
143193163|NCT03305419|516251495|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
143193164|NCT03305419|516251496|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
143193165|NCT03305419|516251497|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
143193166|NCT03305419|516251498|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
143193167|NCT03305419|516251499|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
143193168|NCT03305419|516251492|FG000|Part B (14 Days)|Adverse Event|0|||
143193169|NCT03305419|516251493|FG001|Part B (14 Days)|Adverse Event|0|||
143193170|NCT03305419|516251494|FG002|Part B (14 Days)|Adverse Event|0|||
143193171|NCT03305419|516251495|FG003|Part B (14 Days)|Adverse Event|0|||
143193172|NCT03305419|516251496|FG004|Part B (14 Days)|Adverse Event|1|||
143193173|NCT03305419|516251497|FG005|Part B (14 Days)|Adverse Event|2|||
143193174|NCT03305419|516251498|FG006|Part B (14 Days)|Adverse Event|4|||
143193175|NCT03305419|516251499|FG007|Part B (14 Days)|Adverse Event|0|||
143193176|NCT03305419|516251492|FG000|Part B (14 Days)|Physician Decision|0|||
143193177|NCT03305419|516251493|FG001|Part B (14 Days)|Physician Decision|0|||
143193178|NCT03305419|516251494|FG002|Part B (14 Days)|Physician Decision|0|||
143193179|NCT03305419|516251495|FG003|Part B (14 Days)|Physician Decision|0|||
143193180|NCT03305419|516251496|FG004|Part B (14 Days)|Physician Decision|2|||
143193181|NCT03305419|516251497|FG005|Part B (14 Days)|Physician Decision|8|||
143193182|NCT03305419|516251498|FG006|Part B (14 Days)|Physician Decision|1|||
143193183|NCT03305419|516251499|FG007|Part B (14 Days)|Physician Decision|0|||
143193184|NCT02210689|516251500|FG000|Overall Study|Withdrawal by Subject|7|||
143193185|NCT02210689|516251501|FG001|Overall Study|Withdrawal by Subject|4|||
143193186|NCT02210689|516251502|FG002|Overall Study|Withdrawal by Subject|2|||
143193187|NCT02210689|516251500|FG000|Overall Study|Adverse Event|0|||
143193188|NCT02210689|516251501|FG001|Overall Study|Adverse Event|1|||
143193189|NCT02210689|516251502|FG002|Overall Study|Adverse Event|0|||
143193190|NCT02210689|516251500|FG000|Overall Study|Protocol Violation|1|||
143193191|NCT02210689|516251501|FG001|Overall Study|Protocol Violation|0|||
143193192|NCT02210689|516251502|FG002|Overall Study|Protocol Violation|0|||
143193193|NCT02210689|516251500|FG000|Overall Study|Lost to Follow-up|11|||
143193194|NCT02210689|516251501|FG001|Overall Study|Lost to Follow-up|9|||
143193195|NCT02210689|516251502|FG002|Overall Study|Lost to Follow-up|5|||
143193196|NCT02210689|516251500|FG000|Overall Study|Pregnancy|0|||
143193197|NCT02210689|516251501|FG001|Overall Study|Pregnancy|1|||
143193198|NCT02210689|516251502|FG002|Overall Study|Pregnancy|0|||
143193199|NCT02210689|516251500|FG000|Overall Study|Lack of Efficacy|0|||
143193200|NCT02210689|516251501|FG001|Overall Study|Lack of Efficacy|1|||
143193201|NCT02210689|516251502|FG002|Overall Study|Lack of Efficacy|5|||
143193202|NCT02210689|516251500|FG000|Overall Study|Prohibited medication|2|||
143193203|NCT02210689|516251501|FG001|Overall Study|Prohibited medication|8|||
143193204|NCT02210689|516251502|FG002|Overall Study|Prohibited medication|1|||
143193205|NCT02210689|516251500|FG000|Overall Study|Negative Nugent score at baseline|6|||
143193206|NCT02210689|516251501|FG001|Overall Study|Negative Nugent score at baseline|2|||
143193207|NCT02210689|516251502|FG002|Overall Study|Negative Nugent score at baseline|2|||
143193208|NCT02210689|516251500|FG000|Overall Study|Other|25|||
143193209|NCT02210689|516251501|FG001|Overall Study|Other|21|||
143193210|NCT02210689|516251502|FG002|Overall Study|Other|8|||
143193211|NCT00075946|516251503|FG000|Overall Study|Path ineligible: undetermined histology|0|||
143193212|NCT00075946|516251504|FG001|Overall Study|Path ineligible: undetermined histology|0|||
143193213|NCT00075946|516251505|FG002|Overall Study|Path ineligible: undetermined histology|0|||
143193214|NCT00075946|516251506|FG003|Overall Study|Path ineligible: undetermined histology|0|||
143193215|NCT00075946|516251507|FG004|Overall Study|Path ineligible: undetermined histology|6|||
143193216|NCT00075946|516251503|FG000|Overall Study|Did not achieve response after induction|0|||
143193217|NCT00075946|516251504|FG001|Overall Study|Did not achieve response after induction|0|||
143193218|NCT00075946|516251505|FG002|Overall Study|Did not achieve response after induction|0|||
143193219|NCT00075946|516251506|FG003|Overall Study|Did not achieve response after induction|0|||
143193220|NCT00075946|516251507|FG004|Overall Study|Did not achieve response after induction|182|||
143193221|NCT00075946|516251503|FG000|Overall Study|Incorrectly randomized (no response)|5|||
143193222|NCT00075946|516251504|FG001|Overall Study|Incorrectly randomized (no response)|5|||
143193223|NCT00075946|516251505|FG002|Overall Study|Incorrectly randomized (no response)|5|||
143193224|NCT00075946|516251506|FG003|Overall Study|Incorrectly randomized (no response)|1|||
143193225|NCT00075946|516251507|FG004|Overall Study|Incorrectly randomized (no response)|0|||
143193226|NCT00075946|516251503|FG000|Overall Study|Adverse Event|2|||
143193227|NCT00075946|516251504|FG001|Overall Study|Adverse Event|10|||
143193228|NCT00075946|516251505|FG002|Overall Study|Adverse Event|0|||
143193229|NCT00075946|516251506|FG003|Overall Study|Adverse Event|2|||
143193230|NCT00075946|516251507|FG004|Overall Study|Adverse Event|0|||
143193231|NCT00075946|516251503|FG000|Overall Study|Death|0|||
143193232|NCT00075946|516251504|FG001|Overall Study|Death|1|||
143193233|NCT00075946|516251505|FG002|Overall Study|Death|0|||
143193234|NCT00075946|516251506|FG003|Overall Study|Death|0|||
143193235|NCT00075946|516251507|FG004|Overall Study|Death|0|||
143193236|NCT00075946|516251503|FG000|Overall Study|Withdrawal by Subject|23|||
143193237|NCT00075946|516251504|FG001|Overall Study|Withdrawal by Subject|58|||
143193238|NCT00075946|516251505|FG002|Overall Study|Withdrawal by Subject|4|||
143193239|NCT00075946|516251506|FG003|Overall Study|Withdrawal by Subject|9|||
143193240|NCT00075946|516251507|FG004|Overall Study|Withdrawal by Subject|0|||
143193241|NCT00075946|516251503|FG000|Overall Study|Alternative therapy|16|||
143193242|NCT00075946|516251504|FG001|Overall Study|Alternative therapy|2|||
143193243|NCT00075946|516251505|FG002|Overall Study|Alternative therapy|5|||
143193244|NCT00075946|516251506|FG003|Overall Study|Alternative therapy|0|||
143193245|NCT00075946|516251507|FG004|Overall Study|Alternative therapy|0|||
143193246|NCT00075946|516251503|FG000|Overall Study|Other complicating disease|7|||
143193247|NCT00075946|516251504|FG001|Overall Study|Other complicating disease|13|||
143193248|NCT00075946|516251505|FG002|Overall Study|Other complicating disease|1|||
143193249|NCT00075946|516251506|FG003|Overall Study|Other complicating disease|4|||
143193250|NCT00075946|516251507|FG004|Overall Study|Other complicating disease|0|||
143193251|NCT00075946|516251503|FG000|Overall Study|No response to retreatment|23|||
143193252|NCT00075946|516251504|FG001|Overall Study|No response to retreatment|0|||
143193253|NCT00075946|516251505|FG002|Overall Study|No response to retreatment|2|||
143193254|NCT00075946|516251506|FG003|Overall Study|No response to retreatment|0|||
143193255|NCT00075946|516251507|FG004|Overall Study|No response to retreatment|0|||
143193256|NCT00075946|516251503|FG000|Overall Study|Time to progression less than 6 months|15|||
143193257|NCT00075946|516251504|FG001|Overall Study|Time to progression less than 6 months|30|||
143193258|NCT00075946|516251505|FG002|Overall Study|Time to progression less than 6 months|8|||
143193259|NCT00075946|516251506|FG003|Overall Study|Time to progression less than 6 months|3|||
143193260|NCT00075946|516251507|FG004|Overall Study|Time to progression less than 6 months|0|||
143193261|NCT00075946|516251503|FG000|Overall Study|Other|57|||
143193262|NCT00075946|516251504|FG001|Overall Study|Other|32|||
143193263|NCT00075946|516251505|FG002|Overall Study|Other|3|||
143193264|NCT00075946|516251506|FG003|Overall Study|Other|11|||
143193265|NCT00075946|516251507|FG004|Overall Study|Other|0|||
143193266|NCT00889603|516251508|FG000|Overall Study|Adverse Event|7|||
143193267|NCT00889603|516251508|FG000|Overall Study|Death|3|||
143193268|NCT00889603|516251508|FG000|Overall Study|Lost to Follow-up|19|||
143193269|NCT00889603|516251508|FG000|Overall Study|No longer willing to participant in stud|4|||
143193270|NCT00889603|516251508|FG000|Overall Study|Other|4|||
143193271|NCT02231892|516251509|FG000|Overall Study|Lost to Follow-up|1|||
143193272|NCT02231892|516251510|FG001|Overall Study|Lost to Follow-up|0|||
143193273|NCT02231892|516251511|FG002|Overall Study|Lost to Follow-up|3|||
143193274|NCT02231892|516251509|FG000|Overall Study|Withdrawal by Subject|4|||
143193275|NCT02231892|516251510|FG001|Overall Study|Withdrawal by Subject|3|||
143193276|NCT02231892|516251511|FG002|Overall Study|Withdrawal by Subject|15|||
143193277|NCT02231892|516251509|FG000|Overall Study|Physician Decision|0|||
143193278|NCT02231892|516251510|FG001|Overall Study|Physician Decision|2|||
143193279|NCT02231892|516251511|FG002|Overall Study|Physician Decision|4|||
143193280|NCT02231892|516251509|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
143193281|NCT02231892|516251510|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
143193282|NCT02231892|516251511|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
143193283|NCT02231892|516251509|FG000|Overall Study|Participant motor threshold was >83%|0|||
143193284|NCT02231892|516251510|FG001|Overall Study|Participant motor threshold was >83%|0|||
143193285|NCT02231892|516251511|FG002|Overall Study|Participant motor threshold was >83%|9|||
143193286|NCT02231892|516251509|FG000|Overall Study|Could not find motor threshold|2|||
143193287|NCT02231892|516251510|FG001|Overall Study|Could not find motor threshold|0|||
143193288|NCT02231892|516251511|FG002|Overall Study|Could not find motor threshold|1|||
143193289|NCT02231892|516251509|FG000|Overall Study|Could not find reliable motor hotspot|0|||
143193290|NCT02231892|516251510|FG001|Overall Study|Could not find reliable motor hotspot|0|||
143193291|NCT02231892|516251511|FG002|Overall Study|Could not find reliable motor hotspot|1|||
143193292|NCT02602275|516251515|FG000|Day 1|Physician Decision|0|||
143193293|NCT02602275|516251516|FG001|Day 1|Physician Decision|1|||
143193294|NCT05596734|516251517|FG000|Substudy A|Withdrawal by Subject|1|||
143193295|NCT05596734|516251518|FG001|Substudy A|Withdrawal by Subject|0|||
143193296|NCT05596734|516251519|FG002|Substudy A|Withdrawal by Subject|0|||
143193297|NCT05596734|516251520|FG003|Substudy A|Withdrawal by Subject|0|||
143193298|NCT05596734|516251521|FG004|Substudy A|Withdrawal by Subject|0|||
143193299|NCT05596734|516251522|FG005|Substudy A|Withdrawal by Subject|0|||
143193300|NCT05596734|516251523|FG006|Substudy A|Withdrawal by Subject|1|||
143193301|NCT05596734|516251524|FG007|Substudy A|Withdrawal by Subject|0|||
143193302|NCT05596734|516251525|FG008|Substudy A|Withdrawal by Subject|0|||
143193303|NCT05596734|516251526|FG009|Substudy A|Withdrawal by Subject|0|||
143193304|NCT05596734|516251527|FG010|Substudy A|Withdrawal by Subject|0|||
143193305|NCT05596734|516251528|FG011|Substudy A|Withdrawal by Subject|0|||
143193306|NCT05596734|516251529|FG012|Substudy A|Withdrawal by Subject|0|||
143193307|NCT05596734|516251530|FG013|Substudy A|Withdrawal by Subject|0|||
143193308|NCT05596734|516251531|FG014|Substudy A|Withdrawal by Subject|0|||
143193309|NCT05596734|516251532|FG015|Substudy A|Withdrawal by Subject|0|||
143193310|NCT05596734|516251533|FG016|Substudy A|Withdrawal by Subject|0|||
143193311|NCT05596734|516251534|FG017|Substudy A|Withdrawal by Subject|0|||
143193312|NCT05596734|516251535|FG018|Substudy A|Withdrawal by Subject|0|||
143193313|NCT05596734|516251536|FG019|Substudy A|Withdrawal by Subject|0|||
143193314|NCT05596734|516251537|FG020|Substudy A|Withdrawal by Subject|0|||
143193315|NCT05596734|516251538|FG021|Substudy A|Withdrawal by Subject|0|||
143193316|NCT05596734|516251539|FG022|Substudy A|Withdrawal by Subject|0|||
143193317|NCT05596734|516251540|FG023|Substudy A|Withdrawal by Subject|0|||
143193318|NCT05596734|516251517|FG000|Substudy A|Lost to Follow-up|1|||
143193319|NCT05596734|516251518|FG001|Substudy A|Lost to Follow-up|0|||
143193320|NCT05596734|516251519|FG002|Substudy A|Lost to Follow-up|1|||
143193321|NCT05596734|516251520|FG003|Substudy A|Lost to Follow-up|0|||
143193322|NCT05596734|516251521|FG004|Substudy A|Lost to Follow-up|0|||
143193323|NCT05596734|516251522|FG005|Substudy A|Lost to Follow-up|0|||
143193324|NCT05596734|516251523|FG006|Substudy A|Lost to Follow-up|0|||
143193325|NCT05596734|516251524|FG007|Substudy A|Lost to Follow-up|0|||
143193326|NCT05596734|516251525|FG008|Substudy A|Lost to Follow-up|0|||
143193327|NCT05596734|516251526|FG009|Substudy A|Lost to Follow-up|0|||
143193328|NCT05596734|516251527|FG010|Substudy A|Lost to Follow-up|0|||
143193329|NCT05596734|516251528|FG011|Substudy A|Lost to Follow-up|0|||
143193330|NCT05596734|516251529|FG012|Substudy A|Lost to Follow-up|0|||
143193331|NCT05596734|516251530|FG013|Substudy A|Lost to Follow-up|0|||
143193332|NCT05596734|516251531|FG014|Substudy A|Lost to Follow-up|0|||
143193333|NCT05596734|516251532|FG015|Substudy A|Lost to Follow-up|0|||
143193334|NCT05596734|516251533|FG016|Substudy A|Lost to Follow-up|0|||
143193335|NCT05596734|516251534|FG017|Substudy A|Lost to Follow-up|0|||
143193336|NCT05596734|516251535|FG018|Substudy A|Lost to Follow-up|0|||
143193337|NCT05596734|516251536|FG019|Substudy A|Lost to Follow-up|0|||
143193338|NCT05596734|516251537|FG020|Substudy A|Lost to Follow-up|0|||
143193339|NCT05596734|516251538|FG021|Substudy A|Lost to Follow-up|0|||
143193340|NCT05596734|516251539|FG022|Substudy A|Lost to Follow-up|0|||
143193341|NCT05596734|516251540|FG023|Substudy A|Lost to Follow-up|0|||
143193342|NCT05596734|516251517|FG000|Substudy B|Withdrawal by Subject|0|||
143193343|NCT05596734|516251518|FG001|Substudy B|Withdrawal by Subject|0|||
143193344|NCT05596734|516251519|FG002|Substudy B|Withdrawal by Subject|0|||
143193345|NCT05596734|516251520|FG003|Substudy B|Withdrawal by Subject|0|||
143193346|NCT05596734|516251521|FG004|Substudy B|Withdrawal by Subject|0|||
143193347|NCT05596734|516251522|FG005|Substudy B|Withdrawal by Subject|0|||
143193348|NCT05596734|516251523|FG006|Substudy B|Withdrawal by Subject|0|||
143193349|NCT05596734|516251524|FG007|Substudy B|Withdrawal by Subject|0|||
143193350|NCT05596734|516251525|FG008|Substudy B|Withdrawal by Subject|0|||
143193351|NCT05596734|516251526|FG009|Substudy B|Withdrawal by Subject|0|||
143193352|NCT05596734|516251527|FG010|Substudy B|Withdrawal by Subject|0|||
143193353|NCT05596734|516251528|FG011|Substudy B|Withdrawal by Subject|0|||
143193354|NCT05596734|516251529|FG012|Substudy B|Withdrawal by Subject|1|||
143193355|NCT05596734|516251530|FG013|Substudy B|Withdrawal by Subject|0|||
143193356|NCT05596734|516251531|FG014|Substudy B|Withdrawal by Subject|1|||
143193357|NCT05596734|516251532|FG015|Substudy B|Withdrawal by Subject|2|||
143193358|NCT05596734|516251533|FG016|Substudy B|Withdrawal by Subject|2|||
143193359|NCT05596734|516251534|FG017|Substudy B|Withdrawal by Subject|1|||
143193360|NCT05596734|516251535|FG018|Substudy B|Withdrawal by Subject|2|||
143193361|NCT05596734|516251536|FG019|Substudy B|Withdrawal by Subject|0|||
143193362|NCT05596734|516251537|FG020|Substudy B|Withdrawal by Subject|0|||
143193363|NCT05596734|516251538|FG021|Substudy B|Withdrawal by Subject|0|||
143193364|NCT05596734|516251539|FG022|Substudy B|Withdrawal by Subject|0|||
143193365|NCT05596734|516251540|FG023|Substudy B|Withdrawal by Subject|1|||
143193366|NCT05596734|516251517|FG000|Substudy B|Physician Decision|0|||
143193367|NCT05596734|516251518|FG001|Substudy B|Physician Decision|0|||
143193368|NCT05596734|516251519|FG002|Substudy B|Physician Decision|0|||
143193369|NCT05596734|516251520|FG003|Substudy B|Physician Decision|0|||
143193370|NCT05596734|516251521|FG004|Substudy B|Physician Decision|0|||
143193371|NCT05596734|516251522|FG005|Substudy B|Physician Decision|0|||
143193372|NCT05596734|516251523|FG006|Substudy B|Physician Decision|0|||
143193373|NCT05596734|516251524|FG007|Substudy B|Physician Decision|0|||
143193374|NCT05596734|516251525|FG008|Substudy B|Physician Decision|0|||
143193375|NCT05596734|516251526|FG009|Substudy B|Physician Decision|0|||
143193376|NCT05596734|516251527|FG010|Substudy B|Physician Decision|0|||
143193377|NCT05596734|516251528|FG011|Substudy B|Physician Decision|0|||
143193378|NCT05596734|516251529|FG012|Substudy B|Physician Decision|0|||
143193379|NCT05596734|516251530|FG013|Substudy B|Physician Decision|0|||
143193380|NCT05596734|516251531|FG014|Substudy B|Physician Decision|0|||
143193381|NCT05596734|516251532|FG015|Substudy B|Physician Decision|1|||
143193382|NCT05596734|516251533|FG016|Substudy B|Physician Decision|0|||
143193383|NCT05596734|516251534|FG017|Substudy B|Physician Decision|0|||
143193384|NCT05596734|516251535|FG018|Substudy B|Physician Decision|0|||
143193385|NCT05596734|516251536|FG019|Substudy B|Physician Decision|0|||
143193386|NCT05596734|516251537|FG020|Substudy B|Physician Decision|0|||
143193387|NCT05596734|516251538|FG021|Substudy B|Physician Decision|0|||
143193388|NCT05596734|516251539|FG022|Substudy B|Physician Decision|0|||
143193389|NCT05596734|516251540|FG023|Substudy B|Physician Decision|0|||
143193390|NCT05596734|516251517|FG000|Substudy B|Lost to Follow-up|0|||
143193391|NCT05596734|516251518|FG001|Substudy B|Lost to Follow-up|0|||
143193392|NCT05596734|516251519|FG002|Substudy B|Lost to Follow-up|0|||
143193393|NCT05596734|516251520|FG003|Substudy B|Lost to Follow-up|0|||
143193394|NCT05596734|516251521|FG004|Substudy B|Lost to Follow-up|0|||
143193395|NCT05596734|516251522|FG005|Substudy B|Lost to Follow-up|0|||
143193396|NCT05596734|516251523|FG006|Substudy B|Lost to Follow-up|0|||
143193397|NCT05596734|516251524|FG007|Substudy B|Lost to Follow-up|0|||
143193398|NCT05596734|516251525|FG008|Substudy B|Lost to Follow-up|0|||
143193399|NCT05596734|516251526|FG009|Substudy B|Lost to Follow-up|0|||
143193400|NCT05596734|516251527|FG010|Substudy B|Lost to Follow-up|0|||
143193401|NCT05596734|516251528|FG011|Substudy B|Lost to Follow-up|0|||
143193402|NCT05596734|516251529|FG012|Substudy B|Lost to Follow-up|1|||
143193403|NCT05596734|516251530|FG013|Substudy B|Lost to Follow-up|0|||
143193404|NCT05596734|516251531|FG014|Substudy B|Lost to Follow-up|1|||
143193405|NCT05596734|516251532|FG015|Substudy B|Lost to Follow-up|1|||
143193406|NCT05596734|516251533|FG016|Substudy B|Lost to Follow-up|0|||
143193407|NCT05596734|516251534|FG017|Substudy B|Lost to Follow-up|0|||
143193408|NCT05596734|516251535|FG018|Substudy B|Lost to Follow-up|0|||
143193409|NCT05596734|516251536|FG019|Substudy B|Lost to Follow-up|0|||
143193410|NCT05596734|516251537|FG020|Substudy B|Lost to Follow-up|0|||
143193411|NCT05596734|516251538|FG021|Substudy B|Lost to Follow-up|0|||
143193412|NCT05596734|516251539|FG022|Substudy B|Lost to Follow-up|0|||
143193413|NCT05596734|516251540|FG023|Substudy B|Lost to Follow-up|0|||
143193414|NCT01974206|516251541|FG000|Overall Study|Did Not Take Study Drug|0|||
143193415|NCT01974206|516251542|FG001|Overall Study|Did Not Take Study Drug|1|||
143193416|NCT01974206|516251541|FG000|Overall Study|Physician Decision|1|||
143193417|NCT01974206|516251542|FG001|Overall Study|Physician Decision|0|||
143193418|NCT01974206|516251541|FG000|Overall Study|Withdrawal by Subject|3|||
143193419|NCT01974206|516251542|FG001|Overall Study|Withdrawal by Subject|0|||
143193420|NCT01974206|516251541|FG000|Overall Study|Lost to Follow-up|1|||
143193421|NCT01974206|516251542|FG001|Overall Study|Lost to Follow-up|0|||
143193422|NCT01974206|516251541|FG000|Overall Study|Death|1|||
143193423|NCT01974206|516251542|FG001|Overall Study|Death|0|||
143193424|NCT00778258|516251545|FG000|Overall Study|Adverse Event|1|||
143193425|NCT00778258|516251546|FG001|Overall Study|Adverse Event|0|||
143193426|NCT00778258|516251547|FG002|Overall Study|Adverse Event|0|||
143193427|NCT00778258|516251548|FG003|Overall Study|Adverse Event|0|||
143193428|NCT00778258|516251549|FG004|Overall Study|Adverse Event|0|||
143193429|NCT00778258|516251550|FG005|Overall Study|Adverse Event|1|||
143193430|NCT00778258|516251551|FG006|Overall Study|Adverse Event|0|||
143193431|NCT00778258|516251552|FG007|Overall Study|Adverse Event|0|||
143193432|NCT00778258|516251553|FG008|Overall Study|Adverse Event|0|||
143193433|NCT00778258|516251545|FG000|Overall Study|Lost to Follow-up|0|||
143193434|NCT00778258|516251546|FG001|Overall Study|Lost to Follow-up|0|||
143193435|NCT00778258|516251547|FG002|Overall Study|Lost to Follow-up|2|||
143193436|NCT00778258|516251548|FG003|Overall Study|Lost to Follow-up|0|||
143193437|NCT00778258|516251549|FG004|Overall Study|Lost to Follow-up|0|||
143193438|NCT00778258|516251550|FG005|Overall Study|Lost to Follow-up|3|||
143193439|NCT00778258|516251551|FG006|Overall Study|Lost to Follow-up|2|||
143193440|NCT00778258|516251552|FG007|Overall Study|Lost to Follow-up|2|||
143193441|NCT00778258|516251553|FG008|Overall Study|Lost to Follow-up|0|||
143193442|NCT00778258|516251545|FG000|Overall Study|Withdrawal by Subject|6|||
143193443|NCT00778258|516251546|FG001|Overall Study|Withdrawal by Subject|2|||
143193444|NCT00778258|516251547|FG002|Overall Study|Withdrawal by Subject|8|||
143193445|NCT00778258|516251548|FG003|Overall Study|Withdrawal by Subject|2|||
143193446|NCT00778258|516251549|FG004|Overall Study|Withdrawal by Subject|0|||
143193447|NCT00778258|516251550|FG005|Overall Study|Withdrawal by Subject|6|||
143193448|NCT00778258|516251551|FG006|Overall Study|Withdrawal by Subject|12|||
143193449|NCT00778258|516251552|FG007|Overall Study|Withdrawal by Subject|12|||
143193450|NCT00778258|516251553|FG008|Overall Study|Withdrawal by Subject|4|||
143193451|NCT00778258|516251545|FG000|Overall Study|New Contraindication|0|||
143193452|NCT00778258|516251546|FG001|Overall Study|New Contraindication|0|||
143193453|NCT00778258|516251547|FG002|Overall Study|New Contraindication|0|||
143193454|NCT00778258|516251548|FG003|Overall Study|New Contraindication|0|||
143193455|NCT00778258|516251549|FG004|Overall Study|New Contraindication|0|||
143193456|NCT00778258|516251550|FG005|Overall Study|New Contraindication|0|||
143193457|NCT00778258|516251551|FG006|Overall Study|New Contraindication|0|||
143193458|NCT00778258|516251552|FG007|Overall Study|New Contraindication|1|||
143193459|NCT00778258|516251553|FG008|Overall Study|New Contraindication|0|||
143193460|NCT00778258|516251545|FG000|Overall Study|Non-compliance|0|||
143193461|NCT00778258|516251546|FG001|Overall Study|Non-compliance|0|||
143193462|NCT00778258|516251547|FG002|Overall Study|Non-compliance|0|||
143193463|NCT00778258|516251548|FG003|Overall Study|Non-compliance|1|||
143193464|NCT00778258|516251549|FG004|Overall Study|Non-compliance|0|||
143193465|NCT00778258|516251550|FG005|Overall Study|Non-compliance|0|||
143193466|NCT00778258|516251551|FG006|Overall Study|Non-compliance|0|||
143193467|NCT00778258|516251552|FG007|Overall Study|Non-compliance|0|||
143193468|NCT00778258|516251553|FG008|Overall Study|Non-compliance|0|||
143193469|NCT00778258|516251545|FG000|Overall Study|Other|0|||
143193470|NCT00778258|516251546|FG001|Overall Study|Other|0|||
143193471|NCT00778258|516251547|FG002|Overall Study|Other|0|||
143193472|NCT00778258|516251548|FG003|Overall Study|Other|0|||
143193473|NCT00778258|516251549|FG004|Overall Study|Other|0|||
143193474|NCT00778258|516251550|FG005|Overall Study|Other|0|||
143193475|NCT00778258|516251551|FG006|Overall Study|Other|1|||
143193476|NCT00778258|516251552|FG007|Overall Study|Other|0|||
143193477|NCT00778258|516251553|FG008|Overall Study|Other|0|||
143193478|NCT01952665|516253395|FG000|Overall Study|Physician Decision|3|||
143193479|NCT01952665|516253396|FG001|Overall Study|Physician Decision|2|||
143193480|NCT01952665|516253395|FG000|Overall Study|Lost to Follow-up|1|||
143193481|NCT01952665|516253396|FG001|Overall Study|Lost to Follow-up|2|||
143193482|NCT01952665|516253395|FG000|Overall Study|Adverse Event|2|||
143193483|NCT01952665|516253396|FG001|Overall Study|Adverse Event|1|||
143193484|NCT01952665|516253395|FG000|Overall Study|Protocol Violation|0|||
143193485|NCT01952665|516253396|FG001|Overall Study|Protocol Violation|1|||
143193486|NCT01537081|516253397|FG000|Overall Study|Adverse Event|5|||
143193487|NCT01537081|516253398|FG001|Overall Study|Adverse Event|2|||
143193488|NCT01537081|516253399|FG002|Overall Study|Adverse Event|2|||
143193489|NCT01537081|516253397|FG000|Overall Study|Lack of Efficacy|2|||
143193490|NCT01537081|516253398|FG001|Overall Study|Lack of Efficacy|1|||
143193491|NCT01537081|516253399|FG002|Overall Study|Lack of Efficacy|0|||
143193492|NCT01537081|516253397|FG000|Overall Study|Lost to Follow-up|17|||
143193493|NCT01537081|516253398|FG001|Overall Study|Lost to Follow-up|15|||
143193494|NCT01537081|516253399|FG002|Overall Study|Lost to Follow-up|9|||
143193495|NCT01537081|516253397|FG000|Overall Study|Protocol Violation|3|||
143193496|NCT01537081|516253398|FG001|Overall Study|Protocol Violation|2|||
143193497|NCT01537081|516253399|FG002|Overall Study|Protocol Violation|2|||
143193498|NCT01537081|516253397|FG000|Overall Study|Withdrawal by Subject|6|||
143193499|NCT01537081|516253398|FG001|Overall Study|Withdrawal by Subject|11|||
143193500|NCT01537081|516253399|FG002|Overall Study|Withdrawal by Subject|3|||
143193501|NCT01537081|516253397|FG000|Overall Study|Physician Decision|5|||
143193502|NCT01537081|516253398|FG001|Overall Study|Physician Decision|6|||
143193503|NCT01537081|516253399|FG002|Overall Study|Physician Decision|0|||
143193504|NCT01537081|516253397|FG000|Overall Study|Sponsor decision|0|||
143193505|NCT01537081|516253398|FG001|Overall Study|Sponsor decision|1|||
143193506|NCT01537081|516253399|FG002|Overall Study|Sponsor decision|0|||
143193507|NCT01537081|516253397|FG000|Overall Study|Assigned but never dosed|1|||
143193508|NCT01537081|516253398|FG001|Overall Study|Assigned but never dosed|0|||
143193509|NCT01537081|516253399|FG002|Overall Study|Assigned but never dosed|0|||
143193510|NCT01463111|516253402|FG000|Overall Study|Withdrawal by Subject|2|||
143193511|NCT01463111|516253402|FG000|Overall Study|Lost to Follow-up|5|||
143193512|NCT01463111|516253402|FG000|Overall Study|Physician Decision|2|||
143193513|NCT03285958|516253403|FG000|Overall Study|Lost to Follow-up|1|||
143193514|NCT03285958|516253404|FG001|Overall Study|Lost to Follow-up|1|||
143193515|NCT03285958|516253403|FG000|Overall Study|Withdrawal by Subject|1|||
143193516|NCT03285958|516253404|FG001|Overall Study|Withdrawal by Subject|0|||
143193517|NCT03285958|516253403|FG000|Overall Study|Not able to attend required orientation|3|||
143193518|NCT03285958|516253404|FG001|Overall Study|Not able to attend required orientation|0|||
143193519|NCT03116828|516253407|FG000|Overall Study|Adverse Event|1|||
143193520|NCT03116828|516253408|FG001|Overall Study|Adverse Event|10|||
143193521|NCT03116828|516253407|FG000|Overall Study|Withdrawal by Subject|4|||
143193522|NCT03116828|516253408|FG001|Overall Study|Withdrawal by Subject|8|||
143193523|NCT03116828|516253407|FG000|Overall Study|OTHER|3|||
143193524|NCT03116828|516253408|FG001|Overall Study|OTHER|3|||
143193525|NCT01559259|516253417|FG000|Overall Study|Withdrawal by Subject|0|||
143193526|NCT01559259|516253418|FG001|Overall Study|Withdrawal by Subject|0|||
143193527|NCT01559259|516253419|FG002|Overall Study|Withdrawal by Subject|0|||
143193528|NCT01559259|516253420|FG003|Overall Study|Withdrawal by Subject|1|||
143193529|NCT01559259|516253421|FG004|Overall Study|Withdrawal by Subject|0|||
143193530|NCT01559259|516253417|FG000|Overall Study|Adverse Event|0|||
143193531|NCT01559259|516253418|FG001|Overall Study|Adverse Event|1|||
143193532|NCT01559259|516253419|FG002|Overall Study|Adverse Event|1|||
143193533|NCT01559259|516253420|FG003|Overall Study|Adverse Event|0|||
143369639|NCT02698241|516896184|FG000|Overall Study|Lost to Follow-up|3|||
143193534|NCT01559259|516253421|FG004|Overall Study|Adverse Event|0|||
143193535|NCT01995669|516253422|FG000|Overall Study|Progression|2|||
143193536|NCT01995669|516253423|FG001|Overall Study|Progression|1|||
143193537|NCT01995669|516253424|FG002|Overall Study|Progression|1|||
143193538|NCT01995669|516253425|FG003|Overall Study|Progression|13|||
143193539|NCT01995669|516253422|FG000|Overall Study|Adverse Event|0|||
143193540|NCT01995669|516253423|FG001|Overall Study|Adverse Event|0|||
143193541|NCT01995669|516253424|FG002|Overall Study|Adverse Event|0|||
143193542|NCT01995669|516253425|FG003|Overall Study|Adverse Event|3|||
143193543|NCT01995669|516253422|FG000|Overall Study|Death|0|||
143193544|NCT01995669|516253423|FG001|Overall Study|Death|0|||
143369640|NCT02698241|516896184|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
143193545|NCT01995669|516253424|FG002|Overall Study|Death|0|||
143193546|NCT01995669|516253425|FG003|Overall Study|Death|6|||
143193547|NCT01995669|516253422|FG000|Overall Study|Withdrawal by Subject|0|||
143193548|NCT01995669|516253423|FG001|Overall Study|Withdrawal by Subject|0|||
143193549|NCT01995669|516253424|FG002|Overall Study|Withdrawal by Subject|0|||
143193550|NCT01995669|516253425|FG003|Overall Study|Withdrawal by Subject|6|||
143193551|NCT01995669|516253422|FG000|Overall Study|Insurance Expired|0|||
143193552|NCT01995669|516253423|FG001|Overall Study|Insurance Expired|0|||
143193553|NCT01995669|516253424|FG002|Overall Study|Insurance Expired|0|||
143193554|NCT01995669|516253425|FG003|Overall Study|Insurance Expired|1|||
143193555|NCT05425732|516253426|FG000|Overall Study|Death|4|||
143193556|NCT05425732|516253427|FG001|Overall Study|Death|2|||
143193557|NCT05425732|516253428|FG002|Overall Study|Death|0|||
143193558|NCT05425732|516253429|FG003|Overall Study|Death|0|||
143193559|NCT05425732|516253426|FG000|Overall Study|Lost to Follow-up|10|||
143193560|NCT05425732|516253427|FG001|Overall Study|Lost to Follow-up|15|||
143193561|NCT05425732|516253428|FG002|Overall Study|Lost to Follow-up|5|||
143193562|NCT05425732|516253429|FG003|Overall Study|Lost to Follow-up|3|||
143193563|NCT05425732|516253426|FG000|Overall Study|Physician Decision|0|||
143193564|NCT05425732|516253427|FG001|Overall Study|Physician Decision|2|||
143193565|NCT05425732|516253428|FG002|Overall Study|Physician Decision|0|||
143193566|NCT05425732|516253429|FG003|Overall Study|Physician Decision|0|||
143193567|NCT05425732|516253426|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
143193568|NCT05425732|516253427|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
143193569|NCT05425732|516253428|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
143193570|NCT05425732|516253429|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
143193571|NCT05425732|516253426|FG000|Overall Study|Withdrawal by Subject|4|||
143193572|NCT05425732|516253427|FG001|Overall Study|Withdrawal by Subject|8|||
143193573|NCT05425732|516253428|FG002|Overall Study|Withdrawal by Subject|1|||
143193574|NCT05425732|516253429|FG003|Overall Study|Withdrawal by Subject|1|||
143193575|NCT05425732|516253426|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
143193576|NCT05425732|516253427|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
143193577|NCT05425732|516253428|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
143193578|NCT05425732|516253429|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
143193579|NCT01681069|516253433|FG000|Overall Study|Withdrawal by Subject|4|||
143193580|NCT01681069|516253434|FG001|Overall Study|Withdrawal by Subject|5|||
143193581|NCT01681069|516253433|FG000|Overall Study|Protocol Violation|1|||
143193582|NCT01681069|516253434|FG001|Overall Study|Protocol Violation|1|||
143193583|NCT01681069|516253433|FG000|Overall Study|Adverse Event|0|||
143193584|NCT01681069|516253434|FG001|Overall Study|Adverse Event|1|||
143193585|NCT03883165|516253435|FG000|Overall Study|Withdrawal by Subject|4|||
143193586|NCT03883165|516253436|FG001|Overall Study|Withdrawal by Subject|3|||
143193587|NCT00245050|516253438|FG000|Overall Study|Adverse Event|3|||
143193588|NCT00245050|516253439|FG001|Overall Study|Adverse Event|2|||
143193589|NCT00368836|516253446|FG000|Phase II|Screen Failure|1|||
143193590|NCT00368836|516253446|FG000|Phase II|Withdrawal by Subject|1|||
143193591|NCT00368836|516253446|FG000|Phase II|unable to collect blood and/or breath|17|||
143193592|NCT00368836|516253446|FG000|Phase II|Protocol Violation|2|||
143193593|NCT01345591|516253451|FG000|Overall Study|Lost to Follow-up|1|||
143193594|NCT00090142|516253452|FG000|Treatment Period I|Lost to Follow-up|1|||
143193595|NCT00090142|516253453|FG001|Treatment Period I|Lost to Follow-up|2|||
143193596|NCT00090142|516253452|FG000|Treatment Period I|Protocol Violation|2|||
143193597|NCT00090142|516253453|FG001|Treatment Period I|Protocol Violation|0|||
143193598|NCT00090142|516253452|FG000|Treatment Period I|Withdrawal by Subject|2|||
143193599|NCT00090142|516253453|FG001|Treatment Period I|Withdrawal by Subject|0|||
143193600|NCT00090142|516253452|FG000|Treatment Period I|Other|0|||
143193601|NCT00090142|516253453|FG001|Treatment Period I|Other|1|||
143193602|NCT00090142|516253452|FG000|Treatment Period II|Other|1|||
143193603|NCT00090142|516253453|FG001|Treatment Period II|Other|0|||
143193604|NCT02442310|516253454|FG000|Overall Study|Adverse Event|2|||
143193605|NCT02442310|516253454|FG000|Overall Study|Withdrawal by Subject|1|||
143193606|NCT01126437|516253455|FG000|Overall Study|Not treated|11|||
143193607|NCT01126437|516253456|FG001|Overall Study|Not treated|18|||
143193608|NCT01126437|516253457|FG002|Overall Study|Not treated|19|||
143193609|NCT01126437|516253455|FG000|Overall Study|Sites with data irregularities/fraud|6|||
143193610|NCT01126437|516253456|FG001|Overall Study|Sites with data irregularities/fraud|6|||
143193611|NCT01126437|516253457|FG002|Overall Study|Sites with data irregularities/fraud|7|||
143193612|NCT01126437|516253455|FG000|Overall Study|Adverse Event|602|||
143193613|NCT01126437|516253456|FG001|Overall Study|Adverse Event|606|||
143193614|NCT01126437|516253457|FG002|Overall Study|Adverse Event|635|||
143193615|NCT01126437|516253455|FG000|Overall Study|Lack of Efficacy|65|||
143193616|NCT01126437|516253456|FG001|Overall Study|Lack of Efficacy|60|||
143193617|NCT01126437|516253457|FG002|Overall Study|Lack of Efficacy|59|||
143193618|NCT01126437|516253455|FG000|Overall Study|Protocol Violation|64|||
143193619|NCT01126437|516253456|FG001|Overall Study|Protocol Violation|66|||
143193620|NCT01126437|516253457|FG002|Overall Study|Protocol Violation|41|||
143193621|NCT01126437|516253455|FG000|Overall Study|Lost to Follow-up|52|||
143193622|NCT01126437|516253456|FG001|Overall Study|Lost to Follow-up|63|||
143193623|NCT01126437|516253457|FG002|Overall Study|Lost to Follow-up|55|||
143193624|NCT01126437|516253455|FG000|Overall Study|Withdrawal by Subject|331|||
143193625|NCT01126437|516253456|FG001|Overall Study|Withdrawal by Subject|335|||
143193626|NCT01126437|516253457|FG002|Overall Study|Withdrawal by Subject|319|||
143193627|NCT01126437|516253455|FG000|Overall Study|Other reason not specified|210|||
143193628|NCT01126437|516253456|FG001|Overall Study|Other reason not specified|176|||
143193629|NCT01126437|516253457|FG002|Overall Study|Other reason not specified|178|||
143193630|NCT00006046|516253469|FG000|Overall Study|Adverse Event|3|||
143193631|NCT00006046|516253470|FG001|Overall Study|Adverse Event|0|||
143193632|NCT00006046|516253471|FG002|Overall Study|Adverse Event|0|||
143193633|NCT00006046|516253472|FG003|Overall Study|Adverse Event|0|||
143193634|NCT00006046|516253473|FG004|Overall Study|Adverse Event|0|||
143193635|NCT00006046|516253469|FG000|Overall Study|Disease Progression|2|||
143193636|NCT00006046|516253470|FG001|Overall Study|Disease Progression|0|||
143193637|NCT00006046|516253471|FG002|Overall Study|Disease Progression|0|||
143193638|NCT00006046|516253472|FG003|Overall Study|Disease Progression|0|||
143193639|NCT00006046|516253473|FG004|Overall Study|Disease Progression|0|||
143193640|NCT01972308|516253474|FG000|Overall Study|Withdrawal by Subject|0|||
143193641|NCT01972308|516253475|FG001|Overall Study|Withdrawal by Subject|1|||
143193642|NCT01972308|516253474|FG000|Overall Study|Lost to Follow-up|4|||
143193643|NCT01972308|516253475|FG001|Overall Study|Lost to Follow-up|6|||
143193644|NCT01972308|516253474|FG000|Overall Study|Death|4|||
143193645|NCT01972308|516253475|FG001|Overall Study|Death|1|||
143193646|NCT00596154|516253476|FG000|Overall Study|Not Evaluable|2|||
143193647|NCT01846663|516253481|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
143193648|NCT01846663|516253482|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
143193649|NCT01846663|516253481|FG000|Overall Study|Withdrawal by Subject|1|||
143193650|NCT01846663|516253482|FG001|Overall Study|Withdrawal by Subject|0|||
143193651|NCT01846663|516253481|FG000|Overall Study|Adverse Event|1|||
143193652|NCT01846663|516253482|FG001|Overall Study|Adverse Event|2|||
143193653|NCT02851797|516253490|FG000|Overall Study|Withdrawal by Subject|4|||
143193654|NCT02851797|516253491|FG001|Overall Study|Withdrawal by Subject|2|||
143193655|NCT02851797|516253490|FG000|Overall Study|Adverse Event|3|||
143193656|NCT02851797|516253491|FG001|Overall Study|Adverse Event|0|||
143193657|NCT00813865|516253492|FG000|Overall Study|Failure to Respond|3|||
143193658|NCT00813865|516253492|FG000|Overall Study|Lost to Follow-up|3|||
143193659|NCT00813865|516253492|FG000|Overall Study|Withdrawal by Subject|1|||
143193660|NCT02256384|516253494|FG000|Overall Study|Withdrawal by Subject|12|||
143193661|NCT02256384|516253494|FG000|Overall Study|Equipment not capturing data|2|||
143193662|NCT00624585|516253506|FG000|Overall Study|Death|3|||
143193663|NCT00624585|516253506|FG000|Overall Study|Disease Progression|6|||
143193664|NCT00624585|516253506|FG000|Overall Study|Adverse Event|3|||
143193665|NCT01425359|516253511|FG000|Overall Study|Randomized but Not Treated|2|||
143193666|NCT01425359|516253512|FG001|Overall Study|Randomized but Not Treated|3|||
143369641|NCT02698241|516896184|FG000|Overall Study|geographic and licensing issue|1|||
143369642|NCT02698241|516896184|FG000|Overall Study|Death|2|||
143193667|NCT01425359|516253511|FG000|Overall Study|Adverse Event|9|||
143369643|NCT00906282|516896185|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
143369644|NCT00906282|516896185|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
143369645|NCT00906282|516896185|FG000|Preoperative Chemotherapy|Progressive disease|6|||
143193668|NCT01425359|516253512|FG001|Overall Study|Adverse Event|8|||
143193669|NCT01425359|516253511|FG000|Overall Study|Revascularization|0|||
143193670|NCT01425359|516253512|FG001|Overall Study|Revascularization|1|||
143193671|NCT01425359|516253511|FG000|Overall Study|Death|0|||
143193672|NCT01425359|516253512|FG001|Overall Study|Death|1|||
143193673|NCT01425359|516253511|FG000|Overall Study|Unsatisfactory Response|1|||
143193674|NCT01425359|516253512|FG001|Overall Study|Unsatisfactory Response|0|||
143193675|NCT01425359|516253511|FG000|Overall Study|Protocol Violation|1|||
143193676|NCT01425359|516253512|FG001|Overall Study|Protocol Violation|2|||
143193677|NCT01425359|516253511|FG000|Overall Study|Subject Withdrew Consent|1|||
143193678|NCT01425359|516253512|FG001|Overall Study|Subject Withdrew Consent|2|||
143193679|NCT01425359|516253511|FG000|Overall Study|Investigator's Discretion|2|||
143193680|NCT01425359|516253512|FG001|Overall Study|Investigator's Discretion|0|||
143193681|NCT01425359|516253511|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
143193682|NCT01425359|516253512|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
143193683|NCT01229254|516253523|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
143193684|NCT01229254|516253524|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
143193685|NCT01229254|516253525|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
143193686|NCT01229254|516253523|FG000|Overall Study|Adverse Event|4|||
143193687|NCT01229254|516253524|FG001|Overall Study|Adverse Event|5|||
143193688|NCT01229254|516253525|FG002|Overall Study|Adverse Event|3|||
143193689|NCT01229254|516253523|FG000|Overall Study|Lost to Follow-up|3|||
143193690|NCT01229254|516253524|FG001|Overall Study|Lost to Follow-up|0|||
143193691|NCT01229254|516253525|FG002|Overall Study|Lost to Follow-up|1|||
143193692|NCT01229254|516253523|FG000|Overall Study|Physician Decision|0|||
143193693|NCT01229254|516253524|FG001|Overall Study|Physician Decision|3|||
143193694|NCT01229254|516253525|FG002|Overall Study|Physician Decision|0|||
143193695|NCT01229254|516253523|FG000|Overall Study|Protocol Violation|4|||
143193696|NCT01229254|516253524|FG001|Overall Study|Protocol Violation|6|||
143193697|NCT01229254|516253525|FG002|Overall Study|Protocol Violation|5|||
143193698|NCT01229254|516253523|FG000|Overall Study|Withdrawal by Subject|1|||
143193699|NCT01229254|516253524|FG001|Overall Study|Withdrawal by Subject|0|||
143193700|NCT01229254|516253525|FG002|Overall Study|Withdrawal by Subject|1|||
143193701|NCT01229254|516253523|FG000|Overall Study|Non-compliance with Study Drug|0|||
143193702|NCT01229254|516253524|FG001|Overall Study|Non-compliance with Study Drug|1|||
143193703|NCT01229254|516253525|FG002|Overall Study|Non-compliance with Study Drug|1|||
143193704|NCT02186652|516253528|FG000|Overall Study|Lost to Follow-up|2|||
143193705|NCT02186652|516253529|FG001|Overall Study|Lost to Follow-up|0|||
143193706|NCT00503776|516253530|FG000|Overall Study|Withdrawal by Subject|1|||
143193707|NCT00503776|516253531|FG001|Overall Study|Withdrawal by Subject|0|||
143193708|NCT00503776|516253532|FG002|Overall Study|Withdrawal by Subject|1|||
143193709|NCT00503776|516253533|FG003|Overall Study|Withdrawal by Subject|1|||
143193710|NCT00503776|516253530|FG000|Overall Study|Physician Decision|0|||
143193711|NCT00503776|516253531|FG001|Overall Study|Physician Decision|0|||
143193712|NCT00503776|516253532|FG002|Overall Study|Physician Decision|1|||
143193713|NCT00503776|516253533|FG003|Overall Study|Physician Decision|1|||
143193714|NCT02247011|516253538|FG000|Overall Study|Poor quality of radiological results|125|||
143193715|NCT02901054|516253540|FG000|Overall Study|Physician Decision|1|||
143193716|NCT02901054|516253540|FG000|Overall Study|Withdrawal by Subject|3|||
143193717|NCT01453205|516253543|FG000|Overall Study|Lost to Follow-up|3|||
143193718|NCT01453205|516253544|FG001|Overall Study|Lost to Follow-up|0|||
143193719|NCT01453205|516253545|FG002|Overall Study|Lost to Follow-up|1|||
143193720|NCT01453205|516253543|FG000|Overall Study|Withdrawal by Subject|8|||
143193721|NCT01453205|516253544|FG001|Overall Study|Withdrawal by Subject|3|||
143193722|NCT01453205|516253545|FG002|Overall Study|Withdrawal by Subject|0|||
143193723|NCT01453205|516253543|FG000|Overall Study|Death|24|||
143193724|NCT01453205|516253544|FG001|Overall Study|Death|22|||
143193725|NCT01453205|516253545|FG002|Overall Study|Death|18|||
143193726|NCT01453205|516253543|FG000|Overall Study|Other|45|||
143193727|NCT01453205|516253544|FG001|Overall Study|Other|27|||
143193728|NCT01453205|516253545|FG002|Overall Study|Other|35|||
143193729|NCT05593913|516253548|FG000|Overall Study|Insufficient image quality|39|||
143193730|NCT03989349|516253551|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
143193731|NCT03989349|516253552|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
143193732|NCT03989349|516253553|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
143193733|NCT03989349|516253554|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
143193734|NCT03989349|516253555|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
143193735|NCT03989349|516253556|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
143193736|NCT03989349|516253551|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
143193737|NCT03989349|516253552|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
143261554|NCT01975831|516510607|FG001|Overall Study|Death|1|||
143193738|NCT03989349|516253553|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
143193739|NCT03989349|516253554|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
143193740|NCT03989349|516253555|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
143193741|NCT03989349|516253556|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
143193742|NCT03989349|516253551|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
143193743|NCT03989349|516253552|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
143193744|NCT03989349|516253553|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
143193745|NCT03989349|516253554|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
143193746|NCT03989349|516253555|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
143193747|NCT03989349|516253556|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
143193748|NCT03989349|516253551|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
143193749|NCT03989349|516253552|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
143193750|NCT03989349|516253553|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
143193751|NCT03989349|516253554|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
143193752|NCT03989349|516253555|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
143193753|NCT03989349|516253556|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
143193754|NCT03989349|516253551|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
143193755|NCT03989349|516253552|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
143193756|NCT03989349|516253553|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
143193757|NCT03989349|516253554|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
143193758|NCT03989349|516253555|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
143193759|NCT03989349|516253556|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
143193760|NCT03989349|516253551|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
143193761|NCT03989349|516253552|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
143193762|NCT03989349|516253553|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
143193763|NCT03989349|516253554|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
143193764|NCT03989349|516253555|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
143193765|NCT03989349|516253556|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
143193766|NCT03989349|516253551|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
143193767|NCT03989349|516253552|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
143193768|NCT03989349|516253553|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
143193769|NCT03989349|516253554|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
143193770|NCT03989349|516253555|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
143193771|NCT03989349|516253556|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
143193772|NCT03989349|516253551|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
143193773|NCT03989349|516253552|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
143193774|NCT03989349|516253553|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
143193775|NCT03989349|516253554|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
143193776|NCT03989349|516253555|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
143193777|NCT03989349|516253556|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
143193778|NCT03989349|516253551|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
143193779|NCT03989349|516253552|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
143193780|NCT03989349|516253553|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
143193781|NCT03989349|516253554|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
143193782|NCT03989349|516253555|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
143193783|NCT03989349|516253556|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
143193784|NCT03989349|516253551|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
143193785|NCT03989349|516253552|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
143261555|NCT01975831|516510608|FG002|Overall Study|Death|0|||
143193786|NCT03989349|516253553|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
143193787|NCT03989349|516253554|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
143193788|NCT03989349|516253555|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
143193789|NCT03989349|516253556|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
143193790|NCT03989349|516253551|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
143193791|NCT03989349|516253552|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
143193792|NCT03989349|516253553|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
143193793|NCT03989349|516253554|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
143193794|NCT03989349|516253555|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
143193795|NCT03989349|516253556|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
143193796|NCT03989349|516253551|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
143193797|NCT03989349|516253552|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
143261556|NCT01975831|516510609|FG003|Overall Study|Death|0|||
143261557|NCT01975831|516510610|FG004|Overall Study|Death|1|||
143261558|NCT01975831|516510611|FG005|Overall Study|Death|0|||
143261559|NCT01975831|516510612|FG006|Overall Study|Death|1|||
143261560|NCT01975831|516510613|FG007|Overall Study|Death|0|||
143193798|NCT03989349|516253553|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
143193799|NCT03989349|516253554|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
143193800|NCT03989349|516253555|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
143193801|NCT03989349|516253556|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
143193802|NCT03989349|516253551|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
143193803|NCT03989349|516253552|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
143193804|NCT03989349|516253553|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
143193805|NCT03989349|516253554|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
143193806|NCT03989349|516253555|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
143193807|NCT03989349|516253556|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
143193808|NCT03989349|516253551|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
143193809|NCT03989349|516253552|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
143193810|NCT03989349|516253553|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
143193811|NCT03989349|516253554|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
143193812|NCT03989349|516253555|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
143193813|NCT03989349|516253556|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
143193814|NCT03219034|516253557|FG000|Overall Study|Lost to Follow-up|9|||
143193815|NCT03219034|516253558|FG001|Overall Study|Lost to Follow-up|13|||
143193816|NCT03219034|516253557|FG000|Overall Study|Additional dental work needed|1|||
143193817|NCT03219034|516253558|FG001|Overall Study|Additional dental work needed|0|||
143193818|NCT03219034|516253557|FG000|Overall Study|UPPP Surgery|1|||
143193819|NCT03219034|516253558|FG001|Overall Study|UPPP Surgery|0|||
143193820|NCT03219034|516253557|FG000|Overall Study|Dental sensitivity|0|||
143193821|NCT03219034|516253558|FG001|Overall Study|Dental sensitivity|1|||
143193822|NCT03219034|516253557|FG000|Overall Study|Death in family|0|||
143193823|NCT03219034|516253558|FG001|Overall Study|Death in family|1|||
143193824|NCT01802580|516253559|FG000|Overall Study|Physician Decision|1|||
143193825|NCT01802580|516253560|FG001|Overall Study|Physician Decision|0|||
143193826|NCT01802580|516253559|FG000|Overall Study|Protocol Violation|2|||
143193827|NCT01802580|516253560|FG001|Overall Study|Protocol Violation|0|||
143193828|NCT01802580|516253559|FG000|Overall Study|Withdrawal by Subject|5|||
143193829|NCT01802580|516253560|FG001|Overall Study|Withdrawal by Subject|6|||
143193830|NCT01802580|516253559|FG000|Overall Study|Other|1|||
143193831|NCT01802580|516253560|FG001|Overall Study|Other|3|||
143193832|NCT01802580|516253559|FG000|Overall Study|Lack of Efficacy|0|||
143193833|NCT01802580|516253560|FG001|Overall Study|Lack of Efficacy|2|||
143193834|NCT02438683|516253561|FG000|Overall Study|Adverse Event|1|||
143193835|NCT02438683|516253562|FG001|Overall Study|Adverse Event|0|||
143193836|NCT02438683|516253563|FG002|Overall Study|Adverse Event|0|||
143193837|NCT02438683|516253564|FG003|Overall Study|Adverse Event|0|||
143193838|NCT02438683|516253565|FG004|Overall Study|Adverse Event|0|||
143193839|NCT02438683|516253566|FG005|Overall Study|Adverse Event|0|||
143193840|NCT02136680|516253569|FG000|Overall Study|No Longer Interested|1|||
143193841|NCT02136680|516253570|FG001|Overall Study|No Longer Interested|1|||
143193842|NCT02136680|516253569|FG000|Overall Study|No longer receiving care at clinic|3|||
143193843|NCT02136680|516253570|FG001|Overall Study|No longer receiving care at clinic|5|||
143193844|NCT02136680|516253569|FG000|Overall Study|Moved away|5|||
143193845|NCT02136680|516253570|FG001|Overall Study|Moved away|4|||
143193846|NCT02136680|516253569|FG000|Overall Study|Unable to schedule|17|||
143193847|NCT02136680|516253570|FG001|Overall Study|Unable to schedule|16|||
143193848|NCT02136680|516253569|FG000|Overall Study|Study ended before interview due|6|||
143193849|NCT02136680|516253570|FG001|Overall Study|Study ended before interview due|3|||
143193850|NCT01846299|516253575|FG000|Overall Study|Physician Decision|4|||
143193851|NCT01846299|516253576|FG001|Overall Study|Physician Decision|2|||
143193852|NCT01846299|516253575|FG000|Overall Study|Protocol deviation|1|||
143193853|NCT01846299|516253576|FG001|Overall Study|Protocol deviation|0|||
143193854|NCT01846299|516253575|FG000|Overall Study|Death|1|||
143193855|NCT01846299|516253576|FG001|Overall Study|Death|2|||
143193856|NCT01846299|516253575|FG000|Overall Study|Lost to Follow-up|3|||
143193857|NCT01846299|516253576|FG001|Overall Study|Lost to Follow-up|0|||
143193858|NCT01846299|516253575|FG000|Overall Study|Withdrawal by Subject|1|||
143193859|NCT01846299|516253576|FG001|Overall Study|Withdrawal by Subject|6|||
143193860|NCT01846299|516253575|FG000|Overall Study|Adverse Event|2|||
143193861|NCT01846299|516253576|FG001|Overall Study|Adverse Event|0|||
143193862|NCT03559517|516253577|FG000|Overall Study|Withdrawal by Subject|1|||
143193863|NCT03559517|516253578|FG001|Overall Study|Withdrawal by Subject|0|||
143193864|NCT03559517|516253579|FG002|Overall Study|Withdrawal by Subject|0|||
143369646|NCT00906282|516896185|FG000|Preoperative Chemotherapy|Toxicity|1|||
143193865|NCT05243745|516255529|FG000|Overall Study|Withdrawal by Subject|0|||
143193866|NCT05243745|516255530|FG001|Overall Study|Withdrawal by Subject|0|||
143193867|NCT05243745|516255531|FG002|Overall Study|Withdrawal by Subject|0|||
143193868|NCT05243745|516255532|FG003|Overall Study|Withdrawal by Subject|1|||
143193869|NCT05243745|516255529|FG000|Overall Study|Unable to Attend Visit 6|0|||
143193870|NCT05243745|516255530|FG001|Overall Study|Unable to Attend Visit 6|0|||
143193871|NCT05243745|516255531|FG002|Overall Study|Unable to Attend Visit 6|1|||
143193872|NCT05243745|516255532|FG003|Overall Study|Unable to Attend Visit 6|0|||
143193873|NCT04187144|516255543|FG000|Overall Study|Lost to Follow-up|12|||
143193874|NCT04187144|516255544|FG001|Overall Study|Lost to Follow-up|11|||
143193875|NCT04187144|516255543|FG000|Overall Study|Withdrawal by Subject|20|||
143193876|NCT04187144|516255544|FG001|Overall Study|Withdrawal by Subject|18|||
143193877|NCT04187144|516255543|FG000|Overall Study|Adverse Event|19|||
143193878|NCT04187144|516255544|FG001|Overall Study|Adverse Event|4|||
143193879|NCT04187144|516255543|FG000|Overall Study|Physician Decision|5|||
143193880|NCT04187144|516255544|FG001|Overall Study|Physician Decision|3|||
143193881|NCT04187144|516255543|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
143193882|NCT04187144|516255544|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
143193883|NCT04187144|516255543|FG000|Overall Study|Protocol Deviation|1|||
143193884|NCT04187144|516255544|FG001|Overall Study|Protocol Deviation|4|||
143193885|NCT03842969|516255545|FG000|Overall Study|Participant declined follow-up visit|0|||
143193886|NCT03842969|516255546|FG001|Overall Study|Participant declined follow-up visit|1|||
143193887|NCT03842969|516255547|FG002|Overall Study|Participant declined follow-up visit|0|||
143193888|NCT03842969|516255545|FG000|Overall Study|Sponsor's decision|12|||
143193889|NCT03842969|516255546|FG001|Overall Study|Sponsor's decision|99|||
143193890|NCT03842969|516255547|FG002|Overall Study|Sponsor's decision|61|||
143193891|NCT03842969|516255545|FG000|Overall Study|Pregnancy|0|||
143193892|NCT03842969|516255546|FG001|Overall Study|Pregnancy|0|||
143193893|NCT03842969|516255547|FG002|Overall Study|Pregnancy|1|||
143193894|NCT03842969|516255545|FG000|Overall Study|Death|1|||
143193895|NCT03842969|516255546|FG001|Overall Study|Death|0|||
143193896|NCT03842969|516255547|FG002|Overall Study|Death|1|||
143193897|NCT03842969|516255545|FG000|Overall Study|Withdrawal by Subject|3|||
143193898|NCT03842969|516255546|FG001|Overall Study|Withdrawal by Subject|30|||
143193899|NCT03842969|516255547|FG002|Overall Study|Withdrawal by Subject|18|||
143193900|NCT03842969|516255545|FG000|Overall Study|Protocol Violation|1|||
143193901|NCT03842969|516255546|FG001|Overall Study|Protocol Violation|1|||
143193902|NCT03842969|516255547|FG002|Overall Study|Protocol Violation|0|||
143193903|NCT03842969|516255545|FG000|Overall Study|Physician Decision|0|||
143193904|NCT03842969|516255546|FG001|Overall Study|Physician Decision|3|||
143193905|NCT03842969|516255547|FG002|Overall Study|Physician Decision|0|||
143193906|NCT03842969|516255545|FG000|Overall Study|Lost to Follow-up|0|||
143193907|NCT03842969|516255546|FG001|Overall Study|Lost to Follow-up|2|||
143193908|NCT03842969|516255547|FG002|Overall Study|Lost to Follow-up|0|||
143193909|NCT03842969|516255545|FG000|Overall Study|Adverse Event|0|||
143193910|NCT03842969|516255546|FG001|Overall Study|Adverse Event|2|||
143193911|NCT03842969|516255547|FG002|Overall Study|Adverse Event|0|||
143193912|NCT01468207|516255548|FG000|Treatment Period 1|Adverse Event|1|||
143193913|NCT01468207|516255549|FG001|Treatment Period 1|Adverse Event|0|||
143193914|NCT01468207|516255550|FG002|Treatment Period 1|Adverse Event|0|||
143193915|NCT01468207|516255551|FG003|Treatment Period 1|Adverse Event|0|||
143193916|NCT01468207|516255552|FG004|Treatment Period 1|Adverse Event|0|||
143193917|NCT01468207|516255553|FG005|Treatment Period 1|Adverse Event|0|||
143193918|NCT01468207|516255548|FG000|Treatment Period 1|Protocol Violation|1|||
143193919|NCT01468207|516255549|FG001|Treatment Period 1|Protocol Violation|1|||
143193920|NCT01468207|516255550|FG002|Treatment Period 1|Protocol Violation|0|||
143193921|NCT01468207|516255551|FG003|Treatment Period 1|Protocol Violation|0|||
143193922|NCT01468207|516255552|FG004|Treatment Period 1|Protocol Violation|0|||
143193923|NCT01468207|516255553|FG005|Treatment Period 1|Protocol Violation|0|||
143193924|NCT01468207|516255548|FG000|Treatment Period 1|Withdrawal by Subject|5|||
143193925|NCT01468207|516255549|FG001|Treatment Period 1|Withdrawal by Subject|4|||
143369647|NCT01278862|516896188|FG000|Overall Study|Lost to Follow-up|1|||
143193926|NCT01468207|516255550|FG002|Treatment Period 1|Withdrawal by Subject|0|||
143193927|NCT01468207|516255551|FG003|Treatment Period 1|Withdrawal by Subject|0|||
143193928|NCT01468207|516255552|FG004|Treatment Period 1|Withdrawal by Subject|0|||
143193929|NCT01468207|516255553|FG005|Treatment Period 1|Withdrawal by Subject|0|||
143193930|NCT01468207|516255548|FG000|Treatment Period 1|Lost to Follow-up|2|||
143193931|NCT01468207|516255549|FG001|Treatment Period 1|Lost to Follow-up|1|||
143193932|NCT01468207|516255550|FG002|Treatment Period 1|Lost to Follow-up|0|||
143193933|NCT01468207|516255551|FG003|Treatment Period 1|Lost to Follow-up|0|||
143193934|NCT01468207|516255552|FG004|Treatment Period 1|Lost to Follow-up|0|||
143193935|NCT01468207|516255553|FG005|Treatment Period 1|Lost to Follow-up|0|||
143193936|NCT01468207|516255548|FG000|Treatment Period 1|Other|0|||
143193937|NCT01468207|516255549|FG001|Treatment Period 1|Other|2|||
143193938|NCT01468207|516255550|FG002|Treatment Period 1|Other|0|||
143193939|NCT01468207|516255551|FG003|Treatment Period 1|Other|0|||
143193940|NCT01468207|516255552|FG004|Treatment Period 1|Other|0|||
143193941|NCT01468207|516255553|FG005|Treatment Period 1|Other|0|||
143193942|NCT01468207|516255548|FG000|Treatment Period 2|Adverse Event|0|||
143193943|NCT01468207|516255549|FG001|Treatment Period 2|Adverse Event|0|||
143193944|NCT01468207|516255550|FG002|Treatment Period 2|Adverse Event|6|||
143193945|NCT01468207|516255551|FG003|Treatment Period 2|Adverse Event|1|||
143193946|NCT01468207|516255552|FG004|Treatment Period 2|Adverse Event|2|||
143193947|NCT01468207|516255553|FG005|Treatment Period 2|Adverse Event|1|||
143193948|NCT01468207|516255548|FG000|Treatment Period 2|Lack of Efficacy|0|||
143193949|NCT01468207|516255549|FG001|Treatment Period 2|Lack of Efficacy|0|||
143193950|NCT01468207|516255550|FG002|Treatment Period 2|Lack of Efficacy|1|||
143193951|NCT01468207|516255551|FG003|Treatment Period 2|Lack of Efficacy|1|||
143193952|NCT01468207|516255552|FG004|Treatment Period 2|Lack of Efficacy|0|||
143193953|NCT01468207|516255553|FG005|Treatment Period 2|Lack of Efficacy|2|||
143193954|NCT01468207|516255548|FG000|Treatment Period 2|Withdrawal by Subject|0|||
143193955|NCT01468207|516255549|FG001|Treatment Period 2|Withdrawal by Subject|0|||
143193956|NCT01468207|516255550|FG002|Treatment Period 2|Withdrawal by Subject|5|||
143193957|NCT01468207|516255551|FG003|Treatment Period 2|Withdrawal by Subject|0|||
143193958|NCT01468207|516255552|FG004|Treatment Period 2|Withdrawal by Subject|0|||
143193959|NCT01468207|516255553|FG005|Treatment Period 2|Withdrawal by Subject|2|||
143193960|NCT01468207|516255548|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
143193961|NCT01468207|516255549|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
143193962|NCT01468207|516255550|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
143193963|NCT01468207|516255551|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
143193964|NCT01468207|516255552|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
143193965|NCT01468207|516255553|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
143193966|NCT01468207|516255548|FG000|Treatment Period 2|Lost to Follow-up|0|||
143193967|NCT01468207|516255549|FG001|Treatment Period 2|Lost to Follow-up|0|||
143193968|NCT01468207|516255550|FG002|Treatment Period 2|Lost to Follow-up|5|||
143193969|NCT01468207|516255551|FG003|Treatment Period 2|Lost to Follow-up|1|||
143193970|NCT01468207|516255552|FG004|Treatment Period 2|Lost to Follow-up|0|||
143193971|NCT01468207|516255553|FG005|Treatment Period 2|Lost to Follow-up|0|||
143193972|NCT01468207|516255548|FG000|Treatment Period 2|Other|0|||
143193973|NCT01468207|516255549|FG001|Treatment Period 2|Other|0|||
143193974|NCT01468207|516255550|FG002|Treatment Period 2|Other|5|||
143193975|NCT01468207|516255551|FG003|Treatment Period 2|Other|1|||
143193976|NCT01468207|516255552|FG004|Treatment Period 2|Other|1|||
143193977|NCT01468207|516255553|FG005|Treatment Period 2|Other|2|||
143193978|NCT00539513|516255554|FG000|Overall Study|Withdrawal by Subject|2|||
143193979|NCT00539513|516255555|FG001|Overall Study|Withdrawal by Subject|1|||
143193980|NCT00539513|516255554|FG000|Overall Study|Lost to Follow-up|0|||
143193981|NCT00539513|516255555|FG001|Overall Study|Lost to Follow-up|1|||
143193982|NCT03002818|516255556|FG000|Overall Study|Decision of the investigator|1|||
143193983|NCT01328041|516255557|FG000|Overall Study|Adverse Event|7|||
143193984|NCT01328041|516255557|FG000|Overall Study|Lack of Efficacy|27|||
143193985|NCT01328041|516255557|FG000|Overall Study|Protocol Violation|7|||
143193986|NCT01328041|516255557|FG000|Overall Study|Lost to Follow-up|7|||
143261561|NCT01975831|516510614|FG008|Overall Study|Death|0|||
143261562|NCT01975831|516510606|FG000|Overall Study|Progressive Disease|1|||
143261563|NCT01975831|516510607|FG001|Overall Study|Progressive Disease|3|||
143261564|NCT01975831|516510608|FG002|Overall Study|Progressive Disease|2|||
143193987|NCT01328041|516255557|FG000|Overall Study|Physician Decision|2|||
143193988|NCT01328041|516255557|FG000|Overall Study|Withdrawal by Subject|7|||
143193989|NCT00711113|516255558|FG000|Overall Study|Lost to Follow-up|9|||
143193990|NCT00711113|516255558|FG000|Overall Study|Implant lost|2|||
143193991|NCT02688088|516255561|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
143193992|NCT02688088|516255562|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
143193993|NCT02688088|516255563|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
143261565|NCT01975831|516510609|FG003|Overall Study|Progressive Disease|4|||
143261566|NCT01975831|516510610|FG004|Overall Study|Progressive Disease|13|||
143193994|NCT02688088|516255564|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
143193995|NCT02688088|516255565|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
143193996|NCT02688088|516255561|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
143193997|NCT02688088|516255562|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
143193998|NCT02688088|516255563|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
143193999|NCT02688088|516255564|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
143194000|NCT02688088|516255565|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
143194001|NCT02688088|516255561|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
143194002|NCT02688088|516255562|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
143194003|NCT02688088|516255563|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
143194004|NCT02688088|516255564|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
143194005|NCT02688088|516255565|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
143194006|NCT02688088|516255561|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
143194007|NCT02688088|516255562|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
143194008|NCT02688088|516255563|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
143194009|NCT02688088|516255564|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
143194010|NCT02688088|516255565|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
143194011|NCT02688088|516255561|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
143194012|NCT02688088|516255562|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
143194013|NCT02688088|516255563|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
143194014|NCT02688088|516255564|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
143194015|NCT02688088|516255565|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
143194016|NCT02688088|516255561|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
143194017|NCT02688088|516255562|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
143194018|NCT02688088|516255563|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
143194019|NCT02688088|516255564|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
143194020|NCT02688088|516255565|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
143194021|NCT02688088|516255561|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
143194022|NCT02688088|516255562|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
143194023|NCT02688088|516255563|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
143194024|NCT02688088|516255564|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
143194025|NCT02688088|516255565|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
143194026|NCT02688088|516255561|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
143194027|NCT02688088|516255562|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
143194028|NCT02688088|516255563|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
143194029|NCT02688088|516255564|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
143194030|NCT02688088|516255565|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
143194031|NCT02688088|516255561|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
143194032|NCT02688088|516255562|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
143194033|NCT02688088|516255563|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
143194034|NCT02688088|516255564|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
143194035|NCT02688088|516255565|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
143194036|NCT01231321|516255569|FG000|Overall Study|Adverse Event|3|||
143194037|NCT01231321|516255569|FG000|Overall Study|Lack of Efficacy|2|||
143194038|NCT04021524|516255570|FG000|Overall Study|Change in surgical intervention|0|||
143194039|NCT04021524|516255571|FG001|Overall Study|Change in surgical intervention|1|||
143194040|NCT00730041|516255572|FG000|Overall Study|Lost to Follow-up|0|||
143194041|NCT00730041|516255573|FG001|Overall Study|Lost to Follow-up|2|||
143369648|NCT01278862|516896189|FG001|Overall Study|Lost to Follow-up|1|||
143194042|NCT02301546|516255574|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
143194043|NCT02301546|516255575|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
143194044|NCT02301546|516255574|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
143194045|NCT02301546|516255575|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
143194046|NCT02301546|516255574|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
143194047|NCT02301546|516255575|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
143194048|NCT02301546|516255574|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
143194049|NCT02301546|516255575|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
143194050|NCT02301546|516255574|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
143194051|NCT02301546|516255575|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
143194052|NCT02301546|516255574|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
143194053|NCT02301546|516255575|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
143194054|NCT02301546|516255574|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
143194055|NCT02301546|516255575|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
143194056|NCT05526781|516255578|FG000|Overall Study|Lost to Follow-up|1|||
143194057|NCT01801436|516255581|FG000|Overall Study|Withdrawal by Subject|3|||
143194058|NCT01801436|516255581|FG000|Overall Study|Adverse Event|2|||
143194059|NCT01801436|516255581|FG000|Overall Study|Progressive disease|4|||
143194060|NCT04085458|516255582|FG000|Overall Study|Other|1|||
143194061|NCT04085458|516255582|FG000|Overall Study|Withdrawal by Subject|2|||
143194062|NCT04085458|516255582|FG000|Overall Study|Adverse Event|2|||
143194063|NCT02447250|516255583|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
143194064|NCT02447250|516255583|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
143194065|NCT02447250|516255583|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
143194066|NCT03632993|516255584|FG000|Overall Study|Withdrawal by Subject|1|||
143194067|NCT03632993|516255585|FG001|Overall Study|Withdrawal by Subject|0|||
143194068|NCT03632993|516255586|FG002|Overall Study|Withdrawal by Subject|0|||
143194069|NCT03632993|516255587|FG003|Overall Study|Withdrawal by Subject|0|||
143194070|NCT03632993|516255588|FG004|Overall Study|Withdrawal by Subject|0|||
143194071|NCT03632993|516255589|FG005|Overall Study|Withdrawal by Subject|0|||
143194072|NCT03632993|516255590|FG006|Overall Study|Withdrawal by Subject|0|||
143194073|NCT03632993|516255591|FG007|Overall Study|Withdrawal by Subject|0|||
143194074|NCT03632993|516255592|FG008|Overall Study|Withdrawal by Subject|0|||
143194075|NCT03632993|516255593|FG009|Overall Study|Withdrawal by Subject|1|||
143194076|NCT03632993|516255584|FG000|Overall Study|Protocol Non-compliance|0|||
143194077|NCT03632993|516255585|FG001|Overall Study|Protocol Non-compliance|1|||
143194078|NCT03632993|516255586|FG002|Overall Study|Protocol Non-compliance|0|||
143194079|NCT03632993|516255587|FG003|Overall Study|Protocol Non-compliance|0|||
143194080|NCT03632993|516255588|FG004|Overall Study|Protocol Non-compliance|0|||
143194081|NCT03632993|516255589|FG005|Overall Study|Protocol Non-compliance|0|||
143194082|NCT03632993|516255590|FG006|Overall Study|Protocol Non-compliance|0|||
143194083|NCT03632993|516255591|FG007|Overall Study|Protocol Non-compliance|0|||
143194084|NCT03632993|516255592|FG008|Overall Study|Protocol Non-compliance|0|||
143194085|NCT03632993|516255593|FG009|Overall Study|Protocol Non-compliance|0|||
143194086|NCT03632993|516255584|FG000|Overall Study|Lost to Follow-up|0|||
143194087|NCT03632993|516255585|FG001|Overall Study|Lost to Follow-up|0|||
143194088|NCT03632993|516255586|FG002|Overall Study|Lost to Follow-up|0|||
143194089|NCT03632993|516255587|FG003|Overall Study|Lost to Follow-up|0|||
143194090|NCT03632993|516255588|FG004|Overall Study|Lost to Follow-up|0|||
143194091|NCT03632993|516255589|FG005|Overall Study|Lost to Follow-up|1|||
143194092|NCT03632993|516255590|FG006|Overall Study|Lost to Follow-up|0|||
143194093|NCT03632993|516255591|FG007|Overall Study|Lost to Follow-up|1|||
143194094|NCT03632993|516255592|FG008|Overall Study|Lost to Follow-up|0|||
143194095|NCT03632993|516255593|FG009|Overall Study|Lost to Follow-up|0|||
143194096|NCT03632993|516255584|FG000|Overall Study|Adverse Event|0|||
143194097|NCT03632993|516255585|FG001|Overall Study|Adverse Event|0|||
143194098|NCT03632993|516255586|FG002|Overall Study|Adverse Event|0|||
143194099|NCT03632993|516255587|FG003|Overall Study|Adverse Event|0|||
143194100|NCT03632993|516255588|FG004|Overall Study|Adverse Event|0|||
143194101|NCT03632993|516255589|FG005|Overall Study|Adverse Event|1|||
143194102|NCT03632993|516255590|FG006|Overall Study|Adverse Event|0|||
143194103|NCT03632993|516255591|FG007|Overall Study|Adverse Event|1|||
143194104|NCT03632993|516255592|FG008|Overall Study|Adverse Event|0|||
143194105|NCT03632993|516255593|FG009|Overall Study|Adverse Event|0|||
143194106|NCT01032291|516255594|FG000|Safety Lead-in|Adverse Event|1|||
143261567|NCT01975831|516510611|FG005|Overall Study|Progressive Disease|9|||
143261568|NCT01975831|516510612|FG006|Overall Study|Progressive Disease|10|||
143261569|NCT01975831|516510613|FG007|Overall Study|Progressive Disease|8|||
143261570|NCT01975831|516510614|FG008|Overall Study|Progressive Disease|10|||
143261571|NCT01975831|516510606|FG000|Overall Study|Withdrawal by Subject|0|||
143261572|NCT01975831|516510607|FG001|Overall Study|Withdrawal by Subject|3|||
143261573|NCT01975831|516510608|FG002|Overall Study|Withdrawal by Subject|0|||
143261574|NCT01975831|516510609|FG003|Overall Study|Withdrawal by Subject|0|||
143261575|NCT01975831|516510610|FG004|Overall Study|Withdrawal by Subject|3|||
143261576|NCT01975831|516510611|FG005|Overall Study|Withdrawal by Subject|1|||
143261577|NCT01975831|516510612|FG006|Overall Study|Withdrawal by Subject|1|||
143194107|NCT01032291|516255595|FG001|Safety Lead-in|Adverse Event|0|||
143194108|NCT01032291|516255596|FG002|Safety Lead-in|Adverse Event|0|||
143261578|NCT01975831|516510613|FG007|Overall Study|Withdrawal by Subject|0|||
143369649|NCT00603447|516896190|FG000|Overall Study|Adverse Event|0|||
143194109|NCT01032291|516255594|FG000|Safety Lead-in|Death|1|||
143194110|NCT01032291|516255595|FG001|Safety Lead-in|Death|0|||
143194111|NCT01032291|516255596|FG002|Safety Lead-in|Death|0|||
143194112|NCT01032291|516255594|FG000|Proof of Concept|Adverse Event|0|||
143194113|NCT01032291|516255595|FG001|Proof of Concept|Adverse Event|5|||
143194114|NCT01032291|516255596|FG002|Proof of Concept|Adverse Event|1|||
143194115|NCT01032291|516255594|FG000|Proof of Concept|Death|0|||
143194116|NCT01032291|516255595|FG001|Proof of Concept|Death|1|||
143261579|NCT01975831|516510614|FG008|Overall Study|Withdrawal by Subject|0|||
143194117|NCT01032291|516255596|FG002|Proof of Concept|Death|2|||
143194118|NCT01032291|516255594|FG000|Proof of Concept|Lack of Efficacy|0|||
143194119|NCT01032291|516255595|FG001|Proof of Concept|Lack of Efficacy|1|||
143194120|NCT01032291|516255596|FG002|Proof of Concept|Lack of Efficacy|0|||
143194121|NCT01032291|516255594|FG000|Proof of Concept|Never Received Study Drug|0|||
143194122|NCT01032291|516255595|FG001|Proof of Concept|Never Received Study Drug|1|||
143194123|NCT01032291|516255596|FG002|Proof of Concept|Never Received Study Drug|0|||
143194124|NCT02449889|516255597|FG000|Overall Study|Adverse Event|1|||
143194125|NCT02449889|516255598|FG001|Overall Study|Adverse Event|2|||
143194126|NCT02449889|516255599|FG002|Overall Study|Adverse Event|0|||
143194127|NCT02449889|516255597|FG000|Overall Study|Protocol Violation|0|||
143194128|NCT02449889|516255598|FG001|Overall Study|Protocol Violation|4|||
143194129|NCT02449889|516255599|FG002|Overall Study|Protocol Violation|1|||
143194130|NCT01973387|516255600|FG000|Overall Study|Adverse Event|14|||
143194131|NCT01973387|516255601|FG001|Overall Study|Adverse Event|4|||
143194132|NCT01973387|516255600|FG000|Overall Study|Withdrawal by Subject|7|||
143194133|NCT01973387|516255601|FG001|Overall Study|Withdrawal by Subject|4|||
143194134|NCT01973387|516255600|FG000|Overall Study|Study terminated by sponsor|63|||
143194135|NCT01973387|516255601|FG001|Overall Study|Study terminated by sponsor|0|||
143194136|NCT01973387|516255600|FG000|Overall Study|Progressive disease or relapse|16|||
143194137|NCT01973387|516255601|FG001|Overall Study|Progressive disease or relapse|5|||
143194138|NCT01973387|516255600|FG000|Overall Study|Death|4|||
143194139|NCT01973387|516255601|FG001|Overall Study|Death|3|||
143194140|NCT01973387|516255600|FG000|Overall Study|Randomized, not treated|2|||
143194141|NCT01973387|516255601|FG001|Overall Study|Randomized, not treated|2|||
143194142|NCT03327220|516255602|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
143194143|NCT03327220|516255603|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
143194144|NCT03327220|516255602|FG000|Overall Study|Investigator Decision|2|||
143194145|NCT03327220|516255603|FG001|Overall Study|Investigator Decision|0|||
143194146|NCT03327220|516255602|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
143194147|NCT03327220|516255603|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
143194148|NCT03327220|516255602|FG000|Overall Study|Fungal infection|1|||
143194149|NCT03327220|516255603|FG001|Overall Study|Fungal infection|0|||
143194150|NCT03327220|516255602|FG000|Overall Study|Discharged to Rehabilitation|0|||
143194151|NCT03327220|516255603|FG001|Overall Study|Discharged to Rehabilitation|1|||
143194152|NCT03327220|516255602|FG000|Overall Study|Missing|1|||
143194153|NCT03327220|516255603|FG001|Overall Study|Missing|0|||
143194154|NCT01498575|516255604|FG000|Overall Sample|Withdrawal by Subject|60|||
143194155|NCT01498575|516255605|FG001|Overall Sample|Withdrawal by Subject|14|||
143194156|NCT01498575|516255604|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
143194157|NCT01498575|516255605|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
143194158|NCT01498575|516255604|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
143194159|NCT01498575|516255605|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
143194160|NCT00693017|516255607|FG000|Overall Study|Sponsor Decision|2|||
143194161|NCT00693017|516255608|FG001|Overall Study|Sponsor Decision|1|||
143194162|NCT00693017|516255607|FG000|Overall Study|Death|0|||
143194163|NCT00693017|516255608|FG001|Overall Study|Death|1|||
143194164|NCT00688324|516255610|FG000|Overall Study|Withdrawal by Subject|2|||
143194165|NCT00688324|516255610|FG000|Overall Study|Physician Decision|5|||
143194166|NCT00688324|516255610|FG000|Overall Study|Lost to Follow-up|1|||
143194167|NCT03272828|516255611|FG000|Overall Study|Lost to Follow-up|7|||
143261580|NCT01975831|516510606|FG000|Overall Study|Physician Decision|0|||
143261581|NCT01975831|516510607|FG001|Overall Study|Physician Decision|0|||
143261582|NCT01975831|516510608|FG002|Overall Study|Physician Decision|0|||
143261583|NCT01975831|516510609|FG003|Overall Study|Physician Decision|0|||
143261584|NCT01975831|516510610|FG004|Overall Study|Physician Decision|0|||
143194168|NCT03272828|516255612|FG001|Overall Study|Lost to Follow-up|7|||
143194169|NCT03272828|516255611|FG000|Overall Study|Withdrawal by Subject|2|||
143194170|NCT03272828|516255612|FG001|Overall Study|Withdrawal by Subject|0|||
143194171|NCT03272828|516255611|FG000|Overall Study|Deceased|1|||
143194172|NCT03272828|516255612|FG001|Overall Study|Deceased|1|||
143261585|NCT01975831|516510611|FG005|Overall Study|Physician Decision|1|||
143261586|NCT01975831|516510612|FG006|Overall Study|Physician Decision|0|||
143194173|NCT03272828|516255611|FG000|Overall Study|Failed implant|1|||
143194174|NCT03272828|516255612|FG001|Overall Study|Failed implant|2|||
143194175|NCT03176472|516255613|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
143194176|NCT03176472|516255614|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
143194177|NCT03176472|516255613|FG000|Double Blind Treatment Period|Adverse Event|0|||
143194178|NCT03176472|516255614|FG001|Double Blind Treatment Period|Adverse Event|5|||
143194179|NCT03176472|516255613|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
143194180|NCT03176472|516255614|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
143194181|NCT03176472|516255613|FG000|Double Blind Treatment Period|Physician Decision|0|||
143261587|NCT01975831|516510613|FG007|Overall Study|Physician Decision|1|||
143194182|NCT03176472|516255614|FG001|Double Blind Treatment Period|Physician Decision|1|||
143194183|NCT03176472|516255613|FG000|Double Blind Treatment Period|Protocol Violation|1|||
143194184|NCT03176472|516255614|FG001|Double Blind Treatment Period|Protocol Violation|0|||
143194185|NCT03176472|516255613|FG000|Double Blind Treatment Period|Not Provided|1|||
143194186|NCT03176472|516255614|FG001|Double Blind Treatment Period|Not Provided|0|||
143194187|NCT03176472|516255613|FG000|Open Label Extension|Withdrawal by Subject|3|||
143194188|NCT03176472|516255614|FG001|Open Label Extension|Withdrawal by Subject|4|||
143194189|NCT03176472|516255613|FG000|Open Label Extension|Adverse Event|2|||
143194190|NCT03176472|516255614|FG001|Open Label Extension|Adverse Event|4|||
143194191|NCT03176472|516255613|FG000|Open Label Extension|Lost to Follow-up|1|||
143194192|NCT03176472|516255614|FG001|Open Label Extension|Lost to Follow-up|2|||
143194193|NCT03176472|516255613|FG000|Open Label Extension|Protocol Violation|0|||
143194194|NCT03176472|516255614|FG001|Open Label Extension|Protocol Violation|1|||
143194195|NCT03176472|516255613|FG000|Open Label Extension|Not Provided|2|||
143194196|NCT03176472|516255614|FG001|Open Label Extension|Not Provided|1|||
143194197|NCT00642369|516255615|FG000|Overall Study|Adverse Event|2|||
143194198|NCT00642369|516255616|FG001|Overall Study|Adverse Event|3|||
143194199|NCT00642369|516255615|FG000|Overall Study|Withdrawal by Subject|1|||
143194200|NCT00642369|516255616|FG001|Overall Study|Withdrawal by Subject|0|||
143194201|NCT00642369|516255615|FG000|Overall Study|misdiagnosis|0|||
143194202|NCT00642369|516255616|FG001|Overall Study|misdiagnosis|1|||
143194203|NCT00642369|516255615|FG000|Overall Study|Lack of Efficacy|2|||
143194204|NCT00642369|516255616|FG001|Overall Study|Lack of Efficacy|2|||
143194205|NCT00847665|516255617|FG000|Overall Study|Withdrawal by Subject|1|||
143194206|NCT00847665|516255618|FG001|Overall Study|Withdrawal by Subject|0|||
143194207|NCT04295681|516255619|FG000|Overall Study|Eligibility error|1|||
143194208|NCT04295681|516255620|FG001|Overall Study|Eligibility error|3|||
143194209|NCT01535599|516255621|FG000|Overall Study|Adverse Event|6|||
143194210|NCT01535599|516255622|FG001|Overall Study|Adverse Event|15|||
143194211|NCT01535599|516255621|FG000|Overall Study|Lost to Follow-up|3|||
143194212|NCT01535599|516255622|FG001|Overall Study|Lost to Follow-up|4|||
143194213|NCT01535599|516255621|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
143194214|NCT01535599|516255622|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
143194215|NCT01535599|516255621|FG000|Overall Study|Treatment Failure|33|||
143194216|NCT01535599|516255622|FG001|Overall Study|Treatment Failure|66|||
143194217|NCT01535599|516255621|FG000|Overall Study|BL Culture + for Group A Strep|0|||
143194218|NCT01535599|516255622|FG001|Overall Study|BL Culture + for Group A Strep|1|||
143194219|NCT01535599|516255621|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
143194220|NCT01535599|516255622|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
143194221|NCT01535599|516255621|FG000|Overall Study|Randomized in Error|2|||
143194222|NCT01535599|516255622|FG001|Overall Study|Randomized in Error|4|||
143194223|NCT01535599|516255621|FG000|Overall Study|Did not use product|1|||
143194224|NCT01535599|516255622|FG001|Overall Study|Did not use product|0|||
143194225|NCT01535599|516255621|FG000|Overall Study|Other|1|||
143194226|NCT01535599|516255622|FG001|Overall Study|Other|0|||
143194227|NCT01535599|516255621|FG000|Overall Study|Stopped medication|0|||
143194228|NCT01535599|516255622|FG001|Overall Study|Stopped medication|1|||
143194229|NCT01535599|516255621|FG000|Overall Study|Noncompliance|0|||
143194230|NCT01535599|516255622|FG001|Overall Study|Noncompliance|1|||
143194231|NCT03172325|516255623|FG000|Overall Study|Adverse Event|2|||
143194232|NCT03172325|516255624|FG001|Overall Study|Adverse Event|3|||
143194233|NCT03172325|516255623|FG000|Overall Study|Positive PPD|1|||
143194234|NCT03172325|516255624|FG001|Overall Study|Positive PPD|0|||
143194235|NCT03172325|516255623|FG000|Overall Study|Poor Compliance|1|||
143194236|NCT03172325|516255624|FG001|Overall Study|Poor Compliance|1|||
143194237|NCT01694121|516255626|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
143194238|NCT01694121|516255627|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
143194239|NCT00744978|516255628|FG000|Period 1|Lost to Follow-up|1|||
143194240|NCT00744978|516255629|FG001|Period 1|Lost to Follow-up|0|||
143194241|NCT00744978|516255628|FG000|Period 1|Withdrawal by Subject|0|||
143194242|NCT00744978|516255629|FG001|Period 1|Withdrawal by Subject|2|||
143194243|NCT00744978|516255628|FG000|Period 1|Other|0|||
143194244|NCT00744978|516255629|FG001|Period 1|Other|2|||
143194245|NCT00744978|516255628|FG000|Period 1|Adverse Event|4|||
143261588|NCT01975831|516510614|FG008|Overall Study|Physician Decision|0|||
143261589|NCT01975831|516510606|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
143194246|NCT00744978|516255629|FG001|Period 1|Adverse Event|0|||
143261590|NCT01975831|516510607|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
143261591|NCT01975831|516510608|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
143194247|NCT00744978|516255628|FG000|Period 1|Randomized but not Treated|1|||
143194248|NCT00744978|516255629|FG001|Period 1|Randomized but not Treated|1|||
143194249|NCT00744978|516255628|FG000|Period 2|Adverse Event|0|||
143194250|NCT00744978|516255629|FG001|Period 2|Adverse Event|1|||
143194251|NCT05427539|516255632|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
143194252|NCT05427539|516255633|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
143194253|NCT05427539|516255632|FG000|Period 1|Withdrawal by Subject|1|||
143194254|NCT05427539|516255633|FG001|Period 1|Withdrawal by Subject|0|||
143194255|NCT00223977|516255634|FG000|Overall Study|Adverse Event|7|||
143194256|NCT00223977|516255635|FG001|Overall Study|Adverse Event|10|||
143194257|NCT00223977|516255636|FG002|Overall Study|Adverse Event|0|||
143194258|NCT00223977|516255634|FG000|Overall Study|Protocol Violation|0|||
143194259|NCT00223977|516255635|FG001|Overall Study|Protocol Violation|0|||
143194260|NCT00223977|516255636|FG002|Overall Study|Protocol Violation|1|||
143194261|NCT00223977|516255634|FG000|Overall Study|Withdrawal by Subject|1|||
143194262|NCT00223977|516255635|FG001|Overall Study|Withdrawal by Subject|1|||
143194263|NCT00223977|516255636|FG002|Overall Study|Withdrawal by Subject|2|||
143194264|NCT00223977|516255634|FG000|Overall Study|Other|1|||
143194265|NCT00223977|516255635|FG001|Overall Study|Other|0|||
143194266|NCT00223977|516255636|FG002|Overall Study|Other|0|||
143194267|NCT03359785|516255637|FG000|Overall Study|Protocol Violation|0|||
143194268|NCT03359785|516255638|FG001|Overall Study|Protocol Violation|1|||
143194269|NCT03359785|516255639|FG002|Overall Study|Protocol Violation|0|||
143194270|NCT03359785|516255640|FG003|Overall Study|Protocol Violation|0|||
143194271|NCT03359785|516255637|FG000|Overall Study|Early study termination due to study pause|0|||
143194272|NCT03359785|516255638|FG001|Overall Study|Early study termination due to study pause|0|||
143194273|NCT03359785|516255639|FG002|Overall Study|Early study termination due to study pause|2|||
143194274|NCT03359785|516255640|FG003|Overall Study|Early study termination due to study pause|0|||
143194275|NCT03359785|516255637|FG000|Overall Study|Withdrawal by Subject|2|||
143194276|NCT03359785|516255638|FG001|Overall Study|Withdrawal by Subject|2|||
143194277|NCT03359785|516255639|FG002|Overall Study|Withdrawal by Subject|0|||
143194278|NCT03359785|516255640|FG003|Overall Study|Withdrawal by Subject|0|||
143194279|NCT01895543|516255641|FG000|Overall Study|Withdrawal by Subject|43|||
143194280|NCT01895543|516255641|FG000|Overall Study|Lost to Follow-up|25|||
143194281|NCT01895543|516255641|FG000|Overall Study|Adverse Event|28|||
143194282|NCT01895543|516255641|FG000|Overall Study|Subject's substantial non-compliance|6|||
143194283|NCT01895543|516255641|FG000|Overall Study|Protocol Violation|1|||
143194284|NCT01895543|516255641|FG000|Overall Study|Physician Decision|2|||
143194285|NCT01895543|516255641|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
143194286|NCT04659174|516255650|FG000|Overall Study|Sponsor decision to discontinue study|0|||
143194287|NCT04659174|516255651|FG001|Overall Study|Sponsor decision to discontinue study|2|||
143194288|NCT04659174|516255650|FG000|Overall Study|Lost to Follow-up|9|||
143194289|NCT04659174|516255651|FG001|Overall Study|Lost to Follow-up|11|||
143194290|NCT04659174|516255650|FG000|Overall Study|Adverse Event|8|||
143194291|NCT04659174|516255651|FG001|Overall Study|Adverse Event|5|||
143194292|NCT04659174|516255650|FG000|Overall Study|Withdrawal by Subject|17|||
143194293|NCT04659174|516255651|FG001|Overall Study|Withdrawal by Subject|33|||
143194294|NCT04659174|516255650|FG000|Overall Study|Progressive disease|0|||
143194295|NCT04659174|516255651|FG001|Overall Study|Progressive disease|2|||
143194296|NCT04659174|516255650|FG000|Overall Study|Other reasons|0|||
143194297|NCT04659174|516255651|FG001|Overall Study|Other reasons|2|||
143194298|NCT04659174|516255650|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
143194299|NCT04659174|516255651|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
143194300|NCT04659174|516255650|FG000|Overall Study|Alcohol or illegal drug use|0|||
143194301|NCT04659174|516255651|FG001|Overall Study|Alcohol or illegal drug use|3|||
143194302|NCT04659174|516255650|FG000|Overall Study|Violation of entry criteria|1|||
143194303|NCT04659174|516255651|FG001|Overall Study|Violation of entry criteria|0|||
143194304|NCT04659174|516255650|FG000|Overall Study|Death|0|||
143194305|NCT04659174|516255651|FG001|Overall Study|Death|1|||
143194306|NCT03276026|516255654|FG000|Overall Study|Protocol Violation|1|||
143194307|NCT03276026|516255655|FG001|Overall Study|Protocol Violation|0|||
143194308|NCT03650803|516255657|FG000|Overall Study|Lost to Follow-up|6|||
143194309|NCT01534260|516255658|FG000|Overall Study|Adverse Event|1|||
143194310|NCT01534260|516255659|FG001|Overall Study|Adverse Event|8|||
143194311|NCT01534260|516255658|FG000|Overall Study|Death|2|||
143194312|NCT01534260|516255659|FG001|Overall Study|Death|0|||
143194313|NCT01534260|516255658|FG000|Overall Study|Lack of Efficacy|1|||
143194314|NCT01534260|516255659|FG001|Overall Study|Lack of Efficacy|1|||
143194315|NCT01534260|516255658|FG000|Overall Study|Withdrawal by Subject|1|||
143194316|NCT01534260|516255659|FG001|Overall Study|Withdrawal by Subject|3|||
143194317|NCT01534260|516255658|FG000|Overall Study|Disease Progression|8|||
143194318|NCT01534260|516255659|FG001|Overall Study|Disease Progression|6|||
143194319|NCT01534260|516255658|FG000|Overall Study|Physician Decision|3|||
143194320|NCT01534260|516255659|FG001|Overall Study|Physician Decision|1|||
143194321|NCT01534260|516255658|FG000|Overall Study|No treatment, per protocol|0|||
143194322|NCT01534260|516255659|FG001|Overall Study|No treatment, per protocol|1|||
143194323|NCT02359045|516255660|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
143194324|NCT02359045|516255661|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
143194325|NCT02359045|516255660|FG000|Overall Study|Lost to Follow-up|1|||
143194326|NCT02359045|516255661|FG001|Overall Study|Lost to Follow-up|1|||
143194327|NCT02359045|516255660|FG000|Overall Study|Adverse Event|0|||
143194328|NCT02359045|516255661|FG001|Overall Study|Adverse Event|1|||
143194329|NCT02649218|516255667|FG000|Overall Study|Adverse Event|8|||
143194330|NCT02649218|516255667|FG000|Overall Study|Lack of Efficacy|8|||
143194331|NCT02649218|516255667|FG000|Overall Study|Pregnancy|3|||
143194332|NCT02649218|516255667|FG000|Overall Study|Protocol Violation|3|||
143194333|NCT02649218|516255667|FG000|Overall Study|Physician Decision|1|||
143194334|NCT02649218|516255667|FG000|Overall Study|Withdrawal by Subject|2|||
143194335|NCT04470908|516255668|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
143194336|NCT04376684|516255669|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
143194337|NCT04376684|516255670|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
143194338|NCT04376684|516255671|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
143194339|NCT04376684|516255672|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
143194340|NCT04376684|516255669|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
143194341|NCT04376684|516255670|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
143194342|NCT04376684|516255671|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
143194343|NCT04376684|516255672|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
143194344|NCT04376684|516255669|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
143194345|NCT04376684|516255670|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
143194346|NCT04376684|516255671|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
143194347|NCT04376684|516255672|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
143194348|NCT04376684|516255669|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
143194349|NCT04376684|516255670|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
143194350|NCT04376684|516255671|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
143194351|NCT04376684|516255672|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
143194352|NCT04376684|516255669|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
143194353|NCT04376684|516255670|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
143194354|NCT04376684|516255671|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
143194355|NCT04376684|516255672|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
143194356|NCT04376684|516255669|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
143194357|NCT04376684|516255670|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
143194358|NCT04376684|516255671|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
143194359|NCT04376684|516255672|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
143194360|NCT04376684|516255669|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
143194361|NCT04376684|516255670|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
143194362|NCT04376684|516255671|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
143194363|NCT04376684|516255672|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
143194364|NCT01301066|516255678|FG000|Overall Study|Lost to Follow-up|5|||
143194365|NCT01301066|516255679|FG001|Overall Study|Lost to Follow-up|11|||
143194366|NCT01301066|516255678|FG000|Overall Study|Protocol Violation|8|||
143194367|NCT01301066|516255679|FG001|Overall Study|Protocol Violation|7|||
143194368|NCT01301066|516255678|FG000|Overall Study|Withdrawal by Subject|4|||
143194369|NCT01301066|516255679|FG001|Overall Study|Withdrawal by Subject|9|||
143194370|NCT01301066|516255678|FG000|Overall Study|Adverse Event|6|||
143194371|NCT01301066|516255679|FG001|Overall Study|Adverse Event|6|||
143194372|NCT01301066|516255678|FG000|Overall Study|Sponsor Decision|2|||
143194373|NCT01301066|516255679|FG001|Overall Study|Sponsor Decision|1|||
143194374|NCT01301066|516255678|FG000|Overall Study|Physician Decision|0|||
143194375|NCT01301066|516255679|FG001|Overall Study|Physician Decision|1|||
143194376|NCT01301066|516255678|FG000|Overall Study|Other|2|||
143194377|NCT01301066|516255679|FG001|Overall Study|Other|0|||
143194378|NCT01330628|516255684|FG000|Overall Study|Death|2|||
143194379|NCT01330628|516255685|FG001|Overall Study|Death|3|||
143194380|NCT01330628|516255684|FG000|Overall Study|Lost to Follow-up|5|||
143194381|NCT01330628|516255685|FG001|Overall Study|Lost to Follow-up|6|||
143194382|NCT01330628|516255684|FG000|Overall Study|Adverse Event|44|||
143194383|NCT01330628|516255685|FG001|Overall Study|Adverse Event|25|||
143194384|NCT01330628|516255684|FG000|Overall Study|Withdrawn|18|||
143194385|NCT01330628|516255685|FG001|Overall Study|Withdrawn|6|||
143194386|NCT01330628|516255684|FG000|Overall Study|Didn't receive study treatment|1|||
143194387|NCT01330628|516255685|FG001|Overall Study|Didn't receive study treatment|0|||
143194388|NCT02825420|516255687|FG000|Overall Study|Death|30|||
143194389|NCT02825420|516255688|FG001|Overall Study|Death|12|||
143194390|NCT02825420|516255687|FG000|Overall Study|Progressive disease|6|||
143194391|NCT02825420|516255688|FG001|Overall Study|Progressive disease|1|||
143194392|NCT02825420|516255687|FG000|Overall Study|Lost to Follow-up|2|||
143194393|NCT02825420|516255688|FG001|Overall Study|Lost to Follow-up|2|||
143194394|NCT02825420|516255687|FG000|Overall Study|Withdrawal by Subject|1|||
143369650|NCT00603447|516896191|FG001|Overall Study|Adverse Event|1|||
143194395|NCT02825420|516255688|FG001|Overall Study|Withdrawal by Subject|1|||
143194396|NCT02825420|516255687|FG000|Overall Study|Protocol amendment not signed|1|||
143194397|NCT02825420|516255688|FG001|Overall Study|Protocol amendment not signed|1|||
143194398|NCT02825420|516255687|FG000|Overall Study|Physician Decision|1|||
143194399|NCT02825420|516255688|FG001|Overall Study|Physician Decision|0|||
143194400|NCT02825420|516255687|FG000|Overall Study|Did not receive PLD|2|||
143194401|NCT02825420|516255688|FG001|Overall Study|Did not receive PLD|0|||
143194402|NCT01740089|516257097|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
143194403|NCT01740089|516257098|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
143194404|NCT01740089|516257099|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
143194405|NCT01740089|516257097|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
143194406|NCT01740089|516257098|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
143194407|NCT01740089|516257099|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
143194408|NCT01740089|516257097|FG000|After 12 Weeks|Lack of Efficacy|3|||
143194409|NCT01740089|516257098|FG001|After 12 Weeks|Lack of Efficacy|1|||
143194410|NCT01740089|516257099|FG002|After 12 Weeks|Lack of Efficacy|4|||
143194411|NCT01740089|516257097|FG000|After 12 Weeks|Adverse Event|2|||
143194412|NCT01740089|516257098|FG001|After 12 Weeks|Adverse Event|0|||
143194413|NCT01740089|516257099|FG002|After 12 Weeks|Adverse Event|5|||
143194414|NCT01740089|516257097|FG000|After 12 Weeks|Protocol Violation|1|||
143194415|NCT01740089|516257098|FG001|After 12 Weeks|Protocol Violation|1|||
143194416|NCT01740089|516257099|FG002|After 12 Weeks|Protocol Violation|1|||
143194417|NCT01740089|516257097|FG000|After 12 Weeks|Withdrawal by Subject|1|||
143194418|NCT01740089|516257098|FG001|After 12 Weeks|Withdrawal by Subject|1|||
143194419|NCT01740089|516257099|FG002|After 12 Weeks|Withdrawal by Subject|1|||
143194420|NCT01448824|516257100|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
143194421|NCT01448824|516257101|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
143194422|NCT01448824|516257102|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
143194423|NCT01448824|516257103|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
143194424|NCT01448824|516257104|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
143194425|NCT01448824|516257105|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
143194426|NCT01448824|516257106|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
143194427|NCT01448824|516257107|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
143194428|NCT01448824|516257100|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
143194429|NCT01448824|516257101|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
143194430|NCT01448824|516257102|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
143194431|NCT01448824|516257103|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
143194432|NCT01448824|516257104|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
143194433|NCT01448824|516257105|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
143194434|NCT01448824|516257106|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
143194435|NCT01448824|516257107|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
143194436|NCT01448824|516257100|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
143194437|NCT01448824|516257101|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
143194438|NCT01448824|516257102|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
143194439|NCT01448824|516257103|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
143194440|NCT01448824|516257104|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
143194441|NCT01448824|516257105|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
143194442|NCT01448824|516257106|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
143194443|NCT01448824|516257107|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
143194444|NCT01448824|516257100|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
143194445|NCT01448824|516257101|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
143194446|NCT01448824|516257102|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
143194447|NCT01448824|516257103|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
143194448|NCT01448824|516257104|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
143194449|NCT01448824|516257105|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
143194450|NCT01448824|516257106|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
143194451|NCT01448824|516257107|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
143194452|NCT01448824|516257100|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
143194453|NCT01448824|516257101|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
143194454|NCT01448824|516257102|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
143194455|NCT01448824|516257103|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
143194456|NCT01448824|516257104|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
143194457|NCT01448824|516257105|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
143194458|NCT01448824|516257106|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
143194459|NCT01448824|516257107|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
143194460|NCT01448824|516257100|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
143194461|NCT01448824|516257101|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
143194462|NCT01448824|516257102|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
143194463|NCT01448824|516257103|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
143194464|NCT01448824|516257104|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
143194465|NCT01448824|516257105|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
143194466|NCT01448824|516257106|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
143194467|NCT01448824|516257107|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
143194468|NCT01448824|516257100|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
143194469|NCT01448824|516257101|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
143194470|NCT01448824|516257102|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
143194471|NCT01448824|516257103|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
143194472|NCT01448824|516257104|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
143194473|NCT01448824|516257105|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
143194474|NCT01448824|516257106|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
143194475|NCT01448824|516257107|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
143194476|NCT01448824|516257100|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
143194477|NCT01448824|516257101|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
143194478|NCT01448824|516257102|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
143194479|NCT01448824|516257103|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
143194480|NCT01448824|516257104|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
143194481|NCT01448824|516257105|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
143194482|NCT01448824|516257106|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
143194483|NCT01448824|516257107|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
143194484|NCT02998203|516257110|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
143194485|NCT02998203|516257111|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
143194486|NCT02998203|516257110|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
143194487|NCT02998203|516257111|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
143194488|NCT02264665|516257114|FG000|Overall Study|Other|0|||
143194489|NCT02264665|516257115|FG001|Overall Study|Other|0|||
143194490|NCT02264665|516257116|FG002|Overall Study|Other|3|||
143194491|NCT02264665|516257117|FG003|Overall Study|Other|0|||
143194492|NCT02264665|516257118|FG004|Overall Study|Other|0|||
143194493|NCT02264665|516257119|FG005|Overall Study|Other|0|||
143194494|NCT02264665|516257120|FG006|Overall Study|Other|0|||
143194495|NCT02264665|516257114|FG000|Overall Study|Death|9|||
143194496|NCT02264665|516257115|FG001|Overall Study|Death|8|||
143194497|NCT02264665|516257116|FG002|Overall Study|Death|13|||
143194498|NCT02264665|516257117|FG003|Overall Study|Death|5|||
143194499|NCT02264665|516257118|FG004|Overall Study|Death|0|||
143194500|NCT02264665|516257119|FG005|Overall Study|Death|0|||
143194501|NCT02264665|516257120|FG006|Overall Study|Death|1|||
143194502|NCT02264665|516257114|FG000|Overall Study|Lost to Follow-up|1|||
143194503|NCT02264665|516257115|FG001|Overall Study|Lost to Follow-up|0|||
143194504|NCT02264665|516257116|FG002|Overall Study|Lost to Follow-up|2|||
143194505|NCT02264665|516257117|FG003|Overall Study|Lost to Follow-up|1|||
143194506|NCT02264665|516257118|FG004|Overall Study|Lost to Follow-up|0|||
143194507|NCT02264665|516257119|FG005|Overall Study|Lost to Follow-up|0|||
143194508|NCT02264665|516257120|FG006|Overall Study|Lost to Follow-up|0|||
143194509|NCT02264665|516257114|FG000|Overall Study|Participant decision|0|||
143194510|NCT02264665|516257115|FG001|Overall Study|Participant decision|0|||
143194511|NCT02264665|516257116|FG002|Overall Study|Participant decision|0|||
143194512|NCT02264665|516257117|FG003|Overall Study|Participant decision|1|||
143194513|NCT02264665|516257118|FG004|Overall Study|Participant decision|0|||
143194514|NCT02264665|516257119|FG005|Overall Study|Participant decision|0|||
143194515|NCT02264665|516257120|FG006|Overall Study|Participant decision|0|||
143194516|NCT02264665|516257114|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
143194517|NCT02264665|516257115|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
143194518|NCT02264665|516257116|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
143194519|NCT02264665|516257117|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
143194520|NCT02264665|516257118|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
143194521|NCT02264665|516257119|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
143194522|NCT02264665|516257120|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
143194523|NCT02264665|516257114|FG000|Overall Study|Data Missing|0|||
143194524|NCT02264665|516257115|FG001|Overall Study|Data Missing|0|||
143194525|NCT02264665|516257116|FG002|Overall Study|Data Missing|1|||
143194526|NCT02264665|516257117|FG003|Overall Study|Data Missing|0|||
143194527|NCT02264665|516257118|FG004|Overall Study|Data Missing|0|||
143194528|NCT02264665|516257119|FG005|Overall Study|Data Missing|0|||
143194529|NCT02264665|516257120|FG006|Overall Study|Data Missing|0|||
143194530|NCT00789581|516257121|FG000|AC Therapy|Adverse Event|2|||
143194531|NCT00789581|516257122|FG001|AC Therapy|Adverse Event|3|||
143194532|NCT00789581|516257121|FG000|AC Therapy|Withdrawal by Subject|4|||
143194533|NCT00789581|516257122|FG001|AC Therapy|Withdrawal by Subject|7|||
143194534|NCT00789581|516257121|FG000|AC Therapy|Disease recurrence|3|||
143194535|NCT00789581|516257122|FG001|AC Therapy|Disease recurrence|1|||
143194536|NCT00789581|516257121|FG000|AC Therapy|Intercurrent Illness|1|||
143194537|NCT00789581|516257122|FG001|AC Therapy|Intercurrent Illness|0|||
143194538|NCT00789581|516257121|FG000|AC Therapy|Never Treated|1|||
143194539|NCT00789581|516257122|FG001|AC Therapy|Never Treated|4|||
143194540|NCT00789581|516257121|FG000|AC Therapy|Other|0|||
143194541|NCT00789581|516257122|FG001|AC Therapy|Other|2|||
143194542|NCT00789581|516257121|FG000|Adjuvant Therapy|Never treated|2|||
143261592|NCT01975831|516510609|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
143194543|NCT00789581|516257122|FG001|Adjuvant Therapy|Never treated|2|||
143194544|NCT00789581|516257121|FG000|Adjuvant Therapy|Adverse Event|20|||
143194545|NCT00789581|516257122|FG001|Adjuvant Therapy|Adverse Event|44|||
143194546|NCT00789581|516257121|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
143194547|NCT00789581|516257122|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
143194548|NCT00789581|516257121|FG000|Adjuvant Therapy|Disease recurrence|2|||
143194549|NCT00789581|516257122|FG001|Adjuvant Therapy|Disease recurrence|1|||
143194550|NCT00789581|516257121|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
143194551|NCT00789581|516257122|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
143194552|NCT00789581|516257121|FG000|Adjuvant Therapy|Protocol Violation|1|||
143194553|NCT00789581|516257122|FG001|Adjuvant Therapy|Protocol Violation|1|||
143261593|NCT01975831|516510610|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
143261594|NCT01975831|516510611|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
143261595|NCT01975831|516510612|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
143261596|NCT01975831|516510613|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
143261597|NCT01975831|516510614|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
143261598|NCT01975831|516510606|FG000|Overall Study|Entered Hospice|0|||
143261599|NCT01975831|516510607|FG001|Overall Study|Entered Hospice|0|||
143261600|NCT01975831|516510608|FG002|Overall Study|Entered Hospice|0|||
143261601|NCT01975831|516510609|FG003|Overall Study|Entered Hospice|0|||
143261602|NCT01975831|516510610|FG004|Overall Study|Entered Hospice|0|||
143261603|NCT01975831|516510611|FG005|Overall Study|Entered Hospice|1|||
143261604|NCT01975831|516510612|FG006|Overall Study|Entered Hospice|0|||
143261605|NCT01975831|516510613|FG007|Overall Study|Entered Hospice|0|||
143261606|NCT01975831|516510614|FG008|Overall Study|Entered Hospice|0|||
143261607|NCT01975831|516510606|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
143261608|NCT01975831|516510607|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
143261609|NCT01975831|516510608|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
143261610|NCT01975831|516510609|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
143261611|NCT01975831|516510610|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
143261612|NCT01975831|516510611|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
143261613|NCT01975831|516510612|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
143261614|NCT01975831|516510613|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
143261615|NCT01975831|516510614|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
143261616|NCT01401959|516510615|FG000|Enrolled|Withdrawal by Subject|1|||
143261617|NCT01401959|516510616|FG001|Enrolled|Withdrawal by Subject|0|||
143261618|NCT01401959|516510617|FG002|Enrolled|Withdrawal by Subject|0|||
143261619|NCT01401959|516510615|FG000|Treated|Disease Progression|2|||
143261620|NCT01401959|516510616|FG001|Treated|Disease Progression|2|||
143261621|NCT01401959|516510617|FG002|Treated|Disease Progression|1|||
143261622|NCT01401959|516510615|FG000|Treated|Adverse Event|4|||
143261623|NCT01401959|516510616|FG001|Treated|Adverse Event|3|||
143261624|NCT01401959|516510617|FG002|Treated|Adverse Event|2|||
143261625|NCT01401959|516510615|FG000|Treated|Withdrawal by Subject|1|||
143261626|NCT01401959|516510616|FG001|Treated|Withdrawal by Subject|2|||
143261627|NCT01401959|516510617|FG002|Treated|Withdrawal by Subject|2|||
143261628|NCT01401959|516510615|FG000|Treated|Protocol Violation|0|||
143261629|NCT01401959|516510616|FG001|Treated|Protocol Violation|1|||
143261630|NCT01401959|516510617|FG002|Treated|Protocol Violation|0|||
143261631|NCT00251004|516510618|FG000|Overall Study|Withdrawal by Subject|23|||
143261632|NCT00251004|516510619|FG001|Overall Study|Withdrawal by Subject|16|||
143261633|NCT00251004|516510620|FG002|Overall Study|Withdrawal by Subject|14|||
143261634|NCT00251004|516510618|FG000|Overall Study|Death|9|||
143261635|NCT00251004|516510619|FG001|Overall Study|Death|10|||
143261636|NCT00251004|516510620|FG002|Overall Study|Death|8|||
143261637|NCT00251004|516510618|FG000|Overall Study|Lost to Follow-up|1|||
143261638|NCT00251004|516510619|FG001|Overall Study|Lost to Follow-up|2|||
143261639|NCT00251004|516510620|FG002|Overall Study|Lost to Follow-up|1|||
143261640|NCT00251004|516510618|FG000|Overall Study|Graft Loss|12|||
143261641|NCT00251004|516510619|FG001|Overall Study|Graft Loss|13|||
143261642|NCT00251004|516510620|FG002|Overall Study|Graft Loss|8|||
143194554|NCT00789581|516257121|FG000|Adjuvant Therapy|Other|0|||
143194555|NCT00789581|516257122|FG001|Adjuvant Therapy|Other|1|||
143261643|NCT02694718|516510625|FG000|Overall Study|Death|1|||
143261644|NCT02694718|516510625|FG000|Overall Study|Withdrawal by Subject|1|||
143261645|NCT02925793|516510626|FG000|Overall Study|Adverse Event|3|||
143261646|NCT02925793|516510627|FG001|Overall Study|Adverse Event|3|||
143261647|NCT02925793|516510628|FG002|Overall Study|Adverse Event|6|||
143261648|NCT02925793|516510626|FG000|Overall Study|Withdrawal by Subject|16|||
143261649|NCT02925793|516510627|FG001|Overall Study|Withdrawal by Subject|15|||
143261650|NCT02925793|516510628|FG002|Overall Study|Withdrawal by Subject|13|||
143261651|NCT02925793|516510626|FG000|Overall Study|Investigator Discretion|0|||
143261652|NCT02925793|516510627|FG001|Overall Study|Investigator Discretion|1|||
143261653|NCT02925793|516510628|FG002|Overall Study|Investigator Discretion|1|||
143261654|NCT02925793|516510626|FG000|Overall Study|Lost to Follow-up|2|||
143261655|NCT02925793|516510627|FG001|Overall Study|Lost to Follow-up|3|||
143261656|NCT02925793|516510628|FG002|Overall Study|Lost to Follow-up|1|||
143261657|NCT02925793|516510626|FG000|Overall Study|Lack of Efficacy|2|||
143261658|NCT02925793|516510627|FG001|Overall Study|Lack of Efficacy|6|||
143261659|NCT02925793|516510628|FG002|Overall Study|Lack of Efficacy|4|||
143261660|NCT02925793|516510626|FG000|Overall Study|Other:|2|||
143261661|NCT02925793|516510627|FG001|Overall Study|Other:|1|||
143261662|NCT02925793|516510628|FG002|Overall Study|Other:|3|||
143261663|NCT01244490|516510629|FG000|Overall Study|Lack of Efficacy|14|||
143261664|NCT01244490|516510630|FG001|Overall Study|Lack of Efficacy|5|||
143261665|NCT01244490|516510631|FG002|Overall Study|Lack of Efficacy|5|||
143261666|NCT01244490|516510629|FG000|Overall Study|Withdrawal by Subject|4|||
143194556|NCT01606787|516257129|FG000|Overall Study|Withdrawal by Subject|4|||
143194557|NCT01606787|516257130|FG001|Overall Study|Withdrawal by Subject|5|||
143194558|NCT01606787|516257129|FG000|Overall Study|Surgery canceled|0|||
143194559|NCT01606787|516257130|FG001|Overall Study|Surgery canceled|2|||
143194560|NCT05312632|516257134|FG000|Overall Study|Adverse Event|12|||
143194561|NCT05312632|516257134|FG000|Overall Study|Withdrawal by Subject|10|||
143194562|NCT05312632|516257134|FG000|Overall Study|Lack of Efficacy|4|||
143194563|NCT05312632|516257134|FG000|Overall Study|Non-compliance with study procedures|9|||
143194564|NCT05312632|516257134|FG000|Overall Study|Other|4|||
143194565|NCT02743949|516257137|FG000|Overall Study|Adverse Event|0|||
143194566|NCT02743949|516257138|FG001|Overall Study|Adverse Event|0|||
143194567|NCT02743949|516257139|FG002|Overall Study|Adverse Event|2|||
143194568|NCT02743949|516257137|FG000|Overall Study|Significant Protocol Deviation|2|||
143194569|NCT02743949|516257138|FG001|Overall Study|Significant Protocol Deviation|0|||
143194570|NCT02743949|516257139|FG002|Overall Study|Significant Protocol Deviation|1|||
143194571|NCT02743949|516257137|FG000|Overall Study|Voluntary Withdrawal|2|||
143194572|NCT02743949|516257138|FG001|Overall Study|Voluntary Withdrawal|1|||
143194573|NCT02743949|516257139|FG002|Overall Study|Voluntary Withdrawal|0|||
143194574|NCT01921218|516257140|FG000|Overall Study|Death|2|||
143194575|NCT01921218|516257141|FG001|Overall Study|Death|1|||
143194576|NCT01921218|516257140|FG000|Overall Study|Withdrawal by Subject|0|||
143194577|NCT01921218|516257141|FG001|Overall Study|Withdrawal by Subject|2|||
143194578|NCT01921218|516257140|FG000|Overall Study|Kidney transplant|1|||
143194579|NCT01921218|516257141|FG001|Overall Study|Kidney transplant|1|||
143194580|NCT03389555|516257142|FG000|Overall Study|Protocol Violation|1|||
143194581|NCT03389555|516257143|FG001|Overall Study|Protocol Violation|3|||
143194582|NCT03389555|516257142|FG000|Overall Study|Death|1|||
143194583|NCT03389555|516257143|FG001|Overall Study|Death|0|||
143194584|NCT01885208|516257144|FG000|Overall Study|Unclassified|32|||
143194585|NCT01885208|516257145|FG001|Overall Study|Unclassified|38|||
143194586|NCT00920218|516257146|FG000|Overall Study|Serious Adverse Event|2|||
143194587|NCT00920218|516257147|FG001|Overall Study|Serious Adverse Event|0|||
143194588|NCT00920218|516257148|FG002|Overall Study|Serious Adverse Event|2|||
143194589|NCT00920218|516257149|FG003|Overall Study|Serious Adverse Event|1|||
143194590|NCT00920218|516257146|FG000|Overall Study|Withdrawal by Subject|0|||
143194591|NCT00920218|516257147|FG001|Overall Study|Withdrawal by Subject|3|||
143194592|NCT00920218|516257148|FG002|Overall Study|Withdrawal by Subject|2|||
143194593|NCT00920218|516257149|FG003|Overall Study|Withdrawal by Subject|0|||
143194594|NCT00920218|516257146|FG000|Overall Study|Migrated/moved from study area|0|||
143194595|NCT00920218|516257147|FG001|Overall Study|Migrated/moved from study area|0|||
143194596|NCT00920218|516257148|FG002|Overall Study|Migrated/moved from study area|1|||
143194597|NCT00920218|516257149|FG003|Overall Study|Migrated/moved from study area|0|||
143194598|NCT00920218|516257146|FG000|Overall Study|Lost to Follow-up|0|||
143194599|NCT00920218|516257147|FG001|Overall Study|Lost to Follow-up|1|||
143194600|NCT00920218|516257148|FG002|Overall Study|Lost to Follow-up|0|||
143194601|NCT00920218|516257149|FG003|Overall Study|Lost to Follow-up|3|||
143194602|NCT00920218|516257146|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
143194603|NCT00920218|516257147|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
143194604|NCT00920218|516257148|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
143261667|NCT01244490|516510630|FG001|Overall Study|Withdrawal by Subject|4|||
143261668|NCT01244490|516510631|FG002|Overall Study|Withdrawal by Subject|9|||
143261669|NCT01244490|516510629|FG000|Overall Study|Adverse Event|1|||
143261670|NCT01244490|516510630|FG001|Overall Study|Adverse Event|9|||
143261671|NCT01244490|516510631|FG002|Overall Study|Adverse Event|5|||
143261672|NCT01244490|516510629|FG000|Overall Study|Lost to Follow-up|0|||
143194605|NCT00920218|516257149|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
143194606|NCT00920218|516257146|FG000|Overall Study|Other|0|||
143194607|NCT00920218|516257147|FG001|Overall Study|Other|0|||
143194608|NCT00920218|516257148|FG002|Overall Study|Other|1|||
143194609|NCT00920218|516257149|FG003|Overall Study|Other|0|||
143194610|NCT03224507|516257153|FG000|Overall Study|Death|3|||
143194611|NCT03224507|516257154|FG001|Overall Study|Death|0|||
143261673|NCT01244490|516510630|FG001|Overall Study|Lost to Follow-up|6|||
143261674|NCT01244490|516510631|FG002|Overall Study|Lost to Follow-up|3|||
143261675|NCT01244490|516510629|FG000|Overall Study|Other|0|||
143194612|NCT03224507|516257153|FG000|Overall Study|Lack of Efficacy|6|||
143194613|NCT03224507|516257154|FG001|Overall Study|Lack of Efficacy|0|||
143194614|NCT03224507|516257153|FG000|Overall Study|Withdrawal by Subject|6|||
143194615|NCT03224507|516257154|FG001|Overall Study|Withdrawal by Subject|0|||
143194616|NCT00585546|516257163|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
143194617|NCT00585546|516257163|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
143194618|NCT01562314|516257164|FG000|Overall Study|Adverse Event|10|||
143194619|NCT01562314|516257165|FG001|Overall Study|Adverse Event|5|||
143194620|NCT01562314|516257164|FG000|Overall Study|Met Withdrawal Criteria|3|||
143194621|NCT01562314|516257165|FG001|Overall Study|Met Withdrawal Criteria|2|||
143194622|NCT01562314|516257164|FG000|Overall Study|Withdrawal by Subject|0|||
143194623|NCT01562314|516257165|FG001|Overall Study|Withdrawal by Subject|1|||
143194624|NCT03077438|516257168|FG000|Overall Study|Protocol Violation|3|||
143194625|NCT03077438|516257169|FG001|Overall Study|Protocol Violation|5|||
143194626|NCT03077438|516257168|FG000|Overall Study|Withdrawal by Subject|3|||
143194627|NCT03077438|516257169|FG001|Overall Study|Withdrawal by Subject|6|||
143194628|NCT03077438|516257168|FG000|Overall Study|Lost to Follow-up|6|||
143194629|NCT03077438|516257169|FG001|Overall Study|Lost to Follow-up|3|||
143194630|NCT04154345|516257178|FG000|Overall Study|Covid-19 pandemic|4|||
143194631|NCT04686084|516257180|FG000|Overall Study|Lost to Follow-up|1|||
143194632|NCT01779856|516257181|FG000|Overall Study|Withdrawal by Subject|15|||
143194633|NCT01779856|516257181|FG000|Overall Study|Death|3|||
143194634|NCT01779856|516257181|FG000|Overall Study|Physician Decision|1|||
143194635|NCT01779856|516257181|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
143194636|NCT01779856|516257181|FG000|Overall Study|Delays in scheduling implant|1|||
143194637|NCT01779856|516257181|FG000|Overall Study|Subject ineligible for Implant|2|||
143194638|NCT00676520|516257186|FG000|Overall Study|Withdrawal by Subject|163|||
143194639|NCT00676520|516257186|FG000|Overall Study|Lost to Follow-up|162|||
143194640|NCT00676520|516257186|FG000|Overall Study|Death|159|||
143194641|NCT00676520|516257186|FG000|Overall Study|Physician Decision|20|||
143194642|NCT00676520|516257186|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
143194643|NCT00676520|516257186|FG000|Overall Study|Other Reason|18|||
143194644|NCT00385944|516257187|FG000|1st Maintenance Dose Period|Physician Decision|1|||
143194645|NCT00385944|516257188|FG001|1st Maintenance Dose Period|Physician Decision|0|||
143194646|NCT00385944|516257189|FG002|1st Maintenance Dose Period|Physician Decision|0|||
143194647|NCT00385944|516257187|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
143194648|NCT00385944|516257188|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
143194649|NCT00385944|516257189|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
143194650|NCT00385944|516257187|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
143194651|NCT00385944|516257188|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
143194652|NCT00385944|516257189|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
143194653|NCT00385944|516257187|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
143194654|NCT00385944|516257188|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
143194655|NCT00385944|516257189|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
143194656|NCT01778049|516257195|FG000|Open Label Treatment Period|Adverse Event|5|||
143194657|NCT01778049|516257196|FG001|Open Label Treatment Period|Adverse Event|15|||
143194658|NCT01778049|516257197|FG002|Open Label Treatment Period|Adverse Event|0|||
143194659|NCT01778049|516257198|FG003|Open Label Treatment Period|Adverse Event|0|||
143194660|NCT01778049|516257199|FG004|Open Label Treatment Period|Adverse Event|0|||
143194661|NCT01778049|516257200|FG005|Open Label Treatment Period|Adverse Event|0|||
143194662|NCT01778049|516257195|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
143194663|NCT01778049|516257196|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
143194664|NCT01778049|516257197|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
143194665|NCT01778049|516257198|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
143194666|NCT01778049|516257199|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
143194667|NCT01778049|516257200|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
143194668|NCT01778049|516257195|FG000|Open Label Treatment Period|Protocol Violation|5|||
143194669|NCT01778049|516257196|FG001|Open Label Treatment Period|Protocol Violation|5|||
143261676|NCT01244490|516510630|FG001|Overall Study|Other|0|||
143194670|NCT01778049|516257197|FG002|Open Label Treatment Period|Protocol Violation|0|||
143194671|NCT01778049|516257198|FG003|Open Label Treatment Period|Protocol Violation|0|||
143194672|NCT01778049|516257199|FG004|Open Label Treatment Period|Protocol Violation|0|||
143194673|NCT01778049|516257200|FG005|Open Label Treatment Period|Protocol Violation|0|||
143261677|NCT01244490|516510631|FG002|Overall Study|Other|1|||
143194674|NCT01778049|516257195|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
143194675|NCT01778049|516257196|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
143194676|NCT01778049|516257197|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
143194677|NCT01778049|516257198|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
143194678|NCT01778049|516257199|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
143194679|NCT01778049|516257200|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
143194680|NCT01778049|516257195|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
143194681|NCT01778049|516257196|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
143194682|NCT01778049|516257197|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
143194683|NCT01778049|516257198|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
143194684|NCT01778049|516257199|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
143194685|NCT01778049|516257200|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
143194686|NCT01778049|516257195|FG000|Open Label Treatment Period|Not treated|2|||
143194687|NCT01778049|516257196|FG001|Open Label Treatment Period|Not treated|1|||
143194688|NCT01778049|516257197|FG002|Open Label Treatment Period|Not treated|0|||
143261678|NCT00393042|516510632|FG000|First Intervention|Withdrawal by Subject|1|||
143261679|NCT00393042|516510633|FG001|First Intervention|Withdrawal by Subject|2|||
143261680|NCT00393042|516510632|FG000|First Intervention|Lost to Follow-up|3|||
143261681|NCT00393042|516510633|FG001|First Intervention|Lost to Follow-up|3|||
143261682|NCT00393042|516510632|FG000|First Intervention|Protocol Violation|1|||
143261683|NCT00393042|516510633|FG001|First Intervention|Protocol Violation|0|||
143261684|NCT00393042|516510632|FG000|First Intervention|Adverse Event|0|||
143261685|NCT00393042|516510633|FG001|First Intervention|Adverse Event|1|||
143261686|NCT00393042|516510632|FG000|Second Intervetion|Adverse Event|0|||
143261687|NCT00393042|516510633|FG001|Second Intervetion|Adverse Event|3|||
143261688|NCT00393042|516510632|FG000|Second Intervetion|Withdrawal by Subject|0|||
143261689|NCT00393042|516510633|FG001|Second Intervetion|Withdrawal by Subject|2|||
143261690|NCT00393042|516510632|FG000|Second Intervetion|Lack of Efficacy|1|||
143261691|NCT00393042|516510633|FG001|Second Intervetion|Lack of Efficacy|0|||
143261692|NCT00393042|516510632|FG000|Second Intervetion|Lost to Follow-up|0|||
143261693|NCT00393042|516510633|FG001|Second Intervetion|Lost to Follow-up|2|||
143369651|NCT00603447|516896192|FG002|Overall Study|Adverse Event|1|||
143261694|NCT00393042|516510632|FG000|Second Intervetion|Protocol Violation|1|||
143261695|NCT00393042|516510633|FG001|Second Intervetion|Protocol Violation|1|||
143261696|NCT00727532|516510634|FG000|Overall Study|Adverse Event|1|||
143261697|NCT00727532|516510634|FG000|Overall Study|Withdrawal by Subject|1|||
143261698|NCT00829933|516510635|FG000|Overall Study|Adverse Event|2|||
143261699|NCT00829933|516510636|FG001|Overall Study|Adverse Event|3|||
143261700|NCT00829933|516510637|FG002|Overall Study|Adverse Event|2|||
143261701|NCT00829933|516510638|FG003|Overall Study|Adverse Event|1|||
143261702|NCT00829933|516510635|FG000|Overall Study|Death|0|||
143261703|NCT00829933|516510636|FG001|Overall Study|Death|0|||
143261704|NCT00829933|516510637|FG002|Overall Study|Death|1|||
143261705|NCT00829933|516510638|FG003|Overall Study|Death|1|||
143261706|NCT00829933|516510635|FG000|Overall Study|Lack of Efficacy|0|||
143194689|NCT01778049|516257198|FG003|Open Label Treatment Period|Not treated|0|||
143194690|NCT01778049|516257199|FG004|Open Label Treatment Period|Not treated|0|||
143194691|NCT01778049|516257200|FG005|Open Label Treatment Period|Not treated|0|||
143194692|NCT01778049|516257195|FG000|Open Label Treatment Period|Other reason not defined above|77|||
143194693|NCT01778049|516257196|FG001|Open Label Treatment Period|Other reason not defined above|94|||
143194694|NCT01778049|516257197|FG002|Open Label Treatment Period|Other reason not defined above|0|||
143194695|NCT01778049|516257198|FG003|Open Label Treatment Period|Other reason not defined above|0|||
143194696|NCT01778049|516257199|FG004|Open Label Treatment Period|Other reason not defined above|0|||
143194697|NCT01778049|516257200|FG005|Open Label Treatment Period|Other reason not defined above|0|||
143194698|NCT01778049|516257195|FG000|Double Blind Treatment Period|Adverse Event|0|||
143194699|NCT01778049|516257196|FG001|Double Blind Treatment Period|Adverse Event|0|||
143194700|NCT01778049|516257197|FG002|Double Blind Treatment Period|Adverse Event|4|||
143194701|NCT01778049|516257198|FG003|Double Blind Treatment Period|Adverse Event|5|||
143194702|NCT01778049|516257199|FG004|Double Blind Treatment Period|Adverse Event|3|||
143194703|NCT01778049|516257200|FG005|Double Blind Treatment Period|Adverse Event|2|||
143194704|NCT01778049|516257195|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
143194705|NCT01778049|516257196|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
143194706|NCT01778049|516257197|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
143194707|NCT01778049|516257198|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
143194708|NCT01778049|516257199|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
143194709|NCT01778049|516257200|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
143194710|NCT01778049|516257195|FG000|Double Blind Treatment Period|Protocol Violation|0|||
143194711|NCT01778049|516257196|FG001|Double Blind Treatment Period|Protocol Violation|0|||
143194712|NCT01778049|516257197|FG002|Double Blind Treatment Period|Protocol Violation|2|||
143194713|NCT01778049|516257198|FG003|Double Blind Treatment Period|Protocol Violation|0|||
143194714|NCT01778049|516257199|FG004|Double Blind Treatment Period|Protocol Violation|0|||
143194715|NCT01778049|516257200|FG005|Double Blind Treatment Period|Protocol Violation|0|||
143194716|NCT01778049|516257195|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
143194717|NCT01778049|516257196|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
143194718|NCT01778049|516257197|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
143194719|NCT01778049|516257198|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
143194720|NCT01778049|516257199|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
143194721|NCT01778049|516257200|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
143194722|NCT01778049|516257195|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
143194723|NCT01778049|516257196|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
143261707|NCT00829933|516510636|FG001|Overall Study|Lack of Efficacy|1|||
143261708|NCT00829933|516510637|FG002|Overall Study|Lack of Efficacy|0|||
143261709|NCT00829933|516510638|FG003|Overall Study|Lack of Efficacy|0|||
143194724|NCT01778049|516257197|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
143261710|NCT00829933|516510635|FG000|Overall Study|Physician Decision|5|||
143261711|NCT00829933|516510636|FG001|Overall Study|Physician Decision|7|||
143261712|NCT00829933|516510637|FG002|Overall Study|Physician Decision|8|||
143261713|NCT00829933|516510638|FG003|Overall Study|Physician Decision|1|||
143261714|NCT00829933|516510635|FG000|Overall Study|Pregnancy|0|||
143261715|NCT00829933|516510636|FG001|Overall Study|Pregnancy|0|||
143261716|NCT00829933|516510637|FG002|Overall Study|Pregnancy|0|||
143194725|NCT01778049|516257198|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
143194726|NCT01778049|516257199|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
143194727|NCT01778049|516257200|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
143194728|NCT01778049|516257195|FG000|Double Blind Treatment Period|Not treated|0|||
143194729|NCT01778049|516257196|FG001|Double Blind Treatment Period|Not treated|0|||
143194730|NCT01778049|516257197|FG002|Double Blind Treatment Period|Not treated|0|||
143194731|NCT01778049|516257198|FG003|Double Blind Treatment Period|Not treated|2|||
143194732|NCT01778049|516257199|FG004|Double Blind Treatment Period|Not treated|2|||
143194733|NCT01778049|516257200|FG005|Double Blind Treatment Period|Not treated|0|||
143194734|NCT01778049|516257195|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
143194735|NCT01778049|516257196|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
143194736|NCT01778049|516257197|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
143194737|NCT01778049|516257198|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
143194738|NCT01778049|516257199|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
143194739|NCT01778049|516257200|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
143194740|NCT03773133|516257204|FG000|Overall Study|Screen Failure|8|||
143194741|NCT00866047|516257205|FG000|Treatment Period|Progressive disease|13|||
143194742|NCT00866047|516257205|FG000|Treatment Period|Adverse Event|16|||
143194743|NCT00866047|516257205|FG000|Treatment Period|Physician Decision|14|||
143194744|NCT00866047|516257205|FG000|Treatment Period|Withdrawal by Subject|5|||
143194745|NCT00866047|516257205|FG000|Follow-up Period|Lost to Follow-up|5|||
143194746|NCT02928029|516257206|FG000|Overall Study|Withdrawal by Subject|0|||
143194747|NCT02928029|516257207|FG001|Overall Study|Withdrawal by Subject|1|||
143194748|NCT02928029|516257206|FG000|Overall Study|Radiological progression|1|||
143194749|NCT02928029|516257207|FG001|Overall Study|Radiological progression|0|||
143194750|NCT02928029|516257206|FG000|Overall Study|Clinical progression|1|||
143194751|NCT02928029|516257207|FG001|Overall Study|Clinical progression|2|||
143194752|NCT02928029|516257206|FG000|Overall Study|AE not related to clinical progression|1|||
143194753|NCT02928029|516257207|FG001|Overall Study|AE not related to clinical progression|1|||
143194754|NCT03943550|516257208|FG000|Overall Study|Adverse Event|0|||
143194755|NCT03943550|516257209|FG001|Overall Study|Adverse Event|0|||
143194756|NCT03943550|516257210|FG002|Overall Study|Adverse Event|1|||
143194757|NCT03943550|516257208|FG000|Overall Study|Lost to Follow-up|0|||
143194758|NCT03943550|516257209|FG001|Overall Study|Lost to Follow-up|0|||
143194759|NCT03943550|516257210|FG002|Overall Study|Lost to Follow-up|1|||
143194760|NCT03943550|516257208|FG000|Overall Study|Progressive Disease|0|||
143194761|NCT03943550|516257209|FG001|Overall Study|Progressive Disease|0|||
143194762|NCT03943550|516257210|FG002|Overall Study|Progressive Disease|2|||
143194763|NCT03943550|516257208|FG000|Overall Study|Participant Moved Out of the Country|0|||
143194764|NCT03943550|516257209|FG001|Overall Study|Participant Moved Out of the Country|1|||
143261717|NCT00829933|516510638|FG003|Overall Study|Pregnancy|2|||
143261718|NCT00829933|516510635|FG000|Overall Study|Protocol Violation|2|||
143261719|NCT00829933|516510636|FG001|Overall Study|Protocol Violation|1|||
143194765|NCT03943550|516257210|FG002|Overall Study|Participant Moved Out of the Country|0|||
143194766|NCT00503581|516257211|FG000|Overall Study|Study closed|3|||
143194767|NCT00503581|516257212|FG001|Overall Study|Study closed|4|||
143194768|NCT00503581|516257213|FG002|Overall Study|Study closed|2|||
143194769|NCT04262882|516257214|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
143194770|NCT04262882|516257215|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
143194771|NCT04262882|516257214|FG000|Overall Study|Lost to Follow-up|1|||
143194772|NCT04262882|516257215|FG001|Overall Study|Lost to Follow-up|0|||
143194773|NCT04730635|516257216|FG000|Overall Study|Lost to Follow-up|1|||
143194774|NCT04730635|516257217|FG001|Overall Study|Lost to Follow-up|0|||
143194775|NCT04730635|516257216|FG000|Overall Study|Withdrawal by Subject|0|||
143194776|NCT04730635|516257217|FG001|Overall Study|Withdrawal by Subject|1|||
143194777|NCT04934800|516257218|FG000|Overall Study|Other|1|||
143194778|NCT04934800|516257218|FG000|Overall Study|Withdrawal by Subject|5|||
143194779|NCT04934800|516257218|FG000|Overall Study|Lack of Efficacy|1|||
143194780|NCT04934800|516257218|FG000|Overall Study|Adverse Event|9|||
143194781|NCT04934800|516257218|FG000|Overall Study|Lost to Follow-up|5|||
143194782|NCT04934800|516257218|FG000|Overall Study|Enrolled but not treated|1|||
143194783|NCT00516906|516257219|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
143194784|NCT00516906|516257220|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
143194785|NCT01327053|516257226|FG000|Overall Study|Adverse Event|23|||
143194786|NCT01327053|516257227|FG001|Overall Study|Adverse Event|57|||
143194787|NCT01327053|516257226|FG000|Overall Study|Patient/guardian decision|11|||
143194788|NCT01327053|516257227|FG001|Overall Study|Patient/guardian decision|35|||
143194789|NCT01327053|516257226|FG000|Overall Study|Physician Decision|10|||
143194790|NCT01327053|516257227|FG001|Overall Study|Physician Decision|14|||
143194791|NCT01327053|516257226|FG000|Overall Study|Death|1|||
143194792|NCT01327053|516257227|FG001|Overall Study|Death|5|||
143194793|NCT01327053|516257226|FG000|Overall Study|Lost to Follow-up|2|||
143194794|NCT01327053|516257227|FG001|Overall Study|Lost to Follow-up|4|||
143194795|NCT01327053|516257226|FG000|Overall Study|Non-compliance with study treatment|0|||
143194796|NCT01327053|516257227|FG001|Overall Study|Non-compliance with study treatment|5|||
143194797|NCT01327053|516257226|FG000|Overall Study|Study terminated by Sponsor|1|||
143194798|NCT01327053|516257227|FG001|Overall Study|Study terminated by Sponsor|3|||
143194799|NCT01327053|516257226|FG000|Overall Study|Progressive disease|31|||
143194800|NCT01327053|516257227|FG001|Overall Study|Progressive disease|26|||
143194801|NCT01327053|516257226|FG000|Overall Study|Protocol Violation|0|||
143194802|NCT01327053|516257227|FG001|Overall Study|Protocol Violation|1|||
143194803|NCT01327053|516257226|FG000|Overall Study|Untreated|0|||
143194804|NCT01327053|516257227|FG001|Overall Study|Untreated|1|||
143194805|NCT00721578|516257229|FG000|Overall Study|Death|1|||
143194806|NCT00721578|516257230|FG001|Overall Study|Death|1|||
143194807|NCT00721578|516257229|FG000|Overall Study|Withdrawal by Subject|1|||
143194808|NCT00721578|516257230|FG001|Overall Study|Withdrawal by Subject|1|||
143194809|NCT05032690|516257239|FG000|Period 1|Adverse Event|0|||
143194810|NCT05032690|516257240|FG001|Period 1|Adverse Event|1|||
143194811|NCT05032690|516257241|FG002|Period 1|Adverse Event|0|||
143194812|NCT05032690|516257242|FG003|Period 1|Adverse Event|0|||
143194813|NCT05032690|516257239|FG000|Period 1|Withdrawal by Subject|1|||
143194814|NCT05032690|516257240|FG001|Period 1|Withdrawal by Subject|0|||
143194815|NCT05032690|516257241|FG002|Period 1|Withdrawal by Subject|0|||
143194816|NCT05032690|516257242|FG003|Period 1|Withdrawal by Subject|0|||
143194817|NCT05032690|516257239|FG000|Period 1|No longer meets eligibility criteria|0|||
143194818|NCT05032690|516257240|FG001|Period 1|No longer meets eligibility criteria|1|||
143194819|NCT05032690|516257241|FG002|Period 1|No longer meets eligibility criteria|0|||
143194820|NCT05032690|516257242|FG003|Period 1|No longer meets eligibility criteria|0|||
143194821|NCT05032690|516257239|FG000|Period 2|Adverse Event|1|||
143194822|NCT05032690|516257240|FG001|Period 2|Adverse Event|0|||
143194823|NCT05032690|516257241|FG002|Period 2|Adverse Event|0|||
143194824|NCT05032690|516257242|FG003|Period 2|Adverse Event|0|||
143194825|NCT05032690|516257239|FG000|Period 2|Withdrawal by Subject|0|||
143194826|NCT05032690|516257240|FG001|Period 2|Withdrawal by Subject|1|||
143194827|NCT05032690|516257241|FG002|Period 2|Withdrawal by Subject|0|||
143194828|NCT05032690|516257242|FG003|Period 2|Withdrawal by Subject|0|||
143194829|NCT05032690|516257239|FG000|Period 2|No longer meets eligibility criteria|0|||
143194830|NCT05032690|516257240|FG001|Period 2|No longer meets eligibility criteria|1|||
143194831|NCT05032690|516257241|FG002|Period 2|No longer meets eligibility criteria|0|||
143194832|NCT05032690|516257242|FG003|Period 2|No longer meets eligibility criteria|0|||
143194833|NCT05032690|516257239|FG000|Period 3|Adverse Event|0|||
143194834|NCT05032690|516257240|FG001|Period 3|Adverse Event|1|||
143194835|NCT05032690|516257241|FG002|Period 3|Adverse Event|0|||
143194836|NCT05032690|516257242|FG003|Period 3|Adverse Event|0|||
143194837|NCT00840060|516259477|FG000|Overall Study|Withdrawal by Subject|1|||
143194838|NCT00840060|516259478|FG001|Overall Study|Withdrawal by Subject|0|||
143194839|NCT00840060|516259477|FG000|Overall Study|Change in emotional/behavioral status|0|||
143194840|NCT00840060|516259478|FG001|Overall Study|Change in emotional/behavioral status|1|||
143194841|NCT00871923|516259479|FG000|Overall Study|Death|1|||
143194842|NCT00871923|516259479|FG000|Overall Study|Withdrawal by Subject|1|||
143194843|NCT01263015|516259480|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
143194844|NCT01263015|516259481|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
143194845|NCT01263015|516259480|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
143194846|NCT01263015|516259481|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
143194847|NCT01263015|516259480|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
143194848|NCT01263015|516259481|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
143194849|NCT01263015|516259480|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
143194850|NCT01263015|516259481|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
143194851|NCT01263015|516259480|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
143194852|NCT01263015|516259481|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
143194853|NCT01263015|516259480|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
143194854|NCT01263015|516259481|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
143194855|NCT01263015|516259480|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
143194856|NCT01263015|516259481|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
143194857|NCT01263015|516259480|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
143194858|NCT01263015|516259481|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
143194859|NCT01263015|516259480|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
143194860|NCT01263015|516259481|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
143194861|NCT01263015|516259480|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
143194862|NCT01263015|516259481|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
143194863|NCT01263015|516259480|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
143194864|NCT01263015|516259481|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
143194865|NCT01263015|516259480|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
143194866|NCT01263015|516259481|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
143194867|NCT05599451|516259482|FG000|Overall Study|Not randomized|11|||
143194868|NCT05599451|516259483|FG001|Overall Study|Not randomized|0|||
143194869|NCT05599451|516259484|FG002|Overall Study|Not randomized|0|||
143194870|NCT05599451|516259485|FG003|Overall Study|Not randomized|0|||
143194871|NCT05599451|516259486|FG004|Overall Study|Not randomized|0|||
143194872|NCT05599451|516259482|FG000|Overall Study|Physician Decision|0|||
143194873|NCT05599451|516259483|FG001|Overall Study|Physician Decision|0|||
143194874|NCT05599451|516259484|FG002|Overall Study|Physician Decision|0|||
143194875|NCT05599451|516259485|FG003|Overall Study|Physician Decision|1|||
143194876|NCT05599451|516259486|FG004|Overall Study|Physician Decision|0|||
143194877|NCT04143217|516259488|FG000|Overall Study|Withdrawal by Subject|42|||
143194878|NCT04143217|516259488|FG000|Overall Study|Adverse Event|29|||
143194879|NCT04143217|516259488|FG000|Overall Study|Lost to Follow-up|29|||
143194880|NCT04143217|516259488|FG000|Overall Study|Lack of Efficacy|15|||
143194881|NCT04143217|516259488|FG000|Overall Study|Physician Decision|1|||
143194882|NCT04143217|516259488|FG000|Overall Study|Non-Compliance With Study Drug|6|||
143194883|NCT04143217|516259488|FG000|Overall Study|Other, Multiple Categories|11|||
143194884|NCT01962987|516259489|FG000|Overall Study|Adverse Event|4|||
143194885|NCT01962987|516259490|FG001|Overall Study|Adverse Event|4|||
143194886|NCT01962987|516259491|FG002|Overall Study|Adverse Event|0|||
143194887|NCT01962987|516259489|FG000|Overall Study|Lost to Follow-up|0|||
143194888|NCT01962987|516259490|FG001|Overall Study|Lost to Follow-up|0|||
143194889|NCT01962987|516259491|FG002|Overall Study|Lost to Follow-up|1|||
143194890|NCT01962987|516259489|FG000|Overall Study|Non compliance with dosing requirements|4|||
143194891|NCT01962987|516259490|FG001|Overall Study|Non compliance with dosing requirements|2|||
143194892|NCT01962987|516259491|FG002|Overall Study|Non compliance with dosing requirements|0|||
143261720|NCT00829933|516510637|FG002|Overall Study|Protocol Violation|0|||
143261721|NCT00829933|516510638|FG003|Overall Study|Protocol Violation|0|||
143261722|NCT00829933|516510635|FG000|Overall Study|withdrew before treatment started|5|||
143261723|NCT00829933|516510636|FG001|Overall Study|withdrew before treatment started|1|||
143261724|NCT00829933|516510637|FG002|Overall Study|withdrew before treatment started|2|||
143261725|NCT00829933|516510638|FG003|Overall Study|withdrew before treatment started|9|||
143261726|NCT01683019|516512467|FG000|Overall Study|Withdrawal by Subject|2|||
143261727|NCT01683019|516512468|FG001|Overall Study|Withdrawal by Subject|1|||
143261728|NCT01683019|516512469|FG002|Overall Study|Withdrawal by Subject|4|||
143261729|NCT00597701|516512474|FG000|Overall Study|Withdrawal by Subject|5|||
143261730|NCT00597701|516512475|FG001|Overall Study|Withdrawal by Subject|5|||
143261731|NCT00597701|516512474|FG000|Overall Study|Death|0|||
143261732|NCT00597701|516512475|FG001|Overall Study|Death|1|||
143261733|NCT00597701|516512474|FG000|Overall Study|Physician Decision|2|||
143261734|NCT00597701|516512475|FG001|Overall Study|Physician Decision|0|||
143261735|NCT00597701|516512474|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
143261736|NCT00597701|516512475|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
143261737|NCT01107418|516512476|FG000|Overall Study|Disease Progression|45|||
143261738|NCT01107418|516512476|FG000|Overall Study|Adverse Event|3|||
143194893|NCT01962987|516259489|FG000|Overall Study|Miscellaneous|1|||
143194894|NCT01962987|516259490|FG001|Overall Study|Miscellaneous|9|||
143194895|NCT01962987|516259491|FG002|Overall Study|Miscellaneous|2|||
143194896|NCT01962987|516259489|FG000|Overall Study|Restricted medication|5|||
143194897|NCT01962987|516259490|FG001|Overall Study|Restricted medication|1|||
143194898|NCT01962987|516259491|FG002|Overall Study|Restricted medication|1|||
143194899|NCT01962987|516259489|FG000|Overall Study|Serious Adverse Event|1|||
143194900|NCT01962987|516259490|FG001|Overall Study|Serious Adverse Event|0|||
143194901|NCT01962987|516259491|FG002|Overall Study|Serious Adverse Event|0|||
143261739|NCT01107418|516512476|FG000|Overall Study|Withdrawal by Subject|1|||
143194902|NCT01962987|516259489|FG000|Overall Study|Withdrawal by Subject|11|||
143194903|NCT01962987|516259490|FG001|Overall Study|Withdrawal by Subject|10|||
143194904|NCT01962987|516259491|FG002|Overall Study|Withdrawal by Subject|6|||
143194905|NCT01962987|516259489|FG000|Overall Study|Randomized in Error|4|||
143194906|NCT01962987|516259490|FG001|Overall Study|Randomized in Error|2|||
143194907|NCT01962987|516259491|FG002|Overall Study|Randomized in Error|2|||
143194908|NCT01967823|516259492|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
143194909|NCT00316693|516259493|FG000|Overall Study|Adverse Event|6|||
143194910|NCT00316693|516259494|FG001|Overall Study|Adverse Event|1|||
143194911|NCT00316693|516259493|FG000|Overall Study|Protocol Violation|1|||
143194912|NCT00316693|516259494|FG001|Overall Study|Protocol Violation|0|||
143194913|NCT00316693|516259493|FG000|Overall Study|Withdrawal by Subject|6|||
143194914|NCT00316693|516259494|FG001|Overall Study|Withdrawal by Subject|6|||
143194915|NCT00316693|516259493|FG000|Overall Study|Lost to Follow-up|26|||
143194916|NCT00316693|516259494|FG001|Overall Study|Lost to Follow-up|34|||
143194917|NCT00316693|516259493|FG000|Overall Study|Other|38|||
143194918|NCT00316693|516259494|FG001|Overall Study|Other|44|||
143194919|NCT00413894|516259502|FG000|Overall Study|Withdrawal by Subject|10|||
143194920|NCT00413894|516259502|FG000|Overall Study|Administrative Reasons|1|||
143194921|NCT00413894|516259502|FG000|Overall Study|Hb <10 grams/deciliter|12|||
143194922|NCT00413894|516259502|FG000|Overall Study|Adverse Event|28|||
143194923|NCT00413894|516259502|FG000|Overall Study|Protocol Violation|11|||
143194924|NCT00413894|516259502|FG000|Overall Study|Other|18|||
143194925|NCT01942161|516259503|FG000|Overall Study|Adverse Event|1|||
143194926|NCT01942161|516259504|FG001|Overall Study|Adverse Event|2|||
143194927|NCT01942161|516259505|FG002|Overall Study|Adverse Event|5|||
143194928|NCT01942161|516259503|FG000|Overall Study|Physician Decision|3|||
143194929|NCT01942161|516259504|FG001|Overall Study|Physician Decision|1|||
143194930|NCT01942161|516259505|FG002|Overall Study|Physician Decision|0|||
143194931|NCT01942161|516259503|FG000|Overall Study|Protocol Violation|1|||
143194932|NCT01942161|516259504|FG001|Overall Study|Protocol Violation|0|||
143194933|NCT01942161|516259505|FG002|Overall Study|Protocol Violation|0|||
143194934|NCT01942161|516259503|FG000|Overall Study|Withdrawal by Subject|3|||
143194935|NCT01942161|516259504|FG001|Overall Study|Withdrawal by Subject|3|||
143194936|NCT01942161|516259505|FG002|Overall Study|Withdrawal by Subject|1|||
143194937|NCT05289271|516259506|FG000|Overall Study|Mistakenly allocated, untreated|1|||
143194938|NCT05289271|516259507|FG001|Overall Study|Mistakenly allocated, untreated|0|||
143194939|NCT03356977|516259511|FG000|Overall Study|Lost to Follow-up|3|||
143194940|NCT03356977|516259511|FG000|Overall Study|Withdrawal by parent/guardian|2|||
143194941|NCT01728077|516259516|FG000|Overall Study|Lack of Efficacy|3|||
143194942|NCT01728077|516259517|FG001|Overall Study|Lack of Efficacy|1|||
143194943|NCT01728077|516259516|FG000|Overall Study|Lost to Follow-up|1|||
143194944|NCT01728077|516259517|FG001|Overall Study|Lost to Follow-up|0|||
143194945|NCT01728077|516259516|FG000|Overall Study|Subject choice|2|||
143194946|NCT01728077|516259517|FG001|Overall Study|Subject choice|3|||
143194947|NCT01728077|516259516|FG000|Overall Study|Death|0|||
143194948|NCT01728077|516259517|FG001|Overall Study|Death|1|||
143194949|NCT01728077|516259516|FG000|Overall Study|Patient moving|1|||
143194950|NCT01728077|516259517|FG001|Overall Study|Patient moving|0|||
143261740|NCT01107418|516512476|FG000|Overall Study|Study Closing|1|||
143194951|NCT01728077|516259516|FG000|Overall Study|Non compliance|1|||
143194952|NCT01728077|516259517|FG001|Overall Study|Non compliance|0|||
143194953|NCT00416715|516259520|FG000|Overall Study|Not evaluable for joint aches|7|||
143194954|NCT00416715|516259520|FG000|Overall Study|Vitamin D levels not evaluable|8|||
143194955|NCT00489736|516259521|FG000|Overall Study|Lack of Efficacy|53|||
143194956|NCT00489736|516259522|FG001|Overall Study|Lack of Efficacy|14|||
143194957|NCT00489736|516259521|FG000|Overall Study|Adverse Event|32|||
143261741|NCT01107418|516512476|FG000|Overall Study|Started Other Therapy|1|||
143194958|NCT00489736|516259522|FG001|Overall Study|Adverse Event|45|||
143194959|NCT00489736|516259521|FG000|Overall Study|Poor compliance|6|||
143194960|NCT00489736|516259522|FG001|Overall Study|Poor compliance|2|||
143194961|NCT00489736|516259521|FG000|Overall Study|Not coded/ Not pre-specified|5|||
143194962|NCT00489736|516259522|FG001|Overall Study|Not coded/ Not pre-specified|8|||
143194963|NCT01007435|516259527|FG000|Overall Study|Adverse Event|16|||
143194964|NCT01007435|516259528|FG001|Overall Study|Adverse Event|25|||
143194965|NCT01007435|516259529|FG002|Overall Study|Adverse Event|47|||
143194966|NCT01007435|516259530|FG003|Overall Study|Adverse Event|31|||
143194967|NCT01007435|516259527|FG000|Overall Study|Death|2|||
143194968|NCT01007435|516259528|FG001|Overall Study|Death|4|||
143194969|NCT01007435|516259529|FG002|Overall Study|Death|2|||
143194970|NCT01007435|516259530|FG003|Overall Study|Death|1|||
143194971|NCT01007435|516259527|FG000|Overall Study|Insufficient Therapeutic Response|21|||
143194972|NCT01007435|516259528|FG001|Overall Study|Insufficient Therapeutic Response|7|||
143194973|NCT01007435|516259529|FG002|Overall Study|Insufficient Therapeutic Response|2|||
143194974|NCT01007435|516259530|FG003|Overall Study|Insufficient Therapeutic Response|9|||
143194975|NCT01007435|516259527|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
143194976|NCT01007435|516259528|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
143194977|NCT01007435|516259529|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
143194978|NCT01007435|516259530|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
143194979|NCT01007435|516259527|FG000|Overall Study|Other Protocol Violation|2|||
143194980|NCT01007435|516259528|FG001|Overall Study|Other Protocol Violation|0|||
143194981|NCT01007435|516259529|FG002|Overall Study|Other Protocol Violation|1|||
143194982|NCT01007435|516259530|FG003|Overall Study|Other Protocol Violation|0|||
143194983|NCT01007435|516259527|FG000|Overall Study|Refused Treatment|13|||
143194984|NCT01007435|516259528|FG001|Overall Study|Refused Treatment|13|||
143194985|NCT01007435|516259529|FG002|Overall Study|Refused Treatment|5|||
143194986|NCT01007435|516259530|FG003|Overall Study|Refused Treatment|8|||
143194987|NCT01007435|516259527|FG000|Overall Study|Failure to Return|5|||
143194988|NCT01007435|516259528|FG001|Overall Study|Failure to Return|4|||
143194989|NCT01007435|516259529|FG002|Overall Study|Failure to Return|3|||
143194990|NCT01007435|516259530|FG003|Overall Study|Failure to Return|6|||
143194991|NCT01007435|516259527|FG000|Overall Study|Reason not Specified|1|||
143194992|NCT01007435|516259528|FG001|Overall Study|Reason not Specified|1|||
143194993|NCT01007435|516259529|FG002|Overall Study|Reason not Specified|2|||
143194994|NCT01007435|516259530|FG003|Overall Study|Reason not Specified|1|||
143194995|NCT00347438|516259531|FG000|Overall Study|Withdrawal by Subject|1|||
143194996|NCT00347438|516259531|FG000|Overall Study|Physician Decision|1|||
143194997|NCT02545517|516259532|FG000|Overall Study|Death|2|||
143194998|NCT02545517|516259533|FG001|Overall Study|Death|2|||
143194999|NCT02545517|516259534|FG002|Overall Study|Death|1|||
143195000|NCT02545517|516259532|FG000|Overall Study|Lost to Follow-up|14|||
143195001|NCT02545517|516259533|FG001|Overall Study|Lost to Follow-up|13|||
143195002|NCT02545517|516259534|FG002|Overall Study|Lost to Follow-up|17|||
143195003|NCT02545517|516259532|FG000|Overall Study|Protocol Violation|0|||
143195004|NCT02545517|516259533|FG001|Overall Study|Protocol Violation|1|||
143195005|NCT02545517|516259534|FG002|Overall Study|Protocol Violation|1|||
143195006|NCT02545517|516259532|FG000|Overall Study|Withdrawal by Subject|5|||
143195007|NCT02545517|516259533|FG001|Overall Study|Withdrawal by Subject|8|||
143195008|NCT02545517|516259534|FG002|Overall Study|Withdrawal by Subject|9|||
143195009|NCT02545517|516259532|FG000|Overall Study|Administrative reason|5|||
143195010|NCT02545517|516259533|FG001|Overall Study|Administrative reason|6|||
143195011|NCT02545517|516259534|FG002|Overall Study|Administrative reason|10|||
143195012|NCT02545517|516259532|FG000|Overall Study|Other|2|||
143195013|NCT02545517|516259533|FG001|Overall Study|Other|4|||
143195014|NCT02545517|516259534|FG002|Overall Study|Other|3|||
143195015|NCT01529515|516259535|FG000|TRANSITION PHASE|Adverse Event|16|||
143195016|NCT01529515|516259536|FG001|TRANSITION PHASE|Adverse Event|0|||
143195017|NCT01529515|516259537|FG002|TRANSITION PHASE|Adverse Event|0|||
143195018|NCT01529515|516259538|FG003|TRANSITION PHASE|Adverse Event|0|||
143195019|NCT01529515|516259535|FG000|TRANSITION PHASE|Death|1|||
143195020|NCT01529515|516259536|FG001|TRANSITION PHASE|Death|0|||
143195021|NCT01529515|516259537|FG002|TRANSITION PHASE|Death|0|||
143195022|NCT01529515|516259538|FG003|TRANSITION PHASE|Death|0|||
143195023|NCT01529515|516259535|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
143195024|NCT01529515|516259536|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
143195025|NCT01529515|516259537|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
143195026|NCT01529515|516259538|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
143195027|NCT01529515|516259535|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
143195028|NCT01529515|516259536|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
143195029|NCT01529515|516259537|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
143369652|NCT00603447|516896193|FG003|Overall Study|Adverse Event|2|||
143195030|NCT01529515|516259538|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
143195031|NCT01529515|516259535|FG000|TRANSITION PHASE|Protocol Violation|4|||
143195032|NCT01529515|516259536|FG001|TRANSITION PHASE|Protocol Violation|0|||
143195033|NCT01529515|516259537|FG002|TRANSITION PHASE|Protocol Violation|0|||
143195034|NCT01529515|516259538|FG003|TRANSITION PHASE|Protocol Violation|0|||
143195035|NCT01529515|516259535|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
143195036|NCT01529515|516259536|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
143195037|NCT01529515|516259537|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
143195038|NCT01529515|516259538|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
143195039|NCT01529515|516259535|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
143195040|NCT01529515|516259536|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
143195041|NCT01529515|516259537|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
143195042|NCT01529515|516259538|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
143195043|NCT01529515|516259535|FG000|TRANSITION PHASE|Other|9|||
143195044|NCT01529515|516259536|FG001|TRANSITION PHASE|Other|0|||
143195045|NCT01529515|516259537|FG002|TRANSITION PHASE|Other|0|||
143195046|NCT01529515|516259538|FG003|TRANSITION PHASE|Other|0|||
143195047|NCT01529515|516259535|FG000|MAINTENANCE PHASE|Adverse Event|0|||
143195048|NCT01529515|516259536|FG001|MAINTENANCE PHASE|Adverse Event|10|||
143195049|NCT01529515|516259537|FG002|MAINTENANCE PHASE|Adverse Event|0|||
143195050|NCT01529515|516259538|FG003|MAINTENANCE PHASE|Adverse Event|0|||
143195051|NCT01529515|516259535|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
143195052|NCT01529515|516259536|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
143195053|NCT01529515|516259537|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
143195054|NCT01529515|516259538|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
143195055|NCT01529515|516259535|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
143195056|NCT01529515|516259536|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
143195057|NCT01529515|516259537|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
143195058|NCT01529515|516259538|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
143195059|NCT01529515|516259535|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
143195060|NCT01529515|516259536|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
143195061|NCT01529515|516259537|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
143195062|NCT01529515|516259538|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
143195063|NCT01529515|516259535|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
143195064|NCT01529515|516259536|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
143195065|NCT01529515|516259537|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
143195066|NCT01529515|516259538|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
143195067|NCT01529515|516259535|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
143195068|NCT01529515|516259536|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
143195069|NCT01529515|516259537|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
143195070|NCT01529515|516259538|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
143195071|NCT01529515|516259535|FG000|MAINTENANCE PHASE|Other|0|||
143195072|NCT01529515|516259536|FG001|MAINTENANCE PHASE|Other|10|||
143195073|NCT01529515|516259537|FG002|MAINTENANCE PHASE|Other|0|||
143195074|NCT01529515|516259538|FG003|MAINTENANCE PHASE|Other|0|||
143195075|NCT01529515|516259535|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
143195076|NCT01529515|516259536|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
143195077|NCT01529515|516259537|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
143195078|NCT01529515|516259538|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
143195079|NCT01529515|516259535|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
143195080|NCT01529515|516259536|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
143195081|NCT01529515|516259537|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
143195082|NCT01529515|516259538|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
143195083|NCT01529515|516259535|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
143195084|NCT01529515|516259536|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
143195085|NCT01529515|516259537|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
143195086|NCT01529515|516259538|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
143195087|NCT01529515|516259535|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
143195088|NCT01529515|516259536|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
143195089|NCT01529515|516259537|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
143195090|NCT01529515|516259538|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
143195091|NCT01529515|516259535|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
143195092|NCT01529515|516259536|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
143195093|NCT01529515|516259537|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
143195094|NCT01529515|516259538|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
143195095|NCT01529515|516259535|FG000|DOUBLE BLIND PHASE|Other|0|||
143195096|NCT01529515|516259536|FG001|DOUBLE BLIND PHASE|Other|0|||
143261742|NCT01107418|516512476|FG000|Overall Study|Entered Extension Study|1|||
143261743|NCT01314911|516512478|FG000|Overall Study|Lost to Follow-up|3|||
143195097|NCT01529515|516259537|FG002|DOUBLE BLIND PHASE|Other|9|||
143195098|NCT01529515|516259538|FG003|DOUBLE BLIND PHASE|Other|2|||
143195099|NCT03334851|516259540|FG000|Overall Study|Other|0|||
143195100|NCT03334851|516259541|FG001|Overall Study|Other|0|||
143195101|NCT03334851|516259542|FG002|Overall Study|Other|0|||
143195102|NCT03334851|516259543|FG003|Overall Study|Other|0|||
143195103|NCT03334851|516259544|FG004|Overall Study|Other|0|||
143195104|NCT03334851|516259545|FG005|Overall Study|Other|0|||
143195105|NCT03334851|516259546|FG006|Overall Study|Other|0|||
143195106|NCT03334851|516259547|FG007|Overall Study|Other|1|||
143195107|NCT03334851|516259548|FG008|Overall Study|Other|0|||
143195108|NCT03334851|516259549|FG009|Overall Study|Other|0|||
143195109|NCT03334851|516259550|FG010|Overall Study|Other|0|||
143195110|NCT03334851|516259551|FG011|Overall Study|Other|0|||
143195111|NCT03334851|516259552|FG012|Overall Study|Other|0|||
143195112|NCT03334851|516259540|FG000|Overall Study|Adverse Event|0|||
143195113|NCT03334851|516259541|FG001|Overall Study|Adverse Event|0|||
143195114|NCT03334851|516259542|FG002|Overall Study|Adverse Event|0|||
143195115|NCT03334851|516259543|FG003|Overall Study|Adverse Event|0|||
143195116|NCT03334851|516259544|FG004|Overall Study|Adverse Event|0|||
143195117|NCT03334851|516259545|FG005|Overall Study|Adverse Event|0|||
143195118|NCT03334851|516259546|FG006|Overall Study|Adverse Event|0|||
143195119|NCT03334851|516259547|FG007|Overall Study|Adverse Event|1|||
143195120|NCT03334851|516259548|FG008|Overall Study|Adverse Event|0|||
143195121|NCT03334851|516259549|FG009|Overall Study|Adverse Event|0|||
143195122|NCT03334851|516259550|FG010|Overall Study|Adverse Event|0|||
143195123|NCT03334851|516259551|FG011|Overall Study|Adverse Event|0|||
143195124|NCT03334851|516259552|FG012|Overall Study|Adverse Event|0|||
143195125|NCT03334851|516259540|FG000|Overall Study|Withdrawal by Subject|0|||
143195126|NCT03334851|516259541|FG001|Overall Study|Withdrawal by Subject|0|||
143195127|NCT03334851|516259542|FG002|Overall Study|Withdrawal by Subject|0|||
143195128|NCT03334851|516259543|FG003|Overall Study|Withdrawal by Subject|0|||
143195129|NCT03334851|516259544|FG004|Overall Study|Withdrawal by Subject|0|||
143195130|NCT03334851|516259545|FG005|Overall Study|Withdrawal by Subject|0|||
143195131|NCT03334851|516259546|FG006|Overall Study|Withdrawal by Subject|0|||
143195132|NCT03334851|516259547|FG007|Overall Study|Withdrawal by Subject|0|||
143195133|NCT03334851|516259548|FG008|Overall Study|Withdrawal by Subject|0|||
143195134|NCT03334851|516259549|FG009|Overall Study|Withdrawal by Subject|0|||
143195135|NCT03334851|516259550|FG010|Overall Study|Withdrawal by Subject|1|||
143195136|NCT03334851|516259551|FG011|Overall Study|Withdrawal by Subject|0|||
143195137|NCT03334851|516259552|FG012|Overall Study|Withdrawal by Subject|1|||
143195138|NCT03334851|516259540|FG000|Overall Study|Lost to Follow-up|0|||
143195139|NCT03334851|516259541|FG001|Overall Study|Lost to Follow-up|0|||
143195140|NCT03334851|516259542|FG002|Overall Study|Lost to Follow-up|0|||
143195141|NCT03334851|516259543|FG003|Overall Study|Lost to Follow-up|0|||
143195142|NCT03334851|516259544|FG004|Overall Study|Lost to Follow-up|0|||
143195143|NCT03334851|516259545|FG005|Overall Study|Lost to Follow-up|0|||
143195144|NCT03334851|516259546|FG006|Overall Study|Lost to Follow-up|0|||
143195145|NCT03334851|516259547|FG007|Overall Study|Lost to Follow-up|0|||
143195146|NCT03334851|516259548|FG008|Overall Study|Lost to Follow-up|0|||
143195147|NCT03334851|516259549|FG009|Overall Study|Lost to Follow-up|0|||
143195148|NCT03334851|516259550|FG010|Overall Study|Lost to Follow-up|2|||
143195149|NCT03334851|516259551|FG011|Overall Study|Lost to Follow-up|1|||
143195150|NCT03334851|516259552|FG012|Overall Study|Lost to Follow-up|0|||
143195151|NCT00523705|516259553|FG000|Overall Study|No time for study.|0|||
143195152|NCT00523705|516259554|FG001|Overall Study|No time for study.|1|||
143195153|NCT01190475|516259556|FG000|Overall Study|Withdrawal by Subject|0|||
143195154|NCT01190475|516259557|FG001|Overall Study|Withdrawal by Subject|0|||
143195155|NCT01190475|516259558|FG002|Overall Study|Withdrawal by Subject|1|||
143195156|NCT00543803|516259559|FG000|Overall Study|Adverse Event|14|||
143195157|NCT00543803|516259559|FG000|Overall Study|Lack of Efficacy|22|||
143195158|NCT00543803|516259559|FG000|Overall Study|Lost to Follow-up|20|||
143195159|NCT00543803|516259559|FG000|Overall Study|Other|86|||
143195160|NCT00666588|516259560|FG000|Overall Study|ineligible|2|||
143195161|NCT00666588|516259561|FG001|Overall Study|ineligible|0|||
143195162|NCT00666588|516259562|FG002|Overall Study|ineligible|0|||
143195163|NCT00666588|516259563|FG003|Overall Study|ineligible|2|||
143195164|NCT00666588|516259560|FG000|Overall Study|inevaluable|2|||
143195165|NCT00666588|516259561|FG001|Overall Study|inevaluable|0|||
143195166|NCT00666588|516259562|FG002|Overall Study|inevaluable|0|||
143195167|NCT00666588|516259563|FG003|Overall Study|inevaluable|0|||
143195168|NCT04043234|516259566|FG000|Overall Study|Lost to Follow-up|1|||
143195169|NCT04043234|516259566|FG000|Overall Study|Withdrawal by Subject|1|||
143195170|NCT03622112|516259570|FG000|Overall Study|Withdrawal by Subject|6|||
143195171|NCT03622112|516259571|FG001|Overall Study|Withdrawal by Subject|2|||
143195172|NCT03622112|516259572|FG002|Overall Study|Withdrawal by Subject|4|||
143195173|NCT03622112|516259573|FG003|Overall Study|Withdrawal by Subject|2|||
143195174|NCT03622112|516259574|FG004|Overall Study|Withdrawal by Subject|1|||
143195175|NCT03622112|516259575|FG005|Overall Study|Withdrawal by Subject|2|||
143195176|NCT03622112|516259576|FG006|Overall Study|Withdrawal by Subject|2|||
143195177|NCT03622112|516259570|FG000|Overall Study|Death|0|||
143195178|NCT03622112|516259571|FG001|Overall Study|Death|0|||
143195179|NCT03622112|516259572|FG002|Overall Study|Death|0|||
143195180|NCT03622112|516259573|FG003|Overall Study|Death|1|||
143195181|NCT03622112|516259574|FG004|Overall Study|Death|0|||
143195182|NCT03622112|516259575|FG005|Overall Study|Death|0|||
143195183|NCT03622112|516259576|FG006|Overall Study|Death|0|||
143195184|NCT03622112|516259570|FG000|Overall Study|Lost to Follow-up|1|||
143195185|NCT03622112|516259571|FG001|Overall Study|Lost to Follow-up|1|||
143195186|NCT03622112|516259572|FG002|Overall Study|Lost to Follow-up|0|||
143195187|NCT03622112|516259573|FG003|Overall Study|Lost to Follow-up|0|||
143195188|NCT03622112|516259574|FG004|Overall Study|Lost to Follow-up|0|||
143195189|NCT03622112|516259575|FG005|Overall Study|Lost to Follow-up|0|||
143195190|NCT03622112|516259576|FG006|Overall Study|Lost to Follow-up|0|||
143195191|NCT03622112|516259570|FG000|Overall Study|Study-specific withdrawal criteria|10|||
143195192|NCT03622112|516259571|FG001|Overall Study|Study-specific withdrawal criteria|8|||
143195193|NCT03622112|516259572|FG002|Overall Study|Study-specific withdrawal criteria|7|||
143195194|NCT03622112|516259573|FG003|Overall Study|Study-specific withdrawal criteria|6|||
143195195|NCT03622112|516259574|FG004|Overall Study|Study-specific withdrawal criteria|4|||
143195196|NCT03622112|516259575|FG005|Overall Study|Study-specific withdrawal criteria|18|||
143195197|NCT03622112|516259576|FG006|Overall Study|Study-specific withdrawal criteria|4|||
143195198|NCT03622112|516259570|FG000|Overall Study|Protocol Violation|2|||
143195199|NCT03622112|516259571|FG001|Overall Study|Protocol Violation|0|||
143195200|NCT03622112|516259572|FG002|Overall Study|Protocol Violation|1|||
143195201|NCT03622112|516259573|FG003|Overall Study|Protocol Violation|1|||
143195202|NCT03622112|516259574|FG004|Overall Study|Protocol Violation|0|||
143195203|NCT03622112|516259575|FG005|Overall Study|Protocol Violation|0|||
143195204|NCT03622112|516259576|FG006|Overall Study|Protocol Violation|0|||
143195205|NCT03622112|516259570|FG000|Overall Study|Adverse Event|6|||
143195206|NCT03622112|516259571|FG001|Overall Study|Adverse Event|8|||
143195207|NCT03622112|516259572|FG002|Overall Study|Adverse Event|4|||
143195208|NCT03622112|516259573|FG003|Overall Study|Adverse Event|11|||
143195209|NCT03622112|516259574|FG004|Overall Study|Adverse Event|4|||
143195210|NCT03622112|516259575|FG005|Overall Study|Adverse Event|20|||
143195211|NCT03622112|516259576|FG006|Overall Study|Adverse Event|2|||
143195212|NCT03622112|516259570|FG000|Overall Study|Reason not specified|0|||
143195213|NCT03622112|516259571|FG001|Overall Study|Reason not specified|1|||
143195214|NCT03622112|516259572|FG002|Overall Study|Reason not specified|0|||
143195215|NCT03622112|516259573|FG003|Overall Study|Reason not specified|1|||
143195216|NCT03622112|516259574|FG004|Overall Study|Reason not specified|1|||
143195217|NCT03622112|516259575|FG005|Overall Study|Reason not specified|2|||
143195218|NCT03622112|516259576|FG006|Overall Study|Reason not specified|1|||
143195219|NCT01165320|516259577|FG000|Overall Study|Clinical adverse experience|2|||
143195220|NCT01165320|516259578|FG001|Overall Study|Clinical adverse experience|1|||
143195221|NCT01165320|516259579|FG002|Overall Study|Clinical adverse experience|0|||
143195222|NCT01165320|516259577|FG000|Overall Study|Laboratory adverse experience|1|||
143195223|NCT01165320|516259578|FG001|Overall Study|Laboratory adverse experience|0|||
143195224|NCT01165320|516259579|FG002|Overall Study|Laboratory adverse experience|0|||
143195225|NCT01165320|516259577|FG000|Overall Study|Lack of Efficacy|0|||
143195226|NCT01165320|516259578|FG001|Overall Study|Lack of Efficacy|2|||
143195227|NCT01165320|516259579|FG002|Overall Study|Lack of Efficacy|0|||
143195228|NCT01165320|516259577|FG000|Overall Study|Reason unknown|0|||
143195229|NCT01165320|516259578|FG001|Overall Study|Reason unknown|1|||
143195230|NCT01165320|516259579|FG002|Overall Study|Reason unknown|0|||
143195231|NCT02680041|516259580|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
143195232|NCT02680041|516259580|FG000|Overall Study|Lost to Follow-up|2|||
143195233|NCT00521599|516259581|FG000|Overall Study|Adverse Event|5|||
143195234|NCT00521599|516259582|FG001|Overall Study|Adverse Event|7|||
143195235|NCT00521599|516259583|FG002|Overall Study|Adverse Event|6|||
143195236|NCT00521599|516259581|FG000|Overall Study|Treatment Failure|8|||
143195237|NCT00521599|516259582|FG001|Overall Study|Treatment Failure|9|||
143195238|NCT00521599|516259583|FG002|Overall Study|Treatment Failure|22|||
143195239|NCT00521599|516259581|FG000|Overall Study|Lost to Follow-up|2|||
143195240|NCT00521599|516259582|FG001|Overall Study|Lost to Follow-up|1|||
143195241|NCT00521599|516259583|FG002|Overall Study|Lost to Follow-up|2|||
143195242|NCT00521599|516259581|FG000|Overall Study|Withdrawal by Subject|3|||
143195243|NCT00521599|516259582|FG001|Overall Study|Withdrawal by Subject|5|||
143195244|NCT00521599|516259583|FG002|Overall Study|Withdrawal by Subject|1|||
143195245|NCT00521599|516259581|FG000|Overall Study|Withdrawal by subject treatment related|3|||
143195246|NCT00521599|516259582|FG001|Overall Study|Withdrawal by subject treatment related|1|||
143195247|NCT00521599|516259583|FG002|Overall Study|Withdrawal by subject treatment related|2|||
143261744|NCT01314911|516512479|FG001|Overall Study|Lost to Follow-up|2|||
143195248|NCT00521599|516259581|FG000|Overall Study|Protocol Violation|2|||
143261745|NCT01314911|516512478|FG000|Overall Study|Withdrawal by Subject|1|||
143261746|NCT01314911|516512479|FG001|Overall Study|Withdrawal by Subject|3|||
143195249|NCT00521599|516259582|FG001|Overall Study|Protocol Violation|4|||
143195250|NCT00521599|516259583|FG002|Overall Study|Protocol Violation|2|||
143195251|NCT00521599|516259581|FG000|Overall Study|Did not meet protocol eligibility|2|||
143195252|NCT00521599|516259582|FG001|Overall Study|Did not meet protocol eligibility|2|||
143195253|NCT00521599|516259583|FG002|Overall Study|Did not meet protocol eligibility|1|||
143195254|NCT00515294|516259584|FG000|Overall Study|Lost to Follow-up|3|||
143195255|NCT00515294|516259585|FG001|Overall Study|Lost to Follow-up|2|||
143195256|NCT00515294|516259586|FG002|Overall Study|Lost to Follow-up|3|||
143195257|NCT00515294|516259587|FG003|Overall Study|Lost to Follow-up|1|||
143195258|NCT00515294|516259584|FG000|Overall Study|Driver simulator problems|1|||
143261747|NCT01314911|516512478|FG000|Overall Study|Received Non-randomized Study Drug|0|||
143261748|NCT01314911|516512479|FG001|Overall Study|Received Non-randomized Study Drug|1|||
143195259|NCT00515294|516259585|FG001|Overall Study|Driver simulator problems|1|||
143195260|NCT00515294|516259586|FG002|Overall Study|Driver simulator problems|1|||
143195261|NCT00515294|516259587|FG003|Overall Study|Driver simulator problems|3|||
143195262|NCT00515294|516259584|FG000|Overall Study|Caffeine amount inaccurate|5|||
143195263|NCT00515294|516259585|FG001|Overall Study|Caffeine amount inaccurate|0|||
143195264|NCT00515294|516259586|FG002|Overall Study|Caffeine amount inaccurate|7|||
143195265|NCT00515294|516259587|FG003|Overall Study|Caffeine amount inaccurate|0|||
143195266|NCT01639339|516259593|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
143195267|NCT01639339|516259594|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
143195268|NCT01639339|516259593|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
143195269|NCT01639339|516259594|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
143195270|NCT01639339|516259593|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
143195271|NCT01639339|516259594|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
143195272|NCT01639339|516259593|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
143195273|NCT01639339|516259594|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
143195274|NCT01639339|516259593|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
143195275|NCT01639339|516259594|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
143195276|NCT01639339|516259593|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
143195277|NCT01639339|516259594|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
143195278|NCT01639339|516259593|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
143195279|NCT01639339|516259594|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
143195280|NCT01639339|516259593|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
143195281|NCT01639339|516259594|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
143195282|NCT01639339|516259593|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
143195283|NCT01639339|516259594|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
143195284|NCT01639339|516259593|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
143195285|NCT01639339|516259594|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
143195286|NCT00367744|516259595|FG000|Overall Study|Lost to Follow-up|4|||
143195287|NCT00367744|516259596|FG001|Overall Study|Lost to Follow-up|5|||
143195288|NCT00096226|516259603|FG000|Overall Study|Ineligible|2|||
143195289|NCT00096226|516259603|FG000|Overall Study|Protocol treatment not started|1|||
143195290|NCT01666119|516259604|FG000|Overall Study|Adverse Event|6|||
143195291|NCT01666119|516259604|FG000|Overall Study|Withdrawal by Subject|16|||
143195292|NCT01666119|516259604|FG000|Overall Study|Lost to Follow-up|7|||
143195293|NCT01666119|516259604|FG000|Overall Study|non compliance with study medication, pa|18|||
143195294|NCT01666119|516259604|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
143195295|NCT02979093|516259615|FG000|First Scan Session|Scanning data problems|1|||
143195296|NCT02979093|516259616|FG001|First Scan Session|Scanning data problems|2|||
143195297|NCT02979093|516259617|FG002|First Scan Session|Scanning data problems|2|||
143195298|NCT02979093|516259618|FG003|First Scan Session|Scanning data problems|0|||
143195299|NCT02979093|516259615|FG000|Second Scan Session|Scanning data problems|3|||
143261749|NCT01314911|516512478|FG000|Overall Study|Never Started Treatment|1|||
143261750|NCT01314911|516512479|FG001|Overall Study|Never Started Treatment|0|||
143261751|NCT03442764|516512485|FG000|Overall Study|Adverse Event|1|||
143261752|NCT03442764|516512486|FG001|Overall Study|Adverse Event|0|||
143195300|NCT02979093|516259616|FG001|Second Scan Session|Scanning data problems|0|||
143195301|NCT02979093|516259617|FG002|Second Scan Session|Scanning data problems|1|||
143195302|NCT02979093|516259618|FG003|Second Scan Session|Scanning data problems|3|||
143195303|NCT06107803|516259619|FG000|Overall Study|Adverse Event|1|||
143195304|NCT06107803|516259619|FG000|Overall Study|Withdrawal by Subject|2|||
143195305|NCT06107803|516259619|FG000|Overall Study|Protocol Violation|1|||
143195306|NCT03070223|516259621|FG000|Overall Study|Lost to Follow-up|34|||
143195307|NCT03070223|516259622|FG001|Overall Study|Lost to Follow-up|27|||
143195308|NCT03070223|516259621|FG000|Overall Study|Withdrawal by Subject|12|||
143195309|NCT03070223|516259622|FG001|Overall Study|Withdrawal by Subject|22|||
143195310|NCT03070223|516259621|FG000|Overall Study|Protocol Violation|0|||
143195311|NCT03070223|516259622|FG001|Overall Study|Protocol Violation|1|||
143195312|NCT02684058|516259625|FG000|Treatment Period|Progressive disease|4|||
143195313|NCT02684058|516259626|FG001|Treatment Period|Progressive disease|10|||
143195314|NCT02684058|516259627|FG002|Treatment Period|Progressive disease|19|||
143195315|NCT02684058|516259625|FG000|Treatment Period|Adverse Event|3|||
143195316|NCT02684058|516259626|FG001|Treatment Period|Adverse Event|8|||
143195317|NCT02684058|516259627|FG002|Treatment Period|Adverse Event|1|||
143195318|NCT02684058|516259625|FG000|Treatment Period|Physician Decision|5|||
143195319|NCT02684058|516259626|FG001|Treatment Period|Physician Decision|1|||
143195320|NCT02684058|516259627|FG002|Treatment Period|Physician Decision|2|||
143195321|NCT02684058|516259625|FG000|Treatment Period|New therapy for study indication|1|||
143195322|NCT02684058|516259626|FG001|Treatment Period|New therapy for study indication|0|||
143195323|NCT02684058|516259627|FG002|Treatment Period|New therapy for study indication|0|||
143195324|NCT02684058|516259625|FG000|Treatment Period|Protocol deviation|0|||
143195325|NCT02684058|516259626|FG001|Treatment Period|Protocol deviation|1|||
143195326|NCT02684058|516259627|FG002|Treatment Period|Protocol deviation|0|||
143195327|NCT02684058|516259625|FG000|Treatment Period|Subject/guardian decision|4|||
143195328|NCT02684058|516259626|FG001|Treatment Period|Subject/guardian decision|3|||
143195329|NCT02684058|516259627|FG002|Treatment Period|Subject/guardian decision|0|||
143195330|NCT02684058|516259625|FG000|Treatment Period|Death|0|||
143195331|NCT02684058|516259626|FG001|Treatment Period|Death|0|||
143195332|NCT02684058|516259627|FG002|Treatment Period|Death|2|||
143195333|NCT02684058|516259625|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
143195334|NCT02684058|516259626|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
143195335|NCT02684058|516259627|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
143195336|NCT02684058|516259625|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
143195337|NCT02684058|516259626|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
143195338|NCT02684058|516259627|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
143195339|NCT02684058|516259625|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
143195340|NCT02684058|516259626|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
143195341|NCT02684058|516259627|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
143195342|NCT02684058|516259625|FG000|Post-treatment Efficacy Follow-up|Death|0|||
143195343|NCT02684058|516259626|FG001|Post-treatment Efficacy Follow-up|Death|0|||
143195344|NCT02684058|516259627|FG002|Post-treatment Efficacy Follow-up|Death|3|||
143195345|NCT02684058|516259625|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
143195346|NCT02684058|516259626|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
143195347|NCT02684058|516259627|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
143195348|NCT02684058|516259625|FG000|Post-treatment Survival Follow-up|Death|0|||
143195349|NCT02684058|516259626|FG001|Post-treatment Survival Follow-up|Death|0|||
143195350|NCT02684058|516259627|FG002|Post-treatment Survival Follow-up|Death|7|||
143195351|NCT02684058|516259625|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
143195352|NCT02684058|516259626|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
143195353|NCT02684058|516259627|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
143195354|NCT02684058|516259625|FG000|Crossover Treatment Period|Progressive disease|0|||
143195355|NCT02684058|516259626|FG001|Crossover Treatment Period|Progressive disease|1|||
143195356|NCT02684058|516259627|FG002|Crossover Treatment Period|Progressive disease|0|||
143195357|NCT05151445|516259632|FG000|Overall Study|Withdrawal by Subject|3|||
143195358|NCT01638013|516259633|FG000|Overall Study|Adverse Event|36|||
143195359|NCT01638013|516259634|FG001|Overall Study|Adverse Event|29|||
143195360|NCT01638013|516259635|FG002|Overall Study|Adverse Event|48|||
143195361|NCT01638013|516259633|FG000|Overall Study|Lack of Efficacy|39|||
143195362|NCT01638013|516259634|FG001|Overall Study|Lack of Efficacy|11|||
143195363|NCT01638013|516259635|FG002|Overall Study|Lack of Efficacy|14|||
143195364|NCT01638013|516259633|FG000|Overall Study|Protocol Violation|10|||
143195365|NCT01638013|516259634|FG001|Overall Study|Protocol Violation|7|||
143195366|NCT01638013|516259635|FG002|Overall Study|Protocol Violation|11|||
143195367|NCT01638013|516259633|FG000|Overall Study|Met discontinuation criteria|4|||
143195368|NCT01638013|516259634|FG001|Overall Study|Met discontinuation criteria|0|||
143195369|NCT01638013|516259635|FG002|Overall Study|Met discontinuation criteria|7|||
143195370|NCT01638013|516259633|FG000|Overall Study|Subject Lost to Follow up|1|||
143195371|NCT01638013|516259634|FG001|Overall Study|Subject Lost to Follow up|0|||
143195372|NCT01638013|516259635|FG002|Overall Study|Subject Lost to Follow up|1|||
143195373|NCT01638013|516259633|FG000|Overall Study|Miscellaneous|25|||
143195374|NCT01638013|516259634|FG001|Overall Study|Miscellaneous|19|||
143195375|NCT01638013|516259635|FG002|Overall Study|Miscellaneous|23|||
143195376|NCT01638013|516259633|FG000|Overall Study|Withdrawal of Consent|16|||
143195377|NCT01638013|516259634|FG001|Overall Study|Withdrawal of Consent|12|||
143195378|NCT01638013|516259635|FG002|Overall Study|Withdrawal of Consent|16|||
143195379|NCT01638013|516259633|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
143195380|NCT01638013|516259634|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
143195381|NCT01638013|516259635|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
143195382|NCT02298179|516259636|FG000|Overall Study|Lost to Follow-up|0|||
143195383|NCT02298179|516259637|FG001|Overall Study|Lost to Follow-up|0|||
143195384|NCT02298179|516259638|FG002|Overall Study|Lost to Follow-up|1|||
143195385|NCT02298179|516259639|FG003|Overall Study|Lost to Follow-up|0|||
143195386|NCT02298179|516259640|FG004|Overall Study|Lost to Follow-up|0|||
143195387|NCT02298179|516259641|FG005|Overall Study|Lost to Follow-up|0|||
143195388|NCT02298179|516259642|FG006|Overall Study|Lost to Follow-up|0|||
143195389|NCT02298179|516259643|FG007|Overall Study|Lost to Follow-up|1|||
143195390|NCT02298179|516259644|FG008|Overall Study|Lost to Follow-up|0|||
143195391|NCT02298179|516259645|FG009|Overall Study|Lost to Follow-up|0|||
143195392|NCT02298179|516259646|FG010|Overall Study|Lost to Follow-up|0|||
143195393|NCT02298179|516259647|FG011|Overall Study|Lost to Follow-up|0|||
143195394|NCT01440517|516262089|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
143195395|NCT01288612|516262091|FG000|Overall Study|Unable to contact|11|||
143195396|NCT01288612|516262092|FG001|Overall Study|Unable to contact|16|||
143195397|NCT01288612|516262093|FG002|Overall Study|Unable to contact|20|||
143195398|NCT01288612|516262091|FG000|Overall Study|Declined|78|||
143195399|NCT01288612|516262092|FG001|Overall Study|Declined|63|||
143195400|NCT01288612|516262093|FG002|Overall Study|Declined|62|||
143195401|NCT01288612|516262091|FG000|Overall Study|Unable to intubate|0|||
143195402|NCT01288612|516262092|FG001|Overall Study|Unable to intubate|3|||
143195403|NCT01288612|516262093|FG002|Overall Study|Unable to intubate|0|||
143195404|NCT02723006|516262098|FG000|Overall Study|Withdrawal by Subject|0|||
143195405|NCT02723006|516262099|FG001|Overall Study|Withdrawal by Subject|1|||
143195406|NCT02723006|516262100|FG002|Overall Study|Withdrawal by Subject|1|||
143195407|NCT02723006|516262098|FG000|Overall Study|Study Terminated by Sponsor|1|||
143195408|NCT02723006|516262099|FG001|Overall Study|Study Terminated by Sponsor|6|||
143195409|NCT02723006|516262100|FG002|Overall Study|Study Terminated by Sponsor|6|||
143195410|NCT04225676|516262101|FG000|Overall Study|Physician Decision|1|||
143195411|NCT04225676|516262101|FG000|Overall Study|Lack of Efficacy|1|||
143195412|NCT04225676|516262101|FG000|Overall Study|Study terminated by sponsor|3|||
143195413|NCT01257568|516262104|FG000|Overall Study|Lost to Follow-up|2|||
143195414|NCT01257568|516262104|FG000|Overall Study|Withdrawal by Subject|6|||
143195415|NCT01257568|516262104|FG000|Overall Study|Terminated|1|||
143195416|NCT01257568|516262104|FG000|Overall Study|Component Revision|24|||
143195417|NCT03392883|516262105|FG000|Overall Study|Lost to Follow-up|122|||
143195418|NCT03392883|516262106|FG001|Overall Study|Lost to Follow-up|13|||
143195419|NCT03392883|516262107|FG002|Overall Study|Lost to Follow-up|9|||
143195420|NCT03392883|516262105|FG000|Overall Study|Death|4|||
143195421|NCT03392883|516262106|FG001|Overall Study|Death|0|||
143195422|NCT03392883|516262107|FG002|Overall Study|Death|0|||
143195423|NCT03392883|516262105|FG000|Overall Study|Lack of Efficacy|29|||
143195424|NCT03392883|516262106|FG001|Overall Study|Lack of Efficacy|0|||
143195425|NCT03392883|516262107|FG002|Overall Study|Lack of Efficacy|0|||
143195426|NCT03392883|516262105|FG000|Overall Study|Withdrawal by Subject|180|||
143195427|NCT03392883|516262106|FG001|Overall Study|Withdrawal by Subject|0|||
143195428|NCT03392883|516262107|FG002|Overall Study|Withdrawal by Subject|0|||
143195429|NCT03392883|516262105|FG000|Overall Study|Adverse Event|1|||
143195430|NCT03392883|516262106|FG001|Overall Study|Adverse Event|0|||
143195431|NCT03392883|516262107|FG002|Overall Study|Adverse Event|0|||
143195432|NCT01739933|516262114|FG000|Overall Study|Death|89|||
143195433|NCT01739933|516262115|FG001|Overall Study|Death|86|||
143195434|NCT01739933|516262114|FG000|Overall Study|Withdrawal by Subject|10|||
143195435|NCT01739933|516262115|FG001|Overall Study|Withdrawal by Subject|8|||
143195436|NCT01739933|516262114|FG000|Overall Study|Lost to Follow-up|3|||
143195437|NCT01739933|516262115|FG001|Overall Study|Lost to Follow-up|10|||
143195438|NCT01739933|516262114|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
143195439|NCT01739933|516262115|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
143195440|NCT00908115|516262119|FG000|Overall Study|Other|14|||
143195441|NCT03812185|516262120|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
143195442|NCT02075047|516262122|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
143195443|NCT02075047|516262123|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
143195444|NCT02075047|516262122|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
143195445|NCT02075047|516262123|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
143195446|NCT02075047|516262122|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
143195447|NCT02075047|516262123|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
143195448|NCT02075047|516262122|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
143195449|NCT02075047|516262123|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
143195450|NCT02075047|516262122|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
143195451|NCT02075047|516262123|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
143195452|NCT02075047|516262122|FG000|Treatment Phase (4 Weeks)|Other|1|||
143195453|NCT02075047|516262123|FG001|Treatment Phase (4 Weeks)|Other|1|||
143195454|NCT02075047|516262122|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
143195455|NCT02075047|516262123|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
143195456|NCT02075047|516262122|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
143195457|NCT02075047|516262123|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
143195458|NCT02075047|516262122|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
143195459|NCT02075047|516262123|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
143195460|NCT02075047|516262122|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
143195461|NCT02075047|516262123|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
143195462|NCT02075047|516262122|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
143195463|NCT02075047|516262123|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
143195464|NCT02075047|516262122|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
143195465|NCT02075047|516262123|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
143195466|NCT02075047|516262122|FG000|Follow up Phase (5 Weeks)|Other|1|||
143261753|NCT03442764|516512487|FG002|Overall Study|Adverse Event|0|||
143261754|NCT04478123|516512488|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
143195467|NCT02075047|516262123|FG001|Follow up Phase (5 Weeks)|Other|2|||
143195468|NCT02075047|516262122|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
143195469|NCT02075047|516262123|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
143195470|NCT00590824|516262124|FG000|Overall Study|Disease could not be resected|0|||
143195471|NCT00590824|516262125|FG001|Overall Study|Disease could not be resected|2|||
143195472|NCT00590824|516262126|FG002|Overall Study|Disease could not be resected|1|||
143195473|NCT00590824|516262127|FG003|Overall Study|Disease could not be resected|0|||
143195474|NCT00590824|516262124|FG000|Overall Study|Adverse Event|0|||
143195475|NCT00590824|516262125|FG001|Overall Study|Adverse Event|0|||
143195476|NCT00590824|516262126|FG002|Overall Study|Adverse Event|0|||
143195477|NCT00590824|516262127|FG003|Overall Study|Adverse Event|1|||
143195478|NCT01155466|516262128|FG000|Overall Study|Adverse Event|13|||
143195479|NCT01155466|516262129|FG001|Overall Study|Adverse Event|15|||
143195480|NCT01155466|516262130|FG002|Overall Study|Adverse Event|6|||
143195481|NCT01155466|516262131|FG003|Overall Study|Adverse Event|17|||
143195482|NCT01155466|516262132|FG004|Overall Study|Adverse Event|18|||
143195483|NCT01155466|516262128|FG000|Overall Study|Lost to Follow-up|0|||
143195484|NCT01155466|516262129|FG001|Overall Study|Lost to Follow-up|0|||
143195485|NCT01155466|516262130|FG002|Overall Study|Lost to Follow-up|0|||
143195486|NCT01155466|516262131|FG003|Overall Study|Lost to Follow-up|0|||
143195487|NCT01155466|516262132|FG004|Overall Study|Lost to Follow-up|2|||
143195488|NCT01155466|516262128|FG000|Overall Study|Withdrawal by Subject|7|||
143195489|NCT01155466|516262129|FG001|Overall Study|Withdrawal by Subject|5|||
143195490|NCT01155466|516262130|FG002|Overall Study|Withdrawal by Subject|9|||
143195491|NCT01155466|516262131|FG003|Overall Study|Withdrawal by Subject|4|||
143195492|NCT01155466|516262132|FG004|Overall Study|Withdrawal by Subject|4|||
143195493|NCT01155466|516262128|FG000|Overall Study|Protocol Violation|0|||
143195494|NCT01155466|516262129|FG001|Overall Study|Protocol Violation|0|||
143195495|NCT01155466|516262130|FG002|Overall Study|Protocol Violation|2|||
143195496|NCT01155466|516262131|FG003|Overall Study|Protocol Violation|0|||
143195497|NCT01155466|516262132|FG004|Overall Study|Protocol Violation|1|||
143195498|NCT01155466|516262128|FG000|Overall Study|Administrative|0|||
143195499|NCT01155466|516262129|FG001|Overall Study|Administrative|3|||
143195500|NCT01155466|516262130|FG002|Overall Study|Administrative|0|||
143195501|NCT01155466|516262131|FG003|Overall Study|Administrative|0|||
143369653|NCT00603447|516896194|FG004|Overall Study|Adverse Event|1|||
143369654|NCT00603447|516896195|FG005|Overall Study|Adverse Event|2|||
143369655|NCT00603447|516896196|FG006|Overall Study|Adverse Event|10|||
143369656|NCT00603447|516896190|FG000|Overall Study|Other|0|||
143195502|NCT01155466|516262132|FG004|Overall Study|Administrative|0|||
143195503|NCT01155466|516262128|FG000|Overall Study|Randomized not treated|2|||
143195504|NCT01155466|516262129|FG001|Overall Study|Randomized not treated|2|||
143195505|NCT01155466|516262130|FG002|Overall Study|Randomized not treated|3|||
143195506|NCT01155466|516262131|FG003|Overall Study|Randomized not treated|0|||
143195507|NCT01155466|516262132|FG004|Overall Study|Randomized not treated|2|||
143195508|NCT01610713|516262138|FG000|Overall Study|Adverse Event|3|||
143195509|NCT01610713|516262139|FG001|Overall Study|Adverse Event|0|||
143195510|NCT01610713|516262138|FG000|Overall Study|Lack of Efficacy|1|||
143195511|NCT01610713|516262139|FG001|Overall Study|Lack of Efficacy|0|||
143195512|NCT01610713|516262138|FG000|Overall Study|low mood and poor motivation|1|||
143195513|NCT01610713|516262139|FG001|Overall Study|low mood and poor motivation|0|||
143195514|NCT01610713|516262138|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
143195515|NCT01610713|516262139|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
143195516|NCT01610713|516262138|FG000|Overall Study|Lost to Follow-up|0|||
143195517|NCT01610713|516262139|FG001|Overall Study|Lost to Follow-up|1|||
143195518|NCT03770728|516262142|FG000|Overall Study|Adverse Event|1|||
143195519|NCT03770728|516262143|FG001|Overall Study|Adverse Event|0|||
143195520|NCT03770728|516262144|FG002|Overall Study|Adverse Event|1|||
143195521|NCT03770728|516262145|FG003|Overall Study|Adverse Event|0|||
143195522|NCT03770728|516262142|FG000|Overall Study|Poor compliance to protocol|0|||
143195523|NCT03770728|516262143|FG001|Overall Study|Poor compliance to protocol|0|||
143195524|NCT03770728|516262144|FG002|Overall Study|Poor compliance to protocol|1|||
143195525|NCT03770728|516262145|FG003|Overall Study|Poor compliance to protocol|0|||
143195526|NCT03770728|516262142|FG000|Overall Study|Withdrawal by Subject|13|||
143195527|NCT03770728|516262143|FG001|Overall Study|Withdrawal by Subject|8|||
143195528|NCT03770728|516262144|FG002|Overall Study|Withdrawal by Subject|9|||
143195529|NCT03770728|516262145|FG003|Overall Study|Withdrawal by Subject|13|||
143195530|NCT03770728|516262142|FG000|Overall Study|Other than specified|24|||
143195531|NCT03770728|516262143|FG001|Overall Study|Other than specified|23|||
143195532|NCT03770728|516262144|FG002|Overall Study|Other than specified|21|||
143195533|NCT03770728|516262145|FG003|Overall Study|Other than specified|22|||
143195534|NCT02778555|516262146|FG000|Overall Study|Withdrawal by Subject|55|||
143195535|NCT02778555|516262147|FG001|Overall Study|Withdrawal by Subject|32|||
143195536|NCT02778555|516262148|FG002|Overall Study|Withdrawal by Subject|107|||
143195537|NCT02379988|516262149|FG000|Overall Study|Not eligible|1|||
143369657|NCT00603447|516896191|FG001|Overall Study|Other|0|||
143195538|NCT00107315|516262150|FG000|Overall Study|Disease Progression|9|||
143195539|NCT00107315|516262150|FG000|Overall Study|Adverse Event|4|||
143195540|NCT00107315|516262150|FG000|Overall Study|Withdrawal by Subject|2|||
143195541|NCT02509039|516262151|FG000|Overall Study|Adverse Event|0|||
143195542|NCT02509039|516262152|FG001|Overall Study|Adverse Event|1|||
143195543|NCT02509039|516262153|FG002|Overall Study|Adverse Event|1|||
143195544|NCT02509039|516262154|FG003|Overall Study|Adverse Event|1|||
143195545|NCT02509039|516262151|FG000|Overall Study|Withdrawal by Subject|0|||
143195546|NCT02509039|516262152|FG001|Overall Study|Withdrawal by Subject|0|||
143195547|NCT02509039|516262153|FG002|Overall Study|Withdrawal by Subject|1|||
143195548|NCT02509039|516262154|FG003|Overall Study|Withdrawal by Subject|0|||
143195549|NCT02509039|516262151|FG000|Overall Study|Progressive disease|2|||
143195550|NCT02509039|516262152|FG001|Overall Study|Progressive disease|2|||
143195551|NCT02509039|516262153|FG002|Overall Study|Progressive disease|1|||
143195552|NCT02509039|516262154|FG003|Overall Study|Progressive disease|5|||
143195553|NCT02509039|516262151|FG000|Overall Study|Study terminated by Sponsor|1|||
143195554|NCT02509039|516262152|FG001|Overall Study|Study terminated by Sponsor|0|||
143195555|NCT02509039|516262153|FG002|Overall Study|Study terminated by Sponsor|0|||
143195556|NCT02509039|516262154|FG003|Overall Study|Study terminated by Sponsor|0|||
143195557|NCT00557310|516262161|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
143195558|NCT00557310|516262161|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
143195559|NCT00557310|516262161|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
143195560|NCT00557310|516262161|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
143195561|NCT00557310|516262161|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
143195562|NCT00557310|516262161|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
143195563|NCT03447314|516262164|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
143195564|NCT03447314|516262165|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
143195565|NCT03447314|516262166|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
143195566|NCT03447314|516262167|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
143195567|NCT03447314|516262168|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
143195568|NCT03447314|516262169|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
143195569|NCT03447314|516262170|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
143195570|NCT03447314|516262171|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
143195571|NCT03447314|516262172|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
143195572|NCT03447314|516262173|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
143195573|NCT03447314|516262174|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
143195574|NCT03447314|516262175|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
143195575|NCT03447314|516262176|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
143195576|NCT03447314|516262177|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
143195577|NCT03447314|516262178|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
143195578|NCT03447314|516262179|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
143195579|NCT03447314|516262180|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
143195580|NCT03447314|516262181|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
143195581|NCT03447314|516262164|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
143195582|NCT03447314|516262165|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
143195583|NCT03447314|516262166|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
143195584|NCT03447314|516262167|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
143195585|NCT03447314|516262168|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
143195586|NCT03447314|516262169|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
143195587|NCT03447314|516262170|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
143195588|NCT03447314|516262171|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
143195589|NCT03447314|516262172|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
143195590|NCT03447314|516262173|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
143195591|NCT03447314|516262174|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
143195592|NCT03447314|516262175|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
143195593|NCT03447314|516262176|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
143195594|NCT03447314|516262177|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
143195595|NCT03447314|516262178|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
143195596|NCT03447314|516262179|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
143195597|NCT03447314|516262180|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
143195598|NCT03447314|516262181|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
143195599|NCT03447314|516262164|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
143195600|NCT03447314|516262165|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
143195601|NCT03447314|516262166|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
143195602|NCT03447314|516262167|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
143195603|NCT03447314|516262168|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
143195604|NCT03447314|516262169|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
143195605|NCT03447314|516262170|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
143195606|NCT03447314|516262171|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
143195607|NCT03447314|516262172|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
143195608|NCT03447314|516262173|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
143195609|NCT03447314|516262174|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
143195610|NCT03447314|516262175|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
143195611|NCT03447314|516262176|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
143195612|NCT03447314|516262177|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
143195613|NCT03447314|516262178|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
143195614|NCT03447314|516262179|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
143195615|NCT03447314|516262180|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
143195616|NCT03447314|516262181|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
143195617|NCT03447314|516262164|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
143195618|NCT03447314|516262165|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
143195619|NCT03447314|516262166|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
143195620|NCT03447314|516262167|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
143195621|NCT03447314|516262168|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
143195622|NCT03447314|516262169|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
143261755|NCT04478123|516512488|FG000|Overall Study|NE|1|||
143261756|NCT02395016|516512489|FG000|Overall Study|Adverse Event|4|||
143261757|NCT02395016|516512490|FG001|Overall Study|Adverse Event|3|||
143261758|NCT02395016|516512489|FG000|Overall Study|Withdrawal by Subject|9|||
143261759|NCT02395016|516512490|FG001|Overall Study|Withdrawal by Subject|6|||
143261760|NCT02395016|516512489|FG000|Overall Study|Protocol Violation|2|||
143261761|NCT02395016|516512490|FG001|Overall Study|Protocol Violation|3|||
143261762|NCT04444895|516512491|FG000|Overall Study|Adverse Event|2|||
143261763|NCT04444895|516512491|FG000|Overall Study|Lost to Follow-up|2|||
143261764|NCT04444895|516512491|FG000|Overall Study|Withdrawal by Subject|5|||
143261765|NCT00719264|516512492|FG000|Overall Study|Adverse Event|41|||
143261766|NCT00719264|516512493|FG001|Overall Study|Adverse Event|49|||
143261767|NCT00719264|516512492|FG000|Overall Study|Death|13|||
143261768|NCT00719264|516512493|FG001|Overall Study|Death|10|||
143261769|NCT00719264|516512492|FG000|Overall Study|Administrative Problems|6|||
143261770|NCT00719264|516512493|FG001|Overall Study|Administrative Problems|4|||
143261771|NCT00719264|516512492|FG000|Overall Study|Lost to Follow-up|1|||
143261772|NCT00719264|516512493|FG001|Overall Study|Lost to Follow-up|1|||
143261773|NCT00719264|516512492|FG000|Overall Study|Withdrawal by Subject|12|||
143261774|NCT00719264|516512493|FG001|Overall Study|Withdrawal by Subject|7|||
143261775|NCT00719264|516512492|FG000|Overall Study|Protocol Deviation|1|||
143261776|NCT00719264|516512493|FG001|Overall Study|Protocol Deviation|3|||
143261777|NCT00719264|516512492|FG000|Overall Study|New Cancer Therapy|4|||
143261778|NCT00719264|516512493|FG001|Overall Study|New Cancer Therapy|2|||
143261779|NCT00719264|516512492|FG000|Overall Study|Disease Progression|104|||
143261780|NCT00719264|516512493|FG001|Overall Study|Disease Progression|107|||
143261781|NCT00814879|516512494|FG000|By Week 24|Cancer Diagnosis|1|||
143261782|NCT00814879|516512495|FG001|By Week 24|Cancer Diagnosis|0|||
143261783|NCT00814879|516512494|FG000|By Week 24|Incarceration|0|||
143261784|NCT00814879|516512495|FG001|By Week 24|Incarceration|1|||
143261785|NCT00814879|516512494|FG000|By Week 48|Lost to Follow-up|2|||
143261786|NCT00814879|516512495|FG001|By Week 48|Lost to Follow-up|2|||
143261787|NCT00814879|516512494|FG000|By Week 48|Death|0|||
143261788|NCT00814879|516512495|FG001|By Week 48|Death|1|||
143261789|NCT00478881|516512496|FG000|Overall Study|Adverse Event|31|||
143261790|NCT00478881|516512497|FG001|Overall Study|Adverse Event|12|||
143261791|NCT00478881|516512496|FG000|Overall Study|Lack of Efficacy|0|||
143261792|NCT00478881|516512497|FG001|Overall Study|Lack of Efficacy|3|||
143261793|NCT00478881|516512496|FG000|Overall Study|Lost to Follow-up|0|||
143195623|NCT03447314|516262170|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
143195624|NCT03447314|516262171|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
143195625|NCT03447314|516262172|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
143195626|NCT03447314|516262173|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
143195627|NCT03447314|516262174|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
143195628|NCT03447314|516262175|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
143195629|NCT03447314|516262176|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
143195630|NCT03447314|516262177|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
143195631|NCT03447314|516262178|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
143195632|NCT03447314|516262179|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
143195633|NCT03447314|516262180|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
143195634|NCT03447314|516262181|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
143195635|NCT03447314|516262164|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
143195636|NCT03447314|516262165|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
143195637|NCT03447314|516262166|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
143195638|NCT03447314|516262167|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
143195639|NCT03447314|516262168|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
143195640|NCT03447314|516262169|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
143195641|NCT03447314|516262170|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
143195642|NCT03447314|516262171|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
143195643|NCT03447314|516262172|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
143195644|NCT03447314|516262173|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
143195645|NCT03447314|516262174|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
143195646|NCT03447314|516262175|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
143195647|NCT03447314|516262176|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
143195648|NCT03447314|516262177|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
143195649|NCT03447314|516262178|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
143195650|NCT03447314|516262179|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
143195651|NCT03447314|516262180|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
143195652|NCT03447314|516262181|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
143195653|NCT03447314|516262164|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
143195654|NCT03447314|516262165|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
143195655|NCT03447314|516262166|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
143195656|NCT03447314|516262167|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
143195657|NCT03447314|516262168|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
143195658|NCT03447314|516262169|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
143195659|NCT03447314|516262170|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
143195660|NCT03447314|516262171|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
143195661|NCT03447314|516262172|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
143195662|NCT03447314|516262173|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
143195663|NCT03447314|516262174|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
143195664|NCT03447314|516262175|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
143195665|NCT03447314|516262176|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
143195666|NCT03447314|516262177|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
143195667|NCT03447314|516262178|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
143195668|NCT03447314|516262179|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
143195669|NCT03447314|516262180|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
143195670|NCT03447314|516262181|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
143195671|NCT01703208|516262184|FG000|Overall Study|Death|61|||
143195672|NCT01703208|516262185|FG001|Overall Study|Death|48|||
143195673|NCT01703208|516262184|FG000|Overall Study|Lack of Efficacy|1|||
143195674|NCT01703208|516262185|FG001|Overall Study|Lack of Efficacy|2|||
143195675|NCT01703208|516262184|FG000|Overall Study|Lost to Follow-up|68|||
143195676|NCT01703208|516262185|FG001|Overall Study|Lost to Follow-up|62|||
143195677|NCT01703208|516262184|FG000|Overall Study|Non-Compliance with Study Drug|1|||
143195678|NCT01703208|516262185|FG001|Overall Study|Non-Compliance with Study Drug|0|||
143195679|NCT01703208|516262184|FG000|Overall Study|Excluded Medication|1|||
143195680|NCT01703208|516262185|FG001|Overall Study|Excluded Medication|2|||
143195681|NCT01703208|516262184|FG000|Overall Study|Site Discontinued Study Participation|23|||
143195682|NCT01703208|516262185|FG001|Overall Study|Site Discontinued Study Participation|27|||
143195683|NCT01703208|516262184|FG000|Overall Study|Physician Decision|11|||
143195684|NCT01703208|516262185|FG001|Overall Study|Physician Decision|13|||
143195685|NCT01703208|516262184|FG000|Overall Study|Progressive disease|2|||
143195686|NCT01703208|516262185|FG001|Overall Study|Progressive disease|2|||
143195687|NCT01703208|516262184|FG000|Overall Study|Protocol Violation|1|||
143195688|NCT01703208|516262185|FG001|Overall Study|Protocol Violation|1|||
143195689|NCT01703208|516262184|FG000|Overall Study|Study Terminated by Sponsor|1710|||
143195690|NCT01703208|516262185|FG001|Overall Study|Study Terminated by Sponsor|1716|||
143195691|NCT01703208|516262184|FG000|Overall Study|Withdrawal by Subject|205|||
143195692|NCT01703208|516262185|FG001|Overall Study|Withdrawal by Subject|209|||
143195693|NCT01703208|516262184|FG000|Overall Study|Adverse Event|14|||
143195694|NCT01703208|516262185|FG001|Overall Study|Adverse Event|19|||
143195695|NCT01703208|516262184|FG000|Overall Study|Technical Problems|0|||
143195696|NCT01703208|516262185|FG001|Overall Study|Technical Problems|1|||
143195697|NCT01703208|516262184|FG000|Overall Study|Protocol Deviation|2|||
143195698|NCT01703208|516262185|FG001|Overall Study|Protocol Deviation|0|||
143195699|NCT01271712|516262190|FG000|Double Blind Treatment|Death|2|||
143195700|NCT01271712|516262191|FG001|Double Blind Treatment|Death|0|||
143195701|NCT01271712|516262190|FG000|Double Blind Treatment|Lack of Efficacy|1|||
143195702|NCT01271712|516262191|FG001|Double Blind Treatment|Lack of Efficacy|0|||
143195703|NCT01271712|516262190|FG000|Double Blind Treatment|Adverse Event|9|||
143195704|NCT01271712|516262191|FG001|Double Blind Treatment|Adverse Event|4|||
143195705|NCT01271712|516262190|FG000|Double Blind Treatment|Progressive disease|23|||
143195706|NCT01271712|516262191|FG001|Double Blind Treatment|Progressive disease|3|||
143195707|NCT01271712|516262190|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
143195708|NCT01271712|516262191|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
143195709|NCT01271712|516262190|FG000|Double Blind Treatment|Non compliance with study drug|2|||
143195710|NCT01271712|516262191|FG001|Double Blind Treatment|Non compliance with study drug|0|||
143195711|NCT01271712|516262190|FG000|Double Blind Treatment|receive no study drug|1|||
143195712|NCT01271712|516262191|FG001|Double Blind Treatment|receive no study drug|0|||
143195713|NCT01271712|516262190|FG000|Open Label Treatment|Death|6|||
143261794|NCT00478881|516512497|FG001|Overall Study|Lost to Follow-up|1|||
143261795|NCT00478881|516512496|FG000|Overall Study|Protocol Violation|2|||
143261796|NCT00478881|516512497|FG001|Overall Study|Protocol Violation|2|||
143261797|NCT00478881|516512496|FG000|Overall Study|Withdrawal by Subject|6|||
143261798|NCT00478881|516512497|FG001|Overall Study|Withdrawal by Subject|2|||
143261799|NCT00478881|516512496|FG000|Overall Study|Non-Compliance with Study Medication|0|||
143261800|NCT00478881|516512497|FG001|Overall Study|Non-Compliance with Study Medication|2|||
143261801|NCT00749580|516512498|FG000|Overall Study|Lost to Follow-up|4|||
143261802|NCT00749580|516512499|FG001|Overall Study|Lost to Follow-up|8|||
143261803|NCT00749580|516512498|FG000|Overall Study|Adverse Event|0|||
143195714|NCT01271712|516262191|FG001|Open Label Treatment|Death|5|||
143195715|NCT01271712|516262190|FG000|Open Label Treatment|Withdrawal by Subject|6|||
143195716|NCT01271712|516262191|FG001|Open Label Treatment|Withdrawal by Subject|11|||
143195717|NCT01271712|516262190|FG000|Open Label Treatment|Physician Decision|2|||
143195718|NCT01271712|516262191|FG001|Open Label Treatment|Physician Decision|0|||
143195719|NCT01271712|516262190|FG000|Open Label Treatment|Adverse Event|14|||
143195720|NCT01271712|516262191|FG001|Open Label Treatment|Adverse Event|8|||
143195721|NCT01271712|516262190|FG000|Open Label Treatment|Progressive disease|59|||
143195722|NCT01271712|516262191|FG001|Open Label Treatment|Progressive disease|32|||
143195723|NCT01271712|516262190|FG000|Open Label Treatment|transferred to rollover study|1|||
143261804|NCT00749580|516512499|FG001|Overall Study|Adverse Event|1|||
143261805|NCT04704154|516512502|FG000|Overall Study|Adverse Event|3|||
143261806|NCT04704154|516512503|FG001|Overall Study|Adverse Event|2|||
143261807|NCT04704154|516512504|FG002|Overall Study|Adverse Event|4|||
143195724|NCT01271712|516262191|FG001|Open Label Treatment|transferred to rollover study|0|||
143195725|NCT01271712|516262190|FG000|Open Label Treatment|Non-compliance with study drug|1|||
143195726|NCT01271712|516262191|FG001|Open Label Treatment|Non-compliance with study drug|0|||
143195727|NCT01271712|516262190|FG000|Open Label Treatment|Protocol Violation|0|||
143261808|NCT04704154|516512505|FG003|Overall Study|Adverse Event|2|||
143261809|NCT04704154|516512506|FG004|Overall Study|Adverse Event|3|||
143195728|NCT01271712|516262191|FG001|Open Label Treatment|Protocol Violation|1|||
143195729|NCT01271712|516262190|FG000|Open Label Treatment|Switching to other therapy|2|||
143261810|NCT04704154|516512507|FG005|Overall Study|Adverse Event|0|||
143261811|NCT04704154|516512502|FG000|Overall Study|Death|3|||
143261812|NCT04704154|516512503|FG001|Overall Study|Death|0|||
143261813|NCT04704154|516512504|FG002|Overall Study|Death|0|||
143195730|NCT01271712|516262191|FG001|Open Label Treatment|Switching to other therapy|1|||
143195731|NCT01271712|516262190|FG000|Safety Follow-up|Death|11|||
143195732|NCT01271712|516262191|FG001|Safety Follow-up|Death|7|||
143195733|NCT01271712|516262190|FG000|Safety Follow-up|Withdrawal by Subject|4|||
143195734|NCT01271712|516262191|FG001|Safety Follow-up|Withdrawal by Subject|2|||
143195735|NCT01271712|516262190|FG000|Safety Follow-up|Protocol Violation|1|||
143195736|NCT01271712|516262191|FG001|Safety Follow-up|Protocol Violation|1|||
143195737|NCT01271712|516262190|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
143195738|NCT01271712|516262191|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
143195739|NCT01271712|516262190|FG000|Safety Follow-up|No follow-up|1|||
143195740|NCT01271712|516262191|FG001|Safety Follow-up|No follow-up|1|||
143195741|NCT01271712|516262190|FG000|Safety Follow-up|Progressive disease|1|||
143195742|NCT01271712|516262191|FG001|Safety Follow-up|Progressive disease|0|||
143195743|NCT01271712|516262190|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
143195744|NCT01271712|516262191|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
143195745|NCT03099174|516262195|FG000|Overall Study|Withdrawal by Subject|0|||
143195746|NCT03099174|516262196|FG001|Overall Study|Withdrawal by Subject|0|||
143195747|NCT03099174|516262197|FG002|Overall Study|Withdrawal by Subject|1|||
143195748|NCT03099174|516262198|FG003|Overall Study|Withdrawal by Subject|0|||
143195749|NCT03099174|516262199|FG004|Overall Study|Withdrawal by Subject|2|||
143195750|NCT03099174|516262200|FG005|Overall Study|Withdrawal by Subject|2|||
143195751|NCT03099174|516262201|FG006|Overall Study|Withdrawal by Subject|1|||
143195752|NCT03099174|516262202|FG007|Overall Study|Withdrawal by Subject|4|||
143195753|NCT03099174|516262195|FG000|Overall Study|Adverse Event|0|||
143195754|NCT03099174|516262196|FG001|Overall Study|Adverse Event|1|||
143195755|NCT03099174|516262197|FG002|Overall Study|Adverse Event|1|||
143195756|NCT03099174|516262198|FG003|Overall Study|Adverse Event|2|||
143195757|NCT03099174|516262199|FG004|Overall Study|Adverse Event|5|||
143195758|NCT03099174|516262200|FG005|Overall Study|Adverse Event|3|||
143195759|NCT03099174|516262201|FG006|Overall Study|Adverse Event|6|||
143195760|NCT03099174|516262202|FG007|Overall Study|Adverse Event|4|||
143195761|NCT03099174|516262195|FG000|Overall Study|Other than listed|6|||
143195762|NCT03099174|516262196|FG001|Overall Study|Other than listed|6|||
143195763|NCT03099174|516262197|FG002|Overall Study|Other than listed|5|||
143195764|NCT03099174|516262198|FG003|Overall Study|Other than listed|6|||
143195765|NCT03099174|516262199|FG004|Overall Study|Other than listed|19|||
143195766|NCT03099174|516262200|FG005|Overall Study|Other than listed|10|||
143195767|NCT03099174|516262201|FG006|Overall Study|Other than listed|26|||
143195768|NCT03099174|516262202|FG007|Overall Study|Other than listed|23|||
143195769|NCT02308163|516262203|FG000|Overall Study|Not fulfill eligible criteria|1|||
143195770|NCT02308163|516262204|FG001|Overall Study|Not fulfill eligible criteria|2|||
143195771|NCT02308163|516262205|FG002|Overall Study|Not fulfill eligible criteria|0|||
143195772|NCT02308163|516262206|FG003|Overall Study|Not fulfill eligible criteria|1|||
143195773|NCT02308163|516262207|FG004|Overall Study|Not fulfill eligible criteria|1|||
143195774|NCT02308163|516262203|FG000|Overall Study|Adverse Event|9|||
143195775|NCT02308163|516262204|FG001|Overall Study|Adverse Event|5|||
143195776|NCT02308163|516262205|FG002|Overall Study|Adverse Event|2|||
143195777|NCT02308163|516262206|FG003|Overall Study|Adverse Event|2|||
143195778|NCT02308163|516262207|FG004|Overall Study|Adverse Event|11|||
143195779|NCT02308163|516262203|FG000|Overall Study|Lack of Efficacy|11|||
143195780|NCT02308163|516262204|FG001|Overall Study|Lack of Efficacy|3|||
143195781|NCT02308163|516262205|FG002|Overall Study|Lack of Efficacy|8|||
143195782|NCT02308163|516262206|FG003|Overall Study|Lack of Efficacy|4|||
143195783|NCT02308163|516262207|FG004|Overall Study|Lack of Efficacy|6|||
143195784|NCT02308163|516262203|FG000|Overall Study|Withdrawal of consent|2|||
143195785|NCT02308163|516262204|FG001|Overall Study|Withdrawal of consent|3|||
143195786|NCT02308163|516262205|FG002|Overall Study|Withdrawal of consent|0|||
143195787|NCT02308163|516262206|FG003|Overall Study|Withdrawal of consent|2|||
143195788|NCT02308163|516262207|FG004|Overall Study|Withdrawal of consent|6|||
143195789|NCT02308163|516262203|FG000|Overall Study|Protocol Violation|3|||
143195790|NCT02308163|516262204|FG001|Overall Study|Protocol Violation|3|||
143195791|NCT02308163|516262205|FG002|Overall Study|Protocol Violation|3|||
143195792|NCT02308163|516262206|FG003|Overall Study|Protocol Violation|2|||
143195793|NCT02308163|516262207|FG004|Overall Study|Protocol Violation|5|||
143195794|NCT02308163|516262203|FG000|Overall Study|Lab data met discontinuation criteria|3|||
143195795|NCT02308163|516262204|FG001|Overall Study|Lab data met discontinuation criteria|0|||
143195796|NCT02308163|516262205|FG002|Overall Study|Lab data met discontinuation criteria|0|||
143195797|NCT02308163|516262206|FG003|Overall Study|Lab data met discontinuation criteria|2|||
143195798|NCT02308163|516262207|FG004|Overall Study|Lab data met discontinuation criteria|0|||
143195799|NCT02308163|516262203|FG000|Overall Study|Miscellaneous|2|||
143195800|NCT02308163|516262204|FG001|Overall Study|Miscellaneous|2|||
143195801|NCT02308163|516262205|FG002|Overall Study|Miscellaneous|1|||
143195802|NCT02308163|516262206|FG003|Overall Study|Miscellaneous|0|||
143195803|NCT02308163|516262207|FG004|Overall Study|Miscellaneous|5|||
143195804|NCT02118766|516262213|FG000|Overall Study|Adverse Event|7|||
143195805|NCT02118766|516262214|FG001|Overall Study|Adverse Event|2|||
143195806|NCT02118766|516262213|FG000|Overall Study|Withdrawal by Subject|3|||
143195807|NCT02118766|516262214|FG001|Overall Study|Withdrawal by Subject|6|||
143195808|NCT02118766|516262213|FG000|Overall Study|Lost to Follow-up|5|||
143195809|NCT02118766|516262214|FG001|Overall Study|Lost to Follow-up|4|||
143195810|NCT02118766|516262213|FG000|Overall Study|Withdrawal by parent/guardian|12|||
143195811|NCT02118766|516262214|FG001|Overall Study|Withdrawal by parent/guardian|18|||
143195812|NCT02118766|516262213|FG000|Overall Study|Other|3|||
143195813|NCT02118766|516262214|FG001|Overall Study|Other|1|||
143195814|NCT00443053|516262215|FG000|Overall Study|Adverse Event|2|||
143195815|NCT00443053|516262216|FG001|Overall Study|Adverse Event|1|||
143195816|NCT00443053|516262215|FG000|Overall Study|Withdrawal by Subject|9|||
143195817|NCT00443053|516262216|FG001|Overall Study|Withdrawal by Subject|18|||
143195818|NCT00443053|516262215|FG000|Overall Study|Lost to Follow-up|4|||
143195819|NCT00443053|516262216|FG001|Overall Study|Lost to Follow-up|5|||
143195820|NCT00443053|516262215|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
143195821|NCT00443053|516262216|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
143195822|NCT00443053|516262215|FG000|Overall Study|Noncompliance|2|||
143195823|NCT00443053|516262216|FG001|Overall Study|Noncompliance|1|||
143195824|NCT00443053|516262215|FG000|Overall Study|Other|3|||
143195825|NCT00443053|516262216|FG001|Overall Study|Other|4|||
143195826|NCT00443053|516262215|FG000|Overall Study|Physician Decision|0|||
143195827|NCT00443053|516262216|FG001|Overall Study|Physician Decision|4|||
143195828|NCT00541866|516262217|FG000|Overall Study|Adverse Event|3|||
143195829|NCT00541866|516262218|FG001|Overall Study|Adverse Event|0|||
143195830|NCT00541866|516262219|FG002|Overall Study|Adverse Event|0|||
143195831|NCT00541866|516262220|FG003|Overall Study|Adverse Event|0|||
143195832|NCT00541866|516262221|FG004|Overall Study|Adverse Event|0|||
143195833|NCT00541866|516262217|FG000|Overall Study|Death|1|||
143195834|NCT00541866|516262218|FG001|Overall Study|Death|0|||
143195835|NCT00541866|516262219|FG002|Overall Study|Death|0|||
143195836|NCT00541866|516262220|FG003|Overall Study|Death|0|||
143195837|NCT00541866|516262221|FG004|Overall Study|Death|0|||
143195838|NCT00541866|516262217|FG000|Overall Study|Lack of Efficacy|19|||
143195839|NCT00541866|516262218|FG001|Overall Study|Lack of Efficacy|15|||
143195840|NCT00541866|516262219|FG002|Overall Study|Lack of Efficacy|10|||
143195841|NCT00541866|516262220|FG003|Overall Study|Lack of Efficacy|12|||
143195842|NCT00541866|516262221|FG004|Overall Study|Lack of Efficacy|14|||
143195843|NCT00541866|516262217|FG000|Overall Study|Not Reported or Other|11|||
143195844|NCT00541866|516262218|FG001|Overall Study|Not Reported or Other|3|||
143195845|NCT00541866|516262219|FG002|Overall Study|Not Reported or Other|3|||
143195846|NCT00541866|516262220|FG003|Overall Study|Not Reported or Other|3|||
143195847|NCT00541866|516262221|FG004|Overall Study|Not Reported or Other|1|||
143195848|NCT00541866|516262217|FG000|Overall Study|Physician Decision|0|||
143195849|NCT00541866|516262218|FG001|Overall Study|Physician Decision|0|||
143195850|NCT00541866|516262219|FG002|Overall Study|Physician Decision|2|||
143195851|NCT00541866|516262220|FG003|Overall Study|Physician Decision|1|||
143195852|NCT00541866|516262221|FG004|Overall Study|Physician Decision|0|||
143195853|NCT00522418|516262222|FG000|Overall Study|Local IRB Consent Violation|5|||
143195854|NCT00522418|516262223|FG001|Overall Study|Local IRB Consent Violation|5|||
143195855|NCT00522418|516262222|FG000|Overall Study|Early Study Termination|46|||
143195856|NCT00522418|516262223|FG001|Overall Study|Early Study Termination|47|||
143195857|NCT00522418|516262222|FG000|Overall Study|Noncompliance|2|||
143195858|NCT00522418|516262223|FG001|Overall Study|Noncompliance|2|||
143195859|NCT00522418|516262222|FG000|Overall Study|Reason Not Specified|3|||
143195860|NCT00522418|516262223|FG001|Overall Study|Reason Not Specified|1|||
143195861|NCT00522418|516262222|FG000|Overall Study|Consent Withdraw|1|||
143195862|NCT00522418|516262223|FG001|Overall Study|Consent Withdraw|2|||
143195863|NCT00522418|516262222|FG000|Overall Study|Lack of Efficacy|0|||
143195864|NCT00522418|516262223|FG001|Overall Study|Lack of Efficacy|1|||
143195865|NCT01574157|516262224|FG000|Overall Study|Withdrawal by Subject|4|||
143195866|NCT01574157|516262225|FG001|Overall Study|Withdrawal by Subject|5|||
143195867|NCT01574157|516262224|FG000|Overall Study|Lost to Follow-up|0|||
143195868|NCT01574157|516262225|FG001|Overall Study|Lost to Follow-up|3|||
143195869|NCT00578877|516262228|FG000|Overall Study|Lost to Follow-up|8|||
143195870|NCT00578877|516262229|FG001|Overall Study|Lost to Follow-up|10|||
143195871|NCT00578877|516262228|FG000|Overall Study|early discontinue|61|||
143195872|NCT00578877|516262229|FG001|Overall Study|early discontinue|101|||
143195873|NCT00578877|516262228|FG000|Overall Study|did not provide follow-up data|12|||
143195874|NCT00578877|516262229|FG001|Overall Study|did not provide follow-up data|17|||
143195875|NCT01944098|516262230|FG000|Overall Study|Physician Decision|1|||
143195876|NCT01944098|516262231|FG001|Overall Study|Physician Decision|0|||
143195877|NCT04669262|516262232|FG000|Overall Study|Withdrawal by Subject|0|||
143195878|NCT04669262|516262233|FG001|Overall Study|Withdrawal by Subject|0|||
143195879|NCT04669262|516262234|FG002|Overall Study|Withdrawal by Subject|0|||
143195880|NCT04669262|516262235|FG003|Overall Study|Withdrawal by Subject|1|||
143195881|NCT04669262|516262232|FG000|Overall Study|Randomized but Not Treated|0|||
143195882|NCT04669262|516262233|FG001|Overall Study|Randomized but Not Treated|1|||
143195883|NCT04669262|516262234|FG002|Overall Study|Randomized but Not Treated|0|||
143195884|NCT04669262|516262235|FG003|Overall Study|Randomized but Not Treated|0|||
143195885|NCT00350272|516262237|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
143195886|NCT00350272|516262238|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
143195887|NCT00350272|516262237|FG000|Blinded 12-Week Treatment|Death|1|||
143195888|NCT00350272|516262238|FG001|Blinded 12-Week Treatment|Death|0|||
143195889|NCT00350272|516262237|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
143195890|NCT00350272|516262238|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
143195891|NCT00350272|516262237|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
143195892|NCT00350272|516262238|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
143195893|NCT00350272|516262237|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
143195894|NCT00350272|516262238|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
143195895|NCT00350272|516262237|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
143195896|NCT00350272|516262238|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
143195897|NCT00350272|516262237|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
143195898|NCT00350272|516262238|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
143195899|NCT00350272|516262237|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
143195900|NCT00350272|516262238|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
143195901|NCT00350272|516262237|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
143195902|NCT00350272|516262238|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
143195903|NCT00350272|516262237|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
143195904|NCT00350272|516262238|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
143195905|NCT00350272|516262237|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
143195906|NCT00350272|516262238|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
143195907|NCT00098748|516262241|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
143195908|NCT00098748|516262242|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
143195909|NCT00098748|516262243|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
143195910|NCT00098748|516262241|FG000|Received Study Treatment|Death|2|||
143195911|NCT00098748|516262242|FG001|Received Study Treatment|Death|1|||
143195912|NCT00098748|516262243|FG002|Received Study Treatment|Death|2|||
143195913|NCT00098748|516262241|FG000|Received Study Treatment|Adverse Event|1|||
143195914|NCT00098748|516262242|FG001|Received Study Treatment|Adverse Event|2|||
143195915|NCT00098748|516262243|FG002|Received Study Treatment|Adverse Event|5|||
143195916|NCT00098748|516262241|FG000|Received Study Treatment|Lack of Efficacy|40|||
143195917|NCT00098748|516262242|FG001|Received Study Treatment|Lack of Efficacy|27|||
143195918|NCT00098748|516262243|FG002|Received Study Treatment|Lack of Efficacy|27|||
143195919|NCT00098748|516262241|FG000|Received Study Treatment|Other|2|||
143195920|NCT00098748|516262242|FG001|Received Study Treatment|Other|2|||
143195921|NCT00098748|516262243|FG002|Received Study Treatment|Other|6|||
143195922|NCT00098748|516262241|FG000|Received Study Treatment|Subject defaulted|3|||
143195923|NCT00098748|516262242|FG001|Received Study Treatment|Subject defaulted|4|||
143195924|NCT00098748|516262243|FG002|Received Study Treatment|Subject defaulted|4|||
143195925|NCT00098748|516262241|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
143195926|NCT00098748|516262242|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
143195927|NCT00098748|516262243|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
143195928|NCT00098748|516262241|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
143195929|NCT00098748|516262242|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
143195930|NCT00098748|516262243|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
143195931|NCT00098748|516262241|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
143195932|NCT00098748|516262242|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
143195933|NCT00098748|516262243|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
143195934|NCT00098748|516262241|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
143195935|NCT00098748|516262242|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
143195936|NCT00098748|516262243|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
143195937|NCT00098748|516262241|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
143195938|NCT00098748|516262242|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
143195939|NCT00098748|516262243|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
143195940|NCT00433160|516262248|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
143195941|NCT00433160|516262249|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
143369658|NCT00603447|516896192|FG002|Overall Study|Other|1|||
143369659|NCT00603447|516896193|FG003|Overall Study|Other|0|||
143369660|NCT00603447|516896194|FG004|Overall Study|Other|3|||
143369661|NCT00603447|516896195|FG005|Overall Study|Other|0|||
143369662|NCT00603447|516896196|FG006|Overall Study|Other|13|||
143369663|NCT00603447|516896190|FG000|Overall Study|Withdrew Consent|0|||
143369664|NCT00603447|516896191|FG001|Overall Study|Withdrew Consent|2|||
143369665|NCT00603447|516896192|FG002|Overall Study|Withdrew Consent|0|||
143369666|NCT00603447|516896193|FG003|Overall Study|Withdrew Consent|0|||
143369667|NCT00603447|516896194|FG004|Overall Study|Withdrew Consent|1|||
143369668|NCT00603447|516896195|FG005|Overall Study|Withdrew Consent|0|||
143369669|NCT00603447|516896196|FG006|Overall Study|Withdrew Consent|1|||
143369670|NCT00798265|516896197|FG000|Overall Study|Lost to Follow-up|1|||
143369671|NCT00798265|516896198|FG001|Overall Study|Lost to Follow-up|10|||
143369672|NCT00798265|516896197|FG000|Overall Study|Study closing|7|||
143369673|NCT00798265|516896198|FG001|Overall Study|Study closing|6|||
143369674|NCT00798265|516896197|FG000|Overall Study|Withdrawal by Subject|0|||
143369675|NCT00798265|516896198|FG001|Overall Study|Withdrawal by Subject|1|||
143369676|NCT00798265|516896197|FG000|Overall Study|Screen failure|0|||
143369677|NCT00798265|516896198|FG001|Overall Study|Screen failure|1|||
143369678|NCT01838200|516896199|FG000|Overall Study|Adverse Event|0|||
143369679|NCT01838200|516896200|FG001|Overall Study|Adverse Event|2|||
143369680|NCT01838200|516896199|FG000|Overall Study|Progressive disease|3|||
143369681|NCT01838200|516896200|FG001|Overall Study|Progressive disease|0|||
143369682|NCT00470626|516897149|FG000|Overall Study|Lost to Follow-up|10|||
143369683|NCT00470626|516897149|FG000|Overall Study|Withdrawal by Subject|7|||
143369684|NCT02689349|516897150|FG000|Overall Study|Not implanted|4|||
143369685|NCT02689349|516897151|FG001|Overall Study|Not implanted|0|||
143195942|NCT00433160|516262248|FG000|52-Week Double-Blind (DB) Period|Death|0|||
143195943|NCT00433160|516262249|FG001|52-Week Double-Blind (DB) Period|Death|0|||
143195944|NCT00433160|516262248|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
143195945|NCT00433160|516262249|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
143195946|NCT00433160|516262248|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
143195947|NCT00433160|516262249|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
143195948|NCT00433160|516262248|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
143195949|NCT00433160|516262249|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
143195950|NCT00433160|516262248|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
143195951|NCT00433160|516262249|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
143195952|NCT00433160|516262248|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
143195953|NCT00433160|516262249|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
143195954|NCT00433160|516262248|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
143195955|NCT00433160|516262249|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
143195956|NCT00433160|516262248|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
143195957|NCT00433160|516262249|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
143195958|NCT00433160|516262248|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
143195959|NCT00433160|516262249|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
143195960|NCT00433160|516262248|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
143195961|NCT00433160|516262249|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
143195962|NCT00433160|516262248|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
143195963|NCT00433160|516262249|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
143195964|NCT00433160|516262248|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
143195965|NCT00433160|516262249|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
143195966|NCT00433160|516262248|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
143369686|NCT02689349|516897150|FG000|Overall Study|Withdrawal by Subject|9|||
143369687|NCT02689349|516897151|FG001|Overall Study|Withdrawal by Subject|0|||
143369688|NCT03518112|516897152|FG000|Overall Study|Withdrawal by Subject|1|||
143369689|NCT02930343|516897153|FG000|Overall Study|Lost to Follow-up|9|||
143369690|NCT02930343|516897154|FG001|Overall Study|Lost to Follow-up|7|||
143369691|NCT01185522|516897157|FG000|Overall Study|Lack of Efficacy|28|||
143195967|NCT00433160|516262249|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
143369692|NCT01185522|516897157|FG000|Overall Study|Lost to Follow-up|19|||
143369693|NCT01185522|516897157|FG000|Overall Study|Withdrawal by Subject|10|||
143369694|NCT01185522|516897157|FG000|Overall Study|Poor tolerance|39|||
143369695|NCT01185522|516897157|FG000|Overall Study|Other reasons|12|||
143369696|NCT01649791|516897158|FG000|Overall Study|Disease Progression|2|||
143369697|NCT01649791|516897158|FG000|Overall Study|Adverse Event|1|||
143195968|NCT00433160|516262248|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
143195969|NCT00433160|516262249|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
143195970|NCT00433160|516262248|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
143195971|NCT00433160|516262249|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
143195972|NCT03222973|516262258|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
143195973|NCT03222973|516262259|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
143195974|NCT03222973|516262260|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
143195975|NCT03222973|516262261|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
143195976|NCT03222973|516262258|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
143195977|NCT03222973|516262259|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
143195978|NCT03222973|516262260|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
143195979|NCT03222973|516262261|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
143195980|NCT03222973|516262258|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
143195981|NCT03222973|516262259|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
143195982|NCT03222973|516262260|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
143195983|NCT03222973|516262261|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
143195984|NCT03222973|516262258|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
143195985|NCT03222973|516262259|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
143195986|NCT03222973|516262260|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
143195987|NCT03222973|516262261|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
143195988|NCT03222973|516262258|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
143195989|NCT03222973|516262259|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
143195990|NCT03222973|516262260|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
143195991|NCT03222973|516262261|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
143195992|NCT03222973|516262258|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
143195993|NCT03222973|516262259|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
143195994|NCT03222973|516262260|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
143195995|NCT03222973|516262261|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
143195996|NCT03222973|516262258|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
143195997|NCT03222973|516262259|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
143195998|NCT03222973|516262260|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
143195999|NCT03222973|516262261|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
143196000|NCT03222973|516262258|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
143196001|NCT03222973|516262259|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
143196002|NCT03222973|516262260|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
143196003|NCT03222973|516262261|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
143196004|NCT03222973|516262258|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
143196005|NCT03222973|516262259|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
143196006|NCT03222973|516262260|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
143196007|NCT03222973|516262261|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
143196008|NCT03222973|516262258|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
143196009|NCT03222973|516262259|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
143196010|NCT03222973|516262260|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
143196011|NCT03222973|516262261|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
143196012|NCT03222973|516262258|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
143196013|NCT03222973|516262259|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
143196014|NCT03222973|516262260|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
143196015|NCT03222973|516262261|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
143196016|NCT03222973|516262258|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
143196017|NCT03222973|516262259|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
143196018|NCT03222973|516262260|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
143196019|NCT03222973|516262261|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
143196020|NCT02080481|516262262|FG000|Overall Study|Never received a block.|1|||
143196021|NCT02080481|516262263|FG001|Overall Study|Never received a block.|0|||
143196022|NCT03551665|516262264|FG000|Overall Study|Lost to Follow-up|11|||
143196023|NCT03551665|516262265|FG001|Overall Study|Lost to Follow-up|2|||
143196024|NCT02226198|516263577|FG000|Lead-in Phase|Protocol Violation|1|||
143196025|NCT02226198|516263578|FG001|Lead-in Phase|Protocol Violation|0|||
143196026|NCT02226198|516263579|FG002|Lead-in Phase|Protocol Violation|0|||
143261814|NCT04704154|516512505|FG003|Overall Study|Death|0|||
143261815|NCT04704154|516512506|FG004|Overall Study|Death|3|||
143196027|NCT02226198|516263577|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
143196028|NCT02226198|516263578|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
143196029|NCT02226198|516263579|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
143196030|NCT04258995|516263582|FG000|Overall Study|Lost to Follow-up|1|||
143196031|NCT04258995|516263583|FG001|Overall Study|Lost to Follow-up|1|||
143196032|NCT00983515|516263588|FG000|Ritonavir Alone|liver panel out of range|6|||
143196033|NCT00983515|516263588|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
143261816|NCT04704154|516512507|FG005|Overall Study|Death|0|||
143196034|NCT00642174|516263597|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
143196035|NCT00642174|516263598|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
143196036|NCT01730339|516263599|FG000|Overall Study|Withdrawal by Subject|3|||
143196037|NCT01730339|516263600|FG001|Overall Study|Withdrawal by Subject|2|||
143196038|NCT01730339|516263599|FG000|Overall Study|Lost to Follow-up|1|||
143196039|NCT01730339|516263600|FG001|Overall Study|Lost to Follow-up|1|||
143196040|NCT01730339|516263599|FG000|Overall Study|Un-specified|1|||
143196041|NCT01730339|516263600|FG001|Overall Study|Un-specified|0|||
143196042|NCT00896363|516263601|FG000|Overall Study|Adverse Event|3|||
143196043|NCT00896363|516263602|FG001|Overall Study|Adverse Event|4|||
143196044|NCT00896363|516263603|FG002|Overall Study|Adverse Event|2|||
143196045|NCT00896363|516263601|FG000|Overall Study|Lack of Efficacy|0|||
143196046|NCT00896363|516263602|FG001|Overall Study|Lack of Efficacy|2|||
143196047|NCT00896363|516263603|FG002|Overall Study|Lack of Efficacy|1|||
143196048|NCT00896363|516263601|FG000|Overall Study|Withdrawal by Subject|3|||
143196049|NCT00896363|516263602|FG001|Overall Study|Withdrawal by Subject|5|||
143196050|NCT00896363|516263603|FG002|Overall Study|Withdrawal by Subject|5|||
143196051|NCT01145352|516263608|FG000|Overall Study|Found to have been registered twice|6|||
143196052|NCT01145352|516263608|FG000|Overall Study|Treated before marketing approval|4|||
143196053|NCT01145352|516263608|FG000|Overall Study|Syringe formulation was used|1|||
143196054|NCT03095027|516263609|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
143196055|NCT03095027|516263610|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
143196056|NCT02982018|516263611|FG000|Overall Study|Incorrect Lens Dispensed|1|||
143196057|NCT02982018|516263612|FG001|Overall Study|Incorrect Lens Dispensed|0|||
143196058|NCT02982018|516263611|FG000|Overall Study|Protocol Violation|1|||
143196059|NCT02982018|516263612|FG001|Overall Study|Protocol Violation|1|||
143196060|NCT02982018|516263611|FG000|Overall Study|Adverse Event|1|||
143196061|NCT02982018|516263612|FG001|Overall Study|Adverse Event|1|||
143196062|NCT02982018|516263611|FG000|Overall Study|Lens Discomfort|2|||
143196063|NCT02982018|516263612|FG001|Overall Study|Lens Discomfort|0|||
143196064|NCT02982018|516263611|FG000|Overall Study|Withdrawal by Subject|0|||
143196065|NCT02982018|516263612|FG001|Overall Study|Withdrawal by Subject|1|||
143196066|NCT00445939|516263615|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
143196067|NCT00445939|516263616|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
143196068|NCT00445939|516263617|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
143196069|NCT00445939|516263618|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
143196070|NCT00445939|516263615|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
143196071|NCT00445939|516263616|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
143196072|NCT00445939|516263617|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
143196073|NCT00445939|516263618|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
143196074|NCT00378599|516263622|FG000|Overall Study|Adverse Event|38|||
143196075|NCT00378599|516263622|FG000|Overall Study|Protocol Violation|2|||
143196076|NCT00378599|516263622|FG000|Overall Study|Treatment failure|7|||
143196077|NCT00378599|516263622|FG000|Overall Study|Withdrawal by Subject|5|||
143196078|NCT02576535|516263635|FG000|Overall Study|Withdrawal by Subject|2|||
143196079|NCT00322023|516263638|FG000|Overall Study|various|0|||
143196080|NCT00322023|516263639|FG001|Overall Study|various|2|||
143196081|NCT00322023|516263640|FG002|Overall Study|various|6|||
143196082|NCT03920293|516263641|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
143196083|NCT03920293|516263642|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
143196084|NCT03920293|516263641|FG000|Randomized-Controlled Period|Physician Decision|1|||
143196085|NCT03920293|516263642|FG001|Randomized-Controlled Period|Physician Decision|2|||
143196086|NCT03920293|516263641|FG000|Randomized-Controlled Period|Adverse Event|0|||
143196087|NCT03920293|516263642|FG001|Randomized-Controlled Period|Adverse Event|2|||
143196088|NCT03920293|516263641|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
143196089|NCT03920293|516263642|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
143196090|NCT03920293|516263641|FG000|Randomized-Controlled Period|Death|2|||
143196091|NCT03920293|516263642|FG001|Randomized-Controlled Period|Death|0|||
143196092|NCT03920293|516263641|FG000|Randomized-Controlled Period|Protocol Violation|1|||
143196093|NCT03920293|516263642|FG001|Randomized-Controlled Period|Protocol Violation|0|||
143196094|NCT03920293|516263641|FG000|Randomized-Controlled Period|Noncompliance|1|||
143196095|NCT03920293|516263642|FG001|Randomized-Controlled Period|Noncompliance|0|||
143196096|NCT03920293|516263641|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
143196097|NCT03920293|516263642|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
143196098|NCT03920293|516263641|FG000|Open- Label Extension Period|Death|3|||
143196099|NCT03920293|516263642|FG001|Open- Label Extension Period|Death|3|||
143196100|NCT03920293|516263641|FG000|Open- Label Extension Period|Physician Decision|5|||
143196101|NCT03920293|516263642|FG001|Open- Label Extension Period|Physician Decision|3|||
143196102|NCT03920293|516263641|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
143196103|NCT03920293|516263642|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
143196104|NCT01691885|516263648|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
143196105|NCT01691885|516263649|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
143196106|NCT01691885|516263648|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
143196107|NCT01691885|516263649|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
143196108|NCT00996281|516263650|FG000|Overall Study|Adverse Event|75|||
143196109|NCT00996281|516263651|FG001|Overall Study|Adverse Event|37|||
143196110|NCT00996281|516263650|FG000|Overall Study|Major Protocol Deviation|6|||
143196111|NCT00996281|516263651|FG001|Overall Study|Major Protocol Deviation|7|||
143196112|NCT00996281|516263650|FG000|Overall Study|Lost to Follow-up|14|||
143196113|NCT00996281|516263651|FG001|Overall Study|Lost to Follow-up|16|||
143196114|NCT00996281|516263650|FG000|Overall Study|Withdrawal by Subject|31|||
143196115|NCT00996281|516263651|FG001|Overall Study|Withdrawal by Subject|20|||
143196116|NCT00996281|516263650|FG000|Overall Study|Lack of Efficacy|0|||
143196117|NCT00996281|516263651|FG001|Overall Study|Lack of Efficacy|2|||
143196118|NCT00996281|516263650|FG000|Overall Study|Other|5|||
143196119|NCT00996281|516263651|FG001|Overall Study|Other|7|||
143196120|NCT03505788|516263652|FG000|Overall Study|Lost to Follow-up|2|||
143196121|NCT03505788|516263653|FG001|Overall Study|Lost to Follow-up|1|||
143196122|NCT03505788|516263652|FG000|Overall Study|Withdrawal by Subject|1|||
143196123|NCT03505788|516263653|FG001|Overall Study|Withdrawal by Subject|3|||
143196124|NCT03505788|516263652|FG000|Overall Study|Physician Decision|0|||
143196125|NCT03505788|516263653|FG001|Overall Study|Physician Decision|1|||
143196126|NCT03575065|516263654|FG000|Overall Study|Death|31|||
143196127|NCT03575065|516263655|FG001|Overall Study|Death|12|||
143196128|NCT03575065|516263654|FG000|Overall Study|Sponsor's Decision|28|||
143196129|NCT03575065|516263655|FG001|Overall Study|Sponsor's Decision|13|||
143196130|NCT03575065|516263654|FG000|Overall Study|Withdrawal by Subject|2|||
143196131|NCT03575065|516263655|FG001|Overall Study|Withdrawal by Subject|1|||
143196132|NCT03575065|516263654|FG000|Overall Study|Lost to Follow-up|1|||
143196133|NCT03575065|516263655|FG001|Overall Study|Lost to Follow-up|0|||
143196134|NCT03344549|516263660|FG000|Overall Study|Withdrawal by Subject|3|||
143196135|NCT03344549|516263661|FG001|Overall Study|Withdrawal by Subject|2|||
143196136|NCT03344549|516263660|FG000|Overall Study|Dialysis|2|||
143196137|NCT03344549|516263661|FG001|Overall Study|Dialysis|0|||
143196138|NCT03344549|516263660|FG000|Overall Study|Cancer|1|||
143196139|NCT03344549|516263661|FG001|Overall Study|Cancer|0|||
143196140|NCT03344549|516263660|FG000|Overall Study|Lack of electronic device|1|||
143196141|NCT03344549|516263661|FG001|Overall Study|Lack of electronic device|0|||
143196142|NCT03344549|516263660|FG000|Overall Study|Transportation difficulty|0|||
143196143|NCT03344549|516263661|FG001|Overall Study|Transportation difficulty|13|||
143196144|NCT00113399|516263662|FG000|Overall Study|Death|1|||
143196145|NCT00113399|516263663|FG001|Overall Study|Death|1|||
143196146|NCT00113399|516263662|FG000|Overall Study|Withdrawal by Subject|1|||
143196147|NCT00113399|516263663|FG001|Overall Study|Withdrawal by Subject|2|||
143196148|NCT00113399|516263662|FG000|Overall Study|Complete Response|0|||
143196149|NCT00113399|516263663|FG001|Overall Study|Complete Response|1|||
143196150|NCT00113399|516263662|FG000|Overall Study|Other|0|||
143196151|NCT00113399|516263663|FG001|Overall Study|Other|1|||
143196152|NCT00396136|516263664|FG000|Overall Study|Death|43|||
143196153|NCT00396136|516263664|FG000|Overall Study|Withdrawal by Subject|59|||
143196154|NCT00396136|516263664|FG000|Overall Study|Lost to Follow-up|15|||
143196155|NCT00396136|516263664|FG000|Overall Study|Study device explanted|8|||
143196156|NCT01774097|516263669|FG000|Overall Study|Withdrawal by Subject|1|||
143196157|NCT01774097|516263670|FG001|Overall Study|Withdrawal by Subject|1|||
143196158|NCT01774097|516263669|FG000|Overall Study|Adverse Event|1|||
143196159|NCT01774097|516263670|FG001|Overall Study|Adverse Event|1|||
143196160|NCT00543296|516263671|FG000|Overall Study|Physician Decision|7|||
143196161|NCT00934947|516263672|FG000|Overall Study|Adverse Event|0|||
143196162|NCT00934947|516263673|FG001|Overall Study|Adverse Event|2|||
143196163|NCT00252694|516263677|FG000|Overall Study|Withdrawal by Subject|83|||
143196164|NCT00252694|516263678|FG001|Overall Study|Withdrawal by Subject|91|||
143196165|NCT00252694|516263677|FG000|Overall Study|Death|36|||
143196166|NCT00252694|516263678|FG001|Overall Study|Death|34|||
143196167|NCT00252694|516263677|FG000|Overall Study|Mostly Lost to Follow Up|8|||
143196168|NCT00252694|516263678|FG001|Overall Study|Mostly Lost to Follow Up|13|||
143196169|NCT00252694|516263677|FG000|Overall Study|Patient Moving|17|||
143261817|NCT04704154|516512502|FG000|Overall Study|Physician Decision|1|||
143196170|NCT00252694|516263678|FG001|Overall Study|Patient Moving|16|||
143196171|NCT03664674|516263680|FG000|Overall Study|Adverse Event|1|||
143196172|NCT03664674|516263681|FG001|Overall Study|Adverse Event|1|||
143196173|NCT03664674|516263680|FG000|Overall Study|Physician Decision|0|||
143196174|NCT03664674|516263681|FG001|Overall Study|Physician Decision|1|||
143196175|NCT03664674|516263680|FG000|Overall Study|Withdrawal by Subject|2|||
143196176|NCT03664674|516263681|FG001|Overall Study|Withdrawal by Subject|0|||
143196177|NCT03022097|516263682|FG000|Overall Study|Adverse Event|3|||
143196178|NCT03022097|516263683|FG001|Overall Study|Adverse Event|4|||
143196179|NCT03022097|516263684|FG002|Overall Study|Adverse Event|1|||
143196180|NCT03022097|516263685|FG003|Overall Study|Adverse Event|3|||
143196181|NCT03022097|516263682|FG000|Overall Study|Progressive Disease|2|||
143196182|NCT03022097|516263683|FG001|Overall Study|Progressive Disease|0|||
143196183|NCT03022097|516263684|FG002|Overall Study|Progressive Disease|5|||
143196184|NCT03022097|516263685|FG003|Overall Study|Progressive Disease|2|||
143196185|NCT03022097|516263682|FG000|Overall Study|Lack of Efficacy|0|||
143196186|NCT03022097|516263683|FG001|Overall Study|Lack of Efficacy|0|||
143196187|NCT03022097|516263684|FG002|Overall Study|Lack of Efficacy|3|||
143196188|NCT03022097|516263685|FG003|Overall Study|Lack of Efficacy|3|||
143196189|NCT03022097|516263682|FG000|Overall Study|Protocol Violation|1|||
143196190|NCT03022097|516263683|FG001|Overall Study|Protocol Violation|0|||
143196191|NCT03022097|516263684|FG002|Overall Study|Protocol Violation|1|||
143196192|NCT03022097|516263685|FG003|Overall Study|Protocol Violation|0|||
143196193|NCT03022097|516263682|FG000|Overall Study|Withdrawal by Subject|11|||
143196194|NCT03022097|516263683|FG001|Overall Study|Withdrawal by Subject|13|||
143196195|NCT03022097|516263684|FG002|Overall Study|Withdrawal by Subject|15|||
143196196|NCT03022097|516263685|FG003|Overall Study|Withdrawal by Subject|21|||
143196197|NCT03022097|516263682|FG000|Overall Study|Lost to Follow-up|0|||
143196198|NCT03022097|516263683|FG001|Overall Study|Lost to Follow-up|0|||
143196199|NCT03022097|516263684|FG002|Overall Study|Lost to Follow-up|1|||
143196200|NCT03022097|516263685|FG003|Overall Study|Lost to Follow-up|1|||
143196201|NCT03022097|516263682|FG000|Overall Study|Other|4|||
143196202|NCT03022097|516263683|FG001|Overall Study|Other|1|||
143196203|NCT03022097|516263684|FG002|Overall Study|Other|6|||
143196204|NCT03022097|516263685|FG003|Overall Study|Other|4|||
143196205|NCT03022097|516263682|FG000|Overall Study|Due to COVID-19 pandemic|0|||
143196206|NCT03022097|516263683|FG001|Overall Study|Due to COVID-19 pandemic|1|||
143196207|NCT03022097|516263684|FG002|Overall Study|Due to COVID-19 pandemic|0|||
143196208|NCT03022097|516263685|FG003|Overall Study|Due to COVID-19 pandemic|0|||
143196209|NCT01451931|516263686|FG000|Overall Study|Lost to Follow-up|17|||
143196210|NCT01451931|516263687|FG001|Overall Study|Lost to Follow-up|36|||
143196211|NCT01451931|516263688|FG002|Overall Study|Lost to Follow-up|21|||
143196212|NCT01451931|516263686|FG000|Overall Study|Withdrawal by Subject|16|||
143196213|NCT01451931|516263687|FG001|Overall Study|Withdrawal by Subject|22|||
143196214|NCT01451931|516263688|FG002|Overall Study|Withdrawal by Subject|22|||
143196215|NCT04003207|516263691|FG000|Overall Study|Protocol Violation|1|||
143196216|NCT04173260|516263693|FG000|Overall Study|Early termination|4|||
143196217|NCT03941964|516263694|FG000|Overall Study|Adverse Event|1|||
143196218|NCT03941964|516263695|FG001|Overall Study|Adverse Event|8|||
143196219|NCT03941964|516263694|FG000|Overall Study|Progressive disease|7|||
143196220|NCT03941964|516263695|FG001|Overall Study|Progressive disease|3|||
143196221|NCT03941964|516263694|FG000|Overall Study|Lack of Efficacy|0|||
143196222|NCT03941964|516263695|FG001|Overall Study|Lack of Efficacy|1|||
143196223|NCT03941964|516263694|FG000|Overall Study|Death|3|||
143196224|NCT03941964|516263695|FG001|Overall Study|Death|1|||
143196225|NCT03941964|516263694|FG000|Overall Study|Withdrew consent|1|||
143196226|NCT03941964|516263695|FG001|Overall Study|Withdrew consent|3|||
143196227|NCT03941964|516263694|FG000|Overall Study|Physician Decision|9|||
143196228|NCT03941964|516263695|FG001|Overall Study|Physician Decision|2|||
143196229|NCT03941964|516263694|FG000|Overall Study|Other, not specified|2|||
143196230|NCT03941964|516263695|FG001|Overall Study|Other, not specified|1|||
143196231|NCT00118846|516263698|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
143196232|NCT00118846|516263699|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
143196233|NCT00118846|516263698|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
143196234|NCT00118846|516263699|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
143196235|NCT00118846|516263698|FG000|Overall Study|Physician Decision|1|||
143196236|NCT00118846|516263699|FG001|Overall Study|Physician Decision|0|||
143196237|NCT00118846|516263698|FG000|Overall Study|Medical condition|2|||
143261818|NCT04704154|516512503|FG001|Overall Study|Physician Decision|0|||
143196238|NCT00118846|516263699|FG001|Overall Study|Medical condition|2|||
143196239|NCT00118846|516263698|FG000|Overall Study|Lost to Follow-up|0|||
143196240|NCT00118846|516263699|FG001|Overall Study|Lost to Follow-up|2|||
143196241|NCT00118846|516263698|FG000|Overall Study|Personal reason|4|||
143196242|NCT00118846|516263699|FG001|Overall Study|Personal reason|5|||
143196243|NCT01632241|516263706|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
143196244|NCT01632241|516263707|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
143196245|NCT01632241|516263706|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
143196246|NCT01632241|516263707|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
143261819|NCT04704154|516512504|FG002|Overall Study|Physician Decision|1|||
143196247|NCT01632241|516263706|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
143196248|NCT01632241|516263707|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
143196249|NCT01632241|516263706|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
143196250|NCT01632241|516263707|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
143196251|NCT01632241|516263706|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
143196252|NCT01632241|516263707|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
143196253|NCT01632241|516263706|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
143196254|NCT01632241|516263707|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
143196255|NCT01632241|516263706|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
143196256|NCT01632241|516263707|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
143196257|NCT01632241|516263706|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
143196258|NCT01632241|516263707|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
143196259|NCT01632241|516263706|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
143196260|NCT01632241|516263707|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
143196261|NCT01632241|516263706|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
143196262|NCT01632241|516263707|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
143196263|NCT01632241|516263706|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
143196264|NCT01632241|516263707|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
143196265|NCT01632241|516263706|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
143196266|NCT01632241|516263707|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
143196267|NCT01632241|516263706|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
143196268|NCT01632241|516263707|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
143196269|NCT01632241|516263706|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
143196270|NCT01632241|516263707|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
143196271|NCT05463744|516263708|FG000|Treatment Period|Withdrawal by Subject|19|||
143196272|NCT05463744|516263709|FG001|Treatment Period|Withdrawal by Subject|16|||
143196273|NCT05463744|516263708|FG000|Treatment Period|Adverse Event|4|||
143196274|NCT05463744|516263709|FG001|Treatment Period|Adverse Event|4|||
143196275|NCT05463744|516263708|FG000|Treatment Period|Pregnancy|0|||
143196276|NCT05463744|516263709|FG001|Treatment Period|Pregnancy|3|||
143196277|NCT05463744|516263708|FG000|Treatment Period|Lost to Follow-up|1|||
143196278|NCT05463744|516263709|FG001|Treatment Period|Lost to Follow-up|3|||
143196279|NCT05463744|516263708|FG000|Treatment Period|Inadvertent enrollment|2|||
143196280|NCT05463744|516263709|FG001|Treatment Period|Inadvertent enrollment|1|||
143196281|NCT05463744|516263708|FG000|Treatment Period|Death|0|||
143196282|NCT05463744|516263709|FG001|Treatment Period|Death|1|||
143196283|NCT05463744|516263708|FG000|Treatment Period|Non-compliance with Study Drug|1|||
143196284|NCT05463744|516263709|FG001|Treatment Period|Non-compliance with Study Drug|0|||
143196285|NCT05463744|516263708|FG000|Treatment Period|Subject Terminated by Sponsor|0|||
143196286|NCT05463744|516263709|FG001|Treatment Period|Subject Terminated by Sponsor|1|||
143196287|NCT05463744|516263708|FG000|Treatment Period|Physician Decision|0|||
143196288|NCT05463744|516263709|FG001|Treatment Period|Physician Decision|1|||
143196289|NCT05463744|516263708|FG000|Follow-Up Period|Withdrawal by Subject|3|||
143196290|NCT05463744|516263709|FG001|Follow-Up Period|Withdrawal by Subject|1|||
143196291|NCT05463744|516263708|FG000|Follow-Up Period|Lost to Follow-up|1|||
143196292|NCT05463744|516263709|FG001|Follow-Up Period|Lost to Follow-up|1|||
143196293|NCT01357161|516263711|FG000|Part 1 (Open Label Run-in)|Death|5|||
143196294|NCT01357161|516263712|FG001|Part 1 (Open Label Run-in)|Death|0|||
143196295|NCT01357161|516263713|FG002|Part 1 (Open Label Run-in)|Death|0|||
143196296|NCT01357161|516263711|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
143196297|NCT01357161|516263712|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
143196298|NCT01357161|516263713|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
143196299|NCT01357161|516263711|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
143196300|NCT01357161|516263712|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
143196301|NCT01357161|516263713|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
143196302|NCT01357161|516263711|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
143196303|NCT01357161|516263712|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
143196304|NCT01357161|516263713|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
143196305|NCT01357161|516263711|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
143196306|NCT01357161|516263712|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
143196307|NCT01357161|516263713|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
143196308|NCT01357161|516263711|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
143196309|NCT01357161|516263712|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
143196310|NCT01357161|516263713|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
143196311|NCT01357161|516263711|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
143261820|NCT04704154|516512505|FG003|Overall Study|Physician Decision|0|||
143261821|NCT04704154|516512506|FG004|Overall Study|Physician Decision|2|||
143261822|NCT04704154|516512507|FG005|Overall Study|Physician Decision|0|||
143261823|NCT04704154|516512502|FG000|Overall Study|Participant Decision|1|||
143261824|NCT04704154|516512503|FG001|Overall Study|Participant Decision|1|||
143196312|NCT01357161|516263712|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
143196313|NCT01357161|516263713|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
143196314|NCT01357161|516263711|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
143196315|NCT01357161|516263712|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
143196316|NCT01357161|516263713|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
143196317|NCT01357161|516263711|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
143196318|NCT01357161|516263712|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
143196319|NCT01357161|516263713|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
143196320|NCT01357161|516263711|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
143196321|NCT01357161|516263712|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
143196322|NCT01357161|516263713|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
143196323|NCT01357161|516263711|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
143196324|NCT01357161|516263712|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
143196325|NCT01357161|516263713|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
143196326|NCT00496483|516265034|FG000|Overall Study|Not dosed|9|||
143196327|NCT00496483|516265034|FG000|Overall Study|Adverse Event|2|||
143196328|NCT00496483|516265034|FG000|Overall Study|Lack of Efficacy|1|||
143196329|NCT00303446|516265036|FG000|Overall Study|Withdrawal by Subject|2|||
143196330|NCT00303446|516265037|FG001|Overall Study|Withdrawal by Subject|2|||
143196331|NCT00303446|516265036|FG000|Overall Study|Death|0|||
143196332|NCT00303446|516265037|FG001|Overall Study|Death|1|||
143196333|NCT00303446|516265036|FG000|Overall Study|Physician Decision|0|||
143196334|NCT00303446|516265037|FG001|Overall Study|Physician Decision|1|||
143196335|NCT00428220|516265038|FG000|Overall Study|Participant died|8|||
143196336|NCT00428220|516265038|FG000|Overall Study|Global deterioration of health status|7|||
143196337|NCT00428220|516265038|FG000|Overall Study|Lost to Follow-up|4|||
143196338|NCT00428220|516265038|FG000|Overall Study|Objective progression or relapse|123|||
143196339|NCT00428220|516265038|FG000|Overall Study|Participant refused continued treatment|7|||
143196340|NCT00428220|516265038|FG000|Overall Study|Adverse Event|51|||
143196341|NCT00428220|516265038|FG000|Overall Study|Other|23|||
143196342|NCT03245736|516265039|FG000|Overall Study|Adverse Event|1|||
143196343|NCT03245736|516265039|FG000|Overall Study|Progressive Disease|4|||
143196344|NCT00132691|516265044|FG000|Overall Study|Lost to Follow-up|5|||
143196345|NCT00132691|516265045|FG001|Overall Study|Lost to Follow-up|8|||
143196346|NCT00132691|516265044|FG000|Overall Study|Missed 2-year visit|4|||
143196347|NCT00132691|516265045|FG001|Overall Study|Missed 2-year visit|4|||
143196348|NCT00132691|516265044|FG000|Overall Study|Death|2|||
143196349|NCT00132691|516265045|FG001|Overall Study|Death|0|||
143196350|NCT02251717|516265046|FG000|Overall Study|Adverse Event|0|||
143196351|NCT02251717|516265047|FG001|Overall Study|Adverse Event|1|||
143196352|NCT02251717|516265046|FG000|Overall Study|Withdrew Consent|1|||
143196353|NCT02251717|516265047|FG001|Overall Study|Withdrew Consent|0|||
143196354|NCT04098367|516265048|FG000|Overall Study|Adverse Event|0|||
143196355|NCT04098367|516265049|FG001|Overall Study|Adverse Event|0|||
143196356|NCT04098367|516265050|FG002|Overall Study|Adverse Event|1|||
143196357|NCT04098367|516265048|FG000|Overall Study|Lost to Follow-up|1|||
143196358|NCT04098367|516265049|FG001|Overall Study|Lost to Follow-up|5|||
143196359|NCT04098367|516265050|FG002|Overall Study|Lost to Follow-up|2|||
143196360|NCT04098367|516265048|FG000|Overall Study|Withdrawal by Subject|0|||
143196361|NCT04098367|516265049|FG001|Overall Study|Withdrawal by Subject|0|||
143196362|NCT04098367|516265050|FG002|Overall Study|Withdrawal by Subject|1|||
143196363|NCT04098367|516265048|FG000|Overall Study|Sick . Could not attend visit|1|||
143196364|NCT04098367|516265049|FG001|Overall Study|Sick . Could not attend visit|0|||
143196365|NCT04098367|516265050|FG002|Overall Study|Sick . Could not attend visit|0|||
143196366|NCT01920568|516265056|FG000|Overall Study|Adverse Event|27|||
143196367|NCT01920568|516265057|FG001|Overall Study|Adverse Event|8|||
143196368|NCT01920568|516265056|FG000|Overall Study|Protocol Violation|5|||
143196369|NCT01920568|516265057|FG001|Overall Study|Protocol Violation|3|||
143196370|NCT01920568|516265056|FG000|Overall Study|Lost to Follow-up|2|||
143196371|NCT01920568|516265057|FG001|Overall Study|Lost to Follow-up|2|||
143196372|NCT01920568|516265056|FG000|Overall Study|Physician Decision|13|||
143196373|NCT01920568|516265057|FG001|Overall Study|Physician Decision|4|||
143196374|NCT01920568|516265056|FG000|Overall Study|Withdrawal by Subject|79|||
143196375|NCT01920568|516265057|FG001|Overall Study|Withdrawal by Subject|55|||
143196376|NCT01920568|516265056|FG000|Overall Study|Death due to disease progression|25|||
143196377|NCT01920568|516265057|FG001|Overall Study|Death due to disease progression|12|||
143196378|NCT04600076|516265058|FG000|Overall Study|Lost to Follow-up|3|||
143196379|NCT01342965|516265059|FG000|Overall Study|Death|58|||
143196380|NCT01342965|516265060|FG001|Overall Study|Death|57|||
143196381|NCT01342965|516265059|FG000|Overall Study|Lost to Follow-up|5|||
143196382|NCT01342965|516265060|FG001|Overall Study|Lost to Follow-up|3|||
143196383|NCT01342965|516265059|FG000|Overall Study|Other Reasons- Unspecified|44|||
143196384|NCT01342965|516265060|FG001|Overall Study|Other Reasons- Unspecified|38|||
143196385|NCT01342965|516265059|FG000|Overall Study|Withdrawal by Subject|2|||
143196386|NCT01342965|516265060|FG001|Overall Study|Withdrawal by Subject|9|||
143196387|NCT01170598|516265061|FG000|Overall Study|Withdrawal by Subject|1|||
143196388|NCT01170598|516265061|FG000|Overall Study|Death|3|||
143196389|NCT01170598|516265061|FG000|Overall Study|Lost to Follow-up|1|||
143196390|NCT01170598|516265061|FG000|Overall Study|Refused|1|||
143196391|NCT02780856|516265064|FG000|Overall Study|Lost to Follow-up|1|||
143196392|NCT05479097|516265065|FG000|Overall Study|Withdrawal by Subject|2|||
143196393|NCT03894969|516265068|FG000|Overall Study|Adverse Event|0|||
143196394|NCT03894969|516265069|FG001|Overall Study|Adverse Event|2|||
143196395|NCT03894969|516265070|FG002|Overall Study|Adverse Event|0|||
143196396|NCT03894969|516265071|FG003|Overall Study|Adverse Event|1|||
143196397|NCT03894969|516265072|FG004|Overall Study|Adverse Event|2|||
143196398|NCT03894969|516265068|FG000|Overall Study|Lost to Follow-up|3|||
143196399|NCT03894969|516265069|FG001|Overall Study|Lost to Follow-up|1|||
143196400|NCT03894969|516265070|FG002|Overall Study|Lost to Follow-up|1|||
143196401|NCT03894969|516265071|FG003|Overall Study|Lost to Follow-up|0|||
143196402|NCT03894969|516265072|FG004|Overall Study|Lost to Follow-up|0|||
143196403|NCT03894969|516265068|FG000|Overall Study|Withdrawal by Subject|2|||
143196404|NCT03894969|516265069|FG001|Overall Study|Withdrawal by Subject|1|||
143196405|NCT03894969|516265070|FG002|Overall Study|Withdrawal by Subject|3|||
143196406|NCT03894969|516265071|FG003|Overall Study|Withdrawal by Subject|4|||
143196407|NCT03894969|516265072|FG004|Overall Study|Withdrawal by Subject|8|||
143196408|NCT03894969|516265068|FG000|Overall Study|Other|0|||
143196409|NCT03894969|516265069|FG001|Overall Study|Other|0|||
143196410|NCT03894969|516265070|FG002|Overall Study|Other|0|||
143196411|NCT03894969|516265071|FG003|Overall Study|Other|0|||
143196412|NCT03894969|516265072|FG004|Overall Study|Other|3|||
143196413|NCT03894969|516265068|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
143196414|NCT03894969|516265069|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
143196415|NCT03894969|516265070|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
143196416|NCT03894969|516265071|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
143196417|NCT03894969|516265072|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
143196418|NCT03894969|516265068|FG000|Overall Study|Solicited Adverse Event|0|||
143196419|NCT03894969|516265069|FG001|Overall Study|Solicited Adverse Event|1|||
143196420|NCT03894969|516265070|FG002|Overall Study|Solicited Adverse Event|0|||
143196421|NCT03894969|516265071|FG003|Overall Study|Solicited Adverse Event|0|||
143196422|NCT03894969|516265072|FG004|Overall Study|Solicited Adverse Event|0|||
143196423|NCT00468676|516265074|FG000|Overall Study|Lost to Follow-up|14|||
143196424|NCT00468676|516265075|FG001|Overall Study|Lost to Follow-up|11|||
143196425|NCT00468676|516265074|FG000|Overall Study|Death|2|||
143196426|NCT00468676|516265075|FG001|Overall Study|Death|1|||
143196427|NCT02378298|516265076|FG000|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
143196428|NCT02378298|516265077|FG001|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|2|||
143196429|NCT02378298|516265078|FG002|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
143196430|NCT02378298|516265076|FG000|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
143196431|NCT02378298|516265077|FG001|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
143196432|NCT02378298|516265078|FG002|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|1|||
143196433|NCT02378298|516265076|FG000|Surveillance (19-68 Weeks)|Death|1|||
143196434|NCT02378298|516265077|FG001|Surveillance (19-68 Weeks)|Death|0|||
143196435|NCT02378298|516265078|FG002|Surveillance (19-68 Weeks)|Death|0|||
143196436|NCT01779869|516265081|FG000|Overall Study|Physician Decision|2|||
143196437|NCT02437409|516265084|FG000|Overall Study|Withdrawal by Subject|3|||
143196438|NCT02437409|516265084|FG000|Overall Study|Screening failure|12|||
143196439|NCT00737568|516265089|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
143196440|NCT00737568|516265090|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
143196441|NCT00737568|516265089|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
143196442|NCT00737568|516265090|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
143196443|NCT00737568|516265089|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
143196444|NCT00737568|516265090|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
143196445|NCT00737568|516265089|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
143196446|NCT00737568|516265090|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
143196447|NCT00737568|516265089|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
143196448|NCT00737568|516265090|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
143196449|NCT00737568|516265089|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
143196450|NCT00737568|516265090|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
143196451|NCT00737568|516265089|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
143196452|NCT00737568|516265090|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
143196453|NCT00737568|516265089|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
143196454|NCT00737568|516265090|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
143196455|NCT00737568|516265089|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
143196456|NCT00737568|516265090|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
143196457|NCT00855933|516265091|FG000|Overall Study|Withdrawal by Subject|0|||
143196458|NCT00855933|516265092|FG001|Overall Study|Withdrawal by Subject|1|||
143196459|NCT00951080|516265093|FG000|Overall Study|Adverse Event|3|||
143196460|NCT00951080|516265094|FG001|Overall Study|Adverse Event|3|||
143196461|NCT00951080|516265093|FG000|Overall Study|Lost to Follow-up|0|||
143196462|NCT00951080|516265094|FG001|Overall Study|Lost to Follow-up|1|||
143196463|NCT00951080|516265093|FG000|Overall Study|Physician Decision|4|||
143196464|NCT00951080|516265094|FG001|Overall Study|Physician Decision|1|||
143196465|NCT00951080|516265093|FG000|Overall Study|Other|19|||
143196466|NCT00951080|516265094|FG001|Overall Study|Other|22|||
143196467|NCT00835640|516265097|FG000|Second Intervention|Protocol Violation|1|||
143196468|NCT00835640|516265098|FG001|Second Intervention|Protocol Violation|0|||
143196469|NCT01904149|516265099|FG000|Overall Study|Adverse Event|3|||
143196470|NCT01904149|516265100|FG001|Overall Study|Adverse Event|4|||
143196471|NCT01904149|516265101|FG002|Overall Study|Adverse Event|0|||
143196472|NCT01904149|516265102|FG003|Overall Study|Adverse Event|1|||
143196473|NCT01904149|516265103|FG004|Overall Study|Adverse Event|1|||
143196474|NCT01904149|516265104|FG005|Overall Study|Adverse Event|2|||
143196475|NCT01904149|516265099|FG000|Overall Study|Lack of Efficacy|0|||
143196476|NCT01904149|516265100|FG001|Overall Study|Lack of Efficacy|3|||
143196477|NCT01904149|516265101|FG002|Overall Study|Lack of Efficacy|1|||
143196478|NCT01904149|516265102|FG003|Overall Study|Lack of Efficacy|3|||
143196479|NCT01904149|516265103|FG004|Overall Study|Lack of Efficacy|3|||
143196480|NCT01904149|516265104|FG005|Overall Study|Lack of Efficacy|1|||
143196481|NCT01904149|516265099|FG000|Overall Study|Withdrawal by Subject|1|||
143196482|NCT01904149|516265100|FG001|Overall Study|Withdrawal by Subject|3|||
143196483|NCT01904149|516265101|FG002|Overall Study|Withdrawal by Subject|1|||
143196484|NCT01904149|516265102|FG003|Overall Study|Withdrawal by Subject|0|||
143196485|NCT01904149|516265103|FG004|Overall Study|Withdrawal by Subject|1|||
143196486|NCT01904149|516265104|FG005|Overall Study|Withdrawal by Subject|0|||
143196487|NCT01904149|516265099|FG000|Overall Study|Protocol Violation|0|||
143196488|NCT01904149|516265100|FG001|Overall Study|Protocol Violation|1|||
143196489|NCT01904149|516265101|FG002|Overall Study|Protocol Violation|0|||
143196490|NCT01904149|516265102|FG003|Overall Study|Protocol Violation|0|||
143196491|NCT01904149|516265103|FG004|Overall Study|Protocol Violation|0|||
143196492|NCT01904149|516265104|FG005|Overall Study|Protocol Violation|0|||
143196493|NCT01904149|516265099|FG000|Overall Study|non compliance with study drug|1|||
143196494|NCT01904149|516265100|FG001|Overall Study|non compliance with study drug|0|||
143196495|NCT01904149|516265101|FG002|Overall Study|non compliance with study drug|0|||
143196496|NCT01904149|516265102|FG003|Overall Study|non compliance with study drug|0|||
143196497|NCT01904149|516265103|FG004|Overall Study|non compliance with study drug|0|||
143196498|NCT01904149|516265104|FG005|Overall Study|non compliance with study drug|0|||
143196499|NCT00068250|516265105|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
143196500|NCT00068250|516265106|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
143196501|NCT00068250|516265107|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
143196502|NCT00068250|516265108|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
143196503|NCT00235391|516265110|FG000|Overall Study|Adverse Event|4|||
143196504|NCT00235391|516265111|FG001|Overall Study|Adverse Event|5|||
143196505|NCT00235391|516265112|FG002|Overall Study|Adverse Event|10|||
143196506|NCT00235391|516265113|FG003|Overall Study|Adverse Event|72|||
143196507|NCT00235391|516265114|FG004|Overall Study|Adverse Event|5|||
143196508|NCT00235391|516265115|FG005|Overall Study|Adverse Event|2|||
143196509|NCT00235391|516265110|FG000|Overall Study|Abnormal laboratory value(s)|3|||
143196510|NCT00235391|516265111|FG001|Overall Study|Abnormal laboratory value(s)|5|||
143196511|NCT00235391|516265112|FG002|Overall Study|Abnormal laboratory value(s)|4|||
143196512|NCT00235391|516265113|FG003|Overall Study|Abnormal laboratory value(s)|27|||
143196513|NCT00235391|516265114|FG004|Overall Study|Abnormal laboratory value(s)|1|||
143196514|NCT00235391|516265115|FG005|Overall Study|Abnormal laboratory value(s)|2|||
143196515|NCT00235391|516265110|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
143196516|NCT00235391|516265111|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
143261825|NCT04704154|516512504|FG002|Overall Study|Participant Decision|0|||
143261826|NCT04704154|516512505|FG003|Overall Study|Participant Decision|0|||
143196517|NCT00235391|516265112|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
143196518|NCT00235391|516265113|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
143196519|NCT00235391|516265114|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
143196520|NCT00235391|516265115|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
143196521|NCT00235391|516265110|FG000|Overall Study|Condition no longer requires treatment|3|||
143196522|NCT00235391|516265111|FG001|Overall Study|Condition no longer requires treatment|0|||
143196523|NCT00235391|516265112|FG002|Overall Study|Condition no longer requires treatment|0|||
143196524|NCT00235391|516265113|FG003|Overall Study|Condition no longer requires treatment|11|||
143196525|NCT00235391|516265114|FG004|Overall Study|Condition no longer requires treatment|1|||
143196526|NCT00235391|516265115|FG005|Overall Study|Condition no longer requires treatment|0|||
143261827|NCT04704154|516512506|FG004|Overall Study|Participant Decision|0|||
143261828|NCT04704154|516512507|FG005|Overall Study|Participant Decision|0|||
143261829|NCT04704154|516512502|FG000|Overall Study|Progressive Disease|19|||
143261830|NCT04704154|516512503|FG001|Overall Study|Progressive Disease|17|||
143261831|NCT04704154|516512504|FG002|Overall Study|Progressive Disease|20|||
143261832|NCT04704154|516512505|FG003|Overall Study|Progressive Disease|18|||
143261833|NCT04704154|516512506|FG004|Overall Study|Progressive Disease|36|||
143261834|NCT04704154|516512507|FG005|Overall Study|Progressive Disease|30|||
143261835|NCT04704154|516512502|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|2|||
143261836|NCT04704154|516512503|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
143261837|NCT04704154|516512504|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
143261838|NCT04704154|516512505|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
143261839|NCT04704154|516512506|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
143261840|NCT04704154|516512507|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
143261841|NCT04704154|516512502|FG000|Overall Study|Patient continued in rollover study for regorafenib|1|||
143261842|NCT04704154|516512503|FG001|Overall Study|Patient continued in rollover study for regorafenib|0|||
143261843|NCT04704154|516512504|FG002|Overall Study|Patient continued in rollover study for regorafenib|4|||
143261844|NCT04704154|516512505|FG003|Overall Study|Patient continued in rollover study for regorafenib|0|||
143369698|NCT01281813|516897175|FG000|Overall Study|Adverse Event|0|||
143196527|NCT00235391|516265110|FG000|Overall Study|Protocol deviation|0|||
143196528|NCT00235391|516265111|FG001|Overall Study|Protocol deviation|0|||
143196529|NCT00235391|516265112|FG002|Overall Study|Protocol deviation|1|||
143196530|NCT00235391|516265113|FG003|Overall Study|Protocol deviation|11|||
143196531|NCT00235391|516265114|FG004|Overall Study|Protocol deviation|0|||
143196532|NCT00235391|516265115|FG005|Overall Study|Protocol deviation|0|||
143196533|NCT00235391|516265110|FG000|Overall Study|Withdrawal by Subject|2|||
143196534|NCT00235391|516265111|FG001|Overall Study|Withdrawal by Subject|3|||
143196535|NCT00235391|516265112|FG002|Overall Study|Withdrawal by Subject|3|||
143196536|NCT00235391|516265113|FG003|Overall Study|Withdrawal by Subject|61|||
143196537|NCT00235391|516265114|FG004|Overall Study|Withdrawal by Subject|5|||
143196538|NCT00235391|516265115|FG005|Overall Study|Withdrawal by Subject|0|||
143196539|NCT00235391|516265110|FG000|Overall Study|Lost to Follow-up|0|||
143196540|NCT00235391|516265111|FG001|Overall Study|Lost to Follow-up|3|||
143196541|NCT00235391|516265112|FG002|Overall Study|Lost to Follow-up|3|||
143196542|NCT00235391|516265113|FG003|Overall Study|Lost to Follow-up|16|||
143196543|NCT00235391|516265114|FG004|Overall Study|Lost to Follow-up|0|||
143196544|NCT00235391|516265115|FG005|Overall Study|Lost to Follow-up|0|||
143196545|NCT00235391|516265110|FG000|Overall Study|Administrative problems|0|||
143196546|NCT00235391|516265111|FG001|Overall Study|Administrative problems|0|||
143196547|NCT00235391|516265112|FG002|Overall Study|Administrative problems|0|||
143196548|NCT00235391|516265113|FG003|Overall Study|Administrative problems|1|||
143196549|NCT00235391|516265114|FG004|Overall Study|Administrative problems|0|||
143196550|NCT00235391|516265115|FG005|Overall Study|Administrative problems|0|||
143196551|NCT00235391|516265110|FG000|Overall Study|Death|0|||
143196552|NCT00235391|516265111|FG001|Overall Study|Death|0|||
143196553|NCT00235391|516265112|FG002|Overall Study|Death|1|||
143196554|NCT00235391|516265113|FG003|Overall Study|Death|4|||
143196555|NCT00235391|516265114|FG004|Overall Study|Death|0|||
143196556|NCT00235391|516265115|FG005|Overall Study|Death|0|||
143196557|NCT01824823|516265116|FG000|Overall Study|Lack of Efficacy|1|||
143196558|NCT01824823|516265117|FG001|Overall Study|Lack of Efficacy|1|||
143196559|NCT01824823|516265116|FG000|Overall Study|Off-treatment reason not submitted|1|||
143196560|NCT01824823|516265117|FG001|Overall Study|Off-treatment reason not submitted|0|||
143196561|NCT03349645|516265120|FG000|Overall Study|Sponsor Terminated Study|75|||
143196562|NCT03349645|516265120|FG000|Overall Study|Withdrawal by Subject|4|||
143196563|NCT03349645|516265120|FG000|Overall Study|Protocol Violation|1|||
143196564|NCT03349645|516265120|FG000|Overall Study|Other|2|||
143196565|NCT02927925|516265123|FG000|Overall Study|Death|16|||
143196566|NCT02927925|516265123|FG000|Overall Study|Physician Decision|1|||
143196567|NCT02927925|516265123|FG000|Overall Study|Withdrawal by Subject|11|||
143196568|NCT02927925|516265123|FG000|Overall Study|Other|3|||
143196569|NCT02927925|516265123|FG000|Overall Study|Disease progression at clinical cutoff|1|||
143196570|NCT00580034|516265130|FG000|Overall Study|Toxicity|10|||
143196571|NCT00580034|516265131|FG001|Overall Study|Toxicity|0|||
143196572|NCT01939002|516265132|FG000|Overall Study|Adverse Event|13|||
143196573|NCT01939002|516265133|FG001|Overall Study|Adverse Event|13|||
143196574|NCT01939002|516265132|FG000|Overall Study|Withdrawal by Subject|5|||
143196575|NCT01939002|516265133|FG001|Overall Study|Withdrawal by Subject|3|||
143196576|NCT01939002|516265132|FG000|Overall Study|Other|1|||
143196577|NCT01939002|516265133|FG001|Overall Study|Other|2|||
143196578|NCT02910401|516265137|FG000|Overall Study|Study closure Study closure|0|||
143196579|NCT02910401|516265138|FG001|Overall Study|Study closure Study closure|0|||
143196580|NCT02910401|516265139|FG002|Overall Study|Study closure Study closure|2|||
143196581|NCT02910401|516265137|FG000|Overall Study|Physician Decision|1|||
143196582|NCT02910401|516265138|FG001|Overall Study|Physician Decision|0|||
143196583|NCT02910401|516265139|FG002|Overall Study|Physician Decision|0|||
143196584|NCT01774253|516265140|FG000|Overall Study|Lack of Efficacy|4|||
143196585|NCT01774253|516265140|FG000|Overall Study|Physician Decision|2|||
143196586|NCT01774253|516265140|FG000|Overall Study|Withdrawal by Subject|2|||
143196587|NCT01774253|516265140|FG000|Overall Study|Death|1|||
143196588|NCT00772369|516265141|FG000|Overall Study|Did not return record release form|1|||
143196589|NCT02240368|516265142|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
143196590|NCT02240368|516265143|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
143196591|NCT02240368|516265144|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
143196592|NCT02240368|516265142|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
143196593|NCT02240368|516265143|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
143196594|NCT02240368|516265144|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
143196595|NCT03372460|516265145|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
143196596|NCT03372460|516265146|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
143196597|NCT02499900|516265147|FG000|Core Study Period|Other|1|||
143196598|NCT02499900|516265148|FG001|Core Study Period|Other|4|||
143196599|NCT02499900|516265147|FG000|Core Study Period|Lost to Follow-up|1|||
143196600|NCT02499900|516265148|FG001|Core Study Period|Lost to Follow-up|2|||
143196601|NCT02499900|516265147|FG000|Core Study Period|Per sponsor request|0|||
143196602|NCT02499900|516265148|FG001|Core Study Period|Per sponsor request|1|||
143196603|NCT02499900|516265147|FG000|Core Study Period|Pregnancy|1|||
143196604|NCT02499900|516265148|FG001|Core Study Period|Pregnancy|0|||
143196605|NCT02499900|516265147|FG000|Core Study Period|Protocol Violation|3|||
143196606|NCT02499900|516265148|FG001|Core Study Period|Protocol Violation|0|||
143196607|NCT02499900|516265147|FG000|Core Study Period|Withdrawal by Subject|11|||
143196608|NCT02499900|516265148|FG001|Core Study Period|Withdrawal by Subject|10|||
143196609|NCT02499900|516265147|FG000|Core Study Period|Adverse Event|18|||
143196610|NCT02499900|516265148|FG001|Core Study Period|Adverse Event|14|||
143196611|NCT02499900|516265147|FG000|Core Study Period|Death|0|||
143196612|NCT02499900|516265148|FG001|Core Study Period|Death|1|||
143196613|NCT02499900|516265147|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
143196614|NCT02499900|516265148|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
143196615|NCT02499900|516265147|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
143196616|NCT02499900|516265148|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
143196617|NCT02499900|516265147|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
143196618|NCT02499900|516265148|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
143196619|NCT02499900|516265147|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
143196620|NCT02499900|516265148|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
143196621|NCT02499900|516265147|FG000|Extension Study Period|Adverse Event|2|||
143196622|NCT02499900|516265148|FG001|Extension Study Period|Adverse Event|4|||
143196623|NCT02499900|516265147|FG000|Extension Study Period|Withdrawal by Subject|5|||
143196624|NCT02499900|516265148|FG001|Extension Study Period|Withdrawal by Subject|2|||
143196625|NCT02499900|516265147|FG000|Extension Study Period|Physician Decision|2|||
143196626|NCT02499900|516265148|FG001|Extension Study Period|Physician Decision|5|||
143196627|NCT02499900|516265147|FG000|Extension Study Period|Pregnancy|1|||
143196628|NCT02499900|516265148|FG001|Extension Study Period|Pregnancy|2|||
143196629|NCT02499900|516265147|FG000|Extension Study Period|Lost to Follow-up|2|||
143196630|NCT02499900|516265148|FG001|Extension Study Period|Lost to Follow-up|5|||
143196631|NCT02499900|516265147|FG000|Extension Study Period|Other|0|||
143196632|NCT02499900|516265148|FG001|Extension Study Period|Other|2|||
143196633|NCT00916058|516265149|FG000|Phase 1|Screen Failure|0|||
143196634|NCT00916058|516265150|FG001|Phase 1|Screen Failure|0|||
143196635|NCT00916058|516265151|FG002|Phase 1|Screen Failure|0|||
143196636|NCT00916058|516265152|FG003|Phase 1|Screen Failure|0|||
143196637|NCT00916058|516265153|FG004|Phase 1|Screen Failure|0|||
143196638|NCT00916058|516265154|FG005|Phase 1|Screen Failure|1|||
143196639|NCT00916058|516265155|FG006|Phase 1|Screen Failure|0|||
143196640|NCT00916058|516265149|FG000|Phase 2|Screen Failure|0|||
143196641|NCT00916058|516265150|FG001|Phase 2|Screen Failure|0|||
143196642|NCT00916058|516265151|FG002|Phase 2|Screen Failure|0|||
143196643|NCT00916058|516265152|FG003|Phase 2|Screen Failure|0|||
143196644|NCT00916058|516265153|FG004|Phase 2|Screen Failure|0|||
143196645|NCT00916058|516265154|FG005|Phase 2|Screen Failure|0|||
143196646|NCT00916058|516265155|FG006|Phase 2|Screen Failure|3|||
143196647|NCT00871117|516265156|FG000|Overall Study|Lost to Follow-up|5|||
143196648|NCT00871117|516265157|FG001|Overall Study|Lost to Follow-up|6|||
143196649|NCT00871117|516265156|FG000|Overall Study|Other|0|||
143196650|NCT00871117|516265157|FG001|Overall Study|Other|4|||
143196651|NCT02439450|516265158|FG000|Overall Study|Adverse Event|4|||
143196652|NCT02439450|516265159|FG001|Overall Study|Adverse Event|1|||
143196653|NCT02439450|516265160|FG002|Overall Study|Adverse Event|0|||
143196654|NCT02439450|516265161|FG003|Overall Study|Adverse Event|0|||
143196655|NCT02439450|516265158|FG000|Overall Study|Withdrawal by Subject|1|||
143196656|NCT02439450|516265159|FG001|Overall Study|Withdrawal by Subject|2|||
143196657|NCT02439450|516265160|FG002|Overall Study|Withdrawal by Subject|0|||
143196658|NCT02439450|516265161|FG003|Overall Study|Withdrawal by Subject|0|||
143196659|NCT02439450|516265158|FG000|Overall Study|Death|3|||
143196660|NCT02439450|516265159|FG001|Overall Study|Death|0|||
143196661|NCT02439450|516265160|FG002|Overall Study|Death|0|||
143196662|NCT02439450|516265161|FG003|Overall Study|Death|1|||
143196663|NCT02439450|516265158|FG000|Overall Study|Progressive Disease|18|||
143196664|NCT02439450|516265159|FG001|Overall Study|Progressive Disease|41|||
143196665|NCT02439450|516265160|FG002|Overall Study|Progressive Disease|2|||
143196666|NCT02439450|516265161|FG003|Overall Study|Progressive Disease|3|||
143196667|NCT01170065|516265164|FG000|Overall Study|Adverse Event|17|||
143196668|NCT01170065|516265165|FG001|Overall Study|Adverse Event|50|||
143196669|NCT01170065|516265166|FG002|Overall Study|Adverse Event|10|||
143196670|NCT01170065|516265164|FG000|Overall Study|Lost to Follow-up|1|||
143196671|NCT01170065|516265165|FG001|Overall Study|Lost to Follow-up|4|||
143196672|NCT01170065|516265166|FG002|Overall Study|Lost to Follow-up|1|||
143196673|NCT01170065|516265164|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
143196674|NCT01170065|516265165|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
143196675|NCT01170065|516265166|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
143196676|NCT01170065|516265164|FG000|Overall Study|Reason other than specified|3|||
143196677|NCT01170065|516265165|FG001|Overall Study|Reason other than specified|8|||
143196678|NCT01170065|516265166|FG002|Overall Study|Reason other than specified|3|||
143196679|NCT01170065|516265164|FG000|Overall Study|Ongoing after planned observation time|5|||
143196680|NCT01170065|516265165|FG001|Overall Study|Ongoing after planned observation time|26|||
143196681|NCT01170065|516265166|FG002|Overall Study|Ongoing after planned observation time|10|||
143196682|NCT01444027|516265173|FG000|Overall Study|Withdrawal by Subject|4|||
143196683|NCT01444027|516265174|FG001|Overall Study|Withdrawal by Subject|10|||
143196684|NCT01444027|516265175|FG002|Overall Study|Withdrawal by Subject|24|||
143196685|NCT01444027|516265173|FG000|Overall Study|Lost to Follow-up|26|||
143196686|NCT01444027|516265174|FG001|Overall Study|Lost to Follow-up|20|||
143196687|NCT01444027|516265175|FG002|Overall Study|Lost to Follow-up|14|||
143196688|NCT03555981|516266497|FG000|Overall Study|Lost to Follow-up|0|||
143196689|NCT03555981|516266498|FG001|Overall Study|Lost to Follow-up|2|||
143196690|NCT00354107|516266499|FG000|Overall Study|Adverse Event|2|||
143196691|NCT00354107|516266499|FG000|Overall Study|Physician Decision|2|||
143196692|NCT00354107|516266499|FG000|Overall Study|Withdrawal by Subject|1|||
143196693|NCT04035564|516266501|FG000|Overall Study|Protocol Violation|1|||
143196694|NCT04035564|516266502|FG001|Overall Study|Protocol Violation|2|||
143196695|NCT04035564|516266501|FG000|Overall Study|No laboratory available|2|||
143196696|NCT04035564|516266502|FG001|Overall Study|No laboratory available|2|||
143196697|NCT04035564|516266501|FG000|Overall Study|Guardian declined consent|1|||
143196698|NCT04035564|516266502|FG001|Overall Study|Guardian declined consent|2|||
143196699|NCT03361189|516266503|FG000|Overall Study|Received heart transplant|1|||
143196700|NCT03361189|516266504|FG001|Overall Study|Received heart transplant|0|||
143196701|NCT03361189|516266503|FG000|Overall Study|Pacemake replacement|0|||
143196702|NCT03361189|516266504|FG001|Overall Study|Pacemake replacement|1|||
143196703|NCT02323126|516266505|FG000|Overall Study|Patient / guardian decision|0|||
143196704|NCT02323126|516266506|FG001|Overall Study|Patient / guardian decision|1|||
143196705|NCT02323126|516266507|FG002|Overall Study|Patient / guardian decision|2|||
143196706|NCT02323126|516266505|FG000|Overall Study|Progressive disease|14|||
143196707|NCT02323126|516266506|FG001|Overall Study|Progressive disease|8|||
143196708|NCT02323126|516266507|FG002|Overall Study|Progressive disease|14|||
143196709|NCT02323126|516266505|FG000|Overall Study|Physician Decision|0|||
143196710|NCT02323126|516266506|FG001|Overall Study|Physician Decision|1|||
143196711|NCT02323126|516266507|FG002|Overall Study|Physician Decision|3|||
143196712|NCT02323126|516266505|FG000|Overall Study|Death|1|||
143196713|NCT02323126|516266506|FG001|Overall Study|Death|1|||
143196714|NCT02323126|516266507|FG002|Overall Study|Death|4|||
143196715|NCT02323126|516266505|FG000|Overall Study|Adverse Event|3|||
143196716|NCT02323126|516266506|FG001|Overall Study|Adverse Event|5|||
143196717|NCT02323126|516266507|FG002|Overall Study|Adverse Event|7|||
143196718|NCT03333252|516266508|FG000|Overall Study|Adverse Event|10|||
143196719|NCT03333252|516266509|FG001|Overall Study|Adverse Event|6|||
143196720|NCT03333252|516266510|FG002|Overall Study|Adverse Event|5|||
143261845|NCT04704154|516512506|FG004|Overall Study|Patient continued in rollover study for regorafenib|0|||
143196721|NCT03333252|516266511|FG003|Overall Study|Adverse Event|2|||
143196722|NCT03333252|516266508|FG000|Overall Study|Death|1|||
143196723|NCT03333252|516266509|FG001|Overall Study|Death|3|||
143196724|NCT03333252|516266510|FG002|Overall Study|Death|0|||
143196725|NCT03333252|516266511|FG003|Overall Study|Death|0|||
143196726|NCT03333252|516266508|FG000|Overall Study|Lack of Efficacy|8|||
143196727|NCT03333252|516266509|FG001|Overall Study|Lack of Efficacy|4|||
143196728|NCT03333252|516266510|FG002|Overall Study|Lack of Efficacy|0|||
143196729|NCT03333252|516266511|FG003|Overall Study|Lack of Efficacy|7|||
143196730|NCT03333252|516266508|FG000|Overall Study|Lost to Follow-up|0|||
143196731|NCT03333252|516266509|FG001|Overall Study|Lost to Follow-up|5|||
143196732|NCT03333252|516266510|FG002|Overall Study|Lost to Follow-up|9|||
143196733|NCT03333252|516266511|FG003|Overall Study|Lost to Follow-up|3|||
143196734|NCT03333252|516266508|FG000|Overall Study|Withdrawal by Subject|14|||
143196735|NCT03333252|516266509|FG001|Overall Study|Withdrawal by Subject|24|||
143196736|NCT03333252|516266510|FG002|Overall Study|Withdrawal by Subject|11|||
143196737|NCT03333252|516266511|FG003|Overall Study|Withdrawal by Subject|17|||
143196738|NCT01685801|516266517|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
143196739|NCT01685801|516266518|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
143196740|NCT01685801|516266519|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
143196741|NCT01685801|516266520|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
143196742|NCT01685801|516266517|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
143196743|NCT01685801|516266518|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
143196744|NCT01685801|516266519|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
143196745|NCT01685801|516266520|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
143196746|NCT03350256|516266521|FG000|Overall Study|Inclusion/exclusion violation|4|||
143196747|NCT03350256|516266521|FG000|Overall Study|Recommended for other therapies|2|||
143196748|NCT03350256|516266521|FG000|Overall Study|Protocol Violation|3|||
143196749|NCT03350256|516266521|FG000|Overall Study|Non compliance|2|||
143196750|NCT03350256|516266521|FG000|Overall Study|Denial by insurance|1|||
143196751|NCT03350256|516266521|FG000|Overall Study|Adverse Event|2|||
143196752|NCT03350256|516266521|FG000|Overall Study|Trial failure|12|||
143196753|NCT03350256|516266521|FG000|Overall Study|Did not proceed to permanent implant|3|||
143196754|NCT03350256|516266521|FG000|Overall Study|Withdrawal by Subject|3|||
143196755|NCT03350256|516266521|FG000|Overall Study|Subject moving out of state|1|||
143196756|NCT03350256|516266521|FG000|Overall Study|Lost to Follow-up|1|||
143196757|NCT03350256|516266521|FG000|Overall Study|Lack of Efficacy|2|||
143196758|NCT03960580|516266522|FG000|Overall Study|Adverse Event|2|||
143196759|NCT03960580|516266523|FG001|Overall Study|Adverse Event|1|||
143196760|NCT03960580|516266524|FG002|Overall Study|Adverse Event|1|||
143196761|NCT03960580|516266522|FG000|Overall Study|Lost to Follow-up|1|||
143196762|NCT03960580|516266523|FG001|Overall Study|Lost to Follow-up|0|||
143196763|NCT03960580|516266524|FG002|Overall Study|Lost to Follow-up|0|||
143196764|NCT03960580|516266522|FG000|Overall Study|Lack of Efficacy|2|||
143196765|NCT03960580|516266523|FG001|Overall Study|Lack of Efficacy|1|||
143196766|NCT03960580|516266524|FG002|Overall Study|Lack of Efficacy|0|||
143196767|NCT03960580|516266522|FG000|Overall Study|Protocol Violation|0|||
143196768|NCT03960580|516266523|FG001|Overall Study|Protocol Violation|0|||
143196769|NCT03960580|516266524|FG002|Overall Study|Protocol Violation|1|||
143196770|NCT03960580|516266522|FG000|Overall Study|Withdrawal by Subject|1|||
143196771|NCT03960580|516266523|FG001|Overall Study|Withdrawal by Subject|1|||
143196772|NCT03960580|516266524|FG002|Overall Study|Withdrawal by Subject|1|||
143196773|NCT03960580|516266522|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
143196774|NCT03960580|516266523|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
143196775|NCT03960580|516266524|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
143196776|NCT03136497|516266532|FG000|Overall Study|Screen Failure|1|||
143196777|NCT03136497|516266533|FG001|Overall Study|Screen Failure|0|||
143196778|NCT03136497|516266534|FG002|Overall Study|Screen Failure|0|||
143196779|NCT04049266|516266537|FG000|Overall Study|Adverse Event|16|||
143196780|NCT04049266|516266538|FG001|Overall Study|Adverse Event|9|||
143196781|NCT04049266|516266537|FG000|Overall Study|Non-compliance with study drug|0|||
143196782|NCT04049266|516266538|FG001|Overall Study|Non-compliance with study drug|3|||
143196783|NCT04049266|516266537|FG000|Overall Study|Withdrawal by Subject|6|||
143196784|NCT04049266|516266538|FG001|Overall Study|Withdrawal by Subject|10|||
143196785|NCT04049266|516266537|FG000|Overall Study|Lost to Follow-up|2|||
143196786|NCT04049266|516266538|FG001|Overall Study|Lost to Follow-up|2|||
143196787|NCT04049266|516266537|FG000|Overall Study|Progressive disease|11|||
143196788|NCT04049266|516266538|FG001|Overall Study|Progressive disease|2|||
143196789|NCT04049266|516266537|FG000|Overall Study|Physician Decision|1|||
143196790|NCT04049266|516266538|FG001|Overall Study|Physician Decision|0|||
143196791|NCT04049266|516266537|FG000|Overall Study|Patient moved out of state|1|||
143196792|NCT04049266|516266538|FG001|Overall Study|Patient moved out of state|0|||
143196793|NCT02174523|516266539|FG000|Overall Study|Withdrawal by Subject|1|||
143196794|NCT02174523|516266540|FG001|Overall Study|Withdrawal by Subject|0|||
143196795|NCT00794365|516266541|FG000|Overall Study|Lost to Follow-up|38|||
143196796|NCT00794365|516266541|FG000|Overall Study|Other|17|||
143196797|NCT00794365|516266541|FG000|Overall Study|Poor Compliance|11|||
143196798|NCT00794365|516266541|FG000|Overall Study|Adverse Event|10|||
143196799|NCT00794365|516266541|FG000|Overall Study|Lack of Efficacy|3|||
143196800|NCT00856206|516266542|FG000|Overall Study|Protocol Violation|6|||
143196801|NCT00856206|516266543|FG001|Overall Study|Protocol Violation|18|||
143196802|NCT00856206|516266542|FG000|Overall Study|Adverse Event|10|||
143196803|NCT00856206|516266543|FG001|Overall Study|Adverse Event|46|||
143196804|NCT00856206|516266542|FG000|Overall Study|Lack of Efficacy|1|||
143196805|NCT00856206|516266543|FG001|Overall Study|Lack of Efficacy|2|||
143196806|NCT00856206|516266542|FG000|Overall Study|Withdrawal by Subject|15|||
143196807|NCT00856206|516266543|FG001|Overall Study|Withdrawal by Subject|36|||
143196808|NCT00856206|516266542|FG000|Overall Study|Lost to Follow-up|13|||
143196809|NCT00856206|516266543|FG001|Overall Study|Lost to Follow-up|39|||
143196810|NCT00856206|516266542|FG000|Overall Study|Death|2|||
143196811|NCT00856206|516266543|FG001|Overall Study|Death|2|||
143196812|NCT00856206|516266542|FG000|Overall Study|Decision by the Sponsor|4|||
143196813|NCT00856206|516266543|FG001|Overall Study|Decision by the Sponsor|8|||
143196814|NCT00856206|516266542|FG000|Overall Study|Other than specified above|3|||
143196815|NCT00856206|516266543|FG001|Overall Study|Other than specified above|10|||
143196816|NCT03006458|516266546|FG000|First Intervention|Unsatisfied Vision|0|||
143196817|NCT03006458|516266547|FG001|First Intervention|Unsatisfied Vision|3|||
143196818|NCT00957944|516266548|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
143196819|NCT00957944|516266549|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
143196820|NCT01482169|516266551|FG000|Overall Study|Physician Decision|2|||
143196821|NCT01468233|516266552|FG000|Treatment Period 1|Adverse Event|5|||
143196822|NCT01468233|516266553|FG001|Treatment Period 1|Adverse Event|3|||
143196823|NCT01468233|516266554|FG002|Treatment Period 1|Adverse Event|0|||
143196824|NCT01468233|516266555|FG003|Treatment Period 1|Adverse Event|0|||
143196825|NCT01468233|516266556|FG004|Treatment Period 1|Adverse Event|0|||
143196826|NCT01468233|516266557|FG005|Treatment Period 1|Adverse Event|0|||
143196827|NCT01468233|516266552|FG000|Treatment Period 1|Withdrawal by Subject|3|||
143261846|NCT04704154|516512507|FG005|Overall Study|Patient continued in rollover study for regorafenib|0|||
143261847|NCT04950608|516512508|FG000|Overall Study|Withdrawal by Subject|2|||
143261848|NCT04950608|516512508|FG000|Overall Study|Physician Decision|3|||
143261849|NCT03220438|516512509|FG000|Overall Study|Lost to Follow-up|0|||
143261850|NCT03220438|516512510|FG001|Overall Study|Lost to Follow-up|0|||
143261851|NCT03220438|516512511|FG002|Overall Study|Lost to Follow-up|1|||
143261852|NCT03220438|516512512|FG003|Overall Study|Lost to Follow-up|0|||
143196828|NCT01468233|516266553|FG001|Treatment Period 1|Withdrawal by Subject|4|||
143196829|NCT01468233|516266554|FG002|Treatment Period 1|Withdrawal by Subject|0|||
143196830|NCT01468233|516266555|FG003|Treatment Period 1|Withdrawal by Subject|0|||
143196831|NCT01468233|516266556|FG004|Treatment Period 1|Withdrawal by Subject|0|||
143196832|NCT01468233|516266557|FG005|Treatment Period 1|Withdrawal by Subject|0|||
143196833|NCT01468233|516266552|FG000|Treatment Period 1|Lost to Follow-up|3|||
143196834|NCT01468233|516266553|FG001|Treatment Period 1|Lost to Follow-up|0|||
143196835|NCT01468233|516266554|FG002|Treatment Period 1|Lost to Follow-up|0|||
143196836|NCT01468233|516266555|FG003|Treatment Period 1|Lost to Follow-up|0|||
143196837|NCT01468233|516266556|FG004|Treatment Period 1|Lost to Follow-up|0|||
143196838|NCT01468233|516266557|FG005|Treatment Period 1|Lost to Follow-up|0|||
143196839|NCT01468233|516266552|FG000|Treatment Period 1|Other|1|||
143196840|NCT01468233|516266553|FG001|Treatment Period 1|Other|1|||
143196841|NCT01468233|516266554|FG002|Treatment Period 1|Other|0|||
143196842|NCT01468233|516266555|FG003|Treatment Period 1|Other|0|||
143196843|NCT01468233|516266556|FG004|Treatment Period 1|Other|0|||
143196844|NCT01468233|516266557|FG005|Treatment Period 1|Other|0|||
143196845|NCT01468233|516266552|FG000|Treatment Period 2|Adverse Event|0|||
143196846|NCT01468233|516266553|FG001|Treatment Period 2|Adverse Event|0|||
143196847|NCT01468233|516266554|FG002|Treatment Period 2|Adverse Event|3|||
143196848|NCT01468233|516266555|FG003|Treatment Period 2|Adverse Event|0|||
143196849|NCT01468233|516266556|FG004|Treatment Period 2|Adverse Event|2|||
143196850|NCT01468233|516266557|FG005|Treatment Period 2|Adverse Event|1|||
143196851|NCT01468233|516266552|FG000|Treatment Period 2|Lack of Efficacy|0|||
143196852|NCT01468233|516266553|FG001|Treatment Period 2|Lack of Efficacy|0|||
143196853|NCT01468233|516266554|FG002|Treatment Period 2|Lack of Efficacy|9|||
143196854|NCT01468233|516266555|FG003|Treatment Period 2|Lack of Efficacy|2|||
143196855|NCT01468233|516266556|FG004|Treatment Period 2|Lack of Efficacy|0|||
143196856|NCT01468233|516266557|FG005|Treatment Period 2|Lack of Efficacy|1|||
143196857|NCT01468233|516266552|FG000|Treatment Period 2|Withdrawal by Subject|0|||
143196858|NCT01468233|516266553|FG001|Treatment Period 2|Withdrawal by Subject|0|||
143196859|NCT01468233|516266554|FG002|Treatment Period 2|Withdrawal by Subject|9|||
143196860|NCT01468233|516266555|FG003|Treatment Period 2|Withdrawal by Subject|1|||
143196861|NCT01468233|516266556|FG004|Treatment Period 2|Withdrawal by Subject|1|||
143196862|NCT01468233|516266557|FG005|Treatment Period 2|Withdrawal by Subject|1|||
143196863|NCT01468233|516266552|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
143261853|NCT04565236|516512513|FG000|Overall Study|Patient/Guardian Decision|0|||
143196864|NCT01468233|516266553|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
143196865|NCT01468233|516266554|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
143196866|NCT01468233|516266555|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
143196867|NCT01468233|516266556|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
143196868|NCT01468233|516266557|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
143196869|NCT01468233|516266552|FG000|Treatment Period 2|Lost to Follow-up|0|||
143196870|NCT01468233|516266553|FG001|Treatment Period 2|Lost to Follow-up|0|||
143196871|NCT01468233|516266554|FG002|Treatment Period 2|Lost to Follow-up|3|||
143196872|NCT01468233|516266555|FG003|Treatment Period 2|Lost to Follow-up|0|||
143196873|NCT01468233|516266556|FG004|Treatment Period 2|Lost to Follow-up|2|||
143196874|NCT01468233|516266557|FG005|Treatment Period 2|Lost to Follow-up|0|||
143196875|NCT01468233|516266552|FG000|Treatment Period 2|Other|0|||
143196876|NCT01468233|516266553|FG001|Treatment Period 2|Other|0|||
143196877|NCT01468233|516266554|FG002|Treatment Period 2|Other|3|||
143196878|NCT01468233|516266555|FG003|Treatment Period 2|Other|0|||
143196879|NCT01468233|516266556|FG004|Treatment Period 2|Other|1|||
143196880|NCT01468233|516266557|FG005|Treatment Period 2|Other|0|||
143196881|NCT00457821|516266563|FG000|Part 2|Withdrawal by Subject|0|||
143196882|NCT00457821|516266564|FG001|Part 2|Withdrawal by Subject|0|||
143196883|NCT00457821|516266565|FG002|Part 2|Withdrawal by Subject|0|||
143196884|NCT00457821|516266566|FG003|Part 2|Withdrawal by Subject|0|||
143196885|NCT00457821|516266567|FG004|Part 2|Withdrawal by Subject|0|||
143196886|NCT00457821|516266568|FG005|Part 2|Withdrawal by Subject|0|||
143196887|NCT00457821|516266569|FG006|Part 2|Withdrawal by Subject|0|||
143196888|NCT00457821|516266570|FG007|Part 2|Withdrawal by Subject|1|||
143196889|NCT01960998|516266575|FG000|Overall Study|Lost to Follow-up|3|||
143196890|NCT01960998|516266576|FG001|Overall Study|Lost to Follow-up|7|||
143196891|NCT01960998|516266575|FG000|Overall Study|Death|0|||
143196892|NCT01960998|516266576|FG001|Overall Study|Death|1|||
143196893|NCT01960998|516266575|FG000|Overall Study|Withdrawal by Subject|8|||
143196894|NCT01960998|516266576|FG001|Overall Study|Withdrawal by Subject|2|||
143196895|NCT01960998|516266575|FG000|Overall Study|lost computer access|0|||
143196896|NCT01960998|516266576|FG001|Overall Study|lost computer access|1|||
143196897|NCT00759356|516266577|FG000|Overall Study|Adverse Event|0|||
143196898|NCT00759356|516266578|FG001|Overall Study|Adverse Event|1|||
143196899|NCT00759356|516266577|FG000|Overall Study|Withdrawal by Subject|0|||
143196900|NCT00759356|516266578|FG001|Overall Study|Withdrawal by Subject|2|||
143196901|NCT00759356|516266577|FG000|Overall Study|Subject was unable to return|1|||
143196902|NCT00759356|516266578|FG001|Overall Study|Subject was unable to return|0|||
143196903|NCT01713283|516266582|FG000|Overall Study|Lack of Efficacy|10|||
143196904|NCT01713283|516266583|FG001|Overall Study|Lack of Efficacy|2|||
143196905|NCT01713283|516266582|FG000|Overall Study|Lost to Follow-up|1|||
143196906|NCT01713283|516266583|FG001|Overall Study|Lost to Follow-up|1|||
143196907|NCT00812006|516266584|FG000|Overall Study|Lost to Follow-up|0|||
143196908|NCT00812006|516266585|FG001|Overall Study|Lost to Follow-up|0|||
143196909|NCT00812006|516266586|FG002|Overall Study|Lost to Follow-up|2|||
143196910|NCT00812006|516266584|FG000|Overall Study|Physician Decision|0|||
143196911|NCT00812006|516266585|FG001|Overall Study|Physician Decision|0|||
143196912|NCT00812006|516266586|FG002|Overall Study|Physician Decision|1|||
143196913|NCT00812006|516266584|FG000|Overall Study|Withdrawal by Subject|2|||
143196914|NCT00812006|516266585|FG001|Overall Study|Withdrawal by Subject|1|||
143196915|NCT00812006|516266586|FG002|Overall Study|Withdrawal by Subject|1|||
143196916|NCT00812006|516266584|FG000|Overall Study|Lack of Qualifying Event|4|||
143196917|NCT00812006|516266585|FG001|Overall Study|Lack of Qualifying Event|2|||
143196918|NCT00812006|516266586|FG002|Overall Study|Lack of Qualifying Event|2|||
143196919|NCT01080768|516266591|FG000|Overall Study|Protocol Deviation|2|||
143196920|NCT01080768|516266592|FG001|Overall Study|Protocol Deviation|1|||
143196921|NCT01071200|516266593|FG000|Overall Study|Lack of ovarian response|1|||
143196922|NCT01071200|516266594|FG001|Overall Study|Lack of ovarian response|1|||
143196923|NCT01071200|516266593|FG000|Overall Study|No fertilization|4|||
143196924|NCT01071200|516266594|FG001|Overall Study|No fertilization|0|||
143196925|NCT01071200|516266593|FG000|Overall Study|No oocytes retrieved|1|||
143196926|NCT01071200|516266594|FG001|Overall Study|No oocytes retrieved|1|||
143196927|NCT01071200|516266593|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
143369699|NCT01281813|516897176|FG001|Overall Study|Adverse Event|0|||
143196928|NCT01071200|516266594|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
143196929|NCT01071200|516266593|FG000|Overall Study|No viable embryos|0|||
143196930|NCT01071200|516266594|FG001|Overall Study|No viable embryos|1|||
143369700|NCT01281813|516897177|FG002|Overall Study|Adverse Event|10|||
143196931|NCT04508751|516266601|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
143196932|NCT04508751|516266602|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
143196933|NCT04508751|516266603|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
143196934|NCT02752958|516266604|FG000|Overall Study|Adverse Event|3|||
143196935|NCT02752958|516266604|FG000|Overall Study|Lost to Follow-up|1|||
143196936|NCT02752958|516266604|FG000|Overall Study|Protocol Violation|1|||
143369701|NCT01281813|516897175|FG000|Overall Study|Lost to Follow-up|0|||
143196937|NCT02752958|516266604|FG000|Overall Study|Withdrawal by Subject|2|||
143196938|NCT02752958|516266604|FG000|Overall Study|Other (Reason not specified)|2|||
143196939|NCT00853125|516266605|FG000|Overall Study|Study participant's donor was CMV +|1|||
143196940|NCT03023826|516266607|FG000|Period 1|Withdrawal by Subject|0|||
143196941|NCT03023826|516266608|FG001|Period 1|Withdrawal by Subject|0|||
143196942|NCT03023826|516266609|FG002|Period 1|Withdrawal by Subject|0|||
143196943|NCT03023826|516266610|FG003|Period 1|Withdrawal by Subject|0|||
143196944|NCT03023826|516266611|FG004|Period 1|Withdrawal by Subject|1|||
143196945|NCT03023826|516266612|FG005|Period 1|Withdrawal by Subject|0|||
143196946|NCT03746600|516266613|FG000|Overall Study|Withdrawal by Subject|3|||
143196947|NCT03746600|516266614|FG001|Overall Study|Withdrawal by Subject|3|||
143196948|NCT03746600|516266613|FG000|Overall Study|dismissed from study|1|||
143196949|NCT03746600|516266614|FG001|Overall Study|dismissed from study|0|||
143196950|NCT03746600|516266613|FG000|Overall Study|Lost to Follow-up|1|||
143196951|NCT03746600|516266614|FG001|Overall Study|Lost to Follow-up|0|||
143196952|NCT01646645|516266615|FG000|Overall Study|No Treated|1|||
143196953|NCT01646645|516266615|FG000|Overall Study|Inevaluable Donor|29|||
143196954|NCT00717522|516266616|FG000|Overall Study|Disease Progression|5|||
143196955|NCT00717522|516266616|FG000|Overall Study|Adverse Event|1|||
143196956|NCT00717522|516266616|FG000|Overall Study|Death|1|||
143196957|NCT00072293|516266617|FG000|Overall Study|Lost to Follow-up|1|||
143196958|NCT00072293|516266618|FG001|Overall Study|Lost to Follow-up|1|||
143196959|NCT00072293|516266617|FG000|Overall Study|Withdrawal by Subject|0|||
143196960|NCT00072293|516266618|FG001|Overall Study|Withdrawal by Subject|1|||
143196961|NCT04209114|516266619|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
143196962|NCT04209114|516266620|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
143196963|NCT04209114|516266621|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
143196964|NCT04209114|516266619|FG000|Pre-Treatment Phase|Other reasons|0|||
143196965|NCT04209114|516266620|FG001|Pre-Treatment Phase|Other reasons|0|||
143196966|NCT04209114|516266621|FG002|Pre-Treatment Phase|Other reasons|1|||
143196967|NCT04209114|516266619|FG000|Pre-Treatment Phase|Death|0|||
143196968|NCT04209114|516266620|FG001|Pre-Treatment Phase|Death|0|||
143196969|NCT04209114|516266621|FG002|Pre-Treatment Phase|Death|1|||
143196970|NCT04209114|516266619|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
143196971|NCT04209114|516266620|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
143196972|NCT04209114|516266621|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
143196973|NCT04209114|516266619|FG000|Treatment Phase|Other reasons|5|||
143196974|NCT04209114|516266620|FG001|Treatment Phase|Other reasons|3|||
143196975|NCT04209114|516266621|FG002|Treatment Phase|Other reasons|0|||
143196976|NCT04209114|516266619|FG000|Treatment Phase|Lost to Follow-up|1|||
143196977|NCT04209114|516266620|FG001|Treatment Phase|Lost to Follow-up|0|||
143196978|NCT04209114|516266621|FG002|Treatment Phase|Lost to Follow-up|0|||
143196979|NCT04209114|516266619|FG000|Treatment Phase|Participant withdrew consent|1|||
143196980|NCT04209114|516266620|FG001|Treatment Phase|Participant withdrew consent|0|||
143196981|NCT04209114|516266621|FG002|Treatment Phase|Participant withdrew consent|0|||
143196982|NCT04209114|516266619|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
143196983|NCT04209114|516266620|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
143196984|NCT04209114|516266621|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
143196985|NCT04209114|516266619|FG000|Treatment Phase|Death|4|||
143196986|NCT04209114|516266620|FG001|Treatment Phase|Death|1|||
143196987|NCT04209114|516266621|FG002|Treatment Phase|Death|0|||
143196988|NCT04209114|516266619|FG000|Treatment Phase|Study drug toxicity|4|||
143196989|NCT04209114|516266620|FG001|Treatment Phase|Study drug toxicity|6|||
143196990|NCT04209114|516266621|FG002|Treatment Phase|Study drug toxicity|0|||
143196991|NCT04209114|516266619|FG000|Treatment Phase|Disease progression|6|||
143196992|NCT04209114|516266620|FG001|Treatment Phase|Disease progression|9|||
143196993|NCT04209114|516266621|FG002|Treatment Phase|Disease progression|0|||
143196994|NCT00405964|516266626|FG000|Overall Study|Treatment Failure|17|||
143196995|NCT00405964|516266627|FG001|Overall Study|Treatment Failure|45|||
143196996|NCT00405964|516266626|FG000|Overall Study|Adverse Event|7|||
143196997|NCT00405964|516266627|FG001|Overall Study|Adverse Event|16|||
143196998|NCT00405964|516266626|FG000|Overall Study|Lost to Follow-up|5|||
143196999|NCT00405964|516266627|FG001|Overall Study|Lost to Follow-up|5|||
143197000|NCT00405964|516266626|FG000|Overall Study|Withdrawal by Subject|19|||
143197001|NCT00405964|516266627|FG001|Overall Study|Withdrawal by Subject|23|||
143197002|NCT00405964|516266626|FG000|Overall Study|Protocol Violation|11|||
143197003|NCT00405964|516266627|FG001|Overall Study|Protocol Violation|6|||
143197004|NCT02981407|516266628|FG000|Overall Study|Withdrawal by Subject|2|||
143197005|NCT02981407|516266629|FG001|Overall Study|Withdrawal by Subject|0|||
143197006|NCT00509093|516268559|FG000|Overall Study|Adverse Event|10|||
143197007|NCT00509093|516268559|FG000|Overall Study|Disease Progression|9|||
143197008|NCT00509093|516268559|FG000|Overall Study|Transformed into MDS|1|||
143197009|NCT00509093|516268559|FG000|Overall Study|Withdrawal by Subject|3|||
143197010|NCT00509093|516268559|FG000|Overall Study|Physician Decision|1|||
143197011|NCT03283098|516268560|FG000|Overall Study|Withdrawal by Subject|0|||
143197012|NCT03283098|516268561|FG001|Overall Study|Withdrawal by Subject|1|||
143197013|NCT00798317|516268562|FG000|Overall Study|Physician Decision|0|||
143197014|NCT00798317|516268563|FG001|Overall Study|Physician Decision|1|||
143261854|NCT04565236|516512514|FG001|Overall Study|Patient/Guardian Decision|0|||
143261855|NCT04565236|516512515|FG002|Overall Study|Patient/Guardian Decision|1|||
143261856|NCT04565236|516512516|FG003|Overall Study|Patient/Guardian Decision|0|||
143261857|NCT00740246|516512520|FG000|Overall Study|Received Blood Transfusion|0|||
143261858|NCT00740246|516512521|FG001|Overall Study|Received Blood Transfusion|1|||
143261859|NCT00740246|516512520|FG000|Overall Study|Adverse Event|1|||
143261860|NCT00740246|516512521|FG001|Overall Study|Adverse Event|2|||
143261861|NCT00740246|516512520|FG000|Overall Study|Selection Criteria/Study Compliance|2|||
143197015|NCT00798317|516268562|FG000|Overall Study|Withdrawal by Subject|5|||
143197016|NCT00798317|516268563|FG001|Overall Study|Withdrawal by Subject|4|||
143197017|NCT00798317|516268562|FG000|Overall Study|Lost to Follow-up|2|||
143197018|NCT00798317|516268563|FG001|Overall Study|Lost to Follow-up|2|||
143197019|NCT00798317|516268562|FG000|Overall Study|Adverse Event|2|||
143197020|NCT00798317|516268563|FG001|Overall Study|Adverse Event|0|||
143197021|NCT00798317|516268562|FG000|Overall Study|Death|1|||
143197022|NCT00798317|516268563|FG001|Overall Study|Death|0|||
143197023|NCT01069861|516268565|FG000|Overall Study|Death|1|||
143197024|NCT01069861|516268565|FG000|Overall Study|Adverse Event|1|||
143197025|NCT01069861|516268565|FG000|Overall Study|Did not meet entrance criteria|1|||
143197026|NCT01187446|516268566|FG000|Overall Study|Patient started non-protocol therapy|0|||
143197027|NCT01187446|516268567|FG001|Overall Study|Patient started non-protocol therapy|1|||
143197028|NCT00823212|516268568|FG000|Overall Study|Death|8|||
143197029|NCT00823212|516268569|FG001|Overall Study|Death|10|||
143197030|NCT00823212|516268568|FG000|Overall Study|Withdrawal by Subject|6|||
143197031|NCT00823212|516268569|FG001|Overall Study|Withdrawal by Subject|1|||
143197032|NCT00823212|516268568|FG000|Overall Study|Incarcerated|0|||
143197033|NCT00823212|516268569|FG001|Overall Study|Incarcerated|1|||
143197034|NCT00823212|516268568|FG000|Overall Study|Missed 12-month visit|21|||
143197035|NCT00823212|516268569|FG001|Overall Study|Missed 12-month visit|21|||
143197036|NCT00791479|516268570|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
143197037|NCT00791479|516268571|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
143197038|NCT00791479|516268572|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
143197039|NCT00791479|516268573|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
143197040|NCT00791479|516268574|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
143197041|NCT00791479|516268575|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
143197042|NCT00791479|516268570|FG000|Overall Study|Adverse Event|0|||
143197043|NCT00791479|516268571|FG001|Overall Study|Adverse Event|1|||
143197044|NCT00791479|516268572|FG002|Overall Study|Adverse Event|0|||
143197045|NCT00791479|516268573|FG003|Overall Study|Adverse Event|2|||
143197046|NCT00791479|516268574|FG004|Overall Study|Adverse Event|0|||
143197047|NCT00791479|516268575|FG005|Overall Study|Adverse Event|1|||
143197048|NCT00791479|516268570|FG000|Overall Study|Lost to Follow-up|0|||
143197049|NCT00791479|516268571|FG001|Overall Study|Lost to Follow-up|1|||
143197050|NCT00791479|516268572|FG002|Overall Study|Lost to Follow-up|0|||
143197051|NCT00791479|516268573|FG003|Overall Study|Lost to Follow-up|0|||
143197052|NCT00791479|516268574|FG004|Overall Study|Lost to Follow-up|0|||
143197053|NCT00791479|516268575|FG005|Overall Study|Lost to Follow-up|1|||
143197054|NCT00791479|516268570|FG000|Overall Study|Protocol Violation|2|||
143197055|NCT00791479|516268571|FG001|Overall Study|Protocol Violation|1|||
143197056|NCT00791479|516268572|FG002|Overall Study|Protocol Violation|0|||
143197057|NCT00791479|516268573|FG003|Overall Study|Protocol Violation|1|||
143197058|NCT00791479|516268574|FG004|Overall Study|Protocol Violation|0|||
143197059|NCT00791479|516268575|FG005|Overall Study|Protocol Violation|0|||
143197060|NCT00791479|516268570|FG000|Overall Study|Withdrawal by Subject|0|||
143197061|NCT00791479|516268571|FG001|Overall Study|Withdrawal by Subject|0|||
143197062|NCT00791479|516268572|FG002|Overall Study|Withdrawal by Subject|0|||
143197063|NCT00791479|516268573|FG003|Overall Study|Withdrawal by Subject|1|||
143197064|NCT00791479|516268574|FG004|Overall Study|Withdrawal by Subject|0|||
143197065|NCT00791479|516268575|FG005|Overall Study|Withdrawal by Subject|1|||
143197066|NCT00496197|516268576|FG000|Overall Study|Discontinued study due to death|43|||
143197067|NCT00496197|516268576|FG000|Overall Study|Adverse Event|13|||
143197068|NCT00496197|516268576|FG000|Overall Study|Does not meet entrance criteria|5|||
143197069|NCT00496197|516268576|FG000|Overall Study|Insufficient clinical response|3|||
143197070|NCT00496197|516268576|FG000|Overall Study|Insufficient bacteriological response|10|||
143197071|NCT00496197|516268576|FG000|Overall Study|Lost to Follow-up|11|||
143197072|NCT00496197|516268576|FG000|Overall Study|Withdrawal by Subject|11|||
143197073|NCT00496197|516268576|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
143197074|NCT00496197|516268576|FG000|Overall Study|Other|14|||
143197075|NCT00496197|516268576|FG000|Overall Study|Protocol Violation|8|||
143197076|NCT04431713|516268577|FG000|Overall Study|Withdrawal by Subject|2|||
143197077|NCT04431713|516268578|FG001|Overall Study|Withdrawal by Subject|0|||
143197078|NCT04431713|516268577|FG000|Overall Study|Death|2|||
143197079|NCT04431713|516268578|FG001|Overall Study|Death|2|||
143197080|NCT00149994|516268579|FG000|Overall Study|Administrative problems:|1|||
143197081|NCT00149994|516268580|FG001|Overall Study|Administrative problems:|0|||
143197082|NCT00149994|516268579|FG000|Overall Study|Protocol Violation|0|||
143197083|NCT00149994|516268580|FG001|Overall Study|Protocol Violation|1|||
143197084|NCT01344538|516268581|FG000|Overall Study|Adverse Event|1|||
143197085|NCT01344538|516268582|FG001|Overall Study|Adverse Event|1|||
143197086|NCT01344538|516268581|FG000|Overall Study|Lost to Follow-up|1|||
143197087|NCT01344538|516268582|FG001|Overall Study|Lost to Follow-up|0|||
143197088|NCT01655381|516268585|FG000|Overall Study|Investigator Decision|1|||
143197089|NCT01655381|516268585|FG000|Overall Study|Moved to Another City|1|||
143197090|NCT01655381|516268585|FG000|Overall Study|Insufficient Treatment Response|1|||
143197091|NCT02324205|516268586|FG000|Overall Study|Withdrawal by Subject|37|||
143197092|NCT04195438|516268587|FG000|Overall Study|Withdrawal by Subject|1|||
143197093|NCT00613925|516268588|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
143197094|NCT00613925|516268589|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
143197095|NCT02891681|516268592|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
143197096|NCT02891681|516268593|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
143197097|NCT02891681|516268594|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
143197098|NCT02891681|516268592|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
143197099|NCT02891681|516268593|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
143197100|NCT02891681|516268594|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
143197101|NCT02891681|516268592|FG000|Overall Study|Taken off study after first imaging appointment|1|||
143197102|NCT02891681|516268593|FG001|Overall Study|Taken off study after first imaging appointment|0|||
143197103|NCT02891681|516268594|FG002|Overall Study|Taken off study after first imaging appointment|0|||
143197104|NCT03538444|516268608|FG000|Overall Study|opioid withdrawal|1|||
143197105|NCT03538444|516268609|FG001|Overall Study|opioid withdrawal|0|||
143197106|NCT04584346|516268614|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
143197107|NCT04584346|516268615|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
143197108|NCT04239222|516268620|FG000|Baseline|Withdrawal by Subject|0|||
143197109|NCT04239222|516268621|FG001|Baseline|Withdrawal by Subject|0|||
143197110|NCT04239222|516268622|FG002|Baseline|Withdrawal by Subject|1|||
143197111|NCT04239222|516268623|FG003|Baseline|Withdrawal by Subject|1|||
143197112|NCT04239222|516268620|FG000|First Foot Assignment|Withdrawal by Subject|0|||
143197113|NCT04239222|516268621|FG001|First Foot Assignment|Withdrawal by Subject|0|||
143197114|NCT04239222|516268622|FG002|First Foot Assignment|Withdrawal by Subject|1|||
143197115|NCT04239222|516268623|FG003|First Foot Assignment|Withdrawal by Subject|0|||
143197116|NCT04239222|516268620|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
143197117|NCT04239222|516268621|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
143197118|NCT04239222|516268622|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
143197119|NCT04239222|516268623|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
143197120|NCT00445848|516268632|FG000|Overall Study|Adverse Event|14|||
143197121|NCT00445848|516268632|FG000|Overall Study|Withdrawal by Subject|4|||
143197122|NCT00445848|516268632|FG000|Overall Study|Progression|62|||
143197123|NCT00445848|516268632|FG000|Overall Study|Other-Not protocol specified|5|||
143197124|NCT00790647|516268635|FG000|Overall Study|Adverse Event|1|||
143197125|NCT03549871|516268650|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
143197126|NCT03549871|516268651|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
143197127|NCT03549871|516268650|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
143197128|NCT03549871|516268651|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
143197129|NCT03549871|516268650|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
143197130|NCT03549871|516268651|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
143197131|NCT03549871|516268650|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
143197132|NCT03549871|516268651|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
143197133|NCT03549871|516268650|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
143197134|NCT03549871|516268651|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
143197135|NCT03549871|516268650|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
143197136|NCT03549871|516268651|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
143197137|NCT03549871|516268650|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
143197138|NCT03549871|516268651|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
143261862|NCT00740246|516512521|FG001|Overall Study|Selection Criteria/Study Compliance|0|||
143197139|NCT03549871|516268650|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
143197140|NCT03549871|516268651|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
143197141|NCT03549871|516268650|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
143197142|NCT03549871|516268651|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
143197143|NCT03549871|516268650|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
143197144|NCT03549871|516268651|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
143197145|NCT03549871|516268650|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
143197146|NCT03549871|516268651|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
143197147|NCT01369680|516268652|FG000|Overall Study|Lost to Follow-up|0|||
143197148|NCT01369680|516268653|FG001|Overall Study|Lost to Follow-up|0|||
143197149|NCT01369680|516268654|FG002|Overall Study|Lost to Follow-up|1|||
143197150|NCT01369680|516268655|FG003|Overall Study|Lost to Follow-up|2|||
143197151|NCT01133626|516268657|FG000|Overall Study|Adverse Event|0|||
143197152|NCT01133626|516268658|FG001|Overall Study|Adverse Event|1|||
143197153|NCT01133626|516268659|FG002|Overall Study|Adverse Event|0|||
143197154|NCT01133626|516268657|FG000|Overall Study|Withdrawal by Subject|1|||
143197155|NCT01133626|516268658|FG001|Overall Study|Withdrawal by Subject|2|||
143197156|NCT01133626|516268659|FG002|Overall Study|Withdrawal by Subject|2|||
143197157|NCT01133626|516268657|FG000|Overall Study|Other|0|||
143197158|NCT01133626|516268658|FG001|Overall Study|Other|2|||
143197159|NCT01133626|516268659|FG002|Overall Study|Other|0|||
143197160|NCT02851407|516268660|FG000|Overall Study|Withdrawal by parent/guardian|2|||
143197161|NCT02851407|516268661|FG001|Overall Study|Withdrawal by parent/guardian|7|||
143197162|NCT02851407|516268660|FG000|Overall Study|Protocol deviation|0|||
143197163|NCT02851407|516268661|FG001|Overall Study|Protocol deviation|1|||
143197164|NCT02851407|516268660|FG000|Overall Study|Transferred to another hospital to continue|1|||
143197165|NCT02851407|516268661|FG001|Overall Study|Transferred to another hospital to continue|0|||
143197166|NCT02851407|516268660|FG000|Overall Study|Other Death|30|||
143197167|NCT02851407|516268661|FG001|Overall Study|Other Death|20|||
143197168|NCT02851407|516268660|FG000|Overall Study|Adverse event, serious fatal|6|||
143197169|NCT02851407|516268661|FG001|Overall Study|Adverse event, serious fatal|8|||
143197170|NCT02851407|516268660|FG000|Overall Study|Consent withdrawn by participant|5|||
143197171|NCT02851407|516268661|FG001|Overall Study|Consent withdrawn by participant|3|||
143197172|NCT02851407|516268660|FG000|Overall Study|Screen failure|2|||
143197173|NCT02851407|516268661|FG001|Overall Study|Screen failure|1|||
143197174|NCT02851407|516268660|FG000|Overall Study|Disease relapse|9|||
143197175|NCT02851407|516268661|FG001|Overall Study|Disease relapse|6|||
143197176|NCT02851407|516268660|FG000|Overall Study|Physician Decision|7|||
143197177|NCT02851407|516268661|FG001|Overall Study|Physician Decision|6|||
143197178|NCT02851407|516268660|FG000|Overall Study|Transferred to hospital closer to home|0|||
143197179|NCT02851407|516268661|FG001|Overall Study|Transferred to hospital closer to home|1|||
143197180|NCT02851407|516268660|FG000|Overall Study|Enrolled in an investigational study|0|||
143197181|NCT02851407|516268661|FG001|Overall Study|Enrolled in an investigational study|1|||
143197182|NCT02851407|516268660|FG000|Overall Study|Early recovery|1|||
143197183|NCT02851407|516268661|FG001|Overall Study|Early recovery|0|||
143197184|NCT02851407|516268660|FG000|Overall Study|Adverse event, non-fatal|7|||
143197185|NCT02851407|516268661|FG001|Overall Study|Adverse event, non-fatal|5|||
143197186|NCT02851407|516268660|FG000|Overall Study|Lost to Follow-up|0|||
143197187|NCT02851407|516268661|FG001|Overall Study|Lost to Follow-up|2|||
143197188|NCT02403635|516268662|FG000|Overall Study|Not eligible|9|||
143197189|NCT03263923|516268666|FG000|Overall Study|Withdrawal by Subject|10|||
143197190|NCT03263923|516268667|FG001|Overall Study|Withdrawal by Subject|8|||
143197191|NCT03263923|516268666|FG000|Overall Study|Lost to Follow-up|15|||
143197192|NCT03263923|516268667|FG001|Overall Study|Lost to Follow-up|13|||
143197193|NCT03362931|516268668|FG000|Overall Study|Adverse Event|1|||
143197194|NCT03362931|516268668|FG000|Overall Study|Death|2|||
143197195|NCT03054350|516268670|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
143197196|NCT03054350|516268671|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
143197197|NCT03054350|516268672|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
143197198|NCT03054350|516268673|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
143197199|NCT03054350|516268674|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
143197200|NCT03054350|516268675|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
143197201|NCT03054350|516268670|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
143197202|NCT03054350|516268671|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
143197203|NCT03054350|516268672|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
143197204|NCT03054350|516268673|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
143197205|NCT03054350|516268674|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
143197206|NCT03054350|516268675|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
143197207|NCT03054350|516268670|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
143197208|NCT03054350|516268671|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
143197209|NCT03054350|516268672|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
143197210|NCT03054350|516268673|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
143261863|NCT00740246|516512520|FG000|Overall Study|Lost to Follow-up|2|||
143197211|NCT03054350|516268674|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
143197212|NCT03054350|516268675|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
143197213|NCT03054350|516268670|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
143197214|NCT03054350|516268671|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
143197215|NCT03054350|516268672|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
143197216|NCT03054350|516268673|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
143197217|NCT03054350|516268674|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
143197218|NCT03054350|516268675|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
143197219|NCT03385265|516268677|FG000|Overall Study|Withdrawal by Subject|5|||
143197220|NCT03385265|516268678|FG001|Overall Study|Withdrawal by Subject|2|||
143197221|NCT03385265|516268679|FG002|Overall Study|Withdrawal by Subject|5|||
143197222|NCT03385265|516268680|FG003|Overall Study|Withdrawal by Subject|2|||
143197223|NCT02437305|516268681|FG000|Overall Study|Lost to Follow-up|18|||
143197224|NCT02437305|516268682|FG001|Overall Study|Lost to Follow-up|12|||
143197225|NCT03730961|516268706|FG000|Overall Study|Adverse Event|0|||
143197226|NCT03730961|516268707|FG001|Overall Study|Adverse Event|1|||
143197227|NCT00919867|516268708|FG000|First Intervention|Withdrawal by Subject|0|||
143197228|NCT00919867|516268709|FG001|First Intervention|Withdrawal by Subject|0|||
143197229|NCT00919867|516268710|FG002|First Intervention|Withdrawal by Subject|1|||
143197230|NCT00919867|516268711|FG003|First Intervention|Withdrawal by Subject|0|||
143197231|NCT00919867|516268712|FG004|First Intervention|Withdrawal by Subject|0|||
143197232|NCT00919867|516268713|FG005|First Intervention|Withdrawal by Subject|0|||
143197233|NCT00919867|516268708|FG000|First Intervention|Physician Decision|0|||
143197234|NCT00919867|516268709|FG001|First Intervention|Physician Decision|0|||
143197235|NCT00919867|516268710|FG002|First Intervention|Physician Decision|0|||
143197236|NCT00919867|516268711|FG003|First Intervention|Physician Decision|0|||
143197237|NCT00919867|516268712|FG004|First Intervention|Physician Decision|0|||
143197238|NCT00919867|516268713|FG005|First Intervention|Physician Decision|1|||
143197239|NCT01920893|516268714|FG000|Overall Study|Adverse Event|5|||
143197240|NCT01920893|516268715|FG001|Overall Study|Adverse Event|2|||
143197241|NCT01920893|516268714|FG000|Overall Study|Lack of Efficacy|2|||
143197242|NCT01920893|516268715|FG001|Overall Study|Lack of Efficacy|0|||
143197243|NCT00468845|516268721|FG000|Overall Study|Adverse Event|9|||
143197244|NCT00468845|516268722|FG001|Overall Study|Adverse Event|14|||
143197245|NCT00468845|516268723|FG002|Overall Study|Adverse Event|11|||
143197246|NCT00468845|516268721|FG000|Overall Study|Lost to Follow-up|2|||
143197247|NCT00468845|516268722|FG001|Overall Study|Lost to Follow-up|1|||
143197248|NCT00468845|516268723|FG002|Overall Study|Lost to Follow-up|2|||
143197249|NCT00468845|516268721|FG000|Overall Study|Other|4|||
143197250|NCT00468845|516268722|FG001|Overall Study|Other|9|||
143197251|NCT00468845|516268723|FG002|Overall Study|Other|5|||
143197252|NCT00468845|516268721|FG000|Overall Study|No longer willing to participate|5|||
143197253|NCT00468845|516268722|FG001|Overall Study|No longer willing to participate|6|||
143197254|NCT00468845|516268723|FG002|Overall Study|No longer willing to participate|10|||
143197255|NCT00468845|516268721|FG000|Overall Study|Randomized, not treated|1|||
143197256|NCT00468845|516268722|FG001|Overall Study|Randomized, not treated|4|||
143197257|NCT00468845|516268723|FG002|Overall Study|Randomized, not treated|2|||
143197258|NCT01896271|516268724|FG000|Overall Study|Physician Decision|10|||
143197259|NCT00953680|516268725|FG000|Period 1|Withdrawal by Subject|0|||
143197260|NCT00953680|516268726|FG001|Period 1|Withdrawal by Subject|1|||
143197261|NCT01514240|516270655|FG000|Overall Study|Adverse Event|4|||
143197262|NCT01514240|516270656|FG001|Overall Study|Adverse Event|4|||
143197263|NCT01514240|516270655|FG000|Overall Study|Subject Decision|2|||
143197264|NCT01514240|516270656|FG001|Overall Study|Subject Decision|7|||
143197265|NCT01103063|516270657|FG000|Overall Study|Adverse Event|3|||
143197266|NCT01103063|516270658|FG001|Overall Study|Adverse Event|1|||
143197267|NCT01103063|516270657|FG000|Overall Study|Lost to Follow-up|68|||
143197268|NCT01103063|516270658|FG001|Overall Study|Lost to Follow-up|51|||
143197269|NCT01103063|516270657|FG000|Overall Study|Withdrawal by Subject|60|||
143197270|NCT01103063|516270658|FG001|Overall Study|Withdrawal by Subject|15|||
143197271|NCT01103063|516270657|FG000|Overall Study|Other|16|||
143197272|NCT01103063|516270658|FG001|Overall Study|Other|11|||
143197273|NCT01103063|516270657|FG000|Overall Study|Protocol Violation|1|||
143197274|NCT01103063|516270658|FG001|Overall Study|Protocol Violation|0|||
143197275|NCT01103063|516270657|FG000|Overall Study|Study terminated by Sponsor|326|||
143197276|NCT01103063|516270658|FG001|Overall Study|Study terminated by Sponsor|342|||
143197277|NCT01103063|516270657|FG000|Overall Study|Death|3|||
143197278|NCT01103063|516270658|FG001|Overall Study|Death|1|||
143197279|NCT05320393|516270659|FG000|Overall Study|Withdrawal by Subject|1|||
143197280|NCT05320393|516270660|FG001|Overall Study|Withdrawal by Subject|0|||
143197281|NCT05320393|516270661|FG002|Overall Study|Withdrawal by Subject|2|||
143197282|NCT05320393|516270659|FG000|Overall Study|Lost to Follow-up|1|||
143197283|NCT05320393|516270660|FG001|Overall Study|Lost to Follow-up|2|||
143197284|NCT05320393|516270661|FG002|Overall Study|Lost to Follow-up|1|||
143197285|NCT05320393|516270659|FG000|Overall Study|Moved; too much driving|0|||
143197286|NCT05320393|516270660|FG001|Overall Study|Moved; too much driving|0|||
143197287|NCT05320393|516270661|FG002|Overall Study|Moved; too much driving|2|||
143197288|NCT05320393|516270659|FG000|Overall Study|Did not receive treatment|0|||
143197289|NCT05320393|516270660|FG001|Overall Study|Did not receive treatment|0|||
143197290|NCT05320393|516270661|FG002|Overall Study|Did not receive treatment|1|||
143197291|NCT00549900|516270662|FG000|Overall Study|Adverse Event|1|||
143197292|NCT03640052|516270668|FG000|Overall Study|Lost to Follow-up|0|||
143197293|NCT03640052|516270669|FG001|Overall Study|Lost to Follow-up|1|||
143197294|NCT03640052|516270670|FG002|Overall Study|Lost to Follow-up|0|||
143197295|NCT03640052|516270671|FG003|Overall Study|Lost to Follow-up|0|||
143197296|NCT03640052|516270672|FG004|Overall Study|Lost to Follow-up|0|||
143197297|NCT00937404|516270673|FG000|Overall Study|Protocol Violation|1|||
143197298|NCT00937404|516270673|FG000|Overall Study|Withdrawal by Subject|1|||
143197299|NCT00230282|516270675|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
143197300|NCT00230282|516270675|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
143197301|NCT00230282|516270675|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
143197302|NCT00230282|516270675|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
143197303|NCT00090233|516270676|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
143197304|NCT00090233|516270677|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
143197305|NCT00090233|516270676|FG000|Overall Study|Adverse Event|214|||
143197306|NCT00090233|516270677|FG001|Overall Study|Adverse Event|198|||
143197307|NCT00090233|516270676|FG000|Overall Study|Lost to Follow-up|68|||
143197308|NCT00090233|516270677|FG001|Overall Study|Lost to Follow-up|95|||
143197309|NCT00090233|516270676|FG000|Overall Study|Protocol Violation|960|||
143197310|NCT00090233|516270677|FG001|Overall Study|Protocol Violation|1022|||
143197311|NCT00090233|516270676|FG000|Overall Study|Withdrawal by Subject|182|||
143197312|NCT00090233|516270677|FG001|Overall Study|Withdrawal by Subject|211|||
143197313|NCT00090233|516270676|FG000|Overall Study|Moved|203|||
143197314|NCT00090233|516270677|FG001|Overall Study|Moved|189|||
143197315|NCT00090233|516270676|FG000|Overall Study|Other|1211|||
143197316|NCT00090233|516270677|FG001|Overall Study|Other|1160|||
143197317|NCT00090233|516270676|FG000|Overall Study|Data not available at data cut-off point|1552|||
143197318|NCT00090233|516270677|FG001|Overall Study|Data not available at data cut-off point|1563|||
143197319|NCT00027378|516270678|FG000|Overall Study|Physician Decision|0|||
143197320|NCT00027378|516270679|FG001|Overall Study|Physician Decision|3|||
143197321|NCT05605691|516270682|FG000|Overall Study|Lost to Follow-up|1|||
143197322|NCT02701777|516270683|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
143197323|NCT02701777|516270684|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
143197324|NCT02701777|516270685|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
143197325|NCT02701777|516270686|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
143197326|NCT02701777|516270683|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
143197327|NCT02701777|516270684|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
143197328|NCT02701777|516270685|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
143197329|NCT02701777|516270686|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
143197330|NCT03199053|516270687|FG000|ST Period|Withdrawal by Subject|2|||
143197331|NCT03199053|516270688|FG001|ST Period|Withdrawal by Subject|4|||
143197332|NCT03199053|516270689|FG002|ST Period|Withdrawal by Subject|6|||
143197333|NCT03199053|516270687|FG000|ST Period|Withdrawal by parent/guardian|1|||
143197334|NCT03199053|516270688|FG001|ST Period|Withdrawal by parent/guardian|1|||
143197335|NCT03199053|516270689|FG002|ST Period|Withdrawal by parent/guardian|1|||
143197336|NCT03199053|516270687|FG000|ST Period|Lost to Follow-up|2|||
143197337|NCT03199053|516270688|FG001|ST Period|Lost to Follow-up|0|||
143197338|NCT03199053|516270689|FG002|ST Period|Lost to Follow-up|1|||
143197339|NCT03199053|516270687|FG000|LT Period|Withdrawal by Subject|1|||
143197340|NCT03199053|516270688|FG001|LT Period|Withdrawal by Subject|3|||
143197341|NCT03199053|516270689|FG002|LT Period|Withdrawal by Subject|3|||
143197342|NCT03199053|516270687|FG000|LT Period|Withdrawal by parent/guardian|0|||
143197343|NCT03199053|516270688|FG001|LT Period|Withdrawal by parent/guardian|0|||
143197344|NCT03199053|516270689|FG002|LT Period|Withdrawal by parent/guardian|1|||
143197345|NCT03199053|516270687|FG000|LT Period|Lost to Follow-up|0|||
143197346|NCT03199053|516270688|FG001|LT Period|Lost to Follow-up|1|||
143197347|NCT03199053|516270689|FG002|LT Period|Lost to Follow-up|1|||
143197348|NCT03199053|516270687|FG000|LT Period|Miscellaneous|0|||
143197349|NCT03199053|516270688|FG001|LT Period|Miscellaneous|0|||
143197350|NCT03199053|516270689|FG002|LT Period|Miscellaneous|2|||
143197351|NCT03199053|516270687|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
143197352|NCT03199053|516270688|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
143197353|NCT03199053|516270689|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
143197354|NCT03199053|516270687|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
143197355|NCT03199053|516270688|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
143197356|NCT03199053|516270689|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
143197357|NCT03199053|516270687|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
143197358|NCT03199053|516270688|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
143197359|NCT03199053|516270689|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
143197360|NCT03199053|516270687|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
143197361|NCT03199053|516270688|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
143197362|NCT03199053|516270689|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
143197363|NCT03298984|516270692|FG000|Overall Study|Physician Decision|1|||
143197364|NCT03298984|516270693|FG001|Overall Study|Physician Decision|0|||
143197365|NCT03298984|516270694|FG002|Overall Study|Physician Decision|0|||
143197366|NCT03298984|516270695|FG003|Overall Study|Physician Decision|6|||
143197367|NCT03298984|516270692|FG000|Overall Study|Lack of Efficacy|0|||
143197368|NCT03298984|516270693|FG001|Overall Study|Lack of Efficacy|1|||
143197369|NCT03298984|516270694|FG002|Overall Study|Lack of Efficacy|1|||
143197370|NCT03298984|516270695|FG003|Overall Study|Lack of Efficacy|4|||
143197371|NCT03298984|516270692|FG000|Overall Study|Relapsed disease (following remission)|0|||
143197372|NCT03298984|516270693|FG001|Overall Study|Relapsed disease (following remission)|0|||
143197373|NCT03298984|516270694|FG002|Overall Study|Relapsed disease (following remission)|1|||
143197374|NCT03298984|516270695|FG003|Overall Study|Relapsed disease (following remission)|1|||
143197375|NCT03298984|516270692|FG000|Overall Study|Adverse Event|0|||
143197376|NCT03298984|516270693|FG001|Overall Study|Adverse Event|0|||
143197377|NCT03298984|516270694|FG002|Overall Study|Adverse Event|0|||
143197378|NCT03298984|516270695|FG003|Overall Study|Adverse Event|1|||
143197379|NCT03298984|516270692|FG000|Overall Study|Death|0|||
143197380|NCT03298984|516270693|FG001|Overall Study|Death|0|||
143197381|NCT03298984|516270694|FG002|Overall Study|Death|0|||
143369702|NCT01281813|516897176|FG001|Overall Study|Lost to Follow-up|0|||
143369703|NCT01281813|516897177|FG002|Overall Study|Lost to Follow-up|31|||
143369704|NCT01281813|516897175|FG000|Overall Study|Withdrawal by Subject|0|||
143369705|NCT01281813|516897176|FG001|Overall Study|Withdrawal by Subject|0|||
143369706|NCT01281813|516897177|FG002|Overall Study|Withdrawal by Subject|13|||
143369707|NCT01281813|516897175|FG000|Overall Study|Subject Non-Compliant|0|||
143369708|NCT01281813|516897176|FG001|Overall Study|Subject Non-Compliant|0|||
143369709|NCT01281813|516897177|FG002|Overall Study|Subject Non-Compliant|6|||
143369710|NCT01281813|516897175|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
143369711|NCT01281813|516897176|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
143369712|NCT01281813|516897177|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
143369713|NCT01281813|516897175|FG000|Overall Study|Sponsor's Decision|4|||
143369714|NCT01281813|516897176|FG001|Overall Study|Sponsor's Decision|3|||
143369715|NCT01281813|516897177|FG002|Overall Study|Sponsor's Decision|7|||
143369716|NCT01281813|516897175|FG000|Overall Study|Switched to Commercially Available Medication|0|||
143369717|NCT01281813|516897176|FG001|Overall Study|Switched to Commercially Available Medication|0|||
143369718|NCT01281813|516897177|FG002|Overall Study|Switched to Commercially Available Medication|26|||
143369719|NCT01281813|516897175|FG000|Overall Study|Other|0|||
143369720|NCT01281813|516897176|FG001|Overall Study|Other|1|||
143369721|NCT01281813|516897177|FG002|Overall Study|Other|39|||
143369722|NCT02614560|516897180|FG000|Overall Study|Death|6|||
143369723|NCT02614560|516897181|FG001|Overall Study|Death|2|||
143369724|NCT00868192|516897183|FG000|Overall Study|Ineligible|4|||
143369725|NCT00798096|516897186|FG000|Overall Study|Ongoing|2|||
143369726|NCT01833065|516897187|FG000|Overall Study|Adverse Event|6|||
143369727|NCT01833065|516897188|FG001|Overall Study|Adverse Event|1|||
143369728|NCT01833065|516897189|FG002|Overall Study|Adverse Event|0|||
143369729|NCT01833065|516897190|FG003|Overall Study|Adverse Event|2|||
143369730|NCT01833065|516897191|FG004|Overall Study|Adverse Event|3|||
143369731|NCT01833065|516897187|FG000|Overall Study|Protocol Violation|1|||
143369732|NCT01833065|516897188|FG001|Overall Study|Protocol Violation|0|||
143369733|NCT01833065|516897189|FG002|Overall Study|Protocol Violation|0|||
143369734|NCT01833065|516897190|FG003|Overall Study|Protocol Violation|0|||
143369735|NCT01833065|516897191|FG004|Overall Study|Protocol Violation|2|||
143369736|NCT01833065|516897187|FG000|Overall Study|Lost to Follow-up|1|||
143369737|NCT01833065|516897188|FG001|Overall Study|Lost to Follow-up|0|||
143369738|NCT01833065|516897189|FG002|Overall Study|Lost to Follow-up|0|||
143369739|NCT01833065|516897190|FG003|Overall Study|Lost to Follow-up|0|||
143369740|NCT01833065|516897191|FG004|Overall Study|Lost to Follow-up|3|||
143369741|NCT01833065|516897187|FG000|Overall Study|Withdrawal by Subject|6|||
143369742|NCT01833065|516897188|FG001|Overall Study|Withdrawal by Subject|2|||
143369743|NCT01833065|516897189|FG002|Overall Study|Withdrawal by Subject|4|||
143369744|NCT01833065|516897190|FG003|Overall Study|Withdrawal by Subject|3|||
143369745|NCT01833065|516897191|FG004|Overall Study|Withdrawal by Subject|11|||
143369746|NCT01833065|516897187|FG000|Overall Study|Subject's substantial non-compliance|0|||
143369747|NCT01833065|516897188|FG001|Overall Study|Subject's substantial non-compliance|1|||
143369748|NCT01833065|516897189|FG002|Overall Study|Subject's substantial non-compliance|0|||
143197382|NCT03298984|516270695|FG003|Overall Study|Death|2|||
143197383|NCT03298984|516270692|FG000|Overall Study|Insurance Company Decision|0|||
143197384|NCT03298984|516270693|FG001|Overall Study|Insurance Company Decision|0|||
143369749|NCT01833065|516897190|FG003|Overall Study|Subject's substantial non-compliance|0|||
143197385|NCT03298984|516270694|FG002|Overall Study|Insurance Company Decision|0|||
143197386|NCT03298984|516270695|FG003|Overall Study|Insurance Company Decision|1|||
143197387|NCT00585221|516270698|FG000|Overall Study|Protocol Violation|8|||
143197388|NCT02509052|516270699|FG000|Overall Study|Non compliance|0|||
143197389|NCT02509052|516270700|FG001|Overall Study|Non compliance|0|||
143197390|NCT02509052|516270701|FG002|Overall Study|Non compliance|1|||
143197391|NCT02098369|516270702|FG000|Overall Study|Withdrawal by Subject|1|||
143197392|NCT02098369|516270703|FG001|Overall Study|Withdrawal by Subject|5|||
143197393|NCT02098369|516270704|FG002|Overall Study|Withdrawal by Subject|0|||
143197394|NCT02098369|516270702|FG000|Overall Study|Lost to Follow-up|5|||
143197395|NCT02098369|516270703|FG001|Overall Study|Lost to Follow-up|1|||
143197396|NCT02098369|516270704|FG002|Overall Study|Lost to Follow-up|3|||
143197397|NCT02098369|516270702|FG000|Overall Study|Death|1|||
143197398|NCT02098369|516270703|FG001|Overall Study|Death|1|||
143197399|NCT02098369|516270704|FG002|Overall Study|Death|1|||
143197400|NCT02098369|516270702|FG000|Overall Study|Other|0|||
143197401|NCT02098369|516270703|FG001|Overall Study|Other|2|||
143197402|NCT02098369|516270704|FG002|Overall Study|Other|1|||
143197403|NCT01323270|516270706|FG000|Overall Study|Withdrawal by Subject|19|||
143197404|NCT01323270|516270707|FG001|Overall Study|Withdrawal by Subject|10|||
143197405|NCT01323270|516270706|FG000|Overall Study|Protocol Violation|9|||
143197406|NCT01323270|516270707|FG001|Overall Study|Protocol Violation|7|||
143197407|NCT01323270|516270706|FG000|Overall Study|Lost to Follow-up|4|||
143197408|NCT01323270|516270707|FG001|Overall Study|Lost to Follow-up|6|||
143197409|NCT01323270|516270706|FG000|Overall Study|Adverse Event|8|||
143197410|NCT01323270|516270707|FG001|Overall Study|Adverse Event|0|||
143197411|NCT01323270|516270706|FG000|Overall Study|Other|0|||
143197412|NCT01323270|516270707|FG001|Overall Study|Other|3|||
143197413|NCT01323270|516270706|FG000|Overall Study|Physician Decision|0|||
143197414|NCT01323270|516270707|FG001|Overall Study|Physician Decision|2|||
143197415|NCT01323270|516270706|FG000|Overall Study|Not eligible|1|||
143197416|NCT01323270|516270707|FG001|Overall Study|Not eligible|1|||
143197417|NCT01323270|516270706|FG000|Overall Study|Death|1|||
143197418|NCT01323270|516270707|FG001|Overall Study|Death|0|||
143197419|NCT01323270|516270706|FG000|Overall Study|Randomized, but not vaccinated|1|||
143197420|NCT01323270|516270707|FG001|Overall Study|Randomized, but not vaccinated|0|||
143197421|NCT03761394|516270708|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
143197422|NCT03761394|516270709|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
143197423|NCT03761394|516270710|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
143197424|NCT03761394|516270711|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
143197425|NCT03761394|516270708|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
143197426|NCT03761394|516270709|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
143197427|NCT03761394|516270710|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
143197428|NCT03761394|516270711|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
143197429|NCT03761394|516270708|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
143197430|NCT03761394|516270709|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
143197431|NCT03761394|516270710|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
143197432|NCT03761394|516270711|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
143197433|NCT03761394|516270708|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
143197434|NCT03761394|516270709|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
143197435|NCT03761394|516270710|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
143197436|NCT03761394|516270711|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
143197437|NCT02229214|516270716|FG000|Overall Study|Adverse Event|2|||
143197438|NCT02229214|516270717|FG001|Overall Study|Adverse Event|0|||
143197439|NCT02229214|516270716|FG000|Overall Study|Withdrawal by Subject|4|||
143197440|NCT02229214|516270717|FG001|Overall Study|Withdrawal by Subject|0|||
143197441|NCT00246025|516270724|FG000|Overall Study|Adverse Event|7|||
143197442|NCT00246025|516270725|FG001|Overall Study|Adverse Event|9|||
143197443|NCT00246025|516270726|FG002|Overall Study|Adverse Event|9|||
143197444|NCT00246025|516270727|FG003|Overall Study|Adverse Event|10|||
143197445|NCT00246025|516270724|FG000|Overall Study|Withdrawal by Subject|3|||
143197446|NCT00246025|516270725|FG001|Overall Study|Withdrawal by Subject|0|||
143197447|NCT00246025|516270726|FG002|Overall Study|Withdrawal by Subject|1|||
143197448|NCT00246025|516270727|FG003|Overall Study|Withdrawal by Subject|2|||
143197449|NCT00246025|516270724|FG000|Overall Study|unsuitable medical history was found|0|||
143197450|NCT00246025|516270725|FG001|Overall Study|unsuitable medical history was found|0|||
143197451|NCT00246025|516270726|FG002|Overall Study|unsuitable medical history was found|0|||
143197452|NCT00246025|516270727|FG003|Overall Study|unsuitable medical history was found|1|||
143197453|NCT01643850|516270728|FG000|Overall Study|Withdrawal by Subject|0|||
143197454|NCT01643850|516270729|FG001|Overall Study|Withdrawal by Subject|0|||
143197455|NCT01643850|516270730|FG002|Overall Study|Withdrawal by Subject|0|||
143197456|NCT01643850|516270731|FG003|Overall Study|Withdrawal by Subject|0|||
143197457|NCT01643850|516270732|FG004|Overall Study|Withdrawal by Subject|1|||
143197458|NCT01643850|516270733|FG005|Overall Study|Withdrawal by Subject|0|||
143197459|NCT01643850|516270734|FG006|Overall Study|Withdrawal by Subject|0|||
143197460|NCT01643850|516270735|FG007|Overall Study|Withdrawal by Subject|0|||
143197461|NCT01643850|516270736|FG008|Overall Study|Withdrawal by Subject|0|||
143197462|NCT01643850|516270728|FG000|Overall Study|Lost to Follow-up|0|||
143197463|NCT01643850|516270729|FG001|Overall Study|Lost to Follow-up|0|||
143197464|NCT01643850|516270730|FG002|Overall Study|Lost to Follow-up|0|||
143197465|NCT01643850|516270731|FG003|Overall Study|Lost to Follow-up|0|||
143197466|NCT01643850|516270732|FG004|Overall Study|Lost to Follow-up|0|||
143197467|NCT01643850|516270733|FG005|Overall Study|Lost to Follow-up|0|||
143197468|NCT01643850|516270734|FG006|Overall Study|Lost to Follow-up|1|||
143197469|NCT01643850|516270735|FG007|Overall Study|Lost to Follow-up|0|||
143197470|NCT01643850|516270736|FG008|Overall Study|Lost to Follow-up|1|||
143197471|NCT01643850|516270728|FG000|Overall Study|Adverse Event|0|||
143197472|NCT01643850|516270729|FG001|Overall Study|Adverse Event|0|||
143197473|NCT01643850|516270730|FG002|Overall Study|Adverse Event|0|||
143197474|NCT01643850|516270731|FG003|Overall Study|Adverse Event|0|||
143197475|NCT01643850|516270732|FG004|Overall Study|Adverse Event|1|||
143197476|NCT01643850|516270733|FG005|Overall Study|Adverse Event|0|||
143197477|NCT01643850|516270734|FG006|Overall Study|Adverse Event|0|||
143197478|NCT01643850|516270735|FG007|Overall Study|Adverse Event|0|||
143197479|NCT01643850|516270736|FG008|Overall Study|Adverse Event|0|||
143197480|NCT01643850|516270728|FG000|Overall Study|Administrative Problems|0|||
143197481|NCT01643850|516270729|FG001|Overall Study|Administrative Problems|0|||
143197482|NCT01643850|516270730|FG002|Overall Study|Administrative Problems|1|||
143197483|NCT01643850|516270731|FG003|Overall Study|Administrative Problems|0|||
143197484|NCT01643850|516270732|FG004|Overall Study|Administrative Problems|1|||
143197485|NCT01643850|516270733|FG005|Overall Study|Administrative Problems|0|||
143197486|NCT01643850|516270734|FG006|Overall Study|Administrative Problems|0|||
143197487|NCT01643850|516270735|FG007|Overall Study|Administrative Problems|0|||
143197488|NCT01643850|516270736|FG008|Overall Study|Administrative Problems|0|||
143197489|NCT00931723|516270737|FG000|Overall Study|Withdrawal by Subject|11|||
143197490|NCT00931723|516270738|FG001|Overall Study|Withdrawal by Subject|13|||
143197491|NCT00931723|516270737|FG000|Overall Study|Adverse Event|6|||
143197492|NCT00931723|516270738|FG001|Overall Study|Adverse Event|13|||
143197493|NCT00931723|516270737|FG000|Overall Study|Lithium found in blood|0|||
143197494|NCT00931723|516270738|FG001|Overall Study|Lithium found in blood|1|||
143197495|NCT00931723|516270737|FG000|Overall Study|Condition under investigation worsened|1|||
143197496|NCT00931723|516270738|FG001|Overall Study|Condition under investigation worsened|2|||
143197497|NCT00931723|516270737|FG000|Overall Study|Lost to Follow-up|1|||
143197498|NCT00931723|516270738|FG001|Overall Study|Lost to Follow-up|2|||
143197499|NCT00931723|516270737|FG000|Overall Study|Study-specific discontinuation criteria|1|||
143197500|NCT00931723|516270738|FG001|Overall Study|Study-specific discontinuation criteria|1|||
143197501|NCT00931723|516270737|FG000|Overall Study|Severe non-compliance to protocol|2|||
143197502|NCT00931723|516270738|FG001|Overall Study|Severe non-compliance to protocol|0|||
143197503|NCT00931723|516270737|FG000|Overall Study|Safety reasons|0|||
143197504|NCT00931723|516270738|FG001|Overall Study|Safety reasons|1|||
143197505|NCT00931723|516270737|FG000|Overall Study|Took prohibited concomitant medication|0|||
143197506|NCT00931723|516270738|FG001|Overall Study|Took prohibited concomitant medication|1|||
143197507|NCT00931723|516270737|FG000|Overall Study|Lack or insufficient theraputic response|2|||
143197508|NCT00931723|516270738|FG001|Overall Study|Lack or insufficient theraputic response|5|||
143197509|NCT00931723|516270737|FG000|Overall Study|Sponsor decision|1|||
143197510|NCT00931723|516270738|FG001|Overall Study|Sponsor decision|0|||
143197511|NCT00931723|516270737|FG000|Overall Study|Late hospital discharge|1|||
143197512|NCT00931723|516270738|FG001|Overall Study|Late hospital discharge|0|||
143197513|NCT03300024|516270739|FG000|Overall Study|Physician Decision|4|||
143197514|NCT03300024|516270740|FG001|Overall Study|Physician Decision|6|||
143197515|NCT03305081|516270741|FG000|Overall Study|Lost to Follow-up|10|||
143197516|NCT03305081|516270742|FG001|Overall Study|Lost to Follow-up|15|||
143197517|NCT00570037|516270743|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
143197518|NCT00570037|516270744|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
143197519|NCT00554619|516270745|FG000|Overall Study|Adverse Event|1|||
143197520|NCT00554619|516270745|FG000|Overall Study|Physician Decision|1|||
143197521|NCT00554619|516270745|FG000|Overall Study|Liver Function Test Abnormality|1|||
143197522|NCT01571284|516270746|FG000|Overall Study|Participant's decision|84|||
143197523|NCT01571284|516270746|FG000|Overall Study|Lost to Follow-up|3|||
143197524|NCT01571284|516270746|FG000|Overall Study|Enrolled but not treated|2|||
143197525|NCT01571284|516270746|FG000|Overall Study|Other than specified above|80|||
143197526|NCT00075725|516270747|FG000|Overall Study|Adverse Event|6|||
143197527|NCT00075725|516270748|FG001|Overall Study|Adverse Event|6|||
143197528|NCT00075725|516270749|FG002|Overall Study|Adverse Event|20|||
143197529|NCT00075725|516270750|FG003|Overall Study|Adverse Event|8|||
143197530|NCT00075725|516270751|FG004|Overall Study|Adverse Event|4|||
143197531|NCT00075725|516270752|FG005|Overall Study|Adverse Event|38|||
143197532|NCT00075725|516270753|FG006|Overall Study|Adverse Event|3|||
143197533|NCT00075725|516270754|FG007|Overall Study|Adverse Event|51|||
143197534|NCT00075725|516270755|FG008|Overall Study|Adverse Event|15|||
143197535|NCT00075725|516270756|FG009|Overall Study|Adverse Event|4|||
143197536|NCT00075725|516270757|FG010|Overall Study|Adverse Event|2|||
143197537|NCT00075725|516270758|FG011|Overall Study|Adverse Event|2|||
143197538|NCT00075725|516270747|FG000|Overall Study|Death|3|||
143197539|NCT00075725|516270748|FG001|Overall Study|Death|5|||
143197540|NCT00075725|516270749|FG002|Overall Study|Death|10|||
143197541|NCT00075725|516270750|FG003|Overall Study|Death|2|||
143197542|NCT00075725|516270751|FG004|Overall Study|Death|3|||
143197543|NCT00075725|516270752|FG005|Overall Study|Death|25|||
143197544|NCT00075725|516270753|FG006|Overall Study|Death|4|||
143197545|NCT00075725|516270754|FG007|Overall Study|Death|22|||
143197546|NCT00075725|516270755|FG008|Overall Study|Death|14|||
143197547|NCT00075725|516270756|FG009|Overall Study|Death|4|||
143197548|NCT00075725|516270757|FG010|Overall Study|Death|3|||
143197549|NCT00075725|516270758|FG011|Overall Study|Death|0|||
143197550|NCT00075725|516270747|FG000|Overall Study|Lost to Follow-up|1|||
143197551|NCT00075725|516270748|FG001|Overall Study|Lost to Follow-up|1|||
143197552|NCT00075725|516270749|FG002|Overall Study|Lost to Follow-up|4|||
143197553|NCT00075725|516270750|FG003|Overall Study|Lost to Follow-up|1|||
143197554|NCT00075725|516270751|FG004|Overall Study|Lost to Follow-up|0|||
143197555|NCT00075725|516270752|FG005|Overall Study|Lost to Follow-up|13|||
143197556|NCT00075725|516270753|FG006|Overall Study|Lost to Follow-up|2|||
143197557|NCT00075725|516270754|FG007|Overall Study|Lost to Follow-up|4|||
143197558|NCT00075725|516270755|FG008|Overall Study|Lost to Follow-up|1|||
143197559|NCT00075725|516270756|FG009|Overall Study|Lost to Follow-up|0|||
143197560|NCT00075725|516270757|FG010|Overall Study|Lost to Follow-up|0|||
143197561|NCT00075725|516270758|FG011|Overall Study|Lost to Follow-up|0|||
143197562|NCT00075725|516270747|FG000|Overall Study|Physician Decision|2|||
143197563|NCT00075725|516270748|FG001|Overall Study|Physician Decision|6|||
143197564|NCT00075725|516270749|FG002|Overall Study|Physician Decision|5|||
143197565|NCT00075725|516270750|FG003|Overall Study|Physician Decision|8|||
143197566|NCT00075725|516270751|FG004|Overall Study|Physician Decision|4|||
143197567|NCT00075725|516270752|FG005|Overall Study|Physician Decision|19|||
143197568|NCT00075725|516270753|FG006|Overall Study|Physician Decision|3|||
143197569|NCT00075725|516270754|FG007|Overall Study|Physician Decision|17|||
143197570|NCT00075725|516270755|FG008|Overall Study|Physician Decision|5|||
143197571|NCT00075725|516270756|FG009|Overall Study|Physician Decision|0|||
143197572|NCT00075725|516270757|FG010|Overall Study|Physician Decision|1|||
143197573|NCT00075725|516270758|FG011|Overall Study|Physician Decision|0|||
143197574|NCT00075725|516270747|FG000|Overall Study|Pregnancy|0|||
143197575|NCT00075725|516270748|FG001|Overall Study|Pregnancy|0|||
143197576|NCT00075725|516270749|FG002|Overall Study|Pregnancy|0|||
143197577|NCT00075725|516270750|FG003|Overall Study|Pregnancy|0|||
143197578|NCT00075725|516270751|FG004|Overall Study|Pregnancy|0|||
143197579|NCT00075725|516270752|FG005|Overall Study|Pregnancy|1|||
143197580|NCT00075725|516270753|FG006|Overall Study|Pregnancy|0|||
143197581|NCT00075725|516270754|FG007|Overall Study|Pregnancy|1|||
143197582|NCT00075725|516270755|FG008|Overall Study|Pregnancy|0|||
143197583|NCT00075725|516270756|FG009|Overall Study|Pregnancy|0|||
143197584|NCT00075725|516270757|FG010|Overall Study|Pregnancy|0|||
143197585|NCT00075725|516270758|FG011|Overall Study|Pregnancy|0|||
143197586|NCT00075725|516270747|FG000|Overall Study|Protocol Violation|1|||
143197587|NCT00075725|516270748|FG001|Overall Study|Protocol Violation|1|||
143197588|NCT00075725|516270749|FG002|Overall Study|Protocol Violation|0|||
143197589|NCT00075725|516270750|FG003|Overall Study|Protocol Violation|3|||
143197590|NCT00075725|516270751|FG004|Overall Study|Protocol Violation|3|||
143197591|NCT00075725|516270752|FG005|Overall Study|Protocol Violation|2|||
143197592|NCT00075725|516270753|FG006|Overall Study|Protocol Violation|1|||
143197593|NCT00075725|516270754|FG007|Overall Study|Protocol Violation|2|||
143197594|NCT00075725|516270755|FG008|Overall Study|Protocol Violation|3|||
143197595|NCT00075725|516270756|FG009|Overall Study|Protocol Violation|0|||
143197596|NCT00075725|516270757|FG010|Overall Study|Protocol Violation|0|||
143197597|NCT00075725|516270758|FG011|Overall Study|Protocol Violation|1|||
143197598|NCT00075725|516270747|FG000|Overall Study|Withdrawal by Subject|12|||
143197599|NCT00075725|516270748|FG001|Overall Study|Withdrawal by Subject|3|||
143197600|NCT00075725|516270749|FG002|Overall Study|Withdrawal by Subject|6|||
143197601|NCT00075725|516270750|FG003|Overall Study|Withdrawal by Subject|10|||
143197602|NCT00075725|516270751|FG004|Overall Study|Withdrawal by Subject|6|||
143197603|NCT00075725|516270752|FG005|Overall Study|Withdrawal by Subject|27|||
143197604|NCT00075725|516270753|FG006|Overall Study|Withdrawal by Subject|7|||
143197605|NCT00075725|516270754|FG007|Overall Study|Withdrawal by Subject|31|||
143197606|NCT00075725|516270755|FG008|Overall Study|Withdrawal by Subject|10|||
143197607|NCT00075725|516270756|FG009|Overall Study|Withdrawal by Subject|2|||
143197608|NCT00075725|516270757|FG010|Overall Study|Withdrawal by Subject|0|||
143197609|NCT00075725|516270758|FG011|Overall Study|Withdrawal by Subject|0|||
143197610|NCT00075725|516270747|FG000|Overall Study|Disease Progression, all other reasons|17|||
143197611|NCT00075725|516270748|FG001|Overall Study|Disease Progression, all other reasons|5|||
143197612|NCT00075725|516270749|FG002|Overall Study|Disease Progression, all other reasons|33|||
143197613|NCT00075725|516270750|FG003|Overall Study|Disease Progression, all other reasons|6|||
143197614|NCT00075725|516270751|FG004|Overall Study|Disease Progression, all other reasons|21|||
143197615|NCT00075725|516270752|FG005|Overall Study|Disease Progression, all other reasons|59|||
143197616|NCT00075725|516270753|FG006|Overall Study|Disease Progression, all other reasons|20|||
143197617|NCT00075725|516270754|FG007|Overall Study|Disease Progression, all other reasons|46|||
143197618|NCT00075725|516270755|FG008|Overall Study|Disease Progression, all other reasons|21|||
143197619|NCT00075725|516270756|FG009|Overall Study|Disease Progression, all other reasons|4|||
143197620|NCT00075725|516270757|FG010|Overall Study|Disease Progression, all other reasons|0|||
143197621|NCT00075725|516270758|FG011|Overall Study|Disease Progression, all other reasons|5|||
143197622|NCT00075725|516270747|FG000|Overall Study|Patient off treatment|0|||
143197623|NCT00075725|516270748|FG001|Overall Study|Patient off treatment|0|||
143197624|NCT00075725|516270749|FG002|Overall Study|Patient off treatment|1|||
143197625|NCT00075725|516270750|FG003|Overall Study|Patient off treatment|2|||
143197626|NCT00075725|516270751|FG004|Overall Study|Patient off treatment|1|||
143197627|NCT00075725|516270752|FG005|Overall Study|Patient off treatment|0|||
143197628|NCT00075725|516270753|FG006|Overall Study|Patient off treatment|0|||
143197629|NCT00075725|516270754|FG007|Overall Study|Patient off treatment|2|||
143197630|NCT00075725|516270755|FG008|Overall Study|Patient off treatment|1|||
143197631|NCT00075725|516270756|FG009|Overall Study|Patient off treatment|0|||
143197632|NCT00075725|516270757|FG010|Overall Study|Patient off treatment|0|||
143197633|NCT00075725|516270758|FG011|Overall Study|Patient off treatment|0|||
143197634|NCT00075725|516270747|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
143197635|NCT00075725|516270748|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
143197636|NCT00075725|516270749|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
143197637|NCT00075725|516270750|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
143197638|NCT00075725|516270751|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
143197639|NCT00075725|516270752|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
143197640|NCT00075725|516270753|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
143197641|NCT00075725|516270754|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
143197642|NCT00075725|516270755|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
143197643|NCT00075725|516270756|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
143197644|NCT00075725|516270757|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
143197645|NCT00075725|516270758|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
143197646|NCT00075725|516270747|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
143197647|NCT00075725|516270748|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
143197648|NCT00075725|516270749|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
143197649|NCT00075725|516270750|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
143197650|NCT00075725|516270751|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
143197651|NCT00075725|516270752|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
143197652|NCT00075725|516270753|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
143197653|NCT00075725|516270754|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
143197654|NCT00075725|516270755|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
143197655|NCT00075725|516270756|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
143197656|NCT00075725|516270757|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
143197657|NCT00075725|516270758|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
143197658|NCT00075725|516270747|FG000|Overall Study|Pt non compliant with therapy|2|||
143197659|NCT00075725|516270748|FG001|Overall Study|Pt non compliant with therapy|1|||
143197660|NCT00075725|516270749|FG002|Overall Study|Pt non compliant with therapy|1|||
143197661|NCT00075725|516270750|FG003|Overall Study|Pt non compliant with therapy|0|||
143197662|NCT00075725|516270751|FG004|Overall Study|Pt non compliant with therapy|2|||
143197663|NCT00075725|516270752|FG005|Overall Study|Pt non compliant with therapy|14|||
143197664|NCT00075725|516270753|FG006|Overall Study|Pt non compliant with therapy|2|||
143197665|NCT00075725|516270754|FG007|Overall Study|Pt non compliant with therapy|5|||
143197666|NCT00075725|516270755|FG008|Overall Study|Pt non compliant with therapy|3|||
143197667|NCT00075725|516270756|FG009|Overall Study|Pt non compliant with therapy|0|||
143197668|NCT00075725|516270757|FG010|Overall Study|Pt non compliant with therapy|0|||
143197669|NCT00075725|516270758|FG011|Overall Study|Pt non compliant with therapy|0|||
143197670|NCT00075725|516270747|FG000|Overall Study|Pt age out of range for treatment|0|||
143261864|NCT00740246|516512521|FG001|Overall Study|Lost to Follow-up|2|||
143261865|NCT00740246|516512520|FG000|Overall Study|Withdrawal by Subject|4|||
143261866|NCT00740246|516512521|FG001|Overall Study|Withdrawal by Subject|3|||
143261867|NCT00740246|516512520|FG000|Overall Study|Withdrawn By Site Due To non-compliance|1|||
143261868|NCT00740246|516512521|FG001|Overall Study|Withdrawn By Site Due To non-compliance|0|||
143261869|NCT00740246|516512520|FG000|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
143261870|NCT00740246|516512521|FG001|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
143261871|NCT00740246|516512520|FG000|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|1|||
143261872|NCT00740246|516512521|FG001|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|0|||
143261873|NCT00740246|516512520|FG000|Overall Study|Unable To Comply With Study Visits|2|||
143261874|NCT00740246|516512521|FG001|Overall Study|Unable To Comply With Study Visits|0|||
143261875|NCT00740246|516512520|FG000|Overall Study|Unable to Access Vein|0|||
143261876|NCT00740246|516512521|FG001|Overall Study|Unable to Access Vein|2|||
143261877|NCT00740246|516512520|FG000|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|0|||
143261878|NCT00740246|516512521|FG001|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|1|||
143261879|NCT03584373|516512524|FG000|Overall Study|Lost to Follow-up|7|||
143261880|NCT03584373|516512525|FG001|Overall Study|Lost to Follow-up|8|||
143261881|NCT01487577|516512526|FG000|Overall Study|Became ineligible after signing consent|1|||
143261882|NCT00662532|516512527|FG000|Overall Study|Adverse Event|0|||
143261883|NCT00662532|516512528|FG001|Overall Study|Adverse Event|1|||
143261884|NCT00662532|516512527|FG000|Overall Study|Lost to Follow-up|0|||
143261885|NCT00662532|516512528|FG001|Overall Study|Lost to Follow-up|1|||
143261886|NCT01315236|516512529|FG000|Double-blind Phase|Death|1|||
143261887|NCT01315236|516512530|FG001|Double-blind Phase|Death|0|||
143261888|NCT01315236|516512529|FG000|Double-blind Phase|Adverse Event|1|||
143261889|NCT01315236|516512530|FG001|Double-blind Phase|Adverse Event|0|||
143261890|NCT01315236|516512529|FG000|Double-blind Phase|Withdrawal of Consent|1|||
143261891|NCT01315236|516512530|FG001|Double-blind Phase|Withdrawal of Consent|0|||
143261892|NCT01315236|516512529|FG000|Double-blind Phase|Lost to Follow-up|1|||
143261893|NCT01315236|516512530|FG001|Double-blind Phase|Lost to Follow-up|0|||
143197671|NCT00075725|516270748|FG001|Overall Study|Pt age out of range for treatment|1|||
143197672|NCT00075725|516270749|FG002|Overall Study|Pt age out of range for treatment|0|||
143197673|NCT00075725|516270750|FG003|Overall Study|Pt age out of range for treatment|0|||
143197674|NCT00075725|516270751|FG004|Overall Study|Pt age out of range for treatment|0|||
143197675|NCT00075725|516270752|FG005|Overall Study|Pt age out of range for treatment|1|||
143197676|NCT00075725|516270753|FG006|Overall Study|Pt age out of range for treatment|0|||
143197677|NCT00075725|516270754|FG007|Overall Study|Pt age out of range for treatment|1|||
143197678|NCT00075725|516270755|FG008|Overall Study|Pt age out of range for treatment|0|||
143197679|NCT00075725|516270756|FG009|Overall Study|Pt age out of range for treatment|0|||
143197680|NCT00075725|516270757|FG010|Overall Study|Pt age out of range for treatment|0|||
143197681|NCT00075725|516270758|FG011|Overall Study|Pt age out of range for treatment|0|||
143197682|NCT00075725|516270747|FG000|Overall Study|Insurance issues|0|||
143197683|NCT00075725|516270748|FG001|Overall Study|Insurance issues|1|||
143197684|NCT00075725|516270749|FG002|Overall Study|Insurance issues|0|||
143197685|NCT00075725|516270750|FG003|Overall Study|Insurance issues|1|||
143197686|NCT00075725|516270751|FG004|Overall Study|Insurance issues|1|||
143197687|NCT00075725|516270752|FG005|Overall Study|Insurance issues|1|||
143197688|NCT00075725|516270753|FG006|Overall Study|Insurance issues|0|||
143197689|NCT00075725|516270754|FG007|Overall Study|Insurance issues|1|||
143197690|NCT00075725|516270755|FG008|Overall Study|Insurance issues|0|||
143197691|NCT00075725|516270756|FG009|Overall Study|Insurance issues|0|||
143197692|NCT00075725|516270757|FG010|Overall Study|Insurance issues|0|||
143197693|NCT00075725|516270758|FG011|Overall Study|Insurance issues|0|||
143197694|NCT00075725|516270747|FG000|Overall Study|MRD positive after extended ind|0|||
143197695|NCT00075725|516270748|FG001|Overall Study|MRD positive after extended ind|1|||
143197696|NCT00075725|516270749|FG002|Overall Study|MRD positive after extended ind|1|||
143197697|NCT00075725|516270750|FG003|Overall Study|MRD positive after extended ind|0|||
143197698|NCT00075725|516270751|FG004|Overall Study|MRD positive after extended ind|1|||
143197699|NCT00075725|516270752|FG005|Overall Study|MRD positive after extended ind|2|||
143197700|NCT00075725|516270753|FG006|Overall Study|MRD positive after extended ind|0|||
143197701|NCT00075725|516270754|FG007|Overall Study|MRD positive after extended ind|1|||
143197702|NCT00075725|516270755|FG008|Overall Study|MRD positive after extended ind|0|||
143261894|NCT01315236|516512529|FG000|Open-label Phase|Death|1|||
143261895|NCT01315236|516512530|FG001|Open-label Phase|Death|0|||
143261896|NCT01315236|516512529|FG000|Open-label Phase|Adverse Event|0|||
143261897|NCT01315236|516512530|FG001|Open-label Phase|Adverse Event|1|||
143261898|NCT01315236|516512529|FG000|Open-label Phase|Other|0|||
143197703|NCT00075725|516270756|FG009|Overall Study|MRD positive after extended ind|0|||
143197704|NCT00075725|516270757|FG010|Overall Study|MRD positive after extended ind|0|||
143197705|NCT00075725|516270758|FG011|Overall Study|MRD positive after extended ind|0|||
143197706|NCT00075725|516270747|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
143197707|NCT00075725|516270748|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
143197708|NCT00075725|516270749|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
143197709|NCT00075725|516270750|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
143197710|NCT00075725|516270751|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
143197711|NCT00075725|516270752|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
143197712|NCT00075725|516270753|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
143197713|NCT00075725|516270754|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
143197714|NCT00075725|516270755|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
143197715|NCT00075725|516270756|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
143197716|NCT00075725|516270757|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
143197717|NCT00075725|516270758|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
143197718|NCT00075725|516270747|FG000|Overall Study|Inevaluable|1|||
143197719|NCT00075725|516270748|FG001|Overall Study|Inevaluable|1|||
143197720|NCT00075725|516270749|FG002|Overall Study|Inevaluable|4|||
143197721|NCT00075725|516270750|FG003|Overall Study|Inevaluable|2|||
143261899|NCT01315236|516512530|FG001|Open-label Phase|Other|1|||
143261900|NCT01315236|516512529|FG000|12-Month Follow-up Period|Death|0|||
143197722|NCT00075725|516270751|FG004|Overall Study|Inevaluable|2|||
143197723|NCT00075725|516270752|FG005|Overall Study|Inevaluable|9|||
143197724|NCT00075725|516270753|FG006|Overall Study|Inevaluable|1|||
143197725|NCT00075725|516270754|FG007|Overall Study|Inevaluable|11|||
143197726|NCT00075725|516270755|FG008|Overall Study|Inevaluable|2|||
143197727|NCT00075725|516270756|FG009|Overall Study|Inevaluable|0|||
143197728|NCT00075725|516270757|FG010|Overall Study|Inevaluable|1|||
143197729|NCT00075725|516270758|FG011|Overall Study|Inevaluable|0|||
143197730|NCT00075725|516270747|FG000|Overall Study|Other|4|||
143197731|NCT00075725|516270748|FG001|Overall Study|Other|2|||
143197732|NCT00075725|516270749|FG002|Overall Study|Other|1|||
143197733|NCT00075725|516270750|FG003|Overall Study|Other|1|||
143197734|NCT00075725|516270751|FG004|Overall Study|Other|1|||
143197735|NCT00075725|516270752|FG005|Overall Study|Other|4|||
143197736|NCT00075725|516270753|FG006|Overall Study|Other|2|||
143197737|NCT00075725|516270754|FG007|Overall Study|Other|9|||
143197738|NCT00075725|516270755|FG008|Overall Study|Other|2|||
143197739|NCT00075725|516270756|FG009|Overall Study|Other|1|||
143197740|NCT00075725|516270757|FG010|Overall Study|Other|0|||
143197741|NCT00075725|516270758|FG011|Overall Study|Other|3|||
143197742|NCT00075725|516270747|FG000|Overall Study|Pt trying to find a BM donor|0|||
143197743|NCT00075725|516270748|FG001|Overall Study|Pt trying to find a BM donor|1|||
143197744|NCT00075725|516270749|FG002|Overall Study|Pt trying to find a BM donor|0|||
143197745|NCT00075725|516270750|FG003|Overall Study|Pt trying to find a BM donor|0|||
143197746|NCT00075725|516270751|FG004|Overall Study|Pt trying to find a BM donor|0|||
143197747|NCT00075725|516270752|FG005|Overall Study|Pt trying to find a BM donor|0|||
143197748|NCT00075725|516270753|FG006|Overall Study|Pt trying to find a BM donor|0|||
143197749|NCT00075725|516270754|FG007|Overall Study|Pt trying to find a BM donor|0|||
143197750|NCT00075725|516270755|FG008|Overall Study|Pt trying to find a BM donor|0|||
143197751|NCT00075725|516270756|FG009|Overall Study|Pt trying to find a BM donor|0|||
143197752|NCT00075725|516270757|FG010|Overall Study|Pt trying to find a BM donor|0|||
143197753|NCT00075725|516270758|FG011|Overall Study|Pt trying to find a BM donor|0|||
143197754|NCT00075725|516270747|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
143197755|NCT00075725|516270748|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
143197756|NCT00075725|516270749|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
143197757|NCT00075725|516270750|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
143197758|NCT00075725|516270751|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
143261901|NCT01315236|516512530|FG001|12-Month Follow-up Period|Death|1|||
143261902|NCT01315236|516512529|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
143261903|NCT01315236|516512530|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
143261904|NCT00442468|516512531|FG000|Overall Study|Adverse Event|4|||
143261905|NCT00442468|516512531|FG000|Overall Study|Withdrawal by Subject|91|||
143197759|NCT00075725|516270752|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
143197760|NCT00075725|516270753|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
143197761|NCT00075725|516270754|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
143261906|NCT00442468|516512531|FG000|Overall Study|Did not complete all study procedures|88|||
143197762|NCT00075725|516270755|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
143197763|NCT00075725|516270756|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
143197764|NCT00075725|516270757|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
143197765|NCT00075725|516270758|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
143197766|NCT00075725|516270747|FG000|Overall Study|Unsuccessful institutional transfer|0|||
143261907|NCT00589784|516512532|FG000|Overall Study|Withdrawal by Subject|0|||
143261908|NCT00589784|516512533|FG001|Overall Study|Withdrawal by Subject|6|||
143261909|NCT00589784|516512532|FG000|Overall Study|Patient inevaluable|1|||
143261910|NCT00589784|516512533|FG001|Overall Study|Patient inevaluable|0|||
143261911|NCT00589784|516512532|FG000|Overall Study|Adverse Event|0|||
143261912|NCT00589784|516512533|FG001|Overall Study|Adverse Event|4|||
143261913|NCT03823378|516512537|FG000|Overall Study|Adverse Event|2|||
143197767|NCT00075725|516270748|FG001|Overall Study|Unsuccessful institutional transfer|0|||
143197768|NCT00075725|516270749|FG002|Overall Study|Unsuccessful institutional transfer|2|||
143197769|NCT00075725|516270750|FG003|Overall Study|Unsuccessful institutional transfer|0|||
143197770|NCT00075725|516270751|FG004|Overall Study|Unsuccessful institutional transfer|0|||
143197771|NCT00075725|516270752|FG005|Overall Study|Unsuccessful institutional transfer|0|||
143197772|NCT00075725|516270753|FG006|Overall Study|Unsuccessful institutional transfer|0|||
143197773|NCT00075725|516270754|FG007|Overall Study|Unsuccessful institutional transfer|0|||
143197774|NCT00075725|516270755|FG008|Overall Study|Unsuccessful institutional transfer|0|||
143197775|NCT00075725|516270756|FG009|Overall Study|Unsuccessful institutional transfer|1|||
143197776|NCT00075725|516270757|FG010|Overall Study|Unsuccessful institutional transfer|0|||
143197777|NCT00075725|516270758|FG011|Overall Study|Unsuccessful institutional transfer|0|||
143197778|NCT00075725|516270747|FG000|Overall Study|specimen(s) not submitted|0|||
143197779|NCT00075725|516270748|FG001|Overall Study|specimen(s) not submitted|0|||
143197780|NCT00075725|516270749|FG002|Overall Study|specimen(s) not submitted|2|||
143197781|NCT00075725|516270750|FG003|Overall Study|specimen(s) not submitted|0|||
143197782|NCT00075725|516270751|FG004|Overall Study|specimen(s) not submitted|0|||
143197783|NCT00075725|516270752|FG005|Overall Study|specimen(s) not submitted|0|||
143197784|NCT00075725|516270753|FG006|Overall Study|specimen(s) not submitted|0|||
143197785|NCT00075725|516270754|FG007|Overall Study|specimen(s) not submitted|0|||
143197786|NCT00075725|516270755|FG008|Overall Study|specimen(s) not submitted|0|||
143197787|NCT00075725|516270756|FG009|Overall Study|specimen(s) not submitted|0|||
143197788|NCT00075725|516270757|FG010|Overall Study|specimen(s) not submitted|0|||
143197789|NCT00075725|516270758|FG011|Overall Study|specimen(s) not submitted|0|||
143197790|NCT00075725|516270747|FG000|Overall Study|Pt went to transplant|0|||
143197791|NCT00075725|516270748|FG001|Overall Study|Pt went to transplant|0|||
143197792|NCT00075725|516270749|FG002|Overall Study|Pt went to transplant|0|||
143197793|NCT00075725|516270750|FG003|Overall Study|Pt went to transplant|1|||
143197794|NCT00075725|516270751|FG004|Overall Study|Pt went to transplant|0|||
143197795|NCT00075725|516270752|FG005|Overall Study|Pt went to transplant|1|||
143197796|NCT00075725|516270753|FG006|Overall Study|Pt went to transplant|0|||
143197797|NCT00075725|516270754|FG007|Overall Study|Pt went to transplant|0|||
143197798|NCT00075725|516270755|FG008|Overall Study|Pt went to transplant|0|||
143197799|NCT00075725|516270756|FG009|Overall Study|Pt went to transplant|0|||
143197800|NCT00075725|516270757|FG010|Overall Study|Pt went to transplant|0|||
143197801|NCT00075725|516270758|FG011|Overall Study|Pt went to transplant|0|||
143197802|NCT00075725|516270747|FG000|Overall Study|Pt received additional steroids|0|||
143197803|NCT00075725|516270748|FG001|Overall Study|Pt received additional steroids|0|||
143197804|NCT00075725|516270749|FG002|Overall Study|Pt received additional steroids|0|||
143197805|NCT00075725|516270750|FG003|Overall Study|Pt received additional steroids|1|||
143197806|NCT00075725|516270751|FG004|Overall Study|Pt received additional steroids|0|||
143197807|NCT00075725|516270752|FG005|Overall Study|Pt received additional steroids|0|||
143197808|NCT00075725|516270753|FG006|Overall Study|Pt received additional steroids|0|||
143197809|NCT00075725|516270754|FG007|Overall Study|Pt received additional steroids|0|||
143197810|NCT00075725|516270755|FG008|Overall Study|Pt received additional steroids|0|||
143197811|NCT00075725|516270756|FG009|Overall Study|Pt received additional steroids|0|||
143197812|NCT00075725|516270757|FG010|Overall Study|Pt received additional steroids|0|||
143197813|NCT00075725|516270758|FG011|Overall Study|Pt received additional steroids|0|||
143197814|NCT00075725|516270747|FG000|Overall Study|Pt relocated|0|||
143197815|NCT00075725|516270748|FG001|Overall Study|Pt relocated|0|||
143197816|NCT00075725|516270749|FG002|Overall Study|Pt relocated|0|||
143197817|NCT00075725|516270750|FG003|Overall Study|Pt relocated|2|||
143197818|NCT00075725|516270751|FG004|Overall Study|Pt relocated|0|||
143197819|NCT00075725|516270752|FG005|Overall Study|Pt relocated|1|||
143197820|NCT00075725|516270753|FG006|Overall Study|Pt relocated|1|||
143197821|NCT00075725|516270754|FG007|Overall Study|Pt relocated|2|||
143197822|NCT00075725|516270755|FG008|Overall Study|Pt relocated|1|||
143197823|NCT00075725|516270756|FG009|Overall Study|Pt relocated|0|||
143197824|NCT00075725|516270757|FG010|Overall Study|Pt relocated|0|||
143197825|NCT00075725|516270758|FG011|Overall Study|Pt relocated|0|||
143197826|NCT00075725|516270747|FG000|Overall Study|Institution Terminated|0|||
143197827|NCT00075725|516270748|FG001|Overall Study|Institution Terminated|0|||
143197828|NCT00075725|516270749|FG002|Overall Study|Institution Terminated|0|||
143197829|NCT00075725|516270750|FG003|Overall Study|Institution Terminated|0|||
143197830|NCT00075725|516270751|FG004|Overall Study|Institution Terminated|1|||
143197831|NCT00075725|516270752|FG005|Overall Study|Institution Terminated|0|||
143197832|NCT00075725|516270753|FG006|Overall Study|Institution Terminated|0|||
143197833|NCT00075725|516270754|FG007|Overall Study|Institution Terminated|3|||
143261914|NCT03823378|516512538|FG001|Overall Study|Adverse Event|2|||
143261915|NCT03823378|516512539|FG002|Overall Study|Adverse Event|0|||
143197834|NCT00075725|516270755|FG008|Overall Study|Institution Terminated|0|||
143197835|NCT00075725|516270756|FG009|Overall Study|Institution Terminated|0|||
143197836|NCT00075725|516270757|FG010|Overall Study|Institution Terminated|0|||
143197837|NCT00075725|516270758|FG011|Overall Study|Institution Terminated|0|||
143197838|NCT00075725|516270747|FG000|Overall Study|Study Closure|1|||
143197839|NCT00075725|516270748|FG001|Overall Study|Study Closure|0|||
143197840|NCT00075725|516270749|FG002|Overall Study|Study Closure|0|||
143197841|NCT00075725|516270750|FG003|Overall Study|Study Closure|0|||
143197842|NCT00075725|516270751|FG004|Overall Study|Study Closure|1|||
143197843|NCT00075725|516270752|FG005|Overall Study|Study Closure|3|||
143197844|NCT00075725|516270753|FG006|Overall Study|Study Closure|0|||
143197845|NCT00075725|516270754|FG007|Overall Study|Study Closure|1|||
143197846|NCT00075725|516270755|FG008|Overall Study|Study Closure|0|||
143197847|NCT00075725|516270756|FG009|Overall Study|Study Closure|0|||
143197848|NCT00075725|516270757|FG010|Overall Study|Study Closure|0|||
143197849|NCT00075725|516270758|FG011|Overall Study|Study Closure|0|||
143197850|NCT00075725|516270747|FG000|Overall Study|Other complications|0|||
143197851|NCT00075725|516270748|FG001|Overall Study|Other complications|0|||
143197852|NCT00075725|516270749|FG002|Overall Study|Other complications|0|||
143197853|NCT00075725|516270750|FG003|Overall Study|Other complications|0|||
143197854|NCT00075725|516270751|FG004|Overall Study|Other complications|0|||
143197855|NCT00075725|516270752|FG005|Overall Study|Other complications|1|||
143197856|NCT00075725|516270753|FG006|Overall Study|Other complications|0|||
143197857|NCT00075725|516270754|FG007|Overall Study|Other complications|0|||
143197858|NCT00075725|516270755|FG008|Overall Study|Other complications|0|||
143197859|NCT00075725|516270756|FG009|Overall Study|Other complications|0|||
143197860|NCT00075725|516270757|FG010|Overall Study|Other complications|0|||
143197861|NCT00075725|516270758|FG011|Overall Study|Other complications|0|||
143197862|NCT00075725|516270747|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
143197863|NCT00075725|516270748|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
143197864|NCT00075725|516270749|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
143197865|NCT00075725|516270750|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
143197866|NCT00075725|516270751|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
143197867|NCT00075725|516270752|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
143197868|NCT00075725|516270753|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
143197869|NCT00075725|516270754|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
143197870|NCT00075725|516270755|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
143197871|NCT00075725|516270756|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
143197872|NCT00075725|516270757|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
143197873|NCT00075725|516270758|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
143197874|NCT00075725|516270747|FG000|Overall Study|Pt incarcerated|0|||
143197875|NCT00075725|516270748|FG001|Overall Study|Pt incarcerated|0|||
143197876|NCT00075725|516270749|FG002|Overall Study|Pt incarcerated|0|||
143197877|NCT00075725|516270750|FG003|Overall Study|Pt incarcerated|0|||
143197878|NCT00075725|516270751|FG004|Overall Study|Pt incarcerated|0|||
143197879|NCT00075725|516270752|FG005|Overall Study|Pt incarcerated|0|||
143197880|NCT00075725|516270753|FG006|Overall Study|Pt incarcerated|0|||
143197881|NCT00075725|516270754|FG007|Overall Study|Pt incarcerated|1|||
143197882|NCT00075725|516270755|FG008|Overall Study|Pt incarcerated|0|||
143197883|NCT00075725|516270756|FG009|Overall Study|Pt incarcerated|0|||
143197884|NCT00075725|516270757|FG010|Overall Study|Pt incarcerated|0|||
143197885|NCT00075725|516270758|FG011|Overall Study|Pt incarcerated|0|||
143197886|NCT03510468|516270759|FG000|Overall Study|Lost to Follow-up|1|||
143197887|NCT03510468|516270759|FG000|Overall Study|Adverse Event|5|||
143197888|NCT03510468|516270759|FG000|Overall Study|Physician Decision|1|||
143197889|NCT03510468|516270759|FG000|Overall Study|non-compliant with treatment|2|||
143197890|NCT03510468|516270759|FG000|Overall Study|Missed visit|1|||
143197891|NCT04677660|516270760|FG000|Overall Study|Lost to Follow-up|0|||
143197892|NCT04677660|516270761|FG001|Overall Study|Lost to Follow-up|2|||
143197893|NCT04677660|516270760|FG000|Overall Study|Withdrawal by Subject|0|||
143197894|NCT04677660|516270761|FG001|Overall Study|Withdrawal by Subject|1|||
143197895|NCT04677660|516270760|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
143197896|NCT04677660|516270761|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
143197897|NCT01560637|516270763|FG000|Overall Study|Adverse Event|63|||
143197898|NCT01560637|516270763|FG000|Overall Study|Death|69|||
143197899|NCT01560637|516270763|FG000|Overall Study|Lost to Follow-up|8|||
143197900|NCT01560637|516270763|FG000|Overall Study|Protocol Violation|8|||
143197901|NCT01560637|516270763|FG000|Overall Study|Withdrawal by Subject|24|||
143197902|NCT01560637|516270763|FG000|Overall Study|Progressive Disease|20|||
143197903|NCT01560637|516270763|FG000|Overall Study|Other Reason Not Specified|6|||
143197904|NCT03220581|516270764|FG000|Overall Study|Withdrawal by Subject|0|||
143197905|NCT03220581|516270765|FG001|Overall Study|Withdrawal by Subject|1|||
143197906|NCT03220581|516270764|FG000|Overall Study|Lost to Follow-up|3|||
143197907|NCT03220581|516270765|FG001|Overall Study|Lost to Follow-up|6|||
143197908|NCT01185964|516270766|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
143197909|NCT01185964|516270767|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
143197910|NCT01185964|516270768|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
143197911|NCT01185964|516270769|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
143197912|NCT01185964|516270766|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
143197913|NCT01185964|516270767|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
143197914|NCT01185964|516270768|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
143197915|NCT01185964|516270769|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
143197916|NCT01185964|516270766|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
143197917|NCT01185964|516270767|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
143197918|NCT01185964|516270768|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
143197919|NCT01185964|516270769|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
143197920|NCT01185964|516270766|FG000|Phase 1b and Phase 2|Adverse Event|1|||
143197921|NCT01185964|516270767|FG001|Phase 1b and Phase 2|Adverse Event|0|||
143197922|NCT01185964|516270768|FG002|Phase 1b and Phase 2|Adverse Event|2|||
143197923|NCT01185964|516270769|FG003|Phase 1b and Phase 2|Adverse Event|0|||
143197924|NCT01185964|516270766|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
143197925|NCT01185964|516270767|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
143197926|NCT01185964|516270768|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
143197927|NCT01185964|516270769|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
143197928|NCT01185964|516270766|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
143197929|NCT01185964|516270767|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
143197930|NCT01185964|516270768|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
143197931|NCT01185964|516270769|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
143197932|NCT01185964|516270766|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
143197933|NCT01185964|516270767|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
143197934|NCT01185964|516270768|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
143197935|NCT01185964|516270769|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
143197936|NCT01185964|516270766|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
143197937|NCT01185964|516270767|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
143197938|NCT01185964|516270768|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
143197939|NCT01185964|516270769|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
143197940|NCT04465877|516270770|FG000|Overall Study|Noncompliant with study requirements|0|||
143197941|NCT04465877|516270771|FG001|Overall Study|Noncompliant with study requirements|0|||
143197942|NCT04465877|516270772|FG002|Overall Study|Noncompliant with study requirements|1|||
143197943|NCT04465877|516270773|FG003|Overall Study|Noncompliant with study requirements|0|||
143197944|NCT02323204|516270774|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
143197945|NCT02323204|516270775|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
143197946|NCT02323204|516270776|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
143197947|NCT02323204|516270777|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
143197948|NCT02323204|516270774|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
143197949|NCT02323204|516270775|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
143197950|NCT02323204|516270776|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
143197951|NCT02323204|516270777|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
143197952|NCT02323204|516270774|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
143197953|NCT02323204|516270775|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
143197954|NCT02323204|516270776|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
143197955|NCT02323204|516270777|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
143197956|NCT02323204|516270774|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
143197957|NCT02323204|516270775|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
143197958|NCT02323204|516270776|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
143197959|NCT02323204|516270777|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
143197960|NCT02323204|516270774|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
143197961|NCT02323204|516270775|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
143197962|NCT02323204|516270776|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
143197963|NCT02323204|516270777|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
143197964|NCT02323204|516270774|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
143197965|NCT02323204|516270775|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
143197966|NCT02323204|516270776|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
143197967|NCT02323204|516270777|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
143197968|NCT02323204|516270774|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
143197969|NCT02323204|516270775|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
143197970|NCT02323204|516270776|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
143197971|NCT02323204|516270777|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
143197972|NCT02323204|516270774|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
143197973|NCT02323204|516270775|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
143197974|NCT02323204|516270776|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
143197975|NCT02323204|516270777|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
143197976|NCT02323204|516270774|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
143261916|NCT03823378|516512540|FG003|Overall Study|Adverse Event|0|||
143261917|NCT03823378|516512541|FG004|Overall Study|Adverse Event|0|||
143261918|NCT03823378|516512542|FG005|Overall Study|Adverse Event|0|||
143261919|NCT03823378|516512537|FG000|Overall Study|Lost to Follow-up|0|||
143261920|NCT03823378|516512538|FG001|Overall Study|Lost to Follow-up|1|||
143261921|NCT03823378|516512539|FG002|Overall Study|Lost to Follow-up|0|||
143261922|NCT03823378|516512540|FG003|Overall Study|Lost to Follow-up|0|||
143261923|NCT03823378|516512541|FG004|Overall Study|Lost to Follow-up|1|||
143261924|NCT03823378|516512542|FG005|Overall Study|Lost to Follow-up|0|||
143261925|NCT03823378|516512537|FG000|Overall Study|Withdrawal by Subject|0|||
143197977|NCT02323204|516270775|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
143197978|NCT02323204|516270776|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
143197979|NCT02323204|516270777|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
143197980|NCT03440918|516270778|FG000|Overall Study|Protocol Violation|0|||
143197981|NCT03440918|516270779|FG001|Overall Study|Protocol Violation|16|||
143197982|NCT03576755|516270791|FG000|Overall Study|Withdrawal by Subject|1|||
143197983|NCT03576755|516270792|FG001|Overall Study|Withdrawal by Subject|0|||
143197984|NCT03576755|516270793|FG002|Overall Study|Withdrawal by Subject|0|||
143197985|NCT03576755|516270794|FG003|Overall Study|Withdrawal by Subject|0|||
143197986|NCT01396265|516270795|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
143197987|NCT03444766|516270796|FG000|Overall Study|Other Reasons|2|||
143197988|NCT03444766|516270796|FG000|Overall Study|Participant Withdrew Consent|5|||
143197989|NCT03444766|516270796|FG000|Overall Study|Lost to Follow-up|2|||
143197990|NCT03444766|516270796|FG000|Overall Study|Death|2|||
143197991|NCT03444766|516270796|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
143197992|NCT03444766|516270796|FG000|Overall Study|Disease Progression|49|||
143197993|NCT01767493|516270797|FG000|Overall Study|screen failures|3|||
143197994|NCT04346108|516270800|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
143197995|NCT04346108|516270801|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
143197996|NCT04346108|516270802|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
143197997|NCT04346108|516270800|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
143197998|NCT04346108|516270801|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
143197999|NCT04346108|516270802|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
143198000|NCT01598753|516270803|FG000|Overall Study|Adverse Event|1|||
143198001|NCT01598753|516270804|FG001|Overall Study|Adverse Event|9|||
143198002|NCT01598753|516270805|FG002|Overall Study|Adverse Event|1|||
143198003|NCT01598753|516270806|FG003|Overall Study|Adverse Event|7|||
143198004|NCT01598753|516270803|FG000|Overall Study|Lost to Follow-up|4|||
143198005|NCT01598753|516270804|FG001|Overall Study|Lost to Follow-up|3|||
143198006|NCT01598753|516270805|FG002|Overall Study|Lost to Follow-up|7|||
143198007|NCT01598753|516270806|FG003|Overall Study|Lost to Follow-up|5|||
143198008|NCT01598753|516270803|FG000|Overall Study|Physician Decision|0|||
143198009|NCT01598753|516270804|FG001|Overall Study|Physician Decision|1|||
143198010|NCT01598753|516270805|FG002|Overall Study|Physician Decision|0|||
143198011|NCT01598753|516270806|FG003|Overall Study|Physician Decision|2|||
143198012|NCT01598753|516270803|FG000|Overall Study|Withdrawal by Subject|7|||
143198013|NCT01598753|516270804|FG001|Overall Study|Withdrawal by Subject|2|||
143198014|NCT01598753|516270805|FG002|Overall Study|Withdrawal by Subject|0|||
143198015|NCT01598753|516270806|FG003|Overall Study|Withdrawal by Subject|1|||
143198016|NCT02275117|516270807|FG000|Overall Study|Adverse Event|0|||
143198017|NCT02275117|516270808|FG001|Overall Study|Adverse Event|0|||
143198018|NCT02275117|516270809|FG002|Overall Study|Adverse Event|0|||
143198019|NCT02275117|516270810|FG003|Overall Study|Adverse Event|0|||
143198020|NCT02275117|516270811|FG004|Overall Study|Adverse Event|1|||
143198021|NCT02275117|516270807|FG000|Overall Study|Lack of Efficacy|6|||
143198022|NCT02275117|516270808|FG001|Overall Study|Lack of Efficacy|7|||
143198023|NCT02275117|516270809|FG002|Overall Study|Lack of Efficacy|5|||
143198024|NCT02275117|516270810|FG003|Overall Study|Lack of Efficacy|2|||
143198025|NCT02275117|516270811|FG004|Overall Study|Lack of Efficacy|10|||
143198026|NCT02275117|516270807|FG000|Overall Study|Lost to Follow-up|11|||
143198027|NCT02275117|516270808|FG001|Overall Study|Lost to Follow-up|16|||
143198028|NCT02275117|516270809|FG002|Overall Study|Lost to Follow-up|15|||
143198029|NCT02275117|516270810|FG003|Overall Study|Lost to Follow-up|16|||
143198030|NCT02275117|516270811|FG004|Overall Study|Lost to Follow-up|8|||
143198031|NCT02275117|516270807|FG000|Overall Study|Physician Decision|0|||
143198032|NCT02275117|516270808|FG001|Overall Study|Physician Decision|1|||
143198033|NCT02275117|516270809|FG002|Overall Study|Physician Decision|1|||
143198034|NCT02275117|516270810|FG003|Overall Study|Physician Decision|0|||
143198035|NCT02275117|516270811|FG004|Overall Study|Physician Decision|1|||
143198036|NCT02275117|516270807|FG000|Overall Study|Protocol Violation|1|||
143198037|NCT02275117|516270808|FG001|Overall Study|Protocol Violation|0|||
143198038|NCT02275117|516270809|FG002|Overall Study|Protocol Violation|1|||
143261926|NCT03823378|516512538|FG001|Overall Study|Withdrawal by Subject|1|||
143261927|NCT03823378|516512539|FG002|Overall Study|Withdrawal by Subject|4|||
143261928|NCT03823378|516512540|FG003|Overall Study|Withdrawal by Subject|2|||
143369750|NCT01833065|516897191|FG004|Overall Study|Subject's substantial non-compliance|0|||
143198039|NCT02275117|516270810|FG003|Overall Study|Protocol Violation|1|||
143198040|NCT02275117|516270811|FG004|Overall Study|Protocol Violation|0|||
143198041|NCT02275117|516270807|FG000|Overall Study|Withdrawal by Subject|6|||
143198042|NCT02275117|516270808|FG001|Overall Study|Withdrawal by Subject|4|||
143198043|NCT02275117|516270809|FG002|Overall Study|Withdrawal by Subject|7|||
143198044|NCT02275117|516270810|FG003|Overall Study|Withdrawal by Subject|3|||
143198045|NCT02275117|516270811|FG004|Overall Study|Withdrawal by Subject|3|||
143198046|NCT02275117|516270807|FG000|Overall Study|Terminated by Sponsor|4|||
143198047|NCT02275117|516270808|FG001|Overall Study|Terminated by Sponsor|4|||
143198048|NCT02275117|516270809|FG002|Overall Study|Terminated by Sponsor|4|||
143198049|NCT02275117|516270810|FG003|Overall Study|Terminated by Sponsor|6|||
143198050|NCT02275117|516270811|FG004|Overall Study|Terminated by Sponsor|4|||
143198051|NCT02275117|516270807|FG000|Overall Study|Worsening of Study Indication|0|||
143198052|NCT02275117|516270808|FG001|Overall Study|Worsening of Study Indication|1|||
143198053|NCT02275117|516270809|FG002|Overall Study|Worsening of Study Indication|2|||
143198054|NCT02275117|516270810|FG003|Overall Study|Worsening of Study Indication|0|||
143198055|NCT02275117|516270811|FG004|Overall Study|Worsening of Study Indication|0|||
143198056|NCT02275117|516270807|FG000|Overall Study|Study Burden|5|||
143198057|NCT02275117|516270808|FG001|Overall Study|Study Burden|4|||
143198058|NCT02275117|516270809|FG002|Overall Study|Study Burden|7|||
143198059|NCT02275117|516270810|FG003|Overall Study|Study Burden|5|||
143198060|NCT02275117|516270811|FG004|Overall Study|Study Burden|7|||
143198061|NCT02275117|516270807|FG000|Overall Study|Other|1|||
143198062|NCT02275117|516270808|FG001|Overall Study|Other|0|||
143198063|NCT02275117|516270809|FG002|Overall Study|Other|0|||
143198064|NCT02275117|516270810|FG003|Overall Study|Other|0|||
143198065|NCT02275117|516270811|FG004|Overall Study|Other|2|||
143198066|NCT01081301|516270812|FG000|Overall Study|Bereaved|3|||
143198067|NCT01081301|516270812|FG000|Overall Study|Too busy|5|||
143198068|NCT01081301|516270812|FG000|Overall Study|Patient too ill|2|||
143198069|NCT01081301|516270812|FG000|Overall Study|Lost to Follow-up|4|||
143198070|NCT01865812|516270813|FG000|Primary Treatment Phase|Adverse Event|2|||
143198071|NCT01865812|516270814|FG001|Primary Treatment Phase|Adverse Event|0|||
143198072|NCT01865812|516270813|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
143198073|NCT01865812|516270814|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
143198074|NCT01865812|516270813|FG000|Long-term Safety Extension Phase|Pruritus|0|||
143198075|NCT01865812|516270814|FG001|Long-term Safety Extension Phase|Pruritus|3|||
143198076|NCT01865812|516270813|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
143198077|NCT01865812|516270814|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
143198078|NCT01865812|516270813|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
143198079|NCT01865812|516270814|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
143198080|NCT00724854|516270815|FG000|Overall Study|Lack of Efficacy|187|||
143198081|NCT00724854|516270816|FG001|Overall Study|Lack of Efficacy|13|||
143198082|NCT00724854|516270815|FG000|Overall Study|Lost to Follow-up|87|||
143198083|NCT00724854|516270816|FG001|Overall Study|Lost to Follow-up|10|||
143198084|NCT00724854|516270815|FG000|Overall Study|Adverse Event|62|||
143198085|NCT00724854|516270816|FG001|Overall Study|Adverse Event|4|||
143198086|NCT00724854|516270815|FG000|Overall Study|Other|42|||
143198087|NCT00724854|516270816|FG001|Overall Study|Other|3|||
143198088|NCT00724854|516270815|FG000|Overall Study|Death|11|||
143261929|NCT03823378|516512541|FG004|Overall Study|Withdrawal by Subject|0|||
143198089|NCT00724854|516270816|FG001|Overall Study|Death|0|||
143198090|NCT00724854|516270815|FG000|Overall Study|Change of treatment|7|||
143261930|NCT03823378|516512542|FG005|Overall Study|Withdrawal by Subject|1|||
143261931|NCT03823378|516512537|FG000|Overall Study|Other, not specified|19|||
143261932|NCT03823378|516512538|FG001|Overall Study|Other, not specified|12|||
143261933|NCT03823378|516512539|FG002|Overall Study|Other, not specified|6|||
143261934|NCT03823378|516512540|FG003|Overall Study|Other, not specified|8|||
143261935|NCT03823378|516512541|FG004|Overall Study|Other, not specified|17|||
143261936|NCT03823378|516512542|FG005|Overall Study|Other, not specified|7|||
143198091|NCT00724854|516270816|FG001|Overall Study|Change of treatment|0|||
143198092|NCT00724854|516270815|FG000|Overall Study|Withdrawal by Subject|5|||
143198093|NCT00724854|516270816|FG001|Overall Study|Withdrawal by Subject|0|||
143198094|NCT00724854|516270815|FG000|Overall Study|Adverse event + lack of efficacy|2|||
143198095|NCT00724854|516270816|FG001|Overall Study|Adverse event + lack of efficacy|1|||
143198096|NCT02142283|516270819|FG000|Overall Study|Death|20|||
143198097|NCT02142283|516270820|FG001|Overall Study|Death|18|||
143198098|NCT02142283|516270819|FG000|Overall Study|Withdrawal by Subject|1|||
143198099|NCT02142283|516270820|FG001|Overall Study|Withdrawal by Subject|3|||
143198100|NCT00747344|516270823|FG000|Controlled Period|Adverse Event|3|||
143198101|NCT00747344|516270824|FG001|Controlled Period|Adverse Event|0|||
143198102|NCT00747344|516270825|FG002|Controlled Period|Adverse Event|0|||
143198103|NCT00747344|516270826|FG003|Controlled Period|Adverse Event|0|||
143198104|NCT00747344|516270823|FG000|Controlled Period|Lack of Efficacy|2|||
143198105|NCT00747344|516270824|FG001|Controlled Period|Lack of Efficacy|1|||
143261937|NCT03190369|516512543|FG000|Overall Study|Poor compliance to protocol|0|||
143261938|NCT03190369|516512544|FG001|Overall Study|Poor compliance to protocol|1|||
143261939|NCT03190369|516512543|FG000|Overall Study|Withdraw before treatment|1|||
143198106|NCT00747344|516270825|FG002|Controlled Period|Lack of Efficacy|0|||
143198107|NCT00747344|516270826|FG003|Controlled Period|Lack of Efficacy|0|||
143198108|NCT00747344|516270823|FG000|Controlled Period|Other|0|||
143198109|NCT00747344|516270824|FG001|Controlled Period|Other|3|||
143198110|NCT00747344|516270825|FG002|Controlled Period|Other|0|||
143198111|NCT00747344|516270826|FG003|Controlled Period|Other|0|||
143261940|NCT03190369|516512544|FG001|Overall Study|Withdraw before treatment|5|||
143261941|NCT03190369|516512543|FG000|Overall Study|Randomized but not treated|0|||
143261942|NCT03190369|516512544|FG001|Overall Study|Randomized but not treated|2|||
143261943|NCT01606254|516512545|FG000|Overall Study|Withdrawal by Subject|1|||
143198112|NCT00747344|516270823|FG000|After Controlled Period|Adverse Event|0|||
143198113|NCT00747344|516270824|FG001|After Controlled Period|Adverse Event|0|||
143198114|NCT00747344|516270825|FG002|After Controlled Period|Adverse Event|0|||
143198115|NCT00747344|516270826|FG003|After Controlled Period|Adverse Event|1|||
143198116|NCT02374814|516270827|FG000|Overall Study|Lost to Follow-up|1|||
143198117|NCT02374814|516270828|FG001|Overall Study|Lost to Follow-up|1|||
143198118|NCT02374814|516270829|FG002|Overall Study|Lost to Follow-up|0|||
143198119|NCT02374814|516270830|FG003|Overall Study|Lost to Follow-up|1|||
143198120|NCT02374814|516270831|FG004|Overall Study|Lost to Follow-up|0|||
143261944|NCT01606254|516512546|FG001|Overall Study|Withdrawal by Subject|3|||
143261945|NCT01606254|516512547|FG002|Overall Study|Withdrawal by Subject|0|||
143261946|NCT01606254|516512548|FG003|Overall Study|Withdrawal by Subject|2|||
143261947|NCT01606254|516512545|FG000|Overall Study|Adverse Event|1|||
143261948|NCT01606254|516512546|FG001|Overall Study|Adverse Event|1|||
143261949|NCT01606254|516512547|FG002|Overall Study|Adverse Event|0|||
143261950|NCT01606254|516512548|FG003|Overall Study|Adverse Event|1|||
143261951|NCT02011893|516512549|FG000|Enrollment to Randomization|Adverse Event|2|||
143261952|NCT02011893|516512550|FG001|Enrollment to Randomization|Adverse Event|0|||
143261953|NCT02011893|516512551|FG002|Enrollment to Randomization|Adverse Event|0|||
143261954|NCT02011893|516512549|FG000|Enrollment to Randomization|Physician Decision|10|||
143261955|NCT02011893|516512550|FG001|Enrollment to Randomization|Physician Decision|0|||
143261956|NCT02011893|516512551|FG002|Enrollment to Randomization|Physician Decision|0|||
143261957|NCT02011893|516512549|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
143261958|NCT02011893|516512550|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
143261959|NCT02011893|516512551|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
143261960|NCT02011893|516512549|FG000|Enrollment to Randomization|Screening Failure|29|||
143261961|NCT02011893|516512550|FG001|Enrollment to Randomization|Screening Failure|0|||
143261962|NCT02011893|516512551|FG002|Enrollment to Randomization|Screening Failure|0|||
143261963|NCT02011893|516512549|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
143261964|NCT02011893|516512550|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
143261965|NCT02011893|516512551|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
143261966|NCT02011893|516512549|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
143261967|NCT02011893|516512550|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
143261968|NCT02011893|516512551|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
143261969|NCT02011893|516512549|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
143261970|NCT02011893|516512550|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
143198121|NCT02374814|516270832|FG005|Overall Study|Lost to Follow-up|0|||
143198122|NCT02374814|516270827|FG000|Overall Study|Withdrawal by Subject|0|||
143198123|NCT02374814|516270828|FG001|Overall Study|Withdrawal by Subject|0|||
143198124|NCT02374814|516270829|FG002|Overall Study|Withdrawal by Subject|1|||
143198125|NCT02374814|516270830|FG003|Overall Study|Withdrawal by Subject|1|||
143198126|NCT02374814|516270831|FG004|Overall Study|Withdrawal by Subject|0|||
143198127|NCT02374814|516270832|FG005|Overall Study|Withdrawal by Subject|0|||
143198128|NCT00884039|516270833|FG000|Overall Study|Withdrawal by Subject|0|||
143198129|NCT00884039|516270834|FG001|Overall Study|Withdrawal by Subject|1|||
143198130|NCT00884039|516270833|FG000|Overall Study|Lack of Efficacy|2|||
143261971|NCT02011893|516512551|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
143198131|NCT00884039|516270834|FG001|Overall Study|Lack of Efficacy|0|||
143198132|NCT02182440|516270837|FG000|Overall Study|Adverse Event|0|||
143198133|NCT02182440|516270838|FG001|Overall Study|Adverse Event|1|||
143198134|NCT02182440|516270839|FG002|Overall Study|Adverse Event|0|||
143261972|NCT02011893|516512549|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
143261973|NCT02011893|516512550|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
143261974|NCT02011893|516512551|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
143261975|NCT02011893|516512549|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
143198135|NCT02182440|516270840|FG003|Overall Study|Adverse Event|0|||
143198136|NCT02182440|516270837|FG000|Overall Study|Death|31|||
143198137|NCT02182440|516270838|FG001|Overall Study|Death|8|||
143198138|NCT02182440|516270839|FG002|Overall Study|Death|5|||
143198139|NCT02182440|516270840|FG003|Overall Study|Death|16|||
143198140|NCT02182440|516270837|FG000|Overall Study|Protocol Violation|0|||
143261976|NCT02011893|516512550|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
143261977|NCT02011893|516512551|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
143198141|NCT02182440|516270838|FG001|Overall Study|Protocol Violation|1|||
143198142|NCT02182440|516270839|FG002|Overall Study|Protocol Violation|0|||
143198143|NCT02182440|516270840|FG003|Overall Study|Protocol Violation|0|||
143198144|NCT02182440|516270837|FG000|Overall Study|Physician Decision|1|||
143198145|NCT02182440|516270838|FG001|Overall Study|Physician Decision|0|||
143198146|NCT02182440|516270839|FG002|Overall Study|Physician Decision|0|||
143198147|NCT02182440|516270840|FG003|Overall Study|Physician Decision|0|||
143198148|NCT02182440|516270837|FG000|Overall Study|Withdrawal by Subject|1|||
143198149|NCT02182440|516270838|FG001|Overall Study|Withdrawal by Subject|1|||
143198150|NCT02182440|516270839|FG002|Overall Study|Withdrawal by Subject|3|||
143198151|NCT02182440|516270840|FG003|Overall Study|Withdrawal by Subject|4|||
143198152|NCT02182440|516270837|FG000|Overall Study|different, e.g adm other hospital|12|||
143198153|NCT02182440|516270838|FG001|Overall Study|different, e.g adm other hospital|3|||
143198154|NCT02182440|516270839|FG002|Overall Study|different, e.g adm other hospital|3|||
143198155|NCT02182440|516270840|FG003|Overall Study|different, e.g adm other hospital|10|||
143198156|NCT02653495|516270841|FG000|Overall Study|Lost to Follow-up|2|||
143198157|NCT02653495|516270842|FG001|Overall Study|Lost to Follow-up|0|||
143198158|NCT02653495|516270841|FG000|Overall Study|Screening Failure|10|||
143198159|NCT02653495|516270842|FG001|Overall Study|Screening Failure|0|||
143198160|NCT02754141|516273388|FG000|Overall Study|Disease progression|11|||
143198161|NCT02754141|516273389|FG001|Overall Study|Disease progression|7|||
143198162|NCT02754141|516273390|FG002|Overall Study|Disease progression|8|||
143198163|NCT02754141|516273391|FG003|Overall Study|Disease progression|5|||
143198164|NCT02754141|516273392|FG004|Overall Study|Disease progression|7|||
143198165|NCT02754141|516273393|FG005|Overall Study|Disease progression|7|||
143198166|NCT02754141|516273394|FG006|Overall Study|Disease progression|7|||
143198167|NCT02754141|516273395|FG007|Overall Study|Disease progression|6|||
143198168|NCT02754141|516273396|FG008|Overall Study|Disease progression|11|||
143198169|NCT02754141|516273397|FG009|Overall Study|Disease progression|16|||
143198170|NCT02754141|516273398|FG010|Overall Study|Disease progression|18|||
143198171|NCT02754141|516273399|FG011|Overall Study|Disease progression|13|||
143198172|NCT02754141|516273400|FG012|Overall Study|Disease progression|10|||
143198173|NCT02754141|516273401|FG013|Overall Study|Disease progression|12|||
143198174|NCT02754141|516273402|FG014|Overall Study|Disease progression|12|||
143198175|NCT02754141|516273403|FG015|Overall Study|Disease progression|14|||
143198176|NCT02754141|516273404|FG016|Overall Study|Disease progression|0|||
143198177|NCT02754141|516273405|FG017|Overall Study|Disease progression|1|||
143198178|NCT02754141|516273388|FG000|Overall Study|Study drug toxicity|1|||
143198179|NCT02754141|516273389|FG001|Overall Study|Study drug toxicity|1|||
143198180|NCT02754141|516273390|FG002|Overall Study|Study drug toxicity|0|||
143198181|NCT02754141|516273391|FG003|Overall Study|Study drug toxicity|0|||
143198182|NCT02754141|516273392|FG004|Overall Study|Study drug toxicity|0|||
143198183|NCT02754141|516273393|FG005|Overall Study|Study drug toxicity|0|||
143198184|NCT02754141|516273394|FG006|Overall Study|Study drug toxicity|0|||
143198185|NCT02754141|516273395|FG007|Overall Study|Study drug toxicity|0|||
143198186|NCT02754141|516273396|FG008|Overall Study|Study drug toxicity|0|||
143198187|NCT02754141|516273397|FG009|Overall Study|Study drug toxicity|0|||
143198188|NCT02754141|516273398|FG010|Overall Study|Study drug toxicity|2|||
143198189|NCT02754141|516273399|FG011|Overall Study|Study drug toxicity|1|||
143198190|NCT02754141|516273400|FG012|Overall Study|Study drug toxicity|1|||
143198191|NCT02754141|516273401|FG013|Overall Study|Study drug toxicity|0|||
143198192|NCT02754141|516273402|FG014|Overall Study|Study drug toxicity|0|||
143198193|NCT02754141|516273403|FG015|Overall Study|Study drug toxicity|0|||
143198194|NCT02754141|516273404|FG016|Overall Study|Study drug toxicity|0|||
143198195|NCT02754141|516273405|FG017|Overall Study|Study drug toxicity|0|||
143198196|NCT02754141|516273388|FG000|Overall Study|AE unrelated to study drug|1|||
143198197|NCT02754141|516273389|FG001|Overall Study|AE unrelated to study drug|1|||
143198198|NCT02754141|516273390|FG002|Overall Study|AE unrelated to study drug|0|||
143198199|NCT02754141|516273391|FG003|Overall Study|AE unrelated to study drug|1|||
143198200|NCT02754141|516273392|FG004|Overall Study|AE unrelated to study drug|3|||
143198201|NCT02754141|516273393|FG005|Overall Study|AE unrelated to study drug|2|||
143198202|NCT02754141|516273394|FG006|Overall Study|AE unrelated to study drug|1|||
143198203|NCT02754141|516273395|FG007|Overall Study|AE unrelated to study drug|0|||
143198204|NCT02754141|516273396|FG008|Overall Study|AE unrelated to study drug|0|||
143198205|NCT02754141|516273397|FG009|Overall Study|AE unrelated to study drug|0|||
143198206|NCT02754141|516273398|FG010|Overall Study|AE unrelated to study drug|0|||
143198207|NCT02754141|516273399|FG011|Overall Study|AE unrelated to study drug|0|||
143198208|NCT02754141|516273400|FG012|Overall Study|AE unrelated to study drug|0|||
143198209|NCT02754141|516273401|FG013|Overall Study|AE unrelated to study drug|0|||
143198210|NCT02754141|516273402|FG014|Overall Study|AE unrelated to study drug|0|||
143198211|NCT02754141|516273403|FG015|Overall Study|AE unrelated to study drug|0|||
143198212|NCT02754141|516273404|FG016|Overall Study|AE unrelated to study drug|0|||
143261978|NCT04543409|516512552|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
143198213|NCT02754141|516273405|FG017|Overall Study|AE unrelated to study drug|0|||
143198214|NCT02754141|516273388|FG000|Overall Study|Request to discontinue|0|||
143198215|NCT02754141|516273389|FG001|Overall Study|Request to discontinue|0|||
143198216|NCT02754141|516273390|FG002|Overall Study|Request to discontinue|0|||
143198217|NCT02754141|516273391|FG003|Overall Study|Request to discontinue|0|||
143198218|NCT02754141|516273392|FG004|Overall Study|Request to discontinue|0|||
143261979|NCT04543409|516512553|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
143198219|NCT02754141|516273393|FG005|Overall Study|Request to discontinue|0|||
143198220|NCT02754141|516273394|FG006|Overall Study|Request to discontinue|0|||
143198221|NCT02754141|516273395|FG007|Overall Study|Request to discontinue|0|||
143198222|NCT02754141|516273396|FG008|Overall Study|Request to discontinue|1|||
143198223|NCT02754141|516273397|FG009|Overall Study|Request to discontinue|0|||
143198224|NCT02754141|516273398|FG010|Overall Study|Request to discontinue|0|||
143198225|NCT02754141|516273399|FG011|Overall Study|Request to discontinue|0|||
143198226|NCT02754141|516273400|FG012|Overall Study|Request to discontinue|0|||
143198227|NCT02754141|516273401|FG013|Overall Study|Request to discontinue|1|||
143198228|NCT02754141|516273402|FG014|Overall Study|Request to discontinue|1|||
143198229|NCT02754141|516273403|FG015|Overall Study|Request to discontinue|0|||
143198230|NCT02754141|516273404|FG016|Overall Study|Request to discontinue|0|||
143198231|NCT02754141|516273405|FG017|Overall Study|Request to discontinue|0|||
143198232|NCT02754141|516273388|FG000|Overall Study|Withdrew consent|0|||
143198233|NCT02754141|516273389|FG001|Overall Study|Withdrew consent|0|||
143198234|NCT02754141|516273390|FG002|Overall Study|Withdrew consent|0|||
143198235|NCT02754141|516273391|FG003|Overall Study|Withdrew consent|0|||
143198236|NCT02754141|516273392|FG004|Overall Study|Withdrew consent|0|||
143198237|NCT02754141|516273393|FG005|Overall Study|Withdrew consent|0|||
143198238|NCT02754141|516273394|FG006|Overall Study|Withdrew consent|0|||
143198239|NCT02754141|516273395|FG007|Overall Study|Withdrew consent|0|||
143198240|NCT02754141|516273396|FG008|Overall Study|Withdrew consent|0|||
143198241|NCT02754141|516273397|FG009|Overall Study|Withdrew consent|1|||
143198242|NCT02754141|516273398|FG010|Overall Study|Withdrew consent|0|||
143198243|NCT02754141|516273399|FG011|Overall Study|Withdrew consent|0|||
143198244|NCT02754141|516273400|FG012|Overall Study|Withdrew consent|0|||
143198245|NCT02754141|516273401|FG013|Overall Study|Withdrew consent|0|||
143198246|NCT02754141|516273402|FG014|Overall Study|Withdrew consent|0|||
143198247|NCT02754141|516273403|FG015|Overall Study|Withdrew consent|0|||
143198248|NCT02754141|516273404|FG016|Overall Study|Withdrew consent|0|||
143198249|NCT02754141|516273405|FG017|Overall Study|Withdrew consent|0|||
143198250|NCT02754141|516273388|FG000|Overall Study|Maximum clinical benefit|0|||
143198251|NCT02754141|516273389|FG001|Overall Study|Maximum clinical benefit|0|||
143198252|NCT02754141|516273390|FG002|Overall Study|Maximum clinical benefit|0|||
143198253|NCT02754141|516273391|FG003|Overall Study|Maximum clinical benefit|1|||
143198254|NCT02754141|516273392|FG004|Overall Study|Maximum clinical benefit|0|||
143198255|NCT02754141|516273393|FG005|Overall Study|Maximum clinical benefit|0|||
143198256|NCT02754141|516273394|FG006|Overall Study|Maximum clinical benefit|0|||
143198257|NCT02754141|516273395|FG007|Overall Study|Maximum clinical benefit|0|||
143198258|NCT02754141|516273396|FG008|Overall Study|Maximum clinical benefit|0|||
143198259|NCT02754141|516273397|FG009|Overall Study|Maximum clinical benefit|0|||
143198260|NCT02754141|516273398|FG010|Overall Study|Maximum clinical benefit|0|||
143198261|NCT02754141|516273399|FG011|Overall Study|Maximum clinical benefit|0|||
143198262|NCT02754141|516273400|FG012|Overall Study|Maximum clinical benefit|0|||
143198263|NCT02754141|516273401|FG013|Overall Study|Maximum clinical benefit|0|||
143198264|NCT02754141|516273402|FG014|Overall Study|Maximum clinical benefit|0|||
143198265|NCT02754141|516273403|FG015|Overall Study|Maximum clinical benefit|0|||
143198266|NCT02754141|516273404|FG016|Overall Study|Maximum clinical benefit|0|||
143198267|NCT02754141|516273405|FG017|Overall Study|Maximum clinical benefit|0|||
143198268|NCT02754141|516273388|FG000|Overall Study|No longer meets study criteria|0|||
143198269|NCT02754141|516273389|FG001|Overall Study|No longer meets study criteria|0|||
143198270|NCT02754141|516273390|FG002|Overall Study|No longer meets study criteria|0|||
143198271|NCT02754141|516273391|FG003|Overall Study|No longer meets study criteria|1|||
143198272|NCT02754141|516273392|FG004|Overall Study|No longer meets study criteria|0|||
143198273|NCT02754141|516273393|FG005|Overall Study|No longer meets study criteria|0|||
143198274|NCT02754141|516273394|FG006|Overall Study|No longer meets study criteria|0|||
143198275|NCT02754141|516273395|FG007|Overall Study|No longer meets study criteria|0|||
143198276|NCT02754141|516273396|FG008|Overall Study|No longer meets study criteria|0|||
143198277|NCT02754141|516273397|FG009|Overall Study|No longer meets study criteria|0|||
143198278|NCT02754141|516273398|FG010|Overall Study|No longer meets study criteria|0|||
143198279|NCT02754141|516273399|FG011|Overall Study|No longer meets study criteria|0|||
143198280|NCT02754141|516273400|FG012|Overall Study|No longer meets study criteria|0|||
143198281|NCT02754141|516273401|FG013|Overall Study|No longer meets study criteria|0|||
143198282|NCT02754141|516273402|FG014|Overall Study|No longer meets study criteria|0|||
143198283|NCT02754141|516273403|FG015|Overall Study|No longer meets study criteria|0|||
143198284|NCT02754141|516273404|FG016|Overall Study|No longer meets study criteria|0|||
143198285|NCT02754141|516273405|FG017|Overall Study|No longer meets study criteria|0|||
143198286|NCT02754141|516273388|FG000|Overall Study|Other reasons|0|||
143198287|NCT02754141|516273389|FG001|Overall Study|Other reasons|0|||
143198288|NCT02754141|516273390|FG002|Overall Study|Other reasons|0|||
143261980|NCT04543409|516512552|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
143198289|NCT02754141|516273391|FG003|Overall Study|Other reasons|0|||
143198290|NCT02754141|516273392|FG004|Overall Study|Other reasons|0|||
143198291|NCT02754141|516273393|FG005|Overall Study|Other reasons|0|||
143198292|NCT02754141|516273394|FG006|Overall Study|Other reasons|0|||
143198293|NCT02754141|516273395|FG007|Overall Study|Other reasons|1|||
143198294|NCT02754141|516273396|FG008|Overall Study|Other reasons|0|||
143198295|NCT02754141|516273397|FG009|Overall Study|Other reasons|0|||
143198296|NCT02754141|516273398|FG010|Overall Study|Other reasons|0|||
143198297|NCT02754141|516273399|FG011|Overall Study|Other reasons|0|||
143198298|NCT02754141|516273400|FG012|Overall Study|Other reasons|2|||
143198299|NCT02754141|516273401|FG013|Overall Study|Other reasons|0|||
143198300|NCT02754141|516273402|FG014|Overall Study|Other reasons|0|||
143198301|NCT02754141|516273403|FG015|Overall Study|Other reasons|0|||
143198302|NCT02754141|516273404|FG016|Overall Study|Other reasons|0|||
143198303|NCT02754141|516273405|FG017|Overall Study|Other reasons|0|||
143198304|NCT02754141|516273388|FG000|Overall Study|Completed treatment as per protocol|0|||
143198305|NCT02754141|516273389|FG001|Overall Study|Completed treatment as per protocol|1|||
143198306|NCT02754141|516273390|FG002|Overall Study|Completed treatment as per protocol|0|||
143198307|NCT02754141|516273391|FG003|Overall Study|Completed treatment as per protocol|0|||
143198308|NCT02754141|516273392|FG004|Overall Study|Completed treatment as per protocol|0|||
143198309|NCT02754141|516273393|FG005|Overall Study|Completed treatment as per protocol|0|||
143198310|NCT02754141|516273394|FG006|Overall Study|Completed treatment as per protocol|0|||
143198311|NCT02754141|516273395|FG007|Overall Study|Completed treatment as per protocol|0|||
143198312|NCT02754141|516273396|FG008|Overall Study|Completed treatment as per protocol|0|||
143198313|NCT02754141|516273397|FG009|Overall Study|Completed treatment as per protocol|0|||
143198314|NCT02754141|516273398|FG010|Overall Study|Completed treatment as per protocol|0|||
143198315|NCT02754141|516273399|FG011|Overall Study|Completed treatment as per protocol|0|||
143198316|NCT02754141|516273400|FG012|Overall Study|Completed treatment as per protocol|1|||
143198317|NCT02754141|516273401|FG013|Overall Study|Completed treatment as per protocol|0|||
143198318|NCT02754141|516273402|FG014|Overall Study|Completed treatment as per protocol|0|||
143198319|NCT02754141|516273403|FG015|Overall Study|Completed treatment as per protocol|0|||
143198320|NCT02754141|516273404|FG016|Overall Study|Completed treatment as per protocol|0|||
143198321|NCT02754141|516273405|FG017|Overall Study|Completed treatment as per protocol|0|||
143198322|NCT02754141|516273388|FG000|Overall Study|Not completing monotherapy|0|||
143198323|NCT02754141|516273389|FG001|Overall Study|Not completing monotherapy|0|||
143198324|NCT02754141|516273390|FG002|Overall Study|Not completing monotherapy|0|||
143198325|NCT02754141|516273391|FG003|Overall Study|Not completing monotherapy|0|||
143198326|NCT02754141|516273392|FG004|Overall Study|Not completing monotherapy|0|||
143198327|NCT02754141|516273393|FG005|Overall Study|Not completing monotherapy|0|||
143198328|NCT02754141|516273394|FG006|Overall Study|Not completing monotherapy|0|||
143198329|NCT02754141|516273395|FG007|Overall Study|Not completing monotherapy|0|||
143198330|NCT02754141|516273396|FG008|Overall Study|Not completing monotherapy|0|||
143198331|NCT02754141|516273397|FG009|Overall Study|Not completing monotherapy|0|||
143198332|NCT02754141|516273398|FG010|Overall Study|Not completing monotherapy|0|||
143198333|NCT02754141|516273399|FG011|Overall Study|Not completing monotherapy|0|||
143198334|NCT02754141|516273400|FG012|Overall Study|Not completing monotherapy|0|||
143198335|NCT02754141|516273401|FG013|Overall Study|Not completing monotherapy|1|||
143198336|NCT02754141|516273402|FG014|Overall Study|Not completing monotherapy|0|||
143198337|NCT02754141|516273403|FG015|Overall Study|Not completing monotherapy|0|||
143198338|NCT02754141|516273404|FG016|Overall Study|Not completing monotherapy|0|||
143198339|NCT02754141|516273405|FG017|Overall Study|Not completing monotherapy|0|||
143198340|NCT01007123|516273410|FG000|Overall Study|Adverse Event|3|||
143198341|NCT01007123|516273411|FG001|Overall Study|Adverse Event|4|||
143198342|NCT01007123|516273412|FG002|Overall Study|Adverse Event|7|||
143198343|NCT01007123|516273413|FG003|Overall Study|Adverse Event|1|||
143198344|NCT01007123|516273410|FG000|Overall Study|Lack of Efficacy|1|||
143198345|NCT01007123|516273411|FG001|Overall Study|Lack of Efficacy|0|||
143198346|NCT01007123|516273412|FG002|Overall Study|Lack of Efficacy|1|||
143198347|NCT01007123|516273413|FG003|Overall Study|Lack of Efficacy|4|||
143198348|NCT01007123|516273410|FG000|Overall Study|Protocol Violation|1|||
143198349|NCT01007123|516273411|FG001|Overall Study|Protocol Violation|1|||
143198350|NCT01007123|516273412|FG002|Overall Study|Protocol Violation|2|||
143198351|NCT01007123|516273413|FG003|Overall Study|Protocol Violation|1|||
143198352|NCT01007123|516273410|FG000|Overall Study|Withdrawal by Subject|1|||
143198353|NCT01007123|516273411|FG001|Overall Study|Withdrawal by Subject|0|||
143198354|NCT01007123|516273412|FG002|Overall Study|Withdrawal by Subject|1|||
143198355|NCT01007123|516273413|FG003|Overall Study|Withdrawal by Subject|0|||
143198356|NCT01007123|516273410|FG000|Overall Study|Lost to Follow-up|0|||
143198357|NCT01007123|516273411|FG001|Overall Study|Lost to Follow-up|1|||
143198358|NCT01007123|516273412|FG002|Overall Study|Lost to Follow-up|0|||
143198359|NCT01007123|516273413|FG003|Overall Study|Lost to Follow-up|0|||
143198360|NCT02838901|516273414|FG000|Overall Study|Withdrawal by Subject|1|||
143198361|NCT02838901|516273415|FG001|Overall Study|Withdrawal by Subject|1|||
143198362|NCT02838901|516273414|FG000|Overall Study|Lost to Follow-up|1|||
143198363|NCT02838901|516273415|FG001|Overall Study|Lost to Follow-up|1|||
143198364|NCT00320255|516273416|FG000|Overall Study|Lack of Efficacy|1|||
143198365|NCT00320255|516273417|FG001|Overall Study|Lack of Efficacy|0|||
143198366|NCT00320255|516273418|FG002|Overall Study|Lack of Efficacy|0|||
143198367|NCT00320255|516273419|FG003|Overall Study|Lack of Efficacy|0|||
143198368|NCT00320255|516273420|FG004|Overall Study|Lack of Efficacy|0|||
143198369|NCT00320255|516273421|FG005|Overall Study|Lack of Efficacy|0|||
143198370|NCT00320255|516273416|FG000|Overall Study|Adverse Event|5|||
143198371|NCT00320255|516273417|FG001|Overall Study|Adverse Event|2|||
143198372|NCT00320255|516273418|FG002|Overall Study|Adverse Event|3|||
143198373|NCT00320255|516273419|FG003|Overall Study|Adverse Event|2|||
143198374|NCT00320255|516273420|FG004|Overall Study|Adverse Event|0|||
143198375|NCT00320255|516273421|FG005|Overall Study|Adverse Event|0|||
143198376|NCT00320255|516273416|FG000|Overall Study|Withdrawal by Subject|1|||
143198377|NCT00320255|516273417|FG001|Overall Study|Withdrawal by Subject|2|||
143198378|NCT00320255|516273418|FG002|Overall Study|Withdrawal by Subject|2|||
143198379|NCT00320255|516273419|FG003|Overall Study|Withdrawal by Subject|4|||
143198380|NCT00320255|516273420|FG004|Overall Study|Withdrawal by Subject|0|||
143198381|NCT00320255|516273421|FG005|Overall Study|Withdrawal by Subject|0|||
143198382|NCT00320255|516273416|FG000|Overall Study|Poor compliance/noncompliance|1|||
143198383|NCT00320255|516273417|FG001|Overall Study|Poor compliance/noncompliance|1|||
143198384|NCT00320255|516273418|FG002|Overall Study|Poor compliance/noncompliance|0|||
143198385|NCT00320255|516273419|FG003|Overall Study|Poor compliance/noncompliance|1|||
143198386|NCT00320255|516273420|FG004|Overall Study|Poor compliance/noncompliance|0|||
143198387|NCT00320255|516273421|FG005|Overall Study|Poor compliance/noncompliance|0|||
143198388|NCT00320255|516273416|FG000|Overall Study|No longer meets study criteria|0|||
143198389|NCT00320255|516273417|FG001|Overall Study|No longer meets study criteria|0|||
143198390|NCT00320255|516273418|FG002|Overall Study|No longer meets study criteria|0|||
143198391|NCT00320255|516273419|FG003|Overall Study|No longer meets study criteria|1|||
143198392|NCT00320255|516273420|FG004|Overall Study|No longer meets study criteria|0|||
143198393|NCT00320255|516273421|FG005|Overall Study|No longer meets study criteria|0|||
143198394|NCT00320255|516273416|FG000|Overall Study|Other|3|||
143198395|NCT00320255|516273417|FG001|Overall Study|Other|2|||
143198396|NCT00320255|516273418|FG002|Overall Study|Other|1|||
143198397|NCT00320255|516273419|FG003|Overall Study|Other|0|||
143198398|NCT00320255|516273420|FG004|Overall Study|Other|0|||
143198399|NCT00320255|516273421|FG005|Overall Study|Other|0|||
143198400|NCT03405935|516273423|FG000|Overall Study|Adverse Event|3|||
143198401|NCT03405935|516273423|FG000|Overall Study|Death|2|||
143198402|NCT03405935|516273423|FG000|Overall Study|Withdrawal by Subject|1|||
143198403|NCT03405935|516273423|FG000|Overall Study|Lost to Follow-up|2|||
143198404|NCT00623545|516273428|FG000|Overall Study|Adverse Event|6|||
143198405|NCT00623545|516273428|FG000|Overall Study|Withdrawal by Subject|4|||
143198406|NCT03500172|516273434|FG000|Period 1: Baseline Randomization|Death|0|||
143198407|NCT03500172|516273435|FG001|Period 1: Baseline Randomization|Death|0|||
143198408|NCT03500172|516273436|FG002|Period 1: Baseline Randomization|Death|0|||
143198409|NCT03500172|516273437|FG003|Period 1: Baseline Randomization|Death|0|||
143198410|NCT03500172|516273438|FG004|Period 1: Baseline Randomization|Death|0|||
143198411|NCT03500172|516273439|FG005|Period 1: Baseline Randomization|Death|0|||
143198412|NCT03500172|516273440|FG006|Period 1: Baseline Randomization|Death|0|||
143198413|NCT03500172|516273441|FG007|Period 1: Baseline Randomization|Death|0|||
143198414|NCT03500172|516273442|FG008|Period 1: Baseline Randomization|Death|0|||
143198415|NCT03500172|516273443|FG009|Period 1: Baseline Randomization|Death|2|||
143198416|NCT03500172|516273444|FG010|Period 1: Baseline Randomization|Death|0|||
143198417|NCT03500172|516273434|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
143198418|NCT03500172|516273435|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
143198419|NCT03500172|516273436|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
143198420|NCT03500172|516273437|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
143198421|NCT03500172|516273438|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
143198422|NCT03500172|516273439|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
143198423|NCT03500172|516273440|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
143198424|NCT03500172|516273441|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
143198425|NCT03500172|516273442|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
143198426|NCT03500172|516273443|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
143198427|NCT03500172|516273444|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
143198428|NCT03500172|516273434|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
143198429|NCT03500172|516273435|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
143198430|NCT03500172|516273436|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
143198431|NCT03500172|516273437|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
143198432|NCT03500172|516273438|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
143198433|NCT03500172|516273439|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
143198434|NCT03500172|516273440|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
143198435|NCT03500172|516273441|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
143198436|NCT03500172|516273442|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
143198437|NCT03500172|516273443|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
143198438|NCT03500172|516273444|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
143198439|NCT03500172|516273434|FG000|Period 2: Re-Randomization|Death|0|||
143198440|NCT03500172|516273435|FG001|Period 2: Re-Randomization|Death|0|||
143198441|NCT03500172|516273436|FG002|Period 2: Re-Randomization|Death|0|||
143198442|NCT03500172|516273437|FG003|Period 2: Re-Randomization|Death|4|||
143198443|NCT03500172|516273438|FG004|Period 2: Re-Randomization|Death|2|||
143198444|NCT03500172|516273439|FG005|Period 2: Re-Randomization|Death|0|||
143198445|NCT03500172|516273440|FG006|Period 2: Re-Randomization|Death|5|||
143198446|NCT03500172|516273441|FG007|Period 2: Re-Randomization|Death|2|||
143198447|NCT03500172|516273442|FG008|Period 2: Re-Randomization|Death|0|||
143198448|NCT03500172|516273443|FG009|Period 2: Re-Randomization|Death|0|||
143198449|NCT03500172|516273444|FG010|Period 2: Re-Randomization|Death|0|||
143198450|NCT01777542|516273448|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
143198451|NCT01777542|516273449|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
143198452|NCT02279719|516273450|FG000|Overall Study|Patients randomized but never treated|0|||
143198453|NCT02279719|516273451|FG001|Overall Study|Patients randomized but never treated|0|||
143198454|NCT02279719|516273452|FG002|Overall Study|Patients randomized but never treated|0|||
143198455|NCT02279719|516273453|FG003|Overall Study|Patients randomized but never treated|0|||
143198456|NCT02279719|516273454|FG004|Overall Study|Patients randomized but never treated|3|||
143198457|NCT02279719|516273455|FG005|Overall Study|Patients randomized but never treated|0|||
143198458|NCT02279719|516273456|FG006|Overall Study|Patients randomized but never treated|3|||
143198459|NCT04706273|516273457|FG000|Overall Study|Withdrawal by Subject|27|||
143198460|NCT04706273|516273457|FG000|Overall Study|Physician Decision|1|||
143198461|NCT04706273|516273457|FG000|Overall Study|Lost to Follow-up|42|||
143198462|NCT04706273|516273457|FG000|Overall Study|Death|85|||
143198463|NCT04706273|516273457|FG000|Overall Study|Amputation that removes study device|2|||
143198464|NCT04706273|516273457|FG000|Overall Study|Surgical bypass|3|||
143198465|NCT04706273|516273457|FG000|Overall Study|Changing hospital|23|||
143198466|NCT04706273|516273457|FG000|Overall Study|Unable to attend hospital|2|||
143198467|NCT03541187|516273458|FG000|Overall Study|Lost to Follow-up|2|||
143198468|NCT03541187|516273459|FG001|Overall Study|Lost to Follow-up|6|||
143198469|NCT03541187|516273458|FG000|Overall Study|Pregnancy|0|||
143198470|NCT03541187|516273459|FG001|Overall Study|Pregnancy|1|||
143198471|NCT03541187|516273458|FG000|Overall Study|Withdrawal by Subject|6|||
143198472|NCT03541187|516273459|FG001|Overall Study|Withdrawal by Subject|2|||
143198473|NCT03541187|516273458|FG000|Overall Study|Moved out of town|1|||
143198474|NCT03541187|516273459|FG001|Overall Study|Moved out of town|0|||
143198475|NCT03541187|516273458|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
143198476|NCT03541187|516273459|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
143198477|NCT03541187|516273458|FG000|Overall Study|Did not meet randomization criteria|1|||
143198478|NCT03541187|516273459|FG001|Overall Study|Did not meet randomization criteria|1|||
143198479|NCT03541187|516273458|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
143198480|NCT03541187|516273459|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
143198481|NCT03541187|516273458|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
143198482|NCT03541187|516273459|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
143198483|NCT00869050|516273460|FG000|Overall Study|Screen Failure|3|||
143198484|NCT00294645|516273465|FG000|Overall Study|Death|10|||
143198485|NCT00294645|516273466|FG001|Overall Study|Death|18|||
143198486|NCT00294645|516273465|FG000|Overall Study|Lost to Follow-up|1|||
143198487|NCT00294645|516273466|FG001|Overall Study|Lost to Follow-up|10|||
143198488|NCT00294645|516273465|FG000|Overall Study|Withdrawal by Subject|18|||
143198489|NCT00294645|516273466|FG001|Overall Study|Withdrawal by Subject|34|||
143198490|NCT00294645|516273465|FG000|Overall Study|Physician Decision|15|||
143198491|NCT00294645|516273466|FG001|Overall Study|Physician Decision|20|||
143198492|NCT00294645|516273465|FG000|Overall Study|Other|4|||
143198493|NCT00294645|516273466|FG001|Overall Study|Other|10|||
143198494|NCT02585830|516273467|FG000|Overall Study|Withdrawal by Subject|3|||
143198495|NCT02419131|516273479|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
143198496|NCT02419131|516273480|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
143198497|NCT02419131|516273481|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
143198498|NCT02419131|516273479|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
143198499|NCT02419131|516273480|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
143198500|NCT02419131|516273481|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
143198501|NCT03242772|516273482|FG000|Overall Study|Lost to Follow-up|2|||
143198502|NCT03242772|516273483|FG001|Overall Study|Lost to Follow-up|0|||
143198503|NCT03242772|516273482|FG000|Overall Study|Physician Decision|0|||
143198504|NCT03242772|516273483|FG001|Overall Study|Physician Decision|1|||
143198505|NCT03242772|516273482|FG000|Overall Study|Withdrawal by Subject|1|||
143198506|NCT03242772|516273483|FG001|Overall Study|Withdrawal by Subject|0|||
143198507|NCT04065074|516273486|FG000|Overall Study|Adverse Event|1|||
143198508|NCT04065074|516273486|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
143261981|NCT04543409|516512553|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
143261982|NCT04543409|516512552|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
143261983|NCT04543409|516512553|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
143261984|NCT04543409|516512552|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
143261985|NCT04543409|516512553|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
143198509|NCT02434354|516273487|FG000|Overall Study|screen fail|3|||
143198510|NCT04962230|516273493|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
143198511|NCT04962230|516273493|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
143198512|NCT02014480|516273498|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
143198513|NCT02014480|516273499|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
143198514|NCT02014480|516273500|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
143198515|NCT02014480|516273501|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
143198516|NCT02014480|516273502|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
143198517|NCT02014480|516273503|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
143198518|NCT02014480|516273498|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
143198519|NCT02014480|516273499|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
143198520|NCT02014480|516273500|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
143198521|NCT02014480|516273501|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
143198522|NCT02014480|516273502|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
143198523|NCT02014480|516273503|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
143198524|NCT02014480|516273498|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
143198525|NCT02014480|516273499|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
143198526|NCT02014480|516273500|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
143198527|NCT02014480|516273501|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
143198528|NCT02014480|516273502|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
143198529|NCT02014480|516273503|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
143198530|NCT02014480|516273498|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
143198531|NCT02014480|516273499|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
143198532|NCT02014480|516273500|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
143198533|NCT02014480|516273501|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
143198534|NCT02014480|516273502|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
143198535|NCT02014480|516273503|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
143198536|NCT02014480|516273498|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
143198537|NCT02014480|516273499|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
143198538|NCT02014480|516273500|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
143198539|NCT02014480|516273501|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
143198540|NCT02014480|516273502|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
143198541|NCT02014480|516273503|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
143198542|NCT02014480|516273498|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
143198543|NCT02014480|516273499|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
143198544|NCT02014480|516273500|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
143198545|NCT02014480|516273501|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
143198546|NCT02014480|516273502|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
143198547|NCT02014480|516273503|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
143198548|NCT02014480|516273498|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
143198549|NCT02014480|516273499|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
143198550|NCT02014480|516273500|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
143198551|NCT02014480|516273501|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
143198552|NCT02014480|516273502|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
143198553|NCT02014480|516273503|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
143198554|NCT01095653|516273504|FG000|Overall Study|Lack of Efficacy|3|||
143198555|NCT01095653|516273505|FG001|Overall Study|Lack of Efficacy|0|||
143198556|NCT01095653|516273506|FG002|Overall Study|Lack of Efficacy|0|||
143198557|NCT01095653|516273504|FG000|Overall Study|Adverse Event|1|||
143198558|NCT01095653|516273505|FG001|Overall Study|Adverse Event|4|||
143198559|NCT01095653|516273506|FG002|Overall Study|Adverse Event|4|||
143198560|NCT01095653|516273504|FG000|Overall Study|Lost to Follow-up|1|||
143198561|NCT01095653|516273505|FG001|Overall Study|Lost to Follow-up|0|||
143198562|NCT01095653|516273506|FG002|Overall Study|Lost to Follow-up|4|||
143198563|NCT01095653|516273504|FG000|Overall Study|Withdrawal by Subject|4|||
143198564|NCT01095653|516273505|FG001|Overall Study|Withdrawal by Subject|5|||
143198565|NCT01095653|516273506|FG002|Overall Study|Withdrawal by Subject|3|||
143198566|NCT01095653|516273504|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
143198567|NCT01095653|516273505|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
143198568|NCT01095653|516273506|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
143261986|NCT04543409|516512552|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
143198569|NCT02046226|516273507|FG000|Overall Study|Lost to Follow-up|7|||
143198570|NCT00171925|516273508|FG000|Overall Study|Adverse Event|10|||
143198571|NCT00171925|516273509|FG001|Overall Study|Adverse Event|6|||
143198572|NCT00171925|516273508|FG000|Overall Study|Protocol Violation|1|||
143198573|NCT00171925|516273509|FG001|Overall Study|Protocol Violation|1|||
143198574|NCT00171925|516273508|FG000|Overall Study|Withdrawal by Subject|6|||
143198575|NCT00171925|516273509|FG001|Overall Study|Withdrawal by Subject|9|||
143198576|NCT00171925|516273508|FG000|Overall Study|Lost to Follow-up|2|||
143198577|NCT00171925|516273509|FG001|Overall Study|Lost to Follow-up|2|||
143198578|NCT00171925|516273508|FG000|Overall Study|Administrative problems|10|||
143198579|NCT00171925|516273509|FG001|Overall Study|Administrative problems|11|||
143198580|NCT00171925|516273508|FG000|Overall Study|Death|1|||
143198581|NCT00171925|516273509|FG001|Overall Study|Death|2|||
143198582|NCT02692040|516273513|FG000|Overall Study|Protocol Violation|0|||
143198583|NCT02692040|516273514|FG001|Overall Study|Protocol Violation|0|||
143198584|NCT02692040|516273515|FG002|Overall Study|Protocol Violation|0|||
143198585|NCT02692040|516273516|FG003|Overall Study|Protocol Violation|0|||
143198586|NCT02692040|516273517|FG004|Overall Study|Protocol Violation|0|||
143198587|NCT02692040|516273518|FG005|Overall Study|Protocol Violation|0|||
143198588|NCT02692040|516273519|FG006|Overall Study|Protocol Violation|0|||
143198589|NCT02692040|516273520|FG007|Overall Study|Protocol Violation|0|||
143198590|NCT02692040|516273521|FG008|Overall Study|Protocol Violation|0|||
143198591|NCT02692040|516273522|FG009|Overall Study|Protocol Violation|0|||
143198592|NCT02692040|516273523|FG010|Overall Study|Protocol Violation|0|||
143198593|NCT02692040|516273524|FG011|Overall Study|Protocol Violation|0|||
143198594|NCT02692040|516273525|FG012|Overall Study|Protocol Violation|1|||
143198595|NCT02692040|516273526|FG013|Overall Study|Protocol Violation|0|||
143198596|NCT02692040|516273527|FG014|Overall Study|Protocol Violation|0|||
143198597|NCT02692040|516273528|FG015|Overall Study|Protocol Violation|0|||
143198598|NCT02692040|516273529|FG016|Overall Study|Protocol Violation|0|||
143198599|NCT02692040|516273513|FG000|Overall Study|Adverse Event|0|||
143198600|NCT02692040|516273514|FG001|Overall Study|Adverse Event|0|||
143198601|NCT02692040|516273515|FG002|Overall Study|Adverse Event|0|||
143198602|NCT02692040|516273516|FG003|Overall Study|Adverse Event|0|||
143198603|NCT02692040|516273517|FG004|Overall Study|Adverse Event|0|||
143198604|NCT02692040|516273518|FG005|Overall Study|Adverse Event|0|||
143198605|NCT02692040|516273519|FG006|Overall Study|Adverse Event|0|||
143198606|NCT02692040|516273520|FG007|Overall Study|Adverse Event|0|||
143198607|NCT02692040|516273521|FG008|Overall Study|Adverse Event|0|||
143198608|NCT02692040|516273522|FG009|Overall Study|Adverse Event|0|||
143198609|NCT02692040|516273523|FG010|Overall Study|Adverse Event|0|||
143198610|NCT02692040|516273524|FG011|Overall Study|Adverse Event|0|||
143198611|NCT02692040|516273525|FG012|Overall Study|Adverse Event|0|||
143198612|NCT02692040|516273526|FG013|Overall Study|Adverse Event|3|||
143198613|NCT02692040|516273527|FG014|Overall Study|Adverse Event|1|||
143198614|NCT02692040|516273528|FG015|Overall Study|Adverse Event|1|||
143198615|NCT02692040|516273529|FG016|Overall Study|Adverse Event|0|||
143198616|NCT01819129|516273530|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
143198617|NCT01819129|516273531|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
143198618|NCT01819129|516273530|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
143198619|NCT01819129|516273531|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
143198620|NCT01819129|516273530|FG000|Overall Study|Other, Subject moved out of the country|0|||
143198621|NCT01819129|516273531|FG001|Overall Study|Other, Subject moved out of the country|1|||
143198622|NCT01819129|516273530|FG000|Overall Study|Withdrawal by Subject|15|||
143198623|NCT01819129|516273531|FG001|Overall Study|Withdrawal by Subject|15|||
143198624|NCT01819129|516273530|FG000|Overall Study|Lost to Follow-up|5|||
143198625|NCT01819129|516273531|FG001|Overall Study|Lost to Follow-up|2|||
143198626|NCT01819129|516273530|FG000|Overall Study|Lack of Efficacy|0|||
143198627|NCT01819129|516273531|FG001|Overall Study|Lack of Efficacy|1|||
143198628|NCT01819129|516273530|FG000|Overall Study|Adverse Event|1|||
143198629|NCT01819129|516273531|FG001|Overall Study|Adverse Event|4|||
143198630|NCT01819129|516273530|FG000|Overall Study|Death|1|||
143198631|NCT01819129|516273531|FG001|Overall Study|Death|1|||
143198632|NCT01819129|516273530|FG000|Overall Study|Withdrawal Criteria|20|||
143198633|NCT01819129|516273531|FG001|Overall Study|Withdrawal Criteria|15|||
143198634|NCT02836873|516273533|FG000|Overall Study|Protocol Violation|0|||
143198635|NCT02836873|516273534|FG001|Overall Study|Protocol Violation|1|||
143198636|NCT02836873|516273533|FG000|Overall Study|Adverse Event|1|||
143198637|NCT02836873|516273534|FG001|Overall Study|Adverse Event|4|||
143198638|NCT02836873|516273533|FG000|Overall Study|Withdrawal by Subject|2|||
143198639|NCT02836873|516273534|FG001|Overall Study|Withdrawal by Subject|2|||
143198640|NCT02836873|516273533|FG000|Overall Study|Lost to Follow-up|1|||
143198641|NCT02836873|516273534|FG001|Overall Study|Lost to Follow-up|3|||
143198642|NCT02836873|516273533|FG000|Overall Study|Physician Decision|0|||
143198643|NCT02836873|516273534|FG001|Overall Study|Physician Decision|1|||
143198644|NCT02836873|516273533|FG000|Overall Study|Other|1|||
143198645|NCT02836873|516273534|FG001|Overall Study|Other|0|||
143198646|NCT00977938|516273540|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
143198647|NCT00977938|516273541|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
143198648|NCT00977938|516273542|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
143198649|NCT00977938|516273543|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
143198650|NCT00977938|516273540|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
143198651|NCT00977938|516273541|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
143198652|NCT00977938|516273542|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
143198653|NCT00977938|516273543|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
143198654|NCT00977938|516273540|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
143198655|NCT00977938|516273541|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
143198656|NCT00977938|516273542|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
143198657|NCT00977938|516273543|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
143198658|NCT00977938|516273540|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
143198659|NCT00977938|516273541|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
143198660|NCT00977938|516273542|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
143198661|NCT00977938|516273543|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
143198662|NCT00977938|516273540|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
143198663|NCT00977938|516273541|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
143198664|NCT00977938|516273542|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
143198665|NCT00977938|516273543|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
143198666|NCT00977938|516273540|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
143198667|NCT00977938|516273541|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
143198668|NCT00977938|516273542|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
143198669|NCT00977938|516273543|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
143198670|NCT02214225|516273549|FG000|Overall Study|Lost to Follow-up|46|||
143198671|NCT02214225|516273550|FG001|Overall Study|Lost to Follow-up|18|||
143198672|NCT02214225|516273551|FG002|Overall Study|Lost to Follow-up|18|||
143198673|NCT02214225|516273549|FG000|Overall Study|Withdrawal by Subject|2|||
143198674|NCT02214225|516273550|FG001|Overall Study|Withdrawal by Subject|0|||
143198675|NCT02214225|516273551|FG002|Overall Study|Withdrawal by Subject|2|||
143198676|NCT02214225|516273549|FG000|Overall Study|Death|5|||
143198677|NCT02214225|516273550|FG001|Overall Study|Death|0|||
143198678|NCT02214225|516273551|FG002|Overall Study|Death|1|||
143198679|NCT02214225|516273549|FG000|Overall Study|randomized in error, not vaccinated|2|||
143198680|NCT02214225|516273550|FG001|Overall Study|randomized in error, not vaccinated|1|||
143198681|NCT02214225|516273551|FG002|Overall Study|randomized in error, not vaccinated|1|||
143198682|NCT03754582|516273552|FG000|Treatment Phase|Adverse Event|0|||
143198683|NCT03754582|516273553|FG001|Treatment Phase|Adverse Event|1|||
143198684|NCT03754582|516273554|FG002|Treatment Phase|Adverse Event|0|||
143198685|NCT03754582|516273552|FG000|Follow-up Phase|Other|0|||
143198686|NCT03754582|516273553|FG001|Follow-up Phase|Other|0|||
143198687|NCT03754582|516273554|FG002|Follow-up Phase|Other|1|||
143198688|NCT01561755|516273557|FG000|Overall Study|Lost to Follow-up|0|||
143198689|NCT01561755|516273558|FG001|Overall Study|Lost to Follow-up|1|||
143198690|NCT01166958|516273559|FG000|Overall Study|Withdrawal by Subject|1|||
143198691|NCT01166958|516273560|FG001|Overall Study|Withdrawal by Subject|0|||
143198692|NCT02680574|516273561|FG000|Overall Study|Death|137|||
143198693|NCT02680574|516273562|FG001|Overall Study|Death|137|||
143198694|NCT02680574|516273561|FG000|Overall Study|Withdrawal by Subject|17|||
143198695|NCT02680574|516273562|FG001|Overall Study|Withdrawal by Subject|9|||
143198696|NCT02680574|516273561|FG000|Overall Study|Lost to Follow-up|4|||
143198697|NCT02680574|516273562|FG001|Overall Study|Lost to Follow-up|6|||
143198698|NCT00624819|516273564|FG000|Follow-up Period: Year 4|Parents decision|0|||
143198699|NCT00624819|516273565|FG001|Follow-up Period: Year 4|Parents decision|0|||
143198700|NCT00624819|516273566|FG002|Follow-up Period: Year 4|Parents decision|1|||
143198701|NCT00624819|516273567|FG003|Follow-up Period: Year 4|Parents decision|0|||
143198702|NCT00624819|516273564|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
143198703|NCT00624819|516273565|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
143198704|NCT00624819|516273566|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
143198705|NCT00624819|516273567|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
143198706|NCT02847858|516273568|FG000|Overall Study|Lost to Follow-up|401|||
143198707|NCT02847858|516273569|FG001|Overall Study|Lost to Follow-up|269|||
143198708|NCT00681564|516273574|FG000|Overall Study|Lost to Follow-up|6|||
143198709|NCT00681564|516273575|FG001|Overall Study|Lost to Follow-up|6|||
143198710|NCT00681564|516273574|FG000|Overall Study|Withdrawal by Subject|0|||
143198711|NCT00681564|516273575|FG001|Overall Study|Withdrawal by Subject|1|||
143198712|NCT00681564|516273574|FG000|Overall Study|Death|0|||
143198713|NCT00681564|516273575|FG001|Overall Study|Death|1|||
143198714|NCT02826421|516273576|FG000|Overall Study|Adverse Event|1|||
143198715|NCT02826421|516273577|FG001|Overall Study|Adverse Event|0|||
143198716|NCT02826421|516273578|FG002|Overall Study|Adverse Event|0|||
143198717|NCT02826421|516273579|FG003|Overall Study|Adverse Event|1|||
143198718|NCT02826421|516273576|FG000|Overall Study|Withdrawal by Subject|1|||
143198719|NCT02826421|516273577|FG001|Overall Study|Withdrawal by Subject|3|||
143198720|NCT02826421|516273578|FG002|Overall Study|Withdrawal by Subject|1|||
143198721|NCT02826421|516273579|FG003|Overall Study|Withdrawal by Subject|1|||
143198722|NCT02826421|516273576|FG000|Overall Study|Reason not given|1|||
143198723|NCT02826421|516273577|FG001|Overall Study|Reason not given|0|||
143198724|NCT02826421|516273578|FG002|Overall Study|Reason not given|1|||
143198725|NCT02826421|516273579|FG003|Overall Study|Reason not given|0|||
143198726|NCT02210221|516273584|FG000|Overall Study|Lack of Efficacy|7|||
143198727|NCT02210221|516273584|FG000|Overall Study|Withdrawal by Subject|43|||
143261987|NCT04543409|516512553|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
143261988|NCT04543409|516512552|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
143261989|NCT04543409|516512553|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
143261990|NCT04543409|516512552|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
143261991|NCT04543409|516512553|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
143261992|NCT04543409|516512552|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
143261993|NCT04543409|516512553|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
143261994|NCT04543409|516512552|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
143261995|NCT04543409|516512553|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
143261996|NCT04543409|516512552|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
143261997|NCT04543409|516512553|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
143261998|NCT04543409|516512552|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
143261999|NCT04543409|516512553|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
143262000|NCT01289782|516512554|FG000|Overall Study|Lost to Follow-up|14|||
143262001|NCT01289782|516512555|FG001|Overall Study|Lost to Follow-up|7|||
143262002|NCT01289782|516512554|FG000|Overall Study|Protocol Violation|1|||
143262003|NCT01289782|516512555|FG001|Overall Study|Protocol Violation|1|||
143262004|NCT01289782|516512554|FG000|Overall Study|Withdrawal by Subject|8|||
143262005|NCT01289782|516512555|FG001|Overall Study|Withdrawal by Subject|2|||
143262006|NCT01289782|516512554|FG000|Overall Study|Sponsor's Decision|1|||
143262007|NCT01289782|516512555|FG001|Overall Study|Sponsor's Decision|0|||
143262008|NCT01289782|516512554|FG000|Overall Study|Reason not specified|1|||
143262009|NCT01289782|516512555|FG001|Overall Study|Reason not specified|2|||
143262010|NCT02131532|516512556|FG000|Overall Study|Withdrawal by Subject|1|||
143262011|NCT02131532|516512556|FG000|Overall Study|Physician Decision|1|||
143262012|NCT02131532|516512556|FG000|Overall Study|Other health conditions|2|||
143262013|NCT02093026|516512557|FG000|Overall Study|Adverse Event|26|||
143262014|NCT02093026|516512557|FG000|Overall Study|Death|10|||
143262015|NCT02093026|516512557|FG000|Overall Study|Other|157|||
143262016|NCT02195011|516512576|FG000|Overall Study|Adverse Event|4|||
143262017|NCT02195011|516512577|FG001|Overall Study|Adverse Event|0|||
143262018|NCT02195011|516512576|FG000|Overall Study|Progressive Disease|18|||
143262019|NCT02195011|516512577|FG001|Overall Study|Progressive Disease|1|||
143262020|NCT02195011|516512576|FG000|Overall Study|Withdrawal by Subject|3|||
143262021|NCT02195011|516512577|FG001|Overall Study|Withdrawal by Subject|0|||
143262022|NCT00174291|516512580|FG000|Overall Study|Lost to Follow-up|1|||
143262023|NCT00174291|516512581|FG001|Overall Study|Lost to Follow-up|1|||
143262024|NCT00174291|516512580|FG000|Overall Study|Protocol Violation|0|||
143262025|NCT00174291|516512581|FG001|Overall Study|Protocol Violation|2|||
143262026|NCT00174291|516512580|FG000|Overall Study|Study terminated by sponsor|1|||
143262027|NCT00174291|516512581|FG001|Overall Study|Study terminated by sponsor|0|||
143262028|NCT00174291|516512580|FG000|Overall Study|Withdrawal by Subject|3|||
143262029|NCT00174291|516512581|FG001|Overall Study|Withdrawal by Subject|3|||
143262030|NCT00450112|516512582|FG000|Overall Study|Other Treatment Required|5|||
143262031|NCT00450112|516512583|FG001|Overall Study|Other Treatment Required|1|||
143262032|NCT00450112|516512582|FG000|Overall Study|Withdrawal by Subject|4|||
143262033|NCT00450112|516512583|FG001|Overall Study|Withdrawal by Subject|1|||
143262034|NCT00450112|516512582|FG000|Overall Study|Lost to Follow-up|2|||
143262035|NCT00450112|516512583|FG001|Overall Study|Lost to Follow-up|1|||
143262036|NCT00450112|516512582|FG000|Overall Study|Others|2|||
143262037|NCT00450112|516512583|FG001|Overall Study|Others|3|||
143262038|NCT00555425|516512584|FG000|Overall Study|Missed Medication > 1 wk|34|||
143262039|NCT00555425|516512585|FG001|Overall Study|Missed Medication > 1 wk|15|||
143262040|NCT00555425|516512584|FG000|Overall Study|Missed 3 physician management visits|1|||
143262041|NCT00555425|516512585|FG001|Overall Study|Missed 3 physician management visits|0|||
143262042|NCT00555425|516512584|FG000|Overall Study|Met criteria for protective transfer|16|||
143262043|NCT00555425|516512585|FG001|Overall Study|Met criteria for protective transfer|3|||
143262044|NCT00555425|516512584|FG000|Overall Study|Became pregnant and transferred care|0|||
143262045|NCT00555425|516512585|FG001|Overall Study|Became pregnant and transferred care|1|||
143262046|NCT00424255|516512587|FG000|Overall Study|Death|115|||
143262047|NCT00424255|516512588|FG001|Overall Study|Death|111|||
143262048|NCT00424255|516512587|FG000|Overall Study|Lost to Follow-up|26|||
143262049|NCT00424255|516512588|FG001|Overall Study|Lost to Follow-up|20|||
143262050|NCT00424255|516512587|FG000|Overall Study|Protocol Violation|0|||
143262051|NCT00424255|516512588|FG001|Overall Study|Protocol Violation|1|||
143262052|NCT00424255|516512587|FG000|Overall Study|Withdrawal by Subject|34|||
143198728|NCT02141490|516273587|FG000|Overall Study|Screening failures|4|||
143262053|NCT00424255|516512588|FG001|Overall Study|Withdrawal by Subject|38|||
143262054|NCT00424255|516512587|FG000|Overall Study|Physician Decision|3|||
143262055|NCT00424255|516512588|FG001|Overall Study|Physician Decision|7|||
143262056|NCT00424255|516512587|FG000|Overall Study|Cognitive Disturbance|1|||
143262057|NCT00424255|516512588|FG001|Overall Study|Cognitive Disturbance|0|||
143262058|NCT00424255|516512587|FG000|Overall Study|Non-compliance by Participants|1|||
143198729|NCT02141490|516273588|FG001|Overall Study|Screening failures|0|||
143198730|NCT02141490|516273589|FG002|Overall Study|Screening failures|0|||
143198731|NCT01253265|516273592|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
143198732|NCT01253265|516273593|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
143198733|NCT01253265|516273594|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
143198734|NCT01253265|516273595|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
143198735|NCT01253265|516273596|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
143198736|NCT01253265|516273592|FG000|Overall Study|Withdrawal by Subject|0|||
143198737|NCT01253265|516273593|FG001|Overall Study|Withdrawal by Subject|0|||
143198738|NCT01253265|516273594|FG002|Overall Study|Withdrawal by Subject|0|||
143198739|NCT01253265|516273595|FG003|Overall Study|Withdrawal by Subject|0|||
143198740|NCT01253265|516273596|FG004|Overall Study|Withdrawal by Subject|1|||
143198741|NCT03271047|516273598|FG000|Phase 1b: Dose Finding Period|Death|8|||
143198742|NCT03271047|516273599|FG001|Phase 1b: Dose Finding Period|Death|8|||
143198743|NCT03271047|516273600|FG002|Phase 1b: Dose Finding Period|Death|0|||
143198744|NCT03271047|516273601|FG003|Phase 1b: Dose Finding Period|Death|0|||
143198745|NCT03271047|516273598|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
143198746|NCT03271047|516273599|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
143198747|NCT03271047|516273600|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
143198748|NCT03271047|516273601|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
143198749|NCT03271047|516273598|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
143198750|NCT03271047|516273599|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
143198751|NCT03271047|516273600|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
143198752|NCT03271047|516273601|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
143198753|NCT03271047|516273598|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
143198754|NCT03271047|516273599|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
143198755|NCT03271047|516273600|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
143198756|NCT03271047|516273601|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
143198757|NCT03271047|516273598|FG000|Randomized Phase 2 Period|Other|0|||
143198758|NCT03271047|516273599|FG001|Randomized Phase 2 Period|Other|0|||
143198759|NCT03271047|516273600|FG002|Randomized Phase 2 Period|Other|0|||
143198760|NCT03271047|516273601|FG003|Randomized Phase 2 Period|Other|1|||
143198761|NCT03271047|516273598|FG000|Randomized Phase 2 Period|Death|0|||
143198762|NCT03271047|516273599|FG001|Randomized Phase 2 Period|Death|0|||
143198763|NCT03271047|516273600|FG002|Randomized Phase 2 Period|Death|20|||
143198764|NCT03271047|516273601|FG003|Randomized Phase 2 Period|Death|21|||
143198765|NCT03271047|516273598|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
143198766|NCT03271047|516273599|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
143198767|NCT03271047|516273600|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
143198768|NCT03271047|516273601|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
143198769|NCT03271047|516273598|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
143198770|NCT03271047|516273599|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
143198771|NCT03271047|516273600|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
143198772|NCT03271047|516273601|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
143198773|NCT03271047|516273598|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
143198774|NCT03271047|516273599|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
143198775|NCT03271047|516273600|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
143198776|NCT03271047|516273601|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
143198777|NCT00434759|516273602|FG000|Overall Study|Lack of Efficacy|5|||
143198778|NCT00434759|516273603|FG001|Overall Study|Lack of Efficacy|4|||
143198779|NCT00434759|516273602|FG000|Overall Study|Withdrawal by Subject|17|||
143198780|NCT00434759|516273603|FG001|Overall Study|Withdrawal by Subject|1|||
143198781|NCT00434759|516273602|FG000|Overall Study|family affairs|2|||
143198782|NCT00434759|516273603|FG001|Overall Study|family affairs|0|||
143198783|NCT00495521|516273604|FG000|Overall Study|Physician Decision|0|||
143198784|NCT00495521|516273605|FG001|Overall Study|Physician Decision|1|||
143198785|NCT00392808|516273606|FG000|Overall Study|Lost to Follow-up|3|||
143198786|NCT00392808|516273607|FG001|Overall Study|Lost to Follow-up|2|||
143198787|NCT00392808|516273608|FG002|Overall Study|Lost to Follow-up|1|||
143198788|NCT00392808|516273609|FG003|Overall Study|Lost to Follow-up|2|||
143198789|NCT00392808|516273606|FG000|Overall Study|Unable to withdraw blood|3|||
143198790|NCT00392808|516273607|FG001|Overall Study|Unable to withdraw blood|1|||
143198791|NCT00392808|516273608|FG002|Overall Study|Unable to withdraw blood|1|||
143198792|NCT00392808|516273609|FG003|Overall Study|Unable to withdraw blood|2|||
143198793|NCT01300819|516273610|FG000|Overall Study|Adverse Event|9|||
143262059|NCT00424255|516512588|FG001|Overall Study|Non-compliance by Participants|0|||
143262060|NCT00424255|516512587|FG000|Overall Study|Fatigue|1|||
143262061|NCT00424255|516512588|FG001|Overall Study|Fatigue|0|||
143262062|NCT00424255|516512587|FG000|Overall Study|Disease Progression|0|||
143198794|NCT01300819|516273611|FG001|Overall Study|Adverse Event|27|||
143198795|NCT01300819|516273610|FG000|Overall Study|Lack of Efficacy|2|||
143198796|NCT01300819|516273611|FG001|Overall Study|Lack of Efficacy|1|||
143198797|NCT01300819|516273610|FG000|Overall Study|Withdrawal by Subject|10|||
143198798|NCT01300819|516273611|FG001|Overall Study|Withdrawal by Subject|12|||
143198799|NCT01300819|516273610|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
143198800|NCT01300819|516273611|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
143198801|NCT01300819|516273610|FG000|Overall Study|Refusal to down titrate study drug|0|||
143198802|NCT01300819|516273611|FG001|Overall Study|Refusal to down titrate study drug|1|||
143198803|NCT01300819|516273610|FG000|Overall Study|Administrative reason|0|||
143198804|NCT01300819|516273611|FG001|Overall Study|Administrative reason|1|||
143198805|NCT01300819|516273610|FG000|Overall Study|Safety follow up not done by mistake|0|||
143198806|NCT01300819|516273611|FG001|Overall Study|Safety follow up not done by mistake|1|||
143198807|NCT01300819|516273610|FG000|Overall Study|Follow up call was not done|1|||
143262063|NCT00424255|516512588|FG001|Overall Study|Disease Progression|2|||
143198808|NCT01300819|516273611|FG001|Overall Study|Follow up call was not done|0|||
143198809|NCT02649855|516273612|FG000|Overall Study|Refused further treatment|2|||
143198810|NCT02649855|516273613|FG001|Overall Study|Refused further treatment|1|||
143198811|NCT02649855|516273614|FG002|Overall Study|Refused further treatment|1|||
143198812|NCT02649855|516273612|FG000|Overall Study|Withdrew consent|0|||
143198813|NCT02649855|516273613|FG001|Overall Study|Withdrew consent|1|||
143198814|NCT02649855|516273614|FG002|Overall Study|Withdrew consent|0|||
143198815|NCT02649855|516273612|FG000|Overall Study|Switched to alternative treatment|0|||
143198816|NCT02649855|516273613|FG001|Overall Study|Switched to alternative treatment|1|||
143198817|NCT02649855|516273614|FG002|Overall Study|Switched to alternative treatment|1|||
143198818|NCT02649855|516273612|FG000|Overall Study|Principal investigator discretion|0|||
143198819|NCT02649855|516273613|FG001|Overall Study|Principal investigator discretion|1|||
143198820|NCT02649855|516273614|FG002|Overall Study|Principal investigator discretion|1|||
143198821|NCT02649855|516273612|FG000|Overall Study|No treatment, per protocol|1|||
143198822|NCT02649855|516273613|FG001|Overall Study|No treatment, per protocol|0|||
143198823|NCT02649855|516273614|FG002|Overall Study|No treatment, per protocol|0|||
143198824|NCT02649855|516273612|FG000|Overall Study|Initiate new treatment|1|||
143198825|NCT02649855|516273613|FG001|Overall Study|Initiate new treatment|0|||
143198826|NCT02649855|516273614|FG002|Overall Study|Initiate new treatment|0|||
143198827|NCT02818036|516273618|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
143198828|NCT02818036|516273619|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
143198829|NCT02818036|516273618|FG000|Overall Study|Withdrawal by Subject|1|||
143198830|NCT02818036|516273619|FG001|Overall Study|Withdrawal by Subject|0|||
143198831|NCT01038713|516273622|FG000|Overall Study|Patient to hospice|1|||
143198832|NCT01038713|516273623|FG001|Overall Study|Patient to hospice|1|||
143198833|NCT01038713|516273624|FG002|Overall Study|Patient to hospice|1|||
143198834|NCT01038713|516273622|FG000|Overall Study|Lost to Follow-up|3|||
143198835|NCT01038713|516273623|FG001|Overall Study|Lost to Follow-up|0|||
143198836|NCT01038713|516273624|FG002|Overall Study|Lost to Follow-up|0|||
143198837|NCT01038713|516273622|FG000|Overall Study|Neuroendocrine Tumor|0|||
143198838|NCT01038713|516273623|FG001|Overall Study|Neuroendocrine Tumor|1|||
143198839|NCT01038713|516273624|FG002|Overall Study|Neuroendocrine Tumor|0|||
143198840|NCT01038713|516273622|FG000|Overall Study|died from PEP|0|||
143198841|NCT01038713|516273623|FG001|Overall Study|died from PEP|1|||
143198842|NCT01038713|516273624|FG002|Overall Study|died from PEP|0|||
143198843|NCT01038713|516273622|FG000|Overall Study|Autoimmune Pancreatitis|1|||
143198844|NCT01038713|516273623|FG001|Overall Study|Autoimmune Pancreatitis|0|||
143198845|NCT01038713|516273624|FG002|Overall Study|Autoimmune Pancreatitis|0|||
143198846|NCT03777917|516273625|FG000|Overall Study|Withdrawal by Subject|1|||
143198847|NCT03777917|516273626|FG001|Overall Study|Withdrawal by Subject|0|||
143198848|NCT03777917|516273625|FG000|Overall Study|Physician Decision|1|||
143198849|NCT03777917|516273626|FG001|Overall Study|Physician Decision|0|||
143198850|NCT03777917|516273625|FG000|Overall Study|Lost to Follow-up|6|||
143198851|NCT03777917|516273626|FG001|Overall Study|Lost to Follow-up|2|||
143198852|NCT03777917|516273625|FG000|Overall Study|Other|1|||
143198853|NCT03777917|516273626|FG001|Overall Study|Other|0|||
143198854|NCT00042432|516273627|FG000|Overall Study|Adverse Event|4|||
143198855|NCT00042432|516273628|FG001|Overall Study|Adverse Event|1|||
143198856|NCT00042432|516273627|FG000|Overall Study|Withdrawal by Subject|1|||
143198857|NCT00042432|516273628|FG001|Overall Study|Withdrawal by Subject|3|||
143198858|NCT00042432|516273627|FG000|Overall Study|Death|0|||
143262064|NCT00424255|516512587|FG000|Overall Study|Sponsor Terminated Study|161|||
143198859|NCT00042432|516273628|FG001|Overall Study|Death|2|||
143198860|NCT00042432|516273627|FG000|Overall Study|Ineligibility determined|1|||
143198861|NCT00042432|516273628|FG001|Overall Study|Ineligibility determined|0|||
143198862|NCT00042432|516273627|FG000|Overall Study|Initiation of maintenance dialysis|1|||
143198863|NCT00042432|516273628|FG001|Overall Study|Initiation of maintenance dialysis|1|||
143198864|NCT00042432|516273627|FG000|Overall Study|Other|2|||
143198865|NCT00042432|516273628|FG001|Overall Study|Other|0|||
143198866|NCT02966795|516273629|FG000|Overall Study|Patient Left the Country|0|||
143198867|NCT02966795|516273630|FG001|Overall Study|Patient Left the Country|1|||
143198868|NCT00432744|516273631|FG000|Months 0-6|Withdrawal by Subject|4|||
143198869|NCT00432744|516273632|FG001|Months 0-6|Withdrawal by Subject|4|||
143198870|NCT00432744|516273631|FG000|Months 0-6|Too disabled to score|1|||
143198871|NCT00432744|516273632|FG001|Months 0-6|Too disabled to score|0|||
143198872|NCT00432744|516273631|FG000|Months 7 - 12|Withdrawal by Subject|1|||
143198873|NCT00432744|516273632|FG001|Months 7 - 12|Withdrawal by Subject|0|||
143198874|NCT00432744|516273631|FG000|Months 7 - 12|Too disabled to score|0|||
143198875|NCT00432744|516273632|FG001|Months 7 - 12|Too disabled to score|1|||
143198876|NCT01416441|516273633|FG000|Overall Study|Lost to Follow-up|5|||
143198877|NCT01416441|516273633|FG000|Overall Study|Adverse Event|6|||
143198878|NCT01416441|516273633|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
143198879|NCT01416441|516273633|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
143198880|NCT01416441|516273633|FG000|Overall Study|Investigator Withdrew Subject|2|||
143198881|NCT01416441|516273633|FG000|Overall Study|Subject Withdrew Consent|12|||
143198882|NCT01416441|516273633|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
143198883|NCT01319721|516273635|FG000|Overall Study|Lost to Follow-up|1|||
143198884|NCT01319721|516273636|FG001|Overall Study|Lost to Follow-up|6|||
143198885|NCT00461305|516273640|FG000|Treatment|Adverse Event|26|||
143198886|NCT00461305|516273641|FG001|Treatment|Adverse Event|3|||
143198887|NCT00461305|516273640|FG000|Treatment|Lost to Follow-up|4|||
143198888|NCT00461305|516273641|FG001|Treatment|Lost to Follow-up|2|||
143198889|NCT00461305|516273640|FG000|Treatment|Protocol Violation|13|||
143198890|NCT00461305|516273641|FG001|Treatment|Protocol Violation|2|||
143198891|NCT00461305|516273640|FG000|Treatment|Withdrawal by Subject|48|||
143198892|NCT00461305|516273641|FG001|Treatment|Withdrawal by Subject|2|||
143262065|NCT00424255|516512588|FG001|Overall Study|Sponsor Terminated Study|167|||
143198893|NCT00461305|516273640|FG000|Treatment|Never dispensed|5|||
143198894|NCT00461305|516273641|FG001|Treatment|Never dispensed|0|||
143198895|NCT00461305|516273640|FG000|Treatment|Study drug not taken|1|||
143198896|NCT00461305|516273641|FG001|Treatment|Study drug not taken|0|||
143198897|NCT00461305|516273640|FG000|Treatment|Partially missing diary|2|||
143198898|NCT00461305|516273641|FG001|Treatment|Partially missing diary|0|||
143198899|NCT00461305|516273640|FG000|Treatment|Other (missing drug etc)|2|||
143198900|NCT00461305|516273641|FG001|Treatment|Other (missing drug etc)|0|||
143198901|NCT00461305|516273640|FG000|Continued Treatment|Adverse Event|26|||
143198902|NCT00461305|516273641|FG001|Continued Treatment|Adverse Event|0|||
143198903|NCT00461305|516273640|FG000|Continued Treatment|Lost to Follow-up|4|||
143198904|NCT00461305|516273641|FG001|Continued Treatment|Lost to Follow-up|0|||
143198905|NCT00461305|516273640|FG000|Continued Treatment|Protocol Violation|13|||
143198906|NCT00461305|516273641|FG001|Continued Treatment|Protocol Violation|0|||
143198907|NCT00461305|516273640|FG000|Continued Treatment|Withdrawal by Subject|48|||
143198908|NCT00461305|516273641|FG001|Continued Treatment|Withdrawal by Subject|0|||
143198909|NCT00461305|516273640|FG000|Continued Treatment|Partially missing diary|2|||
143198910|NCT00461305|516273641|FG001|Continued Treatment|Partially missing diary|0|||
143198911|NCT00461305|516273640|FG000|Continued Treatment|Other (missing drug etc)|2|||
143198912|NCT00461305|516273641|FG001|Continued Treatment|Other (missing drug etc)|0|||
143198913|NCT04030247|516276009|FG000|Overall Study|Withdrawal by Subject|4|||
143198914|NCT04030247|516276009|FG000|Overall Study|Lost to Follow-up|13|||
143198915|NCT03966885|516276010|FG000|Overall Study|Death|1|||
143198916|NCT03966885|516276011|FG001|Overall Study|Death|0|||
143198917|NCT03966885|516276010|FG000|Overall Study|Lost to Follow-up|1|||
143198918|NCT03966885|516276011|FG001|Overall Study|Lost to Follow-up|2|||
143198919|NCT03966885|516276010|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
143198920|NCT03966885|516276011|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
143198921|NCT03966885|516276010|FG000|Overall Study|Moved from study area.|0|||
143198922|NCT03966885|516276011|FG001|Overall Study|Moved from study area.|2|||
143198923|NCT03187834|516276012|FG000|Overall Study|Lost to Follow-up|0|||
143198924|NCT03187834|516276013|FG001|Overall Study|Lost to Follow-up|1|||
143198925|NCT03187834|516276014|FG002|Overall Study|Lost to Follow-up|2|||
143198926|NCT03187834|516276015|FG003|Overall Study|Lost to Follow-up|2|||
143198927|NCT03187834|516276012|FG000|Overall Study|Had invalid anthropometric measurements|5|||
143198928|NCT03187834|516276013|FG001|Overall Study|Had invalid anthropometric measurements|3|||
143198929|NCT03187834|516276014|FG002|Overall Study|Had invalid anthropometric measurements|4|||
143198930|NCT03187834|516276015|FG003|Overall Study|Had invalid anthropometric measurements|2|||
143198931|NCT02210832|516276016|FG000|Overall Study|Pregnancy termination .|3|||
143198932|NCT02210832|516276017|FG001|Overall Study|Pregnancy termination .|4|||
143198933|NCT02210832|516276018|FG002|Overall Study|Pregnancy termination .|1|||
143198934|NCT02210832|516276016|FG000|Overall Study|Lost to Follow-up|26|||
143198935|NCT02210832|516276017|FG001|Overall Study|Lost to Follow-up|32|||
143198936|NCT02210832|516276018|FG002|Overall Study|Lost to Follow-up|17|||
143198937|NCT03710876|516276019|FG000|Overall Study|Death|0|||
143198938|NCT03710876|516276020|FG001|Overall Study|Death|2|||
143262066|NCT03523000|516512589|FG000|Overall Study|Withdrawal by Subject|3|||
143198939|NCT03710876|516276019|FG000|Overall Study|Withdrawal by Subject|0|||
143198940|NCT03710876|516276020|FG001|Overall Study|Withdrawal by Subject|2|||
143198941|NCT04979897|516276026|FG000|Overall Study|Death|1|||
143198942|NCT04979897|516276027|FG001|Overall Study|Death|8|||
143198943|NCT04979897|516276026|FG000|Overall Study|Lost to Follow-up|111|||
143198944|NCT04979897|516276027|FG001|Overall Study|Lost to Follow-up|56|||
143198945|NCT04979897|516276026|FG000|Overall Study|Withdrawal by Subject|7|||
143198946|NCT04979897|516276027|FG001|Overall Study|Withdrawal by Subject|2|||
143198947|NCT03383783|516276034|FG000|Overall Study|Withdrawal by Subject|2|||
143198948|NCT02781792|516276037|FG000|Overall Study|Adverse Event|1|||
143198949|NCT02781792|516276038|FG001|Overall Study|Adverse Event|2|||
143198950|NCT02781792|516276037|FG000|Overall Study|Withdrawal by Subject|3|||
143198951|NCT02781792|516276038|FG001|Overall Study|Withdrawal by Subject|1|||
143198952|NCT02781792|516276037|FG000|Overall Study|Lack of Efficacy|1|||
143198953|NCT02781792|516276038|FG001|Overall Study|Lack of Efficacy|1|||
143262067|NCT03523000|516512590|FG001|Overall Study|Withdrawal by Subject|0|||
143262068|NCT03523000|516512589|FG000|Overall Study|Unsuccessful trial|2|||
143262069|NCT03523000|516512590|FG001|Overall Study|Unsuccessful trial|0|||
143262070|NCT00495131|516512591|FG000|Overall Study|Adverse Event|6|||
143198954|NCT02781792|516276037|FG000|Overall Study|Hospice|0|||
143198955|NCT02781792|516276038|FG001|Overall Study|Hospice|1|||
143198956|NCT01224821|516276047|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
143198957|NCT01224821|516276047|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
143198958|NCT01224821|516276047|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
143198959|NCT01224821|516276047|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
143198960|NCT01224821|516276047|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
143198961|NCT01224821|516276047|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
143198962|NCT01224821|516276047|FG000|Long-Term Follow-Up|Death|2|||
143198963|NCT01224821|516276047|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
143198964|NCT00683917|516276048|FG000|Overall Study|Study prematurely terminated|10|||
143198965|NCT00350623|516276054|FG000|Overall Study|Lost to Follow-up|8|||
143198966|NCT00350623|516276055|FG001|Overall Study|Lost to Follow-up|3|||
143198967|NCT00350623|516276056|FG002|Overall Study|Lost to Follow-up|4|||
143198968|NCT00350623|516276054|FG000|Overall Study|Withdrawal by Subject|0|||
143198969|NCT00350623|516276055|FG001|Overall Study|Withdrawal by Subject|1|||
143198970|NCT00350623|516276056|FG002|Overall Study|Withdrawal by Subject|1|||
143198971|NCT00350623|516276054|FG000|Overall Study|patient traveling outside the country|0|||
143198972|NCT00350623|516276055|FG001|Overall Study|patient traveling outside the country|0|||
143198973|NCT00350623|516276056|FG002|Overall Study|patient traveling outside the country|1|||
143198974|NCT04422561|516276058|FG000|Overall Study|Lost to Follow-up|25|||
143198975|NCT04422561|516276059|FG001|Overall Study|Lost to Follow-up|11|||
143198976|NCT02685748|516276064|FG000|Overall Study|Withdrawal by Subject|3|||
143198977|NCT02685748|516276065|FG001|Overall Study|Withdrawal by Subject|2|||
143198978|NCT04126564|516276066|FG000|Overall Study|Withdrawal by Subject|0|||
143198979|NCT04126564|516276067|FG001|Overall Study|Withdrawal by Subject|2|||
143198980|NCT04126564|516276066|FG000|Overall Study|Lost to Follow-up|0|||
143198981|NCT04126564|516276067|FG001|Overall Study|Lost to Follow-up|1|||
143198982|NCT04599166|516276069|FG000|Overall Study|Technological failure connecting to study app|80|||
143198983|NCT04863248|516276070|FG000|Overall Study|Sponsor Terminated|4|||
143198984|NCT04863248|516276071|FG001|Overall Study|Sponsor Terminated|1|||
143198985|NCT04863248|516276070|FG000|Overall Study|Death|0|||
143198986|NCT04863248|516276071|FG001|Overall Study|Death|1|||
143198987|NCT04863248|516276070|FG000|Overall Study|Withdrawal by Subject|0|||
143198988|NCT04863248|516276071|FG001|Overall Study|Withdrawal by Subject|1|||
143198989|NCT01691105|516276075|FG000|1 Month Follow-up|Lost to Follow-up|41|||
143198990|NCT01691105|516276076|FG001|1 Month Follow-up|Lost to Follow-up|38|||
143198991|NCT01691105|516276075|FG000|1 Month Follow-up|Death|2|||
143198992|NCT01691105|516276076|FG001|1 Month Follow-up|Death|3|||
143198993|NCT01691105|516276075|FG000|6 Month Follow-up|Lost to Follow-up|39|||
143198994|NCT01691105|516276076|FG001|6 Month Follow-up|Lost to Follow-up|58|||
143198995|NCT01691105|516276075|FG000|6 Month Follow-up|Death|13|||
143198996|NCT01691105|516276076|FG001|6 Month Follow-up|Death|13|||
143198997|NCT01691105|516276075|FG000|12 Month Follow-up|Lost to Follow-up|50|||
143198998|NCT01691105|516276076|FG001|12 Month Follow-up|Lost to Follow-up|71|||
143198999|NCT01691105|516276075|FG000|12 Month Follow-up|Death|22|||
143199000|NCT01691105|516276076|FG001|12 Month Follow-up|Death|30|||
143199001|NCT01691105|516276075|FG000|12 Month Biochemical Verification|Death|22|||
143199002|NCT01691105|516276076|FG001|12 Month Biochemical Verification|Death|30|||
143199003|NCT01691105|516276075|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
143199004|NCT01691105|516276076|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
143199005|NCT01691105|516276075|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
143199006|NCT01691105|516276076|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
143262071|NCT00495131|516512592|FG001|Overall Study|Adverse Event|2|||
143199007|NCT02233738|516276077|FG000|Overall Study|Lost to Follow-up|5|||
143199008|NCT02233738|516276078|FG001|Overall Study|Lost to Follow-up|12|||
143199009|NCT02233738|516276077|FG000|Overall Study|Death|0|||
143199010|NCT02233738|516276078|FG001|Overall Study|Death|1|||
143199011|NCT02233738|516276077|FG000|Overall Study|Withdrawal by Subject|0|||
143199012|NCT02233738|516276078|FG001|Overall Study|Withdrawal by Subject|1|||
143199013|NCT02233738|516276077|FG000|Overall Study|Did not return after Baseline|3|||
143199014|NCT02233738|516276078|FG001|Overall Study|Did not return after Baseline|2|||
143199015|NCT03028480|516276082|FG000|Overall Study|No revisit after the first prescription date|2|||
143199016|NCT03028480|516276082|FG000|Overall Study|Did not use the drug|1|||
143199017|NCT03028480|516276082|FG000|Overall Study|Violation of the enrollment deadline|10|||
143199018|NCT03028480|516276082|FG000|Overall Study|Case report forms were not collected|21|||
143199019|NCT03554772|516276088|FG000|Overall Study|Lost to Follow-up|0|||
143199020|NCT03554772|516276089|FG001|Overall Study|Lost to Follow-up|0|||
143199021|NCT03554772|516276090|FG002|Overall Study|Lost to Follow-up|0|||
143199022|NCT03554772|516276091|FG003|Overall Study|Lost to Follow-up|2|||
143199023|NCT01133405|516276096|FG000|Period 1|Withdrawal by Subject|0|||
143199024|NCT01133405|516276097|FG001|Period 1|Withdrawal by Subject|1|||
143199025|NCT01133405|516276098|FG002|Period 1|Withdrawal by Subject|0|||
143199026|NCT01133405|516276099|FG003|Period 1|Withdrawal by Subject|1|||
143199027|NCT01133405|516276100|FG004|Period 1|Withdrawal by Subject|0|||
143199028|NCT01133405|516276101|FG005|Period 1|Withdrawal by Subject|1|||
143199029|NCT01133405|516276102|FG006|Period 1|Withdrawal by Subject|0|||
143199030|NCT01133405|516276103|FG007|Period 1|Withdrawal by Subject|0|||
143199031|NCT01133405|516276104|FG008|Period 1|Withdrawal by Subject|0|||
143199032|NCT01133405|516276105|FG009|Period 1|Withdrawal by Subject|0|||
143199033|NCT01133405|516276096|FG000|Period 1|Physician Decision|0|||
143199034|NCT01133405|516276097|FG001|Period 1|Physician Decision|0|||
143199035|NCT01133405|516276098|FG002|Period 1|Physician Decision|0|||
143199036|NCT01133405|516276099|FG003|Period 1|Physician Decision|1|||
143262072|NCT00495131|516512591|FG000|Overall Study|Lack of Efficacy|0|||
143262073|NCT00495131|516512592|FG001|Overall Study|Lack of Efficacy|2|||
143262074|NCT00495131|516512591|FG000|Overall Study|Lost to Follow-up|0|||
143262075|NCT00495131|516512592|FG001|Overall Study|Lost to Follow-up|2|||
143262076|NCT00495131|516512591|FG000|Overall Study|Withdrawal by Subject|1|||
143262077|NCT00495131|516512592|FG001|Overall Study|Withdrawal by Subject|0|||
143262078|NCT01307020|516512594|FG000|Overall Study|Lost to Follow-up|0|||
143262079|NCT01307020|516512595|FG001|Overall Study|Lost to Follow-up|0|||
143262080|NCT01307020|516512596|FG002|Overall Study|Lost to Follow-up|1|||
143262081|NCT01307020|516512597|FG003|Overall Study|Lost to Follow-up|1|||
143262082|NCT01307020|516512598|FG004|Overall Study|Lost to Follow-up|0|||
143262083|NCT01307020|516512599|FG005|Overall Study|Lost to Follow-up|0|||
143262084|NCT01307020|516512600|FG006|Overall Study|Lost to Follow-up|1|||
143262085|NCT01307020|516512601|FG007|Overall Study|Lost to Follow-up|0|||
143262086|NCT01307020|516512602|FG008|Overall Study|Lost to Follow-up|0|||
143262087|NCT01307020|516512603|FG009|Overall Study|Lost to Follow-up|0|||
143262088|NCT01307020|516512594|FG000|Overall Study|Electronic data capture failure|0|||
143262089|NCT01307020|516512595|FG001|Overall Study|Electronic data capture failure|1|||
143262090|NCT01307020|516512596|FG002|Overall Study|Electronic data capture failure|0|||
143262091|NCT01307020|516512597|FG003|Overall Study|Electronic data capture failure|0|||
143262092|NCT01307020|516512598|FG004|Overall Study|Electronic data capture failure|0|||
143262093|NCT01307020|516512599|FG005|Overall Study|Electronic data capture failure|0|||
143262094|NCT01307020|516512600|FG006|Overall Study|Electronic data capture failure|0|||
143262095|NCT01307020|516512601|FG007|Overall Study|Electronic data capture failure|0|||
143262096|NCT01307020|516512602|FG008|Overall Study|Electronic data capture failure|0|||
143262097|NCT01307020|516512603|FG009|Overall Study|Electronic data capture failure|0|||
143262098|NCT02380690|516512604|FG000|Overall Study|Lost to Follow-up|14|||
143262099|NCT02380690|516512605|FG001|Overall Study|Lost to Follow-up|4|||
143262100|NCT02380690|516512604|FG000|Overall Study|Withdrawal by Subject|20|||
143262101|NCT02380690|516512605|FG001|Overall Study|Withdrawal by Subject|8|||
143262102|NCT00266864|516512606|FG000|Overall Study|Lost to Follow-up|4|||
143262103|NCT00266864|516512607|FG001|Overall Study|Lost to Follow-up|1|||
143262104|NCT00266864|516512606|FG000|Overall Study|Withdrawal by Subject|1|||
143262105|NCT00266864|516512607|FG001|Overall Study|Withdrawal by Subject|1|||
143262106|NCT03687970|516512615|FG000|Overall Study|visit scheduling conflicts|2|||
143262107|NCT03687970|516512616|FG001|Overall Study|visit scheduling conflicts|0|||
143262108|NCT03119701|516512617|FG000|6-day Dosing|Death|4|||
143262109|NCT03119701|516512618|FG001|6-day Dosing|Death|1|||
143262110|NCT03119701|516512617|FG000|6-day Dosing|Adverse Event|3|||
143262111|NCT03119701|516512618|FG001|6-day Dosing|Adverse Event|0|||
143262112|NCT03119701|516512617|FG000|6-day Dosing|Physician Decision|0|||
143262113|NCT03119701|516512618|FG001|6-day Dosing|Physician Decision|1|||
143262114|NCT03119701|516512617|FG000|6-day Dosing|Withdrawal by Subject|0|||
143262115|NCT03119701|516512618|FG001|6-day Dosing|Withdrawal by Subject|1|||
143262116|NCT03119701|516512617|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
143262117|NCT03119701|516512618|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
143262118|NCT01909453|516512630|FG000|Overall Study|Ongoing|118|||
143262119|NCT01909453|516512631|FG001|Overall Study|Ongoing|103|||
143262120|NCT01909453|516512632|FG002|Overall Study|Ongoing|83|||
143262121|NCT01909453|516512633|FG003|Overall Study|Ongoing|164|||
143262122|NCT01909453|516512634|FG004|Overall Study|Ongoing|50|||
143199037|NCT01133405|516276100|FG004|Period 1|Physician Decision|0|||
143199038|NCT01133405|516276101|FG005|Period 1|Physician Decision|0|||
143199039|NCT01133405|516276102|FG006|Period 1|Physician Decision|0|||
143199040|NCT01133405|516276103|FG007|Period 1|Physician Decision|0|||
143199041|NCT01133405|516276104|FG008|Period 1|Physician Decision|0|||
143199042|NCT01133405|516276105|FG009|Period 1|Physician Decision|0|||
143199043|NCT01133405|516276096|FG000|Period 1|Discontinued after randomization|1|||
143199044|NCT01133405|516276097|FG001|Period 1|Discontinued after randomization|0|||
143199045|NCT01133405|516276098|FG002|Period 1|Discontinued after randomization|0|||
143199046|NCT01133405|516276099|FG003|Period 1|Discontinued after randomization|0|||
143199047|NCT01133405|516276100|FG004|Period 1|Discontinued after randomization|0|||
143199048|NCT01133405|516276101|FG005|Period 1|Discontinued after randomization|0|||
143199049|NCT01133405|516276102|FG006|Period 1|Discontinued after randomization|1|||
143199050|NCT01133405|516276103|FG007|Period 1|Discontinued after randomization|0|||
143199051|NCT01133405|516276104|FG008|Period 1|Discontinued after randomization|0|||
143199052|NCT01133405|516276105|FG009|Period 1|Discontinued after randomization|0|||
143199053|NCT01133405|516276096|FG000|Period 1|Received drug only in period 2|0|||
143199054|NCT01133405|516276097|FG001|Period 1|Received drug only in period 2|1|||
143199055|NCT01133405|516276098|FG002|Period 1|Received drug only in period 2|0|||
143199056|NCT01133405|516276099|FG003|Period 1|Received drug only in period 2|2|||
143199057|NCT01133405|516276100|FG004|Period 1|Received drug only in period 2|0|||
143199058|NCT01133405|516276101|FG005|Period 1|Received drug only in period 2|1|||
143199059|NCT01133405|516276102|FG006|Period 1|Received drug only in period 2|0|||
143199060|NCT01133405|516276103|FG007|Period 1|Received drug only in period 2|0|||
143199061|NCT01133405|516276104|FG008|Period 1|Received drug only in period 2|0|||
143199062|NCT01133405|516276105|FG009|Period 1|Received drug only in period 2|0|||
143199063|NCT01133405|516276096|FG000|Period 1|Received drug only in period 3|0|||
143199064|NCT01133405|516276097|FG001|Period 1|Received drug only in period 3|1|||
143199065|NCT01133405|516276098|FG002|Period 1|Received drug only in period 3|1|||
143199066|NCT01133405|516276099|FG003|Period 1|Received drug only in period 3|0|||
143199067|NCT01133405|516276100|FG004|Period 1|Received drug only in period 3|0|||
143199068|NCT01133405|516276101|FG005|Period 1|Received drug only in period 3|0|||
143199069|NCT01133405|516276102|FG006|Period 1|Received drug only in period 3|0|||
143199070|NCT01133405|516276103|FG007|Period 1|Received drug only in period 3|0|||
143199071|NCT01133405|516276104|FG008|Period 1|Received drug only in period 3|0|||
143199072|NCT01133405|516276105|FG009|Period 1|Received drug only in period 3|0|||
143199073|NCT01133405|516276096|FG000|Period 2|Adverse Event|0|||
143199074|NCT01133405|516276097|FG001|Period 2|Adverse Event|0|||
143199075|NCT01133405|516276098|FG002|Period 2|Adverse Event|1|||
143199076|NCT01133405|516276099|FG003|Period 2|Adverse Event|0|||
143199077|NCT01133405|516276100|FG004|Period 2|Adverse Event|0|||
143199078|NCT01133405|516276101|FG005|Period 2|Adverse Event|0|||
143199079|NCT01133405|516276102|FG006|Period 2|Adverse Event|0|||
143199080|NCT01133405|516276103|FG007|Period 2|Adverse Event|0|||
143199081|NCT01133405|516276104|FG008|Period 2|Adverse Event|0|||
143199082|NCT01133405|516276105|FG009|Period 2|Adverse Event|0|||
143199083|NCT01133405|516276096|FG000|Period 2|Withdrawal by Subject|0|||
143199084|NCT01133405|516276097|FG001|Period 2|Withdrawal by Subject|0|||
143199085|NCT01133405|516276098|FG002|Period 2|Withdrawal by Subject|0|||
143199086|NCT01133405|516276099|FG003|Period 2|Withdrawal by Subject|1|||
143199087|NCT01133405|516276100|FG004|Period 2|Withdrawal by Subject|0|||
143199088|NCT01133405|516276101|FG005|Period 2|Withdrawal by Subject|1|||
143199089|NCT01133405|516276102|FG006|Period 2|Withdrawal by Subject|0|||
143262123|NCT01909453|516512630|FG000|Overall Study|Death|69|||
143199090|NCT01133405|516276103|FG007|Period 2|Withdrawal by Subject|0|||
143199091|NCT01133405|516276104|FG008|Period 2|Withdrawal by Subject|0|||
143199092|NCT01133405|516276105|FG009|Period 2|Withdrawal by Subject|0|||
143199093|NCT01133405|516276096|FG000|Period 2|Entry Criteria Not Met|0|||
143199094|NCT01133405|516276097|FG001|Period 2|Entry Criteria Not Met|1|||
143199095|NCT01133405|516276098|FG002|Period 2|Entry Criteria Not Met|0|||
143199096|NCT01133405|516276099|FG003|Period 2|Entry Criteria Not Met|0|||
143199097|NCT01133405|516276100|FG004|Period 2|Entry Criteria Not Met|0|||
143199098|NCT01133405|516276101|FG005|Period 2|Entry Criteria Not Met|0|||
143199099|NCT01133405|516276102|FG006|Period 2|Entry Criteria Not Met|0|||
143199100|NCT01133405|516276103|FG007|Period 2|Entry Criteria Not Met|0|||
143199101|NCT01133405|516276104|FG008|Period 2|Entry Criteria Not Met|0|||
143199102|NCT01133405|516276105|FG009|Period 2|Entry Criteria Not Met|0|||
143199103|NCT01133405|516276096|FG000|Period 2|Physician Decision|0|||
143199104|NCT01133405|516276097|FG001|Period 2|Physician Decision|0|||
143199105|NCT01133405|516276098|FG002|Period 2|Physician Decision|0|||
143199106|NCT01133405|516276099|FG003|Period 2|Physician Decision|0|||
143199107|NCT01133405|516276100|FG004|Period 2|Physician Decision|0|||
143199108|NCT01133405|516276101|FG005|Period 2|Physician Decision|1|||
143199109|NCT01133405|516276102|FG006|Period 2|Physician Decision|0|||
143199110|NCT01133405|516276103|FG007|Period 2|Physician Decision|0|||
143199111|NCT01133405|516276104|FG008|Period 2|Physician Decision|0|||
143199112|NCT01133405|516276105|FG009|Period 2|Physician Decision|0|||
143199113|NCT01238835|516276114|FG000|Overall Study|Death|124|||
143199114|NCT01238835|516276114|FG000|Overall Study|Withdrawal by Subject|9|||
143199115|NCT01238835|516276114|FG000|Overall Study|Lost to Follow-up|1|||
143199116|NCT01238835|516276114|FG000|Overall Study|Site early discontinuation|2|||
143199117|NCT00907803|516276115|FG000|Overall Study|Withdrawal of consent - long commute|1|||
143199118|NCT00907803|516276116|FG001|Overall Study|Withdrawal of consent - long commute|0|||
143199119|NCT00907803|516276117|FG002|Overall Study|Withdrawal of consent - long commute|0|||
143199120|NCT00907803|516276115|FG000|Overall Study|Adverse Event|2|||
143199121|NCT00907803|516276116|FG001|Overall Study|Adverse Event|0|||
143199122|NCT00907803|516276117|FG002|Overall Study|Adverse Event|0|||
143262124|NCT01909453|516512631|FG001|Overall Study|Death|74|||
143262125|NCT01909453|516512632|FG002|Overall Study|Death|88|||
143262126|NCT01909453|516512633|FG003|Overall Study|Death|86|||
143262127|NCT01909453|516512634|FG004|Overall Study|Death|29|||
143262128|NCT01909453|516512630|FG000|Overall Study|Lost to Follow-up|3|||
143262129|NCT01909453|516512631|FG001|Overall Study|Lost to Follow-up|4|||
143199123|NCT00907803|516276115|FG000|Overall Study|Withdrawal by Subject|0|||
143199124|NCT00907803|516276116|FG001|Overall Study|Withdrawal by Subject|1|||
143199125|NCT00907803|516276117|FG002|Overall Study|Withdrawal by Subject|0|||
143199126|NCT00907803|516276115|FG000|Overall Study|Lost to Follow-up|0|||
143199127|NCT00907803|516276116|FG001|Overall Study|Lost to Follow-up|1|||
143199128|NCT00907803|516276117|FG002|Overall Study|Lost to Follow-up|0|||
143199129|NCT00907803|516276115|FG000|Overall Study|Protocol Violation|0|||
143199130|NCT00907803|516276116|FG001|Overall Study|Protocol Violation|1|||
143199131|NCT00907803|516276117|FG002|Overall Study|Protocol Violation|0|||
143199132|NCT03352557|516276118|FG000|PC Period: Day 1 to Week 78|Death|1|||
143199133|NCT03352557|516276119|FG001|PC Period: Day 1 to Week 78|Death|1|||
143199134|NCT03352557|516276120|FG002|PC Period: Day 1 to Week 78|Death|0|||
143199135|NCT03352557|516276121|FG003|PC Period: Day 1 to Week 78|Death|0|||
143199136|NCT03352557|516276122|FG004|PC Period: Day 1 to Week 78|Death|1|||
143199137|NCT03352557|516276123|FG005|PC Period: Day 1 to Week 78|Death|0|||
143199138|NCT03352557|516276124|FG006|PC Period: Day 1 to Week 78|Death|0|||
143199139|NCT03352557|516276125|FG007|PC Period: Day 1 to Week 78|Death|0|||
143199140|NCT03352557|516276126|FG008|PC Period: Day 1 to Week 78|Death|0|||
143199141|NCT03352557|516276127|FG009|PC Period: Day 1 to Week 78|Death|0|||
143199142|NCT03352557|516276118|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
143199143|NCT03352557|516276119|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
143199144|NCT03352557|516276120|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
143199145|NCT03352557|516276121|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
143199146|NCT03352557|516276122|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
143199147|NCT03352557|516276123|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
143199148|NCT03352557|516276124|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
143199149|NCT03352557|516276125|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
143199150|NCT03352557|516276126|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
143199151|NCT03352557|516276127|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
143199152|NCT03352557|516276118|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
143199153|NCT03352557|516276119|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
143199154|NCT03352557|516276120|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
143199155|NCT03352557|516276121|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
143199156|NCT03352557|516276122|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
143199157|NCT03352557|516276123|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
143199158|NCT03352557|516276124|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
143199159|NCT03352557|516276125|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
143199160|NCT03352557|516276126|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
143199161|NCT03352557|516276127|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
143199162|NCT03352557|516276118|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
143199163|NCT03352557|516276119|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
143199164|NCT03352557|516276120|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
143199165|NCT03352557|516276121|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
143199166|NCT03352557|516276122|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
143199167|NCT03352557|516276123|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
143199168|NCT03352557|516276124|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
143199169|NCT03352557|516276125|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
143199170|NCT03352557|516276126|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
143199171|NCT03352557|516276127|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
143199172|NCT03352557|516276118|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
143199173|NCT03352557|516276119|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
143199174|NCT03352557|516276120|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
143262130|NCT01909453|516512632|FG002|Overall Study|Lost to Follow-up|4|||
143262131|NCT01909453|516512633|FG003|Overall Study|Lost to Follow-up|3|||
143262132|NCT01909453|516512634|FG004|Overall Study|Lost to Follow-up|3|||
143262133|NCT01909453|516512630|FG000|Overall Study|Withdrawal by Subject|2|||
143262134|NCT01909453|516512631|FG001|Overall Study|Withdrawal by Subject|13|||
143262135|NCT01909453|516512632|FG002|Overall Study|Withdrawal by Subject|16|||
143262136|NCT01909453|516512633|FG003|Overall Study|Withdrawal by Subject|5|||
143262137|NCT01909453|516512634|FG004|Overall Study|Withdrawal by Subject|4|||
143262138|NCT01155219|516513819|FG000|Overall Study|Adverse Event|3|||
143199175|NCT03352557|516276121|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
143199176|NCT03352557|516276122|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
143199177|NCT03352557|516276123|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
143199178|NCT03352557|516276124|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
143199179|NCT03352557|516276125|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
143199180|NCT03352557|516276126|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
143199181|NCT03352557|516276127|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
143199182|NCT03352557|516276118|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
143199183|NCT03352557|516276119|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
143369751|NCT01833065|516897187|FG000|Overall Study|Trial terminated by sponsor|8|||
143369752|NCT01833065|516897188|FG001|Overall Study|Trial terminated by sponsor|8|||
143369753|NCT01833065|516897189|FG002|Overall Study|Trial terminated by sponsor|7|||
143369754|NCT01833065|516897190|FG003|Overall Study|Trial terminated by sponsor|3|||
143369755|NCT01833065|516897191|FG004|Overall Study|Trial terminated by sponsor|13|||
143369756|NCT01833065|516897187|FG000|Overall Study|Others|2|||
143369757|NCT01833065|516897188|FG001|Overall Study|Others|1|||
143369758|NCT01833065|516897189|FG002|Overall Study|Others|1|||
143369759|NCT01833065|516897190|FG003|Overall Study|Others|1|||
143369760|NCT01833065|516897191|FG004|Overall Study|Others|4|||
143369761|NCT00543725|516897192|FG000|Overall Study|Adverse Event|18|||
143369762|NCT00543725|516897193|FG001|Overall Study|Adverse Event|27|||
143369763|NCT00543725|516897192|FG000|Overall Study|Sponsor's Decision|0|||
143369764|NCT00543725|516897193|FG001|Overall Study|Sponsor's Decision|1|||
143262139|NCT01155219|516513820|FG001|Overall Study|Adverse Event|1|||
143262140|NCT01155219|516513819|FG000|Overall Study|non-medical reason|1|||
143199184|NCT03352557|516276120|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
143199185|NCT03352557|516276121|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
143199186|NCT03352557|516276122|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
143199187|NCT03352557|516276123|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
143199188|NCT03352557|516276124|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
143199189|NCT03352557|516276125|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
143199190|NCT03352557|516276126|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
143199191|NCT03352557|516276127|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
143199192|NCT03352557|516276118|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
143199193|NCT03352557|516276119|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
143199194|NCT03352557|516276120|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
143199195|NCT03352557|516276121|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
143199196|NCT03352557|516276122|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
143199197|NCT03352557|516276123|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
143199198|NCT03352557|516276124|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
143199199|NCT03352557|516276125|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
143199200|NCT03352557|516276126|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
143199201|NCT03352557|516276127|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
143199202|NCT03352557|516276118|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
143199203|NCT03352557|516276119|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
143199204|NCT03352557|516276120|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
143199205|NCT03352557|516276121|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
143199206|NCT03352557|516276122|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
143199207|NCT03352557|516276123|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
143199208|NCT03352557|516276124|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
143199209|NCT03352557|516276125|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
143199210|NCT03352557|516276126|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
143199211|NCT03352557|516276127|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
143199212|NCT03352557|516276118|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
143262141|NCT01155219|516513820|FG001|Overall Study|non-medical reason|2|||
143262142|NCT03150485|516513821|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
143199213|NCT03352557|516276119|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
143199214|NCT03352557|516276120|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
143199215|NCT03352557|516276121|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
143262143|NCT03150485|516513822|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
143262144|NCT03150485|516513823|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
143262145|NCT03150485|516513824|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
143262146|NCT03150485|516513825|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
143369765|NCT00543725|516897192|FG000|Overall Study|Subject Non-Compliant|4|||
143369766|NCT00543725|516897193|FG001|Overall Study|Subject Non-Compliant|4|||
143262147|NCT03150485|516513826|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
143199216|NCT03352557|516276122|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
143199217|NCT03352557|516276123|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
143199218|NCT03352557|516276124|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
143199219|NCT03352557|516276125|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
143199220|NCT03352557|516276126|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
143199221|NCT03352557|516276127|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
143199222|NCT03352557|516276118|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
143199223|NCT03352557|516276119|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
143199224|NCT03352557|516276120|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
143199225|NCT03352557|516276121|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
143199226|NCT03352557|516276122|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
143199227|NCT03352557|516276123|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
143199228|NCT03352557|516276124|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
143199229|NCT03352557|516276125|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
143199230|NCT03352557|516276126|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
143199231|NCT03352557|516276127|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
143199232|NCT03352557|516276118|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
143199233|NCT03352557|516276119|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
143199234|NCT03352557|516276120|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
143199235|NCT03352557|516276121|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
143199236|NCT03352557|516276122|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
143199237|NCT03352557|516276123|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
143199238|NCT03352557|516276124|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
143199239|NCT03352557|516276125|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
143199240|NCT03352557|516276126|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
143199241|NCT03352557|516276127|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
143199242|NCT03352557|516276118|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
143199243|NCT03352557|516276119|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
143199244|NCT03352557|516276120|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
143199245|NCT03352557|516276121|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
143199246|NCT03352557|516276122|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
143199247|NCT03352557|516276123|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
143199248|NCT03352557|516276124|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
143199249|NCT03352557|516276125|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
143199250|NCT03352557|516276126|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
143199251|NCT03352557|516276127|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
143199252|NCT03352557|516276118|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
143199253|NCT03352557|516276119|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
143199254|NCT03352557|516276120|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
143199255|NCT03352557|516276121|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
143199256|NCT03352557|516276122|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
143199257|NCT03352557|516276123|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
143199258|NCT03352557|516276124|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
143199259|NCT03352557|516276125|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
143199260|NCT03352557|516276126|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
143199261|NCT03352557|516276127|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
143199262|NCT03352557|516276118|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
143199263|NCT03352557|516276119|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
143262148|NCT05828095|516513827|FG000|Overall Study|Lost to Follow-up|1|||
143262149|NCT05828095|516513828|FG001|Overall Study|Lost to Follow-up|0|||
143262150|NCT05828095|516513827|FG000|Overall Study|Reactogenicity symptom|0|||
143262151|NCT05828095|516513828|FG001|Overall Study|Reactogenicity symptom|1|||
143262152|NCT00096954|516513829|FG000|Overall Study|Adverse Event|3|||
143262153|NCT00096954|516513830|FG001|Overall Study|Adverse Event|1|||
143199264|NCT03352557|516276120|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
143199265|NCT03352557|516276121|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
143199266|NCT03352557|516276122|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
143199267|NCT03352557|516276123|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
143199268|NCT03352557|516276124|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
143199269|NCT03352557|516276125|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
143199270|NCT03352557|516276126|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
143199271|NCT03352557|516276127|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
143199272|NCT03352557|516276118|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
143199273|NCT03352557|516276119|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
143199274|NCT03352557|516276120|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
143199275|NCT03352557|516276121|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
143199276|NCT03352557|516276122|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
143199277|NCT03352557|516276123|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
143199278|NCT03352557|516276124|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
143199279|NCT03352557|516276125|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
143199280|NCT03352557|516276126|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
143199281|NCT03352557|516276127|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
143199282|NCT03352557|516276118|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
143199283|NCT03352557|516276119|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
143199284|NCT03352557|516276120|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
143199285|NCT03352557|516276121|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
143199286|NCT03352557|516276122|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
143199287|NCT03352557|516276123|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
143199288|NCT03352557|516276124|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
143199289|NCT03352557|516276125|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
143199290|NCT03352557|516276126|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
143199291|NCT03352557|516276127|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
143199292|NCT03352557|516276118|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
143199293|NCT03352557|516276119|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
143199294|NCT03352557|516276120|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
143199295|NCT03352557|516276121|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
143199296|NCT03352557|516276122|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
143199297|NCT03352557|516276123|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
143199298|NCT03352557|516276124|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
143199299|NCT03352557|516276125|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
143199300|NCT03352557|516276126|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
143199301|NCT03352557|516276127|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
143199302|NCT03352557|516276118|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
143199303|NCT03352557|516276119|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
143199304|NCT03352557|516276120|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
143199305|NCT03352557|516276121|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
143199306|NCT03352557|516276122|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
143199307|NCT03352557|516276123|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
143262154|NCT00096954|516513829|FG000|Overall Study|Withdrawal by Subject|9|||
143262155|NCT00096954|516513830|FG001|Overall Study|Withdrawal by Subject|8|||
143262156|NCT00096954|516513829|FG000|Overall Study|Physician Decision|1|||
143262157|NCT00096954|516513830|FG001|Overall Study|Physician Decision|1|||
143369767|NCT00543725|516897192|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
143262158|NCT00096954|516513829|FG000|Overall Study|Sponsors Decision|1|||
143262159|NCT00096954|516513830|FG001|Overall Study|Sponsors Decision|1|||
143262160|NCT00096954|516513829|FG000|Overall Study|Pregnancy|1|||
143262161|NCT00096954|516513830|FG001|Overall Study|Pregnancy|1|||
143262162|NCT00096954|516513829|FG000|Overall Study|Initiation of immunotherapy|1|||
143262163|NCT00096954|516513830|FG001|Overall Study|Initiation of immunotherapy|0|||
143262164|NCT00096954|516513829|FG000|Overall Study|Non-compliance|0|||
143369768|NCT00543725|516897193|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
143199308|NCT03352557|516276124|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
143199309|NCT03352557|516276125|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
143199310|NCT03352557|516276126|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
143199311|NCT03352557|516276127|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
143199312|NCT03352557|516276118|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
143199313|NCT03352557|516276119|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
143199314|NCT03352557|516276120|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
143199315|NCT03352557|516276121|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
143199316|NCT03352557|516276122|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
143199317|NCT03352557|516276123|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
143199318|NCT03352557|516276124|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
143199319|NCT03352557|516276125|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
143199320|NCT03352557|516276126|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
143199321|NCT03352557|516276127|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
143199322|NCT03352557|516276118|FG000|PC Period: Day 1 to Week 78|Other|5|||
143199323|NCT03352557|516276119|FG001|PC Period: Day 1 to Week 78|Other|1|||
143199324|NCT03352557|516276120|FG002|PC Period: Day 1 to Week 78|Other|0|||
143199325|NCT03352557|516276121|FG003|PC Period: Day 1 to Week 78|Other|3|||
143199326|NCT03352557|516276122|FG004|PC Period: Day 1 to Week 78|Other|0|||
143199327|NCT03352557|516276123|FG005|PC Period: Day 1 to Week 78|Other|0|||
143199328|NCT03352557|516276124|FG006|PC Period: Day 1 to Week 78|Other|0|||
143199329|NCT03352557|516276125|FG007|PC Period: Day 1 to Week 78|Other|0|||
143199330|NCT03352557|516276126|FG008|PC Period: Day 1 to Week 78|Other|0|||
143199331|NCT03352557|516276127|FG009|PC Period: Day 1 to Week 78|Other|0|||
143199332|NCT03352557|516276118|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
143199333|NCT03352557|516276119|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
143199334|NCT03352557|516276120|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
143199335|NCT03352557|516276121|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
143199336|NCT03352557|516276122|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
143199337|NCT03352557|516276123|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
143199338|NCT03352557|516276124|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
143199339|NCT03352557|516276125|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
143199340|NCT03352557|516276126|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
143199341|NCT03352557|516276127|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
143199342|NCT03352557|516276118|FG000|LTE Period: Week 80 to Week 173|Death|0|||
143199343|NCT03352557|516276119|FG001|LTE Period: Week 80 to Week 173|Death|0|||
143199344|NCT03352557|516276120|FG002|LTE Period: Week 80 to Week 173|Death|0|||
143199345|NCT03352557|516276121|FG003|LTE Period: Week 80 to Week 173|Death|0|||
143199346|NCT03352557|516276122|FG004|LTE Period: Week 80 to Week 173|Death|0|||
143262165|NCT00096954|516513830|FG001|Overall Study|Non-compliance|3|||
143262166|NCT00096954|516513829|FG000|Overall Study|Lost to Follow-up|8|||
143262167|NCT00096954|516513830|FG001|Overall Study|Lost to Follow-up|5|||
143262168|NCT00588952|516513831|FG000|Overall Study|Adverse Event|0|||
143262169|NCT00588952|516513832|FG001|Overall Study|Adverse Event|2|||
143199347|NCT03352557|516276123|FG005|LTE Period: Week 80 to Week 173|Death|1|||
143199348|NCT03352557|516276124|FG006|LTE Period: Week 80 to Week 173|Death|0|||
143199349|NCT03352557|516276125|FG007|LTE Period: Week 80 to Week 173|Death|1|||
143199350|NCT03352557|516276126|FG008|LTE Period: Week 80 to Week 173|Death|1|||
143199351|NCT03352557|516276127|FG009|LTE Period: Week 80 to Week 173|Death|1|||
143199352|NCT03352557|516276118|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
143199353|NCT03352557|516276119|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
143199354|NCT03352557|516276120|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
143199355|NCT03352557|516276121|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
143199356|NCT03352557|516276122|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
143199357|NCT03352557|516276123|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
143199358|NCT03352557|516276124|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
143199359|NCT03352557|516276125|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
143262170|NCT00588952|516513831|FG000|Overall Study|Withdrawal by Subject|3|||
143262171|NCT00588952|516513832|FG001|Overall Study|Withdrawal by Subject|5|||
143199360|NCT03352557|516276126|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
143199361|NCT03352557|516276127|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
143199362|NCT03352557|516276118|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
143262172|NCT01277042|516513833|FG000|Overall Study|Adverse Event|4|||
143262173|NCT01277042|516513834|FG001|Overall Study|Adverse Event|3|||
143199363|NCT03352557|516276119|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
143199364|NCT03352557|516276120|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
143199365|NCT03352557|516276121|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
143199366|NCT03352557|516276122|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
143199367|NCT03352557|516276123|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
143199368|NCT03352557|516276124|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
143199369|NCT03352557|516276125|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
143262174|NCT01277042|516513833|FG000|Overall Study|Lost to Follow-up|2|||
143199370|NCT03352557|516276126|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
143199371|NCT03352557|516276127|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
143199372|NCT03352557|516276118|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
143199373|NCT03352557|516276119|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
143199374|NCT03352557|516276120|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
143199375|NCT03352557|516276121|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
143199376|NCT03352557|516276122|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
143199377|NCT03352557|516276123|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
143199378|NCT03352557|516276124|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
143199379|NCT03352557|516276125|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
143199380|NCT03352557|516276126|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
143199381|NCT03352557|516276127|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
143199382|NCT03352557|516276118|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
143199383|NCT03352557|516276119|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
143199384|NCT03352557|516276120|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
143199385|NCT03352557|516276121|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
143199386|NCT03352557|516276122|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
143199387|NCT03352557|516276123|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
143199388|NCT03352557|516276124|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
143199389|NCT03352557|516276125|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
143199390|NCT03352557|516276126|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
143199391|NCT03352557|516276127|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
143199392|NCT03352557|516276118|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
143199393|NCT03352557|516276119|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
143199394|NCT03352557|516276120|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
143199395|NCT03352557|516276121|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
143199396|NCT03352557|516276122|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
143199397|NCT03352557|516276123|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
143199398|NCT03352557|516276124|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
143199399|NCT03352557|516276125|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
143199400|NCT03352557|516276126|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
143199401|NCT03352557|516276127|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
143199402|NCT03352557|516276118|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
143199403|NCT03352557|516276119|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
143199404|NCT03352557|516276120|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
143199405|NCT03352557|516276121|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
143199406|NCT03352557|516276122|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
143262175|NCT01277042|516513834|FG001|Overall Study|Lost to Follow-up|2|||
143262176|NCT01277042|516513833|FG000|Overall Study|Withdrawal by Subject|2|||
143199407|NCT03352557|516276123|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
143199408|NCT03352557|516276124|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
143199409|NCT03352557|516276125|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
143199410|NCT03352557|516276126|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
143199411|NCT03352557|516276127|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
143199412|NCT03352557|516276118|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
143199413|NCT03352557|516276119|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
143262177|NCT01277042|516513834|FG001|Overall Study|Withdrawal by Subject|0|||
143262178|NCT01461057|516513835|FG000|Overall Study|Death|10|||
143262179|NCT01461057|516513836|FG001|Overall Study|Death|9|||
143262180|NCT01461057|516513835|FG000|Overall Study|Withdrawal by Subject|2|||
143262181|NCT01461057|516513836|FG001|Overall Study|Withdrawal by Subject|3|||
143199414|NCT03352557|516276120|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
143199415|NCT03352557|516276121|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
143199416|NCT03352557|516276122|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
143262182|NCT01461057|516513835|FG000|Overall Study|Physician Decision|0|||
143262183|NCT01461057|516513836|FG001|Overall Study|Physician Decision|2|||
143262184|NCT01461057|516513835|FG000|Overall Study|Adverse Event|0|||
143262185|NCT01461057|516513836|FG001|Overall Study|Adverse Event|1|||
143262186|NCT01461057|516513835|FG000|Overall Study|Progression of Disease|1|||
143199417|NCT03352557|516276123|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
143199418|NCT03352557|516276124|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
143199419|NCT03352557|516276125|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
143199420|NCT03352557|516276126|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
143199421|NCT03352557|516276127|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
143199422|NCT03352557|516276118|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
143199423|NCT03352557|516276119|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
143199424|NCT03352557|516276120|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
143199425|NCT03352557|516276121|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
143199426|NCT03352557|516276122|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
143199427|NCT03352557|516276123|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
143199428|NCT03352557|516276124|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
143199429|NCT03352557|516276125|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
143199430|NCT03352557|516276126|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
143199431|NCT03352557|516276127|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
143199432|NCT03352557|516276118|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
143199433|NCT03352557|516276119|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
143199434|NCT03352557|516276120|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
143199435|NCT03352557|516276121|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
143199436|NCT03352557|516276122|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
143199437|NCT03352557|516276123|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
143199438|NCT03352557|516276124|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
143199439|NCT03352557|516276125|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
143199440|NCT03352557|516276126|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
143199441|NCT03352557|516276127|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
143199442|NCT03352557|516276118|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
143199443|NCT03352557|516276119|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
143199444|NCT03352557|516276120|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
143199445|NCT03352557|516276121|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
143199446|NCT03352557|516276122|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
143199447|NCT03352557|516276123|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
143199448|NCT03352557|516276124|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
143199449|NCT03352557|516276125|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
143199450|NCT03352557|516276126|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
143199451|NCT03352557|516276127|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
143199452|NCT03352557|516276118|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
143199453|NCT03352557|516276119|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
143199454|NCT03352557|516276120|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
143199455|NCT03352557|516276121|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
143199456|NCT03352557|516276122|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
143199457|NCT03352557|516276123|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
143199458|NCT03352557|516276124|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
143199459|NCT03352557|516276125|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
143199460|NCT03352557|516276126|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
143199461|NCT03352557|516276127|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
143199462|NCT03352557|516276118|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
143199463|NCT03352557|516276119|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
143199464|NCT03352557|516276120|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
143199465|NCT03352557|516276121|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
143262187|NCT01461057|516513836|FG001|Overall Study|Progression of Disease|0|||
143262188|NCT01461057|516513835|FG000|Overall Study|Study Terminated by Sponsor|2|||
143262189|NCT01461057|516513836|FG001|Overall Study|Study Terminated by Sponsor|0|||
143262190|NCT03034200|516513837|FG000|Overall Study|Disease progression|8|||
143262191|NCT03034200|516513838|FG001|Overall Study|Disease progression|10|||
143262192|NCT03034200|516513839|FG002|Overall Study|Disease progression|4|||
143199466|NCT03352557|516276122|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
143199467|NCT03352557|516276123|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
143199468|NCT03352557|516276124|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
143199469|NCT03352557|516276125|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
143199470|NCT03352557|516276126|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
143199471|NCT03352557|516276127|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
143199472|NCT03352557|516276118|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
143199473|NCT03352557|516276119|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
143199474|NCT03352557|516276120|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
143199475|NCT03352557|516276121|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
143199476|NCT03352557|516276122|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
143199477|NCT03352557|516276123|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
143199478|NCT03352557|516276124|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
143199479|NCT03352557|516276125|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
143199480|NCT03352557|516276126|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
143199481|NCT03352557|516276127|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
143199482|NCT03352557|516276118|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
143199483|NCT03352557|516276119|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
143199484|NCT03352557|516276120|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
143199485|NCT03352557|516276121|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
143199486|NCT03352557|516276122|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
143199487|NCT03352557|516276123|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
143199488|NCT03352557|516276124|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
143199489|NCT03352557|516276125|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
143199490|NCT03352557|516276126|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
143199491|NCT03352557|516276127|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
143199492|NCT03352557|516276118|FG000|LTE Period: Week 80 to Week 173|Other|0|||
143199493|NCT03352557|516276119|FG001|LTE Period: Week 80 to Week 173|Other|0|||
143199494|NCT03352557|516276120|FG002|LTE Period: Week 80 to Week 173|Other|0|||
143199495|NCT03352557|516276121|FG003|LTE Period: Week 80 to Week 173|Other|0|||
143199496|NCT03352557|516276122|FG004|LTE Period: Week 80 to Week 173|Other|0|||
143199497|NCT03352557|516276123|FG005|LTE Period: Week 80 to Week 173|Other|0|||
143199498|NCT03352557|516276124|FG006|LTE Period: Week 80 to Week 173|Other|0|||
143199499|NCT03352557|516276125|FG007|LTE Period: Week 80 to Week 173|Other|1|||
143199500|NCT03352557|516276126|FG008|LTE Period: Week 80 to Week 173|Other|0|||
143199501|NCT03352557|516276127|FG009|LTE Period: Week 80 to Week 173|Other|0|||
143199502|NCT01218100|516276128|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
143199503|NCT01218100|516276129|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
143199504|NCT01218100|516276130|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
143199505|NCT01218100|516276131|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
143199506|NCT01218100|516276128|FG000|Overall Study|Adverse Event|4|||
143199507|NCT01218100|516276129|FG001|Overall Study|Adverse Event|6|||
143199508|NCT01218100|516276130|FG002|Overall Study|Adverse Event|6|||
143199509|NCT01218100|516276131|FG003|Overall Study|Adverse Event|7|||
143199510|NCT01218100|516276128|FG000|Overall Study|Lack of Efficacy|9|||
143199511|NCT01218100|516276129|FG001|Overall Study|Lack of Efficacy|6|||
143199512|NCT01218100|516276130|FG002|Overall Study|Lack of Efficacy|5|||
143199513|NCT01218100|516276131|FG003|Overall Study|Lack of Efficacy|12|||
143199514|NCT01218100|516276128|FG000|Overall Study|Protocol Violation|0|||
143199515|NCT01218100|516276129|FG001|Overall Study|Protocol Violation|0|||
143199516|NCT01218100|516276130|FG002|Overall Study|Protocol Violation|1|||
143199517|NCT01218100|516276131|FG003|Overall Study|Protocol Violation|1|||
143199518|NCT01218100|516276128|FG000|Overall Study|Withdrawal by Subject|5|||
143199519|NCT01218100|516276129|FG001|Overall Study|Withdrawal by Subject|2|||
143199520|NCT01218100|516276130|FG002|Overall Study|Withdrawal by Subject|6|||
143199521|NCT01218100|516276131|FG003|Overall Study|Withdrawal by Subject|7|||
143199522|NCT01218100|516276128|FG000|Overall Study|Lost to Follow-up|3|||
143199523|NCT01218100|516276129|FG001|Overall Study|Lost to Follow-up|8|||
143199524|NCT01218100|516276130|FG002|Overall Study|Lost to Follow-up|2|||
143262193|NCT03034200|516513837|FG000|Overall Study|Physician Decision|2|||
143262194|NCT03034200|516513838|FG001|Overall Study|Physician Decision|0|||
143262195|NCT03034200|516513839|FG002|Overall Study|Physician Decision|3|||
143199525|NCT01218100|516276131|FG003|Overall Study|Lost to Follow-up|1|||
143199526|NCT01218100|516276128|FG000|Overall Study|Other Reason|2|||
143199527|NCT01218100|516276129|FG001|Overall Study|Other Reason|2|||
143199528|NCT01218100|516276130|FG002|Overall Study|Other Reason|6|||
143199529|NCT01218100|516276131|FG003|Overall Study|Other Reason|4|||
143199530|NCT01089023|516276136|FG000|Overall Study|Lost to Follow-up|3|||
143199531|NCT01089023|516276136|FG000|Overall Study|Adverse Event|1|||
143199532|NCT01089023|516276136|FG000|Overall Study|Withdrawal by Subject|1|||
143262196|NCT03034200|516513837|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
143199533|NCT01089023|516276136|FG000|Overall Study|Protocol Violation|1|||
143199534|NCT01089023|516276136|FG000|Overall Study|Lack of Efficacy|1|||
143199535|NCT01852825|516276138|FG000|Overall Study|Withdrawal by Subject|2|||
143199536|NCT01852825|516276139|FG001|Overall Study|Withdrawal by Subject|0|||
143199537|NCT01852825|516276140|FG002|Overall Study|Withdrawal by Subject|0|||
143199538|NCT02446418|516276146|FG000|Overall Study|Adverse Event|4|||
143199539|NCT02446418|516276147|FG001|Overall Study|Adverse Event|8|||
143199540|NCT02446418|516276146|FG000|Overall Study|Physician Decision|5|||
143199541|NCT02446418|516276147|FG001|Overall Study|Physician Decision|1|||
143199542|NCT02446418|516276146|FG000|Overall Study|Withdrawal by Subject|3|||
143199543|NCT02446418|516276147|FG001|Overall Study|Withdrawal by Subject|3|||
143199544|NCT02446418|516276146|FG000|Overall Study|Lost to Follow-up|2|||
143199545|NCT02446418|516276147|FG001|Overall Study|Lost to Follow-up|2|||
143199546|NCT02446418|516276146|FG000|Overall Study|Protocol Violation|1|||
143199547|NCT02446418|516276147|FG001|Overall Study|Protocol Violation|2|||
143199548|NCT02446418|516276146|FG000|Overall Study|Lack of Efficacy|2|||
143199549|NCT02446418|516276147|FG001|Overall Study|Lack of Efficacy|0|||
143199550|NCT02446418|516276146|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
143199551|NCT02446418|516276147|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
143199552|NCT01338610|516276148|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
143199553|NCT01338610|516276149|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
143199554|NCT01338610|516276150|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
143199555|NCT01338610|516276148|FG000|Overall Study|Protocol Violation|1|||
143199556|NCT01338610|516276149|FG001|Overall Study|Protocol Violation|0|||
143199557|NCT01338610|516276150|FG002|Overall Study|Protocol Violation|1|||
143199558|NCT01338610|516276148|FG000|Overall Study|Adverse Event|3|||
143199559|NCT01338610|516276149|FG001|Overall Study|Adverse Event|0|||
143199560|NCT01338610|516276150|FG002|Overall Study|Adverse Event|0|||
143199561|NCT01765426|516276151|FG000|Overall Study|Lost to Follow-up|0|||
143199562|NCT01765426|516276152|FG001|Overall Study|Lost to Follow-up|1|||
143199563|NCT01765426|516276153|FG002|Overall Study|Lost to Follow-up|0|||
143199564|NCT01765426|516276154|FG003|Overall Study|Lost to Follow-up|0|||
143199565|NCT00694096|516276163|FG000|Overall Study|Withdrawal by Subject|5|||
143199566|NCT02914548|516276168|FG000|Overall Study|Adverse Event|15|||
143199567|NCT02914548|516276169|FG001|Overall Study|Adverse Event|7|||
143199568|NCT02914548|516276170|FG002|Overall Study|Adverse Event|15|||
143199569|NCT02914548|516276168|FG000|Overall Study|Physician Decision|2|||
143199570|NCT02914548|516276169|FG001|Overall Study|Physician Decision|2|||
143199571|NCT02914548|516276170|FG002|Overall Study|Physician Decision|0|||
143199572|NCT02914548|516276168|FG000|Overall Study|Protocol Violation|1|||
143199573|NCT02914548|516276169|FG001|Overall Study|Protocol Violation|0|||
143199574|NCT02914548|516276170|FG002|Overall Study|Protocol Violation|0|||
143199575|NCT02914548|516276168|FG000|Overall Study|Withdrawal by Subject|3|||
143199576|NCT02914548|516276169|FG001|Overall Study|Withdrawal by Subject|4|||
143199577|NCT02914548|516276170|FG002|Overall Study|Withdrawal by Subject|4|||
143199578|NCT02914548|516276168|FG000|Overall Study|>40% of body surface area|0|||
143199579|NCT02914548|516276169|FG001|Overall Study|>40% of body surface area|1|||
143199580|NCT02914548|516276170|FG002|Overall Study|>40% of body surface area|1|||
143199581|NCT02460783|516276180|FG000|Overall Study|Withdrawal by Subject|1|||
143199582|NCT02460783|516276181|FG001|Overall Study|Withdrawal by Subject|3|||
143199583|NCT02460783|516276180|FG000|Overall Study|Lost to Follow-up|1|||
143199584|NCT02460783|516276181|FG001|Overall Study|Lost to Follow-up|1|||
143199585|NCT01799239|516276184|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
143199586|NCT01799239|516276185|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
143199587|NCT01799239|516276184|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
143262197|NCT03034200|516513838|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
143199588|NCT01799239|516276185|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
143199589|NCT01799239|516276184|FG000|Period 1 (7 Days)|Protocol Violation|0|||
143199590|NCT01799239|516276185|FG001|Period 1 (7 Days)|Protocol Violation|1|||
143199591|NCT01799239|516276184|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
143199592|NCT01799239|516276185|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
143199593|NCT01799239|516276184|FG000|Period 2 (7 Days)|Protocol Violation|1|||
143199594|NCT01799239|516276185|FG001|Period 2 (7 Days)|Protocol Violation|0|||
143199595|NCT01286987|516276186|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
143199596|NCT01286987|516276187|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
143262198|NCT03034200|516513839|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
143199597|NCT01286987|516276188|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
143199598|NCT01286987|516276189|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
143199599|NCT01286987|516276190|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
143199600|NCT01286987|516276191|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
143199601|NCT01286987|516276192|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
143199602|NCT01286987|516276193|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
143199603|NCT01286987|516276194|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
143262199|NCT03034200|516513837|FG000|Overall Study|Adjuvant Therapy|0|||
143199604|NCT01286987|516276195|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
143199605|NCT01286987|516276196|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
143199606|NCT01286987|516276197|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
143199607|NCT01286987|516276198|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
143199608|NCT01286987|516276199|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
143199609|NCT01286987|516276200|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
143199610|NCT01286987|516276186|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
143199611|NCT01286987|516276187|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
143199612|NCT01286987|516276188|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
143199613|NCT01286987|516276189|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
143199614|NCT01286987|516276190|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
143199615|NCT01286987|516276191|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
143199616|NCT01286987|516276192|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
143199617|NCT01286987|516276193|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
143199618|NCT01286987|516276194|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
143199619|NCT01286987|516276195|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
143199620|NCT01286987|516276196|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
143199621|NCT01286987|516276197|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
143199622|NCT01286987|516276198|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
143199623|NCT01286987|516276199|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
143199624|NCT01286987|516276200|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
143199625|NCT01286987|516276186|FG000|Part 1: Dose Escalation|Physician Decision|0|||
143199626|NCT01286987|516276187|FG001|Part 1: Dose Escalation|Physician Decision|0|||
143199627|NCT01286987|516276188|FG002|Part 1: Dose Escalation|Physician Decision|0|||
143199628|NCT01286987|516276189|FG003|Part 1: Dose Escalation|Physician Decision|0|||
143199629|NCT01286987|516276190|FG004|Part 1: Dose Escalation|Physician Decision|1|||
143199630|NCT01286987|516276191|FG005|Part 1: Dose Escalation|Physician Decision|0|||
143199631|NCT01286987|516276192|FG006|Part 1: Dose Escalation|Physician Decision|0|||
143199632|NCT01286987|516276193|FG007|Part 1: Dose Escalation|Physician Decision|0|||
143199633|NCT01286987|516276194|FG008|Part 1: Dose Escalation|Physician Decision|0|||
143199634|NCT01286987|516276195|FG009|Part 1: Dose Escalation|Physician Decision|0|||
143199635|NCT01286987|516276196|FG010|Part 1: Dose Escalation|Physician Decision|0|||
143199636|NCT01286987|516276197|FG011|Part 1: Dose Escalation|Physician Decision|0|||
143199637|NCT01286987|516276198|FG012|Part 1: Dose Escalation|Physician Decision|0|||
143199638|NCT01286987|516276199|FG013|Part 1: Dose Escalation|Physician Decision|0|||
143199639|NCT01286987|516276200|FG014|Part 1: Dose Escalation|Physician Decision|0|||
143199640|NCT01286987|516276186|FG000|Part 2: Dose Expansion|Death|0|||
143199641|NCT01286987|516276187|FG001|Part 2: Dose Expansion|Death|0|||
143199642|NCT01286987|516276188|FG002|Part 2: Dose Expansion|Death|0|||
143199643|NCT01286987|516276189|FG003|Part 2: Dose Expansion|Death|0|||
143199644|NCT01286987|516276190|FG004|Part 2: Dose Expansion|Death|0|||
143199645|NCT01286987|516276191|FG005|Part 2: Dose Expansion|Death|0|||
143199646|NCT01286987|516276192|FG006|Part 2: Dose Expansion|Death|0|||
143199647|NCT01286987|516276193|FG007|Part 2: Dose Expansion|Death|0|||
143199648|NCT01286987|516276194|FG008|Part 2: Dose Expansion|Death|0|||
143199649|NCT01286987|516276195|FG009|Part 2: Dose Expansion|Death|0|||
143262200|NCT03034200|516513838|FG001|Overall Study|Adjuvant Therapy|0|||
143262201|NCT03034200|516513839|FG002|Overall Study|Adjuvant Therapy|1|||
143262202|NCT01288976|516513840|FG000|Overall Study|Withdrawal by Subject|58|||
143262203|NCT01288976|516513841|FG001|Overall Study|Withdrawal by Subject|12|||
143262204|NCT01288976|516513842|FG002|Overall Study|Withdrawal by Subject|9|||
143262205|NCT01288976|516513840|FG000|Overall Study|Death|98|||
143262206|NCT01288976|516513841|FG001|Overall Study|Death|6|||
143262207|NCT01288976|516513842|FG002|Overall Study|Death|4|||
143262208|NCT01288976|516513840|FG000|Overall Study|Data unavailable|22|||
143262209|NCT01288976|516513841|FG001|Overall Study|Data unavailable|9|||
143262210|NCT01288976|516513842|FG002|Overall Study|Data unavailable|7|||
143262211|NCT05523323|516513849|FG000|Overall Study|Death|26|||
143262212|NCT05523323|516513850|FG001|Overall Study|Death|21|||
143262213|NCT05523323|516513849|FG000|Overall Study|Ongoing participants|35|||
143262214|NCT05523323|516513850|FG001|Overall Study|Ongoing participants|30|||
143262215|NCT02469038|516513851|FG000|Overall Study|Physician Decision|4|||
143262216|NCT02469038|516513852|FG001|Overall Study|Physician Decision|5|||
143262217|NCT03435640|516513853|FG000|Overall Study|Withdrawal by Subject|0|||
143262218|NCT03435640|516513854|FG001|Overall Study|Withdrawal by Subject|1|||
143262219|NCT03435640|516513855|FG002|Overall Study|Withdrawal by Subject|0|||
143262220|NCT03435640|516513856|FG003|Overall Study|Withdrawal by Subject|2|||
143262221|NCT03435640|516513857|FG004|Overall Study|Withdrawal by Subject|0|||
143262222|NCT03435640|516513858|FG005|Overall Study|Withdrawal by Subject|0|||
143262223|NCT03435640|516513859|FG006|Overall Study|Withdrawal by Subject|3|||
143262224|NCT03435640|516513860|FG007|Overall Study|Withdrawal by Subject|0|||
143262225|NCT03435640|516513861|FG008|Overall Study|Withdrawal by Subject|0|||
143262226|NCT03435640|516513862|FG009|Overall Study|Withdrawal by Subject|2|||
143262227|NCT03435640|516513863|FG010|Overall Study|Withdrawal by Subject|3|||
143262228|NCT03435640|516513853|FG000|Overall Study|Lost to Follow-up|0|||
143262229|NCT03435640|516513854|FG001|Overall Study|Lost to Follow-up|0|||
143199650|NCT01286987|516276196|FG010|Part 2: Dose Expansion|Death|0|||
143262230|NCT03435640|516513855|FG002|Overall Study|Lost to Follow-up|1|||
143262231|NCT03435640|516513856|FG003|Overall Study|Lost to Follow-up|0|||
143262232|NCT03435640|516513857|FG004|Overall Study|Lost to Follow-up|0|||
143199651|NCT01286987|516276197|FG011|Part 2: Dose Expansion|Death|0|||
143199652|NCT01286987|516276198|FG012|Part 2: Dose Expansion|Death|1|||
143199653|NCT01286987|516276199|FG013|Part 2: Dose Expansion|Death|1|||
143199654|NCT01286987|516276200|FG014|Part 2: Dose Expansion|Death|0|||
143199655|NCT01286987|516276186|FG000|Part 2: Dose Expansion|Physician Decision|0|||
143199656|NCT01286987|516276187|FG001|Part 2: Dose Expansion|Physician Decision|0|||
143199657|NCT01286987|516276188|FG002|Part 2: Dose Expansion|Physician Decision|0|||
143199658|NCT01286987|516276189|FG003|Part 2: Dose Expansion|Physician Decision|0|||
143199659|NCT01286987|516276190|FG004|Part 2: Dose Expansion|Physician Decision|0|||
143199660|NCT01286987|516276191|FG005|Part 2: Dose Expansion|Physician Decision|0|||
143199661|NCT01286987|516276192|FG006|Part 2: Dose Expansion|Physician Decision|0|||
143199662|NCT01286987|516276193|FG007|Part 2: Dose Expansion|Physician Decision|0|||
143199663|NCT01286987|516276194|FG008|Part 2: Dose Expansion|Physician Decision|0|||
143199664|NCT01286987|516276195|FG009|Part 2: Dose Expansion|Physician Decision|0|||
143199665|NCT01286987|516276196|FG010|Part 2: Dose Expansion|Physician Decision|1|||
143199666|NCT01286987|516276197|FG011|Part 2: Dose Expansion|Physician Decision|1|||
143199667|NCT01286987|516276198|FG012|Part 2: Dose Expansion|Physician Decision|0|||
143199668|NCT01286987|516276199|FG013|Part 2: Dose Expansion|Physician Decision|1|||
143199669|NCT01286987|516276200|FG014|Part 2: Dose Expansion|Physician Decision|0|||
143199670|NCT01286987|516276186|FG000|Part 2: Dose Expansion|Other|0|||
143199671|NCT01286987|516276187|FG001|Part 2: Dose Expansion|Other|0|||
143199672|NCT01286987|516276188|FG002|Part 2: Dose Expansion|Other|0|||
143199673|NCT01286987|516276189|FG003|Part 2: Dose Expansion|Other|0|||
143199674|NCT01286987|516276190|FG004|Part 2: Dose Expansion|Other|0|||
143199675|NCT01286987|516276191|FG005|Part 2: Dose Expansion|Other|0|||
143199676|NCT01286987|516276192|FG006|Part 2: Dose Expansion|Other|0|||
143199677|NCT01286987|516276193|FG007|Part 2: Dose Expansion|Other|0|||
143199678|NCT01286987|516276194|FG008|Part 2: Dose Expansion|Other|0|||
143199679|NCT01286987|516276195|FG009|Part 2: Dose Expansion|Other|0|||
143199680|NCT01286987|516276196|FG010|Part 2: Dose Expansion|Other|0|||
143199681|NCT01286987|516276197|FG011|Part 2: Dose Expansion|Other|0|||
143199682|NCT01286987|516276198|FG012|Part 2: Dose Expansion|Other|0|||
143199683|NCT01286987|516276199|FG013|Part 2: Dose Expansion|Other|1|||
143199684|NCT01286987|516276200|FG014|Part 2: Dose Expansion|Other|0|||
143199685|NCT01286987|516276186|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
143199686|NCT01286987|516276187|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
143199687|NCT01286987|516276188|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
143199688|NCT01286987|516276189|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
143199689|NCT01286987|516276190|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
143199690|NCT01286987|516276191|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
143199691|NCT01286987|516276192|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
143199692|NCT01286987|516276193|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
143199693|NCT01286987|516276194|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
143199694|NCT01286987|516276195|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
143199695|NCT01286987|516276196|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
143199696|NCT01286987|516276197|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
143199697|NCT01286987|516276198|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
143199698|NCT01286987|516276199|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
143199699|NCT01286987|516276200|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
143199700|NCT01286987|516276186|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
143199701|NCT01286987|516276187|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
143199702|NCT01286987|516276188|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
143199703|NCT01286987|516276189|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
143199704|NCT01286987|516276190|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
143199705|NCT01286987|516276191|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
143199706|NCT01286987|516276192|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
143199707|NCT01286987|516276193|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
143199708|NCT01286987|516276194|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
143199709|NCT01286987|516276195|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
143199710|NCT01286987|516276196|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
143199711|NCT01286987|516276197|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
143199712|NCT01286987|516276198|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
143199713|NCT01286987|516276199|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
143199714|NCT01286987|516276200|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
143199715|NCT01286987|516276186|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
143199716|NCT01286987|516276187|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
143199717|NCT01286987|516276188|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
143199718|NCT01286987|516276189|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
143199719|NCT01286987|516276190|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
143199720|NCT01286987|516276191|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
143199721|NCT01286987|516276192|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
143199722|NCT01286987|516276193|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
143262233|NCT03435640|516513858|FG005|Overall Study|Lost to Follow-up|0|||
143199723|NCT01286987|516276194|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
143199724|NCT01286987|516276195|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
143199725|NCT01286987|516276196|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
143199726|NCT01286987|516276197|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
143199727|NCT01286987|516276198|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
143199728|NCT01286987|516276199|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
143199729|NCT01286987|516276200|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
143199730|NCT02185014|516276201|FG000|Overall Study|Adverse Event|18|||
143199731|NCT02185014|516276201|FG000|Overall Study|Withdrew Consent|8|||
143199732|NCT02185014|516276201|FG000|Overall Study|Lost to Follow-up|4|||
143199733|NCT02185014|516276201|FG000|Overall Study|Lack of Efficacy|14|||
143199734|NCT02185014|516276201|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
143199735|NCT02185014|516276201|FG000|Overall Study|Subject Noncompliance|1|||
143199736|NCT02185014|516276201|FG000|Overall Study|Other|4|||
143199737|NCT03093974|516276202|FG000|Overall Study|Withdrawal by Subject|32|||
143199738|NCT03093974|516276203|FG001|Overall Study|Withdrawal by Subject|27|||
143199739|NCT03093974|516276202|FG000|Overall Study|Adverse Event|17|||
143199740|NCT03093974|516276203|FG001|Overall Study|Adverse Event|24|||
143199741|NCT03093974|516276202|FG000|Overall Study|Death|0|||
143199742|NCT03093974|516276203|FG001|Overall Study|Death|1|||
143199743|NCT03093974|516276202|FG000|Overall Study|Non-Compliance with Study Drug|1|||
143199744|NCT03093974|516276203|FG001|Overall Study|Non-Compliance with Study Drug|0|||
143199745|NCT03093974|516276202|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
143199746|NCT03093974|516276203|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
143199747|NCT03093974|516276202|FG000|Overall Study|Lost to Follow-up|0|||
143199748|NCT03093974|516276203|FG001|Overall Study|Lost to Follow-up|1|||
143199749|NCT03093974|516276202|FG000|Overall Study|Other|1|||
143199750|NCT03093974|516276203|FG001|Overall Study|Other|2|||
143199751|NCT00033540|516276206|FG000|Overall Study|Adverse Event|14|||
143199752|NCT00033540|516276206|FG000|Overall Study|Death|1|||
143199753|NCT00033540|516276206|FG000|Overall Study|Progression|26|||
143199754|NCT00033540|516276206|FG000|Overall Study|Withdrawal by Subject|6|||
143199755|NCT00033540|516276206|FG000|Overall Study|Other|5|||
143199756|NCT00033540|516276206|FG000|Overall Study|Ineligible|3|||
143199757|NCT00033540|516276206|FG000|Overall Study|Never received treatment|2|||
143199758|NCT02410824|516276212|FG000|First Intervention (One Week)|Headache|0|||
143199759|NCT02410824|516276213|FG001|First Intervention (One Week)|Headache|1|||
143199760|NCT02436408|516276214|FG000|Overall Study|Death|1|||
143199761|NCT02782325|516276215|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
143199762|NCT02782325|516276216|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
143199763|NCT02782325|516276217|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
143199764|NCT02782325|516276215|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
143199765|NCT02782325|516276216|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
143199766|NCT02782325|516276217|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
143199767|NCT00930969|516276218|FG000|Overall Study|Death|5|||
143199768|NCT00930969|516276218|FG000|Overall Study|Lost to Follow-up|1|||
143199769|NCT00930969|516276218|FG000|Overall Study|Physician Decision|13|||
143199770|NCT00930969|516276218|FG000|Overall Study|Withdrawal by Subject|19|||
143199771|NCT00657150|516276219|FG000|Overall Study|Adverse Event|19|||
143199772|NCT00657150|516276220|FG001|Overall Study|Adverse Event|10|||
143199773|NCT00657150|516276219|FG000|Overall Study|Non-compliant with protocol|5|||
143199774|NCT00657150|516276220|FG001|Overall Study|Non-compliant with protocol|9|||
143199775|NCT00657150|516276219|FG000|Overall Study|Lost to Follow-up|2|||
143199776|NCT00657150|516276220|FG001|Overall Study|Lost to Follow-up|0|||
143199777|NCT00657150|516276219|FG000|Overall Study|Withdrawal by Subject|51|||
143199778|NCT00657150|516276220|FG001|Overall Study|Withdrawal by Subject|36|||
143199779|NCT00657150|516276219|FG000|Overall Study|Other|38|||
143199780|NCT00657150|516276220|FG001|Overall Study|Other|38|||
143199781|NCT00657150|516276219|FG000|Treatment|Adverse Event|60|||
143199782|NCT00657150|516276220|FG001|Treatment|Adverse Event|53|||
143199783|NCT00657150|516276219|FG000|Treatment|Non-compliant with protocol|10|||
143199784|NCT00657150|516276220|FG001|Treatment|Non-compliant with protocol|9|||
143199785|NCT00657150|516276219|FG000|Treatment|Lost to Follow-up|1|||
143199786|NCT00657150|516276220|FG001|Treatment|Lost to Follow-up|0|||
143199787|NCT00657150|516276219|FG000|Treatment|Withdrawal by Subject|23|||
143199788|NCT00657150|516276220|FG001|Treatment|Withdrawal by Subject|20|||
143199789|NCT00657150|516276219|FG000|Treatment|Other|13|||
143199790|NCT00657150|516276220|FG001|Treatment|Other|15|||
143199791|NCT04070326|516276227|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
143199792|NCT04070326|516276228|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
143199793|NCT00526110|516276232|FG000|Overall Study|Adverse Event|2|||
143199794|NCT00526110|516276233|FG001|Overall Study|Adverse Event|9|||
143199795|NCT00526110|516276232|FG000|Overall Study|Disease Progression|0|||
143199796|NCT00526110|516276233|FG001|Overall Study|Disease Progression|19|||
143199797|NCT00526110|516276232|FG000|Overall Study|Maximal Response|0|||
143199798|NCT00526110|516276233|FG001|Overall Study|Maximal Response|6|||
143199799|NCT00526110|516276232|FG000|Overall Study|Withdrawal by Subject|0|||
143199800|NCT00526110|516276233|FG001|Overall Study|Withdrawal by Subject|2|||
143199801|NCT00526110|516276232|FG000|Overall Study|Poor Tolerance|0|||
143199802|NCT00526110|516276233|FG001|Overall Study|Poor Tolerance|5|||
143199803|NCT01400243|516276235|FG000|Overall Study|Protocol Violation|8|||
143199804|NCT01400243|516276236|FG001|Overall Study|Protocol Violation|11|||
143199805|NCT02193087|516276237|FG000|Overall Study|Adverse Event|2|||
143199806|NCT02193087|516276238|FG001|Overall Study|Adverse Event|0|||
143199807|NCT02193087|516276239|FG002|Overall Study|Adverse Event|0|||
143199808|NCT02193087|516276240|FG003|Overall Study|Adverse Event|11|||
143199809|NCT02193087|516276237|FG000|Overall Study|Lost to Follow-up|14|||
143199810|NCT02193087|516276238|FG001|Overall Study|Lost to Follow-up|6|||
143199811|NCT02193087|516276239|FG002|Overall Study|Lost to Follow-up|4|||
143199812|NCT02193087|516276240|FG003|Overall Study|Lost to Follow-up|37|||
143199813|NCT02193087|516276237|FG000|Overall Study|Protocol Violation|2|||
143199814|NCT02193087|516276238|FG001|Overall Study|Protocol Violation|0|||
143199815|NCT02193087|516276239|FG002|Overall Study|Protocol Violation|1|||
143199816|NCT02193087|516276240|FG003|Overall Study|Protocol Violation|2|||
143199817|NCT02193087|516276237|FG000|Overall Study|Withdrawal by Subject|10|||
143199818|NCT02193087|516276238|FG001|Overall Study|Withdrawal by Subject|3|||
143199819|NCT02193087|516276239|FG002|Overall Study|Withdrawal by Subject|1|||
143199820|NCT02193087|516276240|FG003|Overall Study|Withdrawal by Subject|19|||
143199821|NCT02193087|516276237|FG000|Overall Study|Other Reason Not Specified|7|||
143199822|NCT02193087|516276238|FG001|Overall Study|Other Reason Not Specified|2|||
143199823|NCT02193087|516276239|FG002|Overall Study|Other Reason Not Specified|1|||
143199824|NCT02193087|516276240|FG003|Overall Study|Other Reason Not Specified|9|||
143199825|NCT02193087|516276237|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
143199826|NCT02193087|516276238|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
143199827|NCT02193087|516276239|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
143199828|NCT02193087|516276240|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
143199829|NCT02278614|516276243|FG000|Overall Study|Withdrawal by Subject|3|||
143199830|NCT02278614|516276244|FG001|Overall Study|Withdrawal by Subject|5|||
143199831|NCT02278614|516276243|FG000|Overall Study|Adverse Event|1|||
143199832|NCT02278614|516276244|FG001|Overall Study|Adverse Event|0|||
143199833|NCT02278614|516276243|FG000|Overall Study|left eye was not eligible|1|||
143199834|NCT02278614|516276244|FG001|Overall Study|left eye was not eligible|0|||
143199835|NCT03762616|516276246|FG000|Overall Study|Protocol Violation|2|||
143199836|NCT00471887|516278991|FG000|Overall Study|Adverse Event|9|||
143199837|NCT01930890|516278992|FG000|Overall Study|Study Termination|14|||
143199838|NCT01930890|516278993|FG001|Overall Study|Study Termination|28|||
143199839|NCT01930890|516278994|FG002|Overall Study|Study Termination|13|||
143199840|NCT01930890|516278995|FG003|Overall Study|Study Termination|25|||
143199841|NCT01930890|516278992|FG000|Overall Study|Death|0|||
143199842|NCT01930890|516278993|FG001|Overall Study|Death|0|||
143199843|NCT01930890|516278994|FG002|Overall Study|Death|0|||
143199844|NCT01930890|516278995|FG003|Overall Study|Death|1|||
143199845|NCT01930890|516278992|FG000|Overall Study|Investigator Decision|0|||
143199846|NCT01930890|516278993|FG001|Overall Study|Investigator Decision|1|||
143199847|NCT01930890|516278994|FG002|Overall Study|Investigator Decision|0|||
143199848|NCT01930890|516278995|FG003|Overall Study|Investigator Decision|0|||
143199849|NCT01930890|516278992|FG000|Overall Study|Consent Withdrawn|0|||
143262234|NCT03435640|516513859|FG006|Overall Study|Lost to Follow-up|0|||
143262235|NCT03435640|516513860|FG007|Overall Study|Lost to Follow-up|0|||
143262236|NCT03435640|516513861|FG008|Overall Study|Lost to Follow-up|0|||
143199850|NCT01930890|516278993|FG001|Overall Study|Consent Withdrawn|3|||
143199851|NCT01930890|516278994|FG002|Overall Study|Consent Withdrawn|0|||
143199852|NCT01930890|516278995|FG003|Overall Study|Consent Withdrawn|1|||
143199853|NCT01930890|516278992|FG000|Overall Study|Adverse Event|0|||
143199854|NCT01930890|516278993|FG001|Overall Study|Adverse Event|1|||
143199855|NCT01930890|516278994|FG002|Overall Study|Adverse Event|0|||
143199856|NCT01930890|516278995|FG003|Overall Study|Adverse Event|0|||
143199857|NCT02091284|516278996|FG000|Overall Study|Withdrawal by Subject|2|||
143199858|NCT02091284|516278997|FG001|Overall Study|Withdrawal by Subject|1|||
143199859|NCT02091284|516278996|FG000|Overall Study|unreliable data|1|||
143199860|NCT02091284|516278997|FG001|Overall Study|unreliable data|0|||
143199861|NCT02536300|516278998|FG000|Overall Study|Investigator's Discretion|17|||
143199862|NCT02536300|516278999|FG001|Overall Study|Investigator's Discretion|11|||
143199863|NCT02536300|516279000|FG002|Overall Study|Investigator's Discretion|2|||
143199864|NCT02536300|516278998|FG000|Overall Study|Progressive Disease|11|||
143262237|NCT03435640|516513862|FG009|Overall Study|Lost to Follow-up|0|||
143262238|NCT03435640|516513863|FG010|Overall Study|Lost to Follow-up|0|||
143262239|NCT00636987|516513864|FG000|Overall Study|Death|44|||
143262240|NCT00636987|516513864|FG000|Overall Study|Explanted|13|||
143199865|NCT02536300|516278999|FG001|Overall Study|Progressive Disease|7|||
143199866|NCT02536300|516279000|FG002|Overall Study|Progressive Disease|6|||
143199867|NCT02536300|516278998|FG000|Overall Study|Study Terminated by Sponsor|6|||
143199868|NCT02536300|516278999|FG001|Overall Study|Study Terminated by Sponsor|4|||
143262241|NCT00636987|516513864|FG000|Overall Study|Lost to Follow-up|63|||
143199869|NCT02536300|516279000|FG002|Overall Study|Study Terminated by Sponsor|7|||
143262242|NCT00636987|516513864|FG000|Overall Study|5 year visit window not complete|69|||
143199870|NCT02536300|516278998|FG000|Overall Study|Death|7|||
143199871|NCT02536300|516278999|FG001|Overall Study|Death|0|||
143199872|NCT02536300|516279000|FG002|Overall Study|Death|5|||
143199873|NCT02536300|516278998|FG000|Overall Study|Withdrew Consent|4|||
143199874|NCT02536300|516278999|FG001|Overall Study|Withdrew Consent|2|||
143199875|NCT02536300|516279000|FG002|Overall Study|Withdrew Consent|0|||
143199876|NCT02536300|516278998|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
143199877|NCT02536300|516278999|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
143199878|NCT02536300|516279000|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
143199879|NCT02536300|516278998|FG000|Overall Study|Enrolled but Never Treated|0|||
143199880|NCT02536300|516278999|FG001|Overall Study|Enrolled but Never Treated|0|||
143199881|NCT02536300|516279000|FG002|Overall Study|Enrolled but Never Treated|1|||
143199882|NCT02536300|516278998|FG000|Overall Study|Non-compliance With Study Drug|1|||
143199883|NCT02536300|516278999|FG001|Overall Study|Non-compliance With Study Drug|0|||
143199884|NCT02536300|516279000|FG002|Overall Study|Non-compliance With Study Drug|0|||
143199885|NCT02536300|516278998|FG000|Overall Study|Protocol Violation|0|||
143199886|NCT02536300|516278999|FG001|Overall Study|Protocol Violation|1|||
143199887|NCT02536300|516279000|FG002|Overall Study|Protocol Violation|0|||
143199888|NCT01974752|516279001|FG000|Overall Study|Death|33|||
143199889|NCT01974752|516279002|FG001|Overall Study|Death|11|||
143199890|NCT01974752|516279001|FG000|Overall Study|Lost to Follow-up|2|||
143199891|NCT01974752|516279002|FG001|Overall Study|Lost to Follow-up|0|||
143199892|NCT01974752|516279001|FG000|Overall Study|Withdrawal by Subject|2|||
143199893|NCT01974752|516279002|FG001|Overall Study|Withdrawal by Subject|3|||
143199894|NCT01974752|516279001|FG000|Overall Study|Other Eligibility Criteria|0|||
143199895|NCT01974752|516279002|FG001|Overall Study|Other Eligibility Criteria|1|||
143199896|NCT02317809|516279003|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
143199897|NCT02317809|516279004|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
143199898|NCT02317809|516279003|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
143199899|NCT02317809|516279004|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
143199900|NCT00096174|516279006|FG000|Overall Study|Lack of Efficacy|9|||
143199901|NCT00096174|516279006|FG000|Overall Study|Adverse Event|15|||
143199902|NCT00096174|516279006|FG000|Overall Study|Death|6|||
143199903|NCT00096174|516279006|FG000|Overall Study|Withdrawal by Subject|15|||
143199904|NCT00096174|516279006|FG000|Overall Study|Not started protocol therapy|3|||
143199905|NCT00096174|516279006|FG000|Overall Study|Ineligible|6|||
143199906|NCT00096174|516279006|FG000|Overall Study|other reason|8|||
143199907|NCT00330928|516279009|FG000|Overall Study|Lost to Follow-up|6|||
143199908|NCT00330928|516279009|FG000|Overall Study|Physician Decision|9|||
143199909|NCT00330928|516279009|FG000|Overall Study|Death|1|||
143199910|NCT00330928|516279009|FG000|Overall Study|IVUS could not be performed.|1|||
143199911|NCT04612842|516279015|FG000|Overall Study|Lost to Follow-up|20|||
143199912|NCT04612842|516279016|FG001|Overall Study|Lost to Follow-up|11|||
143199913|NCT04612842|516279015|FG000|Overall Study|Withdrawal by Subject|26|||
143199914|NCT04612842|516279016|FG001|Overall Study|Withdrawal by Subject|15|||
143199915|NCT04612842|516279015|FG000|Overall Study|Death|2|||
143199916|NCT04612842|516279016|FG001|Overall Study|Death|2|||
143199917|NCT05426031|516279017|FG000|Overall Study|Circulatory Arrest|3|||
143199918|NCT05426031|516279018|FG001|Overall Study|Circulatory Arrest|2|||
143199919|NCT03060512|516279019|FG000|Overall Study|Adverse Event|4|||
143199920|NCT03060512|516279020|FG001|Overall Study|Adverse Event|6|||
143199921|NCT03060512|516279019|FG000|Overall Study|Lost to Follow-up|1|||
143199922|NCT03060512|516279020|FG001|Overall Study|Lost to Follow-up|1|||
143199923|NCT03060512|516279019|FG000|Overall Study|Withdrawal by Subject|1|||
143199924|NCT03060512|516279020|FG001|Overall Study|Withdrawal by Subject|0|||
143199925|NCT03060512|516279019|FG000|Overall Study|Non-compliance with study medication|1|||
143199926|NCT03060512|516279020|FG001|Overall Study|Non-compliance with study medication|2|||
143199927|NCT00089986|516279021|FG000|Overall Study|Adverse Event|6|||
143199928|NCT00089986|516279022|FG001|Overall Study|Adverse Event|9|||
143199929|NCT00089986|516279023|FG002|Overall Study|Adverse Event|6|||
143199930|NCT00089986|516279021|FG000|Overall Study|Lost to Follow-up|3|||
143199931|NCT00089986|516279022|FG001|Overall Study|Lost to Follow-up|1|||
143199932|NCT00089986|516279023|FG002|Overall Study|Lost to Follow-up|1|||
143199933|NCT00089986|516279021|FG000|Overall Study|Protocol Violation|0|||
143199934|NCT00089986|516279022|FG001|Overall Study|Protocol Violation|1|||
143199935|NCT00089986|516279023|FG002|Overall Study|Protocol Violation|0|||
143199936|NCT00089986|516279021|FG000|Overall Study|Patient transferred to another hospital|2|||
143199937|NCT00089986|516279022|FG001|Overall Study|Patient transferred to another hospital|1|||
143199938|NCT00089986|516279023|FG002|Overall Study|Patient transferred to another hospital|0|||
143199939|NCT00089986|516279021|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
143199940|NCT00089986|516279022|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
143199941|NCT00089986|516279023|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
143199942|NCT00089986|516279021|FG000|Overall Study|Hemohlobin stopping rule|0|||
143199943|NCT00089986|516279022|FG001|Overall Study|Hemohlobin stopping rule|1|||
143199944|NCT00089986|516279023|FG002|Overall Study|Hemohlobin stopping rule|0|||
143199945|NCT00089986|516279021|FG000|Overall Study|Investigator decision to withdrew|0|||
143199946|NCT00089986|516279022|FG001|Overall Study|Investigator decision to withdrew|1|||
143199947|NCT00089986|516279023|FG002|Overall Study|Investigator decision to withdrew|0|||
143199948|NCT00089986|516279021|FG000|Overall Study|Enrollment in another study|0|||
143199949|NCT00089986|516279022|FG001|Overall Study|Enrollment in another study|1|||
143199950|NCT00089986|516279023|FG002|Overall Study|Enrollment in another study|0|||
143199951|NCT00089986|516279021|FG000|Overall Study|Family decision|0|||
143199952|NCT00089986|516279022|FG001|Overall Study|Family decision|1|||
143199953|NCT00089986|516279023|FG002|Overall Study|Family decision|0|||
143199954|NCT00089986|516279021|FG000|Overall Study|Do not resuscitate (DNR)|0|||
143199955|NCT00089986|516279022|FG001|Overall Study|Do not resuscitate (DNR)|0|||
143199956|NCT00089986|516279023|FG002|Overall Study|Do not resuscitate (DNR)|1|||
143199957|NCT00089986|516279021|FG000|Overall Study|Withdrawal by Subject|3|||
143199958|NCT00089986|516279022|FG001|Overall Study|Withdrawal by Subject|6|||
143199959|NCT00089986|516279023|FG002|Overall Study|Withdrawal by Subject|2|||
143199960|NCT03946124|516279024|FG000|Overall Study|Withdrawal by Subject|19|||
143199961|NCT00241631|516279029|FG000|Run in (2 Weeks)|Physician Decision|3|||
143199962|NCT00241631|516279030|FG001|Run in (2 Weeks)|Physician Decision|3|||
143199963|NCT00241631|516279029|FG000|Phase 1 (4 Weeks)|sore throat|1|||
143199964|NCT00241631|516279030|FG001|Phase 1 (4 Weeks)|sore throat|0|||
143199965|NCT00241631|516279029|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
143199966|NCT00241631|516279030|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
143199967|NCT00241631|516279029|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
143199968|NCT00241631|516279030|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
143199969|NCT00241631|516279029|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
143199970|NCT00241631|516279030|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
143199971|NCT01118520|516279031|FG000|Overall Study|AAA repair|9|||
143199972|NCT01118520|516279032|FG001|Overall Study|AAA repair|7|||
143199973|NCT01118520|516279033|FG002|Overall Study|AAA repair|9|||
143199974|NCT01118520|516279031|FG000|Overall Study|Adverse Event|3|||
143199975|NCT01118520|516279032|FG001|Overall Study|Adverse Event|3|||
143199976|NCT01118520|516279033|FG002|Overall Study|Adverse Event|3|||
143199977|NCT01118520|516279031|FG000|Overall Study|Withdrawal by Subject|8|||
143199978|NCT01118520|516279032|FG001|Overall Study|Withdrawal by Subject|13|||
143199979|NCT01118520|516279033|FG002|Overall Study|Withdrawal by Subject|8|||
143199980|NCT00413920|516279037|FG000|Overall Study|Adverse Event|9|||
143199981|NCT00413920|516279038|FG001|Overall Study|Adverse Event|11|||
143199982|NCT00413920|516279037|FG000|Overall Study|Lack of Efficacy|11|||
143199983|NCT00413920|516279038|FG001|Overall Study|Lack of Efficacy|9|||
143199984|NCT00413920|516279037|FG000|Overall Study|Death|3|||
143199985|NCT00413920|516279038|FG001|Overall Study|Death|5|||
143199986|NCT00413920|516279037|FG000|Overall Study|Graft Loss|5|||
143199987|NCT00413920|516279038|FG001|Overall Study|Graft Loss|3|||
143199988|NCT03883113|516279040|FG000|Overall Study|Physician Decision|4|||
143199989|NCT03883113|516279041|FG001|Overall Study|Physician Decision|2|||
143199990|NCT03883113|516279040|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
143199991|NCT03883113|516279041|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
143199992|NCT03883113|516279040|FG000|Overall Study|Pregnancy|1|||
143199993|NCT03883113|516279041|FG001|Overall Study|Pregnancy|0|||
143199994|NCT03883113|516279040|FG000|Overall Study|Adverse Event|0|||
143199995|NCT03883113|516279041|FG001|Overall Study|Adverse Event|1|||
143199996|NCT03883113|516279040|FG000|Overall Study|Withdrawal by Subject|1|||
143199997|NCT03883113|516279041|FG001|Overall Study|Withdrawal by Subject|2|||
143199998|NCT03883113|516279040|FG000|Overall Study|Lost to Follow-up|1|||
143199999|NCT03883113|516279041|FG001|Overall Study|Lost to Follow-up|0|||
143200000|NCT03831880|516279042|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
143200001|NCT03831880|516279043|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
143200002|NCT03831880|516279042|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
143200003|NCT03831880|516279043|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
143200004|NCT03958656|516279044|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
143200005|NCT03958656|516279045|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
143200006|NCT03958656|516279046|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
143200007|NCT03958656|516279047|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
143200008|NCT03958656|516279044|FG000|Overall Study|No longer meets eligibility criteria|0|||
143200009|NCT03958656|516279045|FG001|Overall Study|No longer meets eligibility criteria|0|||
143200010|NCT03958656|516279046|FG002|Overall Study|No longer meets eligibility criteria|1|||
143200011|NCT03958656|516279047|FG003|Overall Study|No longer meets eligibility criteria|0|||
143262243|NCT01251146|516513865|FG000|Overall Study|Lost to Follow-up|3|||
143262244|NCT01251146|516513866|FG001|Overall Study|Lost to Follow-up|10|||
143262245|NCT01739400|516513867|FG000|Overall Study|Physician Decision|3|||
143200012|NCT03958656|516279044|FG000|Overall Study|Started anti-cancer treatment|0|||
143200013|NCT03958656|516279045|FG001|Overall Study|Started anti-cancer treatment|0|||
143200014|NCT03958656|516279046|FG002|Overall Study|Started anti-cancer treatment|1|||
143200015|NCT03958656|516279047|FG003|Overall Study|Started anti-cancer treatment|0|||
143200016|NCT03158012|516279048|FG000|Overall Study|Withdrawal by Subject|0|||
143200017|NCT03158012|516279049|FG001|Overall Study|Withdrawal by Subject|1|||
143200018|NCT02788201|516279050|FG000|Overall Study|Death|1|||
143200019|NCT02788201|516279051|FG001|Overall Study|Death|1|||
143200020|NCT02788201|516279052|FG002|Overall Study|Death|1|||
143200021|NCT02788201|516279053|FG003|Overall Study|Death|1|||
143200022|NCT02788201|516279054|FG004|Overall Study|Death|0|||
143200023|NCT02788201|516279055|FG005|Overall Study|Death|1|||
143200024|NCT02788201|516279050|FG000|Overall Study|Ineligible|0|||
143200025|NCT02788201|516279051|FG001|Overall Study|Ineligible|0|||
143200026|NCT02788201|516279052|FG002|Overall Study|Ineligible|0|||
143200027|NCT02788201|516279053|FG003|Overall Study|Ineligible|0|||
143200028|NCT02788201|516279054|FG004|Overall Study|Ineligible|0|||
143200029|NCT02788201|516279055|FG005|Overall Study|Ineligible|1|||
143200030|NCT02788201|516279050|FG000|Overall Study|Withdrawal by Subject|0|||
143200031|NCT02788201|516279051|FG001|Overall Study|Withdrawal by Subject|0|||
143200032|NCT02788201|516279052|FG002|Overall Study|Withdrawal by Subject|0|||
143200033|NCT02788201|516279053|FG003|Overall Study|Withdrawal by Subject|0|||
143200034|NCT02788201|516279054|FG004|Overall Study|Withdrawal by Subject|0|||
143200035|NCT02788201|516279055|FG005|Overall Study|Withdrawal by Subject|1|||
143200036|NCT01414205|516279056|FG000|Overall Study|Death|5|||
143200037|NCT01414205|516279057|FG001|Overall Study|Death|1|||
143200038|NCT01414205|516279056|FG000|Overall Study|Lost to Follow-up|1|||
143200039|NCT01414205|516279057|FG001|Overall Study|Lost to Follow-up|4|||
143200040|NCT01414205|516279056|FG000|Overall Study|Physician Decision|0|||
143200041|NCT01414205|516279057|FG001|Overall Study|Physician Decision|1|||
143200042|NCT01414205|516279056|FG000|Overall Study|Randomized but not Treated|1|||
143200043|NCT01414205|516279057|FG001|Overall Study|Randomized but not Treated|1|||
143200044|NCT03421743|516279062|FG000|Overall Study|Lack of Efficacy|1|||
143200045|NCT03421743|516279063|FG001|Overall Study|Lack of Efficacy|0|||
143200046|NCT03421743|516279062|FG000|Overall Study|Adverse Event|2|||
143200047|NCT03421743|516279063|FG001|Overall Study|Adverse Event|1|||
143200048|NCT03421743|516279062|FG000|Overall Study|Withdrawal by Subject|0|||
143200049|NCT03421743|516279063|FG001|Overall Study|Withdrawal by Subject|1|||
143200050|NCT00435162|516279064|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
143200051|NCT00435162|516279065|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
143200052|NCT00435162|516279066|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
143200053|NCT00435162|516279067|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
143200054|NCT00435162|516279068|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
143200055|NCT00435162|516279069|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
143200056|NCT01457950|516279070|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
143200057|NCT01457950|516279071|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
143200058|NCT01457950|516279072|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
143200059|NCT01457950|516279073|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
143200060|NCT01457950|516279070|FG000|Double-Blind Phase|Protocol Violation|2|||
143200061|NCT01457950|516279071|FG001|Double-Blind Phase|Protocol Violation|1|||
143200062|NCT01457950|516279072|FG002|Double-Blind Phase|Protocol Violation|0|||
143200063|NCT01457950|516279073|FG003|Double-Blind Phase|Protocol Violation|0|||
143200064|NCT01457950|516279070|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
143200065|NCT01457950|516279071|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
143200066|NCT01457950|516279072|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
143200067|NCT01457950|516279073|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
143200068|NCT01457950|516279070|FG000|Open-Label Phase|Adverse Event|0|||
143200069|NCT01457950|516279071|FG001|Open-Label Phase|Adverse Event|0|||
143200070|NCT01457950|516279072|FG002|Open-Label Phase|Adverse Event|0|||
143200071|NCT01457950|516279073|FG003|Open-Label Phase|Adverse Event|1|||
143200072|NCT01457950|516279070|FG000|Open-Label Phase|Protocol Violation|0|||
143200073|NCT01457950|516279071|FG001|Open-Label Phase|Protocol Violation|0|||
143200074|NCT01457950|516279072|FG002|Open-Label Phase|Protocol Violation|0|||
143200075|NCT01457950|516279073|FG003|Open-Label Phase|Protocol Violation|1|||
143200076|NCT01457950|516279070|FG000|Open-Label Phase|Withdrawal by Subject|0|||
143200077|NCT01457950|516279071|FG001|Open-Label Phase|Withdrawal by Subject|0|||
143200078|NCT01457950|516279072|FG002|Open-Label Phase|Withdrawal by Subject|2|||
143200079|NCT01457950|516279073|FG003|Open-Label Phase|Withdrawal by Subject|0|||
143262246|NCT01739400|516513868|FG001|Overall Study|Physician Decision|0|||
143262247|NCT01739400|516513867|FG000|Overall Study|Lost to Follow-up|2|||
143200080|NCT01166373|516279074|FG000|Overall Study|Lost to Follow-up|3|||
143200081|NCT01166373|516279075|FG001|Overall Study|Lost to Follow-up|2|||
143200082|NCT01166373|516279076|FG002|Overall Study|Lost to Follow-up|2|||
143200083|NCT01166373|516279077|FG003|Overall Study|Lost to Follow-up|2|||
143200084|NCT01166373|516279074|FG000|Overall Study|Withdrawal by Subject|1|||
143200085|NCT01166373|516279075|FG001|Overall Study|Withdrawal by Subject|2|||
143200086|NCT01166373|516279076|FG002|Overall Study|Withdrawal by Subject|2|||
143200087|NCT01166373|516279077|FG003|Overall Study|Withdrawal by Subject|3|||
143200088|NCT01166373|516279074|FG000|Overall Study|Physician Decision|1|||
143200089|NCT01166373|516279075|FG001|Overall Study|Physician Decision|0|||
143200090|NCT01166373|516279076|FG002|Overall Study|Physician Decision|0|||
143200091|NCT01166373|516279077|FG003|Overall Study|Physician Decision|0|||
143200092|NCT01510184|516279078|FG000|Overall Study|Sponsor discretion|28|||
143200093|NCT01510184|516279079|FG001|Overall Study|Sponsor discretion|28|||
143200094|NCT01510184|516279078|FG000|Overall Study|Death|1|||
143200095|NCT01510184|516279079|FG001|Overall Study|Death|2|||
143200096|NCT01510184|516279078|FG000|Overall Study|Withdrawal by Subject|1|||
143200097|NCT01510184|516279079|FG001|Overall Study|Withdrawal by Subject|4|||
143200098|NCT01510184|516279078|FG000|Overall Study|Other|0|||
143200099|NCT01510184|516279079|FG001|Overall Study|Other|1|||
143200100|NCT00054691|516279080|FG000|Overall Study|Unmeasurable Disease|2|||
143200101|NCT00054691|516279080|FG000|Overall Study|Noncompliant|1|||
143200102|NCT01484834|516279081|FG000|Overall Study|Lost to Follow-up|5|||
143200103|NCT01484834|516279082|FG001|Overall Study|Lost to Follow-up|8|||
143200104|NCT01484834|516279083|FG002|Overall Study|Lost to Follow-up|1|||
143200105|NCT01484834|516279084|FG003|Overall Study|Lost to Follow-up|4|||
143200106|NCT01371643|516279085|FG000|Overall Study|Withdrawal by Subject|3|||
143200107|NCT01371643|516279086|FG001|Overall Study|Withdrawal by Subject|0|||
143200108|NCT03987932|516279090|FG000|Overall Study|Lost to Follow-up|2|||
143200109|NCT03987932|516279091|FG001|Overall Study|Lost to Follow-up|1|||
143200110|NCT03987932|516279092|FG002|Overall Study|Lost to Follow-up|1|||
143200111|NCT03987932|516279090|FG000|Overall Study|Non-study related elective surgery|0|||
143200112|NCT03987932|516279091|FG001|Overall Study|Non-study related elective surgery|0|||
143200113|NCT03987932|516279092|FG002|Overall Study|Non-study related elective surgery|1|||
143200114|NCT01605227|516279096|FG000|Overall Study|Did not receive study treatment|2|||
143200115|NCT01605227|516279097|FG001|Overall Study|Did not receive study treatment|3|||
143200116|NCT01605227|516279096|FG000|Overall Study|Adverse Event|228|||
143200117|NCT01605227|516279097|FG001|Overall Study|Adverse Event|42|||
143200118|NCT01605227|516279096|FG000|Overall Study|Progressive Disease|132|||
143200119|NCT01605227|516279097|FG001|Overall Study|Progressive Disease|128|||
143200120|NCT01605227|516279096|FG000|Overall Study|Clinical Deterioration|227|||
143200121|NCT01605227|516279097|FG001|Overall Study|Clinical Deterioration|133|||
143200122|NCT01605227|516279096|FG000|Overall Study|Lost to Follow-up|1|||
143200123|NCT01605227|516279097|FG001|Overall Study|Lost to Follow-up|0|||
143200124|NCT01605227|516279096|FG000|Overall Study|Protocol Violation|1|||
143200125|NCT01605227|516279097|FG001|Overall Study|Protocol Violation|0|||
143200126|NCT01605227|516279096|FG000|Overall Study|Physician Decision|9|||
143200127|NCT01605227|516279097|FG001|Overall Study|Physician Decision|7|||
143200128|NCT01605227|516279096|FG000|Overall Study|Withdrawal by Subject|18|||
143200129|NCT01605227|516279097|FG001|Overall Study|Withdrawal by Subject|14|||
143200130|NCT01605227|516279096|FG000|Overall Study|Sponsor Decision|2|||
143200131|NCT01605227|516279097|FG001|Overall Study|Sponsor Decision|0|||
143200132|NCT01605227|516279096|FG000|Overall Study|Started New Therapy|1|||
143200133|NCT01605227|516279097|FG001|Overall Study|Started New Therapy|0|||
143200134|NCT01605227|516279096|FG000|Overall Study|Subject Decision|0|||
143200135|NCT01605227|516279097|FG001|Overall Study|Subject Decision|1|||
143200136|NCT01605227|516279096|FG000|Overall Study|Dose Held >6 weeks|0|||
143200137|NCT01605227|516279097|FG001|Overall Study|Dose Held >6 weeks|1|||
143200138|NCT02078102|516279099|FG000|Overall Study|Adverse Event|1|||
143200139|NCT02078102|516279100|FG001|Overall Study|Adverse Event|0|||
143200140|NCT02078102|516279099|FG000|Overall Study|Withdrawal by Subject|1|||
143200141|NCT02078102|516279100|FG001|Overall Study|Withdrawal by Subject|0|||
143200142|NCT02078102|516279099|FG000|Overall Study|Physician Decision|0|||
143200143|NCT02078102|516279100|FG001|Overall Study|Physician Decision|1|||
143200144|NCT02387164|516279103|FG000|Overall Study|Lost to Follow-up|2|||
143200145|NCT02387164|516279104|FG001|Overall Study|Lost to Follow-up|0|||
143262248|NCT01739400|516513868|FG001|Overall Study|Lost to Follow-up|0|||
143262249|NCT01739400|516513867|FG000|Overall Study|Death|5|||
143262250|NCT01739400|516513868|FG001|Overall Study|Death|2|||
143262251|NCT01739400|516513867|FG000|Overall Study|Withdrawal by Subject|7|||
143262252|NCT01739400|516513868|FG001|Overall Study|Withdrawal by Subject|7|||
143262253|NCT03350984|516513869|FG000|Overall Study|Death|1|||
143200146|NCT02387164|516279103|FG000|Overall Study|Diagnosed|1|||
143200147|NCT02387164|516279104|FG001|Overall Study|Diagnosed|2|||
143200148|NCT02370641|516279105|FG000|Overall Study|dropped study|4|||
143200149|NCT02370641|516279106|FG001|Overall Study|dropped study|2|||
143200150|NCT05291936|516279110|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
143200151|NCT05291936|516279111|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
143200152|NCT05291936|516279110|FG000|Period 1|Withdrew Consent during study|1|||
143200153|NCT05291936|516279111|FG001|Period 1|Withdrew Consent during study|0|||
143262254|NCT03350984|516513870|FG001|Overall Study|Death|0|||
143200154|NCT05291936|516279110|FG000|Period 2|Adverse Event|0|||
143262255|NCT03350984|516513869|FG000|Overall Study|Lost to Follow-up|5|||
143200155|NCT05291936|516279111|FG001|Period 2|Adverse Event|1|||
143200156|NCT05291936|516279110|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
143200157|NCT05291936|516279111|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
143200158|NCT02370095|516279112|FG000|Overall Study|Withdrawal by Subject|0|||
143200159|NCT02370095|516279113|FG001|Overall Study|Withdrawal by Subject|1|||
143262256|NCT03350984|516513870|FG001|Overall Study|Lost to Follow-up|6|||
143262257|NCT03350984|516513869|FG000|Overall Study|Protocol Violation|1|||
143262258|NCT03350984|516513870|FG001|Overall Study|Protocol Violation|2|||
143262259|NCT03350984|516513869|FG000|Overall Study|Physician Decision|1|||
143262260|NCT03350984|516513870|FG001|Overall Study|Physician Decision|0|||
143262261|NCT01347307|516513871|FG000|Overall Study|Death|0|||
143262262|NCT01347307|516513872|FG001|Overall Study|Death|4|||
143262263|NCT01347307|516513871|FG000|Overall Study|Physician Decision|0|||
143262264|NCT01347307|516513872|FG001|Overall Study|Physician Decision|1|||
143262265|NCT00642473|516513873|FG000|Overall Study|Withdrawal by Subject|0|||
143200160|NCT01667562|516279114|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
143369769|NCT00543725|516897192|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
143200161|NCT01667562|516279115|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
143200162|NCT01667562|516279114|FG000|Erlotinib Phase|Lost to Follow-up|0|||
143200163|NCT01667562|516279115|FG001|Erlotinib Phase|Lost to Follow-up|1|||
143200164|NCT01667562|516279114|FG000|Erlotinib Phase|Adverse Event|0|||
143200165|NCT01667562|516279115|FG001|Erlotinib Phase|Adverse Event|1|||
143200166|NCT01667562|516279114|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
143200167|NCT01667562|516279115|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
143200168|NCT01129882|516279116|FG000|Overall Study|Adverse Event|39|||
143200169|NCT01129882|516279116|FG000|Overall Study|Death|6|||
143200170|NCT01129882|516279116|FG000|Overall Study|Lack of Efficacy|5|||
143200171|NCT01129882|516279116|FG000|Overall Study|Lost to Follow-up|13|||
143200172|NCT01129882|516279116|FG000|Overall Study|Physician Decision|27|||
143200173|NCT01129882|516279116|FG000|Overall Study|Protocol Deviation|3|||
143200174|NCT01129882|516279116|FG000|Overall Study|Withdrawal Criteria Met|19|||
143200175|NCT01129882|516279116|FG000|Overall Study|Trial Termination by Sponsor|6|||
143200176|NCT01129882|516279116|FG000|Overall Study|Withdrawal by Subject|160|||
143200177|NCT02130986|516279117|FG000|Overall Study|Withdrawal by Subject|4|||
143200178|NCT02130986|516279118|FG001|Overall Study|Withdrawal by Subject|4|||
143200179|NCT02130986|516279117|FG000|Overall Study|Lost to Follow-up|151|||
143200180|NCT02130986|516279118|FG001|Overall Study|Lost to Follow-up|160|||
143200181|NCT02305849|516279119|FG000|Overall Study|Adverse Event|10|||
143200182|NCT02305849|516279120|FG001|Overall Study|Adverse Event|12|||
143200183|NCT02305849|516279121|FG002|Overall Study|Adverse Event|7|||
143200184|NCT02305849|516279122|FG003|Overall Study|Adverse Event|3|||
143200185|NCT02305849|516279119|FG000|Overall Study|Lack of Efficacy|10|||
143200186|NCT02305849|516279120|FG001|Overall Study|Lack of Efficacy|6|||
143200187|NCT02305849|516279121|FG002|Overall Study|Lack of Efficacy|3|||
143200188|NCT02305849|516279122|FG003|Overall Study|Lack of Efficacy|9|||
143200189|NCT02305849|516279119|FG000|Overall Study|Withdrawal by Subject|2|||
143200190|NCT02305849|516279120|FG001|Overall Study|Withdrawal by Subject|2|||
143200191|NCT02305849|516279121|FG002|Overall Study|Withdrawal by Subject|1|||
143200192|NCT02305849|516279122|FG003|Overall Study|Withdrawal by Subject|4|||
143200193|NCT02305849|516279119|FG000|Overall Study|Lost to Follow-up|0|||
143200194|NCT02305849|516279120|FG001|Overall Study|Lost to Follow-up|2|||
143200195|NCT02305849|516279121|FG002|Overall Study|Lost to Follow-up|0|||
143200196|NCT02305849|516279122|FG003|Overall Study|Lost to Follow-up|0|||
143200197|NCT02305849|516279119|FG000|Overall Study|Protocol Violation|3|||
143200198|NCT02305849|516279120|FG001|Overall Study|Protocol Violation|2|||
143200199|NCT02305849|516279121|FG002|Overall Study|Protocol Violation|1|||
143200200|NCT02305849|516279122|FG003|Overall Study|Protocol Violation|1|||
143200201|NCT02305849|516279119|FG000|Overall Study|Lab data met discontinuation criteria|0|||
143200202|NCT02305849|516279120|FG001|Overall Study|Lab data met discontinuation criteria|1|||
143200203|NCT02305849|516279121|FG002|Overall Study|Lab data met discontinuation criteria|2|||
143200204|NCT02305849|516279122|FG003|Overall Study|Lab data met discontinuation criteria|1|||
143200205|NCT02305849|516279119|FG000|Overall Study|Miscellaneous|1|||
143200206|NCT02305849|516279120|FG001|Overall Study|Miscellaneous|2|||
143200207|NCT02305849|516279121|FG002|Overall Study|Miscellaneous|4|||
143200208|NCT02305849|516279122|FG003|Overall Study|Miscellaneous|1|||
143200209|NCT02305849|516279119|FG000|Overall Study|Not fulfill eligibility criteria|1|||
143200210|NCT02305849|516279120|FG001|Overall Study|Not fulfill eligibility criteria|1|||
143262266|NCT00642473|516513874|FG001|Overall Study|Withdrawal by Subject|5|||
143262267|NCT00642473|516513873|FG000|Overall Study|Progression or death|2|||
143262268|NCT00642473|516513874|FG001|Overall Study|Progression or death|4|||
143262269|NCT00642473|516513873|FG000|Overall Study|Other|2|||
143262270|NCT00642473|516513874|FG001|Overall Study|Other|2|||
143262271|NCT04533880|516513877|FG000|Overall Study|Lost to Follow-up|0|||
143200211|NCT02305849|516279121|FG002|Overall Study|Not fulfill eligibility criteria|0|||
143200212|NCT02305849|516279122|FG003|Overall Study|Not fulfill eligibility criteria|0|||
143200213|NCT00355342|516279123|FG000|Overall Study|Adverse Event|13|||
143200214|NCT00355342|516279124|FG001|Overall Study|Adverse Event|15|||
143262272|NCT04533880|516513878|FG001|Overall Study|Lost to Follow-up|1|||
143262273|NCT04533880|516513879|FG002|Overall Study|Lost to Follow-up|1|||
143262274|NCT02284178|516513882|FG000|Overall Study|Met exclusion criteria|49|||
143262275|NCT02284178|516513883|FG001|Overall Study|Met exclusion criteria|54|||
143262276|NCT01483690|516513886|FG000|Overall Study|Adverse Event|1|||
143262277|NCT01483690|516513887|FG001|Overall Study|Adverse Event|2|||
143200215|NCT00355342|516279123|FG000|Overall Study|Lost to Follow-up|4|||
143200216|NCT00355342|516279124|FG001|Overall Study|Lost to Follow-up|2|||
143200217|NCT00355342|516279123|FG000|Overall Study|Withdrawal by Subject|14|||
143200218|NCT00355342|516279124|FG001|Overall Study|Withdrawal by Subject|11|||
143200219|NCT00355342|516279123|FG000|Overall Study|Sponsor terminated study|2|||
143200220|NCT00355342|516279124|FG001|Overall Study|Sponsor terminated study|2|||
143200221|NCT00355342|516279123|FG000|Overall Study|Overcompliant-PI discretion|1|||
143200222|NCT00355342|516279124|FG001|Overall Study|Overcompliant-PI discretion|0|||
143200223|NCT00355342|516279123|FG000|Overall Study|Use of prohibited medication|1|||
143200224|NCT00355342|516279124|FG001|Overall Study|Use of prohibited medication|0|||
143200225|NCT00355342|516279123|FG000|Overall Study|COPD exacerbation|1|||
143200226|NCT00355342|516279124|FG001|Overall Study|COPD exacerbation|1|||
143200227|NCT00355342|516279123|FG000|Overall Study|Dispensed wrong study drug kit|1|||
143200228|NCT00355342|516279124|FG001|Overall Study|Dispensed wrong study drug kit|0|||
143200229|NCT00355342|516279123|FG000|Overall Study|Non-compliance with Dexa scans|1|||
143200230|NCT00355342|516279124|FG001|Overall Study|Non-compliance with Dexa scans|0|||
143200231|NCT00355342|516279123|FG000|Overall Study|Withdrawal by participant and physician|1|||
143200232|NCT00355342|516279124|FG001|Overall Study|Withdrawal by participant and physician|0|||
143200233|NCT00355342|516279123|FG000|Overall Study|Participant relocated|0|||
143200234|NCT00355342|516279124|FG001|Overall Study|Participant relocated|1|||
143200235|NCT00355342|516279123|FG000|Overall Study|Participant discontinued study drug|0|||
143200236|NCT00355342|516279124|FG001|Overall Study|Participant discontinued study drug|1|||
143200237|NCT00355342|516279123|FG000|Overall Study|Study management|0|||
143200238|NCT00355342|516279124|FG001|Overall Study|Study management|1|||
143200239|NCT00355342|516279123|FG000|Overall Study|Protocol Violation|0|||
143200240|NCT00355342|516279124|FG001|Overall Study|Protocol Violation|1|||
143200241|NCT00355342|516279123|FG000|Overall Study|Use of protocol excluded medication|0|||
143200242|NCT00355342|516279124|FG001|Overall Study|Use of protocol excluded medication|1|||
143200243|NCT00536874|516279125|FG000|Overall Study|Adverse Event|1|||
143200244|NCT00536874|516279125|FG000|Overall Study|Death|2|||
143200245|NCT00536874|516279125|FG000|Overall Study|Withdrawal by Subject|1|||
143200246|NCT01287221|516279127|FG000|Overall Study|Lack of Perceived Benefit|1|||
143200247|NCT01287221|516279128|FG001|Overall Study|Lack of Perceived Benefit|1|||
143200248|NCT01287221|516279127|FG000|Overall Study|Adverse Event|3|||
143200249|NCT01287221|516279128|FG001|Overall Study|Adverse Event|3|||
143200250|NCT01287221|516279127|FG000|Overall Study|Withdrawal by Subject|0|||
143200251|NCT01287221|516279128|FG001|Overall Study|Withdrawal by Subject|1|||
143200252|NCT02761694|516279139|FG000|Overall Study|Lack of Efficacy|0|||
143200253|NCT02761694|516279140|FG001|Overall Study|Lack of Efficacy|0|||
143200254|NCT02761694|516279141|FG002|Overall Study|Lack of Efficacy|0|||
143200255|NCT02761694|516279142|FG003|Overall Study|Lack of Efficacy|0|||
143200256|NCT02761694|516279143|FG004|Overall Study|Lack of Efficacy|0|||
143200257|NCT02761694|516279144|FG005|Overall Study|Lack of Efficacy|0|||
143200258|NCT02761694|516279145|FG006|Overall Study|Lack of Efficacy|6|||
143200259|NCT02761694|516279146|FG007|Overall Study|Lack of Efficacy|0|||
143200260|NCT02761694|516279147|FG008|Overall Study|Lack of Efficacy|0|||
143200261|NCT02761694|516279148|FG009|Overall Study|Lack of Efficacy|1|||
143200262|NCT02761694|516279149|FG010|Overall Study|Lack of Efficacy|1|||
143200263|NCT02761694|516279150|FG011|Overall Study|Lack of Efficacy|4|||
143200264|NCT02761694|516279139|FG000|Overall Study|Death|0|||
143200265|NCT02761694|516279140|FG001|Overall Study|Death|0|||
143200266|NCT02761694|516279141|FG002|Overall Study|Death|0|||
143200267|NCT02761694|516279142|FG003|Overall Study|Death|0|||
143262278|NCT01483690|516513886|FG000|Overall Study|clinical deterioration|1|||
143262279|NCT01483690|516513887|FG001|Overall Study|clinical deterioration|0|||
143262280|NCT01483690|516513886|FG000|Overall Study|Physician Decision|0|||
143200268|NCT02761694|516279143|FG004|Overall Study|Death|0|||
143200269|NCT02761694|516279144|FG005|Overall Study|Death|0|||
143200270|NCT02761694|516279145|FG006|Overall Study|Death|2|||
143200271|NCT02761694|516279146|FG007|Overall Study|Death|0|||
143200272|NCT02761694|516279147|FG008|Overall Study|Death|2|||
143200273|NCT02761694|516279148|FG009|Overall Study|Death|2|||
143200274|NCT02761694|516279149|FG010|Overall Study|Death|1|||
143200275|NCT02761694|516279150|FG011|Overall Study|Death|0|||
143200276|NCT02761694|516279139|FG000|Overall Study|Physician Decision|0|||
143262281|NCT01483690|516513887|FG001|Overall Study|Physician Decision|2|||
143262282|NCT01483690|516513886|FG000|Overall Study|exclusionary procedure|0|||
143200277|NCT02761694|516279140|FG001|Overall Study|Physician Decision|0|||
143200278|NCT02761694|516279141|FG002|Overall Study|Physician Decision|0|||
143200279|NCT02761694|516279142|FG003|Overall Study|Physician Decision|0|||
143200280|NCT02761694|516279143|FG004|Overall Study|Physician Decision|0|||
143200281|NCT02761694|516279144|FG005|Overall Study|Physician Decision|0|||
143200282|NCT02761694|516279145|FG006|Overall Study|Physician Decision|1|||
143200283|NCT02761694|516279146|FG007|Overall Study|Physician Decision|0|||
143200284|NCT02761694|516279147|FG008|Overall Study|Physician Decision|0|||
143200285|NCT02761694|516279148|FG009|Overall Study|Physician Decision|0|||
143200286|NCT02761694|516279149|FG010|Overall Study|Physician Decision|0|||
143200287|NCT02761694|516279150|FG011|Overall Study|Physician Decision|0|||
143200288|NCT02761694|516279139|FG000|Overall Study|Withdrawal by Subject|0|||
143200289|NCT02761694|516279140|FG001|Overall Study|Withdrawal by Subject|0|||
143200290|NCT02761694|516279141|FG002|Overall Study|Withdrawal by Subject|0|||
143200291|NCT02761694|516279142|FG003|Overall Study|Withdrawal by Subject|1|||
143200292|NCT02761694|516279143|FG004|Overall Study|Withdrawal by Subject|0|||
143200293|NCT02761694|516279144|FG005|Overall Study|Withdrawal by Subject|0|||
143200294|NCT02761694|516279145|FG006|Overall Study|Withdrawal by Subject|4|||
143200295|NCT02761694|516279146|FG007|Overall Study|Withdrawal by Subject|0|||
143200296|NCT02761694|516279147|FG008|Overall Study|Withdrawal by Subject|2|||
143200297|NCT02761694|516279148|FG009|Overall Study|Withdrawal by Subject|1|||
143200298|NCT02761694|516279149|FG010|Overall Study|Withdrawal by Subject|0|||
143200299|NCT02761694|516279150|FG011|Overall Study|Withdrawal by Subject|0|||
143200300|NCT02761694|516279139|FG000|Overall Study|Lost to Follow-up|0|||
143200301|NCT02761694|516279140|FG001|Overall Study|Lost to Follow-up|0|||
143200302|NCT02761694|516279141|FG002|Overall Study|Lost to Follow-up|0|||
143200303|NCT02761694|516279142|FG003|Overall Study|Lost to Follow-up|0|||
143200304|NCT02761694|516279143|FG004|Overall Study|Lost to Follow-up|0|||
143200305|NCT02761694|516279144|FG005|Overall Study|Lost to Follow-up|0|||
143200306|NCT02761694|516279145|FG006|Overall Study|Lost to Follow-up|1|||
143200307|NCT02761694|516279146|FG007|Overall Study|Lost to Follow-up|0|||
143200308|NCT02761694|516279147|FG008|Overall Study|Lost to Follow-up|0|||
143200309|NCT02761694|516279148|FG009|Overall Study|Lost to Follow-up|0|||
143200310|NCT02761694|516279149|FG010|Overall Study|Lost to Follow-up|0|||
143200311|NCT02761694|516279150|FG011|Overall Study|Lost to Follow-up|1|||
143200312|NCT02761694|516279139|FG000|Overall Study|Adverse Event|0|||
143200313|NCT02761694|516279140|FG001|Overall Study|Adverse Event|0|||
143200314|NCT02761694|516279141|FG002|Overall Study|Adverse Event|0|||
143200315|NCT02761694|516279142|FG003|Overall Study|Adverse Event|0|||
143200316|NCT02761694|516279143|FG004|Overall Study|Adverse Event|0|||
143200317|NCT02761694|516279144|FG005|Overall Study|Adverse Event|0|||
143200318|NCT02761694|516279145|FG006|Overall Study|Adverse Event|1|||
143200319|NCT02761694|516279146|FG007|Overall Study|Adverse Event|0|||
143200320|NCT02761694|516279147|FG008|Overall Study|Adverse Event|1|||
143200321|NCT02761694|516279148|FG009|Overall Study|Adverse Event|0|||
143200322|NCT02761694|516279149|FG010|Overall Study|Adverse Event|0|||
143262283|NCT01483690|516513887|FG001|Overall Study|exclusionary procedure|1|||
143262284|NCT00958789|516513891|FG000|Overall Study|Death|5|||
143262285|NCT00958789|516513891|FG000|Overall Study|Lost to Follow-up|14|||
143262286|NCT00958789|516513891|FG000|Overall Study|Withdrawal by Subject|17|||
143262287|NCT00958789|516513891|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
143262288|NCT00958789|516513891|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
143369770|NCT00543725|516897193|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
143369771|NCT00543725|516897192|FG000|Overall Study|Protocol Violation|0|||
143200323|NCT02761694|516279150|FG011|Overall Study|Adverse Event|1|||
143200324|NCT02761694|516279139|FG000|Overall Study|Other|4|||
143200325|NCT02761694|516279140|FG001|Overall Study|Other|4|||
143200326|NCT02761694|516279141|FG002|Overall Study|Other|1|||
143369772|NCT00543725|516897193|FG001|Overall Study|Protocol Violation|1|||
143369773|NCT00543725|516897192|FG000|Overall Study|Withdrawal by Subject|4|||
143369774|NCT00543725|516897193|FG001|Overall Study|Withdrawal by Subject|13|||
143369775|NCT00543725|516897192|FG000|Overall Study|Lost to Follow-up|15|||
143369776|NCT00543725|516897193|FG001|Overall Study|Lost to Follow-up|11|||
143369777|NCT00543725|516897192|FG000|Overall Study|Other|3|||
143369778|NCT00543725|516897193|FG001|Overall Study|Other|3|||
143369779|NCT02846415|516897194|FG000|Overall Study|Lost to Follow-up|2|||
143369780|NCT02846415|516897195|FG001|Overall Study|Lost to Follow-up|0|||
143200327|NCT02761694|516279142|FG003|Overall Study|Other|2|||
143200328|NCT02761694|516279143|FG004|Overall Study|Other|3|||
143200329|NCT02761694|516279144|FG005|Overall Study|Other|3|||
143262289|NCT00958789|516513891|FG000|Overall Study|Subject terminated|2|||
143262290|NCT00958789|516513891|FG000|Overall Study|Revision|7|||
143262291|NCT02239224|516513892|FG000|Overall Study|Administrative|0|||
143200330|NCT02761694|516279145|FG006|Overall Study|Other|18|||
143200331|NCT02761694|516279146|FG007|Overall Study|Other|8|||
143200332|NCT02761694|516279147|FG008|Overall Study|Other|0|||
143200333|NCT02761694|516279148|FG009|Overall Study|Other|1|||
143200334|NCT02761694|516279149|FG010|Overall Study|Other|1|||
143200335|NCT02761694|516279150|FG011|Overall Study|Other|0|||
143200336|NCT02395055|516279151|FG000|Overall Study|Withdrawal by Subject|7|||
143200337|NCT02395055|516279152|FG001|Overall Study|Withdrawal by Subject|3|||
143200338|NCT00787930|516279153|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
143369781|NCT02846415|516897194|FG000|Overall Study|Withdrawal by Subject|1|||
143369782|NCT02846415|516897195|FG001|Overall Study|Withdrawal by Subject|1|||
143369783|NCT02155829|516897196|FG000|Overall Study|Adverse Event|1|||
143369784|NCT02155829|516897197|FG001|Overall Study|Adverse Event|0|||
143369785|NCT02155829|516897196|FG000|Overall Study|Withdrawal by Subject|3|||
143369786|NCT02155829|516897197|FG001|Overall Study|Withdrawal by Subject|3|||
143369787|NCT02155829|516897196|FG000|Overall Study|Protocol Violation|2|||
143369788|NCT02155829|516897197|FG001|Overall Study|Protocol Violation|0|||
143262292|NCT02239224|516513893|FG001|Overall Study|Administrative|0|||
143262293|NCT02239224|516513894|FG002|Overall Study|Administrative|3|||
143262294|NCT02239224|516513895|FG003|Overall Study|Administrative|1|||
143262295|NCT01466179|516513897|FG000|Overall Study|Ongoing in core study|2|||
143262296|NCT01466179|516513897|FG000|Overall Study|Physician Decision|46|||
143262297|NCT01466179|516513897|FG000|Overall Study|Progressive disease|43|||
143262298|NCT01466179|516513897|FG000|Overall Study|Adverse Event|32|||
143262299|NCT01466179|516513897|FG000|Overall Study|Disease relapse|23|||
143262300|NCT01466179|516513897|FG000|Overall Study|Lack of Efficacy|14|||
143262301|NCT01466179|516513897|FG000|Overall Study|Death|7|||
143200339|NCT02513823|516279154|FG000|Overall Study|Lost to Follow-up|4|||
143200340|NCT02513823|516279154|FG000|Overall Study|Physician Decision|1|||
143200341|NCT02743780|516279156|FG000|Part 3 (7 Days)|Adverse Event|0|||
143200342|NCT02743780|516279157|FG001|Part 3 (7 Days)|Adverse Event|0|||
143200343|NCT02743780|516279158|FG002|Part 3 (7 Days)|Adverse Event|1|||
143200344|NCT02743780|516279159|FG003|Part 3 (7 Days)|Adverse Event|0|||
143200345|NCT02743780|516279160|FG004|Part 3 (7 Days)|Adverse Event|0|||
143200346|NCT01294462|516279161|FG000|Overall Study|Lost to Follow-up|1|||
143200347|NCT01294462|516279162|FG001|Overall Study|Lost to Follow-up|0|||
143200348|NCT01294462|516279161|FG000|Overall Study|Withdrawal by Subject|65|||
143200349|NCT01294462|516279162|FG001|Overall Study|Withdrawal by Subject|63|||
143200350|NCT04342689|516279170|FG000|Overall Study|Withdrawal by Subject|32|||
143200351|NCT04342689|516279171|FG001|Overall Study|Withdrawal by Subject|33|||
143200352|NCT04342689|516279170|FG000|Overall Study|Lost to Follow-up|10|||
143200353|NCT04342689|516279171|FG001|Overall Study|Lost to Follow-up|12|||
143200354|NCT01460407|516279172|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
143200355|NCT01460407|516279173|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
143200356|NCT01367704|516279176|FG000|Overall Study|Lost to Follow-up|47|||
143200357|NCT01367704|516279177|FG001|Overall Study|Lost to Follow-up|161|||
143200358|NCT01510145|516279178|FG000|Overall Study|Adverse Event|6|||
143200359|NCT01510145|516279178|FG000|Overall Study|Lost to Follow-up|5|||
143200360|NCT01510145|516279178|FG000|Overall Study|Withdrawal by Subject|6|||
143200361|NCT01510145|516279178|FG000|Overall Study|Relative reported subject withdrew|1|||
143200362|NCT02279498|516279182|FG000|Overall Study|Adverse Event|3|||
143200363|NCT02279498|516279183|FG001|Overall Study|Adverse Event|0|||
143200364|NCT02279498|516279182|FG000|Overall Study|Lack of Efficacy|4|||
143200365|NCT02279498|516279183|FG001|Overall Study|Lack of Efficacy|0|||
143200366|NCT02279498|516279182|FG000|Overall Study|Lost to Follow-up|0|||
143200367|NCT02279498|516279183|FG001|Overall Study|Lost to Follow-up|1|||
143200368|NCT02279498|516279182|FG000|Overall Study|Withdrawal by Subject|9|||
143200369|NCT02279498|516279183|FG001|Overall Study|Withdrawal by Subject|2|||
143200370|NCT02279498|516279182|FG000|Overall Study|Undefined|2|||
143200371|NCT02279498|516279183|FG001|Overall Study|Undefined|1|||
143200372|NCT00737711|516279184|FG000|Overall Study|Adverse Event|2|||
143200373|NCT00737711|516279184|FG000|Overall Study|Death|8|||
143200374|NCT00737711|516279184|FG000|Overall Study|Failure to return|4|||
143200375|NCT00737711|516279184|FG000|Overall Study|Protocol Violation|1|||
143200376|NCT00737711|516279184|FG000|Overall Study|Withdrawal by Subject|5|||
143200377|NCT00737711|516279184|FG000|Overall Study|Blood transfusion|6|||
143262302|NCT01466179|516513897|FG000|Overall Study|Withdrawal by Subject|7|||
143369789|NCT00404079|516897198|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
143369790|NCT00404079|516897199|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
143369791|NCT01120275|516897200|FG000|Overall Study|Adverse Event|3|||
143369792|NCT01120275|516897200|FG000|Overall Study|Progression|27|||
143369793|NCT01120275|516897200|FG000|Overall Study|Ineligible|3|||
143369794|NCT01120275|516897200|FG000|Overall Study|Withdrawal by Subject|1|||
143200378|NCT00737711|516279184|FG000|Overall Study|Other|5|||
143200379|NCT00624780|516279188|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
143200380|NCT00624780|516279189|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
143200381|NCT00624780|516279190|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
143200382|NCT00624780|516279191|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
143200383|NCT00624780|516279192|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
143200384|NCT00624780|516279193|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
143262303|NCT01466179|516513897|FG000|Overall Study|Protocol Violation|2|||
143262304|NCT01466179|516513897|FG000|Overall Study|Other|3|||
143262305|NCT03101267|516513899|FG000|Primary Study Period|Withdrawal by Subject|1|||
143262306|NCT03101267|516513900|FG001|Primary Study Period|Withdrawal by Subject|2|||
143369795|NCT01120275|516897200|FG000|Overall Study|Refusal|1|||
143200385|NCT00624780|516279188|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
143200386|NCT00624780|516279189|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
143262307|NCT03101267|516513901|FG002|Primary Study Period|Withdrawal by Subject|3|||
143262308|NCT03101267|516513899|FG000|Primary Study Period|Miscellaneous|2|||
143262309|NCT03101267|516513900|FG001|Primary Study Period|Miscellaneous|0|||
143262310|NCT03101267|516513901|FG002|Primary Study Period|Miscellaneous|0|||
143262311|NCT00107952|516513902|FG000|Overall Study|Death|75|||
143200387|NCT00624780|516279190|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
143200388|NCT00624780|516279191|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
143200389|NCT00624780|516279192|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
143200390|NCT00624780|516279193|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
143200391|NCT00624780|516279188|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
143200392|NCT00624780|516279189|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
143200393|NCT00624780|516279190|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
143200394|NCT00624780|516279191|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
143262312|NCT00107952|516513903|FG001|Overall Study|Death|61|||
143200395|NCT00624780|516279192|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
143200396|NCT00624780|516279193|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
143200397|NCT00624780|516279188|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
143200398|NCT00624780|516279189|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
143200399|NCT00624780|516279190|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
143200400|NCT00624780|516279191|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
143200401|NCT00624780|516279192|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
143200402|NCT00624780|516279193|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
143200403|NCT00624780|516279188|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
143200404|NCT00624780|516279189|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
143200405|NCT00624780|516279190|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
143200406|NCT00624780|516279191|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
143200407|NCT00624780|516279192|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
143200408|NCT00624780|516279193|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
143200409|NCT00624780|516279188|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
143200410|NCT00624780|516279189|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
143200411|NCT00624780|516279190|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
143200412|NCT00624780|516279191|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
143200413|NCT00624780|516279192|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
143200414|NCT00624780|516279193|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
143200415|NCT00624780|516279188|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
143200416|NCT00624780|516279189|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
143200417|NCT00624780|516279190|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
143200418|NCT00624780|516279191|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
143200419|NCT00624780|516279192|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
143200420|NCT00624780|516279193|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
143200421|NCT00624780|516279188|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
143200422|NCT00624780|516279189|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
143200423|NCT00624780|516279190|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
143200424|NCT00624780|516279191|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
143200425|NCT00624780|516279192|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
143200426|NCT00624780|516279193|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
143200427|NCT00624780|516279188|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
143200428|NCT00624780|516279189|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
143200429|NCT00624780|516279190|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
143200430|NCT00624780|516279191|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
143200431|NCT00624780|516279192|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
143200432|NCT00624780|516279193|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
143200433|NCT00624780|516279188|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
143200434|NCT00624780|516279189|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
143200435|NCT00624780|516279190|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
143200436|NCT00624780|516279191|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
143200437|NCT00624780|516279192|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
143200438|NCT00624780|516279193|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
143200439|NCT00624780|516279188|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
143262313|NCT00107952|516513902|FG000|Overall Study|Lost to Follow-up|0|||
143262314|NCT00107952|516513903|FG001|Overall Study|Lost to Follow-up|3|||
143262315|NCT00107952|516513902|FG000|Overall Study|Withdrawal by Subject|9|||
143262316|NCT00107952|516513903|FG001|Overall Study|Withdrawal by Subject|6|||
143200440|NCT00624780|516279189|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
143262317|NCT00107952|516513902|FG000|Overall Study|Other|2|||
143262318|NCT00107952|516513903|FG001|Overall Study|Other|5|||
143200441|NCT00624780|516279190|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
143200442|NCT00624780|516279191|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
143262319|NCT00107952|516513902|FG000|Overall Study|Never received study treatment|9|||
143200443|NCT00624780|516279192|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
143200444|NCT00624780|516279193|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
143200445|NCT00624780|516279188|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
143200446|NCT00624780|516279189|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
143200447|NCT00624780|516279190|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
143200448|NCT00624780|516279191|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
143200449|NCT00624780|516279192|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
143200450|NCT00624780|516279193|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
143200451|NCT00624780|516279188|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
143200452|NCT00624780|516279189|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
143200453|NCT00624780|516279190|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
143200454|NCT00624780|516279191|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
143200455|NCT00624780|516279192|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
143200456|NCT00624780|516279193|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
143200457|NCT00624780|516279188|FG000|Follow-up (Week 26)|Death|0|||
143200458|NCT00624780|516279189|FG001|Follow-up (Week 26)|Death|0|||
143200459|NCT00624780|516279190|FG002|Follow-up (Week 26)|Death|1|||
143200460|NCT00624780|516279191|FG003|Follow-up (Week 26)|Death|0|||
143200461|NCT00624780|516279192|FG004|Follow-up (Week 26)|Death|0|||
143200462|NCT00624780|516279193|FG005|Follow-up (Week 26)|Death|0|||
143200463|NCT00624780|516279188|FG000|Follow-up (Week 26)|Adverse Event|0|||
143200464|NCT00624780|516279189|FG001|Follow-up (Week 26)|Adverse Event|0|||
143200465|NCT00624780|516279190|FG002|Follow-up (Week 26)|Adverse Event|0|||
143200466|NCT00624780|516279191|FG003|Follow-up (Week 26)|Adverse Event|0|||
143200467|NCT00624780|516279192|FG004|Follow-up (Week 26)|Adverse Event|1|||
143200468|NCT00624780|516279193|FG005|Follow-up (Week 26)|Adverse Event|0|||
143200469|NCT00624780|516279188|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
143200470|NCT00624780|516279189|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
143200471|NCT00624780|516279190|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
143200472|NCT00624780|516279191|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
143200473|NCT00624780|516279192|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
143262320|NCT00107952|516513903|FG001|Overall Study|Never received study treatment|6|||
143262321|NCT02045303|516513911|FG000|Overall Study|Protocol Violation|2|||
143262322|NCT02045303|516513912|FG001|Overall Study|Protocol Violation|1|||
143262323|NCT02045303|516513913|FG002|Overall Study|Protocol Violation|0|||
143200474|NCT00624780|516279193|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
143200475|NCT00624780|516279188|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
143200476|NCT00624780|516279189|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
143200477|NCT00624780|516279190|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
143200478|NCT00624780|516279191|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
143200479|NCT00624780|516279192|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
143200480|NCT00624780|516279193|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
143200481|NCT00624780|516279188|FG000|Follow-up (Week 26)|Other|1|||
143200482|NCT00624780|516279189|FG001|Follow-up (Week 26)|Other|1|||
143200483|NCT00624780|516279190|FG002|Follow-up (Week 26)|Other|0|||
143200484|NCT00624780|516279191|FG003|Follow-up (Week 26)|Other|0|||
143200485|NCT00624780|516279192|FG004|Follow-up (Week 26)|Other|0|||
143200486|NCT00624780|516279193|FG005|Follow-up (Week 26)|Other|0|||
143200487|NCT04068519|516279194|FG000|Dose Verification|Death|15|||
143200488|NCT04068519|516279194|FG000|Dose Verification|Withdrawal by Subject|1|||
143200489|NCT04068519|516279194|FG000|Pharmacokinetic Sub-study|Death|35|||
143200490|NCT04068519|516279194|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
143200491|NCT04068519|516279194|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
143200492|NCT04068519|516279194|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
143200493|NCT04068519|516279194|FG000|Indication Expansion|Death|152|||
143200494|NCT04068519|516279194|FG000|Indication Expansion|Withdrawal by Subject|10|||
143200495|NCT04068519|516279194|FG000|Indication Expansion|Lost to Follow-up|7|||
143200496|NCT00969761|516279195|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
143200497|NCT00969761|516279196|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
143200498|NCT00969761|516279197|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
143200499|NCT00969761|516279198|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
143200500|NCT00969761|516279199|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
143262324|NCT02045303|516513911|FG000|Overall Study|Withdrawal by Subject|0|||
143262325|NCT02045303|516513912|FG001|Overall Study|Withdrawal by Subject|2|||
143262326|NCT02045303|516513913|FG002|Overall Study|Withdrawal by Subject|0|||
143200501|NCT00969761|516279200|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
143200502|NCT00969761|516279201|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
143200503|NCT00969761|516279202|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
143200504|NCT00969761|516279203|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
143200505|NCT00969761|516279204|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
143200506|NCT00969761|516279205|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
143200507|NCT00969761|516279206|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
143262327|NCT01856023|516513914|FG000|Overall Study|Death|1|||
143200508|NCT00969761|516279195|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
143200509|NCT00969761|516279196|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
143200510|NCT00969761|516279197|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
143200511|NCT00969761|516279198|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
143200512|NCT00969761|516279199|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
143200513|NCT00969761|516279200|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
143200514|NCT00969761|516279201|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
143200515|NCT00969761|516279202|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
143200516|NCT00969761|516279203|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
143200517|NCT00969761|516279204|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
143200518|NCT00969761|516279205|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
143200519|NCT00969761|516279206|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
143200520|NCT00969761|516279195|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
143200521|NCT00969761|516279196|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
143200522|NCT00969761|516279197|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
143200523|NCT00969761|516279198|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
143200524|NCT00969761|516279199|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
143200525|NCT00969761|516279200|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
143200526|NCT00969761|516279201|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
143200527|NCT00969761|516279202|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
143200528|NCT00969761|516279203|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
143200529|NCT00969761|516279204|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
143200530|NCT00969761|516279205|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
143200531|NCT00969761|516279206|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
143200532|NCT00969761|516279195|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
143200533|NCT00969761|516279196|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
143200534|NCT00969761|516279197|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
143200535|NCT00969761|516279198|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
143200536|NCT00969761|516279199|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
143200537|NCT00969761|516279200|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
143200538|NCT00969761|516279201|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
143200539|NCT00969761|516279202|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
143200540|NCT00969761|516279203|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
143200541|NCT00969761|516279204|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
143200542|NCT00969761|516279205|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
143200543|NCT00969761|516279206|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
143200544|NCT00969761|516279195|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
143200545|NCT00969761|516279196|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
143200546|NCT00969761|516279197|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
143200547|NCT00969761|516279198|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
143200548|NCT00969761|516279199|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
143200549|NCT00969761|516279200|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
143200550|NCT00969761|516279201|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
143200551|NCT00969761|516279202|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
143200552|NCT00969761|516279203|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
143200553|NCT00969761|516279204|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
143200554|NCT00969761|516279205|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
143200555|NCT00969761|516279206|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
143200556|NCT00969761|516279195|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
143200557|NCT00969761|516279196|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
143200558|NCT00969761|516279197|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
143200559|NCT00969761|516279198|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
143200560|NCT00969761|516279199|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
143200561|NCT00969761|516279200|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
143200562|NCT00969761|516279201|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
143200563|NCT00969761|516279202|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
143200564|NCT00969761|516279203|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
143200565|NCT00969761|516279204|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
143200566|NCT00969761|516279205|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
143200567|NCT00969761|516279206|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
143200568|NCT03959982|516280704|FG000|Overall Study|Withdrawal by Subject|1|||
143200569|NCT03959982|516280705|FG001|Overall Study|Withdrawal by Subject|0|||
143200570|NCT03959982|516280704|FG000|Overall Study|Physician Decision|2|||
143200571|NCT03959982|516280705|FG001|Overall Study|Physician Decision|0|||
143200572|NCT03959982|516280704|FG000|Overall Study|Lost to Follow-up|1|||
143200573|NCT03959982|516280705|FG001|Overall Study|Lost to Follow-up|0|||
143200574|NCT00262847|516280706|FG000|Overall Study|Disease Progression|309|||
143200575|NCT00262847|516280707|FG001|Overall Study|Disease Progression|274|||
143200576|NCT00262847|516280708|FG002|Overall Study|Disease Progression|195|||
143200577|NCT00262847|516280706|FG000|Overall Study|Patient Refusal|41|||
143200578|NCT00262847|516280707|FG001|Overall Study|Patient Refusal|52|||
143200579|NCT00262847|516280708|FG002|Overall Study|Patient Refusal|47|||
143200580|NCT00262847|516280706|FG000|Overall Study|Adverse Event|74|||
143200581|NCT00262847|516280707|FG001|Overall Study|Adverse Event|88|||
143200582|NCT00262847|516280708|FG002|Overall Study|Adverse Event|108|||
143200583|NCT00262847|516280706|FG000|Overall Study|Death|8|||
143200584|NCT00262847|516280707|FG001|Overall Study|Death|8|||
143200585|NCT00262847|516280708|FG002|Overall Study|Death|11|||
143200586|NCT00262847|516280706|FG000|Overall Study|Concomitant disease|3|||
143200587|NCT00262847|516280707|FG001|Overall Study|Concomitant disease|2|||
143200588|NCT00262847|516280708|FG002|Overall Study|Concomitant disease|4|||
143200589|NCT00262847|516280706|FG000|Overall Study|Other Reasons|79|||
143200590|NCT00262847|516280707|FG001|Overall Study|Other Reasons|88|||
143200591|NCT00262847|516280708|FG002|Overall Study|Other Reasons|27|||
143200592|NCT00262847|516280706|FG000|Overall Study|Did not receive study treatment|4|||
143200593|NCT00262847|516280707|FG001|Overall Study|Did not receive study treatment|1|||
143200594|NCT00262847|516280708|FG002|Overall Study|Did not receive study treatment|4|||
143200595|NCT00758589|516280709|FG000|Overall Study|Adverse Event|3|||
143200596|NCT00758589|516280710|FG001|Overall Study|Adverse Event|2|||
143200597|NCT00758589|516280711|FG002|Overall Study|Adverse Event|5|||
143200598|NCT00758589|516280712|FG003|Overall Study|Adverse Event|4|||
143200599|NCT00758589|516280709|FG000|Overall Study|Withdrawal by Subject|0|||
143200600|NCT00758589|516280710|FG001|Overall Study|Withdrawal by Subject|1|||
143200601|NCT00758589|516280711|FG002|Overall Study|Withdrawal by Subject|1|||
143200602|NCT00758589|516280712|FG003|Overall Study|Withdrawal by Subject|1|||
143200603|NCT00758589|516280709|FG000|Overall Study|Palm stopped to work|0|||
143200604|NCT00758589|516280710|FG001|Overall Study|Palm stopped to work|0|||
143200605|NCT00758589|516280711|FG002|Overall Study|Palm stopped to work|0|||
143200606|NCT00758589|516280712|FG003|Overall Study|Palm stopped to work|1|||
143200607|NCT05438602|516280716|FG000|Treatment (15 Days)|Adverse Event|2|||
143200608|NCT05438602|516280717|FG001|Treatment (15 Days)|Adverse Event|1|||
143200609|NCT05438602|516280718|FG002|Treatment (15 Days)|Adverse Event|3|||
143200610|NCT05438602|516280716|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
143200611|NCT05438602|516280717|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
143200612|NCT05438602|516280718|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
143200613|NCT05438602|516280716|FG000|Treatment (15 Days)|Other|0|||
143200614|NCT05438602|516280717|FG001|Treatment (15 Days)|Other|0|||
143200615|NCT05438602|516280718|FG002|Treatment (15 Days)|Other|1|||
143200616|NCT05438602|516280716|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
143200617|NCT05438602|516280717|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
143200618|NCT05438602|516280718|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
143200619|NCT05438602|516280716|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
143200620|NCT05438602|516280717|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
143200621|NCT05438602|516280718|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
143262328|NCT01856023|516513915|FG001|Overall Study|Death|2|||
143262329|NCT01856023|516513914|FG000|Overall Study|Adverse Event|2|||
143262330|NCT01856023|516513915|FG001|Overall Study|Adverse Event|1|||
143200622|NCT05438602|516280716|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
143200623|NCT05438602|516280717|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
143200624|NCT05438602|516280718|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
143200625|NCT05438602|516280716|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
143200626|NCT05438602|516280717|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
143200627|NCT05438602|516280718|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
143200628|NCT05438602|516280716|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
143200629|NCT05438602|516280717|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
143200630|NCT05438602|516280718|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
143200631|NCT05438602|516280716|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
143200632|NCT05438602|516280717|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
143200633|NCT05438602|516280718|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
143200634|NCT05438602|516280716|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
143200635|NCT05438602|516280717|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
143200636|NCT05438602|516280718|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
143200637|NCT01278407|516280719|FG000|Confirmatory Phase|Adverse Event|5|||
143200638|NCT01278407|516280720|FG001|Confirmatory Phase|Adverse Event|10|||
143262331|NCT01856023|516513914|FG000|Overall Study|Lack of Efficacy|5|||
143200639|NCT01278407|516280721|FG002|Confirmatory Phase|Adverse Event|1|||
143200640|NCT01278407|516280722|FG003|Confirmatory Phase|Adverse Event|0|||
143369796|NCT01120275|516897200|FG000|Overall Study|Not specific|1|||
143369797|NCT00771849|516897201|FG000|Overall Study|Lost to Follow-up|1|||
143369798|NCT00771849|516897202|FG001|Overall Study|Lost to Follow-up|2|||
143369799|NCT00771849|516897201|FG000|Overall Study|Withdrawal by Subject|1|||
143369800|NCT00771849|516897202|FG001|Overall Study|Withdrawal by Subject|1|||
143369801|NCT00771849|516897201|FG000|Overall Study|Not vaccinated|0|||
143369802|NCT00771849|516897202|FG001|Overall Study|Not vaccinated|1|||
143369803|NCT01972152|516897207|FG000|First Treatment Visit|Lost to Follow-up|0|||
143369804|NCT01972152|516897208|FG001|First Treatment Visit|Lost to Follow-up|1|||
143369805|NCT01972152|516897209|FG002|First Treatment Visit|Lost to Follow-up|0|||
143369806|NCT01972152|516897210|FG003|First Treatment Visit|Lost to Follow-up|0|||
143369807|NCT01972152|516897211|FG004|First Treatment Visit|Lost to Follow-up|0|||
143369808|NCT01972152|516897212|FG005|First Treatment Visit|Lost to Follow-up|0|||
143200641|NCT01278407|516280723|FG004|Confirmatory Phase|Adverse Event|0|||
143200642|NCT01278407|516280719|FG000|Confirmatory Phase|Participant's Choice|3|||
143200643|NCT01278407|516280720|FG001|Confirmatory Phase|Participant's Choice|5|||
143200644|NCT01278407|516280721|FG002|Confirmatory Phase|Participant's Choice|3|||
143200645|NCT01278407|516280722|FG003|Confirmatory Phase|Participant's Choice|0|||
143200646|NCT01278407|516280723|FG004|Confirmatory Phase|Participant's Choice|0|||
143200647|NCT01278407|516280719|FG000|Confirmatory Phase|Other|1|||
143200648|NCT01278407|516280720|FG001|Confirmatory Phase|Other|1|||
143200649|NCT01278407|516280721|FG002|Confirmatory Phase|Other|2|||
143200650|NCT01278407|516280722|FG003|Confirmatory Phase|Other|0|||
143200651|NCT01278407|516280723|FG004|Confirmatory Phase|Other|0|||
143200652|NCT01278407|516280719|FG000|Extension Phase|Adverse Event|0|||
143200653|NCT01278407|516280720|FG001|Extension Phase|Adverse Event|0|||
143200654|NCT01278407|516280721|FG002|Extension Phase|Adverse Event|0|||
143200655|NCT01278407|516280722|FG003|Extension Phase|Adverse Event|7|||
143200656|NCT01278407|516280723|FG004|Extension Phase|Adverse Event|16|||
143200657|NCT01278407|516280719|FG000|Extension Phase|Participant's Choice|0|||
143369809|NCT01972152|516897207|FG000|Second Treatment Visit|Protocol Violation|0|||
143200658|NCT01278407|516280720|FG001|Extension Phase|Participant's Choice|0|||
143200659|NCT01278407|516280721|FG002|Extension Phase|Participant's Choice|0|||
143200660|NCT01278407|516280722|FG003|Extension Phase|Participant's Choice|4|||
143200661|NCT01278407|516280723|FG004|Extension Phase|Participant's Choice|11|||
143200662|NCT01278407|516280719|FG000|Extension Phase|Other|0|||
143200663|NCT01278407|516280720|FG001|Extension Phase|Other|0|||
143200664|NCT01278407|516280721|FG002|Extension Phase|Other|0|||
143200665|NCT01278407|516280722|FG003|Extension Phase|Other|1|||
143200666|NCT01278407|516280723|FG004|Extension Phase|Other|3|||
143200667|NCT02285114|516280729|FG000|Main Phase|Investigator's Discretion|0|||
143200668|NCT02285114|516280730|FG001|Main Phase|Investigator's Discretion|2|||
143200669|NCT02285114|516280731|FG002|Main Phase|Investigator's Discretion|0|||
143200670|NCT02285114|516280732|FG003|Main Phase|Investigator's Discretion|0|||
143200671|NCT02285114|516280733|FG004|Main Phase|Investigator's Discretion|0|||
143200672|NCT02285114|516280734|FG005|Main Phase|Investigator's Discretion|0|||
143200673|NCT02285114|516280729|FG000|Main Phase|Enrolled but Never Treated|1|||
143200674|NCT02285114|516280730|FG001|Main Phase|Enrolled but Never Treated|0|||
143200675|NCT02285114|516280731|FG002|Main Phase|Enrolled but Never Treated|0|||
143200676|NCT02285114|516280732|FG003|Main Phase|Enrolled but Never Treated|0|||
143200677|NCT02285114|516280733|FG004|Main Phase|Enrolled but Never Treated|0|||
143200678|NCT02285114|516280734|FG005|Main Phase|Enrolled but Never Treated|0|||
143200679|NCT02285114|516280729|FG000|Main Phase|Withdrew Consent|0|||
143200680|NCT02285114|516280730|FG001|Main Phase|Withdrew Consent|0|||
143200681|NCT02285114|516280731|FG002|Main Phase|Withdrew Consent|1|||
143200682|NCT02285114|516280732|FG003|Main Phase|Withdrew Consent|0|||
143200683|NCT02285114|516280733|FG004|Main Phase|Withdrew Consent|0|||
143200684|NCT02285114|516280734|FG005|Main Phase|Withdrew Consent|0|||
143200685|NCT02285114|516280729|FG000|Extension Phase|Investigator's Discretion|0|||
143200686|NCT02285114|516280730|FG001|Extension Phase|Investigator's Discretion|0|||
143200687|NCT02285114|516280731|FG002|Extension Phase|Investigator's Discretion|0|||
143200688|NCT02285114|516280732|FG003|Extension Phase|Investigator's Discretion|14|||
143200689|NCT02285114|516280733|FG004|Extension Phase|Investigator's Discretion|1|||
143200690|NCT02285114|516280734|FG005|Extension Phase|Investigator's Discretion|0|||
143200691|NCT02285114|516280729|FG000|Extension Phase|Lost to Follow-up|0|||
143200692|NCT02285114|516280730|FG001|Extension Phase|Lost to Follow-up|0|||
143200693|NCT02285114|516280731|FG002|Extension Phase|Lost to Follow-up|0|||
143200694|NCT02285114|516280732|FG003|Extension Phase|Lost to Follow-up|1|||
143200695|NCT02285114|516280733|FG004|Extension Phase|Lost to Follow-up|1|||
143200696|NCT02285114|516280734|FG005|Extension Phase|Lost to Follow-up|0|||
143200697|NCT02285114|516280729|FG000|Extension Phase|Non-compliance with Study Drug|0|||
143200698|NCT02285114|516280730|FG001|Extension Phase|Non-compliance with Study Drug|0|||
143200699|NCT02285114|516280731|FG002|Extension Phase|Non-compliance with Study Drug|0|||
143200700|NCT02285114|516280732|FG003|Extension Phase|Non-compliance with Study Drug|2|||
143200701|NCT02285114|516280733|FG004|Extension Phase|Non-compliance with Study Drug|0|||
143369810|NCT01972152|516897208|FG001|Second Treatment Visit|Protocol Violation|1|||
143369811|NCT01972152|516897209|FG002|Second Treatment Visit|Protocol Violation|0|||
143369812|NCT01972152|516897210|FG003|Second Treatment Visit|Protocol Violation|0|||
143369813|NCT01972152|516897211|FG004|Second Treatment Visit|Protocol Violation|0|||
143369814|NCT01972152|516897212|FG005|Second Treatment Visit|Protocol Violation|0|||
143369815|NCT00559949|516897213|FG000|Overall Study|Progressive Disease during cycle 1|1|||
143369816|NCT00559949|516897213|FG000|Overall Study|Adverse Event|1|||
143369817|NCT00559949|516897213|FG000|Overall Study|Withdrawal by Subject|4|||
143369818|NCT00559949|516897213|FG000|Overall Study|No disease evaluation per protocol|1|||
143369819|NCT02596035|516897214|FG000|Overall Study|Disease Progression|64|||
143369820|NCT02596035|516897215|FG001|Overall Study|Disease Progression|32|||
143369821|NCT02596035|516897216|FG002|Overall Study|Disease Progression|1|||
143369822|NCT02596035|516897214|FG000|Overall Study|study drug toxicity|12|||
143369823|NCT02596035|516897215|FG001|Overall Study|study drug toxicity|3|||
143369824|NCT02596035|516897216|FG002|Overall Study|study drug toxicity|0|||
143369825|NCT02596035|516897214|FG000|Overall Study|AE unrelated to study drug|5|||
143369826|NCT02596035|516897215|FG001|Overall Study|AE unrelated to study drug|2|||
143369827|NCT02596035|516897216|FG002|Overall Study|AE unrelated to study drug|0|||
143369828|NCT02596035|516897214|FG000|Overall Study|participant request to discontinue study treatment|2|||
143369829|NCT02596035|516897215|FG001|Overall Study|participant request to discontinue study treatment|0|||
143369830|NCT02596035|516897216|FG002|Overall Study|participant request to discontinue study treatment|0|||
143369831|NCT02596035|516897214|FG000|Overall Study|participant withdrew consent|2|||
143369832|NCT02596035|516897215|FG001|Overall Study|participant withdrew consent|2|||
143369833|NCT02596035|516897216|FG002|Overall Study|participant withdrew consent|0|||
143369834|NCT02596035|516897214|FG000|Overall Study|Poor/Non Comlpiance|0|||
143369835|NCT02596035|516897215|FG001|Overall Study|Poor/Non Comlpiance|1|||
143369836|NCT02596035|516897216|FG002|Overall Study|Poor/Non Comlpiance|0|||
143369837|NCT02596035|516897214|FG000|Overall Study|participant no longer meets study criteria|1|||
143369838|NCT02596035|516897215|FG001|Overall Study|participant no longer meets study criteria|0|||
143369839|NCT02596035|516897216|FG002|Overall Study|participant no longer meets study criteria|0|||
143369840|NCT02596035|516897214|FG000|Overall Study|other reasons|11|||
143369841|NCT02596035|516897215|FG001|Overall Study|other reasons|4|||
143369842|NCT02596035|516897216|FG002|Overall Study|other reasons|0|||
143369843|NCT00509769|516897217|FG000|Overall Study|Progressive disease|77|||
143369844|NCT00509769|516897217|FG000|Overall Study|Adverse Event|4|||
143369845|NCT00509769|516897217|FG000|Overall Study|Patient's decision|1|||
143369846|NCT00509769|516897217|FG000|Overall Study|Physician Decision|8|||
143369847|NCT00509769|516897217|FG000|Overall Study|Use of prohibited therapies during study|1|||
143369848|NCT00414648|516897218|FG000|Overall Study|Adverse Event|5|||
143369849|NCT00414648|516897219|FG001|Overall Study|Adverse Event|5|||
143369850|NCT00414648|516897218|FG000|Overall Study|Death|0|||
143369851|NCT00414648|516897219|FG001|Overall Study|Death|1|||
143369852|NCT00414648|516897218|FG000|Overall Study|Lack of Efficacy|0|||
143369853|NCT00414648|516897219|FG001|Overall Study|Lack of Efficacy|2|||
143369854|NCT00414648|516897218|FG000|Overall Study|Withdrawal by Subject|0|||
143369855|NCT00414648|516897219|FG001|Overall Study|Withdrawal by Subject|1|||
143369856|NCT04173572|516897223|FG000|Overall Study|Withdrawal by Subject|1|||
143369857|NCT04173572|516897224|FG001|Overall Study|Withdrawal by Subject|5|||
143369858|NCT04173572|516897223|FG000|Overall Study|Lost to Follow-up|3|||
143369859|NCT04173572|516897224|FG001|Overall Study|Lost to Follow-up|1|||
143369860|NCT01253226|516897225|FG000|Overall Study|Adverse Event|0|||
143369861|NCT01253226|516897226|FG001|Overall Study|Adverse Event|0|||
143369862|NCT01253226|516897227|FG002|Overall Study|Adverse Event|1|||
143369863|NCT01253226|516897228|FG003|Overall Study|Adverse Event|0|||
143369864|NCT01253226|516897229|FG004|Overall Study|Adverse Event|0|||
143369865|NCT01253226|516897225|FG000|Overall Study|Death|0|||
143369866|NCT01253226|516897226|FG001|Overall Study|Death|1|||
143369867|NCT01253226|516897227|FG002|Overall Study|Death|0|||
143369868|NCT01253226|516897228|FG003|Overall Study|Death|0|||
143369869|NCT01253226|516897229|FG004|Overall Study|Death|0|||
143369870|NCT01253226|516897225|FG000|Overall Study|Physician Decision|0|||
143369871|NCT01253226|516897226|FG001|Overall Study|Physician Decision|0|||
143369872|NCT01253226|516897227|FG002|Overall Study|Physician Decision|0|||
143369873|NCT01253226|516897228|FG003|Overall Study|Physician Decision|0|||
143369874|NCT01253226|516897229|FG004|Overall Study|Physician Decision|2|||
143369875|NCT01253226|516897225|FG000|Overall Study|Withdrawal by Subject|0|||
143369876|NCT01253226|516897226|FG001|Overall Study|Withdrawal by Subject|0|||
143200702|NCT02285114|516280734|FG005|Extension Phase|Non-compliance with Study Drug|0|||
143200703|NCT02285114|516280729|FG000|Extension Phase|Pregnancy|0|||
143200704|NCT02285114|516280730|FG001|Extension Phase|Pregnancy|0|||
143369877|NCT01253226|516897227|FG002|Overall Study|Withdrawal by Subject|0|||
143369878|NCT01253226|516897228|FG003|Overall Study|Withdrawal by Subject|1|||
143369879|NCT01253226|516897229|FG004|Overall Study|Withdrawal by Subject|0|||
143369880|NCT03593070|516897230|FG000|Overall Study|administrative withdrawal|1|||
143369881|NCT03593070|516897231|FG001|Overall Study|administrative withdrawal|1|||
143369882|NCT03643211|516897232|FG000|Overall Study|Contract violation/deficiency|12|||
143369883|NCT03643211|516897232|FG000|Overall Study|Invalid registration|3|||
143200705|NCT02285114|516280731|FG002|Extension Phase|Pregnancy|0|||
143200706|NCT02285114|516280732|FG003|Extension Phase|Pregnancy|1|||
143200707|NCT02285114|516280733|FG004|Extension Phase|Pregnancy|0|||
143200708|NCT02285114|516280734|FG005|Extension Phase|Pregnancy|0|||
143200709|NCT01156389|516280735|FG000|Overall Study|Elevated liver enzymes|4|||
143200710|NCT01156389|516280736|FG001|Overall Study|Elevated liver enzymes|0|||
143200711|NCT01156389|516280735|FG000|Overall Study|Vomiting|0|||
143200712|NCT01156389|516280736|FG001|Overall Study|Vomiting|1|||
143200713|NCT02351349|516280742|FG000|Overall Study|Withdrawal by Subject|2|||
143200714|NCT02351349|516280743|FG001|Overall Study|Withdrawal by Subject|3|||
143200715|NCT01703117|516280744|FG000|Overall Study|Adverse Event|4|||
143200716|NCT01703117|516280745|FG001|Overall Study|Adverse Event|3|||
143200717|NCT01703117|516280744|FG000|Overall Study|Withdrawal by Subject|0|||
143200718|NCT01703117|516280745|FG001|Overall Study|Withdrawal by Subject|1|||
143200719|NCT01340937|516280747|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
143200720|NCT01340937|516280748|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
143200721|NCT01340937|516280749|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
143200722|NCT01340937|516280750|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
143200723|NCT01340937|516280747|FG000|Period 1: Infant Series|Adverse Event|0|||
143200724|NCT01340937|516280748|FG001|Period 1: Infant Series|Adverse Event|1|||
143200725|NCT01340937|516280749|FG002|Period 1: Infant Series|Adverse Event|4|||
143200726|NCT01340937|516280750|FG003|Period 1: Infant Series|Adverse Event|0|||
143200727|NCT01340937|516280747|FG000|Period 1: Infant Series|Death|2|||
143200728|NCT01340937|516280748|FG001|Period 1: Infant Series|Death|0|||
143200729|NCT01340937|516280749|FG002|Period 1: Infant Series|Death|2|||
143200730|NCT01340937|516280750|FG003|Period 1: Infant Series|Death|0|||
143200731|NCT01340937|516280747|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
143200732|NCT01340937|516280748|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
143200733|NCT01340937|516280749|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
143200734|NCT01340937|516280750|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
143200735|NCT01340937|516280747|FG000|Period 1: Infant Series|Physician Decision|2|||
143200736|NCT01340937|516280748|FG001|Period 1: Infant Series|Physician Decision|3|||
143200737|NCT01340937|516280749|FG002|Period 1: Infant Series|Physician Decision|1|||
143200738|NCT01340937|516280750|FG003|Period 1: Infant Series|Physician Decision|0|||
143200739|NCT01340937|516280747|FG000|Period 1: Infant Series|Protocol Violation|1|||
143200740|NCT01340937|516280748|FG001|Period 1: Infant Series|Protocol Violation|4|||
143200741|NCT01340937|516280749|FG002|Period 1: Infant Series|Protocol Violation|4|||
143200742|NCT01340937|516280750|FG003|Period 1: Infant Series|Protocol Violation|3|||
143200743|NCT01340937|516280747|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
143200744|NCT01340937|516280748|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
143200745|NCT01340937|516280749|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
143200746|NCT01340937|516280750|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
143200747|NCT01340937|516280747|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
143200748|NCT01340937|516280748|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
143200749|NCT01340937|516280749|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
143200750|NCT01340937|516280750|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
143200751|NCT01340937|516280747|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
143200752|NCT01340937|516280748|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
143200753|NCT01340937|516280749|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
143200754|NCT01340937|516280750|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
143200755|NCT01340937|516280747|FG000|Period 2: Interim Period|Adverse Event|1|||
143200756|NCT01340937|516280748|FG001|Period 2: Interim Period|Adverse Event|0|||
143200757|NCT01340937|516280749|FG002|Period 2: Interim Period|Adverse Event|1|||
143200758|NCT01340937|516280750|FG003|Period 2: Interim Period|Adverse Event|0|||
143200759|NCT01340937|516280747|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
143200760|NCT01340937|516280748|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
143369884|NCT03643211|516897232|FG000|Overall Study|No treatment information|2|||
143369885|NCT03643211|516897232|FG000|Overall Study|No adverse event information - No revisit|4|||
143200761|NCT01340937|516280749|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
143200762|NCT01340937|516280750|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
143200763|NCT01340937|516280747|FG000|Period 2: Interim Period|Physician Decision|0|||
143200764|NCT01340937|516280748|FG001|Period 2: Interim Period|Physician Decision|1|||
143200765|NCT01340937|516280749|FG002|Period 2: Interim Period|Physician Decision|1|||
143200766|NCT01340937|516280750|FG003|Period 2: Interim Period|Physician Decision|0|||
143200767|NCT01340937|516280747|FG000|Period 2: Interim Period|Protocol Violation|5|||
143200768|NCT01340937|516280748|FG001|Period 2: Interim Period|Protocol Violation|3|||
143200769|NCT01340937|516280749|FG002|Period 2: Interim Period|Protocol Violation|6|||
143200770|NCT01340937|516280750|FG003|Period 2: Interim Period|Protocol Violation|3|||
143200771|NCT01340937|516280747|FG000|Period 2: Interim Period|Technical problems|4|||
143200772|NCT01340937|516280748|FG001|Period 2: Interim Period|Technical problems|4|||
143200773|NCT01340937|516280749|FG002|Period 2: Interim Period|Technical problems|6|||
143200774|NCT01340937|516280750|FG003|Period 2: Interim Period|Technical problems|3|||
143262332|NCT01856023|516513915|FG001|Overall Study|Lack of Efficacy|5|||
143262333|NCT01856023|516513914|FG000|Overall Study|non compliance, study closure|1|||
143262334|NCT01856023|516513915|FG001|Overall Study|non compliance, study closure|3|||
143200775|NCT01340937|516280747|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
143200776|NCT01340937|516280748|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
143200777|NCT01340937|516280749|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
143200778|NCT01340937|516280750|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
143200779|NCT01340937|516280747|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
143200780|NCT01340937|516280748|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
143200781|NCT01340937|516280749|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
143200782|NCT01340937|516280750|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
143200783|NCT01340937|516280747|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
143200784|NCT01340937|516280748|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
143200785|NCT01340937|516280749|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
143200786|NCT01340937|516280750|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
143200787|NCT01340937|516280747|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
143200788|NCT01340937|516280748|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
143200789|NCT01340937|516280749|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
143200790|NCT01340937|516280750|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
143200791|NCT00440310|516280751|FG000|Overall Study|Lost to Follow-up|4|||
143200792|NCT00440310|516280752|FG001|Overall Study|Lost to Follow-up|5|||
143200793|NCT00440310|516280751|FG000|Overall Study|Protocol Violation|0|||
143200794|NCT00440310|516280752|FG001|Overall Study|Protocol Violation|1|||
143200795|NCT00440310|516280751|FG000|Overall Study|Withdrawal by Subject|15|||
143200796|NCT00440310|516280752|FG001|Overall Study|Withdrawal by Subject|14|||
143200797|NCT00440310|516280751|FG000|Overall Study|No Reply at EOS|7|||
143200798|NCT00440310|516280752|FG001|Overall Study|No Reply at EOS|7|||
143200799|NCT00440310|516280751|FG000|Overall Study|Other|1|||
143200800|NCT00440310|516280752|FG001|Overall Study|Other|0|||
143200801|NCT00440310|516280751|FG000|Overall Study|Status Unknown|1|||
143200802|NCT00440310|516280752|FG001|Overall Study|Status Unknown|3|||
143200803|NCT02119156|516280753|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
143200804|NCT02119156|516280754|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
143200805|NCT02119156|516280755|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
143200806|NCT02119156|516280753|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
143200807|NCT02119156|516280754|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
143200808|NCT02119156|516280755|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
143200809|NCT02119156|516280753|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
143200810|NCT02119156|516280754|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
143200811|NCT02119156|516280755|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
143200812|NCT02119156|516280753|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
143262335|NCT01856023|516513914|FG000|Overall Study|Withdrawal by Subject|1|||
143200813|NCT02119156|516280754|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
143262336|NCT01856023|516513915|FG001|Overall Study|Withdrawal by Subject|1|||
143262337|NCT00256282|516513916|FG000|Overall Study|Disease progression, relapse during acti|12|||
143262338|NCT00256282|516513916|FG000|Overall Study|Adverse Event|3|||
143262339|NCT00256282|516513916|FG000|Overall Study|Physician Decision|1|||
143262340|NCT00667446|516513917|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
143200814|NCT02119156|516280755|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
143200815|NCT02119156|516280753|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
143200816|NCT02119156|516280754|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
143200817|NCT02119156|516280755|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
143200818|NCT02469415|516280756|FG000|Overall Study|Withdrawal by Subject|1|||
143200819|NCT02469415|516280756|FG000|Overall Study|Investigational agent placed on hold|2|||
143200820|NCT01610596|516280760|FG000|Overall Study|Lost to Follow-up|0|||
143200821|NCT01610596|516280761|FG001|Overall Study|Lost to Follow-up|1|||
143200822|NCT01519674|516280764|FG000|Overall Study|Adverse Event|3|||
143200823|NCT01519674|516280765|FG001|Overall Study|Adverse Event|3|||
143200824|NCT01519674|516280766|FG002|Overall Study|Adverse Event|0|||
143200825|NCT01519674|516280764|FG000|Overall Study|Lack of Efficacy|1|||
143200826|NCT01519674|516280765|FG001|Overall Study|Lack of Efficacy|1|||
143200827|NCT01519674|516280766|FG002|Overall Study|Lack of Efficacy|1|||
143200828|NCT01519674|516280764|FG000|Overall Study|Protocol Violation|0|||
143200829|NCT01519674|516280765|FG001|Overall Study|Protocol Violation|3|||
143200830|NCT01519674|516280766|FG002|Overall Study|Protocol Violation|1|||
143200831|NCT01519674|516280764|FG000|Overall Study|Withdrawal Criteria|7|||
143200832|NCT01519674|516280765|FG001|Overall Study|Withdrawal Criteria|2|||
143200833|NCT01519674|516280766|FG002|Overall Study|Withdrawal Criteria|7|||
143200834|NCT01519674|516280764|FG000|Overall Study|Unsclassified|10|||
143200835|NCT01519674|516280765|FG001|Overall Study|Unsclassified|4|||
143200836|NCT01519674|516280766|FG002|Overall Study|Unsclassified|3|||
143200837|NCT02435680|516280773|FG000|Overall Study|Physician Decision|3|||
143200838|NCT02435680|516280774|FG001|Overall Study|Physician Decision|0|||
143200839|NCT02435680|516280775|FG002|Overall Study|Physician Decision|0|||
143200840|NCT02435680|516280773|FG000|Overall Study|subject / guardian decision|0|||
143200841|NCT02435680|516280774|FG001|Overall Study|subject / guardian decision|3|||
143200842|NCT02435680|516280775|FG002|Overall Study|subject / guardian decision|2|||
143200843|NCT02435680|516280773|FG000|Overall Study|Adverse Event|8|||
143200844|NCT02435680|516280774|FG001|Overall Study|Adverse Event|3|||
143200845|NCT02435680|516280775|FG002|Overall Study|Adverse Event|2|||
143200846|NCT02435680|516280773|FG000|Overall Study|progressive disease|10|||
143200847|NCT02435680|516280774|FG001|Overall Study|progressive disease|7|||
143200848|NCT02435680|516280775|FG002|Overall Study|progressive disease|11|||
143200849|NCT02435680|516280773|FG000|Overall Study|not treated|0|||
143200850|NCT02435680|516280774|FG001|Overall Study|not treated|0|||
143200851|NCT02435680|516280775|FG002|Overall Study|not treated|1|||
143200852|NCT01030874|516280776|FG000|Overall Study|Withdrawal by Subject|1|||
143200853|NCT01030874|516280777|FG001|Overall Study|Withdrawal by Subject|0|||
143200854|NCT01030874|516280776|FG000|Overall Study|Discharged in first 2 weeks|17|||
143200855|NCT01030874|516280777|FG001|Overall Study|Discharged in first 2 weeks|16|||
143200856|NCT00953524|516280778|FG000|Overall Study|Adverse Event|2|||
143262341|NCT00667446|516513918|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
143262342|NCT00667446|516513917|FG000|Treatment Period (36 Months)|Other|2|||
143262343|NCT00667446|516513918|FG001|Treatment Period (36 Months)|Other|2|||
143262344|NCT00667446|516513917|FG000|Treatment Period (36 Months)|Personal reasons|2|||
143262345|NCT00667446|516513918|FG001|Treatment Period (36 Months)|Personal reasons|2|||
143262346|NCT00667446|516513917|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
143262347|NCT00667446|516513918|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
143262348|NCT00667446|516513917|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
143262349|NCT00667446|516513918|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
143262350|NCT00667446|516513917|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
143262351|NCT00667446|516513918|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
143262352|NCT00667446|516513917|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
143262353|NCT00667446|516513918|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
143262354|NCT00667446|516513917|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
143262355|NCT00667446|516513918|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
143262356|NCT00667446|516513917|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
143262357|NCT00667446|516513918|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
143262358|NCT03945175|516513920|FG000|Overall Study|Did not meet inclusion criteria|31|||
143262359|NCT03945175|516513920|FG000|Overall Study|Withdrew consent|2|||
143262360|NCT03945175|516513920|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
143262361|NCT03945175|516513920|FG000|Overall Study|Early termination during Mydayis treatment|1|||
143262362|NCT00769483|516513928|FG000|Overall Study|Withdrawal by Subject|0|||
143262363|NCT00769483|516513929|FG001|Overall Study|Withdrawal by Subject|1|||
143200857|NCT00953524|516280779|FG001|Overall Study|Adverse Event|0|||
143200858|NCT00953524|516280780|FG002|Overall Study|Adverse Event|1|||
143200859|NCT00953524|516280781|FG003|Overall Study|Adverse Event|2|||
143200860|NCT00953524|516280778|FG000|Overall Study|Protocol Violation|18|||
143200861|NCT00953524|516280779|FG001|Overall Study|Protocol Violation|10|||
143200862|NCT00953524|516280780|FG002|Overall Study|Protocol Violation|11|||
143200863|NCT00953524|516280781|FG003|Overall Study|Protocol Violation|6|||
143200864|NCT00953524|516280778|FG000|Overall Study|Lost to Follow-up|0|||
143200865|NCT00953524|516280779|FG001|Overall Study|Lost to Follow-up|1|||
143200866|NCT00953524|516280780|FG002|Overall Study|Lost to Follow-up|1|||
143200867|NCT00953524|516280781|FG003|Overall Study|Lost to Follow-up|0|||
143200868|NCT00953524|516280778|FG000|Overall Study|Withdrawal by Subject|2|||
143200869|NCT00953524|516280779|FG001|Overall Study|Withdrawal by Subject|4|||
143200870|NCT00953524|516280780|FG002|Overall Study|Withdrawal by Subject|1|||
143200871|NCT00953524|516280781|FG003|Overall Study|Withdrawal by Subject|0|||
143200872|NCT01998893|516280787|FG000|Overall Study|Adverse Event|2|||
143200873|NCT01998893|516280787|FG000|Overall Study|Death|1|||
143200874|NCT01998893|516280787|FG000|Overall Study|Lost to Follow-up|8|||
143200875|NCT01998893|516280787|FG000|Overall Study|Physician Decision|2|||
143200876|NCT01998893|516280787|FG000|Overall Study|Protocol Violation|2|||
143200877|NCT01998893|516280787|FG000|Overall Study|Withdrawal by Subject|1|||
143200878|NCT01998893|516280787|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
143200879|NCT01994863|516280788|FG000|Period 1|Adverse Event|4|||
143200880|NCT01994863|516280789|FG001|Period 1|Adverse Event|0|||
143200881|NCT01994863|516280788|FG000|Period 1|Withdrawal by Subject|1|||
143200882|NCT01994863|516280789|FG001|Period 1|Withdrawal by Subject|0|||
143200883|NCT01994863|516280788|FG000|Period 1|Trial stopped by sponsor|1|||
143200884|NCT01994863|516280789|FG001|Period 1|Trial stopped by sponsor|3|||
143200885|NCT01994863|516280788|FG000|Period 1|Lack of Efficacy|1|||
143200886|NCT01994863|516280789|FG001|Period 1|Lack of Efficacy|0|||
143200887|NCT01994863|516280788|FG000|Period 2|Adverse Event|0|||
143200888|NCT01994863|516280789|FG001|Period 2|Adverse Event|1|||
143200889|NCT01994863|516280788|FG000|Period 2|Lack of Efficacy|0|||
143200890|NCT01994863|516280789|FG001|Period 2|Lack of Efficacy|2|||
143200891|NCT01994863|516280788|FG000|Period 2|Withdrawal by Subject|1|||
143200892|NCT01994863|516280789|FG001|Period 2|Withdrawal by Subject|1|||
143200893|NCT00867087|516280790|FG000|Overall Study|Other|1|||
143200894|NCT00867087|516280790|FG000|Overall Study|Withdrawal by Subject|4|||
143200895|NCT00867087|516280790|FG000|Overall Study|Death|37|||
143200896|NCT01891344|516280791|FG000|Overall Study|Ongoing|6|||
143200897|NCT01891344|516280792|FG001|Overall Study|Ongoing|2|||
143200898|NCT01891344|516280793|FG002|Overall Study|Ongoing|0|||
143200899|NCT01891344|516280794|FG003|Overall Study|Ongoing|1|||
143200900|NCT01891344|516280795|FG004|Overall Study|Ongoing|4|||
143200901|NCT01891344|516280796|FG005|Overall Study|Ongoing|1|||
143200902|NCT01891344|516280797|FG006|Overall Study|Ongoing|0|||
143200903|NCT01891344|516280798|FG007|Overall Study|Ongoing|0|||
143200904|NCT03249935|516280804|FG000|Overall Study|Discharged from facility early|36|||
143200905|NCT03249935|516280804|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
143369886|NCT04858425|516897233|FG000|Overall Study|Adverse Event|2|||
143200906|NCT03249935|516280804|FG000|Overall Study|Protocol Violation|5|||
143200907|NCT03593681|516280805|FG000|Overall Study|Inadequate sample collected|12|||
143200908|NCT03593681|516280805|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
143200909|NCT03593681|516280805|FG000|Overall Study|Protocol Violation|3|||
143200910|NCT03593681|516280805|FG000|Overall Study|Withdrawal by Subject|3|||
143200911|NCT03593681|516280805|FG000|Overall Study|Procedure not attempted|3|||
143369887|NCT04858425|516897234|FG001|Overall Study|Adverse Event|2|||
143369888|NCT04858425|516897233|FG000|Overall Study|Withdrawal by Subject|3|||
143369889|NCT04858425|516897234|FG001|Overall Study|Withdrawal by Subject|1|||
143369890|NCT04858425|516897233|FG000|Overall Study|Lost to Follow-up|4|||
143369891|NCT04858425|516897234|FG001|Overall Study|Lost to Follow-up|2|||
143369892|NCT04858425|516897233|FG000|Overall Study|Lost to Follow-up|1|||
143369893|NCT04858425|516897234|FG001|Overall Study|Lost to Follow-up|0|||
143369894|NCT03310983|516897235|FG000|Overall Study|Lost to Follow-up|15|||
143369895|NCT03310983|516897236|FG001|Overall Study|Lost to Follow-up|17|||
143369896|NCT03612804|516897238|FG000|Overall Study|Death|0|||
143369897|NCT03612804|516897239|FG001|Overall Study|Death|7|||
143369898|NCT03612804|516897240|FG002|Overall Study|Death|0|||
143369899|NCT03612804|516897241|FG003|Overall Study|Death|8|||
143200912|NCT03593681|516280805|FG000|Overall Study|Adverse Event|2|||
143200913|NCT03593681|516280805|FG000|Overall Study|Physician Decision|1|||
143200914|NCT00541099|516280808|FG000|Overall Study|Ineligible|3|||
143200915|NCT00066469|516280809|FG000|Overall Study|Death|3|||
143200916|NCT00066469|516280809|FG000|Overall Study|Lack of Efficacy|9|||
143200917|NCT00066469|516280809|FG000|Overall Study|Lost to Follow-up|1|||
143200918|NCT00066469|516280809|FG000|Overall Study|Physician Decision|1|||
143200919|NCT00066469|516280809|FG000|Overall Study|Withdrawal by Subject|1|||
143200920|NCT00066469|516280809|FG000|Overall Study|ineligible|1|||
143200921|NCT00711802|516280810|FG000|Overall Study|Not treated (no further detail)|2|||
143369900|NCT03612804|516897238|FG000|Overall Study|Medication copay coverage issues|0|||
143369901|NCT03612804|516897239|FG001|Overall Study|Medication copay coverage issues|0|||
143200922|NCT00711802|516280811|FG001|Overall Study|Not treated (no further detail)|1|||
143200923|NCT00711802|516280812|FG002|Overall Study|Not treated (no further detail)|2|||
143200924|NCT00711802|516280813|FG003|Overall Study|Not treated (no further detail)|0|||
143200925|NCT00711802|516280814|FG004|Overall Study|Not treated (no further detail)|2|||
143200926|NCT00711802|516280815|FG005|Overall Study|Not treated (no further detail)|0|||
143200927|NCT00711802|516280816|FG006|Overall Study|Not treated (no further detail)|0|||
143200928|NCT00711802|516280817|FG007|Overall Study|Not treated (no further detail)|0|||
143200929|NCT00711802|516280810|FG000|Overall Study|Adverse Event|0|||
143200930|NCT00711802|516280811|FG001|Overall Study|Adverse Event|0|||
143200931|NCT00711802|516280812|FG002|Overall Study|Adverse Event|0|||
143200932|NCT00711802|516280813|FG003|Overall Study|Adverse Event|0|||
143200933|NCT00711802|516280814|FG004|Overall Study|Adverse Event|1|||
143200934|NCT00711802|516280815|FG005|Overall Study|Adverse Event|1|||
143200935|NCT00711802|516280816|FG006|Overall Study|Adverse Event|0|||
143200936|NCT00711802|516280817|FG007|Overall Study|Adverse Event|0|||
143200937|NCT00711802|516280810|FG000|Overall Study|Microbiological failure|0|||
143200938|NCT00711802|516280811|FG001|Overall Study|Microbiological failure|1|||
143200939|NCT00711802|516280812|FG002|Overall Study|Microbiological failure|0|||
143200940|NCT00711802|516280813|FG003|Overall Study|Microbiological failure|0|||
143200941|NCT00711802|516280814|FG004|Overall Study|Microbiological failure|0|||
143262364|NCT00769483|516513930|FG002|Overall Study|Withdrawal by Subject|0|||
143262365|NCT00769483|516513931|FG003|Overall Study|Withdrawal by Subject|0|||
143262366|NCT00769483|516513932|FG004|Overall Study|Withdrawal by Subject|1|||
143262367|NCT00769483|516513933|FG005|Overall Study|Withdrawal by Subject|0|||
143262368|NCT01306877|516513934|FG000|Overall Study|Lost to Follow-up|3|||
143262369|NCT01306877|516513935|FG001|Overall Study|Lost to Follow-up|3|||
143262370|NCT01306877|516513934|FG000|Overall Study|Physician Decision|0|||
143262371|NCT01306877|516513935|FG001|Overall Study|Physician Decision|1|||
143262372|NCT00006389|516513936|FG000|Overall Study|Adverse Event|1|||
143262373|NCT00999921|516513941|FG000|Overall Study|Lost to Follow-up|10|||
143262374|NCT00999921|516513942|FG001|Overall Study|Lost to Follow-up|19|||
143262375|NCT00772070|516513949|FG000|Overall Study|Lost to Follow-up|0|||
143262376|NCT00772070|516513950|FG001|Overall Study|Lost to Follow-up|8|||
143262377|NCT00772070|516513949|FG000|Overall Study|Withdrawal by Subject|0|||
143262378|NCT00772070|516513950|FG001|Overall Study|Withdrawal by Subject|2|||
143262379|NCT00772070|516513949|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
143262380|NCT00772070|516513950|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
143262381|NCT01309308|516513951|FG000|Overall Study|Lost to Follow-up|6|||
143262382|NCT01309308|516513952|FG001|Overall Study|Lost to Follow-up|4|||
143262383|NCT01962922|516513953|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
143262384|NCT01962922|516513954|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
143262385|NCT01962922|516513953|FG000|PK Portion Day 7|non-compliance|1|||
143262386|NCT01962922|516513954|FG001|PK Portion Day 7|non-compliance|0|||
143262387|NCT01962922|516513953|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
143262388|NCT01962922|516513954|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
143262389|NCT01962922|516513953|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
143262390|NCT01962922|516513954|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
143262391|NCT00596362|516513955|FG000|Overall Study|Progressive Disease|1|||
143262392|NCT00817479|516513956|FG000|Overall Study|Physician Decision|1|||
143262393|NCT00817479|516513957|FG001|Overall Study|Physician Decision|1|||
143262394|NCT00282347|516513960|FG000|Treatment Period|Death|2|||
143262395|NCT00282347|516513961|FG001|Treatment Period|Death|0|||
143262396|NCT00282347|516513960|FG000|Treatment Period|Lost to Follow-up|2|||
143262397|NCT00282347|516513961|FG001|Treatment Period|Lost to Follow-up|5|||
143262398|NCT00282347|516513960|FG000|Treatment Period|Withdrawal by Subject|1|||
143262399|NCT00282347|516513961|FG001|Treatment Period|Withdrawal by Subject|3|||
143262400|NCT00282347|516513960|FG000|Treatment Period|Physician Decision|0|||
143262401|NCT00282347|516513961|FG001|Treatment Period|Physician Decision|1|||
143262402|NCT00282347|516513960|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
143262403|NCT00282347|516513961|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
143262404|NCT00282347|516513960|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
143262405|NCT00282347|516513961|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
143262406|NCT00282347|516513960|FG000|Safety Follow-up Period|Physician Decision|1|||
143262407|NCT00282347|516513961|FG001|Safety Follow-up Period|Physician Decision|1|||
143262408|NCT00282347|516513960|FG000|Safety Follow-up Period|Protocol Deviation|0|||
143262409|NCT00282347|516513961|FG001|Safety Follow-up Period|Protocol Deviation|2|||
143262410|NCT00282347|516513960|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
143262411|NCT00282347|516513961|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
143262412|NCT00282347|516513960|FG000|B Cell Follow-up Period|Physician Decision|1|||
143262413|NCT00282347|516513961|FG001|B Cell Follow-up Period|Physician Decision|0|||
143262414|NCT00282347|516513960|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
143262415|NCT00282347|516513961|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
143200942|NCT00711802|516280815|FG005|Overall Study|Microbiological failure|1|||
143200943|NCT00711802|516280816|FG006|Overall Study|Microbiological failure|0|||
143200944|NCT00711802|516280817|FG007|Overall Study|Microbiological failure|0|||
143262416|NCT00543855|516515819|FG000|Overall Study|Adverse Event|3|||
143262417|NCT00543855|516515820|FG001|Overall Study|Adverse Event|1|||
143262418|NCT00543855|516515821|FG002|Overall Study|Adverse Event|3|||
143369902|NCT03612804|516897240|FG002|Overall Study|Medication copay coverage issues|0|||
143369903|NCT03612804|516897241|FG003|Overall Study|Medication copay coverage issues|17|||
143369904|NCT03612804|516897238|FG000|Overall Study|Not current smoker at time of screening|0|||
143369905|NCT03612804|516897239|FG001|Overall Study|Not current smoker at time of screening|1|||
143369906|NCT03612804|516897240|FG002|Overall Study|Not current smoker at time of screening|0|||
143369907|NCT03612804|516897241|FG003|Overall Study|Not current smoker at time of screening|3|||
143369908|NCT03612804|516897238|FG000|Overall Study|Non-veteran status|0|||
143369909|NCT03612804|516897239|FG001|Overall Study|Non-veteran status|1|||
143369910|NCT03612804|516897240|FG002|Overall Study|Non-veteran status|0|||
143369911|NCT03612804|516897241|FG003|Overall Study|Non-veteran status|0|||
143369912|NCT03612804|516897238|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
143369913|NCT03612804|516897239|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
143369914|NCT03612804|516897240|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
143369915|NCT03612804|516897241|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
143369916|NCT03612804|516897238|FG000|Overall Study|Provider retired from VA|0|||
143369917|NCT03612804|516897239|FG001|Overall Study|Provider retired from VA|0|||
143369918|NCT03612804|516897240|FG002|Overall Study|Provider retired from VA|2|||
143369919|NCT03612804|516897241|FG003|Overall Study|Provider retired from VA|0|||
143369920|NCT03612804|516897238|FG000|Overall Study|Withdrawal by Subject|0|||
143369921|NCT03612804|516897239|FG001|Overall Study|Withdrawal by Subject|0|||
143369922|NCT03612804|516897240|FG002|Overall Study|Withdrawal by Subject|7|||
143369923|NCT03612804|516897241|FG003|Overall Study|Withdrawal by Subject|0|||
143369924|NCT03612804|516897238|FG000|Overall Study|Provider involved with study activities|1|||
143369925|NCT03612804|516897239|FG001|Overall Study|Provider involved with study activities|0|||
143369926|NCT03612804|516897240|FG002|Overall Study|Provider involved with study activities|0|||
143369927|NCT03612804|516897241|FG003|Overall Study|Provider involved with study activities|0|||
143369928|NCT01656304|516897242|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
143369929|NCT04391309|516897243|FG000|Overall Study|Death|1|||
143369930|NCT04391309|516897244|FG001|Overall Study|Death|1|||
143369931|NCT04391309|516897243|FG000|Overall Study|Lost to Follow-up|3|||
143369932|NCT04391309|516897244|FG001|Overall Study|Lost to Follow-up|2|||
143369933|NCT04391309|516897243|FG000|Overall Study|Withdrawal by Subject|2|||
143369934|NCT04391309|516897244|FG001|Overall Study|Withdrawal by Subject|2|||
143369935|NCT01155869|516897245|FG000|Overall Study|Lost to Follow-up|3|||
143369936|NCT01155869|516897246|FG001|Overall Study|Lost to Follow-up|1|||
143369937|NCT00881335|516897247|FG000|Overall Study|Lost to Follow-up|3|||
143369938|NCT00881335|516897248|FG001|Overall Study|Lost to Follow-up|2|||
143369939|NCT00554801|516897250|FG000|Overall Study|left area before completion|5|||
143369940|NCT00554801|516897251|FG001|Overall Study|left area before completion|0|||
143369941|NCT00554801|516897250|FG000|Overall Study|Withdrawal by Subject|14|||
143369942|NCT00554801|516897251|FG001|Overall Study|Withdrawal by Subject|0|||
143369943|NCT05826431|516897252|FG000|Overall Study|Withdrawal by Subject|1|||
143369944|NCT02104765|516897255|FG000|Overall Study|Lost to Follow-up|0|||
143369945|NCT02104765|516897256|FG001|Overall Study|Lost to Follow-up|0|||
143369946|NCT02104765|516897257|FG002|Overall Study|Lost to Follow-up|1|||
143369947|NCT02104765|516897258|FG003|Overall Study|Lost to Follow-up|0|||
143369948|NCT02104765|516897259|FG004|Overall Study|Lost to Follow-up|0|||
143369949|NCT02104765|516897260|FG005|Overall Study|Lost to Follow-up|0|||
143369950|NCT02104765|516897261|FG006|Overall Study|Lost to Follow-up|0|||
143369951|NCT02104765|516897255|FG000|Overall Study|Withdrawal by Subject|0|||
143369952|NCT02104765|516897256|FG001|Overall Study|Withdrawal by Subject|0|||
143369953|NCT02104765|516897257|FG002|Overall Study|Withdrawal by Subject|0|||
143369954|NCT02104765|516897258|FG003|Overall Study|Withdrawal by Subject|1|||
143369955|NCT02104765|516897259|FG004|Overall Study|Withdrawal by Subject|1|||
143369956|NCT02104765|516897260|FG005|Overall Study|Withdrawal by Subject|0|||
143369957|NCT02104765|516897261|FG006|Overall Study|Withdrawal by Subject|1|||
143369958|NCT02357784|516897262|FG000|Overall Study|Withdrawal by Subject|1|||
143369959|NCT01697319|516897263|FG000|Primary Phase|Withdrawal by Subject|1|||
143369960|NCT01697319|516897263|FG000|Extension Phase|Terminated by Sponsor|15|||
143369961|NCT00604721|516897268|FG000|Overall Study|Physician Decision|1|||
143369962|NCT00604721|516897268|FG000|Overall Study|Withdrawal by Subject|1|||
143369963|NCT01838551|516897272|FG000|Overall Study|Adverse Event|16|||
143369964|NCT01838551|516897272|FG000|Overall Study|Death|1|||
143369965|NCT01838551|516897272|FG000|Overall Study|Lack of Efficacy|10|||
143369966|NCT01838551|516897272|FG000|Overall Study|Physician Decision|4|||
143369967|NCT01838551|516897272|FG000|Overall Study|Withdrawal by Subject|10|||
143369968|NCT01838551|516897272|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
143369969|NCT04133363|516897275|FG000|Overall Study|Lost to Follow-up|2|||
143369970|NCT04133363|516897276|FG001|Overall Study|Lost to Follow-up|1|||
143369971|NCT04133363|516897277|FG002|Overall Study|Lost to Follow-up|4|||
143369972|NCT01546155|516899032|FG000|Overall Study|could not tolerate long scan duration|3|||
143369973|NCT00486759|516899037|FG000|Treatment|Adverse event/intercurrent illness|86|||
143200945|NCT00711802|516280810|FG000|Overall Study|Protocol Violation|0|||
143200946|NCT00711802|516280811|FG001|Overall Study|Protocol Violation|0|||
143200947|NCT00711802|516280812|FG002|Overall Study|Protocol Violation|0|||
143200948|NCT00711802|516280813|FG003|Overall Study|Protocol Violation|1|||
143200949|NCT00711802|516280814|FG004|Overall Study|Protocol Violation|0|||
143200950|NCT00711802|516280815|FG005|Overall Study|Protocol Violation|0|||
143200951|NCT00711802|516280816|FG006|Overall Study|Protocol Violation|0|||
143200952|NCT00711802|516280817|FG007|Overall Study|Protocol Violation|0|||
143200953|NCT00711802|516280810|FG000|Overall Study|Physician Decision|0|||
143200954|NCT00711802|516280811|FG001|Overall Study|Physician Decision|2|||
143200955|NCT00711802|516280812|FG002|Overall Study|Physician Decision|0|||
143200956|NCT00711802|516280813|FG003|Overall Study|Physician Decision|0|||
143200957|NCT00711802|516280814|FG004|Overall Study|Physician Decision|0|||
143200958|NCT00711802|516280815|FG005|Overall Study|Physician Decision|0|||
143200959|NCT00711802|516280816|FG006|Overall Study|Physician Decision|0|||
143200960|NCT00711802|516280817|FG007|Overall Study|Physician Decision|0|||
143200961|NCT00711802|516280810|FG000|Overall Study|Withdrawal by Subject|0|||
143200962|NCT00711802|516280811|FG001|Overall Study|Withdrawal by Subject|1|||
143200963|NCT00711802|516280812|FG002|Overall Study|Withdrawal by Subject|0|||
143200964|NCT00711802|516280813|FG003|Overall Study|Withdrawal by Subject|1|||
143200965|NCT00711802|516280814|FG004|Overall Study|Withdrawal by Subject|0|||
143200966|NCT00711802|516280815|FG005|Overall Study|Withdrawal by Subject|0|||
143200967|NCT00711802|516280816|FG006|Overall Study|Withdrawal by Subject|0|||
143200968|NCT00711802|516280817|FG007|Overall Study|Withdrawal by Subject|0|||
143200969|NCT00711802|516280810|FG000|Overall Study|Lost to Follow-up|0|||
143200970|NCT00711802|516280811|FG001|Overall Study|Lost to Follow-up|0|||
143200971|NCT00711802|516280812|FG002|Overall Study|Lost to Follow-up|3|||
143200972|NCT00711802|516280813|FG003|Overall Study|Lost to Follow-up|1|||
143200973|NCT00711802|516280814|FG004|Overall Study|Lost to Follow-up|10|||
143200974|NCT00711802|516280815|FG005|Overall Study|Lost to Follow-up|6|||
143200975|NCT00711802|516280816|FG006|Overall Study|Lost to Follow-up|4|||
143200976|NCT00711802|516280817|FG007|Overall Study|Lost to Follow-up|2|||
143200977|NCT00711802|516280810|FG000|Overall Study|Reason not reported|0|||
143200978|NCT00711802|516280811|FG001|Overall Study|Reason not reported|1|||
143200979|NCT00711802|516280812|FG002|Overall Study|Reason not reported|1|||
143200980|NCT00711802|516280813|FG003|Overall Study|Reason not reported|0|||
143200981|NCT00711802|516280814|FG004|Overall Study|Reason not reported|1|||
143200982|NCT00711802|516280815|FG005|Overall Study|Reason not reported|0|||
143200983|NCT00711802|516280816|FG006|Overall Study|Reason not reported|1|||
143200984|NCT00711802|516280817|FG007|Overall Study|Reason not reported|0|||
143200985|NCT00581828|516280818|FG000|Overall Study|Protocol Violation|1|||
143200986|NCT02084238|516280819|FG000|Overall Study|Lost to Follow-up|2|||
143200987|NCT00391391|516280820|FG000|Overall Study|Adverse Event|0|||
143200988|NCT00391391|516280821|FG001|Overall Study|Adverse Event|0|||
143200989|NCT00391391|516280822|FG002|Overall Study|Adverse Event|0|||
143200990|NCT00391391|516280823|FG003|Overall Study|Adverse Event|1|||
143200991|NCT00391391|516280820|FG000|Overall Study|Lost to Follow-up|1|||
143200992|NCT00391391|516280821|FG001|Overall Study|Lost to Follow-up|3|||
143200993|NCT00391391|516280822|FG002|Overall Study|Lost to Follow-up|7|||
143200994|NCT00391391|516280823|FG003|Overall Study|Lost to Follow-up|4|||
143200995|NCT00391391|516280820|FG000|Overall Study|Protocol Violation|2|||
143200996|NCT00391391|516280821|FG001|Overall Study|Protocol Violation|3|||
143200997|NCT00391391|516280822|FG002|Overall Study|Protocol Violation|6|||
143200998|NCT00391391|516280823|FG003|Overall Study|Protocol Violation|7|||
143200999|NCT00391391|516280820|FG000|Overall Study|Withdrawal by Subject|6|||
143201000|NCT00391391|516280821|FG001|Overall Study|Withdrawal by Subject|4|||
143201001|NCT00391391|516280822|FG002|Overall Study|Withdrawal by Subject|10|||
143201002|NCT00391391|516280823|FG003|Overall Study|Withdrawal by Subject|7|||
143201003|NCT01154283|516280824|FG000|0-6 Weeks|Withdrawal by Subject|7|||
143201004|NCT01154283|516280825|FG001|0-6 Weeks|Withdrawal by Subject|2|||
143201005|NCT01154283|516280824|FG000|0-6 Weeks|Death|0|||
143201006|NCT01154283|516280825|FG001|0-6 Weeks|Death|1|||
143201007|NCT01154283|516280824|FG000|7-12 Weeks|Death|1|||
143201008|NCT01154283|516280825|FG001|7-12 Weeks|Death|0|||
143201009|NCT01154283|516280824|FG000|7-12 Weeks|Withdrawal by Subject|0|||
143201010|NCT01154283|516280825|FG001|7-12 Weeks|Withdrawal by Subject|1|||
143201011|NCT00320372|516280826|FG000|Overall Study|Physician Decision|4|||
143201012|NCT00320372|516280827|FG001|Overall Study|Physician Decision|7|||
143201013|NCT00320372|516280826|FG000|Overall Study|Death|7|||
143201014|NCT00320372|516280827|FG001|Overall Study|Death|8|||
143201015|NCT00320372|516280826|FG000|Overall Study|Withdrawal by Subject|55|||
143201016|NCT00320372|516280827|FG001|Overall Study|Withdrawal by Subject|37|||
143201017|NCT00320372|516280826|FG000|Overall Study|Non-Compliance|40|||
143201018|NCT00320372|516280827|FG001|Overall Study|Non-Compliance|39|||
143201019|NCT00320372|516280826|FG000|Overall Study|Did not Meet (I/E)|3|||
143201020|NCT00320372|516280827|FG001|Overall Study|Did not Meet (I/E)|1|||
143201021|NCT00320372|516280826|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
143201022|NCT00320372|516280827|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
143201023|NCT01853072|516280828|FG000|Overall Study|Adverse event prior to treatment|0|||
143201024|NCT01853072|516280829|FG001|Overall Study|Adverse event prior to treatment|1|||
143201025|NCT01853072|516280828|FG000|Overall Study|Adverse Event|0|||
143201026|NCT01853072|516280829|FG001|Overall Study|Adverse Event|3|||
143201027|NCT01853072|516280828|FG000|Overall Study|Death|1|||
143201028|NCT01853072|516280829|FG001|Overall Study|Death|4|||
143201029|NCT01853072|516280828|FG000|Overall Study|Lost to Follow-up|0|||
143201030|NCT01853072|516280829|FG001|Overall Study|Lost to Follow-up|3|||
143201031|NCT01853072|516280828|FG000|Overall Study|Non-compliance with study drug|0|||
143201032|NCT01853072|516280829|FG001|Overall Study|Non-compliance with study drug|1|||
143201033|NCT01853072|516280828|FG000|Overall Study|Physician Decision|1|||
143201034|NCT01853072|516280829|FG001|Overall Study|Physician Decision|1|||
143201035|NCT01853072|516280828|FG000|Overall Study|Withdrawal by Subject|1|||
143201036|NCT01853072|516280829|FG001|Overall Study|Withdrawal by Subject|2|||
143201037|NCT01853072|516280828|FG000|Overall Study|Reason not specified|9|||
143201038|NCT01853072|516280829|FG001|Overall Study|Reason not specified|6|||
143201039|NCT03412604|516280830|FG000|Overall Study|Withdrawal by Subject|1|||
143201040|NCT03464422|516280832|FG000|Overall Study|Lost to Follow-up|2|||
143201041|NCT03464422|516280832|FG000|Overall Study|Withdrawal by Subject|2|||
143201042|NCT00475865|516280836|FG000|Overall Study|Adverse Event|0|||
143201043|NCT00475865|516280837|FG001|Overall Study|Adverse Event|3|||
143201044|NCT00475865|516280838|FG002|Overall Study|Adverse Event|4|||
143201045|NCT00475865|516280836|FG000|Overall Study|Lack of Efficacy|1|||
143201046|NCT00475865|516280837|FG001|Overall Study|Lack of Efficacy|0|||
143201047|NCT00475865|516280838|FG002|Overall Study|Lack of Efficacy|0|||
143201048|NCT00475865|516280836|FG000|Overall Study|Progressive disease|0|||
143201049|NCT00475865|516280837|FG001|Overall Study|Progressive disease|1|||
143201050|NCT00475865|516280838|FG002|Overall Study|Progressive disease|2|||
143201051|NCT00475865|516280836|FG000|Overall Study|Participant did not wish to continue|1|||
143201052|NCT00475865|516280837|FG001|Overall Study|Participant did not wish to continue|0|||
143201053|NCT00475865|516280838|FG002|Overall Study|Participant did not wish to continue|0|||
143201054|NCT00475865|516280836|FG000|Overall Study|Other than above|0|||
143201055|NCT00475865|516280837|FG001|Overall Study|Other than above|1|||
143201056|NCT00475865|516280838|FG002|Overall Study|Other than above|0|||
143201057|NCT01360398|516280842|FG000|Overall Study|Withdrawal by Subject|14|||
143201058|NCT01360398|516280842|FG000|Overall Study|Other|7|||
143201059|NCT01360398|516280842|FG000|Overall Study|Migrated/moved from study area|1|||
143201060|NCT00846040|516280843|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
143201061|NCT00846040|516280844|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
143201062|NCT00846040|516280845|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
143201063|NCT00846040|516280843|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
143201064|NCT00846040|516280844|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
143201065|NCT00846040|516280845|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
143201066|NCT03158272|516280848|FG000|Overall Study|Disease progression|3|||
143201067|NCT03158272|516280849|FG001|Overall Study|Disease progression|3|||
143201068|NCT03158272|516280850|FG002|Overall Study|Disease progression|4|||
143201069|NCT03158272|516280851|FG003|Overall Study|Disease progression|6|||
143201070|NCT03158272|516280848|FG000|Overall Study|Death|0|||
143201071|NCT03158272|516280849|FG001|Overall Study|Death|0|||
143201072|NCT03158272|516280850|FG002|Overall Study|Death|1|||
143201073|NCT03158272|516280851|FG003|Overall Study|Death|0|||
143201074|NCT03158272|516280848|FG000|Overall Study|Other reasons|0|||
143201075|NCT03158272|516280849|FG001|Overall Study|Other reasons|0|||
143201076|NCT03158272|516280850|FG002|Overall Study|Other reasons|1|||
143262419|NCT00543855|516515822|FG003|Overall Study|Adverse Event|4|||
143262420|NCT00543855|516515819|FG000|Overall Study|Lost to Follow-up|0|||
143262421|NCT00543855|516515820|FG001|Overall Study|Lost to Follow-up|0|||
143262422|NCT00543855|516515821|FG002|Overall Study|Lost to Follow-up|1|||
143262423|NCT00543855|516515822|FG003|Overall Study|Lost to Follow-up|0|||
143262424|NCT00543855|516515819|FG000|Overall Study|Withdrawal by Subject|0|||
143262425|NCT00543855|516515820|FG001|Overall Study|Withdrawal by Subject|1|||
143262426|NCT00543855|516515821|FG002|Overall Study|Withdrawal by Subject|2|||
143262427|NCT00543855|516515822|FG003|Overall Study|Withdrawal by Subject|0|||
143262428|NCT00543855|516515819|FG000|Overall Study|Protocol Violation|1|||
143262429|NCT00543855|516515820|FG001|Overall Study|Protocol Violation|0|||
143262430|NCT00543855|516515821|FG002|Overall Study|Protocol Violation|0|||
143262431|NCT00543855|516515822|FG003|Overall Study|Protocol Violation|0|||
143262432|NCT04285580|516515823|FG000|Overall Study|Protocol Violation|0|||
143262433|NCT04285580|516515824|FG001|Overall Study|Protocol Violation|1|||
143262434|NCT02582255|516515825|FG000|Overall Study|Protocol Violation|0|||
143262435|NCT02582255|516515826|FG001|Overall Study|Protocol Violation|3|||
143262436|NCT01709578|516515828|FG000|Overall Study|Rescued and entered in long term safety|63|||
143262437|NCT01709578|516515829|FG001|Overall Study|Rescued and entered in long term safety|25|||
143262438|NCT01709578|516515830|FG002|Overall Study|Rescued and entered in long term safety|26|||
143262439|NCT01709578|516515828|FG000|Overall Study|Adverse Event|9|||
143262440|NCT01709578|516515829|FG001|Overall Study|Adverse Event|18|||
143262441|NCT01709578|516515830|FG002|Overall Study|Adverse Event|17|||
143201077|NCT03158272|516280851|FG003|Overall Study|Other reasons|0|||
143201078|NCT03158272|516280848|FG000|Overall Study|Adverse event unrelated to the drug|0|||
143201079|NCT03158272|516280849|FG001|Overall Study|Adverse event unrelated to the drug|1|||
143262442|NCT01709578|516515828|FG000|Overall Study|Lack of Efficacy|5|||
143262443|NCT01709578|516515829|FG001|Overall Study|Lack of Efficacy|4|||
143201080|NCT03158272|516280850|FG002|Overall Study|Adverse event unrelated to the drug|0|||
143201081|NCT03158272|516280851|FG003|Overall Study|Adverse event unrelated to the drug|0|||
143201082|NCT01822535|516280852|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
143201083|NCT01822535|516280853|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
143201084|NCT01822535|516280852|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
143201085|NCT01822535|516280853|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
143201086|NCT01822535|516280852|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
143201087|NCT01822535|516280853|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
143201088|NCT01048866|516280854|FG000|Overall Study|Adverse Event|1|||
143201089|NCT01048866|516280855|FG001|Overall Study|Adverse Event|0|||
143201090|NCT01048866|516280854|FG000|Overall Study|Protocol Violation|1|||
143201091|NCT01048866|516280855|FG001|Overall Study|Protocol Violation|0|||
143201092|NCT01048866|516280854|FG000|Overall Study|Physician Decision|1|||
143201093|NCT01048866|516280855|FG001|Overall Study|Physician Decision|0|||
143201094|NCT01048866|516280854|FG000|Overall Study|Withdrawal by Subject|0|||
143201095|NCT01048866|516280855|FG001|Overall Study|Withdrawal by Subject|2|||
143201096|NCT01048866|516280854|FG000|Overall Study|Lost to Follow-up|0|||
143201097|NCT01048866|516280855|FG001|Overall Study|Lost to Follow-up|2|||
143201098|NCT01048866|516280854|FG000|Overall Study|Other|1|||
143201099|NCT01048866|516280855|FG001|Overall Study|Other|1|||
143201100|NCT03582813|516280856|FG000|Overall Study|Lost to Follow-up|18|||
143201101|NCT03582813|516280857|FG001|Overall Study|Lost to Follow-up|21|||
143201102|NCT03582813|516280856|FG000|Overall Study|Withdrawal by Subject|1|||
143201103|NCT03582813|516280857|FG001|Overall Study|Withdrawal by Subject|0|||
143201104|NCT02230683|516280858|FG000|Overall Study|Adverse Event|1|||
143201105|NCT05013424|516282497|FG000|Overall Study|Lost to Follow-up|1|||
143201106|NCT05013424|516282498|FG001|Overall Study|Lost to Follow-up|1|||
143201107|NCT05013424|516282499|FG002|Overall Study|Lost to Follow-up|1|||
143201108|NCT05013424|516282497|FG000|Overall Study|Withdrawal by Subject|0|||
143201109|NCT05013424|516282498|FG001|Overall Study|Withdrawal by Subject|1|||
143201110|NCT05013424|516282499|FG002|Overall Study|Withdrawal by Subject|0|||
143201111|NCT04411420|516282500|FG000|Overall Study (All Participants)|Lost to Follow-up|350|||
143201112|NCT04411420|516282501|FG001|Overall Study (All Participants)|Lost to Follow-up|469|||
143201113|NCT04411420|516282500|FG000|Survey Subset|Lost to Follow-up|134|||
143201114|NCT04411420|516282501|FG001|Survey Subset|Lost to Follow-up|120|||
143201115|NCT03899064|516282504|FG000|Overall Study|Lost to Follow-up|1|||
143201116|NCT03899064|516282504|FG000|Overall Study|Protocol Violation|2|||
143201117|NCT03899064|516282504|FG000|Overall Study|Withdrawal by Subject|2|||
143201118|NCT03899064|516282504|FG000|Overall Study|Other|2|||
143201119|NCT03559699|516282507|FG000|Overall Study|Withdrawal by Subject|6|||
143201120|NCT03559699|516282507|FG000|Overall Study|Lost to Follow-up|1|||
143201121|NCT00031460|516282508|FG000|Overall Study|Lost to Follow-up|0|||
143201122|NCT00031460|516282509|FG001|Overall Study|Lost to Follow-up|1|||
143201123|NCT00031460|516282508|FG000|Overall Study|Withdrawal by Subject|1|||
143201124|NCT00031460|516282509|FG001|Overall Study|Withdrawal by Subject|1|||
143201125|NCT00031460|516282508|FG000|Overall Study|Non-Compliant|1|||
143201126|NCT00031460|516282509|FG001|Overall Study|Non-Compliant|1|||
143201127|NCT00031460|516282508|FG000|Overall Study|Death|0|||
143201128|NCT00031460|516282509|FG001|Overall Study|Death|1|||
143201129|NCT00031460|516282508|FG000|Overall Study|Reactivation of Disease|5|||
143201130|NCT00031460|516282509|FG001|Overall Study|Reactivation of Disease|9|||
143201131|NCT00031460|516282508|FG000|Overall Study|Disruption of blinded drug supply|2|||
143201132|NCT00031460|516282509|FG001|Overall Study|Disruption of blinded drug supply|0|||
143201133|NCT00031460|516282508|FG000|Overall Study|Confirmed unevaluable|0|||
143201134|NCT00031460|516282509|FG001|Overall Study|Confirmed unevaluable|1|||
143201135|NCT02534935|516282510|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
143201136|NCT02534935|516282511|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
143201137|NCT02534935|516282512|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
143201138|NCT02534935|516282510|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
143201139|NCT02534935|516282511|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
143201140|NCT02534935|516282512|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
143201141|NCT02534935|516282510|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
143201142|NCT02534935|516282511|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
143201143|NCT02534935|516282512|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
143201144|NCT02534935|516282510|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
143201145|NCT02534935|516282511|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
143201146|NCT02534935|516282512|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
143201147|NCT02534935|516282510|FG000|Stage 1: 24 Months|Adverse Event|0|||
143201148|NCT02534935|516282511|FG001|Stage 1: 24 Months|Adverse Event|2|||
143201149|NCT02534935|516282512|FG002|Stage 1: 24 Months|Adverse Event|0|||
143201150|NCT02534935|516282510|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
143201151|NCT02534935|516282511|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
143201152|NCT02534935|516282512|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
143201153|NCT02534935|516282510|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
143262444|NCT01709578|516515830|FG002|Overall Study|Lack of Efficacy|2|||
143262445|NCT01709578|516515828|FG000|Overall Study|Poor compliance to protocol|1|||
143262446|NCT01709578|516515829|FG001|Overall Study|Poor compliance to protocol|2|||
143262447|NCT01709578|516515830|FG002|Overall Study|Poor compliance to protocol|1|||
143262448|NCT01709578|516515828|FG000|Overall Study|Other, not related to safety or efficacy|2|||
143262449|NCT01709578|516515829|FG001|Overall Study|Other, not related to safety or efficacy|7|||
143262450|NCT01709578|516515830|FG002|Overall Study|Other, not related to safety or efficacy|5|||
143201154|NCT02534935|516282511|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
143201155|NCT02534935|516282512|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
143201156|NCT01596335|516282516|FG000|Overall Study|exacerbation of primary disease|5|||
143201157|NCT01596335|516282517|FG001|Overall Study|exacerbation of primary disease|9|||
143201158|NCT01460719|516282518|FG000|Overall Study|Adverse Event|1|||
143201159|NCT01460719|516282518|FG000|Overall Study|Withdrawal by Subject|1|||
143201160|NCT04524455|516282531|FG000|Overall Study|Death|3|||
143201161|NCT04524455|516282532|FG001|Overall Study|Death|3|||
143201162|NCT04524455|516282531|FG000|Overall Study|Decision by Sponsor|0|||
143201163|NCT04524455|516282532|FG001|Overall Study|Decision by Sponsor|2|||
143201164|NCT04524455|516282531|FG000|Overall Study|Withdrawal of Consent From Study|1|||
143201165|NCT04524455|516282532|FG001|Overall Study|Withdrawal of Consent From Study|0|||
143201166|NCT04524455|516282531|FG000|Overall Study|Lost to Follow-up|0|||
143201167|NCT04524455|516282532|FG001|Overall Study|Lost to Follow-up|1|||
143201168|NCT01176565|516282533|FG000|Overall Study|Lost to Follow-up|12|||
143201169|NCT01176565|516282534|FG001|Overall Study|Lost to Follow-up|16|||
143201170|NCT01176565|516282533|FG000|Overall Study|Withdrawal by Subject|7|||
143201171|NCT01176565|516282534|FG001|Overall Study|Withdrawal by Subject|1|||
143201172|NCT01176565|516282533|FG000|Overall Study|Not Analyzed (any other reason)|1|||
143201173|NCT01176565|516282534|FG001|Overall Study|Not Analyzed (any other reason)|2|||
143201174|NCT03602885|516282536|FG000|Overall Study|Lost to Follow-up|3|||
143201175|NCT03602885|516282537|FG001|Overall Study|Lost to Follow-up|0|||
143201176|NCT00076336|516282540|FG000|Overall Study|Death|13|||
143201177|NCT00076336|516282541|FG001|Overall Study|Death|17|||
143201178|NCT00076336|516282540|FG000|Overall Study|Adverse Event|4|||
143201179|NCT00076336|516282541|FG001|Overall Study|Adverse Event|4|||
143201180|NCT00076336|516282540|FG000|Overall Study|Lost to Follow-up|4|||
143201181|NCT00076336|516282541|FG001|Overall Study|Lost to Follow-up|4|||
143201182|NCT00076336|516282540|FG000|Overall Study|Non-Compliance|2|||
143201183|NCT00076336|516282541|FG001|Overall Study|Non-Compliance|0|||
143201184|NCT00076336|516282540|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
143201185|NCT00076336|516282541|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
143201186|NCT00076336|516282540|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
143201187|NCT00076336|516282541|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
143201188|NCT00076336|516282540|FG000|Overall Study|Liver Transplantation|3|||
143201189|NCT00076336|516282541|FG001|Overall Study|Liver Transplantation|3|||
143201190|NCT00076336|516282540|FG000|Overall Study|Virologic Breakthrough|14|||
143201191|NCT00076336|516282541|FG001|Overall Study|Virologic Breakthrough|16|||
143201192|NCT00076336|516282540|FG000|Overall Study|Treatment failure|4|||
143201193|NCT00076336|516282541|FG001|Overall Study|Treatment failure|5|||
143201194|NCT00524589|516282542|FG000|Overall Study|Withdrawal by Subject|2|||
143201195|NCT00524589|516282542|FG000|Overall Study|Disease Progression|16|||
143201196|NCT00098722|516282548|FG000|Double Blind Phase|Adverse Event|7|||
143201197|NCT00098722|516282549|FG001|Double Blind Phase|Adverse Event|7|||
143201198|NCT00098722|516282550|FG002|Double Blind Phase|Adverse Event|3|||
143201199|NCT00098722|516282551|FG003|Double Blind Phase|Adverse Event|0|||
143201200|NCT00098722|516282552|FG004|Double Blind Phase|Adverse Event|0|||
143201201|NCT00098722|516282553|FG005|Double Blind Phase|Adverse Event|0|||
143201202|NCT00098722|516282554|FG006|Double Blind Phase|Adverse Event|0|||
143201203|NCT00098722|516282548|FG000|Double Blind Phase|Death|2|||
143201204|NCT00098722|516282549|FG001|Double Blind Phase|Death|5|||
143201205|NCT00098722|516282550|FG002|Double Blind Phase|Death|0|||
143201206|NCT00098722|516282551|FG003|Double Blind Phase|Death|0|||
143262451|NCT00076024|516515833|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
143262452|NCT00076024|516515834|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
143262453|NCT00076024|516515835|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
143262454|NCT00076024|516515836|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
143262455|NCT00076024|516515833|FG000|Phase 1, Lead-in|Adverse Event|1|||
143201207|NCT00098722|516282552|FG004|Double Blind Phase|Death|0|||
143201208|NCT00098722|516282553|FG005|Double Blind Phase|Death|0|||
143201209|NCT00098722|516282554|FG006|Double Blind Phase|Death|0|||
143201210|NCT00098722|516282548|FG000|Double Blind Phase|Lack of Efficacy|21|||
143201211|NCT00098722|516282549|FG001|Double Blind Phase|Lack of Efficacy|23|||
143201212|NCT00098722|516282550|FG002|Double Blind Phase|Lack of Efficacy|15|||
143201213|NCT00098722|516282551|FG003|Double Blind Phase|Lack of Efficacy|0|||
143201214|NCT00098722|516282552|FG004|Double Blind Phase|Lack of Efficacy|0|||
143201215|NCT00098722|516282553|FG005|Double Blind Phase|Lack of Efficacy|0|||
143201216|NCT00098722|516282554|FG006|Double Blind Phase|Lack of Efficacy|0|||
143201217|NCT00098722|516282548|FG000|Double Blind Phase|Participant defaulted|16|||
143201218|NCT00098722|516282549|FG001|Double Blind Phase|Participant defaulted|11|||
143201219|NCT00098722|516282550|FG002|Double Blind Phase|Participant defaulted|9|||
143201220|NCT00098722|516282551|FG003|Double Blind Phase|Participant defaulted|0|||
143201221|NCT00098722|516282552|FG004|Double Blind Phase|Participant defaulted|0|||
143201222|NCT00098722|516282553|FG005|Double Blind Phase|Participant defaulted|0|||
143201223|NCT00098722|516282554|FG006|Double Blind Phase|Participant defaulted|0|||
143201224|NCT00098722|516282548|FG000|Double Blind Phase|Pregnancy|1|||
143201225|NCT00098722|516282549|FG001|Double Blind Phase|Pregnancy|0|||
143201226|NCT00098722|516282550|FG002|Double Blind Phase|Pregnancy|0|||
143201227|NCT00098722|516282551|FG003|Double Blind Phase|Pregnancy|0|||
143201228|NCT00098722|516282552|FG004|Double Blind Phase|Pregnancy|0|||
143201229|NCT00098722|516282553|FG005|Double Blind Phase|Pregnancy|0|||
143201230|NCT00098722|516282554|FG006|Double Blind Phase|Pregnancy|0|||
143201231|NCT00098722|516282548|FG000|Double Blind Phase|Randomized, not treated|4|||
143201232|NCT00098722|516282549|FG001|Double Blind Phase|Randomized, not treated|3|||
143201233|NCT00098722|516282550|FG002|Double Blind Phase|Randomized, not treated|3|||
143201234|NCT00098722|516282551|FG003|Double Blind Phase|Randomized, not treated|0|||
143201235|NCT00098722|516282552|FG004|Double Blind Phase|Randomized, not treated|0|||
143201236|NCT00098722|516282553|FG005|Double Blind Phase|Randomized, not treated|0|||
143201237|NCT00098722|516282554|FG006|Double Blind Phase|Randomized, not treated|0|||
143201238|NCT00098722|516282548|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
143201239|NCT00098722|516282549|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
143201240|NCT00098722|516282550|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
143201241|NCT00098722|516282551|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
143201242|NCT00098722|516282552|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
143201243|NCT00098722|516282553|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
143201244|NCT00098722|516282554|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
143201245|NCT00098722|516282548|FG000|Double Blind Phase|Other|7|||
143201246|NCT00098722|516282549|FG001|Double Blind Phase|Other|8|||
143201247|NCT00098722|516282550|FG002|Double Blind Phase|Other|7|||
143201248|NCT00098722|516282551|FG003|Double Blind Phase|Other|0|||
143201249|NCT00098722|516282552|FG004|Double Blind Phase|Other|0|||
143201250|NCT00098722|516282553|FG005|Double Blind Phase|Other|0|||
143201251|NCT00098722|516282554|FG006|Double Blind Phase|Other|0|||
143201252|NCT00098722|516282548|FG000|Open Label Phase|Adverse Event|0|||
143201253|NCT00098722|516282549|FG001|Open Label Phase|Adverse Event|0|||
143201254|NCT00098722|516282550|FG002|Open Label Phase|Adverse Event|0|||
143201255|NCT00098722|516282551|FG003|Open Label Phase|Adverse Event|5|||
143201256|NCT00098722|516282552|FG004|Open Label Phase|Adverse Event|0|||
143201257|NCT00098722|516282553|FG005|Open Label Phase|Adverse Event|0|||
143201258|NCT00098722|516282554|FG006|Open Label Phase|Adverse Event|0|||
143201259|NCT00098722|516282548|FG000|Open Label Phase|Death|0|||
143201260|NCT00098722|516282549|FG001|Open Label Phase|Death|0|||
143201261|NCT00098722|516282550|FG002|Open Label Phase|Death|0|||
143201262|NCT00098722|516282551|FG003|Open Label Phase|Death|2|||
143201263|NCT00098722|516282552|FG004|Open Label Phase|Death|0|||
143201264|NCT00098722|516282553|FG005|Open Label Phase|Death|0|||
143201265|NCT00098722|516282554|FG006|Open Label Phase|Death|0|||
143201266|NCT00098722|516282548|FG000|Open Label Phase|Lack of Efficacy|0|||
143201267|NCT00098722|516282549|FG001|Open Label Phase|Lack of Efficacy|0|||
143201268|NCT00098722|516282550|FG002|Open Label Phase|Lack of Efficacy|0|||
143201269|NCT00098722|516282551|FG003|Open Label Phase|Lack of Efficacy|8|||
143201270|NCT00098722|516282552|FG004|Open Label Phase|Lack of Efficacy|0|||
143201271|NCT00098722|516282553|FG005|Open Label Phase|Lack of Efficacy|0|||
143201272|NCT00098722|516282554|FG006|Open Label Phase|Lack of Efficacy|0|||
143201273|NCT00098722|516282548|FG000|Open Label Phase|Pregnancy|0|||
143201274|NCT00098722|516282549|FG001|Open Label Phase|Pregnancy|0|||
143201275|NCT00098722|516282550|FG002|Open Label Phase|Pregnancy|0|||
143201276|NCT00098722|516282551|FG003|Open Label Phase|Pregnancy|1|||
143201277|NCT00098722|516282552|FG004|Open Label Phase|Pregnancy|0|||
143201278|NCT00098722|516282553|FG005|Open Label Phase|Pregnancy|0|||
143201279|NCT00098722|516282554|FG006|Open Label Phase|Pregnancy|0|||
143201280|NCT00098722|516282548|FG000|Open Label Phase|Participant defaulted|0|||
143201281|NCT00098722|516282549|FG001|Open Label Phase|Participant defaulted|0|||
143201282|NCT00098722|516282550|FG002|Open Label Phase|Participant defaulted|0|||
143201283|NCT00098722|516282551|FG003|Open Label Phase|Participant defaulted|18|||
143201284|NCT00098722|516282552|FG004|Open Label Phase|Participant defaulted|0|||
143201285|NCT00098722|516282553|FG005|Open Label Phase|Participant defaulted|0|||
143262456|NCT00076024|516515834|FG001|Phase 1, Lead-in|Adverse Event|0|||
143262457|NCT00076024|516515835|FG002|Phase 1, Lead-in|Adverse Event|0|||
143201286|NCT00098722|516282554|FG006|Open Label Phase|Participant defaulted|0|||
143201287|NCT00098722|516282548|FG000|Open Label Phase|Ongoing at cut-off date|0|||
143201288|NCT00098722|516282549|FG001|Open Label Phase|Ongoing at cut-off date|0|||
143201289|NCT00098722|516282550|FG002|Open Label Phase|Ongoing at cut-off date|0|||
143201290|NCT00098722|516282551|FG003|Open Label Phase|Ongoing at cut-off date|220|||
143201291|NCT00098722|516282552|FG004|Open Label Phase|Ongoing at cut-off date|50|||
143201292|NCT00098722|516282553|FG005|Open Label Phase|Ongoing at cut-off date|0|||
143201293|NCT00098722|516282554|FG006|Open Label Phase|Ongoing at cut-off date|0|||
143201294|NCT00098722|516282548|FG000|Open Label Phase|Other|0|||
143201295|NCT00098722|516282549|FG001|Open Label Phase|Other|0|||
143201296|NCT00098722|516282550|FG002|Open Label Phase|Other|0|||
143201297|NCT00098722|516282551|FG003|Open Label Phase|Other|18|||
143201298|NCT00098722|516282552|FG004|Open Label Phase|Other|0|||
143201299|NCT00098722|516282553|FG005|Open Label Phase|Other|0|||
143201300|NCT00098722|516282554|FG006|Open Label Phase|Other|0|||
143201301|NCT00098722|516282548|FG000|Observation Phase|Death|0|||
143201302|NCT00098722|516282549|FG001|Observation Phase|Death|0|||
143201303|NCT00098722|516282550|FG002|Observation Phase|Death|0|||
143201304|NCT00098722|516282551|FG003|Observation Phase|Death|0|||
143201305|NCT00098722|516282552|FG004|Observation Phase|Death|0|||
143201306|NCT00098722|516282553|FG005|Observation Phase|Death|5|||
143201307|NCT00098722|516282554|FG006|Observation Phase|Death|3|||
143201308|NCT00098722|516282548|FG000|Observation Phase|Lack of Efficacy|0|||
143201309|NCT00098722|516282549|FG001|Observation Phase|Lack of Efficacy|0|||
143201310|NCT00098722|516282550|FG002|Observation Phase|Lack of Efficacy|0|||
143201311|NCT00098722|516282551|FG003|Observation Phase|Lack of Efficacy|0|||
143201312|NCT00098722|516282552|FG004|Observation Phase|Lack of Efficacy|0|||
143201313|NCT00098722|516282553|FG005|Observation Phase|Lack of Efficacy|2|||
143201314|NCT00098722|516282554|FG006|Observation Phase|Lack of Efficacy|0|||
143201315|NCT00098722|516282548|FG000|Observation Phase|Participant defaulted|0|||
143201316|NCT00098722|516282549|FG001|Observation Phase|Participant defaulted|0|||
143201317|NCT00098722|516282550|FG002|Observation Phase|Participant defaulted|0|||
143201318|NCT00098722|516282551|FG003|Observation Phase|Participant defaulted|0|||
143201319|NCT00098722|516282552|FG004|Observation Phase|Participant defaulted|0|||
143201320|NCT00098722|516282553|FG005|Observation Phase|Participant defaulted|17|||
143201321|NCT00098722|516282554|FG006|Observation Phase|Participant defaulted|4|||
143201322|NCT00098722|516282548|FG000|Observation Phase|Other|0|||
143201323|NCT00098722|516282549|FG001|Observation Phase|Other|0|||
143201324|NCT00098722|516282550|FG002|Observation Phase|Other|0|||
143201325|NCT00098722|516282551|FG003|Observation Phase|Other|0|||
143201326|NCT00098722|516282552|FG004|Observation Phase|Other|0|||
143201327|NCT00098722|516282553|FG005|Observation Phase|Other|21|||
143201328|NCT00098722|516282554|FG006|Observation Phase|Other|10|||
143201329|NCT00799591|516282555|FG000|Overall Study|De-escalation of doses|20|||
143201330|NCT00799591|516282555|FG000|Overall Study|Death|14|||
143201331|NCT00799591|516282555|FG000|Overall Study|Technical failure|12|||
143201332|NCT00799591|516282555|FG000|Overall Study|Resistant germ|11|||
143201333|NCT00799591|516282555|FG000|Overall Study|New infection|4|||
143201334|NCT00799591|516282555|FG000|Overall Study|Resistance germ and technical failure|2|||
143201335|NCT00799591|516282555|FG000|Overall Study|Persistance of fever undetermined origin|1|||
143201336|NCT00799591|516282555|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
143201337|NCT00799591|516282555|FG000|Overall Study|Infectious origin not probable|1|||
143201338|NCT03276052|516282561|FG000|Overall Study|Withdrawal by Subject|5|||
143201339|NCT03276052|516282561|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
143201340|NCT05136898|516282562|FG000|Overall Study|Adverse Event|2|||
143201341|NCT03784846|516282563|FG000|Pre-COVID Study|Lost to Follow-up|3|||
143201342|NCT03784846|516282564|FG001|Pre-COVID Study|Lost to Follow-up|3|||
143201343|NCT03784846|516282565|FG002|Pre-COVID Study|Lost to Follow-up|2|||
143201344|NCT03784846|516282563|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
143201345|NCT03784846|516282564|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
143201346|NCT03784846|516282565|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
143201347|NCT03784846|516282563|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
143201348|NCT03784846|516282564|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
143201349|NCT03784846|516282565|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
143201350|NCT03784846|516282563|FG000|Post-COVID Study|Lost to Follow-up|3|||
143201351|NCT03784846|516282564|FG001|Post-COVID Study|Lost to Follow-up|5|||
143201352|NCT03784846|516282565|FG002|Post-COVID Study|Lost to Follow-up|1|||
143201353|NCT03784846|516282563|FG000|Post-COVID Study|Withdrawal by Subject|1|||
143201354|NCT03784846|516282564|FG001|Post-COVID Study|Withdrawal by Subject|2|||
143201355|NCT03784846|516282565|FG002|Post-COVID Study|Withdrawal by Subject|0|||
143201356|NCT02334683|516282570|FG000|First 12 Week Period|Lost to Follow-up|1|||
143201357|NCT02334683|516282571|FG001|First 12 Week Period|Lost to Follow-up|0|||
143201358|NCT02334683|516282570|FG000|Second 12 Week Period|Adverse Event|0|||
143201359|NCT02334683|516282571|FG001|Second 12 Week Period|Adverse Event|1|||
143201360|NCT01062841|516282572|FG000|Overall Study|Indwelling Device Removed|41|||
143201361|NCT01062841|516282573|FG001|Overall Study|Indwelling Device Removed|48|||
143201362|NCT01062841|516282572|FG000|Overall Study|Death|3|||
143201363|NCT01062841|516282573|FG001|Overall Study|Death|5|||
143201364|NCT01062841|516282572|FG000|Overall Study|Withdrawal by Subject|2|||
143201365|NCT01062841|516282573|FG001|Overall Study|Withdrawal by Subject|0|||
143201366|NCT01062841|516282572|FG000|Overall Study|Withdrawal by Study|3|||
143201367|NCT01062841|516282573|FG001|Overall Study|Withdrawal by Study|0|||
143201368|NCT02046174|516282574|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
143201369|NCT02046174|516282575|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
143201370|NCT02763254|516282577|FG000|Overall Study|Adverse Event|1|||
143201371|NCT02498067|516282578|FG000|Overall Study|Lost to Follow-up|22|||
143201372|NCT02498067|516282578|FG000|Overall Study|Did not meet inclusion criteria|11|||
143201373|NCT00765882|516282579|FG000|Overall Study|Adverse Event|10|||
143201374|NCT00765882|516282580|FG001|Overall Study|Adverse Event|21|||
143201375|NCT00765882|516282581|FG002|Overall Study|Adverse Event|20|||
143201376|NCT00765882|516282579|FG000|Overall Study|Lack of Efficacy|4|||
143201377|NCT00765882|516282580|FG001|Overall Study|Lack of Efficacy|0|||
143201378|NCT00765882|516282581|FG002|Overall Study|Lack of Efficacy|1|||
143201379|NCT00765882|516282579|FG000|Overall Study|Protocol Violation|4|||
143201380|NCT00765882|516282580|FG001|Overall Study|Protocol Violation|3|||
143201381|NCT00765882|516282581|FG002|Overall Study|Protocol Violation|1|||
143201382|NCT00765882|516282579|FG000|Overall Study|Withdrawal by Subject|2|||
143201383|NCT00765882|516282580|FG001|Overall Study|Withdrawal by Subject|6|||
143201384|NCT00765882|516282581|FG002|Overall Study|Withdrawal by Subject|6|||
143201385|NCT00765882|516282579|FG000|Overall Study|Lost to Follow-up|1|||
143201386|NCT00765882|516282580|FG001|Overall Study|Lost to Follow-up|9|||
143201387|NCT00765882|516282581|FG002|Overall Study|Lost to Follow-up|6|||
143201388|NCT00765882|516282579|FG000|Overall Study|Other Reason|3|||
143201389|NCT00765882|516282580|FG001|Overall Study|Other Reason|1|||
143201390|NCT00765882|516282581|FG002|Overall Study|Other Reason|2|||
143201391|NCT03351114|516282582|FG000|Overall Study|Withdrawal by Subject|1|||
143201392|NCT01665430|516282583|FG000|Overall Study|Adverse Event|1|||
143201393|NCT01665430|516282583|FG000|Overall Study|Withdrawal by Subject|6|||
143201394|NCT01665430|516282583|FG000|Overall Study|Other Unspecified|2|||
143201395|NCT02231762|516282584|FG000|Combination Phase|Adverse Event|10|||
143201396|NCT02231762|516282585|FG001|Combination Phase|Adverse Event|0|||
143201397|NCT02231762|516282586|FG002|Combination Phase|Adverse Event|0|||
143201398|NCT02231762|516282587|FG003|Combination Phase|Adverse Event|0|||
143201399|NCT02231762|516282584|FG000|Combination Phase|Withdrawal by Subject|2|||
143201400|NCT02231762|516282585|FG001|Combination Phase|Withdrawal by Subject|0|||
143201401|NCT02231762|516282586|FG002|Combination Phase|Withdrawal by Subject|0|||
143201402|NCT02231762|516282587|FG003|Combination Phase|Withdrawal by Subject|0|||
143201403|NCT02231762|516282584|FG000|Combination Phase|Disease Progression|6|||
143201404|NCT02231762|516282585|FG001|Combination Phase|Disease Progression|0|||
143201405|NCT02231762|516282586|FG002|Combination Phase|Disease Progression|0|||
143201406|NCT02231762|516282587|FG003|Combination Phase|Disease Progression|0|||
143201407|NCT02231762|516282584|FG000|Combination Phase|Did not meet inclusion criteria|1|||
143201408|NCT02231762|516282585|FG001|Combination Phase|Did not meet inclusion criteria|0|||
143201409|NCT02231762|516282586|FG002|Combination Phase|Did not meet inclusion criteria|0|||
143201410|NCT02231762|516282587|FG003|Combination Phase|Did not meet inclusion criteria|0|||
143201411|NCT02231762|516282584|FG000|Combination Phase|Protocol Violation|1|||
143201412|NCT02231762|516282585|FG001|Combination Phase|Protocol Violation|0|||
143201413|NCT02231762|516282586|FG002|Combination Phase|Protocol Violation|0|||
143201414|NCT02231762|516282587|FG003|Combination Phase|Protocol Violation|0|||
143201415|NCT02231762|516282584|FG000|Maintenance Phase|Disease progression|0|||
143201416|NCT02231762|516282585|FG001|Maintenance Phase|Disease progression|3|||
143201417|NCT02231762|516282586|FG002|Maintenance Phase|Disease progression|4|||
143201418|NCT02231762|516282587|FG003|Maintenance Phase|Disease progression|3|||
143201419|NCT02231762|516282584|FG000|Maintenance Phase|Adverse Event|0|||
143201420|NCT02231762|516282585|FG001|Maintenance Phase|Adverse Event|0|||
143201421|NCT02231762|516282586|FG002|Maintenance Phase|Adverse Event|1|||
143262458|NCT00076024|516515836|FG003|Phase 1, Lead-in|Adverse Event|0|||
143262459|NCT00076024|516515833|FG000|Phase 1, Lead-in|Clinical progression|1|||
143262460|NCT00076024|516515834|FG001|Phase 1, Lead-in|Clinical progression|0|||
143262461|NCT00076024|516515835|FG002|Phase 1, Lead-in|Clinical progression|0|||
143262462|NCT00076024|516515836|FG003|Phase 1, Lead-in|Clinical progression|0|||
143262463|NCT00076024|516515833|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
143201422|NCT02231762|516282587|FG003|Maintenance Phase|Adverse Event|2|||
143201423|NCT02310230|516282588|FG000|Overall Study|Physician Decision|1|||
143201424|NCT02310230|516282589|FG001|Overall Study|Physician Decision|3|||
143201425|NCT02310230|516282588|FG000|Overall Study|monitor baseline taken after induction|2|||
143201426|NCT02310230|516282589|FG001|Overall Study|monitor baseline taken after induction|7|||
143262464|NCT00076024|516515834|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
143262465|NCT00076024|516515835|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
143262466|NCT00076024|516515836|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
143369974|NCT00486759|516899038|FG001|Treatment|Adverse event/intercurrent illness|39|||
143201427|NCT02310230|516282588|FG000|Overall Study|Poor signal quality|5|||
143201428|NCT02310230|516282589|FG001|Overall Study|Poor signal quality|8|||
143201429|NCT02310230|516282588|FG000|Overall Study|Case cancelled|1|||
143201430|NCT02310230|516282589|FG001|Overall Study|Case cancelled|0|||
143201431|NCT01149486|516282599|FG000|First Intervention|Adverse Event|0|||
143201432|NCT01149486|516282600|FG001|First Intervention|Adverse Event|1|||
143201433|NCT01669421|516282601|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
143201434|NCT01669421|516282601|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
143262467|NCT00076024|516515833|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
143262468|NCT00076024|516515834|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
143369975|NCT00486759|516899037|FG000|Treatment|Insufficient therapeutic response|37|||
143369976|NCT00486759|516899038|FG001|Treatment|Insufficient therapeutic response|39|||
143201435|NCT02961790|516282604|FG000|Overall Study|Canceled|4|||
143201436|NCT02961790|516282605|FG001|Overall Study|Canceled|5|||
143201437|NCT02961790|516282606|FG002|Overall Study|Canceled|1|||
143201438|NCT02961790|516282607|FG003|Overall Study|Canceled|4|||
143201439|NCT02961790|516282604|FG000|Overall Study|without baseline data|4|||
143201440|NCT02961790|516282605|FG001|Overall Study|without baseline data|0|||
143201441|NCT02961790|516282606|FG002|Overall Study|without baseline data|1|||
143201442|NCT02961790|516282607|FG003|Overall Study|without baseline data|0|||
143201443|NCT02961790|516282604|FG000|Overall Study|without post baseline data|7|||
143201444|NCT02961790|516282605|FG001|Overall Study|without post baseline data|6|||
143201445|NCT02961790|516282606|FG002|Overall Study|without post baseline data|4|||
143201446|NCT02961790|516282607|FG003|Overall Study|without post baseline data|1|||
143201447|NCT01135914|516282608|FG000|Overall Study|Withdrawal by Subject|1|||
143201448|NCT01135914|516282609|FG001|Overall Study|Withdrawal by Subject|3|||
143201449|NCT01135914|516282610|FG002|Overall Study|Withdrawal by Subject|6|||
143201450|NCT01135914|516282608|FG000|Overall Study|Lost to Follow-up|1|||
143201451|NCT01135914|516282609|FG001|Overall Study|Lost to Follow-up|0|||
143201452|NCT01135914|516282610|FG002|Overall Study|Lost to Follow-up|1|||
143201453|NCT01135914|516282608|FG000|Overall Study|Protocol Violation|0|||
143201454|NCT01135914|516282609|FG001|Overall Study|Protocol Violation|0|||
143201455|NCT01135914|516282610|FG002|Overall Study|Protocol Violation|3|||
143201456|NCT01135914|516282608|FG000|Overall Study|Lack of Efficacy|2|||
143201457|NCT01135914|516282609|FG001|Overall Study|Lack of Efficacy|1|||
143201458|NCT01135914|516282610|FG002|Overall Study|Lack of Efficacy|10|||
143201459|NCT01135914|516282608|FG000|Overall Study|Adverse Event|0|||
143201460|NCT01135914|516282609|FG001|Overall Study|Adverse Event|1|||
143201461|NCT01135914|516282610|FG002|Overall Study|Adverse Event|2|||
143201462|NCT01479595|516282616|FG000|Overall Study|Protocol deviation|0|||
143201463|NCT01479595|516282617|FG001|Overall Study|Protocol deviation|1|||
143201464|NCT01479595|516282616|FG000|Overall Study|Adverse Event|2|||
143201465|NCT01479595|516282617|FG001|Overall Study|Adverse Event|1|||
143201466|NCT00810901|516282618|FG000|Overall Study|Lost to Follow-up|88|||
143201467|NCT00810901|516282619|FG001|Overall Study|Lost to Follow-up|58|||
143201468|NCT02133664|516282620|FG000|Overall Study|Lost to Follow-up|2|||
143201469|NCT02133664|516282621|FG001|Overall Study|Lost to Follow-up|1|||
143201470|NCT02133664|516282620|FG000|Overall Study|Adverse Event|3|||
143201471|NCT02133664|516282621|FG001|Overall Study|Adverse Event|6|||
143201472|NCT01009346|516282624|FG000|Overall Study|Adverse Event|4|||
143201473|NCT03906656|516282625|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
143201474|NCT03906656|516282626|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
143201475|NCT03906656|516282625|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
143201476|NCT03906656|516282626|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
143201477|NCT03906656|516282625|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
143201478|NCT03906656|516282626|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
143201479|NCT03906656|516282625|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
143201480|NCT03906656|516282626|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
143201481|NCT03906656|516282625|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
143201482|NCT03906656|516282626|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
143201483|NCT03906656|516282625|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
143201484|NCT03906656|516282626|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
143201485|NCT03906656|516282625|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
143201486|NCT03906656|516282626|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
143201487|NCT03906656|516282625|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
143201488|NCT03906656|516282626|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
143201489|NCT03906656|516282625|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
143201490|NCT03906656|516282626|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
143201491|NCT03906656|516282625|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
143201492|NCT03906656|516282626|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
143201493|NCT03906656|516282625|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
143201494|NCT03906656|516282626|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
143201495|NCT03906656|516282625|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
143201496|NCT03906656|516282626|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
143201497|NCT03906656|516282625|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
143201498|NCT03906656|516282626|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
143201499|NCT03906656|516282625|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
143201500|NCT03906656|516282626|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
143201501|NCT03906656|516282625|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
143201502|NCT03906656|516282626|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
143201503|NCT03906656|516282625|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
143201504|NCT03906656|516282626|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
143201505|NCT03906656|516282625|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
143201506|NCT03906656|516282626|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
143201507|NCT03906656|516282625|FG000|Home Use 2 (3 Months)|Death|2|||
143201508|NCT03906656|516282626|FG001|Home Use 2 (3 Months)|Death|0|||
143201509|NCT03906656|516282625|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
143201510|NCT03906656|516282626|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
143201511|NCT03906656|516282625|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
143201512|NCT03906656|516282626|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
143201513|NCT03366103|516282627|FG000|Overall Study|Disease Progression|3|||
143201514|NCT03366103|516282628|FG001|Overall Study|Disease Progression|1|||
143201515|NCT03366103|516282629|FG002|Overall Study|Disease Progression|0|||
143201516|NCT03366103|516282627|FG000|Overall Study|Adverse Event|0|||
143201517|NCT03366103|516282628|FG001|Overall Study|Adverse Event|1|||
143201518|NCT03366103|516282629|FG002|Overall Study|Adverse Event|0|||
143201519|NCT05590000|516282635|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
143201520|NCT00762996|516282636|FG000|Period One|Protocol Violation|0|||
143201521|NCT00762996|516282637|FG001|Period One|Protocol Violation|0|||
143201522|NCT00762996|516282638|FG002|Period One|Protocol Violation|1|||
143201523|NCT00762996|516282639|FG003|Period One|Protocol Violation|0|||
143201524|NCT00762996|516282636|FG000|Period One|ineligible|0|||
143201525|NCT00762996|516282637|FG001|Period One|ineligible|0|||
143201526|NCT00762996|516282638|FG002|Period One|ineligible|1|||
143201527|NCT00762996|516282639|FG003|Period One|ineligible|1|||
143201528|NCT00762996|516282636|FG000|Period One|Adverse Event|0|||
143201529|NCT00762996|516282637|FG001|Period One|Adverse Event|0|||
143201530|NCT00762996|516282638|FG002|Period One|Adverse Event|1|||
143201531|NCT00762996|516282639|FG003|Period One|Adverse Event|0|||
143201532|NCT00762996|516282636|FG000|Period One|Withdrawal by Subject|0|||
143201533|NCT00762996|516282637|FG001|Period One|Withdrawal by Subject|0|||
143201534|NCT00762996|516282638|FG002|Period One|Withdrawal by Subject|1|||
143201535|NCT00762996|516282639|FG003|Period One|Withdrawal by Subject|0|||
143201536|NCT02689076|516282642|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
143201537|NCT02689076|516282643|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
143201538|NCT02689076|516282644|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
143201539|NCT02689076|516282642|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
143201540|NCT02689076|516282643|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
143201541|NCT02689076|516282644|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
143201542|NCT02689076|516282642|FG000|Overall Study|Did not have an HIE match|2|||
143201543|NCT02689076|516282643|FG001|Overall Study|Did not have an HIE match|0|||
143201544|NCT02689076|516282644|FG002|Overall Study|Did not have an HIE match|0|||
143201545|NCT02689076|516282642|FG000|Overall Study|Death during non-VA encounter|2|||
143201546|NCT02689076|516282643|FG001|Overall Study|Death during non-VA encounter|5|||
143201547|NCT02689076|516282644|FG002|Overall Study|Death during non-VA encounter|0|||
143201548|NCT02689076|516282642|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
143201549|NCT02689076|516282643|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
143201550|NCT02689076|516282644|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
143201551|NCT02689076|516282642|FG000|Overall Study|Participant no longer active in VA system|1|||
143201552|NCT02689076|516282643|FG001|Overall Study|Participant no longer active in VA system|0|||
143201553|NCT02689076|516282644|FG002|Overall Study|Participant no longer active in VA system|0|||
143201554|NCT02689076|516282642|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
143201555|NCT02689076|516282643|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
143201556|NCT02689076|516282644|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
143201557|NCT01816906|516282650|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
143201558|NCT01816906|516282651|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
143201559|NCT01816906|516282650|FG000|Six Months|Lost to Follow-up|14|||
143201560|NCT01816906|516282651|FG001|Six Months|Lost to Follow-up|16|||
143201561|NCT01816906|516282650|FG000|12 Months|Adverse Event|2|||
143201562|NCT01816906|516282651|FG001|12 Months|Adverse Event|2|||
143201563|NCT01816906|516282650|FG000|12 Months|Death|0|||
143201564|NCT01816906|516282651|FG001|12 Months|Death|2|||
143201565|NCT01816906|516282650|FG000|12 Months|Lost to Follow-up|2|||
143201566|NCT01816906|516282651|FG001|12 Months|Lost to Follow-up|1|||
143262469|NCT00076024|516515835|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
143262470|NCT00076024|516515836|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
143262471|NCT00076024|516515833|FG000|Phase 2, Double-blind|Adverse Event|0|||
143262472|NCT00076024|516515834|FG001|Phase 2, Double-blind|Adverse Event|25|||
143262473|NCT00076024|516515835|FG002|Phase 2, Double-blind|Adverse Event|6|||
143262474|NCT00076024|516515836|FG003|Phase 2, Double-blind|Adverse Event|0|||
143201567|NCT00746733|516282652|FG000|Second Intervention|Adverse Event|1|||
143201568|NCT00746733|516282653|FG001|Second Intervention|Adverse Event|0|||
143262475|NCT00076024|516515833|FG000|Phase 2, Double-blind|Un-specified|0|||
143262476|NCT00076024|516515834|FG001|Phase 2, Double-blind|Un-specified|14|||
143262477|NCT00076024|516515835|FG002|Phase 2, Double-blind|Un-specified|6|||
143369977|NCT00486759|516899037|FG000|Treatment|Death|17|||
143369978|NCT00486759|516899038|FG001|Treatment|Death|10|||
143201569|NCT00746733|516282652|FG000|Third Intervention|Withdrawal by Subject|1|||
143201570|NCT00746733|516282653|FG001|Third Intervention|Withdrawal by Subject|1|||
143201571|NCT00993499|516282656|FG000|Run-in Period (8 Days)|Adverse Event|0|||
143201572|NCT00993499|516282657|FG001|Run-in Period (8 Days)|Adverse Event|1|||
143201573|NCT00993499|516282658|FG002|Run-in Period (8 Days)|Adverse Event|0|||
143201574|NCT00993499|516282659|FG003|Run-in Period (8 Days)|Adverse Event|0|||
143201575|NCT00993499|516282660|FG004|Run-in Period (8 Days)|Adverse Event|0|||
143201576|NCT00993499|516282661|FG005|Run-in Period (8 Days)|Adverse Event|0|||
143201577|NCT00993499|516282656|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
143201578|NCT00993499|516282657|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
143201579|NCT00993499|516282658|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
143201580|NCT00993499|516282659|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
143201581|NCT00993499|516282660|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
143201582|NCT00993499|516282661|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
143201583|NCT00993499|516282656|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
143201584|NCT00993499|516282657|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
143201585|NCT00993499|516282658|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
143201586|NCT00993499|516282659|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
143201587|NCT00993499|516282660|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
143201588|NCT00993499|516282661|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
143201589|NCT00993499|516282656|FG000|Run-in Period (8 Days)|Progressive disease|0|||
143201590|NCT00993499|516282657|FG001|Run-in Period (8 Days)|Progressive disease|1|||
143201591|NCT00993499|516282658|FG002|Run-in Period (8 Days)|Progressive disease|1|||
143201592|NCT00993499|516282659|FG003|Run-in Period (8 Days)|Progressive disease|0|||
143201593|NCT00993499|516282660|FG004|Run-in Period (8 Days)|Progressive disease|0|||
143201594|NCT00993499|516282661|FG005|Run-in Period (8 Days)|Progressive disease|0|||
143201595|NCT00993499|516282656|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
143201596|NCT00993499|516282657|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
143201597|NCT00993499|516282658|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
143201598|NCT00993499|516282659|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
143201599|NCT00993499|516282660|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
143201600|NCT00993499|516282661|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
143201601|NCT00993499|516282656|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
143201602|NCT00993499|516282657|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
143201603|NCT00993499|516282658|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
143201604|NCT00993499|516282659|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
143201605|NCT00993499|516282660|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
143201606|NCT00993499|516282661|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
143201607|NCT00993499|516282656|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
143201608|NCT00993499|516282657|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
143201609|NCT00993499|516282658|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
143201610|NCT00993499|516282659|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
143201611|NCT00993499|516282660|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
143201612|NCT00993499|516282661|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
143201613|NCT00993499|516282656|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
143201614|NCT00993499|516282657|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
143201615|NCT00993499|516282658|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
143201616|NCT00993499|516282659|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
143201617|NCT00993499|516282660|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
143201618|NCT00993499|516282661|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
143201619|NCT00993499|516282656|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
143201620|NCT00993499|516282657|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
143201621|NCT00993499|516282658|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
143201622|NCT00993499|516282659|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
143201623|NCT00993499|516282660|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
143201624|NCT00993499|516282661|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
143201625|NCT00993499|516282656|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
143369979|NCT00486759|516899037|FG000|Treatment|Withdrew consent|15|||
143369980|NCT00486759|516899038|FG001|Treatment|Withdrew consent|12|||
143369981|NCT00486759|516899037|FG000|Treatment|Administrative/reason not specified|17|||
143369982|NCT00486759|516899038|FG001|Treatment|Administrative/reason not specified|21|||
143369983|NCT00486759|516899037|FG000|Treatment|Refused treatment|10|||
143369984|NCT00486759|516899038|FG001|Treatment|Refused treatment|7|||
143369985|NCT00486759|516899037|FG000|Treatment|Violation of selection criteria at entry|3|||
143201626|NCT00993499|516282657|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
143201627|NCT00993499|516282658|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
143201628|NCT00993499|516282659|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
143262478|NCT00076024|516515836|FG003|Phase 2, Double-blind|Un-specified|0|||
143262479|NCT00076024|516515833|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
143262480|NCT00076024|516515834|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
143262481|NCT00076024|516515835|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
143262482|NCT00076024|516515836|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
143262483|NCT00076024|516515833|FG000|Phase 2, Open-label|Adverse Event|0|||
143262484|NCT00076024|516515834|FG001|Phase 2, Open-label|Adverse Event|0|||
143262485|NCT00076024|516515835|FG002|Phase 2, Open-label|Adverse Event|0|||
143262486|NCT00076024|516515836|FG003|Phase 2, Open-label|Adverse Event|2|||
143262487|NCT00076024|516515833|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
143262488|NCT00076024|516515834|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
143262489|NCT00076024|516515835|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
143262490|NCT00076024|516515836|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
143262491|NCT00076024|516515833|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
143262492|NCT00076024|516515834|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
143262493|NCT00076024|516515835|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
143262494|NCT00076024|516515836|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
143262495|NCT00076024|516515833|FG000|Phase 2, Open-label|Other|0|||
143262496|NCT00076024|516515834|FG001|Phase 2, Open-label|Other|0|||
143262497|NCT00076024|516515835|FG002|Phase 2, Open-label|Other|0|||
143262498|NCT00076024|516515836|FG003|Phase 2, Open-label|Other|2|||
143262499|NCT00301821|516515841|FG000|Overall Study|Ineligible|25|||
143262500|NCT00301821|516515841|FG000|Overall Study|Cancel|1|||
143262501|NCT02294773|516515842|FG000|Overall Study|Withdrawal by Subject|0|||
143262502|NCT02294773|516515843|FG001|Overall Study|Withdrawal by Subject|2|||
143262503|NCT03052764|516515844|FG000|Double-Blind Treatment Period|Adverse Event|2|||
143262504|NCT03052764|516515845|FG001|Double-Blind Treatment Period|Adverse Event|0|||
143201629|NCT00993499|516282660|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
143201630|NCT00993499|516282661|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
143201631|NCT00993499|516282656|FG000|Discontinued After Starting Course 3|DLT|1|||
143201632|NCT00993499|516282657|FG001|Discontinued After Starting Course 3|DLT|0|||
143201633|NCT00993499|516282658|FG002|Discontinued After Starting Course 3|DLT|2|||
143201634|NCT00993499|516282659|FG003|Discontinued After Starting Course 3|DLT|1|||
143201635|NCT00993499|516282660|FG004|Discontinued After Starting Course 3|DLT|0|||
143201636|NCT00993499|516282661|FG005|Discontinued After Starting Course 3|DLT|0|||
143201637|NCT00993499|516282656|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
143201638|NCT00993499|516282657|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
143201639|NCT00993499|516282658|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
143201640|NCT00993499|516282659|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
143201641|NCT00993499|516282660|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
143201642|NCT00993499|516282661|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
143201643|NCT01945775|516282662|FG000|Overall Study|Death|214|||
143201644|NCT01945775|516282663|FG001|Overall Study|Death|98|||
143201645|NCT01945775|516282662|FG000|Overall Study|Lost to Follow-up|12|||
143201646|NCT01945775|516282663|FG001|Overall Study|Lost to Follow-up|7|||
143201647|NCT01945775|516282662|FG000|Overall Study|Withdrawal by Subject|11|||
143201648|NCT01945775|516282663|FG001|Overall Study|Withdrawal by Subject|21|||
143201649|NCT01945775|516282662|FG000|Overall Study|Other|50|||
143201650|NCT01945775|516282663|FG001|Overall Study|Other|18|||
143201651|NCT02876328|516282664|FG000|Overall Study|Death|2|||
143201652|NCT02876328|516282665|FG001|Overall Study|Death|1|||
143201653|NCT02876328|516282666|FG002|Overall Study|Death|3|||
143201654|NCT02876328|516282667|FG003|Overall Study|Death|0|||
143201655|NCT02876328|516282668|FG004|Overall Study|Death|0|||
143201656|NCT02876328|516282669|FG005|Overall Study|Death|0|||
143201657|NCT02876328|516282670|FG006|Overall Study|Death|1|||
143201658|NCT02876328|516282671|FG007|Overall Study|Death|3|||
143201659|NCT02876328|516282672|FG008|Overall Study|Death|0|||
143262505|NCT03052764|516515844|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
143262506|NCT03052764|516515845|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
143262507|NCT03052764|516515844|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
143262508|NCT03052764|516515845|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
143201660|NCT02876328|516282673|FG009|Overall Study|Death|1|||
143201661|NCT02876328|516282674|FG010|Overall Study|Death|1|||
143201662|NCT02876328|516282675|FG011|Overall Study|Death|0|||
143201663|NCT02876328|516282676|FG012|Overall Study|Death|0|||
143201664|NCT02876328|516282677|FG013|Overall Study|Death|0|||
143201665|NCT02876328|516282678|FG014|Overall Study|Death|0|||
143201666|NCT02876328|516282679|FG015|Overall Study|Death|0|||
143262509|NCT03052764|516515844|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
143262510|NCT03052764|516515845|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
143201667|NCT02876328|516282680|FG016|Overall Study|Death|1|||
143201668|NCT02876328|516282681|FG017|Overall Study|Death|1|||
143201669|NCT02876328|516282682|FG018|Overall Study|Death|0|||
143201670|NCT02876328|516282683|FG019|Overall Study|Death|0|||
143201671|NCT02876328|516282684|FG020|Overall Study|Death|0|||
143201672|NCT02876328|516282685|FG021|Overall Study|Death|1|||
143201673|NCT02876328|516282686|FG022|Overall Study|Death|0|||
143201674|NCT02876328|516282687|FG023|Overall Study|Death|0|||
143201675|NCT02876328|516282664|FG000|Overall Study|Withdrawal by Subject|0|||
143201676|NCT02876328|516282665|FG001|Overall Study|Withdrawal by Subject|2|||
143201677|NCT02876328|516282666|FG002|Overall Study|Withdrawal by Subject|3|||
143201678|NCT02876328|516282667|FG003|Overall Study|Withdrawal by Subject|3|||
143201679|NCT02876328|516282668|FG004|Overall Study|Withdrawal by Subject|0|||
143201680|NCT02876328|516282669|FG005|Overall Study|Withdrawal by Subject|1|||
143201681|NCT02876328|516282670|FG006|Overall Study|Withdrawal by Subject|0|||
143201682|NCT02876328|516282671|FG007|Overall Study|Withdrawal by Subject|1|||
143201683|NCT02876328|516282672|FG008|Overall Study|Withdrawal by Subject|1|||
143201684|NCT02876328|516282673|FG009|Overall Study|Withdrawal by Subject|2|||
143201685|NCT02876328|516282674|FG010|Overall Study|Withdrawal by Subject|0|||
143201686|NCT02876328|516282675|FG011|Overall Study|Withdrawal by Subject|0|||
143201687|NCT02876328|516282676|FG012|Overall Study|Withdrawal by Subject|0|||
143201688|NCT02876328|516282677|FG013|Overall Study|Withdrawal by Subject|0|||
143201689|NCT02876328|516282678|FG014|Overall Study|Withdrawal by Subject|0|||
143201690|NCT02876328|516282679|FG015|Overall Study|Withdrawal by Subject|0|||
143201691|NCT02876328|516282680|FG016|Overall Study|Withdrawal by Subject|1|||
143201692|NCT02876328|516282681|FG017|Overall Study|Withdrawal by Subject|3|||
143201693|NCT02876328|516282682|FG018|Overall Study|Withdrawal by Subject|0|||
143201694|NCT02876328|516282683|FG019|Overall Study|Withdrawal by Subject|0|||
143201695|NCT02876328|516282684|FG020|Overall Study|Withdrawal by Subject|1|||
143201696|NCT02876328|516282685|FG021|Overall Study|Withdrawal by Subject|0|||
143201697|NCT02876328|516282686|FG022|Overall Study|Withdrawal by Subject|0|||
143201698|NCT02876328|516282687|FG023|Overall Study|Withdrawal by Subject|0|||
143201699|NCT02876328|516282664|FG000|Overall Study|Missed 12 Month Visit|15|||
143201700|NCT02876328|516282665|FG001|Overall Study|Missed 12 Month Visit|10|||
143201701|NCT02876328|516282666|FG002|Overall Study|Missed 12 Month Visit|11|||
143201702|NCT02876328|516282667|FG003|Overall Study|Missed 12 Month Visit|6|||
143201703|NCT02876328|516282668|FG004|Overall Study|Missed 12 Month Visit|10|||
143201704|NCT02876328|516282669|FG005|Overall Study|Missed 12 Month Visit|14|||
143201705|NCT02876328|516282670|FG006|Overall Study|Missed 12 Month Visit|3|||
143201706|NCT02876328|516282671|FG007|Overall Study|Missed 12 Month Visit|8|||
143201707|NCT02876328|516282672|FG008|Overall Study|Missed 12 Month Visit|9|||
143201708|NCT02876328|516282673|FG009|Overall Study|Missed 12 Month Visit|5|||
143201709|NCT02876328|516282674|FG010|Overall Study|Missed 12 Month Visit|4|||
143201710|NCT02876328|516282675|FG011|Overall Study|Missed 12 Month Visit|1|||
143201711|NCT02876328|516282676|FG012|Overall Study|Missed 12 Month Visit|5|||
143201712|NCT02876328|516282677|FG013|Overall Study|Missed 12 Month Visit|4|||
143201713|NCT02876328|516282678|FG014|Overall Study|Missed 12 Month Visit|4|||
143201714|NCT02876328|516282679|FG015|Overall Study|Missed 12 Month Visit|4|||
143201715|NCT02876328|516282680|FG016|Overall Study|Missed 12 Month Visit|3|||
143201716|NCT02876328|516282681|FG017|Overall Study|Missed 12 Month Visit|6|||
143201717|NCT02876328|516282682|FG018|Overall Study|Missed 12 Month Visit|2|||
143201718|NCT02876328|516282683|FG019|Overall Study|Missed 12 Month Visit|2|||
143201719|NCT02876328|516282684|FG020|Overall Study|Missed 12 Month Visit|11|||
143201720|NCT02876328|516282685|FG021|Overall Study|Missed 12 Month Visit|7|||
143201721|NCT02876328|516282686|FG022|Overall Study|Missed 12 Month Visit|1|||
143201722|NCT02876328|516282687|FG023|Overall Study|Missed 12 Month Visit|0|||
143201723|NCT00387647|516283965|FG000|Overall Study|Death|18|||
143201724|NCT02032407|516283966|FG000|Overall Study|Lost to Follow-up|2|||
143201725|NCT02032407|516283966|FG000|Overall Study|Pregnancy|1|||
143201726|NCT02032407|516283966|FG000|Overall Study|Other Miscellaneous Reasons|2|||
143201727|NCT01309269|516283967|FG000|Overall Study|Adverse Event|56|||
143201728|NCT01309269|516283967|FG000|Overall Study|Withdrawal by Subject|25|||
143201729|NCT01309269|516283967|FG000|Overall Study|Lack of Acceptance|15|||
143201730|NCT01309269|516283967|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
143201731|NCT01309269|516283967|FG000|Overall Study|Kidney Transplant|25|||
143201732|NCT01309269|516283967|FG000|Overall Study|Administrative Problems|141|||
143201733|NCT01309269|516283967|FG000|Overall Study|Other|256|||
143201734|NCT01309269|516283967|FG000|Overall Study|Other|1|||
143201735|NCT01309269|516283967|FG000|Overall Study|Study Completion Data Not Recorded|95|||
143201736|NCT01309269|516283967|FG000|Overall Study|Enrolled but not Treated|107|||
143201737|NCT00046930|516283978|FG000|Overall Study|Ineligible|12|||
143201738|NCT00046930|516283979|FG001|Overall Study|Ineligible|4|||
143201739|NCT02088073|516283982|FG000|Acute Phase|Withdrawal by Subject|5|||
143201740|NCT02088073|516283983|FG001|Acute Phase|Withdrawal by Subject|0|||
143201741|NCT02088073|516283984|FG002|Acute Phase|Withdrawal by Subject|0|||
143201742|NCT02088073|516283985|FG003|Acute Phase|Withdrawal by Subject|0|||
143201743|NCT02088073|516283986|FG004|Acute Phase|Withdrawal by Subject|0|||
143201744|NCT02088073|516283982|FG000|Acute Phase|Hyperkalemia|2|||
143201745|NCT02088073|516283983|FG001|Acute Phase|Hyperkalemia|0|||
143201746|NCT02088073|516283984|FG002|Acute Phase|Hyperkalemia|0|||
143201747|NCT02088073|516283985|FG003|Acute Phase|Hyperkalemia|0|||
143201748|NCT02088073|516283986|FG004|Acute Phase|Hyperkalemia|0|||
143201749|NCT02088073|516283982|FG000|Maintanance Phase|Withdrawal by Subject|0|||
143201750|NCT02088073|516283983|FG001|Maintanance Phase|Withdrawal by Subject|2|||
143201751|NCT02088073|516283984|FG002|Maintanance Phase|Withdrawal by Subject|0|||
143201752|NCT02088073|516283985|FG003|Maintanance Phase|Withdrawal by Subject|0|||
143201753|NCT02088073|516283986|FG004|Maintanance Phase|Withdrawal by Subject|0|||
143201754|NCT02088073|516283982|FG000|Maintanance Phase|Adverse Event|0|||
143201755|NCT02088073|516283983|FG001|Maintanance Phase|Adverse Event|0|||
143201756|NCT02088073|516283984|FG002|Maintanance Phase|Adverse Event|3|||
143201757|NCT02088073|516283985|FG003|Maintanance Phase|Adverse Event|0|||
143201758|NCT02088073|516283986|FG004|Maintanance Phase|Adverse Event|1|||
143201759|NCT02088073|516283982|FG000|Maintanance Phase|Physician Decision|0|||
143201760|NCT02088073|516283983|FG001|Maintanance Phase|Physician Decision|0|||
143201761|NCT02088073|516283984|FG002|Maintanance Phase|Physician Decision|0|||
143201762|NCT02088073|516283985|FG003|Maintanance Phase|Physician Decision|0|||
143201763|NCT02088073|516283986|FG004|Maintanance Phase|Physician Decision|1|||
143201764|NCT02088073|516283982|FG000|Maintanance Phase|Sponsor's decision|0|||
143201765|NCT02088073|516283983|FG001|Maintanance Phase|Sponsor's decision|2|||
143201766|NCT02088073|516283984|FG002|Maintanance Phase|Sponsor's decision|0|||
143201767|NCT02088073|516283985|FG003|Maintanance Phase|Sponsor's decision|2|||
143201768|NCT02088073|516283986|FG004|Maintanance Phase|Sponsor's decision|1|||
143201769|NCT02088073|516283982|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
143201770|NCT02088073|516283983|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
143201771|NCT02088073|516283984|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
143201772|NCT02088073|516283985|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
143201773|NCT02088073|516283986|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
143201774|NCT02088073|516283982|FG000|Maintanance Phase|Miscellaneous|0|||
143201775|NCT02088073|516283983|FG001|Maintanance Phase|Miscellaneous|2|||
143201776|NCT02088073|516283984|FG002|Maintanance Phase|Miscellaneous|1|||
143201777|NCT02088073|516283985|FG003|Maintanance Phase|Miscellaneous|2|||
143201778|NCT02088073|516283986|FG004|Maintanance Phase|Miscellaneous|1|||
143201779|NCT02088073|516283982|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
143201780|NCT02088073|516283983|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
143201781|NCT02088073|516283984|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
143201782|NCT02088073|516283985|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
143201783|NCT02088073|516283986|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
143201784|NCT02088073|516283982|FG000|Maintanance Phase|Subject compliance|0|||
143201785|NCT02088073|516283983|FG001|Maintanance Phase|Subject compliance|1|||
143201786|NCT02088073|516283984|FG002|Maintanance Phase|Subject compliance|0|||
143201787|NCT02088073|516283985|FG003|Maintanance Phase|Subject compliance|0|||
143201788|NCT02088073|516283986|FG004|Maintanance Phase|Subject compliance|0|||
143201789|NCT00520013|516283987|FG000|Overall Study|Withdrawal by Subject|0|||
143201790|NCT00520013|516283988|FG001|Overall Study|Withdrawal by Subject|0|||
143201791|NCT00520013|516283989|FG002|Overall Study|Withdrawal by Subject|1|||
143201792|NCT00520013|516283987|FG000|Overall Study|Adverse Event|2|||
143201793|NCT00520013|516283988|FG001|Overall Study|Adverse Event|10|||
143201794|NCT00520013|516283989|FG002|Overall Study|Adverse Event|7|||
143201795|NCT00520013|516283987|FG000|Overall Study|Progressive Disease|7|||
143201796|NCT00520013|516283988|FG001|Overall Study|Progressive Disease|3|||
143201797|NCT00520013|516283989|FG002|Overall Study|Progressive Disease|0|||
143201798|NCT00520013|516283987|FG000|Overall Study|Clinical Progression|3|||
143201799|NCT00520013|516283988|FG001|Overall Study|Clinical Progression|1|||
143201800|NCT00520013|516283989|FG002|Overall Study|Clinical Progression|0|||
143201801|NCT00520013|516283987|FG000|Overall Study|Death|0|||
143201802|NCT00520013|516283988|FG001|Overall Study|Death|1|||
143201803|NCT00520013|516283989|FG002|Overall Study|Death|0|||
143201804|NCT00520013|516283987|FG000|Overall Study|Physician Decision|0|||
143201805|NCT00520013|516283988|FG001|Overall Study|Physician Decision|0|||
143201806|NCT00520013|516283989|FG002|Overall Study|Physician Decision|3|||
143201807|NCT02969590|516283990|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
143262511|NCT03052764|516515844|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
143262512|NCT03052764|516515845|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
143262513|NCT03206073|516515846|FG000|Overall Study|Participant Noncompliance|0|||
143201808|NCT02969590|516283991|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
143201809|NCT02969590|516283992|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
143201810|NCT03294135|516283993|FG000|Overall Study|Serious Adverse Event|1|||
143201811|NCT03294135|516283994|FG001|Overall Study|Serious Adverse Event|0|||
143201812|NCT03294135|516283995|FG002|Overall Study|Serious Adverse Event|0|||
143201813|NCT03294135|516283993|FG000|Overall Study|Lost to Follow-up|1|||
143201814|NCT03294135|516283994|FG001|Overall Study|Lost to Follow-up|0|||
143201815|NCT03294135|516283995|FG002|Overall Study|Lost to Follow-up|1|||
143201816|NCT03294135|516283993|FG000|Overall Study|Withdrawal by Subject|0|||
143201817|NCT03294135|516283994|FG001|Overall Study|Withdrawal by Subject|0|||
143201818|NCT03294135|516283995|FG002|Overall Study|Withdrawal by Subject|1|||
143201819|NCT03294135|516283993|FG000|Overall Study|Other|2|||
143201820|NCT03294135|516283994|FG001|Overall Study|Other|0|||
143201821|NCT03294135|516283995|FG002|Overall Study|Other|0|||
143201822|NCT00186537|516283996|FG000|Overall Study|Withdrawal by Subject|4|||
143369986|NCT00486759|516899038|FG001|Treatment|Violation of selection criteria at entry|3|||
143369987|NCT00486759|516899037|FG000|Treatment|Other protocol violation|1|||
143369988|NCT00486759|516899038|FG001|Treatment|Other protocol violation|5|||
143369989|NCT00486759|516899037|FG000|Treatment|Failure to return|1|||
143369990|NCT00486759|516899038|FG001|Treatment|Failure to return|1|||
143369991|NCT00486759|516899037|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
143369992|NCT00486759|516899038|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
143369993|NCT00486759|516899037|FG000|Safety Follow-up|Death|40|||
143369994|NCT00486759|516899038|FG001|Safety Follow-up|Death|29|||
143369995|NCT00486759|516899037|FG000|Safety Follow-up|Withdrew consent|32|||
143369996|NCT00486759|516899038|FG001|Safety Follow-up|Withdrew consent|23|||
143369997|NCT00486759|516899037|FG000|Safety Follow-up|Failure to return|9|||
143369998|NCT00486759|516899038|FG001|Safety Follow-up|Failure to return|6|||
143369999|NCT00486759|516899037|FG000|Safety Follow-up|Administrative/not specified|8|||
143370000|NCT00486759|516899038|FG001|Safety Follow-up|Administrative/not specified|6|||
143370001|NCT00486759|516899037|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
143370002|NCT00486759|516899038|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
143370003|NCT00486759|516899037|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
143370004|NCT00486759|516899038|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
143370005|NCT00954707|516899039|FG000|Overall Study|Death|34|||
143370006|NCT00954707|516899039|FG000|Overall Study|Withdrawal by Subject|100|||
143370007|NCT00954707|516899039|FG000|Overall Study|Lost to Follow-up|33|||
143370008|NCT01025843|516899040|FG000|Washout 4|Withdrawal by Subject|0|||
143370009|NCT01025843|516899041|FG001|Washout 4|Withdrawal by Subject|0|||
143370010|NCT01025843|516899042|FG002|Washout 4|Withdrawal by Subject|1|||
143370011|NCT01025843|516899043|FG003|Washout 4|Withdrawal by Subject|1|||
143370012|NCT01025843|516899044|FG004|Washout 4|Withdrawal by Subject|0|||
143370013|NCT01025843|516899045|FG005|Washout 4|Withdrawal by Subject|0|||
143370014|NCT01025843|516899046|FG006|Washout 4|Withdrawal by Subject|0|||
143370015|NCT01025843|516899047|FG007|Washout 4|Withdrawal by Subject|0|||
143370016|NCT01025843|516899048|FG008|Washout 4|Withdrawal by Subject|0|||
143370017|NCT01025843|516899049|FG009|Washout 4|Withdrawal by Subject|0|||
143370018|NCT03646669|516899054|FG000|Overall Study|Withdrawal by Subject|5|||
143370019|NCT03646669|516899055|FG001|Overall Study|Withdrawal by Subject|0|||
143370020|NCT00309452|516899056|FG000|Overall Study|Withdrawal by Subject|3|||
143370021|NCT00309452|516899057|FG001|Overall Study|Withdrawal by Subject|0|||
143370022|NCT00771667|516899058|FG000|Induction Phase|Adverse Event|5|||
143370023|NCT00771667|516899059|FG001|Induction Phase|Adverse Event|2|||
143370024|NCT00771667|516899060|FG002|Induction Phase|Adverse Event|4|||
143370025|NCT00771667|516899061|FG003|Induction Phase|Adverse Event|1|||
143370026|NCT00771667|516899062|FG004|Induction Phase|Adverse Event|0|||
143370027|NCT00771667|516899063|FG005|Induction Phase|Adverse Event|0|||
143370028|NCT00771667|516899064|FG006|Induction Phase|Adverse Event|0|||
143370029|NCT00771667|516899065|FG007|Induction Phase|Adverse Event|0|||
143370030|NCT00771667|516899066|FG008|Induction Phase|Adverse Event|0|||
143370031|NCT00771667|516899067|FG009|Induction Phase|Adverse Event|0|||
143370032|NCT00771667|516899058|FG000|Induction Phase|Lack of Efficacy|9|||
143370033|NCT00771667|516899059|FG001|Induction Phase|Lack of Efficacy|2|||
143370034|NCT00771667|516899060|FG002|Induction Phase|Lack of Efficacy|4|||
143370035|NCT00771667|516899061|FG003|Induction Phase|Lack of Efficacy|3|||
143370036|NCT00771667|516899062|FG004|Induction Phase|Lack of Efficacy|0|||
143370037|NCT00771667|516899063|FG005|Induction Phase|Lack of Efficacy|0|||
143370038|NCT00771667|516899064|FG006|Induction Phase|Lack of Efficacy|0|||
143370039|NCT00771667|516899065|FG007|Induction Phase|Lack of Efficacy|0|||
143370040|NCT00771667|516899066|FG008|Induction Phase|Lack of Efficacy|0|||
143370041|NCT00771667|516899067|FG009|Induction Phase|Lack of Efficacy|0|||
143370042|NCT00771667|516899058|FG000|Induction Phase|Lost to Follow-up|1|||
143370043|NCT00771667|516899059|FG001|Induction Phase|Lost to Follow-up|0|||
143370044|NCT00771667|516899060|FG002|Induction Phase|Lost to Follow-up|1|||
143370045|NCT00771667|516899061|FG003|Induction Phase|Lost to Follow-up|0|||
143370046|NCT00771667|516899062|FG004|Induction Phase|Lost to Follow-up|0|||
143370047|NCT00771667|516899063|FG005|Induction Phase|Lost to Follow-up|0|||
143370048|NCT00771667|516899064|FG006|Induction Phase|Lost to Follow-up|0|||
143370049|NCT00771667|516899065|FG007|Induction Phase|Lost to Follow-up|0|||
143370050|NCT00771667|516899066|FG008|Induction Phase|Lost to Follow-up|0|||
143370051|NCT00771667|516899067|FG009|Induction Phase|Lost to Follow-up|0|||
143370052|NCT00771667|516899058|FG000|Induction Phase|Other|4|||
143370053|NCT00771667|516899059|FG001|Induction Phase|Other|6|||
143370054|NCT00771667|516899060|FG002|Induction Phase|Other|3|||
143370055|NCT00771667|516899061|FG003|Induction Phase|Other|4|||
143370056|NCT00771667|516899062|FG004|Induction Phase|Other|0|||
143370057|NCT00771667|516899063|FG005|Induction Phase|Other|0|||
143201823|NCT00186537|516283997|FG001|Overall Study|Withdrawal by Subject|0|||
143370058|NCT00771667|516899064|FG006|Induction Phase|Other|0|||
143370059|NCT00771667|516899065|FG007|Induction Phase|Other|0|||
143370060|NCT00771667|516899066|FG008|Induction Phase|Other|0|||
143370061|NCT00771667|516899067|FG009|Induction Phase|Other|0|||
143370062|NCT00771667|516899058|FG000|Maintenance Phase|Adverse Event|0|||
143370063|NCT00771667|516899059|FG001|Maintenance Phase|Adverse Event|0|||
143370064|NCT00771667|516899060|FG002|Maintenance Phase|Adverse Event|0|||
143370065|NCT00771667|516899061|FG003|Maintenance Phase|Adverse Event|0|||
143370066|NCT00771667|516899062|FG004|Maintenance Phase|Adverse Event|1|||
143370067|NCT00771667|516899063|FG005|Maintenance Phase|Adverse Event|3|||
143370068|NCT00771667|516899064|FG006|Maintenance Phase|Adverse Event|5|||
143370069|NCT00771667|516899065|FG007|Maintenance Phase|Adverse Event|1|||
143370070|NCT00771667|516899066|FG008|Maintenance Phase|Adverse Event|8|||
143370071|NCT00771667|516899067|FG009|Maintenance Phase|Adverse Event|7|||
143370072|NCT00771667|516899058|FG000|Maintenance Phase|Lack of Efficacy|0|||
143370073|NCT00771667|516899059|FG001|Maintenance Phase|Lack of Efficacy|0|||
143370074|NCT00771667|516899060|FG002|Maintenance Phase|Lack of Efficacy|0|||
143370075|NCT00771667|516899061|FG003|Maintenance Phase|Lack of Efficacy|0|||
143370076|NCT00771667|516899062|FG004|Maintenance Phase|Lack of Efficacy|1|||
143370077|NCT00771667|516899063|FG005|Maintenance Phase|Lack of Efficacy|3|||
143370078|NCT00771667|516899064|FG006|Maintenance Phase|Lack of Efficacy|3|||
143370079|NCT00771667|516899065|FG007|Maintenance Phase|Lack of Efficacy|2|||
143370080|NCT00771667|516899066|FG008|Maintenance Phase|Lack of Efficacy|11|||
143370081|NCT00771667|516899067|FG009|Maintenance Phase|Lack of Efficacy|7|||
143370082|NCT00771667|516899058|FG000|Maintenance Phase|Other|0|||
143370083|NCT00771667|516899059|FG001|Maintenance Phase|Other|0|||
143201824|NCT00186537|516283998|FG002|Overall Study|Withdrawal by Subject|3|||
143201825|NCT00186537|516283996|FG000|Overall Study|ALT > 1.5 x ULN|3|||
143201826|NCT00186537|516283997|FG001|Overall Study|ALT > 1.5 x ULN|0|||
143201827|NCT00186537|516283998|FG002|Overall Study|ALT > 1.5 x ULN|0|||
143201828|NCT01143051|516284000|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
143201829|NCT01143051|516284001|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
143201830|NCT01143051|516284002|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
143201831|NCT01143051|516284003|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
143201832|NCT01143051|516284004|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
143201833|NCT01143051|516284005|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
143201834|NCT01143051|516284000|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
143201835|NCT01143051|516284001|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
143201836|NCT01143051|516284002|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
143201837|NCT01143051|516284003|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
143201838|NCT01143051|516284004|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
143201839|NCT01143051|516284005|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
143201840|NCT01874275|516284009|FG000|Overall Study|Lost to Follow-up|1|||
143201841|NCT01874275|516284010|FG001|Overall Study|Lost to Follow-up|0|||
143201842|NCT00989235|516284013|FG000|Overall Study|Death|0|||
143201843|NCT00989235|516284014|FG001|Overall Study|Death|1|||
143201844|NCT00989235|516284013|FG000|Overall Study|Adverse Event|0|||
143201845|NCT00989235|516284014|FG001|Overall Study|Adverse Event|1|||
143201846|NCT00989235|516284013|FG000|Overall Study|Lack of Efficacy|1|||
143201847|NCT00989235|516284014|FG001|Overall Study|Lack of Efficacy|0|||
143201848|NCT00989235|516284013|FG000|Overall Study|Withdrawal of Consent|1|||
143201849|NCT00989235|516284014|FG001|Overall Study|Withdrawal of Consent|1|||
143201850|NCT00989235|516284013|FG000|Overall Study|Desire to Become Pregnant|1|||
143201851|NCT00989235|516284014|FG001|Overall Study|Desire to Become Pregnant|0|||
143201852|NCT00989235|516284013|FG000|Overall Study|Randomized by Mistake|0|||
143201853|NCT00989235|516284014|FG001|Overall Study|Randomized by Mistake|2|||
143201854|NCT00989235|516284013|FG000|Overall Study|Lost to Follow-up|0|||
143201855|NCT00989235|516284014|FG001|Overall Study|Lost to Follow-up|1|||
143201856|NCT04662073|516284019|FG000|Overall Study|Withdrawal by Subject|1|||
143201857|NCT04662073|516284020|FG001|Overall Study|Withdrawal by Subject|0|||
143201858|NCT02594098|516284021|FG000|Overall Study|Lack of Efficacy|17|||
143201859|NCT02594098|516284022|FG001|Overall Study|Lack of Efficacy|6|||
143201860|NCT02594098|516284021|FG000|Overall Study|Withdrawal by Subject|1|||
143201861|NCT02594098|516284022|FG001|Overall Study|Withdrawal by Subject|3|||
143201862|NCT02594098|516284021|FG000|Overall Study|Terminated participation|6|||
143201863|NCT02594098|516284022|FG001|Overall Study|Terminated participation|2|||
143201864|NCT02594098|516284021|FG000|Overall Study|Seek alternative treatment|2|||
143201865|NCT02594098|516284022|FG001|Overall Study|Seek alternative treatment|1|||
143370084|NCT00771667|516899060|FG002|Maintenance Phase|Other|0|||
143370085|NCT00771667|516899061|FG003|Maintenance Phase|Other|0|||
143370086|NCT00771667|516899062|FG004|Maintenance Phase|Other|0|||
143370087|NCT00771667|516899063|FG005|Maintenance Phase|Other|1|||
143370088|NCT00771667|516899064|FG006|Maintenance Phase|Other|2|||
143370089|NCT00771667|516899065|FG007|Maintenance Phase|Other|2|||
143370090|NCT00771667|516899066|FG008|Maintenance Phase|Other|3|||
143370091|NCT00771667|516899067|FG009|Maintenance Phase|Other|3|||
143201866|NCT02594098|516284021|FG000|Overall Study|Other|0|||
143201867|NCT02594098|516284022|FG001|Overall Study|Other|1|||
143370092|NCT01897233|516899068|FG000|Part B (24 Weeks)|Adverse Event|1|||
143370093|NCT01897233|516899068|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
143262514|NCT03206073|516515847|FG001|Overall Study|Participant Noncompliance|1|||
143201868|NCT01813721|516284023|FG000|Overall Study|Ineligibility determined|63|||
143201869|NCT01813721|516284023|FG000|Overall Study|Withdrawal by Subject|1|||
143201870|NCT00693472|516284026|FG000|Part 1|Adverse Event|1|||
143201871|NCT00693472|516284027|FG001|Part 1|Adverse Event|1|||
143201872|NCT00693472|516284028|FG002|Part 1|Adverse Event|0|||
143201873|NCT00693472|516284029|FG003|Part 1|Adverse Event|0|||
143201874|NCT00693472|516284026|FG000|Part 1|Lost to Follow-up|0|||
143201875|NCT00693472|516284027|FG001|Part 1|Lost to Follow-up|1|||
143201876|NCT00693472|516284028|FG002|Part 1|Lost to Follow-up|0|||
143201877|NCT00693472|516284029|FG003|Part 1|Lost to Follow-up|0|||
143201878|NCT00693472|516284026|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
143201879|NCT00693472|516284027|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
143201880|NCT00693472|516284028|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
143201881|NCT00693472|516284029|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
143201882|NCT00693472|516284026|FG000|Part 2|Adverse Event|0|||
143201883|NCT00693472|516284027|FG001|Part 2|Adverse Event|0|||
143201884|NCT00693472|516284028|FG002|Part 2|Adverse Event|1|||
143201885|NCT00693472|516284029|FG003|Part 2|Adverse Event|0|||
143201886|NCT00693472|516284026|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
143201887|NCT00693472|516284027|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
143201888|NCT00693472|516284028|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
143201889|NCT00693472|516284029|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
143201890|NCT04063787|516284030|FG000|Overall Study|Inadequate Doppler data|4|||
143201891|NCT04063787|516284030|FG000|Overall Study|Lost to Follow-up|2|||
143201892|NCT04063787|516284030|FG000|Overall Study|Death|3|||
143201893|NCT01527383|516284031|FG000|Overall Study|Adverse Event|5|||
143201894|NCT01527383|516284032|FG001|Overall Study|Adverse Event|0|||
143201895|NCT01527383|516284031|FG000|Overall Study|Lost to Follow-up|3|||
143201896|NCT01527383|516284032|FG001|Overall Study|Lost to Follow-up|0|||
143201897|NCT01527383|516284031|FG000|Overall Study|Physician Decision|2|||
143201898|NCT01527383|516284032|FG001|Overall Study|Physician Decision|0|||
143201899|NCT01527383|516284031|FG000|Overall Study|Pregnancy|1|||
143201900|NCT01527383|516284032|FG001|Overall Study|Pregnancy|0|||
143201901|NCT01527383|516284031|FG000|Overall Study|Protocol Violation|1|||
143201902|NCT01527383|516284032|FG001|Overall Study|Protocol Violation|0|||
143201903|NCT01527383|516284031|FG000|Overall Study|Screen failure|1|||
143201904|NCT01527383|516284032|FG001|Overall Study|Screen failure|0|||
143201905|NCT01527383|516284031|FG000|Overall Study|Participant moved|0|||
143201906|NCT01527383|516284032|FG001|Overall Study|Participant moved|1|||
143201907|NCT01527383|516284031|FG000|Overall Study|Withdrawal by Subject|2|||
143201908|NCT01527383|516284032|FG001|Overall Study|Withdrawal by Subject|3|||
143201909|NCT03515941|516284043|FG000|Overall Study|Adverse Event|1|||
143201910|NCT03515941|516284044|FG001|Overall Study|Adverse Event|0|||
143201911|NCT01406015|516284047|FG000|Overall Study|Withdrawal by Subject|3|||
143201912|NCT01406015|516284048|FG001|Overall Study|Withdrawal by Subject|3|||
143201913|NCT00787137|516284049|FG000|Overall Study|Study Termination|0|||
143201914|NCT00787137|516284050|FG001|Overall Study|Study Termination|0|||
143201915|NCT00787137|516284051|FG002|Overall Study|Study Termination|1|||
143201916|NCT01628367|516284059|FG000|Overall Study|Adverse Event|1|||
143201917|NCT01628367|516284060|FG001|Overall Study|Adverse Event|0|||
143201918|NCT03688555|516284061|FG000|Treatment Period|Adverse Event|0|||
143201919|NCT03688555|516284062|FG001|Treatment Period|Adverse Event|0|||
143201920|NCT03688555|516284063|FG002|Treatment Period|Adverse Event|1|||
143201921|NCT00844805|516284069|FG000|Treatment Phase|Adverse Event|5|||
143201922|NCT00844805|516284070|FG001|Treatment Phase|Adverse Event|1|||
143201923|NCT00844805|516284071|FG002|Treatment Phase|Adverse Event|0|||
143201924|NCT00844805|516284072|FG003|Treatment Phase|Adverse Event|0|||
143262515|NCT03206073|516515848|FG002|Overall Study|Participant Noncompliance|0|||
143262516|NCT03206073|516515849|FG003|Overall Study|Participant Noncompliance|0|||
143262517|NCT03206073|516515846|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
143262518|NCT03206073|516515847|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
143201925|NCT00844805|516284069|FG000|Treatment Phase|Withdrawal by Subject|3|||
143201926|NCT00844805|516284070|FG001|Treatment Phase|Withdrawal by Subject|4|||
143201927|NCT00844805|516284071|FG002|Treatment Phase|Withdrawal by Subject|0|||
143201928|NCT00844805|516284072|FG003|Treatment Phase|Withdrawal by Subject|0|||
143201929|NCT00844805|516284069|FG000|Treatment Phase|Noncompliance With Protocol|1|||
143201930|NCT00844805|516284070|FG001|Treatment Phase|Noncompliance With Protocol|0|||
143201931|NCT00844805|516284071|FG002|Treatment Phase|Noncompliance With Protocol|0|||
143201932|NCT00844805|516284072|FG003|Treatment Phase|Noncompliance With Protocol|0|||
143201933|NCT00844805|516284069|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
143201934|NCT00844805|516284070|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
143201935|NCT00844805|516284071|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
143201936|NCT00844805|516284072|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
143201937|NCT00844805|516284069|FG000|Follow-Up Phase|Adverse Event|0|||
143201938|NCT00844805|516284070|FG001|Follow-Up Phase|Adverse Event|0|||
143201939|NCT00844805|516284071|FG002|Follow-Up Phase|Adverse Event|1|||
143201940|NCT00844805|516284072|FG003|Follow-Up Phase|Adverse Event|0|||
143262519|NCT03206073|516515848|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
143262520|NCT03206073|516515849|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
143262521|NCT03206073|516515846|FG000|Overall Study|Death|0|||
143262522|NCT03206073|516515847|FG001|Overall Study|Death|0|||
143262523|NCT03206073|516515848|FG002|Overall Study|Death|1|||
143201941|NCT00844805|516284069|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
143201942|NCT00844805|516284070|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
143201943|NCT00844805|516284071|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
143201944|NCT00844805|516284072|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
143201945|NCT00844805|516284069|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
143201946|NCT00844805|516284070|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
143201947|NCT00844805|516284071|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
143201948|NCT00844805|516284072|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
143201949|NCT00844805|516284069|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
143201950|NCT00844805|516284070|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
143201951|NCT00844805|516284071|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
143201952|NCT00844805|516284072|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
143201953|NCT00844805|516284069|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
143201954|NCT00844805|516284070|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
143201955|NCT00844805|516284071|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
143201956|NCT00844805|516284072|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
143201957|NCT02639338|516284073|FG000|Overall Study|Lost to Follow-up|2|||
143201958|NCT02639338|516284074|FG001|Overall Study|Lost to Follow-up|2|||
143201959|NCT02639338|516284073|FG000|Overall Study|Withdrew Consent|1|||
143201960|NCT02639338|516284074|FG001|Overall Study|Withdrew Consent|2|||
143201961|NCT02639338|516284073|FG000|Overall Study|Death|1|||
143201962|NCT02639338|516284074|FG001|Overall Study|Death|0|||
143201963|NCT02639338|516284073|FG000|Overall Study|Randomized but Not Treated|0|||
143201964|NCT02639338|516284074|FG001|Overall Study|Randomized but Not Treated|1|||
143201965|NCT04096820|516284075|FG000|Overall Study|Did not return for intervention|2|||
143262524|NCT03206073|516515849|FG003|Overall Study|Death|0|||
143201966|NCT04096820|516284075|FG000|Overall Study|Death|1|||
143201967|NCT00613080|516284079|FG000|Overall Study|Ineligible / no protocol treatment|11|||
143262525|NCT03206073|516515846|FG000|Overall Study|Taken off active treatment|0|||
143201968|NCT04316741|516284080|FG000|Baseline Enrollment|Lost to Follow-up|1|||
143201969|NCT04316741|516284081|FG001|Baseline Enrollment|Lost to Follow-up|1|||
143201970|NCT04316741|516284080|FG000|Immediate Post-Test|Lost to Follow-up|5|||
143201971|NCT04316741|516284081|FG001|Immediate Post-Test|Lost to Follow-up|1|||
143201972|NCT04316741|516284080|FG000|1-month Post-test|Lost to Follow-up|7|||
143201973|NCT04316741|516284081|FG001|1-month Post-test|Lost to Follow-up|2|||
143201974|NCT04316741|516284080|FG000|3-month Follow-up|Lost to Follow-up|10|||
143201975|NCT04316741|516284081|FG001|3-month Follow-up|Lost to Follow-up|2|||
143201976|NCT02726880|516284082|FG000|Overall Study|Withdrawal by Subject|2|||
143201977|NCT02726880|516284083|FG001|Overall Study|Withdrawal by Subject|0|||
143201978|NCT02726880|516284082|FG000|Overall Study|Lost to Follow-up|1|||
143201979|NCT02726880|516284083|FG001|Overall Study|Lost to Follow-up|3|||
143201980|NCT00787202|516284084|FG000|Overall Study|Adverse Event|3|||
143201981|NCT00787202|516284085|FG001|Overall Study|Adverse Event|2|||
143201982|NCT00787202|516284086|FG002|Overall Study|Adverse Event|0|||
143201983|NCT00787202|516284087|FG003|Overall Study|Adverse Event|0|||
143201984|NCT00787202|516284088|FG004|Overall Study|Adverse Event|2|||
143201985|NCT00787202|516284084|FG000|Overall Study|Lack of Efficacy|5|||
143201986|NCT00787202|516284085|FG001|Overall Study|Lack of Efficacy|6|||
143201987|NCT00787202|516284086|FG002|Overall Study|Lack of Efficacy|5|||
143201988|NCT00787202|516284087|FG003|Overall Study|Lack of Efficacy|2|||
143201989|NCT00787202|516284088|FG004|Overall Study|Lack of Efficacy|1|||
143201990|NCT00787202|516284084|FG000|Overall Study|Lost to Follow-up|1|||
143201991|NCT00787202|516284085|FG001|Overall Study|Lost to Follow-up|0|||
143201992|NCT00787202|516284086|FG002|Overall Study|Lost to Follow-up|0|||
143201993|NCT00787202|516284087|FG003|Overall Study|Lost to Follow-up|0|||
143201994|NCT00787202|516284088|FG004|Overall Study|Lost to Follow-up|0|||
143201995|NCT00787202|516284084|FG000|Overall Study|Withdrawal by Subject|2|||
143201996|NCT00787202|516284085|FG001|Overall Study|Withdrawal by Subject|2|||
143201997|NCT00787202|516284086|FG002|Overall Study|Withdrawal by Subject|2|||
143201998|NCT00787202|516284087|FG003|Overall Study|Withdrawal by Subject|0|||
143201999|NCT00787202|516284088|FG004|Overall Study|Withdrawal by Subject|0|||
143202000|NCT00787202|516284084|FG000|Overall Study|Protocol Violation|2|||
143202001|NCT00787202|516284085|FG001|Overall Study|Protocol Violation|1|||
143202002|NCT00787202|516284086|FG002|Overall Study|Protocol Violation|0|||
143202003|NCT00787202|516284087|FG003|Overall Study|Protocol Violation|0|||
143202004|NCT00787202|516284088|FG004|Overall Study|Protocol Violation|1|||
143202005|NCT00787202|516284084|FG000|Overall Study|Randomized, not treated|1|||
143202006|NCT00787202|516284085|FG001|Overall Study|Randomized, not treated|0|||
143202007|NCT00787202|516284086|FG002|Overall Study|Randomized, not treated|0|||
143202008|NCT00787202|516284087|FG003|Overall Study|Randomized, not treated|0|||
143202009|NCT00787202|516284088|FG004|Overall Study|Randomized, not treated|0|||
143202010|NCT01453946|516284089|FG000|Overall Study|Did not receive drug for the taper phase|1|||
143202011|NCT01453946|516284089|FG000|Overall Study|Protocol Violation|2|||
143202012|NCT01453946|516284089|FG000|Overall Study|Lack of Efficacy|3|||
143202013|NCT01453946|516284089|FG000|Overall Study|Adverse Event|3|||
143202014|NCT02153346|516284090|FG000|Overall Study|Lost to Follow-up|11|||
143202015|NCT03697993|516284092|FG000|Overall Study|Became Ineligible after Enrollment|1|||
143202016|NCT03697993|516284093|FG001|Overall Study|Became Ineligible after Enrollment|3|||
143202017|NCT03697993|516284092|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
143202018|NCT03697993|516284093|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
143202019|NCT03697993|516284092|FG000|Overall Study|Lost to Follow-up|3|||
143202020|NCT03697993|516284093|FG001|Overall Study|Lost to Follow-up|0|||
143202021|NCT03697993|516284092|FG000|Overall Study|Physician Decision|4|||
143202022|NCT03697993|516284093|FG001|Overall Study|Physician Decision|0|||
143202023|NCT03697993|516284092|FG000|Overall Study|Initial Urine Culture Negative|0|||
143202024|NCT03697993|516284093|FG001|Overall Study|Initial Urine Culture Negative|1|||
143202025|NCT02366767|516284098|FG000|Overall Study|left for home after 1 day at camp|1|||
143202026|NCT02366767|516284099|FG001|Overall Study|left for home after 1 day at camp|0|||
143202027|NCT02558400|516284102|FG000|Overall Study|Adverse Event|47|||
143202028|NCT02558400|516284103|FG001|Overall Study|Adverse Event|53|||
143202029|NCT02558400|516284104|FG002|Overall Study|Adverse Event|4|||
143202030|NCT02558400|516284102|FG000|Overall Study|Withdrawal by Subject|13|||
143202031|NCT02558400|516284103|FG001|Overall Study|Withdrawal by Subject|9|||
143202032|NCT02558400|516284104|FG002|Overall Study|Withdrawal by Subject|8|||
143262526|NCT03206073|516515847|FG001|Overall Study|Taken off active treatment|0|||
143262527|NCT03206073|516515848|FG002|Overall Study|Taken off active treatment|3|||
143202033|NCT02558400|516284102|FG000|Overall Study|Non-Compliant|0|||
143202034|NCT02558400|516284103|FG001|Overall Study|Non-Compliant|1|||
143202035|NCT02558400|516284104|FG002|Overall Study|Non-Compliant|3|||
143202036|NCT02558400|516284102|FG000|Overall Study|Lost to Follow-up|5|||
143262528|NCT03206073|516515849|FG003|Overall Study|Taken off active treatment|0|||
143202037|NCT02558400|516284103|FG001|Overall Study|Lost to Follow-up|5|||
143202038|NCT02558400|516284104|FG002|Overall Study|Lost to Follow-up|4|||
143202039|NCT02558400|516284102|FG000|Overall Study|Lack of Efficacy|0|||
143202040|NCT02558400|516284103|FG001|Overall Study|Lack of Efficacy|13|||
143202041|NCT02558400|516284104|FG002|Overall Study|Lack of Efficacy|1|||
143202042|NCT02558400|516284102|FG000|Overall Study|Disallowed Concurrent Medication|6|||
143202043|NCT02558400|516284103|FG001|Overall Study|Disallowed Concurrent Medication|7|||
143202044|NCT02558400|516284104|FG002|Overall Study|Disallowed Concurrent Medication|5|||
143202045|NCT02558400|516284102|FG000|Overall Study|Physician Decision|2|||
143202046|NCT02558400|516284103|FG001|Overall Study|Physician Decision|2|||
143202047|NCT02558400|516284104|FG002|Overall Study|Physician Decision|0|||
143202048|NCT02558400|516284102|FG000|Overall Study|Protocol Violation|6|||
143202049|NCT02558400|516284103|FG001|Overall Study|Protocol Violation|3|||
143202050|NCT02558400|516284104|FG002|Overall Study|Protocol Violation|8|||
143202051|NCT02558400|516284102|FG000|Overall Study|Death|0|||
143202052|NCT02558400|516284103|FG001|Overall Study|Death|1|||
143202053|NCT02558400|516284104|FG002|Overall Study|Death|0|||
143202054|NCT02558400|516284102|FG000|Overall Study|Ineligible for the study|0|||
143202055|NCT02558400|516284103|FG001|Overall Study|Ineligible for the study|2|||
143202056|NCT02558400|516284104|FG002|Overall Study|Ineligible for the study|0|||
143202057|NCT00260065|516284105|FG000|Overall Study|Progressive Disease|22|||
143202058|NCT00260065|516284105|FG000|Overall Study|Adverse Event|17|||
143202059|NCT00260065|516284105|FG000|Overall Study|Death|13|||
143202060|NCT00260065|516284105|FG000|Overall Study|Withdrawal by Subject|13|||
143202061|NCT00260065|516284105|FG000|Overall Study|Physician Decision|19|||
143202062|NCT00260065|516284105|FG000|Overall Study|Not otherwise specified|8|||
143202063|NCT00260065|516284105|FG000|Overall Study|Medication Noncompliance|1|||
143202064|NCT03081858|516286445|FG000|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|2|||
143202065|NCT03081858|516286446|FG001|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
143202066|NCT03081858|516286447|FG002|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
143202067|NCT03081858|516286448|FG003|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
143202068|NCT02191605|516286449|FG000|Overall Study|Lost to Follow-up|9|||
143202069|NCT02191605|516286450|FG001|Overall Study|Lost to Follow-up|4|||
143202070|NCT02191605|516286451|FG002|Overall Study|Lost to Follow-up|7|||
143202071|NCT02191605|516286452|FG003|Overall Study|Lost to Follow-up|3|||
143202072|NCT02191605|516286453|FG004|Overall Study|Lost to Follow-up|4|||
143202073|NCT00734071|516286454|FG000|Overall Study|Adverse Event|4|||
143202074|NCT00734071|516286455|FG001|Overall Study|Adverse Event|3|||
143202075|NCT00734071|516286454|FG000|Overall Study|Lack of Efficacy|3|||
143202076|NCT00734071|516286455|FG001|Overall Study|Lack of Efficacy|1|||
143202077|NCT00734071|516286454|FG000|Overall Study|Noncompliance|2|||
143202078|NCT00734071|516286455|FG001|Overall Study|Noncompliance|2|||
143202079|NCT00734071|516286454|FG000|Overall Study|Protocol Deviations|3|||
143202080|NCT00734071|516286455|FG001|Overall Study|Protocol Deviations|4|||
143202081|NCT00734071|516286454|FG000|Overall Study|Voluntary Withdrawal|9|||
143202082|NCT00734071|516286455|FG001|Overall Study|Voluntary Withdrawal|7|||
143202083|NCT00734071|516286454|FG000|Overall Study|Lost to Follow-up|16|||
143202084|NCT00734071|516286455|FG001|Overall Study|Lost to Follow-up|8|||
143202085|NCT00734071|516286454|FG000|Overall Study|Other|1|||
143202086|NCT00734071|516286455|FG001|Overall Study|Other|2|||
143202087|NCT01062061|516286456|FG000|Overall Study|Enrolled more than once|2|||
143202088|NCT01062061|516286456|FG000|Overall Study|Investigated before study start|13|||
143202089|NCT01062061|516286456|FG000|Overall Study|Outside chief indications|10|||
143202090|NCT01062061|516286456|FG000|Overall Study|Failed to meet inclusion criteria|2|||
143202091|NCT01145053|516286457|FG000|Overall Study|Adverse Event|22|||
143202092|NCT01145053|516286457|FG000|Overall Study|Lost to Follow-up|28|||
143202093|NCT01145053|516286457|FG000|Overall Study|Withdrawal by Subject|25|||
143202094|NCT01145053|516286457|FG000|Overall Study|Other|18|||
143202095|NCT03684304|516286458|FG000|Overall Study|Lost to Follow-up|19|||
143202096|NCT03684304|516286459|FG001|Overall Study|Lost to Follow-up|17|||
143202097|NCT02813668|516286460|FG000|Overall Study|Death|4|||
143202098|NCT02813668|516286460|FG000|Overall Study|Lost to Follow-up|509|||
143202099|NCT02813668|516286460|FG000|Overall Study|Withdrawal by Subject|148|||
143202100|NCT02813668|516286460|FG000|Overall Study|No longer at worksite|85|||
143202101|NCT02813668|516286460|FG000|Overall Study|Medical reasons not related to the study|4|||
143202102|NCT00598078|516286465|FG000|Period 2 (Day 2)|Adverse Event|1|||
143202103|NCT00598078|516286466|FG001|Period 2 (Day 2)|Adverse Event|0|||
143202104|NCT01036529|516286467|FG000|Overall Study|Adverse Event|0|||
143202105|NCT01036529|516286468|FG001|Overall Study|Adverse Event|1|||
143202106|NCT01036529|516286467|FG000|Overall Study|Lost to Follow-up|0|||
143202107|NCT01036529|516286468|FG001|Overall Study|Lost to Follow-up|1|||
143202108|NCT01036529|516286467|FG000|Overall Study|Physician Decision|1|||
143202109|NCT01036529|516286468|FG001|Overall Study|Physician Decision|0|||
143202110|NCT01036529|516286467|FG000|Overall Study|Withdrawal by Subject|1|||
143202111|NCT01036529|516286468|FG001|Overall Study|Withdrawal by Subject|1|||
143202112|NCT01036529|516286467|FG000|Overall Study|Sponsor study termination|11|||
143202113|NCT01036529|516286468|FG001|Overall Study|Sponsor study termination|12|||
143202114|NCT02120365|516286475|FG000|Overall Study|Withdrawal by Subject|0|||
143202115|NCT02120365|516286476|FG001|Overall Study|Withdrawal by Subject|0|||
143202116|NCT02120365|516286477|FG002|Overall Study|Withdrawal by Subject|2|||
143202117|NCT02120365|516286478|FG003|Overall Study|Withdrawal by Subject|4|||
143202118|NCT02120365|516286479|FG004|Overall Study|Withdrawal by Subject|0|||
143202119|NCT02120365|516286480|FG005|Overall Study|Withdrawal by Subject|2|||
143202120|NCT00343915|516286481|FG000|Primary Study|Withdrawal by Subject|1|||
143202121|NCT00343915|516286482|FG001|Primary Study|Withdrawal by Subject|0|||
143202122|NCT00343915|516286481|FG000|Primary Study|Lost to Follow-up|2|||
143202123|NCT00343915|516286482|FG001|Primary Study|Lost to Follow-up|3|||
143202124|NCT00343915|516286481|FG000|Primary Study|Other|1|||
143202125|NCT00343915|516286482|FG001|Primary Study|Other|0|||
143202126|NCT01719003|516286488|FG000|Overall Study|Non compliant with protocol|1|||
143202127|NCT01719003|516286489|FG001|Overall Study|Non compliant with protocol|1|||
143202128|NCT01719003|516286490|FG002|Overall Study|Non compliant with protocol|0|||
143202129|NCT01719003|516286491|FG003|Overall Study|Non compliant with protocol|1|||
143202130|NCT01719003|516286492|FG004|Overall Study|Non compliant with protocol|2|||
143202131|NCT01719003|516286493|FG005|Overall Study|Non compliant with protocol|1|||
143202132|NCT01719003|516286494|FG006|Overall Study|Non compliant with protocol|2|||
143202133|NCT01719003|516286495|FG007|Overall Study|Non compliant with protocol|3|||
143202134|NCT01719003|516286496|FG008|Overall Study|Non compliant with protocol|0|||
143202135|NCT01719003|516286488|FG000|Overall Study|Adverse Event|6|||
143202136|NCT01719003|516286489|FG001|Overall Study|Adverse Event|5|||
143202137|NCT01719003|516286490|FG002|Overall Study|Adverse Event|4|||
143202138|NCT01719003|516286491|FG003|Overall Study|Adverse Event|3|||
143262529|NCT03332771|516515850|FG000|Overall Study|Adverse Event|6|||
143262530|NCT03332771|516515851|FG001|Overall Study|Adverse Event|4|||
143262531|NCT03332771|516515852|FG002|Overall Study|Adverse Event|1|||
143262532|NCT03332771|516515853|FG003|Overall Study|Adverse Event|3|||
143262533|NCT03332771|516515850|FG000|Overall Study|Poor Compliance to Protocol|0|||
143262534|NCT03332771|516515851|FG001|Overall Study|Poor Compliance to Protocol|1|||
143262535|NCT03332771|516515852|FG002|Overall Study|Poor Compliance to Protocol|0|||
143262536|NCT03332771|516515853|FG003|Overall Study|Poor Compliance to Protocol|1|||
143262537|NCT03332771|516515850|FG000|Overall Study|Lost to Follow-up|2|||
143262538|NCT03332771|516515851|FG001|Overall Study|Lost to Follow-up|2|||
143262539|NCT03332771|516515852|FG002|Overall Study|Lost to Follow-up|1|||
143262540|NCT03332771|516515853|FG003|Overall Study|Lost to Follow-up|2|||
143262541|NCT03332771|516515850|FG000|Overall Study|At the Participant's own request|20|||
143262542|NCT03332771|516515851|FG001|Overall Study|At the Participant's own request|26|||
143262543|NCT03332771|516515852|FG002|Overall Study|At the Participant's own request|14|||
143262544|NCT03332771|516515853|FG003|Overall Study|At the Participant's own request|23|||
143202139|NCT01719003|516286492|FG004|Overall Study|Adverse Event|4|||
143202140|NCT01719003|516286493|FG005|Overall Study|Adverse Event|3|||
143202141|NCT01719003|516286494|FG006|Overall Study|Adverse Event|6|||
143202142|NCT01719003|516286495|FG007|Overall Study|Adverse Event|5|||
143202143|NCT01719003|516286496|FG008|Overall Study|Adverse Event|0|||
143202144|NCT01719003|516286488|FG000|Overall Study|Lost to Follow-up|0|||
143202145|NCT01719003|516286489|FG001|Overall Study|Lost to Follow-up|6|||
143202146|NCT01719003|516286490|FG002|Overall Study|Lost to Follow-up|7|||
143202147|NCT01719003|516286491|FG003|Overall Study|Lost to Follow-up|2|||
143202148|NCT01719003|516286492|FG004|Overall Study|Lost to Follow-up|3|||
143202149|NCT01719003|516286493|FG005|Overall Study|Lost to Follow-up|4|||
143202150|NCT01719003|516286494|FG006|Overall Study|Lost to Follow-up|3|||
143202151|NCT01719003|516286495|FG007|Overall Study|Lost to Follow-up|2|||
143202152|NCT01719003|516286496|FG008|Overall Study|Lost to Follow-up|2|||
143202153|NCT01719003|516286488|FG000|Overall Study|Refusal to continue, not due to AE|2|||
143202154|NCT01719003|516286489|FG001|Overall Study|Refusal to continue, not due to AE|5|||
143202155|NCT01719003|516286490|FG002|Overall Study|Refusal to continue, not due to AE|4|||
143262545|NCT03332771|516515850|FG000|Overall Study|Reason Not Specified|6|||
143262546|NCT03332771|516515851|FG001|Overall Study|Reason Not Specified|18|||
143262547|NCT03332771|516515852|FG002|Overall Study|Reason Not Specified|16|||
143262548|NCT03332771|516515853|FG003|Overall Study|Reason Not Specified|19|||
143202156|NCT01719003|516286491|FG003|Overall Study|Refusal to continue, not due to AE|4|||
143202157|NCT01719003|516286492|FG004|Overall Study|Refusal to continue, not due to AE|4|||
143262549|NCT01711879|516515859|FG000|Overall Study|Death|1|||
143262550|NCT01711879|516515860|FG001|Overall Study|Death|0|||
143202158|NCT01719003|516286493|FG005|Overall Study|Refusal to continue, not due to AE|3|||
143202159|NCT01719003|516286494|FG006|Overall Study|Refusal to continue, not due to AE|8|||
143202160|NCT01719003|516286495|FG007|Overall Study|Refusal to continue, not due to AE|7|||
143202161|NCT01719003|516286496|FG008|Overall Study|Refusal to continue, not due to AE|1|||
143202162|NCT01719003|516286488|FG000|Overall Study|Reason other than those specified|0|||
143202163|NCT01719003|516286489|FG001|Overall Study|Reason other than those specified|0|||
143202164|NCT01719003|516286490|FG002|Overall Study|Reason other than those specified|2|||
143202165|NCT01719003|516286491|FG003|Overall Study|Reason other than those specified|3|||
143202166|NCT01719003|516286492|FG004|Overall Study|Reason other than those specified|4|||
143202167|NCT01719003|516286493|FG005|Overall Study|Reason other than those specified|1|||
143202168|NCT01719003|516286494|FG006|Overall Study|Reason other than those specified|0|||
143202169|NCT01719003|516286495|FG007|Overall Study|Reason other than those specified|3|||
143202170|NCT01719003|516286496|FG008|Overall Study|Reason other than those specified|1|||
143202171|NCT01719003|516286488|FG000|Overall Study|Lack of Efficacy|0|||
143202172|NCT01719003|516286489|FG001|Overall Study|Lack of Efficacy|0|||
143202173|NCT01719003|516286490|FG002|Overall Study|Lack of Efficacy|0|||
143202174|NCT01719003|516286491|FG003|Overall Study|Lack of Efficacy|0|||
143202175|NCT01719003|516286492|FG004|Overall Study|Lack of Efficacy|0|||
143202176|NCT01719003|516286493|FG005|Overall Study|Lack of Efficacy|0|||
143202177|NCT01719003|516286494|FG006|Overall Study|Lack of Efficacy|1|||
143202178|NCT01719003|516286495|FG007|Overall Study|Lack of Efficacy|0|||
143202179|NCT01719003|516286496|FG008|Overall Study|Lack of Efficacy|0|||
143202180|NCT00882908|516286497|FG000|Overall Study|Adverse Event|0|||
143202181|NCT00882908|516286498|FG001|Overall Study|Adverse Event|0|||
143202182|NCT00882908|516286499|FG002|Overall Study|Adverse Event|1|||
143202183|NCT00882908|516286500|FG003|Overall Study|Adverse Event|0|||
143202184|NCT00882908|516286501|FG004|Overall Study|Adverse Event|1|||
143202185|NCT00882908|516286497|FG000|Overall Study|Lost to Follow-up|3|||
143202186|NCT00882908|516286498|FG001|Overall Study|Lost to Follow-up|5|||
143202187|NCT00882908|516286499|FG002|Overall Study|Lost to Follow-up|3|||
143202188|NCT00882908|516286500|FG003|Overall Study|Lost to Follow-up|1|||
143202189|NCT00882908|516286501|FG004|Overall Study|Lost to Follow-up|2|||
143202190|NCT00882908|516286497|FG000|Overall Study|Protocol Violation|0|||
143202191|NCT00882908|516286498|FG001|Overall Study|Protocol Violation|1|||
143202192|NCT00882908|516286499|FG002|Overall Study|Protocol Violation|0|||
143202193|NCT00882908|516286500|FG003|Overall Study|Protocol Violation|0|||
143202194|NCT00882908|516286501|FG004|Overall Study|Protocol Violation|0|||
143202195|NCT00882908|516286497|FG000|Overall Study|Withdrawal by Subject|0|||
143202196|NCT00882908|516286498|FG001|Overall Study|Withdrawal by Subject|0|||
143202197|NCT00882908|516286499|FG002|Overall Study|Withdrawal by Subject|3|||
143202198|NCT00882908|516286500|FG003|Overall Study|Withdrawal by Subject|5|||
143202199|NCT00882908|516286501|FG004|Overall Study|Withdrawal by Subject|2|||
143202200|NCT00882908|516286497|FG000|Overall Study|Subject reached a virologic endpoint|0|||
143202201|NCT00882908|516286498|FG001|Overall Study|Subject reached a virologic endpoint|0|||
143202202|NCT00882908|516286499|FG002|Overall Study|Subject reached a virologic endpoint|0|||
143202203|NCT00882908|516286500|FG003|Overall Study|Subject reached a virologic endpoint|0|||
143202204|NCT00882908|516286501|FG004|Overall Study|Subject reached a virologic endpoint|1|||
143202205|NCT00882908|516286497|FG000|Overall Study|Study terminated in error|0|||
143202206|NCT00882908|516286498|FG001|Overall Study|Study terminated in error|0|||
143202207|NCT00882908|516286499|FG002|Overall Study|Study terminated in error|0|||
143202208|NCT00882908|516286500|FG003|Overall Study|Study terminated in error|1|||
143202209|NCT00882908|516286501|FG004|Overall Study|Study terminated in error|0|||
143202210|NCT01344629|516286503|FG000|Crossover Period 2|Withdrawal by Subject|0|||
143202211|NCT01344629|516286504|FG001|Crossover Period 2|Withdrawal by Subject|1|||
143202212|NCT00900146|516286505|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
143202213|NCT00900146|516286506|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
143202214|NCT00900146|516286507|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
143202215|NCT00900146|516286508|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
143202216|NCT00900146|516286509|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
143202217|NCT00900146|516286505|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
143202218|NCT00900146|516286506|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
143202219|NCT00900146|516286507|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
143202220|NCT00900146|516286508|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
143202221|NCT00900146|516286509|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
143202222|NCT00900146|516286505|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
143202223|NCT00900146|516286506|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
143202224|NCT00900146|516286507|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
143202225|NCT00900146|516286508|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
143202226|NCT00900146|516286509|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
143202227|NCT00900146|516286505|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
143202228|NCT00900146|516286506|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
143202229|NCT00900146|516286507|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
143202230|NCT00900146|516286508|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
143202231|NCT00900146|516286509|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
143202232|NCT00900146|516286505|FG000|Intermediate: Period III|Lost to Follow-up|2|||
143202233|NCT00900146|516286506|FG001|Intermediate: Period III|Lost to Follow-up|0|||
143202234|NCT00900146|516286507|FG002|Intermediate: Period III|Lost to Follow-up|0|||
143202235|NCT00900146|516286508|FG003|Intermediate: Period III|Lost to Follow-up|0|||
143202236|NCT00900146|516286509|FG004|Intermediate: Period III|Lost to Follow-up|1|||
143202237|NCT00900146|516286505|FG000|Intermediate: Period III|Administrative problems|85|||
143202238|NCT00900146|516286506|FG001|Intermediate: Period III|Administrative problems|92|||
143202239|NCT00900146|516286507|FG002|Intermediate: Period III|Administrative problems|84|||
143202240|NCT00900146|516286508|FG003|Intermediate: Period III|Administrative problems|90|||
143202241|NCT00900146|516286509|FG004|Intermediate: Period III|Administrative problems|163|||
143202242|NCT00700102|516286510|FG000|Overall Study|Died|394|||
143202243|NCT00700102|516286511|FG001|Overall Study|Died|385|||
143202244|NCT00700102|516286510|FG000|Overall Study|Lost to Follow-up|8|||
143202245|NCT00700102|516286511|FG001|Overall Study|Lost to Follow-up|10|||
143202246|NCT02525939|516286516|FG000|Overall Study|Lost to Follow-up|27|||
143202247|NCT02525939|516286517|FG001|Overall Study|Lost to Follow-up|24|||
143202248|NCT02525939|516286516|FG000|Overall Study|Physician Decision|0|||
143202249|NCT02525939|516286517|FG001|Overall Study|Physician Decision|1|||
143202250|NCT02525939|516286516|FG000|Overall Study|Withdrawal by Subject|24|||
143202251|NCT02525939|516286517|FG001|Overall Study|Withdrawal by Subject|39|||
143202252|NCT02525939|516286516|FG000|Overall Study|Death|180|||
143202253|NCT02525939|516286517|FG001|Overall Study|Death|179|||
143202254|NCT01635764|516286518|FG000|Overall Study|Adverse Event|46|||
143202255|NCT01635764|516286518|FG000|Overall Study|Lack of Efficacy|76|||
143202256|NCT01635764|516286518|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
143202257|NCT01635764|516286518|FG000|Overall Study|Protocol Deviation|1|||
143202258|NCT01635764|516286518|FG000|Overall Study|Withdrew Consent|67|||
143202259|NCT01635764|516286518|FG000|Overall Study|Lost to Follow-up|53|||
143202260|NCT01635764|516286518|FG000|Overall Study|Other|28|||
143202261|NCT01174004|516286519|FG000|Overall Study|Adverse Event|2|||
143202262|NCT01174004|516286520|FG001|Overall Study|Adverse Event|10|||
143202263|NCT01174004|516286519|FG000|Overall Study|Withdrawal by Subject|2|||
143202264|NCT01174004|516286520|FG001|Overall Study|Withdrawal by Subject|3|||
143202265|NCT01174004|516286519|FG000|Overall Study|At Discretion of Sponsor|2|||
143202266|NCT01174004|516286520|FG001|Overall Study|At Discretion of Sponsor|2|||
143202267|NCT01174004|516286519|FG000|Overall Study|Protocol Violation|0|||
143202268|NCT01174004|516286520|FG001|Overall Study|Protocol Violation|1|||
143202269|NCT01174004|516286519|FG000|Overall Study|Physician Decision|1|||
143202270|NCT01174004|516286520|FG001|Overall Study|Physician Decision|0|||
143202271|NCT00933244|516286521|FG000|Overall Study|Withdrawal by Subject|5|||
143202272|NCT00933244|516286522|FG001|Overall Study|Withdrawal by Subject|1|||
143202273|NCT00933244|516286523|FG002|Overall Study|Withdrawal by Subject|3|||
143202274|NCT02266875|516286525|FG000|Overall Study|Withdrawal by Subject|9|||
143202275|NCT02266875|516286526|FG001|Overall Study|Withdrawal by Subject|0|||
143202276|NCT02266875|516286525|FG000|Overall Study|Lost to Follow-up|2|||
143202277|NCT02266875|516286526|FG001|Overall Study|Lost to Follow-up|0|||
143202278|NCT02956850|516286528|FG000|Overall Study|Withdrawal by Subject|0|||
143202279|NCT02956850|516286529|FG001|Overall Study|Withdrawal by Subject|0|||
143202280|NCT02956850|516286530|FG002|Overall Study|Withdrawal by Subject|0|||
143202281|NCT02956850|516286531|FG003|Overall Study|Withdrawal by Subject|0|||
143202282|NCT02956850|516286532|FG004|Overall Study|Withdrawal by Subject|0|||
143202283|NCT02956850|516286533|FG005|Overall Study|Withdrawal by Subject|0|||
143202284|NCT02956850|516286534|FG006|Overall Study|Withdrawal by Subject|0|||
143202285|NCT02956850|516286535|FG007|Overall Study|Withdrawal by Subject|0|||
143202286|NCT02956850|516286536|FG008|Overall Study|Withdrawal by Subject|0|||
143202287|NCT02956850|516286537|FG009|Overall Study|Withdrawal by Subject|0|||
143202288|NCT02956850|516286538|FG010|Overall Study|Withdrawal by Subject|0|||
143202289|NCT02956850|516286539|FG011|Overall Study|Withdrawal by Subject|0|||
143202290|NCT02956850|516286540|FG012|Overall Study|Withdrawal by Subject|0|||
143202291|NCT02956850|516286541|FG013|Overall Study|Withdrawal by Subject|0|||
143202292|NCT02956850|516286542|FG014|Overall Study|Withdrawal by Subject|0|||
143202293|NCT02956850|516286543|FG015|Overall Study|Withdrawal by Subject|0|||
143202294|NCT02956850|516286544|FG016|Overall Study|Withdrawal by Subject|0|||
143202295|NCT02956850|516286545|FG017|Overall Study|Withdrawal by Subject|1|||
143202296|NCT01920152|516286548|FG000|Overall Study|Withdrawal by Subject|1|||
143262551|NCT00737464|516515868|FG000|Overall Study|Adverse Event|1|||
143262552|NCT00737464|516515868|FG000|Overall Study|Death|6|||
143202297|NCT01920152|516286549|FG001|Overall Study|Withdrawal by Subject|2|||
143202298|NCT01304329|516286550|FG000|Third Intervention (3 Days)|Adverse Event|0|||
143202299|NCT01304329|516286551|FG001|Third Intervention (3 Days)|Adverse Event|1|||
143202300|NCT01304329|516286552|FG002|Third Intervention (3 Days)|Adverse Event|0|||
143202301|NCT01304329|516286553|FG003|Third Intervention (3 Days)|Adverse Event|0|||
143202302|NCT01304329|516286554|FG004|Third Intervention (3 Days)|Adverse Event|0|||
143262553|NCT00737464|516515868|FG000|Overall Study|Other - Failure to Return|1|||
143202303|NCT01304329|516286555|FG005|Third Intervention (3 Days)|Adverse Event|0|||
143202304|NCT00276094|516286556|FG000|Overall Study|Adverse Event|15|||
143202305|NCT00276094|516286557|FG001|Overall Study|Adverse Event|13|||
143202306|NCT00276094|516286558|FG002|Overall Study|Adverse Event|11|||
143202307|NCT00276094|516286556|FG000|Overall Study|Withdrawal by Subject|14|||
143202308|NCT00276094|516286557|FG001|Overall Study|Withdrawal by Subject|14|||
143202309|NCT00276094|516286558|FG002|Overall Study|Withdrawal by Subject|12|||
143202310|NCT00276094|516286556|FG000|Overall Study|Protocol Violation|16|||
143202311|NCT00276094|516286557|FG001|Overall Study|Protocol Violation|7|||
143202312|NCT00276094|516286558|FG002|Overall Study|Protocol Violation|10|||
143202313|NCT00276094|516286556|FG000|Overall Study|Lost to Follow-up|8|||
143202314|NCT00276094|516286557|FG001|Overall Study|Lost to Follow-up|6|||
143202315|NCT00276094|516286558|FG002|Overall Study|Lost to Follow-up|4|||
143202316|NCT00276094|516286556|FG000|Overall Study|Other-Subject moved out of country|1|||
143202317|NCT00276094|516286557|FG001|Overall Study|Other-Subject moved out of country|0|||
143202318|NCT00276094|516286558|FG002|Overall Study|Other-Subject moved out of country|0|||
143202319|NCT00276094|516286556|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
143202320|NCT00276094|516286557|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
143202321|NCT00276094|516286558|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
143202322|NCT00276094|516286556|FG000|Overall Study|Other-Lack of efficacy|1|||
143202323|NCT00276094|516286557|FG001|Overall Study|Other-Lack of efficacy|0|||
143202324|NCT00276094|516286558|FG002|Overall Study|Other-Lack of efficacy|0|||
143202325|NCT00276094|516286556|FG000|Overall Study|Other-Refused follow-up visit|1|||
143202326|NCT00276094|516286557|FG001|Overall Study|Other-Refused follow-up visit|0|||
143202327|NCT00276094|516286558|FG002|Overall Study|Other-Refused follow-up visit|0|||
143202328|NCT00276094|516286556|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
143202329|NCT00276094|516286557|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
143202330|NCT00276094|516286558|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
143202331|NCT00276094|516286556|FG000|Overall Study|Other-Relocation|0|||
143202332|NCT00276094|516286557|FG001|Overall Study|Other-Relocation|1|||
143202333|NCT00276094|516286558|FG002|Overall Study|Other-Relocation|0|||
143202334|NCT00276094|516286556|FG000|Overall Study|Other-Study medication lost|0|||
143202335|NCT00276094|516286557|FG001|Overall Study|Other-Study medication lost|0|||
143202336|NCT00276094|516286558|FG002|Overall Study|Other-Study medication lost|1|||
143202337|NCT02759315|516286559|FG000|Overall Study|Adverse Event|0|||
143202338|NCT02759315|516286560|FG001|Overall Study|Adverse Event|0|||
143202339|NCT02759315|516286561|FG002|Overall Study|Adverse Event|0|||
143202340|NCT02759315|516286562|FG003|Overall Study|Adverse Event|1|||
143202341|NCT02759315|516286563|FG004|Overall Study|Adverse Event|0|||
143202342|NCT02759315|516286559|FG000|Overall Study|Death|0|||
143202343|NCT02759315|516286560|FG001|Overall Study|Death|0|||
143202344|NCT02759315|516286561|FG002|Overall Study|Death|1|||
143202345|NCT02759315|516286562|FG003|Overall Study|Death|0|||
143202346|NCT02759315|516286563|FG004|Overall Study|Death|0|||
143202347|NCT02759315|516286559|FG000|Overall Study|Lost to Follow-up|2|||
143202348|NCT02759315|516286560|FG001|Overall Study|Lost to Follow-up|0|||
143202349|NCT02759315|516286561|FG002|Overall Study|Lost to Follow-up|4|||
143202350|NCT02759315|516286562|FG003|Overall Study|Lost to Follow-up|0|||
143202351|NCT02759315|516286563|FG004|Overall Study|Lost to Follow-up|0|||
143202352|NCT02759315|516286559|FG000|Overall Study|Protocol Violation|0|||
143202353|NCT02759315|516286560|FG001|Overall Study|Protocol Violation|1|||
143202354|NCT02759315|516286561|FG002|Overall Study|Protocol Violation|0|||
143202355|NCT02759315|516286562|FG003|Overall Study|Protocol Violation|0|||
143202356|NCT02759315|516286563|FG004|Overall Study|Protocol Violation|0|||
143202357|NCT02759315|516286559|FG000|Overall Study|Study terminated prior to completion|2|||
143202358|NCT02759315|516286560|FG001|Overall Study|Study terminated prior to completion|0|||
143202359|NCT02759315|516286561|FG002|Overall Study|Study terminated prior to completion|5|||
143202360|NCT02759315|516286562|FG003|Overall Study|Study terminated prior to completion|0|||
143202361|NCT02759315|516286563|FG004|Overall Study|Study terminated prior to completion|1|||
143202362|NCT00554099|516286568|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
143202363|NCT00554099|516286569|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
143202364|NCT00554099|516286570|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
143202365|NCT00554099|516286568|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
143202366|NCT00554099|516286569|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
143202367|NCT00554099|516286570|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
143202368|NCT00554099|516286568|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
143202369|NCT00554099|516286569|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
143202370|NCT00554099|516286570|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
143202371|NCT00554099|516286568|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
143202372|NCT00554099|516286569|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
143202373|NCT00554099|516286570|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
143202374|NCT00554099|516286568|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
143202375|NCT00554099|516286569|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
143202376|NCT00554099|516286570|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
143202377|NCT00554099|516286568|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
143202378|NCT00554099|516286569|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
143202379|NCT00554099|516286570|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
143202380|NCT00554099|516286568|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
143202381|NCT00554099|516286569|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
143202382|NCT00554099|516286570|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
143202383|NCT00554099|516286568|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
143202384|NCT00554099|516286569|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
143202385|NCT00554099|516286570|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
143202386|NCT00554099|516286568|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
143202387|NCT00554099|516286569|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
143202388|NCT00554099|516286570|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
143202389|NCT02075632|516286571|FG000|Overall Study|Adverse Event|1|||
143202390|NCT02075632|516286572|FG001|Overall Study|Adverse Event|1|||
143202391|NCT02075632|516286571|FG000|Overall Study|Lost to Follow-up|0|||
143202392|NCT02075632|516286572|FG001|Overall Study|Lost to Follow-up|3|||
143202393|NCT02075632|516286571|FG000|Overall Study|Withdrawal by Subject|0|||
143202394|NCT02075632|516286572|FG001|Overall Study|Withdrawal by Subject|1|||
143202395|NCT03353922|516286577|FG000|Overall Study|Withdrawal by Subject|1|||
143202396|NCT03353922|516286578|FG001|Overall Study|Withdrawal by Subject|0|||
143202397|NCT03353922|516286579|FG002|Overall Study|Withdrawal by Subject|1|||
143202398|NCT03353922|516286580|FG003|Overall Study|Withdrawal by Subject|1|||
143202399|NCT03353922|516286581|FG004|Overall Study|Withdrawal by Subject|0|||
143202400|NCT03353922|516286582|FG005|Overall Study|Withdrawal by Subject|0|||
143202401|NCT03353922|516286577|FG000|Overall Study|Adverse Event|0|||
143202402|NCT03353922|516286578|FG001|Overall Study|Adverse Event|1|||
143202403|NCT03353922|516286579|FG002|Overall Study|Adverse Event|0|||
143202404|NCT03353922|516286580|FG003|Overall Study|Adverse Event|0|||
143202405|NCT03353922|516286581|FG004|Overall Study|Adverse Event|0|||
143202406|NCT03353922|516286582|FG005|Overall Study|Adverse Event|0|||
143202407|NCT00740714|516286583|FG000|Overall Study|Withdrawal by Subject|17|||
143202408|NCT00740714|516286584|FG001|Overall Study|Withdrawal by Subject|19|||
143202409|NCT00740714|516286585|FG002|Overall Study|Withdrawal by Subject|29|||
143202410|NCT00886119|516286586|FG000|Period 1|Did not meet inclusion criteria|1|||
143202411|NCT00886119|516286587|FG001|Period 1|Did not meet inclusion criteria|0|||
143202412|NCT00394901|516286588|FG000|Baseline Phase|Protocol Violation|0|||
143202413|NCT00394901|516286589|FG001|Baseline Phase|Protocol Violation|0|||
143202414|NCT00394901|516286590|FG002|Baseline Phase|Protocol Violation|1|||
143202415|NCT00394901|516286591|FG003|Baseline Phase|Protocol Violation|0|||
143202416|NCT00394901|516286588|FG000|Double-blind Phase|Adverse Event|5|||
143202417|NCT00394901|516286589|FG001|Double-blind Phase|Adverse Event|7|||
143202418|NCT00394901|516286590|FG002|Double-blind Phase|Adverse Event|16|||
143202419|NCT00394901|516286591|FG003|Double-blind Phase|Adverse Event|20|||
143202420|NCT00394901|516286588|FG000|Double-blind Phase|Lack of Efficacy|6|||
143202421|NCT00394901|516286589|FG001|Double-blind Phase|Lack of Efficacy|4|||
143202422|NCT00394901|516286590|FG002|Double-blind Phase|Lack of Efficacy|1|||
143202423|NCT00394901|516286591|FG003|Double-blind Phase|Lack of Efficacy|3|||
143202424|NCT00394901|516286588|FG000|Double-blind Phase|Withdrawal by Subject|2|||
143202425|NCT00394901|516286589|FG001|Double-blind Phase|Withdrawal by Subject|0|||
143202426|NCT00394901|516286590|FG002|Double-blind Phase|Withdrawal by Subject|0|||
143202427|NCT00394901|516286591|FG003|Double-blind Phase|Withdrawal by Subject|0|||
143202428|NCT00394901|516286588|FG000|Double-blind Phase|Lost to Follow-up|0|||
143202429|NCT00394901|516286589|FG001|Double-blind Phase|Lost to Follow-up|0|||
143202430|NCT00394901|516286590|FG002|Double-blind Phase|Lost to Follow-up|0|||
143202431|NCT00394901|516286591|FG003|Double-blind Phase|Lost to Follow-up|1|||
143202432|NCT00394901|516286588|FG000|Double-blind Phase|Protocol Violation|0|||
143202433|NCT00394901|516286589|FG001|Double-blind Phase|Protocol Violation|0|||
143202434|NCT00394901|516286590|FG002|Double-blind Phase|Protocol Violation|0|||
143202435|NCT00394901|516286591|FG003|Double-blind Phase|Protocol Violation|1|||
143202436|NCT00394901|516286588|FG000|Double-blind Phase|Death|1|||
143202437|NCT00394901|516286589|FG001|Double-blind Phase|Death|0|||
143202438|NCT00394901|516286590|FG002|Double-blind Phase|Death|0|||
143202439|NCT00394901|516286591|FG003|Double-blind Phase|Death|0|||
143202440|NCT00394901|516286588|FG000|Double-blind Phase|Subject's Personal Reason|1|||
143202441|NCT00394901|516286589|FG001|Double-blind Phase|Subject's Personal Reason|0|||
143202442|NCT00394901|516286590|FG002|Double-blind Phase|Subject's Personal Reason|0|||
143202443|NCT00394901|516286591|FG003|Double-blind Phase|Subject's Personal Reason|1|||
143202444|NCT00394901|516286588|FG000|Double-blind Phase|Lack of Compliance|0|||
143202445|NCT00394901|516286589|FG001|Double-blind Phase|Lack of Compliance|3|||
143202446|NCT00394901|516286590|FG002|Double-blind Phase|Lack of Compliance|0|||
143202447|NCT00394901|516286591|FG003|Double-blind Phase|Lack of Compliance|0|||
143202448|NCT00394901|516286588|FG000|Double-blind Phase|Entry into another study was found|0|||
143370094|NCT01897233|516899068|FG000|Part B (24 Weeks)|Physician Decision|1|||
143370095|NCT00628862|516899069|FG000|Overall Study|Adverse Event|6|||
143370096|NCT00628862|516899070|FG001|Overall Study|Adverse Event|8|||
143370097|NCT00628862|516899071|FG002|Overall Study|Adverse Event|10|||
143370098|NCT00628862|516899069|FG000|Overall Study|Withdrawal by Subject|4|||
143370099|NCT00628862|516899070|FG001|Overall Study|Withdrawal by Subject|6|||
143370100|NCT00628862|516899071|FG002|Overall Study|Withdrawal by Subject|11|||
143370101|NCT00628862|516899069|FG000|Overall Study|Lost to Follow-up|0|||
143370102|NCT00628862|516899070|FG001|Overall Study|Lost to Follow-up|2|||
143370103|NCT00628862|516899071|FG002|Overall Study|Lost to Follow-up|1|||
143370104|NCT00628862|516899069|FG000|Overall Study|Protocol Violation|1|||
143202449|NCT00394901|516286589|FG001|Double-blind Phase|Entry into another study was found|0|||
143202450|NCT00394901|516286590|FG002|Double-blind Phase|Entry into another study was found|1|||
143202451|NCT00394901|516286591|FG003|Double-blind Phase|Entry into another study was found|0|||
143202452|NCT00394901|516286588|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
143202453|NCT00394901|516286589|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
143202454|NCT00394901|516286590|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
143202455|NCT00394901|516286591|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
143202456|NCT03002623|516286592|FG000|Overall Study|Lost to Follow-up|1|||
143202457|NCT03002623|516286593|FG001|Overall Study|Lost to Follow-up|0|||
143202458|NCT03002623|516286592|FG000|Overall Study|Physician Decision|1|||
143202459|NCT03002623|516286593|FG001|Overall Study|Physician Decision|1|||
143202460|NCT02256267|516286594|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
143202461|NCT02256267|516286594|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
143202462|NCT01352741|516286598|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
143202463|NCT01352741|516286599|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
143202464|NCT01352741|516286598|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
143202465|NCT01352741|516286599|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
143202466|NCT01352741|516286598|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
143202467|NCT01352741|516286599|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
143202468|NCT01352741|516286598|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
143202469|NCT01352741|516286599|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
143202470|NCT01352741|516286598|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
143202471|NCT01352741|516286599|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
143202472|NCT01352741|516286598|FG000|Open-label Tapentadol Titration Period|Other|4|||
143202473|NCT01352741|516286599|FG001|Open-label Tapentadol Titration Period|Other|0|||
143202474|NCT01352741|516286598|FG000|Double-blind Comparative Period|Protocol Violation|2|||
143202475|NCT01352741|516286599|FG001|Double-blind Comparative Period|Protocol Violation|0|||
143202476|NCT01352741|516286598|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
143202477|NCT01352741|516286599|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
143202478|NCT01352741|516286598|FG000|Double-blind Comparative Period|Adverse Event|16|||
143202479|NCT01352741|516286599|FG001|Double-blind Comparative Period|Adverse Event|17|||
143202480|NCT01352741|516286598|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
143202481|NCT01352741|516286599|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
143202482|NCT01352741|516286598|FG000|Double-blind Comparative Period|Death|0|||
143202483|NCT01352741|516286599|FG001|Double-blind Comparative Period|Death|1|||
143202484|NCT01352741|516286598|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
143202485|NCT01352741|516286599|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
143202486|NCT01352741|516286598|FG000|Double-blind Comparative Period|Other|1|||
143202487|NCT01352741|516286599|FG001|Double-blind Comparative Period|Other|2|||
143202488|NCT01352741|516286598|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
143202489|NCT01352741|516286599|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
143202490|NCT01352741|516286598|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
143202491|NCT01352741|516286599|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
143202492|NCT01352741|516286598|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
143202493|NCT01352741|516286599|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
143202494|NCT01352741|516286598|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
143202495|NCT01352741|516286599|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
143202496|NCT00259298|516286601|FG000|Overall Study|Withdrawal by Subject|1|||
143202497|NCT00259298|516286601|FG000|Overall Study|Physician Decision|2|||
143202498|NCT00645528|516286604|FG000|Overall Study|Did not show up for Visit 2|7|||
143202499|NCT03618628|516286608|FG000|Overall Study|Death|1|||
143202500|NCT03618628|516286608|FG000|Overall Study|Lost to Follow-up|1|||
143202501|NCT01969500|516286609|FG000|Overall Study|Death|0|||
143202502|NCT01969500|516286610|FG001|Overall Study|Death|1|||
143202503|NCT01969500|516286609|FG000|Overall Study|extended hospitalization|1|||
143202504|NCT01969500|516286610|FG001|Overall Study|extended hospitalization|1|||
143202505|NCT02463032|516286611|FG000|Overall Study|Lack of Efficacy|61|||
143370105|NCT00628862|516899070|FG001|Overall Study|Protocol Violation|0|||
143370106|NCT00628862|516899071|FG002|Overall Study|Protocol Violation|0|||
143370107|NCT00628862|516899069|FG000|Overall Study|COPD Exacerbation|0|||
143202506|NCT02463032|516286612|FG001|Overall Study|Lack of Efficacy|50|||
143202507|NCT02463032|516286611|FG000|Overall Study|Death|8|||
143202508|NCT02463032|516286612|FG001|Overall Study|Death|8|||
143202509|NCT02463032|516286611|FG000|Overall Study|Adverse Event|2|||
143202510|NCT02463032|516286612|FG001|Overall Study|Adverse Event|6|||
143202511|NCT01741532|516286613|FG000|Overall Study|Adverse Event|4|||
143202512|NCT01741532|516286614|FG001|Overall Study|Adverse Event|0|||
143202513|NCT01741532|516286613|FG000|Overall Study|Withdrawal by Subject|1|||
143202514|NCT01741532|516286614|FG001|Overall Study|Withdrawal by Subject|1|||
143202515|NCT01741532|516286613|FG000|Overall Study|Protocol Violation|0|||
143202516|NCT01741532|516286614|FG001|Overall Study|Protocol Violation|1|||
143202517|NCT01741532|516286613|FG000|Overall Study|Worsening of the disease|3|||
143202518|NCT01741532|516286614|FG001|Overall Study|Worsening of the disease|1|||
143202519|NCT01741532|516286613|FG000|Overall Study|Sponsor decision|1|||
143202520|NCT01741532|516286614|FG001|Overall Study|Sponsor decision|0|||
143202521|NCT01741532|516286613|FG000|Overall Study|Medical event|1|||
143202522|NCT01741532|516286614|FG001|Overall Study|Medical event|0|||
143202523|NCT02360293|516286615|FG000|Overall Study|Lost to Follow-up|73|||
143202524|NCT02360293|516286616|FG001|Overall Study|Lost to Follow-up|95|||
143202525|NCT02360293|516286615|FG000|Overall Study|Withdrawal by Subject|2|||
143202526|NCT02360293|516286616|FG001|Overall Study|Withdrawal by Subject|1|||
143202527|NCT02360293|516286615|FG000|Overall Study|Excluded|1|||
143202528|NCT02360293|516286616|FG001|Overall Study|Excluded|0|||
143202529|NCT02226549|516286617|FG000|Overall Study|Randomized but Never Treated|1|||
143202530|NCT02226549|516286618|FG001|Overall Study|Randomized but Never Treated|0|||
143202531|NCT02226549|516286617|FG000|Overall Study|Lost to Follow-up|0|||
143202532|NCT02226549|516286618|FG001|Overall Study|Lost to Follow-up|1|||
143202533|NCT00612508|516286620|FG000|Overall Study|Withdrawal by Subject|3|||
143202534|NCT00612508|516286621|FG001|Overall Study|Withdrawal by Subject|4|||
143202535|NCT02008357|516286622|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
143202536|NCT02008357|516286623|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
143202537|NCT02008357|516286622|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
143202538|NCT02008357|516286623|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
143202539|NCT02008357|516286622|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
143202540|NCT02008357|516286623|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
143202541|NCT02008357|516286622|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
143202542|NCT02008357|516286623|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
143202543|NCT02008357|516286622|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
143202544|NCT02008357|516286623|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
143202545|NCT02008357|516286622|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
143202546|NCT02008357|516286623|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
143202547|NCT02008357|516286622|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
143202548|NCT02008357|516286623|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
143202549|NCT02008357|516286622|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
143202550|NCT02008357|516286623|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
143202551|NCT02008357|516286622|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
143202552|NCT02008357|516286623|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
143202553|NCT02008357|516286622|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
143202554|NCT02008357|516286623|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
143202555|NCT02008357|516286622|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
143202556|NCT02008357|516286623|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
143202557|NCT02008357|516286622|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
143202558|NCT02008357|516286623|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
143202559|NCT02008357|516286622|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
143202560|NCT02008357|516286623|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
143202561|NCT02008357|516286622|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
143202562|NCT02008357|516286623|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
143202563|NCT02008357|516286622|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
143202564|NCT02008357|516286623|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
143202565|NCT02008357|516286622|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
143202566|NCT02008357|516286623|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
143202567|NCT02008357|516286622|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
143202568|NCT02008357|516286623|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
143370108|NCT00628862|516899070|FG001|Overall Study|COPD Exacerbation|1|||
143370109|NCT00628862|516899071|FG002|Overall Study|COPD Exacerbation|0|||
143370110|NCT05257798|516899074|FG000|Follow-up Phase|Lost to Follow-up|1|||
143370111|NCT05257798|516899075|FG001|Follow-up Phase|Lost to Follow-up|0|||
143370112|NCT00703911|516899080|FG000|Overall Study|Death|1|||
143202569|NCT02008357|516286622|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
143202570|NCT02008357|516286623|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
143202571|NCT02008357|516286622|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
143202572|NCT02008357|516286623|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
143202573|NCT02008357|516286622|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
143202574|NCT02008357|516286623|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
143202575|NCT02008357|516286622|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
143202576|NCT02008357|516286623|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
143202577|NCT02008357|516286622|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
143202578|NCT02008357|516286623|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
143202579|NCT02008357|516286622|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
143370113|NCT00703911|516899080|FG000|Overall Study|Physician Decision|6|||
143370114|NCT00703911|516899080|FG000|Overall Study|Lost to Follow-up|1|||
143370115|NCT00703911|516899080|FG000|Overall Study|Withdrawal by Subject|2|||
143370116|NCT04033432|516899081|FG000|Overall Study|Progressive Disease|8|||
143370117|NCT04033432|516899081|FG000|Overall Study|Adverse Event|4|||
143370118|NCT04033432|516899081|FG000|Overall Study|Death|1|||
143370119|NCT02082158|516899084|FG000|Overall Study|Withdrawal by Subject|0|||
143202580|NCT02008357|516286623|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
143202581|NCT02008357|516286622|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
143202582|NCT02008357|516286623|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
143202583|NCT02008357|516286622|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
143202584|NCT02008357|516286623|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
143202585|NCT02008357|516286622|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
143202586|NCT02008357|516286623|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
143202587|NCT02008357|516286622|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
143202588|NCT02008357|516286623|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
143202589|NCT02008357|516286622|FG000|Open-label Extension Period|Adverse Event|8|||
143370120|NCT02082158|516899085|FG001|Overall Study|Withdrawal by Subject|0|||
143370121|NCT02082158|516899086|FG002|Overall Study|Withdrawal by Subject|0|||
143370122|NCT02082158|516899087|FG003|Overall Study|Withdrawal by Subject|0|||
143370123|NCT02082158|516899088|FG004|Overall Study|Withdrawal by Subject|1|||
143370124|NCT02082158|516899089|FG005|Overall Study|Withdrawal by Subject|0|||
143370125|NCT02082158|516899084|FG000|Overall Study|Failed Fit-testing|8|||
143370126|NCT02082158|516899085|FG001|Overall Study|Failed Fit-testing|8|||
143370127|NCT02082158|516899086|FG002|Overall Study|Failed Fit-testing|14|||
143370128|NCT02082158|516899087|FG003|Overall Study|Failed Fit-testing|4|||
143370129|NCT02082158|516899088|FG004|Overall Study|Failed Fit-testing|3|||
143370130|NCT02082158|516899089|FG005|Overall Study|Failed Fit-testing|7|||
143370131|NCT00738699|516899093|FG000|Overall Study|Withdrawal by Subject|5|||
143370132|NCT00738699|516899094|FG001|Overall Study|Withdrawal by Subject|0|||
143370133|NCT00738699|516899093|FG000|Overall Study|Lost to Follow-up|1|||
143370134|NCT00738699|516899094|FG001|Overall Study|Lost to Follow-up|0|||
143370135|NCT00738699|516899093|FG000|Overall Study|Death|144|||
143370136|NCT00738699|516899094|FG001|Overall Study|Death|68|||
143370137|NCT00738699|516899093|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
143370138|NCT00738699|516899094|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
143370139|NCT00738699|516899093|FG000|Overall Study|Other|2|||
143370140|NCT00738699|516899094|FG001|Overall Study|Other|0|||
143370141|NCT00549848|516899095|FG000|Overall Study|Death|1|||
143370142|NCT00549848|516899096|FG001|Overall Study|Death|4|||
143370143|NCT00549848|516899097|FG002|Overall Study|Death|13|||
143370144|NCT00549848|516899095|FG000|Overall Study|Physician Decision|0|||
143370145|NCT00549848|516899096|FG001|Overall Study|Physician Decision|0|||
143370146|NCT00549848|516899097|FG002|Overall Study|Physician Decision|4|||
143370147|NCT00549848|516899095|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
143370148|NCT00549848|516899096|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
143370149|NCT00549848|516899097|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
143370150|NCT00549848|516899095|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
143370151|NCT00549848|516899096|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
143370152|NCT00549848|516899097|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
143370153|NCT00549848|516899095|FG000|Overall Study|Participant/Family Withdraw|2|||
143370154|NCT00549848|516899096|FG001|Overall Study|Participant/Family Withdraw|3|||
143370155|NCT00549848|516899097|FG002|Overall Study|Participant/Family Withdraw|5|||
143370156|NCT00549848|516899095|FG000|Overall Study|Second Malignancy|1|||
143370157|NCT00549848|516899096|FG001|Overall Study|Second Malignancy|0|||
143370158|NCT00549848|516899097|FG002|Overall Study|Second Malignancy|0|||
143370159|NCT00549848|516899095|FG000|Overall Study|Transplant|3|||
143202590|NCT02008357|516286623|FG001|Open-label Extension Period|Adverse Event|7|||
143202591|NCT02008357|516286622|FG000|Open-label Extension Period|Death|7|||
143202592|NCT02008357|516286623|FG001|Open-label Extension Period|Death|4|||
143202593|NCT02008357|516286622|FG000|Open-label Extension Period|Lack of Efficacy|9|||
143202594|NCT02008357|516286623|FG001|Open-label Extension Period|Lack of Efficacy|5|||
143202595|NCT02008357|516286622|FG000|Open-label Extension Period|Lost to Follow-up|2|||
143202596|NCT02008357|516286623|FG001|Open-label Extension Period|Lost to Follow-up|2|||
143202597|NCT02008357|516286622|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
143202598|NCT02008357|516286623|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
143202599|NCT02008357|516286622|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
143202600|NCT02008357|516286623|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
143202601|NCT02008357|516286622|FG000|Open-label Extension Period|Safety Risk|2|||
143202602|NCT02008357|516286623|FG001|Open-label Extension Period|Safety Risk|1|||
143202603|NCT02008357|516286622|FG000|Open-label Extension Period|Non-Compliance|0|||
143202604|NCT02008357|516286623|FG001|Open-label Extension Period|Non-Compliance|1|||
143202605|NCT02008357|516286622|FG000|Open-label Extension Period|Investigator Recommendation|0|||
143202606|NCT02008357|516286623|FG001|Open-label Extension Period|Investigator Recommendation|1|||
143202607|NCT02008357|516286622|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
143202608|NCT02008357|516286623|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
143202609|NCT02008357|516286622|FG000|Open-label Extension Period|Coordinating Center Request|2|||
143202610|NCT02008357|516286623|FG001|Open-label Extension Period|Coordinating Center Request|4|||
143202611|NCT02008357|516286622|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
143202612|NCT02008357|516286623|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
143202613|NCT02008357|516286622|FG000|Open-label Extension Period|Study Ended|20|||
143202614|NCT02008357|516286623|FG001|Open-label Extension Period|Study Ended|25|||
143202615|NCT02008357|516286622|FG000|Open-label Extension Period|Personal Reasons|0|||
143202616|NCT02008357|516286623|FG001|Open-label Extension Period|Personal Reasons|1|||
143202617|NCT02008357|516286622|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
143202618|NCT02008357|516286623|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
143202619|NCT02008357|516286622|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
143202620|NCT02008357|516286623|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
143202621|NCT02008357|516286622|FG000|Open-label Extension Period|Other|2|||
143202622|NCT02008357|516286623|FG001|Open-label Extension Period|Other|0|||
143202623|NCT01442064|516286624|FG000|Overall Study|Adverse Event|2|||
143202624|NCT01442064|516286625|FG001|Overall Study|Adverse Event|2|||
143202625|NCT01442064|516286626|FG002|Overall Study|Adverse Event|2|||
143202626|NCT01442064|516286627|FG003|Overall Study|Adverse Event|1|||
143202627|NCT01442064|516286628|FG004|Overall Study|Adverse Event|2|||
143202628|NCT01442064|516286629|FG005|Overall Study|Adverse Event|0|||
143202629|NCT01442064|516286624|FG000|Overall Study|Death|0|||
143202630|NCT01442064|516286625|FG001|Overall Study|Death|1|||
143202631|NCT01442064|516286626|FG002|Overall Study|Death|3|||
143202632|NCT01442064|516286627|FG003|Overall Study|Death|3|||
143202633|NCT01442064|516286628|FG004|Overall Study|Death|1|||
143202634|NCT01442064|516286629|FG005|Overall Study|Death|3|||
143202635|NCT01442064|516286624|FG000|Overall Study|Lost to Follow-up|5|||
143202636|NCT01442064|516286625|FG001|Overall Study|Lost to Follow-up|5|||
143202637|NCT01442064|516286626|FG002|Overall Study|Lost to Follow-up|1|||
143202638|NCT01442064|516286627|FG003|Overall Study|Lost to Follow-up|1|||
143202639|NCT01442064|516286628|FG004|Overall Study|Lost to Follow-up|3|||
143202640|NCT01442064|516286629|FG005|Overall Study|Lost to Follow-up|3|||
143202641|NCT01442064|516286624|FG000|Overall Study|Physician Decision|1|||
143202642|NCT01442064|516286625|FG001|Overall Study|Physician Decision|1|||
143202643|NCT01442064|516286626|FG002|Overall Study|Physician Decision|2|||
143202644|NCT01442064|516286627|FG003|Overall Study|Physician Decision|3|||
143202645|NCT01442064|516286628|FG004|Overall Study|Physician Decision|3|||
143202646|NCT01442064|516286629|FG005|Overall Study|Physician Decision|1|||
143202647|NCT01442064|516286624|FG000|Overall Study|Withdrawal by Subject|6|||
143202648|NCT01442064|516286625|FG001|Overall Study|Withdrawal by Subject|3|||
143202649|NCT01442064|516286626|FG002|Overall Study|Withdrawal by Subject|2|||
143202650|NCT01442064|516286627|FG003|Overall Study|Withdrawal by Subject|2|||
143202651|NCT01442064|516286628|FG004|Overall Study|Withdrawal by Subject|2|||
143202652|NCT01442064|516286629|FG005|Overall Study|Withdrawal by Subject|1|||
143202653|NCT01442064|516286624|FG000|Overall Study|Sponsor decision|82|||
143202654|NCT01442064|516286625|FG001|Overall Study|Sponsor decision|88|||
143202655|NCT01442064|516286626|FG002|Overall Study|Sponsor decision|92|||
143202656|NCT01442064|516286627|FG003|Overall Study|Sponsor decision|88|||
143202657|NCT01442064|516286628|FG004|Overall Study|Sponsor decision|95|||
143202658|NCT01442064|516286629|FG005|Overall Study|Sponsor decision|87|||
143202659|NCT01442064|516286624|FG000|Overall Study|Subject non-compliance|0|||
143202660|NCT01442064|516286625|FG001|Overall Study|Subject non-compliance|0|||
143202661|NCT01442064|516286626|FG002|Overall Study|Subject non-compliance|0|||
143202662|NCT01442064|516286627|FG003|Overall Study|Subject non-compliance|0|||
143202663|NCT01442064|516286628|FG004|Overall Study|Subject non-compliance|0|||
143202664|NCT01442064|516286629|FG005|Overall Study|Subject non-compliance|2|||
143370160|NCT00549848|516899096|FG001|Overall Study|Transplant|3|||
143370161|NCT00549848|516899097|FG002|Overall Study|Transplant|18|||
143370162|NCT00549848|516899095|FG000|Overall Study|Unacceptable Toxicity|1|||
143370163|NCT00549848|516899096|FG001|Overall Study|Unacceptable Toxicity|6|||
143370164|NCT00549848|516899097|FG002|Overall Study|Unacceptable Toxicity|6|||
143370165|NCT02174562|516899104|FG000|Overall Study|Withdrawal by Subject|7|||
143370166|NCT02174562|516899105|FG001|Overall Study|Withdrawal by Subject|2|||
143370167|NCT02174562|516899104|FG000|Overall Study|Death|2|||
143370168|NCT02174562|516899105|FG001|Overall Study|Death|0|||
143370169|NCT02174562|516899104|FG000|Overall Study|Lost to Follow-up|0|||
143370170|NCT02174562|516899105|FG001|Overall Study|Lost to Follow-up|3|||
143370171|NCT05193318|516899107|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
143370172|NCT05193318|516899107|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
143370173|NCT03670602|516899108|FG000|Overall Study|Lost to Follow-up|1|||
143370174|NCT03670602|516899109|FG001|Overall Study|Lost to Follow-up|0|||
143370175|NCT03670602|516899108|FG000|Overall Study|Withdrawal by Subject|0|||
143370176|NCT03670602|516899109|FG001|Overall Study|Withdrawal by Subject|3|||
143370177|NCT03201809|516899110|FG000|Overall Study|Lost to Follow-up|2|||
143370178|NCT03201809|516899111|FG001|Overall Study|Lost to Follow-up|0|||
143370179|NCT00864682|516899113|FG000|Overall Study|Protocol Violation|2|||
143370180|NCT00864682|516899114|FG001|Overall Study|Protocol Violation|1|||
143370181|NCT00864682|516899115|FG002|Overall Study|Protocol Violation|2|||
143370182|NCT00957658|516899116|FG000|Overall Study|Death|1|||
143370183|NCT00957658|516899116|FG000|Overall Study|Lost to Follow-up|4|||
143370184|NCT00957658|516899116|FG000|Overall Study|Withdrawal by Subject|12|||
143370185|NCT00957658|516899116|FG000|Overall Study|Revision|1|||
143370186|NCT00957658|516899116|FG000|Overall Study|Incomplete 2 yr data|28|||
143370187|NCT00957658|516899116|FG000|Overall Study|Site termination|10|||
143370188|NCT00957658|516899116|FG000|Overall Study|unwilling/unable to return|2|||
143370189|NCT00957658|516899116|FG000|Overall Study|surgery cancelled|2|||
143370190|NCT00957658|516899116|FG000|Overall Study|Protocol Violation|5|||
143370191|NCT00975806|516899120|FG000|Overall Study|Adverse Event|2|||
143370192|NCT00975806|516899121|FG001|Overall Study|Adverse Event|1|||
143370193|NCT00975806|516899122|FG002|Overall Study|Adverse Event|2|||
143370194|NCT00975806|516899120|FG000|Overall Study|Disease Progression|1|||
143202665|NCT01442064|516286624|FG000|Overall Study|Condition mandated other intervention|1|||
143202666|NCT01442064|516286625|FG001|Overall Study|Condition mandated other intervention|1|||
143202667|NCT01442064|516286626|FG002|Overall Study|Condition mandated other intervention|2|||
143202668|NCT01442064|516286627|FG003|Overall Study|Condition mandated other intervention|0|||
143202669|NCT01442064|516286628|FG004|Overall Study|Condition mandated other intervention|0|||
143202670|NCT01442064|516286629|FG005|Overall Study|Condition mandated other intervention|2|||
143202671|NCT02312219|516286630|FG000|Overall Study|Withdrawal by Subject|1|||
143202672|NCT02312219|516286631|FG001|Overall Study|Withdrawal by Subject|2|||
143202673|NCT02312219|516286630|FG000|Overall Study|could not schedule imaging in time|0|||
143202674|NCT02312219|516286631|FG001|Overall Study|could not schedule imaging in time|2|||
143202675|NCT02312219|516286630|FG000|Overall Study|Other|0|||
143202676|NCT02312219|516286631|FG001|Overall Study|Other|1|||
143202677|NCT02312219|516286630|FG000|Overall Study|Not randomized. Ineligible|0|||
143202678|NCT02312219|516286631|FG001|Overall Study|Not randomized. Ineligible|1|||
143202679|NCT01269385|516286632|FG000|Overall Study|Adverse Event|1|||
143202680|NCT01269385|516286633|FG001|Overall Study|Adverse Event|1|||
143202681|NCT01269385|516286634|FG002|Overall Study|Adverse Event|0|||
143202682|NCT01269385|516286635|FG003|Overall Study|Adverse Event|0|||
143202683|NCT02741570|516286637|FG000|Pre-Treatment Period|Other reasons|0|||
143202684|NCT02741570|516286638|FG001|Pre-Treatment Period|Other reasons|3|||
143370195|NCT00975806|516899121|FG001|Overall Study|Disease Progression|5|||
143202685|NCT02741570|516286637|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
143202686|NCT02741570|516286638|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
143370196|NCT00975806|516899122|FG002|Overall Study|Disease Progression|1|||
143370197|NCT00975806|516899120|FG000|Overall Study|Withdrawal by Subject|1|||
143370198|NCT00975806|516899121|FG001|Overall Study|Withdrawal by Subject|0|||
143370199|NCT00975806|516899122|FG002|Overall Study|Withdrawal by Subject|0|||
143370200|NCT00975806|516899120|FG000|Overall Study|Death|0|||
143370201|NCT00975806|516899121|FG001|Overall Study|Death|1|||
143370202|NCT00975806|516899122|FG002|Overall Study|Death|0|||
143202687|NCT02741570|516286637|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
143202688|NCT02741570|516286638|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
143202689|NCT02741570|516286637|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
143202690|NCT02741570|516286638|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
143202691|NCT02741570|516286637|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
143202692|NCT02741570|516286638|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
143202693|NCT02741570|516286637|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
143202694|NCT02741570|516286638|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
143202695|NCT02741570|516286637|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
143202696|NCT02741570|516286638|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
143202697|NCT02741570|516286637|FG000|Pre-Treatment Period|Death|0|||
143202698|NCT02741570|516286638|FG001|Pre-Treatment Period|Death|1|||
143202699|NCT02741570|516286637|FG000|Pre-Treatment Period|Disease progression|0|||
143202700|NCT02741570|516286638|FG001|Pre-Treatment Period|Disease progression|1|||
143202701|NCT02741570|516286637|FG000|Treatment Period|Other reasons|47|||
143202702|NCT02741570|516286638|FG001|Treatment Period|Other reasons|12|||
143202703|NCT02741570|516286637|FG000|Treatment Period|Poor/non-compliance|0|||
143202704|NCT02741570|516286638|FG001|Treatment Period|Poor/non-compliance|2|||
143202705|NCT02741570|516286637|FG000|Treatment Period|Maximum clinical benefit|4|||
143202706|NCT02741570|516286638|FG001|Treatment Period|Maximum clinical benefit|6|||
143202707|NCT02741570|516286637|FG000|Treatment Period|Lost to Follow-up|1|||
143202708|NCT02741570|516286638|FG001|Treatment Period|Lost to Follow-up|3|||
143202709|NCT02741570|516286637|FG000|Treatment Period|Participant withdrew consent|9|||
143202710|NCT02741570|516286638|FG001|Treatment Period|Participant withdrew consent|13|||
143202711|NCT02741570|516286637|FG000|Treatment Period|Participant request to discontinue treatment|8|||
143202712|NCT02741570|516286638|FG001|Treatment Period|Participant request to discontinue treatment|23|||
143202713|NCT02741570|516286637|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
143202714|NCT02741570|516286638|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
143202715|NCT02741570|516286637|FG000|Treatment Period|Death|9|||
143202716|NCT02741570|516286638|FG001|Treatment Period|Death|7|||
143202717|NCT02741570|516286637|FG000|Treatment Period|Study drug toxicity|55|||
143202718|NCT02741570|516286638|FG001|Treatment Period|Study drug toxicity|47|||
143202719|NCT02741570|516286637|FG000|Treatment Period|Disease progression|294|||
143202720|NCT02741570|516286638|FG001|Treatment Period|Disease progression|301|||
143202721|NCT02741570|516286637|FG000|Treatment Period|Administrative reason by sponsor|0|||
143202722|NCT02741570|516286638|FG001|Treatment Period|Administrative reason by sponsor|1|||
143202723|NCT01498185|516286639|FG000|Overall Study|Adverse Event|0|||
143202724|NCT01498185|516286640|FG001|Overall Study|Adverse Event|0|||
143202725|NCT01498185|516286641|FG002|Overall Study|Adverse Event|0|||
143202726|NCT01498185|516286642|FG003|Overall Study|Adverse Event|1|||
143202727|NCT01498185|516286643|FG004|Overall Study|Adverse Event|0|||
143202728|NCT01498185|516286639|FG000|Overall Study|Withdrawal by Subject|1|||
143202729|NCT01498185|516286640|FG001|Overall Study|Withdrawal by Subject|1|||
143202730|NCT01498185|516286641|FG002|Overall Study|Withdrawal by Subject|0|||
143202731|NCT01498185|516286642|FG003|Overall Study|Withdrawal by Subject|2|||
143202732|NCT01498185|516286643|FG004|Overall Study|Withdrawal by Subject|1|||
143202733|NCT01498185|516286639|FG000|Overall Study|No longer met criteria, etc|0|||
143202734|NCT01498185|516286640|FG001|Overall Study|No longer met criteria, etc|0|||
143202735|NCT01498185|516286641|FG002|Overall Study|No longer met criteria, etc|0|||
143202736|NCT01498185|516286642|FG003|Overall Study|No longer met criteria, etc|0|||
143202737|NCT01498185|516286643|FG004|Overall Study|No longer met criteria, etc|2|||
143202738|NCT00946322|516286644|FG000|Pre-treatment|participant failure to follow up|1|||
143202739|NCT00946322|516286644|FG000|Post-treatment|participant failure to follow up|2|||
143202740|NCT04384107|516286650|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
143202741|NCT04384107|516286651|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
143202742|NCT04384107|516286650|FG000|Overall Study|Lost to Follow-up|1|||
143202743|NCT04384107|516286651|FG001|Overall Study|Lost to Follow-up|0|||
143202744|NCT00276614|516286654|FG000|Overall Study|Progression of disease under study|3|||
143202745|NCT01522404|516286657|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
143202746|NCT01522404|516286658|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
143202747|NCT01522404|516286657|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
143202748|NCT01522404|516286658|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
143202749|NCT01522404|516286657|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
143202750|NCT01522404|516286658|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
143202751|NCT01591863|516286663|FG000|Overall Study|Adverse Event|3|||
143202752|NCT01591863|516286663|FG000|Overall Study|Withdrawal by Subject|1|||
143202753|NCT01591863|516286663|FG000|Overall Study|recurrence|9|||
143202754|NCT01591863|516286663|FG000|Overall Study|Lack of Efficacy|1|||
143202755|NCT00456599|516286664|FG000|Overall Study|Non-compliance|1|||
143202756|NCT00456599|516286664|FG000|Overall Study|Withdrawal by Subject|2|||
143202757|NCT02198235|516286665|FG000|Overall Study|Lost to Follow-up|3|||
143202758|NCT02198235|516286666|FG001|Overall Study|Lost to Follow-up|2|||
143202759|NCT02198235|516286667|FG002|Overall Study|Lost to Follow-up|2|||
143262554|NCT00737464|516515868|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
143262555|NCT00737464|516515868|FG000|Overall Study|Other reasons|4|||
143262556|NCT01083173|516515877|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
143262557|NCT01083173|516515878|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
143262558|NCT01083173|516515877|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
143262559|NCT01083173|516515878|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
143262560|NCT01083173|516515877|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
143262561|NCT01083173|516515878|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
143262562|NCT01083173|516515877|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
143262563|NCT01083173|516515878|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
143262564|NCT01083173|516515877|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
143262565|NCT01083173|516515878|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
143262566|NCT01083173|516515877|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
143262567|NCT01083173|516515878|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
143262568|NCT01083173|516515877|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
143262569|NCT01083173|516515878|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
143262570|NCT01083173|516515877|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
143262571|NCT01083173|516515878|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
143262572|NCT01083173|516515877|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
143262573|NCT01083173|516515878|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
143262574|NCT01083173|516515877|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
143262575|NCT01083173|516515878|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
143262576|NCT01083173|516515877|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
143262577|NCT01083173|516515878|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
143262578|NCT04177355|516515880|FG000|Overall Study|Lost to Follow-up|0|||
143262579|NCT04177355|516515881|FG001|Overall Study|Lost to Follow-up|2|||
143262580|NCT04177355|516515882|FG002|Overall Study|Lost to Follow-up|0|||
143262581|NCT04177355|516515883|FG003|Overall Study|Lost to Follow-up|1|||
143262582|NCT04177355|516515884|FG004|Overall Study|Lost to Follow-up|2|||
143262583|NCT04177355|516515885|FG005|Overall Study|Lost to Follow-up|0|||
143262584|NCT04177355|516515886|FG006|Overall Study|Lost to Follow-up|1|||
143262585|NCT04177355|516515887|FG007|Overall Study|Lost to Follow-up|0|||
143262586|NCT04177355|516515888|FG008|Overall Study|Lost to Follow-up|0|||
143262587|NCT04177355|516515889|FG009|Overall Study|Lost to Follow-up|0|||
143262588|NCT04177355|516515890|FG010|Overall Study|Lost to Follow-up|0|||
143262589|NCT04177355|516515880|FG000|Overall Study|Withdrawal by Subject|0|||
143262590|NCT04177355|516515881|FG001|Overall Study|Withdrawal by Subject|0|||
143262591|NCT04177355|516515882|FG002|Overall Study|Withdrawal by Subject|0|||
143262592|NCT04177355|516515883|FG003|Overall Study|Withdrawal by Subject|1|||
143262593|NCT04177355|516515884|FG004|Overall Study|Withdrawal by Subject|1|||
143262594|NCT04177355|516515885|FG005|Overall Study|Withdrawal by Subject|0|||
143262595|NCT04177355|516515886|FG006|Overall Study|Withdrawal by Subject|0|||
143262596|NCT04177355|516515887|FG007|Overall Study|Withdrawal by Subject|0|||
143262597|NCT04177355|516515888|FG008|Overall Study|Withdrawal by Subject|1|||
143262598|NCT04177355|516515889|FG009|Overall Study|Withdrawal by Subject|0|||
143262599|NCT04177355|516515890|FG010|Overall Study|Withdrawal by Subject|0|||
143262600|NCT03981822|516515891|FG000|Overall Study|Lost to Follow-up|0|||
143262601|NCT03981822|516515892|FG001|Overall Study|Lost to Follow-up|1|||
143262602|NCT03981822|516515893|FG002|Overall Study|Lost to Follow-up|1|||
143262603|NCT03981822|516515894|FG003|Overall Study|Lost to Follow-up|0|||
143262604|NCT03981822|516515895|FG004|Overall Study|Lost to Follow-up|6|||
143262605|NCT03981822|516515896|FG005|Overall Study|Lost to Follow-up|4|||
143262606|NCT03981822|516515897|FG006|Overall Study|Lost to Follow-up|4|||
143262607|NCT03981822|516515898|FG007|Overall Study|Lost to Follow-up|2|||
143262608|NCT03981822|516515891|FG000|Overall Study|Withdrawal by Subject|0|||
143262609|NCT03981822|516515892|FG001|Overall Study|Withdrawal by Subject|1|||
143370203|NCT00975806|516899120|FG000|Overall Study|Physician decision and disease related|1|||
143262610|NCT03981822|516515893|FG002|Overall Study|Withdrawal by Subject|0|||
143262611|NCT03981822|516515894|FG003|Overall Study|Withdrawal by Subject|0|||
143262612|NCT03981822|516515895|FG004|Overall Study|Withdrawal by Subject|0|||
143262613|NCT03981822|516515896|FG005|Overall Study|Withdrawal by Subject|1|||
143262614|NCT03981822|516515897|FG006|Overall Study|Withdrawal by Subject|0|||
143262615|NCT03981822|516515898|FG007|Overall Study|Withdrawal by Subject|2|||
143262616|NCT03981822|516515891|FG000|Overall Study|COVID-19 Related|0|||
143262617|NCT03981822|516515892|FG001|Overall Study|COVID-19 Related|0|||
143262618|NCT03981822|516515893|FG002|Overall Study|COVID-19 Related|0|||
143202760|NCT00664326|516288649|FG000|Overall Study|Adverse Event|14|||
143202761|NCT00664326|516288649|FG000|Overall Study|Noncompliance with study medication|3|||
143202762|NCT00664326|516288649|FG000|Overall Study|Withdrawal by Subject|1|||
143202763|NCT00664326|516288649|FG000|Overall Study|Physician Decision|1|||
143202764|NCT00664326|516288649|FG000|Overall Study|Other Reasons|3|||
143202765|NCT00664326|516288649|FG000|Overall Study|Death|2|||
143202766|NCT00664326|516288649|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
143202767|NCT05079477|516288652|FG000|Overall Study|Lost to Follow-up|2|||
143202768|NCT05079477|516288653|FG001|Overall Study|Lost to Follow-up|0|||
143202769|NCT05079477|516288652|FG000|Overall Study|Withdrawal by Subject|1|||
143202770|NCT05079477|516288653|FG001|Overall Study|Withdrawal by Subject|0|||
143202771|NCT05079477|516288652|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
143202772|NCT05079477|516288653|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
143202773|NCT05079477|516288652|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
143202774|NCT05079477|516288653|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
143202775|NCT03131596|516288658|FG000|Overall Study|Protocol Violation|3|||
143202776|NCT03131596|516288659|FG001|Overall Study|Protocol Violation|3|||
143202777|NCT03131596|516288658|FG000|Overall Study|Lost to Follow-up|3|||
143202778|NCT03131596|516288659|FG001|Overall Study|Lost to Follow-up|0|||
143202779|NCT03654885|516288660|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
143202780|NCT03654885|516288661|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
143202781|NCT03654885|516288660|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
143202782|NCT03654885|516288661|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
143202783|NCT03654885|516288660|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
143202784|NCT03654885|516288661|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
143202785|NCT03654885|516288660|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
143202786|NCT03654885|516288661|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
143202787|NCT03654885|516288660|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
143202788|NCT03654885|516288661|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
143202789|NCT03654885|516288660|FG000|Overall Study|Adverse Event in Study Eye|3|||
143202790|NCT03654885|516288661|FG001|Overall Study|Adverse Event in Study Eye|0|||
143202791|NCT03654885|516288660|FG000|Overall Study|Consent Withdrawn|1|||
143202792|NCT03654885|516288661|FG001|Overall Study|Consent Withdrawn|0|||
143202793|NCT03654885|516288660|FG000|Overall Study|Death|3|||
143202794|NCT03654885|516288661|FG001|Overall Study|Death|1|||
143202795|NCT03654885|516288660|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
143202796|NCT03654885|516288661|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
143202797|NCT03654885|516288660|FG000|Overall Study|Lost to Follow-up|3|||
143202798|NCT03654885|516288661|FG001|Overall Study|Lost to Follow-up|3|||
143202799|NCT05275582|516288662|FG000|Overall Study|Lost to Follow-up|1|||
143202800|NCT05275582|516288663|FG001|Overall Study|Lost to Follow-up|0|||
143262619|NCT03981822|516515894|FG003|Overall Study|COVID-19 Related|0|||
143262620|NCT03981822|516515895|FG004|Overall Study|COVID-19 Related|2|||
143262621|NCT03981822|516515896|FG005|Overall Study|COVID-19 Related|1|||
143262622|NCT03981822|516515897|FG006|Overall Study|COVID-19 Related|2|||
143262623|NCT03981822|516515898|FG007|Overall Study|COVID-19 Related|1|||
143262624|NCT03489551|516515899|FG000|Overall Study|Withdrawal by Subject|2|||
143262625|NCT00206076|516515901|FG000|Overall Study|Physician Decision|2|||
143262626|NCT00206076|516515902|FG001|Overall Study|Physician Decision|0|||
143262627|NCT00206076|516515901|FG000|Overall Study|Withdrawal by Subject|1|||
143262628|NCT00206076|516515902|FG001|Overall Study|Withdrawal by Subject|1|||
143262629|NCT01142128|516515904|FG000|Overall Study|Physician Decision|1|||
143262630|NCT01142128|516515904|FG000|Overall Study|Lost to Follow-up|1|||
143262631|NCT01142128|516515904|FG000|Overall Study|Withdrawal by Subject|2|||
143262632|NCT00366340|516515905|FG000|Infant Series|Protocol Violation|3|||
143262633|NCT00366340|516515906|FG001|Infant Series|Protocol Violation|4|||
143262634|NCT00366340|516515905|FG000|Infant Series|Withdrawal by Subject|3|||
143262635|NCT00366340|516515906|FG001|Infant Series|Withdrawal by Subject|3|||
143262636|NCT00366340|516515905|FG000|Infant Series|Adverse Event|0|||
143262637|NCT00366340|516515906|FG001|Infant Series|Adverse Event|2|||
143262638|NCT00366340|516515905|FG000|Infant Series|Lost to Follow-up|1|||
143262639|NCT00366340|516515906|FG001|Infant Series|Lost to Follow-up|1|||
143262640|NCT00366340|516515905|FG000|Infant Series|Failure to return|1|||
143202801|NCT05275582|516288662|FG000|Overall Study|Withdrawal by Subject|0|||
143202802|NCT05275582|516288663|FG001|Overall Study|Withdrawal by Subject|2|||
143202803|NCT05275582|516288662|FG000|Overall Study|Did not/could not complete primary care appointment for various reasons|4|||
143202804|NCT05275582|516288663|FG001|Overall Study|Did not/could not complete primary care appointment for various reasons|0|||
143202805|NCT05275582|516288662|FG000|Overall Study|Death|1|||
143202806|NCT05275582|516288663|FG001|Overall Study|Death|0|||
143202807|NCT05275582|516288662|FG000|Overall Study|Protocol Violation|1|||
143202808|NCT05275582|516288663|FG001|Overall Study|Protocol Violation|0|||
143202809|NCT00240110|516288666|FG000|Overall Study|Lost to Follow-up|6|||
143202810|NCT00240110|516288667|FG001|Overall Study|Lost to Follow-up|7|||
143202811|NCT00583791|516288668|FG000|Overall Study|Other|67|||
143202812|NCT00583791|516288668|FG000|Overall Study|Death|6|||
143202813|NCT00203021|516288669|FG000|Overall Study|Death|4|||
143202814|NCT00203021|516288670|FG001|Overall Study|Death|1|||
143202815|NCT00203021|516288669|FG000|Overall Study|Adverse Event|10|||
143202816|NCT00203021|516288670|FG001|Overall Study|Adverse Event|5|||
143202817|NCT00203021|516288669|FG000|Overall Study|Withdrawal by Subject|45|||
143202818|NCT00203021|516288670|FG001|Overall Study|Withdrawal by Subject|48|||
143202819|NCT00203021|516288669|FG000|Overall Study|Lost to Follow-up|9|||
143202820|NCT00203021|516288670|FG001|Overall Study|Lost to Follow-up|7|||
143202821|NCT00203021|516288669|FG000|Overall Study|Other than specified|11|||
143202822|NCT00203021|516288670|FG001|Overall Study|Other than specified|16|||
143370204|NCT00975806|516899121|FG001|Overall Study|Physician decision and disease related|0|||
143370205|NCT00975806|516899122|FG002|Overall Study|Physician decision and disease related|1|||
143202823|NCT02080260|516288671|FG000|Overall Study|Death|18|||
143202824|NCT02080260|516288671|FG000|Overall Study|Withdrawal by Subject|1|||
143202825|NCT03769311|516288672|FG000|Overall Study|Withdrawal by Subject|1|||
143202826|NCT02853435|516288673|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
143202827|NCT02853435|516288674|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
143202828|NCT02853435|516288675|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
143202829|NCT02853435|516288676|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
143202830|NCT02853435|516288677|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
143202831|NCT02853435|516288678|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
143202832|NCT03747120|516288679|FG000|Overall Study|treatment related toxicity|3|||
143202833|NCT03747120|516288680|FG001|Overall Study|treatment related toxicity|0|||
143202834|NCT03747120|516288681|FG002|Overall Study|treatment related toxicity|0|||
143202835|NCT03747120|516288679|FG000|Overall Study|Withdrawal by Subject|0|||
143202836|NCT03747120|516288680|FG001|Overall Study|Withdrawal by Subject|1|||
143202837|NCT03747120|516288681|FG002|Overall Study|Withdrawal by Subject|2|||
143202838|NCT03627065|516288682|FG000|Overall Study|Study Terminated by sponsor|1|||
143202839|NCT03627065|516288682|FG000|Overall Study|Withdrawal by Subject|2|||
143202840|NCT00289198|516288683|FG000|Overall Study|Adverse Event|0|||
143202841|NCT00289198|516288684|FG001|Overall Study|Adverse Event|2|||
143202842|NCT00289198|516288683|FG000|Overall Study|Protocol Violation|2|||
143202843|NCT00289198|516288684|FG001|Overall Study|Protocol Violation|1|||
143202844|NCT00289198|516288683|FG000|Overall Study|Withdrawal by Subject|4|||
143202845|NCT00289198|516288684|FG001|Overall Study|Withdrawal by Subject|1|||
143202846|NCT00289198|516288683|FG000|Overall Study|Lack of Efficacy|2|||
143202847|NCT00289198|516288684|FG001|Overall Study|Lack of Efficacy|0|||
143202848|NCT00289198|516288683|FG000|Overall Study|Other: Low compliance|0|||
143202849|NCT00289198|516288684|FG001|Overall Study|Other: Low compliance|1|||
143202850|NCT00289198|516288683|FG000|Overall Study|Other: Physician's decision|0|||
143202851|NCT00289198|516288684|FG001|Overall Study|Other: Physician's decision|1|||
143202852|NCT00289198|516288683|FG000|Overall Study|Other: Unable to attend on schedule|2|||
143202853|NCT00289198|516288684|FG001|Overall Study|Other: Unable to attend on schedule|1|||
143202854|NCT00289198|516288683|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
143202855|NCT00289198|516288684|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
143370206|NCT00246012|516899123|FG000|Overall Study|Adverse Event|0|||
143370207|NCT00246012|516899124|FG001|Overall Study|Adverse Event|0|||
143370208|NCT00246012|516899125|FG002|Overall Study|Adverse Event|0|||
143370209|NCT00246012|516899126|FG003|Overall Study|Adverse Event|0|||
143370210|NCT00246012|516899127|FG004|Overall Study|Adverse Event|0|||
143202856|NCT00289198|516288683|FG000|Overall Study|Other: Impossible to come on visit|0|||
143202857|NCT00289198|516288684|FG001|Overall Study|Other: Impossible to come on visit|1|||
143202858|NCT01266317|516288685|FG000|Overall Study|Withdrawal by Subject|2|||
143202859|NCT00490776|516288686|FG000|Overall Study|Withdrawal by Subject|1|||
143202860|NCT00490776|516288686|FG000|Overall Study|Administrative Problems|1|||
143202861|NCT00490776|516288686|FG000|Overall Study|Death|1|||
143202862|NCT00490776|516288686|FG000|Overall Study|New Cancer Therapy|1|||
143202863|NCT00490776|516288686|FG000|Overall Study|Disease Progression|5|||
143202864|NCT04912895|516288693|FG000|Overall Study|Unable to provide specimen|2|||
143202865|NCT04912895|516288694|FG001|Overall Study|Unable to provide specimen|0|||
143202866|NCT04912895|516288695|FG002|Overall Study|Unable to provide specimen|0|||
143202867|NCT02785458|516288696|FG000|1 Month|Withdrawal by Subject|2|||
143370211|NCT00246012|516899128|FG005|Overall Study|Adverse Event|1|||
143202868|NCT02785458|516288697|FG001|1 Month|Withdrawal by Subject|1|||
143202869|NCT02785458|516288696|FG000|1 Month|Lost to Follow-up|38|||
143202870|NCT02785458|516288697|FG001|1 Month|Lost to Follow-up|31|||
143202871|NCT02785458|516288696|FG000|1 Month|Deemed Ineligible|1|||
143202872|NCT02785458|516288697|FG001|1 Month|Deemed Ineligible|0|||
143202873|NCT02785458|516288696|FG000|1 Month|Completed Evaluation by Baseline|42|||
143202874|NCT02785458|516288697|FG001|1 Month|Completed Evaluation by Baseline|39|||
143202875|NCT02785458|516288696|FG000|1 Month|Partial Interview|0|||
143202876|NCT02785458|516288697|FG001|1 Month|Partial Interview|4|||
143202877|NCT02785458|516288696|FG000|3 Months|Withdrawal by Subject|3|||
143202878|NCT02785458|516288697|FG001|3 Months|Withdrawal by Subject|1|||
143202879|NCT02785458|516288696|FG000|3 Months|Lost to Follow-up|25|||
143202880|NCT02785458|516288697|FG001|3 Months|Lost to Follow-up|21|||
143202881|NCT02785458|516288696|FG000|3 Months|Completed Evaluation at 1 Month|100|||
143202882|NCT02785458|516288697|FG001|3 Months|Completed Evaluation at 1 Month|89|||
143202883|NCT01866423|516288698|FG000|Overall Study|Lack of Efficacy|3|||
143202884|NCT01866423|516288698|FG000|Overall Study|Sponsor Decision|1|||
143202885|NCT02255565|516288699|FG000|Overall Study|Withdrawal by Subject|0|||
143202886|NCT02255565|516288700|FG001|Overall Study|Withdrawal by Subject|1|||
143202887|NCT02255565|516288701|FG002|Overall Study|Withdrawal by Subject|0|||
143202888|NCT02699450|516288702|FG000|Overall Study|Death|2|||
143202889|NCT02699450|516288703|FG001|Overall Study|Death|1|||
143202890|NCT02699450|516288704|FG002|Overall Study|Death|2|||
143202891|NCT02699450|516288702|FG000|Overall Study|Met Criteria for Study Exit|0|||
143202892|NCT02699450|516288703|FG001|Overall Study|Met Criteria for Study Exit|0|||
143202893|NCT02699450|516288704|FG002|Overall Study|Met Criteria for Study Exit|1|||
143202894|NCT02699450|516288702|FG000|Overall Study|Protocol Violation|4|||
143202895|NCT02699450|516288703|FG001|Overall Study|Protocol Violation|3|||
143202896|NCT02699450|516288704|FG002|Overall Study|Protocol Violation|5|||
143202897|NCT02699450|516288702|FG000|Overall Study|Lost to Follow-up|3|||
143202898|NCT02699450|516288703|FG001|Overall Study|Lost to Follow-up|0|||
143202899|NCT02699450|516288704|FG002|Overall Study|Lost to Follow-up|5|||
143202900|NCT02699450|516288702|FG000|Overall Study|Physician Decision|2|||
143202901|NCT02699450|516288703|FG001|Overall Study|Physician Decision|0|||
143202902|NCT02699450|516288704|FG002|Overall Study|Physician Decision|0|||
143202903|NCT02699450|516288702|FG000|Overall Study|Withdrawal by Subject|3|||
143202904|NCT02699450|516288703|FG001|Overall Study|Withdrawal by Subject|1|||
143202905|NCT02699450|516288704|FG002|Overall Study|Withdrawal by Subject|2|||
143202906|NCT02699450|516288702|FG000|Overall Study|Adverse Event|1|||
143202907|NCT02699450|516288703|FG001|Overall Study|Adverse Event|0|||
143202908|NCT02699450|516288704|FG002|Overall Study|Adverse Event|0|||
143202909|NCT00849875|516288707|FG000|Overall Study|Death|28|||
143202910|NCT00849875|516288707|FG000|Overall Study|Ongoing (unknown completion status)|11|||
143202911|NCT00849875|516288707|FG000|Overall Study|Others|6|||
143202912|NCT00849875|516288707|FG000|Overall Study|Lost to Follow-up|2|||
143202913|NCT01995552|516288714|FG000|Overall Study|Protocol Violation|1|||
143202914|NCT01995552|516288714|FG000|Overall Study|Lack of Efficacy|15|||
143202915|NCT01995552|516288714|FG000|Overall Study|Death|1|||
143202916|NCT02068118|516288718|FG000|18-month Comparative Study Period|Death|90|||
143202917|NCT02068118|516288719|FG001|18-month Comparative Study Period|Death|97|||
143202918|NCT02068118|516288718|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
143202919|NCT02068118|516288719|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
143202920|NCT02068118|516288718|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
143202921|NCT02068118|516288719|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
143202922|NCT02068118|516288718|FG000|18-month Comparative Study Period|Heart transplant|9|||
143202923|NCT02068118|516288719|FG001|18-month Comparative Study Period|Heart transplant|15|||
143202924|NCT02068118|516288718|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
143202925|NCT02068118|516288719|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
143202926|NCT02068118|516288718|FG000|18-month Comparative Study Period|Hemiplegia|0|||
143202927|NCT02068118|516288719|FG001|18-month Comparative Study Period|Hemiplegia|1|||
143202928|NCT02068118|516288718|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
143202929|NCT02068118|516288719|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
143202930|NCT02068118|516288718|FG000|18-month Comparative Study Period|Move|0|||
143202931|NCT02068118|516288719|FG001|18-month Comparative Study Period|Move|1|||
143370212|NCT00246012|516899129|FG006|Overall Study|Adverse Event|0|||
143202932|NCT02068118|516288718|FG000|18-month Comparative Study Period|Hearing loss|0|||
143202933|NCT02068118|516288719|FG001|18-month Comparative Study Period|Hearing loss|1|||
143202934|NCT02068118|516288718|FG000|Extension Period|Death|0|||
143202935|NCT02068118|516288719|FG001|Extension Period|Death|2|||
143202936|NCT02068118|516288718|FG000|Extension Period|Withdrawal by Subject|1|||
143202937|NCT02068118|516288719|FG001|Extension Period|Withdrawal by Subject|0|||
143202938|NCT02068118|516288718|FG000|Extension Period|Heart transplant|1|||
143202939|NCT02068118|516288719|FG001|Extension Period|Heart transplant|0|||
143370213|NCT00246012|516899130|FG007|Overall Study|Adverse Event|0|||
143202940|NCT02068118|516288718|FG000|Extension Period|Wrong device use|0|||
143202941|NCT02068118|516288719|FG001|Extension Period|Wrong device use|1|||
143202942|NCT00334282|516288720|FG000|Overall Study|Lost to Follow-up|11|||
143202943|NCT00334282|516288721|FG001|Overall Study|Lost to Follow-up|5|||
143202944|NCT00334282|516288720|FG000|Overall Study|Withdrawal by Subject|17|||
143202945|NCT00334282|516288721|FG001|Overall Study|Withdrawal by Subject|3|||
143202946|NCT00334282|516288720|FG000|Overall Study|Death|194|||
143202947|NCT00334282|516288721|FG001|Overall Study|Death|100|||
143202948|NCT00283868|516288722|FG000|Overall Study|Lost to Follow-up|7|||
143202949|NCT00283868|516288723|FG001|Overall Study|Lost to Follow-up|8|||
143202950|NCT01515475|516288724|FG000|Overall Study|Lost to Follow-up|20|||
143202951|NCT01515475|516288725|FG001|Overall Study|Lost to Follow-up|15|||
143202952|NCT01515475|516288726|FG002|Overall Study|Lost to Follow-up|12|||
143202953|NCT01515475|516288727|FG003|Overall Study|Lost to Follow-up|12|||
143202954|NCT01420627|516288729|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
143202955|NCT01996592|516288737|FG000|Overall Study|no response to text/no diary entry|32|||
143202956|NCT01996592|516288737|FG000|Overall Study|change in surgical date|4|||
143202957|NCT01996592|516288737|FG000|Overall Study|Withdrawal by Subject|5|||
143202958|NCT01996592|516288737|FG000|Overall Study|change in mode of delivery|4|||
143202959|NCT01886690|516288745|FG000|Overall Study|Protocol Violation|0|||
143202960|NCT01886690|516288746|FG001|Overall Study|Protocol Violation|1|||
143202961|NCT01886690|516288745|FG000|Overall Study|Personal Reasons|0|||
143202962|NCT01886690|516288746|FG001|Overall Study|Personal Reasons|1|||
143202963|NCT03077698|516288747|FG000|Progestin Monotherapy|Stable Disease|8|||
143202964|NCT03077698|516288748|FG001|Progestin Monotherapy|Stable Disease|0|||
143202965|NCT03077698|516288747|FG000|Progestin Monotherapy|Adverse Event|1|||
143202966|NCT03077698|516288748|FG001|Progestin Monotherapy|Adverse Event|0|||
143202967|NCT03077698|516288747|FG000|Progestin Monotherapy|Death|1|||
143202968|NCT03077698|516288748|FG001|Progestin Monotherapy|Death|0|||
143202969|NCT03077698|516288747|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
143202970|NCT03077698|516288748|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
143202971|NCT03077698|516288747|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
143202972|NCT03077698|516288748|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
143202973|NCT03077698|516288747|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
143202974|NCT03077698|516288748|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
143202975|NCT03077698|516288747|FG000|Safety Follow Up|Withdrawal by Subject|2|||
143202976|NCT03077698|516288748|FG001|Safety Follow Up|Withdrawal by Subject|1|||
143202977|NCT03077698|516288747|FG000|Safety Follow Up|Transfer of care to hospice|1|||
143202978|NCT03077698|516288748|FG001|Safety Follow Up|Transfer of care to hospice|0|||
143202979|NCT01873729|516288753|FG000|Overall Study|Withdrawal by Subject|1|||
143202980|NCT01066780|516288754|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
143202981|NCT01066780|516288755|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
143202982|NCT01827332|516288756|FG000|Overall Study|Lost to Follow-up|2|||
143202983|NCT01827332|516288757|FG001|Overall Study|Lost to Follow-up|1|||
143202984|NCT03352453|516288758|FG000|Overall Study|Miscellaneous Reasons|1|||
143202985|NCT03352453|516288759|FG001|Overall Study|Miscellaneous Reasons|2|||
143202986|NCT03352453|516288758|FG000|Overall Study|Lack of Efficacy|1|||
143202987|NCT03352453|516288759|FG001|Overall Study|Lack of Efficacy|0|||
143202988|NCT03352453|516288758|FG000|Overall Study|Withdrawal by Subject|8|||
143202989|NCT03352453|516288759|FG001|Overall Study|Withdrawal by Subject|14|||
143202990|NCT03352453|516288758|FG000|Overall Study|Study Terminated by Sponsor|2|||
143202991|NCT03352453|516288759|FG001|Overall Study|Study Terminated by Sponsor|1|||
143202992|NCT03352453|516288758|FG000|Overall Study|Protocol Deviation|1|||
143202993|NCT03352453|516288759|FG001|Overall Study|Protocol Deviation|0|||
143202994|NCT03352453|516288758|FG000|Overall Study|Lost to Follow-up|7|||
143202995|NCT03352453|516288759|FG001|Overall Study|Lost to Follow-up|6|||
143202996|NCT03352453|516288758|FG000|Overall Study|Adverse Event|2|||
143202997|NCT03352453|516288759|FG001|Overall Study|Adverse Event|9|||
143202998|NCT00459537|516288769|FG000|Overall Study|Adverse Event|1|||
143202999|NCT00459537|516288770|FG001|Overall Study|Adverse Event|6|||
143203000|NCT00459537|516288769|FG000|Overall Study|Lack of Efficacy|10|||
143203001|NCT00459537|516288770|FG001|Overall Study|Lack of Efficacy|11|||
143203002|NCT00459537|516288769|FG000|Overall Study|Withdrawal by Subject|20|||
143203003|NCT00459537|516288770|FG001|Overall Study|Withdrawal by Subject|26|||
143203004|NCT00459537|516288769|FG000|Overall Study|Lost to Follow-up|27|||
143203005|NCT00459537|516288770|FG001|Overall Study|Lost to Follow-up|30|||
143203006|NCT00459537|516288769|FG000|Overall Study|Administrative problems|3|||
143203007|NCT00459537|516288770|FG001|Overall Study|Administrative problems|0|||
143203008|NCT00459537|516288769|FG000|Overall Study|Protocol Violation|4|||
143203009|NCT00459537|516288770|FG001|Overall Study|Protocol Violation|3|||
143203010|NCT00459537|516288769|FG000|Overall Study|Missing|1|||
143203011|NCT00459537|516288770|FG001|Overall Study|Missing|0|||
143203012|NCT01831817|516288771|FG000|Overall Study|Lost to Follow-up|1|||
143203013|NCT01831817|516288772|FG001|Overall Study|Lost to Follow-up|0|||
143203014|NCT01831817|516288773|FG002|Overall Study|Lost to Follow-up|0|||
143203015|NCT01831817|516288774|FG003|Overall Study|Lost to Follow-up|0|||
143203016|NCT01831817|516288771|FG000|Overall Study|Withdrawl of Consent|3|||
143203017|NCT01831817|516288772|FG001|Overall Study|Withdrawl of Consent|0|||
143203018|NCT01831817|516288773|FG002|Overall Study|Withdrawl of Consent|0|||
143203019|NCT01831817|516288774|FG003|Overall Study|Withdrawl of Consent|0|||
143203020|NCT03159104|516288775|FG000|Overall Study|Violation of inclusion criteria|1|||
143203021|NCT03159104|516288776|FG001|Overall Study|Violation of inclusion criteria|2|||
143203022|NCT00958217|516288777|FG000|Overall Study|Death|2|||
143203023|NCT00958217|516288778|FG001|Overall Study|Death|1|||
143203024|NCT00958217|516288777|FG000|Overall Study|Withdrawal by Subject|4|||
143203025|NCT00958217|516288778|FG001|Overall Study|Withdrawal by Subject|3|||
143203026|NCT00958217|516288777|FG000|Overall Study|Lost to Follow-up|17|||
143203027|NCT00958217|516288778|FG001|Overall Study|Lost to Follow-up|19|||
143203028|NCT00958217|516288777|FG000|Overall Study|Moved out of area|1|||
143203029|NCT00958217|516288778|FG001|Overall Study|Moved out of area|1|||
143203030|NCT00958217|516288777|FG000|Overall Study|Inpatient hospitalization|0|||
143203031|NCT00958217|516288778|FG001|Overall Study|Inpatient hospitalization|1|||
143203032|NCT04573881|516288782|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
143203033|NCT01999218|516288783|FG000|Overall Study|Hyperglycemia|18|||
143203034|NCT01999218|516288784|FG001|Overall Study|Hyperglycemia|17|||
143203035|NCT01999218|516288785|FG002|Overall Study|Hyperglycemia|17|||
143203036|NCT01999218|516288783|FG000|Overall Study|Lack of Efficacy|1|||
143203037|NCT01999218|516288784|FG001|Overall Study|Lack of Efficacy|0|||
143203038|NCT01999218|516288785|FG002|Overall Study|Lack of Efficacy|1|||
143203039|NCT01999218|516288783|FG000|Overall Study|Lost to Follow-up|22|||
143203040|NCT01999218|516288784|FG001|Overall Study|Lost to Follow-up|17|||
143203041|NCT01999218|516288785|FG002|Overall Study|Lost to Follow-up|18|||
143203042|NCT01999218|516288783|FG000|Overall Study|Non-Compliance With Study Drug|6|||
143203043|NCT01999218|516288784|FG001|Overall Study|Non-Compliance With Study Drug|4|||
143203044|NCT01999218|516288785|FG002|Overall Study|Non-Compliance With Study Drug|1|||
143203045|NCT01999218|516288783|FG000|Overall Study|Physician Decision|1|||
143203046|NCT01999218|516288784|FG001|Overall Study|Physician Decision|4|||
143203047|NCT01999218|516288785|FG002|Overall Study|Physician Decision|6|||
143203048|NCT01999218|516288783|FG000|Overall Study|Protocol Violation|4|||
143203049|NCT01999218|516288784|FG001|Overall Study|Protocol Violation|5|||
143203050|NCT01999218|516288785|FG002|Overall Study|Protocol Violation|4|||
143203051|NCT01999218|516288783|FG000|Overall Study|Screen failure|0|||
143203052|NCT01999218|516288784|FG001|Overall Study|Screen failure|1|||
143203053|NCT01999218|516288785|FG002|Overall Study|Screen failure|0|||
143203054|NCT01999218|516288783|FG000|Overall Study|Study Terminated By Sponsor|7|||
143203055|NCT01999218|516288784|FG001|Overall Study|Study Terminated By Sponsor|5|||
143203056|NCT01999218|516288785|FG002|Overall Study|Study Terminated By Sponsor|12|||
143203057|NCT01999218|516288783|FG000|Overall Study|Participant moves|2|||
143203058|NCT01999218|516288784|FG001|Overall Study|Participant moves|5|||
143203059|NCT01999218|516288785|FG002|Overall Study|Participant moves|3|||
143203060|NCT01999218|516288783|FG000|Overall Study|Withdrawal by Subject|28|||
143203061|NCT01999218|516288784|FG001|Overall Study|Withdrawal by Subject|29|||
143203062|NCT01999218|516288785|FG002|Overall Study|Withdrawal by Subject|34|||
143203063|NCT01999218|516288783|FG000|Overall Study|Creatinine/eGFR|0|||
143203064|NCT01999218|516288784|FG001|Overall Study|Creatinine/eGFR|0|||
143203065|NCT01999218|516288785|FG002|Overall Study|Creatinine/eGFR|1|||
143203066|NCT01999218|516288783|FG000|Overall Study|Death|7|||
143203067|NCT01999218|516288784|FG001|Overall Study|Death|1|||
143203068|NCT01999218|516288785|FG002|Overall Study|Death|2|||
143203069|NCT01999218|516288783|FG000|Overall Study|Excluded Medication|1|||
143203070|NCT01999218|516288784|FG001|Overall Study|Excluded Medication|1|||
143203071|NCT01999218|516288785|FG002|Overall Study|Excluded Medication|2|||
143203072|NCT01999218|516288783|FG000|Overall Study|Adverse Event|9|||
143203073|NCT01999218|516288784|FG001|Overall Study|Adverse Event|7|||
143203074|NCT01999218|516288785|FG002|Overall Study|Adverse Event|7|||
143203075|NCT01999218|516288783|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
143203076|NCT01999218|516288784|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
143203077|NCT01999218|516288785|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
143203078|NCT03204890|516290484|FG000|Overall Study|Withdrawal by Subject|1|||
143203079|NCT00996801|516290485|FG000|Overall Study|Adverse Event|6|||
143203080|NCT00996801|516290486|FG001|Overall Study|Adverse Event|4|||
143203081|NCT00996801|516290487|FG002|Overall Study|Adverse Event|12|||
143203082|NCT00996801|516290488|FG003|Overall Study|Adverse Event|17|||
143203083|NCT00996801|516290489|FG004|Overall Study|Adverse Event|31|||
143203084|NCT00996801|516290490|FG005|Overall Study|Adverse Event|3|||
143203085|NCT00996801|516290485|FG000|Overall Study|Lack of Efficacy|3|||
143203086|NCT00996801|516290486|FG001|Overall Study|Lack of Efficacy|0|||
143203087|NCT00996801|516290487|FG002|Overall Study|Lack of Efficacy|1|||
143203088|NCT00996801|516290488|FG003|Overall Study|Lack of Efficacy|3|||
143203089|NCT00996801|516290489|FG004|Overall Study|Lack of Efficacy|0|||
143203090|NCT00996801|516290490|FG005|Overall Study|Lack of Efficacy|1|||
143203091|NCT00996801|516290485|FG000|Overall Study|Lost to Follow-up|0|||
143203092|NCT00996801|516290486|FG001|Overall Study|Lost to Follow-up|0|||
143203093|NCT00996801|516290487|FG002|Overall Study|Lost to Follow-up|0|||
143203094|NCT00996801|516290488|FG003|Overall Study|Lost to Follow-up|3|||
143203095|NCT00996801|516290489|FG004|Overall Study|Lost to Follow-up|3|||
143203096|NCT00996801|516290490|FG005|Overall Study|Lost to Follow-up|2|||
143203097|NCT00996801|516290485|FG000|Overall Study|Physician Decision|0|||
143203098|NCT00996801|516290486|FG001|Overall Study|Physician Decision|0|||
143203099|NCT00996801|516290487|FG002|Overall Study|Physician Decision|0|||
143203100|NCT00996801|516290488|FG003|Overall Study|Physician Decision|1|||
143203101|NCT00996801|516290489|FG004|Overall Study|Physician Decision|0|||
143203102|NCT00996801|516290490|FG005|Overall Study|Physician Decision|0|||
143203103|NCT00996801|516290485|FG000|Overall Study|Progressive Disease|0|||
143203104|NCT00996801|516290486|FG001|Overall Study|Progressive Disease|1|||
143203105|NCT00996801|516290487|FG002|Overall Study|Progressive Disease|0|||
143203106|NCT00996801|516290488|FG003|Overall Study|Progressive Disease|0|||
143203107|NCT00996801|516290489|FG004|Overall Study|Progressive Disease|0|||
143203108|NCT00996801|516290490|FG005|Overall Study|Progressive Disease|0|||
143203109|NCT00996801|516290485|FG000|Overall Study|Protocol Violation|3|||
143203110|NCT00996801|516290486|FG001|Overall Study|Protocol Violation|4|||
143203111|NCT00996801|516290487|FG002|Overall Study|Protocol Violation|1|||
143203112|NCT00996801|516290488|FG003|Overall Study|Protocol Violation|2|||
143203113|NCT00996801|516290489|FG004|Overall Study|Protocol Violation|3|||
143203114|NCT00996801|516290490|FG005|Overall Study|Protocol Violation|4|||
143203115|NCT00996801|516290485|FG000|Overall Study|Study Terminated by Sponsor|0|||
143203116|NCT00996801|516290486|FG001|Overall Study|Study Terminated by Sponsor|1|||
143203117|NCT00996801|516290487|FG002|Overall Study|Study Terminated by Sponsor|0|||
143203118|NCT00996801|516290488|FG003|Overall Study|Study Terminated by Sponsor|0|||
143203119|NCT00996801|516290489|FG004|Overall Study|Study Terminated by Sponsor|46|||
143203120|NCT00996801|516290490|FG005|Overall Study|Study Terminated by Sponsor|0|||
143203121|NCT00996801|516290485|FG000|Overall Study|Withdrawal by Subject|8|||
143203122|NCT00996801|516290486|FG001|Overall Study|Withdrawal by Subject|6|||
143203123|NCT00996801|516290487|FG002|Overall Study|Withdrawal by Subject|9|||
143203124|NCT00996801|516290488|FG003|Overall Study|Withdrawal by Subject|5|||
143203125|NCT00996801|516290489|FG004|Overall Study|Withdrawal by Subject|5|||
143203126|NCT00996801|516290490|FG005|Overall Study|Withdrawal by Subject|9|||
143203127|NCT01688739|516290491|FG000|Overall Study|Administrative Decision|1|||
143203128|NCT01688739|516290492|FG001|Overall Study|Administrative Decision|0|||
143203129|NCT01688739|516290493|FG002|Overall Study|Administrative Decision|0|||
143203130|NCT01688739|516290494|FG003|Overall Study|Administrative Decision|0|||
143203131|NCT01688739|516290495|FG004|Overall Study|Administrative Decision|0|||
143203132|NCT01688739|516290496|FG005|Overall Study|Administrative Decision|0|||
143203133|NCT01688739|516290497|FG006|Overall Study|Administrative Decision|0|||
143203134|NCT01688739|516290498|FG007|Overall Study|Administrative Decision|0|||
143203135|NCT01688739|516290499|FG008|Overall Study|Administrative Decision|0|||
143203136|NCT01688739|516290500|FG009|Overall Study|Administrative Decision|0|||
143203137|NCT03369431|516290502|FG000|Overall Study|Lost to Follow-up|1|||
143203138|NCT03369431|516290503|FG001|Overall Study|Lost to Follow-up|3|||
143203139|NCT03369431|516290502|FG000|Overall Study|Withdrawal by Subject|2|||
143203140|NCT03369431|516290503|FG001|Overall Study|Withdrawal by Subject|3|||
143203141|NCT03369431|516290502|FG000|Overall Study|Protocol Violation|1|||
143203142|NCT03369431|516290503|FG001|Overall Study|Protocol Violation|1|||
143203143|NCT01657760|516290504|FG000|Overall Study|Withdrawal by Subject|0|||
143203144|NCT01657760|516290505|FG001|Overall Study|Withdrawal by Subject|0|||
143203145|NCT01657760|516290506|FG002|Overall Study|Withdrawal by Subject|0|||
143203146|NCT01657760|516290507|FG003|Overall Study|Withdrawal by Subject|1|||
143203147|NCT01657760|516290504|FG000|Overall Study|Physician Decision|1|||
143203148|NCT01657760|516290505|FG001|Overall Study|Physician Decision|1|||
143203149|NCT01657760|516290506|FG002|Overall Study|Physician Decision|1|||
143203150|NCT01657760|516290507|FG003|Overall Study|Physician Decision|2|||
143203151|NCT01113580|516290510|FG000|Overall Study|Protocol Violation|1|||
143203152|NCT01113580|516290511|FG001|Overall Study|Protocol Violation|0|||
143203153|NCT00293709|516290519|FG000|Overall Study|Other|47|||
143203154|NCT01146652|516290520|FG000|Overall Study|Adverse Event|506|||
143203155|NCT01146652|516290521|FG001|Overall Study|Adverse Event|15|||
143203156|NCT01146652|516290520|FG000|Overall Study|Lack of Efficacy|91|||
143203157|NCT01146652|516290521|FG001|Overall Study|Lack of Efficacy|7|||
143262641|NCT00366340|516515906|FG001|Infant Series|Failure to return|0|||
143203158|NCT01146652|516290520|FG000|Overall Study|Poor compliance to protocol|38|||
143203159|NCT01146652|516290521|FG001|Overall Study|Poor compliance to protocol|1|||
143203160|NCT01146652|516290520|FG000|Overall Study|Other unspecified reasons|314|||
143203161|NCT01146652|516290521|FG001|Overall Study|Other unspecified reasons|22|||
143203162|NCT01146652|516290520|FG000|Overall Study|Enrolled but not treated|2|||
143203163|NCT01146652|516290521|FG001|Overall Study|Enrolled but not treated|0|||
143203164|NCT02118597|516290523|FG000|Overall Study|Sponsor terminated the study|14|||
143203165|NCT02118597|516290523|FG000|Overall Study|Serious Adverse Event|1|||
143203166|NCT02118597|516290523|FG000|Overall Study|Investigator's decision|1|||
143203167|NCT02590562|516290528|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
143203168|NCT00824005|516290529|FG000|Overall Study|Death|0|||
143203169|NCT00824005|516290530|FG001|Overall Study|Death|1|||
143203170|NCT00824005|516290529|FG000|Overall Study|Lost to Follow-up|0|||
143203171|NCT00824005|516290530|FG001|Overall Study|Lost to Follow-up|1|||
143203172|NCT02677844|516290531|FG000|Period 3|Withdrawal by Subject|0|||
143203173|NCT02677844|516290532|FG001|Period 3|Withdrawal by Subject|0|||
143203174|NCT02677844|516290533|FG002|Period 3|Withdrawal by Subject|0|||
143203175|NCT02677844|516290534|FG003|Period 3|Withdrawal by Subject|1|||
143203176|NCT02677844|516290535|FG004|Period 3|Withdrawal by Subject|0|||
143203177|NCT02677844|516290536|FG005|Period 3|Withdrawal by Subject|0|||
143203178|NCT02677844|516290537|FG006|Period 3|Withdrawal by Subject|0|||
143203179|NCT03458702|516290538|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
143203180|NCT03458702|516290539|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
143203181|NCT03458702|516290538|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
143203182|NCT03458702|516290539|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
143203183|NCT01390779|516290540|FG000|Overall Study|Physician Decision|1|||
143203184|NCT01697462|516290541|FG000|Overall Study|Disease Progression|1|||
143203185|NCT01697462|516290541|FG000|Overall Study|Adverse Event|6|||
143203186|NCT01697462|516290541|FG000|Overall Study|Lost to Follow-up|21|||
143203187|NCT01697462|516290541|FG000|Overall Study|Withdrawal by Subject|12|||
143203188|NCT01697462|516290541|FG000|Overall Study|Investigator Decision|21|||
143203189|NCT01697462|516290541|FG000|Overall Study|Death|1|||
143203190|NCT01697462|516290541|FG000|Overall Study|Other|10|||
143203191|NCT01697462|516290541|FG000|Overall Study|Missing|5|||
143203192|NCT00168103|516290542|FG000|Overall Study|Withdrawal by Subject|1|||
143203193|NCT00168103|516290543|FG001|Overall Study|Withdrawal by Subject|2|||
143203194|NCT00168103|516290544|FG002|Overall Study|Withdrawal by Subject|1|||
143203195|NCT00168103|516290545|FG003|Overall Study|Withdrawal by Subject|0|||
143203196|NCT00168103|516290542|FG000|Overall Study|Lost to Follow-up|1|||
143203197|NCT00168103|516290543|FG001|Overall Study|Lost to Follow-up|3|||
143203198|NCT00168103|516290544|FG002|Overall Study|Lost to Follow-up|0|||
143203199|NCT00168103|516290545|FG003|Overall Study|Lost to Follow-up|0|||
143203200|NCT00545532|516290546|FG000|Overall Study|Withdrawal by Subject|1|||
143203201|NCT00545532|516290547|FG001|Overall Study|Withdrawal by Subject|3|||
143203202|NCT00545532|516290546|FG000|Overall Study|Lost to Follow-up|5|||
143203203|NCT00545532|516290547|FG001|Overall Study|Lost to Follow-up|6|||
143203204|NCT00545532|516290546|FG000|Overall Study|Death|0|||
143203205|NCT00545532|516290547|FG001|Overall Study|Death|1|||
143203206|NCT03630302|516290548|FG000|Surgery|hardware issue prevented LFP recordings|1|||
143203207|NCT03630302|516290548|FG000|3 Month Visit|Adverse Event|2|||
143203208|NCT03630302|516290548|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
143203209|NCT03532932|516290552|FG000|Overall Study|Protocol Deviation|33|||
143203210|NCT03532932|516290553|FG001|Overall Study|Protocol Deviation|31|||
143203211|NCT03532932|516290552|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
143203212|NCT03532932|516290553|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
143203213|NCT03532932|516290552|FG000|Overall Study|Withdrawal by Subject|2|||
143203214|NCT03532932|516290553|FG001|Overall Study|Withdrawal by Subject|0|||
143203215|NCT03532932|516290552|FG000|Overall Study|Lost to Follow-up|15|||
143203216|NCT03532932|516290553|FG001|Overall Study|Lost to Follow-up|9|||
143203217|NCT03532932|516290552|FG000|Overall Study|Adverse Event|4|||
143203218|NCT03532932|516290553|FG001|Overall Study|Adverse Event|3|||
143203219|NCT03532932|516290552|FG000|Overall Study|Death|0|||
143203220|NCT03532932|516290553|FG001|Overall Study|Death|2|||
143203221|NCT03532932|516290552|FG000|Overall Study|Other|11|||
143203222|NCT03532932|516290553|FG001|Overall Study|Other|16|||
143203223|NCT00931801|516290557|FG000|Overall Study|Adverse Event|0|||
143203224|NCT00931801|516290558|FG001|Overall Study|Adverse Event|0|||
143203225|NCT00931801|516290559|FG002|Overall Study|Adverse Event|1|||
143203226|NCT00931801|516290557|FG000|Overall Study|Lost to Follow-up|0|||
143203227|NCT00931801|516290558|FG001|Overall Study|Lost to Follow-up|1|||
143203228|NCT00931801|516290559|FG002|Overall Study|Lost to Follow-up|0|||
143203229|NCT00931801|516290557|FG000|Overall Study|Withdrawal by Subject|1|||
143203230|NCT00931801|516290558|FG001|Overall Study|Withdrawal by Subject|0|||
143203231|NCT00931801|516290559|FG002|Overall Study|Withdrawal by Subject|0|||
143203232|NCT00931801|516290557|FG000|Overall Study|Confirmed Virologic Failure|0|||
143203233|NCT00931801|516290558|FG001|Overall Study|Confirmed Virologic Failure|0|||
143203234|NCT00931801|516290559|FG002|Overall Study|Confirmed Virologic Failure|3|||
143203235|NCT03283150|516290560|FG000|Overall Study|Withdrawal by Subject|6|||
143203236|NCT03283150|516290561|FG001|Overall Study|Withdrawal by Subject|0|||
143203237|NCT03283150|516290562|FG002|Overall Study|Withdrawal by Subject|0|||
143203238|NCT01133275|516290563|FG000|Overall Study|Withdrawal by Subject|1|||
143203239|NCT01133275|516290563|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
143203240|NCT01028716|516290564|FG000|Overall Study|Physician Decision|1|||
143203241|NCT01143896|516290565|FG000|Overall Study|Did not complete Baseline Interview|5|||
143203242|NCT01143896|516290566|FG001|Overall Study|Did not complete Baseline Interview|4|||
143203243|NCT01143896|516290565|FG000|Overall Study|Lost to Follow-up|18|||
143203244|NCT01143896|516290566|FG001|Overall Study|Lost to Follow-up|13|||
143203245|NCT01143896|516290565|FG000|Overall Study|Withdrawal by Subject|13|||
143203246|NCT01143896|516290566|FG001|Overall Study|Withdrawal by Subject|5|||
143203247|NCT01143896|516290565|FG000|Overall Study|Death|6|||
143203248|NCT01143896|516290566|FG001|Overall Study|Death|3|||
143203249|NCT04375397|516290569|FG000|Overall Study|Death|1|||
143203250|NCT04375397|516290570|FG001|Overall Study|Death|1|||
143203251|NCT04375397|516290569|FG000|Overall Study|Withdrew consent|2|||
143203252|NCT04375397|516290570|FG001|Overall Study|Withdrew consent|0|||
143203253|NCT04375397|516290569|FG000|Overall Study|Lost to Follow-up|6|||
143203254|NCT04375397|516290570|FG001|Overall Study|Lost to Follow-up|4|||
143203255|NCT04375397|516290569|FG000|Overall Study|Other, not specified|0|||
143370214|NCT00246012|516899131|FG008|Overall Study|Adverse Event|2|||
143370215|NCT00246012|516899123|FG000|Overall Study|Withdrawal by Subject|0|||
143370216|NCT00246012|516899124|FG001|Overall Study|Withdrawal by Subject|0|||
143370217|NCT00246012|516899125|FG002|Overall Study|Withdrawal by Subject|0|||
143370218|NCT00246012|516899126|FG003|Overall Study|Withdrawal by Subject|0|||
143203256|NCT04375397|516290570|FG001|Overall Study|Other, not specified|1|||
143203257|NCT00086502|516290571|FG000|Overall Study|Adverse Event|11|||
143203258|NCT00086502|516290572|FG001|Overall Study|Adverse Event|2|||
143203259|NCT00086502|516290571|FG000|Overall Study|Lack of Efficacy|0|||
143203260|NCT00086502|516290572|FG001|Overall Study|Lack of Efficacy|2|||
143203261|NCT00086502|516290571|FG000|Overall Study|Lost to Follow-up|3|||
143203262|NCT00086502|516290572|FG001|Overall Study|Lost to Follow-up|1|||
143203263|NCT00086502|516290571|FG000|Overall Study|Physician Decision|1|||
143203264|NCT00086502|516290572|FG001|Overall Study|Physician Decision|1|||
143203265|NCT00086502|516290571|FG000|Overall Study|Pregnancy|0|||
143203266|NCT00086502|516290572|FG001|Overall Study|Pregnancy|1|||
143203267|NCT00086502|516290571|FG000|Overall Study|Protocol Violation|3|||
143203268|NCT00086502|516290572|FG001|Overall Study|Protocol Violation|3|||
143203269|NCT00086502|516290571|FG000|Overall Study|Withdrawal by Subject|5|||
143203270|NCT00086502|516290572|FG001|Overall Study|Withdrawal by Subject|6|||
143203271|NCT00086502|516290571|FG000|Overall Study|Patient Moved|1|||
143203272|NCT00086502|516290572|FG001|Overall Study|Patient Moved|1|||
143203273|NCT00086502|516290571|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
143203274|NCT00086502|516290572|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
143203275|NCT00086502|516290571|FG000|Overall Study|Patient Accidentally Unblinded|1|||
143203276|NCT00086502|516290572|FG001|Overall Study|Patient Accidentally Unblinded|0|||
143370219|NCT00246012|516899127|FG004|Overall Study|Withdrawal by Subject|0|||
143203277|NCT00493636|516290577|FG000|Overall Study|Withdrawal by Subject|1|||
143203278|NCT00493636|516290578|FG001|Overall Study|Withdrawal by Subject|0|||
143203279|NCT00493636|516290577|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
143203280|NCT00493636|516290578|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
143203281|NCT00493636|516290577|FG000|Overall Study|Mis-randomization|1|||
143203282|NCT00493636|516290578|FG001|Overall Study|Mis-randomization|1|||
143203283|NCT02012686|516290579|FG000|Overall Study|muscle contraction|0|||
143203284|NCT02012686|516290580|FG001|Overall Study|muscle contraction|1|||
143203285|NCT02012686|516290579|FG000|Overall Study|electrocardiography monitoring noise|0|||
143203286|NCT02012686|516290580|FG001|Overall Study|electrocardiography monitoring noise|1|||
143203287|NCT01241760|516290584|FG000|Overall Study|Adverse Event|1|||
143203288|NCT01241760|516290585|FG001|Overall Study|Adverse Event|0|||
143203289|NCT01241760|516290584|FG000|Overall Study|Lost to Follow-up|18|||
143203290|NCT01241760|516290585|FG001|Overall Study|Lost to Follow-up|22|||
143203291|NCT01241760|516290584|FG000|Overall Study|Withdrawal by Subject|13|||
143203292|NCT01241760|516290585|FG001|Overall Study|Withdrawal by Subject|13|||
143203293|NCT01241760|516290584|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
143203294|NCT01241760|516290585|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
143203295|NCT01241760|516290584|FG000|Overall Study|Other|1|||
143203296|NCT01241760|516290585|FG001|Overall Study|Other|1|||
143203297|NCT02725593|516290586|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
143203298|NCT02725593|516290587|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
143203299|NCT02725593|516290586|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
143203300|NCT02725593|516290587|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
143203301|NCT02725593|516290586|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
143203302|NCT02725593|516290587|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
143203303|NCT02725593|516290586|FG000|Long Term Extension|Withdrawal by Subject|1|||
143203304|NCT02725593|516290587|FG001|Long Term Extension|Withdrawal by Subject|3|||
143203305|NCT00514020|516290588|FG000|Overall Study|Adverse Event|6|||
143203306|NCT00514020|516290588|FG000|Overall Study|Withdrawal by Subject|3|||
143262642|NCT00366340|516515905|FG000|After the Infant Series|Parent/legal guardian request|1|||
143262643|NCT00366340|516515906|FG001|After the Infant Series|Parent/legal guardian request|1|||
143262644|NCT00366340|516515905|FG000|After the Infant Series|Failed to return|0|||
143262645|NCT00366340|516515906|FG001|After the Infant Series|Failed to return|1|||
143262646|NCT00366340|516515905|FG000|After the Infant Series|Protocol Violation|2|||
143262647|NCT00366340|516515906|FG001|After the Infant Series|Protocol Violation|2|||
143203307|NCT00514020|516290588|FG000|Overall Study|Physician Decision|1|||
143203308|NCT00514020|516290588|FG000|Overall Study|disease progression|9|||
143203309|NCT00514020|516290588|FG000|Overall Study|other complicating disease|2|||
143203310|NCT00514020|516290588|FG000|Overall Study|patient went to radiation treatment|1|||
143203311|NCT00514020|516290588|FG000|Overall Study|"patients moved to the no tx group"|6|||
143203312|NCT03089944|516290589|FG000|Overall Study|Lost to Follow-up|8|||
143203313|NCT03089944|516290589|FG000|Overall Study|Withdrew Consent|2|||
143203314|NCT03089944|516290589|FG000|Overall Study|Adverse Event|1|||
143203315|NCT03089944|516290589|FG000|Overall Study|Other|1|||
143203316|NCT01688921|516290590|FG000|Overall Study|Lost to Follow-up|7|||
143203317|NCT01688921|516290591|FG001|Overall Study|Lost to Follow-up|13|||
143203318|NCT01688921|516290590|FG000|Overall Study|Physician Decision|6|||
143203319|NCT01688921|516290591|FG001|Overall Study|Physician Decision|1|||
143203320|NCT01688921|516290590|FG000|Overall Study|Protocol Violation|0|||
143203321|NCT01688921|516290591|FG001|Overall Study|Protocol Violation|1|||
143203322|NCT01688921|516290590|FG000|Overall Study|informed consent|3|||
143203323|NCT01688921|516290591|FG001|Overall Study|informed consent|0|||
143203324|NCT01636713|516290596|FG000|Overall Study|Adverse Event|16|||
143262648|NCT00366340|516515905|FG000|After the Infant Series|Adverse Event|0|||
143203325|NCT01636713|516290597|FG001|Overall Study|Adverse Event|16|||
143203326|NCT01636713|516290598|FG002|Overall Study|Adverse Event|7|||
143203327|NCT01636713|516290596|FG000|Overall Study|Lack of Efficacy|6|||
143203328|NCT01636713|516290597|FG001|Overall Study|Lack of Efficacy|6|||
143203329|NCT01636713|516290598|FG002|Overall Study|Lack of Efficacy|2|||
143203330|NCT01636713|516290596|FG000|Overall Study|Protocol Violation|3|||
143203331|NCT01636713|516290597|FG001|Overall Study|Protocol Violation|0|||
143203332|NCT01636713|516290598|FG002|Overall Study|Protocol Violation|1|||
143203333|NCT01636713|516290596|FG000|Overall Study|Lost to Follow-up|0|||
143203334|NCT01636713|516290597|FG001|Overall Study|Lost to Follow-up|0|||
143203335|NCT01636713|516290598|FG002|Overall Study|Lost to Follow-up|1|||
143203336|NCT01636713|516290596|FG000|Overall Study|Withdrawal by Subject|5|||
143203337|NCT01636713|516290597|FG001|Overall Study|Withdrawal by Subject|4|||
143203338|NCT01636713|516290598|FG002|Overall Study|Withdrawal by Subject|8|||
143203339|NCT01636713|516290596|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
143203340|NCT01636713|516290597|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
143203341|NCT01636713|516290598|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
143203342|NCT03689244|516290601|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
143203343|NCT03689244|516290602|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
143203344|NCT03689244|516290603|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
143203345|NCT03689244|516290604|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
143203346|NCT03689244|516290601|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
143203347|NCT03689244|516290602|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
143203348|NCT03689244|516290603|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
143203349|NCT03689244|516290604|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
143203350|NCT03689244|516290601|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
143203351|NCT03689244|516290602|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
143203352|NCT03689244|516290603|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
143203353|NCT03689244|516290604|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
143203354|NCT03689244|516290601|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
143203355|NCT03689244|516290602|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
143203356|NCT03689244|516290603|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
143203357|NCT03689244|516290604|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
143203358|NCT03689244|516290601|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
143203359|NCT03689244|516290602|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
143203360|NCT03689244|516290603|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
143203361|NCT03689244|516290604|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
143203362|NCT03689244|516290601|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
143203363|NCT03689244|516290602|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
143203364|NCT03689244|516290603|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
143203365|NCT03689244|516290604|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
143203366|NCT03689244|516290601|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
143203367|NCT03689244|516290602|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
143203368|NCT03689244|516290603|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
143203369|NCT03689244|516290604|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
143203370|NCT03689244|516290601|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
143203371|NCT03689244|516290602|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
143203372|NCT03689244|516290603|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
143203373|NCT03689244|516290604|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
143203374|NCT01490294|516290610|FG000|Overall Study|Prematurely discontinuation|4|||
143203375|NCT01490294|516290611|FG001|Overall Study|Prematurely discontinuation|0|||
143203376|NCT01490294|516290612|FG002|Overall Study|Prematurely discontinuation|1|||
143203377|NCT01490294|516290613|FG003|Overall Study|Prematurely discontinuation|1|||
143203378|NCT01490294|516290610|FG000|Overall Study|Adverse Event|1|||
143203379|NCT01490294|516290611|FG001|Overall Study|Adverse Event|0|||
143203380|NCT01490294|516290612|FG002|Overall Study|Adverse Event|0|||
143203381|NCT01490294|516290613|FG003|Overall Study|Adverse Event|0|||
143203382|NCT01751776|516290616|FG000|Overall Study|Adverse Event|0|||
143203383|NCT01751776|516290617|FG001|Overall Study|Adverse Event|0|||
143203384|NCT01751776|516290618|FG002|Overall Study|Adverse Event|0|||
143203385|NCT01751776|516290619|FG003|Overall Study|Adverse Event|0|||
143203386|NCT01751776|516290620|FG004|Overall Study|Adverse Event|0|||
143370220|NCT00246012|516899128|FG005|Overall Study|Withdrawal by Subject|1|||
143370221|NCT00246012|516899129|FG006|Overall Study|Withdrawal by Subject|0|||
143370222|NCT00246012|516899130|FG007|Overall Study|Withdrawal by Subject|0|||
143370223|NCT00246012|516899131|FG008|Overall Study|Withdrawal by Subject|0|||
143370224|NCT00246012|516899123|FG000|Overall Study|Disease progression|3|||
143370225|NCT00246012|516899124|FG001|Overall Study|Disease progression|1|||
143370226|NCT00246012|516899125|FG002|Overall Study|Disease progression|2|||
143370227|NCT00246012|516899126|FG003|Overall Study|Disease progression|3|||
143203387|NCT01751776|516290621|FG005|Overall Study|Adverse Event|0|||
143203388|NCT01751776|516290622|FG006|Overall Study|Adverse Event|4|||
143203389|NCT01751776|516290623|FG007|Overall Study|Adverse Event|2|||
143203390|NCT01751776|516290616|FG000|Overall Study|Consent withdrawn|0|||
143203391|NCT01751776|516290617|FG001|Overall Study|Consent withdrawn|0|||
143203392|NCT01751776|516290618|FG002|Overall Study|Consent withdrawn|0|||
143203393|NCT01751776|516290619|FG003|Overall Study|Consent withdrawn|0|||
143203394|NCT01751776|516290620|FG004|Overall Study|Consent withdrawn|0|||
143203395|NCT01751776|516290621|FG005|Overall Study|Consent withdrawn|0|||
143203396|NCT01751776|516290622|FG006|Overall Study|Consent withdrawn|0|||
143203397|NCT01751776|516290623|FG007|Overall Study|Consent withdrawn|1|||
143203398|NCT01751776|516290616|FG000|Overall Study|Other reason not specified above|0|||
143203399|NCT01751776|516290617|FG001|Overall Study|Other reason not specified above|0|||
143203400|NCT01751776|516290618|FG002|Overall Study|Other reason not specified above|0|||
143203401|NCT01751776|516290619|FG003|Overall Study|Other reason not specified above|0|||
143203402|NCT01751776|516290620|FG004|Overall Study|Other reason not specified above|0|||
143203403|NCT01751776|516290621|FG005|Overall Study|Other reason not specified above|0|||
143203404|NCT01751776|516290622|FG006|Overall Study|Other reason not specified above|0|||
143203405|NCT01751776|516290623|FG007|Overall Study|Other reason not specified above|1|||
143203406|NCT00160654|516290624|FG000|Overall Study|Adverse Event|14|||
143203407|NCT00160654|516290624|FG000|Overall Study|Lack of Efficacy|4|||
143203408|NCT00160654|516290624|FG000|Overall Study|Lost to Follow-up|2|||
143203409|NCT00160654|516290624|FG000|Overall Study|Intake of expired drug|7|||
143203410|NCT00160654|516290624|FG000|Overall Study|Psychological trauma|1|||
143203411|NCT00160654|516290624|FG000|Overall Study|Sponsor decision|1|||
143203412|NCT00160654|516290624|FG000|Overall Study|Patient met exclusion criteria|1|||
143203413|NCT00160654|516290624|FG000|Overall Study|Patient decision|1|||
143203414|NCT00160654|516290624|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
143203415|NCT00160654|516290624|FG000|Overall Study|Met exclusion criteria|1|||
143203416|NCT02644356|516290625|FG000|Overall Study|Withdrawal by Subject|2|||
143203417|NCT02210091|516290627|FG000|Overall Study|Physician Decision|0|||
143203418|NCT02210091|516290628|FG001|Overall Study|Physician Decision|1|||
143370228|NCT00246012|516899127|FG004|Overall Study|Disease progression|3|||
143370229|NCT00246012|516899128|FG005|Overall Study|Disease progression|25|||
143203419|NCT02210091|516290627|FG000|Overall Study|Withdrawal by Sponsor|0|||
143203420|NCT02210091|516290628|FG001|Overall Study|Withdrawal by Sponsor|1|||
143203421|NCT01711866|516290629|FG000|Overall Study|Noncompliant|3|||
143203422|NCT01711866|516290629|FG000|Overall Study|Withdrawal by Subject|3|||
143203423|NCT01711866|516290629|FG000|Overall Study|Adverse Event|2|||
143203424|NCT00897390|516290630|FG000|Overall Study|Adverse Event|2|||
143203425|NCT00897390|516290630|FG000|Overall Study|No Longer Met Study Criteria|1|||
143203426|NCT00897390|516290630|FG000|Overall Study|Personal Reasons|1|||
143203427|NCT00897390|516290630|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
143203428|NCT00546260|516290635|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
143203429|NCT00546260|516290636|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
143203430|NCT03780959|516290637|FG000|Part 1|Adverse Event|1|||
143203431|NCT03780959|516290638|FG001|Part 1|Adverse Event|0|||
143203432|NCT03780959|516290639|FG002|Part 1|Adverse Event|0|||
143203433|NCT03780959|516290637|FG000|Part 1|Withdrawal by Subject|1|||
143203434|NCT03780959|516290638|FG001|Part 1|Withdrawal by Subject|0|||
143203435|NCT03780959|516290639|FG002|Part 1|Withdrawal by Subject|0|||
143203436|NCT03780959|516290637|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
143203437|NCT03780959|516290638|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
143203438|NCT03780959|516290639|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
143203439|NCT03780959|516290637|FG000|Part 1|Response Status|2|||
143203440|NCT03780959|516290638|FG001|Part 1|Response Status|0|||
143203441|NCT03780959|516290639|FG002|Part 1|Response Status|0|||
143203442|NCT03780959|516290637|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
143203443|NCT03780959|516290638|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
143203444|NCT03780959|516290639|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
143203445|NCT03780959|516290637|FG000|Part 2|Response Status|0|||
143203446|NCT03780959|516290638|FG001|Part 2|Response Status|18|||
143203447|NCT03780959|516290639|FG002|Part 2|Response Status|6|||
143203448|NCT03647267|516292161|FG000|Overall Study|Lost to Follow-up|1|||
143203449|NCT03647267|516292162|FG001|Overall Study|Lost to Follow-up|0|||
143203450|NCT04938037|516292163|FG000|Overall Study|Lost to Follow-up|4|||
143203451|NCT04938037|516292164|FG001|Overall Study|Lost to Follow-up|3|||
143203452|NCT03323736|516292165|FG000|Overall Study|Screen Failure|14|||
143370230|NCT00246012|516899129|FG006|Overall Study|Disease progression|30|||
143203453|NCT03323736|516292166|FG001|Overall Study|Screen Failure|9|||
143203454|NCT03323736|516292167|FG002|Overall Study|Screen Failure|1|||
143203455|NCT03323736|516292165|FG000|Overall Study|Withdrawal Before Treatment|3|||
143203456|NCT03323736|516292166|FG001|Overall Study|Withdrawal Before Treatment|1|||
143203457|NCT03323736|516292167|FG002|Overall Study|Withdrawal Before Treatment|1|||
143203458|NCT03323736|516292165|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
143203459|NCT03323736|516292166|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
143203460|NCT03323736|516292167|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
143203461|NCT01549873|516292169|FG000|Overall Study|Physician Decision|0|||
143203462|NCT01549873|516292170|FG001|Overall Study|Physician Decision|1|||
143203463|NCT02804750|516292182|FG000|Period 1|Adverse Event|0|||
143203464|NCT02804750|516292183|FG001|Period 1|Adverse Event|2|||
143203465|NCT02804750|516292182|FG000|Period 1|Withdrawal by Subject|0|||
143203466|NCT02804750|516292183|FG001|Period 1|Withdrawal by Subject|1|||
143203467|NCT02804750|516292182|FG000|Period 2|Adverse Event|1|||
143203468|NCT02804750|516292183|FG001|Period 2|Adverse Event|0|||
143203469|NCT02804750|516292182|FG000|Period 3|Adverse Event|0|||
143203470|NCT02804750|516292183|FG001|Period 3|Adverse Event|2|||
143203471|NCT02804750|516292182|FG000|Period 4|Adverse Event|0|||
143203472|NCT02804750|516292183|FG001|Period 4|Adverse Event|5|||
143203473|NCT02559414|516292184|FG000|Overall Study|Lost to Follow-up|0|||
143203474|NCT02559414|516292185|FG001|Overall Study|Lost to Follow-up|1|||
143203475|NCT02559414|516292186|FG002|Overall Study|Lost to Follow-up|0|||
143203476|NCT02559414|516292184|FG000|Overall Study|Withdrawal by Subject|1|||
143203477|NCT02559414|516292185|FG001|Overall Study|Withdrawal by Subject|0|||
143203478|NCT02559414|516292186|FG002|Overall Study|Withdrawal by Subject|1|||
143203479|NCT02559414|516292184|FG000|Overall Study|Other|0|||
143203480|NCT02559414|516292185|FG001|Overall Study|Other|1|||
143203481|NCT02559414|516292186|FG002|Overall Study|Other|1|||
143203482|NCT00004445|516292191|FG000|Overall Study|Physician Decision|2|||
143203483|NCT00004445|516292191|FG000|Overall Study|Withdrawal by Subject|1|||
143203484|NCT04619004|516292195|FG000|Overall Study|Death|114|||
143203485|NCT04619004|516292196|FG001|Overall Study|Death|28|||
143203486|NCT04619004|516292195|FG000|Overall Study|Lost to Follow-up|1|||
143203487|NCT04619004|516292196|FG001|Overall Study|Lost to Follow-up|1|||
143203488|NCT04619004|516292195|FG000|Overall Study|Withdrawal by Subject|24|||
143203489|NCT04619004|516292196|FG001|Overall Study|Withdrawal by Subject|7|||
143203490|NCT04619004|516292195|FG000|Overall Study|Other - Not specified|0|||
143203491|NCT04619004|516292196|FG001|Overall Study|Other - Not specified|1|||
143203492|NCT01114360|516292203|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
143203493|NCT01114360|516292204|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
143203494|NCT03106415|516292205|FG000|Phase 1|Withdrawal by Subject|1|||
143203495|NCT03106415|516292206|FG001|Phase 1|Withdrawal by Subject|0|||
143203496|NCT03106415|516292207|FG002|Phase 1|Withdrawal by Subject|0|||
143203497|NCT03106415|516292205|FG000|Phase 1|Adverse Event|1|||
143203498|NCT03106415|516292206|FG001|Phase 1|Adverse Event|1|||
143203499|NCT03106415|516292207|FG002|Phase 1|Adverse Event|0|||
143203500|NCT03106415|516292205|FG000|Phase 1|Protocol Violation|0|||
143203501|NCT03106415|516292206|FG001|Phase 1|Protocol Violation|1|||
143203502|NCT03106415|516292207|FG002|Phase 1|Protocol Violation|0|||
143203503|NCT01804582|516292212|FG000|Overall Study|Lost to Follow-up|47|||
143203504|NCT01804582|516292213|FG001|Overall Study|Lost to Follow-up|56|||
143203505|NCT01804582|516292212|FG000|Overall Study|Physician Decision|2|||
143203506|NCT01804582|516292213|FG001|Overall Study|Physician Decision|0|||
143203507|NCT00875056|516292216|FG000|Overall Study|Adverse Event|6|||
143203508|NCT00875056|516292217|FG001|Overall Study|Adverse Event|1|||
143203509|NCT00875056|516292218|FG002|Overall Study|Adverse Event|2|||
143203510|NCT00875056|516292216|FG000|Overall Study|Progressive Disease|14|||
143203511|NCT00875056|516292217|FG001|Overall Study|Progressive Disease|8|||
143203512|NCT00875056|516292218|FG002|Overall Study|Progressive Disease|3|||
143203513|NCT00875056|516292216|FG000|Overall Study|Withdrawal by Subject|3|||
143203514|NCT00875056|516292217|FG001|Overall Study|Withdrawal by Subject|0|||
143203515|NCT00875056|516292218|FG002|Overall Study|Withdrawal by Subject|1|||
143203516|NCT01318070|516292219|FG000|Overall Study|Adverse Event|1|||
143203517|NCT01318070|516292220|FG001|Overall Study|Adverse Event|1|||
143203518|NCT01318070|516292221|FG002|Overall Study|Adverse Event|5|||
143203519|NCT01318070|516292219|FG000|Overall Study|Withdrawal by Subject|0|||
143203520|NCT01318070|516292220|FG001|Overall Study|Withdrawal by Subject|1|||
143203521|NCT01318070|516292221|FG002|Overall Study|Withdrawal by Subject|1|||
143203522|NCT01318070|516292219|FG000|Overall Study|Lack of Efficacy|0|||
143203523|NCT01318070|516292220|FG001|Overall Study|Lack of Efficacy|0|||
143203524|NCT01318070|516292221|FG002|Overall Study|Lack of Efficacy|1|||
143203525|NCT01318070|516292219|FG000|Overall Study|Principal Investigator Discretion|1|||
143203526|NCT01318070|516292220|FG001|Overall Study|Principal Investigator Discretion|0|||
143203527|NCT01318070|516292221|FG002|Overall Study|Principal Investigator Discretion|0|||
143203528|NCT05545644|516292223|FG000|Overall Study|Lost to Follow-up|4|||
143203529|NCT05545644|516292224|FG001|Overall Study|Lost to Follow-up|3|||
143203530|NCT00610441|516292225|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
143203531|NCT00610441|516292226|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
143370231|NCT00246012|516899130|FG007|Overall Study|Disease progression|27|||
143203532|NCT00610441|516292227|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
143203533|NCT00610441|516292228|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
143203534|NCT00610441|516292225|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
143203535|NCT00610441|516292226|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
143203536|NCT00610441|516292227|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
143203537|NCT00610441|516292228|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
143203538|NCT00610441|516292225|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
143203539|NCT00610441|516292226|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
143203540|NCT00610441|516292227|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
143203541|NCT00610441|516292228|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
143203542|NCT00610441|516292225|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
143203543|NCT00610441|516292226|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
143203544|NCT00610441|516292227|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
143203545|NCT00610441|516292228|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
143203546|NCT00610441|516292225|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
143203547|NCT00610441|516292226|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
143203548|NCT00610441|516292227|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
143203549|NCT00610441|516292228|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
143203550|NCT00610441|516292225|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
143203551|NCT00610441|516292226|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
143203552|NCT00610441|516292227|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
143203553|NCT00610441|516292228|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
143203554|NCT00610441|516292225|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
143203555|NCT00610441|516292226|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
143203556|NCT00610441|516292227|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
143370232|NCT00246012|516899131|FG008|Overall Study|Disease progression|26|||
143203557|NCT00610441|516292228|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
143203558|NCT00610441|516292225|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
143203559|NCT00610441|516292226|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
143203560|NCT00610441|516292227|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
143203561|NCT00610441|516292228|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
143203562|NCT00610441|516292225|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
143203563|NCT00610441|516292226|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
143203564|NCT00610441|516292227|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
143203565|NCT00610441|516292228|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
143203566|NCT01842581|516292232|FG000|Overall Study|Adverse Event|6|||
143203567|NCT01842581|516292233|FG001|Overall Study|Adverse Event|4|||
143203568|NCT01842581|516292232|FG000|Overall Study|HE breakthrough|26|||
143203569|NCT01842581|516292233|FG001|Overall Study|HE breakthrough|13|||
143203570|NCT01842581|516292232|FG000|Overall Study|Liver transplant|2|||
143203571|NCT01842581|516292233|FG001|Overall Study|Liver transplant|0|||
143203572|NCT01842581|516292232|FG000|Overall Study|Lost to Follow-up|2|||
143203573|NCT01842581|516292233|FG001|Overall Study|Lost to Follow-up|5|||
143203574|NCT01842581|516292232|FG000|Overall Study|Withdrawal by Subject|5|||
143203575|NCT01842581|516292233|FG001|Overall Study|Withdrawal by Subject|7|||
143203576|NCT01842581|516292232|FG000|Overall Study|Other than specified|3|||
143203577|NCT01842581|516292233|FG001|Overall Study|Other than specified|1|||
143203578|NCT01287195|516292234|FG000|Overall Study|Withdrawal by Subject|2|||
143203579|NCT00837876|516292235|FG000|Overall Study|Death|2|||
143203580|NCT00837876|516292235|FG000|Overall Study|Adverse Event|7|||
143203581|NCT00837876|516292235|FG000|Overall Study|Physician Decision|1|||
143203582|NCT00837876|516292235|FG000|Overall Study|Withdrawal by Subject|3|||
143203583|NCT00837876|516292235|FG000|Overall Study|disease progression|24|||
143203584|NCT00453973|516292237|FG000|Overall Study|Adverse Event|4|||
143203585|NCT00453973|516292238|FG001|Overall Study|Adverse Event|9|||
143203586|NCT00453973|516292237|FG000|Overall Study|Withdrawal by Subject|7|||
143203587|NCT00453973|516292238|FG001|Overall Study|Withdrawal by Subject|6|||
143203588|NCT00453973|516292237|FG000|Overall Study|PI Decision|0|||
143203589|NCT00453973|516292238|FG001|Overall Study|PI Decision|2|||
143203590|NCT00453973|516292237|FG000|Overall Study|Relocation|1|||
143203591|NCT00453973|516292238|FG001|Overall Study|Relocation|0|||
143203592|NCT00453973|516292237|FG000|Overall Study|Renal transplant|1|||
143203593|NCT00453973|516292238|FG001|Overall Study|Renal transplant|1|||
143203594|NCT00453973|516292237|FG000|Overall Study|Site closed by sponsor|3|||
143203595|NCT00453973|516292238|FG001|Overall Study|Site closed by sponsor|0|||
143203596|NCT00453973|516292237|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
143203597|NCT00453973|516292238|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
143203598|NCT00870194|516292239|FG000|Overall Study|Adverse Event|10|||
143203599|NCT00870194|516292240|FG001|Overall Study|Adverse Event|5|||
143203600|NCT00870194|516292239|FG000|Overall Study|Lack of Efficacy|0|||
143203601|NCT00870194|516292240|FG001|Overall Study|Lack of Efficacy|1|||
143203602|NCT00870194|516292239|FG000|Overall Study|Lost to Follow-up|2|||
143203603|NCT00870194|516292240|FG001|Overall Study|Lost to Follow-up|0|||
143203604|NCT00870194|516292239|FG000|Overall Study|Physician Decision|3|||
143203605|NCT00870194|516292240|FG001|Overall Study|Physician Decision|1|||
143203606|NCT00870194|516292239|FG000|Overall Study|Protocol Violation|3|||
143203607|NCT00870194|516292240|FG001|Overall Study|Protocol Violation|3|||
143203608|NCT00870194|516292239|FG000|Overall Study|Entry Criteria Not Met|1|||
143203609|NCT00870194|516292240|FG001|Overall Study|Entry Criteria Not Met|2|||
143203610|NCT00870194|516292239|FG000|Overall Study|Subject Decision|7|||
143203611|NCT00870194|516292240|FG001|Overall Study|Subject Decision|2|||
143203612|NCT04957758|516292241|FG000|Overall Study|Adverse Event|1|||
143203613|NCT04957758|516292242|FG001|Overall Study|Adverse Event|0|||
143203614|NCT04957758|516292241|FG000|Overall Study|Lost to Follow-up|0|||
143203615|NCT04957758|516292242|FG001|Overall Study|Lost to Follow-up|2|||
143203616|NCT04957758|516292241|FG000|Overall Study|Withdrawal by Subject|4|||
143203617|NCT04957758|516292242|FG001|Overall Study|Withdrawal by Subject|2|||
143203618|NCT04957758|516292241|FG000|Overall Study|Protocol Violation|0|||
143203619|NCT04957758|516292242|FG001|Overall Study|Protocol Violation|1|||
143203620|NCT00707746|516292243|FG000|Treatment Period|Adverse Event|2|||
143203621|NCT00707746|516292244|FG001|Treatment Period|Adverse Event|4|||
143203622|NCT00707746|516292243|FG000|Treatment Period|Ineligibility|0|||
143203623|NCT00707746|516292244|FG001|Treatment Period|Ineligibility|1|||
143203624|NCT01685983|516292246|FG000|Overall Study|Adverse Event|7|||
143203625|NCT01685983|516292246|FG000|Overall Study|Death|1|||
143203626|NCT01685983|516292246|FG000|Overall Study|Withdrawal by Subject|19|||
143203627|NCT01685983|516292246|FG000|Overall Study|Protocol Violation|2|||
143203628|NCT01685983|516292246|FG000|Overall Study|Physician Decision|13|||
143203629|NCT01685983|516292246|FG000|Overall Study|Other|7|||
143203630|NCT01685983|516292246|FG000|Overall Study|Progressive Disease|32|||
143203631|NCT01685983|516292246|FG000|Overall Study|Noncompliance with Study Drug|1|||
143203632|NCT00364533|516292247|FG000|Overall Study|Adverse Event|8|||
143203633|NCT00364533|516292248|FG001|Overall Study|Adverse Event|7|||
143203634|NCT00364533|516292249|FG002|Overall Study|Adverse Event|15|||
143203635|NCT00364533|516292250|FG003|Overall Study|Adverse Event|5|||
143203636|NCT00364533|516292251|FG004|Overall Study|Adverse Event|2|||
143203637|NCT00364533|516292247|FG000|Overall Study|Withdrawal by Subject|4|||
143203638|NCT00364533|516292248|FG001|Overall Study|Withdrawal by Subject|8|||
143203639|NCT00364533|516292249|FG002|Overall Study|Withdrawal by Subject|6|||
143203640|NCT00364533|516292250|FG003|Overall Study|Withdrawal by Subject|6|||
143203641|NCT00364533|516292251|FG004|Overall Study|Withdrawal by Subject|6|||
143203642|NCT00364533|516292247|FG000|Overall Study|Lack of Efficacy|22|||
143203643|NCT00364533|516292248|FG001|Overall Study|Lack of Efficacy|22|||
143203644|NCT00364533|516292249|FG002|Overall Study|Lack of Efficacy|21|||
143203645|NCT00364533|516292250|FG003|Overall Study|Lack of Efficacy|17|||
143203646|NCT00364533|516292251|FG004|Overall Study|Lack of Efficacy|42|||
143203647|NCT00364533|516292247|FG000|Overall Study|Subject discharged from hospital|4|||
143203648|NCT00364533|516292248|FG001|Overall Study|Subject discharged from hospital|1|||
143203649|NCT00364533|516292249|FG002|Overall Study|Subject discharged from hospital|2|||
143203650|NCT00364533|516292250|FG003|Overall Study|Subject discharged from hospital|3|||
143203651|NCT00364533|516292251|FG004|Overall Study|Subject discharged from hospital|1|||
143203652|NCT00364533|516292247|FG000|Overall Study|Variations in drug compliance|2|||
143203653|NCT00364533|516292248|FG001|Overall Study|Variations in drug compliance|1|||
143203654|NCT00364533|516292249|FG002|Overall Study|Variations in drug compliance|1|||
143203655|NCT00364533|516292250|FG003|Overall Study|Variations in drug compliance|0|||
143203656|NCT00364533|516292251|FG004|Overall Study|Variations in drug compliance|0|||
143203657|NCT00364533|516292247|FG000|Overall Study|Non-compliance|1|||
143203658|NCT00364533|516292248|FG001|Overall Study|Non-compliance|0|||
143203659|NCT00364533|516292249|FG002|Overall Study|Non-compliance|0|||
143203660|NCT00364533|516292250|FG003|Overall Study|Non-compliance|0|||
143203661|NCT00364533|516292251|FG004|Overall Study|Non-compliance|0|||
143203662|NCT00364533|516292247|FG000|Overall Study|Protocol Violation|1|||
143203663|NCT00364533|516292248|FG001|Overall Study|Protocol Violation|1|||
143203664|NCT00364533|516292249|FG002|Overall Study|Protocol Violation|0|||
143203665|NCT00364533|516292250|FG003|Overall Study|Protocol Violation|0|||
143203666|NCT00364533|516292251|FG004|Overall Study|Protocol Violation|0|||
143203667|NCT02758301|516292252|FG000|Overall Study|Death|12|||
143203668|NCT02758301|516292253|FG001|Overall Study|Death|0|||
143203669|NCT02758301|516292252|FG000|Overall Study|Physician Decision|10|||
143203670|NCT02758301|516292253|FG001|Overall Study|Physician Decision|1|||
143203671|NCT02758301|516292252|FG000|Overall Study|Withdrawal by Subject|5|||
143203672|NCT02758301|516292253|FG001|Overall Study|Withdrawal by Subject|6|||
143203673|NCT02758301|516292252|FG000|Overall Study|Lost to Follow-up|7|||
143203674|NCT02758301|516292253|FG001|Overall Study|Lost to Follow-up|0|||
143203675|NCT02758301|516292252|FG000|Overall Study|Protocol Violation|0|||
143203676|NCT02758301|516292253|FG001|Overall Study|Protocol Violation|1|||
143203677|NCT00582738|516292254|FG000|Overall Study|Administrative Problems|7|||
143203678|NCT00582738|516292255|FG001|Overall Study|Administrative Problems|8|||
143203679|NCT00582738|516292254|FG000|Overall Study|Adverse Event|0|||
143203680|NCT00582738|516292255|FG001|Overall Study|Adverse Event|5|||
143203681|NCT00582738|516292254|FG000|Overall Study|Graft Lost|0|||
143203682|NCT00582738|516292255|FG001|Overall Study|Graft Lost|1|||
143203683|NCT00582738|516292254|FG000|Overall Study|Other|1|||
143203684|NCT00582738|516292255|FG001|Overall Study|Other|0|||
143203685|NCT00582738|516292254|FG000|Overall Study|Protocol Violation|1|||
143203686|NCT00582738|516292255|FG001|Overall Study|Protocol Violation|1|||
143203687|NCT00582738|516292254|FG000|Overall Study|Withdrawal by Subject|0|||
143203688|NCT00582738|516292255|FG001|Overall Study|Withdrawal by Subject|3|||
143203689|NCT02642965|516292257|FG000|Overall Study|Lack of Efficacy|4|||
143203690|NCT02642965|516292257|FG000|Overall Study|Physician Decision|9|||
143203691|NCT01167907|516292259|FG000|Overall Study|Protocol Violation|1|||
143203692|NCT01167907|516292260|FG001|Overall Study|Protocol Violation|0|||
143203693|NCT01167907|516292259|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
143203694|NCT01167907|516292260|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
143203695|NCT01011933|516292261|FG000|Overall Study|Wrong cell type|1|||
143203696|NCT01011933|516292261|FG000|Overall Study|Improper pre-protocol Rx|1|||
143203697|NCT01011933|516292261|FG000|Overall Study|Inadequate pathology|1|||
143203698|NCT01011933|516292261|FG000|Overall Study|Never treated|1|||
143203699|NCT03461406|516292262|FG000|Overall Study|Death|1|||
143203700|NCT03461406|516292263|FG001|Overall Study|Death|2|||
143203701|NCT03461406|516292262|FG000|Overall Study|Consent Withdrawn by Participant|0|||
143203702|NCT03461406|516292263|FG001|Overall Study|Consent Withdrawn by Participant|1|||
143203703|NCT03461406|516292262|FG000|Overall Study|Screen Failure|3|||
143203704|NCT03461406|516292263|FG001|Overall Study|Screen Failure|1|||
143203705|NCT03461406|516292262|FG000|Overall Study|Reason not Specified|1|||
143203706|NCT03461406|516292263|FG001|Overall Study|Reason not Specified|3|||
143203707|NCT03461406|516292262|FG000|Overall Study|Lost to Follow-up|3|||
143203708|NCT03461406|516292263|FG001|Overall Study|Lost to Follow-up|0|||
143203709|NCT01439074|516292264|FG000|Overall Study|Lost to Follow-up|3|||
143203710|NCT01439074|516292265|FG001|Overall Study|Lost to Follow-up|4|||
143203711|NCT01439074|516292264|FG000|Overall Study|Subject shedding|1|||
143203712|NCT01439074|516292265|FG001|Overall Study|Subject shedding|0|||
143203713|NCT01439074|516292264|FG000|Overall Study|Withdrawal by Subject|1|||
143203714|NCT01439074|516292265|FG001|Overall Study|Withdrawal by Subject|5|||
143203715|NCT01439074|516292264|FG000|Overall Study|Other|4|||
143203716|NCT01439074|516292265|FG001|Overall Study|Other|4|||
143203717|NCT01140568|516292266|FG000|Overall Study|disease progression|31|||
143203718|NCT01140568|516292266|FG000|Overall Study|Withdrawal by Subject|1|||
143203719|NCT01140568|516292266|FG000|Overall Study|Screen Fail|4|||
143203720|NCT00815191|516292267|FG000|Overall Study|Protocol Violation|1|||
143203721|NCT00815191|516292268|FG001|Overall Study|Protocol Violation|1|||
143203722|NCT03553498|516292271|FG000|Overall Study|Missing primary outcome|1|||
143203723|NCT03553498|516292272|FG001|Overall Study|Missing primary outcome|2|||
143203724|NCT04941807|516292273|FG000|Overall Study|Lost to Follow-up|1|||
143203725|NCT04941807|516292274|FG001|Overall Study|Lost to Follow-up|1|||
143203726|NCT02124772|516292276|FG000|Overall Study|Lack of Efficacy|2|||
143203727|NCT02124772|516292277|FG001|Overall Study|Lack of Efficacy|0|||
143203728|NCT02124772|516292278|FG002|Overall Study|Lack of Efficacy|0|||
143203729|NCT02124772|516292279|FG003|Overall Study|Lack of Efficacy|1|||
143203730|NCT02124772|516292280|FG004|Overall Study|Lack of Efficacy|2|||
143203731|NCT02124772|516292281|FG005|Overall Study|Lack of Efficacy|3|||
143203732|NCT02124772|516292282|FG006|Overall Study|Lack of Efficacy|0|||
143203733|NCT02124772|516292283|FG007|Overall Study|Lack of Efficacy|2|||
143203734|NCT02124772|516292284|FG008|Overall Study|Lack of Efficacy|0|||
143203735|NCT02124772|516292285|FG009|Overall Study|Lack of Efficacy|1|||
143203736|NCT02124772|516292286|FG010|Overall Study|Lack of Efficacy|0|||
143203737|NCT02124772|516292287|FG011|Overall Study|Lack of Efficacy|0|||
143203738|NCT02124772|516292288|FG012|Overall Study|Lack of Efficacy|1|||
143203739|NCT02124772|516292276|FG000|Overall Study|Adverse Event|1|||
143203740|NCT02124772|516292277|FG001|Overall Study|Adverse Event|4|||
143203741|NCT02124772|516292278|FG002|Overall Study|Adverse Event|1|||
143203742|NCT02124772|516292279|FG003|Overall Study|Adverse Event|5|||
143203743|NCT02124772|516292280|FG004|Overall Study|Adverse Event|2|||
143203744|NCT02124772|516292281|FG005|Overall Study|Adverse Event|1|||
143203745|NCT02124772|516292282|FG006|Overall Study|Adverse Event|1|||
143203746|NCT02124772|516292283|FG007|Overall Study|Adverse Event|5|||
143203747|NCT02124772|516292284|FG008|Overall Study|Adverse Event|0|||
143203748|NCT02124772|516292285|FG009|Overall Study|Adverse Event|3|||
143203749|NCT02124772|516292286|FG010|Overall Study|Adverse Event|1|||
143203750|NCT02124772|516292287|FG011|Overall Study|Adverse Event|3|||
143203751|NCT02124772|516292288|FG012|Overall Study|Adverse Event|1|||
143203752|NCT02124772|516292276|FG000|Overall Study|Withdrawal consent|0|||
143203753|NCT02124772|516292277|FG001|Overall Study|Withdrawal consent|1|||
143203754|NCT02124772|516292278|FG002|Overall Study|Withdrawal consent|1|||
143203755|NCT02124772|516292279|FG003|Overall Study|Withdrawal consent|1|||
143203756|NCT02124772|516292280|FG004|Overall Study|Withdrawal consent|0|||
143203757|NCT02124772|516292281|FG005|Overall Study|Withdrawal consent|1|||
143203758|NCT02124772|516292282|FG006|Overall Study|Withdrawal consent|1|||
143203759|NCT02124772|516292283|FG007|Overall Study|Withdrawal consent|0|||
143203760|NCT02124772|516292284|FG008|Overall Study|Withdrawal consent|0|||
143203761|NCT02124772|516292285|FG009|Overall Study|Withdrawal consent|1|||
143203762|NCT02124772|516292286|FG010|Overall Study|Withdrawal consent|0|||
143203763|NCT02124772|516292287|FG011|Overall Study|Withdrawal consent|1|||
143203764|NCT02124772|516292288|FG012|Overall Study|Withdrawal consent|0|||
143203765|NCT02124772|516292276|FG000|Overall Study|Investigator discretion|0|||
143203766|NCT02124772|516292277|FG001|Overall Study|Investigator discretion|2|||
143203767|NCT02124772|516292278|FG002|Overall Study|Investigator discretion|2|||
143203768|NCT02124772|516292279|FG003|Overall Study|Investigator discretion|1|||
143203769|NCT02124772|516292280|FG004|Overall Study|Investigator discretion|1|||
143203770|NCT02124772|516292281|FG005|Overall Study|Investigator discretion|0|||
143203771|NCT02124772|516292282|FG006|Overall Study|Investigator discretion|1|||
143203772|NCT02124772|516292283|FG007|Overall Study|Investigator discretion|0|||
143203773|NCT02124772|516292284|FG008|Overall Study|Investigator discretion|0|||
143203774|NCT02124772|516292285|FG009|Overall Study|Investigator discretion|1|||
143203775|NCT02124772|516292286|FG010|Overall Study|Investigator discretion|0|||
143203776|NCT02124772|516292287|FG011|Overall Study|Investigator discretion|1|||
143203777|NCT02124772|516292288|FG012|Overall Study|Investigator discretion|0|||
143203778|NCT02124772|516292276|FG000|Overall Study|Progressive disease|0|||
143203779|NCT02124772|516292277|FG001|Overall Study|Progressive disease|0|||
143262649|NCT00366340|516515906|FG001|After the Infant Series|Adverse Event|1|||
143203780|NCT02124772|516292278|FG002|Overall Study|Progressive disease|0|||
143203781|NCT02124772|516292279|FG003|Overall Study|Progressive disease|0|||
143203782|NCT02124772|516292280|FG004|Overall Study|Progressive disease|0|||
143203783|NCT02124772|516292281|FG005|Overall Study|Progressive disease|0|||
143203784|NCT02124772|516292282|FG006|Overall Study|Progressive disease|1|||
143203785|NCT02124772|516292283|FG007|Overall Study|Progressive disease|1|||
143203786|NCT02124772|516292284|FG008|Overall Study|Progressive disease|0|||
143203787|NCT02124772|516292285|FG009|Overall Study|Progressive disease|0|||
143203788|NCT02124772|516292286|FG010|Overall Study|Progressive disease|0|||
143203789|NCT02124772|516292287|FG011|Overall Study|Progressive disease|0|||
143203790|NCT02124772|516292288|FG012|Overall Study|Progressive disease|0|||
143203791|NCT02124772|516292276|FG000|Overall Study|Other|0|||
143203792|NCT02124772|516292277|FG001|Overall Study|Other|7|||
143203793|NCT02124772|516292278|FG002|Overall Study|Other|2|||
143203794|NCT02124772|516292279|FG003|Overall Study|Other|5|||
143203795|NCT02124772|516292280|FG004|Overall Study|Other|4|||
143203796|NCT02124772|516292281|FG005|Overall Study|Other|3|||
143203797|NCT02124772|516292282|FG006|Overall Study|Other|4|||
143203798|NCT02124772|516292283|FG007|Overall Study|Other|1|||
143203799|NCT02124772|516292284|FG008|Overall Study|Other|1|||
143203800|NCT02124772|516292285|FG009|Overall Study|Other|1|||
143203801|NCT02124772|516292286|FG010|Overall Study|Other|1|||
143203802|NCT02124772|516292287|FG011|Overall Study|Other|1|||
143203803|NCT02124772|516292288|FG012|Overall Study|Other|0|||
143203804|NCT02308488|516292289|FG000|Overall Study|Withdrawal by Subject|2|||
143203805|NCT01541917|516292290|FG000|Overall Study|Lost to Follow-up|2|||
143203806|NCT01541917|516292291|FG001|Overall Study|Lost to Follow-up|2|||
143203807|NCT01541917|516292290|FG000|Overall Study|Withdrawal by Subject|13|||
143203808|NCT01541917|516292291|FG001|Overall Study|Withdrawal by Subject|7|||
143203809|NCT03759041|516292301|FG000|Overall Study|Withdrawal by Subject|4|||
143203810|NCT03759041|516292302|FG001|Overall Study|Withdrawal by Subject|10|||
143203811|NCT03759041|516292303|FG002|Overall Study|Withdrawal by Subject|10|||
143370233|NCT00246012|516899123|FG000|Overall Study|Other|0|||
143370234|NCT00246012|516899124|FG001|Overall Study|Other|0|||
143370235|NCT00246012|516899125|FG002|Overall Study|Other|0|||
143370236|NCT00246012|516899126|FG003|Overall Study|Other|0|||
143370237|NCT00246012|516899127|FG004|Overall Study|Other|0|||
143370238|NCT00246012|516899128|FG005|Overall Study|Other|0|||
143370239|NCT00246012|516899129|FG006|Overall Study|Other|0|||
143370240|NCT00246012|516899130|FG007|Overall Study|Other|1|||
143370241|NCT00246012|516899131|FG008|Overall Study|Other|0|||
143370242|NCT00246012|516899123|FG000|Overall Study|Randomly assigned but not treated|0|||
143370243|NCT00246012|516899124|FG001|Overall Study|Randomly assigned but not treated|0|||
143370244|NCT00246012|516899125|FG002|Overall Study|Randomly assigned but not treated|0|||
143370245|NCT00246012|516899126|FG003|Overall Study|Randomly assigned but not treated|0|||
143370246|NCT00246012|516899127|FG004|Overall Study|Randomly assigned but not treated|0|||
143370247|NCT00246012|516899128|FG005|Overall Study|Randomly assigned but not treated|1|||
143370248|NCT00246012|516899129|FG006|Overall Study|Randomly assigned but not treated|1|||
143370249|NCT00246012|516899130|FG007|Overall Study|Randomly assigned but not treated|0|||
143370250|NCT00246012|516899131|FG008|Overall Study|Randomly assigned but not treated|0|||
143370251|NCT02377362|516899132|FG000|Part A Second Treatment|Protocol Violation|0|||
143370252|NCT02377362|516899133|FG001|Part A Second Treatment|Protocol Violation|0|||
143370253|NCT02377362|516899134|FG002|Part A Second Treatment|Protocol Violation|0|||
143370254|NCT02377362|516899135|FG003|Part A Second Treatment|Protocol Violation|0|||
143370255|NCT02377362|516899136|FG004|Part A Second Treatment|Protocol Violation|1|||
143370256|NCT02377362|516899137|FG005|Part A Second Treatment|Protocol Violation|0|||
143370257|NCT02377362|516899138|FG006|Part A Second Treatment|Protocol Violation|0|||
143370258|NCT02377362|516899139|FG007|Part A Second Treatment|Protocol Violation|0|||
143203812|NCT03759041|516292301|FG000|Overall Study|Adverse Event|1|||
143203813|NCT03759041|516292302|FG001|Overall Study|Adverse Event|3|||
143203814|NCT03759041|516292303|FG002|Overall Study|Adverse Event|4|||
143203815|NCT03759041|516292301|FG000|Overall Study|Lack of Efficacy|0|||
143203816|NCT03759041|516292302|FG001|Overall Study|Lack of Efficacy|0|||
143203817|NCT03759041|516292303|FG002|Overall Study|Lack of Efficacy|1|||
143203818|NCT03759041|516292301|FG000|Overall Study|Study Terminated by Sponsor|15|||
143203819|NCT03759041|516292302|FG001|Overall Study|Study Terminated by Sponsor|16|||
143203820|NCT03759041|516292303|FG002|Overall Study|Study Terminated by Sponsor|10|||
143203821|NCT03759041|516292301|FG000|Overall Study|Other reason for discontinuation|0|||
143370259|NCT02377362|516899140|FG008|Part A Second Treatment|Protocol Violation|0|||
143370260|NCT02377362|516899141|FG009|Part A Second Treatment|Protocol Violation|0|||
143370261|NCT02377362|516899142|FG010|Part A Second Treatment|Protocol Violation|0|||
143203822|NCT03759041|516292302|FG001|Overall Study|Other reason for discontinuation|2|||
143203823|NCT03759041|516292303|FG002|Overall Study|Other reason for discontinuation|1|||
143203824|NCT03759041|516292301|FG000|Overall Study|Lost to Follow-up|7|||
143203825|NCT03759041|516292302|FG001|Overall Study|Lost to Follow-up|2|||
143203826|NCT03759041|516292303|FG002|Overall Study|Lost to Follow-up|2|||
143203827|NCT03759041|516292301|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
143370262|NCT02377362|516899143|FG011|Part A Second Treatment|Protocol Violation|0|||
143370263|NCT02377362|516899144|FG012|Part A Second Treatment|Protocol Violation|0|||
143370264|NCT02377362|516899132|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
143203828|NCT03759041|516292302|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
143203829|NCT03759041|516292303|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
143203830|NCT02242981|516292307|FG000|Overall Study|Withdrawal by Subject|1|||
143203831|NCT03474081|516292308|FG000|Overall Study|Adverse Event|6|||
143203832|NCT03474081|516292309|FG001|Overall Study|Adverse Event|3|||
143203833|NCT03474081|516292308|FG000|Overall Study|Lost to Follow-up|2|||
143203834|NCT03474081|516292309|FG001|Overall Study|Lost to Follow-up|1|||
143203835|NCT03474081|516292308|FG000|Overall Study|Physician Decision|3|||
143203836|NCT03474081|516292309|FG001|Overall Study|Physician Decision|2|||
143203837|NCT03474081|516292308|FG000|Overall Study|Withdrawal by Subject|5|||
143203838|NCT03474081|516292309|FG001|Overall Study|Withdrawal by Subject|7|||
143203839|NCT03474081|516292308|FG000|Overall Study|Investigator site closed|1|||
143203840|NCT03474081|516292309|FG001|Overall Study|Investigator site closed|0|||
143203841|NCT02290938|516292315|FG000|Overall Study|Lost to Follow-up|14|||
143203842|NCT02290938|516292316|FG001|Overall Study|Lost to Follow-up|43|||
143203843|NCT02753127|516293590|FG000|Overall Study|Lost to Follow-up|13|||
143203844|NCT02753127|516293591|FG001|Overall Study|Lost to Follow-up|11|||
143203845|NCT02753127|516293590|FG000|Overall Study|Withdrawal by Subject|37|||
143203846|NCT02753127|516293591|FG001|Overall Study|Withdrawal by Subject|47|||
143203847|NCT02753127|516293590|FG000|Overall Study|Other|3|||
143203848|NCT02753127|516293591|FG001|Overall Study|Other|8|||
143203849|NCT02753127|516293590|FG000|Overall Study|Hospice|0|||
143203850|NCT02753127|516293591|FG001|Overall Study|Hospice|2|||
143203851|NCT00940485|516293594|FG000|Overall Study|HBeAb positive at Baseline|3|||
143203852|NCT00940485|516293595|FG001|Overall Study|HBeAb positive at Baseline|2|||
143203853|NCT00940485|516293594|FG000|Overall Study|Lost to Follow-up|2|||
143203854|NCT00940485|516293595|FG001|Overall Study|Lost to Follow-up|3|||
143203855|NCT00940485|516293594|FG000|Overall Study|Adverse Event|8|||
143203856|NCT00940485|516293595|FG001|Overall Study|Adverse Event|0|||
143203857|NCT00940485|516293594|FG000|Overall Study|Withdrawal by Subject|1|||
143203858|NCT00940485|516293595|FG001|Overall Study|Withdrawal by Subject|1|||
143203859|NCT00940485|516293594|FG000|Overall Study|Others|1|||
143203860|NCT00940485|516293595|FG001|Overall Study|Others|1|||
143203861|NCT04271475|516293596|FG000|DB Period: Day 1 up to EODBT|Death|1|||
143203862|NCT04271475|516293597|FG001|DB Period: Day 1 up to EODBT|Death|0|||
143203863|NCT04271475|516293598|FG002|DB Period: Day 1 up to EODBT|Death|0|||
143203864|NCT04271475|516293599|FG003|DB Period: Day 1 up to EODBT|Death|0|||
143203865|NCT04271475|516293596|FG000|DB Period: Day 1 up to EODBT|Physician Decision|8|||
143203866|NCT04271475|516293597|FG001|DB Period: Day 1 up to EODBT|Physician Decision|1|||
143203867|NCT04271475|516293598|FG002|DB Period: Day 1 up to EODBT|Physician Decision|0|||
143203868|NCT04271475|516293599|FG003|DB Period: Day 1 up to EODBT|Physician Decision|0|||
143203869|NCT04271475|516293596|FG000|DB Period: Day 1 up to EODBT|Withdrawal by Subject|5|||
143203870|NCT04271475|516293597|FG001|DB Period: Day 1 up to EODBT|Withdrawal by Subject|4|||
143203871|NCT04271475|516293598|FG002|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
143203872|NCT04271475|516293599|FG003|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
143203873|NCT04271475|516293596|FG000|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|41|||
143203874|NCT04271475|516293597|FG001|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|52|||
143203875|NCT04271475|516293598|FG002|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
143203876|NCT04271475|516293599|FG003|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
143203877|NCT04271475|516293596|FG000|DB Period: Day 1 up to EODBT|Other|8|||
143203878|NCT04271475|516293597|FG001|DB Period: Day 1 up to EODBT|Other|5|||
143203879|NCT04271475|516293598|FG002|DB Period: Day 1 up to EODBT|Other|0|||
143203880|NCT04271475|516293599|FG003|DB Period: Day 1 up to EODBT|Other|0|||
143203881|NCT04271475|516293596|FG000|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
143262650|NCT00366340|516515905|FG000|After the Infant Series|Lost to Follow-up|0|||
143262651|NCT00366340|516515906|FG001|After the Infant Series|Lost to Follow-up|1|||
143262652|NCT00366340|516515905|FG000|Toddler Dose|Failed to return|1|||
143262653|NCT00366340|516515906|FG001|Toddler Dose|Failed to return|0|||
143262654|NCT00366340|516515905|FG000|Toddler Dose|Parent/legal guardian request|0|||
143262655|NCT00366340|516515906|FG001|Toddler Dose|Parent/legal guardian request|1|||
143262656|NCT03355664|516515907|FG000|Overall Study|Adverse Event|1|||
143262657|NCT03355664|516515908|FG001|Overall Study|Adverse Event|2|||
143262658|NCT03355664|516515907|FG000|Overall Study|Lost to Follow-up|11|||
143262659|NCT03355664|516515908|FG001|Overall Study|Lost to Follow-up|7|||
143262660|NCT03355664|516515907|FG000|Overall Study|Protocol Violation|1|||
143262661|NCT03355664|516515908|FG001|Overall Study|Protocol Violation|2|||
143262662|NCT03355664|516515907|FG000|Overall Study|Withdrawal by Subject|2|||
143262663|NCT03355664|516515908|FG001|Overall Study|Withdrawal by Subject|1|||
143262664|NCT00423670|516515912|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
143262665|NCT00423670|516515913|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
143262666|NCT00423670|516515914|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
143262667|NCT00423670|516515915|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
143262668|NCT00423670|516515916|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
143262669|NCT00423670|516515917|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
143262670|NCT00423670|516515918|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
143262671|NCT00423670|516515919|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
143262672|NCT00423670|516515912|FG000|Treatment Period|Adverse Event|8|||
143262673|NCT00423670|516515913|FG001|Treatment Period|Adverse Event|12|||
143262674|NCT00423670|516515914|FG002|Treatment Period|Adverse Event|15|||
143262675|NCT00423670|516515915|FG003|Treatment Period|Adverse Event|20|||
143262676|NCT00423670|516515916|FG004|Treatment Period|Adverse Event|9|||
143262677|NCT00423670|516515917|FG005|Treatment Period|Adverse Event|4|||
143262678|NCT00423670|516515918|FG006|Treatment Period|Adverse Event|7|||
143262679|NCT00423670|516515919|FG007|Treatment Period|Adverse Event|2|||
143262680|NCT00423670|516515912|FG000|Treatment Period|Protocol-defined clinical event|0|||
143262681|NCT00423670|516515913|FG001|Treatment Period|Protocol-defined clinical event|7|||
143262682|NCT00423670|516515914|FG002|Treatment Period|Protocol-defined clinical event|4|||
143262683|NCT00423670|516515915|FG003|Treatment Period|Protocol-defined clinical event|12|||
143262684|NCT00423670|516515916|FG004|Treatment Period|Protocol-defined clinical event|5|||
143262685|NCT00423670|516515917|FG005|Treatment Period|Protocol-defined clinical event|4|||
143262686|NCT00423670|516515918|FG006|Treatment Period|Protocol-defined clinical event|16|||
143262687|NCT00423670|516515919|FG007|Treatment Period|Protocol-defined clinical event|15|||
143262688|NCT00423670|516515912|FG000|Treatment Period|Lost to Follow-up|2|||
143262689|NCT00423670|516515913|FG001|Treatment Period|Lost to Follow-up|1|||
143262690|NCT00423670|516515914|FG002|Treatment Period|Lost to Follow-up|3|||
143262691|NCT00423670|516515915|FG003|Treatment Period|Lost to Follow-up|1|||
143370265|NCT02377362|516899133|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
143370266|NCT02377362|516899134|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
143370267|NCT02377362|516899135|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
143370268|NCT02377362|516899136|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
143370269|NCT02377362|516899137|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
143370270|NCT02377362|516899138|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
143370271|NCT02377362|516899139|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
143203882|NCT04271475|516293597|FG001|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
143203883|NCT04271475|516293598|FG002|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|1|||
143203884|NCT04271475|516293599|FG003|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|5|||
143203885|NCT04271475|516293596|FG000|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
143203886|NCT04271475|516293597|FG001|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
143203887|NCT04271475|516293598|FG002|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
143203888|NCT04271475|516293599|FG003|OL Period:Day 1 Upto End of OL Treatment|Other|1|||
143203889|NCT06250738|516293602|FG000|Overall Study|Lost to Follow-up|1|||
143203890|NCT02936284|516293604|FG000|Overall Study|Withdrawal by Subject|3|||
143203891|NCT02936284|516293605|FG001|Overall Study|Withdrawal by Subject|1|||
143203892|NCT02936284|516293604|FG000|Overall Study|Lost to Follow-up|7|||
143203893|NCT02936284|516293605|FG001|Overall Study|Lost to Follow-up|8|||
143203894|NCT02981524|516293609|FG000|Overall Study|Progressive Disease|14|||
143203895|NCT02981524|516293609|FG000|Overall Study|Death (unrelated)|1|||
143203896|NCT02981524|516293609|FG000|Overall Study|Treatment Related Toxicity|1|||
143203897|NCT02981524|516293609|FG000|Overall Study|Withdrawal by Subject|1|||
143203898|NCT00159913|516293613|FG000|Overall Study|Adverse Event|1|||
143203899|NCT00159913|516293614|FG001|Overall Study|Adverse Event|0|||
143203900|NCT00159913|516293615|FG002|Overall Study|Adverse Event|1|||
143262692|NCT00423670|516515916|FG004|Treatment Period|Lost to Follow-up|6|||
143262693|NCT00423670|516515917|FG005|Treatment Period|Lost to Follow-up|0|||
143203901|NCT00159913|516293616|FG003|Overall Study|Adverse Event|0|||
143203902|NCT00159913|516293613|FG000|Overall Study|Withdrawal by Subject|0|||
143203903|NCT00159913|516293614|FG001|Overall Study|Withdrawal by Subject|0|||
143203904|NCT00159913|516293615|FG002|Overall Study|Withdrawal by Subject|0|||
143203905|NCT00159913|516293616|FG003|Overall Study|Withdrawal by Subject|1|||
143203906|NCT00159913|516293613|FG000|Overall Study|Lost to Follow-up|0|||
143203907|NCT00159913|516293614|FG001|Overall Study|Lost to Follow-up|0|||
143203908|NCT00159913|516293615|FG002|Overall Study|Lost to Follow-up|0|||
143203909|NCT00159913|516293616|FG003|Overall Study|Lost to Follow-up|1|||
143203910|NCT00159913|516293613|FG000|Overall Study|Protocol Violation|1|||
143203911|NCT00159913|516293614|FG001|Overall Study|Protocol Violation|0|||
143203912|NCT00159913|516293615|FG002|Overall Study|Protocol Violation|1|||
143203913|NCT00159913|516293616|FG003|Overall Study|Protocol Violation|0|||
143203914|NCT01146288|516293617|FG000|First Intervention(1 Day)|Adverse Event|0|||
143203915|NCT01146288|516293618|FG001|First Intervention(1 Day)|Adverse Event|1|||
143203916|NCT00385723|516293619|FG000|Overall Study|Lost to Follow-up|1|||
143203917|NCT00385723|516293620|FG001|Overall Study|Lost to Follow-up|1|||
143203918|NCT00385723|516293621|FG002|Overall Study|Lost to Follow-up|0|||
143203919|NCT00385723|516293619|FG000|Overall Study|Withdrawal by Subject|1|||
143203920|NCT00385723|516293620|FG001|Overall Study|Withdrawal by Subject|0|||
143203921|NCT00385723|516293621|FG002|Overall Study|Withdrawal by Subject|2|||
143203922|NCT03455829|516293622|FG000|Overall Study|Death|2|||
143203923|NCT03455829|516293623|FG001|Overall Study|Death|3|||
143203924|NCT03455829|516293624|FG002|Overall Study|Death|2|||
143203925|NCT03455829|516293625|FG003|Overall Study|Death|4|||
143203926|NCT03455829|516293626|FG004|Overall Study|Death|2|||
143203927|NCT03455829|516293622|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
143203928|NCT03455829|516293623|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
143203929|NCT03455829|516293624|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
143203930|NCT03455829|516293625|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
143203931|NCT03455829|516293626|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
143203932|NCT03455829|516293622|FG000|Overall Study|Disease progression|0|||
143203933|NCT03455829|516293623|FG001|Overall Study|Disease progression|0|||
143203934|NCT03455829|516293624|FG002|Overall Study|Disease progression|0|||
143203935|NCT03455829|516293625|FG003|Overall Study|Disease progression|1|||
143203936|NCT03455829|516293626|FG004|Overall Study|Disease progression|1|||
143203937|NCT00096018|516293636|FG000|Overall Study|Became Ineligible (not treated)|0|||
143203938|NCT00096018|516293637|FG001|Overall Study|Became Ineligible (not treated)|3|||
143203939|NCT00096018|516293636|FG000|Overall Study|Miscellaneous (not treated)|0|||
143203940|NCT00096018|516293637|FG001|Overall Study|Miscellaneous (not treated)|2|||
143203941|NCT00096018|516293636|FG000|Overall Study|Adverse Event|0|||
143203942|NCT00096018|516293637|FG001|Overall Study|Adverse Event|5|||
143203943|NCT00096018|516293636|FG000|Overall Study|Death|0|||
143203944|NCT00096018|516293637|FG001|Overall Study|Death|1|||
143203945|NCT00096018|516293636|FG000|Overall Study|Withdrawal by Subject|0|||
143203946|NCT00096018|516293637|FG001|Overall Study|Withdrawal by Subject|2|||
143203947|NCT00096018|516293636|FG000|Overall Study|Miscellaneous|2|||
143203948|NCT00096018|516293637|FG001|Overall Study|Miscellaneous|1|||
143203949|NCT03689712|516293638|FG000|Overall Study|Adverse Event|1|||
143203950|NCT03689712|516293639|FG001|Overall Study|Adverse Event|0|||
143203951|NCT03689712|516293638|FG000|Overall Study|Death|20|||
143203952|NCT03689712|516293639|FG001|Overall Study|Death|10|||
143203953|NCT03689712|516293638|FG000|Overall Study|Lost to Follow-up|6|||
143203954|NCT03689712|516293639|FG001|Overall Study|Lost to Follow-up|6|||
143203955|NCT03689712|516293638|FG000|Overall Study|Other|1|||
143203956|NCT03689712|516293639|FG001|Overall Study|Other|0|||
143203957|NCT03689712|516293638|FG000|Overall Study|Patient Non-Compliance|0|||
143203958|NCT03689712|516293639|FG001|Overall Study|Patient Non-Compliance|1|||
143203959|NCT03689712|516293638|FG000|Overall Study|Withdrawal by Subject|20|||
143203960|NCT03689712|516293639|FG001|Overall Study|Withdrawal by Subject|4|||
143203961|NCT03689712|516293638|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
143203962|NCT03689712|516293639|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
143370272|NCT02377362|516899140|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
143203963|NCT03689712|516293638|FG000|Overall Study|Randomized but not Treated|13|||
143203964|NCT03689712|516293639|FG001|Overall Study|Randomized but not Treated|7|||
143203965|NCT03689712|516293638|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
143203966|NCT03689712|516293639|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
143203967|NCT00689793|516293640|FG000|Overall Study|Lost to Follow-up|4|||
143203968|NCT00689793|516293641|FG001|Overall Study|Lost to Follow-up|5|||
143203969|NCT02066129|516293642|FG000|Overall Study|Lost to Follow-up|13|||
143203970|NCT02066129|516293643|FG001|Overall Study|Lost to Follow-up|12|||
143203971|NCT02066129|516293642|FG000|Overall Study|Withdrawal by Subject|7|||
143203972|NCT02066129|516293643|FG001|Overall Study|Withdrawal by Subject|10|||
143203973|NCT02066129|516293642|FG000|Overall Study|Lack of Efficacy|8|||
143203974|NCT02066129|516293643|FG001|Overall Study|Lack of Efficacy|10|||
143203975|NCT02066129|516293642|FG000|Overall Study|Physician Decision|1|||
143203976|NCT02066129|516293643|FG001|Overall Study|Physician Decision|1|||
143203977|NCT02322190|516293644|FG000|Overall Study|Death on study|1|||
143203978|NCT02322190|516293645|FG001|Overall Study|Death on study|0|||
143203979|NCT00357656|516293646|FG000|Overall Study|Other, No surgery performed|0|||
143203980|NCT00357656|516293647|FG001|Overall Study|Other, No surgery performed|3|||
143203981|NCT02573246|516293651|FG000|Overall Study|Lost to Follow-up|2|||
143203982|NCT02573246|516293652|FG001|Overall Study|Lost to Follow-up|0|||
143203983|NCT02573246|516293653|FG002|Overall Study|Lost to Follow-up|0|||
143203984|NCT02573246|516293654|FG003|Overall Study|Lost to Follow-up|0|||
143203985|NCT02573246|516293655|FG004|Overall Study|Lost to Follow-up|1|||
143203986|NCT02573246|516293651|FG000|Overall Study|Withdrawal by Subject|0|||
143203987|NCT02573246|516293652|FG001|Overall Study|Withdrawal by Subject|0|||
143203988|NCT02573246|516293653|FG002|Overall Study|Withdrawal by Subject|0|||
143203989|NCT02573246|516293654|FG003|Overall Study|Withdrawal by Subject|0|||
143203990|NCT02573246|516293655|FG004|Overall Study|Withdrawal by Subject|1|||
143203991|NCT02573246|516293651|FG000|Overall Study|Physician Decision|1|||
143203992|NCT02573246|516293652|FG001|Overall Study|Physician Decision|1|||
143203993|NCT02573246|516293653|FG002|Overall Study|Physician Decision|3|||
143203994|NCT02573246|516293654|FG003|Overall Study|Physician Decision|2|||
143203995|NCT02573246|516293655|FG004|Overall Study|Physician Decision|2|||
143203996|NCT01219933|516293657|FG000|Overall Study|Adverse Event|8|||
143203997|NCT01219933|516293657|FG000|Overall Study|No LDA reached|5|||
143203998|NCT01219933|516293657|FG000|Overall Study|No LDA maintained|7|||
143203999|NCT01219933|516293657|FG000|Overall Study|Lost to Follow-up|3|||
143204000|NCT01219933|516293657|FG000|Overall Study|GC free|1|||
143204001|NCT01219933|516293657|FG000|Overall Study|Withdrawal by Subject|5|||
143204002|NCT01219933|516293657|FG000|Overall Study|Protocol Violation|8|||
143204003|NCT01219933|516293657|FG000|Overall Study|Lack of Efficacy|1|||
143204004|NCT01902888|516293658|FG000|Overall Study|Study Terminated|3|||
143204005|NCT03149003|516293659|FG000|Overall Study|Randomized but not treated|0|||
143204006|NCT03149003|516293660|FG001|Overall Study|Randomized but not treated|1|||
143204007|NCT03149003|516293661|FG002|Overall Study|Randomized but not treated|18|||
143204008|NCT01443130|516293663|FG000|Overall Study|Lost to Follow-up|44|||
143204009|NCT01443130|516293664|FG001|Overall Study|Lost to Follow-up|42|||
143204010|NCT01443130|516293665|FG002|Overall Study|Lost to Follow-up|50|||
143204011|NCT01443130|516293666|FG003|Overall Study|Lost to Follow-up|23|||
143204012|NCT01443130|516293667|FG004|Overall Study|Lost to Follow-up|25|||
143204013|NCT01443130|516293668|FG005|Overall Study|Lost to Follow-up|21|||
143204014|NCT01443130|516293663|FG000|Overall Study|Death|0|||
143204015|NCT01443130|516293664|FG001|Overall Study|Death|1|||
143204016|NCT01443130|516293665|FG002|Overall Study|Death|0|||
143204017|NCT01443130|516293666|FG003|Overall Study|Death|7|||
143204018|NCT01443130|516293667|FG004|Overall Study|Death|10|||
143204019|NCT01443130|516293668|FG005|Overall Study|Death|8|||
143262694|NCT00423670|516515918|FG006|Treatment Period|Lost to Follow-up|3|||
143262695|NCT00423670|516515919|FG007|Treatment Period|Lost to Follow-up|1|||
143262696|NCT00423670|516515912|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
143262697|NCT00423670|516515913|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
143262698|NCT00423670|516515914|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
143204020|NCT01443130|516293663|FG000|Overall Study|Adverse Event|2|||
143204021|NCT01443130|516293664|FG001|Overall Study|Adverse Event|1|||
143262699|NCT00423670|516515915|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
143204022|NCT01443130|516293665|FG002|Overall Study|Adverse Event|1|||
143204023|NCT01443130|516293666|FG003|Overall Study|Adverse Event|0|||
143204024|NCT01443130|516293667|FG004|Overall Study|Adverse Event|0|||
143204025|NCT01443130|516293668|FG005|Overall Study|Adverse Event|0|||
143204026|NCT01443130|516293663|FG000|Overall Study|Protocol Violation|2|||
143204027|NCT01443130|516293664|FG001|Overall Study|Protocol Violation|1|||
143204028|NCT01443130|516293665|FG002|Overall Study|Protocol Violation|3|||
143204029|NCT01443130|516293666|FG003|Overall Study|Protocol Violation|2|||
143204030|NCT01443130|516293667|FG004|Overall Study|Protocol Violation|2|||
143204031|NCT01443130|516293668|FG005|Overall Study|Protocol Violation|3|||
143204032|NCT01443130|516293663|FG000|Overall Study|Withdrawal by Subject|15|||
143204033|NCT01443130|516293664|FG001|Overall Study|Withdrawal by Subject|14|||
143204034|NCT01443130|516293665|FG002|Overall Study|Withdrawal by Subject|12|||
143204035|NCT01443130|516293666|FG003|Overall Study|Withdrawal by Subject|7|||
143204036|NCT01443130|516293667|FG004|Overall Study|Withdrawal by Subject|7|||
143204037|NCT01443130|516293668|FG005|Overall Study|Withdrawal by Subject|2|||
143204038|NCT01443130|516293663|FG000|Overall Study|Death of Subject's Infant|5|||
143204039|NCT01443130|516293664|FG001|Overall Study|Death of Subject's Infant|10|||
143204040|NCT01443130|516293665|FG002|Overall Study|Death of Subject's Infant|11|||
143204041|NCT01443130|516293666|FG003|Overall Study|Death of Subject's Infant|0|||
143204042|NCT01443130|516293667|FG004|Overall Study|Death of Subject's Infant|0|||
143204043|NCT01443130|516293668|FG005|Overall Study|Death of Subject's Infant|0|||
143204044|NCT00685373|516293669|FG000|Overall Study|Adverse Event|3|||
143204045|NCT00685373|516293669|FG000|Overall Study|Withdrawal by Subject|5|||
143204046|NCT00685373|516293669|FG000|Overall Study|Lack of Efficacy|3|||
143204047|NCT00685373|516293669|FG000|Overall Study|Condition no longer requires study drug|1|||
143204048|NCT00685373|516293669|FG000|Overall Study|Lost to Follow-up|2|||
143204049|NCT00685373|516293669|FG000|Overall Study|Protocol Violation|1|||
143204050|NCT02900170|516293675|FG000|Overall Study|Lost to Follow-up|8|||
143204051|NCT01814670|516293678|FG000|Overall Study|Protocol Violation|12|||
143204052|NCT00973102|516293679|FG000|Overall Study|Protocol Violation|1|||
143204053|NCT00973102|516293680|FG001|Overall Study|Protocol Violation|0|||
143204054|NCT00973102|516293679|FG000|Overall Study|Prisoner|0|||
143204055|NCT00973102|516293680|FG001|Overall Study|Prisoner|1|||
143204056|NCT03099148|516293681|FG000|Wash-out|scheduling conflict|0|||
143262700|NCT00423670|516515916|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
143262701|NCT00423670|516515917|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
143262702|NCT00423670|516515918|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
143262703|NCT00423670|516515919|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
143262704|NCT00423670|516515912|FG000|Treatment Period|Investigator decision|0|||
143262705|NCT00423670|516515913|FG001|Treatment Period|Investigator decision|0|||
143262706|NCT00423670|516515914|FG002|Treatment Period|Investigator decision|0|||
143262707|NCT00423670|516515915|FG003|Treatment Period|Investigator decision|0|||
143262708|NCT00423670|516515916|FG004|Treatment Period|Investigator decision|0|||
143262709|NCT00423670|516515917|FG005|Treatment Period|Investigator decision|0|||
143262710|NCT00423670|516515918|FG006|Treatment Period|Investigator decision|0|||
143262711|NCT00423670|516515919|FG007|Treatment Period|Investigator decision|1|||
143262712|NCT00423670|516515912|FG000|Treatment Period|Non-compliance with protocol|3|||
143262713|NCT00423670|516515913|FG001|Treatment Period|Non-compliance with protocol|1|||
143262714|NCT00423670|516515914|FG002|Treatment Period|Non-compliance with protocol|1|||
143262715|NCT00423670|516515915|FG003|Treatment Period|Non-compliance with protocol|3|||
143262716|NCT00423670|516515916|FG004|Treatment Period|Non-compliance with protocol|2|||
143262717|NCT00423670|516515917|FG005|Treatment Period|Non-compliance with protocol|0|||
143262718|NCT00423670|516515918|FG006|Treatment Period|Non-compliance with protocol|2|||
143262719|NCT00423670|516515919|FG007|Treatment Period|Non-compliance with protocol|2|||
143262720|NCT00423670|516515912|FG000|Follow-up Period|Lost to Follow-up|0|||
143262721|NCT00423670|516515913|FG001|Follow-up Period|Lost to Follow-up|12|||
143262722|NCT00423670|516515914|FG002|Follow-up Period|Lost to Follow-up|8|||
143262723|NCT00423670|516515915|FG003|Follow-up Period|Lost to Follow-up|3|||
143262724|NCT00423670|516515916|FG004|Follow-up Period|Lost to Follow-up|1|||
143262725|NCT00423670|516515917|FG005|Follow-up Period|Lost to Follow-up|0|||
143262726|NCT00423670|516515918|FG006|Follow-up Period|Lost to Follow-up|5|||
143262727|NCT00423670|516515919|FG007|Follow-up Period|Lost to Follow-up|0|||
143262728|NCT00423670|516515912|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
143262729|NCT00423670|516515913|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
143262730|NCT00423670|516515914|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
143262731|NCT00423670|516515915|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
143262732|NCT00423670|516515916|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
143262733|NCT00423670|516515917|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
143262734|NCT00423670|516515918|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
143262735|NCT00423670|516515919|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
143262736|NCT00423670|516515912|FG000|Follow-up Period|Non-compliance with protocol|2|||
143262737|NCT00423670|516515913|FG001|Follow-up Period|Non-compliance with protocol|0|||
143262738|NCT00423670|516515914|FG002|Follow-up Period|Non-compliance with protocol|1|||
143262739|NCT00423670|516515915|FG003|Follow-up Period|Non-compliance with protocol|1|||
143262740|NCT00423670|516515916|FG004|Follow-up Period|Non-compliance with protocol|0|||
143262741|NCT00423670|516515917|FG005|Follow-up Period|Non-compliance with protocol|0|||
143262742|NCT00423670|516515918|FG006|Follow-up Period|Non-compliance with protocol|3|||
143262743|NCT00423670|516515919|FG007|Follow-up Period|Non-compliance with protocol|2|||
143262744|NCT04163718|516515922|FG000|Overall Study|Study terminated|12|||
143262745|NCT03418571|516515924|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
143262746|NCT03418571|516515925|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
143204057|NCT03099148|516293682|FG001|Wash-out|scheduling conflict|1|||
143204058|NCT03099148|516293683|FG002|Wash-out|scheduling conflict|0|||
143204059|NCT03099148|516293684|FG003|Wash-out|scheduling conflict|0|||
143204060|NCT03099148|516293681|FG000|Wash-out|Adverse Event|0|||
143204061|NCT03099148|516293682|FG001|Wash-out|Adverse Event|1|||
143204062|NCT03099148|516293683|FG002|Wash-out|Adverse Event|0|||
143204063|NCT03099148|516293684|FG003|Wash-out|Adverse Event|0|||
143204064|NCT00966719|516293685|FG000|Overall Study|Lost to Follow-up|6|||
143204065|NCT00966719|516293686|FG001|Overall Study|Lost to Follow-up|11|||
143204066|NCT01100567|516293687|FG000|Overall Study|Withdrawal by Subject|5|||
143204067|NCT01100567|516293688|FG001|Overall Study|Withdrawal by Subject|8|||
143204068|NCT01100567|516293687|FG000|Overall Study|Early Hospital Discharge|6|||
143204069|NCT01100567|516293688|FG001|Overall Study|Early Hospital Discharge|4|||
143204070|NCT01100567|516293687|FG000|Overall Study|Lost to Follow-up|1|||
143204071|NCT01100567|516293688|FG001|Overall Study|Lost to Follow-up|2|||
143204072|NCT01100567|516293687|FG000|Overall Study|Physician Decision|0|||
143204073|NCT01100567|516293688|FG001|Overall Study|Physician Decision|1|||
143204074|NCT01100567|516293687|FG000|Overall Study|Deemed ineligible after consent|0|||
143204075|NCT01100567|516293688|FG001|Overall Study|Deemed ineligible after consent|1|||
143204076|NCT01703065|516293689|FG000|Overall Study|Lack of Efficacy|1|||
143204077|NCT01703065|516293690|FG001|Overall Study|Lack of Efficacy|0|||
143204078|NCT00160199|516293692|FG000|Overall Study|Adverse Event|5|||
143204079|NCT00160199|516293693|FG001|Overall Study|Adverse Event|14|||
143204080|NCT00160199|516293692|FG000|Overall Study|Lack of Efficacy|0|||
143204081|NCT00160199|516293693|FG001|Overall Study|Lack of Efficacy|1|||
143204082|NCT00160199|516293692|FG000|Overall Study|Lost to Follow-up|7|||
143204083|NCT00160199|516293693|FG001|Overall Study|Lost to Follow-up|7|||
143204084|NCT00160199|516293692|FG000|Overall Study|Withdrawal by Subject|4|||
143204085|NCT00160199|516293693|FG001|Overall Study|Withdrawal by Subject|6|||
143204086|NCT00160199|516293692|FG000|Overall Study|Administrative|0|||
143204087|NCT00160199|516293693|FG001|Overall Study|Administrative|1|||
143204088|NCT00160199|516293692|FG000|Overall Study|Protocol Violation|8|||
143204089|NCT00160199|516293693|FG001|Overall Study|Protocol Violation|8|||
143204090|NCT01710527|516293696|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
143204091|NCT01710527|516293697|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
143204092|NCT01739803|516293700|FG000|Overall Study|Lost to Follow-up|9|||
143204093|NCT01739803|516293701|FG001|Overall Study|Lost to Follow-up|6|||
143204094|NCT01565564|516293703|FG000|Overall Study|Lost to Follow-up|5|||
143204095|NCT01565564|516293704|FG001|Overall Study|Lost to Follow-up|1|||
143204096|NCT03995355|516293705|FG000|Overall Study|Adverse Event|1|||
143204097|NCT03995355|516293706|FG001|Overall Study|Adverse Event|0|||
143204098|NCT03995355|516293705|FG000|Overall Study|Withdrawal by Subject|1|||
143204099|NCT03995355|516293706|FG001|Overall Study|Withdrawal by Subject|0|||
143204100|NCT03995355|516293705|FG000|Overall Study|Scheduling Issues|0|||
143204101|NCT03995355|516293706|FG001|Overall Study|Scheduling Issues|1|||
143204102|NCT00094107|516293707|FG000|Overall Study|Lack of Efficacy|23|||
143204103|NCT00094107|516293707|FG000|Overall Study|Death|5|||
143204104|NCT00094107|516293707|FG000|Overall Study|Adverse Event|3|||
143204105|NCT00094107|516293707|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
143204106|NCT02698371|516293710|FG000|All Participants Flow|Lost to Follow-up|3|||
143204107|NCT02698371|516293710|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
143204108|NCT02698371|516293710|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
143204109|NCT02698371|516293710|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
143204110|NCT02698371|516293710|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
143204111|NCT02698371|516293710|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
143204112|NCT02698371|516293710|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
143204113|NCT02525094|516293711|FG000|Overall Study|Lost to Follow-up|2|||
143204114|NCT02525094|516293712|FG001|Overall Study|Lost to Follow-up|1|||
143204115|NCT02525094|516293711|FG000|Overall Study|Withdrawal by Subject|5|||
143204116|NCT02525094|516293712|FG001|Overall Study|Withdrawal by Subject|6|||
143204117|NCT02525094|516293711|FG000|Overall Study|Not Treated|1|||
143204118|NCT02525094|516293712|FG001|Overall Study|Not Treated|1|||
143204119|NCT00831701|516293717|FG000|Overall Study|Withdrawal by Subject|2|||
143204120|NCT00831701|516293718|FG001|Overall Study|Withdrawal by Subject|0|||
143204121|NCT00831701|516293717|FG000|Overall Study|Stone expulsion before first medication|2|||
143204122|NCT00831701|516293718|FG001|Overall Study|Stone expulsion before first medication|2|||
143204123|NCT00831701|516293717|FG000|Overall Study|Lost to Follow-up|1|||
143204124|NCT00831701|516293718|FG001|Overall Study|Lost to Follow-up|3|||
143204125|NCT01440881|516293719|FG000|Overall Study|Death|0|||
143204126|NCT01440881|516293720|FG001|Overall Study|Death|1|||
143204127|NCT02739321|516293721|FG000|Overall Study|Lack of Efficacy|1|||
143204128|NCT02739321|516293722|FG001|Overall Study|Lack of Efficacy|1|||
143204129|NCT02739321|516293721|FG000|Overall Study|Lost to Follow-up|1|||
143204130|NCT02739321|516293722|FG001|Overall Study|Lost to Follow-up|1|||
143204131|NCT02739321|516293721|FG000|Overall Study|Withdrawal by Subject|1|||
143204132|NCT02739321|516293722|FG001|Overall Study|Withdrawal by Subject|2|||
143204133|NCT00528996|516295060|FG000|Overall Study|Other reasons than listing|6|||
143204134|NCT00528996|516295061|FG001|Overall Study|Other reasons than listing|7|||
143204135|NCT00528996|516295062|FG002|Overall Study|Other reasons than listing|14|||
143204136|NCT00528996|516295063|FG003|Overall Study|Other reasons than listing|11|||
143204137|NCT00528996|516295064|FG004|Overall Study|Other reasons than listing|5|||
143204138|NCT00528996|516295060|FG000|Overall Study|Refused continue medication|16|||
143204139|NCT00528996|516295061|FG001|Overall Study|Refused continue medication|0|||
143204140|NCT00528996|516295062|FG002|Overall Study|Refused continue medication|3|||
143204141|NCT00528996|516295063|FG003|Overall Study|Refused continue medication|3|||
143204142|NCT00528996|516295064|FG004|Overall Study|Refused continue medication|6|||
143204143|NCT00528996|516295060|FG000|Overall Study|Lost to Follow-up|2|||
143204144|NCT00528996|516295061|FG001|Overall Study|Lost to Follow-up|0|||
143204145|NCT00528996|516295062|FG002|Overall Study|Lost to Follow-up|4|||
143204146|NCT00528996|516295063|FG003|Overall Study|Lost to Follow-up|1|||
143204147|NCT00528996|516295064|FG004|Overall Study|Lost to Follow-up|3|||
143204148|NCT00528996|516295060|FG000|Overall Study|Protocol Violation|1|||
143204149|NCT00528996|516295061|FG001|Overall Study|Protocol Violation|2|||
143204150|NCT00528996|516295062|FG002|Overall Study|Protocol Violation|3|||
143204151|NCT00528996|516295063|FG003|Overall Study|Protocol Violation|3|||
143204152|NCT00528996|516295064|FG004|Overall Study|Protocol Violation|2|||
143204153|NCT00528996|516295060|FG000|Overall Study|Lack of Efficacy|7|||
143204154|NCT00528996|516295061|FG001|Overall Study|Lack of Efficacy|2|||
143204155|NCT00528996|516295062|FG002|Overall Study|Lack of Efficacy|1|||
143204156|NCT00528996|516295063|FG003|Overall Study|Lack of Efficacy|3|||
143204157|NCT00528996|516295064|FG004|Overall Study|Lack of Efficacy|3|||
143204158|NCT00528996|516295060|FG000|Overall Study|Adverse Event|32|||
143204159|NCT00528996|516295061|FG001|Overall Study|Adverse Event|13|||
143204160|NCT00528996|516295062|FG002|Overall Study|Adverse Event|18|||
143204161|NCT00528996|516295063|FG003|Overall Study|Adverse Event|29|||
143204162|NCT00528996|516295064|FG004|Overall Study|Adverse Event|18|||
143204163|NCT02831933|516295065|FG000|Overall Study|Physician Decision|11|||
143204164|NCT05065190|516295072|FG000|Overall Study|Other than listed|2|||
143204165|NCT05065190|516295073|FG001|Overall Study|Other than listed|12|||
143204166|NCT05065190|516295072|FG000|Overall Study|Lack of Efficacy|4|||
143204167|NCT05065190|516295073|FG001|Overall Study|Lack of Efficacy|0|||
143204168|NCT05065190|516295072|FG000|Overall Study|Adverse Event|1|||
143204169|NCT05065190|516295073|FG001|Overall Study|Adverse Event|10|||
143204170|NCT01350115|516295074|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
143204171|NCT01350115|516295075|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
143204172|NCT01350115|516295074|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
143204173|NCT01350115|516295075|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
143204174|NCT01350115|516295074|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
143204175|NCT01350115|516295075|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
143204176|NCT04544683|516295076|FG000|Overall Study|Lost to Follow-up|2|||
143204177|NCT04544683|516295076|FG000|Overall Study|Underwent cervical spine surgery|6|||
143204178|NCT05160766|516295079|FG000|Overall Study|Adverse Event|0|||
143204179|NCT05160766|516295080|FG001|Overall Study|Adverse Event|1|||
143204180|NCT05160766|516295081|FG002|Overall Study|Adverse Event|0|||
143204181|NCT05160766|516295082|FG003|Overall Study|Adverse Event|0|||
143204182|NCT05160766|516295079|FG000|Overall Study|COVID-19 infection|0|||
143204183|NCT05160766|516295080|FG001|Overall Study|COVID-19 infection|1|||
143204184|NCT05160766|516295081|FG002|Overall Study|COVID-19 infection|0|||
143204185|NCT05160766|516295082|FG003|Overall Study|COVID-19 infection|0|||
143204186|NCT05160766|516295079|FG000|Overall Study|travel time|1|||
143204187|NCT05160766|516295080|FG001|Overall Study|travel time|0|||
143204188|NCT05160766|516295081|FG002|Overall Study|travel time|0|||
143204189|NCT05160766|516295082|FG003|Overall Study|travel time|1|||
143204190|NCT05160766|516295079|FG000|Overall Study|Withdrawal by Subject|3|||
143204191|NCT05160766|516295080|FG001|Overall Study|Withdrawal by Subject|5|||
143204192|NCT05160766|516295081|FG002|Overall Study|Withdrawal by Subject|4|||
143204193|NCT05160766|516295082|FG003|Overall Study|Withdrawal by Subject|2|||
143204194|NCT05160766|516295079|FG000|Overall Study|Death|0|||
143204195|NCT05160766|516295080|FG001|Overall Study|Death|0|||
143204196|NCT05160766|516295081|FG002|Overall Study|Death|2|||
143204197|NCT05160766|516295082|FG003|Overall Study|Death|5|||
143204198|NCT05160766|516295079|FG000|Overall Study|Lost to Follow-up|0|||
143204199|NCT05160766|516295080|FG001|Overall Study|Lost to Follow-up|0|||
143204200|NCT05160766|516295081|FG002|Overall Study|Lost to Follow-up|1|||
143204201|NCT05160766|516295082|FG003|Overall Study|Lost to Follow-up|2|||
143204202|NCT05160766|516295079|FG000|Overall Study|No show|0|||
143204203|NCT05160766|516295080|FG001|Overall Study|No show|0|||
143204204|NCT05160766|516295081|FG002|Overall Study|No show|1|||
143204205|NCT05160766|516295082|FG003|Overall Study|No show|1|||
143204206|NCT05160766|516295079|FG000|Overall Study|Physician Decision|0|||
143204207|NCT05160766|516295080|FG001|Overall Study|Physician Decision|0|||
143204208|NCT05160766|516295081|FG002|Overall Study|Physician Decision|0|||
143204209|NCT05160766|516295082|FG003|Overall Study|Physician Decision|1|||
143204210|NCT05160766|516295079|FG000|Overall Study|Protocol Violation|0|||
143204211|NCT05160766|516295080|FG001|Overall Study|Protocol Violation|0|||
143204212|NCT05160766|516295081|FG002|Overall Study|Protocol Violation|1|||
143204213|NCT05160766|516295082|FG003|Overall Study|Protocol Violation|0|||
143204214|NCT02654236|516295085|FG000|Overall Study|Withdrawal by Subject|0|||
143204215|NCT02654236|516295086|FG001|Overall Study|Withdrawal by Subject|0|||
143204216|NCT02654236|516295087|FG002|Overall Study|Withdrawal by Subject|2|||
143204217|NCT05149313|516295089|FG000|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
143262747|NCT00586326|516515926|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
143262748|NCT00586326|516515926|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
143204218|NCT05149313|516295090|FG001|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
143204219|NCT05149313|516295091|FG002|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
143204220|NCT05149313|516295092|FG003|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
143204221|NCT05149313|516295089|FG000|Double-blind Induction Period (16-weeks)|Lost to Follow-up|2|||
143204222|NCT05149313|516295090|FG001|Double-blind Induction Period (16-weeks)|Lost to Follow-up|3|||
143204223|NCT05149313|516295091|FG002|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
143204224|NCT05149313|516295092|FG003|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
143204225|NCT05149313|516295089|FG000|Double-blind Induction Period (16-weeks)|Pregnancy|1|||
143204226|NCT05149313|516295090|FG001|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
143204227|NCT05149313|516295091|FG002|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
143204228|NCT05149313|516295092|FG003|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
143204229|NCT05149313|516295089|FG000|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|2|||
143204230|NCT05149313|516295090|FG001|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|5|||
143204231|NCT05149313|516295091|FG002|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
143204232|NCT05149313|516295092|FG003|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
143204233|NCT05149313|516295089|FG000|Double-blind Induction Period (16-weeks)|Physician Decision|1|||
143204234|NCT05149313|516295090|FG001|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
143204235|NCT05149313|516295091|FG002|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
143204236|NCT05149313|516295092|FG003|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
143204237|NCT05149313|516295089|FG000|Double-blind Induction Period (16-weeks)|Other|0|||
143204238|NCT05149313|516295090|FG001|Double-blind Induction Period (16-weeks)|Other|1|||
143204239|NCT05149313|516295091|FG002|Double-blind Induction Period (16-weeks)|Other|0|||
143204240|NCT05149313|516295092|FG003|Double-blind Induction Period (16-weeks)|Other|0|||
143204241|NCT05149313|516295089|FG000|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
143204242|NCT05149313|516295090|FG001|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
143204243|NCT05149313|516295091|FG002|Open-label Maintenance Period (36 Weeks)|Adverse Event|7|||
143204244|NCT05149313|516295092|FG003|Open-label Maintenance Period (36 Weeks)|Adverse Event|1|||
143204245|NCT05149313|516295089|FG000|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
143204246|NCT05149313|516295090|FG001|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
143204247|NCT05149313|516295091|FG002|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|14|||
143204248|NCT05149313|516295092|FG003|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|7|||
143204249|NCT05149313|516295089|FG000|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
143204250|NCT05149313|516295090|FG001|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
143204251|NCT05149313|516295091|FG002|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|6|||
143204252|NCT05149313|516295092|FG003|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|5|||
143204253|NCT05149313|516295089|FG000|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
143204254|NCT05149313|516295090|FG001|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
143204255|NCT05149313|516295091|FG002|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|4|||
143204256|NCT05149313|516295092|FG003|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
143204257|NCT05149313|516295089|FG000|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
143204258|NCT05149313|516295090|FG001|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
143204259|NCT05149313|516295091|FG002|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|1|||
143204260|NCT05149313|516295092|FG003|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
143204261|NCT03199391|516295093|FG000|Overall Study|Death|1|||
143204262|NCT03199391|516295093|FG000|Overall Study|Lost to Follow-up|3|||
143204263|NCT03199391|516295093|FG000|Overall Study|Adverse Event|2|||
143204264|NCT03199391|516295093|FG000|Overall Study|Withdrawal by Subject|10|||
143204265|NCT01867086|516295094|FG000|Overall Study|Disease Progression|1|||
143204266|NCT03826342|516295104|FG000|Overall Study|Withdrawal by Subject|8|||
143204267|NCT03826342|516295105|FG001|Overall Study|Withdrawal by Subject|1|||
143204268|NCT03826342|516295104|FG000|Overall Study|Lost to Follow-up|7|||
143204269|NCT03826342|516295105|FG001|Overall Study|Lost to Follow-up|7|||
143204270|NCT03826342|516295104|FG000|Overall Study|Miscarriage - Loss of Eligibility to Participate|1|||
143204271|NCT03826342|516295105|FG001|Overall Study|Miscarriage - Loss of Eligibility to Participate|3|||
143204272|NCT01818284|516295112|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
143204273|NCT01818284|516295113|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
143204274|NCT01818284|516295112|FG000|Overall Study|Death|0|||
143204275|NCT01818284|516295113|FG001|Overall Study|Death|2|||
143204276|NCT03681678|516295114|FG000|Overall Study|Lost to Follow-up|20|||
143204277|NCT00895661|516295122|FG000|Overall Study|Death|1|||
143204278|NCT00895661|516295122|FG000|Overall Study|reason unknown|2|||
143204279|NCT02006069|516295125|FG000|Overall Study|MPP other programming|239|||
143204280|NCT02006069|516295126|FG001|Overall Study|MPP other programming|0|||
143204281|NCT02006069|516295125|FG000|Overall Study|RV only pacing|0|||
143204282|NCT02006069|516295126|FG001|Overall Study|RV only pacing|3|||
143204283|NCT00791557|516295127|FG000|Overall Study|Adverse Event|1|||
143204284|NCT00316888|516295131|FG000|Overall Study|Adverse Event|4|||
143204285|NCT00316888|516295132|FG001|Overall Study|Adverse Event|5|||
143204286|NCT00316888|516295131|FG000|Overall Study|Withdrawal by Subject|2|||
143204287|NCT00316888|516295132|FG001|Overall Study|Withdrawal by Subject|2|||
143204288|NCT00316888|516295131|FG000|Overall Study|Not start protocol therapy|0|||
143204289|NCT00316888|516295132|FG001|Overall Study|Not start protocol therapy|1|||
143204290|NCT03757130|516295136|FG000|Overall Study|Lost to Follow-up|0|||
143204291|NCT03757130|516295137|FG001|Overall Study|Lost to Follow-up|0|||
143204292|NCT03757130|516295138|FG002|Overall Study|Lost to Follow-up|0|||
143204293|NCT03757130|516295139|FG003|Overall Study|Lost to Follow-up|1|||
143204294|NCT03757130|516295140|FG004|Overall Study|Lost to Follow-up|0|||
143204295|NCT03757130|516295141|FG005|Overall Study|Lost to Follow-up|0|||
143204296|NCT03757130|516295142|FG006|Overall Study|Lost to Follow-up|0|||
143204297|NCT03757130|516295143|FG007|Overall Study|Lost to Follow-up|1|||
143204298|NCT03757130|516295136|FG000|Overall Study|Withdrawal by Subject|0|||
143204299|NCT03757130|516295137|FG001|Overall Study|Withdrawal by Subject|0|||
143204300|NCT03757130|516295138|FG002|Overall Study|Withdrawal by Subject|0|||
143204301|NCT03757130|516295139|FG003|Overall Study|Withdrawal by Subject|0|||
143204302|NCT03757130|516295140|FG004|Overall Study|Withdrawal by Subject|0|||
143204303|NCT03757130|516295141|FG005|Overall Study|Withdrawal by Subject|0|||
143204304|NCT03757130|516295142|FG006|Overall Study|Withdrawal by Subject|1|||
143204305|NCT03757130|516295143|FG007|Overall Study|Withdrawal by Subject|0|||
143204306|NCT01439126|516295146|FG000|Overall Study|Adverse Event|2|||
143204307|NCT01439126|516295147|FG001|Overall Study|Adverse Event|0|||
143204308|NCT01439126|516295146|FG000|Overall Study|Withdrawal by Subject|5|||
143204309|NCT01439126|516295147|FG001|Overall Study|Withdrawal by Subject|21|||
143204310|NCT01439126|516295146|FG000|Overall Study|Protocol Violation|6|||
143204311|NCT01439126|516295147|FG001|Overall Study|Protocol Violation|4|||
143204312|NCT01439126|516295146|FG000|Overall Study|Lost to Follow-up|6|||
143204313|NCT01439126|516295147|FG001|Overall Study|Lost to Follow-up|3|||
143204314|NCT01439126|516295146|FG000|Overall Study|Other-Use of prohibited treatment|0|||
143204315|NCT01439126|516295147|FG001|Overall Study|Other-Use of prohibited treatment|2|||
143204316|NCT01439126|516295146|FG000|Overall Study|Other-Miscellaneous|12|||
143204317|NCT01439126|516295147|FG001|Overall Study|Other-Miscellaneous|12|||
143204318|NCT02635347|516295150|FG000|Overall Study|Failed screening|20|||
143204319|NCT02635347|516295151|FG001|Overall Study|Failed screening|7|||
143204320|NCT01617447|516295153|FG000|Overall Study|Adverse Event|0|||
143370273|NCT02377362|516899141|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
143370274|NCT02377362|516899142|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
143204321|NCT01617447|516295154|FG001|Overall Study|Adverse Event|1|||
143204322|NCT01617447|516295153|FG000|Overall Study|Physician Decision|0|||
143204323|NCT01617447|516295154|FG001|Overall Study|Physician Decision|2|||
143204324|NCT03443427|516295155|FG000|Overall Study|Adverse Event|2|||
143204325|NCT03443427|516295156|FG001|Overall Study|Adverse Event|3|||
143204326|NCT03443427|516295155|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
143204327|NCT03443427|516295156|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
143204328|NCT03443427|516295155|FG000|Overall Study|Other|4|||
143204329|NCT03443427|516295156|FG001|Overall Study|Other|6|||
143204330|NCT02713529|516295157|FG000|Overall Study|Withdrawal by Subject|3|||
143204331|NCT02713529|516295158|FG001|Overall Study|Withdrawal by Subject|1|||
143204332|NCT02713529|516295159|FG002|Overall Study|Withdrawal by Subject|4|||
143204333|NCT02713529|516295160|FG003|Overall Study|Withdrawal by Subject|2|||
143204334|NCT02713529|516295161|FG004|Overall Study|Withdrawal by Subject|0|||
143204335|NCT02713529|516295162|FG005|Overall Study|Withdrawal by Subject|1|||
143204336|NCT02713529|516295163|FG006|Overall Study|Withdrawal by Subject|1|||
143204337|NCT02713529|516295157|FG000|Overall Study|Lost to Follow-up|1|||
143204338|NCT02713529|516295158|FG001|Overall Study|Lost to Follow-up|0|||
143204339|NCT02713529|516295159|FG002|Overall Study|Lost to Follow-up|1|||
143204340|NCT02713529|516295160|FG003|Overall Study|Lost to Follow-up|0|||
143204341|NCT02713529|516295161|FG004|Overall Study|Lost to Follow-up|0|||
143204342|NCT02713529|516295162|FG005|Overall Study|Lost to Follow-up|0|||
143204343|NCT02713529|516295163|FG006|Overall Study|Lost to Follow-up|0|||
143204344|NCT02713529|516295157|FG000|Overall Study|Death|3|||
143204345|NCT02713529|516295158|FG001|Overall Study|Death|3|||
143370275|NCT02377362|516899143|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
143370276|NCT02377362|516899144|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
143204346|NCT02713529|516295159|FG002|Overall Study|Death|26|||
143204347|NCT02713529|516295160|FG003|Overall Study|Death|27|||
143204348|NCT02713529|516295161|FG004|Overall Study|Death|3|||
143204349|NCT02713529|516295162|FG005|Overall Study|Death|13|||
143204350|NCT02713529|516295163|FG006|Overall Study|Death|3|||
143204351|NCT00780273|516295164|FG000|Overall Study|Death|1|||
143204352|NCT00780273|516295164|FG000|Overall Study|Lost to Follow-up|1|||
143204353|NCT02827500|516295165|FG000|Overall Study|Death|7|||
143204354|NCT02827500|516295166|FG001|Overall Study|Death|3|||
143204355|NCT02827500|516295165|FG000|Overall Study|Lost to Follow-up|1|||
143204356|NCT02827500|516295166|FG001|Overall Study|Lost to Follow-up|1|||
143204357|NCT02827500|516295165|FG000|Overall Study|Withdrawal by Subject|3|||
143204358|NCT02827500|516295166|FG001|Overall Study|Withdrawal by Subject|1|||
143204359|NCT02827500|516295165|FG000|Overall Study|Missing primary endpoint data|3|||
143204360|NCT02827500|516295166|FG001|Overall Study|Missing primary endpoint data|1|||
143204361|NCT02827500|516295165|FG000|Overall Study|Other|5|||
143204362|NCT02827500|516295166|FG001|Overall Study|Other|1|||
143204363|NCT02449018|516295167|FG000|Overall Study|Abnormal laboratory value|0|||
143204364|NCT02449018|516295168|FG001|Overall Study|Abnormal laboratory value|1|||
143204365|NCT02449018|516295167|FG000|Overall Study|Administrative problems|1|||
143204366|NCT02449018|516295168|FG001|Overall Study|Administrative problems|0|||
143204367|NCT02449018|516295167|FG000|Overall Study|Adverse Event|5|||
143204368|NCT02449018|516295168|FG001|Overall Study|Adverse Event|1|||
143370277|NCT02377362|516899132|FG000|Part B Overall|Protocol Violation|0|||
143370278|NCT02377362|516899133|FG001|Part B Overall|Protocol Violation|0|||
143370279|NCT02377362|516899134|FG002|Part B Overall|Protocol Violation|0|||
143370280|NCT02377362|516899135|FG003|Part B Overall|Protocol Violation|0|||
143370281|NCT02377362|516899136|FG004|Part B Overall|Protocol Violation|0|||
143370282|NCT02377362|516899137|FG005|Part B Overall|Protocol Violation|0|||
143370283|NCT02377362|516899138|FG006|Part B Overall|Protocol Violation|0|||
143370284|NCT02377362|516899139|FG007|Part B Overall|Protocol Violation|0|||
143370285|NCT02377362|516899140|FG008|Part B Overall|Protocol Violation|0|||
143370286|NCT02377362|516899141|FG009|Part B Overall|Protocol Violation|1|||
143370287|NCT02377362|516899142|FG010|Part B Overall|Protocol Violation|0|||
143370288|NCT02377362|516899143|FG011|Part B Overall|Protocol Violation|0|||
143370289|NCT02377362|516899144|FG012|Part B Overall|Protocol Violation|0|||
143370290|NCT02377362|516899132|FG000|Part B Overall|Adverse Event|0|||
143370291|NCT02377362|516899133|FG001|Part B Overall|Adverse Event|0|||
143370292|NCT02377362|516899134|FG002|Part B Overall|Adverse Event|0|||
143370293|NCT02377362|516899135|FG003|Part B Overall|Adverse Event|0|||
143370294|NCT02377362|516899136|FG004|Part B Overall|Adverse Event|0|||
143370295|NCT02377362|516899137|FG005|Part B Overall|Adverse Event|0|||
143370296|NCT02377362|516899138|FG006|Part B Overall|Adverse Event|1|||
143370297|NCT02377362|516899139|FG007|Part B Overall|Adverse Event|1|||
143370298|NCT02377362|516899140|FG008|Part B Overall|Adverse Event|0|||
143370299|NCT02377362|516899141|FG009|Part B Overall|Adverse Event|0|||
143370300|NCT02377362|516899142|FG010|Part B Overall|Adverse Event|0|||
143370301|NCT02377362|516899143|FG011|Part B Overall|Adverse Event|0|||
143370302|NCT02377362|516899144|FG012|Part B Overall|Adverse Event|0|||
143204369|NCT02449018|516295167|FG000|Overall Study|Protocol deviation|4|||
143204370|NCT02449018|516295168|FG001|Overall Study|Protocol deviation|0|||
143204371|NCT02449018|516295167|FG000|Overall Study|Patient decision|2|||
143204372|NCT02449018|516295168|FG001|Overall Study|Patient decision|0|||
143204373|NCT00525824|516295174|FG000|Overall Study|Adverse Event|7|||
143204374|NCT00525824|516295175|FG001|Overall Study|Adverse Event|11|||
143204375|NCT00525824|516295176|FG002|Overall Study|Adverse Event|6|||
143204376|NCT00525824|516295177|FG003|Overall Study|Adverse Event|7|||
143204377|NCT00525824|516295174|FG000|Overall Study|Withdrawal by Subject|5|||
143204378|NCT00525824|516295175|FG001|Overall Study|Withdrawal by Subject|9|||
143204379|NCT00525824|516295176|FG002|Overall Study|Withdrawal by Subject|3|||
143204380|NCT00525824|516295177|FG003|Overall Study|Withdrawal by Subject|4|||
143204381|NCT00525824|516295174|FG000|Overall Study|Lost to Follow-up|4|||
143204382|NCT00525824|516295175|FG001|Overall Study|Lost to Follow-up|2|||
143204383|NCT00525824|516295176|FG002|Overall Study|Lost to Follow-up|4|||
143204384|NCT00525824|516295177|FG003|Overall Study|Lost to Follow-up|0|||
143204385|NCT00525824|516295174|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
143204386|NCT00525824|516295175|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
143204387|NCT00525824|516295176|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
143204388|NCT00525824|516295177|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
143204389|NCT00525824|516295174|FG000|Overall Study|Severe non-compliance|0|||
143204390|NCT00525824|516295175|FG001|Overall Study|Severe non-compliance|1|||
143204391|NCT00525824|516295176|FG002|Overall Study|Severe non-compliance|1|||
143204392|NCT00525824|516295177|FG003|Overall Study|Severe non-compliance|1|||
143204393|NCT00525824|516295174|FG000|Overall Study|Safety reasons|1|||
143204394|NCT00525824|516295175|FG001|Overall Study|Safety reasons|0|||
143204395|NCT00525824|516295176|FG002|Overall Study|Safety reasons|1|||
143204396|NCT00525824|516295177|FG003|Overall Study|Safety reasons|0|||
143204397|NCT00525824|516295174|FG000|Overall Study|Other|1|||
143204398|NCT00525824|516295175|FG001|Overall Study|Other|3|||
143204399|NCT00525824|516295176|FG002|Overall Study|Other|3|||
143204400|NCT00525824|516295177|FG003|Overall Study|Other|1|||
143204401|NCT01672866|516295203|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
143204402|NCT01672866|516295204|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
143204403|NCT01672866|516295205|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
143204404|NCT01672866|516295203|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
143204405|NCT01672866|516295204|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
143204406|NCT01672866|516295205|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
143370303|NCT02377362|516899132|FG000|Part B Overall|Withdrawal by Subject|0|||
143370304|NCT02377362|516899133|FG001|Part B Overall|Withdrawal by Subject|0|||
143370305|NCT02377362|516899134|FG002|Part B Overall|Withdrawal by Subject|0|||
143370306|NCT02377362|516899135|FG003|Part B Overall|Withdrawal by Subject|0|||
143370307|NCT02377362|516899136|FG004|Part B Overall|Withdrawal by Subject|0|||
143370308|NCT02377362|516899137|FG005|Part B Overall|Withdrawal by Subject|0|||
143370309|NCT02377362|516899138|FG006|Part B Overall|Withdrawal by Subject|1|||
143204407|NCT01672866|516295203|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
143204408|NCT01672866|516295204|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
143204409|NCT01672866|516295205|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
143204410|NCT01672866|516295203|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
143204411|NCT01672866|516295204|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
143204412|NCT01672866|516295205|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
143204413|NCT01672866|516295203|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
143204414|NCT01672866|516295204|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
143204415|NCT01672866|516295205|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
143204416|NCT01672866|516295203|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
143204417|NCT01672866|516295204|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
143204418|NCT01672866|516295205|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
143204419|NCT01672866|516295203|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
143204420|NCT01672866|516295204|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
143204421|NCT01672866|516295205|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
143204422|NCT01672866|516295203|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
143204423|NCT01672866|516295204|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
143204424|NCT01672866|516295205|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
143204425|NCT01672866|516295203|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
143204426|NCT01672866|516295204|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
143204427|NCT01672866|516295205|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
143204428|NCT01672866|516295203|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
143204429|NCT01672866|516295204|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
143204430|NCT01672866|516295205|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
143204431|NCT01672866|516295203|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
143204432|NCT01672866|516295204|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
143204433|NCT01672866|516295205|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
143204434|NCT01672866|516295203|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
143204435|NCT01672866|516295204|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
143204436|NCT01672866|516295205|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
143204437|NCT01672866|516295203|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
143204438|NCT01672866|516295204|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
143262749|NCT00586326|516515926|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
143262750|NCT00586326|516515926|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
143262751|NCT00586326|516515926|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
143262752|NCT00586326|516515926|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
143262753|NCT00586326|516515926|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
143262754|NCT00586326|516515926|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
143262755|NCT00586326|516515926|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
143262756|NCT00586326|516515926|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
143262757|NCT00586326|516515926|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
143262758|NCT00586326|516515926|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
143262759|NCT00586326|516515926|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
143262760|NCT00586326|516515926|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
143262761|NCT00586326|516515926|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
143262762|NCT00586326|516515926|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
143262763|NCT00586326|516515926|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
143262764|NCT01439347|516515927|FG000|Overall Study|Death|10|||
143262765|NCT01439347|516515928|FG001|Overall Study|Death|9|||
143262766|NCT01439347|516515927|FG000|Overall Study|Withdrawal by Subject|0|||
143262767|NCT01439347|516515928|FG001|Overall Study|Withdrawal by Subject|1|||
143262768|NCT01439347|516515927|FG000|Overall Study|Physician Decision|1|||
143262769|NCT01439347|516515928|FG001|Overall Study|Physician Decision|0|||
143262770|NCT01439347|516515927|FG000|Overall Study|Sponsor Terminated Study|2|||
143262771|NCT01439347|516515928|FG001|Overall Study|Sponsor Terminated Study|3|||
143262772|NCT00542451|516515929|FG000|Overall Study|Adverse Event|31|||
143262773|NCT00542451|516515929|FG000|Overall Study|Withdrawal by Subject|30|||
143262774|NCT00542451|516515929|FG000|Overall Study|Physician Decision|4|||
143262775|NCT00542451|516515929|FG000|Overall Study|Recurrent disease|1|||
143262776|NCT00542451|516515929|FG000|Overall Study|unknown reason|1|||
143262777|NCT00542451|516515929|FG000|Overall Study|Death|2|||
143262778|NCT00542451|516515929|FG000|Overall Study|Lost to Follow-up|10|||
143262779|NCT03519386|516515930|FG000|Overall Study|Withdrawal by Subject|4|||
143262780|NCT03519386|516515931|FG001|Overall Study|Withdrawal by Subject|1|||
143262781|NCT03519386|516515932|FG002|Overall Study|Withdrawal by Subject|2|||
143262782|NCT03519386|516515930|FG000|Overall Study|Physician Decision|1|||
143262783|NCT03519386|516515931|FG001|Overall Study|Physician Decision|1|||
143262784|NCT03519386|516515932|FG002|Overall Study|Physician Decision|1|||
143262785|NCT03519386|516515930|FG000|Overall Study|Lost to Follow-up|0|||
143262786|NCT03519386|516515931|FG001|Overall Study|Lost to Follow-up|1|||
143262787|NCT03519386|516515932|FG002|Overall Study|Lost to Follow-up|1|||
143204439|NCT01672866|516295205|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
143204440|NCT02117349|516295208|FG000|Overall Study|Withdrawal by Subject|1|||
143204441|NCT02117349|516295209|FG001|Overall Study|Withdrawal by Subject|0|||
143204442|NCT02117349|516295208|FG000|Overall Study|Lost to Follow-up|1|||
143204443|NCT02117349|516295209|FG001|Overall Study|Lost to Follow-up|1|||
143204444|NCT02117349|516295208|FG000|Overall Study|Death|1|||
143204445|NCT02117349|516295209|FG001|Overall Study|Death|0|||
143204446|NCT02535416|516295212|FG000|Overall Study|Family bereavement overseas|1|||
143204447|NCT02535416|516295213|FG001|Overall Study|Family bereavement overseas|0|||
143204448|NCT02535416|516295214|FG002|Overall Study|Family bereavement overseas|0|||
143204449|NCT02535416|516295215|FG003|Overall Study|Family bereavement overseas|0|||
143204450|NCT02535416|516295216|FG004|Overall Study|Family bereavement overseas|0|||
143204451|NCT02535416|516295217|FG005|Overall Study|Family bereavement overseas|0|||
143204452|NCT02535416|516295218|FG006|Overall Study|Family bereavement overseas|0|||
143204453|NCT02535416|516295219|FG007|Overall Study|Family bereavement overseas|0|||
143204454|NCT02535416|516295220|FG008|Overall Study|Family bereavement overseas|0|||
143204455|NCT01977690|516295221|FG000|Overall Study|Withdrawal by Subject|0|||
143204456|NCT01977690|516295222|FG001|Overall Study|Withdrawal by Subject|4|||
143204457|NCT05565937|516296554|FG000|Overall Study|Adverse Event|0|||
143204458|NCT05565937|516296555|FG001|Overall Study|Adverse Event|1|||
143204459|NCT05565937|516296554|FG000|Overall Study|Persistent study-related symptoms /complaints|1|||
143204460|NCT05565937|516296555|FG001|Overall Study|Persistent study-related symptoms /complaints|1|||
143204461|NCT05565937|516296554|FG000|Overall Study|Lost to Follow-up|2|||
143204462|NCT05565937|516296555|FG001|Overall Study|Lost to Follow-up|0|||
143204463|NCT05565937|516296554|FG000|Overall Study|Pregnancy|0|||
143204464|NCT05565937|516296555|FG001|Overall Study|Pregnancy|2|||
143204465|NCT05565937|516296554|FG000|Overall Study|Anisometropia|0|||
143204466|NCT05565937|516296555|FG001|Overall Study|Anisometropia|1|||
143204467|NCT00151372|516296556|FG000|Overall Study|Death|12|||
143204468|NCT00151372|516296557|FG001|Overall Study|Death|11|||
143204469|NCT00151372|516296556|FG000|Overall Study|Lost to Follow-up|5|||
143204470|NCT00151372|516296557|FG001|Overall Study|Lost to Follow-up|5|||
143204471|NCT00151372|516296556|FG000|Overall Study|Too sick medically to continue|5|||
143204472|NCT00151372|516296557|FG001|Overall Study|Too sick medically to continue|6|||
143204473|NCT00151372|516296556|FG000|Overall Study|Withdrawal by Subject|7|||
143204474|NCT00151372|516296557|FG001|Overall Study|Withdrawal by Subject|7|||
143204475|NCT00541346|516296560|FG000|Follow-up|Adverse Event|1|||
143204476|NCT04732949|516296563|FG000|Overall Study|Withdrawal by Subject|23|||
143204477|NCT04732949|516296564|FG001|Overall Study|Withdrawal by Subject|27|||
143204478|NCT04732949|516296563|FG000|Overall Study|Protocol Violation|0|||
143204479|NCT04732949|516296564|FG001|Overall Study|Protocol Violation|1|||
143204480|NCT04732949|516296563|FG000|Overall Study|Non-compliance|0|||
143204481|NCT04732949|516296564|FG001|Overall Study|Non-compliance|2|||
143204482|NCT04732949|516296563|FG000|Overall Study|Physician Decision|2|||
143204483|NCT04732949|516296564|FG001|Overall Study|Physician Decision|1|||
143204484|NCT04732949|516296563|FG000|Overall Study|Serious adverse event (Fatal)|16|||
143204485|NCT04732949|516296564|FG001|Overall Study|Serious adverse event (Fatal)|18|||
143204486|NCT04732949|516296563|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
143204487|NCT04732949|516296564|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
143204488|NCT04732949|516296563|FG000|Overall Study|Non-serious adverse event|1|||
143204489|NCT04732949|516296564|FG001|Overall Study|Non-serious adverse event|3|||
143204490|NCT04732949|516296563|FG000|Overall Study|Lost to Follow-up|26|||
143204491|NCT04732949|516296564|FG001|Overall Study|Lost to Follow-up|27|||
143204492|NCT04732949|516296563|FG000|Overall Study|Other|6|||
143204493|NCT04732949|516296564|FG001|Overall Study|Other|3|||
143204494|NCT01286077|516296567|FG000|Overall Study|Adverse Event|2|||
143204495|NCT01286077|516296568|FG001|Overall Study|Adverse Event|0|||
143204496|NCT01286077|516296567|FG000|Overall Study|Death|1|||
143204497|NCT01286077|516296568|FG001|Overall Study|Death|0|||
143204498|NCT01286077|516296567|FG000|Overall Study|Protocol Violation|1|||
143204499|NCT01286077|516296568|FG001|Overall Study|Protocol Violation|1|||
143204500|NCT01286077|516296567|FG000|Overall Study|Withdrawal by Subject|0|||
143204501|NCT01286077|516296568|FG001|Overall Study|Withdrawal by Subject|2|||
143204502|NCT01286077|516296567|FG000|Overall Study|Intercurrent illness|1|||
143204503|NCT01286077|516296568|FG001|Overall Study|Intercurrent illness|0|||
143204504|NCT01286077|516296567|FG000|Overall Study|Non-compliance|1|||
143204505|NCT01286077|516296568|FG001|Overall Study|Non-compliance|0|||
143204506|NCT01286077|516296567|FG000|Overall Study|The subject starts with alternative MMY|0|||
143204507|NCT01286077|516296568|FG001|Overall Study|The subject starts with alternative MMY|3|||
143204508|NCT01286077|516296567|FG000|Overall Study|Patient's decision to stop treatment|3|||
143204509|NCT01286077|516296568|FG001|Overall Study|Patient's decision to stop treatment|0|||
143204510|NCT01286077|516296567|FG000|Overall Study|Progression of disease|0|||
143204511|NCT01286077|516296568|FG001|Overall Study|Progression of disease|1|||
143204512|NCT01286077|516296567|FG000|Overall Study|refill medication not received in time|1|||
143204513|NCT01286077|516296568|FG001|Overall Study|refill medication not received in time|0|||
143204514|NCT01282294|516296569|FG000|Overall Study|Lost to Follow-up|14|||
143204515|NCT01282294|516296569|FG000|Overall Study|Screening failure|1|||
143204516|NCT01282294|516296569|FG000|Overall Study|Adverse Event|1|||
143204517|NCT01282294|516296569|FG000|Overall Study|Patient non-compliance|2|||
143204518|NCT01282294|516296569|FG000|Overall Study|Physician Decision|1|||
143204519|NCT02943915|516296570|FG000|Overall Study|Withdrawal by Subject|2|||
143204520|NCT02943915|516296571|FG001|Overall Study|Withdrawal by Subject|1|||
143204521|NCT02943915|516296572|FG002|Overall Study|Withdrawal by Subject|0|||
143204522|NCT02943915|516296573|FG003|Overall Study|Withdrawal by Subject|0|||
143204523|NCT02943915|516296570|FG000|Overall Study|Lost to Follow-up|3|||
143204524|NCT02943915|516296571|FG001|Overall Study|Lost to Follow-up|1|||
143204525|NCT02943915|516296572|FG002|Overall Study|Lost to Follow-up|0|||
143204526|NCT02943915|516296573|FG003|Overall Study|Lost to Follow-up|0|||
143204527|NCT02943915|516296570|FG000|Overall Study|excluded|0|||
143204528|NCT02943915|516296571|FG001|Overall Study|excluded|1|||
143204529|NCT02943915|516296572|FG002|Overall Study|excluded|0|||
143204530|NCT02943915|516296573|FG003|Overall Study|excluded|0|||
143204531|NCT00701805|516296574|FG000|Overall Study|Withdrawal by Subject|3|||
143204532|NCT00701805|516296575|FG001|Overall Study|Withdrawal by Subject|1|||
143204533|NCT00701805|516296576|FG002|Overall Study|Withdrawal by Subject|4|||
143204534|NCT00701805|516296577|FG003|Overall Study|Withdrawal by Subject|3|||
143204535|NCT00701805|516296574|FG000|Overall Study|Adverse Event|0|||
143204536|NCT00701805|516296575|FG001|Overall Study|Adverse Event|1|||
143204537|NCT00701805|516296576|FG002|Overall Study|Adverse Event|1|||
143204538|NCT00701805|516296577|FG003|Overall Study|Adverse Event|0|||
143204539|NCT00701805|516296574|FG000|Overall Study|Missed 7 consecutive doses|0|||
143204540|NCT00701805|516296575|FG001|Overall Study|Missed 7 consecutive doses|1|||
143204541|NCT00701805|516296576|FG002|Overall Study|Missed 7 consecutive doses|0|||
143204542|NCT00701805|516296577|FG003|Overall Study|Missed 7 consecutive doses|0|||
143204543|NCT00701805|516296574|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
143204544|NCT00701805|516296575|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
143204545|NCT00701805|516296576|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
143204546|NCT00701805|516296577|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
143204547|NCT00701805|516296574|FG000|Overall Study|Physician decision, change of therapy|0|||
143204548|NCT00701805|516296575|FG001|Overall Study|Physician decision, change of therapy|0|||
143204549|NCT00701805|516296576|FG002|Overall Study|Physician decision, change of therapy|0|||
143204550|NCT00701805|516296577|FG003|Overall Study|Physician decision, change of therapy|1|||
143204551|NCT00701805|516296574|FG000|Overall Study|Difficult to travel to dialysis site|0|||
143204552|NCT00701805|516296575|FG001|Overall Study|Difficult to travel to dialysis site|0|||
143204553|NCT00701805|516296576|FG002|Overall Study|Difficult to travel to dialysis site|1|||
143204554|NCT00701805|516296577|FG003|Overall Study|Difficult to travel to dialysis site|0|||
143204555|NCT00701805|516296574|FG000|Overall Study|Resumption criteria were not met|0|||
143204556|NCT00701805|516296575|FG001|Overall Study|Resumption criteria were not met|1|||
143204557|NCT00701805|516296576|FG002|Overall Study|Resumption criteria were not met|0|||
143204558|NCT00701805|516296577|FG003|Overall Study|Resumption criteria were not met|0|||
143204559|NCT04692077|516296582|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
143204560|NCT02212678|516296587|FG000|Overall Study|Adverse Event|1|||
143204561|NCT02337634|516296588|FG000|Overall Study|Protocol Violation|3|||
143204562|NCT02337634|516296589|FG001|Overall Study|Protocol Violation|1|||
143204563|NCT02337634|516296588|FG000|Overall Study|Lost to Follow-up|1|||
143204564|NCT02337634|516296589|FG001|Overall Study|Lost to Follow-up|0|||
143204565|NCT04068610|516296590|FG000|Overall Study|Death|4|||
143204566|NCT04068610|516296591|FG001|Overall Study|Death|8|||
143262788|NCT03519386|516515930|FG000|Overall Study|Death|1|||
143262789|NCT03519386|516515931|FG001|Overall Study|Death|0|||
143262790|NCT03519386|516515932|FG002|Overall Study|Death|4|||
143262791|NCT03519386|516515930|FG000|Overall Study|Adverse Event|2|||
143262792|NCT03519386|516515931|FG001|Overall Study|Adverse Event|1|||
143204567|NCT04068610|516296592|FG002|Overall Study|Death|13|||
143204568|NCT04068610|516296590|FG000|Overall Study|Lost to Follow-up|0|||
143204569|NCT04068610|516296591|FG001|Overall Study|Lost to Follow-up|2|||
143204570|NCT04068610|516296592|FG002|Overall Study|Lost to Follow-up|0|||
143204571|NCT04068610|516296590|FG000|Overall Study|Withdrawal by Subject|0|||
143204572|NCT04068610|516296591|FG001|Overall Study|Withdrawal by Subject|4|||
143204573|NCT04068610|516296592|FG002|Overall Study|Withdrawal by Subject|2|||
143204574|NCT04068610|516296590|FG000|Overall Study|Other|3|||
143204575|NCT04068610|516296591|FG001|Overall Study|Other|12|||
143204576|NCT04068610|516296592|FG002|Overall Study|Other|11|||
143204577|NCT02046070|516296593|FG000|Overall Study|Progressive Disease|18|||
143204578|NCT02046070|516296594|FG001|Overall Study|Progressive Disease|11|||
143204579|NCT02046070|516296595|FG002|Overall Study|Progressive Disease|40|||
143204580|NCT02046070|516296593|FG000|Overall Study|Adverse Event|8|||
143262793|NCT03519386|516515932|FG002|Overall Study|Adverse Event|2|||
143204581|NCT02046070|516296594|FG001|Overall Study|Adverse Event|10|||
143204582|NCT02046070|516296595|FG002|Overall Study|Adverse Event|17|||
143262794|NCT03519386|516515930|FG000|Overall Study|Explanted|2|||
143262795|NCT03519386|516515931|FG001|Overall Study|Explanted|1|||
143262796|NCT03519386|516515932|FG002|Overall Study|Explanted|0|||
143204583|NCT02046070|516296593|FG000|Overall Study|Withdrawal by Subject|1|||
143204584|NCT02046070|516296594|FG001|Overall Study|Withdrawal by Subject|2|||
143204585|NCT02046070|516296595|FG002|Overall Study|Withdrawal by Subject|6|||
143204586|NCT02046070|516296593|FG000|Overall Study|Study Terminated by Sponsor|1|||
143204587|NCT02046070|516296594|FG001|Overall Study|Study Terminated by Sponsor|1|||
143204588|NCT02046070|516296595|FG002|Overall Study|Study Terminated by Sponsor|1|||
143204589|NCT02046070|516296593|FG000|Overall Study|Reason not Specified|4|||
143204590|NCT02046070|516296594|FG001|Overall Study|Reason not Specified|4|||
143204591|NCT02046070|516296595|FG002|Overall Study|Reason not Specified|6|||
143204592|NCT04030962|516296596|FG000|Stage 2|Adverse Event|0|||
143204593|NCT04030962|516296597|FG001|Stage 2|Adverse Event|0|||
143204594|NCT04030962|516296598|FG002|Stage 2|Adverse Event|0|||
143204595|NCT04030962|516296599|FG003|Stage 2|Adverse Event|0|||
143204596|NCT04030962|516296600|FG004|Stage 2|Adverse Event|0|||
143204597|NCT04030962|516296601|FG005|Stage 2|Adverse Event|0|||
143204598|NCT04030962|516296602|FG006|Stage 2|Adverse Event|0|||
143204599|NCT04030962|516296603|FG007|Stage 2|Adverse Event|0|||
143204600|NCT04030962|516296604|FG008|Stage 2|Adverse Event|1|||
143204601|NCT04030962|516296605|FG009|Stage 2|Adverse Event|0|||
143204602|NCT04030962|516296606|FG010|Stage 2|Adverse Event|1|||
143204603|NCT04030962|516296607|FG011|Stage 2|Adverse Event|1|||
143204604|NCT04030962|516296608|FG012|Stage 2|Adverse Event|1|||
143204605|NCT04030962|516296596|FG000|Stage 2|Withdrawal by Subject|0|||
143262797|NCT03519386|516515930|FG000|Overall Study|Ongoing in study|190|||
143262798|NCT03519386|516515931|FG001|Overall Study|Ongoing in study|192|||
143262799|NCT03519386|516515932|FG002|Overall Study|Ongoing in study|183|||
143262800|NCT03063203|516515933|FG000|Overall Study|Chose alternative therapy|3|||
143262801|NCT03063203|516515933|FG000|Overall Study|Death|2|||
143262802|NCT03063203|516515933|FG000|Overall Study|Disease progression|4|||
143262803|NCT03063203|516515933|FG000|Overall Study|Physician Decision|5|||
143262804|NCT01642407|516515934|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
143262805|NCT01642407|516515934|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
143262806|NCT01642407|516515934|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
143370310|NCT02377362|516899139|FG007|Part B Overall|Withdrawal by Subject|0|||
143370311|NCT02377362|516899140|FG008|Part B Overall|Withdrawal by Subject|0|||
143370312|NCT02377362|516899141|FG009|Part B Overall|Withdrawal by Subject|0|||
143370313|NCT02377362|516899142|FG010|Part B Overall|Withdrawal by Subject|0|||
143370314|NCT02377362|516899143|FG011|Part B Overall|Withdrawal by Subject|1|||
143204606|NCT04030962|516296597|FG001|Stage 2|Withdrawal by Subject|0|||
143204607|NCT04030962|516296598|FG002|Stage 2|Withdrawal by Subject|0|||
143204608|NCT04030962|516296599|FG003|Stage 2|Withdrawal by Subject|0|||
143204609|NCT04030962|516296600|FG004|Stage 2|Withdrawal by Subject|0|||
143204610|NCT04030962|516296601|FG005|Stage 2|Withdrawal by Subject|0|||
143204611|NCT04030962|516296602|FG006|Stage 2|Withdrawal by Subject|0|||
143204612|NCT04030962|516296603|FG007|Stage 2|Withdrawal by Subject|0|||
143262807|NCT00829283|516515935|FG000|Overall Study|Lost to Follow-up|7|||
143262808|NCT00829283|516515936|FG001|Overall Study|Lost to Follow-up|25|||
143204613|NCT04030962|516296604|FG008|Stage 2|Withdrawal by Subject|1|||
143204614|NCT04030962|516296605|FG009|Stage 2|Withdrawal by Subject|0|||
143204615|NCT04030962|516296606|FG010|Stage 2|Withdrawal by Subject|0|||
143204616|NCT04030962|516296607|FG011|Stage 2|Withdrawal by Subject|2|||
143204617|NCT04030962|516296608|FG012|Stage 2|Withdrawal by Subject|1|||
143204618|NCT04030962|516296596|FG000|Stage 2|Lost to Follow-up|0|||
143204619|NCT04030962|516296597|FG001|Stage 2|Lost to Follow-up|0|||
143204620|NCT04030962|516296598|FG002|Stage 2|Lost to Follow-up|0|||
143204621|NCT04030962|516296599|FG003|Stage 2|Lost to Follow-up|0|||
143204622|NCT04030962|516296600|FG004|Stage 2|Lost to Follow-up|0|||
143262809|NCT02431247|516515937|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
143262810|NCT02431247|516515938|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
143262811|NCT02431247|516515939|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
143262812|NCT02431247|516515937|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
143262813|NCT02431247|516515938|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
143262814|NCT02431247|516515939|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
143262815|NCT02431247|516515937|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
143262816|NCT02431247|516515938|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
143262817|NCT02431247|516515939|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
143262818|NCT02431247|516515937|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
143262819|NCT02431247|516515938|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
143262820|NCT02431247|516515939|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
143262821|NCT02431247|516515937|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
143262822|NCT02431247|516515938|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
143262823|NCT02431247|516515939|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
143262824|NCT02431247|516515937|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
143262825|NCT02431247|516515938|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
143204623|NCT04030962|516296601|FG005|Stage 2|Lost to Follow-up|0|||
143204624|NCT04030962|516296602|FG006|Stage 2|Lost to Follow-up|0|||
143204625|NCT04030962|516296603|FG007|Stage 2|Lost to Follow-up|0|||
143204626|NCT04030962|516296604|FG008|Stage 2|Lost to Follow-up|1|||
143204627|NCT04030962|516296605|FG009|Stage 2|Lost to Follow-up|0|||
143204628|NCT04030962|516296606|FG010|Stage 2|Lost to Follow-up|0|||
143204629|NCT04030962|516296607|FG011|Stage 2|Lost to Follow-up|0|||
143204630|NCT04030962|516296608|FG012|Stage 2|Lost to Follow-up|0|||
143204631|NCT04030962|516296596|FG000|Stage 2|Technical Problems|0|||
143204632|NCT04030962|516296597|FG001|Stage 2|Technical Problems|0|||
143204633|NCT04030962|516296598|FG002|Stage 2|Technical Problems|0|||
143204634|NCT04030962|516296599|FG003|Stage 2|Technical Problems|0|||
143204635|NCT04030962|516296600|FG004|Stage 2|Technical Problems|0|||
143204636|NCT04030962|516296601|FG005|Stage 2|Technical Problems|0|||
143204637|NCT04030962|516296602|FG006|Stage 2|Technical Problems|0|||
143204638|NCT04030962|516296603|FG007|Stage 2|Technical Problems|0|||
143204639|NCT04030962|516296604|FG008|Stage 2|Technical Problems|0|||
143204640|NCT04030962|516296605|FG009|Stage 2|Technical Problems|0|||
143204641|NCT04030962|516296606|FG010|Stage 2|Technical Problems|0|||
143204642|NCT04030962|516296607|FG011|Stage 2|Technical Problems|1|||
143204643|NCT04030962|516296608|FG012|Stage 2|Technical Problems|0|||
143204644|NCT04284813|516296611|FG000|Overall Study|Withdrawal by Subject|1|||
143204645|NCT03921554|516296612|FG000|Overall Study|Adverse Event|2|||
143204646|NCT03921554|516296612|FG000|Overall Study|Withdrawal by Subject|1|||
143204647|NCT03921554|516296612|FG000|Overall Study|Death|3|||
143204648|NCT05824936|516296613|FG000|Overall Study|Lost to Follow-up|1|||
143204649|NCT00673881|516296614|FG000|Overall Study|Withdrawal by Subject|1|||
143204650|NCT03968159|516296618|FG000|Overall Study|Adverse Event|4|||
143204651|NCT03968159|516296619|FG001|Overall Study|Adverse Event|4|||
143204652|NCT03968159|516296618|FG000|Overall Study|Lost to Follow-up|1|||
143204653|NCT03968159|516296619|FG001|Overall Study|Lost to Follow-up|1|||
143204654|NCT03968159|516296618|FG000|Overall Study|Use of prohibited medication|0|||
143204655|NCT03968159|516296619|FG001|Overall Study|Use of prohibited medication|1|||
143204656|NCT03968159|516296618|FG000|Overall Study|Protocol Violation|2|||
143204657|NCT03968159|516296619|FG001|Overall Study|Protocol Violation|2|||
143204658|NCT03968159|516296618|FG000|Overall Study|Withdrawal by Subject|4|||
143204659|NCT03968159|516296619|FG001|Overall Study|Withdrawal by Subject|6|||
143204660|NCT03968159|516296618|FG000|Overall Study|Lack of Efficacy|0|||
143204661|NCT03968159|516296619|FG001|Overall Study|Lack of Efficacy|1|||
143204662|NCT03968159|516296618|FG000|Overall Study|Not further specified|2|||
143204663|NCT03968159|516296619|FG001|Overall Study|Not further specified|0|||
143204664|NCT01299571|516296622|FG000|Overall Study|Protocol Violation|107|||
143204665|NCT00413010|516296623|FG000|Overall Study|Adverse Event|8|||
143204666|NCT00413010|516296624|FG001|Overall Study|Adverse Event|4|||
143204667|NCT00413010|516296623|FG000|Overall Study|Laboratory abnormality|0|||
143204668|NCT00413010|516296624|FG001|Overall Study|Laboratory abnormality|2|||
143204669|NCT00413010|516296623|FG000|Overall Study|Lack of Efficacy|0|||
143204670|NCT00413010|516296624|FG001|Overall Study|Lack of Efficacy|3|||
143204671|NCT00413010|516296623|FG000|Overall Study|Lost to Follow-up|3|||
143204672|NCT00413010|516296624|FG001|Overall Study|Lost to Follow-up|0|||
143204673|NCT00413010|516296623|FG000|Overall Study|Withdrawal by Subject|7|||
143204674|NCT00413010|516296624|FG001|Overall Study|Withdrawal by Subject|2|||
143204675|NCT00413010|516296623|FG000|Overall Study|Due to termination of the study|54|||
143204676|NCT00413010|516296624|FG001|Overall Study|Due to termination of the study|52|||
143204677|NCT00708734|516296625|FG000|Overall Study|scheduling conflict|2|||
143204678|NCT00708734|516296625|FG000|Overall Study|moved|1|||
143204679|NCT00708734|516296625|FG000|Overall Study|leg injury|1|||
143204680|NCT00708734|516296625|FG000|Overall Study|knee replacement|1|||
143204681|NCT00708734|516296625|FG000|Overall Study|vertigo|1|||
143204682|NCT00708734|516296625|FG000|Overall Study|leg fracture|1|||
143204683|NCT01533922|516296626|FG000|Overall Study|Adverse Event|5|||
143204684|NCT01533922|516296627|FG001|Overall Study|Adverse Event|8|||
143204685|NCT01533922|516296628|FG002|Overall Study|Adverse Event|6|||
143204686|NCT01533922|516296629|FG003|Overall Study|Adverse Event|3|||
143204687|NCT01533922|516296630|FG004|Overall Study|Adverse Event|4|||
143204688|NCT01533922|516296626|FG000|Overall Study|Lack of Efficacy|0|||
143204689|NCT01533922|516296627|FG001|Overall Study|Lack of Efficacy|0|||
143204690|NCT01533922|516296628|FG002|Overall Study|Lack of Efficacy|1|||
143204691|NCT01533922|516296629|FG003|Overall Study|Lack of Efficacy|0|||
143204692|NCT01533922|516296630|FG004|Overall Study|Lack of Efficacy|0|||
143204693|NCT01533922|516296626|FG000|Overall Study|Protocol Violation|0|||
143204694|NCT01533922|516296627|FG001|Overall Study|Protocol Violation|3|||
143204695|NCT01533922|516296628|FG002|Overall Study|Protocol Violation|0|||
143204696|NCT01533922|516296629|FG003|Overall Study|Protocol Violation|0|||
143204697|NCT01533922|516296630|FG004|Overall Study|Protocol Violation|1|||
143204698|NCT01533922|516296626|FG000|Overall Study|Withdrawal by Subject|3|||
143204699|NCT01533922|516296627|FG001|Overall Study|Withdrawal by Subject|1|||
143204700|NCT01533922|516296628|FG002|Overall Study|Withdrawal by Subject|2|||
143204701|NCT01533922|516296629|FG003|Overall Study|Withdrawal by Subject|2|||
143204702|NCT01533922|516296630|FG004|Overall Study|Withdrawal by Subject|1|||
143262826|NCT02431247|516515939|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
143262827|NCT02431247|516515937|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
143262828|NCT02431247|516515938|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
143262829|NCT02431247|516515939|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
143262830|NCT02431247|516515937|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
143262831|NCT02431247|516515938|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
143262832|NCT02431247|516515939|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
143262833|NCT02431247|516515937|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
143262834|NCT02431247|516515938|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
143262835|NCT02431247|516515939|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
143262836|NCT02431247|516515937|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
143262837|NCT02431247|516515938|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
143262838|NCT02431247|516515939|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
143262839|NCT02431247|516515937|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
143262840|NCT02431247|516515938|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
143262841|NCT02431247|516515939|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
143262842|NCT02431247|516515937|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
143262843|NCT02431247|516515938|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
143262844|NCT02431247|516515939|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
143262845|NCT02431247|516515937|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
143262846|NCT02431247|516515938|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
143262847|NCT02431247|516515939|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
143262848|NCT02431247|516515937|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
143262849|NCT02431247|516515938|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
143262850|NCT02431247|516515939|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
143262851|NCT00322153|516515940|FG000|Overall Study|Adverse Event|21|||
143262852|NCT00322153|516515941|FG001|Overall Study|Adverse Event|34|||
143262853|NCT00322153|516515940|FG000|Overall Study|Protocol Violation|6|||
143262854|NCT00322153|516515941|FG001|Overall Study|Protocol Violation|14|||
143262855|NCT00322153|516515940|FG000|Overall Study|Withdrawal by Subject|18|||
143262856|NCT00322153|516515941|FG001|Overall Study|Withdrawal by Subject|10|||
143262857|NCT00322153|516515940|FG000|Overall Study|Lack of Efficacy|8|||
143262858|NCT00322153|516515941|FG001|Overall Study|Lack of Efficacy|3|||
143262859|NCT00322153|516515940|FG000|Overall Study|Lost to Follow-up|5|||
143262860|NCT00322153|516515941|FG001|Overall Study|Lost to Follow-up|4|||
143262861|NCT00322153|516515940|FG000|Overall Study|Withdrawn for other reasons|5|||
143262862|NCT00322153|516515941|FG001|Overall Study|Withdrawn for other reasons|4|||
143262863|NCT02414139|516515944|FG000|Treatment Period|Adverse Event|11|||
143262864|NCT02414139|516515945|FG001|Treatment Period|Adverse Event|6|||
143262865|NCT02414139|516515946|FG002|Treatment Period|Adverse Event|8|||
143262866|NCT02414139|516515947|FG003|Treatment Period|Adverse Event|5|||
143262867|NCT02414139|516515948|FG004|Treatment Period|Adverse Event|14|||
143262868|NCT02414139|516515949|FG005|Treatment Period|Adverse Event|3|||
143262869|NCT02414139|516515950|FG006|Treatment Period|Adverse Event|6|||
143262870|NCT02414139|516515951|FG007|Treatment Period|Adverse Event|1|||
143262871|NCT02414139|516515952|FG008|Treatment Period|Adverse Event|6|||
143262872|NCT02414139|516515953|FG009|Treatment Period|Adverse Event|8|||
143262873|NCT02414139|516515944|FG000|Treatment Period|Death|0|||
143262874|NCT02414139|516515945|FG001|Treatment Period|Death|0|||
143262875|NCT02414139|516515946|FG002|Treatment Period|Death|1|||
143262876|NCT02414139|516515947|FG003|Treatment Period|Death|1|||
143262877|NCT02414139|516515948|FG004|Treatment Period|Death|0|||
143262878|NCT02414139|516515949|FG005|Treatment Period|Death|0|||
143262879|NCT02414139|516515950|FG006|Treatment Period|Death|0|||
143262880|NCT02414139|516515951|FG007|Treatment Period|Death|0|||
143262881|NCT02414139|516515952|FG008|Treatment Period|Death|0|||
143262882|NCT02414139|516515953|FG009|Treatment Period|Death|1|||
143262883|NCT02414139|516515944|FG000|Treatment Period|Physician Decision|5|||
143262884|NCT02414139|516515945|FG001|Treatment Period|Physician Decision|4|||
143262885|NCT02414139|516515946|FG002|Treatment Period|Physician Decision|6|||
143262886|NCT02414139|516515947|FG003|Treatment Period|Physician Decision|1|||
143262887|NCT02414139|516515948|FG004|Treatment Period|Physician Decision|4|||
143262888|NCT02414139|516515949|FG005|Treatment Period|Physician Decision|0|||
143262889|NCT02414139|516515950|FG006|Treatment Period|Physician Decision|2|||
143262890|NCT02414139|516515951|FG007|Treatment Period|Physician Decision|0|||
143262891|NCT02414139|516515952|FG008|Treatment Period|Physician Decision|1|||
143262892|NCT02414139|516515953|FG009|Treatment Period|Physician Decision|4|||
143204703|NCT01533922|516296626|FG000|Overall Study|Other reason not defined above|2|||
143204704|NCT01533922|516296627|FG001|Overall Study|Other reason not defined above|0|||
143204705|NCT01533922|516296628|FG002|Overall Study|Other reason not defined above|1|||
143204706|NCT01533922|516296629|FG003|Overall Study|Other reason not defined above|0|||
143204707|NCT01533922|516296630|FG004|Overall Study|Other reason not defined above|0|||
143204708|NCT02634606|516296631|FG000|Overall Study|unable to obtain the drug at start|13|||
143204709|NCT05432167|516296634|FG000|Overall Study|Adverse Event|0|||
143204710|NCT05432167|516296635|FG001|Overall Study|Adverse Event|2|||
143204711|NCT05432167|516296636|FG002|Overall Study|Adverse Event|1|||
143204712|NCT05432167|516296634|FG000|Overall Study|Lost to Follow-up|3|||
143204713|NCT05432167|516296635|FG001|Overall Study|Lost to Follow-up|3|||
143204714|NCT05432167|516296636|FG002|Overall Study|Lost to Follow-up|2|||
143204715|NCT05432167|516296634|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
143204716|NCT05432167|516296635|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
143204717|NCT05432167|516296636|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
143262893|NCT02414139|516515944|FG000|Treatment Period|Progressive disease|48|||
143262894|NCT02414139|516515945|FG001|Treatment Period|Progressive disease|31|||
143262895|NCT02414139|516515946|FG002|Treatment Period|Progressive disease|37|||
143262896|NCT02414139|516515947|FG003|Treatment Period|Progressive disease|21|||
143262897|NCT02414139|516515948|FG004|Treatment Period|Progressive disease|43|||
143262898|NCT02414139|516515949|FG005|Treatment Period|Progressive disease|12|||
143262899|NCT02414139|516515950|FG006|Treatment Period|Progressive disease|16|||
143262900|NCT02414139|516515951|FG007|Treatment Period|Progressive disease|2|||
143262901|NCT02414139|516515952|FG008|Treatment Period|Progressive disease|20|||
143262902|NCT02414139|516515953|FG009|Treatment Period|Progressive disease|14|||
143262903|NCT02414139|516515944|FG000|Treatment Period|Protocol deviation|0|||
143262904|NCT02414139|516515945|FG001|Treatment Period|Protocol deviation|0|||
143262905|NCT02414139|516515946|FG002|Treatment Period|Protocol deviation|1|||
143262906|NCT02414139|516515947|FG003|Treatment Period|Protocol deviation|0|||
143262907|NCT02414139|516515948|FG004|Treatment Period|Protocol deviation|0|||
143262908|NCT02414139|516515949|FG005|Treatment Period|Protocol deviation|0|||
143262909|NCT02414139|516515950|FG006|Treatment Period|Protocol deviation|0|||
143262910|NCT02414139|516515951|FG007|Treatment Period|Protocol deviation|0|||
143262911|NCT02414139|516515952|FG008|Treatment Period|Protocol deviation|0|||
143262912|NCT02414139|516515953|FG009|Treatment Period|Protocol deviation|0|||
143262913|NCT02414139|516515944|FG000|Treatment Period|Subject/Guardian decision|5|||
143262914|NCT02414139|516515945|FG001|Treatment Period|Subject/Guardian decision|1|||
143262915|NCT02414139|516515946|FG002|Treatment Period|Subject/Guardian decision|1|||
143262916|NCT02414139|516515947|FG003|Treatment Period|Subject/Guardian decision|2|||
143262917|NCT02414139|516515948|FG004|Treatment Period|Subject/Guardian decision|5|||
143262918|NCT02414139|516515949|FG005|Treatment Period|Subject/Guardian decision|0|||
143262919|NCT02414139|516515950|FG006|Treatment Period|Subject/Guardian decision|2|||
143204718|NCT05432167|516296634|FG000|Overall Study|Physician Decision|1|||
143204719|NCT05432167|516296635|FG001|Overall Study|Physician Decision|0|||
143262920|NCT02414139|516515951|FG007|Treatment Period|Subject/Guardian decision|0|||
143204720|NCT05432167|516296636|FG002|Overall Study|Physician Decision|0|||
143204721|NCT05432167|516296634|FG000|Overall Study|Withdrawal by Subject|7|||
143204722|NCT05432167|516296635|FG001|Overall Study|Withdrawal by Subject|4|||
143204723|NCT05432167|516296636|FG002|Overall Study|Withdrawal by Subject|11|||
143204724|NCT05432167|516296634|FG000|Overall Study|Other|0|||
143204725|NCT05432167|516296635|FG001|Overall Study|Other|0|||
143204726|NCT05432167|516296636|FG002|Overall Study|Other|1|||
143204727|NCT01267175|516296637|FG000|Overall Study|Withdrawal by Subject|1|||
143262921|NCT02414139|516515952|FG008|Treatment Period|Subject/Guardian decision|1|||
143262922|NCT02414139|516515953|FG009|Treatment Period|Subject/Guardian decision|1|||
143262923|NCT02414139|516515944|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
143262924|NCT02414139|516515945|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
143262925|NCT02414139|516515946|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
143262926|NCT02414139|516515947|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
143262927|NCT02414139|516515948|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
143204728|NCT01267175|516296637|FG000|Overall Study|Lost to Follow-up|1|||
143204729|NCT00353873|516296639|FG000|Overall Study|Protocol Violation|1|||
143204730|NCT00353873|516296640|FG001|Overall Study|Protocol Violation|2|||
143204731|NCT00353873|516296639|FG000|Overall Study|Exacerbation|1|||
143204732|NCT00353873|516296640|FG001|Overall Study|Exacerbation|0|||
143204733|NCT00353873|516296639|FG000|Overall Study|Adverse Event|1|||
143204734|NCT00353873|516296640|FG001|Overall Study|Adverse Event|0|||
143204735|NCT00353873|516296639|FG000|Overall Study|Physician Decision|2|||
143204736|NCT00353873|516296640|FG001|Overall Study|Physician Decision|0|||
143204737|NCT00353873|516296639|FG000|Overall Study|Withdrawal by Subject|1|||
143204738|NCT00353873|516296640|FG001|Overall Study|Withdrawal by Subject|1|||
143204739|NCT00286221|516296643|FG000|Overall Study|Protocol Violation|2|||
143204740|NCT00286221|516296644|FG001|Overall Study|Protocol Violation|1|||
143204741|NCT00286221|516296645|FG002|Overall Study|Protocol Violation|6|||
143204742|NCT00286221|516296646|FG003|Overall Study|Protocol Violation|4|||
143204743|NCT00286221|516296643|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
143204744|NCT00286221|516296644|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
143204745|NCT00286221|516296645|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
143204746|NCT00286221|516296646|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
143204747|NCT00286221|516296643|FG000|Overall Study|Inability to trigger PCA|2|||
143204748|NCT00286221|516296644|FG001|Overall Study|Inability to trigger PCA|0|||
143204749|NCT00286221|516296645|FG002|Overall Study|Inability to trigger PCA|0|||
143204750|NCT00286221|516296646|FG003|Overall Study|Inability to trigger PCA|0|||
143204751|NCT00286221|516296643|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
143204752|NCT00286221|516296644|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
143204753|NCT00286221|516296645|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
143204754|NCT00286221|516296646|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
143204755|NCT02690649|516296647|FG000|Overall Study|Withdrawal by Subject|1|||
143204756|NCT02690649|516296648|FG001|Overall Study|Withdrawal by Subject|1|||
143204757|NCT02690649|516296647|FG000|Overall Study|Protocol Violation|0|||
143204758|NCT02690649|516296648|FG001|Overall Study|Protocol Violation|3|||
143204759|NCT02276547|516296649|FG000|Overall Study|Death|2|||
143204760|NCT02276547|516296649|FG000|Overall Study|Explant|2|||
143204761|NCT00530920|516296650|FG000|Overall Study|Randomized but not treated|0|||
143204762|NCT00530920|516296651|FG001|Overall Study|Randomized but not treated|2|||
143204763|NCT00530920|516296652|FG002|Overall Study|Randomized but not treated|0|||
143204764|NCT00530920|516296650|FG000|Overall Study|Adverse Event|0|||
143204765|NCT00530920|516296651|FG001|Overall Study|Adverse Event|0|||
143204766|NCT00530920|516296652|FG002|Overall Study|Adverse Event|3|||
143204767|NCT00530920|516296650|FG000|Overall Study|Withdrawal by Subject|0|||
143204768|NCT00530920|516296651|FG001|Overall Study|Withdrawal by Subject|0|||
143204769|NCT00530920|516296652|FG002|Overall Study|Withdrawal by Subject|1|||
143204770|NCT02616393|516296656|FG000|Overall Study|Death|5|||
143204771|NCT02616393|516296657|FG001|Overall Study|Death|12|||
143204772|NCT02616393|516296658|FG002|Overall Study|Death|1|||
143204773|NCT02616393|516296656|FG000|Overall Study|Termination by Sponsor|4|||
143204774|NCT02616393|516296657|FG001|Overall Study|Termination by Sponsor|5|||
143204775|NCT02616393|516296658|FG002|Overall Study|Termination by Sponsor|2|||
143204776|NCT02616393|516296656|FG000|Overall Study|Other|3|||
143204777|NCT02616393|516296657|FG001|Overall Study|Other|0|||
143204778|NCT02616393|516296658|FG002|Overall Study|Other|0|||
143204779|NCT02616393|516296656|FG000|Overall Study|Withdrawal by Subject|1|||
143204780|NCT02616393|516296657|FG001|Overall Study|Withdrawal by Subject|1|||
143204781|NCT02616393|516296658|FG002|Overall Study|Withdrawal by Subject|0|||
143204782|NCT02616393|516296656|FG000|Overall Study|Lost to Follow-up|0|||
143204783|NCT02616393|516296657|FG001|Overall Study|Lost to Follow-up|2|||
143204784|NCT02616393|516296658|FG002|Overall Study|Lost to Follow-up|0|||
143204785|NCT02713867|516296659|FG000|Randomization|Other Reason|2|||
143204786|NCT02713867|516296660|FG001|Randomization|Other Reason|1|||
143204787|NCT02713867|516296659|FG000|Randomization|Participant Withdrew consent|0|||
143204788|NCT02713867|516296660|FG001|Randomization|Participant Withdrew consent|2|||
143204789|NCT02713867|516296659|FG000|Treatment Period|Other Reasons|22|||
143204790|NCT02713867|516296660|FG001|Treatment Period|Other Reasons|28|||
143204791|NCT02713867|516296659|FG000|Treatment Period|Administrative reason by sponsor|21|||
143204792|NCT02713867|516296660|FG001|Treatment Period|Administrative reason by sponsor|16|||
143204793|NCT02713867|516296659|FG000|Treatment Period|No longer meets study criteria|2|||
143204794|NCT02713867|516296660|FG001|Treatment Period|No longer meets study criteria|1|||
143204795|NCT02713867|516296659|FG000|Treatment Period|Poor/Non Compliance|1|||
143204796|NCT02713867|516296660|FG001|Treatment Period|Poor/Non Compliance|0|||
143204797|NCT02713867|516296659|FG000|Treatment Period|Maximum Clinical Benefit|5|||
143204798|NCT02713867|516296660|FG001|Treatment Period|Maximum Clinical Benefit|6|||
143204799|NCT02713867|516296659|FG000|Treatment Period|Withdrew consent|3|||
143204800|NCT02713867|516296660|FG001|Treatment Period|Withdrew consent|6|||
143204801|NCT02713867|516296659|FG000|Treatment Period|Requested to Discontinue|8|||
143204802|NCT02713867|516296660|FG001|Treatment Period|Requested to Discontinue|8|||
143204803|NCT02713867|516296659|FG000|Treatment Period|AE unrelated to Study Drug|11|||
143204804|NCT02713867|516296660|FG001|Treatment Period|AE unrelated to Study Drug|10|||
143204805|NCT02713867|516296659|FG000|Treatment Period|Death|7|||
143204806|NCT02713867|516296660|FG001|Treatment Period|Death|3|||
143204807|NCT02713867|516296659|FG000|Treatment Period|Study Drug Toxicity|16|||
143204808|NCT02713867|516296660|FG001|Treatment Period|Study Drug Toxicity|19|||
143204809|NCT02713867|516296659|FG000|Treatment Period|Disease Progression|82|||
143204810|NCT02713867|516296660|FG001|Treatment Period|Disease Progression|83|||
143204811|NCT03242018|516296664|FG000|Overall Study|Adverse Event|7|||
143204812|NCT03242018|516296665|FG001|Overall Study|Adverse Event|7|||
143204813|NCT03242018|516296666|FG002|Overall Study|Adverse Event|6|||
143204814|NCT03242018|516296664|FG000|Overall Study|Lost to Follow-up|2|||
143204815|NCT03242018|516296665|FG001|Overall Study|Lost to Follow-up|2|||
143204816|NCT03242018|516296666|FG002|Overall Study|Lost to Follow-up|2|||
143204817|NCT03242018|516296664|FG000|Overall Study|At the Participant's Own Request|5|||
143204818|NCT03242018|516296665|FG001|Overall Study|At the Participant's Own Request|1|||
143262928|NCT02414139|516515949|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
143204819|NCT03242018|516296666|FG002|Overall Study|At the Participant's Own Request|4|||
143204820|NCT03242018|516296664|FG000|Overall Study|Reason Not Specified|3|||
143204821|NCT03242018|516296665|FG001|Overall Study|Reason Not Specified|4|||
143204822|NCT03242018|516296666|FG002|Overall Study|Reason Not Specified|1|||
143204823|NCT03242018|516296664|FG000|Overall Study|Study Terminated by Sponsor|1|||
143262929|NCT02414139|516515950|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
143262930|NCT02414139|516515951|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
143262931|NCT02414139|516515952|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
143262932|NCT02414139|516515953|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
143262933|NCT02414139|516515944|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
143262934|NCT02414139|516515945|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
143262935|NCT02414139|516515946|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
143262936|NCT02414139|516515947|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
143262937|NCT02414139|516515948|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
143262938|NCT02414139|516515949|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
143262939|NCT02414139|516515950|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
143262940|NCT02414139|516515951|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
143370315|NCT02377362|516899144|FG012|Part B Overall|Withdrawal by Subject|0|||
143370316|NCT04889664|516899145|FG000|Screen|Lost to Follow-up|1|||
143262941|NCT02414139|516515952|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
143262942|NCT02414139|516515953|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
143262943|NCT02414139|516515944|FG000|Post-treatment Efficacy Follow-up|Death|0|||
143262944|NCT02414139|516515945|FG001|Post-treatment Efficacy Follow-up|Death|1|||
143262945|NCT02414139|516515946|FG002|Post-treatment Efficacy Follow-up|Death|0|||
143262946|NCT02414139|516515947|FG003|Post-treatment Efficacy Follow-up|Death|0|||
143262947|NCT02414139|516515948|FG004|Post-treatment Efficacy Follow-up|Death|1|||
143262948|NCT02414139|516515949|FG005|Post-treatment Efficacy Follow-up|Death|0|||
143262949|NCT02414139|516515950|FG006|Post-treatment Efficacy Follow-up|Death|0|||
143262950|NCT02414139|516515951|FG007|Post-treatment Efficacy Follow-up|Death|0|||
143370317|NCT04889664|516899145|FG000|Screen|Failed to meet screening criteria|1|||
143370318|NCT04889664|516899145|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
143204824|NCT03242018|516296665|FG001|Overall Study|Study Terminated by Sponsor|0|||
143204825|NCT03242018|516296666|FG002|Overall Study|Study Terminated by Sponsor|1|||
143204826|NCT00687609|516296667|FG000|Overall Study|Physician Decision|1|||
143204827|NCT00687609|516296667|FG000|Overall Study|Withdrawal by Subject|2|||
143204828|NCT00249613|516296668|FG000|12 Month Follow-up|Death|1|||
143204829|NCT00249613|516296669|FG001|12 Month Follow-up|Death|1|||
143204830|NCT00249613|516296668|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
143204831|NCT00249613|516296669|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
143204832|NCT00249613|516296668|FG000|12 Month Follow-up|Lost to Follow-up|10|||
143204833|NCT00249613|516296669|FG001|12 Month Follow-up|Lost to Follow-up|8|||
143262951|NCT02414139|516515952|FG008|Post-treatment Efficacy Follow-up|Death|0|||
143262952|NCT02414139|516515953|FG009|Post-treatment Efficacy Follow-up|Death|1|||
143262953|NCT02414139|516515944|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
143262954|NCT02414139|516515945|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
143262955|NCT02414139|516515946|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
143262956|NCT02414139|516515947|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
143262957|NCT02414139|516515948|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
143262958|NCT02414139|516515949|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
143262959|NCT02414139|516515950|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
143262960|NCT02414139|516515951|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
143262961|NCT02414139|516515952|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
143262962|NCT02414139|516515953|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
143262963|NCT02414139|516515944|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
143262964|NCT02414139|516515945|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
143262965|NCT02414139|516515946|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
143262966|NCT02414139|516515947|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
143262967|NCT02414139|516515948|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
143262968|NCT02414139|516515949|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
143262969|NCT02414139|516515950|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
143262970|NCT02414139|516515951|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
143262971|NCT02414139|516515952|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
143262972|NCT02414139|516515953|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
143262973|NCT02414139|516515944|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
143262974|NCT02414139|516515945|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
143262975|NCT02414139|516515946|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
143262976|NCT02414139|516515947|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
143262977|NCT02414139|516515948|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
143262978|NCT02414139|516515949|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
143262979|NCT02414139|516515950|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
143262980|NCT02414139|516515951|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
143262981|NCT02414139|516515952|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
143262982|NCT02414139|516515953|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
143262983|NCT02414139|516515944|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
143262984|NCT02414139|516515945|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
143262985|NCT02414139|516515946|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
143262986|NCT02414139|516515947|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
143262987|NCT02414139|516515948|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
143262988|NCT02414139|516515949|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
143262989|NCT02414139|516515950|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
143262990|NCT02414139|516515951|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
143262991|NCT02414139|516515952|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
143262992|NCT02414139|516515953|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
143262993|NCT02414139|516515944|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
143262994|NCT02414139|516515945|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
143262995|NCT02414139|516515946|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
143262996|NCT02414139|516515947|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
143262997|NCT02414139|516515948|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
143262998|NCT02414139|516515949|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
143262999|NCT02414139|516515950|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
143263000|NCT02414139|516515951|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
143263001|NCT02414139|516515952|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
143263002|NCT02414139|516515953|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
143204834|NCT00806442|516296670|FG000|Overall Study|Lost to Follow-up|3|||
143204835|NCT00806442|516296671|FG001|Overall Study|Lost to Follow-up|2|||
143204836|NCT00806442|516296670|FG000|Overall Study|Withdrawal by Subject|1|||
143204837|NCT00806442|516296671|FG001|Overall Study|Withdrawal by Subject|5|||
143204838|NCT00969436|516296679|FG000|Overall Study|Protocol Violation|1|||
143204839|NCT00969436|516296680|FG001|Overall Study|Protocol Violation|3|||
143204840|NCT00969436|516296681|FG002|Overall Study|Protocol Violation|0|||
143204841|NCT00969436|516296679|FG000|Overall Study|Migrated/moved from study area|12|||
143204842|NCT00969436|516296680|FG001|Overall Study|Migrated/moved from study area|10|||
143204843|NCT00969436|516296681|FG002|Overall Study|Migrated/moved from study area|2|||
143204844|NCT00969436|516296679|FG000|Overall Study|Father - serious health problem|0|||
143204845|NCT00969436|516296680|FG001|Overall Study|Father - serious health problem|0|||
143204846|NCT00969436|516296681|FG002|Overall Study|Father - serious health problem|1|||
143204847|NCT00969436|516296679|FG000|Overall Study|Parents personal problem|0|||
143204848|NCT00969436|516296680|FG001|Overall Study|Parents personal problem|0|||
143204849|NCT00969436|516296681|FG002|Overall Study|Parents personal problem|1|||
143204850|NCT00969436|516296679|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
143204851|NCT00969436|516296680|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
143204852|NCT00969436|516296681|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
143204853|NCT00969436|516296679|FG000|Overall Study|Withdrawal by Subject|3|||
143204854|NCT00969436|516296680|FG001|Overall Study|Withdrawal by Subject|0|||
143204855|NCT00969436|516296681|FG002|Overall Study|Withdrawal by Subject|2|||
143204856|NCT00969436|516296679|FG000|Overall Study|Lost to Follow-up|8|||
143204857|NCT00969436|516296680|FG001|Overall Study|Lost to Follow-up|8|||
143263003|NCT00591578|516515954|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
143263004|NCT00591578|516515955|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
143263005|NCT00591578|516515956|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
143263006|NCT00591578|516515954|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
143263007|NCT00591578|516515955|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
143263008|NCT00591578|516515956|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
143263009|NCT00591578|516515954|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
143263010|NCT00591578|516515955|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
143263011|NCT00591578|516515956|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
143263012|NCT00591578|516515954|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
143263013|NCT00591578|516515955|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
143263014|NCT00591578|516515956|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
143263015|NCT00591578|516515954|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
143263016|NCT00591578|516515955|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
143263017|NCT00591578|516515956|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
143263018|NCT00591578|516515954|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
143263019|NCT00591578|516515955|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
143263020|NCT00591578|516515956|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
143263021|NCT00591578|516515954|FG000|Double-Blind Treatment Phase|Other|4|||
143263022|NCT00591578|516515955|FG001|Double-Blind Treatment Phase|Other|9|||
143263023|NCT00591578|516515956|FG002|Double-Blind Treatment Phase|Other|4|||
143263024|NCT00591578|516515954|FG000|Open-Label Extension Phase|Adverse Event|3|||
143204858|NCT00969436|516296681|FG002|Overall Study|Lost to Follow-up|5|||
143204859|NCT02440789|516296694|FG000|Overall Study|Withdrawal by Subject|3|||
143204860|NCT02440789|516296694|FG000|Overall Study|Not willing to adhere to reqs|1|||
143204861|NCT03172130|516298344|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
143204862|NCT03172130|516298345|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
143204863|NCT01825941|516298348|FG000|Overall Study|Lost to Follow-up|4|||
143204864|NCT01825941|516298349|FG001|Overall Study|Lost to Follow-up|1|||
143204865|NCT02769962|516298356|FG000|Overall Study|Physician Decision|0|||
143204866|NCT02769962|516298357|FG001|Overall Study|Physician Decision|0|||
143204867|NCT02769962|516298358|FG002|Overall Study|Physician Decision|0|||
143204868|NCT02769962|516298359|FG003|Overall Study|Physician Decision|0|||
143204869|NCT02769962|516298360|FG004|Overall Study|Physician Decision|0|||
143204870|NCT02769962|516298361|FG005|Overall Study|Physician Decision|1|||
143204871|NCT02769962|516298362|FG006|Overall Study|Physician Decision|0|||
143204872|NCT02769962|516298363|FG007|Overall Study|Physician Decision|1|||
143204873|NCT02769962|516298356|FG000|Overall Study|Refused further treatment|0|||
143204874|NCT02769962|516298357|FG001|Overall Study|Refused further treatment|0|||
143204875|NCT02769962|516298358|FG002|Overall Study|Refused further treatment|0|||
143204876|NCT02769962|516298359|FG003|Overall Study|Refused further treatment|0|||
143204877|NCT02769962|516298360|FG004|Overall Study|Refused further treatment|0|||
143204878|NCT02769962|516298361|FG005|Overall Study|Refused further treatment|1|||
143204879|NCT02769962|516298362|FG006|Overall Study|Refused further treatment|1|||
143204880|NCT02769962|516298363|FG007|Overall Study|Refused further treatment|0|||
143204881|NCT01073930|516298365|FG000|Overall Study|Withdrawal by Subject|3|||
143204882|NCT01073930|516298366|FG001|Overall Study|Withdrawal by Subject|2|||
143204883|NCT01073930|516298365|FG000|Overall Study|Lost to Follow-up|0|||
143204884|NCT01073930|516298366|FG001|Overall Study|Lost to Follow-up|1|||
143204885|NCT01073930|516298365|FG000|Overall Study|Adverse Event|0|||
143204886|NCT01073930|516298366|FG001|Overall Study|Adverse Event|1|||
143204887|NCT01073930|516298365|FG000|Overall Study|Noncompliance with study drug|0|||
143204888|NCT01073930|516298366|FG001|Overall Study|Noncompliance with study drug|1|||
143204889|NCT01073930|516298365|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
143204890|NCT01073930|516298366|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
143204891|NCT01266590|516298367|FG000|Overall Study|Adverse Event|3|||
143204892|NCT01266590|516298367|FG000|Overall Study|Lost to Follow-up|1|||
143204893|NCT01266590|516298367|FG000|Overall Study|Withdrawal by Subject|1|||
143204894|NCT01266590|516298367|FG000|Overall Study|Physician Decision|1|||
143204895|NCT00720343|516298370|FG000|Overall Study|Lost to Follow-up|1|||
143204896|NCT00720343|516298371|FG001|Overall Study|Lost to Follow-up|0|||
143204897|NCT00720343|516298370|FG000|Overall Study|Protocol Violation|0|||
143204898|NCT00720343|516298371|FG001|Overall Study|Protocol Violation|2|||
143204899|NCT02783170|516298372|FG000|Overall Study|Randomized but not Vaccinated|1|||
143204900|NCT02783170|516298373|FG001|Overall Study|Randomized but not Vaccinated|0|||
143204901|NCT02008773|516298374|FG000|Overall Study|Adverse Event|3|||
143204902|NCT02008773|516298375|FG001|Overall Study|Adverse Event|3|||
143204903|NCT02008773|516298376|FG002|Overall Study|Adverse Event|1|||
143204904|NCT02008773|516298377|FG003|Overall Study|Adverse Event|2|||
143204905|NCT02008773|516298374|FG000|Overall Study|Medication Non-compliance|2|||
143204906|NCT02008773|516298375|FG001|Overall Study|Medication Non-compliance|1|||
143204907|NCT02008773|516298376|FG002|Overall Study|Medication Non-compliance|3|||
143204908|NCT02008773|516298377|FG003|Overall Study|Medication Non-compliance|2|||
143204909|NCT02008773|516298374|FG000|Overall Study|Withdrawal by Subject|8|||
143204910|NCT02008773|516298375|FG001|Overall Study|Withdrawal by Subject|4|||
143204911|NCT02008773|516298376|FG002|Overall Study|Withdrawal by Subject|7|||
143204912|NCT02008773|516298377|FG003|Overall Study|Withdrawal by Subject|6|||
143204913|NCT02008773|516298374|FG000|Overall Study|Lost to Follow-up|0|||
143204914|NCT02008773|516298375|FG001|Overall Study|Lost to Follow-up|1|||
143204915|NCT02008773|516298376|FG002|Overall Study|Lost to Follow-up|3|||
143204916|NCT02008773|516298377|FG003|Overall Study|Lost to Follow-up|2|||
143204917|NCT01806064|516298378|FG000|Overall Study|Randomized Not Enrolled|0|||
143204918|NCT01806064|516298379|FG001|Overall Study|Randomized Not Enrolled|0|||
143204919|NCT01806064|516298380|FG002|Overall Study|Randomized Not Enrolled|0|||
143204920|NCT01806064|516298381|FG003|Overall Study|Randomized Not Enrolled|1|||
143204921|NCT01806064|516298382|FG004|Overall Study|Randomized Not Enrolled|2|||
143204922|NCT02408523|516298383|FG000|Overall Study|Adverse Event|4|||
143204923|NCT02408523|516298384|FG001|Overall Study|Adverse Event|10|||
143204924|NCT02408523|516298383|FG000|Overall Study|Lack of Efficacy|0|||
143204925|NCT02408523|516298384|FG001|Overall Study|Lack of Efficacy|1|||
143204926|NCT02408523|516298383|FG000|Overall Study|Protocol Violation|1|||
143204927|NCT02408523|516298384|FG001|Overall Study|Protocol Violation|2|||
143204928|NCT02408523|516298383|FG000|Overall Study|Lost to Follow-up|2|||
143204929|NCT02408523|516298384|FG001|Overall Study|Lost to Follow-up|3|||
143204930|NCT02408523|516298383|FG000|Overall Study|Withdrawal by Subject|3|||
143204931|NCT02408523|516298384|FG001|Overall Study|Withdrawal by Subject|1|||
143204932|NCT02408523|516298383|FG000|Overall Study|Sponsor request|1|||
143204933|NCT02408523|516298384|FG001|Overall Study|Sponsor request|0|||
143204934|NCT02408523|516298383|FG000|Overall Study|Did not satisfy extension conditions|0|||
143204935|NCT02408523|516298384|FG001|Overall Study|Did not satisfy extension conditions|1|||
143204936|NCT04256512|516298385|FG000|Overall Study|Withdrawal by Subject|1|||
143204937|NCT04435600|516298393|FG000|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
143204938|NCT04435600|516298394|FG001|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
143204939|NCT04435600|516298395|FG002|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|1|||
143204940|NCT04435600|516298396|FG003|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
143204941|NCT04435600|516298397|FG004|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
143204942|NCT04435600|516298398|FG005|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
143204943|NCT04435600|516298399|FG006|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
143204944|NCT04435600|516298400|FG007|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
143204945|NCT04435600|516298401|FG008|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
143204946|NCT04435600|516298402|FG009|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
143204947|NCT04435600|516298393|FG000|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
143204948|NCT04435600|516298394|FG001|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
143204949|NCT04435600|516298395|FG002|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
143204950|NCT04435600|516298396|FG003|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
143204951|NCT04435600|516298397|FG004|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
143204952|NCT04435600|516298398|FG005|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
143204953|NCT04435600|516298399|FG006|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
143204954|NCT04435600|516298400|FG007|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
143204955|NCT04435600|516298401|FG008|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
143204956|NCT04435600|516298402|FG009|Part 4 (Baseline to Week 52)|Withdrawal by Subject|1|||
143204957|NCT04435600|516298393|FG000|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
143263025|NCT00591578|516515955|FG001|Open-Label Extension Phase|Adverse Event|5|||
143263026|NCT00591578|516515956|FG002|Open-Label Extension Phase|Adverse Event|0|||
143263027|NCT00591578|516515954|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
143263028|NCT00591578|516515955|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
143263029|NCT00591578|516515956|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
143263030|NCT00591578|516515954|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
143263031|NCT00591578|516515955|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
143263032|NCT00591578|516515956|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
143204958|NCT04435600|516298394|FG001|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
143204959|NCT04435600|516298395|FG002|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
143204960|NCT04435600|516298396|FG003|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
143204961|NCT04435600|516298397|FG004|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
143204962|NCT04435600|516298398|FG005|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
143204963|NCT04435600|516298399|FG006|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
143204964|NCT04435600|516298400|FG007|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
143204965|NCT04435600|516298401|FG008|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
143204966|NCT04435600|516298402|FG009|Part 4 (Baseline to Week 52)|Lost to Follow-up|1|||
143204967|NCT04435600|516298393|FG000|Part 4 (Baseline to Week 52)|Other than specified|0|||
143204968|NCT04435600|516298394|FG001|Part 4 (Baseline to Week 52)|Other than specified|0|||
143204969|NCT04435600|516298395|FG002|Part 4 (Baseline to Week 52)|Other than specified|0|||
143204970|NCT04435600|516298396|FG003|Part 4 (Baseline to Week 52)|Other than specified|0|||
143204971|NCT04435600|516298397|FG004|Part 4 (Baseline to Week 52)|Other than specified|0|||
143204972|NCT04435600|516298398|FG005|Part 4 (Baseline to Week 52)|Other than specified|0|||
143204973|NCT04435600|516298399|FG006|Part 4 (Baseline to Week 52)|Other than specified|0|||
143204974|NCT04435600|516298400|FG007|Part 4 (Baseline to Week 52)|Other than specified|0|||
143204975|NCT04435600|516298401|FG008|Part 4 (Baseline to Week 52)|Other than specified|0|||
143204976|NCT04435600|516298402|FG009|Part 4 (Baseline to Week 52)|Other than specified|1|||
143204977|NCT02797184|516298405|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
143204978|NCT02797184|516298406|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
143204979|NCT05601102|516298408|FG000|Overall Study|Death|1|||
143204980|NCT05601102|516298409|FG001|Overall Study|Death|2|||
143204981|NCT05601102|516298408|FG000|Overall Study|Withdrawal by Subject|1|||
143204982|NCT05601102|516298409|FG001|Overall Study|Withdrawal by Subject|1|||
143204983|NCT05601102|516298408|FG000|Overall Study|Lost to Follow-up|0|||
143204984|NCT05601102|516298409|FG001|Overall Study|Lost to Follow-up|2|||
143204985|NCT05288166|516298410|FG000|Overall Study|Adverse Event|1|||
143263033|NCT00591578|516515954|FG000|Open-Label Extension Phase|Other|1|||
143263034|NCT00591578|516515955|FG001|Open-Label Extension Phase|Other|0|||
143204986|NCT05288166|516298411|FG001|Overall Study|Adverse Event|0|||
143204987|NCT05288166|516298410|FG000|Overall Study|Lost to Follow-up|2|||
143204988|NCT05288166|516298411|FG001|Overall Study|Lost to Follow-up|0|||
143204989|NCT05288166|516298410|FG000|Overall Study|Physician Decision|0|||
143263035|NCT00591578|516515956|FG002|Open-Label Extension Phase|Other|0|||
143263036|NCT02632838|516515957|FG000|Overall Study|Withdrawal by Subject|3|||
143204990|NCT05288166|516298411|FG001|Overall Study|Physician Decision|2|||
143204991|NCT05288166|516298410|FG000|Overall Study|Screen Failure|1|||
143204992|NCT05288166|516298411|FG001|Overall Study|Screen Failure|1|||
143204993|NCT05288166|516298410|FG000|Overall Study|Withdrawal by Subject|4|||
143204994|NCT05288166|516298411|FG001|Overall Study|Withdrawal by Subject|2|||
143204995|NCT05288166|516298410|FG000|Overall Study|On Study Treatment|408|||
143204996|NCT05288166|516298411|FG001|Overall Study|On Study Treatment|418|||
143204997|NCT03007745|516298412|FG000|Overall Study|Sleep test negative for OSA|53|||
143204998|NCT03007745|516298413|FG001|Overall Study|Sleep test negative for OSA|49|||
143204999|NCT03007745|516298412|FG000|Overall Study|Physician Decision|6|||
143263037|NCT02632838|516515958|FG001|Overall Study|Withdrawal by Subject|0|||
143263038|NCT02632838|516515957|FG000|Overall Study|Lost to Follow-up|0|||
143263039|NCT02632838|516515958|FG001|Overall Study|Lost to Follow-up|2|||
143263040|NCT03631355|516515959|FG000|Overall Study|Lost to Follow-up|1|||
143205000|NCT03007745|516298413|FG001|Overall Study|Physician Decision|9|||
143205001|NCT03007745|516298412|FG000|Overall Study|Withdrawal by Subject|38|||
143205002|NCT03007745|516298413|FG001|Overall Study|Withdrawal by Subject|16|||
143205003|NCT03007745|516298412|FG000|Overall Study|Lost to Follow-up|19|||
143205004|NCT03007745|516298413|FG001|Overall Study|Lost to Follow-up|25|||
143205005|NCT03007745|516298412|FG000|Overall Study|Unable to login to website|17|||
143205006|NCT03007745|516298413|FG001|Overall Study|Unable to login to website|4|||
143205007|NCT01300351|516298417|FG000|Overall Study|Did not receive treatment|2|||
143205008|NCT01300351|516298418|FG001|Overall Study|Did not receive treatment|0|||
143205009|NCT01300351|516298417|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
143205010|NCT01300351|516298418|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
143263041|NCT03631355|516515960|FG001|Overall Study|Lost to Follow-up|2|||
143263042|NCT02810340|516515961|FG000|Overall Study|Withdrawal by Subject|1|||
143263043|NCT02810340|516515962|FG001|Overall Study|Withdrawal by Subject|0|||
143263044|NCT02810340|516515963|FG002|Overall Study|Withdrawal by Subject|0|||
143263045|NCT02810340|516515961|FG000|Overall Study|Incarceration|0|||
143263046|NCT02810340|516515962|FG001|Overall Study|Incarceration|1|||
143263047|NCT02810340|516515963|FG002|Overall Study|Incarceration|0|||
143370319|NCT02469064|516899152|FG000|Overall Study|Request not to receive intervention.|1|||
143370320|NCT02469064|516899153|FG001|Overall Study|Request not to receive intervention.|3|||
143370321|NCT02736799|516899160|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
143370322|NCT02736799|516899161|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
143370323|NCT02736799|516899162|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
143370324|NCT02736799|516899163|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
143370325|NCT01194258|516899166|FG000|Titration Period|Withdrawal by Subject|6|||
143370326|NCT01194258|516899167|FG001|Titration Period|Withdrawal by Subject|0|||
143370327|NCT01194258|516899168|FG002|Titration Period|Withdrawal by Subject|0|||
143370328|NCT01194258|516899169|FG003|Titration Period|Withdrawal by Subject|0|||
143370329|NCT01194258|516899170|FG004|Titration Period|Withdrawal by Subject|0|||
143370330|NCT01194258|516899166|FG000|Titration Period|Lost to Follow-up|2|||
143370331|NCT01194258|516899167|FG001|Titration Period|Lost to Follow-up|0|||
143370332|NCT01194258|516899168|FG002|Titration Period|Lost to Follow-up|0|||
143370333|NCT01194258|516899169|FG003|Titration Period|Lost to Follow-up|0|||
143370334|NCT01194258|516899170|FG004|Titration Period|Lost to Follow-up|0|||
143370335|NCT01194258|516899166|FG000|Titration Period|Titration failure|3|||
143370336|NCT01194258|516899167|FG001|Titration Period|Titration failure|0|||
143370337|NCT01194258|516899168|FG002|Titration Period|Titration failure|0|||
143370338|NCT01194258|516899169|FG003|Titration Period|Titration failure|0|||
143370339|NCT01194258|516899170|FG004|Titration Period|Titration failure|0|||
143370340|NCT01194258|516899166|FG000|Period 1 (12 Weeks)|Death|0|||
143370341|NCT01194258|516899167|FG001|Period 1 (12 Weeks)|Death|0|||
143370342|NCT01194258|516899168|FG002|Period 1 (12 Weeks)|Death|0|||
143370343|NCT01194258|516899169|FG003|Period 1 (12 Weeks)|Death|0|||
143370344|NCT01194258|516899170|FG004|Period 1 (12 Weeks)|Death|1|||
143370345|NCT01194258|516899166|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
143205011|NCT01300351|516298417|FG000|Overall Study|Lost to Follow-up|0|||
143370346|NCT01194258|516899167|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
143370347|NCT01194258|516899168|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
143205012|NCT01300351|516298418|FG001|Overall Study|Lost to Follow-up|1|||
143205013|NCT01300351|516298417|FG000|Overall Study|Adverse Event|0|||
143205014|NCT01300351|516298418|FG001|Overall Study|Adverse Event|4|||
143205015|NCT01300351|516298417|FG000|Overall Study|Withdrawal by Subject|7|||
143205016|NCT01300351|516298418|FG001|Overall Study|Withdrawal by Subject|10|||
143205017|NCT00431951|516298420|FG000|Overall Study|Inability to follow study procedures|1|||
143205018|NCT00431951|516298421|FG001|Overall Study|Inability to follow study procedures|0|||
143205019|NCT00431951|516298422|FG002|Overall Study|Inability to follow study procedures|1|||
143205020|NCT00431951|516298423|FG003|Overall Study|Inability to follow study procedures|2|||
143205021|NCT00431951|516298420|FG000|Overall Study|Lost to Follow-up|0|||
143205022|NCT00431951|516298421|FG001|Overall Study|Lost to Follow-up|1|||
143205023|NCT00431951|516298422|FG002|Overall Study|Lost to Follow-up|0|||
143205024|NCT00431951|516298423|FG003|Overall Study|Lost to Follow-up|0|||
143205025|NCT00431951|516298420|FG000|Overall Study|Withdrawal by Subject|0|||
143205026|NCT00431951|516298421|FG001|Overall Study|Withdrawal by Subject|1|||
143205027|NCT00431951|516298422|FG002|Overall Study|Withdrawal by Subject|0|||
143205028|NCT00431951|516298423|FG003|Overall Study|Withdrawal by Subject|0|||
143205029|NCT00431951|516298420|FG000|Overall Study|Adverse Event|0|||
143205030|NCT00431951|516298421|FG001|Overall Study|Adverse Event|0|||
143205031|NCT00431951|516298422|FG002|Overall Study|Adverse Event|1|||
143205032|NCT00431951|516298423|FG003|Overall Study|Adverse Event|0|||
143205033|NCT04094584|516298431|FG000|Overall Study|No interest in study|88|||
143205034|NCT04094584|516298431|FG000|Overall Study|Unwilling to undergo screening tests|36|||
143205035|NCT04094584|516298431|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
143205036|NCT04094584|516298431|FG000|Overall Study|Opioid use|7|||
143205037|NCT04094584|516298431|FG000|Overall Study|Need for major surgery in study period|4|||
143205038|NCT04094584|516298431|FG000|Overall Study|eligible but declined enrollment|4|||
143205039|NCT04094584|516298431|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
143205040|NCT04094584|516298431|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
143205041|NCT04094584|516298431|FG000|Overall Study|Lost to Follow-up|3|||
143205042|NCT04094584|516298431|FG000|Overall Study|Withdrawal by Subject|2|||
143205043|NCT00106691|516298432|FG000|Overall Study|Adverse Event|60|||
143205044|NCT00106691|516298433|FG001|Overall Study|Adverse Event|64|||
143205045|NCT00106691|516298432|FG000|Overall Study|Lost to Follow-up|23|||
143205046|NCT00106691|516298433|FG001|Overall Study|Lost to Follow-up|18|||
143205047|NCT00106691|516298432|FG000|Overall Study|Physician Decision|18|||
143205048|NCT00106691|516298433|FG001|Overall Study|Physician Decision|21|||
143205049|NCT00106691|516298432|FG000|Overall Study|Protocol Violation|13|||
143205050|NCT00106691|516298433|FG001|Overall Study|Protocol Violation|18|||
143205051|NCT00106691|516298432|FG000|Overall Study|Withdrawal by Subject|75|||
143205052|NCT00106691|516298433|FG001|Overall Study|Withdrawal by Subject|70|||
143205053|NCT00106691|516298432|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
143205054|NCT00106691|516298433|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
143205055|NCT00106691|516298432|FG000|Overall Study|QTc>480|3|||
143205056|NCT00106691|516298433|FG001|Overall Study|QTc>480|1|||
143205057|NCT00106691|516298432|FG000|Overall Study|mililtary deployment|2|||
143205058|NCT00106691|516298433|FG001|Overall Study|mililtary deployment|0|||
143205059|NCT00106691|516298432|FG000|Overall Study|Study Site Closing/PI Moved|1|||
143205060|NCT00106691|516298433|FG001|Overall Study|Study Site Closing/PI Moved|2|||
143205061|NCT00106691|516298432|FG000|Overall Study|Cardiologist recommendation|1|||
143205062|NCT00106691|516298433|FG001|Overall Study|Cardiologist recommendation|0|||
143205063|NCT00106691|516298432|FG000|Overall Study|Pt. moved to another state|1|||
143205064|NCT00106691|516298433|FG001|Overall Study|Pt. moved to another state|0|||
143205065|NCT00106691|516298432|FG000|Overall Study|Taking exclusionary avodart|1|||
143205066|NCT00106691|516298433|FG001|Overall Study|Taking exclusionary avodart|0|||
143205067|NCT00106691|516298432|FG000|Overall Study|Not able to discontinue plavix|0|||
143205068|NCT00106691|516298433|FG001|Overall Study|Not able to discontinue plavix|1|||
143205069|NCT01302054|516298435|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
143205070|NCT01302054|516298436|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
143205071|NCT01302054|516298437|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
143205072|NCT01302054|516298435|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
143205073|NCT01302054|516298436|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
143205074|NCT01302054|516298437|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
143205075|NCT01302054|516298435|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
143205076|NCT01302054|516298436|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
143205077|NCT01302054|516298437|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
143205078|NCT01302054|516298435|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
143205079|NCT01302054|516298436|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
143205080|NCT01302054|516298437|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
143205081|NCT01302054|516298435|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
143205082|NCT01302054|516298436|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
143205083|NCT01302054|516298437|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
143205084|NCT01302054|516298435|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
143205085|NCT01302054|516298436|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
143205086|NCT01302054|516298437|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
143205087|NCT01302054|516298435|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
143205088|NCT01302054|516298436|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
143205089|NCT01302054|516298437|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
143205090|NCT01302054|516298435|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
143205091|NCT01302054|516298436|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
143205092|NCT01302054|516298437|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
143205093|NCT01302054|516298435|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
143205094|NCT01302054|516298436|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
143205095|NCT01302054|516298437|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
143205096|NCT01302054|516298435|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
143205097|NCT01302054|516298436|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
143205098|NCT01302054|516298437|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
143205099|NCT01302054|516298435|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
143205100|NCT01302054|516298436|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
143205101|NCT01302054|516298437|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
143205102|NCT01302054|516298435|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
143205103|NCT01302054|516298436|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
143205104|NCT01302054|516298437|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
143205105|NCT01302054|516298435|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
143205106|NCT01302054|516298436|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
143205107|NCT01302054|516298437|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
143205108|NCT01302054|516298435|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
143205109|NCT01302054|516298436|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
143205110|NCT01302054|516298437|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
143205111|NCT01302054|516298435|FG000|Double-Blind Treatment Phase|Other|0|||
143205112|NCT01302054|516298436|FG001|Double-Blind Treatment Phase|Other|4|||
143205113|NCT01302054|516298437|FG002|Double-Blind Treatment Phase|Other|9|||
143205114|NCT00857948|516298438|FG000|Overall Study|Withdrawal by Subject|2|||
143205115|NCT00857948|516298439|FG001|Overall Study|Withdrawal by Subject|0|||
143263048|NCT02810340|516515961|FG000|Overall Study|Lost to Follow-up|0|||
143263049|NCT02810340|516515962|FG001|Overall Study|Lost to Follow-up|0|||
143205116|NCT00857948|516298440|FG002|Overall Study|Withdrawal by Subject|0|||
143205117|NCT00857948|516298441|FG003|Overall Study|Withdrawal by Subject|0|||
143205118|NCT00857948|516298438|FG000|Overall Study|Protocol Violation|1|||
143205119|NCT00857948|516298439|FG001|Overall Study|Protocol Violation|0|||
143205120|NCT00857948|516298440|FG002|Overall Study|Protocol Violation|1|||
143205121|NCT00857948|516298441|FG003|Overall Study|Protocol Violation|0|||
143205122|NCT04135859|516298443|FG000|Overall Study|Withdrawal by Subject|1|||
143205123|NCT04135859|516298444|FG001|Overall Study|Withdrawal by Subject|0|||
143205124|NCT04135859|516298443|FG000|Overall Study|Withdrawal due to screening failure|1|||
143205125|NCT04135859|516298444|FG001|Overall Study|Withdrawal due to screening failure|2|||
143205126|NCT04135859|516298443|FG000|Overall Study|Did not complete stress test|3|||
143205127|NCT04135859|516298444|FG001|Overall Study|Did not complete stress test|3|||
143205128|NCT04135859|516298443|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
143205129|NCT04135859|516298444|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
143205130|NCT03629912|516298445|FG000|Overall Study|Lost to Follow-up|19|||
143205131|NCT03629912|516298446|FG001|Overall Study|Lost to Follow-up|7|||
143205132|NCT03629912|516298447|FG002|Overall Study|Lost to Follow-up|5|||
143205133|NCT03629912|516298448|FG003|Overall Study|Lost to Follow-up|1|||
143205134|NCT03629912|516298445|FG000|Overall Study|Withdrawal by Subject|6|||
143205135|NCT03629912|516298446|FG001|Overall Study|Withdrawal by Subject|0|||
143205136|NCT03629912|516298447|FG002|Overall Study|Withdrawal by Subject|1|||
143205137|NCT03629912|516298448|FG003|Overall Study|Withdrawal by Subject|2|||
143205138|NCT03629912|516298445|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
143205139|NCT03629912|516298446|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
143205140|NCT03629912|516298447|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
143205141|NCT03629912|516298448|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
143205142|NCT03629912|516298445|FG000|Overall Study|Death|1|||
143205143|NCT03629912|516298446|FG001|Overall Study|Death|0|||
143205144|NCT03629912|516298447|FG002|Overall Study|Death|0|||
143205145|NCT03629912|516298448|FG003|Overall Study|Death|0|||
143205146|NCT02365285|516298449|FG000|Overall Study|Physician Decision|0|||
143205147|NCT02365285|516298450|FG001|Overall Study|Physician Decision|1|||
143205148|NCT02365285|516298451|FG002|Overall Study|Physician Decision|1|||
143205149|NCT02365285|516298452|FG003|Overall Study|Physician Decision|0|||
143205150|NCT02365285|516298449|FG000|Overall Study|Adverse Event|0|||
143205151|NCT02365285|516298450|FG001|Overall Study|Adverse Event|0|||
143205152|NCT02365285|516298451|FG002|Overall Study|Adverse Event|0|||
143205153|NCT02365285|516298452|FG003|Overall Study|Adverse Event|2|||
143205154|NCT03262116|516298453|FG000|Overall Study|Physician Decision|0|||
143205155|NCT03262116|516298454|FG001|Overall Study|Physician Decision|2|||
143205156|NCT03262116|516298455|FG002|Overall Study|Physician Decision|1|||
143205157|NCT03262116|516298456|FG003|Overall Study|Physician Decision|1|||
143205158|NCT03262116|516298457|FG004|Overall Study|Physician Decision|1|||
143205159|NCT03262116|516298458|FG005|Overall Study|Physician Decision|2|||
143205160|NCT02608450|516298459|FG000|Overall Study|Lost to Follow-up|39|||
143205161|NCT02608450|516298460|FG001|Overall Study|Lost to Follow-up|32|||
143205162|NCT02608450|516298459|FG000|Overall Study|Withdrawal by Subject|21|||
143205163|NCT02608450|516298460|FG001|Overall Study|Withdrawal by Subject|15|||
143263050|NCT02810340|516515963|FG002|Overall Study|Lost to Follow-up|1|||
143263051|NCT02125604|516515970|FG000|Overall Study|Other|4|||
143263052|NCT02125604|516515970|FG000|Overall Study|Investigator Decision|1|||
143263053|NCT02125604|516515970|FG000|Overall Study|Lost to Follow-up|2|||
143205164|NCT02608450|516298459|FG000|Overall Study|Adverse Event|3|||
143205165|NCT02608450|516298460|FG001|Overall Study|Adverse Event|6|||
143205166|NCT02608450|516298459|FG000|Overall Study|Withdrawal by parent|2|||
143205167|NCT02608450|516298460|FG001|Overall Study|Withdrawal by parent|3|||
143263054|NCT02125604|516515970|FG000|Overall Study|Consent Withdrawn|4|||
143205168|NCT02608450|516298459|FG000|Overall Study|Lack of Efficacy|0|||
143205169|NCT02608450|516298460|FG001|Overall Study|Lack of Efficacy|3|||
143263055|NCT02125604|516515970|FG000|Overall Study|Adverse Event|20|||
143205170|NCT02608450|516298459|FG000|Overall Study|Noncompliance with study drug|0|||
143205171|NCT02608450|516298460|FG001|Overall Study|Noncompliance with study drug|2|||
143205172|NCT02608450|516298459|FG000|Overall Study|Physician Decision|0|||
143205173|NCT02608450|516298460|FG001|Overall Study|Physician Decision|1|||
143205174|NCT02608450|516298459|FG000|Overall Study|Pregnancy|0|||
143205175|NCT02608450|516298460|FG001|Overall Study|Pregnancy|1|||
143205176|NCT02608450|516298459|FG000|Overall Study|Progressive disease|1|||
143205177|NCT02608450|516298460|FG001|Overall Study|Progressive disease|0|||
143205178|NCT02608450|516298459|FG000|Overall Study|Multiple reasons|0|||
143205179|NCT02608450|516298460|FG001|Overall Study|Multiple reasons|2|||
143263056|NCT04340063|516515971|FG000|Overall Study|Withdrawal by Subject|1|||
143263057|NCT04340063|516515972|FG001|Overall Study|Withdrawal by Subject|2|||
143205180|NCT00635089|516298461|FG000|Overall Study|Adverse Event|7|||
143205181|NCT00635089|516298461|FG000|Overall Study|Lack of Efficacy|28|||
143205182|NCT00635089|516298461|FG000|Overall Study|Protocol Deviation|4|||
143205183|NCT00635089|516298461|FG000|Overall Study|Lost to Follow-up|8|||
143205184|NCT00635089|516298461|FG000|Overall Study|Other|31|||
143205185|NCT01283542|516298463|FG000|Main Phase|Acute or progressive vision loss|1|||
143205186|NCT01283542|516298463|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
143205187|NCT01283542|516298463|FG000|Main Phase|abnormal laboratory values|5|||
143205188|NCT01283542|516298463|FG000|Extension Phase|Physician Decision|1|||
143205189|NCT01283542|516298463|FG000|Extension Phase|Adverse Event|1|||
143263058|NCT04340063|516515971|FG000|Overall Study|Lost to Follow-up|3|||
143263059|NCT04340063|516515972|FG001|Overall Study|Lost to Follow-up|1|||
143263060|NCT04340063|516515971|FG000|Overall Study|Protocol Violation|0|||
143263061|NCT04340063|516515972|FG001|Overall Study|Protocol Violation|1|||
143263062|NCT00356122|516515973|FG000|TREATMENT|Lack of Efficacy|26|||
143263063|NCT00356122|516515973|FG000|TREATMENT|Adverse Event|10|||
143263064|NCT00356122|516515973|FG000|TREATMENT|Subject's request|4|||
143263065|NCT00356122|516515973|FG000|TREATMENT|Other|4|||
143263066|NCT00356122|516515973|FG000|TREATMENT|Did not receive study medication|1|||
143205190|NCT01283542|516298463|FG000|Extension Phase|Administrative problems|1|||
143205191|NCT02636946|516298464|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
143205192|NCT02636946|516298465|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
143205193|NCT02636946|516298464|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
143205194|NCT02636946|516298465|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
143205195|NCT02636946|516298464|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
143205196|NCT02636946|516298465|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
143205197|NCT02636946|516298464|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
143205198|NCT02636946|516298465|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
143205199|NCT02636946|516298464|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
143205200|NCT02636946|516298465|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
143205201|NCT02636946|516298464|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
143263067|NCT00356122|516515973|FG000|FOLLOW-UP|Death|37|||
143263068|NCT00356122|516515973|FG000|FOLLOW-UP|Lost to Follow-up|2|||
143263069|NCT00356122|516515973|FG000|FOLLOW-UP|Other|2|||
143370348|NCT01194258|516899169|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
143370349|NCT01194258|516899170|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
143370350|NCT01194258|516899166|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
143370351|NCT01194258|516899167|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
143370352|NCT01194258|516899168|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
143370353|NCT01194258|516899169|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
143370354|NCT01194258|516899170|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
143370355|NCT01194258|516899166|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
143370356|NCT01194258|516899167|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
143370357|NCT01194258|516899168|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
143370358|NCT01194258|516899169|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
143370359|NCT01194258|516899170|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
143370360|NCT03098030|516899179|FG000|Overall Study|Death|10|||
143370361|NCT03098030|516899180|FG001|Overall Study|Death|156|||
143370362|NCT03098030|516899181|FG002|Overall Study|Death|156|||
143370363|NCT03098030|516899182|FG003|Overall Study|Death|82|||
143370364|NCT03098030|516899179|FG000|Overall Study|Withdrawal by Subject|0|||
143370365|NCT03098030|516899180|FG001|Overall Study|Withdrawal by Subject|7|||
143370366|NCT03098030|516899181|FG002|Overall Study|Withdrawal by Subject|8|||
143370367|NCT03098030|516899182|FG003|Overall Study|Withdrawal by Subject|2|||
143370368|NCT03098030|516899179|FG000|Overall Study|Lost to Follow-up|0|||
143370369|NCT03098030|516899180|FG001|Overall Study|Lost to Follow-up|0|||
143370370|NCT03098030|516899181|FG002|Overall Study|Lost to Follow-up|2|||
143370371|NCT03098030|516899182|FG003|Overall Study|Lost to Follow-up|1|||
143370372|NCT04771273|516899183|FG000|Dose Escalation Period|Not treated with trial medication|0|||
143370373|NCT04771273|516899184|FG001|Dose Escalation Period|Not treated with trial medication|1|||
143370374|NCT04771273|516899185|FG002|Dose Escalation Period|Not treated with trial medication|1|||
143370375|NCT04771273|516899186|FG003|Dose Escalation Period|Not treated with trial medication|0|||
143370376|NCT04771273|516899183|FG000|Dose Escalation Period|Other reasons than listed|2|||
143370377|NCT04771273|516899184|FG001|Dose Escalation Period|Other reasons than listed|0|||
143370378|NCT04771273|516899185|FG002|Dose Escalation Period|Other reasons than listed|2|||
143370379|NCT04771273|516899186|FG003|Dose Escalation Period|Other reasons than listed|1|||
143370380|NCT04771273|516899183|FG000|Dose Escalation Period|Protocol Violation|0|||
143370381|NCT04771273|516899184|FG001|Dose Escalation Period|Protocol Violation|0|||
143370382|NCT04771273|516899185|FG002|Dose Escalation Period|Protocol Violation|3|||
143370383|NCT04771273|516899186|FG003|Dose Escalation Period|Protocol Violation|1|||
143370384|NCT04771273|516899183|FG000|Dose Escalation Period|Burden of study procedures|1|||
143370385|NCT04771273|516899184|FG001|Dose Escalation Period|Burden of study procedures|0|||
143370386|NCT04771273|516899185|FG002|Dose Escalation Period|Burden of study procedures|0|||
143205202|NCT02636946|516298465|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
143205203|NCT05059977|516298466|FG000|Overall Study|Withdrawal by Subject|0|||
143205204|NCT05059977|516298467|FG001|Overall Study|Withdrawal by Subject|0|||
143263070|NCT00491556|516515974|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
143263071|NCT00491556|516515975|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
143263072|NCT00491556|516515974|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
143370387|NCT04771273|516899186|FG003|Dose Escalation Period|Burden of study procedures|0|||
143370388|NCT04771273|516899183|FG000|Dose Escalation Period|Change of residence|0|||
143370389|NCT04771273|516899184|FG001|Dose Escalation Period|Change of residence|0|||
143263073|NCT00491556|516515975|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
143263074|NCT00491556|516515974|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
143263075|NCT00491556|516515975|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
143263076|NCT00491556|516515974|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
143263077|NCT00491556|516515975|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
143263078|NCT00491556|516515974|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
143263079|NCT00491556|516515975|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
143263080|NCT00491556|516515974|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
143205205|NCT05059977|516298468|FG002|Overall Study|Withdrawal by Subject|1|||
143205206|NCT02576860|516298469|FG000|Overall Study|Adverse Event|6|||
143205207|NCT02576860|516298470|FG001|Overall Study|Adverse Event|6|||
143205208|NCT02576860|516298469|FG000|Overall Study|Lost to Follow-up|5|||
143205209|NCT02576860|516298470|FG001|Overall Study|Lost to Follow-up|7|||
143205210|NCT02576860|516298469|FG000|Overall Study|Physician Decision|0|||
143205211|NCT02576860|516298470|FG001|Overall Study|Physician Decision|1|||
143205212|NCT02576860|516298469|FG000|Overall Study|Protocol Violation|0|||
143205213|NCT02576860|516298470|FG001|Overall Study|Protocol Violation|2|||
143205214|NCT02576860|516298469|FG000|Overall Study|Withdrawal by Subject|13|||
143205215|NCT02576860|516298470|FG001|Overall Study|Withdrawal by Subject|8|||
143205216|NCT02576860|516298469|FG000|Overall Study|Disallowed medication|1|||
143205217|NCT02576860|516298470|FG001|Overall Study|Disallowed medication|0|||
143205218|NCT00477269|516298471|FG000|Core Study|Adverse Event|6|||
143205219|NCT00477269|516298472|FG001|Core Study|Adverse Event|4|||
143205220|NCT00477269|516298473|FG002|Core Study|Adverse Event|0|||
143205221|NCT00477269|516298471|FG000|Core Study|Death|3|||
143205222|NCT00477269|516298472|FG001|Core Study|Death|3|||
143205223|NCT00477269|516298473|FG002|Core Study|Death|0|||
143205224|NCT00477269|516298471|FG000|Core Study|Withdrawn Consent|0|||
143205225|NCT00477269|516298472|FG001|Core Study|Withdrawn Consent|1|||
143205226|NCT00477269|516298473|FG002|Core Study|Withdrawn Consent|0|||
143205227|NCT00477269|516298471|FG000|Open Label Extension|Adverse Event|0|||
143205228|NCT00477269|516298472|FG001|Open Label Extension|Adverse Event|0|||
143205229|NCT00477269|516298473|FG002|Open Label Extension|Adverse Event|4|||
143205230|NCT00477269|516298471|FG000|Open Label Extension|Abnormal laboratory values|0|||
143205231|NCT00477269|516298472|FG001|Open Label Extension|Abnormal laboratory values|0|||
143205232|NCT00477269|516298473|FG002|Open Label Extension|Abnormal laboratory values|1|||
143205233|NCT00477269|516298471|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
143205234|NCT00477269|516298472|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
143205235|NCT00477269|516298473|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
143205236|NCT00477269|516298471|FG000|Open Label Extension|Adminiatrative problems|0|||
143205237|NCT00477269|516298472|FG001|Open Label Extension|Adminiatrative problems|0|||
143205238|NCT00477269|516298473|FG002|Open Label Extension|Adminiatrative problems|2|||
143205239|NCT00477269|516298471|FG000|Open Label Extension|Death|0|||
143205240|NCT00477269|516298472|FG001|Open Label Extension|Death|0|||
143205241|NCT00477269|516298473|FG002|Open Label Extension|Death|4|||
143205242|NCT02358044|516298474|FG000|Overall Study|Adverse Event|0|||
143205243|NCT02358044|516298475|FG001|Overall Study|Adverse Event|1|||
143205244|NCT02358044|516298474|FG000|Overall Study|Lost to Follow-up|2|||
143205245|NCT02358044|516298475|FG001|Overall Study|Lost to Follow-up|1|||
143205246|NCT02358044|516298474|FG000|Overall Study|Physician Decision|0|||
143205247|NCT02358044|516298475|FG001|Overall Study|Physician Decision|1|||
143205248|NCT02358044|516298474|FG000|Overall Study|Withdrawal by Subject|0|||
143205249|NCT02358044|516298475|FG001|Overall Study|Withdrawal by Subject|4|||
143205250|NCT00121641|516298478|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
143205251|NCT00121641|516298479|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
143205252|NCT00121641|516298480|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
143205253|NCT00121641|516298481|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
143205254|NCT00121641|516298482|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
143205255|NCT00121641|516298478|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
143205256|NCT00121641|516298479|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
143205257|NCT00121641|516298480|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
143205258|NCT00121641|516298481|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
143205259|NCT00121641|516298482|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
143205260|NCT00121641|516298478|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
143205261|NCT00121641|516298479|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
143205262|NCT00121641|516298480|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
143205263|NCT00121641|516298481|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
143205264|NCT00121641|516298482|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
143205265|NCT00121641|516298478|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
143205266|NCT00121641|516298479|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
143205267|NCT00121641|516298480|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
143205268|NCT00121641|516298481|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
143205269|NCT00121641|516298482|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
143205270|NCT00121641|516298478|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
143205271|NCT00121641|516298479|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
143205272|NCT00121641|516298480|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
143205273|NCT00121641|516298481|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
143205274|NCT00121641|516298482|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
143205275|NCT00121641|516298478|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
143205276|NCT00121641|516298479|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
143205277|NCT00121641|516298480|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
143205278|NCT00121641|516298481|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
143205279|NCT00121641|516298482|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
143205280|NCT00121641|516298478|FG000|24-week Short-term Treatment Period|Other Reason|1|||
143205281|NCT00121641|516298479|FG001|24-week Short-term Treatment Period|Other Reason|0|||
143205282|NCT00121641|516298480|FG002|24-week Short-term Treatment Period|Other Reason|0|||
143205283|NCT00121641|516298481|FG003|24-week Short-term Treatment Period|Other Reason|0|||
143205284|NCT00121641|516298482|FG004|24-week Short-term Treatment Period|Other Reason|0|||
143205285|NCT00121641|516298478|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
143205286|NCT00121641|516298479|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
143205287|NCT00121641|516298480|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
143205288|NCT00121641|516298481|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
143205289|NCT00121641|516298482|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
143205290|NCT00121641|516298478|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
143205291|NCT00121641|516298479|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
143370390|NCT04771273|516899185|FG002|Dose Escalation Period|Change of residence|0|||
143205292|NCT00121641|516298480|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
143205293|NCT00121641|516298481|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
143205294|NCT00121641|516298482|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
143205295|NCT00121641|516298478|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
143205296|NCT00121641|516298479|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
143205297|NCT00121641|516298480|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
143205298|NCT00121641|516298481|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
143205299|NCT00121641|516298482|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
143205300|NCT00121641|516298478|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
143205301|NCT00121641|516298479|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
143205302|NCT00121641|516298480|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
143205303|NCT00121641|516298481|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
143205304|NCT00121641|516298482|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
143205305|NCT00121641|516298478|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
143205306|NCT00121641|516298479|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
143205307|NCT00121641|516298480|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
143205308|NCT00121641|516298481|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
143205309|NCT00121641|516298482|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
143205310|NCT00121641|516298478|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
143205311|NCT00121641|516298479|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
143205312|NCT00121641|516298480|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
143205313|NCT00121641|516298481|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
143205314|NCT00121641|516298482|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
143205315|NCT00121641|516298478|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
143205316|NCT00121641|516298479|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
143205317|NCT00121641|516298480|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
143205318|NCT00121641|516298481|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
143205319|NCT00121641|516298482|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
143205320|NCT00121641|516298478|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
143205321|NCT00121641|516298479|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
143205322|NCT00121641|516298480|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
143205323|NCT00121641|516298481|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
143205324|NCT00121641|516298482|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
143205325|NCT00121641|516298478|FG000|48-month Short Term + Long Term Period|Death|0|||
143205326|NCT00121641|516298479|FG001|48-month Short Term + Long Term Period|Death|0|||
143205327|NCT00121641|516298480|FG002|48-month Short Term + Long Term Period|Death|0|||
143205328|NCT00121641|516298481|FG003|48-month Short Term + Long Term Period|Death|1|||
143205329|NCT00121641|516298482|FG004|48-month Short Term + Long Term Period|Death|0|||
143205330|NCT00121641|516298478|FG000|48-month Short Term + Long Term Period|Missing|0|||
143205331|NCT00121641|516298479|FG001|48-month Short Term + Long Term Period|Missing|0|||
143205332|NCT00121641|516298480|FG002|48-month Short Term + Long Term Period|Missing|1|||
143205333|NCT00121641|516298481|FG003|48-month Short Term + Long Term Period|Missing|0|||
143205334|NCT00121641|516298482|FG004|48-month Short Term + Long Term Period|Missing|0|||
143205335|NCT00121641|516298478|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
143205336|NCT00121641|516298479|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
143205337|NCT00121641|516298480|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
143205338|NCT00121641|516298481|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
143205339|NCT00121641|516298482|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
143205340|NCT02544373|516298489|FG000|Overall Study|Lost to Follow-up|5|||
143205341|NCT02544373|516298490|FG001|Overall Study|Lost to Follow-up|3|||
143205342|NCT02544373|516298489|FG000|Overall Study|Withdrawal by Subject|8|||
143205343|NCT02544373|516298490|FG001|Overall Study|Withdrawal by Subject|2|||
143205344|NCT02404649|516298492|FG000|Overall Study|Adverse Event|1|||
143205345|NCT02404649|516298493|FG001|Overall Study|Adverse Event|2|||
143205346|NCT00162266|516298494|FG000|Double-Blind Period|Adverse Event|5|||
143205347|NCT00162266|516298495|FG001|Double-Blind Period|Adverse Event|9|||
143205348|NCT00162266|516298496|FG002|Double-Blind Period|Adverse Event|11|||
143205349|NCT00162266|516298497|FG003|Double-Blind Period|Adverse Event|0|||
143205350|NCT00162266|516298494|FG000|Double-Blind Period|Death|0|||
143205351|NCT00162266|516298495|FG001|Double-Blind Period|Death|1|||
143205352|NCT00162266|516298496|FG002|Double-Blind Period|Death|0|||
143205353|NCT00162266|516298497|FG003|Double-Blind Period|Death|0|||
143205354|NCT00162266|516298494|FG000|Double-Blind Period|Lost to Follow-up|1|||
143205355|NCT00162266|516298495|FG001|Double-Blind Period|Lost to Follow-up|2|||
143205356|NCT00162266|516298496|FG002|Double-Blind Period|Lost to Follow-up|0|||
143205357|NCT00162266|516298497|FG003|Double-Blind Period|Lost to Follow-up|0|||
143205358|NCT00162266|516298494|FG000|Double-Blind Period|Other Reason|1|||
143205359|NCT00162266|516298495|FG001|Double-Blind Period|Other Reason|0|||
143205360|NCT00162266|516298496|FG002|Double-Blind Period|Other Reason|1|||
143205361|NCT00162266|516298497|FG003|Double-Blind Period|Other Reason|0|||
143205362|NCT00162266|516298494|FG000|Double-Blind Period|Lack of Efficacy|13|||
143205363|NCT00162266|516298495|FG001|Double-Blind Period|Lack of Efficacy|17|||
143205364|NCT00162266|516298496|FG002|Double-Blind Period|Lack of Efficacy|30|||
143205365|NCT00162266|516298497|FG003|Double-Blind Period|Lack of Efficacy|0|||
143205366|NCT00162266|516298494|FG000|Double-Blind Period|Withdrawal by Subject|5|||
143205367|NCT00162266|516298495|FG001|Double-Blind Period|Withdrawal by Subject|2|||
143205368|NCT00162266|516298496|FG002|Double-Blind Period|Withdrawal by Subject|6|||
143205369|NCT00162266|516298497|FG003|Double-Blind Period|Withdrawal by Subject|0|||
143205370|NCT00162266|516298494|FG000|Open-Label Period|Death|0|||
143205371|NCT00162266|516298495|FG001|Open-Label Period|Death|0|||
143205372|NCT00162266|516298496|FG002|Open-Label Period|Death|0|||
143205373|NCT00162266|516298497|FG003|Open-Label Period|Death|7|||
143205374|NCT00162266|516298494|FG000|Open-Label Period|Adverse Event|0|||
143205375|NCT00162266|516298495|FG001|Open-Label Period|Adverse Event|0|||
143205376|NCT00162266|516298496|FG002|Open-Label Period|Adverse Event|0|||
143205377|NCT00162266|516298497|FG003|Open-Label Period|Adverse Event|46|||
143205378|NCT00162266|516298494|FG000|Open-Label Period|Lack of Efficacy|0|||
143205379|NCT00162266|516298495|FG001|Open-Label Period|Lack of Efficacy|0|||
143205380|NCT00162266|516298496|FG002|Open-Label Period|Lack of Efficacy|0|||
143205381|NCT00162266|516298497|FG003|Open-Label Period|Lack of Efficacy|26|||
143205382|NCT00162266|516298494|FG000|Open-Label Period|Lost to Follow-up|0|||
143205383|NCT00162266|516298495|FG001|Open-Label Period|Lost to Follow-up|0|||
143205384|NCT00162266|516298496|FG002|Open-Label Period|Lost to Follow-up|0|||
143205385|NCT00162266|516298497|FG003|Open-Label Period|Lost to Follow-up|3|||
143205386|NCT00162266|516298494|FG000|Open-Label Period|Withdrawal by Subject|0|||
143205387|NCT00162266|516298495|FG001|Open-Label Period|Withdrawal by Subject|0|||
143205388|NCT00162266|516298496|FG002|Open-Label Period|Withdrawal by Subject|0|||
143205389|NCT00162266|516298497|FG003|Open-Label Period|Withdrawal by Subject|31|||
143263081|NCT00491556|516515975|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
143205390|NCT00162266|516298494|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
143205391|NCT00162266|516298495|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
143205392|NCT00162266|516298496|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
143205393|NCT00162266|516298497|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
143205394|NCT00162266|516298494|FG000|Open-Label Period|Other Reasons|0|||
143205395|NCT00162266|516298495|FG001|Open-Label Period|Other Reasons|0|||
143205396|NCT00162266|516298496|FG002|Open-Label Period|Other Reasons|0|||
143205397|NCT00162266|516298497|FG003|Open-Label Period|Other Reasons|15|||
143205398|NCT04208087|516298498|FG000|Overall Study|Adverse Event|1|||
143205399|NCT04208087|516298499|FG001|Overall Study|Adverse Event|0|||
143205400|NCT04208087|516298500|FG002|Overall Study|Adverse Event|0|||
143205401|NCT04208087|516298501|FG003|Overall Study|Adverse Event|0|||
143205402|NCT04208087|516298502|FG004|Overall Study|Adverse Event|0|||
143205403|NCT04208087|516298498|FG000|Overall Study|Withdrawal by Subject|0|||
143205404|NCT04208087|516298499|FG001|Overall Study|Withdrawal by Subject|0|||
143205405|NCT04208087|516298500|FG002|Overall Study|Withdrawal by Subject|1|||
143205406|NCT04208087|516298501|FG003|Overall Study|Withdrawal by Subject|0|||
143205407|NCT04208087|516298502|FG004|Overall Study|Withdrawal by Subject|0|||
143205408|NCT04208087|516298498|FG000|Overall Study|Other|0|||
143205409|NCT04208087|516298499|FG001|Overall Study|Other|0|||
143205410|NCT04208087|516298500|FG002|Overall Study|Other|0|||
143205411|NCT04208087|516298501|FG003|Overall Study|Other|0|||
143205412|NCT04208087|516298502|FG004|Overall Study|Other|1|||
143205413|NCT01839656|516298503|FG000|Overall Study|Withdrawal by Subject|1|||
143205414|NCT01839656|516298504|FG001|Overall Study|Withdrawal by Subject|1|||
143205415|NCT01839656|516298503|FG000|Overall Study|Adverse event, serious fatal|1|||
143205416|NCT01839656|516298504|FG001|Overall Study|Adverse event, serious fatal|4|||
143205417|NCT01839656|516298503|FG000|Overall Study|Early study closure|0|||
143205418|NCT01839656|516298504|FG001|Overall Study|Early study closure|11|||
143205419|NCT01839656|516298503|FG000|Overall Study|Adverse Event|1|||
143205420|NCT01839656|516298504|FG001|Overall Study|Adverse Event|0|||
143205421|NCT01595581|516298505|FG000|Overall Study|Withdrawal by Subject|1|||
143205422|NCT01595581|516298506|FG001|Overall Study|Withdrawal by Subject|0|||
143205423|NCT02621073|516298507|FG000|Overall Study|Lost to Follow-up|0|||
143205424|NCT02621073|516298508|FG001|Overall Study|Lost to Follow-up|1|||
143205425|NCT02621073|516298507|FG000|Overall Study|Physician Decision|3|||
143205426|NCT02621073|516298508|FG001|Overall Study|Physician Decision|2|||
143205427|NCT00495755|516298512|FG000|Overall Study|Adverse Event|3|||
143205428|NCT02273960|516298513|FG000|Short Term Period|Lost to Follow-up|1|||
143205429|NCT02273960|516298514|FG001|Short Term Period|Lost to Follow-up|0|||
143205430|NCT02273960|516298515|FG002|Short Term Period|Lost to Follow-up|0|||
143205431|NCT02273960|516298516|FG003|Short Term Period|Lost to Follow-up|0|||
143205432|NCT02273960|516298513|FG000|Short Term Period|Lack of Efficacy|0|||
143205433|NCT02273960|516298514|FG001|Short Term Period|Lack of Efficacy|0|||
143205434|NCT02273960|516298515|FG002|Short Term Period|Lack of Efficacy|0|||
143205435|NCT02273960|516298516|FG003|Short Term Period|Lack of Efficacy|1|||
143205436|NCT02273960|516298513|FG000|Short Term Period|ST complete, not entering LTE|4|||
143205437|NCT02273960|516298514|FG001|Short Term Period|ST complete, not entering LTE|6|||
143205438|NCT02273960|516298515|FG002|Short Term Period|ST complete, not entering LTE|4|||
143205439|NCT02273960|516298516|FG003|Short Term Period|ST complete, not entering LTE|5|||
143205440|NCT02273960|516298513|FG000|Long Term Extension|Death|0|||
143205441|NCT02273960|516298514|FG001|Long Term Extension|Death|0|||
143205442|NCT02273960|516298515|FG002|Long Term Extension|Death|0|||
143263082|NCT00491556|516515974|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
143263083|NCT00491556|516515975|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
143263084|NCT00491556|516515974|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
143263085|NCT00491556|516515975|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
143263086|NCT00491556|516515974|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
143263087|NCT00491556|516515975|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
143263088|NCT00491556|516515974|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
143263089|NCT00491556|516515975|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
143263090|NCT00491556|516515974|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
143263091|NCT00491556|516515975|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
143263092|NCT00491556|516515974|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
143263093|NCT00491556|516515975|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
143263094|NCT00491556|516515974|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
143263095|NCT00491556|516515975|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
143263096|NCT00491556|516515974|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
143205443|NCT02273960|516298516|FG003|Long Term Extension|Death|1|||
143205444|NCT01012323|516298517|FG000|Overall Study|Investigator Judgment|1|||
143205445|NCT01918332|516299944|FG000|Overall Study|Adverse Event|0|||
143205446|NCT01918332|516299945|FG001|Overall Study|Adverse Event|0|||
143263097|NCT00491556|516515975|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
143205447|NCT01918332|516299946|FG002|Overall Study|Adverse Event|0|||
143205448|NCT01918332|516299947|FG003|Overall Study|Adverse Event|1|||
143205449|NCT01918332|516299944|FG000|Overall Study|Withdrawal by Subject|2|||
143205450|NCT01918332|516299945|FG001|Overall Study|Withdrawal by Subject|3|||
143205451|NCT01918332|516299946|FG002|Overall Study|Withdrawal by Subject|2|||
143205452|NCT01918332|516299947|FG003|Overall Study|Withdrawal by Subject|3|||
143205453|NCT01918332|516299944|FG000|Overall Study|Protocol Violation|6|||
143205454|NCT01918332|516299945|FG001|Overall Study|Protocol Violation|2|||
143205455|NCT01918332|516299946|FG002|Overall Study|Protocol Violation|6|||
143205456|NCT01918332|516299947|FG003|Overall Study|Protocol Violation|3|||
143205457|NCT01918332|516299944|FG000|Overall Study|lipid result by central lab did not meet|0|||
143205458|NCT01918332|516299945|FG001|Overall Study|lipid result by central lab did not meet|0|||
143205459|NCT01918332|516299946|FG002|Overall Study|lipid result by central lab did not meet|1|||
143205460|NCT01918332|516299947|FG003|Overall Study|lipid result by central lab did not meet|0|||
143205461|NCT02258529|516299948|FG000|Overall Study|Study Terminated by Sponsor|9|||
143205462|NCT02258529|516299948|FG000|Overall Study|Adverse Event|1|||
143205463|NCT00443781|516299949|FG000|Overall Study|Lost to Follow-up|10|||
143205464|NCT00443781|516299949|FG000|Overall Study|Physician Decision|2|||
143205465|NCT00443781|516299949|FG000|Overall Study|Protocol Violation|1|||
143205466|NCT00443781|516299949|FG000|Overall Study|Withdrawal by Subject|6|||
143205467|NCT00443781|516299949|FG000|Overall Study|Unable to comply with study follow up|2|||
143205468|NCT00443781|516299949|FG000|Overall Study|Investigator terminated participation|1|||
143205469|NCT00443781|516299949|FG000|Overall Study|Insurance not covered|2|||
143205470|NCT00443781|516299949|FG000|Overall Study|PD/FAD not done|1|||
143205471|NCT02066415|516299950|FG000|Overall Study|Decision by Sponsor|5|||
143205472|NCT02066415|516299951|FG001|Overall Study|Decision by Sponsor|4|||
143205473|NCT02066415|516299952|FG002|Overall Study|Decision by Sponsor|2|||
143205474|NCT02066415|516299950|FG000|Overall Study|Withdrawal by Subject|9|||
143205475|NCT02066415|516299951|FG001|Overall Study|Withdrawal by Subject|1|||
143205476|NCT02066415|516299952|FG002|Overall Study|Withdrawal by Subject|4|||
143205477|NCT02066415|516299950|FG000|Overall Study|Lost to Follow-up|7|||
143205478|NCT02066415|516299951|FG001|Overall Study|Lost to Follow-up|2|||
143205479|NCT02066415|516299952|FG002|Overall Study|Lost to Follow-up|2|||
143205480|NCT00430937|516299953|FG000|Overall Study|Adverse Event|3|||
143205481|NCT00430937|516299954|FG001|Overall Study|Adverse Event|8|||
143205482|NCT00430937|516299953|FG000|Overall Study|Death|0|||
143205483|NCT00430937|516299954|FG001|Overall Study|Death|1|||
143205484|NCT00430937|516299953|FG000|Overall Study|Lost to Follow-up|6|||
143205485|NCT00430937|516299954|FG001|Overall Study|Lost to Follow-up|6|||
143205486|NCT00430937|516299953|FG000|Overall Study|Withdrawal by Subject|5|||
143205487|NCT00430937|516299954|FG001|Overall Study|Withdrawal by Subject|2|||
143205488|NCT00430937|516299953|FG000|Overall Study|Protocol Violation|3|||
143205489|NCT00430937|516299954|FG001|Overall Study|Protocol Violation|2|||
143205490|NCT00430937|516299953|FG000|Overall Study|Lack of Efficacy|6|||
143205491|NCT00430937|516299954|FG001|Overall Study|Lack of Efficacy|5|||
143205492|NCT00430937|516299953|FG000|Overall Study|Inappropriate enrollment|2|||
143205493|NCT00430937|516299954|FG001|Overall Study|Inappropriate enrollment|1|||
143205494|NCT00430937|516299953|FG000|Overall Study|Administrative reasons|1|||
143205495|NCT00430937|516299954|FG001|Overall Study|Administrative reasons|0|||
143205496|NCT00430937|516299953|FG000|Overall Study|Protocol discontinuation criteria met|1|||
143205497|NCT00430937|516299954|FG001|Overall Study|Protocol discontinuation criteria met|2|||
143205498|NCT00430937|516299953|FG000|Overall Study|Unable to classify|0|||
143205499|NCT00430937|516299954|FG001|Overall Study|Unable to classify|1|||
143205500|NCT01116427|516299955|FG000|Core Phase|Adverse Event|0|||
143205501|NCT01116427|516299956|FG001|Core Phase|Adverse Event|1|||
143205502|NCT01116427|516299955|FG000|Core Phase|Lost to Follow-up|1|||
143205503|NCT01116427|516299956|FG001|Core Phase|Lost to Follow-up|0|||
143205504|NCT01116427|516299955|FG000|Core Phase|Withdrawal by Subject|3|||
143205505|NCT01116427|516299956|FG001|Core Phase|Withdrawal by Subject|0|||
143205506|NCT01116427|516299955|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
143205507|NCT01116427|516299956|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
143205508|NCT01116427|516299955|FG000|Extension Phase|Adverse Event|1|||
143205509|NCT01116427|516299956|FG001|Extension Phase|Adverse Event|1|||
143205510|NCT01116427|516299955|FG000|Extension Phase|Lost to Follow-up|2|||
143205511|NCT01116427|516299956|FG001|Extension Phase|Lost to Follow-up|0|||
143205512|NCT01116427|516299955|FG000|Extension Phase|Withdrawal by Subject|5|||
143205513|NCT01116427|516299956|FG001|Extension Phase|Withdrawal by Subject|1|||
143205514|NCT01116427|516299955|FG000|Extension Phase|Not using appropriate birth control|1|||
143205515|NCT01116427|516299956|FG001|Extension Phase|Not using appropriate birth control|0|||
143205516|NCT02989805|516299957|FG000|Overall Study|invalid consent|6|||
143205517|NCT02989805|516299958|FG001|Overall Study|invalid consent|4|||
143205518|NCT03743064|516299959|FG000|Overall Study|Adverse Event|7|||
143263098|NCT00491556|516515974|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
143205519|NCT03743064|516299960|FG001|Overall Study|Adverse Event|9|||
143205520|NCT03743064|516299959|FG000|Overall Study|Death|25|||
143205521|NCT03743064|516299960|FG001|Overall Study|Death|28|||
143205522|NCT03743064|516299959|FG000|Overall Study|Lost to Follow-up|3|||
143205523|NCT03743064|516299960|FG001|Overall Study|Lost to Follow-up|6|||
143205524|NCT03743064|516299959|FG000|Overall Study|Withdrawal by Subject|28|||
143205525|NCT03743064|516299960|FG001|Overall Study|Withdrawal by Subject|25|||
143205526|NCT03743064|516299959|FG000|Overall Study|Physician Decision|2|||
143205527|NCT03743064|516299960|FG001|Overall Study|Physician Decision|4|||
143205528|NCT03743064|516299959|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
143205529|NCT03743064|516299960|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
143205530|NCT02648217|516299965|FG000|Overall Study|Adverse Event|0|||
143205531|NCT02648217|516299966|FG001|Overall Study|Adverse Event|1|||
143205532|NCT02648217|516299965|FG000|Overall Study|Lost to Follow-up|1|||
143370391|NCT04771273|516899186|FG003|Dose Escalation Period|Change of residence|1|||
143205533|NCT02648217|516299966|FG001|Overall Study|Lost to Follow-up|1|||
143205534|NCT02648217|516299965|FG000|Overall Study|Withdrawal by Subject|4|||
143205535|NCT02648217|516299966|FG001|Overall Study|Withdrawal by Subject|3|||
143205536|NCT02648217|516299965|FG000|Overall Study|Unclassified|5|||
143205537|NCT02648217|516299966|FG001|Overall Study|Unclassified|0|||
143205538|NCT02553538|516299967|FG000|Overall Study|Could Not Reach by Telephone|133|||
143205539|NCT02553538|516299968|FG001|Overall Study|Could Not Reach by Telephone|0|||
143205540|NCT02553538|516299967|FG000|Overall Study|Died or Left Network|54|||
143205541|NCT02553538|516299968|FG001|Overall Study|Died or Left Network|56|||
143205542|NCT00907296|516299969|FG000|Overall Study|Ineligibility Determined|1|||
143205543|NCT00907296|516299970|FG001|Overall Study|Ineligibility Determined|0|||
143205544|NCT00907296|516299971|FG002|Overall Study|Ineligibility Determined|0|||
143205545|NCT00907296|516299972|FG003|Overall Study|Ineligibility Determined|1|||
143205546|NCT00907296|516299973|FG004|Overall Study|Ineligibility Determined|0|||
143205547|NCT00907296|516299974|FG005|Overall Study|Ineligibility Determined|0|||
143205548|NCT00907296|516299975|FG006|Overall Study|Ineligibility Determined|0|||
143205549|NCT00907296|516299976|FG007|Overall Study|Ineligibility Determined|1|||
143205550|NCT00907296|516299977|FG008|Overall Study|Ineligibility Determined|0|||
143205551|NCT00907296|516299978|FG009|Overall Study|Ineligibility Determined|0|||
143205552|NCT00907296|516299969|FG000|Overall Study|Protocol Deviation|0|||
143205553|NCT00907296|516299970|FG001|Overall Study|Protocol Deviation|1|||
143205554|NCT00907296|516299971|FG002|Overall Study|Protocol Deviation|0|||
143205555|NCT00907296|516299972|FG003|Overall Study|Protocol Deviation|0|||
143205556|NCT00907296|516299973|FG004|Overall Study|Protocol Deviation|0|||
143205557|NCT00907296|516299974|FG005|Overall Study|Protocol Deviation|0|||
143205558|NCT00907296|516299975|FG006|Overall Study|Protocol Deviation|0|||
143205559|NCT00907296|516299976|FG007|Overall Study|Protocol Deviation|0|||
143205560|NCT00907296|516299977|FG008|Overall Study|Protocol Deviation|0|||
143205561|NCT00907296|516299978|FG009|Overall Study|Protocol Deviation|0|||
143205562|NCT00907296|516299969|FG000|Overall Study|Noncompliance|1|||
143205563|NCT00907296|516299970|FG001|Overall Study|Noncompliance|1|||
143205564|NCT00907296|516299971|FG002|Overall Study|Noncompliance|1|||
143205565|NCT00907296|516299972|FG003|Overall Study|Noncompliance|0|||
143205566|NCT00907296|516299973|FG004|Overall Study|Noncompliance|0|||
143205567|NCT00907296|516299974|FG005|Overall Study|Noncompliance|1|||
143205568|NCT00907296|516299975|FG006|Overall Study|Noncompliance|0|||
143205569|NCT00907296|516299976|FG007|Overall Study|Noncompliance|2|||
143205570|NCT00907296|516299977|FG008|Overall Study|Noncompliance|0|||
143205571|NCT00907296|516299978|FG009|Overall Study|Noncompliance|0|||
143205572|NCT00907296|516299969|FG000|Overall Study|Adverse Event|2|||
143205573|NCT00907296|516299970|FG001|Overall Study|Adverse Event|0|||
143205574|NCT00907296|516299971|FG002|Overall Study|Adverse Event|0|||
143205575|NCT00907296|516299972|FG003|Overall Study|Adverse Event|0|||
143205576|NCT00907296|516299973|FG004|Overall Study|Adverse Event|0|||
143205577|NCT00907296|516299974|FG005|Overall Study|Adverse Event|0|||
143205578|NCT00907296|516299975|FG006|Overall Study|Adverse Event|1|||
143205579|NCT00907296|516299976|FG007|Overall Study|Adverse Event|0|||
143205580|NCT00907296|516299977|FG008|Overall Study|Adverse Event|0|||
143205581|NCT00907296|516299978|FG009|Overall Study|Adverse Event|1|||
143205582|NCT00907296|516299969|FG000|Overall Study|Withdrawal by Subject|7|||
143205583|NCT00907296|516299970|FG001|Overall Study|Withdrawal by Subject|2|||
143205584|NCT00907296|516299971|FG002|Overall Study|Withdrawal by Subject|1|||
143205585|NCT00907296|516299972|FG003|Overall Study|Withdrawal by Subject|1|||
143205586|NCT00907296|516299973|FG004|Overall Study|Withdrawal by Subject|1|||
143370392|NCT04771273|516899183|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
143205587|NCT00907296|516299974|FG005|Overall Study|Withdrawal by Subject|5|||
143205588|NCT00907296|516299975|FG006|Overall Study|Withdrawal by Subject|3|||
143205589|NCT00907296|516299976|FG007|Overall Study|Withdrawal by Subject|2|||
143205590|NCT00907296|516299977|FG008|Overall Study|Withdrawal by Subject|4|||
143205591|NCT00907296|516299978|FG009|Overall Study|Withdrawal by Subject|2|||
143205592|NCT00907296|516299969|FG000|Overall Study|Lost to Follow-up|9|||
143205593|NCT00907296|516299970|FG001|Overall Study|Lost to Follow-up|1|||
143205594|NCT00907296|516299971|FG002|Overall Study|Lost to Follow-up|0|||
143205595|NCT00907296|516299972|FG003|Overall Study|Lost to Follow-up|2|||
143205596|NCT00907296|516299973|FG004|Overall Study|Lost to Follow-up|0|||
143205597|NCT00907296|516299974|FG005|Overall Study|Lost to Follow-up|3|||
143205598|NCT00907296|516299975|FG006|Overall Study|Lost to Follow-up|2|||
143205599|NCT00907296|516299976|FG007|Overall Study|Lost to Follow-up|2|||
143205600|NCT00907296|516299977|FG008|Overall Study|Lost to Follow-up|0|||
143205601|NCT00907296|516299978|FG009|Overall Study|Lost to Follow-up|4|||
143205602|NCT00652899|516299984|FG000|Overall Study|Death|1|||
143205603|NCT00652899|516299984|FG000|Overall Study|Treating physician decision|1|||
143205604|NCT00551291|516299985|FG000|Overall Study|Physician Decision|1|||
143205605|NCT03230292|516299988|FG000|Overall Study|Adverse Event|1|||
143205606|NCT03230292|516299988|FG000|Overall Study|Protocol Violation|1|||
143205607|NCT03230292|516299988|FG000|Overall Study|Lost to Follow-up|1|||
143205608|NCT03230292|516299988|FG000|Overall Study|Withdrawal by Subject|3|||
143205609|NCT04047420|516299989|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
143205610|NCT04047420|516299989|FG000|Washout Period|Refused Participation|2|||
143205611|NCT04405245|516299992|FG000|Overall Study|Adverse Event|0|||
143205612|NCT04405245|516299993|FG001|Overall Study|Adverse Event|1|||
143205613|NCT04405245|516299994|FG002|Overall Study|Adverse Event|0|||
143205614|NCT00576472|516299995|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
143205615|NCT00576472|516299996|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
143205616|NCT00576472|516299997|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
143205617|NCT00576472|516299998|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
143205618|NCT00576472|516299999|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
143205619|NCT00576472|516300000|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
143205620|NCT00576472|516300001|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
143205621|NCT00576472|516300002|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
143205622|NCT00576472|516300003|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
143205623|NCT00576472|516300004|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
143205624|NCT00576472|516300005|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
143205625|NCT00576472|516300006|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
143205626|NCT00576472|516300007|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
143205627|NCT00576472|516300008|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
143205628|NCT00576472|516300009|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
143205629|NCT00576472|516299995|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
143205630|NCT00576472|516299996|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
143205631|NCT00576472|516299997|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
143205632|NCT00576472|516299998|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
143205633|NCT00576472|516299999|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
143205634|NCT00576472|516300000|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
143205635|NCT00576472|516300001|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
143205636|NCT00576472|516300002|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
143205637|NCT00576472|516300003|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
143205638|NCT00576472|516300004|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
143205639|NCT00576472|516300005|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
143205640|NCT00576472|516300006|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
143205641|NCT00576472|516300007|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
143205642|NCT00576472|516300008|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
143205643|NCT00576472|516300009|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
143205644|NCT00576472|516299995|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
143205645|NCT00576472|516299996|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
143205646|NCT00576472|516299997|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
143205647|NCT00576472|516299998|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
143205648|NCT00576472|516299999|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
143205649|NCT00576472|516300000|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
143205650|NCT00576472|516300001|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
143205651|NCT00576472|516300002|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
143205652|NCT00576472|516300003|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
143205653|NCT00576472|516300004|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
143205654|NCT00576472|516300005|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
143205655|NCT00576472|516300006|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
143205656|NCT00576472|516300007|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
143205657|NCT00576472|516300008|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
143205658|NCT00576472|516300009|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
143205659|NCT00576472|516299995|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
143205660|NCT00576472|516299996|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
143205661|NCT00576472|516299997|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
143205662|NCT00576472|516299998|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
143205663|NCT00576472|516299999|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
143205664|NCT00576472|516300000|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
143205665|NCT00576472|516300001|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
143205666|NCT00576472|516300002|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
143205667|NCT00576472|516300003|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
143205668|NCT00576472|516300004|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
143205669|NCT00576472|516300005|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
143205670|NCT00576472|516300006|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
143205671|NCT00576472|516300007|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
143205672|NCT00576472|516300008|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
143205673|NCT00576472|516300009|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
143205674|NCT00576472|516299995|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
143205675|NCT00576472|516299996|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
143205676|NCT00576472|516299997|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
143205677|NCT00576472|516299998|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
143205678|NCT00576472|516299999|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
143205679|NCT00576472|516300000|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
143205680|NCT00576472|516300001|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
143205681|NCT00576472|516300002|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
143205682|NCT00576472|516300003|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
143205683|NCT00576472|516300004|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
143205684|NCT00576472|516300005|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
143205685|NCT00576472|516300006|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
143205686|NCT00576472|516300007|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
143205687|NCT00576472|516300008|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
143205688|NCT00576472|516300009|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
143205689|NCT00576472|516299995|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
143205690|NCT00576472|516299996|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
143205691|NCT00576472|516299997|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
143205692|NCT00576472|516299998|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
143205693|NCT00576472|516299999|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
143205694|NCT00576472|516300000|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
143205695|NCT00576472|516300001|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
143205696|NCT00576472|516300002|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
143205697|NCT00576472|516300003|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
143205698|NCT00576472|516300004|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
143205699|NCT00576472|516300005|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
143205700|NCT00576472|516300006|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
143205701|NCT00576472|516300007|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
143205702|NCT00576472|516300008|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
143205703|NCT00576472|516300009|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
143205704|NCT00576472|516299995|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
143205705|NCT00576472|516299996|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
143205706|NCT00576472|516299997|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
143205707|NCT00576472|516299998|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
143205708|NCT00576472|516299999|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
143205709|NCT00576472|516300000|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
143205710|NCT00576472|516300001|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
143205711|NCT00576472|516300002|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
143205712|NCT00576472|516300003|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
143205713|NCT00576472|516300004|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
143205714|NCT00576472|516300005|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
143205715|NCT00576472|516300006|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
143205716|NCT00576472|516300007|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
143205717|NCT00576472|516300008|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
143205718|NCT00576472|516300009|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
143205719|NCT00576472|516299995|FG000|MPH Cross Over Phase|Physician Decision|0|||
143263099|NCT00491556|516515975|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
143263100|NCT00491556|516515974|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
143263101|NCT00491556|516515975|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
143205720|NCT00576472|516299996|FG001|MPH Cross Over Phase|Physician Decision|0|||
143205721|NCT00576472|516299997|FG002|MPH Cross Over Phase|Physician Decision|0|||
143205722|NCT00576472|516299998|FG003|MPH Cross Over Phase|Physician Decision|0|||
143205723|NCT00576472|516299999|FG004|MPH Cross Over Phase|Physician Decision|0|||
143205724|NCT00576472|516300000|FG005|MPH Cross Over Phase|Physician Decision|0|||
143205725|NCT00576472|516300001|FG006|MPH Cross Over Phase|Physician Decision|4|||
143205726|NCT00576472|516300002|FG007|MPH Cross Over Phase|Physician Decision|0|||
143205727|NCT00576472|516300003|FG008|MPH Cross Over Phase|Physician Decision|0|||
143263102|NCT00491556|516515974|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
143263103|NCT00491556|516515975|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
143263104|NCT00491556|516515974|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
143263105|NCT00491556|516515975|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
143205728|NCT00576472|516300004|FG009|MPH Cross Over Phase|Physician Decision|0|||
143205729|NCT00576472|516300005|FG010|MPH Cross Over Phase|Physician Decision|0|||
143205730|NCT00576472|516300006|FG011|MPH Cross Over Phase|Physician Decision|0|||
143205731|NCT00576472|516300007|FG012|MPH Cross Over Phase|Physician Decision|0|||
143205732|NCT00576472|516300008|FG013|MPH Cross Over Phase|Physician Decision|0|||
143205733|NCT00576472|516300009|FG014|MPH Cross Over Phase|Physician Decision|0|||
143205734|NCT00576472|516299995|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
143205735|NCT00576472|516299996|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
143205736|NCT00576472|516299997|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
143205737|NCT00576472|516299998|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
143205738|NCT00576472|516299999|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
143205739|NCT00576472|516300000|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
143205740|NCT00576472|516300001|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
143205741|NCT00576472|516300002|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
143205742|NCT00576472|516300003|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
143205743|NCT00576472|516300004|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
143205744|NCT00576472|516300005|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
143205745|NCT00576472|516300006|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
143205746|NCT00576472|516300007|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
143205747|NCT00576472|516300008|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
143205748|NCT00576472|516300009|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
143205749|NCT00576472|516299995|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
143205750|NCT00576472|516299996|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
143205751|NCT00576472|516299997|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
143205752|NCT00576472|516299998|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
143205753|NCT00576472|516299999|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
143205754|NCT00576472|516300000|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
143205755|NCT00576472|516300001|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
143205756|NCT00576472|516300002|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
143205757|NCT00576472|516300003|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
143205758|NCT00576472|516300004|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
143205759|NCT00576472|516300005|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
143205760|NCT00576472|516300006|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
143205761|NCT00576472|516300007|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
143205762|NCT00576472|516300008|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
143205763|NCT00576472|516300009|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
143205764|NCT00576472|516299995|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
143205765|NCT00576472|516299996|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
143263106|NCT00491556|516515974|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
143263107|NCT00491556|516515975|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
143263108|NCT00491556|516515974|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
143263109|NCT00491556|516515975|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
143263110|NCT04480424|516515976|FG000|Overall Study|Withdrawal by Subject|0|||
143263111|NCT04480424|516515977|FG001|Overall Study|Withdrawal by Subject|2|||
143263112|NCT04480424|516515976|FG000|Overall Study|Lost to Follow-up|3|||
143263113|NCT04480424|516515977|FG001|Overall Study|Lost to Follow-up|3|||
143263114|NCT04480424|516515976|FG000|Overall Study|Death|14|||
143263115|NCT04480424|516515977|FG001|Overall Study|Death|16|||
143263116|NCT04480424|516515976|FG000|Overall Study|Reason not Specified|5|||
143263117|NCT04480424|516515977|FG001|Overall Study|Reason not Specified|5|||
143263118|NCT00734747|516515981|FG000|SRS Procedure|No staples placed|3|||
143263119|NCT00734747|516515981|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
143263120|NCT03670836|516515982|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
143263121|NCT03670836|516515983|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
143263122|NCT03670836|516515982|FG000|Per Protocol Population (PP)|Physician Decision|9|||
143263123|NCT03670836|516515983|FG001|Per Protocol Population (PP)|Physician Decision|10|||
143263124|NCT03670836|516515982|FG000|Per Protocol Population (PP)|Physician Decision|4|||
143263125|NCT03670836|516515983|FG001|Per Protocol Population (PP)|Physician Decision|6|||
143263126|NCT03670836|516515982|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
143263127|NCT03670836|516515983|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
143263128|NCT03287635|516515984|FG000|Overall Study|Lost to Follow-up|5|||
143263129|NCT03287635|516515984|FG000|Overall Study|Withdrawal by Subject|1|||
143263130|NCT03287635|516515984|FG000|Overall Study|Physician Decision|1|||
143263131|NCT00323869|516515987|FG000|Overall Study|Death|1|||
143263132|NCT00920829|516517481|FG000|Allocation|No post randomization data|3|||
143263133|NCT00920829|516517482|FG001|Allocation|No post randomization data|1|||
143263134|NCT00920829|516517483|FG002|Allocation|No post randomization data|0|||
143263135|NCT00920829|516517484|FG003|Allocation|No post randomization data|2|||
143263136|NCT00920829|516517481|FG000|Available for Analysis|Withdrawal by Subject|6|||
143205766|NCT00576472|516299997|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
143205767|NCT00576472|516299998|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
143205768|NCT00576472|516299999|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
143205769|NCT00576472|516300000|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
143205770|NCT00576472|516300001|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
143205771|NCT00576472|516300002|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
143205772|NCT00576472|516300003|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
143205773|NCT00576472|516300004|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
143205774|NCT00576472|516300005|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
143205775|NCT00576472|516300006|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
143370393|NCT04771273|516899184|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
143370394|NCT04771273|516899185|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
143370395|NCT04771273|516899186|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
143205776|NCT00576472|516300007|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
143205777|NCT00576472|516300008|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
143205778|NCT00576472|516300009|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
143205779|NCT00576472|516299995|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
143205780|NCT00576472|516299996|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
143205781|NCT00576472|516299997|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
143205782|NCT00576472|516299998|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
143205783|NCT00576472|516299999|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
143205784|NCT00576472|516300000|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
143205785|NCT00576472|516300001|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
143205786|NCT00576472|516300002|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
143205787|NCT00576472|516300003|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
143205788|NCT00576472|516300004|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
143205789|NCT00576472|516300005|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
143205790|NCT00576472|516300006|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
143205791|NCT00576472|516300007|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
143205792|NCT00576472|516300008|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
143205793|NCT00576472|516300009|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
143205794|NCT00576472|516299995|FG000|MPH Home Maintenance Phase|Side effects|0|||
143205795|NCT00576472|516299996|FG001|MPH Home Maintenance Phase|Side effects|0|||
143205796|NCT00576472|516299997|FG002|MPH Home Maintenance Phase|Side effects|0|||
143205797|NCT00576472|516299998|FG003|MPH Home Maintenance Phase|Side effects|0|||
143205798|NCT00576472|516299999|FG004|MPH Home Maintenance Phase|Side effects|0|||
143205799|NCT00576472|516300000|FG005|MPH Home Maintenance Phase|Side effects|0|||
143205800|NCT00576472|516300001|FG006|MPH Home Maintenance Phase|Side effects|0|||
143205801|NCT00576472|516300002|FG007|MPH Home Maintenance Phase|Side effects|0|||
143205802|NCT00576472|516300003|FG008|MPH Home Maintenance Phase|Side effects|0|||
143205803|NCT00576472|516300004|FG009|MPH Home Maintenance Phase|Side effects|0|||
143205804|NCT00576472|516300005|FG010|MPH Home Maintenance Phase|Side effects|0|||
143205805|NCT00576472|516300006|FG011|MPH Home Maintenance Phase|Side effects|0|||
143205806|NCT00576472|516300007|FG012|MPH Home Maintenance Phase|Side effects|0|||
143205807|NCT00576472|516300008|FG013|MPH Home Maintenance Phase|Side effects|0|||
143205808|NCT00576472|516300009|FG014|MPH Home Maintenance Phase|Side effects|8|||
143205809|NCT00576472|516299995|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
143205810|NCT00576472|516299996|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
143205811|NCT00576472|516299997|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
143205812|NCT00576472|516299998|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
143205813|NCT00576472|516299999|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
143205814|NCT00576472|516300000|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
143205815|NCT00576472|516300001|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
143205816|NCT00576472|516300002|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
143205817|NCT00576472|516300003|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
143205818|NCT00576472|516300004|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
143205819|NCT00576472|516300005|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
143205820|NCT00576472|516300006|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
143205821|NCT00576472|516300007|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
143205822|NCT00576472|516300008|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
143205823|NCT00576472|516300009|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
143205824|NCT00576472|516299995|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
143205825|NCT00576472|516299996|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
143205826|NCT00576472|516299997|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
143205827|NCT00576472|516299998|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
143205828|NCT00576472|516299999|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
143205829|NCT00576472|516300000|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
143370396|NCT04771273|516899183|FG000|Dose Escalation Period|Adverse Event|8|||
143205830|NCT00576472|516300001|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
143205831|NCT00576472|516300002|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
143205832|NCT00576472|516300003|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
143205833|NCT00576472|516300004|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
143205834|NCT00576472|516300005|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
143205835|NCT00576472|516300006|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
143205836|NCT00576472|516300007|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
143205837|NCT00576472|516300008|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
143205838|NCT00576472|516300009|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
143205839|NCT00576472|516299995|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
143205840|NCT00576472|516299996|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
143205841|NCT00576472|516299997|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
143205842|NCT00576472|516299998|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
143205843|NCT00576472|516299999|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
143205844|NCT00576472|516300000|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
143205845|NCT00576472|516300001|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
143205846|NCT00576472|516300002|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
143205847|NCT00576472|516300003|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
143205848|NCT00576472|516300004|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
143205849|NCT00576472|516300005|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
143205850|NCT00576472|516300006|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
143205851|NCT00576472|516300007|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
143205852|NCT00576472|516300008|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
143205853|NCT00576472|516300009|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
143205854|NCT00424190|516300022|FG000|Overall Study|Withdrew consent|3|||
143205855|NCT00424190|516300023|FG001|Overall Study|Withdrew consent|4|||
143205856|NCT00424190|516300022|FG000|Overall Study|Death|3|||
143205857|NCT00424190|516300023|FG001|Overall Study|Death|0|||
143205858|NCT00424190|516300022|FG000|Overall Study|Noncompliance|1|||
143205859|NCT00424190|516300023|FG001|Overall Study|Noncompliance|2|||
143205860|NCT00424190|516300022|FG000|Overall Study|Request of sponsor or investigator|0|||
143205861|NCT00424190|516300023|FG001|Overall Study|Request of sponsor or investigator|2|||
143205862|NCT00424190|516300022|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
143205863|NCT00424190|516300023|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
143205864|NCT00424190|516300022|FG000|Overall Study|Other|15|||
143205865|NCT00424190|516300023|FG001|Overall Study|Other|21|||
143205866|NCT00351273|516300024|FG000|Overall Study|Lost to Follow-up|1|||
143205867|NCT00351273|516300025|FG001|Overall Study|Lost to Follow-up|2|||
143205868|NCT00351273|516300026|FG002|Overall Study|Lost to Follow-up|5|||
143205869|NCT01378429|516300028|FG000|Overall Study|Noncompliance with study drug|1|||
143263137|NCT00920829|516517482|FG001|Available for Analysis|Withdrawal by Subject|6|||
143263138|NCT00920829|516517483|FG002|Available for Analysis|Withdrawal by Subject|6|||
143263139|NCT00920829|516517484|FG003|Available for Analysis|Withdrawal by Subject|10|||
143263140|NCT00920829|516517481|FG000|Available for Analysis|Required Medical Treatment|0|||
143263141|NCT00920829|516517482|FG001|Available for Analysis|Required Medical Treatment|1|||
143263142|NCT00920829|516517483|FG002|Available for Analysis|Required Medical Treatment|2|||
143263143|NCT00920829|516517484|FG003|Available for Analysis|Required Medical Treatment|0|||
143205870|NCT01378429|516300029|FG001|Overall Study|Noncompliance with study drug|0|||
143205871|NCT00619489|516300030|FG000|Overall Study|Adverse Event|0|||
143205872|NCT00619489|516300031|FG001|Overall Study|Adverse Event|7|||
143205873|NCT00619489|516300030|FG000|Overall Study|Withdrawal by Subject|1|||
143205874|NCT00619489|516300031|FG001|Overall Study|Withdrawal by Subject|1|||
143205875|NCT00619489|516300030|FG000|Overall Study|Lack of Efficacy|0|||
143205876|NCT00619489|516300031|FG001|Overall Study|Lack of Efficacy|11|||
143205877|NCT00619489|516300030|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
143205878|NCT00619489|516300031|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
143205879|NCT02241187|516300032|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
143205880|NCT02356887|516300033|FG000|Overall Study|poor compliance|2|||
143205881|NCT00199888|516300034|FG000|Overall Study|Lost to Follow-up|1|||
143205882|NCT05219669|516300039|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
143205883|NCT05219669|516300040|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
143205884|NCT05219669|516300041|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
143205885|NCT05219669|516300042|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
143205886|NCT05219669|516300043|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
143205887|NCT05219669|516300044|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
143205888|NCT00330668|516300047|FG000|BID Dosing Period|Adverse Event|1|||
143205889|NCT00330668|516300047|FG000|BID Dosing Period|Lost to Follow-up|7|||
143205890|NCT00330668|516300047|FG000|BID Dosing Period|Non-Compliance|5|||
143205891|NCT00330668|516300047|FG000|BID Dosing Period|Withdrawal by Subject|19|||
143205892|NCT00330668|516300047|FG000|BID Dosing Period|Sponsor's decision|1|||
143205893|NCT00330668|516300047|FG000|BID Dosing Period|Other|3|||
143205894|NCT00330668|516300047|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
143205895|NCT00330668|516300047|FG000|QD Dosing Period|Other|1|||
143205896|NCT00330668|516300047|FG000|QD Dosing Period|Withdrawal by Subject|1|||
143205897|NCT00330668|516300047|FG000|QD Dosing Period|Lost to Follow-up|2|||
143205898|NCT02265796|516300048|FG000|Overall Study|Death|1|||
143205899|NCT02265796|516300049|FG001|Overall Study|Death|0|||
143205900|NCT02265796|516300048|FG000|Overall Study|started on excluded medication|1|||
143205901|NCT02265796|516300049|FG001|Overall Study|started on excluded medication|0|||
143205902|NCT02265796|516300048|FG000|Overall Study|Withdrawal by Subject|1|||
143205903|NCT02265796|516300049|FG001|Overall Study|Withdrawal by Subject|1|||
143205904|NCT00558272|516300050|FG000|Overall Study|Adverse Event|10|||
143205905|NCT00558272|516300051|FG001|Overall Study|Adverse Event|0|||
143205906|NCT00558272|516300050|FG000|Overall Study|Death|1|||
143205907|NCT00558272|516300051|FG001|Overall Study|Death|0|||
143205908|NCT00558272|516300050|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
143205909|NCT00558272|516300051|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
143205910|NCT00558272|516300050|FG000|Overall Study|AZ study team decision|0|||
143205911|NCT00558272|516300051|FG001|Overall Study|AZ study team decision|1|||
143205912|NCT00558272|516300050|FG000|Overall Study|Incorrectly enrolled|1|||
143205913|NCT00558272|516300051|FG001|Overall Study|Incorrectly enrolled|0|||
143205914|NCT00558272|516300050|FG000|Overall Study|Withdrawal by Subject|0|||
143205915|NCT00558272|516300051|FG001|Overall Study|Withdrawal by Subject|1|||
143205916|NCT02920957|516300052|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
143205917|NCT02920957|516300053|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
143205918|NCT02920957|516300052|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
143205919|NCT02920957|516300053|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
143205920|NCT02920957|516300052|FG000|First Intervention : 1 Month|Adverse Event|1|||
143205921|NCT02920957|516300053|FG001|First Intervention : 1 Month|Adverse Event|0|||
143205922|NCT02920957|516300052|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
143205923|NCT02920957|516300053|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
143205924|NCT02745535|516300060|FG000|Overall Study|Death|1|||
143205925|NCT02745535|516300060|FG000|Overall Study|Adverse Event|3|||
143205926|NCT02745535|516300060|FG000|Overall Study|Lost to Follow-up|2|||
143205927|NCT01789606|516300061|FG000|Overall Study|Participant not Purchased the Product|0|||
143205928|NCT01789606|516300062|FG001|Overall Study|Participant not Purchased the Product|20|||
143205929|NCT01789606|516300061|FG000|Overall Study|Withdrawal by Subject|0|||
143205930|NCT01789606|516300062|FG001|Overall Study|Withdrawal by Subject|1|||
143205931|NCT01789606|516300061|FG000|Overall Study|Ineligible|6|||
143205932|NCT01789606|516300062|FG001|Overall Study|Ineligible|2|||
143205933|NCT01789606|516300061|FG000|Overall Study|Administrative Reasons|17|||
143205934|NCT01789606|516300062|FG001|Overall Study|Administrative Reasons|6|||
143205935|NCT01789606|516300061|FG000|Overall Study|No Study Medication Taken|0|||
143205936|NCT01789606|516300062|FG001|Overall Study|No Study Medication Taken|1|||
143205937|NCT01789606|516300061|FG000|Overall Study|Protocol Violation|0|||
143205938|NCT01789606|516300062|FG001|Overall Study|Protocol Violation|55|||
143205939|NCT01789606|516300061|FG000|Overall Study|Adverse Event|0|||
143205940|NCT01789606|516300062|FG001|Overall Study|Adverse Event|3|||
143205941|NCT01789606|516300061|FG000|Overall Study|Lost to Follow-up|0|||
143205942|NCT01789606|516300062|FG001|Overall Study|Lost to Follow-up|14|||
143370397|NCT04771273|516899184|FG001|Dose Escalation Period|Adverse Event|9|||
143205943|NCT01789606|516300061|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
143370398|NCT04771273|516899185|FG002|Dose Escalation Period|Adverse Event|12|||
143205944|NCT01789606|516300062|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
143205945|NCT01345682|516300066|FG000|Overall Study|Progressive disease per RECIST|226|||
143205946|NCT01345682|516300067|FG001|Overall Study|Progressive disease per RECIST|93|||
143205947|NCT01345682|516300066|FG000|Overall Study|Worsening of underlying cancer disease|23|||
143205948|NCT01345682|516300067|FG001|Overall Study|Worsening of underlying cancer disease|12|||
143205949|NCT01345682|516300066|FG000|Overall Study|Adverse Event|51|||
143205950|NCT01345682|516300067|FG001|Overall Study|Adverse Event|41|||
143205951|NCT01345682|516300066|FG000|Overall Study|Non-compliance with protocol|0|||
143205952|NCT01345682|516300067|FG001|Overall Study|Non-compliance with protocol|1|||
143205953|NCT01345682|516300066|FG000|Overall Study|Lost to Follow-up|0|||
143205954|NCT01345682|516300067|FG001|Overall Study|Lost to Follow-up|1|||
143205955|NCT01345682|516300066|FG000|Overall Study|Refused to continue trial medication|16|||
143205956|NCT01345682|516300067|FG001|Overall Study|Refused to continue trial medication|9|||
143205957|NCT01345682|516300066|FG000|Overall Study|Not treated|2|||
143205958|NCT01345682|516300067|FG001|Overall Study|Not treated|1|||
143205959|NCT01345682|516300066|FG000|Overall Study|Reason other than those specified above|4|||
143205960|NCT01345682|516300067|FG001|Overall Study|Reason other than those specified above|3|||
143205961|NCT01105377|516300073|FG000|Overall Study|Withdrawal by Subject|0|||
143205962|NCT01105377|516300074|FG001|Overall Study|Withdrawal by Subject|1|||
143205963|NCT01075984|516300075|FG000|Treatment Phase|Adverse Event|0|||
143205964|NCT01075984|516300076|FG001|Treatment Phase|Adverse Event|1|||
143205965|NCT01075984|516300077|FG002|Treatment Phase|Adverse Event|3|||
143205966|NCT01075984|516300078|FG003|Treatment Phase|Adverse Event|7|||
143205967|NCT01075984|516300079|FG004|Treatment Phase|Adverse Event|35|||
143205968|NCT01075984|516300075|FG000|Treatment Phase|Protocol Violation|0|||
143205969|NCT01075984|516300076|FG001|Treatment Phase|Protocol Violation|0|||
143205970|NCT01075984|516300077|FG002|Treatment Phase|Protocol Violation|1|||
143205971|NCT01075984|516300078|FG003|Treatment Phase|Protocol Violation|0|||
143205972|NCT01075984|516300079|FG004|Treatment Phase|Protocol Violation|3|||
143205973|NCT01075984|516300075|FG000|Treatment Phase|Withdrawal by Subject|0|||
143205974|NCT01075984|516300076|FG001|Treatment Phase|Withdrawal by Subject|0|||
143205975|NCT01075984|516300077|FG002|Treatment Phase|Withdrawal by Subject|2|||
143205976|NCT01075984|516300078|FG003|Treatment Phase|Withdrawal by Subject|0|||
143205977|NCT01075984|516300079|FG004|Treatment Phase|Withdrawal by Subject|15|||
143205978|NCT01075984|516300075|FG000|Treatment Phase|Treatment Failure|0|||
143205979|NCT01075984|516300076|FG001|Treatment Phase|Treatment Failure|0|||
143205980|NCT01075984|516300077|FG002|Treatment Phase|Treatment Failure|1|||
143205981|NCT01075984|516300078|FG003|Treatment Phase|Treatment Failure|0|||
143205982|NCT01075984|516300079|FG004|Treatment Phase|Treatment Failure|5|||
143205983|NCT01075984|516300075|FG000|Treatment Phase|Progression of disease|0|||
143205984|NCT01075984|516300076|FG001|Treatment Phase|Progression of disease|0|||
143205985|NCT01075984|516300077|FG002|Treatment Phase|Progression of disease|0|||
143205986|NCT01075984|516300078|FG003|Treatment Phase|Progression of disease|0|||
143205987|NCT01075984|516300079|FG004|Treatment Phase|Progression of disease|2|||
143205988|NCT01075984|516300075|FG000|Follow-up Phase|Protocol Violation|0|||
143205989|NCT01075984|516300076|FG001|Follow-up Phase|Protocol Violation|0|||
143205990|NCT01075984|516300077|FG002|Follow-up Phase|Protocol Violation|1|||
143205991|NCT01075984|516300078|FG003|Follow-up Phase|Protocol Violation|0|||
143205992|NCT01075984|516300079|FG004|Follow-up Phase|Protocol Violation|3|||
143205993|NCT01075984|516300075|FG000|Follow-up Phase|Adverse Event|0|||
143205994|NCT01075984|516300076|FG001|Follow-up Phase|Adverse Event|0|||
143205995|NCT01075984|516300077|FG002|Follow-up Phase|Adverse Event|0|||
143205996|NCT01075984|516300078|FG003|Follow-up Phase|Adverse Event|2|||
143205997|NCT01075984|516300079|FG004|Follow-up Phase|Adverse Event|27|||
143205998|NCT01075984|516300075|FG000|Follow-up Phase|Administrative|0|||
143205999|NCT01075984|516300076|FG001|Follow-up Phase|Administrative|0|||
143206000|NCT01075984|516300077|FG002|Follow-up Phase|Administrative|0|||
143206001|NCT01075984|516300078|FG003|Follow-up Phase|Administrative|0|||
143206002|NCT01075984|516300079|FG004|Follow-up Phase|Administrative|1|||
143206003|NCT01075984|516300075|FG000|Follow-up Phase|Withdrawal by Subject|0|||
143206004|NCT01075984|516300076|FG001|Follow-up Phase|Withdrawal by Subject|0|||
143206005|NCT01075984|516300077|FG002|Follow-up Phase|Withdrawal by Subject|0|||
143206006|NCT01075984|516300078|FG003|Follow-up Phase|Withdrawal by Subject|0|||
143206007|NCT01075984|516300079|FG004|Follow-up Phase|Withdrawal by Subject|10|||
143206008|NCT01075984|516300075|FG000|Follow-up Phase|Progression of disease|0|||
143206009|NCT01075984|516300076|FG001|Follow-up Phase|Progression of disease|0|||
143206010|NCT01075984|516300077|FG002|Follow-up Phase|Progression of disease|0|||
143206011|NCT01075984|516300078|FG003|Follow-up Phase|Progression of disease|0|||
143206012|NCT01075984|516300079|FG004|Follow-up Phase|Progression of disease|2|||
143206013|NCT01075984|516300075|FG000|Follow-up Phase|Treatment failure|0|||
143206014|NCT01075984|516300076|FG001|Follow-up Phase|Treatment failure|0|||
143263144|NCT00920829|516517481|FG000|Available for Analysis|Adverse Event|1|||
143206015|NCT01075984|516300077|FG002|Follow-up Phase|Treatment failure|0|||
143206016|NCT01075984|516300078|FG003|Follow-up Phase|Treatment failure|0|||
143206017|NCT01075984|516300079|FG004|Follow-up Phase|Treatment failure|4|||
143206018|NCT00483002|516300088|FG000|Overall Study|Adverse Event|68|||
143206019|NCT00483002|516300088|FG000|Overall Study|Lack of Efficacy|555|||
143206020|NCT00483002|516300088|FG000|Overall Study|Lost to Follow-up|962|||
143206021|NCT00483002|516300088|FG000|Overall Study|Other|2|||
143206022|NCT00483002|516300088|FG000|Overall Study|Other|967|||
143206023|NCT02014584|516300089|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
143206024|NCT02014584|516300090|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
143206025|NCT02014584|516300091|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
143206026|NCT02014584|516300092|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
143206027|NCT02014584|516300093|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
143206028|NCT02014584|516300094|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
143206029|NCT02014584|516300089|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
143206030|NCT02014584|516300090|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
143206031|NCT02014584|516300091|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
143206032|NCT02014584|516300092|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
143206033|NCT02014584|516300093|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
143206034|NCT02014584|516300094|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
143206035|NCT02014584|516300089|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
143206036|NCT02014584|516300090|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
143206037|NCT02014584|516300091|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
143206038|NCT02014584|516300092|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
143206039|NCT02014584|516300093|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
143206040|NCT02014584|516300094|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
143206041|NCT02014584|516300089|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
143206042|NCT02014584|516300090|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
143206043|NCT02014584|516300091|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
143206044|NCT02014584|516300092|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
143206045|NCT02014584|516300093|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
143206046|NCT02014584|516300094|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
143206047|NCT02014584|516300089|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
143206048|NCT02014584|516300090|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
143206049|NCT02014584|516300091|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
143206050|NCT02014584|516300092|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
143206051|NCT02014584|516300093|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
143206052|NCT02014584|516300094|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
143206053|NCT03442296|516300095|FG000|3 Month Follow-up|Death|3|||
143206054|NCT03442296|516300096|FG001|3 Month Follow-up|Death|1|||
143206055|NCT03442296|516300095|FG000|3 Month Follow-up|Lost to Follow-up|1|||
143206056|NCT03442296|516300096|FG001|3 Month Follow-up|Lost to Follow-up|1|||
143206057|NCT03442296|516300095|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
143206058|NCT03442296|516300096|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
143206059|NCT03442296|516300095|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
143206060|NCT03442296|516300096|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
143206061|NCT03442296|516300095|FG000|12 Month Follow-up|Incomplete measurement|1|||
143206062|NCT03442296|516300096|FG001|12 Month Follow-up|Incomplete measurement|1|||
143206063|NCT03684694|516300097|FG000|Phase 1|Withdrawal by Subject|1|||
143206064|NCT03684694|516300098|FG001|Phase 1|Withdrawal by Subject|0|||
143206065|NCT03684694|516300099|FG002|Phase 1|Withdrawal by Subject|0|||
143206066|NCT03684694|516300100|FG003|Phase 1|Withdrawal by Subject|0|||
143206067|NCT03684694|516300101|FG004|Phase 1|Withdrawal by Subject|0|||
143206068|NCT03684694|516300102|FG005|Phase 1|Withdrawal by Subject|0|||
143206069|NCT03684694|516300097|FG000|Phase 1|Investigator/Sponsor Decision|12|||
143206070|NCT03684694|516300098|FG001|Phase 1|Investigator/Sponsor Decision|2|||
143206071|NCT03684694|516300099|FG002|Phase 1|Investigator/Sponsor Decision|1|||
143206072|NCT03684694|516300100|FG003|Phase 1|Investigator/Sponsor Decision|0|||
143206073|NCT03684694|516300101|FG004|Phase 1|Investigator/Sponsor Decision|0|||
143206074|NCT03684694|516300102|FG005|Phase 1|Investigator/Sponsor Decision|0|||
143206075|NCT03684694|516300097|FG000|Phase 1|Death|24|||
143206076|NCT03684694|516300098|FG001|Phase 1|Death|0|||
143206077|NCT03684694|516300099|FG002|Phase 1|Death|3|||
143206078|NCT03684694|516300100|FG003|Phase 1|Death|0|||
143206079|NCT03684694|516300101|FG004|Phase 1|Death|0|||
143206080|NCT03684694|516300102|FG005|Phase 1|Death|0|||
143206081|NCT03684694|516300097|FG000|Phase 1|Lost to Follow-up|0|||
143206082|NCT03684694|516300098|FG001|Phase 1|Lost to Follow-up|0|||
143206083|NCT03684694|516300099|FG002|Phase 1|Lost to Follow-up|1|||
143206084|NCT03684694|516300100|FG003|Phase 1|Lost to Follow-up|0|||
143206085|NCT03684694|516300101|FG004|Phase 1|Lost to Follow-up|0|||
143206086|NCT03684694|516300102|FG005|Phase 1|Lost to Follow-up|0|||
143206087|NCT03684694|516300097|FG000|Phase 1|Miscellaneous|0|||
143206088|NCT03684694|516300098|FG001|Phase 1|Miscellaneous|1|||
143206089|NCT03684694|516300099|FG002|Phase 1|Miscellaneous|0|||
143206090|NCT03684694|516300100|FG003|Phase 1|Miscellaneous|0|||
143206091|NCT03684694|516300101|FG004|Phase 1|Miscellaneous|0|||
143206092|NCT03684694|516300102|FG005|Phase 1|Miscellaneous|0|||
143206093|NCT03684694|516300097|FG000|Phase 2|Withdrawal by Subject|0|||
143206094|NCT03684694|516300098|FG001|Phase 2|Withdrawal by Subject|0|||
143263145|NCT00920829|516517482|FG001|Available for Analysis|Adverse Event|2|||
143263146|NCT00920829|516517483|FG002|Available for Analysis|Adverse Event|1|||
143263147|NCT00920829|516517484|FG003|Available for Analysis|Adverse Event|0|||
143206095|NCT03684694|516300099|FG002|Phase 2|Withdrawal by Subject|0|||
143206096|NCT03684694|516300100|FG003|Phase 2|Withdrawal by Subject|0|||
143206097|NCT03684694|516300101|FG004|Phase 2|Withdrawal by Subject|0|||
143206098|NCT03684694|516300102|FG005|Phase 2|Withdrawal by Subject|1|||
143206099|NCT03684694|516300097|FG000|Phase 2|Investigator/Sponsor Decision|0|||
143206100|NCT03684694|516300098|FG001|Phase 2|Investigator/Sponsor Decision|0|||
143206101|NCT03684694|516300099|FG002|Phase 2|Investigator/Sponsor Decision|0|||
143206102|NCT03684694|516300100|FG003|Phase 2|Investigator/Sponsor Decision|17|||
143206103|NCT03684694|516300101|FG004|Phase 2|Investigator/Sponsor Decision|16|||
143206104|NCT03684694|516300102|FG005|Phase 2|Investigator/Sponsor Decision|6|||
143206105|NCT03684694|516300097|FG000|Phase 2|Death|0|||
143206106|NCT03684694|516300098|FG001|Phase 2|Death|0|||
143206107|NCT03684694|516300099|FG002|Phase 2|Death|0|||
143206108|NCT03684694|516300100|FG003|Phase 2|Death|28|||
143206109|NCT03684694|516300101|FG004|Phase 2|Death|14|||
143206110|NCT03684694|516300102|FG005|Phase 2|Death|3|||
143206111|NCT03684694|516300097|FG000|Phase 2|Lost to Follow-up|0|||
143206112|NCT03684694|516300098|FG001|Phase 2|Lost to Follow-up|0|||
143206113|NCT03684694|516300099|FG002|Phase 2|Lost to Follow-up|0|||
143206114|NCT03684694|516300100|FG003|Phase 2|Lost to Follow-up|1|||
143206115|NCT03684694|516300101|FG004|Phase 2|Lost to Follow-up|0|||
143206116|NCT03684694|516300102|FG005|Phase 2|Lost to Follow-up|0|||
143206117|NCT03684694|516300097|FG000|Phase 2|Miscellaneous|0|||
143206118|NCT03684694|516300098|FG001|Phase 2|Miscellaneous|0|||
143206119|NCT03684694|516300099|FG002|Phase 2|Miscellaneous|0|||
143206120|NCT03684694|516300100|FG003|Phase 2|Miscellaneous|3|||
143206121|NCT03684694|516300101|FG004|Phase 2|Miscellaneous|0|||
143206122|NCT03684694|516300102|FG005|Phase 2|Miscellaneous|0|||
143206123|NCT03495102|516301466|FG000|Overall Study|Adverse Event|5|||
143206124|NCT03495102|516301467|FG001|Overall Study|Adverse Event|7|||
143206125|NCT03495102|516301468|FG002|Overall Study|Adverse Event|10|||
143206126|NCT03495102|516301466|FG000|Overall Study|Death|3|||
143206127|NCT03495102|516301467|FG001|Overall Study|Death|4|||
143206128|NCT03495102|516301468|FG002|Overall Study|Death|4|||
143206129|NCT03495102|516301466|FG000|Overall Study|Lost to Follow-up|15|||
143206130|NCT03495102|516301467|FG001|Overall Study|Lost to Follow-up|16|||
143206131|NCT03495102|516301468|FG002|Overall Study|Lost to Follow-up|17|||
143206132|NCT03495102|516301466|FG000|Overall Study|Physician Decision|2|||
143206133|NCT03495102|516301467|FG001|Overall Study|Physician Decision|0|||
143206134|NCT03495102|516301468|FG002|Overall Study|Physician Decision|2|||
143206135|NCT03495102|516301466|FG000|Overall Study|Withdrawal by Subject|25|||
143206136|NCT03495102|516301467|FG001|Overall Study|Withdrawal by Subject|36|||
143206137|NCT03495102|516301468|FG002|Overall Study|Withdrawal by Subject|18|||
143206138|NCT03495102|516301466|FG000|Overall Study|Protocol Violation|1|||
143206139|NCT03495102|516301467|FG001|Overall Study|Protocol Violation|1|||
143206140|NCT03495102|516301468|FG002|Overall Study|Protocol Violation|0|||
143206141|NCT03495102|516301466|FG000|Overall Study|Site Closure|3|||
143206142|NCT03495102|516301467|FG001|Overall Study|Site Closure|1|||
143206143|NCT03495102|516301468|FG002|Overall Study|Site Closure|2|||
143206144|NCT03495102|516301466|FG000|Overall Study|Non-compliance|1|||
143206145|NCT03495102|516301467|FG001|Overall Study|Non-compliance|0|||
143206146|NCT03495102|516301468|FG002|Overall Study|Non-compliance|0|||
143206147|NCT03495102|516301466|FG000|Overall Study|Participant Duplicated at Another Site|0|||
143206148|NCT03495102|516301467|FG001|Overall Study|Participant Duplicated at Another Site|0|||
143263148|NCT00920829|516517481|FG000|Available for Analysis|Death|1|||
143206149|NCT03495102|516301468|FG002|Overall Study|Participant Duplicated at Another Site|1|||
143206150|NCT03495102|516301466|FG000|Overall Study|Primary Care Physician Recommendation|0|||
143206151|NCT03495102|516301467|FG001|Overall Study|Primary Care Physician Recommendation|1|||
143206152|NCT03495102|516301468|FG002|Overall Study|Primary Care Physician Recommendation|0|||
143206153|NCT03495102|516301466|FG000|Overall Study|Relocated to Another Country|0|||
143206154|NCT03495102|516301467|FG001|Overall Study|Relocated to Another Country|1|||
143206155|NCT03495102|516301468|FG002|Overall Study|Relocated to Another Country|0|||
143206156|NCT03495102|516301466|FG000|Overall Study|Participant was in Rehabilitation|1|||
143206157|NCT03495102|516301467|FG001|Overall Study|Participant was in Rehabilitation|0|||
143206158|NCT03495102|516301468|FG002|Overall Study|Participant was in Rehabilitation|0|||
143206159|NCT01161537|516301470|FG000|Part B|Withdrawal by Subject|2|||
143206160|NCT00358436|516301473|FG000|Overall Study|Adverse Event|29|||
143206161|NCT00358436|516301474|FG001|Overall Study|Adverse Event|13|||
143206162|NCT00358436|516301473|FG000|Overall Study|Lack of Efficacy|34|||
143206163|NCT00358436|516301474|FG001|Overall Study|Lack of Efficacy|36|||
143206164|NCT00358436|516301473|FG000|Overall Study|Lost to Follow-up|11|||
143206165|NCT00358436|516301474|FG001|Overall Study|Lost to Follow-up|6|||
143206166|NCT00358436|516301473|FG000|Overall Study|Protocol Violation|8|||
143206167|NCT00358436|516301474|FG001|Overall Study|Protocol Violation|3|||
143206168|NCT00358436|516301473|FG000|Overall Study|Withdrawal by Subject|40|||
143206169|NCT00358436|516301474|FG001|Overall Study|Withdrawal by Subject|17|||
143206170|NCT00358436|516301473|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
143206171|NCT00358436|516301474|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
143206172|NCT00358436|516301473|FG000|Overall Study|COPD exacerbation|22|||
143206173|NCT00358436|516301474|FG001|Overall Study|COPD exacerbation|10|||
143206174|NCT00358436|516301473|FG000|Overall Study|Other|6|||
143206175|NCT00358436|516301474|FG001|Overall Study|Other|1|||
143206176|NCT04327024|516301475|FG000|Overall Study|Death|1|||
143206177|NCT04327024|516301476|FG001|Overall Study|Death|2|||
143206178|NCT04327024|516301477|FG002|Overall Study|Death|1|||
143206179|NCT04327024|516301475|FG000|Overall Study|Non-compliance with study drug|0|||
143206180|NCT04327024|516301476|FG001|Overall Study|Non-compliance with study drug|1|||
143263149|NCT00920829|516517482|FG001|Available for Analysis|Death|0|||
143263150|NCT00920829|516517483|FG002|Available for Analysis|Death|0|||
143263151|NCT00920829|516517484|FG003|Available for Analysis|Death|0|||
143263152|NCT00920829|516517481|FG000|Available for Analysis|Protocol Violation|0|||
143263153|NCT00920829|516517482|FG001|Available for Analysis|Protocol Violation|0|||
143263154|NCT00920829|516517483|FG002|Available for Analysis|Protocol Violation|1|||
143263155|NCT00920829|516517484|FG003|Available for Analysis|Protocol Violation|0|||
143263156|NCT00920829|516517481|FG000|Available for Analysis|Required more treatment|0|||
143263157|NCT00920829|516517482|FG001|Available for Analysis|Required more treatment|2|||
143263158|NCT00920829|516517483|FG002|Available for Analysis|Required more treatment|0|||
143263159|NCT00920829|516517484|FG003|Available for Analysis|Required more treatment|1|||
143263160|NCT04123665|516517485|FG000|Overall Study|Withdrawal by Subject|7|||
143263161|NCT04123665|516517486|FG001|Overall Study|Withdrawal by Subject|0|||
143263162|NCT04123665|516517485|FG000|Overall Study|Lost to Follow-up|1|||
143263163|NCT04123665|516517486|FG001|Overall Study|Lost to Follow-up|0|||
143263164|NCT00053365|516517487|FG000|Overall Study|Incorrect cell type|1|||
143263165|NCT00053365|516517487|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
143263166|NCT00053365|516517487|FG000|Overall Study|Never treated|4|||
143263167|NCT03183778|516517490|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
143263168|NCT00721123|516517491|FG000|Overall Study|Adverse Event|96|||
143263169|NCT00721123|516517491|FG000|Overall Study|Death|10|||
143263170|NCT00721123|516517491|FG000|Overall Study|Insufficient Therapeutic Response|21|||
143263171|NCT00721123|516517491|FG000|Overall Study|Protocol Violation|1|||
143263172|NCT00721123|516517491|FG000|Overall Study|Refused Treatment|41|||
143206181|NCT04327024|516301477|FG002|Overall Study|Non-compliance with study drug|0|||
143206182|NCT04327024|516301475|FG000|Overall Study|Withdrawal by Subject|1|||
143206183|NCT04327024|516301476|FG001|Overall Study|Withdrawal by Subject|1|||
143206184|NCT04327024|516301477|FG002|Overall Study|Withdrawal by Subject|2|||
143206185|NCT03938324|516301480|FG000|Overall Study|Lost to Follow-up|42|||
143206186|NCT03938324|516301481|FG001|Overall Study|Lost to Follow-up|21|||
143206187|NCT03938324|516301480|FG000|Overall Study|Withdrawal by Subject|6|||
143263173|NCT00721123|516517491|FG000|Overall Study|Failure to Return|9|||
143206188|NCT03938324|516301481|FG001|Overall Study|Withdrawal by Subject|1|||
143263174|NCT00721123|516517491|FG000|Overall Study|Withdrawal by Subject|5|||
143263175|NCT03228420|516517497|FG000|Overall Study|Lost to Follow-up|5|||
143263176|NCT03228420|516517498|FG001|Overall Study|Lost to Follow-up|3|||
143206189|NCT00837759|516301482|FG000|Overall Study|Protocol Violation|3|||
143206190|NCT00837759|516301482|FG000|Overall Study|Lost to Follow-up|1|||
143263177|NCT03228420|516517497|FG000|Overall Study|Withdrawal by Subject|10|||
143263178|NCT03228420|516517498|FG001|Overall Study|Withdrawal by Subject|0|||
143206191|NCT01022424|516301483|FG000|Overall Study|Adverse Event|1|||
143206192|NCT01022424|516301483|FG000|Overall Study|Physician Decision|1|||
143206193|NCT01022424|516301483|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
143206194|NCT02100969|516301484|FG000|Overall Study|Did not pass screening phase|1|||
143206195|NCT03459365|516301485|FG000|Overall Study|Withdrawal by Subject|6|||
143206196|NCT03459365|516301485|FG000|Overall Study|Protocol Violation|8|||
143206197|NCT04037254|516301486|FG000|Overall Study|Protocol Violation|1|||
143206198|NCT04037254|516301487|FG001|Overall Study|Protocol Violation|0|||
143206199|NCT04037254|516301488|FG002|Overall Study|Protocol Violation|0|||
143206200|NCT04037254|516301489|FG003|Overall Study|Protocol Violation|0|||
143206201|NCT04037254|516301490|FG004|Overall Study|Protocol Violation|0|||
143206202|NCT04037254|516301486|FG000|Overall Study|Withdrawal by Subject|0|||
143206203|NCT04037254|516301487|FG001|Overall Study|Withdrawal by Subject|0|||
143206204|NCT04037254|516301488|FG002|Overall Study|Withdrawal by Subject|1|||
143206205|NCT04037254|516301489|FG003|Overall Study|Withdrawal by Subject|0|||
143206206|NCT04037254|516301490|FG004|Overall Study|Withdrawal by Subject|0|||
143206207|NCT04037254|516301486|FG000|Overall Study|Delayed or incomplete treatment|0|||
143206208|NCT04037254|516301487|FG001|Overall Study|Delayed or incomplete treatment|2|||
143206209|NCT04037254|516301488|FG002|Overall Study|Delayed or incomplete treatment|1|||
143206210|NCT04037254|516301489|FG003|Overall Study|Delayed or incomplete treatment|0|||
143206211|NCT04037254|516301490|FG004|Overall Study|Delayed or incomplete treatment|0|||
143206212|NCT03320330|516301491|FG000|Overall Study|Lack of Efficacy|5|||
143206213|NCT03320330|516301492|FG001|Overall Study|Lack of Efficacy|5|||
143206214|NCT03320330|516301493|FG002|Overall Study|Lack of Efficacy|14|||
143206215|NCT03320330|516301491|FG000|Overall Study|Physician Decision|1|||
143206216|NCT03320330|516301492|FG001|Overall Study|Physician Decision|0|||
143206217|NCT03320330|516301493|FG002|Overall Study|Physician Decision|0|||
143206218|NCT02198794|516301494|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
143206219|NCT02198794|516301495|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
143206220|NCT02198794|516301496|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
143206221|NCT02198794|516301497|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
143206222|NCT02198794|516301494|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
143206223|NCT02198794|516301495|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
143206224|NCT02198794|516301496|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
143206225|NCT02198794|516301497|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
143206226|NCT02198794|516301494|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
143206227|NCT02198794|516301495|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
143206228|NCT02198794|516301496|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
143206229|NCT02198794|516301497|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
143206230|NCT02198794|516301494|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
143206231|NCT02198794|516301495|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
143206232|NCT02198794|516301496|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
143206233|NCT02198794|516301497|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
143206234|NCT02198794|516301494|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
143206235|NCT02198794|516301495|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
143206236|NCT02198794|516301496|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
143206237|NCT02198794|516301497|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
143206238|NCT02198794|516301494|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
143206239|NCT02198794|516301495|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
143206240|NCT02198794|516301496|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
143206241|NCT02198794|516301497|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
143206242|NCT02198794|516301494|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
143206243|NCT02198794|516301495|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
143206244|NCT02198794|516301496|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
143206245|NCT02198794|516301497|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
143206246|NCT02198794|516301494|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
143206247|NCT02198794|516301495|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
143206248|NCT02198794|516301496|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
143206249|NCT02198794|516301497|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
143206250|NCT02198794|516301494|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
143206251|NCT02198794|516301495|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
143206252|NCT02198794|516301496|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
143206253|NCT02198794|516301497|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
143206254|NCT02198794|516301494|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
143263179|NCT03228420|516517497|FG000|Overall Study|Adverse Event|5|||
143206255|NCT02198794|516301495|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
143206256|NCT02198794|516301496|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
143206257|NCT02198794|516301497|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
143206258|NCT02198794|516301494|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
143206259|NCT02198794|516301495|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
143263180|NCT03228420|516517498|FG001|Overall Study|Adverse Event|2|||
143206260|NCT02198794|516301496|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
143206261|NCT02198794|516301497|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
143206262|NCT02198794|516301494|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
143206263|NCT02198794|516301495|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
143206264|NCT02198794|516301496|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
143206265|NCT02198794|516301497|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
143206266|NCT02198794|516301494|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
143206267|NCT02198794|516301495|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
143206268|NCT02198794|516301496|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
143206269|NCT02198794|516301497|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
143206270|NCT02198794|516301494|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
143206271|NCT02198794|516301495|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
143206272|NCT02198794|516301496|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
143206273|NCT02198794|516301497|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
143206274|NCT02198794|516301494|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
143206275|NCT02198794|516301495|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
143206276|NCT02198794|516301496|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
143206277|NCT02198794|516301497|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
143206278|NCT05063539|516301499|FG000|Overall Study|Adverse Event|1|||
143206279|NCT05063539|516301500|FG001|Overall Study|Adverse Event|2|||
143206280|NCT05063539|516301501|FG002|Overall Study|Adverse Event|1|||
143206281|NCT05063539|516301499|FG000|Overall Study|Death|0|||
143206282|NCT05063539|516301500|FG001|Overall Study|Death|1|||
143206283|NCT05063539|516301501|FG002|Overall Study|Death|1|||
143206284|NCT05063539|516301499|FG000|Overall Study|Lost to Follow-up|0|||
143206285|NCT05063539|516301500|FG001|Overall Study|Lost to Follow-up|1|||
143206286|NCT05063539|516301501|FG002|Overall Study|Lost to Follow-up|0|||
143206287|NCT05063539|516301499|FG000|Overall Study|Physician Decision|4|||
143206288|NCT05063539|516301500|FG001|Overall Study|Physician Decision|3|||
143206289|NCT05063539|516301501|FG002|Overall Study|Physician Decision|1|||
143206290|NCT05063539|516301499|FG000|Overall Study|Progressive Disease|0|||
143206291|NCT05063539|516301500|FG001|Overall Study|Progressive Disease|2|||
143206292|NCT05063539|516301501|FG002|Overall Study|Progressive Disease|0|||
143206293|NCT05063539|516301499|FG000|Overall Study|Withdrawal by Subject|17|||
143206294|NCT05063539|516301500|FG001|Overall Study|Withdrawal by Subject|26|||
143206295|NCT05063539|516301501|FG002|Overall Study|Withdrawal by Subject|14|||
143206296|NCT05063539|516301499|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
143206297|NCT05063539|516301500|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
143206298|NCT05063539|516301501|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|0|||
143206299|NCT05063539|516301499|FG000|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|1|||
143206300|NCT05063539|516301500|FG001|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
143206301|NCT05063539|516301501|FG002|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
143206302|NCT05063539|516301499|FG000|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
143206303|NCT05063539|516301500|FG001|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
143206304|NCT05063539|516301501|FG002|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|1|||
143206305|NCT05063539|516301499|FG000|Overall Study|Discontinued due to Common Close Design|0|||
143206306|NCT05063539|516301500|FG001|Overall Study|Discontinued due to Common Close Design|1|||
143206307|NCT05063539|516301501|FG002|Overall Study|Discontinued due to Common Close Design|0|||
143206308|NCT05063539|516301499|FG000|Overall Study|Participant not co-operative|0|||
143206309|NCT05063539|516301500|FG001|Overall Study|Participant not co-operative|1|||
143206310|NCT05063539|516301501|FG002|Overall Study|Participant not co-operative|0|||
143206311|NCT05063539|516301499|FG000|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
143206312|NCT05063539|516301500|FG001|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
143206313|NCT05063539|516301501|FG002|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|1|||
143206314|NCT05063539|516301499|FG000|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
143206315|NCT05063539|516301500|FG001|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|1|||
143206316|NCT05063539|516301501|FG002|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
143206317|NCT03344172|516301503|FG000|Overall Study|Received <1 dose of treatment|1|||
143206318|NCT03344172|516301504|FG001|Overall Study|Received <1 dose of treatment|0|||
143263181|NCT03954041|516517501|FG000|Overall Study|Lost to Follow-up|3|||
143263182|NCT03954041|516517502|FG001|Overall Study|Lost to Follow-up|3|||
143263183|NCT03954041|516517503|FG002|Overall Study|Lost to Follow-up|6|||
143206319|NCT00680368|516301505|FG000|Overall Study|not supervised, not eligible|15|||
143206320|NCT00483041|516301506|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
143263184|NCT03954041|516517501|FG000|Overall Study|Death|4|||
143263185|NCT03954041|516517502|FG001|Overall Study|Death|0|||
143206321|NCT00483041|516301507|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
143206322|NCT03779503|516301508|FG000|First Intervention|Adverse Event|0|||
143206323|NCT03779503|516301509|FG001|First Intervention|Adverse Event|1|||
143206324|NCT03779503|516301508|FG000|First Intervention|Withdrawal by Subject|1|||
143206325|NCT03779503|516301509|FG001|First Intervention|Withdrawal by Subject|0|||
143206326|NCT00864851|516301510|FG000|Overall Study|Withdrawal by Subject|0|||
143206327|NCT00864851|516301511|FG001|Overall Study|Withdrawal by Subject|1|||
143206328|NCT00864851|516301512|FG002|Overall Study|Withdrawal by Subject|0|||
143206329|NCT00864851|516301510|FG000|Overall Study|Physician Decision|1|||
143206330|NCT00864851|516301511|FG001|Overall Study|Physician Decision|0|||
143206331|NCT00864851|516301512|FG002|Overall Study|Physician Decision|0|||
143206332|NCT00864851|516301510|FG000|Overall Study|Death|1|||
143206333|NCT00864851|516301511|FG001|Overall Study|Death|0|||
143206334|NCT00864851|516301512|FG002|Overall Study|Death|0|||
143206335|NCT00864851|516301510|FG000|Overall Study|Patient uncooperative|1|||
143206336|NCT00864851|516301511|FG001|Overall Study|Patient uncooperative|0|||
143206337|NCT00864851|516301512|FG002|Overall Study|Patient uncooperative|0|||
143206338|NCT02771626|516301513|FG000|Overall Study|Adverse Event|1|||
143206339|NCT02771626|516301514|FG001|Overall Study|Adverse Event|5|||
143206340|NCT02771626|516301515|FG002|Overall Study|Adverse Event|3|||
143206341|NCT02771626|516301516|FG003|Overall Study|Adverse Event|0|||
143206342|NCT02771626|516301517|FG004|Overall Study|Adverse Event|1|||
143206343|NCT02771626|516301518|FG005|Overall Study|Adverse Event|1|||
143206344|NCT02771626|516301513|FG000|Overall Study|Radiologic Disease Progression|6|||
143206345|NCT02771626|516301514|FG001|Overall Study|Radiologic Disease Progression|13|||
143206346|NCT02771626|516301515|FG002|Overall Study|Radiologic Disease Progression|10|||
143206347|NCT02771626|516301516|FG003|Overall Study|Radiologic Disease Progression|7|||
143206348|NCT02771626|516301517|FG004|Overall Study|Radiologic Disease Progression|28|||
143206349|NCT02771626|516301518|FG005|Overall Study|Radiologic Disease Progression|15|||
143206350|NCT02771626|516301513|FG000|Overall Study|Symptomatic Deterioration|0|||
143206351|NCT02771626|516301514|FG001|Overall Study|Symptomatic Deterioration|4|||
143206352|NCT02771626|516301515|FG002|Overall Study|Symptomatic Deterioration|2|||
143206353|NCT02771626|516301516|FG003|Overall Study|Symptomatic Deterioration|0|||
143206354|NCT02771626|516301517|FG004|Overall Study|Symptomatic Deterioration|5|||
143206355|NCT02771626|516301518|FG005|Overall Study|Symptomatic Deterioration|2|||
143206356|NCT02771626|516301513|FG000|Overall Study|Participant Request|0|||
143263186|NCT03954041|516517503|FG002|Overall Study|Death|1|||
143263187|NCT03954041|516517501|FG000|Overall Study|Death by neurologic criteria|0|||
143263188|NCT03954041|516517502|FG001|Overall Study|Death by neurologic criteria|0|||
143263189|NCT03954041|516517503|FG002|Overall Study|Death by neurologic criteria|1|||
143263190|NCT03954041|516517501|FG000|Overall Study|Reason not specified|7|||
143206357|NCT02771626|516301514|FG001|Overall Study|Participant Request|1|||
143206358|NCT02771626|516301515|FG002|Overall Study|Participant Request|0|||
143206359|NCT02771626|516301516|FG003|Overall Study|Participant Request|2|||
143263191|NCT03954041|516517502|FG001|Overall Study|Reason not specified|4|||
143263192|NCT03954041|516517503|FG002|Overall Study|Reason not specified|2|||
143263193|NCT03954041|516517501|FG000|Overall Study|Withdrew prior to dosing|4|||
143263194|NCT03954041|516517502|FG001|Overall Study|Withdrew prior to dosing|2|||
143263195|NCT03954041|516517503|FG002|Overall Study|Withdrew prior to dosing|0|||
143263196|NCT02742246|516517506|FG000|Overall Study|Never initiated treatment|5|||
143263197|NCT02742246|516517507|FG001|Overall Study|Never initiated treatment|3|||
143263198|NCT02742246|516517508|FG002|Overall Study|Never initiated treatment|1|||
143263199|NCT02742246|516517506|FG000|Overall Study|dropped out during treatment|7|||
143263200|NCT02742246|516517507|FG001|Overall Study|dropped out during treatment|13|||
143206360|NCT02771626|516301517|FG004|Overall Study|Participant Request|0|||
143206361|NCT02771626|516301518|FG005|Overall Study|Participant Request|1|||
143206362|NCT02771626|516301513|FG000|Overall Study|Investigator Decision|0|||
143206363|NCT02771626|516301514|FG001|Overall Study|Investigator Decision|1|||
143263201|NCT02742246|516517508|FG002|Overall Study|dropped out during treatment|10|||
143206364|NCT02771626|516301515|FG002|Overall Study|Investigator Decision|0|||
143206365|NCT02771626|516301516|FG003|Overall Study|Investigator Decision|0|||
143206366|NCT02771626|516301517|FG004|Overall Study|Investigator Decision|1|||
143206367|NCT02771626|516301518|FG005|Overall Study|Investigator Decision|0|||
143263202|NCT02742246|516517506|FG000|Overall Study|Death|1|||
143263203|NCT02742246|516517507|FG001|Overall Study|Death|0|||
143263204|NCT02742246|516517508|FG002|Overall Study|Death|0|||
143263205|NCT00054717|516517510|FG000|Overall Study|Randomized but not treated|2|||
143206368|NCT02771626|516301513|FG000|Overall Study|Study Termination by Sponsor|0|||
143206369|NCT02771626|516301514|FG001|Overall Study|Study Termination by Sponsor|2|||
143206370|NCT02771626|516301515|FG002|Overall Study|Study Termination by Sponsor|1|||
143206371|NCT02771626|516301516|FG003|Overall Study|Study Termination by Sponsor|0|||
143206372|NCT02771626|516301517|FG004|Overall Study|Study Termination by Sponsor|1|||
143206373|NCT02771626|516301518|FG005|Overall Study|Study Termination by Sponsor|0|||
143206374|NCT02771626|516301513|FG000|Overall Study|Informed Consent Withdrawn|0|||
143206375|NCT02771626|516301514|FG001|Overall Study|Informed Consent Withdrawn|0|||
143206376|NCT02771626|516301515|FG002|Overall Study|Informed Consent Withdrawn|1|||
143206377|NCT02771626|516301516|FG003|Overall Study|Informed Consent Withdrawn|0|||
143206378|NCT02771626|516301517|FG004|Overall Study|Informed Consent Withdrawn|1|||
143206379|NCT02771626|516301518|FG005|Overall Study|Informed Consent Withdrawn|1|||
143206380|NCT02771626|516301513|FG000|Overall Study|Other, Not Specified|1|||
143206381|NCT02771626|516301514|FG001|Overall Study|Other, Not Specified|0|||
143206382|NCT02771626|516301515|FG002|Overall Study|Other, Not Specified|0|||
143206383|NCT02771626|516301516|FG003|Overall Study|Other, Not Specified|0|||
143206384|NCT02771626|516301517|FG004|Overall Study|Other, Not Specified|0|||
143206385|NCT02771626|516301518|FG005|Overall Study|Other, Not Specified|1|||
143206386|NCT01754194|516301519|FG000|Overall Study|Lost to Follow-up|39|||
143206387|NCT01754194|516301520|FG001|Overall Study|Lost to Follow-up|14|||
143206388|NCT01754194|516301519|FG000|Overall Study|Withdrawal by Subject|4|||
143206389|NCT01754194|516301520|FG001|Overall Study|Withdrawal by Subject|5|||
143206390|NCT01754194|516301519|FG000|Overall Study|Other|9|||
143206391|NCT01754194|516301520|FG001|Overall Study|Other|8|||
143206392|NCT02392403|516301521|FG000|Overall Study|Adverse Event|1|||
143206393|NCT02392403|516301521|FG000|Overall Study|Death|1|||
143206394|NCT02392403|516301521|FG000|Overall Study|Withdrawal by Subject|1|||
143206395|NCT03344640|516301522|FG000|Overall Study|Adverse Event|1|||
143206396|NCT03344640|516301523|FG001|Overall Study|Adverse Event|0|||
143206397|NCT03344640|516301522|FG000|Overall Study|Physician Decision|1|||
143206398|NCT03344640|516301523|FG001|Overall Study|Physician Decision|1|||
143206399|NCT03344640|516301522|FG000|Overall Study|Withdrawal by Subject|1|||
143206400|NCT03344640|516301523|FG001|Overall Study|Withdrawal by Subject|2|||
143206401|NCT03344640|516301522|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
143206402|NCT03344640|516301523|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
143206403|NCT02776033|516301524|FG000|Overall Study|Withdrawal by Subject|0|||
143206404|NCT02776033|516301525|FG001|Overall Study|Withdrawal by Subject|0|||
143206405|NCT02776033|516301526|FG002|Overall Study|Withdrawal by Subject|2|||
143206406|NCT02776033|516301524|FG000|Overall Study|Physician Decision|2|||
143206407|NCT02776033|516301525|FG001|Overall Study|Physician Decision|0|||
143206408|NCT02776033|516301526|FG002|Overall Study|Physician Decision|0|||
143206409|NCT02776033|516301524|FG000|Overall Study|Lost to Follow-up|1|||
143206410|NCT02776033|516301525|FG001|Overall Study|Lost to Follow-up|0|||
143206411|NCT02776033|516301526|FG002|Overall Study|Lost to Follow-up|0|||
143206412|NCT02776033|516301524|FG000|Overall Study|Adverse Event|1|||
143206413|NCT02776033|516301525|FG001|Overall Study|Adverse Event|2|||
143206414|NCT02776033|516301526|FG002|Overall Study|Adverse Event|0|||
143206415|NCT00657371|516301530|FG000|Overall Study|Poor bowel preparation|15|||
143206416|NCT00657371|516301530|FG000|Overall Study|Unable to intubate the cecum|5|||
143206417|NCT00657371|516301530|FG000|Overall Study|Protocol Violation|2|||
143206418|NCT00657371|516301530|FG000|Overall Study|Device- related reasons|13|||
143206419|NCT00657371|516301530|FG000|Overall Study|Pre-existing medical condition|4|||
143206420|NCT01943552|516301536|FG000|Overall Study|Adverse Event|3|||
143206421|NCT01943552|516301537|FG001|Overall Study|Adverse Event|2|||
143206422|NCT01943552|516301536|FG000|Overall Study|Withdrawal by Subject|6|||
143206423|NCT01943552|516301537|FG001|Overall Study|Withdrawal by Subject|6|||
143206424|NCT01943552|516301536|FG000|Overall Study|Other Reasons|16|||
143370399|NCT04771273|516899186|FG003|Dose Escalation Period|Adverse Event|2|||
143206425|NCT01943552|516301537|FG001|Overall Study|Other Reasons|17|||
143206426|NCT01600053|516301538|FG000|Overall Study|Adverse Event|2|||
143206427|NCT01600053|516301538|FG000|Overall Study|trial will not meet the interim endpoint|9|||
143206428|NCT02715726|516301539|FG000|Overall Study|Adverse Event|2|||
143206429|NCT02715726|516301540|FG001|Overall Study|Adverse Event|6|||
143206430|NCT02715726|516301539|FG000|Overall Study|Protocol Violation|1|||
143206431|NCT02715726|516301540|FG001|Overall Study|Protocol Violation|0|||
143206432|NCT02715726|516301539|FG000|Overall Study|Death|2|||
143206433|NCT02715726|516301540|FG001|Overall Study|Death|1|||
143206434|NCT02715726|516301539|FG000|Overall Study|Participant moved|1|||
143206435|NCT02715726|516301540|FG001|Overall Study|Participant moved|3|||
143206436|NCT02715726|516301539|FG000|Overall Study|Other than specified above|11|||
143206437|NCT02715726|516301540|FG001|Overall Study|Other than specified above|15|||
143206438|NCT02715726|516301539|FG000|Overall Study|Randomized but not treated|1|||
143206439|NCT02715726|516301540|FG001|Overall Study|Randomized but not treated|2|||
143263206|NCT00054717|516517511|FG001|Overall Study|Randomized but not treated|8|||
143263207|NCT00054717|516517510|FG000|Overall Study|Adverse Event|70|||
143263208|NCT00054717|516517511|FG001|Overall Study|Adverse Event|22|||
143263209|NCT00054717|516517510|FG000|Overall Study|Protocol Violation|18|||
143263210|NCT00054717|516517511|FG001|Overall Study|Protocol Violation|19|||
143263211|NCT00054717|516517510|FG000|Overall Study|Lost to Follow-up|23|||
143263212|NCT00054717|516517511|FG001|Overall Study|Lost to Follow-up|13|||
143263213|NCT00054717|516517510|FG000|Overall Study|Withdrawal by Subject|32|||
143263214|NCT00054717|516517511|FG001|Overall Study|Withdrawal by Subject|20|||
143263215|NCT00054717|516517510|FG000|Overall Study|Other reason not defined above|117|||
143263216|NCT00054717|516517511|FG001|Overall Study|Other reason not defined above|217|||
143263217|NCT03139604|516517514|FG000|Overall Study|Other|7|||
143263218|NCT03139604|516517515|FG001|Overall Study|Other|3|||
143263219|NCT03139604|516517514|FG000|Overall Study|Withdrawal by Subject|16|||
143263220|NCT03139604|516517515|FG001|Overall Study|Withdrawal by Subject|17|||
143263221|NCT03139604|516517514|FG000|Overall Study|Physician Decision|1|||
143263222|NCT03139604|516517515|FG001|Overall Study|Physician Decision|2|||
143263223|NCT03139604|516517514|FG000|Overall Study|Lost to Follow-up|3|||
143263224|NCT03139604|516517515|FG001|Overall Study|Lost to Follow-up|1|||
143263225|NCT03139604|516517514|FG000|Overall Study|Death|65|||
143263226|NCT03139604|516517515|FG001|Overall Study|Death|67|||
143263227|NCT03139604|516517514|FG000|Overall Study|Study Terminated by Sponsor|122|||
143263228|NCT03139604|516517515|FG001|Overall Study|Study Terminated by Sponsor|127|||
143263229|NCT03139604|516517514|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
143263230|NCT03139604|516517515|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
143263231|NCT02806973|516517517|FG000|Period 1|Withdrawal by Subject|0|||
143263232|NCT02806973|516517518|FG001|Period 1|Withdrawal by Subject|2|||
143263233|NCT02806973|516517519|FG002|Period 1|Withdrawal by Subject|1|||
143206440|NCT01177969|516301541|FG000|Overall Study|Protocol Violation|2|||
143206441|NCT01177969|516301542|FG001|Overall Study|Protocol Violation|1|||
143206442|NCT01177969|516301541|FG000|Overall Study|Withdrawal by Subject|1|||
143206443|NCT01177969|516301542|FG001|Overall Study|Withdrawal by Subject|2|||
143206444|NCT01639755|516301543|FG000|Overall Study|Study Ongoing|15|||
143206445|NCT01639755|516301543|FG000|Overall Study|Patient had device explantation|4|||
143206446|NCT03263780|516301551|FG000|Overall Study|Withdrawal by Subject|3|||
143206447|NCT03263780|516301551|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
143206448|NCT01264770|516301556|FG000|Overall Study|Not reported|0|||
143206449|NCT01264770|516301557|FG001|Overall Study|Not reported|0|||
143206450|NCT01264770|516301558|FG002|Overall Study|Not reported|1|||
143206451|NCT01264770|516301559|FG003|Overall Study|Not reported|0|||
143206452|NCT01264770|516301560|FG004|Overall Study|Not reported|0|||
143206453|NCT01264770|516301561|FG005|Overall Study|Not reported|0|||
143206454|NCT01264770|516301556|FG000|Overall Study|e.g., change in circumstances|8|||
143206455|NCT01264770|516301557|FG001|Overall Study|e.g., change in circumstances|3|||
143206456|NCT01264770|516301558|FG002|Overall Study|e.g., change in circumstances|3|||
143206457|NCT01264770|516301559|FG003|Overall Study|e.g., change in circumstances|3|||
143206458|NCT01264770|516301560|FG004|Overall Study|e.g., change in circumstances|4|||
143206459|NCT01264770|516301561|FG005|Overall Study|e.g., change in circumstances|4|||
143206460|NCT01264770|516301556|FG000|Overall Study|Severe non-compliance to protocol|0|||
143206461|NCT01264770|516301557|FG001|Overall Study|Severe non-compliance to protocol|0|||
143206462|NCT01264770|516301558|FG002|Overall Study|Severe non-compliance to protocol|1|||
143206463|NCT01264770|516301559|FG003|Overall Study|Severe non-compliance to protocol|1|||
143206464|NCT01264770|516301560|FG004|Overall Study|Severe non-compliance to protocol|0|||
143206465|NCT01264770|516301561|FG005|Overall Study|Severe non-compliance to protocol|0|||
143206466|NCT01264770|516301556|FG000|Overall Study|Lack of therapeutic response|1|||
143206467|NCT01264770|516301557|FG001|Overall Study|Lack of therapeutic response|0|||
143206468|NCT01264770|516301558|FG002|Overall Study|Lack of therapeutic response|2|||
143206469|NCT01264770|516301559|FG003|Overall Study|Lack of therapeutic response|1|||
143206470|NCT01264770|516301560|FG004|Overall Study|Lack of therapeutic response|1|||
143206471|NCT01264770|516301561|FG005|Overall Study|Lack of therapeutic response|0|||
143206472|NCT01264770|516301556|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
143206473|NCT01264770|516301557|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
143206474|NCT01264770|516301558|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
143206475|NCT01264770|516301559|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
143263234|NCT02806973|516517520|FG003|Period 1|Withdrawal by Subject|1|||
143263235|NCT02806973|516517517|FG000|Period 1|Adverse Event|0|||
143263236|NCT02806973|516517518|FG001|Period 1|Adverse Event|0|||
143263237|NCT02806973|516517519|FG002|Period 1|Adverse Event|0|||
143263238|NCT02806973|516517520|FG003|Period 1|Adverse Event|1|||
143263239|NCT02806973|516517517|FG000|Period 3|Withdrawal by Subject|0|||
143206476|NCT01264770|516301560|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
143263240|NCT02806973|516517518|FG001|Period 3|Withdrawal by Subject|0|||
143263241|NCT02806973|516517519|FG002|Period 3|Withdrawal by Subject|0|||
143206477|NCT01264770|516301561|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
143206478|NCT01264770|516301556|FG000|Overall Study|Lost to Follow-up|0|||
143206479|NCT01264770|516301557|FG001|Overall Study|Lost to Follow-up|0|||
143206480|NCT01264770|516301558|FG002|Overall Study|Lost to Follow-up|1|||
143206481|NCT01264770|516301559|FG003|Overall Study|Lost to Follow-up|1|||
143206482|NCT01264770|516301560|FG004|Overall Study|Lost to Follow-up|0|||
143206483|NCT01264770|516301561|FG005|Overall Study|Lost to Follow-up|0|||
143206484|NCT01264770|516301556|FG000|Overall Study|Adverse Event|7|||
143206485|NCT01264770|516301557|FG001|Overall Study|Adverse Event|7|||
143206486|NCT01264770|516301558|FG002|Overall Study|Adverse Event|8|||
143206487|NCT01264770|516301559|FG003|Overall Study|Adverse Event|0|||
143206488|NCT01264770|516301560|FG004|Overall Study|Adverse Event|2|||
143206489|NCT01264770|516301561|FG005|Overall Study|Adverse Event|1|||
143206490|NCT01455220|516301563|FG000|Overall Study|screen fail|30|||
143206491|NCT00267150|516301564|FG000|Overall Study|Adverse Event|1|||
143206492|NCT04881747|516301565|FG000|Period 2 Washout|Adverse Event|1|||
143206493|NCT04881747|516301566|FG001|Period 2 Washout|Adverse Event|0|||
143206494|NCT04881747|516301567|FG002|Period 2 Washout|Adverse Event|0|||
143206495|NCT04881747|516301568|FG003|Period 2 Washout|Adverse Event|0|||
143206496|NCT04881747|516301569|FG004|Period 2 Washout|Adverse Event|1|||
143206497|NCT04881747|516301570|FG005|Period 2 Washout|Adverse Event|0|||
143206498|NCT04881747|516301565|FG000|Period 2 Washout|Withdrawal by Subject|1|||
143206499|NCT04881747|516301566|FG001|Period 2 Washout|Withdrawal by Subject|0|||
143206500|NCT04881747|516301567|FG002|Period 2 Washout|Withdrawal by Subject|0|||
143206501|NCT04881747|516301568|FG003|Period 2 Washout|Withdrawal by Subject|1|||
143206502|NCT04881747|516301569|FG004|Period 2 Washout|Withdrawal by Subject|0|||
143206503|NCT04881747|516301570|FG005|Period 2 Washout|Withdrawal by Subject|0|||
143206504|NCT00521222|516301572|FG000|Overall Study|Lost to Follow-up|0|||
143206505|NCT00521222|516301573|FG001|Overall Study|Lost to Follow-up|0|||
143206506|NCT00521222|516301574|FG002|Overall Study|Lost to Follow-up|1|||
143206507|NCT00521222|516301575|FG003|Overall Study|Lost to Follow-up|1|||
143206508|NCT00521222|516301572|FG000|Overall Study|Withdrawal by Subject|0|||
143206509|NCT00521222|516301573|FG001|Overall Study|Withdrawal by Subject|0|||
143206510|NCT00521222|516301574|FG002|Overall Study|Withdrawal by Subject|2|||
143206511|NCT00521222|516301575|FG003|Overall Study|Withdrawal by Subject|0|||
143206512|NCT00521222|516301572|FG000|Overall Study|Physician Decision|0|||
143206513|NCT00521222|516301573|FG001|Overall Study|Physician Decision|1|||
143206514|NCT00521222|516301574|FG002|Overall Study|Physician Decision|0|||
143206515|NCT00521222|516301575|FG003|Overall Study|Physician Decision|1|||
143206516|NCT00637572|516301576|FG000|Overall Study|Adverse Event|1|||
143206517|NCT00637572|516301577|FG001|Overall Study|Adverse Event|2|||
143206518|NCT00637572|516301576|FG000|Overall Study|Death|0|||
143206519|NCT00637572|516301577|FG001|Overall Study|Death|1|||
143206520|NCT00637572|516301576|FG000|Overall Study|Lost to Follow-up|0|||
143206521|NCT00637572|516301577|FG001|Overall Study|Lost to Follow-up|1|||
143206522|NCT00637572|516301576|FG000|Overall Study|Physician Decision|1|||
143206523|NCT00637572|516301577|FG001|Overall Study|Physician Decision|1|||
143206524|NCT00637572|516301576|FG000|Overall Study|Withdrawal by Subject|0|||
143206525|NCT00637572|516301577|FG001|Overall Study|Withdrawal by Subject|2|||
143206526|NCT00637572|516301576|FG000|Overall Study|Illicit Drug Use|1|||
143206527|NCT00637572|516301577|FG001|Overall Study|Illicit Drug Use|0|||
143206528|NCT01403116|516301581|FG000|Overall Study|Adverse Event|7|||
143206529|NCT01403116|516301582|FG001|Overall Study|Adverse Event|4|||
143206530|NCT01403116|516301581|FG000|Overall Study|Lost to Follow-up|7|||
143206531|NCT01403116|516301582|FG001|Overall Study|Lost to Follow-up|5|||
143206532|NCT01403116|516301581|FG000|Overall Study|Withdrawal by Subject|12|||
143206533|NCT01403116|516301582|FG001|Overall Study|Withdrawal by Subject|15|||
143206534|NCT01403116|516301581|FG000|Overall Study|Non-compliance of study drug|3|||
143206535|NCT01403116|516301582|FG001|Overall Study|Non-compliance of study drug|0|||
143206536|NCT01403116|516301581|FG000|Overall Study|Protocol Violation|0|||
143206537|NCT01403116|516301582|FG001|Overall Study|Protocol Violation|1|||
143206538|NCT01403116|516301581|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
143206539|NCT01403116|516301582|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
143206540|NCT01403116|516301581|FG000|Overall Study|Hct >54%|2|||
143206541|NCT01403116|516301582|FG001|Overall Study|Hct >54%|0|||
143206542|NCT01403116|516301581|FG000|Overall Study|unable to keep appointments|0|||
143206543|NCT01403116|516301582|FG001|Overall Study|unable to keep appointments|2|||
143206544|NCT00752726|516301583|FG000|Overall Study|Lost to Follow-up|2|||
143263242|NCT02806973|516517520|FG003|Period 3|Withdrawal by Subject|3|||
143206545|NCT00752726|516301584|FG001|Overall Study|Lost to Follow-up|1|||
143206546|NCT00752726|516301583|FG000|Overall Study|Adverse Event|3|||
143206547|NCT00752726|516301584|FG001|Overall Study|Adverse Event|0|||
143206548|NCT00752726|516301583|FG000|Overall Study|Withdrawal by Subject|5|||
143206549|NCT00752726|516301584|FG001|Overall Study|Withdrawal by Subject|10|||
143206550|NCT00752726|516301583|FG000|Overall Study|Other Reason|1|||
143206551|NCT00752726|516301584|FG001|Overall Study|Other Reason|2|||
143206552|NCT01895309|516301585|FG000|Overall Study|Adverse Event|13|||
143206553|NCT01895309|516301586|FG001|Overall Study|Adverse Event|17|||
143206554|NCT01895309|516301585|FG000|Overall Study|Protocol Violation|1|||
143206555|NCT01895309|516301586|FG001|Overall Study|Protocol Violation|0|||
143206556|NCT01895309|516301585|FG000|Overall Study|Lack of Efficacy|1|||
143206557|NCT01895309|516301586|FG001|Overall Study|Lack of Efficacy|3|||
143206558|NCT01895309|516301585|FG000|Overall Study|Lost to Follow-up|1|||
143206559|NCT01895309|516301586|FG001|Overall Study|Lost to Follow-up|3|||
143206560|NCT01895309|516301585|FG000|Overall Study|Physician Decision|15|||
143206561|NCT01895309|516301586|FG001|Overall Study|Physician Decision|10|||
143206562|NCT01895309|516301585|FG000|Overall Study|Withdrawal by Subject|9|||
143206563|NCT01895309|516301586|FG001|Overall Study|Withdrawal by Subject|18|||
143206564|NCT04232215|516301587|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
143206565|NCT04232215|516301588|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
143206566|NCT00447122|516301589|FG000|Overall Study|worsening medical condition -came off|0|||
143206567|NCT00447122|516301590|FG001|Overall Study|worsening medical condition -came off|1|||
143206568|NCT00447122|516301591|FG002|Overall Study|worsening medical condition -came off|0|||
143206569|NCT00447122|516301592|FG003|Overall Study|worsening medical condition -came off|0|||
143206570|NCT01439373|516301593|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
143206571|NCT01439373|516301594|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
143206572|NCT01439373|516301593|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
143206573|NCT01439373|516301594|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
143206574|NCT04576897|516301595|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
143206575|NCT03834220|516301596|FG000|Overall Study|Adverse Event|1|||
143206576|NCT03834220|516301597|FG001|Overall Study|Adverse Event|0|||
143206577|NCT03834220|516301598|FG002|Overall Study|Adverse Event|0|||
143206578|NCT03834220|516301596|FG000|Overall Study|Death|8|||
143206579|NCT03834220|516301597|FG001|Overall Study|Death|1|||
143206580|NCT03834220|516301598|FG002|Overall Study|Death|17|||
143206581|NCT03834220|516301596|FG000|Overall Study|Reason not Specified|9|||
143206582|NCT03834220|516301597|FG001|Overall Study|Reason not Specified|0|||
143206583|NCT03834220|516301598|FG002|Overall Study|Reason not Specified|6|||
143206584|NCT03834220|516301596|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
143206585|NCT03834220|516301597|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
143206586|NCT03834220|516301598|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
143206587|NCT03834220|516301596|FG000|Overall Study|Withdrawal of Consent|2|||
143206588|NCT03834220|516301597|FG001|Overall Study|Withdrawal of Consent|2|||
143206589|NCT03834220|516301598|FG002|Overall Study|Withdrawal of Consent|2|||
143206590|NCT02593318|516301601|FG000|Overall Study|Withdrawal by Subject|1|||
143206591|NCT02593318|516301602|FG001|Overall Study|Withdrawal by Subject|1|||
143206592|NCT00527332|516301607|FG000|Overall Study|Protocol Violation|4|||
143206593|NCT00527332|516301608|FG001|Overall Study|Protocol Violation|8|||
143206594|NCT00527332|516301607|FG000|Overall Study|Withdrew consent|5|||
143206595|NCT00527332|516301608|FG001|Overall Study|Withdrew consent|1|||
143206596|NCT05011513|516302886|FG000|Overall Study|Death|0|||
143206597|NCT05011513|516302887|FG001|Overall Study|Death|1|||
143206598|NCT05011513|516302886|FG000|Overall Study|Lost to Follow-up|4|||
143206599|NCT05011513|516302887|FG001|Overall Study|Lost to Follow-up|0|||
143206600|NCT05011513|516302886|FG000|Overall Study|Withdrawal by Subject|18|||
143206601|NCT05011513|516302887|FG001|Overall Study|Withdrawal by Subject|17|||
143206602|NCT05011513|516302886|FG000|Overall Study|Other|4|||
143206603|NCT05011513|516302887|FG001|Overall Study|Other|2|||
143206604|NCT03667690|516302888|FG000|Overall Study|Adverse Event|0|||
143206605|NCT03667690|516302889|FG001|Overall Study|Adverse Event|3|||
143206606|NCT03667690|516302888|FG000|Overall Study|Death|22|||
143206607|NCT03667690|516302889|FG001|Overall Study|Death|21|||
143206608|NCT03667690|516302888|FG000|Overall Study|Lost to Follow-up|4|||
143206609|NCT03667690|516302889|FG001|Overall Study|Lost to Follow-up|5|||
143206610|NCT03667690|516302888|FG000|Overall Study|Withdrawal by Subject|7|||
143263243|NCT02806973|516517517|FG000|Period 3|Adverse Event|0|||
143263244|NCT02806973|516517518|FG001|Period 3|Adverse Event|0|||
143206611|NCT03667690|516302889|FG001|Overall Study|Withdrawal by Subject|8|||
143206612|NCT03667690|516302888|FG000|Overall Study|Subject could not return for additional investigational product|1|||
143206613|NCT03667690|516302889|FG001|Overall Study|Subject could not return for additional investigational product|0|||
143206614|NCT03667690|516302888|FG000|Overall Study|Subject discharged to hospice care|2|||
143263245|NCT02806973|516517519|FG002|Period 3|Adverse Event|1|||
143206615|NCT03667690|516302889|FG001|Overall Study|Subject discharged to hospice care|0|||
143206616|NCT03667690|516302888|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
143263246|NCT02806973|516517520|FG003|Period 3|Adverse Event|0|||
143206617|NCT03667690|516302889|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
143206618|NCT03667690|516302888|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
143206619|NCT03667690|516302889|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
143206620|NCT03667690|516302888|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
143206621|NCT03667690|516302889|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
143206622|NCT03667690|516302888|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
143206623|NCT03667690|516302889|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
143206624|NCT03667690|516302888|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
143206625|NCT03667690|516302889|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
143206626|NCT01192568|516302898|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
143206627|NCT01192568|516302899|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
143206628|NCT01192568|516302900|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
143206629|NCT01192568|516302901|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
143206630|NCT01192568|516302898|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
143206631|NCT01192568|516302899|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
143206632|NCT01192568|516302900|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
143206633|NCT01192568|516302901|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
143206634|NCT06359080|516302902|FG000|Overall Study|Withdrawal by Subject|3|||
143206635|NCT02428205|516302903|FG000|Overall Study|Lack of Efficacy|1|||
143206636|NCT02428205|516302904|FG001|Overall Study|Lack of Efficacy|0|||
143206637|NCT02428205|516302903|FG000|Overall Study|Lost to Follow-up|1|||
143206638|NCT02428205|516302904|FG001|Overall Study|Lost to Follow-up|1|||
143206639|NCT02428205|516302903|FG000|Overall Study|Worse behavior|0|||
143206640|NCT02428205|516302904|FG001|Overall Study|Worse behavior|1|||
143206641|NCT00527319|516302905|FG000|Overall Study|Withdrawal by Subject|5|||
143206642|NCT00527319|516302906|FG001|Overall Study|Withdrawal by Subject|0|||
143206643|NCT00527319|516302907|FG002|Overall Study|Withdrawal by Subject|1|||
143206644|NCT00527319|516302905|FG000|Overall Study|Lost to Follow-up|1|||
143206645|NCT00527319|516302906|FG001|Overall Study|Lost to Follow-up|0|||
143206646|NCT00527319|516302907|FG002|Overall Study|Lost to Follow-up|0|||
143206647|NCT00527319|516302905|FG000|Overall Study|Death|0|||
143206648|NCT00527319|516302906|FG001|Overall Study|Death|3|||
143206649|NCT00527319|516302907|FG002|Overall Study|Death|1|||
143206650|NCT00527319|516302905|FG000|Overall Study|Intercurrent Medical Illness|0|||
143206651|NCT00527319|516302906|FG001|Overall Study|Intercurrent Medical Illness|1|||
143206652|NCT00527319|516302907|FG002|Overall Study|Intercurrent Medical Illness|3|||
143206653|NCT00527319|516302905|FG000|Overall Study|Adverse Event|0|||
143206654|NCT00527319|516302906|FG001|Overall Study|Adverse Event|0|||
143206655|NCT00527319|516302907|FG002|Overall Study|Adverse Event|1|||
143206656|NCT01646203|516302910|FG000|Overall Study|Adverse Event|2|||
143206657|NCT01646203|516302911|FG001|Overall Study|Adverse Event|0|||
143206658|NCT01646203|516302912|FG002|Overall Study|Adverse Event|1|||
143206659|NCT01646203|516302910|FG000|Overall Study|Withdrawal by Subject|0|||
143206660|NCT01646203|516302911|FG001|Overall Study|Withdrawal by Subject|1|||
143206661|NCT01646203|516302912|FG002|Overall Study|Withdrawal by Subject|0|||
143206662|NCT01646203|516302910|FG000|Overall Study|Physician's Decision|0|||
143206663|NCT01646203|516302911|FG001|Overall Study|Physician's Decision|1|||
143206664|NCT01646203|516302912|FG002|Overall Study|Physician's Decision|0|||
143206665|NCT01100528|516302913|FG000|Overall Study|Death|1|||
143206666|NCT01100528|516302913|FG000|Overall Study|Withdrawal by Subject|2|||
143206667|NCT03242252|516302917|FG000|Overall Study|At the Participant's own Request|18|||
143206668|NCT03242252|516302918|FG001|Overall Study|At the Participant's own Request|10|||
143206669|NCT03242252|516302919|FG002|Overall Study|At the Participant's own Request|15|||
143206670|NCT03242252|516302917|FG000|Overall Study|Adverse Event|8|||
143206671|NCT03242252|516302918|FG001|Overall Study|Adverse Event|6|||
143206672|NCT03242252|516302919|FG002|Overall Study|Adverse Event|9|||
143206673|NCT03242252|516302917|FG000|Overall Study|Poor Compliance to Protocol|0|||
143206674|NCT03242252|516302918|FG001|Overall Study|Poor Compliance to Protocol|2|||
143206675|NCT03242252|516302919|FG002|Overall Study|Poor Compliance to Protocol|3|||
143206676|NCT03242252|516302917|FG000|Overall Study|Study Terminated by Sponsor|1|||
143206677|NCT03242252|516302918|FG001|Overall Study|Study Terminated by Sponsor|0|||
143263247|NCT04209426|516517523|FG000|Overall Study|Lost to Follow-up|3|||
143206678|NCT03242252|516302919|FG002|Overall Study|Study Terminated by Sponsor|0|||
143206679|NCT03242252|516302917|FG000|Overall Study|Reason not Specified|4|||
143206680|NCT03242252|516302918|FG001|Overall Study|Reason not Specified|4|||
143206681|NCT03242252|516302919|FG002|Overall Study|Reason not Specified|1|||
143206682|NCT03242252|516302917|FG000|Overall Study|Lost to Follow-up|5|||
143263248|NCT04209426|516517524|FG001|Overall Study|Lost to Follow-up|2|||
143206683|NCT03242252|516302918|FG001|Overall Study|Lost to Follow-up|1|||
143206684|NCT03242252|516302919|FG002|Overall Study|Lost to Follow-up|4|||
143206685|NCT02211313|516302920|FG000|Overall Study|Treatment Failure|5|||
143206686|NCT02211313|516302921|FG001|Overall Study|Treatment Failure|2|||
143206687|NCT02211313|516302920|FG000|Overall Study|No Follow up Questionnaires|1|||
143206688|NCT02211313|516302921|FG001|Overall Study|No Follow up Questionnaires|1|||
143206689|NCT02717130|516302922|FG000|Overall Study|Withdrawal by Subject|1|||
143206690|NCT02717130|516302922|FG000|Overall Study|Adverse Event|1|||
143206691|NCT02717130|516302922|FG000|Overall Study|Physician Decision|1|||
143206692|NCT02717130|516302922|FG000|Overall Study|Study Closure|4|||
143206693|NCT02445573|516302923|FG000|Overall Study|Withdrawal by Subject|1|||
143206694|NCT02445573|516302924|FG001|Overall Study|Withdrawal by Subject|1|||
143206695|NCT02445573|516302923|FG000|Overall Study|Lost to Follow-up|0|||
143206696|NCT02445573|516302924|FG001|Overall Study|Lost to Follow-up|1|||
143206697|NCT01565941|516302925|FG000|Overall Study|Withdrawn by parent/guardian|3|||
143206698|NCT01565941|516302926|FG001|Overall Study|Withdrawn by parent/guardian|2|||
143206699|NCT01565941|516302925|FG000|Overall Study|Randomized; did not receive intevention|8|||
143206700|NCT01565941|516302926|FG001|Overall Study|Randomized; did not receive intevention|2|||
143206701|NCT02855944|516302927|FG000|Period 1: Treatment|Ongoing|14|||
143206702|NCT02855944|516302928|FG001|Period 1: Treatment|Ongoing|0|||
143206703|NCT02855944|516302927|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
143206704|NCT02855944|516302928|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
143206705|NCT02855944|516302927|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
143206706|NCT02855944|516302928|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
143206707|NCT01475162|516302934|FG000|Overall Study|Physician Decision|1|||
143206708|NCT01475162|516302934|FG000|Overall Study|Death|10|||
143206709|NCT01475162|516302934|FG000|Overall Study|Study closed for safety|3|||
143206710|NCT00490022|516302935|FG000|Overall Study|Adverse Event|0|||
143206711|NCT00490022|516302936|FG001|Overall Study|Adverse Event|2|||
143206712|NCT00490022|516302935|FG000|Overall Study|Withdrawal by Subject|1|||
143206713|NCT00490022|516302936|FG001|Overall Study|Withdrawal by Subject|0|||
143206714|NCT00490022|516302935|FG000|Overall Study|Subject failed to disclose concommitant|0|||
143206715|NCT00490022|516302936|FG001|Overall Study|Subject failed to disclose concommitant|1|||
143206716|NCT02391961|516302940|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
143206717|NCT02391961|516302941|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
143206718|NCT02391961|516302940|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
143206719|NCT02391961|516302941|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
143206720|NCT02391961|516302940|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
143206721|NCT02391961|516302941|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
143206722|NCT01792518|516302944|FG000|Overall Study|Adverse Event|3|||
143206723|NCT01792518|516302945|FG001|Overall Study|Adverse Event|4|||
143206724|NCT01792518|516302944|FG000|Overall Study|Protocol Violation|0|||
143206725|NCT01792518|516302945|FG001|Overall Study|Protocol Violation|1|||
143206726|NCT01792518|516302944|FG000|Overall Study|Lost to Follow-up|3|||
143206727|NCT01792518|516302945|FG001|Overall Study|Lost to Follow-up|1|||
143206728|NCT01792518|516302944|FG000|Overall Study|Withdrawal by Subject|2|||
143206729|NCT01792518|516302945|FG001|Overall Study|Withdrawal by Subject|0|||
143206730|NCT01792518|516302944|FG000|Overall Study|Other Reason|0|||
143206731|NCT01792518|516302945|FG001|Overall Study|Other Reason|1|||
143206732|NCT01504204|516302946|FG000|Overall Study|Lost to Follow-up|1|||
143206733|NCT01504204|516302947|FG001|Overall Study|Lost to Follow-up|1|||
143206734|NCT00903331|516302948|FG000|Overall Study|Death|4|||
143206735|NCT00903331|516302949|FG001|Overall Study|Death|8|||
143206736|NCT00903331|516302948|FG000|Overall Study|Withdrawal of consent|1|||
143206737|NCT00903331|516302949|FG001|Overall Study|Withdrawal of consent|8|||
143206738|NCT00903331|516302948|FG000|Overall Study|Lung transplant|0|||
143206739|NCT00903331|516302949|FG001|Overall Study|Lung transplant|2|||
143206740|NCT00257660|516302950|FG000|Overall Study|Lack of Efficacy|5|||
143206741|NCT00257660|516302951|FG001|Overall Study|Lack of Efficacy|23|||
143206742|NCT00257660|516302950|FG000|Overall Study|Withdrawal by Subject|2|||
143206743|NCT00257660|516302951|FG001|Overall Study|Withdrawal by Subject|0|||
143206744|NCT00257660|516302950|FG000|Overall Study|Lost to Follow-up|1|||
143206745|NCT00257660|516302951|FG001|Overall Study|Lost to Follow-up|0|||
143206746|NCT00257660|516302950|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
143206747|NCT00257660|516302951|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
143206748|NCT00257660|516302950|FG000|Overall Study|No longer wanted to do blood draws|1|||
143206749|NCT00257660|516302951|FG001|Overall Study|No longer wanted to do blood draws|0|||
143206750|NCT03426631|516302954|FG000|Overall Study|Lost to Follow-up|0|||
143206751|NCT03426631|516302955|FG001|Overall Study|Lost to Follow-up|1|||
143206752|NCT00654004|516302958|FG000|Overall Study|Lost to Follow-up|1|||
143206753|NCT00654004|516302959|FG001|Overall Study|Lost to Follow-up|0|||
143206754|NCT00444067|516302964|FG000|Overall Study|Lost to Follow-up|0|||
143206755|NCT00444067|516302965|FG001|Overall Study|Lost to Follow-up|1|||
143206756|NCT00710385|516302966|FG000|Overall Study|Did not qualify|1|||
143206757|NCT00710385|516302966|FG000|Overall Study|Withdrawal by Subject|1|||
143206758|NCT00710385|516302966|FG000|Overall Study|Undisclosed back pain|1|||
143206759|NCT00710385|516302966|FG000|Overall Study|Physician Decision|1|||
143206760|NCT00710385|516302966|FG000|Overall Study|Undisclosed excessive methadone use|1|||
143206761|NCT03134183|516302970|FG000|Overall Study|Withdrawal by Subject|1|||
143206762|NCT03134183|516302971|FG001|Overall Study|Withdrawal by Subject|1|||
143206763|NCT02299076|516302972|FG000|Overall Study|Fraudulent Entries|20|||
143206764|NCT02299076|516302973|FG001|Overall Study|Fraudulent Entries|14|||
143206765|NCT02228096|516302979|FG000|Overall Study|Study terminated by Sponsor|24|||
143206766|NCT02228096|516302979|FG000|Overall Study|Lack of Efficacy|18|||
143206767|NCT02228096|516302979|FG000|Overall Study|Death|12|||
143206768|NCT02228096|516302979|FG000|Overall Study|Physician Decision|3|||
143206769|NCT02228096|516302979|FG000|Overall Study|Subject/guardian decision|2|||
143206770|NCT02228096|516302979|FG000|Overall Study|New therapy for study indication|1|||
143206771|NCT02228096|516302979|FG000|Overall Study|Enrolled, not infused|11|||
143206772|NCT00499746|516302980|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
143206773|NCT00499746|516302980|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
143206774|NCT00499746|516302980|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
143206775|NCT00499746|516302980|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
143206776|NCT01969721|516302981|FG000|Overall Study|Adverse Event|3|||
143206777|NCT01969721|516302982|FG001|Overall Study|Adverse Event|8|||
143206778|NCT01969721|516302983|FG002|Overall Study|Adverse Event|3|||
143206779|NCT01969721|516302984|FG003|Overall Study|Adverse Event|2|||
143206780|NCT01969721|516302981|FG000|Overall Study|Lack of Efficacy|0|||
143206781|NCT01969721|516302982|FG001|Overall Study|Lack of Efficacy|0|||
143206782|NCT01969721|516302983|FG002|Overall Study|Lack of Efficacy|1|||
143206783|NCT01969721|516302984|FG003|Overall Study|Lack of Efficacy|0|||
143206784|NCT01969721|516302981|FG000|Overall Study|Non compliant with protocol|1|||
143206785|NCT01969721|516302982|FG001|Overall Study|Non compliant with protocol|1|||
143206786|NCT01969721|516302983|FG002|Overall Study|Non compliant with protocol|0|||
143206787|NCT01969721|516302984|FG003|Overall Study|Non compliant with protocol|2|||
143206788|NCT01969721|516302981|FG000|Overall Study|Other not defined above|0|||
143206789|NCT01969721|516302982|FG001|Overall Study|Other not defined above|2|||
143206790|NCT01969721|516302983|FG002|Overall Study|Other not defined above|0|||
143206791|NCT01969721|516302984|FG003|Overall Study|Other not defined above|0|||
143206792|NCT01969721|516302981|FG000|Overall Study|Discontinued during washout periods.|0|||
143206793|NCT01969721|516302982|FG001|Overall Study|Discontinued during washout periods.|1|||
143206794|NCT01969721|516302983|FG002|Overall Study|Discontinued during washout periods.|1|||
143206795|NCT01969721|516302984|FG003|Overall Study|Discontinued during washout periods.|2|||
143206796|NCT02383433|516302985|FG000|Overall Study|Disease progression|2|||
143206797|NCT02477553|516302986|FG000|Overall Study|Screening up-to-date|12|||
143206798|NCT02477553|516302987|FG001|Overall Study|Screening up-to-date|13|||
143206799|NCT02477553|516302986|FG000|Overall Study|No MD visit|1|||
143206800|NCT02477553|516302987|FG001|Overall Study|No MD visit|1|||
143206801|NCT02477553|516302986|FG000|Overall Study|Workup consistent w/CRC|1|||
143206802|NCT02477553|516302987|FG001|Overall Study|Workup consistent w/CRC|1|||
143206803|NCT02477553|516302986|FG000|Overall Study|Technical issues with intervention|2|||
143206804|NCT02477553|516302987|FG001|Overall Study|Technical issues with intervention|0|||
143206805|NCT02477553|516302986|FG000|Overall Study|Elevated risk for CRC|2|||
143206806|NCT02477553|516302987|FG001|Overall Study|Elevated risk for CRC|2|||
143206807|NCT02477553|516302986|FG000|Overall Study|MD advised against screening|1|||
143206808|NCT02477553|516302987|FG001|Overall Study|MD advised against screening|3|||
143206809|NCT02477553|516302986|FG000|Overall Study|patient deceased|1|||
143206810|NCT02477553|516302987|FG001|Overall Study|patient deceased|0|||
143206811|NCT04023682|516302989|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
143206812|NCT01291277|516302990|FG000|Overall Study|Death|2|||
143206813|NCT01291277|516302991|FG001|Overall Study|Death|2|||
143206814|NCT01291277|516302990|FG000|Overall Study|Lost to Follow-up|3|||
143206815|NCT01291277|516302991|FG001|Overall Study|Lost to Follow-up|1|||
143206816|NCT01563172|516302994|FG000|Overall Study|Adverse Event|5|||
143206817|NCT01563172|516302994|FG000|Overall Study|Lost to Follow-up|2|||
143206818|NCT01563172|516302994|FG000|Overall Study|Other (Protocol deviation)|5|||
143206819|NCT01563172|516302994|FG000|Overall Study|Other (Not specified)|1|||
143206820|NCT00042666|516302995|FG000|Overall Study|Adverse Event|2|||
143206821|NCT00042666|516302995|FG000|Overall Study|Death|4|||
143206822|NCT00042666|516302995|FG000|Overall Study|Protocol Violation|1|||
143206823|NCT00042666|516302995|FG000|Overall Study|Participant/Physician Perception|1|||
143206824|NCT00042666|516302995|FG000|Overall Study|Progressive Disease|41|||
143206825|NCT00042666|516302995|FG000|Overall Study|Other|1|||
143206826|NCT00042666|516302995|FG000|Overall Study|Other|4|||
143206827|NCT02409342|516302996|FG000|Overall Study|Death|211|||
143206828|NCT02409342|516302997|FG001|Overall Study|Death|201|||
143206829|NCT02409342|516302996|FG000|Overall Study|Withdrawal by Subject|24|||
143206830|NCT02409342|516302997|FG001|Overall Study|Withdrawal by Subject|17|||
143206831|NCT02409342|516302996|FG000|Overall Study|Study Terminated By Sponsor|48|||
143206832|NCT02409342|516302997|FG001|Overall Study|Study Terminated By Sponsor|59|||
143206833|NCT02409342|516302996|FG000|Overall Study|Lost to Follow-up|3|||
143206834|NCT02409342|516302997|FG001|Overall Study|Lost to Follow-up|5|||
143206835|NCT02409342|516302996|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
143206836|NCT02409342|516302997|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
143206837|NCT02409342|516302996|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
143206838|NCT02409342|516302997|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
143206839|NCT02409342|516302996|FG000|Overall Study|Sponsor Decision|1|||
143206840|NCT02409342|516302997|FG001|Overall Study|Sponsor Decision|0|||
143206841|NCT00279812|516303007|FG000|Overall Study|Protocol Violation|1|||
143206842|NCT00279812|516303008|FG001|Overall Study|Protocol Violation|1|||
143206843|NCT00279812|516303009|FG002|Overall Study|Protocol Violation|0|||
143206844|NCT00279812|516303010|FG003|Overall Study|Protocol Violation|0|||
143206845|NCT00279812|516303011|FG004|Overall Study|Protocol Violation|1|||
143206846|NCT00279812|516303012|FG005|Overall Study|Protocol Violation|0|||
143206847|NCT00279812|516303007|FG000|Overall Study|Withdrawal by Subject|0|||
143206848|NCT00279812|516303008|FG001|Overall Study|Withdrawal by Subject|4|||
143206849|NCT00279812|516303009|FG002|Overall Study|Withdrawal by Subject|2|||
143206850|NCT00279812|516303010|FG003|Overall Study|Withdrawal by Subject|0|||
143206851|NCT00279812|516303011|FG004|Overall Study|Withdrawal by Subject|0|||
143206852|NCT00279812|516303012|FG005|Overall Study|Withdrawal by Subject|0|||
143206853|NCT00279812|516303007|FG000|Overall Study|Adverse Event|0|||
143206854|NCT00279812|516303008|FG001|Overall Study|Adverse Event|1|||
143206855|NCT00279812|516303009|FG002|Overall Study|Adverse Event|1|||
143206856|NCT00279812|516303010|FG003|Overall Study|Adverse Event|0|||
143206857|NCT00279812|516303011|FG004|Overall Study|Adverse Event|2|||
143206858|NCT00279812|516303012|FG005|Overall Study|Adverse Event|1|||
143206859|NCT01274429|516303013|FG000|Overall Study|Study closed do to lack of funding|5|||
143206860|NCT05327361|516303019|FG000|Overall Study|Lost to Follow-up|4|||
143206861|NCT04046250|516303022|FG000|Overall Study|Death|0|||
143206862|NCT04046250|516303023|FG001|Overall Study|Death|1|||
143206863|NCT04046250|516303022|FG000|Overall Study|Withdrawal by Subject|3|||
143206864|NCT04046250|516303023|FG001|Overall Study|Withdrawal by Subject|3|||
143206865|NCT01174173|516303030|FG000|Overall Study|drug-drug interaction|1|||
143206866|NCT03268941|516305000|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
143206867|NCT03268941|516305001|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
143206868|NCT03268941|516305002|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
143206869|NCT03268941|516305003|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
143206870|NCT03268941|516305004|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
143206871|NCT03268941|516305005|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
143206872|NCT03268941|516305006|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
143206873|NCT03268941|516305000|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
143206874|NCT03268941|516305001|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
143206875|NCT03268941|516305002|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
143206876|NCT03268941|516305003|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
143206877|NCT03268941|516305004|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
143206878|NCT03268941|516305005|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
143206879|NCT03268941|516305006|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
143206880|NCT03268941|516305000|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
143206881|NCT03268941|516305001|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
143206882|NCT03268941|516305002|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
143206883|NCT03268941|516305003|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
143206884|NCT03268941|516305004|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
143206885|NCT03268941|516305005|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
143206886|NCT03268941|516305006|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
143206887|NCT03268941|516305000|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
143206888|NCT03268941|516305001|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
143206889|NCT03268941|516305002|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
143206890|NCT03268941|516305003|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
143206891|NCT03268941|516305004|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
143206892|NCT03268941|516305005|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
143206893|NCT03268941|516305006|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
143206894|NCT03268941|516305000|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
143206895|NCT03268941|516305001|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
143206896|NCT03268941|516305002|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
143206897|NCT03268941|516305003|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
143206898|NCT03268941|516305004|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
143263249|NCT04423939|516517525|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
143206899|NCT03268941|516305005|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
143206900|NCT03268941|516305006|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
143206901|NCT01216683|516305011|FG000|Induction|Never started treatment|0|||
143206902|NCT01216683|516305012|FG001|Induction|Never started treatment|6|||
143206903|NCT01216683|516305013|FG002|Induction|Never started treatment|3|||
143206904|NCT01216683|516305011|FG000|Induction|Lack of Efficacy|4|||
143206905|NCT01216683|516305012|FG001|Induction|Lack of Efficacy|3|||
143206906|NCT01216683|516305013|FG002|Induction|Lack of Efficacy|7|||
143206907|NCT01216683|516305011|FG000|Induction|Adverse Event|0|||
143206908|NCT01216683|516305012|FG001|Induction|Adverse Event|5|||
143206909|NCT01216683|516305013|FG002|Induction|Adverse Event|5|||
143206910|NCT01216683|516305011|FG000|Induction|Death|0|||
143206911|NCT01216683|516305012|FG001|Induction|Death|0|||
143206912|NCT01216683|516305013|FG002|Induction|Death|2|||
143206913|NCT01216683|516305011|FG000|Induction|Withdrawal by Subject|0|||
143206914|NCT01216683|516305012|FG001|Induction|Withdrawal by Subject|4|||
143206915|NCT01216683|516305013|FG002|Induction|Withdrawal by Subject|2|||
143206916|NCT01216683|516305011|FG000|Induction|Other disease|0|||
143206917|NCT01216683|516305012|FG001|Induction|Other disease|1|||
143206918|NCT01216683|516305013|FG002|Induction|Other disease|2|||
143206919|NCT01216683|516305011|FG000|Continuation|Lack of Efficacy|3|||
143206920|NCT01216683|516305012|FG001|Continuation|Lack of Efficacy|2|||
143206921|NCT01216683|516305013|FG002|Continuation|Lack of Efficacy|7|||
143206922|NCT01216683|516305011|FG000|Continuation|Adverse Event|5|||
143206923|NCT01216683|516305012|FG001|Continuation|Adverse Event|3|||
143206924|NCT01216683|516305013|FG002|Continuation|Adverse Event|16|||
143206925|NCT01216683|516305011|FG000|Continuation|Death|1|||
143206926|NCT01216683|516305012|FG001|Continuation|Death|0|||
143206927|NCT01216683|516305013|FG002|Continuation|Death|2|||
143206928|NCT01216683|516305011|FG000|Continuation|Withdrawal by Subject|4|||
143206929|NCT01216683|516305012|FG001|Continuation|Withdrawal by Subject|5|||
143206930|NCT01216683|516305013|FG002|Continuation|Withdrawal by Subject|9|||
143206931|NCT01216683|516305011|FG000|Continuation|Other diseases|0|||
143206932|NCT01216683|516305012|FG001|Continuation|Other diseases|2|||
143206933|NCT01216683|516305013|FG002|Continuation|Other diseases|1|||
143206934|NCT01216683|516305011|FG000|Continuation|Physician Decision|1|||
143206935|NCT01216683|516305012|FG001|Continuation|Physician Decision|0|||
143206936|NCT01216683|516305013|FG002|Continuation|Physician Decision|1|||
143206937|NCT01216683|516305011|FG000|Continuation|Non-compliance|1|||
143206938|NCT01216683|516305012|FG001|Continuation|Non-compliance|0|||
143206939|NCT01216683|516305013|FG002|Continuation|Non-compliance|1|||
143206940|NCT01216683|516305011|FG000|Continuation|Insurance change|0|||
143206941|NCT01216683|516305012|FG001|Continuation|Insurance change|1|||
143206942|NCT01216683|516305013|FG002|Continuation|Insurance change|0|||
143206943|NCT01216683|516305011|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
143206944|NCT01216683|516305012|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
143206945|NCT01216683|516305013|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
143206946|NCT01216683|516305011|FG000|Continuation|Not reported|0|||
143206947|NCT01216683|516305012|FG001|Continuation|Not reported|0|||
143206948|NCT01216683|516305013|FG002|Continuation|Not reported|1|||
143206949|NCT01216683|516305011|FG000|Continuation|Never started treatment|0|||
143206950|NCT01216683|516305012|FG001|Continuation|Never started treatment|1|||
143206951|NCT01216683|516305013|FG002|Continuation|Never started treatment|5|||
143206952|NCT02720692|516305014|FG000|Overall Study|Withdrawal by Subject|3|||
143206953|NCT02720692|516305015|FG001|Overall Study|Withdrawal by Subject|0|||
143206954|NCT02720692|516305014|FG000|Overall Study|Physician Decision|1|||
143206955|NCT02720692|516305015|FG001|Overall Study|Physician Decision|0|||
143206956|NCT02720692|516305014|FG000|Overall Study|Lost to Follow-up|8|||
143206957|NCT02720692|516305015|FG001|Overall Study|Lost to Follow-up|3|||
143206958|NCT02720692|516305014|FG000|Overall Study|Subject unable to return for visit|1|||
143206959|NCT02720692|516305015|FG001|Overall Study|Subject unable to return for visit|0|||
143206960|NCT02503501|516305016|FG000|Overall Study|Physician Decision|1|||
143206961|NCT02503501|516305017|FG001|Overall Study|Physician Decision|0|||
143206962|NCT02503501|516305016|FG000|Overall Study|Protocol Violation|0|||
143206963|NCT02503501|516305017|FG001|Overall Study|Protocol Violation|1|||
143206964|NCT02503501|516305016|FG000|Overall Study|Withdrawal by Subject|0|||
143206965|NCT02503501|516305017|FG001|Overall Study|Withdrawal by Subject|2|||
143206966|NCT03878758|516305018|FG000|Overall Study|Withdrawal by Subject|1|||
143206967|NCT03878758|516305018|FG000|Overall Study|Protocol defined|2|||
143206968|NCT03878758|516305018|FG000|Overall Study|Improper consent documentation|1|||
143206969|NCT00321464|516305019|FG000|Overall Study|Death|169|||
143206970|NCT00321464|516305020|FG001|Overall Study|Death|174|||
143206971|NCT00321464|516305019|FG000|Overall Study|Disease progression|124|||
143206972|NCT00321464|516305020|FG001|Overall Study|Disease progression|124|||
143206973|NCT00321464|516305019|FG000|Overall Study|Withdrawal by Subject|117|||
143206974|NCT00321464|516305020|FG001|Overall Study|Withdrawal by Subject|118|||
143206975|NCT00321464|516305019|FG000|Overall Study|Participant request|57|||
143206976|NCT00321464|516305020|FG001|Overall Study|Participant request|61|||
143206977|NCT00321464|516305019|FG000|Overall Study|Adverse Event|43|||
143206978|NCT00321464|516305020|FG001|Overall Study|Adverse Event|28|||
143206979|NCT00321464|516305019|FG000|Overall Study|Physician Decision|15|||
143206980|NCT00321464|516305020|FG001|Overall Study|Physician Decision|14|||
143206981|NCT00321464|516305019|FG000|Overall Study|Noncompliance|4|||
143206982|NCT00321464|516305020|FG001|Overall Study|Noncompliance|10|||
143206983|NCT00321464|516305019|FG000|Overall Study|Lost to Follow-up|7|||
143206984|NCT00321464|516305020|FG001|Overall Study|Lost to Follow-up|8|||
143206985|NCT00321464|516305019|FG000|Overall Study|Protocol deviation|0|||
143206986|NCT00321464|516305020|FG001|Overall Study|Protocol deviation|2|||
143206987|NCT00321464|516305019|FG000|Overall Study|Ineligibility determined|2|||
143206988|NCT00321464|516305020|FG001|Overall Study|Ineligibility determined|1|||
143206989|NCT00321464|516305019|FG000|Overall Study|Other|21|||
143206990|NCT00321464|516305020|FG001|Overall Study|Other|18|||
143206991|NCT00652951|516305021|FG000|Booster Phase|Adverse event, non-fatal|0|||
143206992|NCT00652951|516305022|FG001|Booster Phase|Adverse event, non-fatal|1|||
143206993|NCT00652951|516305023|FG002|Booster Phase|Adverse event, non-fatal|0|||
143206994|NCT00652951|516305021|FG000|Booster Phase|Other|1|||
143206995|NCT00652951|516305022|FG001|Booster Phase|Other|0|||
143206996|NCT00652951|516305023|FG002|Booster Phase|Other|0|||
143206997|NCT02081599|516305024|FG000|Period 1：Double-blind Period|Adverse Event|3|||
143206998|NCT02081599|516305025|FG001|Period 1：Double-blind Period|Adverse Event|0|||
143206999|NCT02081599|516305024|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
143207000|NCT02081599|516305025|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
143207001|NCT02081599|516305024|FG000|Period 1：Double-blind Period|Physician Decision|1|||
143207002|NCT02081599|516305025|FG001|Period 1：Double-blind Period|Physician Decision|0|||
143207003|NCT02081599|516305024|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
143207004|NCT02081599|516305025|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
143207005|NCT02081599|516305024|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
143207006|NCT02081599|516305025|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
143207007|NCT02081599|516305024|FG000|Period 1：Double-blind Period|stopping criteria|1|||
143207008|NCT02081599|516305025|FG001|Period 1：Double-blind Period|stopping criteria|0|||
143207009|NCT02081599|516305024|FG000|Period 2：Open-label Period|Adverse Event|1|||
143207010|NCT02081599|516305025|FG001|Period 2：Open-label Period|Adverse Event|0|||
143263250|NCT04423939|516517526|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
143263251|NCT04423939|516517525|FG000|Overall Study|Death|3|||
143263252|NCT04423939|516517526|FG001|Overall Study|Death|0|||
143263253|NCT04423939|516517525|FG000|Overall Study|Withdrawal by Subject|3|||
143263254|NCT04423939|516517526|FG001|Overall Study|Withdrawal by Subject|0|||
143263255|NCT04423939|516517525|FG000|Overall Study|Caregiver to patient who died|0|||
143263256|NCT04423939|516517526|FG001|Overall Study|Caregiver to patient who died|3|||
143263257|NCT04423939|516517525|FG000|Overall Study|Caregiver to patient who withdrew|0|||
143263258|NCT04423939|516517526|FG001|Overall Study|Caregiver to patient who withdrew|3|||
143263259|NCT00427960|516517531|FG000|Overall Study|Adverse Event|2|||
143263260|NCT00427960|516517532|FG001|Overall Study|Adverse Event|0|||
143263261|NCT00427960|516517531|FG000|Overall Study|Withdrawal by Subject|0|||
143263262|NCT00427960|516517532|FG001|Overall Study|Withdrawal by Subject|3|||
143263263|NCT00427960|516517531|FG000|Overall Study|Other|0|||
143263264|NCT00427960|516517532|FG001|Overall Study|Other|1|||
143263265|NCT01751802|516517533|FG000|Overall Study|Adverse Event|4|||
143263266|NCT01751802|516517534|FG001|Overall Study|Adverse Event|2|||
143263267|NCT01052844|516517544|FG000|Overall Study|Adverse Event|0|||
143263268|NCT01052844|516517545|FG001|Overall Study|Adverse Event|1|||
143263269|NCT02376829|516517548|FG000|Overall Study|Withdrawal by Subject|27|||
143263270|NCT02376829|516517549|FG001|Overall Study|Withdrawal by Subject|44|||
143263271|NCT03595774|516517550|FG000|Overall Study|Adverse Event|1|||
143263272|NCT03595774|516517551|FG001|Overall Study|Adverse Event|0|||
143263273|NCT03595774|516517552|FG002|Overall Study|Adverse Event|1|||
143263274|NCT03595774|516517553|FG003|Overall Study|Adverse Event|0|||
143263275|NCT03595774|516517550|FG000|Overall Study|screen failure|0|||
143263276|NCT03595774|516517551|FG001|Overall Study|screen failure|1|||
143263277|NCT03595774|516517552|FG002|Overall Study|screen failure|0|||
143263278|NCT03595774|516517553|FG003|Overall Study|screen failure|1|||
143263279|NCT01309893|516517555|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
143263280|NCT01309893|516517556|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
143207011|NCT02081599|516305024|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
143207012|NCT02081599|516305025|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
143263281|NCT01309893|516517555|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
143263282|NCT01309893|516517556|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
143263283|NCT01343901|516517557|FG000|Overall Study|Death|85|||
143263284|NCT01343901|516517557|FG000|Overall Study|Physician Decision|4|||
143370400|NCT04771273|516899183|FG000|Maintenance Period|Other than listed|4|||
143207013|NCT02081599|516305024|FG000|Period 2：Open-label Period|Physician Decision|1|||
143207014|NCT02081599|516305025|FG001|Period 2：Open-label Period|Physician Decision|0|||
143207015|NCT02081599|516305024|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
143207016|NCT02081599|516305025|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
143207017|NCT01629953|516305026|FG000|Overall Study|Death|3|||
143207018|NCT01629953|516305027|FG001|Overall Study|Death|1|||
143207019|NCT01629953|516305026|FG000|Overall Study|Lost to Follow-up|10|||
143207020|NCT01629953|516305027|FG001|Overall Study|Lost to Follow-up|14|||
143207021|NCT00511134|516305028|FG000|Overall Study|Withdrawal by Subject|0|||
143207022|NCT00511134|516305029|FG001|Overall Study|Withdrawal by Subject|2|||
143207023|NCT01949090|516305030|FG000|Overall Study|Serious Adverse Event|0|||
143207024|NCT01949090|516305031|FG001|Overall Study|Serious Adverse Event|1|||
143207025|NCT01949090|516305032|FG002|Overall Study|Serious Adverse Event|2|||
143207026|NCT01949090|516305033|FG003|Overall Study|Serious Adverse Event|0|||
143207027|NCT01949090|516305034|FG004|Overall Study|Serious Adverse Event|1|||
143207028|NCT01949090|516305030|FG000|Overall Study|Withdrawal by Subject|2|||
143207029|NCT01949090|516305031|FG001|Overall Study|Withdrawal by Subject|0|||
143207030|NCT01949090|516305032|FG002|Overall Study|Withdrawal by Subject|0|||
143207031|NCT01949090|516305033|FG003|Overall Study|Withdrawal by Subject|0|||
143207032|NCT01949090|516305034|FG004|Overall Study|Withdrawal by Subject|1|||
143370401|NCT04771273|516899184|FG001|Maintenance Period|Other than listed|2|||
143370402|NCT04771273|516899185|FG002|Maintenance Period|Other than listed|0|||
143207033|NCT01949090|516305030|FG000|Overall Study|Protocol non-compliance|0|||
143207034|NCT01949090|516305031|FG001|Overall Study|Protocol non-compliance|0|||
143207035|NCT01949090|516305032|FG002|Overall Study|Protocol non-compliance|0|||
143207036|NCT01949090|516305033|FG003|Overall Study|Protocol non-compliance|0|||
143207037|NCT01949090|516305034|FG004|Overall Study|Protocol non-compliance|1|||
143207038|NCT01949090|516305030|FG000|Overall Study|Lost to Follow-up|2|||
143207039|NCT01949090|516305031|FG001|Overall Study|Lost to Follow-up|1|||
143207040|NCT01949090|516305032|FG002|Overall Study|Lost to Follow-up|0|||
143207041|NCT01949090|516305033|FG003|Overall Study|Lost to Follow-up|1|||
143207042|NCT01949090|516305034|FG004|Overall Study|Lost to Follow-up|1|||
143207043|NCT00707954|516305039|FG000|Overall Study|Physician Decision|0|||
143207044|NCT00707954|516305040|FG001|Overall Study|Physician Decision|0|||
143207045|NCT00707954|516305041|FG002|Overall Study|Physician Decision|0|||
143207046|NCT00707954|516305042|FG003|Overall Study|Physician Decision|0|||
143207047|NCT00707954|516305043|FG004|Overall Study|Physician Decision|1|||
143207048|NCT00306527|516305045|FG000|Overall Study|Lost to Follow-up|3|||
143207049|NCT00306527|516305046|FG001|Overall Study|Lost to Follow-up|4|||
143207050|NCT00306527|516305047|FG002|Overall Study|Lost to Follow-up|3|||
143207051|NCT00306527|516305048|FG003|Overall Study|Lost to Follow-up|0|||
143207052|NCT00306527|516305045|FG000|Overall Study|Withdrawal by Subject|2|||
143207053|NCT00306527|516305046|FG001|Overall Study|Withdrawal by Subject|3|||
143207054|NCT00306527|516305047|FG002|Overall Study|Withdrawal by Subject|0|||
143207055|NCT00306527|516305048|FG003|Overall Study|Withdrawal by Subject|3|||
143207056|NCT00306527|516305045|FG000|Overall Study|Adverse Event|0|||
143207057|NCT00306527|516305046|FG001|Overall Study|Adverse Event|0|||
143207058|NCT00306527|516305047|FG002|Overall Study|Adverse Event|1|||
143207059|NCT00306527|516305048|FG003|Overall Study|Adverse Event|1|||
143207060|NCT00306527|516305045|FG000|Overall Study|Death|1|||
143207061|NCT00306527|516305046|FG001|Overall Study|Death|0|||
143207062|NCT00306527|516305047|FG002|Overall Study|Death|1|||
143207063|NCT00306527|516305048|FG003|Overall Study|Death|2|||
143207064|NCT00785980|516305049|FG000|7 Day Washout Period|Protocol Violation|3|||
143207065|NCT00528801|516305050|FG000|Overall Study|Withdrawal by Subject|1|||
143207066|NCT00528801|516305051|FG001|Overall Study|Withdrawal by Subject|1|||
143207067|NCT00528801|516305050|FG000|Overall Study|Protocol Violation|11|||
143207068|NCT00528801|516305051|FG001|Overall Study|Protocol Violation|5|||
143207069|NCT00528801|516305050|FG000|Overall Study|Lost to Follow-up|15|||
143207070|NCT00528801|516305051|FG001|Overall Study|Lost to Follow-up|4|||
143207071|NCT00528801|516305050|FG000|Overall Study|Administrative Reasons|0|||
143207072|NCT00528801|516305051|FG001|Overall Study|Administrative Reasons|1|||
143207073|NCT00344500|516305052|FG000|Overall Study|Adverse Event|6|||
143207074|NCT00344500|516305053|FG001|Overall Study|Adverse Event|2|||
143207075|NCT00344500|516305054|FG002|Overall Study|Adverse Event|0|||
143207076|NCT00344500|516305052|FG000|Overall Study|Lost to Follow-up|5|||
143207077|NCT00344500|516305053|FG001|Overall Study|Lost to Follow-up|13|||
143207078|NCT00344500|516305054|FG002|Overall Study|Lost to Follow-up|1|||
143207079|NCT00344500|516305052|FG000|Overall Study|Withdrawal by Subject|7|||
143370403|NCT04771273|516899186|FG003|Maintenance Period|Other than listed|3|||
143370404|NCT04771273|516899183|FG000|Maintenance Period|Burden of study procedures|1|||
143370405|NCT04771273|516899184|FG001|Maintenance Period|Burden of study procedures|0|||
143207080|NCT00344500|516305053|FG001|Overall Study|Withdrawal by Subject|10|||
143207081|NCT00344500|516305054|FG002|Overall Study|Withdrawal by Subject|0|||
143207082|NCT00344500|516305052|FG000|Overall Study|Protocol Violation|4|||
143207083|NCT00344500|516305053|FG001|Overall Study|Protocol Violation|7|||
143207084|NCT00344500|516305054|FG002|Overall Study|Protocol Violation|1|||
143207085|NCT00344500|516305052|FG000|Overall Study|Not Noted|1|||
143207086|NCT00344500|516305053|FG001|Overall Study|Not Noted|3|||
143207087|NCT00344500|516305054|FG002|Overall Study|Not Noted|0|||
143207088|NCT02207491|516305055|FG000|Overall Study|Adverse Event|20|||
143207089|NCT02207491|516305056|FG001|Overall Study|Adverse Event|4|||
143207090|NCT02207491|516305055|FG000|Overall Study|Withdrawal by Subject|3|||
143207091|NCT02207491|516305056|FG001|Overall Study|Withdrawal by Subject|2|||
143207092|NCT02207491|516305055|FG000|Overall Study|Non-compliant|0|||
143207093|NCT02207491|516305056|FG001|Overall Study|Non-compliant|1|||
143207094|NCT02207491|516305055|FG000|Overall Study|Lost to Follow-up|0|||
143207095|NCT02207491|516305056|FG001|Overall Study|Lost to Follow-up|1|||
143207096|NCT02207491|516305055|FG000|Overall Study|Lack of Efficacy|3|||
143207097|NCT02207491|516305056|FG001|Overall Study|Lack of Efficacy|0|||
143207098|NCT02207491|516305055|FG000|Overall Study|Physician Decision|2|||
143207099|NCT02207491|516305056|FG001|Overall Study|Physician Decision|0|||
143207100|NCT02207491|516305055|FG000|Overall Study|Protocol Violation|3|||
143207101|NCT02207491|516305056|FG001|Overall Study|Protocol Violation|5|||
143207102|NCT00599755|516305057|FG000|Overall Study|Adverse Event|11|||
143207103|NCT00599755|516305057|FG000|Overall Study|Withdrawal by Subject|2|||
143207104|NCT00599755|516305057|FG000|Overall Study|Progression of Disease|3|||
143207105|NCT00599755|516305057|FG000|Overall Study|Other Reason|2|||
143207106|NCT00599755|516305057|FG000|Overall Study|No data available|1|||
143207107|NCT01306656|516305058|FG000|Overall Study|Lost to Follow-up|1|||
143207108|NCT01306656|516305059|FG001|Overall Study|Lost to Follow-up|0|||
143207109|NCT00417963|516305063|FG000|Overall Study|Lost to Follow-up|3|||
143207110|NCT00417963|516305063|FG000|Overall Study|Withdrawal by Subject|18|||
143207111|NCT00417963|516305063|FG000|Overall Study|Death|17|||
143207112|NCT00417963|516305063|FG000|Overall Study|Study device could not be deployed|3|||
143207113|NCT00477152|516305066|FG000|Overall Study|Parent withdrew consent|2|||
143207114|NCT00477152|516305066|FG000|Overall Study|Adverse Event|1|||
143207115|NCT01023672|516305067|FG000|Overall Study|Worsening disease|2|||
143207116|NCT01023672|516305067|FG000|Overall Study|Death|1|||
143207117|NCT02504580|516305068|FG000|Overall Study|Other|1|||
143207118|NCT02504580|516305069|FG001|Overall Study|Other|0|||
143207119|NCT02504580|516305070|FG002|Overall Study|Other|0|||
143207120|NCT02504580|516305071|FG003|Overall Study|Other|2|||
143207121|NCT02504580|516305072|FG004|Overall Study|Other|1|||
143207122|NCT02504580|516305073|FG005|Overall Study|Other|1|||
143207123|NCT02504580|516305074|FG006|Overall Study|Other|1|||
143207124|NCT02504580|516305075|FG007|Overall Study|Other|2|||
143207125|NCT02504580|516305076|FG008|Overall Study|Other|0|||
143207126|NCT02504580|516305077|FG009|Overall Study|Other|0|||
143207127|NCT02504580|516305078|FG010|Overall Study|Other|0|||
143207128|NCT02504580|516305079|FG011|Overall Study|Other|2|||
143207129|NCT02504580|516305068|FG000|Overall Study|Subject refusal to continue|0|||
143207130|NCT02504580|516305069|FG001|Overall Study|Subject refusal to continue|1|||
143207131|NCT02504580|516305070|FG002|Overall Study|Subject refusal to continue|0|||
143207132|NCT02504580|516305071|FG003|Overall Study|Subject refusal to continue|0|||
143207133|NCT02504580|516305072|FG004|Overall Study|Subject refusal to continue|0|||
143207134|NCT02504580|516305073|FG005|Overall Study|Subject refusal to continue|0|||
143263285|NCT01343901|516517557|FG000|Overall Study|Lost to Follow-up|12|||
143263286|NCT01343901|516517557|FG000|Overall Study|Management by another medical team|11|||
143263287|NCT01343901|516517557|FG000|Overall Study|Participant decision|1|||
143263288|NCT00870233|516517558|FG000|Overall Study|Withdrawal by Subject|18|||
143263289|NCT00870233|516517558|FG000|Overall Study|Did not undergo laparotomy|3|||
143263290|NCT00870233|516517558|FG000|Overall Study|Incompatible internet browser|2|||
143263291|NCT00870233|516517558|FG000|Overall Study|Death|1|||
143263292|NCT01369485|516517559|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
143263293|NCT01369485|516517560|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
143263294|NCT01369485|516517559|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
143263295|NCT01369485|516517560|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
143263296|NCT01369485|516517559|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
143263297|NCT01369485|516517560|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
143263298|NCT01369485|516517559|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
143263299|NCT01369485|516517560|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
143263300|NCT01369485|516517559|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
143263301|NCT01369485|516517560|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
143263302|NCT01369485|516517559|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
143263303|NCT01369485|516517560|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
143263304|NCT01369485|516517559|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
143263305|NCT01369485|516517560|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
143263306|NCT01369485|516517559|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
143207135|NCT02504580|516305074|FG006|Overall Study|Subject refusal to continue|0|||
143207136|NCT02504580|516305075|FG007|Overall Study|Subject refusal to continue|0|||
143207137|NCT02504580|516305076|FG008|Overall Study|Subject refusal to continue|0|||
143207138|NCT02504580|516305077|FG009|Overall Study|Subject refusal to continue|0|||
143207139|NCT02504580|516305078|FG010|Overall Study|Subject refusal to continue|0|||
143207140|NCT02504580|516305079|FG011|Overall Study|Subject refusal to continue|0|||
143207141|NCT00448747|516305081|FG000|Overall Study|collapsed veins|1|||
143207142|NCT00448747|516305082|FG001|Overall Study|collapsed veins|0|||
143207143|NCT02905006|516305084|FG000|Overall Study|Adverse Event|1|||
143207144|NCT02905006|516305085|FG001|Overall Study|Adverse Event|1|||
143207145|NCT02905006|516305086|FG002|Overall Study|Adverse Event|1|||
143207146|NCT02905006|516305087|FG003|Overall Study|Adverse Event|1|||
143207147|NCT02905006|516305088|FG004|Overall Study|Adverse Event|0|||
143207148|NCT02905006|516305089|FG005|Overall Study|Adverse Event|1|||
143207149|NCT02905006|516305084|FG000|Overall Study|Lack of Efficacy|1|||
143207150|NCT02905006|516305085|FG001|Overall Study|Lack of Efficacy|0|||
143207151|NCT02905006|516305086|FG002|Overall Study|Lack of Efficacy|0|||
143207152|NCT02905006|516305087|FG003|Overall Study|Lack of Efficacy|0|||
143207153|NCT02905006|516305088|FG004|Overall Study|Lack of Efficacy|0|||
143207154|NCT02905006|516305089|FG005|Overall Study|Lack of Efficacy|0|||
143207155|NCT02905006|516305084|FG000|Overall Study|Protocol Violation|2|||
143207156|NCT02905006|516305085|FG001|Overall Study|Protocol Violation|0|||
143207157|NCT02905006|516305086|FG002|Overall Study|Protocol Violation|0|||
143207158|NCT02905006|516305087|FG003|Overall Study|Protocol Violation|0|||
143207159|NCT02905006|516305088|FG004|Overall Study|Protocol Violation|0|||
143207160|NCT02905006|516305089|FG005|Overall Study|Protocol Violation|0|||
143207161|NCT02905006|516305084|FG000|Overall Study|Lost to Follow-up|0|||
143207162|NCT02905006|516305085|FG001|Overall Study|Lost to Follow-up|0|||
143207163|NCT02905006|516305086|FG002|Overall Study|Lost to Follow-up|0|||
143207164|NCT02905006|516305087|FG003|Overall Study|Lost to Follow-up|1|||
143207165|NCT02905006|516305088|FG004|Overall Study|Lost to Follow-up|1|||
143207166|NCT02905006|516305089|FG005|Overall Study|Lost to Follow-up|0|||
143207167|NCT02905006|516305084|FG000|Overall Study|Withdrawal by Subject|0|||
143207168|NCT02905006|516305085|FG001|Overall Study|Withdrawal by Subject|0|||
143207169|NCT02905006|516305086|FG002|Overall Study|Withdrawal by Subject|1|||
143207170|NCT02905006|516305087|FG003|Overall Study|Withdrawal by Subject|1|||
143207171|NCT02905006|516305088|FG004|Overall Study|Withdrawal by Subject|0|||
143207172|NCT02905006|516305089|FG005|Overall Study|Withdrawal by Subject|1|||
143207173|NCT02905006|516305084|FG000|Overall Study|Screening exclusion criteria met|1|||
143207174|NCT02905006|516305085|FG001|Overall Study|Screening exclusion criteria met|0|||
143207175|NCT02905006|516305086|FG002|Overall Study|Screening exclusion criteria met|0|||
143207176|NCT02905006|516305087|FG003|Overall Study|Screening exclusion criteria met|0|||
143207177|NCT02905006|516305088|FG004|Overall Study|Screening exclusion criteria met|0|||
143207178|NCT02905006|516305089|FG005|Overall Study|Screening exclusion criteria met|0|||
143207179|NCT02905006|516305084|FG000|Overall Study|Lab withdrawal criterion met|0|||
143207180|NCT02905006|516305085|FG001|Overall Study|Lab withdrawal criterion met|1|||
143207181|NCT02905006|516305086|FG002|Overall Study|Lab withdrawal criterion met|2|||
143207182|NCT02905006|516305087|FG003|Overall Study|Lab withdrawal criterion met|2|||
143207183|NCT02905006|516305088|FG004|Overall Study|Lab withdrawal criterion met|2|||
143207184|NCT02905006|516305089|FG005|Overall Study|Lab withdrawal criterion met|1|||
143207185|NCT02905006|516305084|FG000|Overall Study|Positive for Tuberculosis|0|||
143207186|NCT02905006|516305085|FG001|Overall Study|Positive for Tuberculosis|1|||
143207187|NCT02905006|516305086|FG002|Overall Study|Positive for Tuberculosis|0|||
143207188|NCT02905006|516305087|FG003|Overall Study|Positive for Tuberculosis|0|||
143207189|NCT02905006|516305088|FG004|Overall Study|Positive for Tuberculosis|0|||
143207190|NCT02905006|516305089|FG005|Overall Study|Positive for Tuberculosis|0|||
143207191|NCT02905006|516305084|FG000|Overall Study|Subject positive for Hep B|0|||
143207192|NCT02905006|516305085|FG001|Overall Study|Subject positive for Hep B|0|||
143207193|NCT02905006|516305086|FG002|Overall Study|Subject positive for Hep B|1|||
143207194|NCT02905006|516305087|FG003|Overall Study|Subject positive for Hep B|0|||
143207195|NCT02905006|516305088|FG004|Overall Study|Subject positive for Hep B|0|||
143207196|NCT02905006|516305089|FG005|Overall Study|Subject positive for Hep B|0|||
143207197|NCT02905006|516305084|FG000|Overall Study|Patient moved abroad|0|||
143207198|NCT02905006|516305085|FG001|Overall Study|Patient moved abroad|0|||
143207199|NCT02905006|516305086|FG002|Overall Study|Patient moved abroad|0|||
143207200|NCT02905006|516305087|FG003|Overall Study|Patient moved abroad|1|||
143207201|NCT02905006|516305088|FG004|Overall Study|Patient moved abroad|0|||
143207202|NCT02905006|516305089|FG005|Overall Study|Patient moved abroad|0|||
143207203|NCT02905006|516305084|FG000|Overall Study|Patient randomized by mistake|0|||
143207204|NCT02905006|516305085|FG001|Overall Study|Patient randomized by mistake|0|||
143207205|NCT02905006|516305086|FG002|Overall Study|Patient randomized by mistake|0|||
143207206|NCT02905006|516305087|FG003|Overall Study|Patient randomized by mistake|0|||
143207207|NCT02905006|516305088|FG004|Overall Study|Patient randomized by mistake|0|||
143207208|NCT02905006|516305089|FG005|Overall Study|Patient randomized by mistake|1|||
143207209|NCT02252965|516305094|FG000|Overall Study|Adverse Event|9|||
143207210|NCT02252965|516305095|FG001|Overall Study|Adverse Event|14|||
143207211|NCT02252965|516305094|FG000|Overall Study|Lost to Follow-up|16|||
143207212|NCT02252965|516305095|FG001|Overall Study|Lost to Follow-up|8|||
143207213|NCT02252965|516305094|FG000|Overall Study|Protocol Violation|4|||
143207214|NCT02252965|516305095|FG001|Overall Study|Protocol Violation|5|||
143207215|NCT02252965|516305094|FG000|Overall Study|Lack of Efficacy|0|||
143207216|NCT02252965|516305095|FG001|Overall Study|Lack of Efficacy|2|||
143207217|NCT02252965|516305094|FG000|Overall Study|Withdrawal by Subject|7|||
143207218|NCT02252965|516305095|FG001|Overall Study|Withdrawal by Subject|9|||
143207219|NCT02252965|516305094|FG000|Overall Study|Other|4|||
143207220|NCT02252965|516305095|FG001|Overall Study|Other|5|||
143207221|NCT02017522|516305096|FG000|Overall Study|Withdrawal by Subject|1|||
143207222|NCT05856227|516305097|FG000|Overall Study|Adverse Event|0|||
143207223|NCT05856227|516305098|FG001|Overall Study|Adverse Event|1|||
143207224|NCT05856227|516305097|FG000|Overall Study|Due to Investigator absence|1|||
143207225|NCT05856227|516305098|FG001|Overall Study|Due to Investigator absence|0|||
143207226|NCT05856227|516305097|FG000|Overall Study|Cerebrospinal fluid test positive for S. aureus|1|||
143207227|NCT05856227|516305098|FG001|Overall Study|Cerebrospinal fluid test positive for S. aureus|0|||
143207228|NCT01751139|516305099|FG000|Overall Study|Other|135|||
143207229|NCT01751139|516305099|FG000|Overall Study|Sponsor study termination|1609|||
143207230|NCT01751139|516305099|FG000|Overall Study|Lost to Follow-up|240|||
143207231|NCT01751139|516305099|FG000|Overall Study|Withdrawal by Subject|251|||
143207232|NCT01751139|516305099|FG000|Overall Study|Adverse Event|1|||
143207233|NCT01751139|516305099|FG000|Overall Study|Death|31|||
143207234|NCT04736628|516305100|FG000|Overall Study|Not treated|0|||
143207235|NCT04736628|516305101|FG001|Overall Study|Not treated|0|||
143207236|NCT04736628|516305102|FG002|Overall Study|Not treated|0|||
143207237|NCT04736628|516305103|FG003|Overall Study|Not treated|2|||
143207238|NCT04736628|516305100|FG000|Overall Study|Other reason than listed|1|||
143207239|NCT04736628|516305101|FG001|Overall Study|Other reason than listed|2|||
143207240|NCT04736628|516305102|FG002|Overall Study|Other reason than listed|2|||
143207241|NCT04736628|516305103|FG003|Overall Study|Other reason than listed|3|||
143207242|NCT04736628|516305100|FG000|Overall Study|Protocol deviation|0|||
143207243|NCT04736628|516305101|FG001|Overall Study|Protocol deviation|0|||
143207244|NCT04736628|516305102|FG002|Overall Study|Protocol deviation|0|||
143207245|NCT04736628|516305103|FG003|Overall Study|Protocol deviation|1|||
143207246|NCT04736628|516305100|FG000|Overall Study|Burden of study procedures|1|||
143207247|NCT04736628|516305101|FG001|Overall Study|Burden of study procedures|0|||
143207248|NCT04736628|516305102|FG002|Overall Study|Burden of study procedures|0|||
143207249|NCT04736628|516305103|FG003|Overall Study|Burden of study procedures|1|||
143207250|NCT04736628|516305100|FG000|Overall Study|Change of residence|0|||
143207251|NCT04736628|516305101|FG001|Overall Study|Change of residence|1|||
143207252|NCT04736628|516305102|FG002|Overall Study|Change of residence|0|||
143207253|NCT04736628|516305103|FG003|Overall Study|Change of residence|0|||
143207254|NCT04736628|516305100|FG000|Overall Study|Perceived lack of efficacy|1|||
143207255|NCT04736628|516305101|FG001|Overall Study|Perceived lack of efficacy|0|||
143207256|NCT04736628|516305102|FG002|Overall Study|Perceived lack of efficacy|0|||
143207257|NCT04736628|516305103|FG003|Overall Study|Perceived lack of efficacy|1|||
143207258|NCT04736628|516305100|FG000|Overall Study|Adverse Event|3|||
143207259|NCT04736628|516305101|FG001|Overall Study|Adverse Event|2|||
143207260|NCT04736628|516305102|FG002|Overall Study|Adverse Event|4|||
143207261|NCT04736628|516305103|FG003|Overall Study|Adverse Event|3|||
143207262|NCT04279613|516305104|FG000|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
143207263|NCT04279613|516305105|FG001|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
143207264|NCT04279613|516305106|FG002|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
143207265|NCT04279613|516305107|FG003|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
143207266|NCT04279613|516305108|FG004|Cohort 1: Dose Level 1 mg|Protocol Violation|1|||
143207267|NCT04279613|516305104|FG000|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
143207268|NCT04279613|516305105|FG001|Cohort 2: Dose Level 5 mg|Adverse Event|1|||
143207269|NCT04279613|516305106|FG002|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
143207270|NCT04279613|516305107|FG003|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
143207271|NCT04279613|516305108|FG004|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
143207272|NCT04279613|516305104|FG000|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
143207273|NCT04279613|516305105|FG001|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
143207274|NCT04279613|516305106|FG002|Cohort 3: Dose Level 12.5 mg|Protocol Violation|1|||
143207275|NCT04279613|516305107|FG003|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
143207276|NCT04279613|516305108|FG004|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
143207277|NCT04279613|516305104|FG000|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
143207278|NCT04279613|516305105|FG001|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
143207279|NCT04279613|516305106|FG002|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
143207280|NCT04279613|516305107|FG003|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
143207281|NCT04279613|516305108|FG004|Cohort 4: Dose Level 25 mg|Adverse Event|1|||
143207282|NCT04279613|516305104|FG000|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
143207283|NCT04279613|516305105|FG001|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
143207284|NCT04279613|516305106|FG002|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
143207285|NCT04279613|516305107|FG003|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|1|||
143207286|NCT04279613|516305108|FG004|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
143207287|NCT02704689|516305109|FG000|Overall Study|Physician Decision|1|||
143207288|NCT02704689|516305109|FG000|Overall Study|Study device not implanted|2|||
143207289|NCT01424566|516305112|FG000|Single-blind Treatment|Adverse Event|71|||
143207290|NCT01424566|516305113|FG001|Single-blind Treatment|Adverse Event|0|||
143207291|NCT01424566|516305114|FG002|Single-blind Treatment|Adverse Event|0|||
143207292|NCT01424566|516305112|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
143207293|NCT01424566|516305113|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
143207294|NCT01424566|516305114|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
143207295|NCT01424566|516305112|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
143207296|NCT01424566|516305113|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
143207297|NCT01424566|516305114|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
143207298|NCT01424566|516305112|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
143207299|NCT01424566|516305113|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
143207300|NCT01424566|516305114|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
143207301|NCT01424566|516305112|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
143207302|NCT01424566|516305113|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
143207303|NCT01424566|516305114|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
143207304|NCT01424566|516305112|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
143207305|NCT01424566|516305113|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
143207306|NCT01424566|516305114|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
143207307|NCT01424566|516305112|FG000|Double-blind Treatment|Adverse Event|0|||
143207308|NCT01424566|516305113|FG001|Double-blind Treatment|Adverse Event|21|||
143207309|NCT01424566|516305114|FG002|Double-blind Treatment|Adverse Event|13|||
143207310|NCT01424566|516305112|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
143207311|NCT01424566|516305113|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
143207312|NCT01424566|516305114|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
143207313|NCT01424566|516305112|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
143207314|NCT01424566|516305113|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
143207315|NCT01424566|516305114|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
143207316|NCT01424566|516305112|FG000|Double-blind Treatment|Lack of Efficacy|0|||
143207317|NCT01424566|516305113|FG001|Double-blind Treatment|Lack of Efficacy|1|||
143207318|NCT01424566|516305114|FG002|Double-blind Treatment|Lack of Efficacy|1|||
143207319|NCT01659255|516305115|FG000|Overall Study|Adverse Event|0|||
143207320|NCT01659255|516305116|FG001|Overall Study|Adverse Event|0|||
143207321|NCT01659255|516305117|FG002|Overall Study|Adverse Event|0|||
143207322|NCT01659255|516305118|FG003|Overall Study|Adverse Event|0|||
143207323|NCT01659255|516305119|FG004|Overall Study|Adverse Event|0|||
143207324|NCT01659255|516305120|FG005|Overall Study|Adverse Event|1|||
143207325|NCT01659255|516305121|FG006|Overall Study|Adverse Event|1|||
143207326|NCT01659255|516305122|FG007|Overall Study|Adverse Event|0|||
143263307|NCT01369485|516517560|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
143263308|NCT01369485|516517559|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
143263309|NCT01369485|516517560|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
143263310|NCT01369485|516517559|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
143263311|NCT01369485|516517560|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
143263312|NCT01227564|516517563|FG000|Overall Study|No Longer Willing to Participate|4|||
143263313|NCT01227564|516517564|FG001|Overall Study|No Longer Willing to Participate|2|||
143263314|NCT01227564|516517565|FG002|Overall Study|No Longer Willing to Participate|5|||
143263315|NCT01227564|516517563|FG000|Overall Study|Participant moved to another town|0|||
143263316|NCT01227564|516517564|FG001|Overall Study|Participant moved to another town|0|||
143263317|NCT01227564|516517565|FG002|Overall Study|Participant moved to another town|1|||
143263318|NCT02862600|516517582|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
143263319|NCT02862600|516517582|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
143263320|NCT02862600|516517582|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
143263321|NCT02862600|516517582|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
143263322|NCT00704808|516517592|FG000|Overall Study|Discontinued prior to starting treatment|14|||
143263323|NCT00704808|516517592|FG000|Overall Study|Death|7|||
143263324|NCT00704808|516517592|FG000|Overall Study|Tumor progression|80|||
143263325|NCT00704808|516517592|FG000|Overall Study|Patient's decision|11|||
143263326|NCT00704808|516517592|FG000|Overall Study|Early therapy discontinuation|16|||
143263327|NCT00704808|516517592|FG000|Overall Study|Adverse Event|1|||
143263328|NCT00704808|516517592|FG000|Overall Study|Lost to Follow-up|1|||
143263329|NCT00704808|516517592|FG000|Overall Study|Treatment change|1|||
143263330|NCT01017575|516517601|FG000|Overall Study|Lack of Efficacy|0|||
143263331|NCT01017575|516517602|FG001|Overall Study|Lack of Efficacy|1|||
143263332|NCT01017575|516517603|FG002|Overall Study|Lack of Efficacy|0|||
143263333|NCT01017575|516517604|FG003|Overall Study|Lack of Efficacy|1|||
143263334|NCT01017575|516517605|FG004|Overall Study|Lack of Efficacy|1|||
143263335|NCT01017575|516517601|FG000|Overall Study|Adverse Event|0|||
143263336|NCT01017575|516517602|FG001|Overall Study|Adverse Event|1|||
143263337|NCT01017575|516517603|FG002|Overall Study|Adverse Event|0|||
143263338|NCT01017575|516517604|FG003|Overall Study|Adverse Event|0|||
143263339|NCT01017575|516517605|FG004|Overall Study|Adverse Event|2|||
143263340|NCT01017575|516517601|FG000|Overall Study|Withdrawal by Subject|1|||
143207327|NCT01659255|516305123|FG008|Overall Study|Adverse Event|0|||
143207328|NCT01659255|516305124|FG009|Overall Study|Adverse Event|1|||
143207329|NCT01659255|516305125|FG010|Overall Study|Adverse Event|0|||
143207330|NCT01659255|516305126|FG011|Overall Study|Adverse Event|1|||
143207331|NCT01659255|516305127|FG012|Overall Study|Adverse Event|0|||
143207332|NCT01659255|516305128|FG013|Overall Study|Adverse Event|2|||
143263341|NCT01017575|516517602|FG001|Overall Study|Withdrawal by Subject|0|||
143207333|NCT01659255|516305129|FG014|Overall Study|Adverse Event|0|||
143207334|NCT01659255|516305130|FG015|Overall Study|Adverse Event|1|||
143207335|NCT01659255|516305131|FG016|Overall Study|Adverse Event|0|||
143207336|NCT01659255|516305115|FG000|Overall Study|Death|0|||
143207337|NCT01659255|516305116|FG001|Overall Study|Death|1|||
143207338|NCT01659255|516305117|FG002|Overall Study|Death|0|||
143207339|NCT01659255|516305118|FG003|Overall Study|Death|0|||
143207340|NCT01659255|516305119|FG004|Overall Study|Death|0|||
143207341|NCT01659255|516305120|FG005|Overall Study|Death|0|||
143207342|NCT01659255|516305121|FG006|Overall Study|Death|0|||
143207343|NCT01659255|516305122|FG007|Overall Study|Death|1|||
143207344|NCT01659255|516305123|FG008|Overall Study|Death|1|||
143207345|NCT01659255|516305124|FG009|Overall Study|Death|0|||
143207346|NCT01659255|516305125|FG010|Overall Study|Death|0|||
143207347|NCT01659255|516305126|FG011|Overall Study|Death|0|||
143207348|NCT01659255|516305127|FG012|Overall Study|Death|1|||
143207349|NCT01659255|516305128|FG013|Overall Study|Death|1|||
143207350|NCT01659255|516305129|FG014|Overall Study|Death|2|||
143207351|NCT01659255|516305130|FG015|Overall Study|Death|1|||
143207352|NCT01659255|516305131|FG016|Overall Study|Death|0|||
143207353|NCT01659255|516305115|FG000|Overall Study|Progressive Disease|2|||
143207354|NCT01659255|516305116|FG001|Overall Study|Progressive Disease|0|||
143207355|NCT01659255|516305117|FG002|Overall Study|Progressive Disease|0|||
143207356|NCT01659255|516305118|FG003|Overall Study|Progressive Disease|0|||
143207357|NCT01659255|516305119|FG004|Overall Study|Progressive Disease|0|||
143207358|NCT01659255|516305120|FG005|Overall Study|Progressive Disease|0|||
143207359|NCT01659255|516305121|FG006|Overall Study|Progressive Disease|0|||
143207360|NCT01659255|516305122|FG007|Overall Study|Progressive Disease|1|||
143207361|NCT01659255|516305123|FG008|Overall Study|Progressive Disease|0|||
143207362|NCT01659255|516305124|FG009|Overall Study|Progressive Disease|2|||
143207363|NCT01659255|516305125|FG010|Overall Study|Progressive Disease|2|||
143207364|NCT01659255|516305126|FG011|Overall Study|Progressive Disease|3|||
143207365|NCT01659255|516305127|FG012|Overall Study|Progressive Disease|5|||
143207366|NCT01659255|516305128|FG013|Overall Study|Progressive Disease|13|||
143207367|NCT01659255|516305129|FG014|Overall Study|Progressive Disease|6|||
143263342|NCT01017575|516517603|FG002|Overall Study|Withdrawal by Subject|0|||
143263343|NCT01017575|516517604|FG003|Overall Study|Withdrawal by Subject|0|||
143263344|NCT01017575|516517605|FG004|Overall Study|Withdrawal by Subject|0|||
143263345|NCT03500679|516517606|FG000|Overall Study|Lost to Follow-up|6|||
143263346|NCT03500679|516517607|FG001|Overall Study|Lost to Follow-up|3|||
143263347|NCT03500679|516517606|FG000|Overall Study|Withdrawal by Subject|3|||
143263348|NCT03500679|516517607|FG001|Overall Study|Withdrawal by Subject|0|||
143263349|NCT04706416|516517608|FG000|Overall Study|Lost to Follow-up|2|||
143263350|NCT04706416|516517609|FG001|Overall Study|Lost to Follow-up|0|||
143263351|NCT02730208|516517613|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
143263352|NCT02730208|516517614|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
143263353|NCT00995865|516517615|FG000|Overall Study|Protocol Violation|2|||
143263354|NCT00995865|516517616|FG001|Overall Study|Protocol Violation|0|||
143263355|NCT00995865|516517617|FG002|Overall Study|Protocol Violation|0|||
143263356|NCT00995865|516517615|FG000|Overall Study|Lost to Follow-up|0|||
143263357|NCT00995865|516517616|FG001|Overall Study|Lost to Follow-up|0|||
143263358|NCT00995865|516517617|FG002|Overall Study|Lost to Follow-up|1|||
143263359|NCT02021656|516517634|FG000|Overall Study|Adverse Event|1|||
143263360|NCT02021656|516517634|FG000|Overall Study|Lack of Efficacy|2|||
143263361|NCT02021656|516517634|FG000|Overall Study|Lost to Follow-up|1|||
143263362|NCT02021656|516517634|FG000|Overall Study|Withdrew Consent|2|||
143207368|NCT01659255|516305130|FG015|Overall Study|Progressive Disease|2|||
143207369|NCT01659255|516305131|FG016|Overall Study|Progressive Disease|3|||
143207370|NCT01659255|516305115|FG000|Overall Study|Withdrew Consent|0|||
143263363|NCT00510952|516517635|FG000|Overall Study|Adverse Event|1|||
143263364|NCT00510952|516517636|FG001|Overall Study|Adverse Event|0|||
143207371|NCT01659255|516305116|FG001|Overall Study|Withdrew Consent|0|||
143207372|NCT01659255|516305117|FG002|Overall Study|Withdrew Consent|0|||
143263365|NCT00510952|516517635|FG000|Overall Study|Entry Criteria Not Met|3|||
143207373|NCT01659255|516305118|FG003|Overall Study|Withdrew Consent|0|||
143207374|NCT01659255|516305119|FG004|Overall Study|Withdrew Consent|0|||
143207375|NCT01659255|516305120|FG005|Overall Study|Withdrew Consent|0|||
143263366|NCT00510952|516517636|FG001|Overall Study|Entry Criteria Not Met|1|||
143263367|NCT00510952|516517635|FG000|Overall Study|Lost to Follow-up|5|||
143207376|NCT01659255|516305121|FG006|Overall Study|Withdrew Consent|0|||
143207377|NCT01659255|516305122|FG007|Overall Study|Withdrew Consent|0|||
143207378|NCT01659255|516305123|FG008|Overall Study|Withdrew Consent|0|||
143207379|NCT01659255|516305124|FG009|Overall Study|Withdrew Consent|0|||
143207380|NCT01659255|516305125|FG010|Overall Study|Withdrew Consent|1|||
143207381|NCT01659255|516305126|FG011|Overall Study|Withdrew Consent|0|||
143263368|NCT00510952|516517636|FG001|Overall Study|Lost to Follow-up|3|||
143263369|NCT00510952|516517635|FG000|Overall Study|Physician Decision|1|||
143207382|NCT01659255|516305127|FG012|Overall Study|Withdrew Consent|0|||
143207383|NCT01659255|516305128|FG013|Overall Study|Withdrew Consent|1|||
143207384|NCT01659255|516305129|FG014|Overall Study|Withdrew Consent|0|||
143207385|NCT01659255|516305130|FG015|Overall Study|Withdrew Consent|0|||
143207386|NCT01659255|516305131|FG016|Overall Study|Withdrew Consent|0|||
143207387|NCT01659255|516305115|FG000|Overall Study|Investigator Decision|0|||
143207388|NCT01659255|516305116|FG001|Overall Study|Investigator Decision|0|||
143207389|NCT01659255|516305117|FG002|Overall Study|Investigator Decision|0|||
143207390|NCT01659255|516305118|FG003|Overall Study|Investigator Decision|0|||
143207391|NCT01659255|516305119|FG004|Overall Study|Investigator Decision|0|||
143207392|NCT01659255|516305120|FG005|Overall Study|Investigator Decision|0|||
143207393|NCT01659255|516305121|FG006|Overall Study|Investigator Decision|0|||
143207394|NCT01659255|516305122|FG007|Overall Study|Investigator Decision|0|||
143207395|NCT01659255|516305123|FG008|Overall Study|Investigator Decision|0|||
143207396|NCT01659255|516305124|FG009|Overall Study|Investigator Decision|0|||
143207397|NCT01659255|516305125|FG010|Overall Study|Investigator Decision|0|||
143207398|NCT01659255|516305126|FG011|Overall Study|Investigator Decision|0|||
143207399|NCT01659255|516305127|FG012|Overall Study|Investigator Decision|1|||
143207400|NCT01659255|516305128|FG013|Overall Study|Investigator Decision|1|||
143207401|NCT01659255|516305129|FG014|Overall Study|Investigator Decision|0|||
143207402|NCT01659255|516305130|FG015|Overall Study|Investigator Decision|0|||
143207403|NCT01659255|516305131|FG016|Overall Study|Investigator Decision|0|||
143207404|NCT01659255|516305115|FG000|Overall Study|Sponsor's Decision|0|||
143207405|NCT01659255|516305116|FG001|Overall Study|Sponsor's Decision|0|||
143207406|NCT01659255|516305117|FG002|Overall Study|Sponsor's Decision|0|||
143207407|NCT01659255|516305118|FG003|Overall Study|Sponsor's Decision|0|||
143207408|NCT01659255|516305119|FG004|Overall Study|Sponsor's Decision|0|||
143207409|NCT01659255|516305120|FG005|Overall Study|Sponsor's Decision|0|||
143207410|NCT01659255|516305121|FG006|Overall Study|Sponsor's Decision|1|||
143207411|NCT01659255|516305122|FG007|Overall Study|Sponsor's Decision|0|||
143207412|NCT01659255|516305123|FG008|Overall Study|Sponsor's Decision|0|||
143207413|NCT01659255|516305124|FG009|Overall Study|Sponsor's Decision|0|||
143207414|NCT01659255|516305125|FG010|Overall Study|Sponsor's Decision|0|||
143207415|NCT01659255|516305126|FG011|Overall Study|Sponsor's Decision|0|||
143207416|NCT01659255|516305127|FG012|Overall Study|Sponsor's Decision|0|||
143207417|NCT01659255|516305128|FG013|Overall Study|Sponsor's Decision|0|||
143207418|NCT01659255|516305129|FG014|Overall Study|Sponsor's Decision|0|||
143207419|NCT01659255|516305130|FG015|Overall Study|Sponsor's Decision|0|||
143207420|NCT01659255|516305131|FG016|Overall Study|Sponsor's Decision|0|||
143207421|NCT01659255|516305115|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
143207422|NCT01659255|516305116|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
143207423|NCT01659255|516305117|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
143263370|NCT00510952|516517636|FG001|Overall Study|Physician Decision|1|||
143263371|NCT00510952|516517635|FG000|Overall Study|Protocol Violation|7|||
143263372|NCT00510952|516517636|FG001|Overall Study|Protocol Violation|4|||
143263373|NCT00510952|516517635|FG000|Overall Study|Sponsor Decision|1|||
143263374|NCT00510952|516517636|FG001|Overall Study|Sponsor Decision|0|||
143207424|NCT01659255|516305118|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
143263375|NCT00510952|516517635|FG000|Overall Study|Withdrawal by Subject|6|||
143263376|NCT00510952|516517636|FG001|Overall Study|Withdrawal by Subject|7|||
143263377|NCT00510952|516517635|FG000|Overall Study|Did Not Receive Study Drug|2|||
143263378|NCT00510952|516517636|FG001|Overall Study|Did Not Receive Study Drug|0|||
143263379|NCT02793128|516517639|FG000|Overall Study|Death|4|||
143263380|NCT02793128|516517639|FG000|Overall Study|Withdrawal by Subject|2|||
143263381|NCT02793128|516517639|FG000|Overall Study|Physician Decision|1|||
143263382|NCT02793128|516517639|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
143263383|NCT02793128|516517639|FG000|Overall Study|Patient elected nephroureterectomy|1|||
143263384|NCT02101112|516517643|FG000|Overall Study|Adverse Event|0|||
143263385|NCT02101112|516517644|FG001|Overall Study|Adverse Event|0|||
143263386|NCT02101112|516517645|FG002|Overall Study|Adverse Event|1|||
143263387|NCT02101112|516517646|FG003|Overall Study|Adverse Event|0|||
143263388|NCT02101112|516517647|FG004|Overall Study|Adverse Event|0|||
143263389|NCT02101112|516517648|FG005|Overall Study|Adverse Event|0|||
143263390|NCT02101112|516517643|FG000|Overall Study|Withdrawal by Subject|0|||
143263391|NCT02101112|516517644|FG001|Overall Study|Withdrawal by Subject|0|||
143263392|NCT02101112|516517645|FG002|Overall Study|Withdrawal by Subject|0|||
143263393|NCT02101112|516517646|FG003|Overall Study|Withdrawal by Subject|0|||
143263394|NCT02101112|516517647|FG004|Overall Study|Withdrawal by Subject|1|||
143207425|NCT01659255|516305119|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
143207426|NCT01659255|516305120|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
143207427|NCT01659255|516305121|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
143207428|NCT01659255|516305122|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
143207429|NCT01659255|516305123|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
143263395|NCT02101112|516517648|FG005|Overall Study|Withdrawal by Subject|0|||
143263396|NCT00782795|516517649|FG000|Overall Study|Withdrawal by Subject|1|||
143263397|NCT00782795|516517650|FG001|Overall Study|Withdrawal by Subject|2|||
143207430|NCT01659255|516305124|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
143207431|NCT01659255|516305125|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
143207432|NCT01659255|516305126|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
143207433|NCT01659255|516305127|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
143207434|NCT01659255|516305128|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
143207435|NCT01659255|516305129|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
143207436|NCT01659255|516305130|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
143207437|NCT01659255|516305131|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
143207438|NCT01659255|516305115|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
143207439|NCT01659255|516305116|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
143207440|NCT01659255|516305117|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
143207441|NCT01659255|516305118|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
143207442|NCT01659255|516305119|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
143207443|NCT01659255|516305120|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
143207444|NCT01659255|516305121|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
143207445|NCT01659255|516305122|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
143207446|NCT01659255|516305123|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
143263398|NCT02782923|516517651|FG000|Overall Study|Lost to Follow-up|15|||
143207447|NCT01659255|516305124|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
143207448|NCT01659255|516305125|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
143207449|NCT01659255|516305126|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
143207450|NCT01659255|516305127|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
143207451|NCT01659255|516305128|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
143207452|NCT01659255|516305129|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
143207453|NCT01659255|516305130|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
143207454|NCT01659255|516305131|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
143207455|NCT05086510|516305132|FG000|Overall Study|Lost to Follow-up|0|||
143207456|NCT05086510|516305133|FG001|Overall Study|Lost to Follow-up|2|||
143207457|NCT05086510|516305132|FG000|Overall Study|Death|0|||
143207458|NCT05086510|516305133|FG001|Overall Study|Death|2|||
143207459|NCT00413374|516305134|FG000|Overall Study|Ineligible due to screening criteria.|3|||
143207460|NCT00413374|516305135|FG001|Overall Study|Ineligible due to screening criteria.|0|||
143207461|NCT00413374|516305134|FG000|Overall Study|Adverse Event|1|||
143207462|NCT00413374|516305135|FG001|Overall Study|Adverse Event|0|||
143207463|NCT00413374|516305134|FG000|Overall Study|Lost to Follow-up|1|||
143207464|NCT00413374|516305135|FG001|Overall Study|Lost to Follow-up|0|||
143207465|NCT00413374|516305134|FG000|Overall Study|Surgery|1|||
143207466|NCT00413374|516305135|FG001|Overall Study|Surgery|0|||
143207467|NCT00552760|516305136|FG000|Overall Study|Adverse Event|3|||
143207468|NCT00552760|516305137|FG001|Overall Study|Adverse Event|5|||
143207469|NCT00552760|516305136|FG000|Overall Study|Relapsed- Depressed Event|10|||
143207470|NCT00552760|516305137|FG001|Overall Study|Relapsed- Depressed Event|16|||
143207471|NCT00552760|516305136|FG000|Overall Study|Relapse- Manic Event|3|||
143207472|NCT00552760|516305137|FG001|Overall Study|Relapse- Manic Event|3|||
143207473|NCT00552760|516305136|FG000|Overall Study|Relapsed- Mixed Event|3|||
143207474|NCT00552760|516305137|FG001|Overall Study|Relapsed- Mixed Event|5|||
143207475|NCT00552760|516305136|FG000|Overall Study|Protocol Violation|0|||
143207476|NCT00552760|516305137|FG001|Overall Study|Protocol Violation|1|||
143207477|NCT00552760|516305136|FG000|Overall Study|Lost to Follow-up|1|||
143207478|NCT00552760|516305137|FG001|Overall Study|Lost to Follow-up|1|||
143207479|NCT00552760|516305136|FG000|Overall Study|Non-compliance|1|||
143207480|NCT00552760|516305137|FG001|Overall Study|Non-compliance|1|||
143207481|NCT00552760|516305136|FG000|Overall Study|Medical Condition|1|||
143207482|NCT00552760|516305137|FG001|Overall Study|Medical Condition|1|||
143207483|NCT00552760|516305136|FG000|Overall Study|Withdrawal by Subject|3|||
143207484|NCT00552760|516305137|FG001|Overall Study|Withdrawal by Subject|0|||
143207485|NCT00552760|516305136|FG000|Overall Study|Medication Change|1|||
143207486|NCT00552760|516305137|FG001|Overall Study|Medication Change|0|||
143207487|NCT03691779|516305140|FG000|Part B (24 Weeks)|Adverse Event|0|||
143207488|NCT03691779|516305141|FG001|Part B (24 Weeks)|Adverse Event|1|||
143207489|NCT03691779|516305140|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
143207490|NCT03691779|516305141|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
143207491|NCT01561963|516305142|FG000|Overall Study|Adverse Event|1|||
143207492|NCT03869333|516305149|FG000|Overall Study|Lost to Follow-up|1|||
143207493|NCT03869333|516305150|FG001|Overall Study|Lost to Follow-up|0|||
143207494|NCT03869333|516305151|FG002|Overall Study|Lost to Follow-up|0|||
143207495|NCT03869333|516305152|FG003|Overall Study|Lost to Follow-up|0|||
143207496|NCT03869333|516305149|FG000|Overall Study|Pregnancy|1|||
143207497|NCT03869333|516305150|FG001|Overall Study|Pregnancy|0|||
143207498|NCT03869333|516305151|FG002|Overall Study|Pregnancy|0|||
143263399|NCT01994590|516519724|FG000|Overall Study|Adverse Event|1|||
143207499|NCT03869333|516305152|FG003|Overall Study|Pregnancy|0|||
143207500|NCT03869333|516305149|FG000|Overall Study|Physician Decision|0|||
143207501|NCT03869333|516305150|FG001|Overall Study|Physician Decision|1|||
143207502|NCT03869333|516305151|FG002|Overall Study|Physician Decision|0|||
143207503|NCT03869333|516305152|FG003|Overall Study|Physician Decision|0|||
143207504|NCT01927055|516305153|FG000|Open-label|Adverse Event|6|||
143207505|NCT01927055|516305154|FG001|Open-label|Adverse Event|0|||
143207506|NCT01927055|516305155|FG002|Open-label|Adverse Event|0|||
143207507|NCT01927055|516305153|FG000|Open-label|Withdrawal by Subject|1|||
143207508|NCT01927055|516305154|FG001|Open-label|Withdrawal by Subject|0|||
143207509|NCT01927055|516305155|FG002|Open-label|Withdrawal by Subject|0|||
143207510|NCT01927055|516305153|FG000|Open-label|Study Stopped|4|||
143207511|NCT01927055|516305154|FG001|Open-label|Study Stopped|0|||
143207512|NCT01927055|516305155|FG002|Open-label|Study Stopped|0|||
143207513|NCT01927055|516305153|FG000|Open-label|Supine Hypertension|4|||
143207514|NCT01927055|516305154|FG001|Open-label|Supine Hypertension|0|||
143207515|NCT01927055|516305155|FG002|Open-label|Supine Hypertension|0|||
143207516|NCT01927055|516305153|FG000|Open-label|Difficulty attending study visits|1|||
143207517|NCT01927055|516305154|FG001|Open-label|Difficulty attending study visits|0|||
143207518|NCT01927055|516305155|FG002|Open-label|Difficulty attending study visits|0|||
143207519|NCT01927055|516305153|FG000|Double-Blind|Adverse Event|0|||
143207520|NCT01927055|516305154|FG001|Double-Blind|Adverse Event|1|||
143207521|NCT01927055|516305155|FG002|Double-Blind|Adverse Event|1|||
143207522|NCT01927055|516305153|FG000|Double-Blind|Protocol Violation|0|||
143207523|NCT01927055|516305154|FG001|Double-Blind|Protocol Violation|0|||
143207524|NCT01927055|516305155|FG002|Double-Blind|Protocol Violation|1|||
143207525|NCT01927055|516305153|FG000|Double-Blind|Withdrawal by Subject|0|||
143207526|NCT01927055|516305154|FG001|Double-Blind|Withdrawal by Subject|2|||
143207527|NCT01927055|516305155|FG002|Double-Blind|Withdrawal by Subject|3|||
143207528|NCT01927055|516305153|FG000|Double-Blind|Study Stopped|0|||
143207529|NCT01927055|516305154|FG001|Double-Blind|Study Stopped|7|||
143207530|NCT01927055|516305155|FG002|Double-Blind|Study Stopped|7|||
143207531|NCT01927055|516305153|FG000|Double-Blind|Supine Hypertension|0|||
143207532|NCT01927055|516305154|FG001|Double-Blind|Supine Hypertension|0|||
143207533|NCT01927055|516305155|FG002|Double-Blind|Supine Hypertension|1|||
143207534|NCT01927055|516305153|FG000|Double-Blind|Extended Vacation|0|||
143207535|NCT01927055|516305154|FG001|Double-Blind|Extended Vacation|1|||
143207536|NCT01927055|516305155|FG002|Double-Blind|Extended Vacation|0|||
143207537|NCT02598128|516305156|FG000|Period A: Days -7 to -1|Adverse Event|1|||
143207538|NCT02598128|516305157|FG001|Period A: Days -7 to -1|Adverse Event|0|||
143207539|NCT02598128|516305158|FG002|Period A: Days -7 to -1|Adverse Event|0|||
143207540|NCT02598128|516305159|FG003|Period A: Days -7 to -1|Adverse Event|0|||
143207541|NCT01459913|516305160|FG000|Overall Study|Adverse Event|0|||
143207542|NCT01459913|516305161|FG001|Overall Study|Adverse Event|0|||
143207543|NCT01459913|516305162|FG002|Overall Study|Adverse Event|0|||
143207544|NCT01459913|516305163|FG003|Overall Study|Adverse Event|3|||
143207545|NCT01459913|516305160|FG000|Overall Study|Withdrawal by Subject|4|||
143207546|NCT01459913|516305161|FG001|Overall Study|Withdrawal by Subject|0|||
143207547|NCT01459913|516305162|FG002|Overall Study|Withdrawal by Subject|0|||
143207548|NCT01459913|516305163|FG003|Overall Study|Withdrawal by Subject|5|||
143207549|NCT01459913|516305160|FG000|Overall Study|Lost to Follow-up|7|||
143207550|NCT01459913|516305161|FG001|Overall Study|Lost to Follow-up|4|||
143207551|NCT01459913|516305162|FG002|Overall Study|Lost to Follow-up|1|||
143207552|NCT01459913|516305163|FG003|Overall Study|Lost to Follow-up|8|||
143207553|NCT01459913|516305160|FG000|Overall Study|Death|0|||
143207554|NCT01459913|516305161|FG001|Overall Study|Death|0|||
143207555|NCT01459913|516305162|FG002|Overall Study|Death|0|||
143207556|NCT01459913|516305163|FG003|Overall Study|Death|1|||
143207557|NCT01459913|516305160|FG000|Overall Study|Non- Compliance|0|||
143207558|NCT01459913|516305161|FG001|Overall Study|Non- Compliance|0|||
143207559|NCT01459913|516305162|FG002|Overall Study|Non- Compliance|0|||
143207560|NCT01459913|516305163|FG003|Overall Study|Non- Compliance|3|||
143207561|NCT01459913|516305160|FG000|Overall Study|Physician Decision|0|||
143207562|NCT01459913|516305161|FG001|Overall Study|Physician Decision|1|||
143207563|NCT01459913|516305162|FG002|Overall Study|Physician Decision|0|||
143207564|NCT01459913|516305163|FG003|Overall Study|Physician Decision|0|||
143207565|NCT01459913|516305160|FG000|Overall Study|Study Terminated by Sponsor|30|||
143207566|NCT01459913|516305161|FG001|Overall Study|Study Terminated by Sponsor|15|||
143207567|NCT01459913|516305162|FG002|Overall Study|Study Terminated by Sponsor|9|||
143207568|NCT01459913|516305163|FG003|Overall Study|Study Terminated by Sponsor|11|||
143370406|NCT04771273|516899185|FG002|Maintenance Period|Burden of study procedures|0|||
143370407|NCT04771273|516899186|FG003|Maintenance Period|Burden of study procedures|0|||
143370408|NCT04771273|516899183|FG000|Maintenance Period|Change of residence|0|||
143370409|NCT04771273|516899184|FG001|Maintenance Period|Change of residence|1|||
143370410|NCT04771273|516899185|FG002|Maintenance Period|Change of residence|3|||
143370411|NCT04771273|516899186|FG003|Maintenance Period|Change of residence|0|||
143370412|NCT04771273|516899183|FG000|Maintenance Period|Perceived lack of efficacy|0|||
143370413|NCT04771273|516899184|FG001|Maintenance Period|Perceived lack of efficacy|0|||
143370414|NCT04771273|516899185|FG002|Maintenance Period|Perceived lack of efficacy|0|||
143207569|NCT01459913|516305160|FG000|Overall Study|Other|0|||
143207570|NCT01459913|516305161|FG001|Overall Study|Other|0|||
143207571|NCT01459913|516305162|FG002|Overall Study|Other|3|||
143207572|NCT01459913|516305163|FG003|Overall Study|Other|1|||
143207573|NCT01459913|516305160|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
143207574|NCT01459913|516305161|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
143207575|NCT01459913|516305162|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
143207576|NCT01459913|516305163|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
143207577|NCT00849108|516305166|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
143207578|NCT00849108|516305167|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
143207579|NCT00849108|516305166|FG000|Cohort 2 Efficacy|Adverse Event|0|||
143207580|NCT00849108|516305167|FG001|Cohort 2 Efficacy|Adverse Event|1|||
143207581|NCT00849108|516305166|FG000|Cohort 2 Efficacy|Other|0|||
143207582|NCT00849108|516305167|FG001|Cohort 2 Efficacy|Other|9|||
143207583|NCT02963701|516305168|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
143207584|NCT02963701|516305169|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
143207585|NCT03480009|516305170|FG000|Overall Study|Lost to Follow-up|4|||
143207586|NCT03480009|516305171|FG001|Overall Study|Lost to Follow-up|5|||
143207587|NCT03480009|516305172|FG002|Overall Study|Lost to Follow-up|4|||
143207588|NCT03480009|516305173|FG003|Overall Study|Lost to Follow-up|0|||
143207589|NCT00896649|516305176|FG000|Overall Study|Physician Decision|1|||
143207590|NCT00896649|516305176|FG000|Overall Study|Pregnancy|1|||
143207591|NCT00896649|516305176|FG000|Overall Study|missing documentation|1|||
143207592|NCT00896649|516305176|FG000|Overall Study|technical difficulties|2|||
143207593|NCT03652675|516305178|FG000|Overall Study|Lost to Follow-up|4|||
143207594|NCT03652675|516305179|FG001|Overall Study|Lost to Follow-up|4|||
143207595|NCT01638559|516305180|FG000|Overall Study|Lost to Follow-up|1|||
143207596|NCT01638559|516305180|FG000|Overall Study|Withdrawal by Subject|1|||
143207597|NCT01638559|516305180|FG000|Overall Study|Subject declined to travel for biopsy|1|||
143207598|NCT01555125|516305185|FG000|Induction Period|Lost to Follow-up|0|||
143207599|NCT01555125|516305186|FG001|Induction Period|Lost to Follow-up|2|||
143207600|NCT01555125|516305187|FG002|Induction Period|Lost to Follow-up|0|||
143207601|NCT01555125|516305188|FG003|Induction Period|Lost to Follow-up|0|||
143207602|NCT01555125|516305189|FG004|Induction Period|Lost to Follow-up|0|||
143207603|NCT01555125|516305185|FG000|Induction Period|Adverse Event|0|||
143207604|NCT01555125|516305186|FG001|Induction Period|Adverse Event|1|||
143207605|NCT01555125|516305187|FG002|Induction Period|Adverse Event|0|||
143207606|NCT01555125|516305188|FG003|Induction Period|Adverse Event|0|||
143207607|NCT01555125|516305189|FG004|Induction Period|Adverse Event|1|||
143207608|NCT01555125|516305185|FG000|Induction Period|Subject / guardian decision|0|||
143207609|NCT01555125|516305186|FG001|Induction Period|Subject / guardian decision|0|||
143207610|NCT01555125|516305187|FG002|Induction Period|Subject / guardian decision|0|||
143207611|NCT01555125|516305188|FG003|Induction Period|Subject / guardian decision|0|||
143207612|NCT01555125|516305189|FG004|Induction Period|Subject / guardian decision|2|||
143207613|NCT01555125|516305185|FG000|Induction Period|Death|1|||
143207614|NCT01555125|516305186|FG001|Induction Period|Death|0|||
143207615|NCT01555125|516305187|FG002|Induction Period|Death|0|||
143207616|NCT01555125|516305188|FG003|Induction Period|Death|0|||
143207617|NCT01555125|516305189|FG004|Induction Period|Death|0|||
143207618|NCT01555125|516305185|FG000|Maintenance Period|Adverse Event|1|||
143207619|NCT01555125|516305186|FG001|Maintenance Period|Adverse Event|1|||
143207620|NCT01555125|516305187|FG002|Maintenance Period|Adverse Event|0|||
143207621|NCT01555125|516305188|FG003|Maintenance Period|Adverse Event|0|||
143207622|NCT01555125|516305189|FG004|Maintenance Period|Adverse Event|0|||
143207623|NCT01555125|516305185|FG000|Maintenance Period|Subject / guardian decision|1|||
143207624|NCT01555125|516305186|FG001|Maintenance Period|Subject / guardian decision|2|||
143207625|NCT01555125|516305187|FG002|Maintenance Period|Subject / guardian decision|0|||
143207626|NCT01555125|516305188|FG003|Maintenance Period|Subject / guardian decision|0|||
143207627|NCT01555125|516305189|FG004|Maintenance Period|Subject / guardian decision|0|||
143207628|NCT01555125|516305185|FG000|Maintenance Period|Lost to Follow-up|2|||
143207629|NCT01555125|516305186|FG001|Maintenance Period|Lost to Follow-up|0|||
143207630|NCT01555125|516305187|FG002|Maintenance Period|Lost to Follow-up|0|||
143207631|NCT01555125|516305188|FG003|Maintenance Period|Lost to Follow-up|1|||
143207632|NCT01555125|516305189|FG004|Maintenance Period|Lost to Follow-up|0|||
143207633|NCT01555125|516305185|FG000|Maintenance Period|Lack of Efficacy|6|||
143207634|NCT01555125|516305186|FG001|Maintenance Period|Lack of Efficacy|1|||
143207635|NCT01555125|516305187|FG002|Maintenance Period|Lack of Efficacy|3|||
143207636|NCT01555125|516305188|FG003|Maintenance Period|Lack of Efficacy|0|||
143207637|NCT01555125|516305189|FG004|Maintenance Period|Lack of Efficacy|0|||
143207638|NCT01555125|516305185|FG000|Maintenance Period|Physician Decision|0|||
143207639|NCT01555125|516305186|FG001|Maintenance Period|Physician Decision|0|||
143207640|NCT01555125|516305187|FG002|Maintenance Period|Physician Decision|1|||
143207641|NCT01555125|516305188|FG003|Maintenance Period|Physician Decision|0|||
143207642|NCT01555125|516305189|FG004|Maintenance Period|Physician Decision|0|||
143207643|NCT01555125|516305185|FG000|Maintenance Period|Death|0|||
143207644|NCT01555125|516305186|FG001|Maintenance Period|Death|0|||
143207645|NCT01555125|516305187|FG002|Maintenance Period|Death|0|||
143207646|NCT01555125|516305188|FG003|Maintenance Period|Death|1|||
143207647|NCT01555125|516305189|FG004|Maintenance Period|Death|0|||
143207648|NCT01555125|516305185|FG000|Extension|Adverse Event|1|||
143207649|NCT01555125|516305186|FG001|Extension|Adverse Event|2|||
143207650|NCT01555125|516305187|FG002|Extension|Adverse Event|1|||
143207651|NCT01555125|516305188|FG003|Extension|Adverse Event|1|||
143207652|NCT01555125|516305189|FG004|Extension|Adverse Event|0|||
143207653|NCT01555125|516305185|FG000|Extension|Protocol deviation|1|||
143207654|NCT01555125|516305186|FG001|Extension|Protocol deviation|0|||
143207655|NCT01555125|516305187|FG002|Extension|Protocol deviation|0|||
143207656|NCT01555125|516305188|FG003|Extension|Protocol deviation|0|||
143207657|NCT01555125|516305189|FG004|Extension|Protocol deviation|0|||
143207658|NCT01555125|516305185|FG000|Extension|Lack of Efficacy|7|||
143207659|NCT01555125|516305186|FG001|Extension|Lack of Efficacy|6|||
143207660|NCT01555125|516305187|FG002|Extension|Lack of Efficacy|3|||
143207661|NCT01555125|516305188|FG003|Extension|Lack of Efficacy|0|||
143207662|NCT01555125|516305189|FG004|Extension|Lack of Efficacy|0|||
143207663|NCT01555125|516305185|FG000|Extension|Lost to Follow-up|2|||
143207664|NCT01555125|516305186|FG001|Extension|Lost to Follow-up|1|||
143207665|NCT01555125|516305187|FG002|Extension|Lost to Follow-up|2|||
143207666|NCT01555125|516305188|FG003|Extension|Lost to Follow-up|0|||
143207667|NCT01555125|516305189|FG004|Extension|Lost to Follow-up|0|||
143207668|NCT01555125|516305185|FG000|Extension|Study terminated by sponsor|32|||
143207669|NCT01555125|516305186|FG001|Extension|Study terminated by sponsor|33|||
143207670|NCT01555125|516305187|FG002|Extension|Study terminated by sponsor|16|||
143207671|NCT01555125|516305188|FG003|Extension|Study terminated by sponsor|20|||
143207672|NCT01555125|516305189|FG004|Extension|Study terminated by sponsor|0|||
143207673|NCT01555125|516305185|FG000|Extension|Subject/guardian decision|1|||
143207674|NCT01555125|516305186|FG001|Extension|Subject/guardian decision|9|||
143207675|NCT01555125|516305187|FG002|Extension|Subject/guardian decision|1|||
143207676|NCT01555125|516305188|FG003|Extension|Subject/guardian decision|0|||
143207677|NCT01555125|516305189|FG004|Extension|Subject/guardian decision|0|||
143207678|NCT01555125|516305185|FG000|Extension|Technical Problems|1|||
143207679|NCT01555125|516305186|FG001|Extension|Technical Problems|0|||
143207680|NCT01555125|516305187|FG002|Extension|Technical Problems|0|||
143207681|NCT01555125|516305188|FG003|Extension|Technical Problems|1|||
143207682|NCT01555125|516305189|FG004|Extension|Technical Problems|0|||
143207683|NCT01555125|516305185|FG000|Follow-Up Period|Lost to Follow-up|1|||
143207684|NCT01555125|516305186|FG001|Follow-Up Period|Lost to Follow-up|0|||
143207685|NCT01555125|516305187|FG002|Follow-Up Period|Lost to Follow-up|0|||
143207686|NCT01555125|516305188|FG003|Follow-Up Period|Lost to Follow-up|0|||
143207687|NCT01555125|516305189|FG004|Follow-Up Period|Lost to Follow-up|0|||
143207688|NCT01555125|516305185|FG000|Follow-Up Period|Subject / guardian decision|3|||
143207689|NCT01555125|516305186|FG001|Follow-Up Period|Subject / guardian decision|1|||
143207690|NCT01555125|516305187|FG002|Follow-Up Period|Subject / guardian decision|1|||
143207691|NCT01555125|516305188|FG003|Follow-Up Period|Subject / guardian decision|1|||
143207692|NCT01555125|516305189|FG004|Follow-Up Period|Subject / guardian decision|0|||
143207693|NCT02651220|516305190|FG000|Overall Study|Adverse Event|1|||
143207694|NCT02651220|516305191|FG001|Overall Study|Adverse Event|5|||
143207695|NCT02651220|516305192|FG002|Overall Study|Adverse Event|1|||
143207696|NCT02651220|516305190|FG000|Overall Study|Lost to Follow-up|8|||
143207697|NCT02651220|516305191|FG001|Overall Study|Lost to Follow-up|14|||
143207698|NCT02651220|516305192|FG002|Overall Study|Lost to Follow-up|14|||
143207699|NCT02651220|516305190|FG000|Overall Study|Non-Compliance with Study Drug|4|||
143207700|NCT02651220|516305191|FG001|Overall Study|Non-Compliance with Study Drug|0|||
143207701|NCT02651220|516305192|FG002|Overall Study|Non-Compliance with Study Drug|1|||
143207702|NCT02651220|516305190|FG000|Overall Study|Pregnancy|1|||
143207703|NCT02651220|516305191|FG001|Overall Study|Pregnancy|0|||
143207704|NCT02651220|516305192|FG002|Overall Study|Pregnancy|1|||
143207705|NCT02651220|516305190|FG000|Overall Study|Protocol Violation|0|||
143207706|NCT02651220|516305191|FG001|Overall Study|Protocol Violation|0|||
143207707|NCT02651220|516305192|FG002|Overall Study|Protocol Violation|1|||
143207708|NCT02651220|516305190|FG000|Overall Study|Withdrawal by Subject|5|||
143207709|NCT02651220|516305191|FG001|Overall Study|Withdrawal by Subject|6|||
143207710|NCT02651220|516305192|FG002|Overall Study|Withdrawal by Subject|8|||
143207711|NCT02651220|516305190|FG000|Overall Study|Miscellaneous|4|||
143207712|NCT02651220|516305191|FG001|Overall Study|Miscellaneous|1|||
143207713|NCT02651220|516305192|FG002|Overall Study|Miscellaneous|2|||
143207714|NCT02651220|516305190|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
143207715|NCT02651220|516305191|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
143207716|NCT02651220|516305192|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
143207717|NCT04268745|516305193|FG000|Overall Study|Lost to Follow-up|2|||
143207718|NCT04268745|516305194|FG001|Overall Study|Lost to Follow-up|3|||
143207719|NCT04268745|516305193|FG000|Overall Study|Withdrawal by Subject|4|||
143207720|NCT04268745|516305194|FG001|Overall Study|Withdrawal by Subject|2|||
143207721|NCT04268745|516305193|FG000|Overall Study|Death in the family|1|||
143207722|NCT04268745|516305194|FG001|Overall Study|Death in the family|0|||
143207723|NCT02666105|516305198|FG000|Overall Study|Death|1|||
143207724|NCT00765063|516307492|FG000|Overall Study|Lack of Efficacy|5|||
143207725|NCT00765063|516307492|FG000|Overall Study|Withdrawal by Subject|1|||
143207726|NCT00765063|516307492|FG000|Overall Study|Other|16|||
143207727|NCT00765063|516307492|FG000|Overall Study|Protocol Violation|6|||
143207728|NCT00765063|516307492|FG000|Overall Study|Adverse Event|4|||
143207729|NCT03614325|516307493|FG000|Overall Study|Withdrawal by Subject|0|||
143207730|NCT03614325|516307494|FG001|Overall Study|Withdrawal by Subject|2|||
143207731|NCT03614325|516307493|FG000|Overall Study|Surgery Cancelled|2|||
143207732|NCT03614325|516307494|FG001|Overall Study|Surgery Cancelled|1|||
143207733|NCT03614325|516307493|FG000|Overall Study|Lost to Follow-up|2|||
143207734|NCT03614325|516307494|FG001|Overall Study|Lost to Follow-up|1|||
143207735|NCT03614325|516307493|FG000|Overall Study|Surgery never scheduled|1|||
143207736|NCT03614325|516307494|FG001|Overall Study|Surgery never scheduled|0|||
143207737|NCT01597635|516307495|FG000|Part A|Adverse Event|3|||
143207738|NCT01597635|516307496|FG001|Part A|Adverse Event|0|||
143207739|NCT01597635|516307497|FG002|Part A|Adverse Event|0|||
143207740|NCT01597635|516307495|FG000|Part B|Adverse Event|0|||
143207741|NCT01597635|516307496|FG001|Part B|Adverse Event|0|||
143207742|NCT01597635|516307497|FG002|Part B|Adverse Event|1|||
143207743|NCT01597635|516307495|FG000|Part B|Protocol Violation|0|||
143207744|NCT01597635|516307496|FG001|Part B|Protocol Violation|1|||
143207745|NCT01597635|516307497|FG002|Part B|Protocol Violation|0|||
143207746|NCT01597635|516307495|FG000|Part B|Protocol-defined stopping criteria|0|||
143207747|NCT01597635|516307496|FG001|Part B|Protocol-defined stopping criteria|4|||
143207748|NCT01597635|516307497|FG002|Part B|Protocol-defined stopping criteria|3|||
143207749|NCT01597635|516307495|FG000|Part B|Withdrawal by Subject|0|||
143207750|NCT01597635|516307496|FG001|Part B|Withdrawal by Subject|1|||
143207751|NCT01597635|516307497|FG002|Part B|Withdrawal by Subject|0|||
143207752|NCT02593825|516307498|FG000|Intervention|Lost to Follow-up|10|||
143207753|NCT02593825|516307499|FG001|Intervention|Lost to Follow-up|12|||
143207754|NCT02429791|516307503|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
143207755|NCT02429791|516307504|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
143207756|NCT02429791|516307503|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
143207757|NCT02429791|516307504|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
143207758|NCT02429791|516307503|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
143207759|NCT02429791|516307504|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
143207760|NCT02429791|516307503|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
143207761|NCT02429791|516307504|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
143207762|NCT02429791|516307503|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
143207763|NCT02429791|516307504|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
143207764|NCT02429791|516307503|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
143207765|NCT02429791|516307504|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
143207766|NCT02429791|516307503|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
143207767|NCT02429791|516307504|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
143207768|NCT02429791|516307503|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
143207769|NCT02429791|516307504|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
143207770|NCT02429791|516307503|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
143207771|NCT02429791|516307504|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
143207772|NCT02429791|516307503|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
143207773|NCT02429791|516307504|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
143207774|NCT02429791|516307503|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
143207775|NCT02429791|516307504|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
143207776|NCT02429791|516307503|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
143207777|NCT02429791|516307504|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
143207778|NCT02429791|516307503|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
143207779|NCT02429791|516307504|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
143207780|NCT02429791|516307503|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
143207781|NCT02429791|516307504|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
143207782|NCT02429791|516307503|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
143207783|NCT02429791|516307504|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
143207784|NCT02429791|516307503|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
143207785|NCT02429791|516307504|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
143207786|NCT02429791|516307503|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
143207787|NCT02429791|516307504|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
143207788|NCT02429791|516307503|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
143207789|NCT02429791|516307504|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
143207790|NCT02615691|516307505|FG000|Part A: Main Study (5 Years)|Adverse Event|3|||
143207791|NCT02615691|516307505|FG000|Part A: Main Study (5 Years)|Physician Decision|2|||
143207792|NCT02615691|516307505|FG000|Part A: Main Study (5 Years)|Withdrawal by Subject|7|||
143207793|NCT02615691|516307505|FG000|Part A: Main Study (5 Years)|Reason Not Specified|2|||
143207794|NCT04201093|516307506|FG000|Overall Study|Adverse Event|6|||
143207795|NCT04201093|516307507|FG001|Overall Study|Adverse Event|29|||
143207796|NCT04201093|516307508|FG002|Overall Study|Adverse Event|35|||
143207797|NCT04201093|516307506|FG000|Overall Study|Death|2|||
143207798|NCT04201093|516307507|FG001|Overall Study|Death|1|||
143207799|NCT04201093|516307508|FG002|Overall Study|Death|0|||
143207800|NCT04201093|516307506|FG000|Overall Study|Lack of Efficacy|5|||
143207801|NCT04201093|516307507|FG001|Overall Study|Lack of Efficacy|1|||
143207802|NCT04201093|516307508|FG002|Overall Study|Lack of Efficacy|2|||
143207803|NCT04201093|516307506|FG000|Overall Study|Lost to Follow-up|0|||
143207804|NCT04201093|516307507|FG001|Overall Study|Lost to Follow-up|0|||
143207805|NCT04201093|516307508|FG002|Overall Study|Lost to Follow-up|1|||
143207806|NCT04201093|516307506|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
143207807|NCT04201093|516307507|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
143207808|NCT04201093|516307508|FG002|Overall Study|Failure to Meet Continuation Criteria|1|||
143207809|NCT04201093|516307506|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
143207810|NCT04201093|516307507|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
143207811|NCT04201093|516307508|FG002|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
143207812|NCT04201093|516307506|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
143207813|NCT04201093|516307507|FG001|Overall Study|Non-Compliance with Study Schedule|0|||
143207814|NCT04201093|516307508|FG002|Overall Study|Non-Compliance with Study Schedule|1|||
143207815|NCT04201093|516307506|FG000|Overall Study|Physician Decision|1|||
143207816|NCT04201093|516307507|FG001|Overall Study|Physician Decision|0|||
143207817|NCT04201093|516307508|FG002|Overall Study|Physician Decision|0|||
143207818|NCT04201093|516307506|FG000|Overall Study|Protocol Deviation|1|||
143207819|NCT04201093|516307507|FG001|Overall Study|Protocol Deviation|0|||
143207820|NCT04201093|516307508|FG002|Overall Study|Protocol Deviation|0|||
143207821|NCT04201093|516307506|FG000|Overall Study|Site Terminated by Sponsor|5|||
143207822|NCT04201093|516307507|FG001|Overall Study|Site Terminated by Sponsor|3|||
143207823|NCT04201093|516307508|FG002|Overall Study|Site Terminated by Sponsor|1|||
143207824|NCT04201093|516307506|FG000|Overall Study|Withdrawal by Subject|7|||
143207825|NCT04201093|516307507|FG001|Overall Study|Withdrawal by Subject|8|||
143207826|NCT04201093|516307508|FG002|Overall Study|Withdrawal by Subject|15|||
143207827|NCT04201093|516307506|FG000|Overall Study|Other|0|||
143207828|NCT04201093|516307507|FG001|Overall Study|Other|1|||
143207829|NCT04201093|516307508|FG002|Overall Study|Other|2|||
143207830|NCT00007020|516307509|FG000|Overall Study|Death|16|||
143207831|NCT00007020|516307509|FG000|Overall Study|Lost to Follow-up|13|||
143207832|NCT00007020|516307509|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
143207833|NCT00007020|516307509|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
143207834|NCT00007020|516307509|FG000|Overall Study|Pt cared for by outside physician|4|||
143207835|NCT00007020|516307509|FG000|Overall Study|No evidence of treatment|6|||
143207836|NCT00881504|516307510|FG000|Overall Study|Withdrawal by Subject|1|||
143207837|NCT01276223|516307511|FG000|Overall Study|Adverse Event|7|||
143207838|NCT01276223|516307512|FG001|Overall Study|Adverse Event|4|||
143207839|NCT01276223|516307513|FG002|Overall Study|Adverse Event|1|||
143207840|NCT01276223|516307511|FG000|Overall Study|Lost to Follow-up|0|||
143207841|NCT01276223|516307512|FG001|Overall Study|Lost to Follow-up|0|||
143207842|NCT01276223|516307513|FG002|Overall Study|Lost to Follow-up|1|||
143207843|NCT01276223|516307511|FG000|Overall Study|Other|0|||
143207844|NCT01276223|516307512|FG001|Overall Study|Other|0|||
143207845|NCT01276223|516307513|FG002|Overall Study|Other|1|||
143207846|NCT01276223|516307511|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
143207847|NCT01276223|516307512|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
143207848|NCT01276223|516307513|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
143207849|NCT01276223|516307511|FG000|Overall Study|Protocol Violation|1|||
143207850|NCT01276223|516307512|FG001|Overall Study|Protocol Violation|0|||
143263400|NCT01994590|516519724|FG000|Overall Study|Trial Terminated|1|||
143263401|NCT03607422|516519725|FG000|Overall Study|Adverse Event|7|||
143207851|NCT01276223|516307513|FG002|Overall Study|Protocol Violation|0|||
143207852|NCT02478164|516307515|FG000|Overall Study|Lack of Efficacy|13|||
143207853|NCT02478164|516307515|FG000|Overall Study|Adverse Event|1|||
143207854|NCT02478164|516307515|FG000|Overall Study|Withdrawal by Subject|1|||
143207855|NCT00802893|516307516|FG000|Overall Study|study terminated|3|||
143207856|NCT00320424|516307517|FG000|Overall Study|Adverse Event|3|||
143207857|NCT00320424|516307517|FG000|Overall Study|Other|3|||
143207858|NCT04051827|516307519|FG000|Overall Study|Death|1|||
143207859|NCT04051827|516307519|FG000|Overall Study|Withdrawal by Subject|4|||
143207860|NCT04051827|516307519|FG000|Overall Study|Progressive disease|16|||
143207861|NCT04051827|516307519|FG000|Overall Study|Physician Decision|1|||
143207862|NCT04051827|516307519|FG000|Overall Study|Other|4|||
143207863|NCT02888743|516307520|FG000|Overall Study|Withdrawal by Subject|1|||
143207864|NCT02888743|516307521|FG001|Overall Study|Withdrawal by Subject|2|||
143207865|NCT02888743|516307522|FG002|Overall Study|Withdrawal by Subject|2|||
143207866|NCT02888743|516307523|FG003|Overall Study|Withdrawal by Subject|0|||
143207867|NCT02888743|516307524|FG004|Overall Study|Withdrawal by Subject|1|||
143207868|NCT02888743|516307520|FG000|Overall Study|Disease progression before treatment|2|||
143207869|NCT02888743|516307521|FG001|Overall Study|Disease progression before treatment|0|||
143207870|NCT02888743|516307522|FG002|Overall Study|Disease progression before treatment|2|||
143207871|NCT02888743|516307523|FG003|Overall Study|Disease progression before treatment|0|||
143207872|NCT02888743|516307524|FG004|Overall Study|Disease progression before treatment|0|||
143207873|NCT02888743|516307520|FG000|Overall Study|Patient ineligible|1|||
143207874|NCT02888743|516307521|FG001|Overall Study|Patient ineligible|2|||
143207875|NCT02888743|516307522|FG002|Overall Study|Patient ineligible|0|||
143207876|NCT02888743|516307523|FG003|Overall Study|Patient ineligible|0|||
143207877|NCT02888743|516307524|FG004|Overall Study|Patient ineligible|0|||
143207878|NCT03316950|516307532|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
143207879|NCT03316950|516307533|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
143207880|NCT03316950|516307534|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
143207881|NCT03316950|516307535|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
143207882|NCT03316950|516307532|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
143207883|NCT03316950|516307533|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
143207884|NCT03316950|516307534|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
143207885|NCT03316950|516307535|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
143207886|NCT03316950|516307532|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
143207887|NCT03316950|516307533|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
143207888|NCT03316950|516307534|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
143207889|NCT03316950|516307535|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
143207890|NCT02335424|516307536|FG000|Overall Study|Withdrawal by Subject|19|||
143207891|NCT02335424|516307536|FG000|Overall Study|Adverse Event|25|||
143207892|NCT02335424|516307536|FG000|Overall Study|Death|273|||
143207893|NCT02335424|516307536|FG000|Overall Study|Lost to Follow-up|3|||
143207894|NCT02335424|516307536|FG000|Overall Study|Physician Decision|13|||
143207895|NCT02335424|516307536|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
143207896|NCT02335424|516307536|FG000|Overall Study|Protocol Violation|1|||
143207897|NCT02335424|516307536|FG000|Overall Study|Screen failure|1|||
143207898|NCT02712424|516307537|FG000|Overall Study|Lost to Follow-up|34|||
143207899|NCT02712424|516307538|FG001|Overall Study|Lost to Follow-up|32|||
143207900|NCT02809053|516307539|FG000|Overall Study|Death|0|||
143207901|NCT02809053|516307540|FG001|Overall Study|Death|1|||
143207902|NCT02809053|516307539|FG000|Overall Study|Lost to Follow-up|3|||
143207903|NCT02809053|516307540|FG001|Overall Study|Lost to Follow-up|1|||
143207904|NCT02809053|516307539|FG000|Overall Study|Withdrawal by Subject|2|||
143207905|NCT02809053|516307540|FG001|Overall Study|Withdrawal by Subject|3|||
143207906|NCT02809053|516307539|FG000|Overall Study|Disease Progression|2|||
143207907|NCT02809053|516307540|FG001|Overall Study|Disease Progression|1|||
143207908|NCT00908037|516307543|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
143207909|NCT00908037|516307544|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
143207910|NCT00908037|516307545|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
143207911|NCT00908037|516307546|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
143207912|NCT00908037|516307547|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
143207913|NCT00908037|516307548|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
143207914|NCT00908037|516307549|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
143207915|NCT00908037|516307550|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
143207916|NCT00908037|516307551|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
143207917|NCT00908037|516307552|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
143207918|NCT00908037|516307553|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
143207919|NCT00908037|516307554|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
143207920|NCT00908037|516307543|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
143207921|NCT00908037|516307544|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
143207922|NCT00908037|516307545|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
143207923|NCT00908037|516307546|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
143207924|NCT00908037|516307547|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
143207925|NCT00908037|516307548|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
143207926|NCT00908037|516307549|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
143207927|NCT00908037|516307550|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
143370415|NCT04771273|516899186|FG003|Maintenance Period|Perceived lack of efficacy|1|||
143370416|NCT04771273|516899183|FG000|Maintenance Period|Adverse Event|4|||
143370417|NCT04771273|516899184|FG001|Maintenance Period|Adverse Event|5|||
143207928|NCT00908037|516307551|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
143207929|NCT00908037|516307552|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
143207930|NCT00908037|516307553|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
143207931|NCT00908037|516307554|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
143207932|NCT00908037|516307543|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
143207933|NCT00908037|516307544|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
143207934|NCT00908037|516307545|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
143207935|NCT00908037|516307546|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
143207936|NCT00908037|516307547|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
143207937|NCT00908037|516307548|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
143207938|NCT00908037|516307549|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
143207939|NCT00908037|516307550|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
143207940|NCT00908037|516307551|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
143207941|NCT00908037|516307552|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
143207942|NCT00908037|516307553|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
143207943|NCT00908037|516307554|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
143207944|NCT00908037|516307543|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
143207945|NCT00908037|516307544|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
143207946|NCT00908037|516307545|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
143207947|NCT00908037|516307546|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
143207948|NCT00908037|516307547|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
143207949|NCT00908037|516307548|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
143207950|NCT00908037|516307549|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
143207951|NCT00908037|516307550|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
143207952|NCT00908037|516307551|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
143207953|NCT00908037|516307552|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
143207954|NCT00908037|516307553|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
143207955|NCT00908037|516307554|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
143207956|NCT00908037|516307543|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
143207957|NCT00908037|516307544|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
143207958|NCT00908037|516307545|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
143207959|NCT00908037|516307546|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
143207960|NCT00908037|516307547|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
143263402|NCT03607422|516519726|FG001|Overall Study|Adverse Event|3|||
143263403|NCT03607422|516519727|FG002|Overall Study|Adverse Event|2|||
143263404|NCT03607422|516519728|FG003|Overall Study|Adverse Event|0|||
143207961|NCT00908037|516307548|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
143207962|NCT00908037|516307549|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
143207963|NCT00908037|516307550|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
143207964|NCT00908037|516307551|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
143207965|NCT00908037|516307552|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
143207966|NCT00908037|516307553|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
143207967|NCT00908037|516307554|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
143207968|NCT00908037|516307543|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
143207969|NCT00908037|516307544|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
143207970|NCT00908037|516307545|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
143207971|NCT00908037|516307546|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
143263405|NCT03607422|516519729|FG004|Overall Study|Adverse Event|2|||
143263406|NCT03607422|516519730|FG005|Overall Study|Adverse Event|0|||
143263407|NCT03607422|516519725|FG000|Overall Study|Withdrawal by Subject|11|||
143207972|NCT00908037|516307547|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
143207973|NCT00908037|516307548|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
143263408|NCT03607422|516519726|FG001|Overall Study|Withdrawal by Subject|3|||
143263409|NCT03607422|516519727|FG002|Overall Study|Withdrawal by Subject|6|||
143207974|NCT00908037|516307549|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
143207975|NCT00908037|516307550|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
143207976|NCT00908037|516307551|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
143207977|NCT00908037|516307552|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
143207978|NCT00908037|516307553|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
143207979|NCT00908037|516307554|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
143207980|NCT00908037|516307543|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
143207981|NCT00908037|516307544|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
143207982|NCT00908037|516307545|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
143207983|NCT00908037|516307546|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
143207984|NCT00908037|516307547|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
143207985|NCT00908037|516307548|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
143207986|NCT00908037|516307549|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
143207987|NCT00908037|516307550|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
143207988|NCT00908037|516307551|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
143207989|NCT00908037|516307552|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
143207990|NCT00908037|516307553|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
143207991|NCT00908037|516307554|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
143207992|NCT00908037|516307543|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
143207993|NCT00908037|516307544|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
143207994|NCT00908037|516307545|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
143207995|NCT00908037|516307546|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
143207996|NCT00908037|516307547|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
143207997|NCT00908037|516307548|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
143207998|NCT00908037|516307549|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
143207999|NCT00908037|516307550|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
143208000|NCT00908037|516307551|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
143208001|NCT00908037|516307552|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
143208002|NCT00908037|516307553|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
143208003|NCT00908037|516307554|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
143208004|NCT00908037|516307543|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
143208005|NCT00908037|516307544|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
143208006|NCT00908037|516307545|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
143208007|NCT00908037|516307546|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
143208008|NCT00908037|516307547|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
143208009|NCT00908037|516307548|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
143208010|NCT00908037|516307549|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
143208011|NCT00908037|516307550|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
143208012|NCT00908037|516307551|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
143208013|NCT00908037|516307552|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
143208014|NCT00908037|516307553|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
143208015|NCT00908037|516307554|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
143208016|NCT02565810|516307555|FG000|Overall Study|Withdrawal by Subject|1|||
143208017|NCT02723175|516307556|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
143208018|NCT02723175|516307557|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
143208019|NCT02723175|516307556|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
143208020|NCT02723175|516307557|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
143208021|NCT02049138|516307561|FG000|Overall Study|Adverse Event|46|||
143208022|NCT02049138|516307562|FG001|Overall Study|Adverse Event|25|||
143208023|NCT02049138|516307563|FG002|Overall Study|Adverse Event|1|||
143208024|NCT02049138|516307561|FG000|Overall Study|Withdrawal by Subject|57|||
143208025|NCT02049138|516307562|FG001|Overall Study|Withdrawal by Subject|21|||
143208026|NCT02049138|516307563|FG002|Overall Study|Withdrawal by Subject|5|||
143208027|NCT02049138|516307561|FG000|Overall Study|Lost to Follow-up|18|||
143208028|NCT02049138|516307562|FG001|Overall Study|Lost to Follow-up|5|||
143208029|NCT02049138|516307563|FG002|Overall Study|Lost to Follow-up|1|||
143208030|NCT02049138|516307561|FG000|Overall Study|Lack of Efficacy|10|||
143263410|NCT03607422|516519728|FG003|Overall Study|Withdrawal by Subject|2|||
143208031|NCT02049138|516307562|FG001|Overall Study|Lack of Efficacy|26|||
143208032|NCT02049138|516307563|FG002|Overall Study|Lack of Efficacy|1|||
143208033|NCT02049138|516307561|FG000|Overall Study|Non-Compliance|15|||
143208034|NCT02049138|516307562|FG001|Overall Study|Non-Compliance|6|||
143208035|NCT02049138|516307563|FG002|Overall Study|Non-Compliance|0|||
143208036|NCT02049138|516307561|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
143208037|NCT02049138|516307562|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
143208038|NCT02049138|516307563|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
143208039|NCT02049138|516307561|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
143208040|NCT02049138|516307562|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
143208041|NCT02049138|516307563|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
143208042|NCT02049138|516307561|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
143208043|NCT02049138|516307562|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
143208044|NCT02049138|516307563|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
143208045|NCT02049138|516307561|FG000|Overall Study|Other|15|||
143208046|NCT02049138|516307562|FG001|Overall Study|Other|13|||
143208047|NCT02049138|516307563|FG002|Overall Study|Other|0|||
143208048|NCT02049138|516307561|FG000|Overall Study|Missing|0|||
143208049|NCT02049138|516307562|FG001|Overall Study|Missing|1|||
143208050|NCT02049138|516307563|FG002|Overall Study|Missing|0|||
143208051|NCT04109976|516307564|FG000|Overall Study|Withdrawal by Subject|1|||
143208052|NCT04109976|516307565|FG001|Overall Study|Withdrawal by Subject|0|||
143208053|NCT00491608|516307566|FG000|Overall Study|Death|2|||
143208054|NCT00491608|516307566|FG000|Overall Study|Withdrawal by Subject|1|||
143208055|NCT03022981|516307567|FG000|Overall Study|Adverse Event|0|||
143208056|NCT03022981|516307568|FG001|Overall Study|Adverse Event|1|||
143208057|NCT03022981|516307569|FG002|Overall Study|Adverse Event|0|||
143208058|NCT03022981|516307567|FG000|Overall Study|Investigator's Discretion|0|||
143208059|NCT03022981|516307568|FG001|Overall Study|Investigator's Discretion|1|||
143208060|NCT03022981|516307569|FG002|Overall Study|Investigator's Discretion|2|||
143208061|NCT03022981|516307567|FG000|Overall Study|Lost to Follow-up|6|||
143208062|NCT03022981|516307568|FG001|Overall Study|Lost to Follow-up|2|||
143208063|NCT03022981|516307569|FG002|Overall Study|Lost to Follow-up|1|||
143208064|NCT03022981|516307567|FG000|Overall Study|Non-Compliance With Study Drug|0|||
143208065|NCT03022981|516307568|FG001|Overall Study|Non-Compliance With Study Drug|0|||
143208066|NCT03022981|516307569|FG002|Overall Study|Non-Compliance With Study Drug|2|||
143208067|NCT03022981|516307567|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
143208068|NCT03022981|516307568|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
143208069|NCT03022981|516307569|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
143208070|NCT03615066|516307573|FG000|Main Study|Withdrew Consent|0|||
143208071|NCT03615066|516307574|FG001|Main Study|Withdrew Consent|1|||
143208072|NCT03615066|516307575|FG002|Main Study|Withdrew Consent|1|||
143208073|NCT03615066|516307573|FG000|Main Study|Lost to Follow-up|0|||
143208074|NCT03615066|516307574|FG001|Main Study|Lost to Follow-up|0|||
143208075|NCT03615066|516307575|FG002|Main Study|Lost to Follow-up|1|||
143208076|NCT03615066|516307573|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
143208077|NCT03615066|516307574|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
143208078|NCT03615066|516307575|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
143208079|NCT03615066|516307573|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
143208080|NCT03615066|516307574|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
143208081|NCT03615066|516307575|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
143208082|NCT03615066|516307573|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
143208083|NCT03615066|516307574|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
143263411|NCT03607422|516519729|FG004|Overall Study|Withdrawal by Subject|0|||
143263412|NCT03607422|516519730|FG005|Overall Study|Withdrawal by Subject|0|||
143263413|NCT03607422|516519725|FG000|Overall Study|Lost to Follow-up|0|||
143208084|NCT03615066|516307575|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
143263414|NCT03607422|516519726|FG001|Overall Study|Lost to Follow-up|0|||
143263415|NCT03607422|516519727|FG002|Overall Study|Lost to Follow-up|1|||
143208085|NCT00924404|516307576|FG000|Overall Study|Lost to Follow-up|6|||
143208086|NCT00924404|516307577|FG001|Overall Study|Lost to Follow-up|4|||
143208087|NCT02528357|516307578|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
143370418|NCT04771273|516899185|FG002|Maintenance Period|Adverse Event|5|||
143370419|NCT04771273|516899186|FG003|Maintenance Period|Adverse Event|0|||
143370420|NCT02540213|516899187|FG000|Overall Study|Death/adverse event|18|||
143370421|NCT02540213|516899187|FG000|Overall Study|Administrative reasons|3|||
143370422|NCT02540213|516899187|FG000|Overall Study|Kidney transplant|3|||
143370423|NCT02540213|516899187|FG000|Overall Study|Lack of Efficacy|6|||
143370424|NCT02540213|516899187|FG000|Overall Study|Consent withdrawn|7|||
143370425|NCT02540213|516899187|FG000|Overall Study|Enrolled but not treated|2|||
143370426|NCT02289560|516899188|FG000|Overall Study|Lost to Follow-up|6|||
143370427|NCT02289560|516899188|FG000|Overall Study|Alternative Treatment|4|||
143370428|NCT02289560|516899188|FG000|Overall Study|Inadequate Treatment|2|||
143370429|NCT02289560|516899188|FG000|Overall Study|Withdrawal by Subject|23|||
143370430|NCT00038103|516899189|FG000|Overall Study|Adverse Event|5|||
143370431|NCT00038103|516899190|FG001|Overall Study|Adverse Event|6|||
143370432|NCT00038103|516899189|FG000|Overall Study|Lack of Efficacy|48|||
143370433|NCT00038103|516899190|FG001|Overall Study|Lack of Efficacy|41|||
143370434|NCT00038103|516899189|FG000|Overall Study|Withdrawal by Subject|0|||
143370435|NCT00038103|516899190|FG001|Overall Study|Withdrawal by Subject|3|||
143370436|NCT00038103|516899189|FG000|Overall Study|Lost to Follow-up|0|||
143370437|NCT00038103|516899190|FG001|Overall Study|Lost to Follow-up|3|||
143370438|NCT00038103|516899189|FG000|Overall Study|Protocol Violation|0|||
143370439|NCT00038103|516899190|FG001|Overall Study|Protocol Violation|2|||
143370440|NCT00038103|516899189|FG000|Overall Study|Sponsor Decision|0|||
143370441|NCT00038103|516899190|FG001|Overall Study|Sponsor Decision|1|||
143208088|NCT02528357|516307579|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
143208089|NCT02528357|516307580|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
143208090|NCT02528357|516307581|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
143208091|NCT02528357|516307582|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
143208092|NCT02528357|516307583|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
143208093|NCT02528357|516307584|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
143208094|NCT02528357|516307585|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
143208095|NCT02528357|516307586|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
143208096|NCT02528357|516307587|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
143208097|NCT02528357|516307588|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
143208098|NCT02528357|516307589|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
143208099|NCT02528357|516307590|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
143208100|NCT02528357|516307591|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
143208101|NCT02528357|516307592|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
143208102|NCT02528357|516307593|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
143208103|NCT02528357|516307594|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
143208104|NCT02528357|516307595|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
143208105|NCT02528357|516307596|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
143208106|NCT02528357|516307578|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
143208107|NCT02528357|516307579|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
143208108|NCT02528357|516307580|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
143208109|NCT02528357|516307581|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
143208110|NCT02528357|516307582|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
143208111|NCT02528357|516307583|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
143208112|NCT02528357|516307584|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
143208113|NCT02528357|516307585|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
143208114|NCT02528357|516307586|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
143208115|NCT02528357|516307587|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
143263416|NCT03607422|516519728|FG003|Overall Study|Lost to Follow-up|0|||
143263417|NCT03607422|516519729|FG004|Overall Study|Lost to Follow-up|0|||
143263418|NCT03607422|516519730|FG005|Overall Study|Lost to Follow-up|0|||
143263419|NCT03607422|516519725|FG000|Overall Study|Other|12|||
143263420|NCT03607422|516519726|FG001|Overall Study|Other|4|||
143263421|NCT03607422|516519727|FG002|Overall Study|Other|1|||
143263422|NCT03607422|516519728|FG003|Overall Study|Other|2|||
143263423|NCT03607422|516519729|FG004|Overall Study|Other|0|||
143263424|NCT03607422|516519730|FG005|Overall Study|Other|2|||
143263425|NCT03607422|516519725|FG000|Overall Study|Ongoing at Time of Analysis|8|||
143263426|NCT03607422|516519726|FG001|Overall Study|Ongoing at Time of Analysis|0|||
143263427|NCT03607422|516519727|FG002|Overall Study|Ongoing at Time of Analysis|2|||
143370442|NCT00038103|516899189|FG000|Overall Study|Randomized/never treated|2|||
143370443|NCT00038103|516899190|FG001|Overall Study|Randomized/never treated|0|||
143370444|NCT01751724|516899199|FG000|Overall Study|extubated bef.start assigned treatment|1|||
143370445|NCT01751724|516899200|FG001|Overall Study|extubated bef.start assigned treatment|0|||
143208116|NCT02528357|516307588|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
143208117|NCT02528357|516307589|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
143208118|NCT02528357|516307590|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
143208119|NCT02528357|516307591|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
143208120|NCT02528357|516307592|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
143208121|NCT02528357|516307593|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
143208122|NCT02528357|516307594|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
143263428|NCT03607422|516519728|FG003|Overall Study|Ongoing at Time of Analysis|1|||
143263429|NCT03607422|516519729|FG004|Overall Study|Ongoing at Time of Analysis|1|||
143263430|NCT03607422|516519730|FG005|Overall Study|Ongoing at Time of Analysis|1|||
143263431|NCT01801072|516519731|FG000|Overall Study|Lost to Follow-up|17|||
143263432|NCT01801072|516519732|FG001|Overall Study|Lost to Follow-up|14|||
143263433|NCT01801072|516519731|FG000|Overall Study|Physician Decision|2|||
143263434|NCT01801072|516519732|FG001|Overall Study|Physician Decision|3|||
143263435|NCT01801072|516519731|FG000|Overall Study|Withdrawal by Subject|1|||
143263436|NCT01801072|516519732|FG001|Overall Study|Withdrawal by Subject|0|||
143263437|NCT01801072|516519731|FG000|Overall Study|Protocol Violation|2|||
143263438|NCT01801072|516519732|FG001|Overall Study|Protocol Violation|0|||
143263439|NCT01801072|516519731|FG000|Overall Study|Death|7|||
143263440|NCT01801072|516519732|FG001|Overall Study|Death|8|||
143263441|NCT03868124|516519733|FG000|Overall Study|Withdrawal by Subject|4|||
143263442|NCT03868124|516519734|FG001|Overall Study|Withdrawal by Subject|0|||
143263443|NCT03868124|516519735|FG002|Overall Study|Withdrawal by Subject|1|||
143263444|NCT03868124|516519733|FG000|Overall Study|Physician Decision|1|||
143263445|NCT03868124|516519734|FG001|Overall Study|Physician Decision|0|||
143263446|NCT03868124|516519735|FG002|Overall Study|Physician Decision|1|||
143263447|NCT03868124|516519733|FG000|Overall Study|Lost to Follow-up|1|||
143263448|NCT03868124|516519734|FG001|Overall Study|Lost to Follow-up|1|||
143263449|NCT03868124|516519735|FG002|Overall Study|Lost to Follow-up|2|||
143263450|NCT03868124|516519733|FG000|Overall Study|Death|1|||
143263451|NCT03868124|516519734|FG001|Overall Study|Death|1|||
143263452|NCT03868124|516519735|FG002|Overall Study|Death|2|||
143263453|NCT03868124|516519733|FG000|Overall Study|Adverse Event|0|||
143263454|NCT03868124|516519734|FG001|Overall Study|Adverse Event|0|||
143263455|NCT03868124|516519735|FG002|Overall Study|Adverse Event|3|||
143263456|NCT03868124|516519733|FG000|Overall Study|Explanted|2|||
143208123|NCT02528357|516307595|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
143208124|NCT02528357|516307596|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
143208125|NCT02528357|516307578|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
143208126|NCT02528357|516307579|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
143208127|NCT02528357|516307580|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
143208128|NCT02528357|516307581|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
143263457|NCT03868124|516519734|FG001|Overall Study|Explanted|1|||
143263458|NCT03868124|516519735|FG002|Overall Study|Explanted|0|||
143263459|NCT03868124|516519733|FG000|Overall Study|Ongoing in study|176|||
143263460|NCT03868124|516519734|FG001|Overall Study|Ongoing in study|180|||
143263461|NCT03868124|516519735|FG002|Overall Study|Ongoing in study|183|||
143263462|NCT00521001|516519738|FG000|Overall Study|Ineligible|1|||
143263463|NCT02821910|516519739|FG000|Overall Study|Withdrawal by Subject|0|||
143263464|NCT02821910|516519740|FG001|Overall Study|Withdrawal by Subject|0|||
143263465|NCT02821910|516519741|FG002|Overall Study|Withdrawal by Subject|1|||
143263466|NCT02821910|516519742|FG003|Overall Study|Withdrawal by Subject|0|||
143263467|NCT02821910|516519743|FG004|Overall Study|Withdrawal by Subject|0|||
143263468|NCT02821910|516519744|FG005|Overall Study|Withdrawal by Subject|1|||
143263469|NCT02821910|516519739|FG000|Overall Study|Other than specified|1|||
143263470|NCT02821910|516519740|FG001|Overall Study|Other than specified|0|||
143263471|NCT02821910|516519741|FG002|Overall Study|Other than specified|1|||
143263472|NCT02821910|516519742|FG003|Overall Study|Other than specified|0|||
143263473|NCT02821910|516519743|FG004|Overall Study|Other than specified|0|||
143263474|NCT02821910|516519744|FG005|Overall Study|Other than specified|0|||
143263475|NCT00900601|516519745|FG000|Overall Study|Physician Decision|1|||
143263476|NCT01082640|516519746|FG000|Overall Study|Adverse Event|9|||
143263477|NCT01082640|516519747|FG001|Overall Study|Adverse Event|5|||
143263478|NCT01082640|516519748|FG002|Overall Study|Adverse Event|3|||
143263479|NCT01082640|516519746|FG000|Overall Study|Withdrawal by Subject|3|||
143263480|NCT01082640|516519747|FG001|Overall Study|Withdrawal by Subject|3|||
143263481|NCT01082640|516519748|FG002|Overall Study|Withdrawal by Subject|2|||
143263482|NCT01082640|516519746|FG000|Overall Study|Major protocol deviation|3|||
143263483|NCT01082640|516519747|FG001|Overall Study|Major protocol deviation|3|||
143263484|NCT01082640|516519748|FG002|Overall Study|Major protocol deviation|0|||
143263485|NCT01082640|516519746|FG000|Overall Study|Lost to Follow-up|0|||
143263486|NCT01082640|516519747|FG001|Overall Study|Lost to Follow-up|3|||
143370446|NCT01751724|516899199|FG000|Overall Study|withdrawn by parent|0|||
143263487|NCT01082640|516519748|FG002|Overall Study|Lost to Follow-up|0|||
143370447|NCT01751724|516899200|FG001|Overall Study|withdrawn by parent|2|||
143370448|NCT02685033|516899201|FG000|Overall Study|Withdrawal of Consent|0|||
143208129|NCT02528357|516307582|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
143208130|NCT02528357|516307583|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
143208131|NCT02528357|516307584|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
143208132|NCT02528357|516307585|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
143208133|NCT02528357|516307586|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
143208134|NCT02528357|516307587|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
143208135|NCT02528357|516307588|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
143208136|NCT02528357|516307589|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
143208137|NCT02528357|516307590|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
143208138|NCT02528357|516307591|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
143208139|NCT02528357|516307592|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
143208140|NCT02528357|516307593|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
143208141|NCT02528357|516307594|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
143208142|NCT02528357|516307595|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
143208143|NCT02528357|516307596|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
143208144|NCT02528357|516307578|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208145|NCT02528357|516307579|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208146|NCT02528357|516307580|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208147|NCT02528357|516307581|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208148|NCT02528357|516307582|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
143208149|NCT02528357|516307583|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208150|NCT02528357|516307584|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208151|NCT02528357|516307585|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208152|NCT02528357|516307586|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143263488|NCT01082640|516519746|FG000|Overall Study|Other|2|||
143263489|NCT01082640|516519747|FG001|Overall Study|Other|1|||
143263490|NCT01082640|516519748|FG002|Overall Study|Other|3|||
143263491|NCT03739840|516519753|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
143263492|NCT03739840|516519754|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
143208153|NCT02528357|516307587|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208154|NCT02528357|516307588|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208155|NCT02528357|516307589|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208156|NCT02528357|516307590|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208157|NCT02528357|516307591|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208158|NCT02528357|516307592|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208159|NCT02528357|516307593|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208160|NCT02528357|516307594|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208161|NCT02528357|516307595|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208162|NCT02528357|516307596|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208163|NCT02528357|516307578|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
143208164|NCT02528357|516307579|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
143208165|NCT02528357|516307580|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
143208166|NCT02528357|516307581|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
143208167|NCT02528357|516307582|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
143208168|NCT02528357|516307583|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
143208169|NCT02528357|516307584|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
143208170|NCT02528357|516307585|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
143208171|NCT02528357|516307586|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
143208172|NCT02528357|516307587|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
143208173|NCT02528357|516307588|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
143208174|NCT02528357|516307589|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
143208175|NCT02528357|516307590|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
143208176|NCT02528357|516307591|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
143208177|NCT02528357|516307592|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
143208178|NCT02528357|516307593|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
143208179|NCT02528357|516307594|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
143208180|NCT02528357|516307595|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
143208181|NCT02528357|516307596|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
143208182|NCT02528357|516307578|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
143208183|NCT02528357|516307579|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
143208184|NCT02528357|516307580|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
143208185|NCT02528357|516307581|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
143208186|NCT02528357|516307582|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
143208187|NCT02528357|516307583|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
143208188|NCT02528357|516307584|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
143208189|NCT02528357|516307585|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
143208190|NCT02528357|516307586|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
143208191|NCT02528357|516307587|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
143208192|NCT02528357|516307588|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
143208193|NCT02528357|516307589|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
143208194|NCT02528357|516307590|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
143208195|NCT02528357|516307591|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
143208196|NCT02528357|516307592|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
143208197|NCT02528357|516307593|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
143208198|NCT02528357|516307594|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
143208199|NCT02528357|516307595|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
143208200|NCT02528357|516307596|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
143208201|NCT02528357|516307578|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
143208202|NCT02528357|516307579|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
143208203|NCT02528357|516307580|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
143208204|NCT02528357|516307581|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
143208205|NCT02528357|516307582|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
143208206|NCT02528357|516307583|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
143208207|NCT02528357|516307584|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
143208208|NCT02528357|516307585|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
143208209|NCT02528357|516307586|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
143208210|NCT02528357|516307587|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
143208211|NCT02528357|516307588|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
143370449|NCT02685033|516899202|FG001|Overall Study|Withdrawal of Consent|1|||
143370450|NCT02685033|516899201|FG000|Overall Study|Lost to Follow-up|2|||
143370451|NCT02685033|516899202|FG001|Overall Study|Lost to Follow-up|1|||
143370452|NCT02685033|516899201|FG000|Overall Study|Adverse Event|1|||
143370453|NCT02685033|516899202|FG001|Overall Study|Adverse Event|0|||
143370454|NCT02465359|516899205|FG000|Overall Study|Lack of Efficacy|1|||
143370455|NCT02465359|516899205|FG000|Overall Study|Withdrawal by Subject|1|||
143208212|NCT02528357|516307589|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
143370456|NCT02465359|516899205|FG000|Overall Study|Adverse Event|1|||
143370457|NCT02952261|516899206|FG000|Overall Study|Withdrawal by Subject|4|||
143370458|NCT02952261|516899207|FG001|Overall Study|Withdrawal by Subject|5|||
143370459|NCT02952261|516899206|FG000|Overall Study|Protocol Violation|1|||
143370460|NCT02952261|516899207|FG001|Overall Study|Protocol Violation|0|||
143208213|NCT02528357|516307590|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
143208214|NCT02528357|516307591|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
143208215|NCT02528357|516307592|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
143208216|NCT02528357|516307593|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
143208217|NCT02528357|516307594|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
143208218|NCT02528357|516307595|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
143208219|NCT02528357|516307596|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
143208220|NCT02528357|516307578|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208221|NCT02528357|516307579|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208222|NCT02528357|516307580|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208223|NCT02528357|516307581|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208224|NCT02528357|516307582|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208225|NCT02528357|516307583|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208226|NCT02528357|516307584|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208227|NCT02528357|516307585|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143370461|NCT03425643|516899210|FG000|Overall Study|Withdrawal by Subject|10|||
143370462|NCT03425643|516899211|FG001|Overall Study|Withdrawal by Subject|12|||
143370463|NCT03425643|516899210|FG000|Overall Study|Lost to Follow-up|2|||
143370464|NCT03425643|516899211|FG001|Overall Study|Lost to Follow-up|0|||
143370465|NCT03425643|516899210|FG000|Overall Study|Death|109|||
143370466|NCT03425643|516899211|FG001|Overall Study|Death|141|||
143370467|NCT03425643|516899210|FG000|Overall Study|Ongoing in study|276|||
143370468|NCT03425643|516899211|FG001|Overall Study|Ongoing in study|247|||
143370469|NCT03141788|516899212|FG000|Overall Study|Lost to Follow-up|1|||
143370470|NCT03141788|516899212|FG000|Overall Study|Protocol Violation|3|||
143370471|NCT03141788|516899212|FG000|Overall Study|Withdrawal by Subject|4|||
143370472|NCT03354390|516899216|FG000|Level 1|Death|2|||
143370473|NCT03354390|516899217|FG001|Level 1|Death|0|||
143370474|NCT03354390|516899218|FG002|Level 1|Death|0|||
143370475|NCT03354390|516899219|FG003|Level 1|Death|0|||
143370476|NCT03354390|516899216|FG000|Level 1|Physician Decision|1|||
143370477|NCT03354390|516899217|FG001|Level 1|Physician Decision|0|||
143370478|NCT03354390|516899218|FG002|Level 1|Physician Decision|0|||
143370479|NCT03354390|516899219|FG003|Level 1|Physician Decision|0|||
143370480|NCT03354390|516899216|FG000|Level 2|Physician Decision|0|||
143370481|NCT03354390|516899217|FG001|Level 2|Physician Decision|2|||
143208228|NCT02528357|516307586|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
143208229|NCT02528357|516307587|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
143208230|NCT02528357|516307588|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208231|NCT02528357|516307589|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
143208232|NCT02528357|516307590|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
143208233|NCT02528357|516307591|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
143208234|NCT02528357|516307592|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
143370482|NCT03354390|516899218|FG002|Level 2|Physician Decision|0|||
143370483|NCT03354390|516899219|FG003|Level 2|Physician Decision|0|||
143370484|NCT03354390|516899216|FG000|Level 2|Lack of Efficacy|0|||
143370485|NCT03354390|516899217|FG001|Level 2|Lack of Efficacy|1|||
143370486|NCT03354390|516899218|FG002|Level 2|Lack of Efficacy|0|||
143370487|NCT03354390|516899219|FG003|Level 2|Lack of Efficacy|0|||
143370488|NCT03354390|516899216|FG000|Level 2|Lost to Follow-up|0|||
143208235|NCT02528357|516307593|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208236|NCT02528357|516307594|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208237|NCT02528357|516307595|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208238|NCT02528357|516307596|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208239|NCT02528357|516307578|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
143208240|NCT02528357|516307579|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
143208241|NCT02528357|516307580|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
143208242|NCT02528357|516307581|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
143208243|NCT02528357|516307582|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
143208244|NCT02528357|516307583|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
143208245|NCT02528357|516307584|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
143208246|NCT02528357|516307585|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
143208247|NCT02528357|516307586|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
143208248|NCT02528357|516307587|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
143208249|NCT02528357|516307588|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
143208250|NCT02528357|516307589|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
143208251|NCT02528357|516307590|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
143208252|NCT02528357|516307591|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
143208253|NCT02528357|516307592|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
143208254|NCT02528357|516307593|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
143208255|NCT02528357|516307594|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
143208256|NCT02528357|516307595|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
143208257|NCT02528357|516307596|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
143208258|NCT02528357|516307578|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208259|NCT02528357|516307579|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208260|NCT02528357|516307580|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208261|NCT02528357|516307581|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208262|NCT02528357|516307582|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208263|NCT02528357|516307583|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208264|NCT02528357|516307584|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208265|NCT02528357|516307585|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208266|NCT02528357|516307586|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208267|NCT02528357|516307587|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208268|NCT02528357|516307588|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208269|NCT02528357|516307589|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208270|NCT02528357|516307590|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208271|NCT02528357|516307591|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208272|NCT02528357|516307592|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208273|NCT02528357|516307593|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
143208274|NCT02528357|516307594|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
143208275|NCT02528357|516307595|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
143208276|NCT02528357|516307596|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
143208277|NCT01064687|516307598|FG000|Overall Study|Adverse Event|9|||
143208278|NCT01064687|516307599|FG001|Overall Study|Adverse Event|4|||
143208279|NCT01064687|516307600|FG002|Overall Study|Adverse Event|10|||
143208280|NCT01064687|516307601|FG003|Overall Study|Adverse Event|3|||
143208281|NCT01064687|516307598|FG000|Overall Study|Death|1|||
143208282|NCT01064687|516307599|FG001|Overall Study|Death|1|||
143208283|NCT01064687|516307600|FG002|Overall Study|Death|0|||
143208284|NCT01064687|516307601|FG003|Overall Study|Death|0|||
143263493|NCT03739840|516519755|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
143263494|NCT03739840|516519756|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
143263495|NCT03739840|516519753|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
143263496|NCT03739840|516519754|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
143263497|NCT03739840|516519755|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
143263498|NCT03739840|516519756|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
143263499|NCT03739840|516519753|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
143263500|NCT03739840|516519754|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
143263501|NCT03739840|516519755|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
143263502|NCT03739840|516519756|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
143208285|NCT01064687|516307598|FG000|Overall Study|Entry Criteria Not Met|3|||
143208286|NCT01064687|516307599|FG001|Overall Study|Entry Criteria Not Met|0|||
143208287|NCT01064687|516307600|FG002|Overall Study|Entry Criteria Not Met|0|||
143208288|NCT01064687|516307601|FG003|Overall Study|Entry Criteria Not Met|0|||
143208289|NCT01064687|516307598|FG000|Overall Study|Lack of Efficacy|1|||
143208290|NCT01064687|516307599|FG001|Overall Study|Lack of Efficacy|0|||
143208291|NCT01064687|516307600|FG002|Overall Study|Lack of Efficacy|2|||
143208292|NCT01064687|516307601|FG003|Overall Study|Lack of Efficacy|3|||
143208293|NCT01064687|516307598|FG000|Overall Study|Lost to Follow-up|7|||
143208294|NCT01064687|516307599|FG001|Overall Study|Lost to Follow-up|10|||
143208295|NCT01064687|516307600|FG002|Overall Study|Lost to Follow-up|13|||
143208296|NCT01064687|516307601|FG003|Overall Study|Lost to Follow-up|5|||
143208297|NCT01064687|516307598|FG000|Overall Study|Physician Decision|2|||
143208298|NCT01064687|516307599|FG001|Overall Study|Physician Decision|2|||
143208299|NCT01064687|516307600|FG002|Overall Study|Physician Decision|0|||
143208300|NCT01064687|516307601|FG003|Overall Study|Physician Decision|0|||
143208301|NCT01064687|516307598|FG000|Overall Study|Protocol Violation|1|||
143208302|NCT01064687|516307599|FG001|Overall Study|Protocol Violation|1|||
143208303|NCT01064687|516307600|FG002|Overall Study|Protocol Violation|0|||
143208304|NCT01064687|516307601|FG003|Overall Study|Protocol Violation|1|||
143208305|NCT01064687|516307598|FG000|Overall Study|Sponsor Decision|0|||
143208306|NCT01064687|516307599|FG001|Overall Study|Sponsor Decision|0|||
143208307|NCT01064687|516307600|FG002|Overall Study|Sponsor Decision|3|||
143208308|NCT01064687|516307601|FG003|Overall Study|Sponsor Decision|0|||
143208309|NCT01064687|516307598|FG000|Overall Study|Withdrawal by Subject|9|||
143208310|NCT01064687|516307599|FG001|Overall Study|Withdrawal by Subject|7|||
143208311|NCT01064687|516307600|FG002|Overall Study|Withdrawal by Subject|12|||
143208312|NCT01064687|516307601|FG003|Overall Study|Withdrawal by Subject|5|||
143208313|NCT01064687|516307598|FG000|Overall Study|Treatment Noncompliance|1|||
143208314|NCT01064687|516307599|FG001|Overall Study|Treatment Noncompliance|1|||
143208315|NCT01064687|516307600|FG002|Overall Study|Treatment Noncompliance|1|||
143208316|NCT01064687|516307601|FG003|Overall Study|Treatment Noncompliance|0|||
143208317|NCT00845065|516307603|FG000|Overall Study|Adverse Event|3|||
143208318|NCT00845065|516307604|FG001|Overall Study|Adverse Event|23|||
143208319|NCT00845065|516307603|FG000|Overall Study|Lack of Efficacy|43|||
143208320|NCT00845065|516307604|FG001|Overall Study|Lack of Efficacy|21|||
143208321|NCT00845065|516307603|FG000|Overall Study|Non-Medical Reasons|1|||
143208322|NCT00845065|516307604|FG001|Overall Study|Non-Medical Reasons|11|||
143208323|NCT01183468|516307605|FG000|Overall Study|Lost to Follow-up|2|||
143208324|NCT01183468|516307606|FG001|Overall Study|Lost to Follow-up|1|||
143208325|NCT01183468|516307607|FG002|Overall Study|Lost to Follow-up|0|||
143208326|NCT01183468|516307608|FG003|Overall Study|Lost to Follow-up|0|||
143208327|NCT01183468|516307605|FG000|Overall Study|Physician Decision|1|||
143208328|NCT01183468|516307606|FG001|Overall Study|Physician Decision|0|||
143208329|NCT01183468|516307607|FG002|Overall Study|Physician Decision|0|||
143208330|NCT01183468|516307608|FG003|Overall Study|Physician Decision|0|||
143208331|NCT01183468|516307605|FG000|Overall Study|Withdrawal by Subject|0|||
143208332|NCT01183468|516307606|FG001|Overall Study|Withdrawal by Subject|1|||
143208333|NCT01183468|516307607|FG002|Overall Study|Withdrawal by Subject|0|||
143208334|NCT01183468|516307608|FG003|Overall Study|Withdrawal by Subject|0|||
143208335|NCT01198509|516307609|FG000|Overall Study|Withdrawal by Subject|1|||
143208336|NCT01198509|516307610|FG001|Overall Study|Withdrawal by Subject|0|||
143208337|NCT01198509|516307611|FG002|Overall Study|Withdrawal by Subject|0|||
143208338|NCT01198509|516307612|FG003|Overall Study|Withdrawal by Subject|0|||
143208339|NCT01198509|516307613|FG004|Overall Study|Withdrawal by Subject|0|||
143208340|NCT01198509|516307614|FG005|Overall Study|Withdrawal by Subject|0|||
143208341|NCT03180307|516307621|FG000|Overall Study|Lost to Follow-up|2|||
143208342|NCT03180307|516307622|FG001|Overall Study|Lost to Follow-up|0|||
143208343|NCT03180307|516307621|FG000|Overall Study|Death|1|||
143208344|NCT03180307|516307622|FG001|Overall Study|Death|0|||
143208345|NCT03180307|516307621|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
143263503|NCT03739840|516519753|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
143263504|NCT03739840|516519754|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
143263505|NCT03739840|516519755|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
143263506|NCT03739840|516519756|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
143208346|NCT03180307|516307622|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
143208347|NCT00772109|516307623|FG000|Overall Study|Serious adverse event|1|||
143208348|NCT00772109|516307624|FG001|Overall Study|Serious adverse event|0|||
143208349|NCT00772109|516307625|FG002|Overall Study|Serious adverse event|1|||
143208350|NCT00772109|516307626|FG003|Overall Study|Serious adverse event|0|||
143208351|NCT00772109|516307623|FG000|Overall Study|Protocol Violation|5|||
143208352|NCT00772109|516307624|FG001|Overall Study|Protocol Violation|8|||
143208353|NCT00772109|516307625|FG002|Overall Study|Protocol Violation|7|||
143263507|NCT03739840|516519753|FG000|Treatment Period: Wk0-16|Program Termination|3|||
143208354|NCT00772109|516307626|FG003|Overall Study|Protocol Violation|6|||
143208355|NCT00772109|516307623|FG000|Overall Study|Lost to Follow-up|7|||
143208356|NCT00772109|516307624|FG001|Overall Study|Lost to Follow-up|3|||
143208357|NCT00772109|516307625|FG002|Overall Study|Lost to Follow-up|5|||
143208358|NCT00772109|516307626|FG003|Overall Study|Lost to Follow-up|9|||
143208359|NCT00772109|516307623|FG000|Overall Study|Withdrawal by Subject|8|||
143208360|NCT00772109|516307624|FG001|Overall Study|Withdrawal by Subject|8|||
143208361|NCT00772109|516307625|FG002|Overall Study|Withdrawal by Subject|6|||
143208362|NCT00772109|516307626|FG003|Overall Study|Withdrawal by Subject|16|||
143208363|NCT01624090|516307627|FG000|Overall Study|DLT, taken off therapy|0|||
143208364|NCT01624090|516307628|FG001|Overall Study|DLT, taken off therapy|1|||
143208365|NCT01624090|516307629|FG002|Overall Study|DLT, taken off therapy|0|||
143208366|NCT01624090|516307630|FG003|Overall Study|DLT, taken off therapy|0|||
143208367|NCT01624090|516307627|FG000|Overall Study|Withdrew prior to treatment|0|||
143208368|NCT01624090|516307628|FG001|Overall Study|Withdrew prior to treatment|1|||
143208369|NCT01624090|516307629|FG002|Overall Study|Withdrew prior to treatment|0|||
143208370|NCT01624090|516307630|FG003|Overall Study|Withdrew prior to treatment|0|||
143208371|NCT01624090|516307627|FG000|Overall Study|Died on study|0|||
143208372|NCT01624090|516307628|FG001|Overall Study|Died on study|0|||
143208373|NCT01624090|516307629|FG002|Overall Study|Died on study|2|||
143208374|NCT01624090|516307630|FG003|Overall Study|Died on study|0|||
143208375|NCT01624090|516307627|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
143208376|NCT01624090|516307628|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
143208377|NCT01624090|516307629|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
143208378|NCT01624090|516307630|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
143208379|NCT01624090|516307627|FG000|Overall Study|Dose escalated|0|||
143208380|NCT01624090|516307628|FG001|Overall Study|Dose escalated|0|||
143208381|NCT01624090|516307629|FG002|Overall Study|Dose escalated|3|||
143208382|NCT01624090|516307630|FG003|Overall Study|Dose escalated|0|||
143208383|NCT02039856|516307631|FG000|Overall Study|Death|5|||
143208384|NCT02039856|516307632|FG001|Overall Study|Death|3|||
143208385|NCT02039856|516307631|FG000|Overall Study|Partial survey completion|61|||
143208386|NCT02039856|516307632|FG001|Overall Study|Partial survey completion|26|||
143208387|NCT02039856|516307631|FG000|Overall Study|Lost to Follow-up|388|||
143208388|NCT02039856|516307632|FG001|Overall Study|Lost to Follow-up|206|||
143208389|NCT02039856|516307631|FG000|Overall Study|Withdrawal by Subject|1573|||
143208390|NCT02039856|516307632|FG001|Overall Study|Withdrawal by Subject|618|||
143208391|NCT02540291|516307633|FG000|Overall Study|Death|7|||
143208392|NCT02540291|516307634|FG001|Overall Study|Death|7|||
143208393|NCT02540291|516307635|FG002|Overall Study|Death|5|||
143208394|NCT02540291|516307636|FG003|Overall Study|Death|7|||
143208395|NCT02540291|516307633|FG000|Overall Study|Lost to Follow-up|0|||
143208396|NCT02540291|516307634|FG001|Overall Study|Lost to Follow-up|0|||
143208397|NCT02540291|516307635|FG002|Overall Study|Lost to Follow-up|1|||
143208398|NCT02540291|516307636|FG003|Overall Study|Lost to Follow-up|0|||
143208399|NCT02540291|516307633|FG000|Overall Study|Withdrawal Of Consent|0|||
143208400|NCT02540291|516307634|FG001|Overall Study|Withdrawal Of Consent|1|||
143208401|NCT02540291|516307635|FG002|Overall Study|Withdrawal Of Consent|0|||
143208402|NCT02540291|516307636|FG003|Overall Study|Withdrawal Of Consent|0|||
143208403|NCT02540291|516307633|FG000|Overall Study|Study Terminated By Sponsor|1|||
143208404|NCT02540291|516307634|FG001|Overall Study|Study Terminated By Sponsor|0|||
143208405|NCT02540291|516307635|FG002|Overall Study|Study Terminated By Sponsor|0|||
143208406|NCT02540291|516307636|FG003|Overall Study|Study Terminated By Sponsor|0|||
143208407|NCT02540291|516307633|FG000|Overall Study|Other|0|||
143208408|NCT02540291|516307634|FG001|Overall Study|Other|0|||
143208409|NCT02540291|516307635|FG002|Overall Study|Other|1|||
143208410|NCT02540291|516307636|FG003|Overall Study|Other|0|||
143208411|NCT01879072|516307645|FG000|Overall Study|Withdrawal by Subject|121|||
143208412|NCT01879072|516307645|FG000|Overall Study|Not Transplanted|30|||
143208413|NCT01078168|516307653|FG000|Overall Study|Physician Decision|0|||
143263508|NCT03739840|516519754|FG001|Treatment Period: Wk0-16|Program Termination|0|||
143208414|NCT01078168|516307654|FG001|Overall Study|Physician Decision|1|||
143208415|NCT01264419|516307658|FG000|Overall Study|Lost to Follow-up|3|||
143208416|NCT01740401|516310082|FG000|Overall Study|Progression of disease|6|||
143208417|NCT01740401|516310082|FG000|Overall Study|Adverse Event|2|||
143208418|NCT01740401|516310082|FG000|Overall Study|Did not reach primary endpoint|2|||
143208419|NCT02806960|516310083|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
143208420|NCT02806960|516310084|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
143208421|NCT02806960|516310085|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
143208422|NCT02806960|516310086|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
143208423|NCT01769196|516310087|FG000|Overall Study|Adverse Event|24|||
143208424|NCT01769196|516310088|FG001|Overall Study|Adverse Event|20|||
143208425|NCT01769196|516310087|FG000|Overall Study|Death|21|||
143208426|NCT01769196|516310088|FG001|Overall Study|Death|26|||
143208427|NCT01769196|516310087|FG000|Overall Study|Investigator Discretion|7|||
143208428|NCT01769196|516310088|FG001|Overall Study|Investigator Discretion|3|||
143208429|NCT01769196|516310087|FG000|Overall Study|Lack of Efficacy|3|||
143208430|NCT01769196|516310088|FG001|Overall Study|Lack of Efficacy|2|||
143208431|NCT01769196|516310087|FG000|Overall Study|Progressive disease|11|||
143208432|NCT01769196|516310088|FG001|Overall Study|Progressive disease|6|||
143208433|NCT01769196|516310087|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
143208434|NCT01769196|516310088|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
143208435|NCT01769196|516310087|FG000|Overall Study|Protocol Violation|0|||
143263509|NCT03739840|516519755|FG002|Treatment Period: Wk0-16|Program Termination|1|||
143208436|NCT01769196|516310088|FG001|Overall Study|Protocol Violation|3|||
143208437|NCT01769196|516310087|FG000|Overall Study|Study terminated by sponsor|160|||
143208438|NCT01769196|516310088|FG001|Overall Study|Study terminated by sponsor|161|||
143208439|NCT01769196|516310087|FG000|Overall Study|Participant never dosed with study drug|1|||
143208440|NCT01769196|516310088|FG001|Overall Study|Participant never dosed with study drug|0|||
143208441|NCT01769196|516310087|FG000|Overall Study|Withdrew consent|36|||
143208442|NCT01769196|516310088|FG001|Overall Study|Withdrew consent|40|||
143263510|NCT03739840|516519756|FG003|Treatment Period: Wk0-16|Program Termination|1|||
143263511|NCT03739840|516519753|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
143263512|NCT03739840|516519754|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
143263513|NCT03739840|516519755|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
143263514|NCT03739840|516519756|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
143263515|NCT03739840|516519753|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
143263516|NCT03739840|516519754|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
143263517|NCT03739840|516519755|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
143263518|NCT03739840|516519756|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
143263519|NCT03739840|516519753|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
143263520|NCT03739840|516519754|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
143263521|NCT03739840|516519755|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
143263522|NCT03739840|516519756|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
143263523|NCT03739840|516519753|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
143263524|NCT03739840|516519754|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
143263525|NCT03739840|516519755|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
143263526|NCT03739840|516519756|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
143263527|NCT03739840|516519753|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
143263528|NCT03739840|516519754|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
143263529|NCT03739840|516519755|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
143263530|NCT03739840|516519756|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
143263531|NCT03739840|516519753|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
143263532|NCT03739840|516519754|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
143263533|NCT03739840|516519755|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
143263534|NCT03739840|516519756|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
143263535|NCT03739840|516519753|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
143263536|NCT03739840|516519754|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
143263537|NCT03739840|516519755|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
143263538|NCT03739840|516519756|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
143263539|NCT03739840|516519753|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
143263540|NCT03739840|516519754|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
143263541|NCT03739840|516519755|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
143263542|NCT03739840|516519756|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
143263543|NCT03739840|516519753|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
143263544|NCT03739840|516519754|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
143263545|NCT03739840|516519755|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
143263546|NCT03739840|516519756|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
143263547|NCT03739840|516519753|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
143263548|NCT03739840|516519754|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
143263549|NCT03739840|516519755|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
143263550|NCT03739840|516519756|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
143263551|NCT03739840|516519753|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
143263552|NCT03739840|516519754|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
143263553|NCT03739840|516519755|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
143263554|NCT03739840|516519756|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
143263555|NCT03739840|516519753|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
143263556|NCT03739840|516519754|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
143263557|NCT03739840|516519755|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
143208443|NCT01673620|516310089|FG000|Overall Study|Adverse Event|1|||
143208444|NCT01673620|516310090|FG001|Overall Study|Adverse Event|0|||
143208445|NCT01206582|516310091|FG000|Overall Study|Withdrew prior to study|1|||
143208446|NCT01206582|516310092|FG001|Overall Study|Withdrew prior to study|0|||
143208447|NCT01206582|516310091|FG000|Overall Study|Discontinued intervention before week 8|1|||
143263558|NCT03739840|516519756|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
143208448|NCT01206582|516310092|FG001|Overall Study|Discontinued intervention before week 8|2|||
143208449|NCT02522325|516310093|FG000|Overall Study|Adverse Event|0|||
143208450|NCT02522325|516310094|FG001|Overall Study|Adverse Event|1|||
143208451|NCT00126776|516310097|FG000|Overall Study|follow up complete on all patients|0|||
143208452|NCT00126776|516310098|FG001|Overall Study|follow up complete on all patients|0|||
143208453|NCT00387725|516310110|FG000|Overall Study|Adverse Event|0|||
143208454|NCT00387725|516310111|FG001|Overall Study|Adverse Event|0|||
143208455|NCT00387725|516310112|FG002|Overall Study|Adverse Event|0|||
143208456|NCT00387725|516310113|FG003|Overall Study|Adverse Event|1|||
143208457|NCT00387725|516310110|FG000|Overall Study|Protocol Violation|0|||
143208458|NCT00387725|516310111|FG001|Overall Study|Protocol Violation|1|||
143208459|NCT00387725|516310112|FG002|Overall Study|Protocol Violation|0|||
143208460|NCT00387725|516310113|FG003|Overall Study|Protocol Violation|0|||
143208461|NCT00387725|516310110|FG000|Overall Study|Withdrawal by Subject|1|||
143263559|NCT03739840|516519753|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
143263560|NCT03739840|516519754|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
143263561|NCT03739840|516519755|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
143263562|NCT03739840|516519756|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
143263563|NCT03739840|516519753|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
143263564|NCT03739840|516519754|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
143263565|NCT03739840|516519755|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
143263566|NCT03739840|516519756|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
143263567|NCT03739840|516519753|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
143263568|NCT03739840|516519754|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
143263569|NCT03739840|516519755|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
143263570|NCT03739840|516519756|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
143263571|NCT03739840|516519753|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
143263572|NCT03739840|516519754|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
143263573|NCT03739840|516519755|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
143263574|NCT03739840|516519756|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
143263575|NCT03739840|516519753|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
143263576|NCT03739840|516519754|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
143263577|NCT03739840|516519755|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
143263578|NCT03739840|516519756|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
143263579|NCT03739840|516519753|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
143263580|NCT03739840|516519754|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
143263581|NCT03739840|516519755|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
143263582|NCT03739840|516519756|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
143263583|NCT03739840|516519753|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
143263584|NCT03739840|516519754|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
143263585|NCT03739840|516519755|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
143263586|NCT03739840|516519756|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
143263587|NCT03739840|516519753|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
143263588|NCT03739840|516519754|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
143263589|NCT03739840|516519755|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
143263590|NCT03739840|516519756|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
143263591|NCT05153473|516519757|FG000|Overall Study|Death|46|||
143263592|NCT05153473|516519757|FG000|Overall Study|Lost to Follow-up|3|||
143263593|NCT02788474|516519758|FG000|Double Blind Treatment Period|Not treated|1|||
143263594|NCT02788474|516519759|FG001|Double Blind Treatment Period|Not treated|0|||
143263595|NCT02788474|516519758|FG000|Double Blind Treatment Period|Patient's refusal|3|||
143263596|NCT02788474|516519759|FG001|Double Blind Treatment Period|Patient's refusal|0|||
143263597|NCT02788474|516519758|FG000|Double Blind Treatment Period|Adverse Event|6|||
143263598|NCT02788474|516519759|FG001|Double Blind Treatment Period|Adverse Event|4|||
143263599|NCT02788474|516519758|FG000|Open Label Treatment Period|Adverse Event|29|||
143263600|NCT02788474|516519759|FG001|Open Label Treatment Period|Adverse Event|9|||
143263601|NCT02788474|516519758|FG000|Open Label Treatment Period|Other than reason specified|1|||
143263602|NCT02788474|516519759|FG001|Open Label Treatment Period|Other than reason specified|0|||
143263603|NCT02788474|516519758|FG000|Open Label Treatment Period|Patient's refusal|1|||
143263604|NCT02788474|516519759|FG001|Open Label Treatment Period|Patient's refusal|3|||
143263605|NCT02788474|516519758|FG000|Open Label Treatment Period|Non-compliance|1|||
143208462|NCT00387725|516310111|FG001|Overall Study|Withdrawal by Subject|0|||
143208463|NCT00387725|516310112|FG002|Overall Study|Withdrawal by Subject|1|||
143208464|NCT00387725|516310113|FG003|Overall Study|Withdrawal by Subject|0|||
143208465|NCT00387725|516310110|FG000|Overall Study|Parent/legal guardian request|0|||
143208466|NCT00387725|516310111|FG001|Overall Study|Parent/legal guardian request|0|||
143208467|NCT00387725|516310112|FG002|Overall Study|Parent/legal guardian request|1|||
143208468|NCT00387725|516310113|FG003|Overall Study|Parent/legal guardian request|1|||
143208469|NCT01939366|516310114|FG000|Overall Study|Adverse Event|8|||
143208470|NCT01939366|516310115|FG001|Overall Study|Adverse Event|17|||
143208471|NCT01939366|516310116|FG002|Overall Study|Adverse Event|30|||
143208472|NCT01939366|516310117|FG003|Overall Study|Adverse Event|8|||
143208473|NCT01939366|516310118|FG004|Overall Study|Adverse Event|5|||
143208474|NCT01939366|516310114|FG000|Overall Study|Lack of Efficacy|2|||
143208475|NCT01939366|516310115|FG001|Overall Study|Lack of Efficacy|1|||
143208476|NCT01939366|516310116|FG002|Overall Study|Lack of Efficacy|1|||
143208477|NCT01939366|516310117|FG003|Overall Study|Lack of Efficacy|1|||
143208478|NCT01939366|516310118|FG004|Overall Study|Lack of Efficacy|3|||
143208479|NCT01939366|516310114|FG000|Overall Study|Lost to Follow-up|1|||
143208480|NCT01939366|516310115|FG001|Overall Study|Lost to Follow-up|1|||
143208481|NCT01939366|516310116|FG002|Overall Study|Lost to Follow-up|0|||
143208482|NCT01939366|516310117|FG003|Overall Study|Lost to Follow-up|0|||
143208483|NCT01939366|516310118|FG004|Overall Study|Lost to Follow-up|0|||
143208484|NCT01939366|516310114|FG000|Overall Study|Withdrawal by Subject|1|||
143208485|NCT01939366|516310115|FG001|Overall Study|Withdrawal by Subject|0|||
143208486|NCT01939366|516310116|FG002|Overall Study|Withdrawal by Subject|2|||
143208487|NCT01939366|516310117|FG003|Overall Study|Withdrawal by Subject|2|||
143208488|NCT01939366|516310118|FG004|Overall Study|Withdrawal by Subject|3|||
143208489|NCT01939366|516310114|FG000|Overall Study|Inclusion criteria not met|0|||
143208490|NCT01939366|516310115|FG001|Overall Study|Inclusion criteria not met|1|||
143208491|NCT01939366|516310116|FG002|Overall Study|Inclusion criteria not met|1|||
143208492|NCT01939366|516310117|FG003|Overall Study|Inclusion criteria not met|0|||
143208493|NCT01939366|516310118|FG004|Overall Study|Inclusion criteria not met|1|||
143208494|NCT01939366|516310114|FG000|Overall Study|Other|0|||
143208495|NCT01939366|516310115|FG001|Overall Study|Other|0|||
143208496|NCT01939366|516310116|FG002|Overall Study|Other|2|||
143208497|NCT01939366|516310117|FG003|Overall Study|Other|2|||
143208498|NCT01939366|516310118|FG004|Overall Study|Other|1|||
143208499|NCT01939366|516310114|FG000|Overall Study|Protocol Violation|0|||
143208500|NCT01939366|516310115|FG001|Overall Study|Protocol Violation|0|||
143208501|NCT01939366|516310116|FG002|Overall Study|Protocol Violation|0|||
143208502|NCT01939366|516310117|FG003|Overall Study|Protocol Violation|1|||
143208503|NCT01939366|516310118|FG004|Overall Study|Protocol Violation|0|||
143208504|NCT01939366|516310114|FG000|Overall Study|Sponsor decision|0|||
143208505|NCT01939366|516310115|FG001|Overall Study|Sponsor decision|0|||
143208506|NCT01939366|516310116|FG002|Overall Study|Sponsor decision|0|||
143208507|NCT01939366|516310117|FG003|Overall Study|Sponsor decision|0|||
143208508|NCT01939366|516310118|FG004|Overall Study|Sponsor decision|2|||
143208509|NCT01939366|516310114|FG000|Overall Study|GCP non-compliance at site|2|||
143208510|NCT01939366|516310115|FG001|Overall Study|GCP non-compliance at site|3|||
143208511|NCT01939366|516310116|FG002|Overall Study|GCP non-compliance at site|2|||
143208512|NCT01939366|516310117|FG003|Overall Study|GCP non-compliance at site|3|||
143208513|NCT01939366|516310118|FG004|Overall Study|GCP non-compliance at site|3|||
143208514|NCT05011058|516310119|FG000|Overall Study|Sponsor Decision|2|||
143208515|NCT05011058|516310120|FG001|Overall Study|Sponsor Decision|0|||
143208516|NCT05011058|516310121|FG002|Overall Study|Sponsor Decision|14|||
143208517|NCT05011058|516310122|FG003|Overall Study|Sponsor Decision|0|||
143208518|NCT05011058|516310123|FG004|Overall Study|Sponsor Decision|0|||
143208519|NCT05011058|516310124|FG005|Overall Study|Sponsor Decision|1|||
143208520|NCT05011058|516310125|FG006|Overall Study|Sponsor Decision|0|||
143208521|NCT05011058|516310126|FG007|Overall Study|Sponsor Decision|5|||
143208522|NCT02596230|516310127|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
143208523|NCT02596230|516310128|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
143208524|NCT02596230|516310129|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
143208525|NCT02596230|516310130|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
143208526|NCT02596230|516310131|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
143208527|NCT02596230|516310127|FG000|Objective 2, One Year|Lost to Follow-up|0|||
143208528|NCT02596230|516310128|FG001|Objective 2, One Year|Lost to Follow-up|41|||
143208529|NCT02596230|516310129|FG002|Objective 2, One Year|Lost to Follow-up|41|||
143208530|NCT02596230|516310130|FG003|Objective 2, One Year|Lost to Follow-up|32|||
143208531|NCT02596230|516310131|FG004|Objective 2, One Year|Lost to Follow-up|46|||
143208532|NCT02596230|516310127|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
143208533|NCT02596230|516310128|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
143208534|NCT02596230|516310129|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
143208535|NCT02596230|516310130|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
143208536|NCT02596230|516310131|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
143208537|NCT02596230|516310127|FG000|Objective 2, One Year|Adverse drug reaction|0|||
143208538|NCT02596230|516310128|FG001|Objective 2, One Year|Adverse drug reaction|1|||
143208539|NCT02596230|516310129|FG002|Objective 2, One Year|Adverse drug reaction|0|||
143208540|NCT02596230|516310130|FG003|Objective 2, One Year|Adverse drug reaction|0|||
143208541|NCT02596230|516310131|FG004|Objective 2, One Year|Adverse drug reaction|0|||
143208542|NCT02596230|516310127|FG000|Objective 2, One Year|Death|0|||
143208543|NCT02596230|516310128|FG001|Objective 2, One Year|Death|12|||
143263606|NCT02788474|516519759|FG001|Open Label Treatment Period|Non-compliance|0|||
143263607|NCT00048061|516519760|FG000|Overall Study|Adverse Event|41|||
143263608|NCT00048061|516519761|FG001|Overall Study|Adverse Event|32|||
143263609|NCT00048061|516519762|FG002|Overall Study|Adverse Event|44|||
143263610|NCT00048061|516519763|FG003|Overall Study|Adverse Event|37|||
143263611|NCT00048061|516519760|FG000|Overall Study|Lost to Follow-up|3|||
143263612|NCT00048061|516519761|FG001|Overall Study|Lost to Follow-up|2|||
143263613|NCT00048061|516519762|FG002|Overall Study|Lost to Follow-up|4|||
143208544|NCT02596230|516310129|FG002|Objective 2, One Year|Death|41|||
143208545|NCT02596230|516310130|FG003|Objective 2, One Year|Death|21|||
143208546|NCT02596230|516310131|FG004|Objective 2, One Year|Death|30|||
143208547|NCT02596230|516310127|FG000|Objective 2, One Year|Other|0|||
143208548|NCT02596230|516310128|FG001|Objective 2, One Year|Other|3|||
143208549|NCT02596230|516310129|FG002|Objective 2, One Year|Other|2|||
143208550|NCT02596230|516310130|FG003|Objective 2, One Year|Other|0|||
143208551|NCT02596230|516310131|FG004|Objective 2, One Year|Other|0|||
143208552|NCT01571232|516310132|FG000|Overall Study|Lost to Follow-up|0|||
143208553|NCT01571232|516310133|FG001|Overall Study|Lost to Follow-up|1|||
143208554|NCT01571232|516310132|FG000|Overall Study|Withdrawal by Subject|1|||
143208555|NCT01571232|516310133|FG001|Overall Study|Withdrawal by Subject|0|||
143208556|NCT01272869|516310134|FG000|Period 2 (14 Days)|Adverse Event|1|||
143208557|NCT01272869|516310135|FG001|Period 2 (14 Days)|Adverse Event|0|||
143208558|NCT00771615|516310136|FG000|Overall Study|Withdrawal by Subject|0|||
143208559|NCT00771615|516310137|FG001|Overall Study|Withdrawal by Subject|1|||
143208560|NCT00771615|516310138|FG002|Overall Study|Withdrawal by Subject|0|||
143208561|NCT00771615|516310139|FG003|Overall Study|Withdrawal by Subject|0|||
143208562|NCT00771615|516310140|FG004|Overall Study|Withdrawal by Subject|0|||
143208563|NCT00771615|516310141|FG005|Overall Study|Withdrawal by Subject|0|||
143208564|NCT00771615|516310142|FG006|Overall Study|Withdrawal by Subject|0|||
143208565|NCT00771615|516310143|FG007|Overall Study|Withdrawal by Subject|1|||
143208566|NCT00771615|516310144|FG008|Overall Study|Withdrawal by Subject|0|||
143208567|NCT00771615|516310136|FG000|Overall Study|Lost to Follow-up|1|||
143208568|NCT00771615|516310137|FG001|Overall Study|Lost to Follow-up|1|||
143263614|NCT00048061|516519763|FG003|Overall Study|Lost to Follow-up|5|||
143263615|NCT00048061|516519760|FG000|Overall Study|Withdrawal by Subject|20|||
143263616|NCT00048061|516519761|FG001|Overall Study|Withdrawal by Subject|29|||
143263617|NCT00048061|516519762|FG002|Overall Study|Withdrawal by Subject|29|||
143263618|NCT00048061|516519763|FG003|Overall Study|Withdrawal by Subject|32|||
143263619|NCT00048061|516519760|FG000|Overall Study|Did not follow-up|5|||
143263620|NCT00048061|516519761|FG001|Overall Study|Did not follow-up|5|||
143263621|NCT00048061|516519762|FG002|Overall Study|Did not follow-up|4|||
143263622|NCT00048061|516519763|FG003|Overall Study|Did not follow-up|5|||
143263623|NCT00048061|516519760|FG000|Overall Study|Early improvement|6|||
143263624|NCT00048061|516519761|FG001|Overall Study|Early improvement|5|||
143263625|NCT00048061|516519762|FG002|Overall Study|Early improvement|3|||
143263626|NCT00048061|516519763|FG003|Overall Study|Early improvement|0|||
143263627|NCT03555435|516519764|FG000|Overall Study|Lost to Follow-up|17|||
143263628|NCT03555435|516519765|FG001|Overall Study|Lost to Follow-up|19|||
143263629|NCT03555435|516519766|FG002|Overall Study|Lost to Follow-up|8|||
143263630|NCT01058265|516519769|FG000|Overall Study|Lost to Follow-up|11|||
143263631|NCT01058265|516519770|FG001|Overall Study|Lost to Follow-up|12|||
143263632|NCT02869438|516519771|FG000|Overall Study|Lost to Follow-up|1|||
143263633|NCT02869438|516519772|FG001|Overall Study|Lost to Follow-up|0|||
143263634|NCT02869438|516519771|FG000|Overall Study|Adverse Event|1|||
143263635|NCT02869438|516519772|FG001|Overall Study|Adverse Event|0|||
143263636|NCT02869438|516519771|FG000|Overall Study|Withdrawal by Subject|1|||
143263637|NCT02869438|516519772|FG001|Overall Study|Withdrawal by Subject|2|||
143263638|NCT02964507|516519776|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
143263639|NCT02964507|516519777|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
143263640|NCT02964507|516519778|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
143263641|NCT02964507|516519779|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
143263642|NCT02964507|516519780|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
143208569|NCT00771615|516310138|FG002|Overall Study|Lost to Follow-up|1|||
143208570|NCT00771615|516310139|FG003|Overall Study|Lost to Follow-up|1|||
143208571|NCT00771615|516310140|FG004|Overall Study|Lost to Follow-up|0|||
143208572|NCT00771615|516310141|FG005|Overall Study|Lost to Follow-up|1|||
143263643|NCT02964507|516519781|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
143263644|NCT02964507|516519782|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
143263645|NCT02964507|516519783|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
143263646|NCT02964507|516519776|FG000|Overall Study|Study terminated by Sponsor|9|||
143208573|NCT00771615|516310142|FG006|Overall Study|Lost to Follow-up|1|||
143208574|NCT00771615|516310143|FG007|Overall Study|Lost to Follow-up|0|||
143208575|NCT00771615|516310144|FG008|Overall Study|Lost to Follow-up|0|||
143208576|NCT02455076|516310145|FG000|Inpatient|Withdrawal by Subject|1|||
143208577|NCT02455076|516310146|FG001|Inpatient|Withdrawal by Subject|0|||
143208578|NCT02455076|516310147|FG002|Inpatient|Withdrawal by Subject|0|||
143208579|NCT02455076|516310148|FG003|Inpatient|Withdrawal by Subject|0|||
143208580|NCT02455076|516310149|FG004|Inpatient|Withdrawal by Subject|0|||
143208581|NCT02455076|516310145|FG000|Inpatient|Discharged <24 h after admission|0|||
143208582|NCT02455076|516310146|FG001|Inpatient|Discharged <24 h after admission|1|||
143208583|NCT02455076|516310147|FG002|Inpatient|Discharged <24 h after admission|0|||
143208584|NCT02455076|516310148|FG003|Inpatient|Discharged <24 h after admission|0|||
143208585|NCT02455076|516310149|FG004|Inpatient|Discharged <24 h after admission|0|||
143208586|NCT02455076|516310145|FG000|Inpatient|Adverse Event|3|||
143208587|NCT02455076|516310146|FG001|Inpatient|Adverse Event|0|||
143208588|NCT02455076|516310147|FG002|Inpatient|Adverse Event|0|||
143208589|NCT02455076|516310148|FG003|Inpatient|Adverse Event|0|||
143208590|NCT02455076|516310149|FG004|Inpatient|Adverse Event|0|||
143208591|NCT02455076|516310145|FG000|Outpatient|Adverse Event|0|||
143208592|NCT02455076|516310146|FG001|Outpatient|Adverse Event|0|||
143208593|NCT02455076|516310147|FG002|Outpatient|Adverse Event|0|||
143208594|NCT02455076|516310148|FG003|Outpatient|Adverse Event|5|||
143208595|NCT02455076|516310149|FG004|Outpatient|Adverse Event|0|||
143208596|NCT02455076|516310145|FG000|Outpatient|Lost to Follow-up|0|||
143208597|NCT02455076|516310146|FG001|Outpatient|Lost to Follow-up|0|||
143208598|NCT02455076|516310147|FG002|Outpatient|Lost to Follow-up|0|||
143208599|NCT02455076|516310148|FG003|Outpatient|Lost to Follow-up|1|||
143208600|NCT02455076|516310149|FG004|Outpatient|Lost to Follow-up|12|||
143208601|NCT00859937|516310150|FG000|Overall Study|Protocol Violation|1|||
143208602|NCT00859937|516310151|FG001|Overall Study|Protocol Violation|0|||
143208603|NCT03908476|516310152|FG000|Overall Study|Death|3|||
143208604|NCT03908476|516310153|FG001|Overall Study|Death|0|||
143208605|NCT03908476|516310152|FG000|Overall Study|Lost to Follow-up|3|||
143208606|NCT03908476|516310153|FG001|Overall Study|Lost to Follow-up|1|||
143208607|NCT03908476|516310152|FG000|Overall Study|Withdrawal by Subject|7|||
143208608|NCT03908476|516310153|FG001|Overall Study|Withdrawal by Subject|1|||
143208609|NCT03908476|516310152|FG000|Overall Study|Physician Decision|2|||
143208610|NCT03908476|516310153|FG001|Overall Study|Physician Decision|0|||
143208611|NCT03908476|516310152|FG000|Overall Study|System Explanted and not Replaced|4|||
143208612|NCT03908476|516310153|FG001|Overall Study|System Explanted and not Replaced|0|||
143208613|NCT03908476|516310152|FG000|Overall Study|Intrathecal Pump|1|||
143208614|NCT03908476|516310153|FG001|Overall Study|Intrathecal Pump|0|||
143208615|NCT03908476|516310152|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
143208616|NCT03908476|516310153|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
143208617|NCT05194267|516310154|FG000|Overall Study|Withdrawal by Subject|2|||
143208618|NCT02868229|516310155|FG000|Overall Study|Adverse Event|1|||
143208619|NCT02868229|516310156|FG001|Overall Study|Adverse Event|0|||
143208620|NCT02868229|516310157|FG002|Overall Study|Adverse Event|0|||
143208621|NCT02868229|516310158|FG003|Overall Study|Adverse Event|1|||
143208622|NCT02868229|516310155|FG000|Overall Study|Death|0|||
143208623|NCT02868229|516310156|FG001|Overall Study|Death|0|||
143208624|NCT02868229|516310157|FG002|Overall Study|Death|1|||
143208625|NCT02868229|516310158|FG003|Overall Study|Death|1|||
143208626|NCT02868229|516310155|FG000|Overall Study|Missed dose|0|||
143208627|NCT02868229|516310156|FG001|Overall Study|Missed dose|0|||
143208628|NCT02868229|516310157|FG002|Overall Study|Missed dose|0|||
143208629|NCT02868229|516310158|FG003|Overall Study|Missed dose|3|||
143208630|NCT05779007|516310160|FG000|Overall Study|not meeting eligibility criteria|3517|||
143208631|NCT05779007|516310161|FG001|Overall Study|not meeting eligibility criteria|2009|||
143208632|NCT05147662|516310168|FG000|Overall Study|Withdrawal by parent/guardian|3|||
143208633|NCT05147662|516310168|FG000|Overall Study|Assigned to treatment but never treated|1|||
143208634|NCT00231413|516310171|FG000|Overall Study|Non-serious AE|0|||
143208635|NCT00231413|516310172|FG001|Overall Study|Non-serious AE|0|||
143208636|NCT00231413|516310173|FG002|Overall Study|Non-serious AE|1|||
143208637|NCT00231413|516310174|FG003|Overall Study|Non-serious AE|0|||
143208638|NCT00231413|516310175|FG004|Overall Study|Non-serious AE|0|||
143208639|NCT00231413|516310176|FG005|Overall Study|Non-serious AE|0|||
143208640|NCT00231413|516310177|FG006|Overall Study|Non-serious AE|1|||
143208641|NCT00231413|516310171|FG000|Overall Study|Withdrawal by Subject|3|||
143208642|NCT00231413|516310172|FG001|Overall Study|Withdrawal by Subject|1|||
143208643|NCT00231413|516310173|FG002|Overall Study|Withdrawal by Subject|4|||
143208644|NCT00231413|516310174|FG003|Overall Study|Withdrawal by Subject|2|||
143208645|NCT00231413|516310175|FG004|Overall Study|Withdrawal by Subject|2|||
143208646|NCT00231413|516310176|FG005|Overall Study|Withdrawal by Subject|0|||
143208647|NCT00231413|516310177|FG006|Overall Study|Withdrawal by Subject|3|||
143208648|NCT00231413|516310171|FG000|Overall Study|Migrated/moved from study area|0|||
143208649|NCT00231413|516310172|FG001|Overall Study|Migrated/moved from study area|0|||
143208650|NCT00231413|516310173|FG002|Overall Study|Migrated/moved from study area|1|||
143208651|NCT00231413|516310174|FG003|Overall Study|Migrated/moved from study area|0|||
143208652|NCT00231413|516310175|FG004|Overall Study|Migrated/moved from study area|0|||
143263647|NCT02964507|516519777|FG001|Overall Study|Study terminated by Sponsor|1|||
143208653|NCT00231413|516310176|FG005|Overall Study|Migrated/moved from study area|1|||
143208654|NCT00231413|516310177|FG006|Overall Study|Migrated/moved from study area|0|||
143208655|NCT00231413|516310171|FG000|Overall Study|Lost to Follow-up|4|||
143208656|NCT00231413|516310172|FG001|Overall Study|Lost to Follow-up|4|||
143208657|NCT00231413|516310173|FG002|Overall Study|Lost to Follow-up|1|||
143370489|NCT03354390|516899217|FG001|Level 2|Lost to Follow-up|1|||
143370490|NCT03354390|516899218|FG002|Level 2|Lost to Follow-up|0|||
143370491|NCT03354390|516899219|FG003|Level 2|Lost to Follow-up|0|||
143370492|NCT03354390|516899216|FG000|Level 3|Death|0|||
143370493|NCT03354390|516899217|FG001|Level 3|Death|0|||
143370494|NCT03354390|516899218|FG002|Level 3|Death|1|||
143370495|NCT03354390|516899219|FG003|Level 3|Death|0|||
143370496|NCT03354390|516899216|FG000|Level 3|Physician Decision|0|||
143370497|NCT03354390|516899217|FG001|Level 3|Physician Decision|0|||
143370498|NCT03354390|516899218|FG002|Level 3|Physician Decision|2|||
143208658|NCT00231413|516310174|FG003|Overall Study|Lost to Follow-up|1|||
143208659|NCT00231413|516310175|FG004|Overall Study|Lost to Follow-up|1|||
143208660|NCT00231413|516310176|FG005|Overall Study|Lost to Follow-up|4|||
143208661|NCT00231413|516310177|FG006|Overall Study|Lost to Follow-up|0|||
143208662|NCT00231413|516310171|FG000|Overall Study|Pregnancy|1|||
143208663|NCT00231413|516310172|FG001|Overall Study|Pregnancy|0|||
143208664|NCT00231413|516310173|FG002|Overall Study|Pregnancy|0|||
143208665|NCT00231413|516310174|FG003|Overall Study|Pregnancy|0|||
143208666|NCT00231413|516310175|FG004|Overall Study|Pregnancy|0|||
143208667|NCT00231413|516310176|FG005|Overall Study|Pregnancy|0|||
143208668|NCT00231413|516310177|FG006|Overall Study|Pregnancy|0|||
143208669|NCT04676867|516310178|FG000|Overall Study|Screen failure|0|||
143208670|NCT04676867|516310179|FG001|Overall Study|Screen failure|0|||
143208671|NCT04676867|516310180|FG002|Overall Study|Screen failure|6|||
143208672|NCT04676867|516310181|FG003|Overall Study|Screen failure|2|||
143208673|NCT04676867|516310178|FG000|Overall Study|Death|0|||
143208674|NCT04676867|516310179|FG001|Overall Study|Death|0|||
143208675|NCT04676867|516310180|FG002|Overall Study|Death|1|||
143208676|NCT04676867|516310181|FG003|Overall Study|Death|0|||
143208677|NCT04676867|516310178|FG000|Overall Study|Withdrawal by Subject|2|||
143208678|NCT04676867|516310179|FG001|Overall Study|Withdrawal by Subject|2|||
143208679|NCT04676867|516310180|FG002|Overall Study|Withdrawal by Subject|4|||
143208680|NCT04676867|516310181|FG003|Overall Study|Withdrawal by Subject|4|||
143208681|NCT04676867|516310178|FG000|Overall Study|Lost to Follow-up|1|||
143208682|NCT04676867|516310179|FG001|Overall Study|Lost to Follow-up|0|||
143208683|NCT04676867|516310180|FG002|Overall Study|Lost to Follow-up|0|||
143208684|NCT04676867|516310181|FG003|Overall Study|Lost to Follow-up|0|||
143208685|NCT00549770|516310182|FG000|Overall Study|Protocol deviation|1|||
143208686|NCT00549770|516310183|FG001|Overall Study|Protocol deviation|1|||
143208687|NCT00549770|516310184|FG002|Overall Study|Protocol deviation|1|||
143208688|NCT00549770|516310185|FG003|Overall Study|Protocol deviation|2|||
143208689|NCT00549770|516310186|FG004|Overall Study|Protocol deviation|2|||
143208690|NCT00549770|516310187|FG005|Overall Study|Protocol deviation|2|||
143208691|NCT00549770|516310188|FG006|Overall Study|Protocol deviation|1|||
143208692|NCT00549770|516310189|FG007|Overall Study|Protocol deviation|2|||
143208693|NCT00549770|516310182|FG000|Overall Study|Administrative problems|0|||
143208694|NCT00549770|516310183|FG001|Overall Study|Administrative problems|1|||
143208695|NCT00549770|516310184|FG002|Overall Study|Administrative problems|0|||
143208696|NCT00549770|516310185|FG003|Overall Study|Administrative problems|0|||
143208697|NCT00549770|516310186|FG004|Overall Study|Administrative problems|0|||
143208698|NCT00549770|516310187|FG005|Overall Study|Administrative problems|0|||
143208699|NCT00549770|516310188|FG006|Overall Study|Administrative problems|0|||
143208700|NCT00549770|516310189|FG007|Overall Study|Administrative problems|1|||
143208701|NCT00549770|516310182|FG000|Overall Study|Lost to Follow-up|0|||
143208702|NCT00549770|516310183|FG001|Overall Study|Lost to Follow-up|0|||
143208703|NCT00549770|516310184|FG002|Overall Study|Lost to Follow-up|2|||
143208704|NCT00549770|516310185|FG003|Overall Study|Lost to Follow-up|2|||
143208705|NCT00549770|516310186|FG004|Overall Study|Lost to Follow-up|3|||
143208706|NCT00549770|516310187|FG005|Overall Study|Lost to Follow-up|2|||
143208707|NCT00549770|516310188|FG006|Overall Study|Lost to Follow-up|0|||
143208708|NCT00549770|516310189|FG007|Overall Study|Lost to Follow-up|0|||
143208709|NCT00549770|516310182|FG000|Overall Study|Withdrawal by Subject|4|||
143208710|NCT00549770|516310183|FG001|Overall Study|Withdrawal by Subject|6|||
143208711|NCT00549770|516310184|FG002|Overall Study|Withdrawal by Subject|4|||
143208712|NCT00549770|516310185|FG003|Overall Study|Withdrawal by Subject|5|||
143208713|NCT00549770|516310186|FG004|Overall Study|Withdrawal by Subject|6|||
143208714|NCT00549770|516310187|FG005|Overall Study|Withdrawal by Subject|6|||
143208715|NCT00549770|516310188|FG006|Overall Study|Withdrawal by Subject|4|||
143208716|NCT00549770|516310189|FG007|Overall Study|Withdrawal by Subject|9|||
143208717|NCT00549770|516310182|FG000|Overall Study|Lack of Efficacy|1|||
143370499|NCT03354390|516899219|FG003|Level 3|Physician Decision|0|||
143370500|NCT03354390|516899216|FG000|Level 4|Death|0|||
143370501|NCT03354390|516899217|FG001|Level 4|Death|0|||
143208718|NCT00549770|516310183|FG001|Overall Study|Lack of Efficacy|0|||
143208719|NCT00549770|516310184|FG002|Overall Study|Lack of Efficacy|2|||
143208720|NCT00549770|516310185|FG003|Overall Study|Lack of Efficacy|3|||
143208721|NCT00549770|516310186|FG004|Overall Study|Lack of Efficacy|5|||
143208722|NCT00549770|516310187|FG005|Overall Study|Lack of Efficacy|1|||
143208723|NCT00549770|516310188|FG006|Overall Study|Lack of Efficacy|3|||
143208724|NCT00549770|516310189|FG007|Overall Study|Lack of Efficacy|8|||
143208725|NCT00549770|516310182|FG000|Overall Study|Abnormal test procedure results|0|||
143370502|NCT03354390|516899218|FG002|Level 4|Death|0|||
143263648|NCT02964507|516519778|FG002|Overall Study|Study terminated by Sponsor|9|||
143263649|NCT02964507|516519779|FG003|Overall Study|Study terminated by Sponsor|3|||
143263650|NCT02964507|516519780|FG004|Overall Study|Study terminated by Sponsor|3|||
143263651|NCT02964507|516519781|FG005|Overall Study|Study terminated by Sponsor|2|||
143263652|NCT02964507|516519782|FG006|Overall Study|Study terminated by Sponsor|0|||
143263653|NCT02964507|516519783|FG007|Overall Study|Study terminated by Sponsor|0|||
143263654|NCT02964507|516519776|FG000|Overall Study|Other|3|||
143263655|NCT02964507|516519777|FG001|Overall Study|Other|0|||
143263656|NCT02964507|516519778|FG002|Overall Study|Other|0|||
143263657|NCT02964507|516519779|FG003|Overall Study|Other|0|||
143263658|NCT02964507|516519780|FG004|Overall Study|Other|1|||
143263659|NCT02964507|516519781|FG005|Overall Study|Other|0|||
143263660|NCT02964507|516519782|FG006|Overall Study|Other|0|||
143263661|NCT02964507|516519783|FG007|Overall Study|Other|0|||
143263662|NCT02964507|516519776|FG000|Overall Study|Death|11|||
143263663|NCT02964507|516519777|FG001|Overall Study|Death|9|||
143263664|NCT02964507|516519778|FG002|Overall Study|Death|12|||
143263665|NCT02964507|516519779|FG003|Overall Study|Death|2|||
143263666|NCT02964507|516519780|FG004|Overall Study|Death|10|||
143263667|NCT02964507|516519781|FG005|Overall Study|Death|5|||
143263668|NCT02964507|516519782|FG006|Overall Study|Death|0|||
143263669|NCT02964507|516519783|FG007|Overall Study|Death|0|||
143263670|NCT02964507|516519776|FG000|Overall Study|Withdrawal by Subject|1|||
143263671|NCT02964507|516519777|FG001|Overall Study|Withdrawal by Subject|0|||
143263672|NCT02964507|516519778|FG002|Overall Study|Withdrawal by Subject|1|||
143263673|NCT02964507|516519779|FG003|Overall Study|Withdrawal by Subject|1|||
143263674|NCT02964507|516519780|FG004|Overall Study|Withdrawal by Subject|0|||
143263675|NCT02964507|516519781|FG005|Overall Study|Withdrawal by Subject|1|||
143263676|NCT02964507|516519782|FG006|Overall Study|Withdrawal by Subject|0|||
143263677|NCT02964507|516519783|FG007|Overall Study|Withdrawal by Subject|0|||
143263678|NCT02964507|516519776|FG000|Overall Study|Physician Decision|2|||
143263679|NCT02964507|516519777|FG001|Overall Study|Physician Decision|0|||
143263680|NCT02964507|516519778|FG002|Overall Study|Physician Decision|3|||
143263681|NCT02964507|516519779|FG003|Overall Study|Physician Decision|0|||
143263682|NCT02964507|516519780|FG004|Overall Study|Physician Decision|1|||
143263683|NCT02964507|516519781|FG005|Overall Study|Physician Decision|0|||
143263684|NCT02964507|516519782|FG006|Overall Study|Physician Decision|0|||
143263685|NCT02964507|516519783|FG007|Overall Study|Physician Decision|0|||
143263686|NCT04341662|516519784|FG000|Overall Study|Did not have source-verified blood loss data|423|||
143263687|NCT04341662|516519785|FG001|Overall Study|Did not have source-verified blood loss data|514|||
143263688|NCT04025710|516519786|FG000|Overall Study|Death|3|||
143263689|NCT04025710|516519786|FG000|Overall Study|Lost to Follow-up|5|||
143263690|NCT04025710|516519786|FG000|Overall Study|Withdrawal by Subject|1|||
143263691|NCT04025710|516519786|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
143263692|NCT04025710|516519786|FG000|Overall Study|Drop-out according to protocol|34|||
143263693|NCT04718103|516519787|FG000|Overall Study|Adverse Event|1|||
143263694|NCT04718103|516519788|FG001|Overall Study|Adverse Event|1|||
143263695|NCT04718103|516519787|FG000|Overall Study|Lack of Efficacy|4|||
143263696|NCT04718103|516519788|FG001|Overall Study|Lack of Efficacy|1|||
143263697|NCT04718103|516519787|FG000|Overall Study|Lost to Follow-up|2|||
143263698|NCT04718103|516519788|FG001|Overall Study|Lost to Follow-up|2|||
143263699|NCT04718103|516519787|FG000|Overall Study|Physician Decision|2|||
143263700|NCT04718103|516519788|FG001|Overall Study|Physician Decision|0|||
143263701|NCT04718103|516519787|FG000|Overall Study|Pregnancy|0|||
143263702|NCT04718103|516519788|FG001|Overall Study|Pregnancy|1|||
143263703|NCT04718103|516519787|FG000|Overall Study|Withdrawal by Subject|10|||
143263704|NCT04718103|516519788|FG001|Overall Study|Withdrawal by Subject|6|||
143263705|NCT04718103|516519787|FG000|Overall Study|Randomized, not treated|4|||
143263706|NCT04718103|516519788|FG001|Overall Study|Randomized, not treated|1|||
143263707|NCT04718103|516519787|FG000|Overall Study|GCP violations|7|||
143263708|NCT04718103|516519788|FG001|Overall Study|GCP violations|5|||
143263709|NCT00873860|516519789|FG000|Overall Study|Lost to Follow-up|1|||
143263710|NCT00873860|516519790|FG001|Overall Study|Lost to Follow-up|0|||
143263711|NCT00873860|516519791|FG002|Overall Study|Lost to Follow-up|0|||
143263712|NCT00873860|516519792|FG003|Overall Study|Lost to Follow-up|1|||
143263713|NCT00873860|516519789|FG000|Overall Study|Withdrawal by Subject|1|||
143263714|NCT00873860|516519790|FG001|Overall Study|Withdrawal by Subject|0|||
143208726|NCT00549770|516310183|FG001|Overall Study|Abnormal test procedure results|0|||
143208727|NCT00549770|516310184|FG002|Overall Study|Abnormal test procedure results|0|||
143208728|NCT00549770|516310185|FG003|Overall Study|Abnormal test procedure results|2|||
143208729|NCT00549770|516310186|FG004|Overall Study|Abnormal test procedure results|0|||
143208730|NCT00549770|516310187|FG005|Overall Study|Abnormal test procedure results|1|||
143208731|NCT00549770|516310188|FG006|Overall Study|Abnormal test procedure results|1|||
143208732|NCT00549770|516310189|FG007|Overall Study|Abnormal test procedure results|1|||
143208733|NCT00549770|516310182|FG000|Overall Study|Abnormal laboratory values|0|||
143208734|NCT00549770|516310183|FG001|Overall Study|Abnormal laboratory values|0|||
143208735|NCT00549770|516310184|FG002|Overall Study|Abnormal laboratory values|0|||
143208736|NCT00549770|516310185|FG003|Overall Study|Abnormal laboratory values|0|||
143208737|NCT00549770|516310186|FG004|Overall Study|Abnormal laboratory values|0|||
143208738|NCT00549770|516310187|FG005|Overall Study|Abnormal laboratory values|1|||
143208739|NCT00549770|516310188|FG006|Overall Study|Abnormal laboratory values|0|||
143208740|NCT00549770|516310189|FG007|Overall Study|Abnormal laboratory values|0|||
143208741|NCT00549770|516310182|FG000|Overall Study|Adverse Event|1|||
143208742|NCT00549770|516310183|FG001|Overall Study|Adverse Event|3|||
143208743|NCT00549770|516310184|FG002|Overall Study|Adverse Event|1|||
143208744|NCT00549770|516310185|FG003|Overall Study|Adverse Event|2|||
143208745|NCT00549770|516310186|FG004|Overall Study|Adverse Event|1|||
143208746|NCT00549770|516310187|FG005|Overall Study|Adverse Event|0|||
143208747|NCT00549770|516310188|FG006|Overall Study|Adverse Event|5|||
143208748|NCT00549770|516310189|FG007|Overall Study|Adverse Event|4|||
143208749|NCT01079936|516310190|FG000|Phase I: MTD|First Remission Status|2|||
143208750|NCT01079936|516310191|FG001|Phase I: MTD|First Remission Status|0|||
143208751|NCT01079936|516310192|FG002|Phase I: MTD|First Remission Status|0|||
143208752|NCT01079936|516310193|FG003|Phase I: MTD|First Remission Status|0|||
143208753|NCT01079936|516310194|FG004|Phase I: MTD|First Remission Status|0|||
143208754|NCT01079936|516310190|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
143208755|NCT01079936|516310191|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
143208756|NCT01079936|516310192|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
143208757|NCT01079936|516310193|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
143208758|NCT01079936|516310194|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
143208759|NCT01079936|516310190|FG000|Phase II|Adverse Event|0|||
143208760|NCT01079936|516310191|FG001|Phase II|Adverse Event|0|||
143208761|NCT01079936|516310192|FG002|Phase II|Adverse Event|1|||
143208762|NCT01079936|516310193|FG003|Phase II|Adverse Event|0|||
143208763|NCT01079936|516310194|FG004|Phase II|Adverse Event|0|||
143208764|NCT01079936|516310190|FG000|Phase II|Insurance Issue|0|||
143208765|NCT01079936|516310191|FG001|Phase II|Insurance Issue|0|||
143208766|NCT01079936|516310192|FG002|Phase II|Insurance Issue|0|||
143208767|NCT01079936|516310193|FG003|Phase II|Insurance Issue|0|||
143208768|NCT01079936|516310194|FG004|Phase II|Insurance Issue|1|||
143263715|NCT00873860|516519791|FG002|Overall Study|Withdrawal by Subject|2|||
143208769|NCT02294734|516310195|FG000|Overall Study|Adverse Event|5|||
143208770|NCT02294734|516310196|FG001|Overall Study|Adverse Event|5|||
143263716|NCT00873860|516519792|FG003|Overall Study|Withdrawal by Subject|0|||
143208771|NCT02294734|516310195|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
143208772|NCT02294734|516310196|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
143208773|NCT02294734|516310195|FG000|Overall Study|Lost to Follow-up|2|||
143208774|NCT02294734|516310196|FG001|Overall Study|Lost to Follow-up|0|||
143208775|NCT02294734|516310195|FG000|Overall Study|Physician Decision|2|||
143208776|NCT02294734|516310196|FG001|Overall Study|Physician Decision|1|||
143208777|NCT02294734|516310195|FG000|Overall Study|Withdrawal by Subject|4|||
143208778|NCT02294734|516310196|FG001|Overall Study|Withdrawal by Subject|2|||
143208779|NCT00548717|516310197|FG000|Overall Study|Death|5|||
143208780|NCT00548717|516310198|FG001|Overall Study|Death|2|||
143208781|NCT00548717|516310197|FG000|Overall Study|Relapse|3|||
143208782|NCT00548717|516310198|FG001|Overall Study|Relapse|0|||
143208783|NCT00548717|516310197|FG000|Overall Study|Alternative treatment for GVHD|1|||
143208784|NCT00548717|516310198|FG001|Overall Study|Alternative treatment for GVHD|0|||
143208785|NCT00082381|516310201|FG000|Overall Study|Adverse Event|27|||
143208786|NCT00082381|516310202|FG001|Overall Study|Adverse Event|2|||
143208787|NCT00082381|516310201|FG000|Overall Study|Lost to Follow-up|5|||
143208788|NCT00082381|516310202|FG001|Overall Study|Lost to Follow-up|7|||
143208789|NCT00082381|516310201|FG000|Overall Study|Patient Decision|8|||
143208790|NCT00082381|516310202|FG001|Overall Study|Patient Decision|4|||
143208791|NCT00082381|516310201|FG000|Overall Study|Physician Decision|1|||
143208792|NCT00082381|516310202|FG001|Overall Study|Physician Decision|2|||
143208793|NCT00082381|516310201|FG000|Overall Study|Protocol Violation|10|||
143208794|NCT00082381|516310202|FG001|Overall Study|Protocol Violation|11|||
143208795|NCT00082381|516310201|FG000|Overall Study|Loss of Glucose Control|4|||
143208796|NCT00082381|516310202|FG001|Overall Study|Loss of Glucose Control|0|||
143208797|NCT02925741|516310203|FG000|Overall Study|Withdrawal by Subject|11|||
143208798|NCT02925741|516310204|FG001|Overall Study|Withdrawal by Subject|0|||
143208799|NCT00025155|516310205|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
143208800|NCT00025155|516310205|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
143208801|NCT00494507|516310208|FG000|Double-Blind Phase|Adverse Event|2|||
143208802|NCT00494507|516310209|FG001|Double-Blind Phase|Adverse Event|0|||
143208803|NCT00494507|516310210|FG002|Double-Blind Phase|Adverse Event|1|||
143208804|NCT00494507|516310211|FG003|Double-Blind Phase|Adverse Event|0|||
143208805|NCT00494507|516310208|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
143208806|NCT00494507|516310209|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
143208807|NCT00494507|516310210|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
143208808|NCT00494507|516310211|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
143208809|NCT00494507|516310208|FG000|Double-Blind Phase|Subject Non-compliance|0|||
143208810|NCT00494507|516310209|FG001|Double-Blind Phase|Subject Non-compliance|0|||
143208811|NCT00494507|516310210|FG002|Double-Blind Phase|Subject Non-compliance|1|||
143208812|NCT00494507|516310211|FG003|Double-Blind Phase|Subject Non-compliance|0|||
143208813|NCT00494507|516310208|FG000|Double-Blind Phase|Negative DNA test|0|||
143208814|NCT00494507|516310209|FG001|Double-Blind Phase|Negative DNA test|0|||
143208815|NCT00494507|516310210|FG002|Double-Blind Phase|Negative DNA test|0|||
143208816|NCT00494507|516310211|FG003|Double-Blind Phase|Negative DNA test|1|||
143208817|NCT00494507|516310208|FG000|Open-Label Phase|Adverse Event|0|||
143208818|NCT00494507|516310209|FG001|Open-Label Phase|Adverse Event|1|||
143208819|NCT00494507|516310210|FG002|Open-Label Phase|Adverse Event|5|||
143208820|NCT00494507|516310211|FG003|Open-Label Phase|Adverse Event|3|||
143208821|NCT00494507|516310208|FG000|Open-Label Phase|Worsening Disease|0|||
143208822|NCT00494507|516310209|FG001|Open-Label Phase|Worsening Disease|0|||
143208823|NCT00494507|516310210|FG002|Open-Label Phase|Worsening Disease|0|||
143208824|NCT00494507|516310211|FG003|Open-Label Phase|Worsening Disease|2|||
143208825|NCT02437084|516310212|FG000|Overall Study|Withdrawal by Subject|2|||
143208826|NCT02437084|516310212|FG000|Overall Study|Physician Decision|1|||
143208827|NCT00109577|516310213|FG000|Overall Study|Withdrawal by Subject|3|||
143208828|NCT00109577|516310214|FG001|Overall Study|Withdrawal by Subject|3|||
143208829|NCT02613169|516310215|FG000|Overall Study|Withdrawal by Subject|4|||
143208830|NCT02613169|516310216|FG001|Overall Study|Withdrawal by Subject|1|||
143208831|NCT02613169|516310215|FG000|Overall Study|Lost to Follow-up|0|||
143208832|NCT02613169|516310216|FG001|Overall Study|Lost to Follow-up|5|||
143208833|NCT02613169|516310215|FG000|Overall Study|HIV|0|||
143208834|NCT02613169|516310216|FG001|Overall Study|HIV|2|||
143208835|NCT02613169|516310215|FG000|Overall Study|No TB infection endpoint|14|||
143208836|NCT02613169|516310216|FG001|Overall Study|No TB infection endpoint|9|||
143208837|NCT00343382|516310217|FG000|Overall Study|Adverse Event|2|||
143208838|NCT00343382|516310218|FG001|Overall Study|Adverse Event|10|||
143208839|NCT00343382|516310219|FG002|Overall Study|Adverse Event|7|||
143208840|NCT00343382|516310217|FG000|Overall Study|Withdrawal by Subject|1|||
143208841|NCT00343382|516310218|FG001|Overall Study|Withdrawal by Subject|2|||
143208842|NCT00343382|516310219|FG002|Overall Study|Withdrawal by Subject|6|||
143208843|NCT00343382|516310217|FG000|Overall Study|Other Reason Not Specified|1|||
143208844|NCT00343382|516310218|FG001|Overall Study|Other Reason Not Specified|2|||
143208845|NCT00343382|516310219|FG002|Overall Study|Other Reason Not Specified|4|||
143208846|NCT03729245|516310220|FG000|Overall Study|Lost to Follow-up|5|||
143208847|NCT03729245|516310221|FG001|Overall Study|Lost to Follow-up|6|||
143208848|NCT03729245|516310220|FG000|Overall Study|Withdrawal by Subject|16|||
143208849|NCT03729245|516310221|FG001|Overall Study|Withdrawal by Subject|19|||
143208850|NCT03729245|516310220|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
143208851|NCT03729245|516310221|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
143208852|NCT01985360|516310227|FG000|Overall Study|Withdrawal by Subject|4|||
143208853|NCT01985360|516310228|FG001|Overall Study|Withdrawal by Subject|0|||
143208854|NCT01985360|516310227|FG000|Overall Study|Lost to Follow-up|5|||
143208855|NCT01985360|516310228|FG001|Overall Study|Lost to Follow-up|3|||
143208856|NCT02914561|516310229|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
143208857|NCT02914561|516310230|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
143208858|NCT02914561|516310231|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
143208859|NCT02914561|516310232|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
143208860|NCT02914561|516310233|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
143208861|NCT02914561|516310234|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
143208862|NCT02914561|516310235|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
143208863|NCT02914561|516310236|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
143208864|NCT02914561|516310237|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
143208865|NCT02914561|516310238|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
143208866|NCT02914561|516310239|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
143208867|NCT02914561|516310229|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
143208868|NCT02914561|516310230|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
143208869|NCT02914561|516310231|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
143208870|NCT02914561|516310232|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
143208871|NCT02914561|516310233|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
143208872|NCT02914561|516310234|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
143208873|NCT02914561|516310235|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
143208874|NCT02914561|516310236|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
143208875|NCT02914561|516310237|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
143208876|NCT02914561|516310238|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
143208877|NCT02914561|516310239|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
143208878|NCT02914561|516310229|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
143208879|NCT02914561|516310230|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
143208880|NCT02914561|516310231|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
143208881|NCT02914561|516310232|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
143208882|NCT02914561|516310233|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
143208883|NCT02914561|516310234|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
143208884|NCT02914561|516310235|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
143208885|NCT02914561|516310236|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
143208886|NCT02914561|516310237|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
143208887|NCT02914561|516310238|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
143208888|NCT02914561|516310239|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
143208889|NCT02914561|516310229|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
143208890|NCT02914561|516310230|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
143208891|NCT02914561|516310231|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
143208892|NCT02914561|516310232|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
143208893|NCT02914561|516310233|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
143208894|NCT02914561|516310234|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
143208895|NCT02914561|516310235|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
143263717|NCT00873860|516519789|FG000|Overall Study|Death|1|||
143263718|NCT00873860|516519790|FG001|Overall Study|Death|0|||
143263719|NCT00873860|516519791|FG002|Overall Study|Death|0|||
143263720|NCT00873860|516519792|FG003|Overall Study|Death|0|||
143263721|NCT00873860|516519789|FG000|Overall Study|Other|1|||
143263722|NCT00873860|516519790|FG001|Overall Study|Other|0|||
143263723|NCT00873860|516519791|FG002|Overall Study|Other|1|||
143208896|NCT02914561|516310236|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
143208897|NCT02914561|516310237|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
143208898|NCT02914561|516310238|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
143208899|NCT02914561|516310239|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
143208900|NCT02914561|516310229|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
143208901|NCT02914561|516310230|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
143263724|NCT00873860|516519792|FG003|Overall Study|Other|0|||
143263725|NCT01484938|516519793|FG000|Overall Study|Adverse Event|2|||
143263726|NCT01484938|516519793|FG000|Overall Study|Lost to Follow-up|1|||
143263727|NCT01484938|516519793|FG000|Overall Study|Noncompliance|1|||
143263728|NCT02140775|516519794|FG000|Overall Study|Withdrawal by Subject|30|||
143263729|NCT02140775|516519795|FG001|Overall Study|Withdrawal by Subject|7|||
143263730|NCT02942576|516519797|FG000|Overall Study|Adverse Event|28|||
143208902|NCT02914561|516310231|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
143208903|NCT02914561|516310232|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
143208904|NCT02914561|516310233|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
143208905|NCT02914561|516310234|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
143208906|NCT02914561|516310235|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
143208907|NCT02914561|516310236|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
143208908|NCT02914561|516310237|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
143208909|NCT02914561|516310238|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
143208910|NCT02914561|516310239|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
143208911|NCT02914561|516310229|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
143208912|NCT02914561|516310230|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
143208913|NCT02914561|516310231|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
143208914|NCT02914561|516310232|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
143208915|NCT02914561|516310233|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
143208916|NCT02914561|516310234|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
143208917|NCT02914561|516310235|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
143208918|NCT02914561|516310236|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
143208919|NCT02914561|516310237|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
143208920|NCT02914561|516310238|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
143208921|NCT02914561|516310239|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
143208922|NCT02914561|516310229|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
143208923|NCT02914561|516310230|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
143208924|NCT02914561|516310231|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
143208925|NCT02914561|516310232|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
143208926|NCT02914561|516310233|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
143208927|NCT02914561|516310234|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
143208928|NCT02914561|516310235|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
143208929|NCT02914561|516310236|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
143208930|NCT02914561|516310237|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
143208931|NCT02914561|516310238|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
143208932|NCT02914561|516310239|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
143208933|NCT02914561|516310229|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
143208934|NCT02914561|516310230|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
143208935|NCT02914561|516310231|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
143208936|NCT02914561|516310232|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
143208937|NCT02914561|516310233|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
143208938|NCT02914561|516310234|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
143208939|NCT02914561|516310235|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
143208940|NCT02914561|516310236|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
143208941|NCT02914561|516310237|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
143208942|NCT02914561|516310238|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
143208943|NCT02914561|516310239|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
143208944|NCT02914561|516310229|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
143208945|NCT02914561|516310230|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
143208946|NCT02914561|516310231|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
143208947|NCT02914561|516310232|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
143208948|NCT02914561|516310233|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
143208949|NCT02914561|516310234|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
143208950|NCT02914561|516310235|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
143208951|NCT02914561|516310236|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
143208952|NCT02914561|516310237|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
143208953|NCT02914561|516310238|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
143208954|NCT02914561|516310239|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
143208955|NCT02914561|516310229|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
143263731|NCT02942576|516519798|FG001|Overall Study|Adverse Event|6|||
143263732|NCT02942576|516519797|FG000|Overall Study|Withdrawal by Subject|7|||
143263733|NCT02942576|516519798|FG001|Overall Study|Withdrawal by Subject|5|||
143263734|NCT02942576|516519797|FG000|Overall Study|Physician Decision|1|||
143263735|NCT02942576|516519798|FG001|Overall Study|Physician Decision|4|||
143208956|NCT02914561|516310230|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
143208957|NCT02914561|516310231|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
143208958|NCT02914561|516310232|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
143263736|NCT02942576|516519797|FG000|Overall Study|Other|10|||
143263737|NCT02942576|516519798|FG001|Overall Study|Other|8|||
143263738|NCT00938964|516519801|FG000|Overall Study|Death|3|||
143263739|NCT00938964|516519802|FG001|Overall Study|Death|3|||
143263740|NCT00938964|516519801|FG000|Overall Study|Lost to Follow-up|2|||
143263741|NCT00938964|516519802|FG001|Overall Study|Lost to Follow-up|3|||
143208959|NCT02914561|516310233|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
143208960|NCT02914561|516310234|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
143208961|NCT02914561|516310235|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
143208962|NCT02914561|516310236|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
143208963|NCT02914561|516310237|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
143208964|NCT02914561|516310238|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
143208965|NCT02914561|516310239|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
143208966|NCT02914561|516310229|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
143208967|NCT02914561|516310230|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
143208968|NCT02914561|516310231|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
143208969|NCT02914561|516310232|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
143208970|NCT02914561|516310233|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
143208971|NCT02914561|516310234|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
143208972|NCT02914561|516310235|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
143208973|NCT02914561|516310236|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
143208974|NCT02914561|516310237|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
143208975|NCT02914561|516310238|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
143208976|NCT02914561|516310239|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
143208977|NCT02914561|516310229|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
143208978|NCT02914561|516310230|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
143208979|NCT02914561|516310231|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
143208980|NCT02914561|516310232|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
143208981|NCT02914561|516310233|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
143208982|NCT02914561|516310234|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
143208983|NCT02914561|516310235|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
143208984|NCT02914561|516310236|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
143208985|NCT02914561|516310237|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
143208986|NCT02914561|516310238|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
143208987|NCT02914561|516310239|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
143208988|NCT02914561|516310229|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
143208989|NCT02914561|516310230|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
143208990|NCT02914561|516310231|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
143208991|NCT02914561|516310232|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
143208992|NCT02914561|516310233|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
143208993|NCT02914561|516310234|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
143208994|NCT02914561|516310235|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
143208995|NCT02914561|516310236|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
143263742|NCT00938964|516519801|FG000|Overall Study|Withdrawal by Subject|22|||
143263743|NCT00938964|516519802|FG001|Overall Study|Withdrawal by Subject|18|||
143263744|NCT00938964|516519801|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
143208996|NCT02914561|516310237|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
143208997|NCT02914561|516310238|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
143208998|NCT02914561|516310239|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
143263745|NCT00938964|516519802|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
143263746|NCT01858636|516519803|FG000|Overall Study|No Device Deployment Attempted|24|||
143263747|NCT01858636|516519803|FG000|Overall Study|Physician Decision|1|||
143263748|NCT01858636|516519803|FG000|Overall Study|Death|1|||
143208999|NCT02914561|516310229|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
143209000|NCT02914561|516310230|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
143209001|NCT02914561|516310231|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
143209002|NCT02914561|516310232|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
143209003|NCT02914561|516310233|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
143209004|NCT02914561|516310234|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
143209005|NCT02914561|516310235|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
143209006|NCT02914561|516310236|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
143209007|NCT02914561|516310237|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
143209008|NCT02914561|516310238|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
143209009|NCT02914561|516310239|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
143209010|NCT02914561|516310229|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
143209011|NCT02914561|516310230|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
143209012|NCT02914561|516310231|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
143209013|NCT02914561|516310232|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
143209014|NCT02914561|516310233|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
143209015|NCT02914561|516310234|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
143209016|NCT02914561|516310235|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
143209017|NCT02914561|516310236|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
143209018|NCT02914561|516310237|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
143209019|NCT02914561|516310238|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
143209020|NCT02914561|516310239|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
143209021|NCT02914561|516310229|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
143209022|NCT02914561|516310230|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
143209023|NCT02914561|516310231|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
143209024|NCT02914561|516310232|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
143209025|NCT02914561|516310233|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
143209026|NCT02914561|516310234|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
143209027|NCT02914561|516310235|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
143209028|NCT02914561|516310236|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
143209029|NCT02914561|516310237|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
143209030|NCT02914561|516310238|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
143209031|NCT02914561|516310239|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
143209032|NCT02914561|516310229|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
143209033|NCT02914561|516310230|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
143209034|NCT02914561|516310231|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
143209035|NCT02914561|516310232|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
143209036|NCT02914561|516310233|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
143209037|NCT02914561|516310234|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
143209038|NCT02914561|516310235|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
143209039|NCT02914561|516310236|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
143209040|NCT02914561|516310237|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
143209041|NCT02914561|516310238|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
143209042|NCT02914561|516310239|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
143209043|NCT01300455|516310240|FG000|Washout|Withdrawal by Subject|1|||
143209044|NCT01300455|516310241|FG001|Washout|Withdrawal by Subject|0|||
143209045|NCT00084487|516310242|FG000|Overall Study|Death|1|||
143209046|NCT03332160|516310247|FG000|Overall Study|Withdrawal by Subject|1|||
143209047|NCT03332160|516310248|FG001|Overall Study|Withdrawal by Subject|1|||
143209048|NCT03332160|516310247|FG000|Overall Study|Adverse Event|0|||
143209049|NCT03332160|516310248|FG001|Overall Study|Adverse Event|1|||
143209050|NCT03332160|516310247|FG000|Overall Study|Developed Exclusion Criteria|0|||
143209051|NCT03332160|516310248|FG001|Overall Study|Developed Exclusion Criteria|1|||
143209052|NCT03332160|516310247|FG000|Overall Study|Non-adherence to treatment|0|||
143209053|NCT03332160|516310248|FG001|Overall Study|Non-adherence to treatment|2|||
143209054|NCT04598269|516310249|FG000|Overall Study|Adverse Event|0|||
143209055|NCT04598269|516310250|FG001|Overall Study|Adverse Event|3|||
143370503|NCT03354390|516899219|FG003|Level 4|Death|3|||
143370504|NCT02046616|516901030|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
143370505|NCT02046616|516901030|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
143370506|NCT02046616|516901030|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
143370507|NCT02046616|516901030|FG000|24-Week Treatment Period|Physician Decision|3|||
143370508|NCT02046616|516901030|FG000|24-Week Treatment Period|Other|1|||
143370509|NCT02046616|516901030|FG000|8-Week FU Period|Lost to Follow-up|1|||
143370510|NCT01833832|516901034|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
143370511|NCT04842604|516901035|FG000|Overall Study|Death|1|||
143370512|NCT04842604|516901036|FG001|Overall Study|Death|0|||
143370513|NCT04842604|516901035|FG000|Overall Study|Other|4|||
143370514|NCT04842604|516901036|FG001|Overall Study|Other|4|||
143370515|NCT04842604|516901035|FG000|Overall Study|Randomized but not treated|1|||
143370516|NCT04842604|516901036|FG001|Overall Study|Randomized but not treated|0|||
143370517|NCT01156116|516901038|FG000|Overall Study|Withdrawal by Subject|3|||
143370518|NCT01156116|516901039|FG001|Overall Study|Withdrawal by Subject|1|||
143370519|NCT01156116|516901038|FG000|Overall Study|CPAP intolerance|2|||
143370520|NCT01156116|516901039|FG001|Overall Study|CPAP intolerance|0|||
143370521|NCT00344019|516901040|FG000|Overall Study|did not meet final inclusion criteria|0|||
143370522|NCT00344019|516901041|FG001|Overall Study|did not meet final inclusion criteria|0|||
143370523|NCT00344019|516901042|FG002|Overall Study|did not meet final inclusion criteria|74|||
143370524|NCT01565928|516901043|FG000|Overall Study|Adverse Event|3|||
143370525|NCT01565928|516901043|FG000|Overall Study|Other|3|||
143370526|NCT01565928|516901043|FG000|Overall Study|Progressive Disease|13|||
143370527|NCT01565928|516901043|FG000|Overall Study|Withdrawal by Subject|1|||
143370528|NCT01565928|516901043|FG000|Overall Study|Death|2|||
143370529|NCT02503202|516901044|FG000|Base Study: Up to Month 6|Death|1|||
143370530|NCT02503202|516901045|FG001|Base Study: Up to Month 6|Death|1|||
143370531|NCT02503202|516901046|FG002|Base Study: Up to Month 6|Death|0|||
143370532|NCT02503202|516901047|FG003|Base Study: Up to Month 6|Death|0|||
143370533|NCT02503202|516901048|FG004|Base Study: Up to Month 6|Death|0|||
143370534|NCT02503202|516901044|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
143370535|NCT02503202|516901045|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
143370536|NCT02503202|516901046|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
143370537|NCT02503202|516901047|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
143370538|NCT02503202|516901048|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
143370539|NCT02503202|516901044|FG000|Base Study: Up to Month 6|Physician Decision|0|||
143370540|NCT02503202|516901045|FG001|Base Study: Up to Month 6|Physician Decision|0|||
143370541|NCT02503202|516901046|FG002|Base Study: Up to Month 6|Physician Decision|0|||
143370542|NCT02503202|516901047|FG003|Base Study: Up to Month 6|Physician Decision|0|||
143370543|NCT02503202|516901048|FG004|Base Study: Up to Month 6|Physician Decision|1|||
143370544|NCT02503202|516901044|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
143370545|NCT02503202|516901045|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
143370546|NCT02503202|516901046|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
143370547|NCT02503202|516901047|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
143370548|NCT02503202|516901048|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
143370549|NCT02503202|516901044|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
143370550|NCT02503202|516901045|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
143370551|NCT02503202|516901046|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
143370552|NCT02503202|516901047|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
143370553|NCT02503202|516901048|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
143370554|NCT02503202|516901044|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
143370555|NCT02503202|516901045|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
143370556|NCT02503202|516901046|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
143370557|NCT02503202|516901047|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
143370558|NCT02503202|516901048|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
143370559|NCT02503202|516901044|FG000|Extension: Month 6 to 24|Death|1|||
143370560|NCT02503202|516901045|FG001|Extension: Month 6 to 24|Death|0|||
143370561|NCT02503202|516901046|FG002|Extension: Month 6 to 24|Death|0|||
143370562|NCT02503202|516901047|FG003|Extension: Month 6 to 24|Death|0|||
143370563|NCT02503202|516901048|FG004|Extension: Month 6 to 24|Death|0|||
143370564|NCT02503202|516901044|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
143370565|NCT02503202|516901045|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
143370566|NCT02503202|516901046|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
143370567|NCT02503202|516901047|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
143370568|NCT02503202|516901048|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
143370569|NCT02503202|516901044|FG000|Extension: Month 6 to 24|Physician Decision|1|||
143370570|NCT02503202|516901045|FG001|Extension: Month 6 to 24|Physician Decision|0|||
143370571|NCT02503202|516901046|FG002|Extension: Month 6 to 24|Physician Decision|1|||
143370572|NCT02503202|516901047|FG003|Extension: Month 6 to 24|Physician Decision|3|||
143370573|NCT02503202|516901048|FG004|Extension: Month 6 to 24|Physician Decision|0|||
143370574|NCT02503202|516901044|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
143209056|NCT04598269|516310249|FG000|Overall Study|Withdrawal by Subject|1|||
143209057|NCT04598269|516310250|FG001|Overall Study|Withdrawal by Subject|4|||
143209058|NCT04598269|516310249|FG000|Overall Study|Lost to Follow-up|1|||
143209059|NCT04598269|516310250|FG001|Overall Study|Lost to Follow-up|0|||
143209060|NCT04598269|516310249|FG000|Overall Study|Not Treated|2|||
143209061|NCT04598269|516310250|FG001|Overall Study|Not Treated|0|||
143209062|NCT02966015|516310251|FG000|Inclusion Visit|did not answer questionnaire|8|||
143209063|NCT02966015|516310252|FG001|Inclusion Visit|did not answer questionnaire|3|||
143209064|NCT03040986|516310255|FG000|Overall Study|Hospice|1|||
143209065|NCT03040986|516310256|FG001|Overall Study|Hospice|0|||
143263749|NCT01858636|516519803|FG000|Overall Study|Lost to Follow-up|1|||
143263750|NCT01858636|516519803|FG000|Overall Study|Withdrawal by Subject|1|||
143263751|NCT04650854|516519806|FG000|Overall Study|Adverse Event|1|||
143263752|NCT04650854|516519807|FG001|Overall Study|Adverse Event|12|||
143263753|NCT04650854|516519808|FG002|Overall Study|Adverse Event|14|||
143263754|NCT04650854|516519806|FG000|Overall Study|Lack of Efficacy|1|||
143263755|NCT04650854|516519807|FG001|Overall Study|Lack of Efficacy|3|||
143263756|NCT04650854|516519808|FG002|Overall Study|Lack of Efficacy|6|||
143263757|NCT04650854|516519806|FG000|Overall Study|Lost to Follow-up|1|||
143263758|NCT04650854|516519807|FG001|Overall Study|Lost to Follow-up|1|||
143263759|NCT04650854|516519808|FG002|Overall Study|Lost to Follow-up|0|||
143263760|NCT04650854|516519806|FG000|Overall Study|Withdrawal by Subject|2|||
143263761|NCT04650854|516519807|FG001|Overall Study|Withdrawal by Subject|17|||
143263762|NCT04650854|516519808|FG002|Overall Study|Withdrawal by Subject|9|||
143263763|NCT04650854|516519806|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines|0|||
143263764|NCT04650854|516519807|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines|12|||
143263765|NCT04650854|516519808|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines|6|||
143263766|NCT04650854|516519806|FG000|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
143263767|NCT04650854|516519807|FG001|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
143263768|NCT04650854|516519808|FG002|Overall Study|Participant Withdrawn After Drug Approved By FDA|1|||
143263769|NCT04650854|516519806|FG000|Overall Study|Pi Withdrew the Patients From the Study|0|||
143263770|NCT04650854|516519807|FG001|Overall Study|Pi Withdrew the Patients From the Study|0|||
143263771|NCT04650854|516519808|FG002|Overall Study|Pi Withdrew the Patients From the Study|1|||
143263772|NCT04650854|516519806|FG000|Overall Study|Withdraw Per Sponsor's Directive|0|||
143263773|NCT04650854|516519807|FG001|Overall Study|Withdraw Per Sponsor's Directive|1|||
143263774|NCT04650854|516519808|FG002|Overall Study|Withdraw Per Sponsor's Directive|0|||
143263775|NCT04650854|516519806|FG000|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
143263776|NCT04650854|516519807|FG001|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
143263777|NCT04650854|516519808|FG002|Overall Study|Withdrawal Due to Prohibited Treatment|1|||
143263778|NCT04650854|516519806|FG000|Overall Study|Use of Rescue Medication|0|||
143263779|NCT04650854|516519807|FG001|Overall Study|Use of Rescue Medication|0|||
143263780|NCT04650854|516519808|FG002|Overall Study|Use of Rescue Medication|1|||
143263781|NCT04650854|516519806|FG000|Overall Study|Last Treatment Per Sponsor|0|||
143263782|NCT04650854|516519807|FG001|Overall Study|Last Treatment Per Sponsor|0|||
143263783|NCT04650854|516519808|FG002|Overall Study|Last Treatment Per Sponsor|2|||
143263784|NCT04650854|516519806|FG000|Overall Study|Rescue Medication|0|||
143263785|NCT04650854|516519807|FG001|Overall Study|Rescue Medication|0|||
143263786|NCT04650854|516519808|FG002|Overall Study|Rescue Medication|1|||
143263787|NCT04650854|516519806|FG000|Overall Study|Participant Want to Start a Family|0|||
143263788|NCT04650854|516519807|FG001|Overall Study|Participant Want to Start a Family|0|||
143263789|NCT04650854|516519808|FG002|Overall Study|Participant Want to Start a Family|1|||
143263790|NCT04650854|516519806|FG000|Overall Study|Withdraw Based on Sponsor Decision|0|||
143263791|NCT04650854|516519807|FG001|Overall Study|Withdraw Based on Sponsor Decision|0|||
143263792|NCT04650854|516519808|FG002|Overall Study|Withdraw Based on Sponsor Decision|1|||
143263793|NCT04650854|516519806|FG000|Overall Study|Participant Screened For MG0020|0|||
143263794|NCT04650854|516519807|FG001|Overall Study|Participant Screened For MG0020|2|||
143263795|NCT04650854|516519808|FG002|Overall Study|Participant Screened For MG0020|3|||
143263796|NCT04650854|516519806|FG000|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
143263797|NCT04650854|516519807|FG001|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|1|||
143263798|NCT04650854|516519808|FG002|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
143263799|NCT04650854|516519806|FG000|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
143370575|NCT02503202|516901045|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
143370576|NCT02503202|516901046|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
143209066|NCT03040986|516310255|FG000|Overall Study|Adverse Event|2|||
143209067|NCT03040986|516310256|FG001|Overall Study|Adverse Event|1|||
143263800|NCT04650854|516519807|FG001|Overall Study|Subject Performed PEOT, Not a Completed Subject|1|||
143263801|NCT04650854|516519808|FG002|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
143263802|NCT04650854|516519806|FG000|Overall Study|Participant to Be Screened for MG0020 Study|0|||
143209068|NCT03040986|516310255|FG000|Overall Study|Disease progression on study|3|||
143209069|NCT03040986|516310256|FG001|Overall Study|Disease progression on study|1|||
143209070|NCT02879578|516310257|FG000|Overall Study|Adverse Event|1|||
143209071|NCT02879578|516310258|FG001|Overall Study|Adverse Event|2|||
143209072|NCT02879578|516310259|FG002|Overall Study|Adverse Event|14|||
143209073|NCT02879578|516310257|FG000|Overall Study|Protocol Violation|0|||
143209074|NCT02879578|516310258|FG001|Overall Study|Protocol Violation|1|||
143209075|NCT02879578|516310259|FG002|Overall Study|Protocol Violation|1|||
143209076|NCT02879578|516310257|FG000|Overall Study|Withdrawal by Subject|8|||
143209077|NCT02879578|516310258|FG001|Overall Study|Withdrawal by Subject|6|||
143209078|NCT02879578|516310259|FG002|Overall Study|Withdrawal by Subject|9|||
143209079|NCT02879578|516310257|FG000|Overall Study|Lost to Follow-up|1|||
143209080|NCT02879578|516310258|FG001|Overall Study|Lost to Follow-up|0|||
143209081|NCT02879578|516310259|FG002|Overall Study|Lost to Follow-up|4|||
143209082|NCT02879578|516310257|FG000|Overall Study|Physician Decision|0|||
143263803|NCT04650854|516519807|FG001|Overall Study|Participant to Be Screened for MG0020 Study|4|||
143263804|NCT04650854|516519808|FG002|Overall Study|Participant to Be Screened for MG0020 Study|5|||
143263805|NCT04650854|516519806|FG000|Overall Study|End Of Study|0|||
143263806|NCT04650854|516519807|FG001|Overall Study|End Of Study|2|||
143263807|NCT04650854|516519808|FG002|Overall Study|End Of Study|1|||
143263808|NCT04650854|516519806|FG000|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
143263809|NCT04650854|516519807|FG001|Overall Study|Wish To Continue Study IMP in Patient Programme|1|||
143263810|NCT04650854|516519808|FG002|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
143263811|NCT04650854|516519806|FG000|Overall Study|Participant Received Rescue Medication|0|||
143263812|NCT04650854|516519807|FG001|Overall Study|Participant Received Rescue Medication|1|||
143263813|NCT04650854|516519808|FG002|Overall Study|Participant Received Rescue Medication|0|||
143263814|NCT04650854|516519806|FG000|Overall Study|Patient Withdrawn; Lack of IMP Shipments|0|||
143263815|NCT04650854|516519807|FG001|Overall Study|Patient Withdrawn; Lack of IMP Shipments|2|||
143263816|NCT04650854|516519808|FG002|Overall Study|Patient Withdrawn; Lack of IMP Shipments|1|||
143263817|NCT04650854|516519806|FG000|Overall Study|Last Treatment Per Lplv, Screened For MG0020|0|||
143209083|NCT02879578|516310258|FG001|Overall Study|Physician Decision|0|||
143263818|NCT04650854|516519807|FG001|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
143263819|NCT04650854|516519808|FG002|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
143263820|NCT04650854|516519806|FG000|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
143209084|NCT02879578|516310259|FG002|Overall Study|Physician Decision|4|||
143209085|NCT02986854|516310267|FG000|Overall Study|Withdrawal by Subject|0|||
143263821|NCT04650854|516519807|FG001|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
143263822|NCT04650854|516519808|FG002|Overall Study|Discontinued Due to Chronic Heart Failure|1|||
143263823|NCT04650854|516519806|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|0|||
143209086|NCT02986854|516310268|FG001|Overall Study|Withdrawal by Subject|1|||
143209087|NCT02986854|516310269|FG002|Overall Study|Withdrawal by Subject|1|||
143209088|NCT02986854|516310267|FG000|Overall Study|Lost to Follow-up|3|||
143209089|NCT02986854|516310268|FG001|Overall Study|Lost to Follow-up|11|||
143209090|NCT02986854|516310269|FG002|Overall Study|Lost to Follow-up|2|||
143209091|NCT00718770|516310270|FG000|Overall Study|Adverse Event|1|||
143209092|NCT00718770|516310270|FG000|Overall Study|Lack of Efficacy|1|||
143209093|NCT00718770|516310270|FG000|Overall Study|Lack of Efficacy|1|||
143209094|NCT00718770|516310270|FG000|Overall Study|Adverse Event|1|||
143209095|NCT00718770|516310270|FG000|Overall Study|Lack of Efficacy|1|||
143209096|NCT00718770|516310270|FG000|Overall Study|Adverse Event|1|||
143209097|NCT00718770|516310270|FG000|Overall Study|Lack of Efficacy|1|||
143209098|NCT00718770|516310270|FG000|Overall Study|Adverse Event|1|||
143209099|NCT00626405|516310274|FG000|Overall Study|Deemed Ineligible|1|||
143209100|NCT00626405|516310275|FG001|Overall Study|Deemed Ineligible|0|||
143209101|NCT00626405|516310274|FG000|Overall Study|Withdrawal by Subject|0|||
143209102|NCT00626405|516310275|FG001|Overall Study|Withdrawal by Subject|1|||
143209103|NCT00495625|516311977|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
143209104|NCT00527982|516311979|FG000|Overall Study|Physician Decision|1|||
143209105|NCT00527982|516311980|FG001|Overall Study|Physician Decision|0|||
143209106|NCT02271945|516311986|FG000|Overall Study|Death|3|||
143209107|NCT02271945|516311987|FG001|Overall Study|Death|3|||
143209108|NCT02271945|516311986|FG000|Overall Study|Withdrawal by Subject|1|||
143209109|NCT02271945|516311987|FG001|Overall Study|Withdrawal by Subject|1|||
143209110|NCT02271945|516311986|FG000|Overall Study|Other|1|||
143209111|NCT02271945|516311987|FG001|Overall Study|Other|1|||
143209112|NCT06151288|516311988|FG000|Overall Study|Lost to Follow-up|4|||
143209113|NCT06151288|516311989|FG001|Overall Study|Lost to Follow-up|2|||
143209114|NCT06151288|516311990|FG002|Overall Study|Lost to Follow-up|4|||
143209115|NCT06151288|516311991|FG003|Overall Study|Lost to Follow-up|3|||
143209116|NCT06151288|516311988|FG000|Overall Study|Withdrawal by Subject|4|||
143209117|NCT06151288|516311989|FG001|Overall Study|Withdrawal by Subject|5|||
143209118|NCT06151288|516311990|FG002|Overall Study|Withdrawal by Subject|1|||
143209119|NCT06151288|516311991|FG003|Overall Study|Withdrawal by Subject|1|||
143209120|NCT04588389|516311992|FG000|Overall Study|Issues with anesthesia during surgery|2|||
143209121|NCT04588389|516311993|FG001|Overall Study|Issues with anesthesia during surgery|0|||
143209122|NCT04588389|516311994|FG002|Overall Study|Issues with anesthesia during surgery|0|||
143209123|NCT00719680|516311999|FG000|Overall Study|Adverse Event|1|||
143209124|NCT00719680|516311999|FG000|Overall Study|Lost to Follow-up|1|||
143209125|NCT00719680|516311999|FG000|Overall Study|Withdrawal by Subject|3|||
143209126|NCT00658814|516312000|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
143209127|NCT00658814|516312001|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
143209128|NCT00658814|516312000|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
143209129|NCT00658814|516312001|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
143209130|NCT00658814|516312000|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
143209131|NCT00658814|516312001|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
143209132|NCT00658814|516312000|FG000|Remission Induction Chemotherapy|Death|1|||
143209133|NCT00658814|516312001|FG001|Remission Induction Chemotherapy|Death|4|||
143209134|NCT00658814|516312000|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
143209135|NCT00658814|516312001|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
143209136|NCT00658814|516312000|FG000|Remission Induction Chemotherapy|Not eligible|1|||
143209137|NCT00658814|516312001|FG001|Remission Induction Chemotherapy|Not eligible|2|||
143209138|NCT00658814|516312000|FG000|Consolidation Therapy|Not protocol specified|0|||
143209139|NCT00658814|516312001|FG001|Consolidation Therapy|Not protocol specified|1|||
143209140|NCT00658814|516312000|FG000|Consolidation Therapy|Not eligible|2|||
143209141|NCT00658814|516312001|FG001|Consolidation Therapy|Not eligible|2|||
143209142|NCT00658814|516312000|FG000|Maintenance Therapy|Adverse Event|1|||
143209143|NCT00658814|516312001|FG001|Maintenance Therapy|Adverse Event|1|||
143209144|NCT00658814|516312000|FG000|Maintenance Therapy|Not protocol specified|1|||
143209145|NCT00658814|516312001|FG001|Maintenance Therapy|Not protocol specified|0|||
143209146|NCT00658814|516312000|FG000|Maintenance Therapy|Not eligible|1|||
143209147|NCT00658814|516312001|FG001|Maintenance Therapy|Not eligible|0|||
143209148|NCT02911142|516312002|FG000|Phase I - Safety & Tolerability|Did not complete last cycle of EPOCH-R2 due to progressive disease.|1|||
143209149|NCT02911142|516312002|FG000|Phase II - Recommended Phase 2 Dose|Refused further treatment|1|||
143209150|NCT02911142|516312002|FG000|Phase II - Recommended Phase 2 Dose|Physician Decision|2|||
143209151|NCT02911142|516312002|FG000|Phase II - Recommended Phase 2 Dose|Death|1|||
143209152|NCT03270891|516312003|FG000|Overall Study|Lost to Follow-up|3|||
143209153|NCT03270891|516312004|FG001|Overall Study|Lost to Follow-up|6|||
143209154|NCT03270891|516312005|FG002|Overall Study|Lost to Follow-up|0|||
143209155|NCT03270891|516312003|FG000|Overall Study|Withdrawal by Subject|1|||
143209156|NCT03270891|516312004|FG001|Overall Study|Withdrawal by Subject|0|||
143209157|NCT03270891|516312005|FG002|Overall Study|Withdrawal by Subject|0|||
143209158|NCT03270891|516312003|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
143209159|NCT03270891|516312004|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
143209160|NCT03270891|516312005|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
143209161|NCT02540668|516312006|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
143209162|NCT02540668|516312007|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
143209163|NCT03157583|516312010|FG000|Overall Study|Other (did not meet study criteria)|1|||
143209164|NCT01581619|516312019|FG000|Overall Study|Withdrawal by Subject|1|||
143209165|NCT01581619|516312019|FG000|Overall Study|Lost to Follow-up|1|||
143209166|NCT00290498|516312020|FG000|Overall Study|Death|2|||
143209167|NCT00290498|516312021|FG001|Overall Study|Death|0|||
143209168|NCT00290498|516312020|FG000|Overall Study|Physician Decision|1|||
143209169|NCT00290498|516312021|FG001|Overall Study|Physician Decision|0|||
143209170|NCT00290498|516312020|FG000|Overall Study|Withdrawal by Subject|1|||
143209171|NCT00290498|516312021|FG001|Overall Study|Withdrawal by Subject|0|||
143209172|NCT00290498|516312020|FG000|Overall Study|Ineligible|3|||
143209173|NCT00290498|516312021|FG001|Overall Study|Ineligible|0|||
143209174|NCT00290498|516312020|FG000|Overall Study|Non-Compliance|1|||
143209175|NCT00290498|516312021|FG001|Overall Study|Non-Compliance|0|||
143209176|NCT02250664|516312024|FG000|Overall Study|Lost to Follow-up|18|||
143209177|NCT02250664|516312025|FG001|Overall Study|Lost to Follow-up|28|||
143209178|NCT02250664|516312026|FG002|Overall Study|Lost to Follow-up|33|||
143209179|NCT02250664|516312024|FG000|Overall Study|Personal Reasons|7|||
143209180|NCT02250664|516312025|FG001|Overall Study|Personal Reasons|8|||
143209181|NCT02250664|516312026|FG002|Overall Study|Personal Reasons|14|||
143209182|NCT02250664|516312024|FG000|Overall Study|Adverse Event|6|||
143209183|NCT02250664|516312025|FG001|Overall Study|Adverse Event|3|||
143209184|NCT02250664|516312026|FG002|Overall Study|Adverse Event|8|||
143209185|NCT02250664|516312024|FG000|Overall Study|Incarcerated|2|||
143209186|NCT02250664|516312025|FG001|Overall Study|Incarcerated|1|||
143209187|NCT02250664|516312026|FG002|Overall Study|Incarcerated|2|||
143209188|NCT02250664|516312024|FG000|Overall Study|Withdrawal by Subject|0|||
143209189|NCT02250664|516312025|FG001|Overall Study|Withdrawal by Subject|1|||
143209190|NCT02250664|516312026|FG002|Overall Study|Withdrawal by Subject|2|||
143209191|NCT02250664|516312024|FG000|Overall Study|Death|0|||
143209192|NCT02250664|516312025|FG001|Overall Study|Death|1|||
143209193|NCT02250664|516312026|FG002|Overall Study|Death|1|||
143209194|NCT02250664|516312024|FG000|Overall Study|Physician Decision|1|||
143209195|NCT02250664|516312025|FG001|Overall Study|Physician Decision|3|||
143209196|NCT02250664|516312026|FG002|Overall Study|Physician Decision|1|||
143209197|NCT02250664|516312024|FG000|Overall Study|Protocol Violation|1|||
143209198|NCT02250664|516312025|FG001|Overall Study|Protocol Violation|0|||
143209199|NCT02250664|516312026|FG002|Overall Study|Protocol Violation|1|||
143209200|NCT02250664|516312024|FG000|Overall Study|Reason unknown|1|||
143209201|NCT02250664|516312025|FG001|Overall Study|Reason unknown|0|||
143209202|NCT02250664|516312026|FG002|Overall Study|Reason unknown|0|||
143209203|NCT03847909|516312028|FG000|Overall Study|Withdrawal by Subject|1|||
143209204|NCT03847909|516312029|FG001|Overall Study|Withdrawal by Subject|1|||
143209205|NCT04268173|516312034|FG000|Overall Study|Lost to Follow-up|75|||
143209206|NCT04268173|516312035|FG001|Overall Study|Lost to Follow-up|108|||
143209207|NCT00869401|516312036|FG000|Overall Study|Withdrawal by Subject|0|||
143209208|NCT00869401|516312037|FG001|Overall Study|Withdrawal by Subject|0|||
143209209|NCT00869401|516312038|FG002|Overall Study|Withdrawal by Subject|0|||
143209210|NCT00869401|516312039|FG003|Overall Study|Withdrawal by Subject|5|||
143209211|NCT00869401|516312040|FG004|Overall Study|Withdrawal by Subject|3|||
143209212|NCT00975143|516312041|FG000|Overall Study|Adverse Event|19|||
143209213|NCT00975143|516312042|FG001|Overall Study|Adverse Event|15|||
143209214|NCT00975143|516312041|FG000|Overall Study|Withdrawal by Subject|15|||
143209215|NCT00975143|516312042|FG001|Overall Study|Withdrawal by Subject|15|||
143209216|NCT00975143|516312041|FG000|Overall Study|Lost to Follow-up|20|||
143209217|NCT00975143|516312042|FG001|Overall Study|Lost to Follow-up|16|||
143263824|NCT04650854|516519807|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
143209218|NCT00975143|516312041|FG000|Overall Study|Non-compliance|5|||
143209219|NCT00975143|516312042|FG001|Overall Study|Non-compliance|8|||
143209220|NCT00975143|516312041|FG000|Overall Study|Physician Decision|1|||
143209221|NCT00975143|516312042|FG001|Overall Study|Physician Decision|2|||
143209222|NCT00975143|516312041|FG000|Overall Study|Details not available|10|||
143209223|NCT00975143|516312042|FG001|Overall Study|Details not available|4|||
143209224|NCT01147900|516312043|FG000|At Year 10|Lost to Follow-up|0|||
143209225|NCT01147900|516312044|FG001|At Year 10|Lost to Follow-up|1|||
143209226|NCT01147900|516312045|FG002|At Year 10|Lost to Follow-up|0|||
143209227|NCT00545103|516312046|FG000|Overall Study|Lack of Efficacy|48|||
143209228|NCT00545103|516312047|FG001|Overall Study|Lack of Efficacy|45|||
143209229|NCT00545103|516312048|FG002|Overall Study|Lack of Efficacy|31|||
143209230|NCT00545103|516312049|FG003|Overall Study|Lack of Efficacy|27|||
143209231|NCT00545103|516312046|FG000|Overall Study|Withdrawal by Subject|6|||
143209232|NCT00545103|516312047|FG001|Overall Study|Withdrawal by Subject|10|||
143209233|NCT00545103|516312048|FG002|Overall Study|Withdrawal by Subject|18|||
143209234|NCT00545103|516312049|FG003|Overall Study|Withdrawal by Subject|22|||
143209235|NCT00545103|516312046|FG000|Overall Study|Adverse Event|11|||
143209236|NCT00545103|516312047|FG001|Overall Study|Adverse Event|12|||
143209237|NCT00545103|516312048|FG002|Overall Study|Adverse Event|17|||
143209238|NCT00545103|516312049|FG003|Overall Study|Adverse Event|10|||
143209239|NCT00545103|516312046|FG000|Overall Study|Lost to Follow-up|4|||
143209240|NCT00545103|516312047|FG001|Overall Study|Lost to Follow-up|6|||
143209241|NCT00545103|516312048|FG002|Overall Study|Lost to Follow-up|3|||
143209242|NCT00545103|516312049|FG003|Overall Study|Lost to Follow-up|4|||
143209243|NCT00545103|516312046|FG000|Overall Study|Protocol Violation|1|||
143209244|NCT00545103|516312047|FG001|Overall Study|Protocol Violation|2|||
143209245|NCT00545103|516312048|FG002|Overall Study|Protocol Violation|3|||
143209246|NCT00545103|516312049|FG003|Overall Study|Protocol Violation|0|||
143209247|NCT00545103|516312046|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
143209248|NCT00545103|516312047|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
143209249|NCT00545103|516312048|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
143209250|NCT00545103|516312049|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
143209251|NCT00545103|516312046|FG000|Overall Study|Difficult to open package|0|||
143209252|NCT00545103|516312047|FG001|Overall Study|Difficult to open package|0|||
143209253|NCT00545103|516312048|FG002|Overall Study|Difficult to open package|0|||
143209254|NCT00545103|516312049|FG003|Overall Study|Difficult to open package|1|||
143209255|NCT00545103|516312046|FG000|Overall Study|Investigational product not taken|1|||
143209256|NCT00545103|516312047|FG001|Overall Study|Investigational product not taken|0|||
143209257|NCT00545103|516312048|FG002|Overall Study|Investigational product not taken|0|||
143209258|NCT00545103|516312049|FG003|Overall Study|Investigational product not taken|1|||
143209259|NCT00545103|516312046|FG000|Overall Study|Wish to start a family|0|||
143209260|NCT00545103|516312047|FG001|Overall Study|Wish to start a family|0|||
143209261|NCT00545103|516312048|FG002|Overall Study|Wish to start a family|0|||
143209262|NCT00545103|516312049|FG003|Overall Study|Wish to start a family|1|||
143209263|NCT00545103|516312046|FG000|Overall Study|Diverticulitis crisis|0|||
143209264|NCT00545103|516312047|FG001|Overall Study|Diverticulitis crisis|0|||
143209265|NCT00545103|516312048|FG002|Overall Study|Diverticulitis crisis|0|||
143209266|NCT00545103|516312049|FG003|Overall Study|Diverticulitis crisis|1|||
143209267|NCT00545103|516312046|FG000|Overall Study|Personal reasons|1|||
143209268|NCT00545103|516312047|FG001|Overall Study|Personal reasons|0|||
143209269|NCT00545103|516312048|FG002|Overall Study|Personal reasons|0|||
143209270|NCT00545103|516312049|FG003|Overall Study|Personal reasons|0|||
143209271|NCT00545103|516312046|FG000|Overall Study|Subject's decision|1|||
143209272|NCT00545103|516312047|FG001|Overall Study|Subject's decision|0|||
143209273|NCT00545103|516312048|FG002|Overall Study|Subject's decision|0|||
143209274|NCT00545103|516312049|FG003|Overall Study|Subject's decision|0|||
143209275|NCT00545103|516312046|FG000|Overall Study|Noncompliance|0|||
143209276|NCT00545103|516312047|FG001|Overall Study|Noncompliance|1|||
143209277|NCT00545103|516312048|FG002|Overall Study|Noncompliance|0|||
143209278|NCT00545103|516312049|FG003|Overall Study|Noncompliance|0|||
143209279|NCT00545103|516312046|FG000|Overall Study|Investigator decision|0|||
143263825|NCT04650854|516519808|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
143263826|NCT04650854|516519806|FG000|Overall Study|Enrollment Cup|0|||
143263827|NCT04650854|516519807|FG001|Overall Study|Enrollment Cup|0|||
143263828|NCT04650854|516519808|FG002|Overall Study|Enrollment Cup|1|||
143263829|NCT05308290|516519811|FG000|Overall Study|Death|1|||
143263830|NCT05308290|516519812|FG001|Overall Study|Death|0|||
143263831|NCT05308290|516519811|FG000|Overall Study|Lost to Follow-up|2|||
143263832|NCT05308290|516519812|FG001|Overall Study|Lost to Follow-up|1|||
143209280|NCT00545103|516312047|FG001|Overall Study|Investigator decision|0|||
143209281|NCT00545103|516312048|FG002|Overall Study|Investigator decision|1|||
143209282|NCT00545103|516312049|FG003|Overall Study|Investigator decision|0|||
143209283|NCT00545103|516312046|FG000|Overall Study|Subject moved|0|||
143209284|NCT00545103|516312047|FG001|Overall Study|Subject moved|1|||
143209285|NCT00545103|516312048|FG002|Overall Study|Subject moved|0|||
143209286|NCT00545103|516312049|FG003|Overall Study|Subject moved|0|||
143209287|NCT00545103|516312046|FG000|Overall Study|Use of prohibited medication|0|||
143209288|NCT00545103|516312047|FG001|Overall Study|Use of prohibited medication|0|||
143263833|NCT05308290|516519811|FG000|Overall Study|still in study followup|0|||
143263834|NCT05308290|516519812|FG001|Overall Study|still in study followup|1|||
143209289|NCT00545103|516312048|FG002|Overall Study|Use of prohibited medication|1|||
143209290|NCT00545103|516312049|FG003|Overall Study|Use of prohibited medication|0|||
143209291|NCT00545103|516312046|FG000|Overall Study|Does not want to take study drug anymore|1|||
143209292|NCT00545103|516312047|FG001|Overall Study|Does not want to take study drug anymore|0|||
143209293|NCT00545103|516312048|FG002|Overall Study|Does not want to take study drug anymore|1|||
143209294|NCT00545103|516312049|FG003|Overall Study|Does not want to take study drug anymore|0|||
143209295|NCT00545103|516312046|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
143209296|NCT00545103|516312047|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
143209297|NCT00545103|516312048|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
143209298|NCT00545103|516312049|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
143209299|NCT00545103|516312046|FG000|Overall Study|Death|0|||
143209300|NCT00545103|516312047|FG001|Overall Study|Death|1|||
143209301|NCT00545103|516312048|FG002|Overall Study|Death|0|||
143209302|NCT00545103|516312049|FG003|Overall Study|Death|0|||
143209303|NCT03831945|516312050|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
143263835|NCT01285960|516519813|FG000|Overall Study|Withdrawal by Subject|2|||
143263836|NCT01285960|516519813|FG000|Overall Study|Lost to Follow-up|2|||
143263837|NCT01285960|516519813|FG000|Overall Study|2 subjects received less 10 sonications|2|||
143263838|NCT00667420|516519814|FG000|Overall Study|Adverse Event|2|||
143209304|NCT03831945|516312051|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
143209305|NCT03831945|516312050|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
143263839|NCT00667420|516519814|FG000|Overall Study|Lack of Efficacy|5|||
143263840|NCT00667420|516519814|FG000|Overall Study|Physician Decision|1|||
143263841|NCT00667420|516519814|FG000|Overall Study|Withdrawal by Subject|2|||
143263842|NCT04437368|516519817|FG000|Overall Study|Death|3|||
143209306|NCT03831945|516312051|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
143209307|NCT03831945|516312050|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
143209308|NCT03831945|516312051|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
143209309|NCT00295932|516312052|FG000|Overall Study|Not Treated|0|||
143209310|NCT00295932|516312053|FG001|Overall Study|Not Treated|0|||
143209311|NCT00295932|516312054|FG002|Overall Study|Not Treated|0|||
143209312|NCT00295932|516312055|FG003|Overall Study|Not Treated|0|||
143209313|NCT00295932|516312056|FG004|Overall Study|Not Treated|0|||
143209314|NCT00295932|516312057|FG005|Overall Study|Not Treated|0|||
143209315|NCT00295932|516312058|FG006|Overall Study|Not Treated|0|||
143209316|NCT00295932|516312059|FG007|Overall Study|Not Treated|0|||
143209317|NCT00295932|516312060|FG008|Overall Study|Not Treated|0|||
143209318|NCT00295932|516312061|FG009|Overall Study|Not Treated|0|||
143209319|NCT00295932|516312062|FG010|Overall Study|Not Treated|1|||
143263843|NCT04437368|516519818|FG001|Overall Study|Death|0|||
143263844|NCT04437368|516519819|FG002|Overall Study|Death|2|||
143263845|NCT04437368|516519817|FG000|Overall Study|Study terminated by sponsor|16|||
143263846|NCT04437368|516519818|FG001|Overall Study|Study terminated by sponsor|1|||
143263847|NCT04437368|516519819|FG002|Overall Study|Study terminated by sponsor|25|||
143263848|NCT04437368|516519817|FG000|Overall Study|Withdrawal by Subject|4|||
143263849|NCT04437368|516519818|FG001|Overall Study|Withdrawal by Subject|0|||
143263850|NCT04437368|516519819|FG002|Overall Study|Withdrawal by Subject|3|||
143263851|NCT04437368|516519817|FG000|Overall Study|Sponsor instructions|23|||
143263852|NCT04437368|516519818|FG001|Overall Study|Sponsor instructions|0|||
143263853|NCT04437368|516519819|FG002|Overall Study|Sponsor instructions|0|||
143209320|NCT00587847|516312063|FG000|Overall Study|Lack of Efficacy|5|||
143263854|NCT00095628|516519827|FG000|Overall Study|Disease progression prior to treatment|1|||
143263855|NCT04271280|516519828|FG000|Overall Study|Lost to Follow-up|300|||
143263856|NCT04271280|516519828|FG000|Overall Study|Death|153|||
143263857|NCT04271280|516519828|FG000|Overall Study|Withdrawal of consent by patient|59|||
143209321|NCT00587847|516312063|FG000|Overall Study|Adverse Event|2|||
143209322|NCT00884832|516312064|FG000|Overall Study|Withdrawal by Subject|0|||
143209323|NCT00884832|516312065|FG001|Overall Study|Withdrawal by Subject|1|||
143263858|NCT04271280|516519828|FG000|Overall Study|Other|51|||
143370577|NCT02503202|516901047|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
143370578|NCT02503202|516901048|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
143370579|NCT00130637|516901057|FG000|Overall Study|Adverse Event|2|||
143370580|NCT00130637|516901057|FG000|Overall Study|Withdrawal by Subject|1|||
143370581|NCT01191788|516901058|FG000|Overall Study|Lost to Follow-up|21|||
143370582|NCT01191788|516901059|FG001|Overall Study|Lost to Follow-up|22|||
143370583|NCT00217672|516901063|FG000|Allocation|Ineligible|2|||
143370584|NCT00217672|516901064|FG001|Allocation|Ineligible|0|||
143370585|NCT00217672|516901063|FG000|Treatment|disease progression|33|||
143370586|NCT00217672|516901064|FG001|Treatment|disease progression|4|||
143370587|NCT00217672|516901063|FG000|Treatment|Adverse Event|18|||
143370588|NCT00217672|516901064|FG001|Treatment|Adverse Event|2|||
143370589|NCT00217672|516901063|FG000|Treatment|reqd treatment not permitted by protocol|6|||
143370590|NCT00217672|516901064|FG001|Treatment|reqd treatment not permitted by protocol|0|||
143370591|NCT00217672|516901063|FG000|Treatment|Physician Decision|6|||
143370592|NCT00217672|516901064|FG001|Treatment|Physician Decision|0|||
143370593|NCT00217672|516901063|FG000|Treatment|insurance issues|1|||
143370594|NCT00217672|516901064|FG001|Treatment|insurance issues|1|||
143209324|NCT02096263|516312066|FG000|Overall Study|Adverse Event|1|||
143209325|NCT02096263|516312067|FG001|Overall Study|Adverse Event|0|||
143209326|NCT02096263|516312068|FG002|Overall Study|Adverse Event|1|||
143209327|NCT02096263|516312066|FG000|Overall Study|Lost to Follow-up|14|||
143209328|NCT02096263|516312067|FG001|Overall Study|Lost to Follow-up|18|||
143209329|NCT02096263|516312068|FG002|Overall Study|Lost to Follow-up|15|||
143209330|NCT02096263|516312066|FG000|Overall Study|Other|7|||
143209331|NCT02096263|516312067|FG001|Overall Study|Other|9|||
143209332|NCT02096263|516312068|FG002|Overall Study|Other|6|||
143209333|NCT02096263|516312066|FG000|Overall Study|Sponsor study termination|0|||
143209334|NCT02096263|516312067|FG001|Overall Study|Sponsor study termination|0|||
143209335|NCT02096263|516312068|FG002|Overall Study|Sponsor study termination|1|||
143370595|NCT00217672|516901063|FG000|Treatment|Death|2|||
143370596|NCT00217672|516901064|FG001|Treatment|Death|0|||
143209336|NCT02096263|516312066|FG000|Overall Study|Protocol Violation|7|||
143209337|NCT02096263|516312067|FG001|Overall Study|Protocol Violation|2|||
143209338|NCT02096263|516312068|FG002|Overall Study|Protocol Violation|8|||
143209339|NCT02096263|516312066|FG000|Overall Study|Withdrawal by Subject|5|||
143209340|NCT02096263|516312067|FG001|Overall Study|Withdrawal by Subject|7|||
143209341|NCT02096263|516312068|FG002|Overall Study|Withdrawal by Subject|8|||
143209342|NCT03322423|516312069|FG000|Period 1|Subject no longer eligible|0|||
143370597|NCT00217672|516901063|FG000|Treatment|secondary malignancy|1|||
143370598|NCT00217672|516901064|FG001|Treatment|secondary malignancy|0|||
143370599|NCT00217672|516901063|FG000|Follow-up|Withdrawal by Subject|4|||
143370600|NCT00217672|516901064|FG001|Follow-up|Withdrawal by Subject|0|||
143370601|NCT00217672|516901063|FG000|Follow-up|Lost to Follow-up|1|||
143370602|NCT00217672|516901064|FG001|Follow-up|Lost to Follow-up|0|||
143370603|NCT01591616|516901067|FG000|Overall Study|Withdrawal by Subject|1|||
143370604|NCT03939819|516901068|FG000|Overall Study|Death|2|||
143370605|NCT03939819|516901069|FG001|Overall Study|Death|0|||
143370606|NCT03808883|516901077|FG000|Overall Study|Withdrawal by Subject|2|||
143370607|NCT03808883|516901078|FG001|Overall Study|Withdrawal by Subject|0|||
143370608|NCT03808883|516901077|FG000|Overall Study|Did not complete pre test or post test survey|4|||
143370609|NCT03808883|516901078|FG001|Overall Study|Did not complete pre test or post test survey|3|||
143370610|NCT00158054|516901079|FG000|Overall Study|Refused to continue|3|||
143370611|NCT00158054|516901080|FG001|Overall Study|Refused to continue|0|||
143370612|NCT00158054|516901079|FG000|Overall Study|Unavailable for follow up|7|||
143370613|NCT00158054|516901080|FG001|Overall Study|Unavailable for follow up|3|||
143370614|NCT04567888|516901081|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
143370615|NCT04567888|516901082|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
143370616|NCT04567888|516901081|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
143370617|NCT04567888|516901082|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
143370618|NCT04567888|516901081|FG000|Overall Study|Reported Unusual Birth Year|2|||
143370619|NCT04567888|516901082|FG001|Overall Study|Reported Unusual Birth Year|3|||
143370620|NCT04567888|516901081|FG000|Overall Study|Duplicate Responses|0|||
143370621|NCT04567888|516901082|FG001|Overall Study|Duplicate Responses|1|||
143370622|NCT01909336|516901083|FG000|Overall Study|Lost to Follow-up|4|||
143370623|NCT01909336|516901084|FG001|Overall Study|Lost to Follow-up|2|||
143370624|NCT01909336|516901085|FG002|Overall Study|Lost to Follow-up|2|||
143370625|NCT01909336|516901083|FG000|Overall Study|Physician Decision|0|||
143370626|NCT01909336|516901084|FG001|Overall Study|Physician Decision|1|||
143370627|NCT01909336|516901085|FG002|Overall Study|Physician Decision|1|||
143209343|NCT03322423|516312070|FG001|Period 1|Subject no longer eligible|1|||
143209344|NCT03322423|516312069|FG000|Period 1|Withdrawal by Subject|0|||
143209345|NCT03322423|516312070|FG001|Period 1|Withdrawal by Subject|1|||
143209346|NCT03322423|516312069|FG000|Period 1|Incorrect Lens Dispensed|1|||
143209347|NCT03322423|516312070|FG001|Period 1|Incorrect Lens Dispensed|0|||
143209348|NCT03322423|516312069|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
143370628|NCT01235949|516901086|FG000|Primary Phase|Migrated/moved from study area|1|||
143370629|NCT01235949|516901087|FG001|Primary Phase|Migrated/moved from study area|1|||
143209349|NCT03322423|516312070|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
143209350|NCT03322423|516312069|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
143209351|NCT03322423|516312070|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
143209352|NCT03322423|516312069|FG000|Period 2|Protocol Violation|1|||
143209353|NCT03322423|516312070|FG001|Period 2|Protocol Violation|0|||
143209354|NCT03322423|516312069|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
143209355|NCT03322423|516312070|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
143209356|NCT01270256|516312081|FG000|Overall Study|Withdrawal by Subject|1|||
143209357|NCT01270256|516312082|FG001|Overall Study|Withdrawal by Subject|0|||
143209358|NCT02177838|516312083|FG000|Overall Study|Withdrawal by Subject|1|||
143209359|NCT02177838|516312083|FG000|Overall Study|Physician Decision|1|||
143209360|NCT02177838|516312083|FG000|Overall Study|Death|1|||
143263859|NCT04271280|516519828|FG000|Overall Study|No end of study information|42|||
143263860|NCT00744471|516519832|FG000|Overall Study|Randomized but not treated|1|||
143263861|NCT00744471|516519833|FG001|Overall Study|Randomized but not treated|1|||
143263862|NCT00744471|516519834|FG002|Overall Study|Randomized but not treated|4|||
143263863|NCT00744471|516519835|FG003|Overall Study|Randomized but not treated|0|||
143263864|NCT00744471|516519832|FG000|Overall Study|Death|0|||
143263865|NCT00744471|516519833|FG001|Overall Study|Death|0|||
143263866|NCT00744471|516519834|FG002|Overall Study|Death|0|||
143263867|NCT00744471|516519835|FG003|Overall Study|Death|1|||
143263868|NCT00744471|516519832|FG000|Overall Study|Adverse Event|6|||
143263869|NCT00744471|516519833|FG001|Overall Study|Adverse Event|7|||
143263870|NCT00744471|516519834|FG002|Overall Study|Adverse Event|5|||
143263871|NCT00744471|516519835|FG003|Overall Study|Adverse Event|9|||
143263872|NCT00744471|516519832|FG000|Overall Study|Withdrawal by Subject|9|||
143263873|NCT00744471|516519833|FG001|Overall Study|Withdrawal by Subject|9|||
143263874|NCT00744471|516519834|FG002|Overall Study|Withdrawal by Subject|15|||
143263875|NCT00744471|516519835|FG003|Overall Study|Withdrawal by Subject|12|||
143263876|NCT00744471|516519832|FG000|Overall Study|Protocol Violation|1|||
143263877|NCT00744471|516519833|FG001|Overall Study|Protocol Violation|4|||
143263878|NCT00744471|516519834|FG002|Overall Study|Protocol Violation|1|||
143263879|NCT00744471|516519835|FG003|Overall Study|Protocol Violation|2|||
143263880|NCT00744471|516519832|FG000|Overall Study|Entered extension study|41|||
143263881|NCT00744471|516519833|FG001|Overall Study|Entered extension study|84|||
143263882|NCT00744471|516519834|FG002|Overall Study|Entered extension study|100|||
143263883|NCT00744471|516519835|FG003|Overall Study|Entered extension study|91|||
143263884|NCT00744471|516519832|FG000|Overall Study|Other|2|||
143263885|NCT00744471|516519833|FG001|Overall Study|Other|3|||
143263886|NCT00744471|516519834|FG002|Overall Study|Other|6|||
143263887|NCT00744471|516519835|FG003|Overall Study|Other|2|||
143263888|NCT00744471|516519832|FG000|Overall Study|Lack of Efficacy|83|||
143209361|NCT03517566|516312086|FG000|Overall Study|Adverse Event|5|||
143209362|NCT03517566|516312087|FG001|Overall Study|Adverse Event|2|||
143209363|NCT03517566|516312088|FG002|Overall Study|Adverse Event|2|||
143209364|NCT03517566|516312089|FG003|Overall Study|Adverse Event|8|||
143209365|NCT03517566|516312090|FG004|Overall Study|Adverse Event|7|||
143263889|NCT00744471|516519833|FG001|Overall Study|Lack of Efficacy|37|||
143263890|NCT00744471|516519834|FG002|Overall Study|Lack of Efficacy|19|||
143263891|NCT00744471|516519835|FG003|Overall Study|Lack of Efficacy|31|||
143263892|NCT00744471|516519832|FG000|Overall Study|Lost to Follow-up|0|||
143263893|NCT00744471|516519833|FG001|Overall Study|Lost to Follow-up|0|||
143209366|NCT03517566|516312086|FG000|Overall Study|Lack of Efficacy|3|||
143209367|NCT03517566|516312087|FG001|Overall Study|Lack of Efficacy|2|||
143209368|NCT03517566|516312088|FG002|Overall Study|Lack of Efficacy|1|||
143263894|NCT00744471|516519834|FG002|Overall Study|Lost to Follow-up|2|||
143263895|NCT00744471|516519835|FG003|Overall Study|Lost to Follow-up|0|||
143263896|NCT03224546|516519836|FG000|Overall Study|Lost to Follow-up|9|||
143209369|NCT03517566|516312089|FG003|Overall Study|Lack of Efficacy|1|||
143209370|NCT03517566|516312090|FG004|Overall Study|Lack of Efficacy|4|||
143209371|NCT03517566|516312086|FG000|Overall Study|Lost to Follow-up|3|||
143209372|NCT03517566|516312087|FG001|Overall Study|Lost to Follow-up|1|||
143263897|NCT03224546|516519837|FG001|Overall Study|Lost to Follow-up|8|||
143263898|NCT03224546|516519838|FG002|Overall Study|Lost to Follow-up|3|||
143263899|NCT03224546|516519836|FG000|Overall Study|Withdrawal by Subject|7|||
143263900|NCT03224546|516519837|FG001|Overall Study|Withdrawal by Subject|14|||
143209373|NCT03517566|516312088|FG002|Overall Study|Lost to Follow-up|1|||
143209374|NCT03517566|516312089|FG003|Overall Study|Lost to Follow-up|1|||
143209375|NCT03517566|516312090|FG004|Overall Study|Lost to Follow-up|0|||
143209376|NCT03517566|516312086|FG000|Overall Study|Physician Decision|1|||
143209377|NCT03517566|516312087|FG001|Overall Study|Physician Decision|1|||
143263901|NCT03224546|516519838|FG002|Overall Study|Withdrawal by Subject|12|||
143263902|NCT01539317|516519841|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
143263903|NCT01539317|516519842|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
143263904|NCT00976573|516519843|FG000|Overall Study|Ineligible|0|||
143263905|NCT00976573|516519844|FG001|Overall Study|Ineligible|1|||
143263906|NCT00976573|516519843|FG000|Overall Study|Cancel prior to receiving treatment|4|||
143263907|NCT00976573|516519844|FG001|Overall Study|Cancel prior to receiving treatment|2|||
143263908|NCT02117427|516519845|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
143263909|NCT02117427|516519846|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
143263910|NCT02117427|516519847|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
143263911|NCT02117427|516519845|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
143263912|NCT02117427|516519846|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
143263913|NCT02117427|516519847|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
143263914|NCT02117427|516519845|FG000|Overall Study|Physician Decision|0|||
143263915|NCT02117427|516519846|FG001|Overall Study|Physician Decision|2|||
143263916|NCT02117427|516519847|FG002|Overall Study|Physician Decision|0|||
143263917|NCT02117427|516519845|FG000|Overall Study|No longer meets inclusion criteria|0|||
143263918|NCT02117427|516519846|FG001|Overall Study|No longer meets inclusion criteria|1|||
143263919|NCT02117427|516519847|FG002|Overall Study|No longer meets inclusion criteria|0|||
143263920|NCT02117427|516519845|FG000|Overall Study|Death|0|||
143263921|NCT02117427|516519846|FG001|Overall Study|Death|1|||
143263922|NCT02117427|516519847|FG002|Overall Study|Death|0|||
143263923|NCT00364130|516519848|FG000|Intervention Period|Lost to Follow-up|4|||
143263924|NCT00364130|516519849|FG001|Intervention Period|Lost to Follow-up|3|||
143263925|NCT00364130|516519848|FG000|Intervention Period|Pregnancy|1|||
143263926|NCT00364130|516519849|FG001|Intervention Period|Pregnancy|0|||
143263927|NCT00364130|516519848|FG000|Intervention Period|Withdrawal by Subject|4|||
143263928|NCT00364130|516519849|FG001|Intervention Period|Withdrawal by Subject|5|||
143263929|NCT00364130|516519848|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
143263930|NCT00364130|516519849|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
143263931|NCT00410202|516519855|FG000|On-Treatment|Continuing treatment|69|||
143263932|NCT00410202|516519856|FG001|On-Treatment|Continuing treatment|71|||
143263933|NCT00410202|516519857|FG002|On-Treatment|Continuing treatment|66|||
143209378|NCT03517566|516312088|FG002|Overall Study|Physician Decision|0|||
143263934|NCT00410202|516519855|FG000|On-Treatment|Adverse Event|1|||
143263935|NCT00410202|516519856|FG001|On-Treatment|Adverse Event|3|||
143263936|NCT00410202|516519857|FG002|On-Treatment|Adverse Event|2|||
143263937|NCT00410202|516519855|FG000|On-Treatment|Death|1|||
143209379|NCT03517566|516312089|FG003|Overall Study|Physician Decision|1|||
143209380|NCT03517566|516312090|FG004|Overall Study|Physician Decision|0|||
143209381|NCT03517566|516312086|FG000|Overall Study|Pregnancy|0|||
143209382|NCT03517566|516312087|FG001|Overall Study|Pregnancy|1|||
143209383|NCT03517566|516312088|FG002|Overall Study|Pregnancy|0|||
143209384|NCT03517566|516312089|FG003|Overall Study|Pregnancy|0|||
143209385|NCT03517566|516312090|FG004|Overall Study|Pregnancy|0|||
143209386|NCT03517566|516312086|FG000|Overall Study|Protocol Deviation|0|||
143209387|NCT03517566|516312087|FG001|Overall Study|Protocol Deviation|1|||
143209388|NCT03517566|516312088|FG002|Overall Study|Protocol Deviation|0|||
143209389|NCT03517566|516312089|FG003|Overall Study|Protocol Deviation|1|||
143209390|NCT03517566|516312090|FG004|Overall Study|Protocol Deviation|1|||
143209391|NCT03517566|516312086|FG000|Overall Study|Study terminated by Sponsor|11|||
143263938|NCT00410202|516519856|FG001|On-Treatment|Death|0|||
143263939|NCT00410202|516519857|FG002|On-Treatment|Death|0|||
143263940|NCT00410202|516519855|FG000|On-Treatment|Lost to Follow-up|1|||
143263941|NCT00410202|516519856|FG001|On-Treatment|Lost to Follow-up|0|||
143263942|NCT00410202|516519857|FG002|On-Treatment|Lost to Follow-up|1|||
143263943|NCT00410202|516519855|FG000|On-Treatment|Lack of Efficacy|1|||
143263944|NCT00410202|516519856|FG001|On-Treatment|Lack of Efficacy|4|||
143263945|NCT00410202|516519857|FG002|On-Treatment|Lack of Efficacy|0|||
143263946|NCT00410202|516519855|FG000|On-Treatment|Withdrawal by Subject|2|||
143263947|NCT00410202|516519856|FG001|On-Treatment|Withdrawal by Subject|1|||
143263948|NCT00410202|516519857|FG002|On-Treatment|Withdrawal by Subject|1|||
143263949|NCT00410202|516519855|FG000|On-Treatment|Other Reason|0|||
143263950|NCT00410202|516519856|FG001|On-Treatment|Other Reason|0|||
143263951|NCT00410202|516519857|FG002|On-Treatment|Other Reason|1|||
143209392|NCT03517566|516312087|FG001|Overall Study|Study terminated by Sponsor|5|||
143263952|NCT00410202|516519855|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
143263953|NCT00410202|516519856|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
143263954|NCT00410202|516519857|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
143263955|NCT00410202|516519855|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
143209393|NCT03517566|516312088|FG002|Overall Study|Study terminated by Sponsor|6|||
143263956|NCT00410202|516519856|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
143209394|NCT03517566|516312089|FG003|Overall Study|Study terminated by Sponsor|14|||
143263957|NCT00410202|516519857|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
143263958|NCT00410202|516519855|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
143263959|NCT00410202|516519856|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
143263960|NCT00410202|516519857|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
143209395|NCT03517566|516312090|FG004|Overall Study|Study terminated by Sponsor|12|||
143209396|NCT03517566|516312086|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
143209397|NCT03517566|516312087|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
143209398|NCT03517566|516312088|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
143209399|NCT03517566|516312089|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
143209400|NCT03517566|516312090|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
143209401|NCT04311463|516312098|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
143209402|NCT04311463|516312099|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
143209403|NCT04311463|516312098|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
143209404|NCT04311463|516312099|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
143209405|NCT04311463|516312098|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
143209406|NCT04311463|516312099|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
143209407|NCT00952614|516312100|FG000|Overall Study|Death|3|||
143209408|NCT00952614|516312100|FG000|Overall Study|Lost to Follow-up|3|||
143209409|NCT00952614|516312100|FG000|Overall Study|other reason|1|||
143209410|NCT00454649|516312105|FG000|Overall Study|Lack of Efficacy|2|||
143209411|NCT00454649|516312106|FG001|Overall Study|Lack of Efficacy|2|||
143209412|NCT00454649|516312107|FG002|Overall Study|Lack of Efficacy|10|||
143209413|NCT00454649|516312108|FG003|Overall Study|Lack of Efficacy|3|||
143209414|NCT00454649|516312109|FG004|Overall Study|Lack of Efficacy|0|||
143209415|NCT00454649|516312110|FG005|Overall Study|Lack of Efficacy|4|||
143209416|NCT00454649|516312111|FG006|Overall Study|Lack of Efficacy|5|||
143209417|NCT00454649|516312112|FG007|Overall Study|Lack of Efficacy|13|||
143209418|NCT00454649|516312113|FG008|Overall Study|Lack of Efficacy|10|||
143209419|NCT00454649|516312114|FG009|Overall Study|Lack of Efficacy|2|||
143209420|NCT00454649|516312105|FG000|Overall Study|Adverse Event|0|||
143209421|NCT00454649|516312106|FG001|Overall Study|Adverse Event|1|||
143209422|NCT00454649|516312107|FG002|Overall Study|Adverse Event|3|||
143209423|NCT00454649|516312108|FG003|Overall Study|Adverse Event|0|||
143209424|NCT00454649|516312109|FG004|Overall Study|Adverse Event|1|||
143209425|NCT00454649|516312110|FG005|Overall Study|Adverse Event|2|||
143209426|NCT00454649|516312111|FG006|Overall Study|Adverse Event|3|||
143209427|NCT00454649|516312112|FG007|Overall Study|Adverse Event|4|||
143209428|NCT00454649|516312113|FG008|Overall Study|Adverse Event|6|||
143209429|NCT00454649|516312114|FG009|Overall Study|Adverse Event|2|||
143209430|NCT00454649|516312105|FG000|Overall Study|Lost to Follow-up|0|||
143209431|NCT00454649|516312106|FG001|Overall Study|Lost to Follow-up|0|||
143209432|NCT00454649|516312107|FG002|Overall Study|Lost to Follow-up|1|||
143209433|NCT00454649|516312108|FG003|Overall Study|Lost to Follow-up|0|||
143209434|NCT00454649|516312109|FG004|Overall Study|Lost to Follow-up|0|||
143209435|NCT00454649|516312110|FG005|Overall Study|Lost to Follow-up|0|||
143209436|NCT00454649|516312111|FG006|Overall Study|Lost to Follow-up|1|||
143209437|NCT00454649|516312112|FG007|Overall Study|Lost to Follow-up|0|||
143209438|NCT00454649|516312113|FG008|Overall Study|Lost to Follow-up|0|||
143209439|NCT00454649|516312114|FG009|Overall Study|Lost to Follow-up|0|||
143209440|NCT00454649|516312105|FG000|Overall Study|Other|1|||
143209441|NCT00454649|516312106|FG001|Overall Study|Other|1|||
143209442|NCT00454649|516312107|FG002|Overall Study|Other|5|||
143209443|NCT00454649|516312108|FG003|Overall Study|Other|3|||
143209444|NCT00454649|516312109|FG004|Overall Study|Other|0|||
143209445|NCT00454649|516312110|FG005|Overall Study|Other|0|||
143209446|NCT00454649|516312111|FG006|Overall Study|Other|0|||
143209447|NCT00454649|516312112|FG007|Overall Study|Other|0|||
143209448|NCT00454649|516312113|FG008|Overall Study|Other|3|||
143209449|NCT00454649|516312114|FG009|Overall Study|Other|1|||
143209450|NCT00454649|516312105|FG000|Overall Study|Withdrawal by Subject|0|||
143209451|NCT00454649|516312106|FG001|Overall Study|Withdrawal by Subject|0|||
143209452|NCT00454649|516312107|FG002|Overall Study|Withdrawal by Subject|0|||
143209453|NCT00454649|516312108|FG003|Overall Study|Withdrawal by Subject|0|||
143209454|NCT00454649|516312109|FG004|Overall Study|Withdrawal by Subject|0|||
143263961|NCT05080660|516519858|FG000|Overall Study|Adverse Event|4|||
143263962|NCT05080660|516519859|FG001|Overall Study|Adverse Event|0|||
143263963|NCT05080660|516519858|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
143263964|NCT05080660|516519859|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
143263965|NCT05080660|516519858|FG000|Overall Study|Physician Decision|1|||
143263966|NCT05080660|516519859|FG001|Overall Study|Physician Decision|0|||
143263967|NCT05080660|516519858|FG000|Overall Study|Protocol Deviation|2|||
143263968|NCT05080660|516519859|FG001|Overall Study|Protocol Deviation|0|||
143209455|NCT00454649|516312110|FG005|Overall Study|Withdrawal by Subject|1|||
143209456|NCT00454649|516312111|FG006|Overall Study|Withdrawal by Subject|0|||
143209457|NCT00454649|516312112|FG007|Overall Study|Withdrawal by Subject|2|||
143209458|NCT00454649|516312113|FG008|Overall Study|Withdrawal by Subject|1|||
143209459|NCT00454649|516312114|FG009|Overall Study|Withdrawal by Subject|0|||
143209460|NCT00737633|516312115|FG000|Overall Study|Study terminated by sponsor|44|||
143209461|NCT00737633|516312116|FG001|Overall Study|Study terminated by sponsor|55|||
143209462|NCT00737633|516312115|FG000|Overall Study|Lost to Follow-up|0|||
143209463|NCT00737633|516312116|FG001|Overall Study|Lost to Follow-up|1|||
143263969|NCT05080660|516519858|FG000|Overall Study|Withdrawal by Subject|5|||
143209464|NCT00737633|516312115|FG000|Overall Study|protocol non-compliance|0|||
143209465|NCT00737633|516312116|FG001|Overall Study|protocol non-compliance|1|||
143209466|NCT00377364|516312117|FG000|Overall Study|Lost to Follow-up|1|||
143209467|NCT00377364|516312118|FG001|Overall Study|Lost to Follow-up|0|||
143263970|NCT05080660|516519859|FG001|Overall Study|Withdrawal by Subject|2|||
143263971|NCT04221230|516519864|FG000|Overall Study|Lost to Follow-up|12|||
143263972|NCT04221230|516519865|FG001|Overall Study|Lost to Follow-up|12|||
143263973|NCT04221230|516519864|FG000|Overall Study|Protocol Violation|2|||
143263974|NCT04221230|516519865|FG001|Overall Study|Protocol Violation|2|||
143263975|NCT04221230|516519864|FG000|Overall Study|Adverse Event|0|||
143263976|NCT04221230|516519865|FG001|Overall Study|Adverse Event|8|||
143263977|NCT04221230|516519864|FG000|Overall Study|Physician Decision|1|||
143263978|NCT04221230|516519865|FG001|Overall Study|Physician Decision|0|||
143263979|NCT04221230|516519864|FG000|Overall Study|Withdrawal by Subject|13|||
143263980|NCT04221230|516519865|FG001|Overall Study|Withdrawal by Subject|11|||
143263981|NCT04221230|516519864|FG000|Overall Study|Non-Compliance with Study Drug|1|||
143263982|NCT04221230|516519865|FG001|Overall Study|Non-Compliance with Study Drug|1|||
143263983|NCT04221230|516519864|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
143263984|NCT04221230|516519865|FG001|Overall Study|Unsatisfactory Therapeutic Effect|1|||
143263985|NCT04221230|516519864|FG000|Overall Study|Pregnancy|0|||
143263986|NCT04221230|516519865|FG001|Overall Study|Pregnancy|1|||
143263987|NCT04221230|516519864|FG000|Overall Study|Other|1|||
143263988|NCT04221230|516519865|FG001|Overall Study|Other|2|||
143263989|NCT02359851|516519873|FG000|Overall Study|Death|1|||
143263990|NCT02359851|516519873|FG000|Overall Study|Disease progression|1|||
143263991|NCT00055471|516519874|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
143263992|NCT00055471|516519875|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
143263993|NCT00055471|516519876|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
143263994|NCT00055471|516519874|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
143263995|NCT00055471|516519875|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
143263996|NCT00055471|516519876|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
143209468|NCT00377364|516312117|FG000|Overall Study|Withdrawal by Subject|1|||
143209469|NCT00377364|516312118|FG001|Overall Study|Withdrawal by Subject|0|||
143209470|NCT02925728|516312119|FG000|Overall Study|Death|3|||
143209471|NCT02925728|516312120|FG001|Overall Study|Death|5|||
143209472|NCT02925728|516312119|FG000|Overall Study|Physician Decision|1|||
143209473|NCT02925728|516312120|FG001|Overall Study|Physician Decision|0|||
143209474|NCT02925728|516312119|FG000|Overall Study|Withdrawal by Subject|1|||
143209475|NCT02925728|516312120|FG001|Overall Study|Withdrawal by Subject|0|||
143209476|NCT05098509|516312121|FG000|Overall Study|Withdrawal by Subject|0|||
143209477|NCT05098509|516312122|FG001|Overall Study|Withdrawal by Subject|0|||
143209478|NCT05098509|516312123|FG002|Overall Study|Withdrawal by Subject|1|||
143209479|NCT05098509|516312124|FG003|Overall Study|Withdrawal by Subject|0|||
143209480|NCT05098509|516312121|FG000|Overall Study|Early study termination|1|||
143209481|NCT05098509|516312122|FG001|Overall Study|Early study termination|1|||
143263997|NCT00055471|516519874|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
143263998|NCT00055471|516519875|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
143263999|NCT00055471|516519876|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
143264000|NCT01854944|516519877|FG000|Overall Study|Withdrawal by Subject|0|||
143264001|NCT01854944|516519878|FG001|Overall Study|Withdrawal by Subject|0|||
143264002|NCT01854944|516519879|FG002|Overall Study|Withdrawal by Subject|1|||
143264003|NCT02418156|516519882|FG000|Overall Study|Lost to Follow-up|12|||
143264004|NCT02418156|516519882|FG000|Overall Study|Death|2|||
143264005|NCT02418156|516519882|FG000|Overall Study|Physician Decision|1|||
143209482|NCT05098509|516312123|FG002|Overall Study|Early study termination|1|||
143209483|NCT05098509|516312124|FG003|Overall Study|Early study termination|0|||
143264006|NCT02418156|516519882|FG000|Overall Study|Withdrawal by Subject|1|||
143264007|NCT02418156|516519882|FG000|Overall Study|Subject refused to return|1|||
143264008|NCT00993044|516519883|FG000|Irinotecan 50 mg|Physician Decision|1|||
143264009|NCT03172910|516521673|FG000|Overall Study|Adverse Event|0|||
143264010|NCT03172910|516521674|FG001|Overall Study|Adverse Event|0|||
143264011|NCT03172910|516521675|FG002|Overall Study|Adverse Event|0|||
143264012|NCT03172910|516521676|FG003|Overall Study|Adverse Event|0|||
143264013|NCT03172910|516521677|FG004|Overall Study|Adverse Event|1|||
143264014|NCT00451451|516521686|FG000|Overall Study|Adverse Event|11|||
143264015|NCT00451451|516521687|FG001|Overall Study|Adverse Event|21|||
143264016|NCT00451451|516521688|FG002|Overall Study|Adverse Event|26|||
143264017|NCT00451451|516521689|FG003|Overall Study|Adverse Event|10|||
143264018|NCT00451451|516521686|FG000|Overall Study|Lost to Follow-up|11|||
143264019|NCT00451451|516521687|FG001|Overall Study|Lost to Follow-up|9|||
143264020|NCT00451451|516521688|FG002|Overall Study|Lost to Follow-up|8|||
143264021|NCT00451451|516521689|FG003|Overall Study|Lost to Follow-up|11|||
143264022|NCT00451451|516521686|FG000|Overall Study|Consent Withdrawn|14|||
143264023|NCT00451451|516521687|FG001|Overall Study|Consent Withdrawn|9|||
143264024|NCT00451451|516521688|FG002|Overall Study|Consent Withdrawn|17|||
143264025|NCT00451451|516521689|FG003|Overall Study|Consent Withdrawn|17|||
143264026|NCT00451451|516521686|FG000|Overall Study|Investigator Decision|6|||
143264027|NCT00451451|516521687|FG001|Overall Study|Investigator Decision|2|||
143264028|NCT00451451|516521688|FG002|Overall Study|Investigator Decision|1|||
143264029|NCT00451451|516521689|FG003|Overall Study|Investigator Decision|2|||
143264030|NCT00451451|516521686|FG000|Overall Study|Subject Non-Compliance|8|||
143264031|NCT00451451|516521687|FG001|Overall Study|Subject Non-Compliance|4|||
143264032|NCT00451451|516521688|FG002|Overall Study|Subject Non-Compliance|3|||
143264033|NCT00451451|516521689|FG003|Overall Study|Subject Non-Compliance|3|||
143264034|NCT00451451|516521686|FG000|Overall Study|Death|1|||
143264035|NCT00451451|516521687|FG001|Overall Study|Death|0|||
143264036|NCT00451451|516521688|FG002|Overall Study|Death|0|||
143264037|NCT00451451|516521689|FG003|Overall Study|Death|1|||
143264038|NCT00451451|516521686|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
143264039|NCT00451451|516521687|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
143264040|NCT00451451|516521688|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
143264041|NCT00451451|516521689|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
143264042|NCT03693170|516521690|FG000|Overall Study|Disease Progression|48|||
143264043|NCT03693170|516521690|FG000|Overall Study|Adverse Event|16|||
143264044|NCT03693170|516521690|FG000|Overall Study|Physician Decision|6|||
143264045|NCT03693170|516521690|FG000|Overall Study|Protocol Violation|2|||
143264046|NCT03693170|516521690|FG000|Overall Study|Death|1|||
143264047|NCT03693170|516521690|FG000|Overall Study|Non compliance with study drug|1|||
143264048|NCT03693170|516521690|FG000|Overall Study|Withdrawal by Subject|1|||
143264049|NCT03581786|516521691|FG000|Overall Study|Death|67|||
143264050|NCT03581786|516521692|FG001|Overall Study|Death|47|||
143264051|NCT03581786|516521691|FG000|Overall Study|Withdrawal by Subject|2|||
143264052|NCT03581786|516521692|FG001|Overall Study|Withdrawal by Subject|5|||
143264053|NCT03581786|516521691|FG000|Overall Study|Lost to Follow-up|7|||
143264054|NCT03581786|516521692|FG001|Overall Study|Lost to Follow-up|4|||
143264055|NCT03581786|516521691|FG000|Overall Study|reason other than specified above|0|||
143264056|NCT03581786|516521692|FG001|Overall Study|reason other than specified above|1|||
143264057|NCT00510874|516521693|FG000|Overall Study|Withdrawal by Subject|1|||
143264058|NCT00510874|516521694|FG001|Overall Study|Withdrawal by Subject|1|||
143264059|NCT00510874|516521695|FG002|Overall Study|Withdrawal by Subject|0|||
143264060|NCT00510874|516521696|FG003|Overall Study|Withdrawal by Subject|0|||
143264061|NCT00510874|516521697|FG004|Overall Study|Withdrawal by Subject|3|||
143264062|NCT00510874|516521698|FG005|Overall Study|Withdrawal by Subject|0|||
143264063|NCT00510874|516521699|FG006|Overall Study|Withdrawal by Subject|0|||
143264064|NCT00510874|516521693|FG000|Overall Study|Lost to Follow-up|2|||
143264065|NCT00510874|516521694|FG001|Overall Study|Lost to Follow-up|3|||
143264066|NCT00510874|516521695|FG002|Overall Study|Lost to Follow-up|1|||
143264067|NCT00510874|516521696|FG003|Overall Study|Lost to Follow-up|3|||
143264068|NCT00510874|516521697|FG004|Overall Study|Lost to Follow-up|4|||
143264069|NCT00510874|516521698|FG005|Overall Study|Lost to Follow-up|0|||
143264070|NCT00510874|516521699|FG006|Overall Study|Lost to Follow-up|1|||
143264071|NCT00397943|516521701|FG000|Overall Study|Unspecified reasons|12|||
143264072|NCT00397943|516521702|FG001|Overall Study|Unspecified reasons|9|||
143264073|NCT00397943|516521703|FG002|Overall Study|Unspecified reasons|0|||
143264074|NCT00397943|516521704|FG003|Overall Study|Unspecified reasons|0|||
143264075|NCT00397943|516521705|FG004|Overall Study|Unspecified reasons|0|||
143264076|NCT04521777|516521706|FG000|Overall Study|Death|2|||
143264077|NCT04521777|516521706|FG000|Overall Study|Withdrawal by Subject|2|||
143264078|NCT01143207|516521708|FG000|Overall Study|Lost to Follow-up|2|||
143264079|NCT01869725|516521709|FG000|Overall Study|ineligible after registration|1|||
143264080|NCT01869725|516521709|FG000|Overall Study|Death|1|||
143264081|NCT01869725|516521709|FG000|Overall Study|Lost to Follow-up|2|||
143264082|NCT01241240|516521714|FG000|Overall Study|Adverse Event|5|||
143264083|NCT01241240|516521715|FG001|Overall Study|Adverse Event|4|||
143264084|NCT01241240|516521714|FG000|Overall Study|Lost to Follow-up|2|||
143264085|NCT01241240|516521715|FG001|Overall Study|Lost to Follow-up|4|||
143370630|NCT01235949|516901088|FG002|Primary Phase|Migrated/moved from study area|0|||
143370631|NCT01235949|516901089|FG003|Primary Phase|Migrated/moved from study area|0|||
143370632|NCT01235949|516901090|FG004|Primary Phase|Migrated/moved from study area|1|||
143370633|NCT01235949|516901091|FG005|Primary Phase|Migrated/moved from study area|2|||
143370634|NCT01235949|516901092|FG006|Primary Phase|Migrated/moved from study area|0|||
143370635|NCT01235949|516901093|FG007|Primary Phase|Migrated/moved from study area|0|||
143370636|NCT01235949|516901094|FG008|Primary Phase|Migrated/moved from study area|0|||
143370637|NCT01235949|516901095|FG009|Primary Phase|Migrated/moved from study area|0|||
143370638|NCT01235949|516901096|FG010|Primary Phase|Migrated/moved from study area|0|||
143370639|NCT01235949|516901097|FG011|Primary Phase|Migrated/moved from study area|0|||
143209484|NCT03101085|516312125|FG000|Overall Study|Lost to Follow-up|0|||
143209485|NCT03101085|516312126|FG001|Overall Study|Lost to Follow-up|1|||
143209486|NCT01972789|516312129|FG000|Overall Study|Adverse Event|11|||
143209487|NCT01972789|516312130|FG001|Overall Study|Adverse Event|4|||
143209488|NCT01972789|516312129|FG000|Overall Study|Subject withdrew consent|14|||
143209489|NCT01972789|516312130|FG001|Overall Study|Subject withdrew consent|12|||
143209490|NCT01972789|516312129|FG000|Overall Study|Lost to Follow-up|4|||
143209491|NCT01972789|516312130|FG001|Overall Study|Lost to Follow-up|7|||
143209492|NCT01972789|516312129|FG000|Overall Study|Death|7|||
143209493|NCT01972789|516312130|FG001|Overall Study|Death|5|||
143209494|NCT01972789|516312129|FG000|Overall Study|Protocol deviation|1|||
143209495|NCT01972789|516312130|FG001|Overall Study|Protocol deviation|0|||
143209496|NCT01972789|516312129|FG000|Overall Study|Physician Decision|3|||
143209497|NCT01972789|516312130|FG001|Overall Study|Physician Decision|2|||
143209498|NCT00086411|516312136|FG000|Overall Study|Lost to Follow-up|11|||
143209499|NCT00086411|516312137|FG001|Overall Study|Lost to Follow-up|11|||
143209500|NCT00086411|516312138|FG002|Overall Study|Lost to Follow-up|13|||
143209501|NCT00086411|516312139|FG003|Overall Study|Lost to Follow-up|12|||
143209502|NCT00695864|516312140|FG000|Placebo|Withdrawal by Subject|1|||
143209503|NCT00695864|516312140|FG000|Placebo|Physician Decision|4|||
143209504|NCT02315560|516313846|FG000|Overall Study|noncompliance by subjects|3|||
143209505|NCT01041287|516313847|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
143209506|NCT01041287|516313848|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
143209507|NCT01041287|516313847|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
143209508|NCT01041287|516313848|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
143209509|NCT01209078|516313849|FG000|Overall Study|Adverse Event|5|||
143209510|NCT01209078|516313850|FG001|Overall Study|Adverse Event|0|||
143209511|NCT01209078|516313849|FG000|Overall Study|Lost to Follow-up|4|||
143209512|NCT01209078|516313850|FG001|Overall Study|Lost to Follow-up|0|||
143209513|NCT01209078|516313849|FG000|Overall Study|Physician Decision|5|||
143209514|NCT01209078|516313850|FG001|Overall Study|Physician Decision|2|||
143209515|NCT01209078|516313849|FG000|Overall Study|Withdrawal by Subject|2|||
143209516|NCT01209078|516313850|FG001|Overall Study|Withdrawal by Subject|1|||
143209517|NCT00924508|516313851|FG000|Overall Study|Withdrawal by Subject|3|||
143209518|NCT03464019|516313852|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
143209519|NCT03464019|516313853|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
143209520|NCT03464019|516313854|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
143209521|NCT03464019|516313852|FG000|NODE-301 Part 1|Ablation|0|||
143209522|NCT03464019|516313853|FG001|NODE-301 Part 1|Ablation|0|||
143209523|NCT03464019|516313854|FG002|NODE-301 Part 1|Ablation|16|||
143209524|NCT03464019|516313852|FG000|NODE-301 Part 1|Test Dose Failure|0|||
143209525|NCT03464019|516313853|FG001|NODE-301 Part 1|Test Dose Failure|0|||
143209526|NCT03464019|516313854|FG002|NODE-301 Part 1|Test Dose Failure|8|||
143209527|NCT03464019|516313852|FG000|NODE-301 Part 1|Adverse Event|0|||
143209528|NCT03464019|516313853|FG001|NODE-301 Part 1|Adverse Event|0|||
143209529|NCT03464019|516313854|FG002|NODE-301 Part 1|Adverse Event|5|||
143209530|NCT03464019|516313852|FG000|NODE-301 Part 1|Physician Decision|0|||
143209531|NCT03464019|516313853|FG001|NODE-301 Part 1|Physician Decision|0|||
143209532|NCT03464019|516313854|FG002|NODE-301 Part 1|Physician Decision|4|||
143209533|NCT03464019|516313852|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
143370640|NCT01235949|516901098|FG012|Primary Phase|Migrated/moved from study area|0|||
143370641|NCT01235949|516901099|FG013|Primary Phase|Migrated/moved from study area|0|||
143209534|NCT03464019|516313853|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
143209535|NCT03464019|516313854|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
143209536|NCT03464019|516313852|FG000|NODE-301 Part 1|Protocol Violation|0|||
143209537|NCT03464019|516313853|FG001|NODE-301 Part 1|Protocol Violation|0|||
143209538|NCT03464019|516313854|FG002|NODE-301 Part 1|Protocol Violation|2|||
143209539|NCT03464019|516313852|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
143209540|NCT03464019|516313853|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
143209541|NCT03464019|516313854|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
143209542|NCT03464019|516313852|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
143209543|NCT03464019|516313853|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
143209544|NCT03464019|516313854|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
143209545|NCT03464019|516313852|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
143209546|NCT03464019|516313853|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
143209547|NCT03464019|516313854|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
143209548|NCT03464019|516313852|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
143209549|NCT03464019|516313853|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
143209550|NCT03464019|516313854|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
143209551|NCT03464019|516313852|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
143209552|NCT03464019|516313853|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
143209553|NCT03464019|516313854|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
143209554|NCT03464019|516313852|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
143209555|NCT03464019|516313853|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
143209556|NCT03464019|516313854|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
143209557|NCT03464019|516313852|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
143209558|NCT03464019|516313853|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
143209559|NCT03464019|516313854|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
143209560|NCT03464019|516313852|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
143209561|NCT03464019|516313853|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
143209562|NCT03464019|516313854|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
143209563|NCT03464019|516313852|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
143209564|NCT03464019|516313853|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
143209565|NCT03464019|516313854|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
143209566|NCT03464019|516313852|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
143209567|NCT03464019|516313853|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
143209568|NCT03464019|516313854|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
143209569|NCT03464019|516313852|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
143209570|NCT03464019|516313853|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
143209571|NCT03464019|516313854|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
143209572|NCT03464019|516313852|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
143209573|NCT03464019|516313853|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
143209574|NCT03464019|516313854|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
143209575|NCT03464019|516313852|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
143209576|NCT03464019|516313853|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
143209577|NCT03464019|516313854|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
143209578|NCT03464019|516313852|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
143209579|NCT03464019|516313853|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
143209580|NCT03464019|516313854|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
143209581|NCT00767806|516313855|FG000|Overall Study|Adverse Event|30|||
143209582|NCT00767806|516313856|FG001|Overall Study|Adverse Event|11|||
143209583|NCT00767806|516313855|FG000|Overall Study|Withdrawal by Subject|8|||
143209584|NCT00767806|516313856|FG001|Overall Study|Withdrawal by Subject|13|||
143209585|NCT00767806|516313855|FG000|Overall Study|Protocol Violation|6|||
143209586|NCT00767806|516313856|FG001|Overall Study|Protocol Violation|5|||
143209587|NCT00767806|516313855|FG000|Overall Study|Lack of Efficacy|1|||
143209588|NCT00767806|516313856|FG001|Overall Study|Lack of Efficacy|9|||
143209589|NCT00767806|516313855|FG000|Overall Study|Physician Decision|4|||
143209590|NCT00767806|516313856|FG001|Overall Study|Physician Decision|3|||
143209591|NCT00767806|516313855|FG000|Overall Study|Lost to Follow-up|1|||
143209592|NCT00767806|516313856|FG001|Overall Study|Lost to Follow-up|4|||
143209593|NCT00767806|516313855|FG000|Overall Study|Entry Criteria Not Met|1|||
143209594|NCT00767806|516313856|FG001|Overall Study|Entry Criteria Not Met|1|||
143209595|NCT00767806|516313855|FG000|Overall Study|Sponsor Decision|0|||
143264086|NCT01241240|516521714|FG000|Overall Study|Personal Reasons|1|||
143264087|NCT01241240|516521715|FG001|Overall Study|Personal Reasons|1|||
143264088|NCT01025154|516521716|FG000|Overall Study|Lost to Follow-up|1|||
143264089|NCT01025154|516521716|FG000|Overall Study|Withdrawal by Subject|1|||
143264090|NCT01466595|516521717|FG000|Overall Study|Withdrawal by Subject|0|||
143264091|NCT01466595|516521718|FG001|Overall Study|Withdrawal by Subject|1|||
143264092|NCT00057954|516521719|FG000|Overall Study|Death|1|||
143264093|NCT00057954|516521719|FG000|Overall Study|Disease progression|1|||
143264094|NCT00559754|516521720|FG000|Overall Study|Disease progression|1|||
143264095|NCT00559754|516521720|FG000|Overall Study|Adverse Event|5|||
143264096|NCT00559754|516521720|FG000|Overall Study|Protocol Violation|1|||
143264097|NCT00559754|516521720|FG000|Overall Study|Investigator criteria|2|||
143264098|NCT00559754|516521720|FG000|Overall Study|Withdrawal by Subject|2|||
143264099|NCT01243671|516521723|FG000|Overall Study|Adverse Event|3|||
143264100|NCT01243671|516521723|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
143264101|NCT01243671|516521723|FG000|Overall Study|Other|1|||
143264102|NCT02962765|516521724|FG000|Overall Study|Protocol Violation|9|||
143264103|NCT02962765|516521724|FG000|Overall Study|Withdrawal by Subject|3|||
143264104|NCT02962765|516521724|FG000|Overall Study|Lost to Follow-up|1|||
143264105|NCT02962765|516521724|FG000|Overall Study|Death|1|||
143264106|NCT02962765|516521724|FG000|Overall Study|Limited access to study medication|3|||
143264107|NCT00750880|516521730|FG000|Overall Study|Adverse Event|76|||
143370642|NCT01235949|516901100|FG014|Primary Phase|Migrated/moved from study area|0|||
143209596|NCT00767806|516313856|FG001|Overall Study|Sponsor Decision|1|||
143209597|NCT04680975|516313857|FG000|Overall Study|Adverse Event|3|||
143209598|NCT04680975|516313857|FG000|Overall Study|Death|1|||
143209599|NCT04680975|516313857|FG000|Overall Study|Progressive Disease|1|||
143209600|NCT04680975|516313857|FG000|Overall Study|Withdrawal by Subject|1|||
143209601|NCT03909152|516313858|FG000|Overall Study|Adverse Event|14|||
143209602|NCT03909152|516313859|FG001|Overall Study|Adverse Event|5|||
143209603|NCT03909152|516313860|FG002|Overall Study|Adverse Event|1|||
143209604|NCT03909152|516313861|FG003|Overall Study|Adverse Event|14|||
143209605|NCT02702414|516313866|FG000|Overall Study|Death|96|||
143209606|NCT02702414|516313867|FG001|Overall Study|Death|42|||
143209607|NCT02702414|516313866|FG000|Overall Study|Lost to Follow-up|0|||
143209608|NCT02702414|516313867|FG001|Overall Study|Lost to Follow-up|1|||
143209609|NCT02702414|516313866|FG000|Overall Study|Withdrawal by Subject|0|||
143209610|NCT02702414|516313867|FG001|Overall Study|Withdrawal by Subject|1|||
143209611|NCT02702414|516313866|FG000|Overall Study|Protocol Violation|1|||
143209612|NCT02702414|516313867|FG001|Overall Study|Protocol Violation|0|||
143370643|NCT01235949|516901101|FG015|Primary Phase|Migrated/moved from study area|0|||
143209613|NCT02702414|516313866|FG000|Overall Study|Sponsor Decision|8|||
143209614|NCT02702414|516313867|FG001|Overall Study|Sponsor Decision|7|||
143209615|NCT04541628|516313868|FG000|Overall Study|Study Terminated|1|||
143209616|NCT04541628|516313869|FG001|Overall Study|Study Terminated|1|||
143209617|NCT04541628|516313870|FG002|Overall Study|Study Terminated|1|||
143264108|NCT00750880|516521730|FG000|Overall Study|Death|4|||
143264109|NCT00750880|516521730|FG000|Overall Study|Lack of Efficacy|46|||
143264110|NCT00750880|516521730|FG000|Overall Study|Lost to Follow-up|10|||
143264111|NCT00750880|516521730|FG000|Overall Study|Protocol Violation|15|||
143264112|NCT00750880|516521730|FG000|Overall Study|Withdrawal by Subject|33|||
143264113|NCT00750880|516521730|FG000|Overall Study|Physician Decision|20|||
143264114|NCT00750880|516521730|FG000|Overall Study|Administrative|11|||
143264115|NCT03583073|516521731|FG000|Overall Study|Lost to Follow-up|8|||
143264116|NCT03583073|516521732|FG001|Overall Study|Lost to Follow-up|12|||
143264117|NCT05342532|516521733|FG000|Overall Study|Adverse Event|5|||
143264118|NCT05342532|516521734|FG001|Overall Study|Adverse Event|20|||
143209618|NCT01192412|516313875|FG000|Overall Study|Lost to Follow-up|2|||
143209619|NCT01192412|516313876|FG001|Overall Study|Lost to Follow-up|1|||
143209620|NCT01192412|516313875|FG000|Overall Study|Withdrawal by Subject|2|||
143209621|NCT01192412|516313876|FG001|Overall Study|Withdrawal by Subject|1|||
143209622|NCT00151476|516313877|FG000|FAP Identified Subjects|Protocol Violation|0|||
143209623|NCT00151476|516313878|FG001|FAP Identified Subjects|Protocol Violation|1|||
143209624|NCT00151476|516313877|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
143209625|NCT00151476|516313878|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
143209626|NCT00151476|516313877|FG000|FAP Analyzed Subjects|Other study participation|0|||
143209627|NCT00151476|516313878|FG001|FAP Analyzed Subjects|Other study participation|1|||
143209628|NCT03446456|516313879|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
143209629|NCT03446456|516313880|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
143209630|NCT03446456|516313879|FG000|Overall Study|Lost to Follow-up|1|||
143209631|NCT03446456|516313880|FG001|Overall Study|Lost to Follow-up|3|||
143209632|NCT03446456|516313879|FG000|Overall Study|Participant failed the toxicology test|1|||
143209633|NCT03446456|516313880|FG001|Overall Study|Participant failed the toxicology test|0|||
143209634|NCT03446456|516313879|FG000|Overall Study|Break down of the experimental equipment|1|||
143209635|NCT03446456|516313880|FG001|Overall Study|Break down of the experimental equipment|0|||
143209636|NCT01359943|516313883|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
143209637|NCT01359943|516313884|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
143209638|NCT01359943|516313885|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
143209639|NCT01359943|516313883|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
143209640|NCT01359943|516313884|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
143209641|NCT01359943|516313885|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
143209642|NCT01359943|516313883|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
143209643|NCT01359943|516313884|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
143209644|NCT01359943|516313885|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
143209645|NCT01359943|516313883|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
143209646|NCT01359943|516313884|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
143209647|NCT01359943|516313885|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
143209648|NCT01359943|516313883|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
143209649|NCT01359943|516313884|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
143209650|NCT01359943|516313885|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
143209651|NCT01359943|516313883|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
143209652|NCT01359943|516313884|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
143209653|NCT01359943|516313885|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
143209654|NCT01359943|516313883|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
143209655|NCT01359943|516313884|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
143209656|NCT01359943|516313885|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
143209657|NCT01359943|516313883|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
143209658|NCT01359943|516313884|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
143209659|NCT01359943|516313885|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
143209660|NCT01359943|516313883|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
143209661|NCT01359943|516313884|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
143209662|NCT01359943|516313885|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
143209663|NCT01359943|516313883|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
143209664|NCT01359943|516313884|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
143209665|NCT01359943|516313885|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
143209666|NCT01359943|516313883|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
143209667|NCT01359943|516313884|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
143209668|NCT01359943|516313885|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
143209669|NCT01359943|516313883|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
143209670|NCT01359943|516313884|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
143209671|NCT01359943|516313885|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
143209672|NCT01359943|516313883|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
143209673|NCT01359943|516313884|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
143209674|NCT01359943|516313885|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
143209675|NCT01359943|516313883|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
143209676|NCT01359943|516313884|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
143209677|NCT01359943|516313885|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
143209678|NCT01359943|516313883|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
143209679|NCT01359943|516313884|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
143209680|NCT01359943|516313885|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
143209681|NCT04099511|516313895|FG000|Overall Study|Lost to Follow-up|2|||
143209682|NCT04099511|516313896|FG001|Overall Study|Lost to Follow-up|2|||
143209683|NCT04099511|516313895|FG000|Overall Study|Withdrawal by Subject|8|||
143209684|NCT04099511|516313896|FG001|Overall Study|Withdrawal by Subject|4|||
143264119|NCT05342532|516521733|FG000|Overall Study|Lost to Follow-up|10|||
143264120|NCT05342532|516521734|FG001|Overall Study|Lost to Follow-up|15|||
143264121|NCT02675231|516521738|FG000|Overall Study|Withdrawal by Subject|2|||
143264122|NCT02675231|516521739|FG001|Overall Study|Withdrawal by Subject|4|||
143264123|NCT02675231|516521740|FG002|Overall Study|Withdrawal by Subject|2|||
143264124|NCT02675231|516521738|FG000|Overall Study|Lost to Follow-up|3|||
143264125|NCT02675231|516521739|FG001|Overall Study|Lost to Follow-up|4|||
143264126|NCT02675231|516521740|FG002|Overall Study|Lost to Follow-up|3|||
143370644|NCT01235949|516901102|FG016|Primary Phase|Migrated/moved from study area|0|||
143209685|NCT04369950|516313898|FG000|Overall Study|Protocol Violation|2|||
143209686|NCT04369950|516313899|FG001|Overall Study|Protocol Violation|2|||
143209687|NCT00989963|516313900|FG000|Overall Study|Adverse Event|1|||
143209688|NCT00989963|516313901|FG001|Overall Study|Adverse Event|1|||
143209689|NCT00989963|516313902|FG002|Overall Study|Adverse Event|1|||
143209690|NCT01240200|516313910|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
143209691|NCT01240200|516313911|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
143209692|NCT01529034|516313914|FG000|Overall Study|Discontinued prior to study treatment|14|||
143209693|NCT01529034|516313914|FG000|Overall Study|Site closure|62|||
143370645|NCT01235949|516901103|FG017|Primary Phase|Migrated/moved from study area|0|||
143370646|NCT01235949|516901086|FG000|Primary Phase|Adverse Event|0|||
143370647|NCT01235949|516901087|FG001|Primary Phase|Adverse Event|0|||
143370648|NCT01235949|516901088|FG002|Primary Phase|Adverse Event|0|||
143370649|NCT01235949|516901089|FG003|Primary Phase|Adverse Event|1|||
143370650|NCT01235949|516901090|FG004|Primary Phase|Adverse Event|0|||
143370651|NCT01235949|516901091|FG005|Primary Phase|Adverse Event|0|||
143370652|NCT01235949|516901092|FG006|Primary Phase|Adverse Event|0|||
143370653|NCT01235949|516901093|FG007|Primary Phase|Adverse Event|0|||
143370654|NCT01235949|516901094|FG008|Primary Phase|Adverse Event|0|||
143370655|NCT01235949|516901095|FG009|Primary Phase|Adverse Event|0|||
143370656|NCT01235949|516901096|FG010|Primary Phase|Adverse Event|0|||
143209694|NCT01529034|516313914|FG000|Overall Study|Study termination|29|||
143209695|NCT01529034|516313914|FG000|Overall Study|Withdrawal by Subject|25|||
143209696|NCT01529034|516313914|FG000|Overall Study|No treated SCs within protocol window|13|||
143264127|NCT05323656|516521741|FG000|Overall Study|Still On-Treatment|6|||
143264128|NCT05323656|516521742|FG001|Overall Study|Still On-Treatment|6|||
143370657|NCT01235949|516901097|FG011|Primary Phase|Adverse Event|0|||
143264129|NCT05323656|516521741|FG000|Overall Study|Progressive Disease|15|||
143209697|NCT01529034|516313914|FG000|Overall Study|Noncompliance|8|||
143209698|NCT01529034|516313914|FG000|Overall Study|Caregiver no longer available|7|||
143209699|NCT01529034|516313914|FG000|Overall Study|Adverse Event|4|||
143209700|NCT01529034|516313914|FG000|Overall Study|Protocol Violation|4|||
143209701|NCT01529034|516313914|FG000|Overall Study|Lack of Efficacy|4|||
143209702|NCT01529034|516313914|FG000|Overall Study|Investigator no longer available|2|||
143209703|NCT01529034|516313914|FG000|Overall Study|Study drug not available|2|||
143209704|NCT02649894|516313915|FG000|Overall Study|Adverse Event|1|||
143209705|NCT02649894|516313916|FG001|Overall Study|Adverse Event|0|||
143209706|NCT02649894|516313915|FG000|Overall Study|Physician Decision|0|||
143209707|NCT02649894|516313916|FG001|Overall Study|Physician Decision|1|||
143209708|NCT02649894|516313915|FG000|Overall Study|Withdrawal by Subject|5|||
143209709|NCT02649894|516313916|FG001|Overall Study|Withdrawal by Subject|2|||
143209710|NCT02649894|516313915|FG000|Overall Study|Lost to Follow-up|2|||
143209711|NCT02649894|516313916|FG001|Overall Study|Lost to Follow-up|1|||
143209712|NCT02649894|516313915|FG000|Overall Study|Death|30|||
143209713|NCT02649894|516313916|FG001|Overall Study|Death|7|||
143209714|NCT02649894|516313915|FG000|Overall Study|Other, not specified|6|||
143209715|NCT02649894|516313916|FG001|Overall Study|Other, not specified|0|||
143209716|NCT03194438|516313919|FG000|Overall Study|Withdrawal by Subject|2|||
143209717|NCT02708485|516313920|FG000|Overall Study|Withdrawal by Subject|3|||
143209718|NCT02708485|516313921|FG001|Overall Study|Withdrawal by Subject|2|||
143209719|NCT01554514|516313926|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
143209720|NCT01554514|516313926|FG000|Overall Study|Physician Decision|1|||
143209721|NCT00847015|516313927|FG000|Overall Study|Withdrawal by Subject|1|||
143209722|NCT00847015|516313927|FG000|Overall Study|declined any surgery|1|||
143209723|NCT00847015|516313927|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
143209724|NCT01141478|516313928|FG000|Overall Study|Withdrawal by Subject|1|||
143209725|NCT01141478|516313929|FG001|Overall Study|Withdrawal by Subject|1|||
143209726|NCT01375608|516313930|FG000|Overall Study|Withdrawal by Subject|2|||
143209727|NCT00581360|516313931|FG000|Overall Study|Withdrawal by Subject|1|||
143209728|NCT03129360|516313932|FG000|Overall Study|Did not meet entry criteria|0|||
143209729|NCT03129360|516313933|FG001|Overall Study|Did not meet entry criteria|2|||
143209730|NCT03129360|516313934|FG002|Overall Study|Did not meet entry criteria|1|||
143209731|NCT03129360|516313932|FG000|Overall Study|Excluded due to motion in scanner|1|||
143209732|NCT03129360|516313933|FG001|Overall Study|Excluded due to motion in scanner|0|||
143209733|NCT03129360|516313934|FG002|Overall Study|Excluded due to motion in scanner|0|||
143209734|NCT01353911|516313935|FG000|Overall Study|Lost to Follow-up|2|||
143209735|NCT01353911|516313936|FG001|Overall Study|Lost to Follow-up|6|||
143209736|NCT01353911|516313937|FG002|Overall Study|Lost to Follow-up|4|||
143209737|NCT01353911|516313938|FG003|Overall Study|Lost to Follow-up|0|||
143209738|NCT01353911|516313939|FG004|Overall Study|Lost to Follow-up|4|||
143209739|NCT01353911|516313940|FG005|Overall Study|Lost to Follow-up|4|||
143264130|NCT05323656|516521742|FG001|Overall Study|Progressive Disease|14|||
143264131|NCT05323656|516521741|FG000|Overall Study|Adverse Event|2|||
143264132|NCT05323656|516521742|FG001|Overall Study|Adverse Event|3|||
143264133|NCT05323656|516521741|FG000|Overall Study|Death|1|||
143264134|NCT05323656|516521742|FG001|Overall Study|Death|2|||
143264135|NCT05323656|516521741|FG000|Overall Study|Withdrawal by Subject|1|||
143264136|NCT05323656|516521742|FG001|Overall Study|Withdrawal by Subject|0|||
143264137|NCT05323656|516521741|FG000|Overall Study|Clinical disease progression|0|||
143264138|NCT05323656|516521742|FG001|Overall Study|Clinical disease progression|1|||
143264139|NCT05323656|516521741|FG000|Overall Study|Patient and Investigator decision|1|||
143264140|NCT05323656|516521742|FG001|Overall Study|Patient and Investigator decision|0|||
143264141|NCT05323656|516521741|FG000|Overall Study|Physician Decision|0|||
143209740|NCT01353911|516313941|FG006|Overall Study|Lost to Follow-up|3|||
143209741|NCT01353911|516313942|FG007|Overall Study|Lost to Follow-up|6|||
143209742|NCT01353911|516313935|FG000|Overall Study|Withdrawal by Subject|2|||
143209743|NCT01353911|516313936|FG001|Overall Study|Withdrawal by Subject|3|||
143209744|NCT01353911|516313937|FG002|Overall Study|Withdrawal by Subject|4|||
143209745|NCT01353911|516313938|FG003|Overall Study|Withdrawal by Subject|2|||
143209746|NCT01353911|516313939|FG004|Overall Study|Withdrawal by Subject|2|||
143370658|NCT01235949|516901098|FG012|Primary Phase|Adverse Event|0|||
143209747|NCT01353911|516313940|FG005|Overall Study|Withdrawal by Subject|3|||
143209748|NCT01353911|516313941|FG006|Overall Study|Withdrawal by Subject|3|||
143209749|NCT01353911|516313942|FG007|Overall Study|Withdrawal by Subject|9|||
143209750|NCT01353911|516313935|FG000|Overall Study|Status Not Recorded|4|||
143209751|NCT01353911|516313936|FG001|Overall Study|Status Not Recorded|0|||
143209752|NCT01353911|516313937|FG002|Overall Study|Status Not Recorded|1|||
143209753|NCT01353911|516313938|FG003|Overall Study|Status Not Recorded|0|||
143264142|NCT05323656|516521742|FG001|Overall Study|Physician Decision|1|||
143264143|NCT02495233|516521745|FG000|Overall Study|Miscellaneous|0|||
143209754|NCT01353911|516313939|FG004|Overall Study|Status Not Recorded|0|||
143209755|NCT01353911|516313940|FG005|Overall Study|Status Not Recorded|0|||
143209756|NCT01353911|516313941|FG006|Overall Study|Status Not Recorded|0|||
143209757|NCT01353911|516313942|FG007|Overall Study|Status Not Recorded|0|||
143209758|NCT04032080|516313944|FG000|Overall Study|Death|6|||
143209759|NCT02337725|516313945|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
143209760|NCT02337725|516313946|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
143209761|NCT02337725|516313945|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
143209762|NCT02337725|516313946|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
143209763|NCT02337725|516313945|FG000|Overall Study|Major Protocol Deviation|0|||
143209764|NCT02337725|516313946|FG001|Overall Study|Major Protocol Deviation|1|||
143209765|NCT02337725|516313945|FG000|Overall Study|Voluntary Withdrawal|14|||
143209766|NCT02337725|516313946|FG001|Overall Study|Voluntary Withdrawal|3|||
143209767|NCT02337725|516313945|FG000|Overall Study|Lack of Efficacy|4|||
143209768|NCT02337725|516313946|FG001|Overall Study|Lack of Efficacy|0|||
143209769|NCT04891107|516313947|FG000|Overall Study|Physician Decision|1|||
143209770|NCT04891107|516313947|FG000|Overall Study|Withdrawal by Subject|1|||
143209771|NCT04891107|516313947|FG000|Overall Study|Screen failure after consent|1|||
143209772|NCT01571453|516313948|FG000|Overall Study|Adverse Event|14|||
143209773|NCT01571453|516313949|FG001|Overall Study|Adverse Event|32|||
143209774|NCT01571453|516313948|FG000|Overall Study|Lack of Efficacy|8|||
143209775|NCT01571453|516313949|FG001|Overall Study|Lack of Efficacy|3|||
143209776|NCT01571453|516313948|FG000|Overall Study|Non-compliance|2|||
143209777|NCT01571453|516313949|FG001|Overall Study|Non-compliance|4|||
143209778|NCT01571453|516313948|FG000|Overall Study|Protocol Violation|1|||
143209779|NCT01571453|516313949|FG001|Overall Study|Protocol Violation|5|||
143209780|NCT01571453|516313948|FG000|Overall Study|Withdrawal of consent|5|||
143209781|NCT01571453|516313949|FG001|Overall Study|Withdrawal of consent|13|||
143209782|NCT01571453|516313948|FG000|Overall Study|Lost to Follow-up|4|||
143209783|NCT01571453|516313949|FG001|Overall Study|Lost to Follow-up|2|||
143209784|NCT01571453|516313948|FG000|Overall Study|Administrative or other reason(s)|4|||
143209785|NCT01571453|516313949|FG001|Overall Study|Administrative or other reason(s)|3|||
143209786|NCT00500760|516313960|FG000|Overall Study|Death|32|||
143209787|NCT00500760|516313961|FG001|Overall Study|Death|15|||
143209788|NCT00500760|516313960|FG000|Overall Study|Withdrawal by Subject|5|||
143209789|NCT00500760|516313961|FG001|Overall Study|Withdrawal by Subject|7|||
143209790|NCT00500760|516313960|FG000|Overall Study|Administrative decision|2|||
143209791|NCT00500760|516313961|FG001|Overall Study|Administrative decision|0|||
143209792|NCT00500760|516313960|FG000|Overall Study|Lost to Follow-up|3|||
143209793|NCT00500760|516313961|FG001|Overall Study|Lost to Follow-up|0|||
143209794|NCT00500760|516313960|FG000|Overall Study|Other|1|||
143209795|NCT00500760|516313961|FG001|Overall Study|Other|2|||
143209796|NCT00129961|516313962|FG000|Overall Study|Adverse Event|1|||
143209797|NCT00129961|516313963|FG001|Overall Study|Adverse Event|0|||
143209798|NCT00129961|516313962|FG000|Overall Study|Death|1|||
143209799|NCT00129961|516313963|FG001|Overall Study|Death|1|||
143209800|NCT00129961|516313962|FG000|Overall Study|Withdrawal by Sponsor|14|||
143209801|NCT00129961|516313963|FG001|Overall Study|Withdrawal by Sponsor|20|||
143209802|NCT00129961|516313962|FG000|Overall Study|Physician Decision|1|||
143209803|NCT00129961|516313963|FG001|Overall Study|Physician Decision|0|||
143209804|NCT00129961|516313962|FG000|Overall Study|Withdrawal by Subject|2|||
143209805|NCT00129961|516313963|FG001|Overall Study|Withdrawal by Subject|1|||
143209806|NCT00129961|516313962|FG000|Overall Study|Missing Record|0|||
143209807|NCT00129961|516313963|FG001|Overall Study|Missing Record|1|||
143209808|NCT03178669|516313964|FG000|Overall Study|Adverse Event|4|||
143209809|NCT03178669|516313965|FG001|Overall Study|Adverse Event|1|||
143209810|NCT03178669|516313966|FG002|Overall Study|Adverse Event|4|||
143209811|NCT03178669|516313967|FG003|Overall Study|Adverse Event|2|||
143209812|NCT03178669|516313968|FG004|Overall Study|Adverse Event|2|||
143209813|NCT03178669|516313964|FG000|Overall Study|Lack of Efficacy|0|||
143209814|NCT03178669|516313965|FG001|Overall Study|Lack of Efficacy|0|||
143209815|NCT03178669|516313966|FG002|Overall Study|Lack of Efficacy|2|||
143209816|NCT03178669|516313967|FG003|Overall Study|Lack of Efficacy|0|||
143209817|NCT03178669|516313968|FG004|Overall Study|Lack of Efficacy|1|||
143209818|NCT03178669|516313964|FG000|Overall Study|Physician Decision|0|||
143209819|NCT03178669|516313965|FG001|Overall Study|Physician Decision|0|||
143209820|NCT03178669|516313966|FG002|Overall Study|Physician Decision|0|||
143209821|NCT03178669|516313967|FG003|Overall Study|Physician Decision|0|||
143209822|NCT03178669|516313968|FG004|Overall Study|Physician Decision|1|||
143209823|NCT03178669|516313964|FG000|Overall Study|Withdrawal by Subject|1|||
143209824|NCT03178669|516313965|FG001|Overall Study|Withdrawal by Subject|0|||
143209825|NCT03178669|516313966|FG002|Overall Study|Withdrawal by Subject|1|||
143209826|NCT03178669|516313967|FG003|Overall Study|Withdrawal by Subject|1|||
143209827|NCT03178669|516313968|FG004|Overall Study|Withdrawal by Subject|0|||
143209828|NCT03178669|516313964|FG000|Overall Study|Lost to Follow-up|0|||
143209829|NCT03178669|516313965|FG001|Overall Study|Lost to Follow-up|0|||
143209830|NCT03178669|516313966|FG002|Overall Study|Lost to Follow-up|0|||
143209831|NCT03178669|516313967|FG003|Overall Study|Lost to Follow-up|1|||
143209832|NCT03178669|516313968|FG004|Overall Study|Lost to Follow-up|0|||
143209833|NCT01600092|516313969|FG000|Overall Study|Adverse Event|2|||
143209834|NCT01600092|516313970|FG001|Overall Study|Adverse Event|0|||
143209835|NCT01600092|516313969|FG000|Overall Study|Lost to Follow-up|4|||
143209836|NCT01600092|516313970|FG001|Overall Study|Lost to Follow-up|6|||
143209837|NCT01600092|516313969|FG000|Overall Study|Withdrawal by parent/guardian|8|||
143209838|NCT01600092|516313970|FG001|Overall Study|Withdrawal by parent/guardian|6|||
143209839|NCT01600092|516313969|FG000|Overall Study|Physician Decision|1|||
143209840|NCT01600092|516313970|FG001|Overall Study|Physician Decision|1|||
143209841|NCT01600092|516313969|FG000|Overall Study|Randomized but not vaccinated|3|||
143209842|NCT01600092|516313970|FG001|Overall Study|Randomized but not vaccinated|3|||
143209843|NCT02976103|516313972|FG000|Overall Study|Withdrawal by Subject|1|||
143209844|NCT02976103|516313973|FG001|Overall Study|Withdrawal by Subject|0|||
143209845|NCT02976103|516313972|FG000|Overall Study|Lost to Follow-up|12|||
143209846|NCT02976103|516313973|FG001|Overall Study|Lost to Follow-up|8|||
143209847|NCT00565136|516313974|FG000|Overall Study|Lost to Follow-up|1|||
143209848|NCT00565136|516313974|FG000|Overall Study|Withdrawal by Subject|1|||
143209849|NCT00565136|516313974|FG000|Overall Study|Protocol Violation|1|||
143209850|NCT00694304|516313978|FG000|Overall Study|Adverse Event|42|||
143209851|NCT00694304|516313978|FG000|Overall Study|Lack of Efficacy|35|||
143209852|NCT00694304|516313978|FG000|Overall Study|Non-compliance With Study Product|16|||
143209853|NCT00694304|516313978|FG000|Overall Study|Protocol Violation|6|||
143209854|NCT00694304|516313978|FG000|Overall Study|Withdrawal of Consent|61|||
143209855|NCT00694304|516313978|FG000|Overall Study|Lost to Follow-up|15|||
143209856|NCT00694304|516313978|FG000|Overall Study|Administrative or Other Reasons|32|||
143209857|NCT02438813|516313979|FG000|Overall Study|Patient Decision|59|||
143209858|NCT02438813|516313979|FG000|Overall Study|Patient Lost to Follow-Up|137|||
143209859|NCT02438813|516313979|FG000|Overall Study|Study Ended by Sponsor|80|||
143209860|NCT02438813|516313979|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
143209861|NCT01805037|516313982|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
143209862|NCT01805037|516313983|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
143209863|NCT01805037|516313982|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
143209864|NCT01805037|516313983|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
143209865|NCT01805037|516313982|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
143209866|NCT01805037|516313983|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
143209867|NCT01805037|516313982|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
143264144|NCT02495233|516521746|FG001|Overall Study|Miscellaneous|1|||
143264145|NCT03880461|516521748|FG000|Overall Study|Determined ineligible after enrollment|45|||
143264146|NCT03880461|516521749|FG001|Overall Study|Determined ineligible after enrollment|44|||
143264147|NCT03880461|516521748|FG000|Overall Study|No weight measurement after enrollment|24|||
143264148|NCT03880461|516521749|FG001|Overall Study|No weight measurement after enrollment|17|||
143264149|NCT00064298|516521751|FG000|Overall Study|Withdrawal by Subject|2|||
143264150|NCT00064298|516521752|FG001|Overall Study|Withdrawal by Subject|1|||
143264151|NCT00064298|516521751|FG000|Overall Study|Lost to Follow-up|2|||
143264152|NCT00064298|516521752|FG001|Overall Study|Lost to Follow-up|2|||
143264153|NCT00064298|516521751|FG000|Overall Study|Death|0|||
143264154|NCT00064298|516521752|FG001|Overall Study|Death|1|||
143370659|NCT01235949|516901099|FG013|Primary Phase|Adverse Event|0|||
143209868|NCT01805037|516313983|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
143209869|NCT01805037|516313982|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
143264155|NCT00064298|516521751|FG000|Overall Study|Disease Progression|2|||
143264156|NCT00064298|516521752|FG001|Overall Study|Disease Progression|1|||
143370660|NCT01235949|516901100|FG014|Primary Phase|Adverse Event|0|||
143209870|NCT01805037|516313983|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
143209871|NCT01805037|516313982|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
143209872|NCT01805037|516313983|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
143209873|NCT01805037|516313982|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
143209874|NCT01805037|516313983|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
143209875|NCT01805037|516313982|FG000|Follow Up (up to 3 Years)|Death|0|||
143370661|NCT01235949|516901101|FG015|Primary Phase|Adverse Event|0|||
143370662|NCT01235949|516901102|FG016|Primary Phase|Adverse Event|0|||
143370663|NCT01235949|516901103|FG017|Primary Phase|Adverse Event|0|||
143370664|NCT01235949|516901086|FG000|Primary Phase|Withdrawal by Subject|3|||
143370665|NCT01235949|516901087|FG001|Primary Phase|Withdrawal by Subject|2|||
143370666|NCT01235949|516901088|FG002|Primary Phase|Withdrawal by Subject|2|||
143370667|NCT01235949|516901089|FG003|Primary Phase|Withdrawal by Subject|0|||
143370668|NCT01235949|516901090|FG004|Primary Phase|Withdrawal by Subject|0|||
143370669|NCT01235949|516901091|FG005|Primary Phase|Withdrawal by Subject|3|||
143370670|NCT01235949|516901092|FG006|Primary Phase|Withdrawal by Subject|0|||
143370671|NCT01235949|516901093|FG007|Primary Phase|Withdrawal by Subject|0|||
143370672|NCT01235949|516901094|FG008|Primary Phase|Withdrawal by Subject|0|||
143370673|NCT01235949|516901095|FG009|Primary Phase|Withdrawal by Subject|0|||
143370674|NCT01235949|516901096|FG010|Primary Phase|Withdrawal by Subject|0|||
143370675|NCT01235949|516901097|FG011|Primary Phase|Withdrawal by Subject|0|||
143370676|NCT01235949|516901098|FG012|Primary Phase|Withdrawal by Subject|0|||
143370677|NCT01235949|516901099|FG013|Primary Phase|Withdrawal by Subject|0|||
143370678|NCT01235949|516901100|FG014|Primary Phase|Withdrawal by Subject|0|||
143370679|NCT01235949|516901101|FG015|Primary Phase|Withdrawal by Subject|0|||
143370680|NCT01235949|516901102|FG016|Primary Phase|Withdrawal by Subject|0|||
143370681|NCT01235949|516901103|FG017|Primary Phase|Withdrawal by Subject|0|||
143370682|NCT01235949|516901086|FG000|Primary Phase|Lost to Follow-up|0|||
143370683|NCT01235949|516901087|FG001|Primary Phase|Lost to Follow-up|0|||
143370684|NCT01235949|516901088|FG002|Primary Phase|Lost to Follow-up|1|||
143370685|NCT01235949|516901089|FG003|Primary Phase|Lost to Follow-up|1|||
143370686|NCT01235949|516901090|FG004|Primary Phase|Lost to Follow-up|0|||
143370687|NCT01235949|516901091|FG005|Primary Phase|Lost to Follow-up|2|||
143370688|NCT01235949|516901092|FG006|Primary Phase|Lost to Follow-up|0|||
143370689|NCT01235949|516901093|FG007|Primary Phase|Lost to Follow-up|0|||
143370690|NCT01235949|516901094|FG008|Primary Phase|Lost to Follow-up|0|||
143370691|NCT01235949|516901095|FG009|Primary Phase|Lost to Follow-up|0|||
143370692|NCT01235949|516901096|FG010|Primary Phase|Lost to Follow-up|0|||
143370693|NCT01235949|516901097|FG011|Primary Phase|Lost to Follow-up|0|||
143370694|NCT01235949|516901098|FG012|Primary Phase|Lost to Follow-up|0|||
143370695|NCT01235949|516901099|FG013|Primary Phase|Lost to Follow-up|0|||
143370696|NCT01235949|516901100|FG014|Primary Phase|Lost to Follow-up|0|||
143370697|NCT01235949|516901101|FG015|Primary Phase|Lost to Follow-up|0|||
143370698|NCT01235949|516901102|FG016|Primary Phase|Lost to Follow-up|0|||
143370699|NCT01235949|516901103|FG017|Primary Phase|Lost to Follow-up|0|||
143370700|NCT01235949|516901086|FG000|Booster Phase|Migrated/moved from study area|0|||
143370701|NCT01235949|516901087|FG001|Booster Phase|Migrated/moved from study area|0|||
143370702|NCT01235949|516901088|FG002|Booster Phase|Migrated/moved from study area|0|||
143370703|NCT01235949|516901089|FG003|Booster Phase|Migrated/moved from study area|0|||
143370704|NCT01235949|516901090|FG004|Booster Phase|Migrated/moved from study area|0|||
143370705|NCT01235949|516901091|FG005|Booster Phase|Migrated/moved from study area|0|||
143370706|NCT01235949|516901092|FG006|Booster Phase|Migrated/moved from study area|0|||
143209876|NCT01805037|516313983|FG001|Follow Up (up to 3 Years)|Death|2|||
143370707|NCT01235949|516901093|FG007|Booster Phase|Migrated/moved from study area|0|||
143264157|NCT03614975|516521753|FG000|Overall Study|Physician Decision|7|||
143264158|NCT03614975|516521754|FG001|Overall Study|Physician Decision|5|||
143264159|NCT03614975|516521753|FG000|Overall Study|Withdrawal by Subject|2|||
143264160|NCT03614975|516521754|FG001|Overall Study|Withdrawal by Subject|2|||
143264161|NCT03614975|516521753|FG000|Overall Study|Specimens not in lab batch shipment|1|||
143264162|NCT03614975|516521754|FG001|Overall Study|Specimens not in lab batch shipment|1|||
143264163|NCT00450385|516521755|FG000|Overall Study|Death|3|||
143264164|NCT00450385|516521755|FG000|Overall Study|Protocol Violation|1|||
143264165|NCT00450385|516521755|FG000|Overall Study|Withdrawal by Subject|2|||
143264166|NCT00450385|516521755|FG000|Overall Study|Lack of Efficacy|2|||
143264167|NCT00450385|516521755|FG000|Overall Study|Adverse Event|1|||
143264168|NCT00450385|516521755|FG000|Overall Study|Physician Decision|1|||
143264169|NCT00450385|516521755|FG000|Overall Study|Other|3|||
143264170|NCT01569464|516521756|FG000|Overall Study|Adverse Event|4|||
143264171|NCT01569464|516521757|FG001|Overall Study|Adverse Event|0|||
143264172|NCT01569464|516521756|FG000|Overall Study|Lack of Efficacy|1|||
143264173|NCT01569464|516521757|FG001|Overall Study|Lack of Efficacy|0|||
143264174|NCT01569464|516521756|FG000|Overall Study|Protocol Violation|1|||
143264175|NCT01569464|516521757|FG001|Overall Study|Protocol Violation|0|||
143264176|NCT01569464|516521756|FG000|Overall Study|Lost to Follow-up|2|||
143264177|NCT01569464|516521757|FG001|Overall Study|Lost to Follow-up|3|||
143264178|NCT01569464|516521756|FG000|Overall Study|Withdrawal by Subject|1|||
143264179|NCT01569464|516521757|FG001|Overall Study|Withdrawal by Subject|1|||
143264180|NCT01569464|516521756|FG000|Overall Study|Other|1|||
143264181|NCT01569464|516521757|FG001|Overall Study|Other|1|||
143264182|NCT03475875|516521758|FG000|Period 1|Lost to Follow-up|1|||
143264183|NCT03475875|516521759|FG001|Period 1|Lost to Follow-up|0|||
143264184|NCT03475875|516521758|FG000|Period 1|Adverse Event|2|||
143264185|NCT03475875|516521759|FG001|Period 1|Adverse Event|1|||
143264186|NCT03475875|516521758|FG000|Period 2|Adverse Event|3|||
143264187|NCT03475875|516521759|FG001|Period 2|Adverse Event|0|||
143264188|NCT03475875|516521758|FG000|Period 2|Protocol Violation|0|||
143264189|NCT03475875|516521759|FG001|Period 2|Protocol Violation|1|||
143264190|NCT00245583|516521760|FG000|Overall Study|Lost to Follow-up|1|||
143264191|NCT00245583|516521761|FG001|Overall Study|Lost to Follow-up|5|||
143264192|NCT00245583|516521760|FG000|Overall Study|Adverse Event|2|||
143264193|NCT00245583|516521761|FG001|Overall Study|Adverse Event|1|||
143264194|NCT00245583|516521760|FG000|Overall Study|Lack of Efficacy|1|||
143264195|NCT00245583|516521761|FG001|Overall Study|Lack of Efficacy|0|||
143264196|NCT00245583|516521760|FG000|Overall Study|Withdrawal by Subject|2|||
143264197|NCT00245583|516521761|FG001|Overall Study|Withdrawal by Subject|3|||
143264198|NCT02273739|516521762|FG000|Overall Study|Progression of Disease|3|||
143264199|NCT02273739|516521763|FG001|Overall Study|Progression of Disease|4|||
143264200|NCT02273739|516521764|FG002|Overall Study|Progression of Disease|5|||
143264201|NCT02273739|516521765|FG003|Overall Study|Progression of Disease|2|||
143264202|NCT02273739|516521762|FG000|Overall Study|Death|0|||
143264203|NCT02273739|516521763|FG001|Overall Study|Death|0|||
143264204|NCT02273739|516521764|FG002|Overall Study|Death|0|||
143264205|NCT02273739|516521765|FG003|Overall Study|Death|2|||
143264206|NCT02273739|516521762|FG000|Overall Study|Adverse Event|0|||
143264207|NCT02273739|516521763|FG001|Overall Study|Adverse Event|0|||
143264208|NCT02273739|516521764|FG002|Overall Study|Adverse Event|0|||
143264209|NCT02273739|516521765|FG003|Overall Study|Adverse Event|1|||
143264210|NCT02273739|516521762|FG000|Overall Study|Withdrawal by Subject|0|||
143264211|NCT02273739|516521763|FG001|Overall Study|Withdrawal by Subject|0|||
143264212|NCT02273739|516521764|FG002|Overall Study|Withdrawal by Subject|2|||
143264213|NCT02273739|516521765|FG003|Overall Study|Withdrawal by Subject|1|||
143264214|NCT02273739|516521762|FG000|Overall Study|Physician Decision|0|||
143264215|NCT02273739|516521763|FG001|Overall Study|Physician Decision|0|||
143264216|NCT02273739|516521764|FG002|Overall Study|Physician Decision|0|||
143264217|NCT02273739|516521765|FG003|Overall Study|Physician Decision|1|||
143264218|NCT00136604|516521766|FG000|Overall Study|Lost to Follow-up|1|||
143264219|NCT00136604|516521767|FG001|Overall Study|Lost to Follow-up|0|||
143264220|NCT00136604|516521768|FG002|Overall Study|Lost to Follow-up|0|||
143264221|NCT00136604|516521769|FG003|Overall Study|Lost to Follow-up|0|||
143264222|NCT00136604|516521770|FG004|Overall Study|Lost to Follow-up|1|||
143264223|NCT00136604|516521766|FG000|Overall Study|Migrated/moved from study area|0|||
143264224|NCT00136604|516521767|FG001|Overall Study|Migrated/moved from study area|1|||
143264225|NCT00136604|516521768|FG002|Overall Study|Migrated/moved from study area|0|||
143264226|NCT00136604|516521769|FG003|Overall Study|Migrated/moved from study area|0|||
143264227|NCT00136604|516521770|FG004|Overall Study|Migrated/moved from study area|0|||
143264228|NCT02017171|516521771|FG000|Overall Study|Death|10|||
143264229|NCT02017171|516521772|FG001|Overall Study|Death|4|||
143264230|NCT02017171|516521771|FG000|Overall Study|Withdrawal by Subject|23|||
143264231|NCT02017171|516521772|FG001|Overall Study|Withdrawal by Subject|17|||
143264232|NCT02017171|516521771|FG000|Overall Study|Lost to Follow-up|21|||
143264233|NCT02017171|516521772|FG001|Overall Study|Lost to Follow-up|20|||
143264234|NCT02017171|516521771|FG000|Overall Study|ESKD|6|||
143264235|NCT02017171|516521772|FG001|Overall Study|ESKD|2|||
143264236|NCT02017171|516521771|FG000|Overall Study|Miscellaneous|2|||
143264237|NCT02017171|516521772|FG001|Overall Study|Miscellaneous|3|||
143264238|NCT01562873|516521773|FG000|Overall Study|Disease Progression per RECIST|10|||
143264239|NCT01562873|516521774|FG001|Overall Study|Disease Progression per RECIST|0|||
143264240|NCT01562873|516521773|FG000|Overall Study|Adverse Event|1|||
143264241|NCT01562873|516521774|FG001|Overall Study|Adverse Event|0|||
143264242|NCT01562873|516521773|FG000|Overall Study|Clinical Disease Progression|9|||
143264243|NCT01562873|516521774|FG001|Overall Study|Clinical Disease Progression|0|||
143264244|NCT01562873|516521773|FG000|Overall Study|Clinical PD and adverse event|1|||
143264245|NCT01562873|516521774|FG001|Overall Study|Clinical PD and adverse event|0|||
143264246|NCT02536833|516521776|FG000|Overall Study|Discontinued Before Treatment|0|||
143264247|NCT02536833|516521777|FG001|Overall Study|Discontinued Before Treatment|0|||
143264248|NCT02536833|516521778|FG002|Overall Study|Discontinued Before Treatment|1|||
143264249|NCT02536833|516521779|FG003|Overall Study|Discontinued Before Treatment|2|||
143264250|NCT02536833|516521776|FG000|Overall Study|Adverse Event|1|||
143264251|NCT02536833|516521777|FG001|Overall Study|Adverse Event|3|||
143264252|NCT02536833|516521778|FG002|Overall Study|Adverse Event|4|||
143264253|NCT02536833|516521779|FG003|Overall Study|Adverse Event|1|||
143264254|NCT02536833|516521776|FG000|Overall Study|Lost to Follow-up|2|||
143370708|NCT01235949|516901094|FG008|Booster Phase|Migrated/moved from study area|0|||
143209877|NCT01805037|516313982|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
143209878|NCT01805037|516313983|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
143209879|NCT01805037|516313982|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
143209880|NCT01805037|516313983|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
143209881|NCT00671437|516313984|FG000|Overall Study|Progressive disease before C1 week 8|8|||
143209882|NCT00671437|516313984|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
143209883|NCT00671437|516313984|FG000|Overall Study|Adverse Event|3|||
143209884|NCT00671437|516313984|FG000|Overall Study|Ineligible post-hoc|1|||
143209885|NCT03927404|516313985|FG000|Overall Study|Withdrawal by Subject|1|||
143209886|NCT01229449|516313988|FG000|Overall Study|Withdrawal by Subject|0|||
143264255|NCT02536833|516521777|FG001|Overall Study|Lost to Follow-up|1|||
143264256|NCT02536833|516521778|FG002|Overall Study|Lost to Follow-up|2|||
143264257|NCT02536833|516521779|FG003|Overall Study|Lost to Follow-up|2|||
143264258|NCT02536833|516521776|FG000|Overall Study|Physician Decision|0|||
143264259|NCT02536833|516521777|FG001|Overall Study|Physician Decision|0|||
143264260|NCT02536833|516521778|FG002|Overall Study|Physician Decision|0|||
143264261|NCT02536833|516521779|FG003|Overall Study|Physician Decision|1|||
143264262|NCT02536833|516521776|FG000|Overall Study|Site Terminated by Sponsor|2|||
143264263|NCT02536833|516521777|FG001|Overall Study|Site Terminated by Sponsor|2|||
143264264|NCT02536833|516521778|FG002|Overall Study|Site Terminated by Sponsor|2|||
143370709|NCT01235949|516901095|FG009|Booster Phase|Migrated/moved from study area|0|||
143264265|NCT02536833|516521779|FG003|Overall Study|Site Terminated by Sponsor|2|||
143209887|NCT01229449|516313989|FG001|Overall Study|Withdrawal by Subject|3|||
143209888|NCT01229449|516313990|FG002|Overall Study|Withdrawal by Subject|0|||
143209889|NCT01229449|516313991|FG003|Overall Study|Withdrawal by Subject|1|||
143209890|NCT01229449|516313992|FG004|Overall Study|Withdrawal by Subject|1|||
143209891|NCT01229449|516313988|FG000|Overall Study|Lost to Follow-up|1|||
143209892|NCT01229449|516313989|FG001|Overall Study|Lost to Follow-up|1|||
143209893|NCT01229449|516313990|FG002|Overall Study|Lost to Follow-up|1|||
143209894|NCT01229449|516313991|FG003|Overall Study|Lost to Follow-up|0|||
143209895|NCT01229449|516313992|FG004|Overall Study|Lost to Follow-up|0|||
143209896|NCT01229449|516313988|FG000|Overall Study|Physician Decision|0|||
143209897|NCT01229449|516313989|FG001|Overall Study|Physician Decision|0|||
143209898|NCT01229449|516313990|FG002|Overall Study|Physician Decision|1|||
143209899|NCT01229449|516313991|FG003|Overall Study|Physician Decision|0|||
143209900|NCT01229449|516313992|FG004|Overall Study|Physician Decision|0|||
143209901|NCT03203291|516313993|FG000|Overall Study|Withdrawal by Subject|1|||
143209902|NCT04033068|516313994|FG000|Overall Study|Withdrawal by Subject|0|||
143209903|NCT04033068|516313995|FG001|Overall Study|Withdrawal by Subject|0|||
143209904|NCT04033068|516313996|FG002|Overall Study|Withdrawal by Subject|1|||
143209905|NCT04033068|516313997|FG003|Overall Study|Withdrawal by Subject|0|||
143209906|NCT04033068|516313994|FG000|Overall Study|Lost to Follow-up|0|||
143209907|NCT04033068|516313995|FG001|Overall Study|Lost to Follow-up|1|||
143209908|NCT04033068|516313996|FG002|Overall Study|Lost to Follow-up|0|||
143209909|NCT04033068|516313997|FG003|Overall Study|Lost to Follow-up|0|||
143209910|NCT04033068|516313994|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
143209911|NCT04033068|516313995|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
143209912|NCT04033068|516313996|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
143209913|NCT04033068|516313997|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
143209914|NCT02540265|516313998|FG000|Overall Study|Lost to Follow-up|0|||
143209915|NCT02540265|516313999|FG001|Overall Study|Lost to Follow-up|0|||
143209916|NCT02540265|516314000|FG002|Overall Study|Lost to Follow-up|1|||
143209917|NCT00324233|516314001|FG000|First Period|unable to insert catheter|1|||
143209918|NCT00324233|516314002|FG001|First Period|unable to insert catheter|0|||
143209919|NCT00324233|516314001|FG000|Second Period|unable to insert catheter|1|||
143209920|NCT00324233|516314002|FG001|Second Period|unable to insert catheter|1|||
143209921|NCT00324233|516314001|FG000|Second Period|Protocol Violation|4|||
143209922|NCT00324233|516314002|FG001|Second Period|Protocol Violation|6|||
143209923|NCT01704456|516314007|FG000|Overall Study|Lost to Follow-up|8|||
143209924|NCT01704456|516314008|FG001|Overall Study|Lost to Follow-up|14|||
143209925|NCT00498355|516314009|FG000|Overall Study|Lost to Follow-up|1|||
143209926|NCT00410605|516314010|FG000|Overall Study|Adverse Event|12|||
143209927|NCT00410605|516314010|FG000|Overall Study|Physician Decision|3|||
143209928|NCT00410605|516314010|FG000|Overall Study|Withdrawal by Subject|5|||
143209929|NCT00410605|516314010|FG000|Overall Study|Started Non-Protocol Therapy|3|||
143209930|NCT00410605|516314010|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
143209931|NCT00410605|516314010|FG000|Overall Study|Transferred to another Institution|1|||
143209932|NCT04583956|516314011|FG000|Overall Study|Death|9|||
143209933|NCT04583956|516314012|FG001|Overall Study|Death|11|||
143209934|NCT04583956|516314011|FG000|Overall Study|Lost to Follow-up|7|||
143209935|NCT04583956|516314012|FG001|Overall Study|Lost to Follow-up|9|||
143209936|NCT04583956|516314011|FG000|Overall Study|Protocol Violation|2|||
143209937|NCT04583956|516314012|FG001|Overall Study|Protocol Violation|0|||
143209938|NCT04583956|516314011|FG000|Overall Study|Withdrawal by Subject|0|||
143209939|NCT04583956|516314012|FG001|Overall Study|Withdrawal by Subject|2|||
143209940|NCT04583956|516314011|FG000|Overall Study|Randomized but not dosed|2|||
143209941|NCT04583956|516314012|FG001|Overall Study|Randomized but not dosed|3|||
143209942|NCT04583956|516314011|FG000|Overall Study|Withdrawal of consent before product administration|1|||
143209943|NCT04583956|516314012|FG001|Overall Study|Withdrawal of consent before product administration|0|||
143370710|NCT01235949|516901096|FG010|Booster Phase|Migrated/moved from study area|0|||
143209944|NCT02100475|516315519|FG000|Overall Study|Unclassified|1|||
143209945|NCT02100475|516315520|FG001|Overall Study|Unclassified|2|||
143209946|NCT02100475|516315519|FG000|Overall Study|Withdrawal criteria|1|||
143209947|NCT02100475|516315520|FG001|Overall Study|Withdrawal criteria|0|||
143209948|NCT03109184|516315521|FG000|Overall Study|Lost to Follow-up|6|||
143209949|NCT03109184|516315522|FG001|Overall Study|Lost to Follow-up|6|||
143209950|NCT03109184|516315521|FG000|Overall Study|Withdrawal by Subject|1|||
143209951|NCT03109184|516315522|FG001|Overall Study|Withdrawal by Subject|1|||
143370711|NCT01235949|516901097|FG011|Booster Phase|Migrated/moved from study area|1|||
143370712|NCT01235949|516901098|FG012|Booster Phase|Migrated/moved from study area|1|||
143209952|NCT00602420|516315523|FG000|Overall Study|Death|1|||
143209953|NCT00602420|516315524|FG001|Overall Study|Death|4|||
143209954|NCT00602420|516315523|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
143209955|NCT00602420|516315524|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
143209956|NCT00602420|516315523|FG000|Overall Study|Withdrawal by Subject|18|||
143209957|NCT00602420|516315524|FG001|Overall Study|Withdrawal by Subject|17|||
143209958|NCT00602420|516315523|FG000|Overall Study|Adverse Event|1|||
143209959|NCT00602420|516315524|FG001|Overall Study|Adverse Event|0|||
143209960|NCT00649428|516315533|FG000|Overall Study|Adverse Event|2|||
143209961|NCT00649428|516315534|FG001|Overall Study|Adverse Event|2|||
143209962|NCT00649428|516315533|FG000|Overall Study|Withdrawal by Subject|6|||
143209963|NCT00649428|516315534|FG001|Overall Study|Withdrawal by Subject|6|||
143209964|NCT00649428|516315533|FG000|Overall Study|Lost to Follow-up|1|||
143209965|NCT00649428|516315534|FG001|Overall Study|Lost to Follow-up|3|||
143209966|NCT00649428|516315533|FG000|Overall Study|Insufficient manufacturing yield|5|||
143209967|NCT00649428|516315534|FG001|Overall Study|Insufficient manufacturing yield|1|||
143209968|NCT00649428|516315533|FG000|Overall Study|Protocol Violation|6|||
143209969|NCT00649428|516315534|FG001|Overall Study|Protocol Violation|2|||
143209970|NCT00649428|516315533|FG000|Overall Study|Physician Decision|0|||
143209971|NCT00649428|516315534|FG001|Overall Study|Physician Decision|1|||
143209972|NCT04599465|516315535|FG000|Overall Study|Physician Decision|1|||
143209973|NCT04599465|516315535|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
143209974|NCT00965575|516315538|FG000|Overall Study|subject unwillingness to swallow study c|1|||
143209975|NCT00965575|516315539|FG001|Overall Study|subject unwillingness to swallow study c|0|||
143209976|NCT02814175|516315542|FG000|Part 1|Adverse Event|2|||
143209977|NCT02814175|516315543|FG001|Part 1|Adverse Event|3|||
143209978|NCT02814175|516315544|FG002|Part 1|Adverse Event|0|||
143209979|NCT02814175|516315545|FG003|Part 1|Adverse Event|0|||
143209980|NCT02814175|516315546|FG004|Part 1|Adverse Event|0|||
143209981|NCT02814175|516315547|FG005|Part 1|Adverse Event|0|||
143209982|NCT02814175|516315542|FG000|Part 1|Withdrawal Consent|8|||
143209983|NCT02814175|516315543|FG001|Part 1|Withdrawal Consent|1|||
143209984|NCT02814175|516315544|FG002|Part 1|Withdrawal Consent|0|||
143209985|NCT02814175|516315545|FG003|Part 1|Withdrawal Consent|0|||
143209986|NCT02814175|516315546|FG004|Part 1|Withdrawal Consent|0|||
143209987|NCT02814175|516315547|FG005|Part 1|Withdrawal Consent|0|||
143209988|NCT02814175|516315542|FG000|Part 1|Lost to Follow-up|1|||
143209989|NCT02814175|516315543|FG001|Part 1|Lost to Follow-up|0|||
143209990|NCT02814175|516315544|FG002|Part 1|Lost to Follow-up|0|||
143209991|NCT02814175|516315545|FG003|Part 1|Lost to Follow-up|0|||
143209992|NCT02814175|516315546|FG004|Part 1|Lost to Follow-up|0|||
143209993|NCT02814175|516315547|FG005|Part 1|Lost to Follow-up|0|||
143209994|NCT02814175|516315542|FG000|Part 1|Lack of Efficacy|1|||
143209995|NCT02814175|516315543|FG001|Part 1|Lack of Efficacy|2|||
143209996|NCT02814175|516315544|FG002|Part 1|Lack of Efficacy|0|||
143209997|NCT02814175|516315545|FG003|Part 1|Lack of Efficacy|0|||
143209998|NCT02814175|516315546|FG004|Part 1|Lack of Efficacy|0|||
143209999|NCT02814175|516315547|FG005|Part 1|Lack of Efficacy|0|||
143210000|NCT02814175|516315542|FG000|Part 2|Adverse Event|0|||
143210001|NCT02814175|516315543|FG001|Part 2|Adverse Event|0|||
143210002|NCT02814175|516315544|FG002|Part 2|Adverse Event|0|||
143210003|NCT02814175|516315545|FG003|Part 2|Adverse Event|1|||
143210004|NCT02814175|516315546|FG004|Part 2|Adverse Event|1|||
143210005|NCT02814175|516315547|FG005|Part 2|Adverse Event|2|||
143210006|NCT02814175|516315542|FG000|Part 2|Withdrawal Consent|0|||
143210007|NCT02814175|516315543|FG001|Part 2|Withdrawal Consent|0|||
143210008|NCT02814175|516315544|FG002|Part 2|Withdrawal Consent|0|||
143210009|NCT02814175|516315545|FG003|Part 2|Withdrawal Consent|2|||
143210010|NCT02814175|516315546|FG004|Part 2|Withdrawal Consent|1|||
143210011|NCT02814175|516315547|FG005|Part 2|Withdrawal Consent|1|||
143210012|NCT02814175|516315542|FG000|Part 2|Lost to Follow-up|0|||
143210013|NCT02814175|516315543|FG001|Part 2|Lost to Follow-up|0|||
143210014|NCT02814175|516315544|FG002|Part 2|Lost to Follow-up|0|||
143210015|NCT02814175|516315545|FG003|Part 2|Lost to Follow-up|1|||
143210016|NCT02814175|516315546|FG004|Part 2|Lost to Follow-up|0|||
143210017|NCT02814175|516315547|FG005|Part 2|Lost to Follow-up|0|||
143210018|NCT02814175|516315542|FG000|Part 2|Lack of Efficacy|0|||
143210019|NCT02814175|516315543|FG001|Part 2|Lack of Efficacy|0|||
143210020|NCT02814175|516315544|FG002|Part 2|Lack of Efficacy|0|||
143210021|NCT02814175|516315545|FG003|Part 2|Lack of Efficacy|0|||
143210022|NCT02814175|516315546|FG004|Part 2|Lack of Efficacy|0|||
143210023|NCT02814175|516315547|FG005|Part 2|Lack of Efficacy|3|||
143210024|NCT01912339|516315548|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
143210025|NCT01912339|516315549|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
143210026|NCT01912339|516315550|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
143210027|NCT01912339|516315548|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
143210028|NCT01912339|516315549|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
143210029|NCT01912339|516315550|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
143210030|NCT01912339|516315548|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
143210031|NCT01912339|516315549|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
143210032|NCT01912339|516315550|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
143210033|NCT01912339|516315548|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
143210034|NCT01912339|516315549|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
143210035|NCT01912339|516315550|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
143210036|NCT01912339|516315548|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
143210037|NCT01912339|516315549|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
143210038|NCT01912339|516315550|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
143210039|NCT01912339|516315548|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
143210040|NCT01912339|516315549|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
143210041|NCT01912339|516315550|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
143210042|NCT01912339|516315548|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
143210043|NCT01912339|516315549|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
143210044|NCT01912339|516315550|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
143210045|NCT01912339|516315548|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
143210046|NCT01912339|516315549|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
143210047|NCT01912339|516315550|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
143210048|NCT01912339|516315548|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
143210049|NCT01912339|516315549|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
143210050|NCT01912339|516315550|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
143210051|NCT01912339|516315548|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
143210052|NCT01912339|516315549|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
143210053|NCT01912339|516315550|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
143210054|NCT01912339|516315548|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
143210055|NCT01912339|516315549|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
143210056|NCT01912339|516315550|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
143264266|NCT02536833|516521776|FG000|Overall Study|Subject Non-Compliance|0|||
143264267|NCT02536833|516521777|FG001|Overall Study|Subject Non-Compliance|1|||
143264268|NCT02536833|516521778|FG002|Overall Study|Subject Non-Compliance|1|||
143264269|NCT02536833|516521779|FG003|Overall Study|Subject Non-Compliance|0|||
143264270|NCT02536833|516521776|FG000|Overall Study|Withdrawal by Subject|4|||
143264271|NCT02536833|516521777|FG001|Overall Study|Withdrawal by Subject|3|||
143264272|NCT02536833|516521778|FG002|Overall Study|Withdrawal by Subject|5|||
143264273|NCT02536833|516521779|FG003|Overall Study|Withdrawal by Subject|11|||
143264274|NCT03370289|516521780|FG000|Overall Study|Screen Failure|1|||
143264275|NCT03370289|516521780|FG000|Overall Study|Sample Size Sufficient|4|||
143264276|NCT02220998|516521782|FG000|Overall Study|Randomized but Never Treated|1|||
143264277|NCT02220998|516521783|FG001|Overall Study|Randomized but Never Treated|2|||
143264278|NCT02220998|516521782|FG000|Overall Study|Death|2|||
143264279|NCT02220998|516521783|FG001|Overall Study|Death|0|||
143264280|NCT02220998|516521782|FG000|Overall Study|Lack of Efficacy|0|||
143264281|NCT02220998|516521783|FG001|Overall Study|Lack of Efficacy|5|||
143264282|NCT02220998|516521782|FG000|Overall Study|Lost to Follow-up|4|||
143264283|NCT02220998|516521783|FG001|Overall Study|Lost to Follow-up|4|||
143264284|NCT01172275|516521791|FG000|Overall Study|Lost to Follow-up|1|||
143264285|NCT01172275|516521792|FG001|Overall Study|Lost to Follow-up|0|||
143264286|NCT01172275|516521791|FG000|Overall Study|Protocol Violation|1|||
143264287|NCT01172275|516521792|FG001|Overall Study|Protocol Violation|0|||
143264288|NCT00194675|516521797|FG000|Overall Study|Lost to Follow-up|1|||
143264289|NCT00194675|516521798|FG001|Overall Study|Lost to Follow-up|1|||
143264290|NCT00194675|516521797|FG000|Overall Study|lack of interest|1|||
143264291|NCT00194675|516521798|FG001|Overall Study|lack of interest|1|||
143264292|NCT00194675|516521797|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
143264293|NCT00194675|516521798|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
143264294|NCT00194675|516521797|FG000|Overall Study|Protocol Violation|1|||
143264295|NCT00194675|516521798|FG001|Overall Study|Protocol Violation|0|||
143264296|NCT00194675|516521797|FG000|Overall Study|Death|1|||
143264297|NCT00194675|516521798|FG001|Overall Study|Death|0|||
143264298|NCT01280955|516521799|FG000|Overall Study|Death|2|||
143264299|NCT01280955|516521799|FG000|Overall Study|Withdrawal by Subject|1|||
143264300|NCT00144027|516521800|FG000|Overall Study|Lost to Follow-up|1|||
143264301|NCT00144027|516521801|FG001|Overall Study|Lost to Follow-up|3|||
143264302|NCT00144027|516521800|FG000|Overall Study|Withdrawal by Subject|2|||
143264303|NCT00144027|516521801|FG001|Overall Study|Withdrawal by Subject|2|||
143264304|NCT00144027|516521800|FG000|Overall Study|did not complete baseline assessment|0|||
143264305|NCT00144027|516521801|FG001|Overall Study|did not complete baseline assessment|6|||
143264306|NCT01674634|516521802|FG000|Overall Study|Withdrawal by Subject|3|||
143264307|NCT01674634|516521802|FG000|Overall Study|Lost to Follow-up|3|||
143264308|NCT00937391|516521803|FG000|Stage 2|Withdrawal by Subject|1|||
143264309|NCT05063318|516521810|FG000|Overall Study|Progressive disease|2|||
143264310|NCT05063318|516521811|FG001|Overall Study|Progressive disease|0|||
143264311|NCT05063318|516521812|FG002|Overall Study|Progressive disease|3|||
143264312|NCT05063318|516521810|FG000|Overall Study|Compassionate use|1|||
143264313|NCT05063318|516521811|FG001|Overall Study|Compassionate use|3|||
143264314|NCT05063318|516521812|FG002|Overall Study|Compassionate use|3|||
143264315|NCT05063318|516521810|FG000|Overall Study|Adverse Event|0|||
143264316|NCT05063318|516521811|FG001|Overall Study|Adverse Event|1|||
143264317|NCT05063318|516521812|FG002|Overall Study|Adverse Event|0|||
143264318|NCT05063318|516521810|FG000|Overall Study|Withdrawal by Subject|0|||
143264319|NCT05063318|516521811|FG001|Overall Study|Withdrawal by Subject|1|||
143264320|NCT05063318|516521812|FG002|Overall Study|Withdrawal by Subject|0|||
143264321|NCT02237911|516523565|FG000|Overall Study|Withdrawal by Subject|4|||
143264322|NCT02237911|516523566|FG001|Overall Study|Withdrawal by Subject|7|||
143264323|NCT02237911|516523567|FG002|Overall Study|Withdrawal by Subject|2|||
143264324|NCT02237911|516523565|FG000|Overall Study|Lost to Follow-up|3|||
143264325|NCT02237911|516523566|FG001|Overall Study|Lost to Follow-up|1|||
143264326|NCT02237911|516523567|FG002|Overall Study|Lost to Follow-up|1|||
143264327|NCT03416374|516523574|FG000|Between Treatment Period I and II|Other|0|||
143264328|NCT03416374|516523575|FG001|Between Treatment Period I and II|Other|9|||
143264329|NCT03416374|516523574|FG000|Treatment Period II|Lack of Efficacy|3|||
143264330|NCT03416374|516523575|FG001|Treatment Period II|Lack of Efficacy|11|||
143264331|NCT03416374|516523574|FG000|Treatment Period II|Adverse Event|1|||
143264332|NCT03416374|516523575|FG001|Treatment Period II|Adverse Event|4|||
143264333|NCT03416374|516523574|FG000|Treatment Period II|Death|0|||
143264334|NCT03416374|516523575|FG001|Treatment Period II|Death|1|||
143264335|NCT03416374|516523574|FG000|Treatment Period II|Other|0|||
143264336|NCT03416374|516523575|FG001|Treatment Period II|Other|2|||
143264337|NCT03463031|516523576|FG000|Overall Study|Withdrawal by Subject|4|||
143264338|NCT03463031|516523577|FG001|Overall Study|Withdrawal by Subject|2|||
143264339|NCT03463031|516523576|FG000|Overall Study|Investigator/Sponsor Decision|0|||
143264340|NCT03463031|516523577|FG001|Overall Study|Investigator/Sponsor Decision|1|||
143264341|NCT03463031|516523576|FG000|Overall Study|Lost to Follow-up|1|||
143210057|NCT01912339|516315548|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
143210058|NCT01912339|516315549|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
143210059|NCT01912339|516315550|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
143210060|NCT01912339|516315548|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
143210061|NCT01912339|516315549|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
143210062|NCT01912339|516315550|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
143210063|NCT01754493|516315551|FG000|Overall Study|Adverse Event|1|||
143210064|NCT01754493|516315551|FG000|Overall Study|Lost to Follow-up|3|||
143210065|NCT01754493|516315551|FG000|Overall Study|Withdrawal by Subject|1|||
143210066|NCT01754493|516315551|FG000|Overall Study|Moved out of town|1|||
143210067|NCT01754493|516315551|FG000|Overall Study|Scheduling conflict|1|||
143210068|NCT02702180|516315554|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
143210069|NCT02702180|516315555|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
143210070|NCT02702180|516315556|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
143210071|NCT02702180|516315554|FG000|Double-blind Treatment Period|Adverse Event|0|||
143210072|NCT02702180|516315555|FG001|Double-blind Treatment Period|Adverse Event|0|||
143210073|NCT02702180|516315556|FG002|Double-blind Treatment Period|Adverse Event|1|||
143210074|NCT02702180|516315554|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
143210075|NCT02702180|516315555|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
143210076|NCT02702180|516315556|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
143264342|NCT03463031|516523577|FG001|Overall Study|Lost to Follow-up|1|||
143264343|NCT03463031|516523576|FG000|Overall Study|Adverse Event|4|||
143264344|NCT03463031|516523577|FG001|Overall Study|Adverse Event|1|||
143264345|NCT03463031|516523576|FG000|Overall Study|Use of prohibited medication by subject|1|||
143264346|NCT03463031|516523577|FG001|Overall Study|Use of prohibited medication by subject|0|||
143264347|NCT01810432|516523578|FG000|Washout|Protocol Violation|0|||
143264348|NCT01810432|516523579|FG001|Washout|Protocol Violation|1|||
143264349|NCT01810432|516523578|FG000|Washout|Adverse Event|1|||
143264350|NCT01810432|516523579|FG001|Washout|Adverse Event|0|||
143264351|NCT01810432|516523578|FG000|Period 2|Withdrawal by Subject|2|||
143264352|NCT01810432|516523579|FG001|Period 2|Withdrawal by Subject|1|||
143264353|NCT01810432|516523578|FG000|Period 2|Physician Decision|1|||
143264354|NCT01810432|516523579|FG001|Period 2|Physician Decision|0|||
143264355|NCT01810432|516523578|FG000|Period 2|Lost to Follow-up|1|||
143264356|NCT01810432|516523579|FG001|Period 2|Lost to Follow-up|1|||
143264357|NCT01264016|516523580|FG000|Overall Study|Withdrawal by Subject|1|||
143264358|NCT01264016|516523580|FG000|Overall Study|Felt faint at sight of blood|1|||
143264359|NCT01629706|516523581|FG000|Phase 1 PureVision|Screen Failure|4|||
143264360|NCT01629706|516523581|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
143264361|NCT01629706|516523581|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
143264362|NCT01629706|516523581|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
143264363|NCT01629706|516523581|FG000|Phase 2 Habitual|Screen Failure|6|||
143264364|NCT01629706|516523581|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
143264365|NCT01629706|516523581|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
143264366|NCT01629706|516523581|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
143264367|NCT01629706|516523581|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
143264368|NCT02117414|516523582|FG000|Overall Study|Death|5|||
143264369|NCT02117414|516523583|FG001|Overall Study|Death|2|||
143264370|NCT02117414|516523582|FG000|Overall Study|Withdrawal by Subject|10|||
143264371|NCT02117414|516523583|FG001|Overall Study|Withdrawal by Subject|4|||
143264372|NCT02537574|516523584|FG000|Overall Study|Adverse Event|1|||
143264373|NCT02537574|516523585|FG001|Overall Study|Adverse Event|3|||
143264374|NCT02537574|516523586|FG002|Overall Study|Adverse Event|2|||
143264375|NCT02537574|516523584|FG000|Overall Study|Lost to Follow-up|40|||
143264376|NCT02537574|516523585|FG001|Overall Study|Lost to Follow-up|51|||
143264377|NCT02537574|516523586|FG002|Overall Study|Lost to Follow-up|55|||
143264378|NCT02537574|516523584|FG000|Overall Study|Noncompliance with study drug|0|||
143264379|NCT02537574|516523585|FG001|Overall Study|Noncompliance with study drug|1|||
143264380|NCT02537574|516523586|FG002|Overall Study|Noncompliance with study drug|1|||
143264381|NCT02537574|516523584|FG000|Overall Study|Physician Decision|2|||
143264382|NCT02537574|516523585|FG001|Overall Study|Physician Decision|0|||
143264383|NCT02537574|516523586|FG002|Overall Study|Physician Decision|0|||
143264384|NCT02537574|516523584|FG000|Overall Study|Protocol Violation|4|||
143264385|NCT02537574|516523585|FG001|Overall Study|Protocol Violation|2|||
143264386|NCT02537574|516523586|FG002|Overall Study|Protocol Violation|3|||
143264387|NCT02537574|516523584|FG000|Overall Study|Withdrawal by Subject|37|||
143264388|NCT02537574|516523585|FG001|Overall Study|Withdrawal by Subject|27|||
143264389|NCT02537574|516523586|FG002|Overall Study|Withdrawal by Subject|29|||
143264390|NCT02537574|516523584|FG000|Overall Study|Lack of Efficacy|14|||
143264391|NCT02537574|516523585|FG001|Overall Study|Lack of Efficacy|16|||
143264392|NCT02537574|516523586|FG002|Overall Study|Lack of Efficacy|15|||
143264393|NCT02537574|516523584|FG000|Overall Study|Duplicate Patient|1|||
143264394|NCT02537574|516523585|FG001|Overall Study|Duplicate Patient|0|||
143264395|NCT02537574|516523586|FG002|Overall Study|Duplicate Patient|0|||
143264396|NCT02537574|516523584|FG000|Overall Study|Patient not Stable|0|||
143264397|NCT02537574|516523585|FG001|Overall Study|Patient not Stable|1|||
143264398|NCT02537574|516523586|FG002|Overall Study|Patient not Stable|0|||
143264399|NCT02537574|516523584|FG000|Overall Study|Incarceration|0|||
143264400|NCT02537574|516523585|FG001|Overall Study|Incarceration|1|||
143264401|NCT02537574|516523586|FG002|Overall Study|Incarceration|0|||
143264402|NCT02537574|516523584|FG000|Overall Study|Failed Naloxone Challenge|0|||
143264403|NCT02537574|516523585|FG001|Overall Study|Failed Naloxone Challenge|1|||
143264404|NCT02537574|516523586|FG002|Overall Study|Failed Naloxone Challenge|0|||
143264405|NCT02537574|516523584|FG000|Overall Study|Transportation Issues|0|||
143264406|NCT02537574|516523585|FG001|Overall Study|Transportation Issues|0|||
143264407|NCT02537574|516523586|FG002|Overall Study|Transportation Issues|1|||
143264408|NCT02537574|516523584|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
143264409|NCT02537574|516523585|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
143264410|NCT02537574|516523586|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
143264411|NCT02537574|516523584|FG000|Overall Study|Noncompliance with Protocol|0|||
143264412|NCT02537574|516523585|FG001|Overall Study|Noncompliance with Protocol|0|||
143264413|NCT02537574|516523586|FG002|Overall Study|Noncompliance with Protocol|1|||
143264414|NCT02663687|516523587|FG000|Overall Study|Adverse Event|1|||
143264415|NCT02663687|516523588|FG001|Overall Study|Adverse Event|0|||
143264416|NCT02663687|516523589|FG002|Overall Study|Adverse Event|0|||
143264417|NCT02663687|516523590|FG003|Overall Study|Adverse Event|0|||
143264418|NCT02663687|516523591|FG004|Overall Study|Adverse Event|0|||
143264419|NCT02663687|516523587|FG000|Overall Study|Other|1|||
143264420|NCT02663687|516523588|FG001|Overall Study|Other|0|||
143264421|NCT02663687|516523589|FG002|Overall Study|Other|1|||
143264422|NCT02663687|516523590|FG003|Overall Study|Other|0|||
143264423|NCT02663687|516523591|FG004|Overall Study|Other|0|||
143264424|NCT01151098|516523592|FG000|Overall Study|Adverse Event|82|||
143210077|NCT02702180|516315554|FG000|Double-blind Treatment Period|Protocol Violation|0|||
143210078|NCT02702180|516315555|FG001|Double-blind Treatment Period|Protocol Violation|0|||
143210079|NCT02702180|516315556|FG002|Double-blind Treatment Period|Protocol Violation|2|||
143264425|NCT01151098|516523592|FG000|Overall Study|Lost to Follow-up|6|||
143264426|NCT01151098|516523592|FG000|Overall Study|Lack of Efficacy|15|||
143264427|NCT01151098|516523592|FG000|Overall Study|Protocol Violation|1|||
143264428|NCT01151098|516523592|FG000|Overall Study|Miscellaneous|13|||
143264429|NCT03343067|516523595|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
143264430|NCT03343067|516523596|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
143264431|NCT03343067|516523597|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
143264432|NCT00116168|516523598|FG000|Overall Study|Lost to Follow-up|6|||
143264433|NCT00116168|516523599|FG001|Overall Study|Lost to Follow-up|5|||
143264434|NCT00116168|516523600|FG002|Overall Study|Lost to Follow-up|0|||
143264435|NCT00116168|516523601|FG003|Overall Study|Lost to Follow-up|0|||
143264436|NCT01323946|516523602|FG000|Overall Study|Lost to Follow-up|0|||
143264437|NCT01323946|516523603|FG001|Overall Study|Lost to Follow-up|1|||
143264438|NCT01323946|516523604|FG002|Overall Study|Lost to Follow-up|0|||
143370713|NCT01235949|516901099|FG013|Booster Phase|Migrated/moved from study area|0|||
143210080|NCT02702180|516315554|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
143210081|NCT02702180|516315555|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
143210082|NCT02702180|516315556|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
143210083|NCT02702180|516315554|FG000|Open-label Treatment Period|Withdrawn in error|0|||
143370714|NCT01235949|516901100|FG014|Booster Phase|Migrated/moved from study area|0|||
143370715|NCT01235949|516901101|FG015|Booster Phase|Migrated/moved from study area|0|||
143370716|NCT01235949|516901102|FG016|Booster Phase|Migrated/moved from study area|0|||
143210084|NCT02702180|516315555|FG001|Open-label Treatment Period|Withdrawn in error|0|||
143210085|NCT02702180|516315556|FG002|Open-label Treatment Period|Withdrawn in error|1|||
143210086|NCT00372697|516315557|FG000|Overall Study|Protocol Violation|1|||
143210087|NCT00372697|516315558|FG001|Overall Study|Protocol Violation|1|||
143210088|NCT01815840|516315559|FG000|Overall Study|Missing|1|||
143210089|NCT01815840|516315560|FG001|Overall Study|Missing|0|||
143210090|NCT01815840|516315559|FG000|Overall Study|Withdrew Consent|31|||
143210091|NCT01815840|516315560|FG001|Overall Study|Withdrew Consent|30|||
143210092|NCT01815840|516315559|FG000|Overall Study|Administrative/Other|1|||
143210093|NCT01815840|516315560|FG001|Overall Study|Administrative/Other|3|||
143210094|NCT01815840|516315559|FG000|Overall Study|Adverse Event|10|||
143210095|NCT01815840|516315560|FG001|Overall Study|Adverse Event|16|||
143210096|NCT01815840|516315559|FG000|Overall Study|Death|2|||
143210097|NCT01815840|516315560|FG001|Overall Study|Death|2|||
143210098|NCT01815840|516315559|FG000|Overall Study|Disease progression|3|||
143210099|NCT01815840|516315560|FG001|Overall Study|Disease progression|2|||
143210100|NCT01815840|516315559|FG000|Overall Study|Investigators Decision|2|||
143210101|NCT01815840|516315560|FG001|Overall Study|Investigators Decision|3|||
143210102|NCT01815840|516315559|FG000|Overall Study|Lost to Follow-up|3|||
143210103|NCT01815840|516315560|FG001|Overall Study|Lost to Follow-up|6|||
143210104|NCT01815840|516315559|FG000|Overall Study|Refused Treatment|5|||
143210105|NCT01815840|516315560|FG001|Overall Study|Refused Treatment|1|||
143210106|NCT01815840|516315559|FG000|Overall Study|Sponsor Termination Treatment|1|||
143210107|NCT01815840|516315560|FG001|Overall Study|Sponsor Termination Treatment|0|||
143210108|NCT03221842|516315562|FG000|Period 1 (Open-label)|Adverse Event|4|||
143210109|NCT03221842|516315563|FG001|Period 1 (Open-label)|Adverse Event|0|||
143210110|NCT03221842|516315562|FG000|Period 1 (Open-label)|Physician Decision|2|||
143210111|NCT03221842|516315563|FG001|Period 1 (Open-label)|Physician Decision|0|||
143210112|NCT03221842|516315562|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
143210113|NCT03221842|516315563|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
143210114|NCT03221842|516315562|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
143210115|NCT03221842|516315563|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
143210116|NCT03221842|516315562|FG000|Period 1 (Open-label)|Other|2|||
143210117|NCT03221842|516315563|FG001|Period 1 (Open-label)|Other|0|||
143210118|NCT03221842|516315562|FG000|Period 2 (Randomized, Blinded)|Death|0|||
143210119|NCT03221842|516315563|FG001|Period 2 (Randomized, Blinded)|Death|1|||
143210120|NCT03221842|516315562|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
143210121|NCT03221842|516315563|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
143210122|NCT00704288|516315564|FG000|Overall Treatment Period|Adverse Event|11|||
143210123|NCT00704288|516315565|FG001|Overall Treatment Period|Adverse Event|8|||
143210124|NCT00704288|516315566|FG002|Overall Treatment Period|Adverse Event|22|||
143210125|NCT00704288|516315564|FG000|Overall Treatment Period|Death|0|||
143210126|NCT00704288|516315565|FG001|Overall Treatment Period|Death|0|||
143370717|NCT01235949|516901103|FG017|Booster Phase|Migrated/moved from study area|1|||
143210127|NCT00704288|516315566|FG002|Overall Treatment Period|Death|1|||
143210128|NCT00704288|516315564|FG000|Overall Treatment Period|Physician Decision|0|||
143210129|NCT00704288|516315565|FG001|Overall Treatment Period|Physician Decision|2|||
143370718|NCT01235949|516901086|FG000|Booster Phase|Adverse Event|0|||
143210130|NCT00704288|516315566|FG002|Overall Treatment Period|Physician Decision|0|||
143210131|NCT00704288|516315564|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
143210132|NCT00704288|516315565|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
143370719|NCT01235949|516901087|FG001|Booster Phase|Adverse Event|0|||
143370720|NCT01235949|516901088|FG002|Booster Phase|Adverse Event|0|||
143370721|NCT01235949|516901089|FG003|Booster Phase|Adverse Event|0|||
143370722|NCT01235949|516901090|FG004|Booster Phase|Adverse Event|0|||
143370723|NCT01235949|516901091|FG005|Booster Phase|Adverse Event|0|||
143370724|NCT01235949|516901092|FG006|Booster Phase|Adverse Event|0|||
143370725|NCT01235949|516901093|FG007|Booster Phase|Adverse Event|0|||
143370726|NCT01235949|516901094|FG008|Booster Phase|Adverse Event|0|||
143370727|NCT01235949|516901095|FG009|Booster Phase|Adverse Event|0|||
143210133|NCT00704288|516315566|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
143210134|NCT00704288|516315564|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
143210135|NCT00704288|516315565|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
143210136|NCT00704288|516315566|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
143210137|NCT00704288|516315564|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
143210138|NCT00704288|516315565|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
143210139|NCT00704288|516315566|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
143210140|NCT00704288|516315564|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
143210141|NCT00704288|516315565|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
143210142|NCT00704288|516315566|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
143210143|NCT00704288|516315564|FG000|Overall Treatment Period|Roll-over to another study|1|||
143210144|NCT00704288|516315565|FG001|Overall Treatment Period|Roll-over to another study|0|||
143210145|NCT00704288|516315566|FG002|Overall Treatment Period|Roll-over to another study|4|||
143370728|NCT01235949|516901096|FG010|Booster Phase|Adverse Event|0|||
143370729|NCT01235949|516901097|FG011|Booster Phase|Adverse Event|0|||
143370730|NCT01235949|516901098|FG012|Booster Phase|Adverse Event|0|||
143370731|NCT01235949|516901099|FG013|Booster Phase|Adverse Event|0|||
143370732|NCT01235949|516901100|FG014|Booster Phase|Adverse Event|0|||
143370733|NCT01235949|516901101|FG015|Booster Phase|Adverse Event|1|||
143370734|NCT01235949|516901102|FG016|Booster Phase|Adverse Event|0|||
143370735|NCT01235949|516901103|FG017|Booster Phase|Adverse Event|0|||
143370736|NCT01235949|516901086|FG000|Booster Phase|Withdrawal by Subject|0|||
143370737|NCT01235949|516901087|FG001|Booster Phase|Withdrawal by Subject|0|||
143370738|NCT01235949|516901088|FG002|Booster Phase|Withdrawal by Subject|0|||
143210146|NCT00704288|516315564|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
143210147|NCT00704288|516315565|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
143210148|NCT00704288|516315566|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
143210149|NCT00704288|516315564|FG000|Extended Post Treatment Follow Up Period|Death|41|||
143210150|NCT00704288|516315565|FG001|Extended Post Treatment Follow Up Period|Death|50|||
143210151|NCT00704288|516315566|FG002|Extended Post Treatment Follow Up Period|Death|93|||
143210152|NCT00704288|516315564|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
143210153|NCT00704288|516315565|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
143210154|NCT00704288|516315566|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
143210155|NCT00704288|516315564|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
143210156|NCT00704288|516315565|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
143210157|NCT00704288|516315566|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
143210158|NCT00704288|516315564|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
143210159|NCT00704288|516315565|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
143210160|NCT00704288|516315566|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
143210161|NCT01055314|516315567|FG000|Overall Study|Adverse Event|7|||
143210162|NCT01055314|516315568|FG001|Overall Study|Adverse Event|4|||
143210163|NCT01055314|516315567|FG000|Overall Study|Death|2|||
143210164|NCT01055314|516315568|FG001|Overall Study|Death|1|||
143210165|NCT01055314|516315567|FG000|Overall Study|Lack of Efficacy|11|||
143210166|NCT01055314|516315568|FG001|Overall Study|Lack of Efficacy|19|||
143210167|NCT01055314|516315567|FG000|Overall Study|Physician Decision|10|||
143210168|NCT01055314|516315568|FG001|Overall Study|Physician Decision|5|||
143210169|NCT01055314|516315567|FG000|Overall Study|Withdrawal by Subject|1|||
143210170|NCT01055314|516315568|FG001|Overall Study|Withdrawal by Subject|0|||
143210171|NCT01055314|516315567|FG000|Overall Study|Ineligible|3|||
143210172|NCT01055314|516315568|FG001|Overall Study|Ineligible|5|||
143210173|NCT01055314|516315567|FG000|Overall Study|Refusal of further protocol therapy|10|||
143210174|NCT01055314|516315568|FG001|Overall Study|Refusal of further protocol therapy|4|||
143210175|NCT01055314|516315567|FG000|Overall Study|No treatment|1|||
143210176|NCT01055314|516315568|FG001|Overall Study|No treatment|0|||
143210177|NCT00568126|516315569|FG000|Overall Study|Adverse Event|3|||
143370739|NCT01235949|516901089|FG003|Booster Phase|Withdrawal by Subject|0|||
143370740|NCT01235949|516901090|FG004|Booster Phase|Withdrawal by Subject|0|||
143370741|NCT01235949|516901091|FG005|Booster Phase|Withdrawal by Subject|0|||
143370742|NCT01235949|516901092|FG006|Booster Phase|Withdrawal by Subject|0|||
143370743|NCT01235949|516901093|FG007|Booster Phase|Withdrawal by Subject|1|||
143210178|NCT00568126|516315570|FG001|Overall Study|Adverse Event|0|||
143210179|NCT00568126|516315569|FG000|Overall Study|Withdrawal by Subject|2|||
143210180|NCT00568126|516315570|FG001|Overall Study|Withdrawal by Subject|3|||
143210181|NCT00568126|516315569|FG000|Overall Study|Lost to Follow-up|4|||
143210182|NCT00568126|516315570|FG001|Overall Study|Lost to Follow-up|3|||
143210183|NCT00568126|516315569|FG000|Overall Study|Lack of Efficacy|0|||
143210184|NCT00568126|516315570|FG001|Overall Study|Lack of Efficacy|1|||
143210185|NCT00568126|516315569|FG000|Overall Study|Physician Decision|2|||
143210186|NCT00568126|516315570|FG001|Overall Study|Physician Decision|2|||
143210187|NCT04395690|516315571|FG000|Overall Study|Lost to Follow-up|1|||
143210188|NCT04395690|516315572|FG001|Overall Study|Lost to Follow-up|1|||
143210189|NCT04512976|516315574|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
143210190|NCT04512976|516315575|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
143210191|NCT04512976|516315576|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
143210192|NCT04512976|516315577|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
143210193|NCT04512976|516315578|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
143210194|NCT04512976|516315579|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
143210195|NCT01452919|516315580|FG000|Open-Label Treatment|Adverse Event|5|||
143210196|NCT01452919|516315581|FG001|Open-Label Treatment|Adverse Event|0|||
143210197|NCT01452919|516315582|FG002|Open-Label Treatment|Adverse Event|0|||
143210198|NCT01452919|516315580|FG000|Open-Label Treatment|Lost to Follow-up|4|||
143210199|NCT01452919|516315581|FG001|Open-Label Treatment|Lost to Follow-up|0|||
143210200|NCT01452919|516315582|FG002|Open-Label Treatment|Lost to Follow-up|0|||
143210201|NCT01452919|516315580|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
143210202|NCT01452919|516315581|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
143210203|NCT01452919|516315582|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
143210204|NCT01452919|516315580|FG000|Open-Label Treatment|Protocol Violation|4|||
143210205|NCT01452919|516315581|FG001|Open-Label Treatment|Protocol Violation|0|||
143210206|NCT01452919|516315582|FG002|Open-Label Treatment|Protocol Violation|0|||
143210207|NCT01452919|516315580|FG000|Open-Label Treatment|Sponsor Decision|1|||
143210208|NCT01452919|516315581|FG001|Open-Label Treatment|Sponsor Decision|0|||
143210209|NCT01452919|516315582|FG002|Open-Label Treatment|Sponsor Decision|0|||
143210210|NCT01452919|516315580|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
143264439|NCT01323946|516523602|FG000|Overall Study|Parents refused the last blood draw|1|||
143264440|NCT01323946|516523603|FG001|Overall Study|Parents refused the last blood draw|0|||
143264441|NCT01323946|516523604|FG002|Overall Study|Parents refused the last blood draw|0|||
143264442|NCT01323946|516523602|FG000|Overall Study|Withdrawal by Subject|2|||
143264443|NCT01323946|516523603|FG001|Overall Study|Withdrawal by Subject|2|||
143264444|NCT01323946|516523604|FG002|Overall Study|Withdrawal by Subject|0|||
143264445|NCT02169284|516523607|FG000|Overall Study|Physician Decision|0|||
143264446|NCT02169284|516523608|FG001|Overall Study|Physician Decision|1|||
143264447|NCT02652767|516523609|FG000|Overall Study|Death|2|||
143264448|NCT02652767|516523609|FG000|Overall Study|Lost to Follow-up|1|||
143264449|NCT02652767|516523609|FG000|Overall Study|Withdrawal by Subject|1|||
143264450|NCT02325791|516523610|FG000|Overall Study|Adverse Event|0|||
143264451|NCT02325791|516523611|FG001|Overall Study|Adverse Event|1|||
143264452|NCT02325791|516523612|FG002|Overall Study|Adverse Event|1|||
143264453|NCT02325791|516523613|FG003|Overall Study|Adverse Event|0|||
143264454|NCT02325791|516523610|FG000|Overall Study|Death|0|||
143264455|NCT02325791|516523611|FG001|Overall Study|Death|3|||
143264456|NCT02325791|516523612|FG002|Overall Study|Death|0|||
143264457|NCT02325791|516523613|FG003|Overall Study|Death|1|||
143264458|NCT02325791|516523610|FG000|Overall Study|Lost to Follow-up|0|||
143264459|NCT02325791|516523611|FG001|Overall Study|Lost to Follow-up|15|||
143264460|NCT02325791|516523612|FG002|Overall Study|Lost to Follow-up|14|||
143264461|NCT02325791|516523613|FG003|Overall Study|Lost to Follow-up|9|||
143264462|NCT02325791|516523610|FG000|Overall Study|Physician Decision|0|||
143264463|NCT02325791|516523611|FG001|Overall Study|Physician Decision|1|||
143264464|NCT02325791|516523612|FG002|Overall Study|Physician Decision|1|||
143264465|NCT02325791|516523613|FG003|Overall Study|Physician Decision|0|||
143264466|NCT02325791|516523610|FG000|Overall Study|Protocol Violation|0|||
143264467|NCT02325791|516523611|FG001|Overall Study|Protocol Violation|0|||
143264468|NCT02325791|516523612|FG002|Overall Study|Protocol Violation|1|||
143264469|NCT02325791|516523613|FG003|Overall Study|Protocol Violation|0|||
143264470|NCT02325791|516523610|FG000|Overall Study|Withdrawal by Subject|0|||
143264471|NCT02325791|516523611|FG001|Overall Study|Withdrawal by Subject|5|||
143264472|NCT02325791|516523612|FG002|Overall Study|Withdrawal by Subject|8|||
143264473|NCT02325791|516523613|FG003|Overall Study|Withdrawal by Subject|16|||
143264474|NCT01028378|516523615|FG000|Overall Study|Lost to Follow-up|12|||
143264475|NCT01028378|516523615|FG000|Overall Study|Withdrawal by Subject|1|||
143264476|NCT01028378|516523615|FG000|Overall Study|Adminstrative Reasons|4|||
143264477|NCT01298193|516523616|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
143264478|NCT01298193|516523616|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
143264479|NCT01298193|516523616|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
143264480|NCT01298193|516523616|FG000|Efficacy Phase (Second Cycle)|Death|1|||
143264481|NCT00887744|516523628|FG000|Overall Study|Adverse Event|3|||
143264482|NCT00887744|516523628|FG000|Overall Study|Death|1|||
143264483|NCT00887744|516523628|FG000|Overall Study|Lost to Follow-up|3|||
143264484|NCT00887744|516523628|FG000|Overall Study|Withdrawal by Subject|18|||
143264485|NCT00887744|516523628|FG000|Overall Study|Various reasons|9|||
143264486|NCT01115803|516523629|FG000|Overall Study|Withdrawal by Subject|0|||
143264487|NCT01115803|516523630|FG001|Overall Study|Withdrawal by Subject|0|||
143264488|NCT01115803|516523631|FG002|Overall Study|Withdrawal by Subject|0|||
143264489|NCT01115803|516523632|FG003|Overall Study|Withdrawal by Subject|0|||
143264490|NCT01115803|516523633|FG004|Overall Study|Withdrawal by Subject|0|||
143264491|NCT01115803|516523634|FG005|Overall Study|Withdrawal by Subject|0|||
143264492|NCT01115803|516523635|FG006|Overall Study|Withdrawal by Subject|1|||
143264493|NCT01115803|516523629|FG000|Overall Study|Lost to Follow-up|0|||
143264494|NCT01115803|516523630|FG001|Overall Study|Lost to Follow-up|0|||
143264495|NCT01115803|516523631|FG002|Overall Study|Lost to Follow-up|1|||
143264496|NCT01115803|516523632|FG003|Overall Study|Lost to Follow-up|0|||
143264497|NCT01115803|516523633|FG004|Overall Study|Lost to Follow-up|0|||
143264498|NCT01115803|516523634|FG005|Overall Study|Lost to Follow-up|0|||
143264499|NCT01115803|516523635|FG006|Overall Study|Lost to Follow-up|0|||
143264500|NCT01115803|516523629|FG000|Overall Study|Progressive Disease during Cycle1|0|||
143264501|NCT01115803|516523630|FG001|Overall Study|Progressive Disease during Cycle1|0|||
143264502|NCT01115803|516523631|FG002|Overall Study|Progressive Disease during Cycle1|0|||
143264503|NCT01115803|516523632|FG003|Overall Study|Progressive Disease during Cycle1|0|||
143264504|NCT01115803|516523633|FG004|Overall Study|Progressive Disease during Cycle1|0|||
143264505|NCT01115803|516523634|FG005|Overall Study|Progressive Disease during Cycle1|0|||
143264506|NCT01115803|516523635|FG006|Overall Study|Progressive Disease during Cycle1|1|||
143264507|NCT01390220|516523636|FG000|Test Dose Phase|Adverse Event|17|||
143264508|NCT01390220|516523637|FG001|Test Dose Phase|Adverse Event|0|||
143264509|NCT01390220|516523638|FG002|Test Dose Phase|Adverse Event|0|||
143264510|NCT01390220|516523636|FG000|Test Dose Phase|Withdrawal by Subject|8|||
143264511|NCT01390220|516523637|FG001|Test Dose Phase|Withdrawal by Subject|0|||
143264512|NCT01390220|516523638|FG002|Test Dose Phase|Withdrawal by Subject|0|||
143264513|NCT01390220|516523636|FG000|Test Dose Phase|Lost to Follow-up|2|||
143264514|NCT01390220|516523637|FG001|Test Dose Phase|Lost to Follow-up|0|||
143264515|NCT01390220|516523638|FG002|Test Dose Phase|Lost to Follow-up|0|||
143264516|NCT01390220|516523636|FG000|Test Dose Phase|Protocol Violation|8|||
143264517|NCT01390220|516523637|FG001|Test Dose Phase|Protocol Violation|0|||
143370744|NCT01235949|516901094|FG008|Booster Phase|Withdrawal by Subject|1|||
143264518|NCT01390220|516523638|FG002|Test Dose Phase|Protocol Violation|0|||
143264519|NCT01390220|516523636|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
143210211|NCT01452919|516315581|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
143210212|NCT01452919|516315582|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
143210213|NCT01452919|516315580|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
143210214|NCT01452919|516315581|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
143210215|NCT01452919|516315582|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
143210216|NCT01452919|516315580|FG000|Randomization Treatment|Adverse Event|0|||
143210217|NCT01452919|516315581|FG001|Randomization Treatment|Adverse Event|0|||
143210218|NCT01452919|516315582|FG002|Randomization Treatment|Adverse Event|2|||
143210219|NCT01452919|516315580|FG000|Randomization Treatment|Sponsor Decision|0|||
143210220|NCT01452919|516315581|FG001|Randomization Treatment|Sponsor Decision|1|||
143264520|NCT01390220|516523637|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
143264521|NCT01390220|516523638|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
143264522|NCT01390220|516523636|FG000|Test Dose Phase|Study/Site closure|6|||
143210221|NCT01452919|516315582|FG002|Randomization Treatment|Sponsor Decision|0|||
143210222|NCT01452919|516315580|FG000|Randomization Treatment|Withdrawal by Subject|0|||
143210223|NCT01452919|516315581|FG001|Randomization Treatment|Withdrawal by Subject|1|||
143210224|NCT01452919|516315582|FG002|Randomization Treatment|Withdrawal by Subject|0|||
143210225|NCT01452919|516315580|FG000|Randomization Treatment|Subject is moving or has moved|0|||
143210226|NCT01452919|516315581|FG001|Randomization Treatment|Subject is moving or has moved|1|||
143210227|NCT01452919|516315582|FG002|Randomization Treatment|Subject is moving or has moved|0|||
143264523|NCT01390220|516523637|FG001|Test Dose Phase|Study/Site closure|0|||
143264524|NCT01390220|516523638|FG002|Test Dose Phase|Study/Site closure|0|||
143264525|NCT01390220|516523636|FG000|Test Dose Phase|Caregiver no longer available|5|||
143264526|NCT01390220|516523637|FG001|Test Dose Phase|Caregiver no longer available|0|||
143264527|NCT01390220|516523638|FG002|Test Dose Phase|Caregiver no longer available|0|||
143264528|NCT01390220|516523636|FG000|Test Dose Phase|Noncompliance|2|||
143264529|NCT01390220|516523637|FG001|Test Dose Phase|Noncompliance|0|||
143264530|NCT01390220|516523638|FG002|Test Dose Phase|Noncompliance|0|||
143264531|NCT01390220|516523636|FG000|Test Dose Phase|Logistical|6|||
143264532|NCT01390220|516523637|FG001|Test Dose Phase|Logistical|0|||
143264533|NCT01390220|516523638|FG002|Test Dose Phase|Logistical|0|||
143264534|NCT01390220|516523636|FG000|Comparative Phase|Withdrawal by Subject|0|||
143264535|NCT01390220|516523637|FG001|Comparative Phase|Withdrawal by Subject|1|||
143264536|NCT01390220|516523638|FG002|Comparative Phase|Withdrawal by Subject|0|||
143264537|NCT03533686|516523639|FG000|Overall Study|Withdrawal by Subject|1|||
143264538|NCT03533686|516523640|FG001|Overall Study|Withdrawal by Subject|0|||
143264539|NCT03533686|516523641|FG002|Overall Study|Withdrawal by Subject|0|||
143264540|NCT03533686|516523642|FG003|Overall Study|Withdrawal by Subject|3|||
143264541|NCT03533686|516523643|FG004|Overall Study|Withdrawal by Subject|5|||
143264542|NCT03533686|516523644|FG005|Overall Study|Withdrawal by Subject|1|||
143264543|NCT03533686|516523639|FG000|Overall Study|Lost to Follow-up|0|||
143264544|NCT03533686|516523640|FG001|Overall Study|Lost to Follow-up|1|||
143264545|NCT03533686|516523641|FG002|Overall Study|Lost to Follow-up|0|||
143264546|NCT03533686|516523642|FG003|Overall Study|Lost to Follow-up|0|||
143264547|NCT03533686|516523643|FG004|Overall Study|Lost to Follow-up|2|||
143264548|NCT03533686|516523644|FG005|Overall Study|Lost to Follow-up|0|||
143264549|NCT03533686|516523639|FG000|Overall Study|Screen Failure|0|||
143264550|NCT03533686|516523640|FG001|Overall Study|Screen Failure|0|||
143264551|NCT03533686|516523641|FG002|Overall Study|Screen Failure|0|||
143264552|NCT03533686|516523642|FG003|Overall Study|Screen Failure|2|||
143264553|NCT03533686|516523643|FG004|Overall Study|Screen Failure|0|||
143264554|NCT03533686|516523644|FG005|Overall Study|Screen Failure|0|||
143264555|NCT02764190|516523647|FG000|Overall Study|Lost to Follow-up|17|||
143264556|NCT02764190|516523648|FG001|Overall Study|Lost to Follow-up|13|||
143264557|NCT00473746|516523649|FG000|Period 1 (Phase 1)|Adverse Event|1|||
143264558|NCT00473746|516523650|FG001|Period 1 (Phase 1)|Adverse Event|0|||
143264559|NCT00473746|516523651|FG002|Period 1 (Phase 1)|Adverse Event|0|||
143264560|NCT00473746|516523652|FG003|Period 1 (Phase 1)|Adverse Event|0|||
143264561|NCT00473746|516523653|FG004|Period 1 (Phase 1)|Adverse Event|0|||
143264562|NCT00473746|516523649|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
143264563|NCT00473746|516523650|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
143264564|NCT00473746|516523651|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
143264565|NCT00473746|516523652|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
143264566|NCT00473746|516523653|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
143210228|NCT02421588|516315583|FG000|Overall Study|Non-treatment-related AE|8|||
143210229|NCT02421588|516315584|FG001|Overall Study|Non-treatment-related AE|8|||
143210230|NCT02421588|516315583|FG000|Overall Study|Progressive disease|152|||
143210231|NCT02421588|516315584|FG001|Overall Study|Progressive disease|135|||
143210232|NCT02421588|516315583|FG000|Overall Study|Death|11|||
143210233|NCT02421588|516315584|FG001|Overall Study|Death|3|||
143210234|NCT02421588|516315583|FG000|Overall Study|Physician Decision|8|||
143210235|NCT02421588|516315584|FG001|Overall Study|Physician Decision|17|||
143210236|NCT02421588|516315583|FG000|Overall Study|Other reason not specified|3|||
143210237|NCT02421588|516315584|FG001|Overall Study|Other reason not specified|1|||
143264567|NCT00473746|516523649|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
143264568|NCT00473746|516523650|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
143264569|NCT00473746|516523651|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
143264570|NCT00473746|516523652|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
143264571|NCT00473746|516523653|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
143264572|NCT00473746|516523649|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
143264573|NCT00473746|516523650|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
143264574|NCT00473746|516523651|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
143264575|NCT00473746|516523652|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
143370745|NCT01235949|516901095|FG009|Booster Phase|Withdrawal by Subject|0|||
143264576|NCT00473746|516523653|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
143264577|NCT00473746|516523649|FG000|Period 1 (Phase 1)|Reason not specified|0|||
143264578|NCT00473746|516523650|FG001|Period 1 (Phase 1)|Reason not specified|1|||
143210238|NCT02421588|516315583|FG000|Overall Study|Symptomatic deterioration|13|||
143210239|NCT02421588|516315584|FG001|Overall Study|Symptomatic deterioration|19|||
143210240|NCT02421588|516315583|FG000|Overall Study|Treatment-related AE|10|||
143210241|NCT02421588|516315584|FG001|Overall Study|Treatment-related AE|14|||
143210242|NCT02421588|516315583|FG000|Overall Study|Withdrawal by Subject|14|||
143210243|NCT02421588|516315584|FG001|Overall Study|Withdrawal by Subject|16|||
143210244|NCT02421588|516315583|FG000|Overall Study|Not treated|2|||
143210245|NCT02421588|516315584|FG001|Overall Study|Not treated|8|||
143210246|NCT00615030|516315585|FG000|Period I|Administrative problem|0|||
143210247|NCT00615030|516315586|FG001|Period I|Administrative problem|0|||
143210248|NCT00615030|516315587|FG002|Period I|Administrative problem|0|||
143210249|NCT00615030|516315588|FG003|Period I|Administrative problem|0|||
143210250|NCT00615030|516315589|FG004|Period I|Administrative problem|1|||
143210251|NCT00615030|516315590|FG005|Period I|Administrative problem|0|||
143210252|NCT00615030|516315591|FG006|Period I|Administrative problem|0|||
143210253|NCT00615030|516315592|FG007|Period I|Administrative problem|0|||
143210254|NCT00615030|516315593|FG008|Period I|Administrative problem|0|||
143210255|NCT00615030|516315594|FG009|Period I|Administrative problem|0|||
143210256|NCT00615030|516315595|FG010|Period I|Administrative problem|0|||
143210257|NCT00615030|516315596|FG011|Period I|Administrative problem|0|||
143210258|NCT00615030|516315585|FG000|Period I|Protocol deviation|1|||
143210259|NCT00615030|516315586|FG001|Period I|Protocol deviation|0|||
143210260|NCT00615030|516315587|FG002|Period I|Protocol deviation|0|||
143210261|NCT00615030|516315588|FG003|Period I|Protocol deviation|0|||
143210262|NCT00615030|516315589|FG004|Period I|Protocol deviation|0|||
143210263|NCT00615030|516315590|FG005|Period I|Protocol deviation|0|||
143210264|NCT00615030|516315591|FG006|Period I|Protocol deviation|0|||
143210265|NCT00615030|516315592|FG007|Period I|Protocol deviation|0|||
143210266|NCT00615030|516315593|FG008|Period I|Protocol deviation|0|||
143210267|NCT00615030|516315594|FG009|Period I|Protocol deviation|0|||
143210268|NCT00615030|516315595|FG010|Period I|Protocol deviation|0|||
143210269|NCT00615030|516315596|FG011|Period I|Protocol deviation|0|||
143210270|NCT00615030|516315585|FG000|Period I|Subject withdrew consent|0|||
143210271|NCT00615030|516315586|FG001|Period I|Subject withdrew consent|0|||
143210272|NCT00615030|516315587|FG002|Period I|Subject withdrew consent|0|||
143210273|NCT00615030|516315588|FG003|Period I|Subject withdrew consent|0|||
143210274|NCT00615030|516315589|FG004|Period I|Subject withdrew consent|0|||
143210275|NCT00615030|516315590|FG005|Period I|Subject withdrew consent|0|||
143210276|NCT00615030|516315591|FG006|Period I|Subject withdrew consent|0|||
143210277|NCT00615030|516315592|FG007|Period I|Subject withdrew consent|0|||
143210278|NCT00615030|516315593|FG008|Period I|Subject withdrew consent|1|||
143210279|NCT00615030|516315594|FG009|Period I|Subject withdrew consent|0|||
143210280|NCT00615030|516315595|FG010|Period I|Subject withdrew consent|1|||
143210281|NCT00615030|516315596|FG011|Period I|Subject withdrew consent|1|||
143210282|NCT00615030|516315585|FG000|Period I|Abnormal laboratory value(s)|0|||
143210283|NCT00615030|516315586|FG001|Period I|Abnormal laboratory value(s)|0|||
143210284|NCT00615030|516315587|FG002|Period I|Abnormal laboratory value(s)|0|||
143210285|NCT00615030|516315588|FG003|Period I|Abnormal laboratory value(s)|0|||
143210286|NCT00615030|516315589|FG004|Period I|Abnormal laboratory value(s)|0|||
143210287|NCT00615030|516315590|FG005|Period I|Abnormal laboratory value(s)|1|||
143210288|NCT00615030|516315591|FG006|Period I|Abnormal laboratory value(s)|0|||
143210289|NCT00615030|516315592|FG007|Period I|Abnormal laboratory value(s)|0|||
143210290|NCT00615030|516315593|FG008|Period I|Abnormal laboratory value(s)|0|||
143210291|NCT00615030|516315594|FG009|Period I|Abnormal laboratory value(s)|0|||
143210292|NCT00615030|516315595|FG010|Period I|Abnormal laboratory value(s)|0|||
143210293|NCT00615030|516315596|FG011|Period I|Abnormal laboratory value(s)|0|||
143210294|NCT00615030|516315585|FG000|Period II|Adverse Event|0|||
143210295|NCT00615030|516315586|FG001|Period II|Adverse Event|0|||
143210296|NCT00615030|516315587|FG002|Period II|Adverse Event|1|||
143210297|NCT00615030|516315588|FG003|Period II|Adverse Event|0|||
143210298|NCT00615030|516315589|FG004|Period II|Adverse Event|0|||
143210299|NCT00615030|516315590|FG005|Period II|Adverse Event|0|||
143210300|NCT00615030|516315591|FG006|Period II|Adverse Event|0|||
143264579|NCT00473746|516523651|FG002|Period 1 (Phase 1)|Reason not specified|0|||
143264580|NCT00473746|516523652|FG003|Period 1 (Phase 1)|Reason not specified|0|||
143264581|NCT00473746|516523653|FG004|Period 1 (Phase 1)|Reason not specified|0|||
143264582|NCT00473746|516523649|FG000|Period 2 (Phase 2)|Adverse Event|0|||
143264583|NCT00473746|516523650|FG001|Period 2 (Phase 2)|Adverse Event|0|||
143264584|NCT00473746|516523651|FG002|Period 2 (Phase 2)|Adverse Event|0|||
143264585|NCT00473746|516523652|FG003|Period 2 (Phase 2)|Adverse Event|0|||
143264586|NCT00473746|516523653|FG004|Period 2 (Phase 2)|Adverse Event|3|||
143264587|NCT00473746|516523649|FG000|Period 2 (Phase 2)|Death|0|||
143210301|NCT00615030|516315592|FG007|Period II|Adverse Event|0|||
143210302|NCT00615030|516315593|FG008|Period II|Adverse Event|1|||
143210303|NCT00615030|516315594|FG009|Period II|Adverse Event|0|||
143210304|NCT00615030|516315595|FG010|Period II|Adverse Event|0|||
143210305|NCT00615030|516315596|FG011|Period II|Adverse Event|0|||
143210306|NCT00615030|516315585|FG000|Period II|Subject withdrew consent|0|||
143210307|NCT00615030|516315586|FG001|Period II|Subject withdrew consent|0|||
143210308|NCT00615030|516315587|FG002|Period II|Subject withdrew consent|0|||
143210309|NCT00615030|516315588|FG003|Period II|Subject withdrew consent|1|||
143210310|NCT00615030|516315589|FG004|Period II|Subject withdrew consent|0|||
143210311|NCT00615030|516315590|FG005|Period II|Subject withdrew consent|0|||
143210312|NCT00615030|516315591|FG006|Period II|Subject withdrew consent|1|||
143210313|NCT00615030|516315592|FG007|Period II|Subject withdrew consent|0|||
143210314|NCT00615030|516315593|FG008|Period II|Subject withdrew consent|0|||
143264588|NCT00473746|516523650|FG001|Period 2 (Phase 2)|Death|0|||
143210315|NCT00615030|516315594|FG009|Period II|Subject withdrew consent|0|||
143210316|NCT00615030|516315595|FG010|Period II|Subject withdrew consent|0|||
143210317|NCT00615030|516315596|FG011|Period II|Subject withdrew consent|0|||
143210318|NCT00615030|516315585|FG000|Period III|Administrative problems|1|||
143210319|NCT00615030|516315586|FG001|Period III|Administrative problems|0|||
143210320|NCT00615030|516315587|FG002|Period III|Administrative problems|0|||
143210321|NCT00615030|516315588|FG003|Period III|Administrative problems|1|||
143210322|NCT00615030|516315589|FG004|Period III|Administrative problems|0|||
143210323|NCT00615030|516315590|FG005|Period III|Administrative problems|0|||
143210324|NCT00615030|516315591|FG006|Period III|Administrative problems|0|||
143210325|NCT00615030|516315592|FG007|Period III|Administrative problems|0|||
143210326|NCT00615030|516315593|FG008|Period III|Administrative problems|0|||
143210327|NCT00615030|516315594|FG009|Period III|Administrative problems|0|||
143210328|NCT00615030|516315595|FG010|Period III|Administrative problems|0|||
143210329|NCT00615030|516315596|FG011|Period III|Administrative problems|0|||
143210330|NCT01953913|516315597|FG000|Overall Study|Disease Progression|349|||
143210331|NCT01953913|516315597|FG000|Overall Study|Worsening of underlying cancer|22|||
143210332|NCT01953913|516315597|FG000|Overall Study|Adverse Event|20|||
143210333|NCT01953913|516315597|FG000|Overall Study|Protocol Violation|6|||
143210334|NCT01953913|516315597|FG000|Overall Study|Lost to Follow-up|4|||
143210335|NCT01953913|516315597|FG000|Overall Study|Withdrawal by Subject|32|||
143210336|NCT01953913|516315597|FG000|Overall Study|Other than listed|108|||
143210337|NCT01953913|516315597|FG000|Overall Study|Not Treated|1|||
143210338|NCT05026853|516315598|FG000|Overall Study|Cancelled appointment|1|||
143210339|NCT05026853|516315599|FG001|Overall Study|Cancelled appointment|0|||
143210340|NCT05026853|516315598|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
143210341|NCT05026853|516315599|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
143210342|NCT05026853|516315598|FG000|Overall Study|Did not complete 12-week survey|16|||
143210343|NCT05026853|516315599|FG001|Overall Study|Did not complete 12-week survey|16|||
143210344|NCT03836677|516315600|FG000|Period 1|Adverse Event|0|||
143210345|NCT03836677|516315601|FG001|Period 1|Adverse Event|1|||
143210346|NCT03836677|516315600|FG000|Period 2|Severe non-compliance to protocol|1|||
143210347|NCT03836677|516315601|FG001|Period 2|Severe non-compliance to protocol|0|||
143210348|NCT02895945|516315602|FG000|Overall Study|Physician Decision|2|||
143210349|NCT02895945|516315603|FG001|Overall Study|Physician Decision|1|||
143210350|NCT01732913|516315604|FG000|Overall Study|Study Terminated by Sponsor|105|||
143264589|NCT00473746|516523651|FG002|Period 2 (Phase 2)|Death|0|||
143264590|NCT00473746|516523652|FG003|Period 2 (Phase 2)|Death|0|||
143264591|NCT00473746|516523653|FG004|Period 2 (Phase 2)|Death|1|||
143264592|NCT00473746|516523649|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
143264593|NCT00473746|516523650|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
143210351|NCT01732913|516315605|FG001|Overall Study|Study Terminated by Sponsor|55|||
143210352|NCT01732913|516315604|FG000|Overall Study|Withdrawal by Subject|27|||
143210353|NCT01732913|516315605|FG001|Overall Study|Withdrawal by Subject|4|||
143264594|NCT00473746|516523651|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
143210354|NCT01732913|516315604|FG000|Overall Study|Physician Decision|14|||
143210355|NCT01732913|516315605|FG001|Overall Study|Physician Decision|7|||
143210356|NCT01732913|516315604|FG000|Overall Study|Other|7|||
143210357|NCT01732913|516315605|FG001|Overall Study|Other|1|||
143210358|NCT01732913|516315604|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
143210359|NCT01732913|516315605|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
143210360|NCT03233438|516315610|FG000|Overall Study|Lost to Follow-up|4|||
143210361|NCT03233438|516315611|FG001|Overall Study|Lost to Follow-up|9|||
143210362|NCT03233438|516315610|FG000|Overall Study|Withdrawal by Subject|2|||
143210363|NCT03233438|516315611|FG001|Overall Study|Withdrawal by Subject|1|||
143210364|NCT03233438|516315610|FG000|Overall Study|No recording of dalbavancin|0|||
143210365|NCT03233438|516315611|FG001|Overall Study|No recording of dalbavancin|1|||
143210366|NCT03429543|516315612|FG000|Overall Study|Adverse Event|1|||
143210367|NCT03429543|516315613|FG001|Overall Study|Adverse Event|1|||
143210368|NCT03429543|516315614|FG002|Overall Study|Adverse Event|0|||
143210369|NCT03429543|516315615|FG003|Overall Study|Adverse Event|0|||
143210370|NCT03429543|516315616|FG004|Overall Study|Adverse Event|0|||
143210371|NCT03429543|516315617|FG005|Overall Study|Adverse Event|2|||
143210372|NCT03429543|516315618|FG006|Overall Study|Adverse Event|0|||
143210373|NCT03429543|516315612|FG000|Overall Study|Lost to Follow-up|1|||
143210374|NCT03429543|516315613|FG001|Overall Study|Lost to Follow-up|0|||
143210375|NCT03429543|516315614|FG002|Overall Study|Lost to Follow-up|0|||
143210376|NCT03429543|516315615|FG003|Overall Study|Lost to Follow-up|0|||
143210377|NCT03429543|516315616|FG004|Overall Study|Lost to Follow-up|1|||
143210378|NCT03429543|516315617|FG005|Overall Study|Lost to Follow-up|0|||
143210379|NCT03429543|516315618|FG006|Overall Study|Lost to Follow-up|0|||
143210380|NCT03429543|516315612|FG000|Overall Study|Withdrawal by Subject|5|||
143210381|NCT03429543|516315613|FG001|Overall Study|Withdrawal by Subject|0|||
143210382|NCT03429543|516315614|FG002|Overall Study|Withdrawal by Subject|1|||
143210383|NCT03429543|516315615|FG003|Overall Study|Withdrawal by Subject|2|||
143210384|NCT03429543|516315616|FG004|Overall Study|Withdrawal by Subject|6|||
143210385|NCT03429543|516315617|FG005|Overall Study|Withdrawal by Subject|3|||
143210386|NCT03429543|516315618|FG006|Overall Study|Withdrawal by Subject|1|||
143210387|NCT03429543|516315612|FG000|Overall Study|Other reason than listed|0|||
143210388|NCT03429543|516315613|FG001|Overall Study|Other reason than listed|1|||
143210389|NCT03429543|516315614|FG002|Overall Study|Other reason than listed|0|||
143210390|NCT03429543|516315615|FG003|Overall Study|Other reason than listed|0|||
143264595|NCT00473746|516523652|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
143264596|NCT00473746|516523653|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
143210391|NCT03429543|516315616|FG004|Overall Study|Other reason than listed|4|||
143210392|NCT03429543|516315617|FG005|Overall Study|Other reason than listed|4|||
143210393|NCT03429543|516315618|FG006|Overall Study|Other reason than listed|0|||
143210394|NCT03429543|516315612|FG000|Overall Study|Not treated|0|||
143210395|NCT03429543|516315613|FG001|Overall Study|Not treated|0|||
143210396|NCT03429543|516315614|FG002|Overall Study|Not treated|0|||
143210397|NCT03429543|516315615|FG003|Overall Study|Not treated|0|||
143210398|NCT03429543|516315616|FG004|Overall Study|Not treated|1|||
143210399|NCT03429543|516315617|FG005|Overall Study|Not treated|0|||
143210400|NCT03429543|516315618|FG006|Overall Study|Not treated|0|||
143210401|NCT01818492|516315619|FG000|Overall Study|Adverse Event|2|||
143210402|NCT01818492|516315619|FG000|Overall Study|Death|3|||
143210403|NCT01818492|516315619|FG000|Overall Study|Withdrawal by Subject|1|||
143210404|NCT01818492|516315619|FG000|Overall Study|Additional therapy when not allowed PP|4|||
143210405|NCT02345330|516315620|FG000|Overall Study|Death|1|||
143210406|NCT02345330|516315620|FG000|Overall Study|Progressive Disease|2|||
143210407|NCT00079677|516315621|FG000|Overall Study|Adverse Event|5|||
143210408|NCT00079677|516315622|FG001|Overall Study|Adverse Event|6|||
143210409|NCT00079677|516315621|FG000|Overall Study|Lack of Efficacy|1|||
143210410|NCT00079677|516315622|FG001|Overall Study|Lack of Efficacy|0|||
143210411|NCT00079677|516315621|FG000|Overall Study|Lost to Follow-up|2|||
143210412|NCT00079677|516315622|FG001|Overall Study|Lost to Follow-up|2|||
143210413|NCT00079677|516315621|FG000|Overall Study|Physician Decision|3|||
143210414|NCT00079677|516315622|FG001|Overall Study|Physician Decision|0|||
143210415|NCT00079677|516315621|FG000|Overall Study|Protocol Violation|2|||
143210416|NCT00079677|516315622|FG001|Overall Study|Protocol Violation|3|||
143210417|NCT00079677|516315621|FG000|Overall Study|Withdrawal by Subject|5|||
143210418|NCT00079677|516315622|FG001|Overall Study|Withdrawal by Subject|3|||
143210419|NCT00079677|516315621|FG000|Overall Study|Miscellaneous|2|||
143210420|NCT00079677|516315622|FG001|Overall Study|Miscellaneous|0|||
143210421|NCT00989781|516315628|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
143210422|NCT00989781|516315629|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
143210423|NCT00409344|516315632|FG000|Overall Study|no enrollment|0|||
143210424|NCT00409344|516315633|FG001|Overall Study|no enrollment|0|||
143370746|NCT01235949|516901096|FG010|Booster Phase|Withdrawal by Subject|1|||
143370747|NCT01235949|516901097|FG011|Booster Phase|Withdrawal by Subject|1|||
143370748|NCT01235949|516901098|FG012|Booster Phase|Withdrawal by Subject|2|||
143370749|NCT01235949|516901099|FG013|Booster Phase|Withdrawal by Subject|0|||
143370750|NCT01235949|516901100|FG014|Booster Phase|Withdrawal by Subject|2|||
143370751|NCT01235949|516901101|FG015|Booster Phase|Withdrawal by Subject|0|||
143370752|NCT01235949|516901102|FG016|Booster Phase|Withdrawal by Subject|0|||
143370753|NCT01235949|516901103|FG017|Booster Phase|Withdrawal by Subject|0|||
143370754|NCT01235949|516901086|FG000|Booster Phase|Lost to Follow-up|0|||
143370755|NCT01235949|516901087|FG001|Booster Phase|Lost to Follow-up|0|||
143370756|NCT01235949|516901088|FG002|Booster Phase|Lost to Follow-up|0|||
143370757|NCT01235949|516901089|FG003|Booster Phase|Lost to Follow-up|0|||
143210425|NCT05096312|516315634|FG000|Overall Study|Lost to Follow-up|2|||
143370758|NCT01235949|516901090|FG004|Booster Phase|Lost to Follow-up|0|||
143370759|NCT01235949|516901091|FG005|Booster Phase|Lost to Follow-up|0|||
143370760|NCT01235949|516901092|FG006|Booster Phase|Lost to Follow-up|0|||
143370761|NCT01235949|516901093|FG007|Booster Phase|Lost to Follow-up|0|||
143370762|NCT01235949|516901094|FG008|Booster Phase|Lost to Follow-up|1|||
143370763|NCT01235949|516901095|FG009|Booster Phase|Lost to Follow-up|1|||
143370764|NCT01235949|516901096|FG010|Booster Phase|Lost to Follow-up|1|||
143370765|NCT01235949|516901097|FG011|Booster Phase|Lost to Follow-up|1|||
143370766|NCT01235949|516901098|FG012|Booster Phase|Lost to Follow-up|0|||
143370767|NCT01235949|516901099|FG013|Booster Phase|Lost to Follow-up|0|||
143370768|NCT01235949|516901100|FG014|Booster Phase|Lost to Follow-up|0|||
143370769|NCT01235949|516901101|FG015|Booster Phase|Lost to Follow-up|0|||
143370770|NCT01235949|516901102|FG016|Booster Phase|Lost to Follow-up|0|||
143370771|NCT01235949|516901103|FG017|Booster Phase|Lost to Follow-up|1|||
143370772|NCT00754936|516901104|FG000|Overall Study|Lost to Follow-up|3|||
143370773|NCT00754936|516901104|FG000|Overall Study|Physician Decision|1|||
143370774|NCT00754936|516901104|FG000|Overall Study|Withdrawal by Subject|2|||
143370775|NCT00754936|516901104|FG000|Overall Study|Side Effects|3|||
143370776|NCT00754936|516901104|FG000|Overall Study|Inter-current medical events|3|||
143370777|NCT00436644|516901105|FG000|Overall Study|Adverse Event|2|||
143370778|NCT00436644|516901105|FG000|Overall Study|Death|1|||
143370779|NCT00619645|516901106|FG000|Overall Study|Adverse Event|1|||
143370780|NCT04364269|516901107|FG000|Overall Study|Adverse Event|1|||
143210426|NCT05096312|516315635|FG001|Overall Study|Lost to Follow-up|4|||
143210427|NCT05096312|516315634|FG000|Overall Study|Adverse Event|1|||
143210428|NCT05096312|516315635|FG001|Overall Study|Adverse Event|0|||
143210429|NCT00576576|516315636|FG000|Overall Study|Lost to Follow-up|6|||
143210430|NCT00576576|516315636|FG000|Overall Study|Protocol Violation|1|||
143210431|NCT03135210|516315637|FG000|Overall Study|Death|0|||
143210432|NCT03135210|516315638|FG001|Overall Study|Death|1|||
143210433|NCT04566692|516315639|FG000|Overall Study|Adverse Event|2|||
143210434|NCT04566692|516315640|FG001|Overall Study|Adverse Event|0|||
143210435|NCT04566692|516315639|FG000|Overall Study|Withdrawal by Subject|1|||
143370781|NCT04364269|516901108|FG001|Overall Study|Adverse Event|0|||
143370782|NCT04364269|516901109|FG002|Overall Study|Adverse Event|0|||
143370783|NCT04364269|516901107|FG000|Overall Study|Withdrawal by Subject|0|||
143370784|NCT04364269|516901108|FG001|Overall Study|Withdrawal by Subject|1|||
143210436|NCT04566692|516315640|FG001|Overall Study|Withdrawal by Subject|1|||
143210437|NCT03157037|516315644|FG000|Overall Study|Death|1|||
143210438|NCT02102399|516315645|FG000|Overall Study|Withdrawal by Subject|6|||
143210439|NCT02102399|516315646|FG001|Overall Study|Withdrawal by Subject|4|||
143210440|NCT04349033|516315647|FG000|Overall Study|Lost to Follow-up|3|||
143210441|NCT04349033|516315648|FG001|Overall Study|Lost to Follow-up|1|||
143210442|NCT04349033|516315649|FG002|Overall Study|Lost to Follow-up|1|||
143210443|NCT01887353|516315658|FG000|Overall Study|Study stopped early|4|||
143210444|NCT01887353|516315659|FG001|Overall Study|Study stopped early|3|||
143210445|NCT03908970|516315661|FG000|Overall Study|Adverse Event|7|||
143210446|NCT03908970|516315662|FG001|Overall Study|Adverse Event|21|||
143210447|NCT03908970|516315661|FG000|Overall Study|Physician Decision|1|||
143210448|NCT03908970|516315662|FG001|Overall Study|Physician Decision|4|||
143210449|NCT03908970|516315661|FG000|Overall Study|Withdrawal by Subject|9|||
143210450|NCT03908970|516315662|FG001|Overall Study|Withdrawal by Subject|22|||
143210451|NCT04407234|516315663|FG000|Overall Study|Adverse Event|3|||
143210452|NCT04407234|516315664|FG001|Overall Study|Adverse Event|3|||
143210453|NCT03626545|516317396|FG000|Overall Study|Progressive disease|3|||
143210454|NCT03626545|516317397|FG001|Overall Study|Progressive disease|82|||
143210455|NCT03626545|516317398|FG002|Overall Study|Progressive disease|85|||
143264597|NCT00473746|516523649|FG000|Period 2 (Phase 2)|Reason not specified|0|||
143264598|NCT00473746|516523650|FG001|Period 2 (Phase 2)|Reason not specified|0|||
143264599|NCT00473746|516523651|FG002|Period 2 (Phase 2)|Reason not specified|0|||
143264600|NCT00473746|516523652|FG003|Period 2 (Phase 2)|Reason not specified|0|||
143264601|NCT00473746|516523653|FG004|Period 2 (Phase 2)|Reason not specified|3|||
143264602|NCT02280473|516523654|FG000|Overall Study|Adverse Event|1|||
143264603|NCT02280473|516523655|FG001|Overall Study|Adverse Event|1|||
143264604|NCT02280473|516523654|FG000|Overall Study|Lack of Efficacy|0|||
143264605|NCT02280473|516523655|FG001|Overall Study|Lack of Efficacy|1|||
143210456|NCT03626545|516317396|FG000|Overall Study|Adverse Event|3|||
143210457|NCT03626545|516317397|FG001|Overall Study|Adverse Event|13|||
143210458|NCT03626545|516317398|FG002|Overall Study|Adverse Event|10|||
143210459|NCT03626545|516317396|FG000|Overall Study|Physician Decision|1|||
143210460|NCT03626545|516317397|FG001|Overall Study|Physician Decision|18|||
143210461|NCT03626545|516317398|FG002|Overall Study|Physician Decision|14|||
143210462|NCT03626545|516317396|FG000|Overall Study|Subject Decision|0|||
143264606|NCT02280473|516523654|FG000|Overall Study|Lost to Follow-up|0|||
143264607|NCT02280473|516523655|FG001|Overall Study|Lost to Follow-up|1|||
143264608|NCT01484054|516523660|FG000|Period 1|Withdrawal by Subject|0|||
143210463|NCT03626545|516317397|FG001|Overall Study|Subject Decision|5|||
143210464|NCT03626545|516317398|FG002|Overall Study|Subject Decision|5|||
143210465|NCT03626545|516317396|FG000|Overall Study|Death|1|||
143210466|NCT03626545|516317397|FG001|Overall Study|Death|1|||
143210467|NCT03626545|516317398|FG002|Overall Study|Death|1|||
143210468|NCT03626545|516317396|FG000|Overall Study|Protocol Deviation|0|||
143210469|NCT03626545|516317397|FG001|Overall Study|Protocol Deviation|1|||
143210470|NCT03626545|516317398|FG002|Overall Study|Protocol Deviation|1|||
143210471|NCT03626545|516317396|FG000|Overall Study|Guardian Decision|0|||
143210472|NCT03626545|516317397|FG001|Overall Study|Guardian Decision|0|||
143210473|NCT03626545|516317398|FG002|Overall Study|Guardian Decision|1|||
143210474|NCT00679172|516317399|FG000|Overall Study|Non-compliance|1|||
143210475|NCT00679172|516317400|FG001|Overall Study|Non-compliance|1|||
143210476|NCT00679172|516317401|FG002|Overall Study|Non-compliance|0|||
143210477|NCT00679172|516317402|FG003|Overall Study|Non-compliance|1|||
143210478|NCT00679172|516317403|FG004|Overall Study|Non-compliance|0|||
143210479|NCT00679172|516317399|FG000|Overall Study|Other not specified|0|||
143210480|NCT00679172|516317400|FG001|Overall Study|Other not specified|0|||
143210481|NCT00679172|516317401|FG002|Overall Study|Other not specified|1|||
143210482|NCT00679172|516317402|FG003|Overall Study|Other not specified|0|||
143210483|NCT00679172|516317403|FG004|Overall Study|Other not specified|0|||
143210484|NCT00793325|516317405|FG000|Overall Study|Protocol Violation|18|||
143210485|NCT00793325|516317405|FG000|Overall Study|Lost to Follow-up|1|||
143210486|NCT00434642|516317406|FG000|Blinded Treatment Phase|Adverse Event|12|||
143210487|NCT00434642|516317407|FG001|Blinded Treatment Phase|Adverse Event|58|||
143210488|NCT00434642|516317406|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
143210489|NCT00434642|516317407|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
143210490|NCT00434642|516317406|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
143210491|NCT00434642|516317407|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
143210492|NCT00434642|516317406|FG000|Blinded Treatment Phase|Physician Decision|19|||
143210493|NCT00434642|516317407|FG001|Blinded Treatment Phase|Physician Decision|27|||
143210494|NCT00434642|516317406|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
143210495|NCT00434642|516317407|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
143210496|NCT00434642|516317406|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
143210497|NCT00434642|516317407|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
143210498|NCT00434642|516317406|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
143210499|NCT00434642|516317407|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
143210500|NCT00434642|516317406|FG000|Open-label Treatment Phase|Adverse Event|0|||
143264609|NCT01484054|516523661|FG001|Period 1|Withdrawal by Subject|1|||
143210501|NCT00434642|516317407|FG001|Open-label Treatment Phase|Adverse Event|5|||
143210502|NCT00434642|516317406|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
143210503|NCT00434642|516317407|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
143210504|NCT00753454|516317408|FG000|Overall Study|Adverse Event|4|||
143210505|NCT00753454|516317408|FG000|Overall Study|Lack of Efficacy|1|||
143210506|NCT00753454|516317408|FG000|Overall Study|Lost to Follow-up|3|||
143210507|NCT00753454|516317408|FG000|Overall Study|Withdrawal by Subject|5|||
143210508|NCT00753454|516317408|FG000|Overall Study|Investigator Decision|1|||
143210509|NCT05249569|516317409|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
143210510|NCT03927144|516317410|FG000|Core Phase|Adverse Event|9|||
143210511|NCT03927144|516317411|FG001|Core Phase|Adverse Event|5|||
143210512|NCT03927144|516317410|FG000|Core Phase|Lost to Follow-up|3|||
143210513|NCT03927144|516317411|FG001|Core Phase|Lost to Follow-up|2|||
143210514|NCT03927144|516317410|FG000|Core Phase|New Therapy for Study Indication|0|||
143210515|NCT03927144|516317411|FG001|Core Phase|New Therapy for Study Indication|1|||
143210516|NCT03927144|516317410|FG000|Core Phase|No Longer Clinically Benefiting|4|||
143210517|NCT03927144|516317411|FG001|Core Phase|No Longer Clinically Benefiting|4|||
143210518|NCT03927144|516317410|FG000|Core Phase|Physician Decision|2|||
143210519|NCT03927144|516317411|FG001|Core Phase|Physician Decision|8|||
143210520|NCT03927144|516317410|FG000|Core Phase|Protocol Violation|2|||
143210521|NCT03927144|516317411|FG001|Core Phase|Protocol Violation|2|||
143210522|NCT03927144|516317410|FG000|Core Phase|Withdrawal by Subject|16|||
143210523|NCT03927144|516317411|FG001|Core Phase|Withdrawal by Subject|40|||
143210524|NCT03927144|516317410|FG000|Extension Phase|Adverse Event|2|||
143210525|NCT03927144|516317411|FG001|Extension Phase|Adverse Event|1|||
143210526|NCT03927144|516317410|FG000|Extension Phase|No longer clinically benefiting|4|||
143210527|NCT03927144|516317411|FG001|Extension Phase|No longer clinically benefiting|5|||
143210528|NCT03927144|516317410|FG000|Extension Phase|Pregnancy|1|||
143370785|NCT04364269|516901109|FG002|Overall Study|Withdrawal by Subject|0|||
143370786|NCT01157182|516901110|FG000|Washout of 28 Days|Adverse Event|2|||
143210529|NCT03927144|516317411|FG001|Extension Phase|Pregnancy|0|||
143210530|NCT03927144|516317410|FG000|Extension Phase|Protocol Violation|0|||
143210531|NCT03927144|516317411|FG001|Extension Phase|Protocol Violation|1|||
143210532|NCT03927144|516317410|FG000|Extension Phase|Withdrawal by Subject|8|||
143210533|NCT03927144|516317411|FG001|Extension Phase|Withdrawal by Subject|3|||
143210534|NCT03002311|516317416|FG000|Overall Study|Lost to Follow-up|13|||
143210535|NCT03002311|516317417|FG001|Overall Study|Lost to Follow-up|26|||
143210536|NCT03002311|516317416|FG000|Overall Study|Referral provider called to schedule app|3|||
143210537|NCT03002311|516317417|FG001|Overall Study|Referral provider called to schedule app|3|||
143210538|NCT03002311|516317416|FG000|Overall Study|Physician Decision|3|||
143210539|NCT03002311|516317417|FG001|Overall Study|Physician Decision|1|||
143210540|NCT00308074|516317418|FG000|Overall Study|Withdrawal by Subject|1|||
143210541|NCT01329939|516317422|FG000|Overall Study|Lost to Follow-up|3|||
143210542|NCT01329939|516317423|FG001|Overall Study|Lost to Follow-up|0|||
143210543|NCT01329939|516317424|FG002|Overall Study|Lost to Follow-up|1|||
143210544|NCT01329939|516317425|FG003|Overall Study|Lost to Follow-up|2|||
143210545|NCT01329939|516317422|FG000|Overall Study|Withdrawal by Subject|0|||
143210546|NCT01329939|516317423|FG001|Overall Study|Withdrawal by Subject|1|||
143210547|NCT01329939|516317424|FG002|Overall Study|Withdrawal by Subject|0|||
143210548|NCT01329939|516317425|FG003|Overall Study|Withdrawal by Subject|0|||
143210549|NCT01329939|516317422|FG000|Overall Study|Adverse Event|0|||
143370787|NCT01157182|516901111|FG001|Washout of 28 Days|Adverse Event|0|||
143370788|NCT01490580|516901112|FG000|Overall Study|Parents withdrew consent|0|||
143210550|NCT01329939|516317423|FG001|Overall Study|Adverse Event|0|||
143210551|NCT01329939|516317424|FG002|Overall Study|Adverse Event|0|||
143210552|NCT01329939|516317425|FG003|Overall Study|Adverse Event|3|||
143210553|NCT03722524|516317426|FG000|Overall Study|Protocol Violation|86|||
143210554|NCT03722524|516317426|FG000|Overall Study|Adverse Event|7|||
143210555|NCT03722524|516317426|FG000|Overall Study|Lost to Follow-up|1|||
143210556|NCT03722524|516317426|FG000|Overall Study|Reason is not stated|1|||
143210557|NCT03722524|516317426|FG000|Overall Study|Physician Decision|1|||
143210558|NCT03722524|516317426|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
143264610|NCT04223232|516523662|FG000|Overall Study|Withdrawal by Subject|1|||
143264611|NCT05281601|516523669|FG000|Overall Study|Physician Decision|2|||
143264612|NCT05281601|516523670|FG001|Overall Study|Physician Decision|0|||
143264613|NCT05281601|516523669|FG000|Overall Study|Lost to Follow-up|2|||
143210559|NCT04071158|516317427|FG000|Overall Study|Lost to Follow-up|1|||
143210560|NCT04071158|516317428|FG001|Overall Study|Lost to Follow-up|2|||
143264614|NCT05281601|516523670|FG001|Overall Study|Lost to Follow-up|0|||
143264615|NCT05281601|516523669|FG000|Overall Study|Death|1|||
143264616|NCT05281601|516523670|FG001|Overall Study|Death|0|||
143264617|NCT05281601|516523669|FG000|Overall Study|Withdrawal by parent/guardian|2|||
143264618|NCT05281601|516523670|FG001|Overall Study|Withdrawal by parent/guardian|1|||
143264619|NCT00901927|516523671|FG000|Overall Study|Lack of Efficacy|1|||
143264620|NCT00901927|516523671|FG000|Overall Study|Protocol Violation|3|||
143264621|NCT00901927|516523671|FG000|Overall Study|Withdrawal by Subject|2|||
143264622|NCT00586846|516523672|FG000|Overall Study|Physician Decision|1|||
143264623|NCT00586846|516523672|FG000|Overall Study|Death|1|||
143264624|NCT00586846|516523672|FG000|Overall Study|Evaluable for Toxicity Only|4|||
143210561|NCT04071158|516317429|FG002|Overall Study|Lost to Follow-up|3|||
143264625|NCT05298306|516523676|FG000|Overall Study|Physician Decision|0|||
143264626|NCT05298306|516523677|FG001|Overall Study|Physician Decision|0|||
143210562|NCT04071158|516317430|FG003|Overall Study|Lost to Follow-up|3|||
143264627|NCT05298306|516523678|FG002|Overall Study|Physician Decision|0|||
143264628|NCT05298306|516523679|FG003|Overall Study|Physician Decision|1|||
143264629|NCT05298306|516523680|FG004|Overall Study|Physician Decision|0|||
143264630|NCT05298306|516523681|FG005|Overall Study|Physician Decision|0|||
143264631|NCT00191646|516523689|FG000|Overall Study|Toxicity|26|||
143264632|NCT00191646|516523690|FG001|Overall Study|Toxicity|37|||
143264633|NCT00191646|516523689|FG000|Overall Study|Disease Progression|5|||
143264634|NCT00191646|516523690|FG001|Overall Study|Disease Progression|6|||
143264635|NCT00191646|516523689|FG000|Overall Study|Physician Decision|20|||
143264636|NCT00191646|516523690|FG001|Overall Study|Physician Decision|11|||
143264637|NCT00191646|516523689|FG000|Overall Study|Withdrawal by Subject|58|||
143264638|NCT00191646|516523690|FG001|Overall Study|Withdrawal by Subject|39|||
143210563|NCT04071158|516317431|FG004|Overall Study|Lost to Follow-up|5|||
143210564|NCT04071158|516317427|FG000|Overall Study|Randomized but not treated|2|||
143210565|NCT04071158|516317428|FG001|Overall Study|Randomized but not treated|2|||
143210566|NCT04071158|516317429|FG002|Overall Study|Randomized but not treated|0|||
143210567|NCT04071158|516317430|FG003|Overall Study|Randomized but not treated|0|||
143210568|NCT04071158|516317431|FG004|Overall Study|Randomized but not treated|0|||
143210569|NCT01178099|516317432|FG000|Overall Study|Physician Decision|0|||
143210570|NCT01178099|516317433|FG001|Overall Study|Physician Decision|1|||
143210571|NCT02473367|516317434|FG000|Wait 1|Withdrawal by Subject|1|||
143210572|NCT02473367|516317434|FG000|Period 4|Lost to Follow-up|1|||
143210573|NCT04816721|516317435|FG000|Overall Study|Withdrawal by Subject|0|||
143210574|NCT04816721|516317436|FG001|Overall Study|Withdrawal by Subject|2|||
143210575|NCT04816721|516317437|FG002|Overall Study|Withdrawal by Subject|0|||
143210576|NCT04816721|516317438|FG003|Overall Study|Withdrawal by Subject|1|||
143210577|NCT04816721|516317439|FG004|Overall Study|Withdrawal by Subject|1|||
143210578|NCT04816721|516317440|FG005|Overall Study|Withdrawal by Subject|0|||
143210579|NCT04816721|516317441|FG006|Overall Study|Withdrawal by Subject|0|||
143210580|NCT04816721|516317442|FG007|Overall Study|Withdrawal by Subject|0|||
143210581|NCT04816721|516317435|FG000|Overall Study|Miscellaneous|0|||
143210582|NCT04816721|516317436|FG001|Overall Study|Miscellaneous|0|||
143210583|NCT04816721|516317437|FG002|Overall Study|Miscellaneous|0|||
143210584|NCT04816721|516317438|FG003|Overall Study|Miscellaneous|0|||
143210585|NCT04816721|516317439|FG004|Overall Study|Miscellaneous|0|||
143210586|NCT04816721|516317440|FG005|Overall Study|Miscellaneous|1|||
143210587|NCT04816721|516317441|FG006|Overall Study|Miscellaneous|0|||
143210588|NCT04816721|516317442|FG007|Overall Study|Miscellaneous|0|||
143210589|NCT04816721|516317435|FG000|Overall Study|Lost to Follow-up|0|||
143210590|NCT04816721|516317436|FG001|Overall Study|Lost to Follow-up|0|||
143210591|NCT04816721|516317437|FG002|Overall Study|Lost to Follow-up|0|||
143210592|NCT04816721|516317438|FG003|Overall Study|Lost to Follow-up|1|||
143210593|NCT04816721|516317439|FG004|Overall Study|Lost to Follow-up|0|||
143210594|NCT04816721|516317440|FG005|Overall Study|Lost to Follow-up|0|||
143210595|NCT04816721|516317441|FG006|Overall Study|Lost to Follow-up|0|||
143210596|NCT04816721|516317442|FG007|Overall Study|Lost to Follow-up|0|||
143210597|NCT01286740|516317447|FG000|Overall Study|Enrolled but not treated|1|||
143210598|NCT01286740|516317447|FG000|Overall Study|Protocol Violation|1|||
143210599|NCT03266172|516317448|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
143210600|NCT03266172|516317449|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
143210601|NCT03266172|516317450|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
143210602|NCT03266172|516317448|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
143264639|NCT00191646|516523689|FG000|Overall Study|Protocol Violation|5|||
143264640|NCT00191646|516523690|FG001|Overall Study|Protocol Violation|7|||
143264641|NCT00191646|516523689|FG000|Overall Study|Death|6|||
143264642|NCT00191646|516523690|FG001|Overall Study|Death|8|||
143264643|NCT00191646|516523689|FG000|Overall Study|Other|33|||
143264644|NCT00191646|516523690|FG001|Overall Study|Other|34|||
143210603|NCT03266172|516317449|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
143210604|NCT03266172|516317450|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
143210605|NCT03266172|516317448|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
143210606|NCT03266172|516317449|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
143264645|NCT00191646|516523689|FG000|Overall Study|Missing Data|18|||
143210607|NCT03266172|516317450|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
143210608|NCT03266172|516317448|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
143264646|NCT00191646|516523690|FG001|Overall Study|Missing Data|11|||
143264647|NCT03194490|516523696|FG000|Overall Study|Lost to Follow-up|1|||
143210609|NCT03266172|516317449|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
143210610|NCT03266172|516317450|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
143210611|NCT03266172|516317448|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
143210612|NCT03266172|516317449|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
143210613|NCT03266172|516317450|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
143210614|NCT03266172|516317448|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
143210615|NCT03266172|516317449|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
143210616|NCT03266172|516317450|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
143210617|NCT01423916|516317452|FG000|Overall Study|Adverse Event|5|||
143210618|NCT01423916|516317453|FG001|Overall Study|Adverse Event|9|||
143210619|NCT01423916|516317454|FG002|Overall Study|Adverse Event|2|||
143210620|NCT01423916|516317452|FG000|Overall Study|Met Withdrawal Criteria|1|||
143210621|NCT01423916|516317453|FG001|Overall Study|Met Withdrawal Criteria|1|||
143210622|NCT01423916|516317454|FG002|Overall Study|Met Withdrawal Criteria|1|||
143210623|NCT01423916|516317452|FG000|Overall Study|Physician Decision|1|||
143210624|NCT01423916|516317453|FG001|Overall Study|Physician Decision|0|||
143210625|NCT01423916|516317454|FG002|Overall Study|Physician Decision|1|||
143210626|NCT01423916|516317452|FG000|Overall Study|Withdrawal by Subject|3|||
143210627|NCT01423916|516317453|FG001|Overall Study|Withdrawal by Subject|10|||
143210628|NCT01423916|516317454|FG002|Overall Study|Withdrawal by Subject|3|||
143210629|NCT01423916|516317452|FG000|Overall Study|Protocol Deviation|1|||
143210630|NCT01423916|516317453|FG001|Overall Study|Protocol Deviation|0|||
143210631|NCT01423916|516317454|FG002|Overall Study|Protocol Deviation|0|||
143210632|NCT00300365|516317455|FG000|Overall Study|Lost to Follow-up|1|||
143210633|NCT00300365|516317456|FG001|Overall Study|Lost to Follow-up|0|||
143210634|NCT00300365|516317455|FG000|Overall Study|Physician Decision|2|||
143210635|NCT00300365|516317456|FG001|Overall Study|Physician Decision|0|||
143210636|NCT00300365|516317455|FG000|Overall Study|Withdrawal by Subject|1|||
143210637|NCT00300365|516317456|FG001|Overall Study|Withdrawal by Subject|0|||
143210638|NCT00300365|516317455|FG000|Overall Study|Adverse Event|0|||
143210639|NCT00300365|516317456|FG001|Overall Study|Adverse Event|2|||
143210640|NCT01422824|516317461|FG000|Overall Study|Case record form not evaluated|1|||
143210641|NCT01422824|516317461|FG000|Overall Study|Lost to Follow-up|37|||
143210642|NCT00902174|516317462|FG000|Overall Study|Adverse Event|27|||
143210643|NCT00902174|516317463|FG001|Overall Study|Adverse Event|7|||
143210644|NCT00902174|516317462|FG000|Overall Study|Lack of Efficacy|1|||
143210645|NCT00902174|516317463|FG001|Overall Study|Lack of Efficacy|5|||
143210646|NCT00902174|516317462|FG000|Overall Study|Death|2|||
143210647|NCT00902174|516317463|FG001|Overall Study|Death|2|||
143210648|NCT00902174|516317462|FG000|Overall Study|Withdrawal by Subject|2|||
143210649|NCT00902174|516317463|FG001|Overall Study|Withdrawal by Subject|1|||
143210650|NCT00902174|516317462|FG000|Overall Study|Abnormal labs|1|||
143210651|NCT00902174|516317463|FG001|Overall Study|Abnormal labs|1|||
143210652|NCT00902174|516317462|FG000|Overall Study|Protocol Violation|1|||
143210653|NCT00902174|516317463|FG001|Overall Study|Protocol Violation|1|||
143210654|NCT00902174|516317462|FG000|Overall Study|Administration problem|0|||
143210655|NCT00902174|516317463|FG001|Overall Study|Administration problem|1|||
143210656|NCT00454584|516317464|FG000|Controlled Period|Adverse Event|5|||
143210657|NCT00454584|516317465|FG001|Controlled Period|Adverse Event|2|||
143210658|NCT00454584|516317466|FG002|Controlled Period|Adverse Event|1|||
143210659|NCT00454584|516317467|FG003|Controlled Period|Adverse Event|0|||
143210660|NCT00454584|516317468|FG004|Controlled Period|Adverse Event|0|||
143210661|NCT00454584|516317469|FG005|Controlled Period|Adverse Event|0|||
143210662|NCT00454584|516317464|FG000|Controlled Period|Lost to Follow-up|1|||
143210663|NCT00454584|516317465|FG001|Controlled Period|Lost to Follow-up|2|||
143210664|NCT00454584|516317466|FG002|Controlled Period|Lost to Follow-up|2|||
143210665|NCT00454584|516317467|FG003|Controlled Period|Lost to Follow-up|0|||
143210666|NCT00454584|516317468|FG004|Controlled Period|Lost to Follow-up|0|||
143210667|NCT00454584|516317469|FG005|Controlled Period|Lost to Follow-up|0|||
143210668|NCT00454584|516317464|FG000|Controlled Period|Other|5|||
143210669|NCT00454584|516317465|FG001|Controlled Period|Other|4|||
143210670|NCT00454584|516317466|FG002|Controlled Period|Other|2|||
143210671|NCT00454584|516317467|FG003|Controlled Period|Other|0|||
143210672|NCT00454584|516317468|FG004|Controlled Period|Other|0|||
143210673|NCT00454584|516317469|FG005|Controlled Period|Other|0|||
143210674|NCT00454584|516317464|FG000|After Controlled Period|Adverse Event|0|||
143210675|NCT00454584|516317465|FG001|After Controlled Period|Adverse Event|0|||
143210676|NCT00454584|516317466|FG002|After Controlled Period|Adverse Event|0|||
143210677|NCT00454584|516317467|FG003|After Controlled Period|Adverse Event|9|||
143210678|NCT00454584|516317468|FG004|After Controlled Period|Adverse Event|3|||
143210679|NCT00454584|516317469|FG005|After Controlled Period|Adverse Event|9|||
143210680|NCT00454584|516317464|FG000|After Controlled Period|Lack of Efficacy|0|||
143210681|NCT00454584|516317465|FG001|After Controlled Period|Lack of Efficacy|0|||
143210682|NCT00454584|516317466|FG002|After Controlled Period|Lack of Efficacy|0|||
143210683|NCT00454584|516317467|FG003|After Controlled Period|Lack of Efficacy|1|||
143210684|NCT00454584|516317468|FG004|After Controlled Period|Lack of Efficacy|0|||
143210685|NCT00454584|516317469|FG005|After Controlled Period|Lack of Efficacy|0|||
143210686|NCT00454584|516317464|FG000|After Controlled Period|Lost to Follow-up|0|||
143210687|NCT00454584|516317465|FG001|After Controlled Period|Lost to Follow-up|0|||
143210688|NCT00454584|516317466|FG002|After Controlled Period|Lost to Follow-up|0|||
143210689|NCT00454584|516317467|FG003|After Controlled Period|Lost to Follow-up|2|||
143210690|NCT00454584|516317468|FG004|After Controlled Period|Lost to Follow-up|4|||
143210691|NCT00454584|516317469|FG005|After Controlled Period|Lost to Follow-up|6|||
143210692|NCT00454584|516317464|FG000|After Controlled Period|Other|0|||
143210693|NCT00454584|516317465|FG001|After Controlled Period|Other|0|||
143210694|NCT00454584|516317466|FG002|After Controlled Period|Other|0|||
143210695|NCT00454584|516317467|FG003|After Controlled Period|Other|1|||
143210696|NCT00454584|516317468|FG004|After Controlled Period|Other|0|||
143210697|NCT00454584|516317469|FG005|After Controlled Period|Other|0|||
143210698|NCT00454584|516317464|FG000|After Controlled Period|Other|0|||
143210699|NCT00454584|516317465|FG001|After Controlled Period|Other|0|||
143210700|NCT00454584|516317466|FG002|After Controlled Period|Other|0|||
143210701|NCT00454584|516317467|FG003|After Controlled Period|Other|13|||
143210702|NCT00454584|516317468|FG004|After Controlled Period|Other|5|||
143210703|NCT00454584|516317469|FG005|After Controlled Period|Other|17|||
143210704|NCT02421601|516317470|FG000|Overall Study|Adverse Event|4|||
143210705|NCT02421601|516317470|FG000|Overall Study|Lack of Efficacy|5|||
143210706|NCT02421601|516317470|FG000|Overall Study|Physician Decision|1|||
143210707|NCT02421601|516317470|FG000|Overall Study|Withdrawal by Subject|31|||
143210708|NCT02421601|516317470|FG000|Overall Study|Others|41|||
143210709|NCT01716104|516317473|FG000|Overall Study|Do not meet inclusion criteria|6|||
143210710|NCT01716104|516317474|FG001|Overall Study|Do not meet inclusion criteria|7|||
143210711|NCT00117793|516317475|FG000|Overall Study|Withdrawal by Subject|12|||
143210712|NCT00599638|516317478|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
143210713|NCT00599638|516317479|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
143210714|NCT00599638|516317480|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
143264648|NCT03194490|516523697|FG001|Overall Study|Lost to Follow-up|3|||
143210715|NCT00599638|516317481|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
143210716|NCT00599638|516317478|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
143210717|NCT00599638|516317479|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
143210718|NCT00599638|516317480|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
143210719|NCT00599638|516317481|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
143210720|NCT00599638|516317478|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
143210721|NCT00599638|516317479|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
143210722|NCT00599638|516317480|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
143210723|NCT00599638|516317481|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
143210724|NCT00599638|516317478|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
143210725|NCT00599638|516317479|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
143210726|NCT00599638|516317480|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
143210727|NCT00599638|516317481|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
143210728|NCT00599638|516317478|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
143210729|NCT00599638|516317479|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
143210730|NCT00599638|516317480|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
143210731|NCT00599638|516317481|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
143210732|NCT00599638|516317478|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
143210733|NCT00599638|516317479|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
143210734|NCT00599638|516317480|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
143210735|NCT00599638|516317481|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
143210736|NCT00599638|516317478|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
143210737|NCT00599638|516317479|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
143210738|NCT00599638|516317480|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
143210739|NCT00599638|516317481|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
143210740|NCT00599638|516317478|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
143210741|NCT00599638|516317479|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
143210742|NCT00599638|516317480|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
143210743|NCT00599638|516317481|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
143210744|NCT00599638|516317478|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
143210745|NCT00599638|516317479|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
143210746|NCT00599638|516317480|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
143264649|NCT03194490|516523696|FG000|Overall Study|participant developed specific neck pain|1|||
143264650|NCT03194490|516523697|FG001|Overall Study|participant developed specific neck pain|0|||
143264651|NCT01574079|516523698|FG000|Overall Study|Physician Decision|0|||
143264652|NCT01574079|516523699|FG001|Overall Study|Physician Decision|2|||
143264653|NCT01574079|516523698|FG000|Overall Study|Lost to Follow-up|1|||
143210747|NCT00599638|516317481|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
143210748|NCT03006887|516317483|FG000|Overall Study|Adverse Event|1|||
143264654|NCT01574079|516523699|FG001|Overall Study|Lost to Follow-up|0|||
143264655|NCT03640559|516523700|FG000|Overall Study|Physician Decision|1|||
143264656|NCT03640559|516523701|FG001|Overall Study|Physician Decision|1|||
143210749|NCT00462748|516317484|FG000|Overall Study|Adverse Event|7|||
143210750|NCT00462748|516317485|FG001|Overall Study|Adverse Event|5|||
143210751|NCT00462748|516317486|FG002|Overall Study|Adverse Event|9|||
143210752|NCT00462748|516317484|FG000|Overall Study|Protocol Violation|0|||
143210753|NCT00462748|516317485|FG001|Overall Study|Protocol Violation|2|||
143210754|NCT00462748|516317486|FG002|Overall Study|Protocol Violation|1|||
143210755|NCT00462748|516317484|FG000|Overall Study|Withdrew consent|3|||
143210756|NCT00462748|516317485|FG001|Overall Study|Withdrew consent|3|||
143210757|NCT00462748|516317486|FG002|Overall Study|Withdrew consent|0|||
143210758|NCT00462748|516317484|FG000|Overall Study|Lost to Follow-up|1|||
143210759|NCT00462748|516317485|FG001|Overall Study|Lost to Follow-up|1|||
143210760|NCT00462748|516317486|FG002|Overall Study|Lost to Follow-up|1|||
143210761|NCT00462748|516317484|FG000|Overall Study|Discontinued after 41 days Rx|1|||
143210762|NCT00462748|516317485|FG001|Overall Study|Discontinued after 41 days Rx|0|||
143210763|NCT00462748|516317486|FG002|Overall Study|Discontinued after 41 days Rx|0|||
143210764|NCT01729208|516317487|FG000|Baseline|Physician Decision|5|||
143210765|NCT01729208|516317488|FG001|Baseline|Physician Decision|4|||
143210766|NCT01729208|516317487|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
143210767|NCT01729208|516317488|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
143210768|NCT01729208|516317487|FG000|12 Months Follow-up|Lost to Follow-up|3|||
143210769|NCT01729208|516317488|FG001|12 Months Follow-up|Lost to Follow-up|3|||
143210770|NCT01729208|516317487|FG000|24 Months Follow-up|Lost to Follow-up|3|||
143210771|NCT01729208|516317488|FG001|24 Months Follow-up|Lost to Follow-up|0|||
143210772|NCT01729208|516317487|FG000|36 Months Follow-up|Physician Decision|1|||
143210773|NCT01729208|516317488|FG001|36 Months Follow-up|Physician Decision|0|||
143210774|NCT01729208|516317487|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
143210775|NCT01729208|516317488|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
143210776|NCT02428413|516317489|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
143210777|NCT02428413|516317490|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
143210778|NCT02428413|516317489|FG000|Overall Study|Protocol Violation|1|||
143210779|NCT02428413|516317490|FG001|Overall Study|Protocol Violation|2|||
143210780|NCT02428413|516317489|FG000|Overall Study|Case Cancelled|2|||
143210781|NCT02428413|516317490|FG001|Overall Study|Case Cancelled|0|||
143210782|NCT02428413|516317489|FG000|Overall Study|Missed Cases|1|||
143210783|NCT02428413|516317490|FG001|Overall Study|Missed Cases|2|||
143210784|NCT02428413|516317489|FG000|Overall Study|Nurse Refusal|1|||
143210785|NCT02428413|516317490|FG001|Overall Study|Nurse Refusal|0|||
143210786|NCT00454181|516317497|FG000|Overall Study|Adverse Event|1|||
143210787|NCT00454181|516317498|FG001|Overall Study|Adverse Event|1|||
143210788|NCT00454181|516317497|FG000|Overall Study|Lost to Follow-up|11|||
143210789|NCT00454181|516317498|FG001|Overall Study|Lost to Follow-up|1|||
143210790|NCT00454181|516317497|FG000|Overall Study|Protocol Violation|1|||
143210791|NCT00454181|516317498|FG001|Overall Study|Protocol Violation|1|||
143210792|NCT00454181|516317497|FG000|Overall Study|Withdrawal by Subject|2|||
143210793|NCT00454181|516317498|FG001|Overall Study|Withdrawal by Subject|0|||
143210794|NCT02453555|516317499|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
143210795|NCT02453555|516317500|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
143210796|NCT02453555|516317501|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
143210797|NCT02453555|516317502|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
143210798|NCT02453555|516317503|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
143210799|NCT02453555|516317504|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
143210800|NCT02453555|516317499|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
143210801|NCT02453555|516317500|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
143210802|NCT02453555|516317501|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
143370789|NCT01490580|516901113|FG001|Overall Study|Parents withdrew consent|2|||
143210803|NCT02453555|516317502|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
143210804|NCT02453555|516317503|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
143210805|NCT02453555|516317504|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
143210806|NCT02453555|516317499|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
143370790|NCT02026258|516901114|FG000|Randomized|Did not start treatment|2|||
143210807|NCT02453555|516317500|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
143210808|NCT02453555|516317501|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
143210809|NCT02453555|516317502|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
143210810|NCT02453555|516317503|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
143210811|NCT02453555|516317504|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
143210812|NCT02453555|516317499|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
143210813|NCT02453555|516317500|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
143210814|NCT02453555|516317501|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
143210815|NCT02453555|516317502|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
143210816|NCT02453555|516317503|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
143210817|NCT02453555|516317504|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
143210818|NCT02453555|516317499|FG000|Extension Period|Adverse Event|0|||
143210819|NCT02453555|516317500|FG001|Extension Period|Adverse Event|0|||
143210820|NCT02453555|516317501|FG002|Extension Period|Adverse Event|1|||
143210821|NCT02453555|516317502|FG003|Extension Period|Adverse Event|2|||
143210822|NCT02453555|516317503|FG004|Extension Period|Adverse Event|1|||
143210823|NCT02453555|516317504|FG005|Extension Period|Adverse Event|1|||
143210824|NCT02453555|516317499|FG000|Extension Period|Protocol Violation|0|||
143210825|NCT02453555|516317500|FG001|Extension Period|Protocol Violation|0|||
143210826|NCT02453555|516317501|FG002|Extension Period|Protocol Violation|1|||
143210827|NCT02453555|516317502|FG003|Extension Period|Protocol Violation|0|||
143210828|NCT02453555|516317503|FG004|Extension Period|Protocol Violation|0|||
143210829|NCT02453555|516317504|FG005|Extension Period|Protocol Violation|0|||
143210830|NCT02453555|516317499|FG000|Extension Period|Withdrawal by Subject|0|||
143210831|NCT02453555|516317500|FG001|Extension Period|Withdrawal by Subject|0|||
143210832|NCT02453555|516317501|FG002|Extension Period|Withdrawal by Subject|1|||
143210833|NCT02453555|516317502|FG003|Extension Period|Withdrawal by Subject|0|||
143210834|NCT02453555|516317503|FG004|Extension Period|Withdrawal by Subject|0|||
143210835|NCT02453555|516317504|FG005|Extension Period|Withdrawal by Subject|0|||
143210836|NCT03689855|516317509|FG000|Overall Study|Adverse Event|3|||
143210837|NCT03689855|516317509|FG000|Overall Study|Withdrawal by Subject|1|||
143210838|NCT01438177|516317510|FG000|Overall Study|Withdrawal by Subject|1|||
143210839|NCT01438177|516317510|FG000|Overall Study|Initiation of new therapy|1|||
143210840|NCT00619099|516317511|FG000|Overall Study|Progressive Disease|7|||
143210841|NCT00619099|516317512|FG001|Overall Study|Progressive Disease|5|||
143210842|NCT00619099|516317511|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
143210843|NCT00619099|516317512|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
143210844|NCT00619099|516317511|FG000|Overall Study|Adverse Event|4|||
143210845|NCT00619099|516317512|FG001|Overall Study|Adverse Event|3|||
143210846|NCT00619099|516317511|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
143210847|NCT00619099|516317512|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
143210848|NCT00619099|516317511|FG000|Overall Study|Withdrawal by Subject|10|||
143210849|NCT00619099|516317512|FG001|Overall Study|Withdrawal by Subject|2|||
143210850|NCT00619099|516317511|FG000|Overall Study|Physician Decision|9|||
143210851|NCT00619099|516317512|FG001|Overall Study|Physician Decision|6|||
143210852|NCT00885482|516317513|FG000|Overall Study|Pregnancy|1|||
143210853|NCT00885482|516317513|FG000|Overall Study|Lack of Efficacy|1|||
143210854|NCT00885482|516317513|FG000|Overall Study|Death|1|||
143210855|NCT00885482|516317513|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
143210856|NCT02772978|516317514|FG000|Overall Study|Withdrawal by Subject|1|||
143210857|NCT02772978|516317515|FG001|Overall Study|Withdrawal by Subject|1|||
143210858|NCT01026220|516317516|FG000|Induction|Death|1|||
143210859|NCT01026220|516317517|FG001|Induction|Death|0|||
143210860|NCT01026220|516317518|FG002|Induction|Death|0|||
143210861|NCT01026220|516317516|FG000|Induction|Lack of Efficacy|2|||
143210862|NCT01026220|516317517|FG001|Induction|Lack of Efficacy|0|||
143210863|NCT01026220|516317518|FG002|Induction|Lack of Efficacy|0|||
143210864|NCT01026220|516317516|FG000|Induction|Physician Decision|12|||
143210865|NCT01026220|516317517|FG001|Induction|Physician Decision|0|||
143210866|NCT01026220|516317518|FG002|Induction|Physician Decision|0|||
143210867|NCT01026220|516317516|FG000|Induction|Withdrawal by Subject|9|||
143210868|NCT01026220|516317517|FG001|Induction|Withdrawal by Subject|0|||
143210869|NCT01026220|516317518|FG002|Induction|Withdrawal by Subject|0|||
143210870|NCT01026220|516317516|FG000|Induction|Ineligible|1|||
143210871|NCT01026220|516317517|FG001|Induction|Ineligible|0|||
143210872|NCT01026220|516317518|FG002|Induction|Ineligible|0|||
143210873|NCT01026220|516317516|FG000|Consolidation Maintenance|Death|0|||
143210874|NCT01026220|516317517|FG001|Consolidation Maintenance|Death|1|||
143210875|NCT01026220|516317518|FG002|Consolidation Maintenance|Death|0|||
143210876|NCT01026220|516317516|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
143210877|NCT01026220|516317517|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
143210878|NCT01026220|516317518|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
143210879|NCT01026220|516317516|FG000|Consolidation Maintenance|Physician Decision|0|||
143210880|NCT01026220|516317517|FG001|Consolidation Maintenance|Physician Decision|2|||
143210881|NCT01026220|516317518|FG002|Consolidation Maintenance|Physician Decision|7|||
143210882|NCT01026220|516317516|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
143210883|NCT01026220|516317517|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
143210884|NCT01026220|516317518|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
143210885|NCT01009086|516317523|FG000|Overall Study|Lack of Efficacy|16|||
143210886|NCT01009086|516317524|FG001|Overall Study|Lack of Efficacy|15|||
143210887|NCT01009086|516317525|FG002|Overall Study|Lack of Efficacy|9|||
143210888|NCT01009086|516317523|FG000|Overall Study|Lost to Follow-up|4|||
143210889|NCT01009086|516317524|FG001|Overall Study|Lost to Follow-up|5|||
143210890|NCT01009086|516317525|FG002|Overall Study|Lost to Follow-up|3|||
143210891|NCT01009086|516317523|FG000|Overall Study|Adverse Event|12|||
143210892|NCT01009086|516317524|FG001|Overall Study|Adverse Event|11|||
143210893|NCT01009086|516317525|FG002|Overall Study|Adverse Event|8|||
143210894|NCT01009086|516317523|FG000|Overall Study|Withdrawal by Subject|9|||
143210895|NCT01009086|516317524|FG001|Overall Study|Withdrawal by Subject|11|||
143210896|NCT01009086|516317525|FG002|Overall Study|Withdrawal by Subject|13|||
143210897|NCT01009086|516317523|FG000|Overall Study|Other|3|||
143210898|NCT01009086|516317524|FG001|Overall Study|Other|5|||
143210899|NCT01009086|516317525|FG002|Overall Study|Other|1|||
143210900|NCT01389323|516317526|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
143210901|NCT01389323|516317526|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
143210902|NCT01389323|516317526|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
143210903|NCT01389323|516317526|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
143210904|NCT01389323|516317526|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
143210905|NCT01389323|516317526|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
143210906|NCT01389323|516317526|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
143210907|NCT01389323|516317526|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
143210908|NCT01389323|516317526|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
143210909|NCT01389323|516317526|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
143210910|NCT01389323|516317526|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
143210911|NCT00559988|516317528|FG000|Overall Study|Death|147|||
143210912|NCT00559988|516317529|FG001|Overall Study|Death|140|||
143210913|NCT00559988|516317528|FG000|Overall Study|Withdrawal by Subject|152|||
143210914|NCT00559988|516317529|FG001|Overall Study|Withdrawal by Subject|139|||
143210915|NCT00559988|516317528|FG000|Overall Study|Lost to Follow-up|42|||
143264657|NCT03640559|516523700|FG000|Overall Study|Withdrawal by Subject|1|||
143210916|NCT00559988|516317529|FG001|Overall Study|Lost to Follow-up|56|||
143210917|NCT00559988|516317528|FG000|Overall Study|ICD device explanted|10|||
143210918|NCT00559988|516317529|FG001|Overall Study|ICD device explanted|17|||
143210919|NCT00788710|516317530|FG000|Overall Study|Adverse Event|1|||
143210920|NCT00788710|516317531|FG001|Overall Study|Adverse Event|3|||
143210921|NCT00788710|516317532|FG002|Overall Study|Adverse Event|4|||
143210922|NCT00788710|516317530|FG000|Overall Study|Lack of Efficacy|0|||
143210923|NCT00788710|516317531|FG001|Overall Study|Lack of Efficacy|0|||
143210924|NCT00788710|516317532|FG002|Overall Study|Lack of Efficacy|1|||
143210925|NCT00788710|516317530|FG000|Overall Study|Lost to Follow-up|0|||
143210926|NCT00788710|516317531|FG001|Overall Study|Lost to Follow-up|1|||
143210927|NCT00788710|516317532|FG002|Overall Study|Lost to Follow-up|0|||
143210928|NCT00788710|516317530|FG000|Overall Study|Physician Decision|2|||
143210929|NCT00788710|516317531|FG001|Overall Study|Physician Decision|1|||
143210930|NCT00788710|516317532|FG002|Overall Study|Physician Decision|0|||
143210931|NCT00788710|516317530|FG000|Overall Study|Protocol Violation|0|||
143210932|NCT00788710|516317531|FG001|Overall Study|Protocol Violation|1|||
143210933|NCT00788710|516317532|FG002|Overall Study|Protocol Violation|1|||
143210934|NCT00788710|516317530|FG000|Overall Study|Withdrawal by Subject|2|||
143210935|NCT00788710|516317531|FG001|Overall Study|Withdrawal by Subject|2|||
143210936|NCT00788710|516317532|FG002|Overall Study|Withdrawal by Subject|0|||
143210937|NCT00727558|516317540|FG000|Overall Study|Lens issue|0|||
143210938|NCT00727558|516317541|FG001|Overall Study|Lens issue|1|||
143210939|NCT00727558|516317540|FG000|Overall Study|Adverse Event|0|||
143210940|NCT00727558|516317541|FG001|Overall Study|Adverse Event|1|||
143210941|NCT00727558|516317540|FG000|Overall Study|Subject unable to return for follow-up|1|||
143210942|NCT00727558|516317541|FG001|Overall Study|Subject unable to return for follow-up|1|||
143210943|NCT00727558|516317540|FG000|Overall Study|Lost to Follow-up|1|||
143210944|NCT00727558|516317541|FG001|Overall Study|Lost to Follow-up|0|||
143210945|NCT03281304|516317547|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
143210946|NCT03281304|516317548|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
143210947|NCT03281304|516317547|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
143210948|NCT03281304|516317548|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
143210949|NCT03281304|516317547|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
143210950|NCT03281304|516317548|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
143210951|NCT03281304|516317547|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
143210952|NCT03281304|516317548|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
143210953|NCT03281304|516317547|FG000|Treatment Phase (up to 42 Months)|Death|0|||
143210954|NCT03281304|516317548|FG001|Treatment Phase (up to 42 Months)|Death|1|||
143210955|NCT03281304|516317547|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
143210956|NCT03281304|516317548|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
143210957|NCT03281304|516317547|FG000|Treatment Phase (up to 42 Months)|Other|0|||
143210958|NCT03281304|516317548|FG001|Treatment Phase (up to 42 Months)|Other|2|||
143210959|NCT03281304|516317547|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
143210960|NCT03281304|516317548|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
143210961|NCT00488826|516317549|FG000|Overall Study|Withdrawal by Subject|40|||
143210962|NCT00488826|516317550|FG001|Overall Study|Withdrawal by Subject|35|||
143210963|NCT00488826|516317551|FG002|Overall Study|Withdrawal by Subject|19|||
143210964|NCT00488826|516317549|FG000|Overall Study|Protocol Violation|0|||
143210965|NCT00488826|516317550|FG001|Overall Study|Protocol Violation|0|||
143210966|NCT00488826|516317551|FG002|Overall Study|Protocol Violation|2|||
143210967|NCT00488826|516317549|FG000|Overall Study|Adverse Event|9|||
143210968|NCT00488826|516317550|FG001|Overall Study|Adverse Event|15|||
143210969|NCT00488826|516317551|FG002|Overall Study|Adverse Event|4|||
143210970|NCT00488826|516317549|FG000|Overall Study|Lost to Follow-up|5|||
143210971|NCT00488826|516317550|FG001|Overall Study|Lost to Follow-up|1|||
143210972|NCT00488826|516317551|FG002|Overall Study|Lost to Follow-up|0|||
143210973|NCT00488826|516317549|FG000|Overall Study|Protocol Deviations|2|||
143210974|NCT00488826|516317550|FG001|Overall Study|Protocol Deviations|1|||
143210975|NCT00488826|516317551|FG002|Overall Study|Protocol Deviations|1|||
143210976|NCT04667104|516317558|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
143210977|NCT04667104|516317559|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
143264658|NCT03640559|516523701|FG001|Overall Study|Withdrawal by Subject|0|||
143264659|NCT01436162|516523702|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
143264660|NCT01436162|516523703|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
143264661|NCT01436162|516523704|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
143264662|NCT01436162|516523702|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
143264663|NCT01436162|516523703|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
143264664|NCT01436162|516523704|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
143264665|NCT01436162|516523702|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
143264666|NCT01436162|516523703|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
143264667|NCT01436162|516523704|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
143370791|NCT02026258|516901115|FG001|Randomized|Did not start treatment|1|||
143370792|NCT02026258|516901114|FG000|Randomized|Change in treatment plan|1|||
143210978|NCT04667104|516317560|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
143210979|NCT03208088|516317562|FG000|Period 2|Withdrawal by Subject|0|||
143210980|NCT03208088|516317563|FG001|Period 2|Withdrawal by Subject|0|||
143210981|NCT03208088|516317564|FG002|Period 2|Withdrawal by Subject|0|||
143210982|NCT03208088|516317565|FG003|Period 2|Withdrawal by Subject|0|||
143264668|NCT01436162|516523702|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
143264669|NCT01436162|516523703|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
143264670|NCT01436162|516523704|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
143264671|NCT01436162|516523702|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
143264672|NCT01436162|516523703|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
143264673|NCT01436162|516523704|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
143210983|NCT03208088|516317566|FG004|Period 2|Withdrawal by Subject|0|||
143210984|NCT03208088|516317567|FG005|Period 2|Withdrawal by Subject|0|||
143210985|NCT03208088|516317568|FG006|Period 2|Withdrawal by Subject|0|||
143210986|NCT03208088|516317569|FG007|Period 2|Withdrawal by Subject|0|||
143210987|NCT03208088|516317570|FG008|Period 2|Withdrawal by Subject|1|||
143210988|NCT03208088|516317571|FG009|Period 2|Withdrawal by Subject|0|||
143210989|NCT03208088|516317562|FG000|Period 3|Unsatisfactory Test Article|0|||
143210990|NCT03208088|516317563|FG001|Period 3|Unsatisfactory Test Article|0|||
143210991|NCT03208088|516317564|FG002|Period 3|Unsatisfactory Test Article|0|||
143210992|NCT03208088|516317565|FG003|Period 3|Unsatisfactory Test Article|1|||
143210993|NCT03208088|516317566|FG004|Period 3|Unsatisfactory Test Article|0|||
143210994|NCT03208088|516317567|FG005|Period 3|Unsatisfactory Test Article|0|||
143210995|NCT03208088|516317568|FG006|Period 3|Unsatisfactory Test Article|0|||
143210996|NCT03208088|516317569|FG007|Period 3|Unsatisfactory Test Article|0|||
143210997|NCT03208088|516317570|FG008|Period 3|Unsatisfactory Test Article|0|||
143210998|NCT03208088|516317571|FG009|Period 3|Unsatisfactory Test Article|0|||
143210999|NCT03208088|516317562|FG000|Period 4|Unsatisfactory Test Article|0|||
143211000|NCT03208088|516317563|FG001|Period 4|Unsatisfactory Test Article|0|||
143211001|NCT03208088|516317564|FG002|Period 4|Unsatisfactory Test Article|0|||
143211002|NCT03208088|516317565|FG003|Period 4|Unsatisfactory Test Article|1|||
143211003|NCT03208088|516317566|FG004|Period 4|Unsatisfactory Test Article|0|||
143211004|NCT03208088|516317567|FG005|Period 4|Unsatisfactory Test Article|0|||
143211005|NCT03208088|516317568|FG006|Period 4|Unsatisfactory Test Article|0|||
143211006|NCT03208088|516317569|FG007|Period 4|Unsatisfactory Test Article|0|||
143211007|NCT03208088|516317570|FG008|Period 4|Unsatisfactory Test Article|0|||
143211008|NCT03208088|516317571|FG009|Period 4|Unsatisfactory Test Article|0|||
143211009|NCT02008227|516319521|FG000|Overall Study|Lost to Follow-up|7|||
143211010|NCT02008227|516319522|FG001|Overall Study|Lost to Follow-up|9|||
143211011|NCT02008227|516319521|FG000|Overall Study|Death|494|||
143211012|NCT02008227|516319522|FG001|Overall Study|Death|485|||
143211013|NCT02008227|516319521|FG000|Overall Study|Withdrawal by Subject|67|||
143211014|NCT02008227|516319522|FG001|Overall Study|Withdrawal by Subject|36|||
143211015|NCT02008227|516319521|FG000|Overall Study|Study Terminated By Sponsor|44|||
143211016|NCT02008227|516319522|FG001|Overall Study|Study Terminated By Sponsor|83|||
143211017|NCT00742417|516319523|FG000|Randomized|Withdrawal by legal representative|0|||
143211018|NCT00742417|516319524|FG001|Randomized|Withdrawal by legal representative|1|||
143211019|NCT00742417|516319523|FG000|Randomized|Withdrawal by Subject|1|||
143211020|NCT00742417|516319524|FG001|Randomized|Withdrawal by Subject|0|||
143211021|NCT00742417|516319523|FG000|Randomized|Physician Decision|1|||
143211022|NCT00742417|516319524|FG001|Randomized|Physician Decision|0|||
143211023|NCT00742417|516319523|FG000|Intensive Period|Withdrawal by Subject|1|||
143211024|NCT00742417|516319524|FG001|Intensive Period|Withdrawal by Subject|1|||
143211025|NCT00742417|516319523|FG000|Intensive Period|Adverse Event|2|||
143211026|NCT00742417|516319524|FG001|Intensive Period|Adverse Event|0|||
143211027|NCT04566601|516319527|FG000|Overall Study|Other than listed|13|||
143211028|NCT04566601|516319528|FG001|Overall Study|Other than listed|4|||
143211029|NCT04566601|516319529|FG002|Overall Study|Other than listed|2|||
143211030|NCT04566601|516319530|FG003|Overall Study|Other than listed|1|||
143211031|NCT04566601|516319531|FG004|Overall Study|Other than listed|4|||
143211032|NCT04566601|516319527|FG000|Overall Study|Protocol deviation|3|||
143211033|NCT04566601|516319528|FG001|Overall Study|Protocol deviation|0|||
143211034|NCT04566601|516319529|FG002|Overall Study|Protocol deviation|1|||
143211035|NCT04566601|516319530|FG003|Overall Study|Protocol deviation|1|||
143211036|NCT04566601|516319531|FG004|Overall Study|Protocol deviation|1|||
143264674|NCT01436162|516523702|FG000|Single-blind Lead-in Phase|Other|107|||
143264675|NCT01436162|516523703|FG001|Single-blind Lead-in Phase|Other|0|||
143264676|NCT01436162|516523704|FG002|Single-blind Lead-in Phase|Other|0|||
143264677|NCT01436162|516523702|FG000|Randomized Phase|Adverse Event|1|||
143264678|NCT01436162|516523703|FG001|Randomized Phase|Adverse Event|5|||
143264679|NCT01436162|516523704|FG002|Randomized Phase|Adverse Event|6|||
143211037|NCT04566601|516319527|FG000|Overall Study|Technical problems|0|||
143211038|NCT04566601|516319528|FG001|Overall Study|Technical problems|0|||
143211039|NCT04566601|516319529|FG002|Overall Study|Technical problems|1|||
143211040|NCT04566601|516319530|FG003|Overall Study|Technical problems|0|||
143211041|NCT04566601|516319531|FG004|Overall Study|Technical problems|0|||
143211042|NCT04566601|516319527|FG000|Overall Study|No reason available|3|||
143211043|NCT04566601|516319528|FG001|Overall Study|No reason available|2|||
143211044|NCT04566601|516319529|FG002|Overall Study|No reason available|7|||
143211045|NCT04566601|516319530|FG003|Overall Study|No reason available|1|||
143211046|NCT04566601|516319531|FG004|Overall Study|No reason available|5|||
143211047|NCT04566601|516319527|FG000|Overall Study|Burden of study procedures|3|||
143211048|NCT04566601|516319528|FG001|Overall Study|Burden of study procedures|0|||
143211049|NCT04566601|516319529|FG002|Overall Study|Burden of study procedures|0|||
143211050|NCT04566601|516319530|FG003|Overall Study|Burden of study procedures|3|||
143211051|NCT04566601|516319531|FG004|Overall Study|Burden of study procedures|1|||
143211052|NCT04566601|516319527|FG000|Overall Study|Change of residence|2|||
143211053|NCT04566601|516319528|FG001|Overall Study|Change of residence|2|||
143211054|NCT04566601|516319529|FG002|Overall Study|Change of residence|0|||
143264680|NCT01436162|516523702|FG000|Randomized Phase|Protocol Violation|4|||
143264681|NCT01436162|516523703|FG001|Randomized Phase|Protocol Violation|4|||
143264682|NCT01436162|516523704|FG002|Randomized Phase|Protocol Violation|2|||
143264683|NCT01436162|516523702|FG000|Randomized Phase|Withdrawal by Subject|16|||
143264684|NCT01436162|516523703|FG001|Randomized Phase|Withdrawal by Subject|9|||
143264685|NCT01436162|516523704|FG002|Randomized Phase|Withdrawal by Subject|8|||
143264686|NCT01436162|516523702|FG000|Randomized Phase|Lost to Follow-up|17|||
143264687|NCT01436162|516523703|FG001|Randomized Phase|Lost to Follow-up|5|||
143264688|NCT01436162|516523704|FG002|Randomized Phase|Lost to Follow-up|4|||
143264689|NCT01436162|516523702|FG000|Randomized Phase|Lack of Efficacy|0|||
143264690|NCT01436162|516523703|FG001|Randomized Phase|Lack of Efficacy|1|||
143264691|NCT01436162|516523704|FG002|Randomized Phase|Lack of Efficacy|1|||
143264692|NCT01436162|516523702|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
143264693|NCT01436162|516523703|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
143264694|NCT01436162|516523704|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
143264695|NCT01436162|516523702|FG000|Randomized Phase|Other|2|||
143264696|NCT01436162|516523703|FG001|Randomized Phase|Other|5|||
143264697|NCT01436162|516523704|FG002|Randomized Phase|Other|4|||
143264698|NCT01888003|516523705|FG000|Overall Study|Study Terminated|5|||
143264699|NCT01888003|516523706|FG001|Overall Study|Study Terminated|6|||
143264700|NCT01888003|516523707|FG002|Overall Study|Study Terminated|40|||
143264701|NCT03187756|516523708|FG000|Overall Study|Termination of study|4|||
143264702|NCT01931202|516523712|FG000|Overall Study|Withdrawal by Subject|0|||
143264703|NCT01931202|516523713|FG001|Overall Study|Withdrawal by Subject|0|||
143264704|NCT01931202|516523714|FG002|Overall Study|Withdrawal by Subject|2|||
143264705|NCT01931202|516523712|FG000|Overall Study|Lost to Follow-up|0|||
143264706|NCT01931202|516523713|FG001|Overall Study|Lost to Follow-up|5|||
143264707|NCT01931202|516523714|FG002|Overall Study|Lost to Follow-up|2|||
143264708|NCT04597918|516523717|FG000|Overall Study|Withdrawal by Subject|6|||
143264709|NCT04597918|516523717|FG000|Overall Study|Lost to Follow-up|3|||
143264710|NCT04597918|516523717|FG000|Overall Study|Death|1|||
143264711|NCT01876810|516523718|FG000|Overall Study|Physician Decision|0|||
143264712|NCT01876810|516523719|FG001|Overall Study|Physician Decision|1|||
143264713|NCT05140382|516523722|FG000|Overall Study|Death|3|||
143264714|NCT05140382|516523723|FG001|Overall Study|Death|0|||
143264715|NCT05140382|516523724|FG002|Overall Study|Death|0|||
143264716|NCT05140382|516523722|FG000|Overall Study|Investigator decision|1|||
143264717|NCT05140382|516523723|FG001|Overall Study|Investigator decision|0|||
143264718|NCT05140382|516523724|FG002|Overall Study|Investigator decision|0|||
143264719|NCT05140382|516523722|FG000|Overall Study|Other|4|||
143264720|NCT05140382|516523723|FG001|Overall Study|Other|0|||
143211055|NCT04566601|516319530|FG003|Overall Study|Change of residence|1|||
143264721|NCT05140382|516523724|FG002|Overall Study|Other|1|||
143264722|NCT05140382|516523722|FG000|Overall Study|Progressive disease|20|||
143264723|NCT05140382|516523723|FG001|Overall Study|Progressive disease|1|||
143264724|NCT05140382|516523724|FG002|Overall Study|Progressive disease|12|||
143264725|NCT05140382|516523722|FG000|Overall Study|Subjective disease progression|2|||
143264726|NCT05140382|516523723|FG001|Overall Study|Subjective disease progression|1|||
143264727|NCT05140382|516523724|FG002|Overall Study|Subjective disease progression|0|||
143264728|NCT05140382|516523722|FG000|Overall Study|Unknown at data cut-off|0|||
143264729|NCT05140382|516523723|FG001|Overall Study|Unknown at data cut-off|0|||
143264730|NCT05140382|516523724|FG002|Overall Study|Unknown at data cut-off|1|||
143264731|NCT05140382|516523722|FG000|Overall Study|Withdrawal by Subject|1|||
143264732|NCT05140382|516523723|FG001|Overall Study|Withdrawal by Subject|0|||
143264733|NCT05140382|516523724|FG002|Overall Study|Withdrawal by Subject|4|||
143211056|NCT04566601|516319531|FG004|Overall Study|Change of residence|2|||
143264734|NCT05140382|516523722|FG000|Overall Study|Withdrawal of consent|0|||
143264735|NCT05140382|516523723|FG001|Overall Study|Withdrawal of consent|0|||
143264736|NCT05140382|516523724|FG002|Overall Study|Withdrawal of consent|1|||
143264737|NCT03437512|516525046|FG000|Randomized|Withdrawal by Subject|0|||
143264738|NCT03437512|516525047|FG001|Randomized|Withdrawal by Subject|2|||
143211057|NCT04566601|516319527|FG000|Overall Study|Perceived lack of efficacy|2|||
143211058|NCT04566601|516319528|FG001|Overall Study|Perceived lack of efficacy|0|||
143264739|NCT03437512|516525046|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
143264740|NCT03437512|516525047|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
143264741|NCT01897714|516525048|FG000|Phase I (Dose Escalation)|Disease progression|3|||
143264742|NCT01897714|516525049|FG001|Phase I (Dose Escalation)|Disease progression|5|||
143264743|NCT01897714|516525050|FG002|Phase I (Dose Escalation)|Disease progression|1|||
143264744|NCT01897714|516525051|FG003|Phase I (Dose Escalation)|Disease progression|3|||
143264745|NCT01897714|516525052|FG004|Phase I (Dose Escalation)|Disease progression|0|||
143264746|NCT01897714|516525053|FG005|Phase I (Dose Escalation)|Disease progression|0|||
143264747|NCT01897714|516525048|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
143264748|NCT01897714|516525049|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
143264749|NCT01897714|516525050|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
143264750|NCT01897714|516525051|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
143264751|NCT01897714|516525052|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
143264752|NCT01897714|516525053|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
143264753|NCT01897714|516525048|FG000|Phase I (Dose Escalation)|Other|0|||
143264754|NCT01897714|516525049|FG001|Phase I (Dose Escalation)|Other|1|||
143370793|NCT02026258|516901115|FG001|Randomized|Change in treatment plan|0|||
143370794|NCT02026258|516901114|FG000|Randomized|Presence of periodontal disease|1|||
143370795|NCT02026258|516901115|FG001|Randomized|Presence of periodontal disease|1|||
143370796|NCT02026258|516901114|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
143370797|NCT02026258|516901115|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
143370798|NCT02026258|516901114|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
143370799|NCT02026258|516901115|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
143370800|NCT00878722|516901118|FG000|Overall Study|Progressive disease|3|||
143370801|NCT00878722|516901119|FG001|Overall Study|Progressive disease|3|||
143370802|NCT00878722|516901120|FG002|Overall Study|Progressive disease|3|||
143370803|NCT00878722|516901121|FG003|Overall Study|Progressive disease|7|||
143370804|NCT00878722|516901122|FG004|Overall Study|Progressive disease|7|||
143370805|NCT00878722|516901123|FG005|Overall Study|Progressive disease|1|||
143370806|NCT00878722|516901124|FG006|Overall Study|Progressive disease|4|||
143370807|NCT00878722|516901125|FG007|Overall Study|Progressive disease|3|||
143211059|NCT04566601|516319529|FG002|Overall Study|Perceived lack of efficacy|1|||
143264755|NCT01897714|516525050|FG002|Phase I (Dose Escalation)|Other|0|||
143264756|NCT01897714|516525051|FG003|Phase I (Dose Escalation)|Other|0|||
143264757|NCT01897714|516525052|FG004|Phase I (Dose Escalation)|Other|0|||
143264758|NCT01897714|516525053|FG005|Phase I (Dose Escalation)|Other|0|||
143264759|NCT01897714|516525048|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
143264760|NCT01897714|516525049|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
143264761|NCT01897714|516525050|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
143264762|NCT01897714|516525051|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
143264763|NCT01897714|516525052|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
143264764|NCT01897714|516525053|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
143264765|NCT01897714|516525048|FG000|Phase II (MTD)|Lost to Follow-up|0|||
143264766|NCT01897714|516525049|FG001|Phase II (MTD)|Lost to Follow-up|0|||
143264767|NCT01897714|516525050|FG002|Phase II (MTD)|Lost to Follow-up|0|||
143264768|NCT01897714|516525051|FG003|Phase II (MTD)|Lost to Follow-up|0|||
143264769|NCT01897714|516525052|FG004|Phase II (MTD)|Lost to Follow-up|1|||
143264770|NCT01897714|516525053|FG005|Phase II (MTD)|Lost to Follow-up|0|||
143264771|NCT01897714|516525048|FG000|Phase II (MTD)|Death|0|||
143264772|NCT01897714|516525049|FG001|Phase II (MTD)|Death|0|||
143211060|NCT04566601|516319530|FG003|Overall Study|Perceived lack of efficacy|1|||
143211061|NCT04566601|516319531|FG004|Overall Study|Perceived lack of efficacy|2|||
143211062|NCT04566601|516319527|FG000|Overall Study|Adverse Event|7|||
143211063|NCT04566601|516319528|FG001|Overall Study|Adverse Event|4|||
143211064|NCT04566601|516319529|FG002|Overall Study|Adverse Event|6|||
143211065|NCT04566601|516319530|FG003|Overall Study|Adverse Event|5|||
143211066|NCT04566601|516319531|FG004|Overall Study|Adverse Event|12|||
143211067|NCT03047031|516319533|FG000|Overall Study|Other than listed|1|||
143211068|NCT03047031|516319534|FG001|Overall Study|Other than listed|0|||
143211069|NCT03047031|516319535|FG002|Overall Study|Other than listed|0|||
143211070|NCT03047031|516319533|FG000|Overall Study|Lost to Follow-up|4|||
143211071|NCT03047031|516319534|FG001|Overall Study|Lost to Follow-up|0|||
143211072|NCT03047031|516319535|FG002|Overall Study|Lost to Follow-up|0|||
143211073|NCT03047031|516319533|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
143211074|NCT03047031|516319534|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
143211075|NCT03047031|516319535|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
143264773|NCT01897714|516525050|FG002|Phase II (MTD)|Death|0|||
143264774|NCT01897714|516525051|FG003|Phase II (MTD)|Death|0|||
143264775|NCT01897714|516525052|FG004|Phase II (MTD)|Death|25|||
143264776|NCT01897714|516525053|FG005|Phase II (MTD)|Death|10|||
143264777|NCT01897714|516525048|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
143264778|NCT01897714|516525049|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
143370808|NCT00878722|516901118|FG000|Overall Study|Death|0|||
143264779|NCT01897714|516525050|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
143264780|NCT01897714|516525051|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
143264781|NCT01897714|516525052|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
143370809|NCT00878722|516901119|FG001|Overall Study|Death|0|||
143211076|NCT03047031|516319533|FG000|Overall Study|Adverse Event|1|||
143211077|NCT03047031|516319534|FG001|Overall Study|Adverse Event|0|||
143264782|NCT01897714|516525053|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
143264783|NCT01897714|516525048|FG000|Phase II (MTD)|Other|0|||
143264784|NCT01897714|516525049|FG001|Phase II (MTD)|Other|0|||
143264785|NCT01897714|516525050|FG002|Phase II (MTD)|Other|0|||
143211078|NCT03047031|516319535|FG002|Overall Study|Adverse Event|0|||
143211079|NCT03047031|516319533|FG000|Overall Study|Withdrawal by Subject|2|||
143211080|NCT03047031|516319534|FG001|Overall Study|Withdrawal by Subject|0|||
143211081|NCT03047031|516319535|FG002|Overall Study|Withdrawal by Subject|0|||
143211082|NCT03047031|516319533|FG000|Overall Study|Change to other medication|2|||
143211083|NCT03047031|516319534|FG001|Overall Study|Change to other medication|0|||
143211084|NCT03047031|516319535|FG002|Overall Study|Change to other medication|0|||
143211085|NCT03047031|516319533|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
143211086|NCT03047031|516319534|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
143211087|NCT03047031|516319535|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
143211088|NCT01450098|516319536|FG000|Period 3|Protocol Violation|0|||
143211089|NCT01450098|516319537|FG001|Period 3|Protocol Violation|1|||
143211090|NCT01450098|516319536|FG000|Period 3|Withdrawal by Subject|0|||
143211091|NCT01450098|516319537|FG001|Period 3|Withdrawal by Subject|2|||
143211092|NCT03416127|516319538|FG000|Overall Study|Withdrawal by Subject|0|||
143211093|NCT03416127|516319539|FG001|Overall Study|Withdrawal by Subject|1|||
143211094|NCT03416127|516319540|FG002|Overall Study|Withdrawal by Subject|1|||
143211095|NCT01959139|516319541|FG000|Phase II|Disease progression|0|||
143211096|NCT01959139|516319542|FG001|Phase II|Disease progression|0|||
143211097|NCT01959139|516319543|FG002|Phase II|Disease progression|26|||
143211098|NCT01959139|516319544|FG003|Phase II|Disease progression|34|||
143211099|NCT01959139|516319541|FG000|Phase II|Adverse Event|0|||
143211100|NCT01959139|516319542|FG001|Phase II|Adverse Event|0|||
143211101|NCT01959139|516319543|FG002|Phase II|Adverse Event|10|||
143211102|NCT01959139|516319544|FG003|Phase II|Adverse Event|11|||
143211103|NCT01959139|516319541|FG000|Phase II|Patient Refusal|0|||
143211104|NCT01959139|516319542|FG001|Phase II|Patient Refusal|0|||
143211105|NCT01959139|516319543|FG002|Phase II|Patient Refusal|5|||
143211106|NCT01959139|516319544|FG003|Phase II|Patient Refusal|4|||
143211107|NCT01959139|516319541|FG000|Phase II|Death|0|||
143211108|NCT01959139|516319542|FG001|Phase II|Death|0|||
143211109|NCT01959139|516319543|FG002|Phase II|Death|3|||
143211110|NCT01959139|516319544|FG003|Phase II|Death|1|||
143211111|NCT01959139|516319541|FG000|Phase II|Other/Unknown|0|||
143211112|NCT01959139|516319542|FG001|Phase II|Other/Unknown|0|||
143211113|NCT01959139|516319543|FG002|Phase II|Other/Unknown|8|||
143211114|NCT01959139|516319544|FG003|Phase II|Other/Unknown|5|||
143211115|NCT01959139|516319541|FG000|Phase II|On treatment|0|||
143211116|NCT01959139|516319542|FG001|Phase II|On treatment|0|||
143211117|NCT01959139|516319543|FG002|Phase II|On treatment|4|||
143211118|NCT01959139|516319544|FG003|Phase II|On treatment|0|||
143211119|NCT02489942|516319545|FG000|Overall Study|Request by patient|602|||
143211120|NCT02489942|516319545|FG000|Overall Study|Improvement/remission|157|||
143211121|NCT02489942|516319545|FG000|Overall Study|No change/Progressive disease|263|||
143211122|NCT02489942|516319545|FG000|Overall Study|Adverse Event|522|||
143211123|NCT02489942|516319545|FG000|Overall Study|Other personal reasons|1218|||
143211124|NCT02489942|516319545|FG000|Overall Study|Lost to Follow-up|456|||
143211125|NCT02489942|516319545|FG000|Overall Study|Not continuously investigated|7|||
143211126|NCT02489942|516319545|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
143211127|NCT02489942|516319545|FG000|Overall Study|Multiple registration|1|||
143211128|NCT02489942|516319545|FG000|Overall Study|No patient visit after entry|100|||
143211129|NCT02489942|516319545|FG000|Overall Study|No treatment with Jardiance|2|||
143211130|NCT02489942|516319545|FG000|Overall Study|Patient received Jardiance before registration|1|||
143211131|NCT02489942|516319545|FG000|Overall Study|No CRF collected|86|||
143211132|NCT01272635|516319546|FG000|Overall Study|Lost to Follow-up|31|||
143211133|NCT01272635|516319547|FG001|Overall Study|Lost to Follow-up|20|||
143211134|NCT01272635|516319548|FG002|Overall Study|Lost to Follow-up|31|||
143211135|NCT01272635|516319549|FG003|Overall Study|Lost to Follow-up|23|||
143211136|NCT01543776|516319550|FG000|Overall Study|Withdrawal by Subject|2|||
143211137|NCT01543776|516319551|FG001|Overall Study|Withdrawal by Subject|2|||
143211138|NCT00567359|516319552|FG000|Overall Study|Withdrawal by Subject|1|||
143211139|NCT02397057|516319553|FG000|Overall Study|Withdrawal by Subject|6|||
143211140|NCT02397057|516319554|FG001|Overall Study|Withdrawal by Subject|7|||
143211141|NCT02397057|516319553|FG000|Overall Study|Lost to Follow-up|4|||
143211142|NCT02397057|516319554|FG001|Overall Study|Lost to Follow-up|3|||
143211143|NCT02397057|516319553|FG000|Overall Study|Death|1|||
143211144|NCT02397057|516319554|FG001|Overall Study|Death|0|||
143211145|NCT02397057|516319553|FG000|Overall Study|Adverse Event|0|||
143211146|NCT02397057|516319554|FG001|Overall Study|Adverse Event|1|||
143211147|NCT02397057|516319553|FG000|Overall Study|Physician Decision|0|||
143211148|NCT02397057|516319554|FG001|Overall Study|Physician Decision|1|||
143211149|NCT02397057|516319553|FG000|Overall Study|Subject did not receive study drug|0|||
143211150|NCT02397057|516319554|FG001|Overall Study|Subject did not receive study drug|1|||
143211151|NCT03387020|516319556|FG000|Overall Study|Adverse Event|0|||
143211152|NCT03387020|516319557|FG001|Overall Study|Adverse Event|2|||
143211153|NCT03387020|516319558|FG002|Overall Study|Adverse Event|0|||
143211154|NCT03387020|516319556|FG000|Overall Study|Withdrawal by Subject|2|||
143211155|NCT03387020|516319557|FG001|Overall Study|Withdrawal by Subject|0|||
143211156|NCT03387020|516319558|FG002|Overall Study|Withdrawal by Subject|0|||
143211157|NCT02241343|516319563|FG000|Overall Study|Adverse Event|1|||
143211158|NCT02942485|516319566|FG000|Overall Study|Lost to Follow-up|1|||
143211159|NCT02942485|516319567|FG001|Overall Study|Lost to Follow-up|0|||
143211160|NCT02516592|516319571|FG000|Overall Study|Patient withdrew consent|5|||
143211161|NCT02516592|516319572|FG001|Overall Study|Patient withdrew consent|2|||
143211162|NCT02516592|516319571|FG000|Overall Study|Protocol deviation|4|||
143211163|NCT02516592|516319572|FG001|Overall Study|Protocol deviation|4|||
143211164|NCT02516592|516319571|FG000|Overall Study|Lost to Follow-up|2|||
143211165|NCT02516592|516319572|FG001|Overall Study|Lost to Follow-up|3|||
143211166|NCT02516592|516319571|FG000|Overall Study|Patient/guardian decision|2|||
143211167|NCT02516592|516319572|FG001|Overall Study|Patient/guardian decision|1|||
143211168|NCT02516592|516319571|FG000|Overall Study|Adverse Event|1|||
143211169|NCT02516592|516319572|FG001|Overall Study|Adverse Event|2|||
143211170|NCT02516592|516319571|FG000|Overall Study|Abnormal test procedure result|1|||
143211171|NCT02516592|516319572|FG001|Overall Study|Abnormal test procedure result|0|||
143211172|NCT02516592|516319571|FG000|Overall Study|Death|1|||
143211173|NCT02516592|516319572|FG001|Overall Study|Death|1|||
143211174|NCT02678923|516319584|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
143211175|NCT02678923|516319585|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
143211176|NCT02678923|516319584|FG000|Overall Study|Withdrawal by Subject|3|||
143211177|NCT02678923|516319585|FG001|Overall Study|Withdrawal by Subject|2|||
143211178|NCT02678923|516319584|FG000|Overall Study|Lost to Follow-up|1|||
143211179|NCT02678923|516319585|FG001|Overall Study|Lost to Follow-up|0|||
143211180|NCT02678923|516319584|FG000|Overall Study|Did Not Return for Study Visits|1|||
143211181|NCT02678923|516319585|FG001|Overall Study|Did Not Return for Study Visits|0|||
143211182|NCT00455143|516319586|FG000|Overall Study|Physician Decision|1|||
143211183|NCT00455143|516319586|FG000|Overall Study|Withdrawal by Subject|1|||
143211184|NCT00455143|516319586|FG000|Overall Study|Staff was not avail to follow patient|2|||
143211185|NCT00455143|516319586|FG000|Overall Study|No longer met Inclusion Criteria|1|||
143211186|NCT00455143|516319586|FG000|Overall Study|Surgical time, staff not available|1|||
143211187|NCT01374178|516319587|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
143211188|NCT01374178|516319588|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
143211189|NCT01374178|516319587|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
143211190|NCT01374178|516319588|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
143211191|NCT04856904|516319589|FG000|Overall Study|Physician Decision|1|||
143211192|NCT04856904|516319590|FG001|Overall Study|Physician Decision|1|||
143211193|NCT04856904|516319589|FG000|Overall Study|Withdrawal by Subject|13|||
143211194|NCT04856904|516319590|FG001|Overall Study|Withdrawal by Subject|13|||
143211195|NCT04856904|516319589|FG000|Overall Study|Adverse Event|1|||
143211196|NCT04856904|516319590|FG001|Overall Study|Adverse Event|1|||
143211197|NCT04856904|516319589|FG000|Overall Study|Non-compliance with study drug|1|||
143211198|NCT04856904|516319590|FG001|Overall Study|Non-compliance with study drug|1|||
143211199|NCT04856904|516319589|FG000|Overall Study|Lost to Follow-up|4|||
143211200|NCT04856904|516319590|FG001|Overall Study|Lost to Follow-up|4|||
143211201|NCT04856904|516319589|FG000|Overall Study|Withdrawal by Subject|1|||
143211202|NCT04856904|516319590|FG001|Overall Study|Withdrawal by Subject|1|||
143211203|NCT04856904|516319589|FG000|Overall Study|Protocol Violation|1|||
143211204|NCT04856904|516319590|FG001|Overall Study|Protocol Violation|1|||
143211205|NCT00077649|516319591|FG000|Overall Study|Adverse Event|5|||
143211206|NCT00077649|516319592|FG001|Overall Study|Adverse Event|1|||
143211207|NCT00077649|516319593|FG002|Overall Study|Adverse Event|7|||
143211208|NCT00077649|516319594|FG003|Overall Study|Adverse Event|9|||
143211209|NCT00077649|516319591|FG000|Overall Study|Lack of Efficacy|5|||
143211210|NCT00077649|516319592|FG001|Overall Study|Lack of Efficacy|3|||
143211211|NCT00077649|516319593|FG002|Overall Study|Lack of Efficacy|3|||
143211212|NCT00077649|516319594|FG003|Overall Study|Lack of Efficacy|2|||
143211213|NCT00077649|516319591|FG000|Overall Study|Withdrawal by Subject|0|||
143211214|NCT00077649|516319592|FG001|Overall Study|Withdrawal by Subject|1|||
143211215|NCT00077649|516319593|FG002|Overall Study|Withdrawal by Subject|1|||
143211216|NCT00077649|516319594|FG003|Overall Study|Withdrawal by Subject|2|||
143211217|NCT00077649|516319591|FG000|Overall Study|Lost to Follow-up|2|||
143211218|NCT00077649|516319592|FG001|Overall Study|Lost to Follow-up|2|||
143211219|NCT00077649|516319593|FG002|Overall Study|Lost to Follow-up|3|||
143211220|NCT00077649|516319594|FG003|Overall Study|Lost to Follow-up|2|||
143211221|NCT00077649|516319591|FG000|Overall Study|Abnormality of Laboratory Test|1|||
143211222|NCT00077649|516319592|FG001|Overall Study|Abnormality of Laboratory Test|2|||
143211223|NCT00077649|516319593|FG002|Overall Study|Abnormality of Laboratory Test|1|||
143211224|NCT00077649|516319594|FG003|Overall Study|Abnormality of Laboratory Test|2|||
143211225|NCT00077649|516319591|FG000|Overall Study|Randomized but never dosed|1|||
143211226|NCT00077649|516319592|FG001|Overall Study|Randomized but never dosed|0|||
143211227|NCT00077649|516319593|FG002|Overall Study|Randomized but never dosed|0|||
143211228|NCT00077649|516319594|FG003|Overall Study|Randomized but never dosed|0|||
143211229|NCT01641822|516319595|FG000|Run-in Phase|Noncompliance with study drug|1|||
143211230|NCT01641822|516319596|FG001|Run-in Phase|Noncompliance with study drug|0|||
143211231|NCT01641822|516319597|FG002|Run-in Phase|Noncompliance with study drug|0|||
143211232|NCT01641822|516319595|FG000|Run-in Phase|Adverse Event|3|||
143211233|NCT01641822|516319596|FG001|Run-in Phase|Adverse Event|0|||
143211234|NCT01641822|516319597|FG002|Run-in Phase|Adverse Event|0|||
143211235|NCT01641822|516319595|FG000|Run-in Phase|Withdrew consent|1|||
143211236|NCT01641822|516319596|FG001|Run-in Phase|Withdrew consent|0|||
143211237|NCT01641822|516319597|FG002|Run-in Phase|Withdrew consent|0|||
143211238|NCT01641822|516319595|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
143211239|NCT01641822|516319596|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
143211240|NCT01641822|516319597|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
143211241|NCT01641822|516319595|FG000|Comparative Phase|Noncompliance with study drug|0|||
143211242|NCT01641822|516319596|FG001|Comparative Phase|Noncompliance with study drug|1|||
143211243|NCT01641822|516319597|FG002|Comparative Phase|Noncompliance with study drug|0|||
143211244|NCT01641822|516319595|FG000|Comparative Phase|Investigator's discretion|0|||
143211245|NCT01641822|516319596|FG001|Comparative Phase|Investigator's discretion|0|||
143211246|NCT01641822|516319597|FG002|Comparative Phase|Investigator's discretion|1|||
143211247|NCT01641822|516319595|FG000|Comparative Phase|Pregnancy|0|||
143211248|NCT01641822|516319596|FG001|Comparative Phase|Pregnancy|0|||
143211249|NCT01641822|516319597|FG002|Comparative Phase|Pregnancy|1|||
143211250|NCT01641822|516319595|FG000|Comparative Phase|Adverse event, serious fatal|0|||
143211251|NCT01641822|516319596|FG001|Comparative Phase|Adverse event, serious fatal|1|||
143211252|NCT01641822|516319597|FG002|Comparative Phase|Adverse event, serious fatal|0|||
143211253|NCT01641822|516319595|FG000|Comparative Phase|Withdrew consent|0|||
143211254|NCT01641822|516319596|FG001|Comparative Phase|Withdrew consent|3|||
143211255|NCT01641822|516319597|FG002|Comparative Phase|Withdrew consent|7|||
143211256|NCT01641822|516319595|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
143211257|NCT01641822|516319596|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
143211258|NCT01641822|516319597|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
143211259|NCT02760810|516319598|FG000|Overall Study|Protocol Violation|1|||
143211260|NCT00470418|516319599|FG000|Overall Study|Withdrawal by Subject|1|||
143211261|NCT00470418|516319600|FG001|Overall Study|Withdrawal by Subject|0|||
143211262|NCT03688100|516319603|FG000|Overall Study|Lost to Follow-up|21|||
143211263|NCT03688100|516319604|FG001|Overall Study|Lost to Follow-up|15|||
143211264|NCT03688100|516319605|FG002|Overall Study|Lost to Follow-up|15|||
143211265|NCT03688100|516319606|FG003|Overall Study|Lost to Follow-up|18|||
143211266|NCT03688100|516319603|FG000|Overall Study|Withdrawal by Subject|19|||
143211267|NCT03688100|516319604|FG001|Overall Study|Withdrawal by Subject|16|||
143211268|NCT03688100|516319605|FG002|Overall Study|Withdrawal by Subject|0|||
143211269|NCT03688100|516319606|FG003|Overall Study|Withdrawal by Subject|0|||
143211270|NCT03688100|516319603|FG000|Overall Study|Death|36|||
143211271|NCT03688100|516319604|FG001|Overall Study|Death|27|||
143211272|NCT03688100|516319605|FG002|Overall Study|Death|0|||
143211273|NCT03688100|516319606|FG003|Overall Study|Death|0|||
143211274|NCT02409719|516319614|FG000|Overall Study|Lost to Follow-up|3|||
143211275|NCT02409719|516319615|FG001|Overall Study|Lost to Follow-up|3|||
143211276|NCT02479139|516319616|FG000|Overall Study|Lost to Follow-up|2|||
143211277|NCT02479139|516319617|FG001|Overall Study|Lost to Follow-up|4|||
143211278|NCT02479139|516319618|FG002|Overall Study|Lost to Follow-up|4|||
143211279|NCT02479139|516319619|FG003|Overall Study|Lost to Follow-up|2|||
143211280|NCT02479139|516319620|FG004|Overall Study|Lost to Follow-up|3|||
143211281|NCT02479139|516319621|FG005|Overall Study|Lost to Follow-up|5|||
143211282|NCT02479139|516319616|FG000|Overall Study|Withdrew Consent|5|||
143211283|NCT02479139|516319617|FG001|Overall Study|Withdrew Consent|6|||
143211284|NCT02479139|516319618|FG002|Overall Study|Withdrew Consent|1|||
143211285|NCT02479139|516319619|FG003|Overall Study|Withdrew Consent|4|||
143211286|NCT02479139|516319620|FG004|Overall Study|Withdrew Consent|1|||
143211287|NCT02479139|516319621|FG005|Overall Study|Withdrew Consent|1|||
143211288|NCT02479139|516319616|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
143211289|NCT02479139|516319617|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
143211290|NCT02479139|516319618|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
143211291|NCT02479139|516319619|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
143211292|NCT02479139|516319620|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
143211293|NCT02479139|516319621|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
143211294|NCT02479139|516319616|FG000|Overall Study|Other Miscellaneous Reasons|1|||
143211295|NCT02479139|516319617|FG001|Overall Study|Other Miscellaneous Reasons|0|||
143211296|NCT02479139|516319618|FG002|Overall Study|Other Miscellaneous Reasons|1|||
143211297|NCT02479139|516319619|FG003|Overall Study|Other Miscellaneous Reasons|1|||
143370810|NCT00878722|516901120|FG002|Overall Study|Death|0|||
143370811|NCT00878722|516901121|FG003|Overall Study|Death|1|||
143211298|NCT02479139|516319620|FG004|Overall Study|Other Miscellaneous Reasons|1|||
143370812|NCT00878722|516901122|FG004|Overall Study|Death|0|||
143370813|NCT00878722|516901123|FG005|Overall Study|Death|1|||
143211299|NCT02479139|516319621|FG005|Overall Study|Other Miscellaneous Reasons|0|||
143211300|NCT00764673|516319622|FG000|Overall Study|Death|1|||
143211301|NCT00764673|516319622|FG000|Overall Study|Lost to Follow-up|3|||
143211302|NCT00764673|516319622|FG000|Overall Study|Withdrawal by Subject|6|||
143211303|NCT00764673|516319622|FG000|Overall Study|Revision of Device|2|||
143211304|NCT01727336|516319625|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
143211305|NCT01727336|516319626|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
143211306|NCT01727336|516319627|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
143211307|NCT01727336|516319628|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
143211308|NCT01727336|516319629|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
143211309|NCT01727336|516319630|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
143211310|NCT01727336|516319625|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
143211311|NCT01727336|516319626|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
143370814|NCT00878722|516901124|FG006|Overall Study|Death|0|||
143211312|NCT01727336|516319627|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
143211313|NCT01727336|516319628|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
143211314|NCT01727336|516319629|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
143211315|NCT01727336|516319630|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
143211316|NCT01727336|516319625|FG000|Part 2 Blinded|Death|0|||
143211317|NCT01727336|516319626|FG001|Part 2 Blinded|Death|0|||
143211318|NCT01727336|516319627|FG002|Part 2 Blinded|Death|0|||
143211319|NCT01727336|516319628|FG003|Part 2 Blinded|Death|0|||
143211320|NCT01727336|516319629|FG004|Part 2 Blinded|Death|20|||
143211321|NCT01727336|516319630|FG005|Part 2 Blinded|Death|16|||
143211322|NCT01727336|516319625|FG000|Part 2 Blinded|Lack of Efficacy|0|||
143211323|NCT01727336|516319626|FG001|Part 2 Blinded|Lack of Efficacy|0|||
143211324|NCT01727336|516319627|FG002|Part 2 Blinded|Lack of Efficacy|0|||
143211325|NCT01727336|516319628|FG003|Part 2 Blinded|Lack of Efficacy|0|||
143211326|NCT01727336|516319629|FG004|Part 2 Blinded|Lack of Efficacy|42|||
143211327|NCT01727336|516319630|FG005|Part 2 Blinded|Lack of Efficacy|44|||
143211328|NCT01727336|516319625|FG000|Part 2 Blinded|Lost to Follow-up|0|||
143211329|NCT01727336|516319626|FG001|Part 2 Blinded|Lost to Follow-up|0|||
143211330|NCT01727336|516319627|FG002|Part 2 Blinded|Lost to Follow-up|0|||
143211331|NCT01727336|516319628|FG003|Part 2 Blinded|Lost to Follow-up|0|||
143211332|NCT01727336|516319629|FG004|Part 2 Blinded|Lost to Follow-up|0|||
143211333|NCT01727336|516319630|FG005|Part 2 Blinded|Lost to Follow-up|1|||
143211334|NCT01727336|516319625|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
143211335|NCT01727336|516319626|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
143211336|NCT01727336|516319627|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
143211337|NCT01727336|516319628|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
143211338|NCT01727336|516319629|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
143211339|NCT01727336|516319630|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
143211340|NCT01727336|516319625|FG000|Part 2 Blinded|use of prohibited medications|0|||
143211341|NCT01727336|516319626|FG001|Part 2 Blinded|use of prohibited medications|0|||
143211342|NCT01727336|516319627|FG002|Part 2 Blinded|use of prohibited medications|0|||
143211343|NCT01727336|516319628|FG003|Part 2 Blinded|use of prohibited medications|0|||
143211344|NCT01727336|516319629|FG004|Part 2 Blinded|use of prohibited medications|1|||
143211345|NCT01727336|516319630|FG005|Part 2 Blinded|use of prohibited medications|3|||
143211346|NCT01532869|516319631|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
143211347|NCT01532869|516319632|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
143211348|NCT01532869|516319631|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
143211349|NCT01532869|516319632|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
143211350|NCT01532869|516319631|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
143211351|NCT01532869|516319632|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
143211352|NCT01532869|516319631|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
143211353|NCT01532869|516319632|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
143211354|NCT01532869|516319631|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
143211355|NCT01532869|516319632|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
143211356|NCT01532869|516319631|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
143211357|NCT01532869|516319632|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
143211358|NCT01532869|516319631|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
143211359|NCT01532869|516319632|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
143211360|NCT01532869|516319631|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
143211361|NCT01532869|516319632|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
143211362|NCT01532869|516319631|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
143211363|NCT01532869|516319632|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
143211364|NCT01532869|516319631|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
143211365|NCT01532869|516319632|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
143211366|NCT01532869|516319631|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
143211367|NCT01532869|516319632|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
143211368|NCT01532869|516319631|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
143211369|NCT01532869|516319632|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
143264786|NCT01897714|516525051|FG003|Phase II (MTD)|Other|0|||
143211370|NCT01532869|516319631|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
143211371|NCT01532869|516319632|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
143211372|NCT01532869|516319631|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
143211373|NCT01532869|516319632|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
143211374|NCT01532869|516319631|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
143211375|NCT01532869|516319632|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
143211376|NCT01532869|516319631|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
143264787|NCT01897714|516525052|FG004|Phase II (MTD)|Other|3|||
143211377|NCT01532869|516319632|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
143211378|NCT01532869|516319631|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
143211379|NCT01532869|516319632|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
143211380|NCT00778895|516319633|FG000|Active Phase|Adverse Event|3|||
143211381|NCT00778895|516319634|FG001|Active Phase|Adverse Event|1|||
143211382|NCT00778895|516319635|FG002|Active Phase|Adverse Event|0|||
143211383|NCT00778895|516319633|FG000|Active Phase|Withdrawal by Subject|1|||
143211384|NCT00778895|516319634|FG001|Active Phase|Withdrawal by Subject|4|||
143211385|NCT00778895|516319635|FG002|Active Phase|Withdrawal by Subject|0|||
143211386|NCT00778895|516319633|FG000|Active Phase|Lost to Follow-up|1|||
143211387|NCT00778895|516319634|FG001|Active Phase|Lost to Follow-up|1|||
143211388|NCT00778895|516319635|FG002|Active Phase|Lost to Follow-up|0|||
143211389|NCT00778895|516319633|FG000|Active Phase|Other|2|||
143211390|NCT00778895|516319634|FG001|Active Phase|Other|0|||
143211391|NCT00778895|516319635|FG002|Active Phase|Other|0|||
143211392|NCT00778895|516319633|FG000|ESFU Phase|Adverse Event|2|||
143211393|NCT00778895|516319634|FG001|ESFU Phase|Adverse Event|1|||
143211394|NCT00778895|516319635|FG002|ESFU Phase|Adverse Event|0|||
143211395|NCT00778895|516319633|FG000|ESFU Phase|Withdrawal by Subject|1|||
143211396|NCT00778895|516319634|FG001|ESFU Phase|Withdrawal by Subject|4|||
143211397|NCT00778895|516319635|FG002|ESFU Phase|Withdrawal by Subject|0|||
143211398|NCT00778895|516319633|FG000|ESFU Phase|Lost to Follow-up|6|||
143211399|NCT00778895|516319634|FG001|ESFU Phase|Lost to Follow-up|7|||
143211400|NCT00778895|516319635|FG002|ESFU Phase|Lost to Follow-up|2|||
143211401|NCT00778895|516319633|FG000|ESFU Phase|Other|2|||
143211402|NCT00778895|516319634|FG001|ESFU Phase|Other|0|||
143211403|NCT00778895|516319635|FG002|ESFU Phase|Other|0|||
143211404|NCT01424228|516319637|FG000|Overall Study|Withdrawal by Subject|27|||
143211405|NCT01424228|516319638|FG001|Overall Study|Withdrawal by Subject|11|||
143211406|NCT01424228|516319637|FG000|Overall Study|Adverse Event|10|||
143211407|NCT01424228|516319638|FG001|Overall Study|Adverse Event|14|||
143211408|NCT01424228|516319637|FG000|Overall Study|Sponsor's decision|9|||
143211409|NCT01424228|516319638|FG001|Overall Study|Sponsor's decision|12|||
143211410|NCT01424228|516319637|FG000|Overall Study|Lack of Efficacy|5|||
143211411|NCT01424228|516319638|FG001|Overall Study|Lack of Efficacy|7|||
143211412|NCT01424228|516319637|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
143211413|NCT01424228|516319638|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
143211414|NCT01424228|516319637|FG000|Overall Study|Non-compliance|2|||
143211415|NCT01424228|516319638|FG001|Overall Study|Non-compliance|0|||
143211416|NCT01424228|516319637|FG000|Overall Study|Worsening of symptoms|1|||
143211417|NCT01424228|516319638|FG001|Overall Study|Worsening of symptoms|0|||
143211418|NCT01424228|516319637|FG000|Overall Study|Unplanned journey|0|||
143211419|NCT01424228|516319638|FG001|Overall Study|Unplanned journey|1|||
143211420|NCT00590577|516319643|FG000|Overall Study|Lack of Efficacy|31|||
143211421|NCT00590577|516319644|FG001|Overall Study|Lack of Efficacy|28|||
143211422|NCT00590577|516319645|FG002|Overall Study|Lack of Efficacy|23|||
143211423|NCT00590577|516319646|FG003|Overall Study|Lack of Efficacy|45|||
143211424|NCT00590577|516319643|FG000|Overall Study|Withdrawal by Subject|23|||
143211425|NCT00590577|516319644|FG001|Overall Study|Withdrawal by Subject|28|||
143211426|NCT00590577|516319645|FG002|Overall Study|Withdrawal by Subject|30|||
143211427|NCT00590577|516319646|FG003|Overall Study|Withdrawal by Subject|26|||
143211428|NCT00590577|516319643|FG000|Overall Study|Adverse Event|10|||
143211429|NCT00590577|516319644|FG001|Overall Study|Adverse Event|10|||
143211430|NCT00590577|516319645|FG002|Overall Study|Adverse Event|13|||
143211431|NCT00590577|516319646|FG003|Overall Study|Adverse Event|11|||
143211432|NCT00590577|516319643|FG000|Overall Study|Lost to Follow-up|12|||
143211433|NCT00590577|516319644|FG001|Overall Study|Lost to Follow-up|6|||
143211434|NCT00590577|516319645|FG002|Overall Study|Lost to Follow-up|6|||
143211435|NCT00590577|516319646|FG003|Overall Study|Lost to Follow-up|9|||
143211436|NCT00590577|516319643|FG000|Overall Study|Pregnancy|0|||
143211437|NCT00590577|516319644|FG001|Overall Study|Pregnancy|1|||
143211438|NCT00590577|516319645|FG002|Overall Study|Pregnancy|0|||
143211439|NCT00590577|516319646|FG003|Overall Study|Pregnancy|0|||
143211440|NCT00590577|516319643|FG000|Overall Study|Various reasons|1|||
143211441|NCT00590577|516319644|FG001|Overall Study|Various reasons|3|||
143211442|NCT00590577|516319645|FG002|Overall Study|Various reasons|1|||
143211443|NCT00590577|516319646|FG003|Overall Study|Various reasons|2|||
143211444|NCT01300260|516319647|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
143211445|NCT01300260|516319648|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
143211446|NCT01300260|516319647|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
143211447|NCT01300260|516319648|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
143211448|NCT01300260|516319647|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
143211449|NCT01300260|516319648|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
143211450|NCT00293020|516319654|FG000|Overall Study|Withdrawal by Subject|34|||
143370815|NCT00878722|516901125|FG007|Overall Study|Death|2|||
143370816|NCT00878722|516901118|FG000|Overall Study|Adverse Event|0|||
143211451|NCT00293020|516319654|FG000|Overall Study|Adverse Event|30|||
143211452|NCT00293020|516319654|FG000|Overall Study|Death|32|||
143211453|NCT00293020|516319654|FG000|Overall Study|Lack of Efficacy|12|||
143211454|NCT00293020|516319654|FG000|Overall Study|Lost to Follow-up|4|||
143211455|NCT00293020|516319654|FG000|Overall Study|Protocol Violation|6|||
143211456|NCT00293020|516319654|FG000|Overall Study|Physician Decision|21|||
143211457|NCT00293020|516319654|FG000|Overall Study|Other Reason|22|||
143211458|NCT00293020|516319654|FG000|Overall Study|No dose taken|1|||
143211459|NCT01147848|516319655|FG000|Run-in Period|Screen Failure|623|||
143211460|NCT01147848|516319656|FG001|Run-in Period|Screen Failure|0|||
143211461|NCT01147848|516319657|FG002|Run-in Period|Screen Failure|0|||
143211462|NCT01147848|516319655|FG000|Run-in Period|Run-in Failure|135|||
143211463|NCT01147848|516319656|FG001|Run-in Period|Run-in Failure|0|||
143211464|NCT01147848|516319657|FG002|Run-in Period|Run-in Failure|0|||
143211465|NCT01147848|516319655|FG000|Randomized Phase|Adverse Event|0|||
143211466|NCT01147848|516319656|FG001|Randomized Phase|Adverse Event|6|||
143211467|NCT01147848|516319657|FG002|Randomized Phase|Adverse Event|8|||
143211468|NCT01147848|516319655|FG000|Randomized Phase|Lack of Efficacy|0|||
143211469|NCT01147848|516319656|FG001|Randomized Phase|Lack of Efficacy|20|||
143211470|NCT01147848|516319657|FG002|Randomized Phase|Lack of Efficacy|11|||
143211471|NCT01147848|516319655|FG000|Randomized Phase|Protocol Violation|0|||
143211472|NCT01147848|516319656|FG001|Randomized Phase|Protocol Violation|7|||
143211473|NCT01147848|516319657|FG002|Randomized Phase|Protocol Violation|10|||
143211474|NCT01147848|516319655|FG000|Randomized Phase|Lost to Follow-up|0|||
143211475|NCT01147848|516319656|FG001|Randomized Phase|Lost to Follow-up|5|||
143211476|NCT01147848|516319657|FG002|Randomized Phase|Lost to Follow-up|7|||
143211477|NCT01147848|516319655|FG000|Randomized Phase|Physician Decision|0|||
143211478|NCT01147848|516319656|FG001|Randomized Phase|Physician Decision|0|||
143211479|NCT01147848|516319657|FG002|Randomized Phase|Physician Decision|1|||
143211480|NCT01147848|516319655|FG000|Randomized Phase|Withdrawal by Subject|0|||
143211481|NCT01147848|516319656|FG001|Randomized Phase|Withdrawal by Subject|7|||
143211482|NCT01147848|516319657|FG002|Randomized Phase|Withdrawal by Subject|9|||
143211483|NCT01069705|516319658|FG000|Overall Study|Adverse Event|1|||
143211484|NCT01069705|516319658|FG000|Overall Study|Withdrawal by Subject|2|||
143211485|NCT00235716|516319659|FG000|Overall Study|Death|26|||
143211486|NCT00235716|516319660|FG001|Overall Study|Death|39|||
143211487|NCT00235716|516319661|FG002|Overall Study|Death|32|||
143211488|NCT00235716|516319662|FG003|Overall Study|Death|31|||
143211489|NCT00235716|516319659|FG000|Overall Study|Withdrawal by Subject|23|||
143211490|NCT00235716|516319660|FG001|Overall Study|Withdrawal by Subject|19|||
143211491|NCT00235716|516319661|FG002|Overall Study|Withdrawal by Subject|17|||
143211492|NCT00235716|516319662|FG003|Overall Study|Withdrawal by Subject|18|||
143211493|NCT00235716|516319659|FG000|Overall Study|Lost to Follow-up|12|||
143211494|NCT00235716|516319660|FG001|Overall Study|Lost to Follow-up|7|||
143211495|NCT00235716|516319661|FG002|Overall Study|Lost to Follow-up|14|||
143211496|NCT00235716|516319662|FG003|Overall Study|Lost to Follow-up|10|||
143211497|NCT00235716|516319659|FG000|Overall Study|Adverse Event|1|||
143211498|NCT00235716|516319660|FG001|Overall Study|Adverse Event|1|||
143211499|NCT00235716|516319661|FG002|Overall Study|Adverse Event|1|||
143211500|NCT00235716|516319662|FG003|Overall Study|Adverse Event|0|||
143211501|NCT00235716|516319659|FG000|Overall Study|Physician Decision|0|||
143211502|NCT00235716|516319660|FG001|Overall Study|Physician Decision|1|||
143211503|NCT00235716|516319661|FG002|Overall Study|Physician Decision|1|||
143211504|NCT00235716|516319662|FG003|Overall Study|Physician Decision|3|||
143211505|NCT04390841|516319663|FG000|Overall Study|Withdrawal by Subject|2|||
143211506|NCT02607228|516319664|FG000|Overall Study|Progressive Disease|4|||
143211507|NCT02607228|516319665|FG001|Overall Study|Progressive Disease|3|||
143211508|NCT02607228|516319666|FG002|Overall Study|Progressive Disease|1|||
143211509|NCT02607228|516319667|FG003|Overall Study|Progressive Disease|5|||
143211510|NCT02607228|516319668|FG004|Overall Study|Progressive Disease|4|||
143211511|NCT02607228|516319669|FG005|Overall Study|Progressive Disease|3|||
143211512|NCT02607228|516319670|FG006|Overall Study|Progressive Disease|1|||
143211513|NCT02607228|516319664|FG000|Overall Study|Adverse Event|1|||
143370817|NCT00878722|516901119|FG001|Overall Study|Adverse Event|0|||
143211514|NCT02607228|516319665|FG001|Overall Study|Adverse Event|0|||
143211515|NCT02607228|516319666|FG002|Overall Study|Adverse Event|1|||
143211516|NCT02607228|516319667|FG003|Overall Study|Adverse Event|0|||
143211517|NCT02607228|516319668|FG004|Overall Study|Adverse Event|1|||
143211518|NCT02607228|516319669|FG005|Overall Study|Adverse Event|1|||
143211519|NCT02607228|516319670|FG006|Overall Study|Adverse Event|1|||
143211520|NCT02607228|516319664|FG000|Overall Study|Investigator's Discretion|0|||
143211521|NCT02607228|516319665|FG001|Overall Study|Investigator's Discretion|0|||
143211522|NCT02607228|516319666|FG002|Overall Study|Investigator's Discretion|1|||
143211523|NCT02607228|516319667|FG003|Overall Study|Investigator's Discretion|0|||
143211524|NCT02607228|516319668|FG004|Overall Study|Investigator's Discretion|0|||
143211525|NCT02607228|516319669|FG005|Overall Study|Investigator's Discretion|1|||
143211526|NCT02607228|516319670|FG006|Overall Study|Investigator's Discretion|0|||
143211527|NCT02607228|516319664|FG000|Overall Study|Withdrew Consent|0|||
143370818|NCT00878722|516901120|FG002|Overall Study|Adverse Event|0|||
143370819|NCT00878722|516901121|FG003|Overall Study|Adverse Event|0|||
143211528|NCT02607228|516319665|FG001|Overall Study|Withdrew Consent|1|||
143211529|NCT02607228|516319666|FG002|Overall Study|Withdrew Consent|0|||
143211530|NCT02607228|516319667|FG003|Overall Study|Withdrew Consent|0|||
143211531|NCT02607228|516319668|FG004|Overall Study|Withdrew Consent|0|||
143211532|NCT02607228|516319669|FG005|Overall Study|Withdrew Consent|1|||
143211533|NCT02607228|516319670|FG006|Overall Study|Withdrew Consent|0|||
143211534|NCT02607228|516319664|FG000|Overall Study|Study Terminated by Sponsor|0|||
143211535|NCT02607228|516319665|FG001|Overall Study|Study Terminated by Sponsor|0|||
143211536|NCT02607228|516319666|FG002|Overall Study|Study Terminated by Sponsor|0|||
143211537|NCT02607228|516319667|FG003|Overall Study|Study Terminated by Sponsor|1|||
143211538|NCT02607228|516319668|FG004|Overall Study|Study Terminated by Sponsor|0|||
143211539|NCT02607228|516319669|FG005|Overall Study|Study Terminated by Sponsor|0|||
143211540|NCT02607228|516319670|FG006|Overall Study|Study Terminated by Sponsor|0|||
143211541|NCT02516228|516319671|FG000|Overall Study|Lost to Follow-up|1|||
143211542|NCT02516228|516319671|FG000|Overall Study|Withdrawal by Subject|1|||
143211543|NCT02516228|516319671|FG000|Overall Study|Physician Decision|1|||
143211544|NCT03916484|516319672|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
143211545|NCT03916484|516319673|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
143211546|NCT03916484|516319674|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
143211547|NCT03916484|516319675|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
143211548|NCT03916484|516319672|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
143211549|NCT03916484|516319673|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
143211550|NCT03916484|516319674|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
143211551|NCT03916484|516319675|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
143211552|NCT01196416|516319676|FG000|Overall Study|Withdrawal by Subject|2|||
143211553|NCT01717326|516319677|FG000|Overall Study|Death|0|||
143211554|NCT01717326|516319678|FG001|Overall Study|Death|0|||
143211555|NCT01717326|516319679|FG002|Overall Study|Death|0|||
143211556|NCT01717326|516319680|FG003|Overall Study|Death|0|||
143211557|NCT01717326|516319681|FG004|Overall Study|Death|0|||
143211558|NCT01717326|516319682|FG005|Overall Study|Death|0|||
143211559|NCT01717326|516319683|FG006|Overall Study|Death|0|||
143211560|NCT01717326|516319684|FG007|Overall Study|Death|0|||
143211561|NCT01717326|516319685|FG008|Overall Study|Death|0|||
143211562|NCT01717326|516319686|FG009|Overall Study|Death|0|||
143211563|NCT01717326|516319687|FG010|Overall Study|Death|1|||
143211564|NCT01717326|516319688|FG011|Overall Study|Death|0|||
143211565|NCT01717326|516319689|FG012|Overall Study|Death|0|||
143211566|NCT01717326|516319690|FG013|Overall Study|Death|0|||
143211567|NCT01717326|516319691|FG014|Overall Study|Death|0|||
143211568|NCT01717326|516319692|FG015|Overall Study|Death|0|||
143211569|NCT01717326|516319693|FG016|Overall Study|Death|0|||
143211570|NCT01717326|516319694|FG017|Overall Study|Death|0|||
143211571|NCT01717326|516319695|FG018|Overall Study|Death|0|||
143211572|NCT01717326|516319696|FG019|Overall Study|Death|0|||
143211573|NCT01717326|516319677|FG000|Overall Study|Lost to Follow-up|3|||
143211574|NCT01717326|516319678|FG001|Overall Study|Lost to Follow-up|0|||
143211575|NCT01717326|516319679|FG002|Overall Study|Lost to Follow-up|0|||
143211576|NCT01717326|516319680|FG003|Overall Study|Lost to Follow-up|2|||
143211577|NCT01717326|516319681|FG004|Overall Study|Lost to Follow-up|1|||
143211578|NCT01717326|516319682|FG005|Overall Study|Lost to Follow-up|0|||
143211579|NCT01717326|516319683|FG006|Overall Study|Lost to Follow-up|1|||
143211580|NCT01717326|516319684|FG007|Overall Study|Lost to Follow-up|0|||
143211581|NCT01717326|516319685|FG008|Overall Study|Lost to Follow-up|0|||
143211582|NCT01717326|516319686|FG009|Overall Study|Lost to Follow-up|0|||
143211583|NCT01717326|516319687|FG010|Overall Study|Lost to Follow-up|1|||
143211584|NCT01717326|516319688|FG011|Overall Study|Lost to Follow-up|0|||
143211585|NCT01717326|516319689|FG012|Overall Study|Lost to Follow-up|0|||
143211586|NCT01717326|516319690|FG013|Overall Study|Lost to Follow-up|0|||
143211587|NCT01717326|516319691|FG014|Overall Study|Lost to Follow-up|0|||
143211588|NCT01717326|516319692|FG015|Overall Study|Lost to Follow-up|2|||
143211589|NCT01717326|516319693|FG016|Overall Study|Lost to Follow-up|1|||
143211590|NCT01717326|516319694|FG017|Overall Study|Lost to Follow-up|0|||
143211591|NCT01717326|516319695|FG018|Overall Study|Lost to Follow-up|2|||
143211592|NCT01717326|516319696|FG019|Overall Study|Lost to Follow-up|3|||
143370820|NCT00878722|516901122|FG004|Overall Study|Adverse Event|0|||
143370821|NCT00878722|516901123|FG005|Overall Study|Adverse Event|0|||
143211593|NCT01717326|516319677|FG000|Overall Study|Physician Decision|0|||
143211594|NCT01717326|516319678|FG001|Overall Study|Physician Decision|0|||
143211595|NCT01717326|516319679|FG002|Overall Study|Physician Decision|0|||
143211596|NCT01717326|516319680|FG003|Overall Study|Physician Decision|0|||
143211597|NCT01717326|516319681|FG004|Overall Study|Physician Decision|0|||
143211598|NCT01717326|516319682|FG005|Overall Study|Physician Decision|0|||
143211599|NCT01717326|516319683|FG006|Overall Study|Physician Decision|0|||
143211600|NCT01717326|516319684|FG007|Overall Study|Physician Decision|0|||
143211601|NCT01717326|516319685|FG008|Overall Study|Physician Decision|0|||
143211602|NCT01717326|516319686|FG009|Overall Study|Physician Decision|1|||
143211603|NCT01717326|516319687|FG010|Overall Study|Physician Decision|0|||
143211604|NCT01717326|516319688|FG011|Overall Study|Physician Decision|0|||
143211605|NCT01717326|516319689|FG012|Overall Study|Physician Decision|0|||
143211606|NCT01717326|516319690|FG013|Overall Study|Physician Decision|0|||
143211607|NCT01717326|516319691|FG014|Overall Study|Physician Decision|0|||
143211608|NCT01717326|516319692|FG015|Overall Study|Physician Decision|0|||
143211609|NCT01717326|516319693|FG016|Overall Study|Physician Decision|0|||
143211610|NCT01717326|516319694|FG017|Overall Study|Physician Decision|0|||
143211611|NCT01717326|516319695|FG018|Overall Study|Physician Decision|0|||
143211612|NCT01717326|516319696|FG019|Overall Study|Physician Decision|0|||
143211613|NCT01717326|516319677|FG000|Overall Study|Protocol Violation|0|||
143211614|NCT01717326|516319678|FG001|Overall Study|Protocol Violation|0|||
143211615|NCT01717326|516319679|FG002|Overall Study|Protocol Violation|0|||
143211616|NCT01717326|516319680|FG003|Overall Study|Protocol Violation|0|||
143211617|NCT01717326|516319681|FG004|Overall Study|Protocol Violation|1|||
143211618|NCT01717326|516319682|FG005|Overall Study|Protocol Violation|0|||
143211619|NCT01717326|516319683|FG006|Overall Study|Protocol Violation|0|||
143211620|NCT01717326|516319684|FG007|Overall Study|Protocol Violation|0|||
143211621|NCT01717326|516319685|FG008|Overall Study|Protocol Violation|0|||
143211622|NCT01717326|516319686|FG009|Overall Study|Protocol Violation|0|||
143211623|NCT01717326|516319687|FG010|Overall Study|Protocol Violation|0|||
143211624|NCT01717326|516319688|FG011|Overall Study|Protocol Violation|0|||
143211625|NCT01717326|516319689|FG012|Overall Study|Protocol Violation|0|||
143211626|NCT01717326|516319690|FG013|Overall Study|Protocol Violation|0|||
143211627|NCT01717326|516319691|FG014|Overall Study|Protocol Violation|0|||
143211628|NCT01717326|516319692|FG015|Overall Study|Protocol Violation|0|||
143211629|NCT01717326|516319693|FG016|Overall Study|Protocol Violation|0|||
143211630|NCT01717326|516319694|FG017|Overall Study|Protocol Violation|0|||
143211631|NCT01717326|516319695|FG018|Overall Study|Protocol Violation|0|||
143211632|NCT01717326|516319696|FG019|Overall Study|Protocol Violation|0|||
143211633|NCT01717326|516319677|FG000|Overall Study|Withdrawal by Subject|0|||
143264788|NCT01897714|516525053|FG005|Phase II (MTD)|Other|0|||
143264789|NCT00122278|516525054|FG000|Overall Study|Lost to Follow-up|2|||
143264790|NCT00122278|516525055|FG001|Overall Study|Lost to Follow-up|0|||
143264791|NCT01002482|516525056|FG000|Overall Study|Withdrawal by Subject|14|||
143264792|NCT01002482|516525057|FG001|Overall Study|Withdrawal by Subject|21|||
143264793|NCT01002482|516525056|FG000|Overall Study|Included twice|1|||
143264794|NCT01002482|516525057|FG001|Overall Study|Included twice|0|||
143264795|NCT01865084|516525058|FG000|Double Blind Period (DB)|Adverse Event|2|||
143264796|NCT01865084|516525059|FG001|Double Blind Period (DB)|Adverse Event|2|||
143264797|NCT01865084|516525060|FG002|Double Blind Period (DB)|Adverse Event|1|||
143264798|NCT01865084|516525058|FG000|Double Blind Period (DB)|Protocol Violation|0|||
143264799|NCT01865084|516525059|FG001|Double Blind Period (DB)|Protocol Violation|0|||
143264800|NCT01865084|516525060|FG002|Double Blind Period (DB)|Protocol Violation|1|||
143264801|NCT01865084|516525058|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
143264802|NCT01865084|516525059|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
143264803|NCT01865084|516525060|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
143264804|NCT01865084|516525058|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
143264805|NCT01865084|516525059|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
143264806|NCT01865084|516525060|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
143264807|NCT01865084|516525058|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
143264808|NCT01865084|516525059|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
143264809|NCT01865084|516525060|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
143264810|NCT01865084|516525058|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
143264811|NCT01865084|516525059|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
143264812|NCT01865084|516525060|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
143264813|NCT01865084|516525058|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
143264814|NCT01865084|516525059|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
143264815|NCT01865084|516525060|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
143264816|NCT01865084|516525058|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
143264817|NCT01865084|516525059|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
143264818|NCT01865084|516525060|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
143211634|NCT01717326|516319678|FG001|Overall Study|Withdrawal by Subject|1|||
143211635|NCT01717326|516319679|FG002|Overall Study|Withdrawal by Subject|0|||
143211636|NCT01717326|516319680|FG003|Overall Study|Withdrawal by Subject|0|||
143264819|NCT01865084|516525058|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
143264820|NCT01865084|516525059|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
143264821|NCT01865084|516525060|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
143264822|NCT02247531|516525064|FG000|Overall Study|Adverse Event|3|||
143264823|NCT02247531|516525065|FG001|Overall Study|Adverse Event|4|||
143264824|NCT02247531|516525066|FG002|Overall Study|Adverse Event|9|||
143370822|NCT00878722|516901124|FG006|Overall Study|Adverse Event|2|||
143211637|NCT01717326|516319681|FG004|Overall Study|Withdrawal by Subject|0|||
143211638|NCT01717326|516319682|FG005|Overall Study|Withdrawal by Subject|0|||
143211639|NCT01717326|516319683|FG006|Overall Study|Withdrawal by Subject|0|||
143264825|NCT02247531|516525064|FG000|Overall Study|Death|8|||
143264826|NCT02247531|516525065|FG001|Overall Study|Death|9|||
143264827|NCT02247531|516525066|FG002|Overall Study|Death|5|||
143264828|NCT02247531|516525064|FG000|Overall Study|Lost to Follow-up|1|||
143264829|NCT02247531|516525065|FG001|Overall Study|Lost to Follow-up|8|||
143264830|NCT02247531|516525066|FG002|Overall Study|Lost to Follow-up|3|||
143264831|NCT02247531|516525064|FG000|Overall Study|Non-compliance|2|||
143264832|NCT02247531|516525065|FG001|Overall Study|Non-compliance|2|||
143264833|NCT02247531|516525066|FG002|Overall Study|Non-compliance|0|||
143264834|NCT02247531|516525064|FG000|Overall Study|Withdrawal by Subject|26|||
143264835|NCT02247531|516525065|FG001|Overall Study|Withdrawal by Subject|31|||
143264836|NCT02247531|516525066|FG002|Overall Study|Withdrawal by Subject|25|||
143264837|NCT02247531|516525064|FG000|Overall Study|Study Terminated by Sponsor|64|||
143264838|NCT02247531|516525065|FG001|Overall Study|Study Terminated by Sponsor|66|||
143264839|NCT02247531|516525066|FG002|Overall Study|Study Terminated by Sponsor|62|||
143264840|NCT02247531|516525064|FG000|Overall Study|Physician Decision|0|||
143264841|NCT02247531|516525065|FG001|Overall Study|Physician Decision|2|||
143264842|NCT02247531|516525066|FG002|Overall Study|Physician Decision|2|||
143264843|NCT02247531|516525064|FG000|Overall Study|Unspecified Reason|2|||
143264844|NCT02247531|516525065|FG001|Overall Study|Unspecified Reason|3|||
143264845|NCT02247531|516525066|FG002|Overall Study|Unspecified Reason|4|||
143264846|NCT03875118|516525073|FG000|Overall Study|Withdrawal by Subject|4|||
143264847|NCT03875118|516525074|FG001|Overall Study|Withdrawal by Subject|4|||
143264848|NCT01442038|516525075|FG000|Overall Study|Death|35|||
143264849|NCT01442038|516525076|FG001|Overall Study|Death|29|||
143264850|NCT01442038|516525075|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
143264851|NCT01442038|516525076|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
143264852|NCT01442038|516525075|FG000|Overall Study|Participant Withdrew Consent|137|||
143264853|NCT01442038|516525076|FG001|Overall Study|Participant Withdrew Consent|102|||
143264854|NCT01442038|516525075|FG000|Overall Study|Lost to Follow-up|37|||
143264855|NCT01442038|516525076|FG001|Overall Study|Lost to Follow-up|51|||
143264856|NCT01442038|516525075|FG000|Overall Study|Adverse Event|26|||
143264857|NCT01442038|516525076|FG001|Overall Study|Adverse Event|15|||
143264858|NCT01442038|516525075|FG000|Overall Study|Protocol Deviation|9|||
143264859|NCT01442038|516525076|FG001|Overall Study|Protocol Deviation|20|||
143264860|NCT01442038|516525075|FG000|Overall Study|Investigator's Discretion|13|||
143264861|NCT01442038|516525076|FG001|Overall Study|Investigator's Discretion|16|||
143264862|NCT01442038|516525075|FG000|Overall Study|Study Terminated By Sponsor|2|||
143264863|NCT01442038|516525076|FG001|Overall Study|Study Terminated By Sponsor|3|||
143264864|NCT00089284|516525077|FG000|Overall Study|Adverse event before starting treatment|0|||
143264865|NCT00089284|516525078|FG001|Overall Study|Adverse event before starting treatment|0|||
143264866|NCT00089284|516525079|FG002|Overall Study|Adverse event before starting treatment|0|||
143264867|NCT00089284|516525080|FG003|Overall Study|Adverse event before starting treatment|0|||
143264868|NCT00089284|516525081|FG004|Overall Study|Adverse event before starting treatment|0|||
143264869|NCT00089284|516525082|FG005|Overall Study|Adverse event before starting treatment|0|||
143264870|NCT00089284|516525083|FG006|Overall Study|Adverse event before starting treatment|1|||
143264871|NCT02423109|516525084|FG000|Lens 1|Adverse Event|1|||
143264872|NCT02423109|516525085|FG001|Lens 1|Adverse Event|0|||
143264873|NCT02428608|516525086|FG000|Overall Study|Pregnancy|2|||
143264874|NCT02428608|516525086|FG000|Overall Study|Lost to Follow-up|37|||
143264875|NCT02428608|516525086|FG000|Overall Study|Withdrawal by Subject|2|||
143264876|NCT02428608|516525086|FG000|Overall Study|scheduling conflicts|15|||
143264877|NCT02428608|516525086|FG000|Overall Study|moved away|10|||
143264878|NCT02428608|516525086|FG000|Overall Study|Death|1|||
143264879|NCT02428608|516525086|FG000|Overall Study|various|16|||
143264880|NCT01092507|516525087|FG000|Overall Study|Withdrawal by Subject|2|||
143264881|NCT01092507|516525088|FG001|Overall Study|Withdrawal by Subject|0|||
143264882|NCT03468985|516525089|FG000|Overall Study|Adverse Event|0|||
143264883|NCT03468985|516525090|FG001|Overall Study|Adverse Event|2|||
143264884|NCT03468985|516525091|FG002|Overall Study|Adverse Event|0|||
143264885|NCT03468985|516525092|FG003|Overall Study|Adverse Event|0|||
143264886|NCT03468985|516525089|FG000|Overall Study|Withdrawal by Subject|0|||
143264887|NCT03468985|516525090|FG001|Overall Study|Withdrawal by Subject|0|||
143264888|NCT03468985|516525091|FG002|Overall Study|Withdrawal by Subject|0|||
143264889|NCT03468985|516525092|FG003|Overall Study|Withdrawal by Subject|1|||
143264890|NCT04060862|516525093|FG000|Overall Study|Symptomatic Deterioration|1|||
143264891|NCT04060862|516525093|FG000|Overall Study|Un-specified|6|||
143264892|NCT04060862|516525093|FG000|Overall Study|Progressive disease|12|||
143264893|NCT04060862|516525093|FG000|Overall Study|Physician Decision|1|||
143264894|NCT04629508|516525094|FG000|Overall Study|Adverse Event|1|||
143264895|NCT04629508|516525094|FG000|Overall Study|Death|2|||
143264896|NCT04629508|516525094|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
143264897|NCT00608543|516525099|FG000|Overall Study|Adverse Event|4|||
143264898|NCT04087213|516525100|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
143264899|NCT04087213|516525100|FG000|In-Facility Introduction|Adverse Event|1|||
143211640|NCT01717326|516319684|FG007|Overall Study|Withdrawal by Subject|0|||
143211641|NCT01717326|516319685|FG008|Overall Study|Withdrawal by Subject|0|||
143211642|NCT01717326|516319686|FG009|Overall Study|Withdrawal by Subject|1|||
143211643|NCT01717326|516319687|FG010|Overall Study|Withdrawal by Subject|0|||
143211644|NCT01717326|516319688|FG011|Overall Study|Withdrawal by Subject|0|||
143211645|NCT01717326|516319689|FG012|Overall Study|Withdrawal by Subject|1|||
143211646|NCT01717326|516319690|FG013|Overall Study|Withdrawal by Subject|0|||
143211647|NCT01717326|516319691|FG014|Overall Study|Withdrawal by Subject|0|||
143211648|NCT01717326|516319692|FG015|Overall Study|Withdrawal by Subject|1|||
143211649|NCT01717326|516319693|FG016|Overall Study|Withdrawal by Subject|0|||
143211650|NCT01717326|516319694|FG017|Overall Study|Withdrawal by Subject|0|||
143211651|NCT01717326|516319695|FG018|Overall Study|Withdrawal by Subject|2|||
143211652|NCT01717326|516319696|FG019|Overall Study|Withdrawal by Subject|3|||
143211653|NCT01123707|516319697|FG000|Overall Study|Lost to Follow-up|3|||
143211654|NCT01123707|516319698|FG001|Overall Study|Lost to Follow-up|1|||
143211655|NCT01123707|516319699|FG002|Overall Study|Lost to Follow-up|3|||
143211656|NCT01123707|516319700|FG003|Overall Study|Lost to Follow-up|2|||
143211657|NCT01123707|516319697|FG000|Overall Study|Adverse Event|5|||
143211658|NCT01123707|516319698|FG001|Overall Study|Adverse Event|7|||
143211659|NCT01123707|516319699|FG002|Overall Study|Adverse Event|5|||
143211660|NCT01123707|516319700|FG003|Overall Study|Adverse Event|3|||
143211661|NCT01123707|516319697|FG000|Overall Study|Sponsor Discontinued Study|30|||
143211662|NCT01123707|516319698|FG001|Overall Study|Sponsor Discontinued Study|24|||
143211663|NCT01123707|516319699|FG002|Overall Study|Sponsor Discontinued Study|25|||
143211664|NCT01123707|516319700|FG003|Overall Study|Sponsor Discontinued Study|40|||
143211665|NCT01123707|516319697|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
143211666|NCT01123707|516319698|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
143211667|NCT01123707|516319699|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
143211668|NCT01123707|516319700|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
143211669|NCT01123707|516319697|FG000|Overall Study|Investigator Withdrew Participant|0|||
143211670|NCT01123707|516319698|FG001|Overall Study|Investigator Withdrew Participant|1|||
143211671|NCT01123707|516319699|FG002|Overall Study|Investigator Withdrew Participant|1|||
143211672|NCT01123707|516319700|FG003|Overall Study|Investigator Withdrew Participant|1|||
143211673|NCT01123707|516319697|FG000|Overall Study|Subject Withdrew Consent|4|||
143211674|NCT01123707|516319698|FG001|Overall Study|Subject Withdrew Consent|5|||
143211675|NCT01123707|516319699|FG002|Overall Study|Subject Withdrew Consent|1|||
143211676|NCT01123707|516319700|FG003|Overall Study|Subject Withdrew Consent|2|||
143211677|NCT01123707|516319697|FG000|Overall Study|Lack of Efficacy|1|||
143211678|NCT01123707|516319698|FG001|Overall Study|Lack of Efficacy|2|||
143211679|NCT01123707|516319699|FG002|Overall Study|Lack of Efficacy|1|||
143211680|NCT01123707|516319700|FG003|Overall Study|Lack of Efficacy|0|||
143211681|NCT01123707|516319697|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
143211682|NCT01123707|516319698|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
143211683|NCT01123707|516319699|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
143211684|NCT01123707|516319700|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
143211685|NCT01114438|516319701|FG000|Overall Study|Adverse Event|10|||
143211686|NCT01114438|516319701|FG000|Overall Study|concomitant medication|1|||
143211687|NCT01114438|516319701|FG000|Overall Study|Physician Decision|1|||
143211688|NCT01114438|516319701|FG000|Overall Study|Withdrawal by Subject|2|||
143211689|NCT00428844|516319704|FG000|Completed Study Drug Treatment|Adverse Event|2|||
143211690|NCT00428844|516319705|FG001|Completed Study Drug Treatment|Adverse Event|4|||
143211691|NCT00428844|516319706|FG002|Completed Study Drug Treatment|Adverse Event|4|||
143211692|NCT00428844|516319704|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
143211693|NCT00428844|516319705|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
143211694|NCT00428844|516319706|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
143211695|NCT00428844|516319704|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
143211696|NCT00428844|516319705|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
143211697|NCT00428844|516319706|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
143370823|NCT00878722|516901125|FG007|Overall Study|Adverse Event|0|||
143370824|NCT00878722|516901118|FG000|Overall Study|Withdrawal by Subject|0|||
143370825|NCT00878722|516901119|FG001|Overall Study|Withdrawal by Subject|0|||
143370826|NCT00878722|516901120|FG002|Overall Study|Withdrawal by Subject|0|||
143370827|NCT00878722|516901121|FG003|Overall Study|Withdrawal by Subject|0|||
143370828|NCT00878722|516901122|FG004|Overall Study|Withdrawal by Subject|0|||
143370829|NCT00878722|516901123|FG005|Overall Study|Withdrawal by Subject|0|||
143370830|NCT00878722|516901124|FG006|Overall Study|Withdrawal by Subject|0|||
143370831|NCT00878722|516901125|FG007|Overall Study|Withdrawal by Subject|2|||
143370832|NCT00878722|516901118|FG000|Overall Study|Relapse|0|||
143370833|NCT00878722|516901119|FG001|Overall Study|Relapse|0|||
143370834|NCT00878722|516901120|FG002|Overall Study|Relapse|0|||
143370835|NCT00878722|516901121|FG003|Overall Study|Relapse|1|||
143370836|NCT00878722|516901122|FG004|Overall Study|Relapse|0|||
143370837|NCT00878722|516901123|FG005|Overall Study|Relapse|0|||
143370838|NCT00878722|516901124|FG006|Overall Study|Relapse|0|||
143370839|NCT00878722|516901125|FG007|Overall Study|Relapse|0|||
143370840|NCT00383188|516901126|FG000|Overall Study|Adverse Event|4|||
143370841|NCT00383188|516901127|FG001|Overall Study|Adverse Event|7|||
143370842|NCT00383188|516901128|FG002|Overall Study|Adverse Event|9|||
143370843|NCT00383188|516901129|FG003|Overall Study|Adverse Event|8|||
143370844|NCT00383188|516901130|FG004|Overall Study|Adverse Event|8|||
143370845|NCT00383188|516901126|FG000|Overall Study|Lack of Efficacy|9|||
143370846|NCT00383188|516901127|FG001|Overall Study|Lack of Efficacy|3|||
143370847|NCT00383188|516901128|FG002|Overall Study|Lack of Efficacy|3|||
143370848|NCT00383188|516901129|FG003|Overall Study|Lack of Efficacy|2|||
143370849|NCT00383188|516901130|FG004|Overall Study|Lack of Efficacy|6|||
143264900|NCT04087213|516525100|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
143264901|NCT04087213|516525100|FG000|Assisted Evaluable Period|Personal reasons|3|||
143264902|NCT04087213|516525100|FG000|Transition Period B|Renal Transplantation|1|||
143264903|NCT02545075|516525103|FG000|Randomization|Lost to Follow-up|0|||
143264904|NCT02545075|516525104|FG001|Randomization|Lost to Follow-up|1|||
143264905|NCT02545075|516525103|FG000|Randomization|Withdrawal by Subject|0|||
143264906|NCT02545075|516525104|FG001|Randomization|Withdrawal by Subject|6|||
143264907|NCT02545075|516525103|FG000|Treatment|Disease progression|71|||
143264908|NCT02545075|516525104|FG001|Treatment|Disease progression|32|||
143264909|NCT02545075|516525103|FG000|Treatment|Participant dicontinued study treatment|7|||
143264910|NCT02545075|516525104|FG001|Treatment|Participant dicontinued study treatment|9|||
143264911|NCT02545075|516525103|FG000|Treatment|Withdrawal by Subject|1|||
143264912|NCT02545075|516525104|FG001|Treatment|Withdrawal by Subject|0|||
143264913|NCT02545075|516525103|FG000|Treatment|Adverse event not related to study drug|1|||
143264914|NCT02545075|516525104|FG001|Treatment|Adverse event not related to study drug|0|||
143264915|NCT02545075|516525103|FG000|Treatment|Death|1|||
143370850|NCT00383188|516901126|FG000|Overall Study|Other|3|||
143370851|NCT00383188|516901127|FG001|Overall Study|Other|1|||
143370852|NCT00383188|516901128|FG002|Overall Study|Other|0|||
143370853|NCT00383188|516901129|FG003|Overall Study|Other|2|||
143370854|NCT00383188|516901130|FG004|Overall Study|Other|6|||
143370855|NCT00383188|516901126|FG000|Overall Study|No longer willing to participate|1|||
143370856|NCT00383188|516901127|FG001|Overall Study|No longer willing to participate|0|||
143370857|NCT00383188|516901128|FG002|Overall Study|No longer willing to participate|1|||
143370858|NCT00383188|516901129|FG003|Overall Study|No longer willing to participate|0|||
143370859|NCT00383188|516901130|FG004|Overall Study|No longer willing to participate|2|||
143370860|NCT00383188|516901126|FG000|Overall Study|Lost to Follow-up|0|||
143370861|NCT00383188|516901127|FG001|Overall Study|Lost to Follow-up|0|||
143370862|NCT00383188|516901128|FG002|Overall Study|Lost to Follow-up|0|||
143370863|NCT00383188|516901129|FG003|Overall Study|Lost to Follow-up|0|||
143370864|NCT00383188|516901130|FG004|Overall Study|Lost to Follow-up|1|||
143370865|NCT02873754|516901131|FG000|Overall Study|Lost to Follow-up|5|||
143264916|NCT02545075|516525104|FG001|Treatment|Death|0|||
143264917|NCT02545075|516525103|FG000|Treatment|Participant drug toxicity|1|||
143370866|NCT02873754|516901131|FG000|Overall Study|Couldn't complete study procedures|1|||
143370867|NCT00972504|516901132|FG000|Overall Study|Adverse Event|2|||
143370868|NCT00972504|516901132|FG000|Overall Study|Investigator discretion|1|||
143370869|NCT00597519|516901133|FG000|Overall Study|Death|1|||
143370870|NCT04246762|516901134|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
143370871|NCT00410124|516901135|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
143370872|NCT00410124|516901136|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
143370873|NCT00410124|516901135|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
143370874|NCT00410124|516901136|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
143370875|NCT00410124|516901135|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
143370876|NCT00410124|516901136|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
143370877|NCT00410124|516901135|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
143264918|NCT02545075|516525104|FG001|Treatment|Participant drug toxicity|0|||
143264919|NCT02545075|516525103|FG000|Treatment|Completed treatment|40|||
143264920|NCT02545075|516525104|FG001|Treatment|Completed treatment|12|||
143211698|NCT00428844|516319704|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
143211699|NCT00428844|516319705|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
143211700|NCT00428844|516319706|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
143211701|NCT00428844|516319704|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
143211702|NCT00428844|516319705|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
143211703|NCT00428844|516319706|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
143211704|NCT00428844|516319704|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
143211705|NCT00428844|516319705|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
143211706|NCT00428844|516319706|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
143211707|NCT00428844|516319704|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
143211708|NCT00428844|516319705|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
143211709|NCT00428844|516319706|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
143211710|NCT00428844|516319704|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
143211711|NCT00428844|516319705|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
143211712|NCT00428844|516319706|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
143211713|NCT00428844|516319704|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
143211714|NCT00428844|516319705|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
143211715|NCT00428844|516319706|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
143211716|NCT00605345|516319711|FG000|Overall Study|Withdrawal by Subject|1|||
143211717|NCT00605345|516319712|FG001|Overall Study|Withdrawal by Subject|0|||
143211718|NCT00605345|516319711|FG000|Overall Study|Adverse Event|0|||
143211719|NCT00605345|516319712|FG001|Overall Study|Adverse Event|1|||
143211720|NCT00605345|516319711|FG000|Overall Study|Protocol Violation|0|||
143211721|NCT00605345|516319712|FG001|Overall Study|Protocol Violation|2|||
143211722|NCT02577016|516319713|FG000|Overall Study|Adverse Event|2|||
143211723|NCT02577016|516319714|FG001|Overall Study|Adverse Event|1|||
143370878|NCT00410124|516901136|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
143370879|NCT00410124|516901135|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
143211724|NCT02577016|516319713|FG000|Overall Study|Physician Decision|0|||
143211725|NCT02577016|516319714|FG001|Overall Study|Physician Decision|1|||
143211726|NCT02126839|516319715|FG000|Overall Study|Adverse Event|0|||
143211727|NCT02126839|516319716|FG001|Overall Study|Adverse Event|1|||
143211728|NCT02126839|516319715|FG000|Overall Study|Withdrawal by Subject|1|||
143211729|NCT02126839|516319716|FG001|Overall Study|Withdrawal by Subject|0|||
143211730|NCT02126839|516319715|FG000|Overall Study|Withdrawal by parent/guardian|1|||
143211731|NCT02126839|516319716|FG001|Overall Study|Withdrawal by parent/guardian|0|||
143211732|NCT02126839|516319715|FG000|Overall Study|Protocol Violation|2|||
143211733|NCT02126839|516319716|FG001|Overall Study|Protocol Violation|3|||
143211734|NCT02126839|516319715|FG000|Overall Study|Sponsor request|0|||
143211735|NCT02126839|516319716|FG001|Overall Study|Sponsor request|1|||
143211736|NCT02126839|516319715|FG000|Overall Study|Lost to Follow-up|1|||
143211737|NCT02126839|516319716|FG001|Overall Study|Lost to Follow-up|4|||
143211738|NCT02126839|516319715|FG000|Overall Study|Other|5|||
143211739|NCT02126839|516319716|FG001|Overall Study|Other|5|||
143211740|NCT00422383|516319717|FG000|Overall Study|Adverse Event|5|||
143211741|NCT00422383|516319718|FG001|Overall Study|Adverse Event|3|||
143211742|NCT00422383|516319719|FG002|Overall Study|Adverse Event|1|||
143211743|NCT00422383|516319720|FG003|Overall Study|Adverse Event|1|||
143211744|NCT00422383|516319721|FG004|Overall Study|Adverse Event|0|||
143211745|NCT00422383|516319717|FG000|Overall Study|Lack of Efficacy|4|||
143211746|NCT00422383|516319718|FG001|Overall Study|Lack of Efficacy|4|||
143211747|NCT00422383|516319719|FG002|Overall Study|Lack of Efficacy|2|||
143211748|NCT00422383|516319720|FG003|Overall Study|Lack of Efficacy|1|||
143211749|NCT00422383|516319721|FG004|Overall Study|Lack of Efficacy|1|||
143211750|NCT00422383|516319717|FG000|Overall Study|Lost to Follow-up|0|||
143211751|NCT00422383|516319718|FG001|Overall Study|Lost to Follow-up|1|||
143211752|NCT00422383|516319719|FG002|Overall Study|Lost to Follow-up|0|||
143211753|NCT00422383|516319720|FG003|Overall Study|Lost to Follow-up|0|||
143211754|NCT00422383|516319721|FG004|Overall Study|Lost to Follow-up|1|||
143211755|NCT00422383|516319717|FG000|Overall Study|Protocol Violation|1|||
143211756|NCT00422383|516319718|FG001|Overall Study|Protocol Violation|1|||
143211757|NCT00422383|516319719|FG002|Overall Study|Protocol Violation|1|||
143211758|NCT00422383|516319720|FG003|Overall Study|Protocol Violation|0|||
143211759|NCT00422383|516319721|FG004|Overall Study|Protocol Violation|0|||
143211760|NCT00422383|516319717|FG000|Overall Study|Withdrawal by Subject|5|||
143211761|NCT00422383|516319718|FG001|Overall Study|Withdrawal by Subject|5|||
143211762|NCT00422383|516319719|FG002|Overall Study|Withdrawal by Subject|0|||
143211763|NCT00422383|516319720|FG003|Overall Study|Withdrawal by Subject|0|||
143211764|NCT00422383|516319721|FG004|Overall Study|Withdrawal by Subject|1|||
143211765|NCT00566254|516319722|FG000|Overall Study|Adverse Event|3|||
143211766|NCT00566254|516319723|FG001|Overall Study|Adverse Event|1|||
143211767|NCT00566254|516319722|FG000|Overall Study|Protocol Violation|1|||
143211768|NCT00566254|516319723|FG001|Overall Study|Protocol Violation|3|||
143211769|NCT00566254|516319722|FG000|Overall Study|Withdrawal by Subject|1|||
143211770|NCT00566254|516319723|FG001|Overall Study|Withdrawal by Subject|2|||
143211771|NCT00566254|516319722|FG000|Overall Study|Lack of Efficacy|5|||
143211772|NCT00566254|516319723|FG001|Overall Study|Lack of Efficacy|6|||
143211773|NCT00566254|516319722|FG000|Overall Study|Other|0|||
143211774|NCT00566254|516319723|FG001|Overall Study|Other|2|||
143211775|NCT00411632|516319724|FG000|Overall Study|Death|1|||
143211776|NCT01108523|516319725|FG000|Overall Study|Protocol Violation|4|||
143211777|NCT00761527|516319728|FG000|Overall Study|Adverse Event|3|||
143211778|NCT00761527|516319728|FG000|Overall Study|Poor Compliance|8|||
143211779|NCT00761527|516319728|FG000|Overall Study|Lost to Follow-up|9|||
143211780|NCT00761527|516319728|FG000|Overall Study|Unknown reason|2|||
143211781|NCT02467582|516321886|FG000|Allocation|Withdrawal by Subject|1|||
143264921|NCT01068652|516525106|FG000|Overall Study|Adverse Event|4|||
143211782|NCT02467582|516321887|FG001|Allocation|Withdrawal by Subject|0|||
143211783|NCT02467582|516321886|FG000|Follow-up|Death|5|||
143211784|NCT02467582|516321887|FG001|Follow-up|Death|4|||
143211785|NCT02467582|516321886|FG000|Follow-up|Lost to Follow-up|6|||
143211786|NCT02467582|516321887|FG001|Follow-up|Lost to Follow-up|5|||
143211787|NCT00703924|516321888|FG000|Overall Study|Withdrawal by Subject|1|||
143211788|NCT00703924|516321889|FG001|Overall Study|Withdrawal by Subject|1|||
143211789|NCT01031979|516321892|FG000|Overall Study|Lost to Follow-up|5|||
143211790|NCT01031979|516321893|FG001|Overall Study|Lost to Follow-up|4|||
143211791|NCT03592368|516321895|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
143211792|NCT03592368|516321896|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
143264922|NCT01068652|516525107|FG001|Overall Study|Adverse Event|0|||
143211793|NCT03592368|516321897|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
143211794|NCT03592368|516321898|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
143211795|NCT03592368|516321895|FG000|Overall Study|Adverse Event|0|||
143211796|NCT03592368|516321896|FG001|Overall Study|Adverse Event|0|||
143211797|NCT03592368|516321897|FG002|Overall Study|Adverse Event|0|||
143211798|NCT03592368|516321898|FG003|Overall Study|Adverse Event|1|||
143211799|NCT03592368|516321895|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
143211800|NCT03592368|516321896|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
143211801|NCT03592368|516321897|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
143211802|NCT03592368|516321898|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
143211803|NCT03831100|516321899|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
143211804|NCT03831100|516321900|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
143211805|NCT02454478|516321907|FG000|Overall Study|Incomplete DLT Evaluation|1|||
143211806|NCT01971008|516321917|FG000|Overall Study|Protocol Violation|2|||
143211807|NCT01971008|516321918|FG001|Overall Study|Protocol Violation|1|||
143211808|NCT00858208|516321921|FG000|Overall Study|Adverse Event|3|||
143211809|NCT00858208|516321921|FG000|Overall Study|Lost to Follow-up|26|||
143211810|NCT00858208|516321921|FG000|Overall Study|Participant refused|40|||
143211811|NCT00858208|516321921|FG000|Overall Study|Other|10|||
143211812|NCT01110382|516321924|FG000|Overall Study|Withdrawal by Subject|0|||
143211813|NCT01110382|516321925|FG001|Overall Study|Withdrawal by Subject|1|||
143211814|NCT01110382|516321924|FG000|Overall Study|Protocol Violation|0|||
143211815|NCT01110382|516321925|FG001|Overall Study|Protocol Violation|1|||
143211816|NCT00098306|516321928|FG000|Double Blind|Randomized, not treated|9|||
143211817|NCT00098306|516321929|FG001|Double Blind|Randomized, not treated|5|||
143211818|NCT00098306|516321930|FG002|Double Blind|Randomized, not treated|2|||
143211819|NCT00098306|516321931|FG003|Double Blind|Randomized, not treated|0|||
143211820|NCT00098306|516321932|FG004|Double Blind|Randomized, not treated|0|||
143211821|NCT00098306|516321933|FG005|Double Blind|Randomized, not treated|0|||
143211822|NCT00098306|516321934|FG006|Double Blind|Randomized, not treated|0|||
143211823|NCT00098306|516321928|FG000|Double Blind|Ongoing at cut-off date|151|||
143211824|NCT00098306|516321929|FG001|Double Blind|Ongoing at cut-off date|166|||
143211825|NCT00098306|516321930|FG002|Double Blind|Ongoing at cut-off date|72|||
143211826|NCT00098306|516321931|FG003|Double Blind|Ongoing at cut-off date|0|||
143211827|NCT00098306|516321932|FG004|Double Blind|Ongoing at cut-off date|0|||
143264923|NCT01068652|516525106|FG000|Overall Study|Lack of Efficacy|0|||
143264924|NCT01068652|516525107|FG001|Overall Study|Lack of Efficacy|2|||
143264925|NCT01068652|516525106|FG000|Overall Study|Lost to Follow-up|2|||
143264926|NCT01068652|516525107|FG001|Overall Study|Lost to Follow-up|1|||
143264927|NCT01068652|516525106|FG000|Overall Study|Protocol Violation|3|||
143264928|NCT01068652|516525107|FG001|Overall Study|Protocol Violation|6|||
143264929|NCT01068652|516525106|FG000|Overall Study|Withdrawal criteria|1|||
143211828|NCT00098306|516321933|FG005|Double Blind|Ongoing at cut-off date|0|||
143211829|NCT00098306|516321934|FG006|Double Blind|Ongoing at cut-off date|0|||
143211830|NCT00098306|516321928|FG000|Double Blind|Adverse Event|11|||
143211831|NCT00098306|516321929|FG001|Double Blind|Adverse Event|10|||
143211832|NCT00098306|516321930|FG002|Double Blind|Adverse Event|6|||
143211833|NCT00098306|516321931|FG003|Double Blind|Adverse Event|0|||
143211834|NCT00098306|516321932|FG004|Double Blind|Adverse Event|0|||
143211835|NCT00098306|516321933|FG005|Double Blind|Adverse Event|0|||
143211836|NCT00098306|516321934|FG006|Double Blind|Adverse Event|0|||
143211837|NCT00098306|516321928|FG000|Double Blind|Lack of Efficacy|43|||
143211838|NCT00098306|516321929|FG001|Double Blind|Lack of Efficacy|34|||
143211839|NCT00098306|516321930|FG002|Double Blind|Lack of Efficacy|17|||
143211840|NCT00098306|516321931|FG003|Double Blind|Lack of Efficacy|0|||
143211841|NCT00098306|516321932|FG004|Double Blind|Lack of Efficacy|0|||
143211842|NCT00098306|516321933|FG005|Double Blind|Lack of Efficacy|0|||
143211843|NCT00098306|516321934|FG006|Double Blind|Lack of Efficacy|0|||
143264930|NCT01068652|516525107|FG001|Overall Study|Withdrawal criteria|2|||
143264931|NCT01068652|516525106|FG000|Overall Study|Patient was not eligible|1|||
143264932|NCT01068652|516525107|FG001|Overall Study|Patient was not eligible|0|||
143264933|NCT01068652|516525106|FG000|Overall Study|Unclassified|7|||
143264934|NCT01068652|516525107|FG001|Overall Study|Unclassified|4|||
143264935|NCT02147184|516525108|FG000|Overall Study|Lost to Follow-up|28|||
143264936|NCT02147184|516525109|FG001|Overall Study|Lost to Follow-up|15|||
143264937|NCT02147184|516525108|FG000|Overall Study|Study Burden|11|||
143264938|NCT02147184|516525109|FG001|Overall Study|Study Burden|7|||
143264939|NCT02147184|516525108|FG000|Overall Study|Pregnancy|6|||
143264940|NCT02147184|516525109|FG001|Overall Study|Pregnancy|0|||
143264941|NCT02147184|516525108|FG000|Overall Study|Moved out of state|3|||
143264942|NCT02147184|516525109|FG001|Overall Study|Moved out of state|3|||
143264943|NCT02147184|516525108|FG000|Overall Study|Physician Decision|0|||
143264944|NCT02147184|516525109|FG001|Overall Study|Physician Decision|2|||
143264945|NCT02147184|516525108|FG000|Overall Study|Other|1|||
143264946|NCT02147184|516525109|FG001|Overall Study|Other|0|||
143264947|NCT00417482|516525114|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
143264948|NCT00417482|516525115|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
143264949|NCT00417482|516525116|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
143264950|NCT00417482|516525114|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
143264951|NCT00417482|516525115|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
143264952|NCT00417482|516525116|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
143264953|NCT00417482|516525114|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
143264954|NCT00417482|516525115|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
143264955|NCT00417482|516525116|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
143264956|NCT00417482|516525114|FG000|Phase B 1st 16 Weeks|Death|1|||
143264957|NCT00417482|516525115|FG001|Phase B 1st 16 Weeks|Death|0|||
143264958|NCT00417482|516525116|FG002|Phase B 1st 16 Weeks|Death|0|||
143264959|NCT00417482|516525114|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
143264960|NCT00417482|516525115|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
143264961|NCT00417482|516525116|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
143264962|NCT00417482|516525114|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
143264963|NCT00417482|516525115|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
143264964|NCT00417482|516525116|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
143211844|NCT00098306|516321928|FG000|Double Blind|Death|1|||
143264965|NCT00417482|516525114|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
143264966|NCT00417482|516525115|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
143211845|NCT00098306|516321929|FG001|Double Blind|Death|4|||
143211846|NCT00098306|516321930|FG002|Double Blind|Death|1|||
143211847|NCT00098306|516321931|FG003|Double Blind|Death|0|||
143211848|NCT00098306|516321932|FG004|Double Blind|Death|0|||
143211849|NCT00098306|516321933|FG005|Double Blind|Death|0|||
143264967|NCT00417482|516525116|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
143264968|NCT00417482|516525114|FG000|Phase B 2nd 16 Weeks|Death|1|||
143264969|NCT00417482|516525115|FG001|Phase B 2nd 16 Weeks|Death|1|||
143264970|NCT00417482|516525116|FG002|Phase B 2nd 16 Weeks|Death|0|||
143211850|NCT00098306|516321934|FG006|Double Blind|Death|0|||
143211851|NCT00098306|516321928|FG000|Double Blind|Participant defaulted|19|||
143211852|NCT00098306|516321929|FG001|Double Blind|Participant defaulted|18|||
143211853|NCT00098306|516321930|FG002|Double Blind|Participant defaulted|11|||
143264971|NCT06400979|516525117|FG000|Overall Study|Lost to Follow-up|29|||
143264972|NCT06400979|516525117|FG000|Overall Study|Withdrawal by Subject|1|||
143264973|NCT00117286|516525118|FG000|Overall Study|Adverse Event|12|||
143264974|NCT00117286|516525119|FG001|Overall Study|Adverse Event|6|||
143264975|NCT00117286|516525118|FG000|Overall Study|Lost to Follow-up|2|||
143264976|NCT00117286|516525119|FG001|Overall Study|Lost to Follow-up|0|||
143264977|NCT00117286|516525118|FG000|Overall Study|Protocol Violation|3|||
143264978|NCT00117286|516525119|FG001|Overall Study|Protocol Violation|3|||
143211854|NCT00098306|516321931|FG003|Double Blind|Participant defaulted|0|||
143211855|NCT00098306|516321932|FG004|Double Blind|Participant defaulted|0|||
143211856|NCT00098306|516321933|FG005|Double Blind|Participant defaulted|0|||
143264979|NCT00117286|516525118|FG000|Overall Study|Withdrawal by Subject|6|||
143264980|NCT00117286|516525119|FG001|Overall Study|Withdrawal by Subject|2|||
143264981|NCT00117286|516525118|FG000|Overall Study|Physician Decision|3|||
143264982|NCT00117286|516525119|FG001|Overall Study|Physician Decision|7|||
143264983|NCT00117286|516525118|FG000|Overall Study|Lack of Efficacy|2|||
143264984|NCT00117286|516525119|FG001|Overall Study|Lack of Efficacy|1|||
143264985|NCT00117286|516525118|FG000|Overall Study|Research site closing|0|||
143264986|NCT00117286|516525119|FG001|Overall Study|Research site closing|2|||
143264987|NCT01272661|516525120|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
143264988|NCT01272661|516525121|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
143264989|NCT01272661|516525122|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
143264990|NCT02314143|516525123|FG000|Overall Study|Adverse Event|0|||
143264991|NCT02314143|516525124|FG001|Overall Study|Adverse Event|6|||
143264992|NCT02314143|516525125|FG002|Overall Study|Adverse Event|4|||
143264993|NCT02314143|516525123|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
143264994|NCT02314143|516525124|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
143264995|NCT02314143|516525125|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
143264996|NCT02314143|516525123|FG000|Overall Study|Physician Decision|2|||
143264997|NCT02314143|516525124|FG001|Overall Study|Physician Decision|1|||
143264998|NCT02314143|516525125|FG002|Overall Study|Physician Decision|0|||
143264999|NCT02314143|516525123|FG000|Overall Study|Withdrawal by Subject|1|||
143265000|NCT02314143|516525124|FG001|Overall Study|Withdrawal by Subject|0|||
143265001|NCT02314143|516525125|FG002|Overall Study|Withdrawal by Subject|1|||
143265002|NCT01982331|516525126|FG000|Received Vaccination 2|Adverse Event|1|||
143265003|NCT01982331|516525127|FG001|Received Vaccination 2|Adverse Event|2|||
143265004|NCT01982331|516525126|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
143265005|NCT01982331|516525127|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
143265006|NCT01982331|516525126|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
143265007|NCT01982331|516525127|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
143265008|NCT01977937|516525128|FG000|Overall Study|Withdrawal by Subject|2|||
143265009|NCT01977937|516525129|FG001|Overall Study|Withdrawal by Subject|1|||
143265010|NCT01977937|516525128|FG000|Overall Study|Adverse Event|1|||
143265011|NCT01977937|516525129|FG001|Overall Study|Adverse Event|0|||
143265012|NCT01977937|516525128|FG000|Overall Study|Physician Decision|0|||
143265013|NCT01977937|516525129|FG001|Overall Study|Physician Decision|1|||
143265014|NCT03004443|516525130|FG000|Overall Study|Pregnancy|0|||
143265015|NCT03004443|516525131|FG001|Overall Study|Pregnancy|1|||
143265016|NCT00828854|516525135|FG000|Overall Study|Disease Progression|17|||
143265017|NCT00828854|516525135|FG000|Overall Study|Adverse Event|9|||
143265018|NCT00828854|516525135|FG000|Overall Study|Reason not Specified|1|||
143211857|NCT00098306|516321934|FG006|Double Blind|Participant defaulted|0|||
143211858|NCT00098306|516321928|FG000|Double Blind|Un-specified|7|||
143211859|NCT00098306|516321929|FG001|Double Blind|Un-specified|3|||
143211860|NCT00098306|516321930|FG002|Double Blind|Un-specified|11|||
143211861|NCT00098306|516321931|FG003|Double Blind|Un-specified|0|||
143211862|NCT00098306|516321932|FG004|Double Blind|Un-specified|0|||
143211863|NCT00098306|516321933|FG005|Double Blind|Un-specified|0|||
143211864|NCT00098306|516321934|FG006|Double Blind|Un-specified|0|||
143211865|NCT00098306|516321928|FG000|Open Label|Lack of Efficacy|0|||
143211866|NCT00098306|516321929|FG001|Open Label|Lack of Efficacy|0|||
143211867|NCT00098306|516321930|FG002|Open Label|Lack of Efficacy|0|||
143211868|NCT00098306|516321931|FG003|Open Label|Lack of Efficacy|13|||
143211869|NCT00098306|516321932|FG004|Open Label|Lack of Efficacy|0|||
143211870|NCT00098306|516321933|FG005|Open Label|Lack of Efficacy|0|||
143211871|NCT00098306|516321934|FG006|Open Label|Lack of Efficacy|0|||
143265019|NCT00915356|516525136|FG000|Overall Study|Withdrawal by Subject|1|||
143265020|NCT00915356|516525137|FG001|Overall Study|Withdrawal by Subject|0|||
143265021|NCT00915356|516525138|FG002|Overall Study|Withdrawal by Subject|0|||
143265022|NCT00915356|516525139|FG003|Overall Study|Withdrawal by Subject|0|||
143265023|NCT00915356|516525140|FG004|Overall Study|Withdrawal by Subject|0|||
143265024|NCT05211284|516525146|FG000|Overall Study|Study Terminated|3|||
143265025|NCT05211284|516525147|FG001|Overall Study|Study Terminated|1|||
143265026|NCT03911843|516525153|FG000|Overall Study|Adverse Event|2|||
143211872|NCT00098306|516321928|FG000|Open Label|Adverse Event|0|||
143370880|NCT00410124|516901136|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
143370881|NCT00410124|516901135|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
143370882|NCT00410124|516901136|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
143370883|NCT00410124|516901135|FG000|Core Phase Double Blind (15 Months)|Death|7|||
143370884|NCT00410124|516901136|FG001|Core Phase Double Blind (15 Months)|Death|4|||
143370885|NCT00410124|516901135|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
143370886|NCT00410124|516901136|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
143370887|NCT00410124|516901135|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
143370888|NCT00410124|516901136|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
143370889|NCT00410124|516901135|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
143370890|NCT00410124|516901136|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
143370891|NCT00410124|516901135|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
143370892|NCT00410124|516901136|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
143370893|NCT00410124|516901135|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
143370894|NCT00410124|516901136|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
143370895|NCT00410124|516901135|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
143370896|NCT00410124|516901136|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
143370897|NCT00410124|516901135|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
143370898|NCT00410124|516901136|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
143370899|NCT00410124|516901135|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
143370900|NCT00410124|516901136|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
143370901|NCT00410124|516901135|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
143370902|NCT00410124|516901136|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
143370903|NCT02341625|516901144|FG000|Overall Study|Disease Progression|2|||
143370904|NCT02341625|516901145|FG001|Overall Study|Disease Progression|2|||
143370905|NCT02341625|516901146|FG002|Overall Study|Disease Progression|3|||
143370906|NCT02341625|516901147|FG003|Overall Study|Disease Progression|6|||
143370907|NCT02341625|516901148|FG004|Overall Study|Disease Progression|7|||
143370908|NCT02341625|516901149|FG005|Overall Study|Disease Progression|7|||
143370909|NCT02341625|516901150|FG006|Overall Study|Disease Progression|28|||
143370910|NCT02341625|516901151|FG007|Overall Study|Disease Progression|5|||
143370911|NCT02341625|516901152|FG008|Overall Study|Disease Progression|4|||
143370912|NCT02341625|516901153|FG009|Overall Study|Disease Progression|19|||
143370913|NCT02341625|516901144|FG000|Overall Study|Study Drug Toxicity|0|||
143370914|NCT02341625|516901145|FG001|Overall Study|Study Drug Toxicity|0|||
143370915|NCT02341625|516901146|FG002|Overall Study|Study Drug Toxicity|0|||
143370916|NCT02341625|516901147|FG003|Overall Study|Study Drug Toxicity|1|||
143370917|NCT02341625|516901148|FG004|Overall Study|Study Drug Toxicity|0|||
143370918|NCT02341625|516901149|FG005|Overall Study|Study Drug Toxicity|3|||
143370919|NCT02341625|516901150|FG006|Overall Study|Study Drug Toxicity|10|||
143370920|NCT02341625|516901151|FG007|Overall Study|Study Drug Toxicity|0|||
143370921|NCT02341625|516901152|FG008|Overall Study|Study Drug Toxicity|0|||
143370922|NCT02341625|516901153|FG009|Overall Study|Study Drug Toxicity|3|||
143370923|NCT02341625|516901144|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
143370924|NCT02341625|516901145|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
143370925|NCT02341625|516901146|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
143370926|NCT02341625|516901147|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
143370927|NCT02341625|516901148|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
143370928|NCT02341625|516901149|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
143370929|NCT02341625|516901150|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
143370930|NCT02341625|516901151|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
143370931|NCT02341625|516901152|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
143370932|NCT02341625|516901153|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
143370933|NCT02341625|516901144|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
143370934|NCT02341625|516901145|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
143370935|NCT02341625|516901146|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
143370936|NCT02341625|516901147|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
143370937|NCT02341625|516901148|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
143370938|NCT02341625|516901149|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
143370939|NCT02341625|516901150|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
143370940|NCT02341625|516901151|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
143370941|NCT02341625|516901152|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
143370942|NCT02341625|516901153|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
143370943|NCT02341625|516901144|FG000|Overall Study|Participant Withdrew Consent|0|||
143265027|NCT03911843|516525154|FG001|Overall Study|Adverse Event|0|||
143265028|NCT03911843|516525153|FG000|Overall Study|Protocol Violation|2|||
143265029|NCT03911843|516525154|FG001|Overall Study|Protocol Violation|0|||
143265030|NCT03911843|516525153|FG000|Overall Study|Lost to Follow-up|0|||
143265031|NCT03911843|516525154|FG001|Overall Study|Lost to Follow-up|1|||
143265032|NCT02819518|516525155|FG000|Overall Study|Death|9|||
143265033|NCT02819518|516525156|FG001|Overall Study|Death|12|||
143265034|NCT02819518|516525157|FG002|Overall Study|Death|9|||
143265035|NCT02819518|516525158|FG003|Overall Study|Death|475|||
143265036|NCT02819518|516525159|FG004|Overall Study|Death|244|||
143265037|NCT02819518|516525155|FG000|Overall Study|Withdrawal by Subject|0|||
143265038|NCT02819518|516525156|FG001|Overall Study|Withdrawal by Subject|0|||
143265039|NCT02819518|516525157|FG002|Overall Study|Withdrawal by Subject|0|||
143265040|NCT02819518|516525158|FG003|Overall Study|Withdrawal by Subject|25|||
143265041|NCT02819518|516525159|FG004|Overall Study|Withdrawal by Subject|8|||
143265042|NCT02819518|516525155|FG000|Overall Study|Lost to Follow-up|0|||
143265043|NCT02819518|516525156|FG001|Overall Study|Lost to Follow-up|0|||
143265044|NCT02819518|516525157|FG002|Overall Study|Lost to Follow-up|0|||
143265045|NCT02819518|516525158|FG003|Overall Study|Lost to Follow-up|0|||
143265046|NCT02819518|516525159|FG004|Overall Study|Lost to Follow-up|1|||
143265047|NCT02819518|516525155|FG000|Overall Study|Sponsor Decision|1|||
143265048|NCT02819518|516525156|FG001|Overall Study|Sponsor Decision|1|||
143265049|NCT02819518|516525157|FG002|Overall Study|Sponsor Decision|0|||
143265050|NCT02819518|516525158|FG003|Overall Study|Sponsor Decision|34|||
143265051|NCT02819518|516525159|FG004|Overall Study|Sponsor Decision|17|||
143265052|NCT02819518|516525155|FG000|Overall Study|Transferred to extension study|1|||
143265053|NCT02819518|516525156|FG001|Overall Study|Transferred to extension study|1|||
143265054|NCT02819518|516525157|FG002|Overall Study|Transferred to extension study|1|||
143265055|NCT02819518|516525158|FG003|Overall Study|Transferred to extension study|32|||
143265056|NCT02819518|516525159|FG004|Overall Study|Transferred to extension study|11|||
143265057|NCT00880165|516525160|FG000|Overall Study|Withdrawal by Subject|27|||
143265058|NCT00880165|516525161|FG001|Overall Study|Withdrawal by Subject|23|||
143265059|NCT00880165|516525160|FG000|Overall Study|Not diagnosed with OSA|14|||
143265060|NCT00880165|516525161|FG001|Overall Study|Not diagnosed with OSA|8|||
143265061|NCT00880165|516525160|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
143265062|NCT00880165|516525161|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
143265063|NCT00880165|516525160|FG000|Overall Study|Lost to follow|9|||
143265064|NCT00880165|516525161|FG001|Overall Study|Lost to follow|15|||
143265065|NCT01857583|516525162|FG000|Overall Study|Adverse Event|0|||
143265066|NCT01857583|516525163|FG001|Overall Study|Adverse Event|0|||
143265067|NCT01857583|516525164|FG002|Overall Study|Adverse Event|1|||
143265068|NCT01857583|516525165|FG003|Overall Study|Adverse Event|1|||
143265069|NCT01857583|516525162|FG000|Overall Study|Death|0|||
143265070|NCT01857583|516525163|FG001|Overall Study|Death|1|||
143265071|NCT01857583|516525164|FG002|Overall Study|Death|1|||
143265072|NCT01857583|516525165|FG003|Overall Study|Death|0|||
143265073|NCT01857583|516525162|FG000|Overall Study|Physician Decision|0|||
143265074|NCT01857583|516525163|FG001|Overall Study|Physician Decision|0|||
143265075|NCT01857583|516525164|FG002|Overall Study|Physician Decision|0|||
143265076|NCT01857583|516525165|FG003|Overall Study|Physician Decision|1|||
143265077|NCT01857583|516525162|FG000|Overall Study|Withdrawal by Subject|1|||
143265078|NCT01857583|516525163|FG001|Overall Study|Withdrawal by Subject|0|||
143265079|NCT01857583|516525164|FG002|Overall Study|Withdrawal by Subject|1|||
143265080|NCT01857583|516525165|FG003|Overall Study|Withdrawal by Subject|2|||
143265081|NCT02211638|516525166|FG000|Overall Study|Case Report Forms Uncollected|291|||
143265082|NCT02211638|516525166|FG000|Overall Study|Protocol Violation|692|||
143265083|NCT04041700|516525171|FG000|Overall Study|Pregnancy|1|||
143265084|NCT04041700|516525171|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
143265085|NCT02775903|516525172|FG000|Overall Study|Death|7|||
143265086|NCT02775903|516525173|FG001|Overall Study|Death|11|||
143265087|NCT02775903|516525174|FG002|Overall Study|Death|12|||
143265088|NCT02775903|516525175|FG003|Overall Study|Death|11|||
143265089|NCT02775903|516525172|FG000|Overall Study|Adverse Event|0|||
143265090|NCT02775903|516525173|FG001|Overall Study|Adverse Event|1|||
143265091|NCT02775903|516525174|FG002|Overall Study|Adverse Event|12|||
143370944|NCT02341625|516901145|FG001|Overall Study|Participant Withdrew Consent|0|||
143370945|NCT02341625|516901146|FG002|Overall Study|Participant Withdrew Consent|0|||
143265092|NCT02775903|516525175|FG003|Overall Study|Adverse Event|3|||
143265093|NCT02775903|516525172|FG000|Overall Study|Progressive disease|15|||
143265094|NCT02775903|516525173|FG001|Overall Study|Progressive disease|14|||
143265095|NCT02775903|516525174|FG002|Overall Study|Progressive disease|30|||
143265096|NCT02775903|516525175|FG003|Overall Study|Progressive disease|20|||
143265097|NCT02775903|516525172|FG000|Overall Study|Lack of Efficacy|2|||
143265098|NCT02775903|516525173|FG001|Overall Study|Lack of Efficacy|2|||
143265099|NCT02775903|516525174|FG002|Overall Study|Lack of Efficacy|2|||
143265100|NCT02775903|516525175|FG003|Overall Study|Lack of Efficacy|6|||
143265101|NCT02775903|516525172|FG000|Overall Study|Withdrawal by Subject|7|||
143265102|NCT02775903|516525173|FG001|Overall Study|Withdrawal by Subject|5|||
143265103|NCT02775903|516525174|FG002|Overall Study|Withdrawal by Subject|5|||
143265104|NCT02775903|516525175|FG003|Overall Study|Withdrawal by Subject|8|||
143265105|NCT02775903|516525172|FG000|Overall Study|Other reasons|7|||
143265106|NCT02775903|516525173|FG001|Overall Study|Other reasons|8|||
143265107|NCT02775903|516525174|FG002|Overall Study|Other reasons|2|||
143265108|NCT02775903|516525175|FG003|Overall Study|Other reasons|12|||
143265109|NCT00458536|516525178|FG000|Overall Study|Disease progression prior to treatment|7|||
143265110|NCT00458536|516525178|FG000|Overall Study|Unable to make vaccine|3|||
143265111|NCT00458536|516525178|FG000|Overall Study|No measurable disease after surgery|2|||
143265112|NCT00458536|516525178|FG000|Overall Study|Did not have renal cell carcinoma|2|||
143265113|NCT00458536|516525178|FG000|Overall Study|Patient did not have surgery|1|||
143265114|NCT00458536|516525178|FG000|Overall Study|Ineligible due to toxicity|1|||
143265115|NCT00458536|516525178|FG000|Overall Study|Withdrawal by Subject|1|||
143265116|NCT00458536|516525178|FG000|Overall Study|Progressive disease during treatment|2|||
143265117|NCT00285207|516525179|FG000|Overall Study|Lost to Follow-up|3|||
143265118|NCT00285207|516525180|FG001|Overall Study|Lost to Follow-up|2|||
143265119|NCT00285207|516525179|FG000|Overall Study|Withdrawal by Subject|5|||
143265120|NCT00285207|516525180|FG001|Overall Study|Withdrawal by Subject|2|||
143265121|NCT00285207|516525179|FG000|Overall Study|Pregnancy|1|||
143265122|NCT00285207|516525180|FG001|Overall Study|Pregnancy|1|||
143265123|NCT00285207|516525179|FG000|Overall Study|non-compliance|0|||
143265124|NCT00285207|516525180|FG001|Overall Study|non-compliance|1|||
143265125|NCT04571515|516525181|FG000|Overall Study|Physician Decision|0|||
143265126|NCT04571515|516525182|FG001|Overall Study|Physician Decision|0|||
143265127|NCT04571515|516525183|FG002|Overall Study|Physician Decision|0|||
143265128|NCT04571515|516525184|FG003|Overall Study|Physician Decision|0|||
143265129|NCT04571515|516525185|FG004|Overall Study|Physician Decision|1|||
143265130|NCT04571515|516525181|FG000|Overall Study|Withdrawal by Subject|0|||
143265131|NCT04571515|516525182|FG001|Overall Study|Withdrawal by Subject|0|||
143265132|NCT04571515|516525183|FG002|Overall Study|Withdrawal by Subject|0|||
143265133|NCT04571515|516525184|FG003|Overall Study|Withdrawal by Subject|0|||
143265134|NCT04571515|516525185|FG004|Overall Study|Withdrawal by Subject|1|||
143265135|NCT04571515|516525181|FG000|Overall Study|insufficient pain|1|||
143265136|NCT04571515|516525182|FG001|Overall Study|insufficient pain|0|||
143265137|NCT04571515|516525183|FG002|Overall Study|insufficient pain|0|||
143265138|NCT04571515|516525184|FG003|Overall Study|insufficient pain|0|||
143265139|NCT04571515|516525185|FG004|Overall Study|insufficient pain|1|||
143265140|NCT01659658|516526654|FG000|Overall Study|Withdrawal by Patient|18|||
143265141|NCT01659658|516526655|FG001|Overall Study|Withdrawal by Patient|4|||
143265142|NCT01659658|516526656|FG002|Overall Study|Withdrawal by Patient|2|||
143265143|NCT01659658|516526657|FG003|Overall Study|Withdrawal by Patient|0|||
143265144|NCT01659658|516526658|FG004|Overall Study|Withdrawal by Patient|11|||
143265145|NCT01659658|516526654|FG000|Overall Study|Study Terminated by Sponsor|9|||
143265146|NCT01659658|516526655|FG001|Overall Study|Study Terminated by Sponsor|7|||
143265147|NCT01659658|516526656|FG002|Overall Study|Study Terminated by Sponsor|0|||
143265148|NCT01659658|516526657|FG003|Overall Study|Study Terminated by Sponsor|1|||
143265149|NCT01659658|516526658|FG004|Overall Study|Study Terminated by Sponsor|4|||
143265150|NCT01659658|516526654|FG000|Overall Study|Reason not Specified|61|||
143265151|NCT01659658|516526655|FG001|Overall Study|Reason not Specified|15|||
143265152|NCT01659658|516526656|FG002|Overall Study|Reason not Specified|8|||
143265153|NCT01659658|516526657|FG003|Overall Study|Reason not Specified|1|||
143370946|NCT02341625|516901147|FG003|Overall Study|Participant Withdrew Consent|1|||
143370947|NCT02341625|516901148|FG004|Overall Study|Participant Withdrew Consent|0|||
143265154|NCT01659658|516526658|FG004|Overall Study|Reason not Specified|34|||
143265155|NCT01659658|516526654|FG000|Overall Study|Lost to Follow-up|2|||
143265156|NCT01659658|516526655|FG001|Overall Study|Lost to Follow-up|0|||
143265157|NCT01659658|516526656|FG002|Overall Study|Lost to Follow-up|0|||
143265158|NCT01659658|516526657|FG003|Overall Study|Lost to Follow-up|0|||
143265159|NCT01659658|516526658|FG004|Overall Study|Lost to Follow-up|0|||
143265160|NCT01229397|516526661|FG000|Overall Study|Withdrawal by Subject|3|||
143265161|NCT01229397|516526662|FG001|Overall Study|Withdrawal by Subject|3|||
143265162|NCT01229397|516526661|FG000|Overall Study|Lost to Follow-up|7|||
143265163|NCT01229397|516526662|FG001|Overall Study|Lost to Follow-up|6|||
143265164|NCT01229397|516526661|FG000|Overall Study|Migrated/moved from study area|1|||
143265165|NCT01229397|516526662|FG001|Overall Study|Migrated/moved from study area|0|||
143265166|NCT01134315|516526670|FG000|Overall Study|Adverse Event|1|||
143265167|NCT01134315|516526671|FG001|Overall Study|Adverse Event|2|||
143265168|NCT01134315|516526670|FG000|Overall Study|Other Reason|8|||
143265169|NCT01134315|516526671|FG001|Overall Study|Other Reason|17|||
143265170|NCT00736879|516526674|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
143265171|NCT00736879|516526675|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
143265172|NCT00736879|516526676|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
143265173|NCT00736879|516526677|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
143265174|NCT00736879|516526674|FG000|Double Blind Treatment Period|Adverse Event|0|||
143211873|NCT00098306|516321929|FG001|Open Label|Adverse Event|0|||
143211874|NCT00098306|516321930|FG002|Open Label|Adverse Event|0|||
143211875|NCT00098306|516321931|FG003|Open Label|Adverse Event|2|||
143211876|NCT00098306|516321932|FG004|Open Label|Adverse Event|0|||
143211877|NCT00098306|516321933|FG005|Open Label|Adverse Event|0|||
143211878|NCT00098306|516321934|FG006|Open Label|Adverse Event|0|||
143211879|NCT00098306|516321928|FG000|Open Label|Death|0|||
143211880|NCT00098306|516321929|FG001|Open Label|Death|0|||
143265175|NCT00736879|516526675|FG001|Double Blind Treatment Period|Adverse Event|1|||
143265176|NCT00736879|516526676|FG002|Double Blind Treatment Period|Adverse Event|1|||
143265177|NCT00736879|516526677|FG003|Double Blind Treatment Period|Adverse Event|0|||
143265178|NCT00736879|516526674|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
143265179|NCT00736879|516526675|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
143265180|NCT00736879|516526676|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
143265181|NCT00736879|516526677|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
143265182|NCT00736879|516526674|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
143265183|NCT00736879|516526675|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
143265184|NCT00736879|516526676|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
143265185|NCT00736879|516526677|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
143265186|NCT00736879|516526674|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
143265187|NCT00736879|516526675|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
143265188|NCT00736879|516526676|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
143265189|NCT00736879|516526677|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
143265190|NCT00736879|516526674|FG000|Double Blind Treatment Period|No longer met criteria|0|||
143265191|NCT00736879|516526675|FG001|Double Blind Treatment Period|No longer met criteria|1|||
143265192|NCT00736879|516526676|FG002|Double Blind Treatment Period|No longer met criteria|0|||
143265193|NCT00736879|516526677|FG003|Double Blind Treatment Period|No longer met criteria|0|||
143265194|NCT00736879|516526674|FG000|Double Blind Treatment Period|non-specified|0|||
143265195|NCT00736879|516526675|FG001|Double Blind Treatment Period|non-specified|1|||
143265196|NCT00736879|516526676|FG002|Double Blind Treatment Period|non-specified|0|||
143265197|NCT00736879|516526677|FG003|Double Blind Treatment Period|non-specified|0|||
143265198|NCT00736879|516526674|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
143265199|NCT00736879|516526675|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
143265200|NCT00736879|516526676|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
143265201|NCT00736879|516526677|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
143265202|NCT00736879|516526674|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
143265203|NCT00736879|516526675|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
143265204|NCT00736879|516526676|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
143265205|NCT00736879|516526677|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
143265206|NCT00984568|516526678|FG000|Overall Study|Withdrawal by Subject|1|||
143265207|NCT00984568|516526679|FG001|Overall Study|Withdrawal by Subject|2|||
143265208|NCT00984568|516526678|FG000|Overall Study|Lack of Efficacy|2|||
143265209|NCT00984568|516526679|FG001|Overall Study|Lack of Efficacy|0|||
143265210|NCT00984568|516526678|FG000|Overall Study|Adverse Event|2|||
143265211|NCT00984568|516526679|FG001|Overall Study|Adverse Event|0|||
143265212|NCT00984568|516526678|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
143265213|NCT00984568|516526679|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
143265214|NCT00984568|516526678|FG000|Overall Study|Lost to Follow-up|0|||
143265215|NCT00984568|516526679|FG001|Overall Study|Lost to Follow-up|1|||
143265216|NCT00984568|516526678|FG000|Overall Study|Opportunistic Infection|1|||
143265217|NCT00984568|516526679|FG001|Overall Study|Opportunistic Infection|0|||
143265218|NCT00984568|516526678|FG000|Overall Study|Unknown Reason|1|||
143265219|NCT00984568|516526679|FG001|Overall Study|Unknown Reason|3|||
143265220|NCT04505540|516526682|FG000|Baseline|Protocol Violation|10|||
143265221|NCT04505540|516526682|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
143265222|NCT04505540|516526682|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
143265223|NCT04505540|516526682|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
143265224|NCT04505540|516526682|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
143211881|NCT00098306|516321930|FG002|Open Label|Death|0|||
143211882|NCT00098306|516321931|FG003|Open Label|Death|4|||
143265225|NCT04505540|516526682|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
143265226|NCT04505540|516526682|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
143265227|NCT04505540|516526682|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
143265228|NCT04505540|516526682|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
143265229|NCT04505540|516526682|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
143211883|NCT00098306|516321932|FG004|Open Label|Death|0|||
143211884|NCT00098306|516321933|FG005|Open Label|Death|0|||
143211885|NCT00098306|516321934|FG006|Open Label|Death|0|||
143211886|NCT00098306|516321928|FG000|Open Label|Participant defaulted|0|||
143211887|NCT00098306|516321929|FG001|Open Label|Participant defaulted|0|||
143211888|NCT00098306|516321930|FG002|Open Label|Participant defaulted|0|||
143211889|NCT00098306|516321931|FG003|Open Label|Participant defaulted|24|||
143211890|NCT00098306|516321932|FG004|Open Label|Participant defaulted|0|||
143211891|NCT00098306|516321933|FG005|Open Label|Participant defaulted|0|||
143211892|NCT00098306|516321934|FG006|Open Label|Participant defaulted|0|||
143211893|NCT00098306|516321928|FG000|Open Label|Un-specified|0|||
143265230|NCT04505540|516526682|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
143265231|NCT04505540|516526682|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
143265232|NCT04505540|516526682|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
143265233|NCT02791594|516526683|FG000|Overall Study|Physician Decision|2|||
143265234|NCT01367119|516526684|FG000|Overall Study|Adverse Event|1|||
143265235|NCT01367119|516526685|FG001|Overall Study|Adverse Event|0|||
143265236|NCT01367119|516526684|FG000|Overall Study|Withdrawal by Subject|1|||
143265237|NCT01367119|516526685|FG001|Overall Study|Withdrawal by Subject|1|||
143265238|NCT02057393|516526688|FG000|Overall Study|Withdrawal by Subject|1|||
143265239|NCT02057393|516526688|FG000|Overall Study|Patient did not meet criteria|1|||
143265240|NCT03953183|516526694|FG000|Overall Study|Physician Decision|0|||
143265241|NCT03953183|516526695|FG001|Overall Study|Physician Decision|1|||
143265242|NCT03953183|516526694|FG000|Overall Study|Withdrawal by Subject|0|||
143265243|NCT03953183|516526695|FG001|Overall Study|Withdrawal by Subject|1|||
143265244|NCT04508140|516526696|FG000|Overall Study|Adverse Event|2|||
143265245|NCT04508140|516526697|FG001|Overall Study|Adverse Event|2|||
143265246|NCT04508140|516526696|FG000|Overall Study|Withdrawal by Subject|0|||
143265247|NCT04508140|516526697|FG001|Overall Study|Withdrawal by Subject|2|||
143265248|NCT04508140|516526696|FG000|Overall Study|progressive disease|9|||
143265249|NCT04508140|516526697|FG001|Overall Study|progressive disease|3|||
143265250|NCT03091777|516526703|FG000|Overall Study|Pregnancy|2|||
143265251|NCT03091777|516526704|FG001|Overall Study|Pregnancy|1|||
143265252|NCT03091777|516526705|FG002|Overall Study|Pregnancy|0|||
143265253|NCT03091777|516526703|FG000|Overall Study|Adverse Event|2|||
143265254|NCT03091777|516526704|FG001|Overall Study|Adverse Event|1|||
143265255|NCT03091777|516526705|FG002|Overall Study|Adverse Event|4|||
143265256|NCT03091777|516526703|FG000|Overall Study|Withdrawal by Subject|4|||
143265257|NCT03091777|516526704|FG001|Overall Study|Withdrawal by Subject|2|||
143265258|NCT03091777|516526705|FG002|Overall Study|Withdrawal by Subject|6|||
143265259|NCT03091777|516526703|FG000|Overall Study|Protocol Violation|2|||
143265260|NCT03091777|516526704|FG001|Overall Study|Protocol Violation|1|||
143265261|NCT03091777|516526705|FG002|Overall Study|Protocol Violation|1|||
143265262|NCT03091777|516526703|FG000|Overall Study|Lost to Follow-up|12|||
143265263|NCT03091777|516526704|FG001|Overall Study|Lost to Follow-up|14|||
143265264|NCT03091777|516526705|FG002|Overall Study|Lost to Follow-up|7|||
143265265|NCT03091777|516526703|FG000|Overall Study|Lack of Efficacy|0|||
143265266|NCT03091777|516526704|FG001|Overall Study|Lack of Efficacy|0|||
143265267|NCT03091777|516526705|FG002|Overall Study|Lack of Efficacy|5|||
143265268|NCT03091777|516526703|FG000|Overall Study|Noncompliance with study drug|2|||
143265269|NCT03091777|516526704|FG001|Overall Study|Noncompliance with study drug|3|||
143265270|NCT03091777|516526705|FG002|Overall Study|Noncompliance with study drug|1|||
143265271|NCT03091777|516526703|FG000|Overall Study|Physician Decision|1|||
143265272|NCT03091777|516526704|FG001|Overall Study|Physician Decision|0|||
143265273|NCT03091777|516526705|FG002|Overall Study|Physician Decision|1|||
143265274|NCT03091777|516526703|FG000|Overall Study|Abnormal Laboratory Value|7|||
143265275|NCT03091777|516526704|FG001|Overall Study|Abnormal Laboratory Value|11|||
143265276|NCT03091777|516526705|FG002|Overall Study|Abnormal Laboratory Value|12|||
143265277|NCT03309046|516526706|FG000|Overall Study|Withdrawal by Subject|4|||
143265278|NCT03309046|516526707|FG001|Overall Study|Withdrawal by Subject|17|||
143265279|NCT00089674|516526709|FG000|Overall Study|Physician Decision|4|||
143370948|NCT02341625|516901149|FG005|Overall Study|Participant Withdrew Consent|0|||
143211894|NCT00098306|516321929|FG001|Open Label|Un-specified|0|||
143211895|NCT00098306|516321930|FG002|Open Label|Un-specified|0|||
143211896|NCT00098306|516321931|FG003|Open Label|Un-specified|15|||
143211897|NCT00098306|516321932|FG004|Open Label|Un-specified|0|||
143211898|NCT00098306|516321933|FG005|Open Label|Un-specified|0|||
143265280|NCT00089674|516526710|FG001|Overall Study|Physician Decision|2|||
143265281|NCT00089674|516526709|FG000|Overall Study|Adverse Event|23|||
143265282|NCT00089674|516526710|FG001|Overall Study|Adverse Event|29|||
143265283|NCT00089674|516526709|FG000|Overall Study|Withdrawal by Subject|143|||
143265284|NCT00089674|516526710|FG001|Overall Study|Withdrawal by Subject|127|||
143265285|NCT00089674|516526709|FG000|Overall Study|Death|43|||
143265286|NCT00089674|516526710|FG001|Overall Study|Death|43|||
143265287|NCT00089674|516526709|FG000|Overall Study|Disease progression|21|||
143265288|NCT00089674|516526710|FG001|Overall Study|Disease progression|23|||
143265289|NCT00089674|516526709|FG000|Overall Study|Ineligibility determined|8|||
143265290|NCT00089674|516526710|FG001|Overall Study|Ineligibility determined|10|||
143265291|NCT00089674|516526709|FG000|Overall Study|Lost to Follow-up|21|||
143211899|NCT00098306|516321934|FG006|Open Label|Un-specified|0|||
143265292|NCT00089674|516526710|FG001|Overall Study|Lost to Follow-up|17|||
143265293|NCT00089674|516526709|FG000|Overall Study|Noncompliance|7|||
143265294|NCT00089674|516526710|FG001|Overall Study|Noncompliance|3|||
143265295|NCT00089674|516526709|FG000|Overall Study|Other|5|||
143265296|NCT00089674|516526710|FG001|Overall Study|Other|9|||
143265297|NCT00089674|516526709|FG000|Overall Study|Requirement for alternative therapy|14|||
143265298|NCT00089674|516526710|FG001|Overall Study|Requirement for alternative therapy|4|||
143265299|NCT03963401|516526711|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
143265300|NCT03963401|516526712|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
143265301|NCT03963401|516526713|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
143265302|NCT03963401|516526714|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
143265303|NCT03963401|516526715|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
143265304|NCT03963401|516526716|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
143265305|NCT03963401|516526711|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
143265306|NCT03963401|516526712|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
143265307|NCT03963401|516526713|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
143265308|NCT03963401|516526714|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
143265309|NCT03963401|516526715|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
143265310|NCT03963401|516526716|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
143265311|NCT03963401|516526711|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
143265312|NCT03963401|516526712|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
143265313|NCT03963401|516526713|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
143265314|NCT03963401|516526714|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
143265315|NCT03963401|516526715|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
143265316|NCT03963401|516526716|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
143265317|NCT03963401|516526711|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
143265318|NCT03963401|516526712|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
143265319|NCT03963401|516526713|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
143265320|NCT03963401|516526714|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
143265321|NCT03963401|516526715|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
143265322|NCT03963401|516526716|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
143265323|NCT03963401|516526711|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
143265324|NCT03963401|516526712|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
143265325|NCT03963401|516526713|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
143265326|NCT03963401|516526714|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
143265327|NCT03963401|516526715|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
143265328|NCT03963401|516526716|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
143265329|NCT03963401|516526711|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
143265330|NCT03963401|516526712|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
143265331|NCT03963401|516526713|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
143265332|NCT03963401|516526714|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
143265333|NCT03963401|516526715|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
143265334|NCT03963401|516526716|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
143265335|NCT03963401|516526711|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
143211900|NCT00098306|516321928|FG000|Open Label|Ongoing at cut-off date|0|||
143211901|NCT00098306|516321929|FG001|Open Label|Ongoing at cut-off date|0|||
143211902|NCT00098306|516321930|FG002|Open Label|Ongoing at cut-off date|0|||
143211903|NCT00098306|516321931|FG003|Open Label|Ongoing at cut-off date|269|||
143211904|NCT00098306|516321932|FG004|Open Label|Ongoing at cut-off date|62|||
143211905|NCT00098306|516321933|FG005|Open Label|Ongoing at cut-off date|0|||
143211906|NCT00098306|516321934|FG006|Open Label|Ongoing at cut-off date|0|||
143211907|NCT00098306|516321928|FG000|Observational Phase|Death|0|||
143211908|NCT00098306|516321929|FG001|Observational Phase|Death|0|||
143211909|NCT00098306|516321930|FG002|Observational Phase|Death|0|||
143211910|NCT00098306|516321931|FG003|Observational Phase|Death|0|||
143211911|NCT00098306|516321932|FG004|Observational Phase|Death|0|||
143211912|NCT00098306|516321933|FG005|Observational Phase|Death|5|||
143265336|NCT03963401|516526712|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
143265337|NCT03963401|516526713|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
143265338|NCT03963401|516526714|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
143370949|NCT02341625|516901150|FG006|Overall Study|Participant Withdrew Consent|0|||
143211913|NCT00098306|516321934|FG006|Observational Phase|Death|4|||
143211914|NCT00098306|516321928|FG000|Observational Phase|Participant defaulted|0|||
143211915|NCT00098306|516321929|FG001|Observational Phase|Participant defaulted|0|||
143211916|NCT00098306|516321930|FG002|Observational Phase|Participant defaulted|0|||
143211917|NCT00098306|516321931|FG003|Observational Phase|Participant defaulted|0|||
143211918|NCT00098306|516321932|FG004|Observational Phase|Participant defaulted|0|||
143265339|NCT03963401|516526715|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
143265340|NCT03963401|516526716|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
143211919|NCT00098306|516321933|FG005|Observational Phase|Participant defaulted|34|||
143211920|NCT00098306|516321934|FG006|Observational Phase|Participant defaulted|18|||
143211921|NCT00098306|516321928|FG000|Observational Phase|Un-specified|0|||
143211922|NCT00098306|516321929|FG001|Observational Phase|Un-specified|0|||
143211923|NCT00098306|516321930|FG002|Observational Phase|Un-specified|0|||
143211924|NCT00098306|516321931|FG003|Observational Phase|Un-specified|0|||
143211925|NCT00098306|516321932|FG004|Observational Phase|Un-specified|0|||
143211926|NCT00098306|516321933|FG005|Observational Phase|Un-specified|7|||
143265341|NCT03963401|516526711|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
143265342|NCT03963401|516526712|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
143265343|NCT03963401|516526713|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
143265344|NCT03963401|516526714|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
143265345|NCT03963401|516526715|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
143265346|NCT03963401|516526716|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
143265347|NCT03963401|516526711|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
143265348|NCT03963401|516526712|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
143265349|NCT03963401|516526713|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
143265350|NCT03963401|516526714|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
143265351|NCT03963401|516526715|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
143265352|NCT03963401|516526716|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
143265353|NCT03963401|516526711|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
143265354|NCT03963401|516526712|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
143265355|NCT03963401|516526713|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
143265356|NCT03963401|516526714|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
143265357|NCT03963401|516526715|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
143265358|NCT03963401|516526716|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
143265359|NCT03963401|516526711|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
143265360|NCT03963401|516526712|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
143265361|NCT03963401|516526713|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
143265362|NCT03963401|516526714|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
143265363|NCT03963401|516526715|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
143265364|NCT03963401|516526716|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
143265365|NCT01437878|516526717|FG000|Overall Study|Withdrawal by Subject|1|||
143265366|NCT01437878|516526718|FG001|Overall Study|Withdrawal by Subject|0|||
143265367|NCT01070043|516526720|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
143265368|NCT01070043|516526721|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
143265369|NCT01070043|516526722|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
143265370|NCT01070043|516526720|FG000|Double-Blind Treatment|Adverse Event|0|||
143265371|NCT01070043|516526721|FG001|Double-Blind Treatment|Adverse Event|0|||
143265372|NCT01070043|516526722|FG002|Double-Blind Treatment|Adverse Event|2|||
143265373|NCT01528215|516526726|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
143265374|NCT01528215|516526727|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
143265375|NCT01528215|516526726|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
143265376|NCT01528215|516526727|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
143265377|NCT01528215|516526726|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
143265378|NCT01528215|516526727|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
143265379|NCT01528215|516526726|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
143265380|NCT01528215|516526727|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
143265381|NCT01476644|516526728|FG000|Overall Study|Death|5|||
143265382|NCT01476644|516526728|FG000|Overall Study|moved to another state|2|||
143265383|NCT01476644|516526728|FG000|Overall Study|Lost to Follow-up|19|||
143265384|NCT01476644|516526728|FG000|Overall Study|Withdrawal by Subject|13|||
143265385|NCT01610271|516526729|FG000|Overall Study|Surgery not complete|0|||
143265386|NCT01610271|516526730|FG001|Overall Study|Surgery not complete|1|||
143265387|NCT01610271|516526729|FG000|Overall Study|Prosthesis not implanted|2|||
143265388|NCT01610271|516526730|FG001|Overall Study|Prosthesis not implanted|3|||
143265389|NCT02961218|516526731|FG000|Overall Study|Lost to Follow-up|0|||
143265390|NCT02961218|516526732|FG001|Overall Study|Lost to Follow-up|2|||
143265391|NCT02961218|516526731|FG000|Overall Study|Physician Decision|0|||
143265392|NCT02961218|516526732|FG001|Overall Study|Physician Decision|2|||
143265393|NCT02961218|516526731|FG000|Overall Study|Subject/Guardian Decision|3|||
143265394|NCT02961218|516526732|FG001|Overall Study|Subject/Guardian Decision|1|||
143265395|NCT01462227|516526733|FG000|Second Assignment|Lost to Follow-up|1|||
143370950|NCT02341625|516901151|FG007|Overall Study|Participant Withdrew Consent|0|||
143370951|NCT02341625|516901152|FG008|Overall Study|Participant Withdrew Consent|0|||
143370952|NCT02341625|516901153|FG009|Overall Study|Participant Withdrew Consent|0|||
143211927|NCT00098306|516321934|FG006|Observational Phase|Un-specified|4|||
143265396|NCT01462227|516526734|FG001|Second Assignment|Lost to Follow-up|0|||
143265397|NCT01462227|516526735|FG002|Second Assignment|Lost to Follow-up|0|||
143211928|NCT05222555|516321935|FG000|Overall Study|Ongoing|2|||
143370953|NCT02341625|516901144|FG000|Overall Study|Completed Treatment as per Protocol|0|||
143370954|NCT02341625|516901145|FG001|Overall Study|Completed Treatment as per Protocol|0|||
143370955|NCT02341625|516901146|FG002|Overall Study|Completed Treatment as per Protocol|0|||
143370956|NCT02341625|516901147|FG003|Overall Study|Completed Treatment as per Protocol|0|||
143370957|NCT02341625|516901148|FG004|Overall Study|Completed Treatment as per Protocol|0|||
143370958|NCT02341625|516901149|FG005|Overall Study|Completed Treatment as per Protocol|0|||
143370959|NCT02341625|516901150|FG006|Overall Study|Completed Treatment as per Protocol|0|||
143370960|NCT02341625|516901151|FG007|Overall Study|Completed Treatment as per Protocol|0|||
143370961|NCT02341625|516901152|FG008|Overall Study|Completed Treatment as per Protocol|0|||
143370962|NCT02341625|516901153|FG009|Overall Study|Completed Treatment as per Protocol|1|||
143370963|NCT02341625|516901144|FG000|Overall Study|Other Reasons|0|||
143370964|NCT02341625|516901145|FG001|Overall Study|Other Reasons|0|||
143370965|NCT02341625|516901146|FG002|Overall Study|Other Reasons|0|||
143370966|NCT02341625|516901147|FG003|Overall Study|Other Reasons|0|||
143370967|NCT02341625|516901148|FG004|Overall Study|Other Reasons|1|||
143370968|NCT02341625|516901149|FG005|Overall Study|Other Reasons|0|||
143370969|NCT02341625|516901150|FG006|Overall Study|Other Reasons|5|||
143370970|NCT02341625|516901151|FG007|Overall Study|Other Reasons|0|||
143370971|NCT02341625|516901152|FG008|Overall Study|Other Reasons|0|||
143370972|NCT02341625|516901153|FG009|Overall Study|Other Reasons|2|||
143370973|NCT02341625|516901144|FG000|Overall Study|Not Reported|0|||
143370974|NCT02341625|516901145|FG001|Overall Study|Not Reported|0|||
143370975|NCT02341625|516901146|FG002|Overall Study|Not Reported|0|||
143370976|NCT02341625|516901147|FG003|Overall Study|Not Reported|0|||
143370977|NCT02341625|516901148|FG004|Overall Study|Not Reported|0|||
143370978|NCT02341625|516901149|FG005|Overall Study|Not Reported|0|||
143370979|NCT02341625|516901150|FG006|Overall Study|Not Reported|0|||
143370980|NCT02341625|516901151|FG007|Overall Study|Not Reported|0|||
143370981|NCT02341625|516901152|FG008|Overall Study|Not Reported|0|||
143370982|NCT02341625|516901153|FG009|Overall Study|Not Reported|3|||
143370983|NCT01839877|516901156|FG000|Overall Study|Protocol Violation|1|||
143370984|NCT03368001|516901157|FG000|Allocation|Lost to Pretest|16|||
143370985|NCT03368001|516901158|FG001|Allocation|Lost to Pretest|25|||
143370986|NCT03368001|516901157|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
143370987|NCT03368001|516901158|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
143370988|NCT03368001|516901157|FG000|Posttest|Lost to Posttest|7|||
143370989|NCT03368001|516901158|FG001|Posttest|Lost to Posttest|11|||
143370990|NCT03368001|516901157|FG000|Posttest|Discontinued Intervention|6|||
143370991|NCT03368001|516901158|FG001|Posttest|Discontinued Intervention|19|||
143370992|NCT03368001|516901157|FG000|Follow-up|Lost to Follow-up|6|||
143370993|NCT03368001|516901158|FG001|Follow-up|Lost to Follow-up|3|||
143370994|NCT04436120|516901162|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
143370995|NCT04436120|516901163|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
143370996|NCT04436120|516901164|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
143370997|NCT04436120|516901165|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
143370998|NCT04436120|516901166|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
143370999|NCT04436120|516901167|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
143371000|NCT04436120|516901168|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
143371001|NCT04222959|516901170|FG000|Overall Study|Lost to Follow-up|76|||
143371002|NCT04222959|516901171|FG001|Overall Study|Lost to Follow-up|28|||
143371003|NCT04776213|516901174|FG000|Overall Study|Other|1|||
143371004|NCT04776213|516901174|FG000|Overall Study|Withdrawal by Subject|7|||
143371005|NCT04776213|516901174|FG000|Overall Study|Protocol Violation|1|||
143371006|NCT04776213|516901174|FG000|Overall Study|Lost to Follow-up|2|||
143371007|NCT02013037|516901178|FG000|Overall Study|Death|6|||
143371008|NCT02013037|516901178|FG000|Overall Study|Withdrawal by Subject|1|||
143371009|NCT02013037|516901178|FG000|Overall Study|Awaiting Transplantation|7|||
143371010|NCT02013037|516901178|FG000|Overall Study|Transplanted without DSA|2|||
143371011|NCT05233085|516901180|FG000|Overall Study|Adverse Event|1|||
143371012|NCT05233085|516901181|FG001|Overall Study|Adverse Event|0|||
143371013|NCT05233085|516901182|FG002|Overall Study|Adverse Event|0|||
143371014|NCT05233085|516901183|FG003|Overall Study|Adverse Event|0|||
143371015|NCT00726596|516902263|FG000|Overall Study|Adverse Event|2|||
143371016|NCT00726596|516902264|FG001|Overall Study|Adverse Event|1|||
143371017|NCT00726596|516902263|FG000|Overall Study|Withdrawal by Subject|3|||
143371018|NCT00726596|516902264|FG001|Overall Study|Withdrawal by Subject|3|||
143371019|NCT02962674|516902269|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
143371020|NCT00364286|516902270|FG000|Overall Study|Withdrawal by Subject|1|||
143371021|NCT00364286|516902270|FG000|Overall Study|Adverse Event|2|||
143371022|NCT00028769|516902273|FG000|Overall Study|Adverse Event|2|||
143371023|NCT00028769|516902273|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
143371024|NCT00028769|516902273|FG000|Overall Study|Progression or Death|31|||
143371025|NCT00028769|516902273|FG000|Overall Study|Other - Not Protocol Specified|1|||
143211929|NCT05222555|516321936|FG001|Overall Study|Ongoing|18|||
143211930|NCT05222555|516321935|FG000|Overall Study|Adverse Event|1|||
143211931|NCT05222555|516321936|FG001|Overall Study|Adverse Event|1|||
143211932|NCT05222555|516321935|FG000|Overall Study|Death|0|||
143211933|NCT05222555|516321936|FG001|Overall Study|Death|6|||
143211934|NCT05222555|516321935|FG000|Overall Study|Withdrawal by Subject|0|||
143211935|NCT05222555|516321936|FG001|Overall Study|Withdrawal by Subject|11|||
143211936|NCT01966445|516321937|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
143211937|NCT01966445|516321938|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
143211938|NCT01966445|516321939|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
143211939|NCT01966445|516321940|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
143211940|NCT01966445|516321941|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
143211941|NCT01966445|516321942|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
143211942|NCT01966445|516321943|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
143211943|NCT01966445|516321937|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
143211944|NCT01966445|516321938|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
143211945|NCT01966445|516321939|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
143211946|NCT01966445|516321940|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
143211947|NCT01966445|516321941|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
143211948|NCT01966445|516321942|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
143211949|NCT01966445|516321943|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
143211950|NCT01966445|516321937|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
143211951|NCT01966445|516321938|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
143211952|NCT01966445|516321939|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
143211953|NCT01966445|516321940|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
143211954|NCT01966445|516321941|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
143211955|NCT01966445|516321942|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
143211956|NCT01966445|516321943|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
143211957|NCT01966445|516321937|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
143211958|NCT01966445|516321938|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
143211959|NCT01966445|516321939|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
143211960|NCT01966445|516321940|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
143211961|NCT01966445|516321941|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
143211962|NCT01966445|516321942|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
143211963|NCT01966445|516321943|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
143211964|NCT01966445|516321937|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
143211965|NCT01966445|516321938|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
143211966|NCT01966445|516321939|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
143211967|NCT01966445|516321940|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
143211968|NCT01966445|516321941|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
143211969|NCT01966445|516321942|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
143211970|NCT01966445|516321943|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
143211971|NCT01753401|516321946|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
143211972|NCT01753401|516321947|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
143211973|NCT01753401|516321948|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
143211974|NCT01753401|516321949|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
143211975|NCT01753401|516321946|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
143211976|NCT01753401|516321947|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
143211977|NCT01753401|516321948|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
143211978|NCT01753401|516321949|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
143211979|NCT01753401|516321946|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
143211980|NCT01753401|516321947|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
143211981|NCT01753401|516321948|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
143211982|NCT01753401|516321949|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
143211983|NCT01753401|516321946|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
143211984|NCT01753401|516321947|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
143211985|NCT01753401|516321948|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
143211986|NCT01753401|516321949|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
143211987|NCT01753401|516321946|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
143211988|NCT01753401|516321947|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
143211989|NCT01753401|516321948|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
143211990|NCT01753401|516321949|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
143211991|NCT01753401|516321946|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
143211992|NCT01753401|516321947|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
143211993|NCT01753401|516321948|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
143211994|NCT01753401|516321949|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
143211995|NCT01753401|516321946|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
143211996|NCT01753401|516321947|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
143211997|NCT01753401|516321948|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
143211998|NCT01753401|516321949|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
143211999|NCT00084656|516321950|FG000|Overall Study|Other reasons|0|||
143212000|NCT00084656|516321951|FG001|Overall Study|Other reasons|12|||
143212001|NCT00084656|516321952|FG002|Overall Study|Other reasons|11|||
143212002|NCT00084656|516321950|FG000|Overall Study|Withdrawal by Subject|15|||
143212003|NCT00084656|516321951|FG001|Overall Study|Withdrawal by Subject|4|||
143212004|NCT00084656|516321952|FG002|Overall Study|Withdrawal by Subject|4|||
143212005|NCT00084656|516321950|FG000|Overall Study|Disease relapse|0|||
143212006|NCT00084656|516321951|FG001|Overall Study|Disease relapse|9|||
143212007|NCT00084656|516321952|FG002|Overall Study|Disease relapse|10|||
143212008|NCT00084656|516321950|FG000|Overall Study|Disease progression|9|||
143212009|NCT00084656|516321951|FG001|Overall Study|Disease progression|0|||
143212010|NCT00084656|516321952|FG002|Overall Study|Disease progression|0|||
143212011|NCT00084656|516321950|FG000|Overall Study|Lost to Follow-up|1|||
143212012|NCT00084656|516321951|FG001|Overall Study|Lost to Follow-up|0|||
143212013|NCT00084656|516321952|FG002|Overall Study|Lost to Follow-up|1|||
143212014|NCT03596450|516321970|FG000|Overall Study|Death|9|||
143212015|NCT03596450|516321971|FG001|Overall Study|Death|9|||
143212016|NCT03596450|516321970|FG000|Overall Study|Protocol Violation|18|||
143212017|NCT03596450|516321971|FG001|Overall Study|Protocol Violation|26|||
143212018|NCT03596450|516321970|FG000|Overall Study|Lost to Follow-up|50|||
143212019|NCT03596450|516321971|FG001|Overall Study|Lost to Follow-up|56|||
143212020|NCT03596450|516321970|FG000|Overall Study|Adverse Event|14|||
143212021|NCT03596450|516321971|FG001|Overall Study|Adverse Event|7|||
143212022|NCT03596450|516321970|FG000|Overall Study|Withdrawal by Subject|38|||
143212023|NCT03596450|516321971|FG001|Overall Study|Withdrawal by Subject|36|||
143212024|NCT03596450|516321970|FG000|Overall Study|Accidentally Randomized|2|||
143212025|NCT03596450|516321971|FG001|Overall Study|Accidentally Randomized|0|||
143212026|NCT03596450|516321970|FG000|Overall Study|Other reasons|48|||
143212027|NCT03596450|516321971|FG001|Overall Study|Other reasons|53|||
143212028|NCT03596450|516321970|FG000|Overall Study|Pregnancy|2|||
143212029|NCT03596450|516321971|FG001|Overall Study|Pregnancy|0|||
143212030|NCT04058886|516321974|FG000|Overall Study|Withdrawal by Subject|4|||
143212031|NCT04058886|516321974|FG000|Overall Study|Inadequate deafness interpreter service|1|||
143212032|NCT03624127|516321975|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
143212033|NCT03624127|516321976|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
143212034|NCT03624127|516321977|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
143212035|NCT03624127|516321975|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
143212036|NCT03624127|516321976|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
143212037|NCT03624127|516321977|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
143212038|NCT03624127|516321975|FG000|Treatment Week 0 - Week 16|Death|0|||
143212039|NCT03624127|516321976|FG001|Treatment Week 0 - Week 16|Death|1|||
143212040|NCT03624127|516321977|FG002|Treatment Week 0 - Week 16|Death|0|||
143212041|NCT03624127|516321975|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
143212042|NCT03624127|516321976|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
143212043|NCT03624127|516321977|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
143212044|NCT03624127|516321975|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
143212045|NCT03624127|516321976|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
143212046|NCT03624127|516321977|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
143212047|NCT03624127|516321975|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
143212048|NCT03624127|516321976|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
143212049|NCT03624127|516321977|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
143212050|NCT03624127|516321975|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
143212051|NCT03624127|516321976|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
143212052|NCT03624127|516321977|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
143212053|NCT03624127|516321975|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
143212054|NCT03624127|516321976|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
143212055|NCT03624127|516321977|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
143212056|NCT03624127|516321975|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
143212057|NCT03624127|516321976|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
143212058|NCT03624127|516321977|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
143212059|NCT03624127|516321975|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
143212060|NCT03624127|516321976|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
143212061|NCT03624127|516321977|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
143212062|NCT03624127|516321975|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
143212063|NCT03624127|516321976|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
143212064|NCT03624127|516321977|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
143212065|NCT03624127|516321975|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
143371026|NCT00028769|516902273|FG000|Overall Study|Ineligible|5|||
143371027|NCT00028769|516902273|FG000|Overall Study|Not Analyzable|1|||
143371028|NCT00726999|516902275|FG000|Overall Study|Physician Decision|0|||
143212066|NCT03624127|516321976|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
143212067|NCT03624127|516321977|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
143212068|NCT03624127|516321975|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
143212069|NCT03624127|516321976|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
143212070|NCT03624127|516321977|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
143371029|NCT00726999|516902276|FG001|Overall Study|Physician Decision|1|||
143371030|NCT00726999|516902275|FG000|Overall Study|Withdrawal by Subject|2|||
143371031|NCT00726999|516902276|FG001|Overall Study|Withdrawal by Subject|0|||
143371032|NCT00726999|516902275|FG000|Overall Study|Protocol Violation|1|||
143371033|NCT00726999|516902276|FG001|Overall Study|Protocol Violation|0|||
143371034|NCT01227278|516902277|FG000|Overall Study|Withdrawal by Subject|4|||
143371035|NCT01227278|516902278|FG001|Overall Study|Withdrawal by Subject|4|||
143371036|NCT01227278|516902277|FG000|Overall Study|Death|0|||
143371037|NCT01227278|516902278|FG001|Overall Study|Death|2|||
143371038|NCT01227278|516902277|FG000|Overall Study|Other|1|||
143371039|NCT01227278|516902278|FG001|Overall Study|Other|2|||
143371040|NCT03720210|516902282|FG000|Overall Study|Lost to Follow-up|1|||
143371041|NCT02224924|516902283|FG000|Overall Study|Withdrawal by Subject|7|||
143371042|NCT02224924|516902284|FG001|Overall Study|Withdrawal by Subject|6|||
143371043|NCT02224924|516902283|FG000|Overall Study|Biopsy cancelled|20|||
143371044|NCT02224924|516902284|FG001|Overall Study|Biopsy cancelled|14|||
143371045|NCT02224924|516902283|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
143371046|NCT02224924|516902284|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
143371047|NCT02224924|516902283|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
143371048|NCT02224924|516902284|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
143371049|NCT02034916|516902285|FG000|Overall Study|Death|39|||
143371050|NCT02034916|516902286|FG001|Overall Study|Death|28|||
143371051|NCT02034916|516902285|FG000|Overall Study|Withdrawal by Subject|2|||
143371052|NCT02034916|516902286|FG001|Overall Study|Withdrawal by Subject|1|||
143371053|NCT02034916|516902285|FG000|Overall Study|Lost to Follow-up|4|||
143371054|NCT02034916|516902286|FG001|Overall Study|Lost to Follow-up|1|||
143371055|NCT02034916|516902285|FG000|Overall Study|Study terminated by sponsor|4|||
143371056|NCT02034916|516902286|FG001|Overall Study|Study terminated by sponsor|5|||
143371057|NCT00753012|516902294|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
143371058|NCT00753012|516902295|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
143371059|NCT00753012|516902294|FG000|Overall Study|Adverse Event|2|||
143371060|NCT00753012|516902295|FG001|Overall Study|Adverse Event|0|||
143371061|NCT00753012|516902294|FG000|Overall Study|Withdrawal by Subject|0|||
143371062|NCT00753012|516902295|FG001|Overall Study|Withdrawal by Subject|1|||
143371063|NCT00753012|516902294|FG000|Overall Study|Lost to Follow-up|4|||
143371064|NCT00753012|516902295|FG001|Overall Study|Lost to Follow-up|0|||
143371065|NCT00753012|516902294|FG000|Overall Study|Confounded endpoint data|1|||
143371066|NCT00753012|516902295|FG001|Overall Study|Confounded endpoint data|0|||
143371067|NCT01585038|516902297|FG000|Overall Study|Adverse Event|2|||
143371068|NCT01585038|516902298|FG001|Overall Study|Adverse Event|2|||
143371069|NCT03525119|516902308|FG000|Overall Study|Adverse Event|0|||
143371070|NCT03525119|516902309|FG001|Overall Study|Adverse Event|1|||
143371071|NCT03525119|516902310|FG002|Overall Study|Adverse Event|0|||
143371072|NCT03525119|516902308|FG000|Overall Study|Lost to Follow-up|32|||
143371073|NCT03525119|516902309|FG001|Overall Study|Lost to Follow-up|33|||
143371074|NCT03525119|516902310|FG002|Overall Study|Lost to Follow-up|37|||
143371075|NCT03525119|516902308|FG000|Overall Study|Withdrawal by Subject|5|||
143371076|NCT03525119|516902309|FG001|Overall Study|Withdrawal by Subject|4|||
143371077|NCT03525119|516902310|FG002|Overall Study|Withdrawal by Subject|2|||
143371078|NCT03525119|516902308|FG000|Overall Study|Reason not Specified|2|||
143371079|NCT03525119|516902309|FG001|Overall Study|Reason not Specified|1|||
143371080|NCT03525119|516902310|FG002|Overall Study|Reason not Specified|2|||
143371081|NCT03525119|516902308|FG000|Overall Study|Randomized but not Vaccinated|1|||
143371082|NCT03525119|516902309|FG001|Overall Study|Randomized but not Vaccinated|0|||
143371083|NCT03525119|516902310|FG002|Overall Study|Randomized but not Vaccinated|2|||
143371084|NCT05046132|516902311|FG000|Overall Study|Adverse Event|4|||
143371085|NCT05046132|516902312|FG001|Overall Study|Adverse Event|0|||
143212071|NCT03624127|516321975|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
143371086|NCT05046132|516902313|FG002|Overall Study|Adverse Event|0|||
143371087|NCT05046132|516902311|FG000|Overall Study|Withdrawal by Subject|3|||
143371088|NCT05046132|516902312|FG001|Overall Study|Withdrawal by Subject|0|||
143371089|NCT05046132|516902313|FG002|Overall Study|Withdrawal by Subject|0|||
143371090|NCT05046132|516902311|FG000|Overall Study|Positive Covid19 Result.|0|||
143371091|NCT05046132|516902312|FG001|Overall Study|Positive Covid19 Result.|1|||
143371092|NCT05046132|516902313|FG002|Overall Study|Positive Covid19 Result.|0|||
143371093|NCT01959412|516902314|FG000|Overall Study|Protocol deviation|1|||
143371094|NCT01959412|516902315|FG001|Overall Study|Protocol deviation|1|||
143212072|NCT03624127|516321976|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
143371095|NCT01959412|516902316|FG002|Overall Study|Protocol deviation|0|||
143212073|NCT03624127|516321977|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
143212074|NCT03624127|516321975|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
143212075|NCT03624127|516321976|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
143212076|NCT03624127|516321977|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
143212077|NCT03624127|516321975|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
143212078|NCT03624127|516321976|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
143212079|NCT03624127|516321977|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
143212080|NCT03624127|516321975|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
143212081|NCT03624127|516321976|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
143212082|NCT03624127|516321977|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
143212083|NCT03624127|516321975|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
143212084|NCT03624127|516321976|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
143265398|NCT01462227|516526736|FG003|Second Assignment|Lost to Follow-up|0|||
143265399|NCT01462227|516526733|FG000|Second Assignment|Protocol Violation|0|||
143265400|NCT01462227|516526734|FG001|Second Assignment|Protocol Violation|1|||
143265401|NCT01462227|516526735|FG002|Second Assignment|Protocol Violation|1|||
143265402|NCT01462227|516526736|FG003|Second Assignment|Protocol Violation|0|||
143265403|NCT02393690|516526737|FG000|Overall Study|Ineligible|0|||
143265404|NCT02393690|516526738|FG001|Overall Study|Ineligible|1|||
143265405|NCT00591266|516526739|FG000|Overall Study|Adverse Event|2|||
143265406|NCT00591266|516526740|FG001|Overall Study|Adverse Event|2|||
143265407|NCT00591266|516526741|FG002|Overall Study|Adverse Event|3|||
143265408|NCT00591266|516526739|FG000|Overall Study|Lost to Follow-up|0|||
143265409|NCT00591266|516526740|FG001|Overall Study|Lost to Follow-up|1|||
143265410|NCT00591266|516526741|FG002|Overall Study|Lost to Follow-up|0|||
143265411|NCT00591266|516526739|FG000|Overall Study|Protocol Violation|0|||
143265412|NCT00591266|516526740|FG001|Overall Study|Protocol Violation|0|||
143265413|NCT00591266|516526741|FG002|Overall Study|Protocol Violation|1|||
143265414|NCT00591266|516526739|FG000|Overall Study|Withdrawal by Subject|6|||
143265415|NCT00591266|516526740|FG001|Overall Study|Withdrawal by Subject|2|||
143265416|NCT00591266|516526741|FG002|Overall Study|Withdrawal by Subject|5|||
143265417|NCT00591266|516526739|FG000|Overall Study|Lack of Efficacy|0|||
143265418|NCT00591266|516526740|FG001|Overall Study|Lack of Efficacy|2|||
143265419|NCT00591266|516526741|FG002|Overall Study|Lack of Efficacy|0|||
143265420|NCT00591266|516526739|FG000|Overall Study|Other|1|||
143265421|NCT00591266|516526740|FG001|Overall Study|Other|4|||
143265422|NCT00591266|516526741|FG002|Overall Study|Other|5|||
143265423|NCT03488927|516526742|FG000|Overall Study|Withdrawal by Subject|44|||
143265424|NCT03488927|516526743|FG001|Overall Study|Withdrawal by Subject|118|||
143265425|NCT03488927|516526744|FG002|Overall Study|Withdrawal by Subject|217|||
143265426|NCT00586066|516526752|FG000|Overall Study|Lost to Follow-up|6|||
143265427|NCT00586066|516526753|FG001|Overall Study|Lost to Follow-up|3|||
143265428|NCT00586066|516526752|FG000|Overall Study|Lack of Efficacy|5|||
143265429|NCT00586066|516526753|FG001|Overall Study|Lack of Efficacy|3|||
143265430|NCT00586066|516526752|FG000|Overall Study|Adverse Event|2|||
143265431|NCT00586066|516526753|FG001|Overall Study|Adverse Event|2|||
143212085|NCT03624127|516321977|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
143265432|NCT00586066|516526752|FG000|Overall Study|Physician Decision|1|||
143265433|NCT00586066|516526753|FG001|Overall Study|Physician Decision|0|||
143265434|NCT00586066|516526752|FG000|Overall Study|Withdrawal of consent|4|||
143265435|NCT00586066|516526753|FG001|Overall Study|Withdrawal of consent|2|||
143212086|NCT03624127|516321975|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
143212087|NCT03624127|516321976|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
143212088|NCT03624127|516321977|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
143212089|NCT03624127|516321975|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
143212090|NCT03624127|516321976|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
143212091|NCT03624127|516321977|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
143212092|NCT03624127|516321975|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
143212093|NCT03624127|516321976|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
143212094|NCT03624127|516321977|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
143212095|NCT00915551|516321978|FG000|Overall Study|Withdrawal by Subject|0|||
143212096|NCT00915551|516321979|FG001|Overall Study|Withdrawal by Subject|1|||
143212097|NCT02999633|516321980|FG000|Overall Study|Adverse Event|2|||
143212098|NCT02999633|516321980|FG000|Overall Study|Progressive disease|12|||
143212099|NCT03262441|516321981|FG000|Overall Study|Withdrawal by Subject|1|||
143212100|NCT01545050|516321982|FG000|Overall Study|Lack of Efficacy|0|||
143212101|NCT01545050|516321983|FG001|Overall Study|Lack of Efficacy|0|||
143212102|NCT01545050|516321984|FG002|Overall Study|Lack of Efficacy|0|||
143212103|NCT01545050|516321985|FG003|Overall Study|Lack of Efficacy|3|||
143212104|NCT01545050|516321986|FG004|Overall Study|Lack of Efficacy|2|||
143212105|NCT01545050|516321982|FG000|Overall Study|Adverse Event|1|||
143212106|NCT01545050|516321983|FG001|Overall Study|Adverse Event|1|||
143212107|NCT01545050|516321984|FG002|Overall Study|Adverse Event|2|||
143212108|NCT01545050|516321985|FG003|Overall Study|Adverse Event|2|||
143212109|NCT01545050|516321986|FG004|Overall Study|Adverse Event|0|||
143212110|NCT01545050|516321982|FG000|Overall Study|Discontinued study treatment|1|||
143212111|NCT01545050|516321983|FG001|Overall Study|Discontinued study treatment|0|||
143212112|NCT01545050|516321984|FG002|Overall Study|Discontinued study treatment|0|||
143212113|NCT01545050|516321985|FG003|Overall Study|Discontinued study treatment|0|||
143212114|NCT01545050|516321986|FG004|Overall Study|Discontinued study treatment|0|||
143212115|NCT01545050|516321982|FG000|Overall Study|Withdrawal by Subject|1|||
143212116|NCT01545050|516321983|FG001|Overall Study|Withdrawal by Subject|0|||
143212117|NCT01545050|516321984|FG002|Overall Study|Withdrawal by Subject|0|||
143212118|NCT01545050|516321985|FG003|Overall Study|Withdrawal by Subject|2|||
143212119|NCT01545050|516321986|FG004|Overall Study|Withdrawal by Subject|1|||
143212120|NCT01545050|516321982|FG000|Overall Study|Participant no longer meets study criteria|0|||
143212121|NCT01545050|516321983|FG001|Overall Study|Participant no longer meets study criteria|2|||
143212122|NCT01545050|516321984|FG002|Overall Study|Participant no longer meets study criteria|0|||
143212123|NCT01545050|516321985|FG003|Overall Study|Participant no longer meets study criteria|0|||
143212124|NCT01545050|516321986|FG004|Overall Study|Participant no longer meets study criteria|1|||
143212125|NCT01545050|516321982|FG000|Overall Study|Administrative reason by sponsor|4|||
143212126|NCT01545050|516321983|FG001|Overall Study|Administrative reason by sponsor|2|||
143212127|NCT01545050|516321984|FG002|Overall Study|Administrative reason by sponsor|3|||
143212128|NCT01545050|516321985|FG003|Overall Study|Administrative reason by sponsor|5|||
143212129|NCT01545050|516321986|FG004|Overall Study|Administrative reason by sponsor|5|||
143212130|NCT03235089|516321993|FG000|Overall Study|Lost to Follow-up|1|||
143212131|NCT03235089|516321994|FG001|Overall Study|Lost to Follow-up|1|||
143212132|NCT03235089|516321993|FG000|Overall Study|Physician Decision|2|||
143212133|NCT03235089|516321994|FG001|Overall Study|Physician Decision|2|||
143212134|NCT03238924|516321997|FG000|Overall Study|Withdrawal by Subject|2|||
143212135|NCT03238924|516321998|FG001|Overall Study|Withdrawal by Subject|2|||
143212136|NCT03576716|516322002|FG000|Overall Study|Withdrawal by Subject|0|||
143212137|NCT03576716|516322003|FG001|Overall Study|Withdrawal by Subject|1|||
143212138|NCT02249182|516322004|FG000|Treatment Phase|Lost to Follow-up|4|||
143212139|NCT02249182|516322005|FG001|Treatment Phase|Lost to Follow-up|0|||
143212140|NCT02249182|516322006|FG002|Treatment Phase|Lost to Follow-up|0|||
143212141|NCT02249182|516322007|FG003|Treatment Phase|Lost to Follow-up|0|||
143212142|NCT02249182|516322008|FG004|Treatment Phase|Lost to Follow-up|0|||
143212143|NCT01455194|516322009|FG000|Overall Study|Screen Failure|20|||
143212144|NCT01455194|516322010|FG001|Overall Study|Screen Failure|0|||
143212145|NCT01455194|516322011|FG002|Overall Study|Screen Failure|0|||
143212146|NCT01455194|516322012|FG003|Overall Study|Screen Failure|0|||
143212147|NCT01455194|516322009|FG000|Overall Study|Randomisation Failure|90|||
143265436|NCT01178073|516526756|FG000|Overall Study|Adverse Event|34|||
143265437|NCT01178073|516526757|FG001|Overall Study|Adverse Event|27|||
143212148|NCT01455194|516322010|FG001|Overall Study|Randomisation Failure|0|||
143212149|NCT01455194|516322011|FG002|Overall Study|Randomisation Failure|0|||
143212150|NCT01455194|516322012|FG003|Overall Study|Randomisation Failure|0|||
143212151|NCT01455194|516322009|FG000|Overall Study|Deterioration in asthma|12|||
143212152|NCT01455194|516322010|FG001|Overall Study|Deterioration in asthma|6|||
143212153|NCT01455194|516322011|FG002|Overall Study|Deterioration in asthma|14|||
143212154|NCT01455194|516322012|FG003|Overall Study|Deterioration in asthma|9|||
143212155|NCT01455194|516322009|FG000|Overall Study|Adverse Event|1|||
143212156|NCT01455194|516322010|FG001|Overall Study|Adverse Event|1|||
143212157|NCT01455194|516322011|FG002|Overall Study|Adverse Event|1|||
143212158|NCT01455194|516322012|FG003|Overall Study|Adverse Event|3|||
143265438|NCT01178073|516526758|FG002|Overall Study|Adverse Event|24|||
143265439|NCT01178073|516526756|FG000|Overall Study|Protocol Violation|1|||
143265440|NCT01178073|516526757|FG001|Overall Study|Protocol Violation|1|||
143265441|NCT01178073|516526758|FG002|Overall Study|Protocol Violation|1|||
143265442|NCT01178073|516526756|FG000|Overall Study|Lost to Follow-up|2|||
143265443|NCT01178073|516526757|FG001|Overall Study|Lost to Follow-up|0|||
143265444|NCT01178073|516526758|FG002|Overall Study|Lost to Follow-up|3|||
143265445|NCT01178073|516526756|FG000|Overall Study|Physician Decision|14|||
143265446|NCT01178073|516526757|FG001|Overall Study|Physician Decision|10|||
143265447|NCT01178073|516526758|FG002|Overall Study|Physician Decision|10|||
143265448|NCT01178073|516526756|FG000|Overall Study|Withdrawal by Subject|10|||
143265449|NCT01178073|516526757|FG001|Overall Study|Withdrawal by Subject|6|||
143265450|NCT01178073|516526758|FG002|Overall Study|Withdrawal by Subject|8|||
143212159|NCT01455194|516322009|FG000|Overall Study|Withdrawal by Subject|21|||
143212160|NCT01455194|516322010|FG001|Overall Study|Withdrawal by Subject|16|||
143212161|NCT01455194|516322011|FG002|Overall Study|Withdrawal by Subject|12|||
143212162|NCT01455194|516322012|FG003|Overall Study|Withdrawal by Subject|9|||
143212163|NCT01455194|516322009|FG000|Overall Study|Lost to Follow-up|2|||
143212164|NCT01455194|516322010|FG001|Overall Study|Lost to Follow-up|0|||
143212165|NCT01455194|516322011|FG002|Overall Study|Lost to Follow-up|1|||
143212166|NCT01455194|516322012|FG003|Overall Study|Lost to Follow-up|1|||
143212167|NCT01455194|516322009|FG000|Overall Study|Pregnancy|0|||
143212168|NCT01455194|516322010|FG001|Overall Study|Pregnancy|1|||
143212169|NCT01455194|516322011|FG002|Overall Study|Pregnancy|1|||
143212170|NCT01455194|516322012|FG003|Overall Study|Pregnancy|0|||
143212171|NCT01455194|516322009|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
143212172|NCT01455194|516322010|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
143212173|NCT01455194|516322011|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
143212174|NCT01455194|516322012|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
143212175|NCT01455194|516322009|FG000|Overall Study|Miscellaneous|4|||
143212176|NCT01455194|516322010|FG001|Overall Study|Miscellaneous|5|||
143212177|NCT01455194|516322011|FG002|Overall Study|Miscellaneous|1|||
143212178|NCT01455194|516322012|FG003|Overall Study|Miscellaneous|4|||
143212179|NCT02891382|516322015|FG000|Overall Study|Lost to Follow-up|3|||
143212180|NCT02891382|516322016|FG001|Overall Study|Lost to Follow-up|4|||
143212181|NCT02891382|516322017|FG002|Overall Study|Lost to Follow-up|5|||
143212182|NCT02891382|516322018|FG003|Overall Study|Lost to Follow-up|3|||
143212183|NCT02891382|516322019|FG004|Overall Study|Lost to Follow-up|4|||
143212184|NCT00148941|516322024|FG000|Overall Study|Lost to Follow-up|17|||
143212185|NCT00148941|516322025|FG001|Overall Study|Lost to Follow-up|24|||
143212186|NCT00148941|516322026|FG002|Overall Study|Lost to Follow-up|18|||
143212187|NCT00148941|516322027|FG003|Overall Study|Lost to Follow-up|22|||
143212188|NCT00148941|516322024|FG000|Overall Study|Withdrawal by Subject|1|||
143265451|NCT01178073|516526756|FG000|Overall Study|Missing Completion Status|1|||
143265452|NCT01178073|516526757|FG001|Overall Study|Missing Completion Status|0|||
143265453|NCT01178073|516526758|FG002|Overall Study|Missing Completion Status|0|||
143265454|NCT01226043|516526762|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
143265455|NCT01226043|516526763|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
143265456|NCT01226043|516526764|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
143265457|NCT01226043|516526765|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
143265458|NCT01226043|516526762|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
143265459|NCT01226043|516526763|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
143265460|NCT01226043|516526764|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
143265461|NCT01226043|516526765|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
143265462|NCT01226043|516526762|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
143265463|NCT01226043|516526763|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
143265464|NCT01226043|516526764|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
143265465|NCT01226043|516526765|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
143265466|NCT01226043|516526762|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
143265467|NCT01226043|516526763|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
143265468|NCT01226043|516526764|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
143265469|NCT01226043|516526765|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
143265470|NCT01226043|516526762|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
143265471|NCT01226043|516526763|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
143265472|NCT01226043|516526764|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
143265473|NCT01226043|516526765|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
143265474|NCT01226043|516526762|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
143265475|NCT01226043|516526763|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
143265476|NCT01226043|516526764|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
143265477|NCT01226043|516526765|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
143212189|NCT00148941|516322025|FG001|Overall Study|Withdrawal by Subject|0|||
143212190|NCT00148941|516322026|FG002|Overall Study|Withdrawal by Subject|1|||
143212191|NCT00148941|516322027|FG003|Overall Study|Withdrawal by Subject|0|||
143212192|NCT00148941|516322024|FG000|Overall Study|Other|0|||
143212193|NCT00148941|516322025|FG001|Overall Study|Other|0|||
143212194|NCT00148941|516322026|FG002|Overall Study|Other|1|||
143212195|NCT00148941|516322027|FG003|Overall Study|Other|2|||
143212196|NCT03244826|516322028|FG000|Overall Study|Withdrawal by Subject|2|||
143212197|NCT03244826|516322029|FG001|Overall Study|Withdrawal by Subject|0|||
143212198|NCT03244826|516322028|FG000|Overall Study|Transplant delayed or withdrawn|12|||
143265478|NCT01226043|516526762|FG000|6-week Re-randomization Phase|Adverse Event|0|||
143265479|NCT01226043|516526763|FG001|6-week Re-randomization Phase|Adverse Event|0|||
143265480|NCT01226043|516526764|FG002|6-week Re-randomization Phase|Adverse Event|1|||
143371096|NCT01959412|516902317|FG003|Overall Study|Protocol deviation|1|||
143371097|NCT01959412|516902318|FG004|Overall Study|Protocol deviation|3|||
143371098|NCT01959412|516902319|FG005|Overall Study|Protocol deviation|0|||
143371099|NCT01959412|516902314|FG000|Overall Study|Adverse Event|0|||
143371100|NCT01959412|516902315|FG001|Overall Study|Adverse Event|0|||
143371101|NCT01959412|516902316|FG002|Overall Study|Adverse Event|0|||
143371102|NCT01959412|516902317|FG003|Overall Study|Adverse Event|1|||
143371103|NCT01959412|516902318|FG004|Overall Study|Adverse Event|0|||
143371104|NCT01959412|516902319|FG005|Overall Study|Adverse Event|0|||
143371105|NCT01186848|516902320|FG000|Overall Study|Lost to Follow-up|4|||
143371106|NCT01186848|516902320|FG000|Overall Study|Withdrawal by Subject|2|||
143371107|NCT01186848|516902320|FG000|Overall Study|Adverse Event|2|||
143371108|NCT04379713|516902327|FG000|Overall Study|Adverse Event|2|||
143371109|NCT04379713|516902328|FG001|Overall Study|Adverse Event|0|||
143371110|NCT04379713|516902327|FG000|Overall Study|Physician Decision|2|||
143371111|NCT04379713|516902328|FG001|Overall Study|Physician Decision|1|||
143371112|NCT04379713|516902327|FG000|Overall Study|Protocol Violation|11|||
143371113|NCT04379713|516902328|FG001|Overall Study|Protocol Violation|6|||
143371114|NCT04379713|516902327|FG000|Overall Study|No longer met eligibility criteria|14|||
143371115|NCT04379713|516902328|FG001|Overall Study|No longer met eligibility criteria|11|||
143371116|NCT04379713|516902327|FG000|Overall Study|Withdrawal by parent/guardian|36|||
143371117|NCT04379713|516902328|FG001|Overall Study|Withdrawal by parent/guardian|15|||
143371118|NCT04379713|516902327|FG000|Overall Study|Lost to Follow-up|31|||
143371119|NCT04379713|516902328|FG001|Overall Study|Lost to Follow-up|21|||
143371120|NCT02613364|516902337|FG000|Overall Study|Other|19|||
143371121|NCT02613364|516902338|FG001|Overall Study|Other|29|||
143371122|NCT02613364|516902339|FG002|Overall Study|Other|17|||
143371123|NCT02613364|516902337|FG000|Overall Study|Too time consuming|21|||
143371124|NCT02613364|516902338|FG001|Overall Study|Too time consuming|26|||
143371125|NCT02613364|516902339|FG002|Overall Study|Too time consuming|26|||
143371126|NCT02613364|516902337|FG000|Overall Study|Withdrawal by Subject|13|||
143371127|NCT02613364|516902338|FG001|Overall Study|Withdrawal by Subject|18|||
143371128|NCT02613364|516902339|FG002|Overall Study|Withdrawal by Subject|17|||
143371129|NCT02613364|516902337|FG000|Overall Study|Medical|12|||
143371130|NCT02613364|516902338|FG001|Overall Study|Medical|13|||
143371131|NCT02613364|516902339|FG002|Overall Study|Medical|9|||
143371132|NCT02613364|516902337|FG000|Overall Study|Disliked Study Procedure|1|||
143371133|NCT02613364|516902338|FG001|Overall Study|Disliked Study Procedure|1|||
143371134|NCT02613364|516902339|FG002|Overall Study|Disliked Study Procedure|4|||
143371135|NCT02613364|516902337|FG000|Overall Study|Disliked Intervention|0|||
143371136|NCT02613364|516902338|FG001|Overall Study|Disliked Intervention|3|||
143371137|NCT02613364|516902339|FG002|Overall Study|Disliked Intervention|3|||
143371138|NCT00371566|516902345|FG000|Treatment Phase|Withdrawal by Subject|0|||
143371139|NCT00371566|516902346|FG001|Treatment Phase|Withdrawal by Subject|1|||
143371140|NCT00371566|516902345|FG000|Treatment Phase|Adverse Event|0|||
143371141|NCT00371566|516902346|FG001|Treatment Phase|Adverse Event|1|||
143371142|NCT00371566|516902345|FG000|Treatment Phase|Protocol Violation|0|||
143371143|NCT00371566|516902346|FG001|Treatment Phase|Protocol Violation|1|||
143371144|NCT00371566|516902345|FG000|Chemoradiation Phase|Physician Decision|2|||
143371145|NCT00371566|516902346|FG001|Chemoradiation Phase|Physician Decision|0|||
143371146|NCT00371566|516902345|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
143371147|NCT00371566|516902346|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
143371148|NCT00371566|516902345|FG000|Chemoradiation Phase|Non compliant|0|||
143371149|NCT00371566|516902346|FG001|Chemoradiation Phase|Non compliant|1|||
143371150|NCT00371566|516902345|FG000|Chemoradiation Phase|Progressive Disease|1|||
143371151|NCT00371566|516902346|FG001|Chemoradiation Phase|Progressive Disease|1|||
143371152|NCT00371566|516902345|FG000|Chemoradiation Phase|Death|2|||
143371153|NCT00371566|516902346|FG001|Chemoradiation Phase|Death|0|||
143371154|NCT00371566|516902345|FG000|Follow Up Phase|Death|0|||
143371155|NCT00371566|516902346|FG001|Follow Up Phase|Death|5|||
143371156|NCT00371566|516902345|FG000|Follow Up Phase|Disease progression|1|||
143371157|NCT00371566|516902346|FG001|Follow Up Phase|Disease progression|0|||
143371158|NCT00371566|516902345|FG000|Follow Up Phase|Withdrawal by Subject|0|||
143371159|NCT00371566|516902346|FG001|Follow Up Phase|Withdrawal by Subject|1|||
143371160|NCT00371566|516902345|FG000|Follow Up Phase|Physician Decision|1|||
143371161|NCT00371566|516902346|FG001|Follow Up Phase|Physician Decision|1|||
143371162|NCT00371566|516902345|FG000|Follow Up Phase|Lost to Follow-up|1|||
143371163|NCT00371566|516902346|FG001|Follow Up Phase|Lost to Follow-up|0|||
143371164|NCT02878330|516902347|FG000|Overall Study|Death|3|||
143371165|NCT02878330|516902348|FG001|Overall Study|Death|2|||
143371166|NCT02878330|516902347|FG000|Overall Study|Lost to Follow-up|11|||
143371167|NCT02878330|516902348|FG001|Overall Study|Lost to Follow-up|26|||
143371168|NCT02878330|516902347|FG000|Overall Study|Withdrawal by Subject|11|||
143371169|NCT02878330|516902348|FG001|Overall Study|Withdrawal by Subject|21|||
143371170|NCT02878330|516902347|FG000|Overall Study|Other|4|||
143371171|NCT02878330|516902348|FG001|Overall Study|Other|7|||
143371172|NCT00082810|516902349|FG000|Overall Study|Adverse Event|3|||
143371173|NCT00082810|516902349|FG000|Overall Study|Progressive disease|24|||
143371174|NCT00082810|516902349|FG000|Overall Study|Withdrawal by Subject|4|||
143371175|NCT01321606|516902350|FG000|Overall Study|Lost to Follow-up|0|||
143371176|NCT01321606|516902351|FG001|Overall Study|Lost to Follow-up|0|||
143371177|NCT01321606|516902352|FG002|Overall Study|Lost to Follow-up|0|||
143371178|NCT01321606|516902353|FG003|Overall Study|Lost to Follow-up|1|||
143371179|NCT02807493|516902359|FG000|Overall Study|Adverse Event|5|||
143371180|NCT02807493|516902360|FG001|Overall Study|Adverse Event|2|||
143371181|NCT02807493|516902359|FG000|Overall Study|Lost to Follow-up|6|||
143371182|NCT02807493|516902360|FG001|Overall Study|Lost to Follow-up|0|||
143371183|NCT02807493|516902359|FG000|Overall Study|Physician Decision|4|||
143371184|NCT02807493|516902360|FG001|Overall Study|Physician Decision|1|||
143371185|NCT02807493|516902359|FG000|Overall Study|Protocol Violation|7|||
143371186|NCT02807493|516902360|FG001|Overall Study|Protocol Violation|0|||
143371187|NCT02807493|516902359|FG000|Overall Study|Withdrawal by Subject|17|||
143371188|NCT02807493|516902360|FG001|Overall Study|Withdrawal by Subject|10|||
143371189|NCT02807493|516902359|FG000|Overall Study|Other withdrawal|17|||
143371190|NCT02807493|516902360|FG001|Overall Study|Other withdrawal|0|||
143371191|NCT02807493|516902359|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
143371192|NCT02807493|516902360|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
143371193|NCT01227707|516902361|FG000|Overall Study|Adverse Event|10|||
143371194|NCT01227707|516902361|FG000|Overall Study|Progression of disease|3|||
143371195|NCT01227707|516902361|FG000|Overall Study|Withdrawal by Subject|1|||
143371196|NCT01227707|516902361|FG000|Overall Study|Patient non-compliance|3|||
143371197|NCT01227707|516902361|FG000|Overall Study|Medical decision|6|||
143371198|NCT01227707|516902361|FG000|Overall Study|Death|1|||
143371199|NCT05484726|516902364|FG000|Overall Study|Protocol Violation|3|||
143371200|NCT05484726|516902365|FG001|Overall Study|Protocol Violation|3|||
143371201|NCT05484726|516902364|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
143371202|NCT05484726|516902365|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
143371203|NCT05484726|516902364|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
143371204|NCT05484726|516902365|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
143371205|NCT05484726|516902364|FG000|Overall Study|continued need of mechanical ventilation|2|||
143371206|NCT05484726|516902365|FG001|Overall Study|continued need of mechanical ventilation|3|||
143371207|NCT05484726|516902364|FG000|Overall Study|Withdrawal by Subject|2|||
143371208|NCT05484726|516902365|FG001|Overall Study|Withdrawal by Subject|3|||
143371209|NCT05484726|516902364|FG000|Overall Study|IVH (G III & IV)|2|||
143371210|NCT05484726|516902365|FG001|Overall Study|IVH (G III & IV)|1|||
143371211|NCT05484726|516902364|FG000|Overall Study|NEC (stage II & III)|2|||
143371212|NCT05484726|516902365|FG001|Overall Study|NEC (stage II & III)|3|||
143371213|NCT01981356|516902374|FG000|Overall Study|Lost to Follow-up|4|||
143371214|NCT01981356|516902375|FG001|Overall Study|Lost to Follow-up|1|||
143371215|NCT01981356|516902374|FG000|Overall Study|Withdrawal by Subject|1|||
143371216|NCT01981356|516902375|FG001|Overall Study|Withdrawal by Subject|1|||
143371217|NCT01981356|516902374|FG000|Overall Study|Protocol Violation|2|||
143371218|NCT01981356|516902375|FG001|Overall Study|Protocol Violation|0|||
143371219|NCT00290706|516902376|FG000|Overall Study|Withdrawal by Subject|2|||
143371220|NCT00290706|516902377|FG001|Overall Study|Withdrawal by Subject|0|||
143371221|NCT00290706|516902378|FG002|Overall Study|Withdrawal by Subject|0|||
143371222|NCT00290706|516902379|FG003|Overall Study|Withdrawal by Subject|0|||
143371223|NCT00290706|516902376|FG000|Overall Study|Progressive Disease|3|||
143371224|NCT00290706|516902377|FG001|Overall Study|Progressive Disease|5|||
143371225|NCT00290706|516902378|FG002|Overall Study|Progressive Disease|4|||
143371226|NCT00290706|516902379|FG003|Overall Study|Progressive Disease|10|||
143371227|NCT00290706|516902376|FG000|Overall Study|Adverse Event|0|||
143371228|NCT00290706|516902377|FG001|Overall Study|Adverse Event|1|||
143371229|NCT00290706|516902378|FG002|Overall Study|Adverse Event|2|||
143371230|NCT00290706|516902379|FG003|Overall Study|Adverse Event|0|||
143371231|NCT00290706|516902376|FG000|Overall Study|Receive auto transplant or radiation|0|||
143371232|NCT00290706|516902377|FG001|Overall Study|Receive auto transplant or radiation|0|||
143371233|NCT00290706|516902378|FG002|Overall Study|Receive auto transplant or radiation|0|||
143371234|NCT00290706|516902379|FG003|Overall Study|Receive auto transplant or radiation|1|||
143371235|NCT00290706|516902376|FG000|Overall Study|Physician Decision|0|||
143371236|NCT00290706|516902377|FG001|Overall Study|Physician Decision|0|||
143371237|NCT00290706|516902378|FG002|Overall Study|Physician Decision|0|||
143371238|NCT00290706|516902379|FG003|Overall Study|Physician Decision|1|||
143371239|NCT03395353|516902380|FG000|Overall Study|Adverse Event|20|||
143371240|NCT03395353|516902380|FG000|Overall Study|Protocol Violation|1|||
143371241|NCT03395353|516902380|FG000|Overall Study|Lack of Efficacy|3|||
143371242|NCT03395353|516902380|FG000|Overall Study|Withdrawal by Subject|24|||
143371243|NCT03395353|516902380|FG000|Overall Study|Discontinued visit|1|||
143371244|NCT03395353|516902380|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
143371245|NCT03395353|516902380|FG000|Overall Study|Physician Decision|4|||
143371246|NCT03395353|516902380|FG000|Overall Study|Early termination of overall study|33|||
143371247|NCT03121950|516902383|FG000|Overall Study|Withdrawal by Subject|11|||
143371248|NCT03121950|516902384|FG001|Overall Study|Withdrawal by Subject|2|||
143212199|NCT03244826|516322029|FG001|Overall Study|Transplant delayed or withdrawn|10|||
143212200|NCT02673684|516322032|FG000|Overall Study|Study not completed d/t loss of funding|9|||
143212201|NCT02673684|516322033|FG001|Overall Study|Study not completed d/t loss of funding|8|||
143212202|NCT01092663|516322034|FG000|Overall Study|Withdrawal by Subject|3|||
143212203|NCT01092663|516322035|FG001|Overall Study|Withdrawal by Subject|2|||
143212204|NCT01092663|516322034|FG000|Overall Study|Glucose >300mg/dL|1|||
143212205|NCT01092663|516322035|FG001|Overall Study|Glucose >300mg/dL|0|||
143212206|NCT01092663|516322034|FG000|Overall Study|High fasting triglyceride|2|||
143212207|NCT01092663|516322035|FG001|Overall Study|High fasting triglyceride|0|||
143212208|NCT01092663|516322034|FG000|Overall Study|Adverse Event|1|||
143212209|NCT01092663|516322035|FG001|Overall Study|Adverse Event|1|||
143212210|NCT01092663|516322034|FG000|Overall Study|Protocol Violation|0|||
143212211|NCT01092663|516322035|FG001|Overall Study|Protocol Violation|1|||
143212212|NCT04356040|516322036|FG000|Overall Study|Death|2|||
143212213|NCT04356040|516322037|FG001|Overall Study|Death|0|||
143265481|NCT01226043|516526765|FG003|6-week Re-randomization Phase|Adverse Event|1|||
143265482|NCT01226043|516526762|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
143265483|NCT01226043|516526763|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
143265484|NCT01226043|516526764|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
143265485|NCT01226043|516526765|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
143265486|NCT01226043|516526762|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
143265487|NCT01226043|516526763|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
143265488|NCT01226043|516526764|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
143265489|NCT01226043|516526765|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
143265490|NCT01226043|516526762|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
143265491|NCT01226043|516526763|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
143265492|NCT01226043|516526764|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
143265493|NCT01226043|516526765|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
143265494|NCT01226043|516526762|FG000|6-week Re-randomization Phase|Physician Decision|0|||
143265495|NCT01226043|516526763|FG001|6-week Re-randomization Phase|Physician Decision|0|||
143265496|NCT01226043|516526764|FG002|6-week Re-randomization Phase|Physician Decision|3|||
143265497|NCT01226043|516526765|FG003|6-week Re-randomization Phase|Physician Decision|2|||
143265498|NCT01226043|516526762|FG000|6-week Re-randomization Phase|completed in error|0|||
143265499|NCT01226043|516526763|FG001|6-week Re-randomization Phase|completed in error|0|||
143265500|NCT01226043|516526764|FG002|6-week Re-randomization Phase|completed in error|0|||
143265501|NCT01226043|516526765|FG003|6-week Re-randomization Phase|completed in error|1|||
143265502|NCT01226043|516526762|FG000|30-week Observational Phase|Adverse Event|0|||
143265503|NCT01226043|516526763|FG001|30-week Observational Phase|Adverse Event|0|||
143265504|NCT01226043|516526764|FG002|30-week Observational Phase|Adverse Event|1|||
143265505|NCT01226043|516526765|FG003|30-week Observational Phase|Adverse Event|1|||
143265506|NCT01226043|516526762|FG000|30-week Observational Phase|Protocol Violation|0|||
143265507|NCT01226043|516526763|FG001|30-week Observational Phase|Protocol Violation|0|||
143265508|NCT01226043|516526764|FG002|30-week Observational Phase|Protocol Violation|0|||
143265509|NCT01226043|516526765|FG003|30-week Observational Phase|Protocol Violation|1|||
143265510|NCT01226043|516526762|FG000|30-week Observational Phase|Lost to Follow-up|0|||
143265511|NCT01226043|516526763|FG001|30-week Observational Phase|Lost to Follow-up|0|||
143265512|NCT01226043|516526764|FG002|30-week Observational Phase|Lost to Follow-up|2|||
143265513|NCT01226043|516526765|FG003|30-week Observational Phase|Lost to Follow-up|2|||
143265514|NCT01226043|516526762|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
143265515|NCT01226043|516526763|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
143265516|NCT01226043|516526764|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
143265517|NCT01226043|516526765|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
143265518|NCT01226043|516526762|FG000|30-week Observational Phase|Physician Decision|0|||
143265519|NCT01226043|516526763|FG001|30-week Observational Phase|Physician Decision|0|||
143265520|NCT01226043|516526764|FG002|30-week Observational Phase|Physician Decision|2|||
143265521|NCT01226043|516526765|FG003|30-week Observational Phase|Physician Decision|2|||
143265522|NCT01702571|516526766|FG000|Overall Study|Death|1067|||
143265523|NCT01702571|516526767|FG001|Overall Study|Death|76|||
143212214|NCT04356040|516322036|FG000|Overall Study|Lost to Follow-up|1|||
143212215|NCT04356040|516322037|FG001|Overall Study|Lost to Follow-up|0|||
143212216|NCT04356040|516322036|FG000|Overall Study|Physician Decision|0|||
143212217|NCT04356040|516322037|FG001|Overall Study|Physician Decision|1|||
143265524|NCT01702571|516526766|FG000|Overall Study|Lost to Follow-up|144|||
143265525|NCT01702571|516526767|FG001|Overall Study|Lost to Follow-up|10|||
143212218|NCT04356040|516322036|FG000|Overall Study|Withdrawal by Subject|13|||
143212219|NCT04356040|516322037|FG001|Overall Study|Withdrawal by Subject|1|||
143265526|NCT01702571|516526766|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
143265527|NCT01702571|516526767|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
143265528|NCT01702571|516526766|FG000|Overall Study|Investigator Decision|5|||
143265529|NCT01702571|516526767|FG001|Overall Study|Investigator Decision|0|||
143265530|NCT01702571|516526766|FG000|Overall Study|Not Classifiable|1|||
143212220|NCT04356040|516322036|FG000|Overall Study|Enrollment Pause|10|||
143212221|NCT04356040|516322037|FG001|Overall Study|Enrollment Pause|0|||
143371249|NCT01867580|516902386|FG000|Overall Study|Withdrawal by Subject|2|||
143212222|NCT04356040|516322036|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
143212223|NCT04356040|516322037|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
143212224|NCT04356040|516322036|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
143212225|NCT04356040|516322037|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
143212226|NCT04356040|516322036|FG000|Overall Study|PI left institution|3|||
143212227|NCT04356040|516322037|FG001|Overall Study|PI left institution|0|||
143212228|NCT01990859|516322038|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
143212229|NCT01990859|516322038|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
143212230|NCT02262754|516322039|FG000|Overall Study|Adverse Event|3|||
143212231|NCT02262754|516322040|FG001|Overall Study|Adverse Event|4|||
143212232|NCT02262754|516322041|FG002|Overall Study|Adverse Event|0|||
143212233|NCT02262754|516322039|FG000|Overall Study|Lack of Efficacy|2|||
143212234|NCT02262754|516322040|FG001|Overall Study|Lack of Efficacy|0|||
143212235|NCT02262754|516322041|FG002|Overall Study|Lack of Efficacy|1|||
143212236|NCT02262754|516322039|FG000|Overall Study|Lost to Follow-up|0|||
143265531|NCT01702571|516526767|FG001|Overall Study|Not Classifiable|0|||
143265532|NCT01702571|516526766|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
143265533|NCT01702571|516526767|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
143265534|NCT01702571|516526766|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
143265535|NCT01702571|516526767|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
143265536|NCT01702571|516526766|FG000|Overall Study|Progressive Disease|3|||
143265537|NCT01702571|516526767|FG001|Overall Study|Progressive Disease|0|||
143265538|NCT01702571|516526766|FG000|Overall Study|Protocol Violation|2|||
143265539|NCT01702571|516526767|FG001|Overall Study|Protocol Violation|0|||
143265540|NCT01702571|516526766|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
143265541|NCT01702571|516526767|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
143265542|NCT01702571|516526766|FG000|Overall Study|Termination By Sponsor|4|||
143265543|NCT01702571|516526767|FG001|Overall Study|Termination By Sponsor|0|||
143265544|NCT01702571|516526766|FG000|Overall Study|Withdrawal by Subject|177|||
143265545|NCT01702571|516526767|FG001|Overall Study|Withdrawal by Subject|29|||
143265546|NCT00910988|516526768|FG000|Overall Study|Lost to Follow-up|2|||
143265547|NCT00910988|516526769|FG001|Overall Study|Lost to Follow-up|4|||
143265548|NCT00910988|516526770|FG002|Overall Study|Lost to Follow-up|3|||
143265549|NCT00910988|516526771|FG003|Overall Study|Lost to Follow-up|0|||
143265550|NCT01505647|516526774|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
143265551|NCT01505647|516526775|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
143265552|NCT01505647|516526774|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
143265553|NCT01505647|516526775|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
143265554|NCT01505647|516526774|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
143265555|NCT01505647|516526775|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
143265556|NCT01505647|516526774|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
143265557|NCT01505647|516526775|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
143265558|NCT01505647|516526774|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
143265559|NCT01505647|516526775|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
143265560|NCT01907100|516526776|FG000|Overall Study|PD based on modified RECIST criteria|31|||
143265561|NCT01907100|516526777|FG001|Overall Study|PD based on modified RECIST criteria|32|||
143265562|NCT01907100|516526778|FG002|Overall Study|PD based on modified RECIST criteria|95|||
143265563|NCT01907100|516526779|FG003|Overall Study|PD based on modified RECIST criteria|92|||
143265564|NCT01907100|516526776|FG000|Overall Study|Withdrawal by Subject|2|||
143265565|NCT01907100|516526777|FG001|Overall Study|Withdrawal by Subject|5|||
143265566|NCT01907100|516526778|FG002|Overall Study|Withdrawal by Subject|10|||
143265567|NCT01907100|516526779|FG003|Overall Study|Withdrawal by Subject|13|||
143265568|NCT01907100|516526776|FG000|Overall Study|Protocol Violation|0|||
143265569|NCT01907100|516526777|FG001|Overall Study|Protocol Violation|0|||
143265570|NCT01907100|516526778|FG002|Overall Study|Protocol Violation|1|||
143265571|NCT01907100|516526779|FG003|Overall Study|Protocol Violation|1|||
143265572|NCT01907100|516526776|FG000|Overall Study|Lost to Follow-up|0|||
143265573|NCT01907100|516526777|FG001|Overall Study|Lost to Follow-up|0|||
143265574|NCT01907100|516526778|FG002|Overall Study|Lost to Follow-up|0|||
143265575|NCT01907100|516526779|FG003|Overall Study|Lost to Follow-up|1|||
143265576|NCT01907100|516526776|FG000|Overall Study|Not treated|2|||
143265577|NCT01907100|516526777|FG001|Overall Study|Not treated|0|||
143265578|NCT01907100|516526778|FG002|Overall Study|Not treated|1|||
143265579|NCT01907100|516526779|FG003|Overall Study|Not treated|2|||
143265580|NCT01907100|516526776|FG000|Overall Study|Other than reasons specified|1|||
143265581|NCT01907100|516526777|FG001|Overall Study|Other than reasons specified|0|||
143265582|NCT01907100|516526778|FG002|Overall Study|Other than reasons specified|10|||
143265583|NCT01907100|516526779|FG003|Overall Study|Other than reasons specified|6|||
143265584|NCT01907100|516526776|FG000|Overall Study|Adverse event (AE)|6|||
143265585|NCT01907100|516526777|FG001|Overall Study|Adverse event (AE)|3|||
143212237|NCT02262754|516322040|FG001|Overall Study|Lost to Follow-up|0|||
143212238|NCT02262754|516322041|FG002|Overall Study|Lost to Follow-up|1|||
143212239|NCT02262754|516322039|FG000|Overall Study|No longer meets eligibility criteria|0|||
143212240|NCT02262754|516322040|FG001|Overall Study|No longer meets eligibility criteria|1|||
143212241|NCT02262754|516322041|FG002|Overall Study|No longer meets eligibility criteria|0|||
143212242|NCT02262754|516322039|FG000|Overall Study|Study terminated by sponsor|5|||
143212243|NCT02262754|516322040|FG001|Overall Study|Study terminated by sponsor|4|||
143212244|NCT02262754|516322041|FG002|Overall Study|Study terminated by sponsor|4|||
143212245|NCT02262754|516322039|FG000|Overall Study|Protocol Violation|1|||
143212246|NCT02262754|516322040|FG001|Overall Study|Protocol Violation|0|||
143212247|NCT02262754|516322041|FG002|Overall Study|Protocol Violation|0|||
143212248|NCT02262754|516322039|FG000|Overall Study|Withdrawal by Subject|1|||
143212249|NCT02262754|516322040|FG001|Overall Study|Withdrawal by Subject|0|||
143212250|NCT02262754|516322041|FG002|Overall Study|Withdrawal by Subject|1|||
143212251|NCT02262754|516322039|FG000|Overall Study|Other|4|||
143212252|NCT02262754|516322040|FG001|Overall Study|Other|0|||
143212253|NCT02262754|516322041|FG002|Overall Study|Other|2|||
143212254|NCT01067469|516322042|FG000|Overall Study|Withdrawal by Subject|0|||
143212255|NCT01067469|516322043|FG001|Overall Study|Withdrawal by Subject|1|||
143212256|NCT01067469|516322042|FG000|Overall Study|Disease Progression|0|||
143212257|NCT01067469|516322043|FG001|Overall Study|Disease Progression|1|||
143212258|NCT04079114|516322047|FG000|Overall Study|Study prematuely terminated.|166|||
143212259|NCT02292706|516322048|FG000|Overall Study|Lost to Follow-up|20|||
143212260|NCT02292706|516322049|FG001|Overall Study|Lost to Follow-up|44|||
143212261|NCT02292706|516322050|FG002|Overall Study|Lost to Follow-up|24|||
143212262|NCT02292706|516322051|FG003|Overall Study|Lost to Follow-up|61|||
143212263|NCT02292706|516322052|FG004|Overall Study|Lost to Follow-up|21|||
143212264|NCT02292706|516322053|FG005|Overall Study|Lost to Follow-up|52|||
143212265|NCT02292706|516322054|FG006|Overall Study|Lost to Follow-up|25|||
143212266|NCT02292706|516322055|FG007|Overall Study|Lost to Follow-up|0|||
143212267|NCT02292706|516322048|FG000|Overall Study|Withdrew consent|15|||
143212268|NCT02292706|516322049|FG001|Overall Study|Withdrew consent|56|||
143212269|NCT02292706|516322050|FG002|Overall Study|Withdrew consent|43|||
143212270|NCT02292706|516322051|FG003|Overall Study|Withdrew consent|36|||
143212271|NCT02292706|516322052|FG004|Overall Study|Withdrew consent|13|||
143212272|NCT02292706|516322053|FG005|Overall Study|Withdrew consent|51|||
143212273|NCT02292706|516322054|FG006|Overall Study|Withdrew consent|20|||
143212274|NCT02292706|516322055|FG007|Overall Study|Withdrew consent|0|||
143212275|NCT02292706|516322048|FG000|Overall Study|Death|3|||
143212276|NCT02292706|516322049|FG001|Overall Study|Death|11|||
143212277|NCT02292706|516322050|FG002|Overall Study|Death|16|||
143212278|NCT02292706|516322051|FG003|Overall Study|Death|22|||
143212279|NCT02292706|516322052|FG004|Overall Study|Death|8|||
143212280|NCT02292706|516322053|FG005|Overall Study|Death|17|||
143212281|NCT02292706|516322054|FG006|Overall Study|Death|3|||
143212282|NCT02292706|516322055|FG007|Overall Study|Death|0|||
143212283|NCT02292706|516322048|FG000|Overall Study|Study terminated by sponsor|0|||
143212284|NCT02292706|516322049|FG001|Overall Study|Study terminated by sponsor|9|||
143212285|NCT02292706|516322050|FG002|Overall Study|Study terminated by sponsor|4|||
143212286|NCT02292706|516322051|FG003|Overall Study|Study terminated by sponsor|21|||
143212287|NCT02292706|516322052|FG004|Overall Study|Study terminated by sponsor|11|||
143212288|NCT02292706|516322053|FG005|Overall Study|Study terminated by sponsor|13|||
143212289|NCT02292706|516322054|FG006|Overall Study|Study terminated by sponsor|3|||
143212290|NCT02292706|516322055|FG007|Overall Study|Study terminated by sponsor|0|||
143212291|NCT02292706|516322048|FG000|Overall Study|Investigator's discretion|4|||
143212292|NCT02292706|516322049|FG001|Overall Study|Investigator's discretion|9|||
143212293|NCT02292706|516322050|FG002|Overall Study|Investigator's discretion|7|||
143212294|NCT02292706|516322051|FG003|Overall Study|Investigator's discretion|11|||
143212295|NCT02292706|516322052|FG004|Overall Study|Investigator's discretion|4|||
143212296|NCT02292706|516322053|FG005|Overall Study|Investigator's discretion|10|||
143212297|NCT02292706|516322054|FG006|Overall Study|Investigator's discretion|1|||
143212298|NCT02292706|516322055|FG007|Overall Study|Investigator's discretion|0|||
143212299|NCT02292706|516322048|FG000|Overall Study|Liver transplant|1|||
143212300|NCT02292706|516322049|FG001|Overall Study|Liver transplant|1|||
143212301|NCT02292706|516322050|FG002|Overall Study|Liver transplant|11|||
143212302|NCT02292706|516322051|FG003|Overall Study|Liver transplant|16|||
143212303|NCT02292706|516322052|FG004|Overall Study|Liver transplant|5|||
143212304|NCT02292706|516322053|FG005|Overall Study|Liver transplant|6|||
143212305|NCT02292706|516322054|FG006|Overall Study|Liver transplant|5|||
143212306|NCT02292706|516322055|FG007|Overall Study|Liver transplant|0|||
143212307|NCT02292706|516322048|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
143212308|NCT02292706|516322049|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
143212309|NCT02292706|516322050|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
143212310|NCT02292706|516322051|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
143212311|NCT02292706|516322052|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
143212312|NCT02292706|516322053|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
143212313|NCT02292706|516322054|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
143212314|NCT02292706|516322055|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
143212315|NCT02292706|516322048|FG000|Overall Study|Subject terminated by sponsor|1|||
143212316|NCT02292706|516322049|FG001|Overall Study|Subject terminated by sponsor|0|||
143212317|NCT02292706|516322050|FG002|Overall Study|Subject terminated by sponsor|0|||
143212318|NCT02292706|516322051|FG003|Overall Study|Subject terminated by sponsor|2|||
143212319|NCT02292706|516322052|FG004|Overall Study|Subject terminated by sponsor|1|||
143212320|NCT02292706|516322053|FG005|Overall Study|Subject terminated by sponsor|0|||
143212321|NCT02292706|516322054|FG006|Overall Study|Subject terminated by sponsor|0|||
143212322|NCT02292706|516322055|FG007|Overall Study|Subject terminated by sponsor|0|||
143212323|NCT02292706|516322048|FG000|Overall Study|Missing|0|||
143212324|NCT02292706|516322049|FG001|Overall Study|Missing|0|||
143212325|NCT02292706|516322050|FG002|Overall Study|Missing|1|||
143212326|NCT02292706|516322051|FG003|Overall Study|Missing|1|||
143212327|NCT02292706|516322052|FG004|Overall Study|Missing|0|||
143212328|NCT02292706|516322053|FG005|Overall Study|Missing|1|||
143212329|NCT02292706|516322054|FG006|Overall Study|Missing|0|||
143212330|NCT02292706|516322055|FG007|Overall Study|Missing|0|||
143212331|NCT02292706|516322048|FG000|Overall Study|Virologic relapse or reinfection|1|||
143212332|NCT02292706|516322049|FG001|Overall Study|Virologic relapse or reinfection|0|||
143212333|NCT02292706|516322050|FG002|Overall Study|Virologic relapse or reinfection|0|||
143212334|NCT02292706|516322051|FG003|Overall Study|Virologic relapse or reinfection|1|||
143212335|NCT02292706|516322052|FG004|Overall Study|Virologic relapse or reinfection|0|||
143212336|NCT02292706|516322053|FG005|Overall Study|Virologic relapse or reinfection|1|||
143212337|NCT02292706|516322054|FG006|Overall Study|Virologic relapse or reinfection|0|||
143212338|NCT02292706|516322055|FG007|Overall Study|Virologic relapse or reinfection|0|||
143212339|NCT02725866|516322058|FG000|Overall Study|Failure to return|6|||
143212340|NCT02725866|516322058|FG000|Overall Study|Withdrew consent|3|||
143212341|NCT02725866|516322058|FG000|Overall Study|Insufficient virological response|1|||
143212342|NCT02725866|516322058|FG000|Overall Study|Other, not specified|4|||
143212343|NCT01990612|516322059|FG000|Overall Study|Lost to Follow-up|2|||
143212344|NCT01990612|516322060|FG001|Overall Study|Lost to Follow-up|1|||
143212345|NCT01990612|516322059|FG000|Overall Study|Withdrawal by Subject|5|||
143212346|NCT01990612|516322060|FG001|Overall Study|Withdrawal by Subject|2|||
143212347|NCT02188849|516322063|FG000|Overall Study|Lost to Follow-up|3|||
143212348|NCT02188849|516322064|FG001|Overall Study|Lost to Follow-up|8|||
143212349|NCT00812565|516322068|FG000|Overall Study|Did Not Receive Study Medication|1|||
143212350|NCT00812565|516322069|FG001|Overall Study|Did Not Receive Study Medication|1|||
143212351|NCT00812565|516322070|FG002|Overall Study|Did Not Receive Study Medication|0|||
143212352|NCT00812565|516322071|FG003|Overall Study|Did Not Receive Study Medication|0|||
143265586|NCT01907100|516526778|FG002|Overall Study|Adverse event (AE)|22|||
143265587|NCT01907100|516526779|FG003|Overall Study|Adverse event (AE)|23|||
143265588|NCT01907100|516526776|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
143265589|NCT01907100|516526777|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
143265590|NCT01907100|516526778|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
143265591|NCT01907100|516526779|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
143265592|NCT01758289|516526780|FG000|Overall Study|Premature Study Termination|44|||
143265593|NCT01758289|516526780|FG000|Overall Study|Adverse Event|9|||
143265594|NCT00667602|516526783|FG000|Overall Study|Withdrawal by Subject|4|||
143265595|NCT00667602|516526784|FG001|Overall Study|Withdrawal by Subject|9|||
143265596|NCT00667602|516526785|FG002|Overall Study|Withdrawal by Subject|10|||
143265597|NCT00667602|516526783|FG000|Overall Study|Lost to Follow-up|4|||
143265598|NCT00667602|516526784|FG001|Overall Study|Lost to Follow-up|5|||
143265599|NCT00667602|516526785|FG002|Overall Study|Lost to Follow-up|6|||
143265600|NCT00667602|516526783|FG000|Overall Study|Administrative reason|0|||
143265601|NCT00667602|516526784|FG001|Overall Study|Administrative reason|0|||
143265602|NCT00667602|516526785|FG002|Overall Study|Administrative reason|2|||
143265603|NCT00667602|516526783|FG000|Overall Study|Protocol Violation|0|||
143265604|NCT00667602|516526784|FG001|Overall Study|Protocol Violation|1|||
143265605|NCT00667602|516526785|FG002|Overall Study|Protocol Violation|0|||
143265606|NCT00406718|516526790|FG000|Overall Study|Withdrawal by Subject|2|||
143265607|NCT00406718|516526791|FG001|Overall Study|Withdrawal by Subject|9|||
143265608|NCT00406718|516526792|FG002|Overall Study|Withdrawal by Subject|4|||
143265609|NCT00406718|516526790|FG000|Overall Study|Lost to Follow-up|2|||
143265610|NCT00406718|516526791|FG001|Overall Study|Lost to Follow-up|5|||
143265611|NCT00406718|516526792|FG002|Overall Study|Lost to Follow-up|4|||
143265612|NCT00395538|516526796|FG000|Overall Study|Did not re-consent to revised protocol|1|||
143212353|NCT00812565|516322072|FG004|Overall Study|Did Not Receive Study Medication|0|||
143212354|NCT00812565|516322073|FG005|Overall Study|Did Not Receive Study Medication|0|||
143212355|NCT00812565|516322074|FG006|Overall Study|Did Not Receive Study Medication|0|||
143212356|NCT00812565|516322075|FG007|Overall Study|Did Not Receive Study Medication|0|||
143265613|NCT00395538|516526797|FG001|Overall Study|Did not re-consent to revised protocol|10|||
143212357|NCT00812565|516322068|FG000|Overall Study|Adverse Event|0|||
143212358|NCT00812565|516322069|FG001|Overall Study|Adverse Event|0|||
143212359|NCT00812565|516322070|FG002|Overall Study|Adverse Event|0|||
143212360|NCT00812565|516322071|FG003|Overall Study|Adverse Event|2|||
143212361|NCT00812565|516322072|FG004|Overall Study|Adverse Event|0|||
143212362|NCT00812565|516322073|FG005|Overall Study|Adverse Event|0|||
143212363|NCT00812565|516322074|FG006|Overall Study|Adverse Event|0|||
143212364|NCT00812565|516322075|FG007|Overall Study|Adverse Event|1|||
143212365|NCT00812565|516322068|FG000|Overall Study|Did Not Come to Study Visit|1|||
143212366|NCT00812565|516322069|FG001|Overall Study|Did Not Come to Study Visit|0|||
143212367|NCT00812565|516322070|FG002|Overall Study|Did Not Come to Study Visit|0|||
143212368|NCT00812565|516322071|FG003|Overall Study|Did Not Come to Study Visit|0|||
143212369|NCT00812565|516322072|FG004|Overall Study|Did Not Come to Study Visit|0|||
143212370|NCT00812565|516322073|FG005|Overall Study|Did Not Come to Study Visit|0|||
143212371|NCT00812565|516322074|FG006|Overall Study|Did Not Come to Study Visit|0|||
143212372|NCT00812565|516322075|FG007|Overall Study|Did Not Come to Study Visit|0|||
143212373|NCT00812565|516322068|FG000|Overall Study|Withdrawal of Consent|1|||
143212374|NCT00812565|516322069|FG001|Overall Study|Withdrawal of Consent|0|||
143212375|NCT00812565|516322070|FG002|Overall Study|Withdrawal of Consent|0|||
143212376|NCT00812565|516322071|FG003|Overall Study|Withdrawal of Consent|0|||
143212377|NCT00812565|516322072|FG004|Overall Study|Withdrawal of Consent|1|||
143212378|NCT00812565|516322073|FG005|Overall Study|Withdrawal of Consent|0|||
143212379|NCT00812565|516322074|FG006|Overall Study|Withdrawal of Consent|0|||
143212380|NCT00812565|516322075|FG007|Overall Study|Withdrawal of Consent|0|||
143212381|NCT00812565|516322068|FG000|Overall Study|Reason Not Specified|0|||
143212382|NCT00812565|516322069|FG001|Overall Study|Reason Not Specified|0|||
143265614|NCT00395538|516526798|FG002|Overall Study|Did not re-consent to revised protocol|0|||
143265615|NCT00395538|516526796|FG000|Overall Study|FDA partial hold on PTH|0|||
143265616|NCT00395538|516526797|FG001|Overall Study|FDA partial hold on PTH|0|||
143265617|NCT00395538|516526798|FG002|Overall Study|FDA partial hold on PTH|11|||
143265618|NCT00395538|516526796|FG000|Overall Study|Failed screening|0|||
143265619|NCT00395538|516526797|FG001|Overall Study|Failed screening|0|||
143265620|NCT00395538|516526798|FG002|Overall Study|Failed screening|4|||
143265621|NCT00395538|516526796|FG000|Overall Study|Switch to Natpara|0|||
143265622|NCT00395538|516526797|FG001|Overall Study|Switch to Natpara|0|||
143265623|NCT00395538|516526798|FG002|Overall Study|Switch to Natpara|3|||
143265624|NCT00395538|516526796|FG000|Overall Study|Adverse Event|1|||
143265625|NCT00395538|516526797|FG001|Overall Study|Adverse Event|0|||
143265626|NCT00395538|516526798|FG002|Overall Study|Adverse Event|2|||
143265627|NCT00395538|516526796|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
143265628|NCT00395538|516526797|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
143265629|NCT00395538|516526798|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
143265630|NCT00395538|516526796|FG000|Overall Study|Non-compliance with study protocol|0|||
143265631|NCT00395538|516526797|FG001|Overall Study|Non-compliance with study protocol|1|||
143265632|NCT00395538|516526798|FG002|Overall Study|Non-compliance with study protocol|0|||
143265633|NCT00395538|516526796|FG000|Overall Study|PTH resistance|0|||
143265634|NCT00395538|516526797|FG001|Overall Study|PTH resistance|0|||
143265635|NCT00395538|516526798|FG002|Overall Study|PTH resistance|1|||
143212383|NCT00812565|516322070|FG002|Overall Study|Reason Not Specified|0|||
143212384|NCT00812565|516322071|FG003|Overall Study|Reason Not Specified|0|||
143212385|NCT00812565|516322072|FG004|Overall Study|Reason Not Specified|0|||
143212386|NCT00812565|516322073|FG005|Overall Study|Reason Not Specified|1|||
143212387|NCT00812565|516322074|FG006|Overall Study|Reason Not Specified|0|||
143212388|NCT00812565|516322075|FG007|Overall Study|Reason Not Specified|0|||
143212389|NCT00687531|516322080|FG000|Overall Study|Did not meet protocol eligibility|104|||
143212390|NCT00687531|516322080|FG000|Overall Study|Adverse Event|5|||
143212391|NCT00687531|516322080|FG000|Overall Study|Lost to Follow-up|26|||
143265636|NCT00395538|516526796|FG000|Overall Study|Pregnancy|1|||
143265637|NCT00395538|516526797|FG001|Overall Study|Pregnancy|0|||
143265638|NCT00395538|516526798|FG002|Overall Study|Pregnancy|0|||
143265639|NCT00395538|516526796|FG000|Overall Study|Partial recovery of parathyroid function|0|||
143265640|NCT00395538|516526797|FG001|Overall Study|Partial recovery of parathyroid function|0|||
143371250|NCT01867580|516902387|FG001|Overall Study|Withdrawal by Subject|3|||
143371251|NCT01867580|516902386|FG000|Overall Study|Physician Decision|17|||
143371252|NCT01867580|516902387|FG001|Overall Study|Physician Decision|12|||
143371253|NCT01867580|516902386|FG000|Overall Study|Lost to Follow-up|3|||
143371254|NCT01867580|516902387|FG001|Overall Study|Lost to Follow-up|5|||
143371255|NCT01867580|516902386|FG000|Overall Study|Sponsor terminated study|1|||
143371256|NCT01867580|516902387|FG001|Overall Study|Sponsor terminated study|0|||
143371257|NCT01867580|516902386|FG000|Overall Study|Missed follow-up assessment|2|||
143371258|NCT01867580|516902387|FG001|Overall Study|Missed follow-up assessment|1|||
143371259|NCT01867580|516902386|FG000|Overall Study|Interruption to therapy|3|||
143371260|NCT01867580|516902387|FG001|Overall Study|Interruption to therapy|0|||
143371261|NCT01867580|516902386|FG000|Overall Study|Osteomyelitis|0|||
143371262|NCT01867580|516902387|FG001|Overall Study|Osteomyelitis|1|||
143212392|NCT02353728|516322081|FG000|Overall Study|Subject non-compliance|1|||
143212393|NCT02301624|516322082|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
143212394|NCT02301624|516322083|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
143212395|NCT02301624|516322082|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
143212396|NCT02301624|516322083|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
143212397|NCT02301624|516322082|FG000|Open-label Maintenance Phase|Adverse Event|2|||
143212398|NCT02301624|516322083|FG001|Open-label Maintenance Phase|Adverse Event|5|||
143212399|NCT02301624|516322082|FG000|Open-label Maintenance Phase|Physician Decision|3|||
143212400|NCT02301624|516322083|FG001|Open-label Maintenance Phase|Physician Decision|3|||
143212401|NCT02301624|516322082|FG000|Open-label Maintenance Phase|Death|2|||
143212402|NCT02301624|516322083|FG001|Open-label Maintenance Phase|Death|1|||
143212403|NCT02301624|516322082|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
143212404|NCT02301624|516322083|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
143212405|NCT00895310|516322084|FG000|Overall Study|Withdrawal by Subject|1|||
143212406|NCT00659230|516322085|FG000|Overall Study|Lost to Follow-up|2|||
143212407|NCT00659230|516322086|FG001|Overall Study|Lost to Follow-up|5|||
143212408|NCT00659230|516322085|FG000|Overall Study|Lost source documentation|5|||
143212409|NCT00659230|516322086|FG001|Overall Study|Lost source documentation|4|||
143212410|NCT00659230|516322085|FG000|Overall Study|Did not return post-randomization|2|||
143212411|NCT00659230|516322086|FG001|Overall Study|Did not return post-randomization|3|||
143212412|NCT00547521|516322087|FG000|Short Term Study (4 Months)|Adverse Event|1|||
143212413|NCT00547521|516322088|FG001|Short Term Study (4 Months)|Adverse Event|0|||
143212414|NCT00547521|516322087|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
143212415|NCT00547521|516322088|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
143212416|NCT00547521|516322087|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
143212417|NCT00547521|516322088|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
143212418|NCT00547521|516322087|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
143212419|NCT00547521|516322088|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
143212420|NCT00547521|516322087|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
143212421|NCT00547521|516322088|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
143212422|NCT00547521|516322087|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
143212423|NCT00547521|516322088|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
143212424|NCT00547521|516322087|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
143212425|NCT00547521|516322088|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
143212426|NCT00547521|516322087|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
143212427|NCT00547521|516322088|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
143212428|NCT00547521|516322087|FG000|Long Term Extension (LTE) Study|Other|0|||
143212429|NCT00547521|516322088|FG001|Long Term Extension (LTE) Study|Other|2|||
143212430|NCT00547521|516322087|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
143212431|NCT00547521|516322088|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
143212432|NCT05066165|516323960|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
143212433|NCT05066165|516323961|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
143212434|NCT05066165|516323960|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
143212435|NCT05066165|516323961|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
143212436|NCT03210961|516323962|FG000|Overall Study|Adverse Event|0|||
143371263|NCT01867580|516902386|FG000|Overall Study|Continuation of therapy|0|||
143371264|NCT01867580|516902387|FG001|Overall Study|Continuation of therapy|1|||
143371265|NCT01867580|516902386|FG000|Overall Study|Wound recurrence|0|||
143371266|NCT01867580|516902387|FG001|Overall Study|Wound recurrence|1|||
143212437|NCT03210961|516323963|FG001|Overall Study|Adverse Event|0|||
143212438|NCT03210961|516323964|FG002|Overall Study|Adverse Event|0|||
143212439|NCT03210961|516323965|FG003|Overall Study|Adverse Event|0|||
143212440|NCT03210961|516323966|FG004|Overall Study|Adverse Event|0|||
143212441|NCT03210961|516323967|FG005|Overall Study|Adverse Event|0|||
143212442|NCT03210961|516323968|FG006|Overall Study|Adverse Event|0|||
143371267|NCT01304147|516902388|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
143265641|NCT00395538|516526798|FG002|Overall Study|Partial recovery of parathyroid function|1|||
143265642|NCT00395538|516526796|FG000|Overall Study|Participant elected to discontinue|0|||
143265643|NCT00395538|516526797|FG001|Overall Study|Participant elected to discontinue|0|||
143265644|NCT00395538|516526798|FG002|Overall Study|Participant elected to discontinue|1|||
143265645|NCT01927341|516528492|FG000|Phase 1b|Lost to Follow-up|1|||
143265646|NCT01927341|516528493|FG001|Phase 1b|Lost to Follow-up|0|||
143265647|NCT01927341|516528494|FG002|Phase 1b|Lost to Follow-up|0|||
143265648|NCT01927341|516528495|FG003|Phase 1b|Lost to Follow-up|0|||
143265649|NCT01927341|516528496|FG004|Phase 1b|Lost to Follow-up|0|||
143265650|NCT01927341|516528492|FG000|Phase 1b|Death|2|||
143265651|NCT01927341|516528493|FG001|Phase 1b|Death|0|||
143265652|NCT01927341|516528494|FG002|Phase 1b|Death|0|||
143265653|NCT01927341|516528495|FG003|Phase 1b|Death|0|||
143265654|NCT01927341|516528496|FG004|Phase 1b|Death|0|||
143265655|NCT01927341|516528492|FG000|Phase 1b|Follow-up completed|7|||
143265656|NCT01927341|516528493|FG001|Phase 1b|Follow-up completed|0|||
143265657|NCT01927341|516528494|FG002|Phase 1b|Follow-up completed|0|||
143265658|NCT01927341|516528495|FG003|Phase 1b|Follow-up completed|0|||
143265659|NCT01927341|516528496|FG004|Phase 1b|Follow-up completed|0|||
143265660|NCT01927341|516528492|FG000|Phase 2|Lost to Follow-up|0|||
143265661|NCT01927341|516528493|FG001|Phase 2|Lost to Follow-up|1|||
143265662|NCT01927341|516528494|FG002|Phase 2|Lost to Follow-up|0|||
143265663|NCT01927341|516528495|FG003|Phase 2|Lost to Follow-up|0|||
143265664|NCT01927341|516528496|FG004|Phase 2|Lost to Follow-up|0|||
143265665|NCT01927341|516528492|FG000|Phase 2|Participant withdrew consent|0|||
143265666|NCT01927341|516528493|FG001|Phase 2|Participant withdrew consent|2|||
143265667|NCT01927341|516528494|FG002|Phase 2|Participant withdrew consent|1|||
143265668|NCT01927341|516528495|FG003|Phase 2|Participant withdrew consent|2|||
143265669|NCT01927341|516528496|FG004|Phase 2|Participant withdrew consent|3|||
143265670|NCT01927341|516528492|FG000|Phase 2|Death|0|||
143265671|NCT01927341|516528493|FG001|Phase 2|Death|4|||
143265672|NCT01927341|516528494|FG002|Phase 2|Death|0|||
143265673|NCT01927341|516528495|FG003|Phase 2|Death|3|||
143265674|NCT01927341|516528496|FG004|Phase 2|Death|2|||
143265675|NCT01927341|516528492|FG000|Phase 2|New cancer therapy|0|||
143371268|NCT01304147|516902389|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
143371269|NCT01244828|516902390|FG000|Overall Study|Adverse Event|37|||
143212443|NCT03210961|516323969|FG007|Overall Study|Adverse Event|0|||
143212444|NCT03210961|516323970|FG008|Overall Study|Adverse Event|0|||
143212445|NCT03210961|516323971|FG009|Overall Study|Adverse Event|0|||
143212446|NCT03210961|516323972|FG010|Overall Study|Adverse Event|0|||
143212447|NCT03210961|516323973|FG011|Overall Study|Adverse Event|0|||
143212448|NCT03210961|516323974|FG012|Overall Study|Adverse Event|0|||
143212449|NCT03210961|516323975|FG013|Overall Study|Adverse Event|1|||
143212450|NCT03210961|516323976|FG014|Overall Study|Adverse Event|0|||
143212451|NCT03210961|516323962|FG000|Overall Study|Lost to Follow-up|0|||
143212452|NCT03210961|516323963|FG001|Overall Study|Lost to Follow-up|0|||
143212453|NCT03210961|516323964|FG002|Overall Study|Lost to Follow-up|0|||
143212454|NCT03210961|516323965|FG003|Overall Study|Lost to Follow-up|0|||
143212455|NCT03210961|516323966|FG004|Overall Study|Lost to Follow-up|0|||
143212456|NCT03210961|516323967|FG005|Overall Study|Lost to Follow-up|0|||
143212457|NCT03210961|516323968|FG006|Overall Study|Lost to Follow-up|0|||
143212458|NCT03210961|516323969|FG007|Overall Study|Lost to Follow-up|0|||
143212459|NCT03210961|516323970|FG008|Overall Study|Lost to Follow-up|0|||
143212460|NCT03210961|516323971|FG009|Overall Study|Lost to Follow-up|0|||
143212461|NCT03210961|516323972|FG010|Overall Study|Lost to Follow-up|0|||
143212462|NCT03210961|516323973|FG011|Overall Study|Lost to Follow-up|0|||
143212463|NCT03210961|516323974|FG012|Overall Study|Lost to Follow-up|0|||
143212464|NCT03210961|516323975|FG013|Overall Study|Lost to Follow-up|0|||
143212465|NCT03210961|516323976|FG014|Overall Study|Lost to Follow-up|1|||
143212466|NCT03210961|516323962|FG000|Overall Study|Withdrawal by Subject|0|||
143212467|NCT03210961|516323963|FG001|Overall Study|Withdrawal by Subject|0|||
143212468|NCT03210961|516323964|FG002|Overall Study|Withdrawal by Subject|0|||
143212469|NCT03210961|516323965|FG003|Overall Study|Withdrawal by Subject|0|||
143212470|NCT03210961|516323966|FG004|Overall Study|Withdrawal by Subject|0|||
143212471|NCT03210961|516323967|FG005|Overall Study|Withdrawal by Subject|0|||
143212472|NCT03210961|516323968|FG006|Overall Study|Withdrawal by Subject|0|||
143212473|NCT03210961|516323969|FG007|Overall Study|Withdrawal by Subject|0|||
143212474|NCT03210961|516323970|FG008|Overall Study|Withdrawal by Subject|0|||
143265676|NCT01927341|516528493|FG001|Phase 2|New cancer therapy|1|||
143265677|NCT01927341|516528494|FG002|Phase 2|New cancer therapy|0|||
143265678|NCT01927341|516528495|FG003|Phase 2|New cancer therapy|4|||
143265679|NCT01927341|516528496|FG004|Phase 2|New cancer therapy|1|||
143265680|NCT01927341|516528492|FG000|Phase 2|Disease progression|0|||
143265681|NCT01927341|516528493|FG001|Phase 2|Disease progression|1|||
143265682|NCT01927341|516528494|FG002|Phase 2|Disease progression|1|||
143265683|NCT01927341|516528495|FG003|Phase 2|Disease progression|1|||
143265684|NCT01927341|516528496|FG004|Phase 2|Disease progression|0|||
143265685|NCT01927341|516528492|FG000|Phase 2|Follow-up completed|0|||
143265686|NCT01927341|516528493|FG001|Phase 2|Follow-up completed|6|||
143265687|NCT01927341|516528494|FG002|Phase 2|Follow-up completed|3|||
143265688|NCT01927341|516528495|FG003|Phase 2|Follow-up completed|5|||
143265689|NCT01927341|516528496|FG004|Phase 2|Follow-up completed|2|||
143265690|NCT01397201|516528497|FG000|Overall Study|Not treated|0|||
143265691|NCT01397201|516528498|FG001|Overall Study|Not treated|0|||
143265692|NCT01397201|516528499|FG002|Overall Study|Not treated|1|||
143265693|NCT01397201|516528500|FG003|Overall Study|Not treated|0|||
143265694|NCT01397201|516528501|FG004|Overall Study|Not treated|0|||
143265695|NCT01397201|516528497|FG000|Overall Study|Not yet defined|3|||
143265696|NCT01397201|516528498|FG001|Overall Study|Not yet defined|6|||
143265697|NCT01397201|516528499|FG002|Overall Study|Not yet defined|5|||
143265698|NCT01397201|516528500|FG003|Overall Study|Not yet defined|5|||
143265699|NCT01397201|516528501|FG004|Overall Study|Not yet defined|4|||
143265700|NCT01397201|516528497|FG000|Overall Study|Adverse Event|2|||
143265701|NCT01397201|516528498|FG001|Overall Study|Adverse Event|0|||
143265702|NCT01397201|516528499|FG002|Overall Study|Adverse Event|0|||
143265703|NCT01397201|516528500|FG003|Overall Study|Adverse Event|0|||
143265704|NCT01397201|516528501|FG004|Overall Study|Adverse Event|0|||
143265705|NCT00084838|516528502|FG000|Overall Study|Death|1|||
143265706|NCT00084838|516528502|FG000|Overall Study|Adverse Event|2|||
143265707|NCT00084838|516528502|FG000|Overall Study|Withdrawal by Subject|1|||
143265708|NCT00084838|516528502|FG000|Overall Study|Progressive Disease|4|||
143265709|NCT00084838|516528502|FG000|Overall Study|Pt Non-Compliance|1|||
143265710|NCT00084838|516528502|FG000|Overall Study|Ineligible|4|||
143265711|NCT01298531|516528503|FG000|Overall Study|Lack of Efficacy|0|||
143265712|NCT01298531|516528504|FG001|Overall Study|Lack of Efficacy|1|||
143265713|NCT01298531|516528503|FG000|Overall Study|Lost to Follow-up|2|||
143265714|NCT01298531|516528504|FG001|Overall Study|Lost to Follow-up|0|||
143265715|NCT01298531|516528503|FG000|Overall Study|Protocol Violation|1|||
143265716|NCT01298531|516528504|FG001|Overall Study|Protocol Violation|1|||
143265717|NCT01298531|516528503|FG000|Overall Study|Adverse Event|4|||
143265718|NCT01298531|516528504|FG001|Overall Study|Adverse Event|3|||
143265719|NCT01298531|516528503|FG000|Overall Study|Does not meet entrance criteria|0|||
143265720|NCT01298531|516528504|FG001|Overall Study|Does not meet entrance criteria|1|||
143265721|NCT01298531|516528503|FG000|Overall Study|Other|2|||
143265722|NCT01298531|516528504|FG001|Overall Study|Other|1|||
143265723|NCT03646643|516528505|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
143265724|NCT03646643|516528506|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
143265725|NCT03646643|516528505|FG000|Overall Study|Lost to Follow-up|0|||
143265726|NCT03646643|516528506|FG001|Overall Study|Lost to Follow-up|1|||
143265727|NCT01229371|516528509|FG000|Overall Study|Withdrawal by Subject|0|||
143265728|NCT01229371|516528510|FG001|Overall Study|Withdrawal by Subject|1|||
143265729|NCT01229371|516528511|FG002|Overall Study|Withdrawal by Subject|0|||
143265730|NCT01229371|516528512|FG003|Overall Study|Withdrawal by Subject|0|||
143265731|NCT02213042|516528513|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
143265732|NCT02213042|516528514|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
143265733|NCT02213042|516528515|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
143265734|NCT02213042|516528513|FG000|Overall Study|Adverse Event|2|||
143265735|NCT02213042|516528514|FG001|Overall Study|Adverse Event|1|||
143265736|NCT02213042|516528515|FG002|Overall Study|Adverse Event|0|||
143265737|NCT02213042|516528513|FG000|Overall Study|Withdrawal by Subject|0|||
143265738|NCT02213042|516528514|FG001|Overall Study|Withdrawal by Subject|1|||
143265739|NCT02213042|516528515|FG002|Overall Study|Withdrawal by Subject|1|||
143265740|NCT02213042|516528513|FG000|Overall Study|Protocol Violation|1|||
143265741|NCT02213042|516528514|FG001|Overall Study|Protocol Violation|0|||
143265742|NCT02213042|516528515|FG002|Overall Study|Protocol Violation|0|||
143265743|NCT02213042|516528513|FG000|Overall Study|Investigator discretion|0|||
143265744|NCT02213042|516528514|FG001|Overall Study|Investigator discretion|0|||
143265745|NCT02213042|516528515|FG002|Overall Study|Investigator discretion|1|||
143265746|NCT04622735|516528518|FG000|Overall Study|Lost to Follow-up|1|||
143265747|NCT04622735|516528519|FG001|Overall Study|Lost to Follow-up|2|||
143265748|NCT04622735|516528520|FG002|Overall Study|Lost to Follow-up|1|||
143265749|NCT04622735|516528518|FG000|Overall Study|Adverse Event|0|||
143265750|NCT04622735|516528519|FG001|Overall Study|Adverse Event|0|||
143265751|NCT04622735|516528520|FG002|Overall Study|Adverse Event|1|||
143265752|NCT04622735|516528518|FG000|Overall Study|Protocol Violation|1|||
143265753|NCT04622735|516528519|FG001|Overall Study|Protocol Violation|0|||
143265754|NCT04622735|516528520|FG002|Overall Study|Protocol Violation|0|||
143265755|NCT05314478|516528521|FG000|Overall Study|Physician Decision|1|||
143265756|NCT04073368|516528522|FG000|Overall Study|Adverse Event|2|||
143265757|NCT04073368|516528523|FG001|Overall Study|Adverse Event|0|||
143265758|NCT04073368|516528524|FG002|Overall Study|Adverse Event|1|||
143265759|NCT04073368|516528525|FG003|Overall Study|Adverse Event|1|||
143265760|NCT04073368|516528522|FG000|Overall Study|Withdrawal by Subject|2|||
143265761|NCT04073368|516528523|FG001|Overall Study|Withdrawal by Subject|2|||
143265762|NCT04073368|516528524|FG002|Overall Study|Withdrawal by Subject|1|||
143265763|NCT04073368|516528525|FG003|Overall Study|Withdrawal by Subject|1|||
143265764|NCT04073368|516528522|FG000|Overall Study|Lost to Follow-up|1|||
143265765|NCT04073368|516528523|FG001|Overall Study|Lost to Follow-up|1|||
143212475|NCT03210961|516323971|FG009|Overall Study|Withdrawal by Subject|0|||
143212476|NCT03210961|516323972|FG010|Overall Study|Withdrawal by Subject|0|||
143212477|NCT03210961|516323973|FG011|Overall Study|Withdrawal by Subject|0|||
143212478|NCT03210961|516323974|FG012|Overall Study|Withdrawal by Subject|0|||
143212479|NCT03210961|516323975|FG013|Overall Study|Withdrawal by Subject|0|||
143212480|NCT03210961|516323976|FG014|Overall Study|Withdrawal by Subject|1|||
143212481|NCT03210961|516323962|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
143212482|NCT03210961|516323963|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
143212483|NCT03210961|516323964|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
143212484|NCT03210961|516323965|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
143212485|NCT03210961|516323966|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
143212486|NCT03210961|516323967|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
143212487|NCT03210961|516323968|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
143212488|NCT03210961|516323969|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
143212489|NCT03210961|516323970|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
143212490|NCT03210961|516323971|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
143212491|NCT03210961|516323972|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
143212492|NCT03210961|516323973|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
143212493|NCT03210961|516323974|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
143212494|NCT03210961|516323975|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
143212495|NCT03210961|516323976|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
143212496|NCT03210961|516323962|FG000|Overall Study|Other|0|||
143212497|NCT03210961|516323963|FG001|Overall Study|Other|0|||
143212498|NCT03210961|516323964|FG002|Overall Study|Other|0|||
143212499|NCT03210961|516323965|FG003|Overall Study|Other|1|||
143212500|NCT03210961|516323966|FG004|Overall Study|Other|0|||
143212501|NCT03210961|516323967|FG005|Overall Study|Other|0|||
143212502|NCT03210961|516323968|FG006|Overall Study|Other|1|||
143212503|NCT03210961|516323969|FG007|Overall Study|Other|0|||
143212504|NCT03210961|516323970|FG008|Overall Study|Other|0|||
143212505|NCT03210961|516323971|FG009|Overall Study|Other|0|||
143212506|NCT03210961|516323972|FG010|Overall Study|Other|1|||
143212507|NCT03210961|516323973|FG011|Overall Study|Other|0|||
143212508|NCT03210961|516323974|FG012|Overall Study|Other|2|||
143212509|NCT03210961|516323975|FG013|Overall Study|Other|2|||
143212510|NCT03210961|516323976|FG014|Overall Study|Other|0|||
143212511|NCT01487265|516323978|FG000|Overall Study|Adverse Event|8|||
143212512|NCT01487265|516323978|FG000|Overall Study|Withdrawal by Subject|5|||
143212513|NCT01487265|516323978|FG000|Overall Study|Disease Progression|21|||
143212514|NCT01487265|516323978|FG000|Overall Study|Death|2|||
143212515|NCT01487265|516323978|FG000|Overall Study|Still on Treatment|1|||
143212516|NCT01618695|516323979|FG000|Core Phase|Adverse Event|4|||
143212517|NCT01618695|516323980|FG001|Core Phase|Adverse Event|5|||
143212518|NCT01618695|516323981|FG002|Core Phase|Adverse Event|15|||
143212519|NCT01618695|516323982|FG003|Core Phase|Adverse Event|20|||
143212520|NCT01618695|516323979|FG000|Core Phase|Lost to Follow-up|0|||
143212521|NCT01618695|516323980|FG001|Core Phase|Lost to Follow-up|0|||
143212522|NCT01618695|516323981|FG002|Core Phase|Lost to Follow-up|1|||
143212523|NCT01618695|516323982|FG003|Core Phase|Lost to Follow-up|0|||
143212524|NCT01618695|516323979|FG000|Core Phase|Withdrawal by Subject|16|||
143212525|NCT01618695|516323980|FG001|Core Phase|Withdrawal by Subject|11|||
143212526|NCT01618695|516323981|FG002|Core Phase|Withdrawal by Subject|9|||
143212527|NCT01618695|516323982|FG003|Core Phase|Withdrawal by Subject|13|||
143212528|NCT01618695|516323979|FG000|Core Phase|Pregnancy|2|||
143212529|NCT01618695|516323980|FG001|Core Phase|Pregnancy|0|||
143212530|NCT01618695|516323981|FG002|Core Phase|Pregnancy|0|||
143212531|NCT01618695|516323982|FG003|Core Phase|Pregnancy|0|||
143212532|NCT01618695|516323979|FG000|Core Phase|Lack of Efficacy|1|||
143212533|NCT01618695|516323980|FG001|Core Phase|Lack of Efficacy|2|||
143212534|NCT01618695|516323981|FG002|Core Phase|Lack of Efficacy|1|||
143212535|NCT01618695|516323982|FG003|Core Phase|Lack of Efficacy|1|||
143212536|NCT01618695|516323979|FG000|Core Phase|Other than specified|1|||
143212537|NCT01618695|516323980|FG001|Core Phase|Other than specified|2|||
143212538|NCT01618695|516323981|FG002|Core Phase|Other than specified|2|||
143212539|NCT01618695|516323982|FG003|Core Phase|Other than specified|2|||
143212540|NCT01618695|516323979|FG000|Core Phase|Not treated|1|||
143212541|NCT01618695|516323980|FG001|Core Phase|Not treated|0|||
143212542|NCT01618695|516323981|FG002|Core Phase|Not treated|2|||
143212543|NCT01618695|516323982|FG003|Core Phase|Not treated|0|||
143265766|NCT04073368|516528524|FG002|Overall Study|Lost to Follow-up|1|||
143212544|NCT01618695|516323979|FG000|Extension Phase|Lack of Efficacy|17|||
143212545|NCT01618695|516323980|FG001|Extension Phase|Lack of Efficacy|33|||
143212546|NCT01618695|516323981|FG002|Extension Phase|Lack of Efficacy|26|||
143212547|NCT01618695|516323982|FG003|Extension Phase|Lack of Efficacy|24|||
143212548|NCT01618695|516323979|FG000|Extension Phase|Pregnancy|2|||
143212549|NCT01618695|516323980|FG001|Extension Phase|Pregnancy|0|||
143371270|NCT01244828|516902390|FG000|Overall Study|Withdrawal by Subject|31|||
143371271|NCT01244828|516902390|FG000|Overall Study|Lack of Efficacy|7|||
143371272|NCT01244828|516902390|FG000|Overall Study|Lost to Follow-up|2|||
143371273|NCT01244828|516902390|FG000|Overall Study|Other reason (not specified)|1|||
143371274|NCT01066923|516902391|FG000|Overall Study|Withdrawal by Subject|3|||
143371275|NCT01066923|516902392|FG001|Overall Study|Withdrawal by Subject|3|||
143371276|NCT01066923|516902393|FG002|Overall Study|Withdrawal by Subject|8|||
143371277|NCT01066923|516902394|FG003|Overall Study|Withdrawal by Subject|8|||
143371278|NCT05147233|516903801|FG000|Overall Study|Adverse Event|0|||
143371279|NCT05147233|516903802|FG001|Overall Study|Adverse Event|1|||
143371280|NCT05147233|516903801|FG000|Overall Study|Lost to Follow-up|1|||
143371281|NCT05147233|516903802|FG001|Overall Study|Lost to Follow-up|1|||
143371282|NCT05147233|516903801|FG000|Overall Study|Protocol Violation|0|||
143371283|NCT05147233|516903802|FG001|Overall Study|Protocol Violation|1|||
143371284|NCT05147233|516903801|FG000|Overall Study|Withdrawal by Subject|2|||
143265767|NCT04073368|516528525|FG003|Overall Study|Lost to Follow-up|0|||
143265768|NCT04073368|516528522|FG000|Overall Study|Protocol Violation|0|||
143265769|NCT04073368|516528523|FG001|Overall Study|Protocol Violation|1|||
143265770|NCT04073368|516528524|FG002|Overall Study|Protocol Violation|0|||
143265771|NCT04073368|516528525|FG003|Overall Study|Protocol Violation|0|||
143265772|NCT04073368|516528522|FG000|Overall Study|Subject noncompliance|7|||
143265773|NCT04073368|516528523|FG001|Overall Study|Subject noncompliance|4|||
143265774|NCT04073368|516528524|FG002|Overall Study|Subject noncompliance|0|||
143265775|NCT04073368|516528525|FG003|Overall Study|Subject noncompliance|0|||
143265776|NCT00145600|516528526|FG000|Overall Study|Death|1|||
143265777|NCT00145600|516528527|FG001|Overall Study|Death|2|||
143265778|NCT00145600|516528528|FG002|Overall Study|Death|2|||
143265779|NCT00145600|516528529|FG003|Overall Study|Death|6|||
143265780|NCT00145600|516528526|FG000|Overall Study|Ineligible|3|||
143265781|NCT00145600|516528527|FG001|Overall Study|Ineligible|0|||
143265782|NCT00145600|516528528|FG002|Overall Study|Ineligible|1|||
143265783|NCT00145600|516528529|FG003|Overall Study|Ineligible|5|||
143265784|NCT00145600|516528526|FG000|Overall Study|Lost to Follow-up|2|||
143265785|NCT00145600|516528527|FG001|Overall Study|Lost to Follow-up|6|||
143265786|NCT00145600|516528528|FG002|Overall Study|Lost to Follow-up|2|||
143265787|NCT00145600|516528529|FG003|Overall Study|Lost to Follow-up|4|||
143265788|NCT00145600|516528526|FG000|Overall Study|Noncompliance|1|||
143265789|NCT00145600|516528527|FG001|Overall Study|Noncompliance|0|||
143265790|NCT00145600|516528528|FG002|Overall Study|Noncompliance|0|||
143265791|NCT00145600|516528529|FG003|Overall Study|Noncompliance|0|||
143371285|NCT05147233|516903802|FG001|Overall Study|Withdrawal by Subject|1|||
143371286|NCT01049503|516903805|FG000|Overall Study|Lost to Follow-up|11|||
143371287|NCT01049503|516903806|FG001|Overall Study|Lost to Follow-up|12|||
143371288|NCT01049503|516903807|FG002|Overall Study|Lost to Follow-up|24|||
143371289|NCT01049503|516903808|FG003|Overall Study|Lost to Follow-up|26|||
143371290|NCT01049503|516903809|FG004|Overall Study|Lost to Follow-up|27|||
143212550|NCT01618695|516323981|FG002|Extension Phase|Pregnancy|1|||
143212551|NCT01618695|516323982|FG003|Extension Phase|Pregnancy|1|||
143212552|NCT01618695|516323979|FG000|Extension Phase|Withdrawal by Subject|43|||
143212553|NCT01618695|516323980|FG001|Extension Phase|Withdrawal by Subject|48|||
143212554|NCT01618695|516323981|FG002|Extension Phase|Withdrawal by Subject|42|||
143212555|NCT01618695|516323982|FG003|Extension Phase|Withdrawal by Subject|33|||
143212556|NCT01618695|516323979|FG000|Extension Phase|Adverse Event|18|||
143212557|NCT01618695|516323980|FG001|Extension Phase|Adverse Event|16|||
143212558|NCT01618695|516323981|FG002|Extension Phase|Adverse Event|9|||
143212559|NCT01618695|516323982|FG003|Extension Phase|Adverse Event|20|||
143212560|NCT01618695|516323979|FG000|Extension Phase|Lost to Follow-up|2|||
143212561|NCT01618695|516323980|FG001|Extension Phase|Lost to Follow-up|1|||
143212562|NCT01618695|516323981|FG002|Extension Phase|Lost to Follow-up|1|||
143212563|NCT01618695|516323982|FG003|Extension Phase|Lost to Follow-up|1|||
143371291|NCT01049503|516903810|FG005|Overall Study|Lost to Follow-up|8|||
143371292|NCT02974634|516903811|FG000|Overall Study|Advanced disease|12|||
143371293|NCT02974634|516903812|FG001|Overall Study|Advanced disease|3|||
143212564|NCT01618695|516323979|FG000|Extension Phase|Other than specified|13|||
143265792|NCT00145600|516528526|FG000|Overall Study|Withdrawal by Subject|1|||
143265793|NCT00145600|516528527|FG001|Overall Study|Withdrawal by Subject|2|||
143265794|NCT00145600|516528528|FG002|Overall Study|Withdrawal by Subject|0|||
143265795|NCT00145600|516528529|FG003|Overall Study|Withdrawal by Subject|1|||
143371294|NCT02974634|516903811|FG000|Overall Study|Noncompliance|3|||
143212565|NCT01618695|516323980|FG001|Extension Phase|Other than specified|18|||
143212566|NCT01618695|516323981|FG002|Extension Phase|Other than specified|13|||
143212567|NCT01618695|516323982|FG003|Extension Phase|Other than specified|18|||
143265796|NCT03026088|516528530|FG000|Overall Study|Study termination|20|||
143265797|NCT00760214|516528538|FG000|Overall Study|Adverse Event|8|||
143212568|NCT03521141|516323986|FG000|Overall Study|Death|1|||
143212569|NCT03521141|516323987|FG001|Overall Study|Death|0|||
143212570|NCT03521141|516323988|FG002|Overall Study|Death|1|||
143212571|NCT03354273|516323993|FG000|Overall Study|Adverse Event|5|||
143212572|NCT03354273|516323993|FG000|Overall Study|Screen Failure|21|||
143212573|NCT03354273|516323993|FG000|Overall Study|Withdrawal by Subject|34|||
143212574|NCT03354273|516323993|FG000|Overall Study|Technical Problems|30|||
143212575|NCT03354273|516323993|FG000|Overall Study|Lost to Follow-up|4|||
143212576|NCT03354273|516323993|FG000|Overall Study|Investigator Decision|3|||
143212577|NCT03354273|516323993|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
143212578|NCT03354273|516323993|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
143212579|NCT03354273|516323993|FG000|Overall Study|COVID-19 Restrictions|9|||
143212580|NCT03354273|516323993|FG000|Overall Study|Other|5|||
143212581|NCT03229109|516323994|FG000|Overall Study|Withdrawal by Subject|0|||
143212582|NCT03229109|516323995|FG001|Overall Study|Withdrawal by Subject|0|||
143212583|NCT03229109|516323996|FG002|Overall Study|Withdrawal by Subject|0|||
143212584|NCT03229109|516323997|FG003|Overall Study|Withdrawal by Subject|1|||
143212585|NCT04207749|516323998|FG000|Overall Study|Lost to Follow-up|0|||
143265798|NCT00760214|516528539|FG001|Overall Study|Adverse Event|9|||
143265799|NCT00760214|516528540|FG002|Overall Study|Adverse Event|12|||
143265800|NCT00760214|516528538|FG000|Overall Study|Protocol Violation|3|||
143265801|NCT00760214|516528539|FG001|Overall Study|Protocol Violation|0|||
143265802|NCT00760214|516528540|FG002|Overall Study|Protocol Violation|3|||
143265803|NCT00760214|516528538|FG000|Overall Study|Lost to Follow-up|0|||
143265804|NCT00760214|516528539|FG001|Overall Study|Lost to Follow-up|0|||
143265805|NCT00760214|516528540|FG002|Overall Study|Lost to Follow-up|1|||
143265806|NCT00760214|516528538|FG000|Overall Study|Withdrawal by Subject|12|||
143265807|NCT00760214|516528539|FG001|Overall Study|Withdrawal by Subject|14|||
143265808|NCT00760214|516528540|FG002|Overall Study|Withdrawal by Subject|13|||
143265809|NCT00760214|516528538|FG000|Overall Study|Lack of Efficacy|3|||
143265810|NCT00760214|516528539|FG001|Overall Study|Lack of Efficacy|2|||
143265811|NCT00760214|516528540|FG002|Overall Study|Lack of Efficacy|4|||
143265812|NCT00760214|516528538|FG000|Overall Study|Pregnancy|0|||
143265813|NCT00760214|516528539|FG001|Overall Study|Pregnancy|0|||
143265814|NCT00760214|516528540|FG002|Overall Study|Pregnancy|1|||
143265815|NCT00760214|516528538|FG000|Overall Study|Physician Decision|1|||
143265816|NCT00760214|516528539|FG001|Overall Study|Physician Decision|1|||
143265817|NCT00760214|516528540|FG002|Overall Study|Physician Decision|1|||
143265818|NCT00760214|516528538|FG000|Overall Study|Other|3|||
143265819|NCT00760214|516528539|FG001|Overall Study|Other|4|||
143265820|NCT00760214|516528540|FG002|Overall Study|Other|6|||
143265821|NCT03960554|516528544|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
143265822|NCT03960554|516528545|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
143265823|NCT02360111|516528546|FG000|Overall Study|Death|2|||
143265824|NCT01933217|516528551|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
143265825|NCT01933217|516528552|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
143265826|NCT01933217|516528551|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
143265827|NCT01933217|516528552|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
143265828|NCT03923738|516528555|FG000|Period 1|Adverse Event|1|||
143265829|NCT03923738|516528555|FG000|Period 1|Withdrawal by Subject|1|||
143265830|NCT05246397|516528557|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
143265831|NCT03583164|516528560|FG000|Overall Study|Death in Main Phase|35|||
143265832|NCT03583164|516528560|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
143265833|NCT03583164|516528560|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
143265834|NCT03583164|516528560|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
143265835|NCT03583164|516528560|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
143265836|NCT03583164|516528560|FG000|Overall Study|Physician decision in Main Phase|1|||
143265837|NCT03583164|516528560|FG000|Overall Study|Physician decision in Extended Phase|2|||
143265838|NCT03583164|516528560|FG000|Overall Study|Death in Extended Phase|13|||
143265839|NCT03583164|516528560|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
143265840|NCT03583164|516528560|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
143265841|NCT03583164|516528560|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
143265842|NCT03583164|516528560|FG000|Overall Study|Treatment failure in Main Phase|2|||
143265843|NCT03583164|516528560|FG000|Overall Study|Treatment failure in Extended Phase|4|||
143265844|NCT03583164|516528560|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
143265845|NCT03583164|516528560|FG000|Overall Study|Other not specified reason in Main Phase|2|||
143265846|NCT00735254|516528561|FG000|Overall Study|Protocol Violation|1|||
143265847|NCT00735254|516528562|FG001|Overall Study|Protocol Violation|1|||
143265848|NCT00735254|516528563|FG002|Overall Study|Protocol Violation|1|||
143265849|NCT00735254|516528564|FG003|Overall Study|Protocol Violation|0|||
143265850|NCT01251744|516528568|FG000|Overall Study|Lost to Follow-up|1|||
143265851|NCT01251744|516528569|FG001|Overall Study|Lost to Follow-up|0|||
143265852|NCT00214500|516528574|FG000|Treatment Period|Adverse Event|1|||
143265853|NCT00214500|516528574|FG000|Extension Period|Withdrawal by Subject|2|||
143265854|NCT00147251|516528575|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
143212586|NCT04207749|516323999|FG001|Overall Study|Lost to Follow-up|2|||
143212587|NCT04207749|516323998|FG000|Overall Study|Protocol Violation|0|||
143212588|NCT04207749|516323999|FG001|Overall Study|Protocol Violation|1|||
143212589|NCT04207749|516323998|FG000|Overall Study|Withdrawal by Subject|3|||
143212590|NCT04207749|516323999|FG001|Overall Study|Withdrawal by Subject|0|||
143212591|NCT04207749|516323998|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
143212592|NCT04207749|516323999|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
143212593|NCT03775512|516324002|FG000|Overall Study|Death|1|||
143212594|NCT03775512|516324003|FG001|Overall Study|Death|1|||
143212595|NCT03775512|516324002|FG000|Overall Study|Withdrawal by Subject|7|||
143212596|NCT03775512|516324003|FG001|Overall Study|Withdrawal by Subject|4|||
143212597|NCT03775512|516324002|FG000|Overall Study|Lost to Follow-up|5|||
143212598|NCT03775512|516324003|FG001|Overall Study|Lost to Follow-up|5|||
143212599|NCT03775512|516324002|FG000|Overall Study|Excluded before Catheter insertion|14|||
143212600|NCT03775512|516324003|FG001|Overall Study|Excluded before Catheter insertion|5|||
143212601|NCT03775512|516324002|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
143212602|NCT03775512|516324003|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
143212603|NCT03775512|516324002|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
143212604|NCT03775512|516324003|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
143212605|NCT00082407|516324004|FG000|Overall Study|Adverse Event|20|||
143212606|NCT00082407|516324005|FG001|Overall Study|Adverse Event|0|||
143212607|NCT00082407|516324004|FG000|Overall Study|Protocol Violation|14|||
143212608|NCT00082407|516324005|FG001|Overall Study|Protocol Violation|12|||
143212609|NCT00082407|516324004|FG000|Overall Study|Patient Decision|13|||
143212610|NCT00082407|516324005|FG001|Overall Study|Patient Decision|6|||
143212611|NCT00082407|516324004|FG000|Overall Study|Physician Decision|5|||
143212612|NCT00082407|516324005|FG001|Overall Study|Physician Decision|3|||
143212613|NCT00082407|516324004|FG000|Overall Study|Loss of Glucose Control|2|||
143212614|NCT00082407|516324005|FG001|Overall Study|Loss of Glucose Control|2|||
143212615|NCT00082407|516324004|FG000|Overall Study|Death|2|||
143212616|NCT00082407|516324005|FG001|Overall Study|Death|1|||
143212617|NCT00082407|516324004|FG000|Overall Study|Lost to Follow-up|0|||
143212618|NCT00082407|516324005|FG001|Overall Study|Lost to Follow-up|3|||
143212619|NCT02352753|516324006|FG000|6-Month Dosing Period|Decision by sponsor|2|||
143212620|NCT02352753|516324006|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
143212621|NCT02352753|516324006|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
143212622|NCT02352753|516324006|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
143212623|NCT02352753|516324006|FG000|3-Month Dosing Period|Decision by sponsor|14|||
143212624|NCT02352753|516324006|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
143212625|NCT00539305|516324007|FG000|Overall Study|Adverse Event|1|||
143212626|NCT00539305|516324008|FG001|Overall Study|Adverse Event|0|||
143212627|NCT00539305|516324007|FG000|Overall Study|Substance Use|0|||
143212628|NCT00539305|516324008|FG001|Overall Study|Substance Use|1|||
143212629|NCT00539305|516324007|FG000|Overall Study|Withdrawal by Subject|0|||
143212630|NCT00539305|516324008|FG001|Overall Study|Withdrawal by Subject|1|||
143212631|NCT01393639|516324012|FG000|Overall Study|Protocol Violation|0|||
143212632|NCT01393639|516324013|FG001|Overall Study|Protocol Violation|0|||
143212633|NCT01393639|516324014|FG002|Overall Study|Protocol Violation|0|||
143212634|NCT01393639|516324015|FG003|Overall Study|Protocol Violation|1|||
143212635|NCT01393639|516324016|FG004|Overall Study|Protocol Violation|0|||
143212636|NCT01393639|516324017|FG005|Overall Study|Protocol Violation|0|||
143212637|NCT01393639|516324018|FG006|Overall Study|Protocol Violation|0|||
143212638|NCT01393639|516324012|FG000|Overall Study|Other|0|||
143212639|NCT01393639|516324013|FG001|Overall Study|Other|2|||
143212640|NCT01393639|516324014|FG002|Overall Study|Other|0|||
143212641|NCT01393639|516324015|FG003|Overall Study|Other|2|||
143212642|NCT01393639|516324016|FG004|Overall Study|Other|1|||
143212643|NCT01393639|516324017|FG005|Overall Study|Other|0|||
143212644|NCT01393639|516324018|FG006|Overall Study|Other|1|||
143212645|NCT01393639|516324012|FG000|Overall Study|Withdrawal by Subject|1|||
143212646|NCT01393639|516324013|FG001|Overall Study|Withdrawal by Subject|1|||
143212647|NCT01393639|516324014|FG002|Overall Study|Withdrawal by Subject|0|||
143212648|NCT01393639|516324015|FG003|Overall Study|Withdrawal by Subject|0|||
143212649|NCT01393639|516324016|FG004|Overall Study|Withdrawal by Subject|0|||
143212650|NCT01393639|516324017|FG005|Overall Study|Withdrawal by Subject|0|||
143212651|NCT01393639|516324018|FG006|Overall Study|Withdrawal by Subject|1|||
143265855|NCT00147251|516528576|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
143212652|NCT01393639|516324012|FG000|Overall Study|Medication error without associated AE|0|||
143212653|NCT01393639|516324013|FG001|Overall Study|Medication error without associated AE|0|||
143212654|NCT01393639|516324014|FG002|Overall Study|Medication error without associated AE|0|||
143212655|NCT01393639|516324015|FG003|Overall Study|Medication error without associated AE|0|||
143212656|NCT01393639|516324016|FG004|Overall Study|Medication error without associated AE|0|||
143212657|NCT01393639|516324017|FG005|Overall Study|Medication error without associated AE|0|||
143212658|NCT01393639|516324018|FG006|Overall Study|Medication error without associated AE|1|||
143212659|NCT01393639|516324012|FG000|Overall Study|Lost to Follow-up|0|||
143212660|NCT01393639|516324013|FG001|Overall Study|Lost to Follow-up|1|||
143265856|NCT00751621|516528577|FG000|Overall Study|Adverse Event|1|||
143265857|NCT00751621|516528577|FG000|Overall Study|Withdrawal by Subject|1|||
143265858|NCT00751621|516528577|FG000|Overall Study|Subject moved to another country|1|||
143265859|NCT00751621|516528577|FG000|Overall Study|Poor adherence to asthma treatment|1|||
143265860|NCT00573248|516528585|FG000|Overall Study|scheduling conflicts|15|||
143212661|NCT01393639|516324014|FG002|Overall Study|Lost to Follow-up|0|||
143212662|NCT01393639|516324015|FG003|Overall Study|Lost to Follow-up|0|||
143265861|NCT00573248|516528586|FG001|Overall Study|scheduling conflicts|11|||
143265862|NCT03180684|516528587|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
143265863|NCT03180684|516528588|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
143265864|NCT03180684|516528587|FG000|Overall Study|Physician Decision|1|||
143265865|NCT03180684|516528588|FG001|Overall Study|Physician Decision|0|||
143265866|NCT03180684|516528587|FG000|Overall Study|Lost to Follow-up|1|||
143212663|NCT01393639|516324016|FG004|Overall Study|Lost to Follow-up|0|||
143212664|NCT01393639|516324017|FG005|Overall Study|Lost to Follow-up|0|||
143212665|NCT01393639|516324018|FG006|Overall Study|Lost to Follow-up|1|||
143212666|NCT01393639|516324012|FG000|Overall Study|Lack of Efficacy|0|||
143212667|NCT01393639|516324013|FG001|Overall Study|Lack of Efficacy|0|||
143212668|NCT01393639|516324014|FG002|Overall Study|Lack of Efficacy|0|||
143212669|NCT01393639|516324015|FG003|Overall Study|Lack of Efficacy|0|||
143212670|NCT01393639|516324016|FG004|Overall Study|Lack of Efficacy|0|||
143212671|NCT01393639|516324017|FG005|Overall Study|Lack of Efficacy|0|||
143212672|NCT01393639|516324018|FG006|Overall Study|Lack of Efficacy|1|||
143212673|NCT01393639|516324012|FG000|Overall Study|Adverse Event|2|||
143212674|NCT01393639|516324013|FG001|Overall Study|Adverse Event|3|||
143212675|NCT01393639|516324014|FG002|Overall Study|Adverse Event|1|||
143212676|NCT01393639|516324015|FG003|Overall Study|Adverse Event|2|||
143212677|NCT01393639|516324016|FG004|Overall Study|Adverse Event|0|||
143212678|NCT01393639|516324017|FG005|Overall Study|Adverse Event|2|||
143212679|NCT01393639|516324018|FG006|Overall Study|Adverse Event|3|||
143212680|NCT01440816|516324019|FG000|Overall Study|Disease Progression|0|||
143212681|NCT01440816|516324020|FG001|Overall Study|Disease Progression|9|||
143212682|NCT01440816|516324019|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
143212683|NCT01440816|516324020|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
143212684|NCT01832155|516324021|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
143212685|NCT01832155|516324022|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
143212686|NCT01832155|516324021|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
143212687|NCT01832155|516324022|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
143212688|NCT01279616|516324023|FG000|Overall Study|donor could not be located|5|||
143212689|NCT01279616|516324023|FG000|Overall Study|no signs of sickle cell disease|2|||
143212690|NCT02462720|516324024|FG000|Part 2|Withdrawal by Subject|1|||
143212691|NCT02462720|516324025|FG001|Part 2|Withdrawal by Subject|0|||
143212692|NCT02462720|516324024|FG000|Part 2|Protocol Violation|0|||
143212693|NCT02462720|516324025|FG001|Part 2|Protocol Violation|1|||
143212694|NCT00413036|516324026|FG000|Overall Study|Adverse Event|44|||
143212695|NCT00413036|516324026|FG000|Overall Study|Lack of Efficacy|129|||
143212696|NCT00413036|516324026|FG000|Overall Study|Withdrawal by Subject|7|||
143212697|NCT00413036|516324026|FG000|Overall Study|Death|9|||
143212698|NCT00413036|516324026|FG000|Overall Study|Other|26|||
143212699|NCT00413036|516324026|FG000|Overall Study|Missing|2|||
143212700|NCT00183625|516324031|FG000|Overall Study|Withdrawal by Subject|18|||
143212701|NCT00183625|516324032|FG001|Overall Study|Withdrawal by Subject|18|||
143212702|NCT00183625|516324033|FG002|Overall Study|Withdrawal by Subject|19|||
143212703|NCT00183625|516324034|FG003|Overall Study|Withdrawal by Subject|14|||
143212704|NCT01369641|516324039|FG000|Overall Study|Withdrawal by Subject|1|||
143212705|NCT00842543|516324040|FG000|Overall Study|Withdrawal by Subject|2|||
143212706|NCT00842543|516324041|FG001|Overall Study|Withdrawal by Subject|0|||
143212707|NCT00842543|516324042|FG002|Overall Study|Withdrawal by Subject|3|||
143212708|NCT00842543|516324043|FG003|Overall Study|Withdrawal by Subject|4|||
143265867|NCT03180684|516528588|FG001|Overall Study|Lost to Follow-up|0|||
143265868|NCT03180684|516528587|FG000|Overall Study|Progressive Disease|1|||
143265869|NCT03180684|516528588|FG001|Overall Study|Progressive Disease|0|||
143265870|NCT05896748|516528589|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
143265871|NCT05896748|516528589|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
143265872|NCT05896748|516528589|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
143212709|NCT01483183|516324048|FG000|Overall Study|Physician Decision|0|||
143212710|NCT01483183|516324049|FG001|Overall Study|Physician Decision|0|||
143212711|NCT01483183|516324050|FG002|Overall Study|Physician Decision|0|||
143212712|NCT01483183|516324051|FG003|Overall Study|Physician Decision|0|||
143212713|NCT01483183|516324052|FG004|Overall Study|Physician Decision|0|||
143212714|NCT01483183|516324053|FG005|Overall Study|Physician Decision|0|||
143212715|NCT01483183|516324054|FG006|Overall Study|Physician Decision|2|||
143212716|NCT01483183|516324055|FG007|Overall Study|Physician Decision|0|||
143212717|NCT01483183|516324056|FG008|Overall Study|Physician Decision|0|||
143212718|NCT01483183|516324057|FG009|Overall Study|Physician Decision|0|||
143265873|NCT05896748|516528589|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
143371295|NCT02974634|516903812|FG001|Overall Study|Noncompliance|7|||
143212719|NCT01483183|516324048|FG000|Overall Study|Withdrawal by Subject|0|||
143212720|NCT01483183|516324049|FG001|Overall Study|Withdrawal by Subject|0|||
143212721|NCT01483183|516324050|FG002|Overall Study|Withdrawal by Subject|0|||
143212722|NCT01483183|516324051|FG003|Overall Study|Withdrawal by Subject|0|||
143212723|NCT01483183|516324052|FG004|Overall Study|Withdrawal by Subject|0|||
143212724|NCT01483183|516324053|FG005|Overall Study|Withdrawal by Subject|0|||
143212725|NCT01483183|516324054|FG006|Overall Study|Withdrawal by Subject|0|||
143212726|NCT01483183|516324055|FG007|Overall Study|Withdrawal by Subject|0|||
143212727|NCT01483183|516324056|FG008|Overall Study|Withdrawal by Subject|0|||
143212728|NCT01483183|516324057|FG009|Overall Study|Withdrawal by Subject|1|||
143212729|NCT00239928|516324058|FG000|Overall Study|Lack of Efficacy|1|||
143212730|NCT00239928|516324058|FG000|Overall Study|Adverse Event|4|||
143212731|NCT00239928|516324058|FG000|Overall Study|Not need to continue study|3|||
143212732|NCT00239928|516324058|FG000|Overall Study|Withdrawal by Subject|2|||
143212733|NCT03100058|516324060|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
143212734|NCT03100058|516324061|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
143212735|NCT03100058|516324062|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
143212736|NCT03100058|516324063|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
143212737|NCT03100058|516324064|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
143212738|NCT03100058|516324065|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
143212739|NCT03100058|516324066|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
143212740|NCT03100058|516324067|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
143212741|NCT03100058|516324068|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
143212742|NCT03100058|516324069|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
143212743|NCT03100058|516324070|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
143212744|NCT03100058|516324071|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
143212745|NCT03100058|516324072|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
143212746|NCT03100058|516324060|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
143212747|NCT03100058|516324061|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
143212748|NCT03100058|516324062|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
143212749|NCT03100058|516324063|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
143212750|NCT03100058|516324064|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
143212751|NCT03100058|516324065|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
143212752|NCT03100058|516324066|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
143212753|NCT03100058|516324067|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
143212754|NCT03100058|516324068|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
143212755|NCT03100058|516324069|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
143212756|NCT03100058|516324070|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
143212757|NCT03100058|516324071|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
143212758|NCT03100058|516324072|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
143212759|NCT03100058|516324060|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
143212760|NCT03100058|516324061|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
143212761|NCT03100058|516324062|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
143212762|NCT03100058|516324063|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
143212763|NCT03100058|516324064|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
143212764|NCT03100058|516324065|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
143212765|NCT03100058|516324066|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
143212766|NCT03100058|516324067|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
143212767|NCT03100058|516324068|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
143212768|NCT03100058|516324069|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
143212769|NCT03100058|516324070|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
143212770|NCT03100058|516324071|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
143212771|NCT03100058|516324072|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
143212772|NCT03100058|516324060|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
143212773|NCT03100058|516324061|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
143212774|NCT03100058|516324062|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
143212775|NCT03100058|516324063|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
143212776|NCT03100058|516324064|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
143212777|NCT03100058|516324065|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
143212778|NCT03100058|516324066|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
143212779|NCT03100058|516324067|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
143212780|NCT03100058|516324068|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
143212781|NCT03100058|516324069|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
143212782|NCT03100058|516324070|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
143212783|NCT03100058|516324071|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
143212784|NCT03100058|516324072|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
143265874|NCT05896748|516528589|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
143371296|NCT02974634|516903811|FG000|Overall Study|intervention technology related issues|5|||
143371297|NCT02974634|516903812|FG001|Overall Study|intervention technology related issues|0|||
143371298|NCT02974634|516903811|FG000|Overall Study|Death|8|||
143371299|NCT02974634|516903812|FG001|Overall Study|Death|11|||
143371300|NCT01070888|516903819|FG000|First Intervention (14 Days)|Adverse Event|0|||
143371301|NCT01070888|516903820|FG001|First Intervention (14 Days)|Adverse Event|1|||
143371302|NCT01070888|516903819|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
143371303|NCT01070888|516903820|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
143371304|NCT01070888|516903819|FG000|Washout (14 Days)|Physician Decision|1|||
143371305|NCT01070888|516903820|FG001|Washout (14 Days)|Physician Decision|0|||
143371306|NCT02577523|516903821|FG000|Overall Study|Adverse Event|1|||
143371307|NCT02577523|516903822|FG001|Overall Study|Adverse Event|1|||
143371308|NCT02577523|516903821|FG000|Overall Study|Lack of Efficacy|1|||
143371309|NCT02577523|516903822|FG001|Overall Study|Lack of Efficacy|1|||
143371310|NCT02577523|516903821|FG000|Overall Study|Withdrawal by Subject|1|||
143371311|NCT02577523|516903822|FG001|Overall Study|Withdrawal by Subject|0|||
143371312|NCT02631148|516903823|FG000|Overall Study|8 were ineligible|8|||
143371313|NCT02631148|516903824|FG001|Overall Study|8 were ineligible|0|||
143371314|NCT02631148|516903823|FG000|Overall Study|Withdrawal by Subject|1|||
143371315|NCT02631148|516903824|FG001|Overall Study|Withdrawal by Subject|0|||
143371316|NCT02631148|516903823|FG000|Overall Study|PAH not available to study participant|1|||
143371317|NCT02631148|516903824|FG001|Overall Study|PAH not available to study participant|0|||
143212785|NCT03100058|516324060|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
143212786|NCT03100058|516324061|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
143212787|NCT03100058|516324062|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
143212788|NCT03100058|516324063|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
143212789|NCT03100058|516324064|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
143212790|NCT03100058|516324065|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
143212791|NCT03100058|516324066|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
143212792|NCT03100058|516324067|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
143212793|NCT03100058|516324068|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
143212794|NCT03100058|516324069|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
143212795|NCT03100058|516324070|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
143212796|NCT03100058|516324071|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
143212797|NCT03100058|516324072|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
143212798|NCT03100058|516324060|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
143212799|NCT03100058|516324061|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
143212800|NCT03100058|516324062|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
143212801|NCT03100058|516324063|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
143212802|NCT03100058|516324064|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
143212803|NCT03100058|516324065|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
143212804|NCT03100058|516324066|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
143212805|NCT03100058|516324067|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
143212806|NCT03100058|516324068|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
143212807|NCT03100058|516324069|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
143212808|NCT03100058|516324070|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
143212809|NCT03100058|516324071|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
143212810|NCT03100058|516324072|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
143212811|NCT03100058|516324060|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
143212812|NCT03100058|516324061|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
143212813|NCT03100058|516324062|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
143212814|NCT03100058|516324063|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
143212815|NCT03100058|516324064|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
143212816|NCT03100058|516324065|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
143212817|NCT03100058|516324066|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
143212818|NCT03100058|516324067|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
143212819|NCT03100058|516324068|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
143212820|NCT03100058|516324069|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
143212821|NCT03100058|516324070|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
143212822|NCT03100058|516324071|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
143212823|NCT03100058|516324072|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
143212824|NCT03100058|516324060|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
143212825|NCT03100058|516324061|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
143212826|NCT03100058|516324062|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
143212827|NCT03100058|516324063|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
143212828|NCT03100058|516324064|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
143212829|NCT03100058|516324065|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
143212830|NCT03100058|516324066|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
143371318|NCT00357396|516903826|FG000|Overall Study|Adverse Event|1|||
143371319|NCT00357396|516903827|FG001|Overall Study|Adverse Event|0|||
143371320|NCT00487578|516903828|FG000|Overall Study|Adverse Event|1|||
143212831|NCT03100058|516324067|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
143212832|NCT03100058|516324068|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
143212833|NCT03100058|516324069|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
143212834|NCT03100058|516324070|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
143212835|NCT03100058|516324071|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
143212836|NCT03100058|516324072|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
143212837|NCT03100058|516324060|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
143212838|NCT03100058|516324061|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
143212839|NCT03100058|516324062|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
143212840|NCT03100058|516324063|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
143212841|NCT03100058|516324064|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
143212842|NCT03100058|516324065|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
143212843|NCT03100058|516324066|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
143212844|NCT03100058|516324067|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
143212845|NCT03100058|516324068|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
143212846|NCT03100058|516324069|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
143212847|NCT03100058|516324070|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
143212848|NCT03100058|516324071|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
143212849|NCT03100058|516324072|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
143212850|NCT03100058|516324060|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
143212851|NCT03100058|516324061|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
143212852|NCT03100058|516324062|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
143212853|NCT03100058|516324063|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
143212854|NCT03100058|516324064|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
143212855|NCT03100058|516324065|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
143212856|NCT03100058|516324066|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
143212857|NCT03100058|516324067|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
143212858|NCT03100058|516324068|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
143212859|NCT03100058|516324069|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
143212860|NCT03100058|516324070|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
143212861|NCT03100058|516324071|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
143212862|NCT03100058|516324072|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
143212863|NCT03100058|516324060|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
143212864|NCT03100058|516324061|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
143212865|NCT03100058|516324062|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
143212866|NCT03100058|516324063|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
143212867|NCT03100058|516324064|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
143212868|NCT03100058|516324065|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
143212869|NCT03100058|516324066|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
143212870|NCT03100058|516324067|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
143212871|NCT03100058|516324068|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
143212872|NCT03100058|516324069|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
143212873|NCT03100058|516324070|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
143212874|NCT03100058|516324071|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
143212875|NCT03100058|516324072|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
143212876|NCT03100058|516324060|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
143212877|NCT03100058|516324061|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
143212878|NCT03100058|516324062|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
143212879|NCT03100058|516324063|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
143212880|NCT03100058|516324064|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
143212881|NCT03100058|516324065|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
143212882|NCT03100058|516324066|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
143212883|NCT03100058|516324067|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
143212884|NCT03100058|516324068|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
143212885|NCT03100058|516324069|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
143212886|NCT03100058|516324070|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
143212887|NCT03100058|516324071|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
143212888|NCT03100058|516324072|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
143212889|NCT03100058|516324060|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
143212890|NCT03100058|516324061|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
143212891|NCT03100058|516324062|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
143212892|NCT03100058|516324063|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
143265875|NCT00857415|516528590|FG000|Overall Study|Image acquisition failure|2|||
143265876|NCT00857415|516528591|FG001|Overall Study|Image acquisition failure|0|||
143265877|NCT00857415|516528590|FG000|Overall Study|Invalid image or not imaged|3|||
143212893|NCT03100058|516324064|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
143212894|NCT03100058|516324065|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
143265878|NCT00857415|516528591|FG001|Overall Study|Invalid image or not imaged|0|||
143212895|NCT03100058|516324066|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
143212896|NCT03100058|516324067|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
143212897|NCT03100058|516324068|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
143212898|NCT03100058|516324069|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
143212899|NCT03100058|516324070|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
143212900|NCT03100058|516324071|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
143212901|NCT03100058|516324072|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
143212902|NCT03100058|516324060|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
143212903|NCT03100058|516324061|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
143212904|NCT03100058|516324062|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
143212905|NCT03100058|516324063|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
143212906|NCT03100058|516324064|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
143212907|NCT03100058|516324065|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
143212908|NCT03100058|516324066|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
143212909|NCT03100058|516324067|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
143212910|NCT03100058|516324068|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
143212911|NCT03100058|516324069|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
143212912|NCT03100058|516324070|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
143212913|NCT03100058|516324071|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
143212914|NCT03100058|516324072|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
143212915|NCT03100058|516324060|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
143212916|NCT03100058|516324061|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
143212917|NCT03100058|516324062|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
143212918|NCT03100058|516324063|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
143212919|NCT03100058|516324064|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
143212920|NCT03100058|516324065|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
143212921|NCT03100058|516324066|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
143212922|NCT03100058|516324067|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
143212923|NCT03100058|516324068|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
143212924|NCT03100058|516324069|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
143212925|NCT03100058|516324070|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
143212926|NCT03100058|516324071|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
143212927|NCT03100058|516324072|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
143212928|NCT02718716|516324074|FG000|Overall Study|Lack of Efficacy|1|||
143212929|NCT02718716|516324075|FG001|Overall Study|Lack of Efficacy|0|||
143212930|NCT02718716|516324076|FG002|Overall Study|Lack of Efficacy|0|||
143212931|NCT02718716|516324077|FG003|Overall Study|Lack of Efficacy|0|||
143212932|NCT02718716|516324078|FG004|Overall Study|Lack of Efficacy|0|||
143212933|NCT03194646|516324085|FG000|Overall Study|Adverse Event|24|||
143212934|NCT03194646|516324086|FG001|Overall Study|Adverse Event|25|||
143212935|NCT03194646|516324087|FG002|Overall Study|Adverse Event|14|||
143212936|NCT03194646|516324088|FG003|Overall Study|Adverse Event|17|||
143212937|NCT03194646|516324085|FG000|Overall Study|Lack of Efficacy|4|||
143212938|NCT03194646|516324086|FG001|Overall Study|Lack of Efficacy|2|||
143212939|NCT03194646|516324087|FG002|Overall Study|Lack of Efficacy|2|||
143212940|NCT03194646|516324088|FG003|Overall Study|Lack of Efficacy|12|||
143212941|NCT03194646|516324085|FG000|Overall Study|Lost to Follow-up|30|||
143212942|NCT03194646|516324086|FG001|Overall Study|Lost to Follow-up|22|||
143212943|NCT03194646|516324087|FG002|Overall Study|Lost to Follow-up|12|||
143212944|NCT03194646|516324088|FG003|Overall Study|Lost to Follow-up|35|||
143212945|NCT03194646|516324085|FG000|Overall Study|Non-compliance with study drug|4|||
143212946|NCT03194646|516324086|FG001|Overall Study|Non-compliance with study drug|0|||
143212947|NCT03194646|516324087|FG002|Overall Study|Non-compliance with study drug|1|||
143212948|NCT03194646|516324088|FG003|Overall Study|Non-compliance with study drug|1|||
143212949|NCT03194646|516324085|FG000|Overall Study|Other|89|||
143212950|NCT03194646|516324086|FG001|Overall Study|Other|68|||
143212951|NCT03194646|516324087|FG002|Overall Study|Other|34|||
143212952|NCT03194646|516324088|FG003|Overall Study|Other|31|||
143212953|NCT03194646|516324085|FG000|Overall Study|Physician Decision|7|||
143212954|NCT03194646|516324086|FG001|Overall Study|Physician Decision|9|||
143212955|NCT03194646|516324087|FG002|Overall Study|Physician Decision|5|||
143212956|NCT03194646|516324088|FG003|Overall Study|Physician Decision|4|||
143212957|NCT03194646|516324085|FG000|Overall Study|Pregnancy|4|||
143212958|NCT03194646|516324086|FG001|Overall Study|Pregnancy|5|||
143212959|NCT03194646|516324087|FG002|Overall Study|Pregnancy|1|||
143212960|NCT03194646|516324088|FG003|Overall Study|Pregnancy|2|||
143212961|NCT03194646|516324085|FG000|Overall Study|Protocol Violation|4|||
143212962|NCT03194646|516324086|FG001|Overall Study|Protocol Violation|2|||
143212963|NCT03194646|516324087|FG002|Overall Study|Protocol Violation|1|||
143212964|NCT03194646|516324088|FG003|Overall Study|Protocol Violation|1|||
143265879|NCT00857415|516528590|FG000|Overall Study|Subject still living at end of study|110|||
143212965|NCT03194646|516324085|FG000|Overall Study|Site terminated by sponsor|0|||
143212966|NCT03194646|516324086|FG001|Overall Study|Site terminated by sponsor|0|||
143212967|NCT03194646|516324087|FG002|Overall Study|Site terminated by sponsor|2|||
143212968|NCT03194646|516324088|FG003|Overall Study|Site terminated by sponsor|0|||
143212969|NCT03194646|516324085|FG000|Overall Study|Study terminated by sponsor|62|||
143212970|NCT03194646|516324086|FG001|Overall Study|Study terminated by sponsor|61|||
143212971|NCT03194646|516324087|FG002|Overall Study|Study terminated by sponsor|30|||
143212972|NCT03194646|516324088|FG003|Overall Study|Study terminated by sponsor|34|||
143212973|NCT03194646|516324085|FG000|Overall Study|Withdrawal by Subject|75|||
143212974|NCT03194646|516324086|FG001|Overall Study|Withdrawal by Subject|74|||
143212975|NCT03194646|516324087|FG002|Overall Study|Withdrawal by Subject|36|||
143212976|NCT03194646|516324088|FG003|Overall Study|Withdrawal by Subject|131|||
143212977|NCT03194646|516324085|FG000|Overall Study|Missing|1|||
143212978|NCT03194646|516324086|FG001|Overall Study|Missing|0|||
143212979|NCT03194646|516324087|FG002|Overall Study|Missing|1|||
143212980|NCT03194646|516324088|FG003|Overall Study|Missing|12|||
143212981|NCT04869358|516324089|FG000|Overall Study|Wish to have children.|1|||
143212982|NCT04869358|516324090|FG001|Overall Study|Wish to have children.|0|||
143212983|NCT04869358|516324091|FG002|Overall Study|Wish to have children.|0|||
143212984|NCT04869358|516324092|FG003|Overall Study|Wish to have children.|0|||
143212985|NCT02141360|516324093|FG000|Overall Study|Withdrawal by Subject|6|||
143265880|NCT00857415|516528591|FG001|Overall Study|Subject still living at end of study|0|||
143265881|NCT00857415|516528590|FG000|Overall Study|Deceased with no autopsy|2|||
143265882|NCT00857415|516528591|FG001|Overall Study|Deceased with no autopsy|0|||
143265883|NCT02676466|516528592|FG000|Overall Study|Death|0|||
143265884|NCT02676466|516528593|FG001|Overall Study|Death|2|||
143265885|NCT02676466|516528594|FG002|Overall Study|Death|1|||
143265886|NCT02676466|516528595|FG003|Overall Study|Death|0|||
143265887|NCT02676466|516528596|FG004|Overall Study|Death|0|||
143265888|NCT02676466|516528597|FG005|Overall Study|Death|0|||
143265889|NCT02676466|516528598|FG006|Overall Study|Death|0|||
143265890|NCT02676466|516528599|FG007|Overall Study|Death|0|||
143265891|NCT02676466|516528592|FG000|Overall Study|Withdrawal by Subject|4|||
143265892|NCT02676466|516528593|FG001|Overall Study|Withdrawal by Subject|3|||
143265893|NCT02676466|516528594|FG002|Overall Study|Withdrawal by Subject|1|||
143265894|NCT02676466|516528595|FG003|Overall Study|Withdrawal by Subject|0|||
143265895|NCT02676466|516528596|FG004|Overall Study|Withdrawal by Subject|3|||
143265896|NCT02676466|516528597|FG005|Overall Study|Withdrawal by Subject|1|||
143265897|NCT02676466|516528598|FG006|Overall Study|Withdrawal by Subject|1|||
143265898|NCT02676466|516528599|FG007|Overall Study|Withdrawal by Subject|1|||
143265899|NCT03497676|516528600|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
143265900|NCT03497676|516528601|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
143265901|NCT03497676|516528602|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
143265902|NCT03497676|516528603|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
143265903|NCT03497676|516528600|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
143265904|NCT03497676|516528601|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
143265905|NCT03497676|516528602|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
143265906|NCT03497676|516528603|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
143265907|NCT03497676|516528600|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
143265908|NCT03497676|516528601|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
143265909|NCT03497676|516528602|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
143265910|NCT03497676|516528603|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
143265911|NCT03497676|516528600|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
143265912|NCT03497676|516528601|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
143265913|NCT03497676|516528602|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
143265914|NCT03497676|516528603|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
143265915|NCT03497676|516528600|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
143265916|NCT03497676|516528601|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
143265917|NCT03497676|516528602|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
143265918|NCT03497676|516528603|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
143265919|NCT03497676|516528600|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
143265920|NCT03497676|516528601|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
143212986|NCT02141360|516324094|FG001|Overall Study|Withdrawal by Subject|0|||
143212987|NCT02141360|516324095|FG002|Overall Study|Withdrawal by Subject|0|||
143212988|NCT02141360|516324093|FG000|Overall Study|Study Terminated before Visit|1|||
143212989|NCT02141360|516324094|FG001|Overall Study|Study Terminated before Visit|0|||
143265921|NCT03497676|516528602|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
143371321|NCT00487578|516903829|FG001|Overall Study|Adverse Event|2|||
143371322|NCT00487578|516903828|FG000|Overall Study|Lack of Efficacy|0|||
143371323|NCT00487578|516903829|FG001|Overall Study|Lack of Efficacy|1|||
143371324|NCT00487578|516903828|FG000|Overall Study|Lost to Follow-up|0|||
143371325|NCT00487578|516903829|FG001|Overall Study|Lost to Follow-up|1|||
143371326|NCT00955825|516903836|FG000|Overall Study|Adverse Event|15|||
143371327|NCT00955825|516903837|FG001|Overall Study|Adverse Event|2|||
143371328|NCT00955825|516903836|FG000|Overall Study|Withdrawal by Subject|4|||
143371329|NCT00955825|516903837|FG001|Overall Study|Withdrawal by Subject|6|||
143371330|NCT00955825|516903836|FG000|Overall Study|Any other reason not above-mentioned|7|||
143371331|NCT00955825|516903837|FG001|Overall Study|Any other reason not above-mentioned|9|||
143371332|NCT02488980|516903838|FG000|Overall Study|Protocol Violation|2|||
143371333|NCT02488980|516903839|FG001|Overall Study|Protocol Violation|2|||
143371334|NCT02488980|516903840|FG002|Overall Study|Protocol Violation|2|||
143371335|NCT01198275|516903841|FG000|Overall Study|Adverse Event|2|||
143371336|NCT01198275|516903842|FG001|Overall Study|Adverse Event|3|||
143371337|NCT01198275|516903841|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
143371338|NCT01198275|516903842|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
143371339|NCT00150176|516903843|FG000|Overall Study|Adverse Event|16|||
143371340|NCT00150176|516903844|FG001|Overall Study|Adverse Event|53|||
143371341|NCT00150176|516903843|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
143371342|NCT00150176|516903844|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
143371343|NCT00150176|516903843|FG000|Overall Study|Withdrawal by Subject|19|||
143371344|NCT00150176|516903844|FG001|Overall Study|Withdrawal by Subject|12|||
143371345|NCT00150176|516903843|FG000|Overall Study|Lost to Follow-up|3|||
143371346|NCT00150176|516903844|FG001|Overall Study|Lost to Follow-up|3|||
143371347|NCT00150176|516903843|FG000|Overall Study|OTHER|11|||
143371348|NCT00150176|516903844|FG001|Overall Study|OTHER|13|||
143371349|NCT02385669|516903848|FG000|Overall Study|Adverse Event|2|||
143371350|NCT00970307|516903849|FG000|Overall Study|Serious Adverse Event|1|||
143371351|NCT00970307|516903850|FG001|Overall Study|Serious Adverse Event|0|||
143371352|NCT00970307|516903851|FG002|Overall Study|Serious Adverse Event|0|||
143371353|NCT00970307|516903849|FG000|Overall Study|Withdrawal by Subject|2|||
143371354|NCT00970307|516903850|FG001|Overall Study|Withdrawal by Subject|3|||
143371355|NCT00970307|516903851|FG002|Overall Study|Withdrawal by Subject|2|||
143371356|NCT03546907|516903852|FG000|Overall Study|Lack of Efficacy|1|||
143371357|NCT03546907|516903853|FG001|Overall Study|Lack of Efficacy|1|||
143371358|NCT03546907|516903852|FG000|Overall Study|Withdrawal by Subject|8|||
143371359|NCT03546907|516903853|FG001|Overall Study|Withdrawal by Subject|9|||
143371360|NCT03546907|516903852|FG000|Overall Study|Adverse events (AEs)|7|||
143371361|NCT03546907|516903853|FG001|Overall Study|Adverse events (AEs)|10|||
143371362|NCT03546907|516903852|FG000|Overall Study|Other-unspecified|1|||
143371363|NCT03546907|516903853|FG001|Overall Study|Other-unspecified|1|||
143371364|NCT02810080|516903854|FG000|Overall Study|Adverse Event|3|||
143371365|NCT02810080|516903855|FG001|Overall Study|Adverse Event|0|||
143371366|NCT02810080|516903854|FG000|Overall Study|Death|0|||
143371367|NCT02810080|516903855|FG001|Overall Study|Death|2|||
143371368|NCT02810080|516903854|FG000|Overall Study|Physician Decision|4|||
143371369|NCT02810080|516903855|FG001|Overall Study|Physician Decision|0|||
143371370|NCT02810080|516903854|FG000|Overall Study|Withdrawal by Subject|0|||
143371371|NCT02810080|516903855|FG001|Overall Study|Withdrawal by Subject|2|||
143371372|NCT05174013|516903856|FG000|Overall Study|Lost to Follow-up|0|||
143371373|NCT05174013|516903857|FG001|Overall Study|Lost to Follow-up|0|||
143371374|NCT05174013|516903858|FG002|Overall Study|Lost to Follow-up|0|||
143371375|NCT05174013|516903859|FG003|Overall Study|Lost to Follow-up|1|||
143371376|NCT05174013|516903860|FG004|Overall Study|Lost to Follow-up|0|||
143371377|NCT05174013|516903861|FG005|Overall Study|Lost to Follow-up|0|||
143371378|NCT05174013|516903856|FG000|Overall Study|Withdrawal by Subject|0|||
143371379|NCT05174013|516903857|FG001|Overall Study|Withdrawal by Subject|0|||
143371380|NCT05174013|516903858|FG002|Overall Study|Withdrawal by Subject|1|||
143371381|NCT05174013|516903859|FG003|Overall Study|Withdrawal by Subject|0|||
143371382|NCT05174013|516903860|FG004|Overall Study|Withdrawal by Subject|0|||
143371383|NCT05174013|516903861|FG005|Overall Study|Withdrawal by Subject|0|||
143371384|NCT01616654|516903862|FG000|Overall Study|Lack of Efficacy|1|||
143371385|NCT01616654|516903863|FG001|Overall Study|Lack of Efficacy|0|||
143371386|NCT01616654|516903864|FG002|Overall Study|Lack of Efficacy|0|||
143371387|NCT01616654|516903865|FG003|Overall Study|Lack of Efficacy|0|||
143371388|NCT01616654|516903866|FG004|Overall Study|Lack of Efficacy|1|||
143371389|NCT01616654|516903862|FG000|Overall Study|Adverse Event|0|||
143371390|NCT01616654|516903863|FG001|Overall Study|Adverse Event|1|||
143371391|NCT01616654|516903864|FG002|Overall Study|Adverse Event|2|||
143371392|NCT01616654|516903865|FG003|Overall Study|Adverse Event|1|||
143371393|NCT01616654|516903866|FG004|Overall Study|Adverse Event|0|||
143371394|NCT01616654|516903862|FG000|Overall Study|Withdrawal by Subject|2|||
143371395|NCT01616654|516903863|FG001|Overall Study|Withdrawal by Subject|2|||
143371396|NCT01616654|516903864|FG002|Overall Study|Withdrawal by Subject|3|||
143371397|NCT01616654|516903865|FG003|Overall Study|Withdrawal by Subject|1|||
143371398|NCT01616654|516903866|FG004|Overall Study|Withdrawal by Subject|5|||
143371399|NCT01616654|516903862|FG000|Overall Study|Protocol Violation|0|||
143371400|NCT01616654|516903863|FG001|Overall Study|Protocol Violation|5|||
143371401|NCT01616654|516903864|FG002|Overall Study|Protocol Violation|2|||
143371402|NCT01616654|516903865|FG003|Overall Study|Protocol Violation|4|||
143371403|NCT01616654|516903866|FG004|Overall Study|Protocol Violation|4|||
143371404|NCT01616654|516903862|FG000|Overall Study|Lost to Follow-up|1|||
143371405|NCT01616654|516903863|FG001|Overall Study|Lost to Follow-up|0|||
143371406|NCT01616654|516903864|FG002|Overall Study|Lost to Follow-up|3|||
143371407|NCT01616654|516903865|FG003|Overall Study|Lost to Follow-up|2|||
143371408|NCT01616654|516903866|FG004|Overall Study|Lost to Follow-up|1|||
143371409|NCT01616654|516903862|FG000|Overall Study|Pregnancy|1|||
143371410|NCT01616654|516903863|FG001|Overall Study|Pregnancy|0|||
143371411|NCT01616654|516903864|FG002|Overall Study|Pregnancy|0|||
143371412|NCT01616654|516903865|FG003|Overall Study|Pregnancy|0|||
143371413|NCT01616654|516903866|FG004|Overall Study|Pregnancy|1|||
143371414|NCT01027286|516903868|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
143371415|NCT01027286|516903869|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
143371416|NCT01027286|516903868|FG000|Overall Study|Lost to Follow-up|0|||
143371417|NCT01027286|516903869|FG001|Overall Study|Lost to Follow-up|1|||
143371418|NCT00545844|516903870|FG000|Overall Study|Lost to Follow-up|9|||
143371419|NCT00545844|516903870|FG000|Overall Study|Protocol Violation|1|||
143371420|NCT00545844|516903870|FG000|Overall Study|Withdrawal by Subject|2|||
143371421|NCT00094809|516903871|FG000|Overall Study|Protocol deviation|2|||
143371422|NCT00094809|516903872|FG001|Overall Study|Protocol deviation|2|||
143371423|NCT00094809|516903871|FG000|Overall Study|Noncompliance|1|||
143371424|NCT00094809|516903872|FG001|Overall Study|Noncompliance|0|||
143371425|NCT00094809|516903871|FG000|Overall Study|Adverse Event|3|||
143371426|NCT00094809|516903872|FG001|Overall Study|Adverse Event|1|||
143371427|NCT00094809|516903871|FG000|Overall Study|Withdrawal by Subject|8|||
143371428|NCT00094809|516903872|FG001|Overall Study|Withdrawal by Subject|9|||
143371429|NCT00094809|516903871|FG000|Overall Study|Disease progression|3|||
143371430|NCT00094809|516903872|FG001|Overall Study|Disease progression|3|||
143371431|NCT00094809|516903871|FG000|Overall Study|Physician Decision|3|||
143371432|NCT00094809|516903872|FG001|Overall Study|Physician Decision|5|||
143371433|NCT00094809|516903871|FG000|Overall Study|Lost to Follow-up|6|||
143371434|NCT00094809|516903872|FG001|Overall Study|Lost to Follow-up|6|||
143371435|NCT00094809|516903871|FG000|Overall Study|Death|19|||
143371436|NCT00094809|516903872|FG001|Overall Study|Death|25|||
143371437|NCT00094809|516903871|FG000|Overall Study|Protocol-specified criteria|1|||
143371438|NCT00094809|516903872|FG001|Overall Study|Protocol-specified criteria|1|||
143371439|NCT00094809|516903871|FG000|Overall Study|Other|2|||
143371440|NCT00094809|516903872|FG001|Overall Study|Other|4|||
143371441|NCT00094809|516903871|FG000|Overall Study|Informed consent signed after treatment|1|||
143371442|NCT00094809|516903872|FG001|Overall Study|Informed consent signed after treatment|0|||
143371443|NCT00094809|516903871|FG000|Overall Study|Study drug not received|2|||
143371444|NCT00094809|516903872|FG001|Overall Study|Study drug not received|8|||
143371445|NCT00094809|516903871|FG000|Overall Study|Other|1|||
143371446|NCT00094809|516903872|FG001|Overall Study|Other|1|||
143371447|NCT01329328|516903873|FG000|Overall Study|Withdrawal by Subject|2|||
143371448|NCT01329328|516903874|FG001|Overall Study|Withdrawal by Subject|4|||
143371449|NCT01329328|516903875|FG002|Overall Study|Withdrawal by Subject|3|||
143371450|NCT02393716|516903877|FG000|Overall Study|Death|29|||
143371451|NCT02393716|516903877|FG000|Overall Study|Withdrawal by Subject|8|||
143371452|NCT02393716|516903877|FG000|Overall Study|Device Explanted|8|||
143371453|NCT02393716|516903877|FG000|Overall Study|Missed visit|16|||
143371454|NCT01713530|516903881|FG000|Overall Study|Adverse Event|0|||
143371455|NCT01713530|516903882|FG001|Overall Study|Adverse Event|5|||
143371456|NCT01713530|516903881|FG000|Overall Study|Withdrawal criteria|21|||
143371457|NCT01713530|516903882|FG001|Overall Study|Withdrawal criteria|12|||
143371458|NCT01713530|516903881|FG000|Overall Study|Unclassified|4|||
143371459|NCT01713530|516903882|FG001|Overall Study|Unclassified|2|||
143371460|NCT00758602|516903883|FG000|Overall Study|Adverse Event|11|||
143371461|NCT00758602|516903884|FG001|Overall Study|Adverse Event|10|||
143371462|NCT00758602|516903883|FG000|Overall Study|Lost to Follow-up|4|||
143212990|NCT02141360|516324095|FG002|Overall Study|Study Terminated before Visit|0|||
143212991|NCT00646399|516324096|FG000|Overall Study|Death|63|||
143371463|NCT00758602|516903884|FG001|Overall Study|Lost to Follow-up|3|||
143371464|NCT00758602|516903883|FG000|Overall Study|Withdrawal by Subject|1|||
143371465|NCT00758602|516903884|FG001|Overall Study|Withdrawal by Subject|3|||
143371466|NCT00758602|516903883|FG000|Overall Study|Protocol Violation|0|||
143371467|NCT00758602|516903884|FG001|Overall Study|Protocol Violation|2|||
143371468|NCT00758602|516903883|FG000|Overall Study|Death|0|||
143212992|NCT00646399|516324097|FG001|Overall Study|Death|53|||
143371469|NCT00758602|516903884|FG001|Overall Study|Death|1|||
143371470|NCT00758602|516903883|FG000|Overall Study|Reason not specified|3|||
143371471|NCT00758602|516903884|FG001|Overall Study|Reason not specified|3|||
143371472|NCT02148133|516903886|FG000|Overall Study|Investigator discretion|1|||
143371473|NCT02148133|516903886|FG000|Overall Study|Lack of Efficacy|1|||
143371474|NCT02148133|516903886|FG000|Overall Study|Protocol deviation|1|||
143371475|NCT02148133|516903886|FG000|Overall Study|Protocol-defined stopping criteria|2|||
143371476|NCT00855465|516903888|FG000|Treatment Period|Adverse Event|4|||
143371477|NCT00855465|516903889|FG001|Treatment Period|Adverse Event|2|||
143371478|NCT00855465|516903888|FG000|Treatment Period|Death|2|||
143371479|NCT00855465|516903889|FG001|Treatment Period|Death|2|||
143371480|NCT00855465|516903888|FG000|Treatment Period|Lack of Efficacy|2|||
143371481|NCT00855465|516903889|FG001|Treatment Period|Lack of Efficacy|1|||
143371482|NCT00855465|516903888|FG000|Treatment Period|Non-compliance|1|||
143371483|NCT00855465|516903889|FG001|Treatment Period|Non-compliance|0|||
143371484|NCT00855465|516903888|FG000|Treatment Period|Protocol Violation|2|||
143371485|NCT00855465|516903889|FG001|Treatment Period|Protocol Violation|0|||
143371486|NCT00855465|516903888|FG000|Treatment Period|Withdrawal by Subject|2|||
143371487|NCT00855465|516903889|FG001|Treatment Period|Withdrawal by Subject|0|||
143371488|NCT00855465|516903888|FG000|Treatment Period|Not treated|1|||
143371489|NCT00855465|516903889|FG001|Treatment Period|Not treated|0|||
143371490|NCT00855465|516903888|FG000|Follow-up Period (FUP)|Adverse Event|0|||
143371491|NCT00855465|516903889|FG001|Follow-up Period (FUP)|Adverse Event|1|||
143371492|NCT00855465|516903888|FG000|Follow-up Period (FUP)|Death|0|||
143371493|NCT00855465|516903889|FG001|Follow-up Period (FUP)|Death|1|||
143371494|NCT00855465|516903888|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
143371495|NCT00855465|516903889|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
143371496|NCT00855465|516903888|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
143371497|NCT00855465|516903889|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
143371498|NCT00855465|516903888|FG000|Follow-up Period (FUP)|Missing|1|||
143371499|NCT00855465|516903889|FG001|Follow-up Period (FUP)|Missing|0|||
143371500|NCT00079183|516903897|FG000|Overall Study|Withdrawal by Subject|4|||
143371501|NCT00079183|516903897|FG000|Overall Study|Study medication non-compliance|2|||
143371502|NCT00079183|516903897|FG000|Overall Study|Specimen collection non-compliance|1|||
143371503|NCT02371746|516903898|FG000|Overall Study|Consent withdrawn|0|||
143371504|NCT02371746|516903899|FG001|Overall Study|Consent withdrawn|0|||
143371505|NCT02371746|516903900|FG002|Overall Study|Consent withdrawn|0|||
143371506|NCT02371746|516903901|FG003|Overall Study|Consent withdrawn|0|||
143371507|NCT02371746|516903902|FG004|Overall Study|Consent withdrawn|0|||
143371508|NCT02371746|516903903|FG005|Overall Study|Consent withdrawn|0|||
143371509|NCT02371746|516903904|FG006|Overall Study|Consent withdrawn|1|||
143371510|NCT02781584|516903905|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
143371511|NCT02781584|516903906|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
143371512|NCT02781584|516903907|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
143371513|NCT02781584|516903908|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
143371514|NCT02781584|516903909|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
143371515|NCT02781584|516903910|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
143371516|NCT02781584|516903911|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
143371517|NCT02781584|516903912|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
143371518|NCT02781584|516903913|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
143371519|NCT02781584|516903914|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
143371520|NCT02781584|516903915|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
143371521|NCT02781584|516903916|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
143371522|NCT02781584|516903917|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
143371523|NCT02781584|516903905|FG000|Pre-treatment Phase|Adverse Event|0|||
143371524|NCT02781584|516903906|FG001|Pre-treatment Phase|Adverse Event|0|||
143371525|NCT02781584|516903907|FG002|Pre-treatment Phase|Adverse Event|0|||
143371526|NCT02781584|516903908|FG003|Pre-treatment Phase|Adverse Event|0|||
143371527|NCT02781584|516903909|FG004|Pre-treatment Phase|Adverse Event|0|||
143371528|NCT02781584|516903910|FG005|Pre-treatment Phase|Adverse Event|0|||
143371529|NCT02781584|516903911|FG006|Pre-treatment Phase|Adverse Event|0|||
143371530|NCT02781584|516903912|FG007|Pre-treatment Phase|Adverse Event|0|||
143371531|NCT02781584|516903913|FG008|Pre-treatment Phase|Adverse Event|0|||
143371532|NCT02781584|516903914|FG009|Pre-treatment Phase|Adverse Event|0|||
143371533|NCT02781584|516903915|FG010|Pre-treatment Phase|Adverse Event|0|||
143371534|NCT02781584|516903916|FG011|Pre-treatment Phase|Adverse Event|1|||
143371535|NCT02781584|516903917|FG012|Pre-treatment Phase|Adverse Event|0|||
143371536|NCT02781584|516903905|FG000|Treatment Phase|Withdrew Consent|0|||
143371537|NCT02781584|516903906|FG001|Treatment Phase|Withdrew Consent|0|||
143371538|NCT02781584|516903907|FG002|Treatment Phase|Withdrew Consent|0|||
143371539|NCT02781584|516903908|FG003|Treatment Phase|Withdrew Consent|0|||
143371540|NCT02781584|516903909|FG004|Treatment Phase|Withdrew Consent|0|||
143371541|NCT02781584|516903910|FG005|Treatment Phase|Withdrew Consent|1|||
143371542|NCT02781584|516903911|FG006|Treatment Phase|Withdrew Consent|0|||
143371543|NCT02781584|516903912|FG007|Treatment Phase|Withdrew Consent|0|||
143371544|NCT02781584|516903913|FG008|Treatment Phase|Withdrew Consent|0|||
143371545|NCT02781584|516903914|FG009|Treatment Phase|Withdrew Consent|0|||
143371546|NCT02781584|516903915|FG010|Treatment Phase|Withdrew Consent|1|||
143371547|NCT02781584|516903916|FG011|Treatment Phase|Withdrew Consent|2|||
143371548|NCT02781584|516903917|FG012|Treatment Phase|Withdrew Consent|0|||
143371549|NCT02781584|516903905|FG000|Treatment Phase|Adverse Event|0|||
143371550|NCT02781584|516903906|FG001|Treatment Phase|Adverse Event|0|||
143371551|NCT02781584|516903907|FG002|Treatment Phase|Adverse Event|0|||
143371552|NCT02781584|516903908|FG003|Treatment Phase|Adverse Event|0|||
143371553|NCT02781584|516903909|FG004|Treatment Phase|Adverse Event|0|||
143371554|NCT02781584|516903910|FG005|Treatment Phase|Adverse Event|0|||
143371555|NCT02781584|516903911|FG006|Treatment Phase|Adverse Event|0|||
143371556|NCT02781584|516903912|FG007|Treatment Phase|Adverse Event|1|||
143371557|NCT02781584|516903913|FG008|Treatment Phase|Adverse Event|0|||
143371558|NCT02781584|516903914|FG009|Treatment Phase|Adverse Event|0|||
143371559|NCT02781584|516903915|FG010|Treatment Phase|Adverse Event|0|||
143371560|NCT02781584|516903916|FG011|Treatment Phase|Adverse Event|0|||
143371561|NCT02781584|516903917|FG012|Treatment Phase|Adverse Event|0|||
143371562|NCT01093534|516903918|FG000|Overall Study|Adverse Event|2|||
143371563|NCT01093534|516903919|FG001|Overall Study|Adverse Event|5|||
143371564|NCT01093534|516903920|FG002|Overall Study|Adverse Event|2|||
143371565|NCT01093534|516903918|FG000|Overall Study|Lack of Efficacy|2|||
143371566|NCT01093534|516903919|FG001|Overall Study|Lack of Efficacy|1|||
143371567|NCT01093534|516903920|FG002|Overall Study|Lack of Efficacy|1|||
143371568|NCT01093534|516903918|FG000|Overall Study|Withdrawal by Subject|5|||
143371569|NCT01093534|516903919|FG001|Overall Study|Withdrawal by Subject|7|||
143371570|NCT01093534|516903920|FG002|Overall Study|Withdrawal by Subject|2|||
143371571|NCT01093534|516903918|FG000|Overall Study|Other|1|||
143371572|NCT01093534|516903919|FG001|Overall Study|Other|3|||
143371573|NCT01093534|516903920|FG002|Overall Study|Other|4|||
143371574|NCT00811057|516903921|FG000|Overall Study|Protocol Violation|5|||
143371575|NCT00811057|516903922|FG001|Overall Study|Protocol Violation|10|||
143371576|NCT00811057|516903923|FG002|Overall Study|Protocol Violation|10|||
143371577|NCT00995709|516903924|FG000|Overall Study|Adverse Event|4|||
143371578|NCT00995709|516903925|FG001|Overall Study|Adverse Event|2|||
143371579|NCT00995709|516903926|FG002|Overall Study|Adverse Event|0|||
143371580|NCT00995709|516903924|FG000|Overall Study|Lack of Efficacy|0|||
143371581|NCT00995709|516903925|FG001|Overall Study|Lack of Efficacy|1|||
143371582|NCT00995709|516903926|FG002|Overall Study|Lack of Efficacy|4|||
143371583|NCT00995709|516903924|FG000|Overall Study|Withdrawal by Subject|0|||
143371584|NCT00995709|516903925|FG001|Overall Study|Withdrawal by Subject|4|||
143371585|NCT00995709|516903926|FG002|Overall Study|Withdrawal by Subject|1|||
143371586|NCT00995709|516903924|FG000|Overall Study|Lost to Follow-up|1|||
143371587|NCT00995709|516903925|FG001|Overall Study|Lost to Follow-up|0|||
143371588|NCT00995709|516903926|FG002|Overall Study|Lost to Follow-up|0|||
143371589|NCT00995709|516903924|FG000|Overall Study|Death|0|||
143371590|NCT00995709|516903925|FG001|Overall Study|Death|1|||
143371591|NCT00995709|516903926|FG002|Overall Study|Death|0|||
143371592|NCT00995709|516903924|FG000|Overall Study|Protocol Violation|2|||
143371593|NCT00995709|516903925|FG001|Overall Study|Protocol Violation|1|||
143371594|NCT00995709|516903926|FG002|Overall Study|Protocol Violation|0|||
143371595|NCT03008915|516903933|FG000|Treatment 1|Withdrawal by Subject|0|||
143371596|NCT03008915|516903934|FG001|Treatment 1|Withdrawal by Subject|1|||
143371597|NCT00712166|516903937|FG000|Overall Study|Noncompliance|0|||
143371598|NCT00712166|516903938|FG001|Overall Study|Noncompliance|1|||
143371599|NCT01773122|516903939|FG000|Overall Study|Due to amended age eligibility criteria|3|||
143371600|NCT01773122|516903940|FG001|Overall Study|Due to amended age eligibility criteria|1|||
143371601|NCT01773122|516903941|FG002|Overall Study|Due to amended age eligibility criteria|0|||
143371602|NCT01773122|516903942|FG003|Overall Study|Due to amended age eligibility criteria|1|||
143371603|NCT01264718|516903943|FG000|Overall Study|Lost to Follow-up|3|||
143371604|NCT01264718|516903944|FG001|Overall Study|Lost to Follow-up|2|||
143371605|NCT01264718|516903943|FG000|Overall Study|Withdrawal by Subject|9|||
143371606|NCT01264718|516903944|FG001|Overall Study|Withdrawal by Subject|15|||
143371607|NCT01264718|516903943|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
143371608|NCT01264718|516903944|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
143371609|NCT03538054|516903948|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
143371610|NCT03538054|516903948|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
143371611|NCT03538054|516903948|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
143371612|NCT03254394|516903951|FG000|Overall Study|Withdrawal by Subject|0|||
143371613|NCT03254394|516903952|FG001|Overall Study|Withdrawal by Subject|2|||
143371614|NCT02351180|516903953|FG000|Overall Study|Withdrawal by Subject|1|||
143371615|NCT02351180|516903954|FG001|Overall Study|Withdrawal by Subject|0|||
143371616|NCT01768676|516903955|FG000|Overall Study|Adverse Event|3|||
143371617|NCT01768676|516903956|FG001|Overall Study|Adverse Event|3|||
143371618|NCT01768676|516903955|FG000|Overall Study|Lost to Follow-up|13|||
143371619|NCT01768676|516903956|FG001|Overall Study|Lost to Follow-up|16|||
143371620|NCT01768676|516903955|FG000|Overall Study|Protocol Violation|1|||
143371621|NCT01768676|516903956|FG001|Overall Study|Protocol Violation|1|||
143371622|NCT01768676|516903955|FG000|Overall Study|Physician Decision|4|||
143371623|NCT01768676|516903956|FG001|Overall Study|Physician Decision|1|||
143371624|NCT01768676|516903955|FG000|Overall Study|Withdrawal by Subject|3|||
143371625|NCT01768676|516903956|FG001|Overall Study|Withdrawal by Subject|10|||
143371626|NCT00605033|516903958|FG000|Overall Study|Adverse Event|2|||
143371627|NCT00605033|516903959|FG001|Overall Study|Adverse Event|2|||
143371628|NCT00605033|516903958|FG000|Overall Study|Lost to Follow-up|1|||
143371629|NCT00605033|516903959|FG001|Overall Study|Lost to Follow-up|1|||
143371630|NCT00605033|516903958|FG000|Overall Study|Withdrawal by Subject|3|||
143371631|NCT00605033|516903959|FG001|Overall Study|Withdrawal by Subject|4|||
143371632|NCT00605033|516903958|FG000|Overall Study|Protocol Violation|1|||
143371633|NCT00605033|516903959|FG001|Overall Study|Protocol Violation|1|||
143371634|NCT05052983|516903964|FG000|Overall Study|Lack of Efficacy|3|||
143371635|NCT05052983|516903965|FG001|Overall Study|Lack of Efficacy|12|||
143371636|NCT05052983|516903964|FG000|Overall Study|Adverse Event|1|||
143371637|NCT05052983|516903965|FG001|Overall Study|Adverse Event|0|||
143371638|NCT02812966|516903966|FG000|Overall Study|Death|1|||
143371639|NCT02812966|516903967|FG001|Overall Study|Death|0|||
143454060|NCT00291642|517206859|FG000|Overall Study|Intake of prohibited medication|1|||
143454061|NCT00291642|517206860|FG001|Overall Study|Intake of prohibited medication|0|||
143454062|NCT00291642|517206861|FG002|Overall Study|Intake of prohibited medication|0|||
143454063|NCT00291642|517206862|FG003|Overall Study|Intake of prohibited medication|0|||
143454064|NCT00291642|517206863|FG004|Overall Study|Intake of prohibited medication|0|||
143454065|NCT01820585|517206864|FG000|Overall Study|Adverse Event|9|||
143454066|NCT01820585|517206865|FG001|Overall Study|Adverse Event|13|||
143454067|NCT01820585|517206866|FG002|Overall Study|Adverse Event|23|||
143454068|NCT01820585|517206867|FG003|Overall Study|Adverse Event|34|||
143454069|NCT01820585|517206864|FG000|Overall Study|Lack of Efficacy|9|||
143454070|NCT01820585|517206865|FG001|Overall Study|Lack of Efficacy|7|||
143454071|NCT01820585|517206866|FG002|Overall Study|Lack of Efficacy|5|||
143454072|NCT01820585|517206867|FG003|Overall Study|Lack of Efficacy|1|||
143454073|NCT01820585|517206864|FG000|Overall Study|Withdrawal by Subject|3|||
143454074|NCT01820585|517206865|FG001|Overall Study|Withdrawal by Subject|7|||
143454075|NCT01820585|517206866|FG002|Overall Study|Withdrawal by Subject|3|||
143454076|NCT01820585|517206867|FG003|Overall Study|Withdrawal by Subject|8|||
143454077|NCT01820585|517206864|FG000|Overall Study|Lost to Follow-up|3|||
143454078|NCT01820585|517206865|FG001|Overall Study|Lost to Follow-up|3|||
143454079|NCT01820585|517206866|FG002|Overall Study|Lost to Follow-up|0|||
143454080|NCT01820585|517206867|FG003|Overall Study|Lost to Follow-up|3|||
143454081|NCT01820585|517206864|FG000|Overall Study|Protocol Violation|3|||
143454082|NCT01820585|517206865|FG001|Overall Study|Protocol Violation|1|||
143454083|NCT01820585|517206866|FG002|Overall Study|Protocol Violation|1|||
143454084|NCT01820585|517206867|FG003|Overall Study|Protocol Violation|1|||
143454085|NCT01820585|517206864|FG000|Overall Study|Subject non-compliance|0|||
143454086|NCT01820585|517206865|FG001|Overall Study|Subject non-compliance|0|||
143454087|NCT01820585|517206866|FG002|Overall Study|Subject non-compliance|1|||
143212993|NCT00646399|516324096|FG000|Overall Study|Withdrawal by Subject|9|||
143212994|NCT00646399|516324097|FG001|Overall Study|Withdrawal by Subject|10|||
143212995|NCT00646399|516324096|FG000|Overall Study|Other Reason|11|||
143212996|NCT00646399|516324097|FG001|Overall Study|Other Reason|11|||
143212997|NCT04302545|516324100|FG000|Overall Study|Lost to Follow-up|3|||
143212998|NCT04302545|516324101|FG001|Overall Study|Lost to Follow-up|4|||
143212999|NCT01331291|516324102|FG000|Overall Study|Lack of Efficacy|2|||
143213000|NCT01331291|516324103|FG001|Overall Study|Lack of Efficacy|8|||
143213001|NCT01331291|516324102|FG000|Overall Study|Death|0|||
143213002|NCT01331291|516324103|FG001|Overall Study|Death|1|||
143213003|NCT03550404|516324104|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
143213004|NCT03550404|516324105|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
143213005|NCT03550404|516324106|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
143213006|NCT03550404|516324104|FG000|Phase 2|Vacated position|1|||
143213007|NCT03550404|516324105|FG001|Phase 2|Vacated position|0|||
143213008|NCT03550404|516324106|FG002|Phase 2|Vacated position|0|||
143213009|NCT01959243|516324113|FG000|Overall Study|Investigator Decision|3|||
143213010|NCT01959243|516324114|FG001|Overall Study|Investigator Decision|0|||
143213011|NCT01959243|516324113|FG000|Overall Study|Adverse Event|5|||
143213012|NCT01959243|516324114|FG001|Overall Study|Adverse Event|2|||
143213013|NCT01959243|516324113|FG000|Overall Study|Administrative reasons|2|||
143213014|NCT01959243|516324114|FG001|Overall Study|Administrative reasons|1|||
143213015|NCT01959243|516324113|FG000|Overall Study|Lost to Follow-up|3|||
143213016|NCT01959243|516324114|FG001|Overall Study|Lost to Follow-up|1|||
143213017|NCT00629798|516324117|FG000|Overall Study|Not Treated|4|||
143213018|NCT02554981|516324118|FG000|Overall Study|Adverse Event|1|||
143213019|NCT02554981|516324118|FG000|Overall Study|Administrative Reasons|1|||
143213020|NCT02554981|516324118|FG000|Overall Study|Other Miscellaneous Reasons|3|||
143213021|NCT01368081|516324123|FG000|Overall Study|Adverse Event|4|||
143213022|NCT01368081|516324124|FG001|Overall Study|Adverse Event|4|||
143265922|NCT03497676|516528603|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
143265923|NCT03497676|516528600|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
143213023|NCT01368081|516324125|FG002|Overall Study|Adverse Event|3|||
143213024|NCT01368081|516324126|FG003|Overall Study|Adverse Event|2|||
143213025|NCT01368081|516324127|FG004|Overall Study|Adverse Event|2|||
143213026|NCT01368081|516324128|FG005|Overall Study|Adverse Event|5|||
143213027|NCT01368081|516324129|FG006|Overall Study|Adverse Event|6|||
143213028|NCT01368081|516324130|FG007|Overall Study|Adverse Event|2|||
143213029|NCT01368081|516324131|FG008|Overall Study|Adverse Event|3|||
143213030|NCT01368081|516324132|FG009|Overall Study|Adverse Event|5|||
143213031|NCT01368081|516324133|FG010|Overall Study|Adverse Event|6|||
143213032|NCT01368081|516324134|FG011|Overall Study|Adverse Event|1|||
143213033|NCT01368081|516324135|FG012|Overall Study|Adverse Event|3|||
143213034|NCT01368081|516324123|FG000|Overall Study|Lack of Efficacy|0|||
143213035|NCT01368081|516324124|FG001|Overall Study|Lack of Efficacy|1|||
143213036|NCT01368081|516324125|FG002|Overall Study|Lack of Efficacy|0|||
143213037|NCT01368081|516324126|FG003|Overall Study|Lack of Efficacy|1|||
143265924|NCT03497676|516528601|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
143265925|NCT03497676|516528602|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
143265926|NCT03497676|516528603|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
143265927|NCT03497676|516528600|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
143265928|NCT03497676|516528601|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
143265929|NCT03497676|516528602|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
143265930|NCT03497676|516528603|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
143265931|NCT00237185|516528604|FG000|Core|Adverse Event|3|||
143265932|NCT00237185|516528605|FG001|Core|Adverse Event|4|||
143265933|NCT00237185|516528604|FG000|Core|Abnormal laboratory value|0|||
143265934|NCT00237185|516528605|FG001|Core|Abnormal laboratory value|4|||
143265935|NCT00237185|516528604|FG000|Core|Abnormal test procedure results|1|||
143265936|NCT00237185|516528605|FG001|Core|Abnormal test procedure results|0|||
143265937|NCT00237185|516528604|FG000|Core|Lack of Efficacy|30|||
143265938|NCT00237185|516528605|FG001|Core|Lack of Efficacy|23|||
143265939|NCT00237185|516528604|FG000|Core|Protocol Violation|1|||
143265940|NCT00237185|516528605|FG001|Core|Protocol Violation|1|||
143265941|NCT00237185|516528604|FG000|Core|Withdrawal by Subject|4|||
143265942|NCT00237185|516528605|FG001|Core|Withdrawal by Subject|4|||
143265943|NCT00237185|516528604|FG000|Core|Administrative problems|0|||
143265944|NCT00237185|516528605|FG001|Core|Administrative problems|1|||
143265945|NCT00237185|516528604|FG000|Core|Death|4|||
143265946|NCT00237185|516528605|FG001|Core|Death|0|||
143265947|NCT00237185|516528604|FG000|Core|Determined ineligible post randomization|1|||
143265948|NCT00237185|516528605|FG001|Core|Determined ineligible post randomization|0|||
143213038|NCT01368081|516324127|FG004|Overall Study|Lack of Efficacy|0|||
143265949|NCT00237185|516528604|FG000|Extension|Adverse Event|1|||
143265950|NCT00237185|516528605|FG001|Extension|Adverse Event|0|||
143265951|NCT00237185|516528604|FG000|Extension|Abnormal laboratory value|0|||
143265952|NCT00237185|516528605|FG001|Extension|Abnormal laboratory value|1|||
143265953|NCT00237185|516528604|FG000|Extension|Lack of Efficacy|9|||
143265954|NCT00237185|516528605|FG001|Extension|Lack of Efficacy|14|||
143265955|NCT00237185|516528604|FG000|Extension|Condition no longer required study drug|0|||
143265956|NCT00237185|516528605|FG001|Extension|Condition no longer required study drug|1|||
143265957|NCT00237185|516528604|FG000|Extension|Withdrawal by Subject|3|||
143265958|NCT00237185|516528605|FG001|Extension|Withdrawal by Subject|2|||
143265959|NCT00237185|516528604|FG000|Extension|Lost to Follow-up|1|||
143265960|NCT00237185|516528605|FG001|Extension|Lost to Follow-up|0|||
143265961|NCT00237185|516528604|FG000|Extension|Administrative problems|1|||
143265962|NCT00237185|516528605|FG001|Extension|Administrative problems|0|||
143265963|NCT00237185|516528604|FG000|Extension|Death|1|||
143265964|NCT00237185|516528605|FG001|Extension|Death|1|||
143265965|NCT02204007|516528606|FG000|Overall Study|Surgery Canceled|1|||
143213039|NCT01368081|516324128|FG005|Overall Study|Lack of Efficacy|0|||
143213040|NCT01368081|516324129|FG006|Overall Study|Lack of Efficacy|0|||
143213041|NCT01368081|516324130|FG007|Overall Study|Lack of Efficacy|2|||
143213042|NCT01368081|516324131|FG008|Overall Study|Lack of Efficacy|0|||
143213043|NCT01368081|516324132|FG009|Overall Study|Lack of Efficacy|0|||
143213044|NCT01368081|516324133|FG010|Overall Study|Lack of Efficacy|0|||
143213045|NCT01368081|516324134|FG011|Overall Study|Lack of Efficacy|0|||
143213046|NCT01368081|516324135|FG012|Overall Study|Lack of Efficacy|0|||
143213047|NCT01368081|516324123|FG000|Overall Study|Protocol Violation|0|||
143213048|NCT01368081|516324124|FG001|Overall Study|Protocol Violation|0|||
143213049|NCT01368081|516324125|FG002|Overall Study|Protocol Violation|0|||
143213050|NCT01368081|516324126|FG003|Overall Study|Protocol Violation|0|||
143213051|NCT01368081|516324127|FG004|Overall Study|Protocol Violation|0|||
143213052|NCT01368081|516324128|FG005|Overall Study|Protocol Violation|1|||
143265966|NCT02204007|516528607|FG001|Overall Study|Surgery Canceled|1|||
143265967|NCT00760084|516528608|FG000|Overall Study|Physician Decision|5|||
143265968|NCT00760084|516528608|FG000|Overall Study|Withdrawal by Subject|2|||
143265969|NCT00760084|516528608|FG000|Overall Study|Progressive Disease|3|||
143265970|NCT02750943|516528611|FG000|Overall Study|Lost to Follow-up|1|||
143265971|NCT02750943|516528612|FG001|Overall Study|Lost to Follow-up|2|||
143265972|NCT02750943|516528611|FG000|Overall Study|Withdrawal by Subject|5|||
143265973|NCT02750943|516528612|FG001|Overall Study|Withdrawal by Subject|7|||
143265974|NCT04669535|516528613|FG000|Overall Study|Death|1|||
143265975|NCT04669535|516528614|FG001|Overall Study|Death|1|||
143265976|NCT04669535|516528615|FG002|Overall Study|Death|0|||
143265977|NCT04669535|516528616|FG003|Overall Study|Death|0|||
143265978|NCT05169567|516528618|FG000|Overall Study|On study treatment|116|||
143265979|NCT05169567|516528619|FG001|Overall Study|On study treatment|128|||
143265980|NCT05169567|516528618|FG000|Overall Study|Lost to Follow-up|1|||
143265981|NCT05169567|516528619|FG001|Overall Study|Lost to Follow-up|0|||
143265982|NCT05169567|516528618|FG000|Overall Study|Withdrawal by Subject|25|||
143265983|NCT05169567|516528619|FG001|Overall Study|Withdrawal by Subject|21|||
143265984|NCT04382755|516528620|FG000|Overall Study|Withdrawal by Subject|1|||
143265985|NCT04382755|516528621|FG001|Overall Study|Withdrawal by Subject|0|||
143265986|NCT04382755|516528620|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
143265987|NCT04382755|516528621|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
143265988|NCT04382755|516528620|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
143265989|NCT04382755|516528621|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
143265990|NCT03552965|516528625|FG000|Overall Study|Death|1|||
143265991|NCT03552965|516528626|FG001|Overall Study|Death|1|||
143265992|NCT03552965|516528625|FG000|Overall Study|Lost to Follow-up|1|||
143265993|NCT03552965|516528626|FG001|Overall Study|Lost to Follow-up|1|||
143265994|NCT03552965|516528625|FG000|Overall Study|Physician Decision|1|||
143265995|NCT03552965|516528626|FG001|Overall Study|Physician Decision|1|||
143265996|NCT03552965|516528625|FG000|Overall Study|Withdrawal by Subject|0|||
143265997|NCT03552965|516528626|FG001|Overall Study|Withdrawal by Subject|2|||
143371640|NCT02525796|516906279|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
143213053|NCT01368081|516324129|FG006|Overall Study|Protocol Violation|0|||
143213054|NCT01368081|516324130|FG007|Overall Study|Protocol Violation|1|||
143213055|NCT01368081|516324131|FG008|Overall Study|Protocol Violation|0|||
143213056|NCT01368081|516324132|FG009|Overall Study|Protocol Violation|0|||
143213057|NCT01368081|516324133|FG010|Overall Study|Protocol Violation|0|||
143213058|NCT01368081|516324134|FG011|Overall Study|Protocol Violation|0|||
143213059|NCT01368081|516324135|FG012|Overall Study|Protocol Violation|0|||
143213060|NCT01368081|516324123|FG000|Overall Study|Lost to Follow-up|0|||
143213061|NCT01368081|516324124|FG001|Overall Study|Lost to Follow-up|0|||
143213062|NCT01368081|516324125|FG002|Overall Study|Lost to Follow-up|0|||
143265998|NCT03552965|516528625|FG000|Overall Study|Continuation not in patient best interest|1|||
143265999|NCT03552965|516528626|FG001|Overall Study|Continuation not in patient best interest|0|||
143266000|NCT03552965|516528625|FG000|Overall Study|Patient opted to be treated elsewhere|1|||
143266001|NCT03552965|516528626|FG001|Overall Study|Patient opted to be treated elsewhere|0|||
143266002|NCT03120624|516528627|FG000|Overall Study|Withdrawal by Subject|0|||
143266003|NCT03120624|516528628|FG001|Overall Study|Withdrawal by Subject|1|||
143266004|NCT03120624|516528629|FG002|Overall Study|Withdrawal by Subject|0|||
143266005|NCT03120624|516528630|FG003|Overall Study|Withdrawal by Subject|0|||
143266006|NCT03120624|516528631|FG004|Overall Study|Withdrawal by Subject|0|||
143266007|NCT03120624|516528632|FG005|Overall Study|Withdrawal by Subject|0|||
143266008|NCT03120624|516528633|FG006|Overall Study|Withdrawal by Subject|0|||
143266009|NCT03120624|516528634|FG007|Overall Study|Withdrawal by Subject|0|||
143266010|NCT05069259|516528639|FG000|Overall Study|Withdrawal by Subject|1|||
143266011|NCT05069259|516528639|FG000|Overall Study|Sponsor decision|1|||
143266012|NCT01828320|516528641|FG000|Overall Study|Lost to Follow-up|1|||
143266013|NCT01828320|516528642|FG001|Overall Study|Lost to Follow-up|3|||
143266014|NCT01828320|516528641|FG000|Overall Study|Withdrawal by Subject|7|||
143266015|NCT01828320|516528642|FG001|Overall Study|Withdrawal by Subject|2|||
143266016|NCT02160782|516529940|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
143266017|NCT02160782|516529941|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
143266018|NCT02160782|516529942|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
143266019|NCT02160782|516529943|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
143266020|NCT02160782|516529944|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
143266021|NCT02160782|516529940|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
143266022|NCT02160782|516529941|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
143266023|NCT02160782|516529942|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
143266024|NCT02160782|516529943|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
143266025|NCT02160782|516529944|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
143266026|NCT02160782|516529940|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
143266027|NCT02160782|516529941|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
143266028|NCT02160782|516529942|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
143266029|NCT02160782|516529943|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
143266030|NCT02160782|516529944|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
143266031|NCT02160782|516529940|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
143266032|NCT02160782|516529941|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
143266033|NCT02160782|516529942|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
143266034|NCT02160782|516529943|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
143266035|NCT02160782|516529944|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
143266036|NCT02160782|516529940|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
143266037|NCT02160782|516529941|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
143266038|NCT02160782|516529942|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
143266039|NCT02160782|516529943|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
143266040|NCT02160782|516529944|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
143266041|NCT02160782|516529940|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
143266042|NCT02160782|516529941|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
143266043|NCT02160782|516529942|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
143266044|NCT02160782|516529943|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
143266045|NCT02160782|516529944|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
143266046|NCT02160782|516529940|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
143266047|NCT02160782|516529941|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
143266048|NCT02160782|516529942|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
143266049|NCT02160782|516529943|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
143266050|NCT02160782|516529944|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
143266051|NCT01104701|516529949|FG000|Overall Study|Withdrawal by Subject|0|||
143266052|NCT01104701|516529950|FG001|Overall Study|Withdrawal by Subject|1|||
143266053|NCT01104701|516529951|FG002|Overall Study|Withdrawal by Subject|2|||
143266054|NCT01104701|516529952|FG003|Overall Study|Withdrawal by Subject|1|||
143266055|NCT01104701|516529949|FG000|Overall Study|Adverse Event|0|||
143266056|NCT01104701|516529950|FG001|Overall Study|Adverse Event|0|||
143266057|NCT01104701|516529951|FG002|Overall Study|Adverse Event|0|||
143266058|NCT01104701|516529952|FG003|Overall Study|Adverse Event|1|||
143266059|NCT01104701|516529949|FG000|Overall Study|Physician Decision|0|||
143266060|NCT01104701|516529950|FG001|Overall Study|Physician Decision|2|||
143266061|NCT01104701|516529951|FG002|Overall Study|Physician Decision|0|||
143266062|NCT01104701|516529952|FG003|Overall Study|Physician Decision|0|||
143266063|NCT00891462|516529953|FG000|Overall Study|Withdrawal by Subject|9|||
143266064|NCT00891462|516529954|FG001|Overall Study|Withdrawal by Subject|6|||
143266065|NCT00891462|516529955|FG002|Overall Study|Withdrawal by Subject|7|||
143266066|NCT00891462|516529953|FG000|Overall Study|Adverse Event|7|||
143266067|NCT00891462|516529954|FG001|Overall Study|Adverse Event|8|||
143266068|NCT00891462|516529955|FG002|Overall Study|Adverse Event|7|||
143371641|NCT02525796|516906280|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
143371642|NCT02525796|516906281|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
143371643|NCT02525796|516906279|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
143371644|NCT02525796|516906280|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
143371645|NCT02525796|516906281|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
143371646|NCT02525796|516906279|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
143371647|NCT02525796|516906280|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
143371648|NCT02525796|516906281|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
143371649|NCT02525796|516906279|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
143371650|NCT02525796|516906280|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
143371651|NCT02525796|516906281|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
143371652|NCT02525796|516906279|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
143371653|NCT02525796|516906280|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
143371654|NCT02525796|516906281|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
143371655|NCT00393848|516906282|FG000|Overall Study|Surgical schedule|0|||
143371656|NCT00393848|516906283|FG001|Overall Study|Surgical schedule|0|||
143371657|NCT00393848|516906284|FG002|Overall Study|Surgical schedule|0|||
143371658|NCT00393848|516906285|FG003|Overall Study|Surgical schedule|1|||
143371659|NCT00393848|516906282|FG000|Overall Study|Personal reasons|0|||
143371660|NCT00393848|516906283|FG001|Overall Study|Personal reasons|0|||
143371661|NCT00393848|516906284|FG002|Overall Study|Personal reasons|2|||
143371662|NCT00393848|516906285|FG003|Overall Study|Personal reasons|0|||
143371663|NCT02192606|516906286|FG000|Overall Study|surgery type was changed|1|||
143371664|NCT02192606|516906287|FG001|Overall Study|surgery type was changed|1|||
143371665|NCT02192606|516906286|FG000|Overall Study|Physician Decision|1|||
143371666|NCT02192606|516906287|FG001|Overall Study|Physician Decision|2|||
143371667|NCT02192606|516906286|FG000|Overall Study|3D equipment rep unable to join|0|||
143371668|NCT02192606|516906287|FG001|Overall Study|3D equipment rep unable to join|1|||
143371669|NCT01458210|516906294|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
143371670|NCT01458210|516906294|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
143371671|NCT01458210|516906294|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
143371672|NCT01458210|516906294|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
143371673|NCT00943735|516906295|FG000|Overall Study|Adverse Event|12|||
143371674|NCT00943735|516906295|FG000|Overall Study|Withdrawal by Subject|8|||
143213063|NCT01368081|516324126|FG003|Overall Study|Lost to Follow-up|0|||
143213064|NCT01368081|516324127|FG004|Overall Study|Lost to Follow-up|0|||
143213065|NCT01368081|516324128|FG005|Overall Study|Lost to Follow-up|0|||
143371675|NCT00943735|516906295|FG000|Overall Study|Death|1|||
143371676|NCT00943735|516906295|FG000|Overall Study|Other|8|||
143371677|NCT00943735|516906295|FG000|Overall Study|Other|3|||
143371678|NCT00486330|516906296|FG000|Overall Study|Adverse Event|2|||
143371679|NCT01648140|516906297|FG000|Overall Study|Physician Decision|1|||
143371680|NCT01648140|516906298|FG001|Overall Study|Physician Decision|0|||
143371681|NCT01648140|516906299|FG002|Overall Study|Physician Decision|0|||
143371682|NCT01648140|516906300|FG003|Overall Study|Physician Decision|0|||
143371683|NCT01648140|516906297|FG000|Overall Study|Lack of Efficacy|4|||
143371684|NCT01648140|516906298|FG001|Overall Study|Lack of Efficacy|7|||
143371685|NCT01648140|516906299|FG002|Overall Study|Lack of Efficacy|1|||
143371686|NCT01648140|516906300|FG003|Overall Study|Lack of Efficacy|0|||
143371687|NCT01648140|516906297|FG000|Overall Study|Adverse Event|3|||
143371688|NCT01648140|516906298|FG001|Overall Study|Adverse Event|1|||
143371689|NCT01648140|516906299|FG002|Overall Study|Adverse Event|2|||
143371690|NCT01648140|516906300|FG003|Overall Study|Adverse Event|0|||
143371691|NCT01648140|516906297|FG000|Overall Study|Withdrawal by Subject|2|||
143371692|NCT01648140|516906298|FG001|Overall Study|Withdrawal by Subject|3|||
143371693|NCT01648140|516906299|FG002|Overall Study|Withdrawal by Subject|3|||
143371694|NCT01648140|516906300|FG003|Overall Study|Withdrawal by Subject|2|||
143371695|NCT01648140|516906297|FG000|Overall Study|Lost to Follow-up|2|||
143213066|NCT01368081|516324129|FG006|Overall Study|Lost to Follow-up|0|||
143371696|NCT01648140|516906298|FG001|Overall Study|Lost to Follow-up|1|||
143371697|NCT01648140|516906299|FG002|Overall Study|Lost to Follow-up|2|||
143371698|NCT01648140|516906300|FG003|Overall Study|Lost to Follow-up|0|||
143371699|NCT01119950|516906301|FG000|Overall Study|Adverse Event|25|||
143371700|NCT01119950|516906301|FG000|Overall Study|Withdrawal by Subject|9|||
143371701|NCT01119950|516906301|FG000|Overall Study|Protocol Violation|5|||
143371702|NCT01119950|516906301|FG000|Overall Study|Lost to Follow-up|4|||
143371703|NCT01119950|516906301|FG000|Overall Study|Administrative|2|||
143371704|NCT01119950|516906301|FG000|Overall Study|Abnormal lab value|1|||
143371705|NCT01119950|516906301|FG000|Overall Study|Death|1|||
143213067|NCT01368081|516324130|FG007|Overall Study|Lost to Follow-up|0|||
143213068|NCT01368081|516324131|FG008|Overall Study|Lost to Follow-up|0|||
143213069|NCT01368081|516324132|FG009|Overall Study|Lost to Follow-up|0|||
143213070|NCT01368081|516324133|FG010|Overall Study|Lost to Follow-up|0|||
143213071|NCT01368081|516324134|FG011|Overall Study|Lost to Follow-up|0|||
143213072|NCT01368081|516324135|FG012|Overall Study|Lost to Follow-up|1|||
143213073|NCT01368081|516324123|FG000|Overall Study|Withdrawal by Subject|4|||
143213074|NCT01368081|516324124|FG001|Overall Study|Withdrawal by Subject|4|||
143213075|NCT01368081|516324125|FG002|Overall Study|Withdrawal by Subject|1|||
143213076|NCT01368081|516324126|FG003|Overall Study|Withdrawal by Subject|1|||
143213077|NCT01368081|516324127|FG004|Overall Study|Withdrawal by Subject|0|||
143213078|NCT01368081|516324128|FG005|Overall Study|Withdrawal by Subject|3|||
143213079|NCT01368081|516324129|FG006|Overall Study|Withdrawal by Subject|4|||
143213080|NCT01368081|516324130|FG007|Overall Study|Withdrawal by Subject|2|||
143213081|NCT01368081|516324131|FG008|Overall Study|Withdrawal by Subject|5|||
143213082|NCT01368081|516324132|FG009|Overall Study|Withdrawal by Subject|4|||
143213083|NCT01368081|516324133|FG010|Overall Study|Withdrawal by Subject|3|||
143213084|NCT01368081|516324134|FG011|Overall Study|Withdrawal by Subject|2|||
143213085|NCT01368081|516324135|FG012|Overall Study|Withdrawal by Subject|0|||
143213086|NCT01368081|516324123|FG000|Overall Study|Other reason not defined above|2|||
143213087|NCT01368081|516324124|FG001|Overall Study|Other reason not defined above|0|||
143213088|NCT01368081|516324125|FG002|Overall Study|Other reason not defined above|0|||
143213089|NCT01368081|516324126|FG003|Overall Study|Other reason not defined above|1|||
143213090|NCT01368081|516324127|FG004|Overall Study|Other reason not defined above|0|||
143213091|NCT01368081|516324128|FG005|Overall Study|Other reason not defined above|1|||
143213092|NCT01368081|516324129|FG006|Overall Study|Other reason not defined above|2|||
143213093|NCT01368081|516324130|FG007|Overall Study|Other reason not defined above|0|||
143213094|NCT01368081|516324131|FG008|Overall Study|Other reason not defined above|0|||
143213095|NCT01368081|516324132|FG009|Overall Study|Other reason not defined above|1|||
143213096|NCT01368081|516324133|FG010|Overall Study|Other reason not defined above|0|||
143213097|NCT01368081|516324134|FG011|Overall Study|Other reason not defined above|0|||
143213098|NCT01368081|516324135|FG012|Overall Study|Other reason not defined above|3|||
143213099|NCT00238238|516324141|FG000|Overall Study|Withdrawal by Subject|0|||
143213100|NCT00238238|516324142|FG001|Overall Study|Withdrawal by Subject|3|||
143213101|NCT00238238|516324143|FG002|Overall Study|Withdrawal by Subject|0|||
143213102|NCT01345669|516324146|FG000|Overall Study|Primary tumour recurrence|53|||
143213103|NCT01345669|516324147|FG001|Overall Study|Primary tumour recurrence|32|||
143213104|NCT01345669|516324146|FG000|Overall Study|Second primary tumour|4|||
143213105|NCT01345669|516324147|FG001|Overall Study|Second primary tumour|3|||
143213106|NCT01345669|516324146|FG000|Overall Study|Adverse Event|63|||
143213107|NCT01345669|516324147|FG001|Overall Study|Adverse Event|9|||
143213108|NCT01345669|516324146|FG000|Overall Study|Protocol Violation|3|||
143213109|NCT01345669|516324147|FG001|Overall Study|Protocol Violation|1|||
143213110|NCT01345669|516324146|FG000|Overall Study|Lost to Follow-up|1|||
143213111|NCT01345669|516324147|FG001|Overall Study|Lost to Follow-up|1|||
143213112|NCT01345669|516324146|FG000|Overall Study|Withdrawal by Subject|52|||
143213113|NCT01345669|516324147|FG001|Overall Study|Withdrawal by Subject|13|||
143213114|NCT01345669|516324146|FG000|Overall Study|Other Reasons|111|||
143213115|NCT01345669|516324147|FG001|Overall Study|Other Reasons|60|||
143213116|NCT01793883|516324148|FG000|Overall Study|Withdrawal by Subject|3|||
143213117|NCT01793883|516324149|FG001|Overall Study|Withdrawal by Subject|7|||
143213118|NCT01793883|516324150|FG002|Overall Study|Withdrawal by Subject|3|||
143213119|NCT01793883|516324148|FG000|Overall Study|Subject noncompliance|0|||
143213120|NCT01793883|516324149|FG001|Overall Study|Subject noncompliance|1|||
143213121|NCT01793883|516324150|FG002|Overall Study|Subject noncompliance|1|||
143213122|NCT01793883|516324148|FG000|Overall Study|Lost to Follow-up|5|||
143213123|NCT01793883|516324149|FG001|Overall Study|Lost to Follow-up|1|||
143213124|NCT01793883|516324150|FG002|Overall Study|Lost to Follow-up|3|||
143213125|NCT01793883|516324148|FG000|Overall Study|Randomized in error|1|||
143213126|NCT01793883|516324149|FG001|Overall Study|Randomized in error|0|||
143213127|NCT01793883|516324150|FG002|Overall Study|Randomized in error|0|||
143266069|NCT00891462|516529953|FG000|Overall Study|Lack of Efficacy|10|||
143266070|NCT00891462|516529954|FG001|Overall Study|Lack of Efficacy|5|||
143213128|NCT01793883|516324148|FG000|Overall Study|Unable to complete spriometry|1|||
143213129|NCT01793883|516324149|FG001|Overall Study|Unable to complete spriometry|0|||
143213130|NCT01793883|516324150|FG002|Overall Study|Unable to complete spriometry|0|||
143213131|NCT01793883|516324148|FG000|Overall Study|Unable to complete measurements|1|||
143213132|NCT01793883|516324149|FG001|Overall Study|Unable to complete measurements|0|||
143213133|NCT01793883|516324150|FG002|Overall Study|Unable to complete measurements|0|||
143213134|NCT01793883|516324148|FG000|Overall Study|Met exclusion criteria|1|||
143213135|NCT01793883|516324149|FG001|Overall Study|Met exclusion criteria|0|||
143213136|NCT01793883|516324150|FG002|Overall Study|Met exclusion criteria|0|||
143213137|NCT01793883|516324148|FG000|Overall Study|Dosing error|0|||
143371706|NCT00530842|516906309|FG000|Overall Study|Adverse Event|10|||
143371707|NCT00530842|516906310|FG001|Overall Study|Adverse Event|6|||
143371708|NCT00530842|516906309|FG000|Overall Study|Lack of Efficacy|2|||
143371709|NCT00530842|516906310|FG001|Overall Study|Lack of Efficacy|1|||
143371710|NCT00530842|516906309|FG000|Overall Study|Lost to Follow-up|0|||
143371711|NCT00530842|516906310|FG001|Overall Study|Lost to Follow-up|4|||
143371712|NCT00530842|516906309|FG000|Overall Study|Protocol Violation|3|||
143213138|NCT01793883|516324149|FG001|Overall Study|Dosing error|1|||
143213139|NCT01793883|516324150|FG002|Overall Study|Dosing error|0|||
143371713|NCT00530842|516906310|FG001|Overall Study|Protocol Violation|2|||
143371714|NCT00530842|516906309|FG000|Overall Study|Withdrawal by Subject|4|||
143371715|NCT00530842|516906310|FG001|Overall Study|Withdrawal by Subject|5|||
143371716|NCT00530842|516906309|FG000|Overall Study|Individual different reasons|4|||
143371717|NCT00530842|516906310|FG001|Overall Study|Individual different reasons|3|||
143371718|NCT00530842|516906309|FG000|Period 1|Adverse Event|7|||
143371719|NCT00530842|516906310|FG001|Period 1|Adverse Event|3|||
143371720|NCT00530842|516906309|FG000|Period 1|Lack of Efficacy|1|||
143371721|NCT00530842|516906310|FG001|Period 1|Lack of Efficacy|1|||
143371722|NCT00530842|516906309|FG000|Period 1|Protocol Violation|2|||
143371723|NCT00530842|516906310|FG001|Period 1|Protocol Violation|1|||
143371724|NCT00530842|516906309|FG000|Period 1|Withdrawal by Subject|2|||
143371725|NCT00530842|516906310|FG001|Period 1|Withdrawal by Subject|3|||
143371726|NCT00530842|516906309|FG000|Period 1|Individual different reasons|2|||
143371727|NCT00530842|516906310|FG001|Period 1|Individual different reasons|3|||
143371728|NCT00530842|516906309|FG000|Period 2|Adverse Event|3|||
143371729|NCT00530842|516906310|FG001|Period 2|Adverse Event|3|||
143371730|NCT00530842|516906309|FG000|Period 2|Lack of Efficacy|1|||
143371731|NCT00530842|516906310|FG001|Period 2|Lack of Efficacy|0|||
143371732|NCT00530842|516906309|FG000|Period 2|Lost to Follow-up|0|||
143371733|NCT00530842|516906310|FG001|Period 2|Lost to Follow-up|4|||
143371734|NCT00530842|516906309|FG000|Period 2|Protocol Violation|1|||
143371735|NCT00530842|516906310|FG001|Period 2|Protocol Violation|0|||
143371736|NCT00530842|516906309|FG000|Period 2|Withdrawal by Subject|1|||
143371737|NCT00530842|516906310|FG001|Period 2|Withdrawal by Subject|2|||
143371738|NCT00530842|516906309|FG000|Period 2|Individual different reasons|2|||
143371739|NCT00530842|516906310|FG001|Period 2|Individual different reasons|0|||
143371740|NCT00880048|516906311|FG000|Overall Study|Adverse Event|2|||
143371741|NCT00880048|516906312|FG001|Overall Study|Adverse Event|3|||
143371742|NCT00880048|516906313|FG002|Overall Study|Adverse Event|5|||
143371743|NCT00880048|516906311|FG000|Overall Study|Lack of Efficacy|1|||
143371744|NCT00880048|516906312|FG001|Overall Study|Lack of Efficacy|2|||
143371745|NCT00880048|516906313|FG002|Overall Study|Lack of Efficacy|2|||
143371746|NCT00880048|516906311|FG000|Overall Study|Protocol Violation|4|||
143371747|NCT00880048|516906312|FG001|Overall Study|Protocol Violation|6|||
143371748|NCT00880048|516906313|FG002|Overall Study|Protocol Violation|5|||
143371749|NCT00880048|516906311|FG000|Overall Study|Lost to Follow-up|6|||
143371750|NCT00880048|516906312|FG001|Overall Study|Lost to Follow-up|6|||
143371751|NCT00880048|516906313|FG002|Overall Study|Lost to Follow-up|5|||
143371752|NCT00880048|516906311|FG000|Overall Study|Physician Decision|1|||
143371753|NCT00880048|516906312|FG001|Overall Study|Physician Decision|1|||
143371754|NCT00880048|516906313|FG002|Overall Study|Physician Decision|7|||
143371755|NCT00880048|516906311|FG000|Overall Study|Withdrawal by Subject|5|||
143371756|NCT00880048|516906312|FG001|Overall Study|Withdrawal by Subject|8|||
143371757|NCT00880048|516906313|FG002|Overall Study|Withdrawal by Subject|5|||
143371758|NCT00880048|516906311|FG000|Overall Study|Study closed/terminated|9|||
143371759|NCT00880048|516906312|FG001|Overall Study|Study closed/terminated|7|||
143213140|NCT01793883|516324148|FG000|Overall Study|Respiratory distress during spirometry|0|||
143213141|NCT01793883|516324149|FG001|Overall Study|Respiratory distress during spirometry|0|||
143213142|NCT01793883|516324150|FG002|Overall Study|Respiratory distress during spirometry|1|||
143213143|NCT02478255|516324151|FG000|Overall Study|Physician Decision|6|||
143213144|NCT02478255|516324152|FG001|Overall Study|Physician Decision|0|||
143213145|NCT02478255|516324151|FG000|Overall Study|Withdrawal by Subject|2|||
143371760|NCT00880048|516906313|FG002|Overall Study|Study closed/terminated|6|||
143213146|NCT02478255|516324152|FG001|Overall Study|Withdrawal by Subject|0|||
143213147|NCT01730586|516324154|FG000|Overall Study|Progressive Disease|2|||
143213148|NCT01730586|516324154|FG000|Overall Study|Inadequate Trial|8|||
143371761|NCT01069341|516906314|FG000|Overall Study|Lost to Follow-up|1|||
143371762|NCT02950558|516906318|FG000|Overall Study|Lost to Follow-up|2|||
143213149|NCT01730586|516324154|FG000|Overall Study|Adverse Event|2|||
143213150|NCT01730586|516324154|FG000|Overall Study|Hospice|1|||
143371763|NCT02950558|516906319|FG001|Overall Study|Lost to Follow-up|0|||
143371764|NCT01184508|516906320|FG000|Overall Study|Adverse Event|4|||
143371765|NCT01184508|516906321|FG001|Overall Study|Adverse Event|6|||
143371766|NCT01184508|516906320|FG000|Overall Study|Lack of Efficacy|1|||
143371767|NCT01184508|516906321|FG001|Overall Study|Lack of Efficacy|1|||
143371768|NCT01184508|516906320|FG000|Overall Study|Lost to Follow-up|1|||
143213151|NCT00061633|516324155|FG000|Overall Study|Adverse Event|1|||
143213152|NCT00061633|516324156|FG001|Overall Study|Adverse Event|2|||
143213153|NCT00061633|516324155|FG000|Overall Study|Withdrawal by Subject|2|||
143213154|NCT00061633|516324156|FG001|Overall Study|Withdrawal by Subject|2|||
143213155|NCT00061633|516324155|FG000|Overall Study|Lost to Follow-up|1|||
143213156|NCT00061633|516324156|FG001|Overall Study|Lost to Follow-up|4|||
143213157|NCT00061633|516324155|FG000|Overall Study|Other|1|||
143213158|NCT00061633|516324156|FG001|Overall Study|Other|1|||
143213159|NCT00061633|516324155|FG000|Overall Study|Never received study treatment|0|||
143213160|NCT00061633|516324156|FG001|Overall Study|Never received study treatment|2|||
143213161|NCT01431963|516324157|FG000|Overall Study|Adverse Event|18|||
143213162|NCT01431963|516324157|FG000|Overall Study|Lack of Efficacy|7|||
143213163|NCT01431963|516324157|FG000|Overall Study|Protocol Violation|1|||
143213164|NCT01431963|516324157|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
143213165|NCT01431963|516324157|FG000|Overall Study|Physician Decision|4|||
143213166|NCT01431963|516324157|FG000|Overall Study|Withdrawal by Subject|3|||
143213167|NCT01370265|516325993|FG000|First Intervention|Adverse Event|1|||
143213168|NCT01370265|516325994|FG001|First Intervention|Adverse Event|1|||
143213169|NCT03343626|516325995|FG000|Overall Study|Lost to Follow-up|4|||
143213170|NCT03343626|516325996|FG001|Overall Study|Lost to Follow-up|3|||
143213171|NCT03343626|516325997|FG002|Overall Study|Lost to Follow-up|2|||
143213172|NCT03343626|516325998|FG003|Overall Study|Lost to Follow-up|5|||
143213173|NCT03343626|516325999|FG004|Overall Study|Lost to Follow-up|4|||
143213174|NCT03343626|516326000|FG005|Overall Study|Lost to Follow-up|4|||
143213175|NCT03343626|516326001|FG006|Overall Study|Lost to Follow-up|4|||
143213176|NCT03343626|516326002|FG007|Overall Study|Lost to Follow-up|7|||
143213177|NCT03343626|516325995|FG000|Overall Study|Withdrawal of Consent|2|||
143213178|NCT03343626|516325996|FG001|Overall Study|Withdrawal of Consent|1|||
143213179|NCT03343626|516325997|FG002|Overall Study|Withdrawal of Consent|0|||
143213180|NCT03343626|516325998|FG003|Overall Study|Withdrawal of Consent|3|||
143213181|NCT03343626|516325999|FG004|Overall Study|Withdrawal of Consent|3|||
143213182|NCT03343626|516326000|FG005|Overall Study|Withdrawal of Consent|1|||
143213183|NCT03343626|516326001|FG006|Overall Study|Withdrawal of Consent|1|||
143213184|NCT03343626|516326002|FG007|Overall Study|Withdrawal of Consent|2|||
143213185|NCT03343626|516325995|FG000|Overall Study|Reason not Specified|0|||
143213186|NCT03343626|516325996|FG001|Overall Study|Reason not Specified|1|||
143213187|NCT03343626|516325997|FG002|Overall Study|Reason not Specified|0|||
143213188|NCT03343626|516325998|FG003|Overall Study|Reason not Specified|0|||
143213189|NCT03343626|516325999|FG004|Overall Study|Reason not Specified|0|||
143213190|NCT03343626|516326000|FG005|Overall Study|Reason not Specified|0|||
143213191|NCT03343626|516326001|FG006|Overall Study|Reason not Specified|0|||
143213192|NCT03343626|516326002|FG007|Overall Study|Reason not Specified|1|||
143213193|NCT03343626|516325995|FG000|Overall Study|Data Entry Error|0|||
143213194|NCT03343626|516325996|FG001|Overall Study|Data Entry Error|0|||
143213195|NCT03343626|516325997|FG002|Overall Study|Data Entry Error|0|||
143213196|NCT03343626|516325998|FG003|Overall Study|Data Entry Error|0|||
143213197|NCT03343626|516325999|FG004|Overall Study|Data Entry Error|0|||
143213198|NCT03343626|516326000|FG005|Overall Study|Data Entry Error|0|||
143213199|NCT03343626|516326001|FG006|Overall Study|Data Entry Error|0|||
143213200|NCT03343626|516326002|FG007|Overall Study|Data Entry Error|1|||
143213201|NCT02611817|516326003|FG000|Open-label Induction Phase|Reason not Specified|9|||
143213202|NCT02611817|516326004|FG001|Open-label Induction Phase|Reason not Specified|0|||
143213203|NCT02611817|516326005|FG002|Open-label Induction Phase|Reason not Specified|0|||
143213204|NCT02611817|516326003|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
143213205|NCT02611817|516326004|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
143213206|NCT02611817|516326005|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
143213207|NCT02611817|516326003|FG000|Open-label Induction Phase|Pregnancy|1|||
143213208|NCT02611817|516326004|FG001|Open-label Induction Phase|Pregnancy|0|||
143213209|NCT02611817|516326005|FG002|Open-label Induction Phase|Pregnancy|0|||
143213210|NCT02611817|516326003|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
143213211|NCT02611817|516326004|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
143213212|NCT02611817|516326005|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
143213213|NCT02611817|516326003|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
143266071|NCT00891462|516529955|FG002|Overall Study|Lack of Efficacy|1|||
143266072|NCT00891462|516529953|FG000|Overall Study|COPD exacerbation|7|||
143266073|NCT00891462|516529954|FG001|Overall Study|COPD exacerbation|4|||
143266074|NCT00891462|516529955|FG002|Overall Study|COPD exacerbation|1|||
143213214|NCT02611817|516326004|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
143213215|NCT02611817|516326005|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
143213216|NCT02611817|516326003|FG000|Open-label Induction Phase|Protocol Violation|5|||
143213217|NCT02611817|516326004|FG001|Open-label Induction Phase|Protocol Violation|0|||
143213218|NCT02611817|516326005|FG002|Open-label Induction Phase|Protocol Violation|0|||
143213219|NCT02611817|516326003|FG000|Open-label Induction Phase|Adverse Event|16|||
143213220|NCT02611817|516326004|FG001|Open-label Induction Phase|Adverse Event|0|||
143213221|NCT02611817|516326005|FG002|Open-label Induction Phase|Adverse Event|0|||
143213222|NCT02611817|516326003|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
143213223|NCT02611817|516326004|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
143213224|NCT02611817|516326005|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
143213225|NCT02611817|516326003|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
143213226|NCT02611817|516326004|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
143213227|NCT02611817|516326005|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
143213228|NCT02611817|516326003|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
143213229|NCT02611817|516326004|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
143213230|NCT02611817|516326005|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
143371769|NCT01184508|516906321|FG001|Overall Study|Lost to Follow-up|1|||
143371770|NCT01184508|516906320|FG000|Overall Study|Physician Decision|1|||
143371771|NCT01184508|516906321|FG001|Overall Study|Physician Decision|0|||
143371772|NCT01184508|516906320|FG000|Overall Study|Protocol Violation|3|||
143371773|NCT01184508|516906321|FG001|Overall Study|Protocol Violation|1|||
143371774|NCT01184508|516906320|FG000|Overall Study|Sponsor Decision|5|||
143371775|NCT01184508|516906321|FG001|Overall Study|Sponsor Decision|2|||
143371776|NCT01184508|516906320|FG000|Overall Study|Withdrawal by Subject|1|||
143371777|NCT01184508|516906321|FG001|Overall Study|Withdrawal by Subject|3|||
143371778|NCT01184508|516906320|FG000|Overall Study|Randomized, Not Treated|0|||
143371779|NCT01184508|516906321|FG001|Overall Study|Randomized, Not Treated|1|||
143371780|NCT02914522|516906328|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
143371781|NCT02914522|516906329|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
143371782|NCT02914522|516906330|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
143371783|NCT02914522|516906331|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
143371784|NCT02914522|516906332|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
143371785|NCT02914522|516906333|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
143371786|NCT02914522|516906334|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
143371787|NCT02914522|516906335|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
143371788|NCT02914522|516906336|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
143371789|NCT02914522|516906337|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
143371790|NCT02914522|516906338|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
143371791|NCT02914522|516906328|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
143371792|NCT02914522|516906329|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
143371793|NCT02914522|516906330|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
143371794|NCT02914522|516906331|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
143371795|NCT02914522|516906332|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
143371796|NCT02914522|516906333|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
143371797|NCT02914522|516906334|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
143371798|NCT02914522|516906335|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
143371799|NCT02914522|516906336|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
143371800|NCT02914522|516906337|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
143371801|NCT02914522|516906338|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
143371802|NCT02914522|516906328|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
143371803|NCT02914522|516906329|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
143371804|NCT02914522|516906330|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
143371805|NCT02914522|516906331|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
143371806|NCT02914522|516906332|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
143371807|NCT02914522|516906333|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
143371808|NCT02914522|516906334|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
143371809|NCT02914522|516906335|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
143371810|NCT02914522|516906336|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
143371811|NCT02914522|516906337|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
143371812|NCT02914522|516906338|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
143371813|NCT02914522|516906328|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
143371814|NCT02914522|516906329|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
143371815|NCT02914522|516906330|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
143371816|NCT02914522|516906331|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
143371817|NCT02914522|516906332|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
143371818|NCT02914522|516906333|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
143371819|NCT02914522|516906334|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
143371820|NCT02914522|516906335|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
143371821|NCT02914522|516906336|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
143371822|NCT02914522|516906337|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
143371823|NCT02914522|516906338|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
143371824|NCT02914522|516906328|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
143371825|NCT02914522|516906329|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
143371826|NCT02914522|516906330|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
143371827|NCT02914522|516906331|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
143371828|NCT02914522|516906332|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
143371829|NCT02914522|516906333|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
143371830|NCT02914522|516906334|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
143266075|NCT00891462|516529953|FG000|Overall Study|Other Reason|2|||
143266076|NCT00891462|516529954|FG001|Overall Study|Other Reason|5|||
143266077|NCT00891462|516529955|FG002|Overall Study|Other Reason|3|||
143266078|NCT00891462|516529953|FG000|Overall Study|Protocol Violation|2|||
143266079|NCT00891462|516529954|FG001|Overall Study|Protocol Violation|1|||
143266080|NCT00891462|516529955|FG002|Overall Study|Protocol Violation|3|||
143266081|NCT00891462|516529953|FG000|Overall Study|Inclusion/exclusion criteria|0|||
143266082|NCT00891462|516529954|FG001|Overall Study|Inclusion/exclusion criteria|2|||
143266083|NCT00891462|516529955|FG002|Overall Study|Inclusion/exclusion criteria|2|||
143266084|NCT00891462|516529953|FG000|Overall Study|Lost to Follow-up|0|||
143266085|NCT00891462|516529954|FG001|Overall Study|Lost to Follow-up|2|||
143266086|NCT00891462|516529955|FG002|Overall Study|Lost to Follow-up|0|||
143266087|NCT01846104|516529956|FG000|Overall Study|Withdrawal by Subject|1|||
143266088|NCT00851630|516529957|FG000|Overall Study|Death|2|||
143266089|NCT00851630|516529958|FG001|Overall Study|Death|1|||
143266090|NCT00851630|516529957|FG000|Overall Study|Clinical failure|0|||
143266091|NCT00851630|516529958|FG001|Overall Study|Clinical failure|1|||
143266092|NCT00398411|516529960|FG000|Overall Study|Death|0|||
143266093|NCT00398411|516529961|FG001|Overall Study|Death|1|||
143266094|NCT02095223|516529964|FG000|Overall Study|Withdrawal by Subject|1|||
143266095|NCT02095223|516529965|FG001|Overall Study|Withdrawal by Subject|0|||
143266096|NCT01397162|516529966|FG000|Overall Study|Adverse Event|4|||
143266097|NCT01397162|516529967|FG001|Overall Study|Adverse Event|0|||
143266098|NCT01397162|516529968|FG002|Overall Study|Adverse Event|0|||
143266099|NCT01397162|516529969|FG003|Overall Study|Adverse Event|0|||
143266100|NCT01397162|516529970|FG004|Overall Study|Adverse Event|0|||
143266101|NCT01397162|516529966|FG000|Overall Study|Not yet defined|3|||
143371831|NCT02914522|516906335|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
143371832|NCT02914522|516906336|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
143371833|NCT02914522|516906337|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
143266102|NCT01397162|516529967|FG001|Overall Study|Not yet defined|4|||
143266103|NCT01397162|516529968|FG002|Overall Study|Not yet defined|3|||
143266104|NCT01397162|516529969|FG003|Overall Study|Not yet defined|5|||
143266105|NCT01397162|516529970|FG004|Overall Study|Not yet defined|3|||
143266106|NCT00401531|516529973|FG000|Overall Study|Adverse Event|2|||
143266107|NCT00401531|516529974|FG001|Overall Study|Adverse Event|0|||
143266108|NCT00401531|516529973|FG000|Overall Study|Protocol Violation|3|||
143266109|NCT00401531|516529974|FG001|Overall Study|Protocol Violation|7|||
143266110|NCT00401531|516529973|FG000|Overall Study|Lost to Follow-up|1|||
143266111|NCT00401531|516529974|FG001|Overall Study|Lost to Follow-up|1|||
143266112|NCT00401531|516529973|FG000|Overall Study|Withdrawal by Subject|3|||
143371834|NCT02914522|516906338|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
143371835|NCT02914522|516906328|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
143371836|NCT02914522|516906329|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
143371837|NCT02914522|516906330|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
143371838|NCT02914522|516906331|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
143371839|NCT02914522|516906332|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
143371840|NCT02914522|516906333|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
143371841|NCT02914522|516906334|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
143371842|NCT02914522|516906335|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
143371843|NCT02914522|516906336|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
143371844|NCT02914522|516906337|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
143371845|NCT02914522|516906338|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
143371846|NCT02914522|516906328|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
143371847|NCT02914522|516906329|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
143266113|NCT00401531|516529974|FG001|Overall Study|Withdrawal by Subject|2|||
143266114|NCT03906461|516529975|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
143266115|NCT03906461|516529975|FG000|Completed 12-month Follow-up|Missed Visit|6|||
143266116|NCT01795638|516529978|FG000|Overall Study|Death|0|||
143266117|NCT01795638|516529979|FG001|Overall Study|Death|3|||
143266118|NCT01795638|516529978|FG000|Overall Study|transferred to quaternary hospital|2|||
143266119|NCT01795638|516529979|FG001|Overall Study|transferred to quaternary hospital|3|||
143266120|NCT01795638|516529978|FG000|Overall Study|Protocol Violation|3|||
143266121|NCT01795638|516529979|FG001|Overall Study|Protocol Violation|0|||
143266122|NCT01795638|516529978|FG000|Overall Study|discharged from hospital|7|||
143266123|NCT01795638|516529979|FG001|Overall Study|discharged from hospital|5|||
143266124|NCT01795638|516529978|FG000|Overall Study|Withdrawal by Subject|1|||
143266125|NCT01795638|516529979|FG001|Overall Study|Withdrawal by Subject|0|||
143266126|NCT02437513|516529986|FG000|Overall Study|Withdrawal by Subject|2|||
143266127|NCT03956056|516529989|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
143266128|NCT03956056|516529989|FG000|Overall Study|Lack of Efficacy|1|||
143266129|NCT03347188|516529990|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
143266130|NCT03347188|516529991|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
143266131|NCT03347188|516529990|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
143213231|NCT02611817|516326003|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
143213232|NCT02611817|516326004|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
143213233|NCT02611817|516326005|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
143213234|NCT02611817|516326003|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
143213235|NCT02611817|516326004|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
143213236|NCT02611817|516326005|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
143213237|NCT02611817|516326003|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
143213238|NCT02611817|516326004|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
143213239|NCT02611817|516326005|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
143213240|NCT02611817|516326003|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
143213241|NCT02611817|516326004|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
143213242|NCT02611817|516326005|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
143213243|NCT03077919|516326006|FG000|Overall Study|Lost to Follow-up|4|||
143213244|NCT03077919|516326007|FG001|Overall Study|Lost to Follow-up|1|||
143213245|NCT03738618|516326008|FG000|Overall Study|Protocol deviation|23|||
143213246|NCT03738618|516326009|FG001|Overall Study|Protocol deviation|0|||
143213247|NCT03738618|516326008|FG000|Overall Study|Adverse Event|4|||
143371848|NCT02914522|516906330|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
143213248|NCT03738618|516326009|FG001|Overall Study|Adverse Event|0|||
143213249|NCT03738618|516326008|FG000|Overall Study|Lost to Follow-up|2|||
143213250|NCT03738618|516326009|FG001|Overall Study|Lost to Follow-up|0|||
143213251|NCT03738618|516326008|FG000|Overall Study|Randomization failure|1|||
143213252|NCT03738618|516326009|FG001|Overall Study|Randomization failure|0|||
143213253|NCT03738618|516326008|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
143213254|NCT03738618|516326009|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
143213255|NCT03738618|516326008|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
143213256|NCT03738618|516326009|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
143213257|NCT00826618|516326010|FG000|Overall Study|Withdrawal by Subject|1|||
143213258|NCT03499314|516326013|FG000|Overall Study|Time Commitment|1|||
143213259|NCT03499314|516326014|FG001|Overall Study|Time Commitment|2|||
143213260|NCT03499314|516326013|FG000|Overall Study|Medical issue unrelated to research study|1|||
143213261|NCT03499314|516326014|FG001|Overall Study|Medical issue unrelated to research study|1|||
143213262|NCT02291419|516326015|FG000|Overall Study|Early study termination|1|||
143213263|NCT02291419|516326016|FG001|Overall Study|Early study termination|5|||
143213264|NCT01732770|516326021|FG000|Overall Study|Lost to Follow-up|2|||
143213265|NCT01732770|516326022|FG001|Overall Study|Lost to Follow-up|3|||
143213266|NCT01732770|516326021|FG000|Overall Study|Withdrawal by Subject|5|||
143213267|NCT01732770|516326022|FG001|Overall Study|Withdrawal by Subject|3|||
143213268|NCT01732770|516326021|FG000|Overall Study|Decision by Sponsor|2|||
143213269|NCT01732770|516326022|FG001|Overall Study|Decision by Sponsor|2|||
143213270|NCT01732770|516326021|FG000|Overall Study|Death|1|||
143213271|NCT01732770|516326022|FG001|Overall Study|Death|0|||
143213272|NCT01959841|516326023|FG000|Overall Study|Adverse Event|1|||
143213273|NCT01959841|516326024|FG001|Overall Study|Adverse Event|3|||
143213274|NCT01959841|516326025|FG002|Overall Study|Adverse Event|2|||
143213275|NCT01959841|516326023|FG000|Overall Study|Lack of Efficacy|5|||
143213276|NCT01959841|516326024|FG001|Overall Study|Lack of Efficacy|0|||
143213277|NCT01959841|516326025|FG002|Overall Study|Lack of Efficacy|0|||
143213278|NCT01959841|516326023|FG000|Overall Study|Lost to Follow-up|1|||
143213279|NCT01959841|516326024|FG001|Overall Study|Lost to Follow-up|1|||
143213280|NCT01959841|516326025|FG002|Overall Study|Lost to Follow-up|0|||
143213281|NCT01959841|516326023|FG000|Overall Study|Physician Decision|0|||
143213282|NCT01959841|516326024|FG001|Overall Study|Physician Decision|2|||
143213283|NCT01959841|516326025|FG002|Overall Study|Physician Decision|3|||
143213284|NCT01959841|516326023|FG000|Overall Study|Protocol Violation|16|||
143213285|NCT01959841|516326024|FG001|Overall Study|Protocol Violation|23|||
143213286|NCT01959841|516326025|FG002|Overall Study|Protocol Violation|16|||
143213287|NCT01959841|516326023|FG000|Overall Study|Withdrawal by Subject|7|||
143213288|NCT01959841|516326024|FG001|Overall Study|Withdrawal by Subject|7|||
143213289|NCT01959841|516326025|FG002|Overall Study|Withdrawal by Subject|5|||
143213290|NCT01959841|516326023|FG000|Overall Study|Clinical laboratory value|2|||
143213291|NCT01959841|516326024|FG001|Overall Study|Clinical laboratory value|6|||
143213292|NCT01959841|516326025|FG002|Overall Study|Clinical laboratory value|6|||
143213293|NCT01959841|516326023|FG000|Overall Study|Platelet count below on day1 or 4|11|||
143213294|NCT01959841|516326024|FG001|Overall Study|Platelet count below on day1 or 4|15|||
143213295|NCT01959841|516326025|FG002|Overall Study|Platelet count below on day1 or 4|11|||
143213296|NCT00780416|516326026|FG000|Overall Study|Physician Decision|3|||
143213297|NCT00780416|516326027|FG001|Overall Study|Physician Decision|3|||
143213298|NCT00780416|516326026|FG000|Overall Study|Protocol Violation|1|||
143213299|NCT00780416|516326027|FG001|Overall Study|Protocol Violation|0|||
143213300|NCT00780416|516326026|FG000|Overall Study|Withdrawal by Subject|8|||
143213301|NCT00780416|516326027|FG001|Overall Study|Withdrawal by Subject|6|||
143213302|NCT00666224|516326030|FG000|Double-Blind|Adverse Event|15|||
143213303|NCT00666224|516326031|FG001|Double-Blind|Adverse Event|5|||
143213304|NCT00666224|516326030|FG000|Double-Blind|Lost to Follow-up|2|||
143213305|NCT00666224|516326031|FG001|Double-Blind|Lost to Follow-up|2|||
143213306|NCT00666224|516326030|FG000|Double-Blind|Withdrawal by Subject|18|||
143213307|NCT00666224|516326031|FG001|Double-Blind|Withdrawal by Subject|14|||
143213308|NCT00666224|516326030|FG000|Double-Blind|Physician Decision|0|||
143213309|NCT00666224|516326031|FG001|Double-Blind|Physician Decision|3|||
143213310|NCT00666224|516326030|FG000|Double-Blind|Sponsor decision|1|||
143213311|NCT00666224|516326031|FG001|Double-Blind|Sponsor decision|0|||
143213312|NCT00666224|516326030|FG000|Double-Blind|Pregnancy|3|||
143213313|NCT00666224|516326031|FG001|Double-Blind|Pregnancy|2|||
143213314|NCT00666224|516326030|FG000|Double-Blind|Noncompliance|1|||
143266132|NCT03347188|516529991|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
143266133|NCT03347188|516529990|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
143266134|NCT03347188|516529991|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
143266135|NCT03347188|516529990|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
143213315|NCT00666224|516326031|FG001|Double-Blind|Noncompliance|0|||
143213316|NCT00666224|516326030|FG000|Double-Blind|Death|1|||
143213317|NCT00666224|516326031|FG001|Double-Blind|Death|0|||
143213318|NCT00666224|516326030|FG000|Double-Blind|Undefined/Unknown|4|||
143213319|NCT00666224|516326031|FG001|Double-Blind|Undefined/Unknown|1|||
143213320|NCT00666224|516326030|FG000|Open-Label|Adverse Event|8|||
143213321|NCT00666224|516326031|FG001|Open-Label|Adverse Event|43|||
143213322|NCT00666224|516326030|FG000|Open-Label|Lost to Follow-up|4|||
143213323|NCT00666224|516326031|FG001|Open-Label|Lost to Follow-up|5|||
143213324|NCT00666224|516326030|FG000|Open-Label|Withdrawal by Subject|12|||
143213325|NCT00666224|516326031|FG001|Open-Label|Withdrawal by Subject|25|||
143213326|NCT00666224|516326030|FG000|Open-Label|Physician Decision|7|||
143213327|NCT00666224|516326031|FG001|Open-Label|Physician Decision|5|||
143213328|NCT00666224|516326030|FG000|Open-Label|Pregnancy|1|||
143213329|NCT00666224|516326031|FG001|Open-Label|Pregnancy|5|||
143213330|NCT00666224|516326030|FG000|Open-Label|Noncompliance|2|||
143213331|NCT00666224|516326031|FG001|Open-Label|Noncompliance|1|||
143213332|NCT00666224|516326030|FG000|Open-Label|Undefined/Unknown|1|||
143213333|NCT00666224|516326031|FG001|Open-Label|Undefined/Unknown|1|||
143213334|NCT03828617|516326035|FG000|Overall Study|Lost to Follow-up|22|||
143213335|NCT03828617|516326036|FG001|Overall Study|Lost to Follow-up|12|||
143213336|NCT03828617|516326037|FG002|Overall Study|Lost to Follow-up|23|||
143213337|NCT03828617|516326038|FG003|Overall Study|Lost to Follow-up|7|||
143213338|NCT03828617|516326035|FG000|Overall Study|No longer met eligibility criteria|0|||
143213339|NCT03828617|516326036|FG001|Overall Study|No longer met eligibility criteria|1|||
143266136|NCT03347188|516529991|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
143266137|NCT03347188|516529990|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
143266138|NCT03347188|516529991|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
143266139|NCT03347188|516529990|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
143266140|NCT03347188|516529991|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
143266141|NCT03347188|516529990|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
143266142|NCT03347188|516529991|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
143266143|NCT03347188|516529990|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
143266144|NCT03347188|516529991|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
143266145|NCT03403374|516529992|FG000|Overall Study|Lost to Follow-up|1|||
143266146|NCT00107783|516529993|FG000|Overall Study|Adverse Event|0|||
143266147|NCT00107783|516529994|FG001|Overall Study|Adverse Event|2|||
143266148|NCT00107783|516529993|FG000|Overall Study|Death|0|||
143266149|NCT00107783|516529994|FG001|Overall Study|Death|1|||
143266150|NCT00107783|516529993|FG000|Overall Study|Withdrawal by Subject|2|||
143266151|NCT00107783|516529994|FG001|Overall Study|Withdrawal by Subject|0|||
143266152|NCT00107783|516529993|FG000|Overall Study|Second hip replacement|1|||
143266153|NCT00107783|516529994|FG001|Overall Study|Second hip replacement|1|||
143266154|NCT04879225|516529995|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
143213340|NCT03828617|516326037|FG002|Overall Study|No longer met eligibility criteria|1|||
143213341|NCT03828617|516326038|FG003|Overall Study|No longer met eligibility criteria|3|||
143213342|NCT03828617|516326035|FG000|Overall Study|Protocol Violation|0|||
143213343|NCT03828617|516326036|FG001|Overall Study|Protocol Violation|2|||
143213344|NCT03828617|516326037|FG002|Overall Study|Protocol Violation|0|||
143213345|NCT03828617|516326038|FG003|Overall Study|Protocol Violation|0|||
143213346|NCT03828617|516326035|FG000|Overall Study|Withdrawal by Subject|2|||
143213347|NCT03828617|516326036|FG001|Overall Study|Withdrawal by Subject|0|||
143213348|NCT03828617|516326037|FG002|Overall Study|Withdrawal by Subject|2|||
143213349|NCT03828617|516326038|FG003|Overall Study|Withdrawal by Subject|0|||
143213350|NCT01271725|516326039|FG000|Part A|Progressive disease according to RECIST|8|||
143213351|NCT01271725|516326040|FG001|Part A|Progressive disease according to RECIST|0|||
143213352|NCT01271725|516326039|FG000|Part A|Clinical signs/symptoms of progression|2|||
143213353|NCT01271725|516326040|FG001|Part A|Clinical signs/symptoms of progression|0|||
143213354|NCT01271725|516326039|FG000|Part A|Other Adverse Event|8|||
143213355|NCT01271725|516326040|FG001|Part A|Other Adverse Event|0|||
143213356|NCT01271725|516326039|FG000|Part A|Lost to Follow-up|1|||
143213357|NCT01271725|516326040|FG001|Part A|Lost to Follow-up|0|||
143213358|NCT01271725|516326039|FG000|Part A|Withdrawal by Subject|12|||
143266155|NCT04879225|516529995|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
143266156|NCT00736957|516529998|FG000|Overall Study|Adverse Event|43|||
143266157|NCT00736957|516529998|FG000|Overall Study|Withdrawal by Subject|49|||
143266158|NCT00736957|516529998|FG000|Overall Study|violation of eligibility criteria|2|||
143266159|NCT00736957|516529998|FG000|Overall Study|did not attend hospital appointments|1|||
143266160|NCT00736957|516529998|FG000|Overall Study|not eligible for Treatment Period I|22|||
143266161|NCT00736957|516529998|FG000|Overall Study|Physician Decision|5|||
143266162|NCT00422097|516529999|FG000|Dose Level 2|Still on treatment|0|||
143266163|NCT00422097|516530000|FG001|Dose Level 2|Still on treatment|1|||
143266164|NCT00422097|516530001|FG002|Dose Level 2|Still on treatment|0|||
143266165|NCT00422097|516530002|FG003|Dose Level 2|Still on treatment|0|||
143266166|NCT00422097|516530003|FG004|Dose Level 2|Still on treatment|0|||
143266167|NCT00422097|516530004|FG005|Dose Level 2|Still on treatment|0|||
143266168|NCT00422097|516530005|FG006|Dose Level 2|Still on treatment|0|||
143266169|NCT00422097|516530006|FG007|Dose Level 2|Still on treatment|0|||
143266170|NCT02360995|516530007|FG000|Overall Study|Lost to Follow-up|2|||
143266171|NCT02360995|516530008|FG001|Overall Study|Lost to Follow-up|0|||
143266172|NCT02360995|516530009|FG002|Overall Study|Lost to Follow-up|2|||
143266173|NCT02360995|516530007|FG000|Overall Study|Withdrawal by Subject|0|||
143266174|NCT02360995|516530008|FG001|Overall Study|Withdrawal by Subject|1|||
143266175|NCT02360995|516530009|FG002|Overall Study|Withdrawal by Subject|0|||
143266176|NCT01051466|516530010|FG000|Overall Study|Adverse Event|1|||
143266177|NCT01051466|516530011|FG001|Overall Study|Adverse Event|0|||
143266178|NCT01051466|516530010|FG000|Overall Study|Lost to Follow-up|1|||
143266179|NCT01051466|516530011|FG001|Overall Study|Lost to Follow-up|1|||
143266180|NCT01051466|516530010|FG000|Overall Study|Withdrawal by Subject|5|||
143266181|NCT01051466|516530011|FG001|Overall Study|Withdrawal by Subject|1|||
143266182|NCT01051466|516530010|FG000|Overall Study|Entry Criteria Not Met|0|||
143266183|NCT01051466|516530011|FG001|Overall Study|Entry Criteria Not Met|3|||
143266184|NCT01051466|516530010|FG000|Overall Study|Physician Decision|1|||
143266185|NCT01051466|516530011|FG001|Overall Study|Physician Decision|0|||
143266186|NCT00085709|516530012|FG000|Overall Study|Adverse Event|8|||
143266187|NCT00085709|516530013|FG001|Overall Study|Adverse Event|0|||
143266188|NCT00085709|516530012|FG000|Overall Study|Death|8|||
143266189|NCT00085709|516530013|FG001|Overall Study|Death|2|||
143266190|NCT00085709|516530012|FG000|Overall Study|Refusal unrelated to adverse events|1|||
143266191|NCT00085709|516530013|FG001|Overall Study|Refusal unrelated to adverse events|2|||
143266192|NCT00085709|516530012|FG000|Overall Study|Progression|3|||
143266193|NCT00085709|516530013|FG001|Overall Study|Progression|4|||
143266194|NCT00085709|516530012|FG000|Overall Study|Not protocol specified|12|||
143266195|NCT00085709|516530013|FG001|Overall Study|Not protocol specified|22|||
143266196|NCT00085709|516530012|FG000|Overall Study|Not eligible|19|||
143266197|NCT00085709|516530013|FG001|Overall Study|Not eligible|19|||
143266198|NCT00085709|516530012|FG000|Overall Study|Withdrawal by Subject|2|||
143266199|NCT00085709|516530013|FG001|Overall Study|Withdrawal by Subject|1|||
143266200|NCT01409434|516530014|FG000|Overall Study|Protocol Violation|4|||
143266201|NCT04131556|516530015|FG000|Overall Study|Adverse Event|1|||
143266202|NCT04131556|516530015|FG000|Overall Study|Withdrawal by Subject|1|||
143266203|NCT02007512|516530016|FG000|Double Blind Treatment Period|Adverse Event|4|||
143266204|NCT02007512|516530017|FG001|Double Blind Treatment Period|Adverse Event|6|||
143266205|NCT02007512|516530018|FG002|Double Blind Treatment Period|Adverse Event|2|||
143266206|NCT02007512|516530019|FG003|Double Blind Treatment Period|Adverse Event|2|||
143266207|NCT02007512|516530016|FG000|Double Blind Treatment Period|Death|1|||
143266208|NCT02007512|516530017|FG001|Double Blind Treatment Period|Death|0|||
143266209|NCT02007512|516530018|FG002|Double Blind Treatment Period|Death|0|||
143266210|NCT02007512|516530019|FG003|Double Blind Treatment Period|Death|0|||
143266211|NCT02007512|516530016|FG000|Double Blind Treatment Period|Disease progression|51|||
143266212|NCT02007512|516530017|FG001|Double Blind Treatment Period|Disease progression|50|||
143266213|NCT02007512|516530018|FG002|Double Blind Treatment Period|Disease progression|57|||
143266214|NCT02007512|516530019|FG003|Double Blind Treatment Period|Disease progression|52|||
143266215|NCT02007512|516530016|FG000|Double Blind Treatment Period|Withdrawal by Subject|3|||
143266216|NCT02007512|516530017|FG001|Double Blind Treatment Period|Withdrawal by Subject|3|||
143213359|NCT01271725|516326040|FG001|Part A|Withdrawal by Subject|0|||
143266217|NCT02007512|516530018|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
143266218|NCT02007512|516530019|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
143266219|NCT02007512|516530016|FG000|Double Blind Treatment Period|Protocol Violation|1|||
143266220|NCT02007512|516530017|FG001|Double Blind Treatment Period|Protocol Violation|0|||
143266221|NCT02007512|516530018|FG002|Double Blind Treatment Period|Protocol Violation|0|||
143213360|NCT01271725|516326039|FG000|Part A|Other than specified|3|||
143213361|NCT01271725|516326040|FG001|Part A|Other than specified|0|||
143213362|NCT01271725|516326039|FG000|Part A|Protocol Violation|1|||
143213363|NCT01271725|516326040|FG001|Part A|Protocol Violation|0|||
143213364|NCT01271725|516326039|FG000|Part B|Other than specified|0|||
143213365|NCT01271725|516326040|FG001|Part B|Other than specified|2|||
143213366|NCT01271725|516326039|FG000|Part B|Clinical signs/symptoms of progression|0|||
143213367|NCT01271725|516326040|FG001|Part B|Clinical signs/symptoms of progression|2|||
143213368|NCT01271725|516326039|FG000|Part B|Other Adverse Event|0|||
143213369|NCT01271725|516326040|FG001|Part B|Other Adverse Event|1|||
143213370|NCT01271725|516326039|FG000|Part B|Protocol Violation|0|||
143213371|NCT01271725|516326040|FG001|Part B|Protocol Violation|1|||
143213372|NCT01271725|516326039|FG000|Part B|Withdrawal by Subject|0|||
143213373|NCT01271725|516326040|FG001|Part B|Withdrawal by Subject|6|||
143213374|NCT00655629|516326049|FG000|Overall Study|Adverse Event|4|||
143213375|NCT00655629|516326050|FG001|Overall Study|Adverse Event|1|||
143213376|NCT00655629|516326049|FG000|Overall Study|Lack of Efficacy|2|||
143213377|NCT00655629|516326050|FG001|Overall Study|Lack of Efficacy|12|||
143213378|NCT00655629|516326049|FG000|Overall Study|Lost to Follow-up|4|||
143213379|NCT00655629|516326050|FG001|Overall Study|Lost to Follow-up|3|||
143213380|NCT00655629|516326049|FG000|Overall Study|Protocol Violation|5|||
143213381|NCT00655629|516326050|FG001|Overall Study|Protocol Violation|3|||
143213382|NCT00655629|516326049|FG000|Overall Study|consent withdrawn|6|||
143213383|NCT00655629|516326050|FG001|Overall Study|consent withdrawn|4|||
143213384|NCT01363661|516326051|FG000|Overall Study|Adverse Event|9|||
143213385|NCT01363661|516326052|FG001|Overall Study|Adverse Event|2|||
143213386|NCT01363661|516326051|FG000|Overall Study|Withdrawal by Subject|1|||
143213387|NCT01363661|516326052|FG001|Overall Study|Withdrawal by Subject|1|||
143213388|NCT01363661|516326051|FG000|Overall Study|Protocol Violation|1|||
143213389|NCT01363661|516326052|FG001|Overall Study|Protocol Violation|0|||
143213390|NCT01363661|516326051|FG000|Overall Study|Lost to Follow-up|3|||
143213391|NCT01363661|516326052|FG001|Overall Study|Lost to Follow-up|1|||
143213392|NCT00705367|516326053|FG000|Long-term Extension Period|Adverse Event|2|||
143213393|NCT00705367|516326054|FG001|Long-term Extension Period|Adverse Event|0|||
143213394|NCT00705367|516326053|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
143213395|NCT00705367|516326054|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
143213396|NCT00705367|516326053|FG000|Long-term Extension Period|Lack of Efficacy|1|||
143213397|NCT00705367|516326054|FG001|Long-term Extension Period|Lack of Efficacy|0|||
143213398|NCT00705367|516326053|FG000|Long-term Extension Period|No longer met study criteria|1|||
143213399|NCT00705367|516326054|FG001|Long-term Extension Period|No longer met study criteria|0|||
143213400|NCT00705367|516326053|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
143213401|NCT00705367|516326054|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
143213402|NCT01835223|516326055|FG000|Overall Study|Adverse Event|1|||
143213403|NCT01835223|516326056|FG001|Overall Study|Adverse Event|0|||
143213404|NCT01835223|516326055|FG000|Overall Study|Withdrawal by Subject|2|||
143213405|NCT01835223|516326056|FG001|Overall Study|Withdrawal by Subject|0|||
143213406|NCT01835223|516326055|FG000|Overall Study|Disease progression|2|||
143213407|NCT01835223|516326056|FG001|Overall Study|Disease progression|1|||
143213408|NCT01835223|516326055|FG000|Overall Study|Became Inelligible|4|||
143213409|NCT01835223|516326056|FG001|Overall Study|Became Inelligible|0|||
143213410|NCT03149055|516326064|FG000|Overall Study|Not treated|4|||
143213411|NCT02629822|516326065|FG000|Base Study|Lost to Follow-up|2|||
143213412|NCT02629822|516326065|FG000|Base Study|Non-Compliance With Study Drug|1|||
143213413|NCT02629822|516326065|FG000|Extension Study|Adverse Event|1|||
143213414|NCT02629822|516326065|FG000|Extension Study|Lost to Follow-up|1|||
143213415|NCT03679624|516326066|FG000|Overall Study|Adverse Event|1|||
143213416|NCT03679624|516326067|FG001|Overall Study|Adverse Event|0|||
143213417|NCT01610336|516326068|FG000|Overall Study|Progressive Disease|4|||
143213418|NCT01610336|516326069|FG001|Overall Study|Progressive Disease|6|||
143213419|NCT01610336|516326070|FG002|Overall Study|Progressive Disease|6|||
143213420|NCT01610336|516326071|FG003|Overall Study|Progressive Disease|5|||
143213421|NCT01610336|516326072|FG004|Overall Study|Progressive Disease|3|||
143213422|NCT01610336|516326073|FG005|Overall Study|Progressive Disease|10|||
143213423|NCT01610336|516326074|FG006|Overall Study|Progressive Disease|1|||
143213424|NCT01610336|516326075|FG007|Overall Study|Progressive Disease|6|||
143213425|NCT01610336|516326076|FG008|Overall Study|Progressive Disease|6|||
143213426|NCT01610336|516326077|FG009|Overall Study|Progressive Disease|40|||
143213427|NCT01610336|516326078|FG010|Overall Study|Progressive Disease|36|||
143213428|NCT01610336|516326068|FG000|Overall Study|Adverse Event|0|||
143213429|NCT01610336|516326069|FG001|Overall Study|Adverse Event|0|||
143213430|NCT01610336|516326070|FG002|Overall Study|Adverse Event|0|||
143213431|NCT01610336|516326071|FG003|Overall Study|Adverse Event|1|||
143213432|NCT01610336|516326072|FG004|Overall Study|Adverse Event|1|||
143213433|NCT01610336|516326073|FG005|Overall Study|Adverse Event|1|||
143213434|NCT01610336|516326074|FG006|Overall Study|Adverse Event|0|||
143213435|NCT01610336|516326075|FG007|Overall Study|Adverse Event|0|||
143213436|NCT01610336|516326076|FG008|Overall Study|Adverse Event|2|||
143213437|NCT01610336|516326077|FG009|Overall Study|Adverse Event|8|||
143213438|NCT01610336|516326078|FG010|Overall Study|Adverse Event|6|||
143213439|NCT01610336|516326068|FG000|Overall Study|Subject/Guardian decision|1|||
143213440|NCT01610336|516326069|FG001|Overall Study|Subject/Guardian decision|1|||
143213441|NCT01610336|516326070|FG002|Overall Study|Subject/Guardian decision|0|||
143213442|NCT01610336|516326071|FG003|Overall Study|Subject/Guardian decision|1|||
143213443|NCT01610336|516326072|FG004|Overall Study|Subject/Guardian decision|0|||
143213444|NCT01610336|516326073|FG005|Overall Study|Subject/Guardian decision|0|||
143213445|NCT01610336|516326074|FG006|Overall Study|Subject/Guardian decision|0|||
143213446|NCT01610336|516326075|FG007|Overall Study|Subject/Guardian decision|1|||
143213447|NCT01610336|516326076|FG008|Overall Study|Subject/Guardian decision|0|||
143213448|NCT01610336|516326077|FG009|Overall Study|Subject/Guardian decision|2|||
143213449|NCT01610336|516326078|FG010|Overall Study|Subject/Guardian decision|2|||
143213450|NCT01610336|516326068|FG000|Overall Study|Death|0|||
143213451|NCT01610336|516326069|FG001|Overall Study|Death|0|||
143213452|NCT01610336|516326070|FG002|Overall Study|Death|0|||
143213453|NCT01610336|516326071|FG003|Overall Study|Death|0|||
143213454|NCT01610336|516326072|FG004|Overall Study|Death|0|||
143213455|NCT01610336|516326073|FG005|Overall Study|Death|1|||
143213456|NCT01610336|516326074|FG006|Overall Study|Death|3|||
143213457|NCT01610336|516326075|FG007|Overall Study|Death|0|||
143213458|NCT01610336|516326076|FG008|Overall Study|Death|0|||
143213459|NCT01610336|516326077|FG009|Overall Study|Death|1|||
143213460|NCT01610336|516326078|FG010|Overall Study|Death|2|||
143213461|NCT01610336|516326068|FG000|Overall Study|Non-Compliance with study treatment|0|||
143213462|NCT01610336|516326069|FG001|Overall Study|Non-Compliance with study treatment|0|||
143213463|NCT01610336|516326070|FG002|Overall Study|Non-Compliance with study treatment|0|||
143213464|NCT01610336|516326071|FG003|Overall Study|Non-Compliance with study treatment|0|||
143213465|NCT01610336|516326072|FG004|Overall Study|Non-Compliance with study treatment|0|||
143213466|NCT01610336|516326073|FG005|Overall Study|Non-Compliance with study treatment|0|||
143213467|NCT01610336|516326074|FG006|Overall Study|Non-Compliance with study treatment|0|||
143213468|NCT01610336|516326075|FG007|Overall Study|Non-Compliance with study treatment|0|||
143213469|NCT01610336|516326076|FG008|Overall Study|Non-Compliance with study treatment|0|||
143213470|NCT01610336|516326077|FG009|Overall Study|Non-Compliance with study treatment|1|||
143213471|NCT01610336|516326078|FG010|Overall Study|Non-Compliance with study treatment|0|||
143213472|NCT01610336|516326068|FG000|Overall Study|Physician Decision|0|||
143213473|NCT01610336|516326069|FG001|Overall Study|Physician Decision|0|||
143213474|NCT01610336|516326070|FG002|Overall Study|Physician Decision|0|||
143213475|NCT01610336|516326071|FG003|Overall Study|Physician Decision|0|||
143213476|NCT01610336|516326072|FG004|Overall Study|Physician Decision|0|||
143213477|NCT01610336|516326073|FG005|Overall Study|Physician Decision|0|||
143213478|NCT01610336|516326074|FG006|Overall Study|Physician Decision|1|||
143213479|NCT01610336|516326075|FG007|Overall Study|Physician Decision|0|||
143213480|NCT01610336|516326076|FG008|Overall Study|Physician Decision|0|||
143213481|NCT01610336|516326077|FG009|Overall Study|Physician Decision|0|||
143213482|NCT01610336|516326078|FG010|Overall Study|Physician Decision|0|||
143213483|NCT01610336|516326068|FG000|Overall Study|Protocol Deviation|0|||
143213484|NCT01610336|516326069|FG001|Overall Study|Protocol Deviation|0|||
143213485|NCT01610336|516326070|FG002|Overall Study|Protocol Deviation|0|||
143213486|NCT01610336|516326071|FG003|Overall Study|Protocol Deviation|0|||
143213487|NCT01610336|516326072|FG004|Overall Study|Protocol Deviation|0|||
143213488|NCT01610336|516326073|FG005|Overall Study|Protocol Deviation|0|||
143266222|NCT02007512|516530019|FG003|Double Blind Treatment Period|Protocol Violation|1|||
143266223|NCT02007512|516530016|FG000|Double Blind Treatment Period|Other|2|||
143266224|NCT02007512|516530017|FG001|Double Blind Treatment Period|Other|1|||
143266225|NCT02007512|516530018|FG002|Double Blind Treatment Period|Other|1|||
143266226|NCT02007512|516530019|FG003|Double Blind Treatment Period|Other|2|||
143213489|NCT01610336|516326074|FG006|Overall Study|Protocol Deviation|0|||
143213490|NCT01610336|516326075|FG007|Overall Study|Protocol Deviation|0|||
143213491|NCT01610336|516326076|FG008|Overall Study|Protocol Deviation|0|||
143213492|NCT01610336|516326077|FG009|Overall Study|Protocol Deviation|1|||
143213493|NCT01610336|516326078|FG010|Overall Study|Protocol Deviation|0|||
143213494|NCT01610336|516326068|FG000|Overall Study|Transfer to another trial|0|||
143213495|NCT01610336|516326069|FG001|Overall Study|Transfer to another trial|0|||
143213496|NCT01610336|516326070|FG002|Overall Study|Transfer to another trial|0|||
143213497|NCT01610336|516326071|FG003|Overall Study|Transfer to another trial|0|||
143213498|NCT01610336|516326072|FG004|Overall Study|Transfer to another trial|0|||
143266227|NCT02007512|516530016|FG000|Double Blind Treatment Period|Randomized but not treated|1|||
143213499|NCT01610336|516326073|FG005|Overall Study|Transfer to another trial|0|||
143213500|NCT01610336|516326074|FG006|Overall Study|Transfer to another trial|0|||
143213501|NCT01610336|516326075|FG007|Overall Study|Transfer to another trial|0|||
143213502|NCT01610336|516326076|FG008|Overall Study|Transfer to another trial|0|||
143213503|NCT01610336|516326077|FG009|Overall Study|Transfer to another trial|0|||
143213504|NCT01610336|516326078|FG010|Overall Study|Transfer to another trial|1|||
143213505|NCT00741013|516326079|FG000|Overall Study|Adverse Event|1|||
143213506|NCT00741013|516326080|FG001|Overall Study|Adverse Event|0|||
143213507|NCT00741013|516326081|FG002|Overall Study|Adverse Event|0|||
143213508|NCT00741013|516326079|FG000|Overall Study|Withdrawal by Subject|0|||
143213509|NCT00741013|516326080|FG001|Overall Study|Withdrawal by Subject|0|||
143213510|NCT00741013|516326081|FG002|Overall Study|Withdrawal by Subject|1|||
143213511|NCT00741013|516326079|FG000|Overall Study|Discovered failed screen after enrolled|0|||
143213512|NCT00741013|516326080|FG001|Overall Study|Discovered failed screen after enrolled|2|||
143213513|NCT00741013|516326081|FG002|Overall Study|Discovered failed screen after enrolled|0|||
143213514|NCT01378325|516326084|FG000|Overall Study|Protocol Violation|0|||
143213515|NCT01378325|516326085|FG001|Overall Study|Protocol Violation|1|||
143213516|NCT01559675|516326086|FG000|Overall Study|Protocol Violation|1|||
143213517|NCT01559675|516326087|FG001|Overall Study|Protocol Violation|2|||
143213518|NCT01559675|516326086|FG000|Overall Study|2nd operation on same patient excluded|14|||
143213519|NCT01559675|516326087|FG001|Overall Study|2nd operation on same patient excluded|12|||
143213520|NCT00193180|516326090|FG000|Overall Study|Lack of Efficacy|1|||
143213521|NCT00193180|516326090|FG000|Overall Study|Adverse Event|8|||
143213522|NCT00193180|516326090|FG000|Overall Study|Protocol Violation|1|||
143213523|NCT01357551|516326091|FG000|Overall Study|Withdrawal by Subject|6|||
143213524|NCT01357551|516326092|FG001|Overall Study|Withdrawal by Subject|4|||
143213525|NCT01357551|516326091|FG000|Overall Study|Death|0|||
143213526|NCT01357551|516326092|FG001|Overall Study|Death|1|||
143213527|NCT01357551|516326091|FG000|Overall Study|Lost to Follow-up|16|||
143213528|NCT01357551|516326092|FG001|Overall Study|Lost to Follow-up|6|||
143213529|NCT03704688|516326093|FG000|Overall Study|Adverse Event|0|||
143213530|NCT03704688|516326094|FG001|Overall Study|Adverse Event|0|||
143213531|NCT03704688|516326095|FG002|Overall Study|Adverse Event|0|||
143213532|NCT03704688|516326096|FG003|Overall Study|Adverse Event|4|||
143213533|NCT03704688|516326097|FG004|Overall Study|Adverse Event|1|||
143213534|NCT03704688|516326098|FG005|Overall Study|Adverse Event|0|||
143213535|NCT03704688|516326093|FG000|Overall Study|Disease Progression|0|||
143213536|NCT03704688|516326094|FG001|Overall Study|Disease Progression|0|||
143213537|NCT03704688|516326095|FG002|Overall Study|Disease Progression|0|||
143213538|NCT03704688|516326096|FG003|Overall Study|Disease Progression|3|||
143213539|NCT03704688|516326097|FG004|Overall Study|Disease Progression|1|||
143213540|NCT03704688|516326098|FG005|Overall Study|Disease Progression|0|||
143213541|NCT03704688|516326093|FG000|Overall Study|Death|0|||
143213542|NCT03704688|516326094|FG001|Overall Study|Death|0|||
143213543|NCT03704688|516326095|FG002|Overall Study|Death|0|||
143213544|NCT03704688|516326096|FG003|Overall Study|Death|0|||
143213545|NCT03704688|516326097|FG004|Overall Study|Death|3|||
143213546|NCT03704688|516326098|FG005|Overall Study|Death|0|||
143213547|NCT03068754|516326099|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
143213548|NCT03068754|516326100|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
143213549|NCT03068754|516326101|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
143213550|NCT03068754|516326102|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
143213551|NCT03068754|516326099|FG000|Randomized Treatment Period (RTP)|Death|2|||
143213552|NCT03068754|516326100|FG001|Randomized Treatment Period (RTP)|Death|2|||
143213553|NCT03068754|516326101|FG002|Randomized Treatment Period (RTP)|Death|0|||
143213554|NCT03068754|516326102|FG003|Randomized Treatment Period (RTP)|Death|0|||
143213555|NCT03068754|516326099|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
143213556|NCT03068754|516326100|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
143213557|NCT03068754|516326101|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
143213558|NCT03068754|516326102|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
143213559|NCT03068754|516326099|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
143213560|NCT03068754|516326100|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
143213561|NCT03068754|516326101|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
143213562|NCT03068754|516326102|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
143213563|NCT03068754|516326099|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
143213564|NCT03068754|516326100|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
143213565|NCT03068754|516326101|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
143213566|NCT03068754|516326102|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
143213567|NCT03068754|516326099|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
143213568|NCT03068754|516326100|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
143213569|NCT03068754|516326101|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
143213570|NCT03068754|516326102|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
143213571|NCT03068754|516326099|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
143213572|NCT03068754|516326100|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
143213573|NCT03068754|516326101|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
143213574|NCT03068754|516326102|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
143266228|NCT02007512|516530017|FG001|Double Blind Treatment Period|Randomized but not treated|0|||
143213575|NCT03068754|516326099|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
143266229|NCT02007512|516530018|FG002|Double Blind Treatment Period|Randomized but not treated|1|||
143213576|NCT03068754|516326100|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
143213577|NCT03068754|516326101|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
143213578|NCT03068754|516326102|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
143213579|NCT03068754|516326099|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
143213580|NCT03068754|516326100|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
143213581|NCT03068754|516326101|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
143213582|NCT03068754|516326102|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
143213583|NCT03068754|516326099|FG000|Open Label Extension Period (OLE)|Death|0|||
143213584|NCT03068754|516326100|FG001|Open Label Extension Period (OLE)|Death|0|||
143213585|NCT03068754|516326101|FG002|Open Label Extension Period (OLE)|Death|0|||
143213586|NCT03068754|516326102|FG003|Open Label Extension Period (OLE)|Death|1|||
143213587|NCT03068754|516326099|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
143213588|NCT03068754|516326100|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
143213589|NCT03068754|516326101|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
143213590|NCT03068754|516326102|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
143213591|NCT03068754|516326099|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
143213592|NCT03068754|516326100|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
143213593|NCT03068754|516326101|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
143213594|NCT03068754|516326102|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
143213595|NCT03068754|516326099|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
143213596|NCT03068754|516326100|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
143213597|NCT03068754|516326101|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
143213598|NCT03068754|516326102|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
143213599|NCT03068754|516326099|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
143213600|NCT03068754|516326100|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
143213601|NCT03068754|516326101|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
143213602|NCT03068754|516326102|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
143213603|NCT00129467|516326103|FG000|Received Intervention|Death|1|||
143213604|NCT00129467|516326104|FG001|Received Intervention|Death|1|||
143213605|NCT00129467|516326103|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
143213606|NCT00129467|516326104|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
143213607|NCT00129467|516326103|FG000|Received Intervention|Delirium|2|||
143213608|NCT00129467|516326104|FG001|Received Intervention|Delirium|0|||
143213609|NCT00129467|516326103|FG000|Received Intervention|Withdrawal by Subject|1|||
143213610|NCT00129467|516326104|FG001|Received Intervention|Withdrawal by Subject|0|||
143213611|NCT00129467|516326103|FG000|Received Intervention|Nausea|1|||
143213612|NCT00129467|516326104|FG001|Received Intervention|Nausea|0|||
143213613|NCT00129467|516326103|FG000|Received Intervention|Intolerance to citalopram|0|||
143213614|NCT00129467|516326104|FG001|Received Intervention|Intolerance to citalopram|1|||
143213615|NCT00129467|516326103|FG000|Received Intervention|Dizzyness, fatigue|0|||
143213616|NCT00129467|516326104|FG001|Received Intervention|Dizzyness, fatigue|1|||
143213617|NCT00129467|516326103|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
143213618|NCT00129467|516326104|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
143213619|NCT00129467|516326103|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
143213620|NCT00129467|516326104|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
143213621|NCT02540993|516326105|FG000|Overall Study|Lost to Follow-up|5|||
143213622|NCT02540993|516326106|FG001|Overall Study|Lost to Follow-up|3|||
143213623|NCT02540993|516326105|FG000|Overall Study|Withdrawal by Subject|4|||
143213624|NCT02540993|516326106|FG001|Overall Study|Withdrawal by Subject|6|||
143213625|NCT02540993|516326105|FG000|Overall Study|GCP violations|33|||
143213626|NCT02540993|516326106|FG001|Overall Study|GCP violations|27|||
143213627|NCT00844558|516326107|FG000|Overall Study|Withdrawal by Subject|9|||
143213628|NCT00844558|516326108|FG001|Overall Study|Withdrawal by Subject|2|||
143213629|NCT00844558|516326107|FG000|Overall Study|Death|1|||
143213630|NCT00844558|516326108|FG001|Overall Study|Death|0|||
143213631|NCT00844558|516326107|FG000|Overall Study|Protocol Violation|1|||
143213632|NCT00844558|516326108|FG001|Overall Study|Protocol Violation|1|||
143213633|NCT00844558|516326107|FG000|Overall Study|Lost to Follow-up|0|||
143213634|NCT00844558|516326108|FG001|Overall Study|Lost to Follow-up|1|||
143213635|NCT00844558|516326107|FG000|Overall Study|Physician Decision|1|||
143213636|NCT00844558|516326108|FG001|Overall Study|Physician Decision|0|||
143213637|NCT00932165|516326109|FG000|Overall Study|Lost to Follow-up|1|||
143213638|NCT02690714|516326110|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
143213639|NCT02690714|516326110|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
143213640|NCT00588094|516326111|FG000|Overall Study|Adverse Event|3|||
143213641|NCT00588094|516326111|FG000|Overall Study|Progression of Disease|2|||
143213642|NCT01336023|516326112|FG000|Week 0 to Week 26|Adverse Event|8|||
143266230|NCT02007512|516530019|FG003|Double Blind Treatment Period|Randomized but not treated|0|||
143213643|NCT01336023|516326113|FG001|Week 0 to Week 26|Adverse Event|10|||
143213644|NCT01336023|516326114|FG002|Week 0 to Week 26|Adverse Event|24|||
143213645|NCT01336023|516326112|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
143213646|NCT01336023|516326113|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
143213647|NCT01336023|516326114|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
143213648|NCT01336023|516326112|FG000|Week 0 to Week 26|Protocol Violation|1|||
143266231|NCT02007512|516530016|FG000|Open Label Treatment Period|Adverse Event|1|||
143266232|NCT02007512|516530017|FG001|Open Label Treatment Period|Adverse Event|0|||
143266233|NCT02007512|516530018|FG002|Open Label Treatment Period|Adverse Event|0|||
143266234|NCT02007512|516530019|FG003|Open Label Treatment Period|Adverse Event|0|||
143266235|NCT02007512|516530016|FG000|Open Label Treatment Period|Other|1|||
143266236|NCT02007512|516530017|FG001|Open Label Treatment Period|Other|1|||
143266237|NCT02007512|516530018|FG002|Open Label Treatment Period|Other|0|||
143266238|NCT02007512|516530019|FG003|Open Label Treatment Period|Other|0|||
143266239|NCT02007512|516530016|FG000|Open Label Treatment Period|Disease progression|23|||
143266240|NCT02007512|516530017|FG001|Open Label Treatment Period|Disease progression|11|||
143266241|NCT02007512|516530018|FG002|Open Label Treatment Period|Disease progression|0|||
143371849|NCT02914522|516906331|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
143213649|NCT01336023|516326113|FG001|Week 0 to Week 26|Protocol Violation|2|||
143213650|NCT01336023|516326114|FG002|Week 0 to Week 26|Protocol Violation|0|||
143213651|NCT01336023|516326112|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
143213652|NCT01336023|516326113|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
143213653|NCT01336023|516326114|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
143213654|NCT01336023|516326112|FG000|Week 0 to Week 26|Unclassified|5|||
143213655|NCT01336023|516326113|FG001|Week 0 to Week 26|Unclassified|16|||
143213656|NCT01336023|516326114|FG002|Week 0 to Week 26|Unclassified|9|||
143213657|NCT01336023|516326112|FG000|Week 27 to 52|Adverse Event|1|||
143213658|NCT01336023|516326113|FG001|Week 27 to 52|Adverse Event|5|||
143213659|NCT01336023|516326114|FG002|Week 27 to 52|Adverse Event|2|||
143213660|NCT01336023|516326112|FG000|Week 27 to 52|Protocol Violation|0|||
143213661|NCT01336023|516326113|FG001|Week 27 to 52|Protocol Violation|2|||
143213662|NCT01336023|516326114|FG002|Week 27 to 52|Protocol Violation|1|||
143213663|NCT01336023|516326112|FG000|Week 27 to 52|Withdrawal Criteria|14|||
143213664|NCT01336023|516326113|FG001|Week 27 to 52|Withdrawal Criteria|19|||
143213665|NCT01336023|516326114|FG002|Week 27 to 52|Withdrawal Criteria|16|||
143213666|NCT01336023|516326112|FG000|Week 27 to 52|Unclassified|13|||
143213667|NCT01336023|516326113|FG001|Week 27 to 52|Unclassified|18|||
143213668|NCT01336023|516326114|FG002|Week 27 to 52|Unclassified|9|||
143213669|NCT00666965|516326115|FG000|Overall Study|Adverse Event|0|||
143213670|NCT00666965|516326116|FG001|Overall Study|Adverse Event|2|||
143213671|NCT00666965|516326117|FG002|Overall Study|Adverse Event|1|||
143213672|NCT00666965|516326118|FG003|Overall Study|Adverse Event|9|||
143213673|NCT00666965|516326115|FG000|Overall Study|Lack of Efficacy|1|||
143213674|NCT00666965|516326116|FG001|Overall Study|Lack of Efficacy|1|||
143213675|NCT00666965|516326117|FG002|Overall Study|Lack of Efficacy|0|||
143213676|NCT00666965|516326118|FG003|Overall Study|Lack of Efficacy|0|||
143213677|NCT00666965|516326115|FG000|Overall Study|Protocol Violation|0|||
143213678|NCT00666965|516326116|FG001|Overall Study|Protocol Violation|0|||
143266242|NCT02007512|516530019|FG003|Open Label Treatment Period|Disease progression|0|||
143266243|NCT02694523|516530021|FG000|Part A|Adverse Event|7|||
143266244|NCT02694523|516530022|FG001|Part A|Adverse Event|3|||
143371850|NCT02914522|516906332|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
143371851|NCT02914522|516906333|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
143371852|NCT02914522|516906334|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
143371853|NCT02914522|516906335|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
143371854|NCT02914522|516906336|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
143371855|NCT02914522|516906337|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
143371856|NCT02914522|516906338|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
143371857|NCT02914522|516906328|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
143371858|NCT02914522|516906329|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
143371859|NCT02914522|516906330|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
143371860|NCT02914522|516906331|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
143371861|NCT02914522|516906332|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
143371862|NCT02914522|516906333|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
143213679|NCT00666965|516326117|FG002|Overall Study|Protocol Violation|0|||
143213680|NCT00666965|516326118|FG003|Overall Study|Protocol Violation|2|||
143266245|NCT02694523|516530023|FG002|Part A|Adverse Event|0|||
143266246|NCT02694523|516530024|FG003|Part A|Adverse Event|0|||
143213681|NCT00666965|516326115|FG000|Overall Study|Discontinuation criteria|2|||
143213682|NCT00666965|516326116|FG001|Overall Study|Discontinuation criteria|1|||
143213683|NCT00666965|516326117|FG002|Overall Study|Discontinuation criteria|1|||
143213684|NCT00666965|516326118|FG003|Overall Study|Discontinuation criteria|2|||
143213685|NCT00666965|516326115|FG000|Overall Study|Withdrawal by Subject|0|||
143266247|NCT02694523|516530025|FG004|Part A|Adverse Event|0|||
143371863|NCT02914522|516906334|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
143213686|NCT00666965|516326116|FG001|Overall Study|Withdrawal by Subject|0|||
143213687|NCT00666965|516326117|FG002|Overall Study|Withdrawal by Subject|0|||
143266248|NCT02694523|516530026|FG005|Part A|Adverse Event|0|||
143266249|NCT02694523|516530027|FG006|Part A|Adverse Event|0|||
143213688|NCT00666965|516326118|FG003|Overall Study|Withdrawal by Subject|2|||
143213689|NCT05090852|516326121|FG000|Overall Study|Physician Decision|5|||
143213690|NCT00504894|516326122|FG000|Overall Study|fMRI technical problems|1|||
143213691|NCT00504894|516326123|FG001|Overall Study|fMRI technical problems|1|||
143213692|NCT00504894|516326124|FG002|Overall Study|fMRI technical problems|0|||
143213693|NCT00504894|516326122|FG000|Overall Study|Withdrawal by Subject|0|||
143213694|NCT00504894|516326123|FG001|Overall Study|Withdrawal by Subject|1|||
143213695|NCT00504894|516326124|FG002|Overall Study|Withdrawal by Subject|0|||
143213696|NCT00504894|516326122|FG000|Overall Study|Infusion technical problems|0|||
143213697|NCT00504894|516326123|FG001|Overall Study|Infusion technical problems|1|||
143213698|NCT00504894|516326124|FG002|Overall Study|Infusion technical problems|0|||
143213699|NCT00504894|516326122|FG000|Overall Study|poor subject data|2|||
143213700|NCT00504894|516326123|FG001|Overall Study|poor subject data|0|||
143213701|NCT00504894|516326124|FG002|Overall Study|poor subject data|0|||
143213702|NCT00360568|516326125|FG000|Overall Study|Adverse Event|1|||
143213703|NCT00360568|516326126|FG001|Overall Study|Adverse Event|2|||
143213704|NCT00360568|516326125|FG000|Overall Study|Lack of Efficacy|1|||
143213705|NCT00360568|516326126|FG001|Overall Study|Lack of Efficacy|0|||
143213706|NCT00360568|516326125|FG000|Overall Study|Withdrawal by Subject|0|||
143213707|NCT00360568|516326126|FG001|Overall Study|Withdrawal by Subject|3|||
143213708|NCT01008449|516326130|FG000|Overall Study|Lost to Follow-up|29|||
143213709|NCT01008449|516326131|FG001|Overall Study|Lost to Follow-up|19|||
143213710|NCT01220180|516326132|FG000|Overall Study|Lost to Follow-up|76|||
143213711|NCT01220180|516326132|FG000|Overall Study|Other|72|||
143213712|NCT01220180|516326132|FG000|Overall Study|Adverse Event|35|||
143213713|NCT01220180|516326132|FG000|Overall Study|Lack of Efficacy|22|||
143213714|NCT01220180|516326132|FG000|Overall Study|Death|1|||
143213715|NCT01220180|516326132|FG000|Overall Study|Randomized but not treated|1|||
143213716|NCT01364389|516326139|FG000|Overall Study|Withdrawal by Subject|0|||
143213717|NCT01364389|516326140|FG001|Overall Study|Withdrawal by Subject|1|||
143213718|NCT01364389|516326141|FG002|Overall Study|Withdrawal by Subject|0|||
143266250|NCT02694523|516530021|FG000|Part A|Protocol Violation|1|||
143266251|NCT02694523|516530022|FG001|Part A|Protocol Violation|0|||
143266252|NCT02694523|516530023|FG002|Part A|Protocol Violation|0|||
143266253|NCT02694523|516530024|FG003|Part A|Protocol Violation|0|||
143266254|NCT02694523|516530025|FG004|Part A|Protocol Violation|0|||
143266255|NCT02694523|516530026|FG005|Part A|Protocol Violation|0|||
143266256|NCT02694523|516530027|FG006|Part A|Protocol Violation|0|||
143266257|NCT02694523|516530021|FG000|Part A|Lost to Follow-up|1|||
143266258|NCT02694523|516530022|FG001|Part A|Lost to Follow-up|2|||
143266259|NCT02694523|516530023|FG002|Part A|Lost to Follow-up|0|||
143266260|NCT02694523|516530024|FG003|Part A|Lost to Follow-up|0|||
143266261|NCT02694523|516530025|FG004|Part A|Lost to Follow-up|0|||
143266262|NCT02694523|516530026|FG005|Part A|Lost to Follow-up|0|||
143266263|NCT02694523|516530027|FG006|Part A|Lost to Follow-up|0|||
143266264|NCT02694523|516530021|FG000|Part A|Withdrawal by Subject|3|||
143266265|NCT02694523|516530022|FG001|Part A|Withdrawal by Subject|1|||
143266266|NCT02694523|516530023|FG002|Part A|Withdrawal by Subject|0|||
143266267|NCT02694523|516530024|FG003|Part A|Withdrawal by Subject|0|||
143266268|NCT02694523|516530025|FG004|Part A|Withdrawal by Subject|0|||
143266269|NCT02694523|516530026|FG005|Part A|Withdrawal by Subject|0|||
143371864|NCT02914522|516906335|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
143371865|NCT02914522|516906336|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
143371866|NCT02914522|516906337|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
143371867|NCT02914522|516906338|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
143266270|NCT02694523|516530027|FG006|Part A|Withdrawal by Subject|0|||
143266271|NCT02694523|516530021|FG000|Part A|Other|1|||
143266272|NCT02694523|516530022|FG001|Part A|Other|1|||
143371868|NCT02914522|516906328|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
143371869|NCT02914522|516906329|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
143371870|NCT02914522|516906330|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
143371871|NCT02914522|516906331|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
143213719|NCT01364389|516326139|FG000|Overall Study|Protocol deviation|0|||
143213720|NCT01364389|516326140|FG001|Overall Study|Protocol deviation|0|||
143213721|NCT01364389|516326141|FG002|Overall Study|Protocol deviation|1|||
143213722|NCT01364389|516326139|FG000|Overall Study|Administrative problems|1|||
143213723|NCT01364389|516326140|FG001|Overall Study|Administrative problems|0|||
143213724|NCT01364389|516326141|FG002|Overall Study|Administrative problems|0|||
143213725|NCT01364389|516326139|FG000|Overall Study|Adverse Event|1|||
143213726|NCT01364389|516326140|FG001|Overall Study|Adverse Event|0|||
143213727|NCT01364389|516326141|FG002|Overall Study|Adverse Event|0|||
143213728|NCT01534195|516326142|FG000|Overall Study|Withdrawal by Subject|1|||
143266273|NCT02694523|516530023|FG002|Part A|Other|0|||
143266274|NCT02694523|516530024|FG003|Part A|Other|0|||
143213729|NCT01534195|516326143|FG001|Overall Study|Withdrawal by Subject|1|||
143266275|NCT02694523|516530025|FG004|Part A|Other|0|||
143266276|NCT02694523|516530026|FG005|Part A|Other|0|||
143266277|NCT02694523|516530027|FG006|Part A|Other|0|||
143213730|NCT03043651|516326148|FG000|Overall Study|Death|1|||
143213731|NCT03043651|516326148|FG000|Overall Study|Progressive Disease|2|||
143213732|NCT03043651|516326148|FG000|Overall Study|Adverse Event|2|||
143213733|NCT03043651|516326148|FG000|Overall Study|Withdrawal by Subject|4|||
143213734|NCT03043651|516326148|FG000|Overall Study|Study Terminated by Sponsor|39|||
143213735|NCT01630889|516326149|FG000|Overall Study|Death|2|||
143213736|NCT01630889|516326149|FG000|Overall Study|Withdrawal by Subject|1|||
143213737|NCT01630889|516326149|FG000|Overall Study|Other than Specified|2|||
143213738|NCT01630889|516326149|FG000|Overall Study|Lost to Follow-up|4|||
143213739|NCT01630889|516326149|FG000|Overall Study|Other|1|||
143213740|NCT02974842|516326150|FG000|Overall Study|Withdrawal by Subject|4|||
143213741|NCT02974842|516326150|FG000|Overall Study|Screen failures|4|||
143213742|NCT01068158|516326156|FG000|Overall Study|Withdrawal by Subject|1|||
143213743|NCT01068158|516326157|FG001|Overall Study|Withdrawal by Subject|2|||
143213744|NCT01068158|516326156|FG000|Overall Study|Lost to Follow-up|7|||
143213745|NCT01068158|516326157|FG001|Overall Study|Lost to Follow-up|0|||
143213746|NCT01068158|516326156|FG000|Overall Study|Protocol Violation|0|||
143213747|NCT01068158|516326157|FG001|Overall Study|Protocol Violation|2|||
143213748|NCT02277119|516326164|FG000|Overall Study|Lack of Efficacy|1|||
143213749|NCT02277119|516326165|FG001|Overall Study|Lack of Efficacy|1|||
143213750|NCT02277119|516326166|FG002|Overall Study|Lack of Efficacy|1|||
143213751|NCT02277119|516326164|FG000|Overall Study|Protocol Violation|2|||
143213752|NCT02277119|516326165|FG001|Overall Study|Protocol Violation|3|||
143213753|NCT02277119|516326166|FG002|Overall Study|Protocol Violation|7|||
143213754|NCT03068767|516326172|FG000|Overall Study|Lost to Follow-up|7|||
143213755|NCT03068767|516326173|FG001|Overall Study|Lost to Follow-up|3|||
143213756|NCT03068767|516326172|FG000|Overall Study|Protocol Violation|3|||
143213757|NCT03068767|516326173|FG001|Overall Study|Protocol Violation|0|||
143213758|NCT00872599|516327931|FG000|Second Washout Period|Adverse Event|1|||
143213759|NCT00872599|516327932|FG001|Second Washout Period|Adverse Event|1|||
143213760|NCT02510001|516327933|FG000|Overall Study|Early disease progression|0|||
143213761|NCT02510001|516327934|FG001|Overall Study|Early disease progression|0|||
143266278|NCT02694523|516530021|FG000|Part B|Adverse Event|0|||
143266279|NCT02694523|516530022|FG001|Part B|Adverse Event|0|||
143266280|NCT02694523|516530023|FG002|Part B|Adverse Event|7|||
143266281|NCT02694523|516530024|FG003|Part B|Adverse Event|1|||
143266282|NCT02694523|516530025|FG004|Part B|Adverse Event|1|||
143266283|NCT02694523|516530026|FG005|Part B|Adverse Event|2|||
143266284|NCT02694523|516530027|FG006|Part B|Adverse Event|0|||
143266285|NCT02694523|516530021|FG000|Part B|Protocol Violation|0|||
143266286|NCT02694523|516530022|FG001|Part B|Protocol Violation|0|||
143266287|NCT02694523|516530023|FG002|Part B|Protocol Violation|1|||
143266288|NCT02694523|516530024|FG003|Part B|Protocol Violation|0|||
143266289|NCT02694523|516530025|FG004|Part B|Protocol Violation|0|||
143266290|NCT02694523|516530026|FG005|Part B|Protocol Violation|0|||
143266291|NCT02694523|516530027|FG006|Part B|Protocol Violation|0|||
143266292|NCT02694523|516530021|FG000|Part B|Lost to Follow-up|0|||
143266293|NCT02694523|516530022|FG001|Part B|Lost to Follow-up|0|||
143266294|NCT02694523|516530023|FG002|Part B|Lost to Follow-up|2|||
143266295|NCT02694523|516530024|FG003|Part B|Lost to Follow-up|3|||
143266296|NCT02694523|516530025|FG004|Part B|Lost to Follow-up|2|||
143266297|NCT02694523|516530026|FG005|Part B|Lost to Follow-up|0|||
143266298|NCT02694523|516530027|FG006|Part B|Lost to Follow-up|1|||
143266299|NCT02694523|516530021|FG000|Part B|Withdrawal by Subject|0|||
143266300|NCT02694523|516530022|FG001|Part B|Withdrawal by Subject|0|||
143266301|NCT02694523|516530023|FG002|Part B|Withdrawal by Subject|9|||
143266302|NCT02694523|516530024|FG003|Part B|Withdrawal by Subject|0|||
143266303|NCT02694523|516530025|FG004|Part B|Withdrawal by Subject|1|||
143266304|NCT02694523|516530026|FG005|Part B|Withdrawal by Subject|3|||
143213762|NCT02510001|516327935|FG002|Overall Study|Early disease progression|0|||
143213763|NCT02510001|516327936|FG003|Overall Study|Early disease progression|1|||
143213764|NCT02510001|516327937|FG004|Overall Study|Early disease progression|1|||
143213765|NCT02510001|516327938|FG005|Overall Study|Early disease progression|1|||
143213766|NCT02510001|516327939|FG006|Overall Study|Early disease progression|0|||
143213767|NCT02510001|516327940|FG007|Overall Study|Early disease progression|0|||
143266305|NCT02694523|516530027|FG006|Part B|Withdrawal by Subject|0|||
143266306|NCT02694523|516530021|FG000|Part B|Other|0|||
143266307|NCT02694523|516530022|FG001|Part B|Other|0|||
143266308|NCT02694523|516530023|FG002|Part B|Other|1|||
143266309|NCT02694523|516530024|FG003|Part B|Other|0|||
143266310|NCT02694523|516530025|FG004|Part B|Other|0|||
143266311|NCT02694523|516530026|FG005|Part B|Other|0|||
143213768|NCT02510001|516327933|FG000|Overall Study|Adverse Event|0|||
143213769|NCT02510001|516327934|FG001|Overall Study|Adverse Event|0|||
143213770|NCT02510001|516327935|FG002|Overall Study|Adverse Event|0|||
143266312|NCT02694523|516530027|FG006|Part B|Other|1|||
143266313|NCT01086423|516530029|FG000|Overall Study|Protocol Violation|0|||
143266314|NCT01086423|516530030|FG001|Overall Study|Protocol Violation|0|||
143266315|NCT01086423|516530031|FG002|Overall Study|Protocol Violation|1|||
143266316|NCT01086423|516530029|FG000|Overall Study|Migrated/moved from study area|2|||
143266317|NCT01086423|516530030|FG001|Overall Study|Migrated/moved from study area|0|||
143213771|NCT02510001|516327936|FG003|Overall Study|Adverse Event|1|||
143213772|NCT02510001|516327937|FG004|Overall Study|Adverse Event|2|||
143213773|NCT02510001|516327938|FG005|Overall Study|Adverse Event|1|||
143213774|NCT02510001|516327939|FG006|Overall Study|Adverse Event|2|||
143213775|NCT02510001|516327940|FG007|Overall Study|Adverse Event|5|||
143213776|NCT02510001|516327933|FG000|Overall Study|Physician Decision|0|||
143213777|NCT02510001|516327934|FG001|Overall Study|Physician Decision|0|||
143213778|NCT02510001|516327935|FG002|Overall Study|Physician Decision|0|||
143213779|NCT02510001|516327936|FG003|Overall Study|Physician Decision|0|||
143213780|NCT02510001|516327937|FG004|Overall Study|Physician Decision|1|||
143213781|NCT02510001|516327938|FG005|Overall Study|Physician Decision|0|||
143213782|NCT02510001|516327939|FG006|Overall Study|Physician Decision|0|||
143213783|NCT02510001|516327940|FG007|Overall Study|Physician Decision|0|||
143213784|NCT02510001|516327933|FG000|Overall Study|Withdrawal by Subject|0|||
143213785|NCT02510001|516327934|FG001|Overall Study|Withdrawal by Subject|0|||
143213786|NCT02510001|516327935|FG002|Overall Study|Withdrawal by Subject|0|||
143213787|NCT02510001|516327936|FG003|Overall Study|Withdrawal by Subject|0|||
143213788|NCT02510001|516327937|FG004|Overall Study|Withdrawal by Subject|0|||
143213789|NCT02510001|516327938|FG005|Overall Study|Withdrawal by Subject|0|||
143213790|NCT02510001|516327939|FG006|Overall Study|Withdrawal by Subject|0|||
143213791|NCT02510001|516327940|FG007|Overall Study|Withdrawal by Subject|2|||
143213792|NCT02950480|516327948|FG000|Overall Study|Withdrawal by Subject|1|||
143213793|NCT02950480|516327949|FG001|Overall Study|Withdrawal by Subject|0|||
143213794|NCT00891228|516327955|FG000|Overall Study|Adverse Event|0|||
143213795|NCT00891228|516327956|FG001|Overall Study|Adverse Event|2|||
143213796|NCT00891228|516327957|FG002|Overall Study|Adverse Event|3|||
143213797|NCT00891228|516327955|FG000|Overall Study|Withdrawal by Subject|2|||
143213798|NCT00891228|516327956|FG001|Overall Study|Withdrawal by Subject|4|||
143213799|NCT00891228|516327957|FG002|Overall Study|Withdrawal by Subject|5|||
143213800|NCT00891228|516327955|FG000|Overall Study|Protocol Violation|3|||
143213801|NCT00891228|516327956|FG001|Overall Study|Protocol Violation|1|||
143213802|NCT00891228|516327957|FG002|Overall Study|Protocol Violation|2|||
143213803|NCT00891228|516327955|FG000|Overall Study|Physician Decision|2|||
143213804|NCT00891228|516327956|FG001|Overall Study|Physician Decision|1|||
143213805|NCT00891228|516327957|FG002|Overall Study|Physician Decision|0|||
143213806|NCT00891228|516327955|FG000|Overall Study|Lost to Follow-up|4|||
143213807|NCT00891228|516327956|FG001|Overall Study|Lost to Follow-up|4|||
143213808|NCT00891228|516327957|FG002|Overall Study|Lost to Follow-up|5|||
143213809|NCT00891228|516327955|FG000|Overall Study|Pregnancy|0|||
143213810|NCT00891228|516327956|FG001|Overall Study|Pregnancy|1|||
143213811|NCT00891228|516327957|FG002|Overall Study|Pregnancy|0|||
143213812|NCT01726582|516327960|FG000|Overall Study|Physician Decision|99|||
143213813|NCT01726582|516327960|FG000|Overall Study|Death|85|||
143266318|NCT01086423|516530031|FG002|Overall Study|Migrated/moved from study area|4|||
143266319|NCT01086423|516530029|FG000|Overall Study|Adverse event, fatal|1|||
143266320|NCT01086423|516530030|FG001|Overall Study|Adverse event, fatal|1|||
143266321|NCT01086423|516530031|FG002|Overall Study|Adverse event, fatal|0|||
143266322|NCT01086423|516530029|FG000|Overall Study|Adverse event, non-fatal|2|||
143266323|NCT01086423|516530030|FG001|Overall Study|Adverse event, non-fatal|1|||
143213814|NCT01235234|516327961|FG000|Overall Study|Adverse Event|2|||
143213815|NCT01235234|516327962|FG001|Overall Study|Adverse Event|2|||
143213816|NCT01235234|516327963|FG002|Overall Study|Adverse Event|1|||
143213817|NCT00787189|516327968|FG000|Overall Study|Lost to Follow-up|2|||
143213818|NCT00787189|516327969|FG001|Overall Study|Lost to Follow-up|2|||
143213819|NCT03671304|516327970|FG000|Overall Study|study terminated|7|||
143213820|NCT00596830|516327971|FG000|Overall Study|Death|258|||
143266324|NCT01086423|516530031|FG002|Overall Study|Adverse event, non-fatal|0|||
143266325|NCT01086423|516530029|FG000|Overall Study|Withdrawal by Subject|5|||
143266326|NCT01086423|516530030|FG001|Overall Study|Withdrawal by Subject|1|||
143266327|NCT01086423|516530031|FG002|Overall Study|Withdrawal by Subject|3|||
143266328|NCT01086423|516530029|FG000|Overall Study|Lost to Follow-up|0|||
143266329|NCT01086423|516530030|FG001|Overall Study|Lost to Follow-up|0|||
143266330|NCT01086423|516530031|FG002|Overall Study|Lost to Follow-up|1|||
143266331|NCT04950166|516530035|FG000|Overall Study|Withdrawal by Subject|1|||
143266332|NCT01130103|516530039|FG000|Randomized Treatment|Adverse Event|1|||
143266333|NCT01130103|516530040|FG001|Randomized Treatment|Adverse Event|1|||
143266334|NCT01130103|516530039|FG000|Randomized Treatment|Lost to Follow-up|1|||
143213821|NCT00596830|516327972|FG001|Overall Study|Death|247|||
143213822|NCT00596830|516327971|FG000|Overall Study|Lost to Follow-up|7|||
143266335|NCT01130103|516530040|FG001|Randomized Treatment|Lost to Follow-up|0|||
143266336|NCT01130103|516530039|FG000|Randomized Treatment|Protocol Violation|3|||
143266337|NCT01130103|516530040|FG001|Randomized Treatment|Protocol Violation|2|||
143266338|NCT01130103|516530039|FG000|Randomized Treatment|Withdrawal by Subject|1|||
143266339|NCT01130103|516530040|FG001|Randomized Treatment|Withdrawal by Subject|2|||
143213823|NCT00596830|516327972|FG001|Overall Study|Lost to Follow-up|11|||
143213824|NCT00596830|516327971|FG000|Overall Study|Withdrawal by Subject|22|||
143213825|NCT00596830|516327972|FG001|Overall Study|Withdrawal by Subject|12|||
143213826|NCT00596830|516327971|FG000|Overall Study|Study terminated by sponsor|51|||
143213827|NCT00596830|516327972|FG001|Overall Study|Study terminated by sponsor|62|||
143213828|NCT00596830|516327971|FG000|Overall Study|Follow-up was discontinued|1|||
143213829|NCT00596830|516327972|FG001|Overall Study|Follow-up was discontinued|0|||
143213830|NCT00596830|516327971|FG000|Overall Study|Randomized but not treated|3|||
143213831|NCT00596830|516327972|FG001|Overall Study|Randomized but not treated|7|||
143213832|NCT00887926|516327975|FG000|Overall Study|Withdrawal by Subject|0|||
143213833|NCT00887926|516327976|FG001|Overall Study|Withdrawal by Subject|1|||
143213834|NCT00887926|516327977|FG002|Overall Study|Withdrawal by Subject|0|||
143213835|NCT00887926|516327978|FG003|Overall Study|Withdrawal by Subject|0|||
143213836|NCT02097030|516327979|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
143213837|NCT02097030|516327980|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
143213838|NCT02097030|516327979|FG000|First Intervention (3 Days)|Visual Acuity|0|||
143213839|NCT02097030|516327980|FG001|First Intervention (3 Days)|Visual Acuity|1|||
143213840|NCT00774800|516327981|FG000|Intervention 4|Withdrawal by Subject|1|||
143213841|NCT00773747|516327986|FG000|Overall Study|Lack of Efficacy|112|||
143213842|NCT00773747|516327987|FG001|Overall Study|Lack of Efficacy|144|||
143213843|NCT00773747|516327986|FG000|Overall Study|Physician Decision|26|||
143213844|NCT00773747|516327987|FG001|Overall Study|Physician Decision|18|||
143213845|NCT00773747|516327986|FG000|Overall Study|Lost to Follow-up|0|||
143213846|NCT00773747|516327987|FG001|Overall Study|Lost to Follow-up|1|||
143213847|NCT00773747|516327986|FG000|Overall Study|Protocol Violation|2|||
143213848|NCT00773747|516327987|FG001|Overall Study|Protocol Violation|2|||
143213849|NCT00773747|516327986|FG000|Overall Study|Withdrawal by Subject|89|||
143213850|NCT00773747|516327987|FG001|Overall Study|Withdrawal by Subject|61|||
143213851|NCT00773747|516327986|FG000|Overall Study|Adverse Event|61|||
143213852|NCT00773747|516327987|FG001|Overall Study|Adverse Event|62|||
143213853|NCT00773747|516327986|FG000|Overall Study|Death|5|||
143213854|NCT00773747|516327987|FG001|Overall Study|Death|8|||
143213855|NCT00773747|516327986|FG000|Overall Study|Not Treated|2|||
143213856|NCT00773747|516327987|FG001|Overall Study|Not Treated|0|||
143213857|NCT01973998|516327988|FG000|Overall Study|Death|2|||
143213858|NCT01973998|516327989|FG001|Overall Study|Death|2|||
143213859|NCT00820222|516327995|FG000|Overall Study|Lost to Follow-up|10|||
143213860|NCT00820222|516327996|FG001|Overall Study|Lost to Follow-up|9|||
143213861|NCT00820222|516327995|FG000|Overall Study|Withdrawal by Subject|19|||
143213862|NCT00820222|516327996|FG001|Overall Study|Withdrawal by Subject|21|||
143213863|NCT00820222|516327995|FG000|Overall Study|Physician Decision|93|||
143213864|NCT00820222|516327996|FG001|Overall Study|Physician Decision|88|||
143213865|NCT00820222|516327995|FG000|Overall Study|Sponsor Terminated Study|43|||
143213866|NCT00820222|516327996|FG001|Overall Study|Sponsor Terminated Study|65|||
143213867|NCT00820222|516327995|FG000|Overall Study|Unkown|11|||
143213868|NCT00820222|516327996|FG001|Overall Study|Unkown|7|||
143213869|NCT01894022|516328007|FG000|Overall Study|Death|1|||
143213870|NCT01894022|516328008|FG001|Overall Study|Death|0|||
143213871|NCT01894022|516328007|FG000|Overall Study|Adverse Event, non-fatal|1|||
143213872|NCT01894022|516328008|FG001|Overall Study|Adverse Event, non-fatal|0|||
143213873|NCT01894022|516328007|FG000|Overall Study|Study Closed/terminated|7|||
143213874|NCT01894022|516328008|FG001|Overall Study|Study Closed/terminated|10|||
143213875|NCT04496453|516328010|FG000|Overall Study|Lost to Follow-up|6|||
143213876|NCT01361178|516328011|FG000|Overall Study|Death|13|||
143213877|NCT01361178|516328012|FG001|Overall Study|Death|0|||
143213878|NCT03688620|516328020|FG000|Overall Study|Other|0|||
143213879|NCT03688620|516328021|FG001|Overall Study|Other|0|||
143213880|NCT03688620|516328022|FG002|Overall Study|Other|1|||
143213881|NCT03688620|516328020|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
143213882|NCT03688620|516328021|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
143213883|NCT03688620|516328022|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
143213884|NCT03688620|516328020|FG000|Overall Study|Lost to Follow-up|16|||
143213885|NCT03688620|516328021|FG001|Overall Study|Lost to Follow-up|0|||
143213886|NCT03688620|516328022|FG002|Overall Study|Lost to Follow-up|1|||
143213887|NCT03688620|516328020|FG000|Overall Study|Withdrawal by Subject|0|||
143266340|NCT01130103|516530039|FG000|Maintenance Treatment|Lack of Efficacy|0|||
143266341|NCT01130103|516530040|FG001|Maintenance Treatment|Lack of Efficacy|1|||
143266342|NCT01130103|516530039|FG000|Maintenance Treatment|Lost to Follow-up|1|||
143213888|NCT03688620|516328021|FG001|Overall Study|Withdrawal by Subject|0|||
143213889|NCT03688620|516328022|FG002|Overall Study|Withdrawal by Subject|6|||
143213890|NCT02828020|516328023|FG000|Treatment Period|Adverse Event|3|||
143213891|NCT02828020|516328024|FG001|Treatment Period|Adverse Event|1|||
143213892|NCT02828020|516328025|FG002|Treatment Period|Adverse Event|1|||
143213893|NCT02828020|516328023|FG000|Treatment Period|Withdrawal of Consent|10|||
143213894|NCT02828020|516328024|FG001|Treatment Period|Withdrawal of Consent|14|||
143213895|NCT02828020|516328025|FG002|Treatment Period|Withdrawal of Consent|9|||
143213896|NCT02828020|516328023|FG000|Treatment Period|Lost to Follow-up|21|||
143213897|NCT02828020|516328024|FG001|Treatment Period|Lost to Follow-up|24|||
143213898|NCT02828020|516328025|FG002|Treatment Period|Lost to Follow-up|18|||
143213899|NCT02828020|516328023|FG000|Treatment Period|Lack of Qualifying Event|44|||
143213900|NCT02828020|516328024|FG001|Treatment Period|Lack of Qualifying Event|53|||
143213901|NCT02828020|516328025|FG002|Treatment Period|Lack of Qualifying Event|43|||
143213902|NCT02828020|516328023|FG000|Treatment Period|Pregnancy|0|||
143213903|NCT02828020|516328024|FG001|Treatment Period|Pregnancy|2|||
143213904|NCT02828020|516328025|FG002|Treatment Period|Pregnancy|0|||
143213905|NCT02828020|516328023|FG000|Treatment Period|Protocol Violation|2|||
143213906|NCT02828020|516328024|FG001|Treatment Period|Protocol Violation|4|||
143213907|NCT02828020|516328025|FG002|Treatment Period|Protocol Violation|7|||
143213908|NCT02828020|516328023|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
143213909|NCT02828020|516328024|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
143213910|NCT02828020|516328025|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
143213911|NCT02828020|516328023|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
143213912|NCT02828020|516328024|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
143213913|NCT02828020|516328025|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
143213914|NCT02828020|516328023|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
143213915|NCT02828020|516328024|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
143213916|NCT02828020|516328025|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
143213917|NCT02828020|516328023|FG000|Safety Follow-up Period|Protocol Violation|0|||
143213918|NCT02828020|516328024|FG001|Safety Follow-up Period|Protocol Violation|2|||
143213919|NCT02828020|516328025|FG002|Safety Follow-up Period|Protocol Violation|1|||
143213920|NCT02828020|516328023|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
143213921|NCT02828020|516328024|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
143213922|NCT02828020|516328025|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
143213923|NCT01008904|516328026|FG000|Overall Study|Lost to Follow-up|1|||
143213924|NCT01008904|516328026|FG000|Overall Study|Adverse Event|2|||
143213925|NCT01008904|516328026|FG000|Overall Study|unexpected unrelated surgery|1|||
143213926|NCT00416455|516328027|FG000|Overall Study|PET / CT not done|3|||
143213927|NCT00416455|516328028|FG001|Overall Study|PET / CT not done|5|||
143213928|NCT00416455|516328027|FG000|Overall Study|PET / CT poor quality|2|||
143213929|NCT00416455|516328028|FG001|Overall Study|PET / CT poor quality|1|||
143213930|NCT00416455|516328027|FG000|Overall Study|Inadequate pathology|11|||
143213931|NCT00416455|516328028|FG001|Overall Study|Inadequate pathology|2|||
143213932|NCT02456857|516328029|FG000|Overall Study|Disease Progression|4|||
143213933|NCT00781859|516328030|FG000|Overall Study|Adverse Event|2|||
143213934|NCT00781859|516328031|FG001|Overall Study|Adverse Event|2|||
143213935|NCT00781859|516328030|FG000|Overall Study|Withdrawal by Subject|8|||
143213936|NCT00781859|516328031|FG001|Overall Study|Withdrawal by Subject|4|||
143213937|NCT00781859|516328030|FG000|Overall Study|Lost to Follow-up|6|||
143213938|NCT00781859|516328031|FG001|Overall Study|Lost to Follow-up|3|||
143213939|NCT00781859|516328030|FG000|Overall Study|Death|3|||
143213940|NCT00781859|516328031|FG001|Overall Study|Death|0|||
143213941|NCT01983774|516328035|FG000|Overall Study|Lung Transplant|0|||
143213942|NCT01983774|516328036|FG001|Overall Study|Lung Transplant|1|||
143213943|NCT01983774|516328035|FG000|Overall Study|Lost to Follow-up|1|||
143213944|NCT01983774|516328036|FG001|Overall Study|Lost to Follow-up|0|||
143213945|NCT01339897|516328037|FG000|Overall Study|Adverse Event|1|||
143213946|NCT01339897|516328038|FG001|Overall Study|Adverse Event|0|||
143213947|NCT01339897|516328039|FG002|Overall Study|Adverse Event|0|||
143213948|NCT01339897|516328040|FG003|Overall Study|Adverse Event|1|||
143213949|NCT02980133|516328042|FG000|Overall Study|Other than specified|1|||
143213950|NCT02980133|516328043|FG001|Overall Study|Other than specified|1|||
143213951|NCT02980133|516328044|FG002|Overall Study|Other than specified|2|||
143213952|NCT02980133|516328045|FG003|Overall Study|Other than specified|2|||
143213953|NCT02980133|516328042|FG000|Overall Study|Lost to Follow-up|0|||
143213954|NCT02980133|516328043|FG001|Overall Study|Lost to Follow-up|0|||
143213955|NCT02980133|516328044|FG002|Overall Study|Lost to Follow-up|1|||
143213956|NCT02980133|516328045|FG003|Overall Study|Lost to Follow-up|3|||
143213957|NCT02980133|516328042|FG000|Overall Study|Protocol Violation|0|||
143213958|NCT02980133|516328043|FG001|Overall Study|Protocol Violation|1|||
143213959|NCT02980133|516328044|FG002|Overall Study|Protocol Violation|0|||
143213960|NCT02980133|516328045|FG003|Overall Study|Protocol Violation|0|||
143213961|NCT02980133|516328042|FG000|Overall Study|Withdrawal by parent/guardian|6|||
143213962|NCT02980133|516328043|FG001|Overall Study|Withdrawal by parent/guardian|3|||
143213963|NCT02980133|516328044|FG002|Overall Study|Withdrawal by parent/guardian|3|||
143213964|NCT02980133|516328045|FG003|Overall Study|Withdrawal by parent/guardian|1|||
143213965|NCT02980133|516328042|FG000|Overall Study|Withdrawal by Subject|0|||
143213966|NCT02980133|516328043|FG001|Overall Study|Withdrawal by Subject|0|||
143266343|NCT01130103|516530040|FG001|Maintenance Treatment|Lost to Follow-up|1|||
143213967|NCT02980133|516328044|FG002|Overall Study|Withdrawal by Subject|1|||
143213968|NCT02980133|516328045|FG003|Overall Study|Withdrawal by Subject|0|||
143213969|NCT00991406|516328047|FG000|Overall Study|One participant did not respond to FES.|1|||
143213970|NCT03824587|516328048|FG000|Run-in Period|Screen Failure|0|||
143213971|NCT03824587|516328049|FG001|Run-in Period|Screen Failure|275|||
143213972|NCT03824587|516328048|FG000|Treatment Period|Adverse Event|4|||
143213973|NCT03824587|516328049|FG001|Treatment Period|Adverse Event|1|||
143213974|NCT03824587|516328048|FG000|Treatment Period|Withdrawal by Subject|0|||
143213975|NCT03824587|516328049|FG001|Treatment Period|Withdrawal by Subject|1|||
143213976|NCT03824587|516328048|FG000|Treatment Period|Kidney Transplant|1|||
143213977|NCT03824587|516328049|FG001|Treatment Period|Kidney Transplant|1|||
143213978|NCT01300572|516328050|FG000|Overall Study|HAMA + post dosimetry|1|||
143213979|NCT00986362|516328051|FG000|Overall Study|Death|2|||
143213980|NCT00986362|516328052|FG001|Overall Study|Death|0|||
143213981|NCT00986362|516328051|FG000|Overall Study|Lost to Follow-up|0|||
143213982|NCT00986362|516328052|FG001|Overall Study|Lost to Follow-up|1|||
143213983|NCT02160145|516328053|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
143213984|NCT02160145|516328054|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
143213985|NCT02160145|516328055|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
143213986|NCT02160145|516328053|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
143213987|NCT02160145|516328054|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
143213988|NCT02160145|516328055|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
143213989|NCT02160145|516328053|FG000|Randomized Double-blind Period|Subject decision|0|||
143213990|NCT02160145|516328054|FG001|Randomized Double-blind Period|Subject decision|21|||
143213991|NCT02160145|516328055|FG002|Randomized Double-blind Period|Subject decision|20|||
143213992|NCT02160145|516328053|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
143213993|NCT02160145|516328054|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
143213994|NCT02160145|516328055|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
143213995|NCT02160145|516328053|FG000|Randomized Double-blind Period|Physician Decision|0|||
143213996|NCT02160145|516328054|FG001|Randomized Double-blind Period|Physician Decision|7|||
143213997|NCT02160145|516328055|FG002|Randomized Double-blind Period|Physician Decision|5|||
143213998|NCT03597061|516328056|FG000|Overall Study|Lost to Follow-up|1|||
143213999|NCT03597061|516328057|FG001|Overall Study|Lost to Follow-up|0|||
143214000|NCT03597061|516328056|FG000|Overall Study|Protocol Violation|0|||
143214001|NCT03597061|516328057|FG001|Overall Study|Protocol Violation|1|||
143214002|NCT02006979|516328058|FG000|Overall Study|Withdrawal by Subject|1|||
143214003|NCT02006979|516328059|FG001|Overall Study|Withdrawal by Subject|1|||
143214004|NCT02006979|516328058|FG000|Overall Study|Protocol Violation|0|||
143214005|NCT02006979|516328059|FG001|Overall Study|Protocol Violation|1|||
143214006|NCT00375518|516328060|FG000|Overall Study|Withdrawal by Subject|2|||
143214007|NCT00375518|516328061|FG001|Overall Study|Withdrawal by Subject|10|||
143214008|NCT00375518|516328060|FG000|Overall Study|Patient Not Treated|6|||
143214009|NCT00375518|516328061|FG001|Overall Study|Patient Not Treated|6|||
143214010|NCT00375518|516328060|FG000|Overall Study|Death|0|||
143214011|NCT00375518|516328061|FG001|Overall Study|Death|1|||
143214012|NCT02596945|516328062|FG000|Overall Study|No documentation of study drug dosing|3|||
143214013|NCT02596945|516328062|FG000|Overall Study|Other|32|||
143214014|NCT02596945|516328062|FG000|Overall Study|Change to hemodialysis|15|||
143214015|NCT02596945|516328062|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
143214016|NCT02596945|516328062|FG000|Overall Study|Withdrawal by Subject|1|||
143214017|NCT02596945|516328062|FG000|Overall Study|Missing|1|||
143214018|NCT01007838|516328063|FG000|Overall Study|Withdrawal by Subject|1|||
143214019|NCT01007838|516328064|FG001|Overall Study|Withdrawal by Subject|0|||
143214020|NCT01007838|516328065|FG002|Overall Study|Withdrawal by Subject|0|||
143214021|NCT01007838|516328066|FG003|Overall Study|Withdrawal by Subject|0|||
143214022|NCT01007838|516328063|FG000|Overall Study|Physician Decision|1|||
143214023|NCT01007838|516328064|FG001|Overall Study|Physician Decision|0|||
143214024|NCT01007838|516328065|FG002|Overall Study|Physician Decision|0|||
143266344|NCT01130103|516530039|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
143266345|NCT01130103|516530040|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
143266346|NCT01822678|516530043|FG000|Overall Study|Withdrawal by Subject|5|||
143266347|NCT01822678|516530044|FG001|Overall Study|Withdrawal by Subject|4|||
143266348|NCT01822678|516530045|FG002|Overall Study|Withdrawal by Subject|4|||
143266349|NCT01822678|516530043|FG000|Overall Study|Adverse Event|4|||
143266350|NCT01822678|516530044|FG001|Overall Study|Adverse Event|3|||
143266351|NCT01822678|516530045|FG002|Overall Study|Adverse Event|1|||
143266352|NCT01822678|516530043|FG000|Overall Study|Lack of Efficacy|3|||
143371872|NCT02914522|516906332|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
143214025|NCT01007838|516328066|FG003|Overall Study|Physician Decision|0|||
143266353|NCT01822678|516530044|FG001|Overall Study|Lack of Efficacy|6|||
143214026|NCT01007838|516328063|FG000|Overall Study|Started home haemodialysis|1|||
143214027|NCT01007838|516328064|FG001|Overall Study|Started home haemodialysis|0|||
143214028|NCT01007838|516328065|FG002|Overall Study|Started home haemodialysis|0|||
143214029|NCT01007838|516328066|FG003|Overall Study|Started home haemodialysis|0|||
143214030|NCT04699461|516328070|FG000|Overall Study|Withdrawal by Subject|1|||
143214031|NCT04699461|516328071|FG001|Overall Study|Withdrawal by Subject|0|||
143214032|NCT04699461|516328070|FG000|Overall Study|Study termination by sponsor|2|||
143214033|NCT04699461|516328071|FG001|Overall Study|Study termination by sponsor|1|||
143214034|NCT04699461|516328070|FG000|Overall Study|Death|1|||
143266354|NCT01822678|516530045|FG002|Overall Study|Lack of Efficacy|5|||
143214035|NCT04699461|516328071|FG001|Overall Study|Death|0|||
143214036|NCT04699461|516328070|FG000|Overall Study|Radiographic progression|0|||
143214037|NCT04699461|516328071|FG001|Overall Study|Radiographic progression|1|||
143214038|NCT04794270|516329615|FG000|Period 1|Non Compliance|1|||
143214039|NCT04794270|516329616|FG001|Period 1|Non Compliance|0|||
143214040|NCT04794270|516329615|FG000|Period 1|Adverse Event|1|||
143214041|NCT04794270|516329616|FG001|Period 1|Adverse Event|0|||
143214042|NCT04794270|516329615|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
143214043|NCT04794270|516329616|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
143214044|NCT00303485|516329623|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
143214045|NCT00303485|516329624|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
143214046|NCT00303485|516329623|FG000|Overall Study|Failure to return|0|||
143214047|NCT00303485|516329624|FG001|Overall Study|Failure to return|1|||
143214048|NCT00303485|516329623|FG000|Overall Study|Withdrawal by Subject|1|||
143214049|NCT00303485|516329624|FG001|Overall Study|Withdrawal by Subject|0|||
143214050|NCT01504841|516329625|FG000|Overall Study|Withdrawal by Subject|1|||
143214051|NCT01504841|516329626|FG001|Overall Study|Withdrawal by Subject|1|||
143214052|NCT01504841|516329627|FG002|Overall Study|Withdrawal by Subject|0|||
143214053|NCT01496469|516329630|FG000|Overall Study|Adverse Event|1|||
143214054|NCT01496469|516329631|FG001|Overall Study|Adverse Event|0|||
143214055|NCT01496469|516329630|FG000|Overall Study|Protocol Violation|2|||
143214056|NCT01496469|516329631|FG001|Overall Study|Protocol Violation|0|||
143214057|NCT01496469|516329630|FG000|Overall Study|Lost to Follow-up|1|||
143214058|NCT01496469|516329631|FG001|Overall Study|Lost to Follow-up|1|||
143214059|NCT01496469|516329630|FG000|Overall Study|Withdrawal by Subject|4|||
143214060|NCT01496469|516329631|FG001|Overall Study|Withdrawal by Subject|4|||
143214061|NCT01496469|516329630|FG000|Overall Study|BP exceeds protocol limits|1|||
143214062|NCT01496469|516329631|FG001|Overall Study|BP exceeds protocol limits|2|||
143214063|NCT01496469|516329630|FG000|Overall Study|Other|1|||
143214064|NCT01496469|516329631|FG001|Overall Study|Other|1|||
143214065|NCT00630344|516329632|FG000|Overall Study|Adverse Event|5|||
143214066|NCT00630344|516329632|FG000|Overall Study|Progressive Disease|19|||
143214067|NCT00630344|516329632|FG000|Overall Study|Physician Decision|9|||
143214068|NCT00630344|516329632|FG000|Overall Study|Withdrawal by Subject|1|||
143214069|NCT00630344|516329632|FG000|Overall Study|Intercurrent Illness|1|||
143214070|NCT00630344|516329632|FG000|Overall Study|Other|1|||
143214071|NCT02202538|516329643|FG000|Overall Study|Withdrawal by Subject|5|||
143214072|NCT02202538|516329643|FG000|Overall Study|Did not meet all inclusion criteria|2|||
143214073|NCT02202538|516329643|FG000|Overall Study|Investigator Decision|1|||
143214074|NCT01457846|516329645|FG000|Overall Study|Death before treatment|1|||
143214075|NCT01457846|516329646|FG001|Overall Study|Death before treatment|2|||
143214076|NCT01457846|516329645|FG000|Overall Study|Did not receive treatment|0|||
143214077|NCT01457846|516329646|FG001|Overall Study|Did not receive treatment|1|||
143214078|NCT01457846|516329645|FG000|Overall Study|Death|27|||
143214079|NCT01457846|516329646|FG001|Overall Study|Death|16|||
143214080|NCT01457846|516329645|FG000|Overall Study|Unclassified reason for not completed|11|||
143214081|NCT01457846|516329646|FG001|Overall Study|Unclassified reason for not completed|10|||
143214082|NCT01457846|516329645|FG000|Overall Study|Withdrawal by Subject|1|||
143214083|NCT01457846|516329646|FG001|Overall Study|Withdrawal by Subject|1|||
143214084|NCT01457846|516329645|FG000|Overall Study|Lost to Follow-up|1|||
143214085|NCT01457846|516329646|FG001|Overall Study|Lost to Follow-up|0|||
143214086|NCT01853878|516329647|FG000|Overall Study|Recurrence|2|||
143214087|NCT01853878|516329648|FG001|Overall Study|Recurrence|0|||
143266355|NCT01822678|516530043|FG000|Overall Study|Lost to Follow-up|0|||
143266356|NCT01822678|516530044|FG001|Overall Study|Lost to Follow-up|2|||
143266357|NCT01822678|516530045|FG002|Overall Study|Lost to Follow-up|1|||
143266358|NCT04795622|516530048|FG000|Overall Study|Adverse Event|1|||
143266359|NCT04795622|516530049|FG001|Overall Study|Adverse Event|0|||
143266360|NCT04795622|516530048|FG000|Overall Study|Withdrawal by Subject|3|||
143266361|NCT04795622|516530049|FG001|Overall Study|Withdrawal by Subject|3|||
143266362|NCT04795622|516530048|FG000|Overall Study|Protocol Violation|0|||
143266363|NCT04795622|516530049|FG001|Overall Study|Protocol Violation|2|||
143266364|NCT04795622|516530048|FG000|Overall Study|Lost to Follow-up|2|||
143214088|NCT01853878|516329647|FG000|Overall Study|Adverse Event|2|||
143214089|NCT01853878|516329648|FG001|Overall Study|Adverse Event|0|||
143214090|NCT01853878|516329647|FG000|Overall Study|Withdrawal by Subject|3|||
143214091|NCT01853878|516329648|FG001|Overall Study|Withdrawal by Subject|1|||
143214092|NCT01853878|516329647|FG000|Overall Study|Migrated/moved from the study area|1|||
143214093|NCT01853878|516329648|FG001|Overall Study|Migrated/moved from the study area|0|||
143214094|NCT01853878|516329647|FG000|Overall Study|Other|55|||
143214095|NCT01853878|516329648|FG001|Overall Study|Other|43|||
143214096|NCT01846741|516329649|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
143214097|NCT02161757|516329650|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
143266365|NCT04795622|516530049|FG001|Overall Study|Lost to Follow-up|3|||
143266366|NCT04795622|516530048|FG000|Overall Study|Other|7|||
143266367|NCT04795622|516530049|FG001|Overall Study|Other|8|||
143266368|NCT01369615|516530050|FG000|Overall Study|Withdrawal by Subject|0|||
143266369|NCT01369615|516530051|FG001|Overall Study|Withdrawal by Subject|1|||
143214098|NCT02161757|516329651|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
143214099|NCT02161757|516329652|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
143214100|NCT02161757|516329650|FG000|Treatment Through Study Completion|Adverse Event|1|||
143214101|NCT02161757|516329651|FG001|Treatment Through Study Completion|Adverse Event|1|||
143214102|NCT02161757|516329652|FG002|Treatment Through Study Completion|Adverse Event|0|||
143371873|NCT02914522|516906333|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
143214103|NCT02161757|516329650|FG000|Treatment Through Study Completion|Protocol Violation|0|||
143214104|NCT02161757|516329651|FG001|Treatment Through Study Completion|Protocol Violation|1|||
143214105|NCT02161757|516329652|FG002|Treatment Through Study Completion|Protocol Violation|2|||
143214106|NCT02161757|516329650|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
143214107|NCT02161757|516329651|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
143214108|NCT02161757|516329652|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
143214109|NCT02161757|516329650|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
143214110|NCT02161757|516329651|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
143214111|NCT02161757|516329652|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
143214112|NCT02161757|516329650|FG000|Treatment Through Study Completion|Other|20|||
143214113|NCT02161757|516329651|FG001|Treatment Through Study Completion|Other|19|||
143214114|NCT02161757|516329652|FG002|Treatment Through Study Completion|Other|12|||
143214115|NCT02161757|516329650|FG000|Treatment Through Study Completion|Death|2|||
143214116|NCT02161757|516329651|FG001|Treatment Through Study Completion|Death|1|||
143214117|NCT02161757|516329652|FG002|Treatment Through Study Completion|Death|1|||
143214118|NCT04294147|516329660|FG000|Overall Study|Protocol Violation|2|||
143214119|NCT04294147|516329661|FG001|Overall Study|Protocol Violation|0|||
143214120|NCT05392803|516329662|FG000|Overall Study|Lost to Follow-up|0|||
143214121|NCT05392803|516329663|FG001|Overall Study|Lost to Follow-up|2|||
143214122|NCT02332291|516329664|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
143214123|NCT02332291|516329665|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
143214124|NCT02332291|516329664|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
143214125|NCT02332291|516329665|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
143214126|NCT02332291|516329664|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
143214127|NCT02332291|516329665|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
143214128|NCT02332291|516329664|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
143214129|NCT02332291|516329665|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
143214130|NCT02332291|516329664|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
143214131|NCT02332291|516329665|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
143214132|NCT02332291|516329664|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
143371874|NCT02914522|516906334|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
143371875|NCT02914522|516906335|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
143371876|NCT02914522|516906336|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
143371877|NCT02914522|516906337|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
143371878|NCT02914522|516906338|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
143214133|NCT02332291|516329665|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
143214134|NCT00465647|516329670|FG000|Overall Study|Administrative|2|||
143214135|NCT00465647|516329671|FG001|Overall Study|Administrative|2|||
143214136|NCT00465647|516329672|FG002|Overall Study|Administrative|3|||
143214137|NCT00465647|516329673|FG003|Overall Study|Administrative|2|||
143214138|NCT00465647|516329670|FG000|Overall Study|Adverse Event|2|||
143214139|NCT00465647|516329671|FG001|Overall Study|Adverse Event|0|||
143214140|NCT00465647|516329672|FG002|Overall Study|Adverse Event|3|||
143214141|NCT00465647|516329673|FG003|Overall Study|Adverse Event|2|||
143214142|NCT00465647|516329670|FG000|Overall Study|Withdrawal by Subject|1|||
143214143|NCT00465647|516329671|FG001|Overall Study|Withdrawal by Subject|2|||
143214144|NCT00465647|516329672|FG002|Overall Study|Withdrawal by Subject|2|||
143214145|NCT00465647|516329673|FG003|Overall Study|Withdrawal by Subject|7|||
143214146|NCT00465647|516329670|FG000|Overall Study|"The other reasons included loss of IV"|8|||
143214147|NCT00465647|516329671|FG001|Overall Study|"The other reasons included loss of IV"|4|||
143214148|NCT00465647|516329672|FG002|Overall Study|"The other reasons included loss of IV"|3|||
143214149|NCT00465647|516329673|FG003|Overall Study|"The other reasons included loss of IV"|2|||
143214150|NCT03916081|516329674|FG000|Overall Study|Adverse Event|1|||
143214151|NCT03916081|516329675|FG001|Overall Study|Adverse Event|0|||
143214152|NCT03916081|516329676|FG002|Overall Study|Adverse Event|0|||
143214153|NCT03916081|516329674|FG000|Overall Study|Physician Decision|0|||
143214154|NCT03916081|516329675|FG001|Overall Study|Physician Decision|0|||
143214155|NCT03916081|516329676|FG002|Overall Study|Physician Decision|1|||
143214156|NCT03916081|516329674|FG000|Overall Study|Lost to Follow-up|0|||
143214157|NCT03916081|516329675|FG001|Overall Study|Lost to Follow-up|1|||
143214158|NCT03916081|516329676|FG002|Overall Study|Lost to Follow-up|0|||
143266370|NCT01369615|516530050|FG000|Overall Study|Lost to Follow-up|0|||
143266371|NCT01369615|516530051|FG001|Overall Study|Lost to Follow-up|1|||
143266372|NCT04263454|516530052|FG000|Overall Study|Adverse Event|0|||
143266373|NCT04263454|516530053|FG001|Overall Study|Adverse Event|2|||
143266374|NCT04263454|516530052|FG000|Overall Study|Physician Decision|3|||
143266375|NCT04263454|516530053|FG001|Overall Study|Physician Decision|5|||
143266376|NCT04263454|516530052|FG000|Overall Study|Poor Data Quality|0|||
143266377|NCT04263454|516530053|FG001|Overall Study|Poor Data Quality|1|||
143266378|NCT00986479|516530055|FG000|Period 1|Improved mood|1|||
143214159|NCT03916081|516329674|FG000|Overall Study|Withdrawal by Subject|3|||
143214160|NCT03916081|516329675|FG001|Overall Study|Withdrawal by Subject|0|||
143214161|NCT03916081|516329676|FG002|Overall Study|Withdrawal by Subject|1|||
143214162|NCT03916081|516329674|FG000|Overall Study|Worsening of AD|0|||
143214163|NCT03916081|516329675|FG001|Overall Study|Worsening of AD|0|||
143214164|NCT03916081|516329676|FG002|Overall Study|Worsening of AD|1|||
143214165|NCT01240135|516329679|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
143214166|NCT01240135|516329680|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
143214167|NCT01240135|516329679|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
143214168|NCT01240135|516329680|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
143214169|NCT00699335|516329681|FG000|Overall Study|Combination of multiple reasons|176|||
143214170|NCT00699335|516329681|FG000|Overall Study|Missing data|52|||
143214171|NCT01371305|516329686|FG000|Overall Study|Adverse Event|0|||
143214172|NCT01371305|516329687|FG001|Overall Study|Adverse Event|0|||
143214173|NCT01371305|516329688|FG002|Overall Study|Adverse Event|0|||
143214174|NCT01371305|516329689|FG003|Overall Study|Adverse Event|2|||
143214175|NCT01371305|516329690|FG004|Overall Study|Adverse Event|1|||
143214176|NCT01371305|516329691|FG005|Overall Study|Adverse Event|0|||
143214177|NCT01371305|516329686|FG000|Overall Study|Study terminated by sponsor|0|||
143214178|NCT01371305|516329687|FG001|Overall Study|Study terminated by sponsor|0|||
143214179|NCT01371305|516329688|FG002|Overall Study|Study terminated by sponsor|0|||
143214180|NCT01371305|516329689|FG003|Overall Study|Study terminated by sponsor|0|||
143214181|NCT01371305|516329690|FG004|Overall Study|Study terminated by sponsor|3|||
143214182|NCT01371305|516329691|FG005|Overall Study|Study terminated by sponsor|1|||
143214183|NCT01371305|516329686|FG000|Overall Study|Subject request|0|||
143214184|NCT01371305|516329687|FG001|Overall Study|Subject request|0|||
143214185|NCT01371305|516329688|FG002|Overall Study|Subject request|0|||
143214186|NCT01371305|516329689|FG003|Overall Study|Subject request|0|||
143214187|NCT01371305|516329690|FG004|Overall Study|Subject request|0|||
143214188|NCT01371305|516329691|FG005|Overall Study|Subject request|1|||
143214189|NCT02220712|516329692|FG000|Overall Study|Adverse Event|1|||
143214190|NCT02220712|516329692|FG000|Overall Study|Withdrawal by Subject|2|||
143214191|NCT02220712|516329692|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
143214192|NCT00760838|516329693|FG000|Overall Study|Adverse Event|1|||
143214193|NCT00760838|516329694|FG001|Overall Study|Adverse Event|1|||
143214194|NCT00760838|516329693|FG000|Overall Study|Lack of Efficacy|1|||
143214195|NCT00760838|516329694|FG001|Overall Study|Lack of Efficacy|0|||
143214196|NCT00760838|516329693|FG000|Overall Study|Lost to Follow-up|2|||
143214197|NCT00760838|516329694|FG001|Overall Study|Lost to Follow-up|0|||
143214198|NCT00760838|516329693|FG000|Overall Study|Withdrawal by Subject|1|||
143214199|NCT00760838|516329694|FG001|Overall Study|Withdrawal by Subject|1|||
143214200|NCT02726022|516329695|FG000|Overall Study|Adverse Event|14|||
143214201|NCT02726022|516329695|FG000|Overall Study|Treatment Failure|8|||
143214202|NCT02726022|516329695|FG000|Overall Study|Poor Compliance|13|||
143214203|NCT02726022|516329695|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
143214204|NCT01817959|516329696|FG000|Overall Study|Graft loss|1|||
143214205|NCT01817959|516329697|FG001|Overall Study|Graft loss|1|||
143214206|NCT01817959|516329696|FG000|Overall Study|forbidden medication|1|||
143214207|NCT01817959|516329697|FG001|Overall Study|forbidden medication|1|||
143214208|NCT01817959|516329696|FG000|Overall Study|Adverse Event|1|||
143214209|NCT01817959|516329697|FG001|Overall Study|Adverse Event|0|||
143266379|NCT00986479|516530056|FG001|Period 1|Improved mood|0|||
143266380|NCT00986479|516530055|FG000|Period 1|Administrative reasons|1|||
143266381|NCT00986479|516530056|FG001|Period 1|Administrative reasons|0|||
143266382|NCT01721070|516530057|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
143214210|NCT01817959|516329696|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
143214211|NCT01817959|516329697|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
143214212|NCT01183065|516329708|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
143214213|NCT03657095|516329709|FG000|Overall Study|Withdrawal by Subject|1|||
143214214|NCT03657095|516329710|FG001|Overall Study|Withdrawal by Subject|1|||
143214215|NCT03657095|516329709|FG000|Overall Study|Adverse Event|0|||
143214216|NCT03657095|516329710|FG001|Overall Study|Adverse Event|3|||
143214217|NCT03657095|516329709|FG000|Overall Study|Study Terminated by Sponsor|58|||
143214218|NCT03657095|516329710|FG001|Overall Study|Study Terminated by Sponsor|49|||
143214219|NCT00348309|516329713|FG000|Overall Study|Adverse Event|56|||
143214220|NCT00348309|516329714|FG001|Overall Study|Adverse Event|28|||
143214221|NCT00348309|516329715|FG002|Overall Study|Adverse Event|63|||
143214222|NCT00348309|516329713|FG000|Overall Study|Lost to Follow-up|6|||
143214223|NCT00348309|516329714|FG001|Overall Study|Lost to Follow-up|7|||
143214224|NCT00348309|516329715|FG002|Overall Study|Lost to Follow-up|4|||
143214225|NCT00348309|516329713|FG000|Overall Study|Protocol Violation|7|||
143214226|NCT00348309|516329714|FG001|Overall Study|Protocol Violation|12|||
143214227|NCT00348309|516329715|FG002|Overall Study|Protocol Violation|7|||
143214228|NCT00348309|516329713|FG000|Overall Study|Withdrawal by Subject|33|||
143214229|NCT00348309|516329714|FG001|Overall Study|Withdrawal by Subject|37|||
143214230|NCT00348309|516329715|FG002|Overall Study|Withdrawal by Subject|40|||
143214231|NCT00348309|516329713|FG000|Overall Study|Non-compliance|8|||
143214232|NCT00348309|516329714|FG001|Overall Study|Non-compliance|6|||
143214233|NCT00348309|516329715|FG002|Overall Study|Non-compliance|8|||
143214234|NCT00348309|516329713|FG000|Overall Study|Death of caregiver|1|||
143214235|NCT00348309|516329714|FG001|Overall Study|Death of caregiver|0|||
143214236|NCT00348309|516329715|FG002|Overall Study|Death of caregiver|1|||
143214237|NCT00348309|516329713|FG000|Overall Study|Lack of insight, dementia|1|||
143214238|NCT00348309|516329714|FG001|Overall Study|Lack of insight, dementia|0|||
143214239|NCT00348309|516329715|FG002|Overall Study|Lack of insight, dementia|0|||
143214240|NCT00348309|516329713|FG000|Overall Study|Wrong bottle allocated|1|||
143214241|NCT00348309|516329714|FG001|Overall Study|Wrong bottle allocated|0|||
143214242|NCT00348309|516329715|FG002|Overall Study|Wrong bottle allocated|0|||
143214243|NCT00348309|516329713|FG000|Overall Study|Caregiver sick|1|||
143214244|NCT00348309|516329714|FG001|Overall Study|Caregiver sick|0|||
143214245|NCT00348309|516329715|FG002|Overall Study|Caregiver sick|0|||
143214246|NCT00348309|516329713|FG000|Overall Study|Use of prohibited medication|5|||
143214247|NCT00348309|516329714|FG001|Overall Study|Use of prohibited medication|2|||
143214248|NCT00348309|516329715|FG002|Overall Study|Use of prohibited medication|2|||
143214249|NCT00348309|516329713|FG000|Overall Study|Caregiver withdrawal|3|||
143214250|NCT00348309|516329714|FG001|Overall Study|Caregiver withdrawal|0|||
143214251|NCT00348309|516329715|FG002|Overall Study|Caregiver withdrawal|7|||
143214252|NCT00348309|516329713|FG000|Overall Study|Unable to complete ET visit|1|||
143214253|NCT00348309|516329714|FG001|Overall Study|Unable to complete ET visit|0|||
143214254|NCT00348309|516329715|FG002|Overall Study|Unable to complete ET visit|0|||
143214255|NCT00348309|516329713|FG000|Overall Study|PI closing medical practice|1|||
143214256|NCT00348309|516329714|FG001|Overall Study|PI closing medical practice|0|||
143214257|NCT00348309|516329715|FG002|Overall Study|PI closing medical practice|0|||
143214258|NCT00348309|516329713|FG000|Overall Study|Principal investigator's decision|1|||
143214259|NCT00348309|516329714|FG001|Overall Study|Principal investigator's decision|0|||
143214260|NCT00348309|516329715|FG002|Overall Study|Principal investigator's decision|0|||
143214261|NCT00348309|516329713|FG000|Overall Study|No disponibility of medication|1|||
143214262|NCT00348309|516329714|FG001|Overall Study|No disponibility of medication|0|||
143214263|NCT00348309|516329715|FG002|Overall Study|No disponibility of medication|0|||
143214264|NCT00348309|516329713|FG000|Overall Study|Worsened neurodegenerative disease|1|||
143214265|NCT00348309|516329714|FG001|Overall Study|Worsened neurodegenerative disease|0|||
143214266|NCT00348309|516329715|FG002|Overall Study|Worsened neurodegenerative disease|0|||
143214267|NCT00348309|516329713|FG000|Overall Study|Cognitive and behaviour worsening|2|||
143214268|NCT00348309|516329714|FG001|Overall Study|Cognitive and behaviour worsening|0|||
143214269|NCT00348309|516329715|FG002|Overall Study|Cognitive and behaviour worsening|0|||
143214270|NCT00348309|516329713|FG000|Overall Study|Worsening of alzheimer|1|||
143214271|NCT00348309|516329714|FG001|Overall Study|Worsening of alzheimer|0|||
143214272|NCT00348309|516329715|FG002|Overall Study|Worsening of alzheimer|1|||
143214273|NCT00348309|516329713|FG000|Overall Study|Did not appear in time for Visit 3|1|||
143214274|NCT00348309|516329714|FG001|Overall Study|Did not appear in time for Visit 3|0|||
143214275|NCT00348309|516329715|FG002|Overall Study|Did not appear in time for Visit 3|0|||
143214276|NCT00348309|516329713|FG000|Overall Study|Participant died|2|||
143214277|NCT00348309|516329714|FG001|Overall Study|Participant died|1|||
143214278|NCT00348309|516329715|FG002|Overall Study|Participant died|1|||
143214279|NCT00348309|516329713|FG000|Overall Study|Decision of sponsor|1|||
143214280|NCT00348309|516329714|FG001|Overall Study|Decision of sponsor|0|||
143214281|NCT00348309|516329715|FG002|Overall Study|Decision of sponsor|0|||
143214282|NCT00348309|516329713|FG000|Overall Study|Ineffectiveness of treatment|0|||
143214283|NCT00348309|516329714|FG001|Overall Study|Ineffectiveness of treatment|1|||
143214284|NCT00348309|516329715|FG002|Overall Study|Ineffectiveness of treatment|0|||
143214285|NCT00348309|516329713|FG000|Overall Study|A foul of exclusion criteria|0|||
143214286|NCT00348309|516329714|FG001|Overall Study|A foul of exclusion criteria|1|||
143214287|NCT00348309|516329715|FG002|Overall Study|A foul of exclusion criteria|0|||
143214288|NCT00348309|516329713|FG000|Overall Study|Participant was hospitalized|0|||
143214289|NCT00348309|516329714|FG001|Overall Study|Participant was hospitalized|1|||
143214290|NCT00348309|516329715|FG002|Overall Study|Participant was hospitalized|0|||
143214291|NCT00348309|516329713|FG000|Overall Study|Sponsor refuseal|0|||
143214292|NCT00348309|516329714|FG001|Overall Study|Sponsor refuseal|1|||
143214293|NCT00348309|516329715|FG002|Overall Study|Sponsor refuseal|1|||
143214294|NCT00348309|516329713|FG000|Overall Study|Forgot often medication|0|||
143214295|NCT00348309|516329714|FG001|Overall Study|Forgot often medication|1|||
143214296|NCT00348309|516329715|FG002|Overall Study|Forgot often medication|0|||
143214297|NCT00348309|516329713|FG000|Overall Study|Medical Monitor decision|0|||
143214298|NCT00348309|516329714|FG001|Overall Study|Medical Monitor decision|0|||
143214299|NCT00348309|516329715|FG002|Overall Study|Medical Monitor decision|1|||
143214300|NCT00348309|516329713|FG000|Overall Study|Increased dose of Aricept|0|||
143214301|NCT00348309|516329714|FG001|Overall Study|Increased dose of Aricept|0|||
143214302|NCT00348309|516329715|FG002|Overall Study|Increased dose of Aricept|1|||
143214303|NCT00348309|516329713|FG000|Overall Study|Site closure|0|||
143214304|NCT00348309|516329714|FG001|Overall Study|Site closure|0|||
143214305|NCT00348309|516329715|FG002|Overall Study|Site closure|1|||
143214306|NCT00348309|516329713|FG000|Overall Study|Adverse event not attended|0|||
143214307|NCT00348309|516329714|FG001|Overall Study|Adverse event not attended|0|||
143214308|NCT00348309|516329715|FG002|Overall Study|Adverse event not attended|1|||
143214309|NCT00348309|516329713|FG000|Overall Study|ECG abnormal|0|||
143214310|NCT00348309|516329714|FG001|Overall Study|ECG abnormal|0|||
143214311|NCT00348309|516329715|FG002|Overall Study|ECG abnormal|2|||
143214312|NCT00348309|516329713|FG000|Overall Study|Cardiologist recommendations|0|||
143214313|NCT00348309|516329714|FG001|Overall Study|Cardiologist recommendations|0|||
143214314|NCT00348309|516329715|FG002|Overall Study|Cardiologist recommendations|1|||
143214315|NCT00348309|516329713|FG000|Overall Study|HCV career|0|||
143214316|NCT00348309|516329714|FG001|Overall Study|HCV career|0|||
143214317|NCT00348309|516329715|FG002|Overall Study|HCV career|1|||
143214318|NCT00622388|516329716|FG000|Overall Study|Disease Progression|47|||
143214319|NCT00622388|516329716|FG000|Overall Study|Adverse Event|6|||
143214320|NCT00622388|516329716|FG000|Overall Study|Protocol Violation|3|||
143214321|NCT00622388|516329716|FG000|Overall Study|Participant Refusal|1|||
143214322|NCT00622388|516329716|FG000|Overall Study|Death|3|||
143214323|NCT00622388|516329716|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
143214324|NCT00622388|516329716|FG000|Overall Study|Took Prohibited Medication|2|||
143214325|NCT00622388|516329716|FG000|Overall Study|Withdrew Consent|1|||
143214326|NCT00622388|516329716|FG000|Overall Study|Insurance Expired|1|||
143214327|NCT01894243|516329717|FG000|Overall Study|Adverse Event|0|||
143214328|NCT01894243|516329718|FG001|Overall Study|Adverse Event|1|||
143214329|NCT01894243|516329719|FG002|Overall Study|Adverse Event|2|||
143214330|NCT01894243|516329717|FG000|Overall Study|Death|0|||
143214331|NCT01894243|516329718|FG001|Overall Study|Death|0|||
143214332|NCT01894243|516329719|FG002|Overall Study|Death|3|||
143214333|NCT01894243|516329717|FG000|Overall Study|Lack of Efficacy|3|||
143214334|NCT01894243|516329718|FG001|Overall Study|Lack of Efficacy|3|||
143214335|NCT01894243|516329719|FG002|Overall Study|Lack of Efficacy|1|||
143214336|NCT01894243|516329717|FG000|Overall Study|Condition under investigation worsened|8|||
143214337|NCT01894243|516329718|FG001|Overall Study|Condition under investigation worsened|6|||
143214338|NCT01894243|516329719|FG002|Overall Study|Condition under investigation worsened|2|||
143214339|NCT01894243|516329717|FG000|Overall Study|Subject decision|1|||
143214340|NCT01894243|516329718|FG001|Overall Study|Subject decision|0|||
143214341|NCT01894243|516329719|FG002|Overall Study|Subject decision|0|||
143214342|NCT01894243|516329717|FG000|Overall Study|Other|1|||
143214343|NCT01894243|516329718|FG001|Overall Study|Other|0|||
143214344|NCT01894243|516329719|FG002|Overall Study|Other|0|||
143214345|NCT01743040|516329720|FG000|Overall Study|Death|1|||
143214346|NCT01743040|516329720|FG000|Overall Study|Lost to Follow-up|66|||
143214347|NCT01743040|516329720|FG000|Overall Study|Physician Decision|40|||
143214348|NCT01743040|516329720|FG000|Overall Study|Protocol Violation|1|||
143214349|NCT01743040|516329720|FG000|Overall Study|Withdrawal by Subject|121|||
143214350|NCT00828750|516329721|FG000|Overall Study|Lack of Efficacy|3|||
143214351|NCT00828750|516329721|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
143214352|NCT04006392|516329722|FG000|Overall Study|Lost to Follow-up|0|||
143214353|NCT04006392|516329723|FG001|Overall Study|Lost to Follow-up|1|||
143214354|NCT01299116|516329725|FG000|Overall Study|Lost to Follow-up|65|||
143214355|NCT01299116|516329726|FG001|Overall Study|Lost to Follow-up|9|||
143214356|NCT01299116|516329727|FG002|Overall Study|Lost to Follow-up|11|||
143214357|NCT01620944|516329728|FG000|Overall Study|Early termination of Study|2|||
143214358|NCT01620944|516329729|FG001|Overall Study|Early termination of Study|1|||
143214359|NCT04378114|516329730|FG000|Overall Study|Withdrawal by Subject|5|||
143214360|NCT00830180|516329731|FG000|Overall Study|Adverse Event|6|||
143214361|NCT00830180|516329731|FG000|Overall Study|Death|11|||
143214362|NCT00830180|516329731|FG000|Overall Study|Insufficient clinical response|1|||
143214363|NCT00830180|516329731|FG000|Overall Study|Withdrawal by Subject|5|||
143214364|NCT00830180|516329731|FG000|Overall Study|Progressive disease|2|||
143214365|NCT00830180|516329731|FG000|Overall Study|Other - Unspecified|1|||
143214366|NCT01832532|516329732|FG000|Overall Study|Withdrawal by Subject|5|||
143214367|NCT01832532|516329733|FG001|Overall Study|Withdrawal by Subject|2|||
143214368|NCT00392990|516329734|FG000|Treatment on Study|Adverse Event|3|||
143214369|NCT00392990|516329735|FG001|Treatment on Study|Adverse Event|1|||
143214370|NCT00392990|516329734|FG000|Follow up for 2 Years|Death|4|||
143214371|NCT00392990|516329735|FG001|Follow up for 2 Years|Death|0|||
143214372|NCT03052816|516329740|FG000|Overall Study|Withdrawal by Subject|1|||
143214373|NCT03052816|516329741|FG001|Overall Study|Withdrawal by Subject|0|||
143214374|NCT03052816|516329740|FG000|Overall Study|Desired opioids|2|||
143214375|NCT03052816|516329741|FG001|Overall Study|Desired opioids|0|||
143214376|NCT03755661|516329742|FG000|Overall Study|Lost to Follow-up|1|||
143214377|NCT03755661|516329743|FG001|Overall Study|Lost to Follow-up|0|||
143214378|NCT00895453|516329744|FG000|Overall Study|Lost to Follow-up|25|||
143214379|NCT00895453|516329745|FG001|Overall Study|Lost to Follow-up|25|||
143214380|NCT00895453|516329746|FG002|Overall Study|Lost to Follow-up|23|||
143214381|NCT01736618|516329749|FG000|Overall Study|Death|294|||
143214382|NCT01736618|516329749|FG000|Overall Study|Lost to Follow-up|193|||
143214383|NCT01736618|516329749|FG000|Overall Study|Withdrawal by Subject|54|||
143214384|NCT01736618|516329749|FG000|Overall Study|Subject unable to be followed at study location|223|||
143214385|NCT01736618|516329749|FG000|Overall Study|Physician Decision|33|||
143214386|NCT01736618|516329749|FG000|Overall Study|Transplant or removal of target organ|19|||
143214387|NCT01736618|516329749|FG000|Overall Study|Change in indication or condition|78|||
143214388|NCT01736618|516329749|FG000|Overall Study|Study device explant|103|||
143214389|NCT01736618|516329749|FG000|Overall Study|Unable to complete implant|2|||
143214390|NCT04167137|516329751|FG000|Overall Study|Disease progression|1|||
143214391|NCT04167137|516329752|FG001|Overall Study|Disease progression|1|||
143214392|NCT04167137|516329753|FG002|Overall Study|Disease progression|3|||
143214393|NCT04167137|516329754|FG003|Overall Study|Disease progression|3|||
143214394|NCT04167137|516329755|FG004|Overall Study|Disease progression|2|||
143214395|NCT04167137|516329756|FG005|Overall Study|Disease progression|3|||
143214396|NCT04167137|516329757|FG006|Overall Study|Disease progression|2|||
143214397|NCT04167137|516329758|FG007|Overall Study|Disease progression|2|||
143214398|NCT04167137|516329751|FG000|Overall Study|Withdrawal by Subject|1|||
143214399|NCT04167137|516329752|FG001|Overall Study|Withdrawal by Subject|0|||
143214400|NCT04167137|516329753|FG002|Overall Study|Withdrawal by Subject|0|||
143214401|NCT04167137|516329754|FG003|Overall Study|Withdrawal by Subject|1|||
143214402|NCT04167137|516329755|FG004|Overall Study|Withdrawal by Subject|0|||
143214403|NCT04167137|516329756|FG005|Overall Study|Withdrawal by Subject|2|||
143214404|NCT04167137|516329757|FG006|Overall Study|Withdrawal by Subject|1|||
143214405|NCT04167137|516329758|FG007|Overall Study|Withdrawal by Subject|0|||
143214406|NCT04167137|516329751|FG000|Overall Study|Adverse Event|0|||
143214407|NCT04167137|516329752|FG001|Overall Study|Adverse Event|0|||
143214408|NCT04167137|516329753|FG002|Overall Study|Adverse Event|0|||
143214409|NCT04167137|516329754|FG003|Overall Study|Adverse Event|0|||
143214410|NCT04167137|516329755|FG004|Overall Study|Adverse Event|0|||
143214411|NCT04167137|516329756|FG005|Overall Study|Adverse Event|1|||
143214412|NCT04167137|516329757|FG006|Overall Study|Adverse Event|0|||
143214413|NCT04167137|516329758|FG007|Overall Study|Adverse Event|1|||
143214414|NCT04167137|516329751|FG000|Overall Study|Physician Decision|0|||
143214415|NCT04167137|516329752|FG001|Overall Study|Physician Decision|0|||
143214416|NCT04167137|516329753|FG002|Overall Study|Physician Decision|0|||
143214417|NCT04167137|516329754|FG003|Overall Study|Physician Decision|1|||
143214418|NCT04167137|516329755|FG004|Overall Study|Physician Decision|0|||
143214419|NCT04167137|516329756|FG005|Overall Study|Physician Decision|0|||
143214420|NCT04167137|516329757|FG006|Overall Study|Physician Decision|1|||
143214421|NCT04167137|516329758|FG007|Overall Study|Physician Decision|0|||
143214422|NCT04167137|516329751|FG000|Overall Study|Death|0|||
143214423|NCT04167137|516329752|FG001|Overall Study|Death|1|||
143214424|NCT04167137|516329753|FG002|Overall Study|Death|0|||
143214425|NCT04167137|516329754|FG003|Overall Study|Death|0|||
143214426|NCT04167137|516329755|FG004|Overall Study|Death|0|||
143214427|NCT04167137|516329756|FG005|Overall Study|Death|0|||
143214428|NCT04167137|516329757|FG006|Overall Study|Death|0|||
143214429|NCT04167137|516329758|FG007|Overall Study|Death|0|||
143214430|NCT04167137|516329751|FG000|Overall Study|Study terminated by Sponsor|0|||
143214431|NCT04167137|516329752|FG001|Overall Study|Study terminated by Sponsor|0|||
143214432|NCT04167137|516329753|FG002|Overall Study|Study terminated by Sponsor|0|||
143214433|NCT04167137|516329754|FG003|Overall Study|Study terminated by Sponsor|0|||
143214434|NCT04167137|516329755|FG004|Overall Study|Study terminated by Sponsor|0|||
143214435|NCT04167137|516329756|FG005|Overall Study|Study terminated by Sponsor|0|||
143214436|NCT04167137|516329757|FG006|Overall Study|Study terminated by Sponsor|0|||
143214437|NCT04167137|516329758|FG007|Overall Study|Study terminated by Sponsor|1|||
143214438|NCT00400569|516329761|FG000|Overall Study|Death|1|||
143214439|NCT01748825|516329762|FG000|Dose Escalation|Refused further treatment|2|||
143214440|NCT01748825|516329763|FG001|Dose Escalation|Refused further treatment|2|||
143214441|NCT01748825|516329764|FG002|Dose Escalation|Refused further treatment|0|||
143214442|NCT01748825|516329765|FG003|Dose Escalation|Refused further treatment|0|||
143214443|NCT01748825|516329766|FG004|Dose Escalation|Refused further treatment|1|||
143214444|NCT01748825|516329767|FG005|Dose Escalation|Refused further treatment|2|||
143214445|NCT01748825|516329768|FG006|Dose Escalation|Refused further treatment|0|||
143214446|NCT01748825|516329769|FG007|Dose Escalation|Refused further treatment|0|||
143214447|NCT01748825|516329770|FG008|Dose Escalation|Refused further treatment|0|||
143214448|NCT01748825|516329771|FG009|Dose Escalation|Refused further treatment|0|||
143214449|NCT01748825|516329762|FG000|Dose Escalation|Switched to alternative treatment|0|||
143214450|NCT01748825|516329763|FG001|Dose Escalation|Switched to alternative treatment|0|||
143214451|NCT01748825|516329764|FG002|Dose Escalation|Switched to alternative treatment|0|||
143214452|NCT01748825|516329765|FG003|Dose Escalation|Switched to alternative treatment|1|||
143214453|NCT01748825|516329766|FG004|Dose Escalation|Switched to alternative treatment|0|||
143214454|NCT01748825|516329767|FG005|Dose Escalation|Switched to alternative treatment|0|||
143214455|NCT01748825|516329768|FG006|Dose Escalation|Switched to alternative treatment|0|||
143214456|NCT01748825|516329769|FG007|Dose Escalation|Switched to alternative treatment|0|||
143214457|NCT01748825|516329770|FG008|Dose Escalation|Switched to alternative treatment|0|||
143214458|NCT01748825|516329771|FG009|Dose Escalation|Switched to alternative treatment|0|||
143214459|NCT01748825|516329762|FG000|Dose Escalation|Adverse Event|0|||
143214460|NCT01748825|516329763|FG001|Dose Escalation|Adverse Event|0|||
143214461|NCT01748825|516329764|FG002|Dose Escalation|Adverse Event|0|||
143214462|NCT01748825|516329765|FG003|Dose Escalation|Adverse Event|0|||
143214463|NCT01748825|516329766|FG004|Dose Escalation|Adverse Event|0|||
143214464|NCT01748825|516329767|FG005|Dose Escalation|Adverse Event|0|||
143214465|NCT01748825|516329768|FG006|Dose Escalation|Adverse Event|1|||
143214466|NCT01748825|516329769|FG007|Dose Escalation|Adverse Event|0|||
143214467|NCT01748825|516329770|FG008|Dose Escalation|Adverse Event|0|||
143214468|NCT01748825|516329771|FG009|Dose Escalation|Adverse Event|0|||
143214469|NCT01748825|516329762|FG000|Dose Expansion|Refused further treatment|0|||
143214470|NCT01748825|516329763|FG001|Dose Expansion|Refused further treatment|0|||
143214471|NCT01748825|516329764|FG002|Dose Expansion|Refused further treatment|0|||
143214472|NCT01748825|516329765|FG003|Dose Expansion|Refused further treatment|0|||
143214473|NCT01748825|516329766|FG004|Dose Expansion|Refused further treatment|0|||
143214474|NCT01748825|516329767|FG005|Dose Expansion|Refused further treatment|0|||
143214475|NCT01748825|516329768|FG006|Dose Expansion|Refused further treatment|0|||
143214476|NCT01748825|516329769|FG007|Dose Expansion|Refused further treatment|0|||
143214477|NCT01748825|516329770|FG008|Dose Expansion|Refused further treatment|1|||
143214478|NCT01748825|516329771|FG009|Dose Expansion|Refused further treatment|1|||
143214479|NCT01748825|516329762|FG000|Dose Expansion|Switched to alternative treatment|0|||
143214480|NCT01748825|516329763|FG001|Dose Expansion|Switched to alternative treatment|0|||
143214481|NCT01748825|516329764|FG002|Dose Expansion|Switched to alternative treatment|0|||
143214482|NCT01748825|516329765|FG003|Dose Expansion|Switched to alternative treatment|0|||
143214483|NCT01748825|516329766|FG004|Dose Expansion|Switched to alternative treatment|0|||
143266383|NCT02035475|516530058|FG000|Overall Study|Withdrawal by Subject|4|||
143266384|NCT02035475|516530058|FG000|Overall Study|Physician Decision|1|||
143266385|NCT02035475|516530058|FG000|Overall Study|Equipment Error|1|||
143214484|NCT01748825|516329767|FG005|Dose Expansion|Switched to alternative treatment|0|||
143214485|NCT01748825|516329768|FG006|Dose Expansion|Switched to alternative treatment|0|||
143214486|NCT01748825|516329769|FG007|Dose Expansion|Switched to alternative treatment|0|||
143214487|NCT01748825|516329770|FG008|Dose Expansion|Switched to alternative treatment|0|||
143214488|NCT01748825|516329771|FG009|Dose Expansion|Switched to alternative treatment|1|||
143214489|NCT01748825|516329762|FG000|Dose Expansion|Adverse Event|0|||
143214490|NCT01748825|516329763|FG001|Dose Expansion|Adverse Event|0|||
143266386|NCT02047227|516530059|FG000|Overall Study|Adverse Event|2|||
143266387|NCT02047227|516530060|FG001|Overall Study|Adverse Event|4|||
143266388|NCT02047227|516530059|FG000|Overall Study|Lost to Follow-up|0|||
143214491|NCT01748825|516329764|FG002|Dose Expansion|Adverse Event|0|||
143214492|NCT01748825|516329765|FG003|Dose Expansion|Adverse Event|0|||
143214493|NCT01748825|516329766|FG004|Dose Expansion|Adverse Event|0|||
143214494|NCT01748825|516329767|FG005|Dose Expansion|Adverse Event|0|||
143214495|NCT01748825|516329768|FG006|Dose Expansion|Adverse Event|0|||
143266389|NCT02047227|516530060|FG001|Overall Study|Lost to Follow-up|3|||
143266390|NCT02047227|516530059|FG000|Overall Study|Protocol Violation|1|||
143266391|NCT02047227|516530060|FG001|Overall Study|Protocol Violation|0|||
143214496|NCT01748825|516329769|FG007|Dose Expansion|Adverse Event|0|||
143214497|NCT01748825|516329770|FG008|Dose Expansion|Adverse Event|0|||
143214498|NCT01748825|516329771|FG009|Dose Expansion|Adverse Event|3|||
143214499|NCT01748825|516329762|FG000|Dose Expansion|Physician Decision|0|||
143214500|NCT01748825|516329763|FG001|Dose Expansion|Physician Decision|0|||
143214501|NCT01748825|516329764|FG002|Dose Expansion|Physician Decision|0|||
143214502|NCT01748825|516329765|FG003|Dose Expansion|Physician Decision|0|||
143214503|NCT01748825|516329766|FG004|Dose Expansion|Physician Decision|0|||
143214504|NCT01748825|516329767|FG005|Dose Expansion|Physician Decision|0|||
143214505|NCT01748825|516329768|FG006|Dose Expansion|Physician Decision|0|||
143214506|NCT01748825|516329769|FG007|Dose Expansion|Physician Decision|0|||
143214507|NCT01748825|516329770|FG008|Dose Expansion|Physician Decision|1|||
143214508|NCT01748825|516329771|FG009|Dose Expansion|Physician Decision|0|||
143214509|NCT02921087|516329775|FG000|Overall Study|Withdrawal by Subject|0|||
143214510|NCT02921087|516329776|FG001|Overall Study|Withdrawal by Subject|1|||
143214511|NCT03848949|516329777|FG000|Overall Study|Lost to Follow-up|5|||
143214512|NCT03848949|516329778|FG001|Overall Study|Lost to Follow-up|7|||
143214513|NCT00931606|516332356|FG000|Overall Study|Death|1|||
143214514|NCT00931606|516332357|FG001|Overall Study|Death|3|||
143214515|NCT00931606|516332358|FG002|Overall Study|Death|2|||
143214516|NCT00931606|516332359|FG003|Overall Study|Death|0|||
143214517|NCT00931606|516332356|FG000|Overall Study|Lost to Follow-up|0|||
143214518|NCT00931606|516332357|FG001|Overall Study|Lost to Follow-up|1|||
143214519|NCT00931606|516332358|FG002|Overall Study|Lost to Follow-up|0|||
143214520|NCT00931606|516332359|FG003|Overall Study|Lost to Follow-up|0|||
143214521|NCT00931606|516332356|FG000|Overall Study|Physician Decision|0|||
143214522|NCT00931606|516332357|FG001|Overall Study|Physician Decision|0|||
143214523|NCT00931606|516332358|FG002|Overall Study|Physician Decision|3|||
143214524|NCT00931606|516332359|FG003|Overall Study|Physician Decision|0|||
143214525|NCT00931606|516332356|FG000|Overall Study|Sponsor Decision|1|||
143214526|NCT00931606|516332357|FG001|Overall Study|Sponsor Decision|4|||
143214527|NCT00931606|516332358|FG002|Overall Study|Sponsor Decision|0|||
143214528|NCT00931606|516332359|FG003|Overall Study|Sponsor Decision|2|||
143214529|NCT00931606|516332356|FG000|Overall Study|Withdrawal by Subject|3|||
143214530|NCT00931606|516332357|FG001|Overall Study|Withdrawal by Subject|1|||
143214531|NCT00931606|516332358|FG002|Overall Study|Withdrawal by Subject|1|||
143214532|NCT00931606|516332359|FG003|Overall Study|Withdrawal by Subject|1|||
143214533|NCT00871338|516332360|FG000|Prior to Booster|Withdrawal by Subject|1|||
143214534|NCT00871338|516332361|FG001|Prior to Booster|Withdrawal by Subject|3|||
143214535|NCT00871338|516332360|FG000|Prior to Booster|Lost to Follow-up|1|||
143266392|NCT02047227|516530059|FG000|Overall Study|Spontaneous pregnancy|1|||
143266393|NCT02047227|516530060|FG001|Overall Study|Spontaneous pregnancy|0|||
143266394|NCT02047227|516530059|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
143266395|NCT02047227|516530060|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
143266396|NCT02047227|516530059|FG000|Overall Study|No oocytes retrieved|21|||
143266397|NCT02047227|516530060|FG001|Overall Study|No oocytes retrieved|20|||
143266398|NCT02047227|516530059|FG000|Overall Study|No fertilization|61|||
143266399|NCT02047227|516530060|FG001|Overall Study|No fertilization|51|||
143266400|NCT02047227|516530059|FG000|Overall Study|Intention to freeze all embryos|1|||
143266401|NCT02047227|516530060|FG001|Overall Study|Intention to freeze all embryos|0|||
143266402|NCT02047227|516530059|FG000|Overall Study|All embryos discarded|12|||
143266403|NCT02047227|516530060|FG001|Overall Study|All embryos discarded|11|||
143266404|NCT02047227|516530059|FG000|Overall Study|Other|10|||
143266405|NCT02047227|516530060|FG001|Overall Study|Other|9|||
143266406|NCT02059005|516530071|FG000|Overall Study|Death|1|||
143266407|NCT02059005|516530072|FG001|Overall Study|Death|3|||
143266408|NCT02059005|516530071|FG000|Overall Study|Lost to Follow-up|19|||
143266409|NCT02059005|516530072|FG001|Overall Study|Lost to Follow-up|19|||
143266410|NCT02059005|516530071|FG000|Overall Study|Incarceration|0|||
143266411|NCT02059005|516530072|FG001|Overall Study|Incarceration|1|||
143266412|NCT02059005|516530071|FG000|Overall Study|Inpatient|0|||
143214536|NCT00871338|516332361|FG001|Prior to Booster|Lost to Follow-up|0|||
143214537|NCT02391363|516332362|FG000|Overall Study|Lost to Follow-up|5|||
143214538|NCT02391363|516332363|FG001|Overall Study|Lost to Follow-up|5|||
143266413|NCT02059005|516530072|FG001|Overall Study|Inpatient|1|||
143266414|NCT00908011|516530077|FG000|Overall Study|Withdrawal by Subject|2|||
143266415|NCT00908011|516530078|FG001|Overall Study|Withdrawal by Subject|2|||
143214539|NCT02391363|516332362|FG000|Overall Study|Withdrawal by Subject|6|||
143214540|NCT02391363|516332363|FG001|Overall Study|Withdrawal by Subject|3|||
143266416|NCT00739596|516530079|FG000|Overall Study|Adverse Event|12|||
143214541|NCT01702025|516332366|FG000|Overall Study|Equipment failure|1|||
143214542|NCT01702025|516332367|FG001|Overall Study|Equipment failure|0|||
143214543|NCT01702025|516332368|FG002|Overall Study|Equipment failure|0|||
143266417|NCT00739596|516530080|FG001|Overall Study|Adverse Event|6|||
143266418|NCT00739596|516530079|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
143214544|NCT01702025|516332369|FG003|Overall Study|Equipment failure|0|||
143214545|NCT01702025|516332366|FG000|Overall Study|Adverse Event|1|||
143266419|NCT00739596|516530080|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
143266420|NCT00739596|516530079|FG000|Overall Study|Patient Withdrew Consent|8|||
143214546|NCT01702025|516332367|FG001|Overall Study|Adverse Event|1|||
143266421|NCT00739596|516530080|FG001|Overall Study|Patient Withdrew Consent|8|||
143266422|NCT00739596|516530079|FG000|Overall Study|Lost to Follow-up|0|||
143266423|NCT00739596|516530080|FG001|Overall Study|Lost to Follow-up|2|||
143266424|NCT00739596|516530079|FG000|Overall Study|Protocol Deviation|1|||
143266425|NCT00739596|516530080|FG001|Overall Study|Protocol Deviation|1|||
143266426|NCT02301988|516530084|FG000|Overall Study|Withdrawal by Subject|2|||
143266427|NCT02301988|516530085|FG001|Overall Study|Withdrawal by Subject|1|||
143266428|NCT02301988|516530084|FG000|Overall Study|Physician Decision|2|||
143266429|NCT02301988|516530085|FG001|Overall Study|Physician Decision|2|||
143266430|NCT02301988|516530084|FG000|Overall Study|Unknown Reason|1|||
143266431|NCT02301988|516530085|FG001|Overall Study|Unknown Reason|3|||
143266432|NCT02301988|516530084|FG000|Overall Study|Lack of Efficacy|3|||
143266433|NCT02301988|516530085|FG001|Overall Study|Lack of Efficacy|2|||
143266434|NCT02301988|516530084|FG000|Overall Study|Death|1|||
143266435|NCT02301988|516530085|FG001|Overall Study|Death|0|||
143266436|NCT02301988|516530084|FG000|Overall Study|Adverse Event|1|||
143266437|NCT02301988|516530085|FG001|Overall Study|Adverse Event|1|||
143266438|NCT02567552|516530086|FG000|Overall Study|Adverse Event|0|||
143266439|NCT02567552|516530087|FG001|Overall Study|Adverse Event|1|||
143266440|NCT02891161|516530088|FG000|Study Treatment|Disease Progression|2|||
143266441|NCT02891161|516530089|FG001|Study Treatment|Disease Progression|4|||
143266442|NCT02891161|516530088|FG000|Study Treatment|AE/Side Effects/Complications|1|||
143266443|NCT02891161|516530089|FG001|Study Treatment|AE/Side Effects/Complications|5|||
143266444|NCT02891161|516530088|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
143266445|NCT02891161|516530089|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
143266446|NCT02891161|516530088|FG000|Follow up|Death|4|||
143266447|NCT02891161|516530089|FG001|Follow up|Death|8|||
143266448|NCT02891161|516530088|FG000|Follow up|Refused to Follow up|0|||
143266449|NCT02891161|516530089|FG001|Follow up|Refused to Follow up|2|||
143266450|NCT02891161|516530088|FG000|Follow up|Symptomatic deterioration|0|||
143266451|NCT02891161|516530089|FG001|Follow up|Symptomatic deterioration|1|||
143266452|NCT02891161|516530088|FG000|Follow up|Study terminated|0|||
143266453|NCT02891161|516530089|FG001|Follow up|Study terminated|6|||
143266454|NCT05419908|516530092|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
143266455|NCT05419908|516530093|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
143214547|NCT01702025|516332368|FG002|Overall Study|Adverse Event|1|||
143214548|NCT01702025|516332369|FG003|Overall Study|Adverse Event|0|||
143214549|NCT00265317|516332372|FG000|Lead-In|Objective progression or relapse|6|||
143214550|NCT00265317|516332373|FG001|Lead-In|Objective progression or relapse|11|||
143214551|NCT00265317|516332374|FG002|Lead-In|Objective progression or relapse|0|||
143214552|NCT00265317|516332375|FG003|Lead-In|Objective progression or relapse|0|||
143214553|NCT00265317|516332372|FG000|Lead-In|Adverse Event|2|||
143214554|NCT00265317|516332373|FG001|Lead-In|Adverse Event|1|||
143214555|NCT00265317|516332374|FG002|Lead-In|Adverse Event|0|||
143214556|NCT00265317|516332375|FG003|Lead-In|Adverse Event|0|||
143214557|NCT00265317|516332372|FG000|Lead-In|Death|3|||
143214558|NCT00265317|516332373|FG001|Lead-In|Death|5|||
143214559|NCT00265317|516332374|FG002|Lead-In|Death|0|||
143214560|NCT00265317|516332375|FG003|Lead-In|Death|0|||
143214561|NCT00265317|516332372|FG000|Lead-In|Withdrawal/other than adverse event|1|||
143214562|NCT00265317|516332373|FG001|Lead-In|Withdrawal/other than adverse event|0|||
143214563|NCT00265317|516332374|FG002|Lead-In|Withdrawal/other than adverse event|0|||
143266456|NCT05419908|516530092|FG000|Overall Study|Serious Adverse Event|0|||
143266457|NCT05419908|516530093|FG001|Overall Study|Serious Adverse Event|2|||
143266458|NCT05419908|516530092|FG000|Overall Study|Withdrawal by Subject|2|||
143266459|NCT05419908|516530093|FG001|Overall Study|Withdrawal by Subject|0|||
143266460|NCT05419908|516530092|FG000|Overall Study|Miscellaneous|1|||
143266461|NCT05419908|516530093|FG001|Overall Study|Miscellaneous|1|||
143266462|NCT00423722|516531722|FG000|Overall Study|Death|4|||
143214564|NCT00265317|516332375|FG003|Lead-In|Withdrawal/other than adverse event|0|||
143214565|NCT00265317|516332372|FG000|Phase 2|Objective progression or relapse|0|||
143266463|NCT00423722|516531723|FG001|Overall Study|Death|4|||
143266464|NCT00423722|516531722|FG000|Overall Study|Declined to participate|2|||
143266465|NCT00423722|516531723|FG001|Overall Study|Declined to participate|3|||
143266466|NCT00423722|516531722|FG000|Overall Study|Unable to complete questionnaires|4|||
143266467|NCT00423722|516531723|FG001|Overall Study|Unable to complete questionnaires|4|||
143266468|NCT00423722|516531722|FG000|Overall Study|Withdrawal by Subject|4|||
143214566|NCT00265317|516332373|FG001|Phase 2|Objective progression or relapse|0|||
143266469|NCT00423722|516531723|FG001|Overall Study|Withdrawal by Subject|2|||
143266470|NCT00215683|516531726|FG000|Overall Study|Adverse Event|15|||
143266471|NCT00215683|516531727|FG001|Overall Study|Adverse Event|16|||
143266472|NCT00215683|516531728|FG002|Overall Study|Adverse Event|15|||
143214567|NCT00265317|516332374|FG002|Phase 2|Objective progression or relapse|37|||
143214568|NCT00265317|516332375|FG003|Phase 2|Objective progression or relapse|38|||
143214569|NCT00265317|516332372|FG000|Phase 2|Global deterioration of health status|0|||
143266473|NCT00215683|516531726|FG000|Overall Study|Lack of Efficacy|5|||
143266474|NCT00215683|516531727|FG001|Overall Study|Lack of Efficacy|1|||
143214570|NCT00265317|516332373|FG001|Phase 2|Global deterioration of health status|0|||
143214571|NCT00265317|516332374|FG002|Phase 2|Global deterioration of health status|3|||
143214572|NCT00265317|516332375|FG003|Phase 2|Global deterioration of health status|0|||
143214573|NCT00265317|516332372|FG000|Phase 2|Adverse Event|0|||
143214574|NCT00265317|516332373|FG001|Phase 2|Adverse Event|0|||
143214575|NCT00265317|516332374|FG002|Phase 2|Adverse Event|7|||
143214576|NCT00265317|516332375|FG003|Phase 2|Adverse Event|5|||
143214577|NCT00265317|516332372|FG000|Phase 2|Death|0|||
143214578|NCT00265317|516332373|FG001|Phase 2|Death|0|||
143214579|NCT00265317|516332374|FG002|Phase 2|Death|12|||
143214580|NCT00265317|516332375|FG003|Phase 2|Death|15|||
143214581|NCT00265317|516332372|FG000|Phase 2|Protocol Violation|0|||
143214582|NCT00265317|516332373|FG001|Phase 2|Protocol Violation|0|||
143214583|NCT00265317|516332374|FG002|Phase 2|Protocol Violation|1|||
143214584|NCT00265317|516332375|FG003|Phase 2|Protocol Violation|4|||
143214585|NCT00265317|516332372|FG000|Phase 2|Lost to Follow-up|0|||
143214586|NCT00265317|516332373|FG001|Phase 2|Lost to Follow-up|0|||
143214587|NCT00265317|516332374|FG002|Phase 2|Lost to Follow-up|0|||
143214588|NCT00265317|516332375|FG003|Phase 2|Lost to Follow-up|1|||
143214589|NCT00265317|516332372|FG000|Phase 2|Withdrawal/other than adverse event|0|||
143214590|NCT00265317|516332373|FG001|Phase 2|Withdrawal/other than adverse event|0|||
143214591|NCT00265317|516332374|FG002|Phase 2|Withdrawal/other than adverse event|2|||
143214592|NCT00265317|516332375|FG003|Phase 2|Withdrawal/other than adverse event|1|||
143214593|NCT00265317|516332372|FG000|Phase 2|Study terminated by sponsor|0|||
143214594|NCT00265317|516332373|FG001|Phase 2|Study terminated by sponsor|0|||
143214595|NCT00265317|516332374|FG002|Phase 2|Study terminated by sponsor|1|||
143214596|NCT00265317|516332375|FG003|Phase 2|Study terminated by sponsor|0|||
143214597|NCT00265317|516332372|FG000|Phase 2|Other|0|||
143214598|NCT00265317|516332373|FG001|Phase 2|Other|0|||
143214599|NCT00265317|516332374|FG002|Phase 2|Other|1|||
143214600|NCT00265317|516332375|FG003|Phase 2|Other|1|||
143214601|NCT00801229|516332376|FG000|Signed Consent|Withdrawal by Subject|2|||
143214602|NCT00801229|516332377|FG001|Signed Consent|Withdrawal by Subject|2|||
143214603|NCT00801229|516332376|FG000|Signed Consent|Found Ineligible|1|||
143214604|NCT00801229|516332377|FG001|Signed Consent|Found Ineligible|1|||
143214605|NCT00801229|516332376|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
143214606|NCT00801229|516332377|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
143214607|NCT00801229|516332376|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
143214608|NCT00801229|516332377|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
143214609|NCT00801229|516332376|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
143214610|NCT00801229|516332377|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
143214611|NCT00801229|516332376|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
143214612|NCT00801229|516332377|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
143214613|NCT00801229|516332376|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
143214614|NCT00801229|516332377|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
143214615|NCT00801229|516332376|FG000|Received Study Drug/Placebo|Adverse Event|1|||
143214616|NCT00801229|516332377|FG001|Received Study Drug/Placebo|Adverse Event|1|||
143214617|NCT00732875|516332378|FG000|Overall Study|Adverse Event|16|||
143214618|NCT00732875|516332378|FG000|Overall Study|Withdrawal by Subject|6|||
143214619|NCT00732875|516332378|FG000|Overall Study|Lack of Efficacy|13|||
143214620|NCT03826186|516332379|FG000|Overall Study|Protocol Violation|2|||
143214621|NCT03826186|516332380|FG001|Overall Study|Protocol Violation|0|||
143214622|NCT03826186|516332379|FG000|Overall Study|Withdrawal by Subject|1|||
143214623|NCT03826186|516332380|FG001|Overall Study|Withdrawal by Subject|0|||
143214624|NCT02300259|516332385|FG000|Period 1|Adverse Event|0|||
143214625|NCT02300259|516332386|FG001|Period 1|Adverse Event|0|||
143214626|NCT02300259|516332387|FG002|Period 1|Adverse Event|1|||
143214627|NCT02300259|516332385|FG000|Period 1|Withdrawal by Subject|0|||
143214628|NCT02300259|516332386|FG001|Period 1|Withdrawal by Subject|0|||
143214629|NCT02300259|516332387|FG002|Period 1|Withdrawal by Subject|1|||
143214630|NCT02300259|516332385|FG000|Period 2|Adverse Event|1|||
143214631|NCT02300259|516332386|FG001|Period 2|Adverse Event|0|||
143214632|NCT02300259|516332387|FG002|Period 2|Adverse Event|0|||
143214633|NCT02300259|516332385|FG000|Period 2|Withdrawal by Subject|0|||
143214634|NCT02300259|516332386|FG001|Period 2|Withdrawal by Subject|0|||
143214635|NCT02300259|516332387|FG002|Period 2|Withdrawal by Subject|1|||
143214636|NCT02737475|516332388|FG000|Overall Study|Other reasons|0|||
143214637|NCT02737475|516332389|FG001|Overall Study|Other reasons|0|||
143214638|NCT02737475|516332390|FG002|Overall Study|Other reasons|0|||
143214639|NCT02737475|516332391|FG003|Overall Study|Other reasons|0|||
143214640|NCT02737475|516332392|FG004|Overall Study|Other reasons|1|||
143214641|NCT02737475|516332393|FG005|Overall Study|Other reasons|1|||
143214642|NCT02737475|516332394|FG006|Overall Study|Other reasons|0|||
143214643|NCT02737475|516332395|FG007|Overall Study|Other reasons|0|||
143214644|NCT02737475|516332396|FG008|Overall Study|Other reasons|1|||
143214645|NCT02737475|516332397|FG009|Overall Study|Other reasons|0|||
143214646|NCT02737475|516332398|FG010|Overall Study|Other reasons|1|||
143371879|NCT02914522|516906328|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
143214647|NCT02737475|516332399|FG011|Overall Study|Other reasons|0|||
143214648|NCT02737475|516332400|FG012|Overall Study|Other reasons|0|||
143214649|NCT02737475|516332401|FG013|Overall Study|Other reasons|0|||
143214650|NCT02737475|516332402|FG014|Overall Study|Other reasons|0|||
143214651|NCT02737475|516332403|FG015|Overall Study|Other reasons|0|||
143214652|NCT02737475|516332404|FG016|Overall Study|Other reasons|0|||
143214653|NCT02737475|516332405|FG017|Overall Study|Other reasons|0|||
143214654|NCT02737475|516332406|FG018|Overall Study|Other reasons|0|||
143214655|NCT02737475|516332407|FG019|Overall Study|Other reasons|0|||
143214656|NCT02737475|516332408|FG020|Overall Study|Other reasons|0|||
143214657|NCT02737475|516332409|FG021|Overall Study|Other reasons|1|||
143214658|NCT02737475|516332410|FG022|Overall Study|Other reasons|0|||
143214659|NCT02737475|516332411|FG023|Overall Study|Other reasons|1|||
143214660|NCT02737475|516332412|FG024|Overall Study|Other reasons|1|||
143214661|NCT02737475|516332413|FG025|Overall Study|Other reasons|1|||
143214662|NCT02737475|516332414|FG026|Overall Study|Other reasons|0|||
143214663|NCT02737475|516332388|FG000|Overall Study|Death|1|||
143214664|NCT02737475|516332389|FG001|Overall Study|Death|0|||
143214665|NCT02737475|516332390|FG002|Overall Study|Death|0|||
143214666|NCT02737475|516332391|FG003|Overall Study|Death|1|||
143214667|NCT02737475|516332392|FG004|Overall Study|Death|0|||
143214668|NCT02737475|516332393|FG005|Overall Study|Death|0|||
143214669|NCT02737475|516332394|FG006|Overall Study|Death|0|||
143214670|NCT02737475|516332395|FG007|Overall Study|Death|2|||
143214671|NCT02737475|516332396|FG008|Overall Study|Death|0|||
143214672|NCT02737475|516332397|FG009|Overall Study|Death|0|||
143214673|NCT02737475|516332398|FG010|Overall Study|Death|0|||
143214674|NCT02737475|516332399|FG011|Overall Study|Death|4|||
143214675|NCT02737475|516332400|FG012|Overall Study|Death|2|||
143214676|NCT02737475|516332401|FG013|Overall Study|Death|2|||
143214677|NCT02737475|516332402|FG014|Overall Study|Death|0|||
143214678|NCT02737475|516332403|FG015|Overall Study|Death|2|||
143214679|NCT02737475|516332404|FG016|Overall Study|Death|2|||
143214680|NCT02737475|516332405|FG017|Overall Study|Death|2|||
143214681|NCT02737475|516332406|FG018|Overall Study|Death|1|||
143214682|NCT02737475|516332407|FG019|Overall Study|Death|0|||
143214683|NCT02737475|516332408|FG020|Overall Study|Death|0|||
143214684|NCT02737475|516332409|FG021|Overall Study|Death|0|||
143214685|NCT02737475|516332410|FG022|Overall Study|Death|0|||
143371880|NCT02914522|516906329|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
143371881|NCT02914522|516906330|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
143371882|NCT02914522|516906331|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
143371883|NCT02914522|516906332|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
143371884|NCT02914522|516906333|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
143214686|NCT02737475|516332411|FG023|Overall Study|Death|0|||
143371885|NCT02914522|516906334|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
143214687|NCT02737475|516332412|FG024|Overall Study|Death|0|||
143214688|NCT02737475|516332413|FG025|Overall Study|Death|0|||
143214689|NCT02737475|516332414|FG026|Overall Study|Death|0|||
143214690|NCT02737475|516332388|FG000|Overall Study|Participant withdrew consent|0|||
143214691|NCT02737475|516332389|FG001|Overall Study|Participant withdrew consent|0|||
143214692|NCT02737475|516332390|FG002|Overall Study|Participant withdrew consent|0|||
143214693|NCT02737475|516332391|FG003|Overall Study|Participant withdrew consent|0|||
143214694|NCT02737475|516332392|FG004|Overall Study|Participant withdrew consent|0|||
143214695|NCT02737475|516332393|FG005|Overall Study|Participant withdrew consent|2|||
143214696|NCT02737475|516332394|FG006|Overall Study|Participant withdrew consent|0|||
143371886|NCT02914522|516906335|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
143214697|NCT02737475|516332395|FG007|Overall Study|Participant withdrew consent|0|||
143214698|NCT02737475|516332396|FG008|Overall Study|Participant withdrew consent|0|||
143214699|NCT02737475|516332397|FG009|Overall Study|Participant withdrew consent|0|||
143214700|NCT02737475|516332398|FG010|Overall Study|Participant withdrew consent|0|||
143214701|NCT02737475|516332399|FG011|Overall Study|Participant withdrew consent|0|||
143214702|NCT02737475|516332400|FG012|Overall Study|Participant withdrew consent|0|||
143214703|NCT02737475|516332401|FG013|Overall Study|Participant withdrew consent|0|||
143214704|NCT02737475|516332402|FG014|Overall Study|Participant withdrew consent|1|||
143371887|NCT02914522|516906336|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
143371888|NCT02914522|516906337|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
143371889|NCT02914522|516906338|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
143214705|NCT02737475|516332403|FG015|Overall Study|Participant withdrew consent|0|||
143214706|NCT02737475|516332404|FG016|Overall Study|Participant withdrew consent|0|||
143214707|NCT02737475|516332405|FG017|Overall Study|Participant withdrew consent|2|||
143214708|NCT02737475|516332406|FG018|Overall Study|Participant withdrew consent|1|||
143214709|NCT02737475|516332407|FG019|Overall Study|Participant withdrew consent|0|||
143214710|NCT02737475|516332408|FG020|Overall Study|Participant withdrew consent|2|||
143214711|NCT02737475|516332409|FG021|Overall Study|Participant withdrew consent|0|||
143214712|NCT02737475|516332410|FG022|Overall Study|Participant withdrew consent|0|||
143214713|NCT02737475|516332411|FG023|Overall Study|Participant withdrew consent|0|||
143214714|NCT02737475|516332412|FG024|Overall Study|Participant withdrew consent|0|||
143214715|NCT02737475|516332413|FG025|Overall Study|Participant withdrew consent|0|||
143214716|NCT02737475|516332414|FG026|Overall Study|Participant withdrew consent|0|||
143214717|NCT02737475|516332388|FG000|Overall Study|Lost to Follow-up|0|||
143214718|NCT02737475|516332389|FG001|Overall Study|Lost to Follow-up|0|||
143214719|NCT02737475|516332390|FG002|Overall Study|Lost to Follow-up|0|||
143214720|NCT02737475|516332391|FG003|Overall Study|Lost to Follow-up|0|||
143214721|NCT02737475|516332392|FG004|Overall Study|Lost to Follow-up|0|||
143214722|NCT02737475|516332393|FG005|Overall Study|Lost to Follow-up|0|||
143214723|NCT02737475|516332394|FG006|Overall Study|Lost to Follow-up|0|||
143214724|NCT02737475|516332395|FG007|Overall Study|Lost to Follow-up|0|||
143214725|NCT02737475|516332396|FG008|Overall Study|Lost to Follow-up|0|||
143214726|NCT02737475|516332397|FG009|Overall Study|Lost to Follow-up|0|||
143214727|NCT02737475|516332398|FG010|Overall Study|Lost to Follow-up|0|||
143214728|NCT02737475|516332399|FG011|Overall Study|Lost to Follow-up|0|||
143214729|NCT02737475|516332400|FG012|Overall Study|Lost to Follow-up|0|||
143214730|NCT02737475|516332401|FG013|Overall Study|Lost to Follow-up|0|||
143214731|NCT02737475|516332402|FG014|Overall Study|Lost to Follow-up|0|||
143214732|NCT02737475|516332403|FG015|Overall Study|Lost to Follow-up|1|||
143214733|NCT02737475|516332404|FG016|Overall Study|Lost to Follow-up|0|||
143214734|NCT02737475|516332405|FG017|Overall Study|Lost to Follow-up|0|||
143214735|NCT02737475|516332406|FG018|Overall Study|Lost to Follow-up|0|||
143214736|NCT02737475|516332407|FG019|Overall Study|Lost to Follow-up|0|||
143214737|NCT02737475|516332408|FG020|Overall Study|Lost to Follow-up|0|||
143214738|NCT02737475|516332409|FG021|Overall Study|Lost to Follow-up|0|||
143214739|NCT02737475|516332410|FG022|Overall Study|Lost to Follow-up|0|||
143214740|NCT02737475|516332411|FG023|Overall Study|Lost to Follow-up|0|||
143214741|NCT02737475|516332412|FG024|Overall Study|Lost to Follow-up|0|||
143214742|NCT02737475|516332413|FG025|Overall Study|Lost to Follow-up|0|||
143214743|NCT02737475|516332414|FG026|Overall Study|Lost to Follow-up|0|||
143214744|NCT02737475|516332388|FG000|Overall Study|Disease Progression|0|||
143214745|NCT02737475|516332389|FG001|Overall Study|Disease Progression|0|||
143214746|NCT02737475|516332390|FG002|Overall Study|Disease Progression|0|||
143214747|NCT02737475|516332391|FG003|Overall Study|Disease Progression|0|||
143214748|NCT02737475|516332392|FG004|Overall Study|Disease Progression|0|||
143214749|NCT02737475|516332393|FG005|Overall Study|Disease Progression|0|||
143214750|NCT02737475|516332394|FG006|Overall Study|Disease Progression|0|||
143214751|NCT02737475|516332395|FG007|Overall Study|Disease Progression|0|||
143214752|NCT02737475|516332396|FG008|Overall Study|Disease Progression|0|||
143214753|NCT02737475|516332397|FG009|Overall Study|Disease Progression|0|||
143214754|NCT02737475|516332398|FG010|Overall Study|Disease Progression|0|||
143214755|NCT02737475|516332399|FG011|Overall Study|Disease Progression|0|||
143214756|NCT02737475|516332400|FG012|Overall Study|Disease Progression|0|||
143214757|NCT02737475|516332401|FG013|Overall Study|Disease Progression|0|||
143214758|NCT02737475|516332402|FG014|Overall Study|Disease Progression|0|||
143214759|NCT02737475|516332403|FG015|Overall Study|Disease Progression|0|||
143214760|NCT02737475|516332404|FG016|Overall Study|Disease Progression|0|||
143214761|NCT02737475|516332405|FG017|Overall Study|Disease Progression|0|||
143214762|NCT02737475|516332406|FG018|Overall Study|Disease Progression|0|||
143214763|NCT02737475|516332407|FG019|Overall Study|Disease Progression|0|||
143214764|NCT02737475|516332408|FG020|Overall Study|Disease Progression|0|||
143214765|NCT02737475|516332409|FG021|Overall Study|Disease Progression|0|||
143214766|NCT02737475|516332410|FG022|Overall Study|Disease Progression|0|||
143214767|NCT02737475|516332411|FG023|Overall Study|Disease Progression|0|||
143214768|NCT02737475|516332412|FG024|Overall Study|Disease Progression|0|||
143214769|NCT02737475|516332413|FG025|Overall Study|Disease Progression|0|||
143214770|NCT02737475|516332414|FG026|Overall Study|Disease Progression|1|||
143214771|NCT04440813|516332419|FG000|Overall Study|Lost to Follow-up|5|||
143214772|NCT04440813|516332420|FG001|Overall Study|Lost to Follow-up|5|||
143214773|NCT02255461|516332421|FG000|Overall Study|Adverse Event|0|||
143214774|NCT02255461|516332422|FG001|Overall Study|Adverse Event|1|||
143266475|NCT00215683|516531728|FG002|Overall Study|Lack of Efficacy|2|||
143266476|NCT00215683|516531726|FG000|Overall Study|Lost to Follow-up|0|||
143266477|NCT00215683|516531727|FG001|Overall Study|Lost to Follow-up|2|||
143214775|NCT02255461|516332423|FG002|Overall Study|Adverse Event|0|||
143214776|NCT02255461|516332424|FG003|Overall Study|Adverse Event|0|||
143214777|NCT02255461|516332425|FG004|Overall Study|Adverse Event|1|||
143214778|NCT02255461|516332421|FG000|Overall Study|Withdrawal by Subject|0|||
143214779|NCT02255461|516332422|FG001|Overall Study|Withdrawal by Subject|0|||
143214780|NCT02255461|516332423|FG002|Overall Study|Withdrawal by Subject|1|||
143214781|NCT02255461|516332424|FG003|Overall Study|Withdrawal by Subject|0|||
143214782|NCT02255461|516332425|FG004|Overall Study|Withdrawal by Subject|1|||
143214783|NCT02255461|516332421|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
143214784|NCT02255461|516332422|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
143214785|NCT02255461|516332423|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
143266478|NCT00215683|516531728|FG002|Overall Study|Lost to Follow-up|1|||
143214786|NCT02255461|516332424|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
143214787|NCT02255461|516332425|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
143214788|NCT00291018|516332432|FG000|Overall Study|Not Consented or Declined PAS|12|||
143214789|NCT00291018|516332433|FG001|Overall Study|Not Consented or Declined PAS|15|||
143214790|NCT00291018|516332434|FG002|Overall Study|Not Consented or Declined PAS|15|||
143214791|NCT00291018|516332432|FG000|Overall Study|Death|3|||
143214792|NCT00291018|516332433|FG001|Overall Study|Death|3|||
143214793|NCT00291018|516332434|FG002|Overall Study|Death|4|||
143214794|NCT00291018|516332432|FG000|Overall Study|Withdrawal by Subject|2|||
143214795|NCT00291018|516332433|FG001|Overall Study|Withdrawal by Subject|8|||
143214796|NCT00291018|516332434|FG002|Overall Study|Withdrawal by Subject|1|||
143214797|NCT00291018|516332432|FG000|Overall Study|Failures|5|||
143214798|NCT00291018|516332433|FG001|Overall Study|Failures|12|||
143214799|NCT00291018|516332434|FG002|Overall Study|Failures|5|||
143214800|NCT00291018|516332432|FG000|Overall Study|Lost to Follow-up|3|||
143214801|NCT00291018|516332433|FG001|Overall Study|Lost to Follow-up|4|||
143214802|NCT00291018|516332434|FG002|Overall Study|Lost to Follow-up|18|||
143214803|NCT02219334|516332437|FG000|Overall Study|Withdrawal by Subject|1|||
143214804|NCT02219334|516332438|FG001|Overall Study|Withdrawal by Subject|0|||
143214805|NCT02219334|516332437|FG000|Overall Study|Protocol Violation|7|||
143214806|NCT02219334|516332438|FG001|Overall Study|Protocol Violation|3|||
143214807|NCT05362058|516332439|FG000|Treatment Period|Adverse Event|3|||
143214808|NCT05362058|516332440|FG001|Treatment Period|Adverse Event|3|||
143214809|NCT05362058|516332439|FG000|Treatment Period|Assigned treatment by mistake|3|||
143214810|NCT05362058|516332440|FG001|Treatment Period|Assigned treatment by mistake|4|||
143214811|NCT05362058|516332439|FG000|Treatment Period|Death|1|||
143214812|NCT05362058|516332440|FG001|Treatment Period|Death|1|||
143214813|NCT05362058|516332439|FG000|Treatment Period|Lost to Follow-up|6|||
143214814|NCT05362058|516332440|FG001|Treatment Period|Lost to Follow-up|3|||
143214815|NCT05362058|516332439|FG000|Treatment Period|Non-compliance with study drug|0|||
143214816|NCT05362058|516332440|FG001|Treatment Period|Non-compliance with study drug|1|||
143214817|NCT05362058|516332439|FG000|Treatment Period|Physician Decision|1|||
143214818|NCT05362058|516332440|FG001|Treatment Period|Physician Decision|0|||
143214819|NCT05362058|516332439|FG000|Treatment Period|Protocol deviation|1|||
143214820|NCT05362058|516332440|FG001|Treatment Period|Protocol deviation|0|||
143214821|NCT05362058|516332439|FG000|Treatment Period|Withdrawal by Subject|10|||
143214822|NCT05362058|516332440|FG001|Treatment Period|Withdrawal by Subject|11|||
143214823|NCT05362058|516332439|FG000|Follow-Up Period|Death|1|||
143214824|NCT05362058|516332440|FG001|Follow-Up Period|Death|0|||
143214825|NCT05362058|516332439|FG000|Follow-Up Period|Lost to Follow-up|2|||
143214826|NCT05362058|516332440|FG001|Follow-Up Period|Lost to Follow-up|1|||
143214827|NCT05362058|516332439|FG000|Follow-Up Period|Protocol deviation|1|||
143214828|NCT05362058|516332440|FG001|Follow-Up Period|Protocol deviation|1|||
143214829|NCT05362058|516332439|FG000|Follow-Up Period|Withdrawal by Subject|0|||
143214830|NCT05362058|516332440|FG001|Follow-Up Period|Withdrawal by Subject|3|||
143214831|NCT02688985|516332443|FG000|Overall Study|Adverse Event|1|||
143214832|NCT02688985|516332444|FG001|Overall Study|Adverse Event|2|||
143214833|NCT02688985|516332445|FG002|Overall Study|Adverse Event|2|||
143214834|NCT02688985|516332446|FG003|Overall Study|Adverse Event|0|||
143214835|NCT02688985|516332447|FG004|Overall Study|Adverse Event|0|||
143214836|NCT02688985|516332443|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
143214837|NCT02688985|516332444|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
143214838|NCT02688985|516332445|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
143214839|NCT02688985|516332446|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
143214840|NCT02688985|516332447|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
143214841|NCT02688985|516332443|FG000|Overall Study|Death|0|||
143214842|NCT02688985|516332444|FG001|Overall Study|Death|0|||
143214843|NCT02688985|516332445|FG002|Overall Study|Death|0|||
143214844|NCT02688985|516332446|FG003|Overall Study|Death|0|||
143214845|NCT02688985|516332447|FG004|Overall Study|Death|1|||
143214846|NCT02688985|516332443|FG000|Overall Study|Lack of Efficacy|0|||
143214847|NCT02688985|516332444|FG001|Overall Study|Lack of Efficacy|0|||
143214848|NCT02688985|516332445|FG002|Overall Study|Lack of Efficacy|0|||
143214849|NCT02688985|516332446|FG003|Overall Study|Lack of Efficacy|0|||
143214850|NCT02688985|516332447|FG004|Overall Study|Lack of Efficacy|1|||
143214851|NCT02688985|516332443|FG000|Overall Study|Lost to Follow-up|2|||
143371890|NCT02914522|516906328|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
143214852|NCT02688985|516332444|FG001|Overall Study|Lost to Follow-up|0|||
143214853|NCT02688985|516332445|FG002|Overall Study|Lost to Follow-up|1|||
143214854|NCT02688985|516332446|FG003|Overall Study|Lost to Follow-up|1|||
143214855|NCT02688985|516332447|FG004|Overall Study|Lost to Follow-up|1|||
143214856|NCT02688985|516332443|FG000|Overall Study|Non-Compliance With Study Drug|1|||
143214857|NCT02688985|516332444|FG001|Overall Study|Non-Compliance With Study Drug|3|||
143371891|NCT02914522|516906329|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
143214858|NCT02688985|516332445|FG002|Overall Study|Non-Compliance With Study Drug|1|||
143214859|NCT02688985|516332446|FG003|Overall Study|Non-Compliance With Study Drug|0|||
143214860|NCT02688985|516332447|FG004|Overall Study|Non-Compliance With Study Drug|1|||
143214861|NCT02688985|516332443|FG000|Overall Study|Other|3|||
143214862|NCT02688985|516332444|FG001|Overall Study|Other|4|||
143214863|NCT02688985|516332445|FG002|Overall Study|Other|1|||
143214864|NCT02688985|516332446|FG003|Overall Study|Other|0|||
143214865|NCT02688985|516332447|FG004|Overall Study|Other|0|||
143214866|NCT02688985|516332443|FG000|Overall Study|Physician Decision|2|||
143214867|NCT02688985|516332444|FG001|Overall Study|Physician Decision|2|||
143214868|NCT02688985|516332445|FG002|Overall Study|Physician Decision|0|||
143214869|NCT02688985|516332446|FG003|Overall Study|Physician Decision|0|||
143214870|NCT02688985|516332447|FG004|Overall Study|Physician Decision|1|||
143214871|NCT02688985|516332443|FG000|Overall Study|Pregnancy|0|||
143214872|NCT02688985|516332444|FG001|Overall Study|Pregnancy|0|||
143214873|NCT02688985|516332445|FG002|Overall Study|Pregnancy|2|||
143214874|NCT02688985|516332446|FG003|Overall Study|Pregnancy|1|||
143214875|NCT02688985|516332447|FG004|Overall Study|Pregnancy|0|||
143214876|NCT02688985|516332443|FG000|Overall Study|Study Terminated By Sponsor|0|||
143214877|NCT02688985|516332444|FG001|Overall Study|Study Terminated By Sponsor|0|||
143214878|NCT02688985|516332445|FG002|Overall Study|Study Terminated By Sponsor|0|||
143214879|NCT02688985|516332446|FG003|Overall Study|Study Terminated By Sponsor|1|||
143214880|NCT02688985|516332447|FG004|Overall Study|Study Terminated By Sponsor|0|||
143214881|NCT02688985|516332443|FG000|Overall Study|Withdrawal by Subject|2|||
143214882|NCT02688985|516332444|FG001|Overall Study|Withdrawal by Subject|8|||
143214883|NCT02688985|516332445|FG002|Overall Study|Withdrawal by Subject|7|||
143214884|NCT02688985|516332446|FG003|Overall Study|Withdrawal by Subject|1|||
143214885|NCT02688985|516332447|FG004|Overall Study|Withdrawal by Subject|4|||
143214886|NCT01964963|516332450|FG000|Overall Study|Case Report Forms Uncollected|888|||
143214887|NCT01964963|516332450|FG000|Overall Study|Protocol Deviation|50|||
143214888|NCT01964963|516332450|FG000|Overall Study|Data Reliability was not Assured|5|||
143214889|NCT00930553|516332451|FG000|Overall Study|Adverse Event|1|||
143214890|NCT00930553|516332451|FG000|Overall Study|Lack of Efficacy|7|||
143214891|NCT00930553|516332451|FG000|Overall Study|Physician Decision|39|||
143214892|NCT00930553|516332451|FG000|Overall Study|Protocol Violation|1|||
143214893|NCT00930553|516332451|FG000|Overall Study|Pregnancy|1|||
143214894|NCT00930553|516332451|FG000|Overall Study|Withdrawal by Subject|88|||
143214895|NCT00930553|516332451|FG000|Overall Study|Lost to Follow-up|25|||
143214896|NCT00930553|516332451|FG000|Overall Study|Death|9|||
143214897|NCT00930553|516332451|FG000|Overall Study|Study terminated by sponsor|24|||
143214898|NCT00930553|516332451|FG000|Overall Study|Other than specified above|28|||
143214899|NCT02630472|516332452|FG000|Overall Study|Physician Decision|10|||
143214900|NCT02630472|516332453|FG001|Overall Study|Physician Decision|0|||
143214901|NCT00711971|516332454|FG000|Overall Study|Lost to Follow-up|3|||
143214902|NCT00711971|516332455|FG001|Overall Study|Lost to Follow-up|4|||
143214903|NCT00711971|516332456|FG002|Overall Study|Lost to Follow-up|1|||
143214904|NCT04878211|516332460|FG000|Overall Study|Lost to Follow-up|0|||
143266479|NCT00215683|516531726|FG000|Overall Study|Withdrawal by Subject|9|||
143266480|NCT00215683|516531727|FG001|Overall Study|Withdrawal by Subject|4|||
143266481|NCT00215683|516531728|FG002|Overall Study|Withdrawal by Subject|13|||
143266482|NCT00215683|516531726|FG000|Overall Study|Physician Decision|0|||
143266483|NCT00215683|516531727|FG001|Overall Study|Physician Decision|0|||
143266484|NCT00215683|516531728|FG002|Overall Study|Physician Decision|1|||
143266485|NCT00215683|516531726|FG000|Overall Study|Difficult to attend visits|0|||
143266486|NCT00215683|516531727|FG001|Overall Study|Difficult to attend visits|1|||
143266487|NCT00215683|516531728|FG002|Overall Study|Difficult to attend visits|0|||
143266488|NCT00215683|516531726|FG000|Overall Study|No study drug available|0|||
143266489|NCT00215683|516531727|FG001|Overall Study|No study drug available|1|||
143266490|NCT00215683|516531728|FG002|Overall Study|No study drug available|0|||
143266491|NCT00215683|516531726|FG000|Overall Study|Intermittent therapy required|0|||
143266492|NCT00215683|516531727|FG001|Overall Study|Intermittent therapy required|1|||
143266493|NCT00215683|516531728|FG002|Overall Study|Intermittent therapy required|0|||
143266494|NCT01083485|516531729|FG000|Overall Study|Adverse Event|0|||
143214905|NCT04878211|516332461|FG001|Overall Study|Lost to Follow-up|0|||
143214906|NCT04878211|516332462|FG002|Overall Study|Lost to Follow-up|0|||
143214907|NCT04878211|516332463|FG003|Overall Study|Lost to Follow-up|1|||
143214908|NCT04878211|516332464|FG004|Overall Study|Lost to Follow-up|0|||
143214909|NCT04878211|516332465|FG005|Overall Study|Lost to Follow-up|1|||
143266495|NCT01083485|516531730|FG001|Overall Study|Adverse Event|1|||
143266496|NCT01083485|516531729|FG000|Overall Study|Protocol Violation|1|||
143266497|NCT01083485|516531730|FG001|Overall Study|Protocol Violation|0|||
143266498|NCT01083485|516531729|FG000|Overall Study|Withdrawal by Subject|5|||
143214910|NCT04878211|516332460|FG000|Overall Study|Protocol deviation|1|||
143214911|NCT04878211|516332461|FG001|Overall Study|Protocol deviation|0|||
143214912|NCT04878211|516332462|FG002|Overall Study|Protocol deviation|0|||
143214913|NCT04878211|516332463|FG003|Overall Study|Protocol deviation|0|||
143214914|NCT04878211|516332464|FG004|Overall Study|Protocol deviation|0|||
143214915|NCT04878211|516332465|FG005|Overall Study|Protocol deviation|0|||
143214916|NCT04878211|516332460|FG000|Overall Study|Study terminated by sponsor|0|||
143266499|NCT01083485|516531730|FG001|Overall Study|Withdrawal by Subject|2|||
143214917|NCT04878211|516332461|FG001|Overall Study|Study terminated by sponsor|0|||
143214918|NCT04878211|516332462|FG002|Overall Study|Study terminated by sponsor|0|||
143214919|NCT04878211|516332463|FG003|Overall Study|Study terminated by sponsor|0|||
143214920|NCT04878211|516332464|FG004|Overall Study|Study terminated by sponsor|9|||
143214921|NCT04878211|516332465|FG005|Overall Study|Study terminated by sponsor|4|||
143214922|NCT04878211|516332460|FG000|Overall Study|Subject decision|0|||
143214923|NCT04878211|516332461|FG001|Overall Study|Subject decision|0|||
143214924|NCT04878211|516332462|FG002|Overall Study|Subject decision|0|||
143214925|NCT04878211|516332463|FG003|Overall Study|Subject decision|0|||
143214926|NCT04878211|516332464|FG004|Overall Study|Subject decision|1|||
143214927|NCT04878211|516332465|FG005|Overall Study|Subject decision|0|||
143214928|NCT04774926|516332472|FG000|Overall Study|Adverse Event|15|||
143214929|NCT04774926|516332472|FG000|Overall Study|Lost to Follow-up|3|||
143214930|NCT04774926|516332472|FG000|Overall Study|Physician Decision|6|||
143214931|NCT04774926|516332472|FG000|Overall Study|Withdrawal by Subject|3|||
143214932|NCT04774926|516332472|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
143214933|NCT00847886|516332475|FG000|Overall Study|Adverse Event|0|||
143214934|NCT00847886|516332476|FG001|Overall Study|Adverse Event|1|||
143214935|NCT01687101|516332477|FG000|Overall Study|Lost to Follow-up|7|||
143214936|NCT03250182|516332478|FG000|Overall Study|Withdrawal by Subject|1|||
143214937|NCT03668613|516332480|FG000|Overall Study|Adverse Event|1|||
143214938|NCT03668613|516332481|FG001|Overall Study|Adverse Event|2|||
143214939|NCT03668613|516332480|FG000|Overall Study|Lack of Efficacy|5|||
143214940|NCT03668613|516332481|FG001|Overall Study|Lack of Efficacy|1|||
143214941|NCT03668613|516332480|FG000|Overall Study|Pregnancy|0|||
143214942|NCT03668613|516332481|FG001|Overall Study|Pregnancy|2|||
143214943|NCT03668613|516332480|FG000|Overall Study|Protocol Violation|1|||
143214944|NCT03668613|516332481|FG001|Overall Study|Protocol Violation|0|||
143214945|NCT03668613|516332480|FG000|Overall Study|Physician Decision|1|||
143214946|NCT03668613|516332481|FG001|Overall Study|Physician Decision|0|||
143214947|NCT03668613|516332480|FG000|Overall Study|Withdrawal by Subject|2|||
143214948|NCT03668613|516332481|FG001|Overall Study|Withdrawal by Subject|1|||
143214949|NCT03668613|516332480|FG000|Overall Study|Guardian decision|1|||
143214950|NCT03668613|516332481|FG001|Overall Study|Guardian decision|0|||
143214951|NCT01858740|516332484|FG000|Overall Study|Death|4|||
143214952|NCT03386487|516332485|FG000|Overall Study|Lost to Follow-up|5|||
143214953|NCT03386487|516332486|FG001|Overall Study|Lost to Follow-up|6|||
143214954|NCT03386487|516332485|FG000|Overall Study|Withdrawal by Subject|11|||
143214955|NCT03386487|516332486|FG001|Overall Study|Withdrawal by Subject|7|||
143214956|NCT03386487|516332485|FG000|Overall Study|Physician Decision|11|||
143214957|NCT03386487|516332486|FG001|Overall Study|Physician Decision|8|||
143214958|NCT01068769|516332487|FG000|Overall Study|Ineligible|1|||
143214959|NCT04042909|516332488|FG000|Overall Study|Withdrawal by Subject|1|||
143214960|NCT04042909|516332489|FG001|Overall Study|Withdrawal by Subject|0|||
143214961|NCT04042909|516332490|FG002|Overall Study|Withdrawal by Subject|0|||
143214962|NCT04042909|516332488|FG000|Overall Study|duplicate cases|2|||
143214963|NCT04042909|516332489|FG001|Overall Study|duplicate cases|0|||
143214964|NCT04042909|516332490|FG002|Overall Study|duplicate cases|0|||
143214965|NCT04042909|516332488|FG000|Overall Study|technical problem|0|||
143214966|NCT04042909|516332489|FG001|Overall Study|technical problem|1|||
143214967|NCT04042909|516332490|FG002|Overall Study|technical problem|0|||
143214968|NCT04207060|516332493|FG000|Overall Study|Lost to Follow-up|2|||
143214969|NCT04207060|516332494|FG001|Overall Study|Lost to Follow-up|0|||
143214970|NCT02524158|516332495|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
143214971|NCT02524158|516332496|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
143214972|NCT02524158|516332495|FG000|12-weeks Assessment|Lost to Follow-up|18|||
143214973|NCT02524158|516332496|FG001|12-weeks Assessment|Lost to Follow-up|12|||
143214974|NCT02524158|516332495|FG000|6-month Assessment|Withdrawal by Subject|1|||
143214975|NCT02524158|516332496|FG001|6-month Assessment|Withdrawal by Subject|1|||
143214976|NCT02524158|516332495|FG000|6-month Assessment|Lost to Follow-up|21|||
143214977|NCT02524158|516332496|FG001|6-month Assessment|Lost to Follow-up|20|||
143214978|NCT01067144|516332497|FG000|Treatment|Did not receive allocated intervention|4|||
143214979|NCT01067144|516332498|FG001|Treatment|Did not receive allocated intervention|7|||
143214980|NCT01067144|516332497|FG000|Follow-up|Lost to Follow-up|22|||
143214981|NCT01067144|516332498|FG001|Follow-up|Lost to Follow-up|12|||
143214982|NCT01067144|516332497|FG000|Follow-up|Censored owing to second surgery|19|||
143214983|NCT01067144|516332498|FG001|Follow-up|Censored owing to second surgery|28|||
143214984|NCT01067144|516332497|FG000|Follow-up|Withdrawal by Subject|18|||
143214985|NCT01067144|516332498|FG001|Follow-up|Withdrawal by Subject|14|||
143214986|NCT01067144|516332497|FG000|Follow-up|Surgery cancelled|0|||
143214987|NCT01067144|516332498|FG001|Follow-up|Surgery cancelled|1|||
143214988|NCT01067144|516332497|FG000|Follow-up|Death|0|||
143214989|NCT01067144|516332498|FG001|Follow-up|Death|1|||
143214990|NCT01835158|516332501|FG000|Overall Study|Withdrawal by Subject|1|||
143214991|NCT01835158|516332502|FG001|Overall Study|Withdrawal by Subject|6|||
143214992|NCT00296140|516332503|FG000|Overall Study|Lost to Follow-up|1|||
143214993|NCT00296140|516332504|FG001|Overall Study|Lost to Follow-up|0|||
143214994|NCT00296140|516332503|FG000|Overall Study|Withdrawal by Subject|1|||
143214995|NCT00296140|516332504|FG001|Overall Study|Withdrawal by Subject|0|||
143214996|NCT00296140|516332503|FG000|Overall Study|Discharge to Nursing Home|1|||
143214997|NCT00296140|516332504|FG001|Overall Study|Discharge to Nursing Home|0|||
143214998|NCT01856582|516332505|FG000|Overall Study|Died prior to Boost infusion|1|||
143214999|NCT00880191|516332509|FG000|Overall Study|Refused further treatment|4|||
143215000|NCT00880191|516332510|FG001|Overall Study|Refused further treatment|1|||
143215001|NCT00880191|516332509|FG000|Overall Study|Adverse Event|8|||
143215002|NCT00880191|516332510|FG001|Overall Study|Adverse Event|6|||
143215003|NCT00880191|516332509|FG000|Overall Study|Hospitalization/efficacy|1|||
143215004|NCT00880191|516332510|FG001|Overall Study|Hospitalization/efficacy|1|||
143215005|NCT01919801|516332514|FG000|Overall Study|Withdrawal by Subject|1|||
143215006|NCT01919801|516332515|FG001|Overall Study|Withdrawal by Subject|0|||
143215007|NCT01919801|516332514|FG000|Overall Study|Physician Decision|0|||
143215008|NCT01919801|516332515|FG001|Overall Study|Physician Decision|1|||
143215009|NCT01919801|516332514|FG000|Overall Study|Lost to Follow-up|0|||
143215010|NCT01919801|516332515|FG001|Overall Study|Lost to Follow-up|1|||
143215011|NCT01919801|516332514|FG000|Overall Study|Other|0|||
143215012|NCT01919801|516332515|FG001|Overall Study|Other|1|||
143215013|NCT01843062|516332516|FG000|Overall Study|Protocol Violation|1|||
143215014|NCT01843062|516332517|FG001|Overall Study|Protocol Violation|0|||
143215015|NCT01843062|516332516|FG000|Overall Study|New treatment following progression|2|||
143215016|NCT01843062|516332517|FG001|Overall Study|New treatment following progression|0|||
143215017|NCT01843062|516332516|FG000|Overall Study|Pregnancy|1|||
143215018|NCT01843062|516332517|FG001|Overall Study|Pregnancy|0|||
143215019|NCT01843062|516332516|FG000|Overall Study|Adverse Event|2|||
143215020|NCT01843062|516332517|FG001|Overall Study|Adverse Event|0|||
143215021|NCT01843062|516332516|FG000|Overall Study|Incorrect randomisation|1|||
143215022|NCT01843062|516332517|FG001|Overall Study|Incorrect randomisation|0|||
143215023|NCT01843062|516332516|FG000|Overall Study|Withdrawal by Subject|12|||
143215024|NCT01843062|516332517|FG001|Overall Study|Withdrawal by Subject|3|||
143215025|NCT01843062|516332516|FG000|Overall Study|Death|1|||
143215026|NCT01843062|516332517|FG001|Overall Study|Death|2|||
143215027|NCT01843062|516332516|FG000|Overall Study|Lost to Follow-up|2|||
143215028|NCT01843062|516332517|FG001|Overall Study|Lost to Follow-up|4|||
143215029|NCT01677858|516332518|FG000|Overall Study|Adverse Event|0|||
143215030|NCT01677858|516332519|FG001|Overall Study|Adverse Event|0|||
143215031|NCT01677858|516332520|FG002|Overall Study|Adverse Event|2|||
143215032|NCT01677858|516332521|FG003|Overall Study|Adverse Event|3|||
143215033|NCT01677858|516332522|FG004|Overall Study|Adverse Event|13|||
143215034|NCT01677858|516332518|FG000|Overall Study|Death|0|||
143215035|NCT01677858|516332519|FG001|Overall Study|Death|0|||
143215036|NCT01677858|516332520|FG002|Overall Study|Death|0|||
143215037|NCT01677858|516332521|FG003|Overall Study|Death|0|||
143215038|NCT01677858|516332522|FG004|Overall Study|Death|1|||
143215039|NCT01677858|516332518|FG000|Overall Study|Physician Decision|1|||
143215040|NCT01677858|516332519|FG001|Overall Study|Physician Decision|0|||
143215041|NCT01677858|516332520|FG002|Overall Study|Physician Decision|2|||
143215042|NCT01677858|516332521|FG003|Overall Study|Physician Decision|0|||
143215043|NCT01677858|516332522|FG004|Overall Study|Physician Decision|12|||
143215044|NCT01677858|516332518|FG000|Overall Study|Progressive Disease|2|||
143215045|NCT01677858|516332519|FG001|Overall Study|Progressive Disease|1|||
143215046|NCT01677858|516332520|FG002|Overall Study|Progressive Disease|9|||
143215047|NCT01677858|516332521|FG003|Overall Study|Progressive Disease|3|||
143215048|NCT01677858|516332522|FG004|Overall Study|Progressive Disease|43|||
143215049|NCT01677858|516332518|FG000|Overall Study|Withdrawal by Subject|0|||
143215050|NCT01677858|516332519|FG001|Overall Study|Withdrawal by Subject|1|||
143215051|NCT01677858|516332520|FG002|Overall Study|Withdrawal by Subject|1|||
143215052|NCT01677858|516332521|FG003|Overall Study|Withdrawal by Subject|0|||
143266500|NCT01083485|516531729|FG000|Overall Study|Other|1|||
143266501|NCT01083485|516531730|FG001|Overall Study|Other|0|||
143266502|NCT02171065|516531731|FG000|Overall Study|Withdrawal by Subject|1|||
143266503|NCT02171065|516531732|FG001|Overall Study|Withdrawal by Subject|0|||
143266504|NCT02171065|516531733|FG002|Overall Study|Withdrawal by Subject|0|||
143266505|NCT02171065|516531731|FG000|Overall Study|Lost to Follow-up|0|||
143266506|NCT02171065|516531732|FG001|Overall Study|Lost to Follow-up|0|||
143266507|NCT02171065|516531733|FG002|Overall Study|Lost to Follow-up|1|||
143266508|NCT04493333|516531734|FG000|Overall Study|Withdrawal by Subject|1|||
143215053|NCT01677858|516332522|FG004|Overall Study|Withdrawal by Subject|15|||
143215054|NCT01677858|516332518|FG000|Overall Study|Lost to Follow-up|0|||
143266509|NCT04493333|516531735|FG001|Overall Study|Withdrawal by Subject|1|||
143215055|NCT01677858|516332519|FG001|Overall Study|Lost to Follow-up|0|||
143266510|NCT04493333|516531734|FG000|Overall Study|Ineligible|0|||
143266511|NCT04493333|516531735|FG001|Overall Study|Ineligible|1|||
143371892|NCT02914522|516906330|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
143215056|NCT01677858|516332520|FG002|Overall Study|Lost to Follow-up|0|||
143215057|NCT01677858|516332521|FG003|Overall Study|Lost to Follow-up|0|||
143215058|NCT01677858|516332522|FG004|Overall Study|Lost to Follow-up|1|||
143215059|NCT01331109|516332523|FG000|Overall Study|Adverse Event|6|||
143215060|NCT01331109|516332523|FG000|Overall Study|Lack of Efficacy|2|||
143215061|NCT01331109|516332523|FG000|Overall Study|Protocol Violation|3|||
143215062|NCT01331109|516332523|FG000|Overall Study|Withdrawal by Subject|7|||
143215063|NCT01331109|516332523|FG000|Overall Study|Lost to Follow-up|1|||
143215064|NCT01331109|516332523|FG000|Overall Study|Study Terminated by Sponsor|38|||
143215065|NCT00988091|516332527|FG000|Double-blind Period|Withdrawal by Subject|15|||
143215066|NCT00988091|516332528|FG001|Double-blind Period|Withdrawal by Subject|13|||
143215067|NCT00988091|516332527|FG000|Double-blind Period|Lost to Follow-up|12|||
143215068|NCT00988091|516332528|FG001|Double-blind Period|Lost to Follow-up|14|||
143215069|NCT00988091|516332527|FG000|Double-blind Period|Other|8|||
143215070|NCT00988091|516332528|FG001|Double-blind Period|Other|8|||
143215071|NCT00988091|516332527|FG000|Double-blind Period|Adverse Event|6|||
143215072|NCT00988091|516332528|FG001|Double-blind Period|Adverse Event|9|||
143215073|NCT00988091|516332527|FG000|Double-blind Period|Use of exclusionary medication|2|||
143215074|NCT00988091|516332528|FG001|Double-blind Period|Use of exclusionary medication|3|||
143215075|NCT00988091|516332527|FG000|Open-label Period|Adverse Event|4|||
143215076|NCT00988091|516332528|FG001|Open-label Period|Adverse Event|7|||
143215077|NCT00988091|516332527|FG000|Open-label Period|Use of exclusionary medication|1|||
143215078|NCT00988091|516332528|FG001|Open-label Period|Use of exclusionary medication|1|||
143215079|NCT00988091|516332527|FG000|Open-label Period|Protocol Violation|1|||
143215080|NCT00988091|516332528|FG001|Open-label Period|Protocol Violation|1|||
143215081|NCT00988091|516332527|FG000|Open-label Period|Withdrawal by Subject|10|||
143215082|NCT00988091|516332528|FG001|Open-label Period|Withdrawal by Subject|16|||
143215083|NCT00988091|516332527|FG000|Open-label Period|Lost to Follow-up|3|||
143215084|NCT00988091|516332528|FG001|Open-label Period|Lost to Follow-up|5|||
143215085|NCT00988091|516332527|FG000|Open-label Period|Other|2|||
143215086|NCT00988091|516332528|FG001|Open-label Period|Other|3|||
143215087|NCT02669212|516332531|FG000|Overall Study|Lost to Follow-up|1|||
143215088|NCT02669212|516332532|FG001|Overall Study|Lost to Follow-up|0|||
143215089|NCT02669212|516332531|FG000|Overall Study|Medical Condition|3|||
143215090|NCT02669212|516332532|FG001|Overall Study|Medical Condition|4|||
143215091|NCT02669212|516332531|FG000|Overall Study|Withdrawal by Subject|0|||
143215092|NCT02669212|516332532|FG001|Overall Study|Withdrawal by Subject|2|||
143215093|NCT02669212|516332531|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
143215094|NCT02669212|516332532|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
143215095|NCT03549104|516332533|FG000|Overall Study|Withdrawal by Subject|5|||
143215096|NCT03549104|516332534|FG001|Overall Study|Withdrawal by Subject|2|||
143215097|NCT03549104|516332533|FG000|Overall Study|Covid shelter in place|1|||
143215098|NCT03549104|516332534|FG001|Overall Study|Covid shelter in place|2|||
143215099|NCT03078855|516332538|FG000|Overall Study|Lack of Efficacy|62|||
143215100|NCT03078855|516332539|FG001|Overall Study|Lack of Efficacy|31|||
143215101|NCT03078855|516332538|FG000|Overall Study|Death|1|||
143215102|NCT03078855|516332539|FG001|Overall Study|Death|0|||
143215103|NCT03078855|516332538|FG000|Overall Study|Withdrawal by Subject|12|||
143215104|NCT03078855|516332539|FG001|Overall Study|Withdrawal by Subject|6|||
143215105|NCT03078855|516332538|FG000|Overall Study|Physician Decision|3|||
143215106|NCT03078855|516332539|FG001|Overall Study|Physician Decision|2|||
143215107|NCT03078855|516332538|FG000|Overall Study|Second Malignancy|4|||
143215108|NCT03078855|516332539|FG001|Overall Study|Second Malignancy|0|||
143215109|NCT03078855|516332538|FG000|Overall Study|Ineligible|2|||
143215110|NCT03078855|516332539|FG001|Overall Study|Ineligible|0|||
143215111|NCT03078855|516332538|FG000|Overall Study|Withdrew before day 1 treatment|2|||
143215112|NCT03078855|516332539|FG001|Overall Study|Withdrew before day 1 treatment|1|||
143215113|NCT00391027|516332540|FG000|Overall Study|Adverse Event|8|||
143215114|NCT00391027|516332541|FG001|Overall Study|Adverse Event|8|||
143215115|NCT00391027|516332540|FG000|Overall Study|Lack of Efficacy|3|||
143215116|NCT00391027|516332541|FG001|Overall Study|Lack of Efficacy|0|||
143215117|NCT00391027|516332540|FG000|Overall Study|Withdrawal by Subject|10|||
143215118|NCT00391027|516332541|FG001|Overall Study|Withdrawal by Subject|1|||
143215119|NCT00391027|516332540|FG000|Overall Study|Other|4|||
143215120|NCT00391027|516332541|FG001|Overall Study|Other|3|||
143215121|NCT00479856|516332542|FG000|Overall Study|Adverse Event|1|||
143215122|NCT00479856|516332542|FG000|Overall Study|Withdrawal by Subject|1|||
143215123|NCT00479856|516332542|FG000|Overall Study|Physician Decision|1|||
143215124|NCT04164732|516332546|FG000|Treatment run-in Period|Adverse Event|4|||
143215125|NCT04164732|516332547|FG001|Treatment run-in Period|Adverse Event|0|||
143215126|NCT04164732|516332548|FG002|Treatment run-in Period|Adverse Event|0|||
143215127|NCT04164732|516332546|FG000|Treatment run-in Period|Physician Decision|1|||
143215128|NCT04164732|516332547|FG001|Treatment run-in Period|Physician Decision|0|||
143215129|NCT04164732|516332548|FG002|Treatment run-in Period|Physician Decision|0|||
143215130|NCT04164732|516332546|FG000|Treatment run-in Period|Screen Failure|1|||
143215131|NCT04164732|516332547|FG001|Treatment run-in Period|Screen Failure|0|||
143215132|NCT04164732|516332548|FG002|Treatment run-in Period|Screen Failure|0|||
143215133|NCT04164732|516332546|FG000|Randomized Treatment Period|Adverse Event|0|||
143215134|NCT04164732|516332547|FG001|Randomized Treatment Period|Adverse Event|1|||
143215135|NCT04164732|516332548|FG002|Randomized Treatment Period|Adverse Event|0|||
143266512|NCT04493333|516531734|FG000|Overall Study|Noncompliance|2|||
143215136|NCT04164732|516332546|FG000|Randomized Treatment Period|Protocol Deviation|0|||
143215137|NCT04164732|516332547|FG001|Randomized Treatment Period|Protocol Deviation|1|||
143215138|NCT04164732|516332548|FG002|Randomized Treatment Period|Protocol Deviation|1|||
143215139|NCT04164732|516332546|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
143215140|NCT04164732|516332547|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
143215141|NCT04164732|516332548|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
143215142|NCT00661622|516332549|FG000|Overall Study|Protocol Violation|1|||
143215143|NCT00661622|516332550|FG001|Overall Study|Protocol Violation|0|||
143215144|NCT00391625|516332554|FG000|Month 14|Withdrawal by Subject|1|||
143215145|NCT00391625|516332554|FG000|Month 50|Physician Decision|1|||
143215146|NCT03997825|516332555|FG000|Overall Study|Death|3|||
143215147|NCT03997825|516332555|FG000|Overall Study|Lost to Follow-up|10|||
143215148|NCT03997825|516332555|FG000|Overall Study|Withdrawal by Subject|3|||
143215149|NCT03997825|516332555|FG000|Overall Study|Refused participation|1|||
143215150|NCT03664765|516332556|FG000|Overall Study|Withdrawal by Subject|4|||
143215151|NCT03664765|516332557|FG001|Overall Study|Withdrawal by Subject|1|||
143215152|NCT03664765|516332556|FG000|Overall Study|Lost to Follow-up|0|||
143215153|NCT03664765|516332557|FG001|Overall Study|Lost to Follow-up|1|||
143215154|NCT00383162|516332558|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
143215155|NCT00383162|516332559|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
143215156|NCT00383162|516332558|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
143215157|NCT00383162|516332559|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
143215158|NCT00383162|516332558|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
143215159|NCT00383162|516332559|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
143215160|NCT00383162|516332558|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
143215161|NCT00383162|516332559|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
143215162|NCT00383162|516332558|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
143215163|NCT00383162|516332559|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
143215164|NCT00383162|516332558|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
143215165|NCT00383162|516332559|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
143215166|NCT00383162|516332558|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
143215167|NCT00383162|516332559|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
143215168|NCT00383162|516332558|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
143215169|NCT00383162|516332559|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
143215170|NCT00383162|516332558|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
143215171|NCT00383162|516332559|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
143215172|NCT01153698|516332560|FG000|Overall Study|Adverse Event|12|||
143215173|NCT01153698|516332560|FG000|Overall Study|Lost to Follow-up|4|||
143215174|NCT01153698|516332560|FG000|Overall Study|Withdrawal by Subject|2|||
143215175|NCT01153698|516332560|FG000|Overall Study|Switch to other anticoagulants|4|||
143215176|NCT01153698|516332560|FG000|Overall Study|Other|2|||
143215177|NCT01153698|516332560|FG000|Overall Study|Not treated with Pradaxa|5|||
143215178|NCT00825812|516332561|FG000|Overall Study|Never entered follow up|0|||
143215179|NCT00825812|516332562|FG001|Overall Study|Never entered follow up|0|||
143215180|NCT00825812|516332563|FG002|Overall Study|Never entered follow up|0|||
143215181|NCT00825812|516332564|FG003|Overall Study|Never entered follow up|1|||
143215182|NCT00825812|516332561|FG000|Overall Study|Adverse Event|0|||
143215183|NCT00825812|516332562|FG001|Overall Study|Adverse Event|0|||
143215184|NCT00825812|516332563|FG002|Overall Study|Adverse Event|0|||
143215185|NCT00825812|516332564|FG003|Overall Study|Adverse Event|1|||
143215186|NCT00825812|516332561|FG000|Overall Study|Subject withdrew consent|0|||
143215187|NCT00825812|516332562|FG001|Overall Study|Subject withdrew consent|0|||
143215188|NCT00825812|516332563|FG002|Overall Study|Subject withdrew consent|3|||
143215189|NCT00825812|516332564|FG003|Overall Study|Subject withdrew consent|2|||
143215190|NCT00825812|516332561|FG000|Overall Study|Non-compliance with protocol|0|||
143215191|NCT00825812|516332562|FG001|Overall Study|Non-compliance with protocol|0|||
143215192|NCT00825812|516332563|FG002|Overall Study|Non-compliance with protocol|0|||
143215193|NCT00825812|516332564|FG003|Overall Study|Non-compliance with protocol|1|||
143215194|NCT00825812|516332561|FG000|Overall Study|Administrative|0|||
143215195|NCT00825812|516332562|FG001|Overall Study|Administrative|1|||
143215196|NCT00825812|516332563|FG002|Overall Study|Administrative|3|||
143215197|NCT00825812|516332564|FG003|Overall Study|Administrative|5|||
143215198|NCT00398567|516335509|FG000|Overall Study|Disease Progression|3|||
143215199|NCT00398567|516335510|FG001|Overall Study|Disease Progression|4|||
143266513|NCT04493333|516531735|FG001|Overall Study|Noncompliance|1|||
143215200|NCT00398567|516335511|FG002|Overall Study|Disease Progression|27|||
143215201|NCT00398567|516335509|FG000|Overall Study|Withdrawal by Subject|1|||
143215202|NCT00398567|516335510|FG001|Overall Study|Withdrawal by Subject|0|||
143215203|NCT00398567|516335511|FG002|Overall Study|Withdrawal by Subject|4|||
143215204|NCT00398567|516335509|FG000|Overall Study|Adverse Event|0|||
143215205|NCT00398567|516335510|FG001|Overall Study|Adverse Event|0|||
143215206|NCT00398567|516335511|FG002|Overall Study|Adverse Event|2|||
143215207|NCT00398567|516335509|FG000|Overall Study|Protocol Violation|0|||
143266514|NCT00674973|516531738|FG000|Overall Study|Insufficient Therapeutic Response|77|||
143215208|NCT00398567|516335510|FG001|Overall Study|Protocol Violation|0|||
143215209|NCT00398567|516335511|FG002|Overall Study|Protocol Violation|1|||
143215210|NCT03437577|516335516|FG000|Pre-Randomization|Withdrawal by Subject|0|||
143215211|NCT03437577|516335517|FG001|Pre-Randomization|Withdrawal by Subject|0|||
143215212|NCT03437577|516335518|FG002|Pre-Randomization|Withdrawal by Subject|10|||
143215213|NCT03437577|516335516|FG000|Post-Randomization|Physician Decision|0|||
143215214|NCT03437577|516335517|FG001|Post-Randomization|Physician Decision|2|||
143215215|NCT03437577|516335518|FG002|Post-Randomization|Physician Decision|0|||
143215216|NCT00536471|516335521|FG000|Overall Study|Lost to Follow-up|48|||
143215217|NCT00536471|516335522|FG001|Overall Study|Lost to Follow-up|23|||
143215218|NCT00536471|516335523|FG002|Overall Study|Lost to Follow-up|48|||
143215219|NCT00536471|516335524|FG003|Overall Study|Lost to Follow-up|22|||
143215220|NCT00536471|516335521|FG000|Overall Study|Adverse Event|32|||
143215221|NCT00536471|516335522|FG001|Overall Study|Adverse Event|16|||
143215222|NCT00536471|516335523|FG002|Overall Study|Adverse Event|28|||
143215223|NCT00536471|516335524|FG003|Overall Study|Adverse Event|13|||
143215224|NCT00536471|516335521|FG000|Overall Study|Withdrawal by Subject|40|||
143215225|NCT00536471|516335522|FG001|Overall Study|Withdrawal by Subject|24|||
143215226|NCT00536471|516335523|FG002|Overall Study|Withdrawal by Subject|43|||
143215227|NCT00536471|516335524|FG003|Overall Study|Withdrawal by Subject|21|||
143215228|NCT00536471|516335521|FG000|Overall Study|Lack of Efficacy|17|||
143215229|NCT00536471|516335522|FG001|Overall Study|Lack of Efficacy|18|||
143215230|NCT00536471|516335523|FG002|Overall Study|Lack of Efficacy|11|||
143215231|NCT00536471|516335524|FG003|Overall Study|Lack of Efficacy|9|||
143215232|NCT00536471|516335521|FG000|Overall Study|Protocol Violation|8|||
143215233|NCT00536471|516335522|FG001|Overall Study|Protocol Violation|1|||
143215234|NCT00536471|516335523|FG002|Overall Study|Protocol Violation|2|||
143215235|NCT00536471|516335524|FG003|Overall Study|Protocol Violation|3|||
143215236|NCT00536471|516335521|FG000|Overall Study|Physician Decision|11|||
143215237|NCT00536471|516335522|FG001|Overall Study|Physician Decision|1|||
143215238|NCT00536471|516335523|FG002|Overall Study|Physician Decision|3|||
143215239|NCT00536471|516335524|FG003|Overall Study|Physician Decision|2|||
143215240|NCT00536471|516335521|FG000|Overall Study|Death|0|||
143215241|NCT00536471|516335522|FG001|Overall Study|Death|0|||
143215242|NCT00536471|516335523|FG002|Overall Study|Death|1|||
143215243|NCT00536471|516335524|FG003|Overall Study|Death|2|||
143215244|NCT00536471|516335521|FG000|Overall Study|Sponsor Decision|0|||
143215245|NCT00536471|516335522|FG001|Overall Study|Sponsor Decision|1|||
143215246|NCT00536471|516335523|FG002|Overall Study|Sponsor Decision|3|||
143215247|NCT00536471|516335524|FG003|Overall Study|Sponsor Decision|2|||
143215248|NCT04273893|516335527|FG000|Overall Study|Withdrawal by Subject|0|||
143215249|NCT04273893|516335528|FG001|Overall Study|Withdrawal by Subject|2|||
143215250|NCT04273893|516335527|FG000|Overall Study|Treatment of Disease Progression|0|||
143215251|NCT04273893|516335528|FG001|Overall Study|Treatment of Disease Progression|2|||
143215252|NCT04273893|516335527|FG000|Overall Study|Death|1|||
143215253|NCT04273893|516335528|FG001|Overall Study|Death|2|||
143215254|NCT04273893|516335527|FG000|Overall Study|Lost to Follow-up|0|||
143215255|NCT04273893|516335528|FG001|Overall Study|Lost to Follow-up|2|||
143215256|NCT04273893|516335527|FG000|Overall Study|Physician Decision|1|||
143215257|NCT04273893|516335528|FG001|Overall Study|Physician Decision|0|||
143215258|NCT01036321|516335537|FG000|Overall Study|Ineligible after randomization|0|||
143215259|NCT01036321|516335538|FG001|Overall Study|Ineligible after randomization|1|||
143215260|NCT01036321|516335537|FG000|Overall Study|Withdrawal by Subject|3|||
143215261|NCT01036321|516335538|FG001|Overall Study|Withdrawal by Subject|2|||
143215262|NCT01036321|516335537|FG000|Overall Study|Adverse Event|2|||
143215263|NCT01036321|516335538|FG001|Overall Study|Adverse Event|1|||
143215264|NCT00381693|516335539|FG000|Overall Study|Death|1|||
143215265|NCT00381693|516335539|FG000|Overall Study|Adverse Event|4|||
143215266|NCT00381693|516335539|FG000|Overall Study|Patient Choice|1|||
143215267|NCT00381693|516335539|FG000|Overall Study|Progression|2|||
143215268|NCT02003534|516335543|FG000|Overall Study|Lost to Follow-up|47|||
143266515|NCT00674973|516531739|FG001|Overall Study|Insufficient Therapeutic Response|72|||
143266516|NCT00674973|516531738|FG000|Overall Study|Refused Treatment|1|||
143266517|NCT00674973|516531739|FG001|Overall Study|Refused Treatment|5|||
143215269|NCT03920254|516335544|FG000|Overall Study|Adverse Event|1|||
143215270|NCT03920254|516335545|FG001|Overall Study|Adverse Event|0|||
143215271|NCT03920254|516335546|FG002|Overall Study|Adverse Event|0|||
143215272|NCT03920254|516335544|FG000|Overall Study|Physician Decision|0|||
143215273|NCT03920254|516335545|FG001|Overall Study|Physician Decision|1|||
143215274|NCT03920254|516335546|FG002|Overall Study|Physician Decision|2|||
143215275|NCT03920254|516335544|FG000|Overall Study|Study Terminated By Sponsor|12|||
143215276|NCT03920254|516335545|FG001|Overall Study|Study Terminated By Sponsor|17|||
143215277|NCT03920254|516335546|FG002|Overall Study|Study Terminated By Sponsor|12|||
143215278|NCT03920254|516335544|FG000|Overall Study|Withdrawal by Subject|0|||
143215279|NCT03920254|516335545|FG001|Overall Study|Withdrawal by Subject|0|||
143215280|NCT03920254|516335546|FG002|Overall Study|Withdrawal by Subject|1|||
143215281|NCT05274269|516335547|FG000|Overall Study|Adverse Event|0|||
143215282|NCT05274269|516335548|FG001|Overall Study|Adverse Event|3|||
143215283|NCT05274269|516335547|FG000|Overall Study|Death|0|||
143215284|NCT05274269|516335548|FG001|Overall Study|Death|1|||
143215285|NCT05274269|516335547|FG000|Overall Study|Other|0|||
143215286|NCT05274269|516335548|FG001|Overall Study|Other|2|||
143215287|NCT05274269|516335547|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
143215288|NCT05274269|516335548|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
143215289|NCT02206035|516335549|FG000|Overall Study|Physician Decision|10|||
143215290|NCT02206035|516335550|FG001|Overall Study|Physician Decision|0|||
143215291|NCT02206035|516335551|FG002|Overall Study|Physician Decision|175|||
143215292|NCT00709618|516335552|FG000|Overall Study|Withdrawal by Subject|4|||
143215293|NCT00709618|516335552|FG000|Overall Study|Lost to Follow-up|1|||
143215294|NCT00709618|516335552|FG000|Overall Study|Study Closed/Terminated|25|||
143215295|NCT00894361|516335555|FG000|Overall Study|deaths and less than 2 years followup|24|||
143215296|NCT00894361|516335556|FG001|Overall Study|deaths and less than 2 years followup|64|||
143215297|NCT00286494|516335561|FG000|Overall Study|Hyperglycemic rescue|12|||
143215298|NCT00286494|516335562|FG001|Overall Study|Hyperglycemic rescue|19|||
143215299|NCT00286494|516335563|FG002|Overall Study|Hyperglycemic rescue|18|||
143215300|NCT00286494|516335561|FG000|Overall Study|Withdrawal by Subject|2|||
143215301|NCT00286494|516335562|FG001|Overall Study|Withdrawal by Subject|10|||
143215302|NCT00286494|516335563|FG002|Overall Study|Withdrawal by Subject|9|||
143215303|NCT00286494|516335561|FG000|Overall Study|Adverse Event|3|||
143215304|NCT00286494|516335562|FG001|Overall Study|Adverse Event|8|||
143215305|NCT00286494|516335563|FG002|Overall Study|Adverse Event|6|||
143215306|NCT00286494|516335561|FG000|Overall Study|Physician Decision|5|||
143215307|NCT00286494|516335562|FG001|Overall Study|Physician Decision|5|||
143215308|NCT00286494|516335563|FG002|Overall Study|Physician Decision|1|||
143215309|NCT00286494|516335561|FG000|Overall Study|Lost to Follow-up|3|||
143215310|NCT00286494|516335562|FG001|Overall Study|Lost to Follow-up|1|||
143215311|NCT00286494|516335563|FG002|Overall Study|Lost to Follow-up|3|||
143215312|NCT00286494|516335561|FG000|Overall Study|Protocol Violation|1|||
143215313|NCT00286494|516335562|FG001|Overall Study|Protocol Violation|1|||
143215314|NCT00286494|516335563|FG002|Overall Study|Protocol Violation|2|||
143215315|NCT04776317|516335564|FG000|Overall Study|Physician Decision|0|||
143215316|NCT04776317|516335565|FG001|Overall Study|Physician Decision|1|||
143215317|NCT04776317|516335566|FG002|Overall Study|Physician Decision|0|||
143215318|NCT04776317|516335567|FG003|Overall Study|Physician Decision|0|||
143215319|NCT04776317|516335568|FG004|Overall Study|Physician Decision|0|||
143215320|NCT04776317|516335569|FG005|Overall Study|Physician Decision|0|||
143215321|NCT04776317|516335570|FG006|Overall Study|Physician Decision|0|||
143215322|NCT04776317|516335571|FG007|Overall Study|Physician Decision|0|||
143215323|NCT04776317|516335572|FG008|Overall Study|Physician Decision|0|||
143215324|NCT04776317|516335573|FG009|Overall Study|Physician Decision|0|||
143215325|NCT04776317|516335574|FG010|Overall Study|Physician Decision|0|||
143215326|NCT04776317|516335575|FG011|Overall Study|Physician Decision|0|||
143215327|NCT04776317|516335576|FG012|Overall Study|Physician Decision|0|||
143215328|NCT04776317|516335577|FG013|Overall Study|Physician Decision|0|||
143215329|NCT04776317|516335578|FG014|Overall Study|Physician Decision|0|||
143215330|NCT04776317|516335564|FG000|Overall Study|Protocol Violation|0|||
143215331|NCT04776317|516335565|FG001|Overall Study|Protocol Violation|0|||
143215332|NCT04776317|516335566|FG002|Overall Study|Protocol Violation|1|||
143215333|NCT04776317|516335567|FG003|Overall Study|Protocol Violation|0|||
143215334|NCT04776317|516335568|FG004|Overall Study|Protocol Violation|0|||
143215335|NCT04776317|516335569|FG005|Overall Study|Protocol Violation|0|||
143215336|NCT04776317|516335570|FG006|Overall Study|Protocol Violation|0|||
143215337|NCT04776317|516335571|FG007|Overall Study|Protocol Violation|0|||
143215338|NCT04776317|516335572|FG008|Overall Study|Protocol Violation|0|||
143215339|NCT04776317|516335573|FG009|Overall Study|Protocol Violation|0|||
143215340|NCT04776317|516335574|FG010|Overall Study|Protocol Violation|0|||
143215341|NCT04776317|516335575|FG011|Overall Study|Protocol Violation|0|||
143215342|NCT04776317|516335576|FG012|Overall Study|Protocol Violation|0|||
143215343|NCT04776317|516335577|FG013|Overall Study|Protocol Violation|0|||
143215344|NCT04776317|516335578|FG014|Overall Study|Protocol Violation|0|||
143215345|NCT04776317|516335564|FG000|Overall Study|Withdrawal by Subject|0|||
143215346|NCT04776317|516335565|FG001|Overall Study|Withdrawal by Subject|0|||
143215347|NCT04776317|516335566|FG002|Overall Study|Withdrawal by Subject|0|||
143215348|NCT04776317|516335567|FG003|Overall Study|Withdrawal by Subject|0|||
143215349|NCT04776317|516335568|FG004|Overall Study|Withdrawal by Subject|1|||
143215350|NCT04776317|516335569|FG005|Overall Study|Withdrawal by Subject|0|||
143215351|NCT04776317|516335570|FG006|Overall Study|Withdrawal by Subject|0|||
143215352|NCT04776317|516335571|FG007|Overall Study|Withdrawal by Subject|0|||
143215353|NCT04776317|516335572|FG008|Overall Study|Withdrawal by Subject|0|||
143215354|NCT04776317|516335573|FG009|Overall Study|Withdrawal by Subject|0|||
143215355|NCT04776317|516335574|FG010|Overall Study|Withdrawal by Subject|0|||
143215356|NCT04776317|516335575|FG011|Overall Study|Withdrawal by Subject|0|||
143215357|NCT04776317|516335576|FG012|Overall Study|Withdrawal by Subject|0|||
143215358|NCT04776317|516335577|FG013|Overall Study|Withdrawal by Subject|0|||
143215359|NCT04776317|516335578|FG014|Overall Study|Withdrawal by Subject|0|||
143215360|NCT05438576|516335579|FG000|Overall Study|Death|1|||
143215361|NCT05438576|516335580|FG001|Overall Study|Death|1|||
143215362|NCT05438576|516335579|FG000|Overall Study|Withdrawal by Subject|4|||
143215363|NCT05438576|516335580|FG001|Overall Study|Withdrawal by Subject|2|||
143215364|NCT05438576|516335579|FG000|Overall Study|Not Eligible|2|||
143215365|NCT05438576|516335580|FG001|Overall Study|Not Eligible|1|||
143215366|NCT05438576|516335579|FG000|Overall Study|Did not complete baseline testing|22|||
143215367|NCT05438576|516335580|FG001|Overall Study|Did not complete baseline testing|4|||
143215368|NCT01415401|516335589|FG000|Overall Study|Adverse Event|5|||
143215369|NCT01415401|516335589|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
143215370|NCT01415401|516335589|FG000|Overall Study|Terminated by Sponsor|1|||
143215371|NCT00994422|516335590|FG000|Overall Study|Lost to Follow-up|7|||
143215372|NCT00994422|516335591|FG001|Overall Study|Lost to Follow-up|1|||
143215373|NCT03422536|516335592|FG000|Randomized|Physician Decision|1|||
143215374|NCT03422536|516335593|FG001|Randomized|Physician Decision|1|||
143215375|NCT03422536|516335592|FG000|Allocation - Received Intervention|Disease progression|19|||
143215376|NCT03422536|516335593|FG001|Allocation - Received Intervention|Disease progression|25|||
143215377|NCT03422536|516335592|FG000|Allocation - Received Intervention|Death|1|||
143215378|NCT03422536|516335593|FG001|Allocation - Received Intervention|Death|3|||
143215379|NCT03422536|516335592|FG000|Allocation - Received Intervention|Adverse Event|1|||
143215380|NCT03422536|516335593|FG001|Allocation - Received Intervention|Adverse Event|0|||
143215381|NCT03422536|516335592|FG000|Allocation - Received Intervention|Physician Decision|1|||
143215382|NCT03422536|516335593|FG001|Allocation - Received Intervention|Physician Decision|1|||
143215383|NCT03422536|516335592|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
143215384|NCT03422536|516335593|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
143215385|NCT03422536|516335592|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
143215386|NCT03422536|516335593|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
143215387|NCT00532298|516335594|FG000|Overall Study|Adverse Event|1|||
143215388|NCT00532298|516335595|FG001|Overall Study|Adverse Event|0|||
143215389|NCT00532298|516335596|FG002|Overall Study|Adverse Event|0|||
143215390|NCT00532298|516335597|FG003|Overall Study|Adverse Event|0|||
143215391|NCT00532298|516335598|FG004|Overall Study|Adverse Event|1|||
143215392|NCT00532298|516335599|FG005|Overall Study|Adverse Event|1|||
143215393|NCT00532298|516335594|FG000|Overall Study|Lost to Follow-up|1|||
143215394|NCT00532298|516335595|FG001|Overall Study|Lost to Follow-up|1|||
143215395|NCT00532298|516335596|FG002|Overall Study|Lost to Follow-up|1|||
143215396|NCT00532298|516335597|FG003|Overall Study|Lost to Follow-up|0|||
143215397|NCT00532298|516335598|FG004|Overall Study|Lost to Follow-up|0|||
143215398|NCT00532298|516335599|FG005|Overall Study|Lost to Follow-up|1|||
143215399|NCT05232864|516335603|FG000|Overall Study|Adverse Event|0|||
143215400|NCT05232864|516335604|FG001|Overall Study|Adverse Event|1|||
143215401|NCT05232864|516335603|FG000|Overall Study|Study terminated by sponsor|16|||
143215402|NCT05232864|516335604|FG001|Overall Study|Study terminated by sponsor|14|||
143215403|NCT00395850|516335607|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
143215404|NCT00395850|516335608|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
143215405|NCT00395850|516335609|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
143215406|NCT00395850|516335610|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
143215407|NCT00395850|516335607|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
143215408|NCT00395850|516335608|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
143215409|NCT00395850|516335609|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
143215410|NCT00395850|516335610|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
143215411|NCT00395850|516335607|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
143215412|NCT00395850|516335608|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
143215413|NCT00395850|516335609|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
143215414|NCT00395850|516335610|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
143215415|NCT00395850|516335607|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
143215416|NCT00395850|516335608|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
143215417|NCT00395850|516335609|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
143215418|NCT00395850|516335610|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
143215419|NCT00395850|516335607|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
143266518|NCT00674973|516531738|FG000|Overall Study|Failure to Return|1|||
143266519|NCT00674973|516531739|FG001|Overall Study|Failure to Return|0|||
143266520|NCT00674973|516531738|FG000|Overall Study|Adverse Event|2|||
143266521|NCT00674973|516531739|FG001|Overall Study|Adverse Event|9|||
143266522|NCT00674973|516531738|FG000|Overall Study|Death|19|||
143266523|NCT00674973|516531739|FG001|Overall Study|Death|15|||
143215420|NCT00395850|516335608|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
143266524|NCT00674973|516531738|FG000|Overall Study|Protocol Violation|0|||
143266525|NCT00674973|516531739|FG001|Overall Study|Protocol Violation|1|||
143266526|NCT00518687|516531743|FG000|Overall Study|Adverse Event|201|||
143215421|NCT00395850|516335609|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
143266527|NCT00518687|516531744|FG001|Overall Study|Adverse Event|177|||
143215422|NCT00395850|516335610|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
143215423|NCT00395850|516335607|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
143266528|NCT00518687|516531743|FG000|Overall Study|Lost to Follow-up|144|||
143371893|NCT02914522|516906331|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
143215424|NCT00395850|516335608|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
143215425|NCT00395850|516335609|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
143215426|NCT00395850|516335610|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
143215427|NCT00395850|516335607|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
143215428|NCT00395850|516335608|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
143215429|NCT00395850|516335609|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
143215430|NCT00395850|516335610|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
143215431|NCT01844778|516335615|FG000|Overall Study|Protocol deviation|0|||
143215432|NCT01844778|516335616|FG001|Overall Study|Protocol deviation|1|||
143215433|NCT01844778|516335617|FG002|Overall Study|Protocol deviation|2|||
143215434|NCT01844778|516335615|FG000|Overall Study|Withdrawal by Subject|2|||
143215435|NCT01844778|516335616|FG001|Overall Study|Withdrawal by Subject|0|||
143215436|NCT01844778|516335617|FG002|Overall Study|Withdrawal by Subject|0|||
143215437|NCT01844778|516335615|FG000|Overall Study|Adverse Event|0|||
143215438|NCT01844778|516335616|FG001|Overall Study|Adverse Event|2|||
143215439|NCT01844778|516335617|FG002|Overall Study|Adverse Event|2|||
143215440|NCT01620762|516335619|FG000|Overall Study|Protocol Violation|1|||
143215441|NCT01620762|516335620|FG001|Overall Study|Protocol Violation|1|||
143215442|NCT01620762|516335621|FG002|Overall Study|Protocol Violation|1|||
143215443|NCT01620762|516335619|FG000|Overall Study|Adverse Event|9|||
143215444|NCT01620762|516335620|FG001|Overall Study|Adverse Event|5|||
143215445|NCT01620762|516335621|FG002|Overall Study|Adverse Event|2|||
143215446|NCT01620762|516335619|FG000|Overall Study|Withdrawal by Subject|23|||
143215447|NCT01620762|516335620|FG001|Overall Study|Withdrawal by Subject|26|||
143215448|NCT01620762|516335621|FG002|Overall Study|Withdrawal by Subject|27|||
143371894|NCT02914522|516906332|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
143215449|NCT01620762|516335619|FG000|Overall Study|Lost to Follow-up|11|||
143215450|NCT01620762|516335620|FG001|Overall Study|Lost to Follow-up|17|||
143215451|NCT01620762|516335621|FG002|Overall Study|Lost to Follow-up|10|||
143215452|NCT01620762|516335619|FG000|Overall Study|Protocol deviation|1|||
143215453|NCT01620762|516335620|FG001|Overall Study|Protocol deviation|1|||
143215454|NCT01620762|516335621|FG002|Overall Study|Protocol deviation|6|||
143215455|NCT01620762|516335619|FG000|Overall Study|Subject deterioration|0|||
143215456|NCT01620762|516335620|FG001|Overall Study|Subject deterioration|1|||
143215457|NCT01620762|516335621|FG002|Overall Study|Subject deterioration|1|||
143215458|NCT01620762|516335619|FG000|Overall Study|Non-specified|3|||
143215459|NCT01620762|516335620|FG001|Overall Study|Non-specified|6|||
143215460|NCT01620762|516335621|FG002|Overall Study|Non-specified|5|||
143215461|NCT01620762|516335619|FG000|Overall Study|Use of prohibted therapies|0|||
143215462|NCT01620762|516335620|FG001|Overall Study|Use of prohibted therapies|1|||
143215463|NCT01620762|516335621|FG002|Overall Study|Use of prohibted therapies|1|||
143215464|NCT00705146|516335626|FG000|Overall Study|Lost to Follow-up|1|||
143215465|NCT00705146|516335627|FG001|Overall Study|Lost to Follow-up|1|||
143215466|NCT02951429|516335635|FG000|Overall Study|Adverse Event|3|||
143215467|NCT02951429|516335636|FG001|Overall Study|Adverse Event|7|||
143215468|NCT02951429|516335635|FG000|Overall Study|Death|28|||
143215469|NCT02951429|516335636|FG001|Overall Study|Death|36|||
143215470|NCT02951429|516335635|FG000|Overall Study|Lack of Efficacy|0|||
143215471|NCT02951429|516335636|FG001|Overall Study|Lack of Efficacy|1|||
143215472|NCT02951429|516335635|FG000|Overall Study|Lost to Follow-up|0|||
143215473|NCT02951429|516335636|FG001|Overall Study|Lost to Follow-up|1|||
143215474|NCT02951429|516335635|FG000|Overall Study|Lung Transplantation|9|||
143215475|NCT02951429|516335636|FG001|Overall Study|Lung Transplantation|6|||
143215476|NCT02951429|516335635|FG000|Overall Study|Other|1|||
143215477|NCT02951429|516335636|FG001|Overall Study|Other|3|||
143215478|NCT02951429|516335635|FG000|Overall Study|Progressive Disease|1|||
143215479|NCT02951429|516335636|FG001|Overall Study|Progressive Disease|1|||
143215480|NCT02951429|516335635|FG000|Overall Study|Withdrawal by Subject|7|||
143215481|NCT02951429|516335636|FG001|Overall Study|Withdrawal by Subject|11|||
143215482|NCT02951429|516335635|FG000|Overall Study|Participant ongoing in the study|23|||
143215483|NCT02951429|516335636|FG001|Overall Study|Participant ongoing in the study|17|||
143215484|NCT01620528|516335637|FG000|Treatment Period|Did Not Receive Study Drug|0|||
143215485|NCT01620528|516335638|FG001|Treatment Period|Did Not Receive Study Drug|0|||
143215486|NCT01620528|516335639|FG002|Treatment Period|Did Not Receive Study Drug|1|||
143215487|NCT01620528|516335637|FG000|Treatment Period|Withdrawal by Subject|35|||
143215488|NCT01620528|516335638|FG001|Treatment Period|Withdrawal by Subject|21|||
143215489|NCT01620528|516335639|FG002|Treatment Period|Withdrawal by Subject|16|||
143215490|NCT01620528|516335637|FG000|Treatment Period|Adverse Event|17|||
143215491|NCT01620528|516335638|FG001|Treatment Period|Adverse Event|13|||
143215492|NCT01620528|516335639|FG002|Treatment Period|Adverse Event|21|||
143215493|NCT01620528|516335637|FG000|Treatment Period|Lost to Follow-up|16|||
143215494|NCT01620528|516335638|FG001|Treatment Period|Lost to Follow-up|8|||
143215495|NCT01620528|516335639|FG002|Treatment Period|Lost to Follow-up|14|||
143215496|NCT01620528|516335637|FG000|Treatment Period|Other|9|||
143215497|NCT01620528|516335638|FG001|Treatment Period|Other|5|||
143215498|NCT01620528|516335639|FG002|Treatment Period|Other|7|||
143215499|NCT01620528|516335637|FG000|Treatment Period|Subject Noncompliant|11|||
143215500|NCT01620528|516335638|FG001|Treatment Period|Subject Noncompliant|2|||
143215501|NCT01620528|516335639|FG002|Treatment Period|Subject Noncompliant|2|||
143215502|NCT01620528|516335637|FG000|Treatment Period|Pregnancy|7|||
143215503|NCT01620528|516335638|FG001|Treatment Period|Pregnancy|2|||
143215504|NCT01620528|516335639|FG002|Treatment Period|Pregnancy|2|||
143215505|NCT01620528|516335637|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
143215506|NCT01620528|516335638|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
143215507|NCT01620528|516335639|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
143215508|NCT01620528|516335637|FG000|Treatment Period|Exclusionary Medication Received|0|||
143215509|NCT01620528|516335638|FG001|Treatment Period|Exclusionary Medication Received|1|||
143215510|NCT01620528|516335639|FG002|Treatment Period|Exclusionary Medication Received|0|||
143215511|NCT01620528|516335637|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
143215512|NCT01620528|516335638|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
143215513|NCT01620528|516335639|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
143215514|NCT01620528|516335637|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
143215515|NCT01620528|516335638|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
143215516|NCT01620528|516335639|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
143215517|NCT01620528|516335637|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
143215518|NCT01620528|516335638|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
143215519|NCT01620528|516335639|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
143215520|NCT01620528|516335637|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
143215521|NCT01620528|516335638|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
143215522|NCT01620528|516335639|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
143215523|NCT01620528|516335637|FG000|Post-Treatment Follow-Up Period|Other|6|||
143215524|NCT01620528|516335638|FG001|Post-Treatment Follow-Up Period|Other|4|||
143215525|NCT01620528|516335639|FG002|Post-Treatment Follow-Up Period|Other|2|||
143215526|NCT00767819|516335640|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
143215527|NCT00767819|516335641|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
143215528|NCT00767819|516335642|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
143215529|NCT00767819|516335640|FG000|Overall Study|Withdrawal by Subject|1|||
143215530|NCT00767819|516335641|FG001|Overall Study|Withdrawal by Subject|1|||
143215531|NCT00767819|516335642|FG002|Overall Study|Withdrawal by Subject|0|||
143215532|NCT00767819|516335640|FG000|Overall Study|Administrative problems|0|||
143215533|NCT00767819|516335641|FG001|Overall Study|Administrative problems|1|||
143215534|NCT00767819|516335642|FG002|Overall Study|Administrative problems|0|||
143215535|NCT00767819|516335640|FG000|Overall Study|Death|2|||
143215536|NCT00767819|516335641|FG001|Overall Study|Death|3|||
143215537|NCT00767819|516335642|FG002|Overall Study|Death|0|||
143215538|NCT00767819|516335640|FG000|Overall Study|Adverse Event|2|||
143215539|NCT00767819|516335641|FG001|Overall Study|Adverse Event|0|||
143215540|NCT00767819|516335642|FG002|Overall Study|Adverse Event|0|||
143215541|NCT00767819|516335640|FG000|Overall Study|Abnormal lab values|1|||
143215542|NCT00767819|516335641|FG001|Overall Study|Abnormal lab values|0|||
143215543|NCT00767819|516335642|FG002|Overall Study|Abnormal lab values|0|||
143215544|NCT00767819|516335640|FG000|Overall Study|Lost to Follow-up|1|||
143215545|NCT00767819|516335641|FG001|Overall Study|Lost to Follow-up|0|||
143215546|NCT00767819|516335642|FG002|Overall Study|Lost to Follow-up|0|||
143215547|NCT04038567|516335643|FG000|Overall Study|Lost to Follow-up|6|||
143215548|NCT04038567|516335644|FG001|Overall Study|Lost to Follow-up|4|||
143215549|NCT04038567|516335645|FG002|Overall Study|Lost to Follow-up|5|||
143215550|NCT04038567|516335646|FG003|Overall Study|Lost to Follow-up|4|||
143215551|NCT04038567|516335647|FG004|Overall Study|Lost to Follow-up|6|||
143215552|NCT04038567|516335648|FG005|Overall Study|Lost to Follow-up|4|||
143215553|NCT04038567|516335649|FG006|Overall Study|Lost to Follow-up|4|||
143215554|NCT04038567|516335650|FG007|Overall Study|Lost to Follow-up|1|||
143215555|NCT04038567|516335643|FG000|Overall Study|Withdrawal by Subject|2|||
143215556|NCT04038567|516335644|FG001|Overall Study|Withdrawal by Subject|1|||
143215557|NCT04038567|516335645|FG002|Overall Study|Withdrawal by Subject|1|||
143215558|NCT04038567|516335646|FG003|Overall Study|Withdrawal by Subject|1|||
143215559|NCT04038567|516335647|FG004|Overall Study|Withdrawal by Subject|4|||
143215560|NCT04038567|516335648|FG005|Overall Study|Withdrawal by Subject|1|||
143215561|NCT04038567|516335649|FG006|Overall Study|Withdrawal by Subject|1|||
143215562|NCT04038567|516335650|FG007|Overall Study|Withdrawal by Subject|1|||
143215563|NCT04038567|516335643|FG000|Overall Study|missed survey window|1|||
143215564|NCT04038567|516335644|FG001|Overall Study|missed survey window|2|||
143215565|NCT04038567|516335645|FG002|Overall Study|missed survey window|0|||
143215566|NCT04038567|516335646|FG003|Overall Study|missed survey window|0|||
143215567|NCT04038567|516335647|FG004|Overall Study|missed survey window|1|||
143215568|NCT04038567|516335648|FG005|Overall Study|missed survey window|1|||
143215569|NCT04038567|516335649|FG006|Overall Study|missed survey window|2|||
143215570|NCT04038567|516335650|FG007|Overall Study|missed survey window|2|||
143215571|NCT04038567|516335643|FG000|Overall Study|technical issues|0|||
143215572|NCT04038567|516335644|FG001|Overall Study|technical issues|0|||
143215573|NCT04038567|516335645|FG002|Overall Study|technical issues|0|||
143215574|NCT04038567|516335646|FG003|Overall Study|technical issues|0|||
143215575|NCT04038567|516335647|FG004|Overall Study|technical issues|0|||
143215576|NCT04038567|516335648|FG005|Overall Study|technical issues|0|||
143215577|NCT04038567|516335649|FG006|Overall Study|technical issues|1|||
143215578|NCT04038567|516335650|FG007|Overall Study|technical issues|0|||
143215579|NCT04038567|516335643|FG000|Overall Study|Medical issues (i.e., illness)|0|||
143215580|NCT04038567|516335644|FG001|Overall Study|Medical issues (i.e., illness)|1|||
143215581|NCT04038567|516335645|FG002|Overall Study|Medical issues (i.e., illness)|2|||
143215582|NCT04038567|516335646|FG003|Overall Study|Medical issues (i.e., illness)|1|||
143215583|NCT04038567|516335647|FG004|Overall Study|Medical issues (i.e., illness)|1|||
143215584|NCT04038567|516335648|FG005|Overall Study|Medical issues (i.e., illness)|1|||
143215585|NCT04038567|516335649|FG006|Overall Study|Medical issues (i.e., illness)|0|||
143215586|NCT04038567|516335650|FG007|Overall Study|Medical issues (i.e., illness)|0|||
143215587|NCT04038567|516335643|FG000|Overall Study|Death|0|||
143215588|NCT04038567|516335644|FG001|Overall Study|Death|0|||
143215589|NCT04038567|516335645|FG002|Overall Study|Death|0|||
143215590|NCT04038567|516335646|FG003|Overall Study|Death|1|||
143215591|NCT04038567|516335647|FG004|Overall Study|Death|1|||
143215592|NCT04038567|516335648|FG005|Overall Study|Death|0|||
143215593|NCT04038567|516335649|FG006|Overall Study|Death|0|||
143215594|NCT04038567|516335650|FG007|Overall Study|Death|1|||
143215595|NCT01628965|516335654|FG000|Overall Study|Adverse Event|30|||
143215596|NCT01628965|516335654|FG000|Overall Study|Lack of Efficacy|7|||
143215597|NCT01628965|516335654|FG000|Overall Study|Withdrawal by Subject|3|||
143215598|NCT01628965|516335654|FG000|Overall Study|Lost to Follow-up|1|||
143215599|NCT01628965|516335654|FG000|Overall Study|Discontinuation criteria|8|||
143215600|NCT04356352|516335657|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
143215601|NCT04356352|516335658|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
143215602|NCT04356352|516335659|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
143215603|NCT04356352|516335657|FG000|Overall Study|Protocol Violation|0|||
143215604|NCT04356352|516335658|FG001|Overall Study|Protocol Violation|3|||
143215605|NCT04356352|516335659|FG002|Overall Study|Protocol Violation|1|||
143215606|NCT00330681|516335660|FG000|Overall Study|Adverse Event|3|||
143215607|NCT00330681|516335661|FG001|Overall Study|Adverse Event|6|||
143215608|NCT00330681|516335660|FG000|Overall Study|Protocol Violation|0|||
143215609|NCT00330681|516335661|FG001|Overall Study|Protocol Violation|1|||
143215610|NCT00330681|516335660|FG000|Overall Study|Withdrawal by Subject|5|||
143215611|NCT00330681|516335661|FG001|Overall Study|Withdrawal by Subject|5|||
143215612|NCT00330681|516335660|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
143215613|NCT00330681|516335661|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
143215614|NCT01138501|516335662|FG000|Overall Study|Protocol Violation|2|||
143215615|NCT01138501|516335662|FG000|Overall Study|Withdrawal by Subject|3|||
143215616|NCT00847197|516335663|FG000|Overall Study|Adverse Event|21|||
143215617|NCT00847197|516335664|FG001|Overall Study|Adverse Event|3|||
143215618|NCT00847197|516335663|FG000|Overall Study|Protocol Violation|0|||
143215619|NCT00847197|516335664|FG001|Overall Study|Protocol Violation|1|||
143215620|NCT00847197|516335663|FG000|Overall Study|Withdrawal by Subject|3|||
143215621|NCT00847197|516335664|FG001|Overall Study|Withdrawal by Subject|1|||
143215622|NCT03170193|516335665|FG000|Overall Study|Withdrawal by Subject|0|||
143215623|NCT03170193|516335666|FG001|Overall Study|Withdrawal by Subject|0|||
143215624|NCT03170193|516335667|FG002|Overall Study|Withdrawal by Subject|0|||
143215625|NCT03170193|516335668|FG003|Overall Study|Withdrawal by Subject|1|||
143215626|NCT03170193|516335669|FG004|Overall Study|Withdrawal by Subject|0|||
143215627|NCT03170193|516335670|FG005|Overall Study|Withdrawal by Subject|0|||
143215628|NCT03170193|516335671|FG006|Overall Study|Withdrawal by Subject|0|||
143215629|NCT03170193|516335665|FG000|Overall Study|Lost to Follow-up|1|||
143215630|NCT03170193|516335666|FG001|Overall Study|Lost to Follow-up|1|||
143215631|NCT03170193|516335667|FG002|Overall Study|Lost to Follow-up|0|||
143215632|NCT03170193|516335668|FG003|Overall Study|Lost to Follow-up|0|||
143215633|NCT03170193|516335669|FG004|Overall Study|Lost to Follow-up|0|||
143215634|NCT03170193|516335670|FG005|Overall Study|Lost to Follow-up|0|||
143215635|NCT03170193|516335671|FG006|Overall Study|Lost to Follow-up|0|||
143215636|NCT02461745|516335672|FG000|Overall Study|Lack of Efficacy|9|||
143215637|NCT02461745|516335673|FG001|Overall Study|Lack of Efficacy|1|||
143215638|NCT02461745|516335672|FG000|Overall Study|Lost to Follow-up|2|||
143215639|NCT02461745|516335673|FG001|Overall Study|Lost to Follow-up|2|||
143215640|NCT02461745|516335672|FG000|Overall Study|Withdrawal by Subject|3|||
143215641|NCT02461745|516335673|FG001|Overall Study|Withdrawal by Subject|1|||
143215642|NCT00211887|516335674|FG000|Overall Study|Adverse Event|8|||
143215643|NCT00211887|516335675|FG001|Overall Study|Adverse Event|4|||
143215644|NCT00211887|516335676|FG002|Overall Study|Adverse Event|6|||
143215645|NCT00211887|516335674|FG000|Overall Study|Death|1|||
143215646|NCT00211887|516335675|FG001|Overall Study|Death|1|||
143215647|NCT00211887|516335676|FG002|Overall Study|Death|1|||
143215648|NCT00211887|516335674|FG000|Overall Study|Lost to Follow-up|28|||
143215649|NCT00211887|516335675|FG001|Overall Study|Lost to Follow-up|13|||
143215650|NCT00211887|516335676|FG002|Overall Study|Lost to Follow-up|9|||
143215651|NCT00211887|516335674|FG000|Overall Study|Non-medical reason|31|||
143215652|NCT00211887|516335675|FG001|Overall Study|Non-medical reason|14|||
143215653|NCT00211887|516335676|FG002|Overall Study|Non-medical reason|8|||
143215654|NCT00211887|516335674|FG000|Overall Study|Other medical reason|15|||
143215655|NCT00211887|516335675|FG001|Overall Study|Other medical reason|11|||
143215656|NCT00211887|516335676|FG002|Overall Study|Other medical reason|7|||
143266529|NCT00518687|516531744|FG001|Overall Study|Lost to Follow-up|155|||
143266530|NCT00518687|516531743|FG000|Overall Study|Physician Decision|42|||
143266531|NCT00518687|516531744|FG001|Overall Study|Physician Decision|48|||
143266532|NCT00518687|516531743|FG000|Overall Study|Progressive disease|2|||
143266533|NCT00518687|516531744|FG001|Overall Study|Progressive disease|2|||
143266534|NCT00518687|516531743|FG000|Overall Study|Protocol Violation|8|||
143266535|NCT00518687|516531744|FG001|Overall Study|Protocol Violation|10|||
143266536|NCT00518687|516531743|FG000|Overall Study|Study terminated by sponsor|930|||
143266537|NCT00518687|516531744|FG001|Overall Study|Study terminated by sponsor|918|||
143266538|NCT00518687|516531743|FG000|Overall Study|Withdrawal by Subject|110|||
143215657|NCT00211887|516335674|FG000|Overall Study|Side effects|19|||
143215658|NCT00211887|516335675|FG001|Overall Study|Side effects|13|||
143215659|NCT00211887|516335676|FG002|Overall Study|Side effects|5|||
143215660|NCT00852241|516335677|FG000|Overall Study|Physician Decision|18|||
143215661|NCT00619307|516335679|FG000|Overall Study|Adverse Event|0|||
143215662|NCT00619307|516335680|FG001|Overall Study|Adverse Event|1|||
143215663|NCT00619307|516335679|FG000|Overall Study|Lost to Follow-up|0|||
143215664|NCT00619307|516335680|FG001|Overall Study|Lost to Follow-up|1|||
143215665|NCT00619307|516335679|FG000|Overall Study|Protocol Violation|3|||
143215666|NCT00619307|516335680|FG001|Overall Study|Protocol Violation|0|||
143215667|NCT00619307|516335679|FG000|Overall Study|Withdrew consent|1|||
143215668|NCT00619307|516335680|FG001|Overall Study|Withdrew consent|0|||
143215669|NCT00619307|516335679|FG000|Overall Study|Severe migraine|0|||
143371895|NCT02914522|516906333|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
143371896|NCT02914522|516906334|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
143371897|NCT02914522|516906335|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
143371898|NCT02914522|516906336|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
143371899|NCT02914522|516906337|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
143215670|NCT00619307|516335680|FG001|Overall Study|Severe migraine|1|||
143215671|NCT00619307|516335679|FG000|Overall Study|MS attack plus steroids|0|||
143215672|NCT00619307|516335680|FG001|Overall Study|MS attack plus steroids|1|||
143215673|NCT00118430|516335681|FG000|Overall Study|Withdrawal by Subject|6|||
143215674|NCT00118430|516335682|FG001|Overall Study|Withdrawal by Subject|2|||
143215675|NCT00118430|516335683|FG002|Overall Study|Withdrawal by Subject|0|||
143215676|NCT00118430|516335681|FG000|Overall Study|Lost to Follow-up|15|||
143215677|NCT00118430|516335682|FG001|Overall Study|Lost to Follow-up|22|||
143215678|NCT00118430|516335683|FG002|Overall Study|Lost to Follow-up|28|||
143215679|NCT02475278|516337557|FG000|Overall Study|Lost to Follow-up|1|||
143215680|NCT02475278|516337557|FG000|Overall Study|Reason Not Specified|1|||
143215681|NCT01946152|516337558|FG000|Overall Study|Adverse Event|1|||
143215682|NCT01946152|516337559|FG001|Overall Study|Adverse Event|0|||
143215683|NCT01946152|516337560|FG002|Overall Study|Adverse Event|0|||
143215684|NCT01946152|516337561|FG003|Overall Study|Adverse Event|0|||
143215685|NCT01946152|516337558|FG000|Overall Study|Withdrawal by Subject|0|||
143215686|NCT01946152|516337559|FG001|Overall Study|Withdrawal by Subject|2|||
143215687|NCT01946152|516337560|FG002|Overall Study|Withdrawal by Subject|0|||
143215688|NCT01946152|516337561|FG003|Overall Study|Withdrawal by Subject|0|||
143215689|NCT01946152|516337558|FG000|Overall Study|Progression|0|||
143215690|NCT01946152|516337559|FG001|Overall Study|Progression|1|||
143266539|NCT00518687|516531744|FG001|Overall Study|Withdrawal by Subject|110|||
143266540|NCT02598960|516531745|FG000|Treatment Period|Disease Progression|4|||
143266541|NCT02598960|516531746|FG001|Treatment Period|Disease Progression|4|||
143215691|NCT01946152|516337560|FG002|Overall Study|Progression|4|||
143215692|NCT01946152|516337561|FG003|Overall Study|Progression|7|||
143215693|NCT01946152|516337558|FG000|Overall Study|Physician Decision|0|||
143215694|NCT01946152|516337559|FG001|Overall Study|Physician Decision|0|||
143215695|NCT01946152|516337560|FG002|Overall Study|Physician Decision|1|||
143266542|NCT02598960|516531747|FG002|Treatment Period|Disease Progression|4|||
143266543|NCT02598960|516531748|FG003|Treatment Period|Disease Progression|6|||
143215696|NCT01946152|516337561|FG003|Overall Study|Physician Decision|0|||
143215697|NCT01946152|516337558|FG000|Overall Study|Second malignancy|0|||
143215698|NCT01946152|516337559|FG001|Overall Study|Second malignancy|0|||
143215699|NCT01946152|516337560|FG002|Overall Study|Second malignancy|1|||
143215700|NCT01946152|516337561|FG003|Overall Study|Second malignancy|0|||
143215701|NCT01946152|516337558|FG000|Overall Study|Adverse Event|0|||
143215702|NCT01946152|516337559|FG001|Overall Study|Adverse Event|0|||
143215703|NCT01946152|516337560|FG002|Overall Study|Adverse Event|0|||
143266544|NCT02598960|516531749|FG004|Treatment Period|Disease Progression|8|||
143266545|NCT02598960|516531750|FG005|Treatment Period|Disease Progression|2|||
143215704|NCT01946152|516337561|FG003|Overall Study|Adverse Event|1|||
143215705|NCT03712787|516337562|FG000|Overall Study|Adverse Event|2|||
143215706|NCT03712787|516337563|FG001|Overall Study|Adverse Event|3|||
143215707|NCT03712787|516337564|FG002|Overall Study|Adverse Event|0|||
143215708|NCT03712787|516337565|FG003|Overall Study|Adverse Event|4|||
143215709|NCT03712787|516337562|FG000|Overall Study|Withdrawal by Subject|4|||
143215710|NCT03712787|516337563|FG001|Overall Study|Withdrawal by Subject|14|||
143215711|NCT03712787|516337564|FG002|Overall Study|Withdrawal by Subject|12|||
143215712|NCT03712787|516337565|FG003|Overall Study|Withdrawal by Subject|8|||
143215713|NCT03712787|516337562|FG000|Overall Study|Lost to Follow-up|1|||
143215714|NCT03712787|516337563|FG001|Overall Study|Lost to Follow-up|1|||
143215715|NCT03712787|516337564|FG002|Overall Study|Lost to Follow-up|2|||
143215716|NCT03712787|516337565|FG003|Overall Study|Lost to Follow-up|1|||
143215717|NCT03712787|516337562|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
143215718|NCT03712787|516337563|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
143215719|NCT03712787|516337564|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
143215720|NCT03712787|516337565|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
143215721|NCT03712787|516337562|FG000|Overall Study|COVID-19 Infection|0|||
143215722|NCT03712787|516337563|FG001|Overall Study|COVID-19 Infection|1|||
143215723|NCT03712787|516337564|FG002|Overall Study|COVID-19 Infection|0|||
143215724|NCT03712787|516337565|FG003|Overall Study|COVID-19 Infection|0|||
143215725|NCT03712787|516337562|FG000|Overall Study|Other, Not Specified|79|||
143215726|NCT03712787|516337563|FG001|Overall Study|Other, Not Specified|77|||
143215727|NCT03712787|516337564|FG002|Overall Study|Other, Not Specified|74|||
143215728|NCT03712787|516337565|FG003|Overall Study|Other, Not Specified|78|||
143215729|NCT01865448|516337566|FG000|Overall Study|Adverse Event|1|||
143215730|NCT01865448|516337567|FG001|Overall Study|Adverse Event|1|||
143215731|NCT01865448|516337566|FG000|Overall Study|Pregnancy|0|||
143215732|NCT01865448|516337567|FG001|Overall Study|Pregnancy|1|||
143215733|NCT01865448|516337566|FG000|Overall Study|dropout unrelated to study|1|||
143215734|NCT01865448|516337567|FG001|Overall Study|dropout unrelated to study|1|||
143371900|NCT02914522|516906338|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
143371901|NCT02914522|516906328|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
143371902|NCT02914522|516906329|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
143215735|NCT05111249|516337575|FG000|Overall Study|Lost to Follow-up|0|||
143215736|NCT05111249|516337576|FG001|Overall Study|Lost to Follow-up|2|||
143215737|NCT05111249|516337575|FG000|Overall Study|Physician Decision|0|||
143215738|NCT05111249|516337576|FG001|Overall Study|Physician Decision|1|||
143215739|NCT05111249|516337575|FG000|Overall Study|Participant decision|1|||
143215740|NCT05111249|516337576|FG001|Overall Study|Participant decision|5|||
143215741|NCT05128578|516337577|FG000|Overall Study|Withdrawal by Subject|9|||
143215742|NCT05128578|516337577|FG000|Overall Study|Lost to Follow-up|5|||
143215743|NCT00799266|516337582|FG000|Overall Study|Adverse Event|0|||
143215744|NCT00799266|516337583|FG001|Overall Study|Adverse Event|1|||
143215745|NCT00799266|516337582|FG000|Overall Study|Subject withdrew consent|3|||
143215746|NCT00799266|516337583|FG001|Overall Study|Subject withdrew consent|0|||
143215747|NCT01016600|516337584|FG000|Overall Study|Did not start treatment|1|||
143215748|NCT01016600|516337585|FG001|Overall Study|Did not start treatment|0|||
143215749|NCT01016600|516337586|FG002|Overall Study|Did not start treatment|0|||
143215750|NCT01016600|516337587|FG003|Overall Study|Did not start treatment|0|||
143215751|NCT02679755|516337589|FG000|Overall Study|Death|0|||
143215752|NCT02679755|516337590|FG001|Overall Study|Death|3|||
143371903|NCT02914522|516906330|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
143215753|NCT02679755|516337589|FG000|Overall Study|Global deterioration of health status|1|||
143215754|NCT02679755|516337590|FG001|Overall Study|Global deterioration of health status|8|||
143215755|NCT02679755|516337589|FG000|Overall Study|Lost to Follow-up|1|||
143215756|NCT02679755|516337590|FG001|Overall Study|Lost to Follow-up|0|||
143215757|NCT02679755|516337589|FG000|Overall Study|Objective progression or relapse|24|||
143215758|NCT02679755|516337590|FG001|Overall Study|Objective progression or relapse|83|||
143215759|NCT02679755|516337589|FG000|Overall Study|Not defined|0|||
143215760|NCT02679755|516337590|FG001|Overall Study|Not defined|2|||
143215761|NCT02679755|516337589|FG000|Overall Study|Withdrawal by participant|6|||
143215762|NCT02679755|516337590|FG001|Overall Study|Withdrawal by participant|3|||
143215763|NCT02679755|516337589|FG000|Overall Study|Adverse Event|1|||
143215764|NCT02679755|516337590|FG001|Overall Study|Adverse Event|4|||
143371904|NCT02914522|516906331|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
143215765|NCT02679755|516337589|FG000|Overall Study|Adverse events not related to study drug|1|||
143215766|NCT02679755|516337590|FG001|Overall Study|Adverse events not related to study drug|2|||
143215767|NCT01061359|516337591|FG000|Overall Study|Death|32|||
143215768|NCT01061359|516337591|FG000|Overall Study|Lost to Follow-up|1072|||
143215769|NCT01061359|516337591|FG000|Overall Study|Relapse|187|||
143215770|NCT01061359|516337591|FG000|Overall Study|Secondary neoplasm|11|||
143215771|NCT02610777|516337594|FG000|Overall Study|Lost to Follow-up|1|||
143215772|NCT02610777|516337595|FG001|Overall Study|Lost to Follow-up|0|||
143215773|NCT02610777|516337594|FG000|Overall Study|Site Terminated by Sponsor|9|||
143215774|NCT02610777|516337595|FG001|Overall Study|Site Terminated by Sponsor|8|||
143215775|NCT02610777|516337594|FG000|Overall Study|Withdrawal by Subject|2|||
143215776|NCT02610777|516337595|FG001|Overall Study|Withdrawal by Subject|2|||
143215777|NCT02610777|516337594|FG000|Overall Study|Reason not Specified|0|||
143215778|NCT02610777|516337595|FG001|Overall Study|Reason not Specified|1|||
143215779|NCT02610777|516337594|FG000|Overall Study|Death|50|||
143215780|NCT02610777|516337595|FG001|Overall Study|Death|47|||
143215781|NCT03688074|516337596|FG000|Overall Study|Adverse Event|0|||
143215782|NCT03688074|516337597|FG001|Overall Study|Adverse Event|1|||
143215783|NCT03688074|516337596|FG000|Overall Study|Other|1|||
143215784|NCT03688074|516337597|FG001|Overall Study|Other|0|||
143215785|NCT00660179|516337598|FG000|Overall Study|Death|44|||
143215786|NCT00660179|516337599|FG001|Overall Study|Death|47|||
143215787|NCT00660179|516337600|FG002|Overall Study|Death|34|||
143215788|NCT00660179|516337598|FG000|Overall Study|Withdrawal of consent|4|||
143215789|NCT00660179|516337599|FG001|Overall Study|Withdrawal of consent|6|||
143215790|NCT00660179|516337600|FG002|Overall Study|Withdrawal of consent|4|||
143215791|NCT00660179|516337598|FG000|Overall Study|Lost to Follow-up|7|||
143215792|NCT00660179|516337599|FG001|Overall Study|Lost to Follow-up|5|||
143215793|NCT00660179|516337600|FG002|Overall Study|Lost to Follow-up|2|||
143215794|NCT00660179|516337598|FG000|Overall Study|Administrative reason|0|||
143215795|NCT00660179|516337599|FG001|Overall Study|Administrative reason|0|||
143215796|NCT00660179|516337600|FG002|Overall Study|Administrative reason|1|||
143215797|NCT00660179|516337598|FG000|Overall Study|Incorrect randomization|1|||
143215798|NCT00660179|516337599|FG001|Overall Study|Incorrect randomization|0|||
143215799|NCT00660179|516337600|FG002|Overall Study|Incorrect randomization|0|||
143215800|NCT03056339|516337603|FG000|Overall Study|Failed Requirements|0|||
143215801|NCT03056339|516337604|FG001|Overall Study|Failed Requirements|2|||
143215802|NCT03056339|516337605|FG002|Overall Study|Failed Requirements|7|||
143215803|NCT03056339|516337606|FG003|Overall Study|Failed Requirements|1|||
143215804|NCT04171219|516337609|FG000|Overall Study|Adverse Event|1|||
143215805|NCT04171219|516337610|FG001|Overall Study|Adverse Event|0|||
143215806|NCT04171219|516337609|FG000|Overall Study|Death|0|||
143215807|NCT04171219|516337610|FG001|Overall Study|Death|1|||
143215808|NCT04171219|516337609|FG000|Overall Study|Lack of Efficacy|9|||
143215809|NCT04171219|516337610|FG001|Overall Study|Lack of Efficacy|13|||
143215810|NCT04171219|516337609|FG000|Overall Study|Withdrawal by Subject|1|||
143215811|NCT04171219|516337610|FG001|Overall Study|Withdrawal by Subject|2|||
143215812|NCT04171219|516337609|FG000|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
143215813|NCT04171219|516337610|FG001|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
143215814|NCT04171219|516337609|FG000|Overall Study|Clinical PD/Patient choice|1|||
143215815|NCT04171219|516337610|FG001|Overall Study|Clinical PD/Patient choice|0|||
143215816|NCT04171219|516337609|FG000|Overall Study|Toxicity/ Patient choice|1|||
143215817|NCT04171219|516337610|FG001|Overall Study|Toxicity/ Patient choice|0|||
143215818|NCT02974257|516337615|FG000|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|1|||
143215819|NCT02974257|516337616|FG001|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|0|||
143215820|NCT02974257|516337615|FG000|Overall Study|Clinical indication for thiamine|1|||
143215821|NCT02974257|516337616|FG001|Overall Study|Clinical indication for thiamine|0|||
143215822|NCT02974257|516337615|FG000|Overall Study|Already on thiamine|1|||
143215823|NCT02974257|516337616|FG001|Overall Study|Already on thiamine|0|||
143215824|NCT02974257|516337615|FG000|Overall Study|Extubated prior to study drug|0|||
143215825|NCT02974257|516337616|FG001|Overall Study|Extubated prior to study drug|1|||
143215826|NCT02974257|516337615|FG000|Overall Study|Death|0|||
143215827|NCT02974257|516337616|FG001|Overall Study|Death|1|||
143215828|NCT02783599|516337619|FG000|Overall Study|Progressive disease|23|||
143215829|NCT02783599|516337619|FG000|Overall Study|Surgical Resection|10|||
143266546|NCT02598960|516531751|FG006|Treatment Period|Disease Progression|2|||
143266547|NCT02598960|516531752|FG007|Treatment Period|Disease Progression|3|||
143215830|NCT02783599|516337619|FG000|Overall Study|Adverse Event|4|||
143215831|NCT02783599|516337619|FG000|Overall Study|Physician Decision|2|||
143215832|NCT02783599|516337619|FG000|Overall Study|Death|1|||
143215833|NCT00856544|516337620|FG000|Overall Study|Randomized but not treated|3|||
143215834|NCT00856544|516337621|FG001|Overall Study|Randomized but not treated|0|||
143215835|NCT00856544|516337622|FG002|Overall Study|Randomized but not treated|0|||
143215836|NCT00856544|516337623|FG003|Overall Study|Randomized but not treated|0|||
143215837|NCT00856544|516337620|FG000|Overall Study|Death|0|||
143215838|NCT00856544|516337621|FG001|Overall Study|Death|2|||
143215839|NCT00856544|516337622|FG002|Overall Study|Death|0|||
143215840|NCT00856544|516337623|FG003|Overall Study|Death|0|||
143215841|NCT00856544|516337620|FG000|Overall Study|Adverse Event|20|||
143215842|NCT00856544|516337621|FG001|Overall Study|Adverse Event|29|||
143215843|NCT00856544|516337622|FG002|Overall Study|Adverse Event|2|||
143215844|NCT00856544|516337623|FG003|Overall Study|Adverse Event|3|||
143215845|NCT00856544|516337620|FG000|Overall Study|Lack of Efficacy|16|||
143215846|NCT00856544|516337621|FG001|Overall Study|Lack of Efficacy|12|||
143215847|NCT00856544|516337622|FG002|Overall Study|Lack of Efficacy|3|||
143215848|NCT00856544|516337623|FG003|Overall Study|Lack of Efficacy|3|||
143215849|NCT00856544|516337620|FG000|Overall Study|Other|9|||
143215850|NCT00856544|516337621|FG001|Overall Study|Other|16|||
143215851|NCT00856544|516337622|FG002|Overall Study|Other|1|||
143215852|NCT00856544|516337623|FG003|Overall Study|Other|6|||
143215853|NCT00856544|516337620|FG000|Overall Study|Lost to Follow-up|1|||
143215854|NCT00856544|516337621|FG001|Overall Study|Lost to Follow-up|2|||
143215855|NCT00856544|516337622|FG002|Overall Study|Lost to Follow-up|2|||
143215856|NCT00856544|516337623|FG003|Overall Study|Lost to Follow-up|0|||
143215857|NCT00856544|516337620|FG000|Overall Study|Withdrawal by Subject|8|||
143215858|NCT00856544|516337621|FG001|Overall Study|Withdrawal by Subject|5|||
143215859|NCT00856544|516337622|FG002|Overall Study|Withdrawal by Subject|0|||
143215860|NCT00856544|516337623|FG003|Overall Study|Withdrawal by Subject|1|||
143215861|NCT01564732|516337624|FG000|Overall Study|Early termination by the study sponsor|6|||
143215862|NCT01564732|516337625|FG001|Overall Study|Early termination by the study sponsor|5|||
143215863|NCT00394706|516337640|FG000|Overall Study|Withdrawal by Subject|2|||
143215864|NCT00394706|516337641|FG001|Overall Study|Withdrawal by Subject|0|||
143215865|NCT00394706|516337642|FG002|Overall Study|Withdrawal by Subject|1|||
143215866|NCT00394706|516337643|FG003|Overall Study|Withdrawal by Subject|0|||
143215867|NCT00394706|516337644|FG004|Overall Study|Withdrawal by Subject|0|||
143215868|NCT00394706|516337645|FG005|Overall Study|Withdrawal by Subject|2|||
143215869|NCT00394706|516337646|FG006|Overall Study|Withdrawal by Subject|1|||
143215870|NCT00394706|516337647|FG007|Overall Study|Withdrawal by Subject|0|||
143215871|NCT00394706|516337640|FG000|Overall Study|Lost to Follow-up|2|||
143215872|NCT00394706|516337641|FG001|Overall Study|Lost to Follow-up|2|||
143266548|NCT02598960|516531753|FG008|Treatment Period|Disease Progression|7|||
143266549|NCT02598960|516531754|FG009|Treatment Period|Disease Progression|9|||
143266550|NCT02598960|516531755|FG010|Treatment Period|Disease Progression|7|||
143266551|NCT02598960|516531756|FG011|Treatment Period|Disease Progression|143|||
143266552|NCT02598960|516531757|FG012|Treatment Period|Disease Progression|23|||
143215873|NCT00394706|516337642|FG002|Overall Study|Lost to Follow-up|8|||
143215874|NCT00394706|516337643|FG003|Overall Study|Lost to Follow-up|1|||
143215875|NCT00394706|516337644|FG004|Overall Study|Lost to Follow-up|2|||
143215876|NCT00394706|516337645|FG005|Overall Study|Lost to Follow-up|5|||
143215877|NCT00394706|516337646|FG006|Overall Study|Lost to Follow-up|2|||
143215878|NCT00394706|516337647|FG007|Overall Study|Lost to Follow-up|0|||
143215879|NCT03517228|516337651|FG000|Overall Study|Withdrawal by Subject|2|||
143215880|NCT03517228|516337651|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
143215881|NCT03517228|516337651|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
143215882|NCT03517228|516337651|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
143215883|NCT03517228|516337651|FG000|Overall Study|Canceled due to device being updated|1|||
143215884|NCT03517228|516337651|FG000|Overall Study|No V Cares in stock|1|||
143215885|NCT03517228|516337651|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
143266553|NCT02598960|516531745|FG000|Treatment Period|Study drug toxicity|0|||
143266554|NCT02598960|516531746|FG001|Treatment Period|Study drug toxicity|0|||
143215886|NCT03781414|516337658|FG000|Overall Study|Study terminated by sponsor|39|||
143215887|NCT03781414|516337659|FG001|Overall Study|Study terminated by sponsor|34|||
143215888|NCT03781414|516337660|FG002|Overall Study|Study terminated by sponsor|25|||
143215889|NCT03781414|516337658|FG000|Overall Study|Adverse Event|3|||
143215890|NCT03781414|516337659|FG001|Overall Study|Adverse Event|6|||
143215891|NCT03781414|516337660|FG002|Overall Study|Adverse Event|3|||
143215892|NCT03781414|516337658|FG000|Overall Study|Physician Decision|2|||
143215893|NCT03781414|516337659|FG001|Overall Study|Physician Decision|0|||
143215894|NCT03781414|516337660|FG002|Overall Study|Physician Decision|1|||
143215895|NCT03781414|516337658|FG000|Overall Study|Withdrawal by Subject|2|||
143215896|NCT03781414|516337659|FG001|Overall Study|Withdrawal by Subject|3|||
143215897|NCT03781414|516337660|FG002|Overall Study|Withdrawal by Subject|3|||
143215898|NCT03781414|516337658|FG000|Overall Study|Death|1|||
143215899|NCT03781414|516337659|FG001|Overall Study|Death|4|||
143215900|NCT03781414|516337660|FG002|Overall Study|Death|0|||
143215901|NCT03781414|516337658|FG000|Overall Study|Lost to Follow-up|1|||
143215902|NCT03781414|516337659|FG001|Overall Study|Lost to Follow-up|1|||
143215903|NCT03781414|516337660|FG002|Overall Study|Lost to Follow-up|0|||
143215904|NCT02881762|516337661|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
143215905|NCT02881762|516337662|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
143215906|NCT00836186|516337663|FG000|Overall Study|Blood could not be drawn|1|||
143215907|NCT04124705|516337666|FG000|Titration Period|Adverse Event|9|||
143215908|NCT04124705|516337667|FG001|Titration Period|Adverse Event|5|||
143215909|NCT04124705|516337666|FG000|Titration Period|Withdrawal by Subject|6|||
143215910|NCT04124705|516337667|FG001|Titration Period|Withdrawal by Subject|3|||
143215911|NCT04124705|516337666|FG000|Titration Period|Lost to Follow-up|0|||
143215912|NCT04124705|516337667|FG001|Titration Period|Lost to Follow-up|1|||
143215913|NCT04124705|516337666|FG000|Titration Period|Death|1|||
143215914|NCT04124705|516337667|FG001|Titration Period|Death|1|||
143215915|NCT04124705|516337666|FG000|Titration Period|Lack of Efficacy|2|||
143215916|NCT04124705|516337667|FG001|Titration Period|Lack of Efficacy|0|||
143215917|NCT04124705|516337666|FG000|Titration Period|Physician Decision|2|||
143215918|NCT04124705|516337667|FG001|Titration Period|Physician Decision|0|||
143215919|NCT04124705|516337666|FG000|Titration Period|Non-compliance with Study Drug|2|||
143215920|NCT04124705|516337667|FG001|Titration Period|Non-compliance with Study Drug|0|||
143215921|NCT04124705|516337666|FG000|Titration Period|Other|4|||
143215922|NCT04124705|516337667|FG001|Titration Period|Other|9|||
143215923|NCT04124705|516337666|FG000|Stabilization Period|Adverse Event|4|||
143215924|NCT04124705|516337667|FG001|Stabilization Period|Adverse Event|2|||
143215925|NCT04124705|516337666|FG000|Stabilization Period|Withdrawal by Subject|1|||
143215926|NCT04124705|516337667|FG001|Stabilization Period|Withdrawal by Subject|1|||
143215927|NCT04124705|516337666|FG000|Stabilization Period|Lost to Follow-up|0|||
143215928|NCT04124705|516337667|FG001|Stabilization Period|Lost to Follow-up|1|||
143215929|NCT04124705|516337666|FG000|Stabilization Period|Lack of Efficacy|4|||
143215930|NCT04124705|516337667|FG001|Stabilization Period|Lack of Efficacy|2|||
143215931|NCT04124705|516337666|FG000|Stabilization Period|Protocol Deviation|0|||
143266555|NCT02598960|516531747|FG002|Treatment Period|Study drug toxicity|0|||
143266556|NCT02598960|516531748|FG003|Treatment Period|Study drug toxicity|0|||
143266557|NCT02598960|516531749|FG004|Treatment Period|Study drug toxicity|0|||
143266558|NCT02598960|516531750|FG005|Treatment Period|Study drug toxicity|0|||
143266559|NCT02598960|516531751|FG006|Treatment Period|Study drug toxicity|0|||
143266560|NCT02598960|516531752|FG007|Treatment Period|Study drug toxicity|0|||
143266561|NCT02598960|516531753|FG008|Treatment Period|Study drug toxicity|0|||
143266562|NCT02598960|516531754|FG009|Treatment Period|Study drug toxicity|1|||
143266563|NCT02598960|516531755|FG010|Treatment Period|Study drug toxicity|0|||
143266564|NCT02598960|516531756|FG011|Treatment Period|Study drug toxicity|3|||
143266565|NCT02598960|516531757|FG012|Treatment Period|Study drug toxicity|0|||
143266566|NCT02598960|516531745|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
143266567|NCT02598960|516531746|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
143266568|NCT02598960|516531747|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
143266569|NCT02598960|516531748|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
143266570|NCT02598960|516531749|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
143266571|NCT02598960|516531750|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
143266572|NCT02598960|516531751|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
143266573|NCT02598960|516531752|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
143266574|NCT02598960|516531753|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
143215932|NCT04124705|516337667|FG001|Stabilization Period|Protocol Deviation|2|||
143215933|NCT04124705|516337666|FG000|Stabilization Period|Other|2|||
143215934|NCT04124705|516337667|FG001|Stabilization Period|Other|2|||
143215935|NCT02123823|516337668|FG000|Overall Study|Lack of Efficacy|0|||
143215936|NCT02123823|516337669|FG001|Overall Study|Lack of Efficacy|2|||
143215937|NCT02123823|516337670|FG002|Overall Study|Lack of Efficacy|8|||
143215938|NCT02123823|516337671|FG003|Overall Study|Lack of Efficacy|10|||
143215939|NCT02123823|516337668|FG000|Overall Study|Progressive disease|3|||
143215940|NCT02123823|516337669|FG001|Overall Study|Progressive disease|19|||
143215941|NCT02123823|516337670|FG002|Overall Study|Progressive disease|52|||
143215942|NCT02123823|516337671|FG003|Overall Study|Progressive disease|53|||
143215943|NCT02123823|516337668|FG000|Overall Study|Withdrawal by Subject|0|||
143215944|NCT02123823|516337669|FG001|Overall Study|Withdrawal by Subject|0|||
143215945|NCT02123823|516337670|FG002|Overall Study|Withdrawal by Subject|7|||
143215946|NCT02123823|516337671|FG003|Overall Study|Withdrawal by Subject|2|||
143215947|NCT02123823|516337668|FG000|Overall Study|Adverse Event|0|||
143215948|NCT02123823|516337669|FG001|Overall Study|Adverse Event|0|||
143215949|NCT02123823|516337670|FG002|Overall Study|Adverse Event|3|||
143215950|NCT02123823|516337671|FG003|Overall Study|Adverse Event|5|||
143215951|NCT02023996|516337672|FG000|Overall Study|Protocol Violation|6|||
143215952|NCT04765202|516337675|FG000|Overall Study|Lost to Follow-up|1|||
143215953|NCT04765202|516337676|FG001|Overall Study|Lost to Follow-up|1|||
143215954|NCT04765202|516337677|FG002|Overall Study|Lost to Follow-up|2|||
143215955|NCT04765202|516337678|FG003|Overall Study|Lost to Follow-up|2|||
143215956|NCT04765202|516337675|FG000|Overall Study|Physician Decision|0|||
143215957|NCT04765202|516337676|FG001|Overall Study|Physician Decision|0|||
143215958|NCT04765202|516337677|FG002|Overall Study|Physician Decision|1|||
143215959|NCT04765202|516337678|FG003|Overall Study|Physician Decision|1|||
143215960|NCT01636986|516337681|FG000|Overall Study|Withdrawal by Subject|0|||
143215961|NCT01636986|516337682|FG001|Overall Study|Withdrawal by Subject|1|||
143215962|NCT01636986|516337681|FG000|Overall Study|Corneal Staining|0|||
143215963|NCT01636986|516337682|FG001|Overall Study|Corneal Staining|1|||
143215964|NCT00095173|516337689|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
143215965|NCT00095173|516337690|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
143215966|NCT00095173|516337691|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
143215967|NCT00095173|516337692|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
143215968|NCT00095173|516337693|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
143215969|NCT00095173|516337694|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
143215970|NCT00095173|516337689|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
143215971|NCT00095173|516337690|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
143215972|NCT00095173|516337691|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
143215973|NCT00095173|516337692|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
143215974|NCT00095173|516337693|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
143215975|NCT00095173|516337694|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
143215976|NCT00095173|516337689|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
143215977|NCT00095173|516337690|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
143215978|NCT00095173|516337691|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
143215979|NCT00095173|516337692|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
143215980|NCT00095173|516337693|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
143215981|NCT00095173|516337694|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
143215982|NCT00095173|516337689|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
143215983|NCT00095173|516337690|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
143215984|NCT00095173|516337691|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
143215985|NCT00095173|516337692|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
143215986|NCT00095173|516337693|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
143215987|NCT00095173|516337694|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
143215988|NCT00095173|516337689|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
143215989|NCT00095173|516337690|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
143215990|NCT00095173|516337691|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
143215991|NCT00095173|516337692|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
143215992|NCT00095173|516337693|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
143215993|NCT00095173|516337694|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
143215994|NCT00095173|516337689|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
143266575|NCT02598960|516531754|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
143266576|NCT02598960|516531755|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
143266577|NCT02598960|516531756|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
143266578|NCT02598960|516531757|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
143266579|NCT02598960|516531745|FG000|Treatment Period|participant request to discontinue|0|||
143215995|NCT00095173|516337690|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
143215996|NCT00095173|516337691|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
143215997|NCT00095173|516337692|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
143215998|NCT00095173|516337693|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
143215999|NCT00095173|516337694|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
143216000|NCT00095173|516337689|FG000|Open-Label Extension Phase (Period C)|Death|0|||
143216001|NCT00095173|516337690|FG001|Open-Label Extension Phase (Period C)|Death|0|||
143216002|NCT00095173|516337691|FG002|Open-Label Extension Phase (Period C)|Death|0|||
143216003|NCT00095173|516337692|FG003|Open-Label Extension Phase (Period C)|Death|0|||
143216004|NCT00095173|516337693|FG004|Open-Label Extension Phase (Period C)|Death|0|||
143371905|NCT02914522|516906332|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
143371906|NCT02914522|516906333|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
143371907|NCT02914522|516906334|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
143371908|NCT02914522|516906335|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
143371909|NCT02914522|516906336|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
143371910|NCT02914522|516906337|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
143371911|NCT02914522|516906338|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
143371912|NCT02914522|516906328|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
143371913|NCT02914522|516906329|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
143371914|NCT02914522|516906330|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
143371915|NCT02914522|516906331|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
143371916|NCT02914522|516906332|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
143371917|NCT02914522|516906333|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
143371918|NCT02914522|516906334|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
143371919|NCT02914522|516906335|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
143371920|NCT02914522|516906336|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
143371921|NCT02914522|516906337|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
143216005|NCT00095173|516337694|FG005|Open-Label Extension Phase (Period C)|Death|1|||
143216006|NCT00095173|516337689|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
143216007|NCT00095173|516337690|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
143216008|NCT00095173|516337691|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
143216009|NCT00095173|516337692|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
143216010|NCT00095173|516337693|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
143216011|NCT00095173|516337694|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
143216012|NCT00095173|516337689|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
143216013|NCT00095173|516337690|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
143216014|NCT00095173|516337691|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
143216015|NCT00095173|516337692|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
143216016|NCT00095173|516337693|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
143216017|NCT00095173|516337694|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
143216018|NCT00095173|516337689|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
143216019|NCT00095173|516337690|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
143216020|NCT00095173|516337691|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
143216021|NCT00095173|516337692|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
143216022|NCT00095173|516337693|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
143216023|NCT00095173|516337694|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
143216024|NCT00095173|516337689|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
143216025|NCT00095173|516337690|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
143216026|NCT00095173|516337691|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
143216027|NCT00095173|516337692|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
143216028|NCT00095173|516337693|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
143216029|NCT00095173|516337694|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
143216030|NCT00095173|516337689|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
143216031|NCT00095173|516337690|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
143216032|NCT00095173|516337691|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
143216033|NCT00095173|516337692|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
143216034|NCT00095173|516337693|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
143216035|NCT00095173|516337694|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
143216036|NCT00095173|516337689|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
143216037|NCT00095173|516337690|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
143216038|NCT00095173|516337691|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
143216039|NCT00095173|516337692|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
143216040|NCT00095173|516337693|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
143216041|NCT00095173|516337694|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
143216042|NCT00095173|516337689|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
143216043|NCT00095173|516337690|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
143216044|NCT00095173|516337691|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
143216045|NCT00095173|516337692|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
143371922|NCT02914522|516906338|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
143371923|NCT02914522|516906328|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
143371924|NCT02914522|516906329|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
143371925|NCT02914522|516906330|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
143371926|NCT02914522|516906331|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
143371927|NCT02914522|516906332|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
143216046|NCT00095173|516337693|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
143216047|NCT00095173|516337694|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
143216048|NCT00095173|516337689|FG000|Open-Label Extension Phase (Period C)|Other|0|||
143216049|NCT00095173|516337690|FG001|Open-Label Extension Phase (Period C)|Other|0|||
143216050|NCT00095173|516337691|FG002|Open-Label Extension Phase (Period C)|Other|0|||
143216051|NCT00095173|516337692|FG003|Open-Label Extension Phase (Period C)|Other|4|||
143216052|NCT00095173|516337693|FG004|Open-Label Extension Phase (Period C)|Other|6|||
143216053|NCT00095173|516337694|FG005|Open-Label Extension Phase (Period C)|Other|8|||
143216054|NCT01496846|516337695|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
143216055|NCT01496846|516337696|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
143216056|NCT01496846|516337697|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
143216057|NCT01496846|516337698|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
143216058|NCT01496846|516337699|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
143216059|NCT01496846|516337700|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
143216060|NCT00635882|516337708|FG000|Overall Study|Protocol Violation|1|||
143216061|NCT00635882|516337709|FG001|Overall Study|Protocol Violation|0|||
143216062|NCT00635882|516337710|FG002|Overall Study|Protocol Violation|0|||
143216063|NCT00635882|516337711|FG003|Overall Study|Protocol Violation|0|||
143216064|NCT00635882|516337712|FG004|Overall Study|Protocol Violation|0|||
143216065|NCT00635882|516337713|FG005|Overall Study|Protocol Violation|0|||
143216066|NCT00384332|516337714|FG000|Overall Study|Lost to Follow-up|4|||
143216067|NCT00384332|516337715|FG001|Overall Study|Lost to Follow-up|0|||
143216068|NCT02560012|516337716|FG000|Overall Study|Study Terminated|2|||
143216069|NCT02147288|516337725|FG000|Overall Study|post-operative hematoma|1|||
143216070|NCT02147288|516337726|FG001|Overall Study|post-operative hematoma|1|||
143216071|NCT02147288|516337727|FG002|Overall Study|post-operative hematoma|0|||
143216072|NCT02147288|516337728|FG003|Overall Study|post-operative hematoma|0|||
143216073|NCT02147288|516337729|FG004|Overall Study|post-operative hematoma|0|||
143216074|NCT02147288|516337730|FG005|Overall Study|post-operative hematoma|0|||
143216075|NCT02147288|516337731|FG006|Overall Study|post-operative hematoma|0|||
143216076|NCT02147288|516337732|FG007|Overall Study|post-operative hematoma|0|||
143216077|NCT02147288|516337733|FG008|Overall Study|post-operative hematoma|0|||
143216078|NCT02147288|516337734|FG009|Overall Study|post-operative hematoma|0|||
143216079|NCT02147288|516337725|FG000|Overall Study|complications from concurrent hernia rep|0|||
143216080|NCT02147288|516337726|FG001|Overall Study|complications from concurrent hernia rep|1|||
143216081|NCT02147288|516337727|FG002|Overall Study|complications from concurrent hernia rep|0|||
143216082|NCT02147288|516337728|FG003|Overall Study|complications from concurrent hernia rep|0|||
143216083|NCT02147288|516337729|FG004|Overall Study|complications from concurrent hernia rep|0|||
143216084|NCT02147288|516337730|FG005|Overall Study|complications from concurrent hernia rep|0|||
143216085|NCT02147288|516337731|FG006|Overall Study|complications from concurrent hernia rep|0|||
143216086|NCT02147288|516337732|FG007|Overall Study|complications from concurrent hernia rep|0|||
143216087|NCT02147288|516337733|FG008|Overall Study|complications from concurrent hernia rep|0|||
143216088|NCT02147288|516337734|FG009|Overall Study|complications from concurrent hernia rep|0|||
143216089|NCT02069392|516337737|FG000|Overall Study|Withdrawal by Subject|4|||
143216090|NCT02069392|516337738|FG001|Overall Study|Withdrawal by Subject|2|||
143216091|NCT00269633|516337739|FG000|Overall Study|Withdrawal by Subject|1|||
143216092|NCT00269633|516337740|FG001|Overall Study|Withdrawal by Subject|0|||
143216093|NCT00965419|516337741|FG000|Open Label Treatment for Responders|Adverse Event|33|||
143216094|NCT00965419|516337741|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
143216095|NCT00965419|516337741|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
143216096|NCT00965419|516337741|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
143266580|NCT02598960|516531746|FG001|Treatment Period|participant request to discontinue|1|||
143266581|NCT02598960|516531747|FG002|Treatment Period|participant request to discontinue|0|||
143266582|NCT02598960|516531748|FG003|Treatment Period|participant request to discontinue|0|||
143266583|NCT02598960|516531749|FG004|Treatment Period|participant request to discontinue|1|||
143266584|NCT02598960|516531750|FG005|Treatment Period|participant request to discontinue|0|||
143266585|NCT02598960|516531751|FG006|Treatment Period|participant request to discontinue|0|||
143266586|NCT02598960|516531752|FG007|Treatment Period|participant request to discontinue|0|||
143266587|NCT02598960|516531753|FG008|Treatment Period|participant request to discontinue|0|||
143266588|NCT02598960|516531754|FG009|Treatment Period|participant request to discontinue|0|||
143266589|NCT02598960|516531755|FG010|Treatment Period|participant request to discontinue|1|||
143266590|NCT02598960|516531756|FG011|Treatment Period|participant request to discontinue|4|||
143216097|NCT00965419|516337741|FG000|Open Label Treatment for Responders|Physician Decision|6|||
143216098|NCT00965419|516337741|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
143216099|NCT00965419|516337741|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
143216100|NCT00965419|516337741|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
143216101|NCT00965419|516337741|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
143216102|NCT00965419|516337741|FG000|Follow-up Phase|Adverse Event|9|||
143216103|NCT00965419|516337741|FG000|Follow-up Phase|Protocol Violation|4|||
143266591|NCT02598960|516531757|FG012|Treatment Period|participant request to discontinue|0|||
143266592|NCT02598960|516531745|FG000|Treatment Period|participant withdrew consent|0|||
143266593|NCT02598960|516531746|FG001|Treatment Period|participant withdrew consent|0|||
143266594|NCT02598960|516531747|FG002|Treatment Period|participant withdrew consent|0|||
143266595|NCT02598960|516531748|FG003|Treatment Period|participant withdrew consent|0|||
143266596|NCT02598960|516531749|FG004|Treatment Period|participant withdrew consent|0|||
143266597|NCT02598960|516531750|FG005|Treatment Period|participant withdrew consent|0|||
143266598|NCT02598960|516531751|FG006|Treatment Period|participant withdrew consent|0|||
143371928|NCT02914522|516906333|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
143371929|NCT02914522|516906334|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
143371930|NCT02914522|516906335|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
143371931|NCT02914522|516906336|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
143371932|NCT02914522|516906337|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
143371933|NCT02914522|516906338|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
143371934|NCT02914522|516906328|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
143371935|NCT02914522|516906329|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
143371936|NCT02914522|516906330|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
143371937|NCT02914522|516906331|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
143371938|NCT02914522|516906332|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
143371939|NCT02914522|516906333|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
143371940|NCT02914522|516906334|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
143216104|NCT00965419|516337741|FG000|Follow-up Phase|Withdrawal by Subject|8|||
143371941|NCT02914522|516906335|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
143371942|NCT02914522|516906336|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
143371943|NCT02914522|516906337|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
143371944|NCT02914522|516906338|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
143371945|NCT02914522|516906328|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
143371946|NCT02914522|516906329|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
143371947|NCT02914522|516906330|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
143371948|NCT02914522|516906331|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
143371949|NCT02914522|516906332|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
143371950|NCT02914522|516906333|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
143371951|NCT02914522|516906334|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
143371952|NCT02914522|516906335|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
143371953|NCT02914522|516906336|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
143371954|NCT02914522|516906337|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
143371955|NCT02914522|516906338|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
143371956|NCT00177216|516906339|FG000|Overall Study|Withdrawal by Subject|6|||
143371957|NCT00177216|516906340|FG001|Overall Study|Withdrawal by Subject|3|||
143371958|NCT00177216|516906341|FG002|Overall Study|Withdrawal by Subject|1|||
143371959|NCT01161498|516906344|FG000|Overall Study|Disease Progression|0|||
143216105|NCT00965419|516337741|FG000|Follow-up Phase|Physician Decision|4|||
143216106|NCT00965419|516337741|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
143216107|NCT00965419|516337741|FG000|Follow-up Phase|Lack of Efficacy|28|||
143216108|NCT04412707|516337742|FG000|Cycle 1|Death|0|||
143216109|NCT04412707|516337743|FG001|Cycle 1|Death|3|||
143216110|NCT04412707|516337742|FG000|Cycle 1|Disease progression|1|||
143216111|NCT04412707|516337743|FG001|Cycle 1|Disease progression|2|||
143216112|NCT04412707|516337742|FG000|Cycle 2|Death|0|||
143216113|NCT04412707|516337743|FG001|Cycle 2|Death|1|||
143216114|NCT04412707|516337742|FG000|Cycle 2|Disease progression|3|||
143216115|NCT04412707|516337743|FG001|Cycle 2|Disease progression|0|||
143216116|NCT04412707|516337742|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
143266599|NCT02598960|516531752|FG007|Treatment Period|participant withdrew consent|0|||
143266600|NCT02598960|516531753|FG008|Treatment Period|participant withdrew consent|0|||
143266601|NCT02598960|516531754|FG009|Treatment Period|participant withdrew consent|0|||
143266602|NCT02598960|516531755|FG010|Treatment Period|participant withdrew consent|0|||
143371960|NCT01161498|516906345|FG001|Overall Study|Disease Progression|1|||
143371961|NCT01493778|516906350|FG000|Overall Study|Withdrawal by Subject|8|||
143371962|NCT04210180|516906351|FG000|Overall Study|Withdrawal by Subject|2|||
143371963|NCT00741988|516906362|FG000|Overall Study|Adverse Event|2|||
143216117|NCT04412707|516337743|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
143216118|NCT04412707|516337742|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
143216119|NCT04412707|516337743|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
143266603|NCT02598960|516531756|FG011|Treatment Period|participant withdrew consent|3|||
143371964|NCT00741988|516906363|FG001|Overall Study|Adverse Event|4|||
143371965|NCT00741988|516906362|FG000|Overall Study|Lack of Efficacy|2|||
143371966|NCT00741988|516906363|FG001|Overall Study|Lack of Efficacy|0|||
143371967|NCT00768651|516906368|FG000|Overall Study|Withdrawal by Subject|1|||
143371968|NCT01837641|516906369|FG000|Overall Study|Sponsor decision|1|||
143216120|NCT04412707|516337742|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
143216121|NCT04412707|516337743|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
143216122|NCT04412707|516337742|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
143216123|NCT04412707|516337743|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
143216124|NCT02927938|516337744|FG000|Overall Study|Death|0|||
143216125|NCT02927938|516337745|FG001|Overall Study|Death|1|||
143216126|NCT02927938|516337746|FG002|Overall Study|Death|0|||
143216127|NCT02927938|516337747|FG003|Overall Study|Death|4|||
143216128|NCT02927938|516337744|FG000|Overall Study|Early Study Termination|1|||
143216129|NCT02927938|516337745|FG001|Overall Study|Early Study Termination|5|||
143216130|NCT02927938|516337746|FG002|Overall Study|Early Study Termination|4|||
143216131|NCT02927938|516337747|FG003|Overall Study|Early Study Termination|3|||
143216132|NCT02476006|516337748|FG000|Overall Study|Death|4|||
143216133|NCT02476006|516337748|FG000|Overall Study|Lack of treatment efficacy|2|||
143216134|NCT02476006|516337748|FG000|Overall Study|Pregnancy|1|||
143216135|NCT02476006|516337748|FG000|Overall Study|Participant did not wish to continue|39|||
143216136|NCT02476006|516337748|FG000|Overall Study|Adverse Event|41|||
143216137|NCT02476006|516337748|FG000|Overall Study|Poor compliance to study protocol|3|||
143216138|NCT02476006|516337748|FG000|Overall Study|Sponsor decision|6|||
143216139|NCT02476006|516337748|FG000|Overall Study|Lost to Follow-up|5|||
143371969|NCT01837641|516906370|FG001|Overall Study|Sponsor decision|0|||
143371970|NCT01837641|516906371|FG002|Overall Study|Sponsor decision|0|||
143371971|NCT01837641|516906372|FG003|Overall Study|Sponsor decision|0|||
143371972|NCT01837641|516906373|FG004|Overall Study|Sponsor decision|0|||
143216140|NCT02476006|516337748|FG000|Overall Study|Physician Decision|5|||
143216141|NCT02476006|516337748|FG000|Overall Study|Study ended treatment not available|4|||
143216142|NCT02476006|516337748|FG000|Overall Study|Switched to commercial drug|4|||
143216143|NCT02476006|516337748|FG000|Overall Study|Excluded from study|1|||
143216144|NCT02476006|516337748|FG000|Overall Study|Protocol Violation|1|||
143216145|NCT02476006|516337748|FG000|Overall Study|Enrolled but not treated|4|||
143216146|NCT01363908|516339624|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
143371973|NCT01837641|516906374|FG005|Overall Study|Sponsor decision|1|||
143371974|NCT01837641|516906375|FG006|Overall Study|Sponsor decision|0|||
143371975|NCT01837641|516906376|FG007|Overall Study|Sponsor decision|0|||
143216147|NCT01363908|516339625|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
143216148|NCT01363908|516339624|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
143216149|NCT01363908|516339625|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
143216150|NCT01363908|516339624|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
143216151|NCT01363908|516339625|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
143216152|NCT01363908|516339624|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
143216153|NCT01363908|516339625|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
143216154|NCT02644343|516339626|FG000|Overall Study|Withdrawal by Subject|1|||
143216155|NCT03040674|516339632|FG000|Overall Study|Lost to Follow-up|225|||
143216156|NCT03040674|516339632|FG000|Overall Study|Death|23|||
143216157|NCT05173012|516339633|FG000|Overall Study|Adverse Event|2|||
143216158|NCT05173012|516339634|FG001|Overall Study|Adverse Event|3|||
143216159|NCT05173012|516339635|FG002|Overall Study|Adverse Event|4|||
143216160|NCT05173012|516339636|FG003|Overall Study|Adverse Event|13|||
143216161|NCT05173012|516339637|FG004|Overall Study|Adverse Event|0|||
143216162|NCT05173012|516339638|FG005|Overall Study|Adverse Event|0|||
143216163|NCT05173012|516339639|FG006|Overall Study|Adverse Event|2|||
143216164|NCT05173012|516339640|FG007|Overall Study|Adverse Event|4|||
143216165|NCT05173012|516339633|FG000|Overall Study|Lost to Follow-up|0|||
143216166|NCT05173012|516339634|FG001|Overall Study|Lost to Follow-up|0|||
143216167|NCT05173012|516339635|FG002|Overall Study|Lost to Follow-up|0|||
143216168|NCT05173012|516339636|FG003|Overall Study|Lost to Follow-up|1|||
143216169|NCT05173012|516339637|FG004|Overall Study|Lost to Follow-up|0|||
143216170|NCT05173012|516339638|FG005|Overall Study|Lost to Follow-up|0|||
143216171|NCT05173012|516339639|FG006|Overall Study|Lost to Follow-up|0|||
143216172|NCT05173012|516339640|FG007|Overall Study|Lost to Follow-up|0|||
143216173|NCT05173012|516339633|FG000|Overall Study|Withdrawal by Subject|1|||
143216174|NCT05173012|516339634|FG001|Overall Study|Withdrawal by Subject|0|||
143216175|NCT05173012|516339635|FG002|Overall Study|Withdrawal by Subject|1|||
143216176|NCT05173012|516339636|FG003|Overall Study|Withdrawal by Subject|3|||
143266604|NCT02598960|516531757|FG012|Treatment Period|participant withdrew consent|0|||
143266605|NCT02598960|516531745|FG000|Treatment Period|No longer meets study criteria|0|||
143266606|NCT02598960|516531746|FG001|Treatment Period|No longer meets study criteria|0|||
143266607|NCT02598960|516531747|FG002|Treatment Period|No longer meets study criteria|0|||
143266608|NCT02598960|516531748|FG003|Treatment Period|No longer meets study criteria|0|||
143266609|NCT02598960|516531749|FG004|Treatment Period|No longer meets study criteria|0|||
143266610|NCT02598960|516531750|FG005|Treatment Period|No longer meets study criteria|0|||
143266611|NCT02598960|516531751|FG006|Treatment Period|No longer meets study criteria|0|||
143266612|NCT02598960|516531752|FG007|Treatment Period|No longer meets study criteria|0|||
143266613|NCT02598960|516531753|FG008|Treatment Period|No longer meets study criteria|0|||
143266614|NCT02598960|516531754|FG009|Treatment Period|No longer meets study criteria|0|||
143266615|NCT02598960|516531755|FG010|Treatment Period|No longer meets study criteria|0|||
143266616|NCT02598960|516531756|FG011|Treatment Period|No longer meets study criteria|1|||
143266617|NCT02598960|516531757|FG012|Treatment Period|No longer meets study criteria|0|||
143266618|NCT02598960|516531745|FG000|Treatment Period|Other Reasons|0|||
143266619|NCT02598960|516531746|FG001|Treatment Period|Other Reasons|0|||
143266620|NCT02598960|516531747|FG002|Treatment Period|Other Reasons|0|||
143266621|NCT02598960|516531748|FG003|Treatment Period|Other Reasons|0|||
143266622|NCT02598960|516531749|FG004|Treatment Period|Other Reasons|0|||
143266623|NCT02598960|516531750|FG005|Treatment Period|Other Reasons|0|||
143266624|NCT02598960|516531751|FG006|Treatment Period|Other Reasons|0|||
143266625|NCT02598960|516531752|FG007|Treatment Period|Other Reasons|0|||
143266626|NCT02598960|516531753|FG008|Treatment Period|Other Reasons|0|||
143266627|NCT02598960|516531754|FG009|Treatment Period|Other Reasons|0|||
143266628|NCT02598960|516531755|FG010|Treatment Period|Other Reasons|0|||
143266629|NCT02598960|516531756|FG011|Treatment Period|Other Reasons|0|||
143266630|NCT02598960|516531757|FG012|Treatment Period|Other Reasons|1|||
143266631|NCT02598960|516531745|FG000|Participants Entering Follow Up Period|Death|1|||
143266632|NCT02598960|516531746|FG001|Participants Entering Follow Up Period|Death|0|||
143266633|NCT02598960|516531747|FG002|Participants Entering Follow Up Period|Death|0|||
143371976|NCT01837641|516906369|FG000|Overall Study|Adverse Event|0|||
143216177|NCT05173012|516339637|FG004|Overall Study|Withdrawal by Subject|1|||
143216178|NCT05173012|516339638|FG005|Overall Study|Withdrawal by Subject|0|||
143266634|NCT02598960|516531748|FG003|Participants Entering Follow Up Period|Death|0|||
143266635|NCT02598960|516531749|FG004|Participants Entering Follow Up Period|Death|0|||
143266636|NCT02598960|516531750|FG005|Participants Entering Follow Up Period|Death|0|||
143266637|NCT02598960|516531751|FG006|Participants Entering Follow Up Period|Death|0|||
143266638|NCT02598960|516531752|FG007|Participants Entering Follow Up Period|Death|0|||
143266639|NCT02598960|516531753|FG008|Participants Entering Follow Up Period|Death|0|||
143216179|NCT05173012|516339639|FG006|Overall Study|Withdrawal by Subject|1|||
143216180|NCT05173012|516339640|FG007|Overall Study|Withdrawal by Subject|0|||
143216181|NCT05173012|516339633|FG000|Overall Study|Protocol Deviation|0|||
143216182|NCT05173012|516339634|FG001|Overall Study|Protocol Deviation|0|||
143216183|NCT05173012|516339635|FG002|Overall Study|Protocol Deviation|0|||
143216184|NCT05173012|516339636|FG003|Overall Study|Protocol Deviation|1|||
143216185|NCT05173012|516339637|FG004|Overall Study|Protocol Deviation|0|||
143216186|NCT05173012|516339638|FG005|Overall Study|Protocol Deviation|0|||
143216187|NCT05173012|516339639|FG006|Overall Study|Protocol Deviation|0|||
143216188|NCT05173012|516339640|FG007|Overall Study|Protocol Deviation|0|||
143216189|NCT05173012|516339633|FG000|Overall Study|Other|0|||
143216190|NCT05173012|516339634|FG001|Overall Study|Other|0|||
143216191|NCT05173012|516339635|FG002|Overall Study|Other|0|||
143216192|NCT05173012|516339636|FG003|Overall Study|Other|2|||
143216193|NCT05173012|516339637|FG004|Overall Study|Other|0|||
143216194|NCT05173012|516339638|FG005|Overall Study|Other|0|||
143216195|NCT05173012|516339639|FG006|Overall Study|Other|0|||
143216196|NCT05173012|516339640|FG007|Overall Study|Other|0|||
143216197|NCT02936843|516339641|FG000|Overall Study|Lost to Follow-up|3|||
143216198|NCT02936843|516339642|FG001|Overall Study|Lost to Follow-up|1|||
143216199|NCT02936843|516339641|FG000|Overall Study|Withdrawal by Subject|1|||
143216200|NCT02936843|516339642|FG001|Overall Study|Withdrawal by Subject|1|||
143216201|NCT00517361|516339643|FG000|Overall Study|Death|6|||
143216202|NCT00517361|516339643|FG000|Overall Study|The study was terminated|5|||
143216203|NCT04303572|516339645|FG000|Overall Study|Study closed due to poor enrollment|1|||
143216204|NCT06312592|516339646|FG000|Overall Study|Lost to Follow-up|29|||
143216205|NCT06312592|516339647|FG001|Overall Study|Lost to Follow-up|13|||
143216206|NCT06136897|516339650|FG000|Overall Study|Ineligible|3|||
143216207|NCT06136897|516339650|FG000|Overall Study|Mutation status not confirmed|7|||
143216208|NCT06136897|516339650|FG000|Overall Study|Adverse Event|2|||
143216209|NCT06136897|516339650|FG000|Overall Study|Death|1|||
143216210|NCT06136897|516339650|FG000|Overall Study|Disease progression|18|||
143216211|NCT06136897|516339650|FG000|Overall Study|Other complicating disease|1|||
143216212|NCT06136897|516339650|FG000|Overall Study|Withdrawal by Subject|1|||
143216213|NCT06136897|516339650|FG000|Overall Study|Still on treatment|1|||
143216214|NCT06136897|516339650|FG000|Overall Study|Lost to Follow-up|1|||
143216215|NCT03785405|516339651|FG000|Overall Study|Adverse Event|16|||
143216216|NCT03785405|516339652|FG001|Overall Study|Adverse Event|1|||
143216217|NCT03785405|516339651|FG000|Overall Study|Death|6|||
143216218|NCT03785405|516339652|FG001|Overall Study|Death|4|||
143216219|NCT03785405|516339651|FG000|Overall Study|Guardian decision|4|||
143216220|NCT03785405|516339652|FG001|Overall Study|Guardian decision|1|||
143216221|NCT03785405|516339651|FG000|Overall Study|Lost to Follow-up|1|||
143216222|NCT03785405|516339652|FG001|Overall Study|Lost to Follow-up|0|||
143216223|NCT03785405|516339651|FG000|Overall Study|Physician Decision|8|||
143216224|NCT03785405|516339652|FG001|Overall Study|Physician Decision|5|||
143216225|NCT03785405|516339651|FG000|Overall Study|Participant decision|2|||
143216226|NCT03785405|516339652|FG001|Overall Study|Participant decision|0|||
143216227|NCT03785405|516339651|FG000|Overall Study|Other|1|||
143216228|NCT03785405|516339652|FG001|Overall Study|Other|0|||
143216229|NCT03785405|516339651|FG000|Overall Study|No treatment was received|0|||
143216230|NCT03785405|516339652|FG001|Overall Study|No treatment was received|1|||
143216231|NCT03705559|516339653|FG000|Overall Study|COVID Shut down|1|||
143216232|NCT01948063|516339654|FG000|Overall Study|Boston MCI halted research protocol|0|||
143216233|NCT01948063|516339655|FG001|Overall Study|Boston MCI halted research protocol|1|||
143216234|NCT01948063|516339654|FG000|Overall Study|Discovered an enrollment in other study|0|||
143216235|NCT01948063|516339655|FG001|Overall Study|Discovered an enrollment in other study|1|||
143216236|NCT01948063|516339654|FG000|Overall Study|Blood samples were accidentally thawed|1|||
143216237|NCT01948063|516339655|FG001|Overall Study|Blood samples were accidentally thawed|0|||
143216238|NCT01858766|516339656|FG000|Overall Study|Randomized but Never Treated|0|||
143216239|NCT01858766|516339657|FG001|Overall Study|Randomized but Never Treated|0|||
143216240|NCT01858766|516339658|FG002|Overall Study|Randomized but Never Treated|0|||
143216241|NCT01858766|516339659|FG003|Overall Study|Randomized but Never Treated|0|||
143216242|NCT01858766|516339660|FG004|Overall Study|Randomized but Never Treated|0|||
143216243|NCT01858766|516339661|FG005|Overall Study|Randomized but Never Treated|1|||
143216244|NCT01858766|516339662|FG006|Overall Study|Randomized but Never Treated|0|||
143216245|NCT01858766|516339663|FG007|Overall Study|Randomized but Never Treated|0|||
143216246|NCT01858766|516339664|FG008|Overall Study|Randomized but Never Treated|0|||
143216247|NCT01858766|516339665|FG009|Overall Study|Randomized but Never Treated|0|||
143216248|NCT01858766|516339666|FG010|Overall Study|Randomized but Never Treated|0|||
143216249|NCT01858766|516339667|FG011|Overall Study|Randomized but Never Treated|0|||
143216250|NCT01858766|516339668|FG012|Overall Study|Randomized but Never Treated|0|||
143216251|NCT01858766|516339669|FG013|Overall Study|Randomized but Never Treated|0|||
143216252|NCT01858766|516339670|FG014|Overall Study|Randomized but Never Treated|0|||
143216253|NCT01858766|516339671|FG015|Overall Study|Randomized but Never Treated|0|||
143216254|NCT01858766|516339672|FG016|Overall Study|Randomized but Never Treated|0|||
143216255|NCT01858766|516339673|FG017|Overall Study|Randomized but Never Treated|1|||
143216256|NCT01858766|516339674|FG018|Overall Study|Randomized but Never Treated|0|||
143371977|NCT01837641|516906370|FG001|Overall Study|Adverse Event|0|||
143371978|NCT01837641|516906371|FG002|Overall Study|Adverse Event|0|||
143371979|NCT01837641|516906372|FG003|Overall Study|Adverse Event|0|||
143371980|NCT01837641|516906373|FG004|Overall Study|Adverse Event|0|||
143371981|NCT01837641|516906374|FG005|Overall Study|Adverse Event|1|||
143371982|NCT01837641|516906375|FG006|Overall Study|Adverse Event|0|||
143371983|NCT01837641|516906376|FG007|Overall Study|Adverse Event|0|||
143371984|NCT01837641|516906369|FG000|Overall Study|Withdrawal by Subject|0|||
143371985|NCT01837641|516906370|FG001|Overall Study|Withdrawal by Subject|0|||
143216257|NCT01858766|516339656|FG000|Overall Study|Death|0|||
143216258|NCT01858766|516339657|FG001|Overall Study|Death|0|||
143216259|NCT01858766|516339658|FG002|Overall Study|Death|1|||
143216260|NCT01858766|516339659|FG003|Overall Study|Death|0|||
143216261|NCT01858766|516339660|FG004|Overall Study|Death|0|||
143216262|NCT01858766|516339661|FG005|Overall Study|Death|0|||
143216263|NCT01858766|516339662|FG006|Overall Study|Death|0|||
143216264|NCT01858766|516339663|FG007|Overall Study|Death|0|||
143216265|NCT01858766|516339664|FG008|Overall Study|Death|0|||
143216266|NCT01858766|516339665|FG009|Overall Study|Death|0|||
143216267|NCT01858766|516339666|FG010|Overall Study|Death|0|||
143216268|NCT01858766|516339667|FG011|Overall Study|Death|0|||
143216269|NCT01858766|516339668|FG012|Overall Study|Death|0|||
143216270|NCT01858766|516339669|FG013|Overall Study|Death|0|||
143216271|NCT01858766|516339670|FG014|Overall Study|Death|0|||
143216272|NCT01858766|516339671|FG015|Overall Study|Death|0|||
143216273|NCT01858766|516339672|FG016|Overall Study|Death|0|||
143216274|NCT01858766|516339673|FG017|Overall Study|Death|0|||
143216275|NCT01858766|516339674|FG018|Overall Study|Death|0|||
143216276|NCT01858766|516339656|FG000|Overall Study|Lack of Efficacy|1|||
143216277|NCT01858766|516339657|FG001|Overall Study|Lack of Efficacy|0|||
143216278|NCT01858766|516339658|FG002|Overall Study|Lack of Efficacy|0|||
143216279|NCT01858766|516339659|FG003|Overall Study|Lack of Efficacy|0|||
143216280|NCT01858766|516339660|FG004|Overall Study|Lack of Efficacy|1|||
143216281|NCT01858766|516339661|FG005|Overall Study|Lack of Efficacy|2|||
143216282|NCT01858766|516339662|FG006|Overall Study|Lack of Efficacy|0|||
143216283|NCT01858766|516339663|FG007|Overall Study|Lack of Efficacy|0|||
143216284|NCT01858766|516339664|FG008|Overall Study|Lack of Efficacy|0|||
143216285|NCT01858766|516339665|FG009|Overall Study|Lack of Efficacy|0|||
143216286|NCT01858766|516339666|FG010|Overall Study|Lack of Efficacy|0|||
143216287|NCT01858766|516339667|FG011|Overall Study|Lack of Efficacy|3|||
143216288|NCT01858766|516339668|FG012|Overall Study|Lack of Efficacy|5|||
143216289|NCT01858766|516339669|FG013|Overall Study|Lack of Efficacy|3|||
143216290|NCT01858766|516339670|FG014|Overall Study|Lack of Efficacy|5|||
143216291|NCT01858766|516339671|FG015|Overall Study|Lack of Efficacy|5|||
143216292|NCT01858766|516339672|FG016|Overall Study|Lack of Efficacy|2|||
143216293|NCT01858766|516339673|FG017|Overall Study|Lack of Efficacy|3|||
143216294|NCT01858766|516339674|FG018|Overall Study|Lack of Efficacy|3|||
143216295|NCT01858766|516339656|FG000|Overall Study|Lost to Follow-up|0|||
143216296|NCT01858766|516339657|FG001|Overall Study|Lost to Follow-up|0|||
143216297|NCT01858766|516339658|FG002|Overall Study|Lost to Follow-up|0|||
143216298|NCT01858766|516339659|FG003|Overall Study|Lost to Follow-up|0|||
143216299|NCT01858766|516339660|FG004|Overall Study|Lost to Follow-up|0|||
143216300|NCT01858766|516339661|FG005|Overall Study|Lost to Follow-up|1|||
143216301|NCT01858766|516339662|FG006|Overall Study|Lost to Follow-up|0|||
143216302|NCT01858766|516339663|FG007|Overall Study|Lost to Follow-up|2|||
143216303|NCT01858766|516339664|FG008|Overall Study|Lost to Follow-up|0|||
143216304|NCT01858766|516339665|FG009|Overall Study|Lost to Follow-up|0|||
143216305|NCT01858766|516339666|FG010|Overall Study|Lost to Follow-up|0|||
143216306|NCT01858766|516339667|FG011|Overall Study|Lost to Follow-up|1|||
143216307|NCT01858766|516339668|FG012|Overall Study|Lost to Follow-up|0|||
143216308|NCT01858766|516339669|FG013|Overall Study|Lost to Follow-up|0|||
143216309|NCT01858766|516339670|FG014|Overall Study|Lost to Follow-up|3|||
143216310|NCT01858766|516339671|FG015|Overall Study|Lost to Follow-up|1|||
143216311|NCT01858766|516339672|FG016|Overall Study|Lost to Follow-up|1|||
143216312|NCT01858766|516339673|FG017|Overall Study|Lost to Follow-up|0|||
143216313|NCT01858766|516339674|FG018|Overall Study|Lost to Follow-up|1|||
143371986|NCT01837641|516906371|FG002|Overall Study|Withdrawal by Subject|0|||
143216314|NCT01858766|516339656|FG000|Overall Study|Withdrew Consent|0|||
143216315|NCT01858766|516339657|FG001|Overall Study|Withdrew Consent|0|||
143216316|NCT01858766|516339658|FG002|Overall Study|Withdrew Consent|0|||
143216317|NCT01858766|516339659|FG003|Overall Study|Withdrew Consent|0|||
143216318|NCT01858766|516339660|FG004|Overall Study|Withdrew Consent|0|||
143216319|NCT01858766|516339661|FG005|Overall Study|Withdrew Consent|0|||
143216320|NCT01858766|516339662|FG006|Overall Study|Withdrew Consent|0|||
143216321|NCT01858766|516339663|FG007|Overall Study|Withdrew Consent|0|||
143216322|NCT01858766|516339664|FG008|Overall Study|Withdrew Consent|0|||
143216323|NCT01858766|516339665|FG009|Overall Study|Withdrew Consent|0|||
143216324|NCT01858766|516339666|FG010|Overall Study|Withdrew Consent|0|||
143371987|NCT01837641|516906372|FG003|Overall Study|Withdrawal by Subject|0|||
143216325|NCT01858766|516339667|FG011|Overall Study|Withdrew Consent|1|||
143216326|NCT01858766|516339668|FG012|Overall Study|Withdrew Consent|0|||
143216327|NCT01858766|516339669|FG013|Overall Study|Withdrew Consent|0|||
143216328|NCT01858766|516339670|FG014|Overall Study|Withdrew Consent|0|||
143216329|NCT01858766|516339671|FG015|Overall Study|Withdrew Consent|0|||
143216330|NCT01858766|516339672|FG016|Overall Study|Withdrew Consent|0|||
143216331|NCT01858766|516339673|FG017|Overall Study|Withdrew Consent|0|||
143216332|NCT01858766|516339674|FG018|Overall Study|Withdrew Consent|0|||
143216333|NCT00245037|516339677|FG000|Overall Study|Death|17|||
143216334|NCT00719355|516339682|FG000|Overall Study|Death|0|||
143216335|NCT00719355|516339683|FG001|Overall Study|Death|1|||
143216336|NCT00719355|516339682|FG000|Overall Study|Medical|14|||
143216337|NCT00719355|516339683|FG001|Overall Study|Medical|5|||
143216338|NCT00719355|516339682|FG000|Overall Study|Compliance|4|||
143216339|NCT00719355|516339683|FG001|Overall Study|Compliance|6|||
143216340|NCT00719355|516339682|FG000|Overall Study|Moved|0|||
143216341|NCT00719355|516339683|FG001|Overall Study|Moved|1|||
143216342|NCT03364738|516339688|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
143216343|NCT03364738|516339688|FG000|Overall Study|Withdrawal by Subject|1|||
143216344|NCT03364738|516339688|FG000|Overall Study|Adverse Event|1|||
143216345|NCT03245398|516339689|FG000|Overall Study|Travelled to another island|1|||
143216346|NCT03245398|516339690|FG001|Overall Study|Travelled to another island|0|||
143216347|NCT01824355|516339691|FG000|Overall Study|Adverse Event|2|||
143216348|NCT01824355|516339691|FG000|Overall Study|unevaluable reference method results per|1|||
143216349|NCT04531241|516339698|FG000|Period 1|Withdrawal by Subject|2|||
143216350|NCT04531241|516339699|FG001|Period 1|Withdrawal by Subject|0|||
143216351|NCT04531241|516339698|FG000|Period 1|Dispesed incorrect lens power|1|||
143216352|NCT04531241|516339699|FG001|Period 1|Dispesed incorrect lens power|0|||
143216353|NCT04531241|516339698|FG000|Period 1|Protocol Violation|1|||
143216354|NCT04531241|516339699|FG001|Period 1|Protocol Violation|0|||
143216355|NCT04531241|516339698|FG000|Period 1|No longer eligible|0|||
143216356|NCT04531241|516339699|FG001|Period 1|No longer eligible|1|||
143216357|NCT04531241|516339698|FG000|Period 1|Lens Discomfort|0|||
143216358|NCT04531241|516339699|FG001|Period 1|Lens Discomfort|1|||
143216359|NCT04531241|516339698|FG000|Period 2|Covid-19 Related|1|||
143216360|NCT04531241|516339699|FG001|Period 2|Covid-19 Related|1|||
143216361|NCT03724890|516339700|FG000|Overall Study|Death|2|||
143216362|NCT03724890|516339701|FG001|Overall Study|Death|6|||
143216363|NCT03724890|516339702|FG002|Overall Study|Death|3|||
143216364|NCT03724890|516339703|FG003|Overall Study|Death|5|||
143216365|NCT03724890|516339704|FG004|Overall Study|Death|2|||
143216366|NCT03724890|516339705|FG005|Overall Study|Death|0|||
143216367|NCT03724890|516339706|FG006|Overall Study|Death|2|||
143216368|NCT03724890|516339707|FG007|Overall Study|Death|3|||
143216369|NCT03724890|516339708|FG008|Overall Study|Death|4|||
143216370|NCT03724890|516339709|FG009|Overall Study|Death|2|||
143216371|NCT03724890|516339710|FG010|Overall Study|Death|2|||
143216372|NCT03724890|516339700|FG000|Overall Study|Lost to Follow-up|0|||
143216373|NCT03724890|516339701|FG001|Overall Study|Lost to Follow-up|3|||
143216374|NCT03724890|516339702|FG002|Overall Study|Lost to Follow-up|0|||
143216375|NCT03724890|516339703|FG003|Overall Study|Lost to Follow-up|1|||
143216376|NCT03724890|516339704|FG004|Overall Study|Lost to Follow-up|2|||
143216377|NCT03724890|516339705|FG005|Overall Study|Lost to Follow-up|2|||
143216378|NCT03724890|516339706|FG006|Overall Study|Lost to Follow-up|1|||
143216379|NCT03724890|516339707|FG007|Overall Study|Lost to Follow-up|0|||
143216380|NCT03724890|516339708|FG008|Overall Study|Lost to Follow-up|2|||
143216381|NCT03724890|516339709|FG009|Overall Study|Lost to Follow-up|0|||
143216382|NCT03724890|516339710|FG010|Overall Study|Lost to Follow-up|0|||
143216383|NCT03724890|516339700|FG000|Overall Study|Withdrawal by Subject|1|||
143216384|NCT03724890|516339701|FG001|Overall Study|Withdrawal by Subject|2|||
143216385|NCT03724890|516339702|FG002|Overall Study|Withdrawal by Subject|1|||
143216386|NCT03724890|516339703|FG003|Overall Study|Withdrawal by Subject|0|||
143216387|NCT03724890|516339704|FG004|Overall Study|Withdrawal by Subject|0|||
143216388|NCT03724890|516339705|FG005|Overall Study|Withdrawal by Subject|1|||
143216389|NCT03724890|516339706|FG006|Overall Study|Withdrawal by Subject|0|||
143216390|NCT03724890|516339707|FG007|Overall Study|Withdrawal by Subject|0|||
143216391|NCT03724890|516339708|FG008|Overall Study|Withdrawal by Subject|2|||
143216392|NCT03724890|516339709|FG009|Overall Study|Withdrawal by Subject|2|||
143216393|NCT03724890|516339710|FG010|Overall Study|Withdrawal by Subject|1|||
143216394|NCT03724890|516339700|FG000|Overall Study|Other|1|||
143216395|NCT03724890|516339701|FG001|Overall Study|Other|0|||
143216396|NCT03724890|516339702|FG002|Overall Study|Other|0|||
143216397|NCT03724890|516339703|FG003|Overall Study|Other|0|||
143216398|NCT03724890|516339704|FG004|Overall Study|Other|0|||
143216399|NCT03724890|516339705|FG005|Overall Study|Other|0|||
143216400|NCT03724890|516339706|FG006|Overall Study|Other|0|||
143216401|NCT03724890|516339707|FG007|Overall Study|Other|1|||
143216402|NCT03724890|516339708|FG008|Overall Study|Other|1|||
143216403|NCT03724890|516339709|FG009|Overall Study|Other|0|||
143216404|NCT03724890|516339710|FG010|Overall Study|Other|2|||
143216405|NCT04427072|516339712|FG000|Randomized Treatment Phase|Progressive disease|9|||
143216406|NCT04427072|516339713|FG001|Randomized Treatment Phase|Progressive disease|4|||
143216407|NCT04427072|516339712|FG000|Randomized Treatment Phase|Adverse Event|3|||
143216408|NCT04427072|516339713|FG001|Randomized Treatment Phase|Adverse Event|1|||
143216409|NCT04427072|516339712|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
143216410|NCT04427072|516339713|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
143216411|NCT04427072|516339712|FG000|Randomized Treatment Phase|Death|0|||
143216412|NCT04427072|516339713|FG001|Randomized Treatment Phase|Death|1|||
143216413|NCT04427072|516339712|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
143216414|NCT04427072|516339713|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
143216415|NCT04427072|516339712|FG000|Extension Treatment Phase|Progressive disease|0|||
143216416|NCT04427072|516339713|FG001|Extension Treatment Phase|Progressive disease|5|||
143216417|NCT04929249|516339719|FG000|Overall Study|Adverse Event|2|||
143216418|NCT04929249|516339720|FG001|Overall Study|Adverse Event|1|||
143216419|NCT04929249|516339719|FG000|Overall Study|Death|2|||
143216420|NCT04929249|516339720|FG001|Overall Study|Death|1|||
143216421|NCT04929249|516339719|FG000|Overall Study|Lost to Follow-up|3|||
143216422|NCT04929249|516339720|FG001|Overall Study|Lost to Follow-up|11|||
143216423|NCT04929249|516339719|FG000|Overall Study|Technical problems|0|||
143216424|NCT04929249|516339720|FG001|Overall Study|Technical problems|1|||
143216425|NCT04929249|516339719|FG000|Overall Study|Subject decision|6|||
143216426|NCT04929249|516339720|FG001|Overall Study|Subject decision|8|||
143216427|NCT04929249|516339719|FG000|Overall Study|Withdrew consent|0|||
143216428|NCT04929249|516339720|FG001|Overall Study|Withdrew consent|8|||
143216429|NCT01772576|516339723|FG000|Overall Study|Death|15|||
143216430|NCT01772576|516339723|FG000|Overall Study|Protocol Violation|1|||
143216431|NCT01772576|516339723|FG000|Overall Study|Lost to Follow-up|3|||
143216432|NCT01772576|516339723|FG000|Overall Study|Study device not used|3|||
143216433|NCT01772576|516339723|FG000|Overall Study|Adverse Event|6|||
143216434|NCT01772576|516339723|FG000|Overall Study|Withdrawal by Subject|6|||
143216435|NCT00923845|516339724|FG000|Induction Therapy|Poor performance status|0|||
143216436|NCT00923845|516339725|FG001|Induction Therapy|Poor performance status|2|||
143216437|NCT00379912|516339727|FG000|Overall Study|Lack of Efficacy|1|||
143216438|NCT00379912|516339728|FG001|Overall Study|Lack of Efficacy|0|||
143216439|NCT02578186|516339729|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
143216440|NCT02578186|516339730|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
143216441|NCT02578186|516339729|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
143216442|NCT02578186|516339730|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
143216443|NCT02873338|516339731|FG000|Overall Study|Adverse Event|0|||
143216444|NCT02873338|516339732|FG001|Overall Study|Adverse Event|2|||
143216445|NCT02873338|516339733|FG002|Overall Study|Adverse Event|1|||
143216446|NCT02873338|516339731|FG000|Overall Study|Death|2|||
143216447|NCT02873338|516339732|FG001|Overall Study|Death|1|||
143216448|NCT02873338|516339733|FG002|Overall Study|Death|1|||
143216449|NCT02873338|516339731|FG000|Overall Study|Withdrawal by Subject|2|||
143216450|NCT02873338|516339732|FG001|Overall Study|Withdrawal by Subject|1|||
143216451|NCT02873338|516339733|FG002|Overall Study|Withdrawal by Subject|3|||
143216452|NCT02873338|516339731|FG000|Overall Study|Lack of Efficacy|0|||
143216453|NCT02873338|516339732|FG001|Overall Study|Lack of Efficacy|2|||
143216454|NCT02873338|516339733|FG002|Overall Study|Lack of Efficacy|0|||
143216455|NCT02873338|516339731|FG000|Overall Study|Other or Missing|14|||
143216456|NCT02873338|516339732|FG001|Overall Study|Other or Missing|15|||
143216457|NCT02873338|516339733|FG002|Overall Study|Other or Missing|13|||
143216458|NCT02669121|516339734|FG000|Overall Study|Adverse Event|4|||
143216459|NCT02669121|516339735|FG001|Overall Study|Adverse Event|5|||
143216460|NCT02669121|516339734|FG000|Overall Study|Lost to Follow-up|15|||
143216461|NCT02669121|516339735|FG001|Overall Study|Lost to Follow-up|27|||
143216462|NCT02669121|516339734|FG000|Overall Study|Withdrawal by Subject|132|||
143216463|NCT02669121|516339735|FG001|Overall Study|Withdrawal by Subject|140|||
143216464|NCT02669121|516339734|FG000|Overall Study|Pregnancy|0|||
143216465|NCT02669121|516339735|FG001|Overall Study|Pregnancy|1|||
143216466|NCT02669121|516339734|FG000|Overall Study|Discharged from US Military Active Service|117|||
143216467|NCT02669121|516339735|FG001|Overall Study|Discharged from US Military Active Service|91|||
143216468|NCT02669121|516339734|FG000|Overall Study|Reason not Specified|22|||
143216469|NCT02669121|516339735|FG001|Overall Study|Reason not Specified|18|||
143216470|NCT03216746|516339736|FG000|Overall Study|Lost to Follow-up|6|||
143216471|NCT03216746|516339737|FG001|Overall Study|Lost to Follow-up|8|||
143216472|NCT03216746|516339738|FG002|Overall Study|Lost to Follow-up|5|||
143216473|NCT03216746|516339739|FG003|Overall Study|Lost to Follow-up|6|||
143216474|NCT04384523|516339740|FG000|Overall Study|Lost to Follow-up|0|||
143216475|NCT04384523|516339741|FG001|Overall Study|Lost to Follow-up|0|||
143216476|NCT04384523|516339742|FG002|Overall Study|Lost to Follow-up|0|||
143216477|NCT04384523|516339743|FG003|Overall Study|Lost to Follow-up|0|||
143216478|NCT04384523|516339744|FG004|Overall Study|Lost to Follow-up|0|||
143216479|NCT04384523|516339745|FG005|Overall Study|Lost to Follow-up|1|||
143216480|NCT04384523|516339740|FG000|Overall Study|Protocol Violation|0|||
143216481|NCT04384523|516339741|FG001|Overall Study|Protocol Violation|1|||
143216482|NCT04384523|516339742|FG002|Overall Study|Protocol Violation|0|||
143216483|NCT04384523|516339743|FG003|Overall Study|Protocol Violation|0|||
143216484|NCT04384523|516339744|FG004|Overall Study|Protocol Violation|0|||
143216485|NCT04384523|516339745|FG005|Overall Study|Protocol Violation|0|||
143216486|NCT04384523|516339740|FG000|Overall Study|Withdrawal by Subject|1|||
143216487|NCT04384523|516339741|FG001|Overall Study|Withdrawal by Subject|0|||
143216488|NCT04384523|516339742|FG002|Overall Study|Withdrawal by Subject|0|||
143216489|NCT04384523|516339743|FG003|Overall Study|Withdrawal by Subject|0|||
143216490|NCT04384523|516339744|FG004|Overall Study|Withdrawal by Subject|0|||
143216491|NCT04384523|516339745|FG005|Overall Study|Withdrawal by Subject|0|||
143216492|NCT02687581|516339746|FG000|Overall Study|Withdrawal by Subject|1|||
143216493|NCT02687581|516339747|FG001|Overall Study|Withdrawal by Subject|0|||
143216494|NCT02687581|516339748|FG002|Overall Study|Withdrawal by Subject|0|||
143216495|NCT02687581|516339749|FG003|Overall Study|Withdrawal by Subject|1|||
143216496|NCT02687581|516339746|FG000|Overall Study|Lost to Follow-up|2|||
143216497|NCT02687581|516339747|FG001|Overall Study|Lost to Follow-up|2|||
143216498|NCT02687581|516339748|FG002|Overall Study|Lost to Follow-up|0|||
143216499|NCT02687581|516339749|FG003|Overall Study|Lost to Follow-up|0|||
143216500|NCT02687581|516339746|FG000|Overall Study|the device is too small for the patient.|1|||
143216501|NCT02687581|516339747|FG001|Overall Study|the device is too small for the patient.|0|||
143216502|NCT02687581|516339748|FG002|Overall Study|the device is too small for the patient.|0|||
143216503|NCT02687581|516339749|FG003|Overall Study|the device is too small for the patient.|0|||
143216504|NCT00835341|516339750|FG000|Overall Study|Lost to Follow-up|3|||
143216505|NCT00835341|516339751|FG001|Overall Study|Lost to Follow-up|12|||
143216506|NCT04405076|516339753|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
143216507|NCT04405076|516339754|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
143216508|NCT04405076|516339755|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
143216509|NCT04405076|516339756|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
143216510|NCT04405076|516339757|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
143216511|NCT04405076|516339758|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
143216512|NCT04405076|516339759|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
143216513|NCT04405076|516339760|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
143216514|NCT04405076|516339761|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
143216515|NCT04405076|516339753|FG000|Part A (Blinded Phase)|Physician Decision|1|||
143216516|NCT04405076|516339754|FG001|Part A (Blinded Phase)|Physician Decision|2|||
143216517|NCT04405076|516339755|FG002|Part A (Blinded Phase)|Physician Decision|0|||
143216518|NCT04405076|516339756|FG003|Part A (Blinded Phase)|Physician Decision|0|||
143216519|NCT04405076|516339757|FG004|Part A (Blinded Phase)|Physician Decision|0|||
143216520|NCT04405076|516339758|FG005|Part A (Blinded Phase)|Physician Decision|0|||
143216521|NCT04405076|516339759|FG006|Part A (Blinded Phase)|Physician Decision|0|||
143216522|NCT04405076|516339760|FG007|Part A (Blinded Phase)|Physician Decision|0|||
143216523|NCT04405076|516339761|FG008|Part A (Blinded Phase)|Physician Decision|0|||
143216524|NCT04405076|516339753|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
143216525|NCT04405076|516339754|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
143216526|NCT04405076|516339755|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
143216527|NCT04405076|516339756|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
143216528|NCT04405076|516339757|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
143216529|NCT04405076|516339758|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
143216530|NCT04405076|516339759|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
143216531|NCT04405076|516339760|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
143216532|NCT04405076|516339761|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
143216533|NCT04405076|516339753|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
143216534|NCT04405076|516339754|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
143216535|NCT04405076|516339755|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
143216536|NCT04405076|516339756|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
143266640|NCT02598960|516531754|FG009|Participants Entering Follow Up Period|Death|1|||
143266641|NCT02598960|516531755|FG010|Participants Entering Follow Up Period|Death|0|||
143266642|NCT02598960|516531756|FG011|Participants Entering Follow Up Period|Death|11|||
143266643|NCT02598960|516531757|FG012|Participants Entering Follow Up Period|Death|2|||
143266644|NCT02598960|516531745|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
143266645|NCT02598960|516531746|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
143266646|NCT02598960|516531747|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
143266647|NCT02598960|516531748|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
143266648|NCT02598960|516531749|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
143266649|NCT02598960|516531750|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
143266650|NCT02598960|516531751|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
143216537|NCT04405076|516339757|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
143266651|NCT02598960|516531752|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
143216538|NCT04405076|516339758|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
143216539|NCT04405076|516339759|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
143216540|NCT04405076|516339760|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
143216541|NCT04405076|516339761|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
143216542|NCT04405076|516339753|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
143216543|NCT04405076|516339754|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
143216544|NCT04405076|516339755|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
143216545|NCT04405076|516339756|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
143216546|NCT04405076|516339757|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
143216547|NCT04405076|516339758|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
143216548|NCT04405076|516339759|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
143216549|NCT04405076|516339760|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
143216550|NCT04405076|516339761|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
143216551|NCT04405076|516339753|FG000|Part A (Blinded Phase)|Other than Specified|0|||
143216552|NCT04405076|516339754|FG001|Part A (Blinded Phase)|Other than Specified|0|||
143216553|NCT04405076|516339755|FG002|Part A (Blinded Phase)|Other than Specified|3|||
143216554|NCT04405076|516339756|FG003|Part A (Blinded Phase)|Other than Specified|0|||
143216555|NCT04405076|516339757|FG004|Part A (Blinded Phase)|Other than Specified|0|||
143216556|NCT04405076|516339758|FG005|Part A (Blinded Phase)|Other than Specified|0|||
143216557|NCT04405076|516339759|FG006|Part A (Blinded Phase)|Other than Specified|0|||
143216558|NCT04405076|516339760|FG007|Part A (Blinded Phase)|Other than Specified|0|||
143216559|NCT04405076|516339761|FG008|Part A (Blinded Phase)|Other than Specified|0|||
143216560|NCT04405076|516339753|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
143216561|NCT04405076|516339754|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
143216562|NCT04405076|516339755|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
143216563|NCT04405076|516339756|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
143216564|NCT04405076|516339757|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
143216565|NCT04405076|516339758|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
143216566|NCT04405076|516339759|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
143216567|NCT04405076|516339760|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
143216568|NCT04405076|516339761|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
143216569|NCT04405076|516339753|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
143216570|NCT04405076|516339754|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
143216571|NCT04405076|516339755|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
143216572|NCT04405076|516339756|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
143216573|NCT04405076|516339757|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
143216574|NCT04405076|516339758|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
143216575|NCT04405076|516339759|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
143216576|NCT04405076|516339760|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
143216577|NCT04405076|516339761|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
143216578|NCT04405076|516339753|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
143216579|NCT04405076|516339754|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
143216580|NCT04405076|516339755|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
143216581|NCT04405076|516339756|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
143216582|NCT04405076|516339757|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
143216583|NCT04405076|516339758|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
143216584|NCT04405076|516339759|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
143216585|NCT04405076|516339760|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
143216586|NCT04405076|516339761|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
143216587|NCT04405076|516339753|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
143216588|NCT04405076|516339754|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
143216589|NCT04405076|516339755|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
143216590|NCT04405076|516339756|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
143216591|NCT04405076|516339757|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
143216592|NCT04405076|516339758|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
143216593|NCT04405076|516339759|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
143216594|NCT04405076|516339760|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
143216595|NCT04405076|516339761|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
143216596|NCT04405076|516339753|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
143216597|NCT04405076|516339754|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
143216598|NCT04405076|516339755|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
143216599|NCT04405076|516339756|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
143216600|NCT04405076|516339757|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
143216601|NCT04405076|516339758|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
143216602|NCT04405076|516339759|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
143216603|NCT04405076|516339760|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
143216604|NCT04405076|516339761|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
143216605|NCT04310566|516339762|FG000|Period 1|Study Termination due to COVID-19|15|||
143216606|NCT04310566|516339763|FG001|Period 1|Study Termination due to COVID-19|17|||
143216607|NCT04310566|516339762|FG000|Period 1|Protocol Violation|0|||
143216608|NCT04310566|516339763|FG001|Period 1|Protocol Violation|1|||
143216609|NCT04310566|516339762|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
143216610|NCT04310566|516339763|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
143216611|NCT04310566|516339762|FG000|Period 1|Lost to Follow-up|1|||
143216612|NCT04310566|516339763|FG001|Period 1|Lost to Follow-up|0|||
143216613|NCT04310566|516339762|FG000|Period 1|Withdrawal by Subject|0|||
143216614|NCT04310566|516339763|FG001|Period 1|Withdrawal by Subject|1|||
143216615|NCT04310566|516339762|FG000|Period 2|Study Termination|7|||
143216616|NCT04310566|516339763|FG001|Period 2|Study Termination|5|||
143216617|NCT01711645|516339773|FG000|Overall Study|Withdrawal by Subject|8|||
143216618|NCT01711645|516339773|FG000|Overall Study|Lost to Follow-up|6|||
143216619|NCT01711645|516339773|FG000|Overall Study|Physician Decision|5|||
143216620|NCT02218008|516339776|FG000|Stage 1 (S1)|Adverse Event|6|||
143216621|NCT02218008|516339777|FG001|Stage 1 (S1)|Adverse Event|5|||
143216622|NCT02218008|516339778|FG002|Stage 1 (S1)|Adverse Event|11|||
143216623|NCT02218008|516339779|FG003|Stage 1 (S1)|Adverse Event|0|||
143216624|NCT02218008|516339780|FG004|Stage 1 (S1)|Adverse Event|0|||
143216625|NCT02218008|516339781|FG005|Stage 1 (S1)|Adverse Event|0|||
143216626|NCT02218008|516339776|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
143216627|NCT02218008|516339777|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
143216628|NCT02218008|516339778|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
143216629|NCT02218008|516339779|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
143216630|NCT02218008|516339780|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
143216631|NCT02218008|516339781|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
143216632|NCT02218008|516339776|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
143216633|NCT02218008|516339777|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
143216634|NCT02218008|516339778|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
143216635|NCT02218008|516339779|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
143216636|NCT02218008|516339780|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
143216637|NCT02218008|516339781|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
143216638|NCT02218008|516339776|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
143216639|NCT02218008|516339777|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
143216640|NCT02218008|516339778|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
143216641|NCT02218008|516339779|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
143216642|NCT02218008|516339780|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
143216643|NCT02218008|516339781|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
143216644|NCT02218008|516339776|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
143216645|NCT02218008|516339777|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
143216646|NCT02218008|516339778|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
143216647|NCT02218008|516339779|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
143216648|NCT02218008|516339780|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
143216649|NCT02218008|516339781|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
143216650|NCT02218008|516339776|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
143216651|NCT02218008|516339777|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
143216652|NCT02218008|516339778|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
143216653|NCT02218008|516339779|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
143216654|NCT02218008|516339780|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
143216655|NCT02218008|516339781|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
143216656|NCT02218008|516339776|FG000|Stage 1 (S1)|Pregnancy|0|||
143216657|NCT02218008|516339777|FG001|Stage 1 (S1)|Pregnancy|0|||
143216658|NCT02218008|516339778|FG002|Stage 1 (S1)|Pregnancy|1|||
143216659|NCT02218008|516339779|FG003|Stage 1 (S1)|Pregnancy|0|||
143216660|NCT02218008|516339780|FG004|Stage 1 (S1)|Pregnancy|0|||
143216661|NCT02218008|516339781|FG005|Stage 1 (S1)|Pregnancy|0|||
143216662|NCT02218008|516339776|FG000|Stage 1 (S1)|Protocol Violation|0|||
143216663|NCT02218008|516339777|FG001|Stage 1 (S1)|Protocol Violation|0|||
143216664|NCT02218008|516339778|FG002|Stage 1 (S1)|Protocol Violation|1|||
143216665|NCT02218008|516339779|FG003|Stage 1 (S1)|Protocol Violation|0|||
143216666|NCT02218008|516339780|FG004|Stage 1 (S1)|Protocol Violation|0|||
143216667|NCT02218008|516339781|FG005|Stage 1 (S1)|Protocol Violation|0|||
143216668|NCT02218008|516339776|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
143216669|NCT02218008|516339777|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
143216670|NCT02218008|516339778|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
143216671|NCT02218008|516339779|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
143216672|NCT02218008|516339780|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
143216673|NCT02218008|516339781|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
143216674|NCT02218008|516339776|FG000|Stage 2 (S2)|Adverse Event|0|||
143216675|NCT02218008|516339777|FG001|Stage 2 (S2)|Adverse Event|0|||
143216676|NCT02218008|516339778|FG002|Stage 2 (S2)|Adverse Event|0|||
143216677|NCT02218008|516339779|FG003|Stage 2 (S2)|Adverse Event|2|||
143216678|NCT02218008|516339780|FG004|Stage 2 (S2)|Adverse Event|3|||
143216679|NCT02218008|516339781|FG005|Stage 2 (S2)|Adverse Event|3|||
143216680|NCT02218008|516339776|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
143216681|NCT02218008|516339777|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
143216682|NCT02218008|516339778|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
143216683|NCT02218008|516339779|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
143216684|NCT02218008|516339780|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
143266652|NCT02598960|516531753|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
143266653|NCT02598960|516531754|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
143266654|NCT02598960|516531755|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
143266655|NCT02598960|516531756|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
143216685|NCT02218008|516339781|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
143216686|NCT02218008|516339776|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
143216687|NCT02218008|516339777|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
143216688|NCT02218008|516339778|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
143216689|NCT02218008|516339779|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
143216690|NCT02218008|516339780|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
143216691|NCT02218008|516339781|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
143216692|NCT02218008|516339776|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
143216693|NCT02218008|516339777|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
143216694|NCT02218008|516339778|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
143216695|NCT02218008|516339779|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
143216696|NCT02218008|516339780|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
143216697|NCT02218008|516339781|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
143216698|NCT02218008|516339776|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
143216699|NCT02218008|516339777|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
143216700|NCT02218008|516339778|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
143216701|NCT02218008|516339779|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
143216702|NCT02218008|516339780|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
143216703|NCT02218008|516339781|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
143216704|NCT00408434|516339782|FG000|Overall Study|Adverse Event|0|||
143216705|NCT00408434|516339783|FG001|Overall Study|Adverse Event|0|||
143216706|NCT00408434|516339784|FG002|Overall Study|Adverse Event|1|||
143216707|NCT00408434|516339785|FG003|Overall Study|Adverse Event|0|||
143216708|NCT00408434|516339786|FG004|Overall Study|Adverse Event|0|||
143216709|NCT00408434|516339787|FG005|Overall Study|Adverse Event|0|||
143216710|NCT00408434|516339788|FG006|Overall Study|Adverse Event|0|||
143216711|NCT00408434|516339782|FG000|Overall Study|Progressive disease|6|||
143216712|NCT00408434|516339783|FG001|Overall Study|Progressive disease|3|||
143216713|NCT00408434|516339784|FG002|Overall Study|Progressive disease|4|||
143216714|NCT00408434|516339785|FG003|Overall Study|Progressive disease|3|||
143216715|NCT00408434|516339786|FG004|Overall Study|Progressive disease|3|||
143216716|NCT00408434|516339787|FG005|Overall Study|Progressive disease|1|||
143216717|NCT00408434|516339788|FG006|Overall Study|Progressive disease|4|||
143216718|NCT00408434|516339782|FG000|Overall Study|Other|0|||
143216719|NCT00408434|516339783|FG001|Overall Study|Other|0|||
143216720|NCT00408434|516339784|FG002|Overall Study|Other|1|||
143216721|NCT00408434|516339785|FG003|Overall Study|Other|0|||
143216722|NCT00408434|516339786|FG004|Overall Study|Other|2|||
143216723|NCT00408434|516339787|FG005|Overall Study|Other|1|||
143216724|NCT00408434|516339788|FG006|Overall Study|Other|0|||
143216725|NCT00408434|516339782|FG000|Overall Study|Terminated by Investigator|0|||
143216726|NCT00408434|516339783|FG001|Overall Study|Terminated by Investigator|0|||
143216727|NCT00408434|516339784|FG002|Overall Study|Terminated by Investigator|0|||
143216728|NCT00408434|516339785|FG003|Overall Study|Terminated by Investigator|0|||
143216729|NCT00408434|516339786|FG004|Overall Study|Terminated by Investigator|1|||
143266656|NCT02598960|516531757|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
143266657|NCT02598960|516531745|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
143216730|NCT00408434|516339787|FG005|Overall Study|Terminated by Investigator|1|||
143216731|NCT00408434|516339788|FG006|Overall Study|Terminated by Investigator|0|||
143216732|NCT01278797|516339789|FG000|Period 1|Adverse Event|0|||
143216733|NCT01278797|516339790|FG001|Period 1|Adverse Event|1|||
143216734|NCT01278797|516339789|FG000|Period 1|Protocol Violation|1|||
143216735|NCT01278797|516339790|FG001|Period 1|Protocol Violation|0|||
143216736|NCT04000581|516339791|FG000|Overall Study|Withdrawal by Subject|0|||
143216737|NCT04000581|516339792|FG001|Overall Study|Withdrawal by Subject|1|||
143371988|NCT01837641|516906373|FG004|Overall Study|Withdrawal by Subject|1|||
143216738|NCT00588354|516339793|FG000|Baseline to 2 Weeks|Adverse Event|1|||
143216739|NCT00588354|516339794|FG001|Baseline to 2 Weeks|Adverse Event|0|||
143216740|NCT00588354|516339793|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
143216741|NCT00588354|516339794|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
143216742|NCT00588354|516339793|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
143216743|NCT00588354|516339794|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
143216744|NCT03477838|516339795|FG000|Overall Study|Lost to Follow-up|14|||
143216745|NCT00850538|516339798|FG000|Overall Study|unable/unwilling to complete MRI|13|||
143216746|NCT00850538|516339798|FG000|Overall Study|specimen missed due to scheduling error|14|||
143216747|NCT00850538|516339798|FG000|Overall Study|specimen unusable|7|||
143216748|NCT00850538|516339798|FG000|Overall Study|Withdrawal by Subject|3|||
143216749|NCT00850538|516339798|FG000|Overall Study|radiology error|2|||
143216750|NCT00850538|516339798|FG000|Overall Study|Protocol Violation|2|||
143216751|NCT01088399|516339805|FG000|Overall Study|Adverse Event|211|||
143216752|NCT01088399|516339806|FG001|Overall Study|Adverse Event|16|||
143216753|NCT01088399|516339807|FG002|Overall Study|Adverse Event|0|||
143216754|NCT01088399|516339805|FG000|Overall Study|Death|204|||
143216755|NCT01088399|516339806|FG001|Overall Study|Death|45|||
143216756|NCT01088399|516339807|FG002|Overall Study|Death|0|||
143216757|NCT01088399|516339805|FG000|Overall Study|Lack of Efficacy|298|||
143216758|NCT01088399|516339806|FG001|Overall Study|Lack of Efficacy|7|||
143216759|NCT01088399|516339807|FG002|Overall Study|Lack of Efficacy|5|||
143216760|NCT01088399|516339805|FG000|Overall Study|Lost to Follow-up|1070|||
143216761|NCT01088399|516339806|FG001|Overall Study|Lost to Follow-up|278|||
143216762|NCT01088399|516339807|FG002|Overall Study|Lost to Follow-up|58|||
143216763|NCT01088399|516339805|FG000|Overall Study|Physician Decision|531|||
143216764|NCT01088399|516339806|FG001|Overall Study|Physician Decision|88|||
143216765|NCT01088399|516339807|FG002|Overall Study|Physician Decision|16|||
143216766|NCT01088399|516339805|FG000|Overall Study|Withdrawal by Subject|544|||
143216767|NCT01088399|516339806|FG001|Overall Study|Withdrawal by Subject|195|||
143216768|NCT01088399|516339807|FG002|Overall Study|Withdrawal by Subject|33|||
143216769|NCT01088399|516339805|FG000|Overall Study|Change to or start of somatropin therapy|234|||
143216770|NCT01088399|516339806|FG001|Overall Study|Change to or start of somatropin therapy|17|||
143216771|NCT01088399|516339807|FG002|Overall Study|Change to or start of somatropin therapy|12|||
143216772|NCT01088399|516339805|FG000|Overall Study|Sponsor decision|1573|||
143216773|NCT01088399|516339806|FG001|Overall Study|Sponsor decision|298|||
143216774|NCT01088399|516339807|FG002|Overall Study|Sponsor decision|7|||
143216775|NCT01088399|516339805|FG000|Overall Study|Protocol Violation|10|||
143216776|NCT01088399|516339806|FG001|Overall Study|Protocol Violation|1|||
143216777|NCT01088399|516339807|FG002|Overall Study|Protocol Violation|0|||
143216778|NCT01088399|516339805|FG000|Overall Study|Enrollment criteria not met|48|||
143216779|NCT01088399|516339806|FG001|Overall Study|Enrollment criteria not met|119|||
143216780|NCT01088399|516339807|FG002|Overall Study|Enrollment criteria not met|70|||
143216781|NCT01088399|516339805|FG000|Overall Study|Study summary visit not completed|2398|||
143216782|NCT01088399|516339806|FG001|Overall Study|Study summary visit not completed|283|||
143216783|NCT01088399|516339807|FG002|Overall Study|Study summary visit not completed|80|||
143216784|NCT00620113|516339808|FG000|Overall Study|Adverse Event|3|||
143216785|NCT00620113|516339809|FG001|Overall Study|Adverse Event|2|||
143216786|NCT00620113|516339810|FG002|Overall Study|Adverse Event|2|||
143216787|NCT00620113|516339811|FG003|Overall Study|Adverse Event|1|||
143216788|NCT00620113|516339808|FG000|Overall Study|Lack of Efficacy|2|||
143216789|NCT00620113|516339809|FG001|Overall Study|Lack of Efficacy|3|||
143216790|NCT00620113|516339810|FG002|Overall Study|Lack of Efficacy|0|||
143216791|NCT00620113|516339811|FG003|Overall Study|Lack of Efficacy|2|||
143216792|NCT00620113|516339808|FG000|Overall Study|Physician Decision|1|||
143216793|NCT00620113|516339809|FG001|Overall Study|Physician Decision|0|||
143216794|NCT00620113|516339810|FG002|Overall Study|Physician Decision|0|||
143216795|NCT00620113|516339811|FG003|Overall Study|Physician Decision|2|||
143216796|NCT00620113|516339808|FG000|Overall Study|Protocol Violation|2|||
143216797|NCT00620113|516339809|FG001|Overall Study|Protocol Violation|1|||
143216798|NCT00620113|516339810|FG002|Overall Study|Protocol Violation|0|||
143216799|NCT00620113|516339811|FG003|Overall Study|Protocol Violation|0|||
143216800|NCT00620113|516339808|FG000|Overall Study|Withdrawal by Subject|5|||
143216801|NCT00620113|516339809|FG001|Overall Study|Withdrawal by Subject|1|||
143216802|NCT00620113|516339810|FG002|Overall Study|Withdrawal by Subject|3|||
143216803|NCT00620113|516339811|FG003|Overall Study|Withdrawal by Subject|5|||
143216804|NCT04230213|516339816|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
143216805|NCT04230213|516339817|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
143216806|NCT04230213|516339818|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
143216807|NCT04230213|516339816|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
143216808|NCT04230213|516339817|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
143216809|NCT04230213|516339818|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
143216810|NCT04230213|516339816|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
143216811|NCT04230213|516339817|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
143216812|NCT04230213|516339818|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
143216813|NCT04230213|516339816|FG000|TP2: Week 10 to Week 16|Other|0|||
143216814|NCT04230213|516339817|FG001|TP2: Week 10 to Week 16|Other|2|||
143216815|NCT04230213|516339818|FG002|TP2: Week 10 to Week 16|Other|1|||
143216816|NCT04230213|516339816|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
143216817|NCT04230213|516339817|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
143216818|NCT04230213|516339818|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
143216819|NCT04230213|516339816|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
143216820|NCT04230213|516339817|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
143216821|NCT04230213|516339818|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
143216822|NCT04230213|516339816|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
143216823|NCT04230213|516339817|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
143216824|NCT04230213|516339818|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
143216825|NCT04230213|516339816|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
143216826|NCT04230213|516339817|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
143216827|NCT04230213|516339818|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
143216828|NCT04230213|516339816|FG000|TP3: Week 16 to Week 22|Other|0|||
143216829|NCT04230213|516339817|FG001|TP3: Week 16 to Week 22|Other|1|||
143216830|NCT04230213|516339818|FG002|TP3: Week 16 to Week 22|Other|3|||
143216831|NCT04230213|516339816|FG000|TP4: Week 22 to Week 32|Other|0|||
143216832|NCT04230213|516339817|FG001|TP4: Week 22 to Week 32|Other|5|||
143216833|NCT04230213|516339818|FG002|TP4: Week 22 to Week 32|Other|5|||
143216834|NCT04230213|516339816|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
143216835|NCT04230213|516339817|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
143216836|NCT04230213|516339818|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
143216837|NCT04230213|516339816|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
143216838|NCT04230213|516339817|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
143216839|NCT04230213|516339818|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
143216840|NCT04230213|516339816|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
143216841|NCT04230213|516339817|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
143216842|NCT04230213|516339818|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
143216843|NCT04230213|516339816|FG000|Follow up: Week 32 to Week 36|Other|0|||
143216844|NCT04230213|516339817|FG001|Follow up: Week 32 to Week 36|Other|1|||
143216845|NCT04230213|516339818|FG002|Follow up: Week 32 to Week 36|Other|1|||
143216846|NCT01698814|516341142|FG000|Overall Study|Adverse Event|0|||
143216847|NCT01698814|516341143|FG001|Overall Study|Adverse Event|2|||
143216848|NCT01698814|516341142|FG000|Overall Study|Lost to Follow-up|0|||
143216849|NCT01698814|516341143|FG001|Overall Study|Lost to Follow-up|1|||
143216850|NCT01698814|516341142|FG000|Overall Study|Pregnancy|1|||
143216851|NCT01698814|516341143|FG001|Overall Study|Pregnancy|0|||
143216852|NCT01698814|516341142|FG000|Overall Study|Randomized in error|1|||
143216853|NCT01698814|516341143|FG001|Overall Study|Randomized in error|0|||
143216854|NCT00368641|516341144|FG000|Overall Study|Adverse Event|2|||
143216855|NCT00368641|516341145|FG001|Overall Study|Adverse Event|1|||
143216856|NCT00368641|516341144|FG000|Overall Study|Death|1|||
143216857|NCT00368641|516341145|FG001|Overall Study|Death|0|||
143216858|NCT00368641|516341144|FG000|Overall Study|Withdrawal by Subject|1|||
143216859|NCT00368641|516341145|FG001|Overall Study|Withdrawal by Subject|0|||
143216860|NCT00368641|516341144|FG000|Overall Study|Sponsor decision to terminate study|2|||
143216861|NCT00368641|516341145|FG001|Overall Study|Sponsor decision to terminate study|5|||
143216862|NCT01504412|516341150|FG000|Overall Study|Adverse Event|1|||
143216863|NCT01504412|516341151|FG001|Overall Study|Adverse Event|8|||
143216864|NCT01504412|516341152|FG002|Overall Study|Adverse Event|1|||
143216865|NCT01504412|516341153|FG003|Overall Study|Adverse Event|7|||
143216866|NCT01504412|516341154|FG004|Overall Study|Adverse Event|10|||
143216867|NCT01504412|516341150|FG000|Overall Study|Withdrawal by Subject|2|||
143216868|NCT01504412|516341151|FG001|Overall Study|Withdrawal by Subject|1|||
143216869|NCT01504412|516341152|FG002|Overall Study|Withdrawal by Subject|1|||
143216870|NCT01504412|516341153|FG003|Overall Study|Withdrawal by Subject|5|||
143216871|NCT01504412|516341154|FG004|Overall Study|Withdrawal by Subject|1|||
143216872|NCT01504412|516341150|FG000|Overall Study|Other|2|||
143216873|NCT01504412|516341151|FG001|Overall Study|Other|1|||
143266658|NCT02598960|516531746|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
143266659|NCT02598960|516531747|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
143216874|NCT01504412|516341152|FG002|Overall Study|Other|1|||
143216875|NCT01504412|516341153|FG003|Overall Study|Other|6|||
143216876|NCT01504412|516341154|FG004|Overall Study|Other|1|||
143216877|NCT01504412|516341150|FG000|Overall Study|Lost to Follow-up|0|||
143216878|NCT01504412|516341151|FG001|Overall Study|Lost to Follow-up|2|||
143216879|NCT01504412|516341152|FG002|Overall Study|Lost to Follow-up|0|||
143216880|NCT01504412|516341153|FG003|Overall Study|Lost to Follow-up|0|||
143216881|NCT01504412|516341154|FG004|Overall Study|Lost to Follow-up|0|||
143216882|NCT01504412|516341150|FG000|Overall Study|Lack of Efficacy|0|||
143266660|NCT02598960|516531748|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
143266661|NCT02598960|516531749|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
143266662|NCT02598960|516531750|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
143266663|NCT02598960|516531751|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
143216883|NCT01504412|516341151|FG001|Overall Study|Lack of Efficacy|0|||
143266664|NCT02598960|516531752|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
143266665|NCT02598960|516531753|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
143216884|NCT01504412|516341152|FG002|Overall Study|Lack of Efficacy|1|||
143266666|NCT02598960|516531754|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
143216885|NCT01504412|516341153|FG003|Overall Study|Lack of Efficacy|0|||
143216886|NCT01504412|516341154|FG004|Overall Study|Lack of Efficacy|1|||
143216887|NCT01504412|516341150|FG000|Overall Study|Death|0|||
143216888|NCT01504412|516341151|FG001|Overall Study|Death|0|||
143216889|NCT01504412|516341152|FG002|Overall Study|Death|0|||
143216890|NCT01504412|516341153|FG003|Overall Study|Death|1|||
143216891|NCT01504412|516341154|FG004|Overall Study|Death|0|||
143216892|NCT04809285|516341157|FG000|Phase 1|Lost to Follow-up|6|||
143216893|NCT04809285|516341157|FG000|Phase 1|Protocol Violation|2|||
143216894|NCT04809285|516341157|FG000|Phase 1|Physician Decision|3|||
143216895|NCT04809285|516341157|FG000|Phase 1|Withdrawal by Subject|29|||
143216896|NCT04809285|516341157|FG000|Phase 2|Protocol Violation|3|||
143216897|NCT04809285|516341157|FG000|Phase 2|Withdrawal by Subject|4|||
143216898|NCT02837029|516341158|FG000|Screening|Failed to meet screening requirements.|7|||
143216899|NCT02837029|516341159|FG001|Screening|Failed to meet screening requirements.|3|||
143216900|NCT02837029|516341160|FG002|Screening|Failed to meet screening requirements.|0|||
143216901|NCT02837029|516341158|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
143216902|NCT02837029|516341159|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
143216903|NCT02837029|516341160|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
143216904|NCT02837029|516341158|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
143216905|NCT02837029|516341159|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
143216906|NCT02837029|516341160|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
143216907|NCT02837029|516341158|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
143216908|NCT02837029|516341159|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
143216909|NCT02837029|516341160|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
143216910|NCT02837029|516341158|FG000|Cycle 2 and Beyond|Adverse Event|1|||
143216911|NCT02837029|516341159|FG001|Cycle 2 and Beyond|Adverse Event|0|||
143216912|NCT02837029|516341160|FG002|Cycle 2 and Beyond|Adverse Event|0|||
143216913|NCT02837029|516341158|FG000|2 Year Follow-up|Death|6|||
143216914|NCT02837029|516341159|FG001|2 Year Follow-up|Death|7|||
143216915|NCT02837029|516341160|FG002|2 Year Follow-up|Death|0|||
143216916|NCT02034877|516341161|FG000|Overall Study|Lost to Follow-up|0|||
143216917|NCT02034877|516341162|FG001|Overall Study|Lost to Follow-up|3|||
143216918|NCT02034877|516341161|FG000|Overall Study|No Longer Willing to Participate|0|||
143216919|NCT02034877|516341162|FG001|Overall Study|No Longer Willing to Participate|3|||
143216920|NCT02598297|516341163|FG000|Overall Study|Study terminated by Sponsor|21|||
143216921|NCT02598297|516341164|FG001|Overall Study|Study terminated by Sponsor|23|||
143216922|NCT02598297|516341163|FG000|Overall Study|Adverse Event|1|||
143216923|NCT02598297|516341164|FG001|Overall Study|Adverse Event|1|||
143216924|NCT02598297|516341163|FG000|Overall Study|Physician Decision|1|||
143216925|NCT02598297|516341164|FG001|Overall Study|Physician Decision|0|||
143216926|NCT02598297|516341163|FG000|Overall Study|Subject/guardian decision|1|||
143216927|NCT02598297|516341164|FG001|Overall Study|Subject/guardian decision|0|||
143216928|NCT02598297|516341163|FG000|Overall Study|Followed for survival|1|||
143216929|NCT02598297|516341164|FG001|Overall Study|Followed for survival|0|||
143216930|NCT00887549|516341167|FG000|Induction Therapy|Adverse Event|8|||
143216931|NCT00887549|516341167|FG000|Induction Therapy|Physician Decision|1|||
143216932|NCT00887549|516341167|FG000|Induction Therapy|Progressive Disease|13|||
143216933|NCT00887549|516341167|FG000|Induction Therapy|Death due to Study Disease|4|||
143216934|NCT00887549|516341167|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
143216935|NCT00887549|516341167|FG000|Maintenance Therapy|Adverse Event|16|||
143216936|NCT00887549|516341167|FG000|Maintenance Therapy|Physician Decision|1|||
143216937|NCT00887549|516341167|FG000|Maintenance Therapy|Progressive Disease|25|||
143216938|NCT00887549|516341167|FG000|Maintenance Therapy|Death due to adverse event|1|||
143216939|NCT01934010|516341168|FG000|Overall Study|Adverse Event|1|||
143216940|NCT01934010|516341169|FG001|Overall Study|Adverse Event|1|||
143216941|NCT01934010|516341170|FG002|Overall Study|Adverse Event|0|||
143216942|NCT01934010|516341168|FG000|Overall Study|Withdrawal by Subject|15|||
143216943|NCT01934010|516341169|FG001|Overall Study|Withdrawal by Subject|6|||
143216944|NCT01934010|516341170|FG002|Overall Study|Withdrawal by Subject|2|||
143216945|NCT01934010|516341168|FG000|Overall Study|Lost to Follow-up|7|||
143266667|NCT02598960|516531755|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
143266668|NCT02598960|516531756|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
143266669|NCT02598960|516531757|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
143266670|NCT02598960|516531745|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
143266671|NCT02598960|516531746|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
143266672|NCT02598960|516531747|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
143266673|NCT02598960|516531748|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
143266674|NCT02598960|516531749|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
143266675|NCT02598960|516531750|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
143266676|NCT02598960|516531751|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
143266677|NCT02598960|516531752|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
143266678|NCT02598960|516531753|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
143266679|NCT02598960|516531754|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
143216946|NCT01934010|516341169|FG001|Overall Study|Lost to Follow-up|4|||
143216947|NCT01934010|516341170|FG002|Overall Study|Lost to Follow-up|0|||
143216948|NCT00100789|516341171|FG000|Overall Study|Adverse Event|10|||
143216949|NCT00100789|516341171|FG000|Overall Study|Withdrawal by Subject|1|||
143216950|NCT00100789|516341171|FG000|Overall Study|Progression/relapse|42|||
143216951|NCT00100789|516341171|FG000|Overall Study|Death|2|||
143216952|NCT00100789|516341171|FG000|Overall Study|Not protocol specified|5|||
143216953|NCT00100789|516341171|FG000|Overall Study|Ineligible|3|||
143216954|NCT00100789|516341171|FG000|Overall Study|Never received treatment|1|||
143216955|NCT01393821|516341172|FG000|Overall Study|Cancel|1|||
143216956|NCT01393821|516341173|FG001|Overall Study|Cancel|1|||
143216957|NCT01393821|516341172|FG000|Overall Study|not evaluable for primary endpoint|4|||
143216958|NCT01393821|516341173|FG001|Overall Study|not evaluable for primary endpoint|2|||
143216959|NCT00377858|516341184|FG000|Overall Study|Withdrawal by Subject|12|||
143216960|NCT00377858|516341185|FG001|Overall Study|Withdrawal by Subject|11|||
143216961|NCT00377858|516341184|FG000|Overall Study|Lost to Follow-up|6|||
143216962|NCT00377858|516341185|FG001|Overall Study|Lost to Follow-up|1|||
143216963|NCT00377858|516341184|FG000|Overall Study|Physician Decision|5|||
143216964|NCT00377858|516341185|FG001|Overall Study|Physician Decision|5|||
143216965|NCT00377858|516341184|FG000|Overall Study|Protocol Violation|3|||
143216966|NCT00377858|516341185|FG001|Overall Study|Protocol Violation|4|||
143216967|NCT00377858|516341184|FG000|Overall Study|Adverse Event|2|||
143216968|NCT00377858|516341185|FG001|Overall Study|Adverse Event|1|||
143216969|NCT00377858|516341184|FG000|Overall Study|Entry Criteria Not Met|2|||
143216970|NCT00377858|516341185|FG001|Overall Study|Entry Criteria Not Met|0|||
143216971|NCT00377858|516341184|FG000|Overall Study|Sponsor Decision|1|||
143216972|NCT00377858|516341185|FG001|Overall Study|Sponsor Decision|2|||
143216973|NCT00377858|516341184|FG000|Overall Study|Death|0|||
143216974|NCT00377858|516341185|FG001|Overall Study|Death|3|||
143216975|NCT03534141|516341186|FG000|Overall Study|Enrolled in other clinical trial|1|||
143216976|NCT03534141|516341187|FG001|Overall Study|Enrolled in other clinical trial|0|||
143216977|NCT03534141|516341186|FG000|Overall Study|Liver transplant aborted after randomization|0|||
143216978|NCT03534141|516341187|FG001|Overall Study|Liver transplant aborted after randomization|2|||
143216979|NCT03534141|516341186|FG000|Overall Study|Liver graft explanted due to surgical issue|0|||
143216980|NCT03534141|516341187|FG001|Overall Study|Liver graft explanted due to surgical issue|1|||
143216981|NCT02506192|516341190|FG000|Overall Study|Withdrawal by Subject|1|||
143216982|NCT02506192|516341191|FG001|Overall Study|Withdrawal by Subject|1|||
143216983|NCT01685697|516341192|FG000|Overall Study|Protocol Violation|3|||
143216984|NCT01685697|516341193|FG001|Overall Study|Protocol Violation|3|||
143216985|NCT02703324|516341194|FG000|Period Two|Withdrawal by Subject|0|||
143216986|NCT02703324|516341195|FG001|Period Two|Withdrawal by Subject|0|||
143216987|NCT02703324|516341196|FG002|Period Two|Withdrawal by Subject|1|||
143216988|NCT02703324|516341197|FG003|Period Two|Withdrawal by Subject|0|||
143216989|NCT02703324|516341198|FG004|Period Two|Withdrawal by Subject|0|||
143216990|NCT02703324|516341199|FG005|Period Two|Withdrawal by Subject|0|||
143216991|NCT00203424|516341203|FG000|Treatment Period|Withdrawal by Subject|4|||
143216992|NCT00203424|516341203|FG000|Treatment Period|Adverse Event|5|||
143216993|NCT00203424|516341203|FG000|Treatment Period|progressive disease|2|||
143216994|NCT00203424|516341203|FG000|Follow-up Period|Withdrawal by Subject|1|||
143216995|NCT00203424|516341203|FG000|Follow-up Period|progressive disease|4|||
143216996|NCT00203424|516341203|FG000|Follow-up Period|Lost to Follow-up|1|||
143216997|NCT00475709|516341204|FG000|Overall Study|Did not meet eligibility criteria|8|||
143216998|NCT00475709|516341204|FG000|Overall Study|Death|41|||
143216999|NCT00475709|516341204|FG000|Overall Study|Device Explant|6|||
143217000|NCT00475709|516341204|FG000|Overall Study|Lost to Follow-up|21|||
143217001|NCT04752358|516341205|FG000|Overall Study|Death|2|||
143217002|NCT04752358|516341206|FG001|Overall Study|Death|1|||
143217003|NCT00555672|516341207|FG000|Overall Study|Death|0|||
143217004|NCT00555672|516341208|FG001|Overall Study|Death|2|||
143217005|NCT00555672|516341207|FG000|Overall Study|Adverse Event|8|||
143217006|NCT00555672|516341208|FG001|Overall Study|Adverse Event|2|||
143217007|NCT00555672|516341207|FG000|Overall Study|Objective progression or relapse|11|||
143217008|NCT00555672|516341208|FG001|Overall Study|Objective progression or relapse|5|||
143217009|NCT00555672|516341207|FG000|Overall Study|Other|3|||
143266680|NCT02598960|516531755|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
143266681|NCT02598960|516531756|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
143266682|NCT02598960|516531757|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
143266683|NCT02598960|516531745|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
143266684|NCT02598960|516531746|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
143217010|NCT00555672|516341208|FG001|Overall Study|Other|1|||
143217011|NCT00555672|516341207|FG000|Overall Study|Participant refused|2|||
143217012|NCT00555672|516341208|FG001|Overall Study|Participant refused|0|||
143217013|NCT01053988|516341209|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
143217014|NCT01053988|516341210|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
143217015|NCT01053988|516341211|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
143217016|NCT01053988|516341212|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
143217017|NCT01053988|516341213|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
143217018|NCT01053988|516341214|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
143217019|NCT01053988|516341209|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
143217020|NCT01053988|516341210|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
143217021|NCT01053988|516341211|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
143217022|NCT01053988|516341212|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
143217023|NCT01053988|516341213|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
143217024|NCT01053988|516341214|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
143217025|NCT01053988|516341209|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
143217026|NCT01053988|516341210|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
143217027|NCT01053988|516341211|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
143217028|NCT01053988|516341212|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
143217029|NCT01053988|516341213|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
143217030|NCT01053988|516341214|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
143217031|NCT01053988|516341209|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
143217032|NCT01053988|516341210|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
143217033|NCT01053988|516341211|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
143217034|NCT01053988|516341212|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
143217035|NCT01053988|516341213|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
143217036|NCT01053988|516341214|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
143217037|NCT01053988|516341209|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
143217038|NCT01053988|516341210|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
143217039|NCT01053988|516341211|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
143217040|NCT01053988|516341212|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
143217041|NCT01053988|516341213|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
143217042|NCT01053988|516341214|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
143217043|NCT01053988|516341209|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
143217044|NCT01053988|516341210|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
143217045|NCT01053988|516341211|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
143217046|NCT01053988|516341212|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
143217047|NCT01053988|516341213|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
143217048|NCT01053988|516341214|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
143217049|NCT01053988|516341209|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
143217050|NCT01053988|516341210|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
143266685|NCT02598960|516531747|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
143266686|NCT02598960|516531748|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
143266687|NCT02598960|516531749|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
143266688|NCT02598960|516531750|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
143266689|NCT02598960|516531751|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
143266690|NCT02598960|516531752|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
143266691|NCT02598960|516531753|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
143266692|NCT02598960|516531754|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
143266693|NCT02598960|516531755|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
143266694|NCT02598960|516531756|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
143266695|NCT02598960|516531757|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
143266696|NCT05108922|516531758|FG000|Overall Study|Adverse Event|2|||
143266697|NCT05108922|516531759|FG001|Overall Study|Adverse Event|3|||
143266698|NCT05108922|516531758|FG000|Overall Study|Lost to Follow-up|2|||
143266699|NCT05108922|516531759|FG001|Overall Study|Lost to Follow-up|1|||
143266700|NCT05108922|516531758|FG000|Overall Study|Inadvertent enrollment|0|||
143266701|NCT05108922|516531759|FG001|Overall Study|Inadvertent enrollment|1|||
143266702|NCT05108922|516531758|FG000|Overall Study|Physician Decision|2|||
143266703|NCT05108922|516531759|FG001|Overall Study|Physician Decision|3|||
143266704|NCT05108922|516531758|FG000|Overall Study|Protocol deviation|1|||
143266705|NCT05108922|516531759|FG001|Overall Study|Protocol deviation|0|||
143266706|NCT05108922|516531758|FG000|Overall Study|Screen failure|1|||
143266707|NCT05108922|516531759|FG001|Overall Study|Screen failure|0|||
143266708|NCT05108922|516531758|FG000|Overall Study|Withdrawal by Subject|11|||
143266709|NCT05108922|516531759|FG001|Overall Study|Withdrawal by Subject|8|||
143266710|NCT05036369|516531761|FG000|Overall Study|Run In non compliance|1|||
143266711|NCT05036369|516531762|FG001|Overall Study|Run In non compliance|2|||
143266712|NCT05036369|516531761|FG000|Overall Study|Change in eligibility criteria|0|||
143266713|NCT05036369|516531762|FG001|Overall Study|Change in eligibility criteria|1|||
143266714|NCT00426231|516531766|FG000|Overall Study|Withdrawal by Subject|9|||
143266715|NCT00426231|516531767|FG001|Overall Study|Withdrawal by Subject|12|||
143217051|NCT01053988|516341211|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
143217052|NCT01053988|516341212|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
143266716|NCT03061097|516531768|FG000|Overall Study|Withdrawal by Subject|0|||
143266717|NCT03061097|516531769|FG001|Overall Study|Withdrawal by Subject|3|||
143266718|NCT01614600|516531770|FG000|Overall Study|Unacceptable fit|1|||
143266719|NCT01614600|516531770|FG000|Overall Study|Discomfort|1|||
143371989|NCT01837641|516906374|FG005|Overall Study|Withdrawal by Subject|0|||
143217053|NCT01053988|516341213|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
143217054|NCT01053988|516341214|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
143217055|NCT01053988|516341209|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
143217056|NCT01053988|516341210|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
143217057|NCT01053988|516341211|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
143217058|NCT01053988|516341212|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
143217059|NCT01053988|516341213|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
143217060|NCT01053988|516341214|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
143217061|NCT01053988|516341209|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
143217062|NCT01053988|516341210|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
143217063|NCT01053988|516341211|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
143217064|NCT01053988|516341212|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
143217065|NCT01053988|516341213|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
143217066|NCT01053988|516341214|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
143217067|NCT01053988|516341209|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
143217068|NCT01053988|516341210|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
143217069|NCT01053988|516341211|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
143217070|NCT01053988|516341212|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
143217071|NCT01053988|516341213|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
143217072|NCT01053988|516341214|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
143217073|NCT01053988|516341209|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
143217074|NCT01053988|516341210|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
143217075|NCT01053988|516341211|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
143217076|NCT01053988|516341212|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
143217077|NCT01053988|516341213|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
143217078|NCT01053988|516341214|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
143217079|NCT01053988|516341209|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
143217080|NCT01053988|516341210|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
143217081|NCT01053988|516341211|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
143217082|NCT01053988|516341212|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
143217083|NCT01053988|516341213|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
143217084|NCT01053988|516341214|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
143217085|NCT01053988|516341209|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
143217086|NCT01053988|516341210|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
143217087|NCT01053988|516341211|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
143217088|NCT01053988|516341212|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
143217089|NCT01053988|516341213|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
143217090|NCT01053988|516341214|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
143217091|NCT01053988|516341209|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
143217092|NCT01053988|516341210|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
143217093|NCT01053988|516341211|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
143217094|NCT01053988|516341212|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
143217095|NCT01053988|516341213|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
143217096|NCT01053988|516341214|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
143217097|NCT01922271|516341215|FG000|WASHOUT Period|Withdrawal by Subject|1|||
143217098|NCT01922271|516341216|FG001|WASHOUT Period|Withdrawal by Subject|0|||
143217099|NCT02106403|516341232|FG000|Follow-Up Visit 3|Other Reason|0|||
143217100|NCT02106403|516341233|FG001|Follow-Up Visit 3|Other Reason|0|||
143217101|NCT02106403|516341234|FG002|Follow-Up Visit 3|Other Reason|0|||
143217102|NCT02106403|516341235|FG003|Follow-Up Visit 3|Other Reason|0|||
143217103|NCT02106403|516341236|FG004|Follow-Up Visit 3|Other Reason|0|||
143217104|NCT02106403|516341237|FG005|Follow-Up Visit 3|Other Reason|1|||
143371990|NCT01837641|516906375|FG006|Overall Study|Withdrawal by Subject|1|||
143217105|NCT04698993|516341241|FG000|Overall Study|PCR results not accessible|2|||
143217106|NCT04698993|516341242|FG001|Overall Study|PCR results not accessible|7|||
143217107|NCT04698993|516341241|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
143217108|NCT04698993|516341242|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
143217109|NCT01128946|516341243|FG000|Period I|Protocol Violation|0|||
143217110|NCT01128946|516341244|FG001|Period I|Protocol Violation|1|||
143217111|NCT01128946|516341245|FG002|Period I|Protocol Violation|0|||
143217112|NCT01128946|516341246|FG003|Period I|Protocol Violation|0|||
143217113|NCT01128946|516341243|FG000|Period I|Withdrawal by Subject|0|||
143217114|NCT01128946|516341244|FG001|Period I|Withdrawal by Subject|0|||
143217115|NCT01128946|516341245|FG002|Period I|Withdrawal by Subject|1|||
143217116|NCT01128946|516341246|FG003|Period I|Withdrawal by Subject|1|||
143217117|NCT01128946|516341243|FG000|Period II|Protocol Violation|0|||
143217118|NCT01128946|516341244|FG001|Period II|Protocol Violation|1|||
143217119|NCT01128946|516341245|FG002|Period II|Protocol Violation|0|||
143217120|NCT01128946|516341246|FG003|Period II|Protocol Violation|0|||
143217121|NCT01128946|516341243|FG000|Period II|Withdrawal by Subject|0|||
143217122|NCT01128946|516341244|FG001|Period II|Withdrawal by Subject|0|||
143217123|NCT01128946|516341245|FG002|Period II|Withdrawal by Subject|0|||
143217124|NCT01128946|516341246|FG003|Period II|Withdrawal by Subject|1|||
143217125|NCT01128946|516341243|FG000|Period III|Protocol Violation|1|||
143217126|NCT01128946|516341244|FG001|Period III|Protocol Violation|0|||
143217127|NCT01128946|516341245|FG002|Period III|Protocol Violation|0|||
143217128|NCT01128946|516341246|FG003|Period III|Protocol Violation|0|||
143217129|NCT00621140|516341247|FG000|Overall Study|Adverse Event|4|||
143217130|NCT00621140|516341248|FG001|Overall Study|Adverse Event|5|||
143217131|NCT00621140|516341247|FG000|Overall Study|Lost to Follow-up|1|||
143217132|NCT00621140|516341248|FG001|Overall Study|Lost to Follow-up|2|||
143217133|NCT00621140|516341247|FG000|Overall Study|Withdrawal by Subject|4|||
143217134|NCT00621140|516341248|FG001|Overall Study|Withdrawal by Subject|6|||
143217135|NCT00621140|516341247|FG000|Overall Study|Other incl. lack of efficacy|6|||
143217136|NCT00621140|516341248|FG001|Overall Study|Other incl. lack of efficacy|5|||
143217137|NCT00145574|516341249|FG000|Double Blind|Adverse Event|0|||
143217138|NCT00145574|516341250|FG001|Double Blind|Adverse Event|3|||
143217139|NCT00145574|516341251|FG002|Double Blind|Adverse Event|1|||
143217140|NCT00145574|516341249|FG000|Double Blind|Withdrawal by Subject|1|||
143217141|NCT00145574|516341250|FG001|Double Blind|Withdrawal by Subject|1|||
143217142|NCT00145574|516341251|FG002|Double Blind|Withdrawal by Subject|1|||
143217143|NCT00145574|516341249|FG000|Double Blind|required restricted medicine|0|||
143217144|NCT00145574|516341250|FG001|Double Blind|required restricted medicine|1|||
143217145|NCT00145574|516341251|FG002|Double Blind|required restricted medicine|0|||
143217146|NCT00145574|516341249|FG000|Open Label Long-term Extension|Adverse Event|0|||
143217147|NCT00145574|516341250|FG001|Open Label Long-term Extension|Adverse Event|0|||
143217148|NCT00145574|516341251|FG002|Open Label Long-term Extension|Adverse Event|5|||
143217149|NCT00145574|516341249|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
143217150|NCT00145574|516341250|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
143217151|NCT00145574|516341251|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
143217152|NCT00145574|516341249|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
143217153|NCT00145574|516341250|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
143217154|NCT00145574|516341251|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
143217155|NCT00145574|516341249|FG000|Open Label Long-term Extension|required restricted medicine|0|||
143217156|NCT00145574|516341250|FG001|Open Label Long-term Extension|required restricted medicine|0|||
143217157|NCT00145574|516341251|FG002|Open Label Long-term Extension|required restricted medicine|1|||
143217158|NCT00527904|516341252|FG000|Overall Study|Adverse Event|45|||
143217159|NCT00527904|516341252|FG000|Overall Study|Withdrawal by Subject|21|||
143217160|NCT00527904|516341252|FG000|Overall Study|Lost to Follow-up|8|||
143217161|NCT00527904|516341252|FG000|Overall Study|misc|22|||
143217162|NCT03565237|516341254|FG000|Overall Study|Non-compliance of Investigational Product|1|||
143217163|NCT03565237|516341254|FG000|Overall Study|Physician Decision|1|||
143217164|NCT01140061|516341260|FG000|Part I|Adverse Event|1|||
143217165|NCT01140061|516341261|FG001|Part I|Adverse Event|0|||
143217166|NCT01140061|516341262|FG002|Part I|Adverse Event|0|||
143217167|NCT01140061|516341263|FG003|Part I|Adverse Event|0|||
143217168|NCT01140061|516341264|FG004|Part I|Adverse Event|0|||
143217169|NCT01140061|516341265|FG005|Part I|Adverse Event|0|||
143217170|NCT01140061|516341266|FG006|Part I|Adverse Event|0|||
143217171|NCT01140061|516341267|FG007|Part I|Adverse Event|0|||
143217172|NCT01140061|516341268|FG008|Part I|Adverse Event|0|||
143217173|NCT01140061|516341269|FG009|Part I|Adverse Event|0|||
143266720|NCT01614600|516531770|FG000|Overall Study|Unable to remove lens at the end of day|1|||
143266721|NCT01614600|516531770|FG000|Overall Study|Protocol deviation|1|||
143266722|NCT00595465|516531771|FG000|Overall Study|Adverse Event|4|||
143266723|NCT00595465|516531772|FG001|Overall Study|Adverse Event|3|||
143217174|NCT01140061|516341260|FG000|Extension|Laboratory Adverse Event|0|||
143217175|NCT01140061|516341261|FG001|Extension|Laboratory Adverse Event|0|||
143217176|NCT01140061|516341262|FG002|Extension|Laboratory Adverse Event|0|||
143217177|NCT01140061|516341263|FG003|Extension|Laboratory Adverse Event|0|||
143217178|NCT01140061|516341264|FG004|Extension|Laboratory Adverse Event|0|||
143217179|NCT01140061|516341265|FG005|Extension|Laboratory Adverse Event|0|||
143217180|NCT01140061|516341266|FG006|Extension|Laboratory Adverse Event|0|||
143217181|NCT01140061|516341267|FG007|Extension|Laboratory Adverse Event|0|||
143217182|NCT01140061|516341268|FG008|Extension|Laboratory Adverse Event|0|||
143217183|NCT01140061|516341269|FG009|Extension|Laboratory Adverse Event|1|||
143217184|NCT01320202|516341271|FG000|Overall Study|Adverse Event|5|||
143266724|NCT00595465|516531773|FG002|Overall Study|Adverse Event|3|||
143217185|NCT01320202|516341272|FG001|Overall Study|Adverse Event|5|||
143217186|NCT01320202|516341271|FG000|Overall Study|Death|5|||
143217187|NCT01320202|516341272|FG001|Overall Study|Death|3|||
143217188|NCT01320202|516341271|FG000|Overall Study|Lost to Follow-up|1|||
143217189|NCT01320202|516341272|FG001|Overall Study|Lost to Follow-up|0|||
143217190|NCT01320202|516341271|FG000|Overall Study|Physician Decision|3|||
143217191|NCT01320202|516341272|FG001|Overall Study|Physician Decision|1|||
143217192|NCT01320202|516341271|FG000|Overall Study|Protocol Violation|2|||
143217193|NCT01320202|516341272|FG001|Overall Study|Protocol Violation|1|||
143217194|NCT01320202|516341271|FG000|Overall Study|Withdrawal by Subject|10|||
143217195|NCT01320202|516341272|FG001|Overall Study|Withdrawal by Subject|3|||
143217196|NCT01320202|516341271|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
143217197|NCT01320202|516341272|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
143217198|NCT01320202|516341271|FG000|Overall Study|kidney transplant|1|||
143217199|NCT01320202|516341272|FG001|Overall Study|kidney transplant|2|||
143217200|NCT01320202|516341271|FG000|Overall Study|blood transfusion|1|||
143217201|NCT01320202|516341272|FG001|Overall Study|blood transfusion|7|||
143217202|NCT01320202|516341271|FG000|Overall Study|moved/changed dialysis|5|||
143217203|NCT01320202|516341272|FG001|Overall Study|moved/changed dialysis|2|||
143217204|NCT01320202|516341271|FG000|Overall Study|sponsor request|2|||
143217205|NCT01320202|516341272|FG001|Overall Study|sponsor request|0|||
143217206|NCT01320202|516341271|FG000|Overall Study|ineligible|3|||
143217207|NCT01320202|516341272|FG001|Overall Study|ineligible|0|||
143217208|NCT01320202|516341271|FG000|Overall Study|regained renal function|1|||
143217209|NCT01320202|516341272|FG001|Overall Study|regained renal function|0|||
143217210|NCT04565951|516341273|FG000|Overall Study|Lost to Follow-up|66|||
143217211|NCT04565951|516341274|FG001|Overall Study|Lost to Follow-up|38|||
143217212|NCT04565951|516341273|FG000|Overall Study|Withdrawal by Subject|14|||
143217213|NCT04565951|516341274|FG001|Overall Study|Withdrawal by Subject|7|||
143217214|NCT04565951|516341273|FG000|Overall Study|Death|0|||
143217215|NCT04565951|516341274|FG001|Overall Study|Death|1|||
143217216|NCT02038075|516341278|FG000|Overall Study|Withdrawal by Subject|3|||
143217217|NCT02038075|516341279|FG001|Overall Study|Withdrawal by Subject|0|||
143217218|NCT02519595|516341283|FG000|Overall Study|Protocol Violation|8|||
143217219|NCT02519595|516341284|FG001|Overall Study|Protocol Violation|22|||
143217220|NCT02519595|516341285|FG002|Overall Study|Protocol Violation|16|||
143217221|NCT03188510|516341286|FG000|Overall Study|Inappropriate behavior with site staff|0|||
143217222|NCT03188510|516341287|FG001|Overall Study|Inappropriate behavior with site staff|1|||
143217223|NCT03188510|516341288|FG002|Overall Study|Inappropriate behavior with site staff|0|||
143217224|NCT03058692|516342938|FG000|Overall Study|Lost to Follow-up|2|||
143217225|NCT03058692|516342939|FG001|Overall Study|Lost to Follow-up|1|||
143217226|NCT03058692|516342938|FG000|Overall Study|Withdrawal by Subject|1|||
143217227|NCT03058692|516342939|FG001|Overall Study|Withdrawal by Subject|1|||
143217228|NCT00806988|516342940|FG000|Overall Study|Death|15|||
143217229|NCT00806988|516342941|FG001|Overall Study|Death|16|||
143217230|NCT00806988|516342940|FG000|Overall Study|Withdrawal by Subject|8|||
143217231|NCT00806988|516342941|FG001|Overall Study|Withdrawal by Subject|8|||
143217232|NCT00806988|516342940|FG000|Overall Study|Lost to Follow-up|4|||
143217233|NCT00806988|516342941|FG001|Overall Study|Lost to Follow-up|19|||
143217234|NCT04775953|516342942|FG000|Overall Study|Lost to Follow-up|6|||
143217235|NCT04775953|516342943|FG001|Overall Study|Lost to Follow-up|11|||
143217236|NCT04775953|516342942|FG000|Overall Study|Death|5|||
143217237|NCT04775953|516342943|FG001|Overall Study|Death|4|||
143217238|NCT04775953|516342942|FG000|Overall Study|Withdrawal by Subject|3|||
143217239|NCT04775953|516342943|FG001|Overall Study|Withdrawal by Subject|3|||
143217240|NCT04775953|516342942|FG000|Overall Study|Protocol Violation|2|||
143217241|NCT04775953|516342943|FG001|Overall Study|Protocol Violation|0|||
143217242|NCT04775953|516342942|FG000|Overall Study|Participant non-compliance|0|||
143217243|NCT04775953|516342943|FG001|Overall Study|Participant non-compliance|1|||
143217244|NCT00855959|516342944|FG000|Overall Study|Adverse Event|2|||
143217245|NCT00855959|516342944|FG000|Overall Study|Lost to Follow-up|2|||
143217246|NCT00855959|516342944|FG000|Overall Study|Withdrawal by Subject|3|||
143217247|NCT00855959|516342944|FG000|Overall Study|Pregnancy|1|||
143217248|NCT00855959|516342944|FG000|Overall Study|Incorrect enrolment|1|||
143266725|NCT00595465|516531771|FG000|Overall Study|Pregnancy|0|||
143266726|NCT00595465|516531772|FG001|Overall Study|Pregnancy|0|||
143266727|NCT00595465|516531773|FG002|Overall Study|Pregnancy|1|||
143266728|NCT00595465|516531771|FG000|Overall Study|Protocol Violation|2|||
143217249|NCT02813889|516342945|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
143217250|NCT02813889|516342946|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
143217251|NCT04014062|516342952|FG000|Period I: Dosing|Medical Grounds|4|||
143217252|NCT04014062|516342953|FG001|Period I: Dosing|Medical Grounds|5|||
143217253|NCT04014062|516342952|FG000|Period I: Dosing|Withdrawal by Subject|3|||
143217254|NCT04014062|516342953|FG001|Period I: Dosing|Withdrawal by Subject|1|||
143217255|NCT01724866|516342954|FG000|Overall Study|Adverse Event|0|||
143266729|NCT00595465|516531772|FG001|Overall Study|Protocol Violation|1|||
143217256|NCT01724866|516342955|FG001|Overall Study|Adverse Event|0|||
143217257|NCT01724866|516342956|FG002|Overall Study|Adverse Event|1|||
143217258|NCT01724866|516342957|FG003|Overall Study|Adverse Event|1|||
143217259|NCT01724866|516342954|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
143217260|NCT01724866|516342955|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
143217261|NCT01724866|516342956|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
143217262|NCT01724866|516342957|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
143217263|NCT01724866|516342954|FG000|Overall Study|Investigator's Discretion|0|||
143217264|NCT01724866|516342955|FG001|Overall Study|Investigator's Discretion|1|||
143217265|NCT01724866|516342956|FG002|Overall Study|Investigator's Discretion|1|||
143217266|NCT01724866|516342957|FG003|Overall Study|Investigator's Discretion|0|||
143217267|NCT01724866|516342954|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
143217268|NCT01724866|516342955|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
143217269|NCT01724866|516342956|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
143217270|NCT01724866|516342957|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
143217271|NCT01724866|516342954|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
143217272|NCT01724866|516342955|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
143217273|NCT01724866|516342956|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
143217274|NCT01724866|516342957|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
143217275|NCT00546000|516342960|FG000|Overall Study|Adverse Event|1|||
143217276|NCT00546000|516342960|FG000|Overall Study|Lost to Follow-up|1|||
143217277|NCT00546000|516342960|FG000|Overall Study|Baseline HPA Axis Supression|2|||
143217278|NCT04506502|516342968|FG000|Overall Study|Withdrawal by Subject|1|||
143217279|NCT04506502|516342968|FG000|Overall Study|Illness and subsequent quarantine requirements related to SARS-CoV-2 local guidelines|1|||
143217280|NCT01449006|516342969|FG000|Overall Study|Lost to Follow-up|1|||
143217281|NCT01449006|516342970|FG001|Overall Study|Lost to Follow-up|0|||
143217282|NCT01449006|516342969|FG000|Overall Study|Withdrawal by Subject|1|||
143217283|NCT01449006|516342970|FG001|Overall Study|Withdrawal by Subject|0|||
143217284|NCT01449006|516342969|FG000|Overall Study|Protocol Violation|1|||
143217285|NCT01449006|516342970|FG001|Overall Study|Protocol Violation|0|||
143217286|NCT03526146|516342971|FG000|Overall Study|Lost to Follow-up|5|||
143217287|NCT03526146|516342971|FG000|Overall Study|Withdrawal by Subject|6|||
143217288|NCT03526146|516342971|FG000|Overall Study|class canceled due to COVID-19|4|||
143217289|NCT04112303|516342972|FG000|Overall Study|Death|1|||
143217290|NCT03472950|516342973|FG000|Overall Study|Lost to Follow-up|0|||
143217291|NCT03472950|516342974|FG001|Overall Study|Lost to Follow-up|1|||
143217292|NCT03472950|516342973|FG000|Overall Study|Adverse Event|0|||
143217293|NCT03472950|516342974|FG001|Overall Study|Adverse Event|3|||
143217294|NCT01979952|516342981|FG000|Overall Study|Adverse Event|4|||
143217295|NCT01979952|516342982|FG001|Overall Study|Adverse Event|5|||
143217296|NCT01979952|516342981|FG000|Overall Study|Protocol Violation|1|||
143217297|NCT01979952|516342982|FG001|Overall Study|Protocol Violation|0|||
143217298|NCT01979952|516342981|FG000|Overall Study|Withdrawal by Subject|2|||
143217299|NCT01979952|516342982|FG001|Overall Study|Withdrawal by Subject|1|||
143217300|NCT01979952|516342981|FG000|Overall Study|Other than specified above|1|||
143217301|NCT01979952|516342982|FG001|Overall Study|Other than specified above|0|||
143217302|NCT02576795|516342983|FG000|Overall Study|Lost to Follow-up|0|||
143217303|NCT02576795|516342984|FG001|Overall Study|Lost to Follow-up|0|||
143217304|NCT02576795|516342985|FG002|Overall Study|Lost to Follow-up|1|||
143217305|NCT02576795|516342986|FG003|Overall Study|Lost to Follow-up|0|||
143217306|NCT01635855|516342996|FG000|Overall Study|Withdrawal by Subject|4|||
143266730|NCT00595465|516531773|FG002|Overall Study|Protocol Violation|0|||
143266731|NCT00595465|516531771|FG000|Overall Study|Lost to Follow-up|0|||
143266732|NCT00595465|516531772|FG001|Overall Study|Lost to Follow-up|0|||
143266733|NCT00595465|516531773|FG002|Overall Study|Lost to Follow-up|2|||
143266734|NCT00595465|516531771|FG000|Overall Study|administrative reason|0|||
143266735|NCT00595465|516531772|FG001|Overall Study|administrative reason|0|||
143266736|NCT00595465|516531773|FG002|Overall Study|administrative reason|1|||
143266737|NCT02231918|516531774|FG000|Overall Study|Withdrawal by Subject|0|||
143266738|NCT02231918|516531775|FG001|Overall Study|Withdrawal by Subject|1|||
143266739|NCT02231918|516531776|FG002|Overall Study|Withdrawal by Subject|0|||
143266740|NCT02231918|516531774|FG000|Overall Study|Adverse Event|0|||
143266741|NCT02231918|516531775|FG001|Overall Study|Adverse Event|0|||
143266742|NCT02231918|516531776|FG002|Overall Study|Adverse Event|1|||
143266743|NCT00331864|516531784|FG000|Overall Study|Adverse Event|30|||
143266744|NCT00331864|516531785|FG001|Overall Study|Adverse Event|1|||
143266745|NCT00331864|516531784|FG000|Overall Study|Lack of Efficacy|4|||
143371991|NCT01837641|516906376|FG007|Overall Study|Withdrawal by Subject|0|||
143217307|NCT02104947|516342998|FG000|Overall Study|Withdrawal by Subject|10|||
143266746|NCT00331864|516531785|FG001|Overall Study|Lack of Efficacy|0|||
143266747|NCT00331864|516531784|FG000|Overall Study|Protocol Violation|3|||
143217308|NCT02104947|516342999|FG001|Overall Study|Withdrawal by Subject|3|||
143217309|NCT02104947|516342998|FG000|Overall Study|Lost to Follow-up|4|||
143217310|NCT02104947|516342999|FG001|Overall Study|Lost to Follow-up|4|||
143217311|NCT02104947|516342998|FG000|Overall Study|Protocol Violation|6|||
143217312|NCT02104947|516342999|FG001|Overall Study|Protocol Violation|8|||
143217313|NCT02104947|516342998|FG000|Overall Study|Adverse Event|57|||
143217314|NCT02104947|516342999|FG001|Overall Study|Adverse Event|38|||
143217315|NCT02104947|516342998|FG000|Overall Study|Other than stated above|2|||
143217316|NCT02104947|516342999|FG001|Overall Study|Other than stated above|3|||
143217317|NCT01090063|516343006|FG000|Screen|Screen Failed|4|||
143217318|NCT01090063|516343006|FG000|Treatment|Withdrawal by Subject|4|||
143217319|NCT00206440|516343014|FG000|Overall Study|Protocol Violation|1|||
143217320|NCT00206440|516343015|FG001|Overall Study|Protocol Violation|2|||
143266748|NCT00331864|516531785|FG001|Overall Study|Protocol Violation|0|||
143266749|NCT00331864|516531784|FG000|Overall Study|Withdrawal by Subject|10|||
143266750|NCT00331864|516531785|FG001|Overall Study|Withdrawal by Subject|0|||
143266751|NCT00331864|516531784|FG000|Overall Study|Lost to Follow-up|4|||
143266752|NCT00331864|516531785|FG001|Overall Study|Lost to Follow-up|3|||
143371992|NCT01769391|516906377|FG000|Overall Study|Death|10|||
143371993|NCT01769391|516906378|FG001|Overall Study|Death|1|||
143371994|NCT01769391|516906377|FG000|Overall Study|Adverse Event|0|||
143371995|NCT01769391|516906378|FG001|Overall Study|Adverse Event|3|||
143371996|NCT01769391|516906377|FG000|Overall Study|Progressive Disease|1|||
143371997|NCT01769391|516906378|FG001|Overall Study|Progressive Disease|2|||
143371998|NCT01769391|516906377|FG000|Overall Study|Withdrawal by Subject|4|||
143371999|NCT01769391|516906378|FG001|Overall Study|Withdrawal by Subject|3|||
143372000|NCT01769391|516906377|FG000|Overall Study|Investigator Decision|2|||
143372001|NCT01769391|516906378|FG001|Overall Study|Investigator Decision|0|||
143372002|NCT03386929|516906379|FG000|Overall Study|Death|0|||
143372003|NCT03386929|516906380|FG001|Overall Study|Death|0|||
143372004|NCT03386929|516906381|FG002|Overall Study|Death|1|||
143372005|NCT03386929|516906379|FG000|Overall Study|Withdrawal by Subject|0|||
143372006|NCT03386929|516906380|FG001|Overall Study|Withdrawal by Subject|1|||
143372007|NCT03386929|516906381|FG002|Overall Study|Withdrawal by Subject|0|||
143372008|NCT03386929|516906379|FG000|Overall Study|Physician Decision|0|||
143372009|NCT03386929|516906380|FG001|Overall Study|Physician Decision|0|||
143372010|NCT03386929|516906381|FG002|Overall Study|Physician Decision|1|||
143372011|NCT03386929|516906379|FG000|Overall Study|Progression|4|||
143372012|NCT03386929|516906380|FG001|Overall Study|Progression|4|||
143372013|NCT03386929|516906381|FG002|Overall Study|Progression|0|||
143372014|NCT03386929|516906379|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
143372015|NCT03386929|516906380|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
143372016|NCT03386929|516906381|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
143372017|NCT03386929|516906379|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
143372018|NCT03386929|516906380|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
143372019|NCT03386929|516906381|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
143372020|NCT01144182|516906382|FG000|Overall Study|Death|5|||
143372021|NCT01144182|516906383|FG001|Overall Study|Death|6|||
143372022|NCT01144182|516906382|FG000|Overall Study|Withdrawal by Subject|3|||
143372023|NCT01144182|516906383|FG001|Overall Study|Withdrawal by Subject|6|||
143372024|NCT01144182|516906382|FG000|Overall Study|Lost to Follow-up|9|||
143372025|NCT01144182|516906383|FG001|Overall Study|Lost to Follow-up|9|||
143372026|NCT03264456|516906390|FG000|Overall Study|Withdrawal by Subject|3|||
143372027|NCT03264456|516906390|FG000|Overall Study|Lost to Follow-up|1|||
143372028|NCT00208767|516906395|FG000|Overall Study|Adverse Event|9|||
143372029|NCT00208767|516906396|FG001|Overall Study|Adverse Event|1|||
143266753|NCT00331864|516531784|FG000|Overall Study|Administrative Problems|1|||
143266754|NCT00331864|516531785|FG001|Overall Study|Administrative Problems|0|||
143266755|NCT00331864|516531784|FG000|Overall Study|Death|6|||
143266756|NCT00331864|516531785|FG001|Overall Study|Death|0|||
143266757|NCT02395666|516531786|FG000|Overall Study|Physician Decision|3|||
143217321|NCT00206440|516343014|FG000|Overall Study|Adverse Event|4|||
143372030|NCT00208767|516906395|FG000|Overall Study|Withdrawal by Subject|14|||
143372031|NCT00208767|516906396|FG001|Overall Study|Withdrawal by Subject|3|||
143372032|NCT00208767|516906395|FG000|Overall Study|Death|1|||
143372033|NCT00208767|516906396|FG001|Overall Study|Death|0|||
143372034|NCT00208767|516906395|FG000|Overall Study|Lost to Follow-up|3|||
143372035|NCT00208767|516906396|FG001|Overall Study|Lost to Follow-up|3|||
143372036|NCT02317016|516906403|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
143372037|NCT02317016|516906403|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
143217322|NCT00206440|516343015|FG001|Overall Study|Adverse Event|2|||
143266758|NCT02395666|516531787|FG001|Overall Study|Physician Decision|0|||
143266759|NCT02395666|516531786|FG000|Overall Study|Lost to Follow-up|1|||
143266760|NCT02395666|516531787|FG001|Overall Study|Lost to Follow-up|0|||
143266761|NCT02395666|516531786|FG000|Overall Study|Withdrawal by Subject|2|||
143217323|NCT00958165|516343016|FG000|Overall Study|Lost to Follow-up|5|||
143217324|NCT00958165|516343016|FG000|Overall Study|Not eligible|9|||
143217325|NCT01371734|516343017|FG000|Overall Study|Other|2|||
143217326|NCT01371734|516343018|FG001|Overall Study|Other|1|||
143217327|NCT01371734|516343019|FG002|Overall Study|Other|2|||
143217328|NCT01371734|516343017|FG000|Overall Study|Withdrawal by Subject|3|||
143217329|NCT01371734|516343018|FG001|Overall Study|Withdrawal by Subject|4|||
143217330|NCT01371734|516343019|FG002|Overall Study|Withdrawal by Subject|9|||
143217331|NCT01371734|516343017|FG000|Overall Study|Lost to Follow-up|5|||
143217332|NCT01371734|516343018|FG001|Overall Study|Lost to Follow-up|3|||
143217333|NCT01371734|516343019|FG002|Overall Study|Lost to Follow-up|1|||
143217334|NCT01371734|516343017|FG000|Overall Study|Protocol Violation|3|||
143217335|NCT01371734|516343018|FG001|Overall Study|Protocol Violation|1|||
143217336|NCT01371734|516343019|FG002|Overall Study|Protocol Violation|2|||
143217337|NCT01371734|516343017|FG000|Overall Study|Adverse Event|8|||
143217338|NCT01371734|516343018|FG001|Overall Study|Adverse Event|8|||
143217339|NCT01371734|516343019|FG002|Overall Study|Adverse Event|3|||
143217340|NCT01371734|516343017|FG000|Overall Study|Lack of Efficacy|2|||
143217341|NCT01371734|516343018|FG001|Overall Study|Lack of Efficacy|2|||
143217342|NCT01371734|516343019|FG002|Overall Study|Lack of Efficacy|0|||
143217343|NCT01298765|516343020|FG000|Titration Period|Adverse Event|26|||
143217344|NCT01298765|516343020|FG000|Titration Period|Death|1|||
143217345|NCT01298765|516343020|FG000|Titration Period|Lack of Efficacy|21|||
143217346|NCT01298765|516343020|FG000|Titration Period|Lost to Follow-up|9|||
143217347|NCT01298765|516343020|FG000|Titration Period|Physician Decision|1|||
143217348|NCT01298765|516343020|FG000|Titration Period|Withdrawal by Subject|10|||
143217349|NCT01298765|516343020|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
143217350|NCT01298765|516343020|FG000|Long-Term Treatment Period|Adverse Event|19|||
143217351|NCT01298765|516343020|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
143217352|NCT01298765|516343020|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
143217353|NCT01298765|516343020|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
143217354|NCT01298765|516343020|FG000|Long-Term Treatment Period|Physician Decision|1|||
143217355|NCT01298765|516343020|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
143217356|NCT00428389|516343021|FG000|Core Phase|Adverse Event|6|||
143217357|NCT00428389|516343022|FG001|Core Phase|Adverse Event|4|||
143372038|NCT02317016|516906403|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
143372039|NCT02317016|516906403|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
143372040|NCT02317016|516906403|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
143372041|NCT02317016|516906403|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
143372042|NCT02317016|516906403|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
143372043|NCT01123083|516906404|FG000|Overall Study|Investigator recommendation|1|||
143372044|NCT01123083|516906405|FG001|Overall Study|Investigator recommendation|1|||
143372045|NCT01123083|516906404|FG000|Overall Study|Administrative reasons|0|||
143372046|NCT01123083|516906405|FG001|Overall Study|Administrative reasons|4|||
143217358|NCT00428389|516343021|FG000|Core Phase|Lack of Efficacy|2|||
143217359|NCT00428389|516343022|FG001|Core Phase|Lack of Efficacy|0|||
143266762|NCT02395666|516531787|FG001|Overall Study|Withdrawal by Subject|1|||
143266763|NCT02611960|516531788|FG000|Overall Study|Adverse Event|7|||
143266764|NCT02611960|516531789|FG001|Overall Study|Adverse Event|8|||
143266765|NCT02611960|516531788|FG000|Overall Study|Death|98|||
143266766|NCT02611960|516531789|FG001|Overall Study|Death|92|||
143266767|NCT02611960|516531788|FG000|Overall Study|Withdrawal by Subject|1|||
143266768|NCT02611960|516531789|FG001|Overall Study|Withdrawal by Subject|5|||
143266769|NCT02611960|516531788|FG000|Overall Study|Sponsor Decision|11|||
143266770|NCT02611960|516531789|FG001|Overall Study|Sponsor Decision|11|||
143266771|NCT00293215|516531801|FG000|Overall Study|Progressive disease|3|||
143266772|NCT00293215|516531802|FG001|Overall Study|Progressive disease|1|||
143266773|NCT00293215|516531801|FG000|Overall Study|Adverse Event|2|||
143266774|NCT00293215|516531802|FG001|Overall Study|Adverse Event|2|||
143266775|NCT00761579|516531804|FG000|Overall Study|Adverse Event|10|||
143266776|NCT00761579|516531804|FG000|Overall Study|Death|2|||
143266777|NCT00761579|516531804|FG000|Overall Study|Lack of Efficacy|21|||
143217360|NCT00428389|516343021|FG000|Core Phase|Abnormal test procedure result(s)|0|||
143266778|NCT00761579|516531804|FG000|Overall Study|Lost to Follow-up|16|||
143266779|NCT00761579|516531804|FG000|Overall Study|Pregnancy|1|||
143266780|NCT00761579|516531804|FG000|Overall Study|Withdrawal by Subject|34|||
143372047|NCT01123083|516906404|FG000|Overall Study|Lost to Follow-up|2|||
143217361|NCT00428389|516343022|FG001|Core Phase|Abnormal test procedure result(s)|1|||
143217362|NCT00428389|516343021|FG000|Core Phase|Withdrawal by Subject|3|||
143217363|NCT00428389|516343022|FG001|Core Phase|Withdrawal by Subject|4|||
143217364|NCT00428389|516343021|FG000|Core Phase|Protocol deviation|0|||
143266781|NCT00761579|516531804|FG000|Overall Study|Lack of compliance|2|||
143266782|NCT00761579|516531804|FG000|Overall Study|Protocol deviation|1|||
143217365|NCT00428389|516343022|FG001|Core Phase|Protocol deviation|2|||
143217366|NCT00428389|516343021|FG000|Extension Phase|Adverse Event|17|||
143217367|NCT00428389|516343022|FG001|Extension Phase|Adverse Event|11|||
143217368|NCT00428389|516343021|FG000|Extension Phase|Lack of Efficacy|4|||
143266783|NCT00761579|516531804|FG000|Overall Study|Drug overdose|1|||
143372048|NCT01123083|516906405|FG001|Overall Study|Lost to Follow-up|6|||
143372049|NCT01123083|516906404|FG000|Overall Study|Adverse Event|1|||
143372050|NCT01123083|516906405|FG001|Overall Study|Adverse Event|0|||
143372051|NCT01123083|516906404|FG000|Overall Study|Withdrew for another reason not covered|0|||
143372052|NCT01123083|516906405|FG001|Overall Study|Withdrew for another reason not covered|1|||
143372053|NCT01123083|516906404|FG000|Overall Study|Participant/legal representative request|7|||
143217369|NCT00428389|516343022|FG001|Extension Phase|Lack of Efficacy|3|||
143217370|NCT00428389|516343021|FG000|Extension Phase|Withdrawal by Subject|6|||
143217371|NCT00428389|516343022|FG001|Extension Phase|Withdrawal by Subject|6|||
143217372|NCT00428389|516343021|FG000|Extension Phase|Lost to Follow-up|0|||
143217373|NCT00428389|516343022|FG001|Extension Phase|Lost to Follow-up|3|||
143217374|NCT00428389|516343021|FG000|Extension Phase|Death|1|||
143217375|NCT00428389|516343022|FG001|Extension Phase|Death|0|||
143217376|NCT00428389|516343021|FG000|Extension Phase|Protocol Violation|3|||
143217377|NCT00428389|516343022|FG001|Extension Phase|Protocol Violation|2|||
143217378|NCT00428389|516343021|FG000|Extension Phase|Administrative problems|1|||
143217379|NCT00428389|516343022|FG001|Extension Phase|Administrative problems|1|||
143217380|NCT00766051|516343023|FG000|Overall Study|Withdrawal by Subject|2|||
143217381|NCT00766051|516343024|FG001|Overall Study|Withdrawal by Subject|0|||
143217382|NCT02708355|516343025|FG000|Overall Study|Adverse Event|1|||
143217383|NCT02708355|516343026|FG001|Overall Study|Adverse Event|0|||
143217384|NCT02708355|516343027|FG002|Overall Study|Adverse Event|0|||
143217385|NCT04090242|516343028|FG000|Overall Study|Withdrawal by Subject|1|||
143217386|NCT04090242|516343029|FG001|Overall Study|Withdrawal by Subject|0|||
143217387|NCT02513472|516343030|FG000|Overall Study|Radiological Disease Progression|45|||
143217388|NCT02513472|516343031|FG001|Overall Study|Radiological Disease Progression|57|||
143217389|NCT02513472|516343030|FG000|Overall Study|Clinical Disease Progression|5|||
143217390|NCT02513472|516343031|FG001|Overall Study|Clinical Disease Progression|13|||
143217391|NCT02513472|516343030|FG000|Overall Study|Adverse Event|8|||
143217392|NCT02513472|516343031|FG001|Overall Study|Adverse Event|11|||
143217393|NCT02513472|516343030|FG000|Overall Study|Withdrawal by Subject|0|||
143217394|NCT02513472|516343031|FG001|Overall Study|Withdrawal by Subject|4|||
143217395|NCT02513472|516343030|FG000|Overall Study|Subject Choice|2|||
143217396|NCT02513472|516343031|FG001|Overall Study|Subject Choice|7|||
143217397|NCT02513472|516343030|FG000|Overall Study|Treatment Completed as per Protocol|3|||
143217398|NCT02513472|516343031|FG001|Overall Study|Treatment Completed as per Protocol|3|||
143217399|NCT02513472|516343030|FG000|Overall Study|Other|3|||
143217400|NCT02513472|516343031|FG001|Overall Study|Other|6|||
143217401|NCT01019369|516343032|FG000|Overall Study|Lost to Follow-up|10|||
143217402|NCT01019369|516343033|FG001|Overall Study|Lost to Follow-up|6|||
143217403|NCT01019369|516343032|FG000|Overall Study|Withdrawal by Subject|0|||
143217404|NCT01019369|516343033|FG001|Overall Study|Withdrawal by Subject|1|||
143217405|NCT01098305|516343037|FG000|Overall Study|Lost to Follow-up|31|||
143217406|NCT01098305|516343038|FG001|Overall Study|Lost to Follow-up|33|||
143217407|NCT00429169|516343042|FG000|Overall Study|Lost to Follow-up|0|||
143217408|NCT00429169|516343043|FG001|Overall Study|Lost to Follow-up|1|||
143217409|NCT00429169|516343042|FG000|Overall Study|Ineligibility discovered after entry|2|||
143217410|NCT00429169|516343043|FG001|Overall Study|Ineligibility discovered after entry|1|||
143217411|NCT01771250|516343050|FG000|Period 1|Met exclusion criteria|1|||
143217412|NCT01771250|516343051|FG001|Period 1|Met exclusion criteria|0|||
143217413|NCT01180296|516343052|FG000|Overall Study|Protocol Violation|1|||
143217414|NCT01180296|516343053|FG001|Overall Study|Protocol Violation|2|||
143217415|NCT00483938|516343054|FG000|Overall Study|Protocol Violation|0|||
143217416|NCT00483938|516343055|FG001|Overall Study|Protocol Violation|0|||
143217417|NCT00483938|516343056|FG002|Overall Study|Protocol Violation|0|||
143217418|NCT00483938|516343057|FG003|Overall Study|Protocol Violation|0|||
143217419|NCT00483938|516343058|FG004|Overall Study|Protocol Violation|0|||
143217420|NCT00483938|516343059|FG005|Overall Study|Protocol Violation|0|||
143217421|NCT00483938|516343060|FG006|Overall Study|Protocol Violation|3|||
143217422|NCT00483938|516343054|FG000|Overall Study|Withdrawal by Subject|1|||
143217423|NCT00483938|516343055|FG001|Overall Study|Withdrawal by Subject|6|||
143217424|NCT00483938|516343056|FG002|Overall Study|Withdrawal by Subject|0|||
143217425|NCT00483938|516343057|FG003|Overall Study|Withdrawal by Subject|0|||
143217426|NCT00483938|516343058|FG004|Overall Study|Withdrawal by Subject|1|||
143217427|NCT00483938|516343059|FG005|Overall Study|Withdrawal by Subject|3|||
143217428|NCT00483938|516343060|FG006|Overall Study|Withdrawal by Subject|2|||
143217429|NCT00483938|516343054|FG000|Overall Study|Lost to Follow-up|1|||
143217430|NCT00483938|516343055|FG001|Overall Study|Lost to Follow-up|2|||
143217431|NCT00483938|516343056|FG002|Overall Study|Lost to Follow-up|0|||
143217432|NCT00483938|516343057|FG003|Overall Study|Lost to Follow-up|2|||
143217433|NCT00483938|516343058|FG004|Overall Study|Lost to Follow-up|1|||
143217434|NCT00483938|516343059|FG005|Overall Study|Lost to Follow-up|1|||
143372054|NCT01123083|516906405|FG001|Overall Study|Participant/legal representative request|3|||
143372055|NCT00536380|516906406|FG000|Overall Study|Adverse Event|0|||
143217435|NCT00483938|516343060|FG006|Overall Study|Lost to Follow-up|3|||
143217436|NCT00483938|516343054|FG000|Overall Study|Death|0|||
143217437|NCT00483938|516343055|FG001|Overall Study|Death|2|||
143217438|NCT00483938|516343056|FG002|Overall Study|Death|0|||
143217439|NCT00483938|516343057|FG003|Overall Study|Death|0|||
143217440|NCT00483938|516343058|FG004|Overall Study|Death|0|||
143217441|NCT00483938|516343059|FG005|Overall Study|Death|0|||
143217442|NCT00483938|516343060|FG006|Overall Study|Death|0|||
143217443|NCT00483938|516343054|FG000|Overall Study|Other|3|||
143217444|NCT00483938|516343055|FG001|Overall Study|Other|9|||
143217445|NCT00483938|516343056|FG002|Overall Study|Other|0|||
143217446|NCT00483938|516343057|FG003|Overall Study|Other|4|||
143217447|NCT00483938|516343058|FG004|Overall Study|Other|0|||
143217448|NCT00483938|516343059|FG005|Overall Study|Other|4|||
143217449|NCT00483938|516343060|FG006|Overall Study|Other|32|||
143217450|NCT00106353|516343061|FG000|Part 1|Disease progression|3|||
143217451|NCT00106353|516343062|FG001|Part 1|Disease progression|4|||
143217452|NCT00106353|516343063|FG002|Part 1|Disease progression|1|||
143217453|NCT00106353|516343064|FG003|Part 1|Disease progression|3|||
143217454|NCT00106353|516343065|FG004|Part 1|Disease progression|0|||
143266784|NCT00761579|516531804|FG000|Overall Study|Aggravation of depression|1|||
143266785|NCT00761579|516531804|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
143266786|NCT00761579|516531804|FG000|Overall Study|Lost survey form|1|||
143266787|NCT00761579|516531804|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
143217455|NCT00106353|516343066|FG005|Part 1|Disease progression|0|||
143217456|NCT00106353|516343067|FG006|Part 1|Disease progression|0|||
143217457|NCT00106353|516343061|FG000|Part 1|Withdrawal by Subject|0|||
143217458|NCT00106353|516343062|FG001|Part 1|Withdrawal by Subject|0|||
143266788|NCT03611010|516531805|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
143266789|NCT03611010|516531806|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
143266790|NCT03611010|516531807|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
143266791|NCT03611010|516531808|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
143266792|NCT00950911|516531810|FG000|Overall Study|Adverse Event|0|||
143266793|NCT00950911|516531811|FG001|Overall Study|Adverse Event|2|||
143266794|NCT00950911|516531810|FG000|Overall Study|Death|4|||
143266795|NCT00950911|516531811|FG001|Overall Study|Death|6|||
143266796|NCT00950911|516531810|FG000|Overall Study|Disease progression|2|||
143266797|NCT00950911|516531811|FG001|Overall Study|Disease progression|2|||
143266798|NCT00950911|516531810|FG000|Overall Study|Consent withdrawn|1|||
143266799|NCT00950911|516531811|FG001|Overall Study|Consent withdrawn|3|||
143266800|NCT00950911|516531810|FG000|Overall Study|Administrative decision|3|||
143266801|NCT00950911|516531811|FG001|Overall Study|Administrative decision|1|||
143266802|NCT00950911|516531810|FG000|Overall Study|Ineligibility determined|1|||
143266803|NCT00950911|516531811|FG001|Overall Study|Ineligibility determined|0|||
143266804|NCT00950911|516531810|FG000|Overall Study|Noncompliance|1|||
143266805|NCT00950911|516531811|FG001|Overall Study|Noncompliance|0|||
143266806|NCT00950911|516531810|FG000|Overall Study|Poor performance status|0|||
143266807|NCT00950911|516531811|FG001|Overall Study|Poor performance status|1|||
143266808|NCT04587271|516531815|FG000|Overall Study|Lost to Follow-up|2|||
143266809|NCT04587271|516531816|FG001|Overall Study|Lost to Follow-up|2|||
143266810|NCT04587271|516531817|FG002|Overall Study|Lost to Follow-up|0|||
143266811|NCT04587271|516531818|FG003|Overall Study|Lost to Follow-up|2|||
143266812|NCT04587271|516531819|FG004|Overall Study|Lost to Follow-up|2|||
143266813|NCT04587271|516531820|FG005|Overall Study|Lost to Follow-up|0|||
143266814|NCT04587271|516531815|FG000|Overall Study|Caregiver brought child to visits|0|||
143266815|NCT04587271|516531816|FG001|Overall Study|Caregiver brought child to visits|0|||
143266816|NCT04587271|516531817|FG002|Overall Study|Caregiver brought child to visits|0|||
143266817|NCT04587271|516531818|FG003|Overall Study|Caregiver brought child to visits|1|||
143266818|NCT04587271|516531819|FG004|Overall Study|Caregiver brought child to visits|0|||
143266819|NCT04587271|516531820|FG005|Overall Study|Caregiver brought child to visits|0|||
143266820|NCT01031381|516531821|FG000|Overall Study|Physician Decision|3|||
143266821|NCT01031381|516531821|FG000|Overall Study|Withdrawal by Subject|6|||
143266822|NCT00723398|516531822|FG000|Overall Study|Withdrawal by Subject|2|||
143266823|NCT00723398|516531823|FG001|Overall Study|Withdrawal by Subject|6|||
143217459|NCT00106353|516343063|FG002|Part 1|Withdrawal by Subject|1|||
143217460|NCT00106353|516343064|FG003|Part 1|Withdrawal by Subject|2|||
143217461|NCT00106353|516343065|FG004|Part 1|Withdrawal by Subject|0|||
143217462|NCT00106353|516343066|FG005|Part 1|Withdrawal by Subject|0|||
143217463|NCT00106353|516343067|FG006|Part 1|Withdrawal by Subject|0|||
143217464|NCT00106353|516343061|FG000|Part 1|Symptomatic deterioration|0|||
143217465|NCT00106353|516343062|FG001|Part 1|Symptomatic deterioration|0|||
143217466|NCT00106353|516343063|FG002|Part 1|Symptomatic deterioration|1|||
143217467|NCT00106353|516343064|FG003|Part 1|Symptomatic deterioration|0|||
143217468|NCT00106353|516343065|FG004|Part 1|Symptomatic deterioration|0|||
143217469|NCT00106353|516343066|FG005|Part 1|Symptomatic deterioration|0|||
143217470|NCT00106353|516343067|FG006|Part 1|Symptomatic deterioration|0|||
143217471|NCT00106353|516343061|FG000|Part 1|Entered follow-up phase|1|||
143217472|NCT00106353|516343062|FG001|Part 1|Entered follow-up phase|1|||
143217473|NCT00106353|516343063|FG002|Part 1|Entered follow-up phase|0|||
143217474|NCT00106353|516343064|FG003|Part 1|Entered follow-up phase|1|||
143217475|NCT00106353|516343065|FG004|Part 1|Entered follow-up phase|0|||
143217476|NCT00106353|516343066|FG005|Part 1|Entered follow-up phase|0|||
143217477|NCT00106353|516343067|FG006|Part 1|Entered follow-up phase|0|||
143217478|NCT00106353|516343061|FG000|Part 1|Adverse Event|0|||
143217479|NCT00106353|516343062|FG001|Part 1|Adverse Event|0|||
143217480|NCT00106353|516343063|FG002|Part 1|Adverse Event|0|||
143217481|NCT00106353|516343064|FG003|Part 1|Adverse Event|1|||
143217482|NCT00106353|516343065|FG004|Part 1|Adverse Event|0|||
143217483|NCT00106353|516343066|FG005|Part 1|Adverse Event|0|||
143217484|NCT00106353|516343067|FG006|Part 1|Adverse Event|0|||
143217485|NCT00106353|516343061|FG000|Part 2|Disease progression|0|||
143217486|NCT00106353|516343062|FG001|Part 2|Disease progression|0|||
143217487|NCT00106353|516343063|FG002|Part 2|Disease progression|0|||
143217488|NCT00106353|516343064|FG003|Part 2|Disease progression|0|||
143217489|NCT00106353|516343065|FG004|Part 2|Disease progression|8|||
143217490|NCT00106353|516343066|FG005|Part 2|Disease progression|14|||
143217491|NCT00106353|516343067|FG006|Part 2|Disease progression|13|||
143217492|NCT00106353|516343061|FG000|Part 2|Death|0|||
143217493|NCT00106353|516343062|FG001|Part 2|Death|0|||
143217494|NCT00106353|516343063|FG002|Part 2|Death|0|||
143217495|NCT00106353|516343064|FG003|Part 2|Death|0|||
143217496|NCT00106353|516343065|FG004|Part 2|Death|3|||
143217497|NCT00106353|516343066|FG005|Part 2|Death|0|||
143217498|NCT00106353|516343067|FG006|Part 2|Death|1|||
143217499|NCT00106353|516343061|FG000|Part 2|Symptomatic deterioration|0|||
143217500|NCT00106353|516343062|FG001|Part 2|Symptomatic deterioration|0|||
143217501|NCT00106353|516343063|FG002|Part 2|Symptomatic deterioration|0|||
143217502|NCT00106353|516343064|FG003|Part 2|Symptomatic deterioration|0|||
143217503|NCT00106353|516343065|FG004|Part 2|Symptomatic deterioration|3|||
143217504|NCT00106353|516343066|FG005|Part 2|Symptomatic deterioration|0|||
143217505|NCT00106353|516343067|FG006|Part 2|Symptomatic deterioration|0|||
143217506|NCT00106353|516343061|FG000|Part 2|Adverse Event|0|||
143217507|NCT00106353|516343062|FG001|Part 2|Adverse Event|0|||
143217508|NCT00106353|516343063|FG002|Part 2|Adverse Event|0|||
143217509|NCT00106353|516343064|FG003|Part 2|Adverse Event|0|||
143217510|NCT00106353|516343065|FG004|Part 2|Adverse Event|0|||
143217511|NCT00106353|516343066|FG005|Part 2|Adverse Event|2|||
143217512|NCT00106353|516343067|FG006|Part 2|Adverse Event|1|||
143217513|NCT00106353|516343061|FG000|Part 2|Other|0|||
143217514|NCT00106353|516343062|FG001|Part 2|Other|0|||
143217515|NCT00106353|516343063|FG002|Part 2|Other|0|||
143217516|NCT00106353|516343064|FG003|Part 2|Other|0|||
143217517|NCT00106353|516343065|FG004|Part 2|Other|1|||
143217518|NCT00106353|516343066|FG005|Part 2|Other|1|||
143217519|NCT00106353|516343067|FG006|Part 2|Other|1|||
143217520|NCT00106353|516343061|FG000|Part 2|Withdrawal by Subject|0|||
143217521|NCT00106353|516343062|FG001|Part 2|Withdrawal by Subject|0|||
143217522|NCT00106353|516343063|FG002|Part 2|Withdrawal by Subject|0|||
143217523|NCT00106353|516343064|FG003|Part 2|Withdrawal by Subject|0|||
143217524|NCT00106353|516343065|FG004|Part 2|Withdrawal by Subject|1|||
143217525|NCT00106353|516343066|FG005|Part 2|Withdrawal by Subject|0|||
143217526|NCT00106353|516343067|FG006|Part 2|Withdrawal by Subject|0|||
143217527|NCT00106353|516343061|FG000|Part 2|Physician Decision|0|||
143217528|NCT00106353|516343062|FG001|Part 2|Physician Decision|0|||
143217529|NCT00106353|516343063|FG002|Part 2|Physician Decision|0|||
143217530|NCT00106353|516343064|FG003|Part 2|Physician Decision|0|||
143217531|NCT00106353|516343065|FG004|Part 2|Physician Decision|0|||
143217532|NCT00106353|516343066|FG005|Part 2|Physician Decision|1|||
143217533|NCT00106353|516343067|FG006|Part 2|Physician Decision|0|||
143217534|NCT03364309|516343068|FG000|Induction Period|Adverse Event|4|||
143217535|NCT03364309|516343069|FG001|Induction Period|Adverse Event|0|||
143217536|NCT03364309|516343070|FG002|Induction Period|Adverse Event|1|||
143217537|NCT03364309|516343071|FG003|Induction Period|Adverse Event|0|||
143217538|NCT03364309|516343072|FG004|Induction Period|Adverse Event|0|||
143217539|NCT03364309|516343073|FG005|Induction Period|Adverse Event|0|||
143217540|NCT03364309|516343074|FG006|Induction Period|Adverse Event|0|||
143217541|NCT03364309|516343075|FG007|Induction Period|Adverse Event|0|||
143217542|NCT03364309|516343076|FG008|Induction Period|Adverse Event|0|||
143217543|NCT03364309|516343077|FG009|Induction Period|Adverse Event|0|||
143217544|NCT03364309|516343078|FG010|Induction Period|Adverse Event|0|||
143217545|NCT03364309|516343079|FG011|Induction Period|Adverse Event|0|||
143217546|NCT03364309|516343080|FG012|Induction Period|Adverse Event|0|||
143217547|NCT03364309|516343081|FG013|Induction Period|Adverse Event|0|||
143217548|NCT03364309|516343082|FG014|Induction Period|Adverse Event|0|||
143217549|NCT03364309|516343083|FG015|Induction Period|Adverse Event|0|||
143217550|NCT03364309|516343084|FG016|Induction Period|Adverse Event|0|||
143217551|NCT03364309|516343085|FG017|Induction Period|Adverse Event|0|||
143217552|NCT03364309|516343086|FG018|Induction Period|Adverse Event|0|||
143217553|NCT03364309|516343068|FG000|Induction Period|Withdrawal by Subject|1|||
143217554|NCT03364309|516343069|FG001|Induction Period|Withdrawal by Subject|3|||
143217555|NCT03364309|516343070|FG002|Induction Period|Withdrawal by Subject|0|||
143217556|NCT03364309|516343071|FG003|Induction Period|Withdrawal by Subject|0|||
143217557|NCT03364309|516343072|FG004|Induction Period|Withdrawal by Subject|0|||
143217558|NCT03364309|516343073|FG005|Induction Period|Withdrawal by Subject|0|||
143217559|NCT03364309|516343074|FG006|Induction Period|Withdrawal by Subject|0|||
143217560|NCT03364309|516343075|FG007|Induction Period|Withdrawal by Subject|0|||
143217561|NCT03364309|516343076|FG008|Induction Period|Withdrawal by Subject|0|||
143217562|NCT03364309|516343077|FG009|Induction Period|Withdrawal by Subject|0|||
143217563|NCT03364309|516343078|FG010|Induction Period|Withdrawal by Subject|0|||
143217564|NCT03364309|516343079|FG011|Induction Period|Withdrawal by Subject|0|||
143217565|NCT03364309|516343080|FG012|Induction Period|Withdrawal by Subject|0|||
143217566|NCT03364309|516343081|FG013|Induction Period|Withdrawal by Subject|0|||
143217567|NCT03364309|516343082|FG014|Induction Period|Withdrawal by Subject|0|||
143217568|NCT03364309|516343083|FG015|Induction Period|Withdrawal by Subject|0|||
143217569|NCT03364309|516343084|FG016|Induction Period|Withdrawal by Subject|0|||
143217570|NCT03364309|516343085|FG017|Induction Period|Withdrawal by Subject|0|||
143217571|NCT03364309|516343086|FG018|Induction Period|Withdrawal by Subject|0|||
143217572|NCT03364309|516343068|FG000|Induction Period|Lost to Follow-up|1|||
143217573|NCT03364309|516343069|FG001|Induction Period|Lost to Follow-up|0|||
143217574|NCT03364309|516343070|FG002|Induction Period|Lost to Follow-up|0|||
143217575|NCT03364309|516343071|FG003|Induction Period|Lost to Follow-up|0|||
143217576|NCT03364309|516343072|FG004|Induction Period|Lost to Follow-up|0|||
143217577|NCT03364309|516343073|FG005|Induction Period|Lost to Follow-up|0|||
143217578|NCT03364309|516343074|FG006|Induction Period|Lost to Follow-up|0|||
143217579|NCT03364309|516343075|FG007|Induction Period|Lost to Follow-up|0|||
143217580|NCT03364309|516343076|FG008|Induction Period|Lost to Follow-up|0|||
143217581|NCT03364309|516343077|FG009|Induction Period|Lost to Follow-up|0|||
143217582|NCT03364309|516343078|FG010|Induction Period|Lost to Follow-up|0|||
143217583|NCT03364309|516343079|FG011|Induction Period|Lost to Follow-up|0|||
143217584|NCT03364309|516343080|FG012|Induction Period|Lost to Follow-up|0|||
143217585|NCT03364309|516343081|FG013|Induction Period|Lost to Follow-up|0|||
143217586|NCT03364309|516343082|FG014|Induction Period|Lost to Follow-up|0|||
143217587|NCT03364309|516343083|FG015|Induction Period|Lost to Follow-up|0|||
143217588|NCT03364309|516343084|FG016|Induction Period|Lost to Follow-up|0|||
143217589|NCT03364309|516343085|FG017|Induction Period|Lost to Follow-up|0|||
143217590|NCT03364309|516343086|FG018|Induction Period|Lost to Follow-up|0|||
143217591|NCT03364309|516343068|FG000|Induction Period|Physician Decision|0|||
143217592|NCT03364309|516343069|FG001|Induction Period|Physician Decision|1|||
143217593|NCT03364309|516343070|FG002|Induction Period|Physician Decision|0|||
143266824|NCT00723398|516531824|FG002|Overall Study|Withdrawal by Subject|4|||
143266825|NCT00723398|516531825|FG003|Overall Study|Withdrawal by Subject|4|||
143266826|NCT00723398|516531826|FG004|Overall Study|Withdrawal by Subject|4|||
143266827|NCT00723398|516531822|FG000|Overall Study|Protocol Violation|2|||
143266828|NCT00723398|516531823|FG001|Overall Study|Protocol Violation|1|||
143266829|NCT00723398|516531824|FG002|Overall Study|Protocol Violation|5|||
143266830|NCT00723398|516531825|FG003|Overall Study|Protocol Violation|0|||
143266831|NCT00723398|516531826|FG004|Overall Study|Protocol Violation|0|||
143266832|NCT00723398|516531822|FG000|Overall Study|Physician Decision|2|||
143266833|NCT00723398|516531823|FG001|Overall Study|Physician Decision|2|||
143266834|NCT00723398|516531824|FG002|Overall Study|Physician Decision|5|||
143266835|NCT00723398|516531825|FG003|Overall Study|Physician Decision|0|||
143266836|NCT00723398|516531826|FG004|Overall Study|Physician Decision|1|||
143266837|NCT00723398|516531822|FG000|Overall Study|Adverse Event|0|||
143266838|NCT00723398|516531823|FG001|Overall Study|Adverse Event|5|||
143266839|NCT00723398|516531824|FG002|Overall Study|Adverse Event|3|||
143266840|NCT00723398|516531825|FG003|Overall Study|Adverse Event|1|||
143266841|NCT00723398|516531826|FG004|Overall Study|Adverse Event|4|||
143266842|NCT00723398|516531822|FG000|Overall Study|Lost to Follow-up|0|||
143217594|NCT03364309|516343071|FG003|Induction Period|Physician Decision|0|||
143217595|NCT03364309|516343072|FG004|Induction Period|Physician Decision|0|||
143217596|NCT03364309|516343073|FG005|Induction Period|Physician Decision|0|||
143217597|NCT03364309|516343074|FG006|Induction Period|Physician Decision|0|||
143266843|NCT00723398|516531823|FG001|Overall Study|Lost to Follow-up|1|||
143266844|NCT00723398|516531824|FG002|Overall Study|Lost to Follow-up|0|||
143266845|NCT00723398|516531825|FG003|Overall Study|Lost to Follow-up|0|||
143266846|NCT00723398|516531826|FG004|Overall Study|Lost to Follow-up|0|||
143266847|NCT00267189|516531831|FG000|Overall Study|Patient withdrew consent|1|||
143217598|NCT03364309|516343075|FG007|Induction Period|Physician Decision|0|||
143217599|NCT03364309|516343076|FG008|Induction Period|Physician Decision|0|||
143266848|NCT00267189|516531832|FG001|Overall Study|Patient withdrew consent|1|||
143266849|NCT00267189|516531831|FG000|Overall Study|Death|1|||
143217600|NCT03364309|516343077|FG009|Induction Period|Physician Decision|0|||
143217601|NCT03364309|516343078|FG010|Induction Period|Physician Decision|0|||
143217602|NCT03364309|516343079|FG011|Induction Period|Physician Decision|0|||
143217603|NCT03364309|516343080|FG012|Induction Period|Physician Decision|0|||
143217604|NCT03364309|516343081|FG013|Induction Period|Physician Decision|0|||
143217605|NCT03364309|516343082|FG014|Induction Period|Physician Decision|0|||
143217606|NCT03364309|516343083|FG015|Induction Period|Physician Decision|0|||
143217607|NCT03364309|516343084|FG016|Induction Period|Physician Decision|0|||
143217608|NCT03364309|516343085|FG017|Induction Period|Physician Decision|0|||
143217609|NCT03364309|516343086|FG018|Induction Period|Physician Decision|0|||
143217610|NCT03364309|516343068|FG000|Maintenance Period|Withdrawal by Subject|0|||
143217611|NCT03364309|516343069|FG001|Maintenance Period|Withdrawal by Subject|0|||
143217612|NCT03364309|516343070|FG002|Maintenance Period|Withdrawal by Subject|0|||
143217613|NCT03364309|516343071|FG003|Maintenance Period|Withdrawal by Subject|1|||
143217614|NCT03364309|516343072|FG004|Maintenance Period|Withdrawal by Subject|3|||
143217615|NCT03364309|516343073|FG005|Maintenance Period|Withdrawal by Subject|1|||
143217616|NCT03364309|516343074|FG006|Maintenance Period|Withdrawal by Subject|3|||
143217617|NCT03364309|516343075|FG007|Maintenance Period|Withdrawal by Subject|0|||
143217618|NCT03364309|516343076|FG008|Maintenance Period|Withdrawal by Subject|1|||
143217619|NCT03364309|516343077|FG009|Maintenance Period|Withdrawal by Subject|1|||
143217620|NCT03364309|516343078|FG010|Maintenance Period|Withdrawal by Subject|2|||
143217621|NCT03364309|516343079|FG011|Maintenance Period|Withdrawal by Subject|0|||
143217622|NCT03364309|516343080|FG012|Maintenance Period|Withdrawal by Subject|0|||
143217623|NCT03364309|516343081|FG013|Maintenance Period|Withdrawal by Subject|0|||
143217624|NCT03364309|516343082|FG014|Maintenance Period|Withdrawal by Subject|0|||
143217625|NCT03364309|516343083|FG015|Maintenance Period|Withdrawal by Subject|0|||
143266850|NCT00267189|516531832|FG001|Overall Study|Death|0|||
143266851|NCT00267189|516531831|FG000|Overall Study|Missing|3|||
143266852|NCT00267189|516531832|FG001|Overall Study|Missing|0|||
143217626|NCT03364309|516343084|FG016|Maintenance Period|Withdrawal by Subject|0|||
143217627|NCT03364309|516343085|FG017|Maintenance Period|Withdrawal by Subject|0|||
143217628|NCT03364309|516343086|FG018|Maintenance Period|Withdrawal by Subject|0|||
143217629|NCT03364309|516343068|FG000|Maintenance Period|Adverse Event|0|||
143217630|NCT03364309|516343069|FG001|Maintenance Period|Adverse Event|0|||
143217631|NCT03364309|516343070|FG002|Maintenance Period|Adverse Event|0|||
143217632|NCT03364309|516343071|FG003|Maintenance Period|Adverse Event|0|||
143217633|NCT03364309|516343072|FG004|Maintenance Period|Adverse Event|2|||
143217634|NCT03364309|516343073|FG005|Maintenance Period|Adverse Event|0|||
143217635|NCT03364309|516343074|FG006|Maintenance Period|Adverse Event|3|||
143217636|NCT03364309|516343075|FG007|Maintenance Period|Adverse Event|0|||
143217637|NCT03364309|516343076|FG008|Maintenance Period|Adverse Event|1|||
143217638|NCT03364309|516343077|FG009|Maintenance Period|Adverse Event|0|||
143217639|NCT03364309|516343078|FG010|Maintenance Period|Adverse Event|2|||
143217640|NCT03364309|516343079|FG011|Maintenance Period|Adverse Event|0|||
143217641|NCT03364309|516343080|FG012|Maintenance Period|Adverse Event|0|||
143217642|NCT03364309|516343081|FG013|Maintenance Period|Adverse Event|0|||
143217643|NCT03364309|516343082|FG014|Maintenance Period|Adverse Event|0|||
143217644|NCT03364309|516343083|FG015|Maintenance Period|Adverse Event|0|||
143217645|NCT03364309|516343084|FG016|Maintenance Period|Adverse Event|0|||
143217646|NCT03364309|516343085|FG017|Maintenance Period|Adverse Event|0|||
143217647|NCT03364309|516343086|FG018|Maintenance Period|Adverse Event|0|||
143217648|NCT03364309|516343068|FG000|Maintenance Period|Relapsed|0|||
143217649|NCT03364309|516343069|FG001|Maintenance Period|Relapsed|0|||
143217650|NCT03364309|516343070|FG002|Maintenance Period|Relapsed|0|||
143217651|NCT03364309|516343071|FG003|Maintenance Period|Relapsed|43|||
143217652|NCT03364309|516343072|FG004|Maintenance Period|Relapsed|7|||
143217653|NCT03364309|516343073|FG005|Maintenance Period|Relapsed|45|||
143217654|NCT03364309|516343074|FG006|Maintenance Period|Relapsed|10|||
143266853|NCT04137224|516531834|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
143266854|NCT04137224|516531835|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
143266855|NCT04137224|516531834|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
143266856|NCT04137224|516531835|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
143266857|NCT04137224|516531834|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
143217655|NCT03364309|516343075|FG007|Maintenance Period|Relapsed|2|||
143266858|NCT04137224|516531835|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
143266859|NCT00566501|516531836|FG000|Overall Study|Adverse Event|68|||
143266860|NCT00566501|516531837|FG001|Overall Study|Adverse Event|59|||
143266861|NCT00566501|516531836|FG000|Overall Study|Medication Non-compliance|5|||
143266862|NCT00566501|516531837|FG001|Overall Study|Medication Non-compliance|0|||
143266863|NCT00566501|516531836|FG000|Overall Study|Protocol Violation|2|||
143372056|NCT00536380|516906407|FG001|Overall Study|Adverse Event|2|||
143217656|NCT03364309|516343076|FG008|Maintenance Period|Relapsed|0|||
143217657|NCT03364309|516343077|FG009|Maintenance Period|Relapsed|0|||
143217658|NCT03364309|516343078|FG010|Maintenance Period|Relapsed|0|||
143217659|NCT03364309|516343079|FG011|Maintenance Period|Relapsed|0|||
143217660|NCT03364309|516343080|FG012|Maintenance Period|Relapsed|0|||
143217661|NCT03364309|516343081|FG013|Maintenance Period|Relapsed|0|||
143372057|NCT00536380|516906408|FG002|Overall Study|Adverse Event|2|||
143372058|NCT00536380|516906406|FG000|Overall Study|Lost to Follow-up|0|||
143372059|NCT00536380|516906407|FG001|Overall Study|Lost to Follow-up|0|||
143372060|NCT00536380|516906408|FG002|Overall Study|Lost to Follow-up|1|||
143372061|NCT00536380|516906406|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
143372062|NCT00536380|516906407|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
143372063|NCT00536380|516906408|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
143372064|NCT00536380|516906406|FG000|Overall Study|Withdrawal related to study drug|7|||
143217662|NCT03364309|516343082|FG014|Maintenance Period|Relapsed|0|||
143217663|NCT03364309|516343083|FG015|Maintenance Period|Relapsed|0|||
143217664|NCT03364309|516343084|FG016|Maintenance Period|Relapsed|0|||
143217665|NCT03364309|516343085|FG017|Maintenance Period|Relapsed|0|||
143217666|NCT03364309|516343086|FG018|Maintenance Period|Relapsed|0|||
143217667|NCT03364309|516343068|FG000|Maintenance Period|Lack of Efficacy|0|||
143217668|NCT03364309|516343069|FG001|Maintenance Period|Lack of Efficacy|0|||
143217669|NCT03364309|516343070|FG002|Maintenance Period|Lack of Efficacy|0|||
143217670|NCT03364309|516343071|FG003|Maintenance Period|Lack of Efficacy|0|||
143217671|NCT03364309|516343072|FG004|Maintenance Period|Lack of Efficacy|0|||
143217672|NCT03364309|516343073|FG005|Maintenance Period|Lack of Efficacy|0|||
143217673|NCT03364309|516343074|FG006|Maintenance Period|Lack of Efficacy|0|||
143217674|NCT03364309|516343075|FG007|Maintenance Period|Lack of Efficacy|0|||
143217675|NCT03364309|516343076|FG008|Maintenance Period|Lack of Efficacy|1|||
143217676|NCT03364309|516343077|FG009|Maintenance Period|Lack of Efficacy|3|||
143217677|NCT03364309|516343078|FG010|Maintenance Period|Lack of Efficacy|2|||
143217678|NCT03364309|516343079|FG011|Maintenance Period|Lack of Efficacy|0|||
143217679|NCT03364309|516343080|FG012|Maintenance Period|Lack of Efficacy|0|||
143217680|NCT03364309|516343081|FG013|Maintenance Period|Lack of Efficacy|0|||
143217681|NCT03364309|516343082|FG014|Maintenance Period|Lack of Efficacy|0|||
143217682|NCT03364309|516343083|FG015|Maintenance Period|Lack of Efficacy|0|||
143217683|NCT03364309|516343084|FG016|Maintenance Period|Lack of Efficacy|0|||
143217684|NCT03364309|516343085|FG017|Maintenance Period|Lack of Efficacy|0|||
143217685|NCT03364309|516343086|FG018|Maintenance Period|Lack of Efficacy|0|||
143217686|NCT03364309|516343068|FG000|Maintenance Period|Death|0|||
143217687|NCT03364309|516343069|FG001|Maintenance Period|Death|0|||
143217688|NCT03364309|516343070|FG002|Maintenance Period|Death|0|||
143217689|NCT03364309|516343071|FG003|Maintenance Period|Death|0|||
143217690|NCT03364309|516343072|FG004|Maintenance Period|Death|0|||
143217691|NCT03364309|516343073|FG005|Maintenance Period|Death|0|||
143217692|NCT03364309|516343074|FG006|Maintenance Period|Death|0|||
143217693|NCT03364309|516343075|FG007|Maintenance Period|Death|0|||
143217694|NCT03364309|516343076|FG008|Maintenance Period|Death|1|||
143217695|NCT03364309|516343077|FG009|Maintenance Period|Death|0|||
143217696|NCT03364309|516343078|FG010|Maintenance Period|Death|0|||
143217697|NCT03364309|516343079|FG011|Maintenance Period|Death|0|||
143217698|NCT03364309|516343080|FG012|Maintenance Period|Death|0|||
143217699|NCT03364309|516343081|FG013|Maintenance Period|Death|0|||
143217700|NCT03364309|516343082|FG014|Maintenance Period|Death|0|||
143217701|NCT03364309|516343083|FG015|Maintenance Period|Death|0|||
143217702|NCT03364309|516343084|FG016|Maintenance Period|Death|0|||
143217703|NCT03364309|516343085|FG017|Maintenance Period|Death|0|||
143217704|NCT03364309|516343086|FG018|Maintenance Period|Death|0|||
143217705|NCT03364309|516343068|FG000|Maintenance Period|Lost to Follow-up|0|||
143266864|NCT00566501|516531837|FG001|Overall Study|Protocol Violation|2|||
143266865|NCT00566501|516531836|FG000|Overall Study|Request of Investigator or Sponsor|6|||
143266866|NCT00566501|516531837|FG001|Overall Study|Request of Investigator or Sponsor|7|||
143266867|NCT00566501|516531836|FG000|Overall Study|Withdrawal by Subject|33|||
143266868|NCT00566501|516531837|FG001|Overall Study|Withdrawal by Subject|30|||
143266869|NCT00566501|516531836|FG000|Overall Study|Lack of Efficacy|8|||
143266870|NCT00566501|516531837|FG001|Overall Study|Lack of Efficacy|3|||
143266871|NCT00566501|516531836|FG000|Overall Study|Other|25|||
143372065|NCT00536380|516906407|FG001|Overall Study|Withdrawal related to study drug|5|||
143372066|NCT00536380|516906408|FG002|Overall Study|Withdrawal related to study drug|2|||
143372067|NCT00536380|516906406|FG000|Overall Study|Noncompliance with protocol|3|||
143217706|NCT03364309|516343069|FG001|Maintenance Period|Lost to Follow-up|0|||
143266872|NCT00566501|516531837|FG001|Overall Study|Other|21|||
143266873|NCT00925990|516531838|FG000|Overall Study|Adverse Event|1|||
143266874|NCT00925990|516531839|FG001|Overall Study|Adverse Event|3|||
143266875|NCT00925990|516531838|FG000|Overall Study|Withdrawal by Subject|2|||
143372068|NCT00536380|516906407|FG001|Overall Study|Noncompliance with protocol|2|||
143217707|NCT03364309|516343070|FG002|Maintenance Period|Lost to Follow-up|0|||
143217708|NCT03364309|516343071|FG003|Maintenance Period|Lost to Follow-up|0|||
143217709|NCT03364309|516343072|FG004|Maintenance Period|Lost to Follow-up|0|||
143217710|NCT03364309|516343073|FG005|Maintenance Period|Lost to Follow-up|0|||
143217711|NCT03364309|516343074|FG006|Maintenance Period|Lost to Follow-up|0|||
143217712|NCT03364309|516343075|FG007|Maintenance Period|Lost to Follow-up|0|||
143217713|NCT03364309|516343076|FG008|Maintenance Period|Lost to Follow-up|1|||
143217714|NCT03364309|516343077|FG009|Maintenance Period|Lost to Follow-up|0|||
143217715|NCT03364309|516343078|FG010|Maintenance Period|Lost to Follow-up|0|||
143217716|NCT03364309|516343079|FG011|Maintenance Period|Lost to Follow-up|0|||
143217717|NCT03364309|516343080|FG012|Maintenance Period|Lost to Follow-up|0|||
143217718|NCT03364309|516343081|FG013|Maintenance Period|Lost to Follow-up|0|||
143217719|NCT03364309|516343082|FG014|Maintenance Period|Lost to Follow-up|0|||
143217720|NCT03364309|516343083|FG015|Maintenance Period|Lost to Follow-up|0|||
143217721|NCT03364309|516343084|FG016|Maintenance Period|Lost to Follow-up|0|||
143372069|NCT00536380|516906408|FG002|Overall Study|Noncompliance with protocol|2|||
143372070|NCT00536380|516906406|FG000|Overall Study|Did not meet protocol eligibility|0|||
143372071|NCT00536380|516906407|FG001|Overall Study|Did not meet protocol eligibility|0|||
143372072|NCT00536380|516906408|FG002|Overall Study|Did not meet protocol eligibility|1|||
143372073|NCT00536380|516906406|FG000|Overall Study|Administrative|0|||
143372074|NCT00536380|516906407|FG001|Overall Study|Administrative|0|||
143372075|NCT00536380|516906408|FG002|Overall Study|Administrative|1|||
143372076|NCT00387465|516906409|FG000|Overall Study|Withdrawal by Subject|0|||
143372077|NCT00387465|516906410|FG001|Overall Study|Withdrawal by Subject|1|||
143372078|NCT00387465|516906411|FG002|Overall Study|Withdrawal by Subject|0|||
143372079|NCT03545984|516906412|FG000|Overall Study|CSF cases not present during rotation|11|||
143372080|NCT03545984|516906413|FG001|Overall Study|CSF cases not present during rotation|9|||
143372081|NCT03418324|516906414|FG000|Overall Study|Death|0|||
143372082|NCT03418324|516906415|FG001|Overall Study|Death|1|||
143372083|NCT03418324|516906414|FG000|Overall Study|Physician Decision|1|||
143372084|NCT03418324|516906415|FG001|Overall Study|Physician Decision|1|||
143372085|NCT01196429|516906419|FG000|Overall Study|Ineligible - inadequate pathology|1|||
143372086|NCT01196429|516906420|FG001|Overall Study|Ineligible - inadequate pathology|0|||
143217722|NCT03364309|516343085|FG017|Maintenance Period|Lost to Follow-up|0|||
143217723|NCT03364309|516343086|FG018|Maintenance Period|Lost to Follow-up|0|||
143372087|NCT01196429|516906419|FG000|Overall Study|Ineligible - wrong cell type|1|||
143217724|NCT03364309|516343068|FG000|Maintenance Period|Miscellaneous|0|||
143217725|NCT03364309|516343069|FG001|Maintenance Period|Miscellaneous|0|||
143217726|NCT03364309|516343070|FG002|Maintenance Period|Miscellaneous|0|||
143217727|NCT03364309|516343071|FG003|Maintenance Period|Miscellaneous|0|||
143217728|NCT03364309|516343072|FG004|Maintenance Period|Miscellaneous|0|||
143217729|NCT03364309|516343073|FG005|Maintenance Period|Miscellaneous|0|||
143217730|NCT03364309|516343074|FG006|Maintenance Period|Miscellaneous|0|||
143217731|NCT03364309|516343075|FG007|Maintenance Period|Miscellaneous|0|||
143217732|NCT03364309|516343076|FG008|Maintenance Period|Miscellaneous|1|||
143217733|NCT03364309|516343077|FG009|Maintenance Period|Miscellaneous|0|||
143217734|NCT03364309|516343078|FG010|Maintenance Period|Miscellaneous|0|||
143217735|NCT03364309|516343079|FG011|Maintenance Period|Miscellaneous|0|||
143217736|NCT03364309|516343080|FG012|Maintenance Period|Miscellaneous|0|||
143217737|NCT03364309|516343081|FG013|Maintenance Period|Miscellaneous|0|||
143217738|NCT03364309|516343082|FG014|Maintenance Period|Miscellaneous|0|||
143217739|NCT03364309|516343083|FG015|Maintenance Period|Miscellaneous|0|||
143217740|NCT03364309|516343084|FG016|Maintenance Period|Miscellaneous|0|||
143217741|NCT03364309|516343085|FG017|Maintenance Period|Miscellaneous|0|||
143217742|NCT03364309|516343086|FG018|Maintenance Period|Miscellaneous|0|||
143217743|NCT03364309|516343068|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
143217744|NCT03364309|516343069|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
143217745|NCT03364309|516343070|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
143217746|NCT03364309|516343071|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
143217747|NCT03364309|516343072|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
143217748|NCT03364309|516343073|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
143217749|NCT03364309|516343074|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
143217750|NCT03364309|516343075|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
143217751|NCT03364309|516343076|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
143217752|NCT03364309|516343077|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
143217753|NCT03364309|516343078|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
143217754|NCT03364309|516343079|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
143372088|NCT01196429|516906420|FG001|Overall Study|Ineligible - wrong cell type|0|||
143372089|NCT01196429|516906419|FG000|Overall Study|Refused - Never Treated|1|||
143372090|NCT01196429|516906420|FG001|Overall Study|Refused - Never Treated|0|||
143372091|NCT02486588|516906423|FG000|Overall Study|Randomized in error- ineligible|738|||
143372092|NCT02486588|516906424|FG001|Overall Study|Randomized in error- ineligible|750|||
143217755|NCT03364309|516343080|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
143217756|NCT03364309|516343081|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
143217757|NCT03364309|516343082|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
143217758|NCT03364309|516343083|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
143217759|NCT03364309|516343084|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
143372093|NCT02486588|516906425|FG002|Overall Study|Randomized in error- ineligible|755|||
143372094|NCT02486588|516906426|FG003|Overall Study|Randomized in error- ineligible|738|||
143217760|NCT03364309|516343085|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
143217761|NCT03364309|516343086|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
143217762|NCT03364309|516343068|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
143217763|NCT03364309|516343069|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
143217764|NCT03364309|516343070|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
143217765|NCT03364309|516343071|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
143217766|NCT03364309|516343072|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
143217767|NCT03364309|516343073|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
143217768|NCT03364309|516343074|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
143217769|NCT03364309|516343075|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
143217770|NCT03364309|516343076|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
143217771|NCT03364309|516343077|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
143217772|NCT03364309|516343078|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
143217773|NCT03364309|516343079|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
143217774|NCT03364309|516343080|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
143217775|NCT03364309|516343081|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
143217776|NCT03364309|516343082|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
143217777|NCT03364309|516343083|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
143217778|NCT03364309|516343084|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
143217779|NCT03364309|516343085|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
143217780|NCT03364309|516343086|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
143217781|NCT03364309|516343068|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
143217782|NCT03364309|516343069|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
143217783|NCT03364309|516343070|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
143217784|NCT03364309|516343071|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
143217785|NCT03364309|516343072|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
143217786|NCT03364309|516343073|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
143217787|NCT03364309|516343074|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
143217788|NCT03364309|516343075|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
143217789|NCT03364309|516343076|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
143217790|NCT03364309|516343077|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
143217791|NCT03364309|516343078|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
143217792|NCT03364309|516343079|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
143217793|NCT03364309|516343080|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
143217794|NCT03364309|516343081|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
143217795|NCT03364309|516343082|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
143217796|NCT03364309|516343083|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
143217797|NCT03364309|516343084|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
143217798|NCT03364309|516343085|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
143217799|NCT03364309|516343086|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
143217800|NCT03364309|516343068|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
143217801|NCT03364309|516343069|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
143217802|NCT03364309|516343070|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
143217803|NCT03364309|516343071|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
143217804|NCT03364309|516343072|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
143217805|NCT03364309|516343073|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
143217806|NCT03364309|516343074|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
143217807|NCT03364309|516343075|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
143217808|NCT03364309|516343076|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
143217809|NCT03364309|516343077|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
143217810|NCT03364309|516343078|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
143217811|NCT03364309|516343079|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
143217812|NCT03364309|516343080|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
143217813|NCT03364309|516343081|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
143217814|NCT03364309|516343082|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
143217815|NCT03364309|516343083|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
143217816|NCT03364309|516343084|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
143217817|NCT03364309|516343085|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
143217818|NCT03364309|516343086|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
143217819|NCT03364309|516343068|FG000|Post-Treatment Followup Period|Adverse Event|0|||
143217820|NCT03364309|516343069|FG001|Post-Treatment Followup Period|Adverse Event|0|||
143217821|NCT03364309|516343070|FG002|Post-Treatment Followup Period|Adverse Event|0|||
143217822|NCT03364309|516343071|FG003|Post-Treatment Followup Period|Adverse Event|0|||
143217823|NCT03364309|516343072|FG004|Post-Treatment Followup Period|Adverse Event|0|||
143217824|NCT03364309|516343073|FG005|Post-Treatment Followup Period|Adverse Event|0|||
143217825|NCT03364309|516343074|FG006|Post-Treatment Followup Period|Adverse Event|0|||
143217826|NCT03364309|516343075|FG007|Post-Treatment Followup Period|Adverse Event|0|||
143217827|NCT03364309|516343076|FG008|Post-Treatment Followup Period|Adverse Event|0|||
143217828|NCT03364309|516343077|FG009|Post-Treatment Followup Period|Adverse Event|0|||
143217829|NCT03364309|516343078|FG010|Post-Treatment Followup Period|Adverse Event|0|||
143217830|NCT03364309|516343079|FG011|Post-Treatment Followup Period|Adverse Event|0|||
143217831|NCT03364309|516343080|FG012|Post-Treatment Followup Period|Adverse Event|0|||
143217832|NCT03364309|516343081|FG013|Post-Treatment Followup Period|Adverse Event|0|||
143217833|NCT03364309|516343082|FG014|Post-Treatment Followup Period|Adverse Event|0|||
143217834|NCT03364309|516343083|FG015|Post-Treatment Followup Period|Adverse Event|0|||
143217835|NCT03364309|516343084|FG016|Post-Treatment Followup Period|Adverse Event|2|||
143217836|NCT03364309|516343085|FG017|Post-Treatment Followup Period|Adverse Event|6|||
143217837|NCT03364309|516343086|FG018|Post-Treatment Followup Period|Adverse Event|1|||
143217838|NCT03364309|516343068|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
143217839|NCT03364309|516343069|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
143217840|NCT03364309|516343070|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
143217841|NCT03364309|516343071|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
143217842|NCT03364309|516343072|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
143217843|NCT03364309|516343073|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
143217844|NCT03364309|516343074|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
143217845|NCT03364309|516343075|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
143217846|NCT03364309|516343076|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
143217847|NCT03364309|516343077|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
143217848|NCT03364309|516343078|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
143217849|NCT03364309|516343079|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
143217850|NCT03364309|516343080|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
143217851|NCT03364309|516343081|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
143217852|NCT03364309|516343082|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
143217853|NCT03364309|516343083|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
143217854|NCT03364309|516343084|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
143217855|NCT03364309|516343085|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
143217856|NCT03364309|516343086|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
143217857|NCT03364309|516343068|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
143217858|NCT03364309|516343069|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
143217859|NCT03364309|516343070|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
143217860|NCT03364309|516343071|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
143217861|NCT03364309|516343072|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
143217862|NCT03364309|516343073|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
143217863|NCT03364309|516343074|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
143217864|NCT03364309|516343075|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
143217865|NCT03364309|516343076|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
143217866|NCT03364309|516343077|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
143217867|NCT03364309|516343078|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
143217868|NCT03364309|516343079|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
143217869|NCT03364309|516343080|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
143217870|NCT03364309|516343081|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
143217871|NCT03364309|516343082|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
143217872|NCT03364309|516343083|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
143217873|NCT03364309|516343084|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
143217874|NCT03364309|516343085|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
143217875|NCT03364309|516343086|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
143217876|NCT01371552|516343087|FG000|Part 1, First 3 Days|Inconvenience|0|||
143217877|NCT01371552|516343088|FG001|Part 1, First 3 Days|Inconvenience|0|||
143217878|NCT01371552|516343089|FG002|Part 1, First 3 Days|Inconvenience|1|||
143217879|NCT01371552|516343090|FG003|Part 1, First 3 Days|Inconvenience|0|||
143217880|NCT01371552|516343091|FG004|Part 1, First 3 Days|Inconvenience|0|||
143217881|NCT01371552|516343092|FG005|Part 1, First 3 Days|Inconvenience|0|||
143217882|NCT02328027|516343093|FG000|Overall Study|Withdrawal by Subject|0|||
143217883|NCT02328027|516343094|FG001|Overall Study|Withdrawal by Subject|1|||
143217884|NCT02508428|516343095|FG000|Overall Study|Death|32|||
143217885|NCT02508428|516343096|FG001|Overall Study|Death|33|||
143217886|NCT02508428|516343095|FG000|Overall Study|Liner revised|3|||
143217887|NCT02508428|516343096|FG001|Overall Study|Liner revised|19|||
143217888|NCT02508428|516343095|FG000|Overall Study|Incomplete follow-up|17|||
143217889|NCT02508428|516343096|FG001|Overall Study|Incomplete follow-up|15|||
143217890|NCT04371666|516343097|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
143217891|NCT04371666|516343098|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
143217892|NCT04371666|516343097|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
143217893|NCT04371666|516343098|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
143217894|NCT04371666|516343097|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
143217895|NCT04371666|516343098|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
143217896|NCT04371666|516343097|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
143217897|NCT04371666|516343098|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
143217898|NCT04371666|516343097|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
143217899|NCT04371666|516343098|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
143217900|NCT04371666|516343097|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
143217901|NCT04371666|516343098|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
143217902|NCT00534976|516343105|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
143217903|NCT00534976|516343106|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
143217904|NCT00534976|516343105|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
143217905|NCT00534976|516343106|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
143217906|NCT00534976|516343105|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
143217907|NCT00534976|516343106|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
143217908|NCT00861471|516343107|FG000|Overall Study|Withdrawal by Subject|1|||
143217909|NCT00861471|516343107|FG000|Overall Study|Adverse Event|2|||
143217910|NCT00861471|516343107|FG000|Overall Study|Lack of Efficacy|3|||
143217911|NCT00861471|516343107|FG000|Overall Study|treatment for lumbar laminectomy|1|||
143217912|NCT00861471|516343107|FG000|Overall Study|Physician Decision|2|||
143217913|NCT02092025|516343108|FG000|Overall Study|Case Report Forms Uncollected|44|||
143217914|NCT02092025|516343108|FG000|Overall Study|Protocol Deviation|24|||
143217915|NCT00264537|516343109|FG000|Overall Study|Death|0|||
143217916|NCT00264537|516343110|FG001|Overall Study|Death|3|||
143217917|NCT00264537|516343111|FG002|Overall Study|Death|3|||
143217918|NCT00264537|516343112|FG003|Overall Study|Death|2|||
143217919|NCT00264537|516343109|FG000|Overall Study|Lost to Follow-up|3|||
143217920|NCT00264537|516343110|FG001|Overall Study|Lost to Follow-up|4|||
143217921|NCT00264537|516343111|FG002|Overall Study|Lost to Follow-up|7|||
143217922|NCT00264537|516343112|FG003|Overall Study|Lost to Follow-up|6|||
143217923|NCT00264537|516343109|FG000|Overall Study|Adverse Event|21|||
143217924|NCT00264537|516343110|FG001|Overall Study|Adverse Event|32|||
143217925|NCT00264537|516343111|FG002|Overall Study|Adverse Event|24|||
143217926|NCT00264537|516343112|FG003|Overall Study|Adverse Event|34|||
143217927|NCT00264537|516343109|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
143217928|NCT00264537|516343110|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
143217929|NCT00264537|516343111|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
143217930|NCT00264537|516343112|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
143217931|NCT00264537|516343109|FG000|Overall Study|Other|21|||
143217932|NCT00264537|516343110|FG001|Overall Study|Other|11|||
143217933|NCT00264537|516343111|FG002|Overall Study|Other|10|||
143217934|NCT00264537|516343112|FG003|Overall Study|Other|11|||
143217935|NCT00264537|516343109|FG000|Overall Study|Not treated|0|||
143217936|NCT00264537|516343110|FG001|Overall Study|Not treated|2|||
143217937|NCT00264537|516343111|FG002|Overall Study|Not treated|1|||
143217938|NCT00264537|516343112|FG003|Overall Study|Not treated|0|||
143217939|NCT02123576|516343113|FG000|Overall Study|Adverse Event|1|||
143217940|NCT02123576|516343114|FG001|Overall Study|Adverse Event|0|||
143217941|NCT00934128|516343115|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
143217942|NCT00934128|516343116|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
143217943|NCT00934128|516343115|FG000|First Intervention (2 Hours)|Adverse Event|4|||
143217944|NCT00934128|516343116|FG001|First Intervention (2 Hours)|Adverse Event|1|||
143217945|NCT00934128|516343115|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
143217946|NCT00934128|516343116|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
143217947|NCT00934128|516343115|FG000|Washout Period (1 Hour)|Patient preference|1|||
143217948|NCT00934128|516343116|FG001|Washout Period (1 Hour)|Patient preference|3|||
143217949|NCT00934128|516343115|FG000|Washout Period (1 Hour)|Pain|1|||
143217950|NCT00934128|516343116|FG001|Washout Period (1 Hour)|Pain|0|||
143217951|NCT00934128|516343115|FG000|Washout Period (1 Hour)|Too tired|1|||
143217952|NCT00934128|516343116|FG001|Washout Period (1 Hour)|Too tired|0|||
143217953|NCT00934128|516343115|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
143217954|NCT00934128|516343116|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
143217955|NCT00934128|516343115|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
143217956|NCT00934128|516343116|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
143217957|NCT02834247|516343117|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
143217958|NCT02834247|516343118|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
143217959|NCT02834247|516343119|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
143217960|NCT02834247|516343120|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
143217961|NCT02834247|516343117|FG000|Dose Escalation Phase|Death|5|||
143217962|NCT02834247|516343118|FG001|Dose Escalation Phase|Death|6|||
143217963|NCT02834247|516343119|FG002|Dose Escalation Phase|Death|5|||
143217964|NCT02834247|516343120|FG003|Dose Escalation Phase|Death|0|||
143217965|NCT02834247|516343117|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
143217966|NCT02834247|516343118|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
143217967|NCT02834247|516343119|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
143217968|NCT02834247|516343120|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
143217969|NCT02834247|516343117|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
143217970|NCT02834247|516343118|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
143217971|NCT02834247|516343119|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
143217972|NCT02834247|516343120|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
143217973|NCT02834247|516343117|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
143266876|NCT00925990|516531839|FG001|Overall Study|Withdrawal by Subject|2|||
143266877|NCT00925990|516531838|FG000|Overall Study|Lost to Follow-up|1|||
143266878|NCT00925990|516531839|FG001|Overall Study|Lost to Follow-up|3|||
143266879|NCT00925990|516531838|FG000|Overall Study|Physician Decision|1|||
143266880|NCT00925990|516531839|FG001|Overall Study|Physician Decision|1|||
143266881|NCT00925990|516531838|FG000|Overall Study|moved out of state, missed medication|0|||
143266882|NCT00925990|516531839|FG001|Overall Study|moved out of state, missed medication|2|||
143266883|NCT01368432|516531840|FG000|Overall Study|Lost to Follow-up|0|||
143266884|NCT01368432|516531841|FG001|Overall Study|Lost to Follow-up|1|||
143266885|NCT02310321|516531854|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
143266886|NCT02310321|516531855|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
143266887|NCT02310321|516531856|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
143217974|NCT02834247|516343118|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
143217975|NCT02834247|516343119|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
143217976|NCT02834247|516343120|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
143217977|NCT02834247|516343117|FG000|Dose Expansion Phase|Death|0|||
143217978|NCT02834247|516343118|FG001|Dose Expansion Phase|Death|0|||
143217979|NCT02834247|516343119|FG002|Dose Expansion Phase|Death|0|||
143217980|NCT02834247|516343120|FG003|Dose Expansion Phase|Death|8|||
143217981|NCT02834247|516343117|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
143217982|NCT02834247|516343118|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
143217983|NCT02834247|516343119|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
143217984|NCT02834247|516343120|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
143217985|NCT02834247|516343117|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
143217986|NCT02834247|516343118|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
143217987|NCT02834247|516343119|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
143217988|NCT02834247|516343120|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
143217989|NCT01807299|516343121|FG000|Overall Study|Protocol Violation|3|||
143217990|NCT01807299|516343122|FG001|Overall Study|Protocol Violation|1|||
143217991|NCT01807299|516343123|FG002|Overall Study|Protocol Violation|0|||
143217992|NCT01807299|516343124|FG003|Overall Study|Protocol Violation|2|||
143217993|NCT00615017|516345012|FG000|Overall Study|Adverse Event|0|||
143217994|NCT00615017|516345013|FG001|Overall Study|Adverse Event|1|||
143217995|NCT00615017|516345014|FG002|Overall Study|Adverse Event|2|||
143217996|NCT00615017|516345015|FG003|Overall Study|Adverse Event|0|||
143217997|NCT00615017|516345016|FG004|Overall Study|Adverse Event|0|||
143217998|NCT00615017|516345017|FG005|Overall Study|Adverse Event|1|||
143217999|NCT00615017|516345012|FG000|Overall Study|Death|0|||
143218000|NCT00615017|516345013|FG001|Overall Study|Death|0|||
143218001|NCT00615017|516345014|FG002|Overall Study|Death|2|||
143218002|NCT00615017|516345015|FG003|Overall Study|Death|0|||
143218003|NCT00615017|516345016|FG004|Overall Study|Death|1|||
143218004|NCT00615017|516345017|FG005|Overall Study|Death|1|||
143218005|NCT00615017|516345012|FG000|Overall Study|Sepsis resolved|0|||
143218006|NCT00615017|516345013|FG001|Overall Study|Sepsis resolved|0|||
143218007|NCT00615017|516345014|FG002|Overall Study|Sepsis resolved|1|||
143218008|NCT00615017|516345015|FG003|Overall Study|Sepsis resolved|0|||
143218009|NCT00615017|516345016|FG004|Overall Study|Sepsis resolved|0|||
143218010|NCT00615017|516345017|FG005|Overall Study|Sepsis resolved|0|||
143218011|NCT00615017|516345012|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
143218012|NCT00615017|516345013|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
143218013|NCT00615017|516345014|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
143218014|NCT00615017|516345015|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
143218015|NCT00615017|516345016|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
143218016|NCT00615017|516345017|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
143218017|NCT00615017|516345012|FG000|Overall Study|Physician discontinued drug|0|||
143218018|NCT00615017|516345013|FG001|Overall Study|Physician discontinued drug|0|||
143218019|NCT00615017|516345014|FG002|Overall Study|Physician discontinued drug|0|||
143218020|NCT00615017|516345015|FG003|Overall Study|Physician discontinued drug|0|||
143218021|NCT00615017|516345016|FG004|Overall Study|Physician discontinued drug|0|||
143218022|NCT00615017|516345017|FG005|Overall Study|Physician discontinued drug|1|||
143218023|NCT03777059|516345019|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
143218024|NCT03777059|516345020|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
143218025|NCT03777059|516345021|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
143218026|NCT03777059|516345022|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
143218027|NCT03777059|516345019|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
143218028|NCT03777059|516345020|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
143218029|NCT03777059|516345021|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
143218030|NCT03777059|516345022|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
143218031|NCT03777059|516345019|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
143218032|NCT03777059|516345020|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
143218033|NCT03777059|516345021|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
143218034|NCT03777059|516345022|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
143218035|NCT03777059|516345019|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
143218036|NCT03777059|516345020|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
143218037|NCT03777059|516345021|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
143218038|NCT03777059|516345022|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
143218039|NCT03777059|516345019|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
143218040|NCT03777059|516345020|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
143218041|NCT03777059|516345021|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
143218042|NCT03777059|516345022|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
143218043|NCT03777059|516345019|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
143218044|NCT03777059|516345020|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
143218045|NCT03777059|516345021|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
143218046|NCT03777059|516345022|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
143218047|NCT03777059|516345019|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
143218048|NCT03777059|516345020|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
143218049|NCT03777059|516345021|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
143218050|NCT03777059|516345022|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
143218051|NCT03777059|516345019|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
143218052|NCT03777059|516345020|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
143218053|NCT03777059|516345021|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
143218054|NCT03777059|516345022|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
143218055|NCT03777059|516345019|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
143218056|NCT03777059|516345020|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
143218057|NCT03777059|516345021|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
143218058|NCT03777059|516345022|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
143218059|NCT03777059|516345019|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
143218060|NCT03777059|516345020|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
143266888|NCT02310321|516531854|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
143266889|NCT02310321|516531855|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
143266890|NCT02310321|516531856|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
143266891|NCT02310321|516531854|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
143266892|NCT02310321|516531855|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
143266893|NCT02310321|516531856|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
143266894|NCT02310321|516531854|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
143266895|NCT02310321|516531855|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
143266896|NCT02310321|516531856|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
143266897|NCT02310321|516531854|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
143266898|NCT02310321|516531855|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
143266899|NCT02310321|516531856|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
143266900|NCT02310321|516531854|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
143266901|NCT02310321|516531855|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
143266902|NCT02310321|516531856|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
143266903|NCT02310321|516531854|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
143266904|NCT02310321|516531855|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
143266905|NCT02310321|516531856|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
143266906|NCT02310321|516531854|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
143266907|NCT02310321|516531855|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
143266908|NCT02310321|516531856|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
143266909|NCT02310321|516531854|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
143266910|NCT02310321|516531855|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
143266911|NCT02310321|516531856|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
143266912|NCT02310321|516531854|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
143266913|NCT02310321|516531855|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
143266914|NCT02310321|516531856|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
143266915|NCT02310321|516531854|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
143266916|NCT02310321|516531855|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
143266917|NCT02310321|516531856|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
143266918|NCT02310321|516531854|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
143266919|NCT02310321|516531855|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
143266920|NCT02310321|516531856|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
143266921|NCT02310321|516531854|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
143266922|NCT02310321|516531855|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
143266923|NCT02310321|516531856|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
143218061|NCT03777059|516345021|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
143218062|NCT03777059|516345022|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
143218063|NCT03777059|516345019|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
143266924|NCT02310321|516531854|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
143218064|NCT03777059|516345020|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
143218065|NCT03777059|516345021|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
143218066|NCT03777059|516345022|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
143218067|NCT03038126|516345024|FG000|Overall Study|Death|1|||
143218068|NCT03038126|516345025|FG001|Overall Study|Death|1|||
143218069|NCT03038126|516345024|FG000|Overall Study|Withdrawal by Subject|5|||
143218070|NCT03038126|516345025|FG001|Overall Study|Withdrawal by Subject|0|||
143218071|NCT03038126|516345024|FG000|Overall Study|Lost to Follow-up|0|||
143218072|NCT03038126|516345025|FG001|Overall Study|Lost to Follow-up|1|||
143218073|NCT03038126|516345024|FG000|Overall Study|Long Term Hospitalization|2|||
143218074|NCT03038126|516345025|FG001|Overall Study|Long Term Hospitalization|0|||
143218075|NCT03038126|516345024|FG000|Overall Study|Too Ill to Participate|1|||
143218076|NCT03038126|516345025|FG001|Overall Study|Too Ill to Participate|2|||
143218077|NCT02451917|516345026|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
143218078|NCT02451917|516345027|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
143218079|NCT02451917|516345026|FG000|First Intervention (24 Weeks)|Death|0|||
143218080|NCT02451917|516345027|FG001|First Intervention (24 Weeks)|Death|1|||
143218081|NCT02451917|516345026|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
143218082|NCT02451917|516345027|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
143218083|NCT00411671|516345030|FG000|Overall Study|Adverse Event|15|||
143218084|NCT00411671|516345030|FG000|Overall Study|Death|2|||
143218085|NCT00411671|516345030|FG000|Overall Study|Lost to Follow-up|3|||
143218086|NCT01424501|516345031|FG000|Overall Study|Withdrawal by Subject|1|||
143218087|NCT01424501|516345032|FG001|Overall Study|Withdrawal by Subject|0|||
143218088|NCT01424501|516345033|FG002|Overall Study|Withdrawal by Subject|1|||
143218089|NCT01424501|516345034|FG003|Overall Study|Withdrawal by Subject|0|||
143218090|NCT01424501|516345035|FG004|Overall Study|Withdrawal by Subject|0|||
143218091|NCT01424501|516345036|FG005|Overall Study|Withdrawal by Subject|0|||
143218092|NCT01424501|516345031|FG000|Overall Study|Lost to Follow-up|0|||
143218093|NCT01424501|516345032|FG001|Overall Study|Lost to Follow-up|1|||
143218094|NCT01424501|516345033|FG002|Overall Study|Lost to Follow-up|1|||
143218095|NCT01424501|516345034|FG003|Overall Study|Lost to Follow-up|0|||
143218096|NCT01424501|516345035|FG004|Overall Study|Lost to Follow-up|0|||
143218097|NCT01424501|516345036|FG005|Overall Study|Lost to Follow-up|0|||
143266925|NCT02310321|516531855|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
143266926|NCT02310321|516531856|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
143266927|NCT02310321|516531854|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
143266928|NCT02310321|516531855|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
143266929|NCT02310321|516531856|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
143266930|NCT02310321|516531854|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
143266931|NCT02310321|516531855|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
143266932|NCT02310321|516531856|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|7|||
143266933|NCT02310321|516531854|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
143266934|NCT02310321|516531855|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
143266935|NCT02310321|516531856|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|4|||
143266936|NCT02310321|516531854|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
143266937|NCT02310321|516531855|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
143266938|NCT02310321|516531856|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|4|||
143266939|NCT02310321|516531854|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
143266940|NCT02310321|516531855|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
143266941|NCT02310321|516531856|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|11|||
143266942|NCT02310321|516531854|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
143266943|NCT02310321|516531855|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
143266944|NCT02310321|516531856|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|2|||
143266945|NCT02310321|516531854|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
143266946|NCT02310321|516531855|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
143266947|NCT02310321|516531856|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|3|||
143372095|NCT02486588|516906427|FG004|Overall Study|Randomized in error- ineligible|746|||
143372096|NCT02486588|516906428|FG005|Overall Study|Randomized in error- ineligible|746|||
143372097|NCT03768206|516906429|FG000|Overall Study|Lost to Follow-up|2|||
143372098|NCT03768206|516906430|FG001|Overall Study|Lost to Follow-up|1|||
143372099|NCT03768206|516906429|FG000|Overall Study|Withdrawal by Subject|0|||
143218098|NCT01980095|516345037|FG000|Overall Study|Lost to Follow-up|6|||
143218099|NCT01980095|516345038|FG001|Overall Study|Lost to Follow-up|7|||
143218100|NCT01980095|516345037|FG000|Overall Study|Withdrawal by Subject|2|||
143372100|NCT03768206|516906430|FG001|Overall Study|Withdrawal by Subject|1|||
143372101|NCT02551055|516906431|FG000|Overall Study|Death|2|||
143372102|NCT02551055|516906432|FG001|Overall Study|Death|4|||
143218101|NCT01980095|516345038|FG001|Overall Study|Withdrawal by Subject|3|||
143218102|NCT01980095|516345037|FG000|Overall Study|Poor compliance|5|||
143218103|NCT01980095|516345038|FG001|Overall Study|Poor compliance|0|||
143218104|NCT01980095|516345037|FG000|Overall Study|Safety issue|0|||
143218105|NCT01980095|516345038|FG001|Overall Study|Safety issue|1|||
143218106|NCT01980095|516345037|FG000|Overall Study|Study drug discontinued|1|||
143218107|NCT01980095|516345038|FG001|Overall Study|Study drug discontinued|0|||
143218108|NCT01980095|516345037|FG000|Overall Study|Randomized by mistake|1|||
143218109|NCT01980095|516345038|FG001|Overall Study|Randomized by mistake|0|||
143218110|NCT04737278|516345039|FG000|Overall Study|Lost to Follow-up|1|||
143218111|NCT04737278|516345040|FG001|Overall Study|Lost to Follow-up|1|||
143218112|NCT04737278|516345039|FG000|Overall Study|Withdrawal by Subject|1|||
143218113|NCT04737278|516345040|FG001|Overall Study|Withdrawal by Subject|0|||
143218114|NCT04737278|516345039|FG000|Overall Study|Protocol Violation|1|||
143218115|NCT04737278|516345040|FG001|Overall Study|Protocol Violation|1|||
143218116|NCT04737278|516345039|FG000|Overall Study|failure to complete questionnaire|1|||
143218117|NCT04737278|516345040|FG001|Overall Study|failure to complete questionnaire|1|||
143218118|NCT01362608|516345045|FG000|Overall Study|Protocol Violation|0|||
143218119|NCT01362608|516345046|FG001|Overall Study|Protocol Violation|1|||
143218120|NCT01362608|516345045|FG000|Overall Study|Lost to Follow-up|3|||
143218121|NCT01362608|516345046|FG001|Overall Study|Lost to Follow-up|1|||
143218122|NCT01362608|516345045|FG000|Overall Study|Withdrawal by Subject|1|||
143218123|NCT01362608|516345046|FG001|Overall Study|Withdrawal by Subject|2|||
143218124|NCT01362608|516345045|FG000|Overall Study|Lack of Efficacy|0|||
143218125|NCT01362608|516345046|FG001|Overall Study|Lack of Efficacy|2|||
143218126|NCT01362608|516345045|FG000|Overall Study|Adverse Event|0|||
143218127|NCT01362608|516345046|FG001|Overall Study|Adverse Event|2|||
143218128|NCT01128244|516345052|FG000|Overall Study|Adverse Event|1|||
143218129|NCT01128244|516345052|FG000|Overall Study|Scheduling conflict|2|||
143218130|NCT03350815|516345054|FG000|Period 1|Adverse Event|10|||
143218131|NCT03350815|516345055|FG001|Period 1|Adverse Event|0|||
143218132|NCT03350815|516345056|FG002|Period 1|Adverse Event|0|||
143218133|NCT03350815|516345057|FG003|Period 1|Adverse Event|0|||
143218134|NCT03350815|516345054|FG000|Period 1|Technical problems|1|||
143218135|NCT03350815|516345055|FG001|Period 1|Technical problems|0|||
143218136|NCT03350815|516345056|FG002|Period 1|Technical problems|0|||
143218137|NCT03350815|516345057|FG003|Period 1|Technical problems|0|||
143218138|NCT03350815|516345054|FG000|Period 1|Lost to Follow-up|3|||
143218139|NCT03350815|516345055|FG001|Period 1|Lost to Follow-up|0|||
143218140|NCT03350815|516345056|FG002|Period 1|Lost to Follow-up|0|||
143218141|NCT03350815|516345057|FG003|Period 1|Lost to Follow-up|0|||
143218142|NCT03350815|516345054|FG000|Period 1|Physician Decision|1|||
143218143|NCT03350815|516345055|FG001|Period 1|Physician Decision|0|||
143218144|NCT03350815|516345056|FG002|Period 1|Physician Decision|0|||
143218145|NCT03350815|516345057|FG003|Period 1|Physician Decision|0|||
143218146|NCT03350815|516345054|FG000|Period 1|Withdrawal by Subject|8|||
143218147|NCT03350815|516345055|FG001|Period 1|Withdrawal by Subject|0|||
143218148|NCT03350815|516345056|FG002|Period 1|Withdrawal by Subject|0|||
143218149|NCT03350815|516345057|FG003|Period 1|Withdrawal by Subject|0|||
143218150|NCT03350815|516345054|FG000|Period 1|Lack of Efficacy|15|||
143218151|NCT03350815|516345055|FG001|Period 1|Lack of Efficacy|0|||
143218152|NCT03350815|516345056|FG002|Period 1|Lack of Efficacy|0|||
143218153|NCT03350815|516345057|FG003|Period 1|Lack of Efficacy|0|||
143218154|NCT03350815|516345054|FG000|Period 1|Non-compliance with study treatment|2|||
143218155|NCT03350815|516345055|FG001|Period 1|Non-compliance with study treatment|0|||
143218156|NCT03350815|516345056|FG002|Period 1|Non-compliance with study treatment|0|||
143218157|NCT03350815|516345057|FG003|Period 1|Non-compliance with study treatment|0|||
143218158|NCT03350815|516345054|FG000|Period 1|Protocol Violation|3|||
143218159|NCT03350815|516345055|FG001|Period 1|Protocol Violation|0|||
143218160|NCT03350815|516345056|FG002|Period 1|Protocol Violation|0|||
143218161|NCT03350815|516345057|FG003|Period 1|Protocol Violation|0|||
143218162|NCT03350815|516345054|FG000|Period 2|Adverse Event|0|||
143218163|NCT03350815|516345055|FG001|Period 2|Adverse Event|3|||
143218164|NCT03350815|516345056|FG002|Period 2|Adverse Event|5|||
143218165|NCT03350815|516345057|FG003|Period 2|Adverse Event|0|||
143218166|NCT03350815|516345054|FG000|Period 2|Technical problem|0|||
143218167|NCT03350815|516345055|FG001|Period 2|Technical problem|1|||
143218168|NCT03350815|516345056|FG002|Period 2|Technical problem|0|||
143218169|NCT03350815|516345057|FG003|Period 2|Technical problem|0|||
143218170|NCT03350815|516345054|FG000|Period 2|Lost to Follow-up|0|||
143218171|NCT03350815|516345055|FG001|Period 2|Lost to Follow-up|3|||
143218172|NCT03350815|516345056|FG002|Period 2|Lost to Follow-up|3|||
143218173|NCT03350815|516345057|FG003|Period 2|Lost to Follow-up|0|||
143218174|NCT03350815|516345054|FG000|Period 2|Physician Decision|0|||
143218175|NCT03350815|516345055|FG001|Period 2|Physician Decision|0|||
143218176|NCT03350815|516345056|FG002|Period 2|Physician Decision|1|||
143218177|NCT03350815|516345057|FG003|Period 2|Physician Decision|0|||
143218178|NCT03350815|516345054|FG000|Period 2|Withdrawal by Subject|0|||
143218179|NCT03350815|516345055|FG001|Period 2|Withdrawal by Subject|3|||
143218180|NCT03350815|516345056|FG002|Period 2|Withdrawal by Subject|4|||
143218181|NCT03350815|516345057|FG003|Period 2|Withdrawal by Subject|0|||
143218182|NCT03350815|516345054|FG000|Period 2|Lack of Efficacy|0|||
143218183|NCT03350815|516345055|FG001|Period 2|Lack of Efficacy|6|||
143218184|NCT03350815|516345056|FG002|Period 2|Lack of Efficacy|2|||
143218185|NCT03350815|516345057|FG003|Period 2|Lack of Efficacy|0|||
143218186|NCT03350815|516345054|FG000|Period 2|Protocol Violation|0|||
143218187|NCT03350815|516345055|FG001|Period 2|Protocol Violation|0|||
143218188|NCT03350815|516345056|FG002|Period 2|Protocol Violation|1|||
143218189|NCT03350815|516345057|FG003|Period 2|Protocol Violation|0|||
143218190|NCT03350815|516345054|FG000|Period 2|New therapy for study indication|0|||
143218191|NCT03350815|516345055|FG001|Period 2|New therapy for study indication|0|||
143218192|NCT03350815|516345056|FG002|Period 2|New therapy for study indication|1|||
143218193|NCT03350815|516345057|FG003|Period 2|New therapy for study indication|0|||
143218194|NCT02517541|516345062|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
143218195|NCT02517541|516345062|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
143218196|NCT02517541|516345062|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
143218197|NCT02517541|516345062|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
143218198|NCT02517541|516345062|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
143218199|NCT02517541|516345062|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
143218200|NCT00699608|516345063|FG000|First Intervention|Withdrawal by Subject|0|||
143218201|NCT00699608|516345064|FG001|First Intervention|Withdrawal by Subject|0|||
143218202|NCT00699608|516345065|FG002|First Intervention|Withdrawal by Subject|1|||
143218203|NCT00699608|516345066|FG003|First Intervention|Withdrawal by Subject|0|||
143218204|NCT00699608|516345067|FG004|First Intervention|Withdrawal by Subject|0|||
143218205|NCT00699608|516345068|FG005|First Intervention|Withdrawal by Subject|0|||
143218206|NCT00699608|516345063|FG000|First Intervention|Protocol Violation|0|||
143218207|NCT00699608|516345064|FG001|First Intervention|Protocol Violation|0|||
143218208|NCT00699608|516345065|FG002|First Intervention|Protocol Violation|0|||
143218209|NCT00699608|516345066|FG003|First Intervention|Protocol Violation|0|||
143218210|NCT00699608|516345067|FG004|First Intervention|Protocol Violation|1|||
143218211|NCT00699608|516345068|FG005|First Intervention|Protocol Violation|0|||
143218212|NCT00699608|516345063|FG000|Second Intervention|Adverse Event|0|||
143218213|NCT00699608|516345064|FG001|Second Intervention|Adverse Event|0|||
143218214|NCT00699608|516345065|FG002|Second Intervention|Adverse Event|1|||
143218215|NCT00699608|516345066|FG003|Second Intervention|Adverse Event|0|||
143218216|NCT00699608|516345067|FG004|Second Intervention|Adverse Event|0|||
143218217|NCT00699608|516345068|FG005|Second Intervention|Adverse Event|0|||
143218218|NCT00699608|516345063|FG000|Second Intervention|Withdrawal by Subject|0|||
143218219|NCT00699608|516345064|FG001|Second Intervention|Withdrawal by Subject|0|||
143218220|NCT00699608|516345065|FG002|Second Intervention|Withdrawal by Subject|0|||
143218221|NCT00699608|516345066|FG003|Second Intervention|Withdrawal by Subject|1|||
143218222|NCT00699608|516345067|FG004|Second Intervention|Withdrawal by Subject|0|||
143218223|NCT00699608|516345068|FG005|Second Intervention|Withdrawal by Subject|0|||
143218224|NCT02828436|516345069|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
143218225|NCT02828436|516345070|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
143218226|NCT02828436|516345069|FG000|Period 1|Lost to Follow-up|0|||
143218227|NCT02828436|516345070|FG001|Period 1|Lost to Follow-up|1|||
143218228|NCT02828436|516345069|FG000|Period 2|Withdrawal by Subject|4|||
143218229|NCT02828436|516345070|FG001|Period 2|Withdrawal by Subject|0|||
143218230|NCT02828436|516345069|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
143218231|NCT02828436|516345070|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
143218232|NCT02828436|516345069|FG000|Period 2|Lost to Follow-up|1|||
143218233|NCT02828436|516345070|FG001|Period 2|Lost to Follow-up|0|||
143218234|NCT01136408|516345071|FG000|Overall Study|Adverse Event|4|||
143218235|NCT01136408|516345072|FG001|Overall Study|Adverse Event|8|||
143218236|NCT01136408|516345073|FG002|Overall Study|Adverse Event|4|||
143218237|NCT01136408|516345071|FG000|Overall Study|Protocol Violation|1|||
143218238|NCT01136408|516345072|FG001|Overall Study|Protocol Violation|1|||
143218239|NCT01136408|516345073|FG002|Overall Study|Protocol Violation|1|||
143218240|NCT02128724|516345081|FG000|Overall Study|Death|1|||
143218241|NCT02128724|516345082|FG001|Overall Study|Death|0|||
143218242|NCT02128724|516345083|FG002|Overall Study|Death|0|||
143218243|NCT02128724|516345084|FG003|Overall Study|Death|0|||
143218244|NCT02128724|516345081|FG000|Overall Study|Adverse Event|0|||
143218245|NCT02128724|516345082|FG001|Overall Study|Adverse Event|1|||
143218246|NCT02128724|516345083|FG002|Overall Study|Adverse Event|0|||
143218247|NCT02128724|516345084|FG003|Overall Study|Adverse Event|0|||
143218248|NCT02128724|516345081|FG000|Overall Study|Physician Decision|0|||
143218249|NCT02128724|516345082|FG001|Overall Study|Physician Decision|0|||
143218250|NCT02128724|516345083|FG002|Overall Study|Physician Decision|0|||
143218251|NCT02128724|516345084|FG003|Overall Study|Physician Decision|2|||
143218252|NCT02128724|516345081|FG000|Overall Study|Withdrawal by Subject|0|||
143218253|NCT02128724|516345082|FG001|Overall Study|Withdrawal by Subject|0|||
143218254|NCT02128724|516345083|FG002|Overall Study|Withdrawal by Subject|0|||
143218255|NCT02128724|516345084|FG003|Overall Study|Withdrawal by Subject|1|||
143218256|NCT01442714|516345085|FG000|Overall Study|Death|11|||
143218257|NCT01442714|516345085|FG000|Overall Study|Withdrawal by Subject|1|||
143218258|NCT02652156|516345086|FG000|Overall Study|Physician Decision|1|||
143218259|NCT02652156|516345087|FG001|Overall Study|Physician Decision|0|||
143218260|NCT02652156|516345088|FG002|Overall Study|Physician Decision|0|||
143218261|NCT00496080|516345092|FG000|Overall Study|Lost to Follow-up|9|||
143218262|NCT00496080|516345092|FG000|Overall Study|Surgical re-intervention|7|||
143218263|NCT00496080|516345092|FG000|Overall Study|Withdrawal by Subject|5|||
143218264|NCT00496080|516345092|FG000|Overall Study|Physician Decision|6|||
143218265|NCT01290757|516345097|FG000|Overall Study|Adverse Event|1|||
143218266|NCT01290757|516345098|FG001|Overall Study|Adverse Event|0|||
143218267|NCT01290757|516345097|FG000|Overall Study|Protocol Violation|1|||
143218268|NCT01290757|516345098|FG001|Overall Study|Protocol Violation|1|||
143218269|NCT01290757|516345097|FG000|Overall Study|Other|0|||
143218270|NCT01290757|516345098|FG001|Overall Study|Other|1|||
143218271|NCT00570310|516345099|FG000|Overall Study|Adverse Event|1|||
143218272|NCT00570310|516345100|FG001|Overall Study|Adverse Event|2|||
143218273|NCT00570310|516345099|FG000|Overall Study|Lack of Efficacy|1|||
143218274|NCT00570310|516345100|FG001|Overall Study|Lack of Efficacy|4|||
143218275|NCT00479336|516345103|FG000|Overall Study|Adverse Event|1|||
143218276|NCT00479336|516345104|FG001|Overall Study|Adverse Event|1|||
143218277|NCT00479336|516345105|FG002|Overall Study|Adverse Event|1|||
143218278|NCT00479336|516345106|FG003|Overall Study|Adverse Event|3|||
143218279|NCT00479336|516345103|FG000|Overall Study|Lack of Efficacy|1|||
143218280|NCT00479336|516345104|FG001|Overall Study|Lack of Efficacy|0|||
143218281|NCT00479336|516345105|FG002|Overall Study|Lack of Efficacy|0|||
143218282|NCT00479336|516345106|FG003|Overall Study|Lack of Efficacy|0|||
143218283|NCT00479336|516345103|FG000|Overall Study|Protocol Violation|0|||
143218284|NCT00479336|516345104|FG001|Overall Study|Protocol Violation|1|||
143218285|NCT00479336|516345105|FG002|Overall Study|Protocol Violation|0|||
143218286|NCT00479336|516345106|FG003|Overall Study|Protocol Violation|0|||
143218287|NCT00479336|516345103|FG000|Overall Study|Withdrawal by Subject|1|||
143218288|NCT00479336|516345104|FG001|Overall Study|Withdrawal by Subject|2|||
143218289|NCT00479336|516345105|FG002|Overall Study|Withdrawal by Subject|0|||
143218290|NCT00479336|516345106|FG003|Overall Study|Withdrawal by Subject|0|||
143218291|NCT00479336|516345103|FG000|Overall Study|Physician Decision|0|||
143218292|NCT00479336|516345104|FG001|Overall Study|Physician Decision|1|||
143218293|NCT00479336|516345105|FG002|Overall Study|Physician Decision|0|||
143218294|NCT00479336|516345106|FG003|Overall Study|Physician Decision|2|||
143218295|NCT00479336|516345103|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
143218296|NCT00479336|516345104|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
143218297|NCT00479336|516345105|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
143218298|NCT00479336|516345106|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
143218299|NCT03066193|516345107|FG000|Overall Study|Withdrawal by Subject|1|||
143218300|NCT00108862|516345108|FG000|Overall Study|Death|31|||
143218301|NCT00108862|516345109|FG001|Overall Study|Death|37|||
143218302|NCT00108862|516345108|FG000|Overall Study|Withdrawal by Subject|10|||
143218303|NCT00108862|516345109|FG001|Overall Study|Withdrawal by Subject|6|||
143218304|NCT00108862|516345108|FG000|Overall Study|Lost to Follow-up|27|||
143218305|NCT00108862|516345109|FG001|Overall Study|Lost to Follow-up|19|||
143218306|NCT02021643|516345110|FG000|Overall Study|Enrolled but Never Treated|1|||
143218307|NCT02021643|516345111|FG001|Overall Study|Enrolled but Never Treated|0|||
143218308|NCT02021643|516345112|FG002|Overall Study|Enrolled but Never Treated|0|||
143218309|NCT02021643|516345113|FG003|Overall Study|Enrolled but Never Treated|0|||
143218310|NCT02021643|516345110|FG000|Overall Study|Adverse Event|0|||
143218311|NCT02021643|516345111|FG001|Overall Study|Adverse Event|1|||
143218312|NCT02021643|516345112|FG002|Overall Study|Adverse Event|0|||
143218313|NCT02021643|516345113|FG003|Overall Study|Adverse Event|0|||
143218314|NCT02021643|516345110|FG000|Overall Study|Death|0|||
143218315|NCT02021643|516345111|FG001|Overall Study|Death|1|||
143218316|NCT02021643|516345112|FG002|Overall Study|Death|0|||
143218317|NCT02021643|516345113|FG003|Overall Study|Death|0|||
143218318|NCT02021643|516345110|FG000|Overall Study|Investigator's Discretion|1|||
143218319|NCT02021643|516345111|FG001|Overall Study|Investigator's Discretion|0|||
143218320|NCT02021643|516345112|FG002|Overall Study|Investigator's Discretion|0|||
143218321|NCT02021643|516345113|FG003|Overall Study|Investigator's Discretion|0|||
143218322|NCT02021643|516345110|FG000|Overall Study|Lack of Efficacy|7|||
143218323|NCT02021643|516345111|FG001|Overall Study|Lack of Efficacy|6|||
143218324|NCT02021643|516345112|FG002|Overall Study|Lack of Efficacy|0|||
143218325|NCT02021643|516345113|FG003|Overall Study|Lack of Efficacy|12|||
143218326|NCT02021643|516345110|FG000|Overall Study|Lost to Follow-up|0|||
143218327|NCT02021643|516345111|FG001|Overall Study|Lost to Follow-up|1|||
143218328|NCT02021643|516345112|FG002|Overall Study|Lost to Follow-up|0|||
143218329|NCT02021643|516345113|FG003|Overall Study|Lost to Follow-up|0|||
143218330|NCT02021643|516345110|FG000|Overall Study|Withdrew Consent|0|||
143218331|NCT02021643|516345111|FG001|Overall Study|Withdrew Consent|1|||
143218332|NCT02021643|516345112|FG002|Overall Study|Withdrew Consent|0|||
143218333|NCT02021643|516345113|FG003|Overall Study|Withdrew Consent|0|||
143218334|NCT01746368|516345116|FG000|Overall Study|Lost to Follow-up|2|||
143218335|NCT01746368|516345117|FG001|Overall Study|Lost to Follow-up|0|||
143218336|NCT01746368|516345116|FG000|Overall Study|Withdrawal by Subject|0|||
143218337|NCT01746368|516345117|FG001|Overall Study|Withdrawal by Subject|1|||
143218338|NCT01076036|516345120|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
143218339|NCT02221674|516345121|FG000|Overall Study|Lost to Follow-up|1|||
143218340|NCT02221674|516345122|FG001|Overall Study|Lost to Follow-up|0|||
143218341|NCT02221674|516345123|FG002|Overall Study|Lost to Follow-up|0|||
143218342|NCT02557542|516345125|FG000|Overall Study|Poor recruitment|3|||
143218343|NCT02557542|516345126|FG001|Overall Study|Poor recruitment|0|||
143218344|NCT04390880|516345127|FG000|Overall Study|Withdrawal by Subject|1|||
143218345|NCT00195091|516345128|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
143218346|NCT01345188|516345129|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
143218347|NCT01345188|516345129|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
143218348|NCT00577824|516345130|FG000|Overall Study|Adverse Event|6|||
143218349|NCT00577824|516345131|FG001|Overall Study|Adverse Event|18|||
143218350|NCT00577824|516345132|FG002|Overall Study|Adverse Event|1|||
143218351|NCT00577824|516345130|FG000|Overall Study|Patient decision|0|||
143218352|NCT00577824|516345131|FG001|Overall Study|Patient decision|1|||
143218353|NCT00577824|516345132|FG002|Overall Study|Patient decision|1|||
143218354|NCT00577824|516345130|FG000|Overall Study|Protocol Violation|1|||
143218355|NCT00577824|516345131|FG001|Overall Study|Protocol Violation|1|||
143218356|NCT00577824|516345132|FG002|Overall Study|Protocol Violation|0|||
143218357|NCT04079816|516345133|FG000|Overall Study|Request of Subject|2|||
143218358|NCT04079816|516345133|FG000|Overall Study|Unable to draw samples|1|||
143218359|NCT01702246|516345134|FG000|Overall Study|Lost to Follow-up|2|||
143218360|NCT01702246|516345134|FG000|Overall Study|Withdrawal by Subject|2|||
143218361|NCT01702246|516345134|FG000|Overall Study|Physician Decision|1|||
143218362|NCT03400176|516345138|FG000|Dose Escalation|Progressive disease|1|||
143218363|NCT03400176|516345139|FG001|Dose Escalation|Progressive disease|1|||
143218364|NCT03400176|516345140|FG002|Dose Escalation|Progressive disease|0|||
143218365|NCT03400176|516345141|FG003|Dose Escalation|Progressive disease|0|||
143218366|NCT03400176|516345142|FG004|Dose Escalation|Progressive disease|1|||
143218367|NCT03400176|516345138|FG000|Dose Escalation|Patient decision|0|||
143218368|NCT03400176|516345139|FG001|Dose Escalation|Patient decision|0|||
143218369|NCT03400176|516345140|FG002|Dose Escalation|Patient decision|0|||
143218370|NCT03400176|516345141|FG003|Dose Escalation|Patient decision|0|||
143218371|NCT03400176|516345142|FG004|Dose Escalation|Patient decision|1|||
143218372|NCT03400176|516345138|FG000|Dose Expansion|Patient decision|0|||
143218373|NCT03400176|516345139|FG001|Dose Expansion|Patient decision|0|||
143218374|NCT03400176|516345140|FG002|Dose Expansion|Patient decision|0|||
143218375|NCT03400176|516345141|FG003|Dose Expansion|Patient decision|1|||
143218376|NCT03400176|516345142|FG004|Dose Expansion|Patient decision|0|||
143218377|NCT03400176|516345138|FG000|Dose Expansion|Adverse Event|0|||
143218378|NCT03400176|516345139|FG001|Dose Expansion|Adverse Event|0|||
143218379|NCT03400176|516345140|FG002|Dose Expansion|Adverse Event|0|||
143218380|NCT03400176|516345141|FG003|Dose Expansion|Adverse Event|1|||
143218381|NCT03400176|516345142|FG004|Dose Expansion|Adverse Event|0|||
143218382|NCT03400176|516345138|FG000|Dose Expansion|Physician Decision|0|||
143218383|NCT03400176|516345139|FG001|Dose Expansion|Physician Decision|0|||
143218384|NCT03400176|516345140|FG002|Dose Expansion|Physician Decision|0|||
143218385|NCT03400176|516345141|FG003|Dose Expansion|Physician Decision|1|||
143218386|NCT03400176|516345142|FG004|Dose Expansion|Physician Decision|0|||
143218387|NCT03400176|516345138|FG000|Dose Expansion|Progressive disease|0|||
143218388|NCT03400176|516345139|FG001|Dose Expansion|Progressive disease|0|||
143218389|NCT03400176|516345140|FG002|Dose Expansion|Progressive disease|1|||
143218390|NCT03400176|516345141|FG003|Dose Expansion|Progressive disease|1|||
143218391|NCT03400176|516345142|FG004|Dose Expansion|Progressive disease|0|||
143218392|NCT02305238|516345144|FG000|Overall Study|Death|2|||
143218393|NCT02305238|516345145|FG001|Overall Study|Death|1|||
143218394|NCT02305238|516345146|FG002|Overall Study|Death|0|||
143218395|NCT02305238|516345144|FG000|Overall Study|Progressive disease|4|||
143218396|NCT02305238|516345145|FG001|Overall Study|Progressive disease|4|||
143218397|NCT02305238|516345146|FG002|Overall Study|Progressive disease|0|||
143218398|NCT02305238|516345144|FG000|Overall Study|Logistical difficulties|1|||
143218399|NCT02305238|516345145|FG001|Overall Study|Logistical difficulties|3|||
143218400|NCT02305238|516345146|FG002|Overall Study|Logistical difficulties|0|||
143218401|NCT02305238|516345144|FG000|Overall Study|Protocol Violation|0|||
143218402|NCT02305238|516345145|FG001|Overall Study|Protocol Violation|3|||
143218403|NCT02305238|516345146|FG002|Overall Study|Protocol Violation|0|||
143218404|NCT02305238|516345144|FG000|Overall Study|Physician Decision|2|||
143218405|NCT02305238|516345145|FG001|Overall Study|Physician Decision|1|||
143218406|NCT02305238|516345146|FG002|Overall Study|Physician Decision|0|||
143218407|NCT02305238|516345144|FG000|Overall Study|Adverse Event|4|||
143218408|NCT02305238|516345145|FG001|Overall Study|Adverse Event|2|||
143218409|NCT02305238|516345146|FG002|Overall Study|Adverse Event|0|||
143218410|NCT02305238|516345144|FG000|Overall Study|Withdrawal by Subject|3|||
143218411|NCT02305238|516345145|FG001|Overall Study|Withdrawal by Subject|4|||
143218412|NCT02305238|516345146|FG002|Overall Study|Withdrawal by Subject|0|||
143218413|NCT02305238|516345144|FG000|Overall Study|Randomized failure|0|||
143218414|NCT02305238|516345145|FG001|Overall Study|Randomized failure|0|||
143218415|NCT02305238|516345146|FG002|Overall Study|Randomized failure|8|||
143218416|NCT02305238|516345144|FG000|Overall Study|Required procedure failed|0|||
143218417|NCT02305238|516345145|FG001|Overall Study|Required procedure failed|1|||
143218418|NCT02305238|516345146|FG002|Overall Study|Required procedure failed|0|||
143218419|NCT00195663|516345147|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
143218420|NCT00195663|516345148|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
143218421|NCT00195663|516345149|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
143218422|NCT00195663|516345147|FG000|2-year Double-blind Treatment Period|Death|0|||
143218423|NCT00195663|516345148|FG001|2-year Double-blind Treatment Period|Death|2|||
143218424|NCT00195663|516345149|FG002|2-year Double-blind Treatment Period|Death|0|||
143218425|NCT00195663|516345147|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
143218426|NCT00195663|516345148|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
143218427|NCT00195663|516345149|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
143218428|NCT00195663|516345147|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
143218429|NCT00195663|516345148|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
143218430|NCT00195663|516345149|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
143218431|NCT00195663|516345147|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
143218432|NCT00195663|516345148|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
143218433|NCT00195663|516345149|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
143218434|NCT00195663|516345147|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
143218435|NCT00195663|516345148|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
143218436|NCT00195663|516345149|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
143218437|NCT00195663|516345147|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
143218438|NCT00195663|516345148|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
143218439|NCT00195663|516345149|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
143218440|NCT00195663|516345147|FG000|2-year Double-blind Treatment Period|Recovery|1|||
143218441|NCT00195663|516345148|FG001|2-year Double-blind Treatment Period|Recovery|0|||
143218442|NCT00195663|516345149|FG002|2-year Double-blind Treatment Period|Recovery|1|||
143218443|NCT00195663|516345147|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
143218444|NCT00195663|516345148|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
143218445|NCT00195663|516345149|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
143218446|NCT00195663|516345147|FG000|Open-Label Extension Period|Adverse Event|21|||
143218447|NCT00195663|516345148|FG001|Open-Label Extension Period|Adverse Event|32|||
143218448|NCT00195663|516345149|FG002|Open-Label Extension Period|Adverse Event|36|||
143218449|NCT00195663|516345147|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
143218450|NCT00195663|516345148|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
143218451|NCT00195663|516345149|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
143218452|NCT00195663|516345147|FG000|Open-Label Extension Period|Recovery|0|||
143218453|NCT00195663|516345148|FG001|Open-Label Extension Period|Recovery|2|||
143218454|NCT00195663|516345149|FG002|Open-Label Extension Period|Recovery|2|||
143218455|NCT00195663|516345147|FG000|Open-Label Extension Period|Protocol Violation|3|||
143218456|NCT00195663|516345148|FG001|Open-Label Extension Period|Protocol Violation|4|||
143218457|NCT00195663|516345149|FG002|Open-Label Extension Period|Protocol Violation|4|||
143218458|NCT00195663|516345147|FG000|Open-Label Extension Period|Death|2|||
143218459|NCT00195663|516345148|FG001|Open-Label Extension Period|Death|2|||
143218460|NCT00195663|516345149|FG002|Open-Label Extension Period|Death|2|||
143218461|NCT00195663|516345147|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
143218462|NCT00195663|516345148|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
143218463|NCT00195663|516345149|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
143218464|NCT00195663|516345147|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
143218465|NCT00195663|516345148|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
143218466|NCT00195663|516345149|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
143266948|NCT02310321|516531854|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
143266949|NCT02310321|516531855|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
143266950|NCT02310321|516531856|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|1|||
143218467|NCT00195663|516345147|FG000|Open-Label Extension Period|Administrative reasons|11|||
143218468|NCT00195663|516345148|FG001|Open-Label Extension Period|Administrative reasons|11|||
143218469|NCT00195663|516345149|FG002|Open-Label Extension Period|Administrative reasons|13|||
143218470|NCT00604695|516345150|FG000|Overall Study|Did not receive first bolus.|0|||
143218471|NCT00604695|516345151|FG001|Overall Study|Did not receive first bolus.|4|||
143266951|NCT02310321|516531854|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
143218472|NCT03214406|516345152|FG000|Overall Study|did not meet enrollment criteria|9|||
143218473|NCT03214406|516345153|FG001|Overall Study|did not meet enrollment criteria|13|||
143218474|NCT03214406|516345152|FG000|Overall Study|Withdrawal by Subject|1|||
143218475|NCT03214406|516345153|FG001|Overall Study|Withdrawal by Subject|0|||
143218476|NCT03214406|516345152|FG000|Overall Study|Lost to Follow-up|0|||
143218477|NCT03214406|516345153|FG001|Overall Study|Lost to Follow-up|2|||
143218478|NCT01746173|516345156|FG000|Overall Study|Disease Progression|2|||
143218479|NCT00172042|516345159|FG000|Overall Study|Adverse Event|27|||
143218480|NCT00172042|516345160|FG001|Overall Study|Adverse Event|13|||
143266952|NCT02310321|516531855|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
143218481|NCT00172042|516345159|FG000|Overall Study|Abnormal laboratory value(s)|5|||
143218482|NCT00172042|516345160|FG001|Overall Study|Abnormal laboratory value(s)|1|||
143218483|NCT00172042|516345159|FG000|Overall Study|Abnormal test procedure(s)|0|||
143218484|NCT00172042|516345160|FG001|Overall Study|Abnormal test procedure(s)|3|||
143218485|NCT00172042|516345159|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
143218486|NCT00172042|516345160|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
143218487|NCT00172042|516345159|FG000|Overall Study|Patient no longer requires study drug|10|||
143218488|NCT00172042|516345160|FG001|Overall Study|Patient no longer requires study drug|8|||
143218489|NCT00172042|516345159|FG000|Overall Study|Protocol Violation|8|||
143218490|NCT00172042|516345160|FG001|Overall Study|Protocol Violation|7|||
143218491|NCT00172042|516345159|FG000|Overall Study|Withdrawal by Subject|37|||
143218492|NCT00172042|516345160|FG001|Overall Study|Withdrawal by Subject|25|||
143218493|NCT00172042|516345159|FG000|Overall Study|Lost to Follow-up|3|||
143218494|NCT00172042|516345160|FG001|Overall Study|Lost to Follow-up|5|||
143218495|NCT00172042|516345159|FG000|Overall Study|Administrative problems|13|||
143218496|NCT00172042|516345160|FG001|Overall Study|Administrative problems|10|||
143218497|NCT00172042|516345159|FG000|Overall Study|Death|42|||
143218498|NCT00172042|516345160|FG001|Overall Study|Death|42|||
143218499|NCT02465203|516345161|FG000|Overall Study|Protocol Violation|1|||
143218500|NCT02465203|516345162|FG001|Overall Study|Protocol Violation|1|||
143218501|NCT02465203|516345163|FG002|Overall Study|Protocol Violation|1|||
143218502|NCT02465203|516345161|FG000|Overall Study|Study terminated by sponsor|50|||
143218503|NCT02465203|516345162|FG001|Overall Study|Study terminated by sponsor|34|||
143218504|NCT02465203|516345163|FG002|Overall Study|Study terminated by sponsor|11|||
143218505|NCT02465203|516345161|FG000|Overall Study|New therapy for study indication|4|||
143218506|NCT02465203|516345162|FG001|Overall Study|New therapy for study indication|0|||
143218507|NCT02465203|516345163|FG002|Overall Study|New therapy for study indication|0|||
143218508|NCT02465203|516345161|FG000|Overall Study|Patient/guardian decision|1|||
143218509|NCT02465203|516345162|FG001|Overall Study|Patient/guardian decision|1|||
143218510|NCT02465203|516345163|FG002|Overall Study|Patient/guardian decision|1|||
143218511|NCT03228212|516345176|FG000|Period 1|Adverse Event|1|||
143218512|NCT03228212|516345177|FG001|Period 1|Adverse Event|0|||
143218513|NCT03228212|516345176|FG000|Period 1|no longer meets eligibility criteria|0|||
143218514|NCT03228212|516345177|FG001|Period 1|no longer meets eligibility criteria|1|||
143218515|NCT03228212|516345176|FG000|Period 2|Lost to Follow-up|1|||
143218516|NCT03228212|516345177|FG001|Period 2|Lost to Follow-up|0|||
143218517|NCT03078556|516346988|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
143218518|NCT03078556|516346989|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
143218519|NCT03078556|516346990|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
143218520|NCT03078556|516346991|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
143218521|NCT03078556|516346988|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
143218522|NCT03078556|516346989|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
143218523|NCT03078556|516346990|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
143218524|NCT03078556|516346991|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
143218525|NCT03078556|516346988|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
143218526|NCT03078556|516346989|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
143218527|NCT03078556|516346990|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
143218528|NCT03078556|516346991|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
143218529|NCT03078556|516346988|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
143218530|NCT03078556|516346989|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
143218531|NCT03078556|516346990|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
143218532|NCT03078556|516346991|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
143218533|NCT04421482|516346992|FG000|Overall Study|Physician Decision|1|||
143218534|NCT03010319|516346995|FG000|Overall Study|Adverse Event|15|||
143218535|NCT03010319|516346996|FG001|Overall Study|Adverse Event|9|||
143218536|NCT03010319|516346995|FG000|Overall Study|Withdrawal by Subject|1|||
143218537|NCT03010319|516346996|FG001|Overall Study|Withdrawal by Subject|6|||
143218538|NCT03010319|516346995|FG000|Overall Study|Physician Decision|2|||
143218539|NCT03010319|516346996|FG001|Overall Study|Physician Decision|4|||
143218540|NCT03010319|516346995|FG000|Overall Study|Sponsor requested withdrawal|2|||
143218541|NCT03010319|516346996|FG001|Overall Study|Sponsor requested withdrawal|2|||
143218542|NCT03010319|516346995|FG000|Overall Study|Death|1|||
143218543|NCT03010319|516346996|FG001|Overall Study|Death|0|||
143218544|NCT03010319|516346995|FG000|Overall Study|Lost to Follow-up|0|||
143218545|NCT03010319|516346996|FG001|Overall Study|Lost to Follow-up|1|||
143218546|NCT03010319|516346995|FG000|Overall Study|Other Reason|5|||
143218547|NCT03010319|516346996|FG001|Overall Study|Other Reason|7|||
143218548|NCT04306510|516346997|FG000|Overall Study|Voluntarily withdrawal|1|||
143218549|NCT04306510|516346997|FG000|Overall Study|Enrolled but Not Treated|1|||
143218550|NCT04720417|516347003|FG000|Overall Study|one subject did not initiate treatment due to rapid disease progression|1|||
143218551|NCT03329092|516347004|FG000|Overall Study|Other|2|||
143218552|NCT03329092|516347005|FG001|Overall Study|Other|2|||
143218553|NCT03329092|516347004|FG000|Overall Study|Withdrawal by Subject|16|||
143218554|NCT03329092|516347005|FG001|Overall Study|Withdrawal by Subject|3|||
143218555|NCT03329092|516347004|FG000|Overall Study|Physician Decision|1|||
143218556|NCT03329092|516347005|FG001|Overall Study|Physician Decision|0|||
143218557|NCT03329092|516347004|FG000|Overall Study|Death|17|||
143218558|NCT03329092|516347005|FG001|Overall Study|Death|11|||
143218559|NCT03329092|516347004|FG000|Overall Study|Adverse Event|3|||
143218560|NCT03329092|516347005|FG001|Overall Study|Adverse Event|1|||
143218561|NCT03329092|516347004|FG000|Overall Study|Lost to Follow-up|1|||
143218562|NCT03329092|516347005|FG001|Overall Study|Lost to Follow-up|1|||
143218563|NCT03314987|516347006|FG000|Overall Study|Lost to Follow-up|13|||
143218564|NCT03314987|516347007|FG001|Overall Study|Lost to Follow-up|13|||
143218565|NCT03574779|516347008|FG000|Overall Study|Screening failure|13|||
143218566|NCT03574779|516347009|FG001|Overall Study|Screening failure|83|||
143218567|NCT02751580|516347010|FG000|Overall Study|Lost to Follow-up|4|||
143218568|NCT02751580|516347010|FG000|Overall Study|Death|2|||
143218569|NCT02588261|516347011|FG000|Overall Study|Study Terminated by Sponsor|157|||
143218570|NCT02588261|516347012|FG001|Overall Study|Study Terminated by Sponsor|142|||
143218571|NCT02588261|516347011|FG000|Overall Study|Protocol Deviation|1|||
143218572|NCT02588261|516347012|FG001|Overall Study|Protocol Deviation|0|||
143218573|NCT02588261|516347011|FG000|Overall Study|Death|1|||
143218574|NCT02588261|516347012|FG001|Overall Study|Death|2|||
143218575|NCT02588261|516347011|FG000|Overall Study|Withdrawal by Subject|12|||
143218576|NCT02588261|516347012|FG001|Overall Study|Withdrawal by Subject|8|||
143218577|NCT02588261|516347011|FG000|Overall Study|Noncompliance with Study Drug|0|||
143218578|NCT02588261|516347012|FG001|Overall Study|Noncompliance with Study Drug|1|||
143218579|NCT02588261|516347011|FG000|Overall Study|Miscellaneous|5|||
143218580|NCT02588261|516347012|FG001|Overall Study|Miscellaneous|4|||
143218581|NCT02588261|516347011|FG000|Overall Study|Progressive Disease|61|||
143218582|NCT02588261|516347012|FG001|Overall Study|Progressive Disease|82|||
143218583|NCT02588261|516347011|FG000|Overall Study|Adverse Event|29|||
143218584|NCT02588261|516347012|FG001|Overall Study|Adverse Event|24|||
143218585|NCT02588261|516347011|FG000|Overall Study|Lost to Follow-up|1|||
143218586|NCT02588261|516347012|FG001|Overall Study|Lost to Follow-up|0|||
143218587|NCT04829916|516347016|FG000|Overall Study|Withdrawal by Subject|1|||
143218588|NCT04829916|516347017|FG001|Overall Study|Withdrawal by Subject|0|||
143218589|NCT03781778|516347019|FG000|Overall Study|Withdrawal by Subject|2|||
143218590|NCT03781778|516347020|FG001|Overall Study|Withdrawal by Subject|2|||
143218591|NCT04343755|516347028|FG000|Overall Study|Death|11|||
143218592|NCT04343755|516347028|FG000|Overall Study|Screen Failure|1|||
143218593|NCT03755882|516347029|FG000|Period 1|Protocol Violation|1|||
143218594|NCT03755882|516347030|FG001|Period 1|Protocol Violation|0|||
143218595|NCT03755882|516347029|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
143218596|NCT03755882|516347030|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
143218597|NCT02292446|516347031|FG000|Overall Study|Adverse Event|12|||
143218598|NCT02292446|516347031|FG000|Overall Study|Death|1|||
143218599|NCT02292446|516347031|FG000|Overall Study|Disease progression|2|||
143218600|NCT02292446|516347031|FG000|Overall Study|Subject/guardian decision|2|||
143218601|NCT02292446|516347031|FG000|Overall Study|Withdrawal by Subject|3|||
143218602|NCT03329846|516347033|FG000|Overall Study|Disease progression|4|||
143218603|NCT03329846|516347034|FG001|Overall Study|Disease progression|6|||
143218604|NCT03329846|516347033|FG000|Overall Study|Study drug toxicity|1|||
143218605|NCT03329846|516347034|FG001|Overall Study|Study drug toxicity|0|||
143218606|NCT03329846|516347033|FG000|Overall Study|Participant request to discontinue treatment|0|||
143218607|NCT03329846|516347034|FG001|Overall Study|Participant request to discontinue treatment|1|||
143218608|NCT03329846|516347033|FG000|Overall Study|Participant withdrew consent|1|||
143218609|NCT03329846|516347034|FG001|Overall Study|Participant withdrew consent|0|||
143218610|NCT03329846|516347033|FG000|Overall Study|Other reasons|2|||
143218611|NCT03329846|516347034|FG001|Overall Study|Other reasons|2|||
143218612|NCT05636852|516347036|FG000|Overall Study|Withdrawal by Subject|1|||
143218613|NCT05636852|516347036|FG000|Overall Study|Other than specified|1|||
143218614|NCT05292131|516347037|FG000|Overall Study|Lost to Follow-up|1|||
143218615|NCT05292131|516347038|FG001|Overall Study|Lost to Follow-up|1|||
143218616|NCT05292131|516347037|FG000|Overall Study|Withdrawal by Subject|0|||
143218617|NCT05292131|516347038|FG001|Overall Study|Withdrawal by Subject|1|||
143218618|NCT00362648|516347044|FG000|Overall Study|Adverse Event|12|||
143218619|NCT00362648|516347045|FG001|Overall Study|Adverse Event|21|||
143218620|NCT00362648|516347046|FG002|Overall Study|Adverse Event|1|||
143218621|NCT00362648|516347047|FG003|Overall Study|Adverse Event|0|||
143218622|NCT00362648|516347044|FG000|Overall Study|Lost to Follow-up|62|||
143218623|NCT00362648|516347045|FG001|Overall Study|Lost to Follow-up|69|||
143218624|NCT00362648|516347046|FG002|Overall Study|Lost to Follow-up|4|||
143218625|NCT00362648|516347047|FG003|Overall Study|Lost to Follow-up|3|||
143218626|NCT00362648|516347044|FG000|Overall Study|Protocol Violation|4|||
143218627|NCT00362648|516347045|FG001|Overall Study|Protocol Violation|2|||
143218628|NCT00362648|516347046|FG002|Overall Study|Protocol Violation|2|||
143218629|NCT00362648|516347047|FG003|Overall Study|Protocol Violation|2|||
143218630|NCT00362648|516347044|FG000|Overall Study|Withdrawal by Subject|48|||
143218631|NCT00362648|516347045|FG001|Overall Study|Withdrawal by Subject|42|||
143218632|NCT00362648|516347046|FG002|Overall Study|Withdrawal by Subject|2|||
143218633|NCT00362648|516347047|FG003|Overall Study|Withdrawal by Subject|6|||
143218634|NCT02204072|516347048|FG000|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|1|||
143218635|NCT02204072|516347049|FG001|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|0|||
143218636|NCT02204072|516347050|FG002|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|2|||
143218637|NCT02204072|516347051|FG003|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|9|||
143218638|NCT02204072|516347052|FG004|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|6|||
143218639|NCT02204072|516347048|FG000|Overall Study|Discontinued Enzalutamide due to adverse events|0|||
143218640|NCT02204072|516347049|FG001|Overall Study|Discontinued Enzalutamide due to adverse events|3|||
143218641|NCT02204072|516347050|FG002|Overall Study|Discontinued Enzalutamide due to adverse events|1|||
143218642|NCT02204072|516347051|FG003|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
143218643|NCT02204072|516347052|FG004|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
143218644|NCT02204072|516347048|FG000|Overall Study|Discontinued Enzalutamide due to progressive disease|2|||
143218645|NCT02204072|516347049|FG001|Overall Study|Discontinued Enzalutamide due to progressive disease|4|||
143218646|NCT02204072|516347050|FG002|Overall Study|Discontinued Enzalutamide due to progressive disease|19|||
143218647|NCT02204072|516347051|FG003|Overall Study|Discontinued Enzalutamide due to progressive disease|26|||
143266953|NCT02310321|516531856|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|6|||
143218648|NCT02204072|516347052|FG004|Overall Study|Discontinued Enzalutamide due to progressive disease|31|||
143218649|NCT02204072|516347048|FG000|Overall Study|Discontinued Enzalutamide due to other reason|0|||
143218650|NCT02204072|516347049|FG001|Overall Study|Discontinued Enzalutamide due to other reason|0|||
143218651|NCT02204072|516347050|FG002|Overall Study|Discontinued Enzalutamide due to other reason|2|||
143218652|NCT02204072|516347051|FG003|Overall Study|Discontinued Enzalutamide due to other reason|0|||
143218653|NCT02204072|516347052|FG004|Overall Study|Discontinued Enzalutamide due to other reason|0|||
143218654|NCT03983304|516347053|FG000|Overall Study|Withdrawal by Subject|5|||
143218655|NCT03983304|516347053|FG000|Overall Study|Lost to Follow-up|2|||
143218656|NCT01587040|516347059|FG000|Overall Study|Protocol Violation|0|||
143218657|NCT01587040|516347060|FG001|Overall Study|Protocol Violation|0|||
143218658|NCT01587040|516347061|FG002|Overall Study|Protocol Violation|1|||
143218659|NCT01587040|516347062|FG003|Overall Study|Protocol Violation|0|||
143218660|NCT01587040|516347059|FG000|Overall Study|Adverse Event|0|||
143218661|NCT01587040|516347060|FG001|Overall Study|Adverse Event|1|||
143218662|NCT01587040|516347061|FG002|Overall Study|Adverse Event|10|||
143218663|NCT01587040|516347062|FG003|Overall Study|Adverse Event|0|||
143218664|NCT01587040|516347059|FG000|Overall Study|Disease progression|12|||
143218665|NCT01587040|516347060|FG001|Overall Study|Disease progression|1|||
143218666|NCT01587040|516347061|FG002|Overall Study|Disease progression|15|||
143218667|NCT01587040|516347062|FG003|Overall Study|Disease progression|3|||
143218668|NCT01587040|516347059|FG000|Overall Study|Other than specified|5|||
143218669|NCT01587040|516347060|FG001|Overall Study|Other than specified|1|||
143218670|NCT01587040|516347061|FG002|Overall Study|Other than specified|11|||
143218671|NCT01587040|516347062|FG003|Overall Study|Other than specified|1|||
143218672|NCT01518374|516347065|FG000|Overall Study|Withdrawal by Subject|2|||
143218673|NCT01518374|516347065|FG000|Overall Study|Protocol Violation|3|||
143218674|NCT01518374|516347065|FG000|Overall Study|Lost to Follow-up|2|||
143218675|NCT04607837|516347071|FG000|Overall Study|Adverse Event|8|||
143218676|NCT04607837|516347072|FG001|Overall Study|Adverse Event|2|||
143218677|NCT04607837|516347071|FG000|Overall Study|Withdrawal by Subject|8|||
143218678|NCT04607837|516347072|FG001|Overall Study|Withdrawal by Subject|7|||
143218679|NCT04607837|516347071|FG000|Overall Study|Physician Decision|2|||
143218680|NCT04607837|516347072|FG001|Overall Study|Physician Decision|0|||
143218681|NCT04607837|516347071|FG000|Overall Study|Lack of Efficacy|2|||
143218682|NCT04607837|516347072|FG001|Overall Study|Lack of Efficacy|0|||
143266954|NCT01698905|516531857|FG000|Overall Study|Adverse Event|4|||
143266955|NCT01698905|516531857|FG000|Overall Study|Physician Decision|2|||
143266956|NCT01698905|516531857|FG000|Overall Study|Pregnancy|1|||
143266957|NCT01698905|516531857|FG000|Overall Study|Protocol Violation|1|||
143266958|NCT01698905|516531857|FG000|Overall Study|Subject/guardian decision|2|||
143266959|NCT01698905|516531857|FG000|Overall Study|Death|1|||
143266960|NCT00764504|516531858|FG000|Overall Study|Death|12|||
143218683|NCT04607837|516347071|FG000|Overall Study|Participant terminated by sponsor|1|||
143218684|NCT04607837|516347072|FG001|Overall Study|Participant terminated by sponsor|0|||
143218685|NCT04607837|516347071|FG000|Overall Study|Disease worsening|36|||
143218686|NCT04607837|516347072|FG001|Overall Study|Disease worsening|36|||
143218687|NCT04607837|516347071|FG000|Overall Study|Other|1|||
143218688|NCT04607837|516347072|FG001|Overall Study|Other|0|||
143218689|NCT02362464|516347073|FG000|Overall Study|Switched to alternative therapy|1|||
143218690|NCT02362464|516347073|FG000|Overall Study|Refused further treatment|1|||
143218691|NCT02362464|516347073|FG000|Overall Study|Physician Decision|4|||
143218692|NCT00465452|516347074|FG000|Overall Study|Adverse Event|1|||
143266961|NCT00764504|516531859|FG001|Overall Study|Death|6|||
143266962|NCT00764504|516531860|FG002|Overall Study|Death|13|||
143266963|NCT00764504|516531858|FG000|Overall Study|Revision of Device|12|||
143266964|NCT00764504|516531859|FG001|Overall Study|Revision of Device|23|||
143266965|NCT00764504|516531860|FG002|Overall Study|Revision of Device|14|||
143266966|NCT00764504|516531858|FG000|Overall Study|Physician Decision|1|||
143218693|NCT05870865|516347111|FG000|Randomized|Did not receive study treatment|2|||
143218694|NCT05870865|516347112|FG001|Randomized|Did not receive study treatment|4|||
143218695|NCT05870865|516347113|FG002|Randomized|Did not receive study treatment|4|||
143218696|NCT05870865|516347114|FG003|Randomized|Did not receive study treatment|3|||
143218697|NCT05870865|516347111|FG000|Treatment Period|Adverse Event|1|||
143218698|NCT05870865|516347112|FG001|Treatment Period|Adverse Event|1|||
143218699|NCT05870865|516347113|FG002|Treatment Period|Adverse Event|1|||
143218700|NCT05870865|516347114|FG003|Treatment Period|Adverse Event|1|||
143218701|NCT05870865|516347111|FG000|Treatment Period|Lost to Follow-up|0|||
143218702|NCT05870865|516347112|FG001|Treatment Period|Lost to Follow-up|1|||
143218703|NCT05870865|516347113|FG002|Treatment Period|Lost to Follow-up|2|||
143218704|NCT05870865|516347114|FG003|Treatment Period|Lost to Follow-up|0|||
143218705|NCT05870865|516347111|FG000|Treatment Period|Protocol Violation|0|||
143218706|NCT05870865|516347112|FG001|Treatment Period|Protocol Violation|0|||
143218707|NCT05870865|516347113|FG002|Treatment Period|Protocol Violation|0|||
143218708|NCT05870865|516347114|FG003|Treatment Period|Protocol Violation|1|||
143218709|NCT05870865|516347111|FG000|Treatment Period|Withdrawal by Subject|0|||
143218710|NCT05870865|516347112|FG001|Treatment Period|Withdrawal by Subject|1|||
143218711|NCT05870865|516347113|FG002|Treatment Period|Withdrawal by Subject|1|||
143218712|NCT05870865|516347114|FG003|Treatment Period|Withdrawal by Subject|1|||
143218713|NCT00858637|516347115|FG000|Active Comparison Phase|Adverse Event|14|||
143218714|NCT00858637|516347116|FG001|Active Comparison Phase|Adverse Event|0|||
143218715|NCT00858637|516347117|FG002|Active Comparison Phase|Adverse Event|0|||
143218716|NCT00858637|516347118|FG003|Active Comparison Phase|Adverse Event|9|||
143218717|NCT00858637|516347119|FG004|Active Comparison Phase|Adverse Event|0|||
143218718|NCT00858637|516347120|FG005|Active Comparison Phase|Adverse Event|0|||
143218719|NCT00858637|516347115|FG000|Active Comparison Phase|Death|1|||
143218720|NCT00858637|516347116|FG001|Active Comparison Phase|Death|0|||
143218721|NCT00858637|516347117|FG002|Active Comparison Phase|Death|0|||
143218722|NCT00858637|516347118|FG003|Active Comparison Phase|Death|1|||
143218723|NCT00858637|516347119|FG004|Active Comparison Phase|Death|0|||
143218724|NCT00858637|516347120|FG005|Active Comparison Phase|Death|0|||
143218725|NCT00858637|516347115|FG000|Active Comparison Phase|Physician Decision|1|||
143218726|NCT00858637|516347116|FG001|Active Comparison Phase|Physician Decision|0|||
143218727|NCT00858637|516347117|FG002|Active Comparison Phase|Physician Decision|0|||
143218728|NCT00858637|516347118|FG003|Active Comparison Phase|Physician Decision|1|||
143218729|NCT00858637|516347119|FG004|Active Comparison Phase|Physician Decision|0|||
143218730|NCT00858637|516347120|FG005|Active Comparison Phase|Physician Decision|0|||
143218731|NCT00858637|516347115|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
143218732|NCT00858637|516347116|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
143218733|NCT00858637|516347117|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
143218734|NCT00858637|516347118|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
143218735|NCT00858637|516347119|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
143218736|NCT00858637|516347120|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
143218737|NCT00858637|516347115|FG000|Active Comparison Phase|Other Reasons|1|||
143218738|NCT00858637|516347116|FG001|Active Comparison Phase|Other Reasons|0|||
143218739|NCT00858637|516347117|FG002|Active Comparison Phase|Other Reasons|0|||
143218740|NCT00858637|516347118|FG003|Active Comparison Phase|Other Reasons|1|||
143218741|NCT00858637|516347119|FG004|Active Comparison Phase|Other Reasons|0|||
143218742|NCT00858637|516347120|FG005|Active Comparison Phase|Other Reasons|0|||
143218743|NCT00858637|516347115|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
143218744|NCT00858637|516347116|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
143218745|NCT00858637|516347117|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
143218746|NCT00858637|516347118|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
143218747|NCT00858637|516347119|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
143218748|NCT00858637|516347120|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
143218749|NCT00858637|516347115|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
143218750|NCT00858637|516347116|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
143218751|NCT00858637|516347117|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
143218752|NCT00858637|516347118|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
143218753|NCT00858637|516347119|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
143218754|NCT00858637|516347120|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
143218755|NCT04677504|516347121|FG000|Overall Study|Death|51|||
143218756|NCT04677504|516347122|FG001|Overall Study|Death|49|||
143218757|NCT04677504|516347121|FG000|Overall Study|Progressive Disease|1|||
143218758|NCT04677504|516347122|FG001|Overall Study|Progressive Disease|0|||
143218759|NCT04677504|516347121|FG000|Overall Study|Symptomatic Deterioration|1|||
143218760|NCT04677504|516347122|FG001|Overall Study|Symptomatic Deterioration|0|||
143218761|NCT04677504|516347121|FG000|Overall Study|Withdrawal by Subject|2|||
143218762|NCT04677504|516347122|FG001|Overall Study|Withdrawal by Subject|5|||
143218763|NCT04677504|516347121|FG000|Overall Study|Study Terminated By Sponsor|28|||
143218764|NCT04677504|516347122|FG001|Overall Study|Study Terminated By Sponsor|24|||
143218765|NCT04677504|516347121|FG000|Overall Study|Adverse Event|0|||
143218766|NCT04677504|516347122|FG001|Overall Study|Adverse Event|1|||
143218767|NCT03182907|516347123|FG000|Overall Study|Death|3|||
143218768|NCT03182907|516347124|FG001|Overall Study|Death|0|||
143218769|NCT03182907|516347123|FG000|Overall Study|Protocol Violation|4|||
143218770|NCT03182907|516347124|FG001|Overall Study|Protocol Violation|0|||
143218771|NCT03182907|516347123|FG000|Overall Study|Lost to Follow-up|1|||
143218772|NCT03182907|516347124|FG001|Overall Study|Lost to Follow-up|0|||
143218773|NCT03182907|516347123|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
143218774|NCT03182907|516347124|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
143218775|NCT02058563|516347128|FG000|Overall Study|Lost to Follow-up|26|||
143218776|NCT02058563|516347129|FG001|Overall Study|Lost to Follow-up|22|||
143218777|NCT02058563|516347128|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
143218778|NCT02058563|516347129|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
143218779|NCT02058563|516347128|FG000|Overall Study|Consent Withdrawal|1|||
143218780|NCT02058563|516347129|FG001|Overall Study|Consent Withdrawal|1|||
143218781|NCT02058563|516347128|FG000|Overall Study|Other (patient incarcerated)|0|||
143218782|NCT02058563|516347129|FG001|Overall Study|Other (patient incarcerated)|1|||
143218783|NCT00166439|516347130|FG000|Overall Study|Ineligible|5|||
143218784|NCT00615992|516347133|FG000|Overall Study|Protocol Violation|67|||
143218785|NCT03304873|516347134|FG000|Overall Study|Lost to Follow-up|1|||
143218786|NCT03304873|516347135|FG001|Overall Study|Lost to Follow-up|8|||
143218787|NCT01546688|516347136|FG000|Overall Study|Adverse Event|0|||
143218788|NCT01546688|516347137|FG001|Overall Study|Adverse Event|4|||
143218789|NCT01546688|516347136|FG000|Overall Study|Withdrawal by Subject|2|||
143218790|NCT01546688|516347137|FG001|Overall Study|Withdrawal by Subject|1|||
143218791|NCT01546688|516347136|FG000|Overall Study|Lack of Efficacy|1|||
143218792|NCT01546688|516347137|FG001|Overall Study|Lack of Efficacy|0|||
143218793|NCT00782483|516347141|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
143218794|NCT01868477|516347142|FG000|Overall Study|Adverse Event|2|||
143218795|NCT01868477|516347143|FG001|Overall Study|Adverse Event|4|||
143218796|NCT01868477|516347142|FG000|Overall Study|Disease progression|1|||
143218797|NCT01868477|516347143|FG001|Overall Study|Disease progression|1|||
143266967|NCT00764504|516531859|FG001|Overall Study|Physician Decision|0|||
143266968|NCT00764504|516531860|FG002|Overall Study|Physician Decision|0|||
143266969|NCT00764504|516531858|FG000|Overall Study|Withdrawal by Subject|1|||
143266970|NCT00764504|516531859|FG001|Overall Study|Withdrawal by Subject|7|||
143266971|NCT00764504|516531860|FG002|Overall Study|Withdrawal by Subject|4|||
143266972|NCT00764504|516531858|FG000|Overall Study|Lost to Follow-up|40|||
143266973|NCT00764504|516531859|FG001|Overall Study|Lost to Follow-up|34|||
143266974|NCT00764504|516531860|FG002|Overall Study|Lost to Follow-up|72|||
143266975|NCT02456103|516531861|FG000|Overall Study|Study Closure|207|||
143266976|NCT02456103|516531861|FG000|Overall Study|Physician Decision|1|||
143266977|NCT02456103|516531861|FG000|Overall Study|Required prohibited medications|5|||
143266978|NCT02456103|516531861|FG000|Overall Study|Protocol Violation|1|||
143266979|NCT02456103|516531861|FG000|Overall Study|Adverse Event|5|||
143266980|NCT02456103|516531861|FG000|Overall Study|Abnormal Laboratory Value|2|||
143266981|NCT02456103|516531861|FG000|Overall Study|Lost to Follow-up|1|||
143266982|NCT02456103|516531861|FG000|Overall Study|Withdrawal by Subject|24|||
143266983|NCT04010539|516531862|FG000|Overall Study|Withdrawal by Subject|4|||
143266984|NCT04010539|516531863|FG001|Overall Study|Withdrawal by Subject|1|||
143266985|NCT04010539|516531862|FG000|Overall Study|Physician Decision|0|||
143266986|NCT04010539|516531863|FG001|Overall Study|Physician Decision|2|||
143218798|NCT01868477|516347142|FG000|Overall Study|Withdrawal by Subject|1|||
143218799|NCT01868477|516347143|FG001|Overall Study|Withdrawal by Subject|0|||
143218800|NCT01052077|516347145|FG000|Phase A|Lost to Follow-up|22|||
143218801|NCT01052077|516347146|FG001|Phase A|Lost to Follow-up|0|||
143218802|NCT01052077|516347147|FG002|Phase A|Lost to Follow-up|0|||
143266987|NCT04010539|516531862|FG000|Overall Study|Lost to Follow-up|10|||
143266988|NCT04010539|516531863|FG001|Overall Study|Lost to Follow-up|14|||
143218803|NCT01052077|516347148|FG003|Phase A|Lost to Follow-up|0|||
143218804|NCT01052077|516347145|FG000|Phase A|Adverse Event|32|||
143218805|NCT01052077|516347146|FG001|Phase A|Adverse Event|0|||
143266989|NCT04010539|516531862|FG000|Overall Study|Adverse Event|3|||
143266990|NCT04010539|516531863|FG001|Overall Study|Adverse Event|0|||
143218806|NCT01052077|516347147|FG002|Phase A|Adverse Event|0|||
143218807|NCT01052077|516347148|FG003|Phase A|Adverse Event|0|||
143218808|NCT01052077|516347145|FG000|Phase A|Met Withdrawal Criteria|26|||
143218809|NCT01052077|516347146|FG001|Phase A|Met Withdrawal Criteria|0|||
143218810|NCT01052077|516347147|FG002|Phase A|Met Withdrawal Criteria|0|||
143218811|NCT01052077|516347148|FG003|Phase A|Met Withdrawal Criteria|0|||
143218812|NCT01052077|516347145|FG000|Phase A|Physician Decision|10|||
143218813|NCT01052077|516347146|FG001|Phase A|Physician Decision|0|||
143218814|NCT01052077|516347147|FG002|Phase A|Physician Decision|0|||
143218815|NCT01052077|516347148|FG003|Phase A|Physician Decision|0|||
143218816|NCT01052077|516347145|FG000|Phase A|Withdrawal by Subject|29|||
143218817|NCT01052077|516347146|FG001|Phase A|Withdrawal by Subject|0|||
143218818|NCT01052077|516347147|FG002|Phase A|Withdrawal by Subject|0|||
143218819|NCT01052077|516347148|FG003|Phase A|Withdrawal by Subject|0|||
143218820|NCT01052077|516347145|FG000|Phase A|Protocol Deviation|27|||
143218821|NCT01052077|516347146|FG001|Phase A|Protocol Deviation|0|||
143218822|NCT01052077|516347147|FG002|Phase A|Protocol Deviation|0|||
143218823|NCT01052077|516347148|FG003|Phase A|Protocol Deviation|0|||
143218824|NCT01052077|516347145|FG000|Phase B|Lost to Follow-up|0|||
143218825|NCT01052077|516347146|FG001|Phase B|Lost to Follow-up|2|||
143218826|NCT01052077|516347147|FG002|Phase B|Lost to Follow-up|3|||
143218827|NCT01052077|516347148|FG003|Phase B|Lost to Follow-up|0|||
143218828|NCT01052077|516347145|FG000|Phase B|Adverse Event|0|||
143218829|NCT01052077|516347146|FG001|Phase B|Adverse Event|9|||
143218830|NCT01052077|516347147|FG002|Phase B|Adverse Event|2|||
143218831|NCT01052077|516347148|FG003|Phase B|Adverse Event|0|||
143218832|NCT01052077|516347145|FG000|Phase B|Met Withdrawal Criteria|0|||
143218833|NCT01052077|516347146|FG001|Phase B|Met Withdrawal Criteria|2|||
143218834|NCT01052077|516347147|FG002|Phase B|Met Withdrawal Criteria|1|||
143218835|NCT01052077|516347148|FG003|Phase B|Met Withdrawal Criteria|0|||
143218836|NCT01052077|516347145|FG000|Phase B|Physician Decision|0|||
143218837|NCT01052077|516347146|FG001|Phase B|Physician Decision|1|||
143218838|NCT01052077|516347147|FG002|Phase B|Physician Decision|1|||
143218839|NCT01052077|516347148|FG003|Phase B|Physician Decision|0|||
143218840|NCT01052077|516347145|FG000|Phase B|Withdrawal by Subject|0|||
143218841|NCT01052077|516347146|FG001|Phase B|Withdrawal by Subject|0|||
143218842|NCT01052077|516347147|FG002|Phase B|Withdrawal by Subject|5|||
143218843|NCT01052077|516347148|FG003|Phase B|Withdrawal by Subject|0|||
143218844|NCT01052077|516347145|FG000|Phase B|Protocol Deviation|0|||
143218845|NCT01052077|516347146|FG001|Phase B|Protocol Deviation|3|||
143218846|NCT01052077|516347147|FG002|Phase B|Protocol Deviation|4|||
143218847|NCT01052077|516347148|FG003|Phase B|Protocol Deviation|0|||
143218848|NCT01052077|516347145|FG000|Phase B|Lack of Efficacy|0|||
143218849|NCT01052077|516347146|FG001|Phase B|Lack of Efficacy|1|||
143218850|NCT01052077|516347147|FG002|Phase B|Lack of Efficacy|0|||
143218851|NCT01052077|516347148|FG003|Phase B|Lack of Efficacy|0|||
143218852|NCT01052077|516347145|FG000|Phase A+|Lost to Follow-up|0|||
143218853|NCT01052077|516347146|FG001|Phase A+|Lost to Follow-up|0|||
143218854|NCT01052077|516347147|FG002|Phase A+|Lost to Follow-up|0|||
143218855|NCT01052077|516347148|FG003|Phase A+|Lost to Follow-up|8|||
143218856|NCT01052077|516347145|FG000|Phase A+|Adverse Event|0|||
143218857|NCT01052077|516347146|FG001|Phase A+|Adverse Event|0|||
143218858|NCT01052077|516347147|FG002|Phase A+|Adverse Event|0|||
143218859|NCT01052077|516347148|FG003|Phase A+|Adverse Event|4|||
143218860|NCT01052077|516347145|FG000|Phase A+|Met Withdrawal Criteria|0|||
143218861|NCT01052077|516347146|FG001|Phase A+|Met Withdrawal Criteria|0|||
143218862|NCT01052077|516347147|FG002|Phase A+|Met Withdrawal Criteria|0|||
143218863|NCT01052077|516347148|FG003|Phase A+|Met Withdrawal Criteria|2|||
143218864|NCT01052077|516347145|FG000|Phase A+|Withdrawal by Subject|0|||
143218865|NCT01052077|516347146|FG001|Phase A+|Withdrawal by Subject|0|||
143218866|NCT01052077|516347147|FG002|Phase A+|Withdrawal by Subject|0|||
143218867|NCT01052077|516347148|FG003|Phase A+|Withdrawal by Subject|7|||
143218868|NCT00042991|516347150|FG000|Overall Study|Adverse Event|1|||
143218869|NCT00042991|516347151|FG001|Overall Study|Adverse Event|4|||
143218870|NCT00042991|516347152|FG002|Overall Study|Adverse Event|2|||
143218871|NCT00042991|516347153|FG003|Overall Study|Adverse Event|0|||
143218872|NCT00042991|516347154|FG004|Overall Study|Adverse Event|0|||
143218873|NCT00042991|516347155|FG005|Overall Study|Adverse Event|1|||
143218874|NCT00042991|516347156|FG006|Overall Study|Adverse Event|0|||
143218875|NCT00042991|516347150|FG000|Overall Study|Withdrawal by Subject|0|||
143218876|NCT00042991|516347151|FG001|Overall Study|Withdrawal by Subject|7|||
143266991|NCT04010539|516531862|FG000|Overall Study|Participant Did Not Receive IP|0|||
143218877|NCT00042991|516347152|FG002|Overall Study|Withdrawal by Subject|2|||
143218878|NCT00042991|516347153|FG003|Overall Study|Withdrawal by Subject|0|||
143218879|NCT00042991|516347154|FG004|Overall Study|Withdrawal by Subject|1|||
143218880|NCT00042991|516347155|FG005|Overall Study|Withdrawal by Subject|0|||
143218881|NCT00042991|516347156|FG006|Overall Study|Withdrawal by Subject|0|||
143218882|NCT00042991|516347150|FG000|Overall Study|Disease Progression|5|||
143218883|NCT00042991|516347151|FG001|Overall Study|Disease Progression|29|||
143218884|NCT00042991|516347152|FG002|Overall Study|Disease Progression|2|||
143218885|NCT00042991|516347153|FG003|Overall Study|Disease Progression|2|||
143218886|NCT00042991|516347154|FG004|Overall Study|Disease Progression|1|||
143218887|NCT00042991|516347155|FG005|Overall Study|Disease Progression|4|||
143266992|NCT04010539|516531863|FG001|Overall Study|Participant Did Not Receive IP|1|||
143266993|NCT04010539|516531862|FG000|Overall Study|Protocol Deviation|0|||
143266994|NCT04010539|516531863|FG001|Overall Study|Protocol Deviation|1|||
143266995|NCT04010539|516531862|FG000|Overall Study|Randomized in Error/ Mistake|2|||
143266996|NCT04010539|516531863|FG001|Overall Study|Randomized in Error/ Mistake|0|||
143266997|NCT04010539|516531862|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
143218888|NCT00042991|516347156|FG006|Overall Study|Disease Progression|2|||
143218889|NCT00042991|516347150|FG000|Overall Study|Alternative Therapy|0|||
143218890|NCT00042991|516347151|FG001|Overall Study|Alternative Therapy|0|||
143218891|NCT00042991|516347152|FG002|Overall Study|Alternative Therapy|0|||
143218892|NCT00042991|516347153|FG003|Overall Study|Alternative Therapy|0|||
143218893|NCT00042991|516347154|FG004|Overall Study|Alternative Therapy|1|||
143218894|NCT00042991|516347155|FG005|Overall Study|Alternative Therapy|0|||
143218895|NCT00042991|516347156|FG006|Overall Study|Alternative Therapy|0|||
143218896|NCT04072887|516347157|FG000|Overall Study|Withdrawal by Subject|3|||
143218897|NCT04072887|516347158|FG001|Overall Study|Withdrawal by Subject|8|||
143218898|NCT04072887|516347159|FG002|Overall Study|Withdrawal by Subject|1|||
143218899|NCT04072887|516347160|FG003|Overall Study|Withdrawal by Subject|3|||
143218900|NCT04072887|516347161|FG004|Overall Study|Withdrawal by Subject|3|||
143218901|NCT04072887|516347162|FG005|Overall Study|Withdrawal by Subject|13|||
143218902|NCT04072887|516347157|FG000|Overall Study|Adverse Event|2|||
143218903|NCT04072887|516347158|FG001|Overall Study|Adverse Event|4|||
143218904|NCT04072887|516347159|FG002|Overall Study|Adverse Event|1|||
143218905|NCT04072887|516347160|FG003|Overall Study|Adverse Event|4|||
143218906|NCT04072887|516347161|FG004|Overall Study|Adverse Event|0|||
143218907|NCT04072887|516347162|FG005|Overall Study|Adverse Event|1|||
143218908|NCT04072887|516347157|FG000|Overall Study|Physician Decision|2|||
143218909|NCT04072887|516347158|FG001|Overall Study|Physician Decision|0|||
143266998|NCT04010539|516531863|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
143266999|NCT00249288|516531864|FG000|Overall Study|Lost to Follow-up|3|||
143267000|NCT00249288|516531865|FG001|Overall Study|Lost to Follow-up|3|||
143267001|NCT00249288|516531864|FG000|Overall Study|Withdrawal by Subject|2|||
143267002|NCT00249288|516531865|FG001|Overall Study|Withdrawal by Subject|2|||
143267003|NCT03059446|516531866|FG000|Overall Study|Adverse Event|11|||
143267004|NCT03059446|516531866|FG000|Overall Study|Withdrawal of Consent|16|||
143267005|NCT03059446|516531866|FG000|Overall Study|Lost to Follow-up|3|||
143267006|NCT03059446|516531866|FG000|Overall Study|Protocol Violation|1|||
143267007|NCT03059446|516531866|FG000|Overall Study|Study Terminated by Sponsor|131|||
143267008|NCT03059446|516531866|FG000|Overall Study|Reason not Specified|5|||
143267009|NCT00171054|516531871|FG000|Overall Study|Protocol Violation|1|||
143267010|NCT00171054|516531872|FG001|Overall Study|Protocol Violation|2|||
143267011|NCT00171054|516531871|FG000|Overall Study|Patient withdrew consent|1|||
143267012|NCT00171054|516531872|FG001|Overall Study|Patient withdrew consent|0|||
143267013|NCT00171054|516531871|FG000|Overall Study|Lost to Follow-up|0|||
143267014|NCT00171054|516531872|FG001|Overall Study|Lost to Follow-up|1|||
143267015|NCT00171054|516531871|FG000|Overall Study|Adverse Event|8|||
143267016|NCT00171054|516531872|FG001|Overall Study|Adverse Event|8|||
143267017|NCT00171054|516531871|FG000|Overall Study|Condition no longer required study drug|0|||
143267018|NCT00171054|516531872|FG001|Overall Study|Condition no longer required study drug|1|||
143267019|NCT01074047|516531879|FG000|Treatment Phase|Adverse Event|89|||
143267020|NCT01074047|516531880|FG001|Treatment Phase|Adverse Event|66|||
143267021|NCT01074047|516531879|FG000|Treatment Phase|Disease Progression|16|||
143267022|NCT01074047|516531880|FG001|Treatment Phase|Disease Progression|21|||
143267023|NCT01074047|516531879|FG000|Treatment Phase|Withdrawal by Subject|27|||
143267024|NCT01074047|516531880|FG001|Treatment Phase|Withdrawal by Subject|48|||
143267025|NCT01074047|516531879|FG000|Treatment Phase|Death|53|||
143267026|NCT01074047|516531880|FG001|Treatment Phase|Death|58|||
143267027|NCT01074047|516531879|FG000|Treatment Phase|Lost to Follow-up|0|||
143267028|NCT01074047|516531880|FG001|Treatment Phase|Lost to Follow-up|1|||
143267029|NCT01074047|516531879|FG000|Treatment Phase|Protocol Violation|0|||
143267030|NCT01074047|516531880|FG001|Treatment Phase|Protocol Violation|1|||
143267031|NCT01074047|516531879|FG000|Treatment Phase|Miscellaneous|32|||
143267032|NCT01074047|516531880|FG001|Treatment Phase|Miscellaneous|39|||
143267033|NCT01074047|516531879|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
143267034|NCT01074047|516531880|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
143267035|NCT01074047|516531879|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
143267036|NCT01074047|516531880|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
143267037|NCT01074047|516531879|FG000|Survival Follow-Up Phase|Death|116|||
143267038|NCT01074047|516531880|FG001|Survival Follow-Up Phase|Death|124|||
143267039|NCT01074047|516531879|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
143267040|NCT01074047|516531880|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
143372103|NCT02551055|516906433|FG002|Overall Study|Death|2|||
143372104|NCT02551055|516906434|FG003|Overall Study|Death|2|||
143218910|NCT04072887|516347159|FG002|Overall Study|Physician Decision|0|||
143218911|NCT04072887|516347160|FG003|Overall Study|Physician Decision|0|||
143218912|NCT04072887|516347161|FG004|Overall Study|Physician Decision|0|||
143218913|NCT04072887|516347162|FG005|Overall Study|Physician Decision|1|||
143218914|NCT04072887|516347157|FG000|Overall Study|Lost to Follow-up|1|||
143218915|NCT04072887|516347158|FG001|Overall Study|Lost to Follow-up|3|||
143218916|NCT04072887|516347159|FG002|Overall Study|Lost to Follow-up|0|||
143218917|NCT04072887|516347160|FG003|Overall Study|Lost to Follow-up|0|||
143218918|NCT04072887|516347161|FG004|Overall Study|Lost to Follow-up|0|||
143218919|NCT04072887|516347162|FG005|Overall Study|Lost to Follow-up|0|||
143218920|NCT04072887|516347157|FG000|Overall Study|Death|0|||
143218921|NCT04072887|516347158|FG001|Overall Study|Death|2|||
143218922|NCT04072887|516347159|FG002|Overall Study|Death|0|||
143218923|NCT04072887|516347160|FG003|Overall Study|Death|2|||
143218924|NCT04072887|516347161|FG004|Overall Study|Death|3|||
143218925|NCT04072887|516347162|FG005|Overall Study|Death|0|||
143218926|NCT03193736|516347163|FG000|Overall Study|Death|2|||
143218927|NCT03193736|516347163|FG000|Overall Study|Withdrawal by Subject|1|||
143218928|NCT03193736|516347163|FG000|Overall Study|Lost to Follow-up|1|||
143218929|NCT03193736|516347163|FG000|Overall Study|implant not received|1|||
143218930|NCT00856297|516347164|FG000|Overall Study|Unable to classify|2|||
143218931|NCT00856297|516347165|FG001|Overall Study|Unable to classify|0|||
143218932|NCT00856297|516347166|FG002|Overall Study|Unable to classify|0|||
143218933|NCT00856297|516347167|FG003|Overall Study|Unable to classify|0|||
143218934|NCT00856297|516347168|FG004|Overall Study|Unable to classify|0|||
143218935|NCT03369236|516347169|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
143218936|NCT03369236|516347170|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
143218937|NCT03369236|516347169|FG000|Open-label Extension Period|Lack of Efficacy|2|||
143372105|NCT02551055|516906435|FG004|Overall Study|Death|2|||
143372106|NCT02551055|516906436|FG005|Overall Study|Death|1|||
143372107|NCT02551055|516906437|FG006|Overall Study|Death|2|||
143372108|NCT02551055|516906438|FG007|Overall Study|Death|0|||
143372109|NCT02551055|516906431|FG000|Overall Study|Study Terminated by Sponsor|1|||
143372110|NCT02551055|516906432|FG001|Overall Study|Study Terminated by Sponsor|1|||
143372111|NCT02551055|516906433|FG002|Overall Study|Study Terminated by Sponsor|0|||
143372112|NCT02551055|516906434|FG003|Overall Study|Study Terminated by Sponsor|2|||
143372113|NCT02551055|516906435|FG004|Overall Study|Study Terminated by Sponsor|2|||
143372114|NCT02551055|516906436|FG005|Overall Study|Study Terminated by Sponsor|0|||
143372115|NCT02551055|516906437|FG006|Overall Study|Study Terminated by Sponsor|0|||
143372116|NCT02551055|516906438|FG007|Overall Study|Study Terminated by Sponsor|0|||
143372117|NCT02551055|516906431|FG000|Overall Study|Withdrawal by Subject|1|||
143372118|NCT02551055|516906432|FG001|Overall Study|Withdrawal by Subject|1|||
143372119|NCT02551055|516906433|FG002|Overall Study|Withdrawal by Subject|0|||
143372120|NCT02551055|516906434|FG003|Overall Study|Withdrawal by Subject|1|||
143372121|NCT02551055|516906435|FG004|Overall Study|Withdrawal by Subject|2|||
143372122|NCT02551055|516906436|FG005|Overall Study|Withdrawal by Subject|0|||
143218938|NCT03369236|516347170|FG001|Open-label Extension Period|Lack of Efficacy|1|||
143218939|NCT03369236|516347169|FG000|Open-label Extension Period|Adverse Event|0|||
143218940|NCT03369236|516347170|FG001|Open-label Extension Period|Adverse Event|1|||
143218941|NCT03369236|516347169|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
143218942|NCT03369236|516347170|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
143218943|NCT00423449|516347171|FG000|Overall Study|Clinical Adverse Event|1|||
143218944|NCT00423449|516347172|FG001|Overall Study|Clinical Adverse Event|0|||
143218945|NCT00423449|516347173|FG002|Overall Study|Clinical Adverse Event|1|||
143218946|NCT00423449|516347174|FG003|Overall Study|Clinical Adverse Event|8|||
143218947|NCT00423449|516347175|FG004|Overall Study|Clinical Adverse Event|2|||
143218948|NCT00423449|516347171|FG000|Overall Study|Death|1|||
143218949|NCT00423449|516347172|FG001|Overall Study|Death|0|||
143218950|NCT00423449|516347173|FG002|Overall Study|Death|2|||
143218951|NCT00423449|516347174|FG003|Overall Study|Death|1|||
143218952|NCT00423449|516347175|FG004|Overall Study|Death|1|||
143218953|NCT00423449|516347171|FG000|Overall Study|Progressive Disease|1|||
143218954|NCT00423449|516347172|FG001|Overall Study|Progressive Disease|3|||
143218955|NCT00423449|516347173|FG002|Overall Study|Progressive Disease|8|||
143218956|NCT00423449|516347174|FG003|Overall Study|Progressive Disease|11|||
143218957|NCT00423449|516347175|FG004|Overall Study|Progressive Disease|4|||
143218958|NCT00423449|516347171|FG000|Overall Study|Laboratory Adverse Event|0|||
143218959|NCT00423449|516347172|FG001|Overall Study|Laboratory Adverse Event|1|||
143218960|NCT00423449|516347173|FG002|Overall Study|Laboratory Adverse Event|2|||
143218961|NCT00423449|516347174|FG003|Overall Study|Laboratory Adverse Event|0|||
143218962|NCT00423449|516347175|FG004|Overall Study|Laboratory Adverse Event|0|||
143372123|NCT02551055|516906437|FG006|Overall Study|Withdrawal by Subject|0|||
143372124|NCT02551055|516906438|FG007|Overall Study|Withdrawal by Subject|0|||
143372125|NCT02551055|516906431|FG000|Overall Study|Reason not specified|0|||
143372126|NCT02551055|516906432|FG001|Overall Study|Reason not specified|0|||
143372127|NCT02551055|516906433|FG002|Overall Study|Reason not specified|0|||
143218963|NCT00423449|516347171|FG000|Overall Study|Other|0|||
143218964|NCT00423449|516347172|FG001|Overall Study|Other|0|||
143218965|NCT00423449|516347173|FG002|Overall Study|Other|0|||
143218966|NCT00423449|516347174|FG003|Overall Study|Other|1|||
143218967|NCT00423449|516347175|FG004|Overall Study|Other|0|||
143218968|NCT00423449|516347171|FG000|Overall Study|Protocol Violation|0|||
143218969|NCT00423449|516347172|FG001|Overall Study|Protocol Violation|0|||
143218970|NCT00423449|516347173|FG002|Overall Study|Protocol Violation|2|||
143218971|NCT00423449|516347174|FG003|Overall Study|Protocol Violation|1|||
143218972|NCT00423449|516347175|FG004|Overall Study|Protocol Violation|0|||
143218973|NCT01153724|516347176|FG000|Treatment Period 1|Withdrawal by Subject|1|||
143218974|NCT01153724|516347176|FG000|Treatment Period 2|Adverse Event|1|||
143218975|NCT01153724|516347176|FG000|Treatment Period 2|Other reason not defined above|1|||
143218976|NCT01445080|516347180|FG000|Overall Study|Adverse Event|5|||
143218977|NCT01445080|516347181|FG001|Overall Study|Adverse Event|3|||
143218978|NCT01445080|516347182|FG002|Overall Study|Adverse Event|11|||
143218979|NCT01445080|516347183|FG003|Overall Study|Adverse Event|6|||
143218980|NCT01445080|516347184|FG004|Overall Study|Adverse Event|2|||
143218981|NCT01445080|516347185|FG005|Overall Study|Adverse Event|3|||
143218982|NCT01445080|516347186|FG006|Overall Study|Adverse Event|0|||
143218983|NCT01445080|516347187|FG007|Overall Study|Adverse Event|3|||
143218984|NCT01445080|516347188|FG008|Overall Study|Adverse Event|10|||
143218985|NCT01445080|516347180|FG000|Overall Study|Physician Decision|0|||
143218986|NCT01445080|516347181|FG001|Overall Study|Physician Decision|0|||
143218987|NCT01445080|516347182|FG002|Overall Study|Physician Decision|1|||
143218988|NCT01445080|516347183|FG003|Overall Study|Physician Decision|0|||
143218989|NCT01445080|516347184|FG004|Overall Study|Physician Decision|0|||
143218990|NCT01445080|516347185|FG005|Overall Study|Physician Decision|3|||
143218991|NCT01445080|516347186|FG006|Overall Study|Physician Decision|2|||
143218992|NCT01445080|516347187|FG007|Overall Study|Physician Decision|2|||
143218993|NCT01445080|516347188|FG008|Overall Study|Physician Decision|0|||
143218994|NCT01445080|516347180|FG000|Overall Study|Withdrawal by Subject|1|||
143218995|NCT01445080|516347181|FG001|Overall Study|Withdrawal by Subject|0|||
143218996|NCT01445080|516347182|FG002|Overall Study|Withdrawal by Subject|0|||
143218997|NCT01445080|516347183|FG003|Overall Study|Withdrawal by Subject|1|||
143218998|NCT01445080|516347184|FG004|Overall Study|Withdrawal by Subject|0|||
143218999|NCT01445080|516347185|FG005|Overall Study|Withdrawal by Subject|0|||
143219000|NCT01445080|516347186|FG006|Overall Study|Withdrawal by Subject|0|||
143219001|NCT01445080|516347187|FG007|Overall Study|Withdrawal by Subject|0|||
143219002|NCT01445080|516347188|FG008|Overall Study|Withdrawal by Subject|2|||
143219003|NCT01445080|516347180|FG000|Overall Study|Ineligible/Inevaluable|1|||
143219004|NCT01445080|516347181|FG001|Overall Study|Ineligible/Inevaluable|2|||
143219005|NCT01445080|516347182|FG002|Overall Study|Ineligible/Inevaluable|0|||
143219006|NCT01445080|516347183|FG003|Overall Study|Ineligible/Inevaluable|1|||
143219007|NCT01445080|516347184|FG004|Overall Study|Ineligible/Inevaluable|2|||
143219008|NCT01445080|516347185|FG005|Overall Study|Ineligible/Inevaluable|3|||
143219009|NCT01445080|516347186|FG006|Overall Study|Ineligible/Inevaluable|0|||
143219010|NCT01445080|516347187|FG007|Overall Study|Ineligible/Inevaluable|0|||
143219011|NCT01445080|516347188|FG008|Overall Study|Ineligible/Inevaluable|6|||
143219012|NCT00445770|516347189|FG000|Overall Study|Adverse Event|9|||
143219013|NCT00445770|516347190|FG001|Overall Study|Adverse Event|15|||
143219014|NCT00445770|516347191|FG002|Overall Study|Adverse Event|19|||
143219015|NCT00445770|516347189|FG000|Overall Study|Lack of Efficacy|38|||
143219016|NCT00445770|516347190|FG001|Overall Study|Lack of Efficacy|13|||
143219017|NCT00445770|516347191|FG002|Overall Study|Lack of Efficacy|6|||
143219018|NCT00445770|516347189|FG000|Overall Study|Lost to Follow-up|0|||
143219019|NCT00445770|516347190|FG001|Overall Study|Lost to Follow-up|2|||
143219020|NCT00445770|516347191|FG002|Overall Study|Lost to Follow-up|0|||
143219021|NCT00445770|516347189|FG000|Overall Study|Other|6|||
143219022|NCT00445770|516347190|FG001|Overall Study|Other|5|||
143219023|NCT00445770|516347191|FG002|Overall Study|Other|6|||
143219024|NCT03857542|516347192|FG000|Overall Study|Adverse Event|1|||
143219025|NCT03857542|516347193|FG001|Overall Study|Adverse Event|3|||
143219026|NCT03857542|516347192|FG000|Overall Study|Withdrawal by Subject|2|||
143219027|NCT03857542|516347193|FG001|Overall Study|Withdrawal by Subject|1|||
143219028|NCT03857542|516347192|FG000|Overall Study|Lost to Follow-up|2|||
143219029|NCT03857542|516347193|FG001|Overall Study|Lost to Follow-up|1|||
143219030|NCT03857542|516347192|FG000|Overall Study|Reason not Specified|1|||
143219031|NCT03857542|516347193|FG001|Overall Study|Reason not Specified|0|||
143219032|NCT00811174|516347200|FG000|Overall Study|Protocol Violation|2|||
143219033|NCT00811174|516347200|FG000|Overall Study|Sponsors Decision|1|||
143219034|NCT01392547|516348414|FG000|Overall Study|Adverse Event|2|||
143219035|NCT01392547|516348414|FG000|Overall Study|Non-compliance|2|||
143219036|NCT01392547|516348414|FG000|Overall Study|Withdrawal criteria|3|||
143219037|NCT01392547|516348414|FG000|Overall Study|Unclassified|1|||
143219038|NCT02936635|516348416|FG000|Overall Study|Adverse Event|43|||
143219039|NCT02936635|516348417|FG001|Overall Study|Adverse Event|25|||
143219040|NCT02936635|516348416|FG000|Overall Study|Progressive Disease|10|||
143219041|NCT02936635|516348417|FG001|Overall Study|Progressive Disease|18|||
143219042|NCT02936635|516348416|FG000|Overall Study|Sponsor Discretion|10|||
143219043|NCT02936635|516348417|FG001|Overall Study|Sponsor Discretion|16|||
143219044|NCT02936635|516348416|FG000|Overall Study|Death|9|||
143219045|NCT02936635|516348417|FG001|Overall Study|Death|15|||
143219046|NCT02936635|516348416|FG000|Overall Study|Withdrawal by Subject|8|||
143219047|NCT02936635|516348417|FG001|Overall Study|Withdrawal by Subject|15|||
143219048|NCT02936635|516348416|FG000|Overall Study|Physician Decision|2|||
143219049|NCT02936635|516348417|FG001|Overall Study|Physician Decision|9|||
143219050|NCT02936635|516348416|FG000|Overall Study|Lost to Follow-up|1|||
143219051|NCT02936635|516348417|FG001|Overall Study|Lost to Follow-up|2|||
143219052|NCT02936635|516348416|FG000|Overall Study|Protocol Violation|1|||
143219053|NCT02936635|516348417|FG001|Overall Study|Protocol Violation|0|||
143219054|NCT02936635|516348416|FG000|Overall Study|Lack of effect/Entry into other study|31|||
143219055|NCT02936635|516348417|FG001|Overall Study|Lack of effect/Entry into other study|65|||
143219056|NCT00584012|516348418|FG000|Overall Study|Withdrawal by Subject|1|||
143219057|NCT00763386|516348420|FG000|Overall Study|Adverse Event|43|||
143219058|NCT00763386|516348421|FG001|Overall Study|Adverse Event|33|||
143219059|NCT00763386|516348420|FG000|Overall Study|Death|1|||
143219060|NCT00763386|516348421|FG001|Overall Study|Death|2|||
143219061|NCT00763386|516348420|FG000|Overall Study|Lost to Follow-up|3|||
143219062|NCT00763386|516348421|FG001|Overall Study|Lost to Follow-up|3|||
143219063|NCT00763386|516348420|FG000|Overall Study|Withdrawal by Subject|0|||
143219064|NCT00763386|516348421|FG001|Overall Study|Withdrawal by Subject|1|||
143219065|NCT00763386|516348420|FG000|Overall Study|CRF missing|0|||
143219066|NCT00763386|516348421|FG001|Overall Study|CRF missing|1|||
143219067|NCT00763386|516348420|FG000|Overall Study|Study Prosthesis Removed|1|||
143219068|NCT00763386|516348421|FG001|Overall Study|Study Prosthesis Removed|0|||
143219069|NCT00502671|516348422|FG000|Overall Study|Disease Progression|13|||
143219070|NCT00502671|516348422|FG000|Overall Study|Personal Reasons|22|||
143219071|NCT00502671|516348422|FG000|Overall Study|Lost to Follow-up|7|||
143219072|NCT00502671|516348422|FG000|Overall Study|Protocol Violation|16|||
143219073|NCT00502671|516348422|FG000|Overall Study|Adverse Event|19|||
143219074|NCT01402817|516348423|FG000|Overall Study|Withdrawal by Subject|3|||
143219075|NCT01402817|516348423|FG000|Overall Study|Study Suspended by FDA|8|||
143219076|NCT00681629|516348424|FG000|Overall Study|Study termination|4|||
143219077|NCT00681629|516348425|FG001|Overall Study|Study termination|2|||
143219078|NCT00681629|516348424|FG000|Overall Study|Adverse Event|1|||
143219079|NCT00681629|516348425|FG001|Overall Study|Adverse Event|0|||
143219080|NCT01173601|516348427|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
143219081|NCT01173601|516348428|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
143219082|NCT01173601|516348429|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
143219083|NCT01173601|516348430|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
143219084|NCT01173601|516348431|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
143219085|NCT01173601|516348427|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
143219086|NCT01173601|516348428|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
143219087|NCT01173601|516348429|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
143219088|NCT01173601|516348430|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
143219089|NCT01173601|516348431|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
143219090|NCT01173601|516348427|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
143219091|NCT01173601|516348428|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
143219092|NCT01173601|516348429|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
143219093|NCT01173601|516348430|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
143219094|NCT01173601|516348431|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
143219095|NCT01173601|516348427|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
143219096|NCT01173601|516348428|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
143219097|NCT01173601|516348429|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
143219098|NCT01173601|516348430|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
143219099|NCT01173601|516348431|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
143219100|NCT01173601|516348427|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
143219101|NCT01173601|516348428|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
143219102|NCT01173601|516348429|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
143219103|NCT01173601|516348430|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
143219104|NCT01173601|516348431|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
143219105|NCT01173601|516348427|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
143219106|NCT01173601|516348428|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
143219107|NCT01173601|516348429|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
143219108|NCT01173601|516348430|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
143219109|NCT01173601|516348431|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
143267041|NCT01074047|516531879|FG000|Extension Phase|Physician Decision|1|||
143267042|NCT01074047|516531880|FG001|Extension Phase|Physician Decision|0|||
143267043|NCT01074047|516531879|FG000|Extension Phase|Adverse Event|5|||
143267044|NCT01074047|516531880|FG001|Extension Phase|Adverse Event|0|||
143219110|NCT01173601|516348427|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
143219111|NCT01173601|516348428|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
143219112|NCT01173601|516348429|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
143219113|NCT01173601|516348430|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
143219114|NCT01173601|516348431|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
143219115|NCT01173601|516348427|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
143267045|NCT01074047|516531879|FG000|Extension Phase|Disease Progression|9|||
143267046|NCT01074047|516531880|FG001|Extension Phase|Disease Progression|0|||
143267047|NCT01074047|516531879|FG000|Extension Phase|Withdrawal by Subject|2|||
143267048|NCT01074047|516531880|FG001|Extension Phase|Withdrawal by Subject|0|||
143267049|NCT01074047|516531879|FG000|Extension Phase|Death|5|||
143267050|NCT01074047|516531880|FG001|Extension Phase|Death|0|||
143267051|NCT03635788|516531882|FG000|Step 1|Death|1|||
143267052|NCT03635788|516531883|FG001|Step 1|Death|0|||
143267053|NCT03635788|516531884|FG002|Step 1|Death|0|||
143267054|NCT03635788|516531882|FG000|Step 1|Lost to Follow-up|31|||
143267055|NCT03635788|516531883|FG001|Step 1|Lost to Follow-up|0|||
143219116|NCT01173601|516348428|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
143219117|NCT01173601|516348429|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
143219118|NCT01173601|516348430|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
143219119|NCT01173601|516348431|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
143219120|NCT01173601|516348427|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
143219121|NCT01173601|516348428|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
143219122|NCT01173601|516348429|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
143219123|NCT01173601|516348430|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
143219124|NCT01173601|516348431|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
143219125|NCT01173601|516348427|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
143219126|NCT01173601|516348428|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
143219127|NCT01173601|516348429|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
143219128|NCT01173601|516348430|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
143219129|NCT01173601|516348431|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
143219130|NCT01173601|516348427|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
143219131|NCT01173601|516348428|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
143219132|NCT01173601|516348429|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
143219133|NCT01173601|516348430|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
143219134|NCT01173601|516348431|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
143219135|NCT01173601|516348427|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
143219136|NCT01173601|516348428|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
143219137|NCT01173601|516348429|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
143219138|NCT01173601|516348430|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
143219139|NCT01173601|516348431|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
143219140|NCT01173601|516348427|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
143219141|NCT01173601|516348428|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
143219142|NCT01173601|516348429|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
143219143|NCT01173601|516348430|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
143219144|NCT01173601|516348431|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
143219145|NCT01173601|516348427|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
143219146|NCT01173601|516348428|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
143219147|NCT01173601|516348429|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
143219148|NCT01173601|516348430|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
143219149|NCT01173601|516348431|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
143219150|NCT02274792|516348432|FG000|Overall Study|Withdrawal by Subject|13|||
143219151|NCT02274792|516348432|FG000|Overall Study|Lost to Follow-up|8|||
143219152|NCT02274792|516348432|FG000|Overall Study|Protocol Specified Criteria|2|||
143219153|NCT02274792|516348432|FG000|Overall Study|Sponsor Decision|2|||
143219154|NCT01510158|516348433|FG000|Overall Study|Adverse Event|7|||
143219155|NCT01510158|516348434|FG001|Overall Study|Adverse Event|8|||
143219156|NCT01510158|516348435|FG002|Overall Study|Adverse Event|5|||
143219157|NCT01510158|516348433|FG000|Overall Study|Gout flare|1|||
143219158|NCT01510158|516348434|FG001|Overall Study|Gout flare|0|||
143219159|NCT01510158|516348435|FG002|Overall Study|Gout flare|0|||
143219160|NCT01510158|516348433|FG000|Overall Study|Protocol Violation|17|||
143267056|NCT03635788|516531884|FG002|Step 1|Lost to Follow-up|0|||
143267057|NCT03635788|516531882|FG000|Step 1|Pregnancy|1|||
143267058|NCT03635788|516531883|FG001|Step 1|Pregnancy|0|||
143267059|NCT03635788|516531884|FG002|Step 1|Pregnancy|0|||
143267060|NCT03635788|516531882|FG000|Step 1|Protocol Violation|8|||
143267061|NCT03635788|516531883|FG001|Step 1|Protocol Violation|0|||
143219161|NCT01510158|516348434|FG001|Overall Study|Protocol Violation|16|||
143219162|NCT01510158|516348435|FG002|Overall Study|Protocol Violation|24|||
143219163|NCT01510158|516348433|FG000|Overall Study|Sponsor terminated study.|2|||
143219164|NCT01510158|516348434|FG001|Overall Study|Sponsor terminated study.|0|||
143219165|NCT01510158|516348435|FG002|Overall Study|Sponsor terminated study.|2|||
143267062|NCT03635788|516531884|FG002|Step 1|Protocol Violation|0|||
143267063|NCT03635788|516531882|FG000|Step 1|Withdrawal by Subject|13|||
143267064|NCT03635788|516531883|FG001|Step 1|Withdrawal by Subject|0|||
143267065|NCT03635788|516531884|FG002|Step 1|Withdrawal by Subject|0|||
143267066|NCT03635788|516531882|FG000|Step 1|Other reasons|12|||
143267067|NCT03635788|516531883|FG001|Step 1|Other reasons|0|||
143219166|NCT01510158|516348433|FG000|Overall Study|Lost to Follow-up|13|||
143219167|NCT01510158|516348434|FG001|Overall Study|Lost to Follow-up|16|||
143219168|NCT01510158|516348435|FG002|Overall Study|Lost to Follow-up|9|||
143219169|NCT01510158|516348433|FG000|Overall Study|Withdrawal by Subject|10|||
143219170|NCT01510158|516348434|FG001|Overall Study|Withdrawal by Subject|13|||
143219171|NCT01510158|516348435|FG002|Overall Study|Withdrawal by Subject|10|||
143219172|NCT01510158|516348433|FG000|Overall Study|Death|1|||
143219173|NCT01510158|516348434|FG001|Overall Study|Death|0|||
143219174|NCT01510158|516348435|FG002|Overall Study|Death|0|||
143219175|NCT05258149|516348442|FG000|Period 1|Protocol Deviation|1|||
143219176|NCT05258149|516348443|FG001|Period 1|Protocol Deviation|0|||
143219177|NCT05258149|516348442|FG000|Period 1|Adverse Event|0|||
143219178|NCT05258149|516348443|FG001|Period 1|Adverse Event|1|||
143219179|NCT05258149|516348442|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
143219180|NCT05258149|516348443|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
143219181|NCT05258149|516348442|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
143219182|NCT05258149|516348443|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
143219183|NCT05258149|516348442|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
143219184|NCT05258149|516348443|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
143219185|NCT05786508|516348444|FG000|Overall Study|Withdrawal by Subject|2|||
143219186|NCT05786508|516348445|FG001|Overall Study|Withdrawal by Subject|0|||
143219187|NCT04426318|516348446|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
143219188|NCT04426318|516348447|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
143219189|NCT02287467|516348448|FG000|Overall Study|Protocol Violation|12|||
143219190|NCT02287467|516348449|FG001|Overall Study|Protocol Violation|9|||
143219191|NCT01957202|516348450|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
143219192|NCT01957202|516348451|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
143219193|NCT01957202|516348452|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
143219194|NCT01957202|516348453|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
143219195|NCT01957202|516348454|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
143219196|NCT01957202|516348455|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
143219197|NCT01957202|516348456|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
143219198|NCT01957202|516348457|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
143219199|NCT01957202|516348458|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
143219200|NCT01957202|516348459|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
143219201|NCT01957202|516348460|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
143219202|NCT01957202|516348461|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
143219203|NCT01957202|516348462|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
143219204|NCT01957202|516348463|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
143219205|NCT01957202|516348464|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
143219206|NCT01957202|516348465|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
143219207|NCT01957202|516348466|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
143267068|NCT03635788|516531884|FG002|Step 1|Other reasons|0|||
143267069|NCT03635788|516531882|FG000|Step 1|On Step 1 as of February 12, 2024|27|||
143267070|NCT03635788|516531883|FG001|Step 1|On Step 1 as of February 12, 2024|0|||
143267071|NCT03635788|516531884|FG002|Step 1|On Step 1 as of February 12, 2024|0|||
143267072|NCT03635788|516531882|FG000|Step 2|Lost to Follow-up|0|||
143267073|NCT03635788|516531883|FG001|Step 2|Lost to Follow-up|8|||
143267074|NCT03635788|516531884|FG002|Step 2|Lost to Follow-up|15|||
143267075|NCT03635788|516531882|FG000|Step 2|Withdrawal by Subject|0|||
143267076|NCT03635788|516531883|FG001|Step 2|Withdrawal by Subject|6|||
143267077|NCT03635788|516531884|FG002|Step 2|Withdrawal by Subject|6|||
143267078|NCT03635788|516531882|FG000|Step 2|Death|0|||
143267079|NCT03635788|516531883|FG001|Step 2|Death|2|||
143267080|NCT03635788|516531884|FG002|Step 2|Death|0|||
143267081|NCT03635788|516531882|FG000|Step 2|Incarceration|0|||
143267082|NCT03635788|516531883|FG001|Step 2|Incarceration|2|||
143267083|NCT03635788|516531884|FG002|Step 2|Incarceration|0|||
143267084|NCT03635788|516531882|FG000|Step 2|Non-Compliance With Study Requirements|0|||
143267085|NCT03635788|516531883|FG001|Step 2|Non-Compliance With Study Requirements|1|||
143372128|NCT02551055|516906434|FG003|Overall Study|Reason not specified|0|||
143267086|NCT03635788|516531884|FG002|Step 2|Non-Compliance With Study Requirements|1|||
143372129|NCT02551055|516906435|FG004|Overall Study|Reason not specified|1|||
143267087|NCT03635788|516531882|FG000|Step 2|Confounding Medical Condition|0|||
143372130|NCT02551055|516906436|FG005|Overall Study|Reason not specified|0|||
143219208|NCT01957202|516348467|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
143219209|NCT01957202|516348450|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
143219210|NCT01957202|516348451|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
143219211|NCT01957202|516348452|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
143219212|NCT01957202|516348453|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
143219213|NCT01957202|516348454|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
143267088|NCT03635788|516531883|FG001|Step 2|Confounding Medical Condition|0|||
143267089|NCT03635788|516531884|FG002|Step 2|Confounding Medical Condition|1|||
143267090|NCT03635788|516531882|FG000|Step 2|Out Of State With No Plan To Return|0|||
143267091|NCT03635788|516531883|FG001|Step 2|Out Of State With No Plan To Return|1|||
143219214|NCT01957202|516348455|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
143219215|NCT01957202|516348456|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
143219216|NCT01957202|516348457|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
143219217|NCT01957202|516348458|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
143219218|NCT01957202|516348459|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
143219219|NCT01957202|516348460|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
143219220|NCT01957202|516348461|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
143219221|NCT01957202|516348462|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
143219222|NCT01957202|516348463|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
143219223|NCT01957202|516348464|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
143219224|NCT01957202|516348465|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
143219225|NCT01957202|516348466|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
143219226|NCT01957202|516348467|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
143219227|NCT06041919|516348470|FG000|Overall Study|Lost to Follow-up|1|||
143219228|NCT06041919|516348471|FG001|Overall Study|Lost to Follow-up|0|||
143219229|NCT06041919|516348472|FG002|Overall Study|Lost to Follow-up|0|||
143219230|NCT06041919|516348473|FG003|Overall Study|Lost to Follow-up|0|||
143219231|NCT06041919|516348474|FG004|Overall Study|Lost to Follow-up|0|||
143219232|NCT06041919|516348470|FG000|Overall Study|At the request of the investigator or the sponsor|0|||
143219233|NCT06041919|516348471|FG001|Overall Study|At the request of the investigator or the sponsor|1|||
143219234|NCT06041919|516348472|FG002|Overall Study|At the request of the investigator or the sponsor|0|||
143219235|NCT06041919|516348473|FG003|Overall Study|At the request of the investigator or the sponsor|0|||
143219236|NCT06041919|516348474|FG004|Overall Study|At the request of the investigator or the sponsor|0|||
143219237|NCT01625000|516348478|FG000|Overall Study|Physician Decision|15|||
143219238|NCT01625000|516348479|FG001|Overall Study|Physician Decision|7|||
143219239|NCT01625000|516348480|FG002|Overall Study|Physician Decision|7|||
143219240|NCT01625000|516348481|FG003|Overall Study|Physician Decision|2|||
143219241|NCT01625000|516348482|FG004|Overall Study|Physician Decision|15|||
143219242|NCT01625000|516348478|FG000|Overall Study|Protocol Violation|3|||
143219243|NCT01625000|516348479|FG001|Overall Study|Protocol Violation|10|||
143219244|NCT01625000|516348480|FG002|Overall Study|Protocol Violation|4|||
143219245|NCT01625000|516348481|FG003|Overall Study|Protocol Violation|1|||
143219246|NCT01625000|516348482|FG004|Overall Study|Protocol Violation|2|||
143219247|NCT01625000|516348478|FG000|Overall Study|Withdrawal by Subject|19|||
143219248|NCT01625000|516348479|FG001|Overall Study|Withdrawal by Subject|16|||
143219249|NCT01625000|516348480|FG002|Overall Study|Withdrawal by Subject|11|||
143219250|NCT01625000|516348481|FG003|Overall Study|Withdrawal by Subject|9|||
143219251|NCT01625000|516348482|FG004|Overall Study|Withdrawal by Subject|17|||
143219252|NCT01625000|516348478|FG000|Overall Study|Adverse Event (including Death)|15|||
143219253|NCT01625000|516348479|FG001|Overall Study|Adverse Event (including Death)|19|||
143219254|NCT01625000|516348480|FG002|Overall Study|Adverse Event (including Death)|11|||
143219255|NCT01625000|516348481|FG003|Overall Study|Adverse Event (including Death)|7|||
143219256|NCT01625000|516348482|FG004|Overall Study|Adverse Event (including Death)|21|||
143219257|NCT04137731|516348485|FG000|Overall Study|Surgery Cancellation|1|||
143219258|NCT04137731|516348486|FG001|Overall Study|Surgery Cancellation|2|||
143219259|NCT04137731|516348485|FG000|Overall Study|Withdrawal by Subject|2|||
143219260|NCT04137731|516348486|FG001|Overall Study|Withdrawal by Subject|0|||
143219261|NCT04137731|516348485|FG000|Overall Study|Protocol Violation|0|||
143219262|NCT04137731|516348486|FG001|Overall Study|Protocol Violation|1|||
143219263|NCT00310817|516348490|FG000|Overall Study|AE or Death|3|||
143219264|NCT00310817|516348491|FG001|Overall Study|AE or Death|1|||
143219265|NCT00310817|516348492|FG002|Overall Study|AE or Death|0|||
143219266|NCT00310817|516348493|FG003|Overall Study|AE or Death|0|||
143219267|NCT00310817|516348490|FG000|Overall Study|Withdrawal by Subject|1|||
143219268|NCT00310817|516348491|FG001|Overall Study|Withdrawal by Subject|4|||
143219269|NCT00310817|516348492|FG002|Overall Study|Withdrawal by Subject|6|||
143219270|NCT00310817|516348493|FG003|Overall Study|Withdrawal by Subject|7|||
143219271|NCT00310817|516348490|FG000|Overall Study|Lost to Follow-up|2|||
143219272|NCT00310817|516348491|FG001|Overall Study|Lost to Follow-up|1|||
143219273|NCT00310817|516348492|FG002|Overall Study|Lost to Follow-up|0|||
143219274|NCT00310817|516348493|FG003|Overall Study|Lost to Follow-up|0|||
143219275|NCT00310817|516348490|FG000|Overall Study|Inappropriate Enrollment|1|||
143267092|NCT03635788|516531884|FG002|Step 2|Out Of State With No Plan To Return|0|||
143267093|NCT03635788|516531882|FG000|Step 2|Switched To Injectables|0|||
143267094|NCT03635788|516531883|FG001|Step 2|Switched To Injectables|0|||
143219276|NCT00310817|516348491|FG001|Overall Study|Inappropriate Enrollment|0|||
143219277|NCT00310817|516348492|FG002|Overall Study|Inappropriate Enrollment|1|||
143219278|NCT00310817|516348493|FG003|Overall Study|Inappropriate Enrollment|0|||
143219279|NCT00310817|516348490|FG000|Overall Study|Protocol Violation|1|||
143219280|NCT00310817|516348491|FG001|Overall Study|Protocol Violation|1|||
143267095|NCT03635788|516531884|FG002|Step 2|Switched To Injectables|1|||
143219281|NCT00310817|516348492|FG002|Overall Study|Protocol Violation|1|||
143219282|NCT00310817|516348493|FG003|Overall Study|Protocol Violation|1|||
143219283|NCT00310817|516348490|FG000|Overall Study|Unable to classify|3|||
143219284|NCT00310817|516348491|FG001|Overall Study|Unable to classify|1|||
143219285|NCT00310817|516348492|FG002|Overall Study|Unable to classify|0|||
143219286|NCT00310817|516348493|FG003|Overall Study|Unable to classify|0|||
143219287|NCT04300309|516348494|FG000|Overall Study|Lost to Follow-up|1|||
143219288|NCT04300309|516348495|FG001|Overall Study|Lost to Follow-up|0|||
143219289|NCT04346654|516348496|FG000|Overall Study|Adverse Event|2|||
143219290|NCT04346654|516348497|FG001|Overall Study|Adverse Event|0|||
143219291|NCT04346654|516348496|FG000|Overall Study|Non-response|1|||
143219292|NCT04346654|516348497|FG001|Overall Study|Non-response|1|||
143219293|NCT04346654|516348496|FG000|Overall Study|Withdrawal by Subject|2|||
143219294|NCT04346654|516348497|FG001|Overall Study|Withdrawal by Subject|0|||
143219295|NCT04346654|516348496|FG000|Overall Study|Lost to Follow-up|0|||
143219296|NCT04346654|516348497|FG001|Overall Study|Lost to Follow-up|1|||
143219297|NCT04346654|516348496|FG000|Overall Study|Pregnancy|0|||
143219298|NCT04346654|516348497|FG001|Overall Study|Pregnancy|1|||
143219299|NCT03828019|516348501|FG000|Overall Study|Withdrawal by Subject|3|||
143219300|NCT03828019|516348502|FG001|Overall Study|Withdrawal by Subject|8|||
143219301|NCT03828019|516348501|FG000|Overall Study|Lost to Follow-up|1|||
143219302|NCT03828019|516348502|FG001|Overall Study|Lost to Follow-up|6|||
143219303|NCT03828019|516348501|FG000|Overall Study|Incarcerated|1|||
143219304|NCT03828019|516348502|FG001|Overall Study|Incarcerated|0|||
143219305|NCT03828019|516348501|FG000|Overall Study|Adverse Event|0|||
143219306|NCT03828019|516348502|FG001|Overall Study|Adverse Event|1|||
143219307|NCT05715242|516348503|FG000|Overall Study|Lost to Follow-up|0|||
143219308|NCT05715242|516348504|FG001|Overall Study|Lost to Follow-up|0|||
143219309|NCT05715242|516348505|FG002|Overall Study|Lost to Follow-up|1|||
143219310|NCT05715242|516348506|FG003|Overall Study|Lost to Follow-up|0|||
143219311|NCT05715242|516348507|FG004|Overall Study|Lost to Follow-up|0|||
143219312|NCT05715242|516348508|FG005|Overall Study|Lost to Follow-up|1|||
143219313|NCT05715242|516348509|FG006|Overall Study|Lost to Follow-up|0|||
143219314|NCT05715242|516348510|FG007|Overall Study|Lost to Follow-up|0|||
143219315|NCT05715242|516348511|FG008|Overall Study|Lost to Follow-up|0|||
143267096|NCT03635788|516531882|FG000|Step 2|On Step 2 as of February 12, 2024|0|||
143267097|NCT03635788|516531883|FG001|Step 2|On Step 2 as of February 12, 2024|56|||
143267098|NCT03635788|516531884|FG002|Step 2|On Step 2 as of February 12, 2024|56|||
143267099|NCT01015131|516531885|FG000|Overall Study|Physician Decision|1|||
143267100|NCT01015131|516531885|FG000|Overall Study|Protocol Violation|1|||
143267101|NCT01015131|516531885|FG000|Overall Study|Withdrawal by Subject|2|||
143267102|NCT01015131|516531885|FG000|Overall Study|Other Protocol Specified Criteria|4|||
143267103|NCT05521906|516531890|FG000|Overall Study|removed by researchers for offensive or deceptive behavior|9|||
143267104|NCT05521906|516531891|FG001|Overall Study|removed by researchers for offensive or deceptive behavior|1|||
143267105|NCT03148275|516531892|FG000|Overall Study|Death|6|||
143267106|NCT03148275|516531892|FG000|Overall Study|Adverse Event|3|||
143267107|NCT03148275|516531892|FG000|Overall Study|Liver transplant|2|||
143267108|NCT03148275|516531892|FG000|Overall Study|Patient decision|5|||
143267109|NCT03148275|516531892|FG000|Overall Study|transition to commercial drug|1|||
143267110|NCT03148275|516531892|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
143267111|NCT02572388|516533060|FG000|Overall Study|Withdrawal by Subject|1|||
143267112|NCT02572388|516533061|FG001|Overall Study|Withdrawal by Subject|1|||
143267113|NCT02572388|516533062|FG002|Overall Study|Withdrawal by Subject|2|||
143267114|NCT02572388|516533063|FG003|Overall Study|Withdrawal by Subject|2|||
143267115|NCT00810108|516533064|FG000|Overall Study|Withdrawal by Subject|1|||
143267116|NCT00810108|516533065|FG001|Overall Study|Withdrawal by Subject|0|||
143267117|NCT00137631|516533066|FG000|Overall Study|Lost to Follow-up|37|||
143267118|NCT00137631|516533067|FG001|Overall Study|Lost to Follow-up|41|||
143267119|NCT02600351|516533068|FG000|Overall Study|Lack of Efficacy|3|||
143219316|NCT05715242|516348512|FG009|Overall Study|Lost to Follow-up|0|||
143219317|NCT05715242|516348513|FG010|Overall Study|Lost to Follow-up|0|||
143267120|NCT02600351|516533069|FG001|Overall Study|Lack of Efficacy|0|||
143267121|NCT02600351|516533070|FG002|Overall Study|Lack of Efficacy|5|||
143267122|NCT02600351|516533071|FG003|Overall Study|Lack of Efficacy|2|||
143267123|NCT02600351|516533068|FG000|Overall Study|Lost to Follow-up|1|||
143219318|NCT05715242|516348514|FG011|Overall Study|Lost to Follow-up|0|||
143219319|NCT05715242|516348515|FG012|Overall Study|Lost to Follow-up|0|||
143219320|NCT05715242|516348516|FG013|Overall Study|Lost to Follow-up|0|||
143267124|NCT02600351|516533069|FG001|Overall Study|Lost to Follow-up|0|||
143267125|NCT02600351|516533070|FG002|Overall Study|Lost to Follow-up|0|||
143267126|NCT02600351|516533071|FG003|Overall Study|Lost to Follow-up|0|||
143267127|NCT02600351|516533068|FG000|Overall Study|Randomized but Not Treated|1|||
143267128|NCT02600351|516533069|FG001|Overall Study|Randomized but Not Treated|0|||
143219321|NCT05715242|516348517|FG014|Overall Study|Lost to Follow-up|0|||
143219322|NCT05715242|516348518|FG015|Overall Study|Lost to Follow-up|0|||
143219323|NCT00048347|516348521|FG000|Overall Study|Screen failure|2|||
143219324|NCT02343406|516348522|FG000|Overall Study|Progressive disease|72|||
143219325|NCT02343406|516348523|FG001|Overall Study|Progressive disease|70|||
143219326|NCT02343406|516348524|FG002|Overall Study|Progressive disease|43|||
143219327|NCT02343406|516348525|FG003|Overall Study|Progressive disease|15|||
143219328|NCT02343406|516348526|FG004|Overall Study|Progressive disease|5|||
143219329|NCT02343406|516348522|FG000|Overall Study|Adverse Event|6|||
143219330|NCT02343406|516348523|FG001|Overall Study|Adverse Event|8|||
143219331|NCT02343406|516348524|FG002|Overall Study|Adverse Event|6|||
143219332|NCT02343406|516348525|FG003|Overall Study|Adverse Event|3|||
143219333|NCT02343406|516348526|FG004|Overall Study|Adverse Event|0|||
143219334|NCT02343406|516348522|FG000|Overall Study|Withdrawal by Subject|6|||
143219335|NCT02343406|516348523|FG001|Overall Study|Withdrawal by Subject|4|||
143219336|NCT02343406|516348524|FG002|Overall Study|Withdrawal by Subject|8|||
143219337|NCT02343406|516348525|FG003|Overall Study|Withdrawal by Subject|3|||
143219338|NCT02343406|516348526|FG004|Overall Study|Withdrawal by Subject|0|||
143219339|NCT02343406|516348522|FG000|Overall Study|Death|2|||
143219340|NCT02343406|516348523|FG001|Overall Study|Death|1|||
143219341|NCT02343406|516348524|FG002|Overall Study|Death|0|||
143219342|NCT02343406|516348525|FG003|Overall Study|Death|0|||
143219343|NCT02343406|516348526|FG004|Overall Study|Death|0|||
143219344|NCT02343406|516348522|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
143219345|NCT02343406|516348523|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
143219346|NCT02343406|516348524|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
143219347|NCT02343406|516348525|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
143219348|NCT02343406|516348526|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
143219349|NCT02343406|516348522|FG000|Overall Study|Other primary malignancy|0|||
143219350|NCT02343406|516348523|FG001|Overall Study|Other primary malignancy|1|||
143219351|NCT02343406|516348524|FG002|Overall Study|Other primary malignancy|0|||
143219352|NCT02343406|516348525|FG003|Overall Study|Other primary malignancy|0|||
143219353|NCT02343406|516348526|FG004|Overall Study|Other primary malignancy|0|||
143219354|NCT02343406|516348522|FG000|Overall Study|Other, not specified|2|||
143219355|NCT02343406|516348523|FG001|Overall Study|Other, not specified|1|||
143219356|NCT02343406|516348524|FG002|Overall Study|Other, not specified|1|||
143219357|NCT02343406|516348525|FG003|Overall Study|Other, not specified|4|||
143219358|NCT02343406|516348526|FG004|Overall Study|Other, not specified|0|||
143219359|NCT01380834|516348527|FG000|Overall Study|Physician Decision|1|||
143219360|NCT01380834|516348528|FG001|Overall Study|Physician Decision|0|||
143219361|NCT04039217|516348531|FG000|Overall Study|Lost to Follow-up|1|||
143219362|NCT00167310|516348532|FG000|Overall Study|Protocol Violation|5|||
143219363|NCT00167310|516348533|FG001|Overall Study|Protocol Violation|3|||
143219364|NCT00167310|516348532|FG000|Overall Study|Withdrawal by Subject|3|||
143219365|NCT00167310|516348533|FG001|Overall Study|Withdrawal by Subject|7|||
143219366|NCT04522141|516348534|FG000|Overall Study|Withdrawal by Subject|1|||
143219367|NCT04522141|516348535|FG001|Overall Study|Withdrawal by Subject|0|||
143219368|NCT03319212|516348536|FG000|Overall Study|Discontinued as moving out of local area|0|||
143219369|NCT03319212|516348537|FG001|Overall Study|Discontinued as moving out of local area|1|||
143219370|NCT03319212|516348536|FG000|Overall Study|Adverse Event|2|||
143219371|NCT03319212|516348537|FG001|Overall Study|Adverse Event|2|||
143219372|NCT03319212|516348536|FG000|Overall Study|Withdrawal by Subject|0|||
143219373|NCT03319212|516348537|FG001|Overall Study|Withdrawal by Subject|1|||
143219374|NCT03319212|516348536|FG000|Overall Study|Lost to Follow-up|0|||
143219375|NCT03319212|516348537|FG001|Overall Study|Lost to Follow-up|1|||
143219376|NCT03319212|516348536|FG000|Overall Study|Physician Decision|1|||
143219377|NCT03319212|516348537|FG001|Overall Study|Physician Decision|0|||
143219378|NCT00250276|516348538|FG000|Overall Study|Serious Adverse Event|0|||
143219379|NCT00250276|516348539|FG001|Overall Study|Serious Adverse Event|0|||
143219380|NCT00250276|516348540|FG002|Overall Study|Serious Adverse Event|1|||
143219381|NCT00250276|516348541|FG003|Overall Study|Serious Adverse Event|0|||
143219382|NCT00250276|516348538|FG000|Overall Study|Non-serious Adverse Event|2|||
143219383|NCT00250276|516348539|FG001|Overall Study|Non-serious Adverse Event|0|||
143219384|NCT00250276|516348540|FG002|Overall Study|Non-serious Adverse Event|0|||
143219385|NCT00250276|516348541|FG003|Overall Study|Non-serious Adverse Event|2|||
143219386|NCT00250276|516348538|FG000|Overall Study|Protocol Violation|0|||
143219387|NCT00250276|516348539|FG001|Overall Study|Protocol Violation|1|||
143219388|NCT00250276|516348540|FG002|Overall Study|Protocol Violation|0|||
143219389|NCT00250276|516348541|FG003|Overall Study|Protocol Violation|0|||
143219390|NCT00250276|516348538|FG000|Overall Study|Withdrawal by Subject|1|||
143219391|NCT00250276|516348539|FG001|Overall Study|Withdrawal by Subject|2|||
143219392|NCT00250276|516348540|FG002|Overall Study|Withdrawal by Subject|3|||
143219393|NCT00250276|516348541|FG003|Overall Study|Withdrawal by Subject|2|||
143219394|NCT00250276|516348538|FG000|Overall Study|Migrated/moved from study area|3|||
143219395|NCT00250276|516348539|FG001|Overall Study|Migrated/moved from study area|0|||
143219396|NCT00250276|516348540|FG002|Overall Study|Migrated/moved from study area|2|||
143219397|NCT00250276|516348541|FG003|Overall Study|Migrated/moved from study area|7|||
143219398|NCT00250276|516348538|FG000|Overall Study|Lost to Follow-up|11|||
143219399|NCT00250276|516348539|FG001|Overall Study|Lost to Follow-up|18|||
143219400|NCT00250276|516348540|FG002|Overall Study|Lost to Follow-up|13|||
143219401|NCT00250276|516348541|FG003|Overall Study|Lost to Follow-up|8|||
143219402|NCT03543137|516348542|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
143219403|NCT03543137|516348543|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
143219404|NCT03543137|516348542|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
143219405|NCT03543137|516348543|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
143219406|NCT03543137|516348542|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
143219407|NCT03543137|516348543|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
143219408|NCT01811186|516348544|FG000|Overall Study|Adverse Event|54|||
143219409|NCT01811186|516348545|FG001|Overall Study|Adverse Event|38|||
143219410|NCT01811186|516348544|FG000|Overall Study|Protocol Violation|5|||
143219411|NCT01811186|516348545|FG001|Overall Study|Protocol Violation|6|||
143219412|NCT01811186|516348544|FG000|Overall Study|Withdrawal by Subject|5|||
143219413|NCT01811186|516348545|FG001|Overall Study|Withdrawal by Subject|10|||
143219414|NCT01811186|516348544|FG000|Overall Study|Lack of Efficacy|3|||
143219415|NCT01811186|516348545|FG001|Overall Study|Lack of Efficacy|6|||
143219416|NCT01811186|516348544|FG000|Overall Study|Lost to Follow-up|4|||
143219417|NCT01811186|516348545|FG001|Overall Study|Lost to Follow-up|2|||
143219418|NCT00367835|516348550|FG000|Overall Study|Adverse Event|14|||
143219419|NCT00367835|516348551|FG001|Overall Study|Adverse Event|1|||
143219420|NCT00367835|516348550|FG000|Overall Study|Protocol Violation|1|||
143219421|NCT00367835|516348551|FG001|Overall Study|Protocol Violation|7|||
143219422|NCT00367835|516348550|FG000|Overall Study|Withdrawal by Subject|7|||
143219423|NCT00367835|516348551|FG001|Overall Study|Withdrawal by Subject|6|||
143219424|NCT00367835|516348550|FG000|Overall Study|Lost to Follow-up|1|||
143219425|NCT00367835|516348551|FG001|Overall Study|Lost to Follow-up|4|||
143219426|NCT00367835|516348550|FG000|Overall Study|Lack of Efficacy|3|||
143219427|NCT00367835|516348551|FG001|Overall Study|Lack of Efficacy|12|||
143219428|NCT00367835|516348550|FG000|Overall Study|Subject in juvenile detention center|1|||
143219429|NCT00367835|516348551|FG001|Overall Study|Subject in juvenile detention center|0|||
143219430|NCT00367835|516348550|FG000|Overall Study|refused blood collection|1|||
143219431|NCT00367835|516348551|FG001|Overall Study|refused blood collection|0|||
143219432|NCT00367835|516348550|FG000|Overall Study|Did not respond to calls|1|||
143219433|NCT00367835|516348551|FG001|Overall Study|Did not respond to calls|0|||
143219434|NCT00367835|516348550|FG000|Overall Study|History of lead poisoning|0|||
143219435|NCT00367835|516348551|FG001|Overall Study|History of lead poisoning|1|||
143219436|NCT02697435|516348552|FG000|Overall Study|Withdrawal by Subject|1|||
143219437|NCT02697435|516348553|FG001|Overall Study|Withdrawal by Subject|0|||
143219438|NCT02697435|516348552|FG000|Overall Study|Physician Decision|0|||
143219439|NCT02697435|516348553|FG001|Overall Study|Physician Decision|4|||
143219440|NCT01574651|516348554|FG000|Overall Study|Lost to Follow-up|2|||
143219441|NCT01574651|516348555|FG001|Overall Study|Lost to Follow-up|4|||
143219442|NCT01574651|516348554|FG000|Overall Study|Administrative problems|0|||
143219443|NCT01574651|516348555|FG001|Overall Study|Administrative problems|1|||
143219444|NCT01574651|516348554|FG000|Overall Study|Death|3|||
143219445|NCT01574651|516348555|FG001|Overall Study|Death|3|||
143219446|NCT01574651|516348554|FG000|Overall Study|Patient's inability to use the device|0|||
143219447|NCT01574651|516348555|FG001|Overall Study|Patient's inability to use the device|1|||
143219448|NCT01574651|516348554|FG000|Overall Study|Adverse Event|36|||
143219449|NCT01574651|516348555|FG001|Overall Study|Adverse Event|27|||
143219450|NCT01574651|516348554|FG000|Overall Study|Abnormal laboratory value(s)|1|||
143219451|NCT01574651|516348555|FG001|Overall Study|Abnormal laboratory value(s)|0|||
143372131|NCT02551055|516906437|FG006|Overall Study|Reason not specified|1|||
143219452|NCT01574651|516348554|FG000|Overall Study|Abnormal test procedure result(s)|1|||
143219453|NCT01574651|516348555|FG001|Overall Study|Abnormal test procedure result(s)|1|||
143219454|NCT01574651|516348554|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
143219455|NCT01574651|516348555|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
143219456|NCT01574651|516348554|FG000|Overall Study|Protocol Violation|3|||
143219457|NCT01574651|516348555|FG001|Overall Study|Protocol Violation|5|||
143219458|NCT01574651|516348554|FG000|Overall Study|Withdrawal by Subject|9|||
143219459|NCT01574651|516348555|FG001|Overall Study|Withdrawal by Subject|10|||
143219460|NCT02407223|516350643|FG000|Overall Study|Adverse Event|1|||
143219461|NCT02407223|516350644|FG001|Overall Study|Adverse Event|0|||
143219462|NCT02407223|516350645|FG002|Overall Study|Adverse Event|1|||
143219463|NCT02407223|516350643|FG000|Overall Study|Lack of Efficacy|6|||
143219464|NCT02407223|516350644|FG001|Overall Study|Lack of Efficacy|6|||
143219465|NCT02407223|516350645|FG002|Overall Study|Lack of Efficacy|4|||
143219466|NCT02407223|516350643|FG000|Overall Study|Lost to Follow-up|1|||
143219467|NCT02407223|516350644|FG001|Overall Study|Lost to Follow-up|0|||
143219468|NCT02407223|516350645|FG002|Overall Study|Lost to Follow-up|2|||
143219469|NCT02407223|516350643|FG000|Overall Study|Withdrawal by Subject|2|||
143219470|NCT02407223|516350644|FG001|Overall Study|Withdrawal by Subject|4|||
143219471|NCT02407223|516350645|FG002|Overall Study|Withdrawal by Subject|4|||
143219472|NCT02407223|516350643|FG000|Overall Study|Study Terminated by Sponsor|77|||
143219473|NCT02407223|516350644|FG001|Overall Study|Study Terminated by Sponsor|80|||
143219474|NCT02407223|516350645|FG002|Overall Study|Study Terminated by Sponsor|86|||
143219475|NCT02407223|516350643|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
143219476|NCT02407223|516350644|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
143219477|NCT02407223|516350645|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
143219478|NCT02407223|516350643|FG000|Overall Study|Other|29|||
143219479|NCT02407223|516350644|FG001|Overall Study|Other|27|||
143219480|NCT02407223|516350645|FG002|Overall Study|Other|25|||
143219481|NCT04864639|516350646|FG000|Overall Study|Death|1|||
143219482|NCT04864639|516350646|FG000|Overall Study|Lost to Follow-up|1|||
143219483|NCT00447226|516350647|FG000|12-Week Open-label Phase|Adverse Event|0|||
143219484|NCT00447226|516350648|FG001|12-Week Open-label Phase|Adverse Event|3|||
143219485|NCT00447226|516350647|FG000|12-Week Open-label Phase|Protocol Violation|0|||
143219486|NCT00447226|516350648|FG001|12-Week Open-label Phase|Protocol Violation|1|||
143219487|NCT00447226|516350647|FG000|12-Week Open-label Phase|Disease Progression|0|||
143219488|NCT00447226|516350648|FG001|12-Week Open-label Phase|Disease Progression|20|||
143219489|NCT00447226|516350647|FG000|12-Week Open-label Phase|Physician Decision|0|||
143219490|NCT00447226|516350648|FG001|12-Week Open-label Phase|Physician Decision|1|||
143219491|NCT00447226|516350647|FG000|Double-blind Phase|Disease Progression|4|||
143219492|NCT00447226|516350648|FG001|Double-blind Phase|Disease Progression|3|||
143219493|NCT01478971|516350659|FG000|Standard of Care Period|Adverse Event|1|||
143219494|NCT01478971|516350659|FG000|Standard of Care Period|Withdrawal by Subject|3|||
143219495|NCT01478971|516350659|FG000|Standard of Care Period|Death|8|||
143219496|NCT01478971|516350659|FG000|Standard of Care Period|Lost to Follow-up|9|||
143219497|NCT01478971|516350659|FG000|Standard of Care Period|Other|4|||
143219498|NCT01478971|516350659|FG000|Peginesatide Treatment Period|Adverse Event|1|||
143219499|NCT01478971|516350659|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
143219500|NCT01478971|516350659|FG000|Peginesatide Treatment Period|Death|4|||
143219501|NCT01478971|516350659|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
143219502|NCT01478971|516350659|FG000|Peginesatide Treatment Period|Other|4|||
143219503|NCT01525615|516350660|FG000|Overall Study|Adverse Event|11|||
143219504|NCT01525615|516350661|FG001|Overall Study|Adverse Event|7|||
143219505|NCT01525615|516350662|FG002|Overall Study|Adverse Event|5|||
143219506|NCT01525615|516350660|FG000|Overall Study|Lost to Follow-up|1|||
143219507|NCT01525615|516350661|FG001|Overall Study|Lost to Follow-up|0|||
143219508|NCT01525615|516350662|FG002|Overall Study|Lost to Follow-up|0|||
143219509|NCT01525615|516350660|FG000|Overall Study|Withdrawal by Subject|1|||
143219510|NCT01525615|516350661|FG001|Overall Study|Withdrawal by Subject|0|||
143219511|NCT01525615|516350662|FG002|Overall Study|Withdrawal by Subject|0|||
143219512|NCT01525615|516350660|FG000|Overall Study|Other reason not described above|1|||
143219513|NCT01525615|516350661|FG001|Overall Study|Other reason not described above|0|||
143219514|NCT01525615|516350662|FG002|Overall Study|Other reason not described above|1|||
143219515|NCT04050618|516350663|FG000|First Intervention|Withdrawal by Subject|2|||
143219516|NCT04050618|516350664|FG001|First Intervention|Withdrawal by Subject|0|||
143219517|NCT04050618|516350663|FG000|Second Intervention|Withdrawal by Subject|1|||
143219518|NCT04050618|516350664|FG001|Second Intervention|Withdrawal by Subject|0|||
143219519|NCT02451943|516350671|FG000|Overall Study|Withdrawal by Subject|13|||
143219520|NCT02451943|516350672|FG001|Overall Study|Withdrawal by Subject|16|||
143219521|NCT02451943|516350671|FG000|Overall Study|Lost to Follow-up|3|||
143219522|NCT02451943|516350672|FG001|Overall Study|Lost to Follow-up|4|||
143219523|NCT02451943|516350671|FG000|Overall Study|Sponsor Decision|0|||
143219524|NCT02451943|516350672|FG001|Overall Study|Sponsor Decision|4|||
143219525|NCT00587158|516350677|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
143219526|NCT00587158|516350678|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
143219527|NCT00587158|516350677|FG000|Overall Study|Physician Decision|0|||
143219528|NCT00587158|516350678|FG001|Overall Study|Physician Decision|1|||
143219529|NCT00587158|516350677|FG000|Overall Study|Lost to Follow-up|1|||
143219530|NCT00587158|516350678|FG001|Overall Study|Lost to Follow-up|2|||
143219531|NCT00587158|516350677|FG000|Overall Study|Death|0|||
143219532|NCT00587158|516350678|FG001|Overall Study|Death|1|||
143219533|NCT00587158|516350677|FG000|Overall Study|Subject did not want to take study med|0|||
143219534|NCT00587158|516350678|FG001|Overall Study|Subject did not want to take study med|1|||
143267129|NCT02600351|516533070|FG002|Overall Study|Randomized but Not Treated|1|||
143267130|NCT02600351|516533071|FG003|Overall Study|Randomized but Not Treated|3|||
143219535|NCT02114606|516350679|FG000|Overall Study|Unable to swallow Cytosponge|6|||
143219536|NCT02152761|516350683|FG000|Epoch: Treatment Epoch|Technical problems|0|||
143219537|NCT02152761|516350684|FG001|Epoch: Treatment Epoch|Technical problems|0|||
143219538|NCT02152761|516350685|FG002|Epoch: Treatment Epoch|Technical problems|0|||
143219539|NCT02152761|516350686|FG003|Epoch: Treatment Epoch|Technical problems|1|||
143219540|NCT02152761|516350683|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
143219541|NCT02152761|516350684|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
143219542|NCT02152761|516350685|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
143219543|NCT02152761|516350686|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
143219544|NCT02152761|516350683|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
143219545|NCT02152761|516350684|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
143267131|NCT02063880|516533072|FG000|Overall Study|Death|21|||
143267132|NCT02063880|516533073|FG001|Overall Study|Death|18|||
143219546|NCT02152761|516350685|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
143219547|NCT02152761|516350686|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
143219548|NCT02152761|516350683|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
143219549|NCT02152761|516350684|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
143219550|NCT02152761|516350685|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
143219551|NCT02152761|516350686|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
143219552|NCT02152761|516350683|FG000|Epoch: Treatment Epoch|Death|0|||
143219553|NCT02152761|516350684|FG001|Epoch: Treatment Epoch|Death|3|||
143219554|NCT02152761|516350685|FG002|Epoch: Treatment Epoch|Death|1|||
143219555|NCT02152761|516350686|FG003|Epoch: Treatment Epoch|Death|0|||
143219556|NCT02152761|516350683|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
143219557|NCT02152761|516350684|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
143219558|NCT02152761|516350685|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
143219559|NCT02152761|516350686|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
143219560|NCT02152761|516350683|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
143219561|NCT02152761|516350684|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
143219562|NCT02152761|516350685|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
143219563|NCT02152761|516350686|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
143219564|NCT02152761|516350683|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
143219565|NCT02152761|516350684|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
143219566|NCT02152761|516350685|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
143219567|NCT02152761|516350686|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
143219568|NCT02152761|516350683|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
143219569|NCT02152761|516350684|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
143219570|NCT02152761|516350685|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
143219571|NCT02152761|516350686|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
143219572|NCT02152761|516350683|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
143219573|NCT02152761|516350684|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
143219574|NCT02152761|516350685|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
143219575|NCT02152761|516350686|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
143219576|NCT01456169|516350687|FG000|Overall Study|Adverse Event|1|||
143219577|NCT01456169|516350688|FG001|Overall Study|Adverse Event|2|||
143219578|NCT01456169|516350689|FG002|Overall Study|Adverse Event|7|||
143219579|NCT01456169|516350687|FG000|Overall Study|Major Protocol Deviation|3|||
143219580|NCT01456169|516350688|FG001|Overall Study|Major Protocol Deviation|2|||
143219581|NCT01456169|516350689|FG002|Overall Study|Major Protocol Deviation|3|||
143219582|NCT01456169|516350687|FG000|Overall Study|Voluntary Withdrawal|3|||
143219583|NCT01456169|516350688|FG001|Overall Study|Voluntary Withdrawal|0|||
143219584|NCT01456169|516350689|FG002|Overall Study|Voluntary Withdrawal|2|||
143219585|NCT01456169|516350687|FG000|Overall Study|Lack of Efficacy|2|||
143219586|NCT01456169|516350688|FG001|Overall Study|Lack of Efficacy|0|||
143219587|NCT01456169|516350689|FG002|Overall Study|Lack of Efficacy|0|||
143219588|NCT01456169|516350687|FG000|Overall Study|Other|1|||
143219589|NCT01456169|516350688|FG001|Overall Study|Other|1|||
143219590|NCT01456169|516350689|FG002|Overall Study|Other|0|||
143219591|NCT01797263|516350693|FG000|Overall Study|Withdrawal by Subject|21|||
143219592|NCT01797263|516350694|FG001|Overall Study|Withdrawal by Subject|25|||
143219593|NCT01797263|516350693|FG000|Overall Study|Death|1|||
143219594|NCT01797263|516350694|FG001|Overall Study|Death|0|||
143219595|NCT01797263|516350693|FG000|Overall Study|Lost to Follow-up|15|||
143219596|NCT01797263|516350694|FG001|Overall Study|Lost to Follow-up|15|||
143219597|NCT02342223|516350695|FG000|Overall Study|Lost to Follow-up|1|||
143219598|NCT04098809|516350698|FG000|Overall Study|Withdrawal by Subject|1|||
143219599|NCT04098809|516350699|FG001|Overall Study|Withdrawal by Subject|3|||
143267133|NCT02063880|516533072|FG000|Overall Study|Lost to Follow-up|7|||
143267134|NCT02063880|516533073|FG001|Overall Study|Lost to Follow-up|7|||
143267135|NCT02063880|516533072|FG000|Overall Study|Ineligible|0|||
143267136|NCT02063880|516533073|FG001|Overall Study|Ineligible|2|||
143267137|NCT02476422|516533074|FG000|Overall Study|Subject/guardian decision|0|||
143267138|NCT02476422|516533075|FG001|Overall Study|Subject/guardian decision|1|||
143267139|NCT01859143|516533076|FG000|Overall Study|Lost to Follow-up|2|||
143267140|NCT01859143|516533077|FG001|Overall Study|Lost to Follow-up|0|||
143267141|NCT02413372|516533078|FG000|Treatment|Lost to Follow-up|0|||
143267142|NCT02413372|516533079|FG001|Treatment|Lost to Follow-up|2|||
143219600|NCT04098809|516350698|FG000|Overall Study|Physician Decision|2|||
143219601|NCT04098809|516350699|FG001|Overall Study|Physician Decision|1|||
143219602|NCT01200368|516350700|FG000|Infant Series|Adverse Event|2|||
143219603|NCT01200368|516350701|FG001|Infant Series|Adverse Event|2|||
143219604|NCT01200368|516350702|FG002|Infant Series|Adverse Event|3|||
143219605|NCT01200368|516350700|FG000|Infant Series|Withdrawal by Subject|0|||
143219606|NCT01200368|516350701|FG001|Infant Series|Withdrawal by Subject|2|||
143219607|NCT01200368|516350702|FG002|Infant Series|Withdrawal by Subject|2|||
143267143|NCT02413372|516533080|FG002|Treatment|Lost to Follow-up|1|||
143267144|NCT02413372|516533078|FG000|Treatment|Withdrawal by Subject|1|||
143267145|NCT02413372|516533079|FG001|Treatment|Withdrawal by Subject|0|||
143219608|NCT01200368|516350700|FG000|Infant Series|Did not meet entrance criteria|0|||
143219609|NCT01200368|516350701|FG001|Infant Series|Did not meet entrance criteria|1|||
143219610|NCT01200368|516350702|FG002|Infant Series|Did not meet entrance criteria|0|||
143219611|NCT01200368|516350700|FG000|Infant Series|Randomized, not vaccinated|0|||
143219612|NCT01200368|516350701|FG001|Infant Series|Randomized, not vaccinated|1|||
143219613|NCT01200368|516350702|FG002|Infant Series|Randomized, not vaccinated|1|||
143219614|NCT01200368|516350700|FG000|Infant Series|Other|1|||
143219615|NCT01200368|516350701|FG001|Infant Series|Other|0|||
143219616|NCT01200368|516350702|FG002|Infant Series|Other|0|||
143219617|NCT01200368|516350700|FG000|After Infant Series|Adverse Event|6|||
143219618|NCT01200368|516350701|FG001|After Infant Series|Adverse Event|6|||
143219619|NCT01200368|516350702|FG002|After Infant Series|Adverse Event|3|||
143219620|NCT01200368|516350700|FG000|After Infant Series|Withdrawal by Subject|10|||
143219621|NCT01200368|516350701|FG001|After Infant Series|Withdrawal by Subject|8|||
143219622|NCT01200368|516350702|FG002|After Infant Series|Withdrawal by Subject|4|||
143219623|NCT01200368|516350700|FG000|After Infant Series|Lost to Follow-up|1|||
143219624|NCT01200368|516350701|FG001|After Infant Series|Lost to Follow-up|0|||
143219625|NCT01200368|516350702|FG002|After Infant Series|Lost to Follow-up|0|||
143219626|NCT01200368|516350700|FG000|After Infant Series|Other|1|||
143219627|NCT01200368|516350701|FG001|After Infant Series|Other|2|||
143219628|NCT01200368|516350702|FG002|After Infant Series|Other|2|||
143219629|NCT01200368|516350700|FG000|Toddler Dose|Adverse Event|0|||
143219630|NCT01200368|516350701|FG001|Toddler Dose|Adverse Event|3|||
143219631|NCT01200368|516350702|FG002|Toddler Dose|Adverse Event|1|||
143219632|NCT02741596|516350703|FG000|Overall Study|Adverse Event|1|||
143219633|NCT02741596|516350704|FG001|Overall Study|Adverse Event|5|||
143219634|NCT02741596|516350703|FG000|Overall Study|Lost to Follow-up|1|||
143219635|NCT02741596|516350704|FG001|Overall Study|Lost to Follow-up|1|||
143219636|NCT02741596|516350703|FG000|Overall Study|Physician Decision|2|||
143219637|NCT02741596|516350704|FG001|Overall Study|Physician Decision|1|||
143219638|NCT02741596|516350703|FG000|Overall Study|Pregnancy|3|||
143219639|NCT02741596|516350704|FG001|Overall Study|Pregnancy|1|||
143219640|NCT02741596|516350703|FG000|Overall Study|Other (Unspecified)|0|||
143219641|NCT02741596|516350704|FG001|Overall Study|Other (Unspecified)|3|||
143219642|NCT02741596|516350703|FG000|Overall Study|Subject withdrawn-Other|17|||
143219643|NCT02741596|516350704|FG001|Overall Study|Subject withdrawn-Other|4|||
143219644|NCT02741596|516350703|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
143219645|NCT02741596|516350704|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
143219646|NCT04854551|516350707|FG000|Overall Study|Withdrawal by Subject|1|||
143219647|NCT04854551|516350708|FG001|Overall Study|Withdrawal by Subject|1|||
143219648|NCT02859246|516350709|FG000|Overall Study|Screen fails|3|||
143219649|NCT02859246|516350709|FG000|Overall Study|Adverse Event|1|||
143219650|NCT02859246|516350709|FG000|Overall Study|Withdrawal by Subject|1|||
143219651|NCT05280717|516350710|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
143219652|NCT05280717|516350711|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
143219653|NCT05280717|516350712|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
143219654|NCT05280717|516350713|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
143219655|NCT05280717|516350714|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
143219656|NCT05280717|516350715|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
143219657|NCT05280717|516350716|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
143219658|NCT05280717|516350710|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
143219659|NCT05280717|516350711|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
143219660|NCT05280717|516350712|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
143219661|NCT05280717|516350713|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
143219662|NCT05280717|516350714|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
143267146|NCT02413372|516533080|FG002|Treatment|Withdrawal by Subject|0|||
143267147|NCT02413372|516533078|FG000|Follow-up|Lost to Follow-up|1|||
143267148|NCT02413372|516533079|FG001|Follow-up|Lost to Follow-up|1|||
143267149|NCT02413372|516533080|FG002|Follow-up|Lost to Follow-up|0|||
143267150|NCT02413372|516533078|FG000|Follow-up|Subject Withdrew Consent|1|||
143267151|NCT02413372|516533079|FG001|Follow-up|Subject Withdrew Consent|0|||
143219663|NCT05280717|516350715|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
143219664|NCT05280717|516350716|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
143219665|NCT05280717|516350710|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
143219666|NCT05280717|516350711|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
143219667|NCT05280717|516350712|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
143219668|NCT05280717|516350713|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
143219669|NCT05280717|516350714|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
143219670|NCT05280717|516350715|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
143219671|NCT05280717|516350716|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
143267152|NCT02413372|516533080|FG002|Follow-up|Subject Withdrew Consent|1|||
143219672|NCT05280717|516350710|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
143219673|NCT05280717|516350711|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
143219674|NCT05280717|516350712|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
143219675|NCT05280717|516350713|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
143219676|NCT05280717|516350714|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
143219677|NCT05280717|516350715|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
143219678|NCT05280717|516350716|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
143219679|NCT05280717|516350710|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
143219680|NCT05280717|516350711|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
143219681|NCT05280717|516350712|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
143219682|NCT05280717|516350713|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
143219683|NCT05280717|516350714|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
143219684|NCT05280717|516350715|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
143219685|NCT05280717|516350716|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
143219686|NCT05280717|516350710|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
143219687|NCT05280717|516350711|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
143219688|NCT05280717|516350712|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
143219689|NCT05280717|516350713|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
143219690|NCT05280717|516350714|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
143219691|NCT05280717|516350715|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
143219692|NCT05280717|516350716|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
143219693|NCT00080301|516350717|FG000|Overall Study|Randomized but Never Treated|5|||
143219694|NCT00080301|516350718|FG001|Overall Study|Randomized but Never Treated|10|||
143219695|NCT00080301|516350717|FG000|Overall Study|Still on Treatment as of CSR date|0|||
143219696|NCT00080301|516350718|FG001|Overall Study|Still on Treatment as of CSR date|1|||
143219697|NCT00181766|516350719|FG000|Overall Study|Lost to Follow-up|6|||
143219698|NCT00181766|516350719|FG000|Overall Study|Adverse Event|4|||
143219699|NCT00181766|516350719|FG000|Overall Study|non-compliance|2|||
143219700|NCT00687804|516350720|FG000|Core Study|Adverse Event|5|||
143219701|NCT00687804|516350721|FG001|Core Study|Adverse Event|3|||
143219702|NCT00687804|516350722|FG002|Core Study|Adverse Event|3|||
143219703|NCT00687804|516350720|FG000|Core Study|Abnormal laboratory value(s)|1|||
143219704|NCT00687804|516350721|FG001|Core Study|Abnormal laboratory value(s)|0|||
143219705|NCT00687804|516350722|FG002|Core Study|Abnormal laboratory value(s)|0|||
143219706|NCT00687804|516350720|FG000|Core Study|Lack of Efficacy|1|||
143219707|NCT00687804|516350721|FG001|Core Study|Lack of Efficacy|1|||
143219708|NCT00687804|516350722|FG002|Core Study|Lack of Efficacy|1|||
143219709|NCT00687804|516350720|FG000|Core Study|Withdrawal by Subject|4|||
143219710|NCT00687804|516350721|FG001|Core Study|Withdrawal by Subject|7|||
143219711|NCT00687804|516350722|FG002|Core Study|Withdrawal by Subject|7|||
143219712|NCT00687804|516350720|FG000|Core Study|Lost to Follow-up|0|||
143219713|NCT00687804|516350721|FG001|Core Study|Lost to Follow-up|1|||
143219714|NCT00687804|516350722|FG002|Core Study|Lost to Follow-up|0|||
143219715|NCT00687804|516350720|FG000|Core Study|Death|2|||
143219716|NCT00687804|516350721|FG001|Core Study|Death|2|||
143219717|NCT00687804|516350722|FG002|Core Study|Death|2|||
143219718|NCT00687804|516350720|FG000|Core Study|Protocol Violation|1|||
143267153|NCT02413372|516533078|FG000|Follow-up|Subject unable to return for visit|0|||
143267154|NCT02413372|516533079|FG001|Follow-up|Subject unable to return for visit|0|||
143267155|NCT02413372|516533080|FG002|Follow-up|Subject unable to return for visit|1|||
143267156|NCT02180165|516533084|FG000|Overall Study|Not Treated|0|||
143267157|NCT02180165|516533085|FG001|Overall Study|Not Treated|0|||
143267158|NCT02180165|516533086|FG002|Overall Study|Not Treated|1|||
143267159|NCT02180165|516533087|FG003|Overall Study|Not Treated|0|||
143267160|NCT02180165|516533084|FG000|Overall Study|Adverse Event|7|||
143267161|NCT02180165|516533085|FG001|Overall Study|Adverse Event|0|||
143267162|NCT02180165|516533086|FG002|Overall Study|Adverse Event|18|||
143267163|NCT02180165|516533087|FG003|Overall Study|Adverse Event|3|||
143267164|NCT02180165|516533084|FG000|Overall Study|Lack of Efficacy|0|||
143267165|NCT02180165|516533085|FG001|Overall Study|Lack of Efficacy|1|||
143267166|NCT02180165|516533086|FG002|Overall Study|Lack of Efficacy|3|||
143219719|NCT00687804|516350721|FG001|Core Study|Protocol Violation|1|||
143219720|NCT00687804|516350722|FG002|Core Study|Protocol Violation|0|||
143219721|NCT00687804|516350720|FG000|Open-Label Extension Study|Adverse Event|2|||
143219722|NCT00687804|516350721|FG001|Open-Label Extension Study|Adverse Event|2|||
143219723|NCT00687804|516350722|FG002|Open-Label Extension Study|Adverse Event|2|||
143267167|NCT02180165|516533087|FG003|Overall Study|Lack of Efficacy|2|||
143267168|NCT02180165|516533084|FG000|Overall Study|Physician Decision|1|||
143267169|NCT02180165|516533085|FG001|Overall Study|Physician Decision|0|||
143267170|NCT02180165|516533086|FG002|Overall Study|Physician Decision|5|||
143267171|NCT02180165|516533087|FG003|Overall Study|Physician Decision|0|||
143267172|NCT02180165|516533084|FG000|Overall Study|Withdrawal by Subject|3|||
143219724|NCT00687804|516350720|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
143219725|NCT00687804|516350721|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
143219726|NCT00687804|516350722|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
143219727|NCT00687804|516350720|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
143219728|NCT00687804|516350721|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
143219729|NCT00687804|516350722|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
143219730|NCT00687804|516350720|FG000|Open-Label Extension Study|Administrative problems|1|||
143219731|NCT00687804|516350721|FG001|Open-Label Extension Study|Administrative problems|1|||
143219732|NCT00687804|516350722|FG002|Open-Label Extension Study|Administrative problems|0|||
143219733|NCT00687804|516350720|FG000|Open-Label Extension Study|Death|2|||
143219734|NCT00687804|516350721|FG001|Open-Label Extension Study|Death|3|||
143219735|NCT00687804|516350722|FG002|Open-Label Extension Study|Death|3|||
143219736|NCT00413218|516350723|FG000|Overall Study|Randomized but didn't receive study drug|2|||
143219737|NCT00413218|516350724|FG001|Overall Study|Randomized but didn't receive study drug|8|||
143219738|NCT00413218|516350723|FG000|Overall Study|Death|57|||
143219739|NCT00413218|516350724|FG001|Overall Study|Death|56|||
143219740|NCT00413218|516350723|FG000|Overall Study|Lost to Follow-up|14|||
143219741|NCT00413218|516350724|FG001|Overall Study|Lost to Follow-up|17|||
143219742|NCT00413218|516350723|FG000|Overall Study|Admin|20|||
143219743|NCT00413218|516350724|FG001|Overall Study|Admin|14|||
143219744|NCT00413218|516350723|FG000|Overall Study|Missing|1|||
143219745|NCT00413218|516350724|FG001|Overall Study|Missing|0|||
143219746|NCT00413218|516350723|FG000|Overall Study|Withdrawal by Subject|9|||
143219747|NCT00413218|516350724|FG001|Overall Study|Withdrawal by Subject|1|||
143219748|NCT01196026|516350726|FG000|Overall Study|Withdrawal by Subject|1|||
143219749|NCT01196026|516350727|FG001|Overall Study|Withdrawal by Subject|4|||
143219750|NCT01196026|516350728|FG002|Overall Study|Withdrawal by Subject|0|||
143219751|NCT01196026|516350729|FG003|Overall Study|Withdrawal by Subject|0|||
143219752|NCT01196026|516350730|FG004|Overall Study|Withdrawal by Subject|0|||
143219753|NCT01196026|516350731|FG005|Overall Study|Withdrawal by Subject|0|||
143219754|NCT01196026|516350726|FG000|Overall Study|Lost to Follow-up|0|||
143219755|NCT01196026|516350727|FG001|Overall Study|Lost to Follow-up|3|||
143219756|NCT01196026|516350728|FG002|Overall Study|Lost to Follow-up|0|||
143219757|NCT01196026|516350729|FG003|Overall Study|Lost to Follow-up|0|||
143219758|NCT01196026|516350730|FG004|Overall Study|Lost to Follow-up|1|||
143219759|NCT01196026|516350731|FG005|Overall Study|Lost to Follow-up|0|||
143219760|NCT01196026|516350726|FG000|Overall Study|Other|0|||
143219761|NCT01196026|516350727|FG001|Overall Study|Other|1|||
143219762|NCT01196026|516350728|FG002|Overall Study|Other|0|||
143219763|NCT01196026|516350729|FG003|Overall Study|Other|0|||
143219764|NCT01196026|516350730|FG004|Overall Study|Other|0|||
143219765|NCT01196026|516350731|FG005|Overall Study|Other|0|||
143219766|NCT04034004|516350732|FG000|Overall Study|Withdrawal by Subject|1|||
143219767|NCT04034004|516350733|FG001|Overall Study|Withdrawal by Subject|2|||
143219768|NCT04034004|516350734|FG002|Overall Study|Withdrawal by Subject|2|||
143219769|NCT04034004|516350735|FG003|Overall Study|Withdrawal by Subject|3|||
143219770|NCT04034004|516350732|FG000|Overall Study|could not find vein to administer IV|2|||
143219771|NCT04034004|516350733|FG001|Overall Study|could not find vein to administer IV|1|||
143219772|NCT04034004|516350734|FG002|Overall Study|could not find vein to administer IV|0|||
143219773|NCT04034004|516350735|FG003|Overall Study|could not find vein to administer IV|0|||
143219774|NCT04034004|516350732|FG000|Overall Study|nurse accidentally unblinded subject|0|||
143219775|NCT04034004|516350733|FG001|Overall Study|nurse accidentally unblinded subject|0|||
143219776|NCT04034004|516350734|FG002|Overall Study|nurse accidentally unblinded subject|0|||
143219777|NCT04034004|516350735|FG003|Overall Study|nurse accidentally unblinded subject|1|||
143219778|NCT04317040|516350737|FG000|Overall Study|Lost to Follow-up|2|||
143219779|NCT04317040|516350738|FG001|Overall Study|Lost to Follow-up|0|||
143219780|NCT04317040|516350737|FG000|Overall Study|Death|16|||
143219781|NCT04317040|516350738|FG001|Overall Study|Death|18|||
143219782|NCT04317040|516350737|FG000|Overall Study|Withdrawal by Subject|0|||
143219783|NCT04317040|516350738|FG001|Overall Study|Withdrawal by Subject|1|||
143219784|NCT04317040|516350737|FG000|Overall Study|Incomplete assessments|0|||
143219785|NCT04317040|516350738|FG001|Overall Study|Incomplete assessments|1|||
143219786|NCT03672292|516350739|FG000|Overall Study|Adverse Event|3|||
143219787|NCT03672292|516350740|FG001|Overall Study|Adverse Event|1|||
143219788|NCT03672292|516350739|FG000|Overall Study|Physician Decision|0|||
143219789|NCT03672292|516350740|FG001|Overall Study|Physician Decision|1|||
143219790|NCT03672292|516350739|FG000|Overall Study|Withdrawal by Subject|1|||
143219791|NCT03672292|516350740|FG001|Overall Study|Withdrawal by Subject|2|||
143219792|NCT00799903|516350741|FG000|Overall Study|Investigator Site Closed|25|||
143219793|NCT00799903|516350742|FG001|Overall Study|Investigator Site Closed|23|||
143219794|NCT00799903|516350741|FG000|Overall Study|Withdrawal by Subject|179|||
143219795|NCT00799903|516350742|FG001|Overall Study|Withdrawal by Subject|175|||
143219796|NCT00799903|516350741|FG000|Overall Study|Lost to Follow-up|69|||
143219797|NCT00799903|516350742|FG001|Overall Study|Lost to Follow-up|80|||
143219798|NCT02518971|516350743|FG000|Overall Study|Lost to Follow-up|0|||
143267173|NCT02180165|516533085|FG001|Overall Study|Withdrawal by Subject|0|||
143219799|NCT02518971|516350744|FG001|Overall Study|Lost to Follow-up|1|||
143219800|NCT02518971|516350743|FG000|Overall Study|Physician Decision|6|||
143219801|NCT02518971|516350744|FG001|Overall Study|Physician Decision|6|||
143219802|NCT02518971|516350743|FG000|Overall Study|Protocol Violation|6|||
143219803|NCT02518971|516350744|FG001|Overall Study|Protocol Violation|4|||
143219804|NCT02518971|516350743|FG000|Overall Study|Withdrawal by Subject|4|||
143219805|NCT02518971|516350744|FG001|Overall Study|Withdrawal by Subject|5|||
143219806|NCT02518971|516350743|FG000|Overall Study|Side effects|1|||
143219807|NCT02518971|516350744|FG001|Overall Study|Side effects|0|||
143219808|NCT02518971|516350743|FG000|Overall Study|medication lost in mail|0|||
143219809|NCT02518971|516350744|FG001|Overall Study|medication lost in mail|1|||
143219810|NCT02518971|516350743|FG000|Overall Study|eligibility criteria no longer met|6|||
143219811|NCT02518971|516350744|FG001|Overall Study|eligibility criteria no longer met|3|||
143219812|NCT03088917|516350745|FG000|Overall Study|In care/cured elsewhere|15|||
143219813|NCT03088917|516350745|FG000|Overall Study|Refuse re-evaluation|13|||
143219814|NCT03088917|516350745|FG000|Overall Study|Contact not established|13|||
143219815|NCT03088917|516350745|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
143219816|NCT03088917|516350745|FG000|Overall Study|Moved outside study region|50|||
143219817|NCT05150990|516350746|FG000|Overall Study|Decline in health of older adult (unrelated to the intervention)|5|||
143219818|NCT05150990|516350747|FG001|Overall Study|Decline in health of older adult (unrelated to the intervention)|2|||
143219819|NCT05150990|516350746|FG000|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|6|||
143219820|NCT05150990|516350747|FG001|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|2|||
143219821|NCT05150990|516350746|FG000|Overall Study|Adverse response to the intervention - social strain|0|||
143219822|NCT05150990|516350747|FG001|Overall Study|Adverse response to the intervention - social strain|2|||
143219823|NCT05150990|516350746|FG000|Overall Study|Adverse response to the intervention - discomfort using technology|0|||
143219824|NCT05150990|516350747|FG001|Overall Study|Adverse response to the intervention - discomfort using technology|1|||
143219825|NCT05150990|516350746|FG000|Overall Study|External circumstances (family emergency, loss of Wifi)|0|||
143372132|NCT02551055|516906438|FG007|Overall Study|Reason not specified|0|||
143372133|NCT00430300|516906439|FG000|Overall Study|Adverse Event|0|||
143372134|NCT00430300|516906440|FG001|Overall Study|Adverse Event|2|||
143372135|NCT00430300|516906441|FG002|Overall Study|Adverse Event|1|||
143372136|NCT00430300|516906442|FG003|Overall Study|Adverse Event|1|||
143372137|NCT00430300|516906439|FG000|Overall Study|Withdrawal by Subject|1|||
143372138|NCT00430300|516906440|FG001|Overall Study|Withdrawal by Subject|0|||
143372139|NCT00430300|516906441|FG002|Overall Study|Withdrawal by Subject|5|||
143372140|NCT00430300|516906442|FG003|Overall Study|Withdrawal by Subject|0|||
143372141|NCT00430300|516906439|FG000|Overall Study|Laboratory abnormality|1|||
143372142|NCT00430300|516906440|FG001|Overall Study|Laboratory abnormality|0|||
143372143|NCT00430300|516906441|FG002|Overall Study|Laboratory abnormality|0|||
143372144|NCT00430300|516906442|FG003|Overall Study|Laboratory abnormality|0|||
143372145|NCT00430300|516906439|FG000|Overall Study|Other|0|||
143372146|NCT00430300|516906440|FG001|Overall Study|Other|0|||
143372147|NCT00430300|516906441|FG002|Overall Study|Other|0|||
143372148|NCT00430300|516906442|FG003|Overall Study|Other|1|||
143372149|NCT02754479|516906446|FG000|Overall Study|Lost to Follow-up|1|||
143372150|NCT00573833|516906447|FG000|Overall Study|Not Treated|2|||
143372151|NCT04517864|516909433|FG000|Placebo-Controlled Phase|Adverse Event|1|||
143372152|NCT04517864|516909434|FG001|Placebo-Controlled Phase|Adverse Event|0|||
143372153|NCT04517864|516909435|FG002|Placebo-Controlled Phase|Adverse Event|0|||
143372154|NCT04517864|516909433|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
143372155|NCT04517864|516909434|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
143372156|NCT04517864|516909435|FG002|Placebo-Controlled Phase|Lost to Follow-up|0|||
143372157|NCT04517864|516909433|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
143372158|NCT04517864|516909434|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
143372159|NCT04517864|516909435|FG002|Placebo-Controlled Phase|Protocol Violation|0|||
143372160|NCT04517864|516909433|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
143372161|NCT04517864|516909434|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
143372162|NCT04517864|516909435|FG002|Placebo-Controlled Phase|Withdrawal by Subject|0|||
143219826|NCT05150990|516350747|FG001|Overall Study|External circumstances (family emergency, loss of Wifi)|2|||
143219827|NCT05150990|516350746|FG000|Overall Study|Participant no longer eligible due to history of seizures not previously reported|0|||
143219828|NCT05150990|516350747|FG001|Overall Study|Participant no longer eligible due to history of seizures not previously reported|1|||
143219829|NCT05150990|516350746|FG000|Overall Study|Death (unrelated to the intervention)|1|||
143219830|NCT05150990|516350747|FG001|Overall Study|Death (unrelated to the intervention)|2|||
143219831|NCT01397461|516350749|FG000|Overall Study|Withdrawal by Subject|2|||
143219832|NCT01397461|516350750|FG001|Overall Study|Withdrawal by Subject|1|||
143372163|NCT04517864|516909433|FG000|Active Therapy Extension Phase|Adverse Event|1|||
143372164|NCT04517864|516909434|FG001|Active Therapy Extension Phase|Adverse Event|0|||
143372165|NCT04517864|516909435|FG002|Active Therapy Extension Phase|Adverse Event|0|||
143372166|NCT04517864|516909433|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
143372167|NCT04517864|516909434|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
143219833|NCT01397461|516350751|FG002|Overall Study|Withdrawal by Subject|0|||
143219834|NCT01397461|516350749|FG000|Overall Study|Lost to Follow-up|0|||
143219835|NCT01397461|516350750|FG001|Overall Study|Lost to Follow-up|2|||
143219836|NCT01397461|516350751|FG002|Overall Study|Lost to Follow-up|1|||
143219837|NCT01397461|516350749|FG000|Overall Study|Lack of Efficacy|0|||
143219838|NCT01397461|516350750|FG001|Overall Study|Lack of Efficacy|3|||
143219839|NCT01397461|516350751|FG002|Overall Study|Lack of Efficacy|0|||
143219840|NCT01397461|516350749|FG000|Overall Study|Not treated|0|||
143219841|NCT01397461|516350750|FG001|Overall Study|Not treated|0|||
143219842|NCT01397461|516350751|FG002|Overall Study|Not treated|1|||
143219843|NCT05729568|516350768|FG000|Overall Study|Still on Study|52|||
143219844|NCT05729568|516350769|FG001|Overall Study|Still on Study|26|||
143219845|NCT05729568|516350768|FG000|Overall Study|Randomized but Never Treated|3|||
143219846|NCT05729568|516350769|FG001|Overall Study|Randomized but Never Treated|0|||
143219847|NCT05729568|516350768|FG000|Overall Study|Adverse Event|0|||
143219848|NCT05729568|516350769|FG001|Overall Study|Adverse Event|1|||
143219849|NCT05729568|516350768|FG000|Overall Study|Investigator's Discretion|1|||
143219850|NCT05729568|516350769|FG001|Overall Study|Investigator's Discretion|0|||
143219851|NCT04181762|516350770|FG000|Overall Study|Adverse Event|1|||
143219852|NCT04181762|516350771|FG001|Overall Study|Adverse Event|3|||
143219853|NCT04181762|516350770|FG000|Overall Study|Lost to Follow-up|1|||
143219854|NCT04181762|516350771|FG001|Overall Study|Lost to Follow-up|1|||
143219855|NCT04181762|516350770|FG000|Overall Study|Physician Decision|1|||
143219856|NCT04181762|516350771|FG001|Overall Study|Physician Decision|3|||
143219857|NCT04181762|516350770|FG000|Overall Study|Pregnancy|0|||
143219858|NCT04181762|516350771|FG001|Overall Study|Pregnancy|1|||
143219859|NCT04181762|516350770|FG000|Overall Study|Lack of Efficacy|2|||
143219860|NCT04181762|516350771|FG001|Overall Study|Lack of Efficacy|2|||
143219861|NCT04181762|516350770|FG000|Overall Study|Study terminated by sponsor|95|||
143219862|NCT04181762|516350771|FG001|Overall Study|Study terminated by sponsor|97|||
143219863|NCT04181762|516350770|FG000|Overall Study|Subject decision|11|||
143219864|NCT04181762|516350771|FG001|Overall Study|Subject decision|4|||
143219865|NCT04181762|516350770|FG000|Overall Study|Death|1|||
143219866|NCT04181762|516350771|FG001|Overall Study|Death|1|||
143219867|NCT04181762|516350770|FG000|Overall Study|Protocol deviation|1|||
143219868|NCT04181762|516350771|FG001|Overall Study|Protocol deviation|0|||
143219869|NCT04181762|516350770|FG000|Overall Study|Withdrawal of informed consent|1|||
143219870|NCT04181762|516350771|FG001|Overall Study|Withdrawal of informed consent|3|||
143219871|NCT04526145|516350772|FG000|Overall Study|Withdrawal by Subject|5|||
143219872|NCT06964165|516350775|FG000|Overall Study|Withdrawal by Subject|0|||
143219873|NCT06964165|516350776|FG001|Overall Study|Withdrawal by Subject|1|||
143219874|NCT06964165|516350775|FG000|Overall Study|Ongoing at the time of analysis|15|||
143267174|NCT02180165|516533086|FG002|Overall Study|Withdrawal by Subject|2|||
143267175|NCT02180165|516533087|FG003|Overall Study|Withdrawal by Subject|1|||
143267176|NCT01225887|516533089|FG000|Overall Study|Ineligible:required test not done|2|||
143267177|NCT01225887|516533089|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
143267178|NCT01225887|516533089|FG000|Overall Study|Ineligible:inadequate pathology|2|||
143267179|NCT00437320|516533094|FG000|Overall Study|Participant request|2|||
143267180|NCT00437320|516533095|FG001|Overall Study|Participant request|1|||
143267181|NCT00437320|516533096|FG002|Overall Study|Participant request|4|||
143267182|NCT01400815|516533100|FG000|Overall Study|Adverse Event|3|||
143267183|NCT01400815|516533101|FG001|Overall Study|Adverse Event|0|||
143267184|NCT01400815|516533100|FG000|Overall Study|Death|0|||
143267185|NCT01400815|516533101|FG001|Overall Study|Death|1|||
143267186|NCT01400815|516533100|FG000|Overall Study|Lost to Follow-up|18|||
143267187|NCT01400815|516533101|FG001|Overall Study|Lost to Follow-up|11|||
143267188|NCT01400815|516533100|FG000|Overall Study|Protocol Violation|0|||
143267189|NCT01400815|516533101|FG001|Overall Study|Protocol Violation|1|||
143267190|NCT01400815|516533100|FG000|Overall Study|Physician Decision|1|||
143267191|NCT01400815|516533101|FG001|Overall Study|Physician Decision|0|||
143267192|NCT01400815|516533100|FG000|Overall Study|Withdrawal by Subject|15|||
143267193|NCT01400815|516533101|FG001|Overall Study|Withdrawal by Subject|8|||
143219875|NCT06964165|516350776|FG001|Overall Study|Ongoing at the time of analysis|14|||
143219876|NCT06964165|516350775|FG000|Overall Study|Participant discontinued due to relocation to a long-term care facility|0|||
143219877|NCT06964165|516350776|FG001|Overall Study|Participant discontinued due to relocation to a long-term care facility|1|||
143267194|NCT01400815|516533100|FG000|Overall Study|Subject in jail|1|||
143267195|NCT01400815|516533101|FG001|Overall Study|Subject in jail|0|||
143219878|NCT06964165|516350775|FG000|Overall Study|Participant removed due to non-compliance|0|||
143219879|NCT06964165|516350776|FG001|Overall Study|Participant removed due to non-compliance|1|||
143219880|NCT01514201|516350787|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
143219881|NCT01514201|516350788|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
143219882|NCT01514201|516350789|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
143219883|NCT01514201|516350790|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
143219884|NCT01514201|516350787|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
143219885|NCT01514201|516350788|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
143219886|NCT01514201|516350789|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
143372168|NCT04517864|516909435|FG002|Active Therapy Extension Phase|Lack of Efficacy|0|||
143372169|NCT04517864|516909433|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
143372170|NCT04517864|516909434|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
143372171|NCT04517864|516909435|FG002|Active Therapy Extension Phase|Lost to Follow-up|0|||
143372172|NCT04517864|516909433|FG000|Active Therapy Extension Phase|Physician Decision|1|||
143372173|NCT04517864|516909434|FG001|Active Therapy Extension Phase|Physician Decision|0|||
143372174|NCT04517864|516909435|FG002|Active Therapy Extension Phase|Physician Decision|0|||
143372175|NCT04517864|516909433|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
143219887|NCT01514201|516350790|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
143219888|NCT01514201|516350787|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
143219889|NCT01514201|516350788|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
143219890|NCT01514201|516350789|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
143219891|NCT01514201|516350790|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
143219892|NCT01514201|516350787|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
143219893|NCT01514201|516350788|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
143219894|NCT01514201|516350789|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
143219895|NCT01514201|516350790|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
143219896|NCT01514201|516350787|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
143219897|NCT01514201|516350788|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
143219898|NCT01514201|516350789|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
143219899|NCT01514201|516350790|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
143219900|NCT01514201|516350787|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
143219901|NCT01514201|516350788|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
143219902|NCT01514201|516350789|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
143219903|NCT01514201|516350790|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
143219904|NCT01514201|516350787|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
143219905|NCT01514201|516350788|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
143219906|NCT01514201|516350789|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
143219907|NCT01514201|516350790|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
143219908|NCT01514201|516350787|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
143219909|NCT01514201|516350788|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
143219910|NCT01514201|516350789|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
143219911|NCT01514201|516350790|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
143219912|NCT01514201|516350787|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
143219913|NCT01514201|516350788|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
143219914|NCT01514201|516350789|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
143219915|NCT01514201|516350790|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
143219916|NCT01514201|516350787|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
143219917|NCT01514201|516350788|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
143219918|NCT01514201|516350789|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
143219919|NCT01514201|516350790|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
143219920|NCT01514201|516350787|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
143219921|NCT01514201|516350788|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
143219922|NCT01514201|516350789|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
143219923|NCT01514201|516350790|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
143219924|NCT01514201|516350787|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
143219925|NCT01514201|516350788|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
143219926|NCT01514201|516350789|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
143219927|NCT01514201|516350790|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
143219928|NCT05888181|516350792|FG000|Overall Study|Lost to Follow-up|1|||
143219929|NCT05888181|516350793|FG001|Overall Study|Lost to Follow-up|1|||
143219930|NCT05888181|516350794|FG002|Overall Study|Lost to Follow-up|0|||
143219931|NCT02735343|516350796|FG000|Overall Study|screen fail|0|||
143219932|NCT02735343|516350797|FG001|Overall Study|screen fail|2|||
143219933|NCT00637416|516350800|FG000|Overall Study|Lost to Follow-up|1|||
143219934|NCT00637416|516350801|FG001|Overall Study|Lost to Follow-up|1|||
143219935|NCT00637416|516350800|FG000|Overall Study|Unable to take study drug|0|||
143219936|NCT00637416|516350801|FG001|Overall Study|Unable to take study drug|1|||
143219937|NCT02534909|516350809|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
143219938|NCT00566852|516350812|FG000|Overall Study|Protocol Violation|22|||
143219939|NCT00566852|516350813|FG001|Overall Study|Protocol Violation|24|||
143219940|NCT00566852|516350812|FG000|Overall Study|Death|95|||
143219941|NCT00566852|516350813|FG001|Overall Study|Death|78|||
143219942|NCT00566852|516350812|FG000|Overall Study|Withdrawal by Subject|30|||
143219943|NCT00566852|516350813|FG001|Overall Study|Withdrawal by Subject|25|||
143219944|NCT00566852|516350812|FG000|Overall Study|Patient refusal|37|||
143219945|NCT00566852|516350813|FG001|Overall Study|Patient refusal|37|||
143219946|NCT00566852|516350812|FG000|Overall Study|Not tested due to disability|6|||
143219947|NCT00566852|516350813|FG001|Overall Study|Not tested due to disability|12|||
143219948|NCT00566852|516350812|FG000|Overall Study|Missing reason not specified|1|||
143219949|NCT00566852|516350813|FG001|Overall Study|Missing reason not specified|2|||
143219950|NCT00566852|516350812|FG000|Overall Study|Missing reason not reported|16|||
143219951|NCT00566852|516350813|FG001|Overall Study|Missing reason not reported|20|||
143219952|NCT01147055|516350814|FG000|First Intervention Period|Lost to Follow-up|1|||
143219953|NCT01147055|516350815|FG001|First Intervention Period|Lost to Follow-up|0|||
143219954|NCT00132808|516350816|FG000|Stratum I|Adverse Event|2|||
143219955|NCT00132808|516350817|FG001|Stratum I|Adverse Event|1|||
143219956|NCT00132808|516350818|FG002|Stratum I|Adverse Event|0|||
143219957|NCT00132808|516350816|FG000|Stratum I|Lost to Follow-up|3|||
143219958|NCT00132808|516350817|FG001|Stratum I|Lost to Follow-up|4|||
143219959|NCT00132808|516350818|FG002|Stratum I|Lost to Follow-up|1|||
143219960|NCT00132808|516350816|FG000|Stratum I|Withdrawal by Subject|4|||
143219961|NCT00132808|516350817|FG001|Stratum I|Withdrawal by Subject|7|||
143219962|NCT00132808|516350818|FG002|Stratum I|Withdrawal by Subject|3|||
143219963|NCT00132808|516350816|FG000|Stratum I|Abnormal test procedure result (s)|0|||
143219964|NCT00132808|516350817|FG001|Stratum I|Abnormal test procedure result (s)|0|||
143219965|NCT00132808|516350818|FG002|Stratum I|Abnormal test procedure result (s)|1|||
143219966|NCT00132808|516350816|FG000|Stratum II|Adverse Event|1|||
143219967|NCT00132808|516350817|FG001|Stratum II|Adverse Event|2|||
143219968|NCT00132808|516350818|FG002|Stratum II|Adverse Event|1|||
143219969|NCT00132808|516350816|FG000|Stratum II|Death|1|||
143219970|NCT00132808|516350817|FG001|Stratum II|Death|0|||
143219971|NCT00132808|516350818|FG002|Stratum II|Death|0|||
143219972|NCT00132808|516350816|FG000|Stratum II|Lost to Follow-up|2|||
143219973|NCT00132808|516350817|FG001|Stratum II|Lost to Follow-up|2|||
143219974|NCT00132808|516350818|FG002|Stratum II|Lost to Follow-up|1|||
143219975|NCT00132808|516350816|FG000|Stratum II|Protocol Violation|0|||
143219976|NCT00132808|516350817|FG001|Stratum II|Protocol Violation|2|||
143219977|NCT00132808|516350818|FG002|Stratum II|Protocol Violation|1|||
143219978|NCT00132808|516350816|FG000|Stratum II|Withdrawal by Subject|4|||
143219979|NCT00132808|516350817|FG001|Stratum II|Withdrawal by Subject|9|||
143219980|NCT00132808|516350818|FG002|Stratum II|Withdrawal by Subject|6|||
143219981|NCT02715609|516350823|FG000|Overall Study|Patient only completed pre-operative treatment|1|||
143219982|NCT02715609|516350824|FG001|Overall Study|Patient only completed pre-operative treatment|0|||
143219983|NCT02715609|516350825|FG002|Overall Study|Patient only completed pre-operative treatment|0|||
143219984|NCT02715609|516350823|FG000|Overall Study|Withdrawal by Subject|0|||
143219985|NCT02715609|516350824|FG001|Overall Study|Withdrawal by Subject|0|||
143219986|NCT02715609|516350825|FG002|Overall Study|Withdrawal by Subject|1|||
143219987|NCT04209205|516350829|FG000|Overall Study|Adverse Event|2|||
143219988|NCT04209205|516350830|FG001|Overall Study|Adverse Event|3|||
143219989|NCT04209205|516350829|FG000|Overall Study|Lost to Follow-up|3|||
143219990|NCT04209205|516350830|FG001|Overall Study|Lost to Follow-up|1|||
143219991|NCT04209205|516350829|FG000|Overall Study|Physician Decision|1|||
143219992|NCT04209205|516350830|FG001|Overall Study|Physician Decision|1|||
143219993|NCT04209205|516350829|FG000|Overall Study|Subject decision|10|||
143219994|NCT04209205|516350830|FG001|Overall Study|Subject decision|10|||
143219995|NCT04209205|516350829|FG000|Overall Study|Progressive disease|1|||
143219996|NCT04209205|516350830|FG001|Overall Study|Progressive disease|0|||
143219997|NCT04209205|516350829|FG000|Overall Study|Protocol deviation|0|||
143219998|NCT04209205|516350830|FG001|Overall Study|Protocol deviation|1|||
143219999|NCT04209205|516350829|FG000|Overall Study|New therapy for study indication|1|||
143220000|NCT04209205|516350830|FG001|Overall Study|New therapy for study indication|0|||
143220001|NCT04209205|516350829|FG000|Overall Study|Adverse event - placebo not switched|0|||
143220002|NCT04209205|516350830|FG001|Overall Study|Adverse event - placebo not switched|1|||
143220003|NCT04209205|516350829|FG000|Overall Study|Subject decision - placebo not switched|0|||
143220004|NCT04209205|516350830|FG001|Overall Study|Subject decision - placebo not switched|5|||
143220005|NCT04209205|516350829|FG000|Overall Study|Death - placebo not switched|0|||
143220006|NCT04209205|516350830|FG001|Overall Study|Death - placebo not switched|1|||
143220007|NCT03052049|516350832|FG000|Overall Study|Withdrawal by Subject|2|||
143220008|NCT03508609|516350833|FG000|Overall Study|Withdrawal by Subject|1|||
143220009|NCT00999518|516350834|FG000|Overall Study|Adverse Event|1|||
143220010|NCT00999518|516350835|FG001|Overall Study|Adverse Event|6|||
143220011|NCT00999518|516350836|FG002|Overall Study|Adverse Event|3|||
143220012|NCT00999518|516350837|FG003|Overall Study|Adverse Event|1|||
143220013|NCT00999518|516350838|FG004|Overall Study|Adverse Event|2|||
143220014|NCT00999518|516350834|FG000|Overall Study|Lack of Efficacy|2|||
143220015|NCT00999518|516350835|FG001|Overall Study|Lack of Efficacy|0|||
143267196|NCT01123850|516533102|FG000|Overall Study|Slow enrollment|45|||
143267197|NCT00381381|516533110|FG000|Overall Study|Adverse Event|3|||
143267198|NCT00381381|516533110|FG000|Overall Study|Lost to Follow-up|52|||
143267199|NCT00381381|516533110|FG000|Overall Study|Withdrawal by Subject|9|||
143267200|NCT00568685|516533115|FG000|Overall Study|Adverse Event|2|||
143267201|NCT00568685|516533116|FG001|Overall Study|Adverse Event|3|||
143267202|NCT00568685|516533117|FG002|Overall Study|Adverse Event|3|||
143267203|NCT00568685|516533115|FG000|Overall Study|Withdrawal by Subject|7|||
143267204|NCT00568685|516533116|FG001|Overall Study|Withdrawal by Subject|2|||
143267205|NCT00568685|516533117|FG002|Overall Study|Withdrawal by Subject|2|||
143267206|NCT00568685|516533115|FG000|Overall Study|Protocol Violation|1|||
143267207|NCT00568685|516533116|FG001|Overall Study|Protocol Violation|0|||
143267208|NCT00568685|516533117|FG002|Overall Study|Protocol Violation|0|||
143267209|NCT01638819|516533120|FG000|Overall Study|Lost to Follow-up|1|||
143267210|NCT01638819|516533121|FG001|Overall Study|Lost to Follow-up|0|||
143267211|NCT00471146|516533124|FG000|Overall Study|Adverse Event|32|||
143267212|NCT00471146|516533125|FG001|Overall Study|Adverse Event|33|||
143267213|NCT00471146|516533124|FG000|Overall Study|Withdrawal by Subject|14|||
143267214|NCT00471146|516533125|FG001|Overall Study|Withdrawal by Subject|11|||
143267215|NCT00471146|516533124|FG000|Overall Study|Death|11|||
143267216|NCT00471146|516533125|FG001|Overall Study|Death|12|||
143267217|NCT00471146|516533124|FG000|Overall Study|Lost to Follow-up|4|||
143267218|NCT00471146|516533125|FG001|Overall Study|Lost to Follow-up|2|||
143267219|NCT00471146|516533124|FG000|Overall Study|Protocol Violation|2|||
143267220|NCT00471146|516533125|FG001|Overall Study|Protocol Violation|2|||
143267221|NCT00471146|516533124|FG000|Overall Study|Objective progression or relapse|84|||
143267222|NCT00471146|516533125|FG001|Overall Study|Objective progression or relapse|87|||
143267223|NCT00471146|516533124|FG000|Overall Study|Global deterioration of health status|12|||
143267224|NCT00471146|516533125|FG001|Overall Study|Global deterioration of health status|14|||
143267225|NCT00471146|516533124|FG000|Overall Study|Randomized but not treated|9|||
143267226|NCT00471146|516533125|FG001|Overall Study|Randomized but not treated|8|||
143267227|NCT00471146|516533124|FG000|Overall Study|Other|4|||
143267228|NCT00471146|516533125|FG001|Overall Study|Other|5|||
143267229|NCT03538431|516533126|FG000|Overall Study|Physician Decision|0|||
143267230|NCT03538431|516533127|FG001|Overall Study|Physician Decision|1|||
143267231|NCT03538431|516533126|FG000|Overall Study|Withdrawal by Subject|1|||
143267232|NCT03538431|516533127|FG001|Overall Study|Withdrawal by Subject|0|||
143267233|NCT00467610|516533130|FG000|Overall Study|Withdrawal by Subject|1|||
143267234|NCT02001181|516533131|FG000|Overall Study|Adverse Event|0|||
143267235|NCT02001181|516533132|FG001|Overall Study|Adverse Event|2|||
143267236|NCT02001181|516533131|FG000|Overall Study|Lost to Follow-up|1|||
143267237|NCT02001181|516533132|FG001|Overall Study|Lost to Follow-up|0|||
143267238|NCT02001181|516533131|FG000|Overall Study|Withdrawal by Subject|0|||
143267239|NCT02001181|516533132|FG001|Overall Study|Withdrawal by Subject|1|||
143267240|NCT01090973|516533133|FG000|Overall Study|Disease progression|1|||
143267241|NCT02979197|516533136|FG000|Overall Study|Adverse Event|4|||
143372176|NCT04517864|516909434|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
143372177|NCT04517864|516909435|FG002|Active Therapy Extension Phase|Withdrawal by Subject|0|||
143372178|NCT04517864|516909433|FG000|Extension Phase|Adverse Event|0|||
143372179|NCT04517864|516909434|FG001|Extension Phase|Adverse Event|0|||
143372180|NCT04517864|516909435|FG002|Extension Phase|Adverse Event|1|||
143372181|NCT04517864|516909433|FG000|Extension Phase|Lack of Efficacy|0|||
143220016|NCT00999518|516350836|FG002|Overall Study|Lack of Efficacy|0|||
143220017|NCT00999518|516350837|FG003|Overall Study|Lack of Efficacy|2|||
143267242|NCT02979197|516533137|FG001|Overall Study|Adverse Event|2|||
143267243|NCT02979197|516533138|FG002|Overall Study|Adverse Event|0|||
143267244|NCT02979197|516533136|FG000|Overall Study|Protocol Violation|0|||
143267245|NCT02979197|516533137|FG001|Overall Study|Protocol Violation|1|||
143220018|NCT00999518|516350838|FG004|Overall Study|Lack of Efficacy|2|||
143220019|NCT00999518|516350834|FG000|Overall Study|Lost to Follow-up|0|||
143220020|NCT00999518|516350835|FG001|Overall Study|Lost to Follow-up|0|||
143267246|NCT02979197|516533138|FG002|Overall Study|Protocol Violation|0|||
143267247|NCT02979197|516533136|FG000|Overall Study|Subject unable to commit to study dates|0|||
143267248|NCT02979197|516533137|FG001|Overall Study|Subject unable to commit to study dates|1|||
143267249|NCT02979197|516533138|FG002|Overall Study|Subject unable to commit to study dates|0|||
143267250|NCT03438383|516533139|FG000|Overall Study|Protocol Violation|9|||
143267251|NCT03438383|516533140|FG001|Overall Study|Protocol Violation|3|||
143220021|NCT00999518|516350836|FG002|Overall Study|Lost to Follow-up|0|||
143220022|NCT00999518|516350837|FG003|Overall Study|Lost to Follow-up|4|||
143220023|NCT00999518|516350838|FG004|Overall Study|Lost to Follow-up|1|||
143220024|NCT00999518|516350834|FG000|Overall Study|Did not meet entrance criteria|0|||
143220025|NCT00999518|516350835|FG001|Overall Study|Did not meet entrance criteria|0|||
143220026|NCT00999518|516350836|FG002|Overall Study|Did not meet entrance criteria|0|||
143220027|NCT00999518|516350837|FG003|Overall Study|Did not meet entrance criteria|0|||
143220028|NCT00999518|516350838|FG004|Overall Study|Did not meet entrance criteria|1|||
143220029|NCT00999518|516350834|FG000|Overall Study|Study terminated by sponsor|10|||
143220030|NCT00999518|516350835|FG001|Overall Study|Study terminated by sponsor|6|||
143220031|NCT00999518|516350836|FG002|Overall Study|Study terminated by sponsor|5|||
143220032|NCT00999518|516350837|FG003|Overall Study|Study terminated by sponsor|5|||
143220033|NCT00999518|516350838|FG004|Overall Study|Study terminated by sponsor|9|||
143220034|NCT00999518|516350834|FG000|Overall Study|Pregnancy|0|||
143220035|NCT00999518|516350835|FG001|Overall Study|Pregnancy|0|||
143220036|NCT00999518|516350836|FG002|Overall Study|Pregnancy|1|||
143220037|NCT00999518|516350837|FG003|Overall Study|Pregnancy|0|||
143220038|NCT00999518|516350838|FG004|Overall Study|Pregnancy|0|||
143220039|NCT00999518|516350834|FG000|Overall Study|Protocol Violation|0|||
143220040|NCT00999518|516350835|FG001|Overall Study|Protocol Violation|1|||
143220041|NCT00999518|516350836|FG002|Overall Study|Protocol Violation|0|||
143220042|NCT00999518|516350837|FG003|Overall Study|Protocol Violation|0|||
143220043|NCT00999518|516350838|FG004|Overall Study|Protocol Violation|2|||
143220044|NCT00999518|516350834|FG000|Overall Study|Withdrawal by Subject|5|||
143220045|NCT00999518|516350835|FG001|Overall Study|Withdrawal by Subject|4|||
143220046|NCT00999518|516350836|FG002|Overall Study|Withdrawal by Subject|10|||
143220047|NCT00999518|516350837|FG003|Overall Study|Withdrawal by Subject|6|||
143220048|NCT00999518|516350838|FG004|Overall Study|Withdrawal by Subject|1|||
143220049|NCT00999518|516350834|FG000|Overall Study|Other|5|||
143220050|NCT00999518|516350835|FG001|Overall Study|Other|7|||
143220051|NCT00999518|516350836|FG002|Overall Study|Other|1|||
143220052|NCT00999518|516350837|FG003|Overall Study|Other|4|||
143220053|NCT00999518|516350838|FG004|Overall Study|Other|5|||
143220054|NCT00999518|516350834|FG000|Overall Study|Randomized but not Treated|1|||
143220055|NCT00999518|516350835|FG001|Overall Study|Randomized but not Treated|1|||
143220056|NCT00999518|516350836|FG002|Overall Study|Randomized but not Treated|2|||
143220057|NCT00999518|516350837|FG003|Overall Study|Randomized but not Treated|0|||
143220058|NCT00999518|516350838|FG004|Overall Study|Randomized but not Treated|1|||
143220059|NCT00999544|516352637|FG000|Overall Study|Withdrawal by Subject|1|||
143220060|NCT04404556|516352638|FG000|Intervention|Withdrawal by Subject|15|||
143220061|NCT04404556|516352639|FG001|Intervention|Withdrawal by Subject|3|||
143220062|NCT04404556|516352638|FG000|Intervention|Did not complete all intervention sessions|2|||
143220063|NCT04404556|516352639|FG001|Intervention|Did not complete all intervention sessions|1|||
143220064|NCT04404556|516352638|FG000|Post-Intervention|Missing Data|1|||
143220065|NCT04404556|516352639|FG001|Post-Intervention|Missing Data|2|||
143220066|NCT04404556|516352638|FG000|Follow-up 1|Withdrawal by Subject|5|||
143220067|NCT04404556|516352639|FG001|Follow-up 1|Withdrawal by Subject|1|||
143220068|NCT04404556|516352638|FG000|Follow-up 1|Missing Data|4|||
143220069|NCT04404556|516352639|FG001|Follow-up 1|Missing Data|7|||
143220070|NCT04404556|516352638|FG000|Follow-up 2|Withdrawal by Subject|1|||
143220071|NCT04404556|516352639|FG001|Follow-up 2|Withdrawal by Subject|1|||
143220072|NCT04404556|516352638|FG000|Follow-up 2|Missing Data|6|||
143220073|NCT04404556|516352639|FG001|Follow-up 2|Missing Data|5|||
143220074|NCT00412893|516352642|FG000|Overall Study|Adverse Event|31|||
143220075|NCT00412893|516352643|FG001|Overall Study|Adverse Event|53|||
143220076|NCT00412893|516352642|FG000|Overall Study|Death|17|||
143220077|NCT00412893|516352643|FG001|Overall Study|Death|21|||
143220078|NCT00412893|516352642|FG000|Overall Study|Insufficient Therapeutic Response|39|||
143220079|NCT00412893|516352643|FG001|Overall Study|Insufficient Therapeutic Response|23|||
143220080|NCT00412893|516352642|FG000|Overall Study|Lost to Follow-up|2|||
143220081|NCT00412893|516352643|FG001|Overall Study|Lost to Follow-up|1|||
143220082|NCT00412893|516352642|FG000|Overall Study|Violation of Selection at Entry|17|||
143220083|NCT00412893|516352643|FG001|Overall Study|Violation of Selection at Entry|10|||
143220084|NCT00412893|516352642|FG000|Overall Study|Other Protocol Violation|10|||
143220085|NCT00412893|516352643|FG001|Overall Study|Other Protocol Violation|6|||
143220086|NCT00412893|516352642|FG000|Overall Study|Did Not Cooperate|12|||
143220087|NCT00412893|516352643|FG001|Overall Study|Did Not Cooperate|9|||
143220088|NCT00412893|516352642|FG000|Overall Study|Administrative Reason|12|||
143220089|NCT00412893|516352643|FG001|Overall Study|Administrative Reason|15|||
143220090|NCT00412893|516352642|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
143220091|NCT00412893|516352643|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
143220092|NCT03951077|516352644|FG000|Overall Study|Adverse Event|1|||
143267252|NCT02435069|516533141|FG000|Dose Response - First Intervention|Adverse Event|0|||
143267253|NCT02435069|516533142|FG001|Dose Response - First Intervention|Adverse Event|1|||
143220093|NCT03951077|516352645|FG001|Overall Study|Adverse Event|0|||
143220094|NCT03951077|516352646|FG002|Overall Study|Adverse Event|0|||
143220095|NCT03951077|516352647|FG003|Overall Study|Adverse Event|0|||
143220096|NCT03951077|516352648|FG004|Overall Study|Adverse Event|0|||
143220097|NCT03951077|516352649|FG005|Overall Study|Adverse Event|0|||
143220098|NCT03951077|516352644|FG000|Overall Study|Withdrawal by Subject|3|||
143220099|NCT03951077|516352645|FG001|Overall Study|Withdrawal by Subject|3|||
143220100|NCT03951077|516352646|FG002|Overall Study|Withdrawal by Subject|0|||
143220101|NCT03951077|516352647|FG003|Overall Study|Withdrawal by Subject|3|||
143220102|NCT03951077|516352648|FG004|Overall Study|Withdrawal by Subject|3|||
143220103|NCT03951077|516352649|FG005|Overall Study|Withdrawal by Subject|2|||
143220104|NCT03951077|516352644|FG000|Overall Study|Lost to Follow-up|1|||
143220105|NCT03951077|516352645|FG001|Overall Study|Lost to Follow-up|1|||
143220106|NCT03951077|516352646|FG002|Overall Study|Lost to Follow-up|2|||
143220107|NCT03951077|516352647|FG003|Overall Study|Lost to Follow-up|3|||
143220108|NCT03951077|516352648|FG004|Overall Study|Lost to Follow-up|2|||
143220109|NCT03951077|516352649|FG005|Overall Study|Lost to Follow-up|3|||
143220110|NCT03951077|516352644|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
143220111|NCT03951077|516352645|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
143220112|NCT03951077|516352646|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
143220113|NCT03951077|516352647|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
143220114|NCT03951077|516352648|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
143220115|NCT03951077|516352649|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
143220116|NCT03951077|516352644|FG000|Overall Study|Other, Not Specified|12|||
143220117|NCT03951077|516352645|FG001|Overall Study|Other, Not Specified|10|||
143220118|NCT03951077|516352646|FG002|Overall Study|Other, Not Specified|10|||
143220119|NCT03951077|516352647|FG003|Overall Study|Other, Not Specified|5|||
143220120|NCT03951077|516352648|FG004|Overall Study|Other, Not Specified|9|||
143220121|NCT03951077|516352649|FG005|Overall Study|Other, Not Specified|6|||
143220122|NCT03951077|516352644|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
143220123|NCT03951077|516352645|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
143220124|NCT03951077|516352646|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
143220125|NCT03951077|516352647|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
143220126|NCT03951077|516352648|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
143220127|NCT03951077|516352649|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
143220128|NCT01473732|516352651|FG000|Overall Study|Adverse Event|1|||
143220129|NCT01473732|516352652|FG001|Overall Study|Adverse Event|0|||
143220130|NCT01473732|516352651|FG000|Overall Study|Death|1|||
143220131|NCT01473732|516352652|FG001|Overall Study|Death|0|||
143220132|NCT03579940|516352656|FG000|Period 2|Withdrawal by Subject|0|||
143220133|NCT03579940|516352657|FG001|Period 2|Withdrawal by Subject|0|||
143220134|NCT03579940|516352658|FG002|Period 2|Withdrawal by Subject|1|||
143220135|NCT03579940|516352659|FG003|Period 2|Withdrawal by Subject|0|||
143220136|NCT03579940|516352660|FG004|Period 2|Withdrawal by Subject|0|||
143220137|NCT03579940|516352661|FG005|Period 2|Withdrawal by Subject|0|||
143220138|NCT03579940|516352662|FG006|Period 2|Withdrawal by Subject|0|||
143220139|NCT03579940|516352663|FG007|Period 2|Withdrawal by Subject|0|||
143220140|NCT03579940|516352664|FG008|Period 2|Withdrawal by Subject|0|||
143220141|NCT03579940|516352665|FG009|Period 2|Withdrawal by Subject|0|||
143220142|NCT03579940|516352666|FG010|Period 2|Withdrawal by Subject|0|||
143220143|NCT00671034|516352667|FG000|Overall Study|Adverse Event|5|||
143220144|NCT00671034|516352668|FG001|Overall Study|Adverse Event|7|||
143220145|NCT00671034|516352669|FG002|Overall Study|Adverse Event|1|||
143220146|NCT00671034|516352667|FG000|Overall Study|Death|3|||
143220147|NCT00671034|516352668|FG001|Overall Study|Death|2|||
143220148|NCT00671034|516352669|FG002|Overall Study|Death|1|||
143220149|NCT00671034|516352667|FG000|Overall Study|Physician Decision|12|||
143220150|NCT00671034|516352668|FG001|Overall Study|Physician Decision|4|||
143220151|NCT00671034|516352669|FG002|Overall Study|Physician Decision|5|||
143220152|NCT00671034|516352667|FG000|Overall Study|VHR ALL feature|8|||
143220153|NCT00671034|516352668|FG001|Overall Study|VHR ALL feature|3|||
143220154|NCT00671034|516352669|FG002|Overall Study|VHR ALL feature|5|||
143372182|NCT04517864|516909434|FG001|Extension Phase|Lack of Efficacy|0|||
143372183|NCT04517864|516909435|FG002|Extension Phase|Lack of Efficacy|2|||
143220155|NCT00671034|516352667|FG000|Overall Study|Refusal|5|||
143220156|NCT00671034|516352668|FG001|Overall Study|Refusal|3|||
143220157|NCT00671034|516352669|FG002|Overall Study|Refusal|5|||
143220158|NCT00671034|516352667|FG000|Overall Study|includes Alternative therapy, etc.|6|||
143220159|NCT00671034|516352668|FG001|Overall Study|includes Alternative therapy, etc.|1|||
143220160|NCT00671034|516352669|FG002|Overall Study|includes Alternative therapy, etc.|7|||
143220161|NCT00853151|516352670|FG000|Overall Study|Adverse Event|1|||
143220162|NCT00853151|516352671|FG001|Overall Study|Adverse Event|4|||
143220163|NCT00853151|516352672|FG002|Overall Study|Adverse Event|2|||
143220164|NCT00853151|516352673|FG003|Overall Study|Adverse Event|0|||
143220165|NCT00853151|516352670|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
143220166|NCT00853151|516352671|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
143220167|NCT00853151|516352672|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
143220168|NCT00853151|516352673|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
143220169|NCT00853151|516352670|FG000|Overall Study|Lost to Follow-up|2|||
143372184|NCT04517864|516909433|FG000|Extension Phase|Study Terminated By Sponsor|0|||
143220170|NCT00853151|516352671|FG001|Overall Study|Lost to Follow-up|0|||
143267254|NCT02435069|516533143|FG002|Dose Response - First Intervention|Adverse Event|1|||
143267255|NCT02435069|516533144|FG003|Dose Response - First Intervention|Adverse Event|0|||
143267256|NCT02435069|516533145|FG004|Dose Response - First Intervention|Adverse Event|0|||
143267257|NCT02435069|516533141|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
143267258|NCT02435069|516533142|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
143267259|NCT02435069|516533143|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
143267260|NCT02435069|516533144|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
143267261|NCT02435069|516533145|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
143267262|NCT03112590|516533146|FG000|Overall Study|Adverse Event|0|||
143267263|NCT03112590|516533147|FG001|Overall Study|Adverse Event|1|||
143267264|NCT03112590|516533148|FG002|Overall Study|Adverse Event|0|||
143267265|NCT00843726|516533151|FG000|Overall Study|Death|1|||
143267266|NCT00843726|516533152|FG001|Overall Study|Death|0|||
143267267|NCT00843726|516533151|FG000|Overall Study|Withdrawal by Subject|0|||
143267268|NCT00843726|516533152|FG001|Overall Study|Withdrawal by Subject|1|||
143267269|NCT00973349|516533153|FG000|Overall Study|Adverse Event|0|||
143267270|NCT00973349|516533154|FG001|Overall Study|Adverse Event|0|||
143267271|NCT00973349|516533155|FG002|Overall Study|Adverse Event|0|||
143267272|NCT00973349|516533156|FG003|Overall Study|Adverse Event|0|||
143267273|NCT00973349|516533157|FG004|Overall Study|Adverse Event|1|||
143267274|NCT00973349|516533158|FG005|Overall Study|Adverse Event|0|||
143267275|NCT00973349|516533159|FG006|Overall Study|Adverse Event|0|||
143267276|NCT00973349|516533160|FG007|Overall Study|Adverse Event|0|||
143267277|NCT00973349|516533161|FG008|Overall Study|Adverse Event|1|||
143267278|NCT00973349|516533162|FG009|Overall Study|Adverse Event|0|||
143267279|NCT00973349|516533163|FG010|Overall Study|Adverse Event|0|||
143267280|NCT00973349|516533164|FG011|Overall Study|Adverse Event|0|||
143267281|NCT00973349|516533165|FG012|Overall Study|Adverse Event|0|||
143267282|NCT00973349|516533166|FG013|Overall Study|Adverse Event|0|||
143267283|NCT00973349|516533167|FG014|Overall Study|Adverse Event|1|||
143267284|NCT00973349|516533168|FG015|Overall Study|Adverse Event|0|||
143267285|NCT00973349|516533153|FG000|Overall Study|Withdrawal by Subject|1|||
143267286|NCT00973349|516533154|FG001|Overall Study|Withdrawal by Subject|2|||
143267287|NCT00973349|516533155|FG002|Overall Study|Withdrawal by Subject|2|||
143267288|NCT00973349|516533156|FG003|Overall Study|Withdrawal by Subject|3|||
143267289|NCT00973349|516533157|FG004|Overall Study|Withdrawal by Subject|2|||
143372185|NCT04517864|516909434|FG001|Extension Phase|Study Terminated By Sponsor|0|||
143372186|NCT04517864|516909435|FG002|Extension Phase|Study Terminated By Sponsor|32|||
143372187|NCT04517864|516909433|FG000|Extension Phase|Withdrawal by Subject|0|||
143372188|NCT04517864|516909434|FG001|Extension Phase|Withdrawal by Subject|0|||
143372189|NCT04517864|516909435|FG002|Extension Phase|Withdrawal by Subject|3|||
143372190|NCT04517864|516909433|FG000|Extension Phase|Approved Drug Available for Indication|0|||
143372191|NCT04517864|516909434|FG001|Extension Phase|Approved Drug Available for Indication|0|||
143372192|NCT04517864|516909435|FG002|Extension Phase|Approved Drug Available for Indication|7|||
143372193|NCT04722003|516909436|FG000|Overall Study|Lost to Follow-up|2|||
143372194|NCT04722003|516909437|FG001|Overall Study|Lost to Follow-up|0|||
143220171|NCT00853151|516352672|FG002|Overall Study|Lost to Follow-up|3|||
143220172|NCT00853151|516352673|FG003|Overall Study|Lost to Follow-up|0|||
143220173|NCT00853151|516352670|FG000|Overall Study|Death|1|||
143220174|NCT00853151|516352671|FG001|Overall Study|Death|0|||
143220175|NCT00853151|516352672|FG002|Overall Study|Death|0|||
143220176|NCT00853151|516352673|FG003|Overall Study|Death|1|||
143220177|NCT00853151|516352670|FG000|Overall Study|Protocol Violation|0|||
143220178|NCT00853151|516352671|FG001|Overall Study|Protocol Violation|0|||
143220179|NCT00853151|516352672|FG002|Overall Study|Protocol Violation|0|||
143220180|NCT00853151|516352673|FG003|Overall Study|Protocol Violation|1|||
143372195|NCT04722003|516909436|FG000|Overall Study|Physician Decision|1|||
143220181|NCT00853151|516352670|FG000|Overall Study|Withdrawal by Subject|5|||
143220182|NCT00853151|516352671|FG001|Overall Study|Withdrawal by Subject|4|||
143267290|NCT00973349|516533158|FG005|Overall Study|Withdrawal by Subject|0|||
143267291|NCT00973349|516533159|FG006|Overall Study|Withdrawal by Subject|2|||
143267292|NCT00973349|516533160|FG007|Overall Study|Withdrawal by Subject|2|||
143267293|NCT00973349|516533161|FG008|Overall Study|Withdrawal by Subject|0|||
143372196|NCT04722003|516909437|FG001|Overall Study|Physician Decision|0|||
143267294|NCT00973349|516533162|FG009|Overall Study|Withdrawal by Subject|2|||
143220183|NCT00853151|516352672|FG002|Overall Study|Withdrawal by Subject|2|||
143267295|NCT00973349|516533163|FG010|Overall Study|Withdrawal by Subject|0|||
143372197|NCT03538041|516909438|FG000|12-Week Treatment Period|Adverse Event|1|||
143267296|NCT00973349|516533164|FG011|Overall Study|Withdrawal by Subject|1|||
143267297|NCT00973349|516533165|FG012|Overall Study|Withdrawal by Subject|0|||
143267298|NCT00973349|516533166|FG013|Overall Study|Withdrawal by Subject|0|||
143267299|NCT00973349|516533167|FG014|Overall Study|Withdrawal by Subject|0|||
143220184|NCT00853151|516352673|FG003|Overall Study|Withdrawal by Subject|1|||
143220185|NCT00853151|516352670|FG000|Overall Study|Physician Decision|0|||
143220186|NCT00853151|516352671|FG001|Overall Study|Physician Decision|2|||
143220187|NCT00853151|516352672|FG002|Overall Study|Physician Decision|1|||
143220188|NCT00853151|516352673|FG003|Overall Study|Physician Decision|0|||
143220189|NCT00853151|516352670|FG000|Overall Study|Sponsor Decision|0|||
143220190|NCT00853151|516352671|FG001|Overall Study|Sponsor Decision|3|||
143220191|NCT00853151|516352672|FG002|Overall Study|Sponsor Decision|0|||
143220192|NCT00853151|516352673|FG003|Overall Study|Sponsor Decision|0|||
143220193|NCT00713544|516352674|FG000|Overall Study|Adverse Event|5|||
143220194|NCT00713544|516352675|FG001|Overall Study|Adverse Event|3|||
143220195|NCT00713544|516352676|FG002|Overall Study|Adverse Event|7|||
143220196|NCT00713544|516352677|FG003|Overall Study|Adverse Event|7|||
143220197|NCT00713544|516352678|FG004|Overall Study|Adverse Event|3|||
143220198|NCT00713544|516352679|FG005|Overall Study|Adverse Event|5|||
143220199|NCT00713544|516352674|FG000|Overall Study|Withdrawal by Subject|2|||
143220200|NCT00713544|516352675|FG001|Overall Study|Withdrawal by Subject|0|||
143220201|NCT00713544|516352676|FG002|Overall Study|Withdrawal by Subject|3|||
143220202|NCT00713544|516352677|FG003|Overall Study|Withdrawal by Subject|2|||
143220203|NCT00713544|516352678|FG004|Overall Study|Withdrawal by Subject|3|||
143220204|NCT00713544|516352679|FG005|Overall Study|Withdrawal by Subject|1|||
143220205|NCT00713544|516352674|FG000|Overall Study|Protocol Violation|0|||
143220206|NCT00713544|516352675|FG001|Overall Study|Protocol Violation|0|||
143220207|NCT00713544|516352676|FG002|Overall Study|Protocol Violation|0|||
143220208|NCT00713544|516352677|FG003|Overall Study|Protocol Violation|0|||
143220209|NCT00713544|516352678|FG004|Overall Study|Protocol Violation|0|||
143220210|NCT00713544|516352679|FG005|Overall Study|Protocol Violation|1|||
143220211|NCT00713544|516352674|FG000|Overall Study|Physician Decision|0|||
143220212|NCT00713544|516352675|FG001|Overall Study|Physician Decision|0|||
143220213|NCT00713544|516352676|FG002|Overall Study|Physician Decision|0|||
143220214|NCT00713544|516352677|FG003|Overall Study|Physician Decision|0|||
143220215|NCT00713544|516352678|FG004|Overall Study|Physician Decision|0|||
143220216|NCT00713544|516352679|FG005|Overall Study|Physician Decision|2|||
143220217|NCT00713544|516352674|FG000|Overall Study|Lack of Efficacy|0|||
143220218|NCT00713544|516352675|FG001|Overall Study|Lack of Efficacy|1|||
143220219|NCT00713544|516352676|FG002|Overall Study|Lack of Efficacy|0|||
143220220|NCT00713544|516352677|FG003|Overall Study|Lack of Efficacy|1|||
143220221|NCT00713544|516352678|FG004|Overall Study|Lack of Efficacy|1|||
143220222|NCT00713544|516352679|FG005|Overall Study|Lack of Efficacy|0|||
143220223|NCT00713544|516352674|FG000|Overall Study|Lost to Follow-up|0|||
143220224|NCT00713544|516352675|FG001|Overall Study|Lost to Follow-up|0|||
143220225|NCT00713544|516352676|FG002|Overall Study|Lost to Follow-up|1|||
143220226|NCT00713544|516352677|FG003|Overall Study|Lost to Follow-up|0|||
143220227|NCT00713544|516352678|FG004|Overall Study|Lost to Follow-up|0|||
143220228|NCT00713544|516352679|FG005|Overall Study|Lost to Follow-up|0|||
143220229|NCT00713544|516352674|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
143220230|NCT00713544|516352675|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
143220231|NCT00713544|516352676|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
143220232|NCT00713544|516352677|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
143220233|NCT00713544|516352678|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
143220234|NCT00713544|516352679|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
143220235|NCT00713544|516352674|FG000|Overall Study|Incorrect enrollment|0|||
143220236|NCT00713544|516352675|FG001|Overall Study|Incorrect enrollment|1|||
143220237|NCT00713544|516352676|FG002|Overall Study|Incorrect enrollment|0|||
143220238|NCT00713544|516352677|FG003|Overall Study|Incorrect enrollment|0|||
143220239|NCT00713544|516352678|FG004|Overall Study|Incorrect enrollment|0|||
143220240|NCT00713544|516352679|FG005|Overall Study|Incorrect enrollment|0|||
143220241|NCT00713544|516352674|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
143220242|NCT00713544|516352675|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
143220243|NCT00713544|516352676|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
143220244|NCT00713544|516352677|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
143220245|NCT00713544|516352678|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
143220246|NCT00713544|516352679|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
143220247|NCT02380287|516352682|FG000|Overall Study|Adverse Event|0|||
143220248|NCT02380287|516352683|FG001|Overall Study|Adverse Event|0|||
143220249|NCT02380287|516352684|FG002|Overall Study|Adverse Event|1|||
143220250|NCT02380287|516352685|FG003|Overall Study|Adverse Event|0|||
143220251|NCT02380287|516352686|FG004|Overall Study|Adverse Event|0|||
143220252|NCT02380287|516352687|FG005|Overall Study|Adverse Event|0|||
143220253|NCT02380287|516352688|FG006|Overall Study|Adverse Event|0|||
143220254|NCT02380287|516352689|FG007|Overall Study|Adverse Event|0|||
143220255|NCT01751984|516352690|FG000|Overall Study|Adverse Event|5|||
143220256|NCT01751984|516352691|FG001|Overall Study|Adverse Event|3|||
143220257|NCT01751984|516352690|FG000|Overall Study|Withdrawal by Subject|0|||
143220258|NCT01751984|516352691|FG001|Overall Study|Withdrawal by Subject|1|||
143220259|NCT01751984|516352690|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
143220260|NCT01751984|516352691|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
143220261|NCT04473963|516352692|FG000|Overall Study|Withdrawal by Subject|1|||
143220262|NCT04473963|516352693|FG001|Overall Study|Withdrawal by Subject|1|||
143220263|NCT04473963|516352694|FG002|Overall Study|Withdrawal by Subject|0|||
143220264|NCT04473963|516352692|FG000|Overall Study|Not inducible in AF|0|||
143220265|NCT04473963|516352693|FG001|Overall Study|Not inducible in AF|0|||
143220266|NCT04473963|516352694|FG002|Overall Study|Not inducible in AF|2|||
143220267|NCT01641601|516352695|FG000|Overall Study|Study discontinued.|3|||
143220268|NCT01641601|516352696|FG001|Overall Study|Study discontinued.|5|||
143220269|NCT00832416|516352697|FG000|Overall Study|Lack of Efficacy|17|||
143220270|NCT00832416|516352698|FG001|Overall Study|Lack of Efficacy|15|||
143220271|NCT00832416|516352699|FG002|Overall Study|Lack of Efficacy|13|||
143220272|NCT00832416|516352700|FG003|Overall Study|Lack of Efficacy|52|||
143220273|NCT00832416|516352697|FG000|Overall Study|Withdrawal by Subject|5|||
143220274|NCT00832416|516352698|FG001|Overall Study|Withdrawal by Subject|7|||
143220275|NCT00832416|516352699|FG002|Overall Study|Withdrawal by Subject|2|||
143220276|NCT00832416|516352700|FG003|Overall Study|Withdrawal by Subject|10|||
143220277|NCT00832416|516352697|FG000|Overall Study|Physician Decision|2|||
143220278|NCT00832416|516352698|FG001|Overall Study|Physician Decision|12|||
143220279|NCT00832416|516352699|FG002|Overall Study|Physician Decision|5|||
143220280|NCT00832416|516352700|FG003|Overall Study|Physician Decision|10|||
143220281|NCT00832416|516352697|FG000|Overall Study|Administrative|0|||
143220282|NCT00832416|516352698|FG001|Overall Study|Administrative|0|||
143220283|NCT00832416|516352699|FG002|Overall Study|Administrative|0|||
143220284|NCT00832416|516352700|FG003|Overall Study|Administrative|1|||
143220285|NCT00832416|516352697|FG000|Overall Study|Adverse Event|21|||
143220286|NCT00832416|516352698|FG001|Overall Study|Adverse Event|19|||
143220287|NCT00832416|516352699|FG002|Overall Study|Adverse Event|41|||
143220288|NCT00832416|516352700|FG003|Overall Study|Adverse Event|10|||
143220289|NCT00832416|516352697|FG000|Overall Study|Death|1|||
143220290|NCT00832416|516352698|FG001|Overall Study|Death|0|||
143220291|NCT00832416|516352699|FG002|Overall Study|Death|0|||
143220292|NCT00832416|516352700|FG003|Overall Study|Death|0|||
143220293|NCT00757237|516352709|FG000|Overall Study|Lost to Follow-up|0|||
143220294|NCT00757237|516352710|FG001|Overall Study|Lost to Follow-up|1|||
143220295|NCT00757237|516352709|FG000|Overall Study|Protocol Violation|0|||
143220296|NCT00757237|516352710|FG001|Overall Study|Protocol Violation|2|||
143220297|NCT00757237|516352709|FG000|Overall Study|Physician Decision|2|||
143220298|NCT00757237|516352710|FG001|Overall Study|Physician Decision|3|||
143220299|NCT00757237|516352709|FG000|Overall Study|Withdrawal by Subject|8|||
143220300|NCT00757237|516352710|FG001|Overall Study|Withdrawal by Subject|12|||
143220301|NCT00757237|516352709|FG000|Overall Study|Safety or Tolerability|3|||
143220302|NCT00757237|516352710|FG001|Overall Study|Safety or Tolerability|5|||
143220303|NCT00757237|516352709|FG000|Overall Study|Other|0|||
143220304|NCT00757237|516352710|FG001|Overall Study|Other|2|||
143220305|NCT00779025|516352717|FG000|Overall Study|Withdrawal by Subject|1|||
143220306|NCT05236257|516352723|FG000|Overall Study|Ongoing with study treatment|29|||
143220307|NCT05236257|516352724|FG001|Overall Study|Ongoing with study treatment|1|||
143220308|NCT05236257|516352723|FG000|Overall Study|Discontinued study treatment|22|||
143220309|NCT05236257|516352724|FG001|Overall Study|Discontinued study treatment|41|||
143220310|NCT04752332|516352725|FG000|Overall Study|Adverse Event|3|||
143220311|NCT04752332|516352726|FG001|Overall Study|Adverse Event|1|||
143220312|NCT04752332|516352725|FG000|Overall Study|Disease Relapse|1|||
143220313|NCT04752332|516352726|FG001|Overall Study|Disease Relapse|0|||
143220314|NCT04752332|516352725|FG000|Overall Study|Non-compliance With Study Drug|2|||
143220315|NCT04752332|516352726|FG001|Overall Study|Non-compliance With Study Drug|0|||
143220316|NCT04752332|516352725|FG000|Overall Study|Physician Decision|2|||
143220317|NCT04752332|516352726|FG001|Overall Study|Physician Decision|1|||
143220318|NCT04752332|516352725|FG000|Overall Study|Protocol Violation|1|||
143220319|NCT04752332|516352726|FG001|Overall Study|Protocol Violation|1|||
143220320|NCT04752332|516352725|FG000|Overall Study|Study Terminated by IRB/ERB|0|||
143220321|NCT04752332|516352726|FG001|Overall Study|Study Terminated by IRB/ERB|2|||
143220322|NCT04752332|516352725|FG000|Overall Study|Study Terminated by Sponsor|10|||
143220323|NCT04752332|516352726|FG001|Overall Study|Study Terminated by Sponsor|48|||
143220324|NCT04752332|516352725|FG000|Overall Study|Withdrawal by Subject|11|||
143220325|NCT04752332|516352726|FG001|Overall Study|Withdrawal by Subject|3|||
143220326|NCT02915978|516352729|FG000|Overall Study|Adverse Event|2|||
143220327|NCT02915978|516352730|FG001|Overall Study|Adverse Event|1|||
143220328|NCT02915978|516352731|FG002|Overall Study|Adverse Event|0|||
143220329|NCT00924443|516352732|FG000|Overall Study|Physician Decision|2|||
143220330|NCT00924443|516352732|FG000|Overall Study|Protocol Violation|1|||
143220331|NCT00548145|516352736|FG000|Overall Study|Death|0|||
143220332|NCT00548145|516352737|FG001|Overall Study|Death|1|||
143220333|NCT00548145|516352736|FG000|Overall Study|Withdrawal by Subject|0|||
143220334|NCT00548145|516352737|FG001|Overall Study|Withdrawal by Subject|2|||
143220335|NCT00548145|516352736|FG000|Overall Study|Physician Decision|1|||
143220336|NCT00548145|516352737|FG001|Overall Study|Physician Decision|1|||
143220337|NCT00874848|516352738|FG000|Overall Study|Adverse Event|13|||
143220338|NCT00874848|516352739|FG001|Overall Study|Adverse Event|2|||
143220339|NCT00874848|516352738|FG000|Overall Study|Progressive neoplastic disease|38|||
143220340|NCT00874848|516352739|FG001|Overall Study|Progressive neoplastic disease|18|||
143220341|NCT00874848|516352738|FG000|Overall Study|Withdrawal by Subject|7|||
143267300|NCT00973349|516533168|FG015|Overall Study|Withdrawal by Subject|0|||
143267301|NCT00973349|516533153|FG000|Overall Study|Lost to Follow-up|3|||
143267302|NCT00973349|516533154|FG001|Overall Study|Lost to Follow-up|1|||
143267303|NCT00973349|516533155|FG002|Overall Study|Lost to Follow-up|2|||
143267304|NCT00973349|516533156|FG003|Overall Study|Lost to Follow-up|2|||
143267305|NCT00973349|516533157|FG004|Overall Study|Lost to Follow-up|1|||
143267306|NCT00973349|516533158|FG005|Overall Study|Lost to Follow-up|3|||
143267307|NCT00973349|516533159|FG006|Overall Study|Lost to Follow-up|0|||
143267308|NCT00973349|516533160|FG007|Overall Study|Lost to Follow-up|1|||
143267309|NCT00973349|516533161|FG008|Overall Study|Lost to Follow-up|2|||
143267310|NCT00973349|516533162|FG009|Overall Study|Lost to Follow-up|1|||
143267311|NCT00973349|516533163|FG010|Overall Study|Lost to Follow-up|0|||
143267312|NCT00973349|516533164|FG011|Overall Study|Lost to Follow-up|1|||
143267313|NCT00973349|516533165|FG012|Overall Study|Lost to Follow-up|0|||
143267314|NCT00973349|516533166|FG013|Overall Study|Lost to Follow-up|0|||
143267315|NCT00973349|516533167|FG014|Overall Study|Lost to Follow-up|0|||
143267316|NCT00973349|516533168|FG015|Overall Study|Lost to Follow-up|1|||
143267317|NCT00973349|516533153|FG000|Overall Study|Inappropriate enrolment|0|||
143267318|NCT00973349|516533154|FG001|Overall Study|Inappropriate enrolment|0|||
143267319|NCT00973349|516533155|FG002|Overall Study|Inappropriate enrolment|1|||
143267320|NCT00973349|516533156|FG003|Overall Study|Inappropriate enrolment|0|||
143267321|NCT00973349|516533157|FG004|Overall Study|Inappropriate enrolment|0|||
143267322|NCT00973349|516533158|FG005|Overall Study|Inappropriate enrolment|0|||
143267323|NCT00973349|516533159|FG006|Overall Study|Inappropriate enrolment|0|||
143220342|NCT00874848|516352739|FG001|Overall Study|Withdrawal by Subject|4|||
143220343|NCT00874848|516352738|FG000|Overall Study|Noncompliance|1|||
143220344|NCT00874848|516352739|FG001|Overall Study|Noncompliance|1|||
143220345|NCT00874848|516352738|FG000|Overall Study|Failure to comply with protocol|0|||
143220346|NCT00874848|516352739|FG001|Overall Study|Failure to comply with protocol|1|||
143220347|NCT00874848|516352738|FG000|Overall Study|Physician Decision|0|||
143220348|NCT00874848|516352739|FG001|Overall Study|Physician Decision|2|||
143220349|NCT02451124|516352743|FG000|Overall Study|Withdrawal by Subject|1|||
143220350|NCT03301350|516352746|FG000|Overall Study|Withdrawal by Subject|4|||
143220351|NCT03301350|516352746|FG000|Overall Study|Adverse Event|1|||
143220352|NCT03301350|516352746|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
143220353|NCT03301350|516352746|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
143220354|NCT03301350|516352746|FG000|Overall Study|no detail provided|1|||
143220355|NCT01248949|516352747|FG000|Overall Study|Lost to Follow-up|2|||
143220356|NCT01248949|516352748|FG001|Overall Study|Lost to Follow-up|2|||
143220357|NCT01248949|516352749|FG002|Overall Study|Lost to Follow-up|2|||
143220358|NCT01248949|516352750|FG003|Overall Study|Lost to Follow-up|1|||
143220359|NCT01248949|516352751|FG004|Overall Study|Lost to Follow-up|0|||
143220360|NCT01248949|516352747|FG000|Overall Study|Withdrawal by Subject|5|||
143220361|NCT01248949|516352748|FG001|Overall Study|Withdrawal by Subject|3|||
143220362|NCT01248949|516352749|FG002|Overall Study|Withdrawal by Subject|11|||
143220363|NCT01248949|516352750|FG003|Overall Study|Withdrawal by Subject|3|||
143220364|NCT01248949|516352751|FG004|Overall Study|Withdrawal by Subject|1|||
143220365|NCT01248949|516352747|FG000|Overall Study|Death|22|||
143220366|NCT01248949|516352748|FG001|Overall Study|Death|7|||
143220367|NCT01248949|516352749|FG002|Overall Study|Death|21|||
143220368|NCT01248949|516352750|FG003|Overall Study|Death|6|||
143220369|NCT01248949|516352751|FG004|Overall Study|Death|2|||
143220370|NCT01248949|516352747|FG000|Overall Study|Alternative Therapy|1|||
143220371|NCT01248949|516352748|FG001|Overall Study|Alternative Therapy|0|||
143220372|NCT01248949|516352749|FG002|Overall Study|Alternative Therapy|0|||
143220373|NCT01248949|516352750|FG003|Overall Study|Alternative Therapy|0|||
143267324|NCT00973349|516533160|FG007|Overall Study|Inappropriate enrolment|0|||
143267325|NCT00973349|516533161|FG008|Overall Study|Inappropriate enrolment|0|||
143267326|NCT00973349|516533162|FG009|Overall Study|Inappropriate enrolment|2|||
143267327|NCT00973349|516533163|FG010|Overall Study|Inappropriate enrolment|0|||
143267328|NCT00973349|516533164|FG011|Overall Study|Inappropriate enrolment|0|||
143267329|NCT00973349|516533165|FG012|Overall Study|Inappropriate enrolment|1|||
143267330|NCT00973349|516533166|FG013|Overall Study|Inappropriate enrolment|0|||
143267331|NCT00973349|516533167|FG014|Overall Study|Inappropriate enrolment|1|||
143220374|NCT01248949|516352751|FG004|Overall Study|Alternative Therapy|0|||
143220375|NCT01248949|516352747|FG000|Overall Study|Alternative Therapy.|1|||
143220376|NCT01248949|516352748|FG001|Overall Study|Alternative Therapy.|0|||
143267332|NCT00973349|516533168|FG015|Overall Study|Inappropriate enrolment|1|||
143267333|NCT00973349|516533153|FG000|Overall Study|Protocol Violation|0|||
143267334|NCT00973349|516533154|FG001|Overall Study|Protocol Violation|0|||
143267335|NCT00973349|516533155|FG002|Overall Study|Protocol Violation|0|||
143267336|NCT00973349|516533156|FG003|Overall Study|Protocol Violation|0|||
143220377|NCT01248949|516352749|FG002|Overall Study|Alternative Therapy.|0|||
143220378|NCT01248949|516352750|FG003|Overall Study|Alternative Therapy.|0|||
143220379|NCT01248949|516352751|FG004|Overall Study|Alternative Therapy.|0|||
143220380|NCT01248949|516352747|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
143267337|NCT00973349|516533157|FG004|Overall Study|Protocol Violation|0|||
143267338|NCT00973349|516533158|FG005|Overall Study|Protocol Violation|0|||
143220381|NCT01248949|516352748|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
143220382|NCT01248949|516352749|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
143220383|NCT01248949|516352750|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
143220384|NCT01248949|516352751|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
143220385|NCT01248949|516352747|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
143220386|NCT01248949|516352748|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
143220387|NCT01248949|516352749|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
143220388|NCT01248949|516352750|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
143220389|NCT01248949|516352751|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
143220390|NCT01248949|516352747|FG000|Overall Study|Participant Went To Hospice|0|||
143220391|NCT01248949|516352748|FG001|Overall Study|Participant Went To Hospice|0|||
143220392|NCT01248949|516352749|FG002|Overall Study|Participant Went To Hospice|1|||
143220393|NCT01248949|516352750|FG003|Overall Study|Participant Went To Hospice|0|||
143220394|NCT01248949|516352751|FG004|Overall Study|Participant Went To Hospice|0|||
143220395|NCT01248949|516352747|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
143220396|NCT01248949|516352748|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
143220397|NCT01248949|516352749|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
143220398|NCT01248949|516352750|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
143220399|NCT01248949|516352751|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
143220400|NCT01248949|516352747|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
143220401|NCT01248949|516352748|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
143220402|NCT01248949|516352749|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
143220403|NCT01248949|516352750|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
143220404|NCT01248949|516352751|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
143220405|NCT01248949|516352747|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
143220406|NCT01248949|516352748|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
143220407|NCT01248949|516352749|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
143220408|NCT01248949|516352750|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
143220409|NCT01248949|516352751|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
143220410|NCT01248949|516352747|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
143220411|NCT01248949|516352748|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
143220412|NCT01248949|516352749|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
143220413|NCT01248949|516352750|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
143220414|NCT01248949|516352751|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
143220415|NCT00286429|516352752|FG000|Overall Study|Adverse Event|4|||
143220416|NCT00286429|516352753|FG001|Overall Study|Adverse Event|1|||
143220417|NCT00286429|516352754|FG002|Overall Study|Adverse Event|6|||
143220418|NCT00286429|516352752|FG000|Overall Study|Lack of Efficacy|52|||
143220419|NCT00286429|516352753|FG001|Overall Study|Lack of Efficacy|27|||
143220420|NCT00286429|516352754|FG002|Overall Study|Lack of Efficacy|25|||
143220421|NCT00286429|516352752|FG000|Overall Study|Lost to Follow-up|2|||
143220422|NCT00286429|516352753|FG001|Overall Study|Lost to Follow-up|4|||
143220423|NCT00286429|516352754|FG002|Overall Study|Lost to Follow-up|3|||
143220424|NCT00286429|516352752|FG000|Overall Study|Physician Decision|10|||
143220425|NCT00286429|516352753|FG001|Overall Study|Physician Decision|7|||
143220426|NCT00286429|516352754|FG002|Overall Study|Physician Decision|7|||
143220427|NCT00286429|516352752|FG000|Overall Study|Protocol Violation|3|||
143220428|NCT00286429|516352753|FG001|Overall Study|Protocol Violation|5|||
143220429|NCT00286429|516352754|FG002|Overall Study|Protocol Violation|4|||
143220430|NCT00286429|516352752|FG000|Overall Study|Withdrawal by Subject|3|||
143220431|NCT00286429|516352753|FG001|Overall Study|Withdrawal by Subject|2|||
143220432|NCT00286429|516352754|FG002|Overall Study|Withdrawal by Subject|6|||
143220433|NCT00286429|516352752|FG000|Overall Study|Administrative Error|1|||
143220434|NCT00286429|516352753|FG001|Overall Study|Administrative Error|1|||
143220435|NCT00286429|516352754|FG002|Overall Study|Administrative Error|1|||
143220436|NCT00286429|516352752|FG000|Overall Study|Administrative Decision|0|||
143220437|NCT00286429|516352753|FG001|Overall Study|Administrative Decision|1|||
143220438|NCT00286429|516352754|FG002|Overall Study|Administrative Decision|0|||
143220439|NCT01746225|516352757|FG000|Overall Study|Death|1|||
143220440|NCT01746225|516352758|FG001|Overall Study|Death|0|||
143220441|NCT01746225|516352759|FG002|Overall Study|Death|1|||
143220442|NCT01746225|516352757|FG000|Overall Study|Withdrawal by Subject|5|||
143220443|NCT01746225|516352758|FG001|Overall Study|Withdrawal by Subject|15|||
143220444|NCT01746225|516352759|FG002|Overall Study|Withdrawal by Subject|19|||
143220445|NCT01746225|516352757|FG000|Overall Study|Physician Decision|14|||
143220446|NCT01746225|516352758|FG001|Overall Study|Physician Decision|11|||
143220447|NCT01746225|516352759|FG002|Overall Study|Physician Decision|3|||
143220448|NCT01746225|516352757|FG000|Overall Study|Adverse Event|15|||
143220449|NCT01746225|516352758|FG001|Overall Study|Adverse Event|12|||
143220450|NCT01746225|516352759|FG002|Overall Study|Adverse Event|17|||
143220451|NCT01746225|516352757|FG000|Overall Study|Continuing Treatment|5|||
143372198|NCT03538041|516909439|FG001|12-Week Treatment Period|Adverse Event|1|||
143220452|NCT01746225|516352758|FG001|Overall Study|Continuing Treatment|8|||
143220453|NCT01746225|516352759|FG002|Overall Study|Continuing Treatment|3|||
143220454|NCT03245775|516352762|FG000|Overall Study|Lost to Follow-up|25|||
143220455|NCT03245775|516352763|FG001|Overall Study|Lost to Follow-up|26|||
143220456|NCT03245775|516352764|FG002|Overall Study|Lost to Follow-up|16|||
143220457|NCT03245775|516352765|FG003|Overall Study|Lost to Follow-up|16|||
143220458|NCT02713828|516352768|FG000|Overall Study|Death|2|||
143220459|NCT02713828|516352769|FG001|Overall Study|Death|0|||
143220460|NCT02713828|516352768|FG000|Overall Study|Withdrawal by Subject|1|||
143220461|NCT02713828|516352769|FG001|Overall Study|Withdrawal by Subject|0|||
143220462|NCT02713828|516352768|FG000|Overall Study|study terminated but patient allowed to|2|||
143220463|NCT02713828|516352769|FG001|Overall Study|study terminated but patient allowed to|0|||
143220464|NCT03302247|516352770|FG000|Overall Study|the study has closed prematurely|2|||
143220465|NCT03302247|516352770|FG000|Overall Study|Death|1|||
143220466|NCT03197376|516352771|FG000|Primary and Booster Phase|Adverse Event|0|||
143220467|NCT03197376|516352772|FG001|Primary and Booster Phase|Adverse Event|0|||
143220468|NCT03197376|516352773|FG002|Primary and Booster Phase|Adverse Event|0|||
143220469|NCT03197376|516352774|FG003|Primary and Booster Phase|Adverse Event|1|||
143220470|NCT03197376|516352771|FG000|Primary and Booster Phase|Death|1|||
143220471|NCT03197376|516352772|FG001|Primary and Booster Phase|Death|0|||
143220472|NCT03197376|516352773|FG002|Primary and Booster Phase|Death|0|||
143220473|NCT03197376|516352774|FG003|Primary and Booster Phase|Death|2|||
143220474|NCT03197376|516352771|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
143220475|NCT03197376|516352772|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
143220476|NCT03197376|516352773|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
143220477|NCT03197376|516352774|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
143220478|NCT03197376|516352771|FG000|Primary and Booster Phase|Physician Decision|1|||
143220479|NCT03197376|516352772|FG001|Primary and Booster Phase|Physician Decision|0|||
143220480|NCT03197376|516352773|FG002|Primary and Booster Phase|Physician Decision|1|||
143220481|NCT03197376|516352774|FG003|Primary and Booster Phase|Physician Decision|3|||
143220482|NCT03197376|516352771|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
143220483|NCT03197376|516352772|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
143220484|NCT03197376|516352773|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
143220485|NCT03197376|516352774|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
143220486|NCT03197376|516352771|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
143220487|NCT03197376|516352772|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
143220488|NCT03197376|516352773|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
143220489|NCT03197376|516352774|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
143220490|NCT03197376|516352771|FG000|Primary and Booster Phase|Not vaccine related|1|||
143220491|NCT03197376|516352772|FG001|Primary and Booster Phase|Not vaccine related|2|||
143220492|NCT03197376|516352773|FG002|Primary and Booster Phase|Not vaccine related|0|||
143220493|NCT03197376|516352774|FG003|Primary and Booster Phase|Not vaccine related|6|||
143220494|NCT03197376|516352771|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
143220495|NCT03197376|516352772|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
143220496|NCT03197376|516352773|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
143220497|NCT03197376|516352774|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
143220498|NCT03197376|516352771|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
143220499|NCT03197376|516352772|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
143220500|NCT03197376|516352773|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
143220501|NCT03197376|516352774|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
143220502|NCT03197376|516352771|FG000|Immune Persistence Phase|Not vaccine related|1|||
143220503|NCT03197376|516352772|FG001|Immune Persistence Phase|Not vaccine related|0|||
143220504|NCT03197376|516352773|FG002|Immune Persistence Phase|Not vaccine related|1|||
143220505|NCT03197376|516352774|FG003|Immune Persistence Phase|Not vaccine related|1|||
143220506|NCT01123395|516352776|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
143220507|NCT01123395|516352777|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
143220508|NCT03691571|516352778|FG000|Overall Study|Withdrawal by Subject|9|||
143220509|NCT03691571|516352779|FG001|Overall Study|Withdrawal by Subject|2|||
143220510|NCT03887221|516352781|FG000|Overall Study|Protocol Violation|1|||
143220511|NCT03887221|516352782|FG001|Overall Study|Protocol Violation|0|||
143220512|NCT00947115|516352783|FG000|Overall Study|Missed reporting interval|3|||
143220513|NCT00947115|516352784|FG001|Overall Study|Missed reporting interval|4|||
143220514|NCT00947115|516352785|FG002|Overall Study|Missed reporting interval|2|||
143220515|NCT00947115|516352783|FG000|Overall Study|Physician Decision|0|||
143220516|NCT00947115|516352784|FG001|Overall Study|Physician Decision|2|||
143220517|NCT00947115|516352785|FG002|Overall Study|Physician Decision|0|||
143220518|NCT00947115|516352783|FG000|Overall Study|Death|0|||
143220519|NCT00947115|516352784|FG001|Overall Study|Death|1|||
143220520|NCT00947115|516352785|FG002|Overall Study|Death|1|||
143220521|NCT00947115|516352783|FG000|Overall Study|Migrated from study area|2|||
143220522|NCT00947115|516352784|FG001|Overall Study|Migrated from study area|0|||
143220523|NCT00947115|516352785|FG002|Overall Study|Migrated from study area|0|||
143220524|NCT00947115|516352783|FG000|Overall Study|Withdrawal by Subject|1|||
143220525|NCT00947115|516352784|FG001|Overall Study|Withdrawal by Subject|3|||
143220526|NCT00947115|516352785|FG002|Overall Study|Withdrawal by Subject|4|||
143220527|NCT00947115|516352783|FG000|Overall Study|Lost to Follow-up|11|||
143220528|NCT00947115|516352784|FG001|Overall Study|Lost to Follow-up|12|||
143220529|NCT00947115|516352785|FG002|Overall Study|Lost to Follow-up|8|||
143220530|NCT02487030|516352786|FG000|Overall Study|Lack of Efficacy|2|||
143220531|NCT02487030|516352787|FG001|Overall Study|Lack of Efficacy|4|||
143220532|NCT02487030|516352788|FG002|Overall Study|Lack of Efficacy|1|||
143220533|NCT02487030|516352789|FG003|Overall Study|Lack of Efficacy|0|||
143220534|NCT02487030|516352790|FG004|Overall Study|Lack of Efficacy|1|||
143220535|NCT02487030|516352791|FG005|Overall Study|Lack of Efficacy|0|||
143220536|NCT02487030|516352792|FG006|Overall Study|Lack of Efficacy|0|||
143220537|NCT02487030|516352786|FG000|Overall Study|Lost to Follow-up|0|||
143220538|NCT02487030|516352787|FG001|Overall Study|Lost to Follow-up|0|||
143220539|NCT02487030|516352788|FG002|Overall Study|Lost to Follow-up|1|||
143220540|NCT02487030|516352789|FG003|Overall Study|Lost to Follow-up|1|||
143220541|NCT02487030|516352790|FG004|Overall Study|Lost to Follow-up|0|||
143220542|NCT02487030|516352791|FG005|Overall Study|Lost to Follow-up|1|||
143220543|NCT02487030|516352792|FG006|Overall Study|Lost to Follow-up|0|||
143220544|NCT02487030|516352786|FG000|Overall Study|Adverse Event|0|||
143220545|NCT02487030|516352787|FG001|Overall Study|Adverse Event|0|||
143220546|NCT02487030|516352788|FG002|Overall Study|Adverse Event|0|||
143220547|NCT02487030|516352789|FG003|Overall Study|Adverse Event|1|||
143220548|NCT02487030|516352790|FG004|Overall Study|Adverse Event|0|||
143220549|NCT02487030|516352791|FG005|Overall Study|Adverse Event|0|||
143220550|NCT02487030|516352792|FG006|Overall Study|Adverse Event|0|||
143220551|NCT02487030|516352786|FG000|Overall Study|Death|0|||
143220552|NCT02487030|516352787|FG001|Overall Study|Death|0|||
143220553|NCT02487030|516352788|FG002|Overall Study|Death|0|||
143220554|NCT02487030|516352789|FG003|Overall Study|Death|0|||
143220555|NCT02487030|516352790|FG004|Overall Study|Death|1|||
143220556|NCT02487030|516352791|FG005|Overall Study|Death|0|||
143220557|NCT02487030|516352792|FG006|Overall Study|Death|0|||
143220558|NCT00900029|516352795|FG000|Overall Study|Lost to Follow-up|0|||
143220559|NCT00900029|516352796|FG001|Overall Study|Lost to Follow-up|2|||
143220560|NCT00900029|516352797|FG002|Overall Study|Lost to Follow-up|1|||
143220561|NCT00900029|516352798|FG003|Overall Study|Lost to Follow-up|4|||
143220562|NCT00900029|516352799|FG004|Overall Study|Lost to Follow-up|4|||
143220563|NCT00900029|516352795|FG000|Overall Study|Withdrawal by Subject|2|||
143220564|NCT00900029|516352796|FG001|Overall Study|Withdrawal by Subject|2|||
143220565|NCT00900029|516352797|FG002|Overall Study|Withdrawal by Subject|1|||
143220566|NCT00900029|516352798|FG003|Overall Study|Withdrawal by Subject|1|||
143220567|NCT00900029|516352799|FG004|Overall Study|Withdrawal by Subject|1|||
143220568|NCT00900029|516352795|FG000|Overall Study|Adverse Event|0|||
143220569|NCT00900029|516352796|FG001|Overall Study|Adverse Event|0|||
143220570|NCT00900029|516352797|FG002|Overall Study|Adverse Event|1|||
143220571|NCT00900029|516352798|FG003|Overall Study|Adverse Event|1|||
143220572|NCT00900029|516352799|FG004|Overall Study|Adverse Event|1|||
143220573|NCT00900029|516352795|FG000|Overall Study|Death|1|||
143220574|NCT00900029|516352796|FG001|Overall Study|Death|0|||
143220575|NCT00900029|516352797|FG002|Overall Study|Death|0|||
143220576|NCT00900029|516352798|FG003|Overall Study|Death|1|||
143220577|NCT00900029|516352799|FG004|Overall Study|Death|0|||
143220578|NCT00511238|516352800|FG000|Overall Study|Adverse Event|13|||
143220579|NCT00511238|516352801|FG001|Overall Study|Adverse Event|33|||
143220580|NCT00511238|516352800|FG000|Overall Study|Withdrawal by Subject|2|||
143220581|NCT00511238|516352801|FG001|Overall Study|Withdrawal by Subject|22|||
143220582|NCT00511238|516352800|FG000|Overall Study|Progressive Disease|23|||
143220583|NCT00511238|516352801|FG001|Overall Study|Progressive Disease|157|||
143220584|NCT00511238|516352800|FG000|Overall Study|various reasons|4|||
143220585|NCT00511238|516352801|FG001|Overall Study|various reasons|14|||
143220586|NCT02587819|516352804|FG000|Overall Study|Adverse Event|1|||
143267339|NCT00973349|516533159|FG006|Overall Study|Protocol Violation|0|||
143267340|NCT00973349|516533160|FG007|Overall Study|Protocol Violation|0|||
143220587|NCT02587819|516352804|FG000|Overall Study|Lost to Follow-up|1|||
143220588|NCT00163020|516352805|FG000|Overall Study|Lost to Follow-up|0|||
143220589|NCT00163020|516352806|FG001|Overall Study|Lost to Follow-up|2|||
143220590|NCT01101035|516354571|FG000|Overall Study|Adverse Event|191|||
143220591|NCT01101035|516354572|FG001|Overall Study|Adverse Event|172|||
143220592|NCT01101035|516354571|FG000|Overall Study|Major Protocol Deviation|52|||
143220593|NCT01101035|516354572|FG001|Overall Study|Major Protocol Deviation|46|||
143220594|NCT01101035|516354571|FG000|Overall Study|Lost to Follow-up|226|||
143220595|NCT01101035|516354572|FG001|Overall Study|Lost to Follow-up|223|||
143220596|NCT01101035|516354571|FG000|Overall Study|Voluntary Withdrawal|595|||
143220597|NCT01101035|516354572|FG001|Overall Study|Voluntary Withdrawal|587|||
143220598|NCT01101035|516354571|FG000|Overall Study|Reason not Specified|333|||
143220599|NCT01101035|516354572|FG001|Overall Study|Reason not Specified|363|||
143220600|NCT00922623|516354573|FG000|Overall Study|Other|4|||
143220601|NCT00922623|516354573|FG000|Overall Study|Lost to Follow-up|1|||
143220602|NCT02871635|516354574|FG000|Overall Study|Primary lack of efficacy|4|||
143220603|NCT02871635|516354575|FG001|Overall Study|Primary lack of efficacy|4|||
143220604|NCT02871635|516354574|FG000|Overall Study|Protocol Violation|3|||
143220605|NCT02871635|516354575|FG001|Overall Study|Protocol Violation|1|||
143220606|NCT02871635|516354574|FG000|Overall Study|Lost to Follow-up|1|||
143220607|NCT02871635|516354575|FG001|Overall Study|Lost to Follow-up|2|||
143220608|NCT02871635|516354574|FG000|Overall Study|Pregnancy|0|||
143220609|NCT02871635|516354575|FG001|Overall Study|Pregnancy|2|||
143220610|NCT02871635|516354574|FG000|Overall Study|Physician Decision|1|||
143220611|NCT02871635|516354575|FG001|Overall Study|Physician Decision|1|||
143220612|NCT02871635|516354574|FG000|Overall Study|Withdrawal by Subject|3|||
143220613|NCT02871635|516354575|FG001|Overall Study|Withdrawal by Subject|4|||
143220614|NCT02871635|516354574|FG000|Overall Study|Adverse Event|4|||
143220615|NCT02871635|516354575|FG001|Overall Study|Adverse Event|4|||
143220616|NCT02871635|516354574|FG000|Overall Study|Secondary lack of efficacy|2|||
143220617|NCT02871635|516354575|FG001|Overall Study|Secondary lack of efficacy|1|||
143220618|NCT02420379|516354576|FG000|Overall Study|Withdrawal by Subject|0|||
143220619|NCT02420379|516354577|FG001|Overall Study|Withdrawal by Subject|3|||
143220620|NCT02420379|516354576|FG000|Overall Study|Unable to complete due to schooling|0|||
143220621|NCT02420379|516354577|FG001|Overall Study|Unable to complete due to schooling|1|||
143220622|NCT02420379|516354576|FG000|Overall Study|Transitioned to commercial drug|1|||
143220623|NCT02420379|516354577|FG001|Overall Study|Transitioned to commercial drug|0|||
143220624|NCT00217425|516354579|FG000|Overall Study|Never started treatment|2|||
143220625|NCT00217425|516354579|FG000|Overall Study|Patient ineligible|5|||
143220626|NCT00217425|516354579|FG000|Overall Study|Lack of Efficacy|13|||
143220627|NCT00217425|516354579|FG000|Overall Study|Adverse Event|8|||
143220628|NCT00217425|516354579|FG000|Overall Study|Withdrawal by Subject|4|||
143220629|NCT00217425|516354579|FG000|Overall Study|Other complicating disease|1|||
143220630|NCT00217425|516354579|FG000|Overall Study|Other|4|||
143220631|NCT00086047|516354580|FG000|Overall Study|Lost to Follow-up|7|||
143220632|NCT00086047|516354581|FG001|Overall Study|Lost to Follow-up|6|||
143220633|NCT00086047|516354580|FG000|Overall Study|Physician Decision|0|||
143220634|NCT00086047|516354581|FG001|Overall Study|Physician Decision|1|||
143220635|NCT01395901|516354582|FG000|Overall Study|Lost to Follow-up|4|||
143220636|NCT01395901|516354583|FG001|Overall Study|Lost to Follow-up|0|||
143220637|NCT01395901|516354582|FG000|Overall Study|Randomized but not received study drug|5|||
143220638|NCT01395901|516354583|FG001|Overall Study|Randomized but not received study drug|4|||
143220639|NCT01395901|516354582|FG000|Overall Study|Adverse Event|0|||
143220640|NCT01395901|516354583|FG001|Overall Study|Adverse Event|1|||
143220641|NCT01395901|516354582|FG000|Overall Study|Withdrawal of consent|1|||
143220642|NCT01395901|516354583|FG001|Overall Study|Withdrawal of consent|0|||
143220643|NCT01217944|516354589|FG000|Overall Study|Protocol Violation|1|||
143220644|NCT01217944|516354590|FG001|Overall Study|Protocol Violation|1|||
143220645|NCT01217944|516354591|FG002|Overall Study|Protocol Violation|0|||
143220646|NCT01217944|516354589|FG000|Overall Study|Lost to Follow-up|3|||
143220647|NCT01217944|516354590|FG001|Overall Study|Lost to Follow-up|1|||
143220648|NCT01217944|516354591|FG002|Overall Study|Lost to Follow-up|0|||
143220649|NCT01217944|516354589|FG000|Overall Study|Withdrawal by Subject|1|||
143220650|NCT01217944|516354590|FG001|Overall Study|Withdrawal by Subject|2|||
143220651|NCT01217944|516354591|FG002|Overall Study|Withdrawal by Subject|0|||
143220652|NCT01217944|516354589|FG000|Overall Study|Lack of Efficacy|1|||
143220653|NCT01217944|516354590|FG001|Overall Study|Lack of Efficacy|0|||
143220654|NCT01217944|516354591|FG002|Overall Study|Lack of Efficacy|0|||
143220655|NCT00269919|516354595|FG000|Overall Study|Other|26|||
143220656|NCT00269919|516354595|FG000|Overall Study|Started but not treated|1|||
143220657|NCT02471014|516354596|FG000|Overall Study|Lost to Follow-up|2|||
143220658|NCT02471014|516354597|FG001|Overall Study|Lost to Follow-up|2|||
143220659|NCT00786799|516354598|FG000|Overall Study|Lost to Follow-up|1|||
143220660|NCT00786799|516354599|FG001|Overall Study|Lost to Follow-up|1|||
143220661|NCT00950846|516354602|FG000|Overall Study|Death|6|||
143267341|NCT00973349|516533161|FG008|Overall Study|Protocol Violation|1|||
143267342|NCT00973349|516533162|FG009|Overall Study|Protocol Violation|0|||
143267343|NCT00973349|516533163|FG010|Overall Study|Protocol Violation|0|||
143267344|NCT00973349|516533164|FG011|Overall Study|Protocol Violation|0|||
143267345|NCT00973349|516533165|FG012|Overall Study|Protocol Violation|0|||
143267346|NCT00973349|516533166|FG013|Overall Study|Protocol Violation|0|||
143267347|NCT00973349|516533167|FG014|Overall Study|Protocol Violation|0|||
143220662|NCT00950846|516354602|FG000|Overall Study|Lost to Follow-up|3|||
143220663|NCT00950846|516354602|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
143220664|NCT02178995|516354605|FG000|Double Blind|Adverse Event|0|||
143220665|NCT02178995|516354606|FG001|Double Blind|Adverse Event|0|||
143220666|NCT02178995|516354607|FG002|Double Blind|Adverse Event|0|||
143220667|NCT02178995|516354608|FG003|Double Blind|Adverse Event|0|||
143220668|NCT02178995|516354609|FG004|Double Blind|Adverse Event|0|||
143220669|NCT02178995|516354610|FG005|Double Blind|Adverse Event|1|||
143220670|NCT02178995|516354611|FG006|Double Blind|Adverse Event|0|||
143220671|NCT02178995|516354612|FG007|Double Blind|Adverse Event|1|||
143220672|NCT02178995|516354613|FG008|Double Blind|Adverse Event|1|||
143267348|NCT00973349|516533168|FG015|Overall Study|Protocol Violation|0|||
143267349|NCT00973349|516533153|FG000|Overall Study|Unable to classify|0|||
143220673|NCT02178995|516354605|FG000|Double Blind|Lost to Follow-up|0|||
143220674|NCT02178995|516354606|FG001|Double Blind|Lost to Follow-up|1|||
143220675|NCT02178995|516354607|FG002|Double Blind|Lost to Follow-up|0|||
143220676|NCT02178995|516354608|FG003|Double Blind|Lost to Follow-up|0|||
143220677|NCT02178995|516354609|FG004|Double Blind|Lost to Follow-up|0|||
143220678|NCT02178995|516354610|FG005|Double Blind|Lost to Follow-up|0|||
143220679|NCT02178995|516354611|FG006|Double Blind|Lost to Follow-up|0|||
143220680|NCT02178995|516354612|FG007|Double Blind|Lost to Follow-up|1|||
143220681|NCT02178995|516354613|FG008|Double Blind|Lost to Follow-up|0|||
143220682|NCT02178995|516354605|FG000|Open Label|Adverse Event|2|||
143220683|NCT02178995|516354606|FG001|Open Label|Adverse Event|0|||
143220684|NCT02178995|516354607|FG002|Open Label|Adverse Event|0|||
143220685|NCT02178995|516354608|FG003|Open Label|Adverse Event|0|||
143220686|NCT02178995|516354609|FG004|Open Label|Adverse Event|0|||
143220687|NCT02178995|516354610|FG005|Open Label|Adverse Event|0|||
143220688|NCT02178995|516354611|FG006|Open Label|Adverse Event|0|||
143220689|NCT02178995|516354612|FG007|Open Label|Adverse Event|0|||
143220690|NCT02178995|516354613|FG008|Open Label|Adverse Event|0|||
143220691|NCT00981461|516354614|FG000|Overall Study|Lost to Follow-up|5|||
143220692|NCT00981461|516354615|FG001|Overall Study|Lost to Follow-up|2|||
143220693|NCT03361293|516354618|FG000|Overall Study|Lost to Follow-up|0|||
143220694|NCT03361293|516354619|FG001|Overall Study|Lost to Follow-up|2|||
143220695|NCT03361293|516354618|FG000|Overall Study|Withdrawal by Subject|1|||
143220696|NCT03361293|516354619|FG001|Overall Study|Withdrawal by Subject|3|||
143220697|NCT00483405|516354620|FG000|Overall Study|Adverse Event|8|||
143220698|NCT00483405|516354620|FG000|Overall Study|Lack of Efficacy|14|||
143220699|NCT00483405|516354620|FG000|Overall Study|Death|3|||
143220700|NCT00483405|516354620|FG000|Overall Study|Withdrawal by Subject|2|||
143220701|NCT00483405|516354620|FG000|Overall Study|Other complicating disease|1|||
143220702|NCT00571038|516354621|FG000|Overall Study|Lost to Follow-up|1|||
143220703|NCT00571038|516354622|FG001|Overall Study|Lost to Follow-up|4|||
143220704|NCT00571038|516354621|FG000|Overall Study|Death|7|||
143220705|NCT00571038|516354622|FG001|Overall Study|Death|5|||
143220706|NCT00571038|516354621|FG000|Overall Study|Withdrawal by Subject|1|||
143220707|NCT00571038|516354622|FG001|Overall Study|Withdrawal by Subject|3|||
143220708|NCT00571038|516354621|FG000|Overall Study|Moved out of state|2|||
143220709|NCT00571038|516354622|FG001|Overall Study|Moved out of state|2|||
143220710|NCT01426958|516354623|FG000|Overall Study|Adverse Event|2|||
143220711|NCT02631551|516354624|FG000|Overall Study|Adverse Event|1|||
143220712|NCT02631551|516354625|FG001|Overall Study|Adverse Event|2|||
143220713|NCT02631551|516354626|FG002|Overall Study|Adverse Event|4|||
143220714|NCT02631551|516354627|FG003|Overall Study|Adverse Event|0|||
143220715|NCT02631551|516354624|FG000|Overall Study|Lack of Efficacy|0|||
143220716|NCT02631551|516354625|FG001|Overall Study|Lack of Efficacy|0|||
143220717|NCT02631551|516354626|FG002|Overall Study|Lack of Efficacy|1|||
143220718|NCT02631551|516354627|FG003|Overall Study|Lack of Efficacy|0|||
143220719|NCT02631551|516354624|FG000|Overall Study|Lost to Follow-up|1|||
143220720|NCT02631551|516354625|FG001|Overall Study|Lost to Follow-up|2|||
143220721|NCT02631551|516354626|FG002|Overall Study|Lost to Follow-up|0|||
143220722|NCT02631551|516354627|FG003|Overall Study|Lost to Follow-up|3|||
143220723|NCT02631551|516354624|FG000|Overall Study|Withdrawal by Subject|2|||
143220724|NCT02631551|516354625|FG001|Overall Study|Withdrawal by Subject|2|||
143220725|NCT02631551|516354626|FG002|Overall Study|Withdrawal by Subject|0|||
143220726|NCT02631551|516354627|FG003|Overall Study|Withdrawal by Subject|5|||
143220727|NCT02631551|516354624|FG000|Overall Study|Protocol deviation|3|||
143220728|NCT02631551|516354625|FG001|Overall Study|Protocol deviation|6|||
143220729|NCT02631551|516354626|FG002|Overall Study|Protocol deviation|3|||
143220730|NCT02631551|516354627|FG003|Overall Study|Protocol deviation|0|||
143220731|NCT02631551|516354624|FG000|Overall Study|Non-compliance with study procedures|0|||
143220732|NCT02631551|516354625|FG001|Overall Study|Non-compliance with study procedures|0|||
143220733|NCT02631551|516354626|FG002|Overall Study|Non-compliance with study procedures|1|||
143267350|NCT00973349|516533154|FG001|Overall Study|Unable to classify|0|||
143267351|NCT00973349|516533155|FG002|Overall Study|Unable to classify|0|||
143267352|NCT00973349|516533156|FG003|Overall Study|Unable to classify|0|||
143267353|NCT00973349|516533157|FG004|Overall Study|Unable to classify|1|||
143220734|NCT02631551|516354627|FG003|Overall Study|Non-compliance with study procedures|1|||
143220735|NCT02631551|516354624|FG000|Overall Study|Non-compliance with study drug|1|||
143220736|NCT02631551|516354625|FG001|Overall Study|Non-compliance with study drug|0|||
143220737|NCT02631551|516354626|FG002|Overall Study|Non-compliance with study drug|0|||
143220738|NCT02631551|516354627|FG003|Overall Study|Non-compliance with study drug|0|||
143220739|NCT02631551|516354624|FG000|Overall Study|Other, specific reasons not collected|5|||
143220740|NCT02631551|516354625|FG001|Overall Study|Other, specific reasons not collected|7|||
143220741|NCT02631551|516354626|FG002|Overall Study|Other, specific reasons not collected|2|||
143220742|NCT02631551|516354627|FG003|Overall Study|Other, specific reasons not collected|2|||
143220743|NCT02073682|516354635|FG000|Overall Study|Low Creatinine Clearance|1|||
143220744|NCT02073682|516354636|FG001|Overall Study|Low Creatinine Clearance|2|||
143220745|NCT02073682|516354635|FG000|Overall Study|Death|86|||
143220746|NCT02073682|516354636|FG001|Overall Study|Death|100|||
143267354|NCT00973349|516533158|FG005|Overall Study|Unable to classify|1|||
143372199|NCT03538041|516909438|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
143372200|NCT03538041|516909439|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
143372201|NCT03538041|516909438|FG000|Treatment Extension Period|Adverse Event|4|||
143372202|NCT03538041|516909439|FG001|Treatment Extension Period|Adverse Event|1|||
143372203|NCT03538041|516909438|FG000|Treatment Extension Period|Physician Decision|1|||
143372204|NCT03538041|516909439|FG001|Treatment Extension Period|Physician Decision|1|||
143372205|NCT03538041|516909438|FG000|Treatment Extension Period|Lack of Efficacy|1|||
143372206|NCT03538041|516909439|FG001|Treatment Extension Period|Lack of Efficacy|4|||
143372207|NCT03538041|516909438|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
143372208|NCT03538041|516909439|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
143372209|NCT03538041|516909438|FG000|Treatment Extension Period|Death|0|||
143372210|NCT03538041|516909439|FG001|Treatment Extension Period|Death|1|||
143372211|NCT04860258|516909442|FG000|Overall Study|Withdrawal by Subject|0|||
143372212|NCT04860258|516909443|FG001|Overall Study|Withdrawal by Subject|0|||
143372213|NCT04860258|516909444|FG002|Overall Study|Withdrawal by Subject|4|||
143372214|NCT04860258|516909445|FG003|Overall Study|Withdrawal by Subject|1|||
143372215|NCT04860258|516909446|FG004|Overall Study|Withdrawal by Subject|4|||
143372216|NCT04860258|516909447|FG005|Overall Study|Withdrawal by Subject|1|||
143372217|NCT04860258|516909448|FG006|Overall Study|Withdrawal by Subject|0|||
143372218|NCT02496702|516909449|FG000|Overall Study|Lost to Follow-up|8|||
143372219|NCT02496702|516909450|FG001|Overall Study|Lost to Follow-up|6|||
143372220|NCT02496702|516909449|FG000|Overall Study|Only partially tested|0|||
143372221|NCT02496702|516909450|FG001|Overall Study|Only partially tested|2|||
143372222|NCT01499134|516909451|FG000|Overall Study|Withdrawal by Subject|0|||
143372223|NCT01499134|516909452|FG001|Overall Study|Withdrawal by Subject|1|||
143372224|NCT01400776|516909453|FG000|Overall Study|Adverse Event|7|||
143372225|NCT01400776|516909454|FG001|Overall Study|Adverse Event|2|||
143372226|NCT01400776|516909455|FG002|Overall Study|Adverse Event|9|||
143372227|NCT01400776|516909456|FG003|Overall Study|Adverse Event|2|||
143372228|NCT01400776|516909453|FG000|Overall Study|Lost to Follow-up|1|||
143372229|NCT01400776|516909454|FG001|Overall Study|Lost to Follow-up|0|||
143372230|NCT01400776|516909455|FG002|Overall Study|Lost to Follow-up|4|||
143372231|NCT01400776|516909456|FG003|Overall Study|Lost to Follow-up|1|||
143372232|NCT01400776|516909453|FG000|Overall Study|Withdrew Consent|4|||
143372233|NCT01400776|516909454|FG001|Overall Study|Withdrew Consent|2|||
143372234|NCT01400776|516909455|FG002|Overall Study|Withdrew Consent|6|||
143372235|NCT01400776|516909456|FG003|Overall Study|Withdrew Consent|1|||
143372236|NCT01400776|516909453|FG000|Overall Study|Protocol Deviation|6|||
143372237|NCT01400776|516909454|FG001|Overall Study|Protocol Deviation|1|||
143372238|NCT01400776|516909455|FG002|Overall Study|Protocol Deviation|5|||
143372239|NCT01400776|516909456|FG003|Overall Study|Protocol Deviation|2|||
143372240|NCT01400776|516909453|FG000|Overall Study|Reason not Specified|3|||
143372241|NCT01400776|516909454|FG001|Overall Study|Reason not Specified|0|||
143372242|NCT01400776|516909455|FG002|Overall Study|Reason not Specified|4|||
143372243|NCT01400776|516909456|FG003|Overall Study|Reason not Specified|3|||
143220747|NCT02073682|516354635|FG000|Overall Study|Cancer Cured|10|||
143220748|NCT02073682|516354636|FG001|Overall Study|Cancer Cured|15|||
143220749|NCT02073682|516354635|FG000|Overall Study|ID: Patient Noncompliance|1|||
143220750|NCT02073682|516354636|FG001|Overall Study|ID: Patient Noncompliance|2|||
143220751|NCT02073682|516354635|FG000|Overall Study|ID: Palliative Treatment Only|10|||
143220752|NCT02073682|516354636|FG001|Overall Study|ID: Palliative Treatment Only|7|||
143220753|NCT02073682|516354635|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
143220754|NCT02073682|516354636|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
143220755|NCT02073682|516354635|FG000|Overall Study|Platelet Count <50,000/mL|1|||
143220756|NCT02073682|516354636|FG001|Overall Study|Platelet Count <50,000/mL|2|||
143220757|NCT02073682|516354635|FG000|Overall Study|Surgery/Medical Procedure|3|||
143220758|NCT02073682|516354636|FG001|Overall Study|Surgery/Medical Procedure|1|||
143372244|NCT00391846|516909457|FG000|Overall Study|Adverse Event|4|||
143372245|NCT00391846|516909458|FG001|Overall Study|Adverse Event|1|||
143372246|NCT00391846|516909457|FG000|Overall Study|Did not meet the required elig. crit|2|||
143220759|NCT02073682|516354635|FG000|Overall Study|Withdrawal by Subject|6|||
143220760|NCT02073682|516354636|FG001|Overall Study|Withdrawal by Subject|8|||
143220761|NCT02073682|516354635|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
143220762|NCT02073682|516354636|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
143372247|NCT00391846|516909458|FG001|Overall Study|Did not meet the required elig. crit|2|||
143220763|NCT02073682|516354635|FG000|Overall Study|Cancer Progression|53|||
143220764|NCT02073682|516354636|FG001|Overall Study|Cancer Progression|33|||
143372248|NCT00391846|516909457|FG000|Overall Study|Withdrawal by Subject|2|||
143372249|NCT00391846|516909458|FG001|Overall Study|Withdrawal by Subject|3|||
143372250|NCT00391846|516909457|FG000|Overall Study|Developed study specific DC criteria|0|||
143372251|NCT00391846|516909458|FG001|Overall Study|Developed study specific DC criteria|1|||
143372252|NCT04035668|516909460|FG000|Overall Study|Adverse Event|3|||
143372253|NCT04035668|516909461|FG001|Overall Study|Adverse Event|4|||
143372254|NCT04035668|516909462|FG002|Overall Study|Adverse Event|2|||
143220765|NCT02073682|516354635|FG000|Overall Study|Protocol Violation|1|||
143267355|NCT00973349|516533159|FG006|Overall Study|Unable to classify|0|||
143267356|NCT00973349|516533160|FG007|Overall Study|Unable to classify|0|||
143267357|NCT00973349|516533161|FG008|Overall Study|Unable to classify|0|||
143267358|NCT00973349|516533162|FG009|Overall Study|Unable to classify|1|||
143267359|NCT00973349|516533163|FG010|Overall Study|Unable to classify|0|||
143267360|NCT00973349|516533164|FG011|Overall Study|Unable to classify|0|||
143267361|NCT00973349|516533165|FG012|Overall Study|Unable to classify|0|||
143267362|NCT00973349|516533166|FG013|Overall Study|Unable to classify|0|||
143267363|NCT00973349|516533167|FG014|Overall Study|Unable to classify|0|||
143267364|NCT00973349|516533168|FG015|Overall Study|Unable to classify|0|||
143267365|NCT02898116|516533169|FG000|Overall Study|Adverse Event|1|||
143267366|NCT02898116|516533169|FG000|Overall Study|Progressive disease|1|||
143267367|NCT05430022|516533170|FG000|Overall Study|Withdrawal by Subject|4|||
143267368|NCT05430022|516533171|FG001|Overall Study|Withdrawal by Subject|4|||
143220766|NCT02073682|516354636|FG001|Overall Study|Protocol Violation|0|||
143267369|NCT02718300|516533176|FG000|Overall Study|Death|4|||
143267370|NCT02718300|516533177|FG001|Overall Study|Death|5|||
143267371|NCT02718300|516533178|FG002|Overall Study|Death|17|||
143267372|NCT02718300|516533176|FG000|Overall Study|Lost to Follow-up|1|||
143267373|NCT02718300|516533177|FG001|Overall Study|Lost to Follow-up|0|||
143267374|NCT02718300|516533178|FG002|Overall Study|Lost to Follow-up|2|||
143267375|NCT02718300|516533176|FG000|Overall Study|Physician Decision|1|||
143267376|NCT02718300|516533177|FG001|Overall Study|Physician Decision|0|||
143267377|NCT02718300|516533178|FG002|Overall Study|Physician Decision|2|||
143267378|NCT02718300|516533176|FG000|Overall Study|Study Terminated by Sponsor|6|||
143267379|NCT02718300|516533177|FG001|Overall Study|Study Terminated by Sponsor|3|||
143267380|NCT02718300|516533178|FG002|Overall Study|Study Terminated by Sponsor|4|||
143267381|NCT02718300|516533176|FG000|Overall Study|Withdrawal by Subject|0|||
143267382|NCT02718300|516533177|FG001|Overall Study|Withdrawal by Subject|4|||
143267383|NCT02718300|516533178|FG002|Overall Study|Withdrawal by Subject|3|||
143267384|NCT02718300|516533176|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
143267385|NCT02718300|516533177|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
143267386|NCT02718300|516533178|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
143267387|NCT05098938|516533179|FG000|Overall Study|Adverse Event|4|||
143267388|NCT05098938|516533180|FG001|Overall Study|Adverse Event|3|||
143267389|NCT05098938|516533179|FG000|Overall Study|inclusion/exclusion criteria change|11|||
143267390|NCT05098938|516533180|FG001|Overall Study|inclusion/exclusion criteria change|5|||
143267391|NCT05098938|516533179|FG000|Overall Study|lack of compliance|26|||
143267392|NCT05098938|516533180|FG001|Overall Study|lack of compliance|19|||
143267393|NCT05098938|516533179|FG000|Overall Study|Lost to Follow-up|37|||
143267394|NCT05098938|516533180|FG001|Overall Study|Lost to Follow-up|40|||
143267395|NCT05098938|516533179|FG000|Overall Study|Lost in treatment period|17|||
143220767|NCT02073682|516354635|FG000|Overall Study|Adverse Event|79|||
143220768|NCT02073682|516354636|FG001|Overall Study|Adverse Event|62|||
143220769|NCT02073682|516354635|FG000|Overall Study|No reason provided|11|||
143220770|NCT02073682|516354636|FG001|Overall Study|No reason provided|9|||
143220771|NCT02073682|516354635|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
143220772|NCT02073682|516354636|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
143220773|NCT02073682|516354635|FG000|Overall Study|Lost to Follow-up|1|||
143220774|NCT02073682|516354636|FG001|Overall Study|Lost to Follow-up|1|||
143220775|NCT02073682|516354635|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
143220776|NCT02073682|516354636|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
143220777|NCT01687296|516354640|FG000|Overall Study|Lack of Efficacy|1|||
143220778|NCT01687296|516354641|FG001|Overall Study|Lack of Efficacy|1|||
143220779|NCT01687296|516354640|FG000|Overall Study|Protocol Violation|0|||
143220780|NCT01687296|516354641|FG001|Overall Study|Protocol Violation|1|||
143220781|NCT01687296|516354640|FG000|Overall Study|Withdrawal by Subject|6|||
143220782|NCT01687296|516354641|FG001|Overall Study|Withdrawal by Subject|3|||
143220783|NCT01843023|516354642|FG000|Overall Study|Death|1|||
143220784|NCT01843023|516354643|FG001|Overall Study|Death|0|||
143220785|NCT01843023|516354642|FG000|Overall Study|Lost to Follow-up|24|||
143220786|NCT01843023|516354643|FG001|Overall Study|Lost to Follow-up|29|||
143267396|NCT05098938|516533180|FG001|Overall Study|Lost in treatment period|13|||
143220787|NCT01843023|516354642|FG000|Overall Study|Withdrawal by Subject|8|||
143220788|NCT01843023|516354643|FG001|Overall Study|Withdrawal by Subject|6|||
143220789|NCT00466921|516354644|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
143220790|NCT00466921|516354644|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
143220791|NCT00466921|516354644|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
143220792|NCT00466921|516354644|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
143267397|NCT05098938|516533179|FG000|Overall Study|Met an exclusion criterion|0|||
143267398|NCT05098938|516533180|FG001|Overall Study|Met an exclusion criterion|3|||
143267399|NCT05098938|516533179|FG000|Overall Study|no prodromal symptoms after 6 months|1|||
143267400|NCT05098938|516533180|FG001|Overall Study|no prodromal symptoms after 6 months|0|||
143267401|NCT05098938|516533179|FG000|Overall Study|Physician Decision|25|||
143267402|NCT05098938|516533180|FG001|Overall Study|Physician Decision|32|||
143267403|NCT05098938|516533179|FG000|Overall Study|Run in failure in treatment phase|1|||
143220793|NCT00466921|516354644|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
143220794|NCT00466921|516354644|FG000|Follow up for a Minimum of 1 Year|Death|6|||
143220795|NCT03305770|516354645|FG000|Overall Study|Physician Decision - prior to dispense|0|||
143220796|NCT03305770|516354646|FG001|Overall Study|Physician Decision - prior to dispense|1|||
143220797|NCT03305770|516354645|FG000|Overall Study|Subject moved|1|||
143220798|NCT03305770|516354646|FG001|Overall Study|Subject moved|0|||
143220799|NCT03539601|516354647|FG000|Overall Study|Withdraw by parent/guardian|1|||
143220800|NCT03539601|516354648|FG001|Overall Study|Withdraw by parent/guardian|0|||
143220801|NCT03539601|516354649|FG002|Overall Study|Withdraw by parent/guardian|1|||
143220802|NCT03539601|516354650|FG003|Overall Study|Withdraw by parent/guardian|0|||
143220803|NCT03539601|516354647|FG000|Overall Study|Adverse Event|0|||
143220804|NCT03539601|516354648|FG001|Overall Study|Adverse Event|2|||
143220805|NCT03539601|516354649|FG002|Overall Study|Adverse Event|0|||
143220806|NCT03539601|516354650|FG003|Overall Study|Adverse Event|0|||
143220807|NCT03539601|516354647|FG000|Overall Study|Lost to Follow-up|2|||
143220808|NCT03539601|516354648|FG001|Overall Study|Lost to Follow-up|4|||
143220809|NCT03539601|516354649|FG002|Overall Study|Lost to Follow-up|5|||
143220810|NCT03539601|516354650|FG003|Overall Study|Lost to Follow-up|0|||
143220811|NCT03539601|516354647|FG000|Overall Study|Withdrawal by Subject|2|||
143220812|NCT03539601|516354648|FG001|Overall Study|Withdrawal by Subject|0|||
143220813|NCT03539601|516354649|FG002|Overall Study|Withdrawal by Subject|0|||
143220814|NCT03539601|516354650|FG003|Overall Study|Withdrawal by Subject|1|||
143220815|NCT03539601|516354647|FG000|Overall Study|Randomized but not treated|1|||
143220816|NCT03539601|516354648|FG001|Overall Study|Randomized but not treated|1|||
143220817|NCT03539601|516354649|FG002|Overall Study|Randomized but not treated|0|||
143220818|NCT03539601|516354650|FG003|Overall Study|Randomized but not treated|0|||
143220819|NCT00226811|516354654|FG000|Overall Study|Death|8|||
143220820|NCT00226811|516354654|FG000|Overall Study|Adverse Event|11|||
143220821|NCT00226811|516354654|FG000|Overall Study|Lack of Efficacy|55|||
143220822|NCT00226811|516354654|FG000|Overall Study|Withdrawal by Subject|2|||
143220823|NCT02741635|516354657|FG000|Overall Study|Withdrawal by Subject|1|||
143220824|NCT01427933|516354661|FG000|Overall Study|Withdrawal by Subject|5|||
143220825|NCT01427933|516354662|FG001|Overall Study|Withdrawal by Subject|8|||
143220826|NCT01427933|516354661|FG000|Overall Study|Lost to Follow-up|1|||
143220827|NCT01427933|516354662|FG001|Overall Study|Lost to Follow-up|5|||
143220828|NCT01427933|516354661|FG000|Overall Study|Other|1|||
143220829|NCT01427933|516354662|FG001|Overall Study|Other|0|||
143220830|NCT01427933|516354661|FG000|Overall Study|Investigator's Decision|1|||
143220831|NCT01427933|516354662|FG001|Overall Study|Investigator's Decision|0|||
143220832|NCT01633541|516354665|FG000|Overall Study|Death|1|||
143220833|NCT01633541|516354666|FG001|Overall Study|Death|0|||
143220834|NCT03472326|516354667|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
143220835|NCT03472326|516354668|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
143220836|NCT03472326|516354669|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
143220837|NCT03472326|516354670|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
143220838|NCT03472326|516354667|FG000|Part 2: Combination Therapy|Pregnancy|0|||
143220839|NCT03472326|516354668|FG001|Part 2: Combination Therapy|Pregnancy|0|||
143220840|NCT03472326|516354669|FG002|Part 2: Combination Therapy|Pregnancy|0|||
143220841|NCT03472326|516354670|FG003|Part 2: Combination Therapy|Pregnancy|1|||
143220842|NCT01010971|516354671|FG000|Overall Study|Adverse Event|2|||
143220843|NCT01010971|516354672|FG001|Overall Study|Adverse Event|4|||
143372255|NCT04035668|516909460|FG000|Overall Study|Lost to Follow-up|0|||
143372256|NCT04035668|516909461|FG001|Overall Study|Lost to Follow-up|1|||
143372257|NCT04035668|516909462|FG002|Overall Study|Lost to Follow-up|0|||
143372258|NCT04035668|516909460|FG000|Overall Study|Physician Decision|2|||
143372259|NCT04035668|516909461|FG001|Overall Study|Physician Decision|1|||
143220844|NCT01010971|516354673|FG002|Overall Study|Adverse Event|3|||
143372260|NCT04035668|516909462|FG002|Overall Study|Physician Decision|1|||
143220845|NCT01010971|516354671|FG000|Overall Study|Withdrawal by Subject|0|||
143220846|NCT01010971|516354672|FG001|Overall Study|Withdrawal by Subject|2|||
143220847|NCT01010971|516354673|FG002|Overall Study|Withdrawal by Subject|5|||
143220848|NCT01010971|516354671|FG000|Overall Study|Lost to Follow-up|0|||
143220849|NCT01010971|516354672|FG001|Overall Study|Lost to Follow-up|2|||
143220850|NCT01010971|516354673|FG002|Overall Study|Lost to Follow-up|3|||
143220851|NCT01010971|516354671|FG000|Overall Study|Other|1|||
143220852|NCT01010971|516354672|FG001|Overall Study|Other|0|||
143220853|NCT01010971|516354673|FG002|Overall Study|Other|2|||
143220854|NCT05447663|516354674|FG000|Overall Study|Study terminated by Sponsor|5|||
143220855|NCT05447663|516354674|FG000|Overall Study|Death|2|||
143220856|NCT05447663|516354674|FG000|Overall Study|Withdrawal by Subject|1|||
143220857|NCT03386721|516354675|FG000|Overall Study|Death|12|||
143220858|NCT03386721|516354676|FG001|Overall Study|Death|21|||
143220859|NCT03386721|516354677|FG002|Overall Study|Death|2|||
143220860|NCT03386721|516354678|FG003|Overall Study|Death|5|||
143220861|NCT03386721|516354679|FG004|Overall Study|Death|1|||
143220862|NCT03386721|516354680|FG005|Overall Study|Death|12|||
143220863|NCT03386721|516354681|FG006|Overall Study|Death|1|||
143372261|NCT04035668|516909460|FG000|Overall Study|Subject Decision|2|||
143372262|NCT04035668|516909461|FG001|Overall Study|Subject Decision|2|||
143220864|NCT03386721|516354682|FG007|Overall Study|Death|1|||
143220865|NCT03386721|516354683|FG008|Overall Study|Death|12|||
143220866|NCT03386721|516354684|FG009|Overall Study|Death|20|||
143220867|NCT03386721|516354685|FG010|Overall Study|Death|21|||
143220868|NCT03386721|516354686|FG011|Overall Study|Death|21|||
143220869|NCT03386721|516354687|FG012|Overall Study|Death|14|||
143220870|NCT03386721|516354688|FG013|Overall Study|Death|2|||
143220871|NCT03386721|516354689|FG014|Overall Study|Death|1|||
143220872|NCT03386721|516354675|FG000|Overall Study|Lost to Follow-up|1|||
143220873|NCT03386721|516354676|FG001|Overall Study|Lost to Follow-up|3|||
143220874|NCT03386721|516354677|FG002|Overall Study|Lost to Follow-up|0|||
143220875|NCT03386721|516354678|FG003|Overall Study|Lost to Follow-up|0|||
143220876|NCT03386721|516354679|FG004|Overall Study|Lost to Follow-up|0|||
143220877|NCT03386721|516354680|FG005|Overall Study|Lost to Follow-up|2|||
143220878|NCT03386721|516354681|FG006|Overall Study|Lost to Follow-up|1|||
143220879|NCT03386721|516354682|FG007|Overall Study|Lost to Follow-up|0|||
143220880|NCT03386721|516354683|FG008|Overall Study|Lost to Follow-up|1|||
143220881|NCT03386721|516354684|FG009|Overall Study|Lost to Follow-up|2|||
143220882|NCT03386721|516354685|FG010|Overall Study|Lost to Follow-up|1|||
143220883|NCT03386721|516354686|FG011|Overall Study|Lost to Follow-up|0|||
143220884|NCT03386721|516354687|FG012|Overall Study|Lost to Follow-up|0|||
143220885|NCT03386721|516354688|FG013|Overall Study|Lost to Follow-up|0|||
143220886|NCT03386721|516354689|FG014|Overall Study|Lost to Follow-up|0|||
143220887|NCT03386721|516354675|FG000|Overall Study|Reason not specified|3|||
143220888|NCT03386721|516354676|FG001|Overall Study|Reason not specified|0|||
143220889|NCT03386721|516354677|FG002|Overall Study|Reason not specified|0|||
143220890|NCT03386721|516354678|FG003|Overall Study|Reason not specified|0|||
143220891|NCT03386721|516354679|FG004|Overall Study|Reason not specified|0|||
143220892|NCT03386721|516354680|FG005|Overall Study|Reason not specified|3|||
143220893|NCT03386721|516354681|FG006|Overall Study|Reason not specified|1|||
143220894|NCT03386721|516354682|FG007|Overall Study|Reason not specified|0|||
143220895|NCT03386721|516354683|FG008|Overall Study|Reason not specified|0|||
143220896|NCT03386721|516354684|FG009|Overall Study|Reason not specified|1|||
143220897|NCT03386721|516354685|FG010|Overall Study|Reason not specified|2|||
143220898|NCT03386721|516354686|FG011|Overall Study|Reason not specified|6|||
143220899|NCT03386721|516354687|FG012|Overall Study|Reason not specified|1|||
143220900|NCT03386721|516354688|FG013|Overall Study|Reason not specified|0|||
143220901|NCT03386721|516354689|FG014|Overall Study|Reason not specified|0|||
143220902|NCT03386721|516354675|FG000|Overall Study|Progressive Disease|0|||
143220903|NCT03386721|516354676|FG001|Overall Study|Progressive Disease|0|||
143220904|NCT03386721|516354677|FG002|Overall Study|Progressive Disease|1|||
143220905|NCT03386721|516354678|FG003|Overall Study|Progressive Disease|0|||
143220906|NCT03386721|516354679|FG004|Overall Study|Progressive Disease|0|||
143220907|NCT03386721|516354680|FG005|Overall Study|Progressive Disease|1|||
143220908|NCT03386721|516354681|FG006|Overall Study|Progressive Disease|0|||
143220909|NCT03386721|516354682|FG007|Overall Study|Progressive Disease|0|||
143220910|NCT03386721|516354683|FG008|Overall Study|Progressive Disease|2|||
143220911|NCT03386721|516354684|FG009|Overall Study|Progressive Disease|1|||
143220912|NCT03386721|516354685|FG010|Overall Study|Progressive Disease|1|||
143220913|NCT03386721|516354686|FG011|Overall Study|Progressive Disease|0|||
143220914|NCT03386721|516354687|FG012|Overall Study|Progressive Disease|1|||
143220915|NCT03386721|516354688|FG013|Overall Study|Progressive Disease|0|||
143220916|NCT03386721|516354689|FG014|Overall Study|Progressive Disease|0|||
143220917|NCT03386721|516354675|FG000|Overall Study|Site Terminated by Sponsor|5|||
143220918|NCT03386721|516354676|FG001|Overall Study|Site Terminated by Sponsor|5|||
143220919|NCT03386721|516354677|FG002|Overall Study|Site Terminated by Sponsor|0|||
143220920|NCT03386721|516354678|FG003|Overall Study|Site Terminated by Sponsor|0|||
143220921|NCT03386721|516354679|FG004|Overall Study|Site Terminated by Sponsor|1|||
143220922|NCT03386721|516354680|FG005|Overall Study|Site Terminated by Sponsor|3|||
143220923|NCT03386721|516354681|FG006|Overall Study|Site Terminated by Sponsor|0|||
143220924|NCT03386721|516354682|FG007|Overall Study|Site Terminated by Sponsor|1|||
143220925|NCT03386721|516354683|FG008|Overall Study|Site Terminated by Sponsor|4|||
143220926|NCT03386721|516354684|FG009|Overall Study|Site Terminated by Sponsor|5|||
143220927|NCT03386721|516354685|FG010|Overall Study|Site Terminated by Sponsor|3|||
143220928|NCT03386721|516354686|FG011|Overall Study|Site Terminated by Sponsor|11|||
143220929|NCT03386721|516354687|FG012|Overall Study|Site Terminated by Sponsor|6|||
143220930|NCT03386721|516354688|FG013|Overall Study|Site Terminated by Sponsor|0|||
143220931|NCT03386721|516354689|FG014|Overall Study|Site Terminated by Sponsor|0|||
143220932|NCT03386721|516354675|FG000|Overall Study|Symptomatic Deterioration|0|||
143220933|NCT03386721|516354676|FG001|Overall Study|Symptomatic Deterioration|0|||
143220934|NCT03386721|516354677|FG002|Overall Study|Symptomatic Deterioration|0|||
143220935|NCT03386721|516354678|FG003|Overall Study|Symptomatic Deterioration|0|||
143220936|NCT03386721|516354679|FG004|Overall Study|Symptomatic Deterioration|0|||
143220937|NCT03386721|516354680|FG005|Overall Study|Symptomatic Deterioration|0|||
143220938|NCT03386721|516354681|FG006|Overall Study|Symptomatic Deterioration|0|||
143220939|NCT03386721|516354682|FG007|Overall Study|Symptomatic Deterioration|0|||
143220940|NCT03386721|516354683|FG008|Overall Study|Symptomatic Deterioration|1|||
143220941|NCT03386721|516354684|FG009|Overall Study|Symptomatic Deterioration|0|||
143220942|NCT03386721|516354685|FG010|Overall Study|Symptomatic Deterioration|0|||
143220943|NCT03386721|516354686|FG011|Overall Study|Symptomatic Deterioration|1|||
143220944|NCT03386721|516354687|FG012|Overall Study|Symptomatic Deterioration|0|||
143220945|NCT03386721|516354688|FG013|Overall Study|Symptomatic Deterioration|0|||
143220946|NCT03386721|516354689|FG014|Overall Study|Symptomatic Deterioration|0|||
143220947|NCT03386721|516354675|FG000|Overall Study|Withdrawal by Subject|1|||
143220948|NCT03386721|516354676|FG001|Overall Study|Withdrawal by Subject|2|||
143220949|NCT03386721|516354677|FG002|Overall Study|Withdrawal by Subject|0|||
143220950|NCT03386721|516354678|FG003|Overall Study|Withdrawal by Subject|0|||
143220951|NCT03386721|516354679|FG004|Overall Study|Withdrawal by Subject|0|||
143220952|NCT03386721|516354680|FG005|Overall Study|Withdrawal by Subject|0|||
143220953|NCT03386721|516354681|FG006|Overall Study|Withdrawal by Subject|0|||
143220954|NCT03386721|516354682|FG007|Overall Study|Withdrawal by Subject|0|||
143220955|NCT03386721|516354683|FG008|Overall Study|Withdrawal by Subject|2|||
143220956|NCT03386721|516354684|FG009|Overall Study|Withdrawal by Subject|1|||
143220957|NCT03386721|516354685|FG010|Overall Study|Withdrawal by Subject|3|||
143220958|NCT03386721|516354686|FG011|Overall Study|Withdrawal by Subject|2|||
143220959|NCT03386721|516354687|FG012|Overall Study|Withdrawal by Subject|3|||
143220960|NCT03386721|516354688|FG013|Overall Study|Withdrawal by Subject|0|||
143220961|NCT03386721|516354689|FG014|Overall Study|Withdrawal by Subject|0|||
143220962|NCT01100320|516354692|FG000|Period 1|Withdrawal by Subject|2|||
143220963|NCT01100320|516354693|FG001|Period 1|Withdrawal by Subject|4|||
143220964|NCT01100320|516354692|FG000|Period 1|Positive Drug Screen|1|||
143220965|NCT01100320|516354693|FG001|Period 1|Positive Drug Screen|1|||
143220966|NCT01100320|516354692|FG000|Period 1|Adverse Event|2|||
143220967|NCT01100320|516354693|FG001|Period 1|Adverse Event|2|||
143220968|NCT01100320|516354692|FG000|Period 2|Withdrawal by Subject|1|||
143220969|NCT01100320|516354693|FG001|Period 2|Withdrawal by Subject|1|||
143220970|NCT00550953|516354694|FG000|Overall Study|Adverse Event|4|||
143220971|NCT00550953|516354695|FG001|Overall Study|Adverse Event|3|||
143220972|NCT00550953|516354694|FG000|Overall Study|Not able to visit the site|2|||
143220973|NCT00550953|516354695|FG001|Overall Study|Not able to visit the site|3|||
143220974|NCT03797586|516354696|FG000|Overall Study|Lost to Follow-up|3|||
143220975|NCT03797586|516354697|FG001|Overall Study|Lost to Follow-up|6|||
143220976|NCT03797586|516354696|FG000|Overall Study|Death|1|||
143220977|NCT03797586|516354697|FG001|Overall Study|Death|1|||
143220978|NCT03797586|516354696|FG000|Overall Study|Adverse Event|0|||
143220979|NCT03797586|516354697|FG001|Overall Study|Adverse Event|2|||
143220980|NCT04980612|516354698|FG000|Overall Study|Withdrawal by Subject|7|||
143220981|NCT04980612|516354699|FG001|Overall Study|Withdrawal by Subject|5|||
143220982|NCT01502228|516354702|FG000|Overall Study|Death|1|||
143220983|NCT01219985|516354703|FG000|Overall Study|Physician Decision|20|||
143220984|NCT02446717|516354704|FG000|Overall Study|Adverse Event|0|||
143220985|NCT02446717|516354705|FG001|Overall Study|Adverse Event|0|||
143220986|NCT02446717|516354706|FG002|Overall Study|Adverse Event|1|||
143220987|NCT02446717|516354707|FG003|Overall Study|Adverse Event|0|||
143220988|NCT02446717|516354708|FG004|Overall Study|Adverse Event|0|||
143220989|NCT02446717|516354704|FG000|Overall Study|Lost to Follow-up|0|||
143220990|NCT02446717|516354705|FG001|Overall Study|Lost to Follow-up|1|||
143220991|NCT02446717|516354706|FG002|Overall Study|Lost to Follow-up|1|||
143220992|NCT02446717|516354707|FG003|Overall Study|Lost to Follow-up|0|||
143220993|NCT02446717|516354708|FG004|Overall Study|Lost to Follow-up|1|||
143220994|NCT02446717|516354704|FG000|Overall Study|Withdrew consent|0|||
143220995|NCT02446717|516354705|FG001|Overall Study|Withdrew consent|0|||
143220996|NCT02446717|516354706|FG002|Overall Study|Withdrew consent|0|||
143220997|NCT02446717|516354707|FG003|Overall Study|Withdrew consent|1|||
143220998|NCT02446717|516354708|FG004|Overall Study|Withdrew consent|0|||
143220999|NCT02680665|516354709|FG000|Overall Study|No visit after the first prescription|5|||
143221000|NCT04797780|516354710|FG000|Overall Study|Lost to Follow-up|1|||
143221001|NCT04797780|516354711|FG001|Overall Study|Lost to Follow-up|1|||
143221002|NCT04797780|516354710|FG000|Overall Study|Withdrawal by Subject|14|||
143221003|NCT04797780|516354711|FG001|Overall Study|Withdrawal by Subject|9|||
143221004|NCT04797780|516354710|FG000|Overall Study|Death|49|||
143221005|NCT04797780|516354711|FG001|Overall Study|Death|20|||
143221006|NCT04669301|516354712|FG000|Overall Study|Lost to Follow-up|0|||
143221007|NCT04669301|516354713|FG001|Overall Study|Lost to Follow-up|1|||
143221008|NCT04669301|516354714|FG002|Overall Study|Lost to Follow-up|0|||
143221009|NCT04669301|516354712|FG000|Overall Study|Withdrawal by Subject|3|||
143221010|NCT04669301|516354713|FG001|Overall Study|Withdrawal by Subject|2|||
143221011|NCT04669301|516354714|FG002|Overall Study|Withdrawal by Subject|0|||
143221012|NCT01221350|516354717|FG000|Overall Study|Discontinued intervention (GERD)|1|||
143267404|NCT05098938|516533180|FG001|Overall Study|Run in failure in treatment phase|1|||
143221013|NCT01221350|516354718|FG001|Overall Study|Discontinued intervention (GERD)|0|||
143221014|NCT01221350|516354717|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
143221015|NCT01221350|516354718|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
143221016|NCT01221350|516354717|FG000|Overall Study|Withdrawal by Subject|4|||
143221017|NCT01221350|516354718|FG001|Overall Study|Withdrawal by Subject|2|||
143221018|NCT00595478|516354723|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
143221019|NCT00595478|516354724|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
143372263|NCT04035668|516909462|FG002|Overall Study|Subject Decision|0|||
143372264|NCT01376089|516909463|FG000|Overall Study|Patient received no contrast media|3|||
143372265|NCT01376089|516909464|FG001|Overall Study|Patient received no contrast media|4|||
143372266|NCT00419094|516909467|FG000|Overall Study|Adverse Event|3|||
143372267|NCT00419094|516909468|FG001|Overall Study|Adverse Event|7|||
143221020|NCT00595478|516354723|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
143221021|NCT00595478|516354724|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
143221022|NCT03772665|516354730|FG000|Overall Study|Protocol Violation|1|||
143221023|NCT03772665|516354731|FG001|Overall Study|Protocol Violation|0|||
143221024|NCT01594931|516356047|FG000|Overall Study|Adverse Event|3|||
143221025|NCT01594931|516356048|FG001|Overall Study|Adverse Event|1|||
143221026|NCT01594931|516356049|FG002|Overall Study|Adverse Event|1|||
143221027|NCT01594931|516356047|FG000|Overall Study|Withdrawal by Subject|2|||
143221028|NCT01594931|516356048|FG001|Overall Study|Withdrawal by Subject|1|||
143221029|NCT01594931|516356049|FG002|Overall Study|Withdrawal by Subject|1|||
143221030|NCT01594931|516356047|FG000|Overall Study|Lack of Efficacy|7|||
143221031|NCT01594931|516356048|FG001|Overall Study|Lack of Efficacy|2|||
143221032|NCT01594931|516356049|FG002|Overall Study|Lack of Efficacy|2|||
143221033|NCT01594931|516356047|FG000|Overall Study|Lost to Follow-up|4|||
143221034|NCT01594931|516356048|FG001|Overall Study|Lost to Follow-up|3|||
143221035|NCT01594931|516356049|FG002|Overall Study|Lost to Follow-up|3|||
143221036|NCT01594931|516356047|FG000|Overall Study|Protocol Violation|2|||
143221037|NCT01594931|516356048|FG001|Overall Study|Protocol Violation|1|||
143221038|NCT01594931|516356049|FG002|Overall Study|Protocol Violation|0|||
143221039|NCT01594931|516356047|FG000|Overall Study|No defiined|11|||
143221040|NCT01594931|516356048|FG001|Overall Study|No defiined|4|||
143221041|NCT01594931|516356049|FG002|Overall Study|No defiined|7|||
143221042|NCT03937713|516356053|FG000|Overall Study|Withdrawal by Subject|3|||
143221043|NCT03937713|516356054|FG001|Overall Study|Withdrawal by Subject|6|||
143221044|NCT03937713|516356053|FG000|Overall Study|Lost to Follow-up|1|||
143221045|NCT03937713|516356054|FG001|Overall Study|Lost to Follow-up|0|||
143221046|NCT00859547|516356062|FG000|Overall Study|Lost to Follow-up|1|||
143221047|NCT00859547|516356062|FG000|Overall Study|Parent withdrew consent|1|||
143221048|NCT01410890|516356063|FG000|Overall Study|Withdrawal by Subject|0|||
143221049|NCT01410890|516356064|FG001|Overall Study|Withdrawal by Subject|1|||
143221050|NCT00991939|516356067|FG000|Overall Study|Lost to Follow-up|0|||
143221051|NCT00991939|516356068|FG001|Overall Study|Lost to Follow-up|1|||
143221052|NCT00991939|516356067|FG000|Overall Study|Withdrawal by Subject|1|||
143221053|NCT00991939|516356068|FG001|Overall Study|Withdrawal by Subject|0|||
143221054|NCT00991939|516356067|FG000|Overall Study|Entire study terminated|4|||
143221055|NCT00991939|516356068|FG001|Overall Study|Entire study terminated|1|||
143221056|NCT00714415|516356069|FG000|Overall Study|Lack of Efficacy|1|||
143221057|NCT00714415|516356070|FG001|Overall Study|Lack of Efficacy|0|||
143221058|NCT00714415|516356069|FG000|Overall Study|Death|1|||
143221059|NCT00714415|516356070|FG001|Overall Study|Death|0|||
143221060|NCT00740584|516356073|FG000|Overall Study|Withdrawal by Subject|1|||
143221061|NCT01461707|516356076|FG000|Overall Study|Withdrawal by Subject|1|||
143221062|NCT01461707|516356077|FG001|Overall Study|Withdrawal by Subject|0|||
143221063|NCT01450761|516356078|FG000|Randomization|Subject no longer meets study criteria|1|||
143221064|NCT01450761|516356079|FG001|Randomization|Subject no longer meets study criteria|2|||
143221065|NCT01450761|516356078|FG000|Randomization|Withdrawal by Subject|2|||
143221066|NCT01450761|516356079|FG001|Randomization|Withdrawal by Subject|0|||
143221067|NCT01450761|516356078|FG000|Randomization|Disease progression|0|||
143221068|NCT01450761|516356079|FG001|Randomization|Disease progression|2|||
143221069|NCT01450761|516356078|FG000|Randomization|Adverse Event unrelated to study drug|1|||
143221070|NCT01450761|516356079|FG001|Randomization|Adverse Event unrelated to study drug|0|||
143221071|NCT01450761|516356078|FG000|Randomization|Other|0|||
143221072|NCT01450761|516356079|FG001|Randomization|Other|1|||
143372268|NCT00419094|516909467|FG000|Overall Study|Lack of Efficacy|1|||
143372269|NCT00419094|516909468|FG001|Overall Study|Lack of Efficacy|0|||
143372270|NCT00419094|516909467|FG000|Overall Study|Lost to Follow-up|0|||
143372271|NCT00419094|516909468|FG001|Overall Study|Lost to Follow-up|2|||
143221073|NCT01450761|516356078|FG000|Lead-in Chemotherapy|Disease progression|33|||
143221074|NCT01450761|516356079|FG001|Lead-in Chemotherapy|Disease progression|32|||
143221075|NCT01450761|516356078|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
143221076|NCT01450761|516356079|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
143221077|NCT01450761|516356078|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
143221078|NCT01450761|516356079|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
143221079|NCT01450761|516356078|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
143221080|NCT01450761|516356079|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
143221081|NCT01450761|516356078|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
143221082|NCT01450761|516356079|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
143372272|NCT00419094|516909467|FG000|Overall Study|Protocol Violation|1|||
143221083|NCT01450761|516356078|FG000|Lead-in Chemotherapy|Death|3|||
143221084|NCT01450761|516356079|FG001|Lead-in Chemotherapy|Death|3|||
143221085|NCT01450761|516356078|FG000|Lead-in Chemotherapy|Other|2|||
143221086|NCT01450761|516356079|FG001|Lead-in Chemotherapy|Other|2|||
143221087|NCT01450761|516356078|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
143221088|NCT01450761|516356079|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
143221089|NCT01450761|516356078|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
143221090|NCT01450761|516356079|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
143221091|NCT01450761|516356078|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
143221092|NCT01450761|516356079|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
143221093|NCT01450761|516356078|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
143221094|NCT01450761|516356079|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
143221095|NCT01450761|516356078|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
143221096|NCT01450761|516356079|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
143221097|NCT01450761|516356078|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
143221098|NCT01450761|516356079|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
143221099|NCT01450761|516356078|FG000|Treatment With Blinded Study Therapy|Death|5|||
143221100|NCT01450761|516356079|FG001|Treatment With Blinded Study Therapy|Death|6|||
143221101|NCT01450761|516356078|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
143221102|NCT01450761|516356079|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
143221103|NCT01450761|516356078|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
143221104|NCT01450761|516356079|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
143221105|NCT01450761|516356078|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
143221106|NCT01450761|516356079|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
143221107|NCT01450761|516356078|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
143221108|NCT01450761|516356079|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
143221109|NCT01450761|516356078|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
143221110|NCT01450761|516356079|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
143221111|NCT01450761|516356078|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
143221112|NCT01450761|516356079|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
143221113|NCT01450761|516356078|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
143221114|NCT01450761|516356079|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
143221115|NCT03801174|516356101|FG000|Overall Study|Withdrawal by Subject|14|||
143221116|NCT03801174|516356102|FG001|Overall Study|Withdrawal by Subject|15|||
143221117|NCT03801174|516356101|FG000|Overall Study|Death|1|||
143221118|NCT03801174|516356102|FG001|Overall Study|Death|0|||
143221119|NCT03801174|516356101|FG000|Overall Study|Pregnancy|2|||
143221120|NCT03801174|516356102|FG001|Overall Study|Pregnancy|2|||
143221121|NCT03801174|516356101|FG000|Overall Study|Lost to Follow-up|19|||
143221122|NCT03801174|516356102|FG001|Overall Study|Lost to Follow-up|10|||
143221123|NCT03801174|516356101|FG000|Overall Study|Other|4|||
143221124|NCT03801174|516356102|FG001|Overall Study|Other|3|||
143221125|NCT03801174|516356101|FG000|Overall Study|Lack of Efficacy|4|||
143221126|NCT03801174|516356102|FG001|Overall Study|Lack of Efficacy|0|||
143221127|NCT03801174|516356101|FG000|Overall Study|Unwilling to complete activities|5|||
143221128|NCT03801174|516356102|FG001|Overall Study|Unwilling to complete activities|6|||
143221129|NCT03801174|516356101|FG000|Overall Study|Moved out of area|3|||
143221130|NCT03801174|516356102|FG001|Overall Study|Moved out of area|0|||
143221131|NCT00855816|516356103|FG000|Overall Study|Withdrawal by Subject|22|||
143221132|NCT00855816|516356104|FG001|Overall Study|Withdrawal by Subject|15|||
143221133|NCT00855816|516356103|FG000|Overall Study|Lost to Follow-up|3|||
143221134|NCT00855816|516356104|FG001|Overall Study|Lost to Follow-up|5|||
143221135|NCT00855816|516356103|FG000|Overall Study|Death|1|||
143221136|NCT00855816|516356104|FG001|Overall Study|Death|0|||
143221137|NCT00855816|516356103|FG000|Overall Study|Became ineligible|0|||
143221138|NCT00855816|516356104|FG001|Overall Study|Became ineligible|1|||
143221139|NCT01965704|516356108|FG000|Overall Study|Withdrawal by Subject|2|||
143221140|NCT01965704|516356109|FG001|Overall Study|Withdrawal by Subject|2|||
143221141|NCT01965704|516356110|FG002|Overall Study|Withdrawal by Subject|1|||
143221142|NCT01965704|516356111|FG003|Overall Study|Withdrawal by Subject|1|||
143221143|NCT01965704|516356108|FG000|Overall Study|Delivered at home|1|||
143221144|NCT01965704|516356109|FG001|Overall Study|Delivered at home|1|||
143221145|NCT01965704|516356110|FG002|Overall Study|Delivered at home|0|||
143221146|NCT01965704|516356111|FG003|Overall Study|Delivered at home|0|||
143221147|NCT01965704|516356108|FG000|Overall Study|Experienced complications|0|||
143221148|NCT01965704|516356109|FG001|Overall Study|Experienced complications|0|||
143221149|NCT01965704|516356110|FG002|Overall Study|Experienced complications|2|||
143221150|NCT01965704|516356111|FG003|Overall Study|Experienced complications|2|||
143221151|NCT01965704|516356108|FG000|Overall Study|Adverse Event|0|||
143221152|NCT01965704|516356109|FG001|Overall Study|Adverse Event|0|||
143221153|NCT01965704|516356110|FG002|Overall Study|Adverse Event|1|||
143221154|NCT01965704|516356111|FG003|Overall Study|Adverse Event|1|||
143221155|NCT01965704|516356108|FG000|Overall Study|Did not meet inclusion criteria|0|||
143221156|NCT01965704|516356109|FG001|Overall Study|Did not meet inclusion criteria|0|||
143221157|NCT01965704|516356110|FG002|Overall Study|Did not meet inclusion criteria|1|||
143221158|NCT01965704|516356111|FG003|Overall Study|Did not meet inclusion criteria|1|||
143221159|NCT04390243|516356119|FG000|Overall Study|Death|1|||
143221160|NCT04390243|516356119|FG000|Overall Study|Disease Progression|4|||
143221161|NCT04390243|516356119|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
143221162|NCT00337207|516356126|FG000|Overall Study|Withdrawal by Subject|3|||
143221163|NCT01521507|516356127|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
143221164|NCT01521507|516356128|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
143221165|NCT01521507|516356127|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
143221166|NCT01521507|516356128|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
143221167|NCT01521507|516356127|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
143221168|NCT01521507|516356128|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
143221169|NCT01521507|516356127|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
143221170|NCT01521507|516356128|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
143221171|NCT01521507|516356127|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
143221172|NCT01521507|516356128|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
143221173|NCT01521507|516356127|FG000|Stage 2: Observational Design|Physician Decision|1|||
143221174|NCT01521507|516356128|FG001|Stage 2: Observational Design|Physician Decision|0|||
143221175|NCT03573323|516356129|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
143221176|NCT03573323|516356130|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
143221177|NCT03573323|516356129|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
143221178|NCT03573323|516356130|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
143221179|NCT03573323|516356129|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
143221180|NCT03573323|516356130|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
143221181|NCT03573323|516356129|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
143267405|NCT05098938|516533179|FG000|Overall Study|Withdrawal by Subject|0|||
143267406|NCT05098938|516533180|FG001|Overall Study|Withdrawal by Subject|3|||
143267407|NCT05098938|516533179|FG000|Overall Study|Run-in Failure in early study|505|||
143267408|NCT05098938|516533180|FG001|Overall Study|Run-in Failure in early study|514|||
143267409|NCT05098938|516533179|FG000|Overall Study|IMP delivery missed|1|||
143267410|NCT05098938|516533180|FG001|Overall Study|IMP delivery missed|5|||
143267411|NCT05098938|516533179|FG000|Overall Study|6 months visit was missed|2|||
143267412|NCT05098938|516533180|FG001|Overall Study|6 months visit was missed|0|||
143267413|NCT05098938|516533179|FG000|Overall Study|fit for use was not completed within window|3|||
143267414|NCT05098938|516533180|FG001|Overall Study|fit for use was not completed within window|0|||
143267415|NCT05098938|516533179|FG000|Overall Study|V2 visit was not completed within window|0|||
143267416|NCT05098938|516533180|FG001|Overall Study|V2 visit was not completed within window|1|||
143267417|NCT05098938|516533179|FG000|Overall Study|exclusionary medication use|1|||
143267418|NCT05098938|516533180|FG001|Overall Study|exclusionary medication use|2|||
143267419|NCT05098938|516533179|FG000|Overall Study|change in medication|1|||
143267420|NCT05098938|516533180|FG001|Overall Study|change in medication|0|||
143267421|NCT05098938|516533179|FG000|Overall Study|treatment failure|2|||
143267422|NCT05098938|516533180|FG001|Overall Study|treatment failure|1|||
143267423|NCT03803683|516533181|FG000|Overall Study|Lost to Follow-up|41|||
143267424|NCT03803683|516533182|FG001|Overall Study|Lost to Follow-up|18|||
143267425|NCT03803683|516533183|FG002|Overall Study|Lost to Follow-up|12|||
143267426|NCT03803683|516533181|FG000|Overall Study|Withdrawal by Subject|9|||
143267427|NCT03803683|516533182|FG001|Overall Study|Withdrawal by Subject|1|||
143267428|NCT03803683|516533183|FG002|Overall Study|Withdrawal by Subject|4|||
143267429|NCT00492050|516533184|FG000|Overall Study|Adverse Event|1|||
143267430|NCT00492050|516533184|FG000|Overall Study|Lack of Efficacy|1|||
143267431|NCT00492050|516533184|FG000|Overall Study|Withdrawal by Subject|3|||
143267432|NCT00492050|516533184|FG000|Overall Study|Unable to collect SCT|2|||
143267433|NCT00492050|516533184|FG000|Overall Study|Progressive Disease|2|||
143267434|NCT01680965|516535111|FG000|Overall Study|Death|0|||
143267435|NCT01680965|516535112|FG001|Overall Study|Death|0|||
143267436|NCT01680965|516535113|FG002|Overall Study|Death|0|||
143267437|NCT01680965|516535114|FG003|Overall Study|Death|6|||
143267438|NCT00195273|516535115|FG000|Overall Study|Adverse Event|9|||
143267439|NCT00195273|516535116|FG001|Overall Study|Adverse Event|9|||
143267440|NCT00195273|516535115|FG000|Overall Study|Protocol deviation|0|||
143267441|NCT00195273|516535116|FG001|Overall Study|Protocol deviation|1|||
143267442|NCT00195273|516535115|FG000|Overall Study|Lack of Efficacy|3|||
143267443|NCT00195273|516535116|FG001|Overall Study|Lack of Efficacy|1|||
143267444|NCT00195273|516535115|FG000|Overall Study|Procedural complications|9|||
143221182|NCT03573323|516356130|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
143221183|NCT03573323|516356129|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
143267445|NCT00195273|516535116|FG001|Overall Study|Procedural complications|3|||
143267446|NCT02595970|516535117|FG000|Overall Study|Withdrawal by Subject|2|||
143267447|NCT02595970|516535117|FG000|Overall Study|Physician Decision|2|||
143267448|NCT02595970|516535117|FG000|Overall Study|Protocol Violation|4|||
143221184|NCT03573323|516356130|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
143221185|NCT03573323|516356129|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
143221186|NCT03573323|516356130|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
143221187|NCT03573323|516356129|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
143221188|NCT03573323|516356130|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
143221189|NCT03573323|516356129|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
143221190|NCT03573323|516356130|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
143221191|NCT03573323|516356129|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
143221192|NCT03573323|516356130|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
143221193|NCT03573323|516356129|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
143221194|NCT03573323|516356130|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
143221195|NCT03573323|516356129|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
143221196|NCT03573323|516356130|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
143221197|NCT03573323|516356129|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
143221198|NCT03573323|516356130|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
143221199|NCT03573323|516356129|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
143221200|NCT03573323|516356130|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
143221201|NCT03573323|516356129|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
143221202|NCT03573323|516356130|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
143221203|NCT03573323|516356129|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
143221204|NCT03573323|516356130|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
143221205|NCT03573323|516356129|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
143221206|NCT03573323|516356130|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
143221207|NCT03573323|516356129|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
143221208|NCT03573323|516356130|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
143221209|NCT03573323|516356129|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
143221210|NCT03573323|516356130|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
143221211|NCT03573323|516356129|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
143221212|NCT03573323|516356130|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
143221213|NCT03188432|516356131|FG000|Overall Study|Death|3|||
143221214|NCT03188432|516356131|FG000|Overall Study|Withdrawal by Subject|15|||
143221215|NCT03188432|516356131|FG000|Overall Study|Did not complete protocol treatment|9|||
143221216|NCT02336230|516356137|FG000|Overall Study|Adverse Event|1|||
143221217|NCT02336230|516356137|FG000|Overall Study|Withdrawal of consent|1|||
143221218|NCT02336230|516356137|FG000|Overall Study|Death|9|||
143221219|NCT02336230|516356137|FG000|Overall Study|Dose not received due to shipping delay|1|||
143221220|NCT02336230|516356137|FG000|Overall Study|Discontinuation of MSC infusion|1|||
143221221|NCT02524171|516356138|FG000|6-month Follow-up|Lost to Follow-up|53|||
143221222|NCT02524171|516356139|FG001|6-month Follow-up|Lost to Follow-up|45|||
143221223|NCT02524171|516356138|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
143221224|NCT02524171|516356139|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
143221225|NCT00216671|516356140|FG000|Overall Study|Adverse Event|4|||
143221226|NCT00216671|516356141|FG001|Overall Study|Adverse Event|9|||
143221227|NCT00216671|516356140|FG000|Overall Study|Pregnancy|0|||
143221228|NCT00216671|516356141|FG001|Overall Study|Pregnancy|1|||
143221229|NCT00216671|516356140|FG000|Overall Study|Withdrawal by Subject|4|||
143221230|NCT00216671|516356141|FG001|Overall Study|Withdrawal by Subject|2|||
143221231|NCT00216671|516356140|FG000|Overall Study|Refused Injections|3|||
143221232|NCT00216671|516356141|FG001|Overall Study|Refused Injections|13|||
143221233|NCT00216671|516356140|FG000|Overall Study|No Need to Continue Medication|1|||
143221234|NCT00216671|516356141|FG001|Overall Study|No Need to Continue Medication|1|||
143221235|NCT00216671|516356140|FG000|Overall Study|Insufficient Response|9|||
143221236|NCT00216671|516356141|FG001|Overall Study|Insufficient Response|4|||
143221237|NCT00216671|516356140|FG000|Overall Study|Lost to Follow-up|3|||
143221238|NCT00216671|516356141|FG001|Overall Study|Lost to Follow-up|5|||
143221239|NCT00216671|516356140|FG000|Overall Study|Non compliant|2|||
143221240|NCT00216671|516356141|FG001|Overall Study|Non compliant|2|||
143221241|NCT00216671|516356140|FG000|Overall Study|Ineligible|0|||
143221242|NCT00216671|516356141|FG001|Overall Study|Ineligible|2|||
143221243|NCT00216671|516356140|FG000|Overall Study|Physician Decision|1|||
143221244|NCT00216671|516356141|FG001|Overall Study|Physician Decision|1|||
143221245|NCT00216671|516356140|FG000|Overall Study|Protocol Violation|3|||
143221246|NCT00216671|516356141|FG001|Overall Study|Protocol Violation|5|||
143221247|NCT00216671|516356140|FG000|Overall Study|Relapse|1|||
143221248|NCT00216671|516356141|FG001|Overall Study|Relapse|0|||
143221249|NCT00216671|516356140|FG000|Overall Study|Investigator Illness|0|||
143221250|NCT00216671|516356141|FG001|Overall Study|Investigator Illness|1|||
143372273|NCT00419094|516909468|FG001|Overall Study|Protocol Violation|14|||
143221251|NCT00216671|516356140|FG000|Overall Study|Patient Moved|0|||
143221252|NCT00216671|516356141|FG001|Overall Study|Patient Moved|1|||
143221253|NCT00216671|516356140|FG000|Overall Study|Ineligible, no efficacy data|2|||
143221254|NCT00216671|516356141|FG001|Overall Study|Ineligible, no efficacy data|2|||
143221255|NCT00216671|516356140|FG000|Overall Study|Insufficient Response Adverse Event|2|||
143221256|NCT00216671|516356141|FG001|Overall Study|Insufficient Response Adverse Event|1|||
143221257|NCT02863328|516356143|FG000|Overall Study|Lost to Follow-up|4|||
143221258|NCT02863328|516356144|FG001|Overall Study|Lost to Follow-up|10|||
143221259|NCT02863328|516356143|FG000|Overall Study|Withdrawal by Subject|7|||
143221260|NCT02863328|516356144|FG001|Overall Study|Withdrawal by Subject|12|||
143221261|NCT02863328|516356143|FG000|Overall Study|Died|0|||
143221262|NCT02863328|516356144|FG001|Overall Study|Died|1|||
143221263|NCT01870726|516356145|FG000|Overall Study|Withdrawal of informed consent|0|||
143221264|NCT01870726|516356146|FG001|Overall Study|Withdrawal of informed consent|0|||
143221265|NCT01870726|516356147|FG002|Overall Study|Withdrawal of informed consent|0|||
143221266|NCT01870726|516356148|FG003|Overall Study|Withdrawal of informed consent|1|||
143221267|NCT01870726|516356149|FG004|Overall Study|Withdrawal of informed consent|0|||
143221268|NCT01870726|516356150|FG005|Overall Study|Withdrawal of informed consent|0|||
143221269|NCT01870726|516356151|FG006|Overall Study|Withdrawal of informed consent|0|||
143221270|NCT01870726|516356145|FG000|Overall Study|Withdrawal by Subject|0|||
143221271|NCT01870726|516356146|FG001|Overall Study|Withdrawal by Subject|1|||
143221272|NCT01870726|516356147|FG002|Overall Study|Withdrawal by Subject|0|||
143221273|NCT01870726|516356148|FG003|Overall Study|Withdrawal by Subject|0|||
143221274|NCT01870726|516356149|FG004|Overall Study|Withdrawal by Subject|0|||
143221275|NCT01870726|516356150|FG005|Overall Study|Withdrawal by Subject|0|||
143221276|NCT01870726|516356151|FG006|Overall Study|Withdrawal by Subject|0|||
143221277|NCT01870726|516356145|FG000|Overall Study|Adverse Event|0|||
143221278|NCT01870726|516356146|FG001|Overall Study|Adverse Event|0|||
143221279|NCT01870726|516356147|FG002|Overall Study|Adverse Event|0|||
143221280|NCT01870726|516356148|FG003|Overall Study|Adverse Event|0|||
143221281|NCT01870726|516356149|FG004|Overall Study|Adverse Event|1|||
143221282|NCT01870726|516356150|FG005|Overall Study|Adverse Event|1|||
143221283|NCT01870726|516356151|FG006|Overall Study|Adverse Event|0|||
143221284|NCT01870726|516356145|FG000|Overall Study|Progressive disease|5|||
143221285|NCT01870726|516356146|FG001|Overall Study|Progressive disease|5|||
143221286|NCT01870726|516356147|FG002|Overall Study|Progressive disease|4|||
143221287|NCT01870726|516356148|FG003|Overall Study|Progressive disease|5|||
143221288|NCT01870726|516356149|FG004|Overall Study|Progressive disease|6|||
143221289|NCT01870726|516356150|FG005|Overall Study|Progressive disease|4|||
143221290|NCT01870726|516356151|FG006|Overall Study|Progressive disease|10|||
143221291|NCT02978833|516356154|FG000|Overall Study|Study terminated|1|||
143221292|NCT02978833|516356155|FG001|Overall Study|Study terminated|1|||
143221293|NCT00186901|516356157|FG000|Overall Study|Pregnancy|6|||
143221294|NCT00186901|516356158|FG001|Overall Study|Pregnancy|3|||
143221295|NCT00186901|516356159|FG002|Overall Study|Pregnancy|0|||
143221296|NCT00186901|516356157|FG000|Overall Study|Lost to Follow-up|6|||
143221297|NCT00186901|516356158|FG001|Overall Study|Lost to Follow-up|3|||
143221298|NCT00186901|516356159|FG002|Overall Study|Lost to Follow-up|0|||
143221299|NCT00186901|516356157|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
143221300|NCT00186901|516356158|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
143221301|NCT00186901|516356159|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
143221302|NCT00186901|516356157|FG000|Overall Study|ALL relapse or second malignancy|1|||
143221303|NCT00186901|516356158|FG001|Overall Study|ALL relapse or second malignancy|2|||
143221304|NCT00186901|516356159|FG002|Overall Study|ALL relapse or second malignancy|0|||
143221305|NCT00186901|516356157|FG000|Overall Study|Withdrawal by Subject|4|||
143221306|NCT00186901|516356158|FG001|Overall Study|Withdrawal by Subject|5|||
143221307|NCT00186901|516356159|FG002|Overall Study|Withdrawal by Subject|0|||
143221308|NCT00186901|516356157|FG000|Overall Study|Open label|3|||
143221309|NCT00186901|516356158|FG001|Overall Study|Open label|2|||
143221310|NCT00186901|516356159|FG002|Overall Study|Open label|0|||
143221311|NCT00186901|516356157|FG000|Overall Study|Limited adherence to study requirements|20|||
143221312|NCT00186901|516356158|FG001|Overall Study|Limited adherence to study requirements|23|||
143221313|NCT00186901|516356159|FG002|Overall Study|Limited adherence to study requirements|0|||
143221314|NCT00186901|516356157|FG000|Overall Study|Bone Mineral Density > 0|0|||
143221315|NCT00186901|516356158|FG001|Overall Study|Bone Mineral Density > 0|0|||
143221316|NCT00186901|516356159|FG002|Overall Study|Bone Mineral Density > 0|149|||
143221317|NCT00555217|516356160|FG000|Overall Study|Withdrawal by Subject|35|||
143221318|NCT00555217|516356161|FG001|Overall Study|Withdrawal by Subject|31|||
143221319|NCT00555217|516356160|FG000|Overall Study|Lost to Follow-up|19|||
143221320|NCT00555217|516356161|FG001|Overall Study|Lost to Follow-up|20|||
143221321|NCT00555217|516356160|FG000|Overall Study|close out sites|21|||
143221322|NCT00555217|516356161|FG001|Overall Study|close out sites|17|||
143221323|NCT01099397|516356166|FG000|Overall Study|Lost to Follow-up|4|||
143221324|NCT01099397|516356166|FG000|Overall Study|Protocol Violation|4|||
143221325|NCT01099397|516356166|FG000|Overall Study|Withdrawal by Subject|5|||
143221326|NCT02363959|516356167|FG000|Overall Study|Medical instability|1|||
143221327|NCT02363959|516356168|FG001|Overall Study|Medical instability|0|||
143221328|NCT00992459|516356169|FG000|Overall Study|Withdrawal by Subject|0|||
143221329|NCT00992459|516356170|FG001|Overall Study|Withdrawal by Subject|1|||
143221330|NCT00992459|516356169|FG000|Overall Study|Adverse Event|1|||
143221331|NCT00992459|516356170|FG001|Overall Study|Adverse Event|0|||
143221332|NCT00950248|516356178|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
143221333|NCT00950248|516356179|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
143221334|NCT00950248|516356180|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
143221335|NCT00950248|516356178|FG000|Year 1: Baseline|worsening of symptoms|2|||
143221336|NCT00950248|516356179|FG001|Year 1: Baseline|worsening of symptoms|0|||
143221337|NCT00950248|516356180|FG002|Year 1: Baseline|worsening of symptoms|0|||
143221338|NCT00950248|516356178|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
143221339|NCT00950248|516356179|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
143221340|NCT00950248|516356180|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
143221341|NCT00950248|516356178|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
143221342|NCT00950248|516356179|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
143221343|NCT00950248|516356180|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
143221344|NCT00950248|516356178|FG000|Year 2&3 Treatment Randomization|Death|0|||
143221345|NCT00950248|516356179|FG001|Year 2&3 Treatment Randomization|Death|0|||
143221346|NCT00950248|516356180|FG002|Year 2&3 Treatment Randomization|Death|1|||
143221347|NCT00950248|516356178|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
143221348|NCT00950248|516356179|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
143221349|NCT00950248|516356180|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
143221350|NCT00003199|516356183|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
143221351|NCT00003199|516356183|FG000|Overall Study|Lack of insurance clearance|2|||
143221352|NCT00003199|516356183|FG000|Overall Study|Screen fail|15|||
143221353|NCT03761810|516356185|FG000|Overall Study|Adverse Event|12|||
143221354|NCT03761810|516356186|FG001|Overall Study|Adverse Event|0|||
143221355|NCT03761810|516356185|FG000|Overall Study|Lost to Follow-up|15|||
143221356|NCT03761810|516356186|FG001|Overall Study|Lost to Follow-up|7|||
143221357|NCT03761810|516356185|FG000|Overall Study|Pregnancy|1|||
143221358|NCT03761810|516356186|FG001|Overall Study|Pregnancy|0|||
143221359|NCT03761810|516356185|FG000|Overall Study|Withdrawal by Subject|14|||
143221360|NCT03761810|516356186|FG001|Overall Study|Withdrawal by Subject|5|||
143221361|NCT03761810|516356185|FG000|Overall Study|Physician Decision|1|||
143221362|NCT03761810|516356186|FG001|Overall Study|Physician Decision|0|||
143221363|NCT03761810|516356185|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
143221364|NCT03761810|516356186|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
143221365|NCT03761810|516356185|FG000|Overall Study|Other Than Specified|1|||
143221366|NCT03761810|516356186|FG001|Overall Study|Other Than Specified|0|||
143221367|NCT04178720|516356187|FG000|Overall Study|Withdrawal by Subject|2|||
143221368|NCT04178720|516356188|FG001|Overall Study|Withdrawal by Subject|0|||
143221369|NCT04178720|516356187|FG000|Overall Study|Relocation|0|||
143221370|NCT04178720|516356188|FG001|Overall Study|Relocation|1|||
143221371|NCT00869518|516356189|FG000|Overall Study|Lost to Follow-up|1|||
143221372|NCT00869518|516356190|FG001|Overall Study|Lost to Follow-up|1|||
143221373|NCT03932760|516356191|FG000|Overall Study|Became Ineligible|2|||
143221374|NCT03932760|516356192|FG001|Overall Study|Became Ineligible|5|||
143221375|NCT03932760|516356191|FG000|Overall Study|Withdrawal by Subject|6|||
143221376|NCT03932760|516356192|FG001|Overall Study|Withdrawal by Subject|6|||
143221377|NCT03922620|516356195|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
143221378|NCT03922620|516356196|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
143221379|NCT00983385|516356197|FG000|Observation Period|Not eligible to be dosed|20|||
143221380|NCT00983385|516356197|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
143221381|NCT01223183|516356199|FG000|Imaging Day 1|Physician Decision|0|||
143221382|NCT01223183|516356200|FG001|Imaging Day 1|Physician Decision|1|||
143221383|NCT01223183|516356199|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
143221384|NCT01223183|516356200|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
143221385|NCT01223183|516356199|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
143221386|NCT01223183|516356200|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
143221387|NCT02544503|516359289|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
143221388|NCT02544503|516359290|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
143221389|NCT02544503|516359289|FG000|Overall Study|Lost to Follow-up|9|||
143221390|NCT02544503|516359290|FG001|Overall Study|Lost to Follow-up|0|||
143221391|NCT02544503|516359289|FG000|Overall Study|Withdrawal by Subject|1|||
143221392|NCT02544503|516359290|FG001|Overall Study|Withdrawal by Subject|0|||
143221393|NCT01080807|516359291|FG000|Overall Study|Adverse Event|9|||
143221394|NCT01080807|516359292|FG001|Overall Study|Adverse Event|1|||
143221395|NCT01080807|516359291|FG000|Overall Study|Lack of Efficacy|0|||
143221396|NCT01080807|516359292|FG001|Overall Study|Lack of Efficacy|1|||
143221397|NCT01080807|516359291|FG000|Overall Study|Withdrawal by Subject|7|||
143221398|NCT01080807|516359292|FG001|Overall Study|Withdrawal by Subject|2|||
143221399|NCT01080807|516359291|FG000|Overall Study|Protocol Violation|7|||
143221400|NCT01080807|516359292|FG001|Overall Study|Protocol Violation|6|||
143221401|NCT01080807|516359291|FG000|Overall Study|Lost to Follow-up|6|||
143221402|NCT01080807|516359292|FG001|Overall Study|Lost to Follow-up|4|||
143221403|NCT01080807|516359291|FG000|Overall Study|Noncompliance with drug administration|1|||
143221404|NCT01080807|516359292|FG001|Overall Study|Noncompliance with drug administration|1|||
143221405|NCT01080807|516359291|FG000|Overall Study|Noncompliance to study procedures|1|||
143221406|NCT01080807|516359292|FG001|Overall Study|Noncompliance to study procedures|1|||
143221407|NCT01080807|516359291|FG000|Overall Study|Began working day shift|0|||
143221408|NCT01080807|516359292|FG001|Overall Study|Began working day shift|2|||
143221409|NCT01080807|516359291|FG000|Overall Study|Laid off or terminated from job|1|||
143221410|NCT01080807|516359292|FG001|Overall Study|Laid off or terminated from job|2|||
143221411|NCT01080807|516359291|FG000|Overall Study|Stopped working consistent night shifts|0|||
143221412|NCT01080807|516359292|FG001|Overall Study|Stopped working consistent night shifts|1|||
143221413|NCT01080807|516359291|FG000|Overall Study|Work schedule changing|1|||
143221414|NCT01080807|516359292|FG001|Overall Study|Work schedule changing|1|||
143221415|NCT01080807|516359291|FG000|Overall Study|Work schedule and travel|0|||
143221416|NCT01080807|516359292|FG001|Overall Study|Work schedule and travel|1|||
143221417|NCT01080807|516359291|FG000|Overall Study|Switched to first shift|1|||
143221418|NCT01080807|516359292|FG001|Overall Study|Switched to first shift|0|||
143221419|NCT01080807|516359291|FG000|Overall Study|Moved away without notifying center|1|||
143221420|NCT01080807|516359292|FG001|Overall Study|Moved away without notifying center|0|||
143221421|NCT04685798|516359293|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
143221422|NCT04640311|516359294|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
143221423|NCT04640311|516359295|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
143221424|NCT04640311|516359296|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
143221425|NCT04640311|516359297|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
143221426|NCT04640311|516359298|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
143221427|NCT04640311|516359299|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
143221428|NCT04640311|516359300|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
143221429|NCT04640311|516359301|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
143221430|NCT04640311|516359302|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
143221431|NCT04640311|516359303|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
143221432|NCT04640311|516359304|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
143221433|NCT04640311|516359305|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
143221434|NCT04640311|516359306|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
143221435|NCT04640311|516359294|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
143221436|NCT04640311|516359295|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
143221437|NCT04640311|516359296|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
143221438|NCT04640311|516359297|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
143221439|NCT04640311|516359298|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
143221440|NCT04640311|516359299|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
143221441|NCT04640311|516359300|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
143221442|NCT04640311|516359301|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
143221443|NCT04640311|516359302|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
143221444|NCT04640311|516359303|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
143221445|NCT04640311|516359304|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
143221446|NCT04640311|516359305|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
143221447|NCT04640311|516359306|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
143221448|NCT04640311|516359294|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
143221449|NCT04640311|516359295|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
143221450|NCT04640311|516359296|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
143221451|NCT04640311|516359297|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
143221452|NCT04640311|516359298|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
143221453|NCT04640311|516359299|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
143221454|NCT04640311|516359300|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
143221455|NCT04640311|516359301|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
143221456|NCT04640311|516359302|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
143221457|NCT04640311|516359303|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
143221458|NCT04640311|516359304|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
143221459|NCT04640311|516359305|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
143221460|NCT04640311|516359306|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
143221461|NCT04640311|516359294|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
143267449|NCT02595970|516535117|FG000|Overall Study|Adverse Event|5|||
143372274|NCT00419094|516909467|FG000|Overall Study|Withdrawal of consent|1|||
143372275|NCT00419094|516909468|FG001|Overall Study|Withdrawal of consent|5|||
143372276|NCT00419094|516909467|FG000|Overall Study|Other: Error determining exit criteria|1|||
143372277|NCT00419094|516909468|FG001|Overall Study|Other: Error determining exit criteria|0|||
143372278|NCT00419094|516909467|FG000|Overall Study|Other: Patient non-compliant|0|||
143372279|NCT00419094|516909468|FG001|Overall Study|Other: Patient non-compliant|1|||
143221462|NCT04640311|516359295|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
143221463|NCT04640311|516359296|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
143221464|NCT04640311|516359297|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
143221465|NCT04640311|516359298|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
143221466|NCT04640311|516359299|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
143221467|NCT04640311|516359300|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
143221468|NCT04640311|516359301|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
143221469|NCT04640311|516359302|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
143221470|NCT04640311|516359303|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
143221471|NCT04640311|516359304|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
143221472|NCT04640311|516359305|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
143221473|NCT04640311|516359306|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
143221474|NCT04640311|516359294|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
143221475|NCT04640311|516359295|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
143221476|NCT04640311|516359296|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
143221477|NCT04640311|516359297|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
143221478|NCT04640311|516359298|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
143221479|NCT04640311|516359299|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
143221480|NCT04640311|516359300|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
143221481|NCT04640311|516359301|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
143221482|NCT04640311|516359302|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
143221483|NCT04640311|516359303|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
143221484|NCT04640311|516359304|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
143221485|NCT04640311|516359305|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
143221486|NCT04640311|516359306|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
143221487|NCT04640311|516359294|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
143221488|NCT04640311|516359295|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
143221489|NCT04640311|516359296|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
143221490|NCT04640311|516359297|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
143221491|NCT04640311|516359298|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
143267450|NCT02595970|516535117|FG000|Overall Study|Lack of Efficacy|7|||
143267451|NCT02367131|516535118|FG000|Overall Study|Adverse Event|64|||
143267452|NCT02367131|516535118|FG000|Overall Study|No visit since the first visit|3|||
143267453|NCT02367131|516535118|FG000|Overall Study|Request by patient|53|||
143267454|NCT02367131|516535118|FG000|Overall Study|Improvement/remission|2|||
143267455|NCT02367131|516535118|FG000|Overall Study|No change/progressive disease|78|||
143267456|NCT02367131|516535118|FG000|Overall Study|Other than stated above|20|||
143267457|NCT02367131|516535118|FG000|Overall Study|Not treated|2|||
143267458|NCT02923427|516535122|FG000|Overall Study|convert to laparatomy|2|||
143267459|NCT02923427|516535123|FG001|Overall Study|convert to laparatomy|2|||
143267460|NCT02923427|516535122|FG000|Overall Study|destaturation|1|||
143267461|NCT02923427|516535123|FG001|Overall Study|destaturation|0|||
143267462|NCT02923427|516535122|FG000|Overall Study|can not replace LMA|1|||
143267463|NCT02923427|516535123|FG001|Overall Study|can not replace LMA|0|||
143267464|NCT01539642|516535129|FG000|Overall Study|Lack of Efficacy|20|||
143267465|NCT01539642|516535130|FG001|Overall Study|Lack of Efficacy|18|||
143372280|NCT00419094|516909467|FG000|Overall Study|Other: No contact for extended period|0|||
143221492|NCT04640311|516359299|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
143221493|NCT04640311|516359300|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
143221494|NCT04640311|516359301|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
143221495|NCT04640311|516359302|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
143221496|NCT04640311|516359303|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
143221497|NCT04640311|516359304|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
143221498|NCT04640311|516359305|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
143221499|NCT04640311|516359306|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
143221500|NCT04640311|516359294|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
143221501|NCT04640311|516359295|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
143221502|NCT04640311|516359296|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
143221503|NCT04640311|516359297|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
143221504|NCT04640311|516359298|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
143221505|NCT04640311|516359299|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
143221506|NCT04640311|516359300|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
143221507|NCT04640311|516359301|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
143221508|NCT04640311|516359302|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
143221509|NCT04640311|516359303|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
143221510|NCT04640311|516359304|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
143221511|NCT04640311|516359305|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
143221512|NCT04640311|516359306|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
143221513|NCT04640311|516359294|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
143221514|NCT04640311|516359295|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
143221515|NCT04640311|516359296|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
143221516|NCT04640311|516359297|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
143221517|NCT04640311|516359298|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
143221518|NCT04640311|516359299|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
143221519|NCT04640311|516359300|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
143221520|NCT04640311|516359301|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
143221521|NCT04640311|516359302|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
143221522|NCT04640311|516359303|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
143221523|NCT04640311|516359304|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
143221524|NCT04640311|516359305|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
143221525|NCT04640311|516359306|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
143221526|NCT04640311|516359294|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
143221527|NCT04640311|516359295|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
143221528|NCT04640311|516359296|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
143221529|NCT04640311|516359297|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
143221530|NCT04640311|516359298|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
143221531|NCT04640311|516359299|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
143221532|NCT04640311|516359300|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
143221533|NCT04640311|516359301|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
143221534|NCT04640311|516359302|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
143221535|NCT04640311|516359303|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
143221536|NCT04640311|516359304|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
143221537|NCT04640311|516359305|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
143221538|NCT04640311|516359306|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
143221539|NCT01799226|516359310|FG000|Overall Study|Withdrawal by Subject|1|||
143221540|NCT01799226|516359311|FG001|Overall Study|Withdrawal by Subject|0|||
143221541|NCT01799226|516359310|FG000|Overall Study|Disqualified at Day 14|1|||
143267466|NCT01539642|516535129|FG000|Overall Study|Patient ready for early discharge|8|||
143267467|NCT01539642|516535130|FG001|Overall Study|Patient ready for early discharge|7|||
143267468|NCT01539642|516535129|FG000|Overall Study|Adverse Event|6|||
143267469|NCT01539642|516535130|FG001|Overall Study|Adverse Event|4|||
143267470|NCT01539642|516535129|FG000|Overall Study|Withdrawal by Subject|2|||
143267471|NCT01539642|516535130|FG001|Overall Study|Withdrawal by Subject|2|||
143267472|NCT02106910|516535131|FG000|Overall Study|Lost to Follow-up|1|||
143267473|NCT02106910|516535132|FG001|Overall Study|Lost to Follow-up|1|||
143267474|NCT00567593|516535133|FG000|Overall Study|Adverse Event|1|||
143267475|NCT00567593|516535133|FG000|Overall Study|Physician Decision|1|||
143267476|NCT01675427|516535136|FG000|Overall Study|Withdrawal by Subject|7|||
143372281|NCT00419094|516909468|FG001|Overall Study|Other: No contact for extended period|1|||
143372282|NCT01811706|516909469|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
143372283|NCT01811706|516909470|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
143372284|NCT03020745|516909471|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
143372285|NCT03020745|516909472|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
143372286|NCT03020745|516909473|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
143372287|NCT03020745|516909474|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
143372288|NCT03020745|516909475|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
143372289|NCT03020745|516909476|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
143372290|NCT03020745|516909477|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
143221542|NCT01799226|516359311|FG001|Overall Study|Disqualified at Day 14|0|||
143221543|NCT01388907|516359312|FG000|Overall Study|Adverse Event|2|||
143221544|NCT01388907|516359313|FG001|Overall Study|Adverse Event|0|||
143221545|NCT01910402|516359314|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
143221546|NCT01910402|516359315|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
143221547|NCT01910402|516359316|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
143221548|NCT01910402|516359314|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
143221549|NCT01910402|516359315|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
143221550|NCT01910402|516359316|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
143221551|NCT01910402|516359314|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
143221552|NCT01910402|516359315|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
143221553|NCT01910402|516359316|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
143221554|NCT01910402|516359314|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
143221555|NCT01910402|516359315|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
143221556|NCT01910402|516359316|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
143221557|NCT01910402|516359314|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
143221558|NCT01910402|516359315|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
143221559|NCT01910402|516359316|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
143221560|NCT01910402|516359314|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
143221561|NCT01910402|516359315|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
143221562|NCT01910402|516359316|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
143221563|NCT01910402|516359314|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
143221564|NCT01910402|516359315|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
143221565|NCT01910402|516359316|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
143221566|NCT01910402|516359314|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
143221567|NCT01910402|516359315|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
143221568|NCT01910402|516359316|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
143221569|NCT01910402|516359314|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
143221570|NCT01910402|516359315|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
143221571|NCT01910402|516359316|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
143221572|NCT01910402|516359314|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
143221573|NCT01910402|516359315|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
143221574|NCT01910402|516359316|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
143221575|NCT01910402|516359314|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
143221576|NCT01910402|516359315|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
143221577|NCT01910402|516359316|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
143221578|NCT01910402|516359314|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
143221579|NCT01910402|516359315|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
143221580|NCT01910402|516359316|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
143221581|NCT01910402|516359314|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
143221582|NCT01910402|516359315|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
143221583|NCT01910402|516359316|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
143221584|NCT03594773|516359317|FG000|Overall Study|Withdrawal by Subject|3|||
143221585|NCT03594773|516359318|FG001|Overall Study|Withdrawal by Subject|2|||
143221586|NCT03594773|516359317|FG000|Overall Study|Lost to Follow-up|3|||
143221587|NCT03594773|516359318|FG001|Overall Study|Lost to Follow-up|4|||
143221588|NCT00193206|516359319|FG000|Preoperative Therapy|Lack of Efficacy|2|||
143372291|NCT03020745|516909478|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
143372292|NCT03020745|516909479|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
143372293|NCT03020745|516909480|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
143372294|NCT03020745|516909471|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
143372295|NCT03020745|516909472|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
143372296|NCT03020745|516909473|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
143372297|NCT03020745|516909474|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
143221589|NCT00193206|516359319|FG000|Preoperative Therapy|Adverse Event|2|||
143221590|NCT00193206|516359319|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
143221591|NCT00193206|516359319|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
143221592|NCT00193206|516359319|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
143221593|NCT00193206|516359319|FG000|Postoperative Therapy|Physician Decision|3|||
143221594|NCT00193206|516359319|FG000|Postoperative Therapy|Intercurrent Illness|2|||
143221595|NCT00193206|516359319|FG000|Postoperative Therapy|Lack of Efficacy|1|||
143221596|NCT00193206|516359319|FG000|Postoperative Therapy|Protocol Violation|1|||
143221597|NCT02753946|516359330|FG000|Overall Study|Adverse Event|7|||
143221598|NCT02753946|516359331|FG001|Overall Study|Adverse Event|6|||
143221599|NCT02753946|516359330|FG000|Overall Study|Withdrawal by Subject|6|||
143221600|NCT02753946|516359331|FG001|Overall Study|Withdrawal by Subject|1|||
143221601|NCT02753946|516359330|FG000|Overall Study|Lack of Efficacy|1|||
143221602|NCT02753946|516359331|FG001|Overall Study|Lack of Efficacy|0|||
143221603|NCT02753946|516359330|FG000|Overall Study|Physician Decision|0|||
143221604|NCT02753946|516359331|FG001|Overall Study|Physician Decision|2|||
143221605|NCT00556998|516359332|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
143221606|NCT00556998|516359332|FG000|Voriconazole Intravenous (IV)|Other|4|||
143221607|NCT00556998|516359332|FG000|Voriconazole Oral|Adverse Event|1|||
143221608|NCT00556998|516359332|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
143221609|NCT03030417|516359335|FG000|Dose Expansion|Disease progression before treatment|0|||
143221610|NCT03030417|516359336|FG001|Dose Expansion|Disease progression before treatment|0|||
143221611|NCT03030417|516359337|FG002|Dose Expansion|Disease progression before treatment|0|||
143221612|NCT03030417|516359338|FG003|Dose Expansion|Disease progression before treatment|0|||
143221613|NCT03030417|516359339|FG004|Dose Expansion|Disease progression before treatment|0|||
143221614|NCT03030417|516359340|FG005|Dose Expansion|Disease progression before treatment|0|||
143221615|NCT03030417|516359341|FG006|Dose Expansion|Disease progression before treatment|0|||
143221616|NCT03030417|516359342|FG007|Dose Expansion|Disease progression before treatment|0|||
143221617|NCT03030417|516359343|FG008|Dose Expansion|Disease progression before treatment|0|||
143221618|NCT03030417|516359344|FG009|Dose Expansion|Disease progression before treatment|0|||
143221619|NCT03030417|516359345|FG010|Dose Expansion|Disease progression before treatment|0|||
143221620|NCT03030417|516359346|FG011|Dose Expansion|Disease progression before treatment|0|||
143221621|NCT03030417|516359347|FG012|Dose Expansion|Disease progression before treatment|1|||
143221622|NCT02714569|516359348|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
143221623|NCT02714569|516359349|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
143267477|NCT01675427|516535136|FG000|Overall Study|Participant Refused Sample Collection|18|||
143221624|NCT02714569|516359350|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
143267478|NCT01675427|516535136|FG000|Overall Study|Sample not Collected by Mistake|2|||
143221625|NCT02714569|516359351|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
143221626|NCT02714569|516359352|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
143221627|NCT02714569|516359353|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
143221628|NCT02714569|516359354|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
143221629|NCT02714569|516359355|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
143221630|NCT02714569|516359356|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
143221631|NCT02714569|516359357|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
143221632|NCT02714569|516359358|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
143221633|NCT02714569|516359348|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
143221634|NCT02714569|516359349|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
143221635|NCT02714569|516359350|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
143221636|NCT02714569|516359351|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
143221637|NCT02714569|516359352|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
143221638|NCT02714569|516359353|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
143221639|NCT02714569|516359354|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
143221640|NCT02714569|516359355|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
143221641|NCT02714569|516359356|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
143221642|NCT02714569|516359357|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
143221643|NCT02714569|516359358|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
143221644|NCT02714569|516359348|FG000|Part A Third Intervention|Adverse Event|0|||
143221645|NCT02714569|516359349|FG001|Part A Third Intervention|Adverse Event|0|||
143221646|NCT02714569|516359350|FG002|Part A Third Intervention|Adverse Event|1|||
143221647|NCT02714569|516359351|FG003|Part A Third Intervention|Adverse Event|0|||
143221648|NCT02714569|516359352|FG004|Part A Third Intervention|Adverse Event|0|||
143221649|NCT02714569|516359353|FG005|Part A Third Intervention|Adverse Event|0|||
143221650|NCT02714569|516359354|FG006|Part A Third Intervention|Adverse Event|0|||
143221651|NCT02714569|516359355|FG007|Part A Third Intervention|Adverse Event|0|||
143221652|NCT02714569|516359356|FG008|Part A Third Intervention|Adverse Event|0|||
143221653|NCT02714569|516359357|FG009|Part A Third Intervention|Adverse Event|0|||
143221654|NCT02714569|516359358|FG010|Part A Third Intervention|Adverse Event|0|||
143221655|NCT02714569|516359348|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
143221656|NCT02714569|516359349|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
143221657|NCT02714569|516359350|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
143221658|NCT02714569|516359351|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
143221659|NCT02714569|516359352|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
143267479|NCT01675427|516535136|FG000|Overall Study|Lost to Follow-up|5|||
143267480|NCT01675427|516535136|FG000|Overall Study|Other|2|||
143267481|NCT00700570|516535137|FG000|Overall Study|Adverse Event|2|||
143221660|NCT02714569|516359353|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
143221661|NCT02714569|516359354|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
143221662|NCT02714569|516359355|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
143221663|NCT02714569|516359356|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
143221664|NCT02714569|516359357|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
143221665|NCT02714569|516359358|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
143221666|NCT02714569|516359348|FG000|Part B (Overall)|Lost to Follow-up|0|||
143221667|NCT02714569|516359349|FG001|Part B (Overall)|Lost to Follow-up|0|||
143221668|NCT02714569|516359350|FG002|Part B (Overall)|Lost to Follow-up|0|||
143221669|NCT02714569|516359351|FG003|Part B (Overall)|Lost to Follow-up|0|||
143221670|NCT02714569|516359352|FG004|Part B (Overall)|Lost to Follow-up|0|||
143221671|NCT02714569|516359353|FG005|Part B (Overall)|Lost to Follow-up|0|||
143221672|NCT02714569|516359354|FG006|Part B (Overall)|Lost to Follow-up|1|||
143221673|NCT02714569|516359355|FG007|Part B (Overall)|Lost to Follow-up|0|||
143221674|NCT02714569|516359356|FG008|Part B (Overall)|Lost to Follow-up|0|||
143221675|NCT02714569|516359357|FG009|Part B (Overall)|Lost to Follow-up|0|||
143221676|NCT02714569|516359358|FG010|Part B (Overall)|Lost to Follow-up|0|||
143221677|NCT02714569|516359348|FG000|Part B (Overall)|Withdrawal by Subject|0|||
143221678|NCT02714569|516359349|FG001|Part B (Overall)|Withdrawal by Subject|0|||
143221679|NCT02714569|516359350|FG002|Part B (Overall)|Withdrawal by Subject|0|||
143221680|NCT02714569|516359351|FG003|Part B (Overall)|Withdrawal by Subject|0|||
143221681|NCT02714569|516359352|FG004|Part B (Overall)|Withdrawal by Subject|0|||
143221682|NCT02714569|516359353|FG005|Part B (Overall)|Withdrawal by Subject|0|||
143221683|NCT02714569|516359354|FG006|Part B (Overall)|Withdrawal by Subject|0|||
143221684|NCT02714569|516359355|FG007|Part B (Overall)|Withdrawal by Subject|1|||
143221685|NCT02714569|516359356|FG008|Part B (Overall)|Withdrawal by Subject|0|||
143221686|NCT02714569|516359357|FG009|Part B (Overall)|Withdrawal by Subject|1|||
143221687|NCT02714569|516359358|FG010|Part B (Overall)|Withdrawal by Subject|0|||
143221688|NCT02714569|516359348|FG000|Part B (Overall)|Adverse Event|0|||
143221689|NCT02714569|516359349|FG001|Part B (Overall)|Adverse Event|0|||
143221690|NCT02714569|516359350|FG002|Part B (Overall)|Adverse Event|0|||
143221691|NCT02714569|516359351|FG003|Part B (Overall)|Adverse Event|0|||
143221692|NCT02714569|516359352|FG004|Part B (Overall)|Adverse Event|0|||
143221693|NCT02714569|516359353|FG005|Part B (Overall)|Adverse Event|0|||
143221694|NCT02714569|516359354|FG006|Part B (Overall)|Adverse Event|0|||
143221695|NCT02714569|516359355|FG007|Part B (Overall)|Adverse Event|0|||
143221696|NCT02714569|516359356|FG008|Part B (Overall)|Adverse Event|0|||
143221697|NCT02714569|516359357|FG009|Part B (Overall)|Adverse Event|1|||
143221698|NCT02714569|516359358|FG010|Part B (Overall)|Adverse Event|0|||
143267482|NCT00700570|516535138|FG001|Overall Study|Adverse Event|6|||
143267483|NCT00700570|516535137|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
143267484|NCT00700570|516535138|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
143267485|NCT00700570|516535137|FG000|Overall Study|Disease Progression|8|||
143372298|NCT03020745|516909475|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
143372299|NCT03020745|516909476|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
143372300|NCT03020745|516909477|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
143372301|NCT03020745|516909478|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
143372302|NCT03020745|516909479|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
143372303|NCT03020745|516909480|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
143372304|NCT03020745|516909471|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
143372305|NCT03020745|516909472|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
143372306|NCT03020745|516909473|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
143372307|NCT03020745|516909474|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
143372308|NCT03020745|516909475|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
143372309|NCT03020745|516909476|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
143372310|NCT03020745|516909477|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
143372311|NCT03020745|516909478|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
143372312|NCT03020745|516909479|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
143372313|NCT03020745|516909480|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
143372314|NCT03020745|516909471|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
143372315|NCT03020745|516909472|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
143372316|NCT03020745|516909473|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
143372317|NCT03020745|516909474|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
143372318|NCT03020745|516909475|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
143372319|NCT03020745|516909476|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
143372320|NCT03020745|516909477|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
143372321|NCT03020745|516909478|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
143372322|NCT03020745|516909479|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
143372323|NCT03020745|516909480|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
143372324|NCT02057692|516909485|FG000|Overall Study|Adverse Event|1|||
143372325|NCT02057692|516909486|FG001|Overall Study|Adverse Event|0|||
143372326|NCT02057692|516909487|FG002|Overall Study|Adverse Event|0|||
143372327|NCT02057692|516909488|FG003|Overall Study|Adverse Event|0|||
143372328|NCT02057692|516909485|FG000|Overall Study|Lost to Follow-up|0|||
143372329|NCT02057692|516909486|FG001|Overall Study|Lost to Follow-up|0|||
143372330|NCT02057692|516909487|FG002|Overall Study|Lost to Follow-up|0|||
143372331|NCT02057692|516909488|FG003|Overall Study|Lost to Follow-up|1|||
143372332|NCT03923491|516909489|FG000|Overall Study|Lost to Follow-up|5|||
143372333|NCT03923491|516909490|FG001|Overall Study|Lost to Follow-up|8|||
143372334|NCT03923491|516909489|FG000|Overall Study|Withdrawal by Subject|4|||
143372335|NCT03923491|516909490|FG001|Overall Study|Withdrawal by Subject|6|||
143372336|NCT03823300|516909497|FG000|Overall Study|Withdrawal by Subject|16|||
143221699|NCT04915729|516359359|FG000|Overall Study|Lost to Follow-up|20|||
143221700|NCT04915729|516359360|FG001|Overall Study|Lost to Follow-up|10|||
143221701|NCT04915729|516359359|FG000|Overall Study|Withdrawal by Subject|12|||
143221702|NCT04915729|516359360|FG001|Overall Study|Withdrawal by Subject|5|||
143221703|NCT04915729|516359359|FG000|Overall Study|Death|34|||
143221704|NCT04915729|516359360|FG001|Overall Study|Death|44|||
143221705|NCT04915729|516359359|FG000|Overall Study|not treated|3|||
143221706|NCT04915729|516359360|FG001|Overall Study|not treated|6|||
143221707|NCT04915729|516359359|FG000|Overall Study|Investigator removed subject|1|||
143221708|NCT04915729|516359360|FG001|Overall Study|Investigator removed subject|2|||
143221709|NCT04915729|516359359|FG000|Overall Study|questionnaire result not evaluated|1|||
143221710|NCT04915729|516359360|FG001|Overall Study|questionnaire result not evaluated|0|||
143221711|NCT04915729|516359359|FG000|Overall Study|refuse of hospital visit|1|||
143221712|NCT04915729|516359360|FG001|Overall Study|refuse of hospital visit|3|||
143221713|NCT04915729|516359359|FG000|Overall Study|Subject withdrew|1|||
143221714|NCT04915729|516359360|FG001|Overall Study|Subject withdrew|0|||
143221715|NCT04961541|516359361|FG000|Overall Study|Adverse Event|0|||
143221716|NCT04961541|516359362|FG001|Overall Study|Adverse Event|0|||
143221717|NCT04961541|516359363|FG002|Overall Study|Adverse Event|0|||
143221718|NCT04961541|516359364|FG003|Overall Study|Adverse Event|0|||
143221719|NCT04961541|516359365|FG004|Overall Study|Adverse Event|0|||
143221720|NCT04961541|516359366|FG005|Overall Study|Adverse Event|1|||
143221721|NCT04961541|516359367|FG006|Overall Study|Adverse Event|0|||
143221722|NCT04961541|516359368|FG007|Overall Study|Adverse Event|0|||
143221723|NCT04961541|516359369|FG008|Overall Study|Adverse Event|0|||
143221724|NCT04961541|516359370|FG009|Overall Study|Adverse Event|0|||
143221725|NCT04961541|516359371|FG010|Overall Study|Adverse Event|0|||
143221726|NCT04961541|516359372|FG011|Overall Study|Adverse Event|0|||
143221727|NCT04961541|516359373|FG012|Overall Study|Adverse Event|0|||
143221728|NCT04961541|516359374|FG013|Overall Study|Adverse Event|0|||
143221729|NCT04961541|516359361|FG000|Overall Study|Lost to Follow-up|0|||
143221730|NCT04961541|516359362|FG001|Overall Study|Lost to Follow-up|0|||
143221731|NCT04961541|516359363|FG002|Overall Study|Lost to Follow-up|3|||
143221732|NCT04961541|516359364|FG003|Overall Study|Lost to Follow-up|0|||
143221733|NCT04961541|516359365|FG004|Overall Study|Lost to Follow-up|0|||
143221734|NCT04961541|516359366|FG005|Overall Study|Lost to Follow-up|0|||
143221735|NCT04961541|516359367|FG006|Overall Study|Lost to Follow-up|1|||
143221736|NCT04961541|516359368|FG007|Overall Study|Lost to Follow-up|1|||
143221737|NCT04961541|516359369|FG008|Overall Study|Lost to Follow-up|0|||
143221738|NCT04961541|516359370|FG009|Overall Study|Lost to Follow-up|1|||
143221739|NCT04961541|516359371|FG010|Overall Study|Lost to Follow-up|0|||
143221740|NCT04961541|516359372|FG011|Overall Study|Lost to Follow-up|0|||
143221741|NCT04961541|516359373|FG012|Overall Study|Lost to Follow-up|1|||
143221742|NCT04961541|516359374|FG013|Overall Study|Lost to Follow-up|0|||
143221743|NCT04961541|516359361|FG000|Overall Study|Withdrawal by Subject|0|||
143221744|NCT04961541|516359362|FG001|Overall Study|Withdrawal by Subject|0|||
143221745|NCT04961541|516359363|FG002|Overall Study|Withdrawal by Subject|1|||
143221746|NCT04961541|516359364|FG003|Overall Study|Withdrawal by Subject|1|||
143221747|NCT04961541|516359365|FG004|Overall Study|Withdrawal by Subject|0|||
143221748|NCT04961541|516359366|FG005|Overall Study|Withdrawal by Subject|0|||
143221749|NCT04961541|516359367|FG006|Overall Study|Withdrawal by Subject|0|||
143221750|NCT04961541|516359368|FG007|Overall Study|Withdrawal by Subject|0|||
143221751|NCT04961541|516359369|FG008|Overall Study|Withdrawal by Subject|0|||
143221752|NCT04961541|516359370|FG009|Overall Study|Withdrawal by Subject|1|||
143221753|NCT04961541|516359371|FG010|Overall Study|Withdrawal by Subject|0|||
143221754|NCT04961541|516359372|FG011|Overall Study|Withdrawal by Subject|0|||
143221755|NCT04961541|516359373|FG012|Overall Study|Withdrawal by Subject|0|||
143221756|NCT04961541|516359374|FG013|Overall Study|Withdrawal by Subject|0|||
143221757|NCT01684202|516359375|FG000|Dose-escalation Period|Adverse Event|0|||
143221758|NCT01684202|516359376|FG001|Dose-escalation Period|Adverse Event|1|||
143221759|NCT01684202|516359377|FG002|Dose-escalation Period|Adverse Event|0|||
143221760|NCT01684202|516359378|FG003|Dose-escalation Period|Adverse Event|0|||
143221761|NCT01684202|516359375|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
143221762|NCT01684202|516359376|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
143221763|NCT01684202|516359377|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
143221764|NCT01684202|516359378|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
143221765|NCT01684202|516359375|FG000|Maintenance Period|Adverse Event|1|||
143221766|NCT01684202|516359376|FG001|Maintenance Period|Adverse Event|1|||
143221767|NCT01684202|516359377|FG002|Maintenance Period|Adverse Event|1|||
143221768|NCT01684202|516359378|FG003|Maintenance Period|Adverse Event|1|||
143221769|NCT01684202|516359375|FG000|Maintenance Period|Physician Decision|0|||
143221770|NCT01684202|516359376|FG001|Maintenance Period|Physician Decision|1|||
143267486|NCT00700570|516535138|FG001|Overall Study|Disease Progression|11|||
143267487|NCT00700570|516535137|FG000|Overall Study|Withdrawal by Subject|1|||
143267488|NCT00700570|516535138|FG001|Overall Study|Withdrawal by Subject|6|||
143267489|NCT00611533|516535143|FG000|First Intervention (6 Weeks)|Never started study|0|||
143267490|NCT00611533|516535144|FG001|First Intervention (6 Weeks)|Never started study|1|||
143267491|NCT00611533|516535143|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
143267492|NCT00611533|516535144|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
143267493|NCT00611533|516535143|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
143267494|NCT00611533|516535144|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
143267495|NCT02943460|516535146|FG000|Blinded Study Phase|Adverse Event|3|||
143267496|NCT02943460|516535147|FG001|Blinded Study Phase|Adverse Event|0|||
143267497|NCT02943460|516535148|FG002|Blinded Study Phase|Adverse Event|0|||
143267498|NCT02943460|516535146|FG000|Blinded Study Phase|Withdrew Consent|0|||
143267499|NCT02943460|516535147|FG001|Blinded Study Phase|Withdrew Consent|1|||
143267500|NCT02943460|516535148|FG002|Blinded Study Phase|Withdrew Consent|0|||
143267501|NCT02943460|516535146|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
143267502|NCT02943460|516535147|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
143267503|NCT02943460|516535148|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
143267504|NCT02943460|516535146|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
143267505|NCT02943460|516535147|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
143267506|NCT02943460|516535148|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
143267507|NCT02943460|516535146|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
143267508|NCT02943460|516535147|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
143267509|NCT02943460|516535148|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
143267510|NCT04327674|516535152|FG000|Overall Study|Protocol Violation|19|||
143267511|NCT01461980|516535153|FG000|Overall Study|Other|9|||
143267512|NCT01461980|516535154|FG001|Overall Study|Other|8|||
143267513|NCT01461980|516535155|FG002|Overall Study|Other|6|||
143267514|NCT01461980|516535153|FG000|Overall Study|Medication error|7|||
143267515|NCT01461980|516535154|FG001|Overall Study|Medication error|5|||
143267516|NCT01461980|516535155|FG002|Overall Study|Medication error|6|||
143267517|NCT01461980|516535153|FG000|Overall Study|Adverse Event|12|||
143267518|NCT01461980|516535154|FG001|Overall Study|Adverse Event|5|||
143267519|NCT01461980|516535155|FG002|Overall Study|Adverse Event|6|||
143267520|NCT01461980|516535153|FG000|Overall Study|Protocol Violation|12|||
143267521|NCT01461980|516535154|FG001|Overall Study|Protocol Violation|19|||
143267522|NCT01461980|516535155|FG002|Overall Study|Protocol Violation|16|||
143267523|NCT01461980|516535153|FG000|Overall Study|No longer meets eligibility criteria|18|||
143267524|NCT01461980|516535154|FG001|Overall Study|No longer meets eligibility criteria|9|||
143267525|NCT01461980|516535155|FG002|Overall Study|No longer meets eligibility criteria|19|||
143267526|NCT01461980|516535153|FG000|Overall Study|Lost to Follow-up|52|||
143267527|NCT01461980|516535154|FG001|Overall Study|Lost to Follow-up|53|||
143267528|NCT01461980|516535155|FG002|Overall Study|Lost to Follow-up|51|||
143267529|NCT01461980|516535153|FG000|Overall Study|No longer willing to participate|52|||
143267530|NCT01461980|516535154|FG001|Overall Study|No longer willing to participate|38|||
143267531|NCT01461980|516535155|FG002|Overall Study|No longer willing to participate|54|||
143267532|NCT01461980|516535153|FG000|Overall Study|Randomized but not vaccinated|4|||
143267533|NCT01461980|516535154|FG001|Overall Study|Randomized but not vaccinated|8|||
143267534|NCT01461980|516535155|FG002|Overall Study|Randomized but not vaccinated|7|||
143267535|NCT04171765|516535156|FG000|Overall Study|Adverse Event|2|||
143267536|NCT04171765|516535157|FG001|Overall Study|Adverse Event|0|||
143267537|NCT04171765|516535158|FG002|Overall Study|Adverse Event|1|||
143267538|NCT04171765|516535159|FG003|Overall Study|Adverse Event|0|||
143267539|NCT04171765|516535156|FG000|Overall Study|Lost to Follow-up|0|||
143267540|NCT04171765|516535157|FG001|Overall Study|Lost to Follow-up|2|||
143267541|NCT04171765|516535158|FG002|Overall Study|Lost to Follow-up|2|||
143267542|NCT04171765|516535159|FG003|Overall Study|Lost to Follow-up|2|||
143267543|NCT04171765|516535156|FG000|Overall Study|Week 58 visit missed|0|||
143267544|NCT04171765|516535157|FG001|Overall Study|Week 58 visit missed|0|||
143267545|NCT04171765|516535158|FG002|Overall Study|Week 58 visit missed|1|||
143267546|NCT04171765|516535159|FG003|Overall Study|Week 58 visit missed|0|||
143267547|NCT04171765|516535156|FG000|Overall Study|Study terminated by sponsor|2|||
143267548|NCT04171765|516535157|FG001|Overall Study|Study terminated by sponsor|0|||
143267549|NCT04171765|516535158|FG002|Overall Study|Study terminated by sponsor|0|||
143267550|NCT04171765|516535159|FG003|Overall Study|Study terminated by sponsor|0|||
143267551|NCT04171765|516535156|FG000|Overall Study|Withdrawal by Subject|1|||
143267552|NCT04171765|516535157|FG001|Overall Study|Withdrawal by Subject|0|||
143267553|NCT04171765|516535158|FG002|Overall Study|Withdrawal by Subject|0|||
143267554|NCT04171765|516535159|FG003|Overall Study|Withdrawal by Subject|3|||
143267555|NCT00809354|516535161|FG000|Overall Study|Adverse Event|32|||
143267556|NCT00809354|516535162|FG001|Overall Study|Adverse Event|45|||
143267557|NCT00809354|516535163|FG002|Overall Study|Adverse Event|37|||
143267558|NCT00809354|516535164|FG003|Overall Study|Adverse Event|53|||
143267559|NCT00809354|516535165|FG004|Overall Study|Adverse Event|26|||
143267560|NCT00809354|516535166|FG005|Overall Study|Adverse Event|33|||
143267561|NCT00809354|516535167|FG006|Overall Study|Adverse Event|44|||
143221771|NCT01684202|516359377|FG002|Maintenance Period|Physician Decision|0|||
143221772|NCT01684202|516359378|FG003|Maintenance Period|Physician Decision|0|||
143221773|NCT01684202|516359375|FG000|Maintenance Period|Withdrawal by Subject|0|||
143221774|NCT01684202|516359376|FG001|Maintenance Period|Withdrawal by Subject|1|||
143221775|NCT01684202|516359377|FG002|Maintenance Period|Withdrawal by Subject|0|||
143221776|NCT01684202|516359378|FG003|Maintenance Period|Withdrawal by Subject|0|||
143221777|NCT03710642|516359379|FG000|Overall Study|Adverse Event|5|||
143221778|NCT03710642|516359380|FG001|Overall Study|Adverse Event|1|||
143221779|NCT03710642|516359379|FG000|Overall Study|non-site physician recommendation|1|||
143221780|NCT03710642|516359380|FG001|Overall Study|non-site physician recommendation|0|||
143221781|NCT03710642|516359379|FG000|Overall Study|Participant unwilling or unable to participate|1|||
143221782|NCT03710642|516359380|FG001|Overall Study|Participant unwilling or unable to participate|1|||
143221783|NCT03710642|516359379|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
143221784|NCT03710642|516359380|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
143221785|NCT03710642|516359379|FG000|Overall Study|NA-no code provided|1|||
143221786|NCT03710642|516359380|FG001|Overall Study|NA-no code provided|0|||
143221787|NCT03710642|516359379|FG000|Overall Study|Withdrawal by Subject|1|||
143221788|NCT03710642|516359380|FG001|Overall Study|Withdrawal by Subject|0|||
143221789|NCT01970306|516359381|FG000|Overall Study|Not eligible|3|||
143221790|NCT01970306|516359381|FG000|Overall Study|Not able to be treated|9|||
143221791|NCT00700713|516359382|FG000|Overall Study|Protocol Violation|1|||
143221792|NCT00700713|516359383|FG001|Overall Study|Protocol Violation|0|||
143221793|NCT00700713|516359384|FG002|Overall Study|Protocol Violation|1|||
143221794|NCT00700713|516359382|FG000|Overall Study|Withdrawal by Subject|0|||
143267562|NCT00809354|516535168|FG007|Overall Study|Adverse Event|40|||
143267563|NCT00809354|516535169|FG008|Overall Study|Adverse Event|46|||
143267564|NCT00809354|516535170|FG009|Overall Study|Adverse Event|26|||
143267565|NCT00809354|516535161|FG000|Overall Study|Lack of Efficacy|23|||
143267566|NCT00809354|516535162|FG001|Overall Study|Lack of Efficacy|23|||
143267567|NCT00809354|516535163|FG002|Overall Study|Lack of Efficacy|22|||
143267568|NCT00809354|516535164|FG003|Overall Study|Lack of Efficacy|15|||
143267569|NCT00809354|516535165|FG004|Overall Study|Lack of Efficacy|40|||
143267570|NCT00809354|516535166|FG005|Overall Study|Lack of Efficacy|19|||
143267571|NCT00809354|516535167|FG006|Overall Study|Lack of Efficacy|21|||
143267572|NCT00809354|516535168|FG007|Overall Study|Lack of Efficacy|15|||
143267573|NCT00809354|516535169|FG008|Overall Study|Lack of Efficacy|18|||
143267574|NCT00809354|516535170|FG009|Overall Study|Lack of Efficacy|38|||
143267575|NCT00809354|516535161|FG000|Overall Study|Lost to Follow-up|10|||
143267576|NCT00809354|516535162|FG001|Overall Study|Lost to Follow-up|11|||
143267577|NCT00809354|516535163|FG002|Overall Study|Lost to Follow-up|8|||
143267578|NCT00809354|516535164|FG003|Overall Study|Lost to Follow-up|13|||
143267579|NCT00809354|516535165|FG004|Overall Study|Lost to Follow-up|6|||
143267580|NCT00809354|516535166|FG005|Overall Study|Lost to Follow-up|2|||
143267581|NCT00809354|516535167|FG006|Overall Study|Lost to Follow-up|0|||
143267582|NCT00809354|516535168|FG007|Overall Study|Lost to Follow-up|5|||
143267583|NCT00809354|516535169|FG008|Overall Study|Lost to Follow-up|4|||
143267584|NCT00809354|516535170|FG009|Overall Study|Lost to Follow-up|0|||
143267585|NCT00809354|516535161|FG000|Overall Study|Protocol Violation|7|||
143267586|NCT00809354|516535162|FG001|Overall Study|Protocol Violation|14|||
143267587|NCT00809354|516535163|FG002|Overall Study|Protocol Violation|14|||
143267588|NCT00809354|516535164|FG003|Overall Study|Protocol Violation|12|||
143267589|NCT00809354|516535165|FG004|Overall Study|Protocol Violation|14|||
143267590|NCT00809354|516535166|FG005|Overall Study|Protocol Violation|6|||
143267591|NCT00809354|516535167|FG006|Overall Study|Protocol Violation|4|||
143267592|NCT00809354|516535168|FG007|Overall Study|Protocol Violation|6|||
143267593|NCT00809354|516535169|FG008|Overall Study|Protocol Violation|9|||
143267594|NCT00809354|516535170|FG009|Overall Study|Protocol Violation|3|||
143267595|NCT00809354|516535161|FG000|Overall Study|Withdrawal by Subject|32|||
143267596|NCT00809354|516535162|FG001|Overall Study|Withdrawal by Subject|27|||
143267597|NCT00809354|516535163|FG002|Overall Study|Withdrawal by Subject|31|||
143267598|NCT00809354|516535164|FG003|Overall Study|Withdrawal by Subject|33|||
143267599|NCT00809354|516535165|FG004|Overall Study|Withdrawal by Subject|34|||
143267600|NCT00809354|516535166|FG005|Overall Study|Withdrawal by Subject|29|||
143267601|NCT00809354|516535167|FG006|Overall Study|Withdrawal by Subject|27|||
143267602|NCT00809354|516535168|FG007|Overall Study|Withdrawal by Subject|19|||
143267603|NCT00809354|516535169|FG008|Overall Study|Withdrawal by Subject|18|||
143267604|NCT00809354|516535170|FG009|Overall Study|Withdrawal by Subject|20|||
143267605|NCT00809354|516535161|FG000|Overall Study|Other|10|||
143267606|NCT00809354|516535162|FG001|Overall Study|Other|2|||
143267607|NCT00809354|516535163|FG002|Overall Study|Other|7|||
143267608|NCT00809354|516535164|FG003|Overall Study|Other|10|||
143267609|NCT00809354|516535165|FG004|Overall Study|Other|5|||
143267610|NCT00809354|516535166|FG005|Overall Study|Other|3|||
143267611|NCT00809354|516535167|FG006|Overall Study|Other|2|||
143267612|NCT00809354|516535168|FG007|Overall Study|Other|3|||
143267613|NCT00809354|516535169|FG008|Overall Study|Other|4|||
143267614|NCT00809354|516535170|FG009|Overall Study|Other|3|||
143267615|NCT00809354|516535161|FG000|Overall Study|Study terminated by sponsor|138|||
143221795|NCT00700713|516359383|FG001|Overall Study|Withdrawal by Subject|0|||
143267616|NCT00809354|516535162|FG001|Overall Study|Study terminated by sponsor|134|||
143267617|NCT00809354|516535163|FG002|Overall Study|Study terminated by sponsor|129|||
143267618|NCT00809354|516535164|FG003|Overall Study|Study terminated by sponsor|120|||
143267619|NCT00809354|516535165|FG004|Overall Study|Study terminated by sponsor|126|||
143267620|NCT00809354|516535166|FG005|Overall Study|Study terminated by sponsor|133|||
143267621|NCT00809354|516535167|FG006|Overall Study|Study terminated by sponsor|124|||
143267622|NCT00809354|516535168|FG007|Overall Study|Study terminated by sponsor|148|||
143267623|NCT00809354|516535169|FG008|Overall Study|Study terminated by sponsor|127|||
143267624|NCT00809354|516535170|FG009|Overall Study|Study terminated by sponsor|135|||
143221796|NCT00700713|516359384|FG002|Overall Study|Withdrawal by Subject|1|||
143221797|NCT02864901|516359385|FG000|Overall Study|Withdrawal by Subject|1|||
143267625|NCT00809354|516535161|FG000|Overall Study|Withdrawn due to pregnancy|0|||
143372337|NCT03823300|516909498|FG001|Overall Study|Withdrawal by Subject|22|||
143372338|NCT03823300|516909497|FG000|Overall Study|Death|10|||
143372339|NCT03823300|516909498|FG001|Overall Study|Death|14|||
143372340|NCT03823300|516909497|FG000|Overall Study|Adverse Event|3|||
143372341|NCT03823300|516909498|FG001|Overall Study|Adverse Event|5|||
143372342|NCT03823300|516909497|FG000|Overall Study|Physician Decision|1|||
143372343|NCT03823300|516909498|FG001|Overall Study|Physician Decision|7|||
143372344|NCT03823300|516909497|FG000|Overall Study|Lost to Follow-up|1|||
143372345|NCT03823300|516909498|FG001|Overall Study|Lost to Follow-up|3|||
143372346|NCT03823300|516909497|FG000|Overall Study|Protocol Violation|1|||
143372347|NCT03823300|516909498|FG001|Overall Study|Protocol Violation|1|||
143372348|NCT03823300|516909497|FG000|Overall Study|Lack of Efficacy|1|||
143372349|NCT03823300|516909498|FG001|Overall Study|Lack of Efficacy|1|||
143372350|NCT03823300|516909497|FG000|Overall Study|Not Eligible|0|||
143372351|NCT03823300|516909498|FG001|Overall Study|Not Eligible|1|||
143372352|NCT03823300|516909497|FG000|Overall Study|Other|1|||
143372353|NCT03823300|516909498|FG001|Overall Study|Other|0|||
143372354|NCT00241644|516909502|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
143372355|NCT00241644|516909503|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
143372356|NCT00241644|516909504|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
143372357|NCT00241644|516909505|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
143372358|NCT00241644|516909502|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
143372359|NCT00241644|516909503|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
143372360|NCT00241644|516909504|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
143372361|NCT00241644|516909505|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
143372362|NCT00241644|516909502|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
143372363|NCT00241644|516909503|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
143372364|NCT00241644|516909504|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
143372365|NCT00241644|516909505|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
143372366|NCT00241644|516909502|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
143372367|NCT00241644|516909503|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
143372368|NCT00241644|516909504|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
143372369|NCT00241644|516909505|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
143372370|NCT00241644|516909502|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
143372371|NCT00241644|516909503|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
143372372|NCT00241644|516909504|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
143372373|NCT00241644|516909505|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
143372374|NCT00241644|516909502|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
143372375|NCT00241644|516909503|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
143372376|NCT00241644|516909504|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
143372377|NCT00241644|516909505|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
143372378|NCT00241644|516909502|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
143372379|NCT00241644|516909503|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
143372380|NCT00241644|516909504|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
143372381|NCT00241644|516909505|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
143372382|NCT00241644|516909502|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
143372383|NCT00241644|516909503|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
143372384|NCT00241644|516909504|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
143372385|NCT00241644|516909505|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
143372386|NCT00241644|516909502|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
143372387|NCT00241644|516909503|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
143372388|NCT00241644|516909504|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
143372389|NCT00241644|516909505|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
143372390|NCT00241644|516909502|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
143372391|NCT00241644|516909503|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
143221798|NCT02864901|516359386|FG001|Overall Study|Withdrawal by Subject|0|||
143221799|NCT05730387|516359387|FG000|Overall Study|Stillbirth|0|||
143221800|NCT05730387|516359388|FG001|Overall Study|Stillbirth|262|||
143221801|NCT05730387|516359387|FG000|Overall Study|Died during or after delivery|2|||
143221802|NCT05730387|516359388|FG001|Overall Study|Died during or after delivery|85|||
143221803|NCT05730387|516359387|FG000|Overall Study|Died after being admitted|0|||
143221804|NCT05730387|516359388|FG001|Overall Study|Died after being admitted|44|||
143221805|NCT05730387|516359387|FG000|Overall Study|Lost to Follow-up|69|||
143221806|NCT05730387|516359388|FG001|Overall Study|Lost to Follow-up|77|||
143267626|NCT00809354|516535162|FG001|Overall Study|Withdrawn due to pregnancy|1|||
143267627|NCT00809354|516535163|FG002|Overall Study|Withdrawn due to pregnancy|0|||
143267628|NCT00809354|516535164|FG003|Overall Study|Withdrawn due to pregnancy|0|||
143267629|NCT00809354|516535165|FG004|Overall Study|Withdrawn due to pregnancy|0|||
143267630|NCT00809354|516535166|FG005|Overall Study|Withdrawn due to pregnancy|0|||
143267631|NCT00809354|516535167|FG006|Overall Study|Withdrawn due to pregnancy|0|||
143221807|NCT02728089|516359389|FG000|Overall Study|Physician Decision|2|||
143221808|NCT02728089|516359389|FG000|Overall Study|Withdrawal by Subject|1|||
143221809|NCT01369784|516359390|FG000|Overall Study|Protocol Violation|12|||
143221810|NCT02905266|516359391|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
143267632|NCT00809354|516535168|FG007|Overall Study|Withdrawn due to pregnancy|0|||
143267633|NCT00809354|516535169|FG008|Overall Study|Withdrawn due to pregnancy|0|||
143267634|NCT00809354|516535170|FG009|Overall Study|Withdrawn due to pregnancy|0|||
143267635|NCT00809354|516535161|FG000|Overall Study|Randomized but not Treated|3|||
143267636|NCT00809354|516535162|FG001|Overall Study|Randomized but not Treated|1|||
143267637|NCT00809354|516535163|FG002|Overall Study|Randomized but not Treated|6|||
143267638|NCT00809354|516535164|FG003|Overall Study|Randomized but not Treated|0|||
143267639|NCT00809354|516535165|FG004|Overall Study|Randomized but not Treated|5|||
143267640|NCT00809354|516535166|FG005|Overall Study|Randomized but not Treated|0|||
143267641|NCT00809354|516535167|FG006|Overall Study|Randomized but not Treated|1|||
143267642|NCT00809354|516535168|FG007|Overall Study|Randomized but not Treated|1|||
143267643|NCT00809354|516535169|FG008|Overall Study|Randomized but not Treated|2|||
143267644|NCT00809354|516535170|FG009|Overall Study|Randomized but not Treated|1|||
143267645|NCT00809354|516535161|FG000|Overall Study|Death|0|||
143267646|NCT00809354|516535162|FG001|Overall Study|Death|0|||
143267647|NCT00809354|516535163|FG002|Overall Study|Death|0|||
143267648|NCT00809354|516535164|FG003|Overall Study|Death|0|||
143267649|NCT00809354|516535165|FG004|Overall Study|Death|0|||
143267650|NCT00809354|516535166|FG005|Overall Study|Death|0|||
143267651|NCT00809354|516535167|FG006|Overall Study|Death|0|||
143267652|NCT00809354|516535168|FG007|Overall Study|Death|1|||
143267653|NCT00809354|516535169|FG008|Overall Study|Death|0|||
143267654|NCT00809354|516535170|FG009|Overall Study|Death|0|||
143267655|NCT03114488|516535173|FG000|Time Period 2|Withdrawal by Subject|1|||
143267656|NCT03114488|516535174|FG001|Time Period 2|Withdrawal by Subject|3|||
143267657|NCT01199731|516535175|FG000|Overall Study|Adverse Event|0|||
143267658|NCT01199731|516535176|FG001|Overall Study|Adverse Event|1|||
143267659|NCT01199731|516535177|FG002|Overall Study|Adverse Event|0|||
143267660|NCT01199731|516535175|FG000|Overall Study|Study closed/terminated|7|||
143267661|NCT01199731|516535176|FG001|Overall Study|Study closed/terminated|9|||
143267662|NCT01199731|516535177|FG002|Overall Study|Study closed/terminated|7|||
143267663|NCT01199731|516535175|FG000|Overall Study|Lost to Follow-up|0|||
143267664|NCT01199731|516535176|FG001|Overall Study|Lost to Follow-up|0|||
143267665|NCT01199731|516535177|FG002|Overall Study|Lost to Follow-up|2|||
143267666|NCT01199731|516535175|FG000|Overall Study|Physician Decision|0|||
143267667|NCT01199731|516535176|FG001|Overall Study|Physician Decision|1|||
143267668|NCT01199731|516535177|FG002|Overall Study|Physician Decision|1|||
143267669|NCT01199731|516535175|FG000|Overall Study|Withdrawal by Subject|2|||
143267670|NCT01199731|516535176|FG001|Overall Study|Withdrawal by Subject|0|||
143267671|NCT01199731|516535177|FG002|Overall Study|Withdrawal by Subject|0|||
143267672|NCT01465191|516535178|FG000|Overall Study|Protocol Violation|6|||
143267673|NCT01465191|516535179|FG001|Overall Study|Protocol Violation|3|||
143267674|NCT01465191|516535180|FG002|Overall Study|Protocol Violation|3|||
143267675|NCT01465191|516535178|FG000|Overall Study|Lost to Follow-up|3|||
143267676|NCT01465191|516535179|FG001|Overall Study|Lost to Follow-up|6|||
143267677|NCT01465191|516535180|FG002|Overall Study|Lost to Follow-up|4|||
143267678|NCT00943124|516535181|FG000|Period 1|Withdrawal by Subject|1|||
143267679|NCT00943124|516535182|FG001|Period 1|Withdrawal by Subject|1|||
143267680|NCT00943124|516535181|FG000|Period 1|Did Not Follow Study Procedures|1|||
143267681|NCT00943124|516535182|FG001|Period 1|Did Not Follow Study Procedures|0|||
143267682|NCT00943124|516535181|FG000|Period 1|Personal Reasons|0|||
143267683|NCT00943124|516535182|FG001|Period 1|Personal Reasons|1|||
143267684|NCT02992132|516535183|FG000|Overall Study|Adverse Event|4|||
143267685|NCT02992132|516535184|FG001|Overall Study|Adverse Event|1|||
143267686|NCT02992132|516535185|FG002|Overall Study|Adverse Event|3|||
143267687|NCT02992132|516535183|FG000|Overall Study|Lack of Efficacy|2|||
143267688|NCT02992132|516535184|FG001|Overall Study|Lack of Efficacy|0|||
143267689|NCT02992132|516535185|FG002|Overall Study|Lack of Efficacy|0|||
143267690|NCT02992132|516535183|FG000|Overall Study|Non-compliance with study drug|2|||
143267691|NCT02992132|516535184|FG001|Overall Study|Non-compliance with study drug|0|||
143267692|NCT02992132|516535185|FG002|Overall Study|Non-compliance with study drug|0|||
143267693|NCT02992132|516535183|FG000|Overall Study|Progressive disease|1|||
143267694|NCT02992132|516535184|FG001|Overall Study|Progressive disease|0|||
143267695|NCT02992132|516535185|FG002|Overall Study|Progressive disease|0|||
143267696|NCT02992132|516535183|FG000|Overall Study|Protocol Violation|2|||
143267697|NCT02992132|516535184|FG001|Overall Study|Protocol Violation|2|||
143267698|NCT02992132|516535185|FG002|Overall Study|Protocol Violation|0|||
143267699|NCT02992132|516535183|FG000|Overall Study|Caregiver withdrew consent|2|||
143267700|NCT02992132|516535184|FG001|Overall Study|Caregiver withdrew consent|3|||
143267701|NCT02992132|516535185|FG002|Overall Study|Caregiver withdrew consent|2|||
143267702|NCT02992132|516535183|FG000|Overall Study|Withdrawal by Subject|0|||
143267703|NCT02992132|516535184|FG001|Overall Study|Withdrawal by Subject|2|||
143221811|NCT02905266|516359392|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
143221812|NCT02905266|516359391|FG000|Treatment Phase Part 1|Disease Progression|6|||
143372392|NCT00241644|516909504|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
143221813|NCT02905266|516359392|FG001|Treatment Phase Part 1|Disease Progression|7|||
143221814|NCT02905266|516359391|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
143221815|NCT02905266|516359392|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
143221816|NCT02905266|516359391|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
143221817|NCT02905266|516359392|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
143221818|NCT02905266|516359391|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
143221819|NCT02905266|516359392|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
143221820|NCT02905266|516359391|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
143221821|NCT02905266|516359392|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
143221822|NCT02905266|516359391|FG000|Transition From Part 1 to Part 2|Death|0|||
143221823|NCT02905266|516359392|FG001|Transition From Part 1 to Part 2|Death|1|||
143221824|NCT02905266|516359391|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
143221825|NCT02905266|516359392|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
143221826|NCT02905266|516359391|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
143221827|NCT02905266|516359392|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
143221828|NCT02905266|516359391|FG000|Maintenance Phase Part 2|Disease Progression|9|||
143221829|NCT02905266|516359392|FG001|Maintenance Phase Part 2|Disease Progression|2|||
143221830|NCT02905266|516359391|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
143221831|NCT02905266|516359392|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
143221832|NCT02905266|516359391|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
143221833|NCT02905266|516359392|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
143221834|NCT02292719|516359398|FG000|Overall Study|Withdrawal by Subject|0|||
143221835|NCT02292719|516359399|FG001|Overall Study|Withdrawal by Subject|0|||
143221836|NCT02292719|516359400|FG002|Overall Study|Withdrawal by Subject|0|||
143372393|NCT00241644|516909505|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
143372394|NCT00241644|516909502|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
143372395|NCT00241644|516909503|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
143221837|NCT02292719|516359401|FG003|Overall Study|Withdrawal by Subject|1|||
143221838|NCT02292719|516359402|FG004|Overall Study|Withdrawal by Subject|1|||
143221839|NCT02292719|516359403|FG005|Overall Study|Withdrawal by Subject|0|||
143221840|NCT02292719|516359398|FG000|Overall Study|Subject enrolled in new study.|0|||
143221841|NCT02292719|516359399|FG001|Overall Study|Subject enrolled in new study.|0|||
143221842|NCT02292719|516359400|FG002|Overall Study|Subject enrolled in new study.|1|||
143221843|NCT02292719|516359401|FG003|Overall Study|Subject enrolled in new study.|0|||
143221844|NCT02292719|516359402|FG004|Overall Study|Subject enrolled in new study.|0|||
143221845|NCT02292719|516359403|FG005|Overall Study|Subject enrolled in new study.|0|||
143221846|NCT00596752|516359404|FG000|Overall Study|Other Reason|44|||
143221847|NCT00596752|516359405|FG001|Overall Study|Other Reason|49|||
143221848|NCT00596752|516359404|FG000|Overall Study|Adverse Event|34|||
143221849|NCT00596752|516359405|FG001|Overall Study|Adverse Event|34|||
143221850|NCT00596752|516359404|FG000|Overall Study|Lost to Follow-up|22|||
143372396|NCT00241644|516909504|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
143372397|NCT00241644|516909505|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
143372398|NCT00241644|516909502|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
143372399|NCT00241644|516909503|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
143221851|NCT00596752|516359405|FG001|Overall Study|Lost to Follow-up|38|||
143221852|NCT00596752|516359404|FG000|Overall Study|Withdrawal by Subject|12|||
143221853|NCT00596752|516359405|FG001|Overall Study|Withdrawal by Subject|9|||
143221854|NCT00596752|516359404|FG000|Overall Study|Unsatisfactory Compliance|9|||
143221855|NCT00596752|516359405|FG001|Overall Study|Unsatisfactory Compliance|6|||
143221856|NCT00596752|516359404|FG000|Overall Study|Lack of Efficacy|4|||
143221857|NCT00596752|516359405|FG001|Overall Study|Lack of Efficacy|7|||
143221858|NCT00596752|516359404|FG000|Overall Study|Protocol Violation|1|||
143221859|NCT00596752|516359405|FG001|Overall Study|Protocol Violation|0|||
143221860|NCT02940496|516359408|FG000|Overall Study|Adverse Event|1|||
143221861|NCT02940496|516359409|FG001|Overall Study|Adverse Event|0|||
143221862|NCT02940496|516359408|FG000|Overall Study|Death|2|||
143221863|NCT02940496|516359409|FG001|Overall Study|Death|0|||
143221864|NCT02940496|516359408|FG000|Overall Study|Hospice Care|1|||
143221865|NCT02940496|516359409|FG001|Overall Study|Hospice Care|0|||
143221866|NCT02940496|516359408|FG000|Overall Study|No MRE Done|1|||
143221867|NCT02940496|516359409|FG001|Overall Study|No MRE Done|0|||
143221868|NCT02940496|516359408|FG000|Overall Study|MRE Failure|1|||
143221869|NCT02940496|516359409|FG001|Overall Study|MRE Failure|0|||
143221870|NCT02586727|516359410|FG000|Overall Study|Lost to Follow-up|1|||
143221871|NCT02586727|516359411|FG001|Overall Study|Lost to Follow-up|0|||
143221872|NCT05973006|516359412|FG000|Overall Study|Early termination|3|||
143221873|NCT05973006|516359413|FG001|Overall Study|Early termination|9|||
143221874|NCT05167825|516359414|FG000|Overall Study|Ongoing|3|||
143221875|NCT02326597|516359419|FG000|Overall Study|Lost to Follow-up|42|||
143221876|NCT02326597|516359420|FG001|Overall Study|Lost to Follow-up|32|||
143221877|NCT04089761|516359423|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
143221878|NCT04089761|516359423|FG000|"Run In Phase"|Lost to Follow-up|1|||
143221879|NCT04089761|516359423|FG000|"Treatment Phase"|No evaluable data|5|||
143221880|NCT04089761|516359423|FG000|"Treatment Phase"|Lost to Follow-up|1|||
143267704|NCT02992132|516535185|FG002|Overall Study|Withdrawal by Subject|1|||
143221881|NCT00770601|516359424|FG000|Overall Study|Withdrawal by Subject|1|||
143221882|NCT00428948|516359426|FG000|Overall Study|Lost to Follow-up|15|||
143267705|NCT02992132|516535183|FG000|Overall Study|Physician Decision|0|||
143221883|NCT00428948|516359427|FG001|Overall Study|Lost to Follow-up|8|||
143221884|NCT00428948|516359426|FG000|Overall Study|Adverse Event|148|||
143221885|NCT00428948|516359427|FG001|Overall Study|Adverse Event|24|||
143221886|NCT00428948|516359426|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
143221887|NCT00428948|516359427|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
143221888|NCT00428948|516359426|FG000|Overall Study|Investigator Withdrew Subject|3|||
143221889|NCT00428948|516359427|FG001|Overall Study|Investigator Withdrew Subject|4|||
143221890|NCT00428948|516359426|FG000|Overall Study|Subject Withdrew Consent|50|||
143221891|NCT00428948|516359427|FG001|Overall Study|Subject Withdrew Consent|30|||
143221892|NCT00428948|516359426|FG000|Overall Study|Protocol Deviation|1|||
143221893|NCT00428948|516359427|FG001|Overall Study|Protocol Deviation|1|||
143221894|NCT05907395|516359430|FG000|Period 1|No longer met eligibility criteria|0|||
143267706|NCT02992132|516535184|FG001|Overall Study|Physician Decision|0|||
143267707|NCT02992132|516535185|FG002|Overall Study|Physician Decision|1|||
143267708|NCT00470847|516535188|FG000|Overall Study|Pt still receiving treatment|1|||
143267709|NCT00764491|516535194|FG000|Overall Study|Lost to Follow-up|35|||
143267710|NCT00764491|516535195|FG001|Overall Study|Lost to Follow-up|17|||
143267711|NCT00620464|516535196|FG000|Overall Study|Adverse Event|15|||
143267712|NCT00620464|516535197|FG001|Overall Study|Adverse Event|17|||
143267713|NCT00620464|516535196|FG000|Overall Study|Lost to Follow-up|1|||
143267714|NCT00620464|516535197|FG001|Overall Study|Lost to Follow-up|1|||
143267715|NCT00620464|516535196|FG000|Overall Study|Planning Pregnancy|1|||
143221895|NCT05907395|516359431|FG001|Period 1|No longer met eligibility criteria|1|||
143221896|NCT05907395|516359432|FG002|Period 1|No longer met eligibility criteria|0|||
143221897|NCT05907395|516359433|FG003|Period 1|No longer met eligibility criteria|0|||
143221898|NCT05907395|516359434|FG004|Period 1|No longer met eligibility criteria|0|||
143221899|NCT05907395|516359435|FG005|Period 1|No longer met eligibility criteria|1|||
143221900|NCT05907395|516359436|FG006|Period 1|No longer met eligibility criteria|1|||
143221901|NCT05907395|516359437|FG007|Period 1|No longer met eligibility criteria|0|||
143221902|NCT05907395|516359438|FG008|Period 1|No longer met eligibility criteria|0|||
143221903|NCT05907395|516359439|FG009|Period 1|No longer met eligibility criteria|0|||
143221904|NCT05907395|516359440|FG010|Period 1|No longer met eligibility criteria|0|||
143221905|NCT05907395|516359441|FG011|Period 1|No longer met eligibility criteria|0|||
143221906|NCT05907395|516359430|FG000|Period 2|Adverse Event|0|||
143221907|NCT05907395|516359431|FG001|Period 2|Adverse Event|0|||
143221908|NCT05907395|516359432|FG002|Period 2|Adverse Event|0|||
143221909|NCT05907395|516359433|FG003|Period 2|Adverse Event|1|||
143221910|NCT05907395|516359434|FG004|Period 2|Adverse Event|0|||
143221911|NCT05907395|516359435|FG005|Period 2|Adverse Event|0|||
143221912|NCT05907395|516359436|FG006|Period 2|Adverse Event|0|||
143221913|NCT05907395|516359437|FG007|Period 2|Adverse Event|1|||
143221914|NCT05907395|516359438|FG008|Period 2|Adverse Event|0|||
143221915|NCT05907395|516359439|FG009|Period 2|Adverse Event|0|||
143221916|NCT05907395|516359440|FG010|Period 2|Adverse Event|0|||
143221917|NCT05907395|516359441|FG011|Period 2|Adverse Event|0|||
143221918|NCT05907395|516359430|FG000|Period 2|Personal reason|0|||
143221919|NCT05907395|516359431|FG001|Period 2|Personal reason|0|||
143221920|NCT05907395|516359432|FG002|Period 2|Personal reason|0|||
143221921|NCT05907395|516359433|FG003|Period 2|Personal reason|0|||
143221922|NCT05907395|516359434|FG004|Period 2|Personal reason|0|||
143221923|NCT05907395|516359435|FG005|Period 2|Personal reason|0|||
143221924|NCT05907395|516359436|FG006|Period 2|Personal reason|0|||
143221925|NCT05907395|516359437|FG007|Period 2|Personal reason|0|||
143221926|NCT05907395|516359438|FG008|Period 2|Personal reason|0|||
143267716|NCT00620464|516535197|FG001|Overall Study|Planning Pregnancy|4|||
143267717|NCT00620464|516535196|FG000|Overall Study|Personal|2|||
143267718|NCT00620464|516535197|FG001|Overall Study|Personal|2|||
143267719|NCT00620464|516535196|FG000|Overall Study|Used prohibited medication|1|||
143372400|NCT00241644|516909504|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
143372401|NCT00241644|516909505|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
143372402|NCT00241644|516909502|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
143221927|NCT05907395|516359439|FG009|Period 2|Personal reason|1|||
143221928|NCT05907395|516359440|FG010|Period 2|Personal reason|0|||
143267720|NCT00620464|516535197|FG001|Overall Study|Used prohibited medication|0|||
143267721|NCT05394350|516535198|FG000|Overall Study|Death|2|||
143267722|NCT05394350|516535199|FG001|Overall Study|Death|2|||
143372403|NCT00241644|516909503|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
143267723|NCT05394350|516535200|FG002|Overall Study|Death|4|||
143372404|NCT00241644|516909504|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
143372405|NCT00241644|516909505|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
143221929|NCT05907395|516359441|FG011|Period 2|Personal reason|0|||
143221930|NCT05907395|516359430|FG000|Period 3|Adverse Event|0|||
143267724|NCT05394350|516535201|FG003|Overall Study|Death|0|||
143267725|NCT05394350|516535202|FG004|Overall Study|Death|1|||
143221931|NCT05907395|516359431|FG001|Period 3|Adverse Event|0|||
143221932|NCT05907395|516359432|FG002|Period 3|Adverse Event|0|||
143221933|NCT05907395|516359433|FG003|Period 3|Adverse Event|0|||
143221934|NCT05907395|516359434|FG004|Period 3|Adverse Event|1|||
143221935|NCT05907395|516359435|FG005|Period 3|Adverse Event|0|||
143221936|NCT05907395|516359436|FG006|Period 3|Adverse Event|0|||
143221937|NCT05907395|516359437|FG007|Period 3|Adverse Event|0|||
143267726|NCT05394350|516535203|FG005|Overall Study|Death|0|||
143267727|NCT05394350|516535198|FG000|Overall Study|Study terminated by sponsor|1|||
143221938|NCT05907395|516359438|FG008|Period 3|Adverse Event|0|||
143221939|NCT05907395|516359439|FG009|Period 3|Adverse Event|0|||
143221940|NCT05907395|516359440|FG010|Period 3|Adverse Event|0|||
143221941|NCT05907395|516359441|FG011|Period 3|Adverse Event|0|||
143221942|NCT04544956|516359442|FG000|Overall Study|Withdrawal by Subject|1|||
143221943|NCT02119663|516359443|FG000|Overall Study|Disease progression|26|||
143221944|NCT02119663|516359444|FG001|Overall Study|Disease progression|27|||
143221945|NCT02119663|516359443|FG000|Overall Study|Adverse Event|5|||
143221946|NCT02119663|516359444|FG001|Overall Study|Adverse Event|5|||
143221947|NCT02119663|516359443|FG000|Overall Study|Death|3|||
143221948|NCT02119663|516359444|FG001|Overall Study|Death|2|||
143221949|NCT02119663|516359443|FG000|Overall Study|Physician Decision|1|||
143221950|NCT02119663|516359444|FG001|Overall Study|Physician Decision|2|||
143221951|NCT02119663|516359443|FG000|Overall Study|Other unspecified|2|||
143221952|NCT02119663|516359444|FG001|Overall Study|Other unspecified|0|||
143221953|NCT02119663|516359443|FG000|Overall Study|Subject decision|0|||
143221954|NCT02119663|516359444|FG001|Overall Study|Subject decision|1|||
143221955|NCT02119663|516359443|FG000|Overall Study|Study Terminated by the Sponsor|3|||
143221956|NCT02119663|516359444|FG001|Overall Study|Study Terminated by the Sponsor|4|||
143221957|NCT00699660|516359445|FG000|Overall Study|Lost to Follow-up|4|||
143221958|NCT00699660|516359446|FG001|Overall Study|Lost to Follow-up|2|||
143221959|NCT00699660|516359445|FG000|Overall Study|missing reports and recording failures|10|||
143221960|NCT00699660|516359446|FG001|Overall Study|missing reports and recording failures|6|||
143221961|NCT00103740|516359449|FG000|Period 1 - Core|Adverse Event|1|||
143221962|NCT00103740|516359450|FG001|Period 1 - Core|Adverse Event|0|||
143221963|NCT00103740|516359449|FG000|Period 1 - Core|Protocol Violation|3|||
143221964|NCT00103740|516359450|FG001|Period 1 - Core|Protocol Violation|2|||
143221965|NCT00103740|516359449|FG000|Period 1 - Core|Patient withdrew consent|3|||
143221966|NCT00103740|516359450|FG001|Period 1 - Core|Patient withdrew consent|2|||
143221967|NCT00103740|516359449|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
143221968|NCT00103740|516359450|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
143221969|NCT00103740|516359449|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
143221970|NCT00103740|516359450|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
143221971|NCT00103740|516359449|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
143221972|NCT00103740|516359450|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
143221973|NCT00103740|516359449|FG000|Period 2 - Extended Observation Period|Death|6|||
143221974|NCT00103740|516359450|FG001|Period 2 - Extended Observation Period|Death|2|||
143221975|NCT00103740|516359449|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
143221976|NCT00103740|516359450|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
143221977|NCT00940498|516359452|FG000|Overall Study|Death|2|||
143221978|NCT00940498|516359453|FG001|Overall Study|Death|0|||
143267728|NCT05394350|516535199|FG001|Overall Study|Study terminated by sponsor|1|||
143267729|NCT05394350|516535200|FG002|Overall Study|Study terminated by sponsor|7|||
143267730|NCT05394350|516535201|FG003|Overall Study|Study terminated by sponsor|3|||
143267731|NCT05394350|516535202|FG004|Overall Study|Study terminated by sponsor|2|||
143267732|NCT05394350|516535203|FG005|Overall Study|Study terminated by sponsor|4|||
143267733|NCT03911154|516535204|FG000|Overall Study|Withdrawal by Subject|1|||
143267734|NCT01231347|516535205|FG000|Overall Study|Full Consent withdrawn|19|||
143267735|NCT01231347|516535206|FG001|Overall Study|Full Consent withdrawn|19|||
143267736|NCT01231347|516535207|FG002|Overall Study|Full Consent withdrawn|11|||
143267737|NCT01231347|516535205|FG000|Overall Study|Lost to Follow-up|4|||
143267738|NCT01231347|516535206|FG001|Overall Study|Lost to Follow-up|2|||
143267739|NCT01231347|516535207|FG002|Overall Study|Lost to Follow-up|2|||
143267740|NCT01231347|516535205|FG000|Overall Study|Death|202|||
143267741|NCT01231347|516535206|FG001|Overall Study|Death|210|||
143267742|NCT01231347|516535207|FG002|Overall Study|Death|101|||
143267743|NCT01231347|516535205|FG000|Overall Study|other event|7|||
143267744|NCT01231347|516535206|FG001|Overall Study|other event|9|||
143267745|NCT01231347|516535207|FG002|Overall Study|other event|3|||
143267746|NCT01460368|516535208|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
143267747|NCT01460368|516535209|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
143372406|NCT03804918|516909506|FG000|Overall Study|Participant did not use the app|1|||
143221979|NCT00940498|516359454|FG002|Overall Study|Death|0|||
143221980|NCT00940498|516359455|FG003|Overall Study|Death|1|||
143221981|NCT00940498|516359456|FG004|Overall Study|Death|5|||
143221982|NCT00940498|516359457|FG005|Overall Study|Death|0|||
143221983|NCT00940498|516359458|FG006|Overall Study|Death|1|||
143221984|NCT00940498|516359459|FG007|Overall Study|Death|0|||
143221985|NCT00940498|516359452|FG000|Overall Study|Lost to Follow-up|1|||
143267748|NCT01460368|516535210|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
143267749|NCT01460368|516535211|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
143267750|NCT01460368|516535212|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
143267751|NCT01460368|516535213|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
143267752|NCT01460368|516535214|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
143267753|NCT01460368|516535208|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
143221986|NCT00940498|516359453|FG001|Overall Study|Lost to Follow-up|1|||
143221987|NCT00940498|516359454|FG002|Overall Study|Lost to Follow-up|2|||
143221988|NCT00940498|516359455|FG003|Overall Study|Lost to Follow-up|0|||
143221989|NCT00940498|516359456|FG004|Overall Study|Lost to Follow-up|1|||
143221990|NCT00940498|516359457|FG005|Overall Study|Lost to Follow-up|0|||
143221991|NCT00940498|516359458|FG006|Overall Study|Lost to Follow-up|0|||
143221992|NCT00940498|516359459|FG007|Overall Study|Lost to Follow-up|1|||
143221993|NCT00940498|516359452|FG000|Overall Study|Disease Progression|0|||
143221994|NCT00940498|516359453|FG001|Overall Study|Disease Progression|0|||
143221995|NCT00940498|516359454|FG002|Overall Study|Disease Progression|1|||
143221996|NCT00940498|516359455|FG003|Overall Study|Disease Progression|1|||
143221997|NCT00940498|516359456|FG004|Overall Study|Disease Progression|0|||
143221998|NCT00940498|516359457|FG005|Overall Study|Disease Progression|1|||
143221999|NCT00940498|516359458|FG006|Overall Study|Disease Progression|0|||
143222000|NCT00940498|516359459|FG007|Overall Study|Disease Progression|0|||
143222001|NCT00940498|516359452|FG000|Overall Study|Physician Decision|0|||
143222002|NCT00940498|516359453|FG001|Overall Study|Physician Decision|0|||
143222003|NCT00940498|516359454|FG002|Overall Study|Physician Decision|0|||
143222004|NCT00940498|516359455|FG003|Overall Study|Physician Decision|0|||
143222005|NCT00940498|516359456|FG004|Overall Study|Physician Decision|2|||
143222006|NCT00940498|516359457|FG005|Overall Study|Physician Decision|0|||
143222007|NCT00940498|516359458|FG006|Overall Study|Physician Decision|0|||
143222008|NCT00940498|516359459|FG007|Overall Study|Physician Decision|0|||
143222009|NCT00940498|516359452|FG000|Overall Study|Not treated due to disease related pain|0|||
143222010|NCT00940498|516359453|FG001|Overall Study|Not treated due to disease related pain|0|||
143222011|NCT00940498|516359454|FG002|Overall Study|Not treated due to disease related pain|0|||
143222012|NCT00940498|516359455|FG003|Overall Study|Not treated due to disease related pain|0|||
143222013|NCT00940498|516359456|FG004|Overall Study|Not treated due to disease related pain|1|||
143222014|NCT00940498|516359457|FG005|Overall Study|Not treated due to disease related pain|0|||
143222015|NCT00940498|516359458|FG006|Overall Study|Not treated due to disease related pain|0|||
143222016|NCT00940498|516359459|FG007|Overall Study|Not treated due to disease related pain|0|||
143222017|NCT01657292|516359460|FG000|Overall Study|Adverse Event|6|||
143222018|NCT01657292|516359460|FG000|Overall Study|Withdrawal by Subject|2|||
143222019|NCT01657292|516359460|FG000|Overall Study|Violation of eligibility criteria|1|||
143222020|NCT01657292|516359460|FG000|Overall Study|Change of therapy|1|||
143222021|NCT00650845|516359462|FG000|Overall Study|Withdrawal by Subject|5|||
143222022|NCT00650845|516359463|FG001|Overall Study|Withdrawal by Subject|0|||
143222023|NCT00650845|516359462|FG000|Overall Study|Protocol Violation|0|||
143222024|NCT00650845|516359463|FG001|Overall Study|Protocol Violation|13|||
143222025|NCT01900652|516359464|FG000|Overall Study|Progressive Disease|1|||
143222026|NCT01900652|516359465|FG001|Overall Study|Progressive Disease|0|||
143222027|NCT01900652|516359464|FG000|Overall Study|Consent withdrawn by subject|1|||
143222028|NCT01900652|516359465|FG001|Overall Study|Consent withdrawn by subject|1|||
143222029|NCT01900652|516359464|FG000|Overall Study|Death|3|||
143222030|NCT01900652|516359465|FG001|Overall Study|Death|0|||
143222031|NCT01900652|516359464|FG000|Overall Study|Adverse Event|2|||
143222032|NCT01900652|516359465|FG001|Overall Study|Adverse Event|1|||
143222033|NCT01900652|516359464|FG000|Overall Study|Physician Decision|1|||
143222034|NCT01900652|516359465|FG001|Overall Study|Physician Decision|1|||
143222035|NCT02663622|516359468|FG000|Overall Study|Death|3|||
143222036|NCT02663622|516359469|FG001|Overall Study|Death|1|||
143222037|NCT02663622|516359470|FG002|Overall Study|Death|1|||
143222038|NCT02663622|516359471|FG003|Overall Study|Death|8|||
143222039|NCT02663622|516359468|FG000|Overall Study|Protocol Violation|0|||
143222040|NCT02663622|516359469|FG001|Overall Study|Protocol Violation|0|||
143222041|NCT02663622|516359470|FG002|Overall Study|Protocol Violation|0|||
143222042|NCT02663622|516359471|FG003|Overall Study|Protocol Violation|1|||
143222043|NCT04618744|516359472|FG000|Overall Study|Adverse Event|0|||
143222044|NCT04618744|516359473|FG001|Overall Study|Adverse Event|1|||
143222045|NCT04618744|516359472|FG000|Overall Study|Withdrawal by Subject|0|||
143222046|NCT04618744|516359473|FG001|Overall Study|Withdrawal by Subject|1|||
143222047|NCT00930930|516359474|FG000|Overall Study|Death|1|||
143222048|NCT00930930|516359475|FG001|Overall Study|Death|0|||
143222049|NCT00930930|516359474|FG000|Overall Study|Physician Decision|1|||
143222050|NCT00930930|516359475|FG001|Overall Study|Physician Decision|0|||
143222051|NCT00930930|516359474|FG000|Overall Study|Adverse Event|13|||
143222052|NCT00930930|516359475|FG001|Overall Study|Adverse Event|3|||
143222053|NCT00930930|516359474|FG000|Overall Study|Withdrawal by Subject|3|||
143222054|NCT00930930|516359475|FG001|Overall Study|Withdrawal by Subject|1|||
143222055|NCT00930930|516359474|FG000|Overall Study|Disease progression|2|||
143222056|NCT00930930|516359475|FG001|Overall Study|Disease progression|3|||
143267754|NCT01460368|516535209|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
143267755|NCT01460368|516535210|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
143267756|NCT01460368|516535211|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
143267757|NCT01460368|516535212|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
143267758|NCT01460368|516535213|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
143267759|NCT01460368|516535214|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
143372407|NCT02506257|516909507|FG000|Overall Study|Adverse Event|0|||
143372408|NCT02506257|516909508|FG001|Overall Study|Adverse Event|2|||
143372409|NCT02506257|516909509|FG002|Overall Study|Adverse Event|3|||
143372410|NCT02506257|516909510|FG003|Overall Study|Adverse Event|0|||
143372411|NCT02506257|516909507|FG000|Overall Study|Protocol Violation|0|||
143372412|NCT02506257|516909508|FG001|Overall Study|Protocol Violation|0|||
143372413|NCT02506257|516909509|FG002|Overall Study|Protocol Violation|1|||
143222057|NCT00930930|516359474|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
143222058|NCT00930930|516359475|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
143222059|NCT00930930|516359474|FG000|Overall Study|patients not compliant|1|||
143222060|NCT00930930|516359475|FG001|Overall Study|patients not compliant|1|||
143222061|NCT02709330|516359476|FG000|Overall Study|Death|5|||
143222062|NCT02709330|516359477|FG001|Overall Study|Death|0|||
143222063|NCT02709330|516359476|FG000|Overall Study|Lost to Follow-up|2|||
143222064|NCT02709330|516359477|FG001|Overall Study|Lost to Follow-up|0|||
143222065|NCT02709330|516359476|FG000|Overall Study|Physician Decision|2|||
143222066|NCT02709330|516359477|FG001|Overall Study|Physician Decision|0|||
143222067|NCT02709330|516359476|FG000|Overall Study|Withdrawal by Subject|4|||
143222068|NCT02709330|516359477|FG001|Overall Study|Withdrawal by Subject|0|||
143372414|NCT02506257|516909510|FG003|Overall Study|Protocol Violation|0|||
143372415|NCT00964366|516909511|FG000|Overall Study|Did not qualify at Day 1|1|||
143372416|NCT00964366|516909512|FG001|Overall Study|Did not qualify at Day 1|0|||
143372417|NCT00964366|516909511|FG000|Overall Study|Withdrawal by Subject|0|||
143372418|NCT00964366|516909512|FG001|Overall Study|Withdrawal by Subject|1|||
143372419|NCT01370694|516909513|FG000|Overall Study|Switched to rituximab|4|||
143372420|NCT01370694|516909513|FG000|Overall Study|Progressive disease|2|||
143372421|NCT02957539|516909516|FG000|Baseline to Week 16|Lost to Follow-up|8|||
143372422|NCT02957539|516909517|FG001|Baseline to Week 16|Lost to Follow-up|10|||
143372423|NCT02957539|516909518|FG002|Baseline to Week 16|Lost to Follow-up|16|||
143372424|NCT02957539|516909516|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
143372425|NCT02957539|516909517|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
143222069|NCT01467505|516361100|FG000|Overall Study|Adverse Event|1|||
143222070|NCT01467505|516361101|FG001|Overall Study|Adverse Event|0|||
143222071|NCT01467505|516361100|FG000|Overall Study|Withdrawal by Subject|4|||
143222072|NCT01467505|516361101|FG001|Overall Study|Withdrawal by Subject|0|||
143222073|NCT01467505|516361100|FG000|Overall Study|Study Terminated by Sponsor|28|||
143372426|NCT02957539|516909518|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
143372427|NCT02957539|516909516|FG000|Week 16 to 32|Withdrawal by Subject|3|||
143372428|NCT02957539|516909517|FG001|Week 16 to 32|Withdrawal by Subject|3|||
143222074|NCT01467505|516361101|FG001|Overall Study|Study Terminated by Sponsor|3|||
143222075|NCT03449758|516361102|FG000|Overall Study|Major protocol deviation|1|||
143222076|NCT03449758|516361102|FG000|Overall Study|Treatment inefficacy|5|||
143222077|NCT03449758|516361102|FG000|Overall Study|Adverse Event|9|||
143222078|NCT03449758|516361102|FG000|Overall Study|Consent withdrawal|1|||
143222079|NCT03449758|516361102|FG000|Overall Study|Other unspecified reason|3|||
143222080|NCT01550757|516361103|FG000|Overall Study|Lost to Follow-up|21|||
143222081|NCT01550757|516361104|FG001|Overall Study|Lost to Follow-up|14|||
143372429|NCT02957539|516909518|FG002|Week 16 to 32|Withdrawal by Subject|1|||
143222082|NCT01550757|516361105|FG002|Overall Study|Lost to Follow-up|42|||
143372430|NCT02957539|516909516|FG000|Week 16 to 32|Lost to Follow-up|8|||
143222083|NCT01550757|516361106|FG003|Overall Study|Lost to Follow-up|53|||
143222084|NCT01550757|516361103|FG000|Overall Study|Withdrawal by Subject|2|||
143222085|NCT01550757|516361104|FG001|Overall Study|Withdrawal by Subject|0|||
143222086|NCT01550757|516361105|FG002|Overall Study|Withdrawal by Subject|3|||
143222087|NCT01550757|516361106|FG003|Overall Study|Withdrawal by Subject|1|||
143222088|NCT03018691|516361110|FG000|Overall Study|Adverse Event|1|||
143222089|NCT03018691|516361111|FG001|Overall Study|Adverse Event|1|||
143222090|NCT03018691|516361112|FG002|Overall Study|Adverse Event|4|||
143222091|NCT03018691|516361110|FG000|Overall Study|Lack of Efficacy|0|||
143222092|NCT03018691|516361111|FG001|Overall Study|Lack of Efficacy|0|||
143222093|NCT03018691|516361112|FG002|Overall Study|Lack of Efficacy|1|||
143222094|NCT03018691|516361110|FG000|Overall Study|Withdrawal by Subject|0|||
143222095|NCT03018691|516361111|FG001|Overall Study|Withdrawal by Subject|0|||
143222096|NCT03018691|516361112|FG002|Overall Study|Withdrawal by Subject|1|||
143222097|NCT03018691|516361110|FG000|Overall Study|Withdrawal by parent/guardian|1|||
143222098|NCT03018691|516361111|FG001|Overall Study|Withdrawal by parent/guardian|0|||
143222099|NCT03018691|516361112|FG002|Overall Study|Withdrawal by parent/guardian|1|||
143222100|NCT01172535|516361113|FG000|Overall Study|Death|3|||
143222101|NCT01172535|516361113|FG000|Overall Study|Withdrawal by Subject|2|||
143222102|NCT01172535|516361113|FG000|Overall Study|Lost to Follow-up|1|||
143222103|NCT01172535|516361113|FG000|Overall Study|Ineligible at study entry|1|||
143222104|NCT01172535|516361113|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
143222105|NCT01020786|516361114|FG000|Induction Period|Entry Criteria Not Met|2|||
143222106|NCT01020786|516361114|FG000|Induction Period|Adverse Event|10|||
143222107|NCT01020786|516361114|FG000|Induction Period|Progressive Disease|31|||
143222108|NCT01020786|516361114|FG000|Induction Period|Investigator Decision|3|||
143222109|NCT01020786|516361114|FG000|Induction Period|Withdrawal by Subject|3|||
143222110|NCT01020786|516361114|FG000|Maintenance Period|Adverse Event|8|||
143222111|NCT01020786|516361114|FG000|Maintenance Period|Progressive Disease|43|||
143222112|NCT01020786|516361114|FG000|Maintenance Period|Withdrawal by Subject|8|||
143222113|NCT01020786|516361114|FG000|Maintenance Period|Sponsor Decision|1|||
143222114|NCT01818596|516361122|FG000|Overall Study|Enrolled but Not Treated|4|||
143222115|NCT01818596|516361123|FG001|Overall Study|Enrolled but Not Treated|0|||
143222116|NCT01818596|516361122|FG000|Overall Study|Adverse Event|7|||
143222117|NCT01818596|516361123|FG001|Overall Study|Adverse Event|0|||
143222118|NCT01818596|516361122|FG000|Overall Study|Death|3|||
143222119|NCT01818596|516361123|FG001|Overall Study|Death|0|||
143222120|NCT01818596|516361122|FG000|Overall Study|Investigator's Discretion|4|||
143222121|NCT01818596|516361123|FG001|Overall Study|Investigator's Discretion|0|||
143222122|NCT01818596|516361122|FG000|Overall Study|Protocol Violation|1|||
143222123|NCT01818596|516361123|FG001|Overall Study|Protocol Violation|0|||
143222124|NCT01818596|516361122|FG000|Overall Study|Withdrew Consent|5|||
143222125|NCT01818596|516361123|FG001|Overall Study|Withdrew Consent|0|||
143222126|NCT01818596|516361122|FG000|Overall Study|Lost to Follow-up|7|||
143222127|NCT01818596|516361123|FG001|Overall Study|Lost to Follow-up|0|||
143222128|NCT03461146|516361124|FG000|Overall Study|Adverse Event|2|||
143222129|NCT03461146|516361124|FG000|Overall Study|Physician Decision|1|||
143222130|NCT02915263|516361133|FG000|Overall Study|Covid|3|||
143222131|NCT02915263|516361134|FG001|Overall Study|Covid|2|||
143222132|NCT02478463|516361135|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
143222133|NCT02478463|516361135|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
143222134|NCT02478463|516361135|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
143222135|NCT01479868|516361141|FG000|Overall Study|Adverse Event|1|||
143222136|NCT01479868|516361141|FG000|Overall Study|Lost to Follow-up|4|||
143222137|NCT01479868|516361141|FG000|Overall Study|Protocol Violation|1|||
143222138|NCT01479868|516361141|FG000|Overall Study|Withdrawal by Subject|1|||
143222139|NCT01479868|516361141|FG000|Overall Study|Sponsor's Decision|1|||
143222140|NCT01479868|516361141|FG000|Overall Study|Initiation of new HCV Therapy|1|||
143222141|NCT01618669|516361142|FG000|Overall Study|Lost to Follow-up|1|||
143222142|NCT01618669|516361143|FG001|Overall Study|Lost to Follow-up|1|||
143222143|NCT01618669|516361142|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
143222144|NCT01618669|516361143|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
143222145|NCT01618669|516361142|FG000|Overall Study|Adverse Event|16|||
143222146|NCT01618669|516361143|FG001|Overall Study|Adverse Event|7|||
143222147|NCT01618669|516361142|FG000|Overall Study|Protocol Violation|5|||
143222148|NCT01618669|516361143|FG001|Overall Study|Protocol Violation|3|||
143222149|NCT01618669|516361142|FG000|Overall Study|Withdrawal by Subject|9|||
143222150|NCT01618669|516361143|FG001|Overall Study|Withdrawal by Subject|9|||
143222151|NCT01618669|516361142|FG000|Overall Study|Miscellaneous Reason|0|||
143222152|NCT01618669|516361143|FG001|Overall Study|Miscellaneous Reason|1|||
143222153|NCT01879683|516361144|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
143222154|NCT01177007|516361150|FG000|Overall Study|Lost to Follow-up|2|||
143222155|NCT01177007|516361150|FG000|Overall Study|Death|4|||
143222156|NCT01177007|516361150|FG000|Overall Study|Entered hospice care|5|||
143222157|NCT01177007|516361150|FG000|Overall Study|Required additional Y90 treatment|6|||
143222158|NCT01177007|516361150|FG000|Overall Study|Change in treatment modality|21|||
143222159|NCT03600740|516361152|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
143222160|NCT01702558|516361153|FG000|Overall Study|Withdrawal by Subject|0|||
143222161|NCT01702558|516361154|FG001|Overall Study|Withdrawal by Subject|0|||
143222162|NCT01702558|516361155|FG002|Overall Study|Withdrawal by Subject|0|||
143222163|NCT01702558|516361156|FG003|Overall Study|Withdrawal by Subject|12|||
143222164|NCT01702558|516361157|FG004|Overall Study|Withdrawal by Subject|4|||
143222165|NCT01702558|516361153|FG000|Overall Study|Lost to Follow-up|0|||
143222166|NCT01702558|516361154|FG001|Overall Study|Lost to Follow-up|0|||
143222167|NCT01702558|516361155|FG002|Overall Study|Lost to Follow-up|0|||
143222168|NCT01702558|516361156|FG003|Overall Study|Lost to Follow-up|3|||
143222169|NCT01702558|516361157|FG004|Overall Study|Lost to Follow-up|0|||
143222170|NCT01702558|516361153|FG000|Overall Study|Death|4|||
143267760|NCT01460368|516535208|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
143267761|NCT01460368|516535209|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
143267762|NCT01460368|516535210|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
143267763|NCT01460368|516535211|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
143267764|NCT01460368|516535212|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
143267765|NCT01460368|516535213|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
143267766|NCT01460368|516535214|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
143267767|NCT01460368|516535208|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
143267768|NCT01460368|516535209|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
143267769|NCT01460368|516535210|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
143267770|NCT01460368|516535211|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
143267771|NCT01460368|516535212|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
143267772|NCT01460368|516535213|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
143267773|NCT01460368|516535214|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
143267774|NCT01460368|516535208|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
143267775|NCT01460368|516535209|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
143267776|NCT01460368|516535210|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
143267777|NCT01460368|516535211|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
143267778|NCT01460368|516535212|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
143267779|NCT01460368|516535213|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
143267780|NCT01460368|516535214|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
143267781|NCT02322021|516535215|FG000|Core Phase|Adverse Event|1|||
143267782|NCT02322021|516535216|FG001|Core Phase|Adverse Event|3|||
143267783|NCT02322021|516535217|FG002|Core Phase|Adverse Event|4|||
143267784|NCT02322021|516535218|FG003|Core Phase|Adverse Event|2|||
143267785|NCT02322021|516535219|FG004|Core Phase|Adverse Event|0|||
143267786|NCT02322021|516535215|FG000|Core Phase|Participant Choice|4|||
143267787|NCT02322021|516535216|FG001|Core Phase|Participant Choice|5|||
143267788|NCT02322021|516535217|FG002|Core Phase|Participant Choice|4|||
143267789|NCT02322021|516535218|FG003|Core Phase|Participant Choice|2|||
143267790|NCT02322021|516535219|FG004|Core Phase|Participant Choice|0|||
143267791|NCT02322021|516535215|FG000|Core Phase|Lost to Follow-up|0|||
143267792|NCT02322021|516535216|FG001|Core Phase|Lost to Follow-up|0|||
143267793|NCT02322021|516535217|FG002|Core Phase|Lost to Follow-up|0|||
143267794|NCT02322021|516535218|FG003|Core Phase|Lost to Follow-up|1|||
143267795|NCT02322021|516535219|FG004|Core Phase|Lost to Follow-up|0|||
143267796|NCT02322021|516535215|FG000|Core Phase|Other|0|||
143267797|NCT02322021|516535216|FG001|Core Phase|Other|0|||
143267798|NCT02322021|516535217|FG002|Core Phase|Other|1|||
143267799|NCT02322021|516535218|FG003|Core Phase|Other|0|||
143267800|NCT02322021|516535219|FG004|Core Phase|Other|0|||
143267801|NCT02322021|516535215|FG000|Extension Phase|Adverse Event|0|||
143222171|NCT01702558|516361154|FG001|Overall Study|Death|3|||
143222172|NCT01702558|516361155|FG002|Overall Study|Death|3|||
143222173|NCT01702558|516361156|FG003|Overall Study|Death|16|||
143267802|NCT02322021|516535216|FG001|Extension Phase|Adverse Event|0|||
143267803|NCT02322021|516535217|FG002|Extension Phase|Adverse Event|0|||
143267804|NCT02322021|516535218|FG003|Extension Phase|Adverse Event|0|||
143222174|NCT01702558|516361157|FG004|Overall Study|Death|20|||
143222175|NCT01702558|516361153|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
143222176|NCT01702558|516361154|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
143222177|NCT01702558|516361155|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
143222178|NCT01702558|516361156|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
143222179|NCT01702558|516361157|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
143222180|NCT01702558|516361153|FG000|Overall Study|Study Terminated by Sponsor|0|||
143222181|NCT01702558|516361154|FG001|Overall Study|Study Terminated by Sponsor|1|||
143222182|NCT01702558|516361155|FG002|Overall Study|Study Terminated by Sponsor|0|||
143222183|NCT01702558|516361156|FG003|Overall Study|Study Terminated by Sponsor|0|||
143222184|NCT01702558|516361157|FG004|Overall Study|Study Terminated by Sponsor|1|||
143222185|NCT01702558|516361153|FG000|Overall Study|Other|0|||
143222186|NCT01702558|516361154|FG001|Overall Study|Other|0|||
143222187|NCT01702558|516361155|FG002|Overall Study|Other|0|||
143222188|NCT01702558|516361156|FG003|Overall Study|Other|16|||
143222189|NCT01702558|516361157|FG004|Overall Study|Other|17|||
143222190|NCT02396212|516361160|FG000|Overall Study|Adverse Event|1|||
143222191|NCT02396212|516361160|FG000|Overall Study|Lack of Efficacy|2|||
143222192|NCT04950465|516361161|FG000|Overall Study|Lost to Follow-up|1|||
143222193|NCT04950465|516361162|FG001|Overall Study|Lost to Follow-up|0|||
143222194|NCT04950465|516361163|FG002|Overall Study|Lost to Follow-up|0|||
143222195|NCT01338818|516361180|FG000|Overall Study|Adverse Event|8|||
143222196|NCT01338818|516361180|FG000|Overall Study|Lack of Efficacy|5|||
143222197|NCT01338818|516361180|FG000|Overall Study|no longer require study drug|1|||
143222198|NCT01338818|516361180|FG000|Overall Study|Withdrawal by Subject|11|||
143222199|NCT01338818|516361180|FG000|Overall Study|Lost to Follow-up|4|||
143222200|NCT01338818|516361180|FG000|Overall Study|Administrative problems|3|||
143267805|NCT02322021|516535219|FG004|Extension Phase|Adverse Event|3|||
143267806|NCT02322021|516535215|FG000|Extension Phase|Participant Choice|0|||
143267807|NCT02322021|516535216|FG001|Extension Phase|Participant Choice|0|||
143267808|NCT02322021|516535217|FG002|Extension Phase|Participant Choice|0|||
143267809|NCT02322021|516535218|FG003|Extension Phase|Participant Choice|0|||
143267810|NCT02322021|516535219|FG004|Extension Phase|Participant Choice|6|||
143267811|NCT02322021|516535215|FG000|Extension Phase|Other|0|||
143267812|NCT02322021|516535216|FG001|Extension Phase|Other|0|||
143267813|NCT02322021|516535217|FG002|Extension Phase|Other|0|||
143267814|NCT02322021|516535218|FG003|Extension Phase|Other|0|||
143267815|NCT02322021|516535219|FG004|Extension Phase|Other|3|||
143267816|NCT02322021|516535215|FG000|Extension Phase|Lost to Follow-up|0|||
143267817|NCT02322021|516535216|FG001|Extension Phase|Lost to Follow-up|0|||
143267818|NCT02322021|516535217|FG002|Extension Phase|Lost to Follow-up|0|||
143267819|NCT02322021|516535218|FG003|Extension Phase|Lost to Follow-up|0|||
143267820|NCT02322021|516535219|FG004|Extension Phase|Lost to Follow-up|1|||
143267821|NCT02322021|516535215|FG000|Extension Phase|Study terminated by sponsor|0|||
143267822|NCT02322021|516535216|FG001|Extension Phase|Study terminated by sponsor|0|||
143267823|NCT02322021|516535217|FG002|Extension Phase|Study terminated by sponsor|0|||
143267824|NCT02322021|516535218|FG003|Extension Phase|Study terminated by sponsor|0|||
143267825|NCT02322021|516535219|FG004|Extension Phase|Study terminated by sponsor|28|||
143267826|NCT01385371|516535232|FG000|Overall Study|Adverse Event|54|||
143222201|NCT01338818|516361180|FG000|Overall Study|Protocol Deviation|4|||
143222202|NCT01620086|516361181|FG000|Overall Study|Withdrawal by Subject|3|||
143222203|NCT01620086|516361182|FG001|Overall Study|Withdrawal by Subject|3|||
143222204|NCT01620086|516361183|FG002|Overall Study|Withdrawal by Subject|0|||
143222205|NCT01620086|516361181|FG000|Overall Study|failed study criteria|1|||
143222206|NCT01620086|516361182|FG001|Overall Study|failed study criteria|4|||
143267827|NCT01385371|516535233|FG001|Overall Study|Adverse Event|19|||
143267828|NCT01385371|516535232|FG000|Overall Study|Lost to Follow-up|16|||
143267829|NCT01385371|516535233|FG001|Overall Study|Lost to Follow-up|16|||
143267830|NCT01385371|516535232|FG000|Overall Study|Withdrawal by Subject|52|||
143267831|NCT01385371|516535233|FG001|Overall Study|Withdrawal by Subject|39|||
143267832|NCT01385371|516535232|FG000|Overall Study|Protocol Violation|25|||
143267833|NCT01385371|516535233|FG001|Overall Study|Protocol Violation|21|||
143267834|NCT01385371|516535232|FG000|Overall Study|Administrative|2|||
143267835|NCT01385371|516535233|FG001|Overall Study|Administrative|2|||
143267836|NCT00445978|516535239|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
143267837|NCT00445978|516535239|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
143267838|NCT00445978|516535239|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
143267839|NCT00445978|516535239|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
143267840|NCT00445978|516535239|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
143267841|NCT00445978|516535239|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
143372431|NCT02957539|516909517|FG001|Week 16 to 32|Lost to Follow-up|7|||
143222207|NCT01620086|516361183|FG002|Overall Study|failed study criteria|0|||
143222208|NCT01620086|516361181|FG000|Overall Study|Physician Decision|1|||
143222209|NCT01620086|516361182|FG001|Overall Study|Physician Decision|0|||
143222210|NCT01620086|516361183|FG002|Overall Study|Physician Decision|0|||
143222211|NCT01695135|516361184|FG000|Double-blind Treatment Phase|Progressive disease|50|||
143222212|NCT01695135|516361185|FG001|Double-blind Treatment Phase|Progressive disease|110|||
143222213|NCT01695135|516361186|FG002|Double-blind Treatment Phase|Progressive disease|0|||
143222214|NCT01695135|516361187|FG003|Double-blind Treatment Phase|Progressive disease|0|||
143222215|NCT01695135|516361184|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
143222216|NCT01695135|516361185|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
143222217|NCT01695135|516361186|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
143222218|NCT01695135|516361187|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
143222219|NCT01695135|516361184|FG000|Double-blind Treatment Phase|Adverse Event|7|||
143222220|NCT01695135|516361185|FG001|Double-blind Treatment Phase|Adverse Event|7|||
143222221|NCT01695135|516361186|FG002|Double-blind Treatment Phase|Adverse Event|0|||
143222222|NCT01695135|516361187|FG003|Double-blind Treatment Phase|Adverse Event|0|||
143222223|NCT01695135|516361184|FG000|Double-blind Treatment Phase|Other|1|||
143222224|NCT01695135|516361185|FG001|Double-blind Treatment Phase|Other|3|||
143222225|NCT01695135|516361186|FG002|Double-blind Treatment Phase|Other|0|||
143222226|NCT01695135|516361187|FG003|Double-blind Treatment Phase|Other|0|||
143222227|NCT01695135|516361184|FG000|Double-blind Treatment Phase|Physician Decision|6|||
143222228|NCT01695135|516361185|FG001|Double-blind Treatment Phase|Physician Decision|3|||
143222229|NCT01695135|516361186|FG002|Double-blind Treatment Phase|Physician Decision|0|||
143222230|NCT01695135|516361187|FG003|Double-blind Treatment Phase|Physician Decision|0|||
143222231|NCT01695135|516361184|FG000|Double-blind Treatment Phase|Death|1|||
143222232|NCT01695135|516361185|FG001|Double-blind Treatment Phase|Death|1|||
143222233|NCT01695135|516361186|FG002|Double-blind Treatment Phase|Death|0|||
143222234|NCT01695135|516361187|FG003|Double-blind Treatment Phase|Death|0|||
143222235|NCT01695135|516361184|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
143222236|NCT01695135|516361185|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
143222237|NCT01695135|516361186|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
143222238|NCT01695135|516361187|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
143222239|NCT01695135|516361184|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
143222240|NCT01695135|516361185|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
143222241|NCT01695135|516361186|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
143222242|NCT01695135|516361187|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
143222243|NCT01695135|516361184|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
143222244|NCT01695135|516361185|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
143222245|NCT01695135|516361186|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
143222246|NCT01695135|516361187|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
143222247|NCT01695135|516361184|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
143222248|NCT01695135|516361185|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
143222249|NCT01695135|516361186|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
143222250|NCT01695135|516361187|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
143222251|NCT01695135|516361184|FG000|Open Label Extension Treatment Phase|Other|0|||
143222252|NCT01695135|516361185|FG001|Open Label Extension Treatment Phase|Other|0|||
143222253|NCT01695135|516361186|FG002|Open Label Extension Treatment Phase|Other|4|||
143222254|NCT01695135|516361187|FG003|Open Label Extension Treatment Phase|Other|7|||
143222255|NCT01695135|516361184|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
143222256|NCT01695135|516361185|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
143222257|NCT01695135|516361186|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
143222258|NCT01695135|516361187|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
143222259|NCT01695135|516361184|FG000|Open Label Extension Treatment Phase|Death|0|||
143222260|NCT01695135|516361185|FG001|Open Label Extension Treatment Phase|Death|0|||
143222261|NCT01695135|516361186|FG002|Open Label Extension Treatment Phase|Death|2|||
143222262|NCT01695135|516361187|FG003|Open Label Extension Treatment Phase|Death|7|||
143222263|NCT01695135|516361184|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
143222264|NCT01695135|516361185|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
143222265|NCT01695135|516361186|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
143222266|NCT01695135|516361187|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
143222267|NCT00684996|516361193|FG000|Overall Study|Adverse Event|1|||
143222268|NCT00684996|516361193|FG000|Overall Study|Refusal unrelated to adverse event|1|||
143222269|NCT00684996|516361193|FG000|Overall Study|Progression/relapse|2|||
143222270|NCT00684996|516361193|FG000|Overall Study|Other reasons not protocol specified|1|||
143222271|NCT01078441|516361194|FG000|Overall Study|Withdrawal by Subject|1|||
143222272|NCT01425801|516361195|FG000|Period 1|Withdrawal by Subject|0|||
143222273|NCT01425801|516361196|FG001|Period 1|Withdrawal by Subject|0|||
143267842|NCT00445978|516535239|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
143222274|NCT01425801|516361197|FG002|Period 1|Withdrawal by Subject|0|||
143222275|NCT01425801|516361198|FG003|Period 1|Withdrawal by Subject|0|||
143222276|NCT01425801|516361199|FG004|Period 1|Withdrawal by Subject|1|||
143222277|NCT01425801|516361200|FG005|Period 1|Withdrawal by Subject|0|||
143222278|NCT01425801|516361195|FG000|Period 2|Withdrawal by Subject|0|||
143222279|NCT01425801|516361196|FG001|Period 2|Withdrawal by Subject|0|||
143222280|NCT01425801|516361197|FG002|Period 2|Withdrawal by Subject|0|||
143222281|NCT01425801|516361198|FG003|Period 2|Withdrawal by Subject|0|||
143222282|NCT01425801|516361199|FG004|Period 2|Withdrawal by Subject|1|||
143222283|NCT01425801|516361200|FG005|Period 2|Withdrawal by Subject|0|||
143222284|NCT01425801|516361195|FG000|Period 3|Stability criteria not fullfilled|0|||
143222285|NCT01425801|516361196|FG001|Period 3|Stability criteria not fullfilled|0|||
143222286|NCT01425801|516361197|FG002|Period 3|Stability criteria not fullfilled|1|||
143222287|NCT01425801|516361198|FG003|Period 3|Stability criteria not fullfilled|0|||
143222288|NCT01425801|516361199|FG004|Period 3|Stability criteria not fullfilled|0|||
143222289|NCT01425801|516361200|FG005|Period 3|Stability criteria not fullfilled|0|||
143222290|NCT01425801|516361195|FG000|Period 4|Not able to maintain visit schedule|0|||
143222291|NCT01425801|516361196|FG001|Period 4|Not able to maintain visit schedule|0|||
143222292|NCT01425801|516361197|FG002|Period 4|Not able to maintain visit schedule|1|||
143222293|NCT01425801|516361198|FG003|Period 4|Not able to maintain visit schedule|0|||
143222294|NCT01425801|516361199|FG004|Period 4|Not able to maintain visit schedule|0|||
143222295|NCT01425801|516361200|FG005|Period 4|Not able to maintain visit schedule|0|||
143222296|NCT02175017|516361201|FG000|Overall Study|Did not receive the investigational product|1|||
143222297|NCT02175017|516361202|FG001|Overall Study|Did not receive the investigational product|2|||
143222298|NCT02175017|516361201|FG000|Overall Study|Withdrawal by Subject|6|||
143222299|NCT02175017|516361202|FG001|Overall Study|Withdrawal by Subject|3|||
143222300|NCT02175017|516361201|FG000|Overall Study|Met an exclusion criteria|0|||
143222301|NCT02175017|516361202|FG001|Overall Study|Met an exclusion criteria|1|||
143222302|NCT02175017|516361201|FG000|Overall Study|Adverse Event|3|||
143222303|NCT02175017|516361202|FG001|Overall Study|Adverse Event|10|||
143222304|NCT02175017|516361201|FG000|Overall Study|Disease progression|20|||
143222305|NCT02175017|516361202|FG001|Overall Study|Disease progression|27|||
143222306|NCT02175017|516361201|FG000|Overall Study|Other than above reasons|3|||
143222307|NCT02175017|516361202|FG001|Overall Study|Other than above reasons|0|||
143222308|NCT02491983|516361203|FG000|Overall Study|Physician Decision|1|||
143222309|NCT02491983|516361204|FG001|Overall Study|Physician Decision|0|||
143222310|NCT02491983|516361203|FG000|Overall Study|Not meet selection criteria|1|||
143222311|NCT02491983|516361204|FG001|Overall Study|Not meet selection criteria|0|||
143222312|NCT02491983|516361203|FG000|Overall Study|Withdrawal by Subject|0|||
143222313|NCT02491983|516361204|FG001|Overall Study|Withdrawal by Subject|1|||
143222314|NCT00191308|516361205|FG000|Overall Study|Adverse Event|1|||
143222315|NCT00782717|516361207|FG000|Overall Study|Adverse Event|2|||
143222316|NCT00782717|516361208|FG001|Overall Study|Adverse Event|5|||
143222317|NCT00782717|516361207|FG000|Overall Study|Patient decision unrelated to AE|6|||
143222318|NCT00782717|516361208|FG001|Overall Study|Patient decision unrelated to AE|3|||
143222319|NCT00782717|516361207|FG000|Overall Study|Noncompliance|2|||
143222320|NCT00782717|516361208|FG001|Overall Study|Noncompliance|1|||
143222321|NCT00782717|516361207|FG000|Overall Study|Treatment failure|3|||
143222322|NCT00782717|516361208|FG001|Overall Study|Treatment failure|14|||
143267843|NCT00445978|516535239|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
143267844|NCT00445978|516535239|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
143267845|NCT03643159|516535242|FG000|Overall Study|Adverse Event|1|||
143267846|NCT03643159|516535242|FG000|Overall Study|Withdrawal by Subject|1|||
143267847|NCT02766465|516535243|FG000|Overall Study|Withdrawal by Subject|0|||
143267848|NCT02766465|516535244|FG001|Overall Study|Withdrawal by Subject|10|||
143267849|NCT01631812|516535245|FG000|Overall Study|Adverse Event|25|||
143267850|NCT01631812|516535245|FG000|Overall Study|Lack of Efficacy|5|||
143267851|NCT01631812|516535245|FG000|Overall Study|Withdrawal by Subject|4|||
143267852|NCT01631812|516535245|FG000|Overall Study|Physician Decision|3|||
143267853|NCT01528033|516535246|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
143267854|NCT01528033|516535247|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
143222323|NCT00782717|516361207|FG000|Overall Study|Enrollment close prior to surgery|1|||
143222324|NCT00782717|516361208|FG001|Overall Study|Enrollment close prior to surgery|0|||
143222325|NCT00782717|516361207|FG000|Overall Study|Did not meet entrance criteria|1|||
143222326|NCT00782717|516361208|FG001|Overall Study|Did not meet entrance criteria|3|||
143222327|NCT00782717|516361207|FG000|Overall Study|Exited in error|0|||
143222328|NCT00782717|516361208|FG001|Overall Study|Exited in error|2|||
143222329|NCT04739436|516361209|FG000|Overall Study|Lost to Follow-up|21|||
143222330|NCT04739436|516361210|FG001|Overall Study|Lost to Follow-up|23|||
143267855|NCT01528033|516535246|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
143222331|NCT04739436|516361209|FG000|Overall Study|Withdrawal by Subject|4|||
143222332|NCT04739436|516361210|FG001|Overall Study|Withdrawal by Subject|6|||
143267856|NCT01528033|516535247|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
143267857|NCT01528033|516535246|FG000|Primary Endpoint Assessment ITT|Death|2|||
143222333|NCT04739436|516361209|FG000|Overall Study|not randomized properly|1|||
143222334|NCT04739436|516361210|FG001|Overall Study|not randomized properly|0|||
143222335|NCT02701283|516361212|FG000|Overall Study|Death|25|||
143222336|NCT02701283|516361213|FG001|Overall Study|Death|29|||
143222337|NCT02701283|516361214|FG002|Overall Study|Death|19|||
143222338|NCT02701283|516361212|FG000|Overall Study|Lost to Follow-up|3|||
143222339|NCT02701283|516361213|FG001|Overall Study|Lost to Follow-up|8|||
143222340|NCT02701283|516361214|FG002|Overall Study|Lost to Follow-up|1|||
143222341|NCT02701283|516361212|FG000|Overall Study|Withdrawal by Subject|12|||
143222342|NCT02701283|516361213|FG001|Overall Study|Withdrawal by Subject|41|||
143222343|NCT02701283|516361214|FG002|Overall Study|Withdrawal by Subject|1|||
143222344|NCT02701283|516361212|FG000|Overall Study|Missed 2-year visit|22|||
143222345|NCT02701283|516361213|FG001|Overall Study|Missed 2-year visit|27|||
143222346|NCT02701283|516361214|FG002|Overall Study|Missed 2-year visit|0|||
143222347|NCT02701283|516361212|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
143222348|NCT02701283|516361213|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
143222349|NCT02701283|516361214|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
143222350|NCT00892775|516361215|FG000|Overall Study|Protocol Violation|1|||
143222351|NCT00892775|516361216|FG001|Overall Study|Protocol Violation|0|||
143222352|NCT00892775|516361215|FG000|Overall Study|Subject difficulties with blood drawing|1|||
143222353|NCT00892775|516361216|FG001|Overall Study|Subject difficulties with blood drawing|0|||
143222354|NCT00892775|516361215|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
143222355|NCT00892775|516361216|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
143222356|NCT00892775|516361215|FG000|Overall Study|Migrated/ moved from study area|1|||
143222357|NCT00892775|516361216|FG001|Overall Study|Migrated/ moved from study area|0|||
143222358|NCT00892775|516361215|FG000|Overall Study|Withdrawal by Subject|0|||
143222359|NCT00892775|516361216|FG001|Overall Study|Withdrawal by Subject|1|||
143222360|NCT00892775|516361215|FG000|Overall Study|Lost to Follow-up|1|||
143222361|NCT00892775|516361216|FG001|Overall Study|Lost to Follow-up|0|||
143222362|NCT00398320|516361217|FG000|Overall Study|Death|1|||
143222363|NCT00398320|516361217|FG000|Overall Study|Adverse Event|4|||
143222364|NCT00398320|516361217|FG000|Overall Study|Physician Decision|1|||
143222365|NCT00064792|516361218|FG000|Overall Study|Withdrawal by Subject|2|||
143222366|NCT00064792|516361219|FG001|Overall Study|Withdrawal by Subject|0|||
143222367|NCT00064792|516361218|FG000|Overall Study|Adverse Event|3|||
143222368|NCT00064792|516361219|FG001|Overall Study|Adverse Event|0|||
143222369|NCT03160898|516361220|FG000|Overall Study|Adverse Event|4|||
143222370|NCT03160898|516361221|FG001|Overall Study|Adverse Event|8|||
143267858|NCT01528033|516535247|FG001|Primary Endpoint Assessment ITT|Death|2|||
143267859|NCT01528033|516535246|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
143267860|NCT01528033|516535247|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
143222371|NCT03160898|516361222|FG002|Overall Study|Adverse Event|7|||
143222372|NCT03160898|516361223|FG003|Overall Study|Adverse Event|10|||
143222373|NCT03160898|516361220|FG000|Overall Study|Death|1|||
143222374|NCT03160898|516361221|FG001|Overall Study|Death|0|||
143222375|NCT03160898|516361222|FG002|Overall Study|Death|0|||
143222376|NCT03160898|516361223|FG003|Overall Study|Death|1|||
143222377|NCT03160898|516361220|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
143222378|NCT03160898|516361221|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
143267861|NCT01528033|516535246|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
143222379|NCT03160898|516361222|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
143222380|NCT03160898|516361223|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
143267862|NCT01528033|516535247|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
143267863|NCT01528033|516535246|FG000|Follow Up|No data available|46|||
143222381|NCT03160898|516361220|FG000|Overall Study|Lost to Follow-up|1|||
143222382|NCT03160898|516361221|FG001|Overall Study|Lost to Follow-up|1|||
143222383|NCT03160898|516361222|FG002|Overall Study|Lost to Follow-up|1|||
143222384|NCT03160898|516361223|FG003|Overall Study|Lost to Follow-up|2|||
143222385|NCT03160898|516361220|FG000|Overall Study|Physician Decision|1|||
143222386|NCT03160898|516361221|FG001|Overall Study|Physician Decision|0|||
143222387|NCT03160898|516361222|FG002|Overall Study|Physician Decision|0|||
143222388|NCT03160898|516361223|FG003|Overall Study|Physician Decision|1|||
143222389|NCT03160898|516361220|FG000|Overall Study|Progressive Disease|4|||
143222390|NCT03160898|516361221|FG001|Overall Study|Progressive Disease|1|||
143222391|NCT03160898|516361222|FG002|Overall Study|Progressive Disease|2|||
143222392|NCT03160898|516361223|FG003|Overall Study|Progressive Disease|1|||
143222393|NCT03160898|516361220|FG000|Overall Study|Protocol Violation|1|||
143222394|NCT03160898|516361221|FG001|Overall Study|Protocol Violation|0|||
143222395|NCT03160898|516361222|FG002|Overall Study|Protocol Violation|2|||
143222396|NCT03160898|516361223|FG003|Overall Study|Protocol Violation|0|||
143222397|NCT03160898|516361220|FG000|Overall Study|Sponsor Discretion|2|||
143222398|NCT03160898|516361221|FG001|Overall Study|Sponsor Discretion|0|||
143222399|NCT03160898|516361222|FG002|Overall Study|Sponsor Discretion|0|||
143222400|NCT03160898|516361223|FG003|Overall Study|Sponsor Discretion|0|||
143222401|NCT03160898|516361220|FG000|Overall Study|Withdrawal by Subject|1|||
143222402|NCT03160898|516361221|FG001|Overall Study|Withdrawal by Subject|3|||
143222403|NCT03160898|516361222|FG002|Overall Study|Withdrawal by Subject|2|||
143222404|NCT03160898|516361223|FG003|Overall Study|Withdrawal by Subject|1|||
143222405|NCT03160898|516361220|FG000|Overall Study|Other|2|||
143222406|NCT03160898|516361221|FG001|Overall Study|Other|0|||
143222407|NCT03160898|516361222|FG002|Overall Study|Other|2|||
143222408|NCT03160898|516361223|FG003|Overall Study|Other|2|||
143222409|NCT03405818|516361224|FG000|Overall Study|Withdrawal by Subject|4|||
143222410|NCT03405818|516361224|FG000|Overall Study|Lost to Follow-up|4|||
143222411|NCT00291486|516361227|FG000|Overall Study|Adverse Event|0|||
143222412|NCT00291486|516361228|FG001|Overall Study|Adverse Event|3|||
143222413|NCT00291486|516361229|FG002|Overall Study|Adverse Event|0|||
143222414|NCT00291486|516361230|FG003|Overall Study|Adverse Event|1|||
143222415|NCT00291486|516361231|FG004|Overall Study|Adverse Event|0|||
143222416|NCT00291486|516361227|FG000|Overall Study|Withdrawal by Subject|0|||
143222417|NCT00291486|516361228|FG001|Overall Study|Withdrawal by Subject|0|||
143222418|NCT00291486|516361229|FG002|Overall Study|Withdrawal by Subject|0|||
143222419|NCT00291486|516361230|FG003|Overall Study|Withdrawal by Subject|0|||
143222420|NCT00291486|516361231|FG004|Overall Study|Withdrawal by Subject|1|||
143222421|NCT00291486|516361227|FG000|Overall Study|Disease progression|1|||
143222422|NCT00291486|516361228|FG001|Overall Study|Disease progression|0|||
143222423|NCT00291486|516361229|FG002|Overall Study|Disease progression|1|||
143222424|NCT00291486|516361230|FG003|Overall Study|Disease progression|0|||
143222425|NCT00291486|516361231|FG004|Overall Study|Disease progression|0|||
143222426|NCT01045694|516361234|FG000|Overall Study|Withdrawal by Subject|2|||
143222427|NCT01408459|516361238|FG000|Overall Study|Withdrawal by Subject|1|||
143222428|NCT01408459|516361239|FG001|Overall Study|Withdrawal by Subject|1|||
143222429|NCT04725500|516361240|FG000|Screening|Screen Failure|26|||
143222430|NCT04725500|516361240|FG000|Screening|Withdrawal by Subject|1|||
143222431|NCT04725500|516361240|FG000|2 Week Take Home|Screen Fail|5|||
143222432|NCT01792115|516361241|FG000|Overall Study|Lost to Follow-up|0|||
143222433|NCT01792115|516361242|FG001|Overall Study|Lost to Follow-up|1|||
143222434|NCT01792115|516361243|FG002|Overall Study|Lost to Follow-up|0|||
143222435|NCT01633788|516362885|FG000|Overall Study|Adverse Event|1|||
143222436|NCT01633788|516362886|FG001|Overall Study|Adverse Event|3|||
143222437|NCT01633788|516362887|FG002|Overall Study|Adverse Event|3|||
143222438|NCT01633788|516362888|FG003|Overall Study|Adverse Event|3|||
143222439|NCT01633788|516362885|FG000|Overall Study|Lost to Follow-up|2|||
143222440|NCT01633788|516362886|FG001|Overall Study|Lost to Follow-up|2|||
143222441|NCT01633788|516362887|FG002|Overall Study|Lost to Follow-up|2|||
143222442|NCT01633788|516362888|FG003|Overall Study|Lost to Follow-up|0|||
143222443|NCT01633788|516362885|FG000|Overall Study|Personal Reasons|3|||
143222444|NCT01633788|516362886|FG001|Overall Study|Personal Reasons|1|||
143222445|NCT01633788|516362887|FG002|Overall Study|Personal Reasons|1|||
143222446|NCT01633788|516362888|FG003|Overall Study|Personal Reasons|3|||
143222447|NCT01633788|516362885|FG000|Overall Study|Protocol Violation|1|||
143222448|NCT01633788|516362886|FG001|Overall Study|Protocol Violation|0|||
143222449|NCT01633788|516362887|FG002|Overall Study|Protocol Violation|1|||
143267864|NCT01528033|516535247|FG001|Follow Up|No data available|44|||
143267865|NCT02030938|516535250|FG000|Overall Study|Lost to Follow-up|4|||
143267866|NCT02030938|516535250|FG000|Overall Study|Withdrawal by Subject|1|||
143267867|NCT02520661|516535251|FG000|Overall Study|Lost to Follow-up|7|||
143267868|NCT02520661|516535252|FG001|Overall Study|Lost to Follow-up|3|||
143267869|NCT02520661|516535251|FG000|Overall Study|Admitted from ED|49|||
143267870|NCT02520661|516535252|FG001|Overall Study|Admitted from ED|48|||
143267871|NCT02520661|516535251|FG000|Overall Study|ED greater than 24 hours|29|||
143267872|NCT02520661|516535252|FG001|Overall Study|ED greater than 24 hours|38|||
143267873|NCT02520661|516535251|FG000|Overall Study|other ineligibility|14|||
143267874|NCT02520661|516535252|FG001|Overall Study|other ineligibility|22|||
143267875|NCT02520661|516535251|FG000|Overall Study|Withdrawal by Subject|7|||
143267876|NCT02520661|516535252|FG001|Overall Study|Withdrawal by Subject|16|||
143267877|NCT05156073|516535259|FG000|Overall Study|Patient canceled appointment with PCP|1|||
143267878|NCT05597020|516535263|FG000|Washout|Forbidden medication|2|||
143267879|NCT05597020|516535264|FG001|Washout|Forbidden medication|0|||
143222450|NCT01633788|516362888|FG003|Overall Study|Protocol Violation|0|||
143222451|NCT01633788|516362885|FG000|Overall Study|Other Reasons|0|||
143222452|NCT01633788|516362886|FG001|Overall Study|Other Reasons|2|||
143222453|NCT01633788|516362887|FG002|Overall Study|Other Reasons|3|||
143222454|NCT01633788|516362888|FG003|Overall Study|Other Reasons|7|||
143222455|NCT01929226|516362889|FG000|Overall Study|Lost to Follow-up|4|||
143222456|NCT01929226|516362890|FG001|Overall Study|Lost to Follow-up|0|||
143222457|NCT01929226|516362889|FG000|Overall Study|Withdrawal by Subject|1|||
143222458|NCT01929226|516362890|FG001|Overall Study|Withdrawal by Subject|1|||
143222459|NCT03553758|516362891|FG000|Overall Study|Lost to Follow-up|1|||
143222460|NCT03811340|516362899|FG000|Overall Study|subjects did not complete the survey.|90|||
143222461|NCT01045967|516362900|FG000|Second Intervention|Protocol Violation|0|||
143222462|NCT01045967|516362901|FG001|Second Intervention|Protocol Violation|1|||
143222463|NCT05104450|516362902|FG000|Overall Study|Death|1|||
143222464|NCT05104450|516362903|FG001|Overall Study|Death|2|||
143222465|NCT05104450|516362902|FG000|Overall Study|Withdrawal by Subject|3|||
143222466|NCT05104450|516362903|FG001|Overall Study|Withdrawal by Subject|1|||
143222467|NCT02562235|516362904|FG000|Overall Study|Adverse Event|3|||
143222468|NCT03310723|516362905|FG000|Overall Study|Withdrawal by Subject|0|||
143222469|NCT03310723|516362906|FG001|Overall Study|Withdrawal by Subject|1|||
143267880|NCT05597020|516535263|FG000|Treatment Period II|Advice from primary care physician|1|||
143267881|NCT05597020|516535264|FG001|Treatment Period II|Advice from primary care physician|0|||
143267882|NCT05597020|516535263|FG000|Treatment Period II|Subject lost investigational product|1|||
143267883|NCT05597020|516535264|FG001|Treatment Period II|Subject lost investigational product|0|||
143222470|NCT03310723|516362905|FG000|Overall Study|Protocol Violation|0|||
143267884|NCT05597020|516535263|FG000|Treatment Period II|Private reasons|0|||
143267885|NCT05597020|516535264|FG001|Treatment Period II|Private reasons|1|||
143267886|NCT02452697|516535265|FG000|Overall Study|Physician Decision|4|||
143267887|NCT02452697|516535266|FG001|Overall Study|Physician Decision|4|||
143267888|NCT02452697|516535267|FG002|Overall Study|Physician Decision|3|||
143267889|NCT02452697|516535268|FG003|Overall Study|Physician Decision|2|||
143372432|NCT02957539|516909518|FG002|Week 16 to 32|Lost to Follow-up|5|||
143222471|NCT03310723|516362906|FG001|Overall Study|Protocol Violation|2|||
143222472|NCT02098746|516362907|FG000|Overall Study|Changes of Investigator|2|||
143372433|NCT02957539|516909516|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
143222473|NCT02098746|516362907|FG000|Overall Study|Other Miscellaneous Reasons|1|||
143267890|NCT02452697|516535265|FG000|Overall Study|Withdrawal by Subject|1|||
143267891|NCT02452697|516535266|FG001|Overall Study|Withdrawal by Subject|0|||
143222474|NCT02098746|516362907|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
143222475|NCT02098746|516362907|FG000|Overall Study|Data Not Available After Treatment|1|||
143222476|NCT00997035|516362908|FG000|3-week Followup Visit|Lost to Follow-up|9|||
143222477|NCT00997035|516362909|FG001|3-week Followup Visit|Lost to Follow-up|6|||
143222478|NCT00997035|516362908|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
143222479|NCT00997035|516362909|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
143222480|NCT04070989|516362912|FG000|Overall Study|Death|1|||
143222481|NCT04070989|516362913|FG001|Overall Study|Death|0|||
143222482|NCT04070989|516362914|FG002|Overall Study|Death|0|||
143222483|NCT04070989|516362912|FG000|Overall Study|Study Terminated by Sponsor|7|||
143222484|NCT04070989|516362913|FG001|Overall Study|Study Terminated by Sponsor|8|||
143222485|NCT04070989|516362914|FG002|Overall Study|Study Terminated by Sponsor|23|||
143222486|NCT04070989|516362912|FG000|Overall Study|Withdrawal by Subject|0|||
143222487|NCT04070989|516362913|FG001|Overall Study|Withdrawal by Subject|1|||
143222488|NCT04070989|516362914|FG002|Overall Study|Withdrawal by Subject|0|||
143222489|NCT04070989|516362912|FG000|Overall Study|Inclusion/Exclusion Criteria not met|2|||
143222490|NCT04070989|516362913|FG001|Overall Study|Inclusion/Exclusion Criteria not met|0|||
143222491|NCT04070989|516362914|FG002|Overall Study|Inclusion/Exclusion Criteria not met|1|||
143222492|NCT04070989|516362912|FG000|Overall Study|Other|1|||
143222493|NCT04070989|516362913|FG001|Overall Study|Other|1|||
143222494|NCT04070989|516362914|FG002|Overall Study|Other|0|||
143222495|NCT00592904|516362938|FG000|Overall Study|Adverse Event|15|||
143222496|NCT00592904|516362939|FG001|Overall Study|Adverse Event|25|||
143222497|NCT00592904|516362940|FG002|Overall Study|Adverse Event|13|||
143222498|NCT00592904|516362941|FG003|Overall Study|Adverse Event|5|||
143222499|NCT00592904|516362938|FG000|Overall Study|Protocol Violation|1|||
143222500|NCT00592904|516362939|FG001|Overall Study|Protocol Violation|1|||
143222501|NCT00592904|516362940|FG002|Overall Study|Protocol Violation|0|||
143222502|NCT00592904|516362941|FG003|Overall Study|Protocol Violation|1|||
143222503|NCT00592904|516362938|FG000|Overall Study|Withdrawal by Subject|4|||
143222504|NCT00592904|516362939|FG001|Overall Study|Withdrawal by Subject|16|||
143222505|NCT00592904|516362940|FG002|Overall Study|Withdrawal by Subject|1|||
143222506|NCT00592904|516362941|FG003|Overall Study|Withdrawal by Subject|2|||
143222507|NCT00592904|516362938|FG000|Overall Study|Lack of Efficacy|2|||
143222508|NCT00592904|516362939|FG001|Overall Study|Lack of Efficacy|7|||
143222509|NCT00592904|516362940|FG002|Overall Study|Lack of Efficacy|2|||
143222510|NCT00592904|516362941|FG003|Overall Study|Lack of Efficacy|3|||
143222511|NCT00592904|516362938|FG000|Overall Study|Physician Decision|0|||
143222512|NCT00592904|516362939|FG001|Overall Study|Physician Decision|3|||
143222513|NCT00592904|516362940|FG002|Overall Study|Physician Decision|1|||
143222514|NCT00592904|516362941|FG003|Overall Study|Physician Decision|0|||
143222515|NCT00592904|516362938|FG000|Overall Study|Other|3|||
143222516|NCT00592904|516362939|FG001|Overall Study|Other|3|||
143222517|NCT00592904|516362940|FG002|Overall Study|Other|0|||
143222518|NCT00592904|516362941|FG003|Overall Study|Other|0|||
143222519|NCT00824473|516362942|FG000|Overall Study|Adverse Event|4|||
143222520|NCT00824473|516362943|FG001|Overall Study|Adverse Event|5|||
143222521|NCT00824473|516362942|FG000|Overall Study|Lack of Efficacy|2|||
143222522|NCT00824473|516362943|FG001|Overall Study|Lack of Efficacy|2|||
143222523|NCT00824473|516362942|FG000|Overall Study|Protocol Violation|2|||
143222524|NCT00824473|516362943|FG001|Overall Study|Protocol Violation|0|||
143267892|NCT02452697|516535267|FG002|Overall Study|Withdrawal by Subject|0|||
143267893|NCT02452697|516535268|FG003|Overall Study|Withdrawal by Subject|0|||
143267894|NCT02452697|516535265|FG000|Overall Study|still in follow-up|2|||
143222525|NCT00824473|516362942|FG000|Overall Study|Non-Compliance|4|||
143222526|NCT00824473|516362943|FG001|Overall Study|Non-Compliance|2|||
143222527|NCT00824473|516362942|FG000|Overall Study|Withdrawal by Subject|2|||
143222528|NCT00824473|516362943|FG001|Overall Study|Withdrawal by Subject|3|||
143222529|NCT00824473|516362942|FG000|Overall Study|Other|1|||
143222530|NCT00824473|516362943|FG001|Overall Study|Other|1|||
143222531|NCT01359904|516362944|FG000|Overall Study|Withdrawal by Subject|1|||
143222532|NCT01359904|516362945|FG001|Overall Study|Withdrawal by Subject|0|||
143222533|NCT03187132|516362947|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
143222534|NCT03187132|516362948|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
143222535|NCT03187132|516362947|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
143222536|NCT03187132|516362948|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
143222537|NCT03187132|516362947|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
143222538|NCT03187132|516362948|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
143222539|NCT03187132|516362947|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
143267895|NCT02452697|516535266|FG001|Overall Study|still in follow-up|2|||
143267896|NCT02452697|516535267|FG002|Overall Study|still in follow-up|1|||
143267897|NCT02452697|516535268|FG003|Overall Study|still in follow-up|3|||
143267898|NCT02349061|516536765|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
143267899|NCT02349061|516536766|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
143267900|NCT02349061|516536767|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
143267901|NCT02349061|516536765|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
143267902|NCT02349061|516536766|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
143267903|NCT02349061|516536767|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
143267904|NCT02349061|516536765|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
143267905|NCT02349061|516536766|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
143267906|NCT02349061|516536767|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
143267907|NCT02349061|516536765|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
143267908|NCT02349061|516536766|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
143267909|NCT02349061|516536767|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
143267910|NCT02349061|516536765|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
143267911|NCT02349061|516536766|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
143267912|NCT02349061|516536767|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
143267913|NCT02349061|516536765|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
143267914|NCT02349061|516536766|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
143267915|NCT02349061|516536767|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
143267916|NCT02349061|516536765|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
143267917|NCT02349061|516536766|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
143267918|NCT02349061|516536767|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
143267919|NCT02349061|516536765|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
143267920|NCT02349061|516536766|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
143267921|NCT02349061|516536767|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
143267922|NCT02349061|516536765|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
143267923|NCT02349061|516536766|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
143267924|NCT02349061|516536767|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
143267925|NCT02349061|516536765|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
143267926|NCT02349061|516536766|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
143267927|NCT02349061|516536767|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
143267928|NCT02349061|516536765|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
143267929|NCT02349061|516536766|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
143267930|NCT02349061|516536767|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
143222540|NCT03187132|516362948|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
143222541|NCT03187132|516362947|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
143222542|NCT03187132|516362948|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
143222543|NCT03187132|516362947|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
143222544|NCT03187132|516362948|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
143222545|NCT03187132|516362947|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
143222546|NCT03187132|516362948|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
143222547|NCT03187132|516362947|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
143222548|NCT03187132|516362948|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
143222549|NCT03187132|516362947|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
143222550|NCT03187132|516362948|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
143222551|NCT03187132|516362947|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
143222552|NCT03187132|516362948|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
143222553|NCT03187132|516362947|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
143222554|NCT03187132|516362948|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
143222555|NCT03191630|516362951|FG000|Overall Study|Lost to Follow-up|7|||
143222556|NCT03191630|516362952|FG001|Overall Study|Lost to Follow-up|7|||
143222557|NCT02640547|516362953|FG000|Overall Study|Failure to Return|1|||
143222558|NCT02640547|516362953|FG000|Overall Study|Withdrawal by Subject|1|||
143222559|NCT02640547|516362953|FG000|Overall Study|Death|6|||
143222560|NCT02640547|516362953|FG000|Overall Study|Miscellaneous|3|||
143222561|NCT02525588|516362954|FG000|Overall Study|Death|3|||
143222562|NCT02525588|516362955|FG001|Overall Study|Death|1|||
143222563|NCT02525588|516362954|FG000|Overall Study|Lost to Follow-up|2|||
143222564|NCT02525588|516362955|FG001|Overall Study|Lost to Follow-up|0|||
143222565|NCT02525588|516362954|FG000|Overall Study|Withdrawal by Subject|1|||
143267931|NCT02349061|516536765|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
143267932|NCT02349061|516536766|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
143267933|NCT02349061|516536767|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
143267934|NCT02349061|516536765|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
143267935|NCT02349061|516536766|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
143222566|NCT02525588|516362955|FG001|Overall Study|Withdrawal by Subject|1|||
143267936|NCT02349061|516536767|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
143267937|NCT02339285|516536768|FG000|Overall Study|Withdrawal by Subject|0|||
143267938|NCT02339285|516536769|FG001|Overall Study|Withdrawal by Subject|1|||
143267939|NCT02339285|516536770|FG002|Overall Study|Withdrawal by Subject|1|||
143267940|NCT02339285|516536768|FG000|Overall Study|Lost to Follow-up|1|||
143267941|NCT02339285|516536769|FG001|Overall Study|Lost to Follow-up|1|||
143267942|NCT02339285|516536770|FG002|Overall Study|Lost to Follow-up|1|||
143267943|NCT02339285|516536768|FG000|Overall Study|Protocol Deviation|0|||
143267944|NCT02339285|516536769|FG001|Overall Study|Protocol Deviation|1|||
143267945|NCT02339285|516536770|FG002|Overall Study|Protocol Deviation|0|||
143267946|NCT00282412|516536773|FG000|Overall Study|Death|2|||
143267947|NCT01507298|516536776|FG000|Overall Study|Protocol Violation|0|||
143267948|NCT01507298|516536777|FG001|Overall Study|Protocol Violation|6|||
143372434|NCT02957539|516909517|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
143372435|NCT02957539|516909518|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
143372436|NCT02957539|516909516|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
143372437|NCT02957539|516909517|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
143267949|NCT00537238|516536778|FG000|Overall Study|Death|1|||
143267950|NCT00537238|516536779|FG001|Overall Study|Death|2|||
143267951|NCT00537238|516536778|FG000|Overall Study|Adverse Event|31|||
143372438|NCT02957539|516909518|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
143267952|NCT00537238|516536779|FG001|Overall Study|Adverse Event|22|||
143267953|NCT00537238|516536778|FG000|Overall Study|Lack of Efficacy|20|||
143267954|NCT00537238|516536779|FG001|Overall Study|Lack of Efficacy|21|||
143267955|NCT00537238|516536778|FG000|Overall Study|Lost to Follow-up|12|||
143267956|NCT00537238|516536779|FG001|Overall Study|Lost to Follow-up|8|||
143267957|NCT00537238|516536778|FG000|Overall Study|Withdrawal by Subject|51|||
143267958|NCT00537238|516536779|FG001|Overall Study|Withdrawal by Subject|47|||
143267959|NCT00537238|516536778|FG000|Overall Study|Protocol Violation|15|||
143267960|NCT00537238|516536779|FG001|Overall Study|Protocol Violation|19|||
143267961|NCT00537238|516536778|FG000|Overall Study|Does not meet entrance criteria|0|||
143267962|NCT00537238|516536779|FG001|Overall Study|Does not meet entrance criteria|2|||
143267963|NCT00537238|516536778|FG000|Overall Study|Other|44|||
143267964|NCT00537238|516536779|FG001|Overall Study|Other|52|||
143267965|NCT01920555|516536780|FG000|Overall Study|Physician Decision|1|||
143267966|NCT01920555|516536781|FG001|Overall Study|Physician Decision|2|||
143267967|NCT01920555|516536782|FG002|Overall Study|Physician Decision|1|||
143267968|NCT01920555|516536783|FG003|Overall Study|Physician Decision|2|||
143267969|NCT01920555|516536784|FG004|Overall Study|Physician Decision|0|||
143267970|NCT01920555|516536780|FG000|Overall Study|Lack of Efficacy|2|||
143267971|NCT01920555|516536781|FG001|Overall Study|Lack of Efficacy|0|||
143267972|NCT01920555|516536782|FG002|Overall Study|Lack of Efficacy|0|||
143267973|NCT01920555|516536783|FG003|Overall Study|Lack of Efficacy|0|||
143267974|NCT01920555|516536784|FG004|Overall Study|Lack of Efficacy|0|||
143267975|NCT01920555|516536780|FG000|Overall Study|Travel Difficulties|1|||
143267976|NCT01920555|516536781|FG001|Overall Study|Travel Difficulties|1|||
143267977|NCT01920555|516536782|FG002|Overall Study|Travel Difficulties|0|||
143267978|NCT01920555|516536783|FG003|Overall Study|Travel Difficulties|0|||
143267979|NCT01920555|516536784|FG004|Overall Study|Travel Difficulties|1|||
143267980|NCT01920555|516536780|FG000|Overall Study|Lost to Follow-up|0|||
143267981|NCT01920555|516536781|FG001|Overall Study|Lost to Follow-up|1|||
143267982|NCT01920555|516536782|FG002|Overall Study|Lost to Follow-up|0|||
143267983|NCT01920555|516536783|FG003|Overall Study|Lost to Follow-up|1|||
143267984|NCT01920555|516536784|FG004|Overall Study|Lost to Follow-up|0|||
143267985|NCT03911713|516536787|FG000|Overall Study|Lost to Follow-up|0|||
143267986|NCT03911713|516536788|FG001|Overall Study|Lost to Follow-up|2|||
143267987|NCT03911713|516536789|FG002|Overall Study|Lost to Follow-up|0|||
143267988|NCT03911713|516536790|FG003|Overall Study|Lost to Follow-up|0|||
143267989|NCT03911713|516536791|FG004|Overall Study|Lost to Follow-up|0|||
143267990|NCT03911713|516536787|FG000|Overall Study|Other|0|||
143267991|NCT03911713|516536788|FG001|Overall Study|Other|0|||
143267992|NCT03911713|516536789|FG002|Overall Study|Other|0|||
143267993|NCT03911713|516536790|FG003|Overall Study|Other|1|||
143267994|NCT03911713|516536791|FG004|Overall Study|Other|0|||
143267995|NCT03911713|516536787|FG000|Overall Study|Randomized, Never Dosed|1|||
143267996|NCT03911713|516536788|FG001|Overall Study|Randomized, Never Dosed|0|||
143372439|NCT01924767|516909519|FG000|Overall Study|Adverse Event|1|||
143267997|NCT03911713|516536789|FG002|Overall Study|Randomized, Never Dosed|0|||
143267998|NCT03911713|516536790|FG003|Overall Study|Randomized, Never Dosed|1|||
143267999|NCT03911713|516536791|FG004|Overall Study|Randomized, Never Dosed|0|||
143268000|NCT01193660|516536794|FG000|Overall Study|Withdrawal by Subject|2|||
143268001|NCT01193660|516536795|FG001|Overall Study|Withdrawal by Subject|3|||
143268002|NCT01193660|516536796|FG002|Overall Study|Withdrawal by Subject|1|||
143268003|NCT01193660|516536794|FG000|Overall Study|Death|1|||
143372440|NCT01924767|516909520|FG001|Overall Study|Adverse Event|0|||
143268004|NCT01193660|516536795|FG001|Overall Study|Death|0|||
143372441|NCT01924767|516909521|FG002|Overall Study|Adverse Event|1|||
143268005|NCT01193660|516536796|FG002|Overall Study|Death|0|||
143268006|NCT01193660|516536794|FG000|Overall Study|Physician Decision|1|||
143268007|NCT01193660|516536795|FG001|Overall Study|Physician Decision|0|||
143268008|NCT01193660|516536796|FG002|Overall Study|Physician Decision|1|||
143268009|NCT01845818|516536797|FG000|Overall Study|Withdrawal by Subject|0|||
143268010|NCT01845818|516536798|FG001|Overall Study|Withdrawal by Subject|1|||
143222567|NCT02525588|516362954|FG000|Overall Study|Adverse Event|0|||
143222568|NCT02525588|516362955|FG001|Overall Study|Adverse Event|1|||
143222569|NCT03369418|516362956|FG000|Overall Study|Withdrawal by Subject|3|||
143222570|NCT03369418|516362957|FG001|Overall Study|Withdrawal by Subject|3|||
143222571|NCT00837213|516362961|FG000|Overall Study|Lost to Follow-up|3|||
143222572|NCT00837213|516362962|FG001|Overall Study|Lost to Follow-up|2|||
143222573|NCT00837213|516362961|FG000|Overall Study|Withdrawal by Subject|2|||
143222574|NCT00837213|516362962|FG001|Overall Study|Withdrawal by Subject|2|||
143222575|NCT00837213|516362961|FG000|Overall Study|not stated|1|||
143222576|NCT00837213|516362962|FG001|Overall Study|not stated|1|||
143222577|NCT04497116|516362965|FG000|Overall Study|Lost to Follow-up|1|||
143222578|NCT04497116|516362966|FG001|Overall Study|Lost to Follow-up|0|||
143222579|NCT04497116|516362967|FG002|Overall Study|Lost to Follow-up|0|||
143222580|NCT04497116|516362968|FG003|Overall Study|Lost to Follow-up|0|||
143222581|NCT04497116|516362969|FG004|Overall Study|Lost to Follow-up|0|||
143222582|NCT04497116|516362970|FG005|Overall Study|Lost to Follow-up|0|||
143222583|NCT04497116|516362971|FG006|Overall Study|Lost to Follow-up|0|||
143222584|NCT04497116|516362972|FG007|Overall Study|Lost to Follow-up|3|||
143222585|NCT04497116|516362973|FG008|Overall Study|Lost to Follow-up|3|||
143222586|NCT04497116|516362974|FG009|Overall Study|Lost to Follow-up|0|||
143222587|NCT04497116|516362975|FG010|Overall Study|Lost to Follow-up|0|||
143222588|NCT04497116|516362976|FG011|Overall Study|Lost to Follow-up|0|||
143222589|NCT04497116|516362977|FG012|Overall Study|Lost to Follow-up|0|||
143268011|NCT01845818|516536797|FG000|Overall Study|Lost to Follow-up|7|||
143222590|NCT04497116|516362978|FG013|Overall Study|Lost to Follow-up|0|||
143222591|NCT04497116|516362979|FG014|Overall Study|Lost to Follow-up|0|||
143222592|NCT04497116|516362980|FG015|Overall Study|Lost to Follow-up|0|||
143222593|NCT04497116|516362981|FG016|Overall Study|Lost to Follow-up|0|||
143222594|NCT04497116|516362982|FG017|Overall Study|Lost to Follow-up|0|||
143222595|NCT04497116|516362983|FG018|Overall Study|Lost to Follow-up|0|||
143222596|NCT04497116|516362984|FG019|Overall Study|Lost to Follow-up|0|||
143268012|NCT01845818|516536798|FG001|Overall Study|Lost to Follow-up|5|||
143268013|NCT01845818|516536797|FG000|Overall Study|Administrative Reasons|3|||
143268014|NCT01845818|516536798|FG001|Overall Study|Administrative Reasons|1|||
143268015|NCT01845818|516536797|FG000|Overall Study|Serious Adverse Event|1|||
143268016|NCT01845818|516536798|FG001|Overall Study|Serious Adverse Event|1|||
143268017|NCT01845818|516536797|FG000|Overall Study|Other|25|||
143268018|NCT01845818|516536798|FG001|Overall Study|Other|8|||
143268019|NCT01845818|516536797|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
143268020|NCT01845818|516536798|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
143268021|NCT01845818|516536797|FG000|Overall Study|No Follow-Up Data Available|4|||
143268022|NCT01845818|516536798|FG001|Overall Study|No Follow-Up Data Available|1|||
143372442|NCT01924767|516909522|FG003|Overall Study|Adverse Event|0|||
143372443|NCT01924767|516909523|FG004|Overall Study|Adverse Event|0|||
143268023|NCT02570074|516536799|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
143268024|NCT02570074|516536800|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
143268025|NCT01325623|516536804|FG000|Overall Study|Withdrawal by Subject|3|||
143372444|NCT01193153|516909524|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
143268026|NCT00598702|516536805|FG000|Overall Study|Other|0|||
143268027|NCT00598702|516536806|FG001|Overall Study|Other|2|||
143268028|NCT00598702|516536807|FG002|Overall Study|Other|0|||
143268029|NCT00598702|516536808|FG003|Overall Study|Other|0|||
143268030|NCT00598702|516536809|FG004|Overall Study|Other|0|||
143222597|NCT04497116|516362985|FG020|Overall Study|Lost to Follow-up|0|||
143222598|NCT04497116|516362986|FG021|Overall Study|Lost to Follow-up|0|||
143222599|NCT04497116|516362987|FG022|Overall Study|Lost to Follow-up|1|||
143222600|NCT04497116|516362988|FG023|Overall Study|Lost to Follow-up|0|||
143222601|NCT04497116|516362989|FG024|Overall Study|Lost to Follow-up|0|||
143222602|NCT04497116|516362965|FG000|Overall Study|Sponsor decision to terminate study|0|||
143222603|NCT04497116|516362966|FG001|Overall Study|Sponsor decision to terminate study|0|||
143222604|NCT04497116|516362967|FG002|Overall Study|Sponsor decision to terminate study|0|||
143222605|NCT04497116|516362968|FG003|Overall Study|Sponsor decision to terminate study|0|||
143222606|NCT04497116|516362969|FG004|Overall Study|Sponsor decision to terminate study|0|||
143222607|NCT04497116|516362970|FG005|Overall Study|Sponsor decision to terminate study|0|||
143222608|NCT04497116|516362971|FG006|Overall Study|Sponsor decision to terminate study|1|||
143222609|NCT04497116|516362972|FG007|Overall Study|Sponsor decision to terminate study|0|||
143222610|NCT04497116|516362973|FG008|Overall Study|Sponsor decision to terminate study|0|||
143222611|NCT04497116|516362974|FG009|Overall Study|Sponsor decision to terminate study|1|||
143222612|NCT04497116|516362975|FG010|Overall Study|Sponsor decision to terminate study|0|||
143222613|NCT04497116|516362976|FG011|Overall Study|Sponsor decision to terminate study|0|||
143222614|NCT04497116|516362977|FG012|Overall Study|Sponsor decision to terminate study|0|||
143222615|NCT04497116|516362978|FG013|Overall Study|Sponsor decision to terminate study|0|||
143222616|NCT04497116|516362979|FG014|Overall Study|Sponsor decision to terminate study|0|||
143222617|NCT04497116|516362980|FG015|Overall Study|Sponsor decision to terminate study|0|||
143222618|NCT04497116|516362981|FG016|Overall Study|Sponsor decision to terminate study|0|||
143222619|NCT04497116|516362982|FG017|Overall Study|Sponsor decision to terminate study|0|||
143222620|NCT04497116|516362983|FG018|Overall Study|Sponsor decision to terminate study|0|||
143222621|NCT04497116|516362984|FG019|Overall Study|Sponsor decision to terminate study|1|||
143222622|NCT04497116|516362985|FG020|Overall Study|Sponsor decision to terminate study|0|||
143222623|NCT04497116|516362986|FG021|Overall Study|Sponsor decision to terminate study|0|||
143222624|NCT04497116|516362987|FG022|Overall Study|Sponsor decision to terminate study|0|||
143222625|NCT04497116|516362988|FG023|Overall Study|Sponsor decision to terminate study|0|||
143222626|NCT04497116|516362989|FG024|Overall Study|Sponsor decision to terminate study|0|||
143222627|NCT04497116|516362965|FG000|Overall Study|Death|4|||
143222628|NCT04497116|516362966|FG001|Overall Study|Death|5|||
143222629|NCT04497116|516362967|FG002|Overall Study|Death|2|||
143222630|NCT04497116|516362968|FG003|Overall Study|Death|2|||
143222631|NCT04497116|516362969|FG004|Overall Study|Death|1|||
143222632|NCT04497116|516362970|FG005|Overall Study|Death|1|||
143222633|NCT04497116|516362971|FG006|Overall Study|Death|3|||
143222634|NCT04497116|516362972|FG007|Overall Study|Death|10|||
143222635|NCT04497116|516362973|FG008|Overall Study|Death|37|||
143268031|NCT00598702|516536810|FG005|Overall Study|Other|1|||
143268032|NCT00598702|516536811|FG006|Overall Study|Other|0|||
143268033|NCT00598702|516536812|FG007|Overall Study|Other|0|||
143268034|NCT00598702|516536805|FG000|Overall Study|Early discharge from hospital|0|||
143268035|NCT00598702|516536806|FG001|Overall Study|Early discharge from hospital|0|||
143268036|NCT00598702|516536807|FG002|Overall Study|Early discharge from hospital|2|||
143268037|NCT00598702|516536808|FG003|Overall Study|Early discharge from hospital|5|||
143268038|NCT00598702|516536809|FG004|Overall Study|Early discharge from hospital|0|||
143268039|NCT00598702|516536810|FG005|Overall Study|Early discharge from hospital|10|||
143268040|NCT00598702|516536811|FG006|Overall Study|Early discharge from hospital|1|||
143222636|NCT04497116|516362974|FG009|Overall Study|Death|17|||
143222637|NCT04497116|516362975|FG010|Overall Study|Death|2|||
143222638|NCT04497116|516362976|FG011|Overall Study|Death|1|||
143222639|NCT04497116|516362977|FG012|Overall Study|Death|1|||
143222640|NCT04497116|516362978|FG013|Overall Study|Death|3|||
143222641|NCT04497116|516362979|FG014|Overall Study|Death|18|||
143222642|NCT04497116|516362980|FG015|Overall Study|Death|3|||
143222643|NCT04497116|516362981|FG016|Overall Study|Death|2|||
143222644|NCT04497116|516362982|FG017|Overall Study|Death|1|||
143268041|NCT00598702|516536812|FG007|Overall Study|Early discharge from hospital|0|||
143268042|NCT00598702|516536805|FG000|Overall Study|Adverse Event|0|||
143268043|NCT00598702|516536806|FG001|Overall Study|Adverse Event|0|||
143222645|NCT04497116|516362983|FG018|Overall Study|Death|4|||
143222646|NCT04497116|516362984|FG019|Overall Study|Death|17|||
143222647|NCT04497116|516362985|FG020|Overall Study|Death|1|||
143222648|NCT04497116|516362986|FG021|Overall Study|Death|0|||
143222649|NCT04497116|516362987|FG022|Overall Study|Death|3|||
143222650|NCT04497116|516362988|FG023|Overall Study|Death|5|||
143222651|NCT04497116|516362989|FG024|Overall Study|Death|4|||
143222652|NCT04497116|516362965|FG000|Overall Study|Withdrawal by Subject|1|||
143268044|NCT00598702|516536807|FG002|Overall Study|Adverse Event|0|||
143222653|NCT04497116|516362966|FG001|Overall Study|Withdrawal by Subject|0|||
143222654|NCT04497116|516362967|FG002|Overall Study|Withdrawal by Subject|1|||
143222655|NCT04497116|516362968|FG003|Overall Study|Withdrawal by Subject|0|||
143222656|NCT04497116|516362969|FG004|Overall Study|Withdrawal by Subject|0|||
143222657|NCT04497116|516362970|FG005|Overall Study|Withdrawal by Subject|0|||
143222658|NCT04497116|516362971|FG006|Overall Study|Withdrawal by Subject|0|||
143222659|NCT04497116|516362972|FG007|Overall Study|Withdrawal by Subject|7|||
143222660|NCT04497116|516362973|FG008|Overall Study|Withdrawal by Subject|14|||
143222661|NCT04497116|516362974|FG009|Overall Study|Withdrawal by Subject|3|||
143222662|NCT04497116|516362975|FG010|Overall Study|Withdrawal by Subject|3|||
143222663|NCT04497116|516362976|FG011|Overall Study|Withdrawal by Subject|0|||
143222664|NCT04497116|516362977|FG012|Overall Study|Withdrawal by Subject|1|||
143222665|NCT04497116|516362978|FG013|Overall Study|Withdrawal by Subject|0|||
143222666|NCT04497116|516362979|FG014|Overall Study|Withdrawal by Subject|7|||
143222667|NCT04497116|516362980|FG015|Overall Study|Withdrawal by Subject|1|||
143222668|NCT04497116|516362981|FG016|Overall Study|Withdrawal by Subject|3|||
143222669|NCT04497116|516362982|FG017|Overall Study|Withdrawal by Subject|1|||
143222670|NCT04497116|516362983|FG018|Overall Study|Withdrawal by Subject|1|||
143222671|NCT04497116|516362984|FG019|Overall Study|Withdrawal by Subject|5|||
143222672|NCT04497116|516362985|FG020|Overall Study|Withdrawal by Subject|2|||
143222673|NCT04497116|516362986|FG021|Overall Study|Withdrawal by Subject|2|||
143222674|NCT04497116|516362987|FG022|Overall Study|Withdrawal by Subject|2|||
143222675|NCT04497116|516362988|FG023|Overall Study|Withdrawal by Subject|4|||
143222676|NCT04497116|516362989|FG024|Overall Study|Withdrawal by Subject|3|||
143222677|NCT04497116|516362965|FG000|Overall Study|Physician Decision|0|||
143222678|NCT04497116|516362966|FG001|Overall Study|Physician Decision|0|||
143222679|NCT04497116|516362967|FG002|Overall Study|Physician Decision|0|||
143222680|NCT04497116|516362968|FG003|Overall Study|Physician Decision|0|||
143222681|NCT04497116|516362969|FG004|Overall Study|Physician Decision|0|||
143222682|NCT04497116|516362970|FG005|Overall Study|Physician Decision|0|||
143222683|NCT04497116|516362971|FG006|Overall Study|Physician Decision|0|||
143222684|NCT04497116|516362972|FG007|Overall Study|Physician Decision|0|||
143222685|NCT04497116|516362973|FG008|Overall Study|Physician Decision|0|||
143222686|NCT04497116|516362974|FG009|Overall Study|Physician Decision|0|||
143222687|NCT04497116|516362975|FG010|Overall Study|Physician Decision|0|||
143222688|NCT04497116|516362976|FG011|Overall Study|Physician Decision|0|||
143222689|NCT04497116|516362977|FG012|Overall Study|Physician Decision|0|||
143222690|NCT04497116|516362978|FG013|Overall Study|Physician Decision|0|||
143222691|NCT04497116|516362979|FG014|Overall Study|Physician Decision|0|||
143222692|NCT04497116|516362980|FG015|Overall Study|Physician Decision|0|||
143222693|NCT04497116|516362981|FG016|Overall Study|Physician Decision|0|||
143222694|NCT04497116|516362982|FG017|Overall Study|Physician Decision|0|||
143222695|NCT04497116|516362983|FG018|Overall Study|Physician Decision|0|||
143222696|NCT04497116|516362984|FG019|Overall Study|Physician Decision|0|||
143222697|NCT04497116|516362985|FG020|Overall Study|Physician Decision|0|||
143222698|NCT04497116|516362986|FG021|Overall Study|Physician Decision|0|||
143222699|NCT04497116|516362987|FG022|Overall Study|Physician Decision|0|||
143222700|NCT04497116|516362988|FG023|Overall Study|Physician Decision|1|||
143222701|NCT04497116|516362989|FG024|Overall Study|Physician Decision|0|||
143222702|NCT04497116|516362965|FG000|Overall Study|Clinical Progression Related|0|||
143222703|NCT04497116|516362966|FG001|Overall Study|Clinical Progression Related|0|||
143222704|NCT04497116|516362967|FG002|Overall Study|Clinical Progression Related|0|||
143222705|NCT04497116|516362968|FG003|Overall Study|Clinical Progression Related|0|||
143222706|NCT04497116|516362969|FG004|Overall Study|Clinical Progression Related|0|||
143222707|NCT04497116|516362970|FG005|Overall Study|Clinical Progression Related|0|||
143222708|NCT04497116|516362971|FG006|Overall Study|Clinical Progression Related|0|||
143222709|NCT04497116|516362972|FG007|Overall Study|Clinical Progression Related|0|||
143222710|NCT04497116|516362973|FG008|Overall Study|Clinical Progression Related|0|||
143222711|NCT04497116|516362974|FG009|Overall Study|Clinical Progression Related|1|||
143222712|NCT04497116|516362975|FG010|Overall Study|Clinical Progression Related|0|||
143222713|NCT04497116|516362976|FG011|Overall Study|Clinical Progression Related|0|||
143222714|NCT04497116|516362977|FG012|Overall Study|Clinical Progression Related|0|||
143222715|NCT04497116|516362978|FG013|Overall Study|Clinical Progression Related|0|||
143222716|NCT04497116|516362979|FG014|Overall Study|Clinical Progression Related|0|||
143222717|NCT04497116|516362980|FG015|Overall Study|Clinical Progression Related|0|||
143222718|NCT04497116|516362981|FG016|Overall Study|Clinical Progression Related|0|||
143222719|NCT04497116|516362982|FG017|Overall Study|Clinical Progression Related|0|||
143222720|NCT04497116|516362983|FG018|Overall Study|Clinical Progression Related|0|||
143222721|NCT04497116|516362984|FG019|Overall Study|Clinical Progression Related|0|||
143222722|NCT04497116|516362985|FG020|Overall Study|Clinical Progression Related|0|||
143222723|NCT04497116|516362986|FG021|Overall Study|Clinical Progression Related|0|||
143222724|NCT04497116|516362987|FG022|Overall Study|Clinical Progression Related|0|||
143222725|NCT04497116|516362988|FG023|Overall Study|Clinical Progression Related|0|||
143222726|NCT04497116|516362989|FG024|Overall Study|Clinical Progression Related|0|||
143222727|NCT02698826|516362993|FG000|Overall Study|Death|13|||
143222728|NCT02698826|516362993|FG000|Overall Study|Adverse Event|1|||
143222729|NCT01508169|516362996|FG000|Overall Study|Adverse Event|1|||
143222730|NCT01508169|516362997|FG001|Overall Study|Adverse Event|0|||
143222731|NCT01508169|516362996|FG000|Overall Study|Withdrawal by Subject|1|||
143222732|NCT01508169|516362997|FG001|Overall Study|Withdrawal by Subject|0|||
143222733|NCT01508169|516362996|FG000|Overall Study|Lost to Follow-up|1|||
143222734|NCT01508169|516362997|FG001|Overall Study|Lost to Follow-up|2|||
143222735|NCT03259087|516362998|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
143222736|NCT03259087|516362999|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
143222737|NCT03259087|516363000|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
143222738|NCT03259087|516363001|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
143222739|NCT03259087|516363002|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
143222740|NCT03259087|516362998|FG000|Period 2 of Part 2|Adverse Event|0|||
143222741|NCT03259087|516362999|FG001|Period 2 of Part 2|Adverse Event|0|||
143222742|NCT03259087|516363000|FG002|Period 2 of Part 2|Adverse Event|0|||
143222743|NCT03259087|516363001|FG003|Period 2 of Part 2|Adverse Event|0|||
143222744|NCT03259087|516363002|FG004|Period 2 of Part 2|Adverse Event|1|||
143222745|NCT04524858|516363003|FG000|Overall Study|Adverse Event|1|||
143222746|NCT01623115|516363004|FG000|Overall Study|Randomized but not treated|0|||
143222747|NCT01623115|516363005|FG001|Overall Study|Randomized but not treated|1|||
143222748|NCT01623115|516363004|FG000|Overall Study|Physician Decision|1|||
143222749|NCT01623115|516363005|FG001|Overall Study|Physician Decision|0|||
143222750|NCT01623115|516363004|FG000|Overall Study|Participants moved|1|||
143222751|NCT01623115|516363005|FG001|Overall Study|Participants moved|5|||
143222752|NCT01623115|516363004|FG000|Overall Study|Adverse Event|10|||
143222753|NCT01623115|516363005|FG001|Overall Study|Adverse Event|13|||
143222754|NCT01623115|516363004|FG000|Overall Study|Poor compliance to protocol|4|||
143222755|NCT01623115|516363005|FG001|Overall Study|Poor compliance to protocol|10|||
143222756|NCT01623115|516363004|FG000|Overall Study|Consent withdrawn by participant|2|||
143222757|NCT01623115|516363005|FG001|Overall Study|Consent withdrawn by participant|6|||
143222758|NCT01623115|516363004|FG000|Overall Study|Related to study drug administration|0|||
143222759|NCT01623115|516363005|FG001|Overall Study|Related to study drug administration|2|||
143222760|NCT01623115|516363004|FG000|Overall Study|Last visit outside protocol visit window|14|||
143222761|NCT01623115|516363005|FG001|Overall Study|Last visit outside protocol visit window|26|||
143222762|NCT01623115|516363004|FG000|Overall Study|Site closure|1|||
143222763|NCT01623115|516363005|FG001|Overall Study|Site closure|7|||
143222764|NCT01623115|516363004|FG000|Overall Study|Death|0|||
143222765|NCT01623115|516363005|FG001|Overall Study|Death|4|||
143222766|NCT01623115|516363004|FG000|Overall Study|Other than specified above|0|||
143222767|NCT01623115|516363005|FG001|Overall Study|Other than specified above|3|||
143222768|NCT02366195|516363009|FG000|Overall Study|Protocol-specified criteria|3|||
143222769|NCT02366195|516363009|FG000|Overall Study|Withdrawal by Subject|9|||
143222770|NCT02366195|516363009|FG000|Overall Study|Lost to Follow-up|1|||
143222771|NCT02366195|516363009|FG000|Overall Study|Death|41|||
143222772|NCT00113841|516363010|FG000|Overall Study|Disease progression|0|||
143222773|NCT00113841|516363011|FG001|Overall Study|Disease progression|2|||
143222774|NCT00113841|516363010|FG000|Overall Study|Non-compliant|1|||
143222775|NCT00113841|516363011|FG001|Overall Study|Non-compliant|0|||
143222776|NCT01788566|516363012|FG000|Overall Study|Death|4|||
143222777|NCT01788566|516363012|FG000|Overall Study|Adverse Event|1|||
143222778|NCT01788566|516363012|FG000|Overall Study|Clinical Progressive Disease|3|||
143222779|NCT00580723|516363013|FG000|Overall Study|Did not want to participate in extension|3|||
143222780|NCT00580723|516363013|FG000|Overall Study|Lost to Follow-up|5|||
143222781|NCT05202418|516363014|FG000|Overall Study|Withdrawal by Subject|2|||
143222782|NCT05202418|516363015|FG001|Overall Study|Withdrawal by Subject|1|||
143222783|NCT05202418|516363014|FG000|Overall Study|Lost to Follow-up|1|||
143222784|NCT05202418|516363015|FG001|Overall Study|Lost to Follow-up|1|||
143222785|NCT02562716|516363016|FG000|Overall Study|Adverse Event|7|||
143222786|NCT02562716|516363017|FG001|Overall Study|Adverse Event|14|||
143222787|NCT02562716|516363016|FG000|Overall Study|Withdrawal unrelated to AE|7|||
143222788|NCT02562716|516363017|FG001|Overall Study|Withdrawal unrelated to AE|1|||
143222789|NCT02562716|516363016|FG000|Overall Study|Progression|8|||
143222790|NCT02562716|516363017|FG001|Overall Study|Progression|10|||
143222791|NCT02562716|516363016|FG000|Overall Study|Death|2|||
143268045|NCT00598702|516536808|FG003|Overall Study|Adverse Event|1|||
143268046|NCT00598702|516536809|FG004|Overall Study|Adverse Event|0|||
143222792|NCT02562716|516363017|FG001|Overall Study|Death|1|||
143222793|NCT02562716|516363016|FG000|Overall Study|Not protocol specified|4|||
143222794|NCT02562716|516363017|FG001|Overall Study|Not protocol specified|2|||
143222795|NCT02519439|516363018|FG000|Overall Study|Study Termination|19|||
143222796|NCT02519439|516363018|FG000|Overall Study|Withdrawal by Subject|1|||
143222797|NCT02519439|516363018|FG000|Overall Study|Adverse Event|1|||
143222798|NCT01539759|516363023|FG000|Overall Study|Lost to Follow-up|6|||
143222799|NCT01539759|516363024|FG001|Overall Study|Lost to Follow-up|8|||
143222800|NCT01076959|516363025|FG000|Overall Study|Adverse Event|767|||
143222801|NCT01076959|516363025|FG000|Overall Study|Lack of Efficacy|849|||
143222802|NCT01076959|516363025|FG000|Overall Study|Non-compliance|274|||
143222803|NCT01076959|516363025|FG000|Overall Study|Lost to Follow-up|241|||
143222804|NCT01076959|516363025|FG000|Overall Study|Other|119|||
143222805|NCT02868554|516363026|FG000|Overall Study|Lost to Follow-up|3|||
143222806|NCT02868554|516363027|FG001|Overall Study|Lost to Follow-up|0|||
143222807|NCT02868554|516363028|FG002|Overall Study|Lost to Follow-up|1|||
143222808|NCT03081884|516363029|FG000|Overall Study|deferred prostate cancer treatment|1|||
143222809|NCT03081884|516363029|FG000|Overall Study|metastasis managed with systemic therapy|3|||
143222810|NCT03948334|516363030|FG000|Overall Study|Adverse Event|1|||
143222811|NCT03948334|516363031|FG001|Overall Study|Adverse Event|4|||
143222812|NCT03948334|516363030|FG000|Overall Study|Lack of Efficacy|2|||
143222813|NCT03948334|516363031|FG001|Overall Study|Lack of Efficacy|0|||
143222814|NCT03948334|516363030|FG000|Overall Study|Lost to Follow-up|1|||
143222815|NCT03948334|516363031|FG001|Overall Study|Lost to Follow-up|0|||
143222816|NCT03948334|516363030|FG000|Overall Study|Physician Decision|1|||
143222817|NCT03948334|516363031|FG001|Overall Study|Physician Decision|0|||
143222818|NCT03948334|516363030|FG000|Overall Study|Pregnancy|0|||
143222819|NCT03948334|516363031|FG001|Overall Study|Pregnancy|1|||
143222820|NCT03948334|516363030|FG000|Overall Study|Protocol Deviation|1|||
143222821|NCT03948334|516363031|FG001|Overall Study|Protocol Deviation|0|||
143222822|NCT03948334|516363030|FG000|Overall Study|Study terminated by Sponsor|50|||
143222823|NCT03948334|516363031|FG001|Overall Study|Study terminated by Sponsor|51|||
143222824|NCT03948334|516363030|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
143222825|NCT03948334|516363031|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
143222826|NCT03066596|516363032|FG000|Overall Study|Withdrawal by Subject|4|||
143222827|NCT03066596|516363033|FG001|Overall Study|Withdrawal by Subject|2|||
143222828|NCT03066596|516363032|FG000|Overall Study|Lost to Follow-up|14|||
143222829|NCT03066596|516363033|FG001|Overall Study|Lost to Follow-up|10|||
143222830|NCT02330055|516363034|FG000|Overall Study|technical issues|2|||
143222831|NCT02330055|516363035|FG001|Overall Study|technical issues|0|||
143222832|NCT02330055|516363034|FG000|Overall Study|participant forgot to wear device|5|||
143222833|NCT02330055|516363035|FG001|Overall Study|participant forgot to wear device|5|||
143222834|NCT02330055|516363034|FG000|Overall Study|data for less than 60 minutes|3|||
143222835|NCT02330055|516363035|FG001|Overall Study|data for less than 60 minutes|3|||
143222836|NCT02330055|516363034|FG000|Overall Study|participant did not sleep|0|||
143222837|NCT02330055|516363035|FG001|Overall Study|participant did not sleep|1|||
143222838|NCT04628780|516363039|FG000|Overall Study|Death|0|||
143222839|NCT04628780|516363040|FG001|Overall Study|Death|1|||
143222840|NCT04628780|516363041|FG002|Overall Study|Death|0|||
143222841|NCT04628780|516363042|FG003|Overall Study|Death|0|||
143222842|NCT04628780|516363043|FG004|Overall Study|Death|1|||
143222843|NCT04628780|516363044|FG005|Overall Study|Death|0|||
143222844|NCT04628780|516363039|FG000|Overall Study|Physician Decision|2|||
143222845|NCT04628780|516363040|FG001|Overall Study|Physician Decision|0|||
143222846|NCT04628780|516363041|FG002|Overall Study|Physician Decision|0|||
143222847|NCT04628780|516363042|FG003|Overall Study|Physician Decision|0|||
143222848|NCT04628780|516363043|FG004|Overall Study|Physician Decision|2|||
143222849|NCT04628780|516363044|FG005|Overall Study|Physician Decision|0|||
143222850|NCT04628780|516363039|FG000|Overall Study|Progressive disease|2|||
143222851|NCT04628780|516363040|FG001|Overall Study|Progressive disease|2|||
143222852|NCT04628780|516363041|FG002|Overall Study|Progressive disease|2|||
143222853|NCT04628780|516363042|FG003|Overall Study|Progressive disease|3|||
143222854|NCT04628780|516363043|FG004|Overall Study|Progressive disease|9|||
143222855|NCT04628780|516363044|FG005|Overall Study|Progressive disease|4|||
143222856|NCT04628780|516363039|FG000|Overall Study|Withdrawal by Subject|0|||
143222857|NCT04628780|516363040|FG001|Overall Study|Withdrawal by Subject|1|||
143222858|NCT04628780|516363041|FG002|Overall Study|Withdrawal by Subject|2|||
143268047|NCT00598702|516536810|FG005|Overall Study|Adverse Event|0|||
143222859|NCT04628780|516363042|FG003|Overall Study|Withdrawal by Subject|0|||
143222860|NCT04628780|516363043|FG004|Overall Study|Withdrawal by Subject|3|||
143222861|NCT04628780|516363044|FG005|Overall Study|Withdrawal by Subject|1|||
143222862|NCT04628780|516363039|FG000|Overall Study|Global deterioration of health status|0|||
143222863|NCT04628780|516363040|FG001|Overall Study|Global deterioration of health status|0|||
143222864|NCT04628780|516363041|FG002|Overall Study|Global deterioration of health status|0|||
143222865|NCT04628780|516363042|FG003|Overall Study|Global deterioration of health status|0|||
143222866|NCT04628780|516363043|FG004|Overall Study|Global deterioration of health status|1|||
143222867|NCT04628780|516363044|FG005|Overall Study|Global deterioration of health status|1|||
143222868|NCT03269994|516363046|FG000|Overall Study|Withdrawal by Subject|4|||
143222869|NCT03269994|516363047|FG001|Overall Study|Withdrawal by Subject|5|||
143222870|NCT03269994|516363046|FG000|Overall Study|Unresectable at surgery|39|||
143222871|NCT03269994|516363047|FG001|Overall Study|Unresectable at surgery|58|||
143222872|NCT03269994|516363046|FG000|Overall Study|Patient canceled surgery|5|||
143222873|NCT03269994|516363047|FG001|Overall Study|Patient canceled surgery|14|||
143222874|NCT03269994|516363046|FG000|Overall Study|Preoperative progression|14|||
143222875|NCT03269994|516363047|FG001|Overall Study|Preoperative progression|9|||
143222876|NCT03269994|516363046|FG000|Overall Study|Preoperative infection|10|||
143222877|NCT03269994|516363047|FG001|Overall Study|Preoperative infection|4|||
143222878|NCT03269994|516363046|FG000|Overall Study|Kidney insufficiency|1|||
143222879|NCT03269994|516363047|FG001|Overall Study|Kidney insufficiency|0|||
143222880|NCT03269994|516363046|FG000|Overall Study|Drug allergy|0|||
143222881|NCT03269994|516363047|FG001|Overall Study|Drug allergy|2|||
143222882|NCT03269994|516363046|FG000|Overall Study|Operation changed to different resection|9|||
143222883|NCT03269994|516363047|FG001|Overall Study|Operation changed to different resection|0|||
143222884|NCT03269994|516363046|FG000|Overall Study|Preoperative steroid|0|||
143222885|NCT03269994|516363047|FG001|Overall Study|Preoperative steroid|3|||
143222886|NCT03269994|516363046|FG000|Overall Study|Accrual Closed|2|||
143222887|NCT03269994|516363047|FG001|Overall Study|Accrual Closed|0|||
143222888|NCT03269994|516363046|FG000|Overall Study|Operation changed to different resection|0|||
143222889|NCT03269994|516363047|FG001|Overall Study|Operation changed to different resection|10|||
143222890|NCT04378270|516363050|FG000|Overall Study|Lack of Efficacy|1|||
143222891|NCT04378270|516363050|FG000|Overall Study|Withdrawal by Subject|1|||
143222892|NCT04378270|516363050|FG000|Overall Study|Screen Failure|1|||
143222893|NCT04378270|516363050|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
143222894|NCT01327599|516363051|FG000|Overall Study|Adverse Event|1|||
143222895|NCT01327599|516363051|FG000|Overall Study|Could Not Attend Visit|1|||
143222896|NCT01327599|516363051|FG000|Overall Study|Withdrawal of Consent|1|||
143222897|NCT01236521|516363052|FG000|Overall Study|Withdrawal by Subject|12|||
143222898|NCT01236521|516363053|FG001|Overall Study|Withdrawal by Subject|17|||
143222899|NCT01236521|516363052|FG000|Overall Study|Death|2|||
143222900|NCT01236521|516363053|FG001|Overall Study|Death|1|||
143222901|NCT01236521|516363052|FG000|Overall Study|Lost to Follow-up|9|||
143222902|NCT01236521|516363053|FG001|Overall Study|Lost to Follow-up|7|||
143222903|NCT04266795|516363056|FG000|Overall Study|Adverse Event|10|||
143222904|NCT04266795|516363057|FG001|Overall Study|Adverse Event|19|||
143222905|NCT04266795|516363056|FG000|Overall Study|Death|7|||
143222906|NCT04266795|516363057|FG001|Overall Study|Death|8|||
143222907|NCT04266795|516363056|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
143222908|NCT04266795|516363057|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
143222909|NCT04266795|516363056|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
143222910|NCT04266795|516363057|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
143222911|NCT04266795|516363056|FG000|Overall Study|Progressive Disease|12|||
143222912|NCT04266795|516363057|FG001|Overall Study|Progressive Disease|9|||
143222913|NCT04266795|516363056|FG000|Overall Study|Withdrawal by Patient|5|||
143222914|NCT04266795|516363057|FG001|Overall Study|Withdrawal by Patient|6|||
143222915|NCT04266795|516363056|FG000|Overall Study|Disease Relapse|3|||
143222916|NCT04266795|516363057|FG001|Overall Study|Disease Relapse|6|||
143222917|NCT04266795|516363056|FG000|Overall Study|Reason not Specified|12|||
143222918|NCT04266795|516363057|FG001|Overall Study|Reason not Specified|10|||
143222919|NCT04266795|516363056|FG000|Overall Study|Participants Ongoing on Treatment|25|||
143222920|NCT04266795|516363057|FG001|Overall Study|Participants Ongoing on Treatment|23|||
143222921|NCT03043872|516363058|FG000|Overall Study|Withdrawal by Subject|6|||
143222922|NCT03043872|516363059|FG001|Overall Study|Withdrawal by Subject|6|||
143222923|NCT03043872|516363060|FG002|Overall Study|Withdrawal by Subject|15|||
143222924|NCT03043872|516363058|FG000|Overall Study|Lost to Follow-up|2|||
143222925|NCT03043872|516363059|FG001|Overall Study|Lost to Follow-up|1|||
143222926|NCT03043872|516363060|FG002|Overall Study|Lost to Follow-up|1|||
143222927|NCT03043872|516363058|FG000|Overall Study|Death|270|||
143222928|NCT03043872|516363059|FG001|Overall Study|Death|269|||
143222929|NCT03043872|516363060|FG002|Overall Study|Death|296|||
143222930|NCT02807623|516364961|FG000|Overall Study|Lost to Follow-up|23|||
143222931|NCT02807623|516364962|FG001|Overall Study|Lost to Follow-up|18|||
143222932|NCT02807623|516364963|FG002|Overall Study|Lost to Follow-up|22|||
143222933|NCT02807623|516364961|FG000|Overall Study|Drug intolerance|0|||
143222934|NCT02807623|516364962|FG001|Overall Study|Drug intolerance|1|||
143222935|NCT02807623|516364963|FG002|Overall Study|Drug intolerance|0|||
143222936|NCT02807623|516364961|FG000|Overall Study|incomplete blood draw|0|||
143222937|NCT02807623|516364962|FG001|Overall Study|incomplete blood draw|2|||
143222938|NCT02807623|516364963|FG002|Overall Study|incomplete blood draw|1|||
143222939|NCT00330759|516364966|FG000|Overall Study|Death|316|||
143222940|NCT00330759|516364967|FG001|Overall Study|Death|310|||
143222941|NCT00330759|516364966|FG000|Overall Study|Disease progression|104|||
143222942|NCT00330759|516364967|FG001|Overall Study|Disease progression|126|||
143222943|NCT00330759|516364966|FG000|Overall Study|Withdrawal by Subject|143|||
143222944|NCT00330759|516364967|FG001|Overall Study|Withdrawal by Subject|124|||
143222945|NCT00330759|516364966|FG000|Overall Study|Adverse Event|48|||
143222946|NCT00330759|516364967|FG001|Overall Study|Adverse Event|36|||
143222947|NCT00330759|516364966|FG000|Overall Study|Participant request|31|||
143222948|NCT00330759|516364967|FG001|Overall Study|Participant request|22|||
143222949|NCT00330759|516364966|FG000|Overall Study|Lost to Follow-up|16|||
143222950|NCT00330759|516364967|FG001|Overall Study|Lost to Follow-up|22|||
143222951|NCT00330759|516364966|FG000|Overall Study|Noncompliance|15|||
143222952|NCT00330759|516364967|FG001|Overall Study|Noncompliance|17|||
143222953|NCT00330759|516364966|FG000|Overall Study|Physician Decision|1|||
143222954|NCT00330759|516364967|FG001|Overall Study|Physician Decision|2|||
143222955|NCT00330759|516364966|FG000|Overall Study|Protocol deviation|0|||
143222956|NCT00330759|516364967|FG001|Overall Study|Protocol deviation|2|||
143222957|NCT00330759|516364966|FG000|Overall Study|Ineligibility determined|2|||
143222958|NCT00330759|516364967|FG001|Overall Study|Ineligibility determined|1|||
143222959|NCT00330759|516364966|FG000|Overall Study|Other|36|||
143222960|NCT00330759|516364967|FG001|Overall Study|Other|44|||
143222961|NCT01380769|516364968|FG000|Overall Study|Withdrawal by Subject|7|||
143222962|NCT01380769|516364969|FG001|Overall Study|Withdrawal by Subject|11|||
143222963|NCT01380769|516364968|FG000|Overall Study|Physician Decision|1|||
143222964|NCT01380769|516364969|FG001|Overall Study|Physician Decision|1|||
143222965|NCT01380769|516364968|FG000|Overall Study|Adverse Event|1|||
143222966|NCT01380769|516364969|FG001|Overall Study|Adverse Event|1|||
143222967|NCT01380769|516364968|FG000|Overall Study|Protocol Violation|0|||
143222968|NCT01380769|516364969|FG001|Overall Study|Protocol Violation|1|||
143222969|NCT02107703|516364980|FG000|Overall Study|Withdrawal by Subject|46|||
143222970|NCT02107703|516364981|FG001|Overall Study|Withdrawal by Subject|21|||
143222971|NCT02107703|516364980|FG000|Overall Study|Lost to Follow-up|20|||
143222972|NCT02107703|516364981|FG001|Overall Study|Lost to Follow-up|9|||
143222973|NCT02107703|516364980|FG000|Overall Study|On study treatment/follow up|48|||
143222974|NCT02107703|516364981|FG001|Overall Study|On study treatment/follow up|5|||
143222975|NCT03456076|516364986|FG000|Overall Study|Withdrawal by Subject|5|||
143222976|NCT03456076|516364987|FG001|Overall Study|Withdrawal by Subject|9|||
143222977|NCT03456076|516364986|FG000|Overall Study|Protocol deviation|0|||
143222978|NCT03456076|516364987|FG001|Overall Study|Protocol deviation|1|||
143222979|NCT03456076|516364986|FG000|Overall Study|Lost to Follow-up|0|||
143222980|NCT03456076|516364987|FG001|Overall Study|Lost to Follow-up|1|||
143222981|NCT03456076|516364986|FG000|Overall Study|Death|2|||
143222982|NCT03456076|516364987|FG001|Overall Study|Death|5|||
143222983|NCT03456076|516364986|FG000|Overall Study|Study ongoing|123|||
143222984|NCT03456076|516364987|FG001|Overall Study|Study ongoing|111|||
143222985|NCT00466440|516364988|FG000|Overall Study|Adverse Event|0|||
143222986|NCT00466440|516364989|FG001|Overall Study|Adverse Event|3|||
143222987|NCT00466440|516364990|FG002|Overall Study|Adverse Event|1|||
143222988|NCT00466440|516364988|FG000|Overall Study|Death|1|||
143222989|NCT00466440|516364989|FG001|Overall Study|Death|1|||
143222990|NCT00466440|516364990|FG002|Overall Study|Death|0|||
143222991|NCT00466440|516364988|FG000|Overall Study|Progressive disease|13|||
143222992|NCT00466440|516364989|FG001|Overall Study|Progressive disease|5|||
143222993|NCT00466440|516364990|FG002|Overall Study|Progressive disease|4|||
143222994|NCT00466440|516364988|FG000|Overall Study|Lost to Follow-up|0|||
143222995|NCT00466440|516364989|FG001|Overall Study|Lost to Follow-up|1|||
143222996|NCT00466440|516364990|FG002|Overall Study|Lost to Follow-up|0|||
143222997|NCT00466440|516364988|FG000|Overall Study|Physician Decision|0|||
143222998|NCT00466440|516364989|FG001|Overall Study|Physician Decision|1|||
143222999|NCT00466440|516364990|FG002|Overall Study|Physician Decision|2|||
143223000|NCT00466440|516364988|FG000|Overall Study|Protocol entry criteria not met|0|||
143223001|NCT00466440|516364989|FG001|Overall Study|Protocol entry criteria not met|0|||
143223002|NCT00466440|516364990|FG002|Overall Study|Protocol entry criteria not met|4|||
143223003|NCT00466440|516364988|FG000|Overall Study|Withdrawal by Subject|0|||
143223004|NCT00466440|516364989|FG001|Overall Study|Withdrawal by Subject|1|||
143223005|NCT00466440|516364990|FG002|Overall Study|Withdrawal by Subject|0|||
143223006|NCT00466440|516364988|FG000|Overall Study|Sponsor decision|0|||
143223007|NCT00466440|516364989|FG001|Overall Study|Sponsor decision|0|||
143223008|NCT00466440|516364990|FG002|Overall Study|Sponsor decision|1|||
143223009|NCT02045095|516364991|FG000|Overall Study|Other|0|||
143223010|NCT02045095|516364992|FG001|Overall Study|Other|0|||
143223011|NCT02045095|516364993|FG002|Overall Study|Other|1|||
143223012|NCT02045095|516364994|FG003|Overall Study|Other|0|||
143223013|NCT02045095|516364995|FG004|Overall Study|Other|0|||
143223014|NCT02045095|516364996|FG005|Overall Study|Other|2|||
143223015|NCT02045095|516364997|FG006|Overall Study|Other|0|||
143223016|NCT02045095|516364991|FG000|Overall Study|Progressive Disease|3|||
143223017|NCT02045095|516364992|FG001|Overall Study|Progressive Disease|3|||
143223018|NCT02045095|516364993|FG002|Overall Study|Progressive Disease|2|||
143223019|NCT02045095|516364994|FG003|Overall Study|Progressive Disease|4|||
143223020|NCT02045095|516364995|FG004|Overall Study|Progressive Disease|2|||
143223021|NCT02045095|516364996|FG005|Overall Study|Progressive Disease|4|||
143223022|NCT02045095|516364997|FG006|Overall Study|Progressive Disease|1|||
143223023|NCT02045095|516364991|FG000|Overall Study|Withdrawal by Subject|0|||
143223024|NCT02045095|516364992|FG001|Overall Study|Withdrawal by Subject|0|||
143223025|NCT02045095|516364993|FG002|Overall Study|Withdrawal by Subject|0|||
143223026|NCT02045095|516364994|FG003|Overall Study|Withdrawal by Subject|0|||
143223027|NCT02045095|516364995|FG004|Overall Study|Withdrawal by Subject|3|||
143223028|NCT02045095|516364996|FG005|Overall Study|Withdrawal by Subject|0|||
143223029|NCT02045095|516364997|FG006|Overall Study|Withdrawal by Subject|0|||
143223030|NCT02045095|516364991|FG000|Overall Study|Adverse Event|0|||
143223031|NCT02045095|516364992|FG001|Overall Study|Adverse Event|1|||
143223032|NCT02045095|516364993|FG002|Overall Study|Adverse Event|1|||
143223033|NCT02045095|516364994|FG003|Overall Study|Adverse Event|0|||
143223034|NCT02045095|516364995|FG004|Overall Study|Adverse Event|0|||
143223035|NCT02045095|516364996|FG005|Overall Study|Adverse Event|2|||
143223036|NCT02045095|516364997|FG006|Overall Study|Adverse Event|0|||
143223037|NCT01485094|516365000|FG000|Overall Study|Adverse Event|1|||
143223038|NCT01485094|516365001|FG001|Overall Study|Adverse Event|1|||
143223039|NCT01485094|516365002|FG002|Overall Study|Adverse Event|1|||
143223040|NCT01485094|516365000|FG000|Overall Study|Lost to Follow-up|1|||
143223041|NCT01485094|516365001|FG001|Overall Study|Lost to Follow-up|0|||
143223042|NCT01485094|516365002|FG002|Overall Study|Lost to Follow-up|0|||
143223043|NCT01485094|516365000|FG000|Overall Study|Withdrawal by Subject|1|||
143223044|NCT01485094|516365001|FG001|Overall Study|Withdrawal by Subject|1|||
143223045|NCT01485094|516365002|FG002|Overall Study|Withdrawal by Subject|0|||
143223046|NCT00965081|516365003|FG000|Overall Study|Adverse Event|14|||
143223047|NCT00965081|516365004|FG001|Overall Study|Adverse Event|9|||
143223048|NCT00965081|516365003|FG000|Overall Study|Lack of Efficacy|2|||
143223049|NCT00965081|516365004|FG001|Overall Study|Lack of Efficacy|5|||
143223050|NCT00965081|516365003|FG000|Overall Study|Lost to Follow-up|4|||
143223051|NCT00965081|516365004|FG001|Overall Study|Lost to Follow-up|5|||
143268048|NCT00598702|516536811|FG006|Overall Study|Adverse Event|0|||
143268049|NCT00598702|516536812|FG007|Overall Study|Adverse Event|0|||
143268050|NCT00598702|516536805|FG000|Overall Study|Withdrawal by Subject|0|||
143268051|NCT00598702|516536806|FG001|Overall Study|Withdrawal by Subject|0|||
143268052|NCT00598702|516536807|FG002|Overall Study|Withdrawal by Subject|0|||
143268053|NCT00598702|516536808|FG003|Overall Study|Withdrawal by Subject|1|||
143268054|NCT00598702|516536809|FG004|Overall Study|Withdrawal by Subject|1|||
143268055|NCT00598702|516536810|FG005|Overall Study|Withdrawal by Subject|0|||
143223052|NCT00965081|516365003|FG000|Overall Study|Physician Decision|2|||
143223053|NCT00965081|516365004|FG001|Overall Study|Physician Decision|0|||
143223054|NCT00965081|516365003|FG000|Overall Study|Protocol Violation|2|||
143223055|NCT00965081|516365004|FG001|Overall Study|Protocol Violation|5|||
143223056|NCT00965081|516365003|FG000|Overall Study|Sponsor Decision|1|||
143223057|NCT00965081|516365004|FG001|Overall Study|Sponsor Decision|0|||
143268056|NCT00598702|516536811|FG006|Overall Study|Withdrawal by Subject|0|||
143268057|NCT00598702|516536812|FG007|Overall Study|Withdrawal by Subject|0|||
143268058|NCT00598702|516536805|FG000|Overall Study|Physician Decision|0|||
143268059|NCT00598702|516536806|FG001|Overall Study|Physician Decision|0|||
143268060|NCT00598702|516536807|FG002|Overall Study|Physician Decision|0|||
143268061|NCT00598702|516536808|FG003|Overall Study|Physician Decision|0|||
143268062|NCT00598702|516536809|FG004|Overall Study|Physician Decision|1|||
143268063|NCT00598702|516536810|FG005|Overall Study|Physician Decision|0|||
143268064|NCT00598702|516536811|FG006|Overall Study|Physician Decision|0|||
143268065|NCT00598702|516536812|FG007|Overall Study|Physician Decision|0|||
143268066|NCT00598702|516536805|FG000|Overall Study|Dose limiting toxicity|0|||
143268067|NCT00598702|516536806|FG001|Overall Study|Dose limiting toxicity|0|||
143268068|NCT00598702|516536807|FG002|Overall Study|Dose limiting toxicity|0|||
143268069|NCT00598702|516536808|FG003|Overall Study|Dose limiting toxicity|1|||
143268070|NCT00598702|516536809|FG004|Overall Study|Dose limiting toxicity|1|||
143268071|NCT00598702|516536810|FG005|Overall Study|Dose limiting toxicity|1|||
143268072|NCT00598702|516536811|FG006|Overall Study|Dose limiting toxicity|0|||
143268073|NCT00598702|516536812|FG007|Overall Study|Dose limiting toxicity|0|||
143268074|NCT02556203|516536813|FG000|Overall Study|Withdrawal by Subject|21|||
143268075|NCT02556203|516536814|FG001|Overall Study|Withdrawal by Subject|21|||
143268076|NCT02556203|516536813|FG000|Overall Study|Lost to Follow-up|5|||
143268077|NCT02556203|516536814|FG001|Overall Study|Lost to Follow-up|5|||
143268078|NCT02556203|516536813|FG000|Overall Study|Adverse Event|1|||
143223058|NCT00965081|516365003|FG000|Overall Study|Withdrawal by Subject|4|||
143268079|NCT02556203|516536814|FG001|Overall Study|Adverse Event|0|||
143268080|NCT03875768|516536815|FG000|Overall Study|Lost to Follow-up|16|||
143223059|NCT00965081|516365004|FG001|Overall Study|Withdrawal by Subject|7|||
143223060|NCT00965081|516365003|FG000|Overall Study|Switched to Rescue Arm|5|||
143223061|NCT00965081|516365004|FG001|Overall Study|Switched to Rescue Arm|12|||
143223062|NCT01367834|516365005|FG000|Overall Study|Withdrawal by Subject|2|||
143223063|NCT01367834|516365006|FG001|Overall Study|Withdrawal by Subject|2|||
143223064|NCT01367834|516365005|FG000|Overall Study|Study was ended.|0|||
143223065|NCT01367834|516365006|FG001|Overall Study|Study was ended.|1|||
143223066|NCT00988598|516365007|FG000|Overall Study|Withdrawal by Subject|2|||
143223067|NCT00988598|516365008|FG001|Overall Study|Withdrawal by Subject|0|||
143223068|NCT04435366|516365015|FG000|Year 1 (12 Months)|Adverse Event|3|||
143223069|NCT04435366|516365016|FG001|Year 1 (12 Months)|Adverse Event|0|||
143223070|NCT04435366|516365017|FG002|Year 1 (12 Months)|Adverse Event|2|||
143223071|NCT04435366|516365015|FG000|Year 1 (12 Months)|Death|2|||
143223072|NCT04435366|516365016|FG001|Year 1 (12 Months)|Death|0|||
143223073|NCT04435366|516365017|FG002|Year 1 (12 Months)|Death|1|||
143223074|NCT04435366|516365015|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
143223075|NCT04435366|516365016|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
143223076|NCT04435366|516365017|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
143223077|NCT04435366|516365015|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
143223078|NCT04435366|516365016|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
143223079|NCT04435366|516365017|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
143223080|NCT04435366|516365015|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
143223081|NCT04435366|516365016|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
143223082|NCT04435366|516365017|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
143223083|NCT04435366|516365015|FG000|Year 1 (12 Months)|Not treated|0|||
143223084|NCT04435366|516365016|FG001|Year 1 (12 Months)|Not treated|0|||
143223085|NCT04435366|516365017|FG002|Year 1 (12 Months)|Not treated|1|||
143223086|NCT04435366|516365015|FG000|Year 2 (12 Months)|Death|1|||
143223087|NCT04435366|516365016|FG001|Year 2 (12 Months)|Death|4|||
143223088|NCT04435366|516365017|FG002|Year 2 (12 Months)|Death|6|||
143223089|NCT04435366|516365015|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
143223090|NCT04435366|516365016|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
143223091|NCT04435366|516365017|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
143223092|NCT04435366|516365015|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
143223093|NCT04435366|516365016|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
143223094|NCT04435366|516365017|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
143223095|NCT04435366|516365015|FG000|Year 2 (12 Months)|Adverse Event|2|||
143223096|NCT04435366|516365016|FG001|Year 2 (12 Months)|Adverse Event|1|||
143223097|NCT04435366|516365017|FG002|Year 2 (12 Months)|Adverse Event|6|||
143223098|NCT04112810|516365022|FG000|Overall Study|Only 50 pts are evaluable as 1 pt withdrew before treatment.|1|||
143223099|NCT01156714|516365023|FG000|Overall Study|Withdrawal by Subject|9|||
143223100|NCT01156714|516365024|FG001|Overall Study|Withdrawal by Subject|4|||
143223101|NCT01156714|516365025|FG002|Overall Study|Withdrawal by Subject|3|||
143223102|NCT01132313|516365026|FG000|Overall Study|Lack of Efficacy|1|||
143223103|NCT01132313|516365027|FG001|Overall Study|Lack of Efficacy|0|||
143223104|NCT01132313|516365028|FG002|Overall Study|Lack of Efficacy|0|||
143223105|NCT01132313|516365029|FG003|Overall Study|Lack of Efficacy|0|||
143223106|NCT01132313|516365030|FG004|Overall Study|Lack of Efficacy|0|||
143223107|NCT01132313|516365031|FG005|Overall Study|Lack of Efficacy|0|||
143223108|NCT01132313|516365032|FG006|Overall Study|Lack of Efficacy|0|||
143223109|NCT01132313|516365033|FG007|Overall Study|Lack of Efficacy|3|||
143223110|NCT01132313|516365034|FG008|Overall Study|Lack of Efficacy|14|||
143223111|NCT01132313|516365035|FG009|Overall Study|Lack of Efficacy|16|||
143223112|NCT01132313|516365036|FG010|Overall Study|Lack of Efficacy|0|||
143223113|NCT01132313|516365037|FG011|Overall Study|Lack of Efficacy|0|||
143223114|NCT01132313|516365026|FG000|Overall Study|Not treated|2|||
143223115|NCT01132313|516365027|FG001|Overall Study|Not treated|0|||
143223116|NCT01132313|516365028|FG002|Overall Study|Not treated|0|||
143223117|NCT01132313|516365029|FG003|Overall Study|Not treated|0|||
143223118|NCT01132313|516365030|FG004|Overall Study|Not treated|2|||
143223119|NCT01132313|516365031|FG005|Overall Study|Not treated|1|||
143223120|NCT01132313|516365032|FG006|Overall Study|Not treated|3|||
143223121|NCT01132313|516365033|FG007|Overall Study|Not treated|0|||
143223122|NCT01132313|516365034|FG008|Overall Study|Not treated|0|||
143223123|NCT01132313|516365035|FG009|Overall Study|Not treated|0|||
143223124|NCT01132313|516365036|FG010|Overall Study|Not treated|0|||
143223125|NCT01132313|516365037|FG011|Overall Study|Not treated|0|||
143223126|NCT01132313|516365026|FG000|Overall Study|Adverse Event|0|||
143223127|NCT01132313|516365027|FG001|Overall Study|Adverse Event|0|||
143223128|NCT01132313|516365028|FG002|Overall Study|Adverse Event|4|||
143223129|NCT01132313|516365029|FG003|Overall Study|Adverse Event|10|||
143223130|NCT01132313|516365030|FG004|Overall Study|Adverse Event|19|||
143223131|NCT01132313|516365031|FG005|Overall Study|Adverse Event|6|||
143223132|NCT01132313|516365032|FG006|Overall Study|Adverse Event|5|||
143223133|NCT01132313|516365033|FG007|Overall Study|Adverse Event|3|||
143268081|NCT03875768|516536816|FG001|Overall Study|Lost to Follow-up|13|||
143223134|NCT01132313|516365034|FG008|Overall Study|Adverse Event|7|||
143223135|NCT01132313|516365035|FG009|Overall Study|Adverse Event|2|||
143223136|NCT01132313|516365036|FG010|Overall Study|Adverse Event|0|||
143223137|NCT01132313|516365037|FG011|Overall Study|Adverse Event|0|||
143223138|NCT01132313|516365026|FG000|Overall Study|Protocol Violation|0|||
143223139|NCT01132313|516365027|FG001|Overall Study|Protocol Violation|0|||
143223140|NCT01132313|516365028|FG002|Overall Study|Protocol Violation|0|||
143223141|NCT01132313|516365029|FG003|Overall Study|Protocol Violation|1|||
143223142|NCT01132313|516365030|FG004|Overall Study|Protocol Violation|0|||
143223143|NCT01132313|516365031|FG005|Overall Study|Protocol Violation|0|||
143223144|NCT01132313|516365032|FG006|Overall Study|Protocol Violation|0|||
143223145|NCT01132313|516365033|FG007|Overall Study|Protocol Violation|0|||
143223146|NCT01132313|516365034|FG008|Overall Study|Protocol Violation|0|||
143223147|NCT01132313|516365035|FG009|Overall Study|Protocol Violation|0|||
143223148|NCT01132313|516365036|FG010|Overall Study|Protocol Violation|0|||
143223149|NCT01132313|516365037|FG011|Overall Study|Protocol Violation|0|||
143223150|NCT01132313|516365026|FG000|Overall Study|Lost to Follow-up|0|||
143223151|NCT01132313|516365027|FG001|Overall Study|Lost to Follow-up|0|||
143223152|NCT01132313|516365028|FG002|Overall Study|Lost to Follow-up|1|||
143223153|NCT01132313|516365029|FG003|Overall Study|Lost to Follow-up|0|||
143223154|NCT01132313|516365030|FG004|Overall Study|Lost to Follow-up|0|||
143223155|NCT01132313|516365031|FG005|Overall Study|Lost to Follow-up|0|||
143223156|NCT01132313|516365032|FG006|Overall Study|Lost to Follow-up|0|||
143223157|NCT01132313|516365033|FG007|Overall Study|Lost to Follow-up|1|||
143223158|NCT01132313|516365034|FG008|Overall Study|Lost to Follow-up|0|||
143223159|NCT01132313|516365035|FG009|Overall Study|Lost to Follow-up|0|||
143223160|NCT01132313|516365036|FG010|Overall Study|Lost to Follow-up|0|||
143223161|NCT01132313|516365037|FG011|Overall Study|Lost to Follow-up|0|||
143223162|NCT01132313|516365026|FG000|Overall Study|Withdrawal by Subject|0|||
143223163|NCT01132313|516365027|FG001|Overall Study|Withdrawal by Subject|0|||
143223164|NCT01132313|516365028|FG002|Overall Study|Withdrawal by Subject|3|||
143223165|NCT01132313|516365029|FG003|Overall Study|Withdrawal by Subject|3|||
143223166|NCT01132313|516365030|FG004|Overall Study|Withdrawal by Subject|6|||
143223167|NCT01132313|516365031|FG005|Overall Study|Withdrawal by Subject|0|||
143223168|NCT01132313|516365032|FG006|Overall Study|Withdrawal by Subject|1|||
143223169|NCT01132313|516365033|FG007|Overall Study|Withdrawal by Subject|0|||
143223170|NCT01132313|516365034|FG008|Overall Study|Withdrawal by Subject|0|||
143223171|NCT01132313|516365035|FG009|Overall Study|Withdrawal by Subject|2|||
143223172|NCT01132313|516365036|FG010|Overall Study|Withdrawal by Subject|0|||
143223173|NCT01132313|516365037|FG011|Overall Study|Withdrawal by Subject|0|||
143223174|NCT01132313|516365026|FG000|Overall Study|Lack of antiviral response|0|||
143223175|NCT01132313|516365027|FG001|Overall Study|Lack of antiviral response|0|||
143223176|NCT01132313|516365028|FG002|Overall Study|Lack of antiviral response|12|||
143223177|NCT01132313|516365029|FG003|Overall Study|Lack of antiviral response|18|||
143223178|NCT01132313|516365030|FG004|Overall Study|Lack of antiviral response|18|||
143223179|NCT01132313|516365031|FG005|Overall Study|Lack of antiviral response|18|||
143223180|NCT01132313|516365032|FG006|Overall Study|Lack of antiviral response|21|||
143223181|NCT01132313|516365033|FG007|Overall Study|Lack of antiviral response|0|||
143223182|NCT01132313|516365034|FG008|Overall Study|Lack of antiviral response|0|||
143223183|NCT01132313|516365035|FG009|Overall Study|Lack of antiviral response|0|||
143223184|NCT01132313|516365036|FG010|Overall Study|Lack of antiviral response|1|||
143223185|NCT01132313|516365037|FG011|Overall Study|Lack of antiviral response|0|||
143223186|NCT01132313|516365026|FG000|Overall Study|Other reason not defined above|0|||
143223187|NCT01132313|516365027|FG001|Overall Study|Other reason not defined above|0|||
143223188|NCT01132313|516365028|FG002|Overall Study|Other reason not defined above|0|||
143223189|NCT01132313|516365029|FG003|Overall Study|Other reason not defined above|0|||
143223190|NCT01132313|516365030|FG004|Overall Study|Other reason not defined above|0|||
143223191|NCT01132313|516365031|FG005|Overall Study|Other reason not defined above|0|||
143223192|NCT01132313|516365032|FG006|Overall Study|Other reason not defined above|0|||
143223193|NCT01132313|516365033|FG007|Overall Study|Other reason not defined above|1|||
143223194|NCT01132313|516365034|FG008|Overall Study|Other reason not defined above|0|||
143223195|NCT01132313|516365035|FG009|Overall Study|Other reason not defined above|0|||
143223196|NCT01132313|516365036|FG010|Overall Study|Other reason not defined above|0|||
143223197|NCT01132313|516365037|FG011|Overall Study|Other reason not defined above|0|||
143223198|NCT04707469|516365041|FG000|Overall Study|Site closure|0|||
143223199|NCT04707469|516365042|FG001|Overall Study|Site closure|2|||
143223200|NCT04707469|516365043|FG002|Overall Study|Site closure|0|||
143223201|NCT04707469|516365041|FG000|Overall Study|Physician Decision|2|||
143223202|NCT04707469|516365042|FG001|Overall Study|Physician Decision|2|||
143223203|NCT04707469|516365043|FG002|Overall Study|Physician Decision|2|||
143223204|NCT04707469|516365041|FG000|Overall Study|Death|1|||
143223205|NCT04707469|516365042|FG001|Overall Study|Death|6|||
143223206|NCT04707469|516365043|FG002|Overall Study|Death|2|||
143223207|NCT04707469|516365041|FG000|Overall Study|Lost to Follow-up|9|||
143223208|NCT04707469|516365042|FG001|Overall Study|Lost to Follow-up|19|||
143223209|NCT04707469|516365043|FG002|Overall Study|Lost to Follow-up|14|||
143223210|NCT04707469|516365041|FG000|Overall Study|Withdrawal by Subject|17|||
143223211|NCT04707469|516365042|FG001|Overall Study|Withdrawal by Subject|16|||
143223212|NCT04707469|516365043|FG002|Overall Study|Withdrawal by Subject|12|||
143223213|NCT03201419|516365044|FG000|Overall Study|Adverse Event|3|||
143223214|NCT03201419|516365045|FG001|Overall Study|Adverse Event|1|||
143223215|NCT03201419|516365046|FG002|Overall Study|Adverse Event|0|||
143223216|NCT03201419|516365047|FG003|Overall Study|Adverse Event|0|||
143223217|NCT03201419|516365048|FG004|Overall Study|Adverse Event|1|||
143223218|NCT03201419|516365049|FG005|Overall Study|Adverse Event|1|||
143223219|NCT03201419|516365050|FG006|Overall Study|Adverse Event|5|||
143223220|NCT03201419|516365051|FG007|Overall Study|Adverse Event|0|||
143223221|NCT03201419|516365052|FG008|Overall Study|Adverse Event|0|||
143223222|NCT03201419|516365044|FG000|Overall Study|Lost to Follow-up|1|||
143223223|NCT03201419|516365045|FG001|Overall Study|Lost to Follow-up|0|||
143223224|NCT03201419|516365046|FG002|Overall Study|Lost to Follow-up|0|||
143223225|NCT03201419|516365047|FG003|Overall Study|Lost to Follow-up|0|||
143223226|NCT03201419|516365048|FG004|Overall Study|Lost to Follow-up|0|||
143223227|NCT03201419|516365049|FG005|Overall Study|Lost to Follow-up|0|||
143223228|NCT03201419|516365050|FG006|Overall Study|Lost to Follow-up|0|||
143223229|NCT03201419|516365051|FG007|Overall Study|Lost to Follow-up|0|||
143223230|NCT03201419|516365052|FG008|Overall Study|Lost to Follow-up|0|||
143223231|NCT03201419|516365044|FG000|Overall Study|Protocol Deviation|0|||
143223232|NCT03201419|516365045|FG001|Overall Study|Protocol Deviation|0|||
143223233|NCT03201419|516365046|FG002|Overall Study|Protocol Deviation|0|||
143223234|NCT03201419|516365047|FG003|Overall Study|Protocol Deviation|0|||
143223235|NCT03201419|516365048|FG004|Overall Study|Protocol Deviation|0|||
143223236|NCT03201419|516365049|FG005|Overall Study|Protocol Deviation|0|||
143223237|NCT03201419|516365050|FG006|Overall Study|Protocol Deviation|1|||
143223238|NCT03201419|516365051|FG007|Overall Study|Protocol Deviation|0|||
143223239|NCT03201419|516365052|FG008|Overall Study|Protocol Deviation|0|||
143223240|NCT03201419|516365044|FG000|Overall Study|Withdrawal by Subject|4|||
143223241|NCT03201419|516365045|FG001|Overall Study|Withdrawal by Subject|2|||
143223242|NCT03201419|516365046|FG002|Overall Study|Withdrawal by Subject|1|||
143223243|NCT03201419|516365047|FG003|Overall Study|Withdrawal by Subject|0|||
143223244|NCT03201419|516365048|FG004|Overall Study|Withdrawal by Subject|0|||
143223245|NCT03201419|516365049|FG005|Overall Study|Withdrawal by Subject|0|||
143223246|NCT03201419|516365050|FG006|Overall Study|Withdrawal by Subject|0|||
143223247|NCT03201419|516365051|FG007|Overall Study|Withdrawal by Subject|1|||
143223248|NCT03201419|516365052|FG008|Overall Study|Withdrawal by Subject|2|||
143223249|NCT03201419|516365044|FG000|Overall Study|Other|0|||
143223250|NCT03201419|516365045|FG001|Overall Study|Other|0|||
143223251|NCT03201419|516365046|FG002|Overall Study|Other|1|||
143223252|NCT03201419|516365047|FG003|Overall Study|Other|0|||
143223253|NCT03201419|516365048|FG004|Overall Study|Other|0|||
143223254|NCT03201419|516365049|FG005|Overall Study|Other|0|||
143223255|NCT03201419|516365050|FG006|Overall Study|Other|0|||
143223256|NCT03201419|516365051|FG007|Overall Study|Other|0|||
143223257|NCT03201419|516365052|FG008|Overall Study|Other|0|||
143223258|NCT03868943|516365055|FG000|Overall Study|Adverse Event|1|||
143223259|NCT02777827|516365056|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
143223260|NCT02777827|516365057|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
143223261|NCT02777827|516365058|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
143223262|NCT02777827|516365059|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
143223263|NCT02777827|516365060|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
143223264|NCT02777827|516365061|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
143223265|NCT04551066|516365062|FG000|Overall Study|Death|5|||
143223266|NCT04551066|516365063|FG001|Overall Study|Death|3|||
143268082|NCT03875768|516536815|FG000|Overall Study|Withdrawal by Subject|10|||
143268083|NCT03875768|516536816|FG001|Overall Study|Withdrawal by Subject|21|||
143268084|NCT03875768|516536815|FG000|Overall Study|Did not complete assessment|21|||
143223267|NCT04551066|516365062|FG000|Overall Study|Lost to Follow-up|1|||
143223268|NCT04551066|516365063|FG001|Overall Study|Lost to Follow-up|0|||
143223269|NCT04551066|516365062|FG000|Overall Study|Sponsor Decision|104|||
143223270|NCT04551066|516365063|FG001|Overall Study|Sponsor Decision|117|||
143223271|NCT04551066|516365062|FG000|Overall Study|Withdrawal by Subject|8|||
143223272|NCT04551066|516365063|FG001|Overall Study|Withdrawal by Subject|2|||
143223273|NCT04551066|516365062|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|2|||
143223274|NCT04551066|516365063|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
143223275|NCT04551066|516365062|FG000|Overall Study|Adverse Event|2|||
143223276|NCT04551066|516365063|FG001|Overall Study|Adverse Event|0|||
143223277|NCT04551066|516365062|FG000|Overall Study|Physician Decision|2|||
143223278|NCT04551066|516365063|FG001|Overall Study|Physician Decision|0|||
143223279|NCT04551066|516365062|FG000|Overall Study|Protocol Violation|1|||
143223280|NCT04551066|516365063|FG001|Overall Study|Protocol Violation|0|||
143223281|NCT04551066|516365062|FG000|Overall Study|Lack of Efficacy|0|||
143223282|NCT04551066|516365063|FG001|Overall Study|Lack of Efficacy|1|||
143223283|NCT04551066|516365062|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
143223284|NCT04551066|516365063|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
143223285|NCT00369577|516365064|FG000|Overall Study|Withdrawal by Subject|0|||
143223286|NCT00369577|516365065|FG001|Overall Study|Withdrawal by Subject|0|||
143223287|NCT00369577|516365066|FG002|Overall Study|Withdrawal by Subject|1|||
143223288|NCT03915470|516365067|FG000|Overall Study|Death|3|||
143223289|NCT03915470|516365068|FG001|Overall Study|Death|1|||
143223290|NCT03915470|516365067|FG000|Overall Study|Adverse Event|1|||
143223291|NCT03915470|516365068|FG001|Overall Study|Adverse Event|0|||
143223292|NCT03915470|516365067|FG000|Overall Study|Physician Decision|1|||
143223293|NCT03915470|516365068|FG001|Overall Study|Physician Decision|0|||
143223294|NCT03915470|516365067|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
143223295|NCT03915470|516365068|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
143223296|NCT00434109|516365071|FG000|Overall Study|Physician Decision|9|||
143223297|NCT00434109|516365071|FG000|Overall Study|Adverse Event|5|||
143223298|NCT00434109|516365071|FG000|Overall Study|Protocol Violation|1|||
143223299|NCT00434109|516365071|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
143223300|NCT02452424|516365074|FG000|Overall Study|Death|2|||
143223301|NCT02452424|516365075|FG001|Overall Study|Death|2|||
143223302|NCT02452424|516365076|FG002|Overall Study|Death|2|||
143223303|NCT02452424|516365077|FG003|Overall Study|Death|6|||
143223304|NCT02452424|516365078|FG004|Overall Study|Death|2|||
143223305|NCT02452424|516365079|FG005|Overall Study|Death|0|||
143223306|NCT02452424|516365080|FG006|Overall Study|Death|5|||
143223307|NCT02452424|516365081|FG007|Overall Study|Death|1|||
143223308|NCT02452424|516365082|FG008|Overall Study|Death|3|||
143223309|NCT02452424|516365083|FG009|Overall Study|Death|1|||
143223310|NCT02452424|516365084|FG010|Overall Study|Death|0|||
143223311|NCT02452424|516365074|FG000|Overall Study|Lost to Follow-up|0|||
143223312|NCT02452424|516365075|FG001|Overall Study|Lost to Follow-up|1|||
143223313|NCT02452424|516365076|FG002|Overall Study|Lost to Follow-up|1|||
143223314|NCT02452424|516365077|FG003|Overall Study|Lost to Follow-up|0|||
143223315|NCT02452424|516365078|FG004|Overall Study|Lost to Follow-up|0|||
143223316|NCT02452424|516365079|FG005|Overall Study|Lost to Follow-up|0|||
143223317|NCT02452424|516365080|FG006|Overall Study|Lost to Follow-up|0|||
143223318|NCT02452424|516365081|FG007|Overall Study|Lost to Follow-up|0|||
143223319|NCT02452424|516365082|FG008|Overall Study|Lost to Follow-up|0|||
143223320|NCT02452424|516365083|FG009|Overall Study|Lost to Follow-up|0|||
143223321|NCT02452424|516365084|FG010|Overall Study|Lost to Follow-up|0|||
143223322|NCT02452424|516365074|FG000|Overall Study|Withdrawal by Subject|0|||
143223323|NCT02452424|516365075|FG001|Overall Study|Withdrawal by Subject|0|||
143223324|NCT02452424|516365076|FG002|Overall Study|Withdrawal by Subject|3|||
143223325|NCT02452424|516365077|FG003|Overall Study|Withdrawal by Subject|2|||
143223326|NCT02452424|516365078|FG004|Overall Study|Withdrawal by Subject|0|||
143223327|NCT02452424|516365079|FG005|Overall Study|Withdrawal by Subject|0|||
143223328|NCT02452424|516365080|FG006|Overall Study|Withdrawal by Subject|1|||
143223329|NCT02452424|516365081|FG007|Overall Study|Withdrawal by Subject|0|||
143223330|NCT02452424|516365082|FG008|Overall Study|Withdrawal by Subject|1|||
143223331|NCT02452424|516365083|FG009|Overall Study|Withdrawal by Subject|1|||
143223332|NCT02452424|516365084|FG010|Overall Study|Withdrawal by Subject|0|||
143223333|NCT02452424|516365074|FG000|Overall Study|Other|0|||
143223334|NCT02452424|516365075|FG001|Overall Study|Other|0|||
143372445|NCT01193153|516909525|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
143223335|NCT02452424|516365076|FG002|Overall Study|Other|1|||
143223336|NCT02452424|516365077|FG003|Overall Study|Other|0|||
143223337|NCT02452424|516365078|FG004|Overall Study|Other|0|||
143223338|NCT02452424|516365079|FG005|Overall Study|Other|1|||
143223339|NCT02452424|516365080|FG006|Overall Study|Other|4|||
143223340|NCT02452424|516365081|FG007|Overall Study|Other|3|||
143223341|NCT02452424|516365082|FG008|Overall Study|Other|0|||
143223342|NCT02452424|516365083|FG009|Overall Study|Other|0|||
143223343|NCT02452424|516365084|FG010|Overall Study|Other|1|||
143223344|NCT02452424|516365074|FG000|Overall Study|Progressive disease (per RECIST)|0|||
143223345|NCT02452424|516365075|FG001|Overall Study|Progressive disease (per RECIST)|0|||
143223346|NCT02452424|516365076|FG002|Overall Study|Progressive disease (per RECIST)|0|||
143223347|NCT02452424|516365077|FG003|Overall Study|Progressive disease (per RECIST)|0|||
143223348|NCT02452424|516365078|FG004|Overall Study|Progressive disease (per RECIST)|0|||
143223349|NCT02452424|516365079|FG005|Overall Study|Progressive disease (per RECIST)|0|||
143223350|NCT02452424|516365080|FG006|Overall Study|Progressive disease (per RECIST)|0|||
143223351|NCT02452424|516365081|FG007|Overall Study|Progressive disease (per RECIST)|0|||
143223352|NCT02452424|516365082|FG008|Overall Study|Progressive disease (per RECIST)|2|||
143223353|NCT02452424|516365083|FG009|Overall Study|Progressive disease (per RECIST)|0|||
143223354|NCT02452424|516365084|FG010|Overall Study|Progressive disease (per RECIST)|0|||
143223355|NCT02452424|516365074|FG000|Overall Study|Adverse Event|0|||
143223356|NCT02452424|516365075|FG001|Overall Study|Adverse Event|0|||
143223357|NCT02452424|516365076|FG002|Overall Study|Adverse Event|0|||
143223358|NCT02452424|516365077|FG003|Overall Study|Adverse Event|0|||
143223359|NCT02452424|516365078|FG004|Overall Study|Adverse Event|0|||
143223360|NCT02452424|516365079|FG005|Overall Study|Adverse Event|0|||
143223361|NCT02452424|516365080|FG006|Overall Study|Adverse Event|0|||
143223362|NCT02452424|516365081|FG007|Overall Study|Adverse Event|0|||
143223363|NCT02452424|516365082|FG008|Overall Study|Adverse Event|0|||
143223364|NCT02452424|516365083|FG009|Overall Study|Adverse Event|0|||
143223365|NCT02452424|516365084|FG010|Overall Study|Adverse Event|1|||
143223366|NCT01463306|516365085|FG000|Overall Study|Adverse Event|6|||
143223367|NCT01463306|516365086|FG001|Overall Study|Adverse Event|9|||
143223368|NCT01463306|516365087|FG002|Overall Study|Adverse Event|3|||
143223369|NCT01463306|516365085|FG000|Overall Study|Death|3|||
143223370|NCT01463306|516365086|FG001|Overall Study|Death|3|||
143223371|NCT01463306|516365087|FG002|Overall Study|Death|0|||
143223372|NCT01463306|516365085|FG000|Overall Study|Lack of Efficacy|22|||
143223373|NCT01463306|516365086|FG001|Overall Study|Lack of Efficacy|16|||
143223374|NCT01463306|516365087|FG002|Overall Study|Lack of Efficacy|1|||
143223375|NCT01463306|516365085|FG000|Overall Study|Lost to Follow-up|5|||
143223376|NCT01463306|516365086|FG001|Overall Study|Lost to Follow-up|2|||
143223377|NCT01463306|516365087|FG002|Overall Study|Lost to Follow-up|0|||
143223378|NCT01463306|516365085|FG000|Overall Study|Protocol Violation|4|||
143223379|NCT01463306|516365086|FG001|Overall Study|Protocol Violation|0|||
143223380|NCT01463306|516365087|FG002|Overall Study|Protocol Violation|0|||
143223381|NCT01463306|516365085|FG000|Overall Study|Withdrawal by Subject|19|||
143223382|NCT01463306|516365086|FG001|Overall Study|Withdrawal by Subject|9|||
143223383|NCT01463306|516365087|FG002|Overall Study|Withdrawal by Subject|1|||
143223384|NCT01463306|516365085|FG000|Overall Study|Other|26|||
143223385|NCT01463306|516365086|FG001|Overall Study|Other|13|||
143223386|NCT01463306|516365087|FG002|Overall Study|Other|0|||
143223387|NCT01463306|516365085|FG000|Overall Study|Approval expiry at site|1|||
143223388|NCT01463306|516365086|FG001|Overall Study|Approval expiry at site|0|||
143223389|NCT01463306|516365087|FG002|Overall Study|Approval expiry at site|0|||
143223390|NCT01059318|516365090|FG000|Core Study (26 Week)|Adverse Event|3|||
143223391|NCT01059318|516365090|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
143223392|NCT01059318|516365090|FG000|Extension (36 Week)|Adverse Event|3|||
143223393|NCT03790917|516365091|FG000|Overall Study|Death|1|||
143223394|NCT04186871|516365092|FG000|Overall Study|Lack of Efficacy|0|||
143223395|NCT04186871|516365093|FG001|Overall Study|Lack of Efficacy|1|||
143223396|NCT04186871|516365094|FG002|Overall Study|Lack of Efficacy|0|||
143223397|NCT04186871|516365095|FG003|Overall Study|Lack of Efficacy|0|||
143223398|NCT04186871|516365096|FG004|Overall Study|Lack of Efficacy|1|||
143223399|NCT04186871|516365097|FG005|Overall Study|Lack of Efficacy|1|||
143223400|NCT04186871|516365092|FG000|Overall Study|Adverse Event|1|||
143223401|NCT04186871|516365093|FG001|Overall Study|Adverse Event|1|||
143223402|NCT04186871|516365094|FG002|Overall Study|Adverse Event|0|||
143223403|NCT04186871|516365095|FG003|Overall Study|Adverse Event|0|||
143223404|NCT04186871|516365096|FG004|Overall Study|Adverse Event|0|||
143223405|NCT04186871|516365097|FG005|Overall Study|Adverse Event|2|||
143223406|NCT04186871|516365092|FG000|Overall Study|Study terminated by sponsor|1|||
143223407|NCT04186871|516365093|FG001|Overall Study|Study terminated by sponsor|2|||
143223408|NCT04186871|516365094|FG002|Overall Study|Study terminated by sponsor|0|||
143223409|NCT04186871|516365095|FG003|Overall Study|Study terminated by sponsor|1|||
143223410|NCT04186871|516365096|FG004|Overall Study|Study terminated by sponsor|0|||
143223411|NCT04186871|516365097|FG005|Overall Study|Study terminated by sponsor|0|||
143223412|NCT04186871|516365092|FG000|Overall Study|Other reasons|0|||
143223413|NCT04186871|516365093|FG001|Overall Study|Other reasons|0|||
143223414|NCT04186871|516365094|FG002|Overall Study|Other reasons|0|||
143223415|NCT04186871|516365095|FG003|Overall Study|Other reasons|0|||
143223416|NCT04186871|516365096|FG004|Overall Study|Other reasons|0|||
143223417|NCT04186871|516365097|FG005|Overall Study|Other reasons|1|||
143223418|NCT04186871|516365092|FG000|Overall Study|Withdrawal by Subject|0|||
143223419|NCT04186871|516365093|FG001|Overall Study|Withdrawal by Subject|0|||
143223420|NCT04186871|516365094|FG002|Overall Study|Withdrawal by Subject|0|||
143223421|NCT04186871|516365095|FG003|Overall Study|Withdrawal by Subject|0|||
143223422|NCT04186871|516365096|FG004|Overall Study|Withdrawal by Subject|0|||
143223423|NCT04186871|516365097|FG005|Overall Study|Withdrawal by Subject|1|||
143223424|NCT04186871|516365092|FG000|Overall Study|Lost to Follow-up|0|||
143223425|NCT04186871|516365093|FG001|Overall Study|Lost to Follow-up|0|||
143223426|NCT04186871|516365094|FG002|Overall Study|Lost to Follow-up|0|||
143223427|NCT04186871|516365095|FG003|Overall Study|Lost to Follow-up|0|||
143223428|NCT04186871|516365096|FG004|Overall Study|Lost to Follow-up|0|||
143223429|NCT04186871|516365097|FG005|Overall Study|Lost to Follow-up|1|||
143223430|NCT00176462|516365108|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
143223431|NCT00176462|516365109|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
143223432|NCT00176462|516365108|FG000|Induction (4 Weeks)|Death|1|||
143223433|NCT00176462|516365109|FG001|Induction (4 Weeks)|Death|2|||
143223434|NCT00176462|516365108|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
143223435|NCT00176462|516365109|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
143223436|NCT00176462|516365108|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
143223437|NCT00176462|516365109|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
143223438|NCT00176462|516365108|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
143223439|NCT00176462|516365109|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
143223440|NCT00176462|516365108|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
143223441|NCT00176462|516365109|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
143223442|NCT00176462|516365108|FG000|Consolidation (12 Weeks)|Not documented|0|||
143223443|NCT00176462|516365109|FG001|Consolidation (12 Weeks)|Not documented|1|||
143223444|NCT00176462|516365108|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
143223445|NCT00176462|516365109|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
143223446|NCT00176462|516365108|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
143223447|NCT00176462|516365109|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
143223448|NCT01150097|516365115|FG000|Months 24 to 36 Post-transplantation|Death|2|||
143223449|NCT01150097|516365116|FG001|Months 24 to 36 Post-transplantation|Death|0|||
143223450|NCT01150097|516365117|FG002|Months 24 to 36 Post-transplantation|Death|0|||
143223451|NCT01150097|516365115|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
143223452|NCT01150097|516365116|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
143223453|NCT01150097|516365117|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
143223454|NCT01150097|516365115|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
143223455|NCT01150097|516365116|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
143223456|NCT01150097|516365117|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
143223457|NCT01150097|516365115|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
143223458|NCT01150097|516365116|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
143223459|NCT01150097|516365117|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
143223460|NCT01150097|516365115|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
143223461|NCT01150097|516365116|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
143223462|NCT01150097|516365117|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
143223463|NCT01150097|516365115|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
143223464|NCT01150097|516365116|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
143223465|NCT01150097|516365117|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
143223466|NCT01150097|516365115|FG000|Months 24 to 48 Post-transplantation|Death|2|||
143223467|NCT01150097|516365116|FG001|Months 24 to 48 Post-transplantation|Death|0|||
143223468|NCT01150097|516365117|FG002|Months 24 to 48 Post-transplantation|Death|0|||
143223469|NCT00543387|516365120|FG000|Panel 1 + Panel 2|Adverse Event|0|||
143223470|NCT00543387|516365121|FG001|Panel 1 + Panel 2|Adverse Event|1|||
143223471|NCT00543387|516365122|FG002|Panel 1 + Panel 2|Adverse Event|0|||
143223472|NCT00543387|516365123|FG003|Panel 1 + Panel 2|Adverse Event|0|||
143223473|NCT00543387|516365124|FG004|Panel 1 + Panel 2|Adverse Event|0|||
143223474|NCT00543387|516365125|FG005|Panel 1 + Panel 2|Adverse Event|0|||
143223475|NCT00543387|516365126|FG006|Panel 1 + Panel 2|Adverse Event|0|||
143223476|NCT00543387|516365127|FG007|Panel 1 + Panel 2|Adverse Event|1|||
143223477|NCT00543387|516365128|FG008|Panel 1 + Panel 2|Adverse Event|1|||
143268085|NCT03875768|516536816|FG001|Overall Study|Did not complete assessment|12|||
143268086|NCT03875768|516536815|FG000|Overall Study|Became ineligible|1|||
143268087|NCT03875768|516536816|FG001|Overall Study|Became ineligible|0|||
143268088|NCT01925274|516536817|FG000|Overall Study|Death|1|||
143268089|NCT01925274|516536818|FG001|Overall Study|Death|0|||
143268090|NCT01925274|516536819|FG002|Overall Study|Death|0|||
143268091|NCT01925274|516536817|FG000|Overall Study|Lost to Follow-up|0|||
143268092|NCT01925274|516536818|FG001|Overall Study|Lost to Follow-up|1|||
143268093|NCT01925274|516536819|FG002|Overall Study|Lost to Follow-up|0|||
143372446|NCT01193153|516909524|FG000|Open-label Lead in Period|Pregnancy|1|||
143372447|NCT01193153|516909525|FG001|Open-label Lead in Period|Pregnancy|0|||
143372448|NCT01193153|516909524|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
143372449|NCT01193153|516909525|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
143372450|NCT01193153|516909524|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
143268094|NCT01925274|516536817|FG000|Overall Study|Withdrawal by Subject|1|||
143268095|NCT01925274|516536818|FG001|Overall Study|Withdrawal by Subject|2|||
143268096|NCT01925274|516536819|FG002|Overall Study|Withdrawal by Subject|0|||
143268097|NCT01925274|516536817|FG000|Overall Study|Study terminated by sponsor|4|||
143223478|NCT00543387|516365129|FG009|Panel 1 + Panel 2|Adverse Event|0|||
143223479|NCT00543387|516365130|FG010|Panel 1 + Panel 2|Adverse Event|0|||
143268098|NCT01925274|516536818|FG001|Overall Study|Study terminated by sponsor|0|||
143268099|NCT01925274|516536819|FG002|Overall Study|Study terminated by sponsor|0|||
143372451|NCT01193153|516909525|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
143372452|NCT01193153|516909524|FG000|Open-label Lead in Period|Other|14|||
143223480|NCT00543387|516365120|FG000|Panel 1 + Panel 2|Physician Decision|0|||
143223481|NCT00543387|516365121|FG001|Panel 1 + Panel 2|Physician Decision|0|||
143223482|NCT00543387|516365122|FG002|Panel 1 + Panel 2|Physician Decision|1|||
143223483|NCT00543387|516365123|FG003|Panel 1 + Panel 2|Physician Decision|0|||
143223484|NCT00543387|516365124|FG004|Panel 1 + Panel 2|Physician Decision|0|||
143223485|NCT00543387|516365125|FG005|Panel 1 + Panel 2|Physician Decision|0|||
143223486|NCT00543387|516365126|FG006|Panel 1 + Panel 2|Physician Decision|0|||
143223487|NCT00543387|516365127|FG007|Panel 1 + Panel 2|Physician Decision|1|||
143223488|NCT00543387|516365128|FG008|Panel 1 + Panel 2|Physician Decision|0|||
143223489|NCT00543387|516365129|FG009|Panel 1 + Panel 2|Physician Decision|0|||
143223490|NCT00543387|516365130|FG010|Panel 1 + Panel 2|Physician Decision|0|||
143223491|NCT00543387|516365120|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
143223492|NCT00543387|516365121|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
143223493|NCT00543387|516365122|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
143223494|NCT00543387|516365123|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
143223495|NCT00543387|516365124|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
143223496|NCT00543387|516365125|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
143223497|NCT00543387|516365126|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
143223498|NCT00543387|516365127|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
143223499|NCT00543387|516365128|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
143223500|NCT00543387|516365129|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
143223501|NCT00543387|516365130|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
143223502|NCT00543387|516365120|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
143223503|NCT00543387|516365121|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
143223504|NCT00543387|516365122|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
143223505|NCT00543387|516365123|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
143223506|NCT00543387|516365124|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
143223507|NCT00543387|516365125|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
143223508|NCT00543387|516365126|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
143223509|NCT00543387|516365127|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
143223510|NCT00543387|516365128|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
143223511|NCT00543387|516365129|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
143223512|NCT00543387|516365130|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
143223513|NCT00543387|516365120|FG000|Crossover Participants|Progressive Disease|0|||
143223514|NCT00543387|516365121|FG001|Crossover Participants|Progressive Disease|0|||
143223515|NCT00543387|516365122|FG002|Crossover Participants|Progressive Disease|0|||
143223516|NCT00543387|516365123|FG003|Crossover Participants|Progressive Disease|0|||
143223517|NCT00543387|516365124|FG004|Crossover Participants|Progressive Disease|0|||
143223518|NCT00543387|516365125|FG005|Crossover Participants|Progressive Disease|0|||
143223519|NCT00543387|516365126|FG006|Crossover Participants|Progressive Disease|0|||
143223520|NCT00543387|516365127|FG007|Crossover Participants|Progressive Disease|0|||
143223521|NCT00543387|516365128|FG008|Crossover Participants|Progressive Disease|0|||
143223522|NCT00543387|516365129|FG009|Crossover Participants|Progressive Disease|1|||
143372453|NCT01193153|516909525|FG001|Open-label Lead in Period|Other|0|||
143372454|NCT01193153|516909524|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
143372455|NCT01193153|516909525|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
143372456|NCT01193153|516909524|FG000|Open-label Lead in Period|Adverse Event|41|||
143223523|NCT00543387|516365130|FG010|Crossover Participants|Progressive Disease|2|||
143223524|NCT00543387|516365120|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
143223525|NCT00543387|516365121|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
143223526|NCT00543387|516365122|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
143223527|NCT00543387|516365123|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
143223528|NCT00543387|516365124|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
143223529|NCT00543387|516365125|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
143223530|NCT00543387|516365126|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
143223531|NCT00543387|516365127|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
143223532|NCT00543387|516365128|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
143223533|NCT00543387|516365129|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
143223534|NCT00543387|516365130|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
143223535|NCT00549445|516365131|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
143223536|NCT00549445|516365132|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
143223537|NCT01301833|516365133|FG000|Overall Study|Adverse Event|7|||
143223538|NCT01301833|516365134|FG001|Overall Study|Adverse Event|5|||
143223539|NCT01301833|516365135|FG002|Overall Study|Adverse Event|5|||
143223540|NCT01301833|516365136|FG003|Overall Study|Adverse Event|5|||
143223541|NCT01301833|516365133|FG000|Overall Study|Lack of Efficacy|1|||
143223542|NCT01301833|516365134|FG001|Overall Study|Lack of Efficacy|1|||
143223543|NCT01301833|516365135|FG002|Overall Study|Lack of Efficacy|0|||
143223544|NCT01301833|516365136|FG003|Overall Study|Lack of Efficacy|0|||
143223545|NCT01301833|516365133|FG000|Overall Study|Physician Decision|3|||
143223546|NCT01301833|516365134|FG001|Overall Study|Physician Decision|1|||
143223547|NCT01301833|516365135|FG002|Overall Study|Physician Decision|1|||
143223548|NCT01301833|516365136|FG003|Overall Study|Physician Decision|0|||
143223549|NCT01301833|516365133|FG000|Overall Study|Withdrawal by Subject|3|||
143223550|NCT01301833|516365134|FG001|Overall Study|Withdrawal by Subject|1|||
143223551|NCT01301833|516365135|FG002|Overall Study|Withdrawal by Subject|1|||
143223552|NCT01301833|516365136|FG003|Overall Study|Withdrawal by Subject|2|||
143223553|NCT01301833|516365133|FG000|Overall Study|Personal matter|1|||
143223554|NCT01301833|516365134|FG001|Overall Study|Personal matter|0|||
143223555|NCT01301833|516365135|FG002|Overall Study|Personal matter|0|||
143223556|NCT01301833|516365136|FG003|Overall Study|Personal matter|0|||
143223557|NCT03566082|516365137|FG000|Overall Study|Death|7|||
143223558|NCT03566082|516365137|FG000|Overall Study|Failures (revision required)|2|||
143223559|NCT03566082|516365137|FG000|Overall Study|Lost to Follow-up|8|||
143223560|NCT01389882|516366813|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
143223561|NCT01389882|516366814|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
143223562|NCT01389882|516366813|FG000|Overall Study|Withdrawal by Subject|0|||
143223563|NCT01389882|516366814|FG001|Overall Study|Withdrawal by Subject|1|||
143223564|NCT03790111|516366815|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
143223565|NCT00383786|516366829|FG000|Overall Study|Protocol Violation|2|||
143223566|NCT00383786|516366830|FG001|Overall Study|Protocol Violation|6|||
143223567|NCT00383786|516366829|FG000|Overall Study|Withdrawal by Subject|2|||
143223568|NCT00383786|516366830|FG001|Overall Study|Withdrawal by Subject|5|||
143223569|NCT00383786|516366829|FG000|Overall Study|Physician Decision|0|||
143223570|NCT00383786|516366830|FG001|Overall Study|Physician Decision|1|||
143223571|NCT02252146|516366831|FG000|Overall Study|Lack of Efficacy|4|||
143223572|NCT02252146|516366831|FG000|Overall Study|Entered hospice care|1|||
143223573|NCT02252146|516366831|FG000|Overall Study|Inability to travel to study site|1|||
143223574|NCT00531284|516366832|FG000|Overall Study|Progressive Disease|1|||
143223575|NCT00531284|516366833|FG001|Overall Study|Progressive Disease|3|||
143223576|NCT00531284|516366834|FG002|Overall Study|Progressive Disease|5|||
143223577|NCT00531284|516366835|FG003|Overall Study|Progressive Disease|42|||
143223578|NCT00531284|516366836|FG004|Overall Study|Progressive Disease|4|||
143223579|NCT00531284|516366837|FG005|Overall Study|Progressive Disease|4|||
143223580|NCT00531284|516366838|FG006|Overall Study|Progressive Disease|3|||
143223581|NCT00531284|516366839|FG007|Overall Study|Progressive Disease|8|||
143223582|NCT00531284|516366840|FG008|Overall Study|Progressive Disease|6|||
143223583|NCT00531284|516366841|FG009|Overall Study|Progressive Disease|3|||
143223584|NCT00531284|516366842|FG010|Overall Study|Progressive Disease|3|||
143223585|NCT00531284|516366843|FG011|Overall Study|Progressive Disease|14|||
143223586|NCT00531284|516366844|FG012|Overall Study|Progressive Disease|2|||
143223587|NCT00531284|516366845|FG013|Overall Study|Progressive Disease|1|||
143223588|NCT00531284|516366846|FG014|Overall Study|Progressive Disease|2|||
143223589|NCT00531284|516366847|FG015|Overall Study|Progressive Disease|11|||
143223590|NCT00531284|516366848|FG016|Overall Study|Progressive Disease|5|||
143223591|NCT00531284|516366832|FG000|Overall Study|Adverse Event|0|||
143223592|NCT00531284|516366833|FG001|Overall Study|Adverse Event|1|||
143223593|NCT00531284|516366834|FG002|Overall Study|Adverse Event|1|||
143223594|NCT00531284|516366835|FG003|Overall Study|Adverse Event|7|||
143223595|NCT00531284|516366836|FG004|Overall Study|Adverse Event|0|||
143223596|NCT00531284|516366837|FG005|Overall Study|Adverse Event|2|||
143223597|NCT00531284|516366838|FG006|Overall Study|Adverse Event|3|||
143223598|NCT00531284|516366839|FG007|Overall Study|Adverse Event|2|||
143223599|NCT00531284|516366840|FG008|Overall Study|Adverse Event|3|||
143223600|NCT00531284|516366841|FG009|Overall Study|Adverse Event|0|||
143223601|NCT00531284|516366842|FG010|Overall Study|Adverse Event|0|||
143223602|NCT00531284|516366843|FG011|Overall Study|Adverse Event|5|||
143223603|NCT00531284|516366844|FG012|Overall Study|Adverse Event|0|||
143223604|NCT00531284|516366845|FG013|Overall Study|Adverse Event|1|||
143223605|NCT00531284|516366846|FG014|Overall Study|Adverse Event|1|||
143223606|NCT00531284|516366847|FG015|Overall Study|Adverse Event|0|||
143223607|NCT00531284|516366848|FG016|Overall Study|Adverse Event|2|||
143223608|NCT00531284|516366832|FG000|Overall Study|Withdrawal by Subject|1|||
143223609|NCT00531284|516366833|FG001|Overall Study|Withdrawal by Subject|0|||
143223610|NCT00531284|516366834|FG002|Overall Study|Withdrawal by Subject|0|||
143223611|NCT00531284|516366835|FG003|Overall Study|Withdrawal by Subject|4|||
143223612|NCT00531284|516366836|FG004|Overall Study|Withdrawal by Subject|0|||
143223613|NCT00531284|516366837|FG005|Overall Study|Withdrawal by Subject|0|||
143223614|NCT00531284|516366838|FG006|Overall Study|Withdrawal by Subject|0|||
143223615|NCT00531284|516366839|FG007|Overall Study|Withdrawal by Subject|0|||
143223616|NCT00531284|516366840|FG008|Overall Study|Withdrawal by Subject|0|||
143223617|NCT00531284|516366841|FG009|Overall Study|Withdrawal by Subject|0|||
143223618|NCT00531284|516366842|FG010|Overall Study|Withdrawal by Subject|0|||
143223619|NCT00531284|516366843|FG011|Overall Study|Withdrawal by Subject|3|||
143223620|NCT00531284|516366844|FG012|Overall Study|Withdrawal by Subject|0|||
143223621|NCT00531284|516366845|FG013|Overall Study|Withdrawal by Subject|1|||
143223622|NCT00531284|516366846|FG014|Overall Study|Withdrawal by Subject|0|||
143223623|NCT00531284|516366847|FG015|Overall Study|Withdrawal by Subject|1|||
143223624|NCT00531284|516366848|FG016|Overall Study|Withdrawal by Subject|1|||
143223625|NCT00531284|516366832|FG000|Overall Study|Other|1|||
143223626|NCT00531284|516366833|FG001|Overall Study|Other|0|||
143223627|NCT00531284|516366834|FG002|Overall Study|Other|0|||
143223628|NCT00531284|516366835|FG003|Overall Study|Other|10|||
143223629|NCT00531284|516366836|FG004|Overall Study|Other|2|||
143223630|NCT00531284|516366837|FG005|Overall Study|Other|1|||
143223631|NCT00531284|516366838|FG006|Overall Study|Other|0|||
143223632|NCT00531284|516366839|FG007|Overall Study|Other|0|||
143223633|NCT00531284|516366840|FG008|Overall Study|Other|2|||
143223634|NCT00531284|516366841|FG009|Overall Study|Other|1|||
143223635|NCT00531284|516366842|FG010|Overall Study|Other|0|||
143223636|NCT00531284|516366843|FG011|Overall Study|Other|2|||
143223637|NCT00531284|516366844|FG012|Overall Study|Other|0|||
143223638|NCT00531284|516366845|FG013|Overall Study|Other|0|||
143223639|NCT00531284|516366846|FG014|Overall Study|Other|1|||
143223640|NCT00531284|516366847|FG015|Overall Study|Other|0|||
143223641|NCT00531284|516366848|FG016|Overall Study|Other|0|||
143223642|NCT02219464|516366850|FG000|Overall Study|Withdrawal by Subject|1|||
143223643|NCT02219464|516366851|FG001|Overall Study|Withdrawal by Subject|0|||
143223644|NCT02219464|516366850|FG000|Overall Study|case cancelled|1|||
143268100|NCT01925274|516536817|FG000|Overall Study|Protocol amendment|1|||
143268101|NCT01925274|516536818|FG001|Overall Study|Protocol amendment|3|||
143268102|NCT01925274|516536819|FG002|Overall Study|Protocol amendment|6|||
143268103|NCT00122109|516536820|FG000|Overall Study|Did not meet criteria|6|||
143268104|NCT00122109|516536821|FG001|Overall Study|Did not meet criteria|7|||
143223645|NCT02219464|516366851|FG001|Overall Study|case cancelled|0|||
143223646|NCT02219464|516366850|FG000|Overall Study|catheter malfunction|1|||
143223647|NCT02219464|516366851|FG001|Overall Study|catheter malfunction|0|||
143223648|NCT03057496|516366852|FG000|Overall Study|Withdrawal by Subject|8|||
143223649|NCT03057496|516366852|FG000|Overall Study|Lost to Follow-up|5|||
143223650|NCT03057496|516366852|FG000|Overall Study|Did not use device during home trial|3|||
143223651|NCT03057496|516366852|FG000|Overall Study|Device failure|2|||
143223652|NCT00280917|516366856|FG000|Overall Study|Adverse Event|1|||
143223653|NCT00280917|516366857|FG001|Overall Study|Adverse Event|1|||
143223654|NCT00280917|516366858|FG002|Overall Study|Adverse Event|4|||
143223655|NCT00280917|516366859|FG003|Overall Study|Adverse Event|1|||
143223656|NCT00280917|516366856|FG000|Overall Study|Change Therapy|1|||
143223657|NCT00280917|516366857|FG001|Overall Study|Change Therapy|2|||
143223658|NCT00280917|516366858|FG002|Overall Study|Change Therapy|0|||
143223659|NCT00280917|516366859|FG003|Overall Study|Change Therapy|0|||
143223660|NCT00280917|516366856|FG000|Overall Study|Withdrawal by Subject|0|||
143223661|NCT00280917|516366857|FG001|Overall Study|Withdrawal by Subject|2|||
143223662|NCT00280917|516366858|FG002|Overall Study|Withdrawal by Subject|0|||
143223663|NCT00280917|516366859|FG003|Overall Study|Withdrawal by Subject|1|||
143223664|NCT00280917|516366856|FG000|Overall Study|Noncompliance|0|||
143223665|NCT00280917|516366857|FG001|Overall Study|Noncompliance|1|||
143223666|NCT00280917|516366858|FG002|Overall Study|Noncompliance|2|||
143223667|NCT00280917|516366859|FG003|Overall Study|Noncompliance|0|||
143223668|NCT03529110|516366860|FG000|Overall Study|Progressive Disease|66|||
143223669|NCT03529110|516366861|FG001|Overall Study|Progressive Disease|158|||
143223670|NCT03529110|516366860|FG000|Overall Study|Clinical Progression|4|||
143223671|NCT03529110|516366861|FG001|Overall Study|Clinical Progression|12|||
143223672|NCT03529110|516366860|FG000|Overall Study|Adverse Event|35|||
143223673|NCT03529110|516366861|FG001|Overall Study|Adverse Event|17|||
143223674|NCT03529110|516366860|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
143223675|NCT03529110|516366861|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
143223676|NCT03529110|516366860|FG000|Overall Study|Lack of Efficacy|3|||
143223677|NCT03529110|516366861|FG001|Overall Study|Lack of Efficacy|3|||
143223678|NCT03529110|516366860|FG000|Overall Study|Physician Decision|2|||
143223679|NCT03529110|516366861|FG001|Overall Study|Physician Decision|8|||
143223680|NCT03529110|516366860|FG000|Overall Study|Miscellaneous|2|||
143223681|NCT03529110|516366861|FG001|Overall Study|Miscellaneous|5|||
143223682|NCT01584232|516366862|FG000|Overall Study|Adverse Event|3|||
143223683|NCT01584232|516366863|FG001|Overall Study|Adverse Event|1|||
143223684|NCT01584232|516366862|FG000|Overall Study|Withdrawal by Subject|2|||
143223685|NCT01584232|516366863|FG001|Overall Study|Withdrawal by Subject|1|||
143223686|NCT01584232|516366862|FG000|Overall Study|Physician Decision|2|||
143223687|NCT01584232|516366863|FG001|Overall Study|Physician Decision|1|||
143223688|NCT01584232|516366862|FG000|Overall Study|Lost to Follow-up|1|||
143223689|NCT01584232|516366863|FG001|Overall Study|Lost to Follow-up|0|||
143223690|NCT03654690|516366870|FG000|Overall Study|Withdrawal by Subject|1|||
143223691|NCT03654690|516366871|FG001|Overall Study|Withdrawal by Subject|0|||
143223692|NCT03654690|516366872|FG002|Overall Study|Withdrawal by Subject|0|||
143223693|NCT00354679|516366878|FG000|Overall Study|Patient Not Treated|1|||
143223694|NCT01141712|516366881|FG000|Overall Study|Disease progression|3|||
143223695|NCT05963022|516366888|FG000|Overall Study|Adverse Event|0|||
143223696|NCT05963022|516366889|FG001|Overall Study|Adverse Event|1|||
143223697|NCT05963022|516366890|FG002|Overall Study|Adverse Event|1|||
143223698|NCT05963022|516366891|FG003|Overall Study|Adverse Event|0|||
143223699|NCT05963022|516366888|FG000|Overall Study|Protocol Violation|0|||
143223700|NCT05963022|516366889|FG001|Overall Study|Protocol Violation|3|||
143223701|NCT05963022|516366890|FG002|Overall Study|Protocol Violation|0|||
143223702|NCT05963022|516366891|FG003|Overall Study|Protocol Violation|0|||
143223703|NCT05963022|516366888|FG000|Overall Study|Pregnancy|0|||
143223704|NCT05963022|516366889|FG001|Overall Study|Pregnancy|1|||
143223705|NCT05963022|516366890|FG002|Overall Study|Pregnancy|1|||
143223706|NCT05963022|516366891|FG003|Overall Study|Pregnancy|1|||
143223707|NCT05963022|516366888|FG000|Overall Study|Withdrawal by Subject|0|||
143223708|NCT05963022|516366889|FG001|Overall Study|Withdrawal by Subject|0|||
143223709|NCT05963022|516366890|FG002|Overall Study|Withdrawal by Subject|2|||
143223710|NCT05963022|516366891|FG003|Overall Study|Withdrawal by Subject|1|||
143223711|NCT05963022|516366888|FG000|Overall Study|Lost to Follow-up|0|||
143268105|NCT00100178|516536822|FG000|Overall Study|Lost to Follow-up|0|||
143268106|NCT00100178|516536823|FG001|Overall Study|Lost to Follow-up|6|||
143223712|NCT05963022|516366889|FG001|Overall Study|Lost to Follow-up|0|||
143223713|NCT05963022|516366890|FG002|Overall Study|Lost to Follow-up|0|||
143223714|NCT05963022|516366891|FG003|Overall Study|Lost to Follow-up|1|||
143223715|NCT05963022|516366888|FG000|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
143268107|NCT00100178|516536824|FG002|Overall Study|Lost to Follow-up|5|||
143223716|NCT05963022|516366889|FG001|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
143223717|NCT05963022|516366890|FG002|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
143223718|NCT05963022|516366891|FG003|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|1|||
143223719|NCT01358825|516366892|FG000|Overall Study|Blood sample not drawn|0|||
143223720|NCT01358825|516366893|FG001|Overall Study|Blood sample not drawn|1|||
143223721|NCT01012258|516366894|FG000|Overall Study|Death|14|||
143223722|NCT01012258|516366894|FG000|Overall Study|Lost to Follow-up|1|||
143223723|NCT01012258|516366894|FG000|Overall Study|Adverse Event|1|||
143223724|NCT01012258|516366894|FG000|Overall Study|Progressive Disease (PD)|18|||
143223725|NCT01012258|516366894|FG000|Overall Study|Symptomatic Deterioration|1|||
143223726|NCT01012258|516366894|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
143223727|NCT01012258|516366894|FG000|Overall Study|Another Tumor Discovered|1|||
143223728|NCT01012258|516366894|FG000|Overall Study|Ongoing|29|||
143223729|NCT01814527|516366899|FG000|Overall Study|RTP greater than 30 days|6|||
143223730|NCT01814527|516366900|FG001|Overall Study|RTP greater than 30 days|1|||
143223731|NCT03571204|516366901|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
143223732|NCT03571204|516366902|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
143223733|NCT03571204|516366903|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
143223734|NCT03571204|516366901|FG000|Overall Study|Physician Decision|0|||
143223735|NCT03571204|516366902|FG001|Overall Study|Physician Decision|1|||
143223736|NCT03571204|516366903|FG002|Overall Study|Physician Decision|0|||
143223737|NCT03575403|516366908|FG000|Overall Study|Adverse Event|1|||
143223738|NCT03575403|516366909|FG001|Overall Study|Adverse Event|0|||
143223739|NCT03575403|516366910|FG002|Overall Study|Adverse Event|0|||
143223740|NCT03575403|516366908|FG000|Overall Study|One subject left due to personal reasons unrelated to study-procedures|1|||
143223741|NCT03575403|516366909|FG001|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
143223742|NCT03575403|516366910|FG002|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
143223743|NCT05114473|516366911|FG000|Overall Study|Lost to Follow-up|2|||
143223744|NCT05114473|516366912|FG001|Overall Study|Lost to Follow-up|2|||
143223745|NCT05114473|516366913|FG002|Overall Study|Lost to Follow-up|0|||
143223746|NCT00773513|516366914|FG000|Overall Study|Renal Transplant|254|||
143223747|NCT00773513|516366915|FG001|Overall Study|Renal Transplant|263|||
143223748|NCT00773513|516366914|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
143223749|NCT00773513|516366915|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
143223750|NCT00773513|516366914|FG000|Overall Study|Withdrew Consent|68|||
143223751|NCT00773513|516366915|FG001|Overall Study|Withdrew Consent|69|||
143223752|NCT00773513|516366914|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
143223753|NCT00773513|516366915|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
143223754|NCT00773513|516366914|FG000|Overall Study|Failure to Return|22|||
143223755|NCT00773513|516366915|FG001|Overall Study|Failure to Return|8|||
143223756|NCT00773513|516366914|FG000|Overall Study|Insufficient Therapeutic Response|1|||
143223757|NCT00773513|516366915|FG001|Overall Study|Insufficient Therapeutic Response|18|||
143223758|NCT00773513|516366914|FG000|Overall Study|Reason Not Specified|159|||
143223759|NCT00773513|516366915|FG001|Overall Study|Reason Not Specified|126|||
143223760|NCT00773513|516366914|FG000|Overall Study|Death|531|||
143223761|NCT00773513|516366915|FG001|Overall Study|Death|545|||
143223762|NCT02959437|516366916|FG000|Overall Study|Death|33|||
143223763|NCT02959437|516366917|FG001|Overall Study|Death|3|||
143223764|NCT02959437|516366918|FG002|Overall Study|Death|0|||
143223765|NCT02959437|516366919|FG003|Overall Study|Death|0|||
143223766|NCT02959437|516366916|FG000|Overall Study|Lost to Follow-up|3|||
143223767|NCT02959437|516366917|FG001|Overall Study|Lost to Follow-up|1|||
143223768|NCT02959437|516366918|FG002|Overall Study|Lost to Follow-up|0|||
143223769|NCT02959437|516366919|FG003|Overall Study|Lost to Follow-up|0|||
143268108|NCT00100178|516536822|FG000|Overall Study|Adverse Event|2|||
143268109|NCT00100178|516536823|FG001|Overall Study|Adverse Event|2|||
143268110|NCT00100178|516536824|FG002|Overall Study|Adverse Event|1|||
143268111|NCT00100178|516536822|FG000|Overall Study|Withdrawal by Subject|1|||
143268112|NCT00100178|516536823|FG001|Overall Study|Withdrawal by Subject|1|||
143268113|NCT00100178|516536824|FG002|Overall Study|Withdrawal by Subject|1|||
143268114|NCT00100178|516536822|FG000|Overall Study|Physician Decision|6|||
143223770|NCT02959437|516366916|FG000|Overall Study|Withdrawal by Subject|11|||
143223771|NCT02959437|516366917|FG001|Overall Study|Withdrawal by Subject|3|||
143223772|NCT02959437|516366918|FG002|Overall Study|Withdrawal by Subject|0|||
143223773|NCT02959437|516366919|FG003|Overall Study|Withdrawal by Subject|0|||
143223774|NCT02959437|516366916|FG000|Overall Study|Progressive Disease|9|||
143223775|NCT02959437|516366917|FG001|Overall Study|Progressive Disease|1|||
143223776|NCT02959437|516366918|FG002|Overall Study|Progressive Disease|0|||
143223777|NCT02959437|516366919|FG003|Overall Study|Progressive Disease|0|||
143223778|NCT02959437|516366916|FG000|Overall Study|Study Terminated by Sponsor|4|||
143223779|NCT02959437|516366917|FG001|Overall Study|Study Terminated by Sponsor|0|||
143223780|NCT02959437|516366918|FG002|Overall Study|Study Terminated by Sponsor|0|||
143223781|NCT02959437|516366919|FG003|Overall Study|Study Terminated by Sponsor|0|||
143223782|NCT02959437|516366916|FG000|Overall Study|Other Unspecified|2|||
143268115|NCT00100178|516536823|FG001|Overall Study|Physician Decision|1|||
143223783|NCT02959437|516366917|FG001|Overall Study|Other Unspecified|0|||
143223784|NCT02959437|516366918|FG002|Overall Study|Other Unspecified|0|||
143223785|NCT02959437|516366919|FG003|Overall Study|Other Unspecified|0|||
143223786|NCT03359174|516366924|FG000|Overall Study|Adverse Event|1|||
143268116|NCT00100178|516536824|FG002|Overall Study|Physician Decision|3|||
143268117|NCT02477839|516536829|FG000|Overall Study|Adverse Event|0|||
143268118|NCT02477839|516536830|FG001|Overall Study|Adverse Event|1|||
143223787|NCT04445662|516366931|FG000|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|1|||
143223788|NCT04445662|516366932|FG001|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|0|||
143223789|NCT04445662|516366931|FG000|On treatment (0-12 weeks)|Withdrawal by Subject|2|||
143223790|NCT04445662|516366932|FG001|On treatment (0-12 weeks)|Withdrawal by Subject|5|||
143223791|NCT04445662|516366931|FG000|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|1|||
143223792|NCT04445662|516366932|FG001|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|0|||
143223793|NCT04445662|516366931|FG000|Post-treatment (12-24 weeks)|Death|1|||
143223794|NCT04445662|516366932|FG001|Post-treatment (12-24 weeks)|Death|0|||
143223795|NCT01332994|516366933|FG000|Overall Study|Adverse Event|34|||
143223796|NCT01332994|516366933|FG000|Overall Study|Death|1|||
143223797|NCT01332994|516366933|FG000|Overall Study|Lack of Efficacy|1|||
143223798|NCT01332994|516366933|FG000|Overall Study|Lost to Follow-up|4|||
143223799|NCT01332994|516366933|FG000|Overall Study|Protocol Violation|6|||
143223800|NCT01332994|516366933|FG000|Overall Study|Withdrawal by Subject|15|||
143223801|NCT01332994|516366933|FG000|Overall Study|Administrative Problem|2|||
143223802|NCT01332994|516366933|FG000|Overall Study|Other|8|||
143223803|NCT00279916|516366934|FG000|Overall Study|Withdrawal by Subject|4|||
143223804|NCT00279916|516366935|FG001|Overall Study|Withdrawal by Subject|3|||
143223805|NCT00279916|516366934|FG000|Overall Study|Lost to Follow-up|3|||
143223806|NCT00279916|516366935|FG001|Overall Study|Lost to Follow-up|2|||
143268119|NCT02477839|516536829|FG000|Overall Study|Protocol Violation|0|||
143268120|NCT02477839|516536830|FG001|Overall Study|Protocol Violation|2|||
143268121|NCT02477839|516536829|FG000|Overall Study|Withdrawal by Subject|3|||
143268122|NCT02477839|516536830|FG001|Overall Study|Withdrawal by Subject|3|||
143268123|NCT02477839|516536829|FG000|Overall Study|Participant had PGS during V6|0|||
143268124|NCT02477839|516536830|FG001|Overall Study|Participant had PGS during V6|1|||
143268125|NCT02477839|516536829|FG000|Overall Study|Parents decided to stop medication|0|||
143268126|NCT02477839|516536830|FG001|Overall Study|Parents decided to stop medication|1|||
143268127|NCT02477839|516536829|FG000|Overall Study|Lack of tolerability|0|||
143268128|NCT02477839|516536830|FG001|Overall Study|Lack of tolerability|1|||
143268129|NCT02477839|516536829|FG000|Overall Study|Exclusion criterion|0|||
143268130|NCT02477839|516536830|FG001|Overall Study|Exclusion criterion|1|||
143268131|NCT00631696|516536833|FG000|Overall Study|Entered, not randomized to treatment|1|||
143268132|NCT00631696|516536834|FG001|Overall Study|Entered, not randomized to treatment|1|||
143268133|NCT00631696|516536833|FG000|Overall Study|Discontinued after database release date|1|||
143268134|NCT00631696|516536834|FG001|Overall Study|Discontinued after database release date|0|||
143268135|NCT00631696|516536833|FG000|Overall Study|Follow up after database release date|1|||
143268136|NCT00631696|516536834|FG001|Overall Study|Follow up after database release date|0|||
143268137|NCT00631696|516536833|FG000|Overall Study|Lost to Follow-up|7|||
143268138|NCT00631696|516536834|FG001|Overall Study|Lost to Follow-up|10|||
143268139|NCT00631696|516536833|FG000|Overall Study|Withdrawal by Subject|2|||
143268140|NCT00631696|516536834|FG001|Overall Study|Withdrawal by Subject|9|||
143268141|NCT00631696|516536833|FG000|Overall Study|Other|8|||
143268142|NCT00631696|516536834|FG001|Overall Study|Other|8|||
143268143|NCT00631696|516536833|FG000|Overall Study|Protocol Violation|9|||
143268144|NCT00631696|516536834|FG001|Overall Study|Protocol Violation|9|||
143268145|NCT00631696|516536833|FG000|Overall Study|Study terminated by sponsor|3|||
143268146|NCT00631696|516536834|FG001|Overall Study|Study terminated by sponsor|3|||
143268147|NCT00631696|516536833|FG000|Overall Study|Adverse Event|5|||
143268148|NCT00631696|516536834|FG001|Overall Study|Adverse Event|0|||
143268149|NCT01439568|516536836|FG000|Overall Study|Lost to Follow-up|1|||
143268150|NCT01439568|516536837|FG001|Overall Study|Lost to Follow-up|0|||
143268151|NCT01439568|516536836|FG000|Overall Study|Withdrawal by Subject|2|||
143268152|NCT01439568|516536837|FG001|Overall Study|Withdrawal by Subject|2|||
143268153|NCT02607930|516536838|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
143268154|NCT02607930|516536839|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
143268155|NCT02607930|516536840|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
143268156|NCT02607930|516536841|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
143268157|NCT02607930|516536838|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
143268158|NCT02607930|516536839|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
143268159|NCT02607930|516536840|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
143268160|NCT02607930|516536841|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
143268161|NCT02607930|516536838|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
143268162|NCT02607930|516536839|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
143268163|NCT02607930|516536840|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
143223807|NCT00731679|516366937|FG000|Overall Study|Adverse Event|7|||
143223808|NCT00731679|516366938|FG001|Overall Study|Adverse Event|8|||
143268164|NCT02607930|516536841|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
143268165|NCT02607930|516536838|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
143268166|NCT02607930|516536839|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
143268167|NCT02607930|516536840|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
143268168|NCT02607930|516536841|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
143223809|NCT00731679|516366937|FG000|Overall Study|Withdrawal by Subject|8|||
143223810|NCT00731679|516366938|FG001|Overall Study|Withdrawal by Subject|8|||
143223811|NCT00731679|516366937|FG000|Overall Study|Lost to Follow-up|7|||
143223812|NCT00731679|516366938|FG001|Overall Study|Lost to Follow-up|8|||
143223813|NCT00731679|516366937|FG000|Overall Study|Noncompliance|0|||
143223814|NCT00731679|516366938|FG001|Overall Study|Noncompliance|1|||
143223815|NCT00731679|516366937|FG000|Overall Study|Pregnancy|0|||
143223816|NCT00731679|516366938|FG001|Overall Study|Pregnancy|1|||
143223817|NCT02488005|516366941|FG000|Overall Study|Lost to Follow-up|2|||
143223818|NCT03384940|516366942|FG000|Overall Study|Progressive disease|36|||
143223819|NCT03384940|516366943|FG001|Overall Study|Progressive disease|11|||
143223820|NCT03384940|516366944|FG002|Overall Study|Progressive disease|13|||
143372457|NCT01193153|516909525|FG001|Open-label Lead in Period|Adverse Event|0|||
143372458|NCT01193153|516909524|FG000|Open-label Lead in Period|Death|1|||
143372459|NCT01193153|516909525|FG001|Open-label Lead in Period|Death|0|||
143372460|NCT01193153|516909524|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
143372461|NCT01193153|516909525|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
143223821|NCT03384940|516366942|FG000|Overall Study|Clinical progression|4|||
143223822|NCT03384940|516366943|FG001|Overall Study|Clinical progression|0|||
143223823|NCT03384940|516366944|FG002|Overall Study|Clinical progression|3|||
143223824|NCT03384940|516366942|FG000|Overall Study|Adverse Event|7|||
143223825|NCT03384940|516366943|FG001|Overall Study|Adverse Event|1|||
143223826|NCT03384940|516366944|FG002|Overall Study|Adverse Event|1|||
143223827|NCT03384940|516366942|FG000|Overall Study|Withdrawal by Subject|3|||
143223828|NCT03384940|516366943|FG001|Overall Study|Withdrawal by Subject|1|||
143223829|NCT03384940|516366944|FG002|Overall Study|Withdrawal by Subject|0|||
143223830|NCT03384940|516366942|FG000|Overall Study|Physician Decision|1|||
143223831|NCT03384940|516366943|FG001|Overall Study|Physician Decision|1|||
143223832|NCT03384940|516366944|FG002|Overall Study|Physician Decision|0|||
143223833|NCT03384940|516366942|FG000|Overall Study|Death|2|||
143223834|NCT03384940|516366943|FG001|Overall Study|Death|1|||
143223835|NCT03384940|516366944|FG002|Overall Study|Death|0|||
143223836|NCT03384940|516366942|FG000|Overall Study|Other|0|||
143223837|NCT03384940|516366943|FG001|Overall Study|Other|0|||
143223838|NCT03384940|516366944|FG002|Overall Study|Other|1|||
143223839|NCT03089580|516366950|FG000|Overall Study|Lost to Follow-up|2|||
143223840|NCT03087513|516366951|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
143223841|NCT04170543|516366952|FG000|Overall Study|Death|1|||
143223842|NCT04170543|516366953|FG001|Overall Study|Death|1|||
143223843|NCT04170543|516366954|FG002|Overall Study|Death|1|||
143223844|NCT04170543|516366955|FG003|Overall Study|Death|1|||
143223845|NCT04170543|516366956|FG004|Overall Study|Death|1|||
143223846|NCT04170543|516366952|FG000|Overall Study|Lost to Follow-up|3|||
143223847|NCT04170543|516366953|FG001|Overall Study|Lost to Follow-up|3|||
143223848|NCT04170543|516366954|FG002|Overall Study|Lost to Follow-up|0|||
143223849|NCT04170543|516366955|FG003|Overall Study|Lost to Follow-up|3|||
143223850|NCT04170543|516366956|FG004|Overall Study|Lost to Follow-up|1|||
143223851|NCT04170543|516366952|FG000|Overall Study|Withdrawal by Subject|13|||
143223852|NCT04170543|516366953|FG001|Overall Study|Withdrawal by Subject|6|||
143223853|NCT04170543|516366954|FG002|Overall Study|Withdrawal by Subject|5|||
143223854|NCT04170543|516366955|FG003|Overall Study|Withdrawal by Subject|4|||
143223855|NCT04170543|516366956|FG004|Overall Study|Withdrawal by Subject|9|||
143223856|NCT04170543|516366952|FG000|Overall Study|Not able to transition to phase 2b|8|||
143223857|NCT04170543|516366953|FG001|Overall Study|Not able to transition to phase 2b|0|||
143223858|NCT04170543|516366954|FG002|Overall Study|Not able to transition to phase 2b|10|||
143223859|NCT04170543|516366955|FG003|Overall Study|Not able to transition to phase 2b|0|||
143223860|NCT04170543|516366956|FG004|Overall Study|Not able to transition to phase 2b|6|||
143223861|NCT04170543|516366952|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
143223862|NCT04170543|516366953|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
143223863|NCT04170543|516366954|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
143223864|NCT04170543|516366955|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
143372462|NCT01193153|516909524|FG000|Open-label Stabilization Period|Adverse Event|9|||
143372463|NCT01193153|516909525|FG001|Open-label Stabilization Period|Adverse Event|0|||
143223865|NCT04170543|516366956|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
143223866|NCT04170543|516366952|FG000|Overall Study|Not Treated|0|||
143223867|NCT04170543|516366953|FG001|Overall Study|Not Treated|0|||
143223868|NCT04170543|516366954|FG002|Overall Study|Not Treated|0|||
143223869|NCT04170543|516366955|FG003|Overall Study|Not Treated|0|||
143223870|NCT04170543|516366956|FG004|Overall Study|Not Treated|2|||
143223871|NCT04170543|516366952|FG000|Overall Study|(CRF)|16|||
143223872|NCT04170543|516366953|FG001|Overall Study|(CRF)|15|||
143223873|NCT04170543|516366954|FG002|Overall Study|(CRF)|12|||
143223874|NCT04170543|516366955|FG003|Overall Study|(CRF)|17|||
143223875|NCT04170543|516366956|FG004|Overall Study|(CRF)|17|||
143223876|NCT04170543|516366952|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
143223877|NCT04170543|516366953|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
143223878|NCT04170543|516366954|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
143223879|NCT04170543|516366955|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
143223880|NCT04170543|516366956|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
143223881|NCT03622814|516366957|FG000|Overall Study|Lost to Follow-up|8|||
143223882|NCT03622814|516366958|FG001|Overall Study|Lost to Follow-up|14|||
143223883|NCT04417361|516366959|FG000|Overall Study|Withdrawal by Subject|1|||
143223884|NCT04417361|516366960|FG001|Overall Study|Withdrawal by Subject|0|||
143223885|NCT04417361|516366959|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
143223886|NCT04417361|516366960|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
143223887|NCT04303559|516366961|FG000|Overall Study|Study closed due to poor enrollment.|1|||
143223888|NCT01987102|516366964|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
143223889|NCT01987102|516366965|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
143223890|NCT01987102|516366964|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
143223891|NCT01987102|516366965|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
143223892|NCT01987102|516366964|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
143223893|NCT01987102|516366965|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
143223894|NCT01987102|516366964|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
143223895|NCT01987102|516366965|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
143223896|NCT01987102|516366964|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
143223897|NCT01987102|516366965|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
143223898|NCT01987102|516366964|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
143223899|NCT01987102|516366965|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
143223900|NCT04661150|516366971|FG000|Overall Study|Ongoing in study|19|||
143223901|NCT04661150|516366972|FG001|Overall Study|Ongoing in study|20|||
143223902|NCT04661150|516366971|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
143223903|NCT04661150|516366972|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
143268169|NCT02607930|516536838|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
143268170|NCT02607930|516536839|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
143268171|NCT02607930|516536840|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
143268172|NCT02607930|516536841|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
143268173|NCT02607930|516536838|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
143268174|NCT02607930|516536839|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
143268175|NCT02607930|516536840|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
143268176|NCT02607930|516536841|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
143268177|NCT02607930|516536838|FG000|Double-Blinded Treatment Phase|Death|2|||
143268178|NCT02607930|516536839|FG001|Double-Blinded Treatment Phase|Death|1|||
143268179|NCT02607930|516536840|FG002|Double-Blinded Treatment Phase|Death|0|||
143268180|NCT02607930|516536841|FG003|Double-Blinded Treatment Phase|Death|0|||
143268181|NCT02607930|516536838|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
143268182|NCT02607930|516536839|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
143268183|NCT02607930|516536840|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
143268184|NCT02607930|516536841|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
143268185|NCT02607930|516536838|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
143268186|NCT02607930|516536839|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
143268187|NCT02607930|516536840|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
143268188|NCT02607930|516536841|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
143268189|NCT02607930|516536838|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
143268190|NCT02607930|516536839|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
143268191|NCT02607930|516536840|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
143268192|NCT02607930|516536841|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
143268193|NCT02607930|516536838|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
143268194|NCT02607930|516536839|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
143268195|NCT02607930|516536840|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
143268196|NCT02607930|516536841|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
143268197|NCT02607930|516536838|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
143268198|NCT02607930|516536839|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
143268199|NCT02607930|516536840|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
143268200|NCT02607930|516536841|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
143268201|NCT02607930|516536838|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
143268202|NCT02607930|516536839|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
143268203|NCT02607930|516536840|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
143268204|NCT02607930|516536841|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
143268205|NCT02607930|516536838|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
143268206|NCT02607930|516536839|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
143268207|NCT02607930|516536840|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
143268208|NCT02607930|516536841|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
143268209|NCT02607930|516536838|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
143223904|NCT04661150|516366971|FG000|Overall Study|Death|2|||
143223905|NCT04661150|516366972|FG001|Overall Study|Death|0|||
143223906|NCT04965688|516366973|FG000|Overall Study|Withdrawal by Subject|2|||
143223907|NCT05864586|516366974|FG000|Overall Study|Ineligible|4|||
143223908|NCT05864586|516366975|FG001|Overall Study|Ineligible|12|||
143223909|NCT05864586|516366974|FG000|Overall Study|Pregnancy|0|||
143223910|NCT05864586|516366975|FG001|Overall Study|Pregnancy|1|||
143223911|NCT05864586|516366974|FG000|Overall Study|Withdrawal by Subject|0|||
143223912|NCT05864586|516366975|FG001|Overall Study|Withdrawal by Subject|1|||
143223913|NCT03635424|516366976|FG000|Overall Study|Adverse Event|1|||
143223914|NCT03635424|516366976|FG000|Overall Study|Death|1|||
143223915|NCT03635424|516366976|FG000|Overall Study|Device not implanted|1|||
143223916|NCT05081219|516366977|FG000|Overall Study|Withdrawal by Subject|4|||
143223917|NCT05081219|516366978|FG001|Overall Study|Withdrawal by Subject|0|||
143223918|NCT05081219|516366979|FG002|Overall Study|Withdrawal by Subject|0|||
143223919|NCT05081219|516366980|FG003|Overall Study|Withdrawal by Subject|1|||
143223920|NCT04896593|516366984|FG000|Overall Study|Withdrawal by Subject|2|||
143223921|NCT04896593|516366984|FG000|Overall Study|Lost to Follow-up|1|||
143223922|NCT04896593|516366984|FG000|Overall Study|Did not complete onboarding|2|||
143223923|NCT00452790|516366985|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
143223924|NCT00452790|516366986|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
143223925|NCT00452790|516366985|FG000|Infant Series|Parent/legal guardian request|8|||
143268210|NCT02607930|516536839|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
143268211|NCT02607930|516536840|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
143268212|NCT02607930|516536841|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
143268213|NCT02607930|516536838|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
143268214|NCT02607930|516536839|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
143268215|NCT02607930|516536840|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
143268216|NCT02607930|516536841|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
143268217|NCT01578330|516536844|FG000|Overall Study|Adverse Event|2|||
143268218|NCT01578330|516536844|FG000|Overall Study|Protocol Violation|5|||
143268219|NCT03053271|516536845|FG000|Overall Study|Did not meet randomization criteria|3|||
143268220|NCT03053271|516536845|FG000|Overall Study|Withdrawal by Subject|1|||
143268221|NCT00570765|516536846|FG000|DB Phase|Withdrawal by Subject|1|||
143268222|NCT00570765|516536847|FG001|DB Phase|Withdrawal by Subject|0|||
143268223|NCT00570765|516536848|FG002|DB Phase|Withdrawal by Subject|0|||
143268224|NCT00570765|516536849|FG003|DB Phase|Withdrawal by Subject|0|||
143268225|NCT00570765|516536846|FG000|DB Phase|Protocol Violation|0|||
143268226|NCT00570765|516536847|FG001|DB Phase|Protocol Violation|1|||
143268227|NCT00570765|516536848|FG002|DB Phase|Protocol Violation|0|||
143268228|NCT00570765|516536849|FG003|DB Phase|Protocol Violation|0|||
143268229|NCT00570765|516536846|FG000|DB Phase|Adverse Event|3|||
143268230|NCT00570765|516536847|FG001|DB Phase|Adverse Event|6|||
143268231|NCT00570765|516536848|FG002|DB Phase|Adverse Event|0|||
143268232|NCT00570765|516536849|FG003|DB Phase|Adverse Event|0|||
143268233|NCT00570765|516536846|FG000|DB Phase|Did Not Receive Study Drug|0|||
143268234|NCT00570765|516536847|FG001|DB Phase|Did Not Receive Study Drug|0|||
143268235|NCT00570765|516536848|FG002|DB Phase|Did Not Receive Study Drug|1|||
143268236|NCT00570765|516536849|FG003|DB Phase|Did Not Receive Study Drug|0|||
143268237|NCT00570765|516536846|FG000|LTSE Phase|Withdrawal by Subject|0|||
143268238|NCT00570765|516536847|FG001|LTSE Phase|Withdrawal by Subject|0|||
143268239|NCT00570765|516536848|FG002|LTSE Phase|Withdrawal by Subject|0|||
143268240|NCT00570765|516536849|FG003|LTSE Phase|Withdrawal by Subject|1|||
143268241|NCT00570765|516536846|FG000|LTSE Phase|Adverse Event|0|||
143268242|NCT00570765|516536847|FG001|LTSE Phase|Adverse Event|0|||
143268243|NCT00570765|516536848|FG002|LTSE Phase|Adverse Event|0|||
143268244|NCT00570765|516536849|FG003|LTSE Phase|Adverse Event|7|||
143268245|NCT00570765|516536846|FG000|LTSE Phase|Physician Decision|0|||
143268246|NCT00570765|516536847|FG001|LTSE Phase|Physician Decision|0|||
143268247|NCT00570765|516536848|FG002|LTSE Phase|Physician Decision|0|||
143268248|NCT00570765|516536849|FG003|LTSE Phase|Physician Decision|4|||
143268249|NCT02517866|516536850|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
143268250|NCT02517866|516536851|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
143268251|NCT02517866|516536852|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
143268252|NCT02517866|516536850|FG000|Overall Study|Significant Protocol Deviation|4|||
143268253|NCT02517866|516536851|FG001|Overall Study|Significant Protocol Deviation|1|||
143268254|NCT02517866|516536852|FG002|Overall Study|Significant Protocol Deviation|0|||
143268255|NCT02517866|516536850|FG000|Overall Study|Lost to Follow-up|1|||
143268256|NCT02517866|516536851|FG001|Overall Study|Lost to Follow-up|0|||
143268257|NCT02517866|516536852|FG002|Overall Study|Lost to Follow-up|0|||
143268258|NCT02517866|516536850|FG000|Overall Study|Voluntary Withdrawal|2|||
143268259|NCT02517866|516536851|FG001|Overall Study|Voluntary Withdrawal|2|||
143268260|NCT02517866|516536852|FG002|Overall Study|Voluntary Withdrawal|0|||
143268261|NCT02517866|516536850|FG000|Overall Study|Investigator Decision|2|||
143268262|NCT02517866|516536851|FG001|Overall Study|Investigator Decision|1|||
143268263|NCT02517866|516536852|FG002|Overall Study|Investigator Decision|0|||
143268264|NCT02517866|516536850|FG000|Overall Study|Reason not specified|2|||
143268265|NCT02517866|516536851|FG001|Overall Study|Reason not specified|0|||
143372464|NCT01193153|516909524|FG000|Open-label Stabilization Period|Death|2|||
143268266|NCT02517866|516536852|FG002|Overall Study|Reason not specified|0|||
143268267|NCT03711266|516536853|FG000|Overall Study|Lost to Follow-up|10|||
143223926|NCT00452790|516366986|FG001|Infant Series|Parent/legal guardian request|6|||
143223927|NCT00452790|516366985|FG000|Infant Series|Failed to return|4|||
143223928|NCT00452790|516366986|FG001|Infant Series|Failed to return|1|||
143223929|NCT00452790|516366985|FG000|Infant Series|Protocol Violation|1|||
143223930|NCT00452790|516366986|FG001|Infant Series|Protocol Violation|3|||
143223931|NCT00452790|516366985|FG000|Infant Series|Lost to Follow-up|2|||
143223932|NCT00452790|516366986|FG001|Infant Series|Lost to Follow-up|2|||
143223933|NCT00452790|516366985|FG000|Infant Series|Adverse Event|1|||
143223934|NCT00452790|516366986|FG001|Infant Series|Adverse Event|2|||
143223935|NCT00452790|516366985|FG000|Infant Series|Other reasons|1|||
143223936|NCT00452790|516366986|FG001|Infant Series|Other reasons|2|||
143223937|NCT00452790|516366985|FG000|Infant Series|Investigator request|0|||
143223938|NCT00452790|516366986|FG001|Infant Series|Investigator request|1|||
143223939|NCT00452790|516366985|FG000|Infant Series|Death|0|||
143223940|NCT00452790|516366986|FG001|Infant Series|Death|1|||
143223941|NCT00452790|516366985|FG000|After Infant Series|Investigator request|10|||
143223942|NCT00452790|516366986|FG001|After Infant Series|Investigator request|10|||
143223943|NCT00452790|516366985|FG000|After Infant Series|Adverse Event|4|||
143223944|NCT00452790|516366986|FG001|After Infant Series|Adverse Event|1|||
143223945|NCT00452790|516366985|FG000|After Infant Series|Parent/legal guardian request|1|||
143223946|NCT00452790|516366986|FG001|After Infant Series|Parent/legal guardian request|3|||
143223947|NCT00452790|516366985|FG000|After Infant Series|Lost to Follow-up|4|||
143223948|NCT00452790|516366986|FG001|After Infant Series|Lost to Follow-up|0|||
143223949|NCT00452790|516366985|FG000|After Infant Series|Failed to return|1|||
143223950|NCT00452790|516366986|FG001|After Infant Series|Failed to return|0|||
143223951|NCT00452790|516366985|FG000|After Infant Series|Other reasons|1|||
143223952|NCT00452790|516366986|FG001|After Infant Series|Other reasons|0|||
143223953|NCT00452790|516366985|FG000|Toddler Dose|Failed to return|0|||
143223954|NCT00452790|516366986|FG001|Toddler Dose|Failed to return|1|||
143223955|NCT00452790|516366985|FG000|Toddler Dose|Parent/legal guardian request|0|||
143223956|NCT00452790|516366986|FG001|Toddler Dose|Parent/legal guardian request|1|||
143223957|NCT04177212|516366990|FG000|Overall Study|Withdrawal by Subject|9|||
143223958|NCT04177212|516366991|FG001|Overall Study|Withdrawal by Subject|7|||
143223959|NCT04177212|516366990|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
143223960|NCT04177212|516366991|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
143223961|NCT04177212|516366990|FG000|Overall Study|Physician Decision|1|||
143223962|NCT04177212|516366991|FG001|Overall Study|Physician Decision|0|||
143223963|NCT04177212|516366990|FG000|Overall Study|Lost to Follow-up|0|||
143223964|NCT04177212|516366991|FG001|Overall Study|Lost to Follow-up|3|||
143223965|NCT04177212|516366990|FG000|Overall Study|Adverse Event|0|||
143223966|NCT04177212|516366991|FG001|Overall Study|Adverse Event|1|||
143223967|NCT04177212|516366990|FG000|Overall Study|Other|1|||
143223968|NCT04177212|516366991|FG001|Overall Study|Other|2|||
143223969|NCT01279681|516366992|FG000|Overall Study|Disease Progression|9|||
143223970|NCT01279681|516366993|FG001|Overall Study|Disease Progression|6|||
143223971|NCT01279681|516366992|FG000|Overall Study|Withdrawal by Subject|3|||
143223972|NCT01279681|516366993|FG001|Overall Study|Withdrawal by Subject|4|||
143223973|NCT01279681|516366992|FG000|Overall Study|Adverse Event|2|||
143223974|NCT01279681|516366993|FG001|Overall Study|Adverse Event|3|||
143223975|NCT01279681|516366992|FG000|Overall Study|Death|0|||
143223976|NCT01279681|516366993|FG001|Overall Study|Death|1|||
143223977|NCT01279681|516366992|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
143223978|NCT01279681|516366993|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
143223979|NCT01279681|516366992|FG000|Overall Study|Physician Decision|1|||
143223980|NCT01279681|516366993|FG001|Overall Study|Physician Decision|0|||
143223981|NCT01279681|516366992|FG000|Overall Study|Other Reason|0|||
143268268|NCT01669928|516536854|FG000|First Intervention|Withdrawal by Subject|3|||
143268269|NCT01669928|516536855|FG001|First Intervention|Withdrawal by Subject|5|||
143268270|NCT01954342|516536858|FG000|Overall Study|Missing data from 13-16week study visit|0|||
143268271|NCT01954342|516536859|FG001|Overall Study|Missing data from 13-16week study visit|0|||
143268272|NCT01954342|516536860|FG002|Overall Study|Missing data from 13-16week study visit|0|||
143223982|NCT01279681|516366993|FG001|Overall Study|Other Reason|2|||
143223983|NCT02614729|516368808|FG000|Overall Study|Withdrawal by Subject|1|||
143223984|NCT02614729|516368809|FG001|Overall Study|Withdrawal by Subject|0|||
143223985|NCT02539797|516368813|FG000|Overall Study|Lost to Follow-up|0|||
143223986|NCT02539797|516368814|FG001|Overall Study|Lost to Follow-up|1|||
143223987|NCT02539797|516368815|FG002|Overall Study|Lost to Follow-up|0|||
143223988|NCT02796677|516368821|FG000|Overall Study|Adverse Event|11|||
143223989|NCT02796677|516368822|FG001|Overall Study|Adverse Event|22|||
143223990|NCT02796677|516368823|FG002|Overall Study|Adverse Event|14|||
143223991|NCT02796677|516368824|FG003|Overall Study|Adverse Event|14|||
143223992|NCT02796677|516368821|FG000|Overall Study|Protocol Violation|7|||
143223993|NCT02796677|516368822|FG001|Overall Study|Protocol Violation|5|||
143223994|NCT02796677|516368823|FG002|Overall Study|Protocol Violation|4|||
143223995|NCT02796677|516368824|FG003|Overall Study|Protocol Violation|8|||
143223996|NCT02796677|516368821|FG000|Overall Study|Lost to Follow-up|1|||
143223997|NCT02796677|516368822|FG001|Overall Study|Lost to Follow-up|5|||
143223998|NCT02796677|516368823|FG002|Overall Study|Lost to Follow-up|2|||
143223999|NCT02796677|516368824|FG003|Overall Study|Lost to Follow-up|2|||
143224000|NCT02796677|516368821|FG000|Overall Study|Lack of Efficacy|7|||
143224001|NCT02796677|516368822|FG001|Overall Study|Lack of Efficacy|9|||
143224002|NCT02796677|516368823|FG002|Overall Study|Lack of Efficacy|14|||
143224003|NCT02796677|516368824|FG003|Overall Study|Lack of Efficacy|20|||
143224004|NCT02796677|516368821|FG000|Overall Study|Withdrawal by Subject|4|||
143224005|NCT02796677|516368822|FG001|Overall Study|Withdrawal by Subject|14|||
143224006|NCT02796677|516368823|FG002|Overall Study|Withdrawal by Subject|6|||
143224007|NCT02796677|516368824|FG003|Overall Study|Withdrawal by Subject|7|||
143224008|NCT02796677|516368821|FG000|Overall Study|Progressive disease|6|||
143224009|NCT02796677|516368822|FG001|Overall Study|Progressive disease|15|||
143224010|NCT02796677|516368823|FG002|Overall Study|Progressive disease|13|||
143224011|NCT02796677|516368824|FG003|Overall Study|Progressive disease|18|||
143224012|NCT02796677|516368821|FG000|Overall Study|Reason not mentioned|2|||
143224013|NCT02796677|516368822|FG001|Overall Study|Reason not mentioned|3|||
143224014|NCT02796677|516368823|FG002|Overall Study|Reason not mentioned|0|||
143224015|NCT02796677|516368824|FG003|Overall Study|Reason not mentioned|5|||
143224016|NCT03798717|516368825|FG000|Overall Study|Failed Screening|0|||
143224017|NCT03798717|516368826|FG001|Overall Study|Failed Screening|0|||
143224018|NCT03798717|516368827|FG002|Overall Study|Failed Screening|0|||
143224019|NCT03798717|516368828|FG003|Overall Study|Failed Screening|0|||
143224020|NCT03798717|516368829|FG004|Overall Study|Failed Screening|0|||
143268273|NCT01954342|516536861|FG003|Overall Study|Missing data from 13-16week study visit|1|||
143268274|NCT01954342|516536858|FG000|Overall Study|Miscarriage|0|||
143268275|NCT01954342|516536859|FG001|Overall Study|Miscarriage|0|||
143268276|NCT01954342|516536860|FG002|Overall Study|Miscarriage|0|||
143268277|NCT01954342|516536861|FG003|Overall Study|Miscarriage|3|||
143268278|NCT01954342|516536858|FG000|Overall Study|Lost to Follow-up|0|||
143268279|NCT01954342|516536859|FG001|Overall Study|Lost to Follow-up|0|||
143268280|NCT01954342|516536860|FG002|Overall Study|Lost to Follow-up|0|||
143268281|NCT01954342|516536861|FG003|Overall Study|Lost to Follow-up|5|||
143268282|NCT01954342|516536858|FG000|Overall Study|Preterm delivery|0|||
143268283|NCT01954342|516536859|FG001|Overall Study|Preterm delivery|0|||
143268284|NCT01954342|516536860|FG002|Overall Study|Preterm delivery|0|||
143268285|NCT01954342|516536861|FG003|Overall Study|Preterm delivery|3|||
143224021|NCT03798717|516368830|FG005|Overall Study|Failed Screening|1|||
143224022|NCT03798717|516368825|FG000|Overall Study|Physician Decision|1|||
143224023|NCT03798717|516368826|FG001|Overall Study|Physician Decision|0|||
143224024|NCT03798717|516368827|FG002|Overall Study|Physician Decision|1|||
143224025|NCT03798717|516368828|FG003|Overall Study|Physician Decision|0|||
143224026|NCT03798717|516368829|FG004|Overall Study|Physician Decision|0|||
143224027|NCT03798717|516368830|FG005|Overall Study|Physician Decision|0|||
143224028|NCT03798717|516368825|FG000|Overall Study|Withdrawal by Subject|0|||
143224029|NCT03798717|516368826|FG001|Overall Study|Withdrawal by Subject|0|||
143224030|NCT03798717|516368827|FG002|Overall Study|Withdrawal by Subject|0|||
143224031|NCT03798717|516368828|FG003|Overall Study|Withdrawal by Subject|1|||
143224032|NCT03798717|516368829|FG004|Overall Study|Withdrawal by Subject|0|||
143224033|NCT03798717|516368830|FG005|Overall Study|Withdrawal by Subject|0|||
143224034|NCT03798717|516368825|FG000|Overall Study|Lost to Follow-up|1|||
143268286|NCT01954342|516536858|FG000|Overall Study|Pre-eclampsia|0|||
143224035|NCT03798717|516368826|FG001|Overall Study|Lost to Follow-up|0|||
143268287|NCT01954342|516536859|FG001|Overall Study|Pre-eclampsia|0|||
143268288|NCT01954342|516536860|FG002|Overall Study|Pre-eclampsia|0|||
143268289|NCT01954342|516536861|FG003|Overall Study|Pre-eclampsia|4|||
143268290|NCT01954342|516536858|FG000|Overall Study|Unreliable Data|0|||
143268291|NCT01954342|516536859|FG001|Overall Study|Unreliable Data|0|||
143268292|NCT01954342|516536860|FG002|Overall Study|Unreliable Data|0|||
143268293|NCT01954342|516536861|FG003|Overall Study|Unreliable Data|2|||
143224036|NCT03798717|516368827|FG002|Overall Study|Lost to Follow-up|0|||
143268294|NCT01646073|516536864|FG000|Period A (12 Weeks)|Adverse Event|0|||
143268295|NCT01646073|516536865|FG001|Period A (12 Weeks)|Adverse Event|2|||
143224037|NCT03798717|516368828|FG003|Overall Study|Lost to Follow-up|1|||
143224038|NCT03798717|516368829|FG004|Overall Study|Lost to Follow-up|0|||
143224039|NCT03798717|516368830|FG005|Overall Study|Lost to Follow-up|0|||
143224040|NCT03798717|516368825|FG000|Overall Study|Adverse Event|0|||
143224041|NCT03798717|516368826|FG001|Overall Study|Adverse Event|1|||
143224042|NCT03798717|516368827|FG002|Overall Study|Adverse Event|0|||
143224043|NCT03798717|516368828|FG003|Overall Study|Adverse Event|0|||
143224044|NCT03798717|516368829|FG004|Overall Study|Adverse Event|0|||
143224045|NCT03798717|516368830|FG005|Overall Study|Adverse Event|0|||
143268296|NCT01646073|516536864|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
143268297|NCT01646073|516536865|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
143268298|NCT01646073|516536864|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
143268299|NCT01646073|516536865|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
143268300|NCT01646073|516536864|FG000|Period A (12 Weeks)|Protocol Violation|0|||
143268301|NCT01646073|516536865|FG001|Period A (12 Weeks)|Protocol Violation|1|||
143224046|NCT03798717|516368825|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
143224047|NCT03798717|516368826|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
143224048|NCT03798717|516368827|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
143224049|NCT03798717|516368828|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
143224050|NCT03798717|516368829|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
143224051|NCT03798717|516368830|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
143224052|NCT04002960|516368832|FG000|Overall Study|Withdrawn prior to Completion|2|||
143224053|NCT00961181|516368835|FG000|Overall Study|Death|2|||
143224054|NCT00961181|516368835|FG000|Overall Study|Withdrawal by Subject|2|||
143224055|NCT00961181|516368835|FG000|Overall Study|Lost to Follow-up|1|||
143224056|NCT03212326|516368839|FG000|Overall Study|Physician Decision|4|||
143224057|NCT00985673|516368840|FG000|Overall Study|Lost to Follow-up|6|||
143224058|NCT00985673|516368841|FG001|Overall Study|Lost to Follow-up|7|||
143224059|NCT00985673|516368842|FG002|Overall Study|Lost to Follow-up|6|||
143224060|NCT00985673|516368843|FG003|Overall Study|Lost to Follow-up|10|||
143224061|NCT00985673|516368844|FG004|Overall Study|Lost to Follow-up|5|||
143224062|NCT00985673|516368845|FG005|Overall Study|Lost to Follow-up|3|||
143224063|NCT00985673|516368840|FG000|Overall Study|Withdrawal by Subject|0|||
143224064|NCT00985673|516368841|FG001|Overall Study|Withdrawal by Subject|4|||
143224065|NCT00985673|516368842|FG002|Overall Study|Withdrawal by Subject|5|||
143224066|NCT00985673|516368843|FG003|Overall Study|Withdrawal by Subject|2|||
143224067|NCT00985673|516368844|FG004|Overall Study|Withdrawal by Subject|2|||
143224068|NCT00985673|516368845|FG005|Overall Study|Withdrawal by Subject|3|||
143224069|NCT00985673|516368840|FG000|Overall Study|Other|1|||
143224070|NCT00985673|516368841|FG001|Overall Study|Other|0|||
143224071|NCT00985673|516368842|FG002|Overall Study|Other|1|||
143224072|NCT00985673|516368843|FG003|Overall Study|Other|0|||
143224073|NCT00985673|516368844|FG004|Overall Study|Other|1|||
143224074|NCT00985673|516368845|FG005|Overall Study|Other|0|||
143224075|NCT00984256|516368848|FG000|Overall Study|Withdrawal by Subject|0|||
143224076|NCT00984256|516368849|FG001|Overall Study|Withdrawal by Subject|1|||
143224077|NCT02723773|516368850|FG000|Overall Study|Adverse Event|934|||
143224078|NCT02723773|516368851|FG001|Overall Study|Adverse Event|3|||
143224079|NCT02723773|516368852|FG002|Overall Study|Adverse Event|1|||
143224080|NCT02723773|516368853|FG003|Overall Study|Adverse Event|9|||
143224081|NCT02723773|516368850|FG000|Overall Study|Protocol Violation|1|||
143224082|NCT02723773|516368851|FG001|Overall Study|Protocol Violation|0|||
143224083|NCT02723773|516368852|FG002|Overall Study|Protocol Violation|0|||
143224084|NCT02723773|516368853|FG003|Overall Study|Protocol Violation|0|||
143224085|NCT02723773|516368850|FG000|Overall Study|Withdrawal by Subject|360|||
143224086|NCT02723773|516368851|FG001|Overall Study|Withdrawal by Subject|5|||
143224087|NCT02723773|516368852|FG002|Overall Study|Withdrawal by Subject|6|||
143224088|NCT02723773|516368853|FG003|Overall Study|Withdrawal by Subject|10|||
143224089|NCT02723773|516368850|FG000|Overall Study|Migrated/moved from study area|37|||
143224090|NCT02723773|516368851|FG001|Overall Study|Migrated/moved from study area|0|||
143224091|NCT02723773|516368852|FG002|Overall Study|Migrated/moved from study area|0|||
143224092|NCT02723773|516368853|FG003|Overall Study|Migrated/moved from study area|1|||
143224093|NCT02723773|516368850|FG000|Overall Study|Lost to Follow-up|198|||
143224094|NCT02723773|516368851|FG001|Overall Study|Lost to Follow-up|0|||
143224095|NCT02723773|516368852|FG002|Overall Study|Lost to Follow-up|0|||
143224096|NCT02723773|516368853|FG003|Overall Study|Lost to Follow-up|0|||
143224097|NCT02723773|516368850|FG000|Overall Study|Other|189|||
143224098|NCT02723773|516368851|FG001|Overall Study|Other|1|||
143224099|NCT02723773|516368852|FG002|Overall Study|Other|2|||
143224100|NCT02723773|516368853|FG003|Overall Study|Other|2|||
143224101|NCT01790594|516368858|FG000|Overall Study|Death|1|||
143224102|NCT01790594|516368859|FG001|Overall Study|Death|0|||
143224103|NCT01790594|516368860|FG002|Overall Study|Death|0|||
143224104|NCT01790594|516368858|FG000|Overall Study|Physician Decision|2|||
143224105|NCT01790594|516368859|FG001|Overall Study|Physician Decision|1|||
143224106|NCT01790594|516368860|FG002|Overall Study|Physician Decision|0|||
143224107|NCT01790594|516368858|FG000|Overall Study|Withdrawal by Subject|2|||
143224108|NCT01790594|516368859|FG001|Overall Study|Withdrawal by Subject|0|||
143224109|NCT01790594|516368860|FG002|Overall Study|Withdrawal by Subject|0|||
143224110|NCT01790594|516368858|FG000|Overall Study|Transplant was not done|0|||
143224111|NCT01790594|516368859|FG001|Overall Study|Transplant was not done|0|||
143224112|NCT01790594|516368860|FG002|Overall Study|Transplant was not done|3|||
143224113|NCT01790594|516368858|FG000|Overall Study|Terminated prior to week 76|0|||
143224114|NCT01790594|516368859|FG001|Overall Study|Terminated prior to week 76|2|||
143224115|NCT01790594|516368860|FG002|Overall Study|Terminated prior to week 76|0|||
143224116|NCT01855412|516368864|FG000|Overall Study|Death|77|||
143224117|NCT01855412|516368865|FG001|Overall Study|Death|123|||
143224118|NCT01855412|516368866|FG002|Overall Study|Death|30|||
143224119|NCT01855412|516368864|FG000|Overall Study|Lost to Follow-up|28|||
143224120|NCT01855412|516368865|FG001|Overall Study|Lost to Follow-up|46|||
143224121|NCT01855412|516368866|FG002|Overall Study|Lost to Follow-up|15|||
143224122|NCT01855412|516368864|FG000|Overall Study|Withdrawal by Subject|77|||
143224123|NCT01855412|516368865|FG001|Overall Study|Withdrawal by Subject|123|||
143224124|NCT01855412|516368866|FG002|Overall Study|Withdrawal by Subject|24|||
143224125|NCT01855412|516368864|FG000|Overall Study|Physician Decision|25|||
143268302|NCT01646073|516536864|FG000|Period A (12 Weeks)|Other|0|||
143268303|NCT01646073|516536865|FG001|Period A (12 Weeks)|Other|1|||
143268304|NCT01646073|516536864|FG000|Period B (12 Weeks)|Adverse Event|0|||
143268305|NCT01646073|516536865|FG001|Period B (12 Weeks)|Adverse Event|7|||
143224126|NCT01855412|516368865|FG001|Overall Study|Physician Decision|31|||
143224127|NCT01855412|516368866|FG002|Overall Study|Physician Decision|3|||
143224128|NCT01855412|516368864|FG000|Overall Study|Site Closure|4|||
143224129|NCT01855412|516368865|FG001|Overall Study|Site Closure|18|||
143224130|NCT01855412|516368866|FG002|Overall Study|Site Closure|1|||
143224131|NCT01855412|516368864|FG000|Overall Study|Reason not Specified|1|||
143224132|NCT01855412|516368865|FG001|Overall Study|Reason not Specified|2|||
143224133|NCT01855412|516368866|FG002|Overall Study|Reason not Specified|3|||
143224134|NCT00404651|516368868|FG000|Overall Study|Serious Adverse Event|0|||
143224135|NCT00404651|516368869|FG001|Overall Study|Serious Adverse Event|0|||
143224136|NCT00404651|516368870|FG002|Overall Study|Serious Adverse Event|2|||
143224137|NCT00404651|516368871|FG003|Overall Study|Serious Adverse Event|0|||
143224138|NCT00404651|516368868|FG000|Overall Study|Protocol Violation|10|||
143224139|NCT00404651|516368869|FG001|Overall Study|Protocol Violation|5|||
143224140|NCT00404651|516368870|FG002|Overall Study|Protocol Violation|14|||
143224141|NCT00404651|516368871|FG003|Overall Study|Protocol Violation|5|||
143224142|NCT00404651|516368868|FG000|Overall Study|Lost to Follow-up|15|||
143224143|NCT00404651|516368869|FG001|Overall Study|Lost to Follow-up|11|||
143224144|NCT00404651|516368870|FG002|Overall Study|Lost to Follow-up|13|||
143224145|NCT00404651|516368871|FG003|Overall Study|Lost to Follow-up|10|||
143224146|NCT00404651|516368868|FG000|Overall Study|Withdrawal by Subject|14|||
143224147|NCT00404651|516368869|FG001|Overall Study|Withdrawal by Subject|12|||
143224148|NCT00404651|516368870|FG002|Overall Study|Withdrawal by Subject|16|||
143224149|NCT00404651|516368871|FG003|Overall Study|Withdrawal by Subject|6|||
143224150|NCT03347123|516368879|FG000|Overall Study|Death|1|||
143224151|NCT03347123|516368880|FG001|Overall Study|Death|2|||
143224152|NCT03347123|516368881|FG002|Overall Study|Death|0|||
143224153|NCT03347123|516368882|FG003|Overall Study|Death|0|||
143224154|NCT03347123|516368883|FG004|Overall Study|Death|0|||
143224155|NCT03347123|516368884|FG005|Overall Study|Death|0|||
143224156|NCT03347123|516368885|FG006|Overall Study|Death|0|||
143224157|NCT03347123|516368879|FG000|Overall Study|Withdrawal by Subject|1|||
143224158|NCT03347123|516368880|FG001|Overall Study|Withdrawal by Subject|0|||
143224159|NCT03347123|516368881|FG002|Overall Study|Withdrawal by Subject|0|||
143224160|NCT03347123|516368882|FG003|Overall Study|Withdrawal by Subject|0|||
143224161|NCT03347123|516368883|FG004|Overall Study|Withdrawal by Subject|0|||
143224162|NCT03347123|516368884|FG005|Overall Study|Withdrawal by Subject|0|||
143224163|NCT03347123|516368885|FG006|Overall Study|Withdrawal by Subject|0|||
143224164|NCT03347123|516368879|FG000|Overall Study|Reason not Specified|3|||
143224165|NCT03347123|516368880|FG001|Overall Study|Reason not Specified|4|||
143224166|NCT03347123|516368881|FG002|Overall Study|Reason not Specified|0|||
143224167|NCT03347123|516368882|FG003|Overall Study|Reason not Specified|0|||
143224168|NCT03347123|516368883|FG004|Overall Study|Reason not Specified|0|||
143224169|NCT03347123|516368884|FG005|Overall Study|Reason not Specified|0|||
143224170|NCT03347123|516368885|FG006|Overall Study|Reason not Specified|0|||
143224171|NCT01121146|516368893|FG000|Overall Study|Death|17|||
143224172|NCT01121146|516368894|FG001|Overall Study|Death|15|||
143268306|NCT01646073|516536864|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
143268307|NCT01646073|516536865|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
143268308|NCT01646073|516536864|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
143268309|NCT01646073|516536865|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
143224173|NCT01121146|516368893|FG000|Overall Study|Adverse Event|2|||
143224174|NCT01121146|516368894|FG001|Overall Study|Adverse Event|11|||
143224175|NCT01121146|516368893|FG000|Overall Study|Lost to Follow-up|7|||
143224176|NCT01121146|516368894|FG001|Overall Study|Lost to Follow-up|16|||
143224177|NCT01132807|516368898|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
143224178|NCT01132807|516368899|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
143224179|NCT01132807|516368900|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
143224180|NCT01132807|516368898|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
143224181|NCT01132807|516368899|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
143224182|NCT01132807|516368900|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
143224183|NCT05030350|516368903|FG000|Overall Study|Adverse Event|13|||
143224184|NCT05030350|516368903|FG000|Overall Study|Lack of Efficacy|8|||
143224185|NCT05030350|516368903|FG000|Overall Study|Lost to Follow-up|35|||
143224186|NCT05030350|516368903|FG000|Overall Study|Pregnancy|2|||
143224187|NCT05030350|516368903|FG000|Overall Study|Protocol Violation|2|||
143224188|NCT05030350|516368903|FG000|Overall Study|Withdrawal by Subject|60|||
143268310|NCT00057876|516536868|FG000|Overall Study|Adverse Event|8|||
143268311|NCT00057876|516536869|FG001|Overall Study|Adverse Event|8|||
143268312|NCT00057876|516536868|FG000|Overall Study|Death|2|||
143268313|NCT00057876|516536869|FG001|Overall Study|Death|1|||
143268314|NCT00057876|516536868|FG000|Overall Study|Withdrawal by Subject|5|||
143224189|NCT05030350|516368903|FG000|Overall Study|Study terminated by sponsor|349|||
143224190|NCT05030350|516368903|FG000|Overall Study|Positive Drug Screen|4|||
143224191|NCT05030350|516368903|FG000|Overall Study|Other|8|||
143224192|NCT02711137|516368904|FG000|Overall Study|Death|1|||
143224193|NCT02711137|516368905|FG001|Overall Study|Death|4|||
143224194|NCT02711137|516368906|FG002|Overall Study|Death|5|||
143224195|NCT02711137|516368907|FG003|Overall Study|Death|5|||
143224196|NCT02711137|516368908|FG004|Overall Study|Death|3|||
143224197|NCT02711137|516368909|FG005|Overall Study|Death|1|||
143224198|NCT02711137|516368910|FG006|Overall Study|Death|61|||
143224199|NCT02711137|516368911|FG007|Overall Study|Death|3|||
143224200|NCT02711137|516368912|FG008|Overall Study|Death|0|||
143224201|NCT02711137|516368913|FG009|Overall Study|Death|1|||
143224202|NCT02711137|516368914|FG010|Overall Study|Death|1|||
143224203|NCT02711137|516368915|FG011|Overall Study|Death|1|||
143224204|NCT02711137|516368916|FG012|Overall Study|Death|0|||
143224205|NCT02711137|516368917|FG013|Overall Study|Death|0|||
143224206|NCT02711137|516368918|FG014|Overall Study|Death|0|||
143224207|NCT02711137|516368904|FG000|Overall Study|Study Terminated by Sponsor|0|||
143224208|NCT02711137|516368905|FG001|Overall Study|Study Terminated by Sponsor|0|||
143224209|NCT02711137|516368906|FG002|Overall Study|Study Terminated by Sponsor|1|||
143224210|NCT02711137|516368907|FG003|Overall Study|Study Terminated by Sponsor|0|||
143224211|NCT02711137|516368908|FG004|Overall Study|Study Terminated by Sponsor|0|||
143224212|NCT02711137|516368909|FG005|Overall Study|Study Terminated by Sponsor|0|||
143224213|NCT02711137|516368910|FG006|Overall Study|Study Terminated by Sponsor|1|||
143224214|NCT02711137|516368911|FG007|Overall Study|Study Terminated by Sponsor|0|||
143224215|NCT02711137|516368912|FG008|Overall Study|Study Terminated by Sponsor|0|||
143224216|NCT02711137|516368913|FG009|Overall Study|Study Terminated by Sponsor|0|||
143224217|NCT02711137|516368914|FG010|Overall Study|Study Terminated by Sponsor|0|||
143224218|NCT02711137|516368915|FG011|Overall Study|Study Terminated by Sponsor|0|||
143224219|NCT02711137|516368916|FG012|Overall Study|Study Terminated by Sponsor|0|||
143224220|NCT02711137|516368917|FG013|Overall Study|Study Terminated by Sponsor|0|||
143224221|NCT02711137|516368918|FG014|Overall Study|Study Terminated by Sponsor|0|||
143224222|NCT02711137|516368904|FG000|Overall Study|Physician Decision|1|||
143224223|NCT02711137|516368905|FG001|Overall Study|Physician Decision|0|||
143224224|NCT02711137|516368906|FG002|Overall Study|Physician Decision|2|||
143224225|NCT02711137|516368907|FG003|Overall Study|Physician Decision|1|||
143224226|NCT02711137|516368908|FG004|Overall Study|Physician Decision|1|||
143224227|NCT02711137|516368909|FG005|Overall Study|Physician Decision|0|||
143224228|NCT02711137|516368910|FG006|Overall Study|Physician Decision|12|||
143224229|NCT02711137|516368911|FG007|Overall Study|Physician Decision|2|||
143224230|NCT02711137|516368912|FG008|Overall Study|Physician Decision|1|||
143224231|NCT02711137|516368913|FG009|Overall Study|Physician Decision|1|||
143224232|NCT02711137|516368914|FG010|Overall Study|Physician Decision|3|||
143224233|NCT02711137|516368915|FG011|Overall Study|Physician Decision|2|||
143224234|NCT02711137|516368916|FG012|Overall Study|Physician Decision|1|||
143224235|NCT02711137|516368917|FG013|Overall Study|Physician Decision|1|||
143224236|NCT02711137|516368918|FG014|Overall Study|Physician Decision|2|||
143224237|NCT02711137|516368904|FG000|Overall Study|Other|0|||
143224238|NCT02711137|516368905|FG001|Overall Study|Other|1|||
143224239|NCT02711137|516368906|FG002|Overall Study|Other|0|||
143224240|NCT02711137|516368907|FG003|Overall Study|Other|0|||
143224241|NCT02711137|516368908|FG004|Overall Study|Other|0|||
143224242|NCT02711137|516368909|FG005|Overall Study|Other|0|||
143224243|NCT02711137|516368910|FG006|Overall Study|Other|3|||
143224244|NCT02711137|516368911|FG007|Overall Study|Other|0|||
143224245|NCT02711137|516368912|FG008|Overall Study|Other|0|||
143224246|NCT02711137|516368913|FG009|Overall Study|Other|0|||
143224247|NCT02711137|516368914|FG010|Overall Study|Other|0|||
143224248|NCT02711137|516368915|FG011|Overall Study|Other|0|||
143224249|NCT02711137|516368916|FG012|Overall Study|Other|0|||
143224250|NCT02711137|516368917|FG013|Overall Study|Other|0|||
143224251|NCT02711137|516368918|FG014|Overall Study|Other|1|||
143224252|NCT02711137|516368904|FG000|Overall Study|Withdrawal by Subject|1|||
143224253|NCT02711137|516368905|FG001|Overall Study|Withdrawal by Subject|0|||
143224254|NCT02711137|516368906|FG002|Overall Study|Withdrawal by Subject|0|||
143224255|NCT02711137|516368907|FG003|Overall Study|Withdrawal by Subject|1|||
143224256|NCT02711137|516368908|FG004|Overall Study|Withdrawal by Subject|1|||
143224257|NCT02711137|516368909|FG005|Overall Study|Withdrawal by Subject|0|||
143224258|NCT02711137|516368910|FG006|Overall Study|Withdrawal by Subject|7|||
143224259|NCT02711137|516368911|FG007|Overall Study|Withdrawal by Subject|0|||
143224260|NCT02711137|516368912|FG008|Overall Study|Withdrawal by Subject|0|||
143224261|NCT02711137|516368913|FG009|Overall Study|Withdrawal by Subject|0|||
143224262|NCT02711137|516368914|FG010|Overall Study|Withdrawal by Subject|0|||
143224263|NCT02711137|516368915|FG011|Overall Study|Withdrawal by Subject|0|||
143224264|NCT02711137|516368916|FG012|Overall Study|Withdrawal by Subject|0|||
143224265|NCT02711137|516368917|FG013|Overall Study|Withdrawal by Subject|1|||
143224266|NCT02711137|516368918|FG014|Overall Study|Withdrawal by Subject|0|||
143224267|NCT02711137|516368904|FG000|Overall Study|Lost to Follow-up|1|||
143224268|NCT02711137|516368905|FG001|Overall Study|Lost to Follow-up|0|||
143224269|NCT02711137|516368906|FG002|Overall Study|Lost to Follow-up|0|||
143224270|NCT02711137|516368907|FG003|Overall Study|Lost to Follow-up|0|||
143224271|NCT02711137|516368908|FG004|Overall Study|Lost to Follow-up|0|||
143224272|NCT02711137|516368909|FG005|Overall Study|Lost to Follow-up|0|||
143224273|NCT02711137|516368910|FG006|Overall Study|Lost to Follow-up|2|||
143224274|NCT02711137|516368911|FG007|Overall Study|Lost to Follow-up|0|||
143224275|NCT02711137|516368912|FG008|Overall Study|Lost to Follow-up|0|||
143224276|NCT02711137|516368913|FG009|Overall Study|Lost to Follow-up|0|||
143224277|NCT02711137|516368914|FG010|Overall Study|Lost to Follow-up|0|||
143224278|NCT02711137|516368915|FG011|Overall Study|Lost to Follow-up|0|||
143224279|NCT02711137|516368916|FG012|Overall Study|Lost to Follow-up|0|||
143224280|NCT02711137|516368917|FG013|Overall Study|Lost to Follow-up|0|||
143224281|NCT02711137|516368918|FG014|Overall Study|Lost to Follow-up|0|||
143224282|NCT00742183|516368921|FG000|Overall Study|Adverse Event|2|||
143224283|NCT00742183|516368922|FG001|Overall Study|Adverse Event|2|||
143224284|NCT00742183|516368921|FG000|Overall Study|Death|1|||
143224285|NCT00742183|516368922|FG001|Overall Study|Death|0|||
143224286|NCT00742183|516368921|FG000|Overall Study|Physician Decision|0|||
143224287|NCT00742183|516368922|FG001|Overall Study|Physician Decision|2|||
143224288|NCT00742183|516368921|FG000|Overall Study|Lost to Follow-up|4|||
143224289|NCT00742183|516368922|FG001|Overall Study|Lost to Follow-up|4|||
143224290|NCT00742183|516368921|FG000|Overall Study|Required skin-graft|1|||
143224291|NCT00742183|516368922|FG001|Overall Study|Required skin-graft|1|||
143224292|NCT00742183|516368921|FG000|Overall Study|Withdrawal by Subject|1|||
143224293|NCT00742183|516368922|FG001|Overall Study|Withdrawal by Subject|0|||
143224294|NCT00742183|516368921|FG000|Overall Study|Lack of Efficacy|0|||
143224295|NCT00742183|516368922|FG001|Overall Study|Lack of Efficacy|3|||
143224296|NCT03922581|516368927|FG000|Overall Study|Lost to Follow-up|20|||
143224297|NCT03922581|516368928|FG001|Overall Study|Lost to Follow-up|9|||
143224298|NCT03922581|516368927|FG000|Overall Study|Physician Decision|1|||
143224299|NCT03922581|516368928|FG001|Overall Study|Physician Decision|1|||
143224300|NCT03922581|516368927|FG000|Overall Study|Withdrawal by Subject|1|||
143224301|NCT03922581|516368928|FG001|Overall Study|Withdrawal by Subject|0|||
143224302|NCT00764699|516368929|FG000|Overall Study|PI left and study terminated|3|||
143224303|NCT01508312|516368930|FG000|Overall Study|Lost to Follow-up|1|||
143224304|NCT01508312|516368931|FG001|Overall Study|Lost to Follow-up|0|||
143224305|NCT01508312|516368932|FG002|Overall Study|Lost to Follow-up|0|||
143224306|NCT01508312|516368933|FG003|Overall Study|Lost to Follow-up|0|||
143224307|NCT01508312|516368930|FG000|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
143224308|NCT01508312|516368931|FG001|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|1|||
143224309|NCT01508312|516368932|FG002|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
143224310|NCT01508312|516368933|FG003|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
143224311|NCT01508312|516368930|FG000|Overall Study|Adverse Event|0|||
143224312|NCT01508312|516368931|FG001|Overall Study|Adverse Event|0|||
143224313|NCT01508312|516368932|FG002|Overall Study|Adverse Event|2|||
143224314|NCT01508312|516368933|FG003|Overall Study|Adverse Event|0|||
143224315|NCT01508312|516368930|FG000|Overall Study|Lack of Efficacy|0|||
143224316|NCT01508312|516368931|FG001|Overall Study|Lack of Efficacy|0|||
143224317|NCT01508312|516368932|FG002|Overall Study|Lack of Efficacy|1|||
143224318|NCT01508312|516368933|FG003|Overall Study|Lack of Efficacy|0|||
143224319|NCT01508312|516368930|FG000|Overall Study|Withdrawal by Subject|0|||
143224320|NCT01508312|516368931|FG001|Overall Study|Withdrawal by Subject|0|||
143224321|NCT01508312|516368932|FG002|Overall Study|Withdrawal by Subject|1|||
143224322|NCT01508312|516368933|FG003|Overall Study|Withdrawal by Subject|0|||
143224323|NCT02223715|516368934|FG000|Overall Study|Death|31|||
143268315|NCT00057876|516536869|FG001|Overall Study|Withdrawal by Subject|6|||
143268316|NCT00057876|516536868|FG000|Overall Study|Lack of Efficacy|10|||
143268317|NCT00057876|516536869|FG001|Overall Study|Lack of Efficacy|8|||
143268318|NCT00057876|516536868|FG000|Overall Study|Ineligible|1|||
143268319|NCT00057876|516536869|FG001|Overall Study|Ineligible|2|||
143224324|NCT02223715|516368934|FG000|Overall Study|Lost to Follow-up|73|||
143224325|NCT03956550|516368935|FG000|Overall Study|Sponsor decision|65|||
143224326|NCT03956550|516368936|FG001|Overall Study|Sponsor decision|66|||
143224327|NCT03956550|516368937|FG002|Overall Study|Sponsor decision|64|||
143224328|NCT03956550|516368935|FG000|Overall Study|Adverse Event|0|||
143224329|NCT03956550|516368936|FG001|Overall Study|Adverse Event|1|||
143224330|NCT03956550|516368937|FG002|Overall Study|Adverse Event|0|||
143224331|NCT03956550|516368935|FG000|Overall Study|Withdrawal by Subject|5|||
143224332|NCT03956550|516368936|FG001|Overall Study|Withdrawal by Subject|5|||
143224333|NCT03956550|516368937|FG002|Overall Study|Withdrawal by Subject|6|||
143224334|NCT02222558|516368938|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
143224335|NCT02222558|516368939|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
143268320|NCT00057876|516536868|FG000|Overall Study|other reason|2|||
143268321|NCT00057876|516536869|FG001|Overall Study|other reason|2|||
143268322|NCT00057876|516536868|FG000|Overall Study|other complicating disease|1|||
143268323|NCT00057876|516536869|FG001|Overall Study|other complicating disease|0|||
143224336|NCT02222558|516368940|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
143224337|NCT02222558|516368941|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
143224338|NCT02222558|516368942|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
143224339|NCT02222558|516368943|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
143224340|NCT02222558|516368938|FG000|Period 3|Withdrawal by Subject|0|||
143224341|NCT02222558|516368939|FG001|Period 3|Withdrawal by Subject|0|||
143224342|NCT02222558|516368940|FG002|Period 3|Withdrawal by Subject|0|||
143224343|NCT02222558|516368941|FG003|Period 3|Withdrawal by Subject|0|||
143224344|NCT02222558|516368942|FG004|Period 3|Withdrawal by Subject|0|||
143224345|NCT02222558|516368943|FG005|Period 3|Withdrawal by Subject|1|||
143224346|NCT01745367|516368944|FG000|Overall Study|Death|1|||
143224347|NCT01745367|516368945|FG001|Overall Study|Death|0|||
143224348|NCT01745367|516368944|FG000|Overall Study|Withdrawal by Subject|1|||
143224349|NCT01745367|516368945|FG001|Overall Study|Withdrawal by Subject|2|||
143224350|NCT01745367|516368944|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
143224351|NCT01745367|516368945|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
143224352|NCT01745367|516368944|FG000|Overall Study|Other Reasons Unspecified|0|||
143224353|NCT01745367|516368945|FG001|Overall Study|Other Reasons Unspecified|2|||
143224354|NCT02322281|516368948|FG000|Overall Study|Progressive Disease|42|||
143224355|NCT02322281|516368949|FG001|Overall Study|Progressive Disease|14|||
143224356|NCT02322281|516368950|FG002|Overall Study|Progressive Disease|49|||
143224357|NCT02322281|516368948|FG000|Overall Study|Adverse Event|3|||
143224358|NCT02322281|516368949|FG001|Overall Study|Adverse Event|4|||
143224359|NCT02322281|516368950|FG002|Overall Study|Adverse Event|6|||
143224360|NCT02322281|516368948|FG000|Overall Study|Death|3|||
143224361|NCT02322281|516368949|FG001|Overall Study|Death|3|||
143224362|NCT02322281|516368950|FG002|Overall Study|Death|3|||
143224363|NCT02322281|516368948|FG000|Overall Study|Withdrawal by Subject|1|||
143224364|NCT02322281|516368949|FG001|Overall Study|Withdrawal by Subject|1|||
143224365|NCT02322281|516368950|FG002|Overall Study|Withdrawal by Subject|6|||
143224366|NCT02322281|516368948|FG000|Overall Study|Physician Decision|2|||
143224367|NCT02322281|516368949|FG001|Overall Study|Physician Decision|0|||
143224368|NCT02322281|516368950|FG002|Overall Study|Physician Decision|5|||
143224369|NCT02322281|516368948|FG000|Overall Study|Study Terminated by Sponsor|2|||
143224370|NCT02322281|516368949|FG001|Overall Study|Study Terminated by Sponsor|0|||
143224371|NCT02322281|516368950|FG002|Overall Study|Study Terminated by Sponsor|0|||
143224372|NCT02322281|516368948|FG000|Overall Study|Missing|0|||
143224373|NCT02322281|516368949|FG001|Overall Study|Missing|0|||
143224374|NCT02322281|516368950|FG002|Overall Study|Missing|1|||
143224375|NCT02322281|516368948|FG000|Overall Study|Miscellaneous|0|||
143224376|NCT02322281|516368949|FG001|Overall Study|Miscellaneous|0|||
143224377|NCT02322281|516368950|FG002|Overall Study|Miscellaneous|4|||
143224378|NCT01285401|516368951|FG000|Overall Study|Prematurely withdrawn from the study|17|||
143224379|NCT01285401|516368952|FG001|Overall Study|Prematurely withdrawn from the study|29|||
143224380|NCT00936702|516368955|FG000|Overall Study|Disease progression|34|||
143224381|NCT00936702|516368955|FG000|Overall Study|Adverse Event|8|||
143224382|NCT00936702|516368955|FG000|Overall Study|Withdrawal by Subject|2|||
143224383|NCT00936702|516368955|FG000|Overall Study|Alternative Treatment|1|||
143224384|NCT00936702|516368955|FG000|Overall Study|Other|1|||
143224385|NCT03906071|516368956|FG000|Overall Study|Death|180|||
143224386|NCT03906071|516368957|FG001|Overall Study|Death|185|||
143224387|NCT03906071|516368956|FG000|Overall Study|Lost to Follow-up|3|||
143224388|NCT03906071|516368957|FG001|Overall Study|Lost to Follow-up|3|||
143224389|NCT03906071|516368956|FG000|Overall Study|Withdrawal by Subject|15|||
143224390|NCT03906071|516368957|FG001|Overall Study|Withdrawal by Subject|27|||
143224391|NCT03906071|516368956|FG000|Overall Study|Other|2|||
143224392|NCT03906071|516368957|FG001|Overall Study|Other|1|||
143224393|NCT02420093|516368958|FG000|Overall Study|Withdrawal by Subject|1|||
143224394|NCT02420093|516368959|FG001|Overall Study|Withdrawal by Subject|1|||
143224395|NCT05470387|516368963|FG000|Overall Study|Protocol Violation|0|||
143224396|NCT05470387|516368964|FG001|Overall Study|Protocol Violation|3|||
143224397|NCT03480152|516368965|FG000|Phase I|Signed consent. Died before treatment.|1|||
143224398|NCT03480152|516368966|FG001|Phase I|Signed consent. Died before treatment.|0|||
143224399|NCT03480152|516368967|FG002|Phase I|Signed consent. Died before treatment.|0|||
143224400|NCT01363700|516368968|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
143224401|NCT01363700|516368969|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
143224402|NCT01363700|516368970|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
143224403|NCT01363700|516368971|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
143224404|NCT01363700|516368972|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
143224405|NCT02721875|516368973|FG000|Overall Study|Progressive disease/relapse|1|||
143224406|NCT02721875|516368974|FG001|Overall Study|Progressive disease/relapse|0|||
143224407|NCT00857285|516368977|FG000|Overall Study|Adverse Event|4|||
143224408|NCT00857285|516368978|FG001|Overall Study|Adverse Event|2|||
143268324|NCT05095454|516536870|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
143224409|NCT00857285|516368977|FG000|Overall Study|Lack of Efficacy|0|||
143224410|NCT00857285|516368978|FG001|Overall Study|Lack of Efficacy|2|||
143224411|NCT00857285|516368977|FG000|Overall Study|Protocol Violation|3|||
143372465|NCT01193153|516909525|FG001|Open-label Stabilization Period|Death|0|||
143224412|NCT00857285|516368978|FG001|Overall Study|Protocol Violation|1|||
143224413|NCT00857285|516368977|FG000|Overall Study|Withdrawal by Subject|4|||
143372466|NCT01193153|516909524|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
143224414|NCT00857285|516368978|FG001|Overall Study|Withdrawal by Subject|0|||
143224415|NCT00857285|516368977|FG000|Overall Study|Randomization criteria not met|1|||
143224416|NCT00857285|516368978|FG001|Overall Study|Randomization criteria not met|1|||
143224417|NCT01329978|516368985|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
143224418|NCT01329978|516368986|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
143224419|NCT01329978|516368987|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
143224420|NCT01329978|516368988|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
143224421|NCT01329978|516368989|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
143224422|NCT01329978|516368985|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
143224423|NCT01329978|516368986|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
143224424|NCT01329978|516368987|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
143224425|NCT01329978|516368988|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
143224426|NCT01329978|516368989|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
143224427|NCT01329978|516368985|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
143224428|NCT01329978|516368986|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
143224429|NCT01329978|516368987|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
143224430|NCT01329978|516368988|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
143224431|NCT01329978|516368989|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
143224432|NCT01329978|516368985|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
143224433|NCT01329978|516368986|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
143224434|NCT01329978|516368987|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
143224435|NCT01329978|516368988|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
143224436|NCT01329978|516368989|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
143224437|NCT01329978|516368985|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
143224438|NCT01329978|516368986|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
143224439|NCT01329978|516368987|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
143224440|NCT01329978|516368988|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
143224441|NCT01329978|516368989|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
143224442|NCT01329978|516368985|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
143224443|NCT01329978|516368986|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
143224444|NCT01329978|516368987|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
143224445|NCT01329978|516368988|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
143224446|NCT01329978|516368989|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
143224447|NCT01329978|516368985|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
143224448|NCT01329978|516368986|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
143224449|NCT01329978|516368987|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
143224450|NCT01329978|516368988|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
143224451|NCT01329978|516368989|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
143224452|NCT03901144|516368990|FG000|Overall Study|Lost to Follow-up|1|||
143224453|NCT03901144|516368991|FG001|Overall Study|Lost to Follow-up|1|||
143224454|NCT03901144|516368992|FG002|Overall Study|Lost to Follow-up|1|||
143224455|NCT03901144|516368993|FG003|Overall Study|Lost to Follow-up|1|||
143268325|NCT05095454|516536871|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
143268326|NCT00679055|516536872|FG000|Overall Study|Adverse Event|0|||
143268327|NCT00679055|516536873|FG001|Overall Study|Adverse Event|1|||
143268328|NCT00679055|516536872|FG000|Overall Study|Other|0|||
143268329|NCT00679055|516536873|FG001|Overall Study|Other|3|||
143268330|NCT00679055|516536872|FG000|Overall Study|Study Terminated|2|||
143268331|NCT00679055|516536873|FG001|Overall Study|Study Terminated|1|||
143268332|NCT00853073|516536874|FG000|Overall Study|Withdrawal by Subject|3|||
143268333|NCT00853073|516536875|FG001|Overall Study|Withdrawal by Subject|2|||
143268334|NCT02758171|516536876|FG000|Wash-out|Withdrawal by Subject|1|||
143268335|NCT02758171|516536877|FG001|Wash-out|Withdrawal by Subject|0|||
143268336|NCT02758171|516536876|FG000|Wash-out|Other reason|1|||
143372467|NCT01193153|516909525|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
143372468|NCT01193153|516909524|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
143224456|NCT01807598|516368994|FG000|Overall Study|Withdrawal by Subject|4|||
143268337|NCT02758171|516536877|FG001|Wash-out|Other reason|0|||
143268338|NCT01999114|516536878|FG000|Overall Study|Adverse Event|8|||
143372469|NCT01193153|516909525|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
143372470|NCT01193153|516909524|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
143268339|NCT01999114|516536879|FG001|Overall Study|Adverse Event|7|||
143268340|NCT01999114|516536880|FG002|Overall Study|Adverse Event|2|||
143268341|NCT01999114|516536881|FG003|Overall Study|Adverse Event|2|||
143372471|NCT01193153|516909525|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
143372472|NCT01193153|516909524|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
143372473|NCT01193153|516909525|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
143372474|NCT01193153|516909524|FG000|Open-label Stabilization Period|Other|8|||
143372475|NCT01193153|516909525|FG001|Open-label Stabilization Period|Other|0|||
143372476|NCT01193153|516909524|FG000|Double Blind Relapse Prevention Period|Other|2|||
143372477|NCT01193153|516909525|FG001|Double Blind Relapse Prevention Period|Other|3|||
143372478|NCT01193153|516909524|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
143224457|NCT01807598|516368994|FG000|Overall Study|Adverse Event|1|||
143224458|NCT01807598|516368994|FG000|Overall Study|Other Physician Decision|1|||
143224459|NCT01288989|516368997|FG000|Overall Study|Death|0|||
143224460|NCT01288989|516368998|FG001|Overall Study|Death|0|||
143224461|NCT01288989|516368999|FG002|Overall Study|Death|0|||
143224462|NCT01288989|516369000|FG003|Overall Study|Death|1|||
143224463|NCT01288989|516369001|FG004|Overall Study|Death|0|||
143224464|NCT01288989|516368997|FG000|Overall Study|Dose limiting toxicity|1|||
143224465|NCT01288989|516368998|FG001|Overall Study|Dose limiting toxicity|0|||
143224466|NCT01288989|516368999|FG002|Overall Study|Dose limiting toxicity|0|||
143224467|NCT01288989|516369000|FG003|Overall Study|Dose limiting toxicity|0|||
143224468|NCT01288989|516369001|FG004|Overall Study|Dose limiting toxicity|0|||
143224469|NCT01288989|516368997|FG000|Overall Study|Adverse Event|0|||
143224470|NCT01288989|516368998|FG001|Overall Study|Adverse Event|0|||
143224471|NCT01288989|516368999|FG002|Overall Study|Adverse Event|0|||
143224472|NCT01288989|516369000|FG003|Overall Study|Adverse Event|0|||
143224473|NCT01288989|516369001|FG004|Overall Study|Adverse Event|2|||
143224474|NCT01288989|516368997|FG000|Overall Study|Physician Decision|0|||
143224475|NCT01288989|516368998|FG001|Overall Study|Physician Decision|0|||
143224476|NCT01288989|516368999|FG002|Overall Study|Physician Decision|0|||
143224477|NCT01288989|516369000|FG003|Overall Study|Physician Decision|0|||
143224478|NCT01288989|516369001|FG004|Overall Study|Physician Decision|1|||
143224479|NCT01288989|516368997|FG000|Overall Study|Withdrawal by Subject|0|||
143224480|NCT01288989|516368998|FG001|Overall Study|Withdrawal by Subject|0|||
143224481|NCT01288989|516368999|FG002|Overall Study|Withdrawal by Subject|0|||
143224482|NCT01288989|516369000|FG003|Overall Study|Withdrawal by Subject|0|||
143224483|NCT01288989|516369001|FG004|Overall Study|Withdrawal by Subject|3|||
143224484|NCT00165672|516369002|FG000|Overall Study|Adverse Event|0|||
143224485|NCT00165672|516369003|FG001|Overall Study|Adverse Event|1|||
143224486|NCT05477485|516369005|FG000|Overall Study|Lost to Follow-up|0|||
143224487|NCT05477485|516369006|FG001|Overall Study|Lost to Follow-up|4|||
143224488|NCT04194944|516369007|FG000|Overall Study|Lost to Follow-up|3|||
143224489|NCT04194944|516369008|FG001|Overall Study|Lost to Follow-up|0|||
143224490|NCT04194944|516369007|FG000|Overall Study|Withdrawal by Subject|2|||
143224491|NCT04194944|516369008|FG001|Overall Study|Withdrawal by Subject|2|||
143224492|NCT04194944|516369007|FG000|Overall Study|On Treatment|93|||
143224493|NCT04194944|516369008|FG001|Overall Study|On Treatment|30|||
143224494|NCT02719171|516370356|FG000|Overall Study|Adverse Event|1|||
143224495|NCT02719171|516370357|FG001|Overall Study|Adverse Event|2|||
143224496|NCT02719171|516370358|FG002|Overall Study|Adverse Event|0|||
143224497|NCT02719171|516370359|FG003|Overall Study|Adverse Event|0|||
143224498|NCT02719171|516370360|FG004|Overall Study|Adverse Event|2|||
143224499|NCT02719171|516370356|FG000|Overall Study|Lost to Follow-up|0|||
143224500|NCT02719171|516370357|FG001|Overall Study|Lost to Follow-up|0|||
143224501|NCT02719171|516370358|FG002|Overall Study|Lost to Follow-up|1|||
143224502|NCT02719171|516370359|FG003|Overall Study|Lost to Follow-up|0|||
143224503|NCT02719171|516370360|FG004|Overall Study|Lost to Follow-up|0|||
143224504|NCT02719171|516370356|FG000|Overall Study|Subject Withdrawal|0|||
143224505|NCT02719171|516370357|FG001|Overall Study|Subject Withdrawal|2|||
143224506|NCT02719171|516370358|FG002|Overall Study|Subject Withdrawal|2|||
143224507|NCT02719171|516370359|FG003|Overall Study|Subject Withdrawal|1|||
143224508|NCT02719171|516370360|FG004|Overall Study|Subject Withdrawal|0|||
143224509|NCT02719171|516370356|FG000|Overall Study|Other|0|||
143224510|NCT02719171|516370357|FG001|Overall Study|Other|0|||
143224511|NCT02719171|516370358|FG002|Overall Study|Other|0|||
143224512|NCT02719171|516370359|FG003|Overall Study|Other|1|||
143224513|NCT02719171|516370360|FG004|Overall Study|Other|0|||
143224514|NCT00227721|516370361|FG000|Overall Study|On study, but never treated.|1|||
143224515|NCT01777308|516370366|FG000|Overall Study|Withdrawal by Subject|5|||
143224516|NCT01777308|516370367|FG001|Overall Study|Withdrawal by Subject|1|||
143224517|NCT01777308|516370366|FG000|Overall Study|Migrated/moved from study area|1|||
143224518|NCT01777308|516370367|FG001|Overall Study|Migrated/moved from study area|0|||
143224519|NCT01777308|516370366|FG000|Overall Study|Lost to Follow-up|7|||
143224520|NCT01777308|516370367|FG001|Overall Study|Lost to Follow-up|2|||
143224521|NCT01777308|516370366|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
143224522|NCT01777308|516370367|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
143224523|NCT03493945|516370368|FG000|Phase I Dose Escalation|Ineligible|0|||
143224524|NCT03493945|516370369|FG001|Phase I Dose Escalation|Ineligible|0|||
143224525|NCT03493945|516370370|FG002|Phase I Dose Escalation|Ineligible|1|||
143224526|NCT03493945|516370371|FG003|Phase I Dose Escalation|Ineligible|0|||
143224527|NCT03493945|516370372|FG004|Phase I Dose Escalation|Ineligible|0|||
143224528|NCT03493945|516370373|FG005|Phase I Dose Escalation|Ineligible|0|||
143224529|NCT03493945|516370374|FG006|Phase I Dose Escalation|Ineligible|0|||
143224530|NCT03493945|516370368|FG000|Phase I Dose Escalation|New therapy|0|||
143224531|NCT03493945|516370369|FG001|Phase I Dose Escalation|New therapy|1|||
143224532|NCT03493945|516370370|FG002|Phase I Dose Escalation|New therapy|0|||
143224533|NCT03493945|516370371|FG003|Phase I Dose Escalation|New therapy|0|||
143224534|NCT03493945|516370372|FG004|Phase I Dose Escalation|New therapy|0|||
143224535|NCT03493945|516370373|FG005|Phase I Dose Escalation|New therapy|0|||
143224536|NCT03493945|516370374|FG006|Phase I Dose Escalation|New therapy|0|||
143224537|NCT03493945|516370368|FG000|Phase II Dose Expansion|Refused further treatment|0|||
143224538|NCT03493945|516370369|FG001|Phase II Dose Expansion|Refused further treatment|0|||
143224539|NCT03493945|516370370|FG002|Phase II Dose Expansion|Refused further treatment|0|||
143224540|NCT03493945|516370371|FG003|Phase II Dose Expansion|Refused further treatment|0|||
143224541|NCT03493945|516370372|FG004|Phase II Dose Expansion|Refused further treatment|1|||
143224542|NCT03493945|516370373|FG005|Phase II Dose Expansion|Refused further treatment|1|||
143224543|NCT03493945|516370374|FG006|Phase II Dose Expansion|Refused further treatment|0|||
143224544|NCT03493945|516370368|FG000|Phase II Dose Expansion|Switched to alternative therapy|0|||
143224545|NCT03493945|516370369|FG001|Phase II Dose Expansion|Switched to alternative therapy|0|||
143224546|NCT03493945|516370370|FG002|Phase II Dose Expansion|Switched to alternative therapy|0|||
143224547|NCT03493945|516370371|FG003|Phase II Dose Expansion|Switched to alternative therapy|3|||
143224548|NCT03493945|516370372|FG004|Phase II Dose Expansion|Switched to alternative therapy|0|||
143224549|NCT03493945|516370373|FG005|Phase II Dose Expansion|Switched to alternative therapy|0|||
143224550|NCT03493945|516370374|FG006|Phase II Dose Expansion|Switched to alternative therapy|0|||
143224551|NCT01517750|516370375|FG000|Overall Study|Lost to Follow-up|1|||
143224552|NCT01517750|516370376|FG001|Overall Study|Lost to Follow-up|2|||
143224553|NCT01517750|516370377|FG002|Overall Study|Lost to Follow-up|4|||
143224554|NCT01517750|516370378|FG003|Overall Study|Lost to Follow-up|1|||
143224555|NCT04388111|516370379|FG000|Overall Study|Lost to Follow-up|5|||
143224556|NCT04388111|516370380|FG001|Overall Study|Lost to Follow-up|3|||
143224557|NCT04388111|516370379|FG000|Overall Study|Adverse Event|1|||
143224558|NCT04388111|516370380|FG001|Overall Study|Adverse Event|1|||
143224559|NCT04388111|516370379|FG000|Overall Study|Protocol Violation|2|||
143224560|NCT04388111|516370380|FG001|Overall Study|Protocol Violation|4|||
143224561|NCT04388111|516370379|FG000|Overall Study|Withdrawal by Subject|1|||
143224562|NCT04388111|516370380|FG001|Overall Study|Withdrawal by Subject|0|||
143224563|NCT02735239|516370381|FG000|Overall Study|Adverse Event|0|||
143224564|NCT02735239|516370382|FG001|Overall Study|Adverse Event|0|||
143224565|NCT02735239|516370383|FG002|Overall Study|Adverse Event|4|||
143224566|NCT02735239|516370384|FG003|Overall Study|Adverse Event|0|||
143224567|NCT02735239|516370385|FG004|Overall Study|Adverse Event|0|||
143224568|NCT02735239|516370386|FG005|Overall Study|Adverse Event|0|||
143224569|NCT02735239|516370381|FG000|Overall Study|Death|1|||
143224570|NCT02735239|516370382|FG001|Overall Study|Death|1|||
143224571|NCT02735239|516370383|FG002|Overall Study|Death|0|||
143224572|NCT02735239|516370384|FG003|Overall Study|Death|0|||
143224573|NCT02735239|516370385|FG004|Overall Study|Death|0|||
143224574|NCT02735239|516370386|FG005|Overall Study|Death|0|||
143224575|NCT02735239|516370381|FG000|Overall Study|Physician Decision|0|||
143224576|NCT02735239|516370382|FG001|Overall Study|Physician Decision|0|||
143224577|NCT02735239|516370383|FG002|Overall Study|Physician Decision|1|||
143268342|NCT01999114|516536882|FG004|Overall Study|Adverse Event|1|||
143268343|NCT01999114|516536878|FG000|Overall Study|Withdrawal by Subject|0|||
143268344|NCT01999114|516536879|FG001|Overall Study|Withdrawal by Subject|0|||
143268345|NCT01999114|516536880|FG002|Overall Study|Withdrawal by Subject|1|||
143268346|NCT01999114|516536881|FG003|Overall Study|Withdrawal by Subject|0|||
143268347|NCT01999114|516536882|FG004|Overall Study|Withdrawal by Subject|1|||
143268348|NCT01999114|516536878|FG000|Overall Study|Lost to Follow-up|0|||
143268349|NCT01999114|516536879|FG001|Overall Study|Lost to Follow-up|0|||
143224578|NCT02735239|516370384|FG003|Overall Study|Physician Decision|0|||
143224579|NCT02735239|516370385|FG004|Overall Study|Physician Decision|0|||
143224580|NCT02735239|516370386|FG005|Overall Study|Physician Decision|0|||
143224581|NCT02735239|516370381|FG000|Overall Study|Progressive disease|3|||
143268350|NCT01999114|516536880|FG002|Overall Study|Lost to Follow-up|1|||
143268351|NCT01999114|516536881|FG003|Overall Study|Lost to Follow-up|0|||
143268352|NCT01999114|516536882|FG004|Overall Study|Lost to Follow-up|0|||
143224582|NCT02735239|516370382|FG001|Overall Study|Progressive disease|1|||
143224583|NCT02735239|516370383|FG002|Overall Study|Progressive disease|3|||
143224584|NCT02735239|516370384|FG003|Overall Study|Progressive disease|0|||
143224585|NCT02735239|516370385|FG004|Overall Study|Progressive disease|0|||
143268353|NCT01999114|516536878|FG000|Overall Study|Administrative|0|||
143268354|NCT01999114|516536879|FG001|Overall Study|Administrative|0|||
143268355|NCT01999114|516536880|FG002|Overall Study|Administrative|1|||
143224586|NCT02735239|516370386|FG005|Overall Study|Progressive disease|2|||
143224587|NCT02735239|516370381|FG000|Overall Study|Withdrawal by Subject|0|||
143224588|NCT02735239|516370382|FG001|Overall Study|Withdrawal by Subject|1|||
143224589|NCT02735239|516370383|FG002|Overall Study|Withdrawal by Subject|0|||
143224590|NCT02735239|516370384|FG003|Overall Study|Withdrawal by Subject|0|||
143224591|NCT02735239|516370385|FG004|Overall Study|Withdrawal by Subject|0|||
143224592|NCT02735239|516370386|FG005|Overall Study|Withdrawal by Subject|0|||
143224593|NCT03431441|516370394|FG000|Overall Study|Withdrawal by Subject|2|||
143224594|NCT03431441|516370394|FG000|Overall Study|Adverse Event|2|||
143224595|NCT03431441|516370394|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
143224596|NCT00346216|516370395|FG000|Overall Study|Other|181|||
143224597|NCT00346216|516370396|FG001|Overall Study|Other|231|||
143224598|NCT00346216|516370397|FG002|Overall Study|Other|205|||
143268356|NCT01999114|516536881|FG003|Overall Study|Administrative|1|||
143268357|NCT01999114|516536882|FG004|Overall Study|Administrative|2|||
143268358|NCT03139279|516536885|FG000|Overall Study|Physician Decision|2|||
143268359|NCT03139279|516536886|FG001|Overall Study|Physician Decision|0|||
143268360|NCT03139279|516536885|FG000|Overall Study|Protocol Violation|5|||
143268361|NCT03139279|516536886|FG001|Overall Study|Protocol Violation|4|||
143268362|NCT03139279|516536885|FG000|Overall Study|Withdrawal by Subject|0|||
143268363|NCT03139279|516536886|FG001|Overall Study|Withdrawal by Subject|2|||
143268364|NCT01336569|516536887|FG000|Overall Study|Lost to Follow-up|4|||
143268365|NCT00292318|516536890|FG000|Overall Study|Study terminated by officials|2|||
143268366|NCT00292318|516536891|FG001|Overall Study|Study terminated by officials|1|||
143224599|NCT00346216|516370395|FG000|Overall Study|No longer willing to participate|600|||
143224600|NCT00346216|516370396|FG001|Overall Study|No longer willing to participate|606|||
143224601|NCT00346216|516370397|FG002|Overall Study|No longer willing to participate|585|||
143268367|NCT02027376|516536894|FG000|Overall Study|Death|1|||
143268368|NCT02027376|516536895|FG001|Overall Study|Death|0|||
143268369|NCT02027376|516536896|FG002|Overall Study|Death|0|||
143268370|NCT01626495|516536898|FG000|Overall Study|Adverse Event|3|||
143268371|NCT01626495|516536898|FG000|Overall Study|Disease progression|27|||
143268372|NCT01626495|516536898|FG000|Overall Study|Withdrawal by Subject|1|||
143268373|NCT01626495|516536898|FG000|Overall Study|Administrative problem|1|||
143268374|NCT01626495|516536898|FG000|Overall Study|Death|2|||
143268375|NCT01626495|516536898|FG000|Overall Study|Physician Decision|1|||
143268376|NCT01626495|516536898|FG000|Overall Study|New cancer therapy|16|||
143268377|NCT01626495|516536898|FG000|Overall Study|Manufacturing failure|1|||
143268378|NCT01565642|516536899|FG000|Overall Study|Withdrawal by Subject|2|||
143268379|NCT01565642|516536900|FG001|Overall Study|Withdrawal by Subject|1|||
143268380|NCT01934972|516536901|FG000|Overall Study|Withdrawal by Subject|9|||
143268381|NCT01934972|516536902|FG001|Overall Study|Withdrawal by Subject|6|||
143268382|NCT01278160|516536903|FG000|Overall Study|Adverse Event|1|||
143268383|NCT01278160|516536904|FG001|Overall Study|Adverse Event|1|||
143268384|NCT01278160|516536903|FG000|Overall Study|Lost to Follow-up|0|||
143268385|NCT01278160|516536904|FG001|Overall Study|Lost to Follow-up|1|||
143268386|NCT01278160|516536903|FG000|Overall Study|Withdrawal by Subject|3|||
143268387|NCT01278160|516536904|FG001|Overall Study|Withdrawal by Subject|2|||
143268388|NCT01278160|516536903|FG000|Overall Study|Unclassified|1|||
143268389|NCT01278160|516536904|FG001|Overall Study|Unclassified|2|||
143268390|NCT02887859|516536908|FG000|Overall Study|Ongoing|6|||
143268391|NCT02887859|516536908|FG000|Overall Study|Adverse Event|7|||
143268392|NCT02887859|516536908|FG000|Overall Study|Death|1|||
143268393|NCT02887859|516536908|FG000|Overall Study|Physician Decision|1|||
143268394|NCT00257608|516538971|FG000|Chemotherapy Phase|Adverse Event|138|||
143268395|NCT00257608|516538972|FG001|Chemotherapy Phase|Adverse Event|0|||
143268396|NCT00257608|516538973|FG002|Chemotherapy Phase|Adverse Event|0|||
143268397|NCT00257608|516538971|FG000|Chemotherapy Phase|Disease progression|139|||
143224602|NCT00346216|516370395|FG000|Overall Study|Withdrawal by Subject|661|||
143268398|NCT00257608|516538972|FG001|Chemotherapy Phase|Disease progression|0|||
143268399|NCT00257608|516538973|FG002|Chemotherapy Phase|Disease progression|0|||
143268400|NCT00257608|516538971|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
143268401|NCT00257608|516538972|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
143268402|NCT00257608|516538973|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
143268403|NCT00257608|516538971|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
143268404|NCT00257608|516538972|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
143268405|NCT00257608|516538973|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
143268406|NCT00257608|516538971|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
143268407|NCT00257608|516538972|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
143268408|NCT00257608|516538973|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
143268409|NCT00257608|516538971|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
143268410|NCT00257608|516538972|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
143268411|NCT00257608|516538973|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
143224603|NCT00346216|516370396|FG001|Overall Study|Withdrawal by Subject|692|||
143224604|NCT00346216|516370397|FG002|Overall Study|Withdrawal by Subject|651|||
143224605|NCT00346216|516370395|FG000|Overall Study|Lost to Follow-up|611|||
143268412|NCT00257608|516538971|FG000|Chemotherapy Phase|Physician Decision|28|||
143268413|NCT00257608|516538972|FG001|Chemotherapy Phase|Physician Decision|0|||
143268414|NCT00257608|516538973|FG002|Chemotherapy Phase|Physician Decision|0|||
143268415|NCT00257608|516538971|FG000|Post Chemotherapy Phase|Adverse Event|0|||
143268416|NCT00257608|516538972|FG001|Post Chemotherapy Phase|Adverse Event|34|||
143268417|NCT00257608|516538973|FG002|Post Chemotherapy Phase|Adverse Event|38|||
143224606|NCT00346216|516370396|FG001|Overall Study|Lost to Follow-up|588|||
143224607|NCT00346216|516370397|FG002|Overall Study|Lost to Follow-up|542|||
143224608|NCT00346216|516370395|FG000|Overall Study|Physician Decision|80|||
143224609|NCT00346216|516370396|FG001|Overall Study|Physician Decision|76|||
143224610|NCT00346216|516370397|FG002|Overall Study|Physician Decision|59|||
143224611|NCT00346216|516370395|FG000|Overall Study|Does not meet entrance criteria|13|||
143224612|NCT00346216|516370396|FG001|Overall Study|Does not meet entrance criteria|10|||
143224613|NCT00346216|516370397|FG002|Overall Study|Does not meet entrance criteria|8|||
143224614|NCT00346216|516370395|FG000|Overall Study|Death|189|||
143224615|NCT00346216|516370396|FG001|Overall Study|Death|192|||
143224616|NCT00346216|516370397|FG002|Overall Study|Death|228|||
143224617|NCT00346216|516370395|FG000|Overall Study|Study terminated by sponsor|11|||
143224618|NCT00346216|516370396|FG001|Overall Study|Study terminated by sponsor|4|||
143224619|NCT00346216|516370397|FG002|Overall Study|Study terminated by sponsor|8|||
143224620|NCT00346216|516370395|FG000|Overall Study|Missing Subject Summary Status|62|||
143224621|NCT00346216|516370396|FG001|Overall Study|Missing Subject Summary Status|61|||
143224622|NCT00346216|516370397|FG002|Overall Study|Missing Subject Summary Status|62|||
143224623|NCT01276639|516370398|FG000|Week 0 to 16|Death|1|||
143224624|NCT01276639|516370399|FG001|Week 0 to 16|Death|0|||
143224625|NCT01276639|516370400|FG002|Week 0 to 16|Death|0|||
143224626|NCT01276639|516370401|FG003|Week 0 to 16|Death|0|||
143224627|NCT01276639|516370402|FG004|Week 0 to 16|Death|0|||
143224628|NCT01276639|516370398|FG000|Week 0 to 16|Adverse Event|11|||
143224629|NCT01276639|516370399|FG001|Week 0 to 16|Adverse Event|8|||
143224630|NCT01276639|516370400|FG002|Week 0 to 16|Adverse Event|11|||
143224631|NCT01276639|516370401|FG003|Week 0 to 16|Adverse Event|0|||
143224632|NCT01276639|516370402|FG004|Week 0 to 16|Adverse Event|0|||
143224633|NCT01276639|516370398|FG000|Week 0 to 16|Lack of Efficacy|20|||
143224634|NCT01276639|516370399|FG001|Week 0 to 16|Lack of Efficacy|15|||
143224635|NCT01276639|516370400|FG002|Week 0 to 16|Lack of Efficacy|25|||
143224636|NCT01276639|516370401|FG003|Week 0 to 16|Lack of Efficacy|0|||
143224637|NCT01276639|516370402|FG004|Week 0 to 16|Lack of Efficacy|0|||
143224638|NCT01276639|516370398|FG000|Week 0 to 16|Lost to Follow-up|3|||
143224639|NCT01276639|516370399|FG001|Week 0 to 16|Lost to Follow-up|5|||
143224640|NCT01276639|516370400|FG002|Week 0 to 16|Lost to Follow-up|3|||
143224641|NCT01276639|516370401|FG003|Week 0 to 16|Lost to Follow-up|0|||
143224642|NCT01276639|516370402|FG004|Week 0 to 16|Lost to Follow-up|0|||
143224643|NCT01276639|516370398|FG000|Week 0 to 16|Withdrawal by Subject|8|||
143224644|NCT01276639|516370399|FG001|Week 0 to 16|Withdrawal by Subject|5|||
143224645|NCT01276639|516370400|FG002|Week 0 to 16|Withdrawal by Subject|4|||
143224646|NCT01276639|516370401|FG003|Week 0 to 16|Withdrawal by Subject|0|||
143224647|NCT01276639|516370402|FG004|Week 0 to 16|Withdrawal by Subject|0|||
143224648|NCT01276639|516370398|FG000|Week 0 to 16|Other|7|||
143224649|NCT01276639|516370399|FG001|Week 0 to 16|Other|7|||
143224650|NCT01276639|516370400|FG002|Week 0 to 16|Other|2|||
143224651|NCT01276639|516370401|FG003|Week 0 to 16|Other|0|||
143224652|NCT01276639|516370402|FG004|Week 0 to 16|Other|0|||
143224653|NCT01276639|516370398|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
143224654|NCT01276639|516370399|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
143224655|NCT01276639|516370400|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
143224656|NCT01276639|516370401|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
143224657|NCT01276639|516370402|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
143224658|NCT01276639|516370398|FG000|Week 16 to 52|Death|1|||
143224659|NCT01276639|516370399|FG001|Week 16 to 52|Death|0|||
143224660|NCT01276639|516370400|FG002|Week 16 to 52|Death|0|||
143224661|NCT01276639|516370401|FG003|Week 16 to 52|Death|0|||
143224662|NCT01276639|516370402|FG004|Week 16 to 52|Death|0|||
143224663|NCT01276639|516370398|FG000|Week 16 to 52|Adverse Event|10|||
143224664|NCT01276639|516370399|FG001|Week 16 to 52|Adverse Event|13|||
143224665|NCT01276639|516370400|FG002|Week 16 to 52|Adverse Event|0|||
143224666|NCT01276639|516370401|FG003|Week 16 to 52|Adverse Event|1|||
143224667|NCT01276639|516370402|FG004|Week 16 to 52|Adverse Event|3|||
143224668|NCT01276639|516370398|FG000|Week 16 to 52|Lack of Efficacy|99|||
143224669|NCT01276639|516370399|FG001|Week 16 to 52|Lack of Efficacy|71|||
143224670|NCT01276639|516370400|FG002|Week 16 to 52|Lack of Efficacy|0|||
143224671|NCT01276639|516370401|FG003|Week 16 to 52|Lack of Efficacy|14|||
143224672|NCT01276639|516370402|FG004|Week 16 to 52|Lack of Efficacy|13|||
143224673|NCT01276639|516370398|FG000|Week 16 to 52|Lost to Follow-up|3|||
143224674|NCT01276639|516370399|FG001|Week 16 to 52|Lost to Follow-up|1|||
143224675|NCT01276639|516370400|FG002|Week 16 to 52|Lost to Follow-up|0|||
143224676|NCT01276639|516370401|FG003|Week 16 to 52|Lost to Follow-up|0|||
143224677|NCT01276639|516370402|FG004|Week 16 to 52|Lost to Follow-up|1|||
143224678|NCT01276639|516370398|FG000|Week 16 to 52|Withdrawal by Subject|4|||
143224679|NCT01276639|516370399|FG001|Week 16 to 52|Withdrawal by Subject|4|||
143224680|NCT01276639|516370400|FG002|Week 16 to 52|Withdrawal by Subject|0|||
143224681|NCT01276639|516370401|FG003|Week 16 to 52|Withdrawal by Subject|0|||
143224682|NCT01276639|516370402|FG004|Week 16 to 52|Withdrawal by Subject|1|||
143224683|NCT01276639|516370398|FG000|Week 16 to 52|Other|10|||
143224684|NCT01276639|516370399|FG001|Week 16 to 52|Other|12|||
143224685|NCT01276639|516370400|FG002|Week 16 to 52|Other|0|||
143224686|NCT01276639|516370401|FG003|Week 16 to 52|Other|1|||
143224687|NCT01276639|516370402|FG004|Week 16 to 52|Other|3|||
143224688|NCT02532465|516370405|FG000|Overall Study|Protocol Violation|1|||
143224689|NCT02532465|516370406|FG001|Overall Study|Protocol Violation|0|||
143224690|NCT02532465|516370405|FG000|Overall Study|Lack of Efficacy|0|||
143224691|NCT02532465|516370406|FG001|Overall Study|Lack of Efficacy|1|||
143224692|NCT01544920|516370407|FG000|Overall Study|Adverse Event|0|||
143224693|NCT01544920|516370408|FG001|Overall Study|Adverse Event|3|||
143224694|NCT01544920|516370407|FG000|Overall Study|Death|0|||
143224695|NCT01544920|516370408|FG001|Overall Study|Death|1|||
143224696|NCT01544920|516370407|FG000|Overall Study|Lost to Follow-up|11|||
143224697|NCT01544920|516370408|FG001|Overall Study|Lost to Follow-up|12|||
143224698|NCT01544920|516370407|FG000|Overall Study|Protocol Violation|0|||
143224699|NCT01544920|516370408|FG001|Overall Study|Protocol Violation|2|||
143224700|NCT01544920|516370407|FG000|Overall Study|Physician Decision|4|||
143224701|NCT01544920|516370408|FG001|Overall Study|Physician Decision|1|||
143224702|NCT01544920|516370407|FG000|Overall Study|Withdrawal by Subject|4|||
143224703|NCT01544920|516370408|FG001|Overall Study|Withdrawal by Subject|4|||
143224704|NCT01217463|516370409|FG000|Overall Study|Adverse Event|8|||
143224705|NCT01217463|516370410|FG001|Overall Study|Adverse Event|5|||
143224706|NCT01217463|516370409|FG000|Overall Study|Physician Decision|0|||
143224707|NCT01217463|516370410|FG001|Overall Study|Physician Decision|1|||
143224708|NCT01217463|516370409|FG000|Overall Study|Withdrawal by Subject|3|||
143224709|NCT01217463|516370410|FG001|Overall Study|Withdrawal by Subject|0|||
143224710|NCT01217463|516370409|FG000|Overall Study|Surgery on the Target Limb|0|||
143224711|NCT01217463|516370410|FG001|Overall Study|Surgery on the Target Limb|1|||
143224712|NCT01217463|516370409|FG000|Overall Study|Patient Non-compliant|1|||
143224713|NCT01217463|516370410|FG001|Overall Study|Patient Non-compliant|0|||
143224714|NCT01217463|516370409|FG000|Overall Study|Other|1|||
143224715|NCT01217463|516370410|FG001|Overall Study|Other|1|||
143224716|NCT01569841|516370417|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
143224717|NCT01569841|516370418|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
143224718|NCT00057863|516370424|FG000|Overall Study|Death|1|||
143224719|NCT00057863|516370424|FG000|Overall Study|Withdrawal by Subject|2|||
143224720|NCT02090426|516370425|FG000|Overall Study|Lost to Follow-up|12|||
143224721|NCT02090426|516370426|FG001|Overall Study|Lost to Follow-up|6|||
143224722|NCT00148759|516370430|FG000|Overall Study|Withdrawal by Subject|1|||
143224723|NCT00148759|516370431|FG001|Overall Study|Withdrawal by Subject|1|||
143224724|NCT00148759|516370430|FG000|Overall Study|Lost to Follow-up|1|||
143224725|NCT00148759|516370431|FG001|Overall Study|Lost to Follow-up|0|||
143224726|NCT01454596|516370432|FG000|Overall Study|Death|0|||
143224727|NCT01454596|516370433|FG001|Overall Study|Death|0|||
143224728|NCT01454596|516370434|FG002|Overall Study|Death|0|||
143224729|NCT01454596|516370435|FG003|Overall Study|Death|0|||
143224730|NCT01454596|516370436|FG004|Overall Study|Death|0|||
143224731|NCT01454596|516370437|FG005|Overall Study|Death|0|||
143224732|NCT01454596|516370438|FG006|Overall Study|Death|0|||
143224733|NCT01454596|516370439|FG007|Overall Study|Death|0|||
143224734|NCT01454596|516370440|FG008|Overall Study|Death|0|||
143224735|NCT01454596|516370441|FG009|Overall Study|Death|1|||
143224736|NCT01454596|516370442|FG010|Overall Study|Death|1|||
143224737|NCT01454596|516370443|FG011|Overall Study|Death|0|||
143224738|NCT00104650|516370447|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
143224739|NCT00104650|516370448|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
143224740|NCT00104650|516370449|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
143224741|NCT00104650|516370447|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
143224742|NCT00104650|516370448|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
143224743|NCT00104650|516370449|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
143224744|NCT00104650|516370447|FG000|Treatment Period (25 Weeks)|Death|7|||
143224745|NCT00104650|516370448|FG001|Treatment Period (25 Weeks)|Death|5|||
143224746|NCT00104650|516370449|FG002|Treatment Period (25 Weeks)|Death|6|||
143224747|NCT00104650|516370447|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
143224748|NCT00104650|516370448|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
143224749|NCT00104650|516370449|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
143224750|NCT00104650|516370447|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
143224751|NCT00104650|516370448|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
143224752|NCT00104650|516370449|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
143224753|NCT00104650|516370447|FG000|Treatment Period (25 Weeks)|Other|1|||
143224754|NCT00104650|516370448|FG001|Treatment Period (25 Weeks)|Other|0|||
143224755|NCT00104650|516370449|FG002|Treatment Period (25 Weeks)|Other|0|||
143224756|NCT00104650|516370447|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
143224757|NCT00104650|516370448|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
143224758|NCT00104650|516370449|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
143224759|NCT00104650|516370447|FG000|Follow-up Period|Physician Decision|1|||
143224760|NCT00104650|516370448|FG001|Follow-up Period|Physician Decision|1|||
143224761|NCT00104650|516370449|FG002|Follow-up Period|Physician Decision|0|||
143224762|NCT00104650|516370447|FG000|Follow-up Period|Adverse Event|1|||
143224763|NCT00104650|516370448|FG001|Follow-up Period|Adverse Event|0|||
143224764|NCT00104650|516370449|FG002|Follow-up Period|Adverse Event|1|||
143224765|NCT00104650|516370447|FG000|Follow-up Period|Withdrawal by Subject|0|||
143224766|NCT00104650|516370448|FG001|Follow-up Period|Withdrawal by Subject|3|||
143224767|NCT00104650|516370449|FG002|Follow-up Period|Withdrawal by Subject|3|||
143224768|NCT00104650|516370447|FG000|Follow-up Period|Death|6|||
143224769|NCT00104650|516370448|FG001|Follow-up Period|Death|6|||
143224770|NCT00104650|516370449|FG002|Follow-up Period|Death|4|||
143224771|NCT00104650|516370447|FG000|Follow-up Period|Disease progression|3|||
143224772|NCT00104650|516370448|FG001|Follow-up Period|Disease progression|1|||
143224773|NCT00104650|516370449|FG002|Follow-up Period|Disease progression|0|||
143224774|NCT00104650|516370447|FG000|Follow-up Period|Lost to Follow-up|0|||
143224775|NCT00104650|516370448|FG001|Follow-up Period|Lost to Follow-up|1|||
143224776|NCT00104650|516370449|FG002|Follow-up Period|Lost to Follow-up|2|||
143224777|NCT00104650|516370447|FG000|Follow-up Period|Other|0|||
143224778|NCT00104650|516370448|FG001|Follow-up Period|Other|1|||
143224779|NCT00104650|516370449|FG002|Follow-up Period|Other|0|||
143224780|NCT02294058|516370450|FG000|Overall Study|Adverse Event|16|||
143224781|NCT02294058|516370451|FG001|Overall Study|Adverse Event|7|||
143224782|NCT02294058|516370452|FG002|Overall Study|Adverse Event|13|||
143224783|NCT02294058|516370450|FG000|Overall Study|Lack of Efficacy|3|||
143224784|NCT02294058|516370451|FG001|Overall Study|Lack of Efficacy|3|||
143224785|NCT02294058|516370452|FG002|Overall Study|Lack of Efficacy|0|||
143224786|NCT02294058|516370450|FG000|Overall Study|Lost to Follow-up|1|||
143224787|NCT02294058|516370451|FG001|Overall Study|Lost to Follow-up|0|||
143224788|NCT02294058|516370452|FG002|Overall Study|Lost to Follow-up|2|||
143224789|NCT02294058|516370450|FG000|Overall Study|Withdrawal by Subject|10|||
143224790|NCT02294058|516370451|FG001|Overall Study|Withdrawal by Subject|14|||
143224791|NCT02294058|516370452|FG002|Overall Study|Withdrawal by Subject|13|||
143224792|NCT02294058|516370450|FG000|Overall Study|Physician Decision|2|||
143224793|NCT02294058|516370451|FG001|Overall Study|Physician Decision|1|||
143224794|NCT02294058|516370452|FG002|Overall Study|Physician Decision|0|||
143224795|NCT02294058|516370450|FG000|Overall Study|Miscellaneous|4|||
143224796|NCT02294058|516370451|FG001|Overall Study|Miscellaneous|1|||
143224797|NCT02294058|516370452|FG002|Overall Study|Miscellaneous|1|||
143224798|NCT02800863|516370458|FG000|Overall Study|Adverse Event|14|||
143224799|NCT02800863|516370458|FG000|Overall Study|Another Device Implanted|1|||
143224800|NCT02800863|516370458|FG000|Overall Study|Device Explanted|1|||
143224801|NCT02800863|516370458|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
143224802|NCT02800863|516370458|FG000|Overall Study|Health Issues|1|||
143224803|NCT02800863|516370458|FG000|Overall Study|Insurance Denial|8|||
143224804|NCT02800863|516370458|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
143224805|NCT02800863|516370458|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
143224806|NCT02800863|516370458|FG000|Overall Study|Screen Failure|1|||
143224807|NCT02800863|516370458|FG000|Overall Study|Sponsor Request|6|||
143224808|NCT02800863|516370458|FG000|Overall Study|Death|3|||
143224809|NCT02800863|516370458|FG000|Overall Study|Subject Implant at Another Facility|1|||
143224810|NCT02800863|516370458|FG000|Overall Study|Lost to Follow-up|26|||
143224811|NCT02800863|516370458|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
143224812|NCT02800863|516370458|FG000|Overall Study|Subject and/or Family Request|64|||
143224813|NCT02800863|516370458|FG000|Overall Study|Trial Failure|81|||
143224814|NCT02800863|516370458|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
143224815|NCT03957551|516370459|FG000|Overall Study|Adverse Event|2|||
143224816|NCT03957551|516370460|FG001|Overall Study|Adverse Event|2|||
143224817|NCT03957551|516370461|FG002|Overall Study|Adverse Event|6|||
143224818|NCT03957551|516370459|FG000|Overall Study|Physician Decision|1|||
143224819|NCT03957551|516370460|FG001|Overall Study|Physician Decision|0|||
143224820|NCT03957551|516370461|FG002|Overall Study|Physician Decision|2|||
143224821|NCT03957551|516370459|FG000|Overall Study|Withdrawal by Subject|1|||
143224822|NCT03957551|516370460|FG001|Overall Study|Withdrawal by Subject|0|||
143224823|NCT03957551|516370461|FG002|Overall Study|Withdrawal by Subject|2|||
143224824|NCT03957551|516370459|FG000|Overall Study|Disease progression|1|||
143224825|NCT03957551|516370460|FG001|Overall Study|Disease progression|0|||
143224826|NCT03957551|516370461|FG002|Overall Study|Disease progression|8|||
143224827|NCT03775486|516370462|FG000|Initial Therapy Phase|Other reason provided|0|||
143224828|NCT03775486|516370463|FG001|Initial Therapy Phase|Other reason provided|15|||
143224829|NCT03775486|516370462|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
143224830|NCT03775486|516370463|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
143224831|NCT03775486|516370462|FG000|Initial Therapy Phase|Protocol Violation|0|||
143224832|NCT03775486|516370463|FG001|Initial Therapy Phase|Protocol Violation|2|||
143224833|NCT03775486|516370462|FG000|Initial Therapy Phase|Adverse Event|0|||
143224834|NCT03775486|516370463|FG001|Initial Therapy Phase|Adverse Event|34|||
143224835|NCT03775486|516370462|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
143224836|NCT03775486|516370463|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
143224837|NCT03775486|516370462|FG000|Maintenance Phase|Withdrawal by Subject|13|||
143224838|NCT03775486|516370463|FG001|Maintenance Phase|Withdrawal by Subject|12|||
143224839|NCT03775486|516370462|FG000|Maintenance Phase|Death|44|||
143224840|NCT03775486|516370463|FG001|Maintenance Phase|Death|45|||
143224841|NCT01572480|516370464|FG000|Participants Enrolled|Withdrawal by Subject|1|||
143224842|NCT01572480|516370464|FG000|Drug Administration|Discontinued drug/Off Study|1|||
143224843|NCT01572480|516370464|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
143224844|NCT01572480|516370464|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
143224845|NCT00801216|516370465|FG000|Overall Study|Screening Failure|2|||
143224846|NCT05214768|516370466|FG000|Induction Period|Withdrawal by Subject|1|||
143224847|NCT05214768|516370467|FG001|Induction Period|Withdrawal by Subject|0|||
143224848|NCT05214768|516370468|FG002|Induction Period|Withdrawal by Subject|0|||
143224849|NCT05214768|516370469|FG003|Induction Period|Withdrawal by Subject|0|||
143224850|NCT05214768|516370470|FG004|Induction Period|Withdrawal by Subject|0|||
143224851|NCT05214768|516370471|FG005|Induction Period|Withdrawal by Subject|0|||
143224852|NCT05214768|516370466|FG000|Induction Period|Physician Decision|1|||
143224853|NCT05214768|516370467|FG001|Induction Period|Physician Decision|0|||
143224854|NCT05214768|516370468|FG002|Induction Period|Physician Decision|0|||
143224855|NCT05214768|516370469|FG003|Induction Period|Physician Decision|0|||
143224856|NCT05214768|516370470|FG004|Induction Period|Physician Decision|0|||
143224857|NCT05214768|516370471|FG005|Induction Period|Physician Decision|0|||
143224858|NCT05214768|516370466|FG000|Maintenance Period|Other Reasons|0|||
143224859|NCT05214768|516370467|FG001|Maintenance Period|Other Reasons|0|||
143224860|NCT05214768|516370468|FG002|Maintenance Period|Other Reasons|1|||
143224861|NCT05214768|516370469|FG003|Maintenance Period|Other Reasons|1|||
143224862|NCT05214768|516370470|FG004|Maintenance Period|Other Reasons|0|||
143224863|NCT05214768|516370471|FG005|Maintenance Period|Other Reasons|0|||
143224864|NCT05214768|516370466|FG000|Maintenance Period|Withdrawal by Subject|0|||
143224865|NCT05214768|516370467|FG001|Maintenance Period|Withdrawal by Subject|0|||
143224866|NCT05214768|516370468|FG002|Maintenance Period|Withdrawal by Subject|0|||
143224867|NCT05214768|516370469|FG003|Maintenance Period|Withdrawal by Subject|1|||
143224868|NCT05214768|516370470|FG004|Maintenance Period|Withdrawal by Subject|0|||
143224869|NCT05214768|516370471|FG005|Maintenance Period|Withdrawal by Subject|0|||
143224870|NCT05214768|516370466|FG000|Maintenance Period|Lack of Efficacy|0|||
143224871|NCT05214768|516370467|FG001|Maintenance Period|Lack of Efficacy|0|||
143224872|NCT05214768|516370468|FG002|Maintenance Period|Lack of Efficacy|1|||
143224873|NCT05214768|516370469|FG003|Maintenance Period|Lack of Efficacy|0|||
143224874|NCT05214768|516370470|FG004|Maintenance Period|Lack of Efficacy|1|||
143224875|NCT05214768|516370471|FG005|Maintenance Period|Lack of Efficacy|0|||
143224876|NCT05214768|516370466|FG000|Open Label Extension Period|Physician Decision|0|||
143224877|NCT05214768|516370467|FG001|Open Label Extension Period|Physician Decision|0|||
143224878|NCT05214768|516370468|FG002|Open Label Extension Period|Physician Decision|0|||
143224879|NCT05214768|516370469|FG003|Open Label Extension Period|Physician Decision|0|||
143224880|NCT05214768|516370470|FG004|Open Label Extension Period|Physician Decision|0|||
143224881|NCT05214768|516370471|FG005|Open Label Extension Period|Physician Decision|1|||
143224882|NCT05214768|516370466|FG000|Open Label Extension Period|Lack of Efficacy|0|||
143224883|NCT05214768|516370467|FG001|Open Label Extension Period|Lack of Efficacy|0|||
143224884|NCT05214768|516370468|FG002|Open Label Extension Period|Lack of Efficacy|0|||
143224885|NCT05214768|516370469|FG003|Open Label Extension Period|Lack of Efficacy|0|||
143224886|NCT05214768|516370470|FG004|Open Label Extension Period|Lack of Efficacy|0|||
143224887|NCT05214768|516370471|FG005|Open Label Extension Period|Lack of Efficacy|1|||
143224888|NCT05214768|516370466|FG000|Open Label Extension Period|Ongoing Study|0|||
143224889|NCT05214768|516370467|FG001|Open Label Extension Period|Ongoing Study|0|||
143224890|NCT05214768|516370468|FG002|Open Label Extension Period|Ongoing Study|0|||
143224891|NCT05214768|516370469|FG003|Open Label Extension Period|Ongoing Study|0|||
143224892|NCT05214768|516370470|FG004|Open Label Extension Period|Ongoing Study|0|||
143224893|NCT05214768|516370471|FG005|Open Label Extension Period|Ongoing Study|42|||
143224894|NCT05481359|516370472|FG000|Overall Study|Lost to Follow-up|3|||
143224895|NCT05481359|516370472|FG000|Overall Study|Withdrawal by Subject|1|||
143224896|NCT06235905|516370477|FG000|Overall Study|Adverse Event|1|||
143224897|NCT06235905|516370477|FG000|Overall Study|Non-compliant with protocol procedures|1|||
143224898|NCT00319254|516370478|FG000|Overall Study|Withdrawal by Subject|4|||
143224899|NCT00319254|516370478|FG000|Overall Study|Death|46|||
143224900|NCT00319254|516370478|FG000|Overall Study|Lost to Follow-up|2|||
143224901|NCT00319254|516370478|FG000|Overall Study|Enrolled, Not Treated|2|||
143224902|NCT03985761|516373038|FG000|Overall Study|Withdrawal by Subject|2|||
143224903|NCT03985761|516373039|FG001|Overall Study|Withdrawal by Subject|3|||
143224904|NCT03719131|516373044|FG000|Overall Study|Death|1|||
143224905|NCT03719131|516373045|FG001|Overall Study|Death|2|||
143224906|NCT03244917|516373054|FG000|Overall Study|Lost to Follow-up|2|||
143224907|NCT03244917|516373055|FG001|Overall Study|Lost to Follow-up|2|||
143224908|NCT03001557|516373056|FG000|Core Phase|Randomized but not treated|0|||
143224909|NCT03001557|516373057|FG001|Core Phase|Randomized but not treated|0|||
143224910|NCT03001557|516373058|FG002|Core Phase|Randomized but not treated|1|||
143224911|NCT03001557|516373059|FG003|Core Phase|Randomized but not treated|0|||
143268418|NCT00257608|516538971|FG000|Post Chemotherapy Phase|Disease progression|0|||
143224912|NCT03001557|516373060|FG004|Core Phase|Randomized but not treated|0|||
143224913|NCT03001557|516373061|FG005|Core Phase|Randomized but not treated|0|||
143224914|NCT03001557|516373062|FG006|Core Phase|Randomized but not treated|0|||
143224915|NCT03001557|516373063|FG007|Core Phase|Randomized but not treated|0|||
143224916|NCT03001557|516373056|FG000|Extension Phase|Adverse Event|0|||
143224917|NCT03001557|516373057|FG001|Extension Phase|Adverse Event|0|||
143224918|NCT03001557|516373058|FG002|Extension Phase|Adverse Event|0|||
143224919|NCT03001557|516373059|FG003|Extension Phase|Adverse Event|0|||
143224920|NCT03001557|516373060|FG004|Extension Phase|Adverse Event|0|||
143224921|NCT03001557|516373061|FG005|Extension Phase|Adverse Event|2|||
143224922|NCT03001557|516373062|FG006|Extension Phase|Adverse Event|0|||
143224923|NCT03001557|516373063|FG007|Extension Phase|Adverse Event|0|||
143224924|NCT03001557|516373056|FG000|Extension Phase|Withdrawal by Subject|0|||
143224925|NCT03001557|516373057|FG001|Extension Phase|Withdrawal by Subject|0|||
143224926|NCT03001557|516373058|FG002|Extension Phase|Withdrawal by Subject|0|||
143224927|NCT03001557|516373059|FG003|Extension Phase|Withdrawal by Subject|0|||
143224928|NCT03001557|516373060|FG004|Extension Phase|Withdrawal by Subject|0|||
143224929|NCT03001557|516373061|FG005|Extension Phase|Withdrawal by Subject|1|||
143224930|NCT03001557|516373062|FG006|Extension Phase|Withdrawal by Subject|5|||
143224931|NCT03001557|516373063|FG007|Extension Phase|Withdrawal by Subject|2|||
143224932|NCT03001557|516373056|FG000|Extension Phase|Lost to Follow-up|0|||
143224933|NCT03001557|516373057|FG001|Extension Phase|Lost to Follow-up|0|||
143224934|NCT03001557|516373058|FG002|Extension Phase|Lost to Follow-up|0|||
143224935|NCT03001557|516373059|FG003|Extension Phase|Lost to Follow-up|0|||
143224936|NCT03001557|516373060|FG004|Extension Phase|Lost to Follow-up|0|||
143224937|NCT03001557|516373061|FG005|Extension Phase|Lost to Follow-up|0|||
143224938|NCT03001557|516373062|FG006|Extension Phase|Lost to Follow-up|2|||
143224939|NCT03001557|516373063|FG007|Extension Phase|Lost to Follow-up|1|||
143224940|NCT03001557|516373056|FG000|Extension Phase|Administrative Reason|0|||
143224941|NCT03001557|516373057|FG001|Extension Phase|Administrative Reason|0|||
143224942|NCT03001557|516373058|FG002|Extension Phase|Administrative Reason|0|||
143224943|NCT03001557|516373059|FG003|Extension Phase|Administrative Reason|0|||
143224944|NCT03001557|516373060|FG004|Extension Phase|Administrative Reason|0|||
143224945|NCT03001557|516373061|FG005|Extension Phase|Administrative Reason|1|||
143224946|NCT03001557|516373062|FG006|Extension Phase|Administrative Reason|3|||
143224947|NCT03001557|516373063|FG007|Extension Phase|Administrative Reason|3|||
143268419|NCT00257608|516538972|FG001|Post Chemotherapy Phase|Disease progression|204|||
143268420|NCT00257608|516538973|FG002|Post Chemotherapy Phase|Disease progression|168|||
143268421|NCT00257608|516538971|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
143268422|NCT00257608|516538972|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
143268423|NCT00257608|516538973|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
143268424|NCT00257608|516538971|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
143268425|NCT00257608|516538972|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
143268426|NCT00257608|516538973|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
143268427|NCT00257608|516538971|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
143268428|NCT00257608|516538972|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
143268429|NCT00257608|516538973|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
143268430|NCT00257608|516538971|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
143268431|NCT00257608|516538972|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
143268432|NCT00257608|516538973|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
143268433|NCT00257608|516538971|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
143268434|NCT00257608|516538972|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
143224948|NCT03001557|516373056|FG000|Extension Phase|Loss of caregiver|0|||
143224949|NCT03001557|516373057|FG001|Extension Phase|Loss of caregiver|0|||
143224950|NCT03001557|516373058|FG002|Extension Phase|Loss of caregiver|0|||
143224951|NCT03001557|516373059|FG003|Extension Phase|Loss of caregiver|0|||
143224952|NCT03001557|516373060|FG004|Extension Phase|Loss of caregiver|0|||
143224953|NCT03001557|516373061|FG005|Extension Phase|Loss of caregiver|0|||
143268435|NCT00257608|516538973|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
143224954|NCT03001557|516373062|FG006|Extension Phase|Loss of caregiver|1|||
143224955|NCT03001557|516373063|FG007|Extension Phase|Loss of caregiver|0|||
143224956|NCT03001557|516373056|FG000|Extension Phase|Others|0|||
143224957|NCT03001557|516373057|FG001|Extension Phase|Others|0|||
143224958|NCT03001557|516373058|FG002|Extension Phase|Others|0|||
143224959|NCT03001557|516373059|FG003|Extension Phase|Others|0|||
143224960|NCT03001557|516373060|FG004|Extension Phase|Others|0|||
143224961|NCT03001557|516373061|FG005|Extension Phase|Others|1|||
143224962|NCT03001557|516373062|FG006|Extension Phase|Others|3|||
143224963|NCT03001557|516373063|FG007|Extension Phase|Others|0|||
143224964|NCT01794000|516373064|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
143224965|NCT01794000|516373065|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
143224966|NCT01794000|516373064|FG000|Double-Blind Phase (DBP)|Death|1|||
143224967|NCT01794000|516373065|FG001|Double-Blind Phase (DBP)|Death|2|||
143224968|NCT01794000|516373064|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
143268436|NCT00257608|516538971|FG000|Post Chemotherapy Phase|Physician Decision|0|||
143268437|NCT00257608|516538972|FG001|Post Chemotherapy Phase|Physician Decision|8|||
143268438|NCT00257608|516538973|FG002|Post Chemotherapy Phase|Physician Decision|11|||
143268439|NCT00257608|516538971|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
143268440|NCT00257608|516538972|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
143268441|NCT00257608|516538973|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
143268442|NCT00257608|516538971|FG000|Post Chemotherapy Phase|Not treated|0|||
143268443|NCT00257608|516538972|FG001|Post Chemotherapy Phase|Not treated|4|||
143268444|NCT00257608|516538973|FG002|Post Chemotherapy Phase|Not treated|7|||
143268445|NCT01973569|516538980|FG000|Overall Study|Adverse Event|9|||
143268446|NCT01973569|516538981|FG001|Overall Study|Adverse Event|2|||
143224969|NCT01794000|516373065|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
143224970|NCT01794000|516373064|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
143224971|NCT01794000|516373065|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
143224972|NCT01794000|516373064|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
143224973|NCT01794000|516373065|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
143224974|NCT01794000|516373064|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
143224975|NCT01794000|516373065|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
143224976|NCT01794000|516373064|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
143224977|NCT01794000|516373065|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
143224978|NCT01794000|516373064|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
143224979|NCT01794000|516373065|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
143224980|NCT01272232|516373068|FG000|Weeks 0-56|Adverse Event|39|||
143224981|NCT01272232|516373069|FG001|Weeks 0-56|Adverse Event|18|||
143224982|NCT01272232|516373070|FG002|Weeks 0-56|Adverse Event|7|||
143224983|NCT01272232|516373068|FG000|Weeks 0-56|Lack of Efficacy|0|||
143224984|NCT01272232|516373069|FG001|Weeks 0-56|Lack of Efficacy|0|||
143224985|NCT01272232|516373070|FG002|Weeks 0-56|Lack of Efficacy|3|||
143224986|NCT01272232|516373068|FG000|Weeks 0-56|Protocol Violation|12|||
143224987|NCT01272232|516373069|FG001|Weeks 0-56|Protocol Violation|8|||
143224988|NCT01272232|516373070|FG002|Weeks 0-56|Protocol Violation|13|||
143224989|NCT01272232|516373068|FG000|Weeks 0-56|Withdrawal criteria|32|||
143268447|NCT01973569|516538982|FG002|Overall Study|Adverse Event|4|||
143268448|NCT01973569|516538980|FG000|Overall Study|Protocol Violation|2|||
143268449|NCT01973569|516538981|FG001|Overall Study|Protocol Violation|1|||
143268450|NCT01973569|516538982|FG002|Overall Study|Protocol Violation|3|||
143268451|NCT01973569|516538980|FG000|Overall Study|Withdrawal by Subject|7|||
143268452|NCT01973569|516538981|FG001|Overall Study|Withdrawal by Subject|5|||
143268453|NCT01973569|516538982|FG002|Overall Study|Withdrawal by Subject|2|||
143268454|NCT01973569|516538980|FG000|Overall Study|Invasive dental treatment|3|||
143268455|NCT01973569|516538981|FG001|Overall Study|Invasive dental treatment|5|||
143268456|NCT01973569|516538982|FG002|Overall Study|Invasive dental treatment|6|||
143268457|NCT01973569|516538980|FG000|Overall Study|Prohibited concomitant d|1|||
143268458|NCT01973569|516538981|FG001|Overall Study|Prohibited concomitant d|5|||
143268459|NCT01973569|516538982|FG002|Overall Study|Prohibited concomitant d|0|||
143268460|NCT01973569|516538980|FG000|Overall Study|Disease progression|0|||
143268461|NCT01973569|516538981|FG001|Overall Study|Disease progression|3|||
143268462|NCT01973569|516538982|FG002|Overall Study|Disease progression|0|||
143268463|NCT01973569|516538980|FG000|Overall Study|Other|1|||
143268464|NCT01973569|516538981|FG001|Overall Study|Other|1|||
143268465|NCT01973569|516538982|FG002|Overall Study|Other|0|||
143268466|NCT01973569|516538980|FG000|Overall Study|Did not receive study drug|6|||
143268467|NCT01973569|516538981|FG001|Overall Study|Did not receive study drug|3|||
143268468|NCT01973569|516538982|FG002|Overall Study|Did not receive study drug|3|||
143268469|NCT01871142|516538988|FG000|Overall Study|Adverse Event|1|||
143268470|NCT00785928|516538997|FG000|Treatment Phase|Adverse Event|1|||
143268471|NCT00785928|516538998|FG001|Treatment Phase|Adverse Event|1|||
143268472|NCT00785928|516538999|FG002|Treatment Phase|Adverse Event|2|||
143268473|NCT00785928|516539000|FG003|Treatment Phase|Adverse Event|0|||
143268474|NCT00785928|516539001|FG004|Treatment Phase|Adverse Event|0|||
143268475|NCT00785928|516539002|FG005|Treatment Phase|Adverse Event|0|||
143268476|NCT00785928|516539003|FG006|Treatment Phase|Adverse Event|2|||
143268477|NCT00785928|516538997|FG000|Treatment Phase|Inadequate Response|0|||
143224990|NCT01272232|516373069|FG001|Weeks 0-56|Withdrawal criteria|14|||
143224991|NCT01272232|516373070|FG002|Weeks 0-56|Withdrawal criteria|37|||
143224992|NCT01272232|516373068|FG000|Weeks 0-56|Unclassified|16|||
143224993|NCT01272232|516373069|FG001|Weeks 0-56|Unclassified|7|||
143224994|NCT01272232|516373070|FG002|Weeks 0-56|Unclassified|12|||
143224995|NCT01272232|516373068|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
143224996|NCT01272232|516373069|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
143268478|NCT00785928|516538998|FG001|Treatment Phase|Inadequate Response|1|||
143268479|NCT00785928|516538999|FG002|Treatment Phase|Inadequate Response|0|||
143268480|NCT00785928|516539000|FG003|Treatment Phase|Inadequate Response|0|||
143268481|NCT00785928|516539001|FG004|Treatment Phase|Inadequate Response|0|||
143268482|NCT00785928|516539002|FG005|Treatment Phase|Inadequate Response|0|||
143268483|NCT00785928|516539003|FG006|Treatment Phase|Inadequate Response|0|||
143224997|NCT01272232|516373070|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
143224998|NCT01272232|516373068|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
143224999|NCT01272232|516373069|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
143225000|NCT01272232|516373070|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
143225001|NCT01272232|516373068|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
143225002|NCT01272232|516373069|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
143225003|NCT01272232|516373070|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
143225004|NCT01272232|516373068|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
143225005|NCT01272232|516373069|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
143225006|NCT01272232|516373070|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
143225007|NCT01272232|516373068|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
143225008|NCT01272232|516373069|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
143225009|NCT01272232|516373070|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
143225010|NCT00796666|516373071|FG000|Overall Study|Death|2|||
143225011|NCT00796666|516373072|FG001|Overall Study|Death|4|||
143225012|NCT00796666|516373071|FG000|Overall Study|Withdrawal by Subject|2|||
143225013|NCT00796666|516373072|FG001|Overall Study|Withdrawal by Subject|0|||
143225014|NCT00796666|516373071|FG000|Overall Study|Adverse Event|7|||
143225015|NCT00796666|516373072|FG001|Overall Study|Adverse Event|5|||
143225016|NCT00796666|516373071|FG000|Overall Study|Protocol Violation|1|||
143225017|NCT00796666|516373072|FG001|Overall Study|Protocol Violation|0|||
143225018|NCT00796666|516373071|FG000|Overall Study|Other|1|||
143225019|NCT00796666|516373072|FG001|Overall Study|Other|0|||
143225020|NCT00796666|516373071|FG000|Overall Study|Terminated by sponsor|53|||
143225021|NCT00796666|516373072|FG001|Overall Study|Terminated by sponsor|55|||
143225022|NCT00796666|516373071|FG000|Overall Study|Randomized and not treated|1|||
143225023|NCT00796666|516373072|FG001|Overall Study|Randomized and not treated|0|||
143225024|NCT01147666|516373073|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
143225025|NCT01147666|516373074|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
143225026|NCT01147666|516373075|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
143225027|NCT01147666|516373076|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
143225028|NCT01147666|516373077|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
143225029|NCT01147666|516373078|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
143225030|NCT01147666|516373079|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
143225031|NCT01147666|516373080|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
143225032|NCT01147666|516373081|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
143225033|NCT01147666|516373082|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
143225034|NCT01147666|516373083|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
143225035|NCT01147666|516373084|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
143225036|NCT01147666|516373085|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
143225037|NCT01147666|516373086|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
143225038|NCT01147666|516373087|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
143225039|NCT01147666|516373073|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
143225040|NCT01147666|516373074|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
143225041|NCT01147666|516373075|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
143225042|NCT01147666|516373076|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
143225043|NCT01147666|516373077|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
143225044|NCT01147666|516373078|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
143225045|NCT01147666|516373079|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
143225046|NCT01147666|516373080|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
143225047|NCT01147666|516373081|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
143225048|NCT01147666|516373082|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
143225049|NCT01147666|516373083|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
143225050|NCT01147666|516373084|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
143225051|NCT01147666|516373085|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
143225052|NCT01147666|516373086|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
143225053|NCT01147666|516373087|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
143225054|NCT01147666|516373073|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
143225055|NCT01147666|516373074|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
143225056|NCT01147666|516373075|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
143225057|NCT01147666|516373076|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
143225058|NCT01147666|516373077|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
143225059|NCT01147666|516373078|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
143225060|NCT01147666|516373079|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
143225061|NCT01147666|516373080|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
143225062|NCT01147666|516373081|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
143225063|NCT01147666|516373082|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
143225064|NCT01147666|516373083|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
143225065|NCT01147666|516373084|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
143225066|NCT01147666|516373085|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
143225067|NCT01147666|516373086|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
143225068|NCT01147666|516373087|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
143225069|NCT01147666|516373073|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
143225070|NCT01147666|516373074|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
143225071|NCT01147666|516373075|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
143225072|NCT01147666|516373076|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
143225073|NCT01147666|516373077|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
143225074|NCT01147666|516373078|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
143225075|NCT01147666|516373079|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
143225076|NCT01147666|516373080|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
143225077|NCT01147666|516373081|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
143225078|NCT01147666|516373082|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
143225079|NCT01147666|516373083|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
143225080|NCT01147666|516373084|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
143225081|NCT01147666|516373085|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
143225082|NCT01147666|516373086|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
143225083|NCT01147666|516373087|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
143225084|NCT01147666|516373073|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
143225085|NCT01147666|516373074|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
143225086|NCT01147666|516373075|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
143225087|NCT01147666|516373076|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
143225088|NCT01147666|516373077|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
143225089|NCT01147666|516373078|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
143225090|NCT01147666|516373079|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
143225091|NCT01147666|516373080|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
143225092|NCT01147666|516373081|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
143225093|NCT01147666|516373082|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
143225094|NCT01147666|516373083|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
143225095|NCT01147666|516373084|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
143225096|NCT01147666|516373085|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
143225097|NCT01147666|516373086|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
143225098|NCT01147666|516373087|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
143225099|NCT01147666|516373073|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
143225100|NCT01147666|516373074|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
143225101|NCT01147666|516373075|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
143225102|NCT01147666|516373076|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
143225103|NCT01147666|516373077|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
143225104|NCT01147666|516373078|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
143225105|NCT01147666|516373079|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
143225106|NCT01147666|516373080|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
143225107|NCT01147666|516373081|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
143225108|NCT01147666|516373082|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
143225109|NCT01147666|516373083|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
143225110|NCT01147666|516373084|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
143225111|NCT01147666|516373085|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
143225112|NCT01147666|516373086|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
143225113|NCT01147666|516373087|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
143225114|NCT01147666|516373073|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
143225115|NCT01147666|516373074|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
143225116|NCT01147666|516373075|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
143225117|NCT01147666|516373076|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
143225118|NCT01147666|516373077|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
143225119|NCT01147666|516373078|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
143225120|NCT01147666|516373079|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
143225121|NCT01147666|516373080|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
143225122|NCT01147666|516373081|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
143225123|NCT01147666|516373082|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
143225124|NCT01147666|516373083|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
143225125|NCT01147666|516373084|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
143225126|NCT01147666|516373085|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
143225127|NCT01147666|516373086|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
143225128|NCT01147666|516373087|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
143268484|NCT00785928|516538997|FG000|Treatment Phase|Lack of Efficacy|0|||
143268485|NCT00785928|516538998|FG001|Treatment Phase|Lack of Efficacy|1|||
143268486|NCT00785928|516538999|FG002|Treatment Phase|Lack of Efficacy|1|||
143225129|NCT01147666|516373073|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
143225130|NCT01147666|516373074|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
143225131|NCT01147666|516373075|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
143225132|NCT01147666|516373076|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
143225133|NCT01147666|516373077|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
143225134|NCT01147666|516373078|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
143225135|NCT01147666|516373079|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
143225136|NCT01147666|516373080|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
143225137|NCT01147666|516373081|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
143225138|NCT01147666|516373082|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
143225139|NCT01147666|516373083|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
143225140|NCT01147666|516373084|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
143225141|NCT01147666|516373085|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
143225142|NCT01147666|516373086|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
143225143|NCT01147666|516373087|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
143225144|NCT01147666|516373073|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
143225145|NCT01147666|516373074|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
143225146|NCT01147666|516373075|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
143225147|NCT01147666|516373076|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
143225148|NCT01147666|516373077|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
143225149|NCT01147666|516373078|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
143225150|NCT01147666|516373079|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
143225151|NCT01147666|516373080|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
143225152|NCT01147666|516373081|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
143225153|NCT01147666|516373082|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
143225154|NCT01147666|516373083|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
143225155|NCT01147666|516373084|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
143225156|NCT01147666|516373085|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
143225157|NCT01147666|516373086|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
143225158|NCT01147666|516373087|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
143225159|NCT01147666|516373073|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
143225160|NCT01147666|516373074|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
143225161|NCT01147666|516373075|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
143225162|NCT01147666|516373076|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
143225163|NCT01147666|516373077|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
143225164|NCT01147666|516373078|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
143225165|NCT01147666|516373079|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
143225166|NCT01147666|516373080|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
143225167|NCT01147666|516373081|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
143225168|NCT01147666|516373082|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
143225169|NCT01147666|516373083|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
143225170|NCT01147666|516373084|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
143225171|NCT01147666|516373085|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
143225172|NCT01147666|516373086|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
143225173|NCT01147666|516373087|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
143225174|NCT01147666|516373073|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
143225175|NCT01147666|516373074|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
143225176|NCT01147666|516373075|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
143225177|NCT01147666|516373076|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
143225178|NCT01147666|516373077|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
143225179|NCT01147666|516373078|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
143225180|NCT01147666|516373079|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
143225181|NCT01147666|516373080|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
143225182|NCT01147666|516373081|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
143225183|NCT01147666|516373082|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
143225184|NCT01147666|516373083|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
143225185|NCT01147666|516373084|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
143225186|NCT01147666|516373085|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
143268487|NCT00785928|516539000|FG003|Treatment Phase|Lack of Efficacy|0|||
143225187|NCT01147666|516373086|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
143225188|NCT01147666|516373087|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
143225189|NCT01147666|516373073|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
143225190|NCT01147666|516373074|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
143225191|NCT01147666|516373075|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
143225192|NCT01147666|516373076|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
143225193|NCT01147666|516373077|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
143225194|NCT01147666|516373078|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
143225195|NCT01147666|516373079|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
143225196|NCT01147666|516373080|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
143225197|NCT01147666|516373081|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
143225198|NCT01147666|516373082|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
143225199|NCT01147666|516373083|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
143225200|NCT01147666|516373084|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
143225201|NCT01147666|516373085|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
143225202|NCT01147666|516373086|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
143225203|NCT01147666|516373087|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
143225204|NCT01147666|516373073|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
143225205|NCT01147666|516373074|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
143225206|NCT01147666|516373075|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
143225207|NCT01147666|516373076|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
143225208|NCT01147666|516373077|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
143225209|NCT01147666|516373078|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
143225210|NCT01147666|516373079|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
143225211|NCT01147666|516373080|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
143225212|NCT01147666|516373081|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
143225213|NCT01147666|516373082|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
143225214|NCT01147666|516373083|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
143225215|NCT01147666|516373084|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
143225216|NCT01147666|516373085|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
143225217|NCT01147666|516373086|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
143225218|NCT01147666|516373087|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
143225219|NCT01147666|516373073|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
143225220|NCT01147666|516373074|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
143225221|NCT01147666|516373075|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
143225222|NCT01147666|516373076|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
143225223|NCT01147666|516373077|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
143225224|NCT01147666|516373078|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
143225225|NCT01147666|516373079|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
143225226|NCT01147666|516373080|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
143225227|NCT01147666|516373081|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
143225228|NCT01147666|516373082|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
143225229|NCT01147666|516373083|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
143225230|NCT01147666|516373084|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
143225231|NCT01147666|516373085|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
143225232|NCT01147666|516373086|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
143225233|NCT01147666|516373087|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
143225234|NCT02159066|516373088|FG000|Part I|Adverse Event|7|||
143225235|NCT02159066|516373089|FG001|Part I|Adverse Event|5|||
143225236|NCT02159066|516373090|FG002|Part I|Adverse Event|0|||
143225237|NCT02159066|516373091|FG003|Part I|Adverse Event|0|||
143225238|NCT02159066|516373092|FG004|Part I|Adverse Event|0|||
143225239|NCT02159066|516373093|FG005|Part I|Adverse Event|0|||
143225240|NCT02159066|516373088|FG000|Part I|Death|11|||
143225241|NCT02159066|516373089|FG001|Part I|Death|9|||
143225242|NCT02159066|516373090|FG002|Part I|Death|0|||
143225243|NCT02159066|516373091|FG003|Part I|Death|0|||
143225244|NCT02159066|516373092|FG004|Part I|Death|0|||
143225245|NCT02159066|516373093|FG005|Part I|Death|0|||
143225246|NCT02159066|516373088|FG000|Part I|Progressive Disease|37|||
143225247|NCT02159066|516373089|FG001|Part I|Progressive Disease|46|||
143225248|NCT02159066|516373090|FG002|Part I|Progressive Disease|0|||
143225249|NCT02159066|516373091|FG003|Part I|Progressive Disease|0|||
143225250|NCT02159066|516373092|FG004|Part I|Progressive Disease|0|||
143225251|NCT02159066|516373093|FG005|Part I|Progressive Disease|0|||
143225252|NCT02159066|516373088|FG000|Part I|New Therapy for Study Indication|5|||
143225253|NCT02159066|516373089|FG001|Part I|New Therapy for Study Indication|4|||
143225254|NCT02159066|516373090|FG002|Part I|New Therapy for Study Indication|0|||
143225255|NCT02159066|516373091|FG003|Part I|New Therapy for Study Indication|0|||
143225256|NCT02159066|516373092|FG004|Part I|New Therapy for Study Indication|0|||
143225257|NCT02159066|516373093|FG005|Part I|New Therapy for Study Indication|0|||
143225258|NCT02159066|516373088|FG000|Part I|Termination of participants from the study|3|||
143225259|NCT02159066|516373089|FG001|Part I|Termination of participants from the study|3|||
143225260|NCT02159066|516373090|FG002|Part I|Termination of participants from the study|0|||
143225261|NCT02159066|516373091|FG003|Part I|Termination of participants from the study|0|||
143225262|NCT02159066|516373092|FG004|Part I|Termination of participants from the study|0|||
143225263|NCT02159066|516373093|FG005|Part I|Termination of participants from the study|0|||
143225264|NCT02159066|516373088|FG000|Part I|Physician Decision|2|||
143225265|NCT02159066|516373089|FG001|Part I|Physician Decision|9|||
143225266|NCT02159066|516373090|FG002|Part I|Physician Decision|0|||
143225267|NCT02159066|516373091|FG003|Part I|Physician Decision|0|||
143225268|NCT02159066|516373092|FG004|Part I|Physician Decision|0|||
143225269|NCT02159066|516373093|FG005|Part I|Physician Decision|0|||
143225270|NCT02159066|516373088|FG000|Part I|Participant/Guardian Decision|9|||
143225271|NCT02159066|516373089|FG001|Part I|Participant/Guardian Decision|3|||
143225272|NCT02159066|516373090|FG002|Part I|Participant/Guardian Decision|0|||
143225273|NCT02159066|516373091|FG003|Part I|Participant/Guardian Decision|0|||
143225274|NCT02159066|516373092|FG004|Part I|Participant/Guardian Decision|0|||
143225275|NCT02159066|516373093|FG005|Part I|Participant/Guardian Decision|0|||
143225276|NCT02159066|516373088|FG000|Part I|Missing Data|1|||
143225277|NCT02159066|516373089|FG001|Part I|Missing Data|0|||
143225278|NCT02159066|516373090|FG002|Part I|Missing Data|0|||
143225279|NCT02159066|516373091|FG003|Part I|Missing Data|0|||
143225280|NCT02159066|516373092|FG004|Part I|Missing Data|0|||
143225281|NCT02159066|516373093|FG005|Part I|Missing Data|0|||
143225282|NCT02159066|516373088|FG000|Part II|Adverse Event|0|||
143225283|NCT02159066|516373089|FG001|Part II|Adverse Event|0|||
143225284|NCT02159066|516373090|FG002|Part II|Adverse Event|1|||
143225285|NCT02159066|516373091|FG003|Part II|Adverse Event|0|||
143225286|NCT02159066|516373092|FG004|Part II|Adverse Event|1|||
143225287|NCT02159066|516373093|FG005|Part II|Adverse Event|1|||
143225288|NCT02159066|516373088|FG000|Part II|Death|0|||
143225289|NCT02159066|516373089|FG001|Part II|Death|0|||
143225290|NCT02159066|516373090|FG002|Part II|Death|1|||
143225291|NCT02159066|516373091|FG003|Part II|Death|0|||
143225292|NCT02159066|516373092|FG004|Part II|Death|2|||
143225293|NCT02159066|516373093|FG005|Part II|Death|1|||
143225294|NCT02159066|516373088|FG000|Part II|Progressive Disease|0|||
143225295|NCT02159066|516373089|FG001|Part II|Progressive Disease|0|||
143225296|NCT02159066|516373090|FG002|Part II|Progressive Disease|35|||
143225297|NCT02159066|516373091|FG003|Part II|Progressive Disease|1|||
143225298|NCT02159066|516373092|FG004|Part II|Progressive Disease|7|||
143225299|NCT02159066|516373093|FG005|Part II|Progressive Disease|4|||
143225300|NCT02159066|516373088|FG000|Part II|New Therapy for Study Indication|0|||
143372479|NCT01193153|516909525|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
143372480|NCT01193153|516909524|FG000|Double Blind Relapse Prevention Period|Death|2|||
143225301|NCT02159066|516373089|FG001|Part II|New Therapy for Study Indication|0|||
143225302|NCT02159066|516373090|FG002|Part II|New Therapy for Study Indication|0|||
143225303|NCT02159066|516373091|FG003|Part II|New Therapy for Study Indication|0|||
143225304|NCT02159066|516373092|FG004|Part II|New Therapy for Study Indication|1|||
143225305|NCT02159066|516373093|FG005|Part II|New Therapy for Study Indication|0|||
143225306|NCT02159066|516373088|FG000|Part II|Physician Decision|0|||
143225307|NCT02159066|516373089|FG001|Part II|Physician Decision|0|||
143225308|NCT02159066|516373090|FG002|Part II|Physician Decision|1|||
143225309|NCT02159066|516373091|FG003|Part II|Physician Decision|0|||
143225310|NCT02159066|516373092|FG004|Part II|Physician Decision|0|||
143372481|NCT01193153|516909525|FG001|Double Blind Relapse Prevention Period|Death|0|||
143372482|NCT01193153|516909524|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
143372483|NCT01193153|516909525|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
143372484|NCT01193153|516909524|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
143225311|NCT02159066|516373093|FG005|Part II|Physician Decision|0|||
143372485|NCT01193153|516909525|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
143225312|NCT02159066|516373088|FG000|Part II|Participant/Guardian Decision|0|||
143225313|NCT02159066|516373089|FG001|Part II|Participant/Guardian Decision|0|||
143225314|NCT02159066|516373090|FG002|Part II|Participant/Guardian Decision|0|||
143225315|NCT02159066|516373091|FG003|Part II|Participant/Guardian Decision|0|||
143225316|NCT02159066|516373092|FG004|Part II|Participant/Guardian Decision|2|||
143225317|NCT02159066|516373093|FG005|Part II|Participant/Guardian Decision|0|||
143225318|NCT00474955|516373095|FG000|Overall Study|Adverse Event|2|||
143225319|NCT00474955|516373095|FG000|Overall Study|Drug unavailability|1|||
143225320|NCT00474955|516373095|FG000|Overall Study|Personal reasons|5|||
143225321|NCT02576639|516373096|FG000|Overall Study|Withdrawal by Subject|1|||
143225322|NCT02576639|516373097|FG001|Overall Study|Withdrawal by Subject|2|||
143225323|NCT02576639|516373098|FG002|Overall Study|Withdrawal by Subject|1|||
143225324|NCT02576639|516373099|FG003|Overall Study|Withdrawal by Subject|0|||
143225325|NCT02576639|516373100|FG004|Overall Study|Withdrawal by Subject|1|||
143225326|NCT02576639|516373096|FG000|Overall Study|Adverse Event|1|||
143225327|NCT02576639|516373097|FG001|Overall Study|Adverse Event|0|||
143225328|NCT02576639|516373098|FG002|Overall Study|Adverse Event|1|||
143225329|NCT02576639|516373099|FG003|Overall Study|Adverse Event|1|||
143225330|NCT02576639|516373100|FG004|Overall Study|Adverse Event|2|||
143225331|NCT02576639|516373096|FG000|Overall Study|Physician Decision|0|||
143225332|NCT02576639|516373097|FG001|Overall Study|Physician Decision|0|||
143225333|NCT02576639|516373098|FG002|Overall Study|Physician Decision|0|||
143225334|NCT02576639|516373099|FG003|Overall Study|Physician Decision|0|||
143225335|NCT02576639|516373100|FG004|Overall Study|Physician Decision|1|||
143225336|NCT01135134|516373101|FG000|Overall Study|Adverse Event|1|||
143225337|NCT01135134|516373102|FG001|Overall Study|Adverse Event|1|||
143225338|NCT01135134|516373101|FG000|Overall Study|Did not meet protocol eligibility|1|||
143225339|NCT01135134|516373102|FG001|Overall Study|Did not meet protocol eligibility|0|||
143225340|NCT00255190|516373105|FG000|Overall Study|Adverse Event|17|||
143225341|NCT00255190|516373106|FG001|Overall Study|Adverse Event|36|||
143225342|NCT00255190|516373105|FG000|Overall Study|Protocol Violation|2|||
143225343|NCT00255190|516373106|FG001|Overall Study|Protocol Violation|2|||
143225344|NCT00255190|516373105|FG000|Overall Study|Lost to Follow-up|10|||
143225345|NCT00255190|516373106|FG001|Overall Study|Lost to Follow-up|27|||
143225346|NCT00255190|516373105|FG000|Overall Study|Withdrew Consent|17|||
143225347|NCT00255190|516373106|FG001|Overall Study|Withdrew Consent|48|||
143225348|NCT00255190|516373105|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
143225349|NCT00255190|516373106|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
143225350|NCT00255190|516373105|FG000|Overall Study|Erosive esophagitis not healed|0|||
143225351|NCT00255190|516373106|FG001|Overall Study|Erosive esophagitis not healed|20|||
143225352|NCT00255190|516373105|FG000|Overall Study|Various|4|||
143225353|NCT00255190|516373106|FG001|Overall Study|Various|23|||
143225354|NCT01156480|516373110|FG000|Overall Study|change in diagnosis|0|||
143225355|NCT01156480|516373111|FG001|Overall Study|change in diagnosis|1|||
143225356|NCT04537793|516373112|FG000|Part B (24 Weeks)|Adverse Event|0|||
143225357|NCT04537793|516373113|FG001|Part B (24 Weeks)|Adverse Event|1|||
143225358|NCT01176058|516373115|FG000|Overall Study|Adverse Event|1|||
143225359|NCT01176058|516373116|FG001|Overall Study|Adverse Event|0|||
143225360|NCT01176058|516373115|FG000|Overall Study|Insufficient clinical response|2|||
143225361|NCT01176058|516373116|FG001|Overall Study|Insufficient clinical response|2|||
143225362|NCT01176058|516373115|FG000|Overall Study|Insufficient mycological response|0|||
143225363|NCT01176058|516373116|FG001|Overall Study|Insufficient mycological response|1|||
143225364|NCT01176058|516373115|FG000|Overall Study|Withdrawal by Subject|1|||
143225365|NCT01176058|516373116|FG001|Overall Study|Withdrawal by Subject|0|||
143225366|NCT01859923|516373121|FG000|Overall Study|Adverse Event|0|||
143225367|NCT01859923|516373122|FG001|Overall Study|Adverse Event|0|||
143225368|NCT01859923|516373123|FG002|Overall Study|Adverse Event|1|||
143225369|NCT01859923|516373124|FG003|Overall Study|Adverse Event|1|||
143225370|NCT00764361|516373126|FG000|Overall Study|Withdrawal by Subject|2|||
143225371|NCT00764361|516373127|FG001|Overall Study|Withdrawal by Subject|3|||
143225372|NCT00764361|516373126|FG000|Overall Study|Adverse Event|0|||
143225373|NCT00764361|516373127|FG001|Overall Study|Adverse Event|1|||
143225374|NCT02079038|516373128|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
143225375|NCT02079038|516373129|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
143225376|NCT02079038|516373128|FG000|Modified Intent to Treat Population|Death|1|||
143225377|NCT02079038|516373129|FG001|Modified Intent to Treat Population|Death|0|||
143225378|NCT02079038|516373128|FG000|Completed 6 Months|Lost to Follow-up|2|||
143225379|NCT02079038|516373129|FG001|Completed 6 Months|Lost to Follow-up|1|||
143225380|NCT01308736|516373130|FG000|Overall Study|Did not attend a single session|6|||
143225381|NCT01308736|516373131|FG001|Overall Study|Did not attend a single session|5|||
143225382|NCT03634085|516373132|FG000|Overall Study|Adverse Event|1|||
143225383|NCT03634085|516373133|FG001|Overall Study|Adverse Event|0|||
143225384|NCT03634085|516373132|FG000|Overall Study|Withdrawal by Subject|0|||
143225385|NCT03634085|516373133|FG001|Overall Study|Withdrawal by Subject|2|||
143268488|NCT00785928|516539001|FG004|Treatment Phase|Lack of Efficacy|0|||
143225386|NCT01946139|516373134|FG000|Overall Study|Withdrawal by Subject|8|||
143268489|NCT00785928|516539002|FG005|Treatment Phase|Lack of Efficacy|0|||
143225387|NCT01946139|516373134|FG000|Overall Study|ineligible|8|||
143225388|NCT01946139|516373134|FG000|Overall Study|Specimens not available|4|||
143225389|NCT02552966|516373143|FG000|Overall Study|Lost to Follow-up|2|||
143225390|NCT02552966|516373143|FG000|Overall Study|Withdrawal by Subject|3|||
143225391|NCT01721161|516373146|FG000|Overall Study|Adverse Event|2|||
143268490|NCT00785928|516539003|FG006|Treatment Phase|Lack of Efficacy|0|||
143268491|NCT00785928|516538997|FG000|Treatment Phase|Physician Decision|0|||
143225392|NCT01721161|516373147|FG001|Overall Study|Adverse Event|3|||
143268492|NCT00785928|516538998|FG001|Treatment Phase|Physician Decision|0|||
143225393|NCT01721161|516373146|FG000|Overall Study|Lost to Follow-up|1|||
143225394|NCT01721161|516373147|FG001|Overall Study|Lost to Follow-up|2|||
143268493|NCT00785928|516538999|FG002|Treatment Phase|Physician Decision|0|||
143225395|NCT01721161|516373146|FG000|Overall Study|Withdrawal by Subject|1|||
143225396|NCT01721161|516373147|FG001|Overall Study|Withdrawal by Subject|1|||
143225397|NCT01721161|516373146|FG000|Overall Study|Other|0|||
143225398|NCT01721161|516373147|FG001|Overall Study|Other|1|||
143225399|NCT02888106|516373155|FG000|Overall Study|Withdrawal by Subject|1|||
143225400|NCT02888106|516373156|FG001|Overall Study|Withdrawal by Subject|2|||
143225401|NCT02888106|516373157|FG002|Overall Study|Withdrawal by Subject|0|||
143225402|NCT02888106|516373158|FG003|Overall Study|Withdrawal by Subject|1|||
143225403|NCT02888106|516373159|FG004|Overall Study|Withdrawal by Subject|0|||
143225404|NCT02888106|516373160|FG005|Overall Study|Withdrawal by Subject|0|||
143225405|NCT02888106|516373155|FG000|Overall Study|Lost to Follow-up|1|||
143225406|NCT02888106|516373156|FG001|Overall Study|Lost to Follow-up|0|||
143225407|NCT02888106|516373157|FG002|Overall Study|Lost to Follow-up|0|||
143225408|NCT02888106|516373158|FG003|Overall Study|Lost to Follow-up|1|||
143225409|NCT02888106|516373159|FG004|Overall Study|Lost to Follow-up|0|||
143225410|NCT02888106|516373160|FG005|Overall Study|Lost to Follow-up|1|||
143225411|NCT02888106|516373155|FG000|Overall Study|Adverse Event|2|||
143225412|NCT02888106|516373156|FG001|Overall Study|Adverse Event|0|||
143225413|NCT02888106|516373157|FG002|Overall Study|Adverse Event|0|||
143225414|NCT02888106|516373158|FG003|Overall Study|Adverse Event|0|||
143225415|NCT02888106|516373159|FG004|Overall Study|Adverse Event|0|||
143225416|NCT02888106|516373160|FG005|Overall Study|Adverse Event|0|||
143225417|NCT02888106|516373155|FG000|Overall Study|Withdrawal of consent|0|||
143225418|NCT02888106|516373156|FG001|Overall Study|Withdrawal of consent|0|||
143225419|NCT02888106|516373157|FG002|Overall Study|Withdrawal of consent|0|||
143225420|NCT02888106|516373158|FG003|Overall Study|Withdrawal of consent|0|||
143225421|NCT02888106|516373159|FG004|Overall Study|Withdrawal of consent|1|||
143225422|NCT02888106|516373160|FG005|Overall Study|Withdrawal of consent|0|||
143225423|NCT02888106|516373155|FG000|Overall Study|Pregnancy|1|||
143225424|NCT02888106|516373156|FG001|Overall Study|Pregnancy|0|||
143225425|NCT02888106|516373157|FG002|Overall Study|Pregnancy|0|||
143225426|NCT02888106|516373158|FG003|Overall Study|Pregnancy|0|||
143225427|NCT02888106|516373159|FG004|Overall Study|Pregnancy|0|||
143225428|NCT02888106|516373160|FG005|Overall Study|Pregnancy|0|||
143225429|NCT00430716|516373165|FG000|Double Blind Phase|Death|1|||
143225430|NCT00430716|516373166|FG001|Double Blind Phase|Death|0|||
143225431|NCT00430716|516373167|FG002|Double Blind Phase|Death|0|||
143225432|NCT00430716|516373165|FG000|Double Blind Phase|No longer willing to participate|2|||
143225433|NCT00430716|516373166|FG001|Double Blind Phase|No longer willing to participate|1|||
143225434|NCT00430716|516373167|FG002|Double Blind Phase|No longer willing to participate|1|||
143225435|NCT00430716|516373165|FG000|Double Blind Phase|Other|0|||
143225436|NCT00430716|516373166|FG001|Double Blind Phase|Other|2|||
143225437|NCT00430716|516373167|FG002|Double Blind Phase|Other|0|||
143225438|NCT00430716|516373165|FG000|Double Blind Phase|Study terminated by sponsor|1|||
143225439|NCT00430716|516373166|FG001|Double Blind Phase|Study terminated by sponsor|1|||
143225440|NCT00430716|516373167|FG002|Double Blind Phase|Study terminated by sponsor|2|||
143225441|NCT00430716|516373165|FG000|Double Blind Phase|Adverse Event|1|||
143225442|NCT00430716|516373166|FG001|Double Blind Phase|Adverse Event|1|||
143225443|NCT00430716|516373167|FG002|Double Blind Phase|Adverse Event|3|||
143225444|NCT00430716|516373165|FG000|Double Blind Phase|Not treated|1|||
143225445|NCT00430716|516373166|FG001|Double Blind Phase|Not treated|0|||
143225446|NCT00430716|516373167|FG002|Double Blind Phase|Not treated|0|||
143225447|NCT00430716|516373165|FG000|Open Label Phase|Lost to Follow-up|1|||
143225448|NCT00430716|516373166|FG001|Open Label Phase|Lost to Follow-up|0|||
143225449|NCT00430716|516373167|FG002|Open Label Phase|Lost to Follow-up|1|||
143225450|NCT00430716|516373165|FG000|Open Label Phase|No longer willing to participate|0|||
143225451|NCT00430716|516373166|FG001|Open Label Phase|No longer willing to participate|1|||
143225452|NCT00430716|516373167|FG002|Open Label Phase|No longer willing to participate|1|||
143225453|NCT00430716|516373165|FG000|Open Label Phase|Other|3|||
143225454|NCT00430716|516373166|FG001|Open Label Phase|Other|1|||
143225455|NCT00430716|516373167|FG002|Open Label Phase|Other|1|||
143225456|NCT00430716|516373165|FG000|Open Label Phase|Protocol Violation|1|||
143225457|NCT00430716|516373166|FG001|Open Label Phase|Protocol Violation|0|||
143225458|NCT00430716|516373167|FG002|Open Label Phase|Protocol Violation|0|||
143225459|NCT00430716|516373165|FG000|Open Label Phase|Study terminated by sponsor|4|||
143225460|NCT00430716|516373166|FG001|Open Label Phase|Study terminated by sponsor|5|||
143225461|NCT00430716|516373167|FG002|Open Label Phase|Study terminated by sponsor|4|||
143225462|NCT01188772|516373171|FG000|Overall Study|Randomized but Not Treated|0|||
143225463|NCT01188772|516373172|FG001|Overall Study|Randomized but Not Treated|1|||
143225464|NCT01188772|516373173|FG002|Overall Study|Randomized but Not Treated|0|||
143225465|NCT01188772|516373174|FG003|Overall Study|Randomized but Not Treated|0|||
143225466|NCT01188772|516373171|FG000|Overall Study|Adverse Event|0|||
143225467|NCT01188772|516373172|FG001|Overall Study|Adverse Event|1|||
143225468|NCT01188772|516373173|FG002|Overall Study|Adverse Event|2|||
143225469|NCT01188772|516373174|FG003|Overall Study|Adverse Event|0|||
143225470|NCT01188772|516373171|FG000|Overall Study|Lost to Follow-up|4|||
143225471|NCT01188772|516373172|FG001|Overall Study|Lost to Follow-up|1|||
143225472|NCT01188772|516373173|FG002|Overall Study|Lost to Follow-up|1|||
143225473|NCT01188772|516373174|FG003|Overall Study|Lost to Follow-up|1|||
143225474|NCT01188772|516373171|FG000|Overall Study|Non-responder|0|||
143225475|NCT01188772|516373172|FG001|Overall Study|Non-responder|0|||
143225476|NCT01188772|516373173|FG002|Overall Study|Non-responder|3|||
143225477|NCT01188772|516373174|FG003|Overall Study|Non-responder|0|||
143225478|NCT01188772|516373171|FG000|Overall Study|Physician Decision|0|||
143225479|NCT01188772|516373172|FG001|Overall Study|Physician Decision|0|||
143225480|NCT01188772|516373173|FG002|Overall Study|Physician Decision|1|||
143225481|NCT01188772|516373174|FG003|Overall Study|Physician Decision|0|||
143225482|NCT01188772|516373171|FG000|Overall Study|Terminated by Sponsor|0|||
143225483|NCT01188772|516373172|FG001|Overall Study|Terminated by Sponsor|0|||
143225484|NCT01188772|516373173|FG002|Overall Study|Terminated by Sponsor|1|||
143225485|NCT01188772|516373174|FG003|Overall Study|Terminated by Sponsor|0|||
143225486|NCT01188772|516373171|FG000|Overall Study|Treatment Failure|0|||
143225487|NCT01188772|516373172|FG001|Overall Study|Treatment Failure|0|||
143225488|NCT01188772|516373173|FG002|Overall Study|Treatment Failure|1|||
143225489|NCT01188772|516373174|FG003|Overall Study|Treatment Failure|0|||
143225490|NCT01188772|516373171|FG000|Overall Study|Virologic Failure|1|||
143225491|NCT01188772|516373172|FG001|Overall Study|Virologic Failure|0|||
143225492|NCT01188772|516373173|FG002|Overall Study|Virologic Failure|0|||
143225493|NCT01188772|516373174|FG003|Overall Study|Virologic Failure|0|||
143225494|NCT01188772|516373171|FG000|Overall Study|Withdrawal by Subject|0|||
143225495|NCT01188772|516373172|FG001|Overall Study|Withdrawal by Subject|0|||
143225496|NCT01188772|516373173|FG002|Overall Study|Withdrawal by Subject|2|||
143225497|NCT01188772|516373174|FG003|Overall Study|Withdrawal by Subject|0|||
143225498|NCT01433172|516373175|FG000|Overall Study|Withdrawal by Subject|0|||
143225499|NCT01433172|516373176|FG001|Overall Study|Withdrawal by Subject|1|||
143225500|NCT01433172|516373177|FG002|Overall Study|Withdrawal by Subject|0|||
143225501|NCT01433172|516373175|FG000|Overall Study|Disease Progression|0|||
143225502|NCT01433172|516373176|FG001|Overall Study|Disease Progression|0|||
143225503|NCT01433172|516373177|FG002|Overall Study|Disease Progression|1|||
143225504|NCT01433172|516373175|FG000|Overall Study|Death|0|||
143225505|NCT01433172|516373176|FG001|Overall Study|Death|2|||
143225506|NCT01433172|516373177|FG002|Overall Study|Death|0|||
143225507|NCT01894607|516373181|FG000|Overall Study|Ineligible|1|||
143225508|NCT02717494|516373186|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
143225509|NCT02717494|516373187|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
143225510|NCT02717494|516373188|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
143225511|NCT02717494|516373186|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
143225512|NCT02717494|516373187|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
143225513|NCT02717494|516373188|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
143225514|NCT02717494|516373186|FG000|First Intervention (Step 1)|Death|0|||
143225515|NCT02717494|516373187|FG001|First Intervention (Step 1)|Death|0|||
143225516|NCT02717494|516373188|FG002|First Intervention (Step 1)|Death|1|||
143225517|NCT02717494|516373186|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
143225518|NCT02717494|516373187|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
143225519|NCT02717494|516373188|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
143225520|NCT04393493|516373193|FG000|First 4 Days of Intervention|Early improvement|5|||
143225521|NCT04393493|516373194|FG001|First 4 Days of Intervention|Early improvement|7|||
143225522|NCT01125800|516373195|FG000|Phase I|Protocol Violation|0|||
143225523|NCT01125800|516373196|FG001|Phase I|Protocol Violation|3|||
143225524|NCT01125800|516373197|FG002|Phase I|Protocol Violation|1|||
143225525|NCT01125800|516373198|FG003|Phase I|Protocol Violation|1|||
143225526|NCT01125800|516373199|FG004|Phase I|Protocol Violation|0|||
143225527|NCT01125800|516373195|FG000|Phase I|Adverse Event|2|||
143225528|NCT01125800|516373196|FG001|Phase I|Adverse Event|2|||
143225529|NCT01125800|516373197|FG002|Phase I|Adverse Event|1|||
143225530|NCT01125800|516373198|FG003|Phase I|Adverse Event|7|||
143225531|NCT01125800|516373199|FG004|Phase I|Adverse Event|0|||
143225532|NCT01125800|516373195|FG000|Phase I|Administrative problems|1|||
143225533|NCT01125800|516373196|FG001|Phase I|Administrative problems|0|||
143225534|NCT01125800|516373197|FG002|Phase I|Administrative problems|0|||
143225535|NCT01125800|516373198|FG003|Phase I|Administrative problems|0|||
143225536|NCT01125800|516373199|FG004|Phase I|Administrative problems|0|||
143225537|NCT01125800|516373195|FG000|Phase I|Withdrawal by Subject|0|||
143225538|NCT01125800|516373196|FG001|Phase I|Withdrawal by Subject|0|||
143225539|NCT01125800|516373197|FG002|Phase I|Withdrawal by Subject|1|||
143225540|NCT01125800|516373198|FG003|Phase I|Withdrawal by Subject|0|||
143225541|NCT01125800|516373199|FG004|Phase I|Withdrawal by Subject|0|||
143225542|NCT01125800|516373195|FG000|Phase I|Disease progression|5|||
143225543|NCT01125800|516373196|FG001|Phase I|Disease progression|4|||
143225544|NCT01125800|516373197|FG002|Phase I|Disease progression|1|||
143225545|NCT01125800|516373198|FG003|Phase I|Disease progression|3|||
143225546|NCT01125800|516373199|FG004|Phase I|Disease progression|0|||
143225547|NCT01125800|516373195|FG000|Phase II|Protocol Violation|0|||
143225548|NCT01125800|516373196|FG001|Phase II|Protocol Violation|0|||
143225549|NCT01125800|516373197|FG002|Phase II|Protocol Violation|0|||
143225550|NCT01125800|516373198|FG003|Phase II|Protocol Violation|0|||
143225551|NCT01125800|516373199|FG004|Phase II|Protocol Violation|1|||
143225552|NCT01125800|516373195|FG000|Phase II|Adverse Event|0|||
143225553|NCT01125800|516373196|FG001|Phase II|Adverse Event|0|||
143225554|NCT01125800|516373197|FG002|Phase II|Adverse Event|0|||
143225555|NCT01125800|516373198|FG003|Phase II|Adverse Event|0|||
143225556|NCT01125800|516373199|FG004|Phase II|Adverse Event|2|||
143225557|NCT01125800|516373195|FG000|Phase II|Disease progression|0|||
143225558|NCT01125800|516373196|FG001|Phase II|Disease progression|0|||
143225559|NCT01125800|516373197|FG002|Phase II|Disease progression|0|||
143225560|NCT01125800|516373198|FG003|Phase II|Disease progression|1|||
143225561|NCT01125800|516373199|FG004|Phase II|Disease progression|8|||
143225562|NCT03370718|516373200|FG000|Overall Study|Withdrawal by Subject|1|||
143225563|NCT03116685|516373203|FG000|Overall Study|Physician Decision|0|||
143225564|NCT03116685|516373204|FG001|Overall Study|Physician Decision|1|||
143225565|NCT05579977|516373206|FG000|Treatment Phase|Other|0|||
143225566|NCT05579977|516373207|FG001|Treatment Phase|Other|0|||
143225567|NCT05579977|516373208|FG002|Treatment Phase|Other|0|||
143225568|NCT05579977|516373209|FG003|Treatment Phase|Other|2|||
143225569|NCT05579977|516373210|FG004|Treatment Phase|Other|1|||
143225570|NCT05579977|516373211|FG005|Treatment Phase|Other|2|||
143225571|NCT05579977|516373212|FG006|Treatment Phase|Other|1|||
143225572|NCT05579977|516373213|FG007|Treatment Phase|Other|2|||
143225573|NCT05579977|516373214|FG008|Treatment Phase|Other|2|||
143225574|NCT05579977|516373215|FG009|Treatment Phase|Other|1|||
143225575|NCT05579977|516373216|FG010|Treatment Phase|Other|0|||
143225576|NCT05579977|516373217|FG011|Treatment Phase|Other|0|||
143225577|NCT05579977|516373218|FG012|Treatment Phase|Other|3|||
143225578|NCT05579977|516373206|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
143225579|NCT05579977|516373207|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
143225580|NCT05579977|516373208|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
143225581|NCT05579977|516373209|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
143225582|NCT05579977|516373210|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
143225583|NCT05579977|516373211|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
143225584|NCT05579977|516373212|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
143225585|NCT05579977|516373213|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
143225586|NCT05579977|516373214|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
143225587|NCT05579977|516373215|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
143225588|NCT05579977|516373216|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
143225589|NCT05579977|516373217|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
143225590|NCT05579977|516373218|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
143225591|NCT05579977|516373206|FG000|Treatment Phase|Withdrawal by Subject|2|||
143225592|NCT05579977|516373207|FG001|Treatment Phase|Withdrawal by Subject|0|||
143225593|NCT05579977|516373208|FG002|Treatment Phase|Withdrawal by Subject|0|||
143225594|NCT05579977|516373209|FG003|Treatment Phase|Withdrawal by Subject|1|||
143225595|NCT05579977|516373210|FG004|Treatment Phase|Withdrawal by Subject|2|||
143225596|NCT05579977|516373211|FG005|Treatment Phase|Withdrawal by Subject|0|||
143225597|NCT05579977|516373212|FG006|Treatment Phase|Withdrawal by Subject|1|||
143225598|NCT05579977|516373213|FG007|Treatment Phase|Withdrawal by Subject|8|||
143225599|NCT05579977|516373214|FG008|Treatment Phase|Withdrawal by Subject|3|||
143225600|NCT05579977|516373215|FG009|Treatment Phase|Withdrawal by Subject|3|||
143225601|NCT05579977|516373216|FG010|Treatment Phase|Withdrawal by Subject|5|||
143225602|NCT05579977|516373217|FG011|Treatment Phase|Withdrawal by Subject|1|||
143225603|NCT05579977|516373218|FG012|Treatment Phase|Withdrawal by Subject|3|||
143225604|NCT05579977|516373206|FG000|Treatment Phase|Study terminated by sponsor|70|||
143225605|NCT05579977|516373207|FG001|Treatment Phase|Study terminated by sponsor|70|||
143225606|NCT05579977|516373208|FG002|Treatment Phase|Study terminated by sponsor|61|||
143225607|NCT05579977|516373209|FG003|Treatment Phase|Study terminated by sponsor|59|||
143225608|NCT05579977|516373210|FG004|Treatment Phase|Study terminated by sponsor|63|||
143225609|NCT05579977|516373211|FG005|Treatment Phase|Study terminated by sponsor|53|||
143225610|NCT05579977|516373212|FG006|Treatment Phase|Study terminated by sponsor|66|||
143225611|NCT05579977|516373213|FG007|Treatment Phase|Study terminated by sponsor|48|||
143225612|NCT05579977|516373214|FG008|Treatment Phase|Study terminated by sponsor|47|||
143225613|NCT05579977|516373215|FG009|Treatment Phase|Study terminated by sponsor|37|||
143225614|NCT05579977|516373216|FG010|Treatment Phase|Study terminated by sponsor|44|||
143225615|NCT05579977|516373217|FG011|Treatment Phase|Study terminated by sponsor|36|||
143372486|NCT01193153|516909524|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
143225616|NCT05579977|516373218|FG012|Treatment Phase|Study terminated by sponsor|32|||
143225617|NCT05579977|516373206|FG000|Treatment Phase|Pregnancy|0|||
143225618|NCT05579977|516373207|FG001|Treatment Phase|Pregnancy|0|||
143225619|NCT05579977|516373208|FG002|Treatment Phase|Pregnancy|0|||
143225620|NCT05579977|516373209|FG003|Treatment Phase|Pregnancy|0|||
143225621|NCT05579977|516373210|FG004|Treatment Phase|Pregnancy|0|||
143225622|NCT05579977|516373211|FG005|Treatment Phase|Pregnancy|0|||
143225623|NCT05579977|516373212|FG006|Treatment Phase|Pregnancy|0|||
143225624|NCT05579977|516373213|FG007|Treatment Phase|Pregnancy|0|||
143225625|NCT05579977|516373214|FG008|Treatment Phase|Pregnancy|0|||
143225626|NCT05579977|516373215|FG009|Treatment Phase|Pregnancy|1|||
143225627|NCT05579977|516373216|FG010|Treatment Phase|Pregnancy|0|||
143225628|NCT05579977|516373217|FG011|Treatment Phase|Pregnancy|0|||
143225629|NCT05579977|516373218|FG012|Treatment Phase|Pregnancy|0|||
143225630|NCT05579977|516373206|FG000|Treatment Phase|Physician Decision|0|||
143225631|NCT05579977|516373207|FG001|Treatment Phase|Physician Decision|0|||
143225632|NCT05579977|516373208|FG002|Treatment Phase|Physician Decision|0|||
143225633|NCT05579977|516373209|FG003|Treatment Phase|Physician Decision|0|||
143225634|NCT05579977|516373210|FG004|Treatment Phase|Physician Decision|0|||
143225635|NCT05579977|516373211|FG005|Treatment Phase|Physician Decision|0|||
143225636|NCT05579977|516373212|FG006|Treatment Phase|Physician Decision|0|||
143225637|NCT05579977|516373213|FG007|Treatment Phase|Physician Decision|0|||
143225638|NCT05579977|516373214|FG008|Treatment Phase|Physician Decision|0|||
143225639|NCT05579977|516373215|FG009|Treatment Phase|Physician Decision|0|||
143225640|NCT05579977|516373216|FG010|Treatment Phase|Physician Decision|0|||
143225641|NCT05579977|516373217|FG011|Treatment Phase|Physician Decision|1|||
143225642|NCT05579977|516373218|FG012|Treatment Phase|Physician Decision|0|||
143225643|NCT05579977|516373206|FG000|Treatment Phase|Lost to Follow-up|0|||
143225644|NCT05579977|516373207|FG001|Treatment Phase|Lost to Follow-up|0|||
143225645|NCT05579977|516373208|FG002|Treatment Phase|Lost to Follow-up|0|||
143225646|NCT05579977|516373209|FG003|Treatment Phase|Lost to Follow-up|1|||
143225647|NCT05579977|516373210|FG004|Treatment Phase|Lost to Follow-up|1|||
143225648|NCT05579977|516373211|FG005|Treatment Phase|Lost to Follow-up|1|||
143225649|NCT05579977|516373212|FG006|Treatment Phase|Lost to Follow-up|0|||
143225650|NCT05579977|516373213|FG007|Treatment Phase|Lost to Follow-up|1|||
143225651|NCT05579977|516373214|FG008|Treatment Phase|Lost to Follow-up|2|||
143225652|NCT05579977|516373215|FG009|Treatment Phase|Lost to Follow-up|2|||
143268494|NCT00785928|516539000|FG003|Treatment Phase|Physician Decision|0|||
143268495|NCT00785928|516539001|FG004|Treatment Phase|Physician Decision|1|||
143268496|NCT00785928|516539002|FG005|Treatment Phase|Physician Decision|0|||
143268497|NCT00785928|516539003|FG006|Treatment Phase|Physician Decision|0|||
143268498|NCT00785928|516538997|FG000|Treatment Phase|Sponsor Decision|1|||
143268499|NCT00785928|516538998|FG001|Treatment Phase|Sponsor Decision|0|||
143268500|NCT00785928|516538999|FG002|Treatment Phase|Sponsor Decision|0|||
143268501|NCT00785928|516539000|FG003|Treatment Phase|Sponsor Decision|0|||
143268502|NCT00785928|516539001|FG004|Treatment Phase|Sponsor Decision|0|||
143268503|NCT00785928|516539002|FG005|Treatment Phase|Sponsor Decision|0|||
143268504|NCT00785928|516539003|FG006|Treatment Phase|Sponsor Decision|1|||
143268505|NCT00785928|516538997|FG000|Treatment Phase|Withdrawal by Subject|1|||
143268506|NCT00785928|516538998|FG001|Treatment Phase|Withdrawal by Subject|2|||
143268507|NCT00785928|516538999|FG002|Treatment Phase|Withdrawal by Subject|0|||
143268508|NCT00785928|516539000|FG003|Treatment Phase|Withdrawal by Subject|0|||
143268509|NCT00785928|516539001|FG004|Treatment Phase|Withdrawal by Subject|1|||
143268510|NCT00785928|516539002|FG005|Treatment Phase|Withdrawal by Subject|0|||
143268511|NCT00785928|516539003|FG006|Treatment Phase|Withdrawal by Subject|0|||
143268512|NCT05021081|516539009|FG000|Phase 2|Subject enrolled in error|1|||
143268513|NCT05021081|516539010|FG001|Phase 2|Subject enrolled in error|1|||
143268514|NCT05021081|516539011|FG002|Phase 2|Subject enrolled in error|0|||
143268515|NCT02651467|516539012|FG000|Overall Study|Withdrawal by Subject|0|||
143268516|NCT02651467|516539013|FG001|Overall Study|Withdrawal by Subject|0|||
143268517|NCT02651467|516539014|FG002|Overall Study|Withdrawal by Subject|2|||
143268518|NCT02651467|516539012|FG000|Overall Study|Other (Not specified)|1|||
143225653|NCT05579977|516373216|FG010|Treatment Phase|Lost to Follow-up|1|||
143225654|NCT05579977|516373217|FG011|Treatment Phase|Lost to Follow-up|4|||
143225655|NCT05579977|516373218|FG012|Treatment Phase|Lost to Follow-up|3|||
143225656|NCT05579977|516373206|FG000|Treatment Phase|Death|1|||
143225657|NCT05579977|516373207|FG001|Treatment Phase|Death|0|||
143225658|NCT05579977|516373208|FG002|Treatment Phase|Death|0|||
143225659|NCT05579977|516373209|FG003|Treatment Phase|Death|0|||
143225660|NCT05579977|516373210|FG004|Treatment Phase|Death|0|||
143225661|NCT05579977|516373211|FG005|Treatment Phase|Death|0|||
143225662|NCT05579977|516373212|FG006|Treatment Phase|Death|0|||
143225663|NCT05579977|516373213|FG007|Treatment Phase|Death|0|||
143225664|NCT05579977|516373214|FG008|Treatment Phase|Death|0|||
143225665|NCT05579977|516373215|FG009|Treatment Phase|Death|0|||
143225666|NCT05579977|516373216|FG010|Treatment Phase|Death|0|||
143225667|NCT05579977|516373217|FG011|Treatment Phase|Death|0|||
143225668|NCT05579977|516373218|FG012|Treatment Phase|Death|0|||
143225669|NCT05579977|516373206|FG000|Treatment Phase|Adverse Event|0|||
143268519|NCT02651467|516539013|FG001|Overall Study|Other (Not specified)|0|||
143268520|NCT02651467|516539014|FG002|Overall Study|Other (Not specified)|2|||
143225670|NCT05579977|516373207|FG001|Treatment Phase|Adverse Event|3|||
143225671|NCT05579977|516373208|FG002|Treatment Phase|Adverse Event|11|||
143225672|NCT05579977|516373209|FG003|Treatment Phase|Adverse Event|10|||
143225673|NCT05579977|516373210|FG004|Treatment Phase|Adverse Event|5|||
143268521|NCT00408629|516539015|FG000|Overall Study|Adverse Event|13|||
143268522|NCT00408629|516539016|FG001|Overall Study|Adverse Event|27|||
143268523|NCT00408629|516539015|FG000|Overall Study|Withdrawal by Subject|8|||
143268524|NCT00408629|516539016|FG001|Overall Study|Withdrawal by Subject|4|||
143225674|NCT05579977|516373211|FG005|Treatment Phase|Adverse Event|17|||
143225675|NCT05579977|516373212|FG006|Treatment Phase|Adverse Event|5|||
143225676|NCT05579977|516373213|FG007|Treatment Phase|Adverse Event|5|||
143225677|NCT05579977|516373214|FG008|Treatment Phase|Adverse Event|12|||
143225678|NCT05579977|516373215|FG009|Treatment Phase|Adverse Event|20|||
143225679|NCT05579977|516373216|FG010|Treatment Phase|Adverse Event|15|||
143225680|NCT05579977|516373217|FG011|Treatment Phase|Adverse Event|24|||
143225681|NCT05579977|516373218|FG012|Treatment Phase|Adverse Event|23|||
143225682|NCT05579977|516373206|FG000|Treatment Phase|Randomized not treated|0|||
143225683|NCT05579977|516373207|FG001|Treatment Phase|Randomized not treated|0|||
143225684|NCT05579977|516373208|FG002|Treatment Phase|Randomized not treated|0|||
143225685|NCT05579977|516373209|FG003|Treatment Phase|Randomized not treated|0|||
143225686|NCT05579977|516373210|FG004|Treatment Phase|Randomized not treated|1|||
143225687|NCT05579977|516373211|FG005|Treatment Phase|Randomized not treated|0|||
143225688|NCT05579977|516373212|FG006|Treatment Phase|Randomized not treated|0|||
143225689|NCT05579977|516373213|FG007|Treatment Phase|Randomized not treated|0|||
143225690|NCT05579977|516373214|FG008|Treatment Phase|Randomized not treated|0|||
143225691|NCT05579977|516373215|FG009|Treatment Phase|Randomized not treated|0|||
143225692|NCT05579977|516373216|FG010|Treatment Phase|Randomized not treated|0|||
143225693|NCT05579977|516373217|FG011|Treatment Phase|Randomized not treated|0|||
143225694|NCT05579977|516373218|FG012|Treatment Phase|Randomized not treated|0|||
143225695|NCT05579977|516373206|FG000|Follow up|Death|1|||
143225696|NCT05579977|516373207|FG001|Follow up|Death|0|||
143225697|NCT05579977|516373208|FG002|Follow up|Death|0|||
143225698|NCT05579977|516373209|FG003|Follow up|Death|0|||
143225699|NCT05579977|516373210|FG004|Follow up|Death|0|||
143225700|NCT05579977|516373211|FG005|Follow up|Death|0|||
143225701|NCT05579977|516373212|FG006|Follow up|Death|0|||
143225702|NCT05579977|516373213|FG007|Follow up|Death|0|||
143225703|NCT05579977|516373214|FG008|Follow up|Death|0|||
143225704|NCT05579977|516373215|FG009|Follow up|Death|0|||
143225705|NCT05579977|516373216|FG010|Follow up|Death|0|||
143225706|NCT05579977|516373217|FG011|Follow up|Death|0|||
143225707|NCT05579977|516373218|FG012|Follow up|Death|0|||
143225708|NCT05579977|516373206|FG000|Follow up|Lost to Follow-up|0|||
143225709|NCT05579977|516373207|FG001|Follow up|Lost to Follow-up|0|||
143225710|NCT05579977|516373208|FG002|Follow up|Lost to Follow-up|0|||
143225711|NCT05579977|516373209|FG003|Follow up|Lost to Follow-up|1|||
143225712|NCT05579977|516373210|FG004|Follow up|Lost to Follow-up|1|||
143225713|NCT05579977|516373211|FG005|Follow up|Lost to Follow-up|2|||
143225714|NCT05579977|516373212|FG006|Follow up|Lost to Follow-up|1|||
143225715|NCT05579977|516373213|FG007|Follow up|Lost to Follow-up|1|||
143225716|NCT05579977|516373214|FG008|Follow up|Lost to Follow-up|3|||
143225717|NCT05579977|516373215|FG009|Follow up|Lost to Follow-up|2|||
143225718|NCT05579977|516373216|FG010|Follow up|Lost to Follow-up|2|||
143225719|NCT05579977|516373217|FG011|Follow up|Lost to Follow-up|4|||
143225720|NCT05579977|516373218|FG012|Follow up|Lost to Follow-up|4|||
143225721|NCT05579977|516373206|FG000|Follow up|Withdrawal by Subject|2|||
143225722|NCT05579977|516373207|FG001|Follow up|Withdrawal by Subject|0|||
143225723|NCT05579977|516373208|FG002|Follow up|Withdrawal by Subject|0|||
143225724|NCT05579977|516373209|FG003|Follow up|Withdrawal by Subject|0|||
143268525|NCT00408629|516539015|FG000|Overall Study|Lost to Follow-up|1|||
143268526|NCT00408629|516539016|FG001|Overall Study|Lost to Follow-up|1|||
143268527|NCT00408629|516539015|FG000|Overall Study|Lack of Efficacy|63|||
143268528|NCT00408629|516539016|FG001|Overall Study|Lack of Efficacy|73|||
143268529|NCT00408629|516539015|FG000|Overall Study|Protocol Violation|1|||
143268530|NCT00408629|516539016|FG001|Overall Study|Protocol Violation|5|||
143268531|NCT00408629|516539015|FG000|Overall Study|Miscellaneous|11|||
143268532|NCT00408629|516539016|FG001|Overall Study|Miscellaneous|15|||
143225725|NCT05579977|516373210|FG004|Follow up|Withdrawal by Subject|1|||
143225726|NCT05579977|516373211|FG005|Follow up|Withdrawal by Subject|0|||
143225727|NCT05579977|516373212|FG006|Follow up|Withdrawal by Subject|1|||
143225728|NCT05579977|516373213|FG007|Follow up|Withdrawal by Subject|4|||
143225729|NCT05579977|516373214|FG008|Follow up|Withdrawal by Subject|2|||
143225730|NCT05579977|516373215|FG009|Follow up|Withdrawal by Subject|3|||
143225731|NCT05579977|516373216|FG010|Follow up|Withdrawal by Subject|3|||
143225732|NCT05579977|516373217|FG011|Follow up|Withdrawal by Subject|1|||
143225733|NCT05579977|516373218|FG012|Follow up|Withdrawal by Subject|3|||
143225734|NCT01611194|516373220|FG000|Overall Study|Lost to Follow-up|0|||
143225735|NCT01611194|516373221|FG001|Overall Study|Lost to Follow-up|1|||
143225736|NCT01611194|516373220|FG000|Overall Study|Withdrawal by Subject|0|||
143268533|NCT00333801|516539017|FG000|Overall Study|Moved to another state|5|||
143225737|NCT01611194|516373221|FG001|Overall Study|Withdrawal by Subject|1|||
143225738|NCT01611194|516373220|FG000|Overall Study|drug use|0|||
143225739|NCT01611194|516373221|FG001|Overall Study|drug use|1|||
143268534|NCT00333801|516539018|FG001|Overall Study|Moved to another state|3|||
143268535|NCT00333801|516539017|FG000|Overall Study|Lost to Follow-up|2|||
143225740|NCT00348673|516373222|FG000|Stage 1|Randomized but not Treated|0|||
143268536|NCT00333801|516539018|FG001|Overall Study|Lost to Follow-up|0|||
143225741|NCT00348673|516373223|FG001|Stage 1|Randomized but not Treated|0|||
143225742|NCT00348673|516373224|FG002|Stage 1|Randomized but not Treated|1|||
143225743|NCT00348673|516373225|FG003|Stage 1|Randomized but not Treated|0|||
143225744|NCT00348673|516373226|FG004|Stage 1|Randomized but not Treated|0|||
143225745|NCT00348673|516373227|FG005|Stage 1|Randomized but not Treated|0|||
143225746|NCT00348673|516373228|FG006|Stage 1|Randomized but not Treated|0|||
143225747|NCT00348673|516373229|FG007|Stage 1|Randomized but not Treated|0|||
143225748|NCT00348673|516373230|FG008|Stage 1|Randomized but not Treated|0|||
143225749|NCT01712204|516373235|FG000|Overall Study|Adverse Event|3|||
143225750|NCT01712204|516373236|FG001|Overall Study|Adverse Event|1|||
143225751|NCT01712204|516373235|FG000|Overall Study|Withdrawal by Subject|3|||
143225752|NCT01712204|516373236|FG001|Overall Study|Withdrawal by Subject|3|||
143225753|NCT01712204|516373235|FG000|Overall Study|Lost to Follow-up|1|||
143225754|NCT01712204|516373236|FG001|Overall Study|Lost to Follow-up|0|||
143225755|NCT01712204|516373235|FG000|Overall Study|Protocol Violation|1|||
143225756|NCT01712204|516373236|FG001|Overall Study|Protocol Violation|1|||
143225757|NCT02360228|516373237|FG000|Overall Study|Withdrawal by Subject|1|||
143225758|NCT02360228|516373238|FG001|Overall Study|Withdrawal by Subject|0|||
143225759|NCT02360228|516373239|FG002|Overall Study|Withdrawal by Subject|0|||
143225760|NCT02360228|516373237|FG000|Overall Study|Self-discontinued medication|0|||
143225761|NCT02360228|516373238|FG001|Overall Study|Self-discontinued medication|1|||
143225762|NCT02360228|516373239|FG002|Overall Study|Self-discontinued medication|0|||
143225763|NCT02360228|516373237|FG000|Overall Study|Unstable symptoms during screening|0|||
143225764|NCT02360228|516373238|FG001|Overall Study|Unstable symptoms during screening|0|||
143225765|NCT02360228|516373239|FG002|Overall Study|Unstable symptoms during screening|1|||
143225766|NCT02464410|516373240|FG000|Overall Study|Death|3|||
143225767|NCT02464410|516373241|FG001|Overall Study|Death|4|||
143225768|NCT02464410|516373240|FG000|Overall Study|Lost to Follow-up|7|||
143225769|NCT02464410|516373241|FG001|Overall Study|Lost to Follow-up|9|||
143225770|NCT02464410|516373240|FG000|Overall Study|Withdrawal by Subject|12|||
143225771|NCT02464410|516373241|FG001|Overall Study|Withdrawal by Subject|3|||
143225772|NCT02679287|516373242|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
143225773|NCT02679287|516373243|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
143225774|NCT02679287|516373242|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
143225775|NCT02679287|516373243|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
143225776|NCT02679287|516373242|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
143225777|NCT02679287|516373243|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
143225778|NCT02679287|516373242|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
143225779|NCT02679287|516373243|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
143225780|NCT02679287|516373242|FG000|Period 2|Work/Scheduling Conflict|1|||
143225781|NCT02679287|516373243|FG001|Period 2|Work/Scheduling Conflict|0|||
143225782|NCT02679287|516373242|FG000|Period 2|Disliked Mobile System|2|||
143225783|NCT02679287|516373243|FG001|Period 2|Disliked Mobile System|0|||
143225784|NCT02679287|516373242|FG000|Period 3|Work/Scheduling Conflict|0|||
143225785|NCT02679287|516373243|FG001|Period 3|Work/Scheduling Conflict|1|||
143225786|NCT01114828|516373244|FG000|Overall Study|Adverse Event|1|||
143225787|NCT01114828|516373245|FG001|Overall Study|Adverse Event|1|||
143225788|NCT01114828|516373244|FG000|Overall Study|Lack of Efficacy|0|||
143225789|NCT01114828|516373245|FG001|Overall Study|Lack of Efficacy|2|||
143225790|NCT01114828|516373244|FG000|Overall Study|Protocol Violation|2|||
143225791|NCT01114828|516373245|FG001|Overall Study|Protocol Violation|0|||
143225792|NCT01114828|516373244|FG000|Overall Study|Withdrawal by Subject|0|||
143225793|NCT01114828|516373245|FG001|Overall Study|Withdrawal by Subject|1|||
143225794|NCT02544321|516375922|FG000|Overall Study|Withdrawal by Subject|1|||
143225795|NCT02544321|516375923|FG001|Overall Study|Withdrawal by Subject|2|||
143225796|NCT02544321|516375922|FG000|Overall Study|Adverse Event|1|||
143225797|NCT02544321|516375923|FG001|Overall Study|Adverse Event|1|||
143225798|NCT02544321|516375922|FG000|Overall Study|Protocol Violation|0|||
143225799|NCT02544321|516375923|FG001|Overall Study|Protocol Violation|1|||
143372487|NCT01193153|516909525|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
143372488|NCT01193153|516909524|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
143372489|NCT01193153|516909525|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
143372490|NCT01193153|516909524|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
143372491|NCT01193153|516909525|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
143225800|NCT01307319|516375924|FG000|Overall Study|Adverse Event|2|||
143225801|NCT01307319|516375925|FG001|Overall Study|Adverse Event|2|||
143372492|NCT00139737|516909531|FG000|Overall Study|Withdrawal by Subject|190|||
143225802|NCT01307319|516375926|FG002|Overall Study|Adverse Event|1|||
143225803|NCT01307319|516375924|FG000|Overall Study|Lost to Follow-up|1|||
143225804|NCT01307319|516375925|FG001|Overall Study|Lost to Follow-up|0|||
143225805|NCT01307319|516375926|FG002|Overall Study|Lost to Follow-up|1|||
143225806|NCT01307319|516375924|FG000|Overall Study|Protocol Violation|1|||
143225807|NCT01307319|516375925|FG001|Overall Study|Protocol Violation|1|||
143225808|NCT01307319|516375926|FG002|Overall Study|Protocol Violation|0|||
143225809|NCT01307319|516375924|FG000|Overall Study|Withdrawal by Subject|0|||
143225810|NCT01307319|516375925|FG001|Overall Study|Withdrawal by Subject|1|||
143225811|NCT01307319|516375926|FG002|Overall Study|Withdrawal by Subject|2|||
143225812|NCT01307319|516375924|FG000|Overall Study|Other|0|||
143225813|NCT01307319|516375925|FG001|Overall Study|Other|4|||
143225814|NCT01307319|516375926|FG002|Overall Study|Other|3|||
143225815|NCT02152631|516375927|FG000|Overall Study|Adverse Event|32|||
143225816|NCT02152631|516375928|FG001|Overall Study|Adverse Event|4|||
143225817|NCT02152631|516375927|FG000|Overall Study|Withdrawal by Subject|13|||
143225818|NCT02152631|516375928|FG001|Overall Study|Withdrawal by Subject|16|||
143225819|NCT02152631|516375927|FG000|Overall Study|Noncompliance with study drug|1|||
143225820|NCT02152631|516375928|FG001|Overall Study|Noncompliance with study drug|0|||
143225821|NCT02152631|516375927|FG000|Overall Study|Physician Decision|1|||
143225822|NCT02152631|516375928|FG001|Overall Study|Physician Decision|2|||
143225823|NCT02152631|516375927|FG000|Overall Study|Lost to Follow-up|0|||
143225824|NCT02152631|516375928|FG001|Overall Study|Lost to Follow-up|1|||
143225825|NCT02152631|516375927|FG000|Overall Study|On Treatment|19|||
143225826|NCT02152631|516375928|FG001|Overall Study|On Treatment|3|||
143225827|NCT05473026|516375929|FG000|Overall Study|Lost to Follow-up|5|||
143225828|NCT05473026|516375930|FG001|Overall Study|Lost to Follow-up|2|||
143225829|NCT02038153|516375933|FG000|Overall Study|Withdrawal by Subject|1|||
143225830|NCT02647281|516375934|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
143225831|NCT02647281|516375935|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
143225832|NCT02647281|516375936|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
143225833|NCT02647281|516375937|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
143225834|NCT02647281|516375938|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
143225835|NCT02647281|516375939|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
143225836|NCT02647281|516375940|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
143225837|NCT02647281|516375941|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
143225838|NCT02647281|516375942|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
143225839|NCT01050634|516375943|FG000|Overall Study|Enrolled, but Not Treated|56|||
143225840|NCT01050634|516375943|FG000|Overall Study|Death|2|||
143225841|NCT01050634|516375943|FG000|Overall Study|Adverse Event|42|||
143225842|NCT01050634|516375943|FG000|Overall Study|Lost to Follow-up|2|||
143225843|NCT01050634|516375943|FG000|Overall Study|Other|21|||
143225844|NCT01050634|516375943|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
143225845|NCT00527735|516375944|FG000|Overall Study|Disease progression|47|||
143225846|NCT00527735|516375945|FG001|Overall Study|Disease progression|61|||
143225847|NCT00527735|516375946|FG002|Overall Study|Disease progression|53|||
143225848|NCT00527735|516375944|FG000|Overall Study|Death|23|||
143225849|NCT00527735|516375945|FG001|Overall Study|Death|13|||
143225850|NCT00527735|516375946|FG002|Overall Study|Death|15|||
143225851|NCT00527735|516375944|FG000|Overall Study|Completed treatment in treatment phase|14|||
143225852|NCT00527735|516375945|FG001|Overall Study|Completed treatment in treatment phase|13|||
143225853|NCT00527735|516375946|FG002|Overall Study|Completed treatment in treatment phase|18|||
143225854|NCT00527735|516375944|FG000|Overall Study|Adverse Event|10|||
143225855|NCT00527735|516375945|FG001|Overall Study|Adverse Event|6|||
143225856|NCT00527735|516375946|FG002|Overall Study|Adverse Event|7|||
143225857|NCT00527735|516375944|FG000|Overall Study|Not identified|5|||
143225858|NCT00527735|516375945|FG001|Overall Study|Not identified|5|||
143225859|NCT00527735|516375946|FG002|Overall Study|Not identified|5|||
143225860|NCT00527735|516375944|FG000|Overall Study|Withdrawal by Subject|5|||
143225861|NCT00527735|516375945|FG001|Overall Study|Withdrawal by Subject|4|||
143225862|NCT00527735|516375946|FG002|Overall Study|Withdrawal by Subject|3|||
143225863|NCT00527735|516375944|FG000|Overall Study|No longer met study criteria|2|||
143225864|NCT00527735|516375945|FG001|Overall Study|No longer met study criteria|2|||
143225865|NCT00527735|516375946|FG002|Overall Study|No longer met study criteria|1|||
143225866|NCT00527735|516375944|FG000|Overall Study|Lost to Follow-up|0|||
143225867|NCT00527735|516375945|FG001|Overall Study|Lost to Follow-up|0|||
143225868|NCT00527735|516375946|FG002|Overall Study|Lost to Follow-up|3|||
143225869|NCT00527735|516375944|FG000|Overall Study|Poor compliance or noncompliance|0|||
143225870|NCT00527735|516375945|FG001|Overall Study|Poor compliance or noncompliance|1|||
143225871|NCT00527735|516375946|FG002|Overall Study|Poor compliance or noncompliance|1|||
143225872|NCT00527735|516375944|FG000|Overall Study|Completed treatment during maintenance|2|||
143225873|NCT00527735|516375945|FG001|Overall Study|Completed treatment during maintenance|2|||
143225874|NCT00527735|516375946|FG002|Overall Study|Completed treatment during maintenance|1|||
143225875|NCT03400852|516375952|FG000|Blinded Treatment Period|Physician Decision|0|||
143225876|NCT03400852|516375953|FG001|Blinded Treatment Period|Physician Decision|1|||
143225877|NCT03400852|516375954|FG002|Blinded Treatment Period|Physician Decision|0|||
143225878|NCT03400852|516375952|FG000|Blinded Treatment Period|Adverse Event|1|||
143225879|NCT03400852|516375953|FG001|Blinded Treatment Period|Adverse Event|1|||
143225880|NCT03400852|516375954|FG002|Blinded Treatment Period|Adverse Event|0|||
143225881|NCT03400852|516375952|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
143225882|NCT03400852|516375953|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
143225883|NCT03400852|516375954|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
143225884|NCT03400852|516375952|FG000|Open Label Period|Physician Decision|0|||
143225885|NCT03400852|516375953|FG001|Open Label Period|Physician Decision|0|||
143225886|NCT03400852|516375954|FG002|Open Label Period|Physician Decision|1|||
143225887|NCT03400852|516375952|FG000|Open Label Period|Study terminated by sponsor|0|||
143225888|NCT03400852|516375953|FG001|Open Label Period|Study terminated by sponsor|0|||
143225889|NCT03400852|516375954|FG002|Open Label Period|Study terminated by sponsor|21|||
143225890|NCT02366312|516375957|FG000|Overall Study|Lost to Follow-up|0|||
143225891|NCT02366312|516375958|FG001|Overall Study|Lost to Follow-up|1|||
143225892|NCT03294590|516375960|FG000|Overall Study|Lost to Follow-up|105|||
143225893|NCT03294590|516375961|FG001|Overall Study|Lost to Follow-up|107|||
143225894|NCT00628030|516375964|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
143225895|NCT00628030|516375965|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
143225896|NCT00628030|516375964|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
143225897|NCT00628030|516375965|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
143225898|NCT00628030|516375964|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
143225899|NCT00628030|516375965|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
143225900|NCT01255423|516375966|FG000|Overall Study|Abnormal Laboratory value|3|||
143225901|NCT01255423|516375967|FG001|Overall Study|Abnormal Laboratory value|2|||
143225902|NCT01255423|516375966|FG000|Overall Study|Use of prohibited medications|0|||
143225903|NCT01255423|516375967|FG001|Overall Study|Use of prohibited medications|1|||
143225904|NCT03367858|516375968|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
143225905|NCT03367858|516375969|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
143225906|NCT03367858|516375968|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
143225907|NCT03367858|516375969|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
143225908|NCT03367858|516375968|FG000|3 Month Follow Up|Lost to Follow-up|8|||
143225909|NCT03367858|516375969|FG001|3 Month Follow Up|Lost to Follow-up|3|||
143225910|NCT03367858|516375968|FG000|3 Month Follow Up|Moved out of study area|2|||
143225911|NCT03367858|516375969|FG001|3 Month Follow Up|Moved out of study area|6|||
143225912|NCT03367858|516375968|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
143225913|NCT03367858|516375969|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
143225914|NCT03367858|516375968|FG000|3 Month Follow Up|MRI contraindication|2|||
143225915|NCT03367858|516375969|FG001|3 Month Follow Up|MRI contraindication|1|||
143225916|NCT03367858|516375968|FG000|3 Month Follow Up|Incarcerated|0|||
143225917|NCT03367858|516375969|FG001|3 Month Follow Up|Incarcerated|1|||
143225918|NCT03367858|516375968|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
143225919|NCT03367858|516375969|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
143225920|NCT03367858|516375968|FG000|6 Month Follow Up|Lost to Follow-up|5|||
143225921|NCT03367858|516375969|FG001|6 Month Follow Up|Lost to Follow-up|2|||
143225922|NCT03367858|516375968|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
143225923|NCT03367858|516375969|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
143225924|NCT03367858|516375968|FG000|12 Month Follow Up|Lost to Follow-up|3|||
143225925|NCT03367858|516375969|FG001|12 Month Follow Up|Lost to Follow-up|3|||
143225926|NCT03367858|516375968|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
143225927|NCT03367858|516375969|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
143225928|NCT00256724|516375970|FG000|Overall Study|Physician Decision|2|||
143225929|NCT00256724|516375971|FG001|Overall Study|Physician Decision|5|||
143225930|NCT00256724|516375970|FG000|Overall Study|Protocol Violation|3|||
143225931|NCT00256724|516375971|FG001|Overall Study|Protocol Violation|3|||
143225932|NCT01858363|516375972|FG000|Overall Study|Death|35|||
143225933|NCT01858363|516375973|FG001|Overall Study|Death|9|||
143225934|NCT01858363|516375972|FG000|Overall Study|Withdrawal by Subject|28|||
143225935|NCT01858363|516375973|FG001|Overall Study|Withdrawal by Subject|14|||
143225936|NCT01858363|516375972|FG000|Overall Study|Lost to Follow-up|13|||
143225937|NCT01858363|516375973|FG001|Overall Study|Lost to Follow-up|3|||
143225938|NCT04276233|516375974|FG000|Overall Study|Adverse Event|1|||
143225939|NCT04276233|516375974|FG000|Overall Study|Lost to Follow-up|3|||
143225940|NCT04276233|516375974|FG000|Overall Study|Physician Decision|4|||
143225941|NCT04276233|516375974|FG000|Overall Study|Withdrawal by Subject|2|||
143225942|NCT00296816|516375979|FG000|Overall Study|Disease Progression|37|||
143225943|NCT00296816|516375979|FG000|Overall Study|Adverse Event|18|||
143225944|NCT00296816|516375979|FG000|Overall Study|Investigator/Participant request|5|||
143225945|NCT00296816|516375979|FG000|Overall Study|Non-compliance|1|||
143225946|NCT00296816|516375979|FG000|Overall Study|Missing for end of treatment|4|||
143225947|NCT00296816|516375979|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
143225948|NCT00296816|516375979|FG000|Overall Study|Poor performance status|1|||
143225949|NCT00296816|516375979|FG000|Overall Study|Relocation to Florida|1|||
143225950|NCT00296816|516375979|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
143225951|NCT00296816|516375979|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
143225952|NCT00296816|516375979|FG000|Overall Study|Neuropathy/patient preference|1|||
143225953|NCT00296816|516375979|FG000|Overall Study|Proteinuria|1|||
143225954|NCT00296816|516375979|FG000|Overall Study|ineligibility due to radiation treatment|1|||
143225955|NCT00985465|516375980|FG000|Overall Study|Withdrawal by Subject|1|||
143225956|NCT00985465|516375981|FG001|Overall Study|Withdrawal by Subject|2|||
143225957|NCT00985465|516375980|FG000|Overall Study|Considered to be part of the other group|0|||
143225958|NCT00985465|516375981|FG001|Overall Study|Considered to be part of the other group|1|||
143225959|NCT00687401|516375983|FG000|Overall Study|Protocol Violation|7|||
143225960|NCT00687401|516375983|FG000|Overall Study|Adverse Event|6|||
143225961|NCT00687401|516375983|FG000|Overall Study|Lack of Efficacy|6|||
143225962|NCT00687401|516375983|FG000|Overall Study|Withdrawal by Subject|4|||
143225963|NCT00687401|516375983|FG000|Overall Study|Did not return for visit|3|||
143225964|NCT00687401|516375983|FG000|Overall Study|For reasons different from those above|4|||
143225965|NCT03827655|516375984|FG000|Overall Study|Death|0|||
143225966|NCT03827655|516375985|FG001|Overall Study|Death|0|||
143225967|NCT03827655|516375986|FG002|Overall Study|Death|0|||
143225968|NCT03827655|516375987|FG003|Overall Study|Death|0|||
143225969|NCT03827655|516375988|FG004|Overall Study|Death|1|||
143225970|NCT03827655|516375984|FG000|Overall Study|Protocol Deviation|1|||
143225971|NCT03827655|516375985|FG001|Overall Study|Protocol Deviation|0|||
143225972|NCT03827655|516375986|FG002|Overall Study|Protocol Deviation|1|||
143225973|NCT03827655|516375987|FG003|Overall Study|Protocol Deviation|1|||
143225974|NCT03827655|516375988|FG004|Overall Study|Protocol Deviation|0|||
143225975|NCT03827655|516375984|FG000|Overall Study|Withdrawal by Subject|3|||
143225976|NCT03827655|516375985|FG001|Overall Study|Withdrawal by Subject|2|||
143225977|NCT03827655|516375986|FG002|Overall Study|Withdrawal by Subject|2|||
143225978|NCT03827655|516375987|FG003|Overall Study|Withdrawal by Subject|0|||
143225979|NCT03827655|516375988|FG004|Overall Study|Withdrawal by Subject|1|||
143225980|NCT03827655|516375984|FG000|Overall Study|Reason not Specified|3|||
143225981|NCT03827655|516375985|FG001|Overall Study|Reason not Specified|1|||
143225982|NCT03827655|516375986|FG002|Overall Study|Reason not Specified|1|||
143225983|NCT03827655|516375987|FG003|Overall Study|Reason not Specified|1|||
143225984|NCT03827655|516375988|FG004|Overall Study|Reason not Specified|1|||
143225985|NCT01092728|516375989|FG000|Overall Study|Withdrawal by Subject|2|||
143225986|NCT01092728|516375990|FG001|Overall Study|Withdrawal by Subject|0|||
143225987|NCT01092728|516375989|FG000|Overall Study|Adverse Event|0|||
143225988|NCT01092728|516375990|FG001|Overall Study|Adverse Event|1|||
143225989|NCT01092728|516375989|FG000|Overall Study|Disease Progression|1|||
143225990|NCT01092728|516375990|FG001|Overall Study|Disease Progression|13|||
143225991|NCT01092728|516375989|FG000|Overall Study|Prohibited Concomitant Medications|1|||
143225992|NCT01092728|516375990|FG001|Overall Study|Prohibited Concomitant Medications|0|||
143225993|NCT02520726|516375991|FG000|Overall Study|Lost to Follow-up|3|||
143225994|NCT02520726|516375992|FG001|Overall Study|Lost to Follow-up|2|||
143225995|NCT03649217|516375993|FG000|Overall Study|subject had severe ataxia not initially found|1|||
143225996|NCT03649217|516375993|FG000|Overall Study|subject had cognitive issues not initially found|1|||
143225997|NCT02336607|516375994|FG000|Overall Study|Physician Decision|1|||
143225998|NCT02336607|516375995|FG001|Overall Study|Physician Decision|4|||
143225999|NCT02336607|516375996|FG002|Overall Study|Physician Decision|3|||
143226000|NCT02336607|516375997|FG003|Overall Study|Physician Decision|15|||
143226001|NCT02336607|516375994|FG000|Overall Study|Lack of Efficacy|1|||
143226002|NCT02336607|516375995|FG001|Overall Study|Lack of Efficacy|0|||
143226003|NCT02336607|516375996|FG002|Overall Study|Lack of Efficacy|0|||
143226004|NCT02336607|516375997|FG003|Overall Study|Lack of Efficacy|2|||
143226005|NCT02336607|516375994|FG000|Overall Study|Lost to Follow-up|2|||
143226006|NCT02336607|516375995|FG001|Overall Study|Lost to Follow-up|1|||
143226007|NCT02336607|516375996|FG002|Overall Study|Lost to Follow-up|0|||
143226008|NCT02336607|516375997|FG003|Overall Study|Lost to Follow-up|21|||
143226009|NCT02336607|516375994|FG000|Overall Study|Protocol Violation|0|||
143226010|NCT02336607|516375995|FG001|Overall Study|Protocol Violation|1|||
143226011|NCT02336607|516375996|FG002|Overall Study|Protocol Violation|1|||
143226012|NCT02336607|516375997|FG003|Overall Study|Protocol Violation|3|||
143226013|NCT02336607|516375994|FG000|Overall Study|Adverse Event|0|||
143226014|NCT02336607|516375995|FG001|Overall Study|Adverse Event|2|||
143226015|NCT02336607|516375996|FG002|Overall Study|Adverse Event|2|||
143226016|NCT02336607|516375997|FG003|Overall Study|Adverse Event|26|||
143226017|NCT02336607|516375994|FG000|Overall Study|Withdrawal by Subject|0|||
143226018|NCT02336607|516375995|FG001|Overall Study|Withdrawal by Subject|2|||
143226019|NCT02336607|516375996|FG002|Overall Study|Withdrawal by Subject|0|||
143226020|NCT02336607|516375997|FG003|Overall Study|Withdrawal by Subject|20|||
143226021|NCT00721396|516376001|FG000|Overall Study|Adverse Event|4|||
143226022|NCT00721396|516376002|FG001|Overall Study|Adverse Event|7|||
143226023|NCT00721396|516376003|FG002|Overall Study|Adverse Event|2|||
143226024|NCT00721396|516376004|FG003|Overall Study|Adverse Event|0|||
143226025|NCT00721396|516376001|FG000|Overall Study|Withdrawal by Subject|12|||
143226026|NCT00721396|516376002|FG001|Overall Study|Withdrawal by Subject|15|||
143226027|NCT00721396|516376003|FG002|Overall Study|Withdrawal by Subject|3|||
143226028|NCT00721396|516376004|FG003|Overall Study|Withdrawal by Subject|7|||
143226029|NCT00721396|516376001|FG000|Overall Study|Lost to Follow-up|7|||
143226030|NCT00721396|516376002|FG001|Overall Study|Lost to Follow-up|9|||
143226031|NCT00721396|516376003|FG002|Overall Study|Lost to Follow-up|3|||
143226032|NCT00721396|516376004|FG003|Overall Study|Lost to Follow-up|3|||
143226033|NCT00721396|516376001|FG000|Overall Study|Protocol Violation|4|||
143226034|NCT00721396|516376002|FG001|Overall Study|Protocol Violation|3|||
143226035|NCT00721396|516376003|FG002|Overall Study|Protocol Violation|1|||
143226036|NCT00721396|516376004|FG003|Overall Study|Protocol Violation|0|||
143226037|NCT00721396|516376001|FG000|Overall Study|Inappropriate enrollment|0|||
143226038|NCT00721396|516376002|FG001|Overall Study|Inappropriate enrollment|2|||
143226039|NCT00721396|516376003|FG002|Overall Study|Inappropriate enrollment|0|||
143226040|NCT00721396|516376004|FG003|Overall Study|Inappropriate enrollment|0|||
143226041|NCT00721396|516376001|FG000|Overall Study|Administrative reason|3|||
143226042|NCT00721396|516376002|FG001|Overall Study|Administrative reason|0|||
143226043|NCT00721396|516376003|FG002|Overall Study|Administrative reason|1|||
143226044|NCT00721396|516376004|FG003|Overall Study|Administrative reason|0|||
143226045|NCT01216202|516376005|FG000|Overall Study|Withdrawal by Subject|8|||
143226046|NCT01216202|516376006|FG001|Overall Study|Withdrawal by Subject|0|||
143226047|NCT01216202|516376005|FG000|Overall Study|Death|0|||
143226048|NCT01216202|516376006|FG001|Overall Study|Death|2|||
143226049|NCT01216202|516376005|FG000|Overall Study|Lost to Follow-up|14|||
143226050|NCT01216202|516376006|FG001|Overall Study|Lost to Follow-up|0|||
143226051|NCT02365649|516376013|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
143226052|NCT02365649|516376014|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
143226053|NCT02365649|516376015|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
143226054|NCT02365649|516376016|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
143226055|NCT02365649|516376017|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
143226056|NCT02365649|516376018|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
143226057|NCT02365649|516376019|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
143226058|NCT02365649|516376020|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
143226059|NCT02365649|516376021|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
143226060|NCT02365649|516376022|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
143226061|NCT02365649|516376013|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
143226062|NCT02365649|516376014|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
143226063|NCT02365649|516376015|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
143226064|NCT02365649|516376016|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
143226065|NCT02365649|516376017|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
143226066|NCT02365649|516376018|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
143226067|NCT02365649|516376019|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
143226068|NCT02365649|516376020|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
143226069|NCT02365649|516376021|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
143226070|NCT02365649|516376022|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
143226071|NCT02365649|516376013|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
143226072|NCT02365649|516376014|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
143226073|NCT02365649|516376015|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
143226074|NCT02365649|516376016|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
143226075|NCT02365649|516376017|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
143226076|NCT02365649|516376018|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
143226077|NCT02365649|516376019|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
143226078|NCT02365649|516376020|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
143226079|NCT02365649|516376021|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
143268537|NCT00333801|516539017|FG000|Overall Study|Incarcerated|1|||
143268538|NCT00333801|516539018|FG001|Overall Study|Incarcerated|2|||
143268539|NCT00333801|516539017|FG000|Overall Study|Withdrawal by Subject|0|||
143268540|NCT00333801|516539018|FG001|Overall Study|Withdrawal by Subject|1|||
143268541|NCT03633617|516539019|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
143268542|NCT03633617|516539020|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
143268543|NCT03633617|516539021|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
143268544|NCT03633617|516539022|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
143226080|NCT02365649|516376022|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
143226081|NCT02365649|516376013|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
143226082|NCT02365649|516376014|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
143226083|NCT02365649|516376015|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
143226084|NCT02365649|516376016|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
143226085|NCT02365649|516376017|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
143226086|NCT02365649|516376018|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
143226087|NCT02365649|516376019|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
143226088|NCT02365649|516376020|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
143226089|NCT02365649|516376021|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
143226090|NCT02365649|516376022|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
143226091|NCT02365649|516376013|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
143226092|NCT02365649|516376014|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
143226093|NCT02365649|516376015|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
143226094|NCT02365649|516376016|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
143226095|NCT02365649|516376017|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
143226096|NCT02365649|516376018|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
143226097|NCT02365649|516376019|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
143226098|NCT02365649|516376020|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
143226099|NCT02365649|516376021|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
143226100|NCT02365649|516376022|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
143226101|NCT02365649|516376013|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
143226102|NCT02365649|516376014|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
143226103|NCT02365649|516376015|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
143226104|NCT02365649|516376016|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
143226105|NCT02365649|516376017|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
143226106|NCT02365649|516376018|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
143226107|NCT02365649|516376019|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
143226108|NCT02365649|516376020|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
143226109|NCT02365649|516376021|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
143226110|NCT02365649|516376022|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
143226111|NCT02365649|516376013|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
143226112|NCT02365649|516376014|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
143226113|NCT02365649|516376015|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
143226114|NCT02365649|516376016|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
143226115|NCT02365649|516376017|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
143226116|NCT02365649|516376018|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
143226117|NCT02365649|516376019|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
143226118|NCT02365649|516376020|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
143226119|NCT02365649|516376021|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
143226120|NCT02365649|516376022|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
143226121|NCT02365649|516376013|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
143226122|NCT02365649|516376014|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
143226123|NCT02365649|516376015|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
143226124|NCT02365649|516376016|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
143226125|NCT02365649|516376017|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
143226126|NCT02365649|516376018|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
143226127|NCT02365649|516376019|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
143226128|NCT02365649|516376020|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
143226129|NCT02365649|516376021|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
143226130|NCT02365649|516376022|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
143226131|NCT02365649|516376013|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
143226132|NCT02365649|516376014|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
143226133|NCT02365649|516376015|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
143226134|NCT02365649|516376016|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
143226135|NCT02365649|516376017|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
143226136|NCT02365649|516376018|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
143226137|NCT02365649|516376019|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
143226138|NCT02365649|516376020|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
143226139|NCT02365649|516376021|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
143226140|NCT02365649|516376022|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
143226141|NCT02365649|516376013|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
143226142|NCT02365649|516376014|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
143226143|NCT02365649|516376015|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
143226144|NCT02365649|516376016|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
143372493|NCT00139737|516909531|FG000|Overall Study|Adverse Event|58|||
143226145|NCT02365649|516376017|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
143226146|NCT02365649|516376018|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
143226147|NCT02365649|516376019|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
143226148|NCT02365649|516376020|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
143226149|NCT02365649|516376021|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
143226150|NCT02365649|516376022|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
143226151|NCT02365649|516376013|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
143226152|NCT02365649|516376014|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
143226153|NCT02365649|516376015|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
143226154|NCT02365649|516376016|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
143226155|NCT02365649|516376017|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
143226156|NCT02365649|516376018|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
143226157|NCT02365649|516376019|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
143226158|NCT02365649|516376020|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
143226159|NCT02365649|516376021|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
143226160|NCT02365649|516376022|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
143226161|NCT02365649|516376013|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
143226162|NCT02365649|516376014|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
143226163|NCT02365649|516376015|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
143226164|NCT02365649|516376016|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
143226165|NCT02365649|516376017|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
143226166|NCT02365649|516376018|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
143226167|NCT02365649|516376019|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
143226168|NCT02365649|516376020|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
143226169|NCT02365649|516376021|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
143226170|NCT02365649|516376022|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
143226171|NCT01506271|516376023|FG000|Overall Study|Progressive disease|0|||
143226172|NCT01506271|516376024|FG001|Overall Study|Progressive disease|1|||
143226173|NCT01506271|516376025|FG002|Overall Study|Progressive disease|0|||
143226174|NCT01506271|516376023|FG000|Overall Study|Protocol Violation|3|||
143226175|NCT01506271|516376024|FG001|Overall Study|Protocol Violation|1|||
143226176|NCT01506271|516376025|FG002|Overall Study|Protocol Violation|0|||
143226177|NCT01506271|516376023|FG000|Overall Study|Death|0|||
143226178|NCT01506271|516376024|FG001|Overall Study|Death|1|||
143226179|NCT01506271|516376025|FG002|Overall Study|Death|0|||
143226180|NCT01506271|516376023|FG000|Overall Study|Adverse Event|0|||
143226181|NCT01506271|516376024|FG001|Overall Study|Adverse Event|2|||
143226182|NCT01506271|516376025|FG002|Overall Study|Adverse Event|0|||
143226183|NCT01506271|516376023|FG000|Overall Study|Insufficient supply of study drug|1|||
143226184|NCT01506271|516376024|FG001|Overall Study|Insufficient supply of study drug|0|||
143226185|NCT01506271|516376025|FG002|Overall Study|Insufficient supply of study drug|0|||
143226186|NCT01506271|516376023|FG000|Overall Study|Withdrawal by Subject|0|||
143226187|NCT01506271|516376024|FG001|Overall Study|Withdrawal by Subject|1|||
143226188|NCT01506271|516376025|FG002|Overall Study|Withdrawal by Subject|1|||
143226189|NCT01506271|516376023|FG000|Overall Study|Lost to Follow-up|0|||
143226190|NCT01506271|516376024|FG001|Overall Study|Lost to Follow-up|1|||
143226191|NCT01506271|516376025|FG002|Overall Study|Lost to Follow-up|2|||
143226192|NCT02021565|516376039|FG000|Baseline Through Intervention|Death|0|||
143226193|NCT02021565|516376040|FG001|Baseline Through Intervention|Death|1|||
143226194|NCT02021565|516376039|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
143226195|NCT02021565|516376040|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
143226196|NCT02021565|516376039|FG000|Baseline Through Intervention|Protocol Violation|0|||
143226197|NCT02021565|516376040|FG001|Baseline Through Intervention|Protocol Violation|7|||
143226198|NCT02021565|516376039|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
143226199|NCT02021565|516376040|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
143226200|NCT02021565|516376039|FG000|3-month Follow-up|Death|3|||
143226201|NCT02021565|516376040|FG001|3-month Follow-up|Death|0|||
143226202|NCT02021565|516376039|FG000|3-month Follow-up|Withdrawal by Subject|4|||
143226203|NCT02021565|516376040|FG001|3-month Follow-up|Withdrawal by Subject|0|||
143226204|NCT02021565|516376039|FG000|3-month Follow-up|Protocol Violation|3|||
143226205|NCT02021565|516376040|FG001|3-month Follow-up|Protocol Violation|2|||
143226206|NCT03259555|516376049|FG000|Overall Study|Adverse Event|6|||
143226207|NCT03259555|516376050|FG001|Overall Study|Adverse Event|4|||
143226208|NCT03259555|516376049|FG000|Overall Study|Lack of Efficacy|6|||
143226209|NCT03259555|516376050|FG001|Overall Study|Lack of Efficacy|4|||
143226210|NCT03259555|516376049|FG000|Overall Study|Lost to Follow-up|0|||
143226211|NCT03259555|516376050|FG001|Overall Study|Lost to Follow-up|2|||
143226212|NCT03259555|516376049|FG000|Overall Study|Non-Compliance With Study Drug|1|||
143226213|NCT03259555|516376050|FG001|Overall Study|Non-Compliance With Study Drug|0|||
143226214|NCT03259555|516376049|FG000|Overall Study|Progressive Disease|0|||
143226215|NCT03259555|516376050|FG001|Overall Study|Progressive Disease|2|||
143226216|NCT03259555|516376049|FG000|Overall Study|Withdrawal by Subject|19|||
143226217|NCT03259555|516376050|FG001|Overall Study|Withdrawal by Subject|16|||
143226218|NCT03259555|516376049|FG000|Overall Study|Physician Decision|1|||
143226219|NCT03259555|516376050|FG001|Overall Study|Physician Decision|2|||
143226220|NCT03259555|516376049|FG000|Overall Study|Other|1|||
143226221|NCT03259555|516376050|FG001|Overall Study|Other|0|||
143226222|NCT00154297|516376052|FG000|Overall Study|Death|5|||
143226223|NCT00154297|516376053|FG001|Overall Study|Death|2|||
143226224|NCT00154297|516376052|FG000|Overall Study|Withdrawal by Subject|0|||
143226225|NCT00154297|516376053|FG001|Overall Study|Withdrawal by Subject|5|||
143226226|NCT00154297|516376052|FG000|Overall Study|Lost to Follow-up|3|||
143226227|NCT00154297|516376053|FG001|Overall Study|Lost to Follow-up|0|||
143226228|NCT00650767|516376054|FG000|Overall Study|Adverse Event|0|||
143226229|NCT00650767|516376055|FG001|Overall Study|Adverse Event|3|||
143226230|NCT00650767|516376056|FG002|Overall Study|Adverse Event|10|||
143226231|NCT00650767|516376057|FG003|Overall Study|Adverse Event|8|||
143226232|NCT00650767|516376054|FG000|Overall Study|Death|1|||
143226233|NCT00650767|516376055|FG001|Overall Study|Death|0|||
143226234|NCT00650767|516376056|FG002|Overall Study|Death|0|||
143226235|NCT00650767|516376057|FG003|Overall Study|Death|0|||
143226236|NCT00650767|516376054|FG000|Overall Study|Withdrawal by Subject|2|||
143226237|NCT00650767|516376055|FG001|Overall Study|Withdrawal by Subject|4|||
143226238|NCT00650767|516376056|FG002|Overall Study|Withdrawal by Subject|3|||
143226239|NCT00650767|516376057|FG003|Overall Study|Withdrawal by Subject|3|||
143226240|NCT00650767|516376054|FG000|Overall Study|Lost to Follow-up|1|||
143226241|NCT00650767|516376055|FG001|Overall Study|Lost to Follow-up|1|||
143226242|NCT00650767|516376056|FG002|Overall Study|Lost to Follow-up|1|||
143226243|NCT00650767|516376057|FG003|Overall Study|Lost to Follow-up|0|||
143226244|NCT00650767|516376054|FG000|Overall Study|Other|1|||
143226245|NCT00650767|516376055|FG001|Overall Study|Other|1|||
143226246|NCT00650767|516376056|FG002|Overall Study|Other|0|||
143226247|NCT00650767|516376057|FG003|Overall Study|Other|0|||
143226248|NCT01808196|516376067|FG000|Overall Study|Lost to Follow-up|1|||
143226249|NCT00141102|516376070|FG000|Overall Study|Adverse Event|233|||
143226250|NCT00141102|516376071|FG001|Overall Study|Adverse Event|305|||
143226251|NCT00141102|516376070|FG000|Overall Study|Laboratory Abnormality|9|||
143226252|NCT00141102|516376071|FG001|Overall Study|Laboratory Abnormality|33|||
143226253|NCT00141102|516376070|FG000|Overall Study|Lack of Efficacy|21|||
143226254|NCT00141102|516376071|FG001|Overall Study|Lack of Efficacy|26|||
143226255|NCT00141102|516376070|FG000|Overall Study|Lost to Follow-up|29|||
143226256|NCT00141102|516376071|FG001|Overall Study|Lost to Follow-up|32|||
143226257|NCT00141102|516376070|FG000|Overall Study|Other|87|||
143226258|NCT00141102|516376071|FG001|Overall Study|Other|76|||
143226259|NCT00141102|516376070|FG000|Overall Study|Withdrawal by Subject|112|||
143226260|NCT00141102|516376071|FG001|Overall Study|Withdrawal by Subject|142|||
143226261|NCT00141102|516376070|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
143226262|NCT00141102|516376071|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
143226263|NCT00141102|516376070|FG000|Overall Study|Death|2|||
143226264|NCT00141102|516376071|FG001|Overall Study|Death|2|||
143226265|NCT06172348|516376074|FG000|Treatment Period 2|Adverse Event|0|||
143226266|NCT06172348|516376075|FG001|Treatment Period 2|Adverse Event|0|||
143226267|NCT06172348|516376076|FG002|Treatment Period 2|Adverse Event|1|||
143226268|NCT06172348|516376077|FG003|Treatment Period 2|Adverse Event|0|||
143226269|NCT06172348|516376078|FG004|Treatment Period 2|Adverse Event|0|||
143226270|NCT06172348|516376079|FG005|Treatment Period 2|Adverse Event|0|||
143226271|NCT05274958|516376080|FG000|Overall Study|Only completed 1 set of PROMs|22|||
143226272|NCT05274958|516376081|FG001|Overall Study|Only completed 1 set of PROMs|35|||
143226273|NCT04491136|516376082|FG000|Overall Study|Patient withdraw informed consent|9|||
143268545|NCT03633617|516539023|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
143226274|NCT04491136|516376082|FG000|Overall Study|Adverse Event|2|||
143226275|NCT04491136|516376082|FG000|Overall Study|Death|3|||
143226276|NCT04491136|516376082|FG000|Overall Study|Lost to Follow-up|3|||
143226277|NCT04491136|516376082|FG000|Overall Study|Physician Decision|45|||
143226278|NCT04491136|516376082|FG000|Overall Study|sponsor terminated the study early|16|||
143226279|NCT04491136|516376082|FG000|Overall Study|Patient/guardian's decision|1|||
143226280|NCT01505374|516376100|FG000|Overall Study|Lost to Follow-up|1|||
143226281|NCT01505374|516376101|FG001|Overall Study|Lost to Follow-up|0|||
143226282|NCT01232868|516377712|FG000|Overall Study|Lost to Follow-up|2|||
143226283|NCT01232868|516377713|FG001|Overall Study|Lost to Follow-up|4|||
143226284|NCT04481243|516377714|FG000|Overall Study|Withdrawal by Subject|4|||
143226285|NCT02831764|516377715|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
143226286|NCT02831764|516377716|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
143226287|NCT02831764|516377717|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
143226288|NCT02831764|516377718|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
143226289|NCT02831764|516377719|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
143226290|NCT02831764|516377715|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
143268546|NCT03633617|516539024|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
143268547|NCT03633617|516539025|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
143268548|NCT03633617|516539026|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
143268549|NCT03633617|516539027|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
143268550|NCT03633617|516539028|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
143268551|NCT03633617|516539029|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
143226291|NCT02831764|516377716|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
143226292|NCT02831764|516377717|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
143226293|NCT02831764|516377718|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
143226294|NCT02831764|516377719|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
143226295|NCT02831764|516377715|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
143226296|NCT02831764|516377716|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
143226297|NCT02831764|516377717|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
143226298|NCT02831764|516377718|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
143226299|NCT02831764|516377719|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
143226300|NCT02831764|516377715|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
143226301|NCT02831764|516377716|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
143226302|NCT02831764|516377717|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
143226303|NCT02831764|516377718|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
143226304|NCT02831764|516377719|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
143226305|NCT02831764|516377715|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
143226306|NCT02831764|516377716|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
143226307|NCT02831764|516377717|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
143226308|NCT02831764|516377718|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
143226309|NCT02831764|516377719|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
143226310|NCT02831764|516377715|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
143226311|NCT02831764|516377716|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
143226312|NCT02831764|516377717|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
143226313|NCT02831764|516377718|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
143226314|NCT02831764|516377719|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
143226315|NCT02831764|516377715|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
143226316|NCT02831764|516377716|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
143226317|NCT02831764|516377717|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
143226318|NCT02831764|516377718|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
143226319|NCT02831764|516377719|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
143226320|NCT02831764|516377715|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
143226321|NCT02831764|516377716|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
143226322|NCT02831764|516377717|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
143226323|NCT02831764|516377718|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
143226324|NCT02831764|516377719|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
143226325|NCT02831764|516377715|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
143226326|NCT02831764|516377716|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
143268552|NCT03633617|516539019|FG000|Part A|Unconfirmed early termination visit|1|||
143268553|NCT03633617|516539020|FG001|Part A|Unconfirmed early termination visit|0|||
143268554|NCT03633617|516539021|FG002|Part A|Unconfirmed early termination visit|0|||
143268555|NCT03633617|516539022|FG003|Part A|Unconfirmed early termination visit|0|||
143268556|NCT03633617|516539023|FG004|Part A|Unconfirmed early termination visit|0|||
143268557|NCT03633617|516539024|FG005|Part A|Unconfirmed early termination visit|0|||
143268558|NCT03633617|516539025|FG006|Part A|Unconfirmed early termination visit|0|||
143268559|NCT03633617|516539026|FG007|Part A|Unconfirmed early termination visit|0|||
143268560|NCT03633617|516539027|FG008|Part A|Unconfirmed early termination visit|0|||
143268561|NCT03633617|516539028|FG009|Part A|Unconfirmed early termination visit|0|||
143268562|NCT03633617|516539029|FG010|Part A|Unconfirmed early termination visit|0|||
143268563|NCT03633617|516539019|FG000|Part A|Adverse Event|0|||
143268564|NCT03633617|516539020|FG001|Part A|Adverse Event|1|||
143268565|NCT03633617|516539021|FG002|Part A|Adverse Event|0|||
143268566|NCT03633617|516539022|FG003|Part A|Adverse Event|0|||
143268567|NCT03633617|516539023|FG004|Part A|Adverse Event|0|||
143268568|NCT03633617|516539024|FG005|Part A|Adverse Event|0|||
143268569|NCT03633617|516539025|FG006|Part A|Adverse Event|0|||
143268570|NCT03633617|516539026|FG007|Part A|Adverse Event|0|||
143372494|NCT00139737|516909531|FG000|Overall Study|Lack of Efficacy|40|||
143372495|NCT00139737|516909531|FG000|Overall Study|Lost to Follow-up|8|||
143268571|NCT03633617|516539027|FG008|Part A|Adverse Event|0|||
143268572|NCT03633617|516539028|FG009|Part A|Adverse Event|0|||
143268573|NCT03633617|516539029|FG010|Part A|Adverse Event|0|||
143372496|NCT00139737|516909531|FG000|Overall Study|Death|3|||
143226327|NCT02831764|516377717|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
143226328|NCT02831764|516377718|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
143226329|NCT02831764|516377719|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
143226330|NCT02831764|516377715|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
143226331|NCT02831764|516377716|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
143226332|NCT02831764|516377717|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
143226333|NCT02831764|516377718|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
143226334|NCT02831764|516377719|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
143226335|NCT02831764|516377715|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
143226336|NCT02831764|516377716|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
143226337|NCT02831764|516377717|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
143226338|NCT02831764|516377718|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
143226339|NCT02831764|516377719|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
143226340|NCT02831764|516377715|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
143226341|NCT02831764|516377716|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
143226342|NCT02831764|516377717|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
143226343|NCT02831764|516377718|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
143226344|NCT02831764|516377719|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
143226345|NCT02831764|516377715|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
143226346|NCT02831764|516377716|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
143226347|NCT02831764|516377717|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
143226348|NCT02831764|516377718|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
143226349|NCT02831764|516377719|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
143226350|NCT02831764|516377715|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
143226351|NCT02831764|516377716|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
143226352|NCT02831764|516377717|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
143226353|NCT02831764|516377718|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
143226354|NCT02831764|516377719|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
143226355|NCT02831764|516377715|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
143226356|NCT02831764|516377716|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
143226357|NCT02831764|516377717|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
143226358|NCT02831764|516377718|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
143226359|NCT02831764|516377719|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
143226360|NCT02831764|516377715|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
143226361|NCT02831764|516377716|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
143226362|NCT02831764|516377717|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
143226363|NCT02831764|516377718|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
143226364|NCT02831764|516377719|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
143226365|NCT02831764|516377715|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
143226366|NCT02831764|516377716|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
143226367|NCT02831764|516377717|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
143226368|NCT02831764|516377718|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
143226369|NCT02831764|516377719|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
143226370|NCT02831764|516377715|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
143226371|NCT02831764|516377716|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
143226372|NCT02831764|516377717|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
143226373|NCT02831764|516377718|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
143226374|NCT02831764|516377719|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
143226375|NCT02831764|516377715|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
143226376|NCT02831764|516377716|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
143226377|NCT02831764|516377717|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
143226378|NCT02831764|516377718|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
143226379|NCT02831764|516377719|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
143226380|NCT04564846|516377720|FG000|Overall Study|Withdrawal by Subject|2|||
143226381|NCT04564846|516377721|FG001|Overall Study|Withdrawal by Subject|1|||
143226382|NCT04564846|516377720|FG000|Overall Study|Physician Decision|0|||
143226383|NCT04564846|516377721|FG001|Overall Study|Physician Decision|1|||
143226384|NCT04564846|516377720|FG000|Overall Study|Lost to Follow-up|0|||
143226385|NCT04564846|516377721|FG001|Overall Study|Lost to Follow-up|1|||
143226386|NCT04564846|516377720|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
143226387|NCT04564846|516377721|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
143226388|NCT04564846|516377720|FG000|Overall Study|Subject non-compliance|1|||
143226389|NCT04564846|516377721|FG001|Overall Study|Subject non-compliance|0|||
143268574|NCT03633617|516539019|FG000|Part A|Pregnancy|1|||
143268575|NCT03633617|516539020|FG001|Part A|Pregnancy|0|||
143268576|NCT03633617|516539021|FG002|Part A|Pregnancy|0|||
143268577|NCT03633617|516539022|FG003|Part A|Pregnancy|0|||
143268578|NCT03633617|516539023|FG004|Part A|Pregnancy|0|||
143268579|NCT03633617|516539024|FG005|Part A|Pregnancy|0|||
143268580|NCT03633617|516539025|FG006|Part A|Pregnancy|0|||
143268581|NCT03633617|516539026|FG007|Part A|Pregnancy|0|||
143372497|NCT00139737|516909531|FG000|Overall Study|Laboratory Abnormality|2|||
143372498|NCT00139737|516909531|FG000|Overall Study|Protocol Violation|18|||
143372499|NCT00139737|516909531|FG000|Overall Study|Withdrew During Screening Phase|8|||
143372500|NCT00139737|516909531|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
143372501|NCT00139737|516909531|FG000|Overall Study|Screened, Not Treated|13|||
143372502|NCT01988233|516909533|FG000|Overall Study|Lost to Follow-up|64|||
143372503|NCT01988233|516909534|FG001|Overall Study|Lost to Follow-up|51|||
143372504|NCT03621761|516909539|FG000|Overall Study|Lost to Follow-up|1|||
143372505|NCT03621761|516909540|FG001|Overall Study|Lost to Follow-up|1|||
143372506|NCT03621761|516909541|FG002|Overall Study|Lost to Follow-up|2|||
143372507|NCT03621761|516909539|FG000|Overall Study|Withdrawal by Subject|2|||
143372508|NCT03621761|516909540|FG001|Overall Study|Withdrawal by Subject|1|||
143372509|NCT03621761|516909541|FG002|Overall Study|Withdrawal by Subject|1|||
143372510|NCT03621761|516909539|FG000|Overall Study|Became Ineligible|0|||
143372511|NCT03621761|516909540|FG001|Overall Study|Became Ineligible|2|||
143372512|NCT03621761|516909541|FG002|Overall Study|Became Ineligible|0|||
143372513|NCT03781336|516909542|FG000|Overall Study|Withdrawal by Subject|2|||
143372514|NCT03781336|516909543|FG001|Overall Study|Withdrawal by Subject|2|||
143372515|NCT01183780|516909544|FG000|Overall Study|Withdrawal by Subject|25|||
143372516|NCT01183780|516909545|FG001|Overall Study|Withdrawal by Subject|14|||
143372517|NCT01183780|516909544|FG000|Overall Study|Lost to Follow-up|6|||
143372518|NCT01183780|516909545|FG001|Overall Study|Lost to Follow-up|11|||
143372519|NCT03743246|516909546|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
143372520|NCT03743246|516909547|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
143372521|NCT03743246|516909548|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
143372522|NCT03743246|516909549|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
143372523|NCT03743246|516909546|FG000|Pre-Treatment Period|Death|0|||
143372524|NCT03743246|516909547|FG001|Pre-Treatment Period|Death|1|||
143226390|NCT00865345|516377722|FG000|Overall Study|Withdrawal by Subject|2|||
143226391|NCT03737123|516377723|FG000|Study Treatment|Adverse Event|2|||
143226392|NCT03737123|516377724|FG001|Study Treatment|Adverse Event|0|||
143226393|NCT03737123|516377723|FG000|Study Treatment|Disease Progression|2|||
143226394|NCT03737123|516377724|FG001|Study Treatment|Disease Progression|0|||
143226395|NCT03737123|516377723|FG000|Study Treatment|Withdrawal by Subject|2|||
143226396|NCT03737123|516377724|FG001|Study Treatment|Withdrawal by Subject|0|||
143226397|NCT03737123|516377723|FG000|Follow up|Death|1|||
143226398|NCT03737123|516377724|FG001|Follow up|Death|0|||
143226399|NCT03737123|516377723|FG000|Follow up|Withdrawal by Subject|1|||
143226400|NCT03737123|516377724|FG001|Follow up|Withdrawal by Subject|0|||
143226401|NCT03737123|516377723|FG000|Follow up|Termination of study|4|||
143226402|NCT03737123|516377724|FG001|Follow up|Termination of study|0|||
143226403|NCT01519323|516377725|FG000|Overall Study|Death|3|||
143226404|NCT01519323|516377726|FG001|Overall Study|Death|2|||
143226405|NCT01519323|516377725|FG000|Overall Study|Study terminated by sponsor|0|||
143226406|NCT01519323|516377726|FG001|Overall Study|Study terminated by sponsor|1|||
143268582|NCT03633617|516539027|FG008|Part A|Pregnancy|0|||
143372525|NCT03743246|516909548|FG002|Pre-Treatment Period|Death|0|||
143372526|NCT03743246|516909549|FG003|Pre-Treatment Period|Death|1|||
143372527|NCT03743246|516909546|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
143226407|NCT00387881|516377734|FG000|Overall Study|Lost to Follow-up|23|||
143226408|NCT00387881|516377735|FG001|Overall Study|Lost to Follow-up|23|||
143372528|NCT03743246|516909547|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
143372529|NCT03743246|516909548|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
143372530|NCT03743246|516909549|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
143372531|NCT03743246|516909546|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
143226409|NCT00387881|516377734|FG000|Overall Study|Protocol Violation|2|||
143226410|NCT00387881|516377735|FG001|Overall Study|Protocol Violation|12|||
143226411|NCT00387881|516377734|FG000|Overall Study|Withdrawal by Subject|15|||
143268583|NCT03633617|516539028|FG009|Part A|Pregnancy|0|||
143268584|NCT03633617|516539029|FG010|Part A|Pregnancy|0|||
143268585|NCT03633617|516539019|FG000|Part A|Withdrawal by Subject|0|||
143268586|NCT03633617|516539020|FG001|Part A|Withdrawal by Subject|1|||
143372532|NCT03743246|516909547|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
143372533|NCT03743246|516909548|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
143372534|NCT03743246|516909549|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
143268587|NCT03633617|516539021|FG002|Part A|Withdrawal by Subject|0|||
143226412|NCT00387881|516377735|FG001|Overall Study|Withdrawal by Subject|18|||
143226413|NCT00387881|516377734|FG000|Overall Study|Sponsor terminated Study|0|||
143226414|NCT00387881|516377735|FG001|Overall Study|Sponsor terminated Study|1|||
143226415|NCT00387881|516377734|FG000|Overall Study|Not eligible|6|||
143226416|NCT00387881|516377735|FG001|Overall Study|Not eligible|7|||
143226417|NCT00387881|516377734|FG000|Overall Study|No opportunity to treat headache|32|||
143226418|NCT00387881|516377735|FG001|Overall Study|No opportunity to treat headache|34|||
143226419|NCT00387881|516377734|FG000|Overall Study|Not otherwise specified|11|||
143226420|NCT00387881|516377735|FG001|Overall Study|Not otherwise specified|7|||
143226421|NCT03629886|516377736|FG000|Overall Study|Migrated / moved from the study area|0|||
143226422|NCT03629886|516377737|FG001|Overall Study|Migrated / moved from the study area|55|||
143226423|NCT03629886|516377736|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
143226424|NCT03629886|516377737|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
143226425|NCT03629886|516377736|FG000|Overall Study|Study vaccine not administrated|0|||
143226426|NCT03629886|516377737|FG001|Overall Study|Study vaccine not administrated|3|||
143226427|NCT03629886|516377736|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
143226428|NCT03629886|516377737|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
143226429|NCT03629886|516377736|FG000|Overall Study|Refused vaccination step of the study|0|||
143226430|NCT03629886|516377737|FG001|Overall Study|Refused vaccination step of the study|44|||
143226431|NCT03291067|516377739|FG000|Overall Study|Adverse Event|0|||
143226432|NCT03291067|516377740|FG001|Overall Study|Adverse Event|2|||
143226433|NCT03291067|516377741|FG002|Overall Study|Adverse Event|17|||
143226434|NCT03291067|516377742|FG003|Overall Study|Adverse Event|3|||
143226435|NCT03291067|516377739|FG000|Overall Study|Lost to Follow-up|2|||
143226436|NCT03291067|516377740|FG001|Overall Study|Lost to Follow-up|1|||
143226437|NCT03291067|516377741|FG002|Overall Study|Lost to Follow-up|0|||
143226438|NCT03291067|516377742|FG003|Overall Study|Lost to Follow-up|1|||
143226439|NCT03291067|516377739|FG000|Overall Study|Physician Decision|0|||
143226440|NCT03291067|516377740|FG001|Overall Study|Physician Decision|0|||
143226441|NCT03291067|516377741|FG002|Overall Study|Physician Decision|1|||
143226442|NCT03291067|516377742|FG003|Overall Study|Physician Decision|0|||
143226443|NCT03291067|516377739|FG000|Overall Study|Protocol Violation|5|||
143226444|NCT03291067|516377740|FG001|Overall Study|Protocol Violation|3|||
143226445|NCT03291067|516377741|FG002|Overall Study|Protocol Violation|4|||
143226446|NCT03291067|516377742|FG003|Overall Study|Protocol Violation|2|||
143226447|NCT03291067|516377739|FG000|Overall Study|Withdrawal by Subject|3|||
143226448|NCT03291067|516377740|FG001|Overall Study|Withdrawal by Subject|4|||
143226449|NCT03291067|516377741|FG002|Overall Study|Withdrawal by Subject|7|||
143226450|NCT03291067|516377742|FG003|Overall Study|Withdrawal by Subject|5|||
143226451|NCT03291067|516377739|FG000|Overall Study|Other|0|||
143226452|NCT03291067|516377740|FG001|Overall Study|Other|4|||
143226453|NCT03291067|516377741|FG002|Overall Study|Other|4|||
143226454|NCT03291067|516377742|FG003|Overall Study|Other|6|||
143226455|NCT00496015|516377743|FG000|Overall Study|Other|1|||
143226456|NCT00496015|516377744|FG001|Overall Study|Other|0|||
143226457|NCT00496015|516377745|FG002|Overall Study|Other|0|||
143226458|NCT00496015|516377746|FG003|Overall Study|Other|1|||
143226459|NCT00496015|516377747|FG004|Overall Study|Other|0|||
143226460|NCT01535807|516377749|FG000|Overall Study|Withdrawal by Subject|1|||
143226461|NCT01535807|516377750|FG001|Overall Study|Withdrawal by Subject|1|||
143226462|NCT01535807|516377749|FG000|Overall Study|Data collection error|1|||
143226463|NCT01535807|516377750|FG001|Overall Study|Data collection error|1|||
143226464|NCT01702844|516377764|FG000|Overall Study|Adverse Event|9|||
143226465|NCT01702844|516377764|FG000|Overall Study|Death|1|||
143226466|NCT01702844|516377764|FG000|Overall Study|Withdrawal by Subject|3|||
143226467|NCT01702844|516377764|FG000|Overall Study|Physician Decision|6|||
143226468|NCT02123134|516377765|FG000|Overall Study|Withdrawal of consent|3|||
143226469|NCT02123134|516377766|FG001|Overall Study|Withdrawal of consent|2|||
143226470|NCT02123134|516377765|FG000|Overall Study|Administrative decision|0|||
143226471|NCT02123134|516377766|FG001|Overall Study|Administrative decision|1|||
143226472|NCT01731912|516377772|FG000|Overall Study|noncompliance|2|||
143226473|NCT02043938|516377773|FG000|Overall Study|Withdrawal by Subject|7|||
143226474|NCT02043938|516377773|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
143372535|NCT03743246|516909546|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
143372536|NCT03743246|516909547|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
143226475|NCT02043938|516377773|FG000|Overall Study|No show by subject|1|||
143226476|NCT02043938|516377773|FG000|Overall Study|Investigator decision|1|||
143226477|NCT03010527|516377774|FG000|Overall Study|Death|0|||
143226478|NCT03010527|516377775|FG001|Overall Study|Death|0|||
143226479|NCT03010527|516377776|FG002|Overall Study|Death|1|||
143226480|NCT03010527|516377774|FG000|Overall Study|Adverse Event|0|||
143226481|NCT03010527|516377775|FG001|Overall Study|Adverse Event|4|||
143226482|NCT03010527|516377776|FG002|Overall Study|Adverse Event|2|||
143226483|NCT03010527|516377774|FG000|Overall Study|Protocol Violation|0|||
143226484|NCT03010527|516377775|FG001|Overall Study|Protocol Violation|1|||
143226485|NCT03010527|516377776|FG002|Overall Study|Protocol Violation|0|||
143226486|NCT03010527|516377774|FG000|Overall Study|Lost to Follow-up|0|||
143226487|NCT03010527|516377775|FG001|Overall Study|Lost to Follow-up|2|||
143226488|NCT03010527|516377776|FG002|Overall Study|Lost to Follow-up|1|||
143226489|NCT03010527|516377774|FG000|Overall Study|Withdrawal by Subject|0|||
143226490|NCT03010527|516377775|FG001|Overall Study|Withdrawal by Subject|3|||
143226491|NCT03010527|516377776|FG002|Overall Study|Withdrawal by Subject|4|||
143226492|NCT03010527|516377774|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
143226493|NCT03010527|516377775|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
143226494|NCT03010527|516377776|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
143226495|NCT03010527|516377774|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
143226496|NCT03010527|516377775|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
143226497|NCT03010527|516377776|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
143226498|NCT03010527|516377774|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
143226499|NCT03010527|516377775|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
143226500|NCT03010527|516377776|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
143226501|NCT01458639|516377777|FG000|Overall Study|Physician Decision|4|||
143226502|NCT01458639|516377777|FG000|Overall Study|Equipment issue|1|||
143226503|NCT01458639|516377777|FG000|Overall Study|Inability to obtain subject blood sample|1|||
143226504|NCT02656017|516377778|FG000|Overall Study|Study burden|3|||
143226505|NCT02656017|516377779|FG001|Overall Study|Study burden|3|||
143226506|NCT02656017|516377778|FG000|Overall Study|Adverse Event|2|||
143226507|NCT02656017|516377779|FG001|Overall Study|Adverse Event|1|||
143226508|NCT02656017|516377778|FG000|Overall Study|Unable/unwilling to take study medication|2|||
143226509|NCT02656017|516377779|FG001|Overall Study|Unable/unwilling to take study medication|1|||
143226510|NCT02656017|516377778|FG000|Overall Study|Began Tolvaptan|1|||
143226511|NCT02656017|516377779|FG001|Overall Study|Began Tolvaptan|1|||
143226512|NCT02656017|516377778|FG000|Overall Study|Withdrawal by Subject|1|||
143226513|NCT02656017|516377779|FG001|Overall Study|Withdrawal by Subject|0|||
143226514|NCT01755234|516377780|FG000|Overall Study|Lost to Follow-up|11|||
143226515|NCT01755234|516377781|FG001|Overall Study|Lost to Follow-up|6|||
143226516|NCT01755234|516377780|FG000|Overall Study|Change in surgical case|2|||
143226517|NCT01755234|516377781|FG001|Overall Study|Change in surgical case|1|||
143226518|NCT01755234|516377780|FG000|Overall Study|case cancelled|1|||
143226519|NCT01755234|516377781|FG001|Overall Study|case cancelled|0|||
143226520|NCT01755234|516377780|FG000|Overall Study|Withdrawal by Subject|0|||
143226521|NCT01755234|516377781|FG001|Overall Study|Withdrawal by Subject|1|||
143226522|NCT01755234|516377780|FG000|Overall Study|unblinded|1|||
143226523|NCT01755234|516377781|FG001|Overall Study|unblinded|0|||
143226524|NCT00248495|516377782|FG000|Overall Study|Withdrawal by Subject|1|||
143226525|NCT03812380|516377783|FG000|Overall Study|Protocol Violation|3|||
143226526|NCT03812380|516377784|FG001|Overall Study|Protocol Violation|3|||
143226527|NCT03812380|516377783|FG000|Overall Study|Withdrawal by Subject|5|||
143226528|NCT03812380|516377784|FG001|Overall Study|Withdrawal by Subject|4|||
143226529|NCT03812380|516377783|FG000|Overall Study|Early termination of study|14|||
143226530|NCT03812380|516377784|FG001|Overall Study|Early termination of study|14|||
143226531|NCT00981149|516377785|FG000|Overall Study|Lost to Follow-up|1|||
143226532|NCT00981149|516377786|FG001|Overall Study|Lost to Follow-up|2|||
143226533|NCT00981149|516377785|FG000|Overall Study|Withdrawal by Subject|1|||
143226534|NCT00981149|516377786|FG001|Overall Study|Withdrawal by Subject|1|||
143226535|NCT04244253|516377789|FG000|Overall Study|Adverse Event|2|||
143226536|NCT04244253|516377790|FG001|Overall Study|Adverse Event|2|||
143226537|NCT04244253|516377791|FG002|Overall Study|Adverse Event|4|||
143226538|NCT04244253|516377789|FG000|Overall Study|Protocol Violation|1|||
143226539|NCT04244253|516377790|FG001|Overall Study|Protocol Violation|2|||
143226540|NCT04244253|516377791|FG002|Overall Study|Protocol Violation|1|||
143226541|NCT04244253|516377789|FG000|Overall Study|Withdrawal by Subject|0|||
143226542|NCT04244253|516377790|FG001|Overall Study|Withdrawal by Subject|1|||
143226543|NCT04244253|516377791|FG002|Overall Study|Withdrawal by Subject|6|||
143226544|NCT04244253|516377789|FG000|Overall Study|Non-Compliance With Study Drug|0|||
143226545|NCT04244253|516377790|FG001|Overall Study|Non-Compliance With Study Drug|0|||
143226546|NCT04244253|516377791|FG002|Overall Study|Non-Compliance With Study Drug|1|||
143226547|NCT00622505|516377792|FG000|Overall Study|Adverse Event|9|||
143226548|NCT00622505|516377793|FG001|Overall Study|Adverse Event|7|||
143226549|NCT00622505|516377792|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
143226550|NCT00622505|516377793|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
143226551|NCT00622505|516377792|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
143226552|NCT00622505|516377793|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
143226553|NCT00622505|516377792|FG000|Overall Study|Withdrawal by Subject|12|||
143226554|NCT00622505|516377793|FG001|Overall Study|Withdrawal by Subject|5|||
143226555|NCT00622505|516377792|FG000|Overall Study|Administrative Problems|2|||
143226556|NCT00622505|516377793|FG001|Overall Study|Administrative Problems|4|||
143226557|NCT00622505|516377792|FG000|Overall Study|Death|2|||
143268588|NCT03633617|516539022|FG003|Part A|Withdrawal by Subject|0|||
143268589|NCT03633617|516539023|FG004|Part A|Withdrawal by Subject|0|||
143268590|NCT03633617|516539024|FG005|Part A|Withdrawal by Subject|0|||
143268591|NCT03633617|516539025|FG006|Part A|Withdrawal by Subject|0|||
143268592|NCT03633617|516539026|FG007|Part A|Withdrawal by Subject|0|||
143268593|NCT03633617|516539027|FG008|Part A|Withdrawal by Subject|0|||
143268594|NCT03633617|516539028|FG009|Part A|Withdrawal by Subject|0|||
143268595|NCT03633617|516539029|FG010|Part A|Withdrawal by Subject|0|||
143226558|NCT00622505|516377793|FG001|Overall Study|Death|2|||
143268596|NCT03633617|516539019|FG000|Part B|Adverse Event|0|||
143226559|NCT04154943|516377802|FG000|Overall Study|Study Ongoing|68|||
143226560|NCT04154943|516377802|FG000|Overall Study|Lost to Follow-up|1|||
143226561|NCT04154943|516377802|FG000|Overall Study|Decision by the Investigator|1|||
143226562|NCT04154943|516377802|FG000|Overall Study|Death|5|||
143226563|NCT04154943|516377802|FG000|Overall Study|Withdrawal by Subject|4|||
143226564|NCT00101686|516377803|FG000|Overall Study|Progressive Disease|37|||
143226565|NCT00101686|516377804|FG001|Overall Study|Progressive Disease|28|||
143226566|NCT00101686|516377805|FG002|Overall Study|Progressive Disease|37|||
143226567|NCT00101686|516377806|FG003|Overall Study|Progressive Disease|38|||
143226568|NCT00101686|516377807|FG004|Overall Study|Progressive Disease|28|||
143226569|NCT00101686|516377808|FG005|Overall Study|Progressive Disease|25|||
143226570|NCT00101686|516377809|FG006|Overall Study|Progressive Disease|5|||
143226571|NCT00101686|516377810|FG007|Overall Study|Progressive Disease|7|||
143226572|NCT00101686|516377811|FG008|Overall Study|Progressive Disease|10|||
143226573|NCT00101686|516377812|FG009|Overall Study|Progressive Disease|8|||
143226574|NCT00101686|516377803|FG000|Overall Study|initiation other anti-cancer treatment|4|||
143226575|NCT00101686|516377804|FG001|Overall Study|initiation other anti-cancer treatment|3|||
143226576|NCT00101686|516377805|FG002|Overall Study|initiation other anti-cancer treatment|4|||
143226577|NCT00101686|516377806|FG003|Overall Study|initiation other anti-cancer treatment|3|||
143226578|NCT00101686|516377807|FG004|Overall Study|initiation other anti-cancer treatment|1|||
143226579|NCT00101686|516377808|FG005|Overall Study|initiation other anti-cancer treatment|1|||
143226580|NCT00101686|516377809|FG006|Overall Study|initiation other anti-cancer treatment|2|||
143226581|NCT00101686|516377810|FG007|Overall Study|initiation other anti-cancer treatment|2|||
143226582|NCT00101686|516377811|FG008|Overall Study|initiation other anti-cancer treatment|3|||
143226583|NCT00101686|516377812|FG009|Overall Study|initiation other anti-cancer treatment|3|||
143226584|NCT00101686|516377803|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
143226585|NCT00101686|516377804|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
143226586|NCT00101686|516377805|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
143226587|NCT00101686|516377806|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
143226588|NCT00101686|516377807|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
143226589|NCT00101686|516377808|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
143226590|NCT00101686|516377809|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
143226591|NCT00101686|516377810|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
143226592|NCT00101686|516377811|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
143226593|NCT00101686|516377812|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
143226594|NCT00101686|516377803|FG000|Overall Study|unacceptable toxicity|3|||
143226595|NCT00101686|516377804|FG001|Overall Study|unacceptable toxicity|9|||
143226596|NCT00101686|516377805|FG002|Overall Study|unacceptable toxicity|10|||
143226597|NCT00101686|516377806|FG003|Overall Study|unacceptable toxicity|6|||
143226598|NCT00101686|516377807|FG004|Overall Study|unacceptable toxicity|16|||
143226599|NCT00101686|516377808|FG005|Overall Study|unacceptable toxicity|10|||
143226600|NCT00101686|516377809|FG006|Overall Study|unacceptable toxicity|4|||
143226601|NCT00101686|516377810|FG007|Overall Study|unacceptable toxicity|2|||
143268597|NCT03633617|516539020|FG001|Part B|Adverse Event|0|||
143268598|NCT03633617|516539021|FG002|Part B|Adverse Event|2|||
143268599|NCT03633617|516539022|FG003|Part B|Adverse Event|2|||
143268600|NCT03633617|516539023|FG004|Part B|Adverse Event|1|||
143372537|NCT03743246|516909548|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
143372538|NCT03743246|516909549|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
143226602|NCT00101686|516377811|FG008|Overall Study|unacceptable toxicity|1|||
143226603|NCT00101686|516377812|FG009|Overall Study|unacceptable toxicity|4|||
143268601|NCT03633617|516539024|FG005|Part B|Adverse Event|0|||
143268602|NCT03633617|516539025|FG006|Part B|Adverse Event|0|||
143268603|NCT03633617|516539026|FG007|Part B|Adverse Event|0|||
143268604|NCT03633617|516539027|FG008|Part B|Adverse Event|0|||
143268605|NCT03633617|516539028|FG009|Part B|Adverse Event|0|||
143268606|NCT03633617|516539029|FG010|Part B|Adverse Event|0|||
143268607|NCT03633617|516539019|FG000|Part B|Withdrawal by Subject|0|||
143268608|NCT03633617|516539020|FG001|Part B|Withdrawal by Subject|0|||
143268609|NCT03633617|516539021|FG002|Part B|Withdrawal by Subject|1|||
143268610|NCT03633617|516539022|FG003|Part B|Withdrawal by Subject|0|||
143268611|NCT03633617|516539023|FG004|Part B|Withdrawal by Subject|2|||
143268612|NCT03633617|516539024|FG005|Part B|Withdrawal by Subject|0|||
143268613|NCT03633617|516539025|FG006|Part B|Withdrawal by Subject|0|||
143226604|NCT00101686|516377803|FG000|Overall Study|Randomized but did not receive treament|1|||
143226605|NCT00101686|516377804|FG001|Overall Study|Randomized but did not receive treament|6|||
143226606|NCT00101686|516377805|FG002|Overall Study|Randomized but did not receive treament|2|||
143226607|NCT00101686|516377806|FG003|Overall Study|Randomized but did not receive treament|2|||
143226608|NCT00101686|516377807|FG004|Overall Study|Randomized but did not receive treament|2|||
143226609|NCT00101686|516377808|FG005|Overall Study|Randomized but did not receive treament|2|||
143226610|NCT00101686|516377809|FG006|Overall Study|Randomized but did not receive treament|0|||
143226611|NCT00101686|516377810|FG007|Overall Study|Randomized but did not receive treament|1|||
143226612|NCT00101686|516377811|FG008|Overall Study|Randomized but did not receive treament|0|||
143226613|NCT00101686|516377812|FG009|Overall Study|Randomized but did not receive treament|1|||
143226614|NCT00101686|516377803|FG000|Overall Study|intercurrent non-cancer related illness|0|||
143226615|NCT00101686|516377804|FG001|Overall Study|intercurrent non-cancer related illness|0|||
143226616|NCT00101686|516377805|FG002|Overall Study|intercurrent non-cancer related illness|2|||
143226617|NCT00101686|516377806|FG003|Overall Study|intercurrent non-cancer related illness|0|||
143226618|NCT00101686|516377807|FG004|Overall Study|intercurrent non-cancer related illness|1|||
143226619|NCT00101686|516377808|FG005|Overall Study|intercurrent non-cancer related illness|3|||
143226620|NCT00101686|516377809|FG006|Overall Study|intercurrent non-cancer related illness|1|||
143226621|NCT00101686|516377810|FG007|Overall Study|intercurrent non-cancer related illness|0|||
143226622|NCT00101686|516377811|FG008|Overall Study|intercurrent non-cancer related illness|1|||
143226623|NCT00101686|516377812|FG009|Overall Study|intercurrent non-cancer related illness|1|||
143226624|NCT00101686|516377803|FG000|Overall Study|Physician Decision|10|||
143226625|NCT00101686|516377804|FG001|Overall Study|Physician Decision|13|||
143226626|NCT00101686|516377805|FG002|Overall Study|Physician Decision|6|||
143226627|NCT00101686|516377806|FG003|Overall Study|Physician Decision|7|||
143226628|NCT00101686|516377807|FG004|Overall Study|Physician Decision|8|||
143226629|NCT00101686|516377808|FG005|Overall Study|Physician Decision|9|||
143226630|NCT00101686|516377809|FG006|Overall Study|Physician Decision|5|||
143226631|NCT00101686|516377810|FG007|Overall Study|Physician Decision|5|||
143226632|NCT00101686|516377811|FG008|Overall Study|Physician Decision|1|||
143226633|NCT00101686|516377812|FG009|Overall Study|Physician Decision|1|||
143226634|NCT00101686|516377803|FG000|Overall Study|Other|1|||
143226635|NCT00101686|516377804|FG001|Overall Study|Other|4|||
143226636|NCT00101686|516377805|FG002|Overall Study|Other|1|||
143226637|NCT00101686|516377806|FG003|Overall Study|Other|6|||
143226638|NCT00101686|516377807|FG004|Overall Study|Other|2|||
143226639|NCT00101686|516377808|FG005|Overall Study|Other|12|||
143226640|NCT00101686|516377809|FG006|Overall Study|Other|1|||
143226641|NCT00101686|516377810|FG007|Overall Study|Other|5|||
143226642|NCT00101686|516377811|FG008|Overall Study|Other|3|||
143226643|NCT00101686|516377812|FG009|Overall Study|Other|3|||
143226644|NCT00101686|516377803|FG000|Overall Study|Withdrawal by Subject|9|||
143226645|NCT00101686|516377804|FG001|Overall Study|Withdrawal by Subject|8|||
143226646|NCT00101686|516377805|FG002|Overall Study|Withdrawal by Subject|6|||
143226647|NCT00101686|516377806|FG003|Overall Study|Withdrawal by Subject|8|||
143226648|NCT00101686|516377807|FG004|Overall Study|Withdrawal by Subject|8|||
143226649|NCT00101686|516377808|FG005|Overall Study|Withdrawal by Subject|7|||
143268614|NCT03633617|516539026|FG007|Part B|Withdrawal by Subject|0|||
143268615|NCT03633617|516539027|FG008|Part B|Withdrawal by Subject|0|||
143268616|NCT03633617|516539028|FG009|Part B|Withdrawal by Subject|0|||
143268617|NCT03633617|516539029|FG010|Part B|Withdrawal by Subject|0|||
143268618|NCT03633617|516539019|FG000|Part B|Lost to Follow-up|0|||
143268619|NCT03633617|516539020|FG001|Part B|Lost to Follow-up|0|||
143268620|NCT03633617|516539021|FG002|Part B|Lost to Follow-up|0|||
143226650|NCT00101686|516377809|FG006|Overall Study|Withdrawal by Subject|7|||
143226651|NCT00101686|516377810|FG007|Overall Study|Withdrawal by Subject|7|||
143226652|NCT00101686|516377811|FG008|Overall Study|Withdrawal by Subject|8|||
143226653|NCT00101686|516377812|FG009|Overall Study|Withdrawal by Subject|9|||
143226654|NCT01054456|516377813|FG000|Overall Study|Other|1|||
143226655|NCT01292187|516377814|FG000|Overall Study|Adverse Event|10|||
143226656|NCT01292187|516377815|FG001|Overall Study|Adverse Event|5|||
143268621|NCT03633617|516539022|FG003|Part B|Lost to Follow-up|0|||
143268622|NCT03633617|516539023|FG004|Part B|Lost to Follow-up|1|||
143268623|NCT03633617|516539024|FG005|Part B|Lost to Follow-up|0|||
143268624|NCT03633617|516539025|FG006|Part B|Lost to Follow-up|0|||
143226657|NCT01292187|516377814|FG000|Overall Study|Withdrawal by Subject|6|||
143226658|NCT01292187|516377815|FG001|Overall Study|Withdrawal by Subject|5|||
143226659|NCT01292187|516377814|FG000|Overall Study|All other reasons|1|||
143226660|NCT01292187|516377815|FG001|Overall Study|All other reasons|3|||
143226661|NCT00614380|516377816|FG000|Overall Study|Adverse Event|14|||
143226662|NCT00614380|516377817|FG001|Overall Study|Adverse Event|4|||
143268625|NCT03633617|516539026|FG007|Part B|Lost to Follow-up|0|||
143268626|NCT03633617|516539027|FG008|Part B|Lost to Follow-up|0|||
143226663|NCT00614380|516377818|FG002|Overall Study|Adverse Event|0|||
143226664|NCT00614380|516377819|FG003|Overall Study|Adverse Event|0|||
143226665|NCT00614380|516377816|FG000|Overall Study|Lost to Follow-up|6|||
143226666|NCT00614380|516377817|FG001|Overall Study|Lost to Follow-up|1|||
143226667|NCT00614380|516377818|FG002|Overall Study|Lost to Follow-up|0|||
143226668|NCT00614380|516377819|FG003|Overall Study|Lost to Follow-up|0|||
143226669|NCT00614380|516377816|FG000|Overall Study|Non compliant with the protocol|12|||
143226670|NCT00614380|516377817|FG001|Overall Study|Non compliant with the protocol|2|||
143226671|NCT00614380|516377818|FG002|Overall Study|Non compliant with the protocol|1|||
143226672|NCT00614380|516377819|FG003|Overall Study|Non compliant with the protocol|2|||
143226673|NCT00614380|516377816|FG000|Overall Study|Consent withdrawn|3|||
143226674|NCT00614380|516377817|FG001|Overall Study|Consent withdrawn|1|||
143226675|NCT00614380|516377818|FG002|Overall Study|Consent withdrawn|0|||
143226676|NCT00614380|516377819|FG003|Overall Study|Consent withdrawn|0|||
143226677|NCT03084796|516377822|FG000|Overall Study|Adverse Event|4|||
143226678|NCT03084796|516377823|FG001|Overall Study|Adverse Event|5|||
143226679|NCT03084796|516377824|FG002|Overall Study|Adverse Event|6|||
143226680|NCT03084796|516377825|FG003|Overall Study|Adverse Event|2|||
143226681|NCT03084796|516377826|FG004|Overall Study|Adverse Event|3|||
143226682|NCT03084796|516377827|FG005|Overall Study|Adverse Event|5|||
143226683|NCT03084796|516377822|FG000|Overall Study|Withdrawal by Subject|3|||
143226684|NCT03084796|516377823|FG001|Overall Study|Withdrawal by Subject|5|||
143226685|NCT03084796|516377824|FG002|Overall Study|Withdrawal by Subject|2|||
143226686|NCT03084796|516377825|FG003|Overall Study|Withdrawal by Subject|1|||
143226687|NCT03084796|516377826|FG004|Overall Study|Withdrawal by Subject|3|||
143226688|NCT03084796|516377827|FG005|Overall Study|Withdrawal by Subject|0|||
143226689|NCT03084796|516377822|FG000|Overall Study|Protocol Violation|0|||
143226690|NCT03084796|516377823|FG001|Overall Study|Protocol Violation|0|||
143226691|NCT03084796|516377824|FG002|Overall Study|Protocol Violation|1|||
143226692|NCT03084796|516377825|FG003|Overall Study|Protocol Violation|0|||
143226693|NCT03084796|516377826|FG004|Overall Study|Protocol Violation|1|||
143226694|NCT03084796|516377827|FG005|Overall Study|Protocol Violation|1|||
143226695|NCT03084796|516377822|FG000|Overall Study|Lack of Efficacy|0|||
143226696|NCT03084796|516377823|FG001|Overall Study|Lack of Efficacy|0|||
143226697|NCT03084796|516377824|FG002|Overall Study|Lack of Efficacy|1|||
143226698|NCT03084796|516377825|FG003|Overall Study|Lack of Efficacy|0|||
143226699|NCT03084796|516377826|FG004|Overall Study|Lack of Efficacy|1|||
143226700|NCT03084796|516377827|FG005|Overall Study|Lack of Efficacy|0|||
143226701|NCT03084796|516377822|FG000|Overall Study|Lost to Follow-up|0|||
143226702|NCT03084796|516377823|FG001|Overall Study|Lost to Follow-up|0|||
143226703|NCT03084796|516377824|FG002|Overall Study|Lost to Follow-up|1|||
143226704|NCT03084796|516377825|FG003|Overall Study|Lost to Follow-up|1|||
143226705|NCT03084796|516377826|FG004|Overall Study|Lost to Follow-up|3|||
143226706|NCT03084796|516377827|FG005|Overall Study|Lost to Follow-up|1|||
143226707|NCT03084796|516377822|FG000|Overall Study|Randomization error|0|||
143226708|NCT03084796|516377823|FG001|Overall Study|Randomization error|0|||
143226709|NCT03084796|516377824|FG002|Overall Study|Randomization error|1|||
143226710|NCT03084796|516377825|FG003|Overall Study|Randomization error|0|||
143226711|NCT03084796|516377826|FG004|Overall Study|Randomization error|0|||
143226712|NCT03084796|516377827|FG005|Overall Study|Randomization error|0|||
143226713|NCT00607087|516377828|FG000|Overall Study|Withdrawal by Subject|9|||
143226714|NCT00607087|516377829|FG001|Overall Study|Withdrawal by Subject|4|||
143226715|NCT00607087|516377830|FG002|Overall Study|Withdrawal by Subject|4|||
143226716|NCT00607087|516377828|FG000|Overall Study|Adverse Event|3|||
143226717|NCT00607087|516377829|FG001|Overall Study|Adverse Event|2|||
143226718|NCT00607087|516377830|FG002|Overall Study|Adverse Event|3|||
143226719|NCT00607087|516377828|FG000|Overall Study|Other reason|1|||
143226720|NCT00607087|516377829|FG001|Overall Study|Other reason|5|||
143226721|NCT00607087|516377830|FG002|Overall Study|Other reason|2|||
143226722|NCT00607087|516377828|FG000|Overall Study|Poor compliance to protocol|1|||
143226723|NCT00607087|516377829|FG001|Overall Study|Poor compliance to protocol|0|||
143226724|NCT00607087|516377830|FG002|Overall Study|Poor compliance to protocol|1|||
143226725|NCT00607087|516377828|FG000|Overall Study|Lost to Follow-up|1|||
143226726|NCT00607087|516377829|FG001|Overall Study|Lost to Follow-up|0|||
143226727|NCT00607087|516377830|FG002|Overall Study|Lost to Follow-up|0|||
143226728|NCT00607087|516377828|FG000|Period 1|Withdrawal by Subject|7|||
143226729|NCT00607087|516377829|FG001|Period 1|Withdrawal by Subject|2|||
143226730|NCT00607087|516377830|FG002|Period 1|Withdrawal by Subject|3|||
143226731|NCT00607087|516377828|FG000|Period 1|Adverse Event|3|||
143226732|NCT00607087|516377829|FG001|Period 1|Adverse Event|0|||
143226733|NCT00607087|516377830|FG002|Period 1|Adverse Event|0|||
143226734|NCT00607087|516377828|FG000|Period 1|Poor compliance to protocol|1|||
143226735|NCT00607087|516377829|FG001|Period 1|Poor compliance to protocol|0|||
143226736|NCT00607087|516377830|FG002|Period 1|Poor compliance to protocol|0|||
143226737|NCT00607087|516377828|FG000|Period 1|Lost to Follow-up|1|||
143226738|NCT00607087|516377829|FG001|Period 1|Lost to Follow-up|0|||
143226739|NCT00607087|516377830|FG002|Period 1|Lost to Follow-up|0|||
143226740|NCT00607087|516377828|FG000|Period 1|Other reason|0|||
143226741|NCT00607087|516377829|FG001|Period 1|Other reason|4|||
143226742|NCT00607087|516377830|FG002|Period 1|Other reason|2|||
143226743|NCT00607087|516377828|FG000|Period 2|Withdrawal by Subject|0|||
143226744|NCT00607087|516377829|FG001|Period 2|Withdrawal by Subject|1|||
143226745|NCT00607087|516377830|FG002|Period 2|Withdrawal by Subject|1|||
143226746|NCT00607087|516377828|FG000|Period 2|Other reason|1|||
143226747|NCT00607087|516377829|FG001|Period 2|Other reason|1|||
143226748|NCT00607087|516377830|FG002|Period 2|Other reason|0|||
143226749|NCT00607087|516377828|FG000|Period 2|Adverse Event|0|||
143226750|NCT00607087|516377829|FG001|Period 2|Adverse Event|1|||
143226751|NCT00607087|516377830|FG002|Period 2|Adverse Event|3|||
143226752|NCT00607087|516377828|FG000|Period 2|Poor compliance to protocol|0|||
143226753|NCT00607087|516377829|FG001|Period 2|Poor compliance to protocol|0|||
143226754|NCT00607087|516377830|FG002|Period 2|Poor compliance to protocol|1|||
143226755|NCT00607087|516377828|FG000|Period 3|Withdrawal by Subject|2|||
143226756|NCT00607087|516377829|FG001|Period 3|Withdrawal by Subject|1|||
143226757|NCT00607087|516377830|FG002|Period 3|Withdrawal by Subject|0|||
143226758|NCT00607087|516377828|FG000|Period 3|Adverse Event|0|||
143226759|NCT00607087|516377829|FG001|Period 3|Adverse Event|1|||
143226760|NCT00607087|516377830|FG002|Period 3|Adverse Event|0|||
143226761|NCT01774799|516377831|FG000|Overall Study|Lost to Follow-up|1|||
143226762|NCT01774799|516377832|FG001|Overall Study|Lost to Follow-up|1|||
143226763|NCT01774799|516377833|FG002|Overall Study|Lost to Follow-up|0|||
143226764|NCT01774799|516377834|FG003|Overall Study|Lost to Follow-up|0|||
143226765|NCT02910466|516377835|FG000|Overall Study|Adverse Event|1|||
143226766|NCT02910466|516377835|FG000|Overall Study|Withdrawal by Subject|3|||
143226767|NCT02910466|516377835|FG000|Overall Study|Lost to Follow-up|5|||
143226768|NCT02910466|516377835|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
143226769|NCT02910466|516377835|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
143226770|NCT03061201|516377836|FG000|Overall Study|Participants Terminated at Month 36|0|||
143226771|NCT03061201|516377837|FG001|Overall Study|Participants Terminated at Month 36|1|||
143226772|NCT03061201|516377838|FG002|Overall Study|Participants Terminated at Month 36|0|||
143226773|NCT03061201|516377839|FG003|Overall Study|Participants Terminated at Month 36|1|||
143226774|NCT03061201|516377836|FG000|Overall Study|Lost to Follow-up|1|||
143226775|NCT03061201|516377837|FG001|Overall Study|Lost to Follow-up|0|||
143226776|NCT03061201|516377838|FG002|Overall Study|Lost to Follow-up|0|||
143226777|NCT03061201|516377839|FG003|Overall Study|Lost to Follow-up|0|||
143226778|NCT04037891|516377840|FG000|Open-label Period|Withdrawal by Subject|1|||
143226779|NCT04037891|516377841|FG001|Open-label Period|Withdrawal by Subject|0|||
143226780|NCT04037891|516377842|FG002|Open-label Period|Withdrawal by Subject|0|||
143226781|NCT04037891|516377840|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
143226782|NCT04037891|516377841|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
143226783|NCT04037891|516377842|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
143226784|NCT00990106|516377843|FG000|Overall Study|"too busy to continue"|1|||
143226785|NCT00990106|516377844|FG001|Overall Study|"too busy to continue"|2|||
143226786|NCT00990106|516377843|FG000|Overall Study|Lost to Follow-up|1|||
143226787|NCT00990106|516377844|FG001|Overall Study|Lost to Follow-up|3|||
143226788|NCT00990106|516377843|FG000|Overall Study|Withdrawal by Subject|2|||
143226789|NCT00990106|516377844|FG001|Overall Study|Withdrawal by Subject|1|||
143226790|NCT00990106|516377843|FG000|Overall Study|opted for open label prazosin|1|||
143226791|NCT00990106|516377844|FG001|Overall Study|opted for open label prazosin|1|||
143226792|NCT00990106|516377843|FG000|Overall Study|relocation/deployment|4|||
143226793|NCT00990106|516377844|FG001|Overall Study|relocation/deployment|1|||
143226794|NCT00990106|516377843|FG000|Overall Study|started exclusionary medication|0|||
143226795|NCT00990106|516377844|FG001|Overall Study|started exclusionary medication|1|||
143226796|NCT00990106|516377843|FG000|Overall Study|planned major surgery|0|||
143226797|NCT00990106|516377844|FG001|Overall Study|planned major surgery|1|||
143226798|NCT00990106|516377843|FG000|Overall Study|scheduling conflicts|0|||
143226799|NCT00990106|516377844|FG001|Overall Study|scheduling conflicts|2|||
143226800|NCT00866814|516377848|FG000|Overall Study|Lost to Follow-up|12|||
143226801|NCT00866814|516377848|FG000|Overall Study|Adverse Event|2|||
143226802|NCT00866814|516377848|FG000|Overall Study|Physician Decision|1|||
143226803|NCT00866814|516377848|FG000|Overall Study|Death|1|||
143226804|NCT00866814|516377848|FG000|Overall Study|No longer wished to participate|1|||
143226805|NCT00866814|516377848|FG000|Overall Study|Unable to meet follow-up requirements|2|||
143226806|NCT00866814|516377848|FG000|Overall Study|Moved to area without study site|1|||
143226807|NCT00794950|516377849|FG000|BCG Induction|Withdrawal by Subject|2|||
143226808|NCT00794950|516377849|FG000|BCG Induction|ineligible|3|||
143226809|NCT00794950|516377849|FG000|BCG Induction|noncompliant w. BCG|1|||
143226810|NCT00794950|516377849|FG000|BCG Induction|Adverse Event|1|||
143226811|NCT00794950|516377849|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
143226812|NCT00794950|516377849|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
143226813|NCT00794950|516377849|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
143226814|NCT00794950|516377849|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
143226815|NCT02485704|516377850|FG000|Overall Study|Lost to Follow-up|4|||
143226816|NCT02485704|516377851|FG001|Overall Study|Lost to Follow-up|5|||
143226817|NCT02485704|516377850|FG000|Overall Study|Withdrawal by Subject|0|||
143226818|NCT02485704|516377851|FG001|Overall Study|Withdrawal by Subject|3|||
143226819|NCT02485704|516377850|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
143226820|NCT02485704|516377851|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
143226821|NCT01777776|516377852|FG000|Overall Study|Adverse Event|2|||
143226822|NCT01777776|516377853|FG001|Overall Study|Adverse Event|4|||
143226823|NCT01777776|516377854|FG002|Overall Study|Adverse Event|0|||
143226824|NCT01777776|516377855|FG003|Overall Study|Adverse Event|0|||
143226825|NCT01777776|516377852|FG000|Overall Study|Disease Progression|4|||
143226826|NCT01777776|516377853|FG001|Overall Study|Disease Progression|8|||
143226827|NCT01777776|516377854|FG002|Overall Study|Disease Progression|6|||
143226828|NCT01777776|516377855|FG003|Overall Study|Disease Progression|3|||
143226829|NCT01777776|516377852|FG000|Overall Study|Withdrawal by Subject|0|||
143226830|NCT01777776|516377853|FG001|Overall Study|Withdrawal by Subject|0|||
143226831|NCT01777776|516377854|FG002|Overall Study|Withdrawal by Subject|0|||
143226832|NCT01777776|516377855|FG003|Overall Study|Withdrawal by Subject|1|||
143226833|NCT00851786|516377858|FG000|Overall Study|Withdrawal by Subject|0|||
143226834|NCT00851786|516377859|FG001|Overall Study|Withdrawal by Subject|1|||
143226835|NCT00851786|516377858|FG000|Overall Study|Protocol Violation|0|||
143226836|NCT00851786|516377859|FG001|Overall Study|Protocol Violation|1|||
143226837|NCT00851786|516377858|FG000|Overall Study|Lost to Follow-up|1|||
143226838|NCT00851786|516377859|FG001|Overall Study|Lost to Follow-up|0|||
143226839|NCT00851786|516377858|FG000|Overall Study|Incarceration|1|||
143226840|NCT00851786|516377859|FG001|Overall Study|Incarceration|0|||
143226841|NCT00851786|516377858|FG000|Overall Study|Site Closure|1|||
143226842|NCT00851786|516377859|FG001|Overall Study|Site Closure|0|||
143226843|NCT00851786|516377858|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
143226844|NCT00851786|516377859|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
143226845|NCT01943591|516377862|FG000|Overall Study|Lost to Follow-up|3|||
143226846|NCT01943591|516377863|FG001|Overall Study|Lost to Follow-up|4|||
143226847|NCT01943591|516377862|FG000|Overall Study|Death|2|||
143226848|NCT01943591|516377863|FG001|Overall Study|Death|7|||
143226849|NCT03858049|516379418|FG000|Overall Study|Adverse Event|16|||
143226850|NCT03858049|516379419|FG001|Overall Study|Adverse Event|9|||
143226851|NCT03858049|516379418|FG000|Overall Study|Other|1|||
143226852|NCT03858049|516379419|FG001|Overall Study|Other|1|||
143226853|NCT02079740|516379420|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
143226854|NCT02079740|516379421|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
143226855|NCT02079740|516379422|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
143226856|NCT02079740|516379423|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
143226857|NCT02079740|516379424|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
143226858|NCT02079740|516379425|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
143226859|NCT02079740|516379426|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
143226860|NCT02079740|516379427|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
143226861|NCT02079740|516379428|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
143226862|NCT02079740|516379429|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
143226863|NCT02079740|516379430|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
143226864|NCT02079740|516379431|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
143226865|NCT02079740|516379432|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
143226866|NCT02079740|516379420|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
143226867|NCT02079740|516379421|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
143226868|NCT02079740|516379422|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
143268627|NCT03633617|516539028|FG009|Part B|Lost to Follow-up|0|||
143268628|NCT03633617|516539029|FG010|Part B|Lost to Follow-up|0|||
143268629|NCT03633617|516539019|FG000|Part B|Physician Decision|0|||
143268630|NCT03633617|516539020|FG001|Part B|Physician Decision|0|||
143268631|NCT03633617|516539021|FG002|Part B|Physician Decision|0|||
143226869|NCT02079740|516379423|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
143226870|NCT02079740|516379424|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
143226871|NCT02079740|516379425|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
143226872|NCT02079740|516379426|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
143226873|NCT02079740|516379427|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
143268632|NCT03633617|516539022|FG003|Part B|Physician Decision|0|||
143268633|NCT03633617|516539023|FG004|Part B|Physician Decision|1|||
143268634|NCT03633617|516539024|FG005|Part B|Physician Decision|0|||
143268635|NCT03633617|516539025|FG006|Part B|Physician Decision|0|||
143268636|NCT03633617|516539026|FG007|Part B|Physician Decision|0|||
143226874|NCT02079740|516379428|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
143226875|NCT02079740|516379429|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
143226876|NCT02079740|516379430|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
143226877|NCT02079740|516379431|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
143226878|NCT02079740|516379432|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
143226879|NCT02079740|516379420|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
143226880|NCT02079740|516379421|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
143226881|NCT02079740|516379422|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
143226882|NCT02079740|516379423|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
143226883|NCT02079740|516379424|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
143226884|NCT02079740|516379425|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
143226885|NCT02079740|516379426|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
143226886|NCT02079740|516379427|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
143226887|NCT02079740|516379428|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
143226888|NCT02079740|516379429|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
143226889|NCT02079740|516379430|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
143226890|NCT02079740|516379431|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
143226891|NCT02079740|516379432|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
143226892|NCT02079740|516379420|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
143226893|NCT02079740|516379421|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
143226894|NCT02079740|516379422|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
143226895|NCT02079740|516379423|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
143226896|NCT02079740|516379424|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
143226897|NCT02079740|516379425|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
143226898|NCT02079740|516379426|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
143268637|NCT03633617|516539027|FG008|Part B|Physician Decision|0|||
143226899|NCT02079740|516379427|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
143226900|NCT02079740|516379428|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
143226901|NCT02079740|516379429|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
143226902|NCT02079740|516379430|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
143226903|NCT02079740|516379431|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
143226904|NCT02079740|516379432|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
143226905|NCT02079740|516379420|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
143226906|NCT02079740|516379421|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
143226907|NCT02079740|516379422|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
143226908|NCT02079740|516379423|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
143226909|NCT02079740|516379424|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
143226910|NCT02079740|516379425|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
143226911|NCT02079740|516379426|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
143226912|NCT02079740|516379427|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
143226913|NCT02079740|516379428|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
143226914|NCT02079740|516379429|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
143226915|NCT02079740|516379430|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
143226916|NCT02079740|516379431|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
143226917|NCT02079740|516379432|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
143226918|NCT04617782|516379433|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
143226919|NCT04617782|516379433|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
143226920|NCT04617782|516379433|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
143226921|NCT04617782|516379433|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
143226922|NCT04617782|516379433|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
143226923|NCT04617782|516379433|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
143226924|NCT01131507|516379438|FG000|Overall Study|Adverse Event|1|||
143226925|NCT01131507|516379438|FG000|Overall Study|Lost to Follow-up|1|||
143226926|NCT01131507|516379438|FG000|Overall Study|Withdrawal by Subject|1|||
143226927|NCT01474317|516379446|FG000|Overall Study|Adverse Event|1|||
143226928|NCT01474317|516379446|FG000|Overall Study|Subject ineligible for study|1|||
143226929|NCT00453154|516379447|FG000|Double BIind Maintenance|Adverse Event|0|||
143268638|NCT03633617|516539028|FG009|Part B|Physician Decision|0|||
143226930|NCT00453154|516379448|FG001|Double BIind Maintenance|Adverse Event|0|||
143226931|NCT00453154|516379449|FG002|Double BIind Maintenance|Adverse Event|3|||
143226932|NCT00453154|516379450|FG003|Double BIind Maintenance|Adverse Event|12|||
143268639|NCT03633617|516539029|FG010|Part B|Physician Decision|0|||
143268640|NCT03633617|516539019|FG000|Part B|COVID-19 Restrictions|0|||
143268641|NCT03633617|516539020|FG001|Part B|COVID-19 Restrictions|0|||
143268642|NCT03633617|516539021|FG002|Part B|COVID-19 Restrictions|1|||
143268643|NCT03633617|516539022|FG003|Part B|COVID-19 Restrictions|0|||
143268644|NCT03633617|516539023|FG004|Part B|COVID-19 Restrictions|0|||
143268645|NCT03633617|516539024|FG005|Part B|COVID-19 Restrictions|0|||
143268646|NCT03633617|516539025|FG006|Part B|COVID-19 Restrictions|0|||
143268647|NCT03633617|516539026|FG007|Part B|COVID-19 Restrictions|0|||
143268648|NCT03633617|516539027|FG008|Part B|COVID-19 Restrictions|0|||
143268649|NCT03633617|516539028|FG009|Part B|COVID-19 Restrictions|0|||
143268650|NCT03633617|516539029|FG010|Part B|COVID-19 Restrictions|0|||
143268651|NCT03633617|516539019|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
143268652|NCT03633617|516539020|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
143268653|NCT03633617|516539021|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
143268654|NCT03633617|516539022|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
143268655|NCT03633617|516539023|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
143268656|NCT03633617|516539024|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
143268657|NCT03633617|516539025|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
143268658|NCT03633617|516539026|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
143268659|NCT03633617|516539027|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
143226933|NCT00453154|516379447|FG000|Double BIind Maintenance|Death|0|||
143226934|NCT00453154|516379448|FG001|Double BIind Maintenance|Death|0|||
143226935|NCT00453154|516379449|FG002|Double BIind Maintenance|Death|2|||
143226936|NCT00453154|516379450|FG003|Double BIind Maintenance|Death|1|||
143226937|NCT00453154|516379447|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
143226938|NCT00453154|516379448|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
143226939|NCT00453154|516379449|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
143226940|NCT00453154|516379450|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
143226941|NCT00453154|516379447|FG000|Double BIind Maintenance|Progression|0|||
143226942|NCT00453154|516379448|FG001|Double BIind Maintenance|Progression|0|||
143226943|NCT00453154|516379449|FG002|Double BIind Maintenance|Progression|29|||
143226944|NCT00453154|516379450|FG003|Double BIind Maintenance|Progression|26|||
143226945|NCT00453154|516379447|FG000|Double BIind Maintenance|Medical Issues|0|||
143226946|NCT00453154|516379448|FG001|Double BIind Maintenance|Medical Issues|0|||
143226947|NCT00453154|516379449|FG002|Double BIind Maintenance|Medical Issues|3|||
143226948|NCT00453154|516379450|FG003|Double BIind Maintenance|Medical Issues|1|||
143226949|NCT00453154|516379447|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
143226950|NCT00453154|516379448|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
143226951|NCT00453154|516379449|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
143226952|NCT00453154|516379450|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
143226953|NCT03683173|516379451|FG000|Completed Follow-up|Unavailable|235|||
143226954|NCT03683173|516379452|FG001|Completed Follow-up|Unavailable|217|||
143226955|NCT03683173|516379451|FG000|Completed Follow-up|Refused|69|||
143226956|NCT03683173|516379452|FG001|Completed Follow-up|Refused|59|||
143226957|NCT03683173|516379451|FG000|Completed Follow-up|Disconnected phone|65|||
143226958|NCT03683173|516379452|FG001|Completed Follow-up|Disconnected phone|95|||
143226959|NCT03683173|516379451|FG000|Completed Follow-up|Health issue/deceased|10|||
143226960|NCT03683173|516379452|FG001|Completed Follow-up|Health issue/deceased|4|||
143226961|NCT03683173|516379451|FG000|Completed Follow-up|Moved away|8|||
143226962|NCT03683173|516379452|FG001|Completed Follow-up|Moved away|1|||
143226963|NCT03016312|516379453|FG000|Overall Study|discontinued before the treatment started|0|||
143226964|NCT03016312|516379454|FG001|Overall Study|discontinued before the treatment started|1|||
143226965|NCT03016312|516379453|FG000|Overall Study|Withdrawal by Subject|37|||
143226966|NCT03016312|516379454|FG001|Overall Study|Withdrawal by Subject|44|||
143226967|NCT03016312|516379453|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
143226968|NCT03016312|516379454|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
143226969|NCT03016312|516379453|FG000|Overall Study|Physician Decision|1|||
143226970|NCT03016312|516379454|FG001|Overall Study|Physician Decision|3|||
143226971|NCT03016312|516379453|FG000|Overall Study|Lost to Follow-up|12|||
143268660|NCT03633617|516539028|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
143268661|NCT03633617|516539029|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
143268662|NCT03633617|516539019|FG000|Part C (& Follow-up)|Adverse Event|0|||
143268663|NCT03633617|516539020|FG001|Part C (& Follow-up)|Adverse Event|0|||
143268664|NCT03633617|516539021|FG002|Part C (& Follow-up)|Adverse Event|0|||
143268665|NCT03633617|516539022|FG003|Part C (& Follow-up)|Adverse Event|0|||
143268666|NCT03633617|516539023|FG004|Part C (& Follow-up)|Adverse Event|0|||
143268667|NCT03633617|516539024|FG005|Part C (& Follow-up)|Adverse Event|1|||
143226972|NCT03016312|516379454|FG001|Overall Study|Lost to Follow-up|12|||
143226973|NCT03016312|516379453|FG000|Overall Study|Death|210|||
143268668|NCT03633617|516539025|FG006|Part C (& Follow-up)|Adverse Event|0|||
143226974|NCT03016312|516379454|FG001|Overall Study|Death|184|||
143372539|NCT03743246|516909546|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
143372540|NCT03743246|516909547|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
143372541|NCT03743246|516909548|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
143372542|NCT03743246|516909549|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
143226975|NCT03016312|516379453|FG000|Overall Study|loss to contact|1|||
143226976|NCT03016312|516379454|FG001|Overall Study|loss to contact|0|||
143226977|NCT03016312|516379453|FG000|Overall Study|started a new cancer therapy|1|||
143226978|NCT03016312|516379454|FG001|Overall Study|started a new cancer therapy|0|||
143226979|NCT02730728|516379455|FG000|Overall Study|Withdrawal by Subject|0|||
143226980|NCT02730728|516379456|FG001|Overall Study|Withdrawal by Subject|1|||
143226981|NCT02730728|516379457|FG002|Overall Study|Withdrawal by Subject|0|||
143226982|NCT02730728|516379455|FG000|Overall Study|Lack of Efficacy|0|||
143226983|NCT02730728|516379456|FG001|Overall Study|Lack of Efficacy|1|||
143226984|NCT02730728|516379457|FG002|Overall Study|Lack of Efficacy|1|||
143226985|NCT00619515|516379458|FG000|Overall Study|Study Termination by IRB|73|||
143226986|NCT03275740|516379469|FG000|Overall Study|Adverse Event|0|||
143226987|NCT03275740|516379470|FG001|Overall Study|Adverse Event|0|||
143226988|NCT03275740|516379471|FG002|Overall Study|Adverse Event|0|||
143226989|NCT03275740|516379472|FG003|Overall Study|Adverse Event|0|||
143226990|NCT03275740|516379473|FG004|Overall Study|Adverse Event|1|||
143226991|NCT03275740|516379474|FG005|Overall Study|Adverse Event|0|||
143226992|NCT03275740|516379475|FG006|Overall Study|Adverse Event|0|||
143226993|NCT03275740|516379476|FG007|Overall Study|Adverse Event|0|||
143226994|NCT03275740|516379477|FG008|Overall Study|Adverse Event|0|||
143226995|NCT03275740|516379478|FG009|Overall Study|Adverse Event|0|||
143226996|NCT03275740|516379479|FG010|Overall Study|Adverse Event|0|||
143226997|NCT03275740|516379480|FG011|Overall Study|Adverse Event|0|||
143226998|NCT03275740|516379469|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
143226999|NCT03275740|516379470|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
143227000|NCT03275740|516379471|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
143227001|NCT03275740|516379472|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
143227002|NCT03275740|516379473|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
143227003|NCT03275740|516379474|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
143227004|NCT03275740|516379475|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
143227005|NCT03275740|516379476|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
143227006|NCT03275740|516379477|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
143227007|NCT03275740|516379478|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
143227008|NCT03275740|516379479|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
143227009|NCT03275740|516379480|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
143227010|NCT03275740|516379469|FG000|Overall Study|Withdrawal by Subject|0|||
143372543|NCT03743246|516909546|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
143227011|NCT03275740|516379470|FG001|Overall Study|Withdrawal by Subject|0|||
143227012|NCT03275740|516379471|FG002|Overall Study|Withdrawal by Subject|0|||
143227013|NCT03275740|516379472|FG003|Overall Study|Withdrawal by Subject|0|||
143227014|NCT03275740|516379473|FG004|Overall Study|Withdrawal by Subject|0|||
143227015|NCT03275740|516379474|FG005|Overall Study|Withdrawal by Subject|0|||
143227016|NCT03275740|516379475|FG006|Overall Study|Withdrawal by Subject|0|||
143227017|NCT03275740|516379476|FG007|Overall Study|Withdrawal by Subject|0|||
143227018|NCT03275740|516379477|FG008|Overall Study|Withdrawal by Subject|1|||
143227019|NCT03275740|516379478|FG009|Overall Study|Withdrawal by Subject|1|||
143227020|NCT03275740|516379479|FG010|Overall Study|Withdrawal by Subject|0|||
143227021|NCT03275740|516379480|FG011|Overall Study|Withdrawal by Subject|0|||
143227022|NCT00890825|516379481|FG000|Overall Study|Withdrawal by Subject|1|||
143227023|NCT00890825|516379482|FG001|Overall Study|Withdrawal by Subject|0|||
143227024|NCT00890825|516379481|FG000|Overall Study|Alive at data cut off (DCO)|13|||
143227025|NCT00890825|516379482|FG001|Overall Study|Alive at data cut off (DCO)|14|||
143227026|NCT04701333|516379483|FG000|Overall Study|Lost to Follow-up|3|||
143227027|NCT04701333|516379484|FG001|Overall Study|Lost to Follow-up|7|||
143227028|NCT04701333|516379483|FG000|Overall Study|Withdrawal by Subject|0|||
143227029|NCT04701333|516379484|FG001|Overall Study|Withdrawal by Subject|1|||
143227030|NCT02920892|516379485|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
143372544|NCT03743246|516909547|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
143372545|NCT03743246|516909548|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
143372546|NCT03743246|516909549|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
143227031|NCT02920892|516379486|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
143372547|NCT03743246|516909546|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
143227032|NCT02920892|516379487|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
143227033|NCT02920892|516379485|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
143227034|NCT02920892|516379486|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
143227035|NCT02920892|516379487|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
143227036|NCT02920892|516379485|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
143227037|NCT02920892|516379486|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
143227038|NCT02920892|516379487|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
143227039|NCT02920892|516379485|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
143227040|NCT02920892|516379486|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
143227041|NCT02920892|516379487|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
143227042|NCT02920892|516379485|FG000|Placebo-Controlled Period|Physician Decision|0|||
143227043|NCT02920892|516379486|FG001|Placebo-Controlled Period|Physician Decision|0|||
143227044|NCT02920892|516379487|FG002|Placebo-Controlled Period|Physician Decision|1|||
143227045|NCT02920892|516379485|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
143227046|NCT02920892|516379486|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
143227047|NCT02920892|516379487|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
143227048|NCT02920892|516379485|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
143227049|NCT02920892|516379486|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
143227050|NCT02920892|516379487|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
143227051|NCT02920892|516379485|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
143227052|NCT02920892|516379486|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
143227053|NCT02920892|516379487|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
143227054|NCT00462306|516379488|FG000|Overall Study|insufficient data|0|||
143227055|NCT00462306|516379489|FG001|Overall Study|insufficient data|13|||
143227056|NCT01391663|516379490|FG000|Overall Study|Withdrawal by Subject|0|||
143227057|NCT01391663|516379491|FG001|Overall Study|Withdrawal by Subject|0|||
143227058|NCT01391663|516379492|FG002|Overall Study|Withdrawal by Subject|1|||
143227059|NCT01391663|516379493|FG003|Overall Study|Withdrawal by Subject|0|||
143227060|NCT03515824|516379494|FG000|Overall Study|Death|3|||
143227061|NCT03515824|516379495|FG001|Overall Study|Death|2|||
143227062|NCT03515824|516379496|FG002|Overall Study|Death|6|||
143227063|NCT03515824|516379497|FG003|Overall Study|Death|0|||
143227064|NCT03515824|516379494|FG000|Overall Study|Lost to Follow-up|0|||
143227065|NCT03515824|516379495|FG001|Overall Study|Lost to Follow-up|1|||
143227066|NCT03515824|516379496|FG002|Overall Study|Lost to Follow-up|1|||
143227067|NCT03515824|516379497|FG003|Overall Study|Lost to Follow-up|0|||
143227068|NCT03515824|516379494|FG000|Overall Study|Study terminated by sponsor|0|||
143227069|NCT03515824|516379495|FG001|Overall Study|Study terminated by sponsor|1|||
143227070|NCT03515824|516379496|FG002|Overall Study|Study terminated by sponsor|6|||
143227071|NCT03515824|516379497|FG003|Overall Study|Study terminated by sponsor|0|||
143227072|NCT03515824|516379494|FG000|Overall Study|Status not recorded|0|||
143227073|NCT03515824|516379495|FG001|Overall Study|Status not recorded|0|||
143227074|NCT03515824|516379496|FG002|Overall Study|Status not recorded|2|||
143227075|NCT03515824|516379497|FG003|Overall Study|Status not recorded|0|||
143227076|NCT00920855|516379498|FG000|Overall Study|Adverse Event|1|||
143227077|NCT00920855|516379499|FG001|Overall Study|Adverse Event|1|||
143227078|NCT00920855|516379500|FG002|Overall Study|Adverse Event|4|||
143227079|NCT00920855|516379498|FG000|Overall Study|Withdrawal by Subject|2|||
143227080|NCT00920855|516379499|FG001|Overall Study|Withdrawal by Subject|1|||
143227081|NCT00920855|516379500|FG002|Overall Study|Withdrawal by Subject|6|||
143227082|NCT00920855|516379498|FG000|Overall Study|Disease progression|2|||
143227083|NCT00920855|516379499|FG001|Overall Study|Disease progression|1|||
143227084|NCT00920855|516379500|FG002|Overall Study|Disease progression|10|||
143227085|NCT00920855|516379498|FG000|Overall Study|Noncompliance to study medication|0|||
143227086|NCT00920855|516379499|FG001|Overall Study|Noncompliance to study medication|0|||
143227087|NCT00920855|516379500|FG002|Overall Study|Noncompliance to study medication|1|||
143227088|NCT00920855|516379498|FG000|Overall Study|Response plateau; started maintenance|0|||
143227089|NCT00920855|516379499|FG001|Overall Study|Response plateau; started maintenance|0|||
143227090|NCT00920855|516379500|FG002|Overall Study|Response plateau; started maintenance|1|||
143227091|NCT00510835|516379504|FG000|Overall Study|Withdrawal by Subject|6|||
143227092|NCT00510835|516379505|FG001|Overall Study|Withdrawal by Subject|2|||
143227093|NCT00510835|516379506|FG002|Overall Study|Withdrawal by Subject|2|||
143227094|NCT05470985|516379507|FG000|Double Blind Treatment Period|Study terminated by sponsor|1|||
143227095|NCT05470985|516379508|FG001|Double Blind Treatment Period|Study terminated by sponsor|0|||
143227096|NCT05470985|516379507|FG000|Double Blind Treatment Period|Physician Decision|0|||
143227097|NCT05470985|516379508|FG001|Double Blind Treatment Period|Physician Decision|1|||
143227098|NCT05470985|516379507|FG000|Long Term Extension|Adverse Event|0|||
143372548|NCT03743246|516909547|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
143372549|NCT03743246|516909548|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
143372550|NCT03743246|516909549|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
143372551|NCT03743246|516909546|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
143372552|NCT03743246|516909547|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
143372553|NCT03743246|516909548|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
143372554|NCT03743246|516909549|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
143372555|NCT00319436|516909571|FG000|Overall Study|Withdrawal by Subject|6|||
143372556|NCT00319436|516909572|FG001|Overall Study|Withdrawal by Subject|7|||
143372557|NCT00790790|516909573|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
143372558|NCT00790790|516909574|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
143227099|NCT05470985|516379508|FG001|Long Term Extension|Adverse Event|1|||
143227100|NCT05470985|516379507|FG000|Long Term Extension|Study terminated by sponsor|2|||
143227101|NCT05470985|516379508|FG001|Long Term Extension|Study terminated by sponsor|0|||
143227102|NCT02741245|516379510|FG000|Overall Study|Adverse Event|0|||
143227103|NCT02741245|516379511|FG001|Overall Study|Adverse Event|0|||
143227104|NCT02741245|516379512|FG002|Overall Study|Adverse Event|0|||
143227105|NCT02741245|516379513|FG003|Overall Study|Adverse Event|2|||
143227106|NCT02741245|516379514|FG004|Overall Study|Adverse Event|2|||
143227107|NCT02741245|516379510|FG000|Overall Study|Protocol Violation|0|||
143227108|NCT02741245|516379511|FG001|Overall Study|Protocol Violation|1|||
143227109|NCT02741245|516379512|FG002|Overall Study|Protocol Violation|0|||
143227110|NCT02741245|516379513|FG003|Overall Study|Protocol Violation|1|||
143227111|NCT02741245|516379514|FG004|Overall Study|Protocol Violation|0|||
143227112|NCT02741245|516379510|FG000|Overall Study|Withdrawal by Subject|0|||
143227113|NCT02741245|516379511|FG001|Overall Study|Withdrawal by Subject|0|||
143227114|NCT02741245|516379512|FG002|Overall Study|Withdrawal by Subject|0|||
143227115|NCT02741245|516379513|FG003|Overall Study|Withdrawal by Subject|1|||
143227116|NCT02741245|516379514|FG004|Overall Study|Withdrawal by Subject|0|||
143227117|NCT00152503|516379515|FG000|Overall Study|Adverse Event|4|||
143227118|NCT03253679|516379516|FG000|Overall Study|Screen Failure|1|||
143227119|NCT02586623|516379517|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
143227120|NCT02586623|516379518|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
143227121|NCT02586623|516379519|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
143227122|NCT02586623|516379517|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
143227123|NCT02586623|516379518|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
143227124|NCT02586623|516379519|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
143227125|NCT02586623|516379517|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
143227126|NCT02586623|516379518|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
143227127|NCT02586623|516379519|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
143227128|NCT02586623|516379517|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
143227129|NCT02586623|516379518|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
143227130|NCT02586623|516379519|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
143227131|NCT02586623|516379517|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
143227132|NCT02586623|516379518|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
143227133|NCT02586623|516379519|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
143227134|NCT02586623|516379517|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
143227135|NCT02586623|516379518|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
143227136|NCT02586623|516379519|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
143227137|NCT02586623|516379517|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
143227138|NCT02586623|516379518|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
143227139|NCT02586623|516379519|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
143227140|NCT02586623|516379517|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
143227141|NCT02586623|516379518|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
143227142|NCT02586623|516379519|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
143227143|NCT02586623|516379517|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
143227144|NCT02586623|516379518|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
143227145|NCT02586623|516379519|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
143227146|NCT02586623|516379517|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
143227147|NCT02586623|516379518|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
143227148|NCT02586623|516379519|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
143227149|NCT02586623|516379517|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
143227150|NCT02586623|516379518|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
143227151|NCT02586623|516379519|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
143227152|NCT02586623|516379517|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
143227153|NCT02586623|516379518|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
143227154|NCT02586623|516379519|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
143227155|NCT02586623|516379517|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
143227156|NCT02586623|516379518|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
143227157|NCT02586623|516379519|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
143227158|NCT02586623|516379517|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
143227159|NCT02586623|516379518|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
143227160|NCT02586623|516379519|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
143227161|NCT02586623|516379517|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
143227162|NCT02586623|516379518|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
143227163|NCT02586623|516379519|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
143268669|NCT03633617|516539026|FG007|Part C (& Follow-up)|Adverse Event|1|||
143227164|NCT02586623|516379517|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
143227165|NCT02586623|516379518|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
143227166|NCT02586623|516379519|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
143227167|NCT02586623|516379517|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
143268670|NCT03633617|516539027|FG008|Part C (& Follow-up)|Adverse Event|0|||
143227168|NCT02586623|516379518|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
143227169|NCT02586623|516379519|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
143227170|NCT02586623|516379517|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
143227171|NCT02586623|516379518|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
143227172|NCT02586623|516379519|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
143227173|NCT02586623|516379517|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
143227174|NCT02586623|516379518|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
143227175|NCT02586623|516379519|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
143227176|NCT02586623|516379517|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
143227177|NCT02586623|516379518|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
143227178|NCT02586623|516379519|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
143227179|NCT02586623|516379517|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
143227180|NCT02586623|516379518|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
143227181|NCT02586623|516379519|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
143227182|NCT04332107|516379528|FG000|Day 3|Lost to Follow-up|23|||
143227183|NCT04332107|516379529|FG001|Day 3|Lost to Follow-up|14|||
143227184|NCT04332107|516379528|FG000|Day 3|Missing outcome data|3|||
143227185|NCT04332107|516379529|FG001|Day 3|Missing outcome data|6|||
143227186|NCT04332107|516379528|FG000|Day 14|Lost to Follow-up|13|||
143227187|NCT04332107|516379529|FG001|Day 14|Lost to Follow-up|4|||
143227188|NCT04332107|516379528|FG000|Day 14|Missing outcome data|4|||
143227189|NCT04332107|516379529|FG001|Day 14|Missing outcome data|4|||
143227190|NCT04332107|516379528|FG000|Day 21|Lost to Follow-up|10|||
143227191|NCT04332107|516379529|FG001|Day 21|Lost to Follow-up|2|||
143227192|NCT00717249|516379530|FG000|Overall Study|Lens Discomfort|4|||
143227193|NCT00717249|516379531|FG001|Overall Study|Lens Discomfort|1|||
143227194|NCT00717249|516379530|FG000|Overall Study|Unsatisfactory visual Response|0|||
143227195|NCT00717249|516379531|FG001|Overall Study|Unsatisfactory visual Response|2|||
143227196|NCT00717249|516379530|FG000|Overall Study|Adverse Event|4|||
143227197|NCT00717249|516379531|FG001|Overall Study|Adverse Event|2|||
143227198|NCT00717249|516379530|FG000|Overall Study|Lost to Follow-up|2|||
143227199|NCT00717249|516379531|FG001|Overall Study|Lost to Follow-up|0|||
143227200|NCT00717249|516379530|FG000|Overall Study|Withdrawal by Subject|1|||
143227201|NCT00717249|516379531|FG001|Overall Study|Withdrawal by Subject|2|||
143227202|NCT00717249|516379530|FG000|Overall Study|Pregnancy|6|||
143227203|NCT00717249|516379531|FG001|Overall Study|Pregnancy|3|||
143227204|NCT00717249|516379530|FG000|Overall Study|Protocol Violation|0|||
143268671|NCT03633617|516539028|FG009|Part C (& Follow-up)|Adverse Event|0|||
143268672|NCT03633617|516539029|FG010|Part C (& Follow-up)|Adverse Event|0|||
143227205|NCT00717249|516379531|FG001|Overall Study|Protocol Violation|2|||
143227206|NCT00717249|516379530|FG000|Overall Study|Subject became Ineligible|1|||
143227207|NCT00717249|516379531|FG001|Overall Study|Subject became Ineligible|1|||
143227208|NCT00717249|516379530|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
143227209|NCT00717249|516379531|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
143227210|NCT00717249|516379530|FG000|Overall Study|Gastric Surgery|0|||
143227211|NCT00717249|516379531|FG001|Overall Study|Gastric Surgery|1|||
143227212|NCT00717249|516379530|FG000|Overall Study|Diagnosed with Diabetes|1|||
143227213|NCT00717249|516379531|FG001|Overall Study|Diagnosed with Diabetes|0|||
143227214|NCT00717249|516379530|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
143227215|NCT00717249|516379531|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
143227216|NCT00717249|516379530|FG000|Overall Study|Subject relocated|1|||
143227217|NCT00717249|516379531|FG001|Overall Study|Subject relocated|0|||
143227218|NCT00717249|516379530|FG000|Overall Study|Headaches|1|||
143227219|NCT00717249|516379531|FG001|Overall Study|Headaches|0|||
143227220|NCT00871871|516379532|FG000|Part I|Adverse Event|0|||
143227221|NCT00871871|516379533|FG001|Part I|Adverse Event|2|||
143227222|NCT00871871|516379534|FG002|Part I|Adverse Event|0|||
143268673|NCT03633617|516539019|FG000|Part C (& Follow-up)|Pregnancy|0|||
143268674|NCT03633617|516539020|FG001|Part C (& Follow-up)|Pregnancy|0|||
143268675|NCT03633617|516539021|FG002|Part C (& Follow-up)|Pregnancy|0|||
143227223|NCT00871871|516379535|FG003|Part I|Adverse Event|0|||
143227224|NCT00871871|516379532|FG000|Part I|Withdrawal by Subject|3|||
143227225|NCT00871871|516379533|FG001|Part I|Withdrawal by Subject|0|||
143227226|NCT00871871|516379534|FG002|Part I|Withdrawal by Subject|0|||
143227227|NCT00871871|516379535|FG003|Part I|Withdrawal by Subject|0|||
143227228|NCT00871871|516379532|FG000|Part I|Laboratory abnormality|0|||
143227229|NCT00871871|516379533|FG001|Part I|Laboratory abnormality|1|||
143227230|NCT00871871|516379534|FG002|Part I|Laboratory abnormality|0|||
143227231|NCT00871871|516379535|FG003|Part I|Laboratory abnormality|0|||
143227232|NCT00871871|516379532|FG000|Part II|Lack of Efficacy|0|||
143268676|NCT03633617|516539022|FG003|Part C (& Follow-up)|Pregnancy|0|||
143268677|NCT03633617|516539023|FG004|Part C (& Follow-up)|Pregnancy|0|||
143268678|NCT03633617|516539024|FG005|Part C (& Follow-up)|Pregnancy|0|||
143227233|NCT00871871|516379533|FG001|Part II|Lack of Efficacy|0|||
143227234|NCT00871871|516379534|FG002|Part II|Lack of Efficacy|1|||
143227235|NCT00871871|516379535|FG003|Part II|Lack of Efficacy|0|||
143268679|NCT03633617|516539025|FG006|Part C (& Follow-up)|Pregnancy|0|||
143268680|NCT03633617|516539026|FG007|Part C (& Follow-up)|Pregnancy|0|||
143268681|NCT03633617|516539027|FG008|Part C (& Follow-up)|Pregnancy|0|||
143268682|NCT03633617|516539028|FG009|Part C (& Follow-up)|Pregnancy|1|||
143268683|NCT03633617|516539029|FG010|Part C (& Follow-up)|Pregnancy|0|||
143268684|NCT03633617|516539019|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
143268685|NCT03633617|516539020|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
143268686|NCT03633617|516539021|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
143268687|NCT03633617|516539022|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
143268688|NCT03633617|516539023|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
143268689|NCT03633617|516539024|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
143268690|NCT03633617|516539025|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
143268691|NCT03633617|516539026|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
143268692|NCT03633617|516539027|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
143268693|NCT03633617|516539028|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
143268694|NCT03633617|516539029|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
143268695|NCT03633617|516539019|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
143268696|NCT03633617|516539020|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
143268697|NCT03633617|516539021|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
143268698|NCT03633617|516539022|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
143268699|NCT03633617|516539023|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
143268700|NCT03633617|516539024|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
143268701|NCT03633617|516539025|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
143268702|NCT03633617|516539026|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
143268703|NCT03633617|516539027|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
143268704|NCT03633617|516539028|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
143268705|NCT03633617|516539029|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
143268706|NCT03633617|516539019|FG000|Part C (& Follow-up)|Physician Decision|0|||
143227236|NCT00871871|516379532|FG000|Part II|Withdrawal by Subject|0|||
143227237|NCT00871871|516379533|FG001|Part II|Withdrawal by Subject|0|||
143227238|NCT00871871|516379534|FG002|Part II|Withdrawal by Subject|2|||
143227239|NCT00871871|516379535|FG003|Part II|Withdrawal by Subject|1|||
143227240|NCT00871871|516379532|FG000|Part II|Adverse Event|0|||
143227241|NCT00871871|516379533|FG001|Part II|Adverse Event|0|||
143227242|NCT00871871|516379534|FG002|Part II|Adverse Event|1|||
143227243|NCT00871871|516379535|FG003|Part II|Adverse Event|2|||
143227244|NCT00871871|516379532|FG000|Part II|Protocol Violation|0|||
143227245|NCT00871871|516379533|FG001|Part II|Protocol Violation|0|||
143227246|NCT00871871|516379534|FG002|Part II|Protocol Violation|0|||
143227247|NCT00871871|516379535|FG003|Part II|Protocol Violation|1|||
143227248|NCT00479713|516379538|FG000|Overall Study|Adverse Event|8|||
143227249|NCT00479713|516379539|FG001|Overall Study|Adverse Event|6|||
143227250|NCT00479713|516379538|FG000|Overall Study|Death|1|||
143227251|NCT00479713|516379539|FG001|Overall Study|Death|0|||
143227252|NCT00479713|516379538|FG000|Overall Study|Lost to Follow-up|0|||
143227253|NCT00479713|516379539|FG001|Overall Study|Lost to Follow-up|1|||
143227254|NCT00479713|516379538|FG000|Overall Study|Protocol Violation|0|||
143227255|NCT00479713|516379539|FG001|Overall Study|Protocol Violation|1|||
143227256|NCT00479713|516379538|FG000|Overall Study|Withdrawal by Subject|4|||
143227257|NCT00479713|516379539|FG001|Overall Study|Withdrawal by Subject|1|||
143227258|NCT01670721|516379540|FG000|Overall Study|Participant's decision|15|||
143227259|NCT01670721|516379540|FG000|Overall Study|Other than specified above|38|||
143227260|NCT03863509|516379541|FG000|Overall Study|COVID-19 shutdown period|0|||
143227261|NCT03863509|516379542|FG001|Overall Study|COVID-19 shutdown period|4|||
143227262|NCT03863509|516379543|FG002|Overall Study|COVID-19 shutdown period|0|||
143227263|NCT03863509|516379541|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
143227264|NCT03863509|516379542|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
143227265|NCT03863509|516379543|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
143227266|NCT03863509|516379541|FG000|Overall Study|Lost to Follow-up|8|||
143227267|NCT03863509|516379542|FG001|Overall Study|Lost to Follow-up|0|||
143227268|NCT03863509|516379543|FG002|Overall Study|Lost to Follow-up|2|||
143227269|NCT03863509|516379541|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
143227270|NCT03863509|516379542|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
143227271|NCT03863509|516379543|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
143268707|NCT03633617|516539020|FG001|Part C (& Follow-up)|Physician Decision|0|||
143268708|NCT03633617|516539021|FG002|Part C (& Follow-up)|Physician Decision|0|||
143268709|NCT03633617|516539022|FG003|Part C (& Follow-up)|Physician Decision|0|||
143268710|NCT03633617|516539023|FG004|Part C (& Follow-up)|Physician Decision|0|||
143268711|NCT03633617|516539024|FG005|Part C (& Follow-up)|Physician Decision|0|||
143268712|NCT03633617|516539025|FG006|Part C (& Follow-up)|Physician Decision|0|||
143268713|NCT03633617|516539026|FG007|Part C (& Follow-up)|Physician Decision|1|||
143268714|NCT03633617|516539027|FG008|Part C (& Follow-up)|Physician Decision|0|||
143268715|NCT03633617|516539028|FG009|Part C (& Follow-up)|Physician Decision|0|||
143268716|NCT03633617|516539029|FG010|Part C (& Follow-up)|Physician Decision|1|||
143372559|NCT00790790|516909575|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
143372560|NCT00790790|516909573|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
143372561|NCT00790790|516909574|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
143372562|NCT00790790|516909575|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
143372563|NCT00790790|516909573|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
143372564|NCT00790790|516909574|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
143227272|NCT03863509|516379541|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
143227273|NCT03863509|516379542|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
143227274|NCT03863509|516379543|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
143227275|NCT03799341|516379544|FG000|12-Week Treatment Interval|Withdrawal by Investigator|0|||
143227276|NCT03799341|516379545|FG001|12-Week Treatment Interval|Withdrawal by Investigator|0|||
143227277|NCT03799341|516379546|FG002|12-Week Treatment Interval|Withdrawal by Investigator|1|||
143227278|NCT03799341|516379544|FG000|12-Week Treatment Interval|Withdrawal by Subject|0|||
143227279|NCT03799341|516379545|FG001|12-Week Treatment Interval|Withdrawal by Subject|0|||
143227280|NCT03799341|516379546|FG002|12-Week Treatment Interval|Withdrawal by Subject|1|||
143227281|NCT03799341|516379544|FG000|Post-Tx Evaluation Session|Lost to Follow-up|4|||
143227282|NCT03799341|516379545|FG001|Post-Tx Evaluation Session|Lost to Follow-up|4|||
143227283|NCT03799341|516379546|FG002|Post-Tx Evaluation Session|Lost to Follow-up|0|||
143227284|NCT03799341|516379544|FG000|Post-Tx Evaluation Session|Declined or Unavailable|1|||
143227285|NCT03799341|516379545|FG001|Post-Tx Evaluation Session|Declined or Unavailable|2|||
143227286|NCT03799341|516379546|FG002|Post-Tx Evaluation Session|Declined or Unavailable|0|||
143227287|NCT03799341|516379544|FG000|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|12|||
143227288|NCT03799341|516379545|FG001|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|10|||
143227289|NCT03799341|516379546|FG002|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|0|||
143227290|NCT03799341|516379544|FG000|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|1|||
143227291|NCT03799341|516379545|FG001|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
143227292|NCT03799341|516379546|FG002|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
143227293|NCT03446313|516379547|FG000|Overall Study|Lost to Follow-up|1|||
143227294|NCT03446313|516379548|FG001|Overall Study|Lost to Follow-up|2|||
143227295|NCT03446313|516379547|FG000|Overall Study|Failed primary screening|3|||
143227296|NCT03446313|516379548|FG001|Overall Study|Failed primary screening|0|||
143227297|NCT03446313|516379547|FG000|Overall Study|Diagnosed with terminal cancer|1|||
143227298|NCT03446313|516379548|FG001|Overall Study|Diagnosed with terminal cancer|0|||
143227299|NCT03446313|516379547|FG000|Overall Study|Excluded from analysis|1|||
143227300|NCT03446313|516379548|FG001|Overall Study|Excluded from analysis|1|||
143227301|NCT02926638|516379557|FG000|Overall Study|Progression|2|||
143227302|NCT02926638|516379558|FG001|Overall Study|Progression|5|||
143227303|NCT02926638|516379557|FG000|Overall Study|Ineligible|1|||
143227304|NCT02926638|516379558|FG001|Overall Study|Ineligible|0|||
143227305|NCT02926638|516379557|FG000|Overall Study|Not protocol specified|1|||
143227306|NCT02926638|516379558|FG001|Overall Study|Not protocol specified|0|||
143227307|NCT01871519|516379559|FG000|Overall Study|Death|26|||
143227308|NCT01871519|516379559|FG000|Overall Study|Lost to Follow-up|15|||
143227309|NCT01871519|516379559|FG000|Overall Study|Withdrawal by Subject|49|||
143227310|NCT00320515|516379560|FG000|Overall Study|Death|33|||
143227311|NCT00320515|516379560|FG000|Overall Study|Lost to Follow-up|6|||
143227312|NCT00320515|516379560|FG000|Overall Study|Physician Decision|2|||
143227313|NCT00320515|516379560|FG000|Overall Study|Withdrawal by Subject|8|||
143227314|NCT01063153|516379561|FG000|Overall Study|Found Ineligible During Screening|2|||
143227315|NCT01063153|516379562|FG001|Overall Study|Found Ineligible During Screening|0|||
143227316|NCT01063153|516379561|FG000|Overall Study|Lost to Follow-up|0|||
143227317|NCT01063153|516379562|FG001|Overall Study|Lost to Follow-up|7|||
143227318|NCT01063153|516379561|FG000|Overall Study|Withdrawal by Subject|0|||
143227319|NCT01063153|516379562|FG001|Overall Study|Withdrawal by Subject|1|||
143227320|NCT01063153|516379561|FG000|Overall Study|Physician Decision|0|||
143227321|NCT01063153|516379562|FG001|Overall Study|Physician Decision|4|||
143227322|NCT00350844|516379563|FG000|Overall Study|Lost to Follow-up|1|||
143227323|NCT01420926|516379564|FG000|Overall Study|Adverse Event|6|||
143227324|NCT01420926|516379565|FG001|Overall Study|Adverse Event|4|||
143227325|NCT01420926|516379564|FG000|Overall Study|Death|18|||
143227326|NCT01420926|516379565|FG001|Overall Study|Death|17|||
143227327|NCT01420926|516379564|FG000|Overall Study|Withdrawal by Subject|11|||
143372565|NCT00790790|516909575|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
143227328|NCT01420926|516379565|FG001|Overall Study|Withdrawal by Subject|17|||
143227329|NCT01420926|516379564|FG000|Overall Study|Non-protocol treatment|17|||
143227330|NCT01420926|516379565|FG001|Overall Study|Non-protocol treatment|20|||
143268717|NCT03633617|516539019|FG000|Part C (& Follow-up)|COVID-19 related|0|||
143268718|NCT03633617|516539020|FG001|Part C (& Follow-up)|COVID-19 related|0|||
143268719|NCT03633617|516539021|FG002|Part C (& Follow-up)|COVID-19 related|0|||
143268720|NCT03633617|516539022|FG003|Part C (& Follow-up)|COVID-19 related|0|||
143268721|NCT03633617|516539023|FG004|Part C (& Follow-up)|COVID-19 related|0|||
143268722|NCT03633617|516539024|FG005|Part C (& Follow-up)|COVID-19 related|1|||
143268723|NCT03633617|516539025|FG006|Part C (& Follow-up)|COVID-19 related|0|||
143268724|NCT03633617|516539026|FG007|Part C (& Follow-up)|COVID-19 related|0|||
143268725|NCT03633617|516539027|FG008|Part C (& Follow-up)|COVID-19 related|0|||
143268726|NCT03633617|516539028|FG009|Part C (& Follow-up)|COVID-19 related|0|||
143268727|NCT03633617|516539029|FG010|Part C (& Follow-up)|COVID-19 related|0|||
143268728|NCT03633617|516539019|FG000|Part C (& Follow-up)|Protocol Violation|0|||
143372566|NCT00790790|516909573|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
143372567|NCT00790790|516909574|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
143372568|NCT00790790|516909575|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
143372569|NCT00790790|516909573|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
143372570|NCT00790790|516909574|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
143372571|NCT00790790|516909575|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
143372572|NCT02194933|516909576|FG000|Overall Study|Lost to Follow-up|1|||
143372573|NCT02194933|516909577|FG001|Overall Study|Lost to Follow-up|2|||
143372574|NCT02194933|516909576|FG000|Overall Study|Participant met withdrawal criteria|1|||
143372575|NCT02194933|516909577|FG001|Overall Study|Participant met withdrawal criteria|3|||
143372576|NCT02194933|516909576|FG000|Overall Study|Withdrawal by Subject|0|||
143372577|NCT02194933|516909577|FG001|Overall Study|Withdrawal by Subject|2|||
143227331|NCT01420926|516379564|FG000|Overall Study|Physician Decision|8|||
143227332|NCT01420926|516379565|FG001|Overall Study|Physician Decision|5|||
143227333|NCT01342913|516380757|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
143227334|NCT01342913|516380758|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
143227335|NCT01342913|516380759|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
143227336|NCT01342913|516380757|FG000|2-week Run-in Period|Physician Decision|6|||
143227337|NCT01342913|516380758|FG001|2-week Run-in Period|Physician Decision|0|||
143227338|NCT01342913|516380759|FG002|2-week Run-in Period|Physician Decision|0|||
143227339|NCT01342913|516380757|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
143227340|NCT01342913|516380758|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
143227341|NCT01342913|516380759|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
143227342|NCT01342913|516380757|FG000|2-week Run-in Period|Adverse Event|2|||
143227343|NCT01342913|516380758|FG001|2-week Run-in Period|Adverse Event|0|||
143227344|NCT01342913|516380759|FG002|2-week Run-in Period|Adverse Event|0|||
143227345|NCT01342913|516380757|FG000|2-week Run-in Period|Protocol Violation|5|||
143227346|NCT01342913|516380758|FG001|2-week Run-in Period|Protocol Violation|0|||
143227347|NCT01342913|516380759|FG002|2-week Run-in Period|Protocol Violation|0|||
143227348|NCT01342913|516380757|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
143227349|NCT01342913|516380758|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
143227350|NCT01342913|516380759|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
143227351|NCT01342913|516380757|FG000|Double-Blind Treatment Period|Adverse Event|0|||
143227352|NCT01342913|516380758|FG001|Double-Blind Treatment Period|Adverse Event|3|||
143227353|NCT01342913|516380759|FG002|Double-Blind Treatment Period|Adverse Event|6|||
143227354|NCT01342913|516380757|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
143227355|NCT01342913|516380758|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
143227356|NCT01342913|516380759|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
143227357|NCT01342913|516380757|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
143227358|NCT01342913|516380758|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
143227359|NCT01342913|516380759|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
143227360|NCT01342913|516380757|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
143227361|NCT01342913|516380758|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
143227362|NCT01342913|516380759|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
143227363|NCT01342913|516380757|FG000|Double-Blind Treatment Period|Physician Decision|0|||
143227364|NCT01342913|516380758|FG001|Double-Blind Treatment Period|Physician Decision|2|||
143227365|NCT01342913|516380759|FG002|Double-Blind Treatment Period|Physician Decision|0|||
143227366|NCT01342913|516380757|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
143227367|NCT01342913|516380758|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
143227368|NCT01342913|516380759|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
143227369|NCT05482308|516380764|FG000|Overall Study|Withdrawal by Subject|1|||
143227370|NCT05482308|516380765|FG001|Overall Study|Withdrawal by Subject|0|||
143227371|NCT05482308|516380764|FG000|Overall Study|No longer meets eligibility criteria|0|||
143268729|NCT03633617|516539020|FG001|Part C (& Follow-up)|Protocol Violation|0|||
143372578|NCT02194933|516909576|FG000|Overall Study|Lack of Efficacy|1|||
143372579|NCT02194933|516909577|FG001|Overall Study|Lack of Efficacy|2|||
143372580|NCT00756730|516909578|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
143227372|NCT05482308|516380765|FG001|Overall Study|No longer meets eligibility criteria|1|||
143227373|NCT04319198|516380766|FG000|Overall Study|Adverse Events Resolution or Stabilization|3|||
143227374|NCT04319198|516380767|FG001|Overall Study|Adverse Events Resolution or Stabilization|4|||
143227375|NCT04319198|516380768|FG002|Overall Study|Adverse Events Resolution or Stabilization|0|||
143227376|NCT04319198|516380766|FG000|Overall Study|Death|0|||
143227377|NCT04319198|516380767|FG001|Overall Study|Death|3|||
143227378|NCT04319198|516380768|FG002|Overall Study|Death|3|||
143227379|NCT04319198|516380766|FG000|Overall Study|Reason Not Specified|0|||
143227380|NCT04319198|516380767|FG001|Overall Study|Reason Not Specified|2|||
143227381|NCT04319198|516380768|FG002|Overall Study|Reason Not Specified|4|||
143227382|NCT04319198|516380766|FG000|Overall Study|Withdrawal of Consent|0|||
143227383|NCT04319198|516380767|FG001|Overall Study|Withdrawal of Consent|0|||
143227384|NCT04319198|516380768|FG002|Overall Study|Withdrawal of Consent|5|||
143227385|NCT04319198|516380766|FG000|Overall Study|Site Terminated by Sponsor|0|||
143227386|NCT04319198|516380767|FG001|Overall Study|Site Terminated by Sponsor|1|||
143227387|NCT04319198|516380768|FG002|Overall Study|Site Terminated by Sponsor|0|||
143227388|NCT05801991|516380769|FG000|Overall Study|Lost to Follow-up|1|||
143227389|NCT05801991|516380770|FG001|Overall Study|Lost to Follow-up|0|||
143227390|NCT03489863|516380774|FG000|Overall Study|Withdrawal by Subject|0|||
143227391|NCT03489863|516380775|FG001|Overall Study|Withdrawal by Subject|1|||
143227392|NCT02193776|516380776|FG000|Overall Study|Consent withdrawn|1|||
143227393|NCT02193776|516380777|FG001|Overall Study|Consent withdrawn|0|||
143227394|NCT02193776|516380778|FG002|Overall Study|Consent withdrawn|0|||
143227395|NCT02193776|516380779|FG003|Overall Study|Consent withdrawn|0|||
143227396|NCT02193776|516380776|FG000|Overall Study|Failure to comply with protocol|0|||
143227397|NCT02193776|516380777|FG001|Overall Study|Failure to comply with protocol|1|||
143227398|NCT02193776|516380778|FG002|Overall Study|Failure to comply with protocol|0|||
143227399|NCT02193776|516380779|FG003|Overall Study|Failure to comply with protocol|0|||
143227400|NCT02193776|516380776|FG000|Overall Study|Investigator/Sponsor decision|1|||
143227401|NCT02193776|516380777|FG001|Overall Study|Investigator/Sponsor decision|1|||
143227402|NCT02193776|516380778|FG002|Overall Study|Investigator/Sponsor decision|0|||
143227403|NCT02193776|516380779|FG003|Overall Study|Investigator/Sponsor decision|0|||
143227404|NCT02193776|516380776|FG000|Overall Study|Death|1|||
143227405|NCT02193776|516380777|FG001|Overall Study|Death|0|||
143227406|NCT02193776|516380778|FG002|Overall Study|Death|0|||
143227407|NCT02193776|516380779|FG003|Overall Study|Death|0|||
143227408|NCT02193776|516380776|FG000|Overall Study|Adverse event/Specific toxicity|5|||
143227409|NCT02193776|516380777|FG001|Overall Study|Adverse event/Specific toxicity|5|||
143227410|NCT02193776|516380778|FG002|Overall Study|Adverse event/Specific toxicity|2|||
143227411|NCT02193776|516380779|FG003|Overall Study|Adverse event/Specific toxicity|2|||
143227412|NCT02995980|516380780|FG000|Overall Study|Lost to Follow-up|14|||
143227413|NCT01169103|516380782|FG000|Overall Study|Lost to Follow-up|3|||
143227414|NCT01169103|516380783|FG001|Overall Study|Lost to Follow-up|3|||
143227415|NCT01169103|516380782|FG000|Overall Study|Withdrawal by Subject|3|||
143227416|NCT01169103|516380783|FG001|Overall Study|Withdrawal by Subject|1|||
143227417|NCT02792231|516380784|FG000|Overall Study|Patient/guardian decision|32|||
143227418|NCT02792231|516380785|FG001|Overall Study|Patient/guardian decision|42|||
143227419|NCT02792231|516380784|FG000|Overall Study|Adverse Event|15|||
143227420|NCT02792231|516380785|FG001|Overall Study|Adverse Event|11|||
143227421|NCT02792231|516380784|FG000|Overall Study|Physician Decision|14|||
143227422|NCT02792231|516380785|FG001|Overall Study|Physician Decision|12|||
143227423|NCT02792231|516380784|FG000|Overall Study|Lack of Efficacy|7|||
143227424|NCT02792231|516380785|FG001|Overall Study|Lack of Efficacy|9|||
143227425|NCT02792231|516380784|FG000|Overall Study|Lost to Follow-up|9|||
143227426|NCT02792231|516380785|FG001|Overall Study|Lost to Follow-up|5|||
143227427|NCT02792231|516380784|FG000|Overall Study|Pregnancy|1|||
143227428|NCT02792231|516380785|FG001|Overall Study|Pregnancy|3|||
143227429|NCT02792231|516380784|FG000|Overall Study|Non-compliance with study treatment|2|||
143227430|NCT02792231|516380785|FG001|Overall Study|Non-compliance with study treatment|1|||
143227431|NCT02792231|516380784|FG000|Overall Study|Protocol deviation|2|||
143227432|NCT02792231|516380785|FG001|Overall Study|Protocol deviation|0|||
143227433|NCT02792231|516380784|FG000|Overall Study|Technical problems|0|||
143227434|NCT02792231|516380785|FG001|Overall Study|Technical problems|1|||
143227435|NCT05196828|516380786|FG000|Overall Study|Withdrawal by Subject|2|||
143227436|NCT05196828|516380787|FG001|Overall Study|Withdrawal by Subject|0|||
143227437|NCT05196828|516380786|FG000|Overall Study|Lost to Follow-up|0|||
143227438|NCT05196828|516380787|FG001|Overall Study|Lost to Follow-up|4|||
143227439|NCT05196828|516380786|FG000|Overall Study|Adverse Event|1|||
143227440|NCT05196828|516380787|FG001|Overall Study|Adverse Event|0|||
143227441|NCT04073186|516380788|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
143227442|NCT04073186|516380788|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
143227443|NCT04073186|516380788|FG000|First Wearing Cycle|Protocol Violation|1|||
143227444|NCT04073186|516380788|FG000|First Wearing Cycle|Lens Discomfort|2|||
143227445|NCT04073186|516380788|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
143227446|NCT04073186|516380788|FG000|Second Wearing Cycle|Adverse Event|1|||
143227447|NCT00473434|516380789|FG000|Overall Study|Physician Decision|3|||
143268730|NCT03633617|516539021|FG002|Part C (& Follow-up)|Protocol Violation|0|||
143268731|NCT03633617|516539022|FG003|Part C (& Follow-up)|Protocol Violation|0|||
143268732|NCT03633617|516539023|FG004|Part C (& Follow-up)|Protocol Violation|0|||
143268733|NCT03633617|516539024|FG005|Part C (& Follow-up)|Protocol Violation|0|||
143268734|NCT03633617|516539025|FG006|Part C (& Follow-up)|Protocol Violation|0|||
143268735|NCT03633617|516539026|FG007|Part C (& Follow-up)|Protocol Violation|0|||
143268736|NCT03633617|516539027|FG008|Part C (& Follow-up)|Protocol Violation|0|||
143268737|NCT03633617|516539028|FG009|Part C (& Follow-up)|Protocol Violation|3|||
143268738|NCT03633617|516539029|FG010|Part C (& Follow-up)|Protocol Violation|1|||
143268739|NCT03633617|516539019|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
143268740|NCT03633617|516539020|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
143268741|NCT03633617|516539021|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
143268742|NCT03633617|516539022|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
143268743|NCT03633617|516539023|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
143268744|NCT03633617|516539024|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
143268745|NCT03633617|516539025|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
143268746|NCT03633617|516539026|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
143227448|NCT00473434|516380789|FG000|Overall Study|Withdrawal by Subject|9|||
143227449|NCT00473434|516380789|FG000|Overall Study|Compliance|3|||
143227450|NCT00473434|516380789|FG000|Overall Study|Lack of Efficacy|3|||
143227451|NCT00473434|516380789|FG000|Overall Study|Adverse Event|3|||
143227452|NCT00473434|516380789|FG000|Overall Study|Patient was selling medication to others|1|||
143227453|NCT00473434|516380789|FG000|Overall Study|Safety evaluation|1|||
143227454|NCT00473434|516380789|FG000|Overall Study|Reason not specified|6|||
143227455|NCT00473434|516380789|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
143227456|NCT00473434|516380789|FG000|Overall Study|Switching to trial medication|1|||
143227457|NCT00473434|516380789|FG000|Overall Study|No longer required|1|||
143227458|NCT03360682|516380790|FG000|Overall Study|Adverse Event|3|||
143227459|NCT02634333|516380791|FG000|Overall Study|Completed out of Window|3|||
143227460|NCT02634333|516380792|FG001|Overall Study|Completed out of Window|2|||
143227461|NCT02634333|516380791|FG000|Overall Study|Missed Visit|5|||
143227462|NCT02634333|516380792|FG001|Overall Study|Missed Visit|2|||
143227463|NCT02634333|516380791|FG000|Overall Study|Lost to Follow-up|12|||
143227464|NCT02634333|516380792|FG001|Overall Study|Lost to Follow-up|7|||
143227465|NCT02634333|516380791|FG000|Overall Study|Withdrawal by Subject|9|||
143227466|NCT02634333|516380792|FG001|Overall Study|Withdrawal by Subject|13|||
143227467|NCT02634333|516380791|FG000|Overall Study|Death|11|||
143227468|NCT02634333|516380792|FG001|Overall Study|Death|8|||
143227469|NCT02611479|516380793|FG000|Baseline Enrollment|Exited study|13|||
143227470|NCT02611479|516380793|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
143227471|NCT02611479|516380793|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
143227472|NCT02611479|516380793|FG000|Data Cleaning|No baseline function or pain metrics|2|||
143227473|NCT00423657|516380797|FG000|Overall Study|Withdrew consent|10|||
143227474|NCT00423657|516380798|FG001|Overall Study|Withdrew consent|8|||
143227475|NCT00423657|516380797|FG000|Overall Study|Non-compliance|0|||
143227476|NCT00423657|516380798|FG001|Overall Study|Non-compliance|1|||
143227477|NCT00423657|516380797|FG000|Overall Study|Other|15|||
143227478|NCT00423657|516380798|FG001|Overall Study|Other|16|||
143227479|NCT00423657|516380797|FG000|Overall Study|Request of sponsor/investigator|1|||
143227480|NCT00423657|516380798|FG001|Overall Study|Request of sponsor/investigator|0|||
143227481|NCT02748863|516380799|FG000|Treatment Period 1|Adverse Event|0|||
143227482|NCT02748863|516380800|FG001|Treatment Period 1|Adverse Event|1|||
143227483|NCT02748863|516380801|FG002|Treatment Period 1|Adverse Event|0|||
143227484|NCT02748863|516380802|FG003|Treatment Period 1|Adverse Event|0|||
143227485|NCT02748863|516380803|FG004|Treatment Period 1|Adverse Event|0|||
143227486|NCT02748863|516380799|FG000|Treatment Period 1|Lack of Efficacy|0|||
143227487|NCT02748863|516380800|FG001|Treatment Period 1|Lack of Efficacy|0|||
143227488|NCT02748863|516380801|FG002|Treatment Period 1|Lack of Efficacy|1|||
143227489|NCT02748863|516380802|FG003|Treatment Period 1|Lack of Efficacy|0|||
143268747|NCT03633617|516539027|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
143268748|NCT03633617|516539028|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
143268749|NCT03633617|516539029|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
143268750|NCT00777205|516539032|FG000|Overall Study|Lost to Follow-up|25|||
143268751|NCT00777205|516539033|FG001|Overall Study|Lost to Follow-up|9|||
143268752|NCT00777205|516539032|FG000|Overall Study|Withdrawal by Subject|6|||
143268753|NCT00777205|516539033|FG001|Overall Study|Withdrawal by Subject|4|||
143268754|NCT00777205|516539032|FG000|Overall Study|Death|0|||
143227490|NCT02748863|516380803|FG004|Treatment Period 1|Lack of Efficacy|0|||
143227491|NCT02748863|516380799|FG000|Treatment Period 1|Withdrawal by Subject|0|||
143227492|NCT02748863|516380800|FG001|Treatment Period 1|Withdrawal by Subject|1|||
143227493|NCT02748863|516380801|FG002|Treatment Period 1|Withdrawal by Subject|1|||
143227494|NCT02748863|516380802|FG003|Treatment Period 1|Withdrawal by Subject|0|||
143227495|NCT02748863|516380803|FG004|Treatment Period 1|Withdrawal by Subject|0|||
143227496|NCT02748863|516380799|FG000|Treatment Period 2|Lost to Follow-up|2|||
143227497|NCT02748863|516380800|FG001|Treatment Period 2|Lost to Follow-up|0|||
143227498|NCT02748863|516380801|FG002|Treatment Period 2|Lost to Follow-up|0|||
143227499|NCT02748863|516380802|FG003|Treatment Period 2|Lost to Follow-up|0|||
143268755|NCT00777205|516539033|FG001|Overall Study|Death|2|||
143268756|NCT00777205|516539032|FG000|Overall Study|Protocol Violation|0|||
143268757|NCT00777205|516539033|FG001|Overall Study|Protocol Violation|56|||
143268758|NCT01008150|516539035|FG000|Overall Study|did not receive study drug|1|||
143268759|NCT01008150|516539036|FG001|Overall Study|did not receive study drug|1|||
143268760|NCT01008150|516539037|FG002|Overall Study|did not receive study drug|1|||
143268761|NCT01008150|516539038|FG003|Overall Study|did not receive study drug|0|||
143268762|NCT01497275|516539040|FG000|Overall Study|Death|1|||
143268763|NCT01497275|516539040|FG000|Overall Study|Adverse Event|1|||
143268764|NCT01938573|516539041|FG000|Overall Study|Lack of Efficacy|1|||
143268765|NCT01938573|516539042|FG001|Overall Study|Lack of Efficacy|0|||
143268766|NCT01938573|516539041|FG000|Overall Study|Operation at other hospital|1|||
143268767|NCT01938573|516539042|FG001|Overall Study|Operation at other hospital|0|||
143268768|NCT00737438|516539046|FG000|Overall Study|Withdrawal by Subject|2|||
143268769|NCT00737438|516539046|FG000|Overall Study|Patient ineligible|1|||
143268770|NCT02410551|516539050|FG000|Overall Study|Adverse Event|1|||
143268771|NCT02410551|516539050|FG000|Overall Study|Withdrawal by Subject|1|||
143268772|NCT02410551|516539050|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
143268773|NCT01739309|516539051|FG000|Overall Study|Adverse Event|1|||
143268774|NCT01739309|516539051|FG000|Overall Study|Withdrawal by Subject|1|||
143268775|NCT05085730|516539052|FG000|Overall Study|Withdrawal by Subject|4|||
143268776|NCT05085730|516539052|FG000|Overall Study|Physician Decision|1|||
143268777|NCT05447897|516539053|FG000|Overall Study|Did not participate in survey|2|||
143268778|NCT03719586|516539054|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
143268779|NCT03719586|516539055|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
143268780|NCT03719586|516539056|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
143268781|NCT03719586|516539057|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
143268782|NCT00178633|516539058|FG000|Overall Study|Lost to Follow-up|6|||
143268783|NCT03845543|516539059|FG000|Overall Study|Death|25|||
143268784|NCT03845543|516539059|FG000|Overall Study|Withdrawal by Subject|2|||
143268785|NCT03845543|516539059|FG000|Overall Study|Lost to Follow-up|12|||
143268786|NCT03845543|516539059|FG000|Overall Study|Adverse Event|17|||
143268787|NCT02448810|516539065|FG000|Overall Study|Adverse Event|0|||
143268788|NCT02448810|516539066|FG001|Overall Study|Adverse Event|0|||
143268789|NCT02448810|516539067|FG002|Overall Study|Adverse Event|1|||
143268790|NCT02448810|516539068|FG003|Overall Study|Adverse Event|0|||
143268791|NCT02448810|516539069|FG004|Overall Study|Adverse Event|0|||
143268792|NCT02448810|516539070|FG005|Overall Study|Adverse Event|0|||
143268793|NCT02448810|516539071|FG006|Overall Study|Adverse Event|0|||
143268794|NCT02448810|516539072|FG007|Overall Study|Adverse Event|0|||
143268795|NCT02448810|516539065|FG000|Overall Study|Withdrawal by Subject|0|||
143268796|NCT02448810|516539066|FG001|Overall Study|Withdrawal by Subject|0|||
143268797|NCT02448810|516539067|FG002|Overall Study|Withdrawal by Subject|1|||
143268798|NCT02448810|516539068|FG003|Overall Study|Withdrawal by Subject|0|||
143268799|NCT02448810|516539069|FG004|Overall Study|Withdrawal by Subject|3|||
143268800|NCT02448810|516539070|FG005|Overall Study|Withdrawal by Subject|5|||
143268801|NCT02448810|516539071|FG006|Overall Study|Withdrawal by Subject|0|||
143268802|NCT02448810|516539072|FG007|Overall Study|Withdrawal by Subject|2|||
143268803|NCT02448810|516539065|FG000|Overall Study|Other (study terminated by sponsor)|0|||
143268804|NCT02448810|516539066|FG001|Overall Study|Other (study terminated by sponsor)|0|||
143268805|NCT02448810|516539067|FG002|Overall Study|Other (study terminated by sponsor)|0|||
143268806|NCT02448810|516539068|FG003|Overall Study|Other (study terminated by sponsor)|0|||
143268807|NCT02448810|516539069|FG004|Overall Study|Other (study terminated by sponsor)|4|||
143268808|NCT02448810|516539070|FG005|Overall Study|Other (study terminated by sponsor)|2|||
143268809|NCT02448810|516539071|FG006|Overall Study|Other (study terminated by sponsor)|2|||
143268810|NCT02448810|516539072|FG007|Overall Study|Other (study terminated by sponsor)|1|||
143268811|NCT02448810|516539065|FG000|Overall Study|Death|1|||
143268812|NCT02448810|516539066|FG001|Overall Study|Death|0|||
143268813|NCT02448810|516539067|FG002|Overall Study|Death|1|||
143268814|NCT02448810|516539068|FG003|Overall Study|Death|0|||
143268815|NCT02448810|516539069|FG004|Overall Study|Death|1|||
143268816|NCT02448810|516539070|FG005|Overall Study|Death|0|||
143268817|NCT02448810|516539071|FG006|Overall Study|Death|0|||
143268818|NCT02448810|516539072|FG007|Overall Study|Death|0|||
143268819|NCT02448810|516539065|FG000|Overall Study|Other (Progressive disease)|2|||
143268820|NCT02448810|516539066|FG001|Overall Study|Other (Progressive disease)|2|||
143268821|NCT02448810|516539067|FG002|Overall Study|Other (Progressive disease)|0|||
143268822|NCT02448810|516539068|FG003|Overall Study|Other (Progressive disease)|3|||
143268823|NCT02448810|516539069|FG004|Overall Study|Other (Progressive disease)|23|||
143268824|NCT02448810|516539070|FG005|Overall Study|Other (Progressive disease)|9|||
143268825|NCT02448810|516539071|FG006|Overall Study|Other (Progressive disease)|14|||
143268826|NCT02448810|516539072|FG007|Overall Study|Other (Progressive disease)|5|||
143268827|NCT02448810|516539065|FG000|Overall Study|Lost to Follow-up|0|||
143268828|NCT02448810|516539066|FG001|Overall Study|Lost to Follow-up|1|||
143268829|NCT02448810|516539067|FG002|Overall Study|Lost to Follow-up|0|||
143227500|NCT02748863|516380803|FG004|Treatment Period 2|Lost to Follow-up|0|||
143227501|NCT02748863|516380799|FG000|Treatment Period 2|Adverse Event|3|||
143227502|NCT02748863|516380800|FG001|Treatment Period 2|Adverse Event|2|||
143227503|NCT02748863|516380801|FG002|Treatment Period 2|Adverse Event|0|||
143227504|NCT02748863|516380802|FG003|Treatment Period 2|Adverse Event|2|||
143227505|NCT02748863|516380803|FG004|Treatment Period 2|Adverse Event|0|||
143227506|NCT02748863|516380799|FG000|Treatment Period 2|Lack of Efficacy|0|||
143227507|NCT02748863|516380800|FG001|Treatment Period 2|Lack of Efficacy|1|||
143227508|NCT02748863|516380801|FG002|Treatment Period 2|Lack of Efficacy|0|||
143227509|NCT02748863|516380802|FG003|Treatment Period 2|Lack of Efficacy|0|||
143227510|NCT02748863|516380803|FG004|Treatment Period 2|Lack of Efficacy|0|||
143227511|NCT02748863|516380799|FG000|Treatment Period 2|Pregnancy|0|||
143227512|NCT02748863|516380800|FG001|Treatment Period 2|Pregnancy|0|||
143227513|NCT02748863|516380801|FG002|Treatment Period 2|Pregnancy|0|||
143227514|NCT02748863|516380802|FG003|Treatment Period 2|Pregnancy|0|||
143227515|NCT02748863|516380803|FG004|Treatment Period 2|Pregnancy|1|||
143227516|NCT02422498|516380804|FG000|Overall Study|Inevaluable|4|||
143227517|NCT03206216|516380806|FG000|Overall Study|Withdrawal by Subject|0|||
143227518|NCT03206216|516380807|FG001|Overall Study|Withdrawal by Subject|1|||
143227519|NCT00231777|516380808|FG000|Overall Study|Lost to Follow-up|3|||
143227520|NCT00231777|516380809|FG001|Overall Study|Lost to Follow-up|0|||
143227521|NCT00231777|516380808|FG000|Overall Study|Other|3|||
143227522|NCT00231777|516380809|FG001|Overall Study|Other|2|||
143227523|NCT00657046|516380812|FG000|Overall Study|Adverse Event|1|||
143227524|NCT00657046|516380813|FG001|Overall Study|Adverse Event|1|||
143227525|NCT00657046|516380814|FG002|Overall Study|Adverse Event|0|||
143227526|NCT00657046|516380812|FG000|Overall Study|Protocol Violation|2|||
143227527|NCT00657046|516380813|FG001|Overall Study|Protocol Violation|2|||
143227528|NCT00657046|516380814|FG002|Overall Study|Protocol Violation|0|||
143227529|NCT00657046|516380812|FG000|Overall Study|Withdrawal by Subject|1|||
143227530|NCT00657046|516380813|FG001|Overall Study|Withdrawal by Subject|0|||
143227531|NCT00657046|516380814|FG002|Overall Study|Withdrawal by Subject|0|||
143227532|NCT00657046|516380812|FG000|Overall Study|Death|0|||
143227533|NCT00657046|516380813|FG001|Overall Study|Death|0|||
143227534|NCT00657046|516380814|FG002|Overall Study|Death|1|||
143227535|NCT00657046|516380812|FG000|Overall Study|Surgery|0|||
143227536|NCT00657046|516380813|FG001|Overall Study|Surgery|0|||
143227537|NCT00657046|516380814|FG002|Overall Study|Surgery|1|||
143227538|NCT06237049|516380815|FG000|Overall Study|Death|0|||
143227539|NCT06237049|516380816|FG001|Overall Study|Death|0|||
143227540|NCT06237049|516380817|FG002|Overall Study|Death|0|||
143227541|NCT06237049|516380818|FG003|Overall Study|Death|1|||
143227542|NCT06237049|516380815|FG000|Overall Study|Lost to Follow-up|11|||
143227543|NCT06237049|516380816|FG001|Overall Study|Lost to Follow-up|5|||
143227544|NCT06237049|516380817|FG002|Overall Study|Lost to Follow-up|8|||
143227545|NCT06237049|516380818|FG003|Overall Study|Lost to Follow-up|8|||
143227546|NCT06237049|516380815|FG000|Overall Study|Protocol Violation|0|||
143227547|NCT06237049|516380816|FG001|Overall Study|Protocol Violation|1|||
143227548|NCT06237049|516380817|FG002|Overall Study|Protocol Violation|0|||
143227549|NCT06237049|516380818|FG003|Overall Study|Protocol Violation|1|||
143227550|NCT06237049|516380815|FG000|Overall Study|Withdrawal by Subject|4|||
143227551|NCT06237049|516380816|FG001|Overall Study|Withdrawal by Subject|2|||
143227552|NCT06237049|516380817|FG002|Overall Study|Withdrawal by Subject|1|||
143227553|NCT06237049|516380818|FG003|Overall Study|Withdrawal by Subject|0|||
143227554|NCT02525471|516380819|FG000|Overall Study|Screen Failure|6|||
143227555|NCT02525471|516380819|FG000|Overall Study|Withdrawal by Subject|4|||
143227556|NCT02525471|516380819|FG000|Overall Study|Death|1|||
143227557|NCT04621448|516380820|FG000|Baseline to 12 Weeks|Withdrawal by Subject|6|||
143227558|NCT04621448|516380821|FG001|Baseline to 12 Weeks|Withdrawal by Subject|8|||
143227559|NCT04621448|516380822|FG002|Baseline to 12 Weeks|Withdrawal by Subject|6|||
143227560|NCT04621448|516380823|FG003|Baseline to 12 Weeks|Withdrawal by Subject|8|||
143227561|NCT04621448|516380820|FG000|Baseline to 12 Weeks|Lost to Follow-up|0|||
143227562|NCT04621448|516380821|FG001|Baseline to 12 Weeks|Lost to Follow-up|1|||
143227563|NCT04621448|516380822|FG002|Baseline to 12 Weeks|Lost to Follow-up|0|||
143227564|NCT04621448|516380823|FG003|Baseline to 12 Weeks|Lost to Follow-up|1|||
143227565|NCT04621448|516380820|FG000|12 to 24 Weeks|Lost to Follow-up|1|||
143227566|NCT04621448|516380821|FG001|12 to 24 Weeks|Lost to Follow-up|0|||
143227567|NCT04621448|516380822|FG002|12 to 24 Weeks|Lost to Follow-up|1|||
143227568|NCT04621448|516380823|FG003|12 to 24 Weeks|Lost to Follow-up|0|||
143227569|NCT04621448|516380820|FG000|12 to 24 Weeks|Withdrawal by Subject|3|||
143227570|NCT04621448|516380821|FG001|12 to 24 Weeks|Withdrawal by Subject|2|||
143227571|NCT04621448|516380822|FG002|12 to 24 Weeks|Withdrawal by Subject|3|||
143227572|NCT04621448|516380823|FG003|12 to 24 Weeks|Withdrawal by Subject|2|||
143227573|NCT04486235|516380826|FG000|Overall Study|Pregnancy|1|||
143227574|NCT04486235|516380827|FG001|Overall Study|Pregnancy|0|||
143227575|NCT04486235|516380826|FG000|Overall Study|Lost to Follow-up|1|||
143227576|NCT04486235|516380827|FG001|Overall Study|Lost to Follow-up|0|||
143227577|NCT03935126|516380828|FG000|Overall Study|Study termination by sponsor|3|||
143227578|NCT03546621|516380829|FG000|Overall Study|Withdrawal by Subject|0|||
143227579|NCT03546621|516380830|FG001|Overall Study|Withdrawal by Subject|1|||
143268830|NCT02448810|516539068|FG003|Overall Study|Lost to Follow-up|0|||
143268831|NCT02448810|516539069|FG004|Overall Study|Lost to Follow-up|0|||
143268832|NCT02448810|516539070|FG005|Overall Study|Lost to Follow-up|0|||
143268833|NCT02448810|516539071|FG006|Overall Study|Lost to Follow-up|0|||
143268834|NCT02448810|516539072|FG007|Overall Study|Lost to Follow-up|0|||
143268835|NCT02448810|516539065|FG000|Overall Study|Other (unspecified)|0|||
143268836|NCT02448810|516539066|FG001|Overall Study|Other (unspecified)|0|||
143268837|NCT02448810|516539067|FG002|Overall Study|Other (unspecified)|0|||
143268838|NCT02448810|516539068|FG003|Overall Study|Other (unspecified)|0|||
143268839|NCT02448810|516539069|FG004|Overall Study|Other (unspecified)|0|||
143268840|NCT02448810|516539070|FG005|Overall Study|Other (unspecified)|0|||
143268841|NCT02448810|516539071|FG006|Overall Study|Other (unspecified)|2|||
143268842|NCT02448810|516539072|FG007|Overall Study|Other (unspecified)|0|||
143268843|NCT01916967|516539079|FG000|Overall Study|Adverse Event|0|||
143268844|NCT01916967|516539080|FG001|Overall Study|Adverse Event|0|||
143268845|NCT01916967|516539081|FG002|Overall Study|Adverse Event|2|||
143268846|NCT01916967|516539079|FG000|Overall Study|Lack of Efficacy|0|||
143268847|NCT01916967|516539080|FG001|Overall Study|Lack of Efficacy|0|||
143268848|NCT01916967|516539081|FG002|Overall Study|Lack of Efficacy|6|||
143268849|NCT01916967|516539079|FG000|Overall Study|Physician Decision|0|||
143268850|NCT01916967|516539080|FG001|Overall Study|Physician Decision|0|||
143268851|NCT01916967|516539081|FG002|Overall Study|Physician Decision|1|||
143268852|NCT01916967|516539079|FG000|Overall Study|Protocol Violation|0|||
143268853|NCT01916967|516539080|FG001|Overall Study|Protocol Violation|1|||
143268854|NCT01916967|516539081|FG002|Overall Study|Protocol Violation|0|||
143268855|NCT01104155|516539086|FG000|Overall Study|Adverse Event|15|||
143268856|NCT01104155|516539087|FG001|Overall Study|Adverse Event|8|||
143268857|NCT01104155|516539086|FG000|Overall Study|Participant choice|6|||
143268858|NCT01104155|516539087|FG001|Overall Study|Participant choice|5|||
143268859|NCT01104155|516539086|FG000|Overall Study|Withdrawal of consent|1|||
143268860|NCT01104155|516539087|FG001|Overall Study|Withdrawal of consent|1|||
143268861|NCT01104155|516539086|FG000|Overall Study|Other|3|||
143268862|NCT01104155|516539087|FG001|Overall Study|Other|4|||
143268863|NCT02787551|516539093|FG000|Core Period: 26 Weeks|Adverse Event|10|||
143268864|NCT02787551|516539094|FG001|Core Period: 26 Weeks|Adverse Event|0|||
143268865|NCT02787551|516539093|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
143268866|NCT02787551|516539094|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
143268867|NCT02787551|516539093|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
143268868|NCT02787551|516539094|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
143268869|NCT02787551|516539093|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
143268870|NCT02787551|516539094|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
143268871|NCT02787551|516539093|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
143268872|NCT02787551|516539094|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
143268873|NCT02787551|516539093|FG000|Core Period: 26 Weeks|Other than specified|3|||
143268874|NCT02787551|516539094|FG001|Core Period: 26 Weeks|Other than specified|1|||
143268875|NCT02787551|516539093|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
143268876|NCT02787551|516539094|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
143268877|NCT02787551|516539093|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
143268878|NCT02787551|516539094|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
143268879|NCT02787551|516539093|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
143268880|NCT02787551|516539094|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
143268881|NCT03799211|516539095|FG000|Overall Study|Lost to Follow-up|2|||
143268882|NCT03799211|516539096|FG001|Overall Study|Lost to Follow-up|13|||
143268883|NCT03799211|516539095|FG000|Overall Study|Withdrawal by Subject|2|||
143268884|NCT03799211|516539096|FG001|Overall Study|Withdrawal by Subject|0|||
143268885|NCT00923936|516539097|FG000|Overall Study|progressive disease on study|2|||
143268886|NCT00923936|516539098|FG001|Overall Study|progressive disease on study|1|||
143268887|NCT00923936|516539097|FG000|Overall Study|Adverse Event|2|||
143268888|NCT00923936|516539098|FG001|Overall Study|Adverse Event|1|||
143268889|NCT00923936|516539097|FG000|Overall Study|Lost to follow up|2|||
143268890|NCT00923936|516539098|FG001|Overall Study|Lost to follow up|0|||
143268891|NCT00923936|516539097|FG000|Overall Study|Continuing in follow up period|2|||
143268892|NCT00923936|516539098|FG001|Overall Study|Continuing in follow up period|1|||
143268893|NCT02038452|516539100|FG000|Overall Study|Withdrawal by Subject|7|||
143268894|NCT02038452|516539101|FG001|Overall Study|Withdrawal by Subject|9|||
143268895|NCT02038452|516539100|FG000|Overall Study|Lost to Follow-up|31|||
143268896|NCT02038452|516539101|FG001|Overall Study|Lost to Follow-up|28|||
143268897|NCT02337738|516539104|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
143268898|NCT02337738|516539105|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
143268899|NCT02337738|516539106|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
143268900|NCT02337738|516539104|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
143268901|NCT02337738|516539105|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
143268902|NCT02337738|516539106|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
143268903|NCT02337738|516539104|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
143268904|NCT02337738|516539105|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
143268905|NCT02337738|516539106|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
143268906|NCT02337738|516539104|FG000|Overall Study|Voluntary Withdrawal|10|||
143268907|NCT02337738|516539105|FG001|Overall Study|Voluntary Withdrawal|5|||
143268908|NCT02337738|516539106|FG002|Overall Study|Voluntary Withdrawal|2|||
143268909|NCT02337738|516539104|FG000|Overall Study|Lack of Efficacy|2|||
143268910|NCT02337738|516539105|FG001|Overall Study|Lack of Efficacy|4|||
143268911|NCT02337738|516539106|FG002|Overall Study|Lack of Efficacy|0|||
143268912|NCT02337738|516539104|FG000|Overall Study|Investigator's Judgment|1|||
143268913|NCT02337738|516539105|FG001|Overall Study|Investigator's Judgment|1|||
143268914|NCT02337738|516539106|FG002|Overall Study|Investigator's Judgment|3|||
143268915|NCT00406354|516539107|FG000|All Randomized Patients|Protocol Violation|0|||
143268916|NCT00406354|516539108|FG001|All Randomized Patients|Protocol Violation|0|||
143268917|NCT00406354|516539109|FG002|All Randomized Patients|Protocol Violation|1|||
143268918|NCT00406354|516539107|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
143268919|NCT00406354|516539108|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
143268920|NCT00406354|516539109|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
143268921|NCT00406354|516539107|FG000|All Randomized and Treated Patients|Adverse Event|6|||
143268922|NCT00406354|516539108|FG001|All Randomized and Treated Patients|Adverse Event|2|||
143268923|NCT00406354|516539109|FG002|All Randomized and Treated Patients|Adverse Event|1|||
143268924|NCT00406354|516539107|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
143268925|NCT00406354|516539108|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
143268926|NCT00406354|516539109|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
143268927|NCT00406354|516539107|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
143268928|NCT00406354|516539108|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
143268929|NCT00406354|516539109|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
143268930|NCT00406354|516539107|FG000|All Randomized and Treated Patients|Physician Decision|0|||
143268931|NCT00406354|516539108|FG001|All Randomized and Treated Patients|Physician Decision|0|||
143268932|NCT00406354|516539109|FG002|All Randomized and Treated Patients|Physician Decision|1|||
143268933|NCT00304239|516539110|FG000|Overall Study|Protocol Deviations/Violations|15|||
143268934|NCT00304239|516539111|FG001|Overall Study|Protocol Deviations/Violations|0|||
143268935|NCT00304239|516539110|FG000|Overall Study|Adverse Event|2|||
143268936|NCT00304239|516539111|FG001|Overall Study|Adverse Event|0|||
143268937|NCT02436681|516539112|FG000|Overall Study|Lost to Follow-up|10|||
143268938|NCT02436681|516539112|FG000|Overall Study|Withdrawal by Subject|2|||
143268939|NCT02436681|516539112|FG000|Overall Study|Death|2|||
143268940|NCT03954132|516539114|FG000|Overall Study|Adverse Event|2|||
143268941|NCT03954132|516539115|FG001|Overall Study|Adverse Event|0|||
143268942|NCT03954132|516539114|FG000|Overall Study|Patient's wish|5|||
143268943|NCT03954132|516539115|FG001|Overall Study|Patient's wish|0|||
143268944|NCT03954132|516539114|FG000|Overall Study|Lost to Follow-up|10|||
143268945|NCT03954132|516539115|FG001|Overall Study|Lost to Follow-up|0|||
143268946|NCT03954132|516539114|FG000|Overall Study|Screening failure|0|||
143268947|NCT03954132|516539115|FG001|Overall Study|Screening failure|1|||
143268948|NCT03954132|516539114|FG000|Overall Study|No registration after Visit 1|5|||
143268949|NCT03954132|516539115|FG001|Overall Study|No registration after Visit 1|2|||
143268950|NCT03954132|516539114|FG000|Overall Study|Other reason than listed|2|||
143268951|NCT03954132|516539115|FG001|Overall Study|Other reason than listed|2|||
143268952|NCT03954132|516539114|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
143268953|NCT03954132|516539115|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
143268954|NCT03954132|516539114|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
143268955|NCT03954132|516539115|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
143268956|NCT00932737|516539118|FG000|Overall Study|Not treated in second episode|1|||
143268957|NCT00932737|516539119|FG001|Overall Study|Not treated in second episode|0|||
143268958|NCT00932737|516539118|FG000|Overall Study|Adverse Event|0|||
143268959|NCT00932737|516539119|FG001|Overall Study|Adverse Event|1|||
143268960|NCT02906332|516539125|FG000|Overall Study|Withdrawal by Subject|1|||
143268961|NCT02949700|516539126|FG000|Phase I|Withdrawal by Subject|1|||
143268962|NCT02949700|516539127|FG001|Phase I|Withdrawal by Subject|1|||
143268963|NCT02949700|516539128|FG002|Phase I|Withdrawal by Subject|0|||
143268964|NCT02949700|516539129|FG003|Phase I|Withdrawal by Subject|0|||
143268965|NCT02949700|516539126|FG000|Phase I|Protocol Violation|1|||
143268966|NCT02949700|516539127|FG001|Phase I|Protocol Violation|0|||
143268967|NCT02949700|516539128|FG002|Phase I|Protocol Violation|0|||
143268968|NCT02949700|516539129|FG003|Phase I|Protocol Violation|0|||
143268969|NCT02949700|516539126|FG000|Phase II|Withdrawal by Subject|0|||
143268970|NCT02949700|516539127|FG001|Phase II|Withdrawal by Subject|0|||
143268971|NCT02949700|516539128|FG002|Phase II|Withdrawal by Subject|0|||
143268972|NCT02949700|516539129|FG003|Phase II|Withdrawal by Subject|2|||
143268973|NCT02949700|516539126|FG000|Phase II|Protocol Violation|0|||
143372581|NCT00756730|516909579|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
143372582|NCT00756730|516909578|FG000|Overall Study|persistent low-level viremmia|0|||
143268974|NCT02949700|516539127|FG001|Phase II|Protocol Violation|0|||
143268975|NCT02949700|516539128|FG002|Phase II|Protocol Violation|1|||
143268976|NCT02949700|516539129|FG003|Phase II|Protocol Violation|3|||
143268977|NCT01414608|516539133|FG000|Overall Study|Ineligible|5|||
143268978|NCT01414608|516539134|FG001|Overall Study|Ineligible|2|||
143268979|NCT00866788|516540714|FG000|Overall Study|Adverse Event|0|||
143268980|NCT00866788|516540715|FG001|Overall Study|Adverse Event|2|||
143268981|NCT00866788|516540716|FG002|Overall Study|Adverse Event|0|||
143268982|NCT00866788|516540717|FG003|Overall Study|Adverse Event|1|||
143268983|NCT00866788|516540714|FG000|Overall Study|Lost to Follow-up|1|||
143268984|NCT00866788|516540715|FG001|Overall Study|Lost to Follow-up|1|||
143268985|NCT00866788|516540716|FG002|Overall Study|Lost to Follow-up|0|||
143268986|NCT00866788|516540717|FG003|Overall Study|Lost to Follow-up|2|||
143268987|NCT00866788|516540714|FG000|Overall Study|Withdrawal by Subject|2|||
143372583|NCT00756730|516909579|FG001|Overall Study|persistent low-level viremmia|1|||
143372584|NCT03210402|516909580|FG000|Overall Study|Withdrawal by Subject|0|||
143227580|NCT03546621|516380831|FG002|Overall Study|Withdrawal by Subject|2|||
143227581|NCT03546621|516380832|FG003|Overall Study|Withdrawal by Subject|1|||
143227582|NCT03546621|516380829|FG000|Overall Study|Lost to Follow-up|0|||
143227583|NCT03546621|516380830|FG001|Overall Study|Lost to Follow-up|1|||
143227584|NCT03546621|516380831|FG002|Overall Study|Lost to Follow-up|0|||
143227585|NCT03546621|516380832|FG003|Overall Study|Lost to Follow-up|0|||
143227586|NCT03546621|516380829|FG000|Overall Study|Adverse Event|0|||
143227587|NCT03546621|516380830|FG001|Overall Study|Adverse Event|1|||
143227588|NCT03546621|516380831|FG002|Overall Study|Adverse Event|0|||
143227589|NCT03546621|516380832|FG003|Overall Study|Adverse Event|1|||
143227590|NCT03546621|516380829|FG000|Overall Study|Progressive disease|0|||
143227591|NCT03546621|516380830|FG001|Overall Study|Progressive disease|0|||
143227592|NCT03546621|516380831|FG002|Overall Study|Progressive disease|0|||
143227593|NCT03546621|516380832|FG003|Overall Study|Progressive disease|1|||
143227594|NCT00377520|516380838|FG000|Overall Study|Ineligible (Prior radiation)|1|||
143227595|NCT01091675|516380843|FG000|Overall Study|Adverse Event|7|||
143227596|NCT01091675|516380843|FG000|Overall Study|Lack of Efficacy|27|||
143227597|NCT03040141|516380844|FG000|Overall Study|Death|1|||
143227598|NCT03040141|516380845|FG001|Overall Study|Death|2|||
143227599|NCT03040141|516380846|FG002|Overall Study|Death|3|||
143227600|NCT03040141|516380844|FG000|Overall Study|Withdrawal by Subject|3|||
143227601|NCT03040141|516380845|FG001|Overall Study|Withdrawal by Subject|1|||
143227602|NCT03040141|516380846|FG002|Overall Study|Withdrawal by Subject|1|||
143227603|NCT03040141|516380844|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
143227604|NCT03040141|516380845|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
143227605|NCT03040141|516380846|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
143227606|NCT03040141|516380844|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
143227607|NCT03040141|516380845|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
143227608|NCT03040141|516380846|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
143227609|NCT03318549|516380847|FG000|Overall Study|Withdrawal by Subject|5|||
143227610|NCT03318549|516380848|FG001|Overall Study|Withdrawal by Subject|19|||
143227611|NCT03318549|516380849|FG002|Overall Study|Withdrawal by Subject|2|||
143227612|NCT03318549|516380850|FG003|Overall Study|Withdrawal by Subject|0|||
143227613|NCT03318549|516380851|FG004|Overall Study|Withdrawal by Subject|0|||
143227614|NCT03318549|516380852|FG005|Overall Study|Withdrawal by Subject|0|||
143227615|NCT03318549|516380853|FG006|Overall Study|Withdrawal by Subject|0|||
143227616|NCT03318549|516380847|FG000|Overall Study|Physician Decision|0|||
143227617|NCT03318549|516380848|FG001|Overall Study|Physician Decision|4|||
143227618|NCT03318549|516380849|FG002|Overall Study|Physician Decision|1|||
143227619|NCT03318549|516380850|FG003|Overall Study|Physician Decision|0|||
143227620|NCT03318549|516380851|FG004|Overall Study|Physician Decision|0|||
143227621|NCT03318549|516380852|FG005|Overall Study|Physician Decision|0|||
143227622|NCT03318549|516380853|FG006|Overall Study|Physician Decision|0|||
143227623|NCT03318549|516380847|FG000|Overall Study|Lost to Follow-up|0|||
143227624|NCT03318549|516380848|FG001|Overall Study|Lost to Follow-up|3|||
143227625|NCT03318549|516380849|FG002|Overall Study|Lost to Follow-up|3|||
143227626|NCT03318549|516380850|FG003|Overall Study|Lost to Follow-up|0|||
143227627|NCT03318549|516380851|FG004|Overall Study|Lost to Follow-up|0|||
143227628|NCT03318549|516380852|FG005|Overall Study|Lost to Follow-up|0|||
143227629|NCT03318549|516380853|FG006|Overall Study|Lost to Follow-up|0|||
143227630|NCT01787461|516380858|FG000|Overall Study|Adverse Event|4|||
143227631|NCT01787461|516380859|FG001|Overall Study|Adverse Event|3|||
143227632|NCT01787461|516380858|FG000|Overall Study|Lost to Follow-up|3|||
143227633|NCT01787461|516380859|FG001|Overall Study|Lost to Follow-up|2|||
143268988|NCT00866788|516540715|FG001|Overall Study|Withdrawal by Subject|1|||
143268989|NCT00866788|516540716|FG002|Overall Study|Withdrawal by Subject|0|||
143268990|NCT00866788|516540717|FG003|Overall Study|Withdrawal by Subject|1|||
143268991|NCT00866788|516540714|FG000|Overall Study|Pregnancy|0|||
143268992|NCT00866788|516540715|FG001|Overall Study|Pregnancy|1|||
143268993|NCT00866788|516540716|FG002|Overall Study|Pregnancy|0|||
143268994|NCT00866788|516540717|FG003|Overall Study|Pregnancy|0|||
143268995|NCT00866788|516540714|FG000|Overall Study|Disease progression|3|||
143268996|NCT00866788|516540715|FG001|Overall Study|Disease progression|1|||
143268997|NCT00866788|516540716|FG002|Overall Study|Disease progression|1|||
143268998|NCT00866788|516540717|FG003|Overall Study|Disease progression|0|||
143268999|NCT00866788|516540714|FG000|Overall Study|Physician Decision|0|||
143269000|NCT00866788|516540715|FG001|Overall Study|Physician Decision|0|||
143269001|NCT00866788|516540716|FG002|Overall Study|Physician Decision|1|||
143269002|NCT00866788|516540717|FG003|Overall Study|Physician Decision|1|||
143269003|NCT01854658|516540720|FG000|Overall Study|Protocol Violation|6|||
143269004|NCT01854658|516540721|FG001|Overall Study|Protocol Violation|2|||
143269005|NCT01854658|516540722|FG002|Overall Study|Protocol Violation|2|||
143269006|NCT01854658|516540723|FG003|Overall Study|Protocol Violation|1|||
143269007|NCT01854658|516540720|FG000|Overall Study|Physician Decision|7|||
143269008|NCT01854658|516540721|FG001|Overall Study|Physician Decision|5|||
143269009|NCT01854658|516540722|FG002|Overall Study|Physician Decision|2|||
143269010|NCT01854658|516540723|FG003|Overall Study|Physician Decision|4|||
143269011|NCT01854658|516540720|FG000|Overall Study|Lost to Follow-up|8|||
143269012|NCT01854658|516540721|FG001|Overall Study|Lost to Follow-up|9|||
143269013|NCT01854658|516540722|FG002|Overall Study|Lost to Follow-up|8|||
143269014|NCT01854658|516540723|FG003|Overall Study|Lost to Follow-up|4|||
143269015|NCT01854658|516540720|FG000|Overall Study|Withdrawal by Subject|28|||
143269016|NCT01854658|516540721|FG001|Overall Study|Withdrawal by Subject|21|||
143269017|NCT01854658|516540722|FG002|Overall Study|Withdrawal by Subject|29|||
143269018|NCT01854658|516540723|FG003|Overall Study|Withdrawal by Subject|15|||
143269019|NCT01854658|516540720|FG000|Overall Study|Protocol-specified criteria|15|||
143269020|NCT01854658|516540721|FG001|Overall Study|Protocol-specified criteria|15|||
143269021|NCT01854658|516540722|FG002|Overall Study|Protocol-specified criteria|10|||
143269022|NCT01854658|516540723|FG003|Overall Study|Protocol-specified criteria|7|||
143269023|NCT01854658|516540720|FG000|Overall Study|Lack of Efficacy|3|||
143269024|NCT01854658|516540721|FG001|Overall Study|Lack of Efficacy|8|||
143269025|NCT01854658|516540722|FG002|Overall Study|Lack of Efficacy|4|||
143269026|NCT01854658|516540723|FG003|Overall Study|Lack of Efficacy|7|||
143269027|NCT01854658|516540720|FG000|Overall Study|Adverse Event|21|||
143269028|NCT01854658|516540721|FG001|Overall Study|Adverse Event|14|||
143269029|NCT01854658|516540722|FG002|Overall Study|Adverse Event|23|||
143269030|NCT01854658|516540723|FG003|Overall Study|Adverse Event|19|||
143269031|NCT01854658|516540720|FG000|Overall Study|Administrative reasons|5|||
143269032|NCT01854658|516540721|FG001|Overall Study|Administrative reasons|1|||
143269033|NCT01854658|516540722|FG002|Overall Study|Administrative reasons|2|||
143269034|NCT01854658|516540723|FG003|Overall Study|Administrative reasons|2|||
143269035|NCT00697073|516540724|FG000|Overall Study|Withdrawal by Subject|2|||
143269036|NCT00697073|516540724|FG000|Overall Study|Pregnancy|1|||
143269037|NCT00697073|516540724|FG000|Overall Study|non compliance and other|6|||
143269038|NCT03265665|516540725|FG000|24-week Data Collection|Withdrawal by Subject|2|||
143269039|NCT03265665|516540726|FG001|24-week Data Collection|Withdrawal by Subject|2|||
143269040|NCT03265665|516540725|FG000|24-week Data Collection|Lost to Follow-up|4|||
143269041|NCT03265665|516540726|FG001|24-week Data Collection|Lost to Follow-up|5|||
143269042|NCT03265665|516540725|FG000|36-week Data Collection|Lost to Follow-up|6|||
143269043|NCT03265665|516540726|FG001|36-week Data Collection|Lost to Follow-up|8|||
143269044|NCT02486302|516540727|FG000|Overall Study|Discontinued prematurely|410|||
143269045|NCT02486302|516540727|FG000|Overall Study|Documentation not completed|255|||
143269046|NCT02486302|516540727|FG000|Overall Study|Excluded due to legal reasons|8|||
143269047|NCT02486302|516540727|FG000|Overall Study|Not treated|3|||
143269048|NCT05061966|516540730|FG000|Overall Study|Lost to Follow-up|13|||
143269049|NCT05061966|516540731|FG001|Overall Study|Lost to Follow-up|13|||
143269050|NCT03793556|516540732|FG000|Overall Study|Withdrawal by Subject|12|||
143269051|NCT03793556|516540733|FG001|Overall Study|Withdrawal by Subject|1|||
143269052|NCT03793556|516540732|FG000|Overall Study|Lost to Follow-up|1|||
143269053|NCT03793556|516540733|FG001|Overall Study|Lost to Follow-up|1|||
143269054|NCT04416633|516540734|FG000|Overall Study|Death|1|||
143269055|NCT04416633|516540734|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
143269056|NCT04416633|516540734|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
143269057|NCT04416633|516540734|FG000|Overall Study|Adverse Event|6|||
143269058|NCT04416633|516540734|FG000|Overall Study|Withdrawal by Subject|6|||
143269059|NCT00573937|516540736|FG000|Overall Study|Study Terminated|0|||
143269060|NCT00573937|516540737|FG001|Overall Study|Study Terminated|1|||
143269061|NCT01890746|516540740|FG000|Overall Study|Death|39|||
143269062|NCT01890746|516540741|FG001|Overall Study|Death|30|||
143269063|NCT01890746|516540740|FG000|Overall Study|Adverse Event|1|||
143269064|NCT01890746|516540741|FG001|Overall Study|Adverse Event|0|||
143269065|NCT01890746|516540740|FG000|Overall Study|Lost to Follow-up|4|||
143269066|NCT01890746|516540741|FG001|Overall Study|Lost to Follow-up|1|||
143269067|NCT01890746|516540740|FG000|Overall Study|Physician Decision|3|||
143269068|NCT01890746|516540741|FG001|Overall Study|Physician Decision|2|||
143269069|NCT01890746|516540740|FG000|Overall Study|Withdrawal by Subject|5|||
143269070|NCT01890746|516540741|FG001|Overall Study|Withdrawal by Subject|8|||
143269071|NCT03257371|516540744|FG000|Overall Study|Lost to Follow-up|1|||
143269072|NCT03198078|516540747|FG000|Overall Study|Adverse Event|0|||
143269073|NCT03198078|516540748|FG001|Overall Study|Adverse Event|1|||
143269074|NCT03198078|516540749|FG002|Overall Study|Adverse Event|2|||
143269075|NCT03198078|516540747|FG000|Overall Study|Lack of Efficacy|0|||
143269076|NCT03198078|516540748|FG001|Overall Study|Lack of Efficacy|0|||
143269077|NCT03198078|516540749|FG002|Overall Study|Lack of Efficacy|3|||
143269078|NCT03198078|516540747|FG000|Overall Study|Lost to Follow-up|1|||
143269079|NCT03198078|516540748|FG001|Overall Study|Lost to Follow-up|0|||
143269080|NCT03198078|516540749|FG002|Overall Study|Lost to Follow-up|0|||
143269081|NCT03198078|516540747|FG000|Overall Study|Pregnancy|0|||
143269082|NCT03198078|516540748|FG001|Overall Study|Pregnancy|1|||
143269083|NCT03198078|516540749|FG002|Overall Study|Pregnancy|0|||
143269084|NCT03198078|516540747|FG000|Overall Study|Withdrawal by Subject|1|||
143269085|NCT03198078|516540748|FG001|Overall Study|Withdrawal by Subject|0|||
143269086|NCT03198078|516540749|FG002|Overall Study|Withdrawal by Subject|2|||
143269087|NCT03198078|516540747|FG000|Overall Study|Withdrawal by Caregiver|1|||
143269088|NCT03198078|516540748|FG001|Overall Study|Withdrawal by Caregiver|3|||
143269089|NCT03198078|516540749|FG002|Overall Study|Withdrawal by Caregiver|5|||
143269090|NCT01676727|516540750|FG000|Overall Study|Death|18|||
143269091|NCT01676727|516540750|FG000|Overall Study|Withdrawal by Subject|6|||
143269092|NCT01676727|516540750|FG000|Overall Study|Screening failure|5|||
143269093|NCT01676727|516540750|FG000|Overall Study|Not willing to attend 1-year visit|2|||
143269094|NCT01676727|516540750|FG000|Overall Study|Valve explanted|1|||
143269095|NCT01134731|516540751|FG000|Overall Study|Adverse Event|3|||
143269096|NCT01134731|516540752|FG001|Overall Study|Adverse Event|2|||
143269097|NCT01134731|516540753|FG002|Overall Study|Adverse Event|1|||
143269098|NCT01134731|516540751|FG000|Overall Study|Physician Decision|2|||
143269099|NCT01134731|516540752|FG001|Overall Study|Physician Decision|2|||
143269100|NCT01134731|516540753|FG002|Overall Study|Physician Decision|2|||
143269101|NCT01134731|516540751|FG000|Overall Study|Lack of Efficacy|0|||
143269102|NCT01134731|516540752|FG001|Overall Study|Lack of Efficacy|0|||
143269103|NCT01134731|516540753|FG002|Overall Study|Lack of Efficacy|1|||
143269104|NCT01134731|516540751|FG000|Overall Study|Withdrawal by Subject|3|||
143269105|NCT01134731|516540752|FG001|Overall Study|Withdrawal by Subject|3|||
143269106|NCT01134731|516540753|FG002|Overall Study|Withdrawal by Subject|1|||
143269107|NCT01134731|516540751|FG000|Overall Study|Lost to Follow-up|5|||
143269108|NCT01134731|516540752|FG001|Overall Study|Lost to Follow-up|4|||
143269109|NCT01134731|516540753|FG002|Overall Study|Lost to Follow-up|3|||
143269110|NCT01050543|516540754|FG000|Overall Study|Withdrawal by Subject|0|||
143269111|NCT01050543|516540755|FG001|Overall Study|Withdrawal by Subject|2|||
143269112|NCT01050543|516540754|FG000|Overall Study|Protocol Violation|0|||
143269113|NCT01050543|516540755|FG001|Overall Study|Protocol Violation|1|||
143269114|NCT01050543|516540754|FG000|Overall Study|Administrative|4|||
143269115|NCT01050543|516540755|FG001|Overall Study|Administrative|1|||
143269116|NCT00580970|516540758|FG000|Pre-treatment|Non-compliance|1|||
143269117|NCT00580970|516540758|FG000|Treatment (Lovastatin)|Non-compliance|6|||
143269118|NCT00580970|516540758|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
143269119|NCT00580970|516540758|FG000|Treatment (Lovastatin)|Physician Decision|4|||
143269120|NCT00580970|516540758|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
143269121|NCT00580970|516540758|FG000|Treatment (Lovastatin)|Death|1|||
143269122|NCT03161093|516540761|FG000|Overall Study|Protocol Violation|11|||
143269123|NCT03161093|516540762|FG001|Overall Study|Protocol Violation|14|||
143269124|NCT03161093|516540763|FG002|Overall Study|Protocol Violation|6|||
143269125|NCT03161093|516540764|FG003|Overall Study|Protocol Violation|13|||
143269126|NCT03161093|516540765|FG004|Overall Study|Protocol Violation|1|||
143269127|NCT03161093|516540766|FG005|Overall Study|Protocol Violation|0|||
143269128|NCT03161093|516540761|FG000|Overall Study|Adverse Event|5|||
143269129|NCT03161093|516540762|FG001|Overall Study|Adverse Event|21|||
143269130|NCT03161093|516540763|FG002|Overall Study|Adverse Event|16|||
143269131|NCT03161093|516540764|FG003|Overall Study|Adverse Event|35|||
143269132|NCT03161093|516540765|FG004|Overall Study|Adverse Event|2|||
143269133|NCT03161093|516540766|FG005|Overall Study|Adverse Event|1|||
143269134|NCT03161093|516540761|FG000|Overall Study|Lack of Efficacy|9|||
143269135|NCT03161093|516540762|FG001|Overall Study|Lack of Efficacy|13|||
143269136|NCT03161093|516540763|FG002|Overall Study|Lack of Efficacy|9|||
143269137|NCT03161093|516540764|FG003|Overall Study|Lack of Efficacy|24|||
143269138|NCT03161093|516540765|FG004|Overall Study|Lack of Efficacy|4|||
143269139|NCT03161093|516540766|FG005|Overall Study|Lack of Efficacy|1|||
143269140|NCT03161093|516540761|FG000|Overall Study|Physician Decision|0|||
143269141|NCT03161093|516540762|FG001|Overall Study|Physician Decision|1|||
143269142|NCT03161093|516540763|FG002|Overall Study|Physician Decision|0|||
143269143|NCT03161093|516540764|FG003|Overall Study|Physician Decision|2|||
143269144|NCT03161093|516540765|FG004|Overall Study|Physician Decision|17|||
143269145|NCT03161093|516540766|FG005|Overall Study|Physician Decision|15|||
143269146|NCT03161093|516540761|FG000|Overall Study|Withdrawal by Subject|24|||
143269147|NCT03161093|516540762|FG001|Overall Study|Withdrawal by Subject|73|||
143269148|NCT03161093|516540763|FG002|Overall Study|Withdrawal by Subject|44|||
143269149|NCT03161093|516540764|FG003|Overall Study|Withdrawal by Subject|97|||
143269150|NCT03161093|516540765|FG004|Overall Study|Withdrawal by Subject|11|||
143269151|NCT03161093|516540766|FG005|Overall Study|Withdrawal by Subject|10|||
143269152|NCT03161093|516540761|FG000|Overall Study|Lost to Follow-up|3|||
143269153|NCT03161093|516540762|FG001|Overall Study|Lost to Follow-up|12|||
143269154|NCT03161093|516540763|FG002|Overall Study|Lost to Follow-up|4|||
143269155|NCT03161093|516540764|FG003|Overall Study|Lost to Follow-up|7|||
143269156|NCT03161093|516540765|FG004|Overall Study|Lost to Follow-up|8|||
143269157|NCT03161093|516540766|FG005|Overall Study|Lost to Follow-up|13|||
143269158|NCT03161093|516540761|FG000|Overall Study|Death|3|||
143269159|NCT03161093|516540762|FG001|Overall Study|Death|9|||
143269160|NCT03161093|516540763|FG002|Overall Study|Death|7|||
143269161|NCT03161093|516540764|FG003|Overall Study|Death|9|||
143269162|NCT03161093|516540765|FG004|Overall Study|Death|0|||
143269163|NCT03161093|516540766|FG005|Overall Study|Death|0|||
143269164|NCT03161093|516540761|FG000|Overall Study|Unknown - Not reported|0|||
143269165|NCT03161093|516540762|FG001|Overall Study|Unknown - Not reported|1|||
143269166|NCT03161093|516540763|FG002|Overall Study|Unknown - Not reported|0|||
143269167|NCT03161093|516540764|FG003|Overall Study|Unknown - Not reported|0|||
143269168|NCT03161093|516540765|FG004|Overall Study|Unknown - Not reported|0|||
143269169|NCT03161093|516540766|FG005|Overall Study|Unknown - Not reported|1|||
143269170|NCT01031706|516540767|FG000|Overall Study|Adverse Event|1|||
143269171|NCT01031706|516540768|FG001|Overall Study|Adverse Event|0|||
143269172|NCT01031706|516540767|FG000|Overall Study|Withdrawal by Subject|1|||
143269173|NCT01031706|516540768|FG001|Overall Study|Withdrawal by Subject|1|||
143269174|NCT02124161|516540769|FG000|Overall Study|Other unspecified|0|||
143269175|NCT02124161|516540770|FG001|Overall Study|Other unspecified|1|||
143269176|NCT02124161|516540769|FG000|Overall Study|Death|1|||
143269177|NCT02124161|516540770|FG001|Overall Study|Death|0|||
143269178|NCT02124161|516540769|FG000|Overall Study|Protocol Violation|2|||
143269179|NCT02124161|516540770|FG001|Overall Study|Protocol Violation|1|||
143269180|NCT02124161|516540769|FG000|Overall Study|Withdrawal by Subject|1|||
143269181|NCT02124161|516540770|FG001|Overall Study|Withdrawal by Subject|2|||
143269182|NCT02124161|516540769|FG000|Overall Study|Adverse Event|2|||
143269183|NCT02124161|516540770|FG001|Overall Study|Adverse Event|0|||
143269184|NCT02124161|516540769|FG000|Overall Study|Does not meet entrance criteria|2|||
143269185|NCT02124161|516540770|FG001|Overall Study|Does not meet entrance criteria|3|||
143269186|NCT02124161|516540769|FG000|Overall Study|No longer meets eligibility criteria|5|||
143269187|NCT02124161|516540770|FG001|Overall Study|No longer meets eligibility criteria|4|||
143269188|NCT02124161|516540769|FG000|Overall Study|Lost to Follow-up|3|||
143269189|NCT02124161|516540770|FG001|Overall Study|Lost to Follow-up|4|||
143227634|NCT01787461|516380858|FG000|Overall Study|No longer met eligibility criteria|1|||
143227635|NCT01787461|516380859|FG001|Overall Study|No longer met eligibility criteria|0|||
143227636|NCT01787461|516380858|FG000|Overall Study|Withdrawal by Subject|3|||
143227637|NCT01787461|516380859|FG001|Overall Study|Withdrawal by Subject|4|||
143227638|NCT01787461|516380858|FG000|Overall Study|Protocol Violation|3|||
143227639|NCT01787461|516380859|FG001|Overall Study|Protocol Violation|0|||
143227640|NCT05051579|516380860|FG000|Overall Study|Withdrawal by Subject|3|||
143227641|NCT05051579|516380861|FG001|Overall Study|Withdrawal by Subject|5|||
143227642|NCT05051579|516380862|FG002|Overall Study|Withdrawal by Subject|2|||
143227643|NCT05051579|516380863|FG003|Overall Study|Withdrawal by Subject|1|||
143227644|NCT05051579|516380864|FG004|Overall Study|Withdrawal by Subject|4|||
143227645|NCT05051579|516380865|FG005|Overall Study|Withdrawal by Subject|0|||
143227646|NCT05051579|516380866|FG006|Overall Study|Withdrawal by Subject|4|||
143227647|NCT05051579|516380860|FG000|Overall Study|Lost to Follow-up|1|||
143227648|NCT05051579|516380861|FG001|Overall Study|Lost to Follow-up|0|||
143227649|NCT05051579|516380862|FG002|Overall Study|Lost to Follow-up|0|||
143227650|NCT05051579|516380863|FG003|Overall Study|Lost to Follow-up|0|||
143227651|NCT05051579|516380864|FG004|Overall Study|Lost to Follow-up|1|||
143227652|NCT05051579|516380865|FG005|Overall Study|Lost to Follow-up|0|||
143227653|NCT05051579|516380866|FG006|Overall Study|Lost to Follow-up|1|||
143227654|NCT05051579|516380860|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
143227655|NCT05051579|516380861|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
143227656|NCT05051579|516380862|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
143227657|NCT05051579|516380863|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
143227658|NCT05051579|516380864|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
143227659|NCT05051579|516380865|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
143227660|NCT05051579|516380866|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
143227661|NCT05051579|516380860|FG000|Overall Study|Adverse Event|2|||
143227662|NCT05051579|516380861|FG001|Overall Study|Adverse Event|1|||
143227663|NCT05051579|516380862|FG002|Overall Study|Adverse Event|0|||
143227664|NCT05051579|516380863|FG003|Overall Study|Adverse Event|4|||
143227665|NCT05051579|516380864|FG004|Overall Study|Adverse Event|1|||
143227666|NCT05051579|516380865|FG005|Overall Study|Adverse Event|2|||
143227667|NCT05051579|516380866|FG006|Overall Study|Adverse Event|0|||
143227668|NCT05051579|516380860|FG000|Overall Study|Inadvertent Enrollment|0|||
143227669|NCT05051579|516380861|FG001|Overall Study|Inadvertent Enrollment|0|||
143227670|NCT05051579|516380862|FG002|Overall Study|Inadvertent Enrollment|0|||
143227671|NCT05051579|516380863|FG003|Overall Study|Inadvertent Enrollment|0|||
143227672|NCT05051579|516380864|FG004|Overall Study|Inadvertent Enrollment|0|||
143227673|NCT05051579|516380865|FG005|Overall Study|Inadvertent Enrollment|0|||
143227674|NCT05051579|516380866|FG006|Overall Study|Inadvertent Enrollment|1|||
143227675|NCT05051579|516380860|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
143227676|NCT05051579|516380861|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
143227677|NCT05051579|516380862|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
143227678|NCT05051579|516380863|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
143227679|NCT05051579|516380864|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
143227680|NCT05051579|516380865|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
143227681|NCT05051579|516380866|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
143227682|NCT05051579|516380860|FG000|Overall Study|Sponsor Decision|0|||
143227683|NCT05051579|516380861|FG001|Overall Study|Sponsor Decision|0|||
143227684|NCT05051579|516380862|FG002|Overall Study|Sponsor Decision|0|||
143227685|NCT05051579|516380863|FG003|Overall Study|Sponsor Decision|0|||
143227686|NCT05051579|516380864|FG004|Overall Study|Sponsor Decision|1|||
143227687|NCT05051579|516380865|FG005|Overall Study|Sponsor Decision|0|||
143227688|NCT05051579|516380866|FG006|Overall Study|Sponsor Decision|0|||
143227689|NCT05051579|516380860|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
143227690|NCT05051579|516380861|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
143227691|NCT05051579|516380862|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
143227692|NCT05051579|516380863|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
143227693|NCT05051579|516380864|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
143227694|NCT05051579|516380865|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
143227695|NCT05051579|516380866|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
143227696|NCT03861273|516380868|FG000|Screening Phase (3 Weeks)|Other|1|||
143227697|NCT03861273|516380868|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
143227698|NCT03861273|516380868|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
143227699|NCT03861273|516380868|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
143227700|NCT03861273|516380868|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
143269190|NCT03387683|516540773|FG000|Overall Study|In receipt of disallowed medication|1|||
143269191|NCT03387683|516540774|FG001|Overall Study|In receipt of disallowed medication|0|||
143269192|NCT03387683|516540773|FG000|Overall Study|Did not receive treatment|1|||
143269193|NCT03387683|516540774|FG001|Overall Study|Did not receive treatment|0|||
143269194|NCT00629772|516540775|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
143269195|NCT00629772|516540776|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
143269196|NCT00629772|516540775|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
143269197|NCT00629772|516540776|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
143269198|NCT01393301|516540777|FG000|Overall Study|Lost to Follow-up|5|||
143269199|NCT01393301|516540778|FG001|Overall Study|Lost to Follow-up|3|||
143269200|NCT01393301|516540777|FG000|Overall Study|Withdrawal by Subject|2|||
143269201|NCT01393301|516540778|FG001|Overall Study|Withdrawal by Subject|0|||
143269202|NCT01393301|516540777|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
143269203|NCT01393301|516540778|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
143269204|NCT01309165|516540779|FG000|Overall Study|Lost to Follow-up|4|||
143269205|NCT01309165|516540780|FG001|Overall Study|Lost to Follow-up|3|||
143269206|NCT01309165|516540779|FG000|Overall Study|Return to work|1|||
143269207|NCT01309165|516540780|FG001|Overall Study|Return to work|2|||
143269208|NCT01309165|516540779|FG000|Overall Study|Left country|0|||
143269209|NCT01309165|516540780|FG001|Overall Study|Left country|1|||
143269210|NCT01309165|516540779|FG000|Overall Study|No transportation|0|||
143269211|NCT01309165|516540780|FG001|Overall Study|No transportation|1|||
143269212|NCT01309165|516540779|FG000|Overall Study|Admitted to hospital for second stroke|1|||
143269213|NCT01309165|516540780|FG001|Overall Study|Admitted to hospital for second stroke|0|||
143269214|NCT01649804|516540782|FG000|Overall Study|Administrative/Other|8|||
143269215|NCT02028871|516540786|FG000|Overall Study|Positive urine drug screen|1|||
143269216|NCT02028871|516540787|FG001|Overall Study|Positive urine drug screen|1|||
143269217|NCT02028871|516540786|FG000|Overall Study|Withdrawal by Subject|1|||
143269218|NCT02028871|516540787|FG001|Overall Study|Withdrawal by Subject|2|||
143269219|NCT02028871|516540786|FG000|Overall Study|IV placement difficulty|1|||
143269220|NCT02028871|516540787|FG001|Overall Study|IV placement difficulty|0|||
143269221|NCT02028871|516540786|FG000|Overall Study|Current Illness|1|||
143269222|NCT02028871|516540787|FG001|Overall Study|Current Illness|0|||
143269223|NCT02633501|516540790|FG000|Overall Study|Adverse Event|0|||
143269224|NCT02633501|516540791|FG001|Overall Study|Adverse Event|0|||
143269225|NCT02633501|516540792|FG002|Overall Study|Adverse Event|1|||
143269226|NCT02633501|516540793|FG003|Overall Study|Adverse Event|0|||
143269227|NCT02633501|516540794|FG004|Overall Study|Adverse Event|1|||
143269228|NCT02633501|516540795|FG005|Overall Study|Adverse Event|1|||
143269229|NCT02633501|516540790|FG000|Overall Study|Withdrawal by Subject|2|||
143269230|NCT02633501|516540791|FG001|Overall Study|Withdrawal by Subject|1|||
143269231|NCT02633501|516540792|FG002|Overall Study|Withdrawal by Subject|2|||
143269232|NCT02633501|516540793|FG003|Overall Study|Withdrawal by Subject|2|||
143269233|NCT02633501|516540794|FG004|Overall Study|Withdrawal by Subject|1|||
143269234|NCT02633501|516540795|FG005|Overall Study|Withdrawal by Subject|3|||
143269235|NCT02633501|516540790|FG000|Overall Study|Various other reasons|0|||
143269236|NCT02633501|516540791|FG001|Overall Study|Various other reasons|2|||
143269237|NCT02633501|516540792|FG002|Overall Study|Various other reasons|4|||
143269238|NCT02633501|516540793|FG003|Overall Study|Various other reasons|1|||
143269239|NCT02633501|516540794|FG004|Overall Study|Various other reasons|7|||
143269240|NCT02633501|516540795|FG005|Overall Study|Various other reasons|11|||
143269241|NCT02633501|516540790|FG000|Overall Study|Lost to Follow-up|0|||
143269242|NCT02633501|516540791|FG001|Overall Study|Lost to Follow-up|0|||
143269243|NCT02633501|516540792|FG002|Overall Study|Lost to Follow-up|0|||
143269244|NCT02633501|516540793|FG003|Overall Study|Lost to Follow-up|1|||
143269245|NCT02633501|516540794|FG004|Overall Study|Lost to Follow-up|2|||
143269246|NCT02633501|516540795|FG005|Overall Study|Lost to Follow-up|0|||
143269247|NCT01912963|516540796|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
143269248|NCT01912963|516540797|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
143269249|NCT01912963|516540798|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
143269250|NCT01912963|516540796|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
143269251|NCT01912963|516540797|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
143269252|NCT01912963|516540798|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
143269253|NCT01912963|516540796|FG000|Overall Study|Adverse Event|0|||
143269254|NCT01912963|516540797|FG001|Overall Study|Adverse Event|1|||
143269255|NCT01912963|516540798|FG002|Overall Study|Adverse Event|1|||
143269256|NCT01912963|516540796|FG000|Overall Study|Withdrawal by Subject|0|||
143269257|NCT01912963|516540797|FG001|Overall Study|Withdrawal by Subject|1|||
143269258|NCT01912963|516540798|FG002|Overall Study|Withdrawal by Subject|0|||
143269259|NCT01912963|516540796|FG000|Overall Study|Sought treatment locally|0|||
143269260|NCT01912963|516540797|FG001|Overall Study|Sought treatment locally|1|||
143269261|NCT01912963|516540798|FG002|Overall Study|Sought treatment locally|0|||
143269262|NCT01147172|516540804|FG000|Overall Study|Withdrawal by Subject|2|||
143269263|NCT01147172|516540804|FG000|Overall Study|Lost to Follow-up|2|||
143269264|NCT01069627|516540805|FG000|Overall Study|Disease progression|7|||
143269265|NCT01069627|516540805|FG000|Overall Study|Adverse Event|12|||
143269266|NCT01069627|516540805|FG000|Overall Study|Protocol Violation|1|||
143269267|NCT02963935|516540810|FG000|Overall Study|Adverse Event|12|||
143269268|NCT02963935|516540811|FG001|Overall Study|Adverse Event|6|||
143269269|NCT02963935|516540810|FG000|Overall Study|Protocol Violation|2|||
143269270|NCT02963935|516540811|FG001|Overall Study|Protocol Violation|1|||
143269271|NCT02963935|516540810|FG000|Overall Study|Lack of Efficacy|0|||
143269272|NCT02963935|516540811|FG001|Overall Study|Lack of Efficacy|2|||
143269273|NCT02963935|516540810|FG000|Overall Study|Lost to Follow-up|1|||
143269274|NCT02963935|516540811|FG001|Overall Study|Lost to Follow-up|6|||
143269275|NCT02963935|516540810|FG000|Overall Study|Unclassified|13|||
143269276|NCT02963935|516540811|FG001|Overall Study|Unclassified|22|||
143269277|NCT00464269|516540812|FG000|Overall Study|Lack of Efficacy|1|||
143269278|NCT00464269|516540813|FG001|Overall Study|Lack of Efficacy|0|||
143269279|NCT00464269|516540814|FG002|Overall Study|Lack of Efficacy|0|||
143269280|NCT00464269|516540815|FG003|Overall Study|Lack of Efficacy|0|||
143269281|NCT00464269|516540812|FG000|Overall Study|Lost to Follow-up|0|||
143269282|NCT00464269|516540813|FG001|Overall Study|Lost to Follow-up|4|||
143269283|NCT00464269|516540814|FG002|Overall Study|Lost to Follow-up|0|||
143269284|NCT00464269|516540815|FG003|Overall Study|Lost to Follow-up|1|||
143269285|NCT00464269|516540812|FG000|Overall Study|Withdrawal by Subject|0|||
143269286|NCT00464269|516540813|FG001|Overall Study|Withdrawal by Subject|2|||
143269287|NCT00464269|516540814|FG002|Overall Study|Withdrawal by Subject|1|||
143269288|NCT00464269|516540815|FG003|Overall Study|Withdrawal by Subject|1|||
143269289|NCT00464269|516540812|FG000|Overall Study|Other reason|3|||
143269290|NCT00464269|516540813|FG001|Overall Study|Other reason|3|||
143269291|NCT00464269|516540814|FG002|Overall Study|Other reason|1|||
143269292|NCT00464269|516540815|FG003|Overall Study|Other reason|1|||
143269293|NCT00464269|516540812|FG000|Overall Study|AE, serious fatal|0|||
143269294|NCT00464269|516540813|FG001|Overall Study|AE, serious fatal|0|||
143269295|NCT00464269|516540814|FG002|Overall Study|AE, serious fatal|1|||
143269296|NCT00464269|516540815|FG003|Overall Study|AE, serious fatal|1|||
143269297|NCT00464269|516540812|FG000|Overall Study|SAE, non-fatal|0|||
143269298|NCT00464269|516540813|FG001|Overall Study|SAE, non-fatal|0|||
143269299|NCT00464269|516540814|FG002|Overall Study|SAE, non-fatal|0|||
143269300|NCT00464269|516540815|FG003|Overall Study|SAE, non-fatal|1|||
143269301|NCT00464269|516540812|FG000|Overall Study|AE, non-serious non-fatal|2|||
143269302|NCT00464269|516540813|FG001|Overall Study|AE, non-serious non-fatal|8|||
143269303|NCT00464269|516540814|FG002|Overall Study|AE, non-serious non-fatal|3|||
143269304|NCT00464269|516540815|FG003|Overall Study|AE, non-serious non-fatal|4|||
143269305|NCT00464269|516540812|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
143269306|NCT00464269|516540813|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
143269307|NCT00464269|516540814|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
143269308|NCT00464269|516540815|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
143269309|NCT02955797|516540818|FG000|Overall Study|Protocol Violation|1|||
143269310|NCT02955797|516540819|FG001|Overall Study|Protocol Violation|0|||
143269311|NCT02955797|516540820|FG002|Overall Study|Protocol Violation|0|||
143269312|NCT02955797|516540821|FG003|Overall Study|Protocol Violation|1|||
143269313|NCT02955797|516540818|FG000|Overall Study|Withdrawal by Subject|2|||
143269314|NCT02955797|516540819|FG001|Overall Study|Withdrawal by Subject|2|||
143269315|NCT02955797|516540820|FG002|Overall Study|Withdrawal by Subject|0|||
143269316|NCT02955797|516540821|FG003|Overall Study|Withdrawal by Subject|1|||
143269317|NCT02955797|516540818|FG000|Overall Study|Lost to Follow-up|0|||
143269318|NCT02955797|516540819|FG001|Overall Study|Lost to Follow-up|1|||
143269319|NCT02955797|516540820|FG002|Overall Study|Lost to Follow-up|0|||
143269320|NCT02955797|516540821|FG003|Overall Study|Lost to Follow-up|0|||
143269321|NCT03131453|516540822|FG000|Overall Study|Study terminated by Sponsor|424|||
143269322|NCT03131453|516540823|FG001|Overall Study|Study terminated by Sponsor|222|||
143269323|NCT03131453|516540824|FG002|Overall Study|Study terminated by Sponsor|438|||
143269324|NCT03131453|516540822|FG000|Overall Study|Withdrawal by Subject|18|||
143269325|NCT03131453|516540823|FG001|Overall Study|Withdrawal by Subject|7|||
143269326|NCT03131453|516540824|FG002|Overall Study|Withdrawal by Subject|13|||
143269327|NCT03131453|516540822|FG000|Overall Study|Adverse Event|10|||
143269328|NCT03131453|516540823|FG001|Overall Study|Adverse Event|3|||
143269329|NCT03131453|516540824|FG002|Overall Study|Adverse Event|3|||
143269330|NCT03131453|516540822|FG000|Overall Study|Lost to Follow-up|1|||
143269331|NCT03131453|516540823|FG001|Overall Study|Lost to Follow-up|0|||
143269332|NCT03131453|516540824|FG002|Overall Study|Lost to Follow-up|1|||
143269333|NCT03131453|516540822|FG000|Overall Study|Physician Decision|1|||
143269334|NCT03131453|516540823|FG001|Overall Study|Physician Decision|0|||
143269335|NCT03131453|516540824|FG002|Overall Study|Physician Decision|1|||
143269336|NCT03131453|516540822|FG000|Overall Study|Non-compliance with study treatment|1|||
143269337|NCT03131453|516540823|FG001|Overall Study|Non-compliance with study treatment|0|||
143269338|NCT03131453|516540824|FG002|Overall Study|Non-compliance with study treatment|0|||
143269339|NCT03131453|516540822|FG000|Overall Study|Technical problems|1|||
143269340|NCT03131453|516540823|FG001|Overall Study|Technical problems|0|||
143269341|NCT03131453|516540824|FG002|Overall Study|Technical problems|0|||
143269342|NCT03131453|516540822|FG000|Overall Study|Protocol deviation|0|||
143269343|NCT03131453|516540823|FG001|Overall Study|Protocol deviation|1|||
143269344|NCT03131453|516540824|FG002|Overall Study|Protocol deviation|0|||
143269345|NCT02081183|516540825|FG000|Overall Study|Lost to Follow-up|0|||
143269346|NCT02081183|516540826|FG001|Overall Study|Lost to Follow-up|1|||
143269347|NCT02081183|516540825|FG000|Overall Study|Protocol Violation|1|||
143269348|NCT02081183|516540826|FG001|Overall Study|Protocol Violation|0|||
143269349|NCT02081183|516540825|FG000|Overall Study|Other|3|||
143269350|NCT02081183|516540826|FG001|Overall Study|Other|3|||
143269351|NCT04176705|516540827|FG000|Overall Study|Withdrawal by Subject|4|||
143269352|NCT04176705|516540828|FG001|Overall Study|Withdrawal by Subject|4|||
143269353|NCT04176705|516540827|FG000|Overall Study|Death|1|||
143269354|NCT04176705|516540828|FG001|Overall Study|Death|1|||
143269355|NCT04176705|516540827|FG000|Overall Study|Lost to Follow-up|3|||
143269356|NCT04176705|516540828|FG001|Overall Study|Lost to Follow-up|3|||
143269357|NCT02024555|516540829|FG000|Overall Study|Lost to Follow-up|1|||
143269358|NCT02024555|516540830|FG001|Overall Study|Lost to Follow-up|1|||
143269359|NCT02024555|516540829|FG000|Overall Study|Withdrawal by Subject|5|||
143269360|NCT02024555|516540830|FG001|Overall Study|Withdrawal by Subject|1|||
143269361|NCT03805646|516540843|FG000|Overall Study|Death|40|||
143269362|NCT03805646|516540844|FG001|Overall Study|Death|49|||
143269363|NCT03805646|516540843|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
143269364|NCT03805646|516540844|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
143269365|NCT01066000|516540847|FG000|Overall Study|Protocol Violation|4|||
143269366|NCT01066000|516540847|FG000|Overall Study|Death|3|||
143269367|NCT01066000|516540847|FG000|Overall Study|Withdrawal by Subject|1|||
143269368|NCT01066000|516540847|FG000|Overall Study|Adverse Event|1|||
143269369|NCT00560885|516540850|FG000|Overall Study|Death|7|||
143269370|NCT00560885|516540850|FG000|Overall Study|Withdrawal by Subject|1|||
143269371|NCT01554397|516540858|FG000|Overall Study|Withdrawal by Subject|1|||
143269372|NCT01554397|516540859|FG001|Overall Study|Withdrawal by Subject|0|||
143269373|NCT01554397|516540858|FG000|Overall Study|Ineligible|7|||
143269374|NCT01554397|516540859|FG001|Overall Study|Ineligible|0|||
143269375|NCT01896050|516542712|FG000|Overall Study|Adverse Event|37|||
143269376|NCT01896050|516542713|FG001|Overall Study|Adverse Event|2|||
143269377|NCT01896050|516542712|FG000|Overall Study|Death|1|||
143269378|NCT01896050|516542713|FG001|Overall Study|Death|0|||
143269379|NCT03693300|516542714|FG000|Overall Study|Withdrawal by Subject|6|||
143269380|NCT03693300|516542715|FG001|Overall Study|Withdrawal by Subject|0|||
143269381|NCT03693300|516542714|FG000|Overall Study|Death|50|||
143269382|NCT03693300|516542715|FG001|Overall Study|Death|2|||
143269383|NCT03693300|516542714|FG000|Overall Study|Lost to Follow-up|2|||
143269384|NCT03693300|516542715|FG001|Overall Study|Lost to Follow-up|0|||
143269385|NCT02206048|516542716|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
143269386|NCT01858376|516542717|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
143269387|NCT00108433|516542721|FG000|Overall Study|Lack of Efficacy|1|||
143269388|NCT00108433|516542722|FG001|Overall Study|Lack of Efficacy|2|||
143269389|NCT00108433|516542721|FG000|Overall Study|Death|3|||
143269390|NCT00108433|516542722|FG001|Overall Study|Death|0|||
143269391|NCT00108433|516542721|FG000|Overall Study|Adverse Event|3|||
143269392|NCT00108433|516542722|FG001|Overall Study|Adverse Event|1|||
143269393|NCT00108433|516542721|FG000|Overall Study|Other|14|||
143269394|NCT00108433|516542722|FG001|Overall Study|Other|14|||
143269395|NCT02203071|516542723|FG000|Overall Study|Lost to Follow-up|3|||
143269396|NCT02203071|516542724|FG001|Overall Study|Lost to Follow-up|1|||
143269397|NCT01886716|516542727|FG000|Week 1|Lost to Follow-up|0|||
143269398|NCT01886716|516542728|FG001|Week 1|Lost to Follow-up|0|||
143269399|NCT01886716|516542729|FG002|Week 1|Lost to Follow-up|2|||
143269400|NCT01886716|516542730|FG003|Week 1|Lost to Follow-up|2|||
143269401|NCT01886716|516542727|FG000|Week 2|Lost to Follow-up|3|||
143269402|NCT01886716|516542728|FG001|Week 2|Lost to Follow-up|2|||
143269403|NCT01886716|516542729|FG002|Week 2|Lost to Follow-up|1|||
143269404|NCT01886716|516542730|FG003|Week 2|Lost to Follow-up|3|||
143269405|NCT01886716|516542727|FG000|Week 3|Lost to Follow-up|1|||
143269406|NCT01886716|516542728|FG001|Week 3|Lost to Follow-up|1|||
143269407|NCT01886716|516542729|FG002|Week 3|Lost to Follow-up|0|||
143269408|NCT01886716|516542730|FG003|Week 3|Lost to Follow-up|1|||
143269409|NCT03894046|516542731|FG000|Overall Study|Protocol Violation|1|||
143269410|NCT03894046|516542732|FG001|Overall Study|Protocol Violation|0|||
143269411|NCT03894046|516542733|FG002|Overall Study|Protocol Violation|0|||
143269412|NCT03894046|516542731|FG000|Overall Study|Adverse Event|0|||
143372585|NCT03210402|516909581|FG001|Overall Study|Withdrawal by Subject|1|||
143227701|NCT00191334|516380871|FG000|Overall Study|Adverse Event|4|||
143227702|NCT00191334|516380871|FG000|Overall Study|Disease Progression or Relapse|8|||
143227703|NCT00191334|516380871|FG000|Overall Study|Physician Decision|1|||
143227704|NCT00191334|516380871|FG000|Overall Study|Withdrawal by Subject|4|||
143227705|NCT01116648|516380872|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
143227706|NCT01116648|516380873|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
143227707|NCT01116648|516380874|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
143227708|NCT01116648|516380875|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
143227709|NCT01116648|516380876|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
143227710|NCT01116648|516380877|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
143227711|NCT01116648|516380878|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
143227712|NCT01116648|516380879|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
143227713|NCT01116648|516380880|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
143227714|NCT01116648|516380881|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
143227715|NCT01116648|516380882|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
143227716|NCT01116648|516380883|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
143227717|NCT01116648|516380884|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
143227718|NCT01116648|516380885|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
143227719|NCT01116648|516380886|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
143227720|NCT04539938|516380887|FG000|Overall Study|Death|30|||
143227721|NCT04539938|516380887|FG000|Overall Study|Withdrawal by Subject|4|||
143227722|NCT03100149|516380888|FG000|Overall Study|Adverse Event|0|||
143227723|NCT03100149|516380889|FG001|Overall Study|Adverse Event|1|||
143227724|NCT03100149|516380890|FG002|Overall Study|Adverse Event|0|||
143227725|NCT03100149|516380888|FG000|Overall Study|Participant Moved out of Country|0|||
143227726|NCT03100149|516380889|FG001|Overall Study|Participant Moved out of Country|0|||
143227727|NCT03100149|516380890|FG002|Overall Study|Participant Moved out of Country|1|||
143227728|NCT03100149|516380888|FG000|Overall Study|Withdrawal by Subject|0|||
143227729|NCT03100149|516380889|FG001|Overall Study|Withdrawal by Subject|3|||
143227730|NCT03100149|516380890|FG002|Overall Study|Withdrawal by Subject|1|||
143227731|NCT00445549|516382327|FG000|Overall Study|progressive disease|12|||
143227732|NCT01690052|516382330|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
143227733|NCT01690052|516382331|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
143227734|NCT00882440|516382332|FG000|Overall Study|Adverse Event|2|||
143227735|NCT00882440|516382333|FG001|Overall Study|Adverse Event|2|||
143227736|NCT00882440|516382334|FG002|Overall Study|Adverse Event|2|||
143227737|NCT00882440|516382335|FG003|Overall Study|Adverse Event|1|||
143227738|NCT00882440|516382336|FG004|Overall Study|Adverse Event|1|||
143227739|NCT00882440|516382337|FG005|Overall Study|Adverse Event|4|||
143227740|NCT00882440|516382338|FG006|Overall Study|Adverse Event|2|||
143227741|NCT00882440|516382332|FG000|Overall Study|Lack of Efficacy|3|||
143227742|NCT00882440|516382333|FG001|Overall Study|Lack of Efficacy|5|||
143227743|NCT00882440|516382334|FG002|Overall Study|Lack of Efficacy|2|||
143227744|NCT00882440|516382335|FG003|Overall Study|Lack of Efficacy|0|||
143227745|NCT00882440|516382336|FG004|Overall Study|Lack of Efficacy|0|||
143227746|NCT00882440|516382337|FG005|Overall Study|Lack of Efficacy|3|||
143227747|NCT00882440|516382338|FG006|Overall Study|Lack of Efficacy|0|||
143227748|NCT00882440|516382332|FG000|Overall Study|Lost to Follow-up|2|||
143227749|NCT00882440|516382333|FG001|Overall Study|Lost to Follow-up|0|||
143227750|NCT00882440|516382334|FG002|Overall Study|Lost to Follow-up|1|||
143227751|NCT00882440|516382335|FG003|Overall Study|Lost to Follow-up|1|||
143227752|NCT00882440|516382336|FG004|Overall Study|Lost to Follow-up|1|||
143269413|NCT03894046|516542732|FG001|Overall Study|Adverse Event|1|||
143269414|NCT03894046|516542733|FG002|Overall Study|Adverse Event|0|||
143269415|NCT03894046|516542731|FG000|Overall Study|Withdrawal by Subject|2|||
143269416|NCT03894046|516542732|FG001|Overall Study|Withdrawal by Subject|3|||
143269417|NCT03894046|516542733|FG002|Overall Study|Withdrawal by Subject|1|||
143269418|NCT03894046|516542731|FG000|Overall Study|Death|15|||
143269419|NCT03894046|516542732|FG001|Overall Study|Death|21|||
143269420|NCT03894046|516542733|FG002|Overall Study|Death|4|||
143269421|NCT03894046|516542731|FG000|Overall Study|No growth of ABC|2|||
143269422|NCT03894046|516542732|FG001|Overall Study|No growth of ABC|1|||
143269423|NCT03894046|516542733|FG002|Overall Study|No growth of ABC|0|||
143269424|NCT03894046|516542731|FG000|Overall Study|Physician Decision|1|||
143269425|NCT03894046|516542732|FG001|Overall Study|Physician Decision|1|||
143269426|NCT03894046|516542733|FG002|Overall Study|Physician Decision|1|||
143269427|NCT03894046|516542731|FG000|Overall Study|Prohibited concomitant medication|1|||
143269428|NCT03894046|516542732|FG001|Overall Study|Prohibited concomitant medication|0|||
143269429|NCT03894046|516542733|FG002|Overall Study|Prohibited concomitant medication|0|||
143269430|NCT03894046|516542731|FG000|Overall Study|Transferred to other arm/group|1|||
143269431|NCT03894046|516542732|FG001|Overall Study|Transferred to other arm/group|1|||
143269432|NCT03894046|516542733|FG002|Overall Study|Transferred to other arm/group|0|||
143269433|NCT04806503|516542736|FG000|Overall Study|Lost to Follow-up|0|||
143269434|NCT04806503|516542737|FG001|Overall Study|Lost to Follow-up|0|||
143269435|NCT04806503|516542738|FG002|Overall Study|Lost to Follow-up|1|||
143269436|NCT04806503|516542739|FG003|Overall Study|Lost to Follow-up|0|||
143269437|NCT04806503|516542740|FG004|Overall Study|Lost to Follow-up|0|||
143269438|NCT04806503|516542736|FG000|Overall Study|Withdrawal by Subject|1|||
143269439|NCT04806503|516542737|FG001|Overall Study|Withdrawal by Subject|0|||
143269440|NCT04806503|516542738|FG002|Overall Study|Withdrawal by Subject|1|||
143269441|NCT04806503|516542739|FG003|Overall Study|Withdrawal by Subject|1|||
143269442|NCT04806503|516542740|FG004|Overall Study|Withdrawal by Subject|1|||
143269443|NCT04806503|516542736|FG000|Overall Study|Adverse Event|1|||
143269444|NCT04806503|516542737|FG001|Overall Study|Adverse Event|1|||
143269445|NCT04806503|516542738|FG002|Overall Study|Adverse Event|0|||
143269446|NCT04806503|516542739|FG003|Overall Study|Adverse Event|1|||
143269447|NCT04806503|516542740|FG004|Overall Study|Adverse Event|0|||
143269448|NCT03589469|516542741|FG000|Overall Study|Withdrawal by Subject|8|||
143269449|NCT03589469|516542741|FG000|Overall Study|Physician Decision|20|||
143269450|NCT03589469|516542741|FG000|Overall Study|Death|97|||
143269451|NCT03589469|516542741|FG000|Overall Study|Lost to Follow-up|8|||
143269452|NCT03589469|516542741|FG000|Overall Study|Miscellaneous|1|||
143269453|NCT02202837|516542743|FG000|Overall Study|Enbrel treatment discontinued|36|||
143269454|NCT02202837|516542744|FG001|Overall Study|Enbrel treatment discontinued|4|||
143269455|NCT02202837|516542743|FG000|Overall Study|Other|10|||
143269456|NCT02202837|516542744|FG001|Overall Study|Other|0|||
143269457|NCT02202837|516542743|FG000|Overall Study|Lost to Follow-up|7|||
143269458|NCT02202837|516542744|FG001|Overall Study|Lost to Follow-up|1|||
143269459|NCT04195906|516542745|FG000|Part 1|Adverse Event|3|||
143269460|NCT04195906|516542746|FG001|Part 1|Adverse Event|7|||
143269461|NCT04195906|516542745|FG000|Part 1|Withdrawal by Subject|0|||
143269462|NCT04195906|516542746|FG001|Part 1|Withdrawal by Subject|1|||
143269463|NCT04195906|516542745|FG000|Part 2|Adverse Event|1|||
143269464|NCT04195906|516542746|FG001|Part 2|Adverse Event|1|||
143269465|NCT04195906|516542745|FG000|Part 2|Withdrawal by Subject|0|||
143269466|NCT04195906|516542746|FG001|Part 2|Withdrawal by Subject|3|||
143269467|NCT04195906|516542745|FG000|Part 2|Other|1|||
143269468|NCT04195906|516542746|FG001|Part 2|Other|3|||
143269469|NCT00371826|516542752|FG000|Core Phase (12 Months)|Adverse Event|15|||
143269470|NCT00371826|516542753|FG001|Core Phase (12 Months)|Adverse Event|4|||
143269471|NCT00371826|516542754|FG002|Core Phase (12 Months)|Adverse Event|9|||
143269472|NCT00371826|516542752|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
143269473|NCT00371826|516542753|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
143269474|NCT00371826|516542754|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
143269475|NCT00371826|516542752|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
143269476|NCT00371826|516542753|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
143269477|NCT00371826|516542754|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
143269478|NCT00371826|516542752|FG000|Core Phase (12 Months)|Protocol Violation|1|||
143269479|NCT00371826|516542753|FG001|Core Phase (12 Months)|Protocol Violation|0|||
143372586|NCT02517307|516909598|FG000|Overall Study|Withdrawal by Subject|1|||
143269480|NCT00371826|516542754|FG002|Core Phase (12 Months)|Protocol Violation|1|||
143269481|NCT00371826|516542752|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
143269482|NCT00371826|516542753|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
143372587|NCT02517307|516909599|FG001|Overall Study|Withdrawal by Subject|0|||
143269483|NCT00371826|516542754|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
143269484|NCT00371826|516542752|FG000|Core Phase (12 Months)|Administrative problems|1|||
143269485|NCT00371826|516542753|FG001|Core Phase (12 Months)|Administrative problems|0|||
143372588|NCT02517307|516909600|FG002|Overall Study|Withdrawal by Subject|1|||
143269486|NCT00371826|516542754|FG002|Core Phase (12 Months)|Administrative problems|8|||
143269487|NCT00371826|516542752|FG000|Core Phase (12 Months)|Graft Loss|0|||
143269488|NCT00371826|516542753|FG001|Core Phase (12 Months)|Graft Loss|1|||
143269489|NCT00371826|516542754|FG002|Core Phase (12 Months)|Graft Loss|0|||
143269490|NCT00371826|516542752|FG000|Extension Phase (24 Months)|Adverse Event|4|||
143269491|NCT00371826|516542753|FG001|Extension Phase (24 Months)|Adverse Event|5|||
143269492|NCT00371826|516542754|FG002|Extension Phase (24 Months)|Adverse Event|0|||
143269493|NCT00371826|516542752|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
143269494|NCT00371826|516542753|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
143269495|NCT00371826|516542754|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
143269496|NCT00371826|516542752|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
143269497|NCT00371826|516542753|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
143269498|NCT00371826|516542754|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
143269499|NCT00371826|516542752|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
143269500|NCT00371826|516542753|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
143269501|NCT00371826|516542754|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
143269502|NCT00371826|516542752|FG000|Extension Phase (24 Months)|Administrative problems|0|||
143269503|NCT00371826|516542753|FG001|Extension Phase (24 Months)|Administrative problems|0|||
143269504|NCT00371826|516542754|FG002|Extension Phase (24 Months)|Administrative problems|2|||
143269505|NCT00734474|516542755|FG000|Overall Study|Entry Criteria Not Met|0|||
143269506|NCT00734474|516542756|FG001|Overall Study|Entry Criteria Not Met|0|||
143269507|NCT00734474|516542757|FG002|Overall Study|Entry Criteria Not Met|5|||
143269508|NCT00734474|516542758|FG003|Overall Study|Entry Criteria Not Met|0|||
143269509|NCT00734474|516542759|FG004|Overall Study|Entry Criteria Not Met|3|||
143269510|NCT00734474|516542760|FG005|Overall Study|Entry Criteria Not Met|1|||
143269511|NCT00734474|516542761|FG006|Overall Study|Entry Criteria Not Met|0|||
143269512|NCT00734474|516542762|FG007|Overall Study|Entry Criteria Not Met|1|||
143269513|NCT00734474|516542763|FG008|Overall Study|Entry Criteria Not Met|1|||
143269514|NCT00734474|516542755|FG000|Overall Study|Lost to Follow-up|1|||
143269515|NCT00734474|516542756|FG001|Overall Study|Lost to Follow-up|0|||
143269516|NCT00734474|516542757|FG002|Overall Study|Lost to Follow-up|13|||
143269517|NCT00734474|516542758|FG003|Overall Study|Lost to Follow-up|0|||
143269518|NCT00734474|516542759|FG004|Overall Study|Lost to Follow-up|11|||
143269519|NCT00734474|516542760|FG005|Overall Study|Lost to Follow-up|1|||
143269520|NCT00734474|516542761|FG006|Overall Study|Lost to Follow-up|0|||
143269521|NCT00734474|516542762|FG007|Overall Study|Lost to Follow-up|9|||
143269522|NCT00734474|516542763|FG008|Overall Study|Lost to Follow-up|4|||
143269523|NCT00734474|516542755|FG000|Overall Study|Withdrawal by Subject|2|||
143269524|NCT00734474|516542756|FG001|Overall Study|Withdrawal by Subject|1|||
143269525|NCT00734474|516542757|FG002|Overall Study|Withdrawal by Subject|18|||
143269526|NCT00734474|516542758|FG003|Overall Study|Withdrawal by Subject|0|||
143269527|NCT00734474|516542759|FG004|Overall Study|Withdrawal by Subject|24|||
143269528|NCT00734474|516542760|FG005|Overall Study|Withdrawal by Subject|2|||
143269529|NCT00734474|516542761|FG006|Overall Study|Withdrawal by Subject|0|||
143269530|NCT00734474|516542762|FG007|Overall Study|Withdrawal by Subject|36|||
143269531|NCT00734474|516542763|FG008|Overall Study|Withdrawal by Subject|21|||
143269532|NCT00734474|516542755|FG000|Overall Study|Physician Decision|0|||
143269533|NCT00734474|516542756|FG001|Overall Study|Physician Decision|0|||
143269534|NCT00734474|516542757|FG002|Overall Study|Physician Decision|4|||
143269535|NCT00734474|516542758|FG003|Overall Study|Physician Decision|1|||
143269536|NCT00734474|516542759|FG004|Overall Study|Physician Decision|11|||
143269537|NCT00734474|516542760|FG005|Overall Study|Physician Decision|0|||
143269538|NCT00734474|516542761|FG006|Overall Study|Physician Decision|0|||
143269539|NCT00734474|516542762|FG007|Overall Study|Physician Decision|9|||
143269540|NCT00734474|516542763|FG008|Overall Study|Physician Decision|9|||
143269541|NCT00734474|516542755|FG000|Overall Study|Adverse Event|4|||
143269542|NCT00734474|516542756|FG001|Overall Study|Adverse Event|4|||
143269543|NCT00734474|516542757|FG002|Overall Study|Adverse Event|63|||
143269544|NCT00734474|516542758|FG003|Overall Study|Adverse Event|1|||
143269545|NCT00734474|516542759|FG004|Overall Study|Adverse Event|64|||
143269546|NCT00734474|516542760|FG005|Overall Study|Adverse Event|0|||
143269547|NCT00734474|516542761|FG006|Overall Study|Adverse Event|1|||
143269548|NCT00734474|516542762|FG007|Overall Study|Adverse Event|65|||
143269549|NCT00734474|516542763|FG008|Overall Study|Adverse Event|39|||
143269550|NCT00734474|516542755|FG000|Overall Study|Protocol Violation|0|||
143269551|NCT00734474|516542756|FG001|Overall Study|Protocol Violation|0|||
143269552|NCT00734474|516542757|FG002|Overall Study|Protocol Violation|4|||
143269553|NCT00734474|516542758|FG003|Overall Study|Protocol Violation|0|||
143269554|NCT00734474|516542759|FG004|Overall Study|Protocol Violation|3|||
143269555|NCT00734474|516542760|FG005|Overall Study|Protocol Violation|0|||
143269556|NCT00734474|516542761|FG006|Overall Study|Protocol Violation|0|||
143269557|NCT00734474|516542762|FG007|Overall Study|Protocol Violation|3|||
143269558|NCT00734474|516542763|FG008|Overall Study|Protocol Violation|1|||
143269559|NCT00734474|516542755|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
143269560|NCT00734474|516542756|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
143269561|NCT00734474|516542757|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
143269562|NCT00734474|516542758|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
143269563|NCT00734474|516542759|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
143269564|NCT00734474|516542760|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
143269565|NCT00734474|516542761|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
143269566|NCT00734474|516542762|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
143269567|NCT00734474|516542763|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
143269568|NCT00734474|516542755|FG000|Overall Study|Sponsor Decision|0|||
143269569|NCT00734474|516542756|FG001|Overall Study|Sponsor Decision|0|||
143269570|NCT00734474|516542757|FG002|Overall Study|Sponsor Decision|0|||
143269571|NCT00734474|516542758|FG003|Overall Study|Sponsor Decision|0|||
143269572|NCT00734474|516542759|FG004|Overall Study|Sponsor Decision|2|||
143269573|NCT00734474|516542760|FG005|Overall Study|Sponsor Decision|0|||
143269574|NCT00734474|516542761|FG006|Overall Study|Sponsor Decision|0|||
143269575|NCT00734474|516542762|FG007|Overall Study|Sponsor Decision|0|||
143269576|NCT00734474|516542763|FG008|Overall Study|Sponsor Decision|0|||
143269577|NCT00734474|516542755|FG000|Overall Study|Death|0|||
143269578|NCT00734474|516542756|FG001|Overall Study|Death|0|||
143269579|NCT00734474|516542757|FG002|Overall Study|Death|1|||
143269580|NCT00734474|516542758|FG003|Overall Study|Death|0|||
143269581|NCT00734474|516542759|FG004|Overall Study|Death|0|||
143269582|NCT00734474|516542760|FG005|Overall Study|Death|0|||
143269583|NCT00734474|516542761|FG006|Overall Study|Death|0|||
143269584|NCT00734474|516542762|FG007|Overall Study|Death|2|||
143269585|NCT00734474|516542763|FG008|Overall Study|Death|1|||
143269586|NCT00734474|516542755|FG000|Overall Study|Lack of Efficacy|0|||
143269587|NCT00734474|516542756|FG001|Overall Study|Lack of Efficacy|0|||
143269588|NCT00734474|516542757|FG002|Overall Study|Lack of Efficacy|4|||
143269589|NCT00734474|516542758|FG003|Overall Study|Lack of Efficacy|0|||
143269590|NCT00734474|516542759|FG004|Overall Study|Lack of Efficacy|0|||
143269591|NCT00734474|516542760|FG005|Overall Study|Lack of Efficacy|0|||
143269592|NCT00734474|516542761|FG006|Overall Study|Lack of Efficacy|0|||
143269593|NCT00734474|516542762|FG007|Overall Study|Lack of Efficacy|4|||
143269594|NCT00734474|516542763|FG008|Overall Study|Lack of Efficacy|6|||
143269595|NCT00231842|516542764|FG000|Overall Study|Withdrawal by Subject|3|||
143269596|NCT00231842|516542764|FG000|Overall Study|Did not complete the last 3 cycle|8|||
143269597|NCT00428792|516542765|FG000|Overall Study|Lack of Efficacy|1|||
143269598|NCT00428792|516542766|FG001|Overall Study|Lack of Efficacy|3|||
143269599|NCT00428792|516542765|FG000|Overall Study|Lost to Follow-up|0|||
143269600|NCT00428792|516542766|FG001|Overall Study|Lost to Follow-up|1|||
143269601|NCT00639678|516542767|FG000|Overall Study|Withdrawal by Subject|3|||
143269602|NCT00639678|516542768|FG001|Overall Study|Withdrawal by Subject|0|||
143269603|NCT00639678|516542769|FG002|Overall Study|Withdrawal by Subject|4|||
143269604|NCT00639678|516542770|FG003|Overall Study|Withdrawal by Subject|0|||
143269605|NCT00639678|516542767|FG000|Overall Study|Lost to Follow-up|1|||
143269606|NCT00639678|516542768|FG001|Overall Study|Lost to Follow-up|0|||
143269607|NCT00639678|516542769|FG002|Overall Study|Lost to Follow-up|6|||
143269608|NCT00639678|516542770|FG003|Overall Study|Lost to Follow-up|0|||
143269609|NCT00639678|516542767|FG000|Overall Study|Adverse Event|0|||
143269610|NCT00639678|516542768|FG001|Overall Study|Adverse Event|1|||
143269611|NCT00639678|516542769|FG002|Overall Study|Adverse Event|0|||
143269612|NCT00639678|516542770|FG003|Overall Study|Adverse Event|0|||
143269613|NCT00639678|516542767|FG000|Overall Study|Lack of Compliance|0|||
143269614|NCT00639678|516542768|FG001|Overall Study|Lack of Compliance|0|||
143269615|NCT00639678|516542769|FG002|Overall Study|Lack of Compliance|1|||
143269616|NCT00639678|516542770|FG003|Overall Study|Lack of Compliance|0|||
143269617|NCT02436304|516542771|FG000|Overall Study|Lost to Follow-up|0|||
143269618|NCT02436304|516542772|FG001|Overall Study|Lost to Follow-up|1|||
143269619|NCT02436304|516542773|FG002|Overall Study|Lost to Follow-up|0|||
143269620|NCT02436304|516542771|FG000|Overall Study|Withdrawal by Subject|0|||
143269621|NCT02436304|516542772|FG001|Overall Study|Withdrawal by Subject|1|||
143269622|NCT02436304|516542773|FG002|Overall Study|Withdrawal by Subject|0|||
143269623|NCT02436304|516542771|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
143269624|NCT02436304|516542772|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
143269625|NCT02436304|516542773|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
143269626|NCT04612790|516542777|FG000|DB Period (Up to 36 Weeks)|Death|1|||
143269627|NCT04612790|516542778|FG001|DB Period (Up to 36 Weeks)|Death|1|||
143269628|NCT04612790|516542779|FG002|DB Period (Up to 36 Weeks)|Death|0|||
143269629|NCT04612790|516542780|FG003|DB Period (Up to 36 Weeks)|Death|0|||
143269630|NCT04612790|516542777|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
143269631|NCT04612790|516542778|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
143269632|NCT04612790|516542779|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
143269633|NCT04612790|516542780|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
143269634|NCT04612790|516542777|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
143269635|NCT04612790|516542778|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
143269636|NCT04612790|516542779|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
143269637|NCT04612790|516542780|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
143269638|NCT04612790|516542777|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
143269639|NCT04612790|516542778|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
143269640|NCT04612790|516542779|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
143269641|NCT04612790|516542780|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
143269642|NCT04612790|516542777|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
143269643|NCT04612790|516542778|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
143269644|NCT04612790|516542779|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
143269645|NCT04612790|516542780|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
143269646|NCT04612790|516542777|FG000|DB Period (Up to 36 Weeks)|Other|1|||
143269647|NCT04612790|516542778|FG001|DB Period (Up to 36 Weeks)|Other|0|||
143269648|NCT04612790|516542779|FG002|DB Period (Up to 36 Weeks)|Other|0|||
143269649|NCT04612790|516542780|FG003|DB Period (Up to 36 Weeks)|Other|0|||
143269650|NCT04612790|516542777|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
143269651|NCT04612790|516542778|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
143269652|NCT04612790|516542779|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
143269653|NCT04612790|516542780|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
143269654|NCT04612790|516542777|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
143269655|NCT04612790|516542778|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
143269656|NCT04612790|516542779|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
143269657|NCT04612790|516542780|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
143269658|NCT04612790|516542777|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
143269659|NCT04612790|516542778|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
143269660|NCT04612790|516542779|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
143269661|NCT04612790|516542780|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
143269662|NCT04612790|516542777|FG000|OLE Period (Up to 1 Year)|Other|0|||
143269663|NCT04612790|516542778|FG001|OLE Period (Up to 1 Year)|Other|0|||
143269664|NCT04612790|516542779|FG002|OLE Period (Up to 1 Year)|Other|0|||
143269665|NCT04612790|516542780|FG003|OLE Period (Up to 1 Year)|Other|1|||
143269666|NCT00369122|516542789|FG000|Overall Study|Ineligible|10|||
143269667|NCT00369122|516542789|FG000|Overall Study|No protocol treatment|1|||
143269668|NCT00191906|516542792|FG000|Study Period II|Adverse Event|0|||
143269669|NCT00191906|516542793|FG001|Study Period II|Adverse Event|1|||
143269670|NCT00191906|516542794|FG002|Study Period II|Adverse Event|0|||
143269671|NCT00191906|516542795|FG003|Study Period II|Adverse Event|0|||
143269672|NCT00191906|516542792|FG000|Study Period II|Withdrawal by Subject|0|||
143269673|NCT00191906|516542793|FG001|Study Period II|Withdrawal by Subject|3|||
143269674|NCT00191906|516542794|FG002|Study Period II|Withdrawal by Subject|0|||
143269675|NCT00191906|516542795|FG003|Study Period II|Withdrawal by Subject|0|||
143269676|NCT00191906|516542792|FG000|Study Period II|Parent/Caregiver Decision|0|||
143269677|NCT00191906|516542793|FG001|Study Period II|Parent/Caregiver Decision|1|||
143269678|NCT00191906|516542794|FG002|Study Period II|Parent/Caregiver Decision|0|||
143269679|NCT00191906|516542795|FG003|Study Period II|Parent/Caregiver Decision|0|||
143269680|NCT00191906|516542792|FG000|Study Period II|Entry Criteria Exclusion|0|||
143269681|NCT00191906|516542793|FG001|Study Period II|Entry Criteria Exclusion|0|||
143269682|NCT00191906|516542794|FG002|Study Period II|Entry Criteria Exclusion|1|||
143269683|NCT00191906|516542795|FG003|Study Period II|Entry Criteria Exclusion|0|||
143269684|NCT00191906|516542792|FG000|Study Period III|Adverse Event|1|||
143269685|NCT00191906|516542793|FG001|Study Period III|Adverse Event|0|||
143269686|NCT00191906|516542794|FG002|Study Period III|Adverse Event|0|||
143269687|NCT00191906|516542795|FG003|Study Period III|Adverse Event|0|||
143269688|NCT00191906|516542792|FG000|Study Period III|Lost to Follow-up|0|||
143269689|NCT00191906|516542793|FG001|Study Period III|Lost to Follow-up|1|||
143269690|NCT00191906|516542794|FG002|Study Period III|Lost to Follow-up|0|||
143269691|NCT00191906|516542795|FG003|Study Period III|Lost to Follow-up|0|||
143269692|NCT00191906|516542792|FG000|Study Period III|Parent/Caregiver Decision|1|||
143269693|NCT00191906|516542793|FG001|Study Period III|Parent/Caregiver Decision|0|||
143269694|NCT00191906|516542794|FG002|Study Period III|Parent/Caregiver Decision|0|||
143269695|NCT00191906|516542795|FG003|Study Period III|Parent/Caregiver Decision|0|||
143372589|NCT02517307|516909601|FG003|Overall Study|Withdrawal by Subject|0|||
143269696|NCT00191906|516542792|FG000|Study Period III|Lack of Efficacy|3|||
143269697|NCT00191906|516542793|FG001|Study Period III|Lack of Efficacy|3|||
143372590|NCT02517307|516909598|FG000|Overall Study|Protocol Violation|0|||
143269698|NCT00191906|516542794|FG002|Study Period III|Lack of Efficacy|0|||
143372591|NCT02517307|516909599|FG001|Overall Study|Protocol Violation|0|||
143269699|NCT00191906|516542795|FG003|Study Period III|Lack of Efficacy|0|||
143269700|NCT04553679|516542799|FG000|Overall Study|Withdrawal by Subject|2|||
143269701|NCT04553679|516542800|FG001|Overall Study|Withdrawal by Subject|0|||
143269702|NCT04553679|516542799|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
143269703|NCT04553679|516542800|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
143269704|NCT01254292|516542801|FG000|Comparative Phase|Adverse Event|25|||
143269705|NCT01254292|516542802|FG001|Comparative Phase|Adverse Event|25|||
143269706|NCT01254292|516542801|FG000|Comparative Phase|Lost to Follow-up|3|||
143269707|NCT01254292|516542802|FG001|Comparative Phase|Lost to Follow-up|21|||
143269708|NCT01254292|516542801|FG000|Comparative Phase|Pregnancy|2|||
143269709|NCT01254292|516542802|FG001|Comparative Phase|Pregnancy|6|||
143269710|NCT01254292|516542801|FG000|Comparative Phase|Withdrawal by Subject|20|||
143269711|NCT01254292|516542802|FG001|Comparative Phase|Withdrawal by Subject|21|||
143269712|NCT01254292|516542801|FG000|Comparative Phase|Protocol Violation|1|||
143269713|NCT01254292|516542802|FG001|Comparative Phase|Protocol Violation|2|||
143269714|NCT01254292|516542801|FG000|Comparative Phase|Wish for pregnancy|4|||
143269715|NCT01254292|516542802|FG001|Comparative Phase|Wish for pregnancy|6|||
143269716|NCT01254292|516542801|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
143269717|NCT01254292|516542802|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
143269718|NCT01254292|516542801|FG000|LCS12 Extension Phase|Adverse Event|9|||
143269719|NCT01254292|516542802|FG001|LCS12 Extension Phase|Adverse Event|0|||
143269720|NCT01254292|516542801|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
143269721|NCT01254292|516542802|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
143269722|NCT01254292|516542801|FG000|LCS12 Extension Phase|Other unknown|4|||
143269723|NCT01254292|516542802|FG001|LCS12 Extension Phase|Other unknown|0|||
143269724|NCT01254292|516542801|FG000|LCS12 Extension Phase|Pregnancy|2|||
143269725|NCT01254292|516542802|FG001|LCS12 Extension Phase|Pregnancy|0|||
143269726|NCT01254292|516542801|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
143269727|NCT01254292|516542802|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
143269728|NCT01697358|516542804|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
143269729|NCT01697358|516542805|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
143269730|NCT01697358|516542804|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
143269731|NCT01697358|516542805|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
143269732|NCT01697358|516542804|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
143269733|NCT01697358|516542805|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
143269734|NCT01697358|516542804|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
143269735|NCT01697358|516542805|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
143269736|NCT01697358|516542804|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
143269737|NCT01697358|516542805|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
143269738|NCT01697358|516542804|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
143269739|NCT01697358|516542805|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
143269740|NCT01697358|516542804|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
143269741|NCT01697358|516542805|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
143269742|NCT01697358|516542804|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
143269743|NCT01697358|516542805|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
143269744|NCT01697358|516542804|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
143269745|NCT01697358|516542805|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
143269746|NCT01697358|516542804|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
143269747|NCT01697358|516542805|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
143269748|NCT05055128|516542806|FG000|Overall Study|Adverse Event|0|||
143269749|NCT05055128|516542807|FG001|Overall Study|Adverse Event|0|||
143269750|NCT05055128|516542808|FG002|Overall Study|Adverse Event|0|||
143269751|NCT05055128|516542809|FG003|Overall Study|Adverse Event|1|||
143269752|NCT05055128|516542810|FG004|Overall Study|Adverse Event|1|||
143269753|NCT05055128|516542806|FG000|Overall Study|Protocol Violation|0|||
143372592|NCT02517307|516909600|FG002|Overall Study|Protocol Violation|1|||
143269754|NCT05055128|516542807|FG001|Overall Study|Protocol Violation|0|||
143269755|NCT05055128|516542808|FG002|Overall Study|Protocol Violation|0|||
143269756|NCT05055128|516542809|FG003|Overall Study|Protocol Violation|1|||
143269757|NCT05055128|516542810|FG004|Overall Study|Protocol Violation|0|||
143269758|NCT05055128|516542806|FG000|Overall Study|Withdrawal by Subject|5|||
143269759|NCT05055128|516542807|FG001|Overall Study|Withdrawal by Subject|2|||
143269760|NCT05055128|516542808|FG002|Overall Study|Withdrawal by Subject|2|||
143372593|NCT02517307|516909601|FG003|Overall Study|Protocol Violation|1|||
143269761|NCT05055128|516542809|FG003|Overall Study|Withdrawal by Subject|4|||
143269762|NCT05055128|516542810|FG004|Overall Study|Withdrawal by Subject|2|||
143372594|NCT00823979|516909602|FG000|Overall Study|Lack of Efficacy|13|||
143372595|NCT00823979|516909603|FG001|Overall Study|Lack of Efficacy|16|||
143372596|NCT00823979|516909604|FG002|Overall Study|Lack of Efficacy|9|||
143372597|NCT00823979|516909602|FG000|Overall Study|Lost to Follow-up|2|||
143269763|NCT05055128|516542806|FG000|Overall Study|Randomized By Mistake|0|||
143269764|NCT05055128|516542807|FG001|Overall Study|Randomized By Mistake|1|||
143269765|NCT05055128|516542808|FG002|Overall Study|Randomized By Mistake|0|||
143269766|NCT05055128|516542809|FG003|Overall Study|Randomized By Mistake|0|||
143269767|NCT05055128|516542810|FG004|Overall Study|Randomized By Mistake|0|||
143269768|NCT05055128|516542806|FG000|Overall Study|Other|1|||
143269769|NCT05055128|516542807|FG001|Overall Study|Other|0|||
143269770|NCT05055128|516542808|FG002|Overall Study|Other|0|||
143269771|NCT05055128|516542809|FG003|Overall Study|Other|0|||
143269772|NCT05055128|516542810|FG004|Overall Study|Other|0|||
143269773|NCT00747461|516542817|FG000|Overall Study|study terminated by sponsor|5|||
143269774|NCT00299182|516542818|FG000|Overall Study|Withdrawal by Subject|0|||
143269775|NCT00299182|516542819|FG001|Overall Study|Withdrawal by Subject|0|||
143269776|NCT00299182|516542820|FG002|Overall Study|Withdrawal by Subject|1|||
143269777|NCT00299182|516542821|FG003|Overall Study|Withdrawal by Subject|0|||
143269778|NCT00299182|516542822|FG004|Overall Study|Withdrawal by Subject|1|||
143269779|NCT00299182|516542823|FG005|Overall Study|Withdrawal by Subject|2|||
143269780|NCT00299182|516542824|FG006|Overall Study|Withdrawal by Subject|0|||
143269781|NCT00299182|516542818|FG000|Overall Study|Chemotherapy Changed|0|||
143269782|NCT00299182|516542819|FG001|Overall Study|Chemotherapy Changed|0|||
143269783|NCT00299182|516542820|FG002|Overall Study|Chemotherapy Changed|1|||
143269784|NCT00299182|516542821|FG003|Overall Study|Chemotherapy Changed|0|||
143269785|NCT00299182|516542822|FG004|Overall Study|Chemotherapy Changed|1|||
143269786|NCT00299182|516542823|FG005|Overall Study|Chemotherapy Changed|0|||
143269787|NCT00299182|516542824|FG006|Overall Study|Chemotherapy Changed|1|||
143269788|NCT00299182|516542818|FG000|Overall Study|Adverse Event|0|||
143269789|NCT00299182|516542819|FG001|Overall Study|Adverse Event|0|||
143269790|NCT00299182|516542820|FG002|Overall Study|Adverse Event|0|||
143269791|NCT00299182|516542821|FG003|Overall Study|Adverse Event|0|||
143269792|NCT00299182|516542822|FG004|Overall Study|Adverse Event|0|||
143269793|NCT00299182|516542823|FG005|Overall Study|Adverse Event|1|||
143269794|NCT00299182|516542824|FG006|Overall Study|Adverse Event|0|||
143269795|NCT00299182|516542818|FG000|Overall Study|Not Eligible|0|||
143269796|NCT00299182|516542819|FG001|Overall Study|Not Eligible|0|||
143269797|NCT00299182|516542820|FG002|Overall Study|Not Eligible|0|||
143269798|NCT00299182|516542821|FG003|Overall Study|Not Eligible|0|||
143269799|NCT00299182|516542822|FG004|Overall Study|Not Eligible|1|||
143269800|NCT00299182|516542823|FG005|Overall Study|Not Eligible|0|||
143269801|NCT00299182|516542824|FG006|Overall Study|Not Eligible|0|||
143269802|NCT00771316|516542829|FG000|Overall Study|Adverse Event|0|||
143269803|NCT00771316|516542830|FG001|Overall Study|Adverse Event|1|||
143269804|NCT00771316|516542829|FG000|Overall Study|Patient withdrew consent|1|||
143269805|NCT00771316|516542830|FG001|Overall Study|Patient withdrew consent|0|||
143269806|NCT00771316|516542829|FG000|Overall Study|Discontinued due to early termination|1|||
143269807|NCT00771316|516542830|FG001|Overall Study|Discontinued due to early termination|0|||
143269808|NCT00936611|516542831|FG000|Overall Study|Progressive Disease|3|||
143269809|NCT00936611|516542831|FG000|Overall Study|New Systemic Therapy|22|||
143269810|NCT00936611|516542831|FG000|Overall Study|Lost to Follow-up|1|||
143269811|NCT00936611|516542831|FG000|Overall Study|Withdrawal by Subject|2|||
143372598|NCT00823979|516909603|FG001|Overall Study|Lost to Follow-up|1|||
143372599|NCT00823979|516909604|FG002|Overall Study|Lost to Follow-up|0|||
143269812|NCT00936611|516542831|FG000|Overall Study|Still on Follow-up|1|||
143269813|NCT00936611|516542831|FG000|Overall Study|Still on Active Therapy|7|||
143269814|NCT00936611|516542831|FG000|Overall Study|Ineligible for Study Drug|3|||
143269815|NCT01822496|516542834|FG000|Overall Study|Protocol Violation|2|||
143269816|NCT01822496|516542835|FG001|Overall Study|Protocol Violation|2|||
143269817|NCT01822496|516542836|FG002|Overall Study|Protocol Violation|0|||
143269818|NCT01822496|516542837|FG003|Overall Study|Protocol Violation|1|||
143269819|NCT01822496|516542834|FG000|Overall Study|Withdrawal by Subject|0|||
143269820|NCT01822496|516542835|FG001|Overall Study|Withdrawal by Subject|0|||
143269821|NCT01822496|516542836|FG002|Overall Study|Withdrawal by Subject|0|||
143269822|NCT01822496|516542837|FG003|Overall Study|Withdrawal by Subject|3|||
143269823|NCT03841448|516542840|FG000|Double-blind Treatment (DBT) Period|Death|1|||
143269824|NCT03841448|516542841|FG001|Double-blind Treatment (DBT) Period|Death|1|||
143269825|NCT03841448|516542842|FG002|Double-blind Treatment (DBT) Period|Death|0|||
143269826|NCT03841448|516542843|FG003|Double-blind Treatment (DBT) Period|Death|0|||
143372600|NCT00823979|516909602|FG000|Overall Study|Withdrawal by Subject|2|||
143269827|NCT03841448|516542840|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
143269828|NCT03841448|516542841|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
143269829|NCT03841448|516542842|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
143269830|NCT03841448|516542843|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
143269831|NCT03841448|516542840|FG000|Open-Label Extension (OLE) Period|Death|0|||
143269832|NCT03841448|516542841|FG001|Open-Label Extension (OLE) Period|Death|0|||
143269833|NCT03841448|516542842|FG002|Open-Label Extension (OLE) Period|Death|0|||
143269834|NCT03841448|516542843|FG003|Open-Label Extension (OLE) Period|Death|1|||
143269835|NCT03841448|516542840|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
143269836|NCT03841448|516542841|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
143269837|NCT03841448|516542842|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
143269838|NCT03841448|516542843|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
143269839|NCT03841448|516542840|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
143269840|NCT03841448|516542841|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
143269841|NCT03841448|516542842|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
143269842|NCT03841448|516542843|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
143269843|NCT03841448|516542840|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
143269844|NCT03841448|516542841|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
143269845|NCT03841448|516542842|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
143269846|NCT03841448|516542843|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
143269847|NCT00543543|516542844|FG000|Base Study|Adverse Event|1|||
143269848|NCT00543543|516542845|FG001|Base Study|Adverse Event|11|||
143269849|NCT00543543|516542846|FG002|Base Study|Adverse Event|0|||
143269850|NCT00543543|516542847|FG003|Base Study|Adverse Event|5|||
143269851|NCT00543543|516542844|FG000|Base Study|Lost to Follow-up|12|||
143269852|NCT00543543|516542845|FG001|Base Study|Lost to Follow-up|749|||
143269853|NCT00543543|516542846|FG002|Base Study|Lost to Follow-up|9|||
143269854|NCT00543543|516542847|FG003|Base Study|Lost to Follow-up|701|||
143269855|NCT00543543|516542844|FG000|Base Study|Physician Decision|0|||
143269856|NCT00543543|516542845|FG001|Base Study|Physician Decision|4|||
143269857|NCT00543543|516542846|FG002|Base Study|Physician Decision|0|||
143269858|NCT00543543|516542847|FG003|Base Study|Physician Decision|7|||
143269859|NCT00543543|516542844|FG000|Base Study|Protocol Violation|0|||
143269860|NCT00543543|516542845|FG001|Base Study|Protocol Violation|6|||
143269861|NCT00543543|516542846|FG002|Base Study|Protocol Violation|0|||
143269862|NCT00543543|516542847|FG003|Base Study|Protocol Violation|6|||
143269863|NCT00543543|516542844|FG000|Base Study|Withdrawal by Subject|7|||
143269864|NCT00543543|516542845|FG001|Base Study|Withdrawal by Subject|482|||
143269865|NCT00543543|516542846|FG002|Base Study|Withdrawal by Subject|5|||
143269866|NCT00543543|516542847|FG003|Base Study|Withdrawal by Subject|503|||
143372601|NCT00823979|516909603|FG001|Overall Study|Withdrawal by Subject|3|||
143372602|NCT00823979|516909604|FG002|Overall Study|Withdrawal by Subject|2|||
143372603|NCT00823979|516909602|FG000|Overall Study|Protocol Violation|1|||
143269867|NCT00543543|516542844|FG000|Extension Study|Adverse Event|0|||
143269868|NCT00543543|516542845|FG001|Extension Study|Adverse Event|0|||
143269869|NCT00543543|516542846|FG002|Extension Study|Adverse Event|0|||
143269870|NCT00543543|516542847|FG003|Extension Study|Adverse Event|5|||
143269871|NCT00543543|516542844|FG000|Extension Study|Lost to Follow-up|0|||
143269872|NCT00543543|516542845|FG001|Extension Study|Lost to Follow-up|0|||
143269873|NCT00543543|516542846|FG002|Extension Study|Lost to Follow-up|0|||
143269874|NCT00543543|516542847|FG003|Extension Study|Lost to Follow-up|77|||
143269875|NCT00543543|516542844|FG000|Extension Study|Physician Decision|0|||
143269876|NCT00543543|516542845|FG001|Extension Study|Physician Decision|0|||
143269877|NCT00543543|516542846|FG002|Extension Study|Physician Decision|0|||
143269878|NCT00543543|516542847|FG003|Extension Study|Physician Decision|7|||
143269879|NCT00543543|516542844|FG000|Extension Study|Pregnancy|0|||
143269880|NCT00543543|516542845|FG001|Extension Study|Pregnancy|0|||
143269881|NCT00543543|516542846|FG002|Extension Study|Pregnancy|0|||
143269882|NCT00543543|516542847|FG003|Extension Study|Pregnancy|6|||
143269883|NCT00543543|516542844|FG000|Extension Study|Protocol Violation|0|||
143269884|NCT00543543|516542845|FG001|Extension Study|Protocol Violation|0|||
143269885|NCT00543543|516542846|FG002|Extension Study|Protocol Violation|0|||
143269886|NCT00543543|516542847|FG003|Extension Study|Protocol Violation|11|||
143269887|NCT00543543|516542844|FG000|Extension Study|Withdrawal by Subject|0|||
143269888|NCT00543543|516542845|FG001|Extension Study|Withdrawal by Subject|0|||
143269889|NCT00543543|516542846|FG002|Extension Study|Withdrawal by Subject|0|||
143269890|NCT00543543|516542847|FG003|Extension Study|Withdrawal by Subject|120|||
143269891|NCT04308304|516542848|FG000|Overall Study|Withdrawal by Subject|4|||
143372604|NCT00823979|516909603|FG001|Overall Study|Protocol Violation|1|||
143372605|NCT00823979|516909604|FG002|Overall Study|Protocol Violation|0|||
143269892|NCT04308304|516542849|FG001|Overall Study|Withdrawal by Subject|0|||
143269893|NCT04308304|516542848|FG000|Overall Study|Protocol Violation|1|||
143269894|NCT04308304|516542849|FG001|Overall Study|Protocol Violation|0|||
143269895|NCT00945555|516542850|FG000|Overall Study|Referred to another hospital|5|||
143269896|NCT00945555|516542850|FG000|Overall Study|Worsening condition, intensive care unit|1|||
143269897|NCT00945555|516542850|FG000|Overall Study|Withdrawal by Subject|2|||
143269898|NCT00945555|516542850|FG000|Overall Study|Participant continued treatment at home|1|||
143269899|NCT00945555|516542850|FG000|Overall Study|Death|18|||
143269900|NCT00945555|516542850|FG000|Overall Study|Other|1|||
143372606|NCT00823979|516909602|FG000|Overall Study|Pregnancy|0|||
143269901|NCT00165984|516542852|FG000|Overall Study|Death|15|||
143269902|NCT03945266|516542853|FG000|Overall Study|Withdrawal by Subject|1|||
143269903|NCT03945266|516542854|FG001|Overall Study|Withdrawal by Subject|0|||
143269904|NCT03945266|516542853|FG000|Overall Study|Miscarriage|0|||
143269905|NCT03945266|516542854|FG001|Overall Study|Miscarriage|2|||
143269906|NCT03945266|516542853|FG000|Overall Study|Lost to Follow-up|1|||
143269907|NCT03945266|516542854|FG001|Overall Study|Lost to Follow-up|0|||
143269908|NCT01686828|516542855|FG000|Overall Study|Physician Decision|1|||
143269909|NCT01686828|516542856|FG001|Overall Study|Physician Decision|0|||
143269910|NCT01686828|516542857|FG002|Overall Study|Physician Decision|0|||
143269911|NCT01686828|516542858|FG003|Overall Study|Physician Decision|0|||
143269912|NCT01686828|516542855|FG000|Overall Study|New Job|0|||
143269913|NCT01686828|516542856|FG001|Overall Study|New Job|1|||
143269914|NCT01686828|516542857|FG002|Overall Study|New Job|0|||
143269915|NCT01686828|516542858|FG003|Overall Study|New Job|0|||
143269916|NCT01686828|516542855|FG000|Overall Study|Weight Loss|0|||
143269917|NCT01686828|516542856|FG001|Overall Study|Weight Loss|0|||
143269918|NCT01686828|516542857|FG002|Overall Study|Weight Loss|1|||
143269919|NCT01686828|516542858|FG003|Overall Study|Weight Loss|0|||
143269920|NCT01736124|516542871|FG000|Post-intervention Assessment|Death|2|||
143269921|NCT01736124|516542872|FG001|Post-intervention Assessment|Death|2|||
143269922|NCT01736124|516542871|FG000|Post-intervention Assessment|lost computer access|1|||
143269923|NCT01736124|516542872|FG001|Post-intervention Assessment|lost computer access|1|||
143269924|NCT01736124|516542871|FG000|Post-intervention Assessment|Moved away|3|||
143269925|NCT01736124|516542872|FG001|Post-intervention Assessment|Moved away|1|||
143269926|NCT01736124|516542871|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
143269927|NCT01736124|516542872|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
143269928|NCT01736124|516542871|FG000|Post-intervention Assessment|Illness|3|||
143269929|NCT01736124|516542872|FG001|Post-intervention Assessment|Illness|2|||
143269930|NCT01736124|516542871|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
143269931|NCT01736124|516542872|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
143269932|NCT01736124|516542871|FG000|Post-intervention Assessment|Temporarily away|3|||
143269933|NCT01736124|516542872|FG001|Post-intervention Assessment|Temporarily away|1|||
143269934|NCT01736124|516542871|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
143269935|NCT01736124|516542872|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
143269936|NCT01736124|516542871|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
143269937|NCT01736124|516542872|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
143269938|NCT01736124|516542871|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
143269939|NCT01736124|516542872|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
143269940|NCT01736124|516542871|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
143269941|NCT01736124|516542872|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
143269942|NCT01736124|516542871|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
143269943|NCT01736124|516542872|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
143269944|NCT01736124|516542871|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
143269945|NCT01736124|516542872|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
143269946|NCT01736124|516542871|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
143269947|NCT01736124|516542872|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
143269948|NCT01736124|516542871|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
143269949|NCT01736124|516542872|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
143269950|NCT01736124|516542871|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
143269951|NCT01736124|516542872|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
143269952|NCT02734433|516542873|FG000|Overall Study|Disease progression|1|||
143269953|NCT02734433|516542874|FG001|Overall Study|Disease progression|5|||
143269954|NCT02734433|516542873|FG000|Overall Study|Clinical progression|0|||
143269955|NCT02734433|516542874|FG001|Overall Study|Clinical progression|1|||
143269956|NCT02734433|516542873|FG000|Overall Study|Withdrawal by Subject|1|||
143269957|NCT02734433|516542874|FG001|Overall Study|Withdrawal by Subject|2|||
143269958|NCT02628769|516542875|FG000|First Intervention|Adverse Event|1|||
143269959|NCT02628769|516542876|FG001|First Intervention|Adverse Event|0|||
143269960|NCT02628769|516542875|FG000|First Intervention|Withdrawal by Subject|0|||
143269961|NCT02628769|516542876|FG001|First Intervention|Withdrawal by Subject|1|||
143269962|NCT02628769|516542875|FG000|Second Intervention|Adverse Event|2|||
143269963|NCT02628769|516542876|FG001|Second Intervention|Adverse Event|0|||
143269964|NCT02628769|516542875|FG000|Second Intervention|Physician Decision|0|||
143269965|NCT02628769|516542876|FG001|Second Intervention|Physician Decision|1|||
143269966|NCT02130024|516542880|FG000|Overall Study|Adverse Event|10|||
143269967|NCT02130024|516542881|FG001|Overall Study|Adverse Event|11|||
143269968|NCT02130024|516542880|FG000|Overall Study|Death|2|||
143269969|NCT02130024|516542881|FG001|Overall Study|Death|2|||
143269970|NCT02130024|516542880|FG000|Overall Study|Lost to Follow-up|1|||
143269971|NCT02130024|516542881|FG001|Overall Study|Lost to Follow-up|1|||
143269972|NCT02130024|516542880|FG000|Overall Study|Physician Decision|1|||
143269973|NCT02130024|516542881|FG001|Overall Study|Physician Decision|3|||
143269974|NCT02130024|516542880|FG000|Overall Study|Protocol Deviation|4|||
143269975|NCT02130024|516542881|FG001|Overall Study|Protocol Deviation|0|||
143269976|NCT02130024|516542880|FG000|Overall Study|Site Administration Problems|1|||
143269977|NCT02130024|516542881|FG001|Overall Study|Site Administration Problems|0|||
143269978|NCT02130024|516542880|FG000|Overall Study|Subject Withdrew Consent|6|||
143269979|NCT02130024|516542881|FG001|Overall Study|Subject Withdrew Consent|14|||
143269980|NCT02719327|516542887|FG000|Overall Study|Withdrawal by Subject|11|||
143269981|NCT02719327|516542888|FG001|Overall Study|Withdrawal by Subject|8|||
143269982|NCT03001882|516542891|FG000|Overall Study|Death|1|||
143269983|NCT03001882|516542892|FG001|Overall Study|Death|0|||
143269984|NCT03001882|516542893|FG002|Overall Study|Death|0|||
143269985|NCT03001882|516542894|FG003|Overall Study|Death|3|||
143269986|NCT03001882|516542891|FG000|Overall Study|Participant withdrew consent|0|||
143269987|NCT03001882|516542892|FG001|Overall Study|Participant withdrew consent|1|||
143269988|NCT03001882|516542893|FG002|Overall Study|Participant withdrew consent|0|||
143269989|NCT03001882|516542894|FG003|Overall Study|Participant withdrew consent|5|||
143269990|NCT03001882|516542891|FG000|Overall Study|Other reasons|1|||
143269991|NCT03001882|516542892|FG001|Overall Study|Other reasons|2|||
143269992|NCT03001882|516542893|FG002|Overall Study|Other reasons|0|||
143269993|NCT03001882|516542894|FG003|Overall Study|Other reasons|5|||
143269994|NCT03001882|516542891|FG000|Overall Study|Administrative reason by sponsor|0|||
143269995|NCT03001882|516542892|FG001|Overall Study|Administrative reason by sponsor|0|||
143269996|NCT03001882|516542893|FG002|Overall Study|Administrative reason by sponsor|0|||
143269997|NCT03001882|516542894|FG003|Overall Study|Administrative reason by sponsor|1|||
143269998|NCT03001882|516542891|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
143269999|NCT03001882|516542892|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
143270000|NCT03001882|516542893|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
143270001|NCT03001882|516542894|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
143270002|NCT03001882|516542891|FG000|Overall Study|Not reported|0|||
143270003|NCT03001882|516542892|FG001|Overall Study|Not reported|0|||
143270004|NCT03001882|516542893|FG002|Overall Study|Not reported|0|||
143270005|NCT03001882|516542894|FG003|Overall Study|Not reported|6|||
143270006|NCT03001882|516542891|FG000|Overall Study|Maximum clinical benefit|2|||
143270007|NCT03001882|516542892|FG001|Overall Study|Maximum clinical benefit|3|||
143270008|NCT03001882|516542893|FG002|Overall Study|Maximum clinical benefit|0|||
143270009|NCT03001882|516542894|FG003|Overall Study|Maximum clinical benefit|10|||
143270010|NCT03001882|516542891|FG000|Overall Study|AE unrelated to study drug|3|||
143270011|NCT03001882|516542892|FG001|Overall Study|AE unrelated to study drug|3|||
143270012|NCT03001882|516542893|FG002|Overall Study|AE unrelated to study drug|0|||
143270013|NCT03001882|516542894|FG003|Overall Study|AE unrelated to study drug|11|||
143270014|NCT03001882|516542891|FG000|Overall Study|Study Drug Toxicity|8|||
143270015|NCT03001882|516542892|FG001|Overall Study|Study Drug Toxicity|5|||
143270016|NCT03001882|516542893|FG002|Overall Study|Study Drug Toxicity|0|||
143270017|NCT03001882|516542894|FG003|Overall Study|Study Drug Toxicity|37|||
143270018|NCT03001882|516542891|FG000|Overall Study|Disease progression|16|||
143270019|NCT03001882|516542892|FG001|Overall Study|Disease progression|14|||
143270020|NCT03001882|516542893|FG002|Overall Study|Disease progression|1|||
143270021|NCT03001882|516542894|FG003|Overall Study|Disease progression|90|||
143270022|NCT01386008|516542895|FG000|Overall Study|exited w/o incident /study discontinued|17|||
143270023|NCT01386008|516542895|FG000|Overall Study|Adverse Event|3|||
143270024|NCT05268055|516542896|FG000|Overall Study|Lost to Follow-up|68|||
143270025|NCT05268055|516542897|FG001|Overall Study|Lost to Follow-up|68|||
143270026|NCT05268055|516542896|FG000|Overall Study|Withdrawal by Subject|12|||
143270027|NCT05268055|516542897|FG001|Overall Study|Withdrawal by Subject|8|||
143270028|NCT01555983|516542898|FG000|Overall Study|Withdrawal by Subject|1|||
143270029|NCT01555983|516542899|FG001|Overall Study|Withdrawal by Subject|0|||
143270030|NCT01555983|516542900|FG002|Overall Study|Withdrawal by Subject|0|||
143270031|NCT01555983|516542901|FG003|Overall Study|Withdrawal by Subject|0|||
143270032|NCT01555983|516542902|FG004|Overall Study|Withdrawal by Subject|1|||
143270033|NCT01555983|516542903|FG005|Overall Study|Withdrawal by Subject|1|||
143270034|NCT00217620|516544409|FG000|Overall Study|Adverse Event|2|||
143270035|NCT00217620|516544409|FG000|Overall Study|Progression|31|||
143270036|NCT00217620|516544409|FG000|Overall Study|Not Protocol Specified|4|||
143270037|NCT00217620|516544409|FG000|Overall Study|Ineligible|13|||
143270038|NCT00217620|516544409|FG000|Overall Study|Never received treatment|1|||
143270039|NCT01824342|516544416|FG000|Overall Study|Withdrawal by Subject|0|||
143270040|NCT01824342|516544417|FG001|Overall Study|Withdrawal by Subject|3|||
143270041|NCT01824342|516544416|FG000|Overall Study|Adverse Event|1|||
143270042|NCT01824342|516544417|FG001|Overall Study|Adverse Event|1|||
143270043|NCT01824342|516544416|FG000|Overall Study|Disease Progression|1|||
143270044|NCT01824342|516544417|FG001|Overall Study|Disease Progression|1|||
143270045|NCT01824342|516544416|FG000|Overall Study|Physician Decision|5|||
143270046|NCT01824342|516544417|FG001|Overall Study|Physician Decision|0|||
143270047|NCT01824342|516544416|FG000|Overall Study|Death|2|||
143270048|NCT01824342|516544417|FG001|Overall Study|Death|0|||
143270049|NCT00385762|516544424|FG000|Overall Study|Adverse Event|1|||
143270050|NCT00385762|516544424|FG000|Overall Study|Lost to Follow-up|1|||
143270051|NCT02422303|516544427|FG000|Overall Study|Lost to Follow-up|1|||
143270052|NCT02422303|516544428|FG001|Overall Study|Lost to Follow-up|1|||
143372607|NCT00823979|516909603|FG001|Overall Study|Pregnancy|1|||
143270053|NCT00313300|516544429|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
143270054|NCT00313300|516544430|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
143270055|NCT00313300|516544431|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
143270056|NCT00313300|516544432|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
143270057|NCT00313300|516544433|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
143270058|NCT00313300|516544429|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
143270059|NCT00313300|516544430|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
143270060|NCT00313300|516544431|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
143270061|NCT00313300|516544432|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
143270062|NCT00313300|516544433|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
143270063|NCT00313300|516544429|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
143270064|NCT00313300|516544430|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
143270065|NCT00313300|516544431|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
143270066|NCT00313300|516544432|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
143270067|NCT00313300|516544433|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
143270068|NCT00313300|516544429|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
143270069|NCT00313300|516544430|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
143270070|NCT00313300|516544431|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
143270071|NCT00313300|516544432|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
143270072|NCT00313300|516544433|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
143270073|NCT00313300|516544429|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
143270074|NCT00313300|516544430|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
143270075|NCT00313300|516544431|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
143270076|NCT00313300|516544432|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
143270077|NCT00313300|516544433|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
143270078|NCT00313300|516544429|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
143270079|NCT00313300|516544430|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
143270080|NCT00313300|516544431|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
143270081|NCT00313300|516544432|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
143270082|NCT00313300|516544433|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
143270083|NCT00313300|516544429|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
143270084|NCT00313300|516544430|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
143270085|NCT00313300|516544431|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
143270086|NCT00313300|516544432|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
143270087|NCT00313300|516544433|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
143270088|NCT00313300|516544429|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
143270089|NCT00313300|516544430|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
143270090|NCT00313300|516544431|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
143270091|NCT00313300|516544432|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
143270092|NCT00313300|516544433|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
143270093|NCT00313300|516544429|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
143270094|NCT00313300|516544430|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
143270095|NCT00313300|516544431|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
143270096|NCT00313300|516544432|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
143270097|NCT00313300|516544433|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
143270098|NCT00313300|516544429|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
143270099|NCT00313300|516544430|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
143270100|NCT00313300|516544431|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
143270101|NCT00313300|516544432|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
143270102|NCT00313300|516544433|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
143270103|NCT00313300|516544429|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
143270104|NCT00313300|516544430|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
143270105|NCT00313300|516544431|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
143270106|NCT00313300|516544432|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
143270107|NCT00313300|516544433|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
143270108|NCT00313300|516544429|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
143270109|NCT00313300|516544430|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
143270110|NCT00313300|516544431|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
143270111|NCT00313300|516544432|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
143270112|NCT00313300|516544433|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
143270113|NCT00313300|516544429|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
143270114|NCT00313300|516544430|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
143270115|NCT00313300|516544431|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
143270116|NCT00313300|516544432|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
143270117|NCT00313300|516544433|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
143270118|NCT00313300|516544429|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
143270119|NCT00313300|516544430|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
143372608|NCT00823979|516909604|FG002|Overall Study|Pregnancy|0|||
143372609|NCT00823979|516909602|FG000|Overall Study|Adverse Event|0|||
143372610|NCT00823979|516909603|FG001|Overall Study|Adverse Event|2|||
143372611|NCT00823979|516909604|FG002|Overall Study|Adverse Event|4|||
143372612|NCT00823979|516909602|FG000|Overall Study|Other|2|||
143227753|NCT00882440|516382337|FG005|Overall Study|Lost to Follow-up|0|||
143227754|NCT00882440|516382338|FG006|Overall Study|Lost to Follow-up|1|||
143227755|NCT00882440|516382332|FG000|Overall Study|Protocol Violation|0|||
143227756|NCT00882440|516382333|FG001|Overall Study|Protocol Violation|0|||
143227757|NCT00882440|516382334|FG002|Overall Study|Protocol Violation|1|||
143227758|NCT00882440|516382335|FG003|Overall Study|Protocol Violation|1|||
143227759|NCT00882440|516382336|FG004|Overall Study|Protocol Violation|1|||
143227760|NCT00882440|516382337|FG005|Overall Study|Protocol Violation|0|||
143227761|NCT00882440|516382338|FG006|Overall Study|Protocol Violation|0|||
143227762|NCT00882440|516382332|FG000|Overall Study|Withdrawal by Subject|2|||
143227763|NCT00882440|516382333|FG001|Overall Study|Withdrawal by Subject|1|||
143227764|NCT00882440|516382334|FG002|Overall Study|Withdrawal by Subject|1|||
143227765|NCT00882440|516382335|FG003|Overall Study|Withdrawal by Subject|0|||
143227766|NCT00882440|516382336|FG004|Overall Study|Withdrawal by Subject|6|||
143227767|NCT00882440|516382337|FG005|Overall Study|Withdrawal by Subject|0|||
143227768|NCT00882440|516382338|FG006|Overall Study|Withdrawal by Subject|1|||
143227769|NCT00882440|516382332|FG000|Overall Study|Patient Uncooperative|2|||
143227770|NCT00882440|516382333|FG001|Overall Study|Patient Uncooperative|0|||
143227771|NCT00882440|516382334|FG002|Overall Study|Patient Uncooperative|0|||
143227772|NCT00882440|516382335|FG003|Overall Study|Patient Uncooperative|0|||
143227773|NCT00882440|516382336|FG004|Overall Study|Patient Uncooperative|1|||
143227774|NCT00882440|516382337|FG005|Overall Study|Patient Uncooperative|0|||
143227775|NCT00882440|516382338|FG006|Overall Study|Patient Uncooperative|0|||
143227776|NCT04024891|516382339|FG000|Overall Study|Pregnancy|0|||
143227777|NCT04024891|516382340|FG001|Overall Study|Pregnancy|1|||
143227778|NCT01451723|516382357|FG000|Overall Study|study halted|6|||
143227779|NCT01451723|516382358|FG001|Overall Study|study halted|5|||
143227780|NCT01631435|516382360|FG000|Overall Study|Adverse Event|2|||
143227781|NCT01631435|516382360|FG000|Overall Study|Withdrawal by Subject|2|||
143227782|NCT01631435|516382360|FG000|Overall Study|incomplete study procedure|5|||
143227783|NCT00833040|516382361|FG000|Overall Study|Adverse Event|0|||
143227784|NCT00833040|516382362|FG001|Overall Study|Adverse Event|0|||
143227785|NCT00833040|516382363|FG002|Overall Study|Adverse Event|0|||
143227786|NCT00833040|516382364|FG003|Overall Study|Adverse Event|0|||
143227787|NCT00833040|516382365|FG004|Overall Study|Adverse Event|0|||
143227788|NCT00833040|516382366|FG005|Overall Study|Adverse Event|1|||
143227789|NCT00657540|516382367|FG000|Overall Study|Lost to Follow-up|1|||
143227790|NCT00657540|516382368|FG001|Overall Study|Lost to Follow-up|4|||
143227791|NCT01096316|516382369|FG000|Overall Study|Lost to Follow-up|15|||
143227792|NCT01096316|516382370|FG001|Overall Study|Lost to Follow-up|9|||
143227793|NCT02648204|516382373|FG000|Overall Study|Withdrawal by Subject|12|||
143227794|NCT02648204|516382374|FG001|Overall Study|Withdrawal by Subject|8|||
143227795|NCT02648204|516382375|FG002|Overall Study|Withdrawal by Subject|2|||
143227796|NCT02648204|516382376|FG003|Overall Study|Withdrawal by Subject|6|||
143227797|NCT02648204|516382373|FG000|Overall Study|Lost to Follow-up|5|||
143227798|NCT02648204|516382374|FG001|Overall Study|Lost to Follow-up|8|||
143227799|NCT02648204|516382375|FG002|Overall Study|Lost to Follow-up|4|||
143227800|NCT02648204|516382376|FG003|Overall Study|Lost to Follow-up|6|||
143227801|NCT02648204|516382373|FG000|Overall Study|Missing follow-up information|4|||
143227802|NCT02648204|516382374|FG001|Overall Study|Missing follow-up information|4|||
143227803|NCT02648204|516382375|FG002|Overall Study|Missing follow-up information|4|||
143227804|NCT02648204|516382376|FG003|Overall Study|Missing follow-up information|2|||
143227805|NCT02648204|516382373|FG000|Overall Study|Death|1|||
143227806|NCT02648204|516382374|FG001|Overall Study|Death|1|||
143227807|NCT02648204|516382375|FG002|Overall Study|Death|2|||
143227808|NCT02648204|516382376|FG003|Overall Study|Death|2|||
143227809|NCT02648204|516382373|FG000|Overall Study|Adverse Event|0|||
143227810|NCT02648204|516382374|FG001|Overall Study|Adverse Event|0|||
143227811|NCT02648204|516382375|FG002|Overall Study|Adverse Event|1|||
143227812|NCT02648204|516382376|FG003|Overall Study|Adverse Event|0|||
143227813|NCT01008943|516382381|FG000|Overall Study|Withdrawal by Subject|1|||
143227814|NCT00861705|516382384|FG000|Overall Study|Never Began Treatment|7|||
143227815|NCT00861705|516382385|FG001|Overall Study|Never Began Treatment|3|||
143227816|NCT00861705|516382386|FG002|Overall Study|Never Began Treatment|0|||
143227817|NCT00861705|516382387|FG003|Overall Study|Never Began Treatment|1|||
143227818|NCT06418152|516382388|FG000|Overall Study|Frequent DBS setting changes|1|||
143227819|NCT06418152|516382388|FG000|Overall Study|Withdrawal by Subject|2|||
143227820|NCT00667628|516382389|FG000|Overall Study|Lost to Follow-up|1|||
143227821|NCT00667628|516382390|FG001|Overall Study|Lost to Follow-up|0|||
143227822|NCT00667628|516382389|FG000|Overall Study|Death|6|||
143270120|NCT00313300|516544431|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
143270121|NCT00313300|516544432|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
143270122|NCT00313300|516544433|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
143270123|NCT00313300|516544429|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
143270124|NCT00313300|516544430|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
143270125|NCT00313300|516544431|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
143270126|NCT00313300|516544432|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
143270127|NCT00313300|516544433|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
143270128|NCT00313300|516544429|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
143270129|NCT00313300|516544430|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
143270130|NCT00313300|516544431|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
143270131|NCT00313300|516544432|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
143270132|NCT00313300|516544433|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
143270133|NCT00313300|516544429|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
143270134|NCT00313300|516544430|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
143270135|NCT00313300|516544431|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
143270136|NCT00313300|516544432|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
143270137|NCT00313300|516544433|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
143270138|NCT00313300|516544429|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
143270139|NCT00313300|516544430|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
143270140|NCT00313300|516544431|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
143270141|NCT00313300|516544432|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
143270142|NCT00313300|516544433|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
143270143|NCT00313300|516544429|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
143270144|NCT00313300|516544430|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
143270145|NCT00313300|516544431|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
143270146|NCT00313300|516544432|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
143270147|NCT00313300|516544433|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
143270148|NCT00313300|516544429|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
143270149|NCT00313300|516544430|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
143270150|NCT00313300|516544431|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
143270151|NCT00313300|516544432|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
143270152|NCT00313300|516544433|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
143270153|NCT00313300|516544429|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
143270154|NCT00313300|516544430|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
143270155|NCT00313300|516544431|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
143270156|NCT00313300|516544432|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
143270157|NCT00313300|516544433|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
143270158|NCT02336373|516544434|FG000|Overall Study|Protocol closed early|4|||
143270159|NCT02336373|516544434|FG000|Overall Study|Physician Decision|14|||
143270160|NCT00850343|516544435|FG000|Overall Study|Withdrawal by Subject|11|||
143270161|NCT00850343|516544436|FG001|Overall Study|Withdrawal by Subject|0|||
143270162|NCT00850343|516544437|FG002|Overall Study|Withdrawal by Subject|3|||
143270163|NCT00850343|516544438|FG003|Overall Study|Withdrawal by Subject|2|||
143270164|NCT00850343|516544435|FG000|Overall Study|Adverse Event|15|||
143270165|NCT00850343|516544436|FG001|Overall Study|Adverse Event|2|||
143270166|NCT00850343|516544437|FG002|Overall Study|Adverse Event|6|||
143270167|NCT00850343|516544438|FG003|Overall Study|Adverse Event|6|||
143270168|NCT00850343|516544435|FG000|Overall Study|Pregnancy|0|||
143270169|NCT00850343|516544436|FG001|Overall Study|Pregnancy|0|||
143270170|NCT00850343|516544437|FG002|Overall Study|Pregnancy|0|||
143270171|NCT00850343|516544438|FG003|Overall Study|Pregnancy|1|||
143270172|NCT00850343|516544435|FG000|Overall Study|Lack of Efficacy|17|||
143270173|NCT00850343|516544436|FG001|Overall Study|Lack of Efficacy|0|||
143270174|NCT00850343|516544437|FG002|Overall Study|Lack of Efficacy|3|||
143270175|NCT00850343|516544438|FG003|Overall Study|Lack of Efficacy|2|||
143270176|NCT00850343|516544435|FG000|Overall Study|Non-compliance with Study Procedures|1|||
143270177|NCT00850343|516544436|FG001|Overall Study|Non-compliance with Study Procedures|0|||
143270178|NCT00850343|516544437|FG002|Overall Study|Non-compliance with Study Procedures|1|||
143270179|NCT00850343|516544438|FG003|Overall Study|Non-compliance with Study Procedures|1|||
143270180|NCT00850343|516544435|FG000|Overall Study|Physician Decision|2|||
143270181|NCT00850343|516544436|FG001|Overall Study|Physician Decision|1|||
143270182|NCT00850343|516544437|FG002|Overall Study|Physician Decision|1|||
143270183|NCT00850343|516544438|FG003|Overall Study|Physician Decision|1|||
143270184|NCT02497612|516544441|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
143270185|NCT02497612|516544442|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
143270186|NCT02497612|516544443|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
143270187|NCT02497612|516544444|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
143270188|NCT02497612|516544441|FG000|Overall Study|Participant's request|2|||
143270189|NCT02497612|516544442|FG001|Overall Study|Participant's request|3|||
143270190|NCT02497612|516544443|FG002|Overall Study|Participant's request|4|||
143270191|NCT02497612|516544444|FG003|Overall Study|Participant's request|1|||
143270192|NCT02497612|516544441|FG000|Overall Study|Investigator's judgement|1|||
143270193|NCT02497612|516544442|FG001|Overall Study|Investigator's judgement|0|||
143270194|NCT02497612|516544443|FG002|Overall Study|Investigator's judgement|0|||
143270195|NCT02497612|516544444|FG003|Overall Study|Investigator's judgement|2|||
143270196|NCT02497612|516544441|FG000|Overall Study|Adverse Event|3|||
143270197|NCT02497612|516544442|FG001|Overall Study|Adverse Event|1|||
143270198|NCT02497612|516544443|FG002|Overall Study|Adverse Event|4|||
143270199|NCT02497612|516544444|FG003|Overall Study|Adverse Event|1|||
143270200|NCT02497612|516544441|FG000|Overall Study|Lost to Follow-up|1|||
143270201|NCT02497612|516544442|FG001|Overall Study|Lost to Follow-up|1|||
143270202|NCT02497612|516544443|FG002|Overall Study|Lost to Follow-up|0|||
143270203|NCT02497612|516544444|FG003|Overall Study|Lost to Follow-up|1|||
143270204|NCT02497612|516544441|FG000|Overall Study|Other unspecified|1|||
143270205|NCT02497612|516544442|FG001|Overall Study|Other unspecified|1|||
143270206|NCT02497612|516544443|FG002|Overall Study|Other unspecified|2|||
143270207|NCT02497612|516544444|FG003|Overall Study|Other unspecified|0|||
143270208|NCT02497612|516544441|FG000|Overall Study|Not eligible|1|||
143270209|NCT02497612|516544442|FG001|Overall Study|Not eligible|0|||
143270210|NCT02497612|516544443|FG002|Overall Study|Not eligible|0|||
143270211|NCT02497612|516544444|FG003|Overall Study|Not eligible|1|||
143270212|NCT03342963|516544447|FG000|Overall Study|Adverse Event|1|||
143270213|NCT03342963|516544448|FG001|Overall Study|Adverse Event|2|||
143270214|NCT03342963|516544449|FG002|Overall Study|Adverse Event|0|||
143270215|NCT03342963|516544450|FG003|Overall Study|Adverse Event|0|||
143270216|NCT03342963|516544447|FG000|Overall Study|Withdrawal by Subject|1|||
143270217|NCT03342963|516544448|FG001|Overall Study|Withdrawal by Subject|0|||
143270218|NCT03342963|516544449|FG002|Overall Study|Withdrawal by Subject|0|||
143270219|NCT03342963|516544450|FG003|Overall Study|Withdrawal by Subject|0|||
143270220|NCT00722423|516544451|FG000|Overall Study|Protocol Violation|0|||
143270221|NCT00722423|516544452|FG001|Overall Study|Protocol Violation|1|||
143270222|NCT01950169|516544453|FG000|Overall Study|Withdrawal by Subject|2|||
143270223|NCT01950169|516544454|FG001|Overall Study|Withdrawal by Subject|8|||
143270224|NCT01950169|516544455|FG002|Overall Study|Withdrawal by Subject|1|||
143270225|NCT01950169|516544453|FG000|Overall Study|Death|1|||
143270226|NCT01950169|516544454|FG001|Overall Study|Death|0|||
143270227|NCT01950169|516544455|FG002|Overall Study|Death|0|||
143270228|NCT01495975|516544456|FG000|Overall Study|Lost to Follow-up|1|||
143270229|NCT01495975|516544457|FG001|Overall Study|Lost to Follow-up|0|||
143270230|NCT00333840|516544460|FG000|First-line Treatment Period|Adverse Event|38|||
143270231|NCT00333840|516544461|FG001|First-line Treatment Period|Adverse Event|37|||
143270232|NCT00333840|516544462|FG002|First-line Treatment Period|Adverse Event|0|||
143270233|NCT00333840|516544463|FG003|First-line Treatment Period|Adverse Event|0|||
143270234|NCT00333840|516544460|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
143270235|NCT00333840|516544461|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
143270236|NCT00333840|516544462|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
143270237|NCT00333840|516544463|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
143270238|NCT00333840|516544460|FG000|First-line Treatment Period|Abnormal procedure|2|||
143270239|NCT00333840|516544461|FG001|First-line Treatment Period|Abnormal procedure|0|||
143270240|NCT00333840|516544462|FG002|First-line Treatment Period|Abnormal procedure|0|||
143270241|NCT00333840|516544463|FG003|First-line Treatment Period|Abnormal procedure|0|||
143270242|NCT00333840|516544460|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
143270243|NCT00333840|516544461|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
143270244|NCT00333840|516544462|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
143270245|NCT00333840|516544463|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
143270246|NCT00333840|516544460|FG000|First-line Treatment Period|No longer required study drug|21|||
143270247|NCT00333840|516544461|FG001|First-line Treatment Period|No longer required study drug|8|||
143270248|NCT00333840|516544462|FG002|First-line Treatment Period|No longer required study drug|0|||
143270249|NCT00333840|516544463|FG003|First-line Treatment Period|No longer required study drug|0|||
143270250|NCT00333840|516544460|FG000|First-line Treatment Period|Protocol Violation|17|||
143270251|NCT00333840|516544461|FG001|First-line Treatment Period|Protocol Violation|17|||
143270252|NCT00333840|516544462|FG002|First-line Treatment Period|Protocol Violation|0|||
143270253|NCT00333840|516544463|FG003|First-line Treatment Period|Protocol Violation|0|||
143270254|NCT00333840|516544460|FG000|First-line Treatment Period|Subject withdrew consent|57|||
143270255|NCT00333840|516544461|FG001|First-line Treatment Period|Subject withdrew consent|77|||
143270256|NCT00333840|516544462|FG002|First-line Treatment Period|Subject withdrew consent|0|||
143270257|NCT00333840|516544463|FG003|First-line Treatment Period|Subject withdrew consent|0|||
143270258|NCT00333840|516544460|FG000|First-line Treatment Period|Lost to Follow-up|15|||
143270259|NCT00333840|516544461|FG001|First-line Treatment Period|Lost to Follow-up|6|||
143270260|NCT00333840|516544462|FG002|First-line Treatment Period|Lost to Follow-up|0|||
143270261|NCT00333840|516544463|FG003|First-line Treatment Period|Lost to Follow-up|0|||
143270262|NCT00333840|516544460|FG000|First-line Treatment Period|Administrative problems|12|||
143270263|NCT00333840|516544461|FG001|First-line Treatment Period|Administrative problems|6|||
143372613|NCT00823979|516909603|FG001|Overall Study|Other|0|||
143372614|NCT00823979|516909604|FG002|Overall Study|Other|1|||
143227823|NCT00667628|516382390|FG001|Overall Study|Death|6|||
143227824|NCT00667628|516382389|FG000|Overall Study|Investigator Considers in Best Interest|1|||
143227825|NCT00667628|516382390|FG001|Overall Study|Investigator Considers in Best Interest|0|||
143227826|NCT00667628|516382389|FG000|Overall Study|Sponsor Terminated Study|17|||
143227827|NCT00667628|516382390|FG001|Overall Study|Sponsor Terminated Study|21|||
143227828|NCT04663321|516382391|FG000|Overall Study|Study terminated by Sponsor|2|||
143227829|NCT04663321|516382392|FG001|Overall Study|Study terminated by Sponsor|1|||
143227830|NCT04663321|516382393|FG002|Overall Study|Study terminated by Sponsor|2|||
143227831|NCT04663321|516382391|FG000|Overall Study|Withdrawal by Subject|10|||
143227832|NCT04663321|516382392|FG001|Overall Study|Withdrawal by Subject|3|||
143227833|NCT04663321|516382393|FG002|Overall Study|Withdrawal by Subject|2|||
143227834|NCT04663321|516382391|FG000|Overall Study|Not provided|0|||
143227835|NCT04663321|516382392|FG001|Overall Study|Not provided|0|||
143227836|NCT04663321|516382393|FG002|Overall Study|Not provided|1|||
143227837|NCT01962441|516382398|FG000|Randomized Period|Randomized but Never Treated|4|||
143227838|NCT01962441|516382399|FG001|Randomized Period|Randomized but Never Treated|2|||
143227839|NCT01962441|516382400|FG002|Randomized Period|Randomized but Never Treated|3|||
143227840|NCT01962441|516382398|FG000|Randomized Period|Lost to Follow-up|2|||
143227841|NCT01962441|516382399|FG001|Randomized Period|Lost to Follow-up|4|||
143227842|NCT01962441|516382400|FG002|Randomized Period|Lost to Follow-up|4|||
143227843|NCT01962441|516382398|FG000|Randomized Period|Withdrew Consent|3|||
143227844|NCT01962441|516382399|FG001|Randomized Period|Withdrew Consent|3|||
143227845|NCT01962441|516382400|FG002|Randomized Period|Withdrew Consent|2|||
143227846|NCT01962441|516382398|FG000|Randomized Period|Adverse Event|1|||
143227847|NCT01962441|516382399|FG001|Randomized Period|Adverse Event|1|||
143227848|NCT01962441|516382400|FG002|Randomized Period|Adverse Event|0|||
143227849|NCT01962441|516382398|FG000|Randomized Period|Death|0|||
143227850|NCT01962441|516382399|FG001|Randomized Period|Death|0|||
143227851|NCT01962441|516382400|FG002|Randomized Period|Death|2|||
143227852|NCT01962441|516382398|FG000|Randomized Period|Protocol Violation|0|||
143227853|NCT01962441|516382399|FG001|Randomized Period|Protocol Violation|1|||
143227854|NCT01962441|516382400|FG002|Randomized Period|Protocol Violation|0|||
143227855|NCT01962441|516382398|FG000|Retreatment Substudy|Lack of Efficacy|1|||
143227856|NCT01962441|516382399|FG001|Retreatment Substudy|Lack of Efficacy|0|||
143227857|NCT01962441|516382400|FG002|Retreatment Substudy|Lack of Efficacy|0|||
143227858|NCT01962441|516382398|FG000|Retreatment Substudy|Lost to Follow-up|1|||
143227859|NCT01962441|516382399|FG001|Retreatment Substudy|Lost to Follow-up|0|||
143227860|NCT01962441|516382400|FG002|Retreatment Substudy|Lost to Follow-up|0|||
143227861|NCT04862065|516382401|FG000|Screening|Protocol Violation|54|||
143227862|NCT04862065|516382402|FG001|Screening|Protocol Violation|0|||
143227863|NCT04862065|516382403|FG002|Screening|Protocol Violation|0|||
143227864|NCT04862065|516382401|FG000|Screening|Insufficient Sample|1|||
143227865|NCT04862065|516382402|FG001|Screening|Insufficient Sample|0|||
143227866|NCT04862065|516382403|FG002|Screening|Insufficient Sample|0|||
143227867|NCT04862065|516382401|FG000|Follow-Up|Lost to Follow-up|3|||
143227868|NCT04862065|516382402|FG001|Follow-Up|Lost to Follow-up|0|||
143227869|NCT04862065|516382403|FG002|Follow-Up|Lost to Follow-up|0|||
143227870|NCT01453140|516382404|FG000|Overall Study|Adverse Event|3|||
143227871|NCT02653326|516382408|FG000|Overall Study|Lost to Follow-up|10|||
143227872|NCT02653326|516382409|FG001|Overall Study|Lost to Follow-up|7|||
143227873|NCT01960140|516382410|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
143227874|NCT00867165|516382411|FG000|Overall Study|Adverse Event|3|||
143227875|NCT00867165|516382412|FG001|Overall Study|Adverse Event|0|||
143227876|NCT00867165|516382411|FG000|Overall Study|Withdrawal by Subject|1|||
143372615|NCT00823979|516909602|FG000|Overall Study|Randomized but not Treated|4|||
143270264|NCT00333840|516544462|FG002|First-line Treatment Period|Administrative problems|0|||
143270265|NCT00333840|516544463|FG003|First-line Treatment Period|Administrative problems|0|||
143270266|NCT00333840|516544460|FG000|First-line Treatment Period|Death|19|||
143270267|NCT00333840|516544461|FG001|First-line Treatment Period|Death|2|||
143270268|NCT00333840|516544462|FG002|First-line Treatment Period|Death|0|||
143270269|NCT00333840|516544463|FG003|First-line Treatment Period|Death|0|||
143270270|NCT00333840|516544460|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
143270271|NCT00333840|516544461|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
143270272|NCT00333840|516544462|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
143270273|NCT00333840|516544463|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
143270274|NCT00333840|516544460|FG000|Second-line Treatment Period|Adverse Event|0|||
143270275|NCT00333840|516544461|FG001|Second-line Treatment Period|Adverse Event|0|||
143270276|NCT00333840|516544462|FG002|Second-line Treatment Period|Adverse Event|3|||
143270277|NCT00333840|516544463|FG003|Second-line Treatment Period|Adverse Event|34|||
143270278|NCT00333840|516544460|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
143270279|NCT00333840|516544461|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
143270280|NCT00333840|516544462|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
143270281|NCT00333840|516544463|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
143270282|NCT00333840|516544460|FG000|Second-line Treatment Period|Abnormal procedure|0|||
143270283|NCT00333840|516544461|FG001|Second-line Treatment Period|Abnormal procedure|0|||
143270284|NCT00333840|516544462|FG002|Second-line Treatment Period|Abnormal procedure|0|||
143270285|NCT00333840|516544463|FG003|Second-line Treatment Period|Abnormal procedure|1|||
143270286|NCT00333840|516544460|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
143227877|NCT00867165|516382412|FG001|Overall Study|Withdrawal by Subject|0|||
143227878|NCT04678115|516382413|FG000|Overall Study|Lost to Follow-up|1|||
143227879|NCT04678115|516382414|FG001|Overall Study|Lost to Follow-up|0|||
143227880|NCT00844376|516382415|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
143227881|NCT00844376|516382416|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
143227882|NCT00988884|516382417|FG000|Overall Study|Adverse Event|0|||
143227883|NCT00988884|516382418|FG001|Overall Study|Adverse Event|1|||
143227884|NCT00988884|516382417|FG000|Overall Study|Lost to Follow-up|20|||
143227885|NCT00988884|516382418|FG001|Overall Study|Lost to Follow-up|16|||
143227886|NCT00988884|516382417|FG000|Overall Study|Protocol Violation|0|||
143227887|NCT00988884|516382418|FG001|Overall Study|Protocol Violation|1|||
143227888|NCT00988884|516382417|FG000|Overall Study|Withdrawal by Subject|15|||
143227889|NCT00988884|516382418|FG001|Overall Study|Withdrawal by Subject|18|||
143227890|NCT02738008|516382419|FG000|Overall Study|Study Terminated by Sponsor|1|||
143227891|NCT02738008|516382420|FG001|Overall Study|Study Terminated by Sponsor|5|||
143227892|NCT02738008|516382421|FG002|Overall Study|Study Terminated by Sponsor|3|||
143227893|NCT02738008|516382419|FG000|Overall Study|Adverse Event|0|||
143227894|NCT02738008|516382420|FG001|Overall Study|Adverse Event|1|||
143227895|NCT02738008|516382421|FG002|Overall Study|Adverse Event|2|||
143227896|NCT03550378|516382428|FG000|Overall Study|Death|0|||
143227897|NCT03550378|516382429|FG001|Overall Study|Death|1|||
143227898|NCT04590014|516382432|FG000|Overall Study|Withdrawal by Subject|1|||
143227899|NCT04590014|516382433|FG001|Overall Study|Withdrawal by Subject|0|||
143227900|NCT00468299|516382434|FG000|Overall Study|Withdrawal by Subject|0|||
143227901|NCT00468299|516382435|FG001|Overall Study|Withdrawal by Subject|1|||
143227902|NCT00399516|516382436|FG000|Overall Study|Lost to Follow-up|2|||
143227903|NCT00660192|516382439|FG000|Overall Study|Lost to Follow-up|2|||
143227904|NCT00660192|516382440|FG001|Overall Study|Lost to Follow-up|3|||
143227905|NCT04908397|516382442|FG000|Overall Study|Withdrawal by Subject|2|||
143227906|NCT00539994|516382443|FG000|Overall Study|Lost to Follow-up|2|||
143227907|NCT00539994|516382444|FG001|Overall Study|Lost to Follow-up|1|||
143227908|NCT00539994|516382445|FG002|Overall Study|Lost to Follow-up|0|||
143227909|NCT00539994|516382443|FG000|Overall Study|Withdrawal by Subject|1|||
143227910|NCT00539994|516382444|FG001|Overall Study|Withdrawal by Subject|0|||
143227911|NCT00539994|516382445|FG002|Overall Study|Withdrawal by Subject|1|||
143227912|NCT00539994|516382443|FG000|Overall Study|Physician Decision|0|||
143227913|NCT00539994|516382444|FG001|Overall Study|Physician Decision|0|||
143227914|NCT00539994|516382445|FG002|Overall Study|Physician Decision|1|||
143227915|NCT01917747|516382446|FG000|Overall Study|Withdrawal by Subject|1|||
143227916|NCT01917747|516382447|FG001|Overall Study|Withdrawal by Subject|2|||
143227917|NCT01917747|516382446|FG000|Overall Study|Lost to Follow-up|18|||
143227918|NCT01917747|516382447|FG001|Overall Study|Lost to Follow-up|9|||
143227919|NCT01300234|516382449|FG000|Overall Study|Adverse Event|1|||
143227920|NCT01300234|516382450|FG001|Overall Study|Adverse Event|1|||
143227921|NCT01300234|516382449|FG000|Overall Study|Protocol Violation|2|||
143227922|NCT01300234|516382450|FG001|Overall Study|Protocol Violation|3|||
143270287|NCT00333840|516544461|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
143270288|NCT00333840|516544462|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
143270289|NCT00333840|516544463|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
143227923|NCT01300234|516382449|FG000|Overall Study|Withdrawal by Subject|5|||
143227924|NCT01300234|516382450|FG001|Overall Study|Withdrawal by Subject|9|||
143270290|NCT00333840|516544460|FG000|Second-line Treatment Period|No longer required study drug|0|||
143270291|NCT00333840|516544461|FG001|Second-line Treatment Period|No longer required study drug|0|||
143270292|NCT00333840|516544462|FG002|Second-line Treatment Period|No longer required study drug|1|||
143270293|NCT00333840|516544463|FG003|Second-line Treatment Period|No longer required study drug|14|||
143270294|NCT00333840|516544460|FG000|Second-line Treatment Period|Protocol Violation|0|||
143270295|NCT00333840|516544461|FG001|Second-line Treatment Period|Protocol Violation|0|||
143270296|NCT00333840|516544462|FG002|Second-line Treatment Period|Protocol Violation|1|||
143270297|NCT00333840|516544463|FG003|Second-line Treatment Period|Protocol Violation|10|||
143270298|NCT00333840|516544460|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
143270299|NCT00333840|516544461|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
143270300|NCT00333840|516544462|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
143270301|NCT00333840|516544463|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
143270302|NCT00333840|516544460|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
143270303|NCT00333840|516544461|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
143270304|NCT00333840|516544462|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
143270305|NCT00333840|516544463|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
143270306|NCT00333840|516544460|FG000|Second-line Treatment Period|Administrative problems|0|||
143270307|NCT00333840|516544461|FG001|Second-line Treatment Period|Administrative problems|0|||
143270308|NCT00333840|516544462|FG002|Second-line Treatment Period|Administrative problems|0|||
143270309|NCT00333840|516544463|FG003|Second-line Treatment Period|Administrative problems|7|||
143270310|NCT00333840|516544460|FG000|Second-line Treatment Period|Death|0|||
143270311|NCT00333840|516544461|FG001|Second-line Treatment Period|Death|0|||
143270312|NCT00333840|516544462|FG002|Second-line Treatment Period|Death|0|||
143270313|NCT00333840|516544463|FG003|Second-line Treatment Period|Death|9|||
143270314|NCT01484132|516544466|FG000|Overall Study|Lost to Follow-up|8|||
143270315|NCT01484132|516544466|FG000|Overall Study|Difficulty with time commitment|2|||
143270316|NCT01484132|516544466|FG000|Overall Study|Ineligible|1|||
143270317|NCT01484132|516544466|FG000|Overall Study|No pre-treatment urine sample collected|1|||
143270318|NCT01484132|516544466|FG000|Overall Study|No post-treatment urine sample collected|10|||
143270319|NCT04209348|516544476|FG000|Overall Study|Lost to Follow-up|1|||
143270320|NCT04209348|516544477|FG001|Overall Study|Lost to Follow-up|0|||
143270321|NCT02927262|516544478|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
143270322|NCT02927262|516544479|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
143270323|NCT02927262|516544478|FG000|Treatment Period (Up to 744 Days)|Death|1|||
143270324|NCT02927262|516544479|FG001|Treatment Period (Up to 744 Days)|Death|0|||
143270325|NCT02927262|516544478|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
143270326|NCT02927262|516544479|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
143270327|NCT02927262|516544478|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
143270328|NCT02927262|516544479|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
143270329|NCT02927262|516544478|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
143270330|NCT02927262|516544479|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
143270331|NCT02927262|516544478|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
143270332|NCT02927262|516544479|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
143270333|NCT02927262|516544478|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
143270334|NCT02927262|516544479|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
143270335|NCT02927262|516544478|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
143270336|NCT02927262|516544479|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
143270337|NCT02927262|516544478|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
143270338|NCT02927262|516544479|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
143270339|NCT02927262|516544478|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
143270340|NCT02927262|516544479|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
143270341|NCT02927262|516544478|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
143270342|NCT02927262|516544479|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
143270343|NCT02927262|516544478|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
143270344|NCT02927262|516544479|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
143270345|NCT02927262|516544478|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
143270346|NCT02927262|516544479|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
143270347|NCT02927262|516544478|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
143270348|NCT02927262|516544479|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
143270349|NCT02927262|516544478|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
143227925|NCT01300234|516382449|FG000|Overall Study|Lost to Follow-up|14|||
143227926|NCT01300234|516382450|FG001|Overall Study|Lost to Follow-up|12|||
143227927|NCT01300234|516382449|FG000|Overall Study|Pregnancy|2|||
143227928|NCT01300234|516382450|FG001|Overall Study|Pregnancy|1|||
143227929|NCT01300234|516382449|FG000|Overall Study|Participant reached stopping critera|2|||
143227930|NCT01300234|516382450|FG001|Overall Study|Participant reached stopping critera|0|||
143227931|NCT01300234|516382449|FG000|Overall Study|Participant stopped medication|1|||
143227932|NCT01300234|516382450|FG001|Overall Study|Participant stopped medication|1|||
143227933|NCT01300234|516382449|FG000|Overall Study|Participant refused return to hospital|1|||
143227934|NCT01300234|516382450|FG001|Overall Study|Participant refused return to hospital|0|||
143227935|NCT04816214|516382452|FG000|Overall Study|Progressive Disease|4|||
143227936|NCT04816214|516382453|FG001|Overall Study|Progressive Disease|0|||
143227937|NCT04816214|516382454|FG002|Overall Study|Progressive Disease|0|||
143227938|NCT04816214|516382452|FG000|Overall Study|Death|1|||
143227939|NCT04816214|516382453|FG001|Overall Study|Death|0|||
143227940|NCT04816214|516382454|FG002|Overall Study|Death|0|||
143227941|NCT04816214|516382452|FG000|Overall Study|Study Terminated by Sponsor|1|||
143227942|NCT04816214|516382453|FG001|Overall Study|Study Terminated by Sponsor|0|||
143227943|NCT04816214|516382454|FG002|Overall Study|Study Terminated by Sponsor|0|||
143227944|NCT04879628|516382455|FG000|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
143227945|NCT04879628|516382456|FG001|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
143227946|NCT04879628|516382457|FG002|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|1|||
143227947|NCT04879628|516382458|FG003|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
143227948|NCT04879628|516382455|FG000|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
143227949|NCT04879628|516382456|FG001|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
143227950|NCT04879628|516382457|FG002|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|1|||
143227951|NCT04879628|516382458|FG003|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
143227952|NCT04879628|516382455|FG000|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
143227953|NCT04879628|516382456|FG001|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
143227954|NCT04879628|516382457|FG002|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
143227955|NCT04879628|516382458|FG003|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|2|||
143227956|NCT04879628|516382455|FG000|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
143227957|NCT04879628|516382456|FG001|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
143227958|NCT04879628|516382457|FG002|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|63|||
143227959|NCT04879628|516382458|FG003|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|62|||
143227960|NCT03649074|516382459|FG000|Overall Study|Lost to Follow-up|2|||
143227961|NCT03649074|516382460|FG001|Overall Study|Lost to Follow-up|1|||
143227962|NCT03649074|516382459|FG000|Overall Study|Adverse Event|1|||
143227963|NCT03649074|516382460|FG001|Overall Study|Adverse Event|0|||
143227964|NCT03649074|516382459|FG000|Overall Study|Physician Decision|1|||
143227965|NCT03649074|516382460|FG001|Overall Study|Physician Decision|0|||
143227966|NCT03649074|516382459|FG000|Overall Study|Withdrawal by Subject|0|||
143227967|NCT03649074|516382460|FG001|Overall Study|Withdrawal by Subject|2|||
143227968|NCT03649074|516382459|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
143227969|NCT03649074|516382460|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
143227970|NCT03649074|516382459|FG000|Overall Study|Other|1|||
143227971|NCT03649074|516382460|FG001|Overall Study|Other|0|||
143227972|NCT03064490|516382466|FG000|Overall Study|Physician Decision|5|||
143227973|NCT04158583|516382468|FG000|Overall Study|Withdrawal by Subject|1|||
143270350|NCT02927262|516544479|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
143270351|NCT02927262|516544478|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
143270352|NCT02927262|516544479|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
143270353|NCT02149875|516544480|FG000|Overall Study|Lost to Follow-up|3|||
143270354|NCT02149875|516544481|FG001|Overall Study|Lost to Follow-up|4|||
143372616|NCT00823979|516909603|FG001|Overall Study|Randomized but not Treated|3|||
143372617|NCT00823979|516909604|FG002|Overall Study|Randomized but not Treated|1|||
143372618|NCT00823979|516909602|FG000|Overall Study|Study Terminated by Sponsor|5|||
143372619|NCT00823979|516909603|FG001|Overall Study|Study Terminated by Sponsor|5|||
143372620|NCT00823979|516909604|FG002|Overall Study|Study Terminated by Sponsor|7|||
143372621|NCT03586544|516909605|FG000|First Intervention|Adverse Event|0|||
143372622|NCT03586544|516909606|FG001|First Intervention|Adverse Event|1|||
143372623|NCT03586544|516909605|FG000|Second Intervention|Withdrawal by Subject|0|||
143372624|NCT03586544|516909606|FG001|Second Intervention|Withdrawal by Subject|1|||
143372625|NCT03523091|516909607|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
143372626|NCT03523091|516909608|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
143372627|NCT03523091|516909607|FG000|Overall Study|Withdrawal by Subject|0|||
143372628|NCT03523091|516909608|FG001|Overall Study|Withdrawal by Subject|3|||
143372629|NCT03523091|516909607|FG000|Overall Study|Increase Botox dose|0|||
143372630|NCT03523091|516909608|FG001|Overall Study|Increase Botox dose|1|||
143372631|NCT03863834|516909614|FG000|Overall Study|Lost to Follow-up|3|||
143372632|NCT02685488|516909615|FG000|Overall Study|Withdrawal by Subject|0|||
143372633|NCT02685488|516909616|FG001|Overall Study|Withdrawal by Subject|1|||
143372634|NCT05019729|516909617|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
143372635|NCT05019729|516909618|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
143372636|NCT05019729|516909619|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
143372637|NCT05019729|516909620|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
143372638|NCT05019729|516909621|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
143372639|NCT05019729|516909622|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
143372640|NCT00546871|516909628|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
143372641|NCT00546871|516909629|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
143372642|NCT00546871|516909628|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
143372643|NCT00546871|516909629|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
143372644|NCT00546871|516909628|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
143270355|NCT02149875|516544482|FG002|Overall Study|Lost to Follow-up|5|||
143270356|NCT02149875|516544480|FG000|Overall Study|Withdrawal by Subject|3|||
143270357|NCT02149875|516544481|FG001|Overall Study|Withdrawal by Subject|2|||
143270358|NCT02149875|516544482|FG002|Overall Study|Withdrawal by Subject|2|||
143270359|NCT02149875|516544480|FG000|Overall Study|Physician Decision|1|||
143270360|NCT02149875|516544481|FG001|Overall Study|Physician Decision|2|||
143270361|NCT02149875|516544482|FG002|Overall Study|Physician Decision|2|||
143270362|NCT01898208|516544486|FG000|Overall Study|Positive blood culture|17|||
143270363|NCT01898208|516544487|FG001|Overall Study|Positive blood culture|23|||
143270364|NCT01898208|516544488|FG002|Overall Study|Positive blood culture|15|||
143270365|NCT01898208|516544486|FG000|Overall Study|Death/comfort care within 24 hours|10|||
143270366|NCT01898208|516544487|FG001|Overall Study|Death/comfort care within 24 hours|9|||
143270367|NCT01898208|516544488|FG002|Overall Study|Death/comfort care within 24 hours|8|||
143270368|NCT01898208|516544486|FG000|Overall Study|Negative Gram Stain|6|||
143270369|NCT01898208|516544487|FG001|Overall Study|Negative Gram Stain|9|||
143270370|NCT01898208|516544488|FG002|Overall Study|Negative Gram Stain|6|||
143270371|NCT01898208|516544486|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
143270372|NCT01898208|516544487|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
143270373|NCT01898208|516544488|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
143270374|NCT01898208|516544486|FG000|Overall Study|System/Technical Error|1|||
143270375|NCT01898208|516544487|FG001|Overall Study|System/Technical Error|2|||
143270376|NCT01898208|516544488|FG002|Overall Study|System/Technical Error|3|||
143270377|NCT01898208|516544486|FG000|Overall Study|Lost to Follow-up|3|||
143270378|NCT01898208|516544487|FG001|Overall Study|Lost to Follow-up|1|||
143270379|NCT01898208|516544488|FG002|Overall Study|Lost to Follow-up|1|||
143270380|NCT02711345|516544490|FG000|Overall Study|Adverse Event|0|||
143270381|NCT02711345|516544491|FG001|Overall Study|Adverse Event|0|||
143270382|NCT02711345|516544492|FG002|Overall Study|Adverse Event|0|||
143270383|NCT02711345|516544493|FG003|Overall Study|Adverse Event|1|||
143270384|NCT02711345|516544494|FG004|Overall Study|Adverse Event|1|||
143270385|NCT02711345|516544495|FG005|Overall Study|Adverse Event|2|||
143270386|NCT02711345|516544496|FG006|Overall Study|Adverse Event|1|||
143270387|NCT02711345|516544497|FG007|Overall Study|Adverse Event|0|||
143270388|NCT02711345|516544498|FG008|Overall Study|Adverse Event|0|||
143270389|NCT02711345|516544499|FG009|Overall Study|Adverse Event|2|||
143270390|NCT02711345|516544490|FG000|Overall Study|Physician Decision|0|||
143270391|NCT02711345|516544491|FG001|Overall Study|Physician Decision|0|||
143270392|NCT02711345|516544492|FG002|Overall Study|Physician Decision|1|||
143270393|NCT02711345|516544493|FG003|Overall Study|Physician Decision|0|||
143270394|NCT02711345|516544494|FG004|Overall Study|Physician Decision|0|||
143270395|NCT02711345|516544495|FG005|Overall Study|Physician Decision|0|||
143270396|NCT02711345|516544496|FG006|Overall Study|Physician Decision|0|||
143270397|NCT02711345|516544497|FG007|Overall Study|Physician Decision|0|||
143270398|NCT02711345|516544498|FG008|Overall Study|Physician Decision|1|||
143270399|NCT02711345|516544499|FG009|Overall Study|Physician Decision|0|||
143270400|NCT02711345|516544490|FG000|Overall Study|Progressive disease|1|||
143270401|NCT02711345|516544491|FG001|Overall Study|Progressive disease|3|||
143270402|NCT02711345|516544492|FG002|Overall Study|Progressive disease|5|||
143270403|NCT02711345|516544493|FG003|Overall Study|Progressive disease|3|||
143270404|NCT02711345|516544494|FG004|Overall Study|Progressive disease|7|||
143270405|NCT02711345|516544495|FG005|Overall Study|Progressive disease|2|||
143270406|NCT02711345|516544496|FG006|Overall Study|Progressive disease|8|||
143270407|NCT02711345|516544497|FG007|Overall Study|Progressive disease|4|||
143270408|NCT02711345|516544498|FG008|Overall Study|Progressive disease|5|||
143270409|NCT02711345|516544499|FG009|Overall Study|Progressive disease|6|||
143270410|NCT02711345|516544490|FG000|Overall Study|Subject/guardian decision|0|||
143270411|NCT02711345|516544491|FG001|Overall Study|Subject/guardian decision|0|||
143270412|NCT02711345|516544492|FG002|Overall Study|Subject/guardian decision|0|||
143270413|NCT02711345|516544493|FG003|Overall Study|Subject/guardian decision|0|||
143270414|NCT02711345|516544494|FG004|Overall Study|Subject/guardian decision|0|||
143270415|NCT02711345|516544495|FG005|Overall Study|Subject/guardian decision|2|||
143270416|NCT02711345|516544496|FG006|Overall Study|Subject/guardian decision|3|||
143270417|NCT02711345|516544497|FG007|Overall Study|Subject/guardian decision|1|||
143270418|NCT02711345|516544498|FG008|Overall Study|Subject/guardian decision|0|||
143270419|NCT02711345|516544499|FG009|Overall Study|Subject/guardian decision|4|||
143270420|NCT02711345|516544490|FG000|Overall Study|Death|1|||
143270421|NCT02711345|516544491|FG001|Overall Study|Death|0|||
143270422|NCT02711345|516544492|FG002|Overall Study|Death|0|||
143270423|NCT02711345|516544493|FG003|Overall Study|Death|0|||
143270424|NCT02711345|516544494|FG004|Overall Study|Death|0|||
143270425|NCT02711345|516544495|FG005|Overall Study|Death|0|||
143270426|NCT02711345|516544496|FG006|Overall Study|Death|0|||
143270427|NCT02711345|516544497|FG007|Overall Study|Death|1|||
143270428|NCT02711345|516544498|FG008|Overall Study|Death|0|||
143270429|NCT02711345|516544499|FG009|Overall Study|Death|0|||
143270430|NCT00961649|516544500|FG000|Overall Study|Adverse Event|4|||
143270431|NCT00961649|516544501|FG001|Overall Study|Adverse Event|0|||
143270432|NCT00961649|516544502|FG002|Overall Study|Adverse Event|0|||
143270433|NCT00961649|516544503|FG003|Overall Study|Adverse Event|2|||
143270434|NCT00961649|516544500|FG000|Overall Study|Inadequate control of IOP|0|||
143270435|NCT00961649|516544501|FG001|Overall Study|Inadequate control of IOP|0|||
143270436|NCT00961649|516544502|FG002|Overall Study|Inadequate control of IOP|0|||
143372645|NCT00546871|516909629|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
143372646|NCT00546871|516909628|FG000|Study Extension Period|Protocol Violation|1|||
143372647|NCT00546871|516909629|FG001|Study Extension Period|Protocol Violation|0|||
143372648|NCT00546871|516909628|FG000|Study Extension Period|Withdrawal by Subject|0|||
143372649|NCT00546871|516909629|FG001|Study Extension Period|Withdrawal by Subject|1|||
143270437|NCT00961649|516544503|FG003|Overall Study|Inadequate control of IOP|1|||
143270438|NCT00961649|516544500|FG000|Overall Study|Patient has travel plans during holidays|0|||
143372650|NCT01713946|516909630|FG000|Overall Study|Death|0|||
143270439|NCT00961649|516544501|FG001|Overall Study|Patient has travel plans during holidays|0|||
143270440|NCT00961649|516544502|FG002|Overall Study|Patient has travel plans during holidays|1|||
143270441|NCT00961649|516544503|FG003|Overall Study|Patient has travel plans during holidays|0|||
143270442|NCT00961649|516544500|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
143372651|NCT01713946|516909631|FG001|Overall Study|Death|2|||
143372652|NCT01713946|516909632|FG002|Overall Study|Death|2|||
143372653|NCT01713946|516909630|FG000|Overall Study|Adverse Event|19|||
143372654|NCT01713946|516909631|FG001|Overall Study|Adverse Event|14|||
143270443|NCT00961649|516544501|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
143270444|NCT00961649|516544502|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
143270445|NCT00961649|516544503|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
143270446|NCT00961649|516544500|FG000|Overall Study|Study terminated by sponsor|4|||
143372655|NCT01713946|516909632|FG002|Overall Study|Adverse Event|13|||
143270447|NCT00961649|516544501|FG001|Overall Study|Study terminated by sponsor|4|||
143270448|NCT00961649|516544502|FG002|Overall Study|Study terminated by sponsor|4|||
143270449|NCT00961649|516544503|FG003|Overall Study|Study terminated by sponsor|1|||
143270450|NCT04043728|516544504|FG000|Overall Study|Lost to Follow-up|1|||
143270451|NCT04043728|516544505|FG001|Overall Study|Lost to Follow-up|2|||
143270452|NCT04043728|516544506|FG002|Overall Study|Lost to Follow-up|0|||
143270453|NCT04502979|516544508|FG000|Overall Study|Lost to Follow-up|1|||
143270454|NCT04502979|516544509|FG001|Overall Study|Lost to Follow-up|3|||
143270455|NCT04502979|516544508|FG000|Overall Study|Withdrawal by Subject|2|||
143270456|NCT04502979|516544509|FG001|Overall Study|Withdrawal by Subject|1|||
143270457|NCT00586625|516544513|FG000|Overall Study|Adverse Event|6|||
143270458|NCT00586625|516544514|FG001|Overall Study|Adverse Event|6|||
143270459|NCT00586625|516544513|FG000|Overall Study|Protocol Violation|3|||
143270460|NCT00586625|516544514|FG001|Overall Study|Protocol Violation|0|||
143270461|NCT00586625|516544513|FG000|Overall Study|Withdrawal by Subject|32|||
143270462|NCT00586625|516544514|FG001|Overall Study|Withdrawal by Subject|10|||
143270463|NCT00586625|516544513|FG000|Overall Study|Subject non-compliance|0|||
143270464|NCT00586625|516544514|FG001|Overall Study|Subject non-compliance|1|||
143270465|NCT00586625|516544513|FG000|Overall Study|Subject unable to return for visit|2|||
143270466|NCT00586625|516544514|FG001|Overall Study|Subject unable to return for visit|0|||
143270467|NCT04032652|516544515|FG000|Overall Study|The study was terminated and the PI has|1|||
143270468|NCT04032652|516544516|FG001|Overall Study|The study was terminated and the PI has|1|||
143270469|NCT01467583|516544520|FG000|Overall Study|Death|1|||
143270470|NCT01467583|516544521|FG001|Overall Study|Death|1|||
143270471|NCT01467583|516544522|FG002|Overall Study|Death|0|||
143270472|NCT01467583|516544520|FG000|Overall Study|Withdrawal by Subject|1|||
143270473|NCT01467583|516544521|FG001|Overall Study|Withdrawal by Subject|0|||
143270474|NCT01467583|516544522|FG002|Overall Study|Withdrawal by Subject|0|||
143270475|NCT01467583|516544520|FG000|Overall Study|Protocol Violation|0|||
143270476|NCT01467583|516544521|FG001|Overall Study|Protocol Violation|0|||
143270477|NCT01467583|516544522|FG002|Overall Study|Protocol Violation|2|||
143270478|NCT05274165|516544523|FG000|Overall Study|Withdrawal by Subject|3|||
143270479|NCT05274165|516544524|FG001|Overall Study|Withdrawal by Subject|3|||
143270480|NCT02484690|516544526|FG000|Overall Study|Adverse Event|1|||
143270481|NCT02484690|516544527|FG001|Overall Study|Adverse Event|3|||
143270482|NCT02484690|516544528|FG002|Overall Study|Adverse Event|0|||
143270483|NCT02484690|516544529|FG003|Overall Study|Adverse Event|0|||
143270484|NCT02484690|516544530|FG004|Overall Study|Adverse Event|5|||
143270485|NCT02484690|516544526|FG000|Overall Study|Death|0|||
143270486|NCT02484690|516544527|FG001|Overall Study|Death|0|||
143270487|NCT02484690|516544528|FG002|Overall Study|Death|0|||
143270488|NCT02484690|516544529|FG003|Overall Study|Death|0|||
143270489|NCT02484690|516544530|FG004|Overall Study|Death|1|||
143270490|NCT02484690|516544526|FG000|Overall Study|Withdrawal by Subject|1|||
143270491|NCT02484690|516544527|FG001|Overall Study|Withdrawal by Subject|3|||
143270492|NCT02484690|516544528|FG002|Overall Study|Withdrawal by Subject|1|||
143270493|NCT02484690|516544529|FG003|Overall Study|Withdrawal by Subject|2|||
143270494|NCT02484690|516544530|FG004|Overall Study|Withdrawal by Subject|0|||
143270495|NCT02484690|516544526|FG000|Overall Study|Physician Decision|2|||
143270496|NCT02484690|516544527|FG001|Overall Study|Physician Decision|0|||
143270497|NCT02484690|516544528|FG002|Overall Study|Physician Decision|1|||
143270498|NCT02484690|516544529|FG003|Overall Study|Physician Decision|0|||
143270499|NCT02484690|516544530|FG004|Overall Study|Physician Decision|0|||
143270500|NCT02484690|516544526|FG000|Overall Study|Lost to Follow-up|0|||
143270501|NCT02484690|516544527|FG001|Overall Study|Lost to Follow-up|0|||
143270502|NCT02484690|516544528|FG002|Overall Study|Lost to Follow-up|1|||
143270503|NCT02484690|516544529|FG003|Overall Study|Lost to Follow-up|0|||
143270504|NCT02484690|516544530|FG004|Overall Study|Lost to Follow-up|0|||
143270505|NCT00589290|516544532|FG000|Overall Study|Withdrawal by Subject|1|||
143270506|NCT00566111|516544533|FG000|Overall Study|Adverse Event|0|||
143270507|NCT00566111|516544534|FG001|Overall Study|Adverse Event|2|||
143270508|NCT04449861|516544535|FG000|Overall Study|Withdrawal by Subject|4|||
143270509|NCT04449861|516544535|FG000|Overall Study|Lost to Follow-up|5|||
143270510|NCT04449861|516544535|FG000|Overall Study|Death|112|||
143270511|NCT03507400|516544536|FG000|Overall Study|discontinued|5|||
143270512|NCT03507400|516544537|FG001|Overall Study|discontinued|1|||
143270513|NCT03507400|516544536|FG000|Overall Study|Lost to Follow-up|8|||
143270514|NCT03507400|516544537|FG001|Overall Study|Lost to Follow-up|6|||
143270515|NCT03507400|516544536|FG000|Overall Study|Protocol Violation|0|||
143270516|NCT03507400|516544537|FG001|Overall Study|Protocol Violation|1|||
143270517|NCT03817879|516546226|FG000|Overall Study|Drop out|5|||
143270518|NCT03817879|516546227|FG001|Overall Study|Drop out|12|||
143270519|NCT03817879|516546226|FG000|Overall Study|Withdrawal by Subject|0|||
143270520|NCT03817879|516546227|FG001|Overall Study|Withdrawal by Subject|1|||
143270521|NCT00392015|516546229|FG000|Overall Study|Lost to Follow-up|2|||
143270522|NCT00392015|516546230|FG001|Overall Study|Lost to Follow-up|0|||
143270523|NCT00392015|516546231|FG002|Overall Study|Lost to Follow-up|2|||
143270524|NCT00392015|516546232|FG003|Overall Study|Lost to Follow-up|1|||
143270525|NCT00392015|516546233|FG004|Overall Study|Lost to Follow-up|1|||
143270526|NCT00392015|516546234|FG005|Overall Study|Lost to Follow-up|0|||
143270527|NCT00392015|516546229|FG000|Overall Study|Withdrawal by Subject|0|||
143270528|NCT00392015|516546230|FG001|Overall Study|Withdrawal by Subject|0|||
143270529|NCT00392015|516546231|FG002|Overall Study|Withdrawal by Subject|2|||
143270530|NCT00392015|516546232|FG003|Overall Study|Withdrawal by Subject|0|||
143270531|NCT00392015|516546233|FG004|Overall Study|Withdrawal by Subject|0|||
143270532|NCT00392015|516546234|FG005|Overall Study|Withdrawal by Subject|0|||
143270533|NCT00392015|516546229|FG000|Overall Study|Adverse Event|0|||
143270534|NCT00392015|516546230|FG001|Overall Study|Adverse Event|0|||
143270535|NCT00392015|516546231|FG002|Overall Study|Adverse Event|0|||
143270536|NCT00392015|516546232|FG003|Overall Study|Adverse Event|0|||
143270537|NCT00392015|516546233|FG004|Overall Study|Adverse Event|1|||
143270538|NCT00392015|516546234|FG005|Overall Study|Adverse Event|0|||
143270539|NCT00392015|516546229|FG000|Overall Study|Previous trial recipient|0|||
143270540|NCT00392015|516546230|FG001|Overall Study|Previous trial recipient|0|||
143270541|NCT00392015|516546231|FG002|Overall Study|Previous trial recipient|0|||
143270542|NCT00392015|516546232|FG003|Overall Study|Previous trial recipient|0|||
143270543|NCT00392015|516546233|FG004|Overall Study|Previous trial recipient|1|||
143270544|NCT00392015|516546234|FG005|Overall Study|Previous trial recipient|0|||
143270545|NCT00717093|516546235|FG000|Overall Study|Adverse Event|19|||
143270546|NCT00717093|516546236|FG001|Overall Study|Adverse Event|9|||
143270547|NCT00717093|516546235|FG000|Overall Study|Lack of Efficacy|3|||
143270548|NCT00717093|516546236|FG001|Overall Study|Lack of Efficacy|13|||
143270549|NCT00717093|516546235|FG000|Overall Study|Lost to Follow-up|9|||
143270550|NCT00717093|516546236|FG001|Overall Study|Lost to Follow-up|6|||
143270551|NCT00717093|516546235|FG000|Overall Study|Withdrawal by Subject|12|||
143270552|NCT00717093|516546236|FG001|Overall Study|Withdrawal by Subject|19|||
143270553|NCT00717093|516546235|FG000|Overall Study|Other|0|||
143270554|NCT00717093|516546236|FG001|Overall Study|Other|1|||
143270555|NCT00717093|516546235|FG000|Overall Study|Randomized but not treated|1|||
143270556|NCT00717093|516546236|FG001|Overall Study|Randomized but not treated|0|||
143270557|NCT01543698|516546237|FG000|Phase 1b|Disease progression|2|||
143270558|NCT01543698|516546238|FG001|Phase 1b|Disease progression|4|||
143270559|NCT01543698|516546239|FG002|Phase 1b|Disease progression|3|||
143270560|NCT01543698|516546240|FG003|Phase 1b|Disease progression|2|||
143270561|NCT01543698|516546241|FG004|Phase 1b|Disease progression|10|||
143270562|NCT01543698|516546242|FG005|Phase 1b|Disease progression|6|||
143270563|NCT01543698|516546243|FG006|Phase 1b|Disease progression|5|||
143270564|NCT01543698|516546244|FG007|Phase 1b|Disease progression|3|||
143270565|NCT01543698|516546245|FG008|Phase 1b|Disease progression|4|||
143270566|NCT01543698|516546246|FG009|Phase 1b|Disease progression|5|||
143270567|NCT01543698|516546247|FG010|Phase 1b|Disease progression|1|||
143270568|NCT01543698|516546248|FG011|Phase 1b|Disease progression|0|||
143270569|NCT01543698|516546249|FG012|Phase 1b|Disease progression|0|||
143270570|NCT01543698|516546250|FG013|Phase 1b|Disease progression|0|||
143270571|NCT01543698|516546251|FG014|Phase 1b|Disease progression|0|||
143270572|NCT01543698|516546237|FG000|Phase 1b|Death|0|||
143270573|NCT01543698|516546238|FG001|Phase 1b|Death|0|||
143270574|NCT01543698|516546239|FG002|Phase 1b|Death|1|||
143270575|NCT01543698|516546240|FG003|Phase 1b|Death|1|||
143270576|NCT01543698|516546241|FG004|Phase 1b|Death|0|||
143270577|NCT01543698|516546242|FG005|Phase 1b|Death|0|||
143270578|NCT01543698|516546243|FG006|Phase 1b|Death|0|||
143270579|NCT01543698|516546244|FG007|Phase 1b|Death|0|||
143270580|NCT01543698|516546245|FG008|Phase 1b|Death|0|||
143270581|NCT01543698|516546246|FG009|Phase 1b|Death|0|||
143270582|NCT01543698|516546247|FG010|Phase 1b|Death|1|||
143270583|NCT01543698|516546248|FG011|Phase 1b|Death|0|||
143270584|NCT01543698|516546249|FG012|Phase 1b|Death|0|||
143270585|NCT01543698|516546250|FG013|Phase 1b|Death|0|||
143270586|NCT01543698|516546251|FG014|Phase 1b|Death|0|||
143270587|NCT01543698|516546237|FG000|Phase 1b|Withdrawal by Subject|0|||
143270588|NCT01543698|516546238|FG001|Phase 1b|Withdrawal by Subject|1|||
143270589|NCT01543698|516546239|FG002|Phase 1b|Withdrawal by Subject|0|||
143270590|NCT01543698|516546240|FG003|Phase 1b|Withdrawal by Subject|1|||
143270591|NCT01543698|516546241|FG004|Phase 1b|Withdrawal by Subject|0|||
143270592|NCT01543698|516546242|FG005|Phase 1b|Withdrawal by Subject|0|||
143270593|NCT01543698|516546243|FG006|Phase 1b|Withdrawal by Subject|1|||
143270594|NCT01543698|516546244|FG007|Phase 1b|Withdrawal by Subject|0|||
143270595|NCT01543698|516546245|FG008|Phase 1b|Withdrawal by Subject|0|||
143270596|NCT01543698|516546246|FG009|Phase 1b|Withdrawal by Subject|0|||
143270597|NCT01543698|516546247|FG010|Phase 1b|Withdrawal by Subject|0|||
143270598|NCT01543698|516546248|FG011|Phase 1b|Withdrawal by Subject|0|||
143270599|NCT01543698|516546249|FG012|Phase 1b|Withdrawal by Subject|0|||
143270600|NCT01543698|516546250|FG013|Phase 1b|Withdrawal by Subject|0|||
143270601|NCT01543698|516546251|FG014|Phase 1b|Withdrawal by Subject|0|||
143270602|NCT01543698|516546237|FG000|Phase 1b|Adverse Event|1|||
143270603|NCT01543698|516546238|FG001|Phase 1b|Adverse Event|0|||
143270604|NCT01543698|516546239|FG002|Phase 1b|Adverse Event|0|||
143270605|NCT01543698|516546240|FG003|Phase 1b|Adverse Event|1|||
143270606|NCT01543698|516546241|FG004|Phase 1b|Adverse Event|2|||
143270607|NCT01543698|516546242|FG005|Phase 1b|Adverse Event|2|||
143270608|NCT01543698|516546243|FG006|Phase 1b|Adverse Event|0|||
143270609|NCT01543698|516546244|FG007|Phase 1b|Adverse Event|0|||
143227974|NCT04158583|516382469|FG001|Overall Study|Withdrawal by Subject|1|||
143227975|NCT04158583|516382470|FG002|Overall Study|Withdrawal by Subject|0|||
143227976|NCT04158583|516382471|FG003|Overall Study|Withdrawal by Subject|0|||
143227977|NCT04158583|516382472|FG004|Overall Study|Withdrawal by Subject|1|||
143227978|NCT04158583|516382473|FG005|Overall Study|Withdrawal by Subject|0|||
143227979|NCT04158583|516382474|FG006|Overall Study|Withdrawal by Subject|0|||
143227980|NCT04158583|516382475|FG007|Overall Study|Withdrawal by Subject|0|||
143227981|NCT04158583|516382476|FG008|Overall Study|Withdrawal by Subject|2|||
143227982|NCT04158583|516382477|FG009|Overall Study|Withdrawal by Subject|0|||
143227983|NCT04158583|516382468|FG000|Overall Study|Study Terminated by Sponsor|0|||
143227984|NCT04158583|516382469|FG001|Overall Study|Study Terminated by Sponsor|0|||
143227985|NCT04158583|516382470|FG002|Overall Study|Study Terminated by Sponsor|0|||
143227986|NCT04158583|516382471|FG003|Overall Study|Study Terminated by Sponsor|1|||
143227987|NCT04158583|516382472|FG004|Overall Study|Study Terminated by Sponsor|0|||
143227988|NCT04158583|516382473|FG005|Overall Study|Study Terminated by Sponsor|0|||
143227989|NCT04158583|516382474|FG006|Overall Study|Study Terminated by Sponsor|0|||
143227990|NCT04158583|516382475|FG007|Overall Study|Study Terminated by Sponsor|0|||
143227991|NCT04158583|516382476|FG008|Overall Study|Study Terminated by Sponsor|0|||
143227992|NCT04158583|516382477|FG009|Overall Study|Study Terminated by Sponsor|0|||
143227993|NCT04158583|516382468|FG000|Overall Study|Progressive Disease|1|||
143227994|NCT04158583|516382469|FG001|Overall Study|Progressive Disease|0|||
143227995|NCT04158583|516382470|FG002|Overall Study|Progressive Disease|3|||
143227996|NCT04158583|516382471|FG003|Overall Study|Progressive Disease|5|||
143227997|NCT04158583|516382472|FG004|Overall Study|Progressive Disease|0|||
143227998|NCT04158583|516382473|FG005|Overall Study|Progressive Disease|1|||
143227999|NCT04158583|516382474|FG006|Overall Study|Progressive Disease|6|||
143228000|NCT04158583|516382475|FG007|Overall Study|Progressive Disease|2|||
143228001|NCT04158583|516382476|FG008|Overall Study|Progressive Disease|1|||
143228002|NCT04158583|516382477|FG009|Overall Study|Progressive Disease|2|||
143228003|NCT04158583|516382468|FG000|Overall Study|Lost to Follow-up|0|||
143228004|NCT04158583|516382469|FG001|Overall Study|Lost to Follow-up|0|||
143228005|NCT04158583|516382470|FG002|Overall Study|Lost to Follow-up|1|||
143228006|NCT04158583|516382471|FG003|Overall Study|Lost to Follow-up|1|||
143228007|NCT04158583|516382472|FG004|Overall Study|Lost to Follow-up|1|||
143228008|NCT04158583|516382473|FG005|Overall Study|Lost to Follow-up|0|||
143228009|NCT04158583|516382474|FG006|Overall Study|Lost to Follow-up|0|||
143228010|NCT04158583|516382475|FG007|Overall Study|Lost to Follow-up|0|||
143228011|NCT04158583|516382476|FG008|Overall Study|Lost to Follow-up|0|||
143228012|NCT04158583|516382477|FG009|Overall Study|Lost to Follow-up|0|||
143228013|NCT04158583|516382468|FG000|Overall Study|Due To Patient Status|0|||
143228014|NCT04158583|516382469|FG001|Overall Study|Due To Patient Status|0|||
143228015|NCT04158583|516382470|FG002|Overall Study|Due To Patient Status|0|||
143228016|NCT04158583|516382471|FG003|Overall Study|Due To Patient Status|0|||
143228017|NCT04158583|516382472|FG004|Overall Study|Due To Patient Status|0|||
143228018|NCT04158583|516382473|FG005|Overall Study|Due To Patient Status|0|||
143228019|NCT04158583|516382474|FG006|Overall Study|Due To Patient Status|0|||
143228020|NCT04158583|516382475|FG007|Overall Study|Due To Patient Status|0|||
143228021|NCT04158583|516382476|FG008|Overall Study|Due To Patient Status|1|||
143228022|NCT04158583|516382477|FG009|Overall Study|Due To Patient Status|0|||
143228023|NCT04158583|516382468|FG000|Overall Study|Death|3|||
143228024|NCT04158583|516382469|FG001|Overall Study|Death|4|||
143228025|NCT04158583|516382470|FG002|Overall Study|Death|2|||
143228026|NCT04158583|516382471|FG003|Overall Study|Death|2|||
143228027|NCT04158583|516382472|FG004|Overall Study|Death|4|||
143228028|NCT04158583|516382473|FG005|Overall Study|Death|3|||
143228029|NCT04158583|516382474|FG006|Overall Study|Death|5|||
143228030|NCT04158583|516382475|FG007|Overall Study|Death|2|||
143228031|NCT04158583|516382476|FG008|Overall Study|Death|0|||
143228032|NCT04158583|516382477|FG009|Overall Study|Death|1|||
143228033|NCT04158583|516382468|FG000|Overall Study|Clinical Progression Disease|0|||
143228034|NCT04158583|516382469|FG001|Overall Study|Clinical Progression Disease|0|||
143228035|NCT04158583|516382470|FG002|Overall Study|Clinical Progression Disease|0|||
143228036|NCT04158583|516382471|FG003|Overall Study|Clinical Progression Disease|1|||
143228037|NCT04158583|516382472|FG004|Overall Study|Clinical Progression Disease|0|||
143228038|NCT04158583|516382473|FG005|Overall Study|Clinical Progression Disease|0|||
143228039|NCT04158583|516382474|FG006|Overall Study|Clinical Progression Disease|0|||
143228040|NCT04158583|516382475|FG007|Overall Study|Clinical Progression Disease|0|||
143228041|NCT04158583|516382476|FG008|Overall Study|Clinical Progression Disease|0|||
143228042|NCT04158583|516382477|FG009|Overall Study|Clinical Progression Disease|0|||
143228043|NCT04158583|516382468|FG000|Overall Study|Clinical Progression|0|||
143228044|NCT04158583|516382469|FG001|Overall Study|Clinical Progression|0|||
143228045|NCT04158583|516382470|FG002|Overall Study|Clinical Progression|0|||
143228046|NCT04158583|516382471|FG003|Overall Study|Clinical Progression|0|||
143228047|NCT04158583|516382472|FG004|Overall Study|Clinical Progression|1|||
143228048|NCT04158583|516382473|FG005|Overall Study|Clinical Progression|0|||
143228049|NCT04158583|516382474|FG006|Overall Study|Clinical Progression|2|||
143228050|NCT04158583|516382475|FG007|Overall Study|Clinical Progression|0|||
143228051|NCT04158583|516382476|FG008|Overall Study|Clinical Progression|0|||
143228052|NCT04158583|516382477|FG009|Overall Study|Clinical Progression|0|||
143228053|NCT04158583|516382468|FG000|Overall Study|Clinical Deterioration|0|||
143228054|NCT04158583|516382469|FG001|Overall Study|Clinical Deterioration|0|||
143228055|NCT04158583|516382470|FG002|Overall Study|Clinical Deterioration|0|||
143228056|NCT04158583|516382471|FG003|Overall Study|Clinical Deterioration|1|||
143228057|NCT04158583|516382472|FG004|Overall Study|Clinical Deterioration|0|||
143228058|NCT04158583|516382473|FG005|Overall Study|Clinical Deterioration|0|||
143228059|NCT04158583|516382474|FG006|Overall Study|Clinical Deterioration|0|||
143228060|NCT04158583|516382475|FG007|Overall Study|Clinical Deterioration|0|||
143228061|NCT04158583|516382476|FG008|Overall Study|Clinical Deterioration|0|||
143228062|NCT04158583|516382477|FG009|Overall Study|Clinical Deterioration|1|||
143228063|NCT02775916|516382478|FG000|Overall Study|Adverse Event|1|||
143228064|NCT02775916|516382479|FG001|Overall Study|Adverse Event|0|||
143228065|NCT02775916|516382478|FG000|Overall Study|Subject/Guardian Decision|2|||
143228066|NCT02775916|516382479|FG001|Overall Study|Subject/Guardian Decision|0|||
143228067|NCT00644423|516383965|FG000|Overall Study|Lost to Follow-up|1|||
143228068|NCT00644423|516383966|FG001|Overall Study|Lost to Follow-up|1|||
143228069|NCT02426580|516383967|FG000|Overall Study|Death|2|||
143228070|NCT02426580|516383968|FG001|Overall Study|Death|2|||
143228071|NCT02426580|516383967|FG000|Overall Study|Lost to Follow-up|0|||
143228072|NCT02426580|516383968|FG001|Overall Study|Lost to Follow-up|9|||
143228073|NCT02426580|516383967|FG000|Overall Study|transfer to hemodialysis|5|||
143228074|NCT02426580|516383968|FG001|Overall Study|transfer to hemodialysis|5|||
143228075|NCT02426580|516383967|FG000|Overall Study|Kidney transplant|3|||
143228076|NCT02426580|516383968|FG001|Overall Study|Kidney transplant|0|||
143228077|NCT02426580|516383967|FG000|Overall Study|Allergic to egg white|1|||
143228078|NCT02426580|516383968|FG001|Overall Study|Allergic to egg white|0|||
143228079|NCT00383552|516383971|FG000|Overall Study|Adverse Event|7|||
143228080|NCT00383552|516383972|FG001|Overall Study|Adverse Event|6|||
143228081|NCT00383552|516383973|FG002|Overall Study|Adverse Event|9|||
143228082|NCT00383552|516383974|FG003|Overall Study|Adverse Event|6|||
143228083|NCT00383552|516383971|FG000|Overall Study|Lack of Efficacy|4|||
143228084|NCT00383552|516383972|FG001|Overall Study|Lack of Efficacy|13|||
143228085|NCT00383552|516383973|FG002|Overall Study|Lack of Efficacy|29|||
143228086|NCT00383552|516383974|FG003|Overall Study|Lack of Efficacy|42|||
143228087|NCT00383552|516383971|FG000|Overall Study|Lost to Follow-up|0|||
143228088|NCT00383552|516383972|FG001|Overall Study|Lost to Follow-up|1|||
143228089|NCT00383552|516383973|FG002|Overall Study|Lost to Follow-up|5|||
143228090|NCT00383552|516383974|FG003|Overall Study|Lost to Follow-up|1|||
143228091|NCT00383552|516383971|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
143228092|NCT00383552|516383972|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
143228093|NCT00383552|516383973|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
143228094|NCT00383552|516383974|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
143228095|NCT00383552|516383971|FG000|Overall Study|Did not wish to continue (related)|1|||
143228096|NCT00383552|516383972|FG001|Overall Study|Did not wish to continue (related)|0|||
143228097|NCT00383552|516383973|FG002|Overall Study|Did not wish to continue (related)|2|||
143228098|NCT00383552|516383974|FG003|Overall Study|Did not wish to continue (related)|3|||
143228099|NCT00383552|516383971|FG000|Overall Study|Noncompliance with the protocol|11|||
143228100|NCT00383552|516383972|FG001|Overall Study|Noncompliance with the protocol|6|||
143228101|NCT00383552|516383973|FG002|Overall Study|Noncompliance with the protocol|8|||
143228102|NCT00383552|516383974|FG003|Overall Study|Noncompliance with the protocol|10|||
143228103|NCT00383552|516383971|FG000|Overall Study|Did not meet protocol eligibility|8|||
143228104|NCT00383552|516383972|FG001|Overall Study|Did not meet protocol eligibility|6|||
143228105|NCT00383552|516383973|FG002|Overall Study|Did not meet protocol eligibility|2|||
143228106|NCT00383552|516383974|FG003|Overall Study|Did not meet protocol eligibility|3|||
143228107|NCT00383552|516383971|FG000|Overall Study|Administrative|1|||
143228108|NCT00383552|516383972|FG001|Overall Study|Administrative|0|||
143228109|NCT00383552|516383973|FG002|Overall Study|Administrative|1|||
143228110|NCT00383552|516383974|FG003|Overall Study|Administrative|1|||
143228111|NCT03096834|516383975|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
143228112|NCT03096834|516383976|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
143228113|NCT03096834|516383977|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
143228114|NCT03096834|516383978|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
143228115|NCT03096834|516383975|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
143228116|NCT03096834|516383976|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
143228117|NCT03096834|516383977|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
143228118|NCT03096834|516383978|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
143228119|NCT03096834|516383975|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
143228120|NCT03096834|516383976|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
143228121|NCT03096834|516383977|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
143228122|NCT03096834|516383978|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
143228123|NCT03096834|516383975|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
143228124|NCT03096834|516383976|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
143228125|NCT03096834|516383977|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
143228126|NCT03096834|516383978|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
143228127|NCT03096834|516383975|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
143228128|NCT03096834|516383976|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
143228129|NCT03096834|516383977|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
143228130|NCT03096834|516383978|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
143228131|NCT03096834|516383975|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
143228132|NCT03096834|516383976|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
143228133|NCT03096834|516383977|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
143228134|NCT03096834|516383978|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
143228135|NCT03096834|516383975|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
143228136|NCT03096834|516383976|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
143228137|NCT03096834|516383977|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
143228138|NCT03096834|516383978|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
143228139|NCT03096834|516383975|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
143228140|NCT03096834|516383976|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
143228141|NCT03096834|516383977|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
143228142|NCT03096834|516383978|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
143228143|NCT03096834|516383975|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
143228144|NCT03096834|516383976|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
143228145|NCT03096834|516383977|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
143228146|NCT03096834|516383978|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
143228147|NCT03096834|516383975|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
143228148|NCT03096834|516383976|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
143228149|NCT03096834|516383977|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
143228150|NCT03096834|516383978|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
143228151|NCT03096834|516383975|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
143228152|NCT03096834|516383976|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
143228153|NCT03096834|516383977|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
143228154|NCT03096834|516383978|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
143228155|NCT03096834|516383975|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
143228156|NCT03096834|516383976|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
143228157|NCT03096834|516383977|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
143228158|NCT03096834|516383978|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
143228159|NCT01405768|516383991|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
143228160|NCT01405768|516383992|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
143228161|NCT01393158|516383995|FG000|Overall Study|Adverse Event|1|||
143228162|NCT01393158|516383996|FG001|Overall Study|Adverse Event|0|||
143228163|NCT04233801|516383998|FG000|Overall Study|Other than listed|0|||
143228164|NCT04233801|516383999|FG001|Overall Study|Other than listed|0|||
143228165|NCT04233801|516384000|FG002|Overall Study|Other than listed|1|||
143228166|NCT04233801|516383998|FG000|Overall Study|Withdrawal by Subject|0|||
143228167|NCT04233801|516383999|FG001|Overall Study|Withdrawal by Subject|2|||
143228168|NCT04233801|516384000|FG002|Overall Study|Withdrawal by Subject|3|||
143228169|NCT02173769|516384001|FG000|Overall Study|Protocol Violation|4|||
143228170|NCT00762359|516384002|FG000|Overall Study|Adverse Event|20|||
143228171|NCT00762359|516384003|FG001|Overall Study|Adverse Event|23|||
143228172|NCT00762359|516384002|FG000|Overall Study|Protocol Violation|21|||
143228173|NCT00762359|516384003|FG001|Overall Study|Protocol Violation|13|||
143228174|NCT00762359|516384002|FG000|Overall Study|Withdrawal by Subject|13|||
143228175|NCT00762359|516384003|FG001|Overall Study|Withdrawal by Subject|10|||
143228176|NCT00762359|516384002|FG000|Overall Study|Lack of Efficacy|0|||
143228177|NCT00762359|516384003|FG001|Overall Study|Lack of Efficacy|4|||
143228178|NCT00762359|516384002|FG000|Overall Study|Institution closed|2|||
143228179|NCT00762359|516384003|FG001|Overall Study|Institution closed|3|||
143228180|NCT00762359|516384002|FG000|Overall Study|Physician Decision|2|||
143228181|NCT00762359|516384003|FG001|Overall Study|Physician Decision|3|||
143228182|NCT00762359|516384002|FG000|Overall Study|Removal|0|||
143228183|NCT00762359|516384003|FG001|Overall Study|Removal|1|||
143228184|NCT00762359|516384002|FG000|Overall Study|Withdrew consent|1|||
143228185|NCT00762359|516384003|FG001|Overall Study|Withdrew consent|0|||
143228186|NCT00683878|516384006|FG000|Overall Study|Lack of Efficacy|3|||
143228187|NCT00683878|516384007|FG001|Overall Study|Lack of Efficacy|0|||
143228188|NCT00683878|516384008|FG002|Overall Study|Lack of Efficacy|1|||
143228189|NCT00683878|516384006|FG000|Overall Study|Adverse Event|4|||
143228190|NCT00683878|516384007|FG001|Overall Study|Adverse Event|3|||
143228191|NCT00683878|516384008|FG002|Overall Study|Adverse Event|3|||
143228192|NCT00683878|516384006|FG000|Overall Study|Withdrawal by Subject|9|||
143228193|NCT00683878|516384007|FG001|Overall Study|Withdrawal by Subject|8|||
143228194|NCT00683878|516384008|FG002|Overall Study|Withdrawal by Subject|6|||
143228195|NCT00683878|516384006|FG000|Overall Study|Death|0|||
143228196|NCT00683878|516384007|FG001|Overall Study|Death|1|||
143228197|NCT00683878|516384008|FG002|Overall Study|Death|0|||
143228198|NCT00683878|516384006|FG000|Overall Study|Lost to Follow-up|4|||
143228199|NCT00683878|516384007|FG001|Overall Study|Lost to Follow-up|2|||
143228200|NCT00683878|516384008|FG002|Overall Study|Lost to Follow-up|4|||
143228201|NCT00683878|516384006|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
143228202|NCT00683878|516384007|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
143228203|NCT00683878|516384008|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
143228204|NCT02869633|516384012|FG000|Overall Study|Death|2|||
143228205|NCT02869633|516384013|FG001|Overall Study|Death|1|||
143228206|NCT02869633|516384012|FG000|Overall Study|Patient refused follow-up|1|||
143228207|NCT02869633|516384013|FG001|Overall Study|Patient refused follow-up|0|||
143228208|NCT02869633|516384012|FG000|Overall Study|Provider discretion|1|||
143228209|NCT02869633|516384013|FG001|Overall Study|Provider discretion|0|||
143228210|NCT02869633|516384012|FG000|Overall Study|Investigator decision|1|||
143228211|NCT02869633|516384013|FG001|Overall Study|Investigator decision|0|||
143228212|NCT02869633|516384012|FG000|Overall Study|Lost to Follow-up|0|||
143228213|NCT02869633|516384013|FG001|Overall Study|Lost to Follow-up|1|||
143228214|NCT02869633|516384012|FG000|Overall Study|Not eligible|6|||
143228215|NCT02869633|516384013|FG001|Overall Study|Not eligible|1|||
143228216|NCT02869633|516384012|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
143228217|NCT02869633|516384013|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
143228218|NCT02869633|516384012|FG000|Overall Study|Withdrawal by Subject|0|||
143228219|NCT02869633|516384013|FG001|Overall Study|Withdrawal by Subject|1|||
143228220|NCT01381016|516384017|FG000|Overall Study|Lost to Follow-up|1|||
143228221|NCT01381016|516384018|FG001|Overall Study|Lost to Follow-up|1|||
143228222|NCT01381016|516384017|FG000|Overall Study|Screen Failure|2|||
143228223|NCT01381016|516384018|FG001|Overall Study|Screen Failure|2|||
143228224|NCT01381016|516384017|FG000|Overall Study|Withdrawal by Subject|0|||
143228225|NCT01381016|516384018|FG001|Overall Study|Withdrawal by Subject|1|||
143228226|NCT01381016|516384017|FG000|Overall Study|Physician Decision|0|||
143228227|NCT01381016|516384018|FG001|Overall Study|Physician Decision|2|||
143228228|NCT01693029|516384022|FG000|Overall Study|Withdrawal by Subject|15|||
143228229|NCT01693029|516384023|FG001|Overall Study|Withdrawal by Subject|22|||
143228230|NCT01693029|516384022|FG000|Overall Study|Kidney transplantation|7|||
143228231|NCT01693029|516384023|FG001|Overall Study|Kidney transplantation|7|||
143228232|NCT01693029|516384022|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
143228233|NCT01693029|516384023|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
143228234|NCT01693029|516384022|FG000|Overall Study|Protocol Violation|6|||
143228235|NCT01693029|516384023|FG001|Overall Study|Protocol Violation|7|||
143228236|NCT01693029|516384022|FG000|Overall Study|Change in dialysis modality|2|||
143228237|NCT01693029|516384023|FG001|Overall Study|Change in dialysis modality|1|||
143228238|NCT01693029|516384022|FG000|Overall Study|Physician Decision|0|||
143228239|NCT01693029|516384023|FG001|Overall Study|Physician Decision|2|||
143228240|NCT01693029|516384022|FG000|Overall Study|Lost to Follow-up|0|||
143228241|NCT01693029|516384023|FG001|Overall Study|Lost to Follow-up|1|||
143228242|NCT01693029|516384022|FG000|Overall Study|Adverse Event|1|||
143228243|NCT01693029|516384023|FG001|Overall Study|Adverse Event|6|||
143228244|NCT01693029|516384022|FG000|Overall Study|Death|5|||
143228245|NCT01693029|516384023|FG001|Overall Study|Death|8|||
143228246|NCT01693029|516384022|FG000|Overall Study|Non-compliance|2|||
143228247|NCT01693029|516384023|FG001|Overall Study|Non-compliance|1|||
143228248|NCT02210000|516384025|FG000|Overall Study|Study Terminated|11|||
143228249|NCT02210000|516384026|FG001|Overall Study|Study Terminated|12|||
143228250|NCT02210000|516384025|FG000|Overall Study|Withdrawal by Subject|7|||
143228251|NCT02210000|516384026|FG001|Overall Study|Withdrawal by Subject|1|||
143270610|NCT01543698|516546245|FG008|Phase 1b|Adverse Event|1|||
143270611|NCT01543698|516546246|FG009|Phase 1b|Adverse Event|1|||
143270612|NCT01543698|516546247|FG010|Phase 1b|Adverse Event|2|||
143270613|NCT01543698|516546248|FG011|Phase 1b|Adverse Event|0|||
143228252|NCT02210000|516384025|FG000|Overall Study|Adverse Event|1|||
143228253|NCT02210000|516384026|FG001|Overall Study|Adverse Event|5|||
143228254|NCT02210000|516384025|FG000|Overall Study|Lost to Follow-up|0|||
143228255|NCT02210000|516384026|FG001|Overall Study|Lost to Follow-up|2|||
143228256|NCT02210000|516384025|FG000|Overall Study|Physician Decision|0|||
143228257|NCT02210000|516384026|FG001|Overall Study|Physician Decision|1|||
143228258|NCT01329263|516384027|FG000|Overall Study|Lost to Follow-up|4|||
143228259|NCT01329263|516384028|FG001|Overall Study|Lost to Follow-up|21|||
143270614|NCT01543698|516546249|FG012|Phase 1b|Adverse Event|0|||
143270615|NCT01543698|516546250|FG013|Phase 1b|Adverse Event|0|||
143270616|NCT01543698|516546251|FG014|Phase 1b|Adverse Event|0|||
143270617|NCT01543698|516546237|FG000|Phase 1b|Administrative problems|1|||
143270618|NCT01543698|516546238|FG001|Phase 1b|Administrative problems|0|||
143270619|NCT01543698|516546239|FG002|Phase 1b|Administrative problems|0|||
143270620|NCT01543698|516546240|FG003|Phase 1b|Administrative problems|0|||
143270621|NCT01543698|516546241|FG004|Phase 1b|Administrative problems|1|||
143270622|NCT01543698|516546242|FG005|Phase 1b|Administrative problems|0|||
143270623|NCT01543698|516546243|FG006|Phase 1b|Administrative problems|0|||
143270624|NCT01543698|516546244|FG007|Phase 1b|Administrative problems|1|||
143270625|NCT01543698|516546245|FG008|Phase 1b|Administrative problems|0|||
143270626|NCT01543698|516546246|FG009|Phase 1b|Administrative problems|0|||
143270627|NCT01543698|516546247|FG010|Phase 1b|Administrative problems|2|||
143270628|NCT01543698|516546248|FG011|Phase 1b|Administrative problems|0|||
143270629|NCT01543698|516546249|FG012|Phase 1b|Administrative problems|0|||
143270630|NCT01543698|516546250|FG013|Phase 1b|Administrative problems|0|||
143270631|NCT01543698|516546251|FG014|Phase 1b|Administrative problems|0|||
143270632|NCT01543698|516546237|FG000|Phase 1b|Protocol Violation|2|||
143270633|NCT01543698|516546238|FG001|Phase 1b|Protocol Violation|0|||
143270634|NCT01543698|516546239|FG002|Phase 1b|Protocol Violation|0|||
143270635|NCT01543698|516546240|FG003|Phase 1b|Protocol Violation|0|||
143270636|NCT01543698|516546241|FG004|Phase 1b|Protocol Violation|0|||
143270637|NCT01543698|516546242|FG005|Phase 1b|Protocol Violation|0|||
143270638|NCT01543698|516546243|FG006|Phase 1b|Protocol Violation|0|||
143270639|NCT01543698|516546244|FG007|Phase 1b|Protocol Violation|0|||
143270640|NCT01543698|516546245|FG008|Phase 1b|Protocol Violation|0|||
143270641|NCT01543698|516546246|FG009|Phase 1b|Protocol Violation|0|||
143270642|NCT01543698|516546247|FG010|Phase 1b|Protocol Violation|0|||
143270643|NCT01543698|516546248|FG011|Phase 1b|Protocol Violation|0|||
143270644|NCT01543698|516546249|FG012|Phase 1b|Protocol Violation|0|||
143270645|NCT01543698|516546250|FG013|Phase 1b|Protocol Violation|0|||
143270646|NCT01543698|516546251|FG014|Phase 1b|Protocol Violation|0|||
143270647|NCT01543698|516546237|FG000|Phase 2|Protocol Violation|0|||
143270648|NCT01543698|516546238|FG001|Phase 2|Protocol Violation|0|||
143270649|NCT01543698|516546239|FG002|Phase 2|Protocol Violation|0|||
143270650|NCT01543698|516546240|FG003|Phase 2|Protocol Violation|0|||
143270651|NCT01543698|516546241|FG004|Phase 2|Protocol Violation|0|||
143270652|NCT01543698|516546242|FG005|Phase 2|Protocol Violation|0|||
143270653|NCT01543698|516546243|FG006|Phase 2|Protocol Violation|0|||
143270654|NCT01543698|516546244|FG007|Phase 2|Protocol Violation|0|||
143270655|NCT01543698|516546245|FG008|Phase 2|Protocol Violation|0|||
143270656|NCT01543698|516546246|FG009|Phase 2|Protocol Violation|0|||
143270657|NCT01543698|516546247|FG010|Phase 2|Protocol Violation|0|||
143270658|NCT01543698|516546248|FG011|Phase 2|Protocol Violation|0|||
143270659|NCT01543698|516546249|FG012|Phase 2|Protocol Violation|1|||
143270660|NCT01543698|516546250|FG013|Phase 2|Protocol Violation|0|||
143270661|NCT01543698|516546251|FG014|Phase 2|Protocol Violation|0|||
143270662|NCT01543698|516546237|FG000|Phase 2|Disease progression|0|||
143270663|NCT01543698|516546238|FG001|Phase 2|Disease progression|0|||
143270664|NCT01543698|516546239|FG002|Phase 2|Disease progression|0|||
143270665|NCT01543698|516546240|FG003|Phase 2|Disease progression|0|||
143270666|NCT01543698|516546241|FG004|Phase 2|Disease progression|0|||
143270667|NCT01543698|516546242|FG005|Phase 2|Disease progression|0|||
143270668|NCT01543698|516546243|FG006|Phase 2|Disease progression|0|||
143270669|NCT01543698|516546244|FG007|Phase 2|Disease progression|0|||
143270670|NCT01543698|516546245|FG008|Phase 2|Disease progression|0|||
143270671|NCT01543698|516546246|FG009|Phase 2|Disease progression|0|||
143270672|NCT01543698|516546247|FG010|Phase 2|Disease progression|0|||
143270673|NCT01543698|516546248|FG011|Phase 2|Disease progression|10|||
143270674|NCT01543698|516546249|FG012|Phase 2|Disease progression|21|||
143270675|NCT01543698|516546250|FG013|Phase 2|Disease progression|30|||
143270676|NCT01543698|516546251|FG014|Phase 2|Disease progression|25|||
143270677|NCT01543698|516546237|FG000|Phase 2|Death|0|||
143270678|NCT01543698|516546238|FG001|Phase 2|Death|0|||
143270679|NCT01543698|516546239|FG002|Phase 2|Death|0|||
143270680|NCT01543698|516546240|FG003|Phase 2|Death|0|||
143270681|NCT01543698|516546241|FG004|Phase 2|Death|0|||
143270682|NCT01543698|516546242|FG005|Phase 2|Death|0|||
143270683|NCT01543698|516546243|FG006|Phase 2|Death|0|||
143270684|NCT01543698|516546244|FG007|Phase 2|Death|0|||
143270685|NCT01543698|516546245|FG008|Phase 2|Death|0|||
143270686|NCT01543698|516546246|FG009|Phase 2|Death|0|||
143270687|NCT01543698|516546247|FG010|Phase 2|Death|0|||
143270688|NCT01543698|516546248|FG011|Phase 2|Death|0|||
143270689|NCT01543698|516546249|FG012|Phase 2|Death|1|||
143270690|NCT01543698|516546250|FG013|Phase 2|Death|1|||
143270691|NCT01543698|516546251|FG014|Phase 2|Death|1|||
143270692|NCT01543698|516546237|FG000|Phase 2|Administrative problems|0|||
143270693|NCT01543698|516546238|FG001|Phase 2|Administrative problems|0|||
143270694|NCT01543698|516546239|FG002|Phase 2|Administrative problems|0|||
143270695|NCT01543698|516546240|FG003|Phase 2|Administrative problems|0|||
143270696|NCT01543698|516546241|FG004|Phase 2|Administrative problems|0|||
143270697|NCT01543698|516546242|FG005|Phase 2|Administrative problems|0|||
143270698|NCT01543698|516546243|FG006|Phase 2|Administrative problems|0|||
143270699|NCT01543698|516546244|FG007|Phase 2|Administrative problems|0|||
143270700|NCT01543698|516546245|FG008|Phase 2|Administrative problems|0|||
143270701|NCT01543698|516546246|FG009|Phase 2|Administrative problems|0|||
143270702|NCT01543698|516546247|FG010|Phase 2|Administrative problems|0|||
143270703|NCT01543698|516546248|FG011|Phase 2|Administrative problems|0|||
143270704|NCT01543698|516546249|FG012|Phase 2|Administrative problems|0|||
143270705|NCT01543698|516546250|FG013|Phase 2|Administrative problems|3|||
143270706|NCT01543698|516546251|FG014|Phase 2|Administrative problems|1|||
143270707|NCT01543698|516546237|FG000|Phase 2|Withdrawal by Subject|0|||
143270708|NCT01543698|516546238|FG001|Phase 2|Withdrawal by Subject|0|||
143270709|NCT01543698|516546239|FG002|Phase 2|Withdrawal by Subject|0|||
143270710|NCT01543698|516546240|FG003|Phase 2|Withdrawal by Subject|0|||
143270711|NCT01543698|516546241|FG004|Phase 2|Withdrawal by Subject|0|||
143270712|NCT01543698|516546242|FG005|Phase 2|Withdrawal by Subject|0|||
143270713|NCT01543698|516546243|FG006|Phase 2|Withdrawal by Subject|0|||
143270714|NCT01543698|516546244|FG007|Phase 2|Withdrawal by Subject|0|||
143270715|NCT01543698|516546245|FG008|Phase 2|Withdrawal by Subject|0|||
143270716|NCT01543698|516546246|FG009|Phase 2|Withdrawal by Subject|0|||
143270717|NCT01543698|516546247|FG010|Phase 2|Withdrawal by Subject|0|||
143270718|NCT01543698|516546248|FG011|Phase 2|Withdrawal by Subject|0|||
143270719|NCT01543698|516546249|FG012|Phase 2|Withdrawal by Subject|0|||
143270720|NCT01543698|516546250|FG013|Phase 2|Withdrawal by Subject|3|||
143270721|NCT01543698|516546251|FG014|Phase 2|Withdrawal by Subject|1|||
143270722|NCT01543698|516546237|FG000|Phase 2|Adverse Event|0|||
143270723|NCT01543698|516546238|FG001|Phase 2|Adverse Event|0|||
143270724|NCT01543698|516546239|FG002|Phase 2|Adverse Event|0|||
143270725|NCT01543698|516546240|FG003|Phase 2|Adverse Event|0|||
143270726|NCT01543698|516546241|FG004|Phase 2|Adverse Event|0|||
143270727|NCT01543698|516546242|FG005|Phase 2|Adverse Event|0|||
143270728|NCT01543698|516546243|FG006|Phase 2|Adverse Event|0|||
143270729|NCT01543698|516546244|FG007|Phase 2|Adverse Event|0|||
143270730|NCT01543698|516546245|FG008|Phase 2|Adverse Event|0|||
143270731|NCT01543698|516546246|FG009|Phase 2|Adverse Event|0|||
143270732|NCT01543698|516546247|FG010|Phase 2|Adverse Event|0|||
143270733|NCT01543698|516546248|FG011|Phase 2|Adverse Event|1|||
143270734|NCT01543698|516546249|FG012|Phase 2|Adverse Event|3|||
143270735|NCT01543698|516546250|FG013|Phase 2|Adverse Event|5|||
143270736|NCT01543698|516546251|FG014|Phase 2|Adverse Event|14|||
143270737|NCT02925923|516546259|FG000|Overall Study|blood samples hemolyzed|0|||
143270738|NCT02925923|516546260|FG001|Overall Study|blood samples hemolyzed|2|||
143270739|NCT02742441|516546261|FG000|Overall Study|Lost to Follow-up|4|||
143270740|NCT02742441|516546262|FG001|Overall Study|Lost to Follow-up|4|||
143270741|NCT02742441|516546261|FG000|Overall Study|Withdrawal by Subject|2|||
143270742|NCT02742441|516546262|FG001|Overall Study|Withdrawal by Subject|2|||
143270743|NCT02742441|516546261|FG000|Overall Study|Adverse Event|0|||
143270744|NCT02742441|516546262|FG001|Overall Study|Adverse Event|2|||
143270745|NCT01863953|516546264|FG000|Overall Study|Adverse Event|0|||
143270746|NCT01863953|516546265|FG001|Overall Study|Adverse Event|0|||
143270747|NCT01863953|516546266|FG002|Overall Study|Adverse Event|1|||
143270748|NCT02104752|516546267|FG000|Overall Study|Withdrawal by Subject|1|||
143270749|NCT02104752|516546268|FG001|Overall Study|Withdrawal by Subject|0|||
143270750|NCT02104752|516546267|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
143270751|NCT02104752|516546268|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
143270752|NCT05439941|516546269|FG000|Overall Study|Lack of Efficacy|8|||
143270753|NCT05439941|516546270|FG001|Overall Study|Lack of Efficacy|5|||
143270754|NCT05439941|516546271|FG002|Overall Study|Lack of Efficacy|3|||
143270755|NCT05439941|516546269|FG000|Overall Study|Treatment Failure|0|||
143270756|NCT05439941|516546270|FG001|Overall Study|Treatment Failure|1|||
143270757|NCT05439941|516546271|FG002|Overall Study|Treatment Failure|0|||
143270758|NCT05439941|516546269|FG000|Overall Study|Adverse Event|1|||
143270759|NCT05439941|516546270|FG001|Overall Study|Adverse Event|3|||
143270760|NCT05439941|516546271|FG002|Overall Study|Adverse Event|0|||
143270761|NCT05439941|516546269|FG000|Overall Study|Adverse Event - Parent Study|1|||
143270762|NCT05439941|516546270|FG001|Overall Study|Adverse Event - Parent Study|0|||
143270763|NCT05439941|516546271|FG002|Overall Study|Adverse Event - Parent Study|0|||
143270764|NCT05439941|516546269|FG000|Overall Study|Pregnancy|1|||
143270765|NCT05439941|516546270|FG001|Overall Study|Pregnancy|0|||
143270766|NCT05439941|516546271|FG002|Overall Study|Pregnancy|0|||
143270767|NCT05439941|516546269|FG000|Overall Study|Withdrawal by Subject|9|||
143270768|NCT05439941|516546270|FG001|Overall Study|Withdrawal by Subject|6|||
143270769|NCT05439941|516546271|FG002|Overall Study|Withdrawal by Subject|10|||
143270770|NCT05439941|516546269|FG000|Overall Study|Non-Compliance|1|||
143270771|NCT05439941|516546270|FG001|Overall Study|Non-Compliance|1|||
143270772|NCT05439941|516546271|FG002|Overall Study|Non-Compliance|1|||
143270773|NCT05439941|516546269|FG000|Overall Study|Lost to Follow-up|2|||
143270774|NCT05439941|516546270|FG001|Overall Study|Lost to Follow-up|2|||
143270775|NCT05439941|516546271|FG002|Overall Study|Lost to Follow-up|0|||
143270776|NCT05439941|516546269|FG000|Overall Study|Physician Decision|1|||
143270777|NCT05439941|516546270|FG001|Overall Study|Physician Decision|0|||
143270778|NCT05439941|516546271|FG002|Overall Study|Physician Decision|0|||
143270779|NCT05439941|516546269|FG000|Overall Study|Trial Termination by Sponsor|78|||
143270780|NCT05439941|516546270|FG001|Overall Study|Trial Termination by Sponsor|83|||
143270781|NCT05439941|516546271|FG002|Overall Study|Trial Termination by Sponsor|65|||
143270782|NCT05439941|516546269|FG000|Overall Study|Other than Reasons Listed|2|||
143270783|NCT05439941|516546270|FG001|Overall Study|Other than Reasons Listed|1|||
143270784|NCT05439941|516546271|FG002|Overall Study|Other than Reasons Listed|0|||
143270785|NCT00573183|516546272|FG000|Overall Study|Lost to Follow-up|52|||
143270786|NCT00573183|516546273|FG001|Overall Study|Lost to Follow-up|50|||
143270787|NCT00573183|516546272|FG000|Overall Study|Withdrawal by Subject|8|||
143270788|NCT00573183|516546273|FG001|Overall Study|Withdrawal by Subject|2|||
143270789|NCT00573183|516546272|FG000|Overall Study|Death|0|||
143270790|NCT00573183|516546273|FG001|Overall Study|Death|1|||
143270791|NCT00573183|516546272|FG000|Overall Study|Adverse Event|2|||
143270792|NCT00573183|516546273|FG001|Overall Study|Adverse Event|0|||
143270793|NCT00573183|516546272|FG000|Overall Study|Incarceration|5|||
143270794|NCT00573183|516546273|FG001|Overall Study|Incarceration|8|||
143270795|NCT00573183|516546272|FG000|Overall Study|Other|5|||
143270796|NCT00573183|516546273|FG001|Overall Study|Other|2|||
143270797|NCT02899299|516546274|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
143270798|NCT02899299|516546275|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
143270799|NCT02899299|516546274|FG000|Pre-treatment|Participant withdrew consent|1|||
143270800|NCT02899299|516546275|FG001|Pre-treatment|Participant withdrew consent|11|||
143270801|NCT02899299|516546274|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
143270802|NCT02899299|516546275|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
143270803|NCT02899299|516546274|FG000|Pre-treatment|Not reported|0|||
143270804|NCT02899299|516546275|FG001|Pre-treatment|Not reported|1|||
143270805|NCT02899299|516546274|FG000|Treatment|Disease Progression|182|||
143270806|NCT02899299|516546275|FG001|Treatment|Disease Progression|43|||
143270807|NCT02899299|516546274|FG000|Treatment|Study Drug Toxicity|60|||
143270808|NCT02899299|516546275|FG001|Treatment|Study Drug Toxicity|24|||
143270809|NCT02899299|516546274|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
143270810|NCT02899299|516546275|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
143270811|NCT02899299|516546274|FG000|Treatment|Participant request to discontinue Study treatment|4|||
143270812|NCT02899299|516546275|FG001|Treatment|Participant request to discontinue Study treatment|10|||
143270813|NCT02899299|516546274|FG000|Treatment|Participant withdrew consent|6|||
143270814|NCT02899299|516546275|FG001|Treatment|Participant withdrew consent|3|||
143270815|NCT02899299|516546274|FG000|Treatment|Lost to Follow-up|0|||
143270816|NCT02899299|516546275|FG001|Treatment|Lost to Follow-up|2|||
143270817|NCT02899299|516546274|FG000|Treatment|Maximum Clinical Benefit|11|||
143270818|NCT02899299|516546275|FG001|Treatment|Maximum Clinical Benefit|2|||
143270819|NCT02899299|516546274|FG000|Treatment|Poor/Non-compliance|1|||
143270820|NCT02899299|516546275|FG001|Treatment|Poor/Non-compliance|0|||
143270821|NCT02899299|516546274|FG000|Treatment|Participant no longer meets Study criteria|4|||
143270822|NCT02899299|516546275|FG001|Treatment|Participant no longer meets Study criteria|0|||
143270823|NCT02899299|516546274|FG000|Treatment|Administrative reason by Sponsor|2|||
143270824|NCT02899299|516546275|FG001|Treatment|Administrative reason by Sponsor|0|||
143270825|NCT02899299|516546274|FG000|Treatment|Other reasons|12|||
143270826|NCT02899299|516546275|FG001|Treatment|Other reasons|2|||
143270827|NCT02899299|516546274|FG000|Treatment|Not reported|7|||
143270828|NCT02899299|516546275|FG001|Treatment|Not reported|0|||
143270829|NCT01788046|516546277|FG000|Overall Study|Withdrawal by Subject|12|||
143270830|NCT01788046|516546278|FG001|Overall Study|Withdrawal by Subject|12|||
143270831|NCT01788046|516546277|FG000|Overall Study|Lost to Follow-up|12|||
143270832|NCT01788046|516546278|FG001|Overall Study|Lost to Follow-up|19|||
143270833|NCT01788046|516546277|FG000|Overall Study|Death|7|||
143270834|NCT01788046|516546278|FG001|Overall Study|Death|5|||
143270835|NCT01788046|516546277|FG000|Overall Study|Protocol Specified Criteria|25|||
143270836|NCT01788046|516546278|FG001|Overall Study|Protocol Specified Criteria|1|||
143270837|NCT03840174|516546283|FG000|Overall Study|Withdrawal by Subject|1|||
143270838|NCT03840174|516546284|FG001|Overall Study|Withdrawal by Subject|0|||
143270839|NCT03840174|516546285|FG002|Overall Study|Withdrawal by Subject|0|||
143270840|NCT03840174|516546286|FG003|Overall Study|Withdrawal by Subject|0|||
143270841|NCT02038881|516546289|FG000|Overall Study|Withdrawal by Subject|0|||
143270842|NCT02038881|516546290|FG001|Overall Study|Withdrawal by Subject|0|||
143270843|NCT02038881|516546291|FG002|Overall Study|Withdrawal by Subject|1|||
143270844|NCT02038881|516546289|FG000|Overall Study|Lost to Follow-up|2|||
143270845|NCT02038881|516546290|FG001|Overall Study|Lost to Follow-up|0|||
143270846|NCT02038881|516546291|FG002|Overall Study|Lost to Follow-up|0|||
143270847|NCT02038881|516546289|FG000|Overall Study|incarcerated|1|||
143270848|NCT02038881|516546290|FG001|Overall Study|incarcerated|0|||
143270849|NCT02038881|516546291|FG002|Overall Study|incarcerated|0|||
143270850|NCT01453725|516546292|FG000|Overall Study|Adverse Event|3|||
143270851|NCT01453725|516546293|FG001|Overall Study|Adverse Event|3|||
143270852|NCT01453725|516546292|FG000|Overall Study|Lost to Follow-up|4|||
143270853|NCT01453725|516546293|FG001|Overall Study|Lost to Follow-up|0|||
143270854|NCT01453725|516546292|FG000|Overall Study|Non-compliance With Protocol|1|||
143270855|NCT01453725|516546293|FG001|Overall Study|Non-compliance With Protocol|2|||
143270856|NCT01453725|516546292|FG000|Overall Study|Protocol Violation|1|||
143270857|NCT01453725|516546293|FG001|Overall Study|Protocol Violation|0|||
143270858|NCT01453725|516546292|FG000|Overall Study|Withdrawal by Subject|2|||
143270859|NCT01453725|516546293|FG001|Overall Study|Withdrawal by Subject|3|||
143270860|NCT01453725|516546292|FG000|Overall Study|Pregnancy Wish|0|||
143270861|NCT01453725|516546293|FG001|Overall Study|Pregnancy Wish|2|||
143270862|NCT01453725|516546292|FG000|Overall Study|Pregnancy|1|||
143270863|NCT01453725|516546293|FG001|Overall Study|Pregnancy|0|||
143270864|NCT01453725|516546292|FG000|Overall Study|Physician Decision|1|||
143270865|NCT01453725|516546293|FG001|Overall Study|Physician Decision|1|||
143270866|NCT00875979|516546301|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
143270867|NCT00875979|516546302|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
143270868|NCT00875979|516546301|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
143270869|NCT00875979|516546302|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
143270870|NCT00875979|516546301|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
143270871|NCT00875979|516546302|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
143270872|NCT00875979|516546301|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
143270873|NCT00875979|516546302|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
143270874|NCT00875979|516546301|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
143270875|NCT00875979|516546302|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
143270876|NCT00875979|516546301|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
143270877|NCT00875979|516546302|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
143270878|NCT00875979|516546301|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
143270879|NCT00875979|516546302|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
143270880|NCT00875979|516546301|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
143270881|NCT00875979|516546302|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
143270882|NCT00875979|516546301|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
143270883|NCT00875979|516546302|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
143270884|NCT00369707|516546306|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
143270885|NCT00369707|516546306|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
143270886|NCT00369707|516546306|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
143270887|NCT00369707|516546306|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
143270888|NCT00369707|516546306|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
143270889|NCT00369707|516546306|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
143270890|NCT00369707|516546306|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
143270891|NCT00369707|516546306|FG000|Follow up for 2 Years After Treatment|Death|1|||
143270892|NCT00369707|516546306|FG000|Follow up for 2 Years After Treatment|Other|2|||
143270893|NCT03605212|516546312|FG000|Treatment Period|Adverse Event|1|||
143270894|NCT03605212|516546313|FG001|Treatment Period|Adverse Event|0|||
143270895|NCT03605212|516546314|FG002|Treatment Period|Adverse Event|0|||
143270896|NCT03605212|516546315|FG003|Treatment Period|Adverse Event|0|||
143270897|NCT03605212|516546316|FG004|Treatment Period|Adverse Event|0|||
143270898|NCT03605212|516546312|FG000|Treatment Period|Physician Decision|0|||
143270899|NCT03605212|516546313|FG001|Treatment Period|Physician Decision|0|||
143270900|NCT03605212|516546314|FG002|Treatment Period|Physician Decision|0|||
143270901|NCT03605212|516546315|FG003|Treatment Period|Physician Decision|0|||
143270902|NCT03605212|516546316|FG004|Treatment Period|Physician Decision|1|||
143270903|NCT01756053|516546317|FG000|Period 1 (10 Days)|Protocol Violation|1|||
143270904|NCT01756053|516546318|FG001|Period 1 (10 Days)|Protocol Violation|1|||
143270905|NCT01756053|516546317|FG000|Period 2 (10 Days)|Protocol Violation|0|||
143270906|NCT01756053|516546318|FG001|Period 2 (10 Days)|Protocol Violation|2|||
143270907|NCT02083081|516546319|FG000|Overall Study|Lost to Follow-up|31|||
143270908|NCT02083081|516546320|FG001|Overall Study|Lost to Follow-up|9|||
143270909|NCT00285818|516546321|FG000|Overall Study|Withdrawal by Subject|3|||
143270910|NCT00285818|516546322|FG001|Overall Study|Withdrawal by Subject|2|||
143270911|NCT00285818|516546321|FG000|Overall Study|Lost to Follow-up|1|||
143270912|NCT00285818|516546322|FG001|Overall Study|Lost to Follow-up|0|||
143270913|NCT04041375|516546326|FG000|Intervention Phase|Withdrawal by Subject|2|||
143270914|NCT04041375|516546327|FG001|Intervention Phase|Withdrawal by Subject|2|||
143270915|NCT04041375|516546326|FG000|Follow-up Phase|Death|2|||
143270916|NCT04041375|516546327|FG001|Follow-up Phase|Death|0|||
143270917|NCT04041375|516546326|FG000|Follow-up Phase|Lost to Follow-up|2|||
143270918|NCT04041375|516546327|FG001|Follow-up Phase|Lost to Follow-up|1|||
143270919|NCT04041375|516546326|FG000|Follow-up Phase|Too ill|3|||
143270920|NCT04041375|516546327|FG001|Follow-up Phase|Too ill|0|||
143270921|NCT04674644|516546333|FG000|Overall Study|with missing data|37|||
143270922|NCT01230710|516546334|FG000|Overall Study|Disease Progression|41|||
143270923|NCT01230710|516546334|FG000|Overall Study|Lost to Follow-up|3|||
143270924|NCT01230710|516546334|FG000|Overall Study|Death|4|||
143270925|NCT01230710|516546334|FG000|Overall Study|Withdrawal of Consent|1|||
143270926|NCT03277690|516546335|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
143270927|NCT03277690|516546336|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
143270928|NCT03277690|516546335|FG000|Dose Titration and Maintenance|Physician Decision|1|||
143270929|NCT03277690|516546336|FG001|Dose Titration and Maintenance|Physician Decision|0|||
143270930|NCT03277690|516546335|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
143270931|NCT03277690|516546336|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
143270932|NCT03277690|516546335|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
143270933|NCT03277690|516546336|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
143270934|NCT03277690|516546335|FG000|Dose Titration and Maintenance|Adverse Event|15|||
143270935|NCT03277690|516546336|FG001|Dose Titration and Maintenance|Adverse Event|0|||
143270936|NCT03277690|516546335|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
143270937|NCT03277690|516546336|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
143270938|NCT03277690|516546335|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
143270939|NCT03277690|516546336|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
143270940|NCT00747812|516546337|FG000|Overall Study|Research Site Staff Relocation|5|||
143270941|NCT00747812|516546338|FG001|Overall Study|Research Site Staff Relocation|3|||
143270942|NCT01708161|516546339|FG000|Overall Study|Adverse Event|1|||
143270943|NCT01708161|516546340|FG001|Overall Study|Adverse Event|3|||
143270944|NCT01708161|516546341|FG002|Overall Study|Adverse Event|4|||
143270945|NCT01708161|516546342|FG003|Overall Study|Adverse Event|2|||
143270946|NCT01708161|516546343|FG004|Overall Study|Adverse Event|3|||
143270947|NCT01708161|516546344|FG005|Overall Study|Adverse Event|0|||
143270948|NCT01708161|516546339|FG000|Overall Study|Death|0|||
143270949|NCT01708161|516546340|FG001|Overall Study|Death|0|||
143270950|NCT01708161|516546341|FG002|Overall Study|Death|0|||
143270951|NCT01708161|516546342|FG003|Overall Study|Death|1|||
143270952|NCT01708161|516546343|FG004|Overall Study|Death|0|||
143270953|NCT01708161|516546344|FG005|Overall Study|Death|1|||
143270954|NCT01708161|516546339|FG000|Overall Study|Withdrawal by Subject|0|||
143270955|NCT01708161|516546340|FG001|Overall Study|Withdrawal by Subject|1|||
143270956|NCT01708161|516546341|FG002|Overall Study|Withdrawal by Subject|1|||
143270957|NCT01708161|516546342|FG003|Overall Study|Withdrawal by Subject|0|||
143270958|NCT01708161|516546343|FG004|Overall Study|Withdrawal by Subject|0|||
143270959|NCT01708161|516546344|FG005|Overall Study|Withdrawal by Subject|0|||
143270960|NCT01708161|516546339|FG000|Overall Study|Administrative problems|0|||
143270961|NCT01708161|516546340|FG001|Overall Study|Administrative problems|1|||
143270962|NCT01708161|516546341|FG002|Overall Study|Administrative problems|0|||
143270963|NCT01708161|516546342|FG003|Overall Study|Administrative problems|0|||
143270964|NCT01708161|516546343|FG004|Overall Study|Administrative problems|0|||
143270965|NCT01708161|516546344|FG005|Overall Study|Administrative problems|0|||
143270966|NCT01708161|516546339|FG000|Overall Study|Disease progression|3|||
143270967|NCT01708161|516546340|FG001|Overall Study|Disease progression|5|||
143270968|NCT01708161|516546341|FG002|Overall Study|Disease progression|5|||
143270969|NCT01708161|516546342|FG003|Overall Study|Disease progression|13|||
143270970|NCT01708161|516546343|FG004|Overall Study|Disease progression|3|||
143270971|NCT01708161|516546344|FG005|Overall Study|Disease progression|0|||
143270972|NCT03725852|516546346|FG000|Overall Study|Death|1|||
143270973|NCT03725852|516546347|FG001|Overall Study|Death|0|||
143270974|NCT03725852|516546346|FG000|Overall Study|Withdrawal by Subject|1|||
143270975|NCT03725852|516546347|FG001|Overall Study|Withdrawal by Subject|0|||
143270976|NCT03725852|516546346|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
143270977|NCT03725852|516546347|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
143270978|NCT01986140|516546348|FG000|Overall Study|Withdrawal by Subject|31|||
143270979|NCT01986140|516546349|FG001|Overall Study|Withdrawal by Subject|25|||
143270980|NCT01986140|516546348|FG000|Overall Study|alternative treatment|1|||
143270981|NCT01986140|516546349|FG001|Overall Study|alternative treatment|1|||
143270982|NCT01986140|516546348|FG000|Overall Study|found not eligible|3|||
143270983|NCT01986140|516546349|FG001|Overall Study|found not eligible|0|||
143270984|NCT01986140|516546348|FG000|Overall Study|Adverse Event|0|||
143270985|NCT01986140|516546349|FG001|Overall Study|Adverse Event|1|||
143270986|NCT01986140|516546348|FG000|Overall Study|progression disease|0|||
143270987|NCT01986140|516546349|FG001|Overall Study|progression disease|1|||
143270988|NCT02913612|516546350|FG000|Overall Study|Lost to Follow-up|6|||
143270989|NCT02913612|516546351|FG001|Overall Study|Lost to Follow-up|5|||
143270990|NCT02913612|516546352|FG002|Overall Study|Lost to Follow-up|2|||
143270991|NCT02913612|516546353|FG003|Overall Study|Lost to Follow-up|0|||
143270992|NCT02913612|516546350|FG000|Overall Study|Physician Decision|1|||
143270993|NCT02913612|516546351|FG001|Overall Study|Physician Decision|4|||
143270994|NCT02913612|516546352|FG002|Overall Study|Physician Decision|1|||
143270995|NCT02913612|516546353|FG003|Overall Study|Physician Decision|0|||
143270996|NCT02913612|516546350|FG000|Overall Study|Withdrawal by Subject|2|||
143270997|NCT02913612|516546351|FG001|Overall Study|Withdrawal by Subject|4|||
143270998|NCT02913612|516546352|FG002|Overall Study|Withdrawal by Subject|0|||
143270999|NCT02913612|516546353|FG003|Overall Study|Withdrawal by Subject|0|||
143271000|NCT02913612|516546350|FG000|Overall Study|Hemangioma resolved|1|||
143271001|NCT02913612|516546351|FG001|Overall Study|Hemangioma resolved|0|||
143228260|NCT01329263|516384027|FG000|Overall Study|Withdrawal by Subject|1|||
143228261|NCT01329263|516384028|FG001|Overall Study|Withdrawal by Subject|2|||
143228262|NCT02313766|516384029|FG000|Overall Study|surgery cancelled|1|||
143228263|NCT02313766|516384030|FG001|Overall Study|surgery cancelled|0|||
143228264|NCT02313766|516384031|FG002|Overall Study|surgery cancelled|0|||
143228265|NCT02313766|516384029|FG000|Overall Study|Lost to Follow-up|0|||
143228266|NCT02313766|516384030|FG001|Overall Study|Lost to Follow-up|2|||
143228267|NCT02313766|516384031|FG002|Overall Study|Lost to Follow-up|0|||
143228268|NCT02313766|516384029|FG000|Overall Study|Adverse Event|0|||
143228269|NCT02313766|516384030|FG001|Overall Study|Adverse Event|1|||
143228270|NCT02313766|516384031|FG002|Overall Study|Adverse Event|0|||
143228271|NCT00416624|516384037|FG000|Overall Study|Withdrawal by Subject|1|||
143228272|NCT00416624|516384038|FG001|Overall Study|Withdrawal by Subject|6|||
143228273|NCT00416624|516384039|FG002|Overall Study|Withdrawal by Subject|4|||
143228274|NCT00416624|516384040|FG003|Overall Study|Withdrawal by Subject|9|||
143228275|NCT00416624|516384037|FG000|Overall Study|Death|4|||
143228276|NCT00416624|516384038|FG001|Overall Study|Death|7|||
143228277|NCT00416624|516384039|FG002|Overall Study|Death|7|||
143228278|NCT00416624|516384040|FG003|Overall Study|Death|1|||
143228279|NCT00416624|516384037|FG000|Overall Study|Adverse Event|8|||
143228280|NCT00416624|516384038|FG001|Overall Study|Adverse Event|3|||
143228281|NCT00416624|516384039|FG002|Overall Study|Adverse Event|2|||
143228282|NCT00416624|516384040|FG003|Overall Study|Adverse Event|2|||
143228283|NCT00416624|516384037|FG000|Overall Study|Other|8|||
143228284|NCT00416624|516384038|FG001|Overall Study|Other|11|||
143228285|NCT00416624|516384039|FG002|Overall Study|Other|5|||
143228286|NCT00416624|516384040|FG003|Overall Study|Other|5|||
143228287|NCT00416624|516384037|FG000|Overall Study|Cancel|1|||
143228288|NCT00416624|516384038|FG001|Overall Study|Cancel|0|||
143228289|NCT00416624|516384039|FG002|Overall Study|Cancel|0|||
143228290|NCT00416624|516384040|FG003|Overall Study|Cancel|0|||
143228291|NCT01005251|516384041|FG000|Overall Study|Withdrawal by Subject|2|||
143228292|NCT01005251|516384042|FG001|Overall Study|Withdrawal by Subject|5|||
143228293|NCT01005251|516384043|FG002|Overall Study|Withdrawal by Subject|3|||
143228294|NCT01005251|516384044|FG003|Overall Study|Withdrawal by Subject|4|||
143228295|NCT01005251|516384045|FG004|Overall Study|Withdrawal by Subject|9|||
143228296|NCT01005251|516384041|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
143228297|NCT01005251|516384042|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
143228298|NCT01005251|516384043|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
143228299|NCT01005251|516384044|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
143228300|NCT01005251|516384045|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
143228301|NCT01005251|516384041|FG000|Overall Study|Adverse Event|2|||
143228302|NCT01005251|516384042|FG001|Overall Study|Adverse Event|6|||
143228303|NCT01005251|516384043|FG002|Overall Study|Adverse Event|8|||
143228304|NCT01005251|516384044|FG003|Overall Study|Adverse Event|5|||
143228305|NCT01005251|516384045|FG004|Overall Study|Adverse Event|4|||
143228306|NCT01005251|516384041|FG000|Overall Study|Protocol Violation|1|||
143228307|NCT01005251|516384042|FG001|Overall Study|Protocol Violation|0|||
143228308|NCT01005251|516384043|FG002|Overall Study|Protocol Violation|0|||
143228309|NCT01005251|516384044|FG003|Overall Study|Protocol Violation|0|||
143228310|NCT01005251|516384045|FG004|Overall Study|Protocol Violation|2|||
143228311|NCT01005251|516384041|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
143228312|NCT01005251|516384042|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
143228313|NCT01005251|516384043|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
143228314|NCT01005251|516384044|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
143228315|NCT01005251|516384045|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
143228316|NCT01005251|516384041|FG000|Overall Study|Lost to Follow-up|1|||
143228317|NCT01005251|516384042|FG001|Overall Study|Lost to Follow-up|4|||
143228318|NCT01005251|516384043|FG002|Overall Study|Lost to Follow-up|2|||
143228319|NCT01005251|516384044|FG003|Overall Study|Lost to Follow-up|0|||
143228320|NCT01005251|516384045|FG004|Overall Study|Lost to Follow-up|0|||
143228321|NCT01005251|516384041|FG000|Overall Study|Physician Decision|0|||
143228322|NCT01005251|516384042|FG001|Overall Study|Physician Decision|0|||
143228323|NCT01005251|516384043|FG002|Overall Study|Physician Decision|0|||
143228324|NCT01005251|516384044|FG003|Overall Study|Physician Decision|0|||
143228325|NCT01005251|516384045|FG004|Overall Study|Physician Decision|2|||
143271002|NCT02913612|516546352|FG002|Overall Study|Hemangioma resolved|0|||
143372656|NCT01713946|516909630|FG000|Overall Study|Withdrawal by Subject|12|||
143372657|NCT01713946|516909631|FG001|Overall Study|Withdrawal by Subject|12|||
143372658|NCT01713946|516909632|FG002|Overall Study|Withdrawal by Subject|8|||
143372659|NCT01713946|516909630|FG000|Overall Study|Lack of Efficacy|8|||
143372660|NCT01713946|516909631|FG001|Overall Study|Lack of Efficacy|8|||
143372661|NCT01713946|516909632|FG002|Overall Study|Lack of Efficacy|14|||
143372662|NCT01713946|516909630|FG000|Overall Study|Protocol Violation|2|||
143228326|NCT01005251|516384041|FG000|Overall Study|Patient moved|1|||
143228327|NCT01005251|516384042|FG001|Overall Study|Patient moved|0|||
143228328|NCT01005251|516384043|FG002|Overall Study|Patient moved|0|||
143228329|NCT01005251|516384044|FG003|Overall Study|Patient moved|0|||
143228330|NCT01005251|516384045|FG004|Overall Study|Patient moved|0|||
143228331|NCT01005251|516384041|FG000|Overall Study|Wrong drug dispensed|0|||
143228332|NCT01005251|516384042|FG001|Overall Study|Wrong drug dispensed|1|||
143228333|NCT01005251|516384043|FG002|Overall Study|Wrong drug dispensed|0|||
143228334|NCT01005251|516384044|FG003|Overall Study|Wrong drug dispensed|0|||
143228335|NCT01005251|516384045|FG004|Overall Study|Wrong drug dispensed|0|||
143228336|NCT01005251|516384041|FG000|Overall Study|Randomized in error|0|||
143228337|NCT01005251|516384042|FG001|Overall Study|Randomized in error|0|||
143228338|NCT01005251|516384043|FG002|Overall Study|Randomized in error|1|||
143228339|NCT01005251|516384044|FG003|Overall Study|Randomized in error|1|||
143228340|NCT01005251|516384045|FG004|Overall Study|Randomized in error|0|||
143228341|NCT01005251|516384041|FG000|Overall Study|Lack of Efficacy|0|||
143228342|NCT01005251|516384042|FG001|Overall Study|Lack of Efficacy|0|||
143228343|NCT01005251|516384043|FG002|Overall Study|Lack of Efficacy|1|||
143228344|NCT01005251|516384044|FG003|Overall Study|Lack of Efficacy|1|||
143228345|NCT01005251|516384045|FG004|Overall Study|Lack of Efficacy|0|||
143228346|NCT00962208|516384047|FG000|Overall Study|Could not achieve good vision|9|||
143228347|NCT00962208|516384048|FG001|Overall Study|Could not achieve good vision|0|||
143228348|NCT00962208|516384047|FG000|Overall Study|Contraindicated to continue study|5|||
143228349|NCT00962208|516384048|FG001|Overall Study|Contraindicated to continue study|1|||
143228350|NCT00962208|516384047|FG000|Overall Study|Lost to Follow-up|0|||
143228351|NCT00962208|516384048|FG001|Overall Study|Lost to Follow-up|9|||
143228352|NCT00141453|516384049|FG000|Overall Study|Protocol Violation|6|||
143228353|NCT00141453|516384050|FG001|Overall Study|Protocol Violation|5|||
143228354|NCT00443040|516384053|FG000|Overall Study|Withdrawal by Subject|1|||
143228355|NCT00443040|516384054|FG001|Overall Study|Withdrawal by Subject|0|||
143228356|NCT00443040|516384055|FG002|Overall Study|Withdrawal by Subject|0|||
143228357|NCT00443040|516384053|FG000|Overall Study|Converted to an open laparotomy|3|||
143228358|NCT00443040|516384054|FG001|Overall Study|Converted to an open laparotomy|0|||
143228359|NCT00443040|516384055|FG002|Overall Study|Converted to an open laparotomy|1|||
143228360|NCT02469623|516384056|FG000|Overall Study|Not consented for long-term follow-up|4|||
143228361|NCT02469623|516384056|FG000|Overall Study|Lost to Follow-up|4|||
143228362|NCT02469623|516384056|FG000|Overall Study|Withdrawal by Subject|2|||
143228363|NCT02469623|516384056|FG000|Overall Study|Death|3|||
143228364|NCT03309878|516384057|FG000|Overall Study|Adverse Event|1|||
143228365|NCT03309878|516384058|FG001|Overall Study|Adverse Event|0|||
143228366|NCT03309878|516384059|FG002|Overall Study|Adverse Event|0|||
143228367|NCT03309878|516384060|FG003|Overall Study|Adverse Event|0|||
143228368|NCT03309878|516384057|FG000|Overall Study|Did not maintain eligibility|2|||
143228369|NCT03309878|516384058|FG001|Overall Study|Did not maintain eligibility|1|||
143228370|NCT03309878|516384059|FG002|Overall Study|Did not maintain eligibility|0|||
143228371|NCT03309878|516384060|FG003|Overall Study|Did not maintain eligibility|0|||
143228372|NCT03309878|516384057|FG000|Overall Study|Withdrawal by Subject|0|||
143228373|NCT03309878|516384058|FG001|Overall Study|Withdrawal by Subject|1|||
143228374|NCT03309878|516384059|FG002|Overall Study|Withdrawal by Subject|0|||
143228375|NCT03309878|516384060|FG003|Overall Study|Withdrawal by Subject|0|||
143228376|NCT01884077|516384061|FG000|Overall Study|screen fail|0|||
143228377|NCT01884077|516384062|FG001|Overall Study|screen fail|2|||
143228378|NCT01884077|516384061|FG000|Overall Study|canceled surgery|2|||
143228379|NCT01884077|516384062|FG001|Overall Study|canceled surgery|0|||
143228380|NCT01884077|516384061|FG000|Overall Study|Lost to Follow-up|0|||
143228381|NCT01884077|516384062|FG001|Overall Study|Lost to Follow-up|4|||
143228382|NCT01884077|516384061|FG000|Overall Study|study closed|6|||
143228383|NCT01884077|516384062|FG001|Overall Study|study closed|4|||
143228384|NCT02836652|516384063|FG000|Overall Study|Death|3|||
143228385|NCT02836652|516384064|FG001|Overall Study|Death|3|||
143228386|NCT02836652|516384063|FG000|Overall Study|Transplant/Explant|3|||
143228387|NCT02836652|516384064|FG001|Overall Study|Transplant/Explant|4|||
143228388|NCT02836652|516384063|FG000|Overall Study|Withdrawn|9|||
143228389|NCT02836652|516384064|FG001|Overall Study|Withdrawn|9|||
143228390|NCT02836652|516384063|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
143228391|NCT02836652|516384064|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
143228392|NCT02349633|516384065|FG000|Overall Study|Death|0|||
143372663|NCT01713946|516909631|FG001|Overall Study|Protocol Violation|4|||
143228393|NCT02349633|516384066|FG001|Overall Study|Death|1|||
143228394|NCT02349633|516384067|FG002|Overall Study|Death|0|||
143228395|NCT02349633|516384068|FG003|Overall Study|Death|0|||
143271003|NCT02913612|516546353|FG003|Overall Study|Hemangioma resolved|0|||
143271004|NCT02913612|516546350|FG000|Overall Study|Local IRB decision|1|||
143271005|NCT02913612|516546351|FG001|Overall Study|Local IRB decision|0|||
143271006|NCT02913612|516546352|FG002|Overall Study|Local IRB decision|0|||
143271007|NCT02913612|516546353|FG003|Overall Study|Local IRB decision|0|||
143271008|NCT02913612|516546350|FG000|Overall Study|Study drug non-compliance|1|||
143271009|NCT02913612|516546351|FG001|Overall Study|Study drug non-compliance|1|||
143271010|NCT02913612|516546352|FG002|Overall Study|Study drug non-compliance|0|||
143271011|NCT02913612|516546353|FG003|Overall Study|Study drug non-compliance|0|||
143271012|NCT02913612|516546350|FG000|Overall Study|Insurance issues|0|||
143271013|NCT02913612|516546351|FG001|Overall Study|Insurance issues|1|||
143271014|NCT02913612|516546352|FG002|Overall Study|Insurance issues|0|||
143271015|NCT02913612|516546353|FG003|Overall Study|Insurance issues|0|||
143271016|NCT02913612|516546350|FG000|Overall Study|Needed to treat second hemangioma|0|||
143271017|NCT02913612|516546351|FG001|Overall Study|Needed to treat second hemangioma|1|||
143271018|NCT02913612|516546352|FG002|Overall Study|Needed to treat second hemangioma|0|||
143271019|NCT02913612|516546353|FG003|Overall Study|Needed to treat second hemangioma|0|||
143271020|NCT02913612|516546350|FG000|Overall Study|Study completion criteria not met|0|||
143271021|NCT02913612|516546351|FG001|Overall Study|Study completion criteria not met|1|||
143271022|NCT02913612|516546352|FG002|Overall Study|Study completion criteria not met|0|||
143271023|NCT02913612|516546353|FG003|Overall Study|Study completion criteria not met|0|||
143271024|NCT02913612|516546350|FG000|Overall Study|Ineligible|0|||
143271025|NCT02913612|516546351|FG001|Overall Study|Ineligible|1|||
143271026|NCT02913612|516546352|FG002|Overall Study|Ineligible|0|||
143271027|NCT02913612|516546353|FG003|Overall Study|Ineligible|0|||
143271028|NCT01011738|516546354|FG000|Overall Study|Death|12|||
143271029|NCT01011738|516546355|FG001|Overall Study|Death|3|||
143271030|NCT01011738|516546356|FG002|Overall Study|Death|0|||
143271031|NCT01011738|516546354|FG000|Overall Study|Unknown reasons|312|||
143271032|NCT01011738|516546355|FG001|Overall Study|Unknown reasons|291|||
143271033|NCT01011738|516546356|FG002|Overall Study|Unknown reasons|17|||
143271034|NCT00072176|516546359|FG000|Overall Study|Withdrawal by Subject|1|||
143271035|NCT00072176|516546360|FG001|Overall Study|Withdrawal by Subject|0|||
143271036|NCT00072176|516546359|FG000|Overall Study|Protocol Violation|0|||
143271037|NCT00072176|516546360|FG001|Overall Study|Protocol Violation|1|||
143271038|NCT03181893|516546361|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
143271039|NCT03181893|516546362|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
143271040|NCT03181893|516546363|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
143271041|NCT03181893|516546364|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
143271042|NCT03181893|516546365|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
143271043|NCT03181893|516546366|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
143271044|NCT03181893|516546367|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
143271045|NCT03181893|516546368|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
143271046|NCT03181893|516546369|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
143271047|NCT03181893|516546370|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
143271048|NCT03181893|516546371|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
143271049|NCT03181893|516546361|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
143271050|NCT03181893|516546362|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
143271051|NCT03181893|516546363|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
143271052|NCT03181893|516546364|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
143271053|NCT03181893|516546365|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
143271054|NCT03181893|516546366|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
143271055|NCT03181893|516546367|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
143271056|NCT03181893|516546368|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
143271057|NCT03181893|516546369|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
143271058|NCT03181893|516546370|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
143271059|NCT03181893|516546371|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
143271060|NCT03181893|516546361|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
143271061|NCT03181893|516546362|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
143271062|NCT03181893|516546363|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
143271063|NCT03181893|516546364|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
143372664|NCT01713946|516909632|FG002|Overall Study|Protocol Violation|1|||
143372665|NCT01713946|516909630|FG000|Overall Study|Lost to Follow-up|0|||
143271064|NCT03181893|516546365|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
143271065|NCT03181893|516546366|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
143271066|NCT03181893|516546367|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
143271067|NCT03181893|516546368|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
143271068|NCT03181893|516546369|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
143271069|NCT03181893|516546370|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
143271070|NCT03181893|516546371|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
143271071|NCT03181893|516546361|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
143271072|NCT03181893|516546362|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
143271073|NCT03181893|516546363|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
143271074|NCT03181893|516546364|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
143271075|NCT03181893|516546365|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
143271076|NCT03181893|516546366|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
143271077|NCT03181893|516546367|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
143271078|NCT03181893|516546368|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
143271079|NCT03181893|516546369|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
143271080|NCT03181893|516546370|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
143271081|NCT03181893|516546371|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
143271082|NCT03181893|516546361|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
143271083|NCT03181893|516546362|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
143271084|NCT03181893|516546363|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
143271085|NCT03181893|516546364|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
143271086|NCT03181893|516546365|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
143271087|NCT03181893|516546366|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
143271088|NCT03181893|516546367|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
143271089|NCT03181893|516546368|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
143271090|NCT03181893|516546369|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
143271091|NCT03181893|516546370|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
143271092|NCT03181893|516546371|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
143271093|NCT04128371|516546372|FG000|Overall Study|Lack of Efficacy|1|||
143271094|NCT00968864|516546376|FG000|Overall Study|Protocol exception/ not evaluable|1|||
143271095|NCT01558739|516546378|FG000|Overall Study|Adverse Event|7|||
143271096|NCT01558739|516546378|FG000|Overall Study|Withdrawal by Subject|2|||
143271097|NCT01558739|516546378|FG000|Overall Study|Death|3|||
143271098|NCT01558739|516546378|FG000|Overall Study|Disease Progression|4|||
143271099|NCT01558739|516546378|FG000|Overall Study|Protocol Violation|1|||
143271100|NCT02423772|516546379|FG000|Overall Study|Lost to Follow-up|3|||
143271101|NCT02423772|516546380|FG001|Overall Study|Lost to Follow-up|3|||
143271102|NCT02423772|516546379|FG000|Overall Study|Did not begin intervention|2|||
143271103|NCT02423772|516546380|FG001|Overall Study|Did not begin intervention|5|||
143271104|NCT01193842|516546381|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
143271105|NCT01193842|516546382|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
143271106|NCT01193842|516546383|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
143271107|NCT01193842|516546384|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
143271108|NCT01193842|516546385|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
143271109|NCT01193842|516546381|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
143271110|NCT01193842|516546382|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
143271111|NCT01193842|516546383|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
143271112|NCT01193842|516546384|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
143271113|NCT01193842|516546385|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
143271114|NCT01193842|516546381|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
143271115|NCT01193842|516546382|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
143271116|NCT01193842|516546383|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
143271117|NCT01193842|516546384|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
143271118|NCT01193842|516546385|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
143271119|NCT01193842|516546381|FG000|Phase II: Randomized Groups|Death|0|||
143271120|NCT01193842|516546382|FG001|Phase II: Randomized Groups|Death|0|||
143271121|NCT01193842|516546383|FG002|Phase II: Randomized Groups|Death|0|||
143271122|NCT01193842|516546384|FG003|Phase II: Randomized Groups|Death|1|||
143271123|NCT01193842|516546385|FG004|Phase II: Randomized Groups|Death|1|||
143271124|NCT01193842|516546381|FG000|Phase II: Randomized Groups|Adverse Event|0|||
143271125|NCT01193842|516546382|FG001|Phase II: Randomized Groups|Adverse Event|0|||
143271126|NCT01193842|516546383|FG002|Phase II: Randomized Groups|Adverse Event|0|||
143271127|NCT01193842|516546384|FG003|Phase II: Randomized Groups|Adverse Event|5|||
143271128|NCT01193842|516546385|FG004|Phase II: Randomized Groups|Adverse Event|3|||
143271129|NCT01193842|516546381|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
143271130|NCT01193842|516546382|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
143271131|NCT01193842|516546383|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
143271132|NCT01193842|516546384|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
143271133|NCT01193842|516546385|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
143271134|NCT01193842|516546381|FG000|Phase II: Randomized Groups|Ineligible|0|||
143271135|NCT01193842|516546382|FG001|Phase II: Randomized Groups|Ineligible|0|||
143271136|NCT01193842|516546383|FG002|Phase II: Randomized Groups|Ineligible|0|||
143271137|NCT01193842|516546384|FG003|Phase II: Randomized Groups|Ineligible|0|||
143271138|NCT01193842|516546385|FG004|Phase II: Randomized Groups|Ineligible|1|||
143271139|NCT01193842|516546381|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
143271140|NCT01193842|516546382|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
143271141|NCT01193842|516546383|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
143372666|NCT01713946|516909631|FG001|Overall Study|Lost to Follow-up|0|||
143228396|NCT02349633|516384069|FG004|Overall Study|Death|0|||
143228397|NCT02349633|516384070|FG005|Overall Study|Death|1|||
143228398|NCT02349633|516384071|FG006|Overall Study|Death|1|||
143228399|NCT02349633|516384072|FG007|Overall Study|Death|1|||
143228400|NCT02349633|516384073|FG008|Overall Study|Death|0|||
143228401|NCT02349633|516384074|FG009|Overall Study|Death|1|||
143228402|NCT02349633|516384075|FG010|Overall Study|Death|0|||
143228403|NCT02349633|516384076|FG011|Overall Study|Death|0|||
143228404|NCT02349633|516384077|FG012|Overall Study|Death|0|||
143228405|NCT02349633|516384078|FG013|Overall Study|Death|0|||
143228406|NCT02349633|516384065|FG000|Overall Study|Withdrawal by Subject|0|||
143228407|NCT02349633|516384066|FG001|Overall Study|Withdrawal by Subject|0|||
143228408|NCT02349633|516384067|FG002|Overall Study|Withdrawal by Subject|0|||
143228409|NCT02349633|516384068|FG003|Overall Study|Withdrawal by Subject|1|||
143228410|NCT02349633|516384069|FG004|Overall Study|Withdrawal by Subject|0|||
143228411|NCT02349633|516384070|FG005|Overall Study|Withdrawal by Subject|0|||
143228412|NCT02349633|516384071|FG006|Overall Study|Withdrawal by Subject|0|||
143228413|NCT02349633|516384072|FG007|Overall Study|Withdrawal by Subject|2|||
143228414|NCT02349633|516384073|FG008|Overall Study|Withdrawal by Subject|2|||
143228415|NCT02349633|516384074|FG009|Overall Study|Withdrawal by Subject|1|||
143228416|NCT02349633|516384075|FG010|Overall Study|Withdrawal by Subject|0|||
143228417|NCT02349633|516384076|FG011|Overall Study|Withdrawal by Subject|0|||
143228418|NCT02349633|516384077|FG012|Overall Study|Withdrawal by Subject|0|||
143228419|NCT02349633|516384078|FG013|Overall Study|Withdrawal by Subject|0|||
143228420|NCT02349633|516384065|FG000|Overall Study|Withdrawal of informed consent|0|||
143228421|NCT02349633|516384066|FG001|Overall Study|Withdrawal of informed consent|0|||
143228422|NCT02349633|516384067|FG002|Overall Study|Withdrawal of informed consent|0|||
143228423|NCT02349633|516384068|FG003|Overall Study|Withdrawal of informed consent|1|||
143228424|NCT02349633|516384069|FG004|Overall Study|Withdrawal of informed consent|1|||
143228425|NCT02349633|516384070|FG005|Overall Study|Withdrawal of informed consent|0|||
143228426|NCT02349633|516384071|FG006|Overall Study|Withdrawal of informed consent|0|||
143228427|NCT02349633|516384072|FG007|Overall Study|Withdrawal of informed consent|3|||
143228428|NCT02349633|516384073|FG008|Overall Study|Withdrawal of informed consent|0|||
143228429|NCT02349633|516384074|FG009|Overall Study|Withdrawal of informed consent|0|||
143228430|NCT02349633|516384075|FG010|Overall Study|Withdrawal of informed consent|0|||
143228431|NCT02349633|516384076|FG011|Overall Study|Withdrawal of informed consent|0|||
143228432|NCT02349633|516384077|FG012|Overall Study|Withdrawal of informed consent|0|||
143228433|NCT02349633|516384078|FG013|Overall Study|Withdrawal of informed consent|0|||
143228434|NCT02349633|516384065|FG000|Overall Study|Transition to compassionate use|0|||
143228435|NCT02349633|516384066|FG001|Overall Study|Transition to compassionate use|0|||
143228436|NCT02349633|516384067|FG002|Overall Study|Transition to compassionate use|0|||
143228437|NCT02349633|516384068|FG003|Overall Study|Transition to compassionate use|0|||
143228438|NCT02349633|516384069|FG004|Overall Study|Transition to compassionate use|1|||
143228439|NCT02349633|516384070|FG005|Overall Study|Transition to compassionate use|0|||
143228440|NCT02349633|516384071|FG006|Overall Study|Transition to compassionate use|0|||
143228441|NCT02349633|516384072|FG007|Overall Study|Transition to compassionate use|3|||
143228442|NCT02349633|516384073|FG008|Overall Study|Transition to compassionate use|0|||
143228443|NCT02349633|516384074|FG009|Overall Study|Transition to compassionate use|1|||
143228444|NCT02349633|516384075|FG010|Overall Study|Transition to compassionate use|0|||
143228445|NCT02349633|516384076|FG011|Overall Study|Transition to compassionate use|0|||
143228446|NCT02349633|516384077|FG012|Overall Study|Transition to compassionate use|0|||
143228447|NCT02349633|516384078|FG013|Overall Study|Transition to compassionate use|0|||
143228448|NCT02349633|516384065|FG000|Overall Study|Early termination of survival follow-up|0|||
143228449|NCT02349633|516384066|FG001|Overall Study|Early termination of survival follow-up|0|||
143228450|NCT02349633|516384067|FG002|Overall Study|Early termination of survival follow-up|0|||
143228451|NCT02349633|516384068|FG003|Overall Study|Early termination of survival follow-up|0|||
143228452|NCT02349633|516384069|FG004|Overall Study|Early termination of survival follow-up|0|||
143228453|NCT02349633|516384070|FG005|Overall Study|Early termination of survival follow-up|0|||
143228454|NCT02349633|516384071|FG006|Overall Study|Early termination of survival follow-up|0|||
143228455|NCT02349633|516384072|FG007|Overall Study|Early termination of survival follow-up|4|||
143228456|NCT02349633|516384073|FG008|Overall Study|Early termination of survival follow-up|0|||
143228457|NCT02349633|516384074|FG009|Overall Study|Early termination of survival follow-up|0|||
143228458|NCT02349633|516384075|FG010|Overall Study|Early termination of survival follow-up|0|||
143228459|NCT02349633|516384076|FG011|Overall Study|Early termination of survival follow-up|0|||
143271142|NCT01193842|516546384|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
143271143|NCT01193842|516546385|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
143271144|NCT03698331|516546386|FG000|Overall Study|Adverse Event|2|||
143271145|NCT03698331|516546387|FG001|Overall Study|Adverse Event|3|||
143271146|NCT03698331|516546386|FG000|Overall Study|Withdrawal by Subject|1|||
143271147|NCT03698331|516546387|FG001|Overall Study|Withdrawal by Subject|1|||
143271148|NCT03698331|516546386|FG000|Overall Study|Lost to Follow-up|0|||
143271149|NCT03698331|516546387|FG001|Overall Study|Lost to Follow-up|2|||
143271150|NCT03698331|516546386|FG000|Overall Study|Non-compliance with study drug|1|||
143271151|NCT03698331|516546387|FG001|Overall Study|Non-compliance with study drug|0|||
143271152|NCT04916769|516546391|FG000|Period 1|Physician Decision|0|||
143271153|NCT04916769|516546392|FG001|Period 1|Physician Decision|0|||
143271154|NCT04916769|516546393|FG002|Period 1|Physician Decision|0|||
143271155|NCT04916769|516546394|FG003|Period 1|Physician Decision|0|||
143271156|NCT04916769|516546395|FG004|Period 1|Physician Decision|0|||
143271157|NCT04916769|516546396|FG005|Period 1|Physician Decision|1|||
143271158|NCT04916769|516546391|FG000|Period 2|Physician Decision|0|||
143271159|NCT04916769|516546392|FG001|Period 2|Physician Decision|1|||
143271160|NCT04916769|516546393|FG002|Period 2|Physician Decision|0|||
143271161|NCT04916769|516546394|FG003|Period 2|Physician Decision|0|||
143271162|NCT04916769|516546395|FG004|Period 2|Physician Decision|0|||
143271163|NCT04916769|516546396|FG005|Period 2|Physician Decision|0|||
143271164|NCT03672643|516546397|FG000|Overall Study|Adverse Event|3|||
143271165|NCT03672643|516546397|FG000|Overall Study|Death|2|||
143271166|NCT03672643|516546397|FG000|Overall Study|Withdrawal by Subject|1|||
143271167|NCT03672643|516546397|FG000|Overall Study|Progressive disease|11|||
143271168|NCT03672643|516546397|FG000|Overall Study|Global deterioration of health status|1|||
143271169|NCT03672643|516546397|FG000|Overall Study|Refused further treatment|7|||
143271170|NCT03672643|516546397|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
143271171|NCT05736224|516546398|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
143271172|NCT04526509|516546399|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
143271173|NCT04526509|516546400|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
143271174|NCT04526509|516546401|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
143271175|NCT04526509|516546402|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
143271176|NCT04526509|516546403|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
143271177|NCT04526509|516546404|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
143271178|NCT04526509|516546405|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
143271179|NCT04526509|516546399|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
143271180|NCT04526509|516546400|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
143271181|NCT04526509|516546401|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
143271182|NCT04526509|516546402|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
143271183|NCT04526509|516546403|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
143271184|NCT04526509|516546404|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
143271185|NCT04526509|516546405|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
143271186|NCT04526509|516546399|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
143271187|NCT04526509|516546400|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
143271188|NCT04526509|516546401|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
143271189|NCT04526509|516546402|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
143271190|NCT04526509|516546403|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
143271191|NCT04526509|516546404|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
143271192|NCT04526509|516546405|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
143271193|NCT04526509|516546399|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
143271194|NCT04526509|516546400|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
143271195|NCT04526509|516546401|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
143271196|NCT04526509|516546402|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
143271197|NCT04526509|516546403|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
143271198|NCT04526509|516546404|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
143271199|NCT04526509|516546405|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
143271200|NCT04526509|516546399|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
143271201|NCT04526509|516546400|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
143271202|NCT04526509|516546401|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
143271203|NCT04526509|516546402|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
143271204|NCT04526509|516546403|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
143271205|NCT04526509|516546404|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
143271206|NCT04526509|516546405|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
143271207|NCT04526509|516546399|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
143271208|NCT04526509|516546400|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
143271209|NCT04526509|516546401|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
143271210|NCT04526509|516546402|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
143271211|NCT04526509|516546403|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
143271212|NCT04526509|516546404|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
143271213|NCT04526509|516546405|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
143271214|NCT04526509|516546399|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
143271215|NCT04526509|516546400|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
143271216|NCT04526509|516546401|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
143271217|NCT04526509|516546402|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
143271218|NCT04526509|516546403|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
143271219|NCT04526509|516546404|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
143271220|NCT04526509|516546405|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
143271221|NCT04526509|516546399|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
143271222|NCT04526509|516546400|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
143271223|NCT04526509|516546401|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
143271224|NCT04526509|516546402|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
143271225|NCT04526509|516546403|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
143271226|NCT04526509|516546404|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
143271227|NCT04526509|516546405|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
143271228|NCT04526509|516546399|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
143271229|NCT04526509|516546400|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
143271230|NCT04526509|516546401|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
143271231|NCT04526509|516546402|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
143271232|NCT04526509|516546403|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
143271233|NCT04526509|516546404|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
143271234|NCT04526509|516546405|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
143271235|NCT04526509|516546399|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
143271236|NCT04526509|516546400|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
143271237|NCT04526509|516546401|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
143271238|NCT04526509|516546402|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
143271239|NCT04526509|516546403|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
143271240|NCT04526509|516546404|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
143271241|NCT04526509|516546405|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
143271242|NCT04526509|516546399|FG000|Enrolled|Study Terminated by Sponsor|0|||
143271243|NCT04526509|516546400|FG001|Enrolled|Study Terminated by Sponsor|0|||
143271244|NCT04526509|516546401|FG002|Enrolled|Study Terminated by Sponsor|0|||
143271245|NCT04526509|516546402|FG003|Enrolled|Study Terminated by Sponsor|0|||
143271246|NCT04526509|516546403|FG004|Enrolled|Study Terminated by Sponsor|0|||
143271247|NCT04526509|516546404|FG005|Enrolled|Study Terminated by Sponsor|0|||
143271248|NCT04526509|516546405|FG006|Enrolled|Study Terminated by Sponsor|1|||
143271249|NCT04526509|516546399|FG000|Enrolled|Death prior to lymphodepletion|0|||
143271250|NCT04526509|516546400|FG001|Enrolled|Death prior to lymphodepletion|0|||
143271251|NCT04526509|516546401|FG002|Enrolled|Death prior to lymphodepletion|0|||
143271252|NCT04526509|516546402|FG003|Enrolled|Death prior to lymphodepletion|1|||
143271253|NCT04526509|516546403|FG004|Enrolled|Death prior to lymphodepletion|0|||
143271254|NCT04526509|516546404|FG005|Enrolled|Death prior to lymphodepletion|0|||
143271255|NCT04526509|516546405|FG006|Enrolled|Death prior to lymphodepletion|0|||
143271256|NCT04526509|516546399|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
143271257|NCT04526509|516546400|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
143271258|NCT04526509|516546401|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
143271259|NCT04526509|516546402|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
143271260|NCT04526509|516546403|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
143271261|NCT04526509|516546404|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
143271262|NCT04526509|516546405|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
143271263|NCT04526509|516546399|FG000|Enrolled|Physician Decision|0|||
143271264|NCT04526509|516546400|FG001|Enrolled|Physician Decision|1|||
143271265|NCT04526509|516546401|FG002|Enrolled|Physician Decision|0|||
143271266|NCT04526509|516546402|FG003|Enrolled|Physician Decision|0|||
143271267|NCT04526509|516546403|FG004|Enrolled|Physician Decision|0|||
143271268|NCT04526509|516546404|FG005|Enrolled|Physician Decision|0|||
143271269|NCT04526509|516546405|FG006|Enrolled|Physician Decision|0|||
143271270|NCT04340193|516546406|FG000|Overall Study|Other reason|0|||
143271271|NCT04340193|516546407|FG001|Overall Study|Other reason|0|||
143271272|NCT04340193|516546408|FG002|Overall Study|Other reason|1|||
143271273|NCT04340193|516546406|FG000|Overall Study|Disease recurrence|0|||
143271274|NCT04340193|516546407|FG001|Overall Study|Disease recurrence|1|||
143271275|NCT04340193|516546408|FG002|Overall Study|Disease recurrence|0|||
143271276|NCT04340193|516546406|FG000|Overall Study|Study drug toxicity|1|||
143271277|NCT04340193|516546407|FG001|Overall Study|Study drug toxicity|0|||
143271278|NCT04340193|516546408|FG002|Overall Study|Study drug toxicity|0|||
143271279|NCT04340193|516546406|FG000|Overall Study|Disease progression|1|||
143271280|NCT04340193|516546407|FG001|Overall Study|Disease progression|2|||
143271281|NCT04340193|516546408|FG002|Overall Study|Disease progression|3|||
143271282|NCT04340193|516546406|FG000|Overall Study|Administrative reasons by sponsor|0|||
143271283|NCT04340193|516546407|FG001|Overall Study|Administrative reasons by sponsor|1|||
143271284|NCT04340193|516546408|FG002|Overall Study|Administrative reasons by sponsor|0|||
143271285|NCT04340193|516546406|FG000|Overall Study|Adverse Event|1|||
143271286|NCT04340193|516546407|FG001|Overall Study|Adverse Event|1|||
143271287|NCT04340193|516546408|FG002|Overall Study|Adverse Event|0|||
143271288|NCT03350620|516546409|FG000|Stage 2|Adverse Event|0|||
143271289|NCT03350620|516546410|FG001|Stage 2|Adverse Event|1|||
143271290|NCT03350620|516546411|FG002|Stage 2|Adverse Event|1|||
143271291|NCT03350620|516546409|FG000|Stage 2|Lack of Efficacy|0|||
143271292|NCT03350620|516546410|FG001|Stage 2|Lack of Efficacy|2|||
143271293|NCT03350620|516546411|FG002|Stage 2|Lack of Efficacy|0|||
143271294|NCT03350620|516546409|FG000|Stage 2|Lost to Follow-up|1|||
143271295|NCT03350620|516546410|FG001|Stage 2|Lost to Follow-up|2|||
143271296|NCT03350620|516546411|FG002|Stage 2|Lost to Follow-up|2|||
143271297|NCT03350620|516546409|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
143271298|NCT03350620|516546410|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
143271299|NCT03350620|516546411|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
143271300|NCT01067976|516546412|FG000|Overall Study|Study drug never administered|20|||
143271301|NCT01067976|516546412|FG000|Overall Study|Study prematurely discontinued|2|||
143271302|NCT00976677|516546413|FG000|Overall Study|Adverse Event|1|||
143271303|NCT00976677|516546414|FG001|Overall Study|Adverse Event|0|||
143271304|NCT00976677|516546413|FG000|Overall Study|Withdrawal by Subject|0|||
143271305|NCT00976677|516546414|FG001|Overall Study|Withdrawal by Subject|2|||
143271306|NCT00976677|516546413|FG000|Overall Study|Disease progression|1|||
143271307|NCT00976677|516546414|FG001|Overall Study|Disease progression|1|||
143271308|NCT00976677|516546413|FG000|Overall Study|Trial unblinded|2|||
143271309|NCT00976677|516546414|FG001|Overall Study|Trial unblinded|2|||
143271310|NCT00976677|516546413|FG000|Overall Study|Unknown/Missing|1|||
143271311|NCT00976677|516546414|FG001|Overall Study|Unknown/Missing|0|||
143271312|NCT03673046|516548054|FG000|Overall Study|Adverse Event|1|||
143271313|NCT03673046|516548055|FG001|Overall Study|Adverse Event|1|||
143271314|NCT03673046|516548054|FG000|Overall Study|Withdrawal by Subject|8|||
143271315|NCT03673046|516548055|FG001|Overall Study|Withdrawal by Subject|2|||
143271316|NCT02008318|516548062|FG000|Overall Study|Adverse Event|4|||
143271317|NCT02008318|516548063|FG001|Overall Study|Adverse Event|0|||
143271318|NCT02008318|516548062|FG000|Overall Study|Physician Decision|2|||
143271319|NCT02008318|516548063|FG001|Overall Study|Physician Decision|0|||
143271320|NCT02008318|516548062|FG000|Overall Study|Progressive Disease|2|||
143271321|NCT02008318|516548063|FG001|Overall Study|Progressive Disease|0|||
143271322|NCT02008318|516548062|FG000|Overall Study|Protocol Violation|1|||
143271323|NCT02008318|516548063|FG001|Overall Study|Protocol Violation|1|||
143271324|NCT02008318|516548062|FG000|Overall Study|Withdrawal by Subject|3|||
143271325|NCT02008318|516548063|FG001|Overall Study|Withdrawal by Subject|0|||
143271326|NCT02281773|516548064|FG000|Overall Study|Adverse Event|6|||
143271327|NCT02281773|516548065|FG001|Overall Study|Adverse Event|1|||
143271328|NCT02281773|516548066|FG002|Overall Study|Adverse Event|4|||
143271329|NCT02281773|516548067|FG003|Overall Study|Adverse Event|8|||
143271330|NCT02281773|516548068|FG004|Overall Study|Adverse Event|9|||
143271331|NCT02281773|516548064|FG000|Overall Study|Protocol Violation|1|||
143271332|NCT02281773|516548065|FG001|Overall Study|Protocol Violation|0|||
143271333|NCT02281773|516548066|FG002|Overall Study|Protocol Violation|0|||
143271334|NCT02281773|516548067|FG003|Overall Study|Protocol Violation|2|||
143271335|NCT02281773|516548068|FG004|Overall Study|Protocol Violation|2|||
143271336|NCT02281773|516548064|FG000|Overall Study|Lost to Follow-up|2|||
143271337|NCT02281773|516548065|FG001|Overall Study|Lost to Follow-up|2|||
143271338|NCT02281773|516548066|FG002|Overall Study|Lost to Follow-up|6|||
143271339|NCT02281773|516548067|FG003|Overall Study|Lost to Follow-up|2|||
143271340|NCT02281773|516548068|FG004|Overall Study|Lost to Follow-up|10|||
143271341|NCT02281773|516548064|FG000|Overall Study|Withdrawal by Subject|2|||
143271342|NCT02281773|516548065|FG001|Overall Study|Withdrawal by Subject|8|||
143271343|NCT02281773|516548066|FG002|Overall Study|Withdrawal by Subject|6|||
143271344|NCT02281773|516548067|FG003|Overall Study|Withdrawal by Subject|6|||
143271345|NCT02281773|516548068|FG004|Overall Study|Withdrawal by Subject|8|||
143271346|NCT02281773|516548064|FG000|Overall Study|Other Reason|0|||
143271347|NCT02281773|516548065|FG001|Overall Study|Other Reason|4|||
143271348|NCT02281773|516548066|FG002|Overall Study|Other Reason|2|||
143271349|NCT02281773|516548067|FG003|Overall Study|Other Reason|3|||
143271350|NCT02281773|516548068|FG004|Overall Study|Other Reason|1|||
143271351|NCT01926015|516548072|FG000|Overall Study|Withdrawal by parent/guardian|0|||
143271352|NCT01926015|516548073|FG001|Overall Study|Withdrawal by parent/guardian|1|||
143271353|NCT01926015|516548072|FG000|Overall Study|Randomized not treated|2|||
143271354|NCT01926015|516548073|FG001|Overall Study|Randomized not treated|0|||
143271355|NCT01364649|516548074|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
143271356|NCT01364649|516548075|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
143271357|NCT01364649|516548074|FG000|Overall Study|Lack of Efficacy|6|||
143271358|NCT01364649|516548075|FG001|Overall Study|Lack of Efficacy|0|||
143271359|NCT01364649|516548074|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
143271360|NCT01364649|516548075|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
143271361|NCT01364649|516548074|FG000|Overall Study|Protocol Deviations|4|||
143271362|NCT01364649|516548075|FG001|Overall Study|Protocol Deviations|8|||
143271363|NCT01364649|516548074|FG000|Overall Study|Withdrawal of Consent|9|||
143271364|NCT01364649|516548075|FG001|Overall Study|Withdrawal of Consent|7|||
143271365|NCT01364649|516548074|FG000|Overall Study|Lost to Follow-up|12|||
143271366|NCT01364649|516548075|FG001|Overall Study|Lost to Follow-up|13|||
143271367|NCT01364649|516548074|FG000|Overall Study|Other|4|||
143271368|NCT01364649|516548075|FG001|Overall Study|Other|1|||
143271369|NCT02468232|516548078|FG000|Core Part of Study|Adverse Event|0|||
143271370|NCT02468232|516548079|FG001|Core Part of Study|Adverse Event|1|||
143271371|NCT02468232|516548080|FG002|Core Part of Study|Adverse Event|0|||
143271372|NCT02468232|516548081|FG003|Core Part of Study|Adverse Event|0|||
143271373|NCT02468232|516548078|FG000|Core Part of Study|Death|20|||
143271374|NCT02468232|516548079|FG001|Core Part of Study|Death|17|||
143271375|NCT02468232|516548080|FG002|Core Part of Study|Death|0|||
143271376|NCT02468232|516548081|FG003|Core Part of Study|Death|0|||
143271377|NCT02468232|516548078|FG000|Core Part of Study|Technical Problems|1|||
143271378|NCT02468232|516548079|FG001|Core Part of Study|Technical Problems|1|||
143271379|NCT02468232|516548080|FG002|Core Part of Study|Technical Problems|0|||
143271380|NCT02468232|516548081|FG003|Core Part of Study|Technical Problems|0|||
143271381|NCT02468232|516548078|FG000|OLE Part of Study|Adverse Event|0|||
143271382|NCT02468232|516548079|FG001|OLE Part of Study|Adverse Event|0|||
143271383|NCT02468232|516548080|FG002|OLE Part of Study|Adverse Event|4|||
143271384|NCT02468232|516548081|FG003|OLE Part of Study|Adverse Event|5|||
143271385|NCT02468232|516548078|FG000|OLE Part of Study|Death|0|||
143271386|NCT02468232|516548079|FG001|OLE Part of Study|Death|0|||
143271387|NCT02468232|516548080|FG002|OLE Part of Study|Death|4|||
143271388|NCT02468232|516548081|FG003|OLE Part of Study|Death|2|||
143271389|NCT02468232|516548078|FG000|OLE Part of Study|Physician Decision|0|||
143271390|NCT02468232|516548079|FG001|OLE Part of Study|Physician Decision|0|||
143271391|NCT02468232|516548080|FG002|OLE Part of Study|Physician Decision|4|||
143271392|NCT02468232|516548081|FG003|OLE Part of Study|Physician Decision|0|||
143271393|NCT02468232|516548078|FG000|OLE Part of Study|Subject/Guardian decision|0|||
143271394|NCT02468232|516548079|FG001|OLE Part of Study|Subject/Guardian decision|0|||
143271395|NCT02468232|516548080|FG002|OLE Part of Study|Subject/Guardian decision|2|||
143271396|NCT02468232|516548081|FG003|OLE Part of Study|Subject/Guardian decision|5|||
143271397|NCT00902668|516548082|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
143271398|NCT01914757|516548083|FG000|Overall Study|Severe non-compliance to protocol|3|||
143271399|NCT01914757|516548084|FG001|Overall Study|Severe non-compliance to protocol|1|||
143271400|NCT01914757|516548085|FG002|Overall Study|Severe non-compliance to protocol|2|||
143271401|NCT01914757|516548083|FG000|Overall Study|Lost to Follow-up|5|||
143271402|NCT01914757|516548084|FG001|Overall Study|Lost to Follow-up|8|||
143271403|NCT01914757|516548085|FG002|Overall Study|Lost to Follow-up|6|||
143271404|NCT01914757|516548083|FG000|Overall Study|Withdrawal by Subject|15|||
143271405|NCT01914757|516548084|FG001|Overall Study|Withdrawal by Subject|27|||
143271406|NCT01914757|516548085|FG002|Overall Study|Withdrawal by Subject|19|||
143271407|NCT01914757|516548083|FG000|Overall Study|Death|2|||
143271408|NCT01914757|516548084|FG001|Overall Study|Death|2|||
143271409|NCT01914757|516548085|FG002|Overall Study|Death|1|||
143271410|NCT01914757|516548083|FG000|Overall Study|Adverse Event|4|||
143271411|NCT01914757|516548084|FG001|Overall Study|Adverse Event|3|||
143271412|NCT01914757|516548085|FG002|Overall Study|Adverse Event|4|||
143271413|NCT01914757|516548083|FG000|Overall Study|Study specific withdrawal criteria|0|||
143271414|NCT01914757|516548084|FG001|Overall Study|Study specific withdrawal criteria|1|||
143271415|NCT01914757|516548085|FG002|Overall Study|Study specific withdrawal criteria|0|||
143271416|NCT01914757|516548083|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
143271417|NCT01914757|516548084|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
143271418|NCT01914757|516548085|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
143271419|NCT01914757|516548083|FG000|Overall Study|Other reasons|5|||
143271420|NCT01914757|516548084|FG001|Overall Study|Other reasons|9|||
143271421|NCT01914757|516548085|FG002|Overall Study|Other reasons|4|||
143271422|NCT00615108|516548086|FG000|Overall Study|Adverse Event|122|||
143271423|NCT00615108|516548086|FG000|Overall Study|Other|370|||
143271424|NCT00615108|516548086|FG000|Overall Study|Lost to Follow-up|15|||
143271425|NCT00004635|516548087|FG000|Period One|refused|2|||
143271426|NCT00004635|516548088|FG001|Period One|refused|1|||
143271427|NCT00004635|516548087|FG000|Period One|Withdrawal by Subject|1|||
143271428|NCT00004635|516548088|FG001|Period One|Withdrawal by Subject|1|||
143271429|NCT00004635|516548087|FG000|Period One|Protocol Violation|1|||
143271430|NCT00004635|516548088|FG001|Period One|Protocol Violation|0|||
143271431|NCT00004635|516548087|FG000|Period One|PSA did not go <5 ng/mL|1|||
143271432|NCT00004635|516548088|FG001|Period One|PSA did not go <5 ng/mL|0|||
143271433|NCT00004635|516548087|FG000|Period One|second malignancy|1|||
143271434|NCT00004635|516548088|FG001|Period One|second malignancy|0|||
143271435|NCT00004635|516548087|FG000|Period One|progressed|0|||
143271436|NCT00004635|516548088|FG001|Period One|progressed|2|||
143271437|NCT00004635|516548087|FG000|Period One|health problem|0|||
143271438|NCT00004635|516548088|FG001|Period One|health problem|1|||
143271439|NCT00004635|516548087|FG000|Period One|discrepancy in data entry|0|||
143271440|NCT00004635|516548088|FG001|Period One|discrepancy in data entry|1|||
143271441|NCT00004635|516548087|FG000|Period Two|progression|2|||
143271442|NCT00004635|516548088|FG001|Period Two|progression|3|||
143271443|NCT00004635|516548087|FG000|Period Two|Adverse Event|1|||
143271444|NCT00004635|516548088|FG001|Period Two|Adverse Event|0|||
143271445|NCT00004635|516548087|FG000|Period Two|refused|0|||
143271446|NCT00004635|516548088|FG001|Period Two|refused|2|||
143271447|NCT00004635|516548087|FG000|Period Two|health problem|1|||
143271448|NCT00004635|516548088|FG001|Period Two|health problem|1|||
143271449|NCT00004635|516548087|FG000|Period Two|travel issues|0|||
143271450|NCT00004635|516548088|FG001|Period Two|travel issues|1|||
143271451|NCT00004635|516548087|FG000|Period Two|secondary malignancy|1|||
143271452|NCT00004635|516548088|FG001|Period Two|secondary malignancy|1|||
143271453|NCT00004635|516548087|FG000|Period Two|Lost to Follow-up|1|||
143271454|NCT00004635|516548088|FG001|Period Two|Lost to Follow-up|0|||
143271455|NCT00004635|516548087|FG000|Period Two|discrepancy in data entry|0|||
143271456|NCT00004635|516548088|FG001|Period Two|discrepancy in data entry|1|||
143271457|NCT02024529|516548091|FG000|Overall Study|Withdrawal by Subject|11|||
143271458|NCT02024529|516548092|FG001|Overall Study|Withdrawal by Subject|21|||
143271459|NCT02024529|516548091|FG000|Overall Study|Lost to Follow-up|2|||
143271460|NCT02024529|516548092|FG001|Overall Study|Lost to Follow-up|4|||
143271461|NCT00354614|516548093|FG000|Overall Study|Lack of Efficacy|28|||
143271462|NCT03650556|516548094|FG000|Overall Study|Death|2|||
143271463|NCT03650556|516548094|FG000|Overall Study|Withdrawal by Subject|20|||
143228460|NCT02349633|516384077|FG012|Overall Study|Early termination of survival follow-up|0|||
143228461|NCT02349633|516384078|FG013|Overall Study|Early termination of survival follow-up|0|||
143228462|NCT02349633|516384065|FG000|Overall Study|Termination by sponsor|0|||
143228463|NCT02349633|516384066|FG001|Overall Study|Termination by sponsor|0|||
143228464|NCT02349633|516384067|FG002|Overall Study|Termination by sponsor|0|||
143228465|NCT02349633|516384068|FG003|Overall Study|Termination by sponsor|0|||
143228466|NCT02349633|516384069|FG004|Overall Study|Termination by sponsor|0|||
143228467|NCT02349633|516384070|FG005|Overall Study|Termination by sponsor|0|||
143228468|NCT02349633|516384071|FG006|Overall Study|Termination by sponsor|0|||
143228469|NCT02349633|516384072|FG007|Overall Study|Termination by sponsor|1|||
143228470|NCT02349633|516384073|FG008|Overall Study|Termination by sponsor|0|||
143228471|NCT02349633|516384074|FG009|Overall Study|Termination by sponsor|2|||
143228472|NCT02349633|516384075|FG010|Overall Study|Termination by sponsor|0|||
143228473|NCT02349633|516384076|FG011|Overall Study|Termination by sponsor|0|||
143228474|NCT02349633|516384077|FG012|Overall Study|Termination by sponsor|0|||
143228475|NCT02349633|516384078|FG013|Overall Study|Termination by sponsor|0|||
143228476|NCT02349633|516384065|FG000|Overall Study|Other|0|||
143228477|NCT02349633|516384066|FG001|Overall Study|Other|0|||
143228478|NCT02349633|516384067|FG002|Overall Study|Other|0|||
143228479|NCT02349633|516384068|FG003|Overall Study|Other|0|||
143228480|NCT02349633|516384069|FG004|Overall Study|Other|0|||
143228481|NCT02349633|516384070|FG005|Overall Study|Other|0|||
143228482|NCT02349633|516384071|FG006|Overall Study|Other|0|||
143228483|NCT02349633|516384072|FG007|Overall Study|Other|2|||
143228484|NCT02349633|516384073|FG008|Overall Study|Other|0|||
143228485|NCT02349633|516384074|FG009|Overall Study|Other|0|||
143228486|NCT02349633|516384075|FG010|Overall Study|Other|0|||
143228487|NCT02349633|516384076|FG011|Overall Study|Other|0|||
143228488|NCT02349633|516384077|FG012|Overall Study|Other|0|||
143228489|NCT02349633|516384078|FG013|Overall Study|Other|0|||
143228490|NCT02356159|516384081|FG000|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
143228491|NCT02356159|516384082|FG001|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
143228492|NCT02356159|516384083|FG002|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
143228493|NCT02356159|516384084|FG003|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
143228494|NCT02356159|516384085|FG004|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
143228495|NCT02356159|516384086|FG005|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|1|||
143228496|NCT00743249|516384087|FG000|Overall Study|Adverse Event|0|||
143228497|NCT00743249|516384088|FG001|Overall Study|Adverse Event|4|||
143228498|NCT00743249|516384087|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
143228499|NCT00743249|516384088|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
143228500|NCT00743249|516384087|FG000|Overall Study|Unsuccessful insertion of stent|2|||
143228501|NCT00743249|516384088|FG001|Overall Study|Unsuccessful insertion of stent|1|||
143228502|NCT00718510|516384089|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
143228503|NCT00718510|516384090|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
143228504|NCT00718510|516384089|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
143228505|NCT00718510|516384090|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
143228506|NCT04551989|516384091|FG000|Overall Study|Adverse Event|4|||
143228507|NCT04551989|516384091|FG000|Overall Study|Protocol Violation|3|||
143228508|NCT04551989|516384091|FG000|Overall Study|Lost to Follow-up|1|||
143228509|NCT04551989|516384091|FG000|Overall Study|Physician Decision|3|||
143228510|NCT02174731|516384092|FG000|Overall Study|Participant decision|67|||
143228511|NCT02174731|516384093|FG001|Overall Study|Participant decision|64|||
143228512|NCT02174731|516384092|FG000|Overall Study|Incorrect enrolment before randomization|0|||
143228513|NCT02174731|516384093|FG001|Overall Study|Incorrect enrolment before randomization|1|||
143228514|NCT02174731|516384092|FG000|Overall Study|Missing|2|||
143228515|NCT02174731|516384093|FG001|Overall Study|Missing|0|||
143228516|NCT03915717|516384094|FG000|Overall Study|EchoMark Not Implanted|6|||
143228517|NCT01239381|516384096|FG000|Overall Study|Protocol Violation|1|||
143228518|NCT01239381|516384096|FG000|Overall Study|Withdrawal by Subject|1|||
143228519|NCT02903160|516384097|FG000|Overall Study|Adverse Event|2|||
143228520|NCT02903160|516384097|FG000|Overall Study|Death|1|||
143228521|NCT02903160|516384097|FG000|Overall Study|Lost to Follow-up|2|||
143228522|NCT02903160|516384097|FG000|Overall Study|Withdrawal by Subject|1|||
143228523|NCT02903160|516384097|FG000|Overall Study|Medical Insurance Barriers|1|||
143228524|NCT01384734|516384103|FG000|Overall Study|Adverse Event|0|||
143228525|NCT01384734|516384104|FG001|Overall Study|Adverse Event|3|||
143228526|NCT01384734|516384105|FG002|Overall Study|Adverse Event|0|||
143228527|NCT01384734|516384106|FG003|Overall Study|Adverse Event|2|||
143228528|NCT01384734|516384107|FG004|Overall Study|Adverse Event|7|||
143228529|NCT01384734|516384103|FG000|Overall Study|Death|1|||
143228530|NCT01384734|516384104|FG001|Overall Study|Death|0|||
143228531|NCT01384734|516384105|FG002|Overall Study|Death|1|||
143228532|NCT01384734|516384106|FG003|Overall Study|Death|0|||
143228533|NCT01384734|516384107|FG004|Overall Study|Death|0|||
143228534|NCT01384734|516384103|FG000|Overall Study|Continuation criteria not met|0|||
143228535|NCT01384734|516384104|FG001|Overall Study|Continuation criteria not met|0|||
143228536|NCT01384734|516384105|FG002|Overall Study|Continuation criteria not met|1|||
143228537|NCT01384734|516384106|FG003|Overall Study|Continuation criteria not met|1|||
143228538|NCT01384734|516384107|FG004|Overall Study|Continuation criteria not met|0|||
143228539|NCT01384734|516384103|FG000|Overall Study|Lack of Efficacy|3|||
143228540|NCT01384734|516384104|FG001|Overall Study|Lack of Efficacy|7|||
143228541|NCT01384734|516384105|FG002|Overall Study|Lack of Efficacy|4|||
143228542|NCT01384734|516384106|FG003|Overall Study|Lack of Efficacy|4|||
143228543|NCT01384734|516384107|FG004|Overall Study|Lack of Efficacy|2|||
143228544|NCT01384734|516384103|FG000|Overall Study|Lost to Follow-up|5|||
143228545|NCT01384734|516384104|FG001|Overall Study|Lost to Follow-up|3|||
143228546|NCT01384734|516384105|FG002|Overall Study|Lost to Follow-up|3|||
143228547|NCT01384734|516384106|FG003|Overall Study|Lost to Follow-up|8|||
143228548|NCT01384734|516384107|FG004|Overall Study|Lost to Follow-up|5|||
143228549|NCT01384734|516384103|FG000|Overall Study|Non-compliance with study drug|1|||
143228550|NCT01384734|516384104|FG001|Overall Study|Non-compliance with study drug|2|||
143228551|NCT01384734|516384105|FG002|Overall Study|Non-compliance with study drug|6|||
143228552|NCT01384734|516384106|FG003|Overall Study|Non-compliance with study drug|0|||
143228553|NCT01384734|516384107|FG004|Overall Study|Non-compliance with study drug|2|||
143228554|NCT01384734|516384103|FG000|Overall Study|Pregnancy|0|||
143228555|NCT01384734|516384104|FG001|Overall Study|Pregnancy|1|||
143228556|NCT01384734|516384105|FG002|Overall Study|Pregnancy|0|||
143228557|NCT01384734|516384106|FG003|Overall Study|Pregnancy|0|||
143228558|NCT01384734|516384107|FG004|Overall Study|Pregnancy|1|||
143228559|NCT01384734|516384103|FG000|Overall Study|Sponsor terminated|0|||
143228560|NCT01384734|516384104|FG001|Overall Study|Sponsor terminated|0|||
143228561|NCT01384734|516384105|FG002|Overall Study|Sponsor terminated|0|||
143228562|NCT01384734|516384106|FG003|Overall Study|Sponsor terminated|0|||
143228563|NCT01384734|516384107|FG004|Overall Study|Sponsor terminated|1|||
143228564|NCT01384734|516384103|FG000|Overall Study|Withdrawal by Subject|5|||
143228565|NCT01384734|516384104|FG001|Overall Study|Withdrawal by Subject|5|||
143228566|NCT01384734|516384105|FG002|Overall Study|Withdrawal by Subject|6|||
143228567|NCT01384734|516384106|FG003|Overall Study|Withdrawal by Subject|7|||
143228568|NCT01384734|516384107|FG004|Overall Study|Withdrawal by Subject|9|||
143228569|NCT01384734|516384103|FG000|Overall Study|Investigator relocating|0|||
143228570|NCT01384734|516384104|FG001|Overall Study|Investigator relocating|2|||
143228571|NCT01384734|516384105|FG002|Overall Study|Investigator relocating|0|||
143228572|NCT01384734|516384106|FG003|Overall Study|Investigator relocating|3|||
143228573|NCT01384734|516384107|FG004|Overall Study|Investigator relocating|1|||
143228574|NCT01384734|516384103|FG000|Overall Study|Unable to come back for visit|1|||
143228575|NCT01384734|516384104|FG001|Overall Study|Unable to come back for visit|0|||
143228576|NCT01384734|516384105|FG002|Overall Study|Unable to come back for visit|1|||
143228577|NCT01384734|516384106|FG003|Overall Study|Unable to come back for visit|1|||
143228578|NCT01384734|516384107|FG004|Overall Study|Unable to come back for visit|0|||
143228579|NCT01384734|516384103|FG000|Overall Study|Prison|0|||
143228580|NCT01384734|516384104|FG001|Overall Study|Prison|0|||
143228581|NCT01384734|516384105|FG002|Overall Study|Prison|1|||
143228582|NCT01384734|516384106|FG003|Overall Study|Prison|0|||
143228583|NCT01384734|516384107|FG004|Overall Study|Prison|0|||
143228584|NCT01384734|516384103|FG000|Overall Study|As per Exclusion criteria|0|||
143228585|NCT01384734|516384104|FG001|Overall Study|As per Exclusion criteria|1|||
143228586|NCT01384734|516384105|FG002|Overall Study|As per Exclusion criteria|0|||
143228587|NCT01384734|516384106|FG003|Overall Study|As per Exclusion criteria|0|||
143228588|NCT01384734|516384107|FG004|Overall Study|As per Exclusion criteria|0|||
143228589|NCT01384734|516384103|FG000|Overall Study|Missed End of treatment visit|0|||
143228590|NCT01384734|516384104|FG001|Overall Study|Missed End of treatment visit|0|||
143228591|NCT01384734|516384105|FG002|Overall Study|Missed End of treatment visit|0|||
143228592|NCT01384734|516384106|FG003|Overall Study|Missed End of treatment visit|1|||
143228593|NCT01384734|516384107|FG004|Overall Study|Missed End of treatment visit|0|||
143228594|NCT01384734|516384103|FG000|Overall Study|Adhesion problem|0|||
143228595|NCT01384734|516384104|FG001|Overall Study|Adhesion problem|0|||
143228596|NCT01384734|516384105|FG002|Overall Study|Adhesion problem|0|||
143228597|NCT01384734|516384106|FG003|Overall Study|Adhesion problem|1|||
143228598|NCT01384734|516384107|FG004|Overall Study|Adhesion problem|0|||
143228599|NCT01384734|516384103|FG000|Overall Study|Early termination|0|||
143228600|NCT01384734|516384104|FG001|Overall Study|Early termination|0|||
143228601|NCT01384734|516384105|FG002|Overall Study|Early termination|0|||
143228602|NCT01384734|516384106|FG003|Overall Study|Early termination|0|||
143271464|NCT03650556|516548094|FG000|Overall Study|Physician Decision|2|||
143228603|NCT01384734|516384107|FG004|Overall Study|Early termination|1|||
143228604|NCT01384734|516384103|FG000|Overall Study|Physician Decision|1|||
143228605|NCT01384734|516384104|FG001|Overall Study|Physician Decision|0|||
143228606|NCT01384734|516384105|FG002|Overall Study|Physician Decision|0|||
143228607|NCT01384734|516384106|FG003|Overall Study|Physician Decision|0|||
143271465|NCT03650556|516548094|FG000|Overall Study|Lost to Follow-up|8|||
143271466|NCT03650556|516548094|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
143271467|NCT03650556|516548094|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
143271468|NCT03917459|516548097|FG000|Overall Study|Adverse Event|1|||
143271469|NCT03917459|516548098|FG001|Overall Study|Adverse Event|0|||
143271470|NCT03917459|516548097|FG000|Overall Study|Withdrawal by Subject|0|||
143271471|NCT03917459|516548098|FG001|Overall Study|Withdrawal by Subject|1|||
143271472|NCT00676338|516548099|FG000|Overall Study|Adverse Event|6|||
143271473|NCT00676338|516548100|FG001|Overall Study|Adverse Event|6|||
143271474|NCT00676338|516548101|FG002|Overall Study|Adverse Event|5|||
143271475|NCT00676338|516548102|FG003|Overall Study|Adverse Event|1|||
143271476|NCT00676338|516548099|FG000|Overall Study|Lost to Follow-up|4|||
143271477|NCT00676338|516548100|FG001|Overall Study|Lost to Follow-up|1|||
143271478|NCT00676338|516548101|FG002|Overall Study|Lost to Follow-up|3|||
143271479|NCT00676338|516548102|FG003|Overall Study|Lost to Follow-up|4|||
143271480|NCT00676338|516548099|FG000|Overall Study|Physician Decision|3|||
143271481|NCT00676338|516548100|FG001|Overall Study|Physician Decision|3|||
143271482|NCT00676338|516548101|FG002|Overall Study|Physician Decision|2|||
143271483|NCT00676338|516548102|FG003|Overall Study|Physician Decision|3|||
143271484|NCT00676338|516548099|FG000|Overall Study|Protocol Violation|5|||
143271485|NCT00676338|516548100|FG001|Overall Study|Protocol Violation|9|||
143271486|NCT00676338|516548101|FG002|Overall Study|Protocol Violation|2|||
143271487|NCT00676338|516548102|FG003|Overall Study|Protocol Violation|5|||
143271488|NCT00676338|516548099|FG000|Overall Study|Withdrawal by Subject|17|||
143271489|NCT00676338|516548100|FG001|Overall Study|Withdrawal by Subject|9|||
143271490|NCT00676338|516548101|FG002|Overall Study|Withdrawal by Subject|12|||
143271491|NCT00676338|516548102|FG003|Overall Study|Withdrawal by Subject|6|||
143271492|NCT00676338|516548099|FG000|Overall Study|Entry Criteria Not Met|0|||
143271493|NCT00676338|516548100|FG001|Overall Study|Entry Criteria Not Met|2|||
143271494|NCT00676338|516548101|FG002|Overall Study|Entry Criteria Not Met|1|||
143271495|NCT00676338|516548102|FG003|Overall Study|Entry Criteria Not Met|1|||
143271496|NCT00676338|516548099|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
143271497|NCT00676338|516548100|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
143271498|NCT00676338|516548101|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
143228608|NCT01384734|516384107|FG004|Overall Study|Physician Decision|0|||
143228609|NCT00360412|516384108|FG000|Overall Study|Adverse Event|37|||
143228610|NCT00360412|516384109|FG001|Overall Study|Adverse Event|65|||
143228611|NCT00360412|516384108|FG000|Overall Study|Protocol Violation|2|||
143228612|NCT00360412|516384109|FG001|Overall Study|Protocol Violation|5|||
143228613|NCT00360412|516384108|FG000|Overall Study|Patient withdrew consent|27|||
143228614|NCT00360412|516384109|FG001|Overall Study|Patient withdrew consent|52|||
143228615|NCT00360412|516384108|FG000|Overall Study|Lack of therapeutic efficacy|46|||
143228616|NCT00360412|516384109|FG001|Overall Study|Lack of therapeutic efficacy|61|||
143228617|NCT00360412|516384108|FG000|Overall Study|Physician Decision|2|||
143228618|NCT00360412|516384109|FG001|Overall Study|Physician Decision|4|||
143228619|NCT00360412|516384108|FG000|Overall Study|Other|5|||
143228620|NCT00360412|516384109|FG001|Overall Study|Other|6|||
143228621|NCT00360412|516384108|FG000|Overall Study|Study termination by Sponsor|214|||
143228622|NCT00360412|516384109|FG001|Overall Study|Study termination by Sponsor|469|||
143228623|NCT00308139|516385498|FG000|Overall Study|Adverse Event|20|||
143228624|NCT00308139|516385499|FG001|Overall Study|Adverse Event|14|||
143228625|NCT00308139|516385498|FG000|Overall Study|Lost to Follow-up|13|||
143228626|NCT00308139|516385499|FG001|Overall Study|Lost to Follow-up|8|||
143228627|NCT00308139|516385498|FG000|Overall Study|Protocol Violation|3|||
143228628|NCT00308139|516385499|FG001|Overall Study|Protocol Violation|2|||
143228629|NCT00308139|516385498|FG000|Overall Study|Withdrawal of Consent|40|||
143228630|NCT00308139|516385499|FG001|Overall Study|Withdrawal of Consent|42|||
143228631|NCT00308139|516385498|FG000|Overall Study|Investigator Decision|11|||
143228632|NCT00308139|516385499|FG001|Overall Study|Investigator Decision|10|||
143228633|NCT00308139|516385498|FG000|Overall Study|Loss of Glucose Control|5|||
143228634|NCT00308139|516385499|FG001|Overall Study|Loss of Glucose Control|7|||
143228635|NCT00308139|516385498|FG000|Overall Study|Administrative|1|||
143228636|NCT00308139|516385499|FG001|Overall Study|Administrative|4|||
143228637|NCT00308139|516385498|FG000|Overall Study|Other|1|||
143228638|NCT00308139|516385499|FG001|Overall Study|Other|0|||
143228639|NCT01421017|516385500|FG000|Overall Study|Withdrawal by Subject|2|||
143228640|NCT01421017|516385501|FG001|Overall Study|Withdrawal by Subject|0|||
143228641|NCT01421017|516385502|FG002|Overall Study|Withdrawal by Subject|0|||
143228642|NCT01421017|516385500|FG000|Overall Study|POD|0|||
143271499|NCT00676338|516548102|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
143228643|NCT01421017|516385501|FG001|Overall Study|POD|6|||
143228644|NCT01421017|516385502|FG002|Overall Study|POD|3|||
143228645|NCT00791388|516385505|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
143228646|NCT00791388|516385506|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
143228647|NCT00791388|516385507|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
143228648|NCT00791388|516385508|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
143228649|NCT00791388|516385509|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
143228650|NCT00791388|516385505|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
143228651|NCT00791388|516385506|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
143228652|NCT00791388|516385507|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
143228653|NCT00791388|516385508|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
143228654|NCT00791388|516385509|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
143228655|NCT00791388|516385505|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
143228656|NCT00791388|516385506|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
143228657|NCT00791388|516385507|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
143228658|NCT00791388|516385508|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
143228659|NCT00791388|516385509|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
143228660|NCT04245111|516385517|FG000|Overall Study|Lost to Follow-up|5|||
143228661|NCT04245111|516385518|FG001|Overall Study|Lost to Follow-up|1|||
143228662|NCT04245111|516385519|FG002|Overall Study|Lost to Follow-up|1|||
143228663|NCT06039579|516385524|FG000|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
143228664|NCT06039579|516385525|FG001|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
143228665|NCT06039579|516385526|FG002|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
143228666|NCT06039579|516385527|FG003|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
143228667|NCT06039579|516385528|FG004|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
143228668|NCT06039579|516385529|FG005|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
143228669|NCT06039579|516385530|FG006|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
143228670|NCT06039579|516385531|FG007|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|1|||
143228671|NCT02763644|516385536|FG000|Overall Study|Patient/guardian decision|1|||
143228672|NCT02763644|516385537|FG001|Overall Study|Patient/guardian decision|0|||
143228673|NCT02763644|516385536|FG000|Overall Study|Death|1|||
143228674|NCT02763644|516385537|FG001|Overall Study|Death|1|||
143228675|NCT02763644|516385536|FG000|Overall Study|Adverse Event|1|||
143228676|NCT02763644|516385537|FG001|Overall Study|Adverse Event|1|||
143228677|NCT01220167|516385538|FG000|Period 3|Urine positive for substance abuse|0|||
143228678|NCT01220167|516385539|FG001|Period 3|Urine positive for substance abuse|1|||
143228679|NCT01220167|516385540|FG002|Period 3|Urine positive for substance abuse|0|||
143228680|NCT05789745|516385541|FG000|Overall Study|Withdrawal by Subject|0|||
143228681|NCT05789745|516385542|FG001|Overall Study|Withdrawal by Subject|0|||
143228682|NCT05789745|516385543|FG002|Overall Study|Withdrawal by Subject|0|||
143228683|NCT05789745|516385544|FG003|Overall Study|Withdrawal by Subject|0|||
143228684|NCT05789745|516385545|FG004|Overall Study|Withdrawal by Subject|1|||
143228685|NCT02055898|516385548|FG000|First Intervention (5 Days)|Physician Decision|2|||
143228686|NCT02055898|516385549|FG001|First Intervention (5 Days)|Physician Decision|0|||
143228687|NCT02055898|516385548|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
143228688|NCT02055898|516385549|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
143228689|NCT02201524|516385551|FG000|Overall Study|Adverse Event|0|||
143228690|NCT02201524|516385552|FG001|Overall Study|Adverse Event|2|||
143228691|NCT02201524|516385553|FG002|Overall Study|Adverse Event|1|||
143228692|NCT02201524|516385554|FG003|Overall Study|Adverse Event|0|||
143228693|NCT02201524|516385551|FG000|Overall Study|Insufficient clinical response|1|||
143228694|NCT02201524|516385552|FG001|Overall Study|Insufficient clinical response|0|||
143228695|NCT02201524|516385553|FG002|Overall Study|Insufficient clinical response|0|||
143228696|NCT02201524|516385554|FG003|Overall Study|Insufficient clinical response|0|||
143228697|NCT02201524|516385551|FG000|Overall Study|Lost to Follow-up|0|||
143228698|NCT02201524|516385552|FG001|Overall Study|Lost to Follow-up|0|||
143228699|NCT02201524|516385553|FG002|Overall Study|Lost to Follow-up|2|||
143228700|NCT02201524|516385554|FG003|Overall Study|Lost to Follow-up|0|||
143228701|NCT02201524|516385551|FG000|Overall Study|No longer meets eligibility criteria|0|||
143228702|NCT02201524|516385552|FG001|Overall Study|No longer meets eligibility criteria|0|||
143228703|NCT02201524|516385553|FG002|Overall Study|No longer meets eligibility criteria|0|||
143228704|NCT02201524|516385554|FG003|Overall Study|No longer meets eligibility criteria|2|||
143228705|NCT02201524|516385551|FG000|Overall Study|Protocol Violation|0|||
143228706|NCT02201524|516385552|FG001|Overall Study|Protocol Violation|0|||
143228707|NCT02201524|516385553|FG002|Overall Study|Protocol Violation|0|||
143228708|NCT02201524|516385554|FG003|Overall Study|Protocol Violation|1|||
143228709|NCT02201524|516385551|FG000|Overall Study|Withdrawal by Subject|0|||
143228710|NCT02201524|516385552|FG001|Overall Study|Withdrawal by Subject|0|||
143228711|NCT02201524|516385553|FG002|Overall Study|Withdrawal by Subject|1|||
143228712|NCT02201524|516385554|FG003|Overall Study|Withdrawal by Subject|1|||
143271500|NCT02122458|516548103|FG000|Overall Study|Withdrawal by Subject|0|||
143228713|NCT02201524|516385551|FG000|Overall Study|Other|1|||
143228714|NCT02201524|516385552|FG001|Overall Study|Other|1|||
143228715|NCT02201524|516385553|FG002|Overall Study|Other|0|||
143228716|NCT02201524|516385554|FG003|Overall Study|Other|0|||
143228717|NCT02314052|516385555|FG000|Cycle One|Adverse Event|0|||
143228718|NCT02314052|516385556|FG001|Cycle One|Adverse Event|0|||
143228719|NCT02314052|516385557|FG002|Cycle One|Adverse Event|0|||
143271501|NCT02122458|516548104|FG001|Overall Study|Withdrawal by Subject|0|||
143271502|NCT02122458|516548105|FG002|Overall Study|Withdrawal by Subject|0|||
143271503|NCT02122458|516548106|FG003|Overall Study|Withdrawal by Subject|4|||
143271504|NCT02122458|516548107|FG004|Overall Study|Withdrawal by Subject|4|||
143271505|NCT02122458|516548108|FG005|Overall Study|Withdrawal by Subject|4|||
143271506|NCT02122458|516548109|FG006|Overall Study|Withdrawal by Subject|0|||
143271507|NCT02122458|516548103|FG000|Overall Study|Lost to Follow-up|1|||
143271508|NCT02122458|516548104|FG001|Overall Study|Lost to Follow-up|3|||
143271509|NCT02122458|516548105|FG002|Overall Study|Lost to Follow-up|0|||
143271510|NCT02122458|516548106|FG003|Overall Study|Lost to Follow-up|7|||
143271511|NCT02122458|516548107|FG004|Overall Study|Lost to Follow-up|5|||
143271512|NCT02122458|516548108|FG005|Overall Study|Lost to Follow-up|15|||
143271513|NCT02122458|516548109|FG006|Overall Study|Lost to Follow-up|1|||
143271514|NCT02122458|516548103|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
143271515|NCT02122458|516548104|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
143271516|NCT02122458|516548105|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
143271517|NCT02122458|516548106|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
143271518|NCT02122458|516548107|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
143271519|NCT02122458|516548108|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
143271520|NCT02122458|516548109|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
143271521|NCT02122458|516548103|FG000|Overall Study|Adverse Event|1|||
143271522|NCT02122458|516548104|FG001|Overall Study|Adverse Event|0|||
143271523|NCT02122458|516548105|FG002|Overall Study|Adverse Event|0|||
143271524|NCT02122458|516548106|FG003|Overall Study|Adverse Event|0|||
143271525|NCT02122458|516548107|FG004|Overall Study|Adverse Event|0|||
143271526|NCT02122458|516548108|FG005|Overall Study|Adverse Event|0|||
143271527|NCT02122458|516548109|FG006|Overall Study|Adverse Event|0|||
143271528|NCT02122458|516548103|FG000|Overall Study|Experimental Error|0|||
143271529|NCT02122458|516548104|FG001|Overall Study|Experimental Error|0|||
143271530|NCT02122458|516548105|FG002|Overall Study|Experimental Error|0|||
143271531|NCT02122458|516548106|FG003|Overall Study|Experimental Error|0|||
143271532|NCT02122458|516548107|FG004|Overall Study|Experimental Error|3|||
143271533|NCT02122458|516548108|FG005|Overall Study|Experimental Error|0|||
143271534|NCT02122458|516548109|FG006|Overall Study|Experimental Error|0|||
143271535|NCT02122458|516548103|FG000|Overall Study|Deployed or Moved|0|||
143271536|NCT02122458|516548104|FG001|Overall Study|Deployed or Moved|0|||
143271537|NCT02122458|516548105|FG002|Overall Study|Deployed or Moved|0|||
143271538|NCT02122458|516548106|FG003|Overall Study|Deployed or Moved|0|||
143271539|NCT02122458|516548107|FG004|Overall Study|Deployed or Moved|1|||
143271540|NCT02122458|516548108|FG005|Overall Study|Deployed or Moved|0|||
143271541|NCT02122458|516548109|FG006|Overall Study|Deployed or Moved|0|||
143271542|NCT02122458|516548103|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
143271543|NCT02122458|516548104|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
143271544|NCT02122458|516548105|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
143271545|NCT02122458|516548106|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
143271546|NCT02122458|516548107|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
143271547|NCT02122458|516548108|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
143271548|NCT02122458|516548109|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
143271549|NCT02122458|516548103|FG000|Overall Study|Noncompliance|0|||
143271550|NCT02122458|516548104|FG001|Overall Study|Noncompliance|1|||
143271551|NCT02122458|516548105|FG002|Overall Study|Noncompliance|0|||
143271552|NCT02122458|516548106|FG003|Overall Study|Noncompliance|0|||
143271553|NCT02122458|516548107|FG004|Overall Study|Noncompliance|0|||
143271554|NCT02122458|516548108|FG005|Overall Study|Noncompliance|0|||
143271555|NCT02122458|516548109|FG006|Overall Study|Noncompliance|0|||
143271556|NCT00412542|516548110|FG000|Overall Study|Withdrawal by Subject|0|||
143271557|NCT00412542|516548111|FG001|Overall Study|Withdrawal by Subject|2|||
143271558|NCT00412542|516548110|FG000|Overall Study|Not Eligible|0|||
143271559|NCT00412542|516548111|FG001|Overall Study|Not Eligible|1|||
143271560|NCT02833350|516548112|FG000|Overall Study|Adverse Event|0|||
143271561|NCT02833350|516548113|FG001|Overall Study|Adverse Event|3|||
143271562|NCT02833350|516548114|FG002|Overall Study|Adverse Event|4|||
143271563|NCT02833350|516548115|FG003|Overall Study|Adverse Event|4|||
143271564|NCT02833350|516548116|FG004|Overall Study|Adverse Event|1|||
143271565|NCT02833350|516548117|FG005|Overall Study|Adverse Event|0|||
143271566|NCT02833350|516548118|FG006|Overall Study|Adverse Event|1|||
143271567|NCT02833350|516548112|FG000|Overall Study|Death|0|||
143271568|NCT02833350|516548113|FG001|Overall Study|Death|0|||
143271569|NCT02833350|516548114|FG002|Overall Study|Death|1|||
143271570|NCT02833350|516548115|FG003|Overall Study|Death|0|||
143271571|NCT02833350|516548116|FG004|Overall Study|Death|0|||
143271572|NCT02833350|516548117|FG005|Overall Study|Death|0|||
143271573|NCT02833350|516548118|FG006|Overall Study|Death|0|||
143271574|NCT02833350|516548112|FG000|Overall Study|Lack of Efficacy|0|||
143271575|NCT02833350|516548113|FG001|Overall Study|Lack of Efficacy|2|||
143271576|NCT02833350|516548114|FG002|Overall Study|Lack of Efficacy|1|||
143271577|NCT02833350|516548115|FG003|Overall Study|Lack of Efficacy|4|||
143228720|NCT02314052|516385558|FG003|Cycle One|Adverse Event|1|||
143228721|NCT02314052|516385559|FG004|Cycle One|Adverse Event|0|||
143228722|NCT02314052|516385560|FG005|Cycle One|Adverse Event|0|||
143228723|NCT00472108|516385567|FG000|Overall Study|Lost to Follow-up|0|||
143228724|NCT00472108|516385568|FG001|Overall Study|Lost to Follow-up|1|||
143228725|NCT00088530|516385571|FG000|Overall Study|Progressive/Relapsed Disease|28|||
143228726|NCT00088530|516385572|FG001|Overall Study|Progressive/Relapsed Disease|39|||
143228727|NCT00088530|516385571|FG000|Overall Study|Adverse Event|15|||
143228728|NCT00088530|516385572|FG001|Overall Study|Adverse Event|9|||
143228729|NCT00088530|516385571|FG000|Overall Study|Withdrawal by Subject|2|||
143228730|NCT00088530|516385572|FG001|Overall Study|Withdrawal by Subject|5|||
143228731|NCT00088530|516385571|FG000|Overall Study|Lost to Follow-up|2|||
143228732|NCT00088530|516385572|FG001|Overall Study|Lost to Follow-up|0|||
143228733|NCT00088530|516385571|FG000|Overall Study|Physician Decision|2|||
143228734|NCT00088530|516385572|FG001|Overall Study|Physician Decision|0|||
143228735|NCT00088530|516385571|FG000|Overall Study|Sponsor decision|0|||
143228736|NCT00088530|516385572|FG001|Overall Study|Sponsor decision|1|||
143228737|NCT00088530|516385571|FG000|Overall Study|Patient never treated|1|||
143228738|NCT00088530|516385572|FG001|Overall Study|Patient never treated|0|||
143228739|NCT00325897|516385573|FG000|Overall Study|Lost to Follow-up|12|||
143228740|NCT00325897|516385574|FG001|Overall Study|Lost to Follow-up|13|||
143228741|NCT04575155|516385575|FG000|2 Month|Withdrawal by Subject|1|||
143228742|NCT04575155|516385576|FG001|2 Month|Withdrawal by Subject|1|||
143228743|NCT04575155|516385575|FG000|2 Month|Lost to Follow-up|5|||
143228744|NCT04575155|516385576|FG001|2 Month|Lost to Follow-up|3|||
143228745|NCT04575155|516385575|FG000|2 Month|Ineligible|1|||
143228746|NCT04575155|516385576|FG001|2 Month|Ineligible|0|||
143228747|NCT00982735|516385579|FG000|Overall Study|Lost to Follow-up|6|||
143228748|NCT00982735|516385579|FG000|Overall Study|Patient ineligible for trial|224|||
143228749|NCT02734693|516385580|FG000|Overall Study|Adverse Event|1|||
143228750|NCT02734693|516385581|FG001|Overall Study|Adverse Event|3|||
143228751|NCT02734693|516385582|FG002|Overall Study|Adverse Event|3|||
143228752|NCT02734693|516385580|FG000|Overall Study|Lack of Efficacy|1|||
143228753|NCT02734693|516385581|FG001|Overall Study|Lack of Efficacy|0|||
143228754|NCT02734693|516385582|FG002|Overall Study|Lack of Efficacy|0|||
143228755|NCT02734693|516385580|FG000|Overall Study|Lost to Follow-up|2|||
143228756|NCT02734693|516385581|FG001|Overall Study|Lost to Follow-up|0|||
143228757|NCT02734693|516385582|FG002|Overall Study|Lost to Follow-up|0|||
143228758|NCT02734693|516385580|FG000|Overall Study|Protocol Violation|1|||
143228759|NCT02734693|516385581|FG001|Overall Study|Protocol Violation|0|||
143228760|NCT02734693|516385582|FG002|Overall Study|Protocol Violation|0|||
143228761|NCT02734693|516385580|FG000|Overall Study|Withdrawal by Subject|1|||
143228762|NCT02734693|516385581|FG001|Overall Study|Withdrawal by Subject|0|||
143228763|NCT02734693|516385582|FG002|Overall Study|Withdrawal by Subject|0|||
143228764|NCT00689390|516385586|FG000|Overall Study|Adverse Event|19|||
143228765|NCT00689390|516385587|FG001|Overall Study|Adverse Event|0|||
143228766|NCT00689390|516385586|FG000|Overall Study|Lost to Follow-up|179|||
143228767|NCT00689390|516385587|FG001|Overall Study|Lost to Follow-up|7|||
143228768|NCT00689390|516385586|FG000|Overall Study|Withdrawal by Subject|117|||
143228769|NCT00689390|516385587|FG001|Overall Study|Withdrawal by Subject|3|||
143228770|NCT00689390|516385586|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
143228771|NCT00689390|516385587|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
143228772|NCT00689390|516385586|FG000|Overall Study|Non-Compliance With Protocol|21|||
143228773|NCT00689390|516385587|FG001|Overall Study|Non-Compliance With Protocol|0|||
143228774|NCT00689390|516385586|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
143228775|NCT00689390|516385587|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
143228776|NCT00689390|516385586|FG000|Overall Study|Administrative|37|||
143228777|NCT00689390|516385587|FG001|Overall Study|Administrative|0|||
143228778|NCT01290523|516385588|FG000|Overall Study|Death|3|||
143228779|NCT03071263|516385589|FG000|Overall Study|Adverse Event|1|||
143228780|NCT03071263|516385590|FG001|Overall Study|Adverse Event|3|||
143228781|NCT03071263|516385589|FG000|Overall Study|Withdrawal by Subject|1|||
143228782|NCT03071263|516385590|FG001|Overall Study|Withdrawal by Subject|3|||
143228783|NCT03071263|516385589|FG000|Overall Study|Physician Decision|1|||
143228784|NCT03071263|516385590|FG001|Overall Study|Physician Decision|0|||
143228785|NCT03071263|516385589|FG000|Overall Study|Participant moved to another city|0|||
143228786|NCT03071263|516385590|FG001|Overall Study|Participant moved to another city|1|||
143228787|NCT00550407|516385591|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
143228788|NCT00550407|516385592|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
143228789|NCT00550407|516385593|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
143228790|NCT00550407|516385591|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
143228791|NCT00550407|516385592|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
143228792|NCT00550407|516385593|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
143228793|NCT00550407|516385591|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
143228794|NCT00550407|516385592|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
143228795|NCT00550407|516385593|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
143271578|NCT02833350|516548116|FG004|Overall Study|Lack of Efficacy|0|||
143228796|NCT00550407|516385591|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
143228797|NCT00550407|516385592|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
143228798|NCT00550407|516385593|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
143228799|NCT00550407|516385591|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
143228800|NCT00550407|516385592|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
143228801|NCT00550407|516385593|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
143228802|NCT00550407|516385591|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
143228803|NCT00550407|516385592|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
143228804|NCT00550407|516385593|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
143228805|NCT00550407|516385591|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
143228806|NCT00550407|516385592|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
143228807|NCT00550407|516385593|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
143228808|NCT00550407|516385591|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
143228809|NCT00550407|516385592|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
143228810|NCT00550407|516385593|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
143228811|NCT00550407|516385591|FG000|26-Week Randomized Phase|Adverse Event|0|||
143228812|NCT00550407|516385592|FG001|26-Week Randomized Phase|Adverse Event|5|||
143228813|NCT00550407|516385593|FG002|26-Week Randomized Phase|Adverse Event|2|||
143228814|NCT00550407|516385591|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
143228815|NCT00550407|516385592|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
143228816|NCT00550407|516385593|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
143228817|NCT00550407|516385591|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
143228818|NCT00550407|516385592|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
143228819|NCT00550407|516385593|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
143228820|NCT00550407|516385591|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
143228821|NCT00550407|516385592|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
143228822|NCT00550407|516385593|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
143228823|NCT00584415|516385594|FG000|Overall Study|Adverse Event|7|||
143228824|NCT00556894|516385595|FG000|Overall Study|Adverse Event|2|||
143228825|NCT00556894|516385596|FG001|Overall Study|Adverse Event|3|||
143228826|NCT00556894|516385597|FG002|Overall Study|Adverse Event|3|||
143228827|NCT00556894|516385595|FG000|Overall Study|Death|1|||
143228828|NCT00556894|516385596|FG001|Overall Study|Death|0|||
143228829|NCT00556894|516385597|FG002|Overall Study|Death|0|||
143228830|NCT00556894|516385595|FG000|Overall Study|regulatory decision in Bulgaria|10|||
143228831|NCT00556894|516385596|FG001|Overall Study|regulatory decision in Bulgaria|14|||
143228832|NCT00556894|516385597|FG002|Overall Study|regulatory decision in Bulgaria|13|||
143228833|NCT00556894|516385595|FG000|Overall Study|Change in therapy|2|||
143228834|NCT00556894|516385596|FG001|Overall Study|Change in therapy|1|||
143228835|NCT00556894|516385597|FG002|Overall Study|Change in therapy|2|||
143228836|NCT00556894|516385595|FG000|Overall Study|Withdrawal by Subject|1|||
143228837|NCT00556894|516385596|FG001|Overall Study|Withdrawal by Subject|1|||
143228838|NCT00556894|516385597|FG002|Overall Study|Withdrawal by Subject|1|||
143228839|NCT04612725|516385598|FG000|Overall Study|Adverse Event|1|||
143228840|NCT04612725|516385599|FG001|Overall Study|Adverse Event|3|||
143228841|NCT04612725|516385600|FG002|Overall Study|Adverse Event|1|||
143228842|NCT04612725|516385601|FG003|Overall Study|Adverse Event|0|||
143228843|NCT04612725|516385602|FG004|Overall Study|Adverse Event|1|||
143228844|NCT04612725|516385598|FG000|Overall Study|Lost to Follow-up|0|||
143228845|NCT04612725|516385599|FG001|Overall Study|Lost to Follow-up|1|||
143228846|NCT04612725|516385600|FG002|Overall Study|Lost to Follow-up|0|||
143228847|NCT04612725|516385601|FG003|Overall Study|Lost to Follow-up|0|||
143228848|NCT04612725|516385602|FG004|Overall Study|Lost to Follow-up|0|||
143228849|NCT04612725|516385598|FG000|Overall Study|Physician Decision|2|||
143228850|NCT04612725|516385599|FG001|Overall Study|Physician Decision|0|||
143228851|NCT04612725|516385600|FG002|Overall Study|Physician Decision|0|||
143228852|NCT04612725|516385601|FG003|Overall Study|Physician Decision|0|||
143228853|NCT04612725|516385602|FG004|Overall Study|Physician Decision|0|||
143228854|NCT04612725|516385598|FG000|Overall Study|Study terminated by sponsor|3|||
143228855|NCT04612725|516385599|FG001|Overall Study|Study terminated by sponsor|1|||
143228856|NCT04612725|516385600|FG002|Overall Study|Study terminated by sponsor|2|||
143228857|NCT04612725|516385601|FG003|Overall Study|Study terminated by sponsor|4|||
143228858|NCT04612725|516385602|FG004|Overall Study|Study terminated by sponsor|5|||
143228859|NCT04612725|516385598|FG000|Overall Study|Withdrawal by Subject|8|||
143228860|NCT04612725|516385599|FG001|Overall Study|Withdrawal by Subject|3|||
143228861|NCT04612725|516385600|FG002|Overall Study|Withdrawal by Subject|5|||
143228862|NCT04612725|516385601|FG003|Overall Study|Withdrawal by Subject|1|||
143271579|NCT02833350|516548117|FG005|Overall Study|Lack of Efficacy|1|||
143271580|NCT02833350|516548118|FG006|Overall Study|Lack of Efficacy|1|||
143271581|NCT02833350|516548112|FG000|Overall Study|Lost to Follow-up|0|||
143271582|NCT02833350|516548113|FG001|Overall Study|Lost to Follow-up|1|||
143271583|NCT02833350|516548114|FG002|Overall Study|Lost to Follow-up|0|||
143271584|NCT02833350|516548115|FG003|Overall Study|Lost to Follow-up|0|||
143271585|NCT02833350|516548116|FG004|Overall Study|Lost to Follow-up|0|||
143271586|NCT02833350|516548117|FG005|Overall Study|Lost to Follow-up|0|||
143271587|NCT02833350|516548118|FG006|Overall Study|Lost to Follow-up|1|||
143271588|NCT02833350|516548112|FG000|Overall Study|Withdrawal by Subject|3|||
143271589|NCT02833350|516548113|FG001|Overall Study|Withdrawal by Subject|3|||
143271590|NCT02833350|516548114|FG002|Overall Study|Withdrawal by Subject|2|||
143271591|NCT02833350|516548115|FG003|Overall Study|Withdrawal by Subject|0|||
143271592|NCT02833350|516548116|FG004|Overall Study|Withdrawal by Subject|2|||
143271593|NCT02833350|516548117|FG005|Overall Study|Withdrawal by Subject|0|||
143271594|NCT02833350|516548118|FG006|Overall Study|Withdrawal by Subject|2|||
143271595|NCT01500031|516548121|FG000|Overall Study|Death|1|||
143271596|NCT01500031|516548121|FG000|Overall Study|Withdrawal by Subject|4|||
143271597|NCT01147640|516548127|FG000|Overall Study|Adverse Event|2|||
143271598|NCT01147640|516548128|FG001|Overall Study|Adverse Event|0|||
143271599|NCT01147640|516548127|FG000|Overall Study|Physician Decision|1|||
143271600|NCT01147640|516548128|FG001|Overall Study|Physician Decision|0|||
143271601|NCT01147640|516548127|FG000|Overall Study|Withdrawal by Subject|1|||
143271602|NCT01147640|516548128|FG001|Overall Study|Withdrawal by Subject|0|||
143271603|NCT01147640|516548127|FG000|Overall Study|Lost to Follow-up|0|||
143271604|NCT01147640|516548128|FG001|Overall Study|Lost to Follow-up|1|||
143271605|NCT01147640|516548127|FG000|Overall Study|Didn't meet eligibility criteria|1|||
143271606|NCT01147640|516548128|FG001|Overall Study|Didn't meet eligibility criteria|0|||
143271607|NCT01856907|516548131|FG000|Overall Study|Pregnancy|0|||
143271608|NCT01856907|516548132|FG001|Overall Study|Pregnancy|1|||
143271609|NCT01856907|516548133|FG002|Overall Study|Pregnancy|0|||
143271610|NCT01856907|516548131|FG000|Overall Study|Pregnancy|0|||
143271611|NCT01856907|516548132|FG001|Overall Study|Pregnancy|1|||
143271612|NCT01856907|516548133|FG002|Overall Study|Pregnancy|0|||
143271613|NCT01856907|516548131|FG000|Overall Study|Withdrawal by Subject|0|||
143271614|NCT01856907|516548132|FG001|Overall Study|Withdrawal by Subject|1|||
143271615|NCT01856907|516548133|FG002|Overall Study|Withdrawal by Subject|0|||
143271616|NCT00091442|516548135|FG000|Overall Study|Progressive Disease|220|||
143271617|NCT00091442|516548136|FG001|Overall Study|Progressive Disease|189|||
143271618|NCT00091442|516548135|FG000|Overall Study|Physician Decision|61|||
143271619|NCT00091442|516548136|FG001|Overall Study|Physician Decision|58|||
143271620|NCT00091442|516548135|FG000|Overall Study|Withdrawal by Subject|38|||
143271621|NCT00091442|516548136|FG001|Overall Study|Withdrawal by Subject|46|||
143271622|NCT00091442|516548135|FG000|Overall Study|Adverse Event|29|||
143271623|NCT00091442|516548136|FG001|Overall Study|Adverse Event|48|||
143271624|NCT00091442|516548135|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
143271625|NCT00091442|516548136|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
143271626|NCT00091442|516548135|FG000|Overall Study|Death|9|||
143271627|NCT00091442|516548136|FG001|Overall Study|Death|7|||
143271628|NCT00091442|516548135|FG000|Overall Study|Lost to Follow-up|1|||
143271629|NCT00091442|516548136|FG001|Overall Study|Lost to Follow-up|3|||
143271630|NCT00091442|516548135|FG000|Overall Study|Other|2|||
143271631|NCT00091442|516548136|FG001|Overall Study|Other|6|||
143271632|NCT00917501|516548137|FG000|Overall Study|Lost to Follow-up|4|||
143271633|NCT00917501|516548138|FG001|Overall Study|Lost to Follow-up|1|||
143271634|NCT00917501|516548137|FG000|Overall Study|Withdrawal by Subject|3|||
143271635|NCT00917501|516548138|FG001|Overall Study|Withdrawal by Subject|1|||
143271636|NCT00917501|516548137|FG000|Overall Study|Lack of Efficacy|1|||
143271637|NCT00917501|516548138|FG001|Overall Study|Lack of Efficacy|2|||
143271638|NCT00917501|516548137|FG000|Overall Study|trouble swollowing capsules|0|||
143271639|NCT00917501|516548138|FG001|Overall Study|trouble swollowing capsules|1|||
143271640|NCT00075218|516548139|FG000|Double-Blind Treatment|Adverse Event|23|||
143271641|NCT00075218|516548140|FG001|Double-Blind Treatment|Adverse Event|4|||
143271642|NCT00075218|516548141|FG002|Double-Blind Treatment|Adverse Event|0|||
143271643|NCT00075218|516548139|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
143271644|NCT00075218|516548140|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
143271645|NCT00075218|516548141|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
143271646|NCT00075218|516548139|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
143271647|NCT00075218|516548140|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
143271648|NCT00075218|516548141|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
143271649|NCT00075218|516548139|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
143271650|NCT00075218|516548140|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
143271651|NCT00075218|516548141|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
143271652|NCT00075218|516548139|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
143271653|NCT00075218|516548140|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
143271654|NCT00075218|516548141|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
143271655|NCT00075218|516548139|FG000|Double-Blind Treatment|No study medication taken|2|||
143271656|NCT00075218|516548140|FG001|Double-Blind Treatment|No study medication taken|0|||
143271657|NCT00075218|516548141|FG002|Double-Blind Treatment|No study medication taken|0|||
143271658|NCT00075218|516548139|FG000|Open-Label Treatment|Lack of Efficacy|0|||
143271659|NCT00075218|516548140|FG001|Open-Label Treatment|Lack of Efficacy|0|||
143271660|NCT00075218|516548141|FG002|Open-Label Treatment|Lack of Efficacy|174|||
143271661|NCT00075218|516548139|FG000|Open-Label Treatment|Adverse Event|0|||
143271662|NCT00075218|516548140|FG001|Open-Label Treatment|Adverse Event|0|||
143271663|NCT00075218|516548141|FG002|Open-Label Treatment|Adverse Event|51|||
143271664|NCT00075218|516548139|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
143271665|NCT00075218|516548140|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
143271666|NCT00075218|516548141|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
143271667|NCT00075218|516548139|FG000|Open-Label Treatment|Decision of Sponsor|0|||
143271668|NCT00075218|516548140|FG001|Open-Label Treatment|Decision of Sponsor|0|||
143271669|NCT00075218|516548141|FG002|Open-Label Treatment|Decision of Sponsor|8|||
143271670|NCT00075218|516548139|FG000|Open-Label Treatment|Protocol Violation|0|||
143271671|NCT00075218|516548140|FG001|Open-Label Treatment|Protocol Violation|0|||
143271672|NCT00075218|516548141|FG002|Open-Label Treatment|Protocol Violation|1|||
143271673|NCT00075218|516548139|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
143271674|NCT00075218|516548140|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
143271675|NCT00075218|516548141|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
143271676|NCT00986830|516548142|FG000|Overall Study|Death|1|||
143271677|NCT00986830|516548142|FG000|Overall Study|Lost to Follow-up|1|||
143271678|NCT00986830|516548142|FG000|Overall Study|Lack of Efficacy|1|||
143271679|NCT00986830|516548142|FG000|Overall Study|Unable to access sinus with device|5|||
143271680|NCT00808483|516548143|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
143271681|NCT00808483|516548144|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
143271682|NCT00808483|516548143|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
143271683|NCT00808483|516548144|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
143271684|NCT00808483|516548143|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
143271685|NCT00808483|516548144|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
143271686|NCT03945214|516548145|FG000|Overall Study|Lost to Follow-up|3|||
143271687|NCT03945214|516548146|FG001|Overall Study|Lost to Follow-up|4|||
143271688|NCT03945214|516548147|FG002|Overall Study|Lost to Follow-up|7|||
143271689|NCT03945214|516548148|FG003|Overall Study|Lost to Follow-up|4|||
143271690|NCT01436396|516548151|FG000|Overall Study|Protocol Violation|7|||
143271691|NCT01436396|516548152|FG001|Overall Study|Protocol Violation|5|||
143271692|NCT01436396|516548151|FG000|Overall Study|Adverse Event|1|||
143271693|NCT01436396|516548152|FG001|Overall Study|Adverse Event|2|||
143271694|NCT01436396|516548151|FG000|Overall Study|Withdrawal by Subject|19|||
143271695|NCT01436396|516548152|FG001|Overall Study|Withdrawal by Subject|29|||
143271696|NCT01436396|516548151|FG000|Overall Study|Serious adverse event|2|||
143271697|NCT01436396|516548152|FG001|Overall Study|Serious adverse event|3|||
143271698|NCT01436396|516548151|FG000|Overall Study|Lost to Follow-up|3|||
143271699|NCT01436396|516548152|FG001|Overall Study|Lost to Follow-up|3|||
143271700|NCT02191137|516548155|FG000|Treatment|Death|4|||
143271701|NCT02191137|516548155|FG000|Treatment|Withdrawal by Subject|3|||
143271702|NCT02191137|516548155|FG000|Treatment|Adverse Event|2|||
143271703|NCT02191137|516548155|FG000|Treatment|Other|1|||
143271704|NCT02191137|516548155|FG000|Follow-up|Lost to Follow-up|2|||
143271705|NCT02191137|516548155|FG000|Follow-up|Ongoing/unknown|2|||
143271706|NCT02191137|516548155|FG000|Follow-up|Adverse Event|1|||
143271707|NCT01332331|516548156|FG000|Overall Study|Lost to Follow-up|0|||
143271708|NCT01332331|516548157|FG001|Overall Study|Lost to Follow-up|1|||
143271709|NCT01332331|516548156|FG000|Overall Study|Adverse Event|1|||
143271710|NCT01332331|516548157|FG001|Overall Study|Adverse Event|1|||
143271711|NCT01332331|516548156|FG000|Overall Study|Physician Decision|1|||
143271712|NCT01332331|516548157|FG001|Overall Study|Physician Decision|0|||
143271713|NCT00538291|516548158|FG000|Overall Study|Adverse Event|2|||
143271714|NCT00538291|516548158|FG000|Overall Study|Withdrawal by Subject|1|||
143271715|NCT00694707|516548159|FG000|Overall Study|Did Not Receive Treatment|0|||
143271716|NCT00694707|516548160|FG001|Overall Study|Did Not Receive Treatment|0|||
143271717|NCT00694707|516548161|FG002|Overall Study|Did Not Receive Treatment|1|||
143271718|NCT00694707|516548162|FG003|Overall Study|Did Not Receive Treatment|1|||
143271719|NCT00694707|516548163|FG004|Overall Study|Did Not Receive Treatment|1|||
143271720|NCT00694707|516548159|FG000|Overall Study|Adverse Event|22|||
143271721|NCT00694707|516548160|FG001|Overall Study|Adverse Event|14|||
143271722|NCT00694707|516548161|FG002|Overall Study|Adverse Event|8|||
143271723|NCT00694707|516548162|FG003|Overall Study|Adverse Event|12|||
143271724|NCT00694707|516548163|FG004|Overall Study|Adverse Event|13|||
143271725|NCT00694707|516548159|FG000|Overall Study|Insufficient Therapeutic Response|33|||
143271726|NCT00694707|516548160|FG001|Overall Study|Insufficient Therapeutic Response|18|||
143271727|NCT00694707|516548161|FG002|Overall Study|Insufficient Therapeutic Response|17|||
143271728|NCT00694707|516548162|FG003|Overall Study|Insufficient Therapeutic Response|15|||
143271729|NCT00694707|516548163|FG004|Overall Study|Insufficient Therapeutic Response|10|||
143271730|NCT00694707|516548159|FG000|Overall Study|Protocol Violation|1|||
143271731|NCT00694707|516548160|FG001|Overall Study|Protocol Violation|2|||
143271732|NCT00694707|516548161|FG002|Overall Study|Protocol Violation|1|||
143271733|NCT00694707|516548162|FG003|Overall Study|Protocol Violation|3|||
143271734|NCT00694707|516548163|FG004|Overall Study|Protocol Violation|1|||
143271735|NCT00694707|516548159|FG000|Overall Study|Withdrawal of Consent|14|||
143271736|NCT00694707|516548160|FG001|Overall Study|Withdrawal of Consent|18|||
143271737|NCT00694707|516548161|FG002|Overall Study|Withdrawal of Consent|22|||
143271738|NCT00694707|516548162|FG003|Overall Study|Withdrawal of Consent|16|||
143271739|NCT00694707|516548163|FG004|Overall Study|Withdrawal of Consent|15|||
143271740|NCT00694707|516548159|FG000|Overall Study|Lost to Follow-up|0|||
143271741|NCT00694707|516548160|FG001|Overall Study|Lost to Follow-up|1|||
143271742|NCT00694707|516548161|FG002|Overall Study|Lost to Follow-up|2|||
143271743|NCT00694707|516548162|FG003|Overall Study|Lost to Follow-up|0|||
143271744|NCT00694707|516548163|FG004|Overall Study|Lost to Follow-up|0|||
143271745|NCT00694707|516548159|FG000|Overall Study|Jeopardizing Parole Status|1|||
143271746|NCT00694707|516548160|FG001|Overall Study|Jeopardizing Parole Status|0|||
143271747|NCT00694707|516548161|FG002|Overall Study|Jeopardizing Parole Status|0|||
143271748|NCT00694707|516548162|FG003|Overall Study|Jeopardizing Parole Status|0|||
143271749|NCT00694707|516548163|FG004|Overall Study|Jeopardizing Parole Status|0|||
143271750|NCT00694707|516548159|FG000|Overall Study|Death in the Family|1|||
143271751|NCT00694707|516548160|FG001|Overall Study|Death in the Family|0|||
143271752|NCT00694707|516548161|FG002|Overall Study|Death in the Family|0|||
143271753|NCT00694707|516548162|FG003|Overall Study|Death in the Family|0|||
143271754|NCT00694707|516548163|FG004|Overall Study|Death in the Family|0|||
143271755|NCT00694707|516548159|FG000|Overall Study|Arrest by Police|0|||
143271756|NCT00694707|516548160|FG001|Overall Study|Arrest by Police|1|||
143271757|NCT00694707|516548161|FG002|Overall Study|Arrest by Police|0|||
143271758|NCT00694707|516548162|FG003|Overall Study|Arrest by Police|0|||
143271759|NCT00694707|516548163|FG004|Overall Study|Arrest by Police|0|||
143271760|NCT00694707|516548159|FG000|Overall Study|Administrative Reasons|0|||
143271761|NCT00694707|516548160|FG001|Overall Study|Administrative Reasons|1|||
143271762|NCT00694707|516548161|FG002|Overall Study|Administrative Reasons|0|||
143271763|NCT00694707|516548162|FG003|Overall Study|Administrative Reasons|2|||
143271764|NCT00694707|516548163|FG004|Overall Study|Administrative Reasons|0|||
143271765|NCT00694707|516548159|FG000|Overall Study|Notification of Past Head Injury|0|||
143271766|NCT00694707|516548160|FG001|Overall Study|Notification of Past Head Injury|0|||
143271767|NCT00694707|516548161|FG002|Overall Study|Notification of Past Head Injury|0|||
143271768|NCT00694707|516548162|FG003|Overall Study|Notification of Past Head Injury|1|||
143271769|NCT00694707|516548163|FG004|Overall Study|Notification of Past Head Injury|0|||
143271770|NCT01904058|516548170|FG000|Overall Study|Adverse Event|2|||
143271771|NCT01904058|516548171|FG001|Overall Study|Adverse Event|0|||
143271772|NCT01904058|516548172|FG002|Overall Study|Adverse Event|0|||
143271773|NCT01904058|516548173|FG003|Overall Study|Adverse Event|0|||
143271774|NCT01904058|516548170|FG000|Overall Study|Withdrawal by Subject|1|||
143271775|NCT01904058|516548171|FG001|Overall Study|Withdrawal by Subject|0|||
143271776|NCT01904058|516548172|FG002|Overall Study|Withdrawal by Subject|1|||
143271777|NCT01904058|516548173|FG003|Overall Study|Withdrawal by Subject|0|||
143271778|NCT01904058|516548170|FG000|Overall Study|Pregnancy|0|||
143271779|NCT01904058|516548171|FG001|Overall Study|Pregnancy|0|||
143271780|NCT01904058|516548172|FG002|Overall Study|Pregnancy|0|||
143271781|NCT01904058|516548173|FG003|Overall Study|Pregnancy|1|||
143271782|NCT03096483|516548177|FG000|Overall Study|Withdrawal by site|1|||
143271783|NCT02019277|516548180|FG000|Overall Study|Withdrawal by Subject|3|||
143271784|NCT02019277|516548180|FG000|Overall Study|Death|7|||
143271785|NCT02019277|516548180|FG000|Overall Study|Did no Cooperate|1|||
143271786|NCT02019277|516548180|FG000|Overall Study|Adverse Event|1|||
143271787|NCT00395733|516548182|FG000|Period 2|Withdrawal by Subject|1|||
143271788|NCT00395733|516548183|FG001|Period 2|Withdrawal by Subject|2|||
143271789|NCT00395733|516548182|FG000|Period 2|Protocol Violation|0|||
143271790|NCT00395733|516548183|FG001|Period 2|Protocol Violation|1|||
143271791|NCT00395733|516548182|FG000|Period 2|Adverse Event|0|||
143271792|NCT00395733|516548183|FG001|Period 2|Adverse Event|2|||
143271793|NCT00395733|516548182|FG000|Period 2|Technical problems|1|||
143271794|NCT00395733|516548183|FG001|Period 2|Technical problems|0|||
143271795|NCT02808650|516548186|FG000|Overall Study|Death|0|||
143271796|NCT02808650|516548187|FG001|Overall Study|Death|0|||
143271797|NCT02808650|516548188|FG002|Overall Study|Death|0|||
143271798|NCT02808650|516548189|FG003|Overall Study|Death|0|||
143271799|NCT02808650|516548190|FG004|Overall Study|Death|1|||
143271800|NCT02808650|516548186|FG000|Overall Study|Lack of Efficacy|5|||
143271801|NCT02808650|516548187|FG001|Overall Study|Lack of Efficacy|5|||
143271802|NCT02808650|516548188|FG002|Overall Study|Lack of Efficacy|6|||
143271803|NCT02808650|516548189|FG003|Overall Study|Lack of Efficacy|5|||
143271804|NCT02808650|516548190|FG004|Overall Study|Lack of Efficacy|4|||
143271805|NCT02808650|516548186|FG000|Overall Study|Physician Decision|1|||
143271806|NCT02808650|516548187|FG001|Overall Study|Physician Decision|1|||
143271807|NCT02808650|516548188|FG002|Overall Study|Physician Decision|0|||
143271808|NCT02808650|516548189|FG003|Overall Study|Physician Decision|0|||
143271809|NCT02808650|516548190|FG004|Overall Study|Physician Decision|0|||
143228863|NCT04612725|516385602|FG004|Overall Study|Withdrawal by Subject|9|||
143228864|NCT04612725|516385598|FG000|Overall Study|Other|0|||
143228865|NCT04612725|516385599|FG001|Overall Study|Other|0|||
143228866|NCT04612725|516385600|FG002|Overall Study|Other|0|||
143228867|NCT04612725|516385601|FG003|Overall Study|Other|0|||
143228868|NCT04612725|516385602|FG004|Overall Study|Other|1|||
143228869|NCT05190120|516385603|FG000|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
143228870|NCT05190120|516385604|FG001|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
143228871|NCT05190120|516385605|FG002|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
143228872|NCT05190120|516385606|FG003|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|3|||
143228873|NCT05190120|516385603|FG000|Overall Study|Lost to Follow-up|5|||
143228874|NCT05190120|516385604|FG001|Overall Study|Lost to Follow-up|0|||
143228875|NCT05190120|516385605|FG002|Overall Study|Lost to Follow-up|2|||
143228876|NCT05190120|516385606|FG003|Overall Study|Lost to Follow-up|3|||
143228877|NCT02354235|516385607|FG000|Overall Study|Adverse Event|2|||
143228878|NCT02354235|516385608|FG001|Overall Study|Adverse Event|2|||
143228879|NCT02354235|516385607|FG000|Overall Study|Physician Decision|0|||
143228880|NCT02354235|516385608|FG001|Overall Study|Physician Decision|1|||
143228881|NCT02354235|516385607|FG000|Overall Study|Withdrawal by Subject|1|||
143228882|NCT02354235|516385608|FG001|Overall Study|Withdrawal by Subject|3|||
143228883|NCT02354235|516385607|FG000|Overall Study|Conflict with the stopping criteria|0|||
143228884|NCT02354235|516385608|FG001|Overall Study|Conflict with the stopping criteria|1|||
143228885|NCT05148234|516385610|FG000|Phase I|Ineligible|0|||
143228886|NCT05148234|516385611|FG001|Phase I|Ineligible|0|||
143228887|NCT05148234|516385612|FG002|Phase I|Ineligible|0|||
143228888|NCT05148234|516385613|FG003|Phase I|Ineligible|0|||
143228889|NCT05148234|516385614|FG004|Phase I|Ineligible|0|||
143228890|NCT05148234|516385615|FG005|Phase I|Ineligible|0|||
143228891|NCT05148234|516385616|FG006|Phase I|Ineligible|0|||
143228892|NCT05148234|516385617|FG007|Phase I|Ineligible|1|||
143228893|NCT05148234|516385610|FG000|Phase I|Company closed the trial.|0|||
143228894|NCT05148234|516385611|FG001|Phase I|Company closed the trial.|1|||
143228895|NCT05148234|516385612|FG002|Phase I|Company closed the trial.|0|||
143228896|NCT05148234|516385613|FG003|Phase I|Company closed the trial.|0|||
143228897|NCT05148234|516385614|FG004|Phase I|Company closed the trial.|0|||
143228898|NCT05148234|516385615|FG005|Phase I|Company closed the trial.|0|||
143228899|NCT05148234|516385616|FG006|Phase I|Company closed the trial.|0|||
143228900|NCT05148234|516385617|FG007|Phase I|Company closed the trial.|0|||
143228901|NCT00410956|516385618|FG000|Overall Study|Adverse Event|1|||
143228902|NCT00410956|516385618|FG000|Overall Study|Death|2|||
143228903|NCT00410956|516385618|FG000|Overall Study|Lack of Efficacy|10|||
143228904|NCT00410956|516385618|FG000|Overall Study|Physician Decision|6|||
143228905|NCT01650194|516385619|FG000|Overall Study|Progressive Disease (PD)|35|||
143228906|NCT01650194|516385619|FG000|Overall Study|Withdrawal by Subject|2|||
143228907|NCT01650194|516385619|FG000|Overall Study|Miscellaneous|10|||
143228908|NCT01928927|516385620|FG000|Overall Study|Lost to Follow-up|1|||
143228909|NCT01928927|516385621|FG001|Overall Study|Lost to Follow-up|0|||
143228910|NCT01928927|516385620|FG000|Overall Study|Withdrawal by Subject|1|||
143228911|NCT01928927|516385621|FG001|Overall Study|Withdrawal by Subject|1|||
143228912|NCT00948064|516387049|FG000|Phase I|No treatment received|1|||
143228913|NCT00948064|516387050|FG001|Phase I|No treatment received|0|||
143228914|NCT00948064|516387051|FG002|Phase I|No treatment received|0|||
143228915|NCT00948064|516387049|FG000|Phase II|Physician Decision|0|||
143228916|NCT00948064|516387050|FG001|Phase II|Physician Decision|0|||
143228917|NCT00948064|516387051|FG002|Phase II|Physician Decision|1|||
143228918|NCT00948064|516387049|FG000|Phase II|Withdrawal by Subject|0|||
143228919|NCT00948064|516387050|FG001|Phase II|Withdrawal by Subject|1|||
143228920|NCT00948064|516387051|FG002|Phase II|Withdrawal by Subject|0|||
143228921|NCT03409796|516387060|FG000|Overall Study|Adverse Event|2|||
143228922|NCT03409796|516387061|FG001|Overall Study|Adverse Event|0|||
143228923|NCT03409796|516387060|FG000|Overall Study|Other|0|||
143228924|NCT03409796|516387061|FG001|Overall Study|Other|1|||
143228925|NCT01600326|516387062|FG000|Overall Study|Lost to Follow-up|1|||
143228926|NCT01600326|516387063|FG001|Overall Study|Lost to Follow-up|1|||
143228927|NCT04456504|516387064|FG000|Overall Study|Lost to Follow-up|2|||
143228928|NCT01453049|516387065|FG000|Overall Study|Protocol Violation|2|||
143228929|NCT01453049|516387066|FG001|Overall Study|Protocol Violation|5|||
143228930|NCT01453049|516387065|FG000|Overall Study|Lost to Follow-up|2|||
143228931|NCT01453049|516387066|FG001|Overall Study|Lost to Follow-up|1|||
143228932|NCT01453049|516387065|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
143228933|NCT01453049|516387066|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
143228934|NCT01453049|516387065|FG000|Overall Study|Withdrawal by Subject|1|||
143228935|NCT01453049|516387066|FG001|Overall Study|Withdrawal by Subject|0|||
143228936|NCT01453049|516387065|FG000|Overall Study|Randomized in Error|1|||
143228937|NCT01453049|516387066|FG001|Overall Study|Randomized in Error|0|||
143228938|NCT02421172|516387067|FG000|Period 1|Adverse Event|1|||
143271810|NCT02808650|516548186|FG000|Overall Study|Withdrawal by Subject|0|||
143271811|NCT02808650|516548187|FG001|Overall Study|Withdrawal by Subject|0|||
143271812|NCT02808650|516548188|FG002|Overall Study|Withdrawal by Subject|0|||
143271813|NCT02808650|516548189|FG003|Overall Study|Withdrawal by Subject|1|||
143271814|NCT02808650|516548190|FG004|Overall Study|Withdrawal by Subject|1|||
143271815|NCT04251273|516548193|FG000|Overall Study|Lost to Follow-up|331|||
143271816|NCT04251273|516548194|FG001|Overall Study|Lost to Follow-up|290|||
143271817|NCT00810693|516548195|FG000|Treatment Period|Adverse Event|8|||
143271818|NCT00810693|516548196|FG001|Treatment Period|Adverse Event|1|||
143271819|NCT00810693|516548197|FG002|Treatment Period|Adverse Event|7|||
143271820|NCT00810693|516548195|FG000|Treatment Period|Death|0|||
143271821|NCT00810693|516548196|FG001|Treatment Period|Death|1|||
143271822|NCT00810693|516548197|FG002|Treatment Period|Death|2|||
143271823|NCT00810693|516548195|FG000|Treatment Period|Lack of Efficacy|0|||
143271824|NCT00810693|516548196|FG001|Treatment Period|Lack of Efficacy|0|||
143271825|NCT00810693|516548197|FG002|Treatment Period|Lack of Efficacy|1|||
143271826|NCT00810693|516548195|FG000|Treatment Period|Lost to Follow-up|1|||
143271827|NCT00810693|516548196|FG001|Treatment Period|Lost to Follow-up|0|||
143271828|NCT00810693|516548197|FG002|Treatment Period|Lost to Follow-up|0|||
143271829|NCT00810693|516548195|FG000|Treatment Period|Non-compliance|1|||
143271830|NCT00810693|516548196|FG001|Treatment Period|Non-compliance|0|||
143271831|NCT00810693|516548197|FG002|Treatment Period|Non-compliance|0|||
143271832|NCT00810693|516548195|FG000|Treatment Period|Protocol Violation|1|||
143271833|NCT00810693|516548196|FG001|Treatment Period|Protocol Violation|2|||
143271834|NCT00810693|516548197|FG002|Treatment Period|Protocol Violation|2|||
143271835|NCT00810693|516548195|FG000|Treatment Period|Withdrawal by Subject|6|||
143271836|NCT00810693|516548196|FG001|Treatment Period|Withdrawal by Subject|2|||
143271837|NCT00810693|516548197|FG002|Treatment Period|Withdrawal by Subject|3|||
143271838|NCT00810693|516548195|FG000|Treatment Period|Not treated|0|||
143271839|NCT00810693|516548196|FG001|Treatment Period|Not treated|1|||
143271840|NCT00810693|516548197|FG002|Treatment Period|Not treated|1|||
143271841|NCT00810693|516548195|FG000|Follow-up Period (FUP)|Adverse Event|3|||
143271842|NCT00810693|516548196|FG001|Follow-up Period (FUP)|Adverse Event|1|||
143271843|NCT00810693|516548197|FG002|Follow-up Period (FUP)|Adverse Event|1|||
143271844|NCT00810693|516548195|FG000|Follow-up Period (FUP)|Death|2|||
143271845|NCT00810693|516548196|FG001|Follow-up Period (FUP)|Death|0|||
143271846|NCT00810693|516548197|FG002|Follow-up Period (FUP)|Death|1|||
143271847|NCT00810693|516548195|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
143271848|NCT00810693|516548196|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
143271849|NCT00810693|516548197|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
143271850|NCT00810693|516548195|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
143271851|NCT00810693|516548196|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
143271852|NCT00810693|516548197|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
143271853|NCT00810693|516548195|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
143271854|NCT00810693|516548196|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
143271855|NCT00810693|516548197|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
143271856|NCT01033851|516548202|FG000|Overall Study|Withdrawal by Subject|3|||
143271857|NCT01033851|516548203|FG001|Overall Study|Withdrawal by Subject|7|||
143271858|NCT00484094|516548204|FG000|Overall Study|Discontinued|39|||
143271859|NCT00484094|516548204|FG000|Overall Study|Other|3|||
143271860|NCT03553927|516548211|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
143271861|NCT03553927|516548212|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
143271862|NCT03553927|516548211|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
143271863|NCT03553927|516548212|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
143271864|NCT01868503|516549418|FG000|Overall Study|Withdrawal by Subject|1|||
143271865|NCT01868503|516549418|FG000|Overall Study|Protocol Violation|1|||
143271866|NCT02476201|516549423|FG000|Overall Study|Unable to program MPP|9|||
143271867|NCT02476201|516549423|FG000|Overall Study|Study echo not performed|5|||
143271868|NCT02476201|516549423|FG000|Overall Study|Adverse Event|4|||
143271869|NCT02476201|516549423|FG000|Overall Study|Death|2|||
143271870|NCT02476201|516549423|FG000|Overall Study|Lost to Follow-up|2|||
143271871|NCT02476201|516549423|FG000|Overall Study|MPP programmed to OFF|2|||
143271872|NCT02476201|516549423|FG000|Overall Study|Withdrawal by Subject|1|||
143271873|NCT02476201|516549423|FG000|Overall Study|Unsuccessful implant|1|||
143271874|NCT02642029|516549424|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
143271875|NCT02642029|516549425|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
143271876|NCT02642029|516549426|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
143271877|NCT02642029|516549427|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
143271878|NCT02642029|516549428|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
143271879|NCT02642029|516549429|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
143271880|NCT02642029|516549424|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
143271881|NCT02642029|516549425|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
143271882|NCT02642029|516549426|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
143271883|NCT02642029|516549427|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
143271884|NCT02642029|516549428|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
143271885|NCT02642029|516549429|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
143271886|NCT02642029|516549424|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
143271887|NCT02642029|516549425|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
143271888|NCT02642029|516549426|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
143271889|NCT02642029|516549427|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
143271890|NCT02642029|516549428|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
143271891|NCT02642029|516549429|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
143271892|NCT02642029|516549424|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
143271893|NCT02642029|516549425|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
143271894|NCT02642029|516549426|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
143271895|NCT02642029|516549427|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
143271896|NCT02642029|516549428|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
143271897|NCT02642029|516549429|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
143271898|NCT02642029|516549424|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
143271899|NCT02642029|516549425|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
143271900|NCT02642029|516549426|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
143271901|NCT02642029|516549427|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
143271902|NCT02642029|516549428|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
143271903|NCT02642029|516549429|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
143271904|NCT02642029|516549424|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
143271905|NCT02642029|516549425|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
143271906|NCT02642029|516549426|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
143271907|NCT02642029|516549427|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
143271908|NCT02642029|516549428|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
143271909|NCT02642029|516549429|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
143271910|NCT00691301|516549430|FG000|Overall Study|Adverse Event|10|||
143271911|NCT00691301|516549430|FG000|Overall Study|Death|2|||
143271912|NCT00691301|516549430|FG000|Overall Study|Lack of Efficacy|32|||
143271913|NCT00691301|516549430|FG000|Overall Study|Withdrawal by Subject|4|||
143271914|NCT00691301|516549430|FG000|Overall Study|Concurrent illness|2|||
143271915|NCT00691301|516549430|FG000|Overall Study|other reason|3|||
143271916|NCT00691301|516549430|FG000|Overall Study|Did not initiate study treatment|1|||
143271917|NCT01823146|516549431|FG000|Overall Study|Withdrawal by Subject|0|||
143271918|NCT01823146|516549432|FG001|Overall Study|Withdrawal by Subject|1|||
143271919|NCT01823146|516549431|FG000|Overall Study|Lost to Follow-up|2|||
143271920|NCT01823146|516549432|FG001|Overall Study|Lost to Follow-up|1|||
143271921|NCT00463580|516549434|FG000|Overall Study|Lost to Follow-up|1|||
143271922|NCT00463580|516549435|FG001|Overall Study|Lost to Follow-up|0|||
143271923|NCT00463580|516549434|FG000|Overall Study|Schedule conflict|2|||
143271924|NCT00463580|516549435|FG001|Overall Study|Schedule conflict|0|||
143271925|NCT00463580|516549434|FG000|Overall Study|Medical/psychiatric complications|0|||
143271926|NCT00463580|516549435|FG001|Overall Study|Medical/psychiatric complications|2|||
143271927|NCT00736944|516549436|FG000|Induction|Death|1|||
143271928|NCT00736944|516549436|FG000|Definitive Treatment|Physician Decision|1|||
143271929|NCT01426438|516549437|FG000|Overall Study|Lost to Follow-up|1|||
143271930|NCT01426438|516549438|FG001|Overall Study|Lost to Follow-up|3|||
143271931|NCT01426438|516549437|FG000|Overall Study|Off study Treatment|9|||
143271932|NCT01426438|516549438|FG001|Overall Study|Off study Treatment|3|||
143271933|NCT01426438|516549437|FG000|Overall Study|Poor scan quality|3|||
143271934|NCT01426438|516549438|FG001|Overall Study|Poor scan quality|2|||
143271935|NCT01426438|516549437|FG000|Overall Study|Missed Scan|2|||
143271936|NCT01426438|516549438|FG001|Overall Study|Missed Scan|2|||
143271937|NCT01797731|516549439|FG000|Overall Study|Didn't have proper radiographs required|3|||
143271938|NCT01797731|516549440|FG001|Overall Study|Didn't have proper radiographs required|3|||
143271939|NCT01604408|516549441|FG000|Treatment Period 1|Protocol Violation|0|||
143271940|NCT01604408|516549442|FG001|Treatment Period 1|Protocol Violation|1|||
143271941|NCT01604408|516549441|FG000|Treatment Period 2|Withdrawal by Subject|1|||
143271942|NCT01604408|516549442|FG001|Treatment Period 2|Withdrawal by Subject|1|||
143271943|NCT01604408|516549441|FG000|Treatment Period 2|Protocol Violation|1|||
143271944|NCT01604408|516549442|FG001|Treatment Period 2|Protocol Violation|0|||
143271945|NCT01604408|516549441|FG000|Treatment Period 2|Adverse Event|0|||
143271946|NCT01604408|516549442|FG001|Treatment Period 2|Adverse Event|1|||
143271947|NCT01604408|516549441|FG000|Treatment Period 3|Protocol Violation|1|||
143271948|NCT01604408|516549442|FG001|Treatment Period 3|Protocol Violation|1|||
143271949|NCT01604408|516549441|FG000|Treatment Period 3|Adverse Event|0|||
143271950|NCT01604408|516549442|FG001|Treatment Period 3|Adverse Event|3|||
143271951|NCT01604408|516549441|FG000|Treatment Period 3|Withdrawal by Subject|3|||
143271952|NCT01604408|516549442|FG001|Treatment Period 3|Withdrawal by Subject|1|||
143271953|NCT01604408|516549441|FG000|Treatment Period 3|Sponsor Decision|1|||
143271954|NCT01604408|516549442|FG001|Treatment Period 3|Sponsor Decision|0|||
143271955|NCT01604408|516549441|FG000|Treatment Period 4|Death|1|||
143271956|NCT01604408|516549442|FG001|Treatment Period 4|Death|0|||
143271957|NCT01604408|516549441|FG000|Treatment Period 4|Withdrawal by Subject|2|||
143228939|NCT02421172|516387068|FG001|Period 1|Adverse Event|0|||
143228940|NCT02421172|516387069|FG002|Period 1|Adverse Event|0|||
143228941|NCT02421172|516387070|FG003|Period 1|Adverse Event|0|||
143228942|NCT02421172|516387071|FG004|Period 1|Adverse Event|0|||
143228943|NCT02421172|516387067|FG000|Period 1|Lost to Follow-up|3|||
143228944|NCT02421172|516387068|FG001|Period 1|Lost to Follow-up|1|||
143228945|NCT02421172|516387069|FG002|Period 1|Lost to Follow-up|0|||
143228946|NCT02421172|516387070|FG003|Period 1|Lost to Follow-up|0|||
143228947|NCT02421172|516387071|FG004|Period 1|Lost to Follow-up|0|||
143228948|NCT02421172|516387067|FG000|Period 1|Patient/guardian decision|0|||
143228949|NCT02421172|516387068|FG001|Period 1|Patient/guardian decision|1|||
143228950|NCT02421172|516387069|FG002|Period 1|Patient/guardian decision|0|||
143228951|NCT02421172|516387070|FG003|Period 1|Patient/guardian decision|0|||
143228952|NCT02421172|516387071|FG004|Period 1|Patient/guardian decision|0|||
143228953|NCT02421172|516387067|FG000|Period 2|Adverse Event|0|||
143228954|NCT02421172|516387068|FG001|Period 2|Adverse Event|0|||
143228955|NCT02421172|516387069|FG002|Period 2|Adverse Event|4|||
143228956|NCT02421172|516387070|FG003|Period 2|Adverse Event|0|||
143228957|NCT02421172|516387071|FG004|Period 2|Adverse Event|0|||
143228958|NCT02421172|516387067|FG000|Period 2|Lost to Follow-up|0|||
143228959|NCT02421172|516387068|FG001|Period 2|Lost to Follow-up|0|||
143228960|NCT02421172|516387069|FG002|Period 2|Lost to Follow-up|0|||
143228961|NCT02421172|516387070|FG003|Period 2|Lost to Follow-up|1|||
143228962|NCT02421172|516387071|FG004|Period 2|Lost to Follow-up|0|||
143228963|NCT02421172|516387067|FG000|Period 2|Patient/guardian decision|0|||
143228964|NCT02421172|516387068|FG001|Period 2|Patient/guardian decision|0|||
143228965|NCT02421172|516387069|FG002|Period 2|Patient/guardian decision|3|||
143228966|NCT02421172|516387070|FG003|Period 2|Patient/guardian decision|2|||
143228967|NCT02421172|516387071|FG004|Period 2|Patient/guardian decision|1|||
143228968|NCT00928486|516387072|FG000|Overall Study|Adverse Event|2|||
143228969|NCT00928486|516387072|FG000|Overall Study|Disease Progression|7|||
143228970|NCT00928486|516387072|FG000|Overall Study|Withdrawal by Subject|1|||
143228971|NCT00768989|516387075|FG000|Prior to Week 24|Withdrawal by Subject|1|||
143228972|NCT00768989|516387076|FG001|Prior to Week 24|Withdrawal by Subject|0|||
143228973|NCT00768989|516387075|FG000|Prior to Week 24|Adverse Event|3|||
143228974|NCT00768989|516387076|FG001|Prior to Week 24|Adverse Event|0|||
143228975|NCT00768989|516387075|FG000|Prior to Week 24|Lost to Follow-up|0|||
143228976|NCT00768989|516387076|FG001|Prior to Week 24|Lost to Follow-up|1|||
143228977|NCT00768989|516387075|FG000|Prior to Week 24|Protocol Violation|0|||
143228978|NCT00768989|516387076|FG001|Prior to Week 24|Protocol Violation|2|||
143228979|NCT00768989|516387075|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
143228980|NCT00768989|516387076|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
143228981|NCT00768989|516387075|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
143228982|NCT00768989|516387076|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
143228983|NCT00768989|516387075|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
143228984|NCT00768989|516387076|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
143228985|NCT00768989|516387075|FG000|On or After Week 36|Lack of Efficacy|1|||
143228986|NCT00768989|516387076|FG001|On or After Week 36|Lack of Efficacy|0|||
143228987|NCT00768989|516387075|FG000|On or After Week 36|Adverse Event|0|||
143228988|NCT00768989|516387076|FG001|On or After Week 36|Adverse Event|1|||
143228989|NCT00768989|516387075|FG000|On or After Week 36|Lost to Follow-up|1|||
143228990|NCT00768989|516387076|FG001|On or After Week 36|Lost to Follow-up|0|||
143228991|NCT00768989|516387075|FG000|On or After Week 36|Poor Compliance|1|||
143228992|NCT00768989|516387076|FG001|On or After Week 36|Poor Compliance|0|||
143228993|NCT00768989|516387075|FG000|On or After Week 36|Protocol Violation|1|||
143228994|NCT00768989|516387076|FG001|On or After Week 36|Protocol Violation|0|||
143228995|NCT00768989|516387075|FG000|On or After Week 36|Did not attend termination visit|2|||
143228996|NCT00768989|516387076|FG001|On or After Week 36|Did not attend termination visit|0|||
143228997|NCT00768989|516387075|FG000|On or After Week 36|Sponsor Termination|45|||
143228998|NCT00768989|516387076|FG001|On or After Week 36|Sponsor Termination|26|||
143228999|NCT00117637|516387080|FG000|First Intervention (Period 1)|Adverse Event|11|||
143229000|NCT00117637|516387081|FG001|First Intervention (Period 1)|Adverse Event|16|||
143229001|NCT00117637|516387080|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
143229002|NCT00117637|516387081|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
143229003|NCT00117637|516387080|FG000|First Intervention (Period 1)|Protocol Violation|1|||
143229004|NCT00117637|516387081|FG001|First Intervention (Period 1)|Protocol Violation|0|||
143229005|NCT00117637|516387080|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
143229006|NCT00117637|516387081|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
143229007|NCT00117637|516387080|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
143229008|NCT00117637|516387081|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
143271958|NCT01604408|516549442|FG001|Treatment Period 4|Withdrawal by Subject|1|||
143271959|NCT01604408|516549441|FG000|Treatment Period 4|Adverse Event|0|||
143271960|NCT01604408|516549442|FG001|Treatment Period 4|Adverse Event|1|||
143271961|NCT01604408|516549441|FG000|Treatment Period 5|Adverse Event|4|||
143271962|NCT01604408|516549442|FG001|Treatment Period 5|Adverse Event|0|||
143271963|NCT01604408|516549441|FG000|Treatment Period 6|Lost to Follow-up|0|||
143271964|NCT01604408|516549442|FG001|Treatment Period 6|Lost to Follow-up|1|||
143271965|NCT01604408|516549441|FG000|Treatment Period 6|Adverse Event|2|||
143271966|NCT01604408|516549442|FG001|Treatment Period 6|Adverse Event|0|||
143271967|NCT01604408|516549441|FG000|Treatment Period 6|Sponsor decision|0|||
143271968|NCT01604408|516549442|FG001|Treatment Period 6|Sponsor decision|1|||
143271969|NCT01604408|516549441|FG000|Observation Period|Adverse Event|1|||
143271970|NCT01604408|516549442|FG001|Observation Period|Adverse Event|1|||
143271971|NCT01604408|516549441|FG000|Observation Period|Withdrawal by Subject|0|||
143271972|NCT01604408|516549442|FG001|Observation Period|Withdrawal by Subject|2|||
143271973|NCT03643575|516549445|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
143271974|NCT03643575|516549446|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
143271975|NCT03643575|516549447|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
143271976|NCT03643575|516549448|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
143271977|NCT03643575|516549449|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
143271978|NCT03643575|516549450|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
143271979|NCT03643575|516549445|FG000|Washout: 7 Days|Adverse Event|1|||
143271980|NCT03643575|516549446|FG001|Washout: 7 Days|Adverse Event|0|||
143271981|NCT03643575|516549447|FG002|Washout: 7 Days|Adverse Event|0|||
143271982|NCT03643575|516549448|FG003|Washout: 7 Days|Adverse Event|0|||
143271983|NCT03643575|516549449|FG004|Washout: 7 Days|Adverse Event|0|||
143271984|NCT03643575|516549450|FG005|Washout: 7 Days|Adverse Event|0|||
143271985|NCT03643575|516549445|FG000|Washout: 7 Days|Non compliance check in|0|||
143271986|NCT03643575|516549446|FG001|Washout: 7 Days|Non compliance check in|1|||
143271987|NCT03643575|516549447|FG002|Washout: 7 Days|Non compliance check in|0|||
143271988|NCT03643575|516549448|FG003|Washout: 7 Days|Non compliance check in|0|||
143271989|NCT03643575|516549449|FG004|Washout: 7 Days|Non compliance check in|0|||
143271990|NCT03643575|516549450|FG005|Washout: 7 Days|Non compliance check in|0|||
143271991|NCT00131508|516549451|FG000|Overall Study|Disease progression|0|||
143271992|NCT00131508|516549452|FG001|Overall Study|Disease progression|2|||
143271993|NCT00131508|516549451|FG000|Overall Study|Non-Compliance|2|||
143271994|NCT00131508|516549452|FG001|Overall Study|Non-Compliance|4|||
143271995|NCT00131508|516549451|FG000|Overall Study|Withdrawal by Subject|1|||
143271996|NCT00131508|516549452|FG001|Overall Study|Withdrawal by Subject|2|||
143271997|NCT01189604|516549453|FG000|Overall Study|Impossible to visit|0|||
143271998|NCT01189604|516549454|FG001|Overall Study|Impossible to visit|0|||
143271999|NCT01189604|516549455|FG002|Overall Study|Impossible to visit|0|||
143272000|NCT01189604|516549456|FG003|Overall Study|Impossible to visit|0|||
143272001|NCT01189604|516549457|FG004|Overall Study|Impossible to visit|0|||
143272002|NCT01189604|516549458|FG005|Overall Study|Impossible to visit|1|||
143272003|NCT01189604|516549459|FG006|Overall Study|Impossible to visit|0|||
143272004|NCT01189604|516549453|FG000|Overall Study|Adverse Event|0|||
143272005|NCT01189604|516549454|FG001|Overall Study|Adverse Event|1|||
143272006|NCT01189604|516549455|FG002|Overall Study|Adverse Event|0|||
143272007|NCT01189604|516549456|FG003|Overall Study|Adverse Event|0|||
143272008|NCT01189604|516549457|FG004|Overall Study|Adverse Event|2|||
143272009|NCT01189604|516549458|FG005|Overall Study|Adverse Event|0|||
143272010|NCT01189604|516549459|FG006|Overall Study|Adverse Event|1|||
143272011|NCT01189604|516549453|FG000|Overall Study|Withdrawal by Subject|1|||
143272012|NCT01189604|516549454|FG001|Overall Study|Withdrawal by Subject|0|||
143272013|NCT01189604|516549455|FG002|Overall Study|Withdrawal by Subject|0|||
143272014|NCT01189604|516549456|FG003|Overall Study|Withdrawal by Subject|0|||
143272015|NCT01189604|516549457|FG004|Overall Study|Withdrawal by Subject|0|||
143272016|NCT01189604|516549458|FG005|Overall Study|Withdrawal by Subject|0|||
143272017|NCT01189604|516549459|FG006|Overall Study|Withdrawal by Subject|0|||
143272018|NCT03626168|516549460|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
143272019|NCT03626168|516549461|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
143272020|NCT03626168|516549460|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
143272021|NCT03626168|516549461|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
143272022|NCT03626168|516549460|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
143272023|NCT03626168|516549461|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
143272024|NCT02357979|516549462|FG000|Overall Study|Lost to Follow-up|5|||
143272025|NCT02357979|516549463|FG001|Overall Study|Lost to Follow-up|5|||
143272026|NCT04810481|516549468|FG000|Overall Study|Disqualified data sets|10|||
143272027|NCT04810481|516549469|FG001|Overall Study|Disqualified data sets|28|||
143272028|NCT02046733|516549471|FG000|Overall Study|never initiated 'treatment visits'|6|||
143272029|NCT02046733|516549472|FG001|Overall Study|never initiated 'treatment visits'|0|||
143272030|NCT02905149|516549476|FG000|Overall Study|Lost to Follow-up|2|||
143272031|NCT02905149|516549477|FG001|Overall Study|Lost to Follow-up|0|||
143272032|NCT01268150|516549478|FG000|Treatment Phase|Progression of disease|18|||
143272033|NCT01268150|516549478|FG000|Treatment Phase|Adverse Event|3|||
143272034|NCT01268150|516549478|FG000|Treatment Phase|Withdrawal by Subject|3|||
143272035|NCT01268150|516549478|FG000|Treatment Phase|Other|4|||
143272036|NCT01268150|516549478|FG000|Extension Phase|Adverse Event|3|||
143272037|NCT01268150|516549478|FG000|Extension Phase|Disease progression|18|||
143272038|NCT01268150|516549478|FG000|Extension Phase|Other|6|||
143272039|NCT04738734|516549480|FG000|Overall Study|Withdrawal by Subject|2|||
143272040|NCT04738734|516549481|FG001|Overall Study|Withdrawal by Subject|4|||
143272041|NCT04738734|516549480|FG000|Overall Study|Lost to Follow-up|5|||
143272042|NCT04738734|516549481|FG001|Overall Study|Lost to Follow-up|2|||
143272043|NCT04738734|516549480|FG000|Overall Study|Physician Decision|0|||
143272044|NCT04738734|516549481|FG001|Overall Study|Physician Decision|1|||
143272045|NCT04738734|516549480|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
143272046|NCT04738734|516549481|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
143272047|NCT01672736|516549485|FG000|Overall Study|Available drug expired on 31 May 16|3|||
143272048|NCT02853344|516549486|FG000|Overall Study|Lost to Follow-up|1|||
143272049|NCT02853344|516549487|FG001|Overall Study|Lost to Follow-up|1|||
143272050|NCT02853344|516549486|FG000|Overall Study|Withdrawal by Subject|2|||
143272051|NCT02853344|516549487|FG001|Overall Study|Withdrawal by Subject|4|||
143272052|NCT02853344|516549486|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
143272053|NCT02853344|516549487|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
143272054|NCT02853344|516549486|FG000|Overall Study|Death|70|||
143272055|NCT02853344|516549487|FG001|Overall Study|Death|112|||
143272056|NCT02282358|516549490|FG000|Overall Study|Nonevaluable|1|||
143272057|NCT01163266|516549491|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
143272058|NCT01163266|516549492|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
143272059|NCT01163266|516549493|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
143272060|NCT01163266|516549491|FG000|Overall Study|Lack of Efficacy|1|||
143272061|NCT01163266|516549492|FG001|Overall Study|Lack of Efficacy|3|||
143272062|NCT01163266|516549493|FG002|Overall Study|Lack of Efficacy|1|||
143272063|NCT01163266|516549491|FG000|Overall Study|Noncompliance with Study Drug|0|||
143272064|NCT01163266|516549492|FG001|Overall Study|Noncompliance with Study Drug|2|||
143272065|NCT01163266|516549493|FG002|Overall Study|Noncompliance with Study Drug|0|||
143272066|NCT01163266|516549491|FG000|Overall Study|Protocol Deviations|2|||
143272067|NCT01163266|516549492|FG001|Overall Study|Protocol Deviations|2|||
143272068|NCT01163266|516549493|FG002|Overall Study|Protocol Deviations|5|||
143272069|NCT01163266|516549491|FG000|Overall Study|Withdrawal of Consent|5|||
143272070|NCT01163266|516549492|FG001|Overall Study|Withdrawal of Consent|7|||
143272071|NCT01163266|516549493|FG002|Overall Study|Withdrawal of Consent|3|||
143272072|NCT01163266|516549491|FG000|Overall Study|Lost to Follow-up|7|||
143272073|NCT01163266|516549492|FG001|Overall Study|Lost to Follow-up|7|||
143272074|NCT01163266|516549493|FG002|Overall Study|Lost to Follow-up|10|||
143272075|NCT01163266|516549491|FG000|Overall Study|Other|1|||
143272076|NCT01163266|516549492|FG001|Overall Study|Other|1|||
143272077|NCT01163266|516549493|FG002|Overall Study|Other|2|||
143272078|NCT02586064|516549494|FG000|Overall Study|Other Obligations|6|||
143272079|NCT02586064|516549495|FG001|Overall Study|Other Obligations|6|||
143272080|NCT02586064|516549494|FG000|Overall Study|Other|3|||
143272081|NCT02586064|516549495|FG001|Overall Study|Other|7|||
143272082|NCT02586064|516549494|FG000|Overall Study|Never Started|3|||
143272083|NCT02586064|516549495|FG001|Overall Study|Never Started|3|||
143272084|NCT02586064|516549494|FG000|Overall Study|Lost Interest|1|||
143272085|NCT02586064|516549495|FG001|Overall Study|Lost Interest|4|||
143272086|NCT02586064|516549494|FG000|Overall Study|Miscellaneous Life Issues|0|||
143272087|NCT02586064|516549495|FG001|Overall Study|Miscellaneous Life Issues|5|||
143272088|NCT02586064|516549494|FG000|Overall Study|Infrequent Attendance|2|||
143272089|NCT02586064|516549495|FG001|Overall Study|Infrequent Attendance|1|||
143272090|NCT02586064|516549494|FG000|Overall Study|Timed Out|2|||
143272091|NCT02586064|516549495|FG001|Overall Study|Timed Out|0|||
143272092|NCT02586064|516549494|FG000|Overall Study|AUD relapse|0|||
143272093|NCT02586064|516549495|FG001|Overall Study|AUD relapse|2|||
143272094|NCT02586064|516549494|FG000|Overall Study|Legal Issue|1|||
143272095|NCT02586064|516549495|FG001|Overall Study|Legal Issue|0|||
143272096|NCT02919696|516549496|FG000|Overall Study|Adverse Event|1|||
143272097|NCT02919696|516549497|FG001|Overall Study|Adverse Event|2|||
143272098|NCT02919696|516549496|FG000|Overall Study|Withdrawal by Subject|2|||
143272099|NCT02919696|516549497|FG001|Overall Study|Withdrawal by Subject|1|||
143272100|NCT02919696|516549496|FG000|Overall Study|Sponsor Decision|1|||
143272101|NCT02919696|516549497|FG001|Overall Study|Sponsor Decision|1|||
143272102|NCT02919696|516549496|FG000|Overall Study|Never Treated|0|||
143272103|NCT02919696|516549497|FG001|Overall Study|Never Treated|1|||
143272104|NCT02158975|516549498|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
143272105|NCT01346969|516549501|FG000|Overall Study|Withdrawal by Subject|0|||
143272106|NCT01346969|516549502|FG001|Overall Study|Withdrawal by Subject|0|||
143272107|NCT01346969|516549503|FG002|Overall Study|Withdrawal by Subject|1|||
143272108|NCT01346969|516549504|FG003|Overall Study|Withdrawal by Subject|0|||
143272109|NCT01346969|516549501|FG000|Overall Study|Lost to Follow-up|1|||
143272110|NCT01346969|516549502|FG001|Overall Study|Lost to Follow-up|0|||
143272111|NCT01346969|516549503|FG002|Overall Study|Lost to Follow-up|2|||
143272112|NCT01346969|516549504|FG003|Overall Study|Lost to Follow-up|0|||
143272113|NCT01346969|516549501|FG000|Overall Study|Physician Decision|0|||
143272114|NCT01346969|516549502|FG001|Overall Study|Physician Decision|0|||
143272115|NCT01346969|516549503|FG002|Overall Study|Physician Decision|0|||
143272116|NCT01346969|516549504|FG003|Overall Study|Physician Decision|1|||
143272117|NCT01346969|516549501|FG000|Overall Study|Randomized but not treated|1|||
143272118|NCT01346969|516549502|FG001|Overall Study|Randomized but not treated|0|||
143272119|NCT01346969|516549503|FG002|Overall Study|Randomized but not treated|0|||
143272120|NCT01346969|516549504|FG003|Overall Study|Randomized but not treated|0|||
143272121|NCT04815031|516549505|FG000|Overall Study|No adverse event information (missing information)|33|||
143272122|NCT00397215|516549508|FG000|Month 0 (Day 0)|Adverse Event|0|||
143272123|NCT00397215|516549509|FG001|Month 0 (Day 0)|Adverse Event|1|||
143272124|NCT00397215|516549510|FG002|Month 0 (Day 0)|Adverse Event|0|||
143272125|NCT00397215|516549511|FG003|Month 0 (Day 0)|Adverse Event|0|||
143272126|NCT00397215|516549508|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
143272127|NCT00397215|516549509|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
143272128|NCT00397215|516549510|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
143272129|NCT00397215|516549511|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
143272130|NCT00397215|516549508|FG000|Month 0 (Day 0)|Other|4|||
143272131|NCT00397215|516549509|FG001|Month 0 (Day 0)|Other|1|||
143272132|NCT00397215|516549510|FG002|Month 0 (Day 0)|Other|3|||
143272133|NCT00397215|516549511|FG003|Month 0 (Day 0)|Other|3|||
143272134|NCT00397215|516549508|FG000|Month 6 (Day 180)|Adverse Event|0|||
143272135|NCT00397215|516549509|FG001|Month 6 (Day 180)|Adverse Event|3|||
143272136|NCT00397215|516549510|FG002|Month 6 (Day 180)|Adverse Event|2|||
143272137|NCT00397215|516549511|FG003|Month 6 (Day 180)|Adverse Event|0|||
143272138|NCT00397215|516549508|FG000|Month 6 (Day 180)|Other|2|||
143272139|NCT00397215|516549509|FG001|Month 6 (Day 180)|Other|0|||
143272140|NCT00397215|516549510|FG002|Month 6 (Day 180)|Other|3|||
143272141|NCT00397215|516549511|FG003|Month 6 (Day 180)|Other|0|||
143272142|NCT02128932|516549512|FG000|Overall Study|Withdrawal by Subject|11|||
143272143|NCT02128932|516549513|FG001|Overall Study|Withdrawal by Subject|7|||
143272144|NCT02128932|516549514|FG002|Overall Study|Withdrawal by Subject|8|||
143272145|NCT02128932|516549512|FG000|Overall Study|Death|2|||
143272146|NCT02128932|516549513|FG001|Overall Study|Death|0|||
143272147|NCT02128932|516549514|FG002|Overall Study|Death|2|||
143272148|NCT02128932|516549512|FG000|Overall Study|Lost to Follow-up|2|||
143272149|NCT02128932|516549513|FG001|Overall Study|Lost to Follow-up|1|||
143272150|NCT02128932|516549514|FG002|Overall Study|Lost to Follow-up|1|||
143272151|NCT02128932|516549512|FG000|Overall Study|No reason for withdrawal|12|||
143272152|NCT02128932|516549513|FG001|Overall Study|No reason for withdrawal|11|||
143272153|NCT02128932|516549514|FG002|Overall Study|No reason for withdrawal|7|||
143272154|NCT01361568|516549519|FG000|Overall Study|Adverse Event|0|||
143272155|NCT01361568|516549520|FG001|Overall Study|Adverse Event|0|||
143272156|NCT01361568|516549521|FG002|Overall Study|Adverse Event|0|||
143272157|NCT01361568|516549522|FG003|Overall Study|Adverse Event|0|||
143272158|NCT01361568|516549523|FG004|Overall Study|Adverse Event|1|||
143272159|NCT01361568|516549524|FG005|Overall Study|Adverse Event|0|||
143272160|NCT01361568|516549519|FG000|Overall Study|Physician Decision|0|||
143272161|NCT01361568|516549520|FG001|Overall Study|Physician Decision|0|||
143372667|NCT01713946|516909632|FG002|Overall Study|Lost to Follow-up|1|||
143272162|NCT01361568|516549521|FG002|Overall Study|Physician Decision|0|||
143272163|NCT01361568|516549522|FG003|Overall Study|Physician Decision|0|||
143372668|NCT01713946|516909630|FG000|Overall Study|Administrative problems|1|||
143272164|NCT01361568|516549523|FG004|Overall Study|Physician Decision|0|||
143272165|NCT01361568|516549524|FG005|Overall Study|Physician Decision|1|||
143372669|NCT01713946|516909631|FG001|Overall Study|Administrative problems|0|||
143272166|NCT01361568|516549519|FG000|Overall Study|Withdrawal by Subject|2|||
143272167|NCT01361568|516549520|FG001|Overall Study|Withdrawal by Subject|1|||
143272168|NCT01361568|516549521|FG002|Overall Study|Withdrawal by Subject|0|||
143272169|NCT01361568|516549522|FG003|Overall Study|Withdrawal by Subject|0|||
143272170|NCT01361568|516549523|FG004|Overall Study|Withdrawal by Subject|0|||
143272171|NCT01361568|516549524|FG005|Overall Study|Withdrawal by Subject|1|||
143272172|NCT02959983|516549525|FG000|Overall Study|Protocol Violation|0|||
143272173|NCT02959983|516549526|FG001|Overall Study|Protocol Violation|1|||
143272174|NCT02959983|516549525|FG000|Overall Study|Lack of Efficacy|0|||
143272175|NCT02959983|516549526|FG001|Overall Study|Lack of Efficacy|1|||
143272176|NCT02959983|516549525|FG000|Overall Study|Lost to Follow-up|12|||
143272177|NCT02959983|516549526|FG001|Overall Study|Lost to Follow-up|9|||
143272178|NCT02959983|516549525|FG000|Overall Study|Other|1|||
143272179|NCT02959983|516549526|FG001|Overall Study|Other|1|||
143272180|NCT02959983|516549525|FG000|Overall Study|Physician Decision|1|||
143272181|NCT02959983|516549526|FG001|Overall Study|Physician Decision|0|||
143272182|NCT02959983|516549525|FG000|Overall Study|Adverse Event|5|||
143272183|NCT02959983|516549526|FG001|Overall Study|Adverse Event|1|||
143272184|NCT02959983|516549525|FG000|Overall Study|Withdrawal by Subject|7|||
143272185|NCT02959983|516549526|FG001|Overall Study|Withdrawal by Subject|12|||
143272186|NCT01254630|516549527|FG000|Overall Study|Adverse Event|36|||
143272187|NCT01254630|516549528|FG001|Overall Study|Adverse Event|15|||
143272188|NCT01254630|516549529|FG002|Overall Study|Adverse Event|40|||
143272189|NCT01254630|516549530|FG003|Overall Study|Adverse Event|8|||
143272190|NCT01254630|516549527|FG000|Overall Study|Death|461|||
143272191|NCT01254630|516549528|FG001|Overall Study|Death|151|||
143272192|NCT01254630|516549529|FG002|Overall Study|Death|478|||
143272193|NCT01254630|516549530|FG003|Overall Study|Death|139|||
143272194|NCT01254630|516549527|FG000|Overall Study|Lost to Follow-up|80|||
143272195|NCT01254630|516549528|FG001|Overall Study|Lost to Follow-up|26|||
143272196|NCT01254630|516549529|FG002|Overall Study|Lost to Follow-up|89|||
143272197|NCT01254630|516549530|FG003|Overall Study|Lost to Follow-up|32|||
143272198|NCT01254630|516549527|FG000|Overall Study|Physician Decision|24|||
143272199|NCT01254630|516549528|FG001|Overall Study|Physician Decision|8|||
143272200|NCT01254630|516549529|FG002|Overall Study|Physician Decision|16|||
143272201|NCT01254630|516549530|FG003|Overall Study|Physician Decision|7|||
143272202|NCT01254630|516549527|FG000|Overall Study|Withdrawal by Subject|201|||
143272203|NCT01254630|516549528|FG001|Overall Study|Withdrawal by Subject|94|||
143272204|NCT01254630|516549529|FG002|Overall Study|Withdrawal by Subject|188|||
143272205|NCT01254630|516549530|FG003|Overall Study|Withdrawal by Subject|89|||
143272206|NCT01254630|516549527|FG000|Overall Study|Study terminated by sponsor|0|||
143272207|NCT01254630|516549528|FG001|Overall Study|Study terminated by sponsor|994|||
143272208|NCT01254630|516549529|FG002|Overall Study|Study terminated by sponsor|0|||
143272209|NCT01254630|516549530|FG003|Overall Study|Study terminated by sponsor|1010|||
143272210|NCT01254630|516549527|FG000|Overall Study|Status not recorded|0|||
143272211|NCT01254630|516549528|FG001|Overall Study|Status not recorded|0|||
143272212|NCT01254630|516549529|FG002|Overall Study|Status not recorded|1|||
143272213|NCT01254630|516549530|FG003|Overall Study|Status not recorded|0|||
143272214|NCT02020577|516549531|FG000|Overall Study|Progressive disease|3|||
143272215|NCT02020577|516549532|FG001|Overall Study|Progressive disease|38|||
143272216|NCT02020577|516549531|FG000|Overall Study|Other AE or clinical progression|0|||
143272217|NCT02020577|516549532|FG001|Overall Study|Other AE or clinical progression|15|||
143272218|NCT02020577|516549531|FG000|Overall Study|Withdrawal by Subject|0|||
143272219|NCT02020577|516549532|FG001|Overall Study|Withdrawal by Subject|1|||
143272220|NCT02020577|516549531|FG000|Overall Study|Other than stated above|0|||
143272221|NCT02020577|516549532|FG001|Overall Study|Other than stated above|1|||
143272222|NCT02728596|516549533|FG000|Overall Study|Refusal unrelated to adverse event|3|||
143272223|NCT02728596|516549534|FG001|Overall Study|Refusal unrelated to adverse event|6|||
143272224|NCT02728596|516549535|FG002|Overall Study|Refusal unrelated to adverse event|7|||
143272225|NCT02728596|516549536|FG003|Overall Study|Refusal unrelated to adverse event|7|||
143272226|NCT02728596|516549533|FG000|Overall Study|Death|44|||
143272227|NCT02728596|516549534|FG001|Overall Study|Death|42|||
143272228|NCT02728596|516549535|FG002|Overall Study|Death|123|||
143272229|NCT02728596|516549536|FG003|Overall Study|Death|68|||
143272230|NCT03439657|516549537|FG000|Overall Study|Adverse Event|2|||
143272231|NCT03439657|516549538|FG001|Overall Study|Adverse Event|3|||
143272232|NCT03439657|516549537|FG000|Overall Study|Lost to Follow-up|1|||
143272233|NCT03439657|516549538|FG001|Overall Study|Lost to Follow-up|0|||
143272234|NCT03439657|516549537|FG000|Overall Study|Protocol Violation|1|||
143272235|NCT03439657|516549538|FG001|Overall Study|Protocol Violation|1|||
143272236|NCT03439657|516549537|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
143272237|NCT03439657|516549538|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
143272238|NCT02663908|516549539|FG000|Overall Study|Withdrawal by Subject|8|||
143272239|NCT02663908|516549540|FG001|Overall Study|Withdrawal by Subject|5|||
143272240|NCT02663908|516549539|FG000|Overall Study|Lost to Follow-up|1|||
143272241|NCT02663908|516549540|FG001|Overall Study|Lost to Follow-up|5|||
143272242|NCT02663908|516549539|FG000|Overall Study|Adverse Event|13|||
143272243|NCT02663908|516549540|FG001|Overall Study|Adverse Event|11|||
143272244|NCT02663908|516549539|FG000|Overall Study|Protocol Violation|1|||
143272245|NCT02663908|516549540|FG001|Overall Study|Protocol Violation|2|||
143272246|NCT02663908|516549539|FG000|Overall Study|Lack of therapeutic response|2|||
143272247|NCT02663908|516549540|FG001|Overall Study|Lack of therapeutic response|0|||
143272248|NCT02663908|516549539|FG000|Overall Study|COVID-19|1|||
143272249|NCT02663908|516549540|FG001|Overall Study|COVID-19|0|||
143272250|NCT02663908|516549539|FG000|Overall Study|Site closed|1|||
143272251|NCT02663908|516549540|FG001|Overall Study|Site closed|0|||
143272252|NCT02663908|516549539|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
143272253|NCT02663908|516549540|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
143272254|NCT02663908|516549539|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
143272255|NCT02663908|516549540|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
143272256|NCT02663908|516549539|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
143272257|NCT02663908|516549540|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
143272258|NCT02663908|516549539|FG000|Overall Study|Death|1|||
143272259|NCT02663908|516549540|FG001|Overall Study|Death|0|||
143272260|NCT02663908|516549539|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
143272261|NCT02663908|516549540|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
143272262|NCT02663908|516549539|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
143272263|NCT02663908|516549540|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
143272264|NCT00370071|516549541|FG000|Overall Study|Withdrawal by Subject|2|||
143272265|NCT01826604|516551108|FG000|Overall Study|Lost to Follow-up|8|||
143272266|NCT01826604|516551109|FG001|Overall Study|Lost to Follow-up|9|||
143272267|NCT01816074|516551110|FG000|Phase 1|Time commitment issues|0|||
143272268|NCT01816074|516551111|FG001|Phase 1|Time commitment issues|0|||
143272269|NCT01816074|516551112|FG002|Phase 1|Time commitment issues|1|||
143272270|NCT01816074|516551113|FG003|Phase 1|Time commitment issues|0|||
143272271|NCT01816074|516551110|FG000|Phase 2|Time commitment Issues|0|||
143272272|NCT01816074|516551111|FG001|Phase 2|Time commitment Issues|2|||
143272273|NCT01816074|516551112|FG002|Phase 2|Time commitment Issues|0|||
143272274|NCT01816074|516551113|FG003|Phase 2|Time commitment Issues|0|||
143272275|NCT01816074|516551110|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
143272276|NCT01816074|516551111|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
143272277|NCT01816074|516551112|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
143272278|NCT01816074|516551113|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
143272279|NCT01816074|516551110|FG000|Phase 2|Physician Decision|0|||
143272280|NCT01816074|516551111|FG001|Phase 2|Physician Decision|0|||
143272281|NCT01816074|516551112|FG002|Phase 2|Physician Decision|0|||
143272282|NCT01816074|516551113|FG003|Phase 2|Physician Decision|1|||
143272283|NCT01816074|516551110|FG000|Phase 2|Withdrawal by Subject|1|||
143272284|NCT01816074|516551111|FG001|Phase 2|Withdrawal by Subject|0|||
143272285|NCT01816074|516551112|FG002|Phase 2|Withdrawal by Subject|0|||
143272286|NCT01816074|516551113|FG003|Phase 2|Withdrawal by Subject|0|||
143272287|NCT01303861|516551121|FG000|Overall Study|Lost to Follow-up|34|||
143272288|NCT01303861|516551122|FG001|Overall Study|Lost to Follow-up|14|||
143272289|NCT01303861|516551123|FG002|Overall Study|Lost to Follow-up|27|||
143272290|NCT01303861|516551124|FG003|Overall Study|Lost to Follow-up|31|||
143272291|NCT01303861|516551121|FG000|Overall Study|Lack of Efficacy|3|||
143272292|NCT01303861|516551122|FG001|Overall Study|Lack of Efficacy|2|||
143272293|NCT01303861|516551123|FG002|Overall Study|Lack of Efficacy|1|||
143272294|NCT01303861|516551124|FG003|Overall Study|Lack of Efficacy|0|||
143272295|NCT01303861|516551121|FG000|Overall Study|Withdrawal by Subject|16|||
143272296|NCT01303861|516551122|FG001|Overall Study|Withdrawal by Subject|8|||
143272297|NCT01303861|516551123|FG002|Overall Study|Withdrawal by Subject|8|||
143272298|NCT01303861|516551124|FG003|Overall Study|Withdrawal by Subject|23|||
143272299|NCT01303861|516551121|FG000|Overall Study|Adverse Event|4|||
143272300|NCT01303861|516551122|FG001|Overall Study|Adverse Event|1|||
143272301|NCT01303861|516551123|FG002|Overall Study|Adverse Event|0|||
143272302|NCT01303861|516551124|FG003|Overall Study|Adverse Event|5|||
143272303|NCT01303861|516551121|FG000|Overall Study|Pregnancy|1|||
143272304|NCT01303861|516551122|FG001|Overall Study|Pregnancy|0|||
143272305|NCT01303861|516551123|FG002|Overall Study|Pregnancy|0|||
143272306|NCT01303861|516551124|FG003|Overall Study|Pregnancy|0|||
143272307|NCT03270644|516551127|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
143272308|NCT03270644|516551127|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
143272309|NCT05047770|516551128|FG000|Overall Study|Withdrawal by Subject|15|||
143272310|NCT05047770|516551129|FG001|Overall Study|Withdrawal by Subject|10|||
143272311|NCT05047770|516551130|FG002|Overall Study|Withdrawal by Subject|6|||
143272312|NCT05047770|516551131|FG003|Overall Study|Withdrawal by Subject|12|||
143272313|NCT05047770|516551128|FG000|Overall Study|Lost to Follow-up|7|||
143272314|NCT05047770|516551129|FG001|Overall Study|Lost to Follow-up|5|||
143272315|NCT05047770|516551130|FG002|Overall Study|Lost to Follow-up|12|||
143272316|NCT05047770|516551131|FG003|Overall Study|Lost to Follow-up|13|||
143272317|NCT05047770|516551128|FG000|Overall Study|Other|1|||
143272318|NCT05047770|516551129|FG001|Overall Study|Other|0|||
143272319|NCT05047770|516551130|FG002|Overall Study|Other|1|||
143272320|NCT05047770|516551131|FG003|Overall Study|Other|0|||
143272321|NCT00216476|516551133|FG000|Overall Study|Withdrawal by Subject|59|||
143272322|NCT00216476|516551134|FG001|Overall Study|Withdrawal by Subject|72|||
143272323|NCT00216476|516551135|FG002|Overall Study|Withdrawal by Subject|9|||
143272324|NCT00216476|516551133|FG000|Overall Study|Lost to Follow-up|10|||
143272325|NCT00216476|516551134|FG001|Overall Study|Lost to Follow-up|9|||
143272326|NCT00216476|516551135|FG002|Overall Study|Lost to Follow-up|1|||
143272327|NCT00216476|516551133|FG000|Overall Study|Adverse Event|6|||
143272328|NCT00216476|516551134|FG001|Overall Study|Adverse Event|10|||
143272329|NCT00216476|516551135|FG002|Overall Study|Adverse Event|1|||
143272330|NCT00216476|516551133|FG000|Overall Study|Lack of Efficacy|4|||
143272331|NCT00216476|516551134|FG001|Overall Study|Lack of Efficacy|3|||
143272332|NCT00216476|516551135|FG002|Overall Study|Lack of Efficacy|0|||
143272333|NCT00216476|516551133|FG000|Overall Study|Death|2|||
143272334|NCT00216476|516551134|FG001|Overall Study|Death|0|||
143272335|NCT00216476|516551135|FG002|Overall Study|Death|0|||
143272336|NCT00216476|516551133|FG000|Overall Study|Pregnancy|0|||
143272337|NCT00216476|516551134|FG001|Overall Study|Pregnancy|1|||
143272338|NCT00216476|516551135|FG002|Overall Study|Pregnancy|1|||
143272339|NCT00216476|516551133|FG000|Overall Study|Other|0|||
143272340|NCT00216476|516551134|FG001|Overall Study|Other|0|||
143272341|NCT00216476|516551135|FG002|Overall Study|Other|1|||
143272342|NCT00216476|516551133|FG000|Overall Study|Refuses Injection|11|||
143272343|NCT00216476|516551134|FG001|Overall Study|Refuses Injection|0|||
143272344|NCT00216476|516551135|FG002|Overall Study|Refuses Injection|0|||
143272345|NCT00216476|516551133|FG000|Overall Study|No Further Need for Treatment|3|||
143272346|NCT00216476|516551134|FG001|Overall Study|No Further Need for Treatment|4|||
143272347|NCT00216476|516551135|FG002|Overall Study|No Further Need for Treatment|1|||
143272348|NCT00216476|516551133|FG000|Overall Study|Non-compliance|0|||
143272349|NCT00216476|516551134|FG001|Overall Study|Non-compliance|4|||
143272350|NCT00216476|516551135|FG002|Overall Study|Non-compliance|1|||
143272351|NCT00216476|516551133|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
143272352|NCT00216476|516551134|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
143272353|NCT00216476|516551135|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
143272354|NCT00216476|516551133|FG000|Overall Study|Administrative Reasons|1|||
143272355|NCT00216476|516551134|FG001|Overall Study|Administrative Reasons|1|||
143272356|NCT00216476|516551135|FG002|Overall Study|Administrative Reasons|0|||
143272357|NCT00216476|516551133|FG000|Overall Study|Protocol Deviation|5|||
143272358|NCT00216476|516551134|FG001|Overall Study|Protocol Deviation|1|||
143272359|NCT00216476|516551135|FG002|Overall Study|Protocol Deviation|0|||
143272360|NCT00216476|516551133|FG000|Overall Study|Patient Moved|2|||
143272361|NCT00216476|516551134|FG001|Overall Study|Patient Moved|2|||
143272362|NCT00216476|516551135|FG002|Overall Study|Patient Moved|0|||
143272363|NCT01772160|516551136|FG000|Overall Study|Death|3|||
143272364|NCT01772160|516551136|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
143272365|NCT01772160|516551136|FG000|Overall Study|Consent withdrawal|3|||
143272366|NCT01772160|516551136|FG000|Overall Study|Migrated / moved from the study area|4|||
143272367|NCT01772160|516551136|FG000|Overall Study|Lost to Follow-up|30|||
143272368|NCT01772160|516551136|FG000|Overall Study|Other|5|||
143272369|NCT00199875|516551143|FG000|Overall Study|Withdrawal by Subject|0|||
143272370|NCT00199875|516551144|FG001|Overall Study|Withdrawal by Subject|0|||
143272371|NCT00199875|516551145|FG002|Overall Study|Withdrawal by Subject|0|||
143272372|NCT00199875|516551146|FG003|Overall Study|Withdrawal by Subject|0|||
143272373|NCT00199875|516551147|FG004|Overall Study|Withdrawal by Subject|1|||
143272374|NCT03469934|516551150|FG000|Overall Study|Withdrawal by Subject|0|||
143272375|NCT03469934|516551151|FG001|Overall Study|Withdrawal by Subject|1|||
143272376|NCT01024231|516551154|FG000|Overall Study|Other Reasons|1|||
143272377|NCT01024231|516551155|FG001|Overall Study|Other Reasons|2|||
143272378|NCT01024231|516551156|FG002|Overall Study|Other Reasons|0|||
143272379|NCT01024231|516551157|FG003|Overall Study|Other Reasons|0|||
143272380|NCT01024231|516551158|FG004|Overall Study|Other Reasons|2|||
143272381|NCT01024231|516551159|FG005|Overall Study|Other Reasons|0|||
143272382|NCT01024231|516551160|FG006|Overall Study|Other Reasons|1|||
143272383|NCT01024231|516551154|FG000|Overall Study|Maximum Clinical Benefit|1|||
143272384|NCT01024231|516551155|FG001|Overall Study|Maximum Clinical Benefit|2|||
143272385|NCT01024231|516551156|FG002|Overall Study|Maximum Clinical Benefit|0|||
143272386|NCT01024231|516551157|FG003|Overall Study|Maximum Clinical Benefit|1|||
143272387|NCT01024231|516551158|FG004|Overall Study|Maximum Clinical Benefit|1|||
143272388|NCT01024231|516551159|FG005|Overall Study|Maximum Clinical Benefit|0|||
143272389|NCT01024231|516551160|FG006|Overall Study|Maximum Clinical Benefit|0|||
143272390|NCT01024231|516551154|FG000|Overall Study|Disease Progression|3|||
143272391|NCT01024231|516551155|FG001|Overall Study|Disease Progression|1|||
143272392|NCT01024231|516551156|FG002|Overall Study|Disease Progression|3|||
143272393|NCT01024231|516551157|FG003|Overall Study|Disease Progression|0|||
143272394|NCT01024231|516551158|FG004|Overall Study|Disease Progression|4|||
143272395|NCT01024231|516551159|FG005|Overall Study|Disease Progression|11|||
143272396|NCT01024231|516551160|FG006|Overall Study|Disease Progression|6|||
143272397|NCT01024231|516551154|FG000|Overall Study|AE unrelated to Study Drug|0|||
143272398|NCT01024231|516551155|FG001|Overall Study|AE unrelated to Study Drug|1|||
143272399|NCT01024231|516551156|FG002|Overall Study|AE unrelated to Study Drug|0|||
143272400|NCT01024231|516551157|FG003|Overall Study|AE unrelated to Study Drug|0|||
143272401|NCT01024231|516551158|FG004|Overall Study|AE unrelated to Study Drug|0|||
143272402|NCT01024231|516551159|FG005|Overall Study|AE unrelated to Study Drug|0|||
143272403|NCT01024231|516551160|FG006|Overall Study|AE unrelated to Study Drug|0|||
143272404|NCT01024231|516551154|FG000|Overall Study|No longer meets criteria|0|||
143272405|NCT01024231|516551155|FG001|Overall Study|No longer meets criteria|0|||
143272406|NCT01024231|516551156|FG002|Overall Study|No longer meets criteria|0|||
143272407|NCT01024231|516551157|FG003|Overall Study|No longer meets criteria|0|||
143272408|NCT01024231|516551158|FG004|Overall Study|No longer meets criteria|1|||
143272409|NCT01024231|516551159|FG005|Overall Study|No longer meets criteria|0|||
143272410|NCT01024231|516551160|FG006|Overall Study|No longer meets criteria|1|||
143272411|NCT01024231|516551154|FG000|Overall Study|Study Drug Toxicity|1|||
143272412|NCT01024231|516551155|FG001|Overall Study|Study Drug Toxicity|6|||
143272413|NCT01024231|516551156|FG002|Overall Study|Study Drug Toxicity|6|||
143272414|NCT01024231|516551157|FG003|Overall Study|Study Drug Toxicity|4|||
143272415|NCT01024231|516551158|FG004|Overall Study|Study Drug Toxicity|2|||
143272416|NCT01024231|516551159|FG005|Overall Study|Study Drug Toxicity|0|||
143272417|NCT01024231|516551160|FG006|Overall Study|Study Drug Toxicity|7|||
143272418|NCT01024231|516551154|FG000|Overall Study|Death|6|||
143272419|NCT01024231|516551155|FG001|Overall Study|Death|2|||
143272420|NCT01024231|516551156|FG002|Overall Study|Death|1|||
143272421|NCT01024231|516551157|FG003|Overall Study|Death|0|||
143272422|NCT01024231|516551158|FG004|Overall Study|Death|4|||
143272423|NCT01024231|516551159|FG005|Overall Study|Death|3|||
143272424|NCT01024231|516551160|FG006|Overall Study|Death|5|||
143272425|NCT01024231|516551154|FG000|Overall Study|Lost to Follow-up|0|||
143272426|NCT01024231|516551155|FG001|Overall Study|Lost to Follow-up|0|||
143272427|NCT01024231|516551156|FG002|Overall Study|Lost to Follow-up|0|||
143272428|NCT01024231|516551157|FG003|Overall Study|Lost to Follow-up|0|||
143272429|NCT01024231|516551158|FG004|Overall Study|Lost to Follow-up|0|||
143272430|NCT01024231|516551159|FG005|Overall Study|Lost to Follow-up|0|||
143272431|NCT01024231|516551160|FG006|Overall Study|Lost to Follow-up|1|||
143272432|NCT01024231|516551154|FG000|Overall Study|Withdrew Consent|0|||
143272433|NCT01024231|516551155|FG001|Overall Study|Withdrew Consent|1|||
143272434|NCT01024231|516551156|FG002|Overall Study|Withdrew Consent|0|||
143272435|NCT01024231|516551157|FG003|Overall Study|Withdrew Consent|0|||
143272436|NCT01024231|516551158|FG004|Overall Study|Withdrew Consent|0|||
143272437|NCT01024231|516551159|FG005|Overall Study|Withdrew Consent|0|||
143272438|NCT01024231|516551160|FG006|Overall Study|Withdrew Consent|0|||
143272439|NCT01024231|516551154|FG000|Overall Study|Continuing on Treatment|0|||
143272440|NCT01024231|516551155|FG001|Overall Study|Continuing on Treatment|0|||
143272441|NCT01024231|516551156|FG002|Overall Study|Continuing on Treatment|0|||
143272442|NCT01024231|516551157|FG003|Overall Study|Continuing on Treatment|0|||
143272443|NCT01024231|516551158|FG004|Overall Study|Continuing on Treatment|3|||
143272444|NCT01024231|516551159|FG005|Overall Study|Continuing on Treatment|2|||
143272445|NCT01024231|516551160|FG006|Overall Study|Continuing on Treatment|0|||
143272446|NCT01691898|516551161|FG000|Overall Study|Death|34|||
143272447|NCT01691898|516551162|FG001|Overall Study|Death|32|||
143272448|NCT01691898|516551163|FG002|Overall Study|Death|6|||
143272449|NCT01691898|516551164|FG003|Overall Study|Death|3|||
143272450|NCT01691898|516551165|FG004|Overall Study|Death|8|||
143272451|NCT01691898|516551166|FG005|Overall Study|Death|31|||
143272452|NCT01691898|516551161|FG000|Overall Study|Adverse Event|0|||
143272453|NCT01691898|516551162|FG001|Overall Study|Adverse Event|1|||
143272454|NCT01691898|516551163|FG002|Overall Study|Adverse Event|0|||
143272455|NCT01691898|516551164|FG003|Overall Study|Adverse Event|1|||
143272456|NCT01691898|516551165|FG004|Overall Study|Adverse Event|1|||
143272457|NCT01691898|516551166|FG005|Overall Study|Adverse Event|0|||
143272458|NCT01691898|516551161|FG000|Overall Study|Progression of Disease|1|||
143272459|NCT01691898|516551162|FG001|Overall Study|Progression of Disease|2|||
143272460|NCT01691898|516551163|FG002|Overall Study|Progression of Disease|1|||
143272461|NCT01691898|516551164|FG003|Overall Study|Progression of Disease|0|||
143272462|NCT01691898|516551165|FG004|Overall Study|Progression of Disease|0|||
143272463|NCT01691898|516551166|FG005|Overall Study|Progression of Disease|1|||
143272464|NCT01691898|516551161|FG000|Overall Study|Lost to Follow-up|3|||
143272465|NCT01691898|516551162|FG001|Overall Study|Lost to Follow-up|1|||
143272466|NCT01691898|516551163|FG002|Overall Study|Lost to Follow-up|0|||
143272467|NCT01691898|516551164|FG003|Overall Study|Lost to Follow-up|0|||
143272468|NCT01691898|516551165|FG004|Overall Study|Lost to Follow-up|1|||
143272469|NCT01691898|516551166|FG005|Overall Study|Lost to Follow-up|0|||
143272470|NCT01691898|516551161|FG000|Overall Study|Withdrawal by Subject|9|||
143272471|NCT01691898|516551162|FG001|Overall Study|Withdrawal by Subject|8|||
143272472|NCT01691898|516551163|FG002|Overall Study|Withdrawal by Subject|2|||
143272473|NCT01691898|516551164|FG003|Overall Study|Withdrawal by Subject|1|||
143272474|NCT01691898|516551165|FG004|Overall Study|Withdrawal by Subject|3|||
143272475|NCT01691898|516551166|FG005|Overall Study|Withdrawal by Subject|3|||
143272476|NCT01691898|516551161|FG000|Overall Study|Non-Compliance|0|||
143272477|NCT01691898|516551162|FG001|Overall Study|Non-Compliance|0|||
143272478|NCT01691898|516551163|FG002|Overall Study|Non-Compliance|0|||
143272479|NCT01691898|516551164|FG003|Overall Study|Non-Compliance|0|||
143272480|NCT01691898|516551165|FG004|Overall Study|Non-Compliance|1|||
143272481|NCT01691898|516551166|FG005|Overall Study|Non-Compliance|0|||
143272482|NCT01013350|516551167|FG000|Overall Study|Lost to Follow-up|15|||
143272483|NCT01013350|516551168|FG001|Overall Study|Lost to Follow-up|95|||
143272484|NCT01013350|516551167|FG000|Overall Study|Adverse Event|0|||
143272485|NCT01013350|516551168|FG001|Overall Study|Adverse Event|1|||
143272486|NCT01013350|516551167|FG000|Overall Study|Physician Decision|4|||
143272487|NCT01013350|516551168|FG001|Overall Study|Physician Decision|20|||
143272488|NCT01013350|516551167|FG000|Overall Study|Withdrawal by Subject|15|||
143272489|NCT01013350|516551168|FG001|Overall Study|Withdrawal by Subject|38|||
143272490|NCT01013350|516551167|FG000|Overall Study|Death|3|||
143272491|NCT01013350|516551168|FG001|Overall Study|Death|5|||
143272492|NCT01013350|516551167|FG000|Overall Study|Participant entered interventional study|0|||
143272493|NCT01013350|516551168|FG001|Overall Study|Participant entered interventional study|8|||
143272494|NCT01013350|516551167|FG000|Overall Study|Other|1|||
143272495|NCT01013350|516551168|FG001|Overall Study|Other|25|||
143272496|NCT02478372|516551170|FG000|Overall Study|Protocol Violation|12|||
143272497|NCT02478372|516551171|FG001|Overall Study|Protocol Violation|8|||
143272498|NCT02478372|516551170|FG000|Overall Study|Lost to Follow-up|1|||
143272499|NCT02478372|516551171|FG001|Overall Study|Lost to Follow-up|4|||
143272500|NCT02478372|516551170|FG000|Overall Study|Death|0|||
143272501|NCT02478372|516551171|FG001|Overall Study|Death|2|||
143272502|NCT00669396|516551172|FG000|Overall Study|Lost to Follow-up|10|||
143272503|NCT00669396|516551173|FG001|Overall Study|Lost to Follow-up|12|||
143272504|NCT03212690|516551176|FG000|Overall Study|Protocol Violation|1|||
143272505|NCT02507973|516551178|FG000|Overall Study|Adverse Event|1|||
143272506|NCT00331422|516551179|FG000|Overall Study|Did not receive entire study regimen|5|||
143272507|NCT02345226|516551180|FG000|Double-Blind Phase|Adverse Event|5|||
143272508|NCT02345226|516551181|FG001|Double-Blind Phase|Adverse Event|6|||
143272509|NCT02345226|516551180|FG000|Double-Blind Phase|Death|3|||
143272510|NCT02345226|516551181|FG001|Double-Blind Phase|Death|0|||
143272511|NCT02345226|516551180|FG000|Double-Blind Phase|Pregnancy|0|||
143272512|NCT02345226|516551181|FG001|Double-Blind Phase|Pregnancy|1|||
143272513|NCT02345226|516551180|FG000|Double-Blind Phase|Lack of Efficacy|1|||
143272514|NCT02345226|516551181|FG001|Double-Blind Phase|Lack of Efficacy|0|||
143272515|NCT02345226|516551180|FG000|Double-Blind Phase|Investigator's Discretion|4|||
143272516|NCT02345226|516551181|FG001|Double-Blind Phase|Investigator's Discretion|3|||
143272517|NCT02345226|516551180|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
143272518|NCT02345226|516551181|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
143272519|NCT02345226|516551180|FG000|Double-Blind Phase|Withdrew Consent|41|||
143272520|NCT02345226|516551181|FG001|Double-Blind Phase|Withdrew Consent|39|||
143272521|NCT02345226|516551180|FG000|Double-Blind Phase|Lost to Follow-up|12|||
143272522|NCT02345226|516551181|FG001|Double-Blind Phase|Lost to Follow-up|16|||
143272523|NCT02345226|516551180|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
143272524|NCT02345226|516551181|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
143272525|NCT02345226|516551180|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
143272526|NCT02345226|516551181|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
143272527|NCT01710046|516551185|FG000|Overall Study|Lost to Follow-up|1|||
143272528|NCT01710046|516551186|FG001|Overall Study|Lost to Follow-up|0|||
143272529|NCT03386474|516551193|FG000|Overall Study|Death|1|||
143272530|NCT03386474|516551194|FG001|Overall Study|Death|0|||
143272531|NCT03386474|516551193|FG000|Overall Study|Adverse Event|0|||
143272532|NCT03386474|516551194|FG001|Overall Study|Adverse Event|1|||
143272533|NCT00910273|516551195|FG000|Overall Study|Lack of Efficacy|6|||
143272534|NCT00910273|516551196|FG001|Overall Study|Lack of Efficacy|9|||
143272535|NCT00910273|516551195|FG000|Overall Study|Adverse Event|1|||
143272536|NCT00910273|516551196|FG001|Overall Study|Adverse Event|1|||
143272537|NCT00910273|516551195|FG000|Overall Study|Withdrawal by Subject|1|||
143272538|NCT00910273|516551196|FG001|Overall Study|Withdrawal by Subject|0|||
143272539|NCT00910273|516551195|FG000|Overall Study|Discontinuation of study by sponsor|8|||
143272540|NCT00910273|516551196|FG001|Overall Study|Discontinuation of study by sponsor|2|||
143272541|NCT00910273|516551195|FG000|Overall Study|Protocol Violation|1|||
143272542|NCT00910273|516551196|FG001|Overall Study|Protocol Violation|0|||
143272543|NCT00910273|516551195|FG000|Overall Study|Lost to Follow-up|1|||
143272544|NCT00910273|516551196|FG001|Overall Study|Lost to Follow-up|1|||
143272545|NCT02155881|516551197|FG000|Overall Study|Withdrawal by Subject|0|||
143272546|NCT02155881|516551198|FG001|Overall Study|Withdrawal by Subject|2|||
143272547|NCT02155881|516551197|FG000|Overall Study|Inappropriately randomized|2|||
143272548|NCT02155881|516551198|FG001|Overall Study|Inappropriately randomized|2|||
143272549|NCT04357782|516551199|FG000|Overall Study|Discharged from hospital|1|||
143272550|NCT04357782|516551200|FG001|Overall Study|Discharged from hospital|0|||
143272551|NCT04357782|516551199|FG000|Overall Study|Death|0|||
143272552|NCT04357782|516551200|FG001|Overall Study|Death|2|||
143272553|NCT01786148|516551201|FG000|Overall Study|Lost to Follow-up|21|||
143272554|NCT01786148|516551202|FG001|Overall Study|Lost to Follow-up|13|||
143272555|NCT01786148|516551201|FG000|Overall Study|Death|0|||
143272556|NCT01786148|516551202|FG001|Overall Study|Death|1|||
143272557|NCT01786148|516551201|FG000|Overall Study|Withdrawal by Subject|0|||
143272558|NCT01786148|516551202|FG001|Overall Study|Withdrawal by Subject|7|||
143272559|NCT01786148|516551201|FG000|Overall Study|Incarceration|1|||
143272560|NCT01786148|516551202|FG001|Overall Study|Incarceration|1|||
143272561|NCT03780543|516551204|FG000|Overall Study|Adverse Event|1|||
143272562|NCT03780543|516551205|FG001|Overall Study|Adverse Event|0|||
143272563|NCT03780543|516551206|FG002|Overall Study|Adverse Event|2|||
143272564|NCT03780543|516551204|FG000|Overall Study|Lost to Follow-up|2|||
143272565|NCT03780543|516551205|FG001|Overall Study|Lost to Follow-up|0|||
143272566|NCT03780543|516551206|FG002|Overall Study|Lost to Follow-up|1|||
143272567|NCT03780543|516551204|FG000|Overall Study|Study terminated by Sponsor|8|||
143272568|NCT03780543|516551205|FG001|Overall Study|Study terminated by Sponsor|7|||
143272569|NCT03780543|516551206|FG002|Overall Study|Study terminated by Sponsor|13|||
143272570|NCT03780543|516551204|FG000|Overall Study|Withdrawal by Subject|1|||
143272571|NCT03780543|516551205|FG001|Overall Study|Withdrawal by Subject|8|||
143272572|NCT03780543|516551206|FG002|Overall Study|Withdrawal by Subject|1|||
143272573|NCT03780543|516551204|FG000|Overall Study|Noncompliance with study drug|1|||
143272574|NCT03780543|516551205|FG001|Overall Study|Noncompliance with study drug|0|||
143272575|NCT03780543|516551206|FG002|Overall Study|Noncompliance with study drug|0|||
143272576|NCT00066729|516551207|FG000|Overall Study|Lost to Follow-up|1|||
143272577|NCT00066729|516551207|FG000|Overall Study|Disease progression|1|||
143272578|NCT02215096|516551208|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
143272579|NCT02215096|516551209|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
143272580|NCT02215096|516551210|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
143272581|NCT02215096|516551211|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
143272582|NCT02215096|516551212|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
143272583|NCT02215096|516551208|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
143272584|NCT02215096|516551209|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
143272585|NCT02215096|516551210|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
143272586|NCT02215096|516551211|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
143272587|NCT02215096|516551212|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
143272588|NCT02215096|516551208|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
143272589|NCT02215096|516551209|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
143272590|NCT02215096|516551210|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
143272591|NCT02215096|516551211|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
143272592|NCT02215096|516551212|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
143272593|NCT02215096|516551208|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
143272594|NCT02215096|516551209|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
143272595|NCT02215096|516551210|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
143272596|NCT02215096|516551211|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
143272597|NCT02215096|516551212|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
143272598|NCT02349542|516551213|FG000|Overall Study|Withdrawal by Subject|5|||
143272599|NCT03896165|516551214|FG000|Overall Study|Withdrawal by Subject|2|||
143272600|NCT01967173|516551215|FG000|Overall Study|Lost to Follow-up|5|||
143272601|NCT01967173|516551216|FG001|Overall Study|Lost to Follow-up|3|||
143272602|NCT01967173|516551217|FG002|Overall Study|Lost to Follow-up|2|||
143272603|NCT01967173|516551218|FG003|Overall Study|Lost to Follow-up|4|||
143272604|NCT01967173|516551219|FG004|Overall Study|Lost to Follow-up|8|||
143272605|NCT01967173|516551220|FG005|Overall Study|Lost to Follow-up|12|||
143272606|NCT01967173|516551221|FG006|Overall Study|Lost to Follow-up|6|||
143272607|NCT01967173|516551222|FG007|Overall Study|Lost to Follow-up|8|||
143272608|NCT01967173|516551215|FG000|Overall Study|Physician Decision|2|||
143272609|NCT01967173|516551216|FG001|Overall Study|Physician Decision|0|||
143272610|NCT01967173|516551217|FG002|Overall Study|Physician Decision|2|||
143272611|NCT01967173|516551218|FG003|Overall Study|Physician Decision|1|||
143272612|NCT01967173|516551219|FG004|Overall Study|Physician Decision|1|||
143272613|NCT01967173|516551220|FG005|Overall Study|Physician Decision|1|||
143272614|NCT01967173|516551221|FG006|Overall Study|Physician Decision|1|||
143272615|NCT01967173|516551222|FG007|Overall Study|Physician Decision|0|||
143272616|NCT01967173|516551215|FG000|Overall Study|Lack of Efficacy|2|||
143272617|NCT01967173|516551216|FG001|Overall Study|Lack of Efficacy|0|||
143272618|NCT01967173|516551217|FG002|Overall Study|Lack of Efficacy|2|||
143272619|NCT01967173|516551218|FG003|Overall Study|Lack of Efficacy|2|||
143272620|NCT01967173|516551219|FG004|Overall Study|Lack of Efficacy|0|||
143272621|NCT01967173|516551220|FG005|Overall Study|Lack of Efficacy|1|||
143272622|NCT01967173|516551221|FG006|Overall Study|Lack of Efficacy|0|||
143272623|NCT01967173|516551222|FG007|Overall Study|Lack of Efficacy|2|||
143272624|NCT01967173|516551215|FG000|Overall Study|Pregnancy|0|||
143272625|NCT01967173|516551216|FG001|Overall Study|Pregnancy|0|||
143272626|NCT01967173|516551217|FG002|Overall Study|Pregnancy|0|||
143272627|NCT01967173|516551218|FG003|Overall Study|Pregnancy|0|||
143272628|NCT01967173|516551219|FG004|Overall Study|Pregnancy|0|||
143272629|NCT01967173|516551220|FG005|Overall Study|Pregnancy|0|||
143272630|NCT01967173|516551221|FG006|Overall Study|Pregnancy|1|||
143272631|NCT01967173|516551222|FG007|Overall Study|Pregnancy|1|||
143272632|NCT01967173|516551215|FG000|Overall Study|Adverse Event|0|||
143272633|NCT01967173|516551216|FG001|Overall Study|Adverse Event|0|||
143272634|NCT01967173|516551217|FG002|Overall Study|Adverse Event|0|||
143272635|NCT01967173|516551218|FG003|Overall Study|Adverse Event|0|||
143272636|NCT01967173|516551219|FG004|Overall Study|Adverse Event|0|||
143272637|NCT01967173|516551220|FG005|Overall Study|Adverse Event|0|||
143272638|NCT01967173|516551221|FG006|Overall Study|Adverse Event|0|||
143272639|NCT01967173|516551222|FG007|Overall Study|Adverse Event|1|||
143272640|NCT01967173|516551215|FG000|Overall Study|Withdrawal by Subject|15|||
143272641|NCT01967173|516551216|FG001|Overall Study|Withdrawal by Subject|14|||
143272642|NCT01967173|516551217|FG002|Overall Study|Withdrawal by Subject|10|||
143272643|NCT01967173|516551218|FG003|Overall Study|Withdrawal by Subject|7|||
143272644|NCT01967173|516551219|FG004|Overall Study|Withdrawal by Subject|8|||
143272645|NCT01967173|516551220|FG005|Overall Study|Withdrawal by Subject|9|||
143272646|NCT01967173|516551221|FG006|Overall Study|Withdrawal by Subject|10|||
143272647|NCT01967173|516551222|FG007|Overall Study|Withdrawal by Subject|12|||
143272648|NCT03666624|516551230|FG000|Overall Study|participant grieving over recent death of parent|1|||
143272649|NCT03666624|516551231|FG001|Overall Study|participant grieving over recent death of parent|0|||
143272650|NCT03021304|516551232|FG000|Overall Study|Lack of Efficacy|1|||
143272651|NCT04122534|516551233|FG000|Overall Study|Lost to Follow-up|4|||
143272652|NCT03113916|516551239|FG000|Overall Study|Withdrawal by Subject|9|||
143272653|NCT03113916|516551240|FG001|Overall Study|Withdrawal by Subject|7|||
143272654|NCT03113916|516551239|FG000|Overall Study|Pregnancy|1|||
143272655|NCT03113916|516551240|FG001|Overall Study|Pregnancy|3|||
143272656|NCT03113916|516551239|FG000|Overall Study|Lost to Follow-up|1|||
143272657|NCT03113916|516551240|FG001|Overall Study|Lost to Follow-up|2|||
143272658|NCT03360747|516551245|FG000|Overall Study|Voluntary Withdrawal|1|||
143272659|NCT01759511|516551246|FG000|Overall Study|Adverse Event|4|||
143272660|NCT01759511|516551246|FG000|Overall Study|Death|2|||
143272661|NCT01759511|516551246|FG000|Overall Study|Lack of Efficacy|2|||
143272662|NCT01759511|516551246|FG000|Overall Study|Physician Decision|1|||
143272663|NCT01759511|516551246|FG000|Overall Study|Progressive Disease|5|||
143272664|NCT01759511|516551246|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
143272665|NCT01759511|516551246|FG000|Overall Study|Study Terminated by Sponsor|13|||
143272666|NCT01759511|516551246|FG000|Overall Study|Withdrawal by Subject|3|||
143272667|NCT02557295|516551247|FG000|Overall Study|Withdrawal by Subject|9|||
143272668|NCT02557295|516551248|FG001|Overall Study|Withdrawal by Subject|2|||
143272669|NCT02557295|516551249|FG002|Overall Study|Withdrawal by Subject|4|||
143272670|NCT02557295|516551250|FG003|Overall Study|Withdrawal by Subject|0|||
143272671|NCT02557295|516551251|FG004|Overall Study|Withdrawal by Subject|0|||
143272672|NCT02557295|516551252|FG005|Overall Study|Withdrawal by Subject|0|||
143272673|NCT02557295|516551253|FG006|Overall Study|Withdrawal by Subject|15|||
143272674|NCT02557295|516551254|FG007|Overall Study|Withdrawal by Subject|1|||
143272675|NCT02557295|516551255|FG008|Overall Study|Withdrawal by Subject|3|||
143272676|NCT02557295|516551247|FG000|Overall Study|Disease Progression|0|||
143272677|NCT02557295|516551248|FG001|Overall Study|Disease Progression|0|||
143272678|NCT02557295|516551249|FG002|Overall Study|Disease Progression|0|||
143272679|NCT02557295|516551250|FG003|Overall Study|Disease Progression|0|||
143272680|NCT02557295|516551251|FG004|Overall Study|Disease Progression|0|||
143272681|NCT02557295|516551252|FG005|Overall Study|Disease Progression|0|||
143272682|NCT02557295|516551253|FG006|Overall Study|Disease Progression|1|||
143272683|NCT02557295|516551254|FG007|Overall Study|Disease Progression|0|||
143272684|NCT02557295|516551255|FG008|Overall Study|Disease Progression|0|||
143272685|NCT02557295|516551247|FG000|Overall Study|Lack of Efficacy|24|||
143272686|NCT02557295|516551248|FG001|Overall Study|Lack of Efficacy|1|||
143272687|NCT02557295|516551249|FG002|Overall Study|Lack of Efficacy|3|||
143272688|NCT02557295|516551250|FG003|Overall Study|Lack of Efficacy|0|||
143272689|NCT02557295|516551251|FG004|Overall Study|Lack of Efficacy|0|||
143272690|NCT02557295|516551252|FG005|Overall Study|Lack of Efficacy|0|||
143272691|NCT02557295|516551253|FG006|Overall Study|Lack of Efficacy|12|||
143272692|NCT02557295|516551254|FG007|Overall Study|Lack of Efficacy|1|||
143272693|NCT02557295|516551255|FG008|Overall Study|Lack of Efficacy|0|||
143272694|NCT02557295|516551247|FG000|Overall Study|Adverse Event|16|||
143272695|NCT02557295|516551248|FG001|Overall Study|Adverse Event|2|||
143272696|NCT02557295|516551249|FG002|Overall Study|Adverse Event|3|||
143272697|NCT02557295|516551250|FG003|Overall Study|Adverse Event|0|||
143272698|NCT02557295|516551251|FG004|Overall Study|Adverse Event|0|||
143272699|NCT02557295|516551252|FG005|Overall Study|Adverse Event|0|||
143272700|NCT02557295|516551253|FG006|Overall Study|Adverse Event|2|||
143272701|NCT02557295|516551254|FG007|Overall Study|Adverse Event|1|||
143272702|NCT02557295|516551255|FG008|Overall Study|Adverse Event|1|||
143272703|NCT02557295|516551247|FG000|Overall Study|Lost to Follow-up|4|||
143272704|NCT02557295|516551248|FG001|Overall Study|Lost to Follow-up|0|||
143272705|NCT02557295|516551249|FG002|Overall Study|Lost to Follow-up|0|||
143272706|NCT02557295|516551250|FG003|Overall Study|Lost to Follow-up|0|||
143272707|NCT02557295|516551251|FG004|Overall Study|Lost to Follow-up|0|||
143272708|NCT02557295|516551252|FG005|Overall Study|Lost to Follow-up|0|||
143272709|NCT02557295|516551253|FG006|Overall Study|Lost to Follow-up|9|||
143272710|NCT02557295|516551254|FG007|Overall Study|Lost to Follow-up|0|||
143272711|NCT02557295|516551255|FG008|Overall Study|Lost to Follow-up|0|||
143272712|NCT02557295|516551247|FG000|Overall Study|Study Close|54|||
143272713|NCT02557295|516551248|FG001|Overall Study|Study Close|3|||
143272714|NCT02557295|516551249|FG002|Overall Study|Study Close|5|||
143272715|NCT02557295|516551250|FG003|Overall Study|Study Close|3|||
143272716|NCT02557295|516551251|FG004|Overall Study|Study Close|0|||
143272717|NCT02557295|516551252|FG005|Overall Study|Study Close|0|||
143272718|NCT02557295|516551253|FG006|Overall Study|Study Close|37|||
143272719|NCT02557295|516551254|FG007|Overall Study|Study Close|3|||
143272720|NCT02557295|516551255|FG008|Overall Study|Study Close|19|||
143272721|NCT02557295|516551247|FG000|Overall Study|except for study close|4|||
143272722|NCT02557295|516551248|FG001|Overall Study|except for study close|0|||
143272723|NCT02557295|516551249|FG002|Overall Study|except for study close|0|||
143272724|NCT02557295|516551250|FG003|Overall Study|except for study close|0|||
143272725|NCT02557295|516551251|FG004|Overall Study|except for study close|0|||
143272726|NCT02557295|516551252|FG005|Overall Study|except for study close|0|||
143272727|NCT02557295|516551253|FG006|Overall Study|except for study close|5|||
143272728|NCT02557295|516551254|FG007|Overall Study|except for study close|1|||
143272729|NCT02557295|516551255|FG008|Overall Study|except for study close|0|||
143272730|NCT03487549|516551256|FG000|Overall Study|Protocol Violation|0|||
143272731|NCT03487549|516551257|FG001|Overall Study|Protocol Violation|1|||
143272732|NCT03487549|516551256|FG000|Overall Study|Lost to Follow-up|2|||
143272733|NCT03487549|516551257|FG001|Overall Study|Lost to Follow-up|1|||
143272734|NCT03487549|516551256|FG000|Overall Study|Withdrawal by Subject|2|||
143272735|NCT03487549|516551257|FG001|Overall Study|Withdrawal by Subject|0|||
143272736|NCT06238362|516551258|FG000|Overall Study|Insufficient total sleep time|1|||
143272737|NCT06238362|516551259|FG001|Overall Study|Insufficient total sleep time|0|||
143272738|NCT06238362|516551258|FG000|Overall Study|Inadequate signal quality|1|||
143272739|NCT06238362|516551259|FG001|Overall Study|Inadequate signal quality|0|||
143272740|NCT01644565|516553085|FG000|Overall Study|Undisclosed Medical History|1|||
143272741|NCT01644565|516553086|FG001|Overall Study|Undisclosed Medical History|0|||
143272742|NCT01644565|516553087|FG002|Overall Study|Undisclosed Medical History|0|||
143272743|NCT01644565|516553088|FG003|Overall Study|Undisclosed Medical History|0|||
143272744|NCT01644565|516553089|FG004|Overall Study|Undisclosed Medical History|0|||
143272745|NCT01644565|516553090|FG005|Overall Study|Undisclosed Medical History|0|||
143272746|NCT01644565|516553091|FG006|Overall Study|Undisclosed Medical History|0|||
143272747|NCT01644565|516553092|FG007|Overall Study|Undisclosed Medical History|0|||
143272748|NCT01644565|516553093|FG008|Overall Study|Undisclosed Medical History|0|||
143272749|NCT01644565|516553085|FG000|Overall Study|Lost to Follow-up|0|||
143272750|NCT01644565|516553086|FG001|Overall Study|Lost to Follow-up|0|||
143272751|NCT01644565|516553087|FG002|Overall Study|Lost to Follow-up|0|||
143272752|NCT01644565|516553088|FG003|Overall Study|Lost to Follow-up|1|||
143229009|NCT00117637|516387080|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
143229010|NCT00117637|516387081|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
143229011|NCT00117637|516387080|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
143229012|NCT00117637|516387081|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
143229013|NCT00117637|516387080|FG000|First Intervention (Period 1)|reason not reported|0|||
143229014|NCT00117637|516387081|FG001|First Intervention (Period 1)|reason not reported|1|||
143229015|NCT00117637|516387080|FG000|Second Intervention (Period 2)|Adverse Event|0|||
143229016|NCT00117637|516387081|FG001|Second Intervention (Period 2)|Adverse Event|9|||
143229017|NCT00117637|516387080|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
143229018|NCT00117637|516387081|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
143229019|NCT00117637|516387080|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
143229020|NCT00117637|516387081|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
143229021|NCT00117637|516387080|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
143229022|NCT00117637|516387081|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
143229023|NCT00117637|516387080|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
143229024|NCT00117637|516387081|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
143229025|NCT00117637|516387080|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
143229026|NCT00117637|516387081|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
143229027|NCT00117637|516387080|FG000|Second Intervention (Period 2)|reason not reported|1|||
143229028|NCT00117637|516387081|FG001|Second Intervention (Period 2)|reason not reported|0|||
143229029|NCT01620060|516387083|FG000|Overall Study|Adverse Event|9|||
143229030|NCT01620060|516387083|FG000|Overall Study|Protocol Violation|1|||
143229031|NCT01620060|516387083|FG000|Overall Study|Withdrawal by Subject|1|||
143229032|NCT01620060|516387083|FG000|Overall Study|Did not comply with Study Produre|1|||
143229033|NCT01620060|516387083|FG000|Overall Study|Family emergency|1|||
143229034|NCT01620060|516387083|FG000|Overall Study|Per Sponsor Decision|2|||
143229035|NCT02269124|516387084|FG000|Overall Study|Lost to Follow-up|1|||
143229036|NCT02269124|516387085|FG001|Overall Study|Lost to Follow-up|0|||
143229037|NCT02269124|516387084|FG000|Overall Study|Withdrawal by Subject|0|||
143229038|NCT02269124|516387085|FG001|Overall Study|Withdrawal by Subject|2|||
143229039|NCT00614575|516387086|FG000|Overall Study|Adverse Event|106|||
143229040|NCT00614575|516387086|FG000|Overall Study|Lost to Follow-up|55|||
143229041|NCT00614575|516387086|FG000|Overall Study|Lack of Efficacy|14|||
143229042|NCT00614575|516387086|FG000|Overall Study|Withdrawal by Subject|6|||
143229043|NCT00614575|516387086|FG000|Overall Study|Death|3|||
143229044|NCT00614575|516387086|FG000|Overall Study|Physician Decision|2|||
143229045|NCT00614575|516387086|FG000|Overall Study|No data were collected.|18|||
143229046|NCT00614575|516387086|FG000|Overall Study|Irregularly enrolled patients|23|||
143229047|NCT00614575|516387086|FG000|Overall Study|No treatment|1|||
143229048|NCT03452540|516387088|FG000|Overall Study|Adverse Event|1|||
143229049|NCT03452540|516387088|FG000|Overall Study|Withdrawal by Subject|1|||
143229050|NCT03452540|516387088|FG000|Overall Study|Other SAE and AE|2|||
143229051|NCT04664153|516387091|FG000|Overall Study|Lack of Efficacy|0|||
143229052|NCT04664153|516387092|FG001|Overall Study|Lack of Efficacy|0|||
143229053|NCT04664153|516387093|FG002|Overall Study|Lack of Efficacy|1|||
143229054|NCT04664153|516387094|FG003|Overall Study|Lack of Efficacy|0|||
143229055|NCT04664153|516387091|FG000|Overall Study|Physician Decision|0|||
143229056|NCT04664153|516387092|FG001|Overall Study|Physician Decision|0|||
143229057|NCT04664153|516387093|FG002|Overall Study|Physician Decision|1|||
143229058|NCT04664153|516387094|FG003|Overall Study|Physician Decision|0|||
143229059|NCT04664153|516387091|FG000|Overall Study|Withdrawal by Subject|3|||
143229060|NCT04664153|516387092|FG001|Overall Study|Withdrawal by Subject|2|||
143229061|NCT04664153|516387093|FG002|Overall Study|Withdrawal by Subject|1|||
143229062|NCT04664153|516387094|FG003|Overall Study|Withdrawal by Subject|2|||
143229063|NCT04664153|516387091|FG000|Overall Study|Other|0|||
143229064|NCT04664153|516387092|FG001|Overall Study|Other|1|||
143229065|NCT04664153|516387093|FG002|Overall Study|Other|0|||
143229066|NCT04664153|516387094|FG003|Overall Study|Other|0|||
143229067|NCT04664153|516387091|FG000|Overall Study|Adverse Event|4|||
143229068|NCT04664153|516387092|FG001|Overall Study|Adverse Event|0|||
143272753|NCT01644565|516553089|FG004|Overall Study|Lost to Follow-up|0|||
143272754|NCT01644565|516553090|FG005|Overall Study|Lost to Follow-up|0|||
143272755|NCT01644565|516553091|FG006|Overall Study|Lost to Follow-up|0|||
143272756|NCT01644565|516553092|FG007|Overall Study|Lost to Follow-up|2|||
143272757|NCT01644565|516553093|FG008|Overall Study|Lost to Follow-up|0|||
143272758|NCT01644565|516553085|FG000|Overall Study|Family emergency|0|||
143272759|NCT01644565|516553086|FG001|Overall Study|Family emergency|0|||
143272760|NCT01644565|516553087|FG002|Overall Study|Family emergency|0|||
143272761|NCT01644565|516553088|FG003|Overall Study|Family emergency|0|||
143272762|NCT01644565|516553089|FG004|Overall Study|Family emergency|1|||
143272763|NCT01644565|516553090|FG005|Overall Study|Family emergency|0|||
143272764|NCT01644565|516553091|FG006|Overall Study|Family emergency|0|||
143272765|NCT01644565|516553092|FG007|Overall Study|Family emergency|0|||
143272766|NCT01644565|516553093|FG008|Overall Study|Family emergency|0|||
143272767|NCT01644565|516553085|FG000|Overall Study|Relocation|0|||
143272768|NCT01644565|516553086|FG001|Overall Study|Relocation|0|||
143272769|NCT01644565|516553087|FG002|Overall Study|Relocation|0|||
143272770|NCT01644565|516553088|FG003|Overall Study|Relocation|0|||
143272771|NCT01644565|516553089|FG004|Overall Study|Relocation|0|||
143272772|NCT01644565|516553090|FG005|Overall Study|Relocation|0|||
143272773|NCT01644565|516553091|FG006|Overall Study|Relocation|0|||
143272774|NCT01644565|516553092|FG007|Overall Study|Relocation|0|||
143272775|NCT01644565|516553093|FG008|Overall Study|Relocation|1|||
143272776|NCT01313858|516553095|FG000|Overall Study|Premature Treatment Termination|251|||
143272777|NCT01313858|516553096|FG001|Overall Study|Premature Treatment Termination|219|||
143272778|NCT01313858|516553097|FG002|Overall Study|Premature Treatment Termination|191|||
143272779|NCT01313858|516553095|FG000|Overall Study|Lost to Follow-up|35|||
143272780|NCT01313858|516553096|FG001|Overall Study|Lost to Follow-up|51|||
143272781|NCT01313858|516553097|FG002|Overall Study|Lost to Follow-up|47|||
143272782|NCT03689530|516553102|FG000|Overall Study|Withdrawal by Subject|53|||
143272783|NCT03689530|516553103|FG001|Overall Study|Withdrawal by Subject|16|||
143272784|NCT01392443|516553104|FG000|Overall Study|Disease progression|30|||
143272785|NCT01392443|516553104|FG000|Overall Study|Adverse Event|24|||
143272786|NCT01392443|516553104|FG000|Overall Study|Death|7|||
143272787|NCT01392443|516553104|FG000|Overall Study|Withdrawal by Subject|5|||
143272788|NCT01392443|516553104|FG000|Overall Study|Lost to Follow-up|1|||
143272789|NCT01392443|516553104|FG000|Overall Study|Protocol Violation|1|||
143272790|NCT01626456|516553107|FG000|Overall Study|Withdrawal by Subject|21|||
143272791|NCT01626456|516553108|FG001|Overall Study|Withdrawal by Subject|46|||
143272792|NCT01626456|516553107|FG000|Overall Study|Adverse Event|2|||
143272793|NCT01626456|516553108|FG001|Overall Study|Adverse Event|27|||
143272794|NCT01626456|516553107|FG000|Overall Study|Lost to Follow-up|2|||
143272795|NCT01626456|516553108|FG001|Overall Study|Lost to Follow-up|27|||
143272796|NCT01626456|516553107|FG000|Overall Study|Lack of Efficacy|6|||
143272797|NCT01626456|516553108|FG001|Overall Study|Lack of Efficacy|7|||
143272798|NCT01626456|516553107|FG000|Overall Study|Physician Decision|1|||
143272799|NCT01626456|516553108|FG001|Overall Study|Physician Decision|4|||
143272800|NCT01626456|516553107|FG000|Overall Study|Protocol Violation|1|||
143272801|NCT01626456|516553108|FG001|Overall Study|Protocol Violation|1|||
143272802|NCT01626456|516553107|FG000|Overall Study|Site Closure|2|||
143272803|NCT01626456|516553108|FG001|Overall Study|Site Closure|3|||
143272804|NCT01626456|516553107|FG000|Overall Study|Incarceration|0|||
143272805|NCT01626456|516553108|FG001|Overall Study|Incarceration|2|||
143272806|NCT00246753|516553110|FG000|Overall Study|Withdrawal by Subject|2|||
143272807|NCT00246753|516553110|FG000|Overall Study|Physician Decision|2|||
143272808|NCT00246753|516553110|FG000|Overall Study|Adverse Event|2|||
143272809|NCT00246753|516553110|FG000|Overall Study|Unacceptable toxicity|2|||
143272810|NCT01330030|516553126|FG000|Overall Study|Lost to Follow-up|16|||
143272811|NCT01330030|516553127|FG001|Overall Study|Lost to Follow-up|17|||
143272812|NCT01365052|516553128|FG000|Overall Study|Adverse Event|4|||
143272813|NCT01365052|516553129|FG001|Overall Study|Adverse Event|4|||
143272814|NCT00845858|516553130|FG000|Overall Study|Withdrawal by Subject|5|||
143272815|NCT00845858|516553131|FG001|Overall Study|Withdrawal by Subject|1|||
143272816|NCT00845858|516553132|FG002|Overall Study|Withdrawal by Subject|1|||
143272817|NCT00845858|516553130|FG000|Overall Study|Adverse Event|3|||
143272818|NCT00845858|516553131|FG001|Overall Study|Adverse Event|8|||
143272819|NCT00845858|516553132|FG002|Overall Study|Adverse Event|4|||
143272820|NCT00845858|516553130|FG000|Overall Study|Protocol Violation|0|||
143272821|NCT00845858|516553131|FG001|Overall Study|Protocol Violation|0|||
143272822|NCT00845858|516553132|FG002|Overall Study|Protocol Violation|1|||
143272823|NCT00845858|516553130|FG000|Overall Study|not eligible|0|||
143272824|NCT00845858|516553131|FG001|Overall Study|not eligible|3|||
143272825|NCT00845858|516553132|FG002|Overall Study|not eligible|2|||
143272826|NCT00850070|516553133|FG000|Overall Study|Lack of Efficacy|1|||
143272827|NCT00850070|516553134|FG001|Overall Study|Lack of Efficacy|1|||
143272828|NCT00850070|516553133|FG000|Overall Study|Adverse Event|2|||
143272829|NCT00850070|516553134|FG001|Overall Study|Adverse Event|0|||
143272830|NCT00074984|516553135|FG000|Overall Study|Death|1|||
143272831|NCT00074984|516553136|FG001|Overall Study|Death|2|||
143272832|NCT00074984|516553135|FG000|Overall Study|Withdrawal by Subject|2|||
143272833|NCT00074984|516553136|FG001|Overall Study|Withdrawal by Subject|3|||
143229069|NCT04664153|516387093|FG002|Overall Study|Adverse Event|1|||
143229070|NCT04664153|516387094|FG003|Overall Study|Adverse Event|0|||
143229071|NCT00097500|516387095|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
143229072|NCT00097500|516387096|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
143229073|NCT00097500|516387095|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
143229074|NCT00097500|516387096|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
143229075|NCT00097500|516387095|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
143229076|NCT00097500|516387096|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
143229077|NCT00097500|516387095|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
143229078|NCT00097500|516387096|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
143229079|NCT00097500|516387095|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
143229080|NCT00097500|516387096|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
143229081|NCT00097500|516387095|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
143229082|NCT00097500|516387096|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
143229083|NCT00097500|516387095|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
143229084|NCT00097500|516387096|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
143229085|NCT00642356|516387100|FG000|Overall Study|Adverse Event|1|||
143229086|NCT00642356|516387101|FG001|Overall Study|Adverse Event|0|||
143229087|NCT00642356|516387100|FG000|Overall Study|Protocol Violation|0|||
143229088|NCT00642356|516387101|FG001|Overall Study|Protocol Violation|3|||
143229089|NCT00642356|516387100|FG000|Overall Study|Lack of Efficacy|1|||
143229090|NCT00642356|516387101|FG001|Overall Study|Lack of Efficacy|0|||
143229091|NCT01009060|516387110|FG000|Overall Study|Adverse Event|1|||
143229092|NCT01009060|516387111|FG001|Overall Study|Adverse Event|2|||
143229093|NCT01009060|516387110|FG000|Overall Study|Protocol Violation|0|||
143229094|NCT01009060|516387111|FG001|Overall Study|Protocol Violation|1|||
143229095|NCT01009060|516387110|FG000|Overall Study|Lost to Follow-up|1|||
143229096|NCT01009060|516387111|FG001|Overall Study|Lost to Follow-up|0|||
143229097|NCT01009060|516387110|FG000|Overall Study|Physician Decision|1|||
143229098|NCT01009060|516387111|FG001|Overall Study|Physician Decision|1|||
143229099|NCT01009060|516387110|FG000|Overall Study|Withdrawal by Subject|1|||
143229100|NCT01009060|516387111|FG001|Overall Study|Withdrawal by Subject|1|||
143229101|NCT00005906|516387112|FG000|Overall Study|Lack of Efficacy|3|||
143229102|NCT00300755|516387115|FG000|Overall Study|Adverse Event|1|||
143229103|NCT00300755|516387116|FG001|Overall Study|Adverse Event|2|||
143229104|NCT00300755|516387117|FG002|Overall Study|Adverse Event|1|||
143229105|NCT00300755|516387115|FG000|Overall Study|Withdrawal by Subject|0|||
143229106|NCT00300755|516387116|FG001|Overall Study|Withdrawal by Subject|2|||
143229107|NCT00300755|516387117|FG002|Overall Study|Withdrawal by Subject|0|||
143229108|NCT00300755|516387115|FG000|Overall Study|Protocol Violation|0|||
143229109|NCT00300755|516387116|FG001|Overall Study|Protocol Violation|0|||
143229110|NCT00300755|516387117|FG002|Overall Study|Protocol Violation|1|||
143229111|NCT04571944|516387118|FG000|Overall Study|Death|1|||
143229112|NCT04571944|516387119|FG001|Overall Study|Death|0|||
143229113|NCT04571944|516387118|FG000|Overall Study|Withdrawal by Subject|3|||
143229114|NCT04571944|516387119|FG001|Overall Study|Withdrawal by Subject|0|||
143229115|NCT04571944|516387118|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
143229116|NCT04571944|516387119|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
143229117|NCT02694744|516387123|FG000|Overall Study|Adverse Event|2|||
143229118|NCT02694744|516387124|FG001|Overall Study|Adverse Event|1|||
143229119|NCT02694744|516387123|FG000|Overall Study|Withdrawal by Subject|2|||
143229120|NCT02694744|516387124|FG001|Overall Study|Withdrawal by Subject|1|||
143229121|NCT02694744|516387123|FG000|Overall Study|Physician Decision|1|||
143229122|NCT02694744|516387124|FG001|Overall Study|Physician Decision|2|||
143229123|NCT02694744|516387123|FG000|Overall Study|Lost to Follow-up|1|||
143229124|NCT02694744|516387124|FG001|Overall Study|Lost to Follow-up|0|||
143229125|NCT02694744|516387123|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
143229126|NCT02694744|516387124|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
143229127|NCT00686777|516387125|FG000|Overall Study|Adverse Event|2|||
143229128|NCT00686777|516387125|FG000|Overall Study|Pregnancy|1|||
143229129|NCT00686777|516387125|FG000|Overall Study|Withdrawal by Subject|2|||
143229130|NCT00686777|516387125|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
143229131|NCT00686777|516387125|FG000|Overall Study|No Visit|1|||
143229132|NCT00667888|516387126|FG000|Overall Study|Death|1|||
143229133|NCT00667888|516387127|FG001|Overall Study|Death|1|||
143229134|NCT00667888|516387126|FG000|Overall Study|Withdrawal by Subject|6|||
143272834|NCT00074984|516553135|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
143272835|NCT00074984|516553136|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
143272836|NCT03758443|516553137|FG000|Induction Period|Adverse Event|2|||
143272837|NCT03758443|516553138|FG001|Induction Period|Adverse Event|4|||
143272838|NCT03758443|516553139|FG002|Induction Period|Adverse Event|2|||
143272839|NCT03758443|516553140|FG003|Induction Period|Adverse Event|3|||
143272840|NCT03758443|516553137|FG000|Induction Period|Physician Decision|1|||
143272841|NCT03758443|516553138|FG001|Induction Period|Physician Decision|1|||
143272842|NCT03758443|516553139|FG002|Induction Period|Physician Decision|3|||
143272843|NCT03758443|516553140|FG003|Induction Period|Physician Decision|0|||
143272844|NCT03758443|516553137|FG000|Induction Period|Protocol Violation|0|||
143272845|NCT03758443|516553138|FG001|Induction Period|Protocol Violation|0|||
143272846|NCT03758443|516553139|FG002|Induction Period|Protocol Violation|0|||
143272847|NCT03758443|516553140|FG003|Induction Period|Protocol Violation|1|||
143272848|NCT03758443|516553137|FG000|Induction Period|Withdrawal by Subject|3|||
143272849|NCT03758443|516553138|FG001|Induction Period|Withdrawal by Subject|2|||
143272850|NCT03758443|516553139|FG002|Induction Period|Withdrawal by Subject|2|||
143272851|NCT03758443|516553140|FG003|Induction Period|Withdrawal by Subject|4|||
143272852|NCT03758443|516553137|FG000|Extended Induction Period|Adverse Event|1|||
143272853|NCT03758443|516553138|FG001|Extended Induction Period|Adverse Event|1|||
143272854|NCT03758443|516553139|FG002|Extended Induction Period|Adverse Event|0|||
143272855|NCT03758443|516553140|FG003|Extended Induction Period|Adverse Event|1|||
143272856|NCT03758443|516553137|FG000|Extended Induction Period|Lost to Follow-up|1|||
143272857|NCT03758443|516553138|FG001|Extended Induction Period|Lost to Follow-up|0|||
143272858|NCT03758443|516553139|FG002|Extended Induction Period|Lost to Follow-up|0|||
143272859|NCT03758443|516553140|FG003|Extended Induction Period|Lost to Follow-up|0|||
143272860|NCT03758443|516553137|FG000|Extended Induction Period|Physician Decision|2|||
143272861|NCT03758443|516553138|FG001|Extended Induction Period|Physician Decision|1|||
143272862|NCT03758443|516553139|FG002|Extended Induction Period|Physician Decision|2|||
143272863|NCT03758443|516553140|FG003|Extended Induction Period|Physician Decision|2|||
143272864|NCT03758443|516553137|FG000|Extended Induction Period|Protocol Violation|0|||
143272865|NCT03758443|516553138|FG001|Extended Induction Period|Protocol Violation|0|||
143272866|NCT03758443|516553139|FG002|Extended Induction Period|Protocol Violation|0|||
143272867|NCT03758443|516553140|FG003|Extended Induction Period|Protocol Violation|1|||
143272868|NCT03758443|516553137|FG000|Extended Induction Period|Withdrawal by Subject|8|||
143272869|NCT03758443|516553138|FG001|Extended Induction Period|Withdrawal by Subject|1|||
143272870|NCT03758443|516553139|FG002|Extended Induction Period|Withdrawal by Subject|7|||
143272871|NCT03758443|516553140|FG003|Extended Induction Period|Withdrawal by Subject|3|||
143272872|NCT03758443|516553137|FG000|Extended Induction Period|Miscellaneous|1|||
143272873|NCT03758443|516553138|FG001|Extended Induction Period|Miscellaneous|0|||
143272874|NCT03758443|516553139|FG002|Extended Induction Period|Miscellaneous|0|||
143272875|NCT03758443|516553140|FG003|Extended Induction Period|Miscellaneous|0|||
143272876|NCT03758443|516553137|FG000|Maintenance Period|Adverse Event|1|||
143272877|NCT03758443|516553138|FG001|Maintenance Period|Adverse Event|2|||
143272878|NCT03758443|516553139|FG002|Maintenance Period|Adverse Event|0|||
143272879|NCT03758443|516553140|FG003|Maintenance Period|Adverse Event|0|||
143272880|NCT03758443|516553137|FG000|Maintenance Period|Lost to Follow-up|0|||
143272881|NCT03758443|516553138|FG001|Maintenance Period|Lost to Follow-up|0|||
143272882|NCT03758443|516553139|FG002|Maintenance Period|Lost to Follow-up|0|||
143272883|NCT03758443|516553140|FG003|Maintenance Period|Lost to Follow-up|1|||
143272884|NCT03758443|516553137|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
143272885|NCT03758443|516553138|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
143272886|NCT03758443|516553139|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
143272887|NCT03758443|516553140|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
143272888|NCT03758443|516553137|FG000|Maintenance Period|Protocol Violation|0|||
143272889|NCT03758443|516553138|FG001|Maintenance Period|Protocol Violation|1|||
143272890|NCT03758443|516553139|FG002|Maintenance Period|Protocol Violation|0|||
143272891|NCT03758443|516553140|FG003|Maintenance Period|Protocol Violation|0|||
143272892|NCT03758443|516553137|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
143272893|NCT03758443|516553138|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
143272894|NCT03758443|516553139|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
143272895|NCT03758443|516553140|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
143272896|NCT03758443|516553137|FG000|Maintenance Period|Withdrawal by Subject|1|||
143272897|NCT03758443|516553138|FG001|Maintenance Period|Withdrawal by Subject|0|||
143272898|NCT03758443|516553139|FG002|Maintenance Period|Withdrawal by Subject|1|||
143272899|NCT03758443|516553140|FG003|Maintenance Period|Withdrawal by Subject|1|||
143272900|NCT03758443|516553137|FG000|Maintenance Period|Miscellaneous|0|||
143272901|NCT03758443|516553138|FG001|Maintenance Period|Miscellaneous|0|||
143272902|NCT03758443|516553139|FG002|Maintenance Period|Miscellaneous|1|||
143272903|NCT03758443|516553140|FG003|Maintenance Period|Miscellaneous|0|||
143272904|NCT02202980|516553141|FG000|Overall Study|Lack of Efficacy|1|||
143272905|NCT02202980|516553142|FG001|Overall Study|Lack of Efficacy|0|||
143272906|NCT02202980|516553143|FG002|Overall Study|Lack of Efficacy|7|||
143272907|NCT02202980|516553144|FG003|Overall Study|Lack of Efficacy|0|||
143229135|NCT00667888|516387127|FG001|Overall Study|Withdrawal by Subject|3|||
143229136|NCT00667888|516387126|FG000|Overall Study|Proceed with other treatment|3|||
143229137|NCT00667888|516387127|FG001|Overall Study|Proceed with other treatment|3|||
143229138|NCT00667888|516387126|FG000|Overall Study|Ineligible after SIM|0|||
143229139|NCT00667888|516387127|FG001|Overall Study|Ineligible after SIM|2|||
143229140|NCT01945021|516387128|FG000|Overall Study|Adverse Event|1|||
143229141|NCT01945021|516387128|FG000|Overall Study|Withdrawal of consent|12|||
143229142|NCT01945021|516387128|FG000|Overall Study|Lost to Follow-up|5|||
143229143|NCT01945021|516387128|FG000|Overall Study|Death|65|||
143229144|NCT02163902|516387129|FG000|Overall Study|Subject's Request|3|||
143229145|NCT02163902|516387130|FG001|Overall Study|Subject's Request|4|||
143229146|NCT02163902|516387129|FG000|Overall Study|Lost to Follow-up|6|||
143229147|NCT02163902|516387130|FG001|Overall Study|Lost to Follow-up|7|||
143229148|NCT02163902|516387129|FG000|Overall Study|Administrative Decision|2|||
143229149|NCT02163902|516387130|FG001|Overall Study|Administrative Decision|2|||
143229150|NCT00883779|516387131|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
143229151|NCT00883779|516387132|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
143229152|NCT00883779|516387131|FG000|Primary Study Treatment Phase|Disease progression|75|||
143229153|NCT00883779|516387132|FG001|Primary Study Treatment Phase|Disease progression|59|||
143229154|NCT00883779|516387131|FG000|Primary Study Treatment Phase|Adverse Event|16|||
143229155|NCT00883779|516387132|FG001|Primary Study Treatment Phase|Adverse Event|16|||
143229156|NCT00883779|516387131|FG000|Primary Study Treatment Phase|Death|2|||
143229157|NCT00883779|516387132|FG001|Primary Study Treatment Phase|Death|3|||
143229158|NCT00883779|516387131|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
143229159|NCT00883779|516387132|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
143229160|NCT00883779|516387131|FG000|Primary Study Treatment Phase|Other|3|||
143229161|NCT00883779|516387132|FG001|Primary Study Treatment Phase|Other|0|||
143229162|NCT00883779|516387131|FG000|Post-Study Treatment Phase|Adverse Event|2|||
143229163|NCT00883779|516387132|FG001|Post-Study Treatment Phase|Adverse Event|3|||
143229164|NCT00883779|516387131|FG000|Post-Study Treatment Phase|Death|1|||
143229165|NCT00883779|516387132|FG001|Post-Study Treatment Phase|Death|3|||
143229166|NCT00883779|516387131|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
143229167|NCT00883779|516387132|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
143229168|NCT00883779|516387131|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
143229169|NCT00883779|516387132|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
143229170|NCT00883779|516387131|FG000|Post-Study Treatment Phase|Disease progression|103|||
143229171|NCT00883779|516387132|FG001|Post-Study Treatment Phase|Disease progression|122|||
143229172|NCT00883779|516387131|FG000|Post-Study Treatment Phase|Other|3|||
143229173|NCT00883779|516387132|FG001|Post-Study Treatment Phase|Other|0|||
143229174|NCT00883779|516387131|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
143229175|NCT00883779|516387132|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
143229176|NCT00883779|516387131|FG000|Off-study Phase|Death|185|||
143229177|NCT00883779|516387132|FG001|Off-study Phase|Death|174|||
143229178|NCT00883779|516387131|FG000|Off-study Phase|Refused treatment|1|||
143229179|NCT00883779|516387132|FG001|Off-study Phase|Refused treatment|1|||
143229180|NCT00883779|516387131|FG000|Off-study Phase|Failure to return|5|||
143229181|NCT00883779|516387132|FG001|Off-study Phase|Failure to return|6|||
143229182|NCT00883779|516387131|FG000|Off-study Phase|Other|18|||
143229183|NCT00883779|516387132|FG001|Off-study Phase|Other|21|||
143229184|NCT02140047|516387133|FG000|Overall Study|Withdrawal by parent/guardian|1|||
143229185|NCT02140047|516387134|FG001|Overall Study|Withdrawal by parent/guardian|1|||
143229186|NCT02140047|516387135|FG002|Overall Study|Withdrawal by parent/guardian|0|||
143229187|NCT00499681|516387136|FG000|Overall Study|toxicity|0|||
143229188|NCT00499681|516387137|FG001|Overall Study|toxicity|1|||
143229189|NCT00499681|516387136|FG000|Overall Study|disease progression|0|||
143229190|NCT00499681|516387137|FG001|Overall Study|disease progression|1|||
143229191|NCT00079040|516387138|FG000|Overall Study|Withdrew before treatment|1|||
143229192|NCT00079040|516387138|FG000|Overall Study|Ineligible|1|||
143229193|NCT03119259|516387139|FG000|Overall Study|Withdrawn as no longer eligible|1|||
143229194|NCT03119259|516387140|FG001|Overall Study|Withdrawn as no longer eligible|0|||
143229195|NCT03119259|516387139|FG000|Overall Study|Withdrawal by Subject|4|||
143229196|NCT03119259|516387140|FG001|Overall Study|Withdrawal by Subject|2|||
143229197|NCT03119259|516387139|FG000|Overall Study|Lost to Follow-up|0|||
143229198|NCT03119259|516387140|FG001|Overall Study|Lost to Follow-up|1|||
143229199|NCT00739401|516387145|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
143229200|NCT00739401|516387145|FG000|Overall Study|Death|3|||
143229201|NCT00739401|516387145|FG000|Overall Study|Withdrawal by Subject|4|||
143229202|NCT03748823|516387146|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
143229203|NCT03748823|516387147|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
143229204|NCT03748823|516387146|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
143229205|NCT03748823|516387147|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
143229206|NCT03748823|516387146|FG000|Extension Period|Withdrawal by Subject|9|||
143229207|NCT03748823|516387147|FG001|Extension Period|Withdrawal by Subject|12|||
143229208|NCT03748823|516387146|FG000|Extension Period|Death|2|||
143272908|NCT02202980|516553145|FG004|Overall Study|Lack of Efficacy|3|||
143272909|NCT02202980|516553146|FG005|Overall Study|Lack of Efficacy|1|||
143272910|NCT02202980|516553147|FG006|Overall Study|Lack of Efficacy|11|||
143272911|NCT02202980|516553148|FG007|Overall Study|Lack of Efficacy|2|||
143272912|NCT02202980|516553149|FG008|Overall Study|Lack of Efficacy|2|||
143272913|NCT02202980|516553150|FG009|Overall Study|Lack of Efficacy|0|||
143272914|NCT02202980|516553151|FG010|Overall Study|Lack of Efficacy|0|||
143272915|NCT02202980|516553152|FG011|Overall Study|Lack of Efficacy|3|||
143272916|NCT02202980|516553153|FG012|Overall Study|Lack of Efficacy|10|||
143272917|NCT02202980|516553154|FG013|Overall Study|Lack of Efficacy|0|||
143272918|NCT02202980|516553141|FG000|Overall Study|Protocol Violation|0|||
143272919|NCT02202980|516553142|FG001|Overall Study|Protocol Violation|0|||
143272920|NCT02202980|516553143|FG002|Overall Study|Protocol Violation|0|||
143272921|NCT02202980|516553144|FG003|Overall Study|Protocol Violation|3|||
143272922|NCT02202980|516553145|FG004|Overall Study|Protocol Violation|3|||
143272923|NCT02202980|516553146|FG005|Overall Study|Protocol Violation|0|||
143272924|NCT02202980|516553147|FG006|Overall Study|Protocol Violation|0|||
143272925|NCT02202980|516553148|FG007|Overall Study|Protocol Violation|0|||
143272926|NCT02202980|516553149|FG008|Overall Study|Protocol Violation|0|||
143272927|NCT02202980|516553150|FG009|Overall Study|Protocol Violation|0|||
143272928|NCT02202980|516553151|FG010|Overall Study|Protocol Violation|0|||
143272929|NCT02202980|516553152|FG011|Overall Study|Protocol Violation|0|||
143272930|NCT02202980|516553153|FG012|Overall Study|Protocol Violation|0|||
143272931|NCT02202980|516553154|FG013|Overall Study|Protocol Violation|0|||
143272932|NCT02202980|516553141|FG000|Overall Study|Lost to Follow-up|0|||
143272933|NCT02202980|516553142|FG001|Overall Study|Lost to Follow-up|1|||
143272934|NCT02202980|516553143|FG002|Overall Study|Lost to Follow-up|1|||
143272935|NCT02202980|516553144|FG003|Overall Study|Lost to Follow-up|1|||
143272936|NCT02202980|516553145|FG004|Overall Study|Lost to Follow-up|0|||
143272937|NCT02202980|516553146|FG005|Overall Study|Lost to Follow-up|0|||
143272938|NCT02202980|516553147|FG006|Overall Study|Lost to Follow-up|0|||
143272939|NCT02202980|516553148|FG007|Overall Study|Lost to Follow-up|1|||
143272940|NCT02202980|516553149|FG008|Overall Study|Lost to Follow-up|1|||
143272941|NCT02202980|516553150|FG009|Overall Study|Lost to Follow-up|0|||
143272942|NCT02202980|516553151|FG010|Overall Study|Lost to Follow-up|0|||
143272943|NCT02202980|516553152|FG011|Overall Study|Lost to Follow-up|0|||
143272944|NCT02202980|516553153|FG012|Overall Study|Lost to Follow-up|1|||
143272945|NCT02202980|516553154|FG013|Overall Study|Lost to Follow-up|0|||
143272946|NCT02202980|516553141|FG000|Overall Study|Withdrew Consent|0|||
143272947|NCT02202980|516553142|FG001|Overall Study|Withdrew Consent|1|||
143272948|NCT02202980|516553143|FG002|Overall Study|Withdrew Consent|2|||
143272949|NCT02202980|516553144|FG003|Overall Study|Withdrew Consent|0|||
143272950|NCT02202980|516553145|FG004|Overall Study|Withdrew Consent|0|||
143272951|NCT02202980|516553146|FG005|Overall Study|Withdrew Consent|0|||
143272952|NCT02202980|516553147|FG006|Overall Study|Withdrew Consent|0|||
143272953|NCT02202980|516553148|FG007|Overall Study|Withdrew Consent|0|||
143272954|NCT02202980|516553149|FG008|Overall Study|Withdrew Consent|1|||
143272955|NCT02202980|516553150|FG009|Overall Study|Withdrew Consent|0|||
143272956|NCT02202980|516553151|FG010|Overall Study|Withdrew Consent|0|||
143272957|NCT02202980|516553152|FG011|Overall Study|Withdrew Consent|0|||
143272958|NCT02202980|516553153|FG012|Overall Study|Withdrew Consent|0|||
143272959|NCT02202980|516553154|FG013|Overall Study|Withdrew Consent|0|||
143272960|NCT01522248|516553155|FG000|Overall Study|Lost to Follow-up|1|||
143272961|NCT01522248|516553156|FG001|Overall Study|Lost to Follow-up|0|||
143272962|NCT04138810|516553161|FG000|Overall Study|Withdrawal by Subject|0|||
143272963|NCT04138810|516553162|FG001|Overall Study|Withdrawal by Subject|1|||
143272964|NCT04138810|516553161|FG000|Overall Study|Subject cancelled surgery|1|||
143272965|NCT04138810|516553162|FG001|Overall Study|Subject cancelled surgery|0|||
143272966|NCT00696800|516553163|FG000|Overall Study|Adverse Event|16|||
143272967|NCT00696800|516553164|FG001|Overall Study|Adverse Event|3|||
143272968|NCT00696800|516553163|FG000|Overall Study|Insufficient compliance with medication|2|||
143272969|NCT00696800|516553164|FG001|Overall Study|Insufficient compliance with medication|1|||
143272970|NCT00696800|516553163|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
143272971|NCT00696800|516553164|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
143272972|NCT00696800|516553163|FG000|Overall Study|Insufficient ovarian response|4|||
143272973|NCT00696800|516553164|FG001|Overall Study|Insufficient ovarian response|1|||
143272974|NCT00696800|516553163|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
143272975|NCT00696800|516553164|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
143272976|NCT00696800|516553163|FG000|Overall Study|Too high ovarian response|6|||
143272977|NCT00696800|516553164|FG001|Overall Study|Too high ovarian response|1|||
143272978|NCT00696800|516553163|FG000|Overall Study|No/too few/bad quality oocytes|4|||
143272979|NCT00696800|516553164|FG001|Overall Study|No/too few/bad quality oocytes|3|||
143272980|NCT00696800|516553163|FG000|Overall Study|No/abnormal fertilization|11|||
143272981|NCT00696800|516553164|FG001|Overall Study|No/abnormal fertilization|13|||
143272982|NCT00696800|516553163|FG000|Overall Study|No/too few/bad quality embryos|24|||
143272983|NCT00696800|516553164|FG001|Overall Study|No/too few/bad quality embryos|18|||
143272984|NCT00696800|516553163|FG000|Overall Study|Other Reasons|5|||
143272985|NCT00696800|516553164|FG001|Overall Study|Other Reasons|3|||
143272986|NCT00696800|516553163|FG000|Overall Study|Not treated|1|||
143272987|NCT00696800|516553164|FG001|Overall Study|Not treated|2|||
143272988|NCT00591344|516553165|FG000|Overall Study|Transportation issues|1|||
143272989|NCT00591344|516553166|FG001|Overall Study|Transportation issues|0|||
143272990|NCT00591344|516553165|FG000|Overall Study|Moved out of state|1|||
143272991|NCT00591344|516553166|FG001|Overall Study|Moved out of state|0|||
143272992|NCT00591344|516553165|FG000|Overall Study|Medical complications|1|||
143272993|NCT00591344|516553166|FG001|Overall Study|Medical complications|3|||
143272994|NCT00591344|516553165|FG000|Overall Study|Underwent DBS|2|||
143272995|NCT00591344|516553166|FG001|Overall Study|Underwent DBS|2|||
143272996|NCT00591344|516553165|FG000|Overall Study|Death|0|||
143272997|NCT00591344|516553166|FG001|Overall Study|Death|1|||
143272998|NCT00591344|516553165|FG000|Overall Study|Lost to Follow-up|0|||
143272999|NCT00591344|516553166|FG001|Overall Study|Lost to Follow-up|1|||
143273000|NCT00591344|516553165|FG000|Overall Study|Did not want to come off medication|0|||
143273001|NCT00591344|516553166|FG001|Overall Study|Did not want to come off medication|1|||
143273002|NCT02404220|516553180|FG000|Overall Study|Adverse Event|0|||
143273003|NCT02404220|516553181|FG001|Overall Study|Adverse Event|0|||
143273004|NCT02404220|516553182|FG002|Overall Study|Adverse Event|1|||
143273005|NCT02404220|516553183|FG003|Overall Study|Adverse Event|0|||
143273006|NCT02404220|516553180|FG000|Overall Study|Death|5|||
143273007|NCT02404220|516553181|FG001|Overall Study|Death|5|||
143273008|NCT02404220|516553182|FG002|Overall Study|Death|3|||
143273009|NCT02404220|516553183|FG003|Overall Study|Death|8|||
143273010|NCT02404220|516553180|FG000|Overall Study|Progressive Disease|0|||
143273011|NCT02404220|516553181|FG001|Overall Study|Progressive Disease|0|||
143273012|NCT02404220|516553182|FG002|Overall Study|Progressive Disease|1|||
143273013|NCT02404220|516553183|FG003|Overall Study|Progressive Disease|1|||
143273014|NCT02404220|516553180|FG000|Overall Study|Study Terminated by Sponsor|0|||
143273015|NCT02404220|516553181|FG001|Overall Study|Study Terminated by Sponsor|0|||
143273016|NCT02404220|516553182|FG002|Overall Study|Study Terminated by Sponsor|2|||
143273017|NCT02404220|516553183|FG003|Overall Study|Study Terminated by Sponsor|1|||
143273018|NCT02404220|516553180|FG000|Overall Study|Withdrawal by Subject|0|||
143273019|NCT02404220|516553181|FG001|Overall Study|Withdrawal by Subject|1|||
143273020|NCT02404220|516553182|FG002|Overall Study|Withdrawal by Subject|0|||
143273021|NCT02404220|516553183|FG003|Overall Study|Withdrawal by Subject|0|||
143273022|NCT02404220|516553180|FG000|Overall Study|Enrolled but Never Treated|0|||
143273023|NCT02404220|516553181|FG001|Overall Study|Enrolled but Never Treated|2|||
143273024|NCT02404220|516553182|FG002|Overall Study|Enrolled but Never Treated|0|||
143273025|NCT02404220|516553183|FG003|Overall Study|Enrolled but Never Treated|0|||
143273026|NCT02639546|516553184|FG000|Overall Study|Death|2|||
143273027|NCT02639546|516553185|FG001|Overall Study|Death|2|||
143273028|NCT02639546|516553186|FG002|Overall Study|Death|1|||
143273029|NCT02639546|516553187|FG003|Overall Study|Death|2|||
143273030|NCT02639546|516553188|FG004|Overall Study|Death|2|||
143273031|NCT02639546|516553189|FG005|Overall Study|Death|2|||
143273032|NCT02639546|516553190|FG006|Overall Study|Death|0|||
143273033|NCT02639546|516553191|FG007|Overall Study|Death|0|||
143273034|NCT02639546|516553184|FG000|Overall Study|Lost to Follow-up|0|||
143273035|NCT02639546|516553185|FG001|Overall Study|Lost to Follow-up|0|||
143273036|NCT02639546|516553186|FG002|Overall Study|Lost to Follow-up|1|||
143273037|NCT02639546|516553187|FG003|Overall Study|Lost to Follow-up|0|||
143273038|NCT02639546|516553188|FG004|Overall Study|Lost to Follow-up|1|||
143273039|NCT02639546|516553189|FG005|Overall Study|Lost to Follow-up|1|||
143273040|NCT02639546|516553190|FG006|Overall Study|Lost to Follow-up|0|||
143273041|NCT02639546|516553191|FG007|Overall Study|Lost to Follow-up|1|||
143273042|NCT02639546|516553184|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
143273043|NCT02639546|516553185|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
143273044|NCT02639546|516553186|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
143273045|NCT02639546|516553187|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
143273046|NCT02639546|516553188|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
143273047|NCT02639546|516553189|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
143273048|NCT02639546|516553190|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
143273049|NCT02639546|516553191|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
143273050|NCT02639546|516553184|FG000|Overall Study|Study Terminated By Sponsor|0|||
143273051|NCT02639546|516553185|FG001|Overall Study|Study Terminated By Sponsor|2|||
143273052|NCT02639546|516553186|FG002|Overall Study|Study Terminated By Sponsor|3|||
143273053|NCT02639546|516553187|FG003|Overall Study|Study Terminated By Sponsor|4|||
143273054|NCT02639546|516553188|FG004|Overall Study|Study Terminated By Sponsor|4|||
143273055|NCT02639546|516553189|FG005|Overall Study|Study Terminated By Sponsor|3|||
143273056|NCT02639546|516553190|FG006|Overall Study|Study Terminated By Sponsor|3|||
143273057|NCT02639546|516553191|FG007|Overall Study|Study Terminated By Sponsor|9|||
143273058|NCT02639546|516553184|FG000|Overall Study|Withdrawal by Subject|2|||
143273059|NCT02639546|516553185|FG001|Overall Study|Withdrawal by Subject|2|||
143273060|NCT02639546|516553186|FG002|Overall Study|Withdrawal by Subject|1|||
143273061|NCT02639546|516553187|FG003|Overall Study|Withdrawal by Subject|0|||
143273062|NCT02639546|516553188|FG004|Overall Study|Withdrawal by Subject|0|||
143273063|NCT02639546|516553189|FG005|Overall Study|Withdrawal by Subject|1|||
143273064|NCT02639546|516553190|FG006|Overall Study|Withdrawal by Subject|2|||
143273065|NCT02639546|516553191|FG007|Overall Study|Withdrawal by Subject|1|||
143273066|NCT00116428|516553192|FG000|Overall Study|Withdrawal by Subject|2|||
143273067|NCT00116428|516553193|FG001|Overall Study|Withdrawal by Subject|5|||
143273068|NCT00116428|516553192|FG000|Overall Study|Did not meet inclusion criteria|1|||
143273069|NCT00116428|516553193|FG001|Overall Study|Did not meet inclusion criteria|0|||
143273070|NCT00113087|516553194|FG000|Overall Study|Death or Transplant|14|||
143273071|NCT00113087|516553195|FG001|Overall Study|Death or Transplant|16|||
143273072|NCT00113087|516553194|FG000|Overall Study|Family or MD withdrew subject|10|||
143273073|NCT00113087|516553195|FG001|Overall Study|Family or MD withdrew subject|5|||
143273074|NCT03452228|516553196|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
143273075|NCT03452228|516553197|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
143273076|NCT03452228|516553198|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
143273077|NCT03452228|516553196|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
143273078|NCT03452228|516553197|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
143273079|NCT03452228|516553198|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
143273080|NCT03452228|516553196|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
143273081|NCT03452228|516553197|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
143273082|NCT03452228|516553198|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
143273083|NCT03452228|516553196|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
143273084|NCT03452228|516553197|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
143273085|NCT03452228|516553198|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
143273086|NCT00386607|516553199|FG000|Core|Adverse Event|40|||
143273087|NCT00386607|516553200|FG001|Core|Adverse Event|0|||
143273088|NCT00386607|516553199|FG000|Core|Abnormal laboratory value(s)|3|||
143273089|NCT00386607|516553200|FG001|Core|Abnormal laboratory value(s)|0|||
143273090|NCT00386607|516553199|FG000|Core|Unsatisfactory therapeutic effect|23|||
143273091|NCT00386607|516553200|FG001|Core|Unsatisfactory therapeutic effect|0|||
143273092|NCT00386607|516553199|FG000|Core|Condition no longer requires study drug|4|||
143273093|NCT00386607|516553200|FG001|Core|Condition no longer requires study drug|0|||
143273094|NCT00386607|516553199|FG000|Core|Patient withdrew consent|15|||
143273095|NCT00386607|516553200|FG001|Core|Patient withdrew consent|0|||
143273096|NCT00386607|516553199|FG000|Core|Lost to Follow-up|23|||
143273097|NCT00386607|516553200|FG001|Core|Lost to Follow-up|0|||
143273098|NCT00386607|516553199|FG000|Core|Administrative problems|1|||
143273099|NCT00386607|516553200|FG001|Core|Administrative problems|0|||
143273100|NCT00386607|516553199|FG000|Core|Protocol Deviation|6|||
143273101|NCT00386607|516553200|FG001|Core|Protocol Deviation|0|||
143273102|NCT00386607|516553199|FG000|Extension|Adverse Event|0|||
143273103|NCT00386607|516553200|FG001|Extension|Adverse Event|6|||
143273104|NCT00386607|516553199|FG000|Extension|Abnormal laboratory value(s)|0|||
143273105|NCT00386607|516553200|FG001|Extension|Abnormal laboratory value(s)|1|||
143273106|NCT00386607|516553199|FG000|Extension|Administrative problems|0|||
143273107|NCT00386607|516553200|FG001|Extension|Administrative problems|1|||
143273108|NCT00386607|516553199|FG000|Extension|Lost to Follow-up|0|||
143273109|NCT00386607|516553200|FG001|Extension|Lost to Follow-up|3|||
143273110|NCT00386607|516553199|FG000|Extension|Patient withdrew consent|0|||
143273111|NCT00386607|516553200|FG001|Extension|Patient withdrew consent|5|||
143273112|NCT00386607|516553199|FG000|Extension|Unsatisfactory therapeutic effect|0|||
143273113|NCT00386607|516553200|FG001|Extension|Unsatisfactory therapeutic effect|1|||
143273114|NCT01262573|516553201|FG000|Overall Study|Withdrawal by Subject|0|||
143273115|NCT01262573|516553202|FG001|Overall Study|Withdrawal by Subject|1|||
143273116|NCT04402060|516553203|FG000|Overall Study|Death|1|||
143273117|NCT04402060|516553204|FG001|Overall Study|Death|12|||
143273118|NCT04402060|516553205|FG002|Overall Study|Death|7|||
143273119|NCT04402060|516553203|FG000|Overall Study|Adverse Event|0|||
143273120|NCT04402060|516553204|FG001|Overall Study|Adverse Event|0|||
143273121|NCT04402060|516553205|FG002|Overall Study|Adverse Event|1|||
143273122|NCT04402060|516553203|FG000|Overall Study|Withdrawal by Subject|0|||
143273123|NCT04402060|516553204|FG001|Overall Study|Withdrawal by Subject|1|||
143273124|NCT04402060|516553205|FG002|Overall Study|Withdrawal by Subject|2|||
143273125|NCT04402060|516553203|FG000|Overall Study|Sponsor Request|0|||
143273126|NCT04402060|516553204|FG001|Overall Study|Sponsor Request|2|||
143273127|NCT04402060|516553205|FG002|Overall Study|Sponsor Request|0|||
143273128|NCT04402060|516553203|FG000|Overall Study|Physician Decision|0|||
143273129|NCT04402060|516553204|FG001|Overall Study|Physician Decision|0|||
143273130|NCT04402060|516553205|FG002|Overall Study|Physician Decision|1|||
143273131|NCT04402060|516553203|FG000|Overall Study|Other|0|||
143273132|NCT04402060|516553204|FG001|Overall Study|Other|1|||
143273133|NCT04402060|516553205|FG002|Overall Study|Other|0|||
143273134|NCT01297920|516553206|FG000|Overall Study|Adverse Event|42|||
143273135|NCT01297920|516553207|FG001|Overall Study|Adverse Event|10|||
143273136|NCT01297920|516553208|FG002|Overall Study|Adverse Event|38|||
143273137|NCT01297920|516553206|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
143273138|NCT01297920|516553207|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
143273139|NCT01297920|516553208|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
143273140|NCT01297920|516553206|FG000|Overall Study|Noncompliance|1|||
143273141|NCT01297920|516553207|FG001|Overall Study|Noncompliance|0|||
143273142|NCT01297920|516553208|FG002|Overall Study|Noncompliance|0|||
143273143|NCT01297920|516553206|FG000|Overall Study|Protocol Violation|1|||
143273144|NCT01297920|516553207|FG001|Overall Study|Protocol Violation|3|||
143273145|NCT01297920|516553208|FG002|Overall Study|Protocol Violation|0|||
143273146|NCT01297920|516553206|FG000|Overall Study|Inadequate Control of IOP|7|||
143273147|NCT01297920|516553207|FG001|Overall Study|Inadequate Control of IOP|9|||
143273148|NCT01297920|516553208|FG002|Overall Study|Inadequate Control of IOP|17|||
143273149|NCT01297920|516553206|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
143273150|NCT01297920|516553207|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
143273151|NCT01297920|516553208|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
143273152|NCT03800173|516553210|FG000|Overall Study|Lost to Follow-up|0|||
143273153|NCT03800173|516553211|FG001|Overall Study|Lost to Follow-up|0|||
143273154|NCT03800173|516553212|FG002|Overall Study|Lost to Follow-up|0|||
143273155|NCT03800173|516553213|FG003|Overall Study|Lost to Follow-up|0|||
143273156|NCT03800173|516553214|FG004|Overall Study|Lost to Follow-up|1|||
143273157|NCT00474760|516553215|FG000|Overall Study|Death|0|||
143273158|NCT00474760|516553216|FG001|Overall Study|Death|0|||
143273159|NCT00474760|516553217|FG002|Overall Study|Death|0|||
143273160|NCT00474760|516553218|FG003|Overall Study|Death|0|||
143273161|NCT00474760|516553219|FG004|Overall Study|Death|2|||
143273162|NCT00474760|516553220|FG005|Overall Study|Death|0|||
143273163|NCT00474760|516553221|FG006|Overall Study|Death|0|||
143273164|NCT00474760|516553215|FG000|Overall Study|Adverse Event|0|||
143273165|NCT00474760|516553216|FG001|Overall Study|Adverse Event|0|||
143273166|NCT00474760|516553217|FG002|Overall Study|Adverse Event|0|||
143273167|NCT00474760|516553218|FG003|Overall Study|Adverse Event|0|||
143273168|NCT00474760|516553219|FG004|Overall Study|Adverse Event|1|||
143273169|NCT00474760|516553220|FG005|Overall Study|Adverse Event|7|||
143273170|NCT00474760|516553221|FG006|Overall Study|Adverse Event|0|||
143273171|NCT00474760|516553215|FG000|Overall Study|Laboratory abnormality|0|||
143273172|NCT00474760|516553216|FG001|Overall Study|Laboratory abnormality|0|||
143273173|NCT00474760|516553217|FG002|Overall Study|Laboratory abnormality|0|||
143273174|NCT00474760|516553218|FG003|Overall Study|Laboratory abnormality|0|||
143273175|NCT00474760|516553219|FG004|Overall Study|Laboratory abnormality|0|||
143273176|NCT00474760|516553220|FG005|Overall Study|Laboratory abnormality|1|||
143273177|NCT00474760|516553221|FG006|Overall Study|Laboratory abnormality|0|||
143273178|NCT00474760|516553215|FG000|Overall Study|Withdrawal by Subject|0|||
143273179|NCT00474760|516553216|FG001|Overall Study|Withdrawal by Subject|0|||
143273180|NCT00474760|516553217|FG002|Overall Study|Withdrawal by Subject|0|||
143273181|NCT00474760|516553218|FG003|Overall Study|Withdrawal by Subject|1|||
143273182|NCT00474760|516553219|FG004|Overall Study|Withdrawal by Subject|0|||
143273183|NCT00474760|516553220|FG005|Overall Study|Withdrawal by Subject|1|||
143273184|NCT00474760|516553221|FG006|Overall Study|Withdrawal by Subject|1|||
143273185|NCT00474760|516553215|FG000|Overall Study|Other|0|||
143273186|NCT00474760|516553216|FG001|Overall Study|Other|1|||
143273187|NCT00474760|516553217|FG002|Overall Study|Other|0|||
143273188|NCT00474760|516553218|FG003|Overall Study|Other|0|||
143273189|NCT00474760|516553219|FG004|Overall Study|Other|1|||
143273190|NCT00474760|516553220|FG005|Overall Study|Other|0|||
143273191|NCT00474760|516553221|FG006|Overall Study|Other|0|||
143273192|NCT00474760|516553215|FG000|Overall Study|Progressive disease|3|||
143273193|NCT00474760|516553216|FG001|Overall Study|Progressive disease|2|||
143273194|NCT00474760|516553217|FG002|Overall Study|Progressive disease|3|||
143273195|NCT00474760|516553218|FG003|Overall Study|Progressive disease|2|||
143273196|NCT00474760|516553219|FG004|Overall Study|Progressive disease|8|||
143273197|NCT00474760|516553220|FG005|Overall Study|Progressive disease|20|||
143273198|NCT00474760|516553221|FG006|Overall Study|Progressive disease|7|||
143229209|NCT03748823|516387147|FG001|Extension Period|Death|2|||
143229210|NCT03748823|516387146|FG000|Extension Period|Other than Specified|0|||
143229211|NCT03748823|516387147|FG001|Extension Period|Other than Specified|1|||
143229212|NCT03748823|516387146|FG000|Extension Period|Protocol Violation|1|||
143229213|NCT03748823|516387147|FG001|Extension Period|Protocol Violation|0|||
143229214|NCT03748823|516387146|FG000|Extension Period|Lost to Follow-up|0|||
143229215|NCT03748823|516387147|FG001|Extension Period|Lost to Follow-up|1|||
143229216|NCT03748823|516387146|FG000|Extension Period|Lack of Efficacy|0|||
143229217|NCT03748823|516387147|FG001|Extension Period|Lack of Efficacy|1|||
143229218|NCT03748823|516387146|FG000|Extension Period|Physician Decision|1|||
143229219|NCT03748823|516387147|FG001|Extension Period|Physician Decision|2|||
143229220|NCT01664910|516387150|FG000|Overall Study|Adverse Event|0|||
143229221|NCT01664910|516387151|FG001|Overall Study|Adverse Event|0|||
143229222|NCT01664910|516387152|FG002|Overall Study|Adverse Event|1|||
143229223|NCT00651924|516387155|FG000|Overall Study|Withdrawal by PI|0|||
143229224|NCT00651924|516387156|FG001|Overall Study|Withdrawal by PI|2|||
143229225|NCT00651924|516387155|FG000|Overall Study|Withdrawal by Subject|0|||
143229226|NCT00651924|516387156|FG001|Overall Study|Withdrawal by Subject|5|||
143229227|NCT00960063|516387157|FG000|Overall Study|Adverse Event|1|||
143229228|NCT00960063|516387158|FG001|Overall Study|Adverse Event|0|||
143229229|NCT00960063|516387159|FG002|Overall Study|Adverse Event|0|||
143229230|NCT00960063|516387157|FG000|Overall Study|Progression of Disease|0|||
143229231|NCT00960063|516387158|FG001|Overall Study|Progression of Disease|0|||
143229232|NCT00960063|516387159|FG002|Overall Study|Progression of Disease|3|||
143229233|NCT02898454|516387160|FG000|Overall Study|Adverse Event|4|||
143229234|NCT02898454|516387161|FG001|Overall Study|Adverse Event|1|||
143229235|NCT02898454|516387162|FG002|Overall Study|Adverse Event|2|||
143229236|NCT02898454|516387160|FG000|Overall Study|Protocol Violation|1|||
143229237|NCT02898454|516387161|FG001|Overall Study|Protocol Violation|0|||
143229238|NCT02898454|516387162|FG002|Overall Study|Protocol Violation|1|||
143229239|NCT02898454|516387160|FG000|Overall Study|Lack of Efficacy|4|||
143229240|NCT02898454|516387161|FG001|Overall Study|Lack of Efficacy|1|||
143229241|NCT02898454|516387162|FG002|Overall Study|Lack of Efficacy|0|||
143229242|NCT02898454|516387160|FG000|Overall Study|Withdrawal by Subject|6|||
143229243|NCT02898454|516387161|FG001|Overall Study|Withdrawal by Subject|3|||
143229244|NCT02898454|516387162|FG002|Overall Study|Withdrawal by Subject|3|||
143229245|NCT02898454|516387160|FG000|Overall Study|Lost to Follow-up|1|||
143229246|NCT02898454|516387161|FG001|Overall Study|Lost to Follow-up|0|||
143229247|NCT02898454|516387162|FG002|Overall Study|Lost to Follow-up|0|||
143229248|NCT02898454|516387160|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
143229249|NCT02898454|516387161|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
143229250|NCT02898454|516387162|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
143229251|NCT02343263|516387163|FG000|Overall Study|Physician Decision|5|||
143229252|NCT02343263|516387164|FG001|Overall Study|Physician Decision|3|||
143229253|NCT02343263|516387165|FG002|Overall Study|Physician Decision|1|||
143229254|NCT04264442|516387168|FG000|Overall Study|Lack of Efficacy|6|||
143229255|NCT04264442|516387168|FG000|Overall Study|Lost to Follow-up|2|||
143229256|NCT04264442|516387168|FG000|Overall Study|Sponsor Decision|23|||
143229257|NCT04264442|516387168|FG000|Overall Study|Withdrawal by Subject|11|||
143229258|NCT04264442|516387168|FG000|Overall Study|Study Termination|5|||
143229259|NCT03289208|516387173|FG000|Overall Study|Adverse Event|1|||
143229260|NCT03289208|516387174|FG001|Overall Study|Adverse Event|0|||
143229261|NCT03289208|516387175|FG002|Overall Study|Adverse Event|0|||
143229262|NCT00647296|516387177|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
143229263|NCT00647296|516387178|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
143229264|NCT00647296|516387179|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
143229265|NCT00647296|516387180|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
143229266|NCT00647296|516387177|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
143229267|NCT00647296|516387178|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
143229268|NCT00647296|516387179|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
143229269|NCT00647296|516387180|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
143229270|NCT00647296|516387177|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
143229271|NCT00647296|516387178|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
143229272|NCT00647296|516387179|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
143229273|NCT00647296|516387180|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
143229274|NCT00647296|516387177|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
143229275|NCT00647296|516387178|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
143229276|NCT00647296|516387179|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
143229277|NCT00647296|516387180|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
143229278|NCT00647296|516387177|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
143229279|NCT00647296|516387178|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
143229280|NCT00647296|516387179|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
143273199|NCT00474760|516553215|FG000|Overall Study|Terminated by sponsor|0|||
143273200|NCT00474760|516553216|FG001|Overall Study|Terminated by sponsor|0|||
143273201|NCT00474760|516553217|FG002|Overall Study|Terminated by sponsor|0|||
143273202|NCT00474760|516553218|FG003|Overall Study|Terminated by sponsor|0|||
143273203|NCT00474760|516553219|FG004|Overall Study|Terminated by sponsor|0|||
143273204|NCT00474760|516553220|FG005|Overall Study|Terminated by sponsor|0|||
143273205|NCT00474760|516553221|FG006|Overall Study|Terminated by sponsor|2|||
143273206|NCT01927627|516553223|FG000|Overall Study|Adverse Event|3|||
143273207|NCT01927627|516553223|FG000|Overall Study|Lack of Efficacy|1|||
143273208|NCT01927627|516553223|FG000|Overall Study|Financial Concerns|1|||
143273209|NCT00423514|516553233|FG000|Overall Study|Ineligible|1|||
143273210|NCT00423514|516553234|FG001|Overall Study|Ineligible|0|||
143273211|NCT04729621|516553235|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
143273212|NCT04729621|516553236|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
143273213|NCT04729621|516553237|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
143273214|NCT04729621|516553238|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
143273215|NCT04729621|516553239|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
143273216|NCT04729621|516553235|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
143273217|NCT04729621|516553236|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
143273218|NCT04729621|516553237|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
143273219|NCT04729621|516553238|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
143273220|NCT04729621|516553239|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
143273221|NCT04729621|516553235|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
143273222|NCT04729621|516553236|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
143273223|NCT04729621|516553237|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
143273224|NCT04729621|516553238|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
143273225|NCT04729621|516553239|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
143273226|NCT04729621|516553235|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
143273227|NCT04729621|516553236|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
143273228|NCT04729621|516553237|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
143273229|NCT04729621|516553238|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
143273230|NCT04729621|516553239|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
143273231|NCT04729621|516553235|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
143273232|NCT04729621|516553236|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
143273233|NCT04729621|516553237|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
143273234|NCT04729621|516553238|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
143273235|NCT04729621|516553239|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
143273236|NCT04729621|516553235|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
143273237|NCT04729621|516553236|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
143273238|NCT04729621|516553237|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
143273239|NCT04729621|516553238|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
143273240|NCT04729621|516553239|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
143273241|NCT02004522|516553240|FG000|Overall Study|Adverse Event|55|||
143273242|NCT02004522|516553241|FG001|Overall Study|Adverse Event|6|||
143273243|NCT02004522|516553240|FG000|Overall Study|Withdrawal by Subject|13|||
143273244|NCT02004522|516553241|FG001|Overall Study|Withdrawal by Subject|7|||
143273245|NCT02004522|516553240|FG000|Overall Study|Death|12|||
143273246|NCT02004522|516553241|FG001|Overall Study|Death|3|||
143273247|NCT02004522|516553240|FG000|Overall Study|Physician Decision|3|||
143273248|NCT02004522|516553241|FG001|Overall Study|Physician Decision|4|||
143273249|NCT02004522|516553240|FG000|Overall Study|Protocol Violation|1|||
143273250|NCT02004522|516553241|FG001|Overall Study|Protocol Violation|0|||
143273251|NCT02004522|516553240|FG000|Overall Study|Other is reason listed by PI|4|||
143273252|NCT02004522|516553241|FG001|Overall Study|Other is reason listed by PI|1|||
143273253|NCT02004522|516553240|FG000|Overall Study|Never Dosed|2|||
143273254|NCT02004522|516553241|FG001|Overall Study|Never Dosed|4|||
143273255|NCT02004522|516553240|FG000|Overall Study|Disease Progression|35|||
143273256|NCT02004522|516553241|FG001|Overall Study|Disease Progression|31|||
143273257|NCT02004522|516553240|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
143273258|NCT02004522|516553241|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
143273259|NCT01787331|516553242|FG000|Overall Study|Physician Decision|1|||
143273260|NCT01787331|516553242|FG000|Overall Study|Withdrawal by Subject|1|||
143273261|NCT01999868|516553244|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
143273262|NCT01999868|516553245|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
143273263|NCT01999868|516553246|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
143273264|NCT01999868|516553244|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
143273265|NCT01999868|516553245|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
143273266|NCT01999868|516553246|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
143273267|NCT01999868|516553244|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
143273268|NCT01999868|516553245|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
143273269|NCT01999868|516553246|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
143273270|NCT01999868|516553244|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
143273271|NCT01999868|516553245|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
143273272|NCT01999868|516553246|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
143273273|NCT01999868|516553244|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
143273274|NCT01999868|516553245|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
143273275|NCT01999868|516553246|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
143273276|NCT01999868|516553244|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
143273277|NCT01999868|516553245|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
143273278|NCT01999868|516553246|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
143273279|NCT01999868|516553244|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
143273280|NCT01999868|516553245|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
143273281|NCT01999868|516553246|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
143273282|NCT01999868|516553244|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
143273283|NCT01999868|516553245|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
143273284|NCT01999868|516553246|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
143273285|NCT01999868|516553244|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
143273286|NCT01999868|516553245|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
143273287|NCT01999868|516553246|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
143273288|NCT01999868|516553244|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
143273289|NCT01999868|516553245|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
143273290|NCT01999868|516553246|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
143273291|NCT01999868|516553244|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
143273292|NCT01999868|516553245|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
143273293|NCT01999868|516553246|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
143273294|NCT01999868|516553244|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
143273295|NCT01999868|516553245|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
143273296|NCT01999868|516553246|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
143273297|NCT01999868|516553244|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
143273298|NCT01999868|516553245|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
143273299|NCT01999868|516553246|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
143273300|NCT01999868|516553244|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
143273301|NCT01999868|516553245|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
143273302|NCT01999868|516553246|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
143273303|NCT01999868|516553244|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
143273304|NCT01999868|516553245|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
143273305|NCT01999868|516553246|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
143273306|NCT00761631|516553247|FG000|Overall Study|Parent/legal guardian request|8|||
143273307|NCT00761631|516553248|FG001|Overall Study|Parent/legal guardian request|3|||
143273308|NCT00761631|516553249|FG002|Overall Study|Parent/legal guardian request|8|||
143273309|NCT00761631|516553250|FG003|Overall Study|Parent/legal guardian request|0|||
143273310|NCT00761631|516553251|FG004|Overall Study|Parent/legal guardian request|5|||
143273311|NCT00761631|516553252|FG005|Overall Study|Parent/legal guardian request|0|||
143273312|NCT00761631|516553247|FG000|Overall Study|Lost to Follow-up|2|||
143273313|NCT00761631|516553248|FG001|Overall Study|Lost to Follow-up|4|||
143273314|NCT00761631|516553249|FG002|Overall Study|Lost to Follow-up|7|||
143273315|NCT00761631|516553250|FG003|Overall Study|Lost to Follow-up|1|||
143273316|NCT00761631|516553251|FG004|Overall Study|Lost to Follow-up|6|||
143273317|NCT00761631|516553252|FG005|Overall Study|Lost to Follow-up|1|||
143273318|NCT00761631|516553247|FG000|Overall Study|Protocol Violation|2|||
143273319|NCT00761631|516553248|FG001|Overall Study|Protocol Violation|0|||
143273320|NCT00761631|516553249|FG002|Overall Study|Protocol Violation|0|||
143273321|NCT00761631|516553250|FG003|Overall Study|Protocol Violation|1|||
143273322|NCT00761631|516553251|FG004|Overall Study|Protocol Violation|5|||
143273323|NCT00761631|516553252|FG005|Overall Study|Protocol Violation|1|||
143273324|NCT00761631|516553247|FG000|Overall Study|Randomized, not treated|1|||
143273325|NCT00761631|516553248|FG001|Overall Study|Randomized, not treated|0|||
143273326|NCT00761631|516553249|FG002|Overall Study|Randomized, not treated|0|||
143273327|NCT00761631|516553250|FG003|Overall Study|Randomized, not treated|0|||
143273328|NCT00761631|516553251|FG004|Overall Study|Randomized, not treated|0|||
143273329|NCT00761631|516553252|FG005|Overall Study|Randomized, not treated|0|||
143273330|NCT00761631|516553247|FG000|Overall Study|Failed to return|1|||
143273331|NCT00761631|516553248|FG001|Overall Study|Failed to return|0|||
143273332|NCT00761631|516553249|FG002|Overall Study|Failed to return|1|||
143273333|NCT00761631|516553250|FG003|Overall Study|Failed to return|1|||
143273334|NCT00761631|516553251|FG004|Overall Study|Failed to return|5|||
143273335|NCT00761631|516553252|FG005|Overall Study|Failed to return|2|||
143273336|NCT00761631|516553247|FG000|Overall Study|Physician Decision|1|||
143273337|NCT00761631|516553248|FG001|Overall Study|Physician Decision|0|||
143273338|NCT00761631|516553249|FG002|Overall Study|Physician Decision|0|||
143273339|NCT00761631|516553250|FG003|Overall Study|Physician Decision|0|||
143273340|NCT00761631|516553251|FG004|Overall Study|Physician Decision|0|||
143273341|NCT00761631|516553252|FG005|Overall Study|Physician Decision|0|||
143273342|NCT00761631|516553247|FG000|Overall Study|Other|0|||
143273343|NCT00761631|516553248|FG001|Overall Study|Other|0|||
143273344|NCT00761631|516553249|FG002|Overall Study|Other|0|||
143273345|NCT00761631|516553250|FG003|Overall Study|Other|0|||
143273346|NCT00761631|516553251|FG004|Overall Study|Other|1|||
143273347|NCT00761631|516553252|FG005|Overall Study|Other|1|||
143273348|NCT00289016|516553255|FG000|Overall Study|Disease Progression|29|||
143273349|NCT00289016|516553255|FG000|Overall Study|Death|2|||
143273350|NCT00289016|516553255|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
143273351|NCT00289016|516553255|FG000|Overall Study|Withdrawal by Subject|2|||
143273352|NCT00289016|516553255|FG000|Overall Study|Adverse Event|1|||
143273353|NCT00289016|516553255|FG000|Overall Study|Other|1|||
143273354|NCT00319501|516553256|FG000|Double-blind Period|Withdrawal by Subject|0|||
143273355|NCT00319501|516553257|FG001|Double-blind Period|Withdrawal by Subject|3|||
143273356|NCT00319501|516553256|FG000|Double-blind Period|Sponsor Request|1|||
143273357|NCT00319501|516553257|FG001|Double-blind Period|Sponsor Request|0|||
143273358|NCT00319501|516553256|FG000|Double-blind Period|Did not receive treatment|42|||
143273359|NCT00319501|516553257|FG001|Double-blind Period|Did not receive treatment|29|||
143273360|NCT00319501|516553256|FG000|Open-label Period|Adverse Event|5|||
143273361|NCT00319501|516553257|FG001|Open-label Period|Adverse Event|0|||
143273362|NCT00319501|516553256|FG000|Open-label Period|Protocol Violation|6|||
143273363|NCT00319501|516553257|FG001|Open-label Period|Protocol Violation|0|||
143273364|NCT00319501|516553256|FG000|Open-label Period|Withdrawal by Subject|38|||
143273365|NCT00319501|516553257|FG001|Open-label Period|Withdrawal by Subject|0|||
143273366|NCT00319501|516553256|FG000|Open-label Period|Principal Investigator decision|6|||
143273367|NCT00319501|516553257|FG001|Open-label Period|Principal Investigator decision|0|||
143273368|NCT00319501|516553256|FG000|Open-label Period|Sponsor request|12|||
143273369|NCT00319501|516553257|FG001|Open-label Period|Sponsor request|0|||
143273370|NCT00319501|516553256|FG000|Open-label Period|Lost to Follow-up|5|||
143273371|NCT00319501|516553257|FG001|Open-label Period|Lost to Follow-up|0|||
143273372|NCT00319501|516553256|FG000|Open-label Period|Did not receive treatment|33|||
143273373|NCT00319501|516553257|FG001|Open-label Period|Did not receive treatment|0|||
143273374|NCT00319501|516553256|FG000|Open-label Period|Other|11|||
143273375|NCT00319501|516553257|FG001|Open-label Period|Other|0|||
143273376|NCT00319501|516553256|FG000|Open-label Extension Period|Adverse Event|2|||
143273377|NCT00319501|516553257|FG001|Open-label Extension Period|Adverse Event|0|||
143273378|NCT00319501|516553256|FG000|Open-label Extension Period|Did not receive treatment|18|||
143273379|NCT00319501|516553257|FG001|Open-label Extension Period|Did not receive treatment|0|||
143273380|NCT00319501|516553256|FG000|Open-label Extension Period|Other|1|||
143273381|NCT00319501|516553257|FG001|Open-label Extension Period|Other|0|||
143273382|NCT00319501|516553256|FG000|Open-label Extension Period|Principal investigator decision|2|||
143273383|NCT00319501|516553257|FG001|Open-label Extension Period|Principal investigator decision|0|||
143273384|NCT00319501|516553256|FG000|Open-label Extension Period|Sponsor request|26|||
143273385|NCT00319501|516553257|FG001|Open-label Extension Period|Sponsor request|0|||
143273386|NCT00319501|516553256|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
143273387|NCT00319501|516553257|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
143273388|NCT00667875|516553259|FG000|Overall Study|Adverse Event|0|||
143273389|NCT00667875|516553260|FG001|Overall Study|Adverse Event|2|||
143273390|NCT00667875|516553261|FG002|Overall Study|Adverse Event|6|||
143273391|NCT00667875|516553259|FG000|Overall Study|Withdrawal by Subject|10|||
143273392|NCT00667875|516553260|FG001|Overall Study|Withdrawal by Subject|9|||
143273393|NCT00667875|516553261|FG002|Overall Study|Withdrawal by Subject|7|||
143273394|NCT00450255|516553262|FG000|Overall Study|Prior RFA ablation of liver|1|||
143273395|NCT01441180|516553268|FG000|Overall Study|Lost to Follow-up|1|||
143273396|NCT01441180|516553269|FG001|Overall Study|Lost to Follow-up|1|||
143273397|NCT01441180|516553270|FG002|Overall Study|Lost to Follow-up|1|||
143273398|NCT01441180|516553268|FG000|Overall Study|Discontinued|0|||
143273399|NCT01441180|516553269|FG001|Overall Study|Discontinued|0|||
143273400|NCT01441180|516553270|FG002|Overall Study|Discontinued|2|||
143273401|NCT01402011|516553273|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
143273402|NCT01402011|516553274|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
143273403|NCT01402011|516553275|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
143273404|NCT01402011|516553273|FG000|Active Treatment Period|Withdrawal by Subject|1|||
143273405|NCT01402011|516553274|FG001|Active Treatment Period|Withdrawal by Subject|3|||
143273406|NCT01402011|516553275|FG002|Active Treatment Period|Withdrawal by Subject|0|||
143273407|NCT01402011|516553273|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
143273408|NCT01402011|516553274|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
143273409|NCT01402011|516553275|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
143273410|NCT00142298|516553276|FG000|Overall Study|Adverse Event|10|||
143273411|NCT00142298|516553277|FG001|Overall Study|Adverse Event|10|||
143273412|NCT00142298|516553278|FG002|Overall Study|Adverse Event|1|||
143273413|NCT00142298|516553279|FG003|Overall Study|Adverse Event|5|||
143273414|NCT00142298|516553280|FG004|Overall Study|Adverse Event|2|||
143273415|NCT00142298|516553281|FG005|Overall Study|Adverse Event|2|||
143273416|NCT00142298|516553282|FG006|Overall Study|Adverse Event|0|||
143273417|NCT00142298|516553283|FG007|Overall Study|Adverse Event|0|||
143273418|NCT00142298|516553284|FG008|Overall Study|Adverse Event|0|||
143273419|NCT00142298|516553285|FG009|Overall Study|Adverse Event|0|||
143273420|NCT00142298|516553276|FG000|Overall Study|Clinical disease progression|1|||
143273421|NCT00142298|516553277|FG001|Overall Study|Clinical disease progression|0|||
143273422|NCT00142298|516553278|FG002|Overall Study|Clinical disease progression|0|||
143273423|NCT00142298|516553279|FG003|Overall Study|Clinical disease progression|0|||
143273424|NCT00142298|516553280|FG004|Overall Study|Clinical disease progression|0|||
143273425|NCT00142298|516553281|FG005|Overall Study|Clinical disease progression|0|||
143273426|NCT00142298|516553282|FG006|Overall Study|Clinical disease progression|0|||
143273427|NCT00142298|516553283|FG007|Overall Study|Clinical disease progression|0|||
143273428|NCT00142298|516553284|FG008|Overall Study|Clinical disease progression|0|||
143273429|NCT00142298|516553285|FG009|Overall Study|Clinical disease progression|0|||
143273430|NCT00142298|516553276|FG000|Overall Study|Death|1|||
143273431|NCT00142298|516553277|FG001|Overall Study|Death|1|||
143273432|NCT00142298|516553278|FG002|Overall Study|Death|1|||
143273433|NCT00142298|516553279|FG003|Overall Study|Death|0|||
143273434|NCT00142298|516553280|FG004|Overall Study|Death|0|||
143273435|NCT00142298|516553281|FG005|Overall Study|Death|6|||
143273436|NCT00142298|516553282|FG006|Overall Study|Death|0|||
143273437|NCT00142298|516553283|FG007|Overall Study|Death|0|||
143273438|NCT00142298|516553284|FG008|Overall Study|Death|0|||
143273439|NCT00142298|516553285|FG009|Overall Study|Death|0|||
143273440|NCT00142298|516553276|FG000|Overall Study|Lack of Efficacy|44|||
143273441|NCT00142298|516553277|FG001|Overall Study|Lack of Efficacy|62|||
143273442|NCT00142298|516553278|FG002|Overall Study|Lack of Efficacy|9|||
143273443|NCT00142298|516553279|FG003|Overall Study|Lack of Efficacy|12|||
143273444|NCT00142298|516553280|FG004|Overall Study|Lack of Efficacy|1|||
143273445|NCT00142298|516553281|FG005|Overall Study|Lack of Efficacy|0|||
143273446|NCT00142298|516553282|FG006|Overall Study|Lack of Efficacy|0|||
143273447|NCT00142298|516553283|FG007|Overall Study|Lack of Efficacy|1|||
143273448|NCT00142298|516553284|FG008|Overall Study|Lack of Efficacy|0|||
143273449|NCT00142298|516553285|FG009|Overall Study|Lack of Efficacy|0|||
143273450|NCT00142298|516553276|FG000|Overall Study|Non-compliance|15|||
143273451|NCT00142298|516553277|FG001|Overall Study|Non-compliance|13|||
143273452|NCT00142298|516553278|FG002|Overall Study|Non-compliance|0|||
143273453|NCT00142298|516553279|FG003|Overall Study|Non-compliance|6|||
143273454|NCT00142298|516553280|FG004|Overall Study|Non-compliance|1|||
143273455|NCT00142298|516553281|FG005|Overall Study|Non-compliance|0|||
143273456|NCT00142298|516553282|FG006|Overall Study|Non-compliance|0|||
143273457|NCT00142298|516553283|FG007|Overall Study|Non-compliance|3|||
143273458|NCT00142298|516553284|FG008|Overall Study|Non-compliance|3|||
143273459|NCT00142298|516553285|FG009|Overall Study|Non-compliance|0|||
143273460|NCT00142298|516553276|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
143273461|NCT00142298|516553277|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
143273462|NCT00142298|516553278|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
143273463|NCT00142298|516553279|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
143273464|NCT00142298|516553280|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
143273465|NCT00142298|516553281|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
143273466|NCT00142298|516553282|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
143273467|NCT00142298|516553283|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
143273468|NCT00142298|516553284|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
143273469|NCT00142298|516553285|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
143273470|NCT00142298|516553276|FG000|Overall Study|Pregnancy|4|||
143273471|NCT00142298|516553277|FG001|Overall Study|Pregnancy|4|||
143273472|NCT00142298|516553278|FG002|Overall Study|Pregnancy|2|||
143273473|NCT00142298|516553279|FG003|Overall Study|Pregnancy|3|||
143273474|NCT00142298|516553280|FG004|Overall Study|Pregnancy|0|||
143273475|NCT00142298|516553281|FG005|Overall Study|Pregnancy|0|||
143273476|NCT00142298|516553282|FG006|Overall Study|Pregnancy|0|||
143273477|NCT00142298|516553283|FG007|Overall Study|Pregnancy|0|||
143273478|NCT00142298|516553284|FG008|Overall Study|Pregnancy|1|||
143273479|NCT00142298|516553285|FG009|Overall Study|Pregnancy|0|||
143273480|NCT00142298|516553276|FG000|Overall Study|Virologic breakthrough|19|||
143273481|NCT00142298|516553277|FG001|Overall Study|Virologic breakthrough|23|||
143273482|NCT00142298|516553278|FG002|Overall Study|Virologic breakthrough|9|||
143273483|NCT00142298|516553279|FG003|Overall Study|Virologic breakthrough|7|||
143273484|NCT00142298|516553280|FG004|Overall Study|Virologic breakthrough|2|||
143273485|NCT00142298|516553281|FG005|Overall Study|Virologic breakthrough|3|||
143273486|NCT00142298|516553282|FG006|Overall Study|Virologic breakthrough|3|||
143273487|NCT00142298|516553283|FG007|Overall Study|Virologic breakthrough|0|||
143273488|NCT00142298|516553284|FG008|Overall Study|Virologic breakthrough|0|||
143273489|NCT00142298|516553285|FG009|Overall Study|Virologic breakthrough|0|||
143273490|NCT00142298|516553276|FG000|Overall Study|Other- not specified|0|||
143273491|NCT00142298|516553277|FG001|Overall Study|Other- not specified|3|||
143273492|NCT00142298|516553278|FG002|Overall Study|Other- not specified|0|||
143273493|NCT00142298|516553279|FG003|Overall Study|Other- not specified|1|||
143273494|NCT00142298|516553280|FG004|Overall Study|Other- not specified|0|||
143273495|NCT00142298|516553281|FG005|Overall Study|Other- not specified|0|||
143273496|NCT00142298|516553282|FG006|Overall Study|Other- not specified|0|||
143273497|NCT00142298|516553283|FG007|Overall Study|Other- not specified|0|||
143273498|NCT00142298|516553284|FG008|Overall Study|Other- not specified|0|||
143273499|NCT00142298|516553285|FG009|Overall Study|Other- not specified|0|||
143273500|NCT00142298|516553276|FG000|Overall Study|Lost to Follow-up|0|||
143273501|NCT00142298|516553277|FG001|Overall Study|Lost to Follow-up|0|||
143273502|NCT00142298|516553278|FG002|Overall Study|Lost to Follow-up|0|||
143273503|NCT00142298|516553279|FG003|Overall Study|Lost to Follow-up|0|||
143273504|NCT00142298|516553280|FG004|Overall Study|Lost to Follow-up|0|||
143273505|NCT00142298|516553281|FG005|Overall Study|Lost to Follow-up|0|||
143273506|NCT00142298|516553282|FG006|Overall Study|Lost to Follow-up|2|||
143273507|NCT00142298|516553283|FG007|Overall Study|Lost to Follow-up|0|||
143273508|NCT00142298|516553284|FG008|Overall Study|Lost to Follow-up|0|||
143273509|NCT00142298|516553285|FG009|Overall Study|Lost to Follow-up|0|||
143273510|NCT00142298|516553276|FG000|Overall Study|Treatment Failure|0|||
143273511|NCT00142298|516553277|FG001|Overall Study|Treatment Failure|0|||
143273512|NCT00142298|516553278|FG002|Overall Study|Treatment Failure|0|||
143273513|NCT00142298|516553279|FG003|Overall Study|Treatment Failure|0|||
143273514|NCT00142298|516553280|FG004|Overall Study|Treatment Failure|0|||
143273515|NCT00142298|516553281|FG005|Overall Study|Treatment Failure|2|||
143273516|NCT00142298|516553282|FG006|Overall Study|Treatment Failure|2|||
143273517|NCT00142298|516553283|FG007|Overall Study|Treatment Failure|0|||
143273518|NCT00142298|516553284|FG008|Overall Study|Treatment Failure|0|||
143273519|NCT00142298|516553285|FG009|Overall Study|Treatment Failure|0|||
143273520|NCT02569671|516553286|FG000|Overall Study|Lost to Follow-up|2|||
143273521|NCT02569671|516553287|FG001|Overall Study|Lost to Follow-up|1|||
143273522|NCT02569671|516553286|FG000|Overall Study|Withdrawal by Subject|1|||
143273523|NCT02569671|516553287|FG001|Overall Study|Withdrawal by Subject|3|||
143273524|NCT02612129|516553288|FG000|Single Dose Treatment Period|Screening Failure|1|||
143273525|NCT02612129|516553289|FG001|Single Dose Treatment Period|Screening Failure|0|||
143273526|NCT02612129|516553290|FG002|Single Dose Treatment Period|Screening Failure|0|||
143273527|NCT02612129|516553288|FG000|Continuous Treatment Period|Early Escape|0|||
143273528|NCT02612129|516553289|FG001|Continuous Treatment Period|Early Escape|2|||
143273529|NCT02612129|516553290|FG002|Continuous Treatment Period|Early Escape|0|||
143273530|NCT02612129|516553288|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
143273531|NCT02612129|516553289|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
143273532|NCT02612129|516553290|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
143273533|NCT02612129|516553288|FG000|Continuous Treatment Period|Safety Reasons|0|||
143273534|NCT02612129|516553289|FG001|Continuous Treatment Period|Safety Reasons|3|||
143273535|NCT02612129|516553290|FG002|Continuous Treatment Period|Safety Reasons|0|||
143273536|NCT02612129|516553288|FG000|Continuous Treatment Period|Death|0|||
143273537|NCT02612129|516553289|FG001|Continuous Treatment Period|Death|1|||
143273538|NCT02612129|516553290|FG002|Continuous Treatment Period|Death|0|||
143273539|NCT02612129|516553288|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
143273540|NCT02612129|516553289|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
143273541|NCT02612129|516553290|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
143273542|NCT01757535|516553291|FG000|Overall Study|Disease Relapse|151|||
143273543|NCT01757535|516553292|FG001|Overall Study|Disease Relapse|181|||
143273544|NCT01757535|516553291|FG000|Overall Study|Other Reasons|28|||
143273545|NCT01757535|516553292|FG001|Overall Study|Other Reasons|27|||
143273546|NCT01757535|516553291|FG000|Overall Study|Adverse Event|31|||
143273547|NCT01757535|516553292|FG001|Overall Study|Adverse Event|11|||
143273548|NCT01757535|516553291|FG000|Overall Study|Withdrew Consent|19|||
143273549|NCT01757535|516553292|FG001|Overall Study|Withdrew Consent|13|||
143273550|NCT01757535|516553291|FG000|Overall Study|Physician Decision|7|||
143273551|NCT01757535|516553292|FG001|Overall Study|Physician Decision|0|||
143273552|NCT01757535|516553291|FG000|Overall Study|Death|2|||
143273553|NCT01757535|516553292|FG001|Overall Study|Death|2|||
143273554|NCT00531934|516555232|FG000|Overall Study|Adverse Event|4|||
143273555|NCT00531934|516555233|FG001|Overall Study|Adverse Event|8|||
143273556|NCT00531934|516555232|FG000|Overall Study|Progression|52|||
143273557|NCT00531934|516555233|FG001|Overall Study|Progression|42|||
143273558|NCT00531934|516555232|FG000|Overall Study|Death|7|||
143273559|NCT00531934|516555233|FG001|Overall Study|Death|10|||
143273560|NCT00531934|516555232|FG000|Overall Study|Withdrawal by Subject|1|||
143273561|NCT00531934|516555233|FG001|Overall Study|Withdrawal by Subject|1|||
143273562|NCT00531934|516555232|FG000|Overall Study|Other|2|||
143273563|NCT00531934|516555233|FG001|Overall Study|Other|2|||
143273564|NCT00150709|516555234|FG000|Overall Study|Protocol Violation|7|||
143273565|NCT00150709|516555235|FG001|Overall Study|Protocol Violation|8|||
143273566|NCT00150709|516555236|FG002|Overall Study|Protocol Violation|3|||
143273567|NCT00150709|516555237|FG003|Overall Study|Protocol Violation|1|||
143273568|NCT00150709|516555234|FG000|Overall Study|Adverse Event|8|||
143273569|NCT00150709|516555235|FG001|Overall Study|Adverse Event|2|||
143273570|NCT00150709|516555236|FG002|Overall Study|Adverse Event|2|||
143273571|NCT00150709|516555237|FG003|Overall Study|Adverse Event|3|||
143273572|NCT00150709|516555234|FG000|Overall Study|Lack of Efficacy|6|||
143273573|NCT00150709|516555235|FG001|Overall Study|Lack of Efficacy|11|||
143273574|NCT00150709|516555236|FG002|Overall Study|Lack of Efficacy|9|||
143273575|NCT00150709|516555237|FG003|Overall Study|Lack of Efficacy|0|||
143273576|NCT00150709|516555234|FG000|Overall Study|Withdrawal by Subject|7|||
143273577|NCT00150709|516555235|FG001|Overall Study|Withdrawal by Subject|10|||
143273578|NCT00150709|516555236|FG002|Overall Study|Withdrawal by Subject|5|||
143273579|NCT00150709|516555237|FG003|Overall Study|Withdrawal by Subject|0|||
143273580|NCT00150709|516555234|FG000|Overall Study|Lost to Follow-up|3|||
143273581|NCT00150709|516555235|FG001|Overall Study|Lost to Follow-up|2|||
143273582|NCT00150709|516555236|FG002|Overall Study|Lost to Follow-up|0|||
143273583|NCT00150709|516555237|FG003|Overall Study|Lost to Follow-up|0|||
143273584|NCT00150709|516555234|FG000|Overall Study|Sponsor decision|0|||
143273585|NCT00150709|516555235|FG001|Overall Study|Sponsor decision|0|||
143273586|NCT00150709|516555236|FG002|Overall Study|Sponsor decision|0|||
143273587|NCT00150709|516555237|FG003|Overall Study|Sponsor decision|1|||
143273588|NCT00150709|516555234|FG000|Overall Study|Site/Investigator discontinued the study|5|||
143273589|NCT00150709|516555235|FG001|Overall Study|Site/Investigator discontinued the study|5|||
143273590|NCT00150709|516555236|FG002|Overall Study|Site/Investigator discontinued the study|2|||
143273591|NCT00150709|516555237|FG003|Overall Study|Site/Investigator discontinued the study|0|||
143273592|NCT00150709|516555234|FG000|Overall Study|Decision of parent(s)|1|||
143273593|NCT00150709|516555235|FG001|Overall Study|Decision of parent(s)|2|||
143273594|NCT00150709|516555236|FG002|Overall Study|Decision of parent(s)|0|||
143273595|NCT00150709|516555237|FG003|Overall Study|Decision of parent(s)|0|||
143273596|NCT00150709|516555234|FG000|Overall Study|Decision of parent(s) and investigator|3|||
143273597|NCT00150709|516555235|FG001|Overall Study|Decision of parent(s) and investigator|0|||
143273598|NCT00150709|516555236|FG002|Overall Study|Decision of parent(s) and investigator|0|||
143273599|NCT00150709|516555237|FG003|Overall Study|Decision of parent(s) and investigator|0|||
143273600|NCT00150709|516555234|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
143273601|NCT00150709|516555235|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
143273602|NCT00150709|516555236|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
143273603|NCT00150709|516555237|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
143273604|NCT00150709|516555234|FG000|Overall Study|Investigator decision|1|||
143273605|NCT00150709|516555235|FG001|Overall Study|Investigator decision|0|||
143273606|NCT00150709|516555236|FG002|Overall Study|Investigator decision|0|||
143273607|NCT00150709|516555237|FG003|Overall Study|Investigator decision|1|||
143273608|NCT00150709|516555234|FG000|Overall Study|Subject relocated|2|||
143273609|NCT00150709|516555235|FG001|Overall Study|Subject relocated|2|||
143273610|NCT00150709|516555236|FG002|Overall Study|Subject relocated|1|||
143273611|NCT00150709|516555237|FG003|Overall Study|Subject relocated|0|||
143273612|NCT00150709|516555234|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
143273613|NCT00150709|516555235|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
143273614|NCT00150709|516555236|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
143273615|NCT00150709|516555237|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
143273616|NCT00150709|516555234|FG000|Overall Study|Convenience|0|||
143273617|NCT00150709|516555235|FG001|Overall Study|Convenience|1|||
143273618|NCT00150709|516555236|FG002|Overall Study|Convenience|0|||
143273619|NCT00150709|516555237|FG003|Overall Study|Convenience|0|||
143273620|NCT00150709|516555234|FG000|Overall Study|Subject entered new drug study|0|||
143273621|NCT00150709|516555235|FG001|Overall Study|Subject entered new drug study|1|||
143273622|NCT00150709|516555236|FG002|Overall Study|Subject entered new drug study|0|||
143273623|NCT00150709|516555237|FG003|Overall Study|Subject entered new drug study|0|||
143273624|NCT00150709|516555234|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
143273625|NCT00150709|516555235|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
143273626|NCT00150709|516555236|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
143273627|NCT00150709|516555237|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
143273628|NCT00150709|516555234|FG000|Overall Study|Lack of ease of swallowing|0|||
143273629|NCT00150709|516555235|FG001|Overall Study|Lack of ease of swallowing|1|||
143273630|NCT00150709|516555236|FG002|Overall Study|Lack of ease of swallowing|0|||
143273631|NCT00150709|516555237|FG003|Overall Study|Lack of ease of swallowing|0|||
143273632|NCT02280304|516555243|FG000|Overall Study|Lost to Follow-up|7|||
143273633|NCT02280304|516555244|FG001|Overall Study|Lost to Follow-up|8|||
143273634|NCT01977794|516555254|FG000|Overall Study|Adverse Event|2|||
143273635|NCT01977794|516555255|FG001|Overall Study|Adverse Event|2|||
143273636|NCT01977794|516555254|FG000|Overall Study|Lost to Follow-up|2|||
143273637|NCT01977794|516555255|FG001|Overall Study|Lost to Follow-up|1|||
143273638|NCT01977794|516555254|FG000|Overall Study|Protocol Violation|1|||
143273639|NCT01977794|516555255|FG001|Overall Study|Protocol Violation|0|||
143273640|NCT01977794|516555254|FG000|Overall Study|Death|1|||
143273641|NCT01977794|516555255|FG001|Overall Study|Death|1|||
143273642|NCT01977794|516555254|FG000|Overall Study|Withdrew consent|2|||
143273643|NCT01977794|516555255|FG001|Overall Study|Withdrew consent|1|||
143273644|NCT01977794|516555254|FG000|Overall Study|Other|0|||
143273645|NCT01977794|516555255|FG001|Overall Study|Other|1|||
143273646|NCT00533897|516555256|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
143273647|NCT00533897|516555257|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
143273648|NCT00533897|516555258|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
143273649|NCT00533897|516555259|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
143273650|NCT00533897|516555260|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
143273651|NCT00533897|516555261|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
143273652|NCT00533897|516555262|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
143273653|NCT00533897|516555263|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
143273654|NCT00533897|516555256|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
143273655|NCT00533897|516555257|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
143273656|NCT00533897|516555258|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
143273657|NCT00533897|516555259|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
143273658|NCT00533897|516555260|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
143273659|NCT00533897|516555261|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
143273660|NCT00533897|516555262|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
143273661|NCT00533897|516555263|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
143273662|NCT00533897|516555256|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
143273663|NCT00533897|516555257|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
143273664|NCT00533897|516555258|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
143273665|NCT00533897|516555259|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
143273666|NCT00533897|516555260|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
143273667|NCT00533897|516555261|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
143273668|NCT00533897|516555262|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
143273669|NCT00533897|516555263|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
143273670|NCT00533897|516555256|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
143273671|NCT00533897|516555257|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
143273672|NCT00533897|516555258|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
143273673|NCT00533897|516555259|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
143273674|NCT00533897|516555260|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
143273675|NCT00533897|516555261|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
143273676|NCT00533897|516555262|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
143273677|NCT00533897|516555263|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
143273678|NCT00533897|516555256|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
143273679|NCT00533897|516555257|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
143273680|NCT00533897|516555258|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
143273681|NCT00533897|516555259|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
143273682|NCT00533897|516555260|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
143273683|NCT00533897|516555261|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
143273684|NCT00533897|516555262|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
143273685|NCT00533897|516555263|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
143273686|NCT00533897|516555256|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
143273687|NCT00533897|516555257|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
143273688|NCT00533897|516555258|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
143273689|NCT00533897|516555259|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
143273690|NCT00533897|516555260|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
143273691|NCT00533897|516555261|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
143273692|NCT00533897|516555262|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
143273693|NCT00533897|516555263|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
143273694|NCT00533897|516555256|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
143273695|NCT00533897|516555257|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
143273696|NCT00533897|516555258|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
143273697|NCT00533897|516555259|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
143273698|NCT00533897|516555260|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
143273699|NCT00533897|516555261|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
143273700|NCT00533897|516555262|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
143273701|NCT00533897|516555263|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
143273702|NCT00533897|516555256|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
143273703|NCT00533897|516555257|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
143273704|NCT00533897|516555258|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
143273705|NCT00533897|516555259|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
143273706|NCT00533897|516555260|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
143273707|NCT00533897|516555261|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
143273708|NCT00533897|516555262|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
143273709|NCT00533897|516555263|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
143273710|NCT00533897|516555256|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
143273711|NCT00533897|516555257|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
143273712|NCT00533897|516555258|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
143273713|NCT00533897|516555259|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
143273714|NCT00533897|516555260|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
143273715|NCT00533897|516555261|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
143273716|NCT00533897|516555262|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
143273717|NCT00533897|516555263|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
143273718|NCT00533897|516555256|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
143273719|NCT00533897|516555257|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
143273720|NCT00533897|516555258|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
143273721|NCT00533897|516555259|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
143273722|NCT00533897|516555260|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
143273723|NCT00533897|516555261|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
143273724|NCT00533897|516555262|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
143273725|NCT00533897|516555263|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
143273726|NCT00533897|516555256|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
143273727|NCT00533897|516555257|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
143273728|NCT00533897|516555258|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
143273729|NCT00533897|516555259|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
143273730|NCT00533897|516555260|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
143273731|NCT00533897|516555261|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
143273732|NCT00533897|516555262|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
143273733|NCT00533897|516555263|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
143273734|NCT00533897|516555256|FG000|Long Term Extension (LTE)|Death|0|||
143273735|NCT00533897|516555257|FG001|Long Term Extension (LTE)|Death|0|||
143273736|NCT00533897|516555258|FG002|Long Term Extension (LTE)|Death|0|||
143273737|NCT00533897|516555259|FG003|Long Term Extension (LTE)|Death|0|||
143273738|NCT00533897|516555260|FG004|Long Term Extension (LTE)|Death|0|||
143273739|NCT00533897|516555261|FG005|Long Term Extension (LTE)|Death|0|||
143273740|NCT00533897|516555262|FG006|Long Term Extension (LTE)|Death|1|||
143273741|NCT00533897|516555263|FG007|Long Term Extension (LTE)|Death|3|||
143273742|NCT00533897|516555256|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
143273743|NCT00533897|516555257|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
143273744|NCT00533897|516555258|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
143273745|NCT00533897|516555259|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
143273746|NCT00533897|516555260|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
143273747|NCT00533897|516555261|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
143273748|NCT00533897|516555262|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
143273749|NCT00533897|516555263|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
143273750|NCT00533897|516555256|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
143273751|NCT00533897|516555257|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
143273752|NCT00533897|516555258|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
143273753|NCT00533897|516555259|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
143273754|NCT00533897|516555260|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
143273755|NCT00533897|516555261|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
143273756|NCT00533897|516555262|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
143273757|NCT00533897|516555263|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
143273758|NCT00533897|516555256|FG000|Long Term Extension (LTE)|Adverse Event|0|||
143273759|NCT00533897|516555257|FG001|Long Term Extension (LTE)|Adverse Event|0|||
143273760|NCT00533897|516555258|FG002|Long Term Extension (LTE)|Adverse Event|0|||
143273761|NCT00533897|516555259|FG003|Long Term Extension (LTE)|Adverse Event|0|||
143273762|NCT00533897|516555260|FG004|Long Term Extension (LTE)|Adverse Event|0|||
143273763|NCT00533897|516555261|FG005|Long Term Extension (LTE)|Adverse Event|0|||
143273764|NCT00533897|516555262|FG006|Long Term Extension (LTE)|Adverse Event|2|||
143273765|NCT00533897|516555263|FG007|Long Term Extension (LTE)|Adverse Event|5|||
143273766|NCT00533897|516555256|FG000|Long Term Extension (LTE)|Pregnancy|0|||
143273767|NCT00533897|516555257|FG001|Long Term Extension (LTE)|Pregnancy|0|||
143273768|NCT00533897|516555258|FG002|Long Term Extension (LTE)|Pregnancy|0|||
143273769|NCT00533897|516555259|FG003|Long Term Extension (LTE)|Pregnancy|0|||
143273770|NCT00533897|516555260|FG004|Long Term Extension (LTE)|Pregnancy|0|||
143273771|NCT00533897|516555261|FG005|Long Term Extension (LTE)|Pregnancy|0|||
143273772|NCT00533897|516555262|FG006|Long Term Extension (LTE)|Pregnancy|0|||
143273773|NCT00533897|516555263|FG007|Long Term Extension (LTE)|Pregnancy|2|||
143273774|NCT00533897|516555256|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
143273775|NCT00533897|516555257|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
143273776|NCT00533897|516555258|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
143273777|NCT00533897|516555259|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
143273778|NCT00533897|516555260|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
143273779|NCT00533897|516555261|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
143273780|NCT00533897|516555262|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
143273781|NCT00533897|516555263|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
143273782|NCT00533897|516555256|FG000|Long Term Extension (LTE)|Other|0|||
143273783|NCT00533897|516555257|FG001|Long Term Extension (LTE)|Other|0|||
143273784|NCT00533897|516555258|FG002|Long Term Extension (LTE)|Other|0|||
143273785|NCT00533897|516555259|FG003|Long Term Extension (LTE)|Other|0|||
143273786|NCT00533897|516555260|FG004|Long Term Extension (LTE)|Other|0|||
143273787|NCT00533897|516555261|FG005|Long Term Extension (LTE)|Other|0|||
143273788|NCT00533897|516555262|FG006|Long Term Extension (LTE)|Other|1|||
143273789|NCT00533897|516555263|FG007|Long Term Extension (LTE)|Other|6|||
143273790|NCT04015336|516555264|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
143273791|NCT01603355|516555265|FG000|Overall Study|Lack of Efficacy|2|||
143273792|NCT03019185|516555267|FG000|Overall Study|Lost to Follow-up|3|||
143273793|NCT03019185|516555268|FG001|Overall Study|Lost to Follow-up|0|||
143273794|NCT03019185|516555269|FG002|Overall Study|Lost to Follow-up|2|||
143273795|NCT03019185|516555267|FG000|Overall Study|Withdrawal by Subject|1|||
143273796|NCT03019185|516555268|FG001|Overall Study|Withdrawal by Subject|1|||
143273797|NCT03019185|516555269|FG002|Overall Study|Withdrawal by Subject|0|||
143273798|NCT03019185|516555267|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
143273799|NCT03019185|516555268|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
143273800|NCT03019185|516555269|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
143273801|NCT03019185|516555267|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
143273802|NCT03019185|516555268|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
143273803|NCT03019185|516555269|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
143273804|NCT02764333|516555270|FG000|Overall Study|Ineligible|1|||
143273805|NCT03355365|516555271|FG000|Year 1, First Intervention|Withdrawal by Subject|1|||
143273806|NCT03355365|516555272|FG001|Year 1, First Intervention|Withdrawal by Subject|0|||
143273807|NCT03355365|516555271|FG000|Year 1, First Intervention|Protocol Violation|1|||
143273808|NCT03355365|516555272|FG001|Year 1, First Intervention|Protocol Violation|0|||
143273809|NCT03355365|516555271|FG000|Year 1, First Intervention|pandemic travel limitation|1|||
143273810|NCT03355365|516555272|FG001|Year 1, First Intervention|pandemic travel limitation|0|||
143273811|NCT03355365|516555271|FG000|Year 2, Crossover Intervention|pandemic travel limitation|1|||
143273812|NCT03355365|516555272|FG001|Year 2, Crossover Intervention|pandemic travel limitation|0|||
143273813|NCT03355365|516555271|FG000|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|1|||
143273814|NCT03355365|516555272|FG001|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|0|||
143273815|NCT03355365|516555271|FG000|Year 2, Crossover Intervention|severe COVID|0|||
143273816|NCT03355365|516555272|FG001|Year 2, Crossover Intervention|severe COVID|1|||
143273817|NCT03355365|516555271|FG000|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|0|||
143273818|NCT03355365|516555272|FG001|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|1|||
143273819|NCT04622306|516555273|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
143273820|NCT04622306|516555274|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
143273821|NCT04622306|516555275|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
143273822|NCT04622306|516555276|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
143273823|NCT04622306|516555277|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
143273824|NCT04622306|516555278|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
143273825|NCT04622306|516555273|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
143273826|NCT04622306|516555274|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
143273827|NCT04622306|516555275|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
143273828|NCT04622306|516555276|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
143273829|NCT04622306|516555277|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
143273830|NCT04622306|516555278|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
143273831|NCT00617851|516555279|FG000|Overall Study|Death|0|||
143273832|NCT00617851|516555280|FG001|Overall Study|Death|0|||
143273833|NCT00617851|516555281|FG002|Overall Study|Death|0|||
143273834|NCT00617851|516555282|FG003|Overall Study|Death|1|||
143273835|NCT00617851|516555279|FG000|Overall Study|Withdrawal by Subject|14|||
143273836|NCT00617851|516555280|FG001|Overall Study|Withdrawal by Subject|7|||
143273837|NCT00617851|516555281|FG002|Overall Study|Withdrawal by Subject|12|||
143273838|NCT00617851|516555282|FG003|Overall Study|Withdrawal by Subject|4|||
143273839|NCT00617851|516555279|FG000|Overall Study|Lost to Follow-up|27|||
143273840|NCT00617851|516555280|FG001|Overall Study|Lost to Follow-up|29|||
143273841|NCT00617851|516555281|FG002|Overall Study|Lost to Follow-up|31|||
143273842|NCT00617851|516555282|FG003|Overall Study|Lost to Follow-up|19|||
143273843|NCT00617851|516555279|FG000|Overall Study|Inappropriate Enrollment|5|||
143273844|NCT00617851|516555280|FG001|Overall Study|Inappropriate Enrollment|4|||
143273845|NCT00617851|516555281|FG002|Overall Study|Inappropriate Enrollment|1|||
143273846|NCT00617851|516555282|FG003|Overall Study|Inappropriate Enrollment|1|||
143273847|NCT00617851|516555279|FG000|Overall Study|Unable to classify|1|||
143273848|NCT00617851|516555280|FG001|Overall Study|Unable to classify|0|||
143273849|NCT00617851|516555281|FG002|Overall Study|Unable to classify|1|||
143273850|NCT00617851|516555282|FG003|Overall Study|Unable to classify|0|||
143273851|NCT01200524|516555283|FG000|Overall Study|Withdrawal by Subject|1|||
143273852|NCT01200524|516555284|FG001|Overall Study|Withdrawal by Subject|1|||
143273853|NCT01200524|516555285|FG002|Overall Study|Withdrawal by Subject|3|||
143273854|NCT01200524|516555283|FG000|Overall Study|Adverse Event|1|||
143273855|NCT01200524|516555284|FG001|Overall Study|Adverse Event|0|||
143273856|NCT01200524|516555285|FG002|Overall Study|Adverse Event|0|||
143273857|NCT01200524|516555283|FG000|Overall Study|Non availability of study nurse|0|||
143273858|NCT01200524|516555284|FG001|Overall Study|Non availability of study nurse|0|||
143273859|NCT01200524|516555285|FG002|Overall Study|Non availability of study nurse|1|||
143273860|NCT00491764|516555289|FG000|Overall Study|Adverse Event|1|||
143273861|NCT00491764|516555290|FG001|Overall Study|Adverse Event|2|||
143273862|NCT00491764|516555291|FG002|Overall Study|Adverse Event|4|||
143273863|NCT00491764|516555292|FG003|Overall Study|Adverse Event|4|||
143273864|NCT00491764|516555293|FG004|Overall Study|Adverse Event|0|||
143273865|NCT00491764|516555294|FG005|Overall Study|Adverse Event|1|||
143273866|NCT00491764|516555289|FG000|Overall Study|Lost to Follow-up|0|||
143273867|NCT00491764|516555290|FG001|Overall Study|Lost to Follow-up|1|||
143273868|NCT00491764|516555291|FG002|Overall Study|Lost to Follow-up|0|||
143273869|NCT00491764|516555292|FG003|Overall Study|Lost to Follow-up|1|||
143273870|NCT00491764|516555293|FG004|Overall Study|Lost to Follow-up|0|||
143273871|NCT00491764|516555294|FG005|Overall Study|Lost to Follow-up|3|||
143273872|NCT00491764|516555289|FG000|Overall Study|Withdrawal by Subject|2|||
143273873|NCT00491764|516555290|FG001|Overall Study|Withdrawal by Subject|3|||
143273874|NCT00491764|516555291|FG002|Overall Study|Withdrawal by Subject|1|||
143273875|NCT00491764|516555292|FG003|Overall Study|Withdrawal by Subject|2|||
143273876|NCT00491764|516555293|FG004|Overall Study|Withdrawal by Subject|2|||
143273877|NCT00491764|516555294|FG005|Overall Study|Withdrawal by Subject|4|||
143273878|NCT00491764|516555289|FG000|Overall Study|Non Compliance with the Protocol|1|||
143273879|NCT00491764|516555290|FG001|Overall Study|Non Compliance with the Protocol|0|||
143273880|NCT00491764|516555291|FG002|Overall Study|Non Compliance with the Protocol|0|||
143273881|NCT00491764|516555292|FG003|Overall Study|Non Compliance with the Protocol|0|||
143273882|NCT00491764|516555293|FG004|Overall Study|Non Compliance with the Protocol|0|||
143273883|NCT00491764|516555294|FG005|Overall Study|Non Compliance with the Protocol|0|||
143273884|NCT00491764|516555289|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
143273885|NCT00491764|516555290|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
143273886|NCT00491764|516555291|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
143273887|NCT00491764|516555292|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
143273888|NCT00491764|516555293|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
143273889|NCT00491764|516555294|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
143273890|NCT00491764|516555289|FG000|Overall Study|Administrative|1|||
143273891|NCT00491764|516555290|FG001|Overall Study|Administrative|0|||
143273892|NCT00491764|516555291|FG002|Overall Study|Administrative|2|||
143273893|NCT00491764|516555292|FG003|Overall Study|Administrative|1|||
143273894|NCT00491764|516555293|FG004|Overall Study|Administrative|0|||
143273895|NCT00491764|516555294|FG005|Overall Study|Administrative|0|||
143273896|NCT01601132|516555296|FG000|Overall Study|Patient withdrew consent|1|||
143273897|NCT01601132|516555296|FG000|Overall Study|Protocol deviation|1|||
143273898|NCT02110238|516555297|FG000|12 Week Pivotal Phase|Adverse Event|3|||
143273899|NCT02110238|516555298|FG001|12 Week Pivotal Phase|Adverse Event|0|||
143273900|NCT02110238|516555297|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
143273901|NCT02110238|516555298|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
143273902|NCT02110238|516555297|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
143273903|NCT02110238|516555298|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
143273904|NCT02110238|516555297|FG000|12 Week Pivotal Phase|Physician Decision|0|||
143273905|NCT02110238|516555298|FG001|12 Week Pivotal Phase|Physician Decision|2|||
143273906|NCT02110238|516555297|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
143273907|NCT02110238|516555298|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
143273908|NCT02110238|516555297|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
143273909|NCT02110238|516555298|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
143273910|NCT02110238|516555297|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
143273911|NCT02110238|516555298|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
143273912|NCT02110238|516555297|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
143273913|NCT02110238|516555298|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
143273914|NCT02110238|516555297|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
143273915|NCT02110238|516555298|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
143273916|NCT02110238|516555297|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
143273917|NCT02110238|516555298|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
143273918|NCT02110238|516555297|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
143273919|NCT02110238|516555298|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
143273920|NCT00697788|516555305|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
143273921|NCT00697788|516555306|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
143273922|NCT00697788|516555307|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
143273923|NCT00697788|516555308|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
143273924|NCT00697788|516555309|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
143273925|NCT00697788|516555310|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
143273926|NCT00697788|516555311|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
143273927|NCT00697788|516555312|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
143273928|NCT00697788|516555305|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
143273929|NCT00697788|516555306|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
143273930|NCT00697788|516555307|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
143273931|NCT00697788|516555308|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
143273932|NCT00697788|516555309|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
143273933|NCT00697788|516555310|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
143273934|NCT00697788|516555311|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
143273935|NCT00697788|516555312|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
143273936|NCT03228433|516555313|FG000|Overall Study|Lost to Follow-up|1|||
143273937|NCT03228433|516555314|FG001|Overall Study|Lost to Follow-up|0|||
143273938|NCT03228433|516555315|FG002|Overall Study|Lost to Follow-up|0|||
143273939|NCT03228433|516555316|FG003|Overall Study|Lost to Follow-up|0|||
143273940|NCT03228433|516555317|FG004|Overall Study|Lost to Follow-up|0|||
143273941|NCT03228433|516555318|FG005|Overall Study|Lost to Follow-up|0|||
143273942|NCT03228433|516555313|FG000|Overall Study|Positive alcohol test|0|||
143273943|NCT03228433|516555314|FG001|Overall Study|Positive alcohol test|0|||
143273944|NCT03228433|516555315|FG002|Overall Study|Positive alcohol test|0|||
143273945|NCT03228433|516555316|FG003|Overall Study|Positive alcohol test|1|||
143273946|NCT03228433|516555317|FG004|Overall Study|Positive alcohol test|0|||
143273947|NCT03228433|516555318|FG005|Overall Study|Positive alcohol test|0|||
143273948|NCT01696695|516555319|FG000|Overall Study|Disease progression|373|||
143273949|NCT01696695|516555319|FG000|Overall Study|Death|29|||
143273950|NCT01696695|516555319|FG000|Overall Study|Adverse Event|74|||
143273951|NCT01696695|516555319|FG000|Overall Study|Withdrawal by Subject|92|||
143273952|NCT01696695|516555319|FG000|Overall Study|Lost to Follow-up|48|||
143273953|NCT01696695|516555319|FG000|Overall Study|Other|74|||
143273954|NCT01696695|516555319|FG000|Overall Study|Major Protocol Violation|192|||
143273955|NCT05224141|516555320|FG000|Overall Study|Ongoing|75|||
143273956|NCT05224141|516555321|FG001|Overall Study|Ongoing|88|||
143273957|NCT05224141|516555320|FG000|Overall Study|Withdrawal by Subject|2|||
143273958|NCT05224141|516555321|FG001|Overall Study|Withdrawal by Subject|4|||
143273959|NCT05224141|516555320|FG000|Overall Study|Death|153|||
143273960|NCT05224141|516555321|FG001|Overall Study|Death|138|||
143273961|NCT01058655|516555329|FG000|Overall Study|Withdrawal by Subject|1|||
143273962|NCT01058655|516555330|FG001|Overall Study|Withdrawal by Subject|0|||
143273963|NCT01058655|516555331|FG002|Overall Study|Withdrawal by Subject|3|||
143273964|NCT01058655|516555332|FG003|Overall Study|Withdrawal by Subject|4|||
143372670|NCT01713946|516909632|FG002|Overall Study|Administrative problems|0|||
143372671|NCT01713946|516909630|FG000|Overall Study|Did not continue in Ext|0|||
143273965|NCT01058655|516555329|FG000|Overall Study|Prolonged Treatment Delay|0|||
143273966|NCT01058655|516555330|FG001|Overall Study|Prolonged Treatment Delay|0|||
143273967|NCT01058655|516555331|FG002|Overall Study|Prolonged Treatment Delay|0|||
143273968|NCT01058655|516555332|FG003|Overall Study|Prolonged Treatment Delay|2|||
143273969|NCT01058655|516555329|FG000|Overall Study|Symptomatic Deterioration|0|||
143372672|NCT01713946|516909631|FG001|Overall Study|Did not continue in Ext|3|||
143372673|NCT01713946|516909632|FG002|Overall Study|Did not continue in Ext|0|||
143273970|NCT01058655|516555330|FG001|Overall Study|Symptomatic Deterioration|0|||
143273971|NCT01058655|516555331|FG002|Overall Study|Symptomatic Deterioration|0|||
143273972|NCT01058655|516555332|FG003|Overall Study|Symptomatic Deterioration|1|||
143273973|NCT01058655|516555329|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
143273974|NCT01058655|516555330|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
143273975|NCT01058655|516555331|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
143273976|NCT01058655|516555332|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
143273977|NCT01058655|516555329|FG000|Overall Study|Death|0|||
143273978|NCT01058655|516555330|FG001|Overall Study|Death|1|||
143273979|NCT01058655|516555331|FG002|Overall Study|Death|1|||
143273980|NCT01058655|516555332|FG003|Overall Study|Death|0|||
143273981|NCT01058655|516555329|FG000|Overall Study|Disease Progression|1|||
143273982|NCT01058655|516555330|FG001|Overall Study|Disease Progression|2|||
143273983|NCT01058655|516555331|FG002|Overall Study|Disease Progression|4|||
143273984|NCT01058655|516555332|FG003|Overall Study|Disease Progression|24|||
143273985|NCT01058655|516555329|FG000|Overall Study|Other|0|||
143273986|NCT01058655|516555330|FG001|Overall Study|Other|0|||
143273987|NCT01058655|516555331|FG002|Overall Study|Other|0|||
143273988|NCT01058655|516555332|FG003|Overall Study|Other|4|||
143273989|NCT00619177|516555335|FG000|Overall Study|Adverse Event|18|||
143273990|NCT00619177|516555335|FG000|Overall Study|Lost to Follow-up|2|||
143273991|NCT00619177|516555335|FG000|Overall Study|Lack of Efficacy|1|||
143273992|NCT00619177|516555335|FG000|Overall Study|Missing termination information|481|||
143273993|NCT00619177|516555335|FG000|Overall Study|Not specified reasons|6|||
143273994|NCT02435147|516555337|FG000|Overall Study|non-evaluable DXA scan|11|||
143273995|NCT02939079|516555338|FG000|Overall Study|Adverse Event|2|||
143273996|NCT02939079|516555339|FG001|Overall Study|Adverse Event|1|||
143273997|NCT02939079|516555338|FG000|Overall Study|Lost to Follow-up|0|||
143273998|NCT02939079|516555339|FG001|Overall Study|Lost to Follow-up|2|||
143273999|NCT02939079|516555338|FG000|Overall Study|Protocol Violation|1|||
143274000|NCT02939079|516555339|FG001|Overall Study|Protocol Violation|0|||
143274001|NCT02939079|516555338|FG000|Overall Study|Withdrawal by Subject|0|||
143274002|NCT02939079|516555339|FG001|Overall Study|Withdrawal by Subject|1|||
143274003|NCT02939079|516555338|FG000|Overall Study|relapse during the study|1|||
143274004|NCT02939079|516555339|FG001|Overall Study|relapse during the study|1|||
143274005|NCT04093414|516555340|FG000|3 Month Follow up|Physician Decision|0|||
143274006|NCT04093414|516555341|FG001|3 Month Follow up|Physician Decision|1|||
143274007|NCT04093414|516555340|FG000|6month Follow up|Physician Decision|1|||
143274008|NCT04093414|516555341|FG001|6month Follow up|Physician Decision|3|||
143274009|NCT04889222|516555342|FG000|Overall Study|Did not meet eligibility criteria|8|||
143274010|NCT04889222|516555342|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
143274011|NCT04889222|516555342|FG000|Overall Study|Did not proceed due to time constraints|5|||
143274012|NCT01180647|516555343|FG000|Overall Study|Lost to Follow-up|5|||
143274013|NCT01180647|516555344|FG001|Overall Study|Lost to Follow-up|6|||
143274014|NCT01903031|516555368|FG000|Overall Study|Not Able to Attend Clinic|1|||
143274015|NCT01903031|516555369|FG001|Overall Study|Not Able to Attend Clinic|1|||
143274016|NCT01903031|516555370|FG002|Overall Study|Not Able to Attend Clinic|0|||
143274017|NCT01903031|516555368|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
143274018|NCT01903031|516555369|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
143274019|NCT01903031|516555370|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
143274020|NCT01903031|516555368|FG000|Overall Study|Adverse Event|0|||
143274021|NCT01903031|516555369|FG001|Overall Study|Adverse Event|1|||
143274022|NCT01903031|516555370|FG002|Overall Study|Adverse Event|0|||
143274023|NCT01903031|516555368|FG000|Overall Study|Withdrawal by Subject|0|||
143274024|NCT01903031|516555369|FG001|Overall Study|Withdrawal by Subject|1|||
143274025|NCT01903031|516555370|FG002|Overall Study|Withdrawal by Subject|1|||
143274026|NCT01903031|516555368|FG000|Overall Study|Protocol Violation|0|||
143274027|NCT01903031|516555369|FG001|Overall Study|Protocol Violation|0|||
143274028|NCT01903031|516555370|FG002|Overall Study|Protocol Violation|2|||
143274029|NCT01903031|516555368|FG000|Overall Study|Lost to Follow-up|0|||
143274030|NCT01903031|516555369|FG001|Overall Study|Lost to Follow-up|0|||
143274031|NCT01903031|516555370|FG002|Overall Study|Lost to Follow-up|1|||
143274032|NCT01903031|516555368|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
143274033|NCT01903031|516555369|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
143274034|NCT01903031|516555370|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
143274035|NCT01811225|516555371|FG000|Treatment Period 1|Adverse Event|2|||
143274036|NCT01811225|516555372|FG001|Treatment Period 1|Adverse Event|3|||
143372674|NCT01713946|516909630|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
143274037|NCT01811225|516555371|FG000|Treatment Period 1|Lost to Follow-up|12|||
143274038|NCT01811225|516555372|FG001|Treatment Period 1|Lost to Follow-up|8|||
143274039|NCT01811225|516555371|FG000|Treatment Period 1|transporation|1|||
143274040|NCT01811225|516555372|FG001|Treatment Period 1|transporation|0|||
143274041|NCT01811225|516555371|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
143274042|NCT01811225|516555372|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
143274043|NCT01811225|516555371|FG000|Treatment Period 2|Lost to Follow-up|1|||
143274044|NCT01811225|516555372|FG001|Treatment Period 2|Lost to Follow-up|2|||
143274045|NCT01811225|516555371|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
143274046|NCT01811225|516555372|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
143274047|NCT00287365|516555373|FG000|Overall Study|sample not acquired|13|||
143274048|NCT03000569|516555374|FG000|Overall Study|Withdrawal by Subject|1|||
143274049|NCT03000569|516555375|FG001|Overall Study|Withdrawal by Subject|0|||
143274050|NCT02298023|516555376|FG000|Overall Study|Withdrawal by Subject|1|||
143274051|NCT02298023|516555377|FG001|Overall Study|Withdrawal by Subject|0|||
143274052|NCT02298023|516555378|FG002|Overall Study|Withdrawal by Subject|0|||
143274053|NCT02840721|516555379|FG000|Treatment Period|Adverse Event|1|||
143274054|NCT02840721|516555379|FG000|Follow-Up|Lack of Efficacy|1|||
143274055|NCT02840721|516555379|FG000|Follow-Up|Withdrawal by Subject|4|||
143274056|NCT02840721|516555379|FG000|Follow-Up|Withdrawal of Consent|2|||
143274057|NCT03540030|516555381|FG000|Overall Study|Withdrawal by Subject|2|||
143274058|NCT03540030|516555382|FG001|Overall Study|Withdrawal by Subject|1|||
143274059|NCT03540030|516555381|FG000|Overall Study|screen fail|7|||
143274060|NCT03540030|516555382|FG001|Overall Study|screen fail|1|||
143274061|NCT03540030|516555381|FG000|Overall Study|never had surgery after signing consent|9|||
143274062|NCT03540030|516555382|FG001|Overall Study|never had surgery after signing consent|1|||
143274063|NCT03308786|516555383|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
143274064|NCT01546207|516556351|FG000|Overall Study|Death|1|||
143274065|NCT00713323|516556352|FG000|Overall Study|Adverse Event|75|||
143274066|NCT00713323|516556352|FG000|Overall Study|Withdrawal by Subject|15|||
143274067|NCT00713323|516556352|FG000|Overall Study|Lost to Follow-up|11|||
143274068|NCT00713323|516556352|FG000|Overall Study|Lack of Efficacy|36|||
143274069|NCT00713323|516556352|FG000|Overall Study|Low creatine clearance at screening|1|||
143274070|NCT00713323|516556352|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
143274071|NCT00713323|516556352|FG000|Overall Study|Surgery cured allodynic pain|1|||
143274072|NCT00713323|516556352|FG000|Overall Study|Pain free|1|||
143274073|NCT00713323|516556352|FG000|Overall Study|Non-compliance|1|||
143274074|NCT00713323|516556352|FG000|Overall Study|Pain resolved|1|||
143274075|NCT00713323|516556352|FG000|Overall Study|Subject travelling to USA|1|||
143274076|NCT00713323|516556352|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
143274077|NCT00713323|516556352|FG000|Overall Study|Treatment that may interact with Sativex|1|||
143274078|NCT00506662|516556354|FG000|Overall Study|Adverse Event|0|||
143274079|NCT00506662|516556355|FG001|Overall Study|Adverse Event|2|||
143274080|NCT00506662|516556354|FG000|Overall Study|Lack of Efficacy|1|||
143274081|NCT00506662|516556355|FG001|Overall Study|Lack of Efficacy|0|||
143274082|NCT00506662|516556354|FG000|Overall Study|Protocol Violation|2|||
143274083|NCT00506662|516556355|FG001|Overall Study|Protocol Violation|4|||
143274084|NCT00506662|516556354|FG000|Overall Study|Trial terminated|10|||
143274085|NCT00506662|516556355|FG001|Overall Study|Trial terminated|16|||
143274086|NCT00506662|516556354|FG000|Overall Study|Not recorded|4|||
143274087|NCT00506662|516556355|FG001|Overall Study|Not recorded|6|||
143274088|NCT00491075|516556356|FG000|Overall Study|Withdrawal by Subject|1|||
143274089|NCT00491075|516556356|FG000|Overall Study|Physician Decision|1|||
143274090|NCT00142935|516556361|FG000|Overall Study|Other reason|1|||
143274091|NCT00142935|516556362|FG001|Overall Study|Other reason|1|||
143274092|NCT00142935|516556363|FG002|Overall Study|Other reason|1|||
143274093|NCT00142935|516556361|FG000|Overall Study|Lost to Follow-up|2|||
143274094|NCT00142935|516556362|FG001|Overall Study|Lost to Follow-up|5|||
143274095|NCT00142935|516556363|FG002|Overall Study|Lost to Follow-up|5|||
143274096|NCT00142935|516556361|FG000|Overall Study|Death|0|||
143274097|NCT00142935|516556362|FG001|Overall Study|Death|2|||
143274098|NCT00142935|516556363|FG002|Overall Study|Death|1|||
143274099|NCT02980783|516556369|FG000|Overall Study|Lost to Follow-up|1|||
143274100|NCT04289623|516556370|FG000|Wave 1 Emails|Email was not delivered|268|||
143274101|NCT04289623|516556371|FG001|Wave 1 Emails|Email was not delivered|257|||
143274102|NCT04289623|516556372|FG002|Wave 1 Emails|Email was not delivered|0|||
143274103|NCT04289623|516556373|FG003|Wave 1 Emails|Email was not delivered|0|||
143274104|NCT04289623|516556374|FG004|Wave 1 Emails|Email was not delivered|0|||
143274105|NCT04289623|516556375|FG005|Wave 1 Emails|Email was not delivered|0|||
143274106|NCT03080454|516556376|FG000|Baseline|Adverse Event|2|||
143274107|NCT03080454|516556376|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
143274108|NCT03080454|516556376|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
143274109|NCT04515394|516556388|FG000|Overall Study|Participant did not receive treatment|1|||
143274110|NCT01609231|516556389|FG000|Overall Study|Adverse Event|1|||
143274111|NCT01609231|516556390|FG001|Overall Study|Adverse Event|3|||
143274112|NCT01609231|516556389|FG000|Overall Study|Physician Decision|1|||
143274113|NCT01609231|516556390|FG001|Overall Study|Physician Decision|0|||
143274114|NCT01609231|516556389|FG000|Overall Study|Withdrawal by Subject|1|||
143274115|NCT01609231|516556390|FG001|Overall Study|Withdrawal by Subject|0|||
143274116|NCT02761733|516556391|FG000|Overall Study|Death|3|||
143274117|NCT02761733|516556392|FG001|Overall Study|Death|5|||
143274118|NCT02761733|516556393|FG002|Overall Study|Death|1|||
143274119|NCT02761733|516556394|FG003|Overall Study|Death|1|||
143274120|NCT02761733|516556391|FG000|Overall Study|Lost to Follow-up|6|||
143274121|NCT02761733|516556392|FG001|Overall Study|Lost to Follow-up|7|||
143274122|NCT02761733|516556393|FG002|Overall Study|Lost to Follow-up|0|||
143274123|NCT02761733|516556394|FG003|Overall Study|Lost to Follow-up|3|||
143274124|NCT02761733|516556391|FG000|Overall Study|Physician Decision|4|||
143274125|NCT02761733|516556392|FG001|Overall Study|Physician Decision|0|||
143274126|NCT02761733|516556393|FG002|Overall Study|Physician Decision|0|||
143274127|NCT02761733|516556394|FG003|Overall Study|Physician Decision|0|||
143274128|NCT02761733|516556391|FG000|Overall Study|Withdrawal by Subject|2|||
143274129|NCT02761733|516556392|FG001|Overall Study|Withdrawal by Subject|0|||
143274130|NCT02761733|516556393|FG002|Overall Study|Withdrawal by Subject|0|||
143274131|NCT02761733|516556394|FG003|Overall Study|Withdrawal by Subject|0|||
143274132|NCT02761733|516556391|FG000|Overall Study|Discharged from Study Site|10|||
143274133|NCT02761733|516556392|FG001|Overall Study|Discharged from Study Site|9|||
143274134|NCT02761733|516556393|FG002|Overall Study|Discharged from Study Site|25|||
143274135|NCT02761733|516556394|FG003|Overall Study|Discharged from Study Site|11|||
143274136|NCT02761733|516556391|FG000|Overall Study|Cognitive Impairment|5|||
143274137|NCT02761733|516556392|FG001|Overall Study|Cognitive Impairment|0|||
143274138|NCT02761733|516556393|FG002|Overall Study|Cognitive Impairment|1|||
143274139|NCT02761733|516556394|FG003|Overall Study|Cognitive Impairment|0|||
143274140|NCT00338104|516556399|FG000|Overall Study|Protocol Violation|2|||
143274141|NCT00338104|516556400|FG001|Overall Study|Protocol Violation|1|||
143274142|NCT00338104|516556401|FG002|Overall Study|Protocol Violation|3|||
143274143|NCT00633750|516556403|FG000|Overall Study|Adverse Event|2|||
143274144|NCT00633750|516556403|FG000|Overall Study|Withdrawal by Subject|3|||
143274145|NCT02362269|516556404|FG000|Overall Study|Moved|1|||
143274146|NCT02362269|516556405|FG001|Overall Study|Moved|0|||
143274147|NCT02362269|516556404|FG000|Overall Study|Lost to Follow-up|0|||
143274148|NCT02362269|516556405|FG001|Overall Study|Lost to Follow-up|6|||
143274149|NCT00569270|516556407|FG000|Period: First Intervention|Protocol Violation|0|||
143274150|NCT00569270|516556408|FG001|Period: First Intervention|Protocol Violation|1|||
143274151|NCT00447005|516556409|FG000|Overall Study|Adverse Event|1|||
143274152|NCT00447005|516556409|FG000|Overall Study|Lack of Efficacy|11|||
143274153|NCT00492531|516556410|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
143274154|NCT00492531|516556411|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
143274155|NCT03685123|516556415|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
143274156|NCT03685123|516556416|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
143274157|NCT03685123|516556417|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
143274158|NCT03685123|516556415|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
143274159|NCT03685123|516556416|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
143274160|NCT03685123|516556417|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
143274161|NCT03685123|516556415|FG000|Weight Loss Phase|Lost to Follow-up|1|||
143274162|NCT03685123|516556416|FG001|Weight Loss Phase|Lost to Follow-up|0|||
143274163|NCT03685123|516556417|FG002|Weight Loss Phase|Lost to Follow-up|0|||
143274164|NCT03685123|516556415|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
143274165|NCT03685123|516556416|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
143274166|NCT03685123|516556417|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
143274167|NCT03685123|516556415|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
143274168|NCT03685123|516556416|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
143274169|NCT03685123|516556417|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
143274170|NCT03685123|516556415|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
143274171|NCT03685123|516556416|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
143372675|NCT01713946|516909631|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
143274172|NCT03685123|516556417|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
143274173|NCT00400764|516556419|FG000|Phase Ib|Adverse Event|1|||
143274174|NCT00400764|516556420|FG001|Phase Ib|Adverse Event|0|||
143274175|NCT00400764|516556421|FG002|Phase Ib|Adverse Event|0|||
143274176|NCT00400764|516556422|FG003|Phase Ib|Adverse Event|0|||
143274177|NCT00400764|516556423|FG004|Phase Ib|Adverse Event|0|||
143274178|NCT00400764|516556419|FG000|Phase Ib|Death|1|||
143274179|NCT00400764|516556420|FG001|Phase Ib|Death|0|||
143274180|NCT00400764|516556421|FG002|Phase Ib|Death|0|||
143274181|NCT00400764|516556422|FG003|Phase Ib|Death|0|||
143274182|NCT00400764|516556423|FG004|Phase Ib|Death|0|||
143274183|NCT00400764|516556419|FG000|Phase Ib|Disease Progression|4|||
143274184|NCT00400764|516556420|FG001|Phase Ib|Disease Progression|4|||
143274185|NCT00400764|516556421|FG002|Phase Ib|Disease Progression|0|||
143274186|NCT00400764|516556422|FG003|Phase Ib|Disease Progression|0|||
143274187|NCT00400764|516556423|FG004|Phase Ib|Disease Progression|0|||
143274188|NCT00400764|516556419|FG000|Phase II|Death|0|||
143274189|NCT00400764|516556420|FG001|Phase II|Death|0|||
143274190|NCT00400764|516556421|FG002|Phase II|Death|1|||
143274191|NCT00400764|516556422|FG003|Phase II|Death|2|||
143274192|NCT00400764|516556423|FG004|Phase II|Death|0|||
143274193|NCT00400764|516556419|FG000|Phase II|Lost to Follow-up|0|||
143274194|NCT00400764|516556420|FG001|Phase II|Lost to Follow-up|0|||
143274195|NCT00400764|516556421|FG002|Phase II|Lost to Follow-up|1|||
143274196|NCT00400764|516556422|FG003|Phase II|Lost to Follow-up|0|||
143274197|NCT00400764|516556423|FG004|Phase II|Lost to Follow-up|0|||
143274198|NCT00400764|516556419|FG000|Phase II|Physician Decision|0|||
143274199|NCT00400764|516556420|FG001|Phase II|Physician Decision|0|||
143274200|NCT00400764|516556421|FG002|Phase II|Physician Decision|1|||
143274201|NCT00400764|516556422|FG003|Phase II|Physician Decision|1|||
143274202|NCT00400764|516556423|FG004|Phase II|Physician Decision|0|||
143274203|NCT00400764|516556419|FG000|Phase II|Sponsor's decision to terminate|0|||
143274204|NCT00400764|516556420|FG001|Phase II|Sponsor's decision to terminate|0|||
143274205|NCT00400764|516556421|FG002|Phase II|Sponsor's decision to terminate|18|||
143274206|NCT00400764|516556422|FG003|Phase II|Sponsor's decision to terminate|22|||
143274207|NCT00400764|516556423|FG004|Phase II|Sponsor's decision to terminate|11|||
143274208|NCT00400764|516556419|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
143274209|NCT00400764|516556420|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
143274210|NCT00400764|516556421|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
143274211|NCT00400764|516556422|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
143274212|NCT00400764|516556423|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
143274213|NCT00400764|516556419|FG000|Phase II|Withdrawal by Subject|0|||
143274214|NCT00400764|516556420|FG001|Phase II|Withdrawal by Subject|0|||
143274215|NCT00400764|516556421|FG002|Phase II|Withdrawal by Subject|1|||
143274216|NCT00400764|516556422|FG003|Phase II|Withdrawal by Subject|1|||
143274217|NCT00400764|516556423|FG004|Phase II|Withdrawal by Subject|0|||
143274218|NCT02130297|516556426|FG000|Overall Study|Lost to Follow-up|4|||
143274219|NCT01387789|516556427|FG000|Overall Study|Adverse Event|5|||
143274220|NCT01387789|516556427|FG000|Overall Study|Lack of Efficacy|2|||
143274221|NCT01387789|516556427|FG000|Overall Study|Lost to Follow-up|1|||
143274222|NCT00508755|516556430|FG000|Overall Study|Withdrawal by Subject|1|||
143274223|NCT03113071|516556431|FG000|Overall Study|Withdrawal by Subject|1|||
143274224|NCT03113071|516556432|FG001|Overall Study|Withdrawal by Subject|0|||
143274225|NCT01790932|516556441|FG000|Overall Study|Disease Progression|41|||
143274226|NCT01790932|516556441|FG000|Overall Study|Adverse Event|7|||
143274227|NCT01790932|516556441|FG000|Overall Study|Physician Decision|1|||
143274228|NCT01790932|516556441|FG000|Overall Study|Withdrawal by Subject|1|||
143274229|NCT04223973|516556444|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
143274230|NCT04223973|516556445|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
143274231|NCT04223973|516556444|FG000|Overall Study|Adverse Event|4|||
143274232|NCT04223973|516556445|FG001|Overall Study|Adverse Event|0|||
143274233|NCT04223973|516556444|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
143274234|NCT04223973|516556445|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
143274235|NCT04223973|516556444|FG000|Overall Study|Physician Decision|1|||
143274236|NCT04223973|516556445|FG001|Overall Study|Physician Decision|1|||
143274237|NCT04223973|516556444|FG000|Overall Study|Withdrawal by Subject|0|||
143274238|NCT04223973|516556445|FG001|Overall Study|Withdrawal by Subject|1|||
143274239|NCT00300274|516556450|FG000|Overall Study|Withdrawal by Subject|12|||
143274240|NCT00300274|516556451|FG001|Overall Study|Withdrawal by Subject|3|||
143274241|NCT00300274|516556452|FG002|Overall Study|Withdrawal by Subject|14|||
143274242|NCT00300274|516556450|FG000|Overall Study|Lost to Follow-up|3|||
143274243|NCT00300274|516556451|FG001|Overall Study|Lost to Follow-up|4|||
143274244|NCT00300274|516556452|FG002|Overall Study|Lost to Follow-up|5|||
143274245|NCT00300274|516556450|FG000|Overall Study|Death|31|||
143274246|NCT00300274|516556451|FG001|Overall Study|Death|20|||
143274247|NCT00300274|516556452|FG002|Overall Study|Death|25|||
143274248|NCT00300274|516556450|FG000|Overall Study|Re-transplant|0|||
143274249|NCT00300274|516556451|FG001|Overall Study|Re-transplant|0|||
143274250|NCT00300274|516556452|FG002|Overall Study|Re-transplant|1|||
143274251|NCT00242216|516556453|FG000|Overall Study|Lost to Follow-up|12|||
143274252|NCT00242216|516556454|FG001|Overall Study|Lost to Follow-up|17|||
143274253|NCT00242216|516556453|FG000|Overall Study|Death|4|||
143274254|NCT00242216|516556454|FG001|Overall Study|Death|2|||
143274255|NCT00242216|516556453|FG000|Overall Study|Lack of Efficacy|1|||
143274256|NCT00242216|516556454|FG001|Overall Study|Lack of Efficacy|2|||
143274257|NCT00242216|516556453|FG000|Overall Study|no medicaiton dispensed|1|||
143274258|NCT00242216|516556454|FG001|Overall Study|no medicaiton dispensed|1|||
143274259|NCT00678080|516556456|FG000|Overall Study|Physician Decision|2|||
143274260|NCT00678080|516556457|FG001|Overall Study|Physician Decision|0|||
143274261|NCT00678080|516556456|FG000|Overall Study|Lost to Follow-up|1|||
143274262|NCT00678080|516556457|FG001|Overall Study|Lost to Follow-up|0|||
143274263|NCT00678080|516556456|FG000|Overall Study|Withdrawal by Subject|0|||
143274264|NCT00678080|516556457|FG001|Overall Study|Withdrawal by Subject|1|||
143274265|NCT05136690|516556458|FG000|Period 1|Withdrawal by Subject|0|||
143274266|NCT05136690|516556459|FG001|Period 1|Withdrawal by Subject|1|||
143274267|NCT05136690|516556458|FG000|Period 2|Lost to Follow-up|0|||
143274268|NCT05136690|516556459|FG001|Period 2|Lost to Follow-up|3|||
143274269|NCT05136690|516556458|FG000|Period 2|Withdrawal by Subject|0|||
143274270|NCT05136690|516556459|FG001|Period 2|Withdrawal by Subject|1|||
143274271|NCT03320057|516558193|FG000|Overall Study|Lost to Follow-up|4|||
143274272|NCT03320057|516558194|FG001|Overall Study|Lost to Follow-up|17|||
143274273|NCT03320057|516558193|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
143274274|NCT03320057|516558194|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
143274275|NCT04092582|516558196|FG000|Overall Study|Death|1|||
143274276|NCT04092582|516558197|FG001|Overall Study|Death|1|||
143274277|NCT04092582|516558196|FG000|Overall Study|Withdrawal by Subject|4|||
143274278|NCT04092582|516558197|FG001|Overall Study|Withdrawal by Subject|1|||
143274279|NCT04092582|516558196|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
143274280|NCT04092582|516558197|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
143274281|NCT00316719|516558198|FG000|Overall Study|Adverse Event|0|||
143274282|NCT00316719|516558199|FG001|Overall Study|Adverse Event|6|||
143274283|NCT00316719|516558198|FG000|Overall Study|Consent withdrawn|2|||
143274284|NCT00316719|516558199|FG001|Overall Study|Consent withdrawn|0|||
143274285|NCT02468674|516558202|FG000|Overall Study|Adverse Event|0|||
143274286|NCT02468674|516558203|FG001|Overall Study|Adverse Event|0|||
143274287|NCT02468674|516558204|FG002|Overall Study|Adverse Event|0|||
143274288|NCT02468674|516558205|FG003|Overall Study|Adverse Event|1|||
143274289|NCT02468674|516558206|FG004|Overall Study|Adverse Event|0|||
143274290|NCT02468674|516558207|FG005|Overall Study|Adverse Event|1|||
143274291|NCT02468674|516558208|FG006|Overall Study|Adverse Event|0|||
143274292|NCT02468674|516558209|FG007|Overall Study|Adverse Event|0|||
143274293|NCT02468674|516558210|FG008|Overall Study|Adverse Event|0|||
143274294|NCT02468674|516558202|FG000|Overall Study|Lost to Follow-up|1|||
143274295|NCT02468674|516558203|FG001|Overall Study|Lost to Follow-up|0|||
143274296|NCT02468674|516558204|FG002|Overall Study|Lost to Follow-up|0|||
143274297|NCT02468674|516558205|FG003|Overall Study|Lost to Follow-up|0|||
143274298|NCT02468674|516558206|FG004|Overall Study|Lost to Follow-up|0|||
143274299|NCT02468674|516558207|FG005|Overall Study|Lost to Follow-up|0|||
143274300|NCT02468674|516558208|FG006|Overall Study|Lost to Follow-up|0|||
143274301|NCT02468674|516558209|FG007|Overall Study|Lost to Follow-up|1|||
143274302|NCT02468674|516558210|FG008|Overall Study|Lost to Follow-up|1|||
143274303|NCT02468674|516558202|FG000|Overall Study|Physician Decision|0|||
143274304|NCT02468674|516558203|FG001|Overall Study|Physician Decision|0|||
143274305|NCT02468674|516558204|FG002|Overall Study|Physician Decision|0|||
143274306|NCT02468674|516558205|FG003|Overall Study|Physician Decision|0|||
143274307|NCT02468674|516558206|FG004|Overall Study|Physician Decision|0|||
143274308|NCT02468674|516558207|FG005|Overall Study|Physician Decision|0|||
143274309|NCT02468674|516558208|FG006|Overall Study|Physician Decision|1|||
143274310|NCT02468674|516558209|FG007|Overall Study|Physician Decision|0|||
143274311|NCT02468674|516558210|FG008|Overall Study|Physician Decision|0|||
143274312|NCT02468674|516558202|FG000|Overall Study|Patient/Guardian Decision|0|||
143274313|NCT02468674|516558203|FG001|Overall Study|Patient/Guardian Decision|0|||
143274314|NCT02468674|516558204|FG002|Overall Study|Patient/Guardian Decision|0|||
143274315|NCT02468674|516558205|FG003|Overall Study|Patient/Guardian Decision|0|||
143274316|NCT02468674|516558206|FG004|Overall Study|Patient/Guardian Decision|1|||
143274317|NCT02468674|516558207|FG005|Overall Study|Patient/Guardian Decision|0|||
143274318|NCT02468674|516558208|FG006|Overall Study|Patient/Guardian Decision|0|||
143274319|NCT02468674|516558209|FG007|Overall Study|Patient/Guardian Decision|2|||
143274320|NCT02468674|516558210|FG008|Overall Study|Patient/Guardian Decision|1|||
143274321|NCT02468674|516558202|FG000|Overall Study|Protocol Deviation|0|||
143274322|NCT02468674|516558203|FG001|Overall Study|Protocol Deviation|0|||
143274323|NCT02468674|516558204|FG002|Overall Study|Protocol Deviation|0|||
143274324|NCT02468674|516558205|FG003|Overall Study|Protocol Deviation|0|||
143274325|NCT02468674|516558206|FG004|Overall Study|Protocol Deviation|0|||
143274326|NCT02468674|516558207|FG005|Overall Study|Protocol Deviation|0|||
143274327|NCT02468674|516558208|FG006|Overall Study|Protocol Deviation|0|||
143274328|NCT02468674|516558209|FG007|Overall Study|Protocol Deviation|1|||
143274329|NCT02468674|516558210|FG008|Overall Study|Protocol Deviation|1|||
143274330|NCT01550289|516558212|FG000|Overall Study|Protocol Violation|1|||
143274331|NCT01550289|516558213|FG001|Overall Study|Protocol Violation|0|||
143274332|NCT01550289|516558212|FG000|Overall Study|Lost to Follow-up|1|||
143274333|NCT01550289|516558213|FG001|Overall Study|Lost to Follow-up|1|||
143274334|NCT01550289|516558212|FG000|Overall Study|Withdrawal by Subject|11|||
143274335|NCT01550289|516558213|FG001|Overall Study|Withdrawal by Subject|3|||
143274336|NCT02975336|516558214|FG000|DBPC (52 Weeks)|Adverse Event|16|||
143274337|NCT02975336|516558215|FG001|DBPC (52 Weeks)|Adverse Event|17|||
143274338|NCT02975336|516558216|FG002|DBPC (52 Weeks)|Adverse Event|13|||
143274339|NCT02975336|516558217|FG003|DBPC (52 Weeks)|Adverse Event|18|||
143274340|NCT02975336|516558218|FG004|DBPC (52 Weeks)|Adverse Event|0|||
143274341|NCT02975336|516558219|FG005|DBPC (52 Weeks)|Adverse Event|0|||
143274342|NCT02975336|516558220|FG006|DBPC (52 Weeks)|Adverse Event|0|||
143274343|NCT02975336|516558221|FG007|DBPC (52 Weeks)|Adverse Event|0|||
143274344|NCT02975336|516558214|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
143274345|NCT02975336|516558215|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
143274346|NCT02975336|516558216|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
143372676|NCT01713946|516909632|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
143372677|NCT01713946|516909630|FG000|Overall Study|Patients never switched to everolimus|0|||
143372678|NCT01713946|516909631|FG001|Overall Study|Patients never switched to everolimus|0|||
143372679|NCT01713946|516909632|FG002|Overall Study|Patients never switched to everolimus|5|||
143274347|NCT02975336|516558217|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
143274348|NCT02975336|516558218|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
143274349|NCT02975336|516558219|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
143274350|NCT02975336|516558220|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
143274351|NCT02975336|516558221|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
143274352|NCT02975336|516558214|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
143274353|NCT02975336|516558215|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
143274354|NCT02975336|516558216|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
143274355|NCT02975336|516558217|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
143274356|NCT02975336|516558218|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
143274357|NCT02975336|516558219|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
143274358|NCT02975336|516558220|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
143274359|NCT02975336|516558221|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
143274360|NCT02975336|516558214|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
143274361|NCT02975336|516558215|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
143274362|NCT02975336|516558216|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
143274363|NCT02975336|516558217|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
143274364|NCT02975336|516558218|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
143274365|NCT02975336|516558219|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
143274366|NCT02975336|516558220|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
143274367|NCT02975336|516558221|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
143274368|NCT02975336|516558214|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
143274369|NCT02975336|516558215|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
143274370|NCT02975336|516558216|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
143274371|NCT02975336|516558217|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
143274372|NCT02975336|516558218|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
143274373|NCT02975336|516558219|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
143274374|NCT02975336|516558220|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
143274375|NCT02975336|516558221|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
143274376|NCT02975336|516558214|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
143274377|NCT02975336|516558215|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
143274378|NCT02975336|516558216|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
143274379|NCT02975336|516558217|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
143372680|NCT03183518|516909633|FG000|Overall Study|Other (Not specified)|2|||
143372681|NCT03183518|516909633|FG000|Overall Study|Other (Withdrawal of consent)|1|||
143372682|NCT04248829|516909634|FG000|Overall Study|Disease progression|44|||
143372683|NCT04248829|516909635|FG001|Overall Study|Disease progression|109|||
143372684|NCT04248829|516909634|FG000|Overall Study|Adverse Event|19|||
143372685|NCT04248829|516909635|FG001|Overall Study|Adverse Event|18|||
143372686|NCT04248829|516909634|FG000|Overall Study|Withdrawal by Subject|11|||
143274380|NCT02975336|516558218|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
143372687|NCT04248829|516909635|FG001|Overall Study|Withdrawal by Subject|2|||
143372688|NCT04248829|516909634|FG000|Overall Study|Lost to Follow-up|0|||
143372689|NCT04248829|516909635|FG001|Overall Study|Lost to Follow-up|1|||
143274381|NCT02975336|516558219|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
143274382|NCT02975336|516558220|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
143274383|NCT02975336|516558221|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
143274384|NCT02975336|516558214|FG000|LTE (104 Weeks)|Adverse Event|0|||
143274385|NCT02975336|516558215|FG001|LTE (104 Weeks)|Adverse Event|0|||
143274386|NCT02975336|516558216|FG002|LTE (104 Weeks)|Adverse Event|0|||
143274387|NCT02975336|516558217|FG003|LTE (104 Weeks)|Adverse Event|0|||
143274388|NCT02975336|516558218|FG004|LTE (104 Weeks)|Adverse Event|7|||
143372690|NCT04248829|516909634|FG000|Overall Study|Death|12|||
143372691|NCT04248829|516909635|FG001|Overall Study|Death|14|||
143274389|NCT02975336|516558219|FG005|LTE (104 Weeks)|Adverse Event|4|||
143274390|NCT02975336|516558220|FG006|LTE (104 Weeks)|Adverse Event|2|||
143274391|NCT02975336|516558221|FG007|LTE (104 Weeks)|Adverse Event|0|||
143274392|NCT02975336|516558214|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
143274393|NCT02975336|516558215|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
143274394|NCT02975336|516558216|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
143274395|NCT02975336|516558217|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
143274396|NCT02975336|516558218|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
143274397|NCT02975336|516558219|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
143274398|NCT02975336|516558220|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
143274399|NCT02975336|516558221|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
143274400|NCT02975336|516558214|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
143274401|NCT02975336|516558215|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
143274402|NCT02975336|516558216|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
143274403|NCT02975336|516558217|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
143274404|NCT02975336|516558218|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
143274405|NCT02975336|516558219|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
143274406|NCT02975336|516558220|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
143274407|NCT02975336|516558221|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
143274408|NCT02975336|516558214|FG000|LTE (104 Weeks)|Other|0|||
143274409|NCT02975336|516558215|FG001|LTE (104 Weeks)|Other|0|||
143274410|NCT02975336|516558216|FG002|LTE (104 Weeks)|Other|0|||
143274411|NCT02975336|516558217|FG003|LTE (104 Weeks)|Other|0|||
143274412|NCT02975336|516558218|FG004|LTE (104 Weeks)|Other|55|||
143274413|NCT02975336|516558219|FG005|LTE (104 Weeks)|Other|63|||
143274414|NCT02975336|516558220|FG006|LTE (104 Weeks)|Other|76|||
143274415|NCT02975336|516558221|FG007|LTE (104 Weeks)|Other|72|||
143274416|NCT01897454|516558222|FG000|Overall Study|Withdrawal by Subject|1|||
143274417|NCT05154578|516558224|FG000|Overall Study|Withdrawal by Subject|2|||
143274418|NCT05154578|516558225|FG001|Overall Study|Withdrawal by Subject|3|||
143274419|NCT05154578|516558226|FG002|Overall Study|Withdrawal by Subject|2|||
143274420|NCT05154578|516558227|FG003|Overall Study|Withdrawal by Subject|4|||
143274421|NCT05154578|516558228|FG004|Overall Study|Withdrawal by Subject|0|||
143274422|NCT05154578|516558224|FG000|Overall Study|Lost to Follow-up|0|||
143274423|NCT05154578|516558225|FG001|Overall Study|Lost to Follow-up|1|||
143274424|NCT05154578|516558226|FG002|Overall Study|Lost to Follow-up|0|||
143274425|NCT05154578|516558227|FG003|Overall Study|Lost to Follow-up|3|||
143274426|NCT05154578|516558228|FG004|Overall Study|Lost to Follow-up|0|||
143274427|NCT05154578|516558224|FG000|Overall Study|Adverse Event|0|||
143274428|NCT05154578|516558225|FG001|Overall Study|Adverse Event|0|||
143274429|NCT05154578|516558226|FG002|Overall Study|Adverse Event|0|||
143274430|NCT05154578|516558227|FG003|Overall Study|Adverse Event|1|||
143274431|NCT05154578|516558228|FG004|Overall Study|Adverse Event|0|||
143274432|NCT05154578|516558224|FG000|Overall Study|Relocated to another province|0|||
143274433|NCT05154578|516558225|FG001|Overall Study|Relocated to another province|0|||
143274434|NCT05154578|516558226|FG002|Overall Study|Relocated to another province|1|||
143274435|NCT05154578|516558227|FG003|Overall Study|Relocated to another province|0|||
143274436|NCT05154578|516558228|FG004|Overall Study|Relocated to another province|1|||
143274437|NCT05154578|516558224|FG000|Overall Study|Baby loss|0|||
143274438|NCT05154578|516558225|FG001|Overall Study|Baby loss|1|||
143274439|NCT05154578|516558226|FG002|Overall Study|Baby loss|0|||
143274440|NCT05154578|516558227|FG003|Overall Study|Baby loss|0|||
143274441|NCT05154578|516558228|FG004|Overall Study|Baby loss|0|||
143274442|NCT00894166|516558236|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
143274443|NCT00894166|516558237|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
143274444|NCT00894166|516558238|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
143274445|NCT00894166|516558239|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
143274446|NCT00894166|516558240|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
143274447|NCT00894166|516558241|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
143274448|NCT00894166|516558242|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
143274449|NCT00894166|516558243|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
143274450|NCT00894166|516558236|FG000|Overall Study|Death|0|||
143274451|NCT00894166|516558237|FG001|Overall Study|Death|0|||
143274452|NCT00894166|516558238|FG002|Overall Study|Death|0|||
143274453|NCT00894166|516558239|FG003|Overall Study|Death|1|||
143274454|NCT00894166|516558240|FG004|Overall Study|Death|0|||
143274455|NCT00894166|516558241|FG005|Overall Study|Death|0|||
143274456|NCT00894166|516558242|FG006|Overall Study|Death|0|||
143274457|NCT00894166|516558243|FG007|Overall Study|Death|0|||
143274458|NCT05350410|516558244|FG000|Overall Study|Withdrawal by Subject|1|||
143274459|NCT03750955|516558245|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
143274460|NCT03750955|516558246|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
143274461|NCT03750955|516558245|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
143274462|NCT03750955|516558246|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
143274463|NCT01773733|516558249|FG000|Overall Study|Adverse Event|3286|||
143274464|NCT01773733|516558250|FG001|Overall Study|Adverse Event|540|||
143274465|NCT01773733|516558249|FG000|Overall Study|Pregnancy|28|||
143274466|NCT01773733|516558250|FG001|Overall Study|Pregnancy|0|||
143274467|NCT01773733|516558249|FG000|Overall Study|Other different categories of not compl|55415|||
143274468|NCT01773733|516558250|FG001|Overall Study|Other different categories of not compl|7781|||
143274469|NCT01180985|516558251|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
143274470|NCT01180985|516558252|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
143274471|NCT00705289|516558253|FG000|Overall Study|Subject or treating physician's choice|131|||
143274472|NCT01030536|516558254|FG000|Overall Study|Withdrawal by Subject|0|||
143274473|NCT01030536|516558255|FG001|Overall Study|Withdrawal by Subject|0|||
143274474|NCT01030536|516558256|FG002|Overall Study|Withdrawal by Subject|1|||
143274475|NCT01030536|516558257|FG003|Overall Study|Withdrawal by Subject|0|||
143274476|NCT01030536|516558258|FG004|Overall Study|Withdrawal by Subject|0|||
143274477|NCT01030536|516558254|FG000|Overall Study|undefined|1|||
143274478|NCT01030536|516558255|FG001|Overall Study|undefined|0|||
143274479|NCT01030536|516558256|FG002|Overall Study|undefined|1|||
143274480|NCT01030536|516558257|FG003|Overall Study|undefined|1|||
143274481|NCT01030536|516558258|FG004|Overall Study|undefined|0|||
143274482|NCT01030536|516558254|FG000|Overall Study|Adverse Event|0|||
143274483|NCT01030536|516558255|FG001|Overall Study|Adverse Event|3|||
143274484|NCT01030536|516558256|FG002|Overall Study|Adverse Event|1|||
143274485|NCT01030536|516558257|FG003|Overall Study|Adverse Event|0|||
143274486|NCT01030536|516558258|FG004|Overall Study|Adverse Event|1|||
143274487|NCT01030536|516558254|FG000|Overall Study|Progressive disease|6|||
143274488|NCT01030536|516558255|FG001|Overall Study|Progressive disease|2|||
143274489|NCT01030536|516558256|FG002|Overall Study|Progressive disease|3|||
143274490|NCT01030536|516558257|FG003|Overall Study|Progressive disease|2|||
143274491|NCT01030536|516558258|FG004|Overall Study|Progressive disease|0|||
143274492|NCT01030536|516558254|FG000|Overall Study|Death|0|||
143274493|NCT01030536|516558255|FG001|Overall Study|Death|1|||
143274494|NCT01030536|516558256|FG002|Overall Study|Death|0|||
143274495|NCT01030536|516558257|FG003|Overall Study|Death|0|||
143274496|NCT01030536|516558258|FG004|Overall Study|Death|0|||
143274497|NCT02601027|516558259|FG000|Registration to Surgery|Withdrawal by Subject|20|||
143274498|NCT02601027|516558260|FG001|Registration to Surgery|Withdrawal by Subject|10|||
143274499|NCT01419626|516558261|FG000|Overall Study|Protocol Violation|3|||
143274500|NCT01419626|516558262|FG001|Overall Study|Protocol Violation|2|||
143274501|NCT01419626|516558263|FG002|Overall Study|Protocol Violation|2|||
143274502|NCT01419626|516558261|FG000|Overall Study|Withdrawal by Subject|1|||
143274503|NCT01419626|516558262|FG001|Overall Study|Withdrawal by Subject|0|||
143274504|NCT01419626|516558263|FG002|Overall Study|Withdrawal by Subject|0|||
143274505|NCT01419626|516558261|FG000|Overall Study|Lost to Follow-up|0|||
143274506|NCT01419626|516558262|FG001|Overall Study|Lost to Follow-up|1|||
143274507|NCT01419626|516558263|FG002|Overall Study|Lost to Follow-up|1|||
143274508|NCT01146912|516558264|FG000|Overall Study|Already received influenza vaccination|817|||
143274509|NCT01146912|516558265|FG001|Overall Study|Already received influenza vaccination|822|||
143274510|NCT01146912|516558266|FG002|Overall Study|Already received influenza vaccination|13|||
143274511|NCT01146912|516558267|FG003|Overall Study|Already received influenza vaccination|15|||
143274512|NCT01146912|516558268|FG004|Overall Study|Already received influenza vaccination|41|||
143274513|NCT01146912|516558269|FG005|Overall Study|Already received influenza vaccination|61|||
143274514|NCT01146912|516558270|FG006|Overall Study|Already received influenza vaccination|56|||
143274515|NCT01146912|516558271|FG007|Overall Study|Already received influenza vaccination|0|||
143274516|NCT01146912|516558264|FG000|Overall Study|< 14 weeks gestational age|0|||
143274517|NCT01146912|516558265|FG001|Overall Study|< 14 weeks gestational age|0|||
143274518|NCT01146912|516558266|FG002|Overall Study|< 14 weeks gestational age|3|||
143274519|NCT01146912|516558267|FG003|Overall Study|< 14 weeks gestational age|2|||
143274520|NCT01146912|516558268|FG004|Overall Study|< 14 weeks gestational age|0|||
143274521|NCT01146912|516558269|FG005|Overall Study|< 14 weeks gestational age|0|||
143274522|NCT01146912|516558270|FG006|Overall Study|< 14 weeks gestational age|0|||
143274523|NCT01146912|516558271|FG007|Overall Study|< 14 weeks gestational age|0|||
143274524|NCT01146912|516558264|FG000|Overall Study|Duplicate patient|0|||
143274525|NCT01146912|516558265|FG001|Overall Study|Duplicate patient|0|||
143274526|NCT01146912|516558266|FG002|Overall Study|Duplicate patient|1|||
143274527|NCT01146912|516558267|FG003|Overall Study|Duplicate patient|0|||
143274528|NCT01146912|516558268|FG004|Overall Study|Duplicate patient|0|||
143274529|NCT01146912|516558269|FG005|Overall Study|Duplicate patient|0|||
143274530|NCT01146912|516558270|FG006|Overall Study|Duplicate patient|0|||
143274531|NCT01146912|516558271|FG007|Overall Study|Duplicate patient|0|||
143274532|NCT02248701|516558274|FG000|Overall Study|Withdrawal by Subject|2|||
143274533|NCT02248701|516558275|FG001|Overall Study|Withdrawal by Subject|1|||
143274534|NCT02248701|516558274|FG000|Overall Study|Physician Decision|0|||
143274535|NCT02248701|516558275|FG001|Overall Study|Physician Decision|1|||
143274536|NCT02248701|516558274|FG000|Overall Study|Adverse Event|1|||
143274537|NCT02248701|516558275|FG001|Overall Study|Adverse Event|0|||
143274538|NCT02248701|516558274|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
143274539|NCT02248701|516558275|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
143274540|NCT01145625|516558276|FG000|Overall Study|Lost to Follow-up|8|||
143274541|NCT01145625|516558277|FG001|Overall Study|Lost to Follow-up|9|||
143274542|NCT01145625|516558276|FG000|Overall Study|Adverse Event|6|||
143274543|NCT01145625|516558277|FG001|Overall Study|Adverse Event|4|||
143274544|NCT01145625|516558276|FG000|Overall Study|Protocol Violation|3|||
143274545|NCT01145625|516558277|FG001|Overall Study|Protocol Violation|1|||
143274546|NCT01145625|516558276|FG000|Overall Study|Withdrawal by Subject|7|||
143274547|NCT01145625|516558277|FG001|Overall Study|Withdrawal by Subject|16|||
143274548|NCT01145625|516558276|FG000|Overall Study|Pregnancy|0|||
143274549|NCT01145625|516558277|FG001|Overall Study|Pregnancy|1|||
143274550|NCT00885846|516558279|FG000|Overall Study|Withdrawal by Subject|2|||
143274551|NCT00885846|516558280|FG001|Overall Study|Withdrawal by Subject|5|||
143274552|NCT00885846|516558281|FG002|Overall Study|Withdrawal by Subject|2|||
143274553|NCT01952145|516558282|FG000|Overall Study|Protocol Violation|2|||
143274554|NCT01952145|516558283|FG001|Overall Study|Protocol Violation|1|||
143274555|NCT01952145|516558282|FG000|Overall Study|Death|0|||
143274556|NCT01952145|516558283|FG001|Overall Study|Death|1|||
143274557|NCT01952145|516558282|FG000|Overall Study|Adverse Event|9|||
143274558|NCT01952145|516558283|FG001|Overall Study|Adverse Event|0|||
143274559|NCT01952145|516558282|FG000|Overall Study|Withdrawal Criteria|16|||
143274560|NCT01952145|516558283|FG001|Overall Study|Withdrawal Criteria|11|||
143274561|NCT01952145|516558282|FG000|Overall Study|Unclassified|1|||
143274562|NCT01952145|516558283|FG001|Overall Study|Unclassified|1|||
143274563|NCT00493025|516558284|FG000|Overall Study|Physician Decision|19|||
143274564|NCT03863197|516558285|FG000|Overall Study|Lost to Follow-up|2|||
143274565|NCT03863197|516558286|FG001|Overall Study|Lost to Follow-up|3|||
143274566|NCT03863197|516558285|FG000|Overall Study|Withdrawal by Subject|4|||
143274567|NCT03863197|516558286|FG001|Overall Study|Withdrawal by Subject|0|||
143274568|NCT03863197|516558285|FG000|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|2|||
143274569|NCT03863197|516558286|FG001|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|0|||
143274570|NCT00413244|516558287|FG000|Overall Study|Withdrawal by Subject|10|||
143274571|NCT00413244|516558288|FG001|Overall Study|Withdrawal by Subject|1|||
143274572|NCT01032174|516558289|FG000|Overall Study|Adverse Event|0|||
143274573|NCT01032174|516558290|FG001|Overall Study|Adverse Event|1|||
143274574|NCT02713204|516558294|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
143274575|NCT02713204|516558295|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
143274576|NCT02713204|516558296|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
143274577|NCT02713204|516558297|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
143274578|NCT02713204|516558298|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
143274579|NCT02713204|516558299|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
143274580|NCT02713204|516558300|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
143274581|NCT02713204|516558301|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
143274582|NCT02713204|516558294|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
143274583|NCT02713204|516558295|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
143274584|NCT02713204|516558296|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
143274585|NCT02713204|516558297|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
143274586|NCT02713204|516558298|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
143274587|NCT02713204|516558299|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
143274588|NCT02713204|516558300|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
143274589|NCT02713204|516558301|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
143274590|NCT02713204|516558294|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
143274591|NCT02713204|516558295|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
143274592|NCT02713204|516558296|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
143274593|NCT02713204|516558297|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
143274594|NCT02713204|516558298|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
143274595|NCT02713204|516558299|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
143274596|NCT02713204|516558300|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
143274597|NCT02713204|516558301|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
143274598|NCT02713204|516558294|FG000|From Week 12 up to Week 36|Adverse Event|1|||
143274599|NCT02713204|516558295|FG001|From Week 12 up to Week 36|Adverse Event|0|||
143274600|NCT02713204|516558296|FG002|From Week 12 up to Week 36|Adverse Event|0|||
143274601|NCT02713204|516558297|FG003|From Week 12 up to Week 36|Adverse Event|1|||
143274602|NCT02713204|516558298|FG004|From Week 12 up to Week 36|Adverse Event|1|||
143274603|NCT02713204|516558299|FG005|From Week 12 up to Week 36|Adverse Event|0|||
143274604|NCT02713204|516558300|FG006|From Week 12 up to Week 36|Adverse Event|2|||
143274605|NCT02713204|516558301|FG007|From Week 12 up to Week 36|Adverse Event|1|||
143274606|NCT02713204|516558294|FG000|From Week 12 up to Week 36|Death|0|||
143274607|NCT02713204|516558295|FG001|From Week 12 up to Week 36|Death|0|||
143274608|NCT02713204|516558296|FG002|From Week 12 up to Week 36|Death|0|||
143274609|NCT02713204|516558297|FG003|From Week 12 up to Week 36|Death|1|||
143274610|NCT02713204|516558298|FG004|From Week 12 up to Week 36|Death|0|||
143274611|NCT02713204|516558299|FG005|From Week 12 up to Week 36|Death|1|||
143274612|NCT02713204|516558300|FG006|From Week 12 up to Week 36|Death|0|||
143274613|NCT02713204|516558301|FG007|From Week 12 up to Week 36|Death|3|||
143274614|NCT02713204|516558294|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
143274615|NCT02713204|516558295|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
143274616|NCT02713204|516558296|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
143372692|NCT04248829|516909634|FG000|Overall Study|Physician Decision|2|||
143274617|NCT02713204|516558297|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
143274618|NCT02713204|516558298|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
143274619|NCT02713204|516558299|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
143274620|NCT02713204|516558300|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
143274621|NCT02713204|516558301|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
143274622|NCT02713204|516558294|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
143274623|NCT02713204|516558295|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
143274624|NCT02713204|516558296|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
143274625|NCT02713204|516558297|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
143274626|NCT02713204|516558298|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
143274627|NCT02713204|516558299|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
143274628|NCT02713204|516558300|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
143274629|NCT02713204|516558301|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
143274630|NCT00467857|516558304|FG000|Overall Study|Adverse Event|1|||
143274631|NCT00467857|516558305|FG001|Overall Study|Adverse Event|0|||
143274632|NCT00467857|516558304|FG000|Overall Study|Withdrew consent|2|||
143274633|NCT00467857|516558305|FG001|Overall Study|Withdrew consent|0|||
143274634|NCT00467857|516558304|FG000|Overall Study|Death|0|||
143274635|NCT00467857|516558305|FG001|Overall Study|Death|1|||
143274636|NCT00467857|516558304|FG000|Overall Study|Discharged from court service|0|||
143274637|NCT00467857|516558305|FG001|Overall Study|Discharged from court service|1|||
143274638|NCT00467857|516558304|FG000|Overall Study|Emergency care required|0|||
143274639|NCT00467857|516558305|FG001|Overall Study|Emergency care required|1|||
143274640|NCT00467857|516558304|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
143274641|NCT00467857|516558305|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
143274642|NCT00467857|516558304|FG000|Overall Study|Discontinuation reason missing|0|||
143274643|NCT00467857|516558305|FG001|Overall Study|Discontinuation reason missing|3|||
143274644|NCT00516074|516558306|FG000|Overall Study|Adverse Event|0|||
143274645|NCT00516074|516558307|FG001|Overall Study|Adverse Event|1|||
143274646|NCT00516074|516558306|FG000|Overall Study|Subject Decision|4|||
143274647|NCT00516074|516558307|FG001|Overall Study|Subject Decision|2|||
143274648|NCT00516074|516558306|FG000|Overall Study|Loss of Glucose Control|2|||
143274649|NCT00516074|516558307|FG001|Overall Study|Loss of Glucose Control|0|||
143274650|NCT03822182|516558309|FG000|Overall Study|Protocol Violation|0|||
143274651|NCT03822182|516558310|FG001|Overall Study|Protocol Violation|1|||
143274652|NCT03822182|516558311|FG002|Overall Study|Protocol Violation|1|||
143274653|NCT00810355|516558312|FG000|Overall Study|Lost to Follow-up|13|||
143274654|NCT00810355|516558313|FG001|Overall Study|Lost to Follow-up|17|||
143274655|NCT00810355|516558314|FG002|Overall Study|Lost to Follow-up|11|||
143274656|NCT00810355|516558312|FG000|Overall Study|Withdrawal by Subject|1|||
143274657|NCT00810355|516558313|FG001|Overall Study|Withdrawal by Subject|0|||
143274658|NCT00810355|516558314|FG002|Overall Study|Withdrawal by Subject|0|||
143274659|NCT01484275|516558315|FG000|Overall Study|Study terminated by sponsor|28|||
143274660|NCT01484275|516558316|FG001|Overall Study|Study terminated by sponsor|32|||
143274661|NCT01484275|516558315|FG000|Overall Study|Other|10|||
143274662|NCT01484275|516558316|FG001|Overall Study|Other|0|||
143274663|NCT01484275|516558315|FG000|Overall Study|Death|3|||
143274664|NCT01484275|516558316|FG001|Overall Study|Death|4|||
143274665|NCT01484275|516558315|FG000|Overall Study|Withdrawal by Subject|1|||
143274666|NCT01484275|516558316|FG001|Overall Study|Withdrawal by Subject|5|||
143274667|NCT01484275|516558315|FG000|Overall Study|Lost to Follow-up|1|||
143274668|NCT01484275|516558316|FG001|Overall Study|Lost to Follow-up|1|||
143372693|NCT04248829|516909635|FG001|Overall Study|Physician Decision|4|||
143372694|NCT04248829|516909634|FG000|Overall Study|Any reason not specifically recorded|0|||
143372695|NCT04248829|516909635|FG001|Overall Study|Any reason not specifically recorded|2|||
143372696|NCT02132702|516909636|FG000|Overall Study|Protocol Violation|2|||
143372697|NCT02132702|516909636|FG000|Overall Study|Adverse Event|3|||
143372698|NCT02132702|516909636|FG000|Overall Study|Withdrawal by Subject|3|||
143372699|NCT02299336|516909637|FG000|Overall Study|Withdrawal by Subject|11|||
143372700|NCT02299336|516909637|FG000|Overall Study|Adverse Event|1|||
143372701|NCT02299336|516909637|FG000|Overall Study|Death|1|||
143372702|NCT02299336|516909637|FG000|Overall Study|Lost to Follow-up|1|||
143372703|NCT01212757|516909643|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
143372704|NCT01212757|516909644|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
143372705|NCT01212757|516909645|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
143372706|NCT01212757|516909646|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
143372707|NCT01212757|516909647|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
143372708|NCT01212757|516909648|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
143372709|NCT01212757|516909649|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
143372710|NCT01212757|516909650|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
143372711|NCT01212757|516909651|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
143372712|NCT01212757|516909643|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
143372713|NCT01212757|516909644|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
143372714|NCT01212757|516909645|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
143372715|NCT01212757|516909646|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
143372716|NCT01212757|516909647|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
143372717|NCT01212757|516909648|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
143372718|NCT01212757|516909649|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
143372719|NCT01212757|516909650|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
143372720|NCT01212757|516909651|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
143372721|NCT01212757|516909643|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
143372722|NCT01212757|516909644|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
143372723|NCT01212757|516909645|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
143372724|NCT01212757|516909646|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
143372725|NCT01212757|516909647|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
143372726|NCT01212757|516909648|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
143372727|NCT01212757|516909649|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
143372728|NCT01212757|516909650|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
143372729|NCT01212757|516909651|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
143372730|NCT01212757|516909643|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
143372731|NCT01212757|516909644|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
143372732|NCT01212757|516909645|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
143372733|NCT01212757|516909646|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
143372734|NCT01212757|516909647|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
143372735|NCT01212757|516909648|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
143372736|NCT01212757|516909649|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
143372737|NCT01212757|516909650|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
143372738|NCT01212757|516909651|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
143372739|NCT01212757|516909643|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
143372740|NCT01212757|516909644|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
143372741|NCT01212757|516909645|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
143372742|NCT01212757|516909646|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
143372743|NCT01212757|516909647|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
143372744|NCT01212757|516909648|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
143372745|NCT01212757|516909649|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
143372746|NCT01212757|516909650|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
143372747|NCT01212757|516909651|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
143372748|NCT01212757|516909643|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
143372749|NCT01212757|516909644|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
143372750|NCT01212757|516909645|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
143372751|NCT01212757|516909646|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
143372752|NCT01212757|516909647|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
143372753|NCT01212757|516909648|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
143372754|NCT01212757|516909649|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
143372755|NCT01212757|516909650|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
143372756|NCT01212757|516909651|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
143372757|NCT01212757|516909643|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
143372758|NCT01212757|516909644|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
143274669|NCT00657358|516558317|FG000|Overall Study|Lack of Efficacy|6|||
143274670|NCT02628938|516558321|FG000|Overall Study|Did not attend the follow up recall|2|||
143274671|NCT02628938|516558322|FG001|Overall Study|Did not attend the follow up recall|2|||
143274672|NCT02628938|516558323|FG002|Overall Study|Did not attend the follow up recall|1|||
143274673|NCT02628938|516558321|FG000|Overall Study|Failure to comply with the instructions|3|||
143274674|NCT02628938|516558322|FG001|Overall Study|Failure to comply with the instructions|0|||
143274675|NCT02628938|516558323|FG002|Overall Study|Failure to comply with the instructions|3|||
143274676|NCT02925117|516558326|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
143274677|NCT02925117|516558327|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
143274678|NCT02925117|516558328|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
143274679|NCT02925117|516558329|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
143274680|NCT02925117|516558330|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
143274681|NCT02925117|516558331|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
143372759|NCT01212757|516909645|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
143372760|NCT01212757|516909646|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
143372761|NCT01212757|516909647|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
143372762|NCT01212757|516909648|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
143372763|NCT01212757|516909649|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
143274682|NCT02925117|516558332|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
143274683|NCT02925117|516558333|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
143274684|NCT02925117|516558334|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
143274685|NCT02925117|516558335|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
143372764|NCT01212757|516909650|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
143372765|NCT01212757|516909651|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
143372766|NCT01212757|516909643|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
143372767|NCT01212757|516909644|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
143372768|NCT01212757|516909645|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
143372769|NCT01212757|516909646|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
143372770|NCT01212757|516909647|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
143372771|NCT01212757|516909648|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
143372772|NCT01212757|516909649|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
143372773|NCT01212757|516909650|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
143372774|NCT01212757|516909651|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
143372775|NCT01212757|516909643|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
143372776|NCT01212757|516909644|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
143372777|NCT01212757|516909645|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
143372778|NCT01212757|516909646|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
143372779|NCT01212757|516909647|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
143372780|NCT01212757|516909648|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
143372781|NCT01212757|516909649|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
143372782|NCT01212757|516909650|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
143372783|NCT01212757|516909651|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
143372784|NCT01212757|516909643|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
143372785|NCT01212757|516909644|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
143372786|NCT01212757|516909645|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
143372787|NCT01212757|516909646|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
143372788|NCT01212757|516909647|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
143372789|NCT01212757|516909648|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
143372790|NCT01212757|516909649|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
143372791|NCT01212757|516909650|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
143372792|NCT01212757|516909651|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
143372793|NCT01212757|516909643|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
143274686|NCT02925117|516558336|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
143274687|NCT02925117|516558337|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
143274688|NCT02925117|516558326|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
143274689|NCT02925117|516558327|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
143274690|NCT02925117|516558328|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
143274691|NCT02925117|516558329|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
143274692|NCT02925117|516558330|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
143274693|NCT02925117|516558331|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
143274694|NCT02925117|516558332|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
143372794|NCT01212757|516909644|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
143372795|NCT01212757|516909645|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
143274695|NCT02925117|516558333|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
143274696|NCT02925117|516558334|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
143274697|NCT02925117|516558335|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
143274698|NCT02925117|516558336|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
143274699|NCT02925117|516558337|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
143274700|NCT02925117|516558326|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
143274701|NCT02925117|516558327|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
143274702|NCT02925117|516558328|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
143274703|NCT02925117|516558329|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
143274704|NCT02925117|516558330|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
143274705|NCT02925117|516558331|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
143274706|NCT02925117|516558332|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
143274707|NCT02925117|516558333|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
143274708|NCT02925117|516558334|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
143274709|NCT02925117|516558335|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
143274710|NCT02925117|516558336|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
143274711|NCT02925117|516558337|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
143274712|NCT02925117|516558326|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
143274713|NCT02925117|516558327|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
143274714|NCT02925117|516558328|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
143274715|NCT02925117|516558329|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
143274716|NCT02925117|516558330|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
143274717|NCT02925117|516558331|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
143274718|NCT02925117|516558332|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
143274719|NCT02925117|516558333|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
143274720|NCT02925117|516558334|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
143274721|NCT02925117|516558335|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
143274722|NCT02925117|516558336|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
143274723|NCT02925117|516558337|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
143274724|NCT02925117|516558326|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
143274725|NCT02925117|516558327|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
143274726|NCT02925117|516558328|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
143274727|NCT02925117|516558329|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
143274728|NCT02925117|516558330|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
143274729|NCT02925117|516558331|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
143274730|NCT02925117|516558332|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
143274731|NCT02925117|516558333|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
143274732|NCT02925117|516558334|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
143274733|NCT02925117|516558335|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
143274734|NCT02925117|516558336|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
143274735|NCT02925117|516558337|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
143274736|NCT02925117|516558326|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
143274737|NCT02925117|516558327|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
143274738|NCT02925117|516558328|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
143274739|NCT02925117|516558329|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
143274740|NCT02925117|516558330|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
143274741|NCT02925117|516558331|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
143274742|NCT02925117|516558332|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
143274743|NCT02925117|516558333|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
143274744|NCT02925117|516558334|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
143274745|NCT02925117|516558335|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
143274746|NCT02925117|516558336|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
143274747|NCT02925117|516558337|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
143274748|NCT02925117|516558326|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
143274749|NCT02925117|516558327|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
143274750|NCT02925117|516558328|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
143274751|NCT02925117|516558329|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
143274752|NCT02925117|516558330|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
143274753|NCT02925117|516558331|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
143274754|NCT02925117|516558332|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
143274755|NCT02925117|516558333|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
143274756|NCT02925117|516558334|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
143274757|NCT02925117|516558335|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
143274758|NCT02925117|516558336|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
143274759|NCT02925117|516558337|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
143274760|NCT02925117|516558326|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
143274761|NCT02925117|516558327|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
143274762|NCT02925117|516558328|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
143274763|NCT02925117|516558329|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
143274764|NCT02925117|516558330|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
143274765|NCT02925117|516558331|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
143274766|NCT02925117|516558332|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
143274767|NCT02925117|516558333|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
143274768|NCT02925117|516558334|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
143274769|NCT02925117|516558335|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
143274770|NCT02925117|516558336|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
143274771|NCT02925117|516558337|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
143274772|NCT00913380|516558342|FG000|Clinical Outcomes|Lost to Follow-up|6|||
143274773|NCT00913380|516558343|FG001|Clinical Outcomes|Lost to Follow-up|6|||
143274774|NCT00806351|516558346|FG000|Overall Study|Death|5|||
143274775|NCT00806351|516558347|FG001|Overall Study|Death|4|||
143274776|NCT01788228|516558348|FG000|Overall Study|Migrated/moved from study area|1|||
143274777|NCT01788228|516558349|FG001|Overall Study|Migrated/moved from study area|0|||
143274778|NCT00945893|516558353|FG000|Overall Study|Lost to Follow-up|2|||
143274779|NCT00945893|516558354|FG001|Overall Study|Lost to Follow-up|8|||
143274780|NCT00945893|516558353|FG000|Overall Study|Withdrawal of consent|1|||
143274781|NCT00945893|516558354|FG001|Overall Study|Withdrawal of consent|2|||
143274782|NCT01602120|516558355|FG000|Overall Study|Adverse Event|3|||
143274783|NCT01602120|516558356|FG001|Overall Study|Adverse Event|6|||
143274784|NCT01602120|516558357|FG002|Overall Study|Adverse Event|0|||
143274785|NCT01602120|516558358|FG003|Overall Study|Adverse Event|2|||
143274786|NCT01602120|516558355|FG000|Overall Study|Death|0|||
143274787|NCT01602120|516558356|FG001|Overall Study|Death|4|||
143274788|NCT01602120|516558357|FG002|Overall Study|Death|0|||
143274789|NCT01602120|516558358|FG003|Overall Study|Death|0|||
143274790|NCT01602120|516558355|FG000|Overall Study|Lost to Follow-up|0|||
143274791|NCT01602120|516558356|FG001|Overall Study|Lost to Follow-up|1|||
143274792|NCT01602120|516558357|FG002|Overall Study|Lost to Follow-up|0|||
143274793|NCT01602120|516558358|FG003|Overall Study|Lost to Follow-up|1|||
143274794|NCT01602120|516558355|FG000|Overall Study|Protocol Violation|1|||
143274795|NCT01602120|516558356|FG001|Overall Study|Protocol Violation|1|||
143274796|NCT01602120|516558357|FG002|Overall Study|Protocol Violation|0|||
143274797|NCT01602120|516558358|FG003|Overall Study|Protocol Violation|0|||
143274798|NCT01602120|516558355|FG000|Overall Study|Non-compliance|0|||
143274799|NCT01602120|516558356|FG001|Overall Study|Non-compliance|3|||
143274800|NCT01602120|516558357|FG002|Overall Study|Non-compliance|0|||
143274801|NCT01602120|516558358|FG003|Overall Study|Non-compliance|1|||
143274802|NCT01602120|516558355|FG000|Overall Study|Withdrawal by Subject|8|||
143274803|NCT01602120|516558356|FG001|Overall Study|Withdrawal by Subject|17|||
143274804|NCT01602120|516558357|FG002|Overall Study|Withdrawal by Subject|0|||
143274805|NCT01602120|516558358|FG003|Overall Study|Withdrawal by Subject|3|||
143274806|NCT01602120|516558355|FG000|Overall Study|Study Terminated by Sponsor|12|||
143274807|NCT01602120|516558356|FG001|Overall Study|Study Terminated by Sponsor|24|||
143274808|NCT01602120|516558357|FG002|Overall Study|Study Terminated by Sponsor|17|||
143274809|NCT01602120|516558358|FG003|Overall Study|Study Terminated by Sponsor|44|||
143274810|NCT01602120|516558355|FG000|Overall Study|Physician Decision|2|||
143274811|NCT01602120|516558356|FG001|Overall Study|Physician Decision|3|||
143274812|NCT01602120|516558357|FG002|Overall Study|Physician Decision|0|||
143274813|NCT01602120|516558358|FG003|Overall Study|Physician Decision|0|||
143274814|NCT01602120|516558355|FG000|Overall Study|Unspecified Reason|3|||
143274815|NCT01602120|516558356|FG001|Overall Study|Unspecified Reason|1|||
143274816|NCT01602120|516558357|FG002|Overall Study|Unspecified Reason|0|||
143274817|NCT01602120|516558358|FG003|Overall Study|Unspecified Reason|2|||
143274818|NCT01187433|516558363|FG000|Overall Study|Protocol Violation|6|||
143274819|NCT01187433|516558364|FG001|Overall Study|Protocol Violation|2|||
143274820|NCT01187433|516558363|FG000|Overall Study|Withdrawal by Subject|5|||
143274821|NCT01187433|516558364|FG001|Overall Study|Withdrawal by Subject|2|||
143274822|NCT00302107|516558365|FG000|Overall Study|Lost to Follow-up|6|||
143274823|NCT00302107|516558366|FG001|Overall Study|Lost to Follow-up|5|||
143274824|NCT00302107|516558365|FG000|Overall Study|Protocol Violation|1|||
143274825|NCT00302107|516558366|FG001|Overall Study|Protocol Violation|0|||
143274826|NCT00302107|516558365|FG000|Overall Study|Relocation|0|||
143274827|NCT00302107|516558366|FG001|Overall Study|Relocation|1|||
143274828|NCT00302107|516558365|FG000|Overall Study|Withdrawal by Subject|0|||
143274829|NCT00302107|516558366|FG001|Overall Study|Withdrawal by Subject|3|||
143274830|NCT00302107|516558365|FG000|Overall Study|Adverse Event|1|||
143274831|NCT00302107|516558366|FG001|Overall Study|Adverse Event|0|||
143274832|NCT00437983|516558367|FG000|Overall Study|Adverse Event|6|||
143274833|NCT00437983|516558368|FG001|Overall Study|Adverse Event|6|||
143274834|NCT00437983|516558367|FG000|Overall Study|Protocol Violation|2|||
143274835|NCT00437983|516558368|FG001|Overall Study|Protocol Violation|1|||
143274836|NCT00437983|516558367|FG000|Overall Study|Withdrawal by Subject|5|||
143274837|NCT00437983|516558368|FG001|Overall Study|Withdrawal by Subject|6|||
143274838|NCT00594659|516558372|FG000|Overall Study|Lost to Follow-up|13|||
143274839|NCT00594659|516558373|FG001|Overall Study|Lost to Follow-up|9|||
143274840|NCT00594659|516558374|FG002|Overall Study|Lost to Follow-up|7|||
143274841|NCT03730012|516558384|FG000|Overall Study|Adverse Event|0|||
143274842|NCT03730012|516558385|FG001|Overall Study|Adverse Event|1|||
143274843|NCT03730012|516558384|FG000|Overall Study|Lack of Efficacy|1|||
143274844|NCT03730012|516558385|FG001|Overall Study|Lack of Efficacy|5|||
143274845|NCT03730012|516558384|FG000|Overall Study|Withdrawal by Subject|0|||
143274846|NCT03730012|516558385|FG001|Overall Study|Withdrawal by Subject|1|||
143274847|NCT03730012|516558384|FG000|Overall Study|Miscellaneous|2|||
143274848|NCT03730012|516558385|FG001|Overall Study|Miscellaneous|1|||
143274849|NCT04680052|516560206|FG000|Overall Study|Ongoing|244|||
143274850|NCT04680052|516560207|FG001|Overall Study|Ongoing|229|||
143274851|NCT04680052|516560208|FG002|Overall Study|Ongoing|39|||
143274852|NCT04680052|516560209|FG003|Overall Study|Ongoing|46|||
143274853|NCT04680052|516560206|FG000|Overall Study|Death|15|||
143274854|NCT04680052|516560207|FG001|Overall Study|Death|22|||
143274855|NCT04680052|516560208|FG002|Overall Study|Death|7|||
143274856|NCT04680052|516560209|FG003|Overall Study|Death|1|||
143274857|NCT04680052|516560206|FG000|Overall Study|Lost to Follow-up|3|||
143274858|NCT04680052|516560207|FG001|Overall Study|Lost to Follow-up|2|||
143274859|NCT04680052|516560208|FG002|Overall Study|Lost to Follow-up|0|||
143274860|NCT04680052|516560209|FG003|Overall Study|Lost to Follow-up|1|||
143274861|NCT04680052|516560206|FG000|Overall Study|Withdrawal by Subject|11|||
143274862|NCT04680052|516560207|FG001|Overall Study|Withdrawal by Subject|19|||
143274863|NCT04680052|516560208|FG002|Overall Study|Withdrawal by Subject|7|||
143274864|NCT04680052|516560209|FG003|Overall Study|Withdrawal by Subject|5|||
143274865|NCT04680052|516560206|FG000|Overall Study|Missing|0|||
143274866|NCT04680052|516560207|FG001|Overall Study|Missing|1|||
143274867|NCT04680052|516560208|FG002|Overall Study|Missing|0|||
143274868|NCT04680052|516560209|FG003|Overall Study|Missing|0|||
143274869|NCT04680052|516560206|FG000|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
143274870|NCT04680052|516560207|FG001|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|1|||
143274871|NCT04680052|516560208|FG002|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
143274872|NCT04680052|516560209|FG003|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
143274873|NCT04680052|516560206|FG000|Overall Study|Physician Decision|0|||
143274874|NCT04680052|516560207|FG001|Overall Study|Physician Decision|1|||
143274875|NCT04680052|516560208|FG002|Overall Study|Physician Decision|0|||
143274876|NCT04680052|516560209|FG003|Overall Study|Physician Decision|0|||
143274877|NCT00825682|516560212|FG000|Overall Study|personal reasons/ inconvenience|13|||
143274878|NCT00825682|516560213|FG001|Overall Study|personal reasons/ inconvenience|5|||
143274879|NCT02478632|516560215|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
143274880|NCT02478632|516560216|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
143274881|NCT02478632|516560215|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
143274882|NCT02478632|516560216|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
143274883|NCT02478632|516560215|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
143274884|NCT02478632|516560216|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
143274885|NCT00129272|516560220|FG000|Overall Study|Lost to Follow-up|12|||
143274886|NCT00129272|516560221|FG001|Overall Study|Lost to Follow-up|11|||
143274887|NCT00129272|516560220|FG000|Overall Study|Withdrawal by Subject|5|||
143274888|NCT00129272|516560221|FG001|Overall Study|Withdrawal by Subject|11|||
143274889|NCT00880542|516560224|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
143372796|NCT01212757|516909646|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
143372797|NCT01212757|516909647|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
143274890|NCT00880542|516560224|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
143274891|NCT00880542|516560224|FG000|REP: Surgical Resection|progressive disease|1|||
143274892|NCT00762385|516560225|FG000|First Intervention|Lens Issue|1|||
143274893|NCT00762385|516560226|FG001|First Intervention|Lens Issue|1|||
143274894|NCT00762385|516560225|FG000|First Intervention|Lost to Follow-up|0|||
143274895|NCT00762385|516560226|FG001|First Intervention|Lost to Follow-up|2|||
143274896|NCT00762385|516560225|FG000|First Intervention|Ineligible|1|||
143274897|NCT00762385|516560226|FG001|First Intervention|Ineligible|0|||
143274898|NCT00762385|516560225|FG000|First Intervention|Protocol Violation|0|||
143274899|NCT00762385|516560226|FG001|First Intervention|Protocol Violation|1|||
143274900|NCT00762385|516560225|FG000|Second Intervention|Protocol Violation|3|||
143274901|NCT00762385|516560226|FG001|Second Intervention|Protocol Violation|3|||
143274902|NCT01540838|516560228|FG000|Overall Study|Open nasogastric tube|9|||
143274903|NCT01540838|516560229|FG001|Overall Study|Open nasogastric tube|7|||
143274904|NCT01540838|516560228|FG000|Overall Study|Treatment doses missing|8|||
143274905|NCT01540838|516560229|FG001|Overall Study|Treatment doses missing|12|||
143274906|NCT01540838|516560228|FG000|Overall Study|Additional antibiotic treatment|1|||
143274907|NCT01540838|516560229|FG001|Overall Study|Additional antibiotic treatment|2|||
143274908|NCT01540838|516560228|FG000|Overall Study|Died before treatment initiation|1|||
143274909|NCT01540838|516560229|FG001|Overall Study|Died before treatment initiation|1|||
143274910|NCT01540838|516560228|FG000|Overall Study|Not BM. Other treatment|3|||
143274911|NCT01540838|516560229|FG001|Overall Study|Not BM. Other treatment|1|||
143274912|NCT02130570|516560230|FG000|Overall Study|Death|3|||
143274913|NCT02130570|516560231|FG001|Overall Study|Death|5|||
143274914|NCT02130570|516560230|FG000|Overall Study|Withdrawal by Subject|6|||
143274915|NCT02130570|516560231|FG001|Overall Study|Withdrawal by Subject|3|||
143274916|NCT02130570|516560230|FG000|Overall Study|Part of practice that discontinued study|0|||
143274917|NCT02130570|516560231|FG001|Overall Study|Part of practice that discontinued study|5|||
143274918|NCT01065597|516560234|FG000|Overall Study|Adverse Event|1|||
143274919|NCT01781975|516560235|FG000|Overall Study|Death|1|||
143274920|NCT01781975|516560236|FG001|Overall Study|Death|0|||
143274921|NCT01781975|516560235|FG000|Overall Study|Withdrawal by Subject|1|||
143274922|NCT01781975|516560236|FG001|Overall Study|Withdrawal by Subject|1|||
143274923|NCT01622231|516560237|FG000|Overall Study|Physician Decision|1|||
143274924|NCT01622231|516560237|FG000|Overall Study|Withdrawal by Subject|1|||
143274925|NCT02329080|516560239|FG000|Overall Study|Adverse Event|1|||
143274926|NCT02329080|516560239|FG000|Overall Study|Death|4|||
143274927|NCT02329080|516560239|FG000|Overall Study|Lack of Efficacy|22|||
143274928|NCT02329080|516560239|FG000|Overall Study|Lost to Follow-up|1|||
143274929|NCT02329080|516560239|FG000|Overall Study|Physician Decision|2|||
143274930|NCT02329080|516560239|FG000|Overall Study|Partial response|4|||
143274931|NCT02329080|516560239|FG000|Overall Study|Complete response|4|||
143274932|NCT04545060|516560241|FG000|Overall Study|Adverse Event|0|||
143274933|NCT04545060|516560242|FG001|Overall Study|Adverse Event|1|||
143274934|NCT04545060|516560241|FG000|Overall Study|Death|0|||
143274935|NCT04545060|516560242|FG001|Overall Study|Death|5|||
143274936|NCT04545060|516560241|FG000|Overall Study|Lost to Follow-up|10|||
143274937|NCT04545060|516560242|FG001|Overall Study|Lost to Follow-up|13|||
143274938|NCT04545060|516560241|FG000|Overall Study|Physician Decision|3|||
143274939|NCT04545060|516560242|FG001|Overall Study|Physician Decision|0|||
143274940|NCT04545060|516560241|FG000|Overall Study|Withdrawal by Subject|17|||
143274941|NCT04545060|516560242|FG001|Overall Study|Withdrawal by Subject|22|||
143274942|NCT00973674|516560245|FG000|Overall Study|Protocol Violation|2|||
143274943|NCT00973674|516560246|FG001|Overall Study|Protocol Violation|0|||
143274944|NCT00071396|516560247|FG000|Overall Study|Withdrawal by Subject|1|||
143274945|NCT00071396|516560247|FG000|Overall Study|Physician Decision|2|||
143274946|NCT03082261|516560248|FG000|Overall Study|Death|4|||
143274947|NCT03082261|516560248|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
143274948|NCT03082261|516560248|FG000|Overall Study|Insurance denial|1|||
143274949|NCT03082261|516560248|FG000|Overall Study|Peripheral lead added|1|||
143274950|NCT03082261|516560248|FG000|Overall Study|Withdrawal by Subject|40|||
143274951|NCT03082261|516560248|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
143274952|NCT03082261|516560248|FG000|Overall Study|Subject implanted with device other than study device|1|||
143274953|NCT03082261|516560248|FG000|Overall Study|Lost to Follow-up|14|||
143274954|NCT03082261|516560248|FG000|Overall Study|Subject moved to a different state|1|||
143274955|NCT03082261|516560248|FG000|Overall Study|Subject non-compliance|2|||
143274956|NCT03082261|516560248|FG000|Overall Study|Subject participation terminated by investigator|9|||
143274957|NCT03082261|516560248|FG000|Overall Study|Subject participation terminated by sponsor|4|||
143274958|NCT03082261|516560248|FG000|Overall Study|System explant|19|||
143274959|NCT03082261|516560248|FG000|Overall Study|Unable to place lead(s)|2|||
143274960|NCT03082261|516560248|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
143274961|NCT00839852|516560249|FG000|Overall Study|Adverse Event|10|||
143274962|NCT00839852|516560249|FG000|Overall Study|Insufficient Therapeutic Response|3|||
143274963|NCT00839852|516560249|FG000|Overall Study|Protocol Violation|9|||
143274964|NCT00839852|516560249|FG000|Overall Study|Withdrawal of Consent|16|||
143274965|NCT00839852|516560249|FG000|Overall Study|Lost to Follow-up|7|||
143274966|NCT00839852|516560249|FG000|Overall Study|Lack of Compliance While in Jail|1|||
143274967|NCT00839852|516560249|FG000|Overall Study|Pregnancy|1|||
143274968|NCT01986907|516560252|FG000|Overall Study|Adverse Event|11|||
143274969|NCT01986907|516560252|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
143274970|NCT01986907|516560252|FG000|Overall Study|Protocol Violation|4|||
143274971|NCT01986907|516560252|FG000|Overall Study|Withdrawal by Subject|76|||
143274972|NCT01986907|516560252|FG000|Overall Study|Lost to Follow-up|38|||
143274973|NCT01986907|516560252|FG000|Overall Study|Death|9|||
143274974|NCT02846324|516560254|FG000|Overall Study|Other|1|||
143274975|NCT02846324|516560255|FG001|Overall Study|Other|0|||
143274976|NCT02846324|516560256|FG002|Overall Study|Other|0|||
143274977|NCT02846324|516560257|FG003|Overall Study|Other|0|||
143274978|NCT02846324|516560254|FG000|Overall Study|Withdrawal by Subject|1|||
143274979|NCT02846324|516560255|FG001|Overall Study|Withdrawal by Subject|0|||
143274980|NCT02846324|516560256|FG002|Overall Study|Withdrawal by Subject|4|||
143274981|NCT02846324|516560257|FG003|Overall Study|Withdrawal by Subject|0|||
143274982|NCT03576495|516560271|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
143274983|NCT03576495|516560272|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
143274984|NCT02635776|516560273|FG000|Overall Study|Physician Decision|1|||
143274985|NCT02635776|516560274|FG001|Overall Study|Physician Decision|0|||
143274986|NCT02635776|516560273|FG000|Overall Study|Adverse Event|51|||
143274987|NCT02635776|516560274|FG001|Overall Study|Adverse Event|3|||
143274988|NCT02635776|516560273|FG000|Overall Study|Withdrawal by Subject|41|||
143274989|NCT02635776|516560274|FG001|Overall Study|Withdrawal by Subject|7|||
143274990|NCT02635776|516560273|FG000|Overall Study|Lost to Follow-up|4|||
143274991|NCT02635776|516560274|FG001|Overall Study|Lost to Follow-up|0|||
143274992|NCT02635776|516560273|FG000|Overall Study|Other reasons|5|||
143274993|NCT02635776|516560274|FG001|Overall Study|Other reasons|1|||
143274994|NCT03208127|516560276|FG000|Overall Study|Death|1|||
143274995|NCT00660673|516560277|FG000|Overall Study|Adverse Event|84|||
143274996|NCT00660673|516560277|FG000|Overall Study|Lack of Efficacy|7|||
143274997|NCT00660673|516560277|FG000|Overall Study|Withdrawal by Subject|22|||
143274998|NCT00660673|516560277|FG000|Overall Study|Administrative|2|||
143274999|NCT00660673|516560277|FG000|Overall Study|Protocol Violation|2|||
143275000|NCT05213481|516560278|FG000|Overall Study|Adverse Event|3|||
143275001|NCT05213481|516560278|FG000|Overall Study|Lost to Follow-up|1|||
143275002|NCT01612858|516560283|FG000|Overall Study|Withdrawal by Subject|5|||
143275003|NCT01612858|516560284|FG001|Overall Study|Withdrawal by Subject|1|||
143275004|NCT00003487|516560285|FG000|Overall Study|Not evaluable|2|||
143275005|NCT02058693|516560288|FG000|Phase 1|Withdrawal by Subject|3|||
143275006|NCT02058693|516560289|FG001|Phase 1|Withdrawal by Subject|2|||
143275007|NCT02058693|516560288|FG000|Phase 1|Adverse Event|0|||
143275008|NCT02058693|516560289|FG001|Phase 1|Adverse Event|1|||
143275009|NCT02058693|516560288|FG000|Phase 1|Lack of Efficacy|1|||
143275010|NCT02058693|516560289|FG001|Phase 1|Lack of Efficacy|0|||
143275011|NCT02058693|516560288|FG000|Phase 1|Physician Decision|1|||
143275012|NCT02058693|516560289|FG001|Phase 1|Physician Decision|1|||
143275013|NCT02058693|516560288|FG000|Phase 2|Withdrawal by Subject|0|||
143275014|NCT02058693|516560289|FG001|Phase 2|Withdrawal by Subject|2|||
143275015|NCT00241358|516560290|FG000|Overall Study|Determined to be not ineligible|0|||
143275016|NCT00241358|516560291|FG001|Overall Study|Determined to be not ineligible|1|||
143275017|NCT00241358|516560292|FG002|Overall Study|Determined to be not ineligible|1|||
143275018|NCT00843856|516560293|FG000|Overall Study|Lost to Follow-up|1|||
143275019|NCT00843856|516560294|FG001|Overall Study|Lost to Follow-up|2|||
143275020|NCT03855228|516560295|FG000|Overall Study|Adverse Event|2|||
143275021|NCT03855228|516560296|FG001|Overall Study|Adverse Event|4|||
143275022|NCT03855228|516560297|FG002|Overall Study|Adverse Event|4|||
143275023|NCT03855228|516560298|FG003|Overall Study|Adverse Event|8|||
143275024|NCT03855228|516560295|FG000|Overall Study|Treatment Failure|1|||
143275025|NCT03855228|516560296|FG001|Overall Study|Treatment Failure|2|||
143275026|NCT03855228|516560297|FG002|Overall Study|Treatment Failure|1|||
143275027|NCT03855228|516560298|FG003|Overall Study|Treatment Failure|8|||
143275028|NCT03855228|516560295|FG000|Overall Study|Lost to Follow-up|0|||
143275029|NCT03855228|516560296|FG001|Overall Study|Lost to Follow-up|0|||
143275030|NCT03855228|516560297|FG002|Overall Study|Lost to Follow-up|0|||
143275031|NCT03855228|516560298|FG003|Overall Study|Lost to Follow-up|1|||
143275032|NCT03855228|516560295|FG000|Overall Study|Protocol Violation|0|||
143275033|NCT03855228|516560296|FG001|Overall Study|Protocol Violation|1|||
143275034|NCT03855228|516560297|FG002|Overall Study|Protocol Violation|2|||
143275035|NCT03855228|516560298|FG003|Overall Study|Protocol Violation|1|||
143275036|NCT03855228|516560295|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
143275037|NCT03855228|516560296|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
143275038|NCT03855228|516560297|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
143275039|NCT03855228|516560298|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
143275040|NCT00621959|516560300|FG000|Overall Study|Adverse Event|4|||
143275041|NCT00621959|516560301|FG001|Overall Study|Adverse Event|2|||
143275042|NCT00621959|516560300|FG000|Overall Study|Lack of Efficacy|1|||
143275043|NCT00621959|516560301|FG001|Overall Study|Lack of Efficacy|1|||
143275044|NCT00621959|516560300|FG000|Overall Study|Lost to Follow-up|0|||
143275045|NCT00621959|516560301|FG001|Overall Study|Lost to Follow-up|2|||
143275046|NCT00621959|516560300|FG000|Overall Study|Withdrawal by Subject|1|||
143275047|NCT00621959|516560301|FG001|Overall Study|Withdrawal by Subject|1|||
143275048|NCT00621959|516560300|FG000|Overall Study|Other|1|||
143275049|NCT00621959|516560301|FG001|Overall Study|Other|3|||
143275050|NCT01758523|516560302|FG000|Overall Study|Adverse Event|2|||
143275051|NCT01758523|516560303|FG001|Overall Study|Adverse Event|1|||
143275052|NCT01758523|516560302|FG000|Overall Study|Lack of Efficacy|4|||
143275053|NCT01758523|516560303|FG001|Overall Study|Lack of Efficacy|2|||
143275054|NCT01758523|516560302|FG000|Overall Study|Lost to Follow-up|3|||
143275055|NCT01758523|516560303|FG001|Overall Study|Lost to Follow-up|4|||
143275056|NCT01758523|516560302|FG000|Overall Study|Withdrawal by Subject|12|||
143275057|NCT01758523|516560303|FG001|Overall Study|Withdrawal by Subject|7|||
143275058|NCT01893203|516560304|FG000|Overall Study|Withdrawal by Subject|1|||
143275059|NCT00722800|516560305|FG000|Overall Study|Withdrawal by Subject|1|||
143275060|NCT00722800|516560306|FG001|Overall Study|Withdrawal by Subject|0|||
143275061|NCT00722800|516560305|FG000|Overall Study|Physician Decision|1|||
143275062|NCT00722800|516560306|FG001|Overall Study|Physician Decision|0|||
143275063|NCT00590135|516560307|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
143275064|NCT00347360|516560319|FG000|Overall Study|Adverse Event|1|||
143275065|NCT00347360|516560320|FG001|Overall Study|Adverse Event|2|||
143275066|NCT00347360|516560321|FG002|Overall Study|Adverse Event|0|||
143275067|NCT00347360|516560322|FG003|Overall Study|Adverse Event|4|||
143275068|NCT00347360|516560323|FG004|Overall Study|Adverse Event|1|||
143275069|NCT00347360|516560324|FG005|Overall Study|Adverse Event|2|||
143275070|NCT00347360|516560325|FG006|Overall Study|Adverse Event|2|||
143275071|NCT00347360|516560326|FG007|Overall Study|Adverse Event|0|||
143275072|NCT00347360|516560327|FG008|Overall Study|Adverse Event|2|||
143275073|NCT00347360|516560328|FG009|Overall Study|Adverse Event|3|||
143275074|NCT00347360|516560329|FG010|Overall Study|Adverse Event|3|||
143275075|NCT00347360|516560330|FG011|Overall Study|Adverse Event|1|||
143275076|NCT00347360|516560331|FG012|Overall Study|Adverse Event|3|||
143275077|NCT00347360|516560332|FG013|Overall Study|Adverse Event|2|||
143275078|NCT00347360|516560333|FG014|Overall Study|Adverse Event|2|||
143275079|NCT00347360|516560319|FG000|Overall Study|Lost to Follow-up|0|||
143275080|NCT00347360|516560320|FG001|Overall Study|Lost to Follow-up|0|||
143275081|NCT00347360|516560321|FG002|Overall Study|Lost to Follow-up|0|||
143275082|NCT00347360|516560322|FG003|Overall Study|Lost to Follow-up|2|||
143275083|NCT00347360|516560323|FG004|Overall Study|Lost to Follow-up|1|||
143275084|NCT00347360|516560324|FG005|Overall Study|Lost to Follow-up|1|||
143275085|NCT00347360|516560325|FG006|Overall Study|Lost to Follow-up|0|||
143275086|NCT00347360|516560326|FG007|Overall Study|Lost to Follow-up|1|||
143275087|NCT00347360|516560327|FG008|Overall Study|Lost to Follow-up|1|||
143275088|NCT00347360|516560328|FG009|Overall Study|Lost to Follow-up|2|||
143372798|NCT01212757|516909648|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
143275089|NCT00347360|516560329|FG010|Overall Study|Lost to Follow-up|0|||
143275090|NCT00347360|516560330|FG011|Overall Study|Lost to Follow-up|0|||
143275091|NCT00347360|516560331|FG012|Overall Study|Lost to Follow-up|1|||
143275092|NCT00347360|516560332|FG013|Overall Study|Lost to Follow-up|0|||
143275093|NCT00347360|516560333|FG014|Overall Study|Lost to Follow-up|0|||
143275094|NCT00347360|516560319|FG000|Overall Study|Protocol Violation|2|||
143275095|NCT00347360|516560320|FG001|Overall Study|Protocol Violation|3|||
143275096|NCT00347360|516560321|FG002|Overall Study|Protocol Violation|1|||
143275097|NCT00347360|516560322|FG003|Overall Study|Protocol Violation|2|||
143275098|NCT00347360|516560323|FG004|Overall Study|Protocol Violation|1|||
143275099|NCT00347360|516560324|FG005|Overall Study|Protocol Violation|2|||
143275100|NCT00347360|516560325|FG006|Overall Study|Protocol Violation|0|||
143275101|NCT00347360|516560326|FG007|Overall Study|Protocol Violation|0|||
143275102|NCT00347360|516560327|FG008|Overall Study|Protocol Violation|1|||
143275103|NCT00347360|516560328|FG009|Overall Study|Protocol Violation|2|||
143275104|NCT00347360|516560329|FG010|Overall Study|Protocol Violation|0|||
143275105|NCT00347360|516560330|FG011|Overall Study|Protocol Violation|0|||
143275106|NCT00347360|516560331|FG012|Overall Study|Protocol Violation|0|||
143275107|NCT00347360|516560332|FG013|Overall Study|Protocol Violation|1|||
143275108|NCT00347360|516560333|FG014|Overall Study|Protocol Violation|0|||
143275109|NCT00347360|516560319|FG000|Overall Study|Withdrawal by Subject|0|||
143275110|NCT00347360|516560320|FG001|Overall Study|Withdrawal by Subject|1|||
143275111|NCT00347360|516560321|FG002|Overall Study|Withdrawal by Subject|2|||
143275112|NCT00347360|516560322|FG003|Overall Study|Withdrawal by Subject|4|||
143275113|NCT00347360|516560323|FG004|Overall Study|Withdrawal by Subject|1|||
143275114|NCT00347360|516560324|FG005|Overall Study|Withdrawal by Subject|2|||
143275115|NCT00347360|516560325|FG006|Overall Study|Withdrawal by Subject|1|||
143275116|NCT00347360|516560326|FG007|Overall Study|Withdrawal by Subject|1|||
143275117|NCT00347360|516560327|FG008|Overall Study|Withdrawal by Subject|1|||
143275118|NCT00347360|516560328|FG009|Overall Study|Withdrawal by Subject|1|||
143275119|NCT00347360|516560329|FG010|Overall Study|Withdrawal by Subject|0|||
143275120|NCT00347360|516560330|FG011|Overall Study|Withdrawal by Subject|3|||
143275121|NCT00347360|516560331|FG012|Overall Study|Withdrawal by Subject|4|||
143275122|NCT00347360|516560332|FG013|Overall Study|Withdrawal by Subject|2|||
143275123|NCT00347360|516560333|FG014|Overall Study|Withdrawal by Subject|1|||
143275124|NCT00347360|516560319|FG000|Overall Study|Lack of Efficacy|1|||
143275125|NCT00347360|516560320|FG001|Overall Study|Lack of Efficacy|1|||
143275126|NCT00347360|516560321|FG002|Overall Study|Lack of Efficacy|3|||
143275127|NCT00347360|516560322|FG003|Overall Study|Lack of Efficacy|1|||
143275128|NCT00347360|516560323|FG004|Overall Study|Lack of Efficacy|0|||
143275129|NCT00347360|516560324|FG005|Overall Study|Lack of Efficacy|1|||
143275130|NCT00347360|516560325|FG006|Overall Study|Lack of Efficacy|0|||
143275131|NCT00347360|516560326|FG007|Overall Study|Lack of Efficacy|1|||
143275132|NCT00347360|516560327|FG008|Overall Study|Lack of Efficacy|1|||
143275133|NCT00347360|516560328|FG009|Overall Study|Lack of Efficacy|0|||
143275134|NCT00347360|516560329|FG010|Overall Study|Lack of Efficacy|0|||
143275135|NCT00347360|516560330|FG011|Overall Study|Lack of Efficacy|0|||
143275136|NCT00347360|516560331|FG012|Overall Study|Lack of Efficacy|0|||
143275137|NCT00347360|516560332|FG013|Overall Study|Lack of Efficacy|0|||
143275138|NCT00347360|516560333|FG014|Overall Study|Lack of Efficacy|0|||
143275139|NCT00347360|516560319|FG000|Overall Study|Reason not listed/blank|1|||
143275140|NCT00347360|516560320|FG001|Overall Study|Reason not listed/blank|0|||
143275141|NCT00347360|516560321|FG002|Overall Study|Reason not listed/blank|0|||
143275142|NCT00347360|516560322|FG003|Overall Study|Reason not listed/blank|0|||
143275143|NCT00347360|516560323|FG004|Overall Study|Reason not listed/blank|0|||
143275144|NCT00347360|516560324|FG005|Overall Study|Reason not listed/blank|0|||
143275145|NCT00347360|516560325|FG006|Overall Study|Reason not listed/blank|1|||
143275146|NCT00347360|516560326|FG007|Overall Study|Reason not listed/blank|0|||
143275147|NCT00347360|516560327|FG008|Overall Study|Reason not listed/blank|0|||
143275148|NCT00347360|516560328|FG009|Overall Study|Reason not listed/blank|0|||
143275149|NCT00347360|516560329|FG010|Overall Study|Reason not listed/blank|0|||
143275150|NCT00347360|516560330|FG011|Overall Study|Reason not listed/blank|0|||
143275151|NCT00347360|516560331|FG012|Overall Study|Reason not listed/blank|0|||
143275152|NCT00347360|516560332|FG013|Overall Study|Reason not listed/blank|1|||
143275153|NCT00347360|516560333|FG014|Overall Study|Reason not listed/blank|0|||
143275154|NCT00347360|516560319|FG000|Overall Study|Per sponsors instruction|0|||
143275155|NCT00347360|516560320|FG001|Overall Study|Per sponsors instruction|1|||
143275156|NCT00347360|516560321|FG002|Overall Study|Per sponsors instruction|0|||
143275157|NCT00347360|516560322|FG003|Overall Study|Per sponsors instruction|0|||
143275158|NCT00347360|516560323|FG004|Overall Study|Per sponsors instruction|0|||
143275159|NCT00347360|516560324|FG005|Overall Study|Per sponsors instruction|0|||
143275160|NCT00347360|516560325|FG006|Overall Study|Per sponsors instruction|0|||
143275161|NCT00347360|516560326|FG007|Overall Study|Per sponsors instruction|0|||
143275162|NCT00347360|516560327|FG008|Overall Study|Per sponsors instruction|0|||
143275163|NCT00347360|516560328|FG009|Overall Study|Per sponsors instruction|0|||
143275164|NCT00347360|516560329|FG010|Overall Study|Per sponsors instruction|0|||
143275165|NCT00347360|516560330|FG011|Overall Study|Per sponsors instruction|0|||
143275166|NCT00347360|516560331|FG012|Overall Study|Per sponsors instruction|0|||
143275167|NCT00347360|516560332|FG013|Overall Study|Per sponsors instruction|0|||
143275168|NCT00347360|516560333|FG014|Overall Study|Per sponsors instruction|0|||
143275169|NCT00347360|516560319|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
143275170|NCT00347360|516560320|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
143275171|NCT00347360|516560321|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
143275172|NCT00347360|516560322|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
143275173|NCT00347360|516560323|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
143275174|NCT00347360|516560324|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
143275175|NCT00347360|516560325|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
143275176|NCT00347360|516560326|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
143275177|NCT00347360|516560327|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
143275178|NCT00347360|516560328|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
143275179|NCT00347360|516560329|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
143275180|NCT00347360|516560330|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
143275181|NCT00347360|516560331|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
143275182|NCT00347360|516560332|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
143275183|NCT00347360|516560333|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
143275184|NCT00347360|516560319|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
143275185|NCT00347360|516560320|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
143275186|NCT00347360|516560321|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
143275187|NCT00347360|516560322|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
143275188|NCT00347360|516560323|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
143275189|NCT00347360|516560324|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
143275190|NCT00347360|516560325|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
143275191|NCT00347360|516560326|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
143275192|NCT00347360|516560327|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
143275193|NCT00347360|516560328|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
143275194|NCT00347360|516560329|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
143275195|NCT00347360|516560330|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
143275196|NCT00347360|516560331|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
143275197|NCT00347360|516560332|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
143275198|NCT00347360|516560333|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
143275199|NCT00347360|516560319|FG000|Overall Study|Abnormal lab values|0|||
143275200|NCT00347360|516560320|FG001|Overall Study|Abnormal lab values|0|||
143275201|NCT00347360|516560321|FG002|Overall Study|Abnormal lab values|0|||
143275202|NCT00347360|516560322|FG003|Overall Study|Abnormal lab values|0|||
143275203|NCT00347360|516560323|FG004|Overall Study|Abnormal lab values|0|||
143275204|NCT00347360|516560324|FG005|Overall Study|Abnormal lab values|0|||
143275205|NCT00347360|516560325|FG006|Overall Study|Abnormal lab values|1|||
143275206|NCT00347360|516560326|FG007|Overall Study|Abnormal lab values|0|||
143275207|NCT00347360|516560327|FG008|Overall Study|Abnormal lab values|0|||
143275208|NCT00347360|516560328|FG009|Overall Study|Abnormal lab values|0|||
143275209|NCT00347360|516560329|FG010|Overall Study|Abnormal lab values|0|||
143275210|NCT00347360|516560330|FG011|Overall Study|Abnormal lab values|0|||
143275211|NCT00347360|516560331|FG012|Overall Study|Abnormal lab values|0|||
143275212|NCT00347360|516560332|FG013|Overall Study|Abnormal lab values|0|||
143275213|NCT00347360|516560333|FG014|Overall Study|Abnormal lab values|0|||
143275214|NCT00347360|516560319|FG000|Overall Study|PI recommended early withdrawal|0|||
143275215|NCT00347360|516560320|FG001|Overall Study|PI recommended early withdrawal|0|||
143275216|NCT00347360|516560321|FG002|Overall Study|PI recommended early withdrawal|0|||
143275217|NCT00347360|516560322|FG003|Overall Study|PI recommended early withdrawal|0|||
143275218|NCT00347360|516560323|FG004|Overall Study|PI recommended early withdrawal|0|||
143275219|NCT00347360|516560324|FG005|Overall Study|PI recommended early withdrawal|0|||
143275220|NCT00347360|516560325|FG006|Overall Study|PI recommended early withdrawal|0|||
143275221|NCT00347360|516560326|FG007|Overall Study|PI recommended early withdrawal|0|||
143275222|NCT00347360|516560327|FG008|Overall Study|PI recommended early withdrawal|0|||
143275223|NCT00347360|516560328|FG009|Overall Study|PI recommended early withdrawal|1|||
143275224|NCT00347360|516560329|FG010|Overall Study|PI recommended early withdrawal|0|||
143275225|NCT00347360|516560330|FG011|Overall Study|PI recommended early withdrawal|0|||
143275226|NCT00347360|516560331|FG012|Overall Study|PI recommended early withdrawal|0|||
143275227|NCT00347360|516560332|FG013|Overall Study|PI recommended early withdrawal|0|||
143275228|NCT00347360|516560333|FG014|Overall Study|PI recommended early withdrawal|0|||
143275229|NCT00347360|516560319|FG000|Overall Study|Did not meet criteria before ABPM|0|||
143275230|NCT00347360|516560320|FG001|Overall Study|Did not meet criteria before ABPM|0|||
143275231|NCT00347360|516560321|FG002|Overall Study|Did not meet criteria before ABPM|0|||
143275232|NCT00347360|516560322|FG003|Overall Study|Did not meet criteria before ABPM|0|||
143275233|NCT00347360|516560323|FG004|Overall Study|Did not meet criteria before ABPM|0|||
143275234|NCT00347360|516560324|FG005|Overall Study|Did not meet criteria before ABPM|0|||
143275235|NCT00347360|516560325|FG006|Overall Study|Did not meet criteria before ABPM|0|||
143275236|NCT00347360|516560326|FG007|Overall Study|Did not meet criteria before ABPM|0|||
143275237|NCT00347360|516560327|FG008|Overall Study|Did not meet criteria before ABPM|0|||
143275238|NCT00347360|516560328|FG009|Overall Study|Did not meet criteria before ABPM|0|||
143275239|NCT00347360|516560329|FG010|Overall Study|Did not meet criteria before ABPM|1|||
143275240|NCT00347360|516560330|FG011|Overall Study|Did not meet criteria before ABPM|0|||
143275241|NCT00347360|516560331|FG012|Overall Study|Did not meet criteria before ABPM|0|||
143275242|NCT00347360|516560332|FG013|Overall Study|Did not meet criteria before ABPM|0|||
143275243|NCT00347360|516560333|FG014|Overall Study|Did not meet criteria before ABPM|0|||
143275244|NCT00347360|516560319|FG000|Overall Study|Randomized in error|0|||
143275245|NCT00347360|516560320|FG001|Overall Study|Randomized in error|0|||
143275246|NCT00347360|516560321|FG002|Overall Study|Randomized in error|0|||
143275247|NCT00347360|516560322|FG003|Overall Study|Randomized in error|0|||
143275248|NCT00347360|516560323|FG004|Overall Study|Randomized in error|0|||
143275249|NCT00347360|516560324|FG005|Overall Study|Randomized in error|0|||
143275250|NCT00347360|516560325|FG006|Overall Study|Randomized in error|0|||
143275251|NCT00347360|516560326|FG007|Overall Study|Randomized in error|0|||
143275252|NCT00347360|516560327|FG008|Overall Study|Randomized in error|0|||
143275253|NCT00347360|516560328|FG009|Overall Study|Randomized in error|0|||
143275254|NCT00347360|516560329|FG010|Overall Study|Randomized in error|0|||
143275255|NCT00347360|516560330|FG011|Overall Study|Randomized in error|1|||
143275256|NCT00347360|516560331|FG012|Overall Study|Randomized in error|0|||
143275257|NCT00347360|516560332|FG013|Overall Study|Randomized in error|0|||
143275258|NCT00347360|516560333|FG014|Overall Study|Randomized in error|0|||
143275259|NCT00347360|516560319|FG000|Overall Study|Failed inclusion criteria #4|0|||
143275260|NCT00347360|516560320|FG001|Overall Study|Failed inclusion criteria #4|0|||
143275261|NCT00347360|516560321|FG002|Overall Study|Failed inclusion criteria #4|0|||
143275262|NCT00347360|516560322|FG003|Overall Study|Failed inclusion criteria #4|0|||
143275263|NCT00347360|516560323|FG004|Overall Study|Failed inclusion criteria #4|0|||
143275264|NCT00347360|516560324|FG005|Overall Study|Failed inclusion criteria #4|0|||
143275265|NCT00347360|516560325|FG006|Overall Study|Failed inclusion criteria #4|0|||
143275266|NCT00347360|516560326|FG007|Overall Study|Failed inclusion criteria #4|0|||
143275267|NCT00347360|516560327|FG008|Overall Study|Failed inclusion criteria #4|0|||
143275268|NCT00347360|516560328|FG009|Overall Study|Failed inclusion criteria #4|0|||
143275269|NCT00347360|516560329|FG010|Overall Study|Failed inclusion criteria #4|0|||
143275270|NCT00347360|516560330|FG011|Overall Study|Failed inclusion criteria #4|1|||
143275271|NCT00347360|516560331|FG012|Overall Study|Failed inclusion criteria #4|0|||
143275272|NCT00347360|516560332|FG013|Overall Study|Failed inclusion criteria #4|0|||
143275273|NCT00347360|516560333|FG014|Overall Study|Failed inclusion criteria #4|0|||
143275274|NCT00347360|516560319|FG000|Overall Study|Prolonged duration between visits|0|||
143275275|NCT00347360|516560320|FG001|Overall Study|Prolonged duration between visits|0|||
143275276|NCT00347360|516560321|FG002|Overall Study|Prolonged duration between visits|0|||
143275277|NCT00347360|516560322|FG003|Overall Study|Prolonged duration between visits|0|||
143275278|NCT00347360|516560323|FG004|Overall Study|Prolonged duration between visits|0|||
143275279|NCT00347360|516560324|FG005|Overall Study|Prolonged duration between visits|0|||
143275280|NCT00347360|516560325|FG006|Overall Study|Prolonged duration between visits|0|||
143275281|NCT00347360|516560326|FG007|Overall Study|Prolonged duration between visits|0|||
143275282|NCT00347360|516560327|FG008|Overall Study|Prolonged duration between visits|0|||
143275283|NCT00347360|516560328|FG009|Overall Study|Prolonged duration between visits|0|||
143275284|NCT00347360|516560329|FG010|Overall Study|Prolonged duration between visits|0|||
143275285|NCT00347360|516560330|FG011|Overall Study|Prolonged duration between visits|0|||
143275286|NCT00347360|516560331|FG012|Overall Study|Prolonged duration between visits|1|||
143275287|NCT00347360|516560332|FG013|Overall Study|Prolonged duration between visits|0|||
143275288|NCT00347360|516560333|FG014|Overall Study|Prolonged duration between visits|0|||
143275289|NCT00347360|516560319|FG000|Overall Study|Subject left town, ran out of study drug|0|||
143275290|NCT00347360|516560320|FG001|Overall Study|Subject left town, ran out of study drug|0|||
143275291|NCT00347360|516560321|FG002|Overall Study|Subject left town, ran out of study drug|0|||
143275292|NCT00347360|516560322|FG003|Overall Study|Subject left town, ran out of study drug|0|||
143275293|NCT00347360|516560323|FG004|Overall Study|Subject left town, ran out of study drug|0|||
143275294|NCT00347360|516560324|FG005|Overall Study|Subject left town, ran out of study drug|0|||
143275295|NCT00347360|516560325|FG006|Overall Study|Subject left town, ran out of study drug|0|||
143275296|NCT00347360|516560326|FG007|Overall Study|Subject left town, ran out of study drug|0|||
143275297|NCT00347360|516560327|FG008|Overall Study|Subject left town, ran out of study drug|0|||
143275298|NCT00347360|516560328|FG009|Overall Study|Subject left town, ran out of study drug|0|||
143275299|NCT00347360|516560329|FG010|Overall Study|Subject left town, ran out of study drug|0|||
143275300|NCT00347360|516560330|FG011|Overall Study|Subject left town, ran out of study drug|0|||
143275301|NCT00347360|516560331|FG012|Overall Study|Subject left town, ran out of study drug|0|||
143275302|NCT00347360|516560332|FG013|Overall Study|Subject left town, ran out of study drug|1|||
143275303|NCT00347360|516560333|FG014|Overall Study|Subject left town, ran out of study drug|0|||
143275304|NCT00347360|516560319|FG000|Overall Study|Subject refuse to sign updated consent|0|||
143275305|NCT00347360|516560320|FG001|Overall Study|Subject refuse to sign updated consent|0|||
143275306|NCT00347360|516560321|FG002|Overall Study|Subject refuse to sign updated consent|0|||
143275307|NCT00347360|516560322|FG003|Overall Study|Subject refuse to sign updated consent|0|||
143275308|NCT00347360|516560323|FG004|Overall Study|Subject refuse to sign updated consent|0|||
143275309|NCT00347360|516560324|FG005|Overall Study|Subject refuse to sign updated consent|0|||
143275310|NCT00347360|516560325|FG006|Overall Study|Subject refuse to sign updated consent|0|||
143275311|NCT00347360|516560326|FG007|Overall Study|Subject refuse to sign updated consent|0|||
143275312|NCT00347360|516560327|FG008|Overall Study|Subject refuse to sign updated consent|0|||
143275313|NCT00347360|516560328|FG009|Overall Study|Subject refuse to sign updated consent|0|||
143275314|NCT00347360|516560329|FG010|Overall Study|Subject refuse to sign updated consent|0|||
143275315|NCT00347360|516560330|FG011|Overall Study|Subject refuse to sign updated consent|0|||
143275316|NCT00347360|516560331|FG012|Overall Study|Subject refuse to sign updated consent|0|||
143275317|NCT00347360|516560332|FG013|Overall Study|Subject refuse to sign updated consent|0|||
143275318|NCT00347360|516560333|FG014|Overall Study|Subject refuse to sign updated consent|1|||
143275319|NCT00347360|516560319|FG000|Overall Study|Visits conflicted with new job|0|||
143275320|NCT00347360|516560320|FG001|Overall Study|Visits conflicted with new job|0|||
143275321|NCT00347360|516560321|FG002|Overall Study|Visits conflicted with new job|0|||
143275322|NCT00347360|516560322|FG003|Overall Study|Visits conflicted with new job|0|||
143275323|NCT00347360|516560323|FG004|Overall Study|Visits conflicted with new job|0|||
143275324|NCT00347360|516560324|FG005|Overall Study|Visits conflicted with new job|0|||
143275325|NCT00347360|516560325|FG006|Overall Study|Visits conflicted with new job|1|||
143275326|NCT00347360|516560326|FG007|Overall Study|Visits conflicted with new job|0|||
143275327|NCT00347360|516560327|FG008|Overall Study|Visits conflicted with new job|0|||
143275328|NCT00347360|516560328|FG009|Overall Study|Visits conflicted with new job|0|||
143275329|NCT00347360|516560329|FG010|Overall Study|Visits conflicted with new job|0|||
143275330|NCT00347360|516560330|FG011|Overall Study|Visits conflicted with new job|0|||
143275331|NCT00347360|516560331|FG012|Overall Study|Visits conflicted with new job|0|||
143275332|NCT00347360|516560332|FG013|Overall Study|Visits conflicted with new job|0|||
143275333|NCT00347360|516560333|FG014|Overall Study|Visits conflicted with new job|0|||
143275334|NCT00306189|516560343|FG000|Overall Study|Physician Decision|0|||
143275335|NCT00306189|516560344|FG001|Overall Study|Physician Decision|0|||
143275336|NCT00306189|516560345|FG002|Overall Study|Physician Decision|0|||
143275337|NCT00306189|516560346|FG003|Overall Study|Physician Decision|1|||
143275338|NCT00306189|516560343|FG000|Overall Study|Adverse Event|3|||
143275339|NCT00306189|516560344|FG001|Overall Study|Adverse Event|3|||
143275340|NCT00306189|516560345|FG002|Overall Study|Adverse Event|2|||
143275341|NCT00306189|516560346|FG003|Overall Study|Adverse Event|2|||
143275342|NCT00306189|516560343|FG000|Overall Study|Withdrawal by Subject|4|||
143275343|NCT00306189|516560344|FG001|Overall Study|Withdrawal by Subject|2|||
143275344|NCT00306189|516560345|FG002|Overall Study|Withdrawal by Subject|8|||
143275345|NCT00306189|516560346|FG003|Overall Study|Withdrawal by Subject|1|||
143275346|NCT00306189|516560343|FG000|Overall Study|Ineligibility determined|1|||
143275347|NCT00306189|516560344|FG001|Overall Study|Ineligibility determined|1|||
143275348|NCT00306189|516560345|FG002|Overall Study|Ineligibility determined|1|||
143275349|NCT00306189|516560346|FG003|Overall Study|Ineligibility determined|1|||
143275350|NCT00306189|516560343|FG000|Overall Study|Other|1|||
143275351|NCT00306189|516560344|FG001|Overall Study|Other|0|||
143275352|NCT00306189|516560345|FG002|Overall Study|Other|0|||
143275353|NCT00306189|516560346|FG003|Overall Study|Other|0|||
143275354|NCT02059408|516560347|FG000|Overall Study|Did not get tested|0|||
143275355|NCT02059408|516560348|FG001|Overall Study|Did not get tested|330|||
143275356|NCT02059408|516560349|FG002|Overall Study|Did not get tested|358|||
143275357|NCT02993757|516560350|FG000|Overall Study|Non compliance with the protocol|155|||
143275358|NCT02993757|516560351|FG001|Overall Study|Non compliance with the protocol|170|||
143275359|NCT02993757|516560350|FG000|Overall Study|Lost to Follow-up|1|||
143275360|NCT02993757|516560351|FG001|Overall Study|Lost to Follow-up|0|||
143275361|NCT02993757|516560350|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
143275362|NCT02993757|516560351|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
143275363|NCT02699593|516560357|FG000|Period 1|Unsatisfactory Visual Response|0|||
143275364|NCT02699593|516560358|FG001|Period 1|Unsatisfactory Visual Response|1|||
143275365|NCT02699593|516560357|FG000|Period 1|Torn Contact Len|4|||
143275366|NCT02699593|516560358|FG001|Period 1|Torn Contact Len|3|||
143275367|NCT02699593|516560357|FG000|Period 1|Protocol Violation|0|||
143275368|NCT02699593|516560358|FG001|Period 1|Protocol Violation|1|||
143275369|NCT02699593|516560357|FG000|Period 1|Withdrawal by Subject|0|||
143275370|NCT02699593|516560358|FG001|Period 1|Withdrawal by Subject|1|||
143275371|NCT02699593|516560357|FG000|Period 1|Adverse Event|1|||
143275372|NCT02699593|516560358|FG001|Period 1|Adverse Event|1|||
143275373|NCT02699593|516560357|FG000|Period 2|Adverse Event|1|||
143275374|NCT02699593|516560358|FG001|Period 2|Adverse Event|1|||
143275375|NCT02699593|516560357|FG000|Period 2|Lost Contact Lens|0|||
143275376|NCT02699593|516560358|FG001|Period 2|Lost Contact Lens|1|||
143275377|NCT02699593|516560357|FG000|Period 2|Torn Contact Lens|1|||
143275378|NCT02699593|516560358|FG001|Period 2|Torn Contact Lens|0|||
143275379|NCT01681472|516560359|FG000|Overall Study|Adverse Event|0|||
143275380|NCT01681472|516560360|FG001|Overall Study|Adverse Event|1|||
143275381|NCT01681472|516560361|FG002|Overall Study|Adverse Event|0|||
143275382|NCT01681472|516560362|FG003|Overall Study|Adverse Event|0|||
143275383|NCT02764697|516560375|FG000|Overall Study|Lack of Efficacy|3|||
143275384|NCT00672646|516560377|FG000|Overall Study|Lost to Follow-up|0|||
143275385|NCT00672646|516560378|FG001|Overall Study|Lost to Follow-up|1|||
143275386|NCT00672646|516560379|FG002|Overall Study|Lost to Follow-up|2|||
143275387|NCT00672646|516560377|FG000|Overall Study|Withdrawal by Subject|0|||
143275388|NCT00672646|516560378|FG001|Overall Study|Withdrawal by Subject|0|||
143275389|NCT00672646|516560379|FG002|Overall Study|Withdrawal by Subject|1|||
143275390|NCT01999179|516560380|FG000|Overall Study|Adverse Event|1|||
143275391|NCT01999179|516560380|FG000|Overall Study|Lost to Follow-up|1|||
143275392|NCT01999179|516560380|FG000|Overall Study|Change in Therapy|3|||
143275393|NCT01999179|516560380|FG000|Overall Study|New catheter|2|||
143275394|NCT04439201|516560381|FG000|Overall Study|Ineligible|2|||
143275395|NCT04439201|516560381|FG000|Overall Study|Never start protocol therapy|1|||
143275396|NCT04439201|516560381|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
143275397|NCT04439201|516560381|FG000|Overall Study|Mutation status not confirmed|4|||
143275398|NCT04439201|516560381|FG000|Overall Study|Adverse Event|1|||
143275399|NCT04439201|516560381|FG000|Overall Study|Death|7|||
143275400|NCT04439201|516560381|FG000|Overall Study|Withdrawal by Subject|2|||
143275401|NCT04439201|516560381|FG000|Overall Study|Disease progression|20|||
143275402|NCT04439201|516560381|FG000|Overall Study|Alternative therapy|1|||
143275403|NCT04439201|516560381|FG000|Overall Study|Physician Decision|1|||
143275404|NCT05147428|516560384|FG000|Overall Study|Removed prior to mailing|289|||
143275405|NCT05147428|516560385|FG001|Overall Study|Removed prior to mailing|306|||
143275406|NCT05147428|516560386|FG002|Overall Study|Removed prior to mailing|270|||
143275407|NCT05147428|516560384|FG000|Overall Study|Died or disenrolled during blackout period|239|||
143275408|NCT05147428|516560385|FG001|Overall Study|Died or disenrolled during blackout period|278|||
143275409|NCT05147428|516560386|FG002|Overall Study|Died or disenrolled during blackout period|273|||
143275410|NCT01367002|516562207|FG000|Overall Study|Withdrawal by Subject|1|||
143275411|NCT01367002|516562208|FG001|Overall Study|Withdrawal by Subject|0|||
143275412|NCT01367002|516562207|FG000|Overall Study|Physician Decision|0|||
143275413|NCT01367002|516562208|FG001|Overall Study|Physician Decision|2|||
143275414|NCT06956170|516562209|FG000|Overall Study|Death|2|||
143275415|NCT06956170|516562210|FG001|Overall Study|Death|1|||
143275416|NCT06956170|516562209|FG000|Overall Study|Withdrawal by Subject|1|||
143275417|NCT06956170|516562210|FG001|Overall Study|Withdrawal by Subject|0|||
143275418|NCT06956170|516562209|FG000|Overall Study|Ongoing|7|||
143275419|NCT06956170|516562210|FG001|Overall Study|Ongoing|10|||
143275420|NCT03281577|516562211|FG000|Overall Study|Adverse Event|0|||
143275421|NCT03281577|516562212|FG001|Overall Study|Adverse Event|0|||
143275422|NCT03281577|516562213|FG002|Overall Study|Adverse Event|0|||
143275423|NCT03281577|516562214|FG003|Overall Study|Adverse Event|1|||
143275424|NCT03281577|516562211|FG000|Overall Study|Withdrawal by Subject|1|||
143275425|NCT03281577|516562212|FG001|Overall Study|Withdrawal by Subject|0|||
143275426|NCT03281577|516562213|FG002|Overall Study|Withdrawal by Subject|0|||
143275427|NCT03281577|516562214|FG003|Overall Study|Withdrawal by Subject|0|||
143275428|NCT02323113|516562215|FG000|Overall Study|Adverse Event|3|||
143275429|NCT02323113|516562216|FG001|Overall Study|Adverse Event|3|||
143275430|NCT02323113|516562217|FG002|Overall Study|Adverse Event|2|||
143275431|NCT02323113|516562218|FG003|Overall Study|Adverse Event|5|||
143275432|NCT02323113|516562219|FG004|Overall Study|Adverse Event|8|||
143275433|NCT02323113|516562220|FG005|Overall Study|Adverse Event|3|||
143275434|NCT02323113|516562221|FG006|Overall Study|Adverse Event|6|||
143275435|NCT02323113|516562222|FG007|Overall Study|Adverse Event|0|||
143275436|NCT02323113|516562215|FG000|Overall Study|Progressive Disease|0|||
143275437|NCT02323113|516562216|FG001|Overall Study|Progressive Disease|1|||
143275438|NCT02323113|516562217|FG002|Overall Study|Progressive Disease|1|||
143275439|NCT02323113|516562218|FG003|Overall Study|Progressive Disease|0|||
143275440|NCT02323113|516562219|FG004|Overall Study|Progressive Disease|0|||
143275441|NCT02323113|516562220|FG005|Overall Study|Progressive Disease|3|||
143275442|NCT02323113|516562221|FG006|Overall Study|Progressive Disease|0|||
143275443|NCT02323113|516562222|FG007|Overall Study|Progressive Disease|0|||
143275444|NCT02323113|516562215|FG000|Overall Study|Symptomatic Deterioration|0|||
143275445|NCT02323113|516562216|FG001|Overall Study|Symptomatic Deterioration|0|||
143275446|NCT02323113|516562217|FG002|Overall Study|Symptomatic Deterioration|1|||
143275447|NCT02323113|516562218|FG003|Overall Study|Symptomatic Deterioration|0|||
143372799|NCT01212757|516909649|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
143372800|NCT01212757|516909650|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
143372801|NCT01212757|516909651|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
143275448|NCT02323113|516562219|FG004|Overall Study|Symptomatic Deterioration|1|||
143275449|NCT02323113|516562220|FG005|Overall Study|Symptomatic Deterioration|0|||
143275450|NCT02323113|516562221|FG006|Overall Study|Symptomatic Deterioration|0|||
143275451|NCT02323113|516562222|FG007|Overall Study|Symptomatic Deterioration|0|||
143275452|NCT02323113|516562215|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
143275453|NCT02323113|516562216|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
143275454|NCT02323113|516562217|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
143275455|NCT02323113|516562218|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
143275456|NCT02323113|516562219|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
143275457|NCT02323113|516562220|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
143275458|NCT02323113|516562221|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
143275459|NCT02323113|516562222|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
143275460|NCT02323113|516562215|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
143275461|NCT02323113|516562216|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
143275462|NCT02323113|516562217|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
143275463|NCT02323113|516562218|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
143275464|NCT02323113|516562219|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
143275465|NCT02323113|516562220|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
143275466|NCT02323113|516562221|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
143275467|NCT02323113|516562222|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
143275468|NCT00403234|516562223|FG000|Overall Study|Withdrawal by Subject|0|||
143275469|NCT00403234|516562224|FG001|Overall Study|Withdrawal by Subject|1|||
143275470|NCT00403234|516562225|FG002|Overall Study|Withdrawal by Subject|0|||
143275471|NCT00403234|516562226|FG003|Overall Study|Withdrawal by Subject|0|||
143275472|NCT00403234|516562223|FG000|Overall Study|Adverse Event|1|||
143275473|NCT00403234|516562224|FG001|Overall Study|Adverse Event|0|||
143275474|NCT00403234|516562225|FG002|Overall Study|Adverse Event|1|||
143275475|NCT00403234|516562226|FG003|Overall Study|Adverse Event|0|||
143275476|NCT00094172|516562229|FG000|Overall Study|Adverse Event|0|||
143275477|NCT00094172|516562230|FG001|Overall Study|Adverse Event|1|||
143275478|NCT00094172|516562229|FG000|Overall Study|Lost to Follow-up|2|||
143275479|NCT00094172|516562230|FG001|Overall Study|Lost to Follow-up|0|||
143275480|NCT00094172|516562229|FG000|Overall Study|Protocol Violation|0|||
143275481|NCT00094172|516562230|FG001|Overall Study|Protocol Violation|1|||
143275482|NCT00094172|516562229|FG000|Overall Study|Withdrawal by Subject|10|||
143275483|NCT00094172|516562230|FG001|Overall Study|Withdrawal by Subject|5|||
143275484|NCT00094172|516562229|FG000|Overall Study|Primary endpoint met.|1|||
143275485|NCT00094172|516562230|FG001|Overall Study|Primary endpoint met.|0|||
143275486|NCT00094172|516562229|FG000|Overall Study|Started other MS therapy due to disease|1|||
143275487|NCT00094172|516562230|FG001|Overall Study|Started other MS therapy due to disease|0|||
143275488|NCT01020981|516562231|FG000|Overall Study|Did not return mailed survey|74|||
143275489|NCT01020981|516562232|FG001|Overall Study|Did not return mailed survey|58|||
143275490|NCT01020981|516562231|FG000|Overall Study|Survey returned undeliverable|8|||
143275491|NCT01020981|516562232|FG001|Overall Study|Survey returned undeliverable|32|||
143275492|NCT01020981|516562231|FG000|Overall Study|Participant declined to complete survey|2|||
143275493|NCT01020981|516562232|FG001|Overall Study|Participant declined to complete survey|0|||
143275494|NCT01947582|516562235|FG000|Overall Study|Withdrawal by Subject|1|||
143275495|NCT00064337|516562236|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
143275496|NCT00064337|516562236|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
143275497|NCT00064337|516562236|FG000|PBSCC or Induction/PBSCC|Progression|3|||
143275498|NCT00064337|516562236|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
143275499|NCT00064337|516562236|FG000|PBSCC or Induction/PBSCC|Death|2|||
143275500|NCT00064337|516562236|FG000|Transplant|Adverse Event|9|||
143275501|NCT00064337|516562236|FG000|Transplant|Not protocol-specified|5|||
143275502|NCT00064337|516562236|FG000|Transplant|Death|3|||
143275503|NCT00064337|516562236|FG000|Transplant|Patient Refusal|2|||
143275504|NCT00064337|516562236|FG000|Transplant|Progression|2|||
143275505|NCT00064337|516562236|FG000|Maintenance|Adverse Event|3|||
143275506|NCT00064337|516562236|FG000|Maintenance|Progression|2|||
143275507|NCT00064337|516562236|FG000|Maintenance|On treatment at time of analysis|2|||
143275508|NCT00064337|516562236|FG000|Maintenance|Not protocol-specified|2|||
143275509|NCT00064337|516562236|FG000|Maintenance|Death|1|||
143275510|NCT00612040|516562237|FG000|Overall Study|Adverse Event|0|||
143275511|NCT00612040|516562238|FG001|Overall Study|Adverse Event|2|||
143275512|NCT00612040|516562239|FG002|Overall Study|Adverse Event|1|||
143275513|NCT00612040|516562237|FG000|Overall Study|Protocol Violation|1|||
143275514|NCT00612040|516562238|FG001|Overall Study|Protocol Violation|2|||
143275515|NCT00612040|516562239|FG002|Overall Study|Protocol Violation|1|||
143275516|NCT00612040|516562237|FG000|Overall Study|Lack of Efficacy|2|||
143275517|NCT00612040|516562238|FG001|Overall Study|Lack of Efficacy|1|||
143275518|NCT00612040|516562239|FG002|Overall Study|Lack of Efficacy|0|||
143275519|NCT00612040|516562237|FG000|Overall Study|Unclassified|2|||
143275520|NCT00612040|516562238|FG001|Overall Study|Unclassified|2|||
143275521|NCT00612040|516562239|FG002|Overall Study|Unclassified|5|||
143275522|NCT00827502|516562240|FG000|Overall Study|randomized but not treated|11|||
143275523|NCT00827502|516562240|FG000|Overall Study|Adverse Event|1|||
143275524|NCT00827502|516562240|FG000|Overall Study|Lost to Follow-up|4|||
143275525|NCT00827502|516562240|FG000|Overall Study|Withdrawal by Subject|5|||
143275526|NCT01397890|516562245|FG000|Overall Study|Withdrawal by Subject|7|||
143275527|NCT01397890|516562246|FG001|Overall Study|Withdrawal by Subject|11|||
143275528|NCT01397890|516562245|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
143275529|NCT01397890|516562246|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
143275530|NCT01397890|516562245|FG000|Overall Study|Death|2|||
143275531|NCT01397890|516562246|FG001|Overall Study|Death|3|||
143275532|NCT01397890|516562245|FG000|Overall Study|Lost to Follow-up|1|||
143275533|NCT01397890|516562246|FG001|Overall Study|Lost to Follow-up|4|||
143275534|NCT01397890|516562245|FG000|Overall Study|Condition under Investigation Worsened|1|||
143275535|NCT01397890|516562246|FG001|Overall Study|Condition under Investigation Worsened|3|||
143275536|NCT01397890|516562245|FG000|Overall Study|Adverse Event|1|||
143275537|NCT01397890|516562246|FG001|Overall Study|Adverse Event|2|||
143275538|NCT01397890|516562245|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
143275539|NCT01397890|516562246|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
143275540|NCT01397890|516562245|FG000|Overall Study|Others|2|||
143275541|NCT01397890|516562246|FG001|Overall Study|Others|1|||
143275542|NCT02924571|516562247|FG000|Overall Study|Lost to Follow-up|1|||
143275543|NCT02924571|516562248|FG001|Overall Study|Lost to Follow-up|1|||
143275544|NCT02924571|516562249|FG002|Overall Study|Lost to Follow-up|0|||
143275545|NCT00434954|516562253|FG000|Overall Study|Adverse Event|17|||
143275546|NCT00434954|516562254|FG001|Overall Study|Adverse Event|2|||
143275547|NCT00434954|516562253|FG000|Overall Study|Entry criteria not met|14|||
143275548|NCT00434954|516562254|FG001|Overall Study|Entry criteria not met|16|||
143275549|NCT00434954|516562253|FG000|Overall Study|Lost to Follow-up|0|||
143275550|NCT00434954|516562254|FG001|Overall Study|Lost to Follow-up|1|||
143275551|NCT00434954|516562253|FG000|Overall Study|Physician Decision|6|||
143275552|NCT00434954|516562254|FG001|Overall Study|Physician Decision|3|||
143275553|NCT00434954|516562253|FG000|Overall Study|Protocol Violation|36|||
143275554|NCT00434954|516562254|FG001|Overall Study|Protocol Violation|27|||
143275555|NCT00434954|516562253|FG000|Overall Study|Sponsor decision|1|||
143275556|NCT00434954|516562254|FG001|Overall Study|Sponsor decision|0|||
143275557|NCT00434954|516562253|FG000|Overall Study|Subject decision|8|||
143275558|NCT00434954|516562254|FG001|Overall Study|Subject decision|22|||
143275559|NCT00002651|516562255|FG000|Induction|Adverse Event|44|||
143275560|NCT00002651|516562256|FG001|Induction|Adverse Event|0|||
143275561|NCT00002651|516562257|FG002|Induction|Adverse Event|0|||
143275562|NCT00002651|516562255|FG000|Induction|Refusal unrelated to adverse event|50|||
143275563|NCT00002651|516562256|FG001|Induction|Refusal unrelated to adverse event|0|||
143275564|NCT00002651|516562257|FG002|Induction|Refusal unrelated to adverse event|0|||
143275565|NCT00002651|516562255|FG000|Induction|Progression/relapse|274|||
143275566|NCT00002651|516562256|FG001|Induction|Progression/relapse|0|||
143275567|NCT00002651|516562257|FG002|Induction|Progression/relapse|0|||
143275568|NCT00002651|516562255|FG000|Induction|Death|62|||
143275569|NCT00002651|516562256|FG001|Induction|Death|0|||
143275570|NCT00002651|516562257|FG002|Induction|Death|0|||
143275571|NCT00002651|516562255|FG000|Induction|Other|823|||
143275572|NCT00002651|516562256|FG001|Induction|Other|0|||
143275573|NCT00002651|516562257|FG002|Induction|Other|0|||
143275574|NCT00002651|516562255|FG000|Induction|not eligible|90|||
143275575|NCT00002651|516562256|FG001|Induction|not eligible|0|||
143275576|NCT00002651|516562257|FG002|Induction|not eligible|0|||
143275577|NCT00002651|516562255|FG000|Consolidation and Randomization|Adverse Event|0|||
143275578|NCT00002651|516562256|FG001|Consolidation and Randomization|Adverse Event|36|||
143275579|NCT00002651|516562257|FG002|Consolidation and Randomization|Adverse Event|14|||
143275580|NCT00002651|516562255|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
143275581|NCT00002651|516562256|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
143275582|NCT00002651|516562257|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
143275583|NCT00002651|516562255|FG000|Consolidation and Randomization|Progression/relapse|0|||
143275584|NCT00002651|516562256|FG001|Consolidation and Randomization|Progression/relapse|295|||
143275585|NCT00002651|516562257|FG002|Consolidation and Randomization|Progression/relapse|298|||
143275586|NCT00002651|516562255|FG000|Consolidation and Randomization|Death|0|||
143275587|NCT00002651|516562256|FG001|Consolidation and Randomization|Death|38|||
143275588|NCT00002651|516562257|FG002|Consolidation and Randomization|Death|48|||
143275589|NCT00002651|516562255|FG000|Consolidation and Randomization|Other|0|||
143275590|NCT00002651|516562256|FG001|Consolidation and Randomization|Other|314|||
143275591|NCT00002651|516562257|FG002|Consolidation and Randomization|Other|313|||
143275592|NCT00002651|516562255|FG000|Consolidation and Randomization|not eligible|0|||
143275593|NCT00002651|516562256|FG001|Consolidation and Randomization|not eligible|102|||
143275594|NCT00002651|516562257|FG002|Consolidation and Randomization|not eligible|112|||
143275595|NCT01705730|516562264|FG000|Overall Study|Lack of Efficacy|1|||
143275596|NCT01705730|516562264|FG000|Overall Study|Adverse Event|3|||
143275597|NCT01705730|516562264|FG000|Overall Study|Lost to Follow-up|1|||
143275598|NCT01705730|516562264|FG000|Overall Study|Reason not Specified|4|||
143275599|NCT03417219|516562267|FG000|Overall Study|Lost to Follow-up|0|||
143372802|NCT01212757|516909643|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
143372803|NCT01212757|516909644|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
143275600|NCT03417219|516562268|FG001|Overall Study|Lost to Follow-up|3|||
143275601|NCT02609828|516562269|FG000|Overall Study|Adverse Event|8|||
143275602|NCT02609828|516562270|FG001|Overall Study|Adverse Event|1|||
143275603|NCT02609828|516562271|FG002|Overall Study|Adverse Event|0|||
143275604|NCT02609828|516562272|FG003|Overall Study|Adverse Event|6|||
143275605|NCT02609828|516562269|FG000|Overall Study|Death|15|||
143275606|NCT02609828|516562270|FG001|Overall Study|Death|1|||
143275607|NCT02609828|516562271|FG002|Overall Study|Death|1|||
143275608|NCT02609828|516562272|FG003|Overall Study|Death|19|||
143275609|NCT02609828|516562269|FG000|Overall Study|Insufficient clinical response|2|||
143275610|NCT02609828|516562270|FG001|Overall Study|Insufficient clinical response|1|||
143275611|NCT02609828|516562271|FG002|Overall Study|Insufficient clinical response|0|||
143275612|NCT02609828|516562272|FG003|Overall Study|Insufficient clinical response|0|||
143275613|NCT02609828|516562269|FG000|Overall Study|Lost to Follow-up|0|||
143275614|NCT02609828|516562270|FG001|Overall Study|Lost to Follow-up|0|||
143275615|NCT02609828|516562271|FG002|Overall Study|Lost to Follow-up|0|||
143275616|NCT02609828|516562272|FG003|Overall Study|Lost to Follow-up|1|||
143275617|NCT02609828|516562269|FG000|Overall Study|Protocol Violation|2|||
143275618|NCT02609828|516562270|FG001|Overall Study|Protocol Violation|0|||
143275619|NCT02609828|516562271|FG002|Overall Study|Protocol Violation|0|||
143275620|NCT02609828|516562272|FG003|Overall Study|Protocol Violation|1|||
143275621|NCT02609828|516562269|FG000|Overall Study|Withdrawal by Subject|12|||
143275622|NCT02609828|516562270|FG001|Overall Study|Withdrawal by Subject|1|||
143275623|NCT02609828|516562271|FG002|Overall Study|Withdrawal by Subject|0|||
143275624|NCT02609828|516562272|FG003|Overall Study|Withdrawal by Subject|10|||
143275625|NCT02609828|516562269|FG000|Overall Study|Other|3|||
143275626|NCT02609828|516562270|FG001|Overall Study|Other|0|||
143275627|NCT02609828|516562271|FG002|Overall Study|Other|0|||
143275628|NCT02609828|516562272|FG003|Overall Study|Other|6|||
143275629|NCT02609828|516562269|FG000|Overall Study|Randomized but not treated|1|||
143275630|NCT02609828|516562270|FG001|Overall Study|Randomized but not treated|0|||
143275631|NCT02609828|516562271|FG002|Overall Study|Randomized but not treated|0|||
143275632|NCT02609828|516562272|FG003|Overall Study|Randomized but not treated|0|||
143275633|NCT00319553|516562273|FG000|Overall Study|Protocol Violation|1|||
143275634|NCT00319553|516562274|FG001|Overall Study|Protocol Violation|2|||
143275635|NCT00319553|516562273|FG000|Overall Study|Lost to Follow-up|2|||
143275636|NCT00319553|516562274|FG001|Overall Study|Lost to Follow-up|1|||
143275637|NCT00319553|516562273|FG000|Overall Study|Withdrawal by Subject|1|||
143275638|NCT00319553|516562274|FG001|Overall Study|Withdrawal by Subject|1|||
143275639|NCT00446251|516562278|FG000|Overall Study|On-study Transplants|2|||
143275640|NCT00446251|516562278|FG000|Overall Study|Rituximab Infusion Reaction|2|||
143275641|NCT00446251|516562278|FG000|Overall Study|Lost to Follow-up|1|||
143275642|NCT04545554|516562279|FG000|Overall Study|Withdrawal by Subject|0|||
143275643|NCT04545554|516562280|FG001|Overall Study|Withdrawal by Subject|0|||
143275644|NCT04545554|516562281|FG002|Overall Study|Withdrawal by Subject|0|||
143275645|NCT04545554|516562282|FG003|Overall Study|Withdrawal by Subject|1|||
143275646|NCT04545554|516562283|FG004|Overall Study|Withdrawal by Subject|0|||
143275647|NCT04545554|516562284|FG005|Overall Study|Withdrawal by Subject|0|||
143275648|NCT01313312|516562289|FG000|Overall Study|Adverse Event|5|||
143275649|NCT01313312|516562289|FG000|Overall Study|Withdrawal by Subject|18|||
143275650|NCT01313312|516562289|FG000|Overall Study|Lack of Efficacy|3|||
143275651|NCT01313312|516562289|FG000|Overall Study|Investigator Decision|1|||
143275652|NCT01313312|516562289|FG000|Overall Study|Observational Phase|1|||
143275653|NCT01313312|516562289|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
143275654|NCT01313312|516562289|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
143275655|NCT04295772|516562290|FG000|Overall Study|Protocol Violation|1|||
143275656|NCT04295772|516562291|FG001|Overall Study|Protocol Violation|0|||
143275657|NCT04295772|516562290|FG000|Overall Study|Ongoing for safety monitoring|14|||
143275658|NCT04295772|516562291|FG001|Overall Study|Ongoing for safety monitoring|1|||
143275659|NCT04295772|516562290|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
143275660|NCT04295772|516562291|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
143275661|NCT02716805|516562292|FG000|Overall Study|Progressive disease|2|||
143275662|NCT02716805|516562293|FG001|Overall Study|Progressive disease|0|||
143275663|NCT02716805|516562294|FG002|Overall Study|Progressive disease|0|||
143275664|NCT02716805|516562295|FG003|Overall Study|Progressive disease|0|||
143275665|NCT00932126|516562296|FG000|Overall Study|Adverse Event|0|||
143275666|NCT00932126|516562297|FG001|Overall Study|Adverse Event|0|||
143275667|NCT00932126|516562298|FG002|Overall Study|Adverse Event|0|||
143275668|NCT00932126|516562299|FG003|Overall Study|Adverse Event|0|||
143275669|NCT00932126|516562300|FG004|Overall Study|Adverse Event|0|||
143275670|NCT00932126|516562301|FG005|Overall Study|Adverse Event|0|||
143275671|NCT00932126|516562302|FG006|Overall Study|Adverse Event|1|||
143275672|NCT00932126|516562303|FG007|Overall Study|Adverse Event|2|||
143275673|NCT00932126|516562296|FG000|Overall Study|Protocol Violation|0|||
143275674|NCT00932126|516562297|FG001|Overall Study|Protocol Violation|0|||
143275675|NCT00932126|516562298|FG002|Overall Study|Protocol Violation|0|||
143275676|NCT00932126|516562299|FG003|Overall Study|Protocol Violation|0|||
143275677|NCT00932126|516562300|FG004|Overall Study|Protocol Violation|1|||
143275678|NCT00932126|516562301|FG005|Overall Study|Protocol Violation|0|||
143275679|NCT00932126|516562302|FG006|Overall Study|Protocol Violation|0|||
143275680|NCT00932126|516562303|FG007|Overall Study|Protocol Violation|0|||
143275681|NCT00932126|516562296|FG000|Overall Study|Withdrawal by Subject|0|||
143275682|NCT00932126|516562297|FG001|Overall Study|Withdrawal by Subject|0|||
143275683|NCT00932126|516562298|FG002|Overall Study|Withdrawal by Subject|1|||
143275684|NCT00932126|516562299|FG003|Overall Study|Withdrawal by Subject|0|||
143275685|NCT00932126|516562300|FG004|Overall Study|Withdrawal by Subject|0|||
143275686|NCT00932126|516562301|FG005|Overall Study|Withdrawal by Subject|0|||
143275687|NCT00932126|516562302|FG006|Overall Study|Withdrawal by Subject|0|||
143275688|NCT00932126|516562303|FG007|Overall Study|Withdrawal by Subject|1|||
143275689|NCT00932126|516562296|FG000|Overall Study|Objective progression or relapse|3|||
143275690|NCT00932126|516562297|FG001|Overall Study|Objective progression or relapse|3|||
143275691|NCT00932126|516562298|FG002|Overall Study|Objective progression or relapse|2|||
143275692|NCT00932126|516562299|FG003|Overall Study|Objective progression or relapse|3|||
143275693|NCT00932126|516562300|FG004|Overall Study|Objective progression or relapse|3|||
143275694|NCT00932126|516562301|FG005|Overall Study|Objective progression or relapse|3|||
143275695|NCT00932126|516562302|FG006|Overall Study|Objective progression or relapse|3|||
143275696|NCT00932126|516562303|FG007|Overall Study|Objective progression or relapse|5|||
143275697|NCT00932126|516562296|FG000|Overall Study|Other|0|||
143275698|NCT00932126|516562297|FG001|Overall Study|Other|0|||
143275699|NCT00932126|516562298|FG002|Overall Study|Other|0|||
143275700|NCT00932126|516562299|FG003|Overall Study|Other|0|||
143275701|NCT00932126|516562300|FG004|Overall Study|Other|1|||
143275702|NCT00932126|516562301|FG005|Overall Study|Other|0|||
143275703|NCT00932126|516562302|FG006|Overall Study|Other|1|||
143275704|NCT00932126|516562303|FG007|Overall Study|Other|2|||
143275705|NCT00066365|516562304|FG000|Overall Study|Adverse Event|1|||
143275706|NCT00066365|516562305|FG001|Overall Study|Adverse Event|0|||
143275707|NCT00066365|516562304|FG000|Overall Study|Lack of Efficacy|15|||
143275708|NCT00066365|516562305|FG001|Overall Study|Lack of Efficacy|12|||
143275709|NCT00066365|516562304|FG000|Overall Study|Physician Decision|1|||
143275710|NCT00066365|516562305|FG001|Overall Study|Physician Decision|0|||
143275711|NCT00066365|516562304|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
143275712|NCT00066365|516562305|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
143275713|NCT00066365|516562304|FG000|Overall Study|Ineligible|4|||
143275714|NCT00066365|516562305|FG001|Overall Study|Ineligible|2|||
143275715|NCT00788073|516562310|FG000|STX209 Then Placebo|Adverse Event|1|||
143275716|NCT00788073|516562311|FG001|STX209 Then Placebo|Adverse Event|0|||
143275717|NCT00788073|516562310|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
143275718|NCT00788073|516562311|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
143275719|NCT00788073|516562310|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
143275720|NCT00788073|516562311|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
143275721|NCT00788073|516562310|FG000|STX209 Then Placebo|unable to return due to travel|0|||
143275722|NCT00788073|516562311|FG001|STX209 Then Placebo|unable to return due to travel|1|||
143275723|NCT00788073|516562310|FG000|Placebo Then STX209|Adverse Event|2|||
143275724|NCT00788073|516562311|FG001|Placebo Then STX209|Adverse Event|0|||
143275725|NCT00788073|516562310|FG000|Placebo Then STX209|Protocol Violation|0|||
143275726|NCT00788073|516562311|FG001|Placebo Then STX209|Protocol Violation|1|||
143275727|NCT03608254|516562312|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
143275728|NCT03608254|516562312|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
143275729|NCT04203797|516562313|FG000|Overall Study|Adverse Event|1|||
143275730|NCT04203797|516562314|FG001|Overall Study|Adverse Event|0|||
143275731|NCT04203797|516562313|FG000|Overall Study|Did not complete End of Study follow-up|1|||
143275732|NCT04203797|516562314|FG001|Overall Study|Did not complete End of Study follow-up|0|||
143275733|NCT04154930|516562320|FG000|Overall Study|Withdrawal by Subject|15|||
143275734|NCT04154930|516562321|FG001|Overall Study|Withdrawal by Subject|6|||
143275735|NCT04154930|516562320|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
143275736|NCT04154930|516562321|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
143275737|NCT04154930|516562320|FG000|Overall Study|Lost to Follow-up|14|||
143275738|NCT04154930|516562321|FG001|Overall Study|Lost to Follow-up|6|||
143275739|NCT04154930|516562320|FG000|Overall Study|Other|6|||
143275740|NCT04154930|516562321|FG001|Overall Study|Other|0|||
143275741|NCT01449539|516562326|FG000|Overall Study|Withdrawal by Subject|3|||
143275742|NCT01449539|516562326|FG000|Overall Study|Toxicity not study related|1|||
143275743|NCT02187744|516562327|FG000|Study|Participant refused further follow-up|1|||
143275744|NCT02187744|516562328|FG001|Study|Participant refused further follow-up|0|||
143275745|NCT02187744|516562327|FG000|Study|Other|2|||
143275746|NCT02187744|516562328|FG001|Study|Other|1|||
143275747|NCT02187744|516562327|FG000|Study|Lost to Follow-up|0|||
143275748|NCT02187744|516562328|FG001|Study|Lost to Follow-up|2|||
143275749|NCT02187744|516562327|FG000|Study|Related adverse event, not serious|0|||
143275750|NCT02187744|516562328|FG001|Study|Related adverse event, not serious|2|||
143275751|NCT02187744|516562327|FG000|Study|Death|1|||
143275752|NCT02187744|516562328|FG001|Study|Death|0|||
143275753|NCT02187744|516562327|FG000|Study|Related adverse event, serious non-fatal|0|||
143275754|NCT02187744|516562328|FG001|Study|Related adverse event, serious non-fatal|1|||
143275755|NCT02187744|516562327|FG000|Treatment|Death|1|||
143275756|NCT02187744|516562328|FG001|Treatment|Death|0|||
143275757|NCT02187744|516562327|FG000|Treatment|Related adverse event, serious non-fatal|0|||
143275758|NCT02187744|516562328|FG001|Treatment|Related adverse event, serious non-fatal|1|||
143275759|NCT02187744|516562327|FG000|Treatment|Related adverse event, not serious|0|||
143275760|NCT02187744|516562328|FG001|Treatment|Related adverse event, not serious|2|||
143275761|NCT02187744|516562327|FG000|Treatment|Lost to Follow-up|0|||
143275762|NCT02187744|516562328|FG001|Treatment|Lost to Follow-up|1|||
143275763|NCT02187744|516562327|FG000|Treatment|Other|2|||
143275764|NCT02187744|516562328|FG001|Treatment|Other|0|||
143275765|NCT02187744|516562327|FG000|Treatment|Participant refused continued treatment|1|||
143275766|NCT02187744|516562328|FG001|Treatment|Participant refused continued treatment|1|||
143275767|NCT01972568|516562329|FG000|Overall Study|Other events|3|||
143275768|NCT01972568|516562330|FG001|Overall Study|Other events|0|||
143275769|NCT01972568|516562331|FG002|Overall Study|Other events|0|||
143275770|NCT01972568|516562329|FG000|Overall Study|Lack of Efficacy|0|||
143275771|NCT01972568|516562330|FG001|Overall Study|Lack of Efficacy|1|||
143275772|NCT01972568|516562331|FG002|Overall Study|Lack of Efficacy|2|||
143275773|NCT01972568|516562329|FG000|Overall Study|Protocol Violation|1|||
143275774|NCT01972568|516562330|FG001|Overall Study|Protocol Violation|2|||
143275775|NCT01972568|516562331|FG002|Overall Study|Protocol Violation|2|||
143275776|NCT01972568|516562329|FG000|Overall Study|Withdrawal by Subject|6|||
143275777|NCT01972568|516562330|FG001|Overall Study|Withdrawal by Subject|3|||
143275778|NCT01972568|516562331|FG002|Overall Study|Withdrawal by Subject|7|||
143275779|NCT01972568|516562329|FG000|Overall Study|Lost to Follow-up|1|||
143275780|NCT01972568|516562330|FG001|Overall Study|Lost to Follow-up|0|||
143275781|NCT01972568|516562331|FG002|Overall Study|Lost to Follow-up|0|||
143275782|NCT01972568|516562329|FG000|Overall Study|Adverse Event|5|||
143275783|NCT01972568|516562330|FG001|Overall Study|Adverse Event|6|||
143275784|NCT01972568|516562331|FG002|Overall Study|Adverse Event|5|||
143275785|NCT00957580|516562332|FG000|Overall Study|Ongoing at data cut-off|0|||
143275786|NCT00957580|516562333|FG001|Overall Study|Ongoing at data cut-off|1|||
143275787|NCT00957580|516562334|FG002|Overall Study|Ongoing at data cut-off|0|||
143275788|NCT00957580|516562332|FG000|Overall Study|Enrolled but not treated|0|||
143275789|NCT00957580|516562333|FG001|Overall Study|Enrolled but not treated|1|||
143275790|NCT00957580|516562334|FG002|Overall Study|Enrolled but not treated|0|||
143275791|NCT01696071|516562335|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
143275792|NCT01696071|516562336|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
143275793|NCT00289783|516562339|FG000|Primary Phase|Adverse Event|10|||
143275794|NCT00289783|516562340|FG001|Primary Phase|Adverse Event|1|||
143275795|NCT00289783|516562339|FG000|Primary Phase|Protocol Violation|27|||
143275796|NCT00289783|516562340|FG001|Primary Phase|Protocol Violation|6|||
143275797|NCT00289783|516562339|FG000|Primary Phase|Withdrawal by Subject|93|||
143275798|NCT00289783|516562340|FG001|Primary Phase|Withdrawal by Subject|40|||
143275799|NCT00289783|516562339|FG000|Primary Phase|Lost to Follow-up|60|||
143275800|NCT00289783|516562340|FG001|Primary Phase|Lost to Follow-up|14|||
143275801|NCT00289783|516562339|FG000|Primary Phase|Migration from the study area|26|||
143275802|NCT00289783|516562340|FG001|Primary Phase|Migration from the study area|10|||
143275803|NCT00289783|516562339|FG000|Primary Phase|Other|32|||
143275804|NCT00289783|516562340|FG001|Primary Phase|Other|12|||
143275805|NCT00289783|516562339|FG000|Fourth Dose Phase|Adverse Event|1|||
143275806|NCT00289783|516562340|FG001|Fourth Dose Phase|Adverse Event|0|||
143275807|NCT00289783|516562339|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
143275808|NCT00289783|516562340|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
143275809|NCT00289783|516562339|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
143275810|NCT00289783|516562340|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
143275811|NCT00289783|516562339|FG000|Fourth Dose Phase|Migration from the study area|1|||
143275812|NCT00289783|516562340|FG001|Fourth Dose Phase|Migration from the study area|1|||
143275813|NCT00289783|516562339|FG000|Fourth Dose Phase|Other|22|||
143275814|NCT00289783|516562340|FG001|Fourth Dose Phase|Other|10|||
143275815|NCT03298867|516562348|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
143275816|NCT03298867|516562349|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
143275817|NCT03298867|516562348|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
143275818|NCT03298867|516562349|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
143275819|NCT03298867|516562348|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
143275820|NCT03298867|516562349|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
143275821|NCT03298867|516562348|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
143275822|NCT03298867|516562349|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
143275823|NCT03298867|516562348|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
143275824|NCT03298867|516562349|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
143275825|NCT03298867|516562348|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
143275826|NCT03298867|516562349|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
143275827|NCT03298867|516562348|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
143372804|NCT01212757|516909645|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
143372805|NCT01212757|516909646|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
143275828|NCT03298867|516562349|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
143275829|NCT03298867|516562348|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
143275830|NCT03298867|516562349|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
143275831|NCT03298867|516562348|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
143275832|NCT03298867|516562349|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
143275833|NCT01453361|516562350|FG000|Overall Study|Disease Progression|6|||
143275834|NCT01453361|516562350|FG000|Overall Study|Screen-Failures|10|||
143275835|NCT01752985|516562351|FG000|Treatment Period|Subject request to discontinue treatment|1|||
143275836|NCT01752985|516562352|FG001|Treatment Period|Subject request to discontinue treatment|0|||
143275837|NCT01752985|516562353|FG002|Treatment Period|Subject request to discontinue treatment|1|||
143275838|NCT01752985|516562351|FG000|Treatment Period|Subject no longer meets study criteria|0|||
143275839|NCT01752985|516562352|FG001|Treatment Period|Subject no longer meets study criteria|1|||
143275840|NCT01752985|516562353|FG002|Treatment Period|Subject no longer meets study criteria|1|||
143275841|NCT01752985|516562351|FG000|Treatment Period|Adverse Event|2|||
143275842|NCT01752985|516562352|FG001|Treatment Period|Adverse Event|1|||
143275843|NCT01752985|516562353|FG002|Treatment Period|Adverse Event|2|||
143275844|NCT01752985|516562351|FG000|Treatment Period|Withdrawal by Subject|1|||
143275845|NCT01752985|516562352|FG001|Treatment Period|Withdrawal by Subject|1|||
143275846|NCT01752985|516562353|FG002|Treatment Period|Withdrawal by Subject|0|||
143275847|NCT01752985|516562351|FG000|Treatment Period|Lost to Follow-up|0|||
143275848|NCT01752985|516562352|FG001|Treatment Period|Lost to Follow-up|0|||
143275849|NCT01752985|516562353|FG002|Treatment Period|Lost to Follow-up|1|||
143275850|NCT03128047|516562354|FG000|Overall Study|Withdrawal by Subject|1|||
143275851|NCT01995825|516563925|FG000|Overall Study|Withdrawal by Subject|1|||
143275852|NCT01995825|516563926|FG001|Overall Study|Withdrawal by Subject|0|||
143275853|NCT01798004|516563927|FG000|Overall Study|Death|2|||
143275854|NCT01798004|516563927|FG000|Overall Study|Lack of Efficacy|8|||
143275855|NCT01798004|516563927|FG000|Overall Study|Physician Decision|25|||
143275856|NCT01798004|516563927|FG000|Overall Study|Withdrawal by Subject|4|||
143275857|NCT01798004|516563927|FG000|Overall Study|Ineligible|4|||
143275858|NCT01798004|516563927|FG000|Overall Study|Patient/parent refusal|7|||
143275859|NCT01798004|516563927|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
143275860|NCT01798004|516563927|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
143275861|NCT01516437|516563928|FG000|Overall Study|Reason not specified|0|||
143275862|NCT01516437|516563929|FG001|Overall Study|Reason not specified|0|||
143275863|NCT01516437|516563930|FG002|Overall Study|Reason not specified|1|||
143275864|NCT01516437|516563931|FG003|Overall Study|Reason not specified|1|||
143275865|NCT01385566|516563935|FG000|Overall Study|Lost to Follow-up|1|||
143275866|NCT01385566|516563936|FG001|Overall Study|Lost to Follow-up|0|||
143275867|NCT01385566|516563937|FG002|Overall Study|Lost to Follow-up|0|||
143275868|NCT01385566|516563938|FG003|Overall Study|Lost to Follow-up|0|||
143275869|NCT01385566|516563939|FG004|Overall Study|Lost to Follow-up|0|||
143275870|NCT01385566|516563940|FG005|Overall Study|Lost to Follow-up|0|||
143275871|NCT01385566|516563935|FG000|Overall Study|Withdrawal by Subject|0|||
143275872|NCT01385566|516563936|FG001|Overall Study|Withdrawal by Subject|0|||
143275873|NCT01385566|516563937|FG002|Overall Study|Withdrawal by Subject|0|||
143275874|NCT01385566|516563938|FG003|Overall Study|Withdrawal by Subject|1|||
143275875|NCT01385566|516563939|FG004|Overall Study|Withdrawal by Subject|0|||
143275876|NCT01385566|516563940|FG005|Overall Study|Withdrawal by Subject|0|||
143275877|NCT00560105|516563949|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
143275878|NCT00560105|516563950|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
143275879|NCT02400333|516563951|FG000|Overall Study|Withdrawal by Subject|0|||
143275880|NCT02400333|516563952|FG001|Overall Study|Withdrawal by Subject|1|||
143275881|NCT02400333|516563953|FG002|Overall Study|Withdrawal by Subject|0|||
143275882|NCT02400333|516563954|FG003|Overall Study|Withdrawal by Subject|1|||
143275883|NCT02400333|516563951|FG000|Overall Study|Protocol Violation|1|||
143275884|NCT02400333|516563952|FG001|Overall Study|Protocol Violation|0|||
143275885|NCT02400333|516563953|FG002|Overall Study|Protocol Violation|2|||
143275886|NCT02400333|516563954|FG003|Overall Study|Protocol Violation|1|||
143275887|NCT00443261|516563955|FG000|Overall Study|Death|1|||
143275888|NCT01663532|516563956|FG000|Overall Study|Lost to Follow-up|9|||
143275889|NCT01663532|516563957|FG001|Overall Study|Lost to Follow-up|10|||
143275890|NCT01663532|516563956|FG000|Overall Study|Adverse Event|7|||
143275891|NCT01663532|516563957|FG001|Overall Study|Adverse Event|13|||
143275892|NCT01663532|516563956|FG000|Overall Study|Met Withdrawal Criteria|7|||
143275893|NCT01663532|516563957|FG001|Overall Study|Met Withdrawal Criteria|6|||
143275894|NCT01663532|516563956|FG000|Overall Study|Physician Decision|1|||
143275895|NCT01663532|516563957|FG001|Overall Study|Physician Decision|1|||
143275896|NCT01663532|516563956|FG000|Overall Study|Withdrawal by Subject|35|||
143275897|NCT01663532|516563957|FG001|Overall Study|Withdrawal by Subject|17|||
143275898|NCT01663532|516563956|FG000|Overall Study|Lack of Efficacy|15|||
143275899|NCT01663532|516563957|FG001|Overall Study|Lack of Efficacy|60|||
143275900|NCT02025621|516563962|FG000|Overall Study|Withdrawal by Subject|1|||
143275901|NCT02025621|516563963|FG001|Overall Study|Withdrawal by Subject|0|||
143275902|NCT02025621|516563962|FG000|Overall Study|Death|0|||
143275903|NCT02025621|516563963|FG001|Overall Study|Death|1|||
143275904|NCT02025621|516563962|FG000|Overall Study|No longer eligible|10|||
143275905|NCT02025621|516563963|FG001|Overall Study|No longer eligible|15|||
143275906|NCT02025621|516563962|FG000|Overall Study|Surgery initiated before infusion|3|||
143275907|NCT02025621|516563963|FG001|Overall Study|Surgery initiated before infusion|3|||
143275908|NCT00739674|516563964|FG000|Overall Study|Screening failures|19|||
143275909|NCT00739674|516563965|FG001|Overall Study|Screening failures|17|||
143275910|NCT00739674|516563964|FG000|Overall Study|Site 212 removal|19|||
143275911|NCT00739674|516563965|FG001|Overall Study|Site 212 removal|13|||
143275912|NCT00739674|516563964|FG000|Overall Study|No follow-up data|33|||
143275913|NCT00739674|516563965|FG001|Overall Study|No follow-up data|18|||
143275914|NCT00739674|516563964|FG000|Overall Study|Dietician consultation >30 days|1|||
143275915|NCT00739674|516563965|FG001|Overall Study|Dietician consultation >30 days|9|||
143275916|NCT00739674|516563964|FG000|Overall Study|Adverse Event|22|||
143275917|NCT00739674|516563965|FG001|Overall Study|Adverse Event|13|||
143275918|NCT00739674|516563964|FG000|Overall Study|Death|1|||
143275919|NCT00739674|516563965|FG001|Overall Study|Death|0|||
143275920|NCT00739674|516563964|FG000|Overall Study|Lack of Efficacy|1|||
143275921|NCT00739674|516563965|FG001|Overall Study|Lack of Efficacy|0|||
143275922|NCT00739674|516563964|FG000|Overall Study|Lost to Follow-up|52|||
143275923|NCT00739674|516563965|FG001|Overall Study|Lost to Follow-up|30|||
143275924|NCT00739674|516563964|FG000|Overall Study|Protocol Violation|5|||
143275925|NCT00739674|516563965|FG001|Overall Study|Protocol Violation|5|||
143275926|NCT00739674|516563964|FG000|Overall Study|Withdrawal by Subject|9|||
143275927|NCT00739674|516563965|FG001|Overall Study|Withdrawal by Subject|9|||
143275928|NCT00739674|516563964|FG000|Overall Study|Reason missing|2|||
143275929|NCT00739674|516563965|FG001|Overall Study|Reason missing|0|||
143275930|NCT00739674|516563964|FG000|Overall Study|Clinic closed|6|||
143275931|NCT00739674|516563965|FG001|Overall Study|Clinic closed|4|||
143275932|NCT00739674|516563964|FG000|Overall Study|Patient moved|3|||
143275933|NCT00739674|516563965|FG001|Overall Study|Patient moved|2|||
143275934|NCT00739674|516563964|FG000|Overall Study|Non compliant|4|||
143275935|NCT00739674|516563965|FG001|Overall Study|Non compliant|0|||
143275936|NCT00739674|516563964|FG000|Overall Study|Unable to attend visit|3|||
143275937|NCT00739674|516563965|FG001|Overall Study|Unable to attend visit|1|||
143275938|NCT00739674|516563964|FG000|Overall Study|Home monitoring off meds|1|||
143275939|NCT00739674|516563965|FG001|Overall Study|Home monitoring off meds|0|||
143275940|NCT00739674|516563964|FG000|Overall Study|Erectile dysfunction|0|||
143275941|NCT00739674|516563965|FG001|Overall Study|Erectile dysfunction|1|||
143275942|NCT04805541|516563967|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
143275943|NCT00283400|516563970|FG000|Overall Study|Withdrawal by Subject|1|||
143275944|NCT00283400|516563971|FG001|Overall Study|Withdrawal by Subject|1|||
143275945|NCT00283400|516563972|FG002|Overall Study|Withdrawal by Subject|0|||
143275946|NCT00283400|516563973|FG003|Overall Study|Withdrawal by Subject|0|||
143275947|NCT00283400|516563970|FG000|Overall Study|Death|1|||
143275948|NCT00283400|516563971|FG001|Overall Study|Death|0|||
143275949|NCT00283400|516563972|FG002|Overall Study|Death|1|||
143275950|NCT00283400|516563973|FG003|Overall Study|Death|0|||
143275951|NCT02195583|516563975|FG000|Overall Study|Lost to Follow-up|1|||
143275952|NCT02195583|516563975|FG000|Overall Study|Withdrawal by Subject|4|||
143275953|NCT02195583|516563975|FG000|Overall Study|Adverse Event|2|||
143275954|NCT02195583|516563975|FG000|Overall Study|Other Reason|2|||
143275955|NCT00983437|516563976|FG000|Overall Study|Adverse Event|9|||
143275956|NCT00983437|516563976|FG000|Overall Study|Lack of Efficacy|1|||
143275957|NCT00983437|516563976|FG000|Overall Study|Withdrawal by Subject|8|||
143275958|NCT00983437|516563976|FG000|Overall Study|Noncompliance to Study Procedures|1|||
143275959|NCT00983437|516563976|FG000|Overall Study|Lost to Follow-up|2|||
143275960|NCT00983437|516563976|FG000|Overall Study|Other Reason|26|||
143275961|NCT00289133|516563979|FG000|Overall Study|Non-study device implanted|12|||
143275962|NCT00289133|516563980|FG001|Overall Study|Non-study device implanted|0|||
143275963|NCT00289133|516563979|FG000|Overall Study|Protocol Violation|32|||
143275964|NCT00289133|516563980|FG001|Overall Study|Protocol Violation|38|||
143275965|NCT00289133|516563979|FG000|Overall Study|Withdrawal by Subject|9|||
143275966|NCT00289133|516563980|FG001|Overall Study|Withdrawal by Subject|10|||
143275967|NCT00289133|516563979|FG000|Overall Study|Death|5|||
143275968|NCT00289133|516563980|FG001|Overall Study|Death|10|||
143275969|NCT00289133|516563979|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
143275970|NCT00289133|516563980|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
143275971|NCT00289133|516563979|FG000|Overall Study|Physician Decision|41|||
143275972|NCT00289133|516563980|FG001|Overall Study|Physician Decision|45|||
143275973|NCT00289133|516563979|FG000|Overall Study|Revision|8|||
143275974|NCT00289133|516563980|FG001|Overall Study|Revision|6|||
143275975|NCT00289133|516563979|FG000|Overall Study|Lost to Follow-up|92|||
143275976|NCT00289133|516563980|FG001|Overall Study|Lost to Follow-up|115|||
143275977|NCT03372096|516563985|FG000|Overall Study|Study Closed|8|||
143275978|NCT00541931|516563986|FG000|Overall Study|Adverse Event|1|||
143275979|NCT00541931|516563987|FG001|Overall Study|Adverse Event|0|||
143275980|NCT00541931|516563986|FG000|Overall Study|Lost to Follow-up|3|||
143275981|NCT00541931|516563987|FG001|Overall Study|Lost to Follow-up|3|||
143275982|NCT00541931|516563986|FG000|Overall Study|Withdrawal by Subject|1|||
143275983|NCT00541931|516563987|FG001|Overall Study|Withdrawal by Subject|0|||
143275984|NCT00541931|516563986|FG000|Overall Study|Transportation Issue|0|||
143275985|NCT00541931|516563987|FG001|Overall Study|Transportation Issue|1|||
143275986|NCT03094169|516563997|FG000|Overall Study|Lack of Efficacy|0|||
143275987|NCT03094169|516563998|FG001|Overall Study|Lack of Efficacy|0|||
143275988|NCT03094169|516563999|FG002|Overall Study|Lack of Efficacy|0|||
143275989|NCT03094169|516564000|FG003|Overall Study|Lack of Efficacy|0|||
143275990|NCT03094169|516564001|FG004|Overall Study|Lack of Efficacy|0|||
143275991|NCT03094169|516564002|FG005|Overall Study|Lack of Efficacy|0|||
143275992|NCT03094169|516564003|FG006|Overall Study|Lack of Efficacy|0|||
143275993|NCT03094169|516564004|FG007|Overall Study|Lack of Efficacy|21|||
143275994|NCT03094169|516563997|FG000|Overall Study|Adverse Event|0|||
143275995|NCT03094169|516563998|FG001|Overall Study|Adverse Event|0|||
143275996|NCT03094169|516563999|FG002|Overall Study|Adverse Event|0|||
143275997|NCT03094169|516564000|FG003|Overall Study|Adverse Event|0|||
143275998|NCT03094169|516564001|FG004|Overall Study|Adverse Event|0|||
143275999|NCT03094169|516564002|FG005|Overall Study|Adverse Event|0|||
143276000|NCT03094169|516564003|FG006|Overall Study|Adverse Event|0|||
143276001|NCT03094169|516564004|FG007|Overall Study|Adverse Event|2|||
143276002|NCT03094169|516563997|FG000|Overall Study|Withdrawal by Subject|0|||
143276003|NCT03094169|516563998|FG001|Overall Study|Withdrawal by Subject|0|||
143276004|NCT03094169|516563999|FG002|Overall Study|Withdrawal by Subject|0|||
143276005|NCT03094169|516564000|FG003|Overall Study|Withdrawal by Subject|0|||
143276006|NCT03094169|516564001|FG004|Overall Study|Withdrawal by Subject|0|||
143276007|NCT03094169|516564002|FG005|Overall Study|Withdrawal by Subject|0|||
143276008|NCT03094169|516564003|FG006|Overall Study|Withdrawal by Subject|1|||
143276009|NCT03094169|516564004|FG007|Overall Study|Withdrawal by Subject|1|||
143276010|NCT03094169|516563997|FG000|Overall Study|Trial Termination|0|||
143276011|NCT03094169|516563998|FG001|Overall Study|Trial Termination|0|||
143276012|NCT03094169|516563999|FG002|Overall Study|Trial Termination|0|||
143276013|NCT03094169|516564000|FG003|Overall Study|Trial Termination|0|||
143276014|NCT03094169|516564001|FG004|Overall Study|Trial Termination|0|||
143276015|NCT03094169|516564002|FG005|Overall Study|Trial Termination|0|||
143276016|NCT03094169|516564003|FG006|Overall Study|Trial Termination|0|||
143276017|NCT03094169|516564004|FG007|Overall Study|Trial Termination|1|||
143276018|NCT03345914|516564005|FG000|Overall Study|Transition to another study at week 16|80|||
143276019|NCT03345914|516564006|FG001|Overall Study|Transition to another study at week 16|86|||
143276020|NCT03345914|516564007|FG002|Overall Study|Transition to another study at week 16|78|||
143276021|NCT03345914|516564005|FG000|Overall Study|Transition to OLE during follow-up|37|||
143276022|NCT03345914|516564006|FG001|Overall Study|Transition to OLE during follow-up|33|||
143276023|NCT03345914|516564007|FG002|Overall Study|Transition to OLE during follow-up|39|||
143276024|NCT03345914|516564005|FG000|Overall Study|Physician Decision|0|||
143276025|NCT03345914|516564006|FG001|Overall Study|Physician Decision|1|||
143276026|NCT03345914|516564007|FG002|Overall Study|Physician Decision|1|||
143276027|NCT03345914|516564005|FG000|Overall Study|Withdrawal by Subject|5|||
143276028|NCT03345914|516564006|FG001|Overall Study|Withdrawal by Subject|1|||
143276029|NCT03345914|516564007|FG002|Overall Study|Withdrawal by Subject|2|||
143276030|NCT03345914|516564005|FG000|Overall Study|Other|1|||
143276031|NCT03345914|516564006|FG001|Overall Study|Other|1|||
143276032|NCT03345914|516564007|FG002|Overall Study|Other|1|||
143276033|NCT03345914|516564005|FG000|Overall Study|Ongoing|0|||
143276034|NCT03345914|516564006|FG001|Overall Study|Ongoing|0|||
143276035|NCT03345914|516564007|FG002|Overall Study|Ongoing|1|||
143276036|NCT04891978|516564011|FG000|Baseline|Protocol Violation|2|||
143276037|NCT04891978|516564012|FG001|Baseline|Protocol Violation|1|||
143276038|NCT04891978|516564013|FG002|Baseline|Protocol Violation|0|||
143276039|NCT04891978|516564011|FG000|Baseline|Missing AIRQ|1|||
143276040|NCT04891978|516564012|FG001|Baseline|Missing AIRQ|0|||
143276041|NCT04891978|516564013|FG002|Baseline|Missing AIRQ|0|||
143276042|NCT04891978|516564011|FG000|Baseline|Did not attend a baseline visit|0|||
143276043|NCT04891978|516564012|FG001|Baseline|Did not attend a baseline visit|0|||
143276044|NCT04891978|516564013|FG002|Baseline|Did not attend a baseline visit|9|||
143276045|NCT02589405|516564014|FG000|Overall Study|Adverse Event|3|||
143276046|NCT02589405|516564014|FG000|Overall Study|Withdrawal by Subject|1|||
143276047|NCT02264639|516564019|FG000|Overall Study|Death (after completing single-dose phase)|1|||
143276048|NCT02264639|516564020|FG001|Overall Study|Death (after completing single-dose phase)|0|||
143276049|NCT02264639|516564021|FG002|Overall Study|Death (after completing single-dose phase)|0|||
143276050|NCT02264639|516564022|FG003|Overall Study|Death (after completing single-dose phase)|0|||
143276051|NCT02264639|516564023|FG004|Overall Study|Death (after completing single-dose phase)|0|||
143276052|NCT02264639|516564019|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
143276053|NCT02264639|516564020|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
143276054|NCT02264639|516564021|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
143276055|NCT02264639|516564022|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
143276056|NCT02264639|516564023|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
143276057|NCT02264639|516564019|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
143276058|NCT02264639|516564020|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
143276059|NCT02264639|516564021|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
143276060|NCT02264639|516564022|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
143276061|NCT02264639|516564023|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
143276062|NCT02264639|516564019|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
143276063|NCT02264639|516564020|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
143276064|NCT02264639|516564021|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
143276065|NCT02264639|516564022|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
143276066|NCT02264639|516564023|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
143276067|NCT02693119|516564025|FG000|Open-Label Period|Withdrawal by Subject|0|||
143276068|NCT02693119|516564026|FG001|Open-Label Period|Withdrawal by Subject|1|||
143276069|NCT02319837|516564027|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
143276070|NCT02319837|516564028|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
143276071|NCT02319837|516564029|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
143276072|NCT02319837|516564027|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
143276073|NCT02319837|516564028|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
143276074|NCT02319837|516564029|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
143276075|NCT02319837|516564027|FG000|Study Treatment Phase|Adverse Event|73|||
143276076|NCT02319837|516564028|FG001|Study Treatment Phase|Adverse Event|36|||
143276077|NCT02319837|516564029|FG002|Study Treatment Phase|Adverse Event|63|||
143276078|NCT02319837|516564027|FG000|Study Treatment Phase|Development of castration resistance|0|||
143276079|NCT02319837|516564028|FG001|Study Treatment Phase|Development of castration resistance|2|||
143276080|NCT02319837|516564029|FG002|Study Treatment Phase|Development of castration resistance|0|||
143276081|NCT02319837|516564027|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
143276082|NCT02319837|516564028|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
143276083|NCT02319837|516564029|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
143276084|NCT02319837|516564027|FG000|Study Treatment Phase|Protocol Violation|2|||
143276085|NCT02319837|516564028|FG001|Study Treatment Phase|Protocol Violation|2|||
143276086|NCT02319837|516564029|FG002|Study Treatment Phase|Protocol Violation|1|||
143276087|NCT02319837|516564027|FG000|Study Treatment Phase|Lost to Follow-up|0|||
143276088|NCT02319837|516564028|FG001|Study Treatment Phase|Lost to Follow-up|1|||
143276089|NCT02319837|516564029|FG002|Study Treatment Phase|Lost to Follow-up|0|||
143276090|NCT02319837|516564027|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
143276091|NCT02319837|516564028|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
143276092|NCT02319837|516564029|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
143276093|NCT02319837|516564027|FG000|Study Treatment Phase|Other|0|||
143276094|NCT02319837|516564028|FG001|Study Treatment Phase|Other|1|||
143276095|NCT02319837|516564029|FG002|Study Treatment Phase|Other|0|||
143276096|NCT02319837|516564027|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
143276097|NCT02319837|516564028|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
143276098|NCT02319837|516564029|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
143276099|NCT02319837|516564027|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
143276100|NCT02319837|516564028|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
143276101|NCT02319837|516564029|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
143276102|NCT02319837|516564027|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
143276103|NCT02319837|516564028|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
143276104|NCT02319837|516564029|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
143276105|NCT02319837|516564027|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
143276106|NCT02319837|516564028|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
143276107|NCT02319837|516564029|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
143276108|NCT02319837|516564027|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
143276109|NCT02319837|516564028|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
143276110|NCT02319837|516564029|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
143276111|NCT02319837|516564027|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
143276112|NCT02319837|516564028|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
143276113|NCT02319837|516564029|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
143276114|NCT02319837|516564027|FG000|Long-Term Follow-Up Phase|Death|33|||
143276115|NCT02319837|516564028|FG001|Long-Term Follow-Up Phase|Death|54|||
143276116|NCT02319837|516564029|FG002|Long-Term Follow-Up Phase|Death|42|||
143276117|NCT00753766|516564032|FG000|Overall Study|Physician Decision|1|||
143276118|NCT00753766|516564033|FG001|Overall Study|Physician Decision|0|||
143276119|NCT00494299|516564040|FG000|Overall Study|Adverse Event|93|||
143276120|NCT00494299|516564041|FG001|Overall Study|Adverse Event|13|||
143276121|NCT00494299|516564040|FG000|Overall Study|Lost to Follow-up|1|||
143276122|NCT00494299|516564041|FG001|Overall Study|Lost to Follow-up|0|||
143276123|NCT00494299|516564040|FG000|Overall Study|Physician Decision|0|||
143276124|NCT00494299|516564041|FG001|Overall Study|Physician Decision|2|||
143276125|NCT00494299|516564040|FG000|Overall Study|Protocol Violation|1|||
143276126|NCT00494299|516564041|FG001|Overall Study|Protocol Violation|2|||
143276127|NCT00494299|516564040|FG000|Overall Study|Withdrawal by Subject|8|||
143276128|NCT00494299|516564041|FG001|Overall Study|Withdrawal by Subject|3|||
143276129|NCT00494299|516564040|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
143276130|NCT00494299|516564041|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
143276131|NCT00494299|516564040|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
143276132|NCT00494299|516564041|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
143276133|NCT00494299|516564040|FG000|Overall Study|Site Closed by Sponsor|6|||
143276134|NCT00494299|516564041|FG001|Overall Study|Site Closed by Sponsor|0|||
143276135|NCT00494299|516564040|FG000|Overall Study|Protocol Driven Decision Point|11|||
143276136|NCT00494299|516564041|FG001|Overall Study|Protocol Driven Decision Point|22|||
143276137|NCT01281137|516564044|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
143276138|NCT01281137|516564045|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
143276139|NCT01281137|516564044|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
143276140|NCT01281137|516564045|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
143276141|NCT01281137|516564044|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
143276142|NCT01281137|516564045|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
143276143|NCT01281137|516564044|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
143276144|NCT01281137|516564045|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
143276145|NCT01281137|516564044|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
143276146|NCT01281137|516564045|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
143276147|NCT01206166|516564046|FG000|Overall Study|No evaluable data|2|||
143276148|NCT01206166|516564047|FG001|Overall Study|No evaluable data|3|||
143276149|NCT00939640|516564051|FG000|Overall Study|Physician Decision|1|||
143276150|NCT00239590|516564052|FG000|Randomized|Lost to Follow-up|0|||
143276151|NCT00239590|516564053|FG001|Randomized|Lost to Follow-up|1|||
143276152|NCT00239590|516564052|FG000|Randomized|Withdrawal by Subject|0|||
143276153|NCT00239590|516564053|FG001|Randomized|Withdrawal by Subject|1|||
143276154|NCT00239590|516564052|FG000|Completed Study Protocol|Adverse Event|1|||
143276155|NCT00239590|516564053|FG001|Completed Study Protocol|Adverse Event|1|||
143276156|NCT00239590|516564052|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
143276157|NCT00239590|516564053|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
143276158|NCT00579098|516564054|FG000|Overall Study|Lost to Follow-up|2|||
143276159|NCT00579098|516564055|FG001|Overall Study|Lost to Follow-up|0|||
143276160|NCT00579098|516564054|FG000|Overall Study|Adverse Event|2|||
143276161|NCT00579098|516564055|FG001|Overall Study|Adverse Event|3|||
143276162|NCT00579098|516564054|FG000|Overall Study|Withdrawal by Subject|2|||
143276163|NCT00579098|516564055|FG001|Overall Study|Withdrawal by Subject|3|||
143276164|NCT00579098|516564054|FG000|Overall Study|AF returned after ablation|3|||
143276165|NCT00579098|516564055|FG001|Overall Study|AF returned after ablation|2|||
143276166|NCT02121522|516564056|FG000|Overall Study|Adverse Event|1|||
143276167|NCT01254331|516564058|FG000|Initial Phase|Adverse Event|3|||
143276168|NCT01254331|516564058|FG000|Initial Phase|Withdrawal by Subject|1|||
143276169|NCT01254331|516564058|FG000|Initial Phase|Pregnancy|1|||
143276170|NCT01254331|516564058|FG000|Extension Phase|Lack of Efficacy|1|||
143276171|NCT01254331|516564058|FG000|Extension Phase|Lost to Follow-up|3|||
143276172|NCT00892047|516564065|FG000|Overall Study|Adverse Event|2|||
143276173|NCT00892047|516564066|FG001|Overall Study|Adverse Event|2|||
143276174|NCT00892047|516564065|FG000|Overall Study|subject burden|2|||
143276175|NCT00892047|516564066|FG001|Overall Study|subject burden|3|||
143276176|NCT00892047|516564065|FG000|Overall Study|Lack of Efficacy|0|||
143276177|NCT00892047|516564066|FG001|Overall Study|Lack of Efficacy|2|||
143276178|NCT05306977|516564067|FG000|Overall Study|Withdrawal by Subject|1|||
143276179|NCT01443078|516564069|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
143276180|NCT01443078|516564069|FG000|Overall Study|Withdrawal by Subject|1|||
143276181|NCT01443078|516564069|FG000|Overall Study|Patient had brain mets|1|||
143276182|NCT00660699|516564070|FG000|Overall Study|Withdrawal by Subject|2|||
143276183|NCT03539081|516565516|FG000|Overall Study|Withdrawal by Subject|2|||
143276184|NCT03539081|516565517|FG001|Overall Study|Withdrawal by Subject|3|||
143276185|NCT03539081|516565518|FG002|Overall Study|Withdrawal by Subject|0|||
143276186|NCT03539081|516565516|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
143276187|NCT03539081|516565517|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
143276188|NCT03539081|516565518|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
143276189|NCT01594281|516565519|FG000|Interventional Core Phase|Protocol Deviation|1|||
143276190|NCT01594281|516565520|FG001|Interventional Core Phase|Protocol Deviation|0|||
143276191|NCT01594281|516565521|FG002|Interventional Core Phase|Protocol Deviation|0|||
143276192|NCT01594281|516565519|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
143276193|NCT01594281|516565520|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
143276194|NCT01594281|516565521|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
143276195|NCT01594281|516565519|FG000|Interventional Core Phase|Death|1|||
143276196|NCT01594281|516565520|FG001|Interventional Core Phase|Death|1|||
143276197|NCT01594281|516565521|FG002|Interventional Core Phase|Death|2|||
143276198|NCT01594281|516565519|FG000|Interventional Core Phase|Lost to Follow-up|1|||
143276199|NCT01594281|516565520|FG001|Interventional Core Phase|Lost to Follow-up|4|||
143276200|NCT01594281|516565521|FG002|Interventional Core Phase|Lost to Follow-up|1|||
143276201|NCT01594281|516565519|FG000|Interventional Core Phase|Adverse Event|4|||
143276202|NCT01594281|516565520|FG001|Interventional Core Phase|Adverse Event|4|||
143276203|NCT01594281|516565521|FG002|Interventional Core Phase|Adverse Event|4|||
143276204|NCT01594281|516565519|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
143276205|NCT01594281|516565520|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
143276206|NCT01594281|516565521|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
143229281|NCT00647296|516387180|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
143229282|NCT00647296|516387177|FG000|Part 2: 4-week Placebo Washout|Death|3|||
143229283|NCT00647296|516387178|FG001|Part 2: 4-week Placebo Washout|Death|0|||
143229284|NCT00647296|516387179|FG002|Part 2: 4-week Placebo Washout|Death|0|||
143229285|NCT00647296|516387180|FG003|Part 2: 4-week Placebo Washout|Death|0|||
143229286|NCT00647296|516387177|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
143229287|NCT00647296|516387178|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
143229288|NCT00647296|516387179|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
143229289|NCT00647296|516387180|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
143229290|NCT00647296|516387177|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
143229291|NCT00647296|516387178|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
143229292|NCT00647296|516387179|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
143229293|NCT00647296|516387180|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
143229294|NCT00647296|516387177|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
143229295|NCT00647296|516387178|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
143229296|NCT00647296|516387179|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
143229297|NCT00647296|516387180|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
143229298|NCT00647296|516387177|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
143229299|NCT00647296|516387178|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
143229300|NCT00647296|516387179|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
143229301|NCT00647296|516387180|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
143229302|NCT00647296|516387177|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
143229303|NCT00647296|516387178|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
143229304|NCT00647296|516387179|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
143229305|NCT00647296|516387180|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
143229306|NCT02922725|516387181|FG000|Overall Study|Withdrawal by Subject|1|||
143229307|NCT02922725|516387182|FG001|Overall Study|Withdrawal by Subject|0|||
143229308|NCT02922725|516387183|FG002|Overall Study|Withdrawal by Subject|0|||
143229309|NCT03883581|516387184|FG000|Overall Study|Withdrawal by Subject|4|||
143229310|NCT03069352|516387185|FG000|Overall Study|Ongoing|12|||
143229311|NCT03069352|516387186|FG001|Overall Study|Ongoing|40|||
143229312|NCT02621424|516387187|FG000|Overall Study|Withdrawal by Subject|1|||
143229313|NCT02621424|516387188|FG001|Overall Study|Withdrawal by Subject|2|||
143229314|NCT03062358|516387189|FG000|Overall Study|Death|269|||
143229315|NCT03062358|516387190|FG001|Overall Study|Death|145|||
143276207|NCT01594281|516565519|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
143276208|NCT01594281|516565520|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
143276209|NCT01594281|516565521|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
143276210|NCT01594281|516565519|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
143276211|NCT01594281|516565520|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
143276212|NCT01594281|516565521|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
143276213|NCT01034631|516565526|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
143276214|NCT01034631|516565527|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
143276215|NCT01034631|516565528|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
143276216|NCT01034631|516565526|FG000|Phase II|Not Evaluable per protocol|0|||
143276217|NCT01034631|516565527|FG001|Phase II|Not Evaluable per protocol|0|||
143276218|NCT01034631|516565528|FG002|Phase II|Not Evaluable per protocol|2|||
143276219|NCT01034631|516565526|FG000|Phase II|Determined Ineligible per protocol|0|||
143276220|NCT01034631|516565527|FG001|Phase II|Determined Ineligible per protocol|1|||
143276221|NCT01034631|516565528|FG002|Phase II|Determined Ineligible per protocol|0|||
143276222|NCT01560403|516565529|FG000|Overall Study|Lost to Follow-up|0|||
143276223|NCT01560403|516565530|FG001|Overall Study|Lost to Follow-up|1|||
143276224|NCT04218695|516565533|FG000|Overall Study|Adverse Event|1|||
143276225|NCT04218695|516565534|FG001|Overall Study|Adverse Event|0|||
143276226|NCT01890473|516565535|FG000|Overall Study|Lost to Follow-up|1|||
143276227|NCT01890473|516565536|FG001|Overall Study|Lost to Follow-up|0|||
143276228|NCT01890473|516565535|FG000|Overall Study|Poor/non-compliance|1|||
143276229|NCT01890473|516565536|FG001|Overall Study|Poor/non-compliance|0|||
143276230|NCT01543958|516565537|FG000|Overall Study|Loss to follow-up|3|||
143276231|NCT01543958|516565537|FG000|Overall Study|ART initiation|1|||
143276232|NCT04019288|516565538|FG000|Overall Study|Death|1|||
143276233|NCT04019288|516565539|FG001|Overall Study|Death|0|||
143276234|NCT04019288|516565540|FG002|Overall Study|Death|0|||
143276235|NCT00934089|516565541|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
143276236|NCT00934089|516565542|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
143276237|NCT00934089|516565541|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
143276238|NCT00934089|516565542|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
143276239|NCT01945281|516565544|FG000|Overall Study|Adverse Event|1|||
143276240|NCT01945281|516565545|FG001|Overall Study|Adverse Event|0|||
143276241|NCT01945281|516565544|FG000|Overall Study|Death|3|||
143276242|NCT01945281|516565545|FG001|Overall Study|Death|3|||
143276243|NCT01945281|516565544|FG000|Overall Study|Physician Decision|1|||
143276244|NCT01945281|516565545|FG001|Overall Study|Physician Decision|1|||
143276245|NCT01945281|516565544|FG000|Overall Study|Technical Problems|1|||
143276246|NCT01945281|516565545|FG001|Overall Study|Technical Problems|0|||
143276247|NCT00003473|516565546|FG000|Overall Study|Three patients were not evaluable.|3|||
143276248|NCT04401423|516565547|FG000|Overall Study|Withdrawal by Subject|3|||
143276249|NCT04401423|516565548|FG001|Overall Study|Withdrawal by Subject|1|||
143276250|NCT04401423|516565547|FG000|Overall Study|Physician Decision|2|||
143276251|NCT04401423|516565548|FG001|Overall Study|Physician Decision|1|||
143276252|NCT00799383|516565551|FG000|Overall Study|Protocol Violation|1|||
143276253|NCT00799383|516565552|FG001|Overall Study|Protocol Violation|1|||
143276254|NCT00799383|516565551|FG000|Overall Study|Adverse Event|0|||
143276255|NCT00799383|516565552|FG001|Overall Study|Adverse Event|1|||
143276256|NCT00799383|516565551|FG000|Overall Study|Lost to Follow-up|1|||
143276257|NCT00799383|516565552|FG001|Overall Study|Lost to Follow-up|2|||
143276258|NCT00799383|516565551|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
143276259|NCT00799383|516565552|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
143276260|NCT00799383|516565551|FG000|Overall Study|Withdrawal by Subject|0|||
143276261|NCT00799383|516565552|FG001|Overall Study|Withdrawal by Subject|1|||
143276262|NCT00040365|516565558|FG000|Overall Study|Death|1|||
143276263|NCT00040365|516565558|FG000|Overall Study|Progressive disease|7|||
143276264|NCT00040365|516565558|FG000|Overall Study|Lost to Follow-up|3|||
143276265|NCT00680017|516565559|FG000|Overall Study|Adverse Event|13|||
143276266|NCT00680017|516565560|FG001|Overall Study|Adverse Event|7|||
143276267|NCT00680017|516565559|FG000|Overall Study|Withdrawal by Subject|2|||
143276268|NCT00680017|516565560|FG001|Overall Study|Withdrawal by Subject|5|||
143276269|NCT00680017|516565559|FG000|Overall Study|Lost to Follow-up|2|||
143276270|NCT00680017|516565560|FG001|Overall Study|Lost to Follow-up|0|||
143276271|NCT02555683|516565561|FG000|Overall Study|Physician Decision|1|||
143276272|NCT02555683|516565562|FG001|Overall Study|Physician Decision|0|||
143276273|NCT02555683|516565563|FG002|Overall Study|Physician Decision|2|||
143276274|NCT02555683|516565561|FG000|Overall Study|Lost to Follow-up|2|||
143276275|NCT02555683|516565562|FG001|Overall Study|Lost to Follow-up|1|||
143276276|NCT02555683|516565563|FG002|Overall Study|Lost to Follow-up|2|||
143276277|NCT02555683|516565561|FG000|Overall Study|Technical Problems|1|||
143276278|NCT02555683|516565562|FG001|Overall Study|Technical Problems|1|||
143276279|NCT02555683|516565563|FG002|Overall Study|Technical Problems|0|||
143276280|NCT02555683|516565561|FG000|Overall Study|Protocol deviation|0|||
143276281|NCT02555683|516565562|FG001|Overall Study|Protocol deviation|1|||
143276282|NCT02555683|516565563|FG002|Overall Study|Protocol deviation|0|||
143276283|NCT02555683|516565561|FG000|Overall Study|Lack of Efficacy|2|||
143276284|NCT02555683|516565562|FG001|Overall Study|Lack of Efficacy|0|||
143276285|NCT02555683|516565563|FG002|Overall Study|Lack of Efficacy|0|||
143276286|NCT02555683|516565561|FG000|Overall Study|Death|0|||
143276287|NCT02555683|516565562|FG001|Overall Study|Death|1|||
143276288|NCT02555683|516565563|FG002|Overall Study|Death|2|||
143276289|NCT02555683|516565561|FG000|Overall Study|Adverse Event|1|||
143276290|NCT02555683|516565562|FG001|Overall Study|Adverse Event|0|||
143276291|NCT02555683|516565563|FG002|Overall Study|Adverse Event|1|||
143276292|NCT02555683|516565561|FG000|Overall Study|Subject/guardian decision|12|||
143276293|NCT02555683|516565562|FG001|Overall Study|Subject/guardian decision|12|||
143276294|NCT02555683|516565563|FG002|Overall Study|Subject/guardian decision|22|||
143276295|NCT02555683|516565561|FG000|Overall Study|Death post Treatment/safety period|0|||
143276296|NCT02555683|516565562|FG001|Overall Study|Death post Treatment/safety period|1|||
143276297|NCT02555683|516565563|FG002|Overall Study|Death post Treatment/safety period|0|||
143276298|NCT01153347|516565564|FG000|Overall Study|Withdrawal by Subject|7|||
143276299|NCT01153347|516565565|FG001|Overall Study|Withdrawal by Subject|7|||
143276300|NCT01153347|516565566|FG002|Overall Study|Withdrawal by Subject|7|||
143276301|NCT01153347|516565567|FG003|Overall Study|Withdrawal by Subject|7|||
143276302|NCT01153347|516565564|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
143276303|NCT01153347|516565565|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
143276304|NCT01153347|516565566|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
143276305|NCT01153347|516565567|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
143276306|NCT01153347|516565564|FG000|Overall Study|Adverse Event|3|||
143276307|NCT01153347|516565565|FG001|Overall Study|Adverse Event|9|||
143276308|NCT01153347|516565566|FG002|Overall Study|Adverse Event|21|||
143276309|NCT01153347|516565567|FG003|Overall Study|Adverse Event|7|||
143276310|NCT01153347|516565564|FG000|Overall Study|Severe non-compliance to protocol|6|||
143276311|NCT01153347|516565565|FG001|Overall Study|Severe non-compliance to protocol|7|||
143276312|NCT01153347|516565566|FG002|Overall Study|Severe non-compliance to protocol|4|||
143276313|NCT01153347|516565567|FG003|Overall Study|Severe non-compliance to protocol|3|||
143276314|NCT01153347|516565564|FG000|Overall Study|Condition under investigation worsened|1|||
143276315|NCT01153347|516565565|FG001|Overall Study|Condition under investigation worsened|1|||
143276316|NCT01153347|516565566|FG002|Overall Study|Condition under investigation worsened|0|||
143276317|NCT01153347|516565567|FG003|Overall Study|Condition under investigation worsened|0|||
143276318|NCT01153347|516565564|FG000|Overall Study|Lack of Efficacy|2|||
143276319|NCT01153347|516565565|FG001|Overall Study|Lack of Efficacy|2|||
143276320|NCT01153347|516565566|FG002|Overall Study|Lack of Efficacy|0|||
143276321|NCT01153347|516565567|FG003|Overall Study|Lack of Efficacy|4|||
143276322|NCT01153347|516565564|FG000|Overall Study|Study-specific withdrawal criteria|4|||
143276323|NCT01153347|516565565|FG001|Overall Study|Study-specific withdrawal criteria|3|||
143276324|NCT01153347|516565566|FG002|Overall Study|Study-specific withdrawal criteria|1|||
143276325|NCT01153347|516565567|FG003|Overall Study|Study-specific withdrawal criteria|2|||
143276326|NCT01153347|516565564|FG000|Overall Study|Lost to Follow-up|4|||
143276327|NCT01153347|516565565|FG001|Overall Study|Lost to Follow-up|9|||
143276328|NCT01153347|516565566|FG002|Overall Study|Lost to Follow-up|11|||
143276329|NCT01153347|516565567|FG003|Overall Study|Lost to Follow-up|8|||
143276330|NCT01153347|516565564|FG000|Overall Study|Other|5|||
143276331|NCT01153347|516565565|FG001|Overall Study|Other|5|||
143276332|NCT01153347|516565566|FG002|Overall Study|Other|4|||
143276333|NCT01153347|516565567|FG003|Overall Study|Other|0|||
143276334|NCT01153347|516565564|FG000|Overall Study|Death|1|||
143276335|NCT01153347|516565565|FG001|Overall Study|Death|0|||
143276336|NCT01153347|516565566|FG002|Overall Study|Death|0|||
143276337|NCT01153347|516565567|FG003|Overall Study|Death|0|||
143276338|NCT05096221|516565568|FG000|Part 2|Physician Decision|0|||
143276339|NCT05096221|516565569|FG001|Part 2|Physician Decision|1|||
143276340|NCT04678661|516565570|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
143276341|NCT04678661|516565571|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
143276342|NCT04678661|516565570|FG000|Overall Study|Protocol Violation|2|||
143276343|NCT04678661|516565571|FG001|Overall Study|Protocol Violation|0|||
143276344|NCT04678661|516565570|FG000|Overall Study|Withdrawal by Subject|1|||
143276345|NCT04678661|516565571|FG001|Overall Study|Withdrawal by Subject|0|||
143276346|NCT04678661|516565570|FG000|Overall Study|Lost to Follow-up|2|||
143276347|NCT04678661|516565571|FG001|Overall Study|Lost to Follow-up|0|||
143276348|NCT04678661|516565570|FG000|Overall Study|Death|2|||
143276349|NCT04678661|516565571|FG001|Overall Study|Death|0|||
143276350|NCT01086033|516565572|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
143276351|NCT01086033|516565572|FG000|Overall Study|Lost to Follow-up|86|||
143276352|NCT01086033|516565572|FG000|Overall Study|Adverse Event|42|||
143276353|NCT01086033|516565572|FG000|Overall Study|Withdrawal by Subject|41|||
143276354|NCT01086033|516565572|FG000|Overall Study|Other|14|||
143276355|NCT01086033|516565572|FG000|Overall Study|Other|13|||
143276356|NCT01086033|516565572|FG000|Overall Study|AE and Withdrew Consent|5|||
143276357|NCT01086033|516565572|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
143276358|NCT01086033|516565572|FG000|Overall Study|Withdrew consent and Other Reason|4|||
143276359|NCT01086033|516565572|FG000|Overall Study|AE and Lack of Efficacy|4|||
143276360|NCT01086033|516565572|FG000|Overall Study|Death|1|||
143276361|NCT01086033|516565572|FG000|Overall Study|AE and Lost to Follow-up|1|||
143276362|NCT01086033|516565572|FG000|Overall Study|AE and Other Reason|1|||
143276363|NCT01086033|516565572|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
143276364|NCT04645953|516565573|FG000|Overall Study|Lost to Follow-up|2|||
143276365|NCT04645953|516565574|FG001|Overall Study|Lost to Follow-up|1|||
143276366|NCT04645953|516565575|FG002|Overall Study|Lost to Follow-up|1|||
143276367|NCT04645953|516565573|FG000|Overall Study|Withdrawal by Subject|0|||
143276368|NCT04645953|516565574|FG001|Overall Study|Withdrawal by Subject|1|||
143276369|NCT04645953|516565575|FG002|Overall Study|Withdrawal by Subject|0|||
143276370|NCT04645953|516565573|FG000|Overall Study|Physician Decision|0|||
143276371|NCT04645953|516565574|FG001|Overall Study|Physician Decision|1|||
143276372|NCT04645953|516565575|FG002|Overall Study|Physician Decision|0|||
143276373|NCT04645953|516565573|FG000|Overall Study|Discontinued Prior to Dosing|0|||
143276374|NCT04645953|516565574|FG001|Overall Study|Discontinued Prior to Dosing|0|||
143276375|NCT04645953|516565575|FG002|Overall Study|Discontinued Prior to Dosing|2|||
143276376|NCT00864721|516565576|FG000|Overall Study|Patient request|11|||
143276377|NCT00864721|516565576|FG000|Overall Study|Hospitalized|1|||
143276378|NCT00864721|516565576|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
143276379|NCT00864721|516565576|FG000|Overall Study|Adverse Event|21|||
143276380|NCT01921387|516565579|FG000|Overall Study|Adverse Event|1|||
143276381|NCT03741062|516565580|FG000|Overall Study|Protocol Violation|1|||
143276382|NCT03741062|516565581|FG001|Overall Study|Protocol Violation|0|||
143276383|NCT02763462|516565584|FG000|Overall Study|Protocol Violation|6|||
143276384|NCT00261807|516565585|FG000|Overall Study|Lost to Follow-up|2|||
143276385|NCT00261807|516565585|FG000|Overall Study|Adverse Event|2|||
143276386|NCT00261807|516565585|FG000|Overall Study|Death|1|||
143276387|NCT00261807|516565585|FG000|Overall Study|Protocol Violation|2|||
143276388|NCT01706146|516565586|FG000|Overall Study|Withdrawal by Subject|1|||
143276389|NCT01706146|516565586|FG000|Overall Study|Adverse Event|3|||
143276390|NCT01706146|516565586|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
143276391|NCT00675948|516565587|FG000|Overall Study|Adverse Event|23|||
143276392|NCT00675948|516565588|FG001|Overall Study|Adverse Event|1|||
143276393|NCT00675948|516565587|FG000|Overall Study|Lack of Efficacy|3|||
143276394|NCT00675948|516565588|FG001|Overall Study|Lack of Efficacy|0|||
143276395|NCT00675948|516565587|FG000|Overall Study|Withdrawal by Subject|7|||
143276396|NCT00675948|516565588|FG001|Overall Study|Withdrawal by Subject|0|||
143276397|NCT00675948|516565587|FG000|Overall Study|Lost to Follow-up|2|||
143276398|NCT00675948|516565588|FG001|Overall Study|Lost to Follow-up|0|||
143276399|NCT00675948|516565587|FG000|Overall Study|Protocol Violation|1|||
143276400|NCT00675948|516565588|FG001|Overall Study|Protocol Violation|0|||
143276401|NCT00675948|516565587|FG000|Overall Study|Pain under control|1|||
143276402|NCT00675948|516565588|FG001|Overall Study|Pain under control|0|||
143276403|NCT00675948|516565587|FG000|Overall Study|Sponsor decision|0|||
143276404|NCT00675948|516565588|FG001|Overall Study|Sponsor decision|1|||
143276405|NCT00675948|516565587|FG000|Overall Study|Patient died|1|||
143276406|NCT00675948|516565588|FG001|Overall Study|Patient died|0|||
143276407|NCT00675948|516565587|FG000|Overall Study|Patient unable to comply with diaries|1|||
143372806|NCT01212757|516909647|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
143276408|NCT00675948|516565588|FG001|Overall Study|Patient unable to comply with diaries|0|||
143276409|NCT00675948|516565587|FG000|Overall Study|Patient feels unable to take medication|0|||
143276410|NCT00675948|516565588|FG001|Overall Study|Patient feels unable to take medication|1|||
143276411|NCT00762229|516565589|FG000|Overall Study|Lost to Follow-up|1|||
143372807|NCT01212757|516909648|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
143276412|NCT00762229|516565590|FG001|Overall Study|Lost to Follow-up|1|||
143276413|NCT00762229|516565589|FG000|Overall Study|did not recveive intervention|0|||
143276414|NCT00762229|516565590|FG001|Overall Study|did not recveive intervention|1|||
143276415|NCT01896102|516565591|FG000|Overall Study|Death|1|||
143276416|NCT01896102|516565591|FG000|Overall Study|Participant to receive allogenic transplant|2|||
143276417|NCT01751178|516565592|FG000|Overall Study|Adverse Event|2|||
143276418|NCT01751178|516565593|FG001|Overall Study|Adverse Event|0|||
143276419|NCT01751178|516565594|FG002|Overall Study|Adverse Event|0|||
143276420|NCT01751178|516565592|FG000|Overall Study|Other Reason (unknown)|1|||
143276421|NCT01751178|516565593|FG001|Overall Study|Other Reason (unknown)|0|||
143276422|NCT01751178|516565594|FG002|Overall Study|Other Reason (unknown)|2|||
143276423|NCT01776840|516565599|FG000|Overall Study|Lost to Follow-up|12|||
143276424|NCT01776840|516565600|FG001|Overall Study|Lost to Follow-up|7|||
143276425|NCT01776840|516565599|FG000|Overall Study|Withdrawal by Subject|32|||
143276426|NCT01776840|516565600|FG001|Overall Study|Withdrawal by Subject|48|||
143276427|NCT01776840|516565599|FG000|Overall Study|Sponsor decision|89|||
143276428|NCT01776840|516565600|FG001|Overall Study|Sponsor decision|87|||
143276429|NCT03641339|516565601|FG000|Overall Study|Physician Decision|1|||
143276430|NCT03641339|516565602|FG001|Overall Study|Physician Decision|0|||
143276431|NCT03641339|516565603|FG002|Overall Study|Physician Decision|0|||
143276432|NCT03641339|516565604|FG003|Overall Study|Physician Decision|0|||
143276433|NCT03641339|516565605|FG004|Overall Study|Physician Decision|0|||
143276434|NCT03641339|516565606|FG005|Overall Study|Physician Decision|0|||
143276435|NCT03641339|516565601|FG000|Overall Study|Withdrawal by Subject|0|||
143276436|NCT03641339|516565602|FG001|Overall Study|Withdrawal by Subject|2|||
143276437|NCT03641339|516565603|FG002|Overall Study|Withdrawal by Subject|0|||
143276438|NCT03641339|516565604|FG003|Overall Study|Withdrawal by Subject|2|||
143276439|NCT03641339|516565605|FG004|Overall Study|Withdrawal by Subject|0|||
143276440|NCT03641339|516565606|FG005|Overall Study|Withdrawal by Subject|1|||
143276441|NCT01416272|516565613|FG000|Overall Study|Unacceptable distance visual acuity|2|||
143276442|NCT01416272|516565613|FG000|Overall Study|Lost to Follow-up|1|||
143276443|NCT01416272|516565613|FG000|Overall Study|Study related complaints|1|||
143276444|NCT01719783|516565616|FG000|Dose 2|Physician Decision|1|||
143276445|NCT01719783|516565617|FG001|Dose 2|Physician Decision|0|||
143276446|NCT01350492|516565618|FG000|Intervention|Lost to Follow-up|2|||
143276447|NCT01350492|516565619|FG001|Intervention|Lost to Follow-up|5|||
143276448|NCT01350492|516565618|FG000|Intervention|Withdrawal by Subject|3|||
143276449|NCT01350492|516565619|FG001|Intervention|Withdrawal by Subject|1|||
143276450|NCT01350492|516565618|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
143276451|NCT01350492|516565619|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
143276452|NCT01350492|516565618|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
143276453|NCT01350492|516565619|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
143276454|NCT00205881|516565620|FG000|Overall Study|Withdrawal by Subject|16|||
143276455|NCT00702689|516565621|FG000|Overall Study|Withdrawal by Subject|4|||
143276456|NCT00702689|516565621|FG000|Overall Study|Recurrent malignancy|1|||
143276457|NCT00702689|516565621|FG000|Overall Study|Adverse Event|1|||
143276458|NCT02805972|516565624|FG000|Washout Period|Lost to Follow-up|3|||
143276459|NCT02805972|516565625|FG001|Washout Period|Lost to Follow-up|0|||
143276460|NCT00369824|516565627|FG000|Overall Study|Adverse Event|0|||
143276461|NCT00369824|516565628|FG001|Overall Study|Adverse Event|2|||
143276462|NCT00369824|516565629|FG002|Overall Study|Adverse Event|0|||
143276463|NCT00369824|516565630|FG003|Overall Study|Adverse Event|0|||
143276464|NCT00369824|516565631|FG004|Overall Study|Adverse Event|1|||
143276465|NCT00369824|516565632|FG005|Overall Study|Adverse Event|0|||
143276466|NCT00369824|516565627|FG000|Overall Study|Protocol Violation|0|||
143276467|NCT00369824|516565628|FG001|Overall Study|Protocol Violation|1|||
143276468|NCT00369824|516565629|FG002|Overall Study|Protocol Violation|0|||
143276469|NCT00369824|516565630|FG003|Overall Study|Protocol Violation|1|||
143276470|NCT00369824|516565631|FG004|Overall Study|Protocol Violation|1|||
143276471|NCT00369824|516565632|FG005|Overall Study|Protocol Violation|0|||
143276472|NCT00369824|516565627|FG000|Overall Study|Withdrawal by Subject|9|||
143276473|NCT00369824|516565628|FG001|Overall Study|Withdrawal by Subject|5|||
143276474|NCT00369824|516565629|FG002|Overall Study|Withdrawal by Subject|5|||
143276475|NCT00369824|516565630|FG003|Overall Study|Withdrawal by Subject|4|||
143276476|NCT00369824|516565631|FG004|Overall Study|Withdrawal by Subject|6|||
143276477|NCT00369824|516565632|FG005|Overall Study|Withdrawal by Subject|2|||
143276478|NCT00369824|516565627|FG000|Overall Study|Lost to Follow-up|6|||
143276479|NCT00369824|516565628|FG001|Overall Study|Lost to Follow-up|11|||
143276480|NCT00369824|516565629|FG002|Overall Study|Lost to Follow-up|7|||
143276481|NCT00369824|516565630|FG003|Overall Study|Lost to Follow-up|8|||
143276482|NCT00369824|516565631|FG004|Overall Study|Lost to Follow-up|9|||
143276483|NCT00369824|516565632|FG005|Overall Study|Lost to Follow-up|6|||
143276484|NCT00369824|516565627|FG000|Overall Study|Other|0|||
143276485|NCT00369824|516565628|FG001|Overall Study|Other|0|||
143276486|NCT00369824|516565629|FG002|Overall Study|Other|0|||
143276487|NCT00369824|516565630|FG003|Overall Study|Other|2|||
143276488|NCT00369824|516565631|FG004|Overall Study|Other|1|||
143276489|NCT00369824|516565632|FG005|Overall Study|Other|3|||
143276490|NCT02572401|516565633|FG000|Overall Study|Lost to Follow-up|5|||
143276491|NCT02572401|516565634|FG001|Overall Study|Lost to Follow-up|8|||
143276492|NCT02572401|516565635|FG002|Overall Study|Lost to Follow-up|9|||
143276493|NCT02572401|516565636|FG003|Overall Study|Lost to Follow-up|9|||
143276494|NCT02572401|516565633|FG000|Overall Study|Death|0|||
143276495|NCT02572401|516565634|FG001|Overall Study|Death|0|||
143276496|NCT02572401|516565635|FG002|Overall Study|Death|0|||
143276497|NCT02572401|516565636|FG003|Overall Study|Death|1|||
143276498|NCT00259610|516565638|FG000|Overall Study|Withdrawal by Subject|33|||
143276499|NCT00259610|516565639|FG001|Overall Study|Withdrawal by Subject|25|||
143276500|NCT00259610|516565640|FG002|Overall Study|Withdrawal by Subject|29|||
143276501|NCT00259610|516565641|FG003|Overall Study|Withdrawal by Subject|19|||
143276502|NCT00259610|516565638|FG000|Overall Study|Lost to Follow-up|19|||
143276503|NCT00259610|516565639|FG001|Overall Study|Lost to Follow-up|8|||
143276504|NCT00259610|516565640|FG002|Overall Study|Lost to Follow-up|18|||
143276505|NCT00259610|516565641|FG003|Overall Study|Lost to Follow-up|15|||
143276506|NCT00259610|516565638|FG000|Overall Study|Physician Decision|6|||
143276507|NCT00259610|516565639|FG001|Overall Study|Physician Decision|4|||
143276508|NCT00259610|516565640|FG002|Overall Study|Physician Decision|7|||
143276509|NCT00259610|516565641|FG003|Overall Study|Physician Decision|2|||
143276510|NCT00259610|516565638|FG000|Overall Study|Death|1|||
143276511|NCT00259610|516565639|FG001|Overall Study|Death|1|||
143276512|NCT00259610|516565640|FG002|Overall Study|Death|2|||
143276513|NCT00259610|516565641|FG003|Overall Study|Death|0|||
143276514|NCT00259610|516565638|FG000|Overall Study|non medical reason|6|||
143276515|NCT00259610|516565639|FG001|Overall Study|non medical reason|2|||
143276516|NCT00259610|516565640|FG002|Overall Study|non medical reason|10|||
143276517|NCT00259610|516565641|FG003|Overall Study|non medical reason|3|||
143276518|NCT00259610|516565638|FG000|Overall Study|Adverse Event|3|||
143276519|NCT00259610|516565639|FG001|Overall Study|Adverse Event|4|||
143276520|NCT00259610|516565640|FG002|Overall Study|Adverse Event|5|||
143276521|NCT00259610|516565641|FG003|Overall Study|Adverse Event|2|||
143276522|NCT00259610|516565638|FG000|Overall Study|Serious Adverse Event|8|||
143276523|NCT00259610|516565639|FG001|Overall Study|Serious Adverse Event|2|||
143276524|NCT00259610|516565640|FG002|Overall Study|Serious Adverse Event|2|||
143276525|NCT00259610|516565641|FG003|Overall Study|Serious Adverse Event|2|||
143276526|NCT01611155|516565642|FG000|Overall Study|Adverse Event|1|||
143276527|NCT01611155|516565643|FG001|Overall Study|Adverse Event|1|||
143276528|NCT01611155|516565642|FG000|Overall Study|Refused further treatment|6|||
143276529|NCT01611155|516565643|FG001|Overall Study|Refused further treatment|4|||
143276530|NCT01611155|516565642|FG000|Overall Study|Disease progression|1|||
143276531|NCT01611155|516565643|FG001|Overall Study|Disease progression|0|||
143276532|NCT01611155|516565642|FG000|Overall Study|Withdrawal by Subject|1|||
143276533|NCT01611155|516565643|FG001|Overall Study|Withdrawal by Subject|0|||
143276534|NCT01611155|516565642|FG000|Overall Study|Alternative treatment|0|||
143276535|NCT01611155|516565643|FG001|Overall Study|Alternative treatment|1|||
143276536|NCT01611155|516565642|FG000|Overall Study|Ineligible patient|0|||
143276537|NCT01611155|516565643|FG001|Overall Study|Ineligible patient|1|||
143276538|NCT00190671|516565645|FG000|Overall Study|Satisfactory Response|4|||
143276539|NCT00190671|516565646|FG001|Overall Study|Satisfactory Response|7|||
143276540|NCT00190671|516565645|FG000|Overall Study|Lack of Efficacy|19|||
143276541|NCT00190671|516565646|FG001|Overall Study|Lack of Efficacy|24|||
143276542|NCT00190671|516565645|FG000|Overall Study|Death from Study Disease|1|||
143276543|NCT00190671|516565646|FG001|Overall Study|Death from Study Disease|1|||
143276544|NCT00190671|516565645|FG000|Overall Study|Adverse Event|3|||
143276545|NCT00190671|516565646|FG001|Overall Study|Adverse Event|2|||
143276546|NCT00190671|516565645|FG000|Overall Study|Clinical Relapse|0|||
143276547|NCT00190671|516565646|FG001|Overall Study|Clinical Relapse|1|||
143276548|NCT00190671|516565645|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
143276549|NCT00190671|516565646|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
143276550|NCT00190671|516565645|FG000|Overall Study|Death from Other Causes|0|||
143276551|NCT00190671|516565646|FG001|Overall Study|Death from Other Causes|2|||
143276552|NCT00190671|516565645|FG000|Overall Study|Protocol Violation|0|||
143276553|NCT00190671|516565646|FG001|Overall Study|Protocol Violation|1|||
143276554|NCT00190671|516565645|FG000|Overall Study|Withdrawal by Subject|0|||
143276555|NCT00190671|516565646|FG001|Overall Study|Withdrawal by Subject|2|||
143276556|NCT00087607|516565647|FG000|Overall Study|Adverse Event|14|||
143276557|NCT00087607|516565648|FG001|Overall Study|Adverse Event|24|||
143276558|NCT00087607|516565647|FG000|Overall Study|Death|0|||
143276559|NCT00087607|516565648|FG001|Overall Study|Death|1|||
143276560|NCT00087607|516565647|FG000|Overall Study|Insufficient Therapeutic Response|53|||
143276561|NCT00087607|516565648|FG001|Overall Study|Insufficient Therapeutic Response|42|||
143276562|NCT00087607|516565647|FG000|Overall Study|Failure to return|21|||
143276563|NCT00087607|516565648|FG001|Overall Study|Failure to return|17|||
143276564|NCT00087607|516565647|FG000|Overall Study|Withdrew Consent|12|||
143276565|NCT00087607|516565648|FG001|Overall Study|Withdrew Consent|16|||
143276566|NCT00087607|516565647|FG000|Overall Study|Administrative|12|||
143276567|NCT00087607|516565648|FG001|Overall Study|Administrative|12|||
143276568|NCT00087607|516565647|FG000|Overall Study|Refused Treatment|5|||
143276569|NCT00087607|516565648|FG001|Overall Study|Refused Treatment|7|||
143276570|NCT00087607|516565647|FG000|Overall Study|Other Protocol Violation|5|||
143229316|NCT03062358|516387189|FG000|Overall Study|Withdrawal by Subject|2|||
143229317|NCT03062358|516387190|FG001|Overall Study|Withdrawal by Subject|1|||
143229318|NCT03062358|516387189|FG000|Overall Study|Sponsor Decision|29|||
143229319|NCT03062358|516387190|FG001|Overall Study|Sponsor Decision|7|||
143229320|NCT04750642|516387193|FG000|Overall Study|Adverse Event|1|||
143229321|NCT04750642|516387194|FG001|Overall Study|Adverse Event|0|||
143229322|NCT04750642|516387193|FG000|Overall Study|Withdrawal by Subject|0|||
143229323|NCT04750642|516387194|FG001|Overall Study|Withdrawal by Subject|1|||
143229324|NCT04750642|516387193|FG000|Overall Study|Protocol Violation|0|||
143229325|NCT04750642|516387194|FG001|Overall Study|Protocol Violation|1|||
143229326|NCT00740220|516388579|FG000|Overall Study|screen failures (non-COPD patients)|9|||
143229327|NCT01602224|516388580|FG000|Overall Study|Adverse Event|0|||
143229328|NCT01602224|516388581|FG001|Overall Study|Adverse Event|1|||
143229329|NCT01602224|516388582|FG002|Overall Study|Adverse Event|0|||
143229330|NCT01602224|516388580|FG000|Overall Study|Investigator Decison|1|||
143229331|NCT01602224|516388581|FG001|Overall Study|Investigator Decison|0|||
143229332|NCT01602224|516388582|FG002|Overall Study|Investigator Decison|0|||
143229333|NCT01602224|516388580|FG000|Overall Study|Lost to Follow-up|0|||
143229334|NCT01602224|516388581|FG001|Overall Study|Lost to Follow-up|0|||
143229335|NCT01602224|516388582|FG002|Overall Study|Lost to Follow-up|1|||
143229336|NCT01602224|516388580|FG000|Overall Study|Protocol Violation|0|||
143229337|NCT01602224|516388581|FG001|Overall Study|Protocol Violation|1|||
143229338|NCT01602224|516388582|FG002|Overall Study|Protocol Violation|0|||
143229339|NCT01602224|516388580|FG000|Overall Study|Sponsor Decision|2|||
143229340|NCT01602224|516388581|FG001|Overall Study|Sponsor Decision|3|||
143229341|NCT01602224|516388582|FG002|Overall Study|Sponsor Decision|2|||
143229342|NCT01602224|516388580|FG000|Overall Study|Withdrawal by Subject|5|||
143229343|NCT01602224|516388581|FG001|Overall Study|Withdrawal by Subject|3|||
143229344|NCT01602224|516388582|FG002|Overall Study|Withdrawal by Subject|3|||
143229345|NCT04906499|516388587|FG000|Overall Study|Lack of time|1|||
143229346|NCT01908426|516388590|FG000|Overall Study|Adverse Event|98|||
143229347|NCT01908426|516388591|FG001|Overall Study|Adverse Event|11|||
143229348|NCT01908426|516388590|FG000|Overall Study|Clinical Deterioration|72|||
143229349|NCT01908426|516388591|FG001|Overall Study|Clinical Deterioration|38|||
143229350|NCT01908426|516388590|FG000|Overall Study|Lack of Efficacy|3|||
143229351|NCT01908426|516388591|FG001|Overall Study|Lack of Efficacy|0|||
143229352|NCT01908426|516388590|FG000|Overall Study|Lost to Follow-up|0|||
143229353|NCT01908426|516388591|FG001|Overall Study|Lost to Follow-up|1|||
143229354|NCT01908426|516388590|FG000|Overall Study|Physician Decision|3|||
143229355|NCT01908426|516388591|FG001|Overall Study|Physician Decision|3|||
143229356|NCT01908426|516388590|FG000|Overall Study|Withdrawal by Subject|11|||
143229357|NCT01908426|516388591|FG001|Overall Study|Withdrawal by Subject|6|||
143229358|NCT01908426|516388590|FG000|Overall Study|Progressive Disease|206|||
143229359|NCT01908426|516388591|FG001|Overall Study|Progressive Disease|152|||
143229360|NCT01908426|516388590|FG000|Overall Study|Protocol Violation|1|||
143229361|NCT01908426|516388591|FG001|Overall Study|Protocol Violation|0|||
143229362|NCT01908426|516388590|FG000|Overall Study|No Study Treatment Given|3|||
143229363|NCT01908426|516388591|FG001|Overall Study|No Study Treatment Given|0|||
143229364|NCT03346434|516388592|FG000|Overall Study|Randomized in Error|0|||
143229365|NCT03346434|516388593|FG001|Overall Study|Randomized in Error|0|||
143229366|NCT03346434|516388594|FG002|Overall Study|Randomized in Error|0|||
143229367|NCT03346434|516388595|FG003|Overall Study|Randomized in Error|0|||
143229368|NCT03346434|516388596|FG004|Overall Study|Randomized in Error|1|||
143229369|NCT03346434|516388597|FG005|Overall Study|Randomized in Error|0|||
143229370|NCT03346434|516388592|FG000|Overall Study|Withdrawal by Subject|0|||
143229371|NCT03346434|516388593|FG001|Overall Study|Withdrawal by Subject|0|||
143229372|NCT03346434|516388594|FG002|Overall Study|Withdrawal by Subject|1|||
143229373|NCT03346434|516388595|FG003|Overall Study|Withdrawal by Subject|0|||
143229374|NCT03346434|516388596|FG004|Overall Study|Withdrawal by Subject|1|||
143229375|NCT03346434|516388597|FG005|Overall Study|Withdrawal by Subject|0|||
143229376|NCT03346434|516388592|FG000|Overall Study|Lost to Follow-up|0|||
143229377|NCT03346434|516388593|FG001|Overall Study|Lost to Follow-up|0|||
143229378|NCT03346434|516388594|FG002|Overall Study|Lost to Follow-up|0|||
143229379|NCT03346434|516388595|FG003|Overall Study|Lost to Follow-up|0|||
143229380|NCT03346434|516388596|FG004|Overall Study|Lost to Follow-up|1|||
143229381|NCT03346434|516388597|FG005|Overall Study|Lost to Follow-up|1|||
143229382|NCT03346434|516388592|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
143229383|NCT03346434|516388593|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
143229384|NCT03346434|516388594|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
143229385|NCT03346434|516388595|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
143229386|NCT03346434|516388596|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
143229387|NCT03346434|516388597|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
143229388|NCT03525444|516388598|FG000|Overall Study|Adverse Event|0|||
143229389|NCT03525444|516388599|FG001|Overall Study|Adverse Event|1|||
143229390|NCT03525444|516388598|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
143229391|NCT03525444|516388599|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
143229392|NCT03525444|516388598|FG000|Overall Study|Other|0|||
143229393|NCT03525444|516388599|FG001|Overall Study|Other|1|||
143229394|NCT02973100|516388603|FG000|Overall Study|Adverse Event|1|||
143229395|NCT02973100|516388604|FG001|Overall Study|Adverse Event|2|||
143229396|NCT02973100|516388605|FG002|Overall Study|Adverse Event|1|||
143229397|NCT02973100|516388606|FG003|Overall Study|Adverse Event|2|||
143229398|NCT02973100|516388603|FG000|Overall Study|Lost to Follow-up|3|||
143276571|NCT00087607|516565648|FG001|Overall Study|Other Protocol Violation|2|||
143276572|NCT00087607|516565647|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
143276573|NCT00087607|516565648|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
143276574|NCT04502433|516565649|FG000|Overall Study|Death|2|||
143276575|NCT04502433|516565650|FG001|Overall Study|Death|4|||
143276576|NCT04502433|516565649|FG000|Overall Study|Lost to Follow-up|1|||
143276577|NCT04502433|516565650|FG001|Overall Study|Lost to Follow-up|0|||
143276578|NCT04502433|516565649|FG000|Overall Study|Physician Decision|0|||
143276579|NCT04502433|516565650|FG001|Overall Study|Physician Decision|1|||
143276580|NCT06934993|516565651|FG000|Overall Study|Withdrawal by Subject|29|||
143276581|NCT06934993|516565651|FG000|Overall Study|elevated postoperative creatinine level|11|||
143276582|NCT06934993|516565651|FG000|Overall Study|Death|3|||
143276583|NCT01687998|516567058|FG000|Overall Study|Withdrawal by Subject|49|||
143276584|NCT01687998|516567059|FG001|Overall Study|Withdrawal by Subject|51|||
143276585|NCT01687998|516567058|FG000|Overall Study|Known to be Alive at Study End|54|||
143276586|NCT01687998|516567059|FG001|Overall Study|Known to be Alive at Study End|62|||
143276587|NCT01687998|516567058|FG000|Overall Study|Lost to Follow-up|9|||
143276588|NCT01687998|516567059|FG001|Overall Study|Lost to Follow-up|7|||
143276589|NCT01871532|516567061|FG000|Overall Study|Withdrawal by Subject|1|||
143276590|NCT01871532|516567062|FG001|Overall Study|Withdrawal by Subject|2|||
143276591|NCT01709513|516567063|FG000|Overall Study|Randomized but not treated|0|||
143276592|NCT01709513|516567064|FG001|Overall Study|Randomized but not treated|1|||
143276593|NCT01709513|516567065|FG002|Overall Study|Randomized but not treated|0|||
143276594|NCT01709513|516567063|FG000|Overall Study|Adverse Event|16|||
143276595|NCT01709513|516567064|FG001|Overall Study|Adverse Event|31|||
143276596|NCT01709513|516567065|FG002|Overall Study|Adverse Event|23|||
143276597|NCT01709513|516567063|FG000|Overall Study|Poor compliance to protocol|2|||
143276598|NCT01709513|516567064|FG001|Overall Study|Poor compliance to protocol|0|||
143276599|NCT01709513|516567065|FG002|Overall Study|Poor compliance to protocol|0|||
143276600|NCT01709513|516567063|FG000|Overall Study|Other|3|||
143276601|NCT01709513|516567064|FG001|Overall Study|Other|11|||
143276602|NCT01709513|516567065|FG002|Overall Study|Other|7|||
143276603|NCT00726986|516567066|FG000|Induction Phase|Adverse Event|4|||
143276604|NCT00726986|516567066|FG000|Induction Phase|Withdrawal by Subject|2|||
143276605|NCT00726986|516567066|FG000|Induction Phase|Death|2|||
143276606|NCT00726986|516567066|FG000|Induction Phase|Lack of Efficacy|5|||
143276607|NCT00726986|516567066|FG000|Induction Phase|Secondary Disease|2|||
143276608|NCT00726986|516567066|FG000|Maintenance Phase|Adverse Event|1|||
143276609|NCT00726986|516567066|FG000|Maintenance Phase|Lack of Efficacy|2|||
143276610|NCT01434667|516567072|FG000|Overall Study|Lost to Follow-up|5|||
143276611|NCT01434667|516567073|FG001|Overall Study|Lost to Follow-up|10|||
143276612|NCT02582983|516567077|FG000|Overall Study|Death|3|||
143276613|NCT02582983|516567077|FG000|Overall Study|Withdrawal by Subject|2|||
143276614|NCT02582983|516567077|FG000|Overall Study|Adverse Event|1|||
143276615|NCT02527161|516567078|FG000|Overall Study|Failed MRI|52|||
143276616|NCT02527161|516567078|FG000|Overall Study|Withdrawal by Subject|19|||
143276617|NCT02527161|516567078|FG000|Overall Study|Delay in or unfit for surgery|16|||
143276618|NCT02527161|516567078|FG000|Overall Study|MRI contraindication|6|||
143276619|NCT02527161|516567078|FG000|Overall Study|Consent violation|4|||
143276620|NCT02527161|516567078|FG000|Overall Study|Only Recruited to Part A|27|||
143276621|NCT02527161|516567078|FG000|Overall Study|Physician Decision|1|||
143276622|NCT02527161|516567078|FG000|Overall Study|Adverse Event|1|||
143276623|NCT02527161|516567078|FG000|Overall Study|Lost to Follow-up|6|||
143276624|NCT02100514|516567079|FG000|Treatment Period|Adverse Event|0|||
143276625|NCT02100514|516567080|FG001|Treatment Period|Adverse Event|5|||
143276626|NCT02100514|516567081|FG002|Treatment Period|Adverse Event|0|||
143276627|NCT02100514|516567082|FG003|Treatment Period|Adverse Event|0|||
143276628|NCT02100514|516567083|FG004|Treatment Period|Adverse Event|0|||
143276629|NCT02100514|516567079|FG000|Treatment Period|Death|2|||
143276630|NCT02100514|516567080|FG001|Treatment Period|Death|2|||
143276631|NCT02100514|516567081|FG002|Treatment Period|Death|0|||
143276632|NCT02100514|516567082|FG003|Treatment Period|Death|0|||
143276633|NCT02100514|516567083|FG004|Treatment Period|Death|0|||
143276634|NCT02100514|516567079|FG000|Treatment Period|Lost to Follow-up|5|||
143276635|NCT02100514|516567080|FG001|Treatment Period|Lost to Follow-up|17|||
143276636|NCT02100514|516567081|FG002|Treatment Period|Lost to Follow-up|0|||
143276637|NCT02100514|516567082|FG003|Treatment Period|Lost to Follow-up|0|||
143276638|NCT02100514|516567083|FG004|Treatment Period|Lost to Follow-up|0|||
143276639|NCT02100514|516567079|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
143276640|NCT02100514|516567080|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
143276641|NCT02100514|516567081|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
143276642|NCT02100514|516567082|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
143276643|NCT02100514|516567083|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
143276644|NCT02100514|516567079|FG000|Treatment Period|Protocol Violation|1|||
143276645|NCT02100514|516567080|FG001|Treatment Period|Protocol Violation|1|||
143276646|NCT02100514|516567081|FG002|Treatment Period|Protocol Violation|0|||
143276647|NCT02100514|516567082|FG003|Treatment Period|Protocol Violation|0|||
143276648|NCT02100514|516567083|FG004|Treatment Period|Protocol Violation|0|||
143276649|NCT02100514|516567079|FG000|Treatment Period|Withdrawal by Subject|12|||
143276650|NCT02100514|516567080|FG001|Treatment Period|Withdrawal by Subject|37|||
143276651|NCT02100514|516567081|FG002|Treatment Period|Withdrawal by Subject|0|||
143276652|NCT02100514|516567082|FG003|Treatment Period|Withdrawal by Subject|0|||
143276653|NCT02100514|516567083|FG004|Treatment Period|Withdrawal by Subject|0|||
143276654|NCT02100514|516567079|FG000|Treatment Period|Other|9|||
143276655|NCT02100514|516567080|FG001|Treatment Period|Other|11|||
143276656|NCT02100514|516567081|FG002|Treatment Period|Other|0|||
143276657|NCT02100514|516567082|FG003|Treatment Period|Other|0|||
143276658|NCT02100514|516567083|FG004|Treatment Period|Other|0|||
143276659|NCT02100514|516567079|FG000|Extension Period|Withdrew consent|0|||
143276660|NCT02100514|516567080|FG001|Extension Period|Withdrew consent|0|||
143276661|NCT02100514|516567081|FG002|Extension Period|Withdrew consent|2|||
143276662|NCT02100514|516567082|FG003|Extension Period|Withdrew consent|0|||
143276663|NCT02100514|516567083|FG004|Extension Period|Withdrew consent|0|||
143276664|NCT01081678|516567096|FG000|Overall Study|Ineligibility Determined|0|||
143276665|NCT01081678|516567097|FG001|Overall Study|Ineligibility Determined|0|||
143276666|NCT01081678|516567098|FG002|Overall Study|Ineligibility Determined|1|||
143276667|NCT01081678|516567099|FG003|Overall Study|Ineligibility Determined|1|||
143276668|NCT01081678|516567096|FG000|Overall Study|Noncompliance|3|||
143276669|NCT01081678|516567097|FG001|Overall Study|Noncompliance|4|||
143276670|NCT01081678|516567098|FG002|Overall Study|Noncompliance|5|||
143276671|NCT01081678|516567099|FG003|Overall Study|Noncompliance|2|||
143276672|NCT01081678|516567096|FG000|Overall Study|Adverse Event|2|||
143276673|NCT01081678|516567097|FG001|Overall Study|Adverse Event|1|||
143276674|NCT01081678|516567098|FG002|Overall Study|Adverse Event|2|||
143276675|NCT01081678|516567099|FG003|Overall Study|Adverse Event|2|||
143276676|NCT01081678|516567096|FG000|Overall Study|Withdrawal by Subject|15|||
143276677|NCT01081678|516567097|FG001|Overall Study|Withdrawal by Subject|7|||
143276678|NCT01081678|516567098|FG002|Overall Study|Withdrawal by Subject|17|||
143276679|NCT01081678|516567099|FG003|Overall Study|Withdrawal by Subject|14|||
143372808|NCT01212757|516909649|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
143276680|NCT01081678|516567096|FG000|Overall Study|Administrative Decision|1|||
143276681|NCT01081678|516567097|FG001|Overall Study|Administrative Decision|0|||
143276682|NCT01081678|516567098|FG002|Overall Study|Administrative Decision|0|||
143276683|NCT01081678|516567099|FG003|Overall Study|Administrative Decision|1|||
143276684|NCT01081678|516567096|FG000|Overall Study|Lost to Follow-up|4|||
143276685|NCT01081678|516567097|FG001|Overall Study|Lost to Follow-up|1|||
143276686|NCT01081678|516567098|FG002|Overall Study|Lost to Follow-up|4|||
143276687|NCT01081678|516567099|FG003|Overall Study|Lost to Follow-up|3|||
143276688|NCT01081678|516567096|FG000|Overall Study|Death|2|||
143276689|NCT01081678|516567097|FG001|Overall Study|Death|2|||
143276690|NCT01081678|516567098|FG002|Overall Study|Death|2|||
143276691|NCT01081678|516567099|FG003|Overall Study|Death|6|||
143276692|NCT01081678|516567096|FG000|Overall Study|Other|0|||
143276693|NCT01081678|516567097|FG001|Overall Study|Other|1|||
143276694|NCT01081678|516567098|FG002|Overall Study|Other|0|||
143276695|NCT01081678|516567099|FG003|Overall Study|Other|0|||
143276696|NCT01281865|516567104|FG000|Overall Study|Adverse Event|1|||
143276697|NCT01281865|516567105|FG001|Overall Study|Adverse Event|1|||
143276698|NCT01281865|516567104|FG000|Overall Study|Withdrawal by Subject|1|||
143276699|NCT01281865|516567105|FG001|Overall Study|Withdrawal by Subject|0|||
143276700|NCT01281865|516567104|FG000|Overall Study|Lack of Efficacy|1|||
143276701|NCT01281865|516567105|FG001|Overall Study|Lack of Efficacy|0|||
143276702|NCT02747875|516567106|FG000|Overall Study|Physician Decision|1|||
143276703|NCT02747875|516567107|FG001|Overall Study|Physician Decision|0|||
143276704|NCT02747875|516567106|FG000|Overall Study|Adverse Event|0|||
143372809|NCT01212757|516909650|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
143372810|NCT01212757|516909651|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
143372811|NCT01212757|516909643|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
143372812|NCT01212757|516909644|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
143372813|NCT01212757|516909645|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
143372814|NCT01212757|516909646|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
143372815|NCT01212757|516909647|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
143276705|NCT02747875|516567107|FG001|Overall Study|Adverse Event|1|||
143276706|NCT03758066|516567108|FG000|Overall Study|Lost to Follow-up|14|||
143276707|NCT03478657|516567109|FG000|Overall Study|Withdrawal by Subject|0|||
143276708|NCT03478657|516567110|FG001|Overall Study|Withdrawal by Subject|1|||
143276709|NCT02590003|516567111|FG000|Overall Study|Death|1|||
143372816|NCT01212757|516909648|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
143372817|NCT01212757|516909649|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
143276710|NCT02590003|516567112|FG001|Overall Study|Death|2|||
143276711|NCT01786668|516567113|FG000|Overall Study|Adverse Event|0|||
143276712|NCT01786668|516567114|FG001|Overall Study|Adverse Event|1|||
143276713|NCT01786668|516567115|FG002|Overall Study|Adverse Event|1|||
143276714|NCT01786668|516567116|FG003|Overall Study|Adverse Event|2|||
143276715|NCT01786668|516567113|FG000|Overall Study|Withdrawal by Subject|0|||
143276716|NCT01786668|516567114|FG001|Overall Study|Withdrawal by Subject|0|||
143276717|NCT01786668|516567115|FG002|Overall Study|Withdrawal by Subject|3|||
143276718|NCT01786668|516567116|FG003|Overall Study|Withdrawal by Subject|1|||
143276719|NCT01786668|516567113|FG000|Overall Study|Pregnancy|0|||
143276720|NCT01786668|516567114|FG001|Overall Study|Pregnancy|0|||
143276721|NCT01786668|516567115|FG002|Overall Study|Pregnancy|0|||
143276722|NCT01786668|516567116|FG003|Overall Study|Pregnancy|1|||
143276723|NCT01786668|516567113|FG000|Overall Study|Lost to Follow-up|1|||
143276724|NCT01786668|516567114|FG001|Overall Study|Lost to Follow-up|0|||
143276725|NCT01786668|516567115|FG002|Overall Study|Lost to Follow-up|1|||
143276726|NCT01786668|516567116|FG003|Overall Study|Lost to Follow-up|0|||
143276727|NCT03570697|516567117|FG000|Overall Study|Lost to Follow-up|0|||
143276728|NCT03570697|516567118|FG001|Overall Study|Lost to Follow-up|1|||
143276729|NCT03570697|516567117|FG000|Overall Study|Death|2|||
143276730|NCT03570697|516567118|FG001|Overall Study|Death|0|||
143276731|NCT03570697|516567117|FG000|Overall Study|Withdrawal by Subject|4|||
143276732|NCT03570697|516567118|FG001|Overall Study|Withdrawal by Subject|2|||
143276733|NCT01849783|516567119|FG000|Overall Study|Adverse Event|5|||
143276734|NCT01849783|516567119|FG000|Overall Study|Death|2|||
143276735|NCT01849783|516567119|FG000|Overall Study|Physician Decision|1|||
143276736|NCT01849783|516567119|FG000|Overall Study|Withdrawal by Subject|1|||
143276737|NCT01849783|516567119|FG000|Overall Study|Unable to comply|2|||
143276738|NCT01849783|516567119|FG000|Overall Study|Disease progression|11|||
143276739|NCT03948581|516567120|FG000|Overall Study|Lost to Follow-up|0|||
143276740|NCT03948581|516567121|FG001|Overall Study|Lost to Follow-up|1|||
143276741|NCT03068455|516567124|FG000|Pre-treatment Period|Disease progression|0|||
143276742|NCT03068455|516567125|FG001|Pre-treatment Period|Disease progression|1|||
143276743|NCT03068455|516567124|FG000|Pre-treatment Period|Participant withdrew consent|1|||
143276744|NCT03068455|516567125|FG001|Pre-treatment Period|Participant withdrew consent|1|||
143276745|NCT03068455|516567124|FG000|Pre-treatment Period|Poor/non-compliance|0|||
143276746|NCT03068455|516567125|FG001|Pre-treatment Period|Poor/non-compliance|1|||
143276747|NCT03068455|516567124|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
143276748|NCT03068455|516567125|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
143276749|NCT03068455|516567124|FG000|Pre-treatment Period|Not reported|2|||
143276750|NCT03068455|516567125|FG001|Pre-treatment Period|Not reported|1|||
143276751|NCT03068455|516567124|FG000|Treatment Period|Disease progression|166|||
143276752|NCT03068455|516567125|FG001|Treatment Period|Disease progression|208|||
143276753|NCT03068455|516567124|FG000|Treatment Period|Study drug toxicity|317|||
143276754|NCT03068455|516567125|FG001|Treatment Period|Study drug toxicity|104|||
143276755|NCT03068455|516567124|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
143276756|NCT03068455|516567125|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
143276757|NCT03068455|516567124|FG000|Treatment Period|Participant request to stop therapy|33|||
143276758|NCT03068455|516567125|FG001|Treatment Period|Participant request to stop therapy|20|||
143276759|NCT03068455|516567124|FG000|Treatment Period|Participant withdrew consent|5|||
143276760|NCT03068455|516567125|FG001|Treatment Period|Participant withdrew consent|10|||
143276761|NCT03068455|516567124|FG000|Treatment Period|Poor/non-compliance|3|||
143276762|NCT03068455|516567125|FG001|Treatment Period|Poor/non-compliance|0|||
143276763|NCT03068455|516567124|FG000|Treatment Period|Participant no longer meets study criteria|1|||
143276764|NCT03068455|516567125|FG001|Treatment Period|Participant no longer meets study criteria|3|||
143276765|NCT03068455|516567124|FG000|Treatment Period|Other reasons|12|||
143276766|NCT03068455|516567125|FG001|Treatment Period|Other reasons|4|||
143276767|NCT01876420|516567127|FG000|Overall Study|Missed 30 day visit|1|||
143276768|NCT03173313|516567128|FG000|Overall Study|Lost to Follow-up|2|||
143276769|NCT03173313|516567129|FG001|Overall Study|Lost to Follow-up|3|||
143276770|NCT03173313|516567128|FG000|Overall Study|Withdrawal by Subject|0|||
143276771|NCT03173313|516567129|FG001|Overall Study|Withdrawal by Subject|1|||
143276772|NCT03173313|516567128|FG000|Overall Study|Death|5|||
143276773|NCT03173313|516567129|FG001|Overall Study|Death|0|||
143276774|NCT03173313|516567128|FG000|Overall Study|Physician Decision|1|||
143276775|NCT03173313|516567129|FG001|Overall Study|Physician Decision|0|||
143276776|NCT03173313|516567128|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
143276777|NCT03173313|516567129|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
143276778|NCT03173313|516567128|FG000|Overall Study|Bone Fracture|1|||
143276779|NCT03173313|516567129|FG001|Overall Study|Bone Fracture|0|||
143276780|NCT05338216|516567132|FG000|Overall Study|Withdrawal by Subject|1|||
143276781|NCT05338216|516567133|FG001|Overall Study|Withdrawal by Subject|1|||
143276782|NCT04457336|516567134|FG000|Period 2: Part A|Withdrawal by Subject|0|||
143276783|NCT04457336|516567135|FG001|Period 2: Part A|Withdrawal by Subject|1|||
143276784|NCT04457336|516567136|FG002|Period 2: Part A|Withdrawal by Subject|1|||
143276785|NCT04457336|516567137|FG003|Period 2: Part A|Withdrawal by Subject|1|||
143276786|NCT04457336|516567138|FG004|Period 2: Part A|Withdrawal by Subject|0|||
143276787|NCT04457336|516567139|FG005|Period 2: Part A|Withdrawal by Subject|0|||
143276788|NCT04457336|516567140|FG006|Period 2: Part A|Withdrawal by Subject|0|||
143276789|NCT04457336|516567141|FG007|Period 2: Part A|Withdrawal by Subject|0|||
143276790|NCT04457336|516567134|FG000|Period 2: Part A|Adverse Event|0|||
143276791|NCT04457336|516567135|FG001|Period 2: Part A|Adverse Event|0|||
143276792|NCT04457336|516567136|FG002|Period 2: Part A|Adverse Event|1|||
143276793|NCT04457336|516567137|FG003|Period 2: Part A|Adverse Event|1|||
143276794|NCT04457336|516567138|FG004|Period 2: Part A|Adverse Event|0|||
143276795|NCT04457336|516567139|FG005|Period 2: Part A|Adverse Event|0|||
143372818|NCT01212757|516909650|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
143372819|NCT01212757|516909651|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
143372820|NCT01212757|516909643|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
143372821|NCT01212757|516909644|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
143372822|NCT01212757|516909645|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
143276796|NCT04457336|516567140|FG006|Period 2: Part A|Adverse Event|0|||
143276797|NCT04457336|516567141|FG007|Period 2: Part A|Adverse Event|0|||
143276798|NCT04457336|516567134|FG000|Period 2: Part A|Study Terminated|0|||
143276799|NCT04457336|516567135|FG001|Period 2: Part A|Study Terminated|0|||
143276800|NCT04457336|516567136|FG002|Period 2: Part A|Study Terminated|1|||
143276801|NCT04457336|516567137|FG003|Period 2: Part A|Study Terminated|0|||
143276802|NCT04457336|516567138|FG004|Period 2: Part A|Study Terminated|0|||
143276803|NCT04457336|516567139|FG005|Period 2: Part A|Study Terminated|0|||
143276804|NCT04457336|516567140|FG006|Period 2: Part A|Study Terminated|0|||
143276805|NCT04457336|516567141|FG007|Period 2: Part A|Study Terminated|0|||
143276806|NCT04457336|516567134|FG000|Period 2: Part A|Protocol Violation|0|||
143276807|NCT04457336|516567135|FG001|Period 2: Part A|Protocol Violation|1|||
143276808|NCT04457336|516567136|FG002|Period 2: Part A|Protocol Violation|0|||
143276809|NCT04457336|516567137|FG003|Period 2: Part A|Protocol Violation|0|||
143276810|NCT04457336|516567138|FG004|Period 2: Part A|Protocol Violation|0|||
143276811|NCT04457336|516567139|FG005|Period 2: Part A|Protocol Violation|0|||
143276812|NCT04457336|516567140|FG006|Period 2: Part A|Protocol Violation|0|||
143276813|NCT04457336|516567141|FG007|Period 2: Part A|Protocol Violation|0|||
143276814|NCT04457336|516567134|FG000|Period 2: Part A|Lost to Follow-up|0|||
143276815|NCT04457336|516567135|FG001|Period 2: Part A|Lost to Follow-up|1|||
143276816|NCT04457336|516567136|FG002|Period 2: Part A|Lost to Follow-up|0|||
143276817|NCT04457336|516567137|FG003|Period 2: Part A|Lost to Follow-up|0|||
143276818|NCT04457336|516567138|FG004|Period 2: Part A|Lost to Follow-up|0|||
143276819|NCT04457336|516567139|FG005|Period 2: Part A|Lost to Follow-up|0|||
143276820|NCT04457336|516567140|FG006|Period 2: Part A|Lost to Follow-up|0|||
143276821|NCT04457336|516567141|FG007|Period 2: Part A|Lost to Follow-up|0|||
143276822|NCT04457336|516567134|FG000|Period 2: Part A|Other|0|||
143276823|NCT04457336|516567135|FG001|Period 2: Part A|Other|1|||
143276824|NCT04457336|516567136|FG002|Period 2: Part A|Other|0|||
143276825|NCT04457336|516567137|FG003|Period 2: Part A|Other|0|||
143276826|NCT04457336|516567138|FG004|Period 2: Part A|Other|0|||
143276827|NCT04457336|516567139|FG005|Period 2: Part A|Other|0|||
143276828|NCT04457336|516567140|FG006|Period 2: Part A|Other|0|||
143276829|NCT04457336|516567141|FG007|Period 2: Part A|Other|0|||
143276830|NCT04457336|516567134|FG000|Period 2: Part A|Physician Decision|0|||
143276831|NCT04457336|516567135|FG001|Period 2: Part A|Physician Decision|0|||
143276832|NCT04457336|516567136|FG002|Period 2: Part A|Physician Decision|0|||
143276833|NCT04457336|516567137|FG003|Period 2: Part A|Physician Decision|1|||
143276834|NCT04457336|516567138|FG004|Period 2: Part A|Physician Decision|0|||
143276835|NCT04457336|516567139|FG005|Period 2: Part A|Physician Decision|0|||
143276836|NCT04457336|516567140|FG006|Period 2: Part A|Physician Decision|0|||
143276837|NCT04457336|516567141|FG007|Period 2: Part A|Physician Decision|0|||
143276838|NCT04457336|516567134|FG000|Period 3: Part B|Study Terminated|0|||
143276839|NCT04457336|516567135|FG001|Period 3: Part B|Study Terminated|0|||
143276840|NCT04457336|516567136|FG002|Period 3: Part B|Study Terminated|0|||
143276841|NCT04457336|516567137|FG003|Period 3: Part B|Study Terminated|0|||
143276842|NCT04457336|516567138|FG004|Period 3: Part B|Study Terminated|1|||
143276843|NCT04457336|516567139|FG005|Period 3: Part B|Study Terminated|10|||
143276844|NCT04457336|516567140|FG006|Period 3: Part B|Study Terminated|13|||
143276845|NCT04457336|516567141|FG007|Period 3: Part B|Study Terminated|0|||
143276846|NCT04457336|516567134|FG000|Period 3: Part B|Withdrawal by Subject|0|||
143276847|NCT04457336|516567135|FG001|Period 3: Part B|Withdrawal by Subject|0|||
143276848|NCT04457336|516567136|FG002|Period 3: Part B|Withdrawal by Subject|0|||
143276849|NCT04457336|516567137|FG003|Period 3: Part B|Withdrawal by Subject|0|||
143276850|NCT04457336|516567138|FG004|Period 3: Part B|Withdrawal by Subject|0|||
143372823|NCT01212757|516909646|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
143276851|NCT04457336|516567139|FG005|Period 3: Part B|Withdrawal by Subject|1|||
143276852|NCT04457336|516567140|FG006|Period 3: Part B|Withdrawal by Subject|2|||
143276853|NCT04457336|516567141|FG007|Period 3: Part B|Withdrawal by Subject|0|||
143276854|NCT04457336|516567134|FG000|Period 4: Part C|Study Terminated|0|||
143276855|NCT04457336|516567135|FG001|Period 4: Part C|Study Terminated|0|||
143276856|NCT04457336|516567136|FG002|Period 4: Part C|Study Terminated|0|||
143276857|NCT04457336|516567137|FG003|Period 4: Part C|Study Terminated|0|||
143276858|NCT04457336|516567138|FG004|Period 4: Part C|Study Terminated|0|||
143276859|NCT04457336|516567139|FG005|Period 4: Part C|Study Terminated|0|||
143276860|NCT04457336|516567140|FG006|Period 4: Part C|Study Terminated|0|||
143276861|NCT04457336|516567141|FG007|Period 4: Part C|Study Terminated|30|||
143276862|NCT04457336|516567134|FG000|Period 4: Part C|Adverse Event|0|||
143276863|NCT04457336|516567135|FG001|Period 4: Part C|Adverse Event|0|||
143276864|NCT04457336|516567136|FG002|Period 4: Part C|Adverse Event|0|||
143276865|NCT04457336|516567137|FG003|Period 4: Part C|Adverse Event|0|||
143276866|NCT04457336|516567138|FG004|Period 4: Part C|Adverse Event|0|||
143276867|NCT04457336|516567139|FG005|Period 4: Part C|Adverse Event|0|||
143276868|NCT04457336|516567140|FG006|Period 4: Part C|Adverse Event|0|||
143276869|NCT04457336|516567141|FG007|Period 4: Part C|Adverse Event|2|||
143276870|NCT04457336|516567134|FG000|Period 4: Part C|Site Terminated|0|||
143276871|NCT04457336|516567135|FG001|Period 4: Part C|Site Terminated|0|||
143276872|NCT04457336|516567136|FG002|Period 4: Part C|Site Terminated|0|||
143276873|NCT04457336|516567137|FG003|Period 4: Part C|Site Terminated|0|||
143276874|NCT04457336|516567138|FG004|Period 4: Part C|Site Terminated|0|||
143276875|NCT04457336|516567139|FG005|Period 4: Part C|Site Terminated|0|||
143276876|NCT04457336|516567140|FG006|Period 4: Part C|Site Terminated|0|||
143276877|NCT04457336|516567141|FG007|Period 4: Part C|Site Terminated|1|||
143276878|NCT04457336|516567134|FG000|Period 4: Part C|Other|0|||
143276879|NCT04457336|516567135|FG001|Period 4: Part C|Other|0|||
143276880|NCT04457336|516567136|FG002|Period 4: Part C|Other|0|||
143276881|NCT04457336|516567137|FG003|Period 4: Part C|Other|0|||
143276882|NCT04457336|516567138|FG004|Period 4: Part C|Other|0|||
143276883|NCT04457336|516567139|FG005|Period 4: Part C|Other|0|||
143276884|NCT04457336|516567140|FG006|Period 4: Part C|Other|0|||
143276885|NCT04457336|516567141|FG007|Period 4: Part C|Other|2|||
143276886|NCT04457336|516567134|FG000|Period 4: Part C|Withdrawal by Subject|0|||
143276887|NCT04457336|516567135|FG001|Period 4: Part C|Withdrawal by Subject|0|||
143276888|NCT04457336|516567136|FG002|Period 4: Part C|Withdrawal by Subject|0|||
143276889|NCT04457336|516567137|FG003|Period 4: Part C|Withdrawal by Subject|0|||
143276890|NCT04457336|516567138|FG004|Period 4: Part C|Withdrawal by Subject|0|||
143276891|NCT04457336|516567139|FG005|Period 4: Part C|Withdrawal by Subject|0|||
143276892|NCT04457336|516567140|FG006|Period 4: Part C|Withdrawal by Subject|0|||
143276893|NCT04457336|516567141|FG007|Period 4: Part C|Withdrawal by Subject|3|||
143276894|NCT03330288|516567148|FG000|Overall Study|Other reason|1|||
143276895|NCT03330288|516567149|FG001|Overall Study|Other reason|1|||
143276896|NCT03330288|516567148|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
143276897|NCT03330288|516567149|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
143276898|NCT03330288|516567148|FG000|Overall Study|Adverse Event|1|||
143276899|NCT03330288|516567149|FG001|Overall Study|Adverse Event|0|||
143276900|NCT03330288|516567148|FG000|Overall Study|Withdrawal by Subject|1|||
143276901|NCT03330288|516567149|FG001|Overall Study|Withdrawal by Subject|0|||
143276902|NCT03330288|516567148|FG000|Overall Study|Lost to Follow-up|26|||
143276903|NCT03330288|516567149|FG001|Overall Study|Lost to Follow-up|7|||
143276904|NCT01042678|516567150|FG000|Overall Study|Physician Decision|1|||
143276905|NCT01042678|516567151|FG001|Overall Study|Physician Decision|0|||
143276906|NCT01042678|516567152|FG002|Overall Study|Physician Decision|0|||
143276907|NCT01042678|516567153|FG003|Overall Study|Physician Decision|0|||
143276908|NCT01042678|516567154|FG004|Overall Study|Physician Decision|0|||
143276909|NCT01042678|516567155|FG005|Overall Study|Physician Decision|0|||
143276910|NCT00415168|516567161|FG000|Overall Study|Death|26|||
143276911|NCT00415168|516567161|FG000|Overall Study|Lost to Follow-up|3|||
143276912|NCT00415168|516567161|FG000|Overall Study|Physician Decision|13|||
143276913|NCT00415168|516567161|FG000|Overall Study|Sponsor Decision|4|||
143276914|NCT00415168|516567161|FG000|Overall Study|Withdrawal by Subject|6|||
143276915|NCT01548287|516567164|FG000|Screening|No reason provided|0|||
143276916|NCT01548287|516567165|FG001|Screening|No reason provided|0|||
143276917|NCT01548287|516567166|FG002|Screening|No reason provided|0|||
143276918|NCT01548287|516567167|FG003|Screening|No reason provided|0|||
143276919|NCT01548287|516567168|FG004|Screening|No reason provided|9|||
143276920|NCT01548287|516567164|FG000|Screening|Did not meet eligibility criteria|0|||
143276921|NCT01548287|516567165|FG001|Screening|Did not meet eligibility criteria|0|||
143276922|NCT01548287|516567166|FG002|Screening|Did not meet eligibility criteria|0|||
143276923|NCT01548287|516567167|FG003|Screening|Did not meet eligibility criteria|0|||
143276924|NCT01548287|516567168|FG004|Screening|Did not meet eligibility criteria|74|||
143276925|NCT01548287|516567164|FG000|Randomized Period|Did not meet inclusion criteria|0|||
143276926|NCT01548287|516567165|FG001|Randomized Period|Did not meet inclusion criteria|0|||
143276927|NCT01548287|516567166|FG002|Randomized Period|Did not meet inclusion criteria|2|||
143276928|NCT01548287|516567167|FG003|Randomized Period|Did not meet inclusion criteria|0|||
143276929|NCT01548287|516567168|FG004|Randomized Period|Did not meet inclusion criteria|0|||
143276930|NCT01548287|516567164|FG000|Randomized Period|Adverse Event|0|||
143276931|NCT01548287|516567165|FG001|Randomized Period|Adverse Event|2|||
143276932|NCT01548287|516567166|FG002|Randomized Period|Adverse Event|5|||
143276933|NCT01548287|516567167|FG003|Randomized Period|Adverse Event|0|||
143276934|NCT01548287|516567168|FG004|Randomized Period|Adverse Event|0|||
143276935|NCT02762578|516567169|FG000|Overall Study|Adverse Event|1|||
143276936|NCT02762578|516567170|FG001|Overall Study|Adverse Event|6|||
143276937|NCT02762578|516567169|FG000|Overall Study|Protocol Violation|4|||
143276938|NCT02762578|516567170|FG001|Overall Study|Protocol Violation|2|||
143276939|NCT02762578|516567169|FG000|Overall Study|Withdrawal by Subject|4|||
143276940|NCT02762578|516567170|FG001|Overall Study|Withdrawal by Subject|2|||
143276941|NCT02762578|516567169|FG000|Overall Study|Unclassified|6|||
143276942|NCT02762578|516567170|FG001|Overall Study|Unclassified|0|||
143276943|NCT01090492|516567173|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
143276944|NCT01090492|516567174|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
143276945|NCT01090492|516567175|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
143276946|NCT01090492|516567176|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
143276947|NCT01090492|516567177|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
143276948|NCT01090492|516567178|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
143276949|NCT01090492|516567179|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
143276950|NCT01090492|516567180|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
143276951|NCT01090492|516567173|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
143276952|NCT01090492|516567174|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
143276953|NCT01090492|516567175|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
143276954|NCT01090492|516567176|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
143276955|NCT01090492|516567177|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
143276956|NCT01090492|516567178|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
143276957|NCT01090492|516567179|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
143276958|NCT01090492|516567180|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
143276959|NCT01090492|516567173|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
143276960|NCT01090492|516567174|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
143276961|NCT01090492|516567175|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
143276962|NCT01090492|516567176|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
143276963|NCT01090492|516567177|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
143276964|NCT01090492|516567178|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
143276965|NCT01090492|516567179|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
143276966|NCT01090492|516567180|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
143276967|NCT01090492|516567173|FG000|First Intervention Period (4 Weeks)|Other|0|||
143276968|NCT01090492|516567174|FG001|First Intervention Period (4 Weeks)|Other|0|||
143276969|NCT01090492|516567175|FG002|First Intervention Period (4 Weeks)|Other|1|||
143276970|NCT01090492|516567176|FG003|First Intervention Period (4 Weeks)|Other|1|||
143276971|NCT01090492|516567177|FG004|First Intervention Period (4 Weeks)|Other|2|||
143276972|NCT01090492|516567178|FG005|First Intervention Period (4 Weeks)|Other|0|||
143276973|NCT01090492|516567179|FG006|First Intervention Period (4 Weeks)|Other|0|||
143276974|NCT01090492|516567180|FG007|First Intervention Period (4 Weeks)|Other|0|||
143276975|NCT01090492|516567173|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
143276976|NCT01090492|516567174|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
143276977|NCT01090492|516567175|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
143276978|NCT01090492|516567176|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
143276979|NCT01090492|516567177|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
143276980|NCT01090492|516567178|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
143276981|NCT01090492|516567179|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
143276982|NCT01090492|516567180|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
143276983|NCT01090492|516567173|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
143276984|NCT01090492|516567174|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
143276985|NCT01090492|516567175|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
143276986|NCT01090492|516567176|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
143276987|NCT01090492|516567177|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
143276988|NCT01090492|516567178|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
143276989|NCT01090492|516567179|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
143276990|NCT01090492|516567180|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
143276991|NCT01090492|516567173|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
143372824|NCT01212757|516909647|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
143372825|NCT01212757|516909648|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
143372826|NCT01212757|516909649|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
143372827|NCT01212757|516909650|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
143276992|NCT01090492|516567174|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
143276993|NCT01090492|516567175|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
143276994|NCT01090492|516567176|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
143276995|NCT01090492|516567177|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
143276996|NCT01090492|516567178|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
143276997|NCT01090492|516567179|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
143372828|NCT01212757|516909651|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
143276998|NCT01090492|516567180|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
143276999|NCT01090492|516567173|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
143277000|NCT01090492|516567174|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
143277001|NCT01090492|516567175|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
143277002|NCT01090492|516567176|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
143277003|NCT01090492|516567177|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
143277004|NCT01090492|516567178|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
143277005|NCT01090492|516567179|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
143277006|NCT01090492|516567180|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
143277007|NCT01090492|516567173|FG000|Second Intervention Period (4 Weeks)|Other|0|||
143277008|NCT01090492|516567174|FG001|Second Intervention Period (4 Weeks)|Other|1|||
143277009|NCT01090492|516567175|FG002|Second Intervention Period (4 Weeks)|Other|1|||
143277010|NCT01090492|516567176|FG003|Second Intervention Period (4 Weeks)|Other|0|||
143277011|NCT01090492|516567177|FG004|Second Intervention Period (4 Weeks)|Other|0|||
143277012|NCT01090492|516567178|FG005|Second Intervention Period (4 Weeks)|Other|0|||
143277013|NCT01090492|516567179|FG006|Second Intervention Period (4 Weeks)|Other|0|||
143277014|NCT01090492|516567180|FG007|Second Intervention Period (4 Weeks)|Other|0|||
143277015|NCT01090492|516567173|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
143277016|NCT01090492|516567174|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
143277017|NCT01090492|516567175|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
143277018|NCT01090492|516567176|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
143277019|NCT01090492|516567177|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
143277020|NCT01090492|516567178|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
143277021|NCT01090492|516567179|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
143277022|NCT01090492|516567180|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
143277023|NCT01090492|516567173|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
143277024|NCT01090492|516567174|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
143277025|NCT01090492|516567175|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
143277026|NCT01090492|516567176|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
143277027|NCT01090492|516567177|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
143277028|NCT01090492|516567178|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
143277029|NCT01090492|516567179|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
143277030|NCT01090492|516567180|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
143277031|NCT01768286|516567181|FG000|Overall Study|Randomized But Not Treated|0|||
143277032|NCT01768286|516567182|FG001|Overall Study|Randomized But Not Treated|0|||
143277033|NCT01768286|516567183|FG002|Overall Study|Randomized But Not Treated|1|||
143277034|NCT01768286|516567184|FG003|Overall Study|Randomized But Not Treated|0|||
143277035|NCT01768286|516567181|FG000|Overall Study|Lack of Efficacy|7|||
143277036|NCT01768286|516567182|FG001|Overall Study|Lack of Efficacy|4|||
143277037|NCT01768286|516567183|FG002|Overall Study|Lack of Efficacy|0|||
143277038|NCT01768286|516567184|FG003|Overall Study|Lack of Efficacy|1|||
143277039|NCT01768286|516567181|FG000|Overall Study|Withdrew Consent|0|||
143277040|NCT01768286|516567182|FG001|Overall Study|Withdrew Consent|0|||
143277041|NCT01768286|516567183|FG002|Overall Study|Withdrew Consent|1|||
143277042|NCT01768286|516567184|FG003|Overall Study|Withdrew Consent|0|||
143277043|NCT02083965|516567185|FG000|Treatment Period|Other|1|||
143277044|NCT02083965|516567186|FG001|Treatment Period|Other|0|||
143277045|NCT02229383|516567188|FG000|Overall Study|Adverse Event|7|||
143277046|NCT02229383|516567189|FG001|Overall Study|Adverse Event|4|||
143277047|NCT02229383|516567188|FG000|Overall Study|Death|0|||
143277048|NCT02229383|516567189|FG001|Overall Study|Death|1|||
143277049|NCT02229383|516567188|FG000|Overall Study|Lost to Follow-up|5|||
143277050|NCT02229383|516567189|FG001|Overall Study|Lost to Follow-up|3|||
143277051|NCT02229383|516567188|FG000|Overall Study|Withdrawal by Subject|4|||
143277052|NCT02229383|516567189|FG001|Overall Study|Withdrawal by Subject|6|||
143277053|NCT02229383|516567188|FG000|Overall Study|Did not receive treatment|1|||
143277054|NCT02229383|516567189|FG001|Overall Study|Did not receive treatment|0|||
143277055|NCT02229383|516567188|FG000|Overall Study|Other|3|||
143277056|NCT02229383|516567189|FG001|Overall Study|Other|8|||
143277057|NCT01218113|516569190|FG000|Overall Study|Withdrawal by Subject|1|||
143277058|NCT01218113|516569191|FG001|Overall Study|Withdrawal by Subject|0|||
143277059|NCT01218113|516569192|FG002|Overall Study|Withdrawal by Subject|1|||
143277060|NCT01218113|516569190|FG000|Overall Study|Lost to Follow-up|4|||
143277061|NCT01218113|516569191|FG001|Overall Study|Lost to Follow-up|1|||
143277062|NCT01218113|516569192|FG002|Overall Study|Lost to Follow-up|4|||
143277063|NCT01218113|516569190|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
143277064|NCT01218113|516569191|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
143277065|NCT01218113|516569192|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
143277066|NCT01433991|516569197|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
143277067|NCT01433991|516569198|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
143277068|NCT01433991|516569199|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
143277069|NCT01433991|516569200|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
143277070|NCT01433991|516569197|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
143277071|NCT01433991|516569198|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
143277072|NCT01433991|516569199|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
143277073|NCT01433991|516569200|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
143277074|NCT01433991|516569197|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
143277075|NCT01433991|516569198|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
143277076|NCT01433991|516569199|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
143277077|NCT01433991|516569200|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
143277078|NCT01433991|516569197|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
143277079|NCT01433991|516569198|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
143277080|NCT01433991|516569199|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
143277081|NCT01433991|516569200|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
143277082|NCT01433991|516569197|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
143277083|NCT01433991|516569198|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
143277084|NCT01433991|516569199|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
143277085|NCT01433991|516569200|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
143277086|NCT01433991|516569197|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
143277087|NCT01433991|516569198|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
143277088|NCT01433991|516569199|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
143277089|NCT01433991|516569200|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
143277090|NCT01433991|516569197|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
143277091|NCT01433991|516569198|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
143277092|NCT01433991|516569199|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
143277093|NCT01433991|516569200|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
143277094|NCT00787891|516569203|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
143277095|NCT00787891|516569204|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
143277096|NCT00787891|516569203|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
143277097|NCT00787891|516569204|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
143277098|NCT00787891|516569203|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
143277099|NCT00787891|516569204|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
143277100|NCT00787891|516569203|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
143277101|NCT00787891|516569204|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
143277102|NCT00787891|516569203|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
143277103|NCT00787891|516569204|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
143277104|NCT00787891|516569203|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
143277105|NCT00787891|516569204|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
143277106|NCT00787891|516569203|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
143277107|NCT00787891|516569204|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
143277108|NCT00787891|516569203|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
143277109|NCT00787891|516569204|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
143277110|NCT00787891|516569203|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
143277111|NCT00787891|516569204|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
143277112|NCT00787891|516569203|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
143277113|NCT00787891|516569204|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
143277114|NCT02550106|516569207|FG000|Overall Study|Adverse Event|1|||
143277115|NCT02550106|516569207|FG000|Overall Study|Lack of Efficacy|3|||
143277116|NCT02550106|516569207|FG000|Overall Study|Protocol Violation|6|||
143277117|NCT02550106|516569207|FG000|Overall Study|Withdrawal by Subject|2|||
143277118|NCT00354744|516569208|FG000|Overall Study|Adverse Event|2|||
143277119|NCT00354744|516569208|FG000|Overall Study|Death|2|||
143277120|NCT00354744|516569208|FG000|Overall Study|Lack of Efficacy|11|||
143277121|NCT00354744|516569208|FG000|Overall Study|Lost to Follow-up|2|||
143277122|NCT00354744|516569208|FG000|Overall Study|Physician Decision|11|||
143277123|NCT00354744|516569208|FG000|Overall Study|Withdrawal by Subject|14|||
143277124|NCT01193530|516569209|FG000|Overall Study|Withdrawal by Subject|2|||
143277125|NCT01193530|516569210|FG001|Overall Study|Withdrawal by Subject|2|||
143277126|NCT01193530|516569209|FG000|Overall Study|Began Contraindicated Therapy|1|||
143277127|NCT01193530|516569210|FG001|Overall Study|Began Contraindicated Therapy|0|||
143277128|NCT01193530|516569209|FG000|Overall Study|Lost Light Box|0|||
143277129|NCT01193530|516569210|FG001|Overall Study|Lost Light Box|1|||
143277130|NCT01193530|516569209|FG000|Overall Study|Returned home - out of state|0|||
143372829|NCT01212757|516909643|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
143277131|NCT01193530|516569210|FG001|Overall Study|Returned home - out of state|1|||
143277132|NCT01193530|516569209|FG000|Overall Study|Non-Compliance|0|||
143277133|NCT01193530|516569210|FG001|Overall Study|Non-Compliance|1|||
143277134|NCT03166735|516569211|FG000|Overall Study|Not Treated|1|||
143277135|NCT03166735|516569212|FG001|Overall Study|Not Treated|0|||
143277136|NCT03166735|516569213|FG002|Overall Study|Not Treated|0|||
143277137|NCT03166735|516569214|FG003|Overall Study|Not Treated|0|||
143277138|NCT03166735|516569215|FG004|Overall Study|Not Treated|0|||
143277139|NCT03166735|516569211|FG000|Overall Study|follow-up not completed as planned|0|||
143277140|NCT03166735|516569212|FG001|Overall Study|follow-up not completed as planned|1|||
143277141|NCT03166735|516569213|FG002|Overall Study|follow-up not completed as planned|1|||
143277142|NCT03166735|516569214|FG003|Overall Study|follow-up not completed as planned|0|||
143277143|NCT03166735|516569215|FG004|Overall Study|follow-up not completed as planned|1|||
143277144|NCT03166735|516569211|FG000|Overall Study|Withdrawal by Subject|0|||
143277145|NCT03166735|516569212|FG001|Overall Study|Withdrawal by Subject|0|||
143277146|NCT03166735|516569213|FG002|Overall Study|Withdrawal by Subject|1|||
143277147|NCT03166735|516569214|FG003|Overall Study|Withdrawal by Subject|1|||
143277148|NCT03166735|516569215|FG004|Overall Study|Withdrawal by Subject|2|||
143277149|NCT03166735|516569211|FG000|Overall Study|Lost to Follow-up|0|||
143277150|NCT03166735|516569212|FG001|Overall Study|Lost to Follow-up|2|||
143277151|NCT03166735|516569213|FG002|Overall Study|Lost to Follow-up|1|||
143277152|NCT03166735|516569214|FG003|Overall Study|Lost to Follow-up|0|||
143277153|NCT03166735|516569215|FG004|Overall Study|Lost to Follow-up|1|||
143277154|NCT00926328|516569216|FG000|Overall Study|Lost to Follow-up|12|||
143277155|NCT00926328|516569217|FG001|Overall Study|Lost to Follow-up|14|||
143277156|NCT03486223|516569221|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
143277157|NCT03486223|516569222|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
143277158|NCT01513343|516569225|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
143277159|NCT01513343|516569226|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
143277160|NCT01513343|516569225|FG000|Post Data Collection|Dropped/withdrew from study|7|||
143277161|NCT01513343|516569226|FG001|Post Data Collection|Dropped/withdrew from study|1|||
143277162|NCT01513343|516569225|FG000|Post Data Collection|Lost to Follow-up|10|||
143277163|NCT01513343|516569226|FG001|Post Data Collection|Lost to Follow-up|23|||
143277164|NCT01513343|516569225|FG000|6-month Follow-up|Lost to Follow-up|28|||
143277165|NCT01513343|516569226|FG001|6-month Follow-up|Lost to Follow-up|17|||
143277166|NCT01513343|516569225|FG000|12-month Follow-up|Lost to Follow-up|10|||
143277167|NCT01513343|516569226|FG001|12-month Follow-up|Lost to Follow-up|3|||
143277168|NCT02165215|516569237|FG000|Induction Phase|Adverse Event|1|||
143277169|NCT02165215|516569238|FG001|Induction Phase|Adverse Event|0|||
143277170|NCT02165215|516569239|FG002|Induction Phase|Adverse Event|0|||
143277171|NCT02165215|516569237|FG000|Induction Phase|Withdrawal by Subject|10|||
143277172|NCT02165215|516569238|FG001|Induction Phase|Withdrawal by Subject|0|||
143277173|NCT02165215|516569239|FG002|Induction Phase|Withdrawal by Subject|0|||
143277174|NCT02165215|516569237|FG000|Induction Phase|Protocol Violation|1|||
143277175|NCT02165215|516569238|FG001|Induction Phase|Protocol Violation|0|||
143277176|NCT02165215|516569239|FG002|Induction Phase|Protocol Violation|0|||
143277177|NCT02165215|516569237|FG000|Induction Phase|Physician Decision|1|||
143277178|NCT02165215|516569238|FG001|Induction Phase|Physician Decision|0|||
143277179|NCT02165215|516569239|FG002|Induction Phase|Physician Decision|0|||
143277180|NCT02165215|516569237|FG000|Induction Phase|Lack of Efficacy|2|||
143277181|NCT02165215|516569238|FG001|Induction Phase|Lack of Efficacy|0|||
143277182|NCT02165215|516569239|FG002|Induction Phase|Lack of Efficacy|0|||
143277183|NCT02165215|516569237|FG000|Induction Phase|Non-Compliance|2|||
143277184|NCT02165215|516569238|FG001|Induction Phase|Non-Compliance|0|||
143277185|NCT02165215|516569239|FG002|Induction Phase|Non-Compliance|0|||
143277186|NCT02165215|516569237|FG000|Induction Phase|Lost to Follow-up|6|||
143277187|NCT02165215|516569238|FG001|Induction Phase|Lost to Follow-up|0|||
143277188|NCT02165215|516569239|FG002|Induction Phase|Lost to Follow-up|0|||
143277189|NCT02165215|516569237|FG000|Maintenance Phase|Withdrawal by Subject|0|||
143277190|NCT02165215|516569238|FG001|Maintenance Phase|Withdrawal by Subject|7|||
143277191|NCT02165215|516569239|FG002|Maintenance Phase|Withdrawal by Subject|3|||
143277192|NCT02165215|516569237|FG000|Maintenance Phase|Multiple reasons|0|||
143277193|NCT02165215|516569238|FG001|Maintenance Phase|Multiple reasons|2|||
143277194|NCT02165215|516569239|FG002|Maintenance Phase|Multiple reasons|1|||
143277195|NCT02165215|516569237|FG000|Maintenance Phase|Lost to Follow-up|0|||
143277196|NCT02165215|516569238|FG001|Maintenance Phase|Lost to Follow-up|2|||
143277197|NCT02165215|516569239|FG002|Maintenance Phase|Lost to Follow-up|0|||
143277198|NCT02165215|516569237|FG000|Maintenance Phase|Adverse Event|0|||
143277199|NCT02165215|516569238|FG001|Maintenance Phase|Adverse Event|1|||
143277200|NCT02165215|516569239|FG002|Maintenance Phase|Adverse Event|1|||
143277201|NCT05074667|516569240|FG000|Overall Study|Death|1|||
143277202|NCT05074667|516569240|FG000|Overall Study|Withdrawal by Subject|4|||
143277203|NCT05074667|516569240|FG000|Overall Study|Lost to Follow-up|10|||
143277204|NCT02279420|516569241|FG000|Overall Study|Lost to Follow-up|23|||
143277205|NCT03535844|516569244|FG000|Overall Study|Withdrawal by Subject|0|||
143277206|NCT03535844|516569245|FG001|Overall Study|Withdrawal by Subject|1|||
143277207|NCT00297830|516569248|FG000|6 Month Visit|Death|1|||
143277208|NCT00297830|516569249|FG001|6 Month Visit|Death|0|||
143277209|NCT00297830|516569250|FG002|6 Month Visit|Death|2|||
143277210|NCT00297830|516569248|FG000|6 Month Visit|Withdrawal by Subject|2|||
143277211|NCT00297830|516569249|FG001|6 Month Visit|Withdrawal by Subject|1|||
143277212|NCT00297830|516569250|FG002|6 Month Visit|Withdrawal by Subject|1|||
143277213|NCT00297830|516569248|FG000|6 Month Visit|Adverse Event|0|||
143277214|NCT00297830|516569249|FG001|6 Month Visit|Adverse Event|1|||
143277215|NCT00297830|516569250|FG002|6 Month Visit|Adverse Event|0|||
143277216|NCT00297830|516569248|FG000|12 Month Visit|Lost to Follow-up|1|||
143277217|NCT00297830|516569249|FG001|12 Month Visit|Lost to Follow-up|0|||
143277218|NCT00297830|516569250|FG002|12 Month Visit|Lost to Follow-up|0|||
143277219|NCT00297830|516569248|FG000|12 Month Visit|Adverse Event|0|||
143277220|NCT00297830|516569249|FG001|12 Month Visit|Adverse Event|3|||
143277221|NCT00297830|516569250|FG002|12 Month Visit|Adverse Event|0|||
143277222|NCT00297830|516569248|FG000|12 Month Visit|Withdrawal by Subject|0|||
143277223|NCT00297830|516569249|FG001|12 Month Visit|Withdrawal by Subject|3|||
143277224|NCT00297830|516569250|FG002|12 Month Visit|Withdrawal by Subject|0|||
143277225|NCT02835820|516569251|FG000|Overall Study|Baseline Screen Failure|0|||
143277226|NCT02835820|516569252|FG001|Overall Study|Baseline Screen Failure|3|||
143277227|NCT01867424|516569256|FG000|Overall Study|Patient noncompliance|2|||
143277228|NCT01867424|516569257|FG001|Overall Study|Patient noncompliance|1|||
143277229|NCT04613375|516569258|FG000|Overall Study|Death|198|||
143277230|NCT04613375|516569258|FG000|Overall Study|Withdrawal by Subject|3|||
143277231|NCT01847274|516569259|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
143277232|NCT01847274|516569260|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
143277233|NCT01847274|516569261|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
143277234|NCT01847274|516569262|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
143277235|NCT01847274|516569263|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
143277236|NCT01847274|516569264|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
143277237|NCT01847274|516569265|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
143277238|NCT01847274|516569266|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
143277239|NCT01847274|516569267|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
143277240|NCT01847274|516569268|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
143277241|NCT01847274|516569269|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
143277242|NCT01847274|516569259|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
143277243|NCT01847274|516569260|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
143277244|NCT01847274|516569261|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
143277245|NCT01847274|516569262|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
143277246|NCT01847274|516569263|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
143277247|NCT01847274|516569264|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
143277248|NCT01847274|516569265|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
143277249|NCT01847274|516569266|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
143277250|NCT01847274|516569267|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
143277251|NCT01847274|516569268|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
143277252|NCT01847274|516569269|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
143277253|NCT01847274|516569259|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
143277254|NCT01847274|516569260|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
143277255|NCT01847274|516569261|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
143277256|NCT01847274|516569262|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
143277257|NCT01847274|516569263|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
143277258|NCT01847274|516569264|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
143277259|NCT01847274|516569265|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
143277260|NCT01847274|516569266|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
143277261|NCT01847274|516569267|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
143277262|NCT01847274|516569268|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
143277263|NCT01847274|516569269|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
143277264|NCT01847274|516569259|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
143277265|NCT01847274|516569260|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
143277266|NCT01847274|516569261|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
143277267|NCT01847274|516569262|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
143277268|NCT01847274|516569263|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
143277269|NCT01847274|516569264|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
143277270|NCT01847274|516569265|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
143277271|NCT01847274|516569266|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
143277272|NCT01847274|516569267|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
143277273|NCT01847274|516569268|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
143277274|NCT01847274|516569269|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
143277275|NCT01847274|516569259|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
143277276|NCT01847274|516569260|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
143277277|NCT01847274|516569261|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
143277278|NCT01847274|516569262|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
143277279|NCT01847274|516569263|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
143277280|NCT01847274|516569264|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
143277281|NCT01847274|516569265|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
143277282|NCT01847274|516569266|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
143277283|NCT01847274|516569267|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
143277284|NCT01847274|516569268|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
143277285|NCT01847274|516569269|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
143277286|NCT01847274|516569259|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
143277287|NCT01847274|516569260|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
143277288|NCT01847274|516569261|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
143277289|NCT01847274|516569262|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
143277290|NCT01847274|516569263|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
143277291|NCT01847274|516569264|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
143277292|NCT01847274|516569265|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
143277293|NCT01847274|516569266|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
143277294|NCT01847274|516569267|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
143277295|NCT01847274|516569268|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
143277296|NCT01847274|516569269|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
143277297|NCT01847274|516569259|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
143277298|NCT01847274|516569260|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
143277299|NCT01847274|516569261|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
143277300|NCT01847274|516569262|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
143277301|NCT01847274|516569263|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
143277302|NCT01847274|516569264|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
143277303|NCT01847274|516569265|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
143277304|NCT01847274|516569266|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
143277305|NCT01847274|516569267|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
143277306|NCT01847274|516569268|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
143277307|NCT01847274|516569269|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
143277308|NCT01847274|516569259|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
143277309|NCT01847274|516569260|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
143277310|NCT01847274|516569261|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
143277311|NCT01847274|516569262|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
143277312|NCT01847274|516569263|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
143277313|NCT01847274|516569264|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
143277314|NCT01847274|516569265|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
143277315|NCT01847274|516569266|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
143277316|NCT01847274|516569267|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
143277317|NCT01847274|516569268|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
143277318|NCT01847274|516569269|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
143277319|NCT01847274|516569259|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
143277320|NCT01847274|516569260|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
143277321|NCT01847274|516569261|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
143277322|NCT01847274|516569262|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
143277323|NCT01847274|516569263|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
143277324|NCT01847274|516569264|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
143277325|NCT01847274|516569265|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
143277326|NCT01847274|516569266|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
143277327|NCT01847274|516569267|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
143277328|NCT01847274|516569268|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
143277329|NCT01847274|516569269|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
143277330|NCT01847274|516569259|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
143277331|NCT01847274|516569260|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
143277332|NCT01847274|516569261|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
143277333|NCT01847274|516569262|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
143277334|NCT01847274|516569263|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
143277335|NCT01847274|516569264|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
143277336|NCT01847274|516569265|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
143277337|NCT01847274|516569266|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
143277338|NCT01847274|516569267|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
143277339|NCT01847274|516569268|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
143277340|NCT01847274|516569269|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
143277341|NCT01847274|516569259|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
143277342|NCT01847274|516569260|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
143277343|NCT01847274|516569261|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
143277344|NCT01847274|516569262|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
143277345|NCT01847274|516569263|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
143277346|NCT01847274|516569264|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
143277347|NCT01847274|516569265|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
143277348|NCT01847274|516569266|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
143277349|NCT01847274|516569267|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
143277350|NCT01847274|516569268|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
143277351|NCT01847274|516569269|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
143277352|NCT01847274|516569259|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
143277353|NCT01847274|516569260|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
143277354|NCT01847274|516569261|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
143277355|NCT01847274|516569262|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
143277356|NCT01847274|516569263|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
143277357|NCT01847274|516569264|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
143277358|NCT01847274|516569265|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
143277359|NCT01847274|516569266|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
143277360|NCT01847274|516569267|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
143277361|NCT01847274|516569268|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
143277362|NCT01847274|516569269|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
143277363|NCT01847274|516569259|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
143277364|NCT01847274|516569260|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
143277365|NCT01847274|516569261|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
143277366|NCT01847274|516569262|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
143277367|NCT01847274|516569263|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
143277368|NCT01847274|516569264|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
143277369|NCT01847274|516569265|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
143277370|NCT01847274|516569266|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
143277371|NCT01847274|516569267|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
143277372|NCT01847274|516569268|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
143277373|NCT01847274|516569269|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
143277374|NCT01847274|516569259|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
143277375|NCT01847274|516569260|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
143372830|NCT01212757|516909644|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
143372831|NCT01212757|516909645|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
143372832|NCT01212757|516909646|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
143372833|NCT01212757|516909647|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
143372834|NCT01212757|516909648|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
143372835|NCT01212757|516909649|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
143372836|NCT01212757|516909650|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
143372837|NCT01212757|516909651|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
143372838|NCT01212757|516909643|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
143372839|NCT01212757|516909644|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
143372840|NCT01212757|516909645|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
143229399|NCT02973100|516388604|FG001|Overall Study|Lost to Follow-up|1|||
143229400|NCT02973100|516388605|FG002|Overall Study|Lost to Follow-up|1|||
143229401|NCT02973100|516388606|FG003|Overall Study|Lost to Follow-up|0|||
143229402|NCT02973100|516388603|FG000|Overall Study|Withdrawal by Subject|3|||
143229403|NCT02973100|516388604|FG001|Overall Study|Withdrawal by Subject|5|||
143229404|NCT02973100|516388605|FG002|Overall Study|Withdrawal by Subject|1|||
143229405|NCT02973100|516388606|FG003|Overall Study|Withdrawal by Subject|4|||
143229406|NCT02973100|516388603|FG000|Overall Study|Notification of change in address|0|||
143229407|NCT02973100|516388604|FG001|Overall Study|Notification of change in address|0|||
143229408|NCT02973100|516388605|FG002|Overall Study|Notification of change in address|0|||
143229409|NCT02973100|516388606|FG003|Overall Study|Notification of change in address|1|||
143229410|NCT02973100|516388603|FG000|Overall Study|Failed to attend Safety followup period|0|||
143229411|NCT02973100|516388604|FG001|Overall Study|Failed to attend Safety followup period|0|||
143229412|NCT02973100|516388605|FG002|Overall Study|Failed to attend Safety followup period|1|||
143229413|NCT02973100|516388606|FG003|Overall Study|Failed to attend Safety followup period|0|||
143229414|NCT00878501|516388615|FG000|Overall Study|Adverse Event|11|||
143229415|NCT00878501|516388616|FG001|Overall Study|Adverse Event|3|||
143229416|NCT00878501|516388617|FG002|Overall Study|Adverse Event|3|||
143229417|NCT00878501|516388615|FG000|Overall Study|Lack of Efficacy|2|||
143229418|NCT00878501|516388616|FG001|Overall Study|Lack of Efficacy|1|||
143229419|NCT00878501|516388617|FG002|Overall Study|Lack of Efficacy|0|||
143229420|NCT00878501|516388615|FG000|Overall Study|Withdrawal by Subject|2|||
143229421|NCT00878501|516388616|FG001|Overall Study|Withdrawal by Subject|1|||
143229422|NCT00878501|516388617|FG002|Overall Study|Withdrawal by Subject|2|||
143229423|NCT00878501|516388615|FG000|Overall Study|Protocol Violation|0|||
143229424|NCT00878501|516388616|FG001|Overall Study|Protocol Violation|0|||
143229425|NCT00878501|516388617|FG002|Overall Study|Protocol Violation|1|||
143229426|NCT00878501|516388615|FG000|Overall Study|Incorrect enrolment|1|||
143229427|NCT00878501|516388616|FG001|Overall Study|Incorrect enrolment|2|||
143229428|NCT00878501|516388617|FG002|Overall Study|Incorrect enrolment|0|||
143229429|NCT00878501|516388615|FG000|Overall Study|Intake of prohibited concom. medication|0|||
143229430|NCT00878501|516388616|FG001|Overall Study|Intake of prohibited concom. medication|0|||
143229431|NCT00878501|516388617|FG002|Overall Study|Intake of prohibited concom. medication|1|||
143229432|NCT00878501|516388615|FG000|Overall Study|Mis-randomisation of patient|1|||
143229433|NCT00878501|516388616|FG001|Overall Study|Mis-randomisation of patient|0|||
143229434|NCT00878501|516388617|FG002|Overall Study|Mis-randomisation of patient|0|||
143229435|NCT00878501|516388615|FG000|Overall Study|Administrative|0|||
143229436|NCT00878501|516388616|FG001|Overall Study|Administrative|0|||
143229437|NCT00878501|516388617|FG002|Overall Study|Administrative|1|||
143229438|NCT00966654|516388622|FG000|Overall Study|Study was terminated,PI left institution|12|||
143229439|NCT04416204|516388625|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
143229440|NCT04416204|516388626|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
143229441|NCT04416204|516388627|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
143229442|NCT04416204|516388628|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
143229443|NCT00812708|516388629|FG000|Overall Study|Device could not be implanted|2|||
143229444|NCT00812708|516388629|FG000|Overall Study|Lack of medical insurance|1|||
143229445|NCT00812708|516388629|FG000|Overall Study|Switched to another study|1|||
143229446|NCT00812708|516388629|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
143229447|NCT00812708|516388629|FG000|Overall Study|Signed consent but later withdrew|3|||
143229448|NCT01419236|516388633|FG000|Overall Study|Adverse Event|1|||
143229449|NCT01419236|516388634|FG001|Overall Study|Adverse Event|0|||
143229450|NCT01419236|516388633|FG000|Overall Study|Lack of Efficacy|0|||
143229451|NCT01419236|516388634|FG001|Overall Study|Lack of Efficacy|1|||
143229452|NCT01419236|516388633|FG000|Overall Study|Lost to Follow-up|1|||
143229453|NCT01419236|516388634|FG001|Overall Study|Lost to Follow-up|0|||
143229454|NCT01419236|516388633|FG000|Overall Study|Physician Decision|1|||
143229455|NCT01419236|516388634|FG001|Overall Study|Physician Decision|0|||
143229456|NCT01419236|516388633|FG000|Overall Study|Withdrawal by Subject|1|||
143229457|NCT01419236|516388634|FG001|Overall Study|Withdrawal by Subject|4|||
143229458|NCT01419236|516388633|FG000|Overall Study|Entry Criteria Not Met|1|||
143229459|NCT01419236|516388634|FG001|Overall Study|Entry Criteria Not Met|0|||
143229460|NCT03287791|516388644|FG000|Overall Study|Insufficient Therapeutic Response|0|||
143229461|NCT03287791|516388645|FG001|Overall Study|Insufficient Therapeutic Response|0|||
143229462|NCT03287791|516388646|FG002|Overall Study|Insufficient Therapeutic Response|1|||
143229463|NCT03287791|516388644|FG000|Overall Study|Adverse Event|0|||
143229464|NCT03287791|516388645|FG001|Overall Study|Adverse Event|4|||
143229465|NCT03287791|516388646|FG002|Overall Study|Adverse Event|3|||
143229466|NCT03287791|516388644|FG000|Overall Study|Withdrawal by Subject|12|||
143229467|NCT03287791|516388645|FG001|Overall Study|Withdrawal by Subject|12|||
143229468|NCT03287791|516388646|FG002|Overall Study|Withdrawal by Subject|17|||
143229469|NCT03287791|516388644|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
143277376|NCT01847274|516569261|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
143277377|NCT01847274|516569262|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
143277378|NCT01847274|516569263|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
143277379|NCT01847274|516569264|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
143277380|NCT01847274|516569265|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
143277381|NCT01847274|516569266|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
143277382|NCT01847274|516569267|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
143277383|NCT01847274|516569268|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
143277384|NCT01847274|516569269|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
143277385|NCT01847274|516569259|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
143277386|NCT01847274|516569260|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
143277387|NCT01847274|516569261|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
143277388|NCT01847274|516569262|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
143277389|NCT01847274|516569263|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
143277390|NCT01847274|516569264|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
143277391|NCT01847274|516569265|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
143277392|NCT01847274|516569266|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
143277393|NCT01847274|516569267|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
143277394|NCT01847274|516569268|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
143277395|NCT01847274|516569269|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
143277396|NCT01847274|516569259|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
143277397|NCT01847274|516569260|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
143277398|NCT01847274|516569261|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
143277399|NCT01847274|516569262|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
143277400|NCT01847274|516569263|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
143277401|NCT01847274|516569264|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
143277402|NCT01847274|516569265|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
143277403|NCT01847274|516569266|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
143277404|NCT01847274|516569267|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
143277405|NCT01847274|516569268|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
143277406|NCT01847274|516569269|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
143277407|NCT05209360|516569270|FG000|Overall Study|Withdrawal by Subject|0|||
143277408|NCT05209360|516569271|FG001|Overall Study|Withdrawal by Subject|0|||
143277409|NCT05209360|516569272|FG002|Overall Study|Withdrawal by Subject|1|||
143277410|NCT05209360|516569273|FG003|Overall Study|Withdrawal by Subject|0|||
143277411|NCT05209360|516569274|FG004|Overall Study|Withdrawal by Subject|0|||
143277412|NCT05209360|516569275|FG005|Overall Study|Withdrawal by Subject|0|||
143277413|NCT00724932|516569276|FG000|Overall Study|Lost to Follow-up|1|||
143277414|NCT00724932|516569277|FG001|Overall Study|Lost to Follow-up|0|||
143277415|NCT00724932|516569276|FG000|Overall Study|Not treated|4|||
143277416|NCT00724932|516569277|FG001|Overall Study|Not treated|3|||
143277417|NCT02021331|516569278|FG000|Overall Study|Adverse Event|0|||
143277418|NCT02021331|516569279|FG001|Overall Study|Adverse Event|2|||
143277419|NCT01619423|516569280|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
143277420|NCT01619423|516569281|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
143277421|NCT01619423|516569282|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
143277422|NCT01619423|516569283|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
143277423|NCT03733470|516569286|FG000|Overall Study|PI Decision|1|||
143277424|NCT03733470|516569287|FG001|Overall Study|PI Decision|1|||
143277425|NCT04203498|516569292|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
143277426|NCT04203498|516569293|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
143277427|NCT04203498|516569292|FG000|Overall Study|Withdrawal of patient consent|7|||
143277428|NCT04203498|516569293|FG001|Overall Study|Withdrawal of patient consent|2|||
143277429|NCT04203498|516569292|FG000|Overall Study|Adverse Event|4|||
143277430|NCT04203498|516569293|FG001|Overall Study|Adverse Event|1|||
143277431|NCT04203498|516569292|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
143277432|NCT04203498|516569293|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
143277433|NCT04203498|516569292|FG000|Overall Study|Did not receive IMP|2|||
143277434|NCT04203498|516569293|FG001|Overall Study|Did not receive IMP|0|||
143277435|NCT02217878|516569294|FG000|Overall Study|required morphine due to chest pain|1|||
143277436|NCT02217878|516569295|FG001|Overall Study|required morphine due to chest pain|2|||
143277437|NCT02217878|516569294|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
143277438|NCT02217878|516569295|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
143277439|NCT02106975|516569296|FG000|Overall Study|Death|25|||
143277440|NCT02106975|516569297|FG001|Overall Study|Death|39|||
143277441|NCT00005044|516569298|FG000|Overall Study|Protocol Violation|37|||
143277442|NCT00005044|516569299|FG001|Overall Study|Protocol Violation|46|||
143277443|NCT00005044|516569298|FG000|Overall Study|Withdrawal by Subject|1|||
143277444|NCT00005044|516569299|FG001|Overall Study|Withdrawal by Subject|5|||
143277445|NCT00005044|516569298|FG000|Overall Study|No protocol treatment|0|||
143277446|NCT00005044|516569299|FG001|Overall Study|No protocol treatment|1|||
143277447|NCT03546062|516569300|FG000|Overall Study|Adverse Event|6|||
143277448|NCT03546062|516569301|FG001|Overall Study|Adverse Event|5|||
143277449|NCT03546062|516569302|FG002|Overall Study|Adverse Event|8|||
143277450|NCT00181155|516569303|FG000|Overall Study|Physician Decision|1|||
143277451|NCT00181155|516569304|FG001|Overall Study|Physician Decision|0|||
143277452|NCT00181155|516569303|FG000|Overall Study|Withdrawal by Subject|1|||
143277453|NCT00181155|516569304|FG001|Overall Study|Withdrawal by Subject|0|||
143277454|NCT00868608|516569308|FG000|Overall Study|Withdrawal by Subject|3|||
143277455|NCT00868608|516569309|FG001|Overall Study|Withdrawal by Subject|1|||
143277456|NCT00868608|516569310|FG002|Overall Study|Withdrawal by Subject|0|||
143277457|NCT00868608|516569308|FG000|Overall Study|Lost to Follow-up|3|||
143277458|NCT00868608|516569309|FG001|Overall Study|Lost to Follow-up|0|||
143277459|NCT00868608|516569310|FG002|Overall Study|Lost to Follow-up|1|||
143277460|NCT00868608|516569308|FG000|Overall Study|Death|16|||
143277461|NCT00868608|516569309|FG001|Overall Study|Death|2|||
143277462|NCT00868608|516569310|FG002|Overall Study|Death|4|||
143277463|NCT00868608|516569308|FG000|Overall Study|Other - Unspecified|1|||
143277464|NCT00868608|516569309|FG001|Overall Study|Other - Unspecified|0|||
143277465|NCT00868608|516569310|FG002|Overall Study|Other - Unspecified|0|||
143277466|NCT02935842|516569311|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
143277467|NCT02935842|516569312|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
143277468|NCT02935842|516569313|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
143277469|NCT02935842|516569314|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
143277470|NCT02935842|516569311|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
143277471|NCT02935842|516569312|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
143277472|NCT02935842|516569313|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
143277473|NCT02935842|516569314|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
143277474|NCT02935842|516569311|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
143277475|NCT02935842|516569312|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
143277476|NCT02935842|516569313|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
143277477|NCT02935842|516569314|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
143277478|NCT02935842|516569311|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
143277479|NCT02935842|516569312|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
143277480|NCT02935842|516569313|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
143277481|NCT02935842|516569314|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
143277482|NCT02935842|516569311|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
143277483|NCT02935842|516569312|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
143277484|NCT02935842|516569313|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
143277485|NCT02935842|516569314|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
143277486|NCT00911547|516569315|FG000|Overall Study|Adverse Event|8|||
143277487|NCT00911547|516569316|FG001|Overall Study|Adverse Event|27|||
143277488|NCT00911547|516569317|FG002|Overall Study|Adverse Event|11|||
143277489|NCT00911547|516569318|FG003|Overall Study|Adverse Event|6|||
143277490|NCT00911547|516569315|FG000|Overall Study|Lost to Follow-up|0|||
143277491|NCT00911547|516569316|FG001|Overall Study|Lost to Follow-up|0|||
143277492|NCT00911547|516569317|FG002|Overall Study|Lost to Follow-up|2|||
143277493|NCT00911547|516569318|FG003|Overall Study|Lost to Follow-up|1|||
143277494|NCT00911547|516569315|FG000|Overall Study|Protocol Violation|0|||
143277495|NCT00911547|516569316|FG001|Overall Study|Protocol Violation|5|||
143277496|NCT00911547|516569317|FG002|Overall Study|Protocol Violation|5|||
143277497|NCT00911547|516569318|FG003|Overall Study|Protocol Violation|1|||
143277498|NCT00911547|516569315|FG000|Overall Study|Withdrawal by Subject|3|||
143277499|NCT00911547|516569316|FG001|Overall Study|Withdrawal by Subject|10|||
143277500|NCT00911547|516569317|FG002|Overall Study|Withdrawal by Subject|4|||
143277501|NCT00911547|516569318|FG003|Overall Study|Withdrawal by Subject|8|||
143277502|NCT01201785|516569319|FG000|Overall Study|Lost to Follow-up|16|||
143277503|NCT02151110|516569320|FG000|Overall Study|Withdrawal by Subject|0|||
143277504|NCT02151110|516569321|FG001|Overall Study|Withdrawal by Subject|0|||
143277505|NCT02151110|516569322|FG002|Overall Study|Withdrawal by Subject|0|||
143277506|NCT02151110|516569323|FG003|Overall Study|Withdrawal by Subject|0|||
143277507|NCT02151110|516569324|FG004|Overall Study|Withdrawal by Subject|0|||
143277508|NCT02151110|516569325|FG005|Overall Study|Withdrawal by Subject|0|||
143277509|NCT02151110|516569326|FG006|Overall Study|Withdrawal by Subject|0|||
143277510|NCT02151110|516569327|FG007|Overall Study|Withdrawal by Subject|1|||
143277511|NCT02151110|516569320|FG000|Overall Study|Lost to Follow-up|0|||
143277512|NCT02151110|516569321|FG001|Overall Study|Lost to Follow-up|0|||
143277513|NCT02151110|516569322|FG002|Overall Study|Lost to Follow-up|0|||
143277514|NCT02151110|516569323|FG003|Overall Study|Lost to Follow-up|0|||
143277515|NCT02151110|516569324|FG004|Overall Study|Lost to Follow-up|0|||
143277516|NCT02151110|516569325|FG005|Overall Study|Lost to Follow-up|0|||
143277517|NCT02151110|516569326|FG006|Overall Study|Lost to Follow-up|0|||
143277518|NCT02151110|516569327|FG007|Overall Study|Lost to Follow-up|2|||
143277519|NCT02015754|516569328|FG000|Overall Study|Disease progression|5|||
143277520|NCT02015754|516569328|FG000|Overall Study|Change in treatment modality|5|||
143277521|NCT02015754|516569328|FG000|Overall Study|Lost to Follow-up|1|||
143277522|NCT02369016|516569329|FG000|Overall Study|AE associated with clinical disease progression|2|||
143277523|NCT02369016|516569330|FG001|Overall Study|AE associated with clinical disease progression|1|||
143277524|NCT02369016|516569329|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
143277525|NCT02369016|516569330|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
143277526|NCT02369016|516569329|FG000|Overall Study|Progressive disease - clinical progression|1|||
143277527|NCT02369016|516569330|FG001|Overall Study|Progressive disease - clinical progression|4|||
143277528|NCT02369016|516569329|FG000|Overall Study|withdrawal by patient|4|||
143277529|NCT02369016|516569330|FG001|Overall Study|withdrawal by patient|0|||
143277530|NCT02369016|516569329|FG000|Overall Study|Progressive disease - radiological progression|6|||
143277531|NCT02369016|516569330|FG001|Overall Study|Progressive disease - radiological progression|2|||
143277532|NCT00939770|516569333|FG000|Overall Study|Adverse Event|1|||
143277533|NCT00939770|516569334|FG001|Overall Study|Adverse Event|1|||
143277534|NCT00939770|516569335|FG002|Overall Study|Adverse Event|0|||
143277535|NCT00939770|516569336|FG003|Overall Study|Adverse Event|0|||
143277536|NCT00939770|516569337|FG004|Overall Study|Adverse Event|6|||
143277537|NCT00939770|516569338|FG005|Overall Study|Adverse Event|2|||
143277538|NCT00939770|516569339|FG006|Overall Study|Adverse Event|1|||
143277539|NCT00939770|516569340|FG007|Overall Study|Adverse Event|1|||
143277540|NCT00939770|516569333|FG000|Overall Study|Lack of Efficacy|4|||
143277541|NCT00939770|516569334|FG001|Overall Study|Lack of Efficacy|6|||
143277542|NCT00939770|516569335|FG002|Overall Study|Lack of Efficacy|13|||
143277543|NCT00939770|516569336|FG003|Overall Study|Lack of Efficacy|9|||
143277544|NCT00939770|516569337|FG004|Overall Study|Lack of Efficacy|16|||
143277545|NCT00939770|516569338|FG005|Overall Study|Lack of Efficacy|8|||
143277546|NCT00939770|516569339|FG006|Overall Study|Lack of Efficacy|11|||
143277547|NCT00939770|516569340|FG007|Overall Study|Lack of Efficacy|1|||
143277548|NCT00939770|516569333|FG000|Overall Study|Lost to Follow-up|0|||
143277549|NCT00939770|516569334|FG001|Overall Study|Lost to Follow-up|0|||
143277550|NCT00939770|516569335|FG002|Overall Study|Lost to Follow-up|0|||
143277551|NCT00939770|516569336|FG003|Overall Study|Lost to Follow-up|0|||
143277552|NCT00939770|516569337|FG004|Overall Study|Lost to Follow-up|1|||
143277553|NCT00939770|516569338|FG005|Overall Study|Lost to Follow-up|0|||
143277554|NCT00939770|516569339|FG006|Overall Study|Lost to Follow-up|0|||
143277555|NCT00939770|516569340|FG007|Overall Study|Lost to Follow-up|0|||
143277556|NCT00939770|516569333|FG000|Overall Study|Physician Decision|0|||
143277557|NCT00939770|516569334|FG001|Overall Study|Physician Decision|0|||
143277558|NCT00939770|516569335|FG002|Overall Study|Physician Decision|2|||
143277559|NCT00939770|516569336|FG003|Overall Study|Physician Decision|0|||
143277560|NCT00939770|516569337|FG004|Overall Study|Physician Decision|7|||
143277561|NCT00939770|516569338|FG005|Overall Study|Physician Decision|1|||
143277562|NCT00939770|516569339|FG006|Overall Study|Physician Decision|0|||
143277563|NCT00939770|516569340|FG007|Overall Study|Physician Decision|6|||
143277564|NCT00939770|516569333|FG000|Overall Study|Protocol Violation|0|||
143277565|NCT00939770|516569334|FG001|Overall Study|Protocol Violation|0|||
143277566|NCT00939770|516569335|FG002|Overall Study|Protocol Violation|0|||
143277567|NCT00939770|516569336|FG003|Overall Study|Protocol Violation|0|||
143277568|NCT00939770|516569337|FG004|Overall Study|Protocol Violation|1|||
143277569|NCT00939770|516569338|FG005|Overall Study|Protocol Violation|0|||
143277570|NCT00939770|516569339|FG006|Overall Study|Protocol Violation|0|||
143277571|NCT00939770|516569340|FG007|Overall Study|Protocol Violation|0|||
143277572|NCT00939770|516569333|FG000|Overall Study|Withdrawal by Subject|0|||
143277573|NCT00939770|516569334|FG001|Overall Study|Withdrawal by Subject|1|||
143277574|NCT00939770|516569335|FG002|Overall Study|Withdrawal by Subject|5|||
143277575|NCT00939770|516569336|FG003|Overall Study|Withdrawal by Subject|2|||
143277576|NCT00939770|516569337|FG004|Overall Study|Withdrawal by Subject|6|||
143277577|NCT00939770|516569338|FG005|Overall Study|Withdrawal by Subject|0|||
143277578|NCT00939770|516569339|FG006|Overall Study|Withdrawal by Subject|2|||
143277579|NCT00939770|516569340|FG007|Overall Study|Withdrawal by Subject|2|||
143277580|NCT01146665|516569341|FG000|Overall Study|Withdrawal by Subject|10|||
143277581|NCT01146665|516569342|FG001|Overall Study|Withdrawal by Subject|16|||
143277582|NCT05248867|516569343|FG000|Double-blind Period|Lost to Follow-up|0|||
143277583|NCT05248867|516569344|FG001|Double-blind Period|Lost to Follow-up|3|||
143277584|NCT05248867|516569345|FG002|Double-blind Period|Lost to Follow-up|0|||
143277585|NCT05248867|516569346|FG003|Double-blind Period|Lost to Follow-up|0|||
143277586|NCT05248867|516569347|FG004|Double-blind Period|Lost to Follow-up|0|||
143277587|NCT05248867|516569348|FG005|Double-blind Period|Lost to Follow-up|0|||
143277588|NCT05248867|516569343|FG000|Double-blind Period|Withdrawal by Subject|5|||
143277589|NCT05248867|516569344|FG001|Double-blind Period|Withdrawal by Subject|14|||
143277590|NCT05248867|516569345|FG002|Double-blind Period|Withdrawal by Subject|0|||
143277591|NCT05248867|516569346|FG003|Double-blind Period|Withdrawal by Subject|0|||
143277592|NCT05248867|516569347|FG004|Double-blind Period|Withdrawal by Subject|0|||
143277593|NCT05248867|516569348|FG005|Double-blind Period|Withdrawal by Subject|0|||
143277594|NCT05248867|516569343|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
143277595|NCT05248867|516569344|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
143277596|NCT05248867|516569345|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
143277597|NCT05248867|516569346|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
143277598|NCT05248867|516569347|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
143277599|NCT05248867|516569348|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
143277600|NCT05248867|516569343|FG000|Double-blind Period|Other, not specified|3|||
143277601|NCT05248867|516569344|FG001|Double-blind Period|Other, not specified|8|||
143277602|NCT05248867|516569345|FG002|Double-blind Period|Other, not specified|0|||
143277603|NCT05248867|516569346|FG003|Double-blind Period|Other, not specified|0|||
143277604|NCT05248867|516569347|FG004|Double-blind Period|Other, not specified|0|||
143277605|NCT05248867|516569348|FG005|Double-blind Period|Other, not specified|0|||
143277606|NCT05248867|516569343|FG000|Open-label Period|Withdrawal by Subject|0|||
143277607|NCT05248867|516569344|FG001|Open-label Period|Withdrawal by Subject|0|||
143277608|NCT05248867|516569345|FG002|Open-label Period|Withdrawal by Subject|3|||
143277609|NCT05248867|516569346|FG003|Open-label Period|Withdrawal by Subject|1|||
143277610|NCT05248867|516569347|FG004|Open-label Period|Withdrawal by Subject|7|||
143277611|NCT05248867|516569348|FG005|Open-label Period|Withdrawal by Subject|9|||
143277612|NCT05248867|516569343|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
143277613|NCT05248867|516569344|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
143277614|NCT05248867|516569345|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
143277615|NCT05248867|516569346|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
143277616|NCT05248867|516569347|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
143277617|NCT05248867|516569348|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
143277618|NCT05248867|516569343|FG000|Open-label Period|Lost to Follow-up|0|||
143277619|NCT05248867|516569344|FG001|Open-label Period|Lost to Follow-up|0|||
143277620|NCT05248867|516569345|FG002|Open-label Period|Lost to Follow-up|0|||
143277621|NCT05248867|516569346|FG003|Open-label Period|Lost to Follow-up|0|||
143277622|NCT05248867|516569347|FG004|Open-label Period|Lost to Follow-up|5|||
143277623|NCT05248867|516569348|FG005|Open-label Period|Lost to Follow-up|2|||
143277624|NCT05248867|516569343|FG000|Open-label Period|COVID-19 Infection|0|||
143277625|NCT05248867|516569344|FG001|Open-label Period|COVID-19 Infection|0|||
143277626|NCT05248867|516569345|FG002|Open-label Period|COVID-19 Infection|0|||
143277627|NCT05248867|516569346|FG003|Open-label Period|COVID-19 Infection|0|||
143277628|NCT05248867|516569347|FG004|Open-label Period|COVID-19 Infection|1|||
143277629|NCT05248867|516569348|FG005|Open-label Period|COVID-19 Infection|0|||
143277630|NCT05248867|516569343|FG000|Open-label Period|Other, not specified|0|||
143277631|NCT05248867|516569344|FG001|Open-label Period|Other, not specified|0|||
143277632|NCT05248867|516569345|FG002|Open-label Period|Other, not specified|0|||
143277633|NCT05248867|516569346|FG003|Open-label Period|Other, not specified|0|||
143277634|NCT05248867|516569347|FG004|Open-label Period|Other, not specified|4|||
143277635|NCT05248867|516569348|FG005|Open-label Period|Other, not specified|0|||
143277636|NCT01064310|516569349|FG000|Period 1|Adverse Event|7|||
143277637|NCT01064310|516569350|FG001|Period 1|Adverse Event|10|||
143277638|NCT01064310|516569351|FG002|Period 1|Adverse Event|0|||
143277639|NCT01064310|516569349|FG000|Period 1|Physician Decision|1|||
143277640|NCT01064310|516569350|FG001|Period 1|Physician Decision|0|||
143277641|NCT01064310|516569351|FG002|Period 1|Physician Decision|0|||
143277642|NCT01064310|516569349|FG000|Period 1|Withdrawal by Subject|2|||
143277643|NCT01064310|516569350|FG001|Period 1|Withdrawal by Subject|2|||
143277644|NCT01064310|516569351|FG002|Period 1|Withdrawal by Subject|0|||
143277645|NCT01064310|516569349|FG000|Period 1|Lack of Efficacy|3|||
143277646|NCT01064310|516569350|FG001|Period 1|Lack of Efficacy|5|||
143277647|NCT01064310|516569351|FG002|Period 1|Lack of Efficacy|0|||
143277648|NCT01064310|516569349|FG000|Period 1|Entered Open-label Period|1|||
143277649|NCT01064310|516569350|FG001|Period 1|Entered Open-label Period|1|||
143277650|NCT01064310|516569351|FG002|Period 1|Entered Open-label Period|0|||
143277651|NCT01064310|516569349|FG000|Period 2|Adverse Event|2|||
143277652|NCT01064310|516569350|FG001|Period 2|Adverse Event|1|||
143277653|NCT01064310|516569351|FG002|Period 2|Adverse Event|0|||
143277654|NCT01064310|516569349|FG000|Period 2|Physician Decision|0|||
143277655|NCT01064310|516569350|FG001|Period 2|Physician Decision|1|||
143277656|NCT01064310|516569351|FG002|Period 2|Physician Decision|0|||
143277657|NCT01064310|516569349|FG000|Period 2|Entered Open-label Period|1|||
143277658|NCT01064310|516569350|FG001|Period 2|Entered Open-label Period|0|||
143277659|NCT01064310|516569351|FG002|Period 2|Entered Open-label Period|0|||
143277660|NCT01064310|516569349|FG000|Period 2|Lack of Efficacy|1|||
143277661|NCT01064310|516569350|FG001|Period 2|Lack of Efficacy|4|||
143277662|NCT01064310|516569351|FG002|Period 2|Lack of Efficacy|0|||
143277663|NCT01064310|516569349|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
143277664|NCT01064310|516569350|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
143277665|NCT01064310|516569351|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
143277666|NCT01064310|516569349|FG000|Open Label Pazopinib|Adverse Event|0|||
143277667|NCT01064310|516569350|FG001|Open Label Pazopinib|Adverse Event|0|||
143277668|NCT01064310|516569351|FG002|Open Label Pazopinib|Adverse Event|12|||
143277669|NCT01064310|516569349|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
143277670|NCT01064310|516569350|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
143277671|NCT01064310|516569351|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
143277672|NCT01064310|516569349|FG000|Open Label Pazopinib|Physician Decision|0|||
143277673|NCT01064310|516569350|FG001|Open Label Pazopinib|Physician Decision|0|||
143277674|NCT01064310|516569351|FG002|Open Label Pazopinib|Physician Decision|20|||
143277675|NCT00873015|516569355|FG000|Overall Study|Withdrawal by Subject|0|||
143277676|NCT00873015|516569356|FG001|Overall Study|Withdrawal by Subject|1|||
143277677|NCT00873015|516569357|FG002|Overall Study|Withdrawal by Subject|0|||
143277678|NCT00873015|516569358|FG003|Overall Study|Withdrawal by Subject|0|||
143277679|NCT03128411|516569359|FG000|Treatment Phase|Adverse Event|21|||
143277680|NCT03128411|516569359|FG000|Treatment Phase|Physician Decision|1|||
143277681|NCT03128411|516569359|FG000|Treatment Phase|Other|2|||
143277682|NCT03128411|516569359|FG000|Long Term Follow-up Phase|Death|2|||
143277683|NCT00345839|516569360|FG000|Overall Study|Withdrawal by Subject|91|||
143277684|NCT00345839|516569361|FG001|Overall Study|Withdrawal by Subject|98|||
143277685|NCT00345839|516569360|FG000|Overall Study|Lost to Follow-up|58|||
143277686|NCT00345839|516569361|FG001|Overall Study|Lost to Follow-up|61|||
143277687|NCT03749447|516570690|FG000|Overall Study|Adverse Event|11|||
143277688|NCT03749447|516570691|FG001|Overall Study|Adverse Event|3|||
143277689|NCT03749447|516570690|FG000|Overall Study|Death|1|||
143277690|NCT03749447|516570691|FG001|Overall Study|Death|1|||
143277691|NCT03749447|516570690|FG000|Overall Study|Lost to Follow-up|2|||
143277692|NCT03749447|516570691|FG001|Overall Study|Lost to Follow-up|2|||
143277693|NCT03749447|516570690|FG000|Overall Study|Reason Not Specified|0|||
143277694|NCT03749447|516570691|FG001|Overall Study|Reason Not Specified|3|||
143277695|NCT03749447|516570690|FG000|Overall Study|Physician Decision|4|||
143277696|NCT03749447|516570691|FG001|Overall Study|Physician Decision|3|||
143277697|NCT03749447|516570690|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
143277698|NCT03749447|516570691|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
143277699|NCT03749447|516570690|FG000|Overall Study|Study Terminated By Sponsor|112|||
143277700|NCT03749447|516570691|FG001|Overall Study|Study Terminated By Sponsor|105|||
143277701|NCT03749447|516570690|FG000|Overall Study|Withdrawal by Subject|12|||
143277702|NCT03749447|516570691|FG001|Overall Study|Withdrawal by Subject|6|||
143277703|NCT03749447|516570690|FG000|Overall Study|Non-compliance With Study Drug|0|||
143277704|NCT03749447|516570691|FG001|Overall Study|Non-compliance With Study Drug|1|||
143277705|NCT00967668|516570692|FG000|Overall Study|Withdrawal by Subject|13|||
143277706|NCT00967668|516570693|FG001|Overall Study|Withdrawal by Subject|8|||
143277707|NCT00967668|516570694|FG002|Overall Study|Withdrawal by Subject|8|||
143277708|NCT00967668|516570692|FG000|Overall Study|Death|0|||
143277709|NCT00967668|516570693|FG001|Overall Study|Death|2|||
143277710|NCT00967668|516570694|FG002|Overall Study|Death|4|||
143277711|NCT00967668|516570692|FG000|Overall Study|Removed due to behavior|1|||
143277712|NCT00967668|516570693|FG001|Overall Study|Removed due to behavior|1|||
143277713|NCT00967668|516570694|FG002|Overall Study|Removed due to behavior|2|||
143277714|NCT00967668|516570692|FG000|Overall Study|Refused Year 2|11|||
143277715|NCT00967668|516570693|FG001|Overall Study|Refused Year 2|6|||
143277716|NCT00967668|516570694|FG002|Overall Study|Refused Year 2|4|||
143277717|NCT00967668|516570692|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
143277718|NCT00967668|516570693|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
143277719|NCT00967668|516570694|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
143277720|NCT00967668|516570692|FG000|Overall Study|Lost to Follow-up|15|||
143277721|NCT00967668|516570693|FG001|Overall Study|Lost to Follow-up|9|||
143277722|NCT00967668|516570694|FG002|Overall Study|Lost to Follow-up|16|||
143277723|NCT00967668|516570692|FG000|Overall Study|Refused 12-mo assessment|3|||
143277724|NCT00967668|516570693|FG001|Overall Study|Refused 12-mo assessment|1|||
143277725|NCT00967668|516570694|FG002|Overall Study|Refused 12-mo assessment|9|||
143277726|NCT00967668|516570692|FG000|Overall Study|Pregnancy|1|||
143277727|NCT00967668|516570693|FG001|Overall Study|Pregnancy|0|||
143277728|NCT00967668|516570694|FG002|Overall Study|Pregnancy|0|||
143277729|NCT00115739|516570696|FG000|Overall Study|Lost to Follow-up|3|||
143277730|NCT00259649|516570697|FG000|Overall Study|Lost to Follow-up|7|||
143277731|NCT00259649|516570697|FG000|Overall Study|irregular menses|3|||
143277732|NCT00745823|516570700|FG000|Overall Study|Adverse Event|5|||
143277733|NCT00745823|516570701|FG001|Overall Study|Adverse Event|3|||
143277734|NCT00745823|516570700|FG000|Overall Study|Lack of Efficacy|20|||
143277735|NCT00745823|516570701|FG001|Overall Study|Lack of Efficacy|6|||
143277736|NCT00745823|516570700|FG000|Overall Study|Lost to Follow-up|10|||
143277737|NCT00745823|516570701|FG001|Overall Study|Lost to Follow-up|11|||
143277738|NCT00745823|516570700|FG000|Overall Study|Physician Decision|10|||
143277739|NCT00745823|516570701|FG001|Overall Study|Physician Decision|5|||
143277740|NCT00745823|516570700|FG000|Overall Study|Pregnancy|0|||
143277741|NCT00745823|516570701|FG001|Overall Study|Pregnancy|4|||
143277742|NCT00745823|516570700|FG000|Overall Study|Withdrawal by Subject|14|||
143277743|NCT00745823|516570701|FG001|Overall Study|Withdrawal by Subject|8|||
143277744|NCT00745823|516570700|FG000|Overall Study|Study Terminated by Sponsor|326|||
143277745|NCT00745823|516570701|FG001|Overall Study|Study Terminated by Sponsor|349|||
143277746|NCT01673867|516570707|FG000|Randomization|Adverse event unrelated to study drug|1|||
143277747|NCT01673867|516570708|FG001|Randomization|Adverse event unrelated to study drug|0|||
143277748|NCT01673867|516570707|FG000|Randomization|Participant request to discontinue study treatment|0|||
143277749|NCT01673867|516570708|FG001|Randomization|Participant request to discontinue study treatment|4|||
143277750|NCT01673867|516570707|FG000|Randomization|Withdrawal by participant|0|||
143277751|NCT01673867|516570708|FG001|Randomization|Withdrawal by participant|12|||
143277752|NCT01673867|516570707|FG000|Randomization|Lost to Follow-up|0|||
143277753|NCT01673867|516570708|FG001|Randomization|Lost to Follow-up|1|||
143277754|NCT01673867|516570707|FG000|Randomization|Participant no longer meets study criteria|4|||
143277755|NCT01673867|516570708|FG001|Randomization|Participant no longer meets study criteria|5|||
143277756|NCT01673867|516570707|FG000|Treatment|Disease Progression|208|||
143277757|NCT01673867|516570708|FG001|Treatment|Disease Progression|178|||
143277758|NCT01673867|516570707|FG000|Treatment|Study Drug Toxicity|23|||
143277759|NCT01673867|516570708|FG001|Treatment|Study Drug Toxicity|43|||
143277760|NCT01673867|516570707|FG000|Treatment|Death|2|||
143277761|NCT01673867|516570708|FG001|Treatment|Death|3|||
143277762|NCT01673867|516570707|FG000|Treatment|Adverse event unrelated to study drug|23|||
143277763|NCT01673867|516570708|FG001|Treatment|Adverse event unrelated to study drug|10|||
143277764|NCT01673867|516570707|FG000|Treatment|Participant request to discontinue study treatment|7|||
143277765|NCT01673867|516570708|FG001|Treatment|Participant request to discontinue study treatment|17|||
143277766|NCT01673867|516570707|FG000|Treatment|Withdrawal by participant|5|||
143277767|NCT01673867|516570708|FG001|Treatment|Withdrawal by participant|5|||
143277768|NCT01673867|516570707|FG000|Treatment|Maximum clinical benefit|1|||
143277769|NCT01673867|516570708|FG001|Treatment|Maximum clinical benefit|10|||
143277770|NCT01673867|516570707|FG000|Treatment|Participant no longer meets study criteria|2|||
143277771|NCT01673867|516570708|FG001|Treatment|Participant no longer meets study criteria|0|||
143277772|NCT01673867|516570707|FG000|Treatment|Administrative reason by sponsor|3|||
143277773|NCT01673867|516570708|FG001|Treatment|Administrative reason by sponsor|0|||
143277774|NCT01673867|516570707|FG000|Treatment|Other reason|11|||
143277775|NCT01673867|516570708|FG001|Treatment|Other reason|2|||
143277776|NCT01819831|516570715|FG000|Overall Study|Withdrawal by Subject|1|||
143277777|NCT02034110|516570718|FG000|Overall Study|Physician Decision|0|||
143277778|NCT02034110|516570719|FG001|Overall Study|Physician Decision|0|||
143277779|NCT02034110|516570720|FG002|Overall Study|Physician Decision|0|||
143277780|NCT02034110|516570721|FG003|Overall Study|Physician Decision|0|||
143277781|NCT02034110|516570722|FG004|Overall Study|Physician Decision|2|||
143277782|NCT02034110|516570723|FG005|Overall Study|Physician Decision|0|||
143277783|NCT02034110|516570724|FG006|Overall Study|Physician Decision|1|||
143277784|NCT02034110|516570725|FG007|Overall Study|Physician Decision|0|||
143277785|NCT02034110|516570718|FG000|Overall Study|Lost to Follow-up|1|||
143277786|NCT02034110|516570719|FG001|Overall Study|Lost to Follow-up|0|||
143277787|NCT02034110|516570720|FG002|Overall Study|Lost to Follow-up|0|||
143277788|NCT02034110|516570721|FG003|Overall Study|Lost to Follow-up|0|||
143277789|NCT02034110|516570722|FG004|Overall Study|Lost to Follow-up|1|||
143277790|NCT02034110|516570723|FG005|Overall Study|Lost to Follow-up|0|||
143277791|NCT02034110|516570724|FG006|Overall Study|Lost to Follow-up|1|||
143277792|NCT02034110|516570725|FG007|Overall Study|Lost to Follow-up|0|||
143277793|NCT02034110|516570718|FG000|Overall Study|Withdrawal by Subject|5|||
143277794|NCT02034110|516570719|FG001|Overall Study|Withdrawal by Subject|7|||
143229470|NCT03287791|516388645|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
143229471|NCT03287791|516388646|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
143229472|NCT03287791|516388644|FG000|Overall Study|Lost to Follow-up|8|||
143229473|NCT03287791|516388645|FG001|Overall Study|Lost to Follow-up|14|||
143229474|NCT03287791|516388646|FG002|Overall Study|Lost to Follow-up|11|||
143229475|NCT03287791|516388644|FG000|Overall Study|Protocol Violation|7|||
143229476|NCT03287791|516388645|FG001|Overall Study|Protocol Violation|2|||
143229477|NCT03287791|516388646|FG002|Overall Study|Protocol Violation|1|||
143229478|NCT03287791|516388644|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
143229479|NCT03287791|516388645|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
143229480|NCT03287791|516388646|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
143229481|NCT03287791|516388644|FG000|Overall Study|Too much time between 2 visits|0|||
143229482|NCT03287791|516388645|FG001|Overall Study|Too much time between 2 visits|1|||
143229483|NCT03287791|516388646|FG002|Overall Study|Too much time between 2 visits|0|||
143229484|NCT03287791|516388644|FG000|Overall Study|Non-compliance|0|||
143229485|NCT03287791|516388645|FG001|Overall Study|Non-compliance|1|||
143229486|NCT03287791|516388646|FG002|Overall Study|Non-compliance|0|||
143229487|NCT03287791|516388644|FG000|Overall Study|Did not meet inclusion criteria|1|||
143229488|NCT03287791|516388645|FG001|Overall Study|Did not meet inclusion criteria|0|||
143229489|NCT03287791|516388646|FG002|Overall Study|Did not meet inclusion criteria|0|||
143229490|NCT03095651|516388648|FG000|Overall Study|Lost to Follow-up|1|||
143229491|NCT03095651|516388649|FG001|Overall Study|Lost to Follow-up|1|||
143229492|NCT03095651|516388650|FG002|Overall Study|Lost to Follow-up|0|||
143229493|NCT03095651|516388651|FG003|Overall Study|Lost to Follow-up|1|||
143229494|NCT03095651|516388652|FG004|Overall Study|Lost to Follow-up|0|||
143229495|NCT03095651|516388653|FG005|Overall Study|Lost to Follow-up|0|||
143229496|NCT03095651|516388654|FG006|Overall Study|Lost to Follow-up|0|||
143229497|NCT03095651|516388655|FG007|Overall Study|Lost to Follow-up|0|||
143229498|NCT03095651|516388648|FG000|Overall Study|Withdrawal by Subject|0|||
143229499|NCT03095651|516388649|FG001|Overall Study|Withdrawal by Subject|0|||
143229500|NCT03095651|516388650|FG002|Overall Study|Withdrawal by Subject|0|||
143229501|NCT03095651|516388651|FG003|Overall Study|Withdrawal by Subject|0|||
143229502|NCT03095651|516388652|FG004|Overall Study|Withdrawal by Subject|0|||
143229503|NCT03095651|516388653|FG005|Overall Study|Withdrawal by Subject|1|||
143229504|NCT03095651|516388654|FG006|Overall Study|Withdrawal by Subject|0|||
143229505|NCT03095651|516388655|FG007|Overall Study|Withdrawal by Subject|0|||
143229506|NCT02891174|516388661|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
143229507|NCT02891174|516388662|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
143229508|NCT02891174|516388661|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
143229509|NCT02891174|516388662|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
143229510|NCT02891174|516388661|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
143229511|NCT02891174|516388662|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
143229512|NCT02891174|516388661|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
143229513|NCT02891174|516388662|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
143229514|NCT02891174|516388661|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
143229515|NCT02891174|516388662|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
143229516|NCT02891174|516388661|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
143229517|NCT02891174|516388662|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
143229518|NCT02891174|516388661|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
143229519|NCT02891174|516388662|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
143229520|NCT04235140|516388663|FG000|Overall Study|Adverse Event|2|||
143229521|NCT04235140|516388663|FG000|Overall Study|Lost to Follow-up|1|||
143229522|NCT04235140|516388663|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
143229523|NCT04235140|516388663|FG000|Overall Study|Commercial drug is available for participants|7|||
143229524|NCT02587520|516388664|FG000|Overall Study|Protocol Violation|2|||
143229525|NCT02587520|516388665|FG001|Overall Study|Protocol Violation|0|||
143229526|NCT02587520|516388666|FG002|Overall Study|Protocol Violation|0|||
143229527|NCT02587520|516388667|FG003|Overall Study|Protocol Violation|2|||
143229528|NCT02587520|516388668|FG004|Overall Study|Protocol Violation|0|||
143229529|NCT02587520|516388669|FG005|Overall Study|Protocol Violation|1|||
143229530|NCT02587520|516388670|FG006|Overall Study|Protocol Violation|1|||
143229531|NCT02587520|516388671|FG007|Overall Study|Protocol Violation|1|||
143229532|NCT02587520|516388672|FG008|Overall Study|Protocol Violation|3|||
143229533|NCT02587520|516388673|FG009|Overall Study|Protocol Violation|3|||
143229534|NCT02587520|516388674|FG010|Overall Study|Protocol Violation|1|||
143229535|NCT02587520|516388675|FG011|Overall Study|Protocol Violation|2|||
143229536|NCT02587520|516388676|FG012|Overall Study|Protocol Violation|0|||
143229537|NCT02587520|516388677|FG013|Overall Study|Protocol Violation|0|||
143229538|NCT02587520|516388678|FG014|Overall Study|Protocol Violation|0|||
143229539|NCT02587520|516388679|FG015|Overall Study|Protocol Violation|0|||
143229540|NCT02587520|516388680|FG016|Overall Study|Protocol Violation|0|||
143277795|NCT02034110|516570720|FG002|Overall Study|Withdrawal by Subject|0|||
143277796|NCT02034110|516570721|FG003|Overall Study|Withdrawal by Subject|3|||
143277797|NCT02034110|516570722|FG004|Overall Study|Withdrawal by Subject|7|||
143277798|NCT02034110|516570723|FG005|Overall Study|Withdrawal by Subject|0|||
143277799|NCT02034110|516570724|FG006|Overall Study|Withdrawal by Subject|3|||
143277800|NCT02034110|516570725|FG007|Overall Study|Withdrawal by Subject|1|||
143277801|NCT02034110|516570718|FG000|Overall Study|Study closed by sponsor|6|||
143277802|NCT02034110|516570719|FG001|Overall Study|Study closed by sponsor|2|||
143277803|NCT02034110|516570720|FG002|Overall Study|Study closed by sponsor|0|||
143277804|NCT02034110|516570721|FG003|Overall Study|Study closed by sponsor|6|||
143277805|NCT02034110|516570722|FG004|Overall Study|Study closed by sponsor|7|||
143277806|NCT02034110|516570723|FG005|Overall Study|Study closed by sponsor|0|||
143277807|NCT02034110|516570724|FG006|Overall Study|Study closed by sponsor|42|||
143277808|NCT02034110|516570725|FG007|Overall Study|Study closed by sponsor|0|||
143277809|NCT02587234|516570726|FG000|Overall Study|Withdrawal by Subject|1|||
143277810|NCT02587234|516570727|FG001|Overall Study|Withdrawal by Subject|1|||
143277811|NCT02587234|516570726|FG000|Overall Study|Lost to Follow-up|0|||
143277812|NCT02587234|516570727|FG001|Overall Study|Lost to Follow-up|2|||
143277813|NCT01877265|516570728|FG000|Treatment Period 1|Sponsor Decision|0|||
143277814|NCT01877265|516570729|FG001|Treatment Period 1|Sponsor Decision|0|||
143277815|NCT01877265|516570730|FG002|Treatment Period 1|Sponsor Decision|1|||
143277816|NCT01877265|516570731|FG003|Treatment Period 1|Sponsor Decision|0|||
143277817|NCT01877265|516570732|FG004|Treatment Period 1|Sponsor Decision|0|||
143277818|NCT01877265|516570733|FG005|Treatment Period 1|Sponsor Decision|0|||
143277819|NCT01877265|516570728|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
143277820|NCT01877265|516570729|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
143277821|NCT01877265|516570730|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
143277822|NCT01877265|516570731|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
143277823|NCT01877265|516570732|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
143277824|NCT01877265|516570733|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
143277825|NCT01877265|516570728|FG000|Treatment Period 3|Lost to Follow-up|1|||
143277826|NCT01877265|516570729|FG001|Treatment Period 3|Lost to Follow-up|0|||
143277827|NCT01877265|516570730|FG002|Treatment Period 3|Lost to Follow-up|0|||
143277828|NCT01877265|516570731|FG003|Treatment Period 3|Lost to Follow-up|0|||
143277829|NCT01877265|516570732|FG004|Treatment Period 3|Lost to Follow-up|0|||
143277830|NCT01877265|516570733|FG005|Treatment Period 3|Lost to Follow-up|0|||
143277831|NCT00590720|516570739|FG000|Overall Study|Lost to Follow-up|1|||
143277832|NCT00590720|516570740|FG001|Overall Study|Lost to Follow-up|0|||
143277833|NCT00590720|516570739|FG000|Overall Study|Withdrawal by Subject|0|||
143277834|NCT00590720|516570740|FG001|Overall Study|Withdrawal by Subject|1|||
143277835|NCT02732119|516570743|FG000|Phase I|Adverse Event|1|||
143277836|NCT02732119|516570744|FG001|Phase I|Adverse Event|3|||
143277837|NCT02732119|516570745|FG002|Phase I|Adverse Event|1|||
143277838|NCT02732119|516570746|FG003|Phase I|Adverse Event|0|||
143277839|NCT02732119|516570747|FG004|Phase I|Adverse Event|0|||
143277840|NCT02732119|516570743|FG000|Phase I|Progressive disease|7|||
143277841|NCT02732119|516570744|FG001|Phase I|Progressive disease|3|||
143277842|NCT02732119|516570745|FG002|Phase I|Progressive disease|2|||
143277843|NCT02732119|516570746|FG003|Phase I|Progressive disease|0|||
143277844|NCT02732119|516570747|FG004|Phase I|Progressive disease|0|||
143277845|NCT02732119|516570743|FG000|Phase I|Protocol deviation|0|||
143277846|NCT02732119|516570744|FG001|Phase I|Protocol deviation|1|||
143277847|NCT02732119|516570745|FG002|Phase I|Protocol deviation|0|||
143277848|NCT02732119|516570746|FG003|Phase I|Protocol deviation|0|||
143277849|NCT02732119|516570747|FG004|Phase I|Protocol deviation|0|||
143277850|NCT02732119|516570743|FG000|Phase I|Physician Decision|0|||
143277851|NCT02732119|516570744|FG001|Phase I|Physician Decision|3|||
143277852|NCT02732119|516570745|FG002|Phase I|Physician Decision|4|||
143277853|NCT02732119|516570746|FG003|Phase I|Physician Decision|0|||
143277854|NCT02732119|516570747|FG004|Phase I|Physician Decision|0|||
143277855|NCT02732119|516570743|FG000|Phase II|Adverse Event|0|||
143277856|NCT02732119|516570744|FG001|Phase II|Adverse Event|0|||
143277857|NCT02732119|516570745|FG002|Phase II|Adverse Event|0|||
143277858|NCT02732119|516570746|FG003|Phase II|Adverse Event|3|||
143277859|NCT02732119|516570747|FG004|Phase II|Adverse Event|3|||
143277860|NCT02732119|516570743|FG000|Phase II|Death|0|||
143277861|NCT02732119|516570744|FG001|Phase II|Death|0|||
143277862|NCT02732119|516570745|FG002|Phase II|Death|0|||
143277863|NCT02732119|516570746|FG003|Phase II|Death|1|||
143277864|NCT02732119|516570747|FG004|Phase II|Death|0|||
143277865|NCT02732119|516570743|FG000|Phase II|Progressive dissease|0|||
143277866|NCT02732119|516570744|FG001|Phase II|Progressive dissease|0|||
143277867|NCT02732119|516570745|FG002|Phase II|Progressive dissease|0|||
143277868|NCT02732119|516570746|FG003|Phase II|Progressive dissease|30|||
143277869|NCT02732119|516570747|FG004|Phase II|Progressive dissease|23|||
143277870|NCT02732119|516570743|FG000|Phase II|Study terminated by sponsor|0|||
143277871|NCT02732119|516570744|FG001|Phase II|Study terminated by sponsor|0|||
143277872|NCT02732119|516570745|FG002|Phase II|Study terminated by sponsor|0|||
143277873|NCT02732119|516570746|FG003|Phase II|Study terminated by sponsor|2|||
143277874|NCT02732119|516570747|FG004|Phase II|Study terminated by sponsor|2|||
143277875|NCT02732119|516570743|FG000|Phase II|Other|0|||
143229541|NCT02587520|516388681|FG017|Overall Study|Protocol Violation|0|||
143229542|NCT02587520|516388664|FG000|Overall Study|Adverse Event|0|||
143229543|NCT02587520|516388665|FG001|Overall Study|Adverse Event|0|||
143229544|NCT02587520|516388666|FG002|Overall Study|Adverse Event|0|||
143229545|NCT02587520|516388667|FG003|Overall Study|Adverse Event|0|||
143229546|NCT02587520|516388668|FG004|Overall Study|Adverse Event|0|||
143229547|NCT02587520|516388669|FG005|Overall Study|Adverse Event|0|||
143229548|NCT02587520|516388670|FG006|Overall Study|Adverse Event|0|||
143229549|NCT02587520|516388671|FG007|Overall Study|Adverse Event|0|||
143229550|NCT02587520|516388672|FG008|Overall Study|Adverse Event|0|||
143229551|NCT02587520|516388673|FG009|Overall Study|Adverse Event|0|||
143229552|NCT02587520|516388674|FG010|Overall Study|Adverse Event|0|||
143229553|NCT02587520|516388675|FG011|Overall Study|Adverse Event|1|||
143229554|NCT02587520|516388676|FG012|Overall Study|Adverse Event|0|||
143229555|NCT02587520|516388677|FG013|Overall Study|Adverse Event|0|||
143229556|NCT02587520|516388678|FG014|Overall Study|Adverse Event|0|||
143229557|NCT02587520|516388679|FG015|Overall Study|Adverse Event|0|||
143229558|NCT02587520|516388680|FG016|Overall Study|Adverse Event|0|||
143229559|NCT02587520|516388681|FG017|Overall Study|Adverse Event|0|||
143229560|NCT02587520|516388664|FG000|Overall Study|Withdrawal by Subject|0|||
143229561|NCT02587520|516388665|FG001|Overall Study|Withdrawal by Subject|0|||
143229562|NCT02587520|516388666|FG002|Overall Study|Withdrawal by Subject|1|||
143229563|NCT02587520|516388667|FG003|Overall Study|Withdrawal by Subject|1|||
143229564|NCT02587520|516388668|FG004|Overall Study|Withdrawal by Subject|0|||
143229565|NCT02587520|516388669|FG005|Overall Study|Withdrawal by Subject|1|||
143229566|NCT02587520|516388670|FG006|Overall Study|Withdrawal by Subject|1|||
143229567|NCT02587520|516388671|FG007|Overall Study|Withdrawal by Subject|0|||
143229568|NCT02587520|516388672|FG008|Overall Study|Withdrawal by Subject|0|||
143229569|NCT02587520|516388673|FG009|Overall Study|Withdrawal by Subject|0|||
143229570|NCT02587520|516388674|FG010|Overall Study|Withdrawal by Subject|0|||
143229571|NCT02587520|516388675|FG011|Overall Study|Withdrawal by Subject|0|||
143229572|NCT02587520|516388676|FG012|Overall Study|Withdrawal by Subject|0|||
143229573|NCT02587520|516388677|FG013|Overall Study|Withdrawal by Subject|1|||
143229574|NCT02587520|516388678|FG014|Overall Study|Withdrawal by Subject|0|||
143229575|NCT02587520|516388679|FG015|Overall Study|Withdrawal by Subject|0|||
143229576|NCT02587520|516388680|FG016|Overall Study|Withdrawal by Subject|0|||
143229577|NCT02587520|516388681|FG017|Overall Study|Withdrawal by Subject|0|||
143229578|NCT02587520|516388664|FG000|Overall Study|Lost to Follow-up|0|||
143229579|NCT02587520|516388665|FG001|Overall Study|Lost to Follow-up|2|||
143229580|NCT02587520|516388666|FG002|Overall Study|Lost to Follow-up|0|||
143229581|NCT02587520|516388667|FG003|Overall Study|Lost to Follow-up|2|||
143229582|NCT02587520|516388668|FG004|Overall Study|Lost to Follow-up|0|||
143229583|NCT02587520|516388669|FG005|Overall Study|Lost to Follow-up|1|||
143229584|NCT02587520|516388670|FG006|Overall Study|Lost to Follow-up|1|||
143229585|NCT02587520|516388671|FG007|Overall Study|Lost to Follow-up|1|||
143229586|NCT02587520|516388672|FG008|Overall Study|Lost to Follow-up|0|||
143229587|NCT02587520|516388673|FG009|Overall Study|Lost to Follow-up|2|||
143229588|NCT02587520|516388674|FG010|Overall Study|Lost to Follow-up|2|||
143229589|NCT02587520|516388675|FG011|Overall Study|Lost to Follow-up|1|||
143229590|NCT02587520|516388676|FG012|Overall Study|Lost to Follow-up|0|||
143229591|NCT02587520|516388677|FG013|Overall Study|Lost to Follow-up|0|||
143229592|NCT02587520|516388678|FG014|Overall Study|Lost to Follow-up|0|||
143229593|NCT02587520|516388679|FG015|Overall Study|Lost to Follow-up|0|||
143229594|NCT02587520|516388680|FG016|Overall Study|Lost to Follow-up|0|||
143229595|NCT02587520|516388681|FG017|Overall Study|Lost to Follow-up|0|||
143229596|NCT03585660|516388684|FG000|Overall Study|operator error|1|||
143229597|NCT03585660|516388684|FG000|Overall Study|technical error|2|||
143229598|NCT03585660|516388684|FG000|Overall Study|hip prosthesis|2|||
143229599|NCT03585660|516388684|FG000|Overall Study|did not undergo biopsy|8|||
143229600|NCT03585660|516388684|FG000|Overall Study|scanner problem|2|||
143229601|NCT00435409|516388685|FG000|Overall Study|Protocol Violation|1|||
143229602|NCT00435409|516388686|FG001|Overall Study|Protocol Violation|2|||
143229603|NCT00435409|516388687|FG002|Overall Study|Protocol Violation|0|||
143229604|NCT00435409|516388685|FG000|Overall Study|Lost to Follow-up|1|||
143229605|NCT00435409|516388686|FG001|Overall Study|Lost to Follow-up|2|||
143229606|NCT00435409|516388687|FG002|Overall Study|Lost to Follow-up|0|||
143229607|NCT00435409|516388685|FG000|Overall Study|Death|8|||
143229608|NCT00435409|516388686|FG001|Overall Study|Death|6|||
143229609|NCT00435409|516388687|FG002|Overall Study|Death|6|||
143229610|NCT00435409|516388685|FG000|Overall Study|Objective progression or relapse|158|||
143229611|NCT00435409|516388686|FG001|Overall Study|Objective progression or relapse|93|||
143229612|NCT00435409|516388687|FG002|Overall Study|Objective progression or relapse|58|||
143229613|NCT00435409|516388685|FG000|Overall Study|Global deterioration of health status|0|||
143229614|NCT00435409|516388686|FG001|Overall Study|Global deterioration of health status|0|||
143229615|NCT00435409|516388687|FG002|Overall Study|Global deterioration of health status|4|||
143277876|NCT02732119|516570744|FG001|Phase II|Other|0|||
143277877|NCT02732119|516570745|FG002|Phase II|Other|0|||
143277878|NCT02732119|516570746|FG003|Phase II|Other|2|||
143277879|NCT02732119|516570747|FG004|Phase II|Other|0|||
143277880|NCT02732119|516570743|FG000|Phase II|Physician Decision|0|||
143277881|NCT02732119|516570744|FG001|Phase II|Physician Decision|0|||
143277882|NCT02732119|516570745|FG002|Phase II|Physician Decision|0|||
143277883|NCT02732119|516570746|FG003|Phase II|Physician Decision|8|||
143277884|NCT02732119|516570747|FG004|Phase II|Physician Decision|5|||
143277885|NCT02193867|516570748|FG000|Overall Study|Death|2|||
143277886|NCT02193867|516570748|FG000|Overall Study|Sponsor Study Termination|2|||
143277887|NCT01056653|516570749|FG000|Overall Study|Lost to Follow-up|0|||
143277888|NCT01056653|516570750|FG001|Overall Study|Lost to Follow-up|0|||
143277889|NCT01056653|516570751|FG002|Overall Study|Lost to Follow-up|2|||
143277890|NCT00781274|516570755|FG000|Overall Study|Withdrawal by Subject|2|||
143277891|NCT03344796|516570756|FG000|Overall Study|Lost to Follow-up|0|||
143277892|NCT03344796|516570757|FG001|Overall Study|Lost to Follow-up|0|||
143277893|NCT03344796|516570758|FG002|Overall Study|Lost to Follow-up|0|||
143277894|NCT03344796|516570759|FG003|Overall Study|Lost to Follow-up|0|||
143277895|NCT03344796|516570760|FG004|Overall Study|Lost to Follow-up|0|||
143277896|NCT03344796|516570761|FG005|Overall Study|Lost to Follow-up|2|||
143277897|NCT01201850|516570764|FG000|Overall Study|Tumor progression|4|||
143277898|NCT00816595|516570769|FG000|Overall Study|Withdrawal by Subject|2|||
143277899|NCT00816595|516570770|FG001|Overall Study|Withdrawal by Subject|0|||
143277900|NCT00566995|516570772|FG000|Overall Study|Toxicity|4|||
143277901|NCT00566995|516570772|FG000|Overall Study|Withdrew consent|3|||
143277902|NCT01558271|516570773|FG000|Overall Study|Adverse Event|6|||
143277903|NCT01558271|516570774|FG001|Overall Study|Adverse Event|3|||
143277904|NCT01558271|516570775|FG002|Overall Study|Adverse Event|4|||
143277905|NCT01558271|516570773|FG000|Overall Study|Lost to Follow-up|1|||
143277906|NCT01558271|516570774|FG001|Overall Study|Lost to Follow-up|0|||
143277907|NCT01558271|516570775|FG002|Overall Study|Lost to Follow-up|0|||
143277908|NCT01558271|516570773|FG000|Overall Study|Protocol Violation|1|||
143277909|NCT01558271|516570774|FG001|Overall Study|Protocol Violation|0|||
143277910|NCT01558271|516570775|FG002|Overall Study|Protocol Violation|0|||
143277911|NCT01558271|516570773|FG000|Overall Study|Withdrawal by Subject|10|||
143277912|NCT01558271|516570774|FG001|Overall Study|Withdrawal by Subject|6|||
143277913|NCT01558271|516570775|FG002|Overall Study|Withdrawal by Subject|12|||
143277914|NCT01558271|516570773|FG000|Overall Study|Physician Decision|0|||
143277915|NCT01558271|516570774|FG001|Overall Study|Physician Decision|2|||
143277916|NCT01558271|516570775|FG002|Overall Study|Physician Decision|1|||
143277917|NCT00743483|516570776|FG000|Baseline Period|Physician Decision|1|||
143277918|NCT00743483|516570776|FG000|Treatment Period|Adverse Event|1|||
143277919|NCT01084083|516570777|FG000|Overall Study|Adverse Event|5|||
143277920|NCT01084083|516570777|FG000|Overall Study|Death|1|||
143277921|NCT01084083|516570777|FG000|Overall Study|Withdrawal by Subject|2|||
143277922|NCT01084083|516570777|FG000|Overall Study|Complicating disease|1|||
143277923|NCT01084083|516570777|FG000|Overall Study|Other|2|||
143277924|NCT01084083|516570777|FG000|Overall Study|Never started assigned therapy|1|||
143277925|NCT00228384|516570778|FG000|Overall Study|Death|9|||
143277926|NCT00228384|516570779|FG001|Overall Study|Death|3|||
143277927|NCT00228384|516570778|FG000|Overall Study|Lost to Follow-up|6|||
143277928|NCT00228384|516570779|FG001|Overall Study|Lost to Follow-up|10|||
143277929|NCT00228384|516570778|FG000|Overall Study|Surgical Intervention (bypass)|5|||
143277930|NCT00228384|516570779|FG001|Overall Study|Surgical Intervention (bypass)|5|||
143277931|NCT00228384|516570778|FG000|Overall Study|Withdrawal by Subject|9|||
143277932|NCT00228384|516570779|FG001|Overall Study|Withdrawal by Subject|10|||
143277933|NCT00228384|516570778|FG000|Overall Study|Physician Decision|0|||
143277934|NCT00228384|516570779|FG001|Overall Study|Physician Decision|1|||
143277935|NCT01273597|516570780|FG000|Overall Study|Adverse Event|5|||
143277936|NCT01273597|516570780|FG000|Overall Study|Underwent Kidney Transplantation|2|||
143277937|NCT01273597|516570780|FG000|Overall Study|Reason Not Reported|1|||
143277938|NCT00873912|516570782|FG000|Overall Study|Withdrawal by Subject|1|||
143277939|NCT00873912|516570783|FG001|Overall Study|Withdrawal by Subject|0|||
143277940|NCT00873912|516570782|FG000|Overall Study|Lost to Follow-up|2|||
143277941|NCT00873912|516570783|FG001|Overall Study|Lost to Follow-up|0|||
143277942|NCT01466153|516570786|FG000|Overall Study|Disease Progression|2|||
143277943|NCT01466153|516570787|FG001|Overall Study|Disease Progression|2|||
143277944|NCT01466153|516570788|FG002|Overall Study|Disease Progression|0|||
143277945|NCT01466153|516570786|FG000|Overall Study|Adverse Event|14|||
143277946|NCT01466153|516570787|FG001|Overall Study|Adverse Event|13|||
143277947|NCT01466153|516570788|FG002|Overall Study|Adverse Event|17|||
143277948|NCT01466153|516570786|FG000|Overall Study|Withdrawal of Consent|2|||
143277949|NCT01466153|516570787|FG001|Overall Study|Withdrawal of Consent|0|||
143277950|NCT01466153|516570788|FG002|Overall Study|Withdrawal of Consent|0|||
143277951|NCT01466153|516570786|FG000|Overall Study|Investigator Discretion|3|||
143277952|NCT01466153|516570787|FG001|Overall Study|Investigator Discretion|2|||
143277953|NCT01466153|516570788|FG002|Overall Study|Investigator Discretion|2|||
143277954|NCT01466153|516570786|FG000|Overall Study|Randomized-Not Treated|2|||
143277955|NCT01466153|516570787|FG001|Overall Study|Randomized-Not Treated|3|||
143277956|NCT01466153|516570788|FG002|Overall Study|Randomized-Not Treated|4|||
143277957|NCT01466153|516570786|FG000|Overall Study|Other-Unspecified|6|||
143277958|NCT01466153|516570787|FG001|Overall Study|Other-Unspecified|4|||
143277959|NCT01466153|516570788|FG002|Overall Study|Other-Unspecified|2|||
143277960|NCT01785069|516570792|FG000|Overall Study|Implanted with nonstudy device|1|||
143277961|NCT01785069|516570793|FG001|Overall Study|Implanted with nonstudy device|2|||
143277962|NCT01785069|516570794|FG002|Overall Study|Implanted with nonstudy device|1|||
143277963|NCT01785069|516570795|FG003|Overall Study|Implanted with nonstudy device|0|||
143277964|NCT01785069|516570792|FG000|Overall Study|Death|0|||
143277965|NCT01785069|516570793|FG001|Overall Study|Death|0|||
143277966|NCT01785069|516570794|FG002|Overall Study|Death|2|||
143277967|NCT01785069|516570795|FG003|Overall Study|Death|0|||
143277968|NCT01785069|516570792|FG000|Overall Study|Subject choice|2|||
143277969|NCT01785069|516570793|FG001|Overall Study|Subject choice|2|||
143277970|NCT01785069|516570794|FG002|Overall Study|Subject choice|0|||
143277971|NCT01785069|516570795|FG003|Overall Study|Subject choice|1|||
143277972|NCT01785069|516570792|FG000|Overall Study|Lost to Follow-up|1|||
143277973|NCT01785069|516570793|FG001|Overall Study|Lost to Follow-up|2|||
143277974|NCT01785069|516570794|FG002|Overall Study|Lost to Follow-up|4|||
143277975|NCT01785069|516570795|FG003|Overall Study|Lost to Follow-up|1|||
143277976|NCT01785069|516570792|FG000|Overall Study|Reason not Specified|1|||
143277977|NCT01785069|516570793|FG001|Overall Study|Reason not Specified|2|||
143277978|NCT01785069|516570794|FG002|Overall Study|Reason not Specified|1|||
143277979|NCT01785069|516570795|FG003|Overall Study|Reason not Specified|4|||
143277980|NCT01785069|516570792|FG000|Overall Study|Not evaluable|7|||
143277981|NCT01785069|516570793|FG001|Overall Study|Not evaluable|4|||
143277982|NCT01785069|516570794|FG002|Overall Study|Not evaluable|5|||
143277983|NCT01785069|516570795|FG003|Overall Study|Not evaluable|8|||
143277984|NCT01088997|516570800|FG000|Overall Study|Physician Decision|1|||
143277985|NCT01088997|516570801|FG001|Overall Study|Physician Decision|1|||
143277986|NCT01088997|516570800|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
143277987|NCT01088997|516570801|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
143277988|NCT01088997|516570800|FG000|Overall Study|Excluded prior to receiving drug|1|||
143277989|NCT01088997|516570801|FG001|Overall Study|Excluded prior to receiving drug|1|||
143277990|NCT05570500|516570806|FG000|Overall Study|Lost to Follow-up|7|||
143277991|NCT05570500|516570807|FG001|Overall Study|Lost to Follow-up|5|||
143277992|NCT01980940|516570809|FG000|Overall Study|Protocol Violation|0|||
143277993|NCT01980940|516570810|FG001|Overall Study|Protocol Violation|0|||
143277994|NCT01980940|516570811|FG002|Overall Study|Protocol Violation|0|||
143277995|NCT01980940|516570812|FG003|Overall Study|Protocol Violation|0|||
143277996|NCT01980940|516570813|FG004|Overall Study|Protocol Violation|0|||
143277997|NCT01980940|516570814|FG005|Overall Study|Protocol Violation|2|||
143277998|NCT01980940|516570815|FG006|Overall Study|Protocol Violation|0|||
143277999|NCT01980940|516570816|FG007|Overall Study|Protocol Violation|0|||
143278000|NCT05695209|516570821|FG000|3-months|Withdrawal by Subject|2|||
143278001|NCT05695209|516570822|FG001|3-months|Withdrawal by Subject|0|||
143278002|NCT05695209|516570821|FG000|3-months|Unable to contact for 3-month data collection|0|||
143278003|NCT05695209|516570822|FG001|3-months|Unable to contact for 3-month data collection|1|||
143278004|NCT05695209|516570821|FG000|6-months|Lost to Follow-up|1|||
143278005|NCT05695209|516570822|FG001|6-months|Lost to Follow-up|1|||
143278006|NCT05358444|516570823|FG000|Overall Study|Withdrawal by Subject|0|||
143278007|NCT05358444|516570824|FG001|Overall Study|Withdrawal by Subject|1|||
143278008|NCT05358444|516570823|FG000|Overall Study|Lost to Follow-up|0|||
143278009|NCT05358444|516570824|FG001|Overall Study|Lost to Follow-up|3|||
143278010|NCT05372419|516570828|FG000|Overall Study|Protocol Deviation|1|||
143278011|NCT05372419|516570828|FG000|Overall Study|Withdrawal by Subject|5|||
143278012|NCT05372419|516570828|FG000|Overall Study|Lost to Follow-up|7|||
143278013|NCT04362072|516570831|FG000|Treatment|Adverse Event|1|||
143278014|NCT04362072|516570831|FG000|Treatment|Death|9|||
143278015|NCT04362072|516570831|FG000|Treatment|Physician Decision|2|||
143278016|NCT04362072|516570831|FG000|Treatment|Progressive disease|27|||
143278017|NCT04362072|516570831|FG000|Treatment|Withdrawal by Subject|4|||
143278018|NCT04362072|516570831|FG000|Treatment|Global deterioration of health status|1|||
143278019|NCT04362072|516570831|FG000|Treatment|Switched to commercial Lorlatinib|13|||
143278020|NCT04362072|516570831|FG000|Treatment|Entered Lorlatinib continuation Study|11|||
143278021|NCT04362072|516570831|FG000|Treatment|Other|3|||
143278022|NCT04362072|516570831|FG000|Follow up|Death|2|||
143278023|NCT04362072|516570831|FG000|Follow up|Other|2|||
143278024|NCT04731363|516570832|FG000|Overall Study|Could not obtain samples|0|||
143278025|NCT04731363|516570833|FG001|Overall Study|Could not obtain samples|1|||
143278026|NCT04731363|516570834|FG002|Overall Study|Could not obtain samples|0|||
143278027|NCT04731363|516570835|FG003|Overall Study|Could not obtain samples|0|||
143278028|NCT04731363|516570832|FG000|Overall Study|Physician Decision|0|||
143278029|NCT04731363|516570833|FG001|Overall Study|Physician Decision|1|||
143278030|NCT04731363|516570834|FG002|Overall Study|Physician Decision|0|||
143278031|NCT04731363|516570835|FG003|Overall Study|Physician Decision|0|||
143278032|NCT04997304|516570836|FG000|Overall Study|Lost to Follow-up|11|||
143278033|NCT04997304|516570836|FG000|Overall Study|Death|1|||
143278034|NCT04997304|516570836|FG000|Overall Study|Withdrawal by Subject|14|||
143278035|NCT04560998|516570837|FG000|Overall Study|Withdrawal by Subject|18|||
143278036|NCT04560998|516570838|FG001|Overall Study|Withdrawal by Subject|12|||
143278037|NCT04560998|516570837|FG000|Overall Study|Lost to Follow-up|8|||
143278038|NCT04560998|516570838|FG001|Overall Study|Lost to Follow-up|5|||
143278039|NCT04560998|516570837|FG000|Overall Study|Physician Decision|4|||
143278040|NCT04560998|516570838|FG001|Overall Study|Physician Decision|0|||
143278041|NCT00867568|516572590|FG000|Overall Study|Lack of Efficacy|10|||
143278042|NCT00867568|516572590|FG000|Overall Study|Adverse Event|4|||
143278043|NCT00867568|516572590|FG000|Overall Study|Withdrawal by Subject|1|||
143278044|NCT03639935|516572591|FG000|Overall Study|Death|3|||
143278045|NCT03639935|516572591|FG000|Overall Study|Adverse Event|1|||
143278046|NCT03727230|516572593|FG000|Overall Study|Lost to Follow-up|12|||
143278047|NCT02059395|516572594|FG000|Overall Study|Lost to Follow-up|2|||
143278048|NCT02059395|516572595|FG001|Overall Study|Lost to Follow-up|4|||
143278049|NCT01606007|516572597|FG000|Overall Study|Reason 'Other' in the protocol|0|||
143278050|NCT01606007|516572598|FG001|Overall Study|Reason 'Other' in the protocol|1|||
143278051|NCT01606007|516572599|FG002|Overall Study|Reason 'Other' in the protocol|1|||
143278052|NCT01606007|516572597|FG000|Overall Study|Pregnancy|0|||
143278053|NCT01606007|516572598|FG001|Overall Study|Pregnancy|1|||
143278054|NCT01606007|516572599|FG002|Overall Study|Pregnancy|1|||
143278055|NCT01606007|516572597|FG000|Overall Study|Withdrawal by Subject|8|||
143278056|NCT01606007|516572598|FG001|Overall Study|Withdrawal by Subject|6|||
143278057|NCT01606007|516572599|FG002|Overall Study|Withdrawal by Subject|1|||
143278058|NCT01606007|516572597|FG000|Overall Study|Adverse Event|0|||
143278059|NCT01606007|516572598|FG001|Overall Study|Adverse Event|1|||
143278060|NCT01606007|516572599|FG002|Overall Study|Adverse Event|1|||
143278061|NCT01606007|516572597|FG000|Overall Study|discontinue study treatment|0|||
143278062|NCT01606007|516572598|FG001|Overall Study|discontinue study treatment|2|||
143278063|NCT01606007|516572599|FG002|Overall Study|discontinue study treatment|1|||
143278064|NCT01606007|516572597|FG000|Overall Study|Lost to Follow-up|6|||
143278065|NCT01606007|516572598|FG001|Overall Study|Lost to Follow-up|8|||
143278066|NCT01606007|516572599|FG002|Overall Study|Lost to Follow-up|5|||
143278067|NCT01606007|516572597|FG000|Overall Study|Poor/Non-compliance|1|||
143278068|NCT01606007|516572598|FG001|Overall Study|Poor/Non-compliance|0|||
143278069|NCT01606007|516572599|FG002|Overall Study|Poor/Non-compliance|0|||
143278070|NCT00555971|516572602|FG000|Overall Study|Adverse Event|1|||
143278071|NCT00555971|516572603|FG001|Overall Study|Adverse Event|1|||
143278072|NCT00518284|516572604|FG000|Overall Study|Adverse Event|0|||
143278073|NCT00518284|516572605|FG001|Overall Study|Adverse Event|1|||
143278074|NCT00518284|516572606|FG002|Overall Study|Adverse Event|0|||
143278075|NCT00518284|516572607|FG003|Overall Study|Adverse Event|0|||
143278076|NCT00518284|516572604|FG000|Overall Study|Study Termination|0|||
143278077|NCT00518284|516572605|FG001|Overall Study|Study Termination|2|||
143278078|NCT00518284|516572606|FG002|Overall Study|Study Termination|1|||
143278079|NCT00518284|516572607|FG003|Overall Study|Study Termination|2|||
143278080|NCT03768414|516572608|FG000|Overall Study|Adverse Event or side effects|72|||
143278081|NCT03768414|516572609|FG001|Overall Study|Adverse Event or side effects|28|||
143278082|NCT03768414|516572608|FG000|Overall Study|Refusal unrelated to adverse event|33|||
143278083|NCT03768414|516572609|FG001|Overall Study|Refusal unrelated to adverse event|33|||
143278084|NCT03768414|516572608|FG000|Overall Study|Progression/relapse|132|||
143278085|NCT03768414|516572609|FG001|Overall Study|Progression/relapse|60|||
143278086|NCT03768414|516572608|FG000|Overall Study|Death|9|||
143278087|NCT03768414|516572609|FG001|Overall Study|Death|6|||
143278088|NCT03768414|516572608|FG000|Overall Study|Other - not protocol specified|45|||
143278089|NCT03768414|516572609|FG001|Overall Study|Other - not protocol specified|18|||
143278090|NCT03768414|516572608|FG000|Overall Study|Reason under review|3|||
143278091|NCT03768414|516572609|FG001|Overall Study|Reason under review|2|||
143278092|NCT00801632|516572611|FG000|Overall Study|Re-transplant|1|||
143278093|NCT01496807|516572616|FG000|Overall Study|Progressive Disease|21|||
143278094|NCT01496807|516572616|FG000|Overall Study|Participant preference/toxicity|8|||
143278095|NCT01496807|516572616|FG000|Overall Study|Change in diagnosis|1|||
143278096|NCT03095612|516572625|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
143278097|NCT03095612|516572626|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
143278098|NCT03095612|516572627|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
143278099|NCT03095612|516572628|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
143278100|NCT03095612|516572629|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
143278101|NCT03095612|516572630|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
143278102|NCT03095612|516572631|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
143278103|NCT04447794|516572632|FG000|Overall Study|Lost to Follow-up|2|||
143278104|NCT04447794|516572633|FG001|Overall Study|Lost to Follow-up|3|||
143278105|NCT04447794|516572634|FG002|Overall Study|Lost to Follow-up|8|||
143278106|NCT04447794|516572632|FG000|Overall Study|Withdrawal by Subject|1|||
143278107|NCT04447794|516572633|FG001|Overall Study|Withdrawal by Subject|1|||
143278108|NCT04447794|516572634|FG002|Overall Study|Withdrawal by Subject|0|||
143278109|NCT02197520|516572635|FG000|Period 1|Withdrawal by Subject|1|||
143278110|NCT02197520|516572636|FG001|Period 1|Withdrawal by Subject|0|||
143278111|NCT02197520|516572635|FG000|Period 2|Adverse Event|0|||
143278112|NCT02197520|516572636|FG001|Period 2|Adverse Event|2|||
143278113|NCT02197520|516572635|FG000|Period 2|Withdrawal by Subject|1|||
143278114|NCT02197520|516572636|FG001|Period 2|Withdrawal by Subject|0|||
143278115|NCT01235689|516572638|FG000|Overall Study|Adverse Event|12|||
143278116|NCT01235689|516572639|FG001|Overall Study|Adverse Event|16|||
143278117|NCT01235689|516572638|FG000|Overall Study|Lack of Efficacy|12|||
143278118|NCT01235689|516572639|FG001|Overall Study|Lack of Efficacy|5|||
143278119|NCT01235689|516572638|FG000|Overall Study|Withdrawal by Subject|3|||
143278120|NCT01235689|516572639|FG001|Overall Study|Withdrawal by Subject|4|||
143278121|NCT01235689|516572638|FG000|Overall Study|Lost to Follow-up|1|||
143278122|NCT01235689|516572639|FG001|Overall Study|Lost to Follow-up|2|||
143278123|NCT01235689|516572638|FG000|Overall Study|Miscellaneous|1|||
143278124|NCT01235689|516572639|FG001|Overall Study|Miscellaneous|5|||
143278125|NCT01390649|516572640|FG000|Overall Study|Physician Decision|1|||
143278126|NCT00389597|516572645|FG000|Overall Study|Lost to Follow-up|8|||
143278127|NCT00389597|516572646|FG001|Overall Study|Lost to Follow-up|6|||
143278128|NCT00389597|516572647|FG002|Overall Study|Lost to Follow-up|4|||
143278129|NCT00389597|516572648|FG003|Overall Study|Lost to Follow-up|6|||
143278130|NCT00334958|516572649|FG000|Overall Study|Medication Noncompliance|0|||
143278131|NCT00334958|516572650|FG001|Overall Study|Medication Noncompliance|3|||
143278132|NCT00334958|516572649|FG000|Overall Study|Protocol Violation|2|||
143278133|NCT00334958|516572650|FG001|Overall Study|Protocol Violation|2|||
143278134|NCT00334958|516572649|FG000|Overall Study|Request of the investigator or sponsor|0|||
143278135|NCT00334958|516572650|FG001|Overall Study|Request of the investigator or sponsor|1|||
143278136|NCT00334958|516572649|FG000|Overall Study|Withdrawal by Subject|7|||
143278137|NCT00334958|516572650|FG001|Overall Study|Withdrawal by Subject|4|||
143278138|NCT00334958|516572649|FG000|Overall Study|Adverse Event|27|||
143278139|NCT00334958|516572650|FG001|Overall Study|Adverse Event|12|||
143278140|NCT00334958|516572649|FG000|Overall Study|Other|1|||
143278141|NCT00334958|516572650|FG001|Overall Study|Other|2|||
143278142|NCT03988088|516572651|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
143278143|NCT03988088|516572652|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
143278144|NCT03988088|516572653|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
143278145|NCT03988088|516572654|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
143278146|NCT03988088|516572651|FG000|Open-Label Addendum|Lost to Follow-up|0|||
143278147|NCT03988088|516572652|FG001|Open-Label Addendum|Lost to Follow-up|0|||
143278148|NCT03988088|516572653|FG002|Open-Label Addendum|Lost to Follow-up|1|||
143278149|NCT03988088|516572654|FG003|Open-Label Addendum|Lost to Follow-up|0|||
143278150|NCT04431453|516572655|FG000|Overall Study|Withdrew Consent|0|||
143278151|NCT04431453|516572656|FG001|Overall Study|Withdrew Consent|1|||
143278152|NCT04431453|516572657|FG002|Overall Study|Withdrew Consent|0|||
143278153|NCT04431453|516572658|FG003|Overall Study|Withdrew Consent|2|||
143278154|NCT04431453|516572659|FG004|Overall Study|Withdrew Consent|0|||
143278155|NCT04431453|516572660|FG005|Overall Study|Withdrew Consent|0|||
143278156|NCT04431453|516572661|FG006|Overall Study|Withdrew Consent|0|||
143278157|NCT04431453|516572662|FG007|Overall Study|Withdrew Consent|0|||
143278158|NCT04431453|516572655|FG000|Overall Study|Death|1|||
143278159|NCT04431453|516572656|FG001|Overall Study|Death|0|||
143278160|NCT04431453|516572657|FG002|Overall Study|Death|0|||
143229616|NCT00435409|516388685|FG000|Overall Study|Withdrawal by Subject|8|||
143229617|NCT00435409|516388686|FG001|Overall Study|Withdrawal by Subject|7|||
143229618|NCT00435409|516388687|FG002|Overall Study|Withdrawal by Subject|1|||
143229619|NCT00435409|516388685|FG000|Overall Study|Other|45|||
143229620|NCT00435409|516388686|FG001|Overall Study|Other|30|||
143229621|NCT00435409|516388687|FG002|Overall Study|Other|1|||
143229622|NCT00435409|516388685|FG000|Overall Study|Adverse Event|0|||
143229623|NCT00435409|516388686|FG001|Overall Study|Adverse Event|0|||
143229624|NCT00435409|516388687|FG002|Overall Study|Adverse Event|8|||
143229625|NCT00435409|516388685|FG000|Overall Study|Sponsor decision|0|||
143229626|NCT00435409|516388686|FG001|Overall Study|Sponsor decision|3|||
143229627|NCT00435409|516388687|FG002|Overall Study|Sponsor decision|0|||
143229628|NCT05635461|516388688|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
143229629|NCT05635461|516388689|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
143229630|NCT05635461|516388690|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
143229631|NCT05635461|516388691|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
143229632|NCT05635461|516388692|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
143229633|NCT05635461|516388693|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
143229634|NCT05635461|516388688|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
143229635|NCT05635461|516388689|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
143229636|NCT05635461|516388690|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
143229637|NCT05635461|516388691|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
143229638|NCT05635461|516388692|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
143229639|NCT05635461|516388693|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
143229640|NCT05635461|516388688|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
143229641|NCT05635461|516388689|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
143229642|NCT05635461|516388690|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
143229643|NCT05635461|516388691|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
143229644|NCT05635461|516388692|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
143229645|NCT05635461|516388693|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
143229646|NCT03661723|516388696|FG000|Overall Study|Disease Progression|4|||
143229647|NCT03661723|516388697|FG001|Overall Study|Disease Progression|24|||
143229648|NCT03661723|516388698|FG002|Overall Study|Disease Progression|4|||
143229649|NCT03661723|516388699|FG003|Overall Study|Disease Progression|19|||
143229650|NCT03661723|516388696|FG000|Overall Study|Withdrawal by Subject|1|||
143229651|NCT03661723|516388697|FG001|Overall Study|Withdrawal by Subject|0|||
143229652|NCT03661723|516388698|FG002|Overall Study|Withdrawal by Subject|2|||
143229653|NCT03661723|516388699|FG003|Overall Study|Withdrawal by Subject|4|||
143229654|NCT03661723|516388696|FG000|Overall Study|Physician Decision|1|||
143229655|NCT03661723|516388697|FG001|Overall Study|Physician Decision|0|||
143229656|NCT03661723|516388698|FG002|Overall Study|Physician Decision|0|||
143229657|NCT03661723|516388699|FG003|Overall Study|Physician Decision|0|||
143229658|NCT03661723|516388696|FG000|Overall Study|Clinical Deterioration|0|||
143229659|NCT03661723|516388697|FG001|Overall Study|Clinical Deterioration|0|||
143229660|NCT03661723|516388698|FG002|Overall Study|Clinical Deterioration|0|||
143229661|NCT03661723|516388699|FG003|Overall Study|Clinical Deterioration|1|||
143229662|NCT01582061|516388700|FG000|Overall Study|Lack of Efficacy|3|||
143229663|NCT01582061|516388701|FG001|Overall Study|Lack of Efficacy|23|||
143229664|NCT01582061|516388700|FG000|Overall Study|Adverse Event|12|||
143229665|NCT01582061|516388701|FG001|Overall Study|Adverse Event|8|||
143229666|NCT01582061|516388700|FG000|Overall Study|Withdrawal by Subject|10|||
143229667|NCT01582061|516388701|FG001|Overall Study|Withdrawal by Subject|4|||
143229668|NCT01582061|516388700|FG000|Overall Study|Abnormal laboratory value(s)|1|||
143229669|NCT01582061|516388701|FG001|Overall Study|Abnormal laboratory value(s)|0|||
143229670|NCT01582061|516388700|FG000|Overall Study|Death|0|||
143229671|NCT01582061|516388701|FG001|Overall Study|Death|1|||
143229672|NCT01582061|516388700|FG000|Overall Study|condition no longer requires study drug|1|||
143229673|NCT01582061|516388701|FG001|Overall Study|condition no longer requires study drug|0|||
143229674|NCT01582061|516388700|FG000|Overall Study|Lost to Follow-up|1|||
143229675|NCT01582061|516388701|FG001|Overall Study|Lost to Follow-up|0|||
143229676|NCT01045460|516388702|FG000|Overall Study|Physician Decision|3|||
143229677|NCT01045460|516388703|FG001|Overall Study|Physician Decision|2|||
143229678|NCT01045460|516388702|FG000|Overall Study|Lost to Follow-up|0|||
143278161|NCT04431453|516572658|FG003|Overall Study|Death|0|||
143278162|NCT04431453|516572659|FG004|Overall Study|Death|0|||
143278163|NCT04431453|516572660|FG005|Overall Study|Death|0|||
143278164|NCT04431453|516572661|FG006|Overall Study|Death|0|||
143278165|NCT04431453|516572662|FG007|Overall Study|Death|1|||
143278166|NCT04431453|516572655|FG000|Overall Study|Lost to Follow-up|0|||
143278167|NCT04431453|516572656|FG001|Overall Study|Lost to Follow-up|0|||
143278168|NCT04431453|516572657|FG002|Overall Study|Lost to Follow-up|1|||
143278169|NCT04431453|516572658|FG003|Overall Study|Lost to Follow-up|1|||
143278170|NCT04431453|516572659|FG004|Overall Study|Lost to Follow-up|0|||
143278171|NCT04431453|516572660|FG005|Overall Study|Lost to Follow-up|0|||
143278172|NCT04431453|516572661|FG006|Overall Study|Lost to Follow-up|0|||
143278173|NCT04431453|516572662|FG007|Overall Study|Lost to Follow-up|0|||
143278174|NCT04431453|516572655|FG000|Overall Study|Enrolled but Never Treated|0|||
143278175|NCT04431453|516572656|FG001|Overall Study|Enrolled but Never Treated|0|||
143278176|NCT04431453|516572657|FG002|Overall Study|Enrolled but Never Treated|0|||
143278177|NCT04431453|516572658|FG003|Overall Study|Enrolled but Never Treated|0|||
143278178|NCT04431453|516572659|FG004|Overall Study|Enrolled but Never Treated|1|||
143278179|NCT04431453|516572660|FG005|Overall Study|Enrolled but Never Treated|0|||
143278180|NCT04431453|516572661|FG006|Overall Study|Enrolled but Never Treated|0|||
143278181|NCT04431453|516572662|FG007|Overall Study|Enrolled but Never Treated|0|||
143278182|NCT00622401|516572663|FG000|Overall Study|Disease progression prior to treatment|3|||
143278183|NCT00622401|516572664|FG001|Overall Study|Disease progression prior to treatment|2|||
143278184|NCT00622401|516572665|FG002|Overall Study|Disease progression prior to treatment|0|||
143278185|NCT02021773|516572672|FG000|Overall Study|Adverse Event|1|||
143278186|NCT02021773|516572673|FG001|Overall Study|Adverse Event|4|||
143278187|NCT02021773|516572674|FG002|Overall Study|Adverse Event|3|||
143278188|NCT02021773|516572672|FG000|Overall Study|Lack of Efficacy|2|||
143278189|NCT02021773|516572673|FG001|Overall Study|Lack of Efficacy|2|||
143278190|NCT02021773|516572674|FG002|Overall Study|Lack of Efficacy|2|||
143278191|NCT02021773|516572672|FG000|Overall Study|Protocol Violation|2|||
143278192|NCT02021773|516572673|FG001|Overall Study|Protocol Violation|3|||
143278193|NCT02021773|516572674|FG002|Overall Study|Protocol Violation|1|||
143278194|NCT02021773|516572672|FG000|Overall Study|Withdrawal by Subject|3|||
143278195|NCT02021773|516572673|FG001|Overall Study|Withdrawal by Subject|4|||
143278196|NCT02021773|516572674|FG002|Overall Study|Withdrawal by Subject|5|||
143278197|NCT02021773|516572672|FG000|Overall Study|Lost to Follow-up|1|||
143278198|NCT02021773|516572673|FG001|Overall Study|Lost to Follow-up|3|||
143278199|NCT02021773|516572674|FG002|Overall Study|Lost to Follow-up|0|||
143278200|NCT02021773|516572672|FG000|Overall Study|Reason not specified|3|||
143278201|NCT02021773|516572673|FG001|Overall Study|Reason not specified|0|||
143278202|NCT02021773|516572674|FG002|Overall Study|Reason not specified|0|||
143278203|NCT01534962|516572675|FG000|Overall Study|Randomized but did not start treatment|2|||
143278204|NCT01534962|516572676|FG001|Overall Study|Randomized but did not start treatment|0|||
143278205|NCT01534962|516572677|FG002|Overall Study|Randomized but did not start treatment|0|||
143278206|NCT01534962|516572678|FG003|Overall Study|Randomized but did not start treatment|1|||
143278207|NCT01534962|516572675|FG000|Overall Study|Discontinued at AF recurrence|35|||
143278208|NCT01534962|516572676|FG001|Overall Study|Discontinued at AF recurrence|26|||
143278209|NCT01534962|516572677|FG002|Overall Study|Discontinued at AF recurrence|24|||
143278210|NCT01534962|516572678|FG003|Overall Study|Discontinued at AF recurrence|31|||
143278211|NCT02243696|516572679|FG000|Overall Study|Death|282|||
143278212|NCT02243696|516572679|FG000|Overall Study|Withdrawal by Subject|79|||
143278213|NCT02243696|516572679|FG000|Overall Study|Lost to Follow-up|57|||
143278214|NCT02243696|516572679|FG000|Overall Study|Subject No Longer has Study System|42|||
143278215|NCT02243696|516572679|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
143278216|NCT02243696|516572679|FG000|Overall Study|Study Terminated for EP PASSION|961|||
143278217|NCT00282984|516572680|FG000|Overall Study|Death|2|||
143278218|NCT00282984|516572681|FG001|Overall Study|Death|5|||
143278219|NCT00282984|516572680|FG000|Overall Study|Adverse Event|8|||
143278220|NCT00282984|516572681|FG001|Overall Study|Adverse Event|5|||
143278221|NCT00282984|516572680|FG000|Overall Study|Lack of Efficacy|0|||
143278222|NCT00282984|516572681|FG001|Overall Study|Lack of Efficacy|2|||
143278223|NCT00282984|516572680|FG000|Overall Study|Lost to Follow-up|14|||
143278224|NCT00282984|516572681|FG001|Overall Study|Lost to Follow-up|10|||
143278225|NCT00282984|516572680|FG000|Overall Study|Withdrawal by Participant|22|||
143278226|NCT00282984|516572681|FG001|Overall Study|Withdrawal by Participant|34|||
143278227|NCT00282984|516572680|FG000|Overall Study|Participant stopped study medication|2|||
143278228|NCT00282984|516572681|FG001|Overall Study|Participant stopped study medication|2|||
143278229|NCT00282984|516572680|FG000|Overall Study|Participant only allowed phone follow-up|0|||
143278230|NCT00282984|516572681|FG001|Overall Study|Participant only allowed phone follow-up|1|||
143278231|NCT00282984|516572680|FG000|Overall Study|Participant used antipsychosis meds|0|||
143278232|NCT00282984|516572681|FG001|Overall Study|Participant used antipsychosis meds|1|||
143278233|NCT00282984|516572680|FG000|Overall Study|lack of motivation|1|||
143278234|NCT00282984|516572681|FG001|Overall Study|lack of motivation|0|||
143278235|NCT00282984|516572680|FG000|Overall Study|in prison|0|||
143278236|NCT00282984|516572681|FG001|Overall Study|in prison|1|||
143278237|NCT00282984|516572680|FG000|Overall Study|Protocol Violation|2|||
143278238|NCT00282984|516572681|FG001|Overall Study|Protocol Violation|0|||
143278239|NCT00191269|516572682|FG000|Overall Study|Protocol Violation|0|||
143278240|NCT00191269|516572683|FG001|Overall Study|Protocol Violation|2|||
143278241|NCT00191269|516572682|FG000|Overall Study|Adverse Event|1|||
143278242|NCT00191269|516572683|FG001|Overall Study|Adverse Event|4|||
143278243|NCT00191269|516572682|FG000|Overall Study|Progression of Disease|4|||
143278244|NCT00191269|516572683|FG001|Overall Study|Progression of Disease|42|||
143278245|NCT00191269|516572682|FG000|Overall Study|Lack of Efficacy|1|||
143278246|NCT00191269|516572683|FG001|Overall Study|Lack of Efficacy|5|||
143278247|NCT00191269|516572682|FG000|Overall Study|Withdrawal by Subject|0|||
143278248|NCT00191269|516572683|FG001|Overall Study|Withdrawal by Subject|1|||
143278249|NCT00191269|516572682|FG000|Overall Study|Pathologic Aggrevation|0|||
143278250|NCT00191269|516572683|FG001|Overall Study|Pathologic Aggrevation|1|||
143278251|NCT00191269|516572682|FG000|Overall Study|Physician Decision|0|||
143278252|NCT00191269|516572683|FG001|Overall Study|Physician Decision|3|||
143372841|NCT01212757|516909646|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
143372842|NCT01212757|516909647|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
143372843|NCT01212757|516909648|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
143372844|NCT01212757|516909649|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
143372845|NCT01212757|516909650|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
143372846|NCT01212757|516909651|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
143372847|NCT01212757|516909643|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
143372848|NCT01212757|516909644|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
143372849|NCT01212757|516909645|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
143372850|NCT01212757|516909646|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
143372851|NCT01212757|516909647|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
143372852|NCT01212757|516909648|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
143372853|NCT01212757|516909649|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
143372854|NCT01212757|516909650|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
143372855|NCT01212757|516909651|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
143372856|NCT01212757|516909643|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
143372857|NCT01212757|516909644|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
143372858|NCT01212757|516909645|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
143372859|NCT01212757|516909646|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
143372860|NCT01212757|516909647|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
143372861|NCT01212757|516909648|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
143372862|NCT01212757|516909649|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
143372863|NCT01212757|516909650|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
143372864|NCT01212757|516909651|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
143372865|NCT01212757|516909643|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
143372866|NCT01212757|516909644|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
143372867|NCT01212757|516909645|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
143372868|NCT01212757|516909646|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
143372869|NCT01212757|516909647|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
143372870|NCT01212757|516909648|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
143372871|NCT01212757|516909649|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
143372872|NCT01212757|516909650|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
143372873|NCT01212757|516909651|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
143372874|NCT01212757|516909643|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
143372875|NCT01212757|516909644|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
143372876|NCT01212757|516909645|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
143372877|NCT01212757|516909646|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
143278253|NCT00915278|516572691|FG000|Overall Study|Death|1|||
143278254|NCT00915278|516572692|FG001|Overall Study|Death|0|||
143278255|NCT00915278|516572693|FG002|Overall Study|Death|0|||
143278256|NCT00915278|516572694|FG003|Overall Study|Death|0|||
143278257|NCT00915278|516572695|FG004|Overall Study|Death|0|||
143278258|NCT00915278|516572696|FG005|Overall Study|Death|0|||
143278259|NCT00915278|516572691|FG000|Overall Study|Lost to Follow-up|0|||
143278260|NCT00915278|516572692|FG001|Overall Study|Lost to Follow-up|1|||
143278261|NCT00915278|516572693|FG002|Overall Study|Lost to Follow-up|0|||
143372878|NCT01212757|516909647|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
143278262|NCT00915278|516572694|FG003|Overall Study|Lost to Follow-up|0|||
143278263|NCT00915278|516572695|FG004|Overall Study|Lost to Follow-up|0|||
143278264|NCT00915278|516572696|FG005|Overall Study|Lost to Follow-up|0|||
143278265|NCT00915278|516572691|FG000|Overall Study|Withdrawal by Subject|0|||
143278266|NCT00915278|516572692|FG001|Overall Study|Withdrawal by Subject|1|||
143278267|NCT00915278|516572693|FG002|Overall Study|Withdrawal by Subject|0|||
143278268|NCT00915278|516572694|FG003|Overall Study|Withdrawal by Subject|0|||
143278269|NCT00915278|516572695|FG004|Overall Study|Withdrawal by Subject|1|||
143278270|NCT00915278|516572696|FG005|Overall Study|Withdrawal by Subject|4|||
143278271|NCT00915278|516572691|FG000|Overall Study|Adverse Event|4|||
143278272|NCT00915278|516572692|FG001|Overall Study|Adverse Event|1|||
143278273|NCT00915278|516572693|FG002|Overall Study|Adverse Event|0|||
143278274|NCT00915278|516572694|FG003|Overall Study|Adverse Event|0|||
143278275|NCT00915278|516572695|FG004|Overall Study|Adverse Event|0|||
143278276|NCT00915278|516572696|FG005|Overall Study|Adverse Event|0|||
143278277|NCT00915278|516572691|FG000|Overall Study|Progressive disease/clinical progression|0|||
143278278|NCT00915278|516572692|FG001|Overall Study|Progressive disease/clinical progression|0|||
143278279|NCT00915278|516572693|FG002|Overall Study|Progressive disease/clinical progression|0|||
143278280|NCT00915278|516572694|FG003|Overall Study|Progressive disease/clinical progression|3|||
143278281|NCT00915278|516572695|FG004|Overall Study|Progressive disease/clinical progression|1|||
143278282|NCT00915278|516572696|FG005|Overall Study|Progressive disease/clinical progression|2|||
143278283|NCT00915278|516572691|FG000|Overall Study|Infusion related AEs|0|||
143278284|NCT00915278|516572692|FG001|Overall Study|Infusion related AEs|0|||
143278285|NCT00915278|516572693|FG002|Overall Study|Infusion related AEs|0|||
143278286|NCT00915278|516572694|FG003|Overall Study|Infusion related AEs|0|||
143278287|NCT00915278|516572695|FG004|Overall Study|Infusion related AEs|0|||
143278288|NCT00915278|516572696|FG005|Overall Study|Infusion related AEs|2|||
143278289|NCT00915278|516572691|FG000|Overall Study|Admission to hospice|0|||
143278290|NCT00915278|516572692|FG001|Overall Study|Admission to hospice|0|||
143278291|NCT00915278|516572693|FG002|Overall Study|Admission to hospice|1|||
143278292|NCT00915278|516572694|FG003|Overall Study|Admission to hospice|0|||
143278293|NCT00915278|516572695|FG004|Overall Study|Admission to hospice|0|||
143278294|NCT00915278|516572696|FG005|Overall Study|Admission to hospice|0|||
143278295|NCT03137537|516572704|FG000|Overall Study|Adverse Event|0|||
143278296|NCT03137537|516572705|FG001|Overall Study|Adverse Event|1|||
143278297|NCT04066023|516572706|FG000|Overall Study|Adverse Event|0|||
143278298|NCT04066023|516572707|FG001|Overall Study|Adverse Event|0|||
143278299|NCT04066023|516572708|FG002|Overall Study|Adverse Event|1|||
143278300|NCT04066023|516572706|FG000|Overall Study|Sponsor decision|3|||
143278301|NCT04066023|516572707|FG001|Overall Study|Sponsor decision|6|||
143278302|NCT04066023|516572708|FG002|Overall Study|Sponsor decision|2|||
143278303|NCT04066023|516572706|FG000|Overall Study|Physician Decision|0|||
143278304|NCT04066023|516572707|FG001|Overall Study|Physician Decision|0|||
143278305|NCT04066023|516572708|FG002|Overall Study|Physician Decision|1|||
143278306|NCT04066023|516572706|FG000|Overall Study|Lost to Follow-up|0|||
143278307|NCT04066023|516572707|FG001|Overall Study|Lost to Follow-up|1|||
143278308|NCT04066023|516572708|FG002|Overall Study|Lost to Follow-up|1|||
143278309|NCT04066023|516572706|FG000|Overall Study|Noncompliance|0|||
143278310|NCT04066023|516572707|FG001|Overall Study|Noncompliance|1|||
143278311|NCT04066023|516572708|FG002|Overall Study|Noncompliance|1|||
143278312|NCT01552694|516572709|FG000|Overall Study|Lost to Follow-up|0|||
143278313|NCT01552694|516572710|FG001|Overall Study|Lost to Follow-up|1|||
143278314|NCT01552694|516572709|FG000|Overall Study|Protocol Violation|0|||
143278315|NCT01552694|516572710|FG001|Overall Study|Protocol Violation|1|||
143278316|NCT00191139|516572711|FG000|Overall Study|Adverse Event|2|||
143278317|NCT00191139|516572712|FG001|Overall Study|Adverse Event|6|||
143278318|NCT00191139|516572711|FG000|Overall Study|Death|2|||
143278319|NCT00191139|516572712|FG001|Overall Study|Death|0|||
143278320|NCT00191139|516572711|FG000|Overall Study|Withdrawal by Subject|0|||
143278321|NCT00191139|516572712|FG001|Overall Study|Withdrawal by Subject|3|||
143278322|NCT00191139|516572711|FG000|Overall Study|Disease Progression|0|||
143278323|NCT00191139|516572712|FG001|Overall Study|Disease Progression|1|||
143278324|NCT00191139|516572711|FG000|Overall Study|Other|1|||
143278325|NCT00191139|516572712|FG001|Overall Study|Other|2|||
143278326|NCT02465515|516572716|FG000|Overall Study|Investigator site closed|4|||
143278327|NCT02465515|516572717|FG001|Overall Study|Investigator site closed|5|||
143278328|NCT02465515|516572716|FG000|Overall Study|Withdrawal by Subject|74|||
143278329|NCT02465515|516572717|FG001|Overall Study|Withdrawal by Subject|43|||
143278330|NCT02465515|516572716|FG000|Overall Study|Physician Decision|8|||
143278331|NCT02465515|516572717|FG001|Overall Study|Physician Decision|12|||
143278332|NCT02465515|516572716|FG000|Overall Study|Lost to Follow-up|68|||
143278333|NCT02465515|516572717|FG001|Overall Study|Lost to Follow-up|51|||
143278334|NCT02564796|516572718|FG000|Overall Study|Physician Decision|2|||
143278335|NCT02564796|516572719|FG001|Overall Study|Physician Decision|2|||
143278336|NCT00293033|516572720|FG000|Open-label Titration Period|Adverse Event|10|||
143278337|NCT00293033|516572720|FG000|Open-label Titration Period|Death|3|||
143278338|NCT00293033|516572720|FG000|Open-label Titration Period|Lack of Efficacy|5|||
143278339|NCT00293033|516572720|FG000|Open-label Titration Period|Protocol Violation|2|||
143278340|NCT00293033|516572720|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
143278341|NCT00293033|516572720|FG000|Open-label Titration Period|Noncompliance and other|27|||
143278342|NCT00293033|516572720|FG000|Double-blind Treatment Period|Adverse Event|3|||
143278343|NCT00293033|516572720|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
143278344|NCT00293033|516572720|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
143278345|NCT00293033|516572720|FG000|Double-blind Treatment Period|Noncompliance|4|||
143278346|NCT00453063|516572721|FG000|Overall Study|Adverse Event|1|||
143278347|NCT00453063|516572722|FG001|Overall Study|Adverse Event|2|||
143278348|NCT00453063|516572721|FG000|Overall Study|Withdrawal by Subject|1|||
143278349|NCT00453063|516572722|FG001|Overall Study|Withdrawal by Subject|1|||
143278350|NCT00453063|516572721|FG000|Overall Study|Protocol Violation|1|||
143278351|NCT00453063|516572722|FG001|Overall Study|Protocol Violation|0|||
143278352|NCT00114530|516572723|FG000|Overall Study|Death|3|||
143278353|NCT00114530|516572724|FG001|Overall Study|Death|11|||
143278354|NCT00114530|516572723|FG000|Overall Study|Lost to Follow-up|1|||
143278355|NCT00114530|516572724|FG001|Overall Study|Lost to Follow-up|1|||
143278356|NCT00114530|516572723|FG000|Overall Study|Physician Decision|1|||
143278357|NCT00114530|516572724|FG001|Overall Study|Physician Decision|1|||
143278358|NCT00114530|516572723|FG000|Overall Study|Withdrawal by Subject|2|||
143278359|NCT00114530|516572724|FG001|Overall Study|Withdrawal by Subject|6|||
143278360|NCT00114530|516572723|FG000|Overall Study|Breast Cancer|1|||
143278361|NCT00114530|516572724|FG001|Overall Study|Breast Cancer|0|||
143278362|NCT00114530|516572723|FG000|Overall Study|Subject decision after endpoint failure|0|||
143278363|NCT00114530|516572724|FG001|Overall Study|Subject decision after endpoint failure|1|||
143278364|NCT00114530|516572723|FG000|Overall Study|Ineligible|1|||
143278365|NCT00114530|516572724|FG001|Overall Study|Ineligible|0|||
143278366|NCT00365508|516572728|FG000|Overall Study|Lost to Follow-up|139|||
143278367|NCT00365508|516572729|FG001|Overall Study|Lost to Follow-up|154|||
143278368|NCT01817530|516572731|FG000|Overall Study|Exclusionary Medication Received|0|||
143278369|NCT01817530|516572732|FG001|Overall Study|Exclusionary Medication Received|0|||
143278370|NCT01817530|516572733|FG002|Overall Study|Exclusionary Medication Received|0|||
143278371|NCT01817530|516572734|FG003|Overall Study|Exclusionary Medication Received|0|||
143278372|NCT01817530|516572735|FG004|Overall Study|Exclusionary Medication Received|1|||
143278373|NCT01817530|516572736|FG005|Overall Study|Exclusionary Medication Received|0|||
143278374|NCT01817530|516572737|FG006|Overall Study|Exclusionary Medication Received|0|||
143278375|NCT01817530|516572738|FG007|Overall Study|Exclusionary Medication Received|0|||
143278376|NCT01817530|516572731|FG000|Overall Study|Adverse Event|6|||
143278377|NCT01817530|516572732|FG001|Overall Study|Adverse Event|3|||
143278378|NCT01817530|516572733|FG002|Overall Study|Adverse Event|2|||
143278379|NCT01817530|516572734|FG003|Overall Study|Adverse Event|5|||
143278380|NCT01817530|516572735|FG004|Overall Study|Adverse Event|0|||
143278381|NCT01817530|516572736|FG005|Overall Study|Adverse Event|10|||
143278382|NCT01817530|516572737|FG006|Overall Study|Adverse Event|5|||
143278383|NCT01817530|516572738|FG007|Overall Study|Adverse Event|8|||
143278384|NCT01817530|516572731|FG000|Overall Study|Subject Noncompliant|3|||
143278385|NCT01817530|516572732|FG001|Overall Study|Subject Noncompliant|1|||
143278386|NCT01817530|516572733|FG002|Overall Study|Subject Noncompliant|0|||
143278387|NCT01817530|516572734|FG003|Overall Study|Subject Noncompliant|4|||
143278388|NCT01817530|516572735|FG004|Overall Study|Subject Noncompliant|0|||
143278389|NCT01817530|516572736|FG005|Overall Study|Subject Noncompliant|1|||
143278390|NCT01817530|516572737|FG006|Overall Study|Subject Noncompliant|1|||
143278391|NCT01817530|516572738|FG007|Overall Study|Subject Noncompliant|1|||
143278392|NCT01817530|516572731|FG000|Overall Study|Lack of Efficacy|1|||
143278393|NCT01817530|516572732|FG001|Overall Study|Lack of Efficacy|0|||
143278394|NCT01817530|516572733|FG002|Overall Study|Lack of Efficacy|0|||
143278395|NCT01817530|516572734|FG003|Overall Study|Lack of Efficacy|0|||
143278396|NCT01817530|516572735|FG004|Overall Study|Lack of Efficacy|0|||
143278397|NCT01817530|516572736|FG005|Overall Study|Lack of Efficacy|1|||
143278398|NCT01817530|516572737|FG006|Overall Study|Lack of Efficacy|0|||
143278399|NCT01817530|516572738|FG007|Overall Study|Lack of Efficacy|1|||
143278400|NCT01817530|516572731|FG000|Overall Study|Pregnancy|0|||
143278401|NCT01817530|516572732|FG001|Overall Study|Pregnancy|0|||
143278402|NCT01817530|516572733|FG002|Overall Study|Pregnancy|0|||
143278403|NCT01817530|516572734|FG003|Overall Study|Pregnancy|0|||
143278404|NCT01817530|516572735|FG004|Overall Study|Pregnancy|0|||
143278405|NCT01817530|516572736|FG005|Overall Study|Pregnancy|1|||
143278406|NCT01817530|516572737|FG006|Overall Study|Pregnancy|0|||
143278407|NCT01817530|516572738|FG007|Overall Study|Pregnancy|0|||
143278408|NCT01817530|516572731|FG000|Overall Study|Other|0|||
143278409|NCT01817530|516572732|FG001|Overall Study|Other|1|||
143278410|NCT01817530|516572733|FG002|Overall Study|Other|0|||
143278411|NCT01817530|516572734|FG003|Overall Study|Other|0|||
143372879|NCT01212757|516909648|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
143372880|NCT01212757|516909649|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
143372881|NCT01212757|516909650|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
143278412|NCT01817530|516572735|FG004|Overall Study|Other|1|||
143278413|NCT01817530|516572736|FG005|Overall Study|Other|0|||
143278414|NCT01817530|516572737|FG006|Overall Study|Other|5|||
143278415|NCT01817530|516572738|FG007|Overall Study|Other|0|||
143278416|NCT01817530|516572731|FG000|Overall Study|Surgery or Invasive Intervention|1|||
143278417|NCT01817530|516572732|FG001|Overall Study|Surgery or Invasive Intervention|0|||
143278418|NCT01817530|516572733|FG002|Overall Study|Surgery or Invasive Intervention|0|||
143278419|NCT01817530|516572734|FG003|Overall Study|Surgery or Invasive Intervention|0|||
143278420|NCT01817530|516572735|FG004|Overall Study|Surgery or Invasive Intervention|1|||
143278421|NCT01817530|516572736|FG005|Overall Study|Surgery or Invasive Intervention|1|||
143278422|NCT01817530|516572737|FG006|Overall Study|Surgery or Invasive Intervention|1|||
143278423|NCT01817530|516572738|FG007|Overall Study|Surgery or Invasive Intervention|0|||
143278424|NCT01817530|516572731|FG000|Overall Study|Consent Withdrawn by Subject|3|||
143278425|NCT01817530|516572732|FG001|Overall Study|Consent Withdrawn by Subject|4|||
143278426|NCT01817530|516572733|FG002|Overall Study|Consent Withdrawn by Subject|7|||
143278427|NCT01817530|516572734|FG003|Overall Study|Consent Withdrawn by Subject|3|||
143278428|NCT01817530|516572735|FG004|Overall Study|Consent Withdrawn by Subject|5|||
143278429|NCT01817530|516572736|FG005|Overall Study|Consent Withdrawn by Subject|3|||
143278430|NCT01817530|516572737|FG006|Overall Study|Consent Withdrawn by Subject|3|||
143278431|NCT01817530|516572738|FG007|Overall Study|Consent Withdrawn by Subject|10|||
143278432|NCT01817530|516572731|FG000|Overall Study|Lost to Follow-up|1|||
143278433|NCT01817530|516572732|FG001|Overall Study|Lost to Follow-up|4|||
143278434|NCT01817530|516572733|FG002|Overall Study|Lost to Follow-up|2|||
143278435|NCT01817530|516572734|FG003|Overall Study|Lost to Follow-up|1|||
143278436|NCT01817530|516572735|FG004|Overall Study|Lost to Follow-up|3|||
143278437|NCT01817530|516572736|FG005|Overall Study|Lost to Follow-up|2|||
143278438|NCT01817530|516572737|FG006|Overall Study|Lost to Follow-up|8|||
143278439|NCT01817530|516572738|FG007|Overall Study|Lost to Follow-up|4|||
143278440|NCT03846804|516572739|FG000|Overall Study|Refused blood draw|1|||
143278441|NCT03846804|516572739|FG000|Overall Study|Protocol Violation|1|||
143278442|NCT02538029|516572740|FG000|Overall Study|unable to complete cognitive assessments|1|||
143278443|NCT02538029|516572741|FG001|Overall Study|unable to complete cognitive assessments|0|||
143278444|NCT02538029|516572742|FG002|Overall Study|unable to complete cognitive assessments|1|||
143278445|NCT00404235|516572746|FG000|Overall Study|Withdrawal by Subject|1|||
143278446|NCT00404235|516572747|FG001|Overall Study|Withdrawal by Subject|2|||
143278447|NCT00001880|516572748|FG000|Overall Study|Death|14|||
143278448|NCT00679432|516572749|FG000|Overall Study|Adverse Event|5|||
143278449|NCT00679432|516572750|FG001|Overall Study|Adverse Event|6|||
143278450|NCT00679432|516572751|FG002|Overall Study|Adverse Event|10|||
143278451|NCT00679432|516572752|FG003|Overall Study|Adverse Event|7|||
143278452|NCT00679432|516572749|FG000|Overall Study|Protocol Violation|1|||
143278453|NCT00679432|516572750|FG001|Overall Study|Protocol Violation|1|||
143278454|NCT00679432|516572751|FG002|Overall Study|Protocol Violation|2|||
143278455|NCT00679432|516572752|FG003|Overall Study|Protocol Violation|1|||
143278456|NCT00679432|516572749|FG000|Overall Study|Withdrawal by Subject|8|||
143278457|NCT00679432|516572750|FG001|Overall Study|Withdrawal by Subject|11|||
143278458|NCT00679432|516572751|FG002|Overall Study|Withdrawal by Subject|10|||
143278459|NCT00679432|516572752|FG003|Overall Study|Withdrawal by Subject|9|||
143278460|NCT00679432|516572749|FG000|Overall Study|Lost to Follow-up|1|||
143278461|NCT00679432|516572750|FG001|Overall Study|Lost to Follow-up|5|||
143278462|NCT00679432|516572751|FG002|Overall Study|Lost to Follow-up|4|||
143278463|NCT00679432|516572752|FG003|Overall Study|Lost to Follow-up|2|||
143278464|NCT00679432|516572749|FG000|Overall Study|Physician Decision|3|||
143278465|NCT00679432|516572750|FG001|Overall Study|Physician Decision|2|||
143278466|NCT00679432|516572751|FG002|Overall Study|Physician Decision|2|||
143278467|NCT00679432|516572752|FG003|Overall Study|Physician Decision|2|||
143278468|NCT00679432|516572749|FG000|Overall Study|Sponsor decision|1|||
143278469|NCT00679432|516572750|FG001|Overall Study|Sponsor decision|0|||
143278470|NCT00679432|516572751|FG002|Overall Study|Sponsor decision|0|||
143278471|NCT00679432|516572752|FG003|Overall Study|Sponsor decision|0|||
143278472|NCT00679432|516572749|FG000|Overall Study|Lack of Efficacy|13|||
143278473|NCT00679432|516572750|FG001|Overall Study|Lack of Efficacy|9|||
143278474|NCT00679432|516572751|FG002|Overall Study|Lack of Efficacy|14|||
143278475|NCT00679432|516572752|FG003|Overall Study|Lack of Efficacy|8|||
143278476|NCT00679432|516572749|FG000|Overall Study|Infectious colitis, normal histology|5|||
143278477|NCT00679432|516572750|FG001|Overall Study|Infectious colitis, normal histology|4|||
143278478|NCT00679432|516572751|FG002|Overall Study|Infectious colitis, normal histology|8|||
143278479|NCT00679432|516572752|FG003|Overall Study|Infectious colitis, normal histology|3|||
143278480|NCT00679432|516572749|FG000|Overall Study|Randomization error, return to prior Rx|0|||
143278481|NCT00679432|516572750|FG001|Overall Study|Randomization error, return to prior Rx|0|||
143278482|NCT00679432|516572751|FG002|Overall Study|Randomization error, return to prior Rx|3|||
143278483|NCT00679432|516572752|FG003|Overall Study|Randomization error, return to prior Rx|0|||
143278484|NCT02639065|516572753|FG000|Study Treatment|Disease Progression|13|||
143278485|NCT02639065|516572753|FG000|Study Treatment|Adverse Event|9|||
143278486|NCT02639065|516572753|FG000|Study Treatment|Withdrawal by Subject|1|||
143229679|NCT01045460|516388703|FG001|Overall Study|Lost to Follow-up|1|||
143229680|NCT01045460|516388702|FG000|Overall Study|Lack of Efficacy|3|||
143229681|NCT01045460|516388703|FG001|Overall Study|Lack of Efficacy|0|||
143229682|NCT03535974|516388704|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
143229683|NCT03535974|516388705|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
143229684|NCT03535974|516388706|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
143229685|NCT03535974|516388704|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
143229686|NCT03535974|516388705|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
143229687|NCT03535974|516388706|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
143229688|NCT00549640|516388707|FG000|Overall Study|Withdrawal by Subject|6|||
143229689|NCT00549640|516388708|FG001|Overall Study|Withdrawal by Subject|12|||
143229690|NCT00549640|516388707|FG000|Overall Study|Adverse Event|5|||
143229691|NCT00549640|516388708|FG001|Overall Study|Adverse Event|0|||
143229692|NCT00549640|516388707|FG000|Overall Study|Lost to Follow-up|7|||
143229693|NCT00549640|516388708|FG001|Overall Study|Lost to Follow-up|4|||
143229694|NCT01362348|516388709|FG000|Overall Study|Protocol-defined stopping criteria|9|||
143229695|NCT01362348|516388709|FG000|Overall Study|Study closed/terminated|5|||
143229696|NCT03740048|516388710|FG000|Overall Study|Withdrawal by Subject|1|||
143229697|NCT03740048|516388711|FG001|Overall Study|Withdrawal by Subject|1|||
143229698|NCT03740048|516388710|FG000|Overall Study|Death|1|||
143229699|NCT03740048|516388711|FG001|Overall Study|Death|6|||
143229700|NCT03740048|516388710|FG000|Overall Study|Switched to thrice-weekly HD|2|||
143229701|NCT03740048|516388711|FG001|Overall Study|Switched to thrice-weekly HD|0|||
143229702|NCT03740048|516388710|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
143229703|NCT03740048|516388711|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
143229704|NCT03740048|516388710|FG000|Overall Study|Lost to Follow-up|0|||
143229705|NCT03740048|516388711|FG001|Overall Study|Lost to Follow-up|1|||
143229706|NCT03740048|516388710|FG000|Overall Study|Non-compliance with HD|0|||
143229707|NCT03740048|516388711|FG001|Overall Study|Non-compliance with HD|1|||
143229708|NCT01476722|516388712|FG000|Overall Study|Adverse Event|1|||
143229709|NCT02675907|516388717|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
143229710|NCT02675907|516388718|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
143229711|NCT02675907|516388717|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
143229712|NCT02675907|516388718|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
143229713|NCT02675907|516388717|FG000|Study Overall|Lack of Efficacy|1|||
143229714|NCT02675907|516388718|FG001|Study Overall|Lack of Efficacy|0|||
143229715|NCT02675907|516388717|FG000|Study Overall|Withdrawal by Subject|2|||
143229716|NCT02675907|516388718|FG001|Study Overall|Withdrawal by Subject|2|||
143229717|NCT02675907|516388717|FG000|Study Overall|Lost to Follow-up|0|||
143229718|NCT02675907|516388718|FG001|Study Overall|Lost to Follow-up|2|||
143229719|NCT01611792|516388719|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
143229720|NCT01611792|516388720|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
143229721|NCT01611792|516388719|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
143229722|NCT01611792|516388720|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
143229723|NCT01129622|516388721|FG000|Overall Study|Withdrawal by Subject|2|||
143229724|NCT00880698|516388729|FG000|Overall Study|Death|0|||
143229725|NCT00880698|516388730|FG001|Overall Study|Death|0|||
143229726|NCT00880698|516388731|FG002|Overall Study|Death|1|||
143229727|NCT00880698|516388732|FG003|Overall Study|Death|2|||
143229728|NCT00880698|516388729|FG000|Overall Study|Lost to Follow-up|1|||
143372882|NCT01212757|516909651|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
143229729|NCT00880698|516388730|FG001|Overall Study|Lost to Follow-up|3|||
143229730|NCT00880698|516388731|FG002|Overall Study|Lost to Follow-up|0|||
143229731|NCT00880698|516388732|FG003|Overall Study|Lost to Follow-up|1|||
143278487|NCT02639065|516572753|FG000|Follow up|Subject refused to follow up|1|||
143278488|NCT02639065|516572753|FG000|Follow up|Symptomatic Deterioration|2|||
143278489|NCT02639065|516572753|FG000|Follow up|Death|2|||
143278490|NCT02639065|516572753|FG000|Follow up|Study Terminated|1|||
143278491|NCT02639065|516572753|FG000|Follow up|Disease Progression|3|||
143278492|NCT00824720|516572754|FG000|Overall Study|failed plug insertion|3|||
143278493|NCT00824720|516572755|FG001|Overall Study|failed plug insertion|1|||
143278494|NCT00824720|516572756|FG002|Overall Study|failed plug insertion|0|||
143278495|NCT00824720|516572754|FG000|Overall Study|Protocol Violation|0|||
143278496|NCT00824720|516572755|FG001|Overall Study|Protocol Violation|0|||
143278497|NCT00824720|516572756|FG002|Overall Study|Protocol Violation|1|||
143278498|NCT00481078|516572757|FG000|Overall Study|Progression of disease|11|||
143278499|NCT00481078|516572758|FG001|Overall Study|Progression of disease|11|||
143278500|NCT00481078|516572757|FG000|Overall Study|Adverse Event|15|||
143278501|NCT00481078|516572758|FG001|Overall Study|Adverse Event|3|||
143278502|NCT00481078|516572757|FG000|Overall Study|Death|5|||
143278503|NCT00481078|516572758|FG001|Overall Study|Death|3|||
143278504|NCT00481078|516572757|FG000|Overall Study|Intercurrent illness|1|||
143278505|NCT00481078|516572758|FG001|Overall Study|Intercurrent illness|0|||
143278506|NCT00481078|516572757|FG000|Overall Study|Withdrawal by Subject|7|||
143278507|NCT00481078|516572758|FG001|Overall Study|Withdrawal by Subject|1|||
143278508|NCT00481078|516572757|FG000|Overall Study|Information not available|1|||
143278509|NCT00481078|516572758|FG001|Overall Study|Information not available|0|||
143278510|NCT00481078|516572757|FG000|Overall Study|Received other treatment|2|||
143278511|NCT00481078|516572758|FG001|Overall Study|Received other treatment|1|||
143278512|NCT00481078|516572757|FG000|Overall Study|Brain metastasis|0|||
143278513|NCT00481078|516572758|FG001|Overall Study|Brain metastasis|1|||
143278514|NCT00709761|516575071|FG000|Overall Study|Withdrawal by Subject|8|||
143278515|NCT00709761|516575071|FG000|Overall Study|study closed/terminated|17|||
143278516|NCT00709761|516575071|FG000|Overall Study|Lost to Follow-up|2|||
143278517|NCT02200211|516575072|FG000|Overall Study|Lost to Follow-up|7|||
143278518|NCT02200211|516575073|FG001|Overall Study|Lost to Follow-up|7|||
143278519|NCT02200211|516575074|FG002|Overall Study|Lost to Follow-up|1|||
143278520|NCT02200211|516575075|FG003|Overall Study|Lost to Follow-up|2|||
143278521|NCT02200211|516575072|FG000|Overall Study|Withdrawal by Subject|1|||
143278522|NCT02200211|516575073|FG001|Overall Study|Withdrawal by Subject|0|||
143278523|NCT02200211|516575074|FG002|Overall Study|Withdrawal by Subject|0|||
143278524|NCT02200211|516575075|FG003|Overall Study|Withdrawal by Subject|0|||
143278525|NCT00381485|516575076|FG000|Open-Label Run-In Period|Adverse Event|9|||
143278526|NCT00381485|516575077|FG001|Open-Label Run-In Period|Adverse Event|0|||
143278527|NCT00381485|516575078|FG002|Open-Label Run-In Period|Adverse Event|0|||
143278528|NCT00381485|516575079|FG003|Open-Label Run-In Period|Adverse Event|0|||
143278529|NCT00381485|516575076|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
143278530|NCT00381485|516575077|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
143278531|NCT00381485|516575078|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
143278532|NCT00381485|516575079|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
143278533|NCT00381485|516575076|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
143278534|NCT00381485|516575077|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
143278535|NCT00381485|516575078|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
143278536|NCT00381485|516575079|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
143278537|NCT00381485|516575076|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
143278538|NCT00381485|516575077|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
143278539|NCT00381485|516575078|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
143278540|NCT00381485|516575079|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
143278541|NCT00381485|516575076|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
143278542|NCT00381485|516575077|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
143278543|NCT00381485|516575078|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
143278544|NCT00381485|516575079|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
143278545|NCT00381485|516575076|FG000|Open-Label Run-In Period|Treatment failure|1|||
143278546|NCT00381485|516575077|FG001|Open-Label Run-In Period|Treatment failure|0|||
143278547|NCT00381485|516575078|FG002|Open-Label Run-In Period|Treatment failure|0|||
143278548|NCT00381485|516575079|FG003|Open-Label Run-In Period|Treatment failure|0|||
143278549|NCT00381485|516575076|FG000|Double-Blind Treatment Period|Adverse Event|0|||
143278550|NCT00381485|516575077|FG001|Double-Blind Treatment Period|Adverse Event|2|||
143278551|NCT00381485|516575078|FG002|Double-Blind Treatment Period|Adverse Event|2|||
143372883|NCT01212757|516909643|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
143278552|NCT00381485|516575079|FG003|Double-Blind Treatment Period|Adverse Event|5|||
143278553|NCT00381485|516575076|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
143278554|NCT00381485|516575077|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
143278555|NCT00381485|516575078|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
143278556|NCT00381485|516575079|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
143278557|NCT00381485|516575076|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
143278558|NCT00381485|516575077|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
143278559|NCT00381485|516575078|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
143278560|NCT00381485|516575079|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
143278561|NCT00381485|516575076|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
143278562|NCT00381485|516575077|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
143278563|NCT00381485|516575078|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
143278564|NCT00381485|516575079|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
143278565|NCT00381485|516575076|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
143278566|NCT00381485|516575077|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
143278567|NCT00381485|516575078|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
143278568|NCT00381485|516575079|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
143278569|NCT00381485|516575076|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
143278570|NCT00381485|516575077|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
143278571|NCT00381485|516575078|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
143278572|NCT00381485|516575079|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
143278573|NCT00381485|516575076|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
143278574|NCT00381485|516575077|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
143278575|NCT00381485|516575078|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
143278576|NCT00381485|516575079|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
143278577|NCT00381485|516575076|FG000|Double-Blind Treatment Period|Administrative|0|||
143278578|NCT00381485|516575077|FG001|Double-Blind Treatment Period|Administrative|1|||
143278579|NCT00381485|516575078|FG002|Double-Blind Treatment Period|Administrative|0|||
143278580|NCT00381485|516575079|FG003|Double-Blind Treatment Period|Administrative|1|||
143278581|NCT01235351|516575080|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
143278582|NCT01235351|516575081|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
143278583|NCT01918774|516575082|FG000|Overall Study|Lost prior to first CBTw session|4|||
143278584|NCT01918774|516575082|FG000|Overall Study|Lost to Follow-up|1|||
143278585|NCT01606800|516575083|FG000|Overall Study|Adverse Event|3|||
143278586|NCT01606800|516575084|FG001|Overall Study|Adverse Event|1|||
143278587|NCT01606800|516575083|FG000|Overall Study|Participant withdrew consent|0|||
143278588|NCT01606800|516575084|FG001|Overall Study|Participant withdrew consent|1|||
143278589|NCT01606800|516575083|FG000|Overall Study|Missing completion status|2|||
143278590|NCT01606800|516575084|FG001|Overall Study|Missing completion status|0|||
143278591|NCT00042289|516575085|FG000|Overall Study|Lost to Follow-up|3|||
143278592|NCT00042289|516575086|FG001|Overall Study|Lost to Follow-up|0|||
143278593|NCT00042289|516575087|FG002|Overall Study|Lost to Follow-up|0|||
143278594|NCT00042289|516575088|FG003|Overall Study|Lost to Follow-up|1|||
143278595|NCT00042289|516575089|FG004|Overall Study|Lost to Follow-up|3|||
143278596|NCT00042289|516575090|FG005|Overall Study|Lost to Follow-up|3|||
143278597|NCT00042289|516575091|FG006|Overall Study|Lost to Follow-up|6|||
143278598|NCT00042289|516575092|FG007|Overall Study|Lost to Follow-up|1|||
143278599|NCT00042289|516575093|FG008|Overall Study|Lost to Follow-up|1|||
143278600|NCT00042289|516575094|FG009|Overall Study|Lost to Follow-up|0|||
143278601|NCT00042289|516575095|FG010|Overall Study|Lost to Follow-up|0|||
143278602|NCT00042289|516575096|FG011|Overall Study|Lost to Follow-up|0|||
143278603|NCT00042289|516575097|FG012|Overall Study|Lost to Follow-up|0|||
143278604|NCT00042289|516575098|FG013|Overall Study|Lost to Follow-up|0|||
143278605|NCT00042289|516575099|FG014|Overall Study|Lost to Follow-up|0|||
143372884|NCT01212757|516909644|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
143372885|NCT01212757|516909645|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
143278606|NCT00042289|516575100|FG015|Overall Study|Lost to Follow-up|1|||
143278607|NCT00042289|516575101|FG016|Overall Study|Lost to Follow-up|1|||
143278608|NCT00042289|516575102|FG017|Overall Study|Lost to Follow-up|0|||
143278609|NCT00042289|516575103|FG018|Overall Study|Lost to Follow-up|3|||
143278610|NCT00042289|516575104|FG019|Overall Study|Lost to Follow-up|2|||
143278611|NCT00042289|516575105|FG020|Overall Study|Lost to Follow-up|0|||
143278612|NCT00042289|516575106|FG021|Overall Study|Lost to Follow-up|0|||
143278613|NCT00042289|516575107|FG022|Overall Study|Lost to Follow-up|0|||
143372886|NCT01212757|516909646|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
143372887|NCT01212757|516909647|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
143372888|NCT01212757|516909648|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
143278614|NCT00042289|516575108|FG023|Overall Study|Lost to Follow-up|0|||
143229732|NCT04972162|516388733|FG000|Washout Period (5 Days)|Withdrawal by Subject|1|||
143229733|NCT04972162|516388734|FG001|Washout Period (5 Days)|Withdrawal by Subject|1|||
143229734|NCT00866177|516390824|FG000|Overall Study|Withdrawal by Subject|1|||
143229735|NCT00866177|516390824|FG000|Overall Study|Not Treated|151|||
143229736|NCT03562195|516390832|FG000|Overall Study|Adverse Event|0|||
143229737|NCT03562195|516390833|FG001|Overall Study|Adverse Event|6|||
143229738|NCT03562195|516390832|FG000|Overall Study|Lack of Efficacy|0|||
143229739|NCT03562195|516390833|FG001|Overall Study|Lack of Efficacy|5|||
143229740|NCT03562195|516390832|FG000|Overall Study|Protocol Violation|0|||
143229741|NCT03562195|516390833|FG001|Overall Study|Protocol Violation|1|||
143229742|NCT03562195|516390832|FG000|Overall Study|Lost to Follow-up|0|||
143229743|NCT03562195|516390833|FG001|Overall Study|Lost to Follow-up|1|||
143229744|NCT03562195|516390832|FG000|Overall Study|Physician Decision|1|||
143229745|NCT03562195|516390833|FG001|Overall Study|Physician Decision|0|||
143229746|NCT03562195|516390832|FG000|Overall Study|Withdrawal by Subject|3|||
143229747|NCT03562195|516390833|FG001|Overall Study|Withdrawal by Subject|0|||
143229748|NCT02529852|516390834|FG000|Overall Study|Withdrawal by Subject|2|||
143229749|NCT03532542|516390835|FG000|Overall Study|Death|1|||
143229750|NCT03532542|516390836|FG001|Overall Study|Death|0|||
143229751|NCT03532542|516390835|FG000|Overall Study|Study Terminated by Sponsor|41|||
143229752|NCT03532542|516390836|FG001|Overall Study|Study Terminated by Sponsor|65|||
143229753|NCT03532542|516390835|FG000|Overall Study|Withdrawal by Subject|6|||
143229754|NCT03532542|516390836|FG001|Overall Study|Withdrawal by Subject|5|||
143229755|NCT00524485|516390840|FG000|Overall Study|Withdrawal by Subject|5|||
143229756|NCT01600885|516390843|FG000|First Period|Adverse Event|1|||
143229757|NCT01600885|516390844|FG001|First Period|Adverse Event|1|||
143278615|NCT00042289|516575109|FG024|Overall Study|Lost to Follow-up|0|||
143278616|NCT00042289|516575110|FG025|Overall Study|Lost to Follow-up|0|||
143278617|NCT00042289|516575111|FG026|Overall Study|Lost to Follow-up|2|||
143229758|NCT01600885|516390843|FG000|First Period|moved out of area|1|||
143229759|NCT01600885|516390844|FG001|First Period|moved out of area|0|||
143229760|NCT00436332|516390845|FG000|Overall Study|Adverse Event|9|||
143229761|NCT00436332|516390845|FG000|Overall Study|Withdrawal by Subject|2|||
143229762|NCT00436332|516390845|FG000|Overall Study|Progression|59|||
143229763|NCT00436332|516390845|FG000|Overall Study|Death|2|||
143229764|NCT00436332|516390845|FG000|Overall Study|Not Protocol Specified|6|||
143278618|NCT00042289|516575112|FG027|Overall Study|Lost to Follow-up|2|||
143278619|NCT00042289|516575113|FG028|Overall Study|Lost to Follow-up|2|||
143278620|NCT00042289|516575114|FG029|Overall Study|Lost to Follow-up|0|||
143278621|NCT00042289|516575115|FG030|Overall Study|Lost to Follow-up|0|||
143278622|NCT00042289|516575116|FG031|Overall Study|Lost to Follow-up|2|||
143278623|NCT00042289|516575117|FG032|Overall Study|Lost to Follow-up|1|||
143278624|NCT00042289|516575118|FG033|Overall Study|Lost to Follow-up|1|||
143278625|NCT00042289|516575119|FG034|Overall Study|Lost to Follow-up|1|||
143278626|NCT00042289|516575120|FG035|Overall Study|Lost to Follow-up|2|||
143278627|NCT00042289|516575121|FG036|Overall Study|Lost to Follow-up|1|||
143278628|NCT00042289|516575122|FG037|Overall Study|Lost to Follow-up|1|||
143278629|NCT00042289|516575123|FG038|Overall Study|Lost to Follow-up|0|||
143278630|NCT00042289|516575124|FG039|Overall Study|Lost to Follow-up|5|||
143278631|NCT00042289|516575125|FG040|Overall Study|Lost to Follow-up|0|||
143278632|NCT00042289|516575126|FG041|Overall Study|Lost to Follow-up|2|||
143278633|NCT00042289|516575127|FG042|Overall Study|Lost to Follow-up|2|||
143278634|NCT00042289|516575128|FG043|Overall Study|Lost to Follow-up|0|||
143278635|NCT00042289|516575129|FG044|Overall Study|Lost to Follow-up|0|||
143278636|NCT00042289|516575130|FG045|Overall Study|Lost to Follow-up|1|||
143278637|NCT00042289|516575131|FG046|Overall Study|Lost to Follow-up|0|||
143278638|NCT00042289|516575085|FG000|Overall Study|Other reason|0|||
143278639|NCT00042289|516575086|FG001|Overall Study|Other reason|0|||
143278640|NCT00042289|516575087|FG002|Overall Study|Other reason|0|||
143278641|NCT00042289|516575088|FG003|Overall Study|Other reason|2|||
143278642|NCT00042289|516575089|FG004|Overall Study|Other reason|0|||
143278643|NCT00042289|516575090|FG005|Overall Study|Other reason|0|||
143278644|NCT00042289|516575091|FG006|Overall Study|Other reason|0|||
143278645|NCT00042289|516575092|FG007|Overall Study|Other reason|0|||
143278646|NCT00042289|516575093|FG008|Overall Study|Other reason|0|||
143278647|NCT00042289|516575094|FG009|Overall Study|Other reason|0|||
143278648|NCT00042289|516575095|FG010|Overall Study|Other reason|0|||
143278649|NCT00042289|516575096|FG011|Overall Study|Other reason|0|||
143278650|NCT00042289|516575097|FG012|Overall Study|Other reason|0|||
143278651|NCT00042289|516575098|FG013|Overall Study|Other reason|0|||
143278652|NCT00042289|516575099|FG014|Overall Study|Other reason|0|||
143278653|NCT00042289|516575100|FG015|Overall Study|Other reason|0|||
143278654|NCT00042289|516575101|FG016|Overall Study|Other reason|0|||
143278655|NCT00042289|516575102|FG017|Overall Study|Other reason|0|||
143278656|NCT00042289|516575103|FG018|Overall Study|Other reason|1|||
143278657|NCT00042289|516575104|FG019|Overall Study|Other reason|0|||
143278658|NCT00042289|516575105|FG020|Overall Study|Other reason|0|||
143278659|NCT00042289|516575106|FG021|Overall Study|Other reason|0|||
143278660|NCT00042289|516575107|FG022|Overall Study|Other reason|0|||
143278661|NCT00042289|516575108|FG023|Overall Study|Other reason|1|||
143278662|NCT00042289|516575109|FG024|Overall Study|Other reason|0|||
143278663|NCT00042289|516575110|FG025|Overall Study|Other reason|0|||
143278664|NCT00042289|516575111|FG026|Overall Study|Other reason|1|||
143278665|NCT00042289|516575112|FG027|Overall Study|Other reason|0|||
143278666|NCT00042289|516575113|FG028|Overall Study|Other reason|3|||
143278667|NCT00042289|516575114|FG029|Overall Study|Other reason|0|||
143278668|NCT00042289|516575115|FG030|Overall Study|Other reason|0|||
143278669|NCT00042289|516575116|FG031|Overall Study|Other reason|1|||
143278670|NCT00042289|516575117|FG032|Overall Study|Other reason|0|||
143278671|NCT00042289|516575118|FG033|Overall Study|Other reason|1|||
143278672|NCT00042289|516575119|FG034|Overall Study|Other reason|0|||
143278673|NCT00042289|516575120|FG035|Overall Study|Other reason|2|||
143278674|NCT00042289|516575121|FG036|Overall Study|Other reason|0|||
143278675|NCT00042289|516575122|FG037|Overall Study|Other reason|0|||
143278676|NCT00042289|516575123|FG038|Overall Study|Other reason|0|||
143278677|NCT00042289|516575124|FG039|Overall Study|Other reason|0|||
143278678|NCT00042289|516575125|FG040|Overall Study|Other reason|0|||
143278679|NCT00042289|516575126|FG041|Overall Study|Other reason|0|||
143278680|NCT00042289|516575127|FG042|Overall Study|Other reason|0|||
143278681|NCT00042289|516575128|FG043|Overall Study|Other reason|1|||
143278682|NCT00042289|516575129|FG044|Overall Study|Other reason|0|||
143278683|NCT00042289|516575130|FG045|Overall Study|Other reason|0|||
143278684|NCT00042289|516575131|FG046|Overall Study|Other reason|0|||
143278685|NCT00042289|516575085|FG000|Overall Study|Severe debilitation, unable to continue|0|||
143229765|NCT00436332|516390845|FG000|Overall Study|Ineligible|2|||
143229766|NCT00436332|516390845|FG000|Overall Study|Never Received Treatment|3|||
143229767|NCT00062439|516390846|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
143229768|NCT00062439|516390846|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
143229769|NCT00062439|516390846|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
143229770|NCT00062439|516390846|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
143229771|NCT00062439|516390846|FG000|Post Chemoradiation Assessment|Death|1|||
143229772|NCT00062439|516390846|FG000|Post Chemoradiation Assessment|Disease progression|2|||
143229773|NCT00062439|516390846|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
143229774|NCT00062439|516390846|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
143229775|NCT00062439|516390846|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
143229776|NCT00062439|516390846|FG000|Surgery|Physician Decision|4|||
143229777|NCT00062439|516390846|FG000|Surgery|Death|1|||
143229778|NCT00062439|516390846|FG000|Surgery|Adverse Event|2|||
143229779|NCT00062439|516390846|FG000|Consolidation Chemotherapy|Adverse Event|2|||
143229780|NCT01924845|516390847|FG000|Overall Study|Adverse Event|3|||
143229781|NCT01924845|516390847|FG000|Overall Study|Withdrawal by Subject|2|||
143229782|NCT01924845|516390847|FG000|Overall Study|Protocol Violation|1|||
143229783|NCT04698343|516390848|FG000|Overall Study|Withdrawal by Subject|6|||
143229784|NCT04698343|516390848|FG000|Overall Study|Physician Decision|2|||
143229785|NCT04698343|516390848|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
143229786|NCT04698343|516390848|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
143229787|NCT04698343|516390848|FG000|Overall Study|Personal reasons|3|||
143229788|NCT04698343|516390848|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
143229789|NCT04201431|516390849|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
143229790|NCT04201431|516390850|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
143229791|NCT04201431|516390851|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
143229792|NCT00286442|516390852|FG000|Overall Study|Hyperglycemic Rescue|19|||
143278686|NCT00042289|516575086|FG001|Overall Study|Severe debilitation, unable to continue|0|||
143278687|NCT00042289|516575087|FG002|Overall Study|Severe debilitation, unable to continue|0|||
143278688|NCT00042289|516575088|FG003|Overall Study|Severe debilitation, unable to continue|0|||
143278689|NCT00042289|516575089|FG004|Overall Study|Severe debilitation, unable to continue|0|||
143278690|NCT00042289|516575090|FG005|Overall Study|Severe debilitation, unable to continue|0|||
143278691|NCT00042289|516575091|FG006|Overall Study|Severe debilitation, unable to continue|0|||
143278692|NCT00042289|516575092|FG007|Overall Study|Severe debilitation, unable to continue|0|||
143278693|NCT00042289|516575093|FG008|Overall Study|Severe debilitation, unable to continue|0|||
143278694|NCT00042289|516575094|FG009|Overall Study|Severe debilitation, unable to continue|0|||
143278695|NCT00042289|516575095|FG010|Overall Study|Severe debilitation, unable to continue|0|||
143278696|NCT00042289|516575096|FG011|Overall Study|Severe debilitation, unable to continue|0|||
143278697|NCT00042289|516575097|FG012|Overall Study|Severe debilitation, unable to continue|0|||
143278698|NCT00042289|516575098|FG013|Overall Study|Severe debilitation, unable to continue|0|||
143278699|NCT00042289|516575099|FG014|Overall Study|Severe debilitation, unable to continue|0|||
143278700|NCT00042289|516575100|FG015|Overall Study|Severe debilitation, unable to continue|0|||
143278701|NCT00042289|516575101|FG016|Overall Study|Severe debilitation, unable to continue|0|||
143278702|NCT00042289|516575102|FG017|Overall Study|Severe debilitation, unable to continue|0|||
143278703|NCT00042289|516575103|FG018|Overall Study|Severe debilitation, unable to continue|0|||
143278704|NCT00042289|516575104|FG019|Overall Study|Severe debilitation, unable to continue|0|||
143278705|NCT00042289|516575105|FG020|Overall Study|Severe debilitation, unable to continue|0|||
143278706|NCT00042289|516575106|FG021|Overall Study|Severe debilitation, unable to continue|1|||
143278707|NCT00042289|516575107|FG022|Overall Study|Severe debilitation, unable to continue|0|||
143278708|NCT00042289|516575108|FG023|Overall Study|Severe debilitation, unable to continue|1|||
143278709|NCT00042289|516575109|FG024|Overall Study|Severe debilitation, unable to continue|0|||
143278710|NCT00042289|516575110|FG025|Overall Study|Severe debilitation, unable to continue|0|||
143278711|NCT00042289|516575111|FG026|Overall Study|Severe debilitation, unable to continue|0|||
143278712|NCT00042289|516575112|FG027|Overall Study|Severe debilitation, unable to continue|1|||
143278713|NCT00042289|516575113|FG028|Overall Study|Severe debilitation, unable to continue|0|||
143278714|NCT00042289|516575114|FG029|Overall Study|Severe debilitation, unable to continue|0|||
143278715|NCT00042289|516575115|FG030|Overall Study|Severe debilitation, unable to continue|0|||
143278716|NCT00042289|516575116|FG031|Overall Study|Severe debilitation, unable to continue|1|||
143278717|NCT00042289|516575117|FG032|Overall Study|Severe debilitation, unable to continue|1|||
143278718|NCT00042289|516575118|FG033|Overall Study|Severe debilitation, unable to continue|0|||
143278719|NCT00042289|516575119|FG034|Overall Study|Severe debilitation, unable to continue|0|||
143278720|NCT00042289|516575120|FG035|Overall Study|Severe debilitation, unable to continue|0|||
143278721|NCT00042289|516575121|FG036|Overall Study|Severe debilitation, unable to continue|0|||
143278722|NCT00042289|516575122|FG037|Overall Study|Severe debilitation, unable to continue|0|||
143229793|NCT00286442|516390853|FG001|Overall Study|Hyperglycemic Rescue|17|||
143229794|NCT00286442|516390854|FG002|Overall Study|Hyperglycemic Rescue|25|||
143229795|NCT00286442|516390852|FG000|Overall Study|Adverse Event|7|||
143229796|NCT00286442|516390853|FG001|Overall Study|Adverse Event|6|||
143229797|NCT00286442|516390854|FG002|Overall Study|Adverse Event|1|||
143229798|NCT00286442|516390852|FG000|Overall Study|Protocol Violation|2|||
143229799|NCT00286442|516390853|FG001|Overall Study|Protocol Violation|4|||
143229800|NCT00286442|516390854|FG002|Overall Study|Protocol Violation|2|||
143229801|NCT00286442|516390852|FG000|Overall Study|Lost to Follow-up|5|||
143229802|NCT00286442|516390853|FG001|Overall Study|Lost to Follow-up|2|||
143229803|NCT00286442|516390854|FG002|Overall Study|Lost to Follow-up|1|||
143229804|NCT00286442|516390852|FG000|Overall Study|Physician Decision|1|||
143229805|NCT00286442|516390853|FG001|Overall Study|Physician Decision|1|||
143229806|NCT00286442|516390854|FG002|Overall Study|Physician Decision|1|||
143229807|NCT00286442|516390852|FG000|Overall Study|Administrative Error|1|||
143229808|NCT00286442|516390853|FG001|Overall Study|Administrative Error|1|||
143229809|NCT00286442|516390854|FG002|Overall Study|Administrative Error|0|||
143229810|NCT00286442|516390852|FG000|Overall Study|Withdrawal by Subject|2|||
143229811|NCT00286442|516390853|FG001|Overall Study|Withdrawal by Subject|14|||
143229812|NCT00286442|516390854|FG002|Overall Study|Withdrawal by Subject|2|||
143229813|NCT02756338|516390857|FG000|Overall Study|Withdrawn by Investigator|1|||
143229814|NCT02756338|516390857|FG000|Overall Study|Device Replaced with Pacemaker|4|||
143229815|NCT01339689|516390860|FG000|Overall Study|Adverse Event|1|||
143229816|NCT01339689|516390861|FG001|Overall Study|Adverse Event|2|||
143229817|NCT01339689|516390860|FG000|Overall Study|Lost to Follow-up|9|||
143229818|NCT01339689|516390861|FG001|Overall Study|Lost to Follow-up|3|||
143229819|NCT01339689|516390860|FG000|Overall Study|Withdrawal by Subject|3|||
143229820|NCT01339689|516390861|FG001|Overall Study|Withdrawal by Subject|0|||
143229821|NCT01339689|516390860|FG000|Overall Study|Noncompliance|1|||
143229822|NCT01339689|516390861|FG001|Overall Study|Noncompliance|0|||
143229823|NCT01339689|516390860|FG000|Overall Study|Relocated out of area|0|||
143229824|NCT01339689|516390861|FG001|Overall Study|Relocated out of area|1|||
143229825|NCT01339689|516390860|FG000|Overall Study|Other|2|||
143229826|NCT01339689|516390861|FG001|Overall Study|Other|2|||
143229827|NCT01339689|516390860|FG000|Overall Study|multiple reasons|1|||
143229828|NCT01339689|516390861|FG001|Overall Study|multiple reasons|1|||
143229829|NCT04079296|516390864|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
143229830|NCT04079296|516390865|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
143229831|NCT04079296|516390866|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
143229832|NCT04079296|516390867|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
143229833|NCT04079296|516390868|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
143229834|NCT04079296|516390864|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
143229835|NCT04079296|516390865|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
143229836|NCT04079296|516390866|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
143229837|NCT04079296|516390867|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
143229838|NCT04079296|516390868|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
143229839|NCT04079296|516390864|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
143229840|NCT04079296|516390865|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
143229841|NCT04079296|516390866|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
143229842|NCT04079296|516390867|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
143229843|NCT04079296|516390868|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
143229844|NCT04079296|516390864|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
143229845|NCT04079296|516390865|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
143229846|NCT04079296|516390866|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
143229847|NCT04079296|516390867|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
143229848|NCT04079296|516390868|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
143229849|NCT04079296|516390864|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
143229850|NCT04079296|516390865|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
143229851|NCT04079296|516390866|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
143229852|NCT04079296|516390867|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
143229853|NCT04079296|516390868|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
143229854|NCT04079296|516390864|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
143229855|NCT04079296|516390865|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
143229856|NCT04079296|516390866|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
143229857|NCT04079296|516390867|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
143229858|NCT04079296|516390868|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
143229859|NCT04079296|516390864|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
143229860|NCT04079296|516390865|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
143229861|NCT04079296|516390866|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
143229862|NCT04079296|516390867|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
143278723|NCT00042289|516575123|FG038|Overall Study|Severe debilitation, unable to continue|0|||
143278724|NCT00042289|516575124|FG039|Overall Study|Severe debilitation, unable to continue|0|||
143278725|NCT00042289|516575125|FG040|Overall Study|Severe debilitation, unable to continue|0|||
143278726|NCT00042289|516575126|FG041|Overall Study|Severe debilitation, unable to continue|0|||
143278727|NCT00042289|516575127|FG042|Overall Study|Severe debilitation, unable to continue|0|||
143278728|NCT00042289|516575128|FG043|Overall Study|Severe debilitation, unable to continue|0|||
143278729|NCT00042289|516575129|FG044|Overall Study|Severe debilitation, unable to continue|0|||
143278730|NCT00042289|516575130|FG045|Overall Study|Severe debilitation, unable to continue|0|||
143278731|NCT00042289|516575131|FG046|Overall Study|Severe debilitation, unable to continue|0|||
143278732|NCT00042289|516575085|FG000|Overall Study|Site closed|0|||
143278733|NCT00042289|516575086|FG001|Overall Study|Site closed|0|||
143278734|NCT00042289|516575087|FG002|Overall Study|Site closed|0|||
143278735|NCT00042289|516575088|FG003|Overall Study|Site closed|0|||
143278736|NCT00042289|516575089|FG004|Overall Study|Site closed|0|||
143278737|NCT00042289|516575090|FG005|Overall Study|Site closed|0|||
143278738|NCT00042289|516575091|FG006|Overall Study|Site closed|0|||
143278739|NCT00042289|516575092|FG007|Overall Study|Site closed|0|||
143278740|NCT00042289|516575093|FG008|Overall Study|Site closed|0|||
143278741|NCT00042289|516575094|FG009|Overall Study|Site closed|0|||
143278742|NCT00042289|516575095|FG010|Overall Study|Site closed|0|||
143278743|NCT00042289|516575096|FG011|Overall Study|Site closed|0|||
143278744|NCT00042289|516575097|FG012|Overall Study|Site closed|0|||
143278745|NCT00042289|516575098|FG013|Overall Study|Site closed|0|||
143278746|NCT00042289|516575099|FG014|Overall Study|Site closed|0|||
143278747|NCT00042289|516575100|FG015|Overall Study|Site closed|0|||
143278748|NCT00042289|516575101|FG016|Overall Study|Site closed|0|||
143278749|NCT00042289|516575102|FG017|Overall Study|Site closed|0|||
143278750|NCT00042289|516575103|FG018|Overall Study|Site closed|0|||
143278751|NCT00042289|516575104|FG019|Overall Study|Site closed|0|||
143278752|NCT00042289|516575105|FG020|Overall Study|Site closed|0|||
143278753|NCT00042289|516575106|FG021|Overall Study|Site closed|0|||
143278754|NCT00042289|516575107|FG022|Overall Study|Site closed|0|||
143278755|NCT00042289|516575108|FG023|Overall Study|Site closed|0|||
143278756|NCT00042289|516575109|FG024|Overall Study|Site closed|0|||
143278757|NCT00042289|516575110|FG025|Overall Study|Site closed|0|||
143278758|NCT00042289|516575111|FG026|Overall Study|Site closed|0|||
143278759|NCT00042289|516575112|FG027|Overall Study|Site closed|0|||
143278760|NCT00042289|516575113|FG028|Overall Study|Site closed|0|||
143278761|NCT00042289|516575114|FG029|Overall Study|Site closed|0|||
143278762|NCT00042289|516575115|FG030|Overall Study|Site closed|0|||
143278763|NCT00042289|516575116|FG031|Overall Study|Site closed|3|||
143278764|NCT00042289|516575117|FG032|Overall Study|Site closed|0|||
143278765|NCT00042289|516575118|FG033|Overall Study|Site closed|0|||
143278766|NCT00042289|516575119|FG034|Overall Study|Site closed|0|||
143278767|NCT00042289|516575120|FG035|Overall Study|Site closed|0|||
143278768|NCT00042289|516575121|FG036|Overall Study|Site closed|1|||
143278769|NCT00042289|516575122|FG037|Overall Study|Site closed|0|||
143278770|NCT00042289|516575123|FG038|Overall Study|Site closed|0|||
143278771|NCT00042289|516575124|FG039|Overall Study|Site closed|0|||
143278772|NCT00042289|516575125|FG040|Overall Study|Site closed|0|||
143278773|NCT00042289|516575126|FG041|Overall Study|Site closed|0|||
143278774|NCT00042289|516575127|FG042|Overall Study|Site closed|1|||
143278775|NCT00042289|516575128|FG043|Overall Study|Site closed|0|||
143278776|NCT00042289|516575129|FG044|Overall Study|Site closed|0|||
143278777|NCT00042289|516575130|FG045|Overall Study|Site closed|0|||
143278778|NCT00042289|516575131|FG046|Overall Study|Site closed|0|||
143278779|NCT00042289|516575085|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
143278780|NCT00042289|516575086|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
143372889|NCT01212757|516909649|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
143372890|NCT01212757|516909650|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
143278781|NCT00042289|516575087|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
143278782|NCT00042289|516575088|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
143278783|NCT00042289|516575089|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
143278784|NCT00042289|516575090|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
143278785|NCT00042289|516575091|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
143278786|NCT00042289|516575092|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
143278787|NCT00042289|516575093|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
143278788|NCT00042289|516575094|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
143278789|NCT00042289|516575095|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
143278790|NCT00042289|516575096|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
143278791|NCT00042289|516575097|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
143278792|NCT00042289|516575098|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
143278793|NCT00042289|516575099|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
143278794|NCT00042289|516575100|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
143278795|NCT00042289|516575101|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
143278796|NCT00042289|516575102|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
143278797|NCT00042289|516575103|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
143278798|NCT00042289|516575104|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
143278799|NCT00042289|516575105|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
143278800|NCT00042289|516575106|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
143278801|NCT00042289|516575107|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
143278802|NCT00042289|516575108|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
143278803|NCT00042289|516575109|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
143278804|NCT00042289|516575110|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
143278805|NCT00042289|516575111|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
143278806|NCT00042289|516575112|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
143278807|NCT00042289|516575113|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
143278808|NCT00042289|516575114|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
143278809|NCT00042289|516575115|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
143278810|NCT00042289|516575116|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
143372891|NCT01212757|516909651|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
143372892|NCT01212757|516909643|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
143372893|NCT01212757|516909644|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
143372894|NCT01212757|516909645|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
143372895|NCT01212757|516909646|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
143372896|NCT01212757|516909647|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
143372897|NCT01212757|516909648|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
143372898|NCT01212757|516909649|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
143372899|NCT01212757|516909650|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
143372900|NCT01212757|516909651|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
143372901|NCT01212757|516909643|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
143372902|NCT01212757|516909644|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
143372903|NCT01212757|516909645|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
143372904|NCT01212757|516909646|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
143372905|NCT01212757|516909647|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
143372906|NCT01212757|516909648|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
143372907|NCT01212757|516909649|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
143372908|NCT01212757|516909650|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
143372909|NCT01212757|516909651|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
143372910|NCT01212757|516909643|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
143372911|NCT01212757|516909644|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
143372912|NCT01212757|516909645|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
143372913|NCT01212757|516909646|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
143372914|NCT01212757|516909647|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
143372915|NCT01212757|516909648|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
143372916|NCT01212757|516909649|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
143372917|NCT01212757|516909650|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
143372918|NCT01212757|516909651|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
143372919|NCT01212757|516909643|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
143372920|NCT01212757|516909644|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
143372921|NCT01212757|516909645|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
143372922|NCT01212757|516909646|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
143372923|NCT01212757|516909647|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
143372924|NCT01212757|516909648|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
143372925|NCT01212757|516909649|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
143372926|NCT01212757|516909650|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
143372927|NCT01212757|516909651|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
143372928|NCT01212757|516909643|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
143372929|NCT01212757|516909644|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
143372930|NCT01212757|516909645|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
143372931|NCT01212757|516909646|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
143372932|NCT01212757|516909647|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
143372933|NCT01212757|516909648|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
143278811|NCT00042289|516575117|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
143278812|NCT00042289|516575118|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
143278813|NCT00042289|516575119|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
143278814|NCT00042289|516575120|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
143278815|NCT00042289|516575121|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
143278816|NCT00042289|516575122|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
143278817|NCT00042289|516575123|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
143278818|NCT00042289|516575124|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
143278819|NCT00042289|516575125|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
143278820|NCT00042289|516575126|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
143278821|NCT00042289|516575127|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
143278822|NCT00042289|516575128|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
143278823|NCT00042289|516575129|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
143278824|NCT00042289|516575130|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
143278825|NCT00042289|516575131|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
143278826|NCT00042289|516575085|FG000|Overall Study|Protocol Violation|0|||
143278827|NCT00042289|516575086|FG001|Overall Study|Protocol Violation|0|||
143278828|NCT00042289|516575087|FG002|Overall Study|Protocol Violation|0|||
143278829|NCT00042289|516575088|FG003|Overall Study|Protocol Violation|0|||
143278830|NCT00042289|516575089|FG004|Overall Study|Protocol Violation|0|||
143278831|NCT00042289|516575090|FG005|Overall Study|Protocol Violation|1|||
143278832|NCT00042289|516575091|FG006|Overall Study|Protocol Violation|0|||
143278833|NCT00042289|516575092|FG007|Overall Study|Protocol Violation|1|||
143278834|NCT00042289|516575093|FG008|Overall Study|Protocol Violation|0|||
143278835|NCT00042289|516575094|FG009|Overall Study|Protocol Violation|0|||
143278836|NCT00042289|516575095|FG010|Overall Study|Protocol Violation|0|||
143278837|NCT00042289|516575096|FG011|Overall Study|Protocol Violation|0|||
143278838|NCT00042289|516575097|FG012|Overall Study|Protocol Violation|0|||
143278839|NCT00042289|516575098|FG013|Overall Study|Protocol Violation|0|||
143278840|NCT00042289|516575099|FG014|Overall Study|Protocol Violation|0|||
143278841|NCT00042289|516575100|FG015|Overall Study|Protocol Violation|0|||
143278842|NCT00042289|516575101|FG016|Overall Study|Protocol Violation|0|||
143278843|NCT00042289|516575102|FG017|Overall Study|Protocol Violation|0|||
143278844|NCT00042289|516575103|FG018|Overall Study|Protocol Violation|0|||
143278845|NCT00042289|516575104|FG019|Overall Study|Protocol Violation|0|||
143278846|NCT00042289|516575105|FG020|Overall Study|Protocol Violation|0|||
143278847|NCT00042289|516575106|FG021|Overall Study|Protocol Violation|0|||
143278848|NCT00042289|516575107|FG022|Overall Study|Protocol Violation|0|||
143278849|NCT00042289|516575108|FG023|Overall Study|Protocol Violation|1|||
143278850|NCT00042289|516575109|FG024|Overall Study|Protocol Violation|1|||
143278851|NCT00042289|516575110|FG025|Overall Study|Protocol Violation|0|||
143278852|NCT00042289|516575111|FG026|Overall Study|Protocol Violation|2|||
143278853|NCT00042289|516575112|FG027|Overall Study|Protocol Violation|0|||
143278854|NCT00042289|516575113|FG028|Overall Study|Protocol Violation|0|||
143278855|NCT00042289|516575114|FG029|Overall Study|Protocol Violation|0|||
143278856|NCT00042289|516575115|FG030|Overall Study|Protocol Violation|1|||
143278857|NCT00042289|516575116|FG031|Overall Study|Protocol Violation|0|||
143278858|NCT00042289|516575117|FG032|Overall Study|Protocol Violation|0|||
143278859|NCT00042289|516575118|FG033|Overall Study|Protocol Violation|0|||
143278860|NCT00042289|516575119|FG034|Overall Study|Protocol Violation|0|||
143278861|NCT00042289|516575120|FG035|Overall Study|Protocol Violation|0|||
143278862|NCT00042289|516575121|FG036|Overall Study|Protocol Violation|0|||
143278863|NCT00042289|516575122|FG037|Overall Study|Protocol Violation|0|||
143278864|NCT00042289|516575123|FG038|Overall Study|Protocol Violation|0|||
143278865|NCT00042289|516575124|FG039|Overall Study|Protocol Violation|0|||
143278866|NCT00042289|516575125|FG040|Overall Study|Protocol Violation|0|||
143278867|NCT00042289|516575126|FG041|Overall Study|Protocol Violation|1|||
143278868|NCT00042289|516575127|FG042|Overall Study|Protocol Violation|1|||
143278869|NCT00042289|516575128|FG043|Overall Study|Protocol Violation|1|||
143278870|NCT00042289|516575129|FG044|Overall Study|Protocol Violation|0|||
143278871|NCT00042289|516575130|FG045|Overall Study|Protocol Violation|0|||
143278872|NCT00042289|516575131|FG046|Overall Study|Protocol Violation|0|||
143278873|NCT00042289|516575085|FG000|Overall Study|Withdrawal by Subject|4|||
143278874|NCT00042289|516575086|FG001|Overall Study|Withdrawal by Subject|1|||
143278875|NCT00042289|516575087|FG002|Overall Study|Withdrawal by Subject|0|||
143278876|NCT00042289|516575088|FG003|Overall Study|Withdrawal by Subject|2|||
143278877|NCT00042289|516575089|FG004|Overall Study|Withdrawal by Subject|0|||
143278878|NCT00042289|516575090|FG005|Overall Study|Withdrawal by Subject|2|||
143278879|NCT00042289|516575091|FG006|Overall Study|Withdrawal by Subject|0|||
143278880|NCT00042289|516575092|FG007|Overall Study|Withdrawal by Subject|0|||
143278881|NCT00042289|516575093|FG008|Overall Study|Withdrawal by Subject|0|||
143278882|NCT00042289|516575094|FG009|Overall Study|Withdrawal by Subject|1|||
143278883|NCT00042289|516575095|FG010|Overall Study|Withdrawal by Subject|0|||
143278884|NCT00042289|516575096|FG011|Overall Study|Withdrawal by Subject|0|||
143278885|NCT00042289|516575097|FG012|Overall Study|Withdrawal by Subject|2|||
143278886|NCT00042289|516575098|FG013|Overall Study|Withdrawal by Subject|0|||
143278887|NCT00042289|516575099|FG014|Overall Study|Withdrawal by Subject|0|||
143278888|NCT00042289|516575100|FG015|Overall Study|Withdrawal by Subject|0|||
143278889|NCT00042289|516575101|FG016|Overall Study|Withdrawal by Subject|0|||
143278890|NCT00042289|516575102|FG017|Overall Study|Withdrawal by Subject|0|||
143278891|NCT00042289|516575103|FG018|Overall Study|Withdrawal by Subject|0|||
143278892|NCT00042289|516575104|FG019|Overall Study|Withdrawal by Subject|0|||
143278893|NCT00042289|516575105|FG020|Overall Study|Withdrawal by Subject|0|||
143278894|NCT00042289|516575106|FG021|Overall Study|Withdrawal by Subject|1|||
143278895|NCT00042289|516575107|FG022|Overall Study|Withdrawal by Subject|1|||
143278896|NCT00042289|516575108|FG023|Overall Study|Withdrawal by Subject|1|||
143278897|NCT00042289|516575109|FG024|Overall Study|Withdrawal by Subject|0|||
143278898|NCT00042289|516575110|FG025|Overall Study|Withdrawal by Subject|0|||
143278899|NCT00042289|516575111|FG026|Overall Study|Withdrawal by Subject|1|||
143278900|NCT00042289|516575112|FG027|Overall Study|Withdrawal by Subject|0|||
143278901|NCT00042289|516575113|FG028|Overall Study|Withdrawal by Subject|2|||
143278902|NCT00042289|516575114|FG029|Overall Study|Withdrawal by Subject|0|||
143278903|NCT00042289|516575115|FG030|Overall Study|Withdrawal by Subject|0|||
143278904|NCT00042289|516575116|FG031|Overall Study|Withdrawal by Subject|1|||
143278905|NCT00042289|516575117|FG032|Overall Study|Withdrawal by Subject|2|||
143278906|NCT00042289|516575118|FG033|Overall Study|Withdrawal by Subject|1|||
143278907|NCT00042289|516575119|FG034|Overall Study|Withdrawal by Subject|0|||
143278908|NCT00042289|516575120|FG035|Overall Study|Withdrawal by Subject|0|||
143278909|NCT00042289|516575121|FG036|Overall Study|Withdrawal by Subject|0|||
143278910|NCT00042289|516575122|FG037|Overall Study|Withdrawal by Subject|1|||
143278911|NCT00042289|516575123|FG038|Overall Study|Withdrawal by Subject|0|||
143278912|NCT00042289|516575124|FG039|Overall Study|Withdrawal by Subject|0|||
143372934|NCT01212757|516909649|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
143372935|NCT01212757|516909650|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
143372936|NCT01212757|516909651|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
143372937|NCT01212757|516909643|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
143372938|NCT01212757|516909644|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
143372939|NCT01212757|516909645|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
143372940|NCT01212757|516909646|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
143372941|NCT01212757|516909647|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
143372942|NCT01212757|516909648|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
143372943|NCT01212757|516909649|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
143372944|NCT01212757|516909650|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
143372945|NCT01212757|516909651|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
143372946|NCT01212757|516909643|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
143372947|NCT01212757|516909644|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
143372948|NCT01212757|516909645|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
143372949|NCT01212757|516909646|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
143372950|NCT01212757|516909647|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
143372951|NCT01212757|516909648|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
143372952|NCT01212757|516909649|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
143372953|NCT01212757|516909650|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
143372954|NCT01212757|516909651|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
143372955|NCT01212757|516909643|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
143372956|NCT01212757|516909644|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
143372957|NCT01212757|516909645|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
143372958|NCT01212757|516909646|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
143372959|NCT01212757|516909647|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
143372960|NCT01212757|516909648|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
143372961|NCT01212757|516909649|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
143372962|NCT01212757|516909650|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
143372963|NCT01212757|516909651|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
143278913|NCT00042289|516575125|FG040|Overall Study|Withdrawal by Subject|0|||
143278914|NCT00042289|516575126|FG041|Overall Study|Withdrawal by Subject|0|||
143278915|NCT00042289|516575127|FG042|Overall Study|Withdrawal by Subject|1|||
143278916|NCT00042289|516575128|FG043|Overall Study|Withdrawal by Subject|0|||
143372964|NCT01212757|516909643|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
143278917|NCT00042289|516575129|FG044|Overall Study|Withdrawal by Subject|0|||
143278918|NCT00042289|516575130|FG045|Overall Study|Withdrawal by Subject|0|||
143278919|NCT00042289|516575131|FG046|Overall Study|Withdrawal by Subject|0|||
143278920|NCT00717197|516575136|FG000|Overall Study|Unable to purchase study drug|5|||
143278921|NCT00717197|516575136|FG000|Overall Study|Tumor Progression|1|||
143278922|NCT00717197|516575136|FG000|Overall Study|Physician Decision|1|||
143278923|NCT00982137|516575137|FG000|Overall Study|Lost to Follow-up|0|||
143278924|NCT00982137|516575138|FG001|Overall Study|Lost to Follow-up|0|||
143278925|NCT00982137|516575139|FG002|Overall Study|Lost to Follow-up|0|||
143278926|NCT00982137|516575140|FG003|Overall Study|Lost to Follow-up|1|||
143278927|NCT00982137|516575137|FG000|Overall Study|Withdrawal by Subject|0|||
143278928|NCT00982137|516575138|FG001|Overall Study|Withdrawal by Subject|1|||
143278929|NCT00982137|516575139|FG002|Overall Study|Withdrawal by Subject|0|||
143278930|NCT00982137|516575140|FG003|Overall Study|Withdrawal by Subject|0|||
143278931|NCT00126191|516575143|FG000|Overall Study|Physician Decision|0|||
143278932|NCT00126191|516575144|FG001|Overall Study|Physician Decision|1|||
143278933|NCT00126191|516575143|FG000|Overall Study|Death|0|||
143278934|NCT00126191|516575144|FG001|Overall Study|Death|1|||
143278935|NCT01648101|516575145|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
143278936|NCT01648101|516575146|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
143278937|NCT01648101|516575147|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
143278938|NCT01648101|516575145|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
143278939|NCT01648101|516575146|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
143278940|NCT01648101|516575147|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
143278941|NCT01648101|516575145|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
143278942|NCT01648101|516575146|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
143278943|NCT01648101|516575147|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
143278944|NCT01648101|516575145|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
143278945|NCT01648101|516575146|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
143278946|NCT01648101|516575147|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
143278947|NCT01648101|516575145|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
143278948|NCT01648101|516575146|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
143278949|NCT01648101|516575147|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
143278950|NCT01648101|516575145|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
143278951|NCT01648101|516575146|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
143278952|NCT01648101|516575147|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
143278953|NCT01648101|516575145|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
143278954|NCT01648101|516575146|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
143278955|NCT01648101|516575147|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
143278956|NCT01648101|516575145|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
143278957|NCT01648101|516575146|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
143278958|NCT01648101|516575147|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
143278959|NCT01648101|516575145|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
143278960|NCT01648101|516575146|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
143278961|NCT01648101|516575147|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
143278962|NCT01648101|516575145|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
143278963|NCT01648101|516575146|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
143278964|NCT01648101|516575147|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
143278965|NCT01648101|516575145|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
143278966|NCT01648101|516575146|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
143278967|NCT01648101|516575147|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
143278968|NCT00307294|516575163|FG000|Overall Study|Withdrawal by Subject|1|||
143278969|NCT03311724|516575166|FG000|Overall Study|Physician Decision|0|||
143278970|NCT03311724|516575167|FG001|Overall Study|Physician Decision|0|||
143278971|NCT03311724|516575168|FG002|Overall Study|Physician Decision|0|||
143278972|NCT03311724|516575169|FG003|Overall Study|Physician Decision|1|||
143278973|NCT03311724|516575166|FG000|Overall Study|Protocol Violation|1|||
143278974|NCT03311724|516575167|FG001|Overall Study|Protocol Violation|0|||
143278975|NCT03311724|516575168|FG002|Overall Study|Protocol Violation|1|||
143278976|NCT03311724|516575169|FG003|Overall Study|Protocol Violation|0|||
143278977|NCT03311724|516575166|FG000|Overall Study|Withdrawal by Subject|1|||
143278978|NCT03311724|516575167|FG001|Overall Study|Withdrawal by Subject|1|||
143278979|NCT03311724|516575168|FG002|Overall Study|Withdrawal by Subject|0|||
143278980|NCT03311724|516575169|FG003|Overall Study|Withdrawal by Subject|0|||
143278981|NCT03311724|516575166|FG000|Overall Study|Lost to Follow-up|1|||
143278982|NCT03311724|516575167|FG001|Overall Study|Lost to Follow-up|0|||
143278983|NCT03311724|516575168|FG002|Overall Study|Lost to Follow-up|0|||
143278984|NCT03311724|516575169|FG003|Overall Study|Lost to Follow-up|0|||
143278985|NCT03311724|516575166|FG000|Overall Study|Sponsor Decision|0|||
143278986|NCT03311724|516575167|FG001|Overall Study|Sponsor Decision|0|||
143278987|NCT03311724|516575168|FG002|Overall Study|Sponsor Decision|1|||
143278988|NCT03311724|516575169|FG003|Overall Study|Sponsor Decision|0|||
143278989|NCT02955602|516575170|FG000|Overall Study|Adverse Event|0|||
143278990|NCT02955602|516575171|FG001|Overall Study|Adverse Event|3|||
143278991|NCT02955602|516575172|FG002|Overall Study|Adverse Event|0|||
143278992|NCT02955602|516575170|FG000|Overall Study|Withdrawal of informed consent|1|||
143278993|NCT02955602|516575171|FG001|Overall Study|Withdrawal of informed consent|3|||
143278994|NCT02955602|516575172|FG002|Overall Study|Withdrawal of informed consent|2|||
143278995|NCT02955602|516575170|FG000|Overall Study|Lost to Follow-up|0|||
143278996|NCT02955602|516575171|FG001|Overall Study|Lost to Follow-up|0|||
143278997|NCT02955602|516575172|FG002|Overall Study|Lost to Follow-up|1|||
143278998|NCT02955602|516575170|FG000|Overall Study|Other|0|||
143278999|NCT02955602|516575171|FG001|Overall Study|Other|1|||
143279000|NCT02955602|516575172|FG002|Overall Study|Other|3|||
143279001|NCT00290888|516575173|FG000|Overall Study|Physician Decision|3|||
143279002|NCT00290888|516575174|FG001|Overall Study|Physician Decision|1|||
143279003|NCT04160195|516575179|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
143279004|NCT04160195|516575180|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
143279005|NCT03068130|516575185|FG000|Overall Study|Adverse Event|19|||
143279006|NCT03068130|516575185|FG000|Overall Study|Death|14|||
143279007|NCT03068130|516575185|FG000|Overall Study|Lost to Follow-up|4|||
143279008|NCT03068130|516575185|FG000|Overall Study|Withdrawal by Subject|26|||
143279009|NCT03068130|516575185|FG000|Overall Study|Administrative Reasons|3|||
143279010|NCT03068130|516575185|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
143279011|NCT03068130|516575185|FG000|Overall Study|Study terminated by sponsor|194|||
143279012|NCT01001377|516575186|FG000|Overall Study|Ineligibility determined|2|||
143279013|NCT01001377|516575187|FG001|Overall Study|Ineligibility determined|0|||
143279014|NCT01001377|516575186|FG000|Overall Study|Withdrawal by Subject|19|||
143279015|NCT01001377|516575187|FG001|Overall Study|Withdrawal by Subject|20|||
143279016|NCT01001377|516575186|FG000|Overall Study|Lost to Follow-up|14|||
143279017|NCT01001377|516575187|FG001|Overall Study|Lost to Follow-up|17|||
143279018|NCT01001377|516575186|FG000|Overall Study|Death|391|||
143279019|NCT01001377|516575187|FG001|Overall Study|Death|384|||
143279020|NCT03039283|516575190|FG000|Overall Study|Protocol Violation|2|||
143279021|NCT00964860|516575191|FG000|Overall Study|Withdrawal by Subject|0|||
143279022|NCT00964860|516575192|FG001|Overall Study|Withdrawal by Subject|1|||
143279023|NCT05275400|516575193|FG000|Treatment Period|Adverse Event|7|||
143279024|NCT05275400|516575194|FG001|Treatment Period|Adverse Event|1|||
143279025|NCT05275400|516575193|FG000|Treatment Period|Assigned Treatment by Mistake|6|||
143372965|NCT01212757|516909644|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
143372966|NCT01212757|516909645|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
143372967|NCT01212757|516909646|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
143372968|NCT01212757|516909647|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
143372969|NCT01212757|516909648|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
143372970|NCT01212757|516909649|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
143372971|NCT01212757|516909650|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
143372972|NCT01212757|516909651|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
143372973|NCT01212757|516909643|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
143372974|NCT01212757|516909644|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
143372975|NCT01212757|516909645|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
143372976|NCT01212757|516909646|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
143372977|NCT01212757|516909647|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
143372978|NCT01212757|516909648|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
143372979|NCT01212757|516909649|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
143372980|NCT01212757|516909650|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
143372981|NCT01212757|516909651|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
143372982|NCT01212757|516909643|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
143372983|NCT01212757|516909644|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
143372984|NCT01212757|516909645|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
143372985|NCT01212757|516909646|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
143372986|NCT01212757|516909647|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
143372987|NCT01212757|516909648|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
143372988|NCT01212757|516909649|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
143372989|NCT01212757|516909650|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
143372990|NCT01212757|516909651|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
143372991|NCT01212757|516909643|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
143372992|NCT01212757|516909644|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
143372993|NCT01212757|516909645|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
143372994|NCT01212757|516909646|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
143279026|NCT05275400|516575194|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
143279027|NCT05275400|516575193|FG000|Treatment Period|Death|5|||
143279028|NCT05275400|516575194|FG001|Treatment Period|Death|2|||
143279029|NCT05275400|516575193|FG000|Treatment Period|Protocol Violation|1|||
143279030|NCT05275400|516575194|FG001|Treatment Period|Protocol Violation|0|||
143279031|NCT05275400|516575193|FG000|Treatment Period|Physician Decision|5|||
143279032|NCT05275400|516575194|FG001|Treatment Period|Physician Decision|4|||
143279033|NCT05275400|516575193|FG000|Treatment Period|Non-Compliance with Study Drug|5|||
143279034|NCT05275400|516575194|FG001|Treatment Period|Non-Compliance with Study Drug|1|||
143279035|NCT05275400|516575193|FG000|Treatment Period|Withdrawal by Subject|30|||
143279036|NCT05275400|516575194|FG001|Treatment Period|Withdrawal by Subject|12|||
143279037|NCT05275400|516575193|FG000|Treatment Period|Lost to Follow-up|1|||
143279038|NCT05275400|516575194|FG001|Treatment Period|Lost to Follow-up|5|||
143279039|NCT05275400|516575193|FG000|Treatment Period|Lack of Efficacy|1|||
143279040|NCT05275400|516575194|FG001|Treatment Period|Lack of Efficacy|0|||
143279041|NCT05275400|516575193|FG000|Treatment Period|Sponsor Decision|1|||
143279042|NCT05275400|516575194|FG001|Treatment Period|Sponsor Decision|0|||
143279043|NCT05275400|516575193|FG000|Follow-Up Period|Death|2|||
143279044|NCT05275400|516575194|FG001|Follow-Up Period|Death|0|||
143279045|NCT05275400|516575193|FG000|Follow-Up Period|Protocol Violation|1|||
143279046|NCT05275400|516575194|FG001|Follow-Up Period|Protocol Violation|0|||
143279047|NCT05275400|516575193|FG000|Follow-Up Period|Withdrawal by Subject|3|||
143279048|NCT05275400|516575194|FG001|Follow-Up Period|Withdrawal by Subject|0|||
143279049|NCT02585960|516575195|FG000|PK/Safety Assessment Period|Physician Decision|0|||
143279050|NCT02585960|516575196|FG001|PK/Safety Assessment Period|Physician Decision|1|||
143279051|NCT02585960|516575197|FG002|PK/Safety Assessment Period|Physician Decision|0|||
143279052|NCT02585960|516575195|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
143279053|NCT02585960|516575196|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
143279054|NCT02585960|516575197|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
143279055|NCT02585960|516575195|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
143279056|NCT02585960|516575196|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
143279057|NCT02585960|516575197|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
143279058|NCT02585960|516575195|FG000|PK/Safety Assessment Period|Other|4|||
143279059|NCT02585960|516575196|FG001|PK/Safety Assessment Period|Other|4|||
143279060|NCT02585960|516575197|FG002|PK/Safety Assessment Period|Other|0|||
143279061|NCT02585960|516575195|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
143279062|NCT02585960|516575196|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
143279063|NCT02585960|516575197|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
143279064|NCT02585960|516575195|FG000|PK/Safety Assessment Period|Screen Failure|0|||
143279065|NCT02585960|516575196|FG001|PK/Safety Assessment Period|Screen Failure|0|||
143279066|NCT02585960|516575197|FG002|PK/Safety Assessment Period|Screen Failure|1|||
143279067|NCT02585960|516575195|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
143279068|NCT02585960|516575196|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
143279069|NCT02585960|516575197|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
143279070|NCT02585960|516575195|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
143279071|NCT02585960|516575196|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
143279072|NCT02585960|516575197|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
143279073|NCT06333613|516575198|FG000|Overall Study|Doesn't Like Wearing Contacts|1|||
143372995|NCT01212757|516909647|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
143372996|NCT01212757|516909648|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
143372997|NCT01212757|516909649|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
143372998|NCT01212757|516909650|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
143372999|NCT01212757|516909651|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
143373000|NCT01212757|516909643|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
143373001|NCT01212757|516909644|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
143373002|NCT01212757|516909645|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
143373003|NCT01212757|516909646|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
143373004|NCT01212757|516909647|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
143373005|NCT01212757|516909648|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
143373006|NCT01212757|516909649|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
143373007|NCT01212757|516909650|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
143373008|NCT01212757|516909651|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
143373009|NCT01212757|516909643|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
143279074|NCT04930965|516575204|FG000|Overall Study|Lost to Follow-up|7|||
143279075|NCT04930965|516575205|FG001|Overall Study|Lost to Follow-up|5|||
143373010|NCT01212757|516909644|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
143373011|NCT01212757|516909645|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
143279076|NCT04377620|516575206|FG000|Overall Study|Death|42|||
143279077|NCT04377620|516575207|FG001|Overall Study|Death|48|||
143279078|NCT04377620|516575208|FG002|Overall Study|Death|36|||
143279079|NCT04377620|516575206|FG000|Overall Study|Withdrawal by Subject|0|||
143279080|NCT04377620|516575207|FG001|Overall Study|Withdrawal by Subject|2|||
143279081|NCT04377620|516575208|FG002|Overall Study|Withdrawal by Subject|0|||
143279082|NCT05587296|516575209|FG000|Overall Study|Adverse Event|15|||
143279083|NCT05587296|516575210|FG001|Overall Study|Adverse Event|7|||
143279084|NCT05587296|516575209|FG000|Overall Study|Lack of Efficacy|2|||
143279085|NCT05587296|516575210|FG001|Overall Study|Lack of Efficacy|0|||
143279086|NCT05587296|516575209|FG000|Overall Study|Lost to Follow-up|1|||
143279087|NCT05587296|516575210|FG001|Overall Study|Lost to Follow-up|0|||
143279088|NCT05587296|516575209|FG000|Overall Study|Withdrawal by Subject|14|||
143279089|NCT05587296|516575210|FG001|Overall Study|Withdrawal by Subject|4|||
143279090|NCT05587296|516575209|FG000|Overall Study|miscellaneous|3|||
143279091|NCT05587296|516575210|FG001|Overall Study|miscellaneous|6|||
143279092|NCT05587296|516575209|FG000|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|19|||
143279093|NCT05587296|516575210|FG001|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|8|||
143279094|NCT00134082|516575211|FG000|Overall Study|Adverse Event|2|||
143279095|NCT00134082|516575211|FG000|Overall Study|Death|1|||
143279096|NCT02849678|516575214|FG000|Overall Study|Protocol Violation|3|||
143279097|NCT02849678|516575215|FG001|Overall Study|Protocol Violation|6|||
143279098|NCT03478930|516575217|FG000|Overall Study|Adverse Event|0|||
143279099|NCT03478930|516575218|FG001|Overall Study|Adverse Event|1|||
143279100|NCT03478930|516575217|FG000|Overall Study|Lack of Efficacy|3|||
143279101|NCT03478930|516575218|FG001|Overall Study|Lack of Efficacy|3|||
143279102|NCT03478930|516575217|FG000|Overall Study|Withdrawal by Subject|6|||
143279103|NCT03478930|516575218|FG001|Overall Study|Withdrawal by Subject|5|||
143279104|NCT04189081|516575219|FG000|Overall Study|Lost to Follow-up|1|||
143279105|NCT04189081|516575220|FG001|Overall Study|Lost to Follow-up|0|||
143279106|NCT04189081|516575221|FG002|Overall Study|Lost to Follow-up|0|||
143279107|NCT04189081|516575219|FG000|Overall Study|Withdrawal by Subject|0|||
143279108|NCT04189081|516575220|FG001|Overall Study|Withdrawal by Subject|0|||
143279109|NCT04189081|516575221|FG002|Overall Study|Withdrawal by Subject|1|||
143279110|NCT00044083|516575222|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
143279111|NCT00044083|516575223|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
143279112|NCT00044083|516575222|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
143279113|NCT00044083|516575223|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
143279114|NCT00044083|516575222|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
143279115|NCT00044083|516575223|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
143279116|NCT00044083|516575222|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
143279117|NCT00044083|516575223|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
143279118|NCT00044083|516575222|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
143279119|NCT00044083|516575223|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
143279120|NCT00044083|516575222|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
143279121|NCT00044083|516575223|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
143279122|NCT00044083|516575222|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
143279123|NCT00044083|516575223|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
143279124|NCT00044083|516575222|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
143279125|NCT00044083|516575223|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
143279126|NCT00044083|516575222|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
143279127|NCT00044083|516575223|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
143279128|NCT00044083|516575222|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
143279129|NCT00044083|516575223|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
143279130|NCT00288054|516575224|FG000|Overall Study|Protocol Violation|2|||
143279131|NCT00288054|516575224|FG000|Overall Study|Lack of Efficacy|16|||
143279132|NCT00288054|516575224|FG000|Overall Study|Adverse Event|3|||
143279133|NCT00288054|516575224|FG000|Overall Study|Withdrawal by Subject|1|||
143279134|NCT00288054|516575224|FG000|Overall Study|Not protocol specified|2|||
143279135|NCT00289991|516575225|FG000|Overall Study|Death|35|||
143279136|NCT00289991|516575226|FG001|Overall Study|Death|38|||
143279137|NCT00289991|516575225|FG000|Overall Study|Adverse Event|15|||
143279138|NCT00289991|516575226|FG001|Overall Study|Adverse Event|13|||
143279139|NCT00289991|516575225|FG000|Overall Study|Failure of prophylaxis|1|||
143279140|NCT00289991|516575226|FG001|Overall Study|Failure of prophylaxis|1|||
143279141|NCT00289991|516575225|FG000|Overall Study|Fungal breakthrough infection|0|||
143279142|NCT00289991|516575226|FG001|Overall Study|Fungal breakthrough infection|1|||
143279143|NCT00289991|516575225|FG000|Overall Study|Lost to Follow-up|0|||
143279144|NCT00289991|516575226|FG001|Overall Study|Lost to Follow-up|1|||
143279145|NCT00289991|516575225|FG000|Overall Study|Withdrawal by Subject|2|||
143279146|NCT00289991|516575226|FG001|Overall Study|Withdrawal by Subject|12|||
143279147|NCT00289991|516575225|FG000|Overall Study|Other|5|||
143279148|NCT00289991|516575226|FG001|Overall Study|Other|14|||
143279149|NCT00444912|516575244|FG000|Overall Study|Death|1|||
143279150|NCT00444912|516575245|FG001|Overall Study|Death|2|||
143279151|NCT00444912|516575244|FG000|Overall Study|Lost to Follow-up|1|||
143279152|NCT00444912|516575245|FG001|Overall Study|Lost to Follow-up|0|||
143279153|NCT00444912|516575244|FG000|Overall Study|Participant Failed Mobilization|1|||
143279154|NCT00444912|516575245|FG001|Overall Study|Participant Failed Mobilization|0|||
143279155|NCT00851747|516575250|FG000|Overall Study|Physician Decision|6|||
143279156|NCT00851747|516575251|FG001|Overall Study|Physician Decision|6|||
143279157|NCT00851747|516575252|FG002|Overall Study|Physician Decision|6|||
143279158|NCT02340975|516575253|FG000|Overall Study|Death|6|||
143279159|NCT02340975|516575254|FG001|Overall Study|Death|23|||
143279160|NCT02340975|516575255|FG002|Overall Study|Death|21|||
143279161|NCT02340975|516575256|FG003|Overall Study|Death|7|||
143279162|NCT02340975|516575257|FG004|Overall Study|Death|21|||
143279163|NCT02340975|516575258|FG005|Overall Study|Death|13|||
143279164|NCT02340975|516575253|FG000|Overall Study|Lost to Follow-up|0|||
143279165|NCT02340975|516575254|FG001|Overall Study|Lost to Follow-up|0|||
143279166|NCT02340975|516575255|FG002|Overall Study|Lost to Follow-up|0|||
143279167|NCT02340975|516575256|FG003|Overall Study|Lost to Follow-up|0|||
143279168|NCT02340975|516575257|FG004|Overall Study|Lost to Follow-up|2|||
143279169|NCT02340975|516575258|FG005|Overall Study|Lost to Follow-up|0|||
143279170|NCT02340975|516575253|FG000|Overall Study|Withdrawal by Subject|0|||
143279171|NCT02340975|516575254|FG001|Overall Study|Withdrawal by Subject|0|||
143279172|NCT02340975|516575255|FG002|Overall Study|Withdrawal by Subject|3|||
143279173|NCT02340975|516575256|FG003|Overall Study|Withdrawal by Subject|3|||
143279174|NCT02340975|516575257|FG004|Overall Study|Withdrawal by Subject|2|||
143279175|NCT02340975|516575258|FG005|Overall Study|Withdrawal by Subject|0|||
143279176|NCT02340975|516575253|FG000|Overall Study|Other|0|||
143279177|NCT02340975|516575254|FG001|Overall Study|Other|4|||
143279178|NCT02340975|516575255|FG002|Overall Study|Other|0|||
143279179|NCT02340975|516575256|FG003|Overall Study|Other|2|||
143279180|NCT02340975|516575257|FG004|Overall Study|Other|0|||
143279181|NCT02340975|516575258|FG005|Overall Study|Other|6|||
143279182|NCT01007812|516575261|FG000|Period 1, One Week|Lost to Follow-up|0|||
143373012|NCT01212757|516909646|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
143373013|NCT01212757|516909647|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
143373014|NCT01212757|516909648|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
143373015|NCT01212757|516909649|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
143373016|NCT01212757|516909650|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
143373017|NCT01212757|516909651|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
143373018|NCT01212757|516909643|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
143373019|NCT01212757|516909644|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
143373020|NCT01212757|516909645|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
143373021|NCT01212757|516909646|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
143373022|NCT01212757|516909647|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
143373023|NCT01212757|516909648|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
143373024|NCT01212757|516909649|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
143373025|NCT01212757|516909650|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
143373026|NCT01212757|516909651|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
143373027|NCT04493242|516909652|FG000|Overall Study|Death|10|||
143373028|NCT04493242|516909653|FG001|Overall Study|Death|14|||
143373029|NCT04493242|516909654|FG002|Overall Study|Death|16|||
143373030|NCT04493242|516909652|FG000|Overall Study|Lost to Follow-up|1|||
143373031|NCT04493242|516909653|FG001|Overall Study|Lost to Follow-up|1|||
143373032|NCT04493242|516909654|FG002|Overall Study|Lost to Follow-up|0|||
143373033|NCT04493242|516909652|FG000|Overall Study|Withdrawal by Subject|1|||
143373034|NCT04493242|516909653|FG001|Overall Study|Withdrawal by Subject|0|||
143373035|NCT04493242|516909654|FG002|Overall Study|Withdrawal by Subject|0|||
143373036|NCT04493242|516909652|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
143373037|NCT04493242|516909653|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
143373038|NCT04493242|516909654|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
143373039|NCT04493242|516909652|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
143454088|NCT01820585|517206867|FG003|Overall Study|Subject non-compliance|2|||
143279183|NCT01007812|516575262|FG001|Period 1, One Week|Lost to Follow-up|1|||
143279184|NCT01007812|516575261|FG000|Period 1, One Week|Discomfort|1|||
143279185|NCT01007812|516575262|FG001|Period 1, One Week|Discomfort|0|||
143279186|NCT01091974|516575265|FG000|Overall Study|Did not start intervention|3|||
143279187|NCT01091974|516575266|FG001|Overall Study|Did not start intervention|1|||
143279188|NCT01091974|516575267|FG002|Overall Study|Did not start intervention|3|||
143279189|NCT01091974|516575268|FG003|Overall Study|Did not start intervention|1|||
143279190|NCT01091974|516575265|FG000|Overall Study|resumed sleep medication|0|||
143454089|NCT01820585|517206864|FG000|Overall Study|at sponsor request|0|||
143454090|NCT01820585|517206865|FG001|Overall Study|at sponsor request|0|||
143454091|NCT01820585|517206866|FG002|Overall Study|at sponsor request|1|||
143454092|NCT01820585|517206867|FG003|Overall Study|at sponsor request|0|||
143454093|NCT01820585|517206864|FG000|Overall Study|Pregnancy|0|||
143454094|NCT01820585|517206865|FG001|Overall Study|Pregnancy|1|||
143279191|NCT01091974|516575266|FG001|Overall Study|resumed sleep medication|0|||
143279192|NCT01091974|516575267|FG002|Overall Study|resumed sleep medication|1|||
143279193|NCT01091974|516575268|FG003|Overall Study|resumed sleep medication|2|||
143279194|NCT01091974|516575265|FG000|Overall Study|Withdrawal by Subject|1|||
143279195|NCT01091974|516575266|FG001|Overall Study|Withdrawal by Subject|3|||
143279196|NCT01091974|516575267|FG002|Overall Study|Withdrawal by Subject|2|||
143279197|NCT01091974|516575268|FG003|Overall Study|Withdrawal by Subject|2|||
143279198|NCT01091974|516575265|FG000|Overall Study|side-effects|1|||
143279199|NCT01091974|516575266|FG001|Overall Study|side-effects|1|||
143279200|NCT01091974|516575267|FG002|Overall Study|side-effects|0|||
143279201|NCT01091974|516575268|FG003|Overall Study|side-effects|2|||
143279202|NCT02499783|516575269|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
143279203|NCT02499783|516575270|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
143279204|NCT02499783|516575271|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
143279205|NCT02499783|516575269|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
143279206|NCT02499783|516575270|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
143279207|NCT02499783|516575271|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
143279208|NCT02499783|516575269|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
143279209|NCT02499783|516575270|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
143279210|NCT02499783|516575271|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
143279211|NCT02499783|516575269|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
143279212|NCT02499783|516575270|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
143279213|NCT02499783|516575271|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
143279214|NCT02499783|516575269|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
143279215|NCT02499783|516575270|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
143279216|NCT02499783|516575271|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
143279217|NCT02499783|516575269|FG000|DB Period: Weeks 0-8|Other|1|||
143279218|NCT02499783|516575270|FG001|DB Period: Weeks 0-8|Other|1|||
143279219|NCT02499783|516575271|FG002|DB Period: Weeks 0-8|Other|0|||
143279220|NCT02499783|516575269|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
143279221|NCT02499783|516575270|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
143279222|NCT02499783|516575271|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
143279223|NCT02499783|516575269|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
143279224|NCT02499783|516575270|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
143279225|NCT02499783|516575271|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
143279226|NCT02499783|516575269|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
143279227|NCT02499783|516575270|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
143279228|NCT02499783|516575271|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
143279229|NCT02499783|516575269|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
143279230|NCT02499783|516575270|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
143279231|NCT02499783|516575271|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
143279232|NCT02228460|516575272|FG000|Overall Study|Adverse Event|1|||
143279233|NCT02228460|516575272|FG000|Overall Study|Lost to Follow-up|1|||
143279234|NCT01243892|516575273|FG000|Overall Study|Did not meet eligibility criteria|2|||
143279235|NCT01243892|516575274|FG001|Overall Study|Did not meet eligibility criteria|0|||
143279236|NCT01866293|516575279|FG000|Overall Study|Adverse Event|2|||
143279237|NCT03066804|516575280|FG000|Overall Study|Physician Decision|0|||
143279238|NCT03066804|516575281|FG001|Overall Study|Physician Decision|4|||
143279239|NCT03066804|516575280|FG000|Overall Study|Death|23|||
143279240|NCT03066804|516575281|FG001|Overall Study|Death|17|||
143279241|NCT03066804|516575280|FG000|Overall Study|Withdrawal by Subject|19|||
143279242|NCT03066804|516575281|FG001|Overall Study|Withdrawal by Subject|25|||
143279243|NCT03066804|516575280|FG000|Overall Study|Lost to Follow-up|2|||
143279244|NCT03066804|516575281|FG001|Overall Study|Lost to Follow-up|0|||
143279245|NCT03066804|516575280|FG000|Overall Study|Adverse Event|2|||
143279246|NCT03066804|516575281|FG001|Overall Study|Adverse Event|3|||
143279247|NCT03066804|516575280|FG000|Overall Study|Technical problems|5|||
143279248|NCT03066804|516575281|FG001|Overall Study|Technical problems|1|||
143279249|NCT03982368|516575286|FG000|Overall Study|Adverse Event|6|||
143279250|NCT03982368|516575287|FG001|Overall Study|Adverse Event|4|||
143279251|NCT03982368|516575288|FG002|Overall Study|Adverse Event|3|||
143279252|NCT03982368|516575286|FG000|Overall Study|Lost to Follow-up|2|||
143279253|NCT03982368|516575287|FG001|Overall Study|Lost to Follow-up|1|||
143279254|NCT03982368|516575288|FG002|Overall Study|Lost to Follow-up|0|||
143279255|NCT03982368|516575286|FG000|Overall Study|Withdrawal by Subject|1|||
143279256|NCT03982368|516575287|FG001|Overall Study|Withdrawal by Subject|2|||
143279257|NCT03982368|516575288|FG002|Overall Study|Withdrawal by Subject|0|||
143279258|NCT03982368|516575286|FG000|Overall Study|unknow|4|||
143279259|NCT03982368|516575287|FG001|Overall Study|unknow|0|||
143279260|NCT03982368|516575288|FG002|Overall Study|unknow|2|||
143279261|NCT02571777|516575289|FG000|Overall Study|Subject/guardian decision|34|||
143279262|NCT02571777|516575290|FG001|Overall Study|Subject/guardian decision|26|||
143279263|NCT02571777|516575291|FG002|Overall Study|Subject/guardian decision|26|||
143279264|NCT02571777|516575292|FG003|Overall Study|Subject/guardian decision|25|||
143279265|NCT02571777|516575293|FG004|Overall Study|Subject/guardian decision|27|||
143229863|NCT04079296|516390868|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
143229864|NCT04079296|516390864|FG000|Dose Expansion Phase (168 Days)|Death|0|||
143229865|NCT04079296|516390865|FG001|Dose Expansion Phase (168 Days)|Death|0|||
143229866|NCT04079296|516390866|FG002|Dose Expansion Phase (168 Days)|Death|0|||
143229867|NCT04079296|516390867|FG003|Dose Expansion Phase (168 Days)|Death|1|||
143229868|NCT04079296|516390868|FG004|Dose Expansion Phase (168 Days)|Death|0|||
143229869|NCT00467740|516390872|FG000|Overall Study|Adverse Event|0|||
143229870|NCT00467740|516390873|FG001|Overall Study|Adverse Event|0|||
143229871|NCT00467740|516390874|FG002|Overall Study|Adverse Event|1|||
143229872|NCT00467740|516390875|FG003|Overall Study|Adverse Event|0|||
143229873|NCT00467740|516390876|FG004|Overall Study|Adverse Event|0|||
143229874|NCT00467740|516390872|FG000|Overall Study|Protocol Violation|0|||
143229875|NCT00467740|516390873|FG001|Overall Study|Protocol Violation|0|||
143229876|NCT00467740|516390874|FG002|Overall Study|Protocol Violation|1|||
143229877|NCT00467740|516390875|FG003|Overall Study|Protocol Violation|0|||
143229878|NCT00467740|516390876|FG004|Overall Study|Protocol Violation|0|||
143229879|NCT00467740|516390872|FG000|Overall Study|Lost to Follow-up|0|||
143229880|NCT00467740|516390873|FG001|Overall Study|Lost to Follow-up|1|||
143229881|NCT00467740|516390874|FG002|Overall Study|Lost to Follow-up|0|||
143229882|NCT00467740|516390875|FG003|Overall Study|Lost to Follow-up|0|||
143229883|NCT00467740|516390876|FG004|Overall Study|Lost to Follow-up|0|||
143229884|NCT00467740|516390872|FG000|Overall Study|Withdrawal by Subject|1|||
143229885|NCT00467740|516390873|FG001|Overall Study|Withdrawal by Subject|1|||
143229886|NCT00467740|516390874|FG002|Overall Study|Withdrawal by Subject|0|||
143229887|NCT00467740|516390875|FG003|Overall Study|Withdrawal by Subject|1|||
143229888|NCT00467740|516390876|FG004|Overall Study|Withdrawal by Subject|0|||
143229889|NCT00467740|516390872|FG000|Overall Study|Lack of Efficacy|0|||
143229890|NCT00467740|516390873|FG001|Overall Study|Lack of Efficacy|1|||
143229891|NCT00467740|516390874|FG002|Overall Study|Lack of Efficacy|0|||
143229892|NCT00467740|516390875|FG003|Overall Study|Lack of Efficacy|0|||
143229893|NCT00467740|516390876|FG004|Overall Study|Lack of Efficacy|0|||
143229894|NCT04949191|516390877|FG000|Overall Study|Non-compliance with Study Drug|1|||
143229895|NCT04949191|516390878|FG001|Overall Study|Non-compliance with Study Drug|0|||
143229896|NCT04949191|516390879|FG002|Overall Study|Non-compliance with Study Drug|0|||
143229897|NCT04949191|516390880|FG003|Overall Study|Non-compliance with Study Drug|0|||
143229898|NCT04949191|516390877|FG000|Overall Study|Progressive Disease|0|||
143229899|NCT04949191|516390878|FG001|Overall Study|Progressive Disease|1|||
143229900|NCT04949191|516390879|FG002|Overall Study|Progressive Disease|0|||
143229901|NCT04949191|516390880|FG003|Overall Study|Progressive Disease|0|||
143229902|NCT04949191|516390877|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
143229903|NCT04949191|516390878|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
143229904|NCT04949191|516390879|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
143229905|NCT04949191|516390880|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
143229906|NCT04949191|516390877|FG000|Overall Study|Sponsor Terminated Study|0|||
143229907|NCT04949191|516390878|FG001|Overall Study|Sponsor Terminated Study|0|||
143229908|NCT04949191|516390879|FG002|Overall Study|Sponsor Terminated Study|1|||
143229909|NCT04949191|516390880|FG003|Overall Study|Sponsor Terminated Study|1|||
143229910|NCT00730158|516390881|FG000|Overall Study|Withdrawal by Subject|1|||
143229911|NCT00730158|516390882|FG001|Overall Study|Withdrawal by Subject|1|||
143229912|NCT01168349|516390883|FG000|Overall Study|Death|157|||
143229913|NCT01168349|516390883|FG000|Overall Study|Lost to Follow-up|34|||
143229914|NCT01168349|516390883|FG000|Overall Study|Withdrawal by Subject|9|||
143229915|NCT01168349|516390883|FG000|Overall Study|Kidney transplantation|3|||
143229916|NCT01168349|516390883|FG000|Overall Study|Other|22|||
143229917|NCT01168349|516390883|FG000|Overall Study|Protocol Violation|76|||
143229918|NCT04059549|516390884|FG000|Overall Study|Withdrawal by Subject|2|||
143229919|NCT04059549|516390885|FG001|Overall Study|Withdrawal by Subject|0|||
143229920|NCT02678351|516390887|FG000|Overall Study|Withdrawal by Subject|1|||
143229921|NCT01919229|516390888|FG000|Overall Study|Subject/guardian decision|0|||
143229922|NCT01919229|516390889|FG001|Overall Study|Subject/guardian decision|0|||
143229923|NCT01919229|516390890|FG002|Overall Study|Subject/guardian decision|1|||
143229924|NCT01011673|516390891|FG000|Randomized|Secondary headache|2|||
143229925|NCT01011673|516390892|FG001|Randomized|Secondary headache|1|||
143229926|NCT01011673|516390891|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
143229927|NCT01011673|516390892|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
143229928|NCT01632020|516390893|FG000|Overall Study|Withdrawal by Subject|1|||
143229929|NCT01632020|516390894|FG001|Overall Study|Withdrawal by Subject|0|||
143229930|NCT01632020|516390893|FG000|Overall Study|Adverse Event|1|||
143229931|NCT01632020|516390894|FG001|Overall Study|Adverse Event|0|||
143229932|NCT00626275|516390897|FG000|Part A - Treatment Period 1|Adverse Event|1|||
143279266|NCT02571777|516575289|FG000|Overall Study|Protocol Deviation|2|||
143279267|NCT02571777|516575290|FG001|Overall Study|Protocol Deviation|3|||
143279268|NCT02571777|516575291|FG002|Overall Study|Protocol Deviation|4|||
143279269|NCT02571777|516575292|FG003|Overall Study|Protocol Deviation|8|||
143279270|NCT02571777|516575293|FG004|Overall Study|Protocol Deviation|4|||
143279271|NCT02571777|516575289|FG000|Overall Study|Death|1|||
143279272|NCT02571777|516575290|FG001|Overall Study|Death|1|||
143279273|NCT02571777|516575291|FG002|Overall Study|Death|4|||
143279274|NCT02571777|516575292|FG003|Overall Study|Death|0|||
143279275|NCT02571777|516575293|FG004|Overall Study|Death|0|||
143279276|NCT02571777|516575289|FG000|Overall Study|Lost to Follow-up|1|||
143279277|NCT02571777|516575290|FG001|Overall Study|Lost to Follow-up|1|||
143279278|NCT02571777|516575291|FG002|Overall Study|Lost to Follow-up|2|||
143279279|NCT02571777|516575292|FG003|Overall Study|Lost to Follow-up|0|||
143279280|NCT02571777|516575293|FG004|Overall Study|Lost to Follow-up|1|||
143279281|NCT02571777|516575289|FG000|Overall Study|Physician Decision|1|||
143279282|NCT02571777|516575290|FG001|Overall Study|Physician Decision|7|||
143279283|NCT02571777|516575291|FG002|Overall Study|Physician Decision|5|||
143279284|NCT02571777|516575292|FG003|Overall Study|Physician Decision|2|||
143279285|NCT02571777|516575293|FG004|Overall Study|Physician Decision|4|||
143279286|NCT02571777|516575289|FG000|Overall Study|Pregnancy|0|||
143279287|NCT02571777|516575290|FG001|Overall Study|Pregnancy|0|||
143279288|NCT02571777|516575291|FG002|Overall Study|Pregnancy|0|||
143279289|NCT02571777|516575292|FG003|Overall Study|Pregnancy|2|||
143279290|NCT02571777|516575293|FG004|Overall Study|Pregnancy|0|||
143279291|NCT03706079|516575294|FG000|Predecessor Study|Death|0|||
143279292|NCT03706079|516575295|FG001|Predecessor Study|Death|2|||
143279293|NCT03706079|516575296|FG002|Predecessor Study|Death|0|||
143279294|NCT03706079|516575297|FG003|Predecessor Study|Death|1|||
143279295|NCT03706079|516575298|FG004|Predecessor Study|Death|0|||
143279296|NCT03706079|516575299|FG005|Predecessor Study|Death|0|||
143279297|NCT03706079|516575294|FG000|Predecessor Study|Lost to Follow-up|5|||
143279298|NCT03706079|516575295|FG001|Predecessor Study|Lost to Follow-up|2|||
143279299|NCT03706079|516575296|FG002|Predecessor Study|Lost to Follow-up|0|||
143279300|NCT03706079|516575297|FG003|Predecessor Study|Lost to Follow-up|0|||
143279301|NCT03706079|516575298|FG004|Predecessor Study|Lost to Follow-up|1|||
143279302|NCT03706079|516575299|FG005|Predecessor Study|Lost to Follow-up|0|||
143279303|NCT03706079|516575294|FG000|Predecessor Study|Withdrawal by Subject|8|||
143279304|NCT03706079|516575295|FG001|Predecessor Study|Withdrawal by Subject|15|||
143279305|NCT03706079|516575296|FG002|Predecessor Study|Withdrawal by Subject|0|||
143279306|NCT03706079|516575297|FG003|Predecessor Study|Withdrawal by Subject|5|||
143279307|NCT03706079|516575298|FG004|Predecessor Study|Withdrawal by Subject|2|||
143279308|NCT03706079|516575299|FG005|Predecessor Study|Withdrawal by Subject|0|||
143279309|NCT03706079|516575294|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
143279310|NCT03706079|516575295|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
143279311|NCT03706079|516575296|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
143279312|NCT03706079|516575297|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
143279313|NCT03706079|516575298|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
143279314|NCT03706079|516575299|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
143279315|NCT03706079|516575294|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
143279316|NCT03706079|516575295|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
143279317|NCT03706079|516575296|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
143279318|NCT03706079|516575297|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
143279319|NCT03706079|516575298|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
143279320|NCT03706079|516575299|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
143279321|NCT03706079|516575294|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
143279322|NCT03706079|516575295|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
143279323|NCT03706079|516575296|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
143279324|NCT03706079|516575297|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
143279325|NCT03706079|516575298|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
143279326|NCT03706079|516575299|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
143279327|NCT03706079|516575294|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
143279328|NCT03706079|516575295|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
143279329|NCT03706079|516575296|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
143279330|NCT03706079|516575297|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
143279331|NCT03706079|516575298|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
143279332|NCT03706079|516575299|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
143279333|NCT03706079|516575294|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
143279334|NCT03706079|516575295|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
143279335|NCT03706079|516575296|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
143279336|NCT03706079|516575297|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
143279337|NCT03706079|516575298|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
143279338|NCT03706079|516575299|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
143279339|NCT03706079|516575294|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
143279340|NCT03706079|516575295|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
143279341|NCT03706079|516575296|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
143279342|NCT03706079|516575297|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
143279343|NCT03706079|516575298|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
143279344|NCT03706079|516575299|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
143279345|NCT03706079|516575294|FG000|Long Term Extension (DESTINATION)|Death|8|||
143279346|NCT03706079|516575295|FG001|Long Term Extension (DESTINATION)|Death|2|||
143279347|NCT03706079|516575296|FG002|Long Term Extension (DESTINATION)|Death|2|||
143279348|NCT03706079|516575297|FG003|Long Term Extension (DESTINATION)|Death|1|||
143279349|NCT03706079|516575298|FG004|Long Term Extension (DESTINATION)|Death|0|||
143279350|NCT03706079|516575299|FG005|Long Term Extension (DESTINATION)|Death|0|||
143279351|NCT00329238|516575300|FG000|Overall Study|Adverse Event|147|||
143279352|NCT00329238|516575301|FG001|Overall Study|Adverse Event|129|||
143279353|NCT00329238|516575300|FG000|Overall Study|Protocol Violation|23|||
143279354|NCT00329238|516575301|FG001|Overall Study|Protocol Violation|34|||
143279355|NCT00329238|516575300|FG000|Overall Study|Lost to Follow-up|2|||
143279356|NCT00329238|516575301|FG001|Overall Study|Lost to Follow-up|6|||
143279357|NCT00329238|516575300|FG000|Overall Study|Withdrawal by Subject|64|||
143279358|NCT00329238|516575301|FG001|Overall Study|Withdrawal by Subject|58|||
143279359|NCT00329238|516575300|FG000|Overall Study|Other reason (not specified)|40|||
143279360|NCT00329238|516575301|FG001|Overall Study|Other reason (not specified)|54|||
143279361|NCT05379231|516575302|FG000|Home Visit|Withdrawal by Subject|2|||
143279362|NCT05379231|516575302|FG000|In-lab Visit|Withdrawal by Subject|2|||
143279363|NCT03338010|516575308|FG000|Overall Study|Withdrawal by Subject|14|||
143279364|NCT03338010|516575309|FG001|Overall Study|Withdrawal by Subject|8|||
143279365|NCT03338010|516575308|FG000|Overall Study|Lost to Follow-up|4|||
143279366|NCT03338010|516575309|FG001|Overall Study|Lost to Follow-up|2|||
143279367|NCT03338010|516575308|FG000|Overall Study|Adverse Event|3|||
143279368|NCT03338010|516575309|FG001|Overall Study|Adverse Event|2|||
143279369|NCT03338010|516575308|FG000|Overall Study|Physician Decision|2|||
143279370|NCT03338010|516575309|FG001|Overall Study|Physician Decision|2|||
143279371|NCT03338010|516575308|FG000|Overall Study|Non-Compliance with Study Drug|0|||
143279372|NCT03338010|516575309|FG001|Overall Study|Non-Compliance with Study Drug|3|||
143279373|NCT03338010|516575308|FG000|Overall Study|Protocol Violation|0|||
143279374|NCT03338010|516575309|FG001|Overall Study|Protocol Violation|1|||
143279375|NCT03583697|516575310|FG000|Overall Study|Withdrawal by Subject|0|||
143279376|NCT03583697|516575311|FG001|Overall Study|Withdrawal by Subject|0|||
143279377|NCT03583697|516575312|FG002|Overall Study|Withdrawal by Subject|1|||
143279378|NCT03583697|516575310|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
143279379|NCT03583697|516575311|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
143279380|NCT03583697|516575312|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
143279381|NCT03724032|516575313|FG000|Overall Study|Physician Decision|1|||
143279382|NCT03724032|516575314|FG001|Overall Study|Physician Decision|0|||
143279383|NCT03724032|516575315|FG002|Overall Study|Physician Decision|0|||
143279384|NCT03724032|516575313|FG000|Overall Study|Protocol Violation|2|||
143279385|NCT03724032|516575314|FG001|Overall Study|Protocol Violation|2|||
143279386|NCT03724032|516575315|FG002|Overall Study|Protocol Violation|1|||
143279387|NCT00751933|516575316|FG000|Overall Study|Withdrawal by Subject|0|||
143279388|NCT00751933|516575317|FG001|Overall Study|Withdrawal by Subject|1|||
143279389|NCT00751933|516575318|FG002|Overall Study|Withdrawal by Subject|0|||
143279390|NCT00751933|516575319|FG003|Overall Study|Withdrawal by Subject|0|||
143279391|NCT00751933|516575316|FG000|Overall Study|Physician Decision|0|||
143279392|NCT00751933|516575317|FG001|Overall Study|Physician Decision|0|||
143279393|NCT00751933|516575318|FG002|Overall Study|Physician Decision|1|||
143279394|NCT00751933|516575319|FG003|Overall Study|Physician Decision|1|||
143279395|NCT05996718|516577008|FG000|Overall Study|Lost to Follow-up|3|||
143279396|NCT03945773|516577009|FG000|Overall Study|Consent Withdrawn|1|||
143279397|NCT03945773|516577010|FG001|Overall Study|Consent Withdrawn|1|||
143279398|NCT03945773|516577009|FG000|Overall Study|Lost to Follow-up|1|||
143279399|NCT03945773|516577010|FG001|Overall Study|Lost to Follow-up|0|||
143279400|NCT03945773|516577009|FG000|Overall Study|Death|46|||
143279401|NCT03945773|516577010|FG001|Overall Study|Death|22|||
143279402|NCT03945773|516577009|FG000|Overall Study|Physician Decision|1|||
143279403|NCT03945773|516577010|FG001|Overall Study|Physician Decision|0|||
143279404|NCT03945773|516577009|FG000|Overall Study|Other|1|||
143279405|NCT03945773|516577010|FG001|Overall Study|Other|0|||
143279406|NCT03945773|516577009|FG000|Overall Study|Ongoing at the time of DCO|4|||
143279407|NCT03945773|516577010|FG001|Overall Study|Ongoing at the time of DCO|3|||
143279408|NCT01713686|516577011|FG000|Overall Study|Lost to Follow-up|9|||
143279409|NCT01713686|516577011|FG000|Overall Study|Withdrawal by Subject|6|||
143279410|NCT03187197|516577015|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
143279411|NCT03187197|516577016|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
143279412|NCT03187197|516577017|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
143279413|NCT03187197|516577015|FG000|Overall Study|Withdrawal by Subject|8|||
143279414|NCT03187197|516577016|FG001|Overall Study|Withdrawal by Subject|63|||
143279415|NCT03187197|516577017|FG002|Overall Study|Withdrawal by Subject|4|||
143279416|NCT03187197|516577015|FG000|Overall Study|Lost to Follow-up|1|||
143279417|NCT03187197|516577016|FG001|Overall Study|Lost to Follow-up|60|||
143279418|NCT03187197|516577017|FG002|Overall Study|Lost to Follow-up|7|||
143279419|NCT03187197|516577015|FG000|Overall Study|Adverse Event|6|||
143279420|NCT03187197|516577016|FG001|Overall Study|Adverse Event|29|||
143279421|NCT03187197|516577017|FG002|Overall Study|Adverse Event|0|||
143279422|NCT03187197|516577015|FG000|Overall Study|Death|0|||
143279423|NCT03187197|516577016|FG001|Overall Study|Death|11|||
143279424|NCT03187197|516577017|FG002|Overall Study|Death|0|||
143279425|NCT03187197|516577015|FG000|Overall Study|Administrative problem|1|||
143279426|NCT03187197|516577016|FG001|Overall Study|Administrative problem|1|||
143279427|NCT03187197|516577017|FG002|Overall Study|Administrative problem|0|||
143279428|NCT03187197|516577015|FG000|Overall Study|Reason not listed|2|||
143279429|NCT03187197|516577016|FG001|Overall Study|Reason not listed|54|||
143279430|NCT03187197|516577017|FG002|Overall Study|Reason not listed|1|||
143279431|NCT03187197|516577015|FG000|Overall Study|Missing|1|||
143279432|NCT03187197|516577016|FG001|Overall Study|Missing|32|||
143279433|NCT03187197|516577017|FG002|Overall Study|Missing|3|||
143279434|NCT03187197|516577015|FG000|Overall Study|Status missing|2|||
143279435|NCT03187197|516577016|FG001|Overall Study|Status missing|33|||
143279436|NCT03187197|516577017|FG002|Overall Study|Status missing|3|||
143279437|NCT03187197|516577015|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
143279438|NCT03187197|516577016|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
143279439|NCT03187197|516577017|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
143279440|NCT02385045|516577018|FG000|Overall Study|Endoscopy could not be completed|4|||
143279441|NCT04840615|516577019|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
143373040|NCT04493242|516909653|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
143373041|NCT04493242|516909654|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
143373042|NCT00589667|516911357|FG000|Overall Study|Adverse Event|2|||
143373043|NCT00589667|516911357|FG000|Overall Study|Withdrawal by Subject|1|||
143373044|NCT03351075|516911360|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
143279442|NCT04840615|516577020|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
143279443|NCT04840615|516577021|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
143279444|NCT02469298|516577027|FG000|Overall Study|Protocol Violation|0|||
143279445|NCT02469298|516577028|FG001|Overall Study|Protocol Violation|1|||
143279446|NCT02469298|516577029|FG002|Overall Study|Protocol Violation|1|||
143279447|NCT02469298|516577030|FG003|Overall Study|Protocol Violation|0|||
143279448|NCT02469298|516577027|FG000|Overall Study|Lost to Follow-up|1|||
143279449|NCT02469298|516577028|FG001|Overall Study|Lost to Follow-up|0|||
143279450|NCT02469298|516577029|FG002|Overall Study|Lost to Follow-up|1|||
143279451|NCT02469298|516577030|FG003|Overall Study|Lost to Follow-up|0|||
143279452|NCT02469298|516577027|FG000|Overall Study|Physician Decision|0|||
143279453|NCT02469298|516577028|FG001|Overall Study|Physician Decision|0|||
143279454|NCT02469298|516577029|FG002|Overall Study|Physician Decision|0|||
143279455|NCT02469298|516577030|FG003|Overall Study|Physician Decision|1|||
143279456|NCT02469298|516577027|FG000|Overall Study|Withdrawal by Subject|0|||
143279457|NCT02469298|516577028|FG001|Overall Study|Withdrawal by Subject|0|||
143279458|NCT02469298|516577029|FG002|Overall Study|Withdrawal by Subject|0|||
143279459|NCT02469298|516577030|FG003|Overall Study|Withdrawal by Subject|1|||
143279460|NCT01575769|516577031|FG000|Overall Study|Adverse Event|1|||
143279461|NCT01575769|516577031|FG000|Overall Study|Study terminated by sponsor|40|||
143279462|NCT03000439|516577034|FG000|Open Label Part 1|Adverse Event|6|||
143279463|NCT03000439|516577035|FG001|Open Label Part 1|Adverse Event|0|||
143279464|NCT03000439|516577036|FG002|Open Label Part 1|Adverse Event|0|||
143279465|NCT03000439|516577037|FG003|Open Label Part 1|Adverse Event|0|||
143279466|NCT03000439|516577034|FG000|Open Label Part 1|Other|2|||
143279467|NCT03000439|516577035|FG001|Open Label Part 1|Other|0|||
143279468|NCT03000439|516577036|FG002|Open Label Part 1|Other|0|||
143279469|NCT03000439|516577037|FG003|Open Label Part 1|Other|0|||
143279470|NCT03000439|516577034|FG000|Open Label Part 1|Insufficient clinical response|16|||
143279471|NCT03000439|516577035|FG001|Open Label Part 1|Insufficient clinical response|0|||
143279472|NCT03000439|516577036|FG002|Open Label Part 1|Insufficient clinical response|0|||
143279473|NCT03000439|516577037|FG003|Open Label Part 1|Insufficient clinical response|0|||
143279474|NCT03000439|516577034|FG000|Open Label Part 2|Other|0|||
143279475|NCT03000439|516577035|FG001|Open Label Part 2|Other|5|||
143279476|NCT03000439|516577036|FG002|Open Label Part 2|Other|0|||
143279477|NCT03000439|516577037|FG003|Open Label Part 2|Other|0|||
143279478|NCT03000439|516577034|FG000|Open Label Part 2|Insufficient clinical response|0|||
143279479|NCT03000439|516577035|FG001|Open Label Part 2|Insufficient clinical response|12|||
143279480|NCT03000439|516577036|FG002|Open Label Part 2|Insufficient clinical response|0|||
143279481|NCT03000439|516577037|FG003|Open Label Part 2|Insufficient clinical response|0|||
143279482|NCT03000439|516577034|FG000|Double Blind Phase|Adverse Event|0|||
143279483|NCT03000439|516577035|FG001|Double Blind Phase|Adverse Event|0|||
143279484|NCT03000439|516577036|FG002|Double Blind Phase|Adverse Event|2|||
143279485|NCT03000439|516577037|FG003|Double Blind Phase|Adverse Event|1|||
143279486|NCT03000439|516577034|FG000|Double Blind Phase|Withdrawal by parent/guardian|0|||
143279487|NCT03000439|516577035|FG001|Double Blind Phase|Withdrawal by parent/guardian|0|||
143279488|NCT03000439|516577036|FG002|Double Blind Phase|Withdrawal by parent/guardian|2|||
143279489|NCT03000439|516577037|FG003|Double Blind Phase|Withdrawal by parent/guardian|0|||
143279490|NCT03000439|516577034|FG000|Double Blind Phase|Other|0|||
143279491|NCT03000439|516577035|FG001|Double Blind Phase|Other|0|||
143279492|NCT03000439|516577036|FG002|Double Blind Phase|Other|10|||
143279493|NCT03000439|516577037|FG003|Double Blind Phase|Other|11|||
143279494|NCT03000439|516577034|FG000|Double Blind Phase|Insufficient clinical response|0|||
143279495|NCT03000439|516577035|FG001|Double Blind Phase|Insufficient clinical response|0|||
143279496|NCT03000439|516577036|FG002|Double Blind Phase|Insufficient clinical response|0|||
143279497|NCT03000439|516577037|FG003|Double Blind Phase|Insufficient clinical response|2|||
143279498|NCT02370160|516577038|FG000|Overall Study|Death|3|||
143279499|NCT02370160|516577039|FG001|Overall Study|Death|4|||
143279500|NCT02370160|516577040|FG002|Overall Study|Death|1|||
143279501|NCT02501473|516577047|FG000|Overall Study|Study Terminated|2|||
143279502|NCT02501473|516577048|FG001|Overall Study|Study Terminated|3|||
143279503|NCT02501473|516577049|FG002|Overall Study|Study Terminated|7|||
143279504|NCT02501473|516577050|FG003|Overall Study|Study Terminated|9|||
143279505|NCT02501473|516577051|FG004|Overall Study|Study Terminated|2|||
143279506|NCT02501473|516577052|FG005|Overall Study|Study Terminated|10|||
143279507|NCT02501473|516577053|FG006|Overall Study|Study Terminated|1|||
143373045|NCT03351075|516911361|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
143279508|NCT02501473|516577054|FG007|Overall Study|Study Terminated|0|||
143279509|NCT02501473|516577047|FG000|Overall Study|Withdrawal by Subject|0|||
143279510|NCT02501473|516577048|FG001|Overall Study|Withdrawal by Subject|0|||
143279511|NCT02501473|516577049|FG002|Overall Study|Withdrawal by Subject|3|||
143279512|NCT02501473|516577050|FG003|Overall Study|Withdrawal by Subject|3|||
143279513|NCT02501473|516577051|FG004|Overall Study|Withdrawal by Subject|2|||
143279514|NCT02501473|516577052|FG005|Overall Study|Withdrawal by Subject|2|||
143279515|NCT02501473|516577053|FG006|Overall Study|Withdrawal by Subject|0|||
143279516|NCT02501473|516577054|FG007|Overall Study|Withdrawal by Subject|0|||
143279517|NCT02501473|516577047|FG000|Overall Study|Death|0|||
143279518|NCT02501473|516577048|FG001|Overall Study|Death|0|||
143279519|NCT02501473|516577049|FG002|Overall Study|Death|1|||
143279520|NCT02501473|516577050|FG003|Overall Study|Death|1|||
143279521|NCT02501473|516577051|FG004|Overall Study|Death|0|||
143279522|NCT02501473|516577052|FG005|Overall Study|Death|1|||
143279523|NCT02501473|516577053|FG006|Overall Study|Death|0|||
143279524|NCT02501473|516577054|FG007|Overall Study|Death|0|||
143279525|NCT02501473|516577047|FG000|Overall Study|Lost to Follow-up|1|||
143279526|NCT02501473|516577048|FG001|Overall Study|Lost to Follow-up|0|||
143279527|NCT02501473|516577049|FG002|Overall Study|Lost to Follow-up|1|||
143279528|NCT02501473|516577050|FG003|Overall Study|Lost to Follow-up|0|||
143279529|NCT02501473|516577051|FG004|Overall Study|Lost to Follow-up|0|||
143279530|NCT02501473|516577052|FG005|Overall Study|Lost to Follow-up|1|||
143279531|NCT02501473|516577053|FG006|Overall Study|Lost to Follow-up|0|||
143279532|NCT02501473|516577054|FG007|Overall Study|Lost to Follow-up|0|||
143279533|NCT02501473|516577047|FG000|Overall Study|Reason not specified|0|||
143279534|NCT02501473|516577048|FG001|Overall Study|Reason not specified|0|||
143279535|NCT02501473|516577049|FG002|Overall Study|Reason not specified|1|||
143279536|NCT02501473|516577050|FG003|Overall Study|Reason not specified|1|||
143279537|NCT02501473|516577051|FG004|Overall Study|Reason not specified|0|||
143279538|NCT02501473|516577052|FG005|Overall Study|Reason not specified|0|||
143279539|NCT02501473|516577053|FG006|Overall Study|Reason not specified|0|||
143279540|NCT02501473|516577054|FG007|Overall Study|Reason not specified|0|||
143279541|NCT01581931|516577055|FG000|Washout|Adverse Event|0|||
143279542|NCT01581931|516577056|FG001|Washout|Adverse Event|1|||
143279543|NCT03851705|516577063|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
143279544|NCT03851705|516577064|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
143279545|NCT03851705|516577065|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
143279546|NCT03851705|516577066|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
143279547|NCT03851705|516577063|FG000|Part 1: Double-Blind Period|Other reason|1|||
143279548|NCT03851705|516577064|FG001|Part 1: Double-Blind Period|Other reason|0|||
143279549|NCT03851705|516577065|FG002|Part 1: Double-Blind Period|Other reason|0|||
143279550|NCT03851705|516577066|FG003|Part 1: Double-Blind Period|Other reason|0|||
143279551|NCT03851705|516577063|FG000|Part 2: Open-Label Period|Other reason|0|||
143279552|NCT03851705|516577064|FG001|Part 2: Open-Label Period|Other reason|0|||
143279553|NCT03851705|516577065|FG002|Part 2: Open-Label Period|Other reason|0|||
143279554|NCT03851705|516577066|FG003|Part 2: Open-Label Period|Other reason|1|||
143279555|NCT03851705|516577063|FG000|Part 2: Open-Label Period|Death|0|||
143279556|NCT03851705|516577064|FG001|Part 2: Open-Label Period|Death|0|||
143279557|NCT03851705|516577065|FG002|Part 2: Open-Label Period|Death|3|||
143279558|NCT03851705|516577066|FG003|Part 2: Open-Label Period|Death|0|||
143279559|NCT03851705|516577063|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
143279560|NCT03851705|516577064|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
143279561|NCT03851705|516577065|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
143279562|NCT03851705|516577066|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
143279563|NCT00621582|516577067|FG000|Overall Study|Adverse Event|7|||
143279564|NCT00621582|516577067|FG000|Overall Study|Protocol Violation|57|||
143279565|NCT00621582|516577067|FG000|Overall Study|Lost to Follow-up|24|||
143279566|NCT00621582|516577067|FG000|Overall Study|issues not identified by investigators|18|||
143279567|NCT01387932|516577069|FG000|Randomized and Treated|Physician Decision|3|||
143279568|NCT01387932|516577070|FG001|Randomized and Treated|Physician Decision|2|||
143279569|NCT01387932|516577069|FG000|Randomized and Treated|Withdrawal by Subject|4|||
143279570|NCT01387932|516577070|FG001|Randomized and Treated|Withdrawal by Subject|2|||
143279571|NCT01387932|516577069|FG000|Survival Follow-up|Liver Transplant|24|||
143279572|NCT01387932|516577070|FG001|Survival Follow-up|Liver Transplant|28|||
143279573|NCT01387932|516577069|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
143279574|NCT01387932|516577070|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
143279575|NCT01387932|516577069|FG000|Survival Follow-up|Withdrawal by Subject|2|||
143279576|NCT01387932|516577070|FG001|Survival Follow-up|Withdrawal by Subject|4|||
143279577|NCT01387932|516577069|FG000|Survival Follow-up|Lost to Follow-up|6|||
143279578|NCT01387932|516577070|FG001|Survival Follow-up|Lost to Follow-up|5|||
143279579|NCT02591290|516577071|FG000|Overall Study|Withdrawal by Subject|2|||
143279580|NCT02571075|516577072|FG000|Overall Study|Lost to Follow-up|20|||
143279581|NCT02571075|516577073|FG001|Overall Study|Lost to Follow-up|24|||
143279582|NCT01306942|516577081|FG000|Phase I|Adverse Event|2|||
143279583|NCT01306942|516577082|FG001|Phase I|Adverse Event|2|||
143279584|NCT01306942|516577083|FG002|Phase I|Adverse Event|0|||
143279585|NCT01306942|516577084|FG003|Phase I|Adverse Event|0|||
143279586|NCT01306942|516577081|FG000|Phase I|Physician Decision|3|||
143279587|NCT01306942|516577082|FG001|Phase I|Physician Decision|1|||
143279588|NCT01306942|516577083|FG002|Phase I|Physician Decision|0|||
143279589|NCT01306942|516577084|FG003|Phase I|Physician Decision|0|||
143279590|NCT01306942|516577081|FG000|Phase II|Adverse Event|0|||
143279591|NCT01306942|516577082|FG001|Phase II|Adverse Event|0|||
143279592|NCT01306942|516577083|FG002|Phase II|Adverse Event|0|||
143279593|NCT01306942|516577084|FG003|Phase II|Adverse Event|6|||
143279594|NCT01306942|516577081|FG000|Phase II|Physician Decision|2|||
143279595|NCT01306942|516577082|FG001|Phase II|Physician Decision|0|||
143279596|NCT01306942|516577083|FG002|Phase II|Physician Decision|0|||
143279597|NCT01306942|516577084|FG003|Phase II|Physician Decision|5|||
143279598|NCT01306942|516577081|FG000|Phase II|Withdrawal by Subject|0|||
143279599|NCT01306942|516577082|FG001|Phase II|Withdrawal by Subject|0|||
143279600|NCT01306942|516577083|FG002|Phase II|Withdrawal by Subject|0|||
143279601|NCT01306942|516577084|FG003|Phase II|Withdrawal by Subject|2|||
143279602|NCT01306942|516577081|FG000|Phase II|Death|0|||
143279603|NCT01306942|516577082|FG001|Phase II|Death|0|||
143279604|NCT01306942|516577083|FG002|Phase II|Death|0|||
143279605|NCT01306942|516577084|FG003|Phase II|Death|1|||
143279606|NCT01306942|516577081|FG000|Phase II|Not finished treatment|0|||
143279607|NCT01306942|516577082|FG001|Phase II|Not finished treatment|0|||
143279608|NCT01306942|516577083|FG002|Phase II|Not finished treatment|0|||
143279609|NCT01306942|516577084|FG003|Phase II|Not finished treatment|1|||
143279610|NCT01306942|516577081|FG000|Phase II|Protocol Violation|0|||
143279611|NCT01306942|516577082|FG001|Phase II|Protocol Violation|0|||
143279612|NCT01306942|516577083|FG002|Phase II|Protocol Violation|0|||
143279613|NCT01306942|516577084|FG003|Phase II|Protocol Violation|1|||
143279614|NCT03385564|516577091|FG000|Overall Study|Adverse Event|0|||
143279615|NCT03385564|516577092|FG001|Overall Study|Adverse Event|0|||
143279616|NCT03385564|516577093|FG002|Overall Study|Adverse Event|3|||
143279617|NCT03385564|516577094|FG003|Overall Study|Adverse Event|3|||
143279618|NCT03385564|516577091|FG000|Overall Study|Other than listed|0|||
143279619|NCT03385564|516577092|FG001|Overall Study|Other than listed|0|||
143279620|NCT03385564|516577093|FG002|Overall Study|Other than listed|0|||
143229933|NCT00626275|516390898|FG001|Part A - Treatment Period 1|Adverse Event|0|||
143229934|NCT00626275|516390899|FG002|Part A - Treatment Period 1|Adverse Event|0|||
143229935|NCT00626275|516390900|FG003|Part A - Treatment Period 1|Adverse Event|0|||
143229936|NCT00626275|516390901|FG004|Part A - Treatment Period 1|Adverse Event|0|||
143229937|NCT00626275|516390902|FG005|Part A - Treatment Period 1|Adverse Event|0|||
143229938|NCT00626275|516390903|FG006|Part A - Treatment Period 1|Adverse Event|0|||
143229939|NCT00626275|516390904|FG007|Part A - Treatment Period 1|Adverse Event|0|||
143229940|NCT00626275|516390897|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
143229941|NCT00626275|516390898|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
143229942|NCT00626275|516390899|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
143229943|NCT00626275|516390900|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
143229944|NCT00626275|516390901|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
143229945|NCT00626275|516390902|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
143229946|NCT00626275|516390903|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
143229947|NCT00626275|516390904|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
143229948|NCT00626275|516390897|FG000|Part B|Lost to Follow-up|0|||
143229949|NCT00626275|516390898|FG001|Part B|Lost to Follow-up|0|||
143229950|NCT00626275|516390899|FG002|Part B|Lost to Follow-up|0|||
143229951|NCT00626275|516390900|FG003|Part B|Lost to Follow-up|0|||
143229952|NCT00626275|516390901|FG004|Part B|Lost to Follow-up|0|||
143229953|NCT00626275|516390902|FG005|Part B|Lost to Follow-up|0|||
143229954|NCT00626275|516390903|FG006|Part B|Lost to Follow-up|1|||
143229955|NCT00626275|516390904|FG007|Part B|Lost to Follow-up|0|||
143229956|NCT00626275|516390897|FG000|Part B|Withdrawal by Subject|0|||
143229957|NCT00626275|516390898|FG001|Part B|Withdrawal by Subject|0|||
143229958|NCT00626275|516390899|FG002|Part B|Withdrawal by Subject|0|||
143229959|NCT00626275|516390900|FG003|Part B|Withdrawal by Subject|0|||
143229960|NCT00626275|516390901|FG004|Part B|Withdrawal by Subject|0|||
143229961|NCT00626275|516390902|FG005|Part B|Withdrawal by Subject|0|||
143229962|NCT00626275|516390903|FG006|Part B|Withdrawal by Subject|0|||
143229963|NCT00626275|516390904|FG007|Part B|Withdrawal by Subject|1|||
143229964|NCT04999839|516390905|FG000|Overall Study|Adverse Event|1|||
143229965|NCT04999839|516390906|FG001|Overall Study|Adverse Event|1|||
143229966|NCT04999839|516390907|FG002|Overall Study|Adverse Event|1|||
143229967|NCT04999839|516390908|FG003|Overall Study|Adverse Event|1|||
143229968|NCT04999839|516390909|FG004|Overall Study|Adverse Event|1|||
143229969|NCT04999839|516390905|FG000|Overall Study|Lost to Follow-up|2|||
143229970|NCT04999839|516390906|FG001|Overall Study|Lost to Follow-up|0|||
143229971|NCT04999839|516390907|FG002|Overall Study|Lost to Follow-up|2|||
143229972|NCT04999839|516390908|FG003|Overall Study|Lost to Follow-up|4|||
143229973|NCT04999839|516390909|FG004|Overall Study|Lost to Follow-up|1|||
143229974|NCT04999839|516390905|FG000|Overall Study|Withdrawal by Subject|6|||
143229975|NCT04999839|516390906|FG001|Overall Study|Withdrawal by Subject|5|||
143229976|NCT04999839|516390907|FG002|Overall Study|Withdrawal by Subject|3|||
143229977|NCT04999839|516390908|FG003|Overall Study|Withdrawal by Subject|2|||
143229978|NCT04999839|516390909|FG004|Overall Study|Withdrawal by Subject|2|||
143229979|NCT04999839|516390905|FG000|Overall Study|Lack of Efficacy|0|||
143229980|NCT04999839|516390906|FG001|Overall Study|Lack of Efficacy|1|||
143229981|NCT04999839|516390907|FG002|Overall Study|Lack of Efficacy|0|||
143229982|NCT04999839|516390908|FG003|Overall Study|Lack of Efficacy|0|||
143229983|NCT04999839|516390909|FG004|Overall Study|Lack of Efficacy|0|||
143229984|NCT04999839|516390905|FG000|Overall Study|Physician Decision|0|||
143229985|NCT04999839|516390906|FG001|Overall Study|Physician Decision|0|||
143229986|NCT04999839|516390907|FG002|Overall Study|Physician Decision|0|||
143229987|NCT04999839|516390908|FG003|Overall Study|Physician Decision|0|||
143229988|NCT04999839|516390909|FG004|Overall Study|Physician Decision|1|||
143229989|NCT04999839|516390905|FG000|Overall Study|Sponsor request|0|||
143229990|NCT04999839|516390906|FG001|Overall Study|Sponsor request|1|||
143229991|NCT04999839|516390907|FG002|Overall Study|Sponsor request|0|||
143229992|NCT04999839|516390908|FG003|Overall Study|Sponsor request|0|||
143279621|NCT03385564|516577094|FG003|Overall Study|Other than listed|5|||
143279622|NCT03385564|516577091|FG000|Overall Study|Withdrawal by Subject|0|||
143279623|NCT03385564|516577092|FG001|Overall Study|Withdrawal by Subject|1|||
143279624|NCT03385564|516577093|FG002|Overall Study|Withdrawal by Subject|1|||
143279625|NCT03385564|516577094|FG003|Overall Study|Withdrawal by Subject|0|||
143279626|NCT03385564|516577091|FG000|Overall Study|Lack of Efficacy|0|||
143279627|NCT03385564|516577092|FG001|Overall Study|Lack of Efficacy|0|||
143279628|NCT03385564|516577093|FG002|Overall Study|Lack of Efficacy|0|||
143279629|NCT03385564|516577094|FG003|Overall Study|Lack of Efficacy|1|||
143279630|NCT03385564|516577091|FG000|Overall Study|Death|0|||
143279631|NCT03385564|516577092|FG001|Overall Study|Death|0|||
143279632|NCT03385564|516577093|FG002|Overall Study|Death|1|||
143279633|NCT03385564|516577094|FG003|Overall Study|Death|0|||
143279634|NCT03087643|516577099|FG000|Overall Study|Withdrawal by Subject|2|||
143279635|NCT03087643|516577100|FG001|Overall Study|Withdrawal by Subject|4|||
143279636|NCT03087643|516577099|FG000|Overall Study|Death|2|||
143279637|NCT03087643|516577100|FG001|Overall Study|Death|2|||
143279638|NCT01546883|516577104|FG000|Overall Study|Withdrawal by Subject|3|||
143279639|NCT01546883|516577104|FG000|Overall Study|Adverse Event|4|||
143279640|NCT01546883|516577104|FG000|Overall Study|Lost to Follow-up|2|||
143279641|NCT01546883|516577104|FG000|Overall Study|early closure of study|2|||
143279642|NCT01546883|516577104|FG000|Overall Study|other unrelated illness|1|||
143279643|NCT01427972|516577107|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
143279644|NCT01427972|516577108|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
143279645|NCT01427972|516577109|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
143279646|NCT01427972|516577110|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
143279647|NCT01427972|516577111|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
143279648|NCT01427972|516577112|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
143279649|NCT01427972|516577113|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
143279650|NCT01427972|516577114|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
143279651|NCT01427972|516577115|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
143279652|NCT01427972|516577116|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
143279653|NCT01427972|516577117|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
143279654|NCT01427972|516577118|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
143279655|NCT01427972|516577107|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
143279656|NCT01427972|516577108|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
143279657|NCT01427972|516577109|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
143279658|NCT01427972|516577110|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
143279659|NCT01427972|516577111|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
143279660|NCT01427972|516577112|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
143279661|NCT01427972|516577113|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
143279662|NCT01427972|516577114|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
143279663|NCT01427972|516577115|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
143279664|NCT01427972|516577116|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
143279665|NCT01427972|516577117|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
143279666|NCT01427972|516577118|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
143279667|NCT01427972|516577107|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
143279668|NCT01427972|516577108|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
143279669|NCT01427972|516577109|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
143279670|NCT01427972|516577110|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
143279671|NCT01427972|516577111|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
143279672|NCT01427972|516577112|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
143279673|NCT01427972|516577113|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
143279674|NCT01427972|516577114|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
143279675|NCT01427972|516577115|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
143279676|NCT01427972|516577116|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
143373046|NCT03351075|516911360|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
143373047|NCT03351075|516911361|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
143279677|NCT01427972|516577117|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
143279678|NCT01427972|516577118|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
143279679|NCT04545385|516577119|FG000|Overall Study|Withdrawal by Subject|2|||
143279680|NCT04545385|516577120|FG001|Overall Study|Withdrawal by Subject|0|||
143279681|NCT04545385|516577119|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
143279682|NCT04545385|516577120|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
143373048|NCT03351075|516911360|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
143373049|NCT03351075|516911361|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
143279683|NCT04545385|516577119|FG000|Overall Study|Study termination|10|||
143279684|NCT04545385|516577120|FG001|Overall Study|Study termination|10|||
143279685|NCT04545385|516577119|FG000|Overall Study|Sponsor decision|2|||
143279686|NCT04545385|516577120|FG001|Overall Study|Sponsor decision|2|||
143279687|NCT04545385|516577119|FG000|Overall Study|Other than specified|1|||
143373050|NCT03351075|516911360|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
143373051|NCT03351075|516911361|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
143229993|NCT04999839|516390909|FG004|Overall Study|Sponsor request|0|||
143229994|NCT04999839|516390905|FG000|Overall Study|Other|0|||
143229995|NCT04999839|516390906|FG001|Overall Study|Other|0|||
143229996|NCT04999839|516390907|FG002|Overall Study|Other|1|||
143229997|NCT04999839|516390908|FG003|Overall Study|Other|0|||
143229998|NCT04999839|516390909|FG004|Overall Study|Other|0|||
143229999|NCT03261336|516390910|FG000|Overall Study|Adverse Event|1|||
143230000|NCT00292942|516390912|FG000|Overall Study|Withdrawal by Subject|0|||
143230001|NCT00292942|516390913|FG001|Overall Study|Withdrawal by Subject|0|||
143230002|NCT00292942|516390914|FG002|Overall Study|Withdrawal by Subject|1|||
143230003|NCT00292942|516390915|FG003|Overall Study|Withdrawal by Subject|0|||
143230004|NCT00292942|516390912|FG000|Overall Study|Adverse Event|0|||
143230005|NCT00292942|516390913|FG001|Overall Study|Adverse Event|0|||
143230006|NCT00292942|516390914|FG002|Overall Study|Adverse Event|0|||
143230007|NCT00292942|516390915|FG003|Overall Study|Adverse Event|1|||
143230008|NCT00644358|516390916|FG000|Overall Study|Adverse Event|124|||
143230009|NCT00644358|516390916|FG000|Overall Study|Lost to Follow-up|105|||
143230010|NCT00644358|516390916|FG000|Overall Study|Consent Withdrawal|64|||
143230011|NCT00644358|516390916|FG000|Overall Study|Lack of Effectiveness|39|||
143230012|NCT00644358|516390916|FG000|Overall Study|Protocol Violation|5|||
143230013|NCT00644358|516390916|FG000|Overall Study|Noncompliance|14|||
143230014|NCT00644358|516390916|FG000|Overall Study|Other Unspecified|11|||
143230015|NCT00758771|516390919|FG000|Overall Study|Withdrawal by Subject|1|||
143230016|NCT00758771|516390920|FG001|Overall Study|Withdrawal by Subject|1|||
143230017|NCT00758771|516390919|FG000|Overall Study|Did not meet eligibility criteria|2|||
143230018|NCT00758771|516390920|FG001|Overall Study|Did not meet eligibility criteria|4|||
143230019|NCT00528957|516390921|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
143230020|NCT00528957|516390922|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
143230021|NCT00528957|516390921|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
143230022|NCT00528957|516390922|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
143230023|NCT00528957|516390921|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
143230024|NCT00528957|516390922|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
143230025|NCT00528957|516390921|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
143230026|NCT00528957|516390922|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
143230027|NCT00528957|516390921|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
143230028|NCT00528957|516390922|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
143230029|NCT00528957|516390921|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
143230030|NCT00528957|516390922|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
143230031|NCT00528957|516390921|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
143230032|NCT00528957|516390922|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
143230033|NCT00528957|516390921|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
143230034|NCT00528957|516390922|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
143230035|NCT00528957|516390921|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
143230036|NCT00528957|516390922|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
143230037|NCT00528957|516390921|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
143230038|NCT00528957|516390922|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
143230039|NCT00528957|516390921|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
143230040|NCT00528957|516390922|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
143230041|NCT00528957|516390921|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
143230042|NCT00528957|516390922|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
143230043|NCT00528957|516390921|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
143230044|NCT00528957|516390922|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
143230045|NCT00528957|516390921|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
143230046|NCT00528957|516390922|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
143230047|NCT00528957|516390921|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
143230048|NCT00528957|516390922|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
143230049|NCT00528957|516390921|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
143230050|NCT00528957|516390922|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
143230051|NCT00539981|516390923|FG000|Overall Study|Adverse events (AE)|3|||
143230052|NCT00539981|516390924|FG001|Overall Study|Adverse events (AE)|3|||
143230053|NCT00539981|516390923|FG000|Overall Study|Lost to Follow-up|260|||
143230054|NCT00539981|516390924|FG001|Overall Study|Lost to Follow-up|251|||
143230055|NCT00539981|516390923|FG000|Overall Study|Withdrew consent|22|||
143230056|NCT00539981|516390924|FG001|Overall Study|Withdrew consent|14|||
143230057|NCT00539981|516390923|FG000|Overall Study|Death|1|||
143230058|NCT00539981|516390924|FG001|Overall Study|Death|1|||
143230059|NCT00539981|516390923|FG000|Overall Study|Other reason-unspecified|9|||
143230060|NCT00539981|516390924|FG001|Overall Study|Other reason-unspecified|13|||
143230061|NCT02051764|516390928|FG000|Overall Study|Study terminated by sponsor|0|||
143230062|NCT02051764|516390929|FG001|Overall Study|Study terminated by sponsor|7|||
143230063|NCT00591006|516390930|FG000|Overall Study|Withdrawal by Subject|0|||
143230064|NCT00591006|516390931|FG001|Overall Study|Withdrawal by Subject|0|||
143230065|NCT00591006|516390932|FG002|Overall Study|Withdrawal by Subject|0|||
143230066|NCT00591006|516390933|FG003|Overall Study|Withdrawal by Subject|0|||
143230067|NCT00591006|516390934|FG004|Overall Study|Withdrawal by Subject|0|||
143230068|NCT00591006|516390935|FG005|Overall Study|Withdrawal by Subject|0|||
143230069|NCT00591006|516390936|FG006|Overall Study|Withdrawal by Subject|0|||
143230070|NCT00591006|516390937|FG007|Overall Study|Withdrawal by Subject|0|||
143230071|NCT00591006|516390938|FG008|Overall Study|Withdrawal by Subject|0|||
143230072|NCT00591006|516390939|FG009|Overall Study|Withdrawal by Subject|0|||
143373052|NCT03175172|516911362|FG000|Overall Study|Death|3|||
143279688|NCT04545385|516577120|FG001|Overall Study|Other than specified|0|||
143279689|NCT01128842|516577121|FG000|Overall Study|Adverse Event|1|||
143279690|NCT01128842|516577121|FG000|Overall Study|Disease Progression|6|||
143279691|NCT05399641|516577128|FG000|Overall Study|Adverse Event|0|||
143279692|NCT05399641|516577129|FG001|Overall Study|Adverse Event|1|||
143279693|NCT05399641|516577130|FG002|Overall Study|Adverse Event|1|||
143279694|NCT05399641|516577128|FG000|Overall Study|Lost to Follow-up|1|||
143279695|NCT05399641|516577129|FG001|Overall Study|Lost to Follow-up|2|||
143279696|NCT05399641|516577130|FG002|Overall Study|Lost to Follow-up|2|||
143279697|NCT05399641|516577128|FG000|Overall Study|Physician Decision|1|||
143279698|NCT05399641|516577129|FG001|Overall Study|Physician Decision|3|||
143279699|NCT05399641|516577130|FG002|Overall Study|Physician Decision|3|||
143279700|NCT05399641|516577128|FG000|Overall Study|Withdrawal by Subject|4|||
143279701|NCT05399641|516577129|FG001|Overall Study|Withdrawal by Subject|11|||
143279702|NCT05399641|516577130|FG002|Overall Study|Withdrawal by Subject|7|||
143279703|NCT05399641|516577128|FG000|Overall Study|Reason not defined|3|||
143279704|NCT05399641|516577129|FG001|Overall Study|Reason not defined|5|||
143279705|NCT05399641|516577130|FG002|Overall Study|Reason not defined|6|||
143279706|NCT02094677|516577131|FG000|Overall Study|Screening|3|||
143279707|NCT02094677|516577132|FG001|Overall Study|Screening|1|||
143279708|NCT03408483|516577133|FG000|Overall Study|Physician Decision|3|||
143279709|NCT03408483|516577134|FG001|Overall Study|Physician Decision|3|||
143279710|NCT03408483|516577133|FG000|Overall Study|Lost to Follow-up|3|||
143279711|NCT03408483|516577134|FG001|Overall Study|Lost to Follow-up|0|||
143279712|NCT00478231|516577135|FG000|Overall Study|Death|7|||
143279713|NCT00478231|516577135|FG000|Overall Study|Lack of Efficacy|47|||
143279714|NCT00478231|516577135|FG000|Overall Study|Lost to Follow-up|7|||
143279715|NCT00478231|516577135|FG000|Overall Study|Withdrawal by Subject|6|||
143279716|NCT00478231|516577135|FG000|Overall Study|Other|9|||
143279717|NCT00478231|516577135|FG000|Overall Study|Adverse Event|5|||
143279718|NCT00478231|516577135|FG000|Overall Study|Randomized, not treated|3|||
143279719|NCT01300650|516577136|FG000|Overall Study|Adverse Event|1|||
143279720|NCT01702961|516577137|FG000|Overall Study|Additional treatment|3|||
143279721|NCT01702961|516577137|FG000|Overall Study|Progressive disease|5|||
143279722|NCT01702961|516577137|FG000|Overall Study|Relapse|20|||
143279723|NCT01702961|516577137|FG000|Overall Study|Death|6|||
143230073|NCT00591006|516390940|FG010|Overall Study|Withdrawal by Subject|0|||
143230074|NCT00591006|516390941|FG011|Overall Study|Withdrawal by Subject|0|||
143230075|NCT00591006|516390942|FG012|Overall Study|Withdrawal by Subject|0|||
143230076|NCT00591006|516390943|FG013|Overall Study|Withdrawal by Subject|0|||
143230077|NCT00591006|516390944|FG014|Overall Study|Withdrawal by Subject|0|||
143230078|NCT00591006|516390945|FG015|Overall Study|Withdrawal by Subject|1|||
143230079|NCT00591006|516390946|FG016|Overall Study|Withdrawal by Subject|0|||
143230080|NCT00591006|516390947|FG017|Overall Study|Withdrawal by Subject|0|||
143230081|NCT00591006|516390948|FG018|Overall Study|Withdrawal by Subject|0|||
143230082|NCT00591006|516390949|FG019|Overall Study|Withdrawal by Subject|0|||
143230083|NCT00591006|516390950|FG020|Overall Study|Withdrawal by Subject|0|||
143230084|NCT00591006|516390951|FG021|Overall Study|Withdrawal by Subject|0|||
143230085|NCT00591006|516390952|FG022|Overall Study|Withdrawal by Subject|0|||
143230086|NCT00591006|516390953|FG023|Overall Study|Withdrawal by Subject|1|||
143230087|NCT00591006|516390930|FG000|Overall Study|Adverse Event|0|||
143230088|NCT00591006|516390931|FG001|Overall Study|Adverse Event|0|||
143230089|NCT00591006|516390932|FG002|Overall Study|Adverse Event|0|||
143230090|NCT00591006|516390933|FG003|Overall Study|Adverse Event|0|||
143230091|NCT00591006|516390934|FG004|Overall Study|Adverse Event|0|||
143279724|NCT01702961|516577137|FG000|Overall Study|Lost to Follow-up|2|||
143279725|NCT01702961|516577137|FG000|Overall Study|Ongoing|11|||
143279726|NCT00674362|516577142|FG000|Double Blind|Adverse Event|6|||
143279727|NCT00674362|516577143|FG001|Double Blind|Adverse Event|6|||
143279728|NCT00674362|516577142|FG000|Double Blind|Lack of Efficacy|2|||
143279729|NCT00674362|516577143|FG001|Double Blind|Lack of Efficacy|6|||
143279730|NCT00674362|516577142|FG000|Double Blind|Loss of efficacy|0|||
143279731|NCT00674362|516577143|FG001|Double Blind|Loss of efficacy|1|||
143279732|NCT00674362|516577142|FG000|Double Blind|Withdrawal by Subject|4|||
143279733|NCT00674362|516577143|FG001|Double Blind|Withdrawal by Subject|3|||
143279734|NCT00674362|516577142|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
143279735|NCT00674362|516577143|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
143279736|NCT00674362|516577142|FG000|Double Blind|Other: Surgery|0|||
143279737|NCT00674362|516577143|FG001|Double Blind|Other: Surgery|1|||
143279738|NCT00674362|516577142|FG000|Open Label|Adverse Event|1|||
143279739|NCT00674362|516577143|FG001|Open Label|Adverse Event|0|||
143279740|NCT00674362|516577142|FG000|Open Label|Other: Subject moved to extension study|1|||
143279741|NCT00674362|516577143|FG001|Open Label|Other: Subject moved to extension study|0|||
143279742|NCT00923156|516577144|FG000|Overall Study|Adverse Event|0|||
143279743|NCT00923156|516577145|FG001|Overall Study|Adverse Event|2|||
143279744|NCT00923156|516577146|FG002|Overall Study|Adverse Event|1|||
143279745|NCT00923156|516577144|FG000|Overall Study|Abnormal laboratory values|0|||
143279746|NCT00923156|516577145|FG001|Overall Study|Abnormal laboratory values|0|||
143279747|NCT00923156|516577146|FG002|Overall Study|Abnormal laboratory values|1|||
143279748|NCT00923156|516577144|FG000|Overall Study|Withdrawal by Subject|0|||
143279749|NCT00923156|516577145|FG001|Overall Study|Withdrawal by Subject|1|||
143279750|NCT00923156|516577146|FG002|Overall Study|Withdrawal by Subject|0|||
143279751|NCT00923156|516577144|FG000|Overall Study|Death|0|||
143279752|NCT00923156|516577145|FG001|Overall Study|Death|1|||
143279753|NCT00923156|516577146|FG002|Overall Study|Death|0|||
143279754|NCT00923156|516577144|FG000|Overall Study|Lack of Efficacy|0|||
143279755|NCT00923156|516577145|FG001|Overall Study|Lack of Efficacy|0|||
143279756|NCT00923156|516577146|FG002|Overall Study|Lack of Efficacy|1|||
143279757|NCT04665856|516577147|FG000|Overall Study|Site Terminated by Sponsor|1|||
143279758|NCT04665856|516577148|FG001|Overall Study|Site Terminated by Sponsor|0|||
143279759|NCT04665856|516577147|FG000|Overall Study|Withdrawal by Subject|2|||
143279760|NCT04665856|516577148|FG001|Overall Study|Withdrawal by Subject|0|||
143279761|NCT04665856|516577147|FG000|Overall Study|Lost to Follow-up|3|||
143279762|NCT04665856|516577148|FG001|Overall Study|Lost to Follow-up|2|||
143279763|NCT04665856|516577147|FG000|Overall Study|Death|39|||
143279764|NCT04665856|516577148|FG001|Overall Study|Death|44|||
143279765|NCT04665856|516577147|FG000|Overall Study|Ongoing in study|17|||
143279766|NCT04665856|516577148|FG001|Overall Study|Ongoing in study|15|||
143279767|NCT03386448|516577149|FG000|Overall Study|Adverse Event|0|||
143279768|NCT03386448|516577150|FG001|Overall Study|Adverse Event|2|||
143279769|NCT02339584|516577151|FG000|Overall Study|Adverse Event|11|||
143279770|NCT02339584|516577152|FG001|Overall Study|Adverse Event|7|||
143279771|NCT02339584|516577151|FG000|Overall Study|Lack of Efficacy|0|||
143279772|NCT02339584|516577152|FG001|Overall Study|Lack of Efficacy|1|||
143279773|NCT02339584|516577151|FG000|Overall Study|Physician Decision|1|||
143279774|NCT02339584|516577152|FG001|Overall Study|Physician Decision|2|||
143279775|NCT02339584|516577151|FG000|Overall Study|Protocol Violation|1|||
143279776|NCT02339584|516577152|FG001|Overall Study|Protocol Violation|1|||
143279777|NCT02339584|516577151|FG000|Overall Study|Withdrawal by Subject|2|||
143279778|NCT02339584|516577152|FG001|Overall Study|Withdrawal by Subject|4|||
143279779|NCT02610725|516577153|FG000|Overall Study|Lost to Follow-up|197|||
143279780|NCT02610725|516577153|FG000|Overall Study|self-reported contraindication|9|||
143279781|NCT04094883|516577154|FG000|Overall Study|Withdrawal by Subject|1|||
143279782|NCT01133522|516577158|FG000|Overall Study|Withdrawal by Subject|0|||
143279783|NCT01133522|516577159|FG001|Overall Study|Withdrawal by Subject|1|||
143279784|NCT01133522|516577160|FG002|Overall Study|Withdrawal by Subject|0|||
143279785|NCT01133522|516577161|FG003|Overall Study|Withdrawal by Subject|1|||
143279786|NCT01133522|516577162|FG004|Overall Study|Withdrawal by Subject|0|||
143279787|NCT01133522|516577163|FG005|Overall Study|Withdrawal by Subject|0|||
143279788|NCT01133522|516577164|FG006|Overall Study|Withdrawal by Subject|0|||
143279789|NCT01133522|516577165|FG007|Overall Study|Withdrawal by Subject|0|||
143279790|NCT01133522|516577166|FG008|Overall Study|Withdrawal by Subject|0|||
143279791|NCT01133522|516577167|FG009|Overall Study|Withdrawal by Subject|0|||
143279792|NCT01133522|516577158|FG000|Overall Study|Physician Decision|0|||
143279793|NCT01133522|516577159|FG001|Overall Study|Physician Decision|0|||
143279794|NCT01133522|516577160|FG002|Overall Study|Physician Decision|0|||
143279795|NCT01133522|516577161|FG003|Overall Study|Physician Decision|0|||
143279796|NCT01133522|516577162|FG004|Overall Study|Physician Decision|1|||
143279797|NCT01133522|516577163|FG005|Overall Study|Physician Decision|0|||
143279798|NCT01133522|516577164|FG006|Overall Study|Physician Decision|0|||
143279799|NCT01133522|516577165|FG007|Overall Study|Physician Decision|0|||
143279800|NCT01133522|516577166|FG008|Overall Study|Physician Decision|0|||
143279801|NCT01133522|516577167|FG009|Overall Study|Physician Decision|0|||
143279802|NCT02513394|516577175|FG000|Overall Study|Withdrawal by Subject|11|||
143279803|NCT02513394|516577176|FG001|Overall Study|Withdrawal by Subject|23|||
143279804|NCT02513394|516577175|FG000|Overall Study|Ineligible|1|||
143279805|NCT02513394|516577176|FG001|Overall Study|Ineligible|0|||
143279806|NCT00688753|516578806|FG000|Overall Study|Disease progression|55|||
143279807|NCT00688753|516578806|FG000|Overall Study|Missing|1|||
143279808|NCT00688753|516578806|FG000|Overall Study|Death|9|||
143279809|NCT00688753|516578806|FG000|Overall Study|Withdrawal by Subject|3|||
143279810|NCT00688753|516578806|FG000|Overall Study|Adverse Event|20|||
143279811|NCT00688753|516578806|FG000|Overall Study|Protocol Violation|1|||
143279812|NCT00688753|516578806|FG000|Overall Study|Lost to Follow-up|3|||
143279813|NCT03192462|516578812|FG000|Overall Study|Death|13|||
143279814|NCT03192462|516578813|FG001|Overall Study|Death|11|||
143279815|NCT03192462|516578814|FG002|Overall Study|Death|10|||
143279816|NCT03192462|516578812|FG000|Overall Study|Lost to Follow-up|0|||
143279817|NCT03192462|516578813|FG001|Overall Study|Lost to Follow-up|1|||
143279818|NCT03192462|516578814|FG002|Overall Study|Lost to Follow-up|0|||
143279819|NCT01898806|516578816|FG000|Overall Study|Withdrawal by Subject|2|||
143279820|NCT01898806|516578816|FG000|Overall Study|Physician Decision|1|||
143279821|NCT03003390|516578817|FG000|Overall Study|Physician Decision|2|||
143279822|NCT03003390|516578818|FG001|Overall Study|Physician Decision|0|||
143279823|NCT03003390|516578817|FG000|Overall Study|Parent refused intervention|2|||
143279824|NCT03003390|516578818|FG001|Overall Study|Parent refused intervention|0|||
143279825|NCT02980601|516578827|FG000|Overall Study|Lost to Follow-up|2|||
143279826|NCT02980601|516578828|FG001|Overall Study|Lost to Follow-up|2|||
143279827|NCT02980601|516578827|FG000|Overall Study|Death|0|||
143279828|NCT02980601|516578828|FG001|Overall Study|Death|1|||
143279829|NCT02980601|516578827|FG000|Overall Study|Graft loss|1|||
143279830|NCT02980601|516578828|FG001|Overall Study|Graft loss|0|||
143279831|NCT02980601|516578827|FG000|Overall Study|Failed to sign consent|2|||
143279832|NCT02980601|516578828|FG001|Overall Study|Failed to sign consent|0|||
143279833|NCT03156543|516578831|FG000|Overall Study|Withdrawal by Subject|1|||
143279834|NCT03156543|516578832|FG001|Overall Study|Withdrawal by Subject|0|||
143279835|NCT01473836|516578833|FG000|Overall Study|Adverse Event|4|||
143279836|NCT01473836|516578833|FG000|Overall Study|Lack of Efficacy|1|||
143279837|NCT01473836|516578833|FG000|Overall Study|Does not meet entrance criteria|1|||
143279838|NCT02954237|516578841|FG000|Overall Study|Withdrawal by Subject|25|||
143279839|NCT02954237|516578841|FG000|Overall Study|Missed visit|16|||
143279840|NCT02954237|516578841|FG000|Overall Study|Death|2|||
143279841|NCT00674700|516578842|FG000|Year 1|Adverse Event|17|||
143279842|NCT00674700|516578843|FG001|Year 1|Adverse Event|20|||
143279843|NCT00674700|516578844|FG002|Year 1|Adverse Event|5|||
143279844|NCT00674700|516578842|FG000|Year 1|Withdrawal by Subject|7|||
143279845|NCT00674700|516578843|FG001|Year 1|Withdrawal by Subject|7|||
143279846|NCT00674700|516578844|FG002|Year 1|Withdrawal by Subject|6|||
143279847|NCT00674700|516578842|FG000|Year 1|Any other reason not above-mentioned|7|||
143279848|NCT00674700|516578843|FG001|Year 1|Any other reason not above-mentioned|7|||
143279849|NCT00674700|516578844|FG002|Year 1|Any other reason not above-mentioned|6|||
143279850|NCT00674700|516578842|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
143279851|NCT00674700|516578843|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
143279852|NCT00674700|516578844|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
143279853|NCT00674700|516578842|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
143279854|NCT00674700|516578843|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
143279855|NCT00674700|516578844|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
143279856|NCT00674700|516578842|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
143279857|NCT00674700|516578843|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
143279858|NCT00674700|516578844|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
143279859|NCT00395304|516578845|FG000|Treatment Period 1|Withdrawal by Subject|0|||
143279860|NCT00395304|516578846|FG001|Treatment Period 1|Withdrawal by Subject|3|||
143279861|NCT00395304|516578847|FG002|Treatment Period 1|Withdrawal by Subject|0|||
143279862|NCT00395304|516578848|FG003|Treatment Period 1|Withdrawal by Subject|2|||
143279863|NCT00395304|516578849|FG004|Treatment Period 1|Withdrawal by Subject|1|||
143279864|NCT00395304|516578850|FG005|Treatment Period 1|Withdrawal by Subject|1|||
143279865|NCT00395304|516578845|FG000|Treatment Period 1|Lost to Follow-up|1|||
143279866|NCT00395304|516578846|FG001|Treatment Period 1|Lost to Follow-up|0|||
143279867|NCT00395304|516578847|FG002|Treatment Period 1|Lost to Follow-up|0|||
143279868|NCT00395304|516578848|FG003|Treatment Period 1|Lost to Follow-up|1|||
143279869|NCT00395304|516578849|FG004|Treatment Period 1|Lost to Follow-up|0|||
143279870|NCT00395304|516578850|FG005|Treatment Period 1|Lost to Follow-up|1|||
143279871|NCT00395304|516578845|FG000|Treatment Period 1|Physician Decision|0|||
143279872|NCT00395304|516578846|FG001|Treatment Period 1|Physician Decision|1|||
143279873|NCT00395304|516578847|FG002|Treatment Period 1|Physician Decision|0|||
143279874|NCT00395304|516578848|FG003|Treatment Period 1|Physician Decision|0|||
143279875|NCT00395304|516578849|FG004|Treatment Period 1|Physician Decision|0|||
143279876|NCT00395304|516578850|FG005|Treatment Period 1|Physician Decision|0|||
143279877|NCT00395304|516578845|FG000|Treatment Period 2|Withdrawal by Subject|0|||
143279878|NCT00395304|516578846|FG001|Treatment Period 2|Withdrawal by Subject|0|||
143279879|NCT00395304|516578847|FG002|Treatment Period 2|Withdrawal by Subject|0|||
143279880|NCT00395304|516578848|FG003|Treatment Period 2|Withdrawal by Subject|1|||
143279881|NCT00395304|516578849|FG004|Treatment Period 2|Withdrawal by Subject|0|||
143279882|NCT00395304|516578850|FG005|Treatment Period 2|Withdrawal by Subject|2|||
143279883|NCT00395304|516578845|FG000|Treatment Period 2|Lost to Follow-up|0|||
143279884|NCT00395304|516578846|FG001|Treatment Period 2|Lost to Follow-up|3|||
143279885|NCT00395304|516578847|FG002|Treatment Period 2|Lost to Follow-up|0|||
143279886|NCT00395304|516578848|FG003|Treatment Period 2|Lost to Follow-up|0|||
143279887|NCT00395304|516578849|FG004|Treatment Period 2|Lost to Follow-up|0|||
143279888|NCT00395304|516578850|FG005|Treatment Period 2|Lost to Follow-up|0|||
143279889|NCT00395304|516578845|FG000|Treatment Period 2|Physician Decision|0|||
143279890|NCT00395304|516578846|FG001|Treatment Period 2|Physician Decision|0|||
143279891|NCT00395304|516578847|FG002|Treatment Period 2|Physician Decision|1|||
143279892|NCT00395304|516578848|FG003|Treatment Period 2|Physician Decision|0|||
143279893|NCT00395304|516578849|FG004|Treatment Period 2|Physician Decision|0|||
143279894|NCT00395304|516578850|FG005|Treatment Period 2|Physician Decision|0|||
143279895|NCT00395304|516578845|FG000|Treatment Period 2|Other|0|||
143279896|NCT00395304|516578846|FG001|Treatment Period 2|Other|1|||
143279897|NCT00395304|516578847|FG002|Treatment Period 2|Other|0|||
143279898|NCT00395304|516578848|FG003|Treatment Period 2|Other|0|||
143279899|NCT00395304|516578849|FG004|Treatment Period 2|Other|0|||
143279900|NCT00395304|516578850|FG005|Treatment Period 2|Other|0|||
143279901|NCT00395304|516578845|FG000|Treatment Period 3|Withdrawal by Subject|0|||
143279902|NCT00395304|516578846|FG001|Treatment Period 3|Withdrawal by Subject|0|||
143279903|NCT00395304|516578847|FG002|Treatment Period 3|Withdrawal by Subject|0|||
143279904|NCT00395304|516578848|FG003|Treatment Period 3|Withdrawal by Subject|1|||
143279905|NCT00395304|516578849|FG004|Treatment Period 3|Withdrawal by Subject|0|||
143279906|NCT00395304|516578850|FG005|Treatment Period 3|Withdrawal by Subject|1|||
143279907|NCT00395304|516578845|FG000|Treatment Period 3|Lost to Follow-up|1|||
143279908|NCT00395304|516578846|FG001|Treatment Period 3|Lost to Follow-up|1|||
143279909|NCT00395304|516578847|FG002|Treatment Period 3|Lost to Follow-up|0|||
143279910|NCT00395304|516578848|FG003|Treatment Period 3|Lost to Follow-up|0|||
143279911|NCT00395304|516578849|FG004|Treatment Period 3|Lost to Follow-up|0|||
143279912|NCT00395304|516578850|FG005|Treatment Period 3|Lost to Follow-up|0|||
143279913|NCT00395304|516578845|FG000|Treatment Period 3|Physician Decision|0|||
143279914|NCT00395304|516578846|FG001|Treatment Period 3|Physician Decision|1|||
143279915|NCT00395304|516578847|FG002|Treatment Period 3|Physician Decision|0|||
143279916|NCT00395304|516578848|FG003|Treatment Period 3|Physician Decision|0|||
143279917|NCT00395304|516578849|FG004|Treatment Period 3|Physician Decision|0|||
143279918|NCT00395304|516578850|FG005|Treatment Period 3|Physician Decision|0|||
143279919|NCT00395304|516578845|FG000|Treatment Period 3|Other|0|||
143279920|NCT00395304|516578846|FG001|Treatment Period 3|Other|0|||
143279921|NCT00395304|516578847|FG002|Treatment Period 3|Other|0|||
143279922|NCT00395304|516578848|FG003|Treatment Period 3|Other|1|||
143279923|NCT00395304|516578849|FG004|Treatment Period 3|Other|0|||
143279924|NCT00395304|516578850|FG005|Treatment Period 3|Other|0|||
143279925|NCT03797014|516578852|FG000|Overall Study|Withdrawal by Subject|1|||
143279926|NCT03797014|516578852|FG000|Overall Study|Lost to Follow-up|1|||
143279927|NCT03797014|516578852|FG000|Overall Study|Protocol Violation|1|||
143279928|NCT01970397|516578853|FG000|Overall Study|Adverse Event|0|||
143279929|NCT01970397|516578854|FG001|Overall Study|Adverse Event|1|||
143279930|NCT01970397|516578853|FG000|Overall Study|Lost to Follow-up|0|||
143279931|NCT01970397|516578854|FG001|Overall Study|Lost to Follow-up|1|||
143279932|NCT01970397|516578853|FG000|Overall Study|Personal Reasons|1|||
143279933|NCT01970397|516578854|FG001|Overall Study|Personal Reasons|2|||
143279934|NCT01970397|516578853|FG000|Overall Study|Protocol Violation|1|||
143279935|NCT01970397|516578854|FG001|Overall Study|Protocol Violation|1|||
143279936|NCT03305575|516578863|FG000|Overall Study|Physician Decision|1|||
143279937|NCT03305575|516578864|FG001|Overall Study|Physician Decision|0|||
143279938|NCT01389817|516578865|FG000|Overall Study|Physician Decision|1|||
143279939|NCT01389817|516578866|FG001|Overall Study|Physician Decision|0|||
143279940|NCT01389817|516578865|FG000|Overall Study|Lost to Follow-up|1|||
143279941|NCT01389817|516578866|FG001|Overall Study|Lost to Follow-up|0|||
143279942|NCT01389817|516578865|FG000|Overall Study|Withdrawal by Subject|2|||
143279943|NCT01389817|516578866|FG001|Overall Study|Withdrawal by Subject|0|||
143279944|NCT00105469|516578867|FG000|Overall Study|Adverse Event|9|||
143279945|NCT00105469|516578868|FG001|Overall Study|Adverse Event|8|||
143279946|NCT00105469|516578867|FG000|Overall Study|Protocol Violation|4|||
143279947|NCT00105469|516578868|FG001|Overall Study|Protocol Violation|0|||
143279948|NCT00105469|516578867|FG000|Overall Study|Withdrawal by Subject|2|||
143279949|NCT00105469|516578868|FG001|Overall Study|Withdrawal by Subject|3|||
143279950|NCT00105469|516578867|FG000|Overall Study|Lost to Follow-up|1|||
143279951|NCT00105469|516578868|FG001|Overall Study|Lost to Follow-up|0|||
143279952|NCT00105469|516578867|FG000|Overall Study|Lack of Efficacy|2|||
143279953|NCT00105469|516578868|FG001|Overall Study|Lack of Efficacy|0|||
143279954|NCT00105469|516578867|FG000|Overall Study|Other Reason|4|||
143279955|NCT00105469|516578868|FG001|Overall Study|Other Reason|0|||
143279956|NCT01749137|516578869|FG000|Overall Study|Adverse Event|4|||
143279957|NCT01749137|516578870|FG001|Overall Study|Adverse Event|4|||
143279958|NCT01749137|516578869|FG000|Overall Study|Lost to Follow-up|2|||
143279959|NCT01749137|516578870|FG001|Overall Study|Lost to Follow-up|3|||
143279960|NCT01749137|516578869|FG000|Overall Study|Physician Decision|1|||
143279961|NCT01749137|516578870|FG001|Overall Study|Physician Decision|0|||
143279962|NCT01749137|516578869|FG000|Overall Study|Withdrawal by Subject|8|||
143279963|NCT01749137|516578870|FG001|Overall Study|Withdrawal by Subject|4|||
143279964|NCT02871297|516578879|FG000|Overall Study|Adverse Event|34|||
143279965|NCT02871297|516578879|FG000|Overall Study|Lack of Efficacy|10|||
143279966|NCT02871297|516578879|FG000|Overall Study|Non-compliance with study drug|15|||
143279967|NCT02871297|516578879|FG000|Overall Study|Protocol Violation|3|||
143279968|NCT02871297|516578879|FG000|Overall Study|Withdrawal by Subject|20|||
143279969|NCT02871297|516578879|FG000|Overall Study|Lost to Follow-up|13|||
143279970|NCT02871297|516578879|FG000|Overall Study|Rolled over to 13546A|2|||
143279971|NCT02871297|516578879|FG000|Overall Study|Other than specified|39|||
143279972|NCT02966028|516578880|FG000|Overall Study|Adverse Event|7|||
143279973|NCT02966028|516578881|FG001|Overall Study|Adverse Event|13|||
143279974|NCT02966028|516578882|FG002|Overall Study|Adverse Event|10|||
143230092|NCT00591006|516390935|FG005|Overall Study|Adverse Event|0|||
143230093|NCT00591006|516390936|FG006|Overall Study|Adverse Event|0|||
143230094|NCT00591006|516390937|FG007|Overall Study|Adverse Event|0|||
143230095|NCT00591006|516390938|FG008|Overall Study|Adverse Event|0|||
143230096|NCT00591006|516390939|FG009|Overall Study|Adverse Event|0|||
143230097|NCT00591006|516390940|FG010|Overall Study|Adverse Event|0|||
143230098|NCT00591006|516390941|FG011|Overall Study|Adverse Event|0|||
143230099|NCT00591006|516390942|FG012|Overall Study|Adverse Event|0|||
143230100|NCT00591006|516390943|FG013|Overall Study|Adverse Event|0|||
143230101|NCT00591006|516390944|FG014|Overall Study|Adverse Event|0|||
143230102|NCT00591006|516390945|FG015|Overall Study|Adverse Event|0|||
143230103|NCT00591006|516390946|FG016|Overall Study|Adverse Event|0|||
143230104|NCT00591006|516390947|FG017|Overall Study|Adverse Event|0|||
143230105|NCT00591006|516390948|FG018|Overall Study|Adverse Event|0|||
143230106|NCT00591006|516390949|FG019|Overall Study|Adverse Event|0|||
143230107|NCT00591006|516390950|FG020|Overall Study|Adverse Event|0|||
143230108|NCT00591006|516390951|FG021|Overall Study|Adverse Event|0|||
143230109|NCT00591006|516390952|FG022|Overall Study|Adverse Event|1|||
143230110|NCT00591006|516390953|FG023|Overall Study|Adverse Event|0|||
143230111|NCT03473236|516390961|FG000|Overall Study|Withdrawal by Subject|0|||
143230112|NCT03473236|516390962|FG001|Overall Study|Withdrawal by Subject|0|||
143230113|NCT03473236|516390963|FG002|Overall Study|Withdrawal by Subject|0|||
143230114|NCT03473236|516390964|FG003|Overall Study|Withdrawal by Subject|0|||
143230115|NCT03473236|516390965|FG004|Overall Study|Withdrawal by Subject|0|||
143230116|NCT03473236|516390966|FG005|Overall Study|Withdrawal by Subject|1|||
143230117|NCT03473236|516390967|FG006|Overall Study|Withdrawal by Subject|0|||
143230118|NCT03473236|516390968|FG007|Overall Study|Withdrawal by Subject|0|||
143230119|NCT03473236|516390969|FG008|Overall Study|Withdrawal by Subject|1|||
143230120|NCT03473236|516390970|FG009|Overall Study|Withdrawal by Subject|0|||
143230121|NCT03155724|516390972|FG000|Overall Study|Death|3|||
143230122|NCT03155724|516390972|FG000|Overall Study|Physician Decision|1|||
143230123|NCT03155724|516390972|FG000|Overall Study|Study closure|7|||
143230124|NCT02370420|516390973|FG000|Overall Study|Physician Decision|3|||
143230125|NCT02370420|516390974|FG001|Overall Study|Physician Decision|3|||
143230126|NCT02370420|516390973|FG000|Overall Study|Lost to Follow-up|11|||
143230127|NCT02370420|516390974|FG001|Overall Study|Lost to Follow-up|9|||
143230128|NCT00880620|516390975|FG000|Overall Study|Adverse Event|4|||
143230129|NCT00880620|516390976|FG001|Overall Study|Adverse Event|5|||
143230130|NCT00880620|516390977|FG002|Overall Study|Adverse Event|15|||
143230131|NCT00880620|516390978|FG003|Overall Study|Adverse Event|15|||
143230132|NCT00880620|516390975|FG000|Overall Study|Death|0|||
143279975|NCT02966028|516578880|FG000|Overall Study|Physician Decision|1|||
143279976|NCT02966028|516578881|FG001|Overall Study|Physician Decision|0|||
143279977|NCT02966028|516578882|FG002|Overall Study|Physician Decision|2|||
143230133|NCT00880620|516390976|FG001|Overall Study|Death|0|||
143230134|NCT00880620|516390977|FG002|Overall Study|Death|1|||
143230135|NCT00880620|516390978|FG003|Overall Study|Death|0|||
143230136|NCT00880620|516390975|FG000|Overall Study|Lack of Efficacy|12|||
143230137|NCT00880620|516390976|FG001|Overall Study|Lack of Efficacy|4|||
143230138|NCT00880620|516390977|FG002|Overall Study|Lack of Efficacy|0|||
143279978|NCT02966028|516578880|FG000|Overall Study|Withdrawal by Subject|7|||
143279979|NCT02966028|516578881|FG001|Overall Study|Withdrawal by Subject|5|||
143279980|NCT02966028|516578882|FG002|Overall Study|Withdrawal by Subject|5|||
143279981|NCT02966028|516578880|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
143279982|NCT02966028|516578881|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
143454095|NCT01820585|517206866|FG002|Overall Study|Pregnancy|0|||
143230139|NCT00880620|516390978|FG003|Overall Study|Lack of Efficacy|1|||
143230140|NCT00880620|516390975|FG000|Overall Study|Lost to Follow-up|0|||
143230141|NCT00880620|516390976|FG001|Overall Study|Lost to Follow-up|1|||
143230142|NCT00880620|516390977|FG002|Overall Study|Lost to Follow-up|1|||
143230143|NCT00880620|516390978|FG003|Overall Study|Lost to Follow-up|0|||
143230144|NCT00880620|516390975|FG000|Overall Study|Protocol Violation|0|||
143230145|NCT00880620|516390976|FG001|Overall Study|Protocol Violation|1|||
143230146|NCT00880620|516390977|FG002|Overall Study|Protocol Violation|0|||
143230147|NCT00880620|516390978|FG003|Overall Study|Protocol Violation|2|||
143230148|NCT00880620|516390975|FG000|Overall Study|Withdrawal by Subject|4|||
143230149|NCT00880620|516390976|FG001|Overall Study|Withdrawal by Subject|3|||
143230150|NCT00880620|516390977|FG002|Overall Study|Withdrawal by Subject|1|||
143230151|NCT00880620|516390978|FG003|Overall Study|Withdrawal by Subject|3|||
143230152|NCT00880620|516390975|FG000|Overall Study|Noncompliance|0|||
143230153|NCT00880620|516390976|FG001|Overall Study|Noncompliance|0|||
143230154|NCT00880620|516390977|FG002|Overall Study|Noncompliance|1|||
143230155|NCT00880620|516390978|FG003|Overall Study|Noncompliance|1|||
143230156|NCT00880620|516390975|FG000|Overall Study|Other|1|||
143230157|NCT00880620|516390976|FG001|Overall Study|Other|1|||
143230158|NCT00880620|516390977|FG002|Overall Study|Other|2|||
143230159|NCT00880620|516390978|FG003|Overall Study|Other|2|||
143230160|NCT05893862|516390979|FG000|Overall Study|Physician Decision|0|||
143230161|NCT05893862|516390980|FG001|Overall Study|Physician Decision|1|||
143230162|NCT05893862|516390981|FG002|Overall Study|Physician Decision|0|||
143230163|NCT05893862|516390982|FG003|Overall Study|Physician Decision|0|||
143230164|NCT05893862|516390983|FG004|Overall Study|Physician Decision|1|||
143230165|NCT05893862|516390984|FG005|Overall Study|Physician Decision|0|||
143230166|NCT05893862|516390979|FG000|Overall Study|Withdrawal by Subject|1|||
143230167|NCT05893862|516390980|FG001|Overall Study|Withdrawal by Subject|7|||
143230168|NCT05893862|516390981|FG002|Overall Study|Withdrawal by Subject|1|||
143230169|NCT05893862|516390982|FG003|Overall Study|Withdrawal by Subject|3|||
143230170|NCT05893862|516390983|FG004|Overall Study|Withdrawal by Subject|3|||
143230171|NCT05893862|516390984|FG005|Overall Study|Withdrawal by Subject|2|||
143230172|NCT05893862|516390979|FG000|Overall Study|Adverse Event|1|||
143230173|NCT05893862|516390980|FG001|Overall Study|Adverse Event|4|||
143230174|NCT05893862|516390981|FG002|Overall Study|Adverse Event|2|||
143230175|NCT05893862|516390982|FG003|Overall Study|Adverse Event|2|||
143230176|NCT05893862|516390983|FG004|Overall Study|Adverse Event|1|||
143230177|NCT05893862|516390984|FG005|Overall Study|Adverse Event|0|||
143230178|NCT01400698|516390985|FG000|Overall Study|Lost to Follow-up|2|||
143230179|NCT01400698|516390986|FG001|Overall Study|Lost to Follow-up|5|||
143230180|NCT01400698|516390987|FG002|Overall Study|Lost to Follow-up|2|||
143230181|NCT01400698|516390988|FG003|Overall Study|Lost to Follow-up|1|||
143230182|NCT01400698|516390989|FG004|Overall Study|Lost to Follow-up|4|||
143230183|NCT01400698|516390990|FG005|Overall Study|Lost to Follow-up|3|||
143230184|NCT01400698|516390985|FG000|Overall Study|Withdrawal by Subject|8|||
143230185|NCT01400698|516390986|FG001|Overall Study|Withdrawal by Subject|2|||
143230186|NCT01400698|516390987|FG002|Overall Study|Withdrawal by Subject|0|||
143230187|NCT01400698|516390988|FG003|Overall Study|Withdrawal by Subject|4|||
143230188|NCT01400698|516390989|FG004|Overall Study|Withdrawal by Subject|1|||
143230189|NCT01400698|516390990|FG005|Overall Study|Withdrawal by Subject|3|||
143230190|NCT01400698|516390985|FG000|Overall Study|Protocol Violation|0|||
143230191|NCT01400698|516390986|FG001|Overall Study|Protocol Violation|1|||
143230192|NCT01400698|516390987|FG002|Overall Study|Protocol Violation|0|||
143230193|NCT01400698|516390988|FG003|Overall Study|Protocol Violation|0|||
143230194|NCT01400698|516390989|FG004|Overall Study|Protocol Violation|1|||
143230195|NCT01400698|516390990|FG005|Overall Study|Protocol Violation|0|||
143230196|NCT01400698|516390985|FG000|Overall Study|Non-compliance|0|||
143230197|NCT01400698|516390986|FG001|Overall Study|Non-compliance|1|||
143230198|NCT01400698|516390987|FG002|Overall Study|Non-compliance|0|||
143230199|NCT01400698|516390988|FG003|Overall Study|Non-compliance|1|||
143230200|NCT01400698|516390989|FG004|Overall Study|Non-compliance|0|||
143230201|NCT01400698|516390990|FG005|Overall Study|Non-compliance|0|||
143230202|NCT01400698|516390985|FG000|Overall Study|Adverse Event|1|||
143230203|NCT01400698|516390986|FG001|Overall Study|Adverse Event|0|||
143230204|NCT01400698|516390987|FG002|Overall Study|Adverse Event|0|||
143230205|NCT01400698|516390988|FG003|Overall Study|Adverse Event|0|||
143230206|NCT01400698|516390989|FG004|Overall Study|Adverse Event|0|||
143230207|NCT01400698|516390990|FG005|Overall Study|Adverse Event|0|||
143230208|NCT01400698|516390985|FG000|Overall Study|Other|4|||
143230209|NCT01400698|516390986|FG001|Overall Study|Other|2|||
143230210|NCT01400698|516390987|FG002|Overall Study|Other|0|||
143454096|NCT01820585|517206867|FG003|Overall Study|Pregnancy|0|||
143454097|NCT00548262|517206868|FG000|Overall Study|Death|21|||
143230211|NCT01400698|516390988|FG003|Overall Study|Other|2|||
143230212|NCT01400698|516390989|FG004|Overall Study|Other|1|||
143230213|NCT01400698|516390990|FG005|Overall Study|Other|0|||
143230214|NCT02919761|516390991|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
143230215|NCT02919761|516390992|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
143230216|NCT02919761|516390993|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
143230217|NCT02919761|516390991|FG000|Part 1: Open Label|Adverse Event|1|||
143230218|NCT02919761|516390992|FG001|Part 1: Open Label|Adverse Event|0|||
143230219|NCT02919761|516390993|FG002|Part 1: Open Label|Adverse Event|0|||
143230220|NCT02919761|516390991|FG000|Part 1: Open Label|Lost to Follow-up|1|||
143230221|NCT02919761|516390992|FG001|Part 1: Open Label|Lost to Follow-up|0|||
143230222|NCT02919761|516390993|FG002|Part 1: Open Label|Lost to Follow-up|0|||
143230223|NCT02919761|516390991|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
143230224|NCT02919761|516390992|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
143230225|NCT02919761|516390993|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
143230226|NCT02919761|516390991|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
143230227|NCT02919761|516390992|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
143230228|NCT02919761|516390993|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
143230229|NCT02919761|516390991|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
143230230|NCT02919761|516390992|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
143230231|NCT02919761|516390993|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
143230232|NCT02919761|516390991|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
143230233|NCT02919761|516390992|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
143230234|NCT02919761|516390993|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
143230235|NCT02919761|516390991|FG000|Part 1: Open Label|Termination by Sponsor|1|||
143230236|NCT02919761|516390992|FG001|Part 1: Open Label|Termination by Sponsor|0|||
143230237|NCT02919761|516390993|FG002|Part 1: Open Label|Termination by Sponsor|0|||
143230238|NCT02919761|516390991|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
143230239|NCT02919761|516390992|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
143230240|NCT02919761|516390993|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
143230241|NCT02919761|516390991|FG000|Part 2: Double-blind|Adverse Event|0|||
143230242|NCT02919761|516390992|FG001|Part 2: Double-blind|Adverse Event|1|||
143230243|NCT02919761|516390993|FG002|Part 2: Double-blind|Adverse Event|0|||
143230244|NCT02919761|516390991|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
143230245|NCT02919761|516390992|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
143230246|NCT02919761|516390993|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
143230247|NCT02919761|516390991|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
143230248|NCT02919761|516390992|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
143230249|NCT02919761|516390993|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
143230250|NCT02919761|516390991|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
143230251|NCT02919761|516390992|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
143230252|NCT02919761|516390993|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
143230253|NCT02919761|516390991|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
143230254|NCT02919761|516390992|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
143230255|NCT02919761|516390993|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
143230256|NCT02919761|516390991|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
143230257|NCT02919761|516390992|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
143230258|NCT02919761|516390993|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
143230259|NCT02919761|516390991|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
143230260|NCT02919761|516390992|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
143230261|NCT02919761|516390993|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
143279983|NCT02966028|516578882|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
143279984|NCT00599924|516578884|FG000|Overall Study|Lack of Efficacy|3|||
143279985|NCT00599924|516578885|FG001|Overall Study|Lack of Efficacy|5|||
143279986|NCT00599924|516578886|FG002|Overall Study|Lack of Efficacy|1|||
143279987|NCT00599924|516578887|FG003|Overall Study|Lack of Efficacy|2|||
143279988|NCT00599924|516578888|FG004|Overall Study|Lack of Efficacy|3|||
143279989|NCT00599924|516578889|FG005|Overall Study|Lack of Efficacy|2|||
143279990|NCT00599924|516578890|FG006|Overall Study|Lack of Efficacy|0|||
143279991|NCT00599924|516578884|FG000|Overall Study|Adverse Event|0|||
143279992|NCT00599924|516578885|FG001|Overall Study|Adverse Event|0|||
143279993|NCT00599924|516578886|FG002|Overall Study|Adverse Event|0|||
143279994|NCT00599924|516578887|FG003|Overall Study|Adverse Event|2|||
143279995|NCT00599924|516578888|FG004|Overall Study|Adverse Event|0|||
143279996|NCT00599924|516578889|FG005|Overall Study|Adverse Event|0|||
143279997|NCT00599924|516578890|FG006|Overall Study|Adverse Event|2|||
143279998|NCT00599924|516578884|FG000|Overall Study|Death|0|||
143279999|NCT00599924|516578885|FG001|Overall Study|Death|0|||
143280000|NCT00599924|516578886|FG002|Overall Study|Death|0|||
143280001|NCT00599924|516578887|FG003|Overall Study|Death|2|||
143280002|NCT00599924|516578888|FG004|Overall Study|Death|0|||
143280003|NCT00599924|516578889|FG005|Overall Study|Death|2|||
143280004|NCT00599924|516578890|FG006|Overall Study|Death|1|||
143280005|NCT00599924|516578884|FG000|Overall Study|Protocol Violation|0|||
143280006|NCT00599924|516578885|FG001|Overall Study|Protocol Violation|0|||
143280007|NCT00599924|516578886|FG002|Overall Study|Protocol Violation|0|||
143280008|NCT00599924|516578887|FG003|Overall Study|Protocol Violation|1|||
143280009|NCT00599924|516578888|FG004|Overall Study|Protocol Violation|0|||
143280010|NCT00599924|516578889|FG005|Overall Study|Protocol Violation|0|||
143280011|NCT00599924|516578890|FG006|Overall Study|Protocol Violation|0|||
143280012|NCT00599924|516578884|FG000|Overall Study|Withdrawal by Subject|0|||
143280013|NCT00599924|516578885|FG001|Overall Study|Withdrawal by Subject|0|||
143280014|NCT00599924|516578886|FG002|Overall Study|Withdrawal by Subject|1|||
143280015|NCT00599924|516578887|FG003|Overall Study|Withdrawal by Subject|0|||
143280016|NCT00599924|516578888|FG004|Overall Study|Withdrawal by Subject|1|||
143280017|NCT00599924|516578889|FG005|Overall Study|Withdrawal by Subject|0|||
143280018|NCT00599924|516578890|FG006|Overall Study|Withdrawal by Subject|0|||
143280019|NCT00599924|516578884|FG000|Overall Study|Other|0|||
143280020|NCT00599924|516578885|FG001|Overall Study|Other|0|||
143280021|NCT00599924|516578886|FG002|Overall Study|Other|0|||
143280022|NCT00599924|516578887|FG003|Overall Study|Other|1|||
143280023|NCT00599924|516578888|FG004|Overall Study|Other|2|||
143280024|NCT00599924|516578889|FG005|Overall Study|Other|0|||
143280025|NCT00599924|516578890|FG006|Overall Study|Other|2|||
143280026|NCT01806298|516578891|FG000|Overall Study|Adverse Event|3|||
143280027|NCT01806298|516578891|FG000|Overall Study|Protocol Non-compliance|1|||
143280028|NCT01806298|516578891|FG000|Overall Study|Withdrawal by Subject|1|||
143280029|NCT01806298|516578891|FG000|Overall Study|Other|5|||
143280030|NCT00980057|516578892|FG000|Overall Study|Death|13|||
143280031|NCT00980057|516578893|FG001|Overall Study|Death|3|||
143280032|NCT00980057|516578892|FG000|Overall Study|Adverse Event|0|||
143280033|NCT00980057|516578893|FG001|Overall Study|Adverse Event|1|||
143280034|NCT00980057|516578892|FG000|Overall Study|Physician Decision|4|||
143280035|NCT00980057|516578893|FG001|Overall Study|Physician Decision|0|||
143280036|NCT00980057|516578892|FG000|Overall Study|Lost to Follow-up|1|||
143280037|NCT00980057|516578893|FG001|Overall Study|Lost to Follow-up|0|||
143280038|NCT00980057|516578892|FG000|Overall Study|Withdrawal by Subject|1|||
143280039|NCT00980057|516578893|FG001|Overall Study|Withdrawal by Subject|1|||
143280040|NCT04980040|516578894|FG000|Overall Study|Violated the Inclusion Criteria|260|||
143280041|NCT04980040|516578894|FG000|Overall Study|Violated the Administration & Dosage|225|||
143280042|NCT04980040|516578894|FG000|Overall Study|Lost to Safety-Follow-up|4|||
143280043|NCT04980040|516578894|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
143280044|NCT00691015|516578898|FG000|Overall Study|Refused further treatment|1|||
143280045|NCT01397084|516578899|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
143280046|NCT01397084|516578899|FG000|Overall Study|Protocol Violation|2|||
143280047|NCT01397084|516578899|FG000|Overall Study|Adverse Event|2|||
143280048|NCT01397084|516578899|FG000|Overall Study|Withdrawal by Subject|1|||
143280049|NCT01397084|516578899|FG000|Overall Study|Lost to Follow-up|1|||
143280050|NCT01397084|516578899|FG000|Overall Study|Used other proton pump inhibitor|1|||
143280051|NCT00592384|516578904|FG000|Overall Study|Withdrawal by Subject|5|||
143280052|NCT00592384|516578905|FG001|Overall Study|Withdrawal by Subject|6|||
143280053|NCT01976338|516578906|FG000|Overall Study|Physician Decision|0|||
143280054|NCT01976338|516578907|FG001|Overall Study|Physician Decision|1|||
143280055|NCT01976338|516578906|FG000|Overall Study|Lost to Follow-up|3|||
143280056|NCT01976338|516578907|FG001|Overall Study|Lost to Follow-up|0|||
143280057|NCT01976338|516578906|FG000|Overall Study|Withdrawal by Subject|5|||
143280058|NCT01976338|516578907|FG001|Overall Study|Withdrawal by Subject|2|||
143280059|NCT01976338|516578906|FG000|Overall Study|Adverse Event|5|||
143280060|NCT01976338|516578907|FG001|Overall Study|Adverse Event|1|||
143280061|NCT02853604|516578908|FG000|Overall Study|Withdrawal by Subject|12|||
143280062|NCT02853604|516578909|FG001|Overall Study|Withdrawal by Subject|35|||
143280063|NCT02853604|516578908|FG000|Overall Study|Lost to Follow-up|4|||
143280064|NCT02853604|516578909|FG001|Overall Study|Lost to Follow-up|8|||
143280065|NCT02853604|516578908|FG000|Overall Study|Death|1|||
143280066|NCT02853604|516578909|FG001|Overall Study|Death|5|||
143280067|NCT02853604|516578908|FG000|Overall Study|Miscellaneous|11|||
143280068|NCT02853604|516578909|FG001|Overall Study|Miscellaneous|2|||
143280069|NCT02853604|516578908|FG000|Overall Study|Progressive Disease|0|||
143280070|NCT02853604|516578909|FG001|Overall Study|Progressive Disease|2|||
143280071|NCT03716024|516578911|FG000|Overall Study|Randomized, not Treated|7|||
143280072|NCT03716024|516578912|FG001|Overall Study|Randomized, not Treated|8|||
143280073|NCT03716024|516578911|FG000|Overall Study|Adverse Event|1|||
143280074|NCT03716024|516578912|FG001|Overall Study|Adverse Event|2|||
143280075|NCT03716024|516578911|FG000|Overall Study|Treatment Failure|1|||
143280076|NCT03716024|516578912|FG001|Overall Study|Treatment Failure|0|||
143280077|NCT03716024|516578911|FG000|Overall Study|Lost to Follow-up|2|||
143280078|NCT03716024|516578912|FG001|Overall Study|Lost to Follow-up|6|||
143280079|NCT03716024|516578911|FG000|Overall Study|Withdrawal by Subject|0|||
143280080|NCT03716024|516578912|FG001|Overall Study|Withdrawal by Subject|1|||
143280081|NCT03716024|516578911|FG000|Overall Study|Missing Reason|0|||
143280082|NCT03716024|516578912|FG001|Overall Study|Missing Reason|1|||
143280083|NCT00587054|516578923|FG000|Overall Study|Patient not treated|9|||
143280084|NCT03010176|516578925|FG000|Overall Study|Death|21|||
143280085|NCT03010176|516578926|FG001|Overall Study|Death|35|||
143280086|NCT03010176|516578927|FG002|Overall Study|Death|19|||
143280087|NCT03010176|516578928|FG003|Overall Study|Death|19|||
143280088|NCT03010176|516578929|FG004|Overall Study|Death|14|||
143280089|NCT03010176|516578930|FG005|Overall Study|Death|0|||
143280090|NCT03010176|516578925|FG000|Overall Study|Lost to Follow-up|0|||
143280091|NCT03010176|516578926|FG001|Overall Study|Lost to Follow-up|0|||
143280092|NCT03010176|516578927|FG002|Overall Study|Lost to Follow-up|0|||
143280093|NCT03010176|516578928|FG003|Overall Study|Lost to Follow-up|0|||
143280094|NCT03010176|516578929|FG004|Overall Study|Lost to Follow-up|1|||
143280095|NCT03010176|516578930|FG005|Overall Study|Lost to Follow-up|0|||
143280096|NCT03010176|516578925|FG000|Overall Study|Physician Decision|0|||
143280097|NCT03010176|516578926|FG001|Overall Study|Physician Decision|4|||
143280098|NCT03010176|516578927|FG002|Overall Study|Physician Decision|0|||
143280099|NCT03010176|516578928|FG003|Overall Study|Physician Decision|1|||
143280100|NCT03010176|516578929|FG004|Overall Study|Physician Decision|0|||
143280101|NCT03010176|516578930|FG005|Overall Study|Physician Decision|0|||
143280102|NCT03010176|516578925|FG000|Overall Study|Sponsor Decision|0|||
143280103|NCT03010176|516578926|FG001|Overall Study|Sponsor Decision|4|||
143280104|NCT03010176|516578927|FG002|Overall Study|Sponsor Decision|4|||
143280105|NCT03010176|516578928|FG003|Overall Study|Sponsor Decision|1|||
143280106|NCT03010176|516578929|FG004|Overall Study|Sponsor Decision|6|||
143280107|NCT03010176|516578930|FG005|Overall Study|Sponsor Decision|0|||
143280108|NCT03010176|516578925|FG000|Overall Study|Withdrawal by Subject|11|||
143280109|NCT03010176|516578926|FG001|Overall Study|Withdrawal by Subject|9|||
143280110|NCT03010176|516578927|FG002|Overall Study|Withdrawal by Subject|3|||
143280111|NCT03010176|516578928|FG003|Overall Study|Withdrawal by Subject|0|||
143280112|NCT03010176|516578929|FG004|Overall Study|Withdrawal by Subject|4|||
143280113|NCT03010176|516578930|FG005|Overall Study|Withdrawal by Subject|0|||
143280114|NCT01651039|516578933|FG000|Overall Study|Non-evaluables|5|||
143280115|NCT01651039|516578933|FG000|Overall Study|Physician Decision|2|||
143280116|NCT01651039|516578933|FG000|Overall Study|Withdrawal by Subject|1|||
143280117|NCT01651039|516578933|FG000|Overall Study|Progressive Disease|22|||
143280118|NCT03600818|516578934|FG000|Overall Study|Adverse Event|4|||
143280119|NCT03600818|516578935|FG001|Overall Study|Adverse Event|7|||
143280120|NCT03600818|516578934|FG000|Overall Study|Lack of Efficacy|9|||
143280121|NCT03600818|516578935|FG001|Overall Study|Lack of Efficacy|4|||
143280122|NCT03600818|516578934|FG000|Overall Study|Withdrawal by Subject|4|||
143280123|NCT03600818|516578935|FG001|Overall Study|Withdrawal by Subject|3|||
143280124|NCT03600818|516578934|FG000|Overall Study|Other-unspecified|5|||
143280125|NCT03600818|516578935|FG001|Overall Study|Other-unspecified|3|||
143280126|NCT03600818|516578934|FG000|Overall Study|Randomized and not treated|0|||
143280127|NCT03600818|516578935|FG001|Overall Study|Randomized and not treated|1|||
143280128|NCT01488370|516578936|FG000|Overall Study|Protocol Violation|0|||
143280129|NCT01488370|516578937|FG001|Overall Study|Protocol Violation|1|||
143280130|NCT01488370|516578938|FG002|Overall Study|Protocol Violation|1|||
143280131|NCT00968513|516578943|FG000|Overall Study|Death|4|||
143280132|NCT00968513|516578944|FG001|Overall Study|Death|10|||
143280133|NCT00968513|516578945|FG002|Overall Study|Death|15|||
143280134|NCT01203098|516578946|FG000|Overall Study|Adverse Event|3|||
143280135|NCT01203098|516578947|FG001|Overall Study|Adverse Event|1|||
143280136|NCT01203098|516578948|FG002|Overall Study|Adverse Event|7|||
143280137|NCT01203098|516578946|FG000|Overall Study|Lost to Follow-up|0|||
143280138|NCT01203098|516578947|FG001|Overall Study|Lost to Follow-up|0|||
143280139|NCT01203098|516578948|FG002|Overall Study|Lost to Follow-up|1|||
143280140|NCT01203098|516578946|FG000|Overall Study|Physician Decision|2|||
143280141|NCT01203098|516578947|FG001|Overall Study|Physician Decision|2|||
143280142|NCT01203098|516578948|FG002|Overall Study|Physician Decision|0|||
143280143|NCT01203098|516578946|FG000|Overall Study|Withdrawal by Subject|1|||
143280144|NCT01203098|516578947|FG001|Overall Study|Withdrawal by Subject|1|||
143280145|NCT01203098|516578948|FG002|Overall Study|Withdrawal by Subject|3|||
143280146|NCT00730405|516578949|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
143280147|NCT00730405|516578950|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
143280148|NCT00730405|516578951|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
143280149|NCT00730405|516578952|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
143280150|NCT00730405|516578953|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
143280151|NCT00730405|516578949|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
143280152|NCT00730405|516578950|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
143280153|NCT00730405|516578951|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
143280154|NCT00730405|516578952|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
143280155|NCT00730405|516578953|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
143280156|NCT00730405|516578949|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
143280157|NCT00730405|516578950|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
143280158|NCT00730405|516578951|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
143280159|NCT00730405|516578952|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
143280160|NCT00730405|516578953|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
143280161|NCT00730405|516578949|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
143280162|NCT00730405|516578950|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
143280163|NCT00730405|516578951|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
143280164|NCT00730405|516578952|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
143280165|NCT00730405|516578953|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
143280166|NCT00730405|516578949|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
143280167|NCT00730405|516578950|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
143280168|NCT00730405|516578951|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
143280169|NCT00730405|516578952|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
143280170|NCT00730405|516578953|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
143280171|NCT00730405|516578949|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
143280172|NCT00730405|516578950|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
143280173|NCT00730405|516578951|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
143280174|NCT00730405|516578952|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
143280175|NCT00730405|516578953|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
143280176|NCT00730405|516578949|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
143280177|NCT00730405|516578950|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
143280178|NCT00730405|516578951|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
143280179|NCT00730405|516578952|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
143280180|NCT00730405|516578953|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
143280181|NCT00730405|516578949|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
143280182|NCT00730405|516578950|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
143280183|NCT00730405|516578951|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
143280184|NCT00730405|516578952|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
143280185|NCT00730405|516578953|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
143280186|NCT00730405|516578949|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
143280187|NCT00730405|516578950|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
143280188|NCT00730405|516578951|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
143280189|NCT00730405|516578952|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
143280190|NCT00730405|516578953|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
143280191|NCT00730405|516578949|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
143280192|NCT00730405|516578950|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
143280193|NCT00730405|516578951|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
143280194|NCT00730405|516578952|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
143280195|NCT00730405|516578953|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
143280196|NCT00730405|516578949|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
143280197|NCT00730405|516578950|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
143280198|NCT00730405|516578951|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
143280199|NCT00730405|516578952|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
143280200|NCT00730405|516578953|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
143280201|NCT00730405|516578949|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
143280202|NCT00730405|516578950|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
143280203|NCT00730405|516578951|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
143280204|NCT00730405|516578952|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
143280205|NCT00730405|516578953|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
143280206|NCT00730405|516578949|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
143280207|NCT00730405|516578950|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
143280208|NCT00730405|516578951|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
143280209|NCT00730405|516578952|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
143280210|NCT00730405|516578953|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
143280211|NCT00730405|516578949|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
143280212|NCT00730405|516578950|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
143454098|NCT00548262|517206868|FG000|Overall Study|Adverse Event|2|||
143454099|NCT00548262|517206868|FG000|Overall Study|Lack of Efficacy|4|||
143454100|NCT00548262|517206868|FG000|Overall Study|Lost to Follow-up|1|||
143454101|NCT00548262|517206868|FG000|Overall Study|Other|3|||
143454102|NCT00548262|517206868|FG000|Overall Study|Withdrawal by Subject|1|||
143454103|NCT02544451|517206869|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
143454104|NCT02544451|517206870|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
143454105|NCT02544451|517206871|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
143454106|NCT02544451|517206872|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
143280213|NCT00730405|516578951|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
143280214|NCT00730405|516578952|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
143280215|NCT00730405|516578953|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
143280216|NCT00730405|516578949|FG000|Overall Study-Treatment Phase|Change of location|0|||
143280217|NCT00730405|516578950|FG001|Overall Study-Treatment Phase|Change of location|0|||
143280218|NCT00730405|516578951|FG002|Overall Study-Treatment Phase|Change of location|0|||
143280219|NCT00730405|516578952|FG003|Overall Study-Treatment Phase|Change of location|1|||
143280220|NCT00730405|516578953|FG004|Overall Study-Treatment Phase|Change of location|0|||
143280221|NCT00730405|516578949|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
143280222|NCT00730405|516578950|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
143280223|NCT00730405|516578951|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
143280224|NCT00730405|516578952|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
143280225|NCT00730405|516578953|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
143280226|NCT00730405|516578949|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
143280227|NCT00730405|516578950|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
143280228|NCT00730405|516578951|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
143280229|NCT00730405|516578952|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
143280230|NCT00730405|516578953|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
143280231|NCT00730405|516578949|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
143280232|NCT00730405|516578950|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
143280233|NCT00730405|516578951|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
143280234|NCT00730405|516578952|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
143280235|NCT00730405|516578953|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
143280236|NCT00730405|516578949|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
143280237|NCT00730405|516578950|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
143280238|NCT00730405|516578951|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
143280239|NCT00730405|516578952|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
143280240|NCT00730405|516578953|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
143280241|NCT00730405|516578949|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
143280242|NCT00730405|516578950|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
143280243|NCT00730405|516578951|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
143280244|NCT00730405|516578952|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
143280245|NCT00730405|516578953|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
143280246|NCT00730405|516578949|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
143280247|NCT00730405|516578950|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
143280248|NCT00730405|516578951|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
143280249|NCT00730405|516578952|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
143280250|NCT00730405|516578953|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
143280251|NCT00730405|516578949|FG000|Overall Study-follow-up Phase|Death|0|||
143280252|NCT00730405|516578950|FG001|Overall Study-follow-up Phase|Death|1|||
143280253|NCT00730405|516578951|FG002|Overall Study-follow-up Phase|Death|0|||
143280254|NCT00730405|516578952|FG003|Overall Study-follow-up Phase|Death|1|||
143280255|NCT00730405|516578953|FG004|Overall Study-follow-up Phase|Death|0|||
143280256|NCT00730405|516578949|FG000|Overall Study-follow-up Phase|Change of location|1|||
143280257|NCT00730405|516578950|FG001|Overall Study-follow-up Phase|Change of location|1|||
143280258|NCT00730405|516578951|FG002|Overall Study-follow-up Phase|Change of location|0|||
143280259|NCT00730405|516578952|FG003|Overall Study-follow-up Phase|Change of location|1|||
143280260|NCT00730405|516578953|FG004|Overall Study-follow-up Phase|Change of location|0|||
143280261|NCT00730405|516578949|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
143280262|NCT00730405|516578950|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
143280263|NCT00730405|516578951|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
143280264|NCT00730405|516578952|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
143280265|NCT00730405|516578953|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
143280266|NCT00730405|516578949|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
143280267|NCT00730405|516578950|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
143280268|NCT00730405|516578951|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
143280269|NCT00730405|516578952|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
143280270|NCT00730405|516578953|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
143280271|NCT00730405|516578949|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
143280272|NCT00730405|516578950|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
143280273|NCT00730405|516578951|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
143280274|NCT00730405|516578952|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
143280275|NCT00730405|516578953|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
143280276|NCT00730405|516578949|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
143280277|NCT00730405|516578950|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
143280278|NCT00730405|516578951|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
143280279|NCT00730405|516578952|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
143280280|NCT00730405|516578953|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
143280281|NCT00730405|516578949|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
143280282|NCT00730405|516578950|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
143280283|NCT00730405|516578951|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
143280284|NCT00730405|516578952|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
143280285|NCT00730405|516578953|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
143280286|NCT00730405|516578949|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
143280287|NCT00730405|516578950|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
143280288|NCT00730405|516578951|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
143280289|NCT00730405|516578952|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
143280290|NCT00730405|516578953|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
143280291|NCT00730405|516578949|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
143280292|NCT00730405|516578950|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
143280293|NCT00730405|516578951|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
143280294|NCT00730405|516578952|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
143280295|NCT00730405|516578953|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
143280296|NCT00730405|516578949|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
143280297|NCT00730405|516578950|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
143280298|NCT00730405|516578951|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
143280299|NCT00730405|516578952|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
143280300|NCT00730405|516578953|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
143280301|NCT00730405|516578949|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
143280302|NCT00730405|516578950|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
143280303|NCT00730405|516578951|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
143280304|NCT00730405|516578952|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
143280305|NCT00730405|516578953|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
143280306|NCT00730405|516578949|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
143280307|NCT00730405|516578950|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
143280308|NCT00730405|516578951|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
143280309|NCT00730405|516578952|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
143280310|NCT00730405|516578953|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
143280311|NCT00730405|516578949|FG000|Overall Study-follow-up Phase|Missing|0|||
143280312|NCT00730405|516578950|FG001|Overall Study-follow-up Phase|Missing|0|||
143280313|NCT00730405|516578951|FG002|Overall Study-follow-up Phase|Missing|2|||
143280314|NCT00730405|516578952|FG003|Overall Study-follow-up Phase|Missing|0|||
143280315|NCT00730405|516578953|FG004|Overall Study-follow-up Phase|Missing|0|||
143280316|NCT00730405|516578949|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
143280317|NCT00730405|516578950|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
143280318|NCT00730405|516578951|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
143280319|NCT00730405|516578952|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
143280320|NCT00730405|516578953|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
143280321|NCT00730405|516578949|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
143280322|NCT00730405|516578950|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
143280323|NCT00730405|516578951|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
143280324|NCT00730405|516578952|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
143280325|NCT00730405|516578953|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
143280326|NCT00730405|516578949|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
143280327|NCT00730405|516578950|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
143280328|NCT00730405|516578951|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
143280329|NCT00730405|516578952|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
143280330|NCT00730405|516578953|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
143280331|NCT00730405|516578949|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
143280332|NCT00730405|516578950|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
143280333|NCT00730405|516578951|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
143280334|NCT00730405|516578952|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
143280335|NCT00730405|516578953|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
143280336|NCT00730405|516578949|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
143280337|NCT00730405|516578950|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
143280338|NCT00730405|516578951|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
143280339|NCT00730405|516578952|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
143280340|NCT00730405|516578953|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
143280341|NCT00730405|516578949|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
143280342|NCT00730405|516578950|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
143280343|NCT00730405|516578951|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
143280344|NCT00730405|516578952|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
143280345|NCT00730405|516578953|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
143280346|NCT00963937|516578957|FG000|Overall Study|Protocol Violation|1|||
143280347|NCT00963937|516578958|FG001|Overall Study|Protocol Violation|1|||
143280348|NCT00963937|516578959|FG002|Overall Study|Protocol Violation|0|||
143280349|NCT00963937|516578957|FG000|Overall Study|Physician Decision|18|||
143280350|NCT00963937|516578958|FG001|Overall Study|Physician Decision|10|||
143280351|NCT00963937|516578959|FG002|Overall Study|Physician Decision|4|||
143280352|NCT00913497|516578960|FG000|Overall Study|Adverse Event|1|||
143280353|NCT00913497|516578960|FG000|Overall Study|Withdrawal by Subject|2|||
143280354|NCT03190915|516578961|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
143280355|NCT03190915|516578961|FG000|Overall Study|Progressive Disease|3|||
143280356|NCT00530946|516578962|FG000|Overall Study|Adverse Event|1|||
143280357|NCT00530946|516578963|FG001|Overall Study|Adverse Event|2|||
143280358|NCT00530946|516578964|FG002|Overall Study|Adverse Event|1|||
143280359|NCT00530946|516578965|FG003|Overall Study|Adverse Event|1|||
143280360|NCT00530946|516578962|FG000|Overall Study|Protocol Violation|0|||
143280361|NCT00530946|516578963|FG001|Overall Study|Protocol Violation|0|||
143280362|NCT00530946|516578964|FG002|Overall Study|Protocol Violation|0|||
143280363|NCT00530946|516578965|FG003|Overall Study|Protocol Violation|1|||
143280364|NCT00530946|516578962|FG000|Overall Study|Noncompliance|1|||
143280365|NCT00530946|516578963|FG001|Overall Study|Noncompliance|0|||
143280366|NCT00530946|516578964|FG002|Overall Study|Noncompliance|0|||
143280367|NCT00530946|516578965|FG003|Overall Study|Noncompliance|0|||
143280368|NCT00457301|516578966|FG000|Overall Study|Withdrawal by Subject|3|||
143280369|NCT00457301|516578967|FG001|Overall Study|Withdrawal by Subject|3|||
143280370|NCT00457301|516578966|FG000|Overall Study|Censored out of the study|15|||
143280371|NCT00457301|516578967|FG001|Overall Study|Censored out of the study|14|||
143280372|NCT00457301|516578966|FG000|Overall Study|Death|5|||
143280373|NCT00457301|516578967|FG001|Overall Study|Death|7|||
143280374|NCT04528732|516578970|FG000|Overall Study|Death|1|||
143280375|NCT04528732|516578971|FG001|Overall Study|Death|0|||
143280376|NCT04528732|516578972|FG002|Overall Study|Death|1|||
143280377|NCT04528732|516578970|FG000|Overall Study|Lost to Follow-up|0|||
143280378|NCT04528732|516578971|FG001|Overall Study|Lost to Follow-up|1|||
143280379|NCT04528732|516578972|FG002|Overall Study|Lost to Follow-up|2|||
143280380|NCT00668707|516578973|FG000|Overall Study|Cancer Recurrence|58|||
143280381|NCT00668707|516578974|FG001|Overall Study|Cancer Recurrence|58|||
143280382|NCT00668707|516578973|FG000|Overall Study|Withdrawal by Subject|117|||
143280383|NCT00668707|516578974|FG001|Overall Study|Withdrawal by Subject|100|||
143280384|NCT00668707|516578973|FG000|Overall Study|Lost to Follow-up|3|||
143280385|NCT00668707|516578974|FG001|Overall Study|Lost to Follow-up|6|||
143280386|NCT00668707|516578973|FG000|Overall Study|Protocol Violation|10|||
143280387|NCT00668707|516578974|FG001|Overall Study|Protocol Violation|12|||
143280388|NCT00668707|516578973|FG000|Overall Study|Death|11|||
143280389|NCT00668707|516578974|FG001|Overall Study|Death|4|||
143280390|NCT00826943|516578975|FG000|Overall Study|Withdrawal by Subject|0|||
143280391|NCT00826943|516578976|FG001|Overall Study|Withdrawal by Subject|0|||
143280392|NCT00826943|516578977|FG002|Overall Study|Withdrawal by Subject|0|||
143280393|NCT00826943|516578978|FG003|Overall Study|Withdrawal by Subject|0|||
143280394|NCT00826943|516578979|FG004|Overall Study|Withdrawal by Subject|1|||
143280395|NCT00826943|516578980|FG005|Overall Study|Withdrawal by Subject|0|||
143280396|NCT01382212|516578981|FG000|Overall Study|Kidney transplant|1|||
143280397|NCT01382212|516578981|FG000|Overall Study|Withdrew consent|1|||
143280398|NCT00621985|516581032|FG000|Dexamethasone Admission|Adverse Event|1|||
143280399|NCT02151591|516581038|FG000|Overall Study|Lost to Follow-up|6|||
143280400|NCT02151591|516581039|FG001|Overall Study|Lost to Follow-up|3|||
143280401|NCT03555591|516581042|FG000|Overall Study|Protocol Violation|77|||
143280402|NCT03633695|516581043|FG000|Overall Study|Lost to Follow-up|4|||
143280403|NCT03633695|516581044|FG001|Overall Study|Lost to Follow-up|5|||
143280404|NCT03633695|516581043|FG000|Overall Study|Discontinued|8|||
143280405|NCT03633695|516581044|FG001|Overall Study|Discontinued|4|||
143280406|NCT00684593|516581045|FG000|Overall Study|Adverse Event|0|||
143280407|NCT00684593|516581046|FG001|Overall Study|Adverse Event|2|||
143280408|NCT00617773|516581054|FG000|Overall Study|Physician Decision|1|||
143280409|NCT00617773|516581054|FG000|Overall Study|Lack of compliance with the protocol|1|||
143280410|NCT00617773|516581054|FG000|Overall Study|Withdrawal by Subject|1|||
143280411|NCT00617773|516581054|FG000|Overall Study|Death|1|||
143280412|NCT00617773|516581054|FG000|Overall Study|Progressive disease|19|||
143280413|NCT00617773|516581054|FG000|Overall Study|Protocol Violation|1|||
143280414|NCT03130257|516581055|FG000|Overall Study|Withdrawal by Subject|1|||
143280415|NCT03130257|516581056|FG001|Overall Study|Withdrawal by Subject|0|||
143280416|NCT03130257|516581057|FG002|Overall Study|Withdrawal by Subject|2|||
143280417|NCT05526716|516581059|FG000|Overall Study|Death|1|||
143280418|NCT05526716|516581060|FG001|Overall Study|Death|2|||
143280419|NCT05526716|516581059|FG000|Overall Study|Lost to Follow-up|17|||
143280420|NCT05526716|516581060|FG001|Overall Study|Lost to Follow-up|15|||
143280421|NCT05526716|516581059|FG000|Overall Study|Physician Decision|0|||
143280422|NCT05526716|516581060|FG001|Overall Study|Physician Decision|1|||
143280423|NCT05526716|516581059|FG000|Overall Study|Randomized by mistake without study treatment|0|||
143280424|NCT05526716|516581060|FG001|Overall Study|Randomized by mistake without study treatment|1|||
143280425|NCT05526716|516581059|FG000|Overall Study|Withdrawal by Subject|12|||
143280426|NCT05526716|516581060|FG001|Overall Study|Withdrawal by Subject|12|||
143280427|NCT05526716|516581059|FG000|Overall Study|Not reported|0|||
143280428|NCT05526716|516581060|FG001|Overall Study|Not reported|2|||
143280429|NCT01751867|516581061|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
143280430|NCT01751867|516581062|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
143280431|NCT01751867|516581061|FG000|Overall Study|Diease Progression|4|||
143280432|NCT01751867|516581062|FG001|Overall Study|Diease Progression|18|||
143280433|NCT01751867|516581061|FG000|Overall Study|Adverse Event|8|||
143280434|NCT01751867|516581062|FG001|Overall Study|Adverse Event|15|||
143280435|NCT01751867|516581061|FG000|Overall Study|Poor Compliance|0|||
143280436|NCT01751867|516581062|FG001|Overall Study|Poor Compliance|5|||
143280437|NCT01751867|516581061|FG000|Overall Study|Withdrawal by Subject|3|||
143280438|NCT01751867|516581062|FG001|Overall Study|Withdrawal by Subject|1|||
143280439|NCT01751867|516581061|FG000|Overall Study|Physician Decision|4|||
143280440|NCT01751867|516581062|FG001|Overall Study|Physician Decision|7|||
143280441|NCT01751867|516581061|FG000|Overall Study|Protocol Violation|0|||
143280442|NCT01751867|516581062|FG001|Overall Study|Protocol Violation|2|||
143280443|NCT01751867|516581061|FG000|Overall Study|Death|0|||
143280444|NCT01751867|516581062|FG001|Overall Study|Death|5|||
143280445|NCT01751867|516581061|FG000|Overall Study|Other|11|||
143280446|NCT01751867|516581062|FG001|Overall Study|Other|37|||
143280447|NCT01751867|516581061|FG000|Overall Study|Randomized but not treated.|2|||
143280448|NCT01751867|516581062|FG001|Overall Study|Randomized but not treated.|1|||
143280449|NCT01438957|516581063|FG000|Overall Study|Physician Decision|1|||
143280450|NCT01438957|516581064|FG001|Overall Study|Physician Decision|1|||
143280451|NCT01438957|516581065|FG002|Overall Study|Physician Decision|0|||
143280452|NCT01438957|516581066|FG003|Overall Study|Physician Decision|1|||
143280453|NCT01438957|516581067|FG004|Overall Study|Physician Decision|0|||
143280454|NCT01396148|516581068|FG000|Overall Study|Patient Decision|1|||
143280455|NCT03095066|516581069|FG000|Overall Study (Baseline to Week 12)|Adverse Event|3|||
143280456|NCT03095066|516581070|FG001|Overall Study (Baseline to Week 12)|Adverse Event|6|||
143280457|NCT03095066|516581071|FG002|Overall Study (Baseline to Week 12)|Adverse Event|0|||
143280458|NCT03095066|516581072|FG003|Overall Study (Baseline to Week 12)|Adverse Event|0|||
143280459|NCT03095066|516581073|FG004|Overall Study (Baseline to Week 12)|Adverse Event|0|||
143280460|NCT03095066|516581074|FG005|Overall Study (Baseline to Week 12)|Adverse Event|0|||
143280461|NCT03095066|516581075|FG006|Overall Study (Baseline to Week 12)|Adverse Event|0|||
143280462|NCT03095066|516581076|FG007|Overall Study (Baseline to Week 12)|Adverse Event|0|||
143280463|NCT03095066|516581069|FG000|Overall Study (Baseline to Week 12)|Lost to Follow-up|6|||
143280464|NCT03095066|516581070|FG001|Overall Study (Baseline to Week 12)|Lost to Follow-up|1|||
143280465|NCT03095066|516581071|FG002|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
143280466|NCT03095066|516581072|FG003|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
143280467|NCT03095066|516581073|FG004|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
143280468|NCT03095066|516581074|FG005|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
143280469|NCT03095066|516581075|FG006|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
143280470|NCT03095066|516581076|FG007|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
143280471|NCT03095066|516581069|FG000|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|2|||
143280472|NCT03095066|516581070|FG001|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|1|||
143280473|NCT03095066|516581071|FG002|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
143280474|NCT03095066|516581072|FG003|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
143280475|NCT03095066|516581073|FG004|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
143280476|NCT03095066|516581074|FG005|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
143280477|NCT03095066|516581075|FG006|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
143280478|NCT03095066|516581076|FG007|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
143280479|NCT03095066|516581069|FG000|Overall Study (Baseline to Week 12)|Physician Decision|0|||
143280480|NCT03095066|516581070|FG001|Overall Study (Baseline to Week 12)|Physician Decision|1|||
143280481|NCT03095066|516581071|FG002|Overall Study (Baseline to Week 12)|Physician Decision|0|||
143280482|NCT03095066|516581072|FG003|Overall Study (Baseline to Week 12)|Physician Decision|0|||
143280483|NCT03095066|516581073|FG004|Overall Study (Baseline to Week 12)|Physician Decision|0|||
143280484|NCT03095066|516581074|FG005|Overall Study (Baseline to Week 12)|Physician Decision|0|||
143280485|NCT03095066|516581075|FG006|Overall Study (Baseline to Week 12)|Physician Decision|0|||
143280486|NCT03095066|516581076|FG007|Overall Study (Baseline to Week 12)|Physician Decision|0|||
143280487|NCT03095066|516581069|FG000|Overall Study (Baseline to Week 12)|Protocol Deviation|1|||
143280488|NCT03095066|516581070|FG001|Overall Study (Baseline to Week 12)|Protocol Deviation|2|||
143280489|NCT03095066|516581071|FG002|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
143280490|NCT03095066|516581072|FG003|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
143373053|NCT03175172|516911362|FG000|Overall Study|Withdrawal by Subject|3|||
143373054|NCT03175172|516911362|FG000|Overall Study|Lost to Follow-up|1|||
143280491|NCT03095066|516581073|FG004|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
143280492|NCT03095066|516581074|FG005|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
143280493|NCT03095066|516581075|FG006|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
143280494|NCT03095066|516581076|FG007|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
143280495|NCT03095066|516581069|FG000|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|1|||
143280496|NCT03095066|516581070|FG001|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
143280497|NCT03095066|516581071|FG002|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
143280498|NCT03095066|516581072|FG003|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
143280499|NCT03095066|516581073|FG004|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
143280500|NCT03095066|516581074|FG005|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
143280501|NCT03095066|516581075|FG006|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
143280502|NCT03095066|516581076|FG007|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
143280503|NCT03095066|516581069|FG000|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
143280504|NCT03095066|516581070|FG001|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
143280505|NCT03095066|516581071|FG002|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
143280506|NCT03095066|516581072|FG003|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
143280507|NCT03095066|516581073|FG004|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
143280508|NCT03095066|516581074|FG005|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
143280509|NCT03095066|516581075|FG006|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
143280510|NCT03095066|516581076|FG007|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
143280511|NCT03095066|516581069|FG000|Overall Study (Baseline to Week 12)|Reason not Specified|8|||
143280512|NCT03095066|516581070|FG001|Overall Study (Baseline to Week 12)|Reason not Specified|2|||
143280513|NCT03095066|516581071|FG002|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
143280514|NCT03095066|516581072|FG003|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
143280515|NCT03095066|516581073|FG004|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
143280516|NCT03095066|516581074|FG005|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
143280517|NCT03095066|516581075|FG006|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
143280518|NCT03095066|516581076|FG007|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
143280519|NCT03095066|516581069|FG000|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
143280520|NCT03095066|516581070|FG001|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
143280521|NCT03095066|516581071|FG002|Stage 1 (Baseline to Week 6)|Adverse Event|2|||
143280522|NCT03095066|516581072|FG003|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
143280523|NCT03095066|516581073|FG004|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
143280524|NCT03095066|516581074|FG005|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
143280525|NCT03095066|516581075|FG006|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
143280526|NCT03095066|516581076|FG007|Stage 1 (Baseline to Week 6)|Adverse Event|6|||
143280527|NCT03095066|516581069|FG000|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
143280528|NCT03095066|516581070|FG001|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
143280529|NCT03095066|516581071|FG002|Stage 1 (Baseline to Week 6)|Lost to Follow-up|3|||
143280530|NCT03095066|516581072|FG003|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
143280531|NCT03095066|516581073|FG004|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
143280532|NCT03095066|516581074|FG005|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
143280533|NCT03095066|516581075|FG006|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
143280534|NCT03095066|516581076|FG007|Stage 1 (Baseline to Week 6)|Lost to Follow-up|1|||
143280535|NCT03095066|516581069|FG000|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
143280536|NCT03095066|516581070|FG001|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
143280537|NCT03095066|516581071|FG002|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|2|||
143280538|NCT03095066|516581072|FG003|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
143280539|NCT03095066|516581073|FG004|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
143280540|NCT03095066|516581074|FG005|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
143280541|NCT03095066|516581075|FG006|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
143280542|NCT03095066|516581076|FG007|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|1|||
143280543|NCT03095066|516581069|FG000|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
143280544|NCT03095066|516581070|FG001|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
143280545|NCT03095066|516581071|FG002|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|2|||
143280546|NCT03095066|516581072|FG003|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
143280547|NCT03095066|516581073|FG004|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
143280548|NCT03095066|516581074|FG005|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
143280549|NCT03095066|516581075|FG006|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
143280550|NCT03095066|516581076|FG007|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|3|||
143280551|NCT03095066|516581069|FG000|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
143280552|NCT03095066|516581070|FG001|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
143373055|NCT03175172|516911362|FG000|Overall Study|Study Terminated by Sponsor|3|||
143373056|NCT03169244|516911363|FG000|Overall Study|Lost to Follow-up|1|||
143280553|NCT03095066|516581071|FG002|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|1|||
143280554|NCT03095066|516581072|FG003|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
143280555|NCT03095066|516581073|FG004|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
143280556|NCT03095066|516581074|FG005|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
143280557|NCT03095066|516581075|FG006|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
143280558|NCT03095066|516581076|FG007|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
143280559|NCT03095066|516581069|FG000|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
143280560|NCT03095066|516581070|FG001|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
143280561|NCT03095066|516581071|FG002|Stage 1 (Baseline to Week 6)|Reason Not Specified|5|||
143280562|NCT03095066|516581072|FG003|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
143280563|NCT03095066|516581073|FG004|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
143280564|NCT03095066|516581074|FG005|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
143280565|NCT03095066|516581075|FG006|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
143280566|NCT03095066|516581076|FG007|Stage 1 (Baseline to Week 6)|Reason Not Specified|2|||
143280567|NCT03095066|516581069|FG000|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
143280568|NCT03095066|516581070|FG001|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
143280569|NCT03095066|516581071|FG002|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
143280570|NCT03095066|516581072|FG003|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
143280571|NCT03095066|516581073|FG004|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
143280572|NCT03095066|516581074|FG005|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
143280573|NCT03095066|516581075|FG006|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
143280574|NCT03095066|516581076|FG007|Stage 1 (Baseline to Week 6)|Physician Decision|1|||
143280575|NCT03095066|516581069|FG000|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
143280576|NCT03095066|516581070|FG001|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
143280577|NCT03095066|516581071|FG002|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
143280578|NCT03095066|516581072|FG003|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
143280579|NCT03095066|516581073|FG004|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
143280580|NCT03095066|516581074|FG005|Stage 2 (Week 7 to Week 12)|Adverse Event|1|||
143280581|NCT03095066|516581075|FG006|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
143280582|NCT03095066|516581076|FG007|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
143280583|NCT03095066|516581069|FG000|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
143280584|NCT03095066|516581070|FG001|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
143280585|NCT03095066|516581071|FG002|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
143280586|NCT03095066|516581072|FG003|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
143280587|NCT03095066|516581073|FG004|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|1|||
143280588|NCT03095066|516581074|FG005|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
143280589|NCT03095066|516581075|FG006|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|2|||
143280590|NCT03095066|516581076|FG007|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
143280591|NCT03095066|516581069|FG000|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
143280592|NCT03095066|516581070|FG001|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
143280593|NCT03095066|516581071|FG002|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
143280594|NCT03095066|516581072|FG003|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
143280595|NCT03095066|516581073|FG004|Stage 2 (Week 7 to Week 12)|Protocol Deviation|1|||
143280596|NCT03095066|516581074|FG005|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
143280597|NCT03095066|516581075|FG006|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
143280598|NCT03095066|516581076|FG007|Stage 2 (Week 7 to Week 12)|Protocol Deviation|2|||
143280599|NCT03095066|516581069|FG000|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
143280600|NCT03095066|516581070|FG001|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
143280601|NCT03095066|516581071|FG002|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
143280602|NCT03095066|516581072|FG003|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
143280603|NCT03095066|516581073|FG004|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|2|||
143280604|NCT03095066|516581074|FG005|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
143280605|NCT03095066|516581075|FG006|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
143280606|NCT03095066|516581076|FG007|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|1|||
143280607|NCT03095066|516581069|FG000|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
143280608|NCT03095066|516581070|FG001|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
143280609|NCT03095066|516581071|FG002|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
143280610|NCT03095066|516581072|FG003|Stage 2 (Week 7 to Week 12)|Reason Not Specified|2|||
143280611|NCT03095066|516581073|FG004|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
143280612|NCT03095066|516581074|FG005|Stage 2 (Week 7 to Week 12)|Reason Not Specified|1|||
143280613|NCT03095066|516581075|FG006|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
143280614|NCT03095066|516581076|FG007|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
143280615|NCT00160693|516581077|FG000|Overall Study|Adverse Event|97|||
143280616|NCT00160693|516581077|FG000|Overall Study|Lack of Efficacy|30|||
143280617|NCT00160693|516581077|FG000|Overall Study|Protocol Violation|24|||
143280618|NCT00160693|516581077|FG000|Overall Study|Lost to Follow-up|15|||
143373057|NCT03169244|516911364|FG001|Overall Study|Lost to Follow-up|2|||
143373058|NCT03169244|516911363|FG000|Overall Study|Adverse Event|1|||
143280619|NCT00160693|516581077|FG000|Overall Study|Withdrawal by Subject|54|||
143280620|NCT00160693|516581077|FG000|Overall Study|Study terminated by sponsor|15|||
143373059|NCT03169244|516911364|FG001|Overall Study|Adverse Event|0|||
143280621|NCT02170298|516581082|FG000|Overall Study|Withdrawal by Subject|0|||
143280622|NCT02170298|516581083|FG001|Overall Study|Withdrawal by Subject|1|||
143280623|NCT02170298|516581082|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
143280624|NCT02170298|516581083|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
143280625|NCT00777608|516581084|FG000|Overall Study|Lost to Follow-up|1|||
143280626|NCT00777608|516581085|FG001|Overall Study|Lost to Follow-up|1|||
143280627|NCT00777608|516581084|FG000|Overall Study|Withdrawal by Subject|1|||
143280628|NCT00777608|516581085|FG001|Overall Study|Withdrawal by Subject|3|||
143280629|NCT00777608|516581084|FG000|Overall Study|Protocol Violation|1|||
143280630|NCT00777608|516581085|FG001|Overall Study|Protocol Violation|0|||
143280631|NCT00777608|516581084|FG000|Overall Study|Investigator Decision|1|||
143280632|NCT00777608|516581085|FG001|Overall Study|Investigator Decision|2|||
143280633|NCT04213079|516581086|FG000|Overall Study|Lost to Follow-up|0|||
143280634|NCT04213079|516581087|FG001|Overall Study|Lost to Follow-up|2|||
143280635|NCT03766581|516581088|FG000|Randomization|Other reasons|2|||
143280636|NCT03766581|516581089|FG001|Randomization|Other reasons|1|||
143280637|NCT03766581|516581090|FG002|Randomization|Other reasons|0|||
143280638|NCT03766581|516581091|FG003|Randomization|Other reasons|1|||
143280639|NCT03766581|516581092|FG004|Randomization|Other reasons|0|||
143280640|NCT03766581|516581093|FG005|Randomization|Other reasons|0|||
143280641|NCT03766581|516581094|FG006|Randomization|Other reasons|0|||
143280642|NCT03766581|516581095|FG007|Randomization|Other reasons|0|||
143280643|NCT03766581|516581088|FG000|Randomization|Participant no longer meets study criteria|5|||
143280644|NCT03766581|516581089|FG001|Randomization|Participant no longer meets study criteria|3|||
143280645|NCT03766581|516581090|FG002|Randomization|Participant no longer meets study criteria|4|||
143280646|NCT03766581|516581091|FG003|Randomization|Participant no longer meets study criteria|0|||
143280647|NCT03766581|516581092|FG004|Randomization|Participant no longer meets study criteria|2|||
143280648|NCT03766581|516581093|FG005|Randomization|Participant no longer meets study criteria|3|||
143280649|NCT03766581|516581094|FG006|Randomization|Participant no longer meets study criteria|0|||
143280650|NCT03766581|516581095|FG007|Randomization|Participant no longer meets study criteria|1|||
143280651|NCT03766581|516581088|FG000|Randomization|Participant request to discontinue study treatment|1|||
143280652|NCT03766581|516581089|FG001|Randomization|Participant request to discontinue study treatment|0|||
143280653|NCT03766581|516581090|FG002|Randomization|Participant request to discontinue study treatment|0|||
143280654|NCT03766581|516581091|FG003|Randomization|Participant request to discontinue study treatment|0|||
143280655|NCT03766581|516581092|FG004|Randomization|Participant request to discontinue study treatment|1|||
143280656|NCT03766581|516581093|FG005|Randomization|Participant request to discontinue study treatment|2|||
143280657|NCT03766581|516581094|FG006|Randomization|Participant request to discontinue study treatment|0|||
143280658|NCT03766581|516581095|FG007|Randomization|Participant request to discontinue study treatment|0|||
143280659|NCT03766581|516581088|FG000|Randomization|Participant withdrew consent|1|||
143280660|NCT03766581|516581089|FG001|Randomization|Participant withdrew consent|0|||
143280661|NCT03766581|516581090|FG002|Randomization|Participant withdrew consent|1|||
143280662|NCT03766581|516581091|FG003|Randomization|Participant withdrew consent|2|||
143280663|NCT03766581|516581092|FG004|Randomization|Participant withdrew consent|1|||
143280664|NCT03766581|516581093|FG005|Randomization|Participant withdrew consent|1|||
143280665|NCT03766581|516581094|FG006|Randomization|Participant withdrew consent|0|||
143280666|NCT03766581|516581095|FG007|Randomization|Participant withdrew consent|0|||
143280667|NCT03766581|516581088|FG000|Treatment|Adverse Event|82|||
143280668|NCT03766581|516581089|FG001|Treatment|Adverse Event|44|||
143280669|NCT03766581|516581090|FG002|Treatment|Adverse Event|47|||
143280670|NCT03766581|516581091|FG003|Treatment|Adverse Event|46|||
143280671|NCT03766581|516581092|FG004|Treatment|Adverse Event|50|||
143280672|NCT03766581|516581093|FG005|Treatment|Adverse Event|77|||
143280673|NCT03766581|516581094|FG006|Treatment|Adverse Event|5|||
143280674|NCT03766581|516581095|FG007|Treatment|Adverse Event|2|||
143280675|NCT03766581|516581088|FG000|Treatment|Participant request to discontinue treatment|34|||
143280676|NCT03766581|516581089|FG001|Treatment|Participant request to discontinue treatment|6|||
143280677|NCT03766581|516581090|FG002|Treatment|Participant request to discontinue treatment|10|||
143280678|NCT03766581|516581091|FG003|Treatment|Participant request to discontinue treatment|10|||
143280679|NCT03766581|516581092|FG004|Treatment|Participant request to discontinue treatment|14|||
143280680|NCT03766581|516581093|FG005|Treatment|Participant request to discontinue treatment|15|||
143280681|NCT03766581|516581094|FG006|Treatment|Participant request to discontinue treatment|0|||
143373060|NCT03169244|516911363|FG000|Overall Study|Withdrawal by Subject|2|||
143280682|NCT03766581|516581095|FG007|Treatment|Participant request to discontinue treatment|1|||
143280683|NCT03766581|516581088|FG000|Treatment|Participant withdrew consent|11|||
143280684|NCT03766581|516581089|FG001|Treatment|Participant withdrew consent|4|||
143280685|NCT03766581|516581090|FG002|Treatment|Participant withdrew consent|5|||
143280686|NCT03766581|516581091|FG003|Treatment|Participant withdrew consent|5|||
143280687|NCT03766581|516581092|FG004|Treatment|Participant withdrew consent|4|||
143373061|NCT03169244|516911364|FG001|Overall Study|Withdrawal by Subject|2|||
143280688|NCT03766581|516581093|FG005|Treatment|Participant withdrew consent|4|||
143280689|NCT03766581|516581094|FG006|Treatment|Participant withdrew consent|0|||
143373062|NCT03169244|516911363|FG000|Overall Study|Physician Decision|1|||
143280690|NCT03766581|516581095|FG007|Treatment|Participant withdrew consent|0|||
143280691|NCT03766581|516581088|FG000|Treatment|Death|1|||
143280692|NCT03766581|516581089|FG001|Treatment|Death|0|||
143280693|NCT03766581|516581090|FG002|Treatment|Death|0|||
143280694|NCT03766581|516581091|FG003|Treatment|Death|0|||
143280695|NCT03766581|516581092|FG004|Treatment|Death|0|||
143280696|NCT03766581|516581093|FG005|Treatment|Death|0|||
143280697|NCT03766581|516581094|FG006|Treatment|Death|0|||
143280698|NCT03766581|516581095|FG007|Treatment|Death|0|||
143280699|NCT03766581|516581088|FG000|Treatment|Lost to Follow-up|1|||
143280700|NCT03766581|516581089|FG001|Treatment|Lost to Follow-up|0|||
143280701|NCT03766581|516581090|FG002|Treatment|Lost to Follow-up|0|||
143280702|NCT03766581|516581091|FG003|Treatment|Lost to Follow-up|1|||
143280703|NCT03766581|516581092|FG004|Treatment|Lost to Follow-up|0|||
143280704|NCT03766581|516581093|FG005|Treatment|Lost to Follow-up|0|||
143280705|NCT03766581|516581094|FG006|Treatment|Lost to Follow-up|0|||
143280706|NCT03766581|516581095|FG007|Treatment|Lost to Follow-up|0|||
143280707|NCT03766581|516581088|FG000|Treatment|Poor/Non compliance|2|||
143280708|NCT03766581|516581089|FG001|Treatment|Poor/Non compliance|2|||
143280709|NCT03766581|516581090|FG002|Treatment|Poor/Non compliance|1|||
143280710|NCT03766581|516581091|FG003|Treatment|Poor/Non compliance|1|||
143280711|NCT03766581|516581092|FG004|Treatment|Poor/Non compliance|1|||
143280712|NCT03766581|516581093|FG005|Treatment|Poor/Non compliance|1|||
143280713|NCT03766581|516581094|FG006|Treatment|Poor/Non compliance|0|||
143280714|NCT03766581|516581095|FG007|Treatment|Poor/Non compliance|0|||
143280715|NCT03766581|516581088|FG000|Treatment|Participant no longer meets study criteria|9|||
143280716|NCT03766581|516581089|FG001|Treatment|Participant no longer meets study criteria|1|||
143280717|NCT03766581|516581090|FG002|Treatment|Participant no longer meets study criteria|5|||
143280718|NCT03766581|516581091|FG003|Treatment|Participant no longer meets study criteria|4|||
143280719|NCT03766581|516581092|FG004|Treatment|Participant no longer meets study criteria|4|||
143280720|NCT03766581|516581093|FG005|Treatment|Participant no longer meets study criteria|4|||
143280721|NCT03766581|516581094|FG006|Treatment|Participant no longer meets study criteria|2|||
143280722|NCT03766581|516581095|FG007|Treatment|Participant no longer meets study criteria|0|||
143280723|NCT03766581|516581088|FG000|Treatment|Other reasons|13|||
143280724|NCT03766581|516581089|FG001|Treatment|Other reasons|8|||
143280725|NCT03766581|516581090|FG002|Treatment|Other reasons|3|||
143280726|NCT03766581|516581091|FG003|Treatment|Other reasons|7|||
143280727|NCT03766581|516581092|FG004|Treatment|Other reasons|3|||
143280728|NCT03766581|516581093|FG005|Treatment|Other reasons|3|||
143280729|NCT03766581|516581094|FG006|Treatment|Other reasons|0|||
143280730|NCT03766581|516581095|FG007|Treatment|Other reasons|0|||
143280731|NCT04182763|516581096|FG000|Double-Blind Period, initial 6 months|Physician Decision|0|||
143280732|NCT04182763|516581097|FG001|Double-Blind Period, initial 6 months|Physician Decision|0|||
143280733|NCT04182763|516581098|FG002|Double-Blind Period, initial 6 months|Physician Decision|0|||
143280734|NCT04182763|516581099|FG003|Double-Blind Period, initial 6 months|Physician Decision|1|||
143280735|NCT04182763|516581100|FG004|Double-Blind Period, initial 6 months|Physician Decision|0|||
143280736|NCT04182763|516581096|FG000|Double-Blind Period, initial 6 months|Death|0|||
143280737|NCT04182763|516581097|FG001|Double-Blind Period, initial 6 months|Death|1|||
143280738|NCT04182763|516581098|FG002|Double-Blind Period, initial 6 months|Death|0|||
143280739|NCT04182763|516581099|FG003|Double-Blind Period, initial 6 months|Death|0|||
143280740|NCT04182763|516581100|FG004|Double-Blind Period, initial 6 months|Death|0|||
143280741|NCT04182763|516581096|FG000|Open-Label Period, subsequent 18 months|Death|3|||
143280742|NCT04182763|516581097|FG001|Open-Label Period, subsequent 18 months|Death|2|||
143280743|NCT04182763|516581098|FG002|Open-Label Period, subsequent 18 months|Death|2|||
143280744|NCT04182763|516581099|FG003|Open-Label Period, subsequent 18 months|Death|0|||
143280745|NCT04182763|516581100|FG004|Open-Label Period, subsequent 18 months|Death|1|||
143280746|NCT04182763|516581096|FG000|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
143280747|NCT04182763|516581097|FG001|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
143280748|NCT04182763|516581098|FG002|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
143280749|NCT04182763|516581099|FG003|Open-Label Period, subsequent 18 months|Withdrawal by Subject|0|||
143280750|NCT04182763|516581100|FG004|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
143280751|NCT04182763|516581096|FG000|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
143280752|NCT04182763|516581097|FG001|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|4|||
143280753|NCT04182763|516581098|FG002|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
143280754|NCT04182763|516581099|FG003|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
143280755|NCT04182763|516581100|FG004|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|0|||
143280756|NCT05988619|516581102|FG000|Overall Study|Lost to Follow-up|1|||
143280757|NCT05988619|516581103|FG001|Overall Study|Lost to Follow-up|4|||
143280758|NCT05988619|516581102|FG000|Overall Study|Withdrawal by Subject|2|||
143280759|NCT05988619|516581103|FG001|Overall Study|Withdrawal by Subject|9|||
143280760|NCT01471171|516581106|FG000|Treatment Period 1|Adverse Event|4|||
143280761|NCT01471171|516581107|FG001|Treatment Period 1|Adverse Event|1|||
143280762|NCT01471171|516581106|FG000|Treatment Period 2|Adverse Event|1|||
143280763|NCT01471171|516581107|FG001|Treatment Period 2|Adverse Event|0|||
143280764|NCT00553644|516581110|FG000|Overall Study|Adverse Event|17|||
143280765|NCT00553644|516581110|FG000|Overall Study|Withdrawal by Subject|4|||
143280766|NCT00553644|516581110|FG000|Overall Study|Physician Decision|1|||
143280767|NCT00553644|516581110|FG000|Overall Study|Alternative therapy|6|||
143280768|NCT00705484|516581111|FG000|Overall Study|Adverse Event|28|||
143280769|NCT00705484|516581112|FG001|Overall Study|Adverse Event|27|||
143280770|NCT00705484|516581111|FG000|Overall Study|Lost to Follow-up|169|||
143280771|NCT00705484|516581112|FG001|Overall Study|Lost to Follow-up|250|||
143280772|NCT00705484|516581111|FG000|Overall Study|Withdrawal by Subject|96|||
143280773|NCT00705484|516581112|FG001|Overall Study|Withdrawal by Subject|72|||
143280774|NCT00705484|516581111|FG000|Overall Study|Administrative|89|||
143280775|NCT00705484|516581112|FG001|Overall Study|Administrative|59|||
143280776|NCT00119106|516581114|FG000|Overall Study|HIV infected at baseline|179|||
143280777|NCT00119106|516581115|FG001|Overall Study|HIV infected at baseline|178|||
143280778|NCT01010061|516581116|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
143280779|NCT01010061|516581117|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
143280780|NCT01010061|516581116|FG000|Overall Study|Disease Progression|2|||
143280781|NCT01010061|516581117|FG001|Overall Study|Disease Progression|8|||
143280782|NCT01010061|516581116|FG000|Overall Study|Withdrew Consent|5|||
143280783|NCT01010061|516581117|FG001|Overall Study|Withdrew Consent|1|||
143280784|NCT01010061|516581116|FG000|Overall Study|Death|3|||
143280785|NCT01010061|516581117|FG001|Overall Study|Death|6|||
143280786|NCT01010061|516581116|FG000|Overall Study|Administrative/Other|0|||
143280787|NCT01010061|516581117|FG001|Overall Study|Administrative/Other|1|||
143280788|NCT01010061|516581116|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
143280789|NCT01010061|516581117|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
143280790|NCT01010061|516581116|FG000|Overall Study|Insufficient Therapeutic Response|1|||
143280791|NCT01010061|516581117|FG001|Overall Study|Insufficient Therapeutic Response|5|||
143280792|NCT01010061|516581116|FG000|Overall Study|Violation of Selection Criteria|0|||
143280793|NCT01010061|516581117|FG001|Overall Study|Violation of Selection Criteria|1|||
143280794|NCT01010061|516581116|FG000|Overall Study|Did Not Receive Treatment|2|||
143280795|NCT01010061|516581117|FG001|Overall Study|Did Not Receive Treatment|2|||
143280796|NCT03470441|516581121|FG000|Overall Study|Death|0|||
143280797|NCT03470441|516581122|FG001|Overall Study|Death|1|||
143280798|NCT03470441|516581123|FG002|Overall Study|Death|1|||
143280799|NCT03470441|516581124|FG003|Overall Study|Death|0|||
143280800|NCT03470441|516581121|FG000|Overall Study|Adverse Event|0|||
143280801|NCT03470441|516581122|FG001|Overall Study|Adverse Event|0|||
143280802|NCT03470441|516581123|FG002|Overall Study|Adverse Event|0|||
143280803|NCT03470441|516581124|FG003|Overall Study|Adverse Event|1|||
143280804|NCT03470441|516581121|FG000|Overall Study|Withdrawal by Subject|1|||
143280805|NCT03470441|516581122|FG001|Overall Study|Withdrawal by Subject|4|||
143280806|NCT03470441|516581123|FG002|Overall Study|Withdrawal by Subject|1|||
143280807|NCT03470441|516581124|FG003|Overall Study|Withdrawal by Subject|3|||
143280808|NCT02883049|516581125|FG000|Induction|Adverse Event|52|||
143280809|NCT02883049|516581126|FG001|Induction|Adverse Event|2|||
143280810|NCT02883049|516581127|FG002|Induction|Adverse Event|0|||
143280811|NCT02883049|516581128|FG003|Induction|Adverse Event|0|||
143280812|NCT02883049|516581129|FG004|Induction|Adverse Event|0|||
143280813|NCT02883049|516581130|FG005|Induction|Adverse Event|0|||
143280814|NCT02883049|516581131|FG006|Induction|Adverse Event|0|||
143280815|NCT02883049|516581132|FG007|Induction|Adverse Event|0|||
143280816|NCT02883049|516581133|FG008|Induction|Adverse Event|0|||
143280817|NCT02883049|516581134|FG009|Induction|Adverse Event|0|||
143280818|NCT02883049|516581135|FG010|Induction|Adverse Event|0|||
143280819|NCT02883049|516581136|FG011|Induction|Adverse Event|0|||
143280820|NCT02883049|516581137|FG012|Induction|Adverse Event|0|||
143280821|NCT02883049|516581138|FG013|Induction|Adverse Event|0|||
143280822|NCT02883049|516581139|FG014|Induction|Adverse Event|0|||
143280823|NCT02883049|516581140|FG015|Induction|Adverse Event|0|||
143280824|NCT02883049|516581125|FG000|Induction|Death|76|||
143280825|NCT02883049|516581126|FG001|Induction|Death|8|||
143280826|NCT02883049|516581127|FG002|Induction|Death|0|||
143280827|NCT02883049|516581128|FG003|Induction|Death|0|||
143280828|NCT02883049|516581129|FG004|Induction|Death|0|||
143280829|NCT02883049|516581130|FG005|Induction|Death|0|||
143280830|NCT02883049|516581131|FG006|Induction|Death|0|||
143280831|NCT02883049|516581132|FG007|Induction|Death|0|||
143280832|NCT02883049|516581133|FG008|Induction|Death|0|||
143280833|NCT02883049|516581134|FG009|Induction|Death|0|||
143280834|NCT02883049|516581135|FG010|Induction|Death|0|||
143280835|NCT02883049|516581136|FG011|Induction|Death|0|||
143280836|NCT02883049|516581137|FG012|Induction|Death|0|||
143280837|NCT02883049|516581138|FG013|Induction|Death|0|||
143280838|NCT02883049|516581139|FG014|Induction|Death|0|||
143280839|NCT02883049|516581140|FG015|Induction|Death|0|||
143280840|NCT02883049|516581125|FG000|Induction|Lost to Follow-up|2|||
143280841|NCT02883049|516581126|FG001|Induction|Lost to Follow-up|0|||
143280842|NCT02883049|516581127|FG002|Induction|Lost to Follow-up|0|||
143280843|NCT02883049|516581128|FG003|Induction|Lost to Follow-up|0|||
143373063|NCT03169244|516911364|FG001|Overall Study|Physician Decision|0|||
143373064|NCT00178399|516911365|FG000|Overall Study|Physician Decision|4|||
143373065|NCT00178399|516911365|FG000|Overall Study|Withdrawal by Subject|8|||
143373066|NCT00178399|516911365|FG000|Overall Study|Lost to Follow-up|1|||
143373067|NCT00446550|516911368|FG000|Overall Study|Adverse Event|1|||
143373068|NCT00446550|516911369|FG001|Overall Study|Adverse Event|0|||
143373069|NCT02937831|516911370|FG000|Overall Study|Protocol Violation|4|||
143373070|NCT03287622|516911371|FG000|Overall Study|Withdrawal by Subject|1|||
143373071|NCT03287622|516911372|FG001|Overall Study|Withdrawal by Subject|0|||
143373072|NCT03287622|516911371|FG000|Overall Study|Lost to Follow-up|27|||
143373073|NCT03287622|516911372|FG001|Overall Study|Lost to Follow-up|15|||
143373074|NCT03287622|516911371|FG000|Overall Study|No prescripion after surgery|28|||
143373075|NCT03287622|516911372|FG001|Overall Study|No prescripion after surgery|31|||
143373076|NCT03287622|516911371|FG000|Overall Study|prolonged Length of stay|2|||
143373077|NCT03287622|516911372|FG001|Overall Study|prolonged Length of stay|0|||
143373078|NCT03287622|516911371|FG000|Overall Study|surgery related|0|||
143373079|NCT03287622|516911372|FG001|Overall Study|surgery related|2|||
143373080|NCT01930045|516911375|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
143373081|NCT01930045|516911376|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
143373082|NCT01930045|516911377|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
143373083|NCT01930045|516911378|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
143373084|NCT01930045|516911379|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
143373085|NCT01930045|516911380|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
143373086|NCT01930045|516911375|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
143373087|NCT01930045|516911376|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
143373088|NCT01930045|516911377|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
143373089|NCT01930045|516911378|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
143373090|NCT01930045|516911379|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
143373091|NCT01930045|516911380|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
143373092|NCT01087762|516911381|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
143373093|NCT01087762|516911382|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
143373094|NCT01087762|516911383|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
143373095|NCT01087762|516911384|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
143373096|NCT01087762|516911385|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
143373097|NCT01087762|516911381|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
143373098|NCT01087762|516911382|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
143373099|NCT01087762|516911383|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
143373100|NCT01087762|516911384|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
143373101|NCT01087762|516911385|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
143373102|NCT01087762|516911381|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
143373103|NCT01087762|516911382|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
143373104|NCT01087762|516911383|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
143373105|NCT01087762|516911384|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
143373106|NCT01087762|516911385|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
143373107|NCT01087762|516911381|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
143373108|NCT01087762|516911382|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
143373109|NCT01087762|516911383|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
143373110|NCT01087762|516911384|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
143373111|NCT01087762|516911385|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
143373112|NCT01087762|516911381|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
143373113|NCT01087762|516911382|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
143373114|NCT01087762|516911383|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
143373115|NCT01087762|516911384|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
143280844|NCT02883049|516581129|FG004|Induction|Lost to Follow-up|0|||
143280845|NCT02883049|516581130|FG005|Induction|Lost to Follow-up|0|||
143280846|NCT02883049|516581131|FG006|Induction|Lost to Follow-up|0|||
143280847|NCT02883049|516581132|FG007|Induction|Lost to Follow-up|0|||
143280848|NCT02883049|516581133|FG008|Induction|Lost to Follow-up|0|||
143280849|NCT02883049|516581134|FG009|Induction|Lost to Follow-up|0|||
143280850|NCT02883049|516581135|FG010|Induction|Lost to Follow-up|0|||
143373116|NCT01087762|516911385|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
143373117|NCT01087762|516911381|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
143373118|NCT01087762|516911382|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
143280851|NCT02883049|516581136|FG011|Induction|Lost to Follow-up|0|||
143280852|NCT02883049|516581137|FG012|Induction|Lost to Follow-up|0|||
143280853|NCT02883049|516581138|FG013|Induction|Lost to Follow-up|0|||
143280854|NCT02883049|516581139|FG014|Induction|Lost to Follow-up|0|||
143280855|NCT02883049|516581140|FG015|Induction|Lost to Follow-up|0|||
143280856|NCT02883049|516581125|FG000|Induction|Physician Decision|1407|||
143280857|NCT02883049|516581126|FG001|Induction|Physician Decision|8|||
143280858|NCT02883049|516581127|FG002|Induction|Physician Decision|0|||
143280859|NCT02883049|516581128|FG003|Induction|Physician Decision|0|||
143280860|NCT02883049|516581129|FG004|Induction|Physician Decision|0|||
143280861|NCT02883049|516581130|FG005|Induction|Physician Decision|0|||
143280862|NCT02883049|516581131|FG006|Induction|Physician Decision|0|||
143280863|NCT02883049|516581132|FG007|Induction|Physician Decision|0|||
143280864|NCT02883049|516581133|FG008|Induction|Physician Decision|0|||
143280865|NCT02883049|516581134|FG009|Induction|Physician Decision|0|||
143280866|NCT02883049|516581135|FG010|Induction|Physician Decision|0|||
143280867|NCT02883049|516581136|FG011|Induction|Physician Decision|0|||
143280868|NCT02883049|516581137|FG012|Induction|Physician Decision|0|||
143280869|NCT02883049|516581138|FG013|Induction|Physician Decision|0|||
143280870|NCT02883049|516581139|FG014|Induction|Physician Decision|0|||
143280871|NCT02883049|516581140|FG015|Induction|Physician Decision|0|||
143280872|NCT02883049|516581125|FG000|Induction|Protocol Violation|6|||
143280873|NCT02883049|516581126|FG001|Induction|Protocol Violation|0|||
143280874|NCT02883049|516581127|FG002|Induction|Protocol Violation|0|||
143280875|NCT02883049|516581128|FG003|Induction|Protocol Violation|0|||
143280876|NCT02883049|516581129|FG004|Induction|Protocol Violation|0|||
143280877|NCT02883049|516581130|FG005|Induction|Protocol Violation|0|||
143280878|NCT02883049|516581131|FG006|Induction|Protocol Violation|0|||
143280879|NCT02883049|516581132|FG007|Induction|Protocol Violation|0|||
143280880|NCT02883049|516581133|FG008|Induction|Protocol Violation|0|||
143280881|NCT02883049|516581134|FG009|Induction|Protocol Violation|0|||
143280882|NCT02883049|516581135|FG010|Induction|Protocol Violation|0|||
143280883|NCT02883049|516581136|FG011|Induction|Protocol Violation|0|||
143280884|NCT02883049|516581137|FG012|Induction|Protocol Violation|0|||
143280885|NCT02883049|516581138|FG013|Induction|Protocol Violation|0|||
143280886|NCT02883049|516581139|FG014|Induction|Protocol Violation|0|||
143280887|NCT02883049|516581140|FG015|Induction|Protocol Violation|0|||
143280888|NCT02883049|516581125|FG000|Induction|Withdrawal by Subject|6|||
143280889|NCT02883049|516581126|FG001|Induction|Withdrawal by Subject|0|||
143280890|NCT02883049|516581127|FG002|Induction|Withdrawal by Subject|0|||
143280891|NCT02883049|516581128|FG003|Induction|Withdrawal by Subject|0|||
143280892|NCT02883049|516581129|FG004|Induction|Withdrawal by Subject|0|||
143280893|NCT02883049|516581130|FG005|Induction|Withdrawal by Subject|0|||
143280894|NCT02883049|516581131|FG006|Induction|Withdrawal by Subject|0|||
143280895|NCT02883049|516581132|FG007|Induction|Withdrawal by Subject|0|||
143280896|NCT02883049|516581133|FG008|Induction|Withdrawal by Subject|0|||
143280897|NCT02883049|516581134|FG009|Induction|Withdrawal by Subject|0|||
143280898|NCT02883049|516581135|FG010|Induction|Withdrawal by Subject|0|||
143280899|NCT02883049|516581136|FG011|Induction|Withdrawal by Subject|0|||
143280900|NCT02883049|516581137|FG012|Induction|Withdrawal by Subject|0|||
143280901|NCT02883049|516581138|FG013|Induction|Withdrawal by Subject|0|||
143280902|NCT02883049|516581139|FG014|Induction|Withdrawal by Subject|0|||
143280903|NCT02883049|516581140|FG015|Induction|Withdrawal by Subject|0|||
143280904|NCT02883049|516581125|FG000|Induction|Ineligible|35|||
143280905|NCT02883049|516581126|FG001|Induction|Ineligible|1|||
143280906|NCT02883049|516581127|FG002|Induction|Ineligible|0|||
143280907|NCT02883049|516581128|FG003|Induction|Ineligible|0|||
143280908|NCT02883049|516581129|FG004|Induction|Ineligible|0|||
143280909|NCT02883049|516581130|FG005|Induction|Ineligible|0|||
143280910|NCT02883049|516581131|FG006|Induction|Ineligible|0|||
143373119|NCT01087762|516911383|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
143373120|NCT01087762|516911384|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
143280911|NCT02883049|516581132|FG007|Induction|Ineligible|0|||
143280912|NCT02883049|516581133|FG008|Induction|Ineligible|0|||
143280913|NCT02883049|516581134|FG009|Induction|Ineligible|0|||
143280914|NCT02883049|516581135|FG010|Induction|Ineligible|0|||
143373121|NCT01087762|516911385|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
143280915|NCT02883049|516581136|FG011|Induction|Ineligible|0|||
143280916|NCT02883049|516581137|FG012|Induction|Ineligible|0|||
143280917|NCT02883049|516581138|FG013|Induction|Ineligible|0|||
143280918|NCT02883049|516581139|FG014|Induction|Ineligible|0|||
143280919|NCT02883049|516581140|FG015|Induction|Ineligible|0|||
143280920|NCT02883049|516581125|FG000|Induction|Refusal of further protocol therapy|466|||
143280921|NCT02883049|516581126|FG001|Induction|Refusal of further protocol therapy|2|||
143280922|NCT02883049|516581127|FG002|Induction|Refusal of further protocol therapy|0|||
143280923|NCT02883049|516581128|FG003|Induction|Refusal of further protocol therapy|0|||
143280924|NCT02883049|516581129|FG004|Induction|Refusal of further protocol therapy|0|||
143280925|NCT02883049|516581130|FG005|Induction|Refusal of further protocol therapy|0|||
143280926|NCT02883049|516581131|FG006|Induction|Refusal of further protocol therapy|0|||
143280927|NCT02883049|516581132|FG007|Induction|Refusal of further protocol therapy|0|||
143373122|NCT01087762|516911381|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
143373123|NCT01087762|516911382|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
143280928|NCT02883049|516581133|FG008|Induction|Refusal of further protocol therapy|0|||
143280929|NCT02883049|516581134|FG009|Induction|Refusal of further protocol therapy|0|||
143280930|NCT02883049|516581135|FG010|Induction|Refusal of further protocol therapy|0|||
143280931|NCT02883049|516581136|FG011|Induction|Refusal of further protocol therapy|0|||
143280932|NCT02883049|516581137|FG012|Induction|Refusal of further protocol therapy|0|||
143280933|NCT02883049|516581138|FG013|Induction|Refusal of further protocol therapy|0|||
143280934|NCT02883049|516581139|FG014|Induction|Refusal of further protocol therapy|0|||
143280935|NCT02883049|516581140|FG015|Induction|Refusal of further protocol therapy|0|||
143280936|NCT02883049|516581125|FG000|Induction|Identified as Ph+ patients|279|||
143280937|NCT02883049|516581126|FG001|Induction|Identified as Ph+ patients|1|||
143280938|NCT02883049|516581127|FG002|Induction|Identified as Ph+ patients|0|||
143280939|NCT02883049|516581128|FG003|Induction|Identified as Ph+ patients|0|||
143280940|NCT02883049|516581129|FG004|Induction|Identified as Ph+ patients|0|||
143280941|NCT02883049|516581130|FG005|Induction|Identified as Ph+ patients|0|||
143280942|NCT02883049|516581131|FG006|Induction|Identified as Ph+ patients|0|||
143280943|NCT02883049|516581132|FG007|Induction|Identified as Ph+ patients|0|||
143280944|NCT02883049|516581133|FG008|Induction|Identified as Ph+ patients|0|||
143280945|NCT02883049|516581134|FG009|Induction|Identified as Ph+ patients|0|||
143280946|NCT02883049|516581135|FG010|Induction|Identified as Ph+ patients|0|||
143280947|NCT02883049|516581136|FG011|Induction|Identified as Ph+ patients|0|||
143280948|NCT02883049|516581137|FG012|Induction|Identified as Ph+ patients|0|||
143280949|NCT02883049|516581138|FG013|Induction|Identified as Ph+ patients|0|||
143280950|NCT02883049|516581139|FG014|Induction|Identified as Ph+ patients|0|||
143280951|NCT02883049|516581140|FG015|Induction|Identified as Ph+ patients|0|||
143280952|NCT02883049|516581125|FG000|Induction|M3 Marrow at Day29|8|||
143280953|NCT02883049|516581126|FG001|Induction|M3 Marrow at Day29|1|||
143280954|NCT02883049|516581127|FG002|Induction|M3 Marrow at Day29|0|||
143280955|NCT02883049|516581128|FG003|Induction|M3 Marrow at Day29|0|||
143280956|NCT02883049|516581129|FG004|Induction|M3 Marrow at Day29|0|||
143280957|NCT02883049|516581130|FG005|Induction|M3 Marrow at Day29|0|||
143280958|NCT02883049|516581131|FG006|Induction|M3 Marrow at Day29|0|||
143280959|NCT02883049|516581132|FG007|Induction|M3 Marrow at Day29|0|||
143280960|NCT02883049|516581133|FG008|Induction|M3 Marrow at Day29|0|||
143280961|NCT02883049|516581134|FG009|Induction|M3 Marrow at Day29|0|||
143280962|NCT02883049|516581135|FG010|Induction|M3 Marrow at Day29|0|||
143280963|NCT02883049|516581136|FG011|Induction|M3 Marrow at Day29|0|||
143280964|NCT02883049|516581137|FG012|Induction|M3 Marrow at Day29|0|||
143280965|NCT02883049|516581138|FG013|Induction|M3 Marrow at Day29|0|||
143280966|NCT02883049|516581139|FG014|Induction|M3 Marrow at Day29|0|||
143280967|NCT02883049|516581140|FG015|Induction|M3 Marrow at Day29|0|||
143280968|NCT02883049|516581125|FG000|Induction|Inevaluable|33|||
143280969|NCT02883049|516581126|FG001|Induction|Inevaluable|1|||
143280970|NCT02883049|516581127|FG002|Induction|Inevaluable|0|||
143280971|NCT02883049|516581128|FG003|Induction|Inevaluable|0|||
143280972|NCT02883049|516581129|FG004|Induction|Inevaluable|0|||
143280973|NCT02883049|516581130|FG005|Induction|Inevaluable|0|||
143280974|NCT02883049|516581131|FG006|Induction|Inevaluable|0|||
143280975|NCT02883049|516581132|FG007|Induction|Inevaluable|0|||
143280976|NCT02883049|516581133|FG008|Induction|Inevaluable|0|||
143280977|NCT02883049|516581134|FG009|Induction|Inevaluable|0|||
143280978|NCT02883049|516581135|FG010|Induction|Inevaluable|0|||
143280979|NCT02883049|516581136|FG011|Induction|Inevaluable|0|||
143280980|NCT02883049|516581137|FG012|Induction|Inevaluable|0|||
143280981|NCT02883049|516581138|FG013|Induction|Inevaluable|0|||
143280982|NCT02883049|516581139|FG014|Induction|Inevaluable|0|||
143280983|NCT02883049|516581140|FG015|Induction|Inevaluable|0|||
143280984|NCT02883049|516581125|FG000|Induction|Identified as VHR at end of Induction|244|||
143280985|NCT02883049|516581126|FG001|Induction|Identified as VHR at end of Induction|0|||
143280986|NCT02883049|516581127|FG002|Induction|Identified as VHR at end of Induction|0|||
143280987|NCT02883049|516581128|FG003|Induction|Identified as VHR at end of Induction|0|||
143280988|NCT02883049|516581129|FG004|Induction|Identified as VHR at end of Induction|0|||
143280989|NCT02883049|516581130|FG005|Induction|Identified as VHR at end of Induction|0|||
143280990|NCT02883049|516581131|FG006|Induction|Identified as VHR at end of Induction|0|||
143280991|NCT02883049|516581132|FG007|Induction|Identified as VHR at end of Induction|0|||
143280992|NCT02883049|516581133|FG008|Induction|Identified as VHR at end of Induction|0|||
143280993|NCT02883049|516581134|FG009|Induction|Identified as VHR at end of Induction|0|||
143280994|NCT02883049|516581135|FG010|Induction|Identified as VHR at end of Induction|0|||
143280995|NCT02883049|516581136|FG011|Induction|Identified as VHR at end of Induction|0|||
143280996|NCT02883049|516581137|FG012|Induction|Identified as VHR at end of Induction|0|||
143280997|NCT02883049|516581138|FG013|Induction|Identified as VHR at end of Induction|0|||
143280998|NCT02883049|516581139|FG014|Induction|Identified as VHR at end of Induction|0|||
143280999|NCT02883049|516581140|FG015|Induction|Identified as VHR at end of Induction|0|||
143373124|NCT01087762|516911383|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
143373125|NCT01087762|516911384|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
143373126|NCT01087762|516911385|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
143373127|NCT01087762|516911381|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
143281000|NCT02883049|516581125|FG000|Induction|Moved to another non-COG institution|3|||
143281001|NCT02883049|516581126|FG001|Induction|Moved to another non-COG institution|0|||
143281002|NCT02883049|516581127|FG002|Induction|Moved to another non-COG institution|0|||
143281003|NCT02883049|516581128|FG003|Induction|Moved to another non-COG institution|0|||
143281004|NCT02883049|516581129|FG004|Induction|Moved to another non-COG institution|0|||
143281005|NCT02883049|516581130|FG005|Induction|Moved to another non-COG institution|0|||
143281006|NCT02883049|516581131|FG006|Induction|Moved to another non-COG institution|0|||
143281007|NCT02883049|516581132|FG007|Induction|Moved to another non-COG institution|0|||
143281008|NCT02883049|516581133|FG008|Induction|Moved to another non-COG institution|0|||
143281009|NCT02883049|516581134|FG009|Induction|Moved to another non-COG institution|0|||
143281010|NCT02883049|516581135|FG010|Induction|Moved to another non-COG institution|0|||
143281011|NCT02883049|516581136|FG011|Induction|Moved to another non-COG institution|0|||
143281012|NCT02883049|516581137|FG012|Induction|Moved to another non-COG institution|0|||
143281013|NCT02883049|516581138|FG013|Induction|Moved to another non-COG institution|0|||
143281014|NCT02883049|516581139|FG014|Induction|Moved to another non-COG institution|0|||
143281015|NCT02883049|516581140|FG015|Induction|Moved to another non-COG institution|0|||
143281016|NCT02883049|516581125|FG000|Induction|Randomization closed|41|||
143281017|NCT02883049|516581126|FG001|Induction|Randomization closed|0|||
143281018|NCT02883049|516581127|FG002|Induction|Randomization closed|0|||
143281019|NCT02883049|516581128|FG003|Induction|Randomization closed|0|||
143281020|NCT02883049|516581129|FG004|Induction|Randomization closed|0|||
143281021|NCT02883049|516581130|FG005|Induction|Randomization closed|0|||
143281022|NCT02883049|516581131|FG006|Induction|Randomization closed|0|||
143281023|NCT02883049|516581132|FG007|Induction|Randomization closed|0|||
143281024|NCT02883049|516581133|FG008|Induction|Randomization closed|0|||
143281025|NCT02883049|516581134|FG009|Induction|Randomization closed|0|||
143281026|NCT02883049|516581135|FG010|Induction|Randomization closed|0|||
143281027|NCT02883049|516581136|FG011|Induction|Randomization closed|0|||
143281028|NCT02883049|516581137|FG012|Induction|Randomization closed|0|||
143281029|NCT02883049|516581138|FG013|Induction|Randomization closed|0|||
143281030|NCT02883049|516581139|FG014|Induction|Randomization closed|0|||
143281031|NCT02883049|516581140|FG015|Induction|Randomization closed|0|||
143281032|NCT02883049|516581125|FG000|Induction|MRD negative|36|||
143281033|NCT02883049|516581126|FG001|Induction|MRD negative|0|||
143281034|NCT02883049|516581127|FG002|Induction|MRD negative|0|||
143281035|NCT02883049|516581128|FG003|Induction|MRD negative|0|||
143281036|NCT02883049|516581129|FG004|Induction|MRD negative|0|||
143281037|NCT02883049|516581130|FG005|Induction|MRD negative|0|||
143281038|NCT02883049|516581131|FG006|Induction|MRD negative|0|||
143281039|NCT02883049|516581132|FG007|Induction|MRD negative|0|||
143281040|NCT02883049|516581133|FG008|Induction|MRD negative|0|||
143281041|NCT02883049|516581134|FG009|Induction|MRD negative|0|||
143281042|NCT02883049|516581135|FG010|Induction|MRD negative|0|||
143281043|NCT02883049|516581136|FG011|Induction|MRD negative|0|||
143281044|NCT02883049|516581137|FG012|Induction|MRD negative|0|||
143281045|NCT02883049|516581138|FG013|Induction|MRD negative|0|||
143281046|NCT02883049|516581139|FG014|Induction|MRD negative|0|||
143281047|NCT02883049|516581140|FG015|Induction|MRD negative|0|||
143281048|NCT02883049|516581125|FG000|Induction|Identified as HR patients|165|||
143281049|NCT02883049|516581126|FG001|Induction|Identified as HR patients|0|||
143281050|NCT02883049|516581127|FG002|Induction|Identified as HR patients|0|||
143281051|NCT02883049|516581128|FG003|Induction|Identified as HR patients|0|||
143281052|NCT02883049|516581129|FG004|Induction|Identified as HR patients|0|||
143281053|NCT02883049|516581130|FG005|Induction|Identified as HR patients|0|||
143281054|NCT02883049|516581131|FG006|Induction|Identified as HR patients|0|||
143281055|NCT02883049|516581132|FG007|Induction|Identified as HR patients|0|||
143281056|NCT02883049|516581133|FG008|Induction|Identified as HR patients|0|||
143281057|NCT02883049|516581134|FG009|Induction|Identified as HR patients|0|||
143281058|NCT02883049|516581135|FG010|Induction|Identified as HR patients|0|||
143281059|NCT02883049|516581136|FG011|Induction|Identified as HR patients|0|||
143281060|NCT02883049|516581137|FG012|Induction|Identified as HR patients|0|||
143281061|NCT02883049|516581138|FG013|Induction|Identified as HR patients|0|||
143281062|NCT02883049|516581139|FG014|Induction|Identified as HR patients|0|||
143373128|NCT01087762|516911382|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
143281063|NCT02883049|516581140|FG015|Induction|Identified as HR patients|0|||
143281064|NCT02883049|516581125|FG000|Induction|Developed SMN|0|||
143281065|NCT02883049|516581126|FG001|Induction|Developed SMN|1|||
143281066|NCT02883049|516581127|FG002|Induction|Developed SMN|0|||
143281067|NCT02883049|516581128|FG003|Induction|Developed SMN|0|||
143281068|NCT02883049|516581129|FG004|Induction|Developed SMN|0|||
143281069|NCT02883049|516581130|FG005|Induction|Developed SMN|0|||
143281070|NCT02883049|516581131|FG006|Induction|Developed SMN|0|||
143281071|NCT02883049|516581132|FG007|Induction|Developed SMN|0|||
143281072|NCT02883049|516581133|FG008|Induction|Developed SMN|0|||
143281073|NCT02883049|516581134|FG009|Induction|Developed SMN|0|||
143281074|NCT02883049|516581135|FG010|Induction|Developed SMN|0|||
143281075|NCT02883049|516581136|FG011|Induction|Developed SMN|0|||
143281076|NCT02883049|516581137|FG012|Induction|Developed SMN|0|||
143281077|NCT02883049|516581138|FG013|Induction|Developed SMN|0|||
143281078|NCT02883049|516581139|FG014|Induction|Developed SMN|0|||
143281079|NCT02883049|516581140|FG015|Induction|Developed SMN|0|||
143281080|NCT02883049|516581125|FG000|Induction|Enrolled onto another COG study|72|||
143281081|NCT02883049|516581126|FG001|Induction|Enrolled onto another COG study|0|||
143281082|NCT02883049|516581127|FG002|Induction|Enrolled onto another COG study|0|||
143281083|NCT02883049|516581128|FG003|Induction|Enrolled onto another COG study|0|||
143281084|NCT02883049|516581129|FG004|Induction|Enrolled onto another COG study|0|||
143281085|NCT02883049|516581130|FG005|Induction|Enrolled onto another COG study|0|||
143281086|NCT02883049|516581131|FG006|Induction|Enrolled onto another COG study|0|||
143281087|NCT02883049|516581132|FG007|Induction|Enrolled onto another COG study|0|||
143281088|NCT02883049|516581133|FG008|Induction|Enrolled onto another COG study|0|||
143281089|NCT02883049|516581134|FG009|Induction|Enrolled onto another COG study|0|||
143281090|NCT02883049|516581135|FG010|Induction|Enrolled onto another COG study|0|||
143281091|NCT02883049|516581136|FG011|Induction|Enrolled onto another COG study|0|||
143281092|NCT02883049|516581137|FG012|Induction|Enrolled onto another COG study|0|||
143281093|NCT02883049|516581138|FG013|Induction|Enrolled onto another COG study|0|||
143281094|NCT02883049|516581139|FG014|Induction|Enrolled onto another COG study|0|||
143281095|NCT02883049|516581140|FG015|Induction|Enrolled onto another COG study|0|||
143281096|NCT02883049|516581125|FG000|Induction|Incomplete induction data|17|||
143281097|NCT02883049|516581126|FG001|Induction|Incomplete induction data|0|||
143281098|NCT02883049|516581127|FG002|Induction|Incomplete induction data|0|||
143281099|NCT02883049|516581128|FG003|Induction|Incomplete induction data|0|||
143281100|NCT02883049|516581129|FG004|Induction|Incomplete induction data|0|||
143281101|NCT02883049|516581130|FG005|Induction|Incomplete induction data|0|||
143281102|NCT02883049|516581131|FG006|Induction|Incomplete induction data|0|||
143281103|NCT02883049|516581132|FG007|Induction|Incomplete induction data|0|||
143281104|NCT02883049|516581133|FG008|Induction|Incomplete induction data|0|||
143281105|NCT02883049|516581134|FG009|Induction|Incomplete induction data|0|||
143281106|NCT02883049|516581135|FG010|Induction|Incomplete induction data|0|||
143281107|NCT02883049|516581136|FG011|Induction|Incomplete induction data|0|||
143281108|NCT02883049|516581137|FG012|Induction|Incomplete induction data|0|||
143281109|NCT02883049|516581138|FG013|Induction|Incomplete induction data|0|||
143281110|NCT02883049|516581139|FG014|Induction|Incomplete induction data|0|||
143281111|NCT02883049|516581140|FG015|Induction|Incomplete induction data|0|||
143281112|NCT02883049|516581125|FG000|Post Induction|Adverse Event|0|||
143281113|NCT02883049|516581126|FG001|Post Induction|Adverse Event|0|||
143281114|NCT02883049|516581127|FG002|Post Induction|Adverse Event|0|||
143281115|NCT02883049|516581128|FG003|Post Induction|Adverse Event|7|||
143281116|NCT02883049|516581129|FG004|Post Induction|Adverse Event|8|||
143281117|NCT02883049|516581130|FG005|Post Induction|Adverse Event|3|||
143281118|NCT02883049|516581131|FG006|Post Induction|Adverse Event|4|||
143281119|NCT02883049|516581132|FG007|Post Induction|Adverse Event|5|||
143281120|NCT02883049|516581133|FG008|Post Induction|Adverse Event|6|||
143281121|NCT02883049|516581134|FG009|Post Induction|Adverse Event|7|||
143281122|NCT02883049|516581135|FG010|Post Induction|Adverse Event|2|||
143281123|NCT02883049|516581136|FG011|Post Induction|Adverse Event|2|||
143281124|NCT02883049|516581137|FG012|Post Induction|Adverse Event|0|||
143281125|NCT02883049|516581138|FG013|Post Induction|Adverse Event|0|||
143281126|NCT02883049|516581139|FG014|Post Induction|Adverse Event|5|||
143281127|NCT02883049|516581140|FG015|Post Induction|Adverse Event|2|||
143281128|NCT02883049|516581125|FG000|Post Induction|Death|0|||
143281129|NCT02883049|516581126|FG001|Post Induction|Death|0|||
143281130|NCT02883049|516581127|FG002|Post Induction|Death|0|||
143281131|NCT02883049|516581128|FG003|Post Induction|Death|9|||
143281132|NCT02883049|516581129|FG004|Post Induction|Death|9|||
143281133|NCT02883049|516581130|FG005|Post Induction|Death|0|||
143281134|NCT02883049|516581131|FG006|Post Induction|Death|1|||
143281135|NCT02883049|516581132|FG007|Post Induction|Death|6|||
143281136|NCT02883049|516581133|FG008|Post Induction|Death|5|||
143281137|NCT02883049|516581134|FG009|Post Induction|Death|3|||
143281138|NCT02883049|516581135|FG010|Post Induction|Death|1|||
143281139|NCT02883049|516581136|FG011|Post Induction|Death|0|||
143281140|NCT02883049|516581137|FG012|Post Induction|Death|1|||
143281141|NCT02883049|516581138|FG013|Post Induction|Death|1|||
143281142|NCT02883049|516581139|FG014|Post Induction|Death|10|||
143281143|NCT02883049|516581140|FG015|Post Induction|Death|2|||
143281144|NCT02883049|516581125|FG000|Post Induction|Lost to Follow-up|0|||
143281145|NCT02883049|516581126|FG001|Post Induction|Lost to Follow-up|0|||
143281146|NCT02883049|516581127|FG002|Post Induction|Lost to Follow-up|0|||
143281147|NCT02883049|516581128|FG003|Post Induction|Lost to Follow-up|0|||
143281148|NCT02883049|516581129|FG004|Post Induction|Lost to Follow-up|1|||
143281149|NCT02883049|516581130|FG005|Post Induction|Lost to Follow-up|1|||
143281150|NCT02883049|516581131|FG006|Post Induction|Lost to Follow-up|0|||
143281151|NCT02883049|516581132|FG007|Post Induction|Lost to Follow-up|0|||
143281152|NCT02883049|516581133|FG008|Post Induction|Lost to Follow-up|3|||
143281153|NCT02883049|516581134|FG009|Post Induction|Lost to Follow-up|0|||
143281154|NCT02883049|516581135|FG010|Post Induction|Lost to Follow-up|1|||
143281155|NCT02883049|516581136|FG011|Post Induction|Lost to Follow-up|0|||
143281156|NCT02883049|516581137|FG012|Post Induction|Lost to Follow-up|0|||
143281157|NCT02883049|516581138|FG013|Post Induction|Lost to Follow-up|0|||
143281158|NCT02883049|516581139|FG014|Post Induction|Lost to Follow-up|0|||
143281159|NCT02883049|516581140|FG015|Post Induction|Lost to Follow-up|0|||
143281160|NCT02883049|516581125|FG000|Post Induction|Physician Decision|0|||
143281161|NCT02883049|516581126|FG001|Post Induction|Physician Decision|0|||
143281162|NCT02883049|516581127|FG002|Post Induction|Physician Decision|0|||
143281163|NCT02883049|516581128|FG003|Post Induction|Physician Decision|27|||
143281164|NCT02883049|516581129|FG004|Post Induction|Physician Decision|27|||
143281165|NCT02883049|516581130|FG005|Post Induction|Physician Decision|23|||
143281166|NCT02883049|516581131|FG006|Post Induction|Physician Decision|30|||
143281167|NCT02883049|516581132|FG007|Post Induction|Physician Decision|56|||
143281168|NCT02883049|516581133|FG008|Post Induction|Physician Decision|85|||
143281169|NCT02883049|516581134|FG009|Post Induction|Physician Decision|12|||
143281170|NCT02883049|516581135|FG010|Post Induction|Physician Decision|5|||
143281171|NCT02883049|516581136|FG011|Post Induction|Physician Decision|14|||
143281172|NCT02883049|516581137|FG012|Post Induction|Physician Decision|1|||
143281173|NCT02883049|516581138|FG013|Post Induction|Physician Decision|11|||
143281174|NCT02883049|516581139|FG014|Post Induction|Physician Decision|19|||
143281175|NCT02883049|516581140|FG015|Post Induction|Physician Decision|5|||
143281176|NCT02883049|516581125|FG000|Post Induction|Protocol Violation|0|||
143281177|NCT02883049|516581126|FG001|Post Induction|Protocol Violation|0|||
143281178|NCT02883049|516581127|FG002|Post Induction|Protocol Violation|0|||
143281179|NCT02883049|516581128|FG003|Post Induction|Protocol Violation|0|||
143281180|NCT02883049|516581129|FG004|Post Induction|Protocol Violation|0|||
143281181|NCT02883049|516581130|FG005|Post Induction|Protocol Violation|0|||
143281182|NCT02883049|516581131|FG006|Post Induction|Protocol Violation|0|||
143281183|NCT02883049|516581132|FG007|Post Induction|Protocol Violation|1|||
143281184|NCT02883049|516581133|FG008|Post Induction|Protocol Violation|0|||
143281185|NCT02883049|516581134|FG009|Post Induction|Protocol Violation|0|||
143281186|NCT02883049|516581135|FG010|Post Induction|Protocol Violation|0|||
143281187|NCT02883049|516581136|FG011|Post Induction|Protocol Violation|0|||
143281188|NCT02883049|516581137|FG012|Post Induction|Protocol Violation|0|||
143281189|NCT02883049|516581138|FG013|Post Induction|Protocol Violation|0|||
143281190|NCT02883049|516581139|FG014|Post Induction|Protocol Violation|0|||
143281191|NCT02883049|516581140|FG015|Post Induction|Protocol Violation|0|||
143281192|NCT02883049|516581125|FG000|Post Induction|Withdrawal by Subject|0|||
143281193|NCT02883049|516581126|FG001|Post Induction|Withdrawal by Subject|0|||
143281194|NCT02883049|516581127|FG002|Post Induction|Withdrawal by Subject|0|||
143281195|NCT02883049|516581128|FG003|Post Induction|Withdrawal by Subject|5|||
143281196|NCT02883049|516581129|FG004|Post Induction|Withdrawal by Subject|2|||
143281197|NCT02883049|516581130|FG005|Post Induction|Withdrawal by Subject|1|||
143281198|NCT02883049|516581131|FG006|Post Induction|Withdrawal by Subject|0|||
143281199|NCT02883049|516581132|FG007|Post Induction|Withdrawal by Subject|0|||
143281200|NCT02883049|516581133|FG008|Post Induction|Withdrawal by Subject|2|||
143281201|NCT02883049|516581134|FG009|Post Induction|Withdrawal by Subject|0|||
143281202|NCT02883049|516581135|FG010|Post Induction|Withdrawal by Subject|1|||
143281203|NCT02883049|516581136|FG011|Post Induction|Withdrawal by Subject|1|||
143281204|NCT02883049|516581137|FG012|Post Induction|Withdrawal by Subject|0|||
143281205|NCT02883049|516581138|FG013|Post Induction|Withdrawal by Subject|0|||
143281206|NCT02883049|516581139|FG014|Post Induction|Withdrawal by Subject|1|||
143281207|NCT02883049|516581140|FG015|Post Induction|Withdrawal by Subject|0|||
143281208|NCT02883049|516581125|FG000|Post Induction|Ineligible|0|||
143281209|NCT02883049|516581126|FG001|Post Induction|Ineligible|0|||
143281210|NCT02883049|516581127|FG002|Post Induction|Ineligible|2|||
143281211|NCT02883049|516581128|FG003|Post Induction|Ineligible|0|||
143281212|NCT02883049|516581129|FG004|Post Induction|Ineligible|0|||
143281213|NCT02883049|516581130|FG005|Post Induction|Ineligible|0|||
143281214|NCT02883049|516581131|FG006|Post Induction|Ineligible|1|||
143281215|NCT02883049|516581132|FG007|Post Induction|Ineligible|0|||
143281216|NCT02883049|516581133|FG008|Post Induction|Ineligible|0|||
143281217|NCT02883049|516581134|FG009|Post Induction|Ineligible|0|||
143281218|NCT02883049|516581135|FG010|Post Induction|Ineligible|1|||
143281219|NCT02883049|516581136|FG011|Post Induction|Ineligible|0|||
143281220|NCT02883049|516581137|FG012|Post Induction|Ineligible|0|||
143281221|NCT02883049|516581138|FG013|Post Induction|Ineligible|0|||
143281222|NCT02883049|516581139|FG014|Post Induction|Ineligible|0|||
143281223|NCT02883049|516581140|FG015|Post Induction|Ineligible|1|||
143281224|NCT02883049|516581125|FG000|Post Induction|Refusal of further protocol therapy|0|||
143281225|NCT02883049|516581126|FG001|Post Induction|Refusal of further protocol therapy|0|||
143281226|NCT02883049|516581127|FG002|Post Induction|Refusal of further protocol therapy|0|||
143281227|NCT02883049|516581128|FG003|Post Induction|Refusal of further protocol therapy|11|||
143281228|NCT02883049|516581129|FG004|Post Induction|Refusal of further protocol therapy|15|||
143281229|NCT02883049|516581130|FG005|Post Induction|Refusal of further protocol therapy|9|||
143281230|NCT02883049|516581131|FG006|Post Induction|Refusal of further protocol therapy|13|||
143281231|NCT02883049|516581132|FG007|Post Induction|Refusal of further protocol therapy|5|||
143281232|NCT02883049|516581133|FG008|Post Induction|Refusal of further protocol therapy|21|||
143281233|NCT02883049|516581134|FG009|Post Induction|Refusal of further protocol therapy|7|||
143281234|NCT02883049|516581135|FG010|Post Induction|Refusal of further protocol therapy|0|||
143281235|NCT02883049|516581136|FG011|Post Induction|Refusal of further protocol therapy|7|||
143281236|NCT02883049|516581137|FG012|Post Induction|Refusal of further protocol therapy|3|||
143281237|NCT02883049|516581138|FG013|Post Induction|Refusal of further protocol therapy|0|||
143281238|NCT02883049|516581139|FG014|Post Induction|Refusal of further protocol therapy|4|||
143281239|NCT02883049|516581140|FG015|Post Induction|Refusal of further protocol therapy|1|||
143281240|NCT02883049|516581125|FG000|Post Induction|Inevaluable|0|||
143281241|NCT02883049|516581126|FG001|Post Induction|Inevaluable|0|||
143281242|NCT02883049|516581127|FG002|Post Induction|Inevaluable|0|||
143281243|NCT02883049|516581128|FG003|Post Induction|Inevaluable|1|||
143281244|NCT02883049|516581129|FG004|Post Induction|Inevaluable|1|||
143281245|NCT02883049|516581130|FG005|Post Induction|Inevaluable|2|||
143281246|NCT02883049|516581131|FG006|Post Induction|Inevaluable|7|||
143281247|NCT02883049|516581132|FG007|Post Induction|Inevaluable|6|||
143281248|NCT02883049|516581133|FG008|Post Induction|Inevaluable|4|||
143281249|NCT02883049|516581134|FG009|Post Induction|Inevaluable|4|||
143281250|NCT02883049|516581135|FG010|Post Induction|Inevaluable|1|||
143281251|NCT02883049|516581136|FG011|Post Induction|Inevaluable|1|||
143281252|NCT02883049|516581137|FG012|Post Induction|Inevaluable|2|||
143281253|NCT02883049|516581138|FG013|Post Induction|Inevaluable|0|||
143281254|NCT02883049|516581139|FG014|Post Induction|Inevaluable|0|||
143281255|NCT02883049|516581140|FG015|Post Induction|Inevaluable|1|||
143281256|NCT02883049|516581125|FG000|Post Induction|Moved to another non-COG institution|0|||
143281257|NCT02883049|516581126|FG001|Post Induction|Moved to another non-COG institution|0|||
143281258|NCT02883049|516581127|FG002|Post Induction|Moved to another non-COG institution|0|||
143281259|NCT02883049|516581128|FG003|Post Induction|Moved to another non-COG institution|0|||
143281260|NCT02883049|516581129|FG004|Post Induction|Moved to another non-COG institution|0|||
143281261|NCT02883049|516581130|FG005|Post Induction|Moved to another non-COG institution|0|||
143281262|NCT02883049|516581131|FG006|Post Induction|Moved to another non-COG institution|0|||
143281263|NCT02883049|516581132|FG007|Post Induction|Moved to another non-COG institution|2|||
143281264|NCT02883049|516581133|FG008|Post Induction|Moved to another non-COG institution|2|||
143281265|NCT02883049|516581134|FG009|Post Induction|Moved to another non-COG institution|0|||
143281266|NCT02883049|516581135|FG010|Post Induction|Moved to another non-COG institution|0|||
143281267|NCT02883049|516581136|FG011|Post Induction|Moved to another non-COG institution|1|||
143281268|NCT02883049|516581137|FG012|Post Induction|Moved to another non-COG institution|0|||
143281269|NCT02883049|516581138|FG013|Post Induction|Moved to another non-COG institution|0|||
143281270|NCT02883049|516581139|FG014|Post Induction|Moved to another non-COG institution|0|||
143281271|NCT02883049|516581140|FG015|Post Induction|Moved to another non-COG institution|0|||
143281272|NCT02883049|516581125|FG000|Post Induction|Randomization closed|0|||
143281273|NCT02883049|516581126|FG001|Post Induction|Randomization closed|0|||
143281274|NCT02883049|516581127|FG002|Post Induction|Randomization closed|0|||
143281275|NCT02883049|516581128|FG003|Post Induction|Randomization closed|0|||
143281276|NCT02883049|516581129|FG004|Post Induction|Randomization closed|0|||
143281277|NCT02883049|516581130|FG005|Post Induction|Randomization closed|0|||
143281278|NCT02883049|516581131|FG006|Post Induction|Randomization closed|0|||
143281279|NCT02883049|516581132|FG007|Post Induction|Randomization closed|20|||
143281280|NCT02883049|516581133|FG008|Post Induction|Randomization closed|0|||
143281281|NCT02883049|516581134|FG009|Post Induction|Randomization closed|0|||
143281282|NCT02883049|516581135|FG010|Post Induction|Randomization closed|0|||
143281283|NCT02883049|516581136|FG011|Post Induction|Randomization closed|0|||
143281284|NCT02883049|516581137|FG012|Post Induction|Randomization closed|0|||
143281285|NCT02883049|516581138|FG013|Post Induction|Randomization closed|0|||
143281286|NCT02883049|516581139|FG014|Post Induction|Randomization closed|0|||
143281287|NCT02883049|516581140|FG015|Post Induction|Randomization closed|0|||
143281288|NCT02883049|516581125|FG000|Post Induction|MRD negative|0|||
143281289|NCT02883049|516581126|FG001|Post Induction|MRD negative|0|||
143281290|NCT02883049|516581127|FG002|Post Induction|MRD negative|0|||
143281291|NCT02883049|516581128|FG003|Post Induction|MRD negative|0|||
143281292|NCT02883049|516581129|FG004|Post Induction|MRD negative|0|||
143281293|NCT02883049|516581130|FG005|Post Induction|MRD negative|0|||
143281294|NCT02883049|516581131|FG006|Post Induction|MRD negative|0|||
143281295|NCT02883049|516581132|FG007|Post Induction|MRD negative|11|||
143281296|NCT02883049|516581133|FG008|Post Induction|MRD negative|0|||
143281297|NCT02883049|516581134|FG009|Post Induction|MRD negative|0|||
143281298|NCT02883049|516581135|FG010|Post Induction|MRD negative|0|||
143281299|NCT02883049|516581136|FG011|Post Induction|MRD negative|0|||
143281300|NCT02883049|516581137|FG012|Post Induction|MRD negative|0|||
143281301|NCT02883049|516581138|FG013|Post Induction|MRD negative|0|||
143281302|NCT02883049|516581139|FG014|Post Induction|MRD negative|0|||
143281303|NCT02883049|516581140|FG015|Post Induction|MRD negative|0|||
143281304|NCT02883049|516581125|FG000|Post Induction|Developed SMN|0|||
143281305|NCT02883049|516581126|FG001|Post Induction|Developed SMN|0|||
143281306|NCT02883049|516581127|FG002|Post Induction|Developed SMN|0|||
143281307|NCT02883049|516581128|FG003|Post Induction|Developed SMN|0|||
143281308|NCT02883049|516581129|FG004|Post Induction|Developed SMN|1|||
143281309|NCT02883049|516581130|FG005|Post Induction|Developed SMN|0|||
143281310|NCT02883049|516581131|FG006|Post Induction|Developed SMN|1|||
143281311|NCT02883049|516581132|FG007|Post Induction|Developed SMN|0|||
143281312|NCT02883049|516581133|FG008|Post Induction|Developed SMN|0|||
143281313|NCT02883049|516581134|FG009|Post Induction|Developed SMN|0|||
143281314|NCT02883049|516581135|FG010|Post Induction|Developed SMN|1|||
143281315|NCT02883049|516581136|FG011|Post Induction|Developed SMN|1|||
143281316|NCT02883049|516581137|FG012|Post Induction|Developed SMN|0|||
143281317|NCT02883049|516581138|FG013|Post Induction|Developed SMN|0|||
143281318|NCT02883049|516581139|FG014|Post Induction|Developed SMN|1|||
143281319|NCT02883049|516581140|FG015|Post Induction|Developed SMN|0|||
143281320|NCT02883049|516581125|FG000|Post Induction|Enrolled onto another COG study|0|||
143281321|NCT02883049|516581126|FG001|Post Induction|Enrolled onto another COG study|0|||
143281322|NCT02883049|516581127|FG002|Post Induction|Enrolled onto another COG study|0|||
143281323|NCT02883049|516581128|FG003|Post Induction|Enrolled onto another COG study|1|||
143281324|NCT02883049|516581129|FG004|Post Induction|Enrolled onto another COG study|1|||
143281325|NCT02883049|516581130|FG005|Post Induction|Enrolled onto another COG study|0|||
143281326|NCT02883049|516581131|FG006|Post Induction|Enrolled onto another COG study|0|||
143281327|NCT02883049|516581132|FG007|Post Induction|Enrolled onto another COG study|4|||
143281328|NCT02883049|516581133|FG008|Post Induction|Enrolled onto another COG study|0|||
143281329|NCT02883049|516581134|FG009|Post Induction|Enrolled onto another COG study|0|||
143281330|NCT02883049|516581135|FG010|Post Induction|Enrolled onto another COG study|0|||
143281331|NCT02883049|516581136|FG011|Post Induction|Enrolled onto another COG study|2|||
143281332|NCT02883049|516581137|FG012|Post Induction|Enrolled onto another COG study|0|||
143281333|NCT02883049|516581138|FG013|Post Induction|Enrolled onto another COG study|1|||
143281334|NCT02883049|516581139|FG014|Post Induction|Enrolled onto another COG study|0|||
143373129|NCT01087762|516911383|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
143281335|NCT02883049|516581140|FG015|Post Induction|Enrolled onto another COG study|0|||
143281336|NCT02883049|516581125|FG000|Post Induction|Recurrent leukemia|0|||
143281337|NCT02883049|516581126|FG001|Post Induction|Recurrent leukemia|0|||
143281338|NCT02883049|516581127|FG002|Post Induction|Recurrent leukemia|0|||
143281339|NCT02883049|516581128|FG003|Post Induction|Recurrent leukemia|17|||
143281340|NCT02883049|516581129|FG004|Post Induction|Recurrent leukemia|12|||
143281341|NCT02883049|516581130|FG005|Post Induction|Recurrent leukemia|4|||
143281342|NCT02883049|516581131|FG006|Post Induction|Recurrent leukemia|1|||
143281343|NCT02883049|516581132|FG007|Post Induction|Recurrent leukemia|13|||
143281344|NCT02883049|516581133|FG008|Post Induction|Recurrent leukemia|27|||
143281345|NCT02883049|516581134|FG009|Post Induction|Recurrent leukemia|5|||
143281346|NCT02883049|516581135|FG010|Post Induction|Recurrent leukemia|3|||
143281347|NCT02883049|516581136|FG011|Post Induction|Recurrent leukemia|12|||
143281348|NCT02883049|516581137|FG012|Post Induction|Recurrent leukemia|1|||
143281349|NCT02883049|516581138|FG013|Post Induction|Recurrent leukemia|1|||
143281350|NCT02883049|516581139|FG014|Post Induction|Recurrent leukemia|9|||
143281351|NCT02883049|516581140|FG015|Post Induction|Recurrent leukemia|3|||
143281352|NCT02883049|516581125|FG000|Post Induction|Induction Failure|0|||
143281353|NCT02883049|516581126|FG001|Post Induction|Induction Failure|0|||
143281354|NCT02883049|516581127|FG002|Post Induction|Induction Failure|0|||
143281355|NCT02883049|516581128|FG003|Post Induction|Induction Failure|0|||
143281356|NCT02883049|516581129|FG004|Post Induction|Induction Failure|0|||
143281357|NCT02883049|516581130|FG005|Post Induction|Induction Failure|0|||
143281358|NCT02883049|516581131|FG006|Post Induction|Induction Failure|0|||
143281359|NCT02883049|516581132|FG007|Post Induction|Induction Failure|2|||
143281360|NCT02883049|516581133|FG008|Post Induction|Induction Failure|2|||
143281361|NCT02883049|516581134|FG009|Post Induction|Induction Failure|0|||
143281362|NCT02883049|516581135|FG010|Post Induction|Induction Failure|0|||
143281363|NCT02883049|516581136|FG011|Post Induction|Induction Failure|0|||
143281364|NCT02883049|516581137|FG012|Post Induction|Induction Failure|0|||
143281365|NCT02883049|516581138|FG013|Post Induction|Induction Failure|2|||
143281366|NCT02883049|516581139|FG014|Post Induction|Induction Failure|0|||
143281367|NCT02883049|516581140|FG015|Post Induction|Induction Failure|0|||
143281368|NCT05393895|516581142|FG000|Overall Study|Adverse Event|2|||
143281369|NCT05393895|516581143|FG001|Overall Study|Adverse Event|3|||
143281370|NCT05393895|516581142|FG000|Overall Study|Lost to Follow-up|4|||
143281371|NCT05393895|516581143|FG001|Overall Study|Lost to Follow-up|3|||
143281372|NCT05393895|516581142|FG000|Overall Study|Protocol Violation|1|||
143281373|NCT05393895|516581143|FG001|Overall Study|Protocol Violation|0|||
143281374|NCT05393895|516581142|FG000|Overall Study|Withdrawal by Subject|1|||
143281375|NCT05393895|516581143|FG001|Overall Study|Withdrawal by Subject|4|||
143281376|NCT02002091|516581148|FG000|Screening|Lost to Follow-up|10|||
143281377|NCT02002091|516581149|FG001|Screening|Lost to Follow-up|12|||
143281378|NCT02002091|516581148|FG000|Screening|Death|3|||
143281379|NCT02002091|516581149|FG001|Screening|Death|2|||
143281380|NCT02083783|516581158|FG000|Overall Study|Withdrawal by Subject|1|||
143281381|NCT02083783|516581159|FG001|Overall Study|Withdrawal by Subject|0|||
143281382|NCT02256631|516581162|FG000|Overall Study|Lost to Follow-up|1|||
143281383|NCT02256631|516581163|FG001|Overall Study|Lost to Follow-up|1|||
143281384|NCT02256631|516581164|FG002|Overall Study|Lost to Follow-up|0|||
143281385|NCT02256631|516581165|FG003|Overall Study|Lost to Follow-up|2|||
143281386|NCT02256631|516581166|FG004|Overall Study|Lost to Follow-up|0|||
143281387|NCT02256631|516581167|FG005|Overall Study|Lost to Follow-up|4|||
143281388|NCT02256631|516581168|FG006|Overall Study|Lost to Follow-up|1|||
143281389|NCT02256631|516581162|FG000|Overall Study|Withdrawal by Subject|0|||
143281390|NCT02256631|516581163|FG001|Overall Study|Withdrawal by Subject|0|||
143281391|NCT02256631|516581164|FG002|Overall Study|Withdrawal by Subject|0|||
143281392|NCT02256631|516581165|FG003|Overall Study|Withdrawal by Subject|1|||
143281393|NCT02256631|516581166|FG004|Overall Study|Withdrawal by Subject|1|||
143281394|NCT02256631|516581167|FG005|Overall Study|Withdrawal by Subject|0|||
143281395|NCT02256631|516581168|FG006|Overall Study|Withdrawal by Subject|1|||
143281396|NCT02256631|516581162|FG000|Overall Study|Unable to get to clinic|0|||
143281397|NCT02256631|516581163|FG001|Overall Study|Unable to get to clinic|2|||
143281398|NCT02256631|516581164|FG002|Overall Study|Unable to get to clinic|0|||
143281399|NCT02256631|516581165|FG003|Overall Study|Unable to get to clinic|1|||
143281400|NCT02256631|516581166|FG004|Overall Study|Unable to get to clinic|0|||
143281401|NCT02256631|516581167|FG005|Overall Study|Unable to get to clinic|1|||
143281402|NCT02256631|516581168|FG006|Overall Study|Unable to get to clinic|2|||
143281403|NCT00622284|516581170|FG000|Overall Study|Lack of Efficacy|45|||
143281404|NCT00622284|516581171|FG001|Overall Study|Lack of Efficacy|15|||
143281405|NCT00622284|516581170|FG000|Overall Study|Adverse Event|61|||
143281406|NCT00622284|516581171|FG001|Overall Study|Adverse Event|90|||
143281407|NCT00622284|516581170|FG000|Overall Study|Protocol Violation|12|||
143373130|NCT01087762|516911384|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
143281408|NCT00622284|516581171|FG001|Overall Study|Protocol Violation|5|||
143281409|NCT00622284|516581170|FG000|Overall Study|Lost to Follow-up|11|||
143281410|NCT00622284|516581171|FG001|Overall Study|Lost to Follow-up|13|||
143281411|NCT00622284|516581170|FG000|Overall Study|Withdrawal by Subject|27|||
143281412|NCT00622284|516581171|FG001|Overall Study|Withdrawal by Subject|24|||
143281413|NCT00622284|516581170|FG000|Overall Study|Other reason (not specified)|33|||
143281414|NCT00622284|516581171|FG001|Overall Study|Other reason (not specified)|24|||
143281415|NCT03943147|516581172|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
143373131|NCT01087762|516911385|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
143281416|NCT03943147|516581173|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
143281417|NCT03943147|516581172|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
143281418|NCT03943147|516581173|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
143281419|NCT03943147|516581172|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
143281420|NCT03943147|516581173|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
143281421|NCT03943147|516581172|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
143281422|NCT03943147|516581173|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
143281423|NCT03943147|516581172|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
143281424|NCT03943147|516581173|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
143281425|NCT03943147|516581172|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
143281426|NCT03943147|516581173|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
143281427|NCT00629707|516581174|FG000|Overall Study|Withdrawal by Subject|0|||
143281428|NCT00629707|516581175|FG001|Overall Study|Withdrawal by Subject|1|||
143281429|NCT00629707|516581174|FG000|Overall Study|Physician Decision|0|||
143281430|NCT00629707|516581175|FG001|Overall Study|Physician Decision|1|||
143281431|NCT00968201|516581179|FG000|Base Study - (Period II)|Adverse Event|8|||
143281432|NCT00968201|516581180|FG001|Base Study - (Period II)|Adverse Event|0|||
143281433|NCT00968201|516581181|FG002|Base Study - (Period II)|Adverse Event|16|||
143281434|NCT00968201|516581179|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
143281435|NCT00968201|516581180|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
143281436|NCT00968201|516581181|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
143281437|NCT00968201|516581179|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
143281438|NCT00968201|516581180|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
143281439|NCT00968201|516581181|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
143281440|NCT00968201|516581179|FG000|Base Study - (Period II)|Protocol Violation|12|||
143281441|NCT00968201|516581180|FG001|Base Study - (Period II)|Protocol Violation|0|||
143281442|NCT00968201|516581181|FG002|Base Study - (Period II)|Protocol Violation|12|||
143281443|NCT00968201|516581179|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
143281444|NCT00968201|516581180|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
143281445|NCT00968201|516581181|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
143281446|NCT00968201|516581179|FG000|Base Study - (Period II)|Site Error|0|||
143281447|NCT00968201|516581180|FG001|Base Study - (Period II)|Site Error|0|||
143281448|NCT00968201|516581181|FG002|Base Study - (Period II)|Site Error|1|||
143281449|NCT00968201|516581179|FG000|Extension Study - (Period III)|Adverse Event|0|||
143281450|NCT00968201|516581180|FG001|Extension Study - (Period III)|Adverse Event|5|||
143281451|NCT00968201|516581181|FG002|Extension Study - (Period III)|Adverse Event|22|||
143281452|NCT00968201|516581179|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
143281453|NCT00968201|516581180|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
143281454|NCT00968201|516581181|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
143281455|NCT00968201|516581179|FG000|Extension Study - (Period III)|Protocol Violation|0|||
143281456|NCT00968201|516581180|FG001|Extension Study - (Period III)|Protocol Violation|17|||
143281457|NCT00968201|516581181|FG002|Extension Study - (Period III)|Protocol Violation|14|||
143281458|NCT00968201|516581179|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
143281459|NCT00968201|516581180|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
143281460|NCT00968201|516581181|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
143281461|NCT00968201|516581179|FG000|Extension Study - (Period III)|Patient Relocated|0|||
143281462|NCT00968201|516581180|FG001|Extension Study - (Period III)|Patient Relocated|1|||
143281463|NCT00968201|516581181|FG002|Extension Study - (Period III)|Patient Relocated|1|||
143281464|NCT00968201|516581179|FG000|Extension Study - (Period III)|Noncompliance|0|||
143281465|NCT00968201|516581180|FG001|Extension Study - (Period III)|Noncompliance|0|||
143281466|NCT00968201|516581181|FG002|Extension Study - (Period III)|Noncompliance|3|||
143281467|NCT00968201|516581179|FG000|Extension Study - (Period III)|Other|0|||
143281468|NCT00968201|516581180|FG001|Extension Study - (Period III)|Other|0|||
143281469|NCT00968201|516581181|FG002|Extension Study - (Period III)|Other|2|||
143281470|NCT00968201|516581179|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
143281471|NCT00968201|516581180|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
143281472|NCT00968201|516581181|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
143281473|NCT02619175|516581182|FG000|Overall Study|Withdrawal by Subject|1|||
143281474|NCT02619175|516581183|FG001|Overall Study|Withdrawal by Subject|0|||
143281475|NCT02619175|516581182|FG000|Overall Study|foot pain|1|||
143281476|NCT02619175|516581183|FG001|Overall Study|foot pain|0|||
143281477|NCT02784431|516581184|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
143281478|NCT02784431|516581184|FG000|Overall Study|Early Study Termination|19|||
143281479|NCT02657369|516581185|FG000|Overall Study|Death|27|||
143281480|NCT02657369|516581185|FG000|Overall Study|Study terminated by sponsor|7|||
143281481|NCT02605824|516581186|FG000|Overall Study|Physician Decision|1|||
143281482|NCT02605824|516581187|FG001|Overall Study|Physician Decision|0|||
143281483|NCT04875195|516581188|FG000|Overall Study|Death|9|||
143281484|NCT04875195|516581189|FG001|Overall Study|Death|3|||
143281485|NCT04875195|516581188|FG000|Overall Study|Withdrawal by Subject|2|||
143281486|NCT04875195|516581189|FG001|Overall Study|Withdrawal by Subject|1|||
143281487|NCT04875195|516581188|FG000|Overall Study|Ongoing in study|49|||
143281488|NCT04875195|516581189|FG001|Overall Study|Ongoing in study|2|||
143281489|NCT00074152|516581190|FG000|Overall Study|Death|21|||
143281490|NCT00074152|516581191|FG001|Overall Study|Death|9|||
143281491|NCT00074152|516581190|FG000|Overall Study|Lack of Efficacy|34|||
143281492|NCT00074152|516581191|FG001|Overall Study|Lack of Efficacy|24|||
143281493|NCT02612727|516581192|FG000|Overall Study|Parent request|4|||
143281494|NCT02612727|516581193|FG001|Overall Study|Parent request|1|||
143281495|NCT02612727|516581192|FG000|Overall Study|Needed treatment incompatible with PT|1|||
143281496|NCT02612727|516581193|FG001|Overall Study|Needed treatment incompatible with PT|1|||
143281497|NCT02612727|516581192|FG000|Overall Study|Direct hyperbilirubinemia|0|||
143281498|NCT02612727|516581193|FG001|Overall Study|Direct hyperbilirubinemia|2|||
143281499|NCT01095731|516581194|FG000|Overall Study|Protocol Violation|1|||
143281500|NCT01095731|516581195|FG001|Overall Study|Protocol Violation|1|||
143281501|NCT01095731|516581194|FG000|Overall Study|Withdrawal by Subject|0|||
143281502|NCT01095731|516581195|FG001|Overall Study|Withdrawal by Subject|1|||
143281503|NCT02302807|516581198|FG000|Overall Study|Withdrawal by Subject|28|||
143281504|NCT02302807|516581199|FG001|Overall Study|Withdrawal by Subject|11|||
143281505|NCT02302807|516581198|FG000|Overall Study|Lost to Follow-up|4|||
143281506|NCT02302807|516581199|FG001|Overall Study|Lost to Follow-up|6|||
143281507|NCT02302807|516581198|FG000|Overall Study|Death|397|||
143281508|NCT02302807|516581199|FG001|Overall Study|Death|385|||
143281509|NCT02302807|516581198|FG000|Overall Study|Study Terminated By Sponsor|35|||
143281510|NCT02302807|516581199|FG001|Overall Study|Study Terminated By Sponsor|64|||
143281511|NCT02302807|516581198|FG000|Overall Study|Physician Decision|0|||
143281512|NCT02302807|516581199|FG001|Overall Study|Physician Decision|1|||
143281513|NCT01446289|516581200|FG000|Overall Study|Withdrawal by Subject|1|||
143281514|NCT01446289|516581201|FG001|Overall Study|Withdrawal by Subject|0|||
143281515|NCT01446289|516581202|FG002|Overall Study|Withdrawal by Subject|1|||
143281516|NCT01446289|516581203|FG003|Overall Study|Withdrawal by Subject|0|||
143281517|NCT02777333|516581206|FG000|Overall Study|Withdrawal by Subject|0|||
143281518|NCT02777333|516581207|FG001|Overall Study|Withdrawal by Subject|1|||
143281519|NCT02777333|516581206|FG000|Overall Study|Lost to Follow-up|0|||
143281520|NCT02777333|516581207|FG001|Overall Study|Lost to Follow-up|1|||
143281521|NCT00837811|516581208|FG000|Overall Study|Adverse Event|4|||
143281522|NCT00837811|516581209|FG001|Overall Study|Adverse Event|6|||
143281523|NCT00837811|516581210|FG002|Overall Study|Adverse Event|0|||
143281524|NCT00837811|516581208|FG000|Overall Study|Death|1|||
143281525|NCT00837811|516581209|FG001|Overall Study|Death|1|||
143281526|NCT00837811|516581210|FG002|Overall Study|Death|0|||
143281527|NCT00837811|516581208|FG000|Overall Study|Lack of Efficacy|0|||
143281528|NCT00837811|516581209|FG001|Overall Study|Lack of Efficacy|11|||
143281529|NCT00837811|516581210|FG002|Overall Study|Lack of Efficacy|0|||
143281530|NCT00837811|516581208|FG000|Overall Study|Lost to Follow-up|1|||
143281531|NCT00837811|516581209|FG001|Overall Study|Lost to Follow-up|3|||
143281532|NCT00837811|516581210|FG002|Overall Study|Lost to Follow-up|0|||
143281533|NCT00837811|516581208|FG000|Overall Study|Physician Decision|0|||
143281534|NCT00837811|516581209|FG001|Overall Study|Physician Decision|2|||
143281535|NCT00837811|516581210|FG002|Overall Study|Physician Decision|1|||
143281536|NCT00837811|516581208|FG000|Overall Study|Withdrawal by Subject|1|||
143281537|NCT00837811|516581209|FG001|Overall Study|Withdrawal by Subject|9|||
143281538|NCT00837811|516581210|FG002|Overall Study|Withdrawal by Subject|0|||
143281539|NCT00837811|516581208|FG000|Overall Study|Sponsor Decision|0|||
143281540|NCT00837811|516581209|FG001|Overall Study|Sponsor Decision|2|||
143281541|NCT00837811|516581210|FG002|Overall Study|Sponsor Decision|0|||
143281542|NCT03307967|516581211|FG000|Overall Study|Lost to Follow-up|4|||
143281543|NCT02578316|516581212|FG000|Extension Phase|Progression of disease|6|||
143281544|NCT03268954|516581213|FG000|Overall Study|Withdrawal by Subject|27|||
143281545|NCT03268954|516581214|FG001|Overall Study|Withdrawal by Subject|17|||
143281546|NCT03268954|516581213|FG000|Overall Study|Lost to Follow-up|2|||
143281547|NCT03268954|516581214|FG001|Overall Study|Lost to Follow-up|3|||
143281548|NCT03268954|516581213|FG000|Overall Study|Reason Not Specified|3|||
143281549|NCT03268954|516581214|FG001|Overall Study|Reason Not Specified|8|||
143281550|NCT02993146|516581217|FG000|Overall Study|Withdrawal by Subject|0|||
143281551|NCT02993146|516581218|FG001|Overall Study|Withdrawal by Subject|0|||
143281552|NCT02993146|516581219|FG002|Overall Study|Withdrawal by Subject|1|||
143281553|NCT02993146|516581220|FG003|Overall Study|Withdrawal by Subject|1|||
143281554|NCT04524689|516581223|FG000|Overall Study|Withdrawal by Subject|1|||
143281555|NCT04524689|516581224|FG001|Overall Study|Withdrawal by Subject|1|||
143281556|NCT04524689|516581225|FG002|Overall Study|Withdrawal by Subject|0|||
143281557|NCT04524689|516581226|FG003|Overall Study|Withdrawal by Subject|0|||
143281558|NCT04524689|516581227|FG004|Overall Study|Withdrawal by Subject|2|||
143281559|NCT04524689|516581228|FG005|Overall Study|Withdrawal by Subject|0|||
143281560|NCT04524689|516581223|FG000|Overall Study|Study terminated by Sponsor|6|||
143281561|NCT04524689|516581224|FG001|Overall Study|Study terminated by Sponsor|0|||
143281562|NCT04524689|516581225|FG002|Overall Study|Study terminated by Sponsor|1|||
143281563|NCT04524689|516581226|FG003|Overall Study|Study terminated by Sponsor|0|||
143281564|NCT04524689|516581227|FG004|Overall Study|Study terminated by Sponsor|4|||
143281565|NCT04524689|516581228|FG005|Overall Study|Study terminated by Sponsor|0|||
143281566|NCT04524689|516581223|FG000|Overall Study|Not related to Coronavirus disease 2019|9|||
143281567|NCT04524689|516581224|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
143281568|NCT04524689|516581225|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
143281569|NCT04524689|516581226|FG003|Overall Study|Not related to Coronavirus disease 2019|0|||
143281570|NCT04524689|516581227|FG004|Overall Study|Not related to Coronavirus disease 2019|0|||
143281571|NCT04524689|516581228|FG005|Overall Study|Not related to Coronavirus disease 2019|1|||
143281572|NCT05766423|516581229|FG000|Overall Study|Withdrawal by Subject|1|||
143281573|NCT05766423|516581230|FG001|Overall Study|Withdrawal by Subject|0|||
143281574|NCT05766423|516581229|FG000|Overall Study|Consented, not scheduled|3|||
143281575|NCT05766423|516581230|FG001|Overall Study|Consented, not scheduled|5|||
143281576|NCT00612690|516583292|FG000|Overall Study|Lost to Follow-up|72|||
143281577|NCT00612690|516583293|FG001|Overall Study|Lost to Follow-up|98|||
143281578|NCT00612690|516583292|FG000|Overall Study|Withdrawal by Subject|32|||
143281579|NCT00612690|516583293|FG001|Overall Study|Withdrawal by Subject|20|||
143281580|NCT00612690|516583292|FG000|Overall Study|Withdrawal by Site|11|||
143281581|NCT00612690|516583293|FG001|Overall Study|Withdrawal by Site|0|||
143281582|NCT01664533|516583294|FG000|Overall Study|Death|42|||
143281583|NCT01664533|516583294|FG000|Overall Study|Lost to Follow-up|3|||
143281584|NCT01664533|516583294|FG000|Overall Study|Study termination|9|||
143281585|NCT01664533|516583294|FG000|Overall Study|Protocol Violation|3|||
143281586|NCT00844831|516583296|FG000|Overall Study|Withdrawal by Subject|4|||
143281587|NCT00844831|516583296|FG000|Overall Study|Adverse Event|1|||
143281588|NCT00844831|516583296|FG000|Overall Study|Physician Decision|1|||
143281589|NCT05255068|516583297|FG000|Overall Study|Lost to Follow-up|0|||
143281590|NCT05255068|516583298|FG001|Overall Study|Lost to Follow-up|1|||
143281591|NCT00540514|516583300|FG000|Overall Study|Still on treatment|3|||
143281592|NCT00540514|516583301|FG001|Overall Study|Still on treatment|0|||
143281593|NCT00540514|516583300|FG000|Overall Study|Unacceptable Toxicity|61|||
143281594|NCT00540514|516583301|FG001|Overall Study|Unacceptable Toxicity|62|||
143281595|NCT00540514|516583300|FG000|Overall Study|Adverse Event|20|||
143281596|NCT00540514|516583301|FG001|Overall Study|Adverse Event|24|||
143281597|NCT00540514|516583300|FG000|Overall Study|Physician Decision|86|||
143281598|NCT00540514|516583301|FG001|Overall Study|Physician Decision|99|||
143281599|NCT00540514|516583300|FG000|Overall Study|Protocol Deviation|3|||
143281600|NCT00540514|516583301|FG001|Overall Study|Protocol Deviation|4|||
143281601|NCT00540514|516583300|FG000|Overall Study|Lost to Follow-up|1|||
143281602|NCT00540514|516583301|FG001|Overall Study|Lost to Follow-up|1|||
143281603|NCT00540514|516583300|FG000|Overall Study|Withdrawal by Subject|65|||
143281604|NCT00540514|516583301|FG001|Overall Study|Withdrawal by Subject|67|||
143281605|NCT00540514|516583300|FG000|Overall Study|Excluded prior to treatment|7|||
143281606|NCT00540514|516583301|FG001|Overall Study|Excluded prior to treatment|7|||
143281607|NCT00540514|516583300|FG000|Overall Study|Paclitaxel not available|0|||
143281608|NCT00540514|516583301|FG001|Overall Study|Paclitaxel not available|2|||
143281609|NCT04487730|516583302|FG000|Overall Study|Withdrawal by Subject|3|||
143281610|NCT04487730|516583303|FG001|Overall Study|Withdrawal by Subject|1|||
143281611|NCT04487730|516583302|FG000|Overall Study|Lost to Follow-up|0|||
143281612|NCT04487730|516583303|FG001|Overall Study|Lost to Follow-up|1|||
143281613|NCT04487730|516583302|FG000|Overall Study|Physician Decision|0|||
143281614|NCT04487730|516583303|FG001|Overall Study|Physician Decision|1|||
143281615|NCT00907777|516583304|FG000|Overall Study|Withdrawal by Subject|0|||
143281616|NCT00907777|516583305|FG001|Overall Study|Withdrawal by Subject|1|||
143281617|NCT03364023|516583308|FG000|Overall Study|Lost to Follow-up|3|||
143281618|NCT03364023|516583308|FG000|Overall Study|Death|14|||
143281619|NCT04115839|516583314|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
143281620|NCT04115839|516583315|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
143281621|NCT04115839|516583316|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
143281622|NCT04115839|516583317|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
143281623|NCT04115839|516583318|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
143281624|NCT04115839|516583319|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
143281625|NCT04115839|516583320|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
143281626|NCT04115839|516583314|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
143281627|NCT04115839|516583315|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
143281628|NCT04115839|516583316|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
143281629|NCT04115839|516583317|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
143281630|NCT04115839|516583318|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
143281631|NCT04115839|516583319|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
143281632|NCT04115839|516583320|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
143281633|NCT04115839|516583314|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
143281634|NCT04115839|516583315|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
143281635|NCT04115839|516583316|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
143281636|NCT04115839|516583317|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
143281637|NCT04115839|516583318|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
143281638|NCT04115839|516583319|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
143281639|NCT04115839|516583320|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
143281640|NCT04115839|516583314|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
143281641|NCT04115839|516583315|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
143281642|NCT04115839|516583316|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
143281643|NCT04115839|516583317|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
143281644|NCT04115839|516583318|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
143281645|NCT04115839|516583319|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
143281646|NCT04115839|516583320|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
143281647|NCT04115839|516583314|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
143281648|NCT04115839|516583315|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
143281649|NCT04115839|516583316|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
143281650|NCT04115839|516583317|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
143281651|NCT04115839|516583318|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
143281652|NCT04115839|516583319|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
143373132|NCT01087762|516911381|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
143373133|NCT01087762|516911382|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
143373134|NCT01087762|516911383|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
143281653|NCT04115839|516583320|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
143281654|NCT04115839|516583314|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
143281655|NCT04115839|516583315|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
143281656|NCT04115839|516583316|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
143281657|NCT04115839|516583317|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
143281658|NCT04115839|516583318|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
143281659|NCT04115839|516583319|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
143281660|NCT04115839|516583320|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
143281661|NCT03808545|516583323|FG000|Overall Study|Withdrawal by Subject|1|||
143281662|NCT03808545|516583324|FG001|Overall Study|Withdrawal by Subject|1|||
143281663|NCT01408485|516583325|FG000|Overall Study|Withdrawal by Subject|21|||
143281664|NCT00618072|516583326|FG000|Overall Study|Lost to Follow-up|2|||
143281665|NCT00618072|516583327|FG001|Overall Study|Lost to Follow-up|0|||
143281666|NCT00618072|516583328|FG002|Overall Study|Lost to Follow-up|3|||
143281667|NCT00618072|516583326|FG000|Overall Study|Physician Decision|0|||
143281668|NCT00618072|516583327|FG001|Overall Study|Physician Decision|1|||
143281669|NCT00618072|516583328|FG002|Overall Study|Physician Decision|1|||
143281670|NCT00573469|516583329|FG000|Overall Study|Adverse Event|1|||
143281671|NCT00573469|516583330|FG001|Overall Study|Adverse Event|1|||
143281672|NCT00573469|516583331|FG002|Overall Study|Adverse Event|1|||
143281673|NCT00573469|516583329|FG000|Overall Study|Withdrawal by Subject|0|||
143281674|NCT00573469|516583330|FG001|Overall Study|Withdrawal by Subject|2|||
143281675|NCT00573469|516583331|FG002|Overall Study|Withdrawal by Subject|0|||
143281676|NCT00573469|516583329|FG000|Overall Study|Other|5|||
143281677|NCT00573469|516583330|FG001|Overall Study|Other|1|||
143281678|NCT00573469|516583331|FG002|Overall Study|Other|3|||
143281679|NCT01338792|516583332|FG000|Overall Study|Adverse Event|2|||
143281680|NCT01338792|516583332|FG000|Overall Study|Death|1|||
143281681|NCT01338792|516583332|FG000|Overall Study|Withdrawal by Subject|1|||
143281682|NCT04932096|516583335|FG000|Overall Study|Withdrawal by Subject|1|||
143281683|NCT04932096|516583336|FG001|Overall Study|Withdrawal by Subject|1|||
143281684|NCT04932096|516583335|FG000|Overall Study|Partial completion (did not complete primary outcome survey)|0|||
143281685|NCT04932096|516583336|FG001|Overall Study|Partial completion (did not complete primary outcome survey)|1|||
143281686|NCT01508650|516583337|FG000|Overall Study|Lost to Follow-up|0|||
143281687|NCT01508650|516583338|FG001|Overall Study|Lost to Follow-up|3|||
143281688|NCT02064894|516583339|FG000|Overall Study|Withdrawal by Subject|43|||
143281689|NCT02064894|516583340|FG001|Overall Study|Withdrawal by Subject|102|||
143281690|NCT02064894|516583341|FG002|Overall Study|Withdrawal by Subject|115|||
143281691|NCT00520936|516583351|FG000|Overall Study|Physician Decision|0|||
143281692|NCT00520936|516583352|FG001|Overall Study|Physician Decision|2|||
143281693|NCT00520936|516583353|FG002|Overall Study|Physician Decision|1|||
143281694|NCT00520936|516583354|FG003|Overall Study|Physician Decision|0|||
143281695|NCT00520936|516583355|FG004|Overall Study|Physician Decision|0|||
143281696|NCT00520936|516583356|FG005|Overall Study|Physician Decision|0|||
143281697|NCT00520936|516583357|FG006|Overall Study|Physician Decision|0|||
143281698|NCT00520936|516583358|FG007|Overall Study|Physician Decision|0|||
143281699|NCT00520936|516583351|FG000|Overall Study|Withdrawal by Subject|0|||
143281700|NCT00520936|516583352|FG001|Overall Study|Withdrawal by Subject|0|||
143281701|NCT00520936|516583353|FG002|Overall Study|Withdrawal by Subject|0|||
143281702|NCT00520936|516583354|FG003|Overall Study|Withdrawal by Subject|0|||
143281703|NCT00520936|516583355|FG004|Overall Study|Withdrawal by Subject|0|||
143281704|NCT00520936|516583356|FG005|Overall Study|Withdrawal by Subject|0|||
143281705|NCT00520936|516583357|FG006|Overall Study|Withdrawal by Subject|0|||
143281706|NCT00520936|516583358|FG007|Overall Study|Withdrawal by Subject|1|||
143281707|NCT00520936|516583351|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
143281708|NCT00520936|516583352|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
143281709|NCT00520936|516583353|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
143281710|NCT00520936|516583354|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
143281711|NCT00520936|516583355|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
143281712|NCT00520936|516583356|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
143281713|NCT00520936|516583357|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
143281714|NCT00520936|516583358|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
143281715|NCT00520936|516583351|FG000|Overall Study|Death|0|||
143281716|NCT00520936|516583352|FG001|Overall Study|Death|0|||
143281717|NCT00520936|516583353|FG002|Overall Study|Death|0|||
143281718|NCT00520936|516583354|FG003|Overall Study|Death|0|||
143373135|NCT01087762|516911384|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
143373136|NCT01087762|516911385|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
143373137|NCT01087762|516911381|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
143373138|NCT01087762|516911382|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
143373139|NCT01087762|516911383|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
143373140|NCT01087762|516911384|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
143281719|NCT00520936|516583355|FG004|Overall Study|Death|0|||
143281720|NCT00520936|516583356|FG005|Overall Study|Death|0|||
143281721|NCT00520936|516583357|FG006|Overall Study|Death|1|||
143281722|NCT00520936|516583358|FG007|Overall Study|Death|0|||
143281723|NCT00520936|516583351|FG000|Overall Study|Protocol Violation|0|||
143281724|NCT00520936|516583352|FG001|Overall Study|Protocol Violation|1|||
143281725|NCT00520936|516583353|FG002|Overall Study|Protocol Violation|1|||
143281726|NCT00520936|516583354|FG003|Overall Study|Protocol Violation|0|||
143281727|NCT00520936|516583355|FG004|Overall Study|Protocol Violation|1|||
143281728|NCT00520936|516583356|FG005|Overall Study|Protocol Violation|0|||
143281729|NCT00520936|516583357|FG006|Overall Study|Protocol Violation|1|||
143281730|NCT00520936|516583358|FG007|Overall Study|Protocol Violation|0|||
143281731|NCT04343261|516583359|FG000|Overall Study|Adverse Event|1|||
143281732|NCT04343261|516583359|FG000|Overall Study|received inadequate amount of antibodies|7|||
143281733|NCT03616600|516583360|FG000|Overall Study|Withdrawal by Subject|1|||
143281734|NCT03616600|516583361|FG001|Overall Study|Withdrawal by Subject|0|||
143281735|NCT03984994|516583362|FG000|Overall Study|Withdrawal by Subject|2|||
143281736|NCT03984994|516583363|FG001|Overall Study|Withdrawal by Subject|1|||
143281737|NCT04220866|516583364|FG000|Overall Study|Death|4|||
143281738|NCT04220866|516583365|FG001|Overall Study|Death|5|||
143281739|NCT04220866|516583364|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
143281740|NCT04220866|516583365|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
143281741|NCT04220866|516583364|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
143281742|NCT04220866|516583365|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
143281743|NCT04220866|516583364|FG000|Overall Study|Withdrawal by Subject|0|||
143281744|NCT04220866|516583365|FG001|Overall Study|Withdrawal by Subject|1|||
143281745|NCT00726232|516583366|FG000|Initial Phase (Dose-finding)|Death|0|||
143281746|NCT00726232|516583367|FG001|Initial Phase (Dose-finding)|Death|0|||
143281747|NCT00726232|516583368|FG002|Initial Phase (Dose-finding)|Death|0|||
143281748|NCT00726232|516583369|FG003|Initial Phase (Dose-finding)|Death|0|||
143281749|NCT00726232|516583370|FG004|Initial Phase (Dose-finding)|Death|1|||
143281750|NCT00726232|516583371|FG005|Initial Phase (Dose-finding)|Death|0|||
143281751|NCT00726232|516583372|FG006|Initial Phase (Dose-finding)|Death|0|||
143281752|NCT00726232|516583373|FG007|Initial Phase (Dose-finding)|Death|0|||
143281753|NCT00726232|516583366|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
143281754|NCT00726232|516583367|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
143281755|NCT00726232|516583368|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
143281756|NCT00726232|516583369|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
143281757|NCT00726232|516583370|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
143281758|NCT00726232|516583371|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
143281759|NCT00726232|516583372|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
143281760|NCT00726232|516583373|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
143281761|NCT00726232|516583366|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
143281762|NCT00726232|516583367|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
143281763|NCT00726232|516583368|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
143281764|NCT00726232|516583369|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
143281765|NCT00726232|516583370|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
143281766|NCT00726232|516583371|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
143281767|NCT00726232|516583372|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
143281768|NCT00726232|516583373|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
143281769|NCT00726232|516583366|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
143281770|NCT00726232|516583367|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
143281771|NCT00726232|516583368|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
143281772|NCT00726232|516583369|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
143281773|NCT00726232|516583370|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
143281774|NCT00726232|516583371|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
143281775|NCT00726232|516583372|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
143281776|NCT00726232|516583373|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
143281777|NCT00726232|516583366|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
143281778|NCT00726232|516583367|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
143281779|NCT00726232|516583368|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
143281780|NCT00726232|516583369|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
143281781|NCT00726232|516583370|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
143281782|NCT00726232|516583371|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
143281783|NCT00726232|516583372|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
143281784|NCT00726232|516583373|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
143281785|NCT00726232|516583366|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
143281786|NCT00726232|516583367|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
143281787|NCT00726232|516583368|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
143373141|NCT01087762|516911385|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
143281788|NCT00726232|516583369|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
143281789|NCT00726232|516583370|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
143281790|NCT00726232|516583371|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
143373142|NCT01087762|516911381|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
143281791|NCT00726232|516583372|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
143281792|NCT00726232|516583373|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
143281793|NCT00726232|516583366|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
143281794|NCT00726232|516583367|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
143281795|NCT00726232|516583368|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
143281796|NCT00726232|516583369|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
143281797|NCT00726232|516583370|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
143281798|NCT00726232|516583371|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
143281799|NCT00726232|516583372|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
143281800|NCT00726232|516583373|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
143281801|NCT00726232|516583366|FG000|Expansion Phase|Death|0|||
143281802|NCT00726232|516583367|FG001|Expansion Phase|Death|0|||
143281803|NCT00726232|516583368|FG002|Expansion Phase|Death|0|||
143281804|NCT00726232|516583369|FG003|Expansion Phase|Death|0|||
143281805|NCT00726232|516583370|FG004|Expansion Phase|Death|0|||
143281806|NCT00726232|516583371|FG005|Expansion Phase|Death|0|||
143281807|NCT00726232|516583372|FG006|Expansion Phase|Death|0|||
143281808|NCT00726232|516583373|FG007|Expansion Phase|Death|1|||
143281809|NCT00726232|516583366|FG000|Expansion Phase|Adverse Event|0|||
143281810|NCT00726232|516583367|FG001|Expansion Phase|Adverse Event|0|||
143281811|NCT00726232|516583368|FG002|Expansion Phase|Adverse Event|0|||
143281812|NCT00726232|516583369|FG003|Expansion Phase|Adverse Event|0|||
143281813|NCT00726232|516583370|FG004|Expansion Phase|Adverse Event|0|||
143281814|NCT00726232|516583371|FG005|Expansion Phase|Adverse Event|0|||
143281815|NCT00726232|516583372|FG006|Expansion Phase|Adverse Event|6|||
143281816|NCT00726232|516583373|FG007|Expansion Phase|Adverse Event|11|||
143281817|NCT00726232|516583366|FG000|Expansion Phase|Withdrawal by Subject|0|||
143281818|NCT00726232|516583367|FG001|Expansion Phase|Withdrawal by Subject|0|||
143281819|NCT00726232|516583368|FG002|Expansion Phase|Withdrawal by Subject|0|||
143281820|NCT00726232|516583369|FG003|Expansion Phase|Withdrawal by Subject|0|||
143281821|NCT00726232|516583370|FG004|Expansion Phase|Withdrawal by Subject|0|||
143281822|NCT00726232|516583371|FG005|Expansion Phase|Withdrawal by Subject|0|||
143281823|NCT00726232|516583372|FG006|Expansion Phase|Withdrawal by Subject|2|||
143281824|NCT00726232|516583373|FG007|Expansion Phase|Withdrawal by Subject|3|||
143281825|NCT00726232|516583366|FG000|Expansion Phase|Disease progression|0|||
143281826|NCT00726232|516583367|FG001|Expansion Phase|Disease progression|0|||
143281827|NCT00726232|516583368|FG002|Expansion Phase|Disease progression|0|||
143281828|NCT00726232|516583369|FG003|Expansion Phase|Disease progression|0|||
143281829|NCT00726232|516583370|FG004|Expansion Phase|Disease progression|0|||
143281830|NCT00726232|516583371|FG005|Expansion Phase|Disease progression|0|||
143281831|NCT00726232|516583372|FG006|Expansion Phase|Disease progression|4|||
143281832|NCT00726232|516583373|FG007|Expansion Phase|Disease progression|0|||
143281833|NCT00726232|516583366|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
143281834|NCT00726232|516583367|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
143281835|NCT00726232|516583368|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
143281836|NCT00726232|516583369|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
143281837|NCT00726232|516583370|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
143281838|NCT00726232|516583371|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
143281839|NCT00726232|516583372|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
143281840|NCT00726232|516583373|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
143281841|NCT00726232|516583366|FG000|Expansion Phase|Per Investigator: lack of response|0|||
143281842|NCT00726232|516583367|FG001|Expansion Phase|Per Investigator: lack of response|0|||
143281843|NCT00726232|516583368|FG002|Expansion Phase|Per Investigator: lack of response|0|||
143281844|NCT00726232|516583369|FG003|Expansion Phase|Per Investigator: lack of response|0|||
143281845|NCT00726232|516583370|FG004|Expansion Phase|Per Investigator: lack of response|0|||
143281846|NCT00726232|516583371|FG005|Expansion Phase|Per Investigator: lack of response|0|||
143281847|NCT00726232|516583372|FG006|Expansion Phase|Per Investigator: lack of response|1|||
143281848|NCT00726232|516583373|FG007|Expansion Phase|Per Investigator: lack of response|7|||
143281849|NCT00726232|516583366|FG000|Expansion Phase|Unspecified reason|0|||
143281850|NCT00726232|516583367|FG001|Expansion Phase|Unspecified reason|0|||
143281851|NCT00726232|516583368|FG002|Expansion Phase|Unspecified reason|0|||
143281852|NCT00726232|516583369|FG003|Expansion Phase|Unspecified reason|0|||
143281853|NCT00726232|516583370|FG004|Expansion Phase|Unspecified reason|0|||
143281854|NCT00726232|516583371|FG005|Expansion Phase|Unspecified reason|0|||
143281855|NCT00726232|516583372|FG006|Expansion Phase|Unspecified reason|1|||
143281856|NCT00726232|516583373|FG007|Expansion Phase|Unspecified reason|0|||
143281857|NCT03858309|516583374|FG000|Overall Study|Withdrawal by Subject|2|||
143281858|NCT03858309|516583375|FG001|Overall Study|Withdrawal by Subject|3|||
143281859|NCT03897465|516583384|FG000|Overall Study|Lost to Follow-up|2|||
143281860|NCT03897465|516583385|FG001|Overall Study|Lost to Follow-up|1|||
143281861|NCT03897465|516583384|FG000|Overall Study|Adverse Event|2|||
143281862|NCT03897465|516583385|FG001|Overall Study|Adverse Event|0|||
143281863|NCT03897465|516583384|FG000|Overall Study|complete healing by V2|1|||
143281864|NCT03897465|516583385|FG001|Overall Study|complete healing by V2|0|||
143281865|NCT03897465|516583384|FG000|Overall Study|occurence of exclusion criterion|1|||
143281866|NCT03897465|516583385|FG001|Overall Study|occurence of exclusion criterion|1|||
143281867|NCT03897465|516583384|FG000|Overall Study|Other|1|||
143373143|NCT01087762|516911382|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
143373144|NCT01087762|516911383|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
143373145|NCT01087762|516911384|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
143373146|NCT01087762|516911385|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
143373147|NCT01087762|516911381|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
143281868|NCT03897465|516583385|FG001|Overall Study|Other|0|||
143281869|NCT02197247|516583386|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
143281870|NCT02197247|516583386|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
143281871|NCT02197247|516583386|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
143281872|NCT02197247|516583386|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
143281873|NCT02197247|516583386|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
143281874|NCT02197247|516583386|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
143281875|NCT02197247|516583386|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
143281876|NCT02197247|516583386|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
143281877|NCT00601458|516583392|FG000|Overall Study|Dosing Error|1|||
143281878|NCT00601458|516583393|FG001|Overall Study|Dosing Error|0|||
143281879|NCT00601458|516583394|FG002|Overall Study|Dosing Error|0|||
143281880|NCT00601458|516583392|FG000|Overall Study|Incomplete Data|0|||
143281881|NCT00601458|516583393|FG001|Overall Study|Incomplete Data|2|||
143281882|NCT00601458|516583394|FG002|Overall Study|Incomplete Data|0|||
143281883|NCT00601458|516583392|FG000|Overall Study|Protocol Violation|3|||
143281884|NCT00601458|516583393|FG001|Overall Study|Protocol Violation|2|||
143281885|NCT00601458|516583394|FG002|Overall Study|Protocol Violation|1|||
143281886|NCT00601458|516583392|FG000|Overall Study|Early Termination|0|||
143281887|NCT00601458|516583393|FG001|Overall Study|Early Termination|1|||
143281888|NCT00601458|516583394|FG002|Overall Study|Early Termination|1|||
143281889|NCT00370032|516583395|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
143281890|NCT00370032|516583396|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
143281891|NCT00370032|516583395|FG000|Washout Period|Withdrawal by Subject|0|||
143281892|NCT00370032|516583396|FG001|Washout Period|Withdrawal by Subject|1|||
143281893|NCT00370032|516583395|FG000|Washout Period|Lost to Follow-up|0|||
143281894|NCT00370032|516583396|FG001|Washout Period|Lost to Follow-up|1|||
143281895|NCT00370032|516583395|FG000|Washout Period|Adverse Event|1|||
143281896|NCT00370032|516583396|FG001|Washout Period|Adverse Event|0|||
143281897|NCT00370032|516583395|FG000|Follow-up Period|Withdrawal by Subject|1|||
143281898|NCT00370032|516583396|FG001|Follow-up Period|Withdrawal by Subject|0|||
143281899|NCT00518986|516583397|FG000|Overall Study|Adverse Event|12|||
143281900|NCT00518986|516583398|FG001|Overall Study|Adverse Event|7|||
143281901|NCT00518986|516583397|FG000|Overall Study|Lack of Efficacy|0|||
143281902|NCT00518986|516583398|FG001|Overall Study|Lack of Efficacy|2|||
143281903|NCT00518986|516583397|FG000|Overall Study|Lost to Follow-up|3|||
143281904|NCT00518986|516583398|FG001|Overall Study|Lost to Follow-up|2|||
143281905|NCT00518986|516583397|FG000|Overall Study|Physician Decision|0|||
143281906|NCT00518986|516583398|FG001|Overall Study|Physician Decision|3|||
143281907|NCT00518986|516583397|FG000|Overall Study|Protocol Violation|5|||
143281908|NCT00518986|516583398|FG001|Overall Study|Protocol Violation|7|||
143281909|NCT00518986|516583397|FG000|Overall Study|Withdrawal by Subject|4|||
143281910|NCT00518986|516583398|FG001|Overall Study|Withdrawal by Subject|4|||
143281911|NCT00518986|516583397|FG000|Overall Study|Non-Specific|2|||
143281912|NCT00518986|516583398|FG001|Overall Study|Non-Specific|1|||
143281913|NCT02166463|516583399|FG000|Overall Study|Lost to Follow-up|0|||
143281914|NCT02166463|516583400|FG001|Overall Study|Lost to Follow-up|1|||
143281915|NCT02166463|516583399|FG000|Overall Study|Physician Decision|10|||
143281916|NCT02166463|516583400|FG001|Overall Study|Physician Decision|10|||
143373148|NCT01087762|516911382|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
143373149|NCT01087762|516911383|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
143373150|NCT01087762|516911384|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
143373151|NCT01087762|516911385|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
143373152|NCT01087762|516911381|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
143373153|NCT01087762|516911382|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
143373154|NCT01087762|516911383|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
143373155|NCT01087762|516911384|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
143373156|NCT01087762|516911385|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
143373157|NCT01563354|516911387|FG000|Core Phase|Adverse Event|5|||
143373158|NCT01563354|516911388|FG001|Core Phase|Adverse Event|15|||
143373159|NCT01563354|516911389|FG002|Core Phase|Adverse Event|13|||
143373160|NCT01563354|516911387|FG000|Core Phase|Withdrawal by Subject|1|||
143373161|NCT01563354|516911388|FG001|Core Phase|Withdrawal by Subject|0|||
143373162|NCT01563354|516911389|FG002|Core Phase|Withdrawal by Subject|3|||
143373163|NCT01563354|516911387|FG000|Core Phase|Lost to Follow-up|1|||
143373164|NCT01563354|516911388|FG001|Core Phase|Lost to Follow-up|0|||
143373165|NCT01563354|516911389|FG002|Core Phase|Lost to Follow-up|0|||
143373166|NCT01563354|516911387|FG000|Core Phase|Death|1|||
143373167|NCT01563354|516911388|FG001|Core Phase|Death|5|||
143373168|NCT01563354|516911389|FG002|Core Phase|Death|2|||
143373169|NCT01563354|516911387|FG000|Core Phase|Diseasse progression|18|||
143373170|NCT01563354|516911388|FG001|Core Phase|Diseasse progression|7|||
143373171|NCT01563354|516911389|FG002|Core Phase|Diseasse progression|8|||
143373172|NCT01563354|516911387|FG000|Core Phase|Protocol deviation|2|||
143373173|NCT01563354|516911388|FG001|Core Phase|Protocol deviation|0|||
143373174|NCT01563354|516911389|FG002|Core Phase|Protocol deviation|0|||
143373175|NCT01563354|516911387|FG000|Core Phase|PI decision - did not enter extension|0|||
143373176|NCT01563354|516911388|FG001|Core Phase|PI decision - did not enter extension|1|||
143373177|NCT01563354|516911389|FG002|Core Phase|PI decision - did not enter extension|0|||
143373178|NCT01563354|516911387|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
143373179|NCT01563354|516911388|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
143373180|NCT01563354|516911389|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
143373181|NCT01563354|516911387|FG000|Extension Phase|Adverse Event|0|||
143373182|NCT01563354|516911388|FG001|Extension Phase|Adverse Event|3|||
143281917|NCT02166463|516583399|FG000|Overall Study|Ineligible|11|||
143281918|NCT02166463|516583400|FG001|Overall Study|Ineligible|2|||
143281919|NCT02166463|516583399|FG000|Overall Study|Progressive Disease|9|||
143281920|NCT02166463|516583400|FG001|Overall Study|Progressive Disease|6|||
143373183|NCT01563354|516911389|FG002|Extension Phase|Adverse Event|2|||
143373184|NCT01563354|516911387|FG000|Extension Phase|Withdrawal by Subject|0|||
143373185|NCT01563354|516911388|FG001|Extension Phase|Withdrawal by Subject|1|||
143373186|NCT01563354|516911389|FG002|Extension Phase|Withdrawal by Subject|0|||
143373187|NCT01563354|516911387|FG000|Extension Phase|Administration problems|3|||
143373188|NCT01563354|516911388|FG001|Extension Phase|Administration problems|2|||
143373189|NCT01563354|516911389|FG002|Extension Phase|Administration problems|3|||
143281921|NCT02166463|516583399|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
143281922|NCT02166463|516583400|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
143281923|NCT02166463|516583399|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
143373190|NCT01563354|516911387|FG000|Extension Phase|Disease progression|9|||
143373191|NCT01563354|516911388|FG001|Extension Phase|Disease progression|8|||
143373192|NCT01563354|516911389|FG002|Extension Phase|Disease progression|10|||
143373193|NCT01050569|516911392|FG000|Overall Study|Lost to Follow-up|20|||
143373194|NCT01050569|516911393|FG001|Overall Study|Lost to Follow-up|14|||
143373195|NCT01050569|516911394|FG002|Overall Study|Lost to Follow-up|16|||
143373196|NCT01050569|516911392|FG000|Overall Study|Withdrawal by Subject|9|||
143373197|NCT01050569|516911393|FG001|Overall Study|Withdrawal by Subject|3|||
143373198|NCT01050569|516911394|FG002|Overall Study|Withdrawal by Subject|11|||
143373199|NCT01050569|516911392|FG000|Overall Study|Lack of Efficacy|5|||
143373200|NCT01050569|516911393|FG001|Overall Study|Lack of Efficacy|4|||
143373201|NCT01050569|516911394|FG002|Overall Study|Lack of Efficacy|3|||
143373202|NCT01050569|516911392|FG000|Overall Study|Adverse Event|1|||
143373203|NCT01050569|516911393|FG001|Overall Study|Adverse Event|0|||
143373204|NCT01050569|516911394|FG002|Overall Study|Adverse Event|0|||
143373205|NCT01050569|516911392|FG000|Overall Study|Physician Decision|3|||
143373206|NCT01050569|516911393|FG001|Overall Study|Physician Decision|3|||
143373207|NCT01050569|516911394|FG002|Overall Study|Physician Decision|3|||
143373208|NCT03987451|516911397|FG000|Overall Study|Lost to Follow-up|1|||
143373209|NCT03987451|516911398|FG001|Overall Study|Lost to Follow-up|0|||
143373210|NCT03987451|516911397|FG000|Overall Study|Withdrawal by Subject|1|||
143373211|NCT03987451|516911398|FG001|Overall Study|Withdrawal by Subject|1|||
143373212|NCT00949975|516911401|FG000|Overall Study|Voluntary discontinuation|6|||
143373213|NCT00949975|516911402|FG001|Overall Study|Voluntary discontinuation|5|||
143373214|NCT00949975|516911403|FG002|Overall Study|Voluntary discontinuation|3|||
143373215|NCT00949975|516911404|FG003|Overall Study|Voluntary discontinuation|6|||
143373216|NCT00949975|516911401|FG000|Overall Study|Adverse Event|11|||
143373217|NCT00949975|516911402|FG001|Overall Study|Adverse Event|11|||
143373218|NCT00949975|516911403|FG002|Overall Study|Adverse Event|10|||
143373219|NCT00949975|516911404|FG003|Overall Study|Adverse Event|10|||
143373220|NCT00949975|516911401|FG000|Overall Study|Safety reason|0|||
143373221|NCT00949975|516911402|FG001|Overall Study|Safety reason|1|||
143373222|NCT00949975|516911403|FG002|Overall Study|Safety reason|0|||
143373223|NCT00949975|516911404|FG003|Overall Study|Safety reason|0|||
143373224|NCT00949975|516911401|FG000|Overall Study|Study-specific criteria|0|||
143373225|NCT00949975|516911402|FG001|Overall Study|Study-specific criteria|1|||
143373226|NCT00949975|516911403|FG002|Overall Study|Study-specific criteria|1|||
143373227|NCT00949975|516911404|FG003|Overall Study|Study-specific criteria|0|||
143373228|NCT00949975|516911401|FG000|Overall Study|Incorrect enrolment|5|||
143373229|NCT00949975|516911402|FG001|Overall Study|Incorrect enrolment|10|||
143373230|NCT00949975|516911403|FG002|Overall Study|Incorrect enrolment|4|||
143373231|NCT00949975|516911404|FG003|Overall Study|Incorrect enrolment|7|||
143373232|NCT00949975|516911401|FG000|Overall Study|Severe non-compliance|3|||
143373233|NCT00949975|516911402|FG001|Overall Study|Severe non-compliance|1|||
143373234|NCT00949975|516911403|FG002|Overall Study|Severe non-compliance|0|||
143373235|NCT00949975|516911404|FG003|Overall Study|Severe non-compliance|2|||
143373236|NCT00949975|516911401|FG000|Overall Study|Lost to Follow-up|1|||
143373237|NCT00949975|516911402|FG001|Overall Study|Lost to Follow-up|0|||
143373238|NCT00949975|516911403|FG002|Overall Study|Lost to Follow-up|1|||
143373239|NCT00949975|516911404|FG003|Overall Study|Lost to Follow-up|3|||
143373240|NCT00949975|516911401|FG000|Overall Study|Other|1|||
143373241|NCT00949975|516911402|FG001|Overall Study|Other|0|||
143373242|NCT00949975|516911403|FG002|Overall Study|Other|0|||
143281924|NCT02166463|516583400|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
143281925|NCT02166463|516583399|FG000|Overall Study|Refusal of further protocol therapy|5|||
143281926|NCT02166463|516583400|FG001|Overall Study|Refusal of further protocol therapy|6|||
143281927|NCT05683249|516583401|FG000|Overall Study|Adverse Event|3|||
143281928|NCT05683249|516583402|FG001|Overall Study|Adverse Event|1|||
143281929|NCT05683249|516583401|FG000|Overall Study|Lack of Efficacy|0|||
143281930|NCT05683249|516583402|FG001|Overall Study|Lack of Efficacy|2|||
143281931|NCT05683249|516583401|FG000|Overall Study|Lost to Follow-up|6|||
143281932|NCT05683249|516583402|FG001|Overall Study|Lost to Follow-up|5|||
143281933|NCT05683249|516583401|FG000|Overall Study|Non-compliance with Study Drug|2|||
143281934|NCT05683249|516583402|FG001|Overall Study|Non-compliance with Study Drug|0|||
143281935|NCT05683249|516583401|FG000|Overall Study|Protocol Violation|6|||
143281936|NCT05683249|516583402|FG001|Overall Study|Protocol Violation|3|||
143281937|NCT05683249|516583401|FG000|Overall Study|Withdrawal by Subject|9|||
143281938|NCT05683249|516583402|FG001|Overall Study|Withdrawal by Subject|8|||
143281939|NCT05683249|516583401|FG000|Overall Study|Other|0|||
143281940|NCT05683249|516583402|FG001|Overall Study|Other|2|||
143281941|NCT05469178|516583403|FG000|Overall Study|Death|1|||
143281942|NCT05469178|516583404|FG001|Overall Study|Death|1|||
143281943|NCT05469178|516583405|FG002|Overall Study|Death|3|||
143281944|NCT05469178|516583406|FG003|Overall Study|Death|6|||
143281945|NCT05469178|516583403|FG000|Overall Study|Lack of Efficacy|2|||
143281946|NCT05469178|516583404|FG001|Overall Study|Lack of Efficacy|2|||
143281947|NCT05469178|516583405|FG002|Overall Study|Lack of Efficacy|1|||
143281948|NCT05469178|516583406|FG003|Overall Study|Lack of Efficacy|10|||
143281949|NCT01328431|516583407|FG000|Baseline|Protocol Violation|0|||
143281950|NCT01328431|516583408|FG001|Baseline|Protocol Violation|2|||
143281951|NCT01328431|516583407|FG000|1 Month (1M)|Lost to Follow-up|55|||
143281952|NCT01328431|516583408|FG001|1 Month (1M)|Lost to Follow-up|58|||
143281953|NCT01328431|516583407|FG000|3 Month (3M)|Death|2|||
143281954|NCT01328431|516583408|FG001|3 Month (3M)|Death|2|||
143281955|NCT01328431|516583407|FG000|3 Month (3M)|Lost to Follow-up|75|||
143281956|NCT01328431|516583408|FG001|3 Month (3M)|Lost to Follow-up|70|||
143281957|NCT01328431|516583407|FG000|12 Month (12M)|Death|2|||
143281958|NCT01328431|516583408|FG001|12 Month (12M)|Death|6|||
143281959|NCT01328431|516583407|FG000|12 Month (12M)|Lost to Follow-up|82|||
143281960|NCT01328431|516583408|FG001|12 Month (12M)|Lost to Follow-up|91|||
143281961|NCT03617185|516583414|FG000|Baseline|Lost to Follow-up|0|||
143281962|NCT03617185|516583415|FG001|Baseline|Lost to Follow-up|2|||
143281963|NCT03617185|516583416|FG002|Baseline|Lost to Follow-up|1|||
143281964|NCT03617185|516583417|FG003|Baseline|Lost to Follow-up|1|||
143281965|NCT03617185|516583414|FG000|Baseline|Withdrawal by Subject|0|||
143281966|NCT03617185|516583415|FG001|Baseline|Withdrawal by Subject|1|||
143281967|NCT03617185|516583416|FG002|Baseline|Withdrawal by Subject|0|||
143281968|NCT03617185|516583417|FG003|Baseline|Withdrawal by Subject|1|||
143281969|NCT03617185|516583414|FG000|Baseline|Driving Distance/Travel|0|||
143281970|NCT03617185|516583415|FG001|Baseline|Driving Distance/Travel|0|||
143281971|NCT03617185|516583416|FG002|Baseline|Driving Distance/Travel|2|||
143281972|NCT03617185|516583417|FG003|Baseline|Driving Distance/Travel|0|||
143281973|NCT03617185|516583414|FG000|Baseline|Family Obligations|0|||
143281974|NCT03617185|516583415|FG001|Baseline|Family Obligations|0|||
143281975|NCT03617185|516583416|FG002|Baseline|Family Obligations|0|||
143281976|NCT03617185|516583417|FG003|Baseline|Family Obligations|1|||
143281977|NCT03617185|516583414|FG000|3 Months|Lost to Follow-up|4|||
143281978|NCT03617185|516583415|FG001|3 Months|Lost to Follow-up|1|||
143281979|NCT03617185|516583416|FG002|3 Months|Lost to Follow-up|0|||
143281980|NCT03617185|516583417|FG003|3 Months|Lost to Follow-up|2|||
143281981|NCT03617185|516583414|FG000|3 Months|Withdrawal by Subject|1|||
143281982|NCT03617185|516583415|FG001|3 Months|Withdrawal by Subject|3|||
143281983|NCT03617185|516583416|FG002|3 Months|Withdrawal by Subject|0|||
143281984|NCT03617185|516583417|FG003|3 Months|Withdrawal by Subject|0|||
143281985|NCT03617185|516583414|FG000|3 Months|Driving Distance/Travel|1|||
143281986|NCT03617185|516583415|FG001|3 Months|Driving Distance/Travel|0|||
143281987|NCT03617185|516583416|FG002|3 Months|Driving Distance/Travel|0|||
143281988|NCT03617185|516583417|FG003|3 Months|Driving Distance/Travel|0|||
143281989|NCT03617185|516583414|FG000|3 Months|Family Obligations|0|||
143281990|NCT03617185|516583415|FG001|3 Months|Family Obligations|0|||
143281991|NCT03617185|516583416|FG002|3 Months|Family Obligations|0|||
143281992|NCT03617185|516583417|FG003|3 Months|Family Obligations|1|||
143281993|NCT03617185|516583414|FG000|12 Months|Lost to Follow-up|3|||
143281994|NCT03617185|516583415|FG001|12 Months|Lost to Follow-up|1|||
143281995|NCT03617185|516583416|FG002|12 Months|Lost to Follow-up|3|||
143281996|NCT03617185|516583417|FG003|12 Months|Lost to Follow-up|0|||
143281997|NCT03617185|516583414|FG000|12 Months|Withdrawal by Subject|0|||
143281998|NCT03617185|516583415|FG001|12 Months|Withdrawal by Subject|0|||
143281999|NCT03617185|516583416|FG002|12 Months|Withdrawal by Subject|0|||
143282000|NCT03617185|516583417|FG003|12 Months|Withdrawal by Subject|1|||
143282001|NCT03617185|516583414|FG000|12 Months|Driving Distance/Travel|0|||
143282002|NCT03617185|516583415|FG001|12 Months|Driving Distance/Travel|0|||
143282003|NCT03617185|516583416|FG002|12 Months|Driving Distance/Travel|1|||
143282004|NCT03617185|516583417|FG003|12 Months|Driving Distance/Travel|0|||
143282005|NCT01964430|516583418|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
143282006|NCT01964430|516583419|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
143282007|NCT01964430|516583418|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
143282008|NCT01964430|516583419|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
143282009|NCT01964430|516583418|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
143282010|NCT01964430|516583419|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
143282011|NCT01964430|516583418|FG000|Treatment Period|Adverse Event|71|||
143282012|NCT01964430|516583419|FG001|Treatment Period|Adverse Event|37|||
143282013|NCT01964430|516583418|FG000|Treatment Period|Withdrawal by Subject|36|||
143282014|NCT01964430|516583419|FG001|Treatment Period|Withdrawal by Subject|27|||
143282015|NCT01964430|516583418|FG000|Treatment Period|Death|1|||
143282016|NCT01964430|516583419|FG001|Treatment Period|Death|3|||
143282017|NCT01964430|516583418|FG000|Treatment Period|Protocol Deviation|0|||
143282018|NCT01964430|516583419|FG001|Treatment Period|Protocol Deviation|1|||
143282019|NCT01964430|516583418|FG000|Treatment Period|Physician Decision|5|||
143282020|NCT01964430|516583419|FG001|Treatment Period|Physician Decision|4|||
143282021|NCT01964430|516583418|FG000|Treatment Period|Disease Relapse|28|||
143282022|NCT01964430|516583419|FG001|Treatment Period|Disease Relapse|38|||
143282023|NCT01964430|516583418|FG000|Treatment Period|Other reasons|1|||
143282024|NCT01964430|516583419|FG001|Treatment Period|Other reasons|3|||
143282025|NCT02801396|516583420|FG000|Period 1|Withdrawal by Subject|0|||
143282026|NCT02801396|516583421|FG001|Period 1|Withdrawal by Subject|0|||
143282027|NCT02801396|516583422|FG002|Period 1|Withdrawal by Subject|0|||
143282028|NCT02801396|516583423|FG003|Period 1|Withdrawal by Subject|0|||
143282029|NCT02801396|516583424|FG004|Period 1|Withdrawal by Subject|1|||
143282030|NCT02801396|516583425|FG005|Period 1|Withdrawal by Subject|0|||
143282031|NCT03322631|516583431|FG000|Overall Study|Withdrawal by Subject|0|||
143282032|NCT03322631|516583432|FG001|Overall Study|Withdrawal by Subject|1|||
143282033|NCT03322631|516583433|FG002|Overall Study|Withdrawal by Subject|0|||
143282034|NCT03322631|516583434|FG003|Overall Study|Withdrawal by Subject|0|||
143282035|NCT03322631|516583431|FG000|Overall Study|Adverse Event|0|||
143282036|NCT03322631|516583432|FG001|Overall Study|Adverse Event|0|||
143282037|NCT03322631|516583433|FG002|Overall Study|Adverse Event|1|||
143282038|NCT03322631|516583434|FG003|Overall Study|Adverse Event|0|||
143282039|NCT02412618|516583435|FG000|Overall Study|Withdrawal by Subject|1|||
143282040|NCT02412618|516583436|FG001|Overall Study|Withdrawal by Subject|1|||
143282041|NCT02412618|516583435|FG000|Overall Study|Expulsion|1|||
143282042|NCT02412618|516583436|FG001|Overall Study|Expulsion|1|||
143282043|NCT02378961|516583438|FG000|Overall Study|Lack of Efficacy|4|||
143282044|NCT02378961|516583439|FG001|Overall Study|Lack of Efficacy|2|||
143282045|NCT02378961|516583440|FG002|Overall Study|Lack of Efficacy|0|||
143282046|NCT02378961|516583441|FG003|Overall Study|Lack of Efficacy|1|||
143282047|NCT02378961|516583438|FG000|Overall Study|Death|0|||
143282048|NCT02378961|516583439|FG001|Overall Study|Death|0|||
143282049|NCT02378961|516583440|FG002|Overall Study|Death|1|||
143282050|NCT02378961|516583441|FG003|Overall Study|Death|0|||
143282051|NCT01253408|516583442|FG000|Overall Study|Adverse Event|0|||
143282052|NCT01253408|516583443|FG001|Overall Study|Adverse Event|1|||
143282053|NCT01253408|516583444|FG002|Overall Study|Adverse Event|0|||
143282054|NCT04967443|516583454|FG000|Open Label Treatment|Death|1|||
143282055|NCT04967443|516583455|FG001|Open Label Treatment|Death|0|||
143282056|NCT04967443|516583456|FG002|Open Label Treatment|Death|0|||
143282057|NCT04967443|516583457|FG003|Open Label Treatment|Death|0|||
143282058|NCT04967443|516583458|FG004|Open Label Treatment|Death|0|||
143282059|NCT04967443|516583459|FG005|Open Label Treatment|Death|0|||
143282060|NCT04967443|516583460|FG006|Open Label Treatment|Death|0|||
143282061|NCT04967443|516583461|FG007|Open Label Treatment|Death|0|||
143282062|NCT04967443|516583454|FG000|Open Label Treatment|Lost to Follow-up|0|||
143282063|NCT04967443|516583455|FG001|Open Label Treatment|Lost to Follow-up|0|||
143282064|NCT04967443|516583456|FG002|Open Label Treatment|Lost to Follow-up|1|||
143282065|NCT04967443|516583457|FG003|Open Label Treatment|Lost to Follow-up|0|||
143282066|NCT04967443|516583458|FG004|Open Label Treatment|Lost to Follow-up|0|||
143282067|NCT04967443|516583459|FG005|Open Label Treatment|Lost to Follow-up|0|||
143282068|NCT04967443|516583460|FG006|Open Label Treatment|Lost to Follow-up|0|||
143282069|NCT04967443|516583461|FG007|Open Label Treatment|Lost to Follow-up|0|||
143282070|NCT04967443|516583454|FG000|Open Label Treatment|Withdrawal by Subject|0|||
143282071|NCT04967443|516583455|FG001|Open Label Treatment|Withdrawal by Subject|1|||
143282072|NCT04967443|516583456|FG002|Open Label Treatment|Withdrawal by Subject|0|||
143282073|NCT04967443|516583457|FG003|Open Label Treatment|Withdrawal by Subject|1|||
143282074|NCT04967443|516583458|FG004|Open Label Treatment|Withdrawal by Subject|0|||
143282075|NCT04967443|516583459|FG005|Open Label Treatment|Withdrawal by Subject|1|||
143282076|NCT04967443|516583460|FG006|Open Label Treatment|Withdrawal by Subject|2|||
143282077|NCT04967443|516583461|FG007|Open Label Treatment|Withdrawal by Subject|3|||
143282078|NCT04967443|516583454|FG000|Follow-Up|Death|1|||
143282079|NCT04967443|516583455|FG001|Follow-Up|Death|0|||
143282080|NCT04967443|516583456|FG002|Follow-Up|Death|0|||
143282081|NCT04967443|516583457|FG003|Follow-Up|Death|0|||
143282082|NCT04967443|516583458|FG004|Follow-Up|Death|0|||
143282083|NCT04967443|516583459|FG005|Follow-Up|Death|0|||
143282084|NCT04967443|516583460|FG006|Follow-Up|Death|0|||
143282085|NCT04967443|516583461|FG007|Follow-Up|Death|0|||
143282086|NCT04967443|516583454|FG000|Follow-Up|Lost to Follow-up|0|||
143282087|NCT04967443|516583455|FG001|Follow-Up|Lost to Follow-up|0|||
143282088|NCT04967443|516583456|FG002|Follow-Up|Lost to Follow-up|1|||
143282089|NCT04967443|516583457|FG003|Follow-Up|Lost to Follow-up|1|||
143282090|NCT04967443|516583458|FG004|Follow-Up|Lost to Follow-up|0|||
143282091|NCT04967443|516583459|FG005|Follow-Up|Lost to Follow-up|0|||
143282092|NCT04967443|516583460|FG006|Follow-Up|Lost to Follow-up|0|||
143282093|NCT04967443|516583461|FG007|Follow-Up|Lost to Follow-up|0|||
143282094|NCT04967443|516583454|FG000|Follow-Up|Withdrawal by Subject|0|||
143282095|NCT04967443|516583455|FG001|Follow-Up|Withdrawal by Subject|1|||
143282096|NCT04967443|516583456|FG002|Follow-Up|Withdrawal by Subject|0|||
143282097|NCT04967443|516583457|FG003|Follow-Up|Withdrawal by Subject|1|||
143282098|NCT04967443|516583458|FG004|Follow-Up|Withdrawal by Subject|0|||
143282099|NCT04967443|516583459|FG005|Follow-Up|Withdrawal by Subject|1|||
143282100|NCT04967443|516583460|FG006|Follow-Up|Withdrawal by Subject|2|||
143282101|NCT04967443|516583461|FG007|Follow-Up|Withdrawal by Subject|3|||
143282102|NCT02405780|516583462|FG000|Period I|Adverse Event|8|||
143282103|NCT02405780|516583463|FG001|Period I|Adverse Event|0|||
143282104|NCT02405780|516583464|FG002|Period I|Adverse Event|3|||
143282105|NCT02405780|516583465|FG003|Period I|Adverse Event|7|||
143282106|NCT02405780|516583462|FG000|Period I|Medical reasons|1|||
143282107|NCT02405780|516583463|FG001|Period I|Medical reasons|1|||
143282108|NCT02405780|516583464|FG002|Period I|Medical reasons|0|||
143282109|NCT02405780|516583465|FG003|Period I|Medical reasons|1|||
143282110|NCT02405780|516583462|FG000|Period I|Screening Failure|1|||
143282111|NCT02405780|516583463|FG001|Period I|Screening Failure|0|||
143282112|NCT02405780|516583464|FG002|Period I|Screening Failure|1|||
143282113|NCT02405780|516583465|FG003|Period I|Screening Failure|0|||
143282114|NCT02405780|516583462|FG000|Period I|Withdrawal by Subject|9|||
143282115|NCT02405780|516583463|FG001|Period I|Withdrawal by Subject|1|||
143282116|NCT02405780|516583464|FG002|Period I|Withdrawal by Subject|3|||
143282117|NCT02405780|516583465|FG003|Period I|Withdrawal by Subject|4|||
143282118|NCT02405780|516583462|FG000|Period I|Non-compliance with study procedures|8|||
143282119|NCT02405780|516583463|FG001|Period I|Non-compliance with study procedures|6|||
143282120|NCT02405780|516583464|FG002|Period I|Non-compliance with study procedures|8|||
143282121|NCT02405780|516583465|FG003|Period I|Non-compliance with study procedures|11|||
143282122|NCT02405780|516583462|FG000|Period II|Adverse Event|3|||
143282123|NCT02405780|516583463|FG001|Period II|Adverse Event|5|||
143282124|NCT02405780|516583464|FG002|Period II|Adverse Event|4|||
143282125|NCT02405780|516583465|FG003|Period II|Adverse Event|11|||
143282126|NCT02405780|516583462|FG000|Period II|Medical reason|0|||
143282127|NCT02405780|516583463|FG001|Period II|Medical reason|1|||
143282128|NCT02405780|516583464|FG002|Period II|Medical reason|0|||
143282129|NCT02405780|516583465|FG003|Period II|Medical reason|0|||
143282130|NCT02405780|516583462|FG000|Period II|Pregnancy|0|||
143282131|NCT02405780|516583463|FG001|Period II|Pregnancy|0|||
143282132|NCT02405780|516583464|FG002|Period II|Pregnancy|1|||
143282133|NCT02405780|516583465|FG003|Period II|Pregnancy|0|||
143282134|NCT02405780|516583462|FG000|Period II|Withdrawal by Subject|7|||
143282135|NCT02405780|516583463|FG001|Period II|Withdrawal by Subject|4|||
143282136|NCT02405780|516583464|FG002|Period II|Withdrawal by Subject|0|||
143282137|NCT02405780|516583465|FG003|Period II|Withdrawal by Subject|3|||
143282138|NCT02405780|516583462|FG000|Period II|Non-compliance with study procedures|5|||
143282139|NCT02405780|516583463|FG001|Period II|Non-compliance with study procedures|2|||
143282140|NCT02405780|516583464|FG002|Period II|Non-compliance with study procedures|7|||
143282141|NCT02405780|516583465|FG003|Period II|Non-compliance with study procedures|4|||
143282142|NCT01654536|516583466|FG000|Overall Study|Lost to Follow-up|5|||
143282143|NCT01654536|516583467|FG001|Overall Study|Lost to Follow-up|5|||
143282144|NCT01654536|516583466|FG000|Overall Study|Physician Decision|12|||
143282145|NCT01654536|516583467|FG001|Overall Study|Physician Decision|8|||
143282146|NCT01654536|516583466|FG000|Overall Study|Withdrawal by Subject|27|||
143373243|NCT00949975|516911404|FG003|Overall Study|Other|0|||
143282147|NCT01654536|516583467|FG001|Overall Study|Withdrawal by Subject|25|||
143282148|NCT00602797|516583468|FG000|Overall Study|Adverse Event|1|||
143282149|NCT04502693|516583470|FG000|Overall Study|Adverse Event|7|||
143282150|NCT04502693|516583471|FG001|Overall Study|Adverse Event|6|||
143282151|NCT04502693|516583472|FG002|Overall Study|Adverse Event|11|||
143282152|NCT04502693|516583473|FG003|Overall Study|Adverse Event|1|||
143282153|NCT04502693|516583470|FG000|Overall Study|Lost to Follow-up|32|||
143282154|NCT04502693|516583471|FG001|Overall Study|Lost to Follow-up|36|||
143282155|NCT04502693|516583472|FG002|Overall Study|Lost to Follow-up|69|||
143282156|NCT04502693|516583473|FG003|Overall Study|Lost to Follow-up|4|||
143282157|NCT04502693|516583470|FG000|Overall Study|Protocol Violation|8|||
143282158|NCT04502693|516583471|FG001|Overall Study|Protocol Violation|8|||
143282159|NCT04502693|516583472|FG002|Overall Study|Protocol Violation|16|||
143282160|NCT04502693|516583473|FG003|Overall Study|Protocol Violation|1|||
143282161|NCT04502693|516583470|FG000|Overall Study|Withdrawal by Subject|46|||
143282162|NCT04502693|516583471|FG001|Overall Study|Withdrawal by Subject|38|||
143282163|NCT04502693|516583472|FG002|Overall Study|Withdrawal by Subject|54|||
143282164|NCT04502693|516583473|FG003|Overall Study|Withdrawal by Subject|7|||
143282165|NCT04502693|516583470|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
143282166|NCT04502693|516583471|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
143282167|NCT04502693|516583472|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
143282168|NCT04502693|516583473|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
143282169|NCT04502693|516583470|FG000|Overall Study|Other|1|||
143282170|NCT04502693|516583471|FG001|Overall Study|Other|0|||
143282171|NCT04502693|516583472|FG002|Overall Study|Other|1|||
143282172|NCT04502693|516583473|FG003|Overall Study|Other|1|||
143282173|NCT03736447|516583476|FG000|Overall Study|Adverse Event|5|||
143282174|NCT03736447|516583477|FG001|Overall Study|Adverse Event|1|||
143282175|NCT03736447|516583476|FG000|Overall Study|Withdrawal by Subject|5|||
143282176|NCT03736447|516583477|FG001|Overall Study|Withdrawal by Subject|1|||
143282177|NCT03736447|516583476|FG000|Overall Study|Lost to Follow-up|1|||
143282178|NCT03736447|516583477|FG001|Overall Study|Lost to Follow-up|0|||
143282179|NCT03736447|516583476|FG000|Overall Study|Physician Decision|1|||
143282180|NCT03736447|516583477|FG001|Overall Study|Physician Decision|0|||
143282181|NCT03736447|516583476|FG000|Overall Study|Continued commitment to study treatment|3|||
143282182|NCT03736447|516583477|FG001|Overall Study|Continued commitment to study treatment|0|||
143282183|NCT03736447|516583476|FG000|Overall Study|Taste aversion to study product|0|||
143282184|NCT03736447|516583477|FG001|Overall Study|Taste aversion to study product|1|||
143282185|NCT00361569|516583479|FG000|Overall Study|Protocol Violation|3|||
143282186|NCT00361569|516583480|FG001|Overall Study|Protocol Violation|2|||
143282187|NCT00361569|516583481|FG002|Overall Study|Protocol Violation|4|||
143282188|NCT00361569|516583482|FG003|Overall Study|Protocol Violation|2|||
143282189|NCT00361569|516583479|FG000|Overall Study|Withdrawal by Subject|2|||
143282190|NCT00361569|516583480|FG001|Overall Study|Withdrawal by Subject|1|||
143282191|NCT00361569|516583481|FG002|Overall Study|Withdrawal by Subject|9|||
143282192|NCT00361569|516583482|FG003|Overall Study|Withdrawal by Subject|14|||
143282193|NCT00361569|516583479|FG000|Overall Study|Adverse Event|3|||
143282194|NCT00361569|516583480|FG001|Overall Study|Adverse Event|5|||
143282195|NCT00361569|516583481|FG002|Overall Study|Adverse Event|2|||
143282196|NCT00361569|516583482|FG003|Overall Study|Adverse Event|2|||
143282197|NCT00361569|516583479|FG000|Overall Study|Lost to Follow-up|2|||
143282198|NCT00361569|516583480|FG001|Overall Study|Lost to Follow-up|3|||
143282199|NCT00361569|516583481|FG002|Overall Study|Lost to Follow-up|3|||
143282200|NCT00361569|516583482|FG003|Overall Study|Lost to Follow-up|2|||
143282201|NCT00361569|516583479|FG000|Overall Study|Not specified by investigator|2|||
143282202|NCT00361569|516583480|FG001|Overall Study|Not specified by investigator|0|||
143282203|NCT00361569|516583481|FG002|Overall Study|Not specified by investigator|0|||
143282204|NCT00361569|516583482|FG003|Overall Study|Not specified by investigator|1|||
143282205|NCT03329573|516583483|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
143282206|NCT03329573|516583484|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
143282207|NCT03329573|516583485|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
143282208|NCT03329573|516583486|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
143282209|NCT03329573|516583483|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
143282210|NCT03329573|516583484|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
143282211|NCT03329573|516583485|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
143282212|NCT03329573|516583486|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
143282213|NCT03329573|516583483|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
143282214|NCT03329573|516583484|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
143282215|NCT03329573|516583485|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
143282216|NCT03329573|516583486|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
143282217|NCT03329573|516583483|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
143282218|NCT03329573|516583484|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
143282219|NCT03329573|516583485|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
143373244|NCT04347954|516911405|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
143373245|NCT04347954|516911406|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
143373246|NCT04347954|516911407|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
143282220|NCT03329573|516583486|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
143282221|NCT04698187|516583490|FG000|Overall Study|Withdrawal by Subject|7|||
143282222|NCT04698187|516583490|FG000|Overall Study|Death|21|||
143282223|NCT04698187|516583490|FG000|Overall Study|Sponsor Decision|15|||
143282224|NCT04698187|516583490|FG000|Overall Study|In-transit Disease|1|||
143282225|NCT03820986|516583491|FG000|Overall Study|Death|201|||
143282226|NCT03820986|516583492|FG001|Overall Study|Death|175|||
143282227|NCT03820986|516583491|FG000|Overall Study|Lost to Follow-up|1|||
143282228|NCT03820986|516583492|FG001|Overall Study|Lost to Follow-up|1|||
143282229|NCT03820986|516583491|FG000|Overall Study|Physician Decision|1|||
143282230|NCT03820986|516583492|FG001|Overall Study|Physician Decision|0|||
143282231|NCT03820986|516583491|FG000|Overall Study|Sponsor Decision|122|||
143282232|NCT03820986|516583492|FG001|Overall Study|Sponsor Decision|160|||
143282233|NCT03820986|516583491|FG000|Overall Study|Withdrawal by Subject|9|||
143282234|NCT03820986|516583492|FG001|Overall Study|Withdrawal by Subject|4|||
143282235|NCT04292743|516583495|FG000|Overall Study|Physician Decision|1|||
143282236|NCT04292743|516583496|FG001|Overall Study|Physician Decision|3|||
143282237|NCT04292743|516583497|FG002|Overall Study|Physician Decision|0|||
143282238|NCT04292743|516583498|FG003|Overall Study|Physician Decision|0|||
143282239|NCT04292743|516583495|FG000|Overall Study|Withdrawal by Subject|0|||
143282240|NCT04292743|516583496|FG001|Overall Study|Withdrawal by Subject|5|||
143282241|NCT04292743|516583497|FG002|Overall Study|Withdrawal by Subject|0|||
143282242|NCT04292743|516583498|FG003|Overall Study|Withdrawal by Subject|0|||
143282243|NCT04292743|516583495|FG000|Overall Study|Death|0|||
143282244|NCT04292743|516583496|FG001|Overall Study|Death|1|||
143282245|NCT04292743|516583497|FG002|Overall Study|Death|0|||
143282246|NCT04292743|516583498|FG003|Overall Study|Death|0|||
143282247|NCT04292743|516583495|FG000|Overall Study|Progression of Disease|2|||
143282248|NCT04292743|516583496|FG001|Overall Study|Progression of Disease|5|||
143282249|NCT04292743|516583497|FG002|Overall Study|Progression of Disease|0|||
143282250|NCT04292743|516583498|FG003|Overall Study|Progression of Disease|0|||
143282251|NCT04292743|516583495|FG000|Overall Study|No Treatment per protocol|0|||
143282252|NCT04292743|516583496|FG001|Overall Study|No Treatment per protocol|2|||
143282253|NCT04292743|516583497|FG002|Overall Study|No Treatment per protocol|0|||
143282254|NCT04292743|516583498|FG003|Overall Study|No Treatment per protocol|0|||
143282255|NCT00790023|516585418|FG000|Overall Study|Adverse Event|2|||
143282256|NCT00790023|516585419|FG001|Overall Study|Adverse Event|1|||
143282257|NCT00790023|516585420|FG002|Overall Study|Adverse Event|4|||
143282258|NCT00790023|516585418|FG000|Overall Study|Protocol Violation|2|||
143282259|NCT00790023|516585419|FG001|Overall Study|Protocol Violation|4|||
143282260|NCT00790023|516585420|FG002|Overall Study|Protocol Violation|2|||
143282261|NCT00790023|516585418|FG000|Overall Study|Withdrawal by Subject|2|||
143282262|NCT00790023|516585419|FG001|Overall Study|Withdrawal by Subject|0|||
143282263|NCT00790023|516585420|FG002|Overall Study|Withdrawal by Subject|6|||
143282264|NCT00790023|516585418|FG000|Overall Study|Lost to Follow-up|0|||
143282265|NCT00790023|516585419|FG001|Overall Study|Lost to Follow-up|0|||
143282266|NCT00790023|516585420|FG002|Overall Study|Lost to Follow-up|1|||
143282267|NCT00790023|516585418|FG000|Overall Study|Other|5|||
143282268|NCT00790023|516585419|FG001|Overall Study|Other|5|||
143282269|NCT00790023|516585420|FG002|Overall Study|Other|8|||
143282270|NCT02468414|516585421|FG000|Overall Study|Early Study Termination by Sponsor|1|||
143282271|NCT02468414|516585422|FG001|Overall Study|Early Study Termination by Sponsor|0|||
143282272|NCT02468414|516585421|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
143282273|NCT02468414|516585422|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
143282274|NCT02468414|516585421|FG000|Overall Study|Screen Failure|1|||
143282275|NCT02468414|516585422|FG001|Overall Study|Screen Failure|0|||
143282276|NCT00429273|516585428|FG000|Overall Study|Lost to Follow-up|1|||
143282277|NCT00429273|516585429|FG001|Overall Study|Lost to Follow-up|2|||
143282278|NCT00429273|516585430|FG002|Overall Study|Lost to Follow-up|2|||
143282279|NCT00429273|516585428|FG000|Overall Study|Physician Decision|6|||
143282280|NCT00429273|516585429|FG001|Overall Study|Physician Decision|5|||
143282281|NCT00429273|516585430|FG002|Overall Study|Physician Decision|5|||
143282282|NCT00429273|516585428|FG000|Overall Study|Adverse Event|1|||
143282283|NCT00429273|516585429|FG001|Overall Study|Adverse Event|1|||
143282284|NCT00429273|516585430|FG002|Overall Study|Adverse Event|2|||
143282285|NCT00884312|516585431|FG000|Overall Study|Non-fatal Progressive Disease|0|||
143282286|NCT00884312|516585432|FG001|Overall Study|Non-fatal Progressive Disease|8|||
143282287|NCT00884312|516585431|FG000|Overall Study|Fatal Progressive Disease|0|||
143282288|NCT00884312|516585432|FG001|Overall Study|Fatal Progressive Disease|1|||
143282289|NCT00884312|516585431|FG000|Overall Study|Non-fatal Adverse Event|1|||
143282290|NCT00884312|516585432|FG001|Overall Study|Non-fatal Adverse Event|0|||
143282291|NCT00884312|516585431|FG000|Overall Study|Fatal Adverse Event|1|||
143282292|NCT00884312|516585432|FG001|Overall Study|Fatal Adverse Event|4|||
143282293|NCT00884312|516585431|FG000|Overall Study|Withdrawal by Subject|0|||
143282294|NCT00884312|516585432|FG001|Overall Study|Withdrawal by Subject|6|||
143282295|NCT00884312|516585431|FG000|Overall Study|Physician Decision|0|||
143282296|NCT00884312|516585432|FG001|Overall Study|Physician Decision|1|||
143282297|NCT00884312|516585431|FG000|Overall Study|Other|0|||
143282298|NCT00884312|516585432|FG001|Overall Study|Other|4|||
143282299|NCT00884312|516585431|FG000|Overall Study|Did Not Receive Study Drug|0|||
143282300|NCT00884312|516585432|FG001|Overall Study|Did Not Receive Study Drug|1|||
143282301|NCT00224042|516585433|FG000|Overall Study|Adverse Event|2|||
143282302|NCT00224042|516585434|FG001|Overall Study|Adverse Event|1|||
143282303|NCT00224042|516585433|FG000|Overall Study|Protocol Violation|0|||
143282304|NCT00224042|516585434|FG001|Overall Study|Protocol Violation|1|||
143282305|NCT00224042|516585433|FG000|Overall Study|Physician Decision|0|||
143282306|NCT00224042|516585434|FG001|Overall Study|Physician Decision|1|||
143282307|NCT00224042|516585433|FG000|Overall Study|Did not meet lab incusion criteria|2|||
143282308|NCT00224042|516585434|FG001|Overall Study|Did not meet lab incusion criteria|3|||
143282309|NCT00224042|516585433|FG000|Overall Study|Other|2|||
143282310|NCT00224042|516585434|FG001|Overall Study|Other|0|||
143282311|NCT01854710|516585436|FG000|Overall Study|Withdrawal by Subject|2|||
143282312|NCT01854710|516585437|FG001|Overall Study|Withdrawal by Subject|1|||
143282313|NCT01854710|516585438|FG002|Overall Study|Withdrawal by Subject|0|||
143282314|NCT01854710|516585439|FG003|Overall Study|Withdrawal by Subject|0|||
143282315|NCT01854710|516585440|FG004|Overall Study|Withdrawal by Subject|0|||
143282316|NCT01854710|516585441|FG005|Overall Study|Withdrawal by Subject|0|||
143282317|NCT01854710|516585436|FG000|Overall Study|CRI procedural error|2|||
143282318|NCT01854710|516585437|FG001|Overall Study|CRI procedural error|2|||
143282319|NCT01854710|516585438|FG002|Overall Study|CRI procedural error|2|||
143282320|NCT01854710|516585439|FG003|Overall Study|CRI procedural error|2|||
143282321|NCT01854710|516585440|FG004|Overall Study|CRI procedural error|2|||
143282322|NCT01854710|516585441|FG005|Overall Study|CRI procedural error|2|||
143282323|NCT02296320|516585442|FG000|Overall Study|Withdrawal by Subject|4|||
143282324|NCT02296320|516585443|FG001|Overall Study|Withdrawal by Subject|0|||
143282325|NCT02296320|516585444|FG002|Overall Study|Withdrawal by Subject|2|||
143282326|NCT02296320|516585442|FG000|Overall Study|Death|24|||
143282327|NCT02296320|516585443|FG001|Overall Study|Death|3|||
143282328|NCT02296320|516585444|FG002|Overall Study|Death|27|||
143282329|NCT02296320|516585442|FG000|Overall Study|Lost to Follow-up|5|||
143282330|NCT02296320|516585443|FG001|Overall Study|Lost to Follow-up|2|||
143282331|NCT02296320|516585444|FG002|Overall Study|Lost to Follow-up|7|||
143282332|NCT02296320|516585442|FG000|Overall Study|Not treated|2|||
143282333|NCT02296320|516585443|FG001|Overall Study|Not treated|0|||
143282334|NCT02296320|516585444|FG002|Overall Study|Not treated|0|||
143282335|NCT02296320|516585442|FG000|Overall Study|Not - specified|0|||
143282336|NCT02296320|516585443|FG001|Overall Study|Not - specified|0|||
143282337|NCT02296320|516585444|FG002|Overall Study|Not - specified|1|||
143282338|NCT02099708|516585445|FG000|Overall Study|Data Not Available|30|||
143282339|NCT02099708|516585445|FG000|Overall Study|Lost to Follow-up|141|||
143282340|NCT02099708|516585445|FG000|Overall Study|Other|29|||
143282341|NCT01930123|516585449|FG000|Overall Study|Adverse Event|1|||
143282342|NCT01930123|516585450|FG001|Overall Study|Adverse Event|0|||
143282343|NCT01930123|516585449|FG000|Overall Study|Physician Decision|21|||
143282344|NCT01930123|516585450|FG001|Overall Study|Physician Decision|8|||
143282345|NCT01930123|516585449|FG000|Overall Study|Withdrawal by Subject|1|||
143282346|NCT01930123|516585450|FG001|Overall Study|Withdrawal by Subject|0|||
143282347|NCT03310021|516585454|FG000|Overall Study|Withdrawal by Subject|0|||
143282348|NCT03310021|516585455|FG001|Overall Study|Withdrawal by Subject|0|||
143282349|NCT03310021|516585456|FG002|Overall Study|Withdrawal by Subject|0|||
143282350|NCT03310021|516585457|FG003|Overall Study|Withdrawal by Subject|0|||
143282351|NCT03310021|516585458|FG004|Overall Study|Withdrawal by Subject|0|||
143282352|NCT03310021|516585459|FG005|Overall Study|Withdrawal by Subject|0|||
143282353|NCT03310021|516585460|FG006|Overall Study|Withdrawal by Subject|1|||
143282354|NCT03310021|516585461|FG007|Overall Study|Withdrawal by Subject|0|||
143282355|NCT03310021|516585462|FG008|Overall Study|Withdrawal by Subject|0|||
143282356|NCT03310021|516585463|FG009|Overall Study|Withdrawal by Subject|0|||
143282357|NCT03310021|516585464|FG010|Overall Study|Withdrawal by Subject|0|||
143282358|NCT03310021|516585465|FG011|Overall Study|Withdrawal by Subject|0|||
143282359|NCT03310021|516585466|FG012|Overall Study|Withdrawal by Subject|0|||
143282360|NCT03310021|516585467|FG013|Overall Study|Withdrawal by Subject|0|||
143282361|NCT03310021|516585468|FG014|Overall Study|Withdrawal by Subject|0|||
143282362|NCT03310021|516585469|FG015|Overall Study|Withdrawal by Subject|0|||
143282363|NCT03310021|516585470|FG016|Overall Study|Withdrawal by Subject|0|||
143282364|NCT03310021|516585471|FG017|Overall Study|Withdrawal by Subject|0|||
143282365|NCT03310021|516585472|FG018|Overall Study|Withdrawal by Subject|0|||
143282366|NCT03310021|516585473|FG019|Overall Study|Withdrawal by Subject|0|||
143282367|NCT03310021|516585454|FG000|Overall Study|Lost to Follow-up|0|||
143282368|NCT03310021|516585455|FG001|Overall Study|Lost to Follow-up|0|||
143282369|NCT03310021|516585456|FG002|Overall Study|Lost to Follow-up|0|||
143282370|NCT03310021|516585457|FG003|Overall Study|Lost to Follow-up|0|||
143282371|NCT03310021|516585458|FG004|Overall Study|Lost to Follow-up|0|||
143282372|NCT03310021|516585459|FG005|Overall Study|Lost to Follow-up|0|||
143282373|NCT03310021|516585460|FG006|Overall Study|Lost to Follow-up|0|||
143282374|NCT03310021|516585461|FG007|Overall Study|Lost to Follow-up|0|||
143282375|NCT03310021|516585462|FG008|Overall Study|Lost to Follow-up|0|||
143282376|NCT03310021|516585463|FG009|Overall Study|Lost to Follow-up|0|||
143282377|NCT03310021|516585464|FG010|Overall Study|Lost to Follow-up|1|||
143282378|NCT03310021|516585465|FG011|Overall Study|Lost to Follow-up|0|||
143282379|NCT03310021|516585466|FG012|Overall Study|Lost to Follow-up|0|||
143282380|NCT03310021|516585467|FG013|Overall Study|Lost to Follow-up|0|||
143282381|NCT03310021|516585468|FG014|Overall Study|Lost to Follow-up|0|||
143282382|NCT03310021|516585469|FG015|Overall Study|Lost to Follow-up|0|||
143282383|NCT03310021|516585470|FG016|Overall Study|Lost to Follow-up|0|||
143282384|NCT03310021|516585471|FG017|Overall Study|Lost to Follow-up|0|||
143282385|NCT03310021|516585472|FG018|Overall Study|Lost to Follow-up|0|||
143282386|NCT03310021|516585473|FG019|Overall Study|Lost to Follow-up|0|||
143282387|NCT03334539|516585476|FG000|Overall Study|Adverse Event|3|||
143282388|NCT03334539|516585477|FG001|Overall Study|Adverse Event|5|||
143282389|NCT03334539|516585478|FG002|Overall Study|Adverse Event|0|||
143282390|NCT03334539|516585476|FG000|Overall Study|Withdrawal by Subject|0|||
143282391|NCT03334539|516585477|FG001|Overall Study|Withdrawal by Subject|1|||
143282392|NCT03334539|516585478|FG002|Overall Study|Withdrawal by Subject|1|||
143282393|NCT03334539|516585476|FG000|Overall Study|Administrative Reasons|1|||
143282394|NCT03334539|516585477|FG001|Overall Study|Administrative Reasons|0|||
143282395|NCT03334539|516585478|FG002|Overall Study|Administrative Reasons|0|||
143282396|NCT03334539|516585476|FG000|Overall Study|Hypertension Not Controlled|0|||
143282397|NCT03334539|516585477|FG001|Overall Study|Hypertension Not Controlled|1|||
143282398|NCT03334539|516585478|FG002|Overall Study|Hypertension Not Controlled|0|||
143282399|NCT03302234|516585480|FG000|Overall Study|Death|191|||
143282400|NCT03302234|516585481|FG001|Overall Study|Death|192|||
143282401|NCT03302234|516585480|FG000|Overall Study|Withdrawal by Subject|2|||
143282402|NCT03302234|516585481|FG001|Overall Study|Withdrawal by Subject|2|||
143282403|NCT03302234|516585480|FG000|Overall Study|Sponsor Decision|90|||
143282404|NCT03302234|516585481|FG001|Overall Study|Sponsor Decision|89|||
143282405|NCT03302234|516585480|FG000|Overall Study|Laryngeal carcinoma|0|||
143282406|NCT03302234|516585481|FG001|Overall Study|Laryngeal carcinoma|1|||
143282407|NCT03302234|516585480|FG000|Overall Study|Not Reported|1|||
143282408|NCT03302234|516585481|FG001|Overall Study|Not Reported|0|||
143282409|NCT01845831|516585482|FG000|Inpatient Phase|Withdrawal by Subject|1|||
143282410|NCT01845831|516585483|FG001|Inpatient Phase|Withdrawal by Subject|1|||
143282411|NCT01845831|516585484|FG002|Inpatient Phase|Withdrawal by Subject|0|||
143282412|NCT01845831|516585485|FG003|Inpatient Phase|Withdrawal by Subject|0|||
143282413|NCT01845831|516585486|FG004|Inpatient Phase|Withdrawal by Subject|0|||
143282414|NCT01348165|516585488|FG000|Overall Study|Adverse Event|0|||
143282415|NCT01348165|516585489|FG001|Overall Study|Adverse Event|0|||
143282416|NCT01348165|516585490|FG002|Overall Study|Adverse Event|0|||
143282417|NCT01348165|516585491|FG003|Overall Study|Adverse Event|0|||
143282418|NCT01348165|516585492|FG004|Overall Study|Adverse Event|0|||
143282419|NCT01348165|516585493|FG005|Overall Study|Adverse Event|0|||
143282420|NCT01348165|516585494|FG006|Overall Study|Adverse Event|1|||
143282421|NCT00393029|516585495|FG000|Overall Study|Not treated|0|||
143282422|NCT00393029|516585496|FG001|Overall Study|Not treated|1|||
143282423|NCT03715530|516585497|FG000|Overall Study|Lost to Follow-up|3|||
143282424|NCT03715530|516585498|FG001|Overall Study|Lost to Follow-up|1|||
143282425|NCT03715530|516585499|FG002|Overall Study|Lost to Follow-up|2|||
143282426|NCT01594762|516585503|FG000|Overall Study|Withdrawal by Subject|1|||
143282427|NCT01594762|516585504|FG001|Overall Study|Withdrawal by Subject|0|||
143282428|NCT01594762|516585503|FG000|Overall Study|Lost to Follow-up|10|||
143282429|NCT01594762|516585504|FG001|Overall Study|Lost to Follow-up|10|||
143282430|NCT00382252|516585505|FG000|Overall Study|Death|4|||
143282431|NCT00382252|516585505|FG000|Overall Study|Protocol Violation|8|||
143282432|NCT00382252|516585505|FG000|Overall Study|Not treated by RFA|1|||
143282433|NCT03338998|516585507|FG000|Treatment Period|Withdrawal by Subject|1|||
143282434|NCT03338998|516585508|FG001|Treatment Period|Withdrawal by Subject|1|||
143282435|NCT03338998|516585507|FG000|Treatment Period|Adverse Event|0|||
143282436|NCT03338998|516585508|FG001|Treatment Period|Adverse Event|2|||
143282437|NCT03338998|516585507|FG000|Treatment Period|Protocol deviation|1|||
143282438|NCT03338998|516585508|FG001|Treatment Period|Protocol deviation|0|||
143282439|NCT03338998|516585507|FG000|Treatment Period|Physician Decision|2|||
143282440|NCT03338998|516585508|FG001|Treatment Period|Physician Decision|0|||
143282441|NCT03338998|516585507|FG000|Treatment Period|Subject failed swallow test|4|||
143282442|NCT03338998|516585508|FG001|Treatment Period|Subject failed swallow test|0|||
143282443|NCT03338998|516585507|FG000|Safety Follow-Up Period|Adverse Event|0|||
143282444|NCT03338998|516585508|FG001|Safety Follow-Up Period|Adverse Event|1|||
143282445|NCT03338998|516585507|FG000|Safety Follow-Up Period|Protocol deviation|1|||
143282446|NCT03338998|516585508|FG001|Safety Follow-Up Period|Protocol deviation|0|||
143282447|NCT03338998|516585507|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
143282448|NCT03338998|516585508|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
143282449|NCT00039130|516585509|FG000|Overall Study|Adverse Event|11|||
143282450|NCT00039130|516585509|FG000|Overall Study|Death|9|||
143282451|NCT00039130|516585509|FG000|Overall Study|Withdrawal by Subject|3|||
143282452|NCT00039130|516585509|FG000|Overall Study|Progression|2|||
143282453|NCT00039130|516585509|FG000|Overall Study|Subsequent treatment|2|||
143282454|NCT00039130|516585509|FG000|Overall Study|Physician Decision|3|||
143282455|NCT03288129|516585510|FG000|Overall Study|Adverse Event|10|||
143282456|NCT03288129|516585510|FG000|Overall Study|Lost to Follow-up|3|||
143282457|NCT03288129|516585510|FG000|Overall Study|Withdrawal by Subject|3|||
143282458|NCT03288129|516585510|FG000|Overall Study|Withdrawal of consent/assent|1|||
143282459|NCT03288129|516585510|FG000|Overall Study|Other|5|||
143282460|NCT01744197|516585518|FG000|Overall Study|Received 1 patch|2|||
143282461|NCT01744197|516585519|FG001|Overall Study|Received 1 patch|1|||
143282462|NCT01744197|516585518|FG000|Overall Study|No patch received|2|||
143282463|NCT01744197|516585519|FG001|Overall Study|No patch received|2|||
143282464|NCT04706091|516585520|FG000|Treatment 2|Withdrawal by Subject|1|||
143282465|NCT04706091|516585521|FG001|Treatment 2|Withdrawal by Subject|0|||
143282466|NCT01063868|516585522|FG000|Overall Study|Adverse Event|9|||
143282467|NCT01063868|516585523|FG001|Overall Study|Adverse Event|7|||
143282468|NCT01063868|516585522|FG000|Overall Study|Withdrawal by Subject|3|||
143282469|NCT01063868|516585523|FG001|Overall Study|Withdrawal by Subject|1|||
143282470|NCT01063868|516585522|FG000|Overall Study|Study Terminated By Sponsor|23|||
143282471|NCT01063868|516585523|FG001|Overall Study|Study Terminated By Sponsor|4|||
143282472|NCT01949506|516585524|FG000|Overall Study|Physician Decision|1|||
143282473|NCT02915016|516585525|FG000|Overall Study|Lost to Follow-up|4|||
143282474|NCT02915016|516585526|FG001|Overall Study|Lost to Follow-up|2|||
143282475|NCT02915016|516585527|FG002|Overall Study|Lost to Follow-up|5|||
143282476|NCT02915016|516585528|FG003|Overall Study|Lost to Follow-up|3|||
143282477|NCT02915016|516585529|FG004|Overall Study|Lost to Follow-up|5|||
143282478|NCT02915016|516585530|FG005|Overall Study|Lost to Follow-up|2|||
143282479|NCT02915016|516585531|FG006|Overall Study|Lost to Follow-up|8|||
143282480|NCT02915016|516585532|FG007|Overall Study|Lost to Follow-up|2|||
143282481|NCT02915016|516585525|FG000|Overall Study|Physician Decision|0|||
143282482|NCT02915016|516585526|FG001|Overall Study|Physician Decision|0|||
143282483|NCT02915016|516585527|FG002|Overall Study|Physician Decision|1|||
143282484|NCT02915016|516585528|FG003|Overall Study|Physician Decision|0|||
143282485|NCT02915016|516585529|FG004|Overall Study|Physician Decision|0|||
143282486|NCT02915016|516585530|FG005|Overall Study|Physician Decision|1|||
143282487|NCT02915016|516585531|FG006|Overall Study|Physician Decision|2|||
143282488|NCT02915016|516585532|FG007|Overall Study|Physician Decision|0|||
143282489|NCT02915016|516585525|FG000|Overall Study|Withdrawal by Subject|2|||
143282490|NCT02915016|516585526|FG001|Overall Study|Withdrawal by Subject|0|||
143282491|NCT02915016|516585527|FG002|Overall Study|Withdrawal by Subject|1|||
143282492|NCT02915016|516585528|FG003|Overall Study|Withdrawal by Subject|0|||
143282493|NCT02915016|516585529|FG004|Overall Study|Withdrawal by Subject|1|||
143282494|NCT02915016|516585530|FG005|Overall Study|Withdrawal by Subject|3|||
143282495|NCT02915016|516585531|FG006|Overall Study|Withdrawal by Subject|1|||
143282496|NCT02915016|516585532|FG007|Overall Study|Withdrawal by Subject|1|||
143282497|NCT02915016|516585525|FG000|Overall Study|Elected not to continue|0|||
143282498|NCT02915016|516585526|FG001|Overall Study|Elected not to continue|0|||
143282499|NCT02915016|516585527|FG002|Overall Study|Elected not to continue|0|||
143282500|NCT02915016|516585528|FG003|Overall Study|Elected not to continue|1|||
143282501|NCT02915016|516585529|FG004|Overall Study|Elected not to continue|0|||
143282502|NCT02915016|516585530|FG005|Overall Study|Elected not to continue|0|||
143282503|NCT02915016|516585531|FG006|Overall Study|Elected not to continue|1|||
143282504|NCT02915016|516585532|FG007|Overall Study|Elected not to continue|0|||
143282505|NCT02915016|516585525|FG000|Overall Study|HIV infection|1|||
143282506|NCT02915016|516585526|FG001|Overall Study|HIV infection|1|||
143282507|NCT02915016|516585527|FG002|Overall Study|HIV infection|1|||
143282508|NCT02915016|516585528|FG003|Overall Study|HIV infection|0|||
143282509|NCT02915016|516585529|FG004|Overall Study|HIV infection|1|||
143282510|NCT02915016|516585530|FG005|Overall Study|HIV infection|0|||
143282511|NCT02915016|516585531|FG006|Overall Study|HIV infection|0|||
143282512|NCT02915016|516585532|FG007|Overall Study|HIV infection|0|||
143282513|NCT02915016|516585525|FG000|Overall Study|Participant unable to adhere|0|||
143282514|NCT02915016|516585526|FG001|Overall Study|Participant unable to adhere|0|||
143282515|NCT02915016|516585527|FG002|Overall Study|Participant unable to adhere|0|||
143282516|NCT02915016|516585528|FG003|Overall Study|Participant unable to adhere|0|||
143282517|NCT02915016|516585529|FG004|Overall Study|Participant unable to adhere|0|||
143282518|NCT02915016|516585530|FG005|Overall Study|Participant unable to adhere|0|||
143282519|NCT02915016|516585531|FG006|Overall Study|Participant unable to adhere|0|||
143282520|NCT02915016|516585532|FG007|Overall Study|Participant unable to adhere|1|||
143282521|NCT02166905|516585533|FG000|Overall Study|Withdrawal by Subject|1|||
143282522|NCT02166905|516585534|FG001|Overall Study|Withdrawal by Subject|0|||
143282523|NCT02166905|516585535|FG002|Overall Study|Withdrawal by Subject|0|||
143282524|NCT02166905|516585536|FG003|Overall Study|Withdrawal by Subject|0|||
143282525|NCT02617628|516585537|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
143282526|NCT02617628|516585538|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
143282527|NCT03278873|516585539|FG000|Overall Study|Withdrawal by Subject|0|||
143282528|NCT03278873|516585540|FG001|Overall Study|Withdrawal by Subject|1|||
143282529|NCT03278873|516585541|FG002|Overall Study|Withdrawal by Subject|0|||
143282530|NCT03278873|516585542|FG003|Overall Study|Withdrawal by Subject|0|||
143282531|NCT03278873|516585539|FG000|Overall Study|Sponsor's decision|0|||
143282532|NCT03278873|516585540|FG001|Overall Study|Sponsor's decision|1|||
143282533|NCT03278873|516585541|FG002|Overall Study|Sponsor's decision|0|||
143282534|NCT03278873|516585542|FG003|Overall Study|Sponsor's decision|0|||
143282535|NCT03278873|516585539|FG000|Overall Study|Early Termination|2|||
143282536|NCT03278873|516585540|FG001|Overall Study|Early Termination|6|||
143282537|NCT03278873|516585541|FG002|Overall Study|Early Termination|0|||
143282538|NCT03278873|516585542|FG003|Overall Study|Early Termination|4|||
143282539|NCT03278873|516585539|FG000|Overall Study|Lost to Follow-up|0|||
143282540|NCT03278873|516585540|FG001|Overall Study|Lost to Follow-up|0|||
143282541|NCT03278873|516585541|FG002|Overall Study|Lost to Follow-up|2|||
143282542|NCT03278873|516585542|FG003|Overall Study|Lost to Follow-up|0|||
143282543|NCT03278873|516585539|FG000|Overall Study|The patient decided to withdraw via email|1|||
143282544|NCT03278873|516585540|FG001|Overall Study|The patient decided to withdraw via email|0|||
143282545|NCT03278873|516585541|FG002|Overall Study|The patient decided to withdraw via email|0|||
143282546|NCT03278873|516585542|FG003|Overall Study|The patient decided to withdraw via email|0|||
143282547|NCT03278873|516585539|FG000|Overall Study|The patient was unresponsive to contact|0|||
143282548|NCT03278873|516585540|FG001|Overall Study|The patient was unresponsive to contact|0|||
143282549|NCT03278873|516585541|FG002|Overall Study|The patient was unresponsive to contact|0|||
143282550|NCT03278873|516585542|FG003|Overall Study|The patient was unresponsive to contact|4|||
143282551|NCT03278873|516585539|FG000|Overall Study|The patient wished to participate no longer|0|||
143282552|NCT03278873|516585540|FG001|Overall Study|The patient wished to participate no longer|1|||
143282553|NCT03278873|516585541|FG002|Overall Study|The patient wished to participate no longer|0|||
143282554|NCT03278873|516585542|FG003|Overall Study|The patient wished to participate no longer|0|||
143282555|NCT03278873|516585539|FG000|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
143373247|NCT04347954|516911405|FG000|Overall Study|Lost to Follow-up|0|||
143282556|NCT03278873|516585540|FG001|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
143282557|NCT03278873|516585541|FG002|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|1|||
143282558|NCT03278873|516585542|FG003|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
143282559|NCT05243641|516585543|FG000|Overall Study|Adverse Event|3|||
143282560|NCT05243641|516585544|FG001|Overall Study|Adverse Event|0|||
143282561|NCT05243641|516585545|FG002|Overall Study|Adverse Event|0|||
143282562|NCT05243641|516585546|FG003|Overall Study|Adverse Event|1|||
143282563|NCT05243641|516585547|FG004|Overall Study|Adverse Event|0|||
143282564|NCT05243641|516585548|FG005|Overall Study|Adverse Event|0|||
143282565|NCT05243641|516585543|FG000|Overall Study|Disease progression|4|||
143282566|NCT05243641|516585544|FG001|Overall Study|Disease progression|0|||
143282567|NCT05243641|516585545|FG002|Overall Study|Disease progression|0|||
143282568|NCT05243641|516585546|FG003|Overall Study|Disease progression|2|||
143282569|NCT05243641|516585547|FG004|Overall Study|Disease progression|0|||
143282570|NCT05243641|516585548|FG005|Overall Study|Disease progression|0|||
143282571|NCT04518306|516585564|FG000|Double-Blind Period|Run in failure|0|||
143282572|NCT04518306|516585565|FG001|Double-Blind Period|Run in failure|0|||
143282573|NCT04518306|516585566|FG002|Double-Blind Period|Run in failure|1|||
143282574|NCT04518306|516585564|FG000|Double-Blind Period|Adverse Event|0|||
143282575|NCT04518306|516585565|FG001|Double-Blind Period|Adverse Event|2|||
143282576|NCT04518306|516585566|FG002|Double-Blind Period|Adverse Event|2|||
143282577|NCT04518306|516585564|FG000|Double-Blind Period|Lost to Follow-up|1|||
143282578|NCT04518306|516585565|FG001|Double-Blind Period|Lost to Follow-up|2|||
143282579|NCT04518306|516585566|FG002|Double-Blind Period|Lost to Follow-up|2|||
143282580|NCT04518306|516585564|FG000|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
143282581|NCT04518306|516585565|FG001|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
143282582|NCT04518306|516585566|FG002|Double-Blind Period|Participant moved to open-label extension (OLE) study|8|||
143282583|NCT04518306|516585564|FG000|Double-Blind Period|Other|0|||
143282584|NCT04518306|516585565|FG001|Double-Blind Period|Other|2|||
143282585|NCT04518306|516585566|FG002|Double-Blind Period|Other|0|||
143282586|NCT04518306|516585564|FG000|Double-Blind Period|Missing|0|||
143282587|NCT04518306|516585565|FG001|Double-Blind Period|Missing|1|||
143282588|NCT04518306|516585566|FG002|Double-Blind Period|Missing|0|||
143282589|NCT02801331|516585567|FG000|Overall Study|Transferred to another hospital|8|||
143282590|NCT02801331|516585568|FG001|Overall Study|Transferred to another hospital|7|||
143282591|NCT02801331|516585567|FG000|Overall Study|Withdrawal by Subject|0|||
143282592|NCT02801331|516585568|FG001|Overall Study|Withdrawal by Subject|4|||
143282593|NCT02801331|516585567|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
143282594|NCT02801331|516585568|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
143282595|NCT02443987|516585569|FG000|Overall Study|Bladder injury|1|||
143282596|NCT02443987|516585570|FG001|Overall Study|Bladder injury|1|||
143282597|NCT02443987|516585569|FG000|Overall Study|Other|0|||
143282598|NCT02443987|516585570|FG001|Overall Study|Other|1|||
143282599|NCT03069378|516585574|FG000|Overall Study|Withdrawal by Subject|1|||
143282600|NCT01397708|516585575|FG000|Overall Study|Withdrawal by Subject|0|||
143282601|NCT01397708|516585576|FG001|Overall Study|Withdrawal by Subject|0|||
143282602|NCT01397708|516585577|FG002|Overall Study|Withdrawal by Subject|1|||
143282603|NCT01397708|516585578|FG003|Overall Study|Withdrawal by Subject|0|||
143282604|NCT01397708|516585579|FG004|Overall Study|Withdrawal by Subject|0|||
143282605|NCT01397708|516585580|FG005|Overall Study|Withdrawal by Subject|0|||
143282606|NCT01397708|516585581|FG006|Overall Study|Withdrawal by Subject|0|||
143282607|NCT01397708|516585582|FG007|Overall Study|Withdrawal by Subject|1|||
143282608|NCT01397708|516585575|FG000|Overall Study|Death|0|||
143282609|NCT01397708|516585576|FG001|Overall Study|Death|0|||
143282610|NCT01397708|516585577|FG002|Overall Study|Death|1|||
143282611|NCT01397708|516585578|FG003|Overall Study|Death|1|||
143282612|NCT01397708|516585579|FG004|Overall Study|Death|0|||
143282613|NCT01397708|516585580|FG005|Overall Study|Death|0|||
143282614|NCT01397708|516585581|FG006|Overall Study|Death|0|||
143282615|NCT01397708|516585582|FG007|Overall Study|Death|0|||
143282616|NCT01397708|516585575|FG000|Overall Study|Lost to Follow-up|0|||
143282617|NCT01397708|516585576|FG001|Overall Study|Lost to Follow-up|0|||
143282618|NCT01397708|516585577|FG002|Overall Study|Lost to Follow-up|0|||
143282619|NCT01397708|516585578|FG003|Overall Study|Lost to Follow-up|0|||
143282620|NCT01397708|516585579|FG004|Overall Study|Lost to Follow-up|1|||
143282621|NCT01397708|516585580|FG005|Overall Study|Lost to Follow-up|0|||
143282622|NCT01397708|516585581|FG006|Overall Study|Lost to Follow-up|0|||
143282623|NCT01397708|516585582|FG007|Overall Study|Lost to Follow-up|0|||
143282624|NCT01397708|516585575|FG000|Overall Study|Other|0|||
143282625|NCT01397708|516585576|FG001|Overall Study|Other|0|||
143282626|NCT01397708|516585577|FG002|Overall Study|Other|0|||
143282627|NCT01397708|516585578|FG003|Overall Study|Other|0|||
143282628|NCT01397708|516585579|FG004|Overall Study|Other|0|||
143282629|NCT01397708|516585580|FG005|Overall Study|Other|0|||
143282630|NCT01397708|516585581|FG006|Overall Study|Other|1|||
143282631|NCT01397708|516585582|FG007|Overall Study|Other|0|||
143282632|NCT01638546|516585593|FG000|Overall Study|Adverse Event|1|||
143282633|NCT01638546|516585594|FG001|Overall Study|Adverse Event|3|||
143373248|NCT04347954|516911406|FG001|Overall Study|Lost to Follow-up|1|||
143282634|NCT04526665|516585595|FG000|Overall Study|Withdrawal by Subject|6|||
143282635|NCT04526665|516585596|FG001|Overall Study|Withdrawal by Subject|3|||
143282636|NCT04526665|516585595|FG000|Overall Study|Adverse Event|4|||
143282637|NCT04526665|516585596|FG001|Overall Study|Adverse Event|1|||
143282638|NCT04526665|516585595|FG000|Overall Study|Physician Decision|2|||
143282639|NCT04526665|516585596|FG001|Overall Study|Physician Decision|2|||
143282640|NCT04526665|516585595|FG000|Overall Study|Death|2|||
143282641|NCT04526665|516585596|FG001|Overall Study|Death|0|||
143282642|NCT04526665|516585595|FG000|Overall Study|Other|0|||
143282643|NCT04526665|516585596|FG001|Overall Study|Other|1|||
143282644|NCT05330702|516585597|FG000|Overall Study|Study terminated before all 6-month visit data could be collected|9|||
143282645|NCT05330702|516585598|FG001|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
143282646|NCT05330702|516585599|FG002|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
143282647|NCT02881554|516585600|FG000|Overall Study|Withdrawal by Subject|2|||
143282648|NCT02881554|516585601|FG001|Overall Study|Withdrawal by Subject|0|||
143282649|NCT02397278|516587116|FG000|Overall Study|Withdrawal by Subject|0|||
143282650|NCT02397278|516587117|FG001|Overall Study|Withdrawal by Subject|2|||
143282651|NCT02397278|516587116|FG000|Overall Study|Deemed ineligible following surgery|1|||
143282652|NCT02397278|516587117|FG001|Overall Study|Deemed ineligible following surgery|1|||
143282653|NCT00331682|516587121|FG000|Overall Study|Adverse Event|1|||
143282654|NCT03292588|516587122|FG000|Overall Study|Death|1|||
143282655|NCT03292588|516587123|FG001|Overall Study|Death|0|||
143282656|NCT03292588|516587122|FG000|Overall Study|Lost to Follow-up|12|||
143282657|NCT03292588|516587123|FG001|Overall Study|Lost to Follow-up|16|||
143282658|NCT03292588|516587122|FG000|Overall Study|Physician Decision|0|||
143282659|NCT03292588|516587123|FG001|Overall Study|Physician Decision|1|||
143282660|NCT03292588|516587122|FG000|Overall Study|Withdrawal by Subject|4|||
143282661|NCT03292588|516587123|FG001|Overall Study|Withdrawal by Subject|4|||
143282662|NCT03292588|516587122|FG000|Overall Study|Move out of town|1|||
143282663|NCT03292588|516587123|FG001|Overall Study|Move out of town|0|||
143282664|NCT03292588|516587122|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
143282665|NCT03292588|516587123|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
143282666|NCT00004978|516587124|FG000|Overall Study|Death|107|||
143282667|NCT00004978|516587125|FG001|Overall Study|Death|116|||
143282668|NCT00004978|516587124|FG000|Overall Study|Lost to Follow-up|101|||
143282669|NCT00004978|516587125|FG001|Overall Study|Lost to Follow-up|108|||
143282670|NCT00004978|516587124|FG000|Overall Study|Withdrawal by Subject|17|||
143282671|NCT00004978|516587125|FG001|Overall Study|Withdrawal by Subject|26|||
143282672|NCT00004978|516587124|FG000|Overall Study|site closure - not in analysis cohort|19|||
143282673|NCT00004978|516587125|FG001|Overall Study|site closure - not in analysis cohort|20|||
143282674|NCT01652703|516587126|FG000|Overall Study|Withdrawal by Subject|0|||
143282675|NCT01652703|516587127|FG001|Overall Study|Withdrawal by Subject|1|||
143282676|NCT01652703|516587128|FG002|Overall Study|Withdrawal by Subject|3|||
143282677|NCT01652703|516587129|FG003|Overall Study|Withdrawal by Subject|1|||
143282678|NCT01652703|516587130|FG004|Overall Study|Withdrawal by Subject|0|||
143282679|NCT01652703|516587131|FG005|Overall Study|Withdrawal by Subject|1|||
143282680|NCT01652703|516587126|FG000|Overall Study|Other|0|||
143282681|NCT01652703|516587127|FG001|Overall Study|Other|0|||
143282682|NCT01652703|516587128|FG002|Overall Study|Other|0|||
143282683|NCT01652703|516587129|FG003|Overall Study|Other|1|||
143282684|NCT01652703|516587130|FG004|Overall Study|Other|1|||
143282685|NCT01652703|516587131|FG005|Overall Study|Other|1|||
143282686|NCT00062374|516587135|FG000|Overall Study|Not treated|12|||
143282687|NCT02155608|516587136|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
143282688|NCT02155608|516587137|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
143282689|NCT02155608|516587136|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
143282690|NCT02155608|516587137|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
143282691|NCT01532414|516587140|FG000|Overall Study|Lost to Follow-up|3|||
143282692|NCT01532414|516587141|FG001|Overall Study|Lost to Follow-up|0|||
143282693|NCT01532414|516587142|FG002|Overall Study|Lost to Follow-up|1|||
143282694|NCT01532414|516587140|FG000|Overall Study|Withdrawal by Subject|3|||
143282695|NCT01532414|516587141|FG001|Overall Study|Withdrawal by Subject|0|||
143282696|NCT01532414|516587142|FG002|Overall Study|Withdrawal by Subject|0|||
143282697|NCT01532414|516587140|FG000|Overall Study|No V6 semen sample|0|||
143282698|NCT01532414|516587141|FG001|Overall Study|No V6 semen sample|1|||
143282699|NCT01532414|516587142|FG002|Overall Study|No V6 semen sample|0|||
143282700|NCT01532414|516587140|FG000|Overall Study|Adverse Event|0|||
143282701|NCT01532414|516587141|FG001|Overall Study|Adverse Event|1|||
143282702|NCT01532414|516587142|FG002|Overall Study|Adverse Event|1|||
143282703|NCT01532414|516587140|FG000|Overall Study|Unable to complete 24 hour PK|0|||
143282704|NCT01532414|516587141|FG001|Overall Study|Unable to complete 24 hour PK|0|||
143282705|NCT01532414|516587142|FG002|Overall Study|Unable to complete 24 hour PK|1|||
143282706|NCT01532414|516587140|FG000|Overall Study|Withdrawn by sponsor|1|||
143282707|NCT01532414|516587141|FG001|Overall Study|Withdrawn by sponsor|0|||
143282708|NCT01532414|516587142|FG002|Overall Study|Withdrawn by sponsor|0|||
143282709|NCT00187486|516587143|FG000|Overall Study|Protocol Violation|1|||
143282710|NCT02380677|516587144|FG000|Overall Study|Adverse Event|0|||
143282711|NCT02380677|516587145|FG001|Overall Study|Adverse Event|0|||
143282712|NCT02380677|516587146|FG002|Overall Study|Adverse Event|0|||
143282713|NCT02380677|516587147|FG003|Overall Study|Adverse Event|1|||
143282714|NCT02380677|516587148|FG004|Overall Study|Adverse Event|1|||
143282715|NCT02380677|516587149|FG005|Overall Study|Adverse Event|4|||
143282716|NCT02380677|516587150|FG006|Overall Study|Adverse Event|2|||
143282717|NCT02380677|516587151|FG007|Overall Study|Adverse Event|2|||
143282718|NCT02380677|516587152|FG008|Overall Study|Adverse Event|2|||
143282719|NCT02380677|516587153|FG009|Overall Study|Adverse Event|1|||
143282720|NCT02380677|516587154|FG010|Overall Study|Adverse Event|2|||
143282721|NCT02380677|516587155|FG011|Overall Study|Adverse Event|1|||
143282722|NCT02380677|516587144|FG000|Overall Study|Physician Decision|1|||
143282723|NCT02380677|516587145|FG001|Overall Study|Physician Decision|0|||
143282724|NCT02380677|516587146|FG002|Overall Study|Physician Decision|1|||
143282725|NCT02380677|516587147|FG003|Overall Study|Physician Decision|1|||
143282726|NCT02380677|516587148|FG004|Overall Study|Physician Decision|0|||
143282727|NCT02380677|516587149|FG005|Overall Study|Physician Decision|0|||
143282728|NCT02380677|516587150|FG006|Overall Study|Physician Decision|0|||
143282729|NCT02380677|516587151|FG007|Overall Study|Physician Decision|0|||
143282730|NCT02380677|516587152|FG008|Overall Study|Physician Decision|0|||
143282731|NCT02380677|516587153|FG009|Overall Study|Physician Decision|0|||
143282732|NCT02380677|516587154|FG010|Overall Study|Physician Decision|0|||
143282733|NCT02380677|516587155|FG011|Overall Study|Physician Decision|0|||
143282734|NCT02380677|516587144|FG000|Overall Study|Lack of Efficacy|0|||
143282735|NCT02380677|516587145|FG001|Overall Study|Lack of Efficacy|1|||
143282736|NCT02380677|516587146|FG002|Overall Study|Lack of Efficacy|2|||
143282737|NCT02380677|516587147|FG003|Overall Study|Lack of Efficacy|0|||
143282738|NCT02380677|516587148|FG004|Overall Study|Lack of Efficacy|4|||
143282739|NCT02380677|516587149|FG005|Overall Study|Lack of Efficacy|1|||
143282740|NCT02380677|516587150|FG006|Overall Study|Lack of Efficacy|1|||
143282741|NCT02380677|516587151|FG007|Overall Study|Lack of Efficacy|2|||
143282742|NCT02380677|516587152|FG008|Overall Study|Lack of Efficacy|2|||
143282743|NCT02380677|516587153|FG009|Overall Study|Lack of Efficacy|0|||
143282744|NCT02380677|516587154|FG010|Overall Study|Lack of Efficacy|2|||
143282745|NCT02380677|516587155|FG011|Overall Study|Lack of Efficacy|1|||
143282746|NCT02380677|516587144|FG000|Overall Study|Withdrawal by Subject|0|||
143282747|NCT02380677|516587145|FG001|Overall Study|Withdrawal by Subject|0|||
143282748|NCT02380677|516587146|FG002|Overall Study|Withdrawal by Subject|0|||
143282749|NCT02380677|516587147|FG003|Overall Study|Withdrawal by Subject|0|||
143282750|NCT02380677|516587148|FG004|Overall Study|Withdrawal by Subject|0|||
143282751|NCT02380677|516587149|FG005|Overall Study|Withdrawal by Subject|0|||
143282752|NCT02380677|516587150|FG006|Overall Study|Withdrawal by Subject|0|||
143282753|NCT02380677|516587151|FG007|Overall Study|Withdrawal by Subject|0|||
143282754|NCT02380677|516587152|FG008|Overall Study|Withdrawal by Subject|0|||
143282755|NCT02380677|516587153|FG009|Overall Study|Withdrawal by Subject|1|||
143282756|NCT02380677|516587154|FG010|Overall Study|Withdrawal by Subject|0|||
143282757|NCT02380677|516587155|FG011|Overall Study|Withdrawal by Subject|3|||
143282758|NCT02380677|516587144|FG000|Overall Study|Other|0|||
143282759|NCT02380677|516587145|FG001|Overall Study|Other|0|||
143282760|NCT02380677|516587146|FG002|Overall Study|Other|0|||
143282761|NCT02380677|516587147|FG003|Overall Study|Other|1|||
143282762|NCT02380677|516587148|FG004|Overall Study|Other|1|||
143282763|NCT02380677|516587149|FG005|Overall Study|Other|1|||
143282764|NCT02380677|516587150|FG006|Overall Study|Other|0|||
143282765|NCT02380677|516587151|FG007|Overall Study|Other|0|||
143282766|NCT02380677|516587152|FG008|Overall Study|Other|0|||
143282767|NCT02380677|516587153|FG009|Overall Study|Other|0|||
143282768|NCT02380677|516587154|FG010|Overall Study|Other|0|||
143282769|NCT02380677|516587155|FG011|Overall Study|Other|0|||
143282770|NCT02599129|516587161|FG000|Overall Study|Lack of Efficacy|2|||
143282771|NCT02599129|516587162|FG001|Overall Study|Lack of Efficacy|2|||
143282772|NCT02599129|516587161|FG000|Overall Study|Lost to Follow-up|1|||
143282773|NCT02599129|516587162|FG001|Overall Study|Lost to Follow-up|0|||
143282774|NCT02599129|516587161|FG000|Overall Study|Withdrawal by Subject|2|||
143282775|NCT02599129|516587162|FG001|Overall Study|Withdrawal by Subject|1|||
143282776|NCT01029795|516587167|FG000|Overall Study|Entry Criteria Not Met|2|||
143282777|NCT01029795|516587168|FG001|Overall Study|Entry Criteria Not Met|1|||
143282778|NCT01029795|516587167|FG000|Overall Study|Physician Decision|2|||
143282779|NCT01029795|516587168|FG001|Overall Study|Physician Decision|1|||
143282780|NCT01029795|516587167|FG000|Overall Study|Sponsor Decision|11|||
143282781|NCT01029795|516587168|FG001|Overall Study|Sponsor Decision|17|||
143282782|NCT01029795|516587167|FG000|Overall Study|Withdrawal by Subject|1|||
143282783|NCT01029795|516587168|FG001|Overall Study|Withdrawal by Subject|3|||
143282784|NCT03217175|516587169|FG000|Overall Study|Physician Decision|4|||
143282785|NCT03217175|516587170|FG001|Overall Study|Physician Decision|1|||
143282786|NCT05035550|516587176|FG000|Overall Study|Withdrawal by Subject|3|||
143282787|NCT05035550|516587177|FG001|Overall Study|Withdrawal by Subject|0|||
143282788|NCT01806545|516587178|FG000|Overall Study|Adverse Event|2|||
143282789|NCT01806545|516587179|FG001|Overall Study|Adverse Event|3|||
143282790|NCT01806545|516587178|FG000|Overall Study|Lost to Follow-up|1|||
143282791|NCT01806545|516587179|FG001|Overall Study|Lost to Follow-up|0|||
143282792|NCT01806545|516587178|FG000|Overall Study|Withdrawal by Subject|3|||
143282793|NCT01806545|516587179|FG001|Overall Study|Withdrawal by Subject|2|||
143282794|NCT00840450|516587181|FG000|Overall Study|Adverse Event|1|||
143282795|NCT00840450|516587181|FG000|Overall Study|Lack of Efficacy|2|||
143282796|NCT00617123|516587182|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
143282797|NCT00617123|516587183|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
143282798|NCT00617123|516587182|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
143282799|NCT00617123|516587183|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
143282800|NCT00617123|516587182|FG000|Referral Screening Period|Adverse Event|0|||
143282801|NCT00617123|516587183|FG001|Referral Screening Period|Adverse Event|1|||
143282802|NCT00617123|516587182|FG000|Study Treatment Period|Withdrawal by Subject|8|||
143282803|NCT00617123|516587183|FG001|Study Treatment Period|Withdrawal by Subject|12|||
143282804|NCT00617123|516587182|FG000|Study Treatment Period|Adverse Event|7|||
143282805|NCT00617123|516587183|FG001|Study Treatment Period|Adverse Event|3|||
143282806|NCT00617123|516587182|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
143282807|NCT00617123|516587183|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
143282808|NCT00617123|516587182|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
143282809|NCT00617123|516587183|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
143282810|NCT00133952|516587185|FG000|Overall Study|Adverse Event|1|||
143282811|NCT00133952|516587186|FG001|Overall Study|Adverse Event|2|||
143282812|NCT00133952|516587185|FG000|Overall Study|Death|3|||
143282813|NCT00133952|516587186|FG001|Overall Study|Death|2|||
143282814|NCT00133952|516587185|FG000|Overall Study|Lost to Follow-up|9|||
143282815|NCT00133952|516587186|FG001|Overall Study|Lost to Follow-up|14|||
143282816|NCT00133952|516587185|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
143282817|NCT00133952|516587186|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
143282818|NCT00133952|516587185|FG000|Overall Study|Protocol Violation|1|||
143282819|NCT00133952|516587186|FG001|Overall Study|Protocol Violation|1|||
143282820|NCT00133952|516587185|FG000|Overall Study|Withdrawal by Subject|20|||
143282821|NCT00133952|516587186|FG001|Overall Study|Withdrawal by Subject|4|||
143282822|NCT00133952|516587185|FG000|Overall Study|Physician Decision|4|||
143282823|NCT00133952|516587186|FG001|Overall Study|Physician Decision|3|||
143282824|NCT00133952|516587185|FG000|Overall Study|Sponsor Decision|0|||
143282825|NCT00133952|516587186|FG001|Overall Study|Sponsor Decision|1|||
143282826|NCT03052725|516587187|FG000|Overall Study|Adverse Event|2|||
143282827|NCT03052725|516587188|FG001|Overall Study|Adverse Event|0|||
143282828|NCT03052725|516587187|FG000|Overall Study|Withdrawal by Subject|3|||
143282829|NCT03052725|516587188|FG001|Overall Study|Withdrawal by Subject|4|||
143282830|NCT03052725|516587187|FG000|Overall Study|Pregnancy|0|||
143282831|NCT03052725|516587188|FG001|Overall Study|Pregnancy|1|||
143282832|NCT03052725|516587187|FG000|Overall Study|Site closure|0|||
143282833|NCT03052725|516587188|FG001|Overall Study|Site closure|1|||
143282834|NCT03052725|516587187|FG000|Overall Study|Study terminated by sponsor|143|||
143282835|NCT03052725|516587188|FG001|Overall Study|Study terminated by sponsor|144|||
143282836|NCT02128113|516587194|FG000|Overall Study|Withdrawal by Subject|3|||
143282837|NCT02128113|516587195|FG001|Overall Study|Withdrawal by Subject|1|||
143282838|NCT02128113|516587196|FG002|Overall Study|Withdrawal by Subject|0|||
143282839|NCT02128113|516587194|FG000|Overall Study|Protocol Violation|0|||
143373249|NCT04347954|516911407|FG002|Overall Study|Lost to Follow-up|0|||
143373250|NCT02534350|516911408|FG000|Overall Study|Randomized But Not Treated|1|||
143373251|NCT02534350|516911409|FG001|Overall Study|Randomized But Not Treated|0|||
143373252|NCT02534350|516911408|FG000|Overall Study|Protocol Violation|1|||
143373253|NCT02534350|516911409|FG001|Overall Study|Protocol Violation|0|||
143373254|NCT02534350|516911408|FG000|Overall Study|Withdrew Consent|2|||
143373255|NCT02534350|516911409|FG001|Overall Study|Withdrew Consent|0|||
143282840|NCT02128113|516587195|FG001|Overall Study|Protocol Violation|1|||
143282841|NCT02128113|516587196|FG002|Overall Study|Protocol Violation|0|||
143282842|NCT02128113|516587194|FG000|Overall Study|Surgery cancelled|0|||
143282843|NCT02128113|516587195|FG001|Overall Study|Surgery cancelled|1|||
143282844|NCT02128113|516587196|FG002|Overall Study|Surgery cancelled|0|||
143282845|NCT02128113|516587194|FG000|Overall Study|Adverse Event|0|||
143282846|NCT02128113|516587195|FG001|Overall Study|Adverse Event|0|||
143282847|NCT02128113|516587196|FG002|Overall Study|Adverse Event|1|||
143373256|NCT03257813|516911410|FG000|Overall Study|Protocol Violation|6|||
143373257|NCT03257813|516911411|FG001|Overall Study|Protocol Violation|3|||
143282848|NCT01061177|516587197|FG000|Overall Study|Adverse Event|117|||
143282849|NCT01061177|516587197|FG000|Overall Study|Withdrawal by Subject|27|||
143282850|NCT01061177|516587197|FG000|Overall Study|Disease progression|17|||
143282851|NCT01061177|516587197|FG000|Overall Study|Protocol Violation|11|||
143282852|NCT01061177|516587197|FG000|Overall Study|Lost to Follow-up|9|||
143282853|NCT01061177|516587197|FG000|Overall Study|New cancer therapy|9|||
143282854|NCT01061177|516587197|FG000|Overall Study|Abnormal laboratory values|6|||
143282855|NCT01061177|516587197|FG000|Overall Study|Abnormal test procedure results|4|||
143282856|NCT01061177|516587197|FG000|Overall Study|Administratie problems|4|||
143282857|NCT01061177|516587197|FG000|Overall Study|Death|4|||
143282858|NCT05147350|516587201|FG000|Overall Study|Death|2|||
143282859|NCT05147350|516587202|FG001|Overall Study|Death|3|||
143282860|NCT05147350|516587203|FG002|Overall Study|Death|3|||
143282861|NCT05147350|516587204|FG003|Overall Study|Death|2|||
143282862|NCT05147350|516587205|FG004|Overall Study|Death|2|||
143282863|NCT05147350|516587206|FG005|Overall Study|Death|1|||
143282864|NCT05147350|516587207|FG006|Overall Study|Death|1|||
143282865|NCT05147350|516587208|FG007|Overall Study|Death|3|||
143282866|NCT05147350|516587201|FG000|Overall Study|Sponsor Decision to Terminate Study|0|||
143282867|NCT05147350|516587202|FG001|Overall Study|Sponsor Decision to Terminate Study|0|||
143282868|NCT05147350|516587203|FG002|Overall Study|Sponsor Decision to Terminate Study|1|||
143282869|NCT05147350|516587204|FG003|Overall Study|Sponsor Decision to Terminate Study|0|||
143282870|NCT05147350|516587205|FG004|Overall Study|Sponsor Decision to Terminate Study|4|||
143282871|NCT05147350|516587206|FG005|Overall Study|Sponsor Decision to Terminate Study|0|||
143282872|NCT05147350|516587207|FG006|Overall Study|Sponsor Decision to Terminate Study|0|||
143282873|NCT05147350|516587208|FG007|Overall Study|Sponsor Decision to Terminate Study|1|||
143282874|NCT05147350|516587201|FG000|Overall Study|Withdrawal by Subject|0|||
143282875|NCT05147350|516587202|FG001|Overall Study|Withdrawal by Subject|0|||
143282876|NCT05147350|516587203|FG002|Overall Study|Withdrawal by Subject|3|||
143282877|NCT05147350|516587204|FG003|Overall Study|Withdrawal by Subject|1|||
143282878|NCT05147350|516587205|FG004|Overall Study|Withdrawal by Subject|1|||
143282879|NCT05147350|516587206|FG005|Overall Study|Withdrawal by Subject|0|||
143282880|NCT05147350|516587207|FG006|Overall Study|Withdrawal by Subject|1|||
143282881|NCT05147350|516587208|FG007|Overall Study|Withdrawal by Subject|0|||
143282882|NCT05147350|516587201|FG000|Overall Study|Other Reasons|0|||
143282883|NCT05147350|516587202|FG001|Overall Study|Other Reasons|0|||
143282884|NCT05147350|516587203|FG002|Overall Study|Other Reasons|2|||
143282885|NCT05147350|516587204|FG003|Overall Study|Other Reasons|0|||
143282886|NCT05147350|516587205|FG004|Overall Study|Other Reasons|0|||
143282887|NCT05147350|516587206|FG005|Overall Study|Other Reasons|2|||
143282888|NCT05147350|516587207|FG006|Overall Study|Other Reasons|1|||
143282889|NCT05147350|516587208|FG007|Overall Study|Other Reasons|1|||
143282890|NCT01539538|516587209|FG000|Overall Study|Adverse Event|13|||
143282891|NCT01539538|516587210|FG001|Overall Study|Adverse Event|18|||
143282892|NCT01539538|516587209|FG000|Overall Study|Lack of Efficacy|13|||
143282893|NCT01539538|516587210|FG001|Overall Study|Lack of Efficacy|16|||
143282894|NCT01539538|516587209|FG000|Overall Study|Withdrawal by Subject|2|||
143282895|NCT01539538|516587210|FG001|Overall Study|Withdrawal by Subject|3|||
143282896|NCT01539538|516587209|FG000|Overall Study|PCA no longer required or PCA problem|3|||
143282897|NCT01539538|516587210|FG001|Overall Study|PCA no longer required or PCA problem|7|||
143282898|NCT00847379|516587211|FG000|Overall Study|Study terminated by Sponsor|59|||
143282899|NCT00847379|516587212|FG001|Overall Study|Study terminated by Sponsor|57|||
143282900|NCT00847379|516587213|FG002|Overall Study|Study terminated by Sponsor|57|||
143282901|NCT00521014|516587214|FG000|Overall Study|Inevaluable, not treated|1|||
143282902|NCT03978832|516587215|FG000|Overall Study|Adverse Event|1|||
143282903|NCT03978832|516587215|FG000|Overall Study|Lost to Follow-up|1|||
143282904|NCT03978832|516587215|FG000|Overall Study|Withdrawal by Subject|6|||
143282905|NCT03978832|516587215|FG000|Overall Study|Physician Decision|2|||
143282906|NCT03978832|516587215|FG000|Overall Study|did not pass screening criteria|44|||
143282907|NCT02864498|516587220|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
143282908|NCT02864498|516587221|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
143282909|NCT02864498|516587222|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
143282910|NCT02864498|516587220|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
143282911|NCT02864498|516587221|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
143282912|NCT02864498|516587222|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
143282913|NCT02864498|516587220|FG000|Overall Study|Investigator Discretion|0|||
143282914|NCT02864498|516587221|FG001|Overall Study|Investigator Discretion|2|||
143282915|NCT02864498|516587222|FG002|Overall Study|Investigator Discretion|1|||
143282916|NCT02864498|516587220|FG000|Overall Study|Lost to Follow-up|8|||
143282917|NCT02864498|516587221|FG001|Overall Study|Lost to Follow-up|6|||
143282918|NCT02864498|516587222|FG002|Overall Study|Lost to Follow-up|3|||
143282919|NCT02864498|516587220|FG000|Overall Study|Lack of Efficacy|5|||
143282920|NCT02864498|516587221|FG001|Overall Study|Lack of Efficacy|3|||
143282921|NCT02864498|516587222|FG002|Overall Study|Lack of Efficacy|3|||
143282922|NCT02864498|516587220|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
143282923|NCT02864498|516587221|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
143282924|NCT02864498|516587222|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
143282925|NCT02864498|516587220|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
143282926|NCT02864498|516587221|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
143282927|NCT02864498|516587222|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
143282928|NCT02864498|516587220|FG000|Overall Study|Subject moved out of the country.|0|||
143282929|NCT02864498|516587221|FG001|Overall Study|Subject moved out of the country.|0|||
143282930|NCT02864498|516587222|FG002|Overall Study|Subject moved out of the country.|1|||
143282931|NCT01256008|516587223|FG000|Overall Study|Lost to Follow-up|6|||
143282932|NCT01256008|516587224|FG001|Overall Study|Lost to Follow-up|4|||
143282933|NCT01256008|516587225|FG002|Overall Study|Lost to Follow-up|11|||
143282934|NCT01256008|516587223|FG000|Overall Study|Withdrawal by Subject|2|||
143282935|NCT01256008|516587224|FG001|Overall Study|Withdrawal by Subject|3|||
143282936|NCT01256008|516587225|FG002|Overall Study|Withdrawal by Subject|10|||
143282937|NCT02244606|516587226|FG000|Overall Study|Adverse Event|0|||
143282938|NCT02244606|516587227|FG001|Overall Study|Adverse Event|1|||
143282939|NCT02244606|516587228|FG002|Overall Study|Adverse Event|1|||
143282940|NCT02244606|516587229|FG003|Overall Study|Adverse Event|0|||
143282941|NCT02244606|516587226|FG000|Overall Study|Lost to Follow-up|2|||
143282942|NCT02244606|516587227|FG001|Overall Study|Lost to Follow-up|2|||
143282943|NCT02244606|516587228|FG002|Overall Study|Lost to Follow-up|1|||
143282944|NCT02244606|516587229|FG003|Overall Study|Lost to Follow-up|0|||
143282945|NCT02244606|516587226|FG000|Overall Study|Protocol Violation|0|||
143282946|NCT02244606|516587227|FG001|Overall Study|Protocol Violation|0|||
143282947|NCT02244606|516587228|FG002|Overall Study|Protocol Violation|0|||
143282948|NCT02244606|516587229|FG003|Overall Study|Protocol Violation|1|||
143282949|NCT02244606|516587226|FG000|Overall Study|Withdrawal by Subject|1|||
143282950|NCT02244606|516587227|FG001|Overall Study|Withdrawal by Subject|1|||
143282951|NCT02244606|516587228|FG002|Overall Study|Withdrawal by Subject|0|||
143282952|NCT02244606|516587229|FG003|Overall Study|Withdrawal by Subject|0|||
143282953|NCT02244606|516587226|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
143282954|NCT02244606|516587227|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
143282955|NCT02244606|516587228|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
143282956|NCT02244606|516587229|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
143282957|NCT00378378|516587232|FG000|Overall Study|Withdrawal by Subject|0|||
143282958|NCT00378378|516587233|FG001|Overall Study|Withdrawal by Subject|1|||
143282959|NCT00378378|516587234|FG002|Overall Study|Withdrawal by Subject|0|||
143282960|NCT00378378|516587232|FG000|Overall Study|Treatment Failure|0|||
143282961|NCT00378378|516587233|FG001|Overall Study|Treatment Failure|0|||
143282962|NCT00378378|516587234|FG002|Overall Study|Treatment Failure|1|||
143282963|NCT00378378|516587232|FG000|Overall Study|Non-compliance with protocol|0|||
143282964|NCT00378378|516587233|FG001|Overall Study|Non-compliance with protocol|0|||
143282965|NCT00378378|516587234|FG002|Overall Study|Non-compliance with protocol|1|||
143282966|NCT03132220|516587242|FG000|Overall Study|Lost to Follow-up|17|||
143282967|NCT03132220|516587243|FG001|Overall Study|Lost to Follow-up|8|||
143282968|NCT03132220|516587242|FG000|Overall Study|Withdrawal by Subject|1|||
143282969|NCT03132220|516587243|FG001|Overall Study|Withdrawal by Subject|4|||
143282970|NCT00730132|516587244|FG000|Overall Study|Protocol Violation|154|||
143282971|NCT00730132|516587244|FG000|Overall Study|Death|1|||
143282972|NCT03208244|516587245|FG000|Overall Study|Death|1|||
143282973|NCT00702923|516587247|FG000|Overall Study|Adverse Event|1|||
143282974|NCT03953820|516587249|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
143282975|NCT03953820|516587250|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
143282976|NCT03953820|516587251|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
143282977|NCT03953820|516587249|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
143282978|NCT03953820|516587250|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
143282979|NCT03953820|516587251|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
143282980|NCT01049308|516587256|FG000|Pill Counts|Withdrawal by Subject|83|||
143282981|NCT01318993|516587260|FG000|Overall Study|Adverse Event|53|||
143282982|NCT01318993|516587260|FG000|Overall Study|Lack of Efficacy|121|||
143282983|NCT01318993|516587260|FG000|Overall Study|Protocol Violation|3|||
143282984|NCT01318993|516587260|FG000|Overall Study|Protocol based stopping criteria|6|||
143282985|NCT01318993|516587260|FG000|Overall Study|Study closed or terminated|174|||
143282986|NCT01318993|516587260|FG000|Overall Study|Lost to Follow-up|4|||
143282987|NCT01318993|516587260|FG000|Overall Study|Physician Decision|13|||
143282988|NCT01318993|516587260|FG000|Overall Study|Withdrawal by Subject|24|||
143282989|NCT04974697|516587261|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
143282990|NCT04974697|516587261|FG000|Overall Study|Lens discomfort|1|||
143282991|NCT03706456|516587262|FG000|Overall Study|Adverse Event|1|||
143282992|NCT03706456|516587262|FG000|Overall Study|Lack of Efficacy|2|||
143282993|NCT02795832|516587266|FG000|Overall Study|Adverse Event|0|||
143282994|NCT02795832|516587267|FG001|Overall Study|Adverse Event|0|||
143282995|NCT02795832|516587268|FG002|Overall Study|Adverse Event|0|||
143282996|NCT02795832|516587269|FG003|Overall Study|Adverse Event|0|||
143282997|NCT02795832|516587270|FG004|Overall Study|Adverse Event|0|||
143282998|NCT02795832|516587271|FG005|Overall Study|Adverse Event|3|||
143282999|NCT00221403|516587272|FG000|Overall Study|Protocol Violation|1|||
143283000|NCT00221403|516587273|FG001|Overall Study|Protocol Violation|0|||
143283001|NCT00221403|516587274|FG002|Overall Study|Protocol Violation|0|||
143283002|NCT00221403|516587272|FG000|Overall Study|Physician Decision|1|||
143283003|NCT00221403|516587273|FG001|Overall Study|Physician Decision|0|||
143283004|NCT00221403|516587274|FG002|Overall Study|Physician Decision|0|||
143283005|NCT00221403|516587272|FG000|Overall Study|Withdrawal by Subject|0|||
143283006|NCT00221403|516587273|FG001|Overall Study|Withdrawal by Subject|3|||
143283007|NCT00221403|516587274|FG002|Overall Study|Withdrawal by Subject|0|||
143283008|NCT00221403|516587272|FG000|Overall Study|Lack of Efficacy|0|||
143283009|NCT00221403|516587273|FG001|Overall Study|Lack of Efficacy|1|||
143283010|NCT00221403|516587274|FG002|Overall Study|Lack of Efficacy|0|||
143283011|NCT00221403|516587272|FG000|Overall Study|Adverse Event|0|||
143283012|NCT00221403|516587273|FG001|Overall Study|Adverse Event|1|||
143283013|NCT00221403|516587274|FG002|Overall Study|Adverse Event|0|||
143283014|NCT02695329|516587277|FG000|Overall Study|Adverse Event|1|||
143283015|NCT02695329|516587278|FG001|Overall Study|Adverse Event|0|||
143283016|NCT02695329|516587277|FG000|Overall Study|Poor X-ray quality for measurement|4|||
143283017|NCT02695329|516587278|FG001|Overall Study|Poor X-ray quality for measurement|5|||
143283018|NCT04659161|516587279|FG000|Overall Study|Adverse Event|10|||
143283019|NCT04659161|516587280|FG001|Overall Study|Adverse Event|6|||
143283020|NCT04659161|516587279|FG000|Overall Study|Withdrawal by Subject|13|||
143283021|NCT04659161|516587280|FG001|Overall Study|Withdrawal by Subject|12|||
143283022|NCT04659161|516587279|FG000|Overall Study|Other|9|||
143283023|NCT04659161|516587280|FG001|Overall Study|Other|8|||
143283024|NCT03547583|516587281|FG000|Overall Study|Adverse Event|16|||
143283025|NCT03547583|516587282|FG001|Overall Study|Adverse Event|11|||
143283026|NCT03547583|516587283|FG002|Overall Study|Adverse Event|10|||
143283027|NCT03547583|516587281|FG000|Overall Study|Death|11|||
143283028|NCT03547583|516587282|FG001|Overall Study|Death|7|||
143283029|NCT03547583|516587283|FG002|Overall Study|Death|4|||
143283030|NCT03547583|516587281|FG000|Overall Study|Lost to Follow-up|1|||
143283031|NCT03547583|516587282|FG001|Overall Study|Lost to Follow-up|0|||
143283032|NCT03547583|516587283|FG002|Overall Study|Lost to Follow-up|0|||
143283033|NCT03547583|516587281|FG000|Overall Study|Non-compliance with study drug|0|||
143283034|NCT03547583|516587282|FG001|Overall Study|Non-compliance with study drug|0|||
143283035|NCT03547583|516587283|FG002|Overall Study|Non-compliance with study drug|1|||
143283036|NCT03547583|516587281|FG000|Overall Study|Physician Decision|1|||
143283037|NCT03547583|516587282|FG001|Overall Study|Physician Decision|0|||
143283038|NCT03547583|516587283|FG002|Overall Study|Physician Decision|3|||
143283039|NCT03547583|516587281|FG000|Overall Study|Protocol Violation|2|||
143283040|NCT03547583|516587282|FG001|Overall Study|Protocol Violation|1|||
143283041|NCT03547583|516587283|FG002|Overall Study|Protocol Violation|1|||
143283042|NCT03547583|516587281|FG000|Overall Study|Withdrawal by Subject|12|||
143283043|NCT03547583|516587282|FG001|Overall Study|Withdrawal by Subject|19|||
143283044|NCT03547583|516587283|FG002|Overall Study|Withdrawal by Subject|10|||
143283045|NCT03547583|516587281|FG000|Overall Study|Other|2|||
143283046|NCT03547583|516587282|FG001|Overall Study|Other|2|||
143283047|NCT03547583|516587283|FG002|Overall Study|Other|3|||
143283048|NCT03291808|516588367|FG000|Overall Study|Lost to Follow-up|6|||
143283049|NCT03291808|516588367|FG000|Overall Study|Research burden|4|||
143283050|NCT02674529|516588368|FG000|Overall Study|Lost to Follow-up|1|||
143283051|NCT02674529|516588369|FG001|Overall Study|Lost to Follow-up|2|||
143283052|NCT02674529|516588368|FG000|Overall Study|Withdrawal by Subject|2|||
143283053|NCT02674529|516588369|FG001|Overall Study|Withdrawal by Subject|1|||
143283054|NCT02674529|516588368|FG000|Overall Study|Physician Decision|0|||
143283055|NCT02674529|516588369|FG001|Overall Study|Physician Decision|1|||
143283056|NCT02674529|516588368|FG000|Overall Study|Protocol Violation|0|||
143283057|NCT02674529|516588369|FG001|Overall Study|Protocol Violation|1|||
143283058|NCT02891850|516588370|FG000|Overall Study|Adverse Event|3|||
143283059|NCT02891850|516588371|FG001|Overall Study|Adverse Event|0|||
143283060|NCT02891850|516588370|FG000|Overall Study|Death|0|||
143283061|NCT02891850|516588371|FG001|Overall Study|Death|4|||
143373258|NCT03478696|516911412|FG000|Overall Study|Adverse Event|1|||
143373259|NCT03478696|516911413|FG001|Overall Study|Adverse Event|5|||
143373260|NCT03478696|516911412|FG000|Overall Study|Lost to Follow-up|1|||
143373261|NCT03478696|516911413|FG001|Overall Study|Lost to Follow-up|0|||
143373262|NCT03478696|516911412|FG000|Overall Study|Physician Decision|6|||
143373263|NCT03478696|516911413|FG001|Overall Study|Physician Decision|3|||
143373264|NCT03478696|516911412|FG000|Overall Study|Withdrawal by Subject|9|||
143373265|NCT03478696|516911413|FG001|Overall Study|Withdrawal by Subject|4|||
143373266|NCT03615924|516911414|FG000|Overall Study|Withdrawal by Subject|2|||
143373267|NCT03615924|516911415|FG001|Overall Study|Withdrawal by Subject|5|||
143373268|NCT03615924|516911414|FG000|Overall Study|Death|3|||
143373269|NCT03615924|516911415|FG001|Overall Study|Death|1|||
143373270|NCT03615924|516911414|FG000|Overall Study|Lost to Follow-up|1|||
143373271|NCT03615924|516911415|FG001|Overall Study|Lost to Follow-up|0|||
143373272|NCT03615924|516911414|FG000|Overall Study|Randomized in error|1|||
143373273|NCT03615924|516911415|FG001|Overall Study|Randomized in error|0|||
143373274|NCT03615924|516911414|FG000|Overall Study|Study termination by Sponsor|94|||
143283062|NCT02891850|516588370|FG000|Overall Study|Physician Decision|1|||
143283063|NCT02891850|516588371|FG001|Overall Study|Physician Decision|0|||
143283064|NCT02891850|516588370|FG000|Overall Study|Pregnancy|1|||
143283065|NCT02891850|516588371|FG001|Overall Study|Pregnancy|0|||
143283066|NCT02891850|516588370|FG000|Overall Study|Withdrawal by Subject|2|||
143373275|NCT03615924|516911415|FG001|Overall Study|Study termination by Sponsor|86|||
143373276|NCT00716144|516911416|FG000|Overall Study|Withdrawal by Subject|4|||
143373277|NCT00716144|516911417|FG001|Overall Study|Withdrawal by Subject|2|||
143283067|NCT02891850|516588371|FG001|Overall Study|Withdrawal by Subject|3|||
143283068|NCT02601469|516588379|FG000|Overall Study|Enrolled in Error|1|||
143283069|NCT02601469|516588380|FG001|Overall Study|Enrolled in Error|0|||
143283070|NCT01411774|516588385|FG000|Overall Study|Withdrawal by Subject|0|||
143283071|NCT01411774|516588386|FG001|Overall Study|Withdrawal by Subject|3|||
143283072|NCT00056316|516588387|FG000|Overall Study|Withdrawal by Subject|2|||
143283073|NCT00056316|516588388|FG001|Overall Study|Withdrawal by Subject|2|||
143283074|NCT00056316|516588387|FG000|Overall Study|Death/NH placement of pt|1|||
143283075|NCT00056316|516588388|FG001|Overall Study|Death/NH placement of pt|1|||
143283076|NCT02820753|516588389|FG000|2 Month|Withdrawal by Subject|3|||
143283077|NCT02820753|516588390|FG001|2 Month|Withdrawal by Subject|3|||
143283078|NCT02820753|516588389|FG000|2 Month|Lost to Follow-up|24|||
143283079|NCT02820753|516588390|FG001|2 Month|Lost to Follow-up|26|||
143283080|NCT02820753|516588389|FG000|2 Month|Stopped per NIH Hold|51|||
143283081|NCT02820753|516588390|FG001|2 Month|Stopped per NIH Hold|13|||
143283082|NCT02820753|516588389|FG000|6 Month|Withdrawal by Subject|2|||
143283083|NCT02820753|516588390|FG001|6 Month|Withdrawal by Subject|2|||
143283084|NCT02820753|516588389|FG000|6 Month|Lost to Follow-up|20|||
143283085|NCT02820753|516588390|FG001|6 Month|Lost to Follow-up|27|||
143283086|NCT02820753|516588389|FG000|6 Month|Stopped per NIH Hold|81|||
143283087|NCT02820753|516588390|FG001|6 Month|Stopped per NIH Hold|81|||
143283088|NCT02820753|516588389|FG000|6 Month|Death|0|||
143283089|NCT02820753|516588390|FG001|6 Month|Death|1|||
143283090|NCT02161731|516588391|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
143283091|NCT02161731|516588392|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
143283092|NCT02161731|516588391|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
143283093|NCT02161731|516588392|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
143283094|NCT01315678|516588397|FG000|Overall Study|Withdrawal by Subject|7|||
143283095|NCT01315678|516588398|FG001|Overall Study|Withdrawal by Subject|3|||
143283096|NCT01315678|516588397|FG000|Overall Study|Adverse Event|3|||
143283097|NCT01315678|516588398|FG001|Overall Study|Adverse Event|1|||
143283098|NCT01315678|516588397|FG000|Overall Study|Lost to Follow-up|1|||
143283099|NCT01315678|516588398|FG001|Overall Study|Lost to Follow-up|0|||
143283100|NCT01315678|516588397|FG000|Overall Study|similar reason to those listed above|3|||
143283101|NCT01315678|516588398|FG001|Overall Study|similar reason to those listed above|2|||
143283102|NCT02269241|516588404|FG000|Overall Study|Lost to Follow-up|269|||
143283103|NCT02269241|516588404|FG000|Overall Study|Withdrawal by Subject|155|||
143283104|NCT02269241|516588404|FG000|Overall Study|Protocol Violation|1|||
143283105|NCT02269241|516588404|FG000|Overall Study|Physician Decision|7|||
143283106|NCT02269241|516588404|FG000|Overall Study|Pregnancy|15|||
143283107|NCT02269241|516588404|FG000|Overall Study|Wish for pregnancy|5|||
143283108|NCT02269241|516588404|FG000|Overall Study|Development of an exclusion criteria|16|||
143283109|NCT02269241|516588404|FG000|Overall Study|Adverse Event|113|||
143283110|NCT02269241|516588404|FG000|Overall Study|At the specific request of the sponsor|20|||
143283111|NCT02269241|516588404|FG000|Overall Study|Several reasons not classified|53|||
143283112|NCT02269241|516588404|FG000|Overall Study|Screening failures|546|||
143283113|NCT03020160|516588405|FG000|Overall Study|Withdrawal by Subject|1|||
143283114|NCT03020160|516588406|FG001|Overall Study|Withdrawal by Subject|0|||
143283115|NCT02548650|516588416|FG000|Triple Therapy|Adverse Event|1|||
143283116|NCT02548650|516588417|FG001|Triple Therapy|Adverse Event|0|||
143283117|NCT02548650|516588416|FG000|Triple Therapy|Withdrawal by Subject|0|||
143283118|NCT02548650|516588417|FG001|Triple Therapy|Withdrawal by Subject|4|||
143283119|NCT02548650|516588416|FG000|Double Therapy|Adverse Event|1|||
143283120|NCT02548650|516588417|FG001|Double Therapy|Adverse Event|1|||
143283121|NCT02548650|516588416|FG000|Double Therapy|Withdrawal by Subject|0|||
143283122|NCT02548650|516588417|FG001|Double Therapy|Withdrawal by Subject|1|||
143283123|NCT00407797|516588418|FG000|Overall Study|Lost to Follow-up|2|||
143283124|NCT00407797|516588418|FG000|Overall Study|Adverse Event|6|||
143283125|NCT00407797|516588418|FG000|Overall Study|Other|7|||
143283126|NCT00407797|516588418|FG000|Overall Study|Withdrawal by Subject|3|||
143283127|NCT01812174|516588419|FG000|Overall Study|Death|1|||
143283128|NCT01812174|516588420|FG001|Overall Study|Death|0|||
143283129|NCT01812174|516588419|FG000|Overall Study|Protocol Violation|2|||
143283130|NCT01812174|516588420|FG001|Overall Study|Protocol Violation|0|||
143283131|NCT01336764|516588425|FG000|Overall Study|Withdrawal by Subject|5|||
143283132|NCT01336764|516588426|FG001|Overall Study|Withdrawal by Subject|5|||
143283133|NCT05537883|516588427|FG000|Overall Study|revisional surgery|4|||
143283134|NCT05537883|516588428|FG001|Overall Study|revisional surgery|2|||
143283135|NCT05537883|516588427|FG000|Overall Study|surgeries were cancelled|0|||
143283136|NCT05537883|516588428|FG001|Overall Study|surgeries were cancelled|2|||
143283137|NCT05537883|516588427|FG000|Overall Study|not being compliant with the Seamless MD app|31|||
143283138|NCT05537883|516588428|FG001|Overall Study|not being compliant with the Seamless MD app|30|||
143283139|NCT05229406|516588429|FG000|Overall Study|Withdrawal by Subject|1|||
143283140|NCT05229406|516588430|FG001|Overall Study|Withdrawal by Subject|2|||
143283141|NCT05466682|516588431|FG000|Overall Study|Withdrawal by Subject|0|||
143283142|NCT05466682|516588432|FG001|Overall Study|Withdrawal by Subject|2|||
143283143|NCT05466682|516588431|FG000|Overall Study|Lost to Follow-up|2|||
143283144|NCT05466682|516588432|FG001|Overall Study|Lost to Follow-up|1|||
143283145|NCT00036270|516588435|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
143283146|NCT00036270|516588436|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
143283147|NCT00036270|516588435|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
143283148|NCT00036270|516588436|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
143283149|NCT00036270|516588435|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
143283150|NCT00036270|516588436|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
143283151|NCT00036270|516588435|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
143283152|NCT00036270|516588436|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
143283153|NCT00036270|516588435|FG000|Study Treatment to 5 Year Report|Other|277|||
143283154|NCT00036270|516588436|FG001|Study Treatment to 5 Year Report|Other|288|||
143283155|NCT00036270|516588435|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
143283156|NCT00036270|516588436|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
143283157|NCT00036270|516588435|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
143283158|NCT00036270|516588436|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
143283159|NCT00036270|516588435|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
143283160|NCT00036270|516588436|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
143283161|NCT00036270|516588435|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
143283162|NCT00036270|516588436|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
143283163|NCT00036270|516588435|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
143283164|NCT00036270|516588436|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
143283165|NCT00036270|516588435|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
143283166|NCT00036270|516588436|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
143283167|NCT01658072|516588437|FG000|Overall Study|Protocol Violation|4|||
143283168|NCT01658072|516588438|FG001|Overall Study|Protocol Violation|2|||
143283169|NCT00799422|516588443|FG000|First Week of Wear|Lost to Follow-up|0|||
143283170|NCT00799422|516588444|FG001|First Week of Wear|Lost to Follow-up|0|||
143283171|NCT00799422|516588445|FG002|First Week of Wear|Lost to Follow-up|1|||
143283172|NCT00799422|516588446|FG003|First Week of Wear|Lost to Follow-up|0|||
143283173|NCT00799422|516588447|FG004|First Week of Wear|Lost to Follow-up|0|||
143283174|NCT00799422|516588448|FG005|First Week of Wear|Lost to Follow-up|0|||
143283175|NCT00799422|516588443|FG000|First Week of Wear|Adverse Event|0|||
143283176|NCT00799422|516588444|FG001|First Week of Wear|Adverse Event|0|||
143283177|NCT00799422|516588445|FG002|First Week of Wear|Adverse Event|0|||
143283178|NCT00799422|516588446|FG003|First Week of Wear|Adverse Event|1|||
143283179|NCT00799422|516588447|FG004|First Week of Wear|Adverse Event|0|||
143283180|NCT00799422|516588448|FG005|First Week of Wear|Adverse Event|0|||
143283181|NCT00880009|516588449|FG000|Overall Study|Study terminated by sponsor|14|||
143283182|NCT00880009|516588449|FG000|Overall Study|Withdrawal by Subject|1|||
143283183|NCT00880009|516588449|FG000|Overall Study|Protocol Violation|1|||
143283184|NCT02010775|516588454|FG000|Overall Study|Adverse Event|0|||
143283185|NCT02010775|516588455|FG001|Overall Study|Adverse Event|0|||
143283186|NCT02010775|516588456|FG002|Overall Study|Adverse Event|0|||
143283187|NCT02010775|516588457|FG003|Overall Study|Adverse Event|0|||
143283188|NCT02010775|516588458|FG004|Overall Study|Adverse Event|1|||
143283189|NCT02010775|516588454|FG000|Overall Study|Pregnancy|0|||
143283190|NCT02010775|516588455|FG001|Overall Study|Pregnancy|0|||
143283191|NCT02010775|516588456|FG002|Overall Study|Pregnancy|2|||
143283192|NCT02010775|516588457|FG003|Overall Study|Pregnancy|0|||
143283193|NCT02010775|516588458|FG004|Overall Study|Pregnancy|0|||
143283194|NCT02010775|516588454|FG000|Overall Study|Lost to Follow-up|2|||
143283195|NCT02010775|516588455|FG001|Overall Study|Lost to Follow-up|0|||
143283196|NCT02010775|516588456|FG002|Overall Study|Lost to Follow-up|0|||
143283197|NCT02010775|516588457|FG003|Overall Study|Lost to Follow-up|1|||
143283198|NCT02010775|516588458|FG004|Overall Study|Lost to Follow-up|1|||
143283199|NCT02010775|516588454|FG000|Overall Study|Personal Reasons|3|||
143283200|NCT02010775|516588455|FG001|Overall Study|Personal Reasons|3|||
143283201|NCT02010775|516588456|FG002|Overall Study|Personal Reasons|1|||
143283202|NCT02010775|516588457|FG003|Overall Study|Personal Reasons|2|||
143283203|NCT02010775|516588458|FG004|Overall Study|Personal Reasons|4|||
143283204|NCT01929343|516588462|FG000|Overall Study|Physician Decision|0|||
143283205|NCT01929343|516588463|FG001|Overall Study|Physician Decision|2|||
143283206|NCT01929343|516588464|FG002|Overall Study|Physician Decision|0|||
143283207|NCT01929343|516588462|FG000|Overall Study|Withdrawal by Subject|1|||
143283208|NCT01929343|516588463|FG001|Overall Study|Withdrawal by Subject|0|||
143283209|NCT01929343|516588464|FG002|Overall Study|Withdrawal by Subject|0|||
143283210|NCT02197130|516588465|FG000|Overall Study|Adverse Event|13|||
143283211|NCT02197130|516588466|FG001|Overall Study|Adverse Event|4|||
143283212|NCT02197130|516588467|FG002|Overall Study|Adverse Event|23|||
143283213|NCT02197130|516588465|FG000|Overall Study|Death|0|||
143283214|NCT02197130|516588466|FG001|Overall Study|Death|1|||
143283215|NCT02197130|516588467|FG002|Overall Study|Death|0|||
143283216|NCT02197130|516588465|FG000|Overall Study|Lost to Follow-up|2|||
143283217|NCT02197130|516588466|FG001|Overall Study|Lost to Follow-up|0|||
143283218|NCT02197130|516588467|FG002|Overall Study|Lost to Follow-up|1|||
143283219|NCT02197130|516588465|FG000|Overall Study|Does not meet entrance criteria|0|||
143373278|NCT00716144|516911418|FG002|Overall Study|Withdrawal by Subject|6|||
143373279|NCT00716144|516911419|FG003|Overall Study|Withdrawal by Subject|6|||
143373280|NCT00716144|516911416|FG000|Overall Study|Lost to Follow-up|2|||
143373281|NCT00716144|516911417|FG001|Overall Study|Lost to Follow-up|2|||
143373282|NCT00716144|516911418|FG002|Overall Study|Lost to Follow-up|1|||
143283220|NCT02197130|516588466|FG001|Overall Study|Does not meet entrance criteria|0|||
143283221|NCT02197130|516588467|FG002|Overall Study|Does not meet entrance criteria|1|||
143283222|NCT02197130|516588465|FG000|Overall Study|Withdrawal by Subject|0|||
143283223|NCT02197130|516588466|FG001|Overall Study|Withdrawal by Subject|3|||
143283224|NCT02197130|516588467|FG002|Overall Study|Withdrawal by Subject|4|||
143283225|NCT02197130|516588465|FG000|Overall Study|Other|1|||
143283226|NCT02197130|516588466|FG001|Overall Study|Other|0|||
143283227|NCT02197130|516588467|FG002|Overall Study|Other|3|||
143283228|NCT01269463|516588476|FG000|First Intervention|Withdrawal by Subject|1|||
143283229|NCT01269463|516588477|FG001|First Intervention|Withdrawal by Subject|0|||
143283230|NCT01269463|516588476|FG000|First Intervention|Adverse Event|1|||
143283231|NCT01269463|516588477|FG001|First Intervention|Adverse Event|0|||
143283232|NCT01269463|516588476|FG000|First Intervention|Lack of Efficacy|0|||
143283233|NCT01269463|516588477|FG001|First Intervention|Lack of Efficacy|1|||
143283234|NCT01269463|516588476|FG000|First Intervention|Physician Decision|0|||
143283235|NCT01269463|516588477|FG001|First Intervention|Physician Decision|1|||
143283236|NCT00317356|516588480|FG000|Overall Study|Adverse Event|0|||
143283237|NCT00317356|516588481|FG001|Overall Study|Adverse Event|0|||
143283238|NCT00317356|516588482|FG002|Overall Study|Adverse Event|1|||
143283239|NCT00317356|516588483|FG003|Overall Study|Adverse Event|0|||
143283240|NCT00317356|516588480|FG000|Overall Study|Lack of Efficacy|1|||
143283241|NCT00317356|516588481|FG001|Overall Study|Lack of Efficacy|1|||
143283242|NCT00317356|516588482|FG002|Overall Study|Lack of Efficacy|0|||
143283243|NCT00317356|516588483|FG003|Overall Study|Lack of Efficacy|3|||
143283244|NCT00317356|516588480|FG000|Overall Study|Physician Decision|0|||
143283245|NCT00317356|516588481|FG001|Overall Study|Physician Decision|1|||
143283246|NCT00317356|516588482|FG002|Overall Study|Physician Decision|0|||
143283247|NCT00317356|516588483|FG003|Overall Study|Physician Decision|0|||
143283248|NCT03199274|516588484|FG000|Overall Study|Withdrawal by Subject|4|||
143283249|NCT03199274|516588485|FG001|Overall Study|Withdrawal by Subject|0|||
143283250|NCT03199274|516588484|FG000|Overall Study|Lost to Follow-up|0|||
143283251|NCT03199274|516588485|FG001|Overall Study|Lost to Follow-up|1|||
143283252|NCT03199274|516588484|FG000|Overall Study|Deemed screen fail because he had no arteries to access during flow study|0|||
143283253|NCT03199274|516588485|FG001|Overall Study|Deemed screen fail because he had no arteries to access during flow study|1|||
143283254|NCT05980182|516588486|FG000|Overall Study|Lost to Follow-up|10|||
143283255|NCT01892293|516590205|FG000|Overall Study|Apheresed but not treated|4|||
143283256|NCT03602482|516590206|FG000|Overall Study|Withdrawal by Subject|6|||
143283257|NCT03602482|516590207|FG001|Overall Study|Withdrawal by Subject|7|||
143283258|NCT03602482|516590208|FG002|Overall Study|Withdrawal by Subject|0|||
143283259|NCT03602482|516590209|FG003|Overall Study|Withdrawal by Subject|0|||
143283260|NCT05048784|516590214|FG000|Period 1|Adverse Event|3|||
143283261|NCT05048784|516590215|FG001|Period 1|Adverse Event|1|||
143283262|NCT05048784|516590216|FG002|Period 1|Adverse Event|0|||
143283263|NCT05048784|516590217|FG003|Period 1|Adverse Event|0|||
143283264|NCT05048784|516590214|FG000|Period 2|Lost to Follow-up|0|||
143283265|NCT05048784|516590215|FG001|Period 2|Lost to Follow-up|1|||
143283266|NCT05048784|516590216|FG002|Period 2|Lost to Follow-up|0|||
143283267|NCT05048784|516590217|FG003|Period 2|Lost to Follow-up|0|||
143283268|NCT02270957|516590220|FG000|Overall Study|Lack of Efficacy|2|||
143283269|NCT02270957|516590221|FG001|Overall Study|Lack of Efficacy|4|||
143283270|NCT02270957|516590220|FG000|Overall Study|Adverse Event|2|||
143283271|NCT02270957|516590221|FG001|Overall Study|Adverse Event|0|||
143283272|NCT01513473|516590222|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
143283273|NCT01513473|516590223|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
143283274|NCT01513473|516590222|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
143283275|NCT01513473|516590223|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
143283276|NCT01513473|516590222|FG000|Main Trial (26 Weeks)|Unclassified|0|||
143283277|NCT01513473|516590223|FG001|Main Trial (26 Weeks)|Unclassified|2|||
143283278|NCT01513473|516590222|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
143283279|NCT01513473|516590223|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
143283280|NCT01513473|516590222|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
143283281|NCT01513473|516590223|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
143283282|NCT03462082|516590224|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
143283283|NCT03462082|516590225|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
143283284|NCT03462082|516590226|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
143283285|NCT03462082|516590227|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
143283286|NCT03462082|516590228|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
143283287|NCT03462082|516590229|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
143283288|NCT03462082|516590230|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
143283289|NCT03462082|516590231|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
143283290|NCT00166114|516590234|FG000|Overall Study|Protocol Violation|2|||
143283291|NCT00166114|516590235|FG001|Overall Study|Protocol Violation|1|||
143283292|NCT00166114|516590234|FG000|Overall Study|Withdrawal by Subject|10|||
143283293|NCT00166114|516590235|FG001|Overall Study|Withdrawal by Subject|4|||
143283294|NCT00166114|516590234|FG000|Overall Study|Adverse Event|2|||
143283295|NCT00166114|516590235|FG001|Overall Study|Adverse Event|1|||
143283296|NCT00545168|516590242|FG000|Overall Study|Lost to Follow-up|5|||
143283297|NCT00545168|516590243|FG001|Overall Study|Lost to Follow-up|5|||
143283298|NCT00545168|516590244|FG002|Overall Study|Lost to Follow-up|5|||
143283299|NCT00545168|516590242|FG000|Overall Study|Withdrawal by Subject|9|||
143283300|NCT00545168|516590243|FG001|Overall Study|Withdrawal by Subject|0|||
143283301|NCT00545168|516590244|FG002|Overall Study|Withdrawal by Subject|13|||
143283302|NCT00545168|516590242|FG000|Overall Study|Protocol Violation|1|||
143283303|NCT00545168|516590243|FG001|Overall Study|Protocol Violation|0|||
143283304|NCT00545168|516590244|FG002|Overall Study|Protocol Violation|1|||
143283305|NCT00545168|516590242|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
143283306|NCT00545168|516590243|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
143283307|NCT00545168|516590244|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
143283308|NCT00489541|516590249|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
143283309|NCT00489541|516590250|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
143283310|NCT00489541|516590249|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
143283311|NCT00489541|516590250|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
143283312|NCT00489541|516590249|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
143283313|NCT00489541|516590250|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
143283314|NCT00489541|516590249|FG000|12-Month Clinical Follow-up|Death|3|||
143283315|NCT00489541|516590250|FG001|12-Month Clinical Follow-up|Death|2|||
143283316|NCT00489541|516590249|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
143283317|NCT00489541|516590250|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
143283318|NCT00489541|516590249|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
143283319|NCT00489541|516590250|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
143283320|NCT00003479|516590251|FG000|Overall Study|Not evaluable|3|||
143283321|NCT00299104|516590252|FG000|Treatment Period|Adverse Event|14|||
143283322|NCT00299104|516590253|FG001|Treatment Period|Adverse Event|9|||
143283323|NCT00299104|516590254|FG002|Treatment Period|Adverse Event|7|||
143283324|NCT00299104|516590252|FG000|Treatment Period|Death|1|||
143283325|NCT00299104|516590253|FG001|Treatment Period|Death|1|||
143283326|NCT00299104|516590254|FG002|Treatment Period|Death|1|||
143283327|NCT00299104|516590252|FG000|Treatment Period|Insufficient therapeutic response|34|||
143283328|NCT00299104|516590253|FG001|Treatment Period|Insufficient therapeutic response|13|||
143283329|NCT00299104|516590254|FG002|Treatment Period|Insufficient therapeutic response|8|||
143283330|NCT00299104|516590252|FG000|Treatment Period|Failure to return|9|||
143283331|NCT00299104|516590253|FG001|Treatment Period|Failure to return|8|||
143283332|NCT00299104|516590254|FG002|Treatment Period|Failure to return|8|||
143283333|NCT00299104|516590252|FG000|Treatment Period|Violation of selection criteria|1|||
143283334|NCT00299104|516590253|FG001|Treatment Period|Violation of selection criteria|2|||
143283335|NCT00299104|516590254|FG002|Treatment Period|Violation of selection criteria|0|||
143283336|NCT00299104|516590252|FG000|Treatment Period|Protocol Violation|1|||
143283337|NCT00299104|516590253|FG001|Treatment Period|Protocol Violation|1|||
143283338|NCT00299104|516590254|FG002|Treatment Period|Protocol Violation|0|||
143283339|NCT00299104|516590252|FG000|Treatment Period|Refused treatment|9|||
143283340|NCT00299104|516590253|FG001|Treatment Period|Refused treatment|2|||
143283341|NCT00299104|516590254|FG002|Treatment Period|Refused treatment|2|||
143283342|NCT00299104|516590252|FG000|Treatment Period|Withdrew consent|14|||
143283343|NCT00299104|516590253|FG001|Treatment Period|Withdrew consent|19|||
143283344|NCT00299104|516590254|FG002|Treatment Period|Withdrew consent|9|||
143283345|NCT00299104|516590252|FG000|Treatment Period|Administrative reasons|106|||
143283346|NCT00299104|516590253|FG001|Treatment Period|Administrative reasons|120|||
143283347|NCT00299104|516590254|FG002|Treatment Period|Administrative reasons|137|||
143283348|NCT00299104|516590252|FG000|Safety Follow-Up (SFU) Period|Death|3|||
143283349|NCT00299104|516590253|FG001|Safety Follow-Up (SFU) Period|Death|2|||
143283350|NCT00299104|516590254|FG002|Safety Follow-Up (SFU) Period|Death|1|||
143283351|NCT00299104|516590252|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
143283352|NCT00299104|516590253|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
143283353|NCT00299104|516590254|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
143283354|NCT00299104|516590252|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
143283355|NCT00299104|516590253|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
143373283|NCT00716144|516911419|FG003|Overall Study|Lost to Follow-up|2|||
143283356|NCT00299104|516590254|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
143283357|NCT00299104|516590252|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
143283358|NCT00299104|516590253|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
143283359|NCT00299104|516590254|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
143283360|NCT00299104|516590252|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
143283361|NCT00299104|516590253|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
143283362|NCT00299104|516590254|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
143283363|NCT00299104|516590252|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
143283364|NCT00299104|516590253|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
143283365|NCT00299104|516590254|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
143283366|NCT00299104|516590252|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
143283367|NCT00299104|516590253|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
143283368|NCT00299104|516590254|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
143283369|NCT00299104|516590252|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
143283370|NCT00299104|516590253|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
143283371|NCT00299104|516590254|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
143283372|NCT04390191|516590264|FG000|Overall Study|Withdrawal by Subject|1|||
143283373|NCT04390191|516590265|FG001|Overall Study|Withdrawal by Subject|0|||
143283374|NCT00003499|516590266|FG000|Overall Study|Not evaluable|8|||
143283375|NCT01402492|516590269|FG000|Overall Study|Withdrawal by Subject|17|||
143283376|NCT01402492|516590270|FG001|Overall Study|Withdrawal by Subject|11|||
143283377|NCT01402492|516590271|FG002|Overall Study|Withdrawal by Subject|11|||
143283378|NCT01402492|516590269|FG000|Overall Study|Adverse Event|2|||
143283379|NCT01402492|516590270|FG001|Overall Study|Adverse Event|3|||
143283380|NCT01402492|516590271|FG002|Overall Study|Adverse Event|4|||
143283381|NCT01402492|516590269|FG000|Overall Study|Physician Decision|0|||
143283382|NCT01402492|516590270|FG001|Overall Study|Physician Decision|3|||
143283383|NCT01402492|516590271|FG002|Overall Study|Physician Decision|0|||
143283384|NCT01402492|516590269|FG000|Overall Study|Incarcerated (N=3)|2|||
143283385|NCT01402492|516590270|FG001|Overall Study|Incarcerated (N=3)|0|||
143283386|NCT01402492|516590271|FG002|Overall Study|Incarcerated (N=3)|1|||
143283387|NCT02321800|516590272|FG000|Overall Study|Withdrawal by Subject|3|||
143283388|NCT02321800|516590273|FG001|Overall Study|Withdrawal by Subject|3|||
143283389|NCT02321800|516590272|FG000|Overall Study|Death|1|||
143283390|NCT02321800|516590273|FG001|Overall Study|Death|0|||
143283391|NCT02321800|516590272|FG000|Overall Study|Protocol Violation|1|||
143283392|NCT02321800|516590273|FG001|Overall Study|Protocol Violation|0|||
143283393|NCT02321800|516590272|FG000|Overall Study|Lost to Follow-up|10|||
143283394|NCT02321800|516590273|FG001|Overall Study|Lost to Follow-up|4|||
143283395|NCT02321800|516590272|FG000|Overall Study|Adverse Event|2|||
143283396|NCT02321800|516590273|FG001|Overall Study|Adverse Event|3|||
143283397|NCT02321800|516590272|FG000|Overall Study|Other, Miscellaneous|3|||
143283398|NCT02321800|516590273|FG001|Overall Study|Other, Miscellaneous|1|||
143283399|NCT00982878|516590274|FG000|Overall Study|Physician Decision|1|||
143283400|NCT01051323|516590279|FG000|Overall Study|Discontinuation of treatment|103|||
143283401|NCT01051323|516590279|FG000|Overall Study|Transplantation|28|||
143283402|NCT01051323|516590279|FG000|Overall Study|Dialysis dependency|22|||
143283403|NCT01051323|516590279|FG000|Overall Study|Withdrawal by Subject|13|||
143283404|NCT01051323|516590279|FG000|Overall Study|Lost to Follow-up|31|||
143283405|NCT01051323|516590279|FG000|Overall Study|Death|129|||
143283406|NCT01051323|516590279|FG000|Overall Study|Hospitalization|28|||
143283407|NCT01051323|516590279|FG000|Overall Study|Other|148|||
143283408|NCT01051323|516590279|FG000|Overall Study|Missing|37|||
143283409|NCT01626391|516590280|FG000|Overall Study|Physician Decision|1|||
143283410|NCT01626391|516590281|FG001|Overall Study|Physician Decision|0|||
143283411|NCT01626391|516590280|FG000|Overall Study|Withdrawal by Subject|1|||
143283412|NCT01626391|516590281|FG001|Overall Study|Withdrawal by Subject|0|||
143283413|NCT02516163|516590283|FG000|Overall Study|Withdrawal by Subject|1|||
143283414|NCT02516163|516590283|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
143283415|NCT02516163|516590283|FG000|Overall Study|Unfit/delay in surgery|3|||
143283416|NCT02516163|516590283|FG000|Overall Study|Use of incorrect measurement technique|5|||
143283417|NCT02516163|516590283|FG000|Overall Study|Data not recorded|2|||
143283418|NCT02516163|516590283|FG000|Overall Study|MRI contraindication exclusion|6|||
143283419|NCT00040664|516590284|FG000|Overall Study|Adverse Event|12|||
143283420|NCT00040664|516590285|FG001|Overall Study|Adverse Event|3|||
143283421|NCT00040664|516590286|FG002|Overall Study|Adverse Event|2|||
143283422|NCT00040664|516590287|FG003|Overall Study|Adverse Event|7|||
143283423|NCT00040664|516590284|FG000|Overall Study|Lack of Efficacy|9|||
143283424|NCT00040664|516590285|FG001|Overall Study|Lack of Efficacy|2|||
143283425|NCT00040664|516590286|FG002|Overall Study|Lack of Efficacy|3|||
143283426|NCT00040664|516590287|FG003|Overall Study|Lack of Efficacy|4|||
143283427|NCT00040664|516590284|FG000|Overall Study|Insufficient CD4 response|1|||
143283428|NCT00040664|516590285|FG001|Overall Study|Insufficient CD4 response|0|||
143283429|NCT00040664|516590286|FG002|Overall Study|Insufficient CD4 response|1|||
143283430|NCT00040664|516590287|FG003|Overall Study|Insufficient CD4 response|0|||
143283431|NCT00040664|516590284|FG000|Overall Study|Lost to Follow-up|4|||
143283432|NCT00040664|516590285|FG001|Overall Study|Lost to Follow-up|2|||
143283433|NCT00040664|516590286|FG002|Overall Study|Lost to Follow-up|0|||
143283434|NCT00040664|516590287|FG003|Overall Study|Lost to Follow-up|2|||
143283435|NCT00040664|516590284|FG000|Overall Study|Protocol Violation|2|||
143283436|NCT00040664|516590285|FG001|Overall Study|Protocol Violation|1|||
143283437|NCT00040664|516590286|FG002|Overall Study|Protocol Violation|0|||
143283438|NCT00040664|516590287|FG003|Overall Study|Protocol Violation|1|||
143283439|NCT00040664|516590284|FG000|Overall Study|Withdrawal by Subject|7|||
143283440|NCT00040664|516590285|FG001|Overall Study|Withdrawal by Subject|0|||
143283441|NCT00040664|516590286|FG002|Overall Study|Withdrawal by Subject|3|||
143283442|NCT00040664|516590287|FG003|Overall Study|Withdrawal by Subject|4|||
143283443|NCT00040664|516590284|FG000|Overall Study|Pregnancy|3|||
143283444|NCT00040664|516590285|FG001|Overall Study|Pregnancy|0|||
143283445|NCT00040664|516590286|FG002|Overall Study|Pregnancy|0|||
143283446|NCT00040664|516590287|FG003|Overall Study|Pregnancy|3|||
143283447|NCT00040664|516590284|FG000|Overall Study|Medication adherence/compliance problems|8|||
143283448|NCT00040664|516590285|FG001|Overall Study|Medication adherence/compliance problems|2|||
143283449|NCT00040664|516590286|FG002|Overall Study|Medication adherence/compliance problems|1|||
143283450|NCT00040664|516590287|FG003|Overall Study|Medication adherence/compliance problems|5|||
143283451|NCT00040664|516590284|FG000|Overall Study|Poor taste|2|||
143283452|NCT00040664|516590285|FG001|Overall Study|Poor taste|0|||
143283453|NCT00040664|516590286|FG002|Overall Study|Poor taste|2|||
143283454|NCT00040664|516590287|FG003|Overall Study|Poor taste|0|||
143283455|NCT00040664|516590284|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
143283456|NCT00040664|516590285|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
143283457|NCT00040664|516590286|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
143283458|NCT00040664|516590287|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
143283459|NCT00040664|516590284|FG000|Overall Study|Change of formulation|2|||
143283460|NCT00040664|516590285|FG001|Overall Study|Change of formulation|2|||
143283461|NCT00040664|516590286|FG002|Overall Study|Change of formulation|0|||
143283462|NCT00040664|516590287|FG003|Overall Study|Change of formulation|0|||
143283463|NCT00040664|516590284|FG000|Overall Study|Non-viability of oral suspension|1|||
143283464|NCT00040664|516590285|FG001|Overall Study|Non-viability of oral suspension|0|||
143283465|NCT00040664|516590286|FG002|Overall Study|Non-viability of oral suspension|1|||
143283466|NCT00040664|516590287|FG003|Overall Study|Non-viability of oral suspension|0|||
143283467|NCT04584645|516590289|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
143283468|NCT04584645|516590290|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
143283469|NCT00390468|516590291|FG000|Overall Study|Protocol Violation|2|||
143283470|NCT00390468|516590291|FG000|Overall Study|Lack of Efficacy|1|||
143283471|NCT03845985|516590298|FG000|Overall Study|Lost to Follow-up|2|||
143283472|NCT03845985|516590299|FG001|Overall Study|Lost to Follow-up|1|||
143283473|NCT03845985|516590298|FG000|Overall Study|Physician Decision|1|||
143283474|NCT03845985|516590299|FG001|Overall Study|Physician Decision|0|||
143283475|NCT03845985|516590298|FG000|Overall Study|Withdrawal by Subject|4|||
143283476|NCT03845985|516590299|FG001|Overall Study|Withdrawal by Subject|1|||
143283477|NCT03926169|516590300|FG000|Period A|Adverse Event|2|||
143283478|NCT03926169|516590301|FG001|Period A|Adverse Event|2|||
143283479|NCT03926169|516590302|FG002|Period A|Adverse Event|1|||
143283480|NCT03926169|516590300|FG000|Period A|Withdrawal by Subject|2|||
143283481|NCT03926169|516590301|FG001|Period A|Withdrawal by Subject|2|||
143283482|NCT03926169|516590302|FG002|Period A|Withdrawal by Subject|2|||
143283483|NCT03926169|516590300|FG000|Period A|Lost to Follow-up|3|||
143283484|NCT03926169|516590301|FG001|Period A|Lost to Follow-up|1|||
143283485|NCT03926169|516590302|FG002|Period A|Lost to Follow-up|0|||
143283486|NCT03926169|516590300|FG000|Period A|Lack of Efficacy|0|||
143283487|NCT03926169|516590301|FG001|Period A|Lack of Efficacy|2|||
143283488|NCT03926169|516590302|FG002|Period A|Lack of Efficacy|2|||
143283489|NCT03926169|516590300|FG000|Period A|COVID-19 Infection|0|||
143283490|NCT03926169|516590301|FG001|Period A|COVID-19 Infection|1|||
143283491|NCT03926169|516590302|FG002|Period A|COVID-19 Infection|0|||
143283492|NCT03926169|516590300|FG000|Period A|COVID-19 Logistical Restrictions|0|||
143283493|NCT03926169|516590301|FG001|Period A|COVID-19 Logistical Restrictions|2|||
143283494|NCT03926169|516590302|FG002|Period A|COVID-19 Logistical Restrictions|1|||
143283495|NCT03926169|516590300|FG000|Period A|Other, Not Specified|1|||
143283496|NCT03926169|516590301|FG001|Period A|Other, Not Specified|0|||
143283497|NCT03926169|516590302|FG002|Period A|Other, Not Specified|0|||
143283498|NCT03926169|516590300|FG000|Period B|Adverse Event|3|||
143283499|NCT03926169|516590301|FG001|Period B|Adverse Event|1|||
143283500|NCT03926169|516590302|FG002|Period B|Adverse Event|1|||
143283501|NCT03926169|516590300|FG000|Period B|Withdrawal by Subject|1|||
143283502|NCT03926169|516590301|FG001|Period B|Withdrawal by Subject|3|||
143283503|NCT03926169|516590302|FG002|Period B|Withdrawal by Subject|0|||
143283504|NCT03926169|516590300|FG000|Period B|Lack of Efficacy|3|||
143283505|NCT03926169|516590301|FG001|Period B|Lack of Efficacy|1|||
143283506|NCT03926169|516590302|FG002|Period B|Lack of Efficacy|1|||
143283507|NCT03926169|516590300|FG000|Period B|Lost to Follow-up|1|||
143283508|NCT03926169|516590301|FG001|Period B|Lost to Follow-up|1|||
143283509|NCT03926169|516590302|FG002|Period B|Lost to Follow-up|4|||
143283510|NCT03926169|516590300|FG000|Period B|Other, Not Specified|62|||
143283511|NCT03926169|516590301|FG001|Period B|Other, Not Specified|57|||
143283512|NCT03926169|516590302|FG002|Period B|Other, Not Specified|65|||
143283513|NCT03708328|516590305|FG000|Overall Study|Death|3|||
143283514|NCT03708328|516590306|FG001|Overall Study|Death|3|||
143283515|NCT03708328|516590307|FG002|Overall Study|Death|4|||
143283516|NCT03708328|516590308|FG003|Overall Study|Death|2|||
143283517|NCT03708328|516590309|FG004|Overall Study|Death|2|||
143283518|NCT03708328|516590310|FG005|Overall Study|Death|13|||
143283519|NCT03708328|516590311|FG006|Overall Study|Death|26|||
143283520|NCT03708328|516590312|FG007|Overall Study|Death|18|||
143283521|NCT03708328|516590313|FG008|Overall Study|Death|13|||
143283522|NCT03708328|516590314|FG009|Overall Study|Death|8|||
143283523|NCT03708328|516590305|FG000|Overall Study|Lost to Follow-up|0|||
143283524|NCT03708328|516590306|FG001|Overall Study|Lost to Follow-up|1|||
143283525|NCT03708328|516590307|FG002|Overall Study|Lost to Follow-up|0|||
143283526|NCT03708328|516590308|FG003|Overall Study|Lost to Follow-up|1|||
143283527|NCT03708328|516590309|FG004|Overall Study|Lost to Follow-up|0|||
143283528|NCT03708328|516590310|FG005|Overall Study|Lost to Follow-up|3|||
143283529|NCT03708328|516590311|FG006|Overall Study|Lost to Follow-up|3|||
143283530|NCT03708328|516590312|FG007|Overall Study|Lost to Follow-up|0|||
143283531|NCT03708328|516590313|FG008|Overall Study|Lost to Follow-up|0|||
143283532|NCT03708328|516590314|FG009|Overall Study|Lost to Follow-up|1|||
143283533|NCT03708328|516590305|FG000|Overall Study|Physician Decision|0|||
143283534|NCT03708328|516590306|FG001|Overall Study|Physician Decision|0|||
143283535|NCT03708328|516590307|FG002|Overall Study|Physician Decision|0|||
143283536|NCT03708328|516590308|FG003|Overall Study|Physician Decision|0|||
143283537|NCT03708328|516590309|FG004|Overall Study|Physician Decision|0|||
143283538|NCT03708328|516590310|FG005|Overall Study|Physician Decision|1|||
143283539|NCT03708328|516590311|FG006|Overall Study|Physician Decision|0|||
143283540|NCT03708328|516590312|FG007|Overall Study|Physician Decision|0|||
143283541|NCT03708328|516590313|FG008|Overall Study|Physician Decision|0|||
143283542|NCT03708328|516590314|FG009|Overall Study|Physician Decision|0|||
143283543|NCT03708328|516590305|FG000|Overall Study|Withdrawal by Subject|0|||
143283544|NCT03708328|516590306|FG001|Overall Study|Withdrawal by Subject|0|||
143283545|NCT03708328|516590307|FG002|Overall Study|Withdrawal by Subject|0|||
143283546|NCT03708328|516590308|FG003|Overall Study|Withdrawal by Subject|0|||
143283547|NCT03708328|516590309|FG004|Overall Study|Withdrawal by Subject|1|||
143283548|NCT03708328|516590310|FG005|Overall Study|Withdrawal by Subject|0|||
143283549|NCT03708328|516590311|FG006|Overall Study|Withdrawal by Subject|2|||
143283550|NCT03708328|516590312|FG007|Overall Study|Withdrawal by Subject|4|||
143283551|NCT03708328|516590313|FG008|Overall Study|Withdrawal by Subject|1|||
143283552|NCT03708328|516590314|FG009|Overall Study|Withdrawal by Subject|5|||
143283553|NCT03708328|516590305|FG000|Overall Study|Study Closed Locally|0|||
143283554|NCT03708328|516590306|FG001|Overall Study|Study Closed Locally|0|||
143283555|NCT03708328|516590307|FG002|Overall Study|Study Closed Locally|0|||
143283556|NCT03708328|516590308|FG003|Overall Study|Study Closed Locally|0|||
143283557|NCT03708328|516590309|FG004|Overall Study|Study Closed Locally|0|||
143283558|NCT03708328|516590310|FG005|Overall Study|Study Closed Locally|0|||
143283559|NCT03708328|516590311|FG006|Overall Study|Study Closed Locally|0|||
143283560|NCT03708328|516590312|FG007|Overall Study|Study Closed Locally|1|||
143283561|NCT03708328|516590313|FG008|Overall Study|Study Closed Locally|0|||
143283562|NCT03708328|516590314|FG009|Overall Study|Study Closed Locally|0|||
143283563|NCT03708328|516590305|FG000|Overall Study|Study Ended By Sponsor|0|||
143283564|NCT03708328|516590306|FG001|Overall Study|Study Ended By Sponsor|0|||
143283565|NCT03708328|516590307|FG002|Overall Study|Study Ended By Sponsor|0|||
143283566|NCT03708328|516590308|FG003|Overall Study|Study Ended By Sponsor|0|||
143283567|NCT03708328|516590309|FG004|Overall Study|Study Ended By Sponsor|0|||
143283568|NCT03708328|516590310|FG005|Overall Study|Study Ended By Sponsor|1|||
143283569|NCT03708328|516590311|FG006|Overall Study|Study Ended By Sponsor|0|||
143283570|NCT03708328|516590312|FG007|Overall Study|Study Ended By Sponsor|1|||
143283571|NCT03708328|516590313|FG008|Overall Study|Study Ended By Sponsor|0|||
143283572|NCT03708328|516590314|FG009|Overall Study|Study Ended By Sponsor|0|||
143283573|NCT03708328|516590305|FG000|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
143283574|NCT03708328|516590306|FG001|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
143283575|NCT03708328|516590307|FG002|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
143283576|NCT03708328|516590308|FG003|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
143283577|NCT03708328|516590309|FG004|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
143283578|NCT03708328|516590310|FG005|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
143283579|NCT03708328|516590311|FG006|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
143283580|NCT03708328|516590312|FG007|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
143283581|NCT03708328|516590313|FG008|Overall Study|Participant Was Alive, Did Not Return to Hospital|1|||
143283582|NCT03708328|516590314|FG009|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
143283583|NCT04523220|516590315|FG000|Main Treatment Period|Physician Decision|1|||
143283584|NCT04523220|516590316|FG001|Main Treatment Period|Physician Decision|1|||
143283585|NCT04523220|516590317|FG002|Main Treatment Period|Physician Decision|0|||
143283586|NCT04523220|516590315|FG000|Main Treatment Period|Other|5|||
143283587|NCT04523220|516590316|FG001|Main Treatment Period|Other|2|||
143283588|NCT04523220|516590317|FG002|Main Treatment Period|Other|4|||
143283589|NCT04523220|516590315|FG000|Main Treatment Period|Subject Decision|5|||
143283590|NCT04523220|516590316|FG001|Main Treatment Period|Subject Decision|7|||
143283591|NCT04523220|516590317|FG002|Main Treatment Period|Subject Decision|3|||
143283592|NCT04523220|516590315|FG000|Main Treatment Period|Death|5|||
143283593|NCT04523220|516590316|FG001|Main Treatment Period|Death|11|||
143283594|NCT04523220|516590317|FG002|Main Treatment Period|Death|4|||
143283595|NCT04523220|516590315|FG000|Main Treatment Period|Adverse Event|11|||
143283596|NCT04523220|516590316|FG001|Main Treatment Period|Adverse Event|9|||
143283597|NCT04523220|516590317|FG002|Main Treatment Period|Adverse Event|9|||
143283598|NCT04523220|516590315|FG000|Main Treatment Period|Withdrawal by Subject|3|||
143283599|NCT04523220|516590316|FG001|Main Treatment Period|Withdrawal by Subject|3|||
143283600|NCT04523220|516590317|FG002|Main Treatment Period|Withdrawal by Subject|4|||
143283601|NCT04523220|516590315|FG000|Main Treatment Period|Study drug never adminstered|10|||
143283602|NCT04523220|516590316|FG001|Main Treatment Period|Study drug never adminstered|3|||
143283603|NCT04523220|516590317|FG002|Main Treatment Period|Study drug never adminstered|5|||
143283604|NCT04523220|516590315|FG000|Extension Treatment Period|Physician Decision|1|||
143283605|NCT04523220|516590316|FG001|Extension Treatment Period|Physician Decision|0|||
143283606|NCT04523220|516590317|FG002|Extension Treatment Period|Physician Decision|3|||
143283607|NCT04523220|516590315|FG000|Extension Treatment Period|Other|2|||
143283608|NCT04523220|516590316|FG001|Extension Treatment Period|Other|6|||
143283609|NCT04523220|516590317|FG002|Extension Treatment Period|Other|6|||
143283610|NCT04523220|516590315|FG000|Extension Treatment Period|Subject Decision|5|||
143283611|NCT04523220|516590316|FG001|Extension Treatment Period|Subject Decision|2|||
143283612|NCT04523220|516590317|FG002|Extension Treatment Period|Subject Decision|4|||
143283613|NCT04523220|516590315|FG000|Extension Treatment Period|Death|6|||
143283614|NCT04523220|516590316|FG001|Extension Treatment Period|Death|4|||
143283615|NCT04523220|516590317|FG002|Extension Treatment Period|Death|7|||
143283616|NCT04523220|516590315|FG000|Extension Treatment Period|Adverse Event|6|||
143283617|NCT04523220|516590316|FG001|Extension Treatment Period|Adverse Event|7|||
143283618|NCT04523220|516590317|FG002|Extension Treatment Period|Adverse Event|9|||
143283619|NCT04523220|516590315|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
143283620|NCT04523220|516590316|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
143283621|NCT04523220|516590317|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
143283622|NCT04523220|516590315|FG000|Extension Treatment Period|Study drug never administered|0|||
143283623|NCT04523220|516590316|FG001|Extension Treatment Period|Study drug never administered|1|||
143283624|NCT04523220|516590317|FG002|Extension Treatment Period|Study drug never administered|0|||
143283625|NCT00571948|516590318|FG000|Overall Study|Lost to Follow-up|2|||
143283626|NCT00571948|516590319|FG001|Overall Study|Lost to Follow-up|0|||
143283627|NCT00571948|516590318|FG000|Overall Study|Withdrawal by Subject|1|||
143283628|NCT00571948|516590319|FG001|Overall Study|Withdrawal by Subject|2|||
143283629|NCT00571948|516590318|FG000|Overall Study|Protocol Violation|3|||
143283630|NCT00571948|516590319|FG001|Overall Study|Protocol Violation|3|||
143283631|NCT00571948|516590318|FG000|Overall Study|infant refused study meal|3|||
143283632|NCT00571948|516590319|FG001|Overall Study|infant refused study meal|4|||
143283633|NCT00571948|516590318|FG000|Overall Study|Parent were afraid of blood colection|2|||
143283634|NCT00571948|516590319|FG001|Overall Study|Parent were afraid of blood colection|5|||
143283635|NCT04112784|516590320|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
143283636|NCT04112784|516590320|FG000|Overall Study|Screen Failures|4|||
143283637|NCT00256750|516590321|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
143283638|NCT00256750|516590322|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
143283639|NCT00256750|516590323|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
143283640|NCT00256750|516590321|FG000|Transplanted Pre-Treatment|Other|2|||
143283641|NCT00256750|516590322|FG001|Transplanted Pre-Treatment|Other|0|||
143283642|NCT00256750|516590323|FG002|Transplanted Pre-Treatment|Other|0|||
143283643|NCT00256750|516590321|FG000|Transplanted Pre-Treatment|Death|1|||
143283644|NCT00256750|516590322|FG001|Transplanted Pre-Treatment|Death|0|||
143283645|NCT00256750|516590323|FG002|Transplanted Pre-Treatment|Death|0|||
143283646|NCT00256750|516590321|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
143283647|NCT00256750|516590322|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
143283648|NCT00256750|516590323|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
143283649|NCT00256750|516590321|FG000|Post-Transplant Treated (12 Months)|Death|3|||
143283650|NCT00256750|516590322|FG001|Post-Transplant Treated (12 Months)|Death|2|||
143283651|NCT00256750|516590323|FG002|Post-Transplant Treated (12 Months)|Death|4|||
143283652|NCT00256750|516590321|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
143283653|NCT00256750|516590322|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
143283654|NCT00256750|516590323|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
143283655|NCT00256750|516590321|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
143283656|NCT00256750|516590322|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
143283657|NCT00256750|516590323|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
143283658|NCT00256750|516590321|FG000|Post-Transplant Treated (12 Months)|Other|5|||
143283659|NCT00256750|516590322|FG001|Post-Transplant Treated (12 Months)|Other|4|||
143283660|NCT00256750|516590323|FG002|Post-Transplant Treated (12 Months)|Other|2|||
143283661|NCT00256750|516590321|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
143283662|NCT00256750|516590322|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
143283663|NCT00256750|516590323|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
143283664|NCT00256750|516590321|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
143283665|NCT00256750|516590322|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
143283666|NCT00256750|516590323|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
143283667|NCT00256750|516590321|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
143283668|NCT00256750|516590322|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
143283669|NCT00256750|516590323|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
143283670|NCT00256750|516590321|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
143283671|NCT00256750|516590322|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
143283672|NCT00256750|516590323|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
143283673|NCT00256750|516590321|FG000|Post-Transplant Treated (24 Months)|Death|3|||
143283674|NCT00256750|516590322|FG001|Post-Transplant Treated (24 Months)|Death|0|||
143283675|NCT00256750|516590323|FG002|Post-Transplant Treated (24 Months)|Death|0|||
143283676|NCT00256750|516590321|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
143283677|NCT00256750|516590322|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
143283678|NCT00256750|516590323|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
143283679|NCT00256750|516590321|FG000|Post-Transplant Treated (24 Months)|Other|2|||
143283680|NCT00256750|516590322|FG001|Post-Transplant Treated (24 Months)|Other|0|||
143283681|NCT00256750|516590323|FG002|Post-Transplant Treated (24 Months)|Other|1|||
143283682|NCT00256750|516590321|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
143283683|NCT00256750|516590322|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
143283684|NCT00256750|516590323|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
143283685|NCT00256750|516590321|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
143283686|NCT00256750|516590322|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
143283687|NCT00256750|516590323|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
143283688|NCT00256750|516590321|FG000|Post-Transplant Treated (36 Months)|Death|0|||
143283689|NCT00256750|516590322|FG001|Post-Transplant Treated (36 Months)|Death|2|||
143283690|NCT00256750|516590323|FG002|Post-Transplant Treated (36 Months)|Death|1|||
143283691|NCT00256750|516590321|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
143283692|NCT00256750|516590322|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
143283693|NCT00256750|516590323|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
143283694|NCT00256750|516590321|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
143283695|NCT00256750|516590322|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
143283696|NCT00256750|516590323|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
143283697|NCT00256750|516590321|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
143283698|NCT00256750|516590322|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
143283699|NCT00256750|516590323|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
143283700|NCT00256750|516590321|FG000|Post-Transplant Treated (36 Months)|Other|0|||
143283701|NCT00256750|516590322|FG001|Post-Transplant Treated (36 Months)|Other|1|||
143283702|NCT00256750|516590323|FG002|Post-Transplant Treated (36 Months)|Other|1|||
143283703|NCT00256750|516590321|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
143283704|NCT00256750|516590322|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
143283705|NCT00256750|516590323|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
143283706|NCT00256750|516590321|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
143283707|NCT00256750|516590322|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
143283708|NCT00256750|516590323|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
143283709|NCT00256750|516590321|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
143283710|NCT00256750|516590322|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
143283711|NCT00256750|516590323|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
143283712|NCT00256750|516590321|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
143283713|NCT00256750|516590322|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
143283714|NCT00256750|516590323|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
143283715|NCT00256750|516590321|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
143283716|NCT00256750|516590322|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
143283717|NCT00256750|516590323|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
143283718|NCT00256750|516590321|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
143283719|NCT00256750|516590322|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
143283720|NCT00256750|516590323|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
143283721|NCT00256750|516590321|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
143283722|NCT00256750|516590322|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
143283723|NCT00256750|516590323|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
143283724|NCT00256750|516590321|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
143283725|NCT00256750|516590322|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
143283726|NCT00256750|516590323|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
143283727|NCT00256750|516590321|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
143283728|NCT00256750|516590322|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
143283729|NCT00256750|516590323|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
143283730|NCT02030041|516590324|FG000|Overall Study|Withdrawal by Subject|2|||
143283731|NCT02030041|516590325|FG001|Overall Study|Withdrawal by Subject|2|||
143283732|NCT02030041|516590326|FG002|Overall Study|Withdrawal by Subject|1|||
143283733|NCT00843024|516590327|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
143283734|NCT00843024|516590328|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
143283735|NCT00843024|516590329|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
143283736|NCT00843024|516590330|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
143283737|NCT00843024|516590331|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
143283738|NCT00843024|516590332|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
143283739|NCT00843024|516590327|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
143283740|NCT00843024|516590328|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
143283741|NCT00843024|516590329|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
143283742|NCT00843024|516590330|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
143283743|NCT00843024|516590331|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
143283744|NCT00843024|516590332|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
143283745|NCT00843024|516590327|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
143283746|NCT00843024|516590328|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
143283747|NCT00843024|516590329|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
143283748|NCT00843024|516590330|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
143283749|NCT00843024|516590331|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
143283750|NCT00843024|516590332|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
143283751|NCT00843024|516590327|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
143283752|NCT00843024|516590328|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
143283753|NCT00843024|516590329|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
143283754|NCT00843024|516590330|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
143283755|NCT00843024|516590331|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
143283756|NCT00843024|516590332|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
143283757|NCT00843024|516590327|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
143283758|NCT00843024|516590328|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
143283759|NCT00843024|516590329|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
143283760|NCT00843024|516590330|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
143283761|NCT00843024|516590331|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
143283762|NCT00843024|516590332|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
143283763|NCT00843024|516590327|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
143283764|NCT00843024|516590328|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
143283765|NCT00843024|516590329|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
143283766|NCT00843024|516590330|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
143283767|NCT00843024|516590331|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
143283768|NCT00843024|516590332|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
143283769|NCT00843024|516590327|FG000|Single-blind Placebo Run-In Phase|Other|0|||
143283770|NCT00843024|516590328|FG001|Single-blind Placebo Run-In Phase|Other|1|||
143283771|NCT00843024|516590329|FG002|Single-blind Placebo Run-In Phase|Other|0|||
143283772|NCT00843024|516590330|FG003|Single-blind Placebo Run-In Phase|Other|0|||
143283773|NCT00843024|516590331|FG004|Single-blind Placebo Run-In Phase|Other|0|||
143283774|NCT00843024|516590332|FG005|Single-blind Placebo Run-In Phase|Other|0|||
143283775|NCT00843024|516590327|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
143283776|NCT00843024|516590328|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
143283777|NCT00843024|516590329|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
143283778|NCT00843024|516590330|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
143283779|NCT00843024|516590331|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
143283780|NCT00843024|516590332|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
143283781|NCT00843024|516590327|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
143283782|NCT00843024|516590328|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
143283783|NCT00843024|516590329|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
143283784|NCT00843024|516590330|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
143283785|NCT00843024|516590331|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
143283786|NCT00843024|516590332|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
143283787|NCT00843024|516590327|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
143283788|NCT00843024|516590328|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
143283789|NCT00843024|516590329|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
143283790|NCT00843024|516590330|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
143283791|NCT00843024|516590331|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
143283792|NCT00843024|516590332|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
143283793|NCT00843024|516590327|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
143283794|NCT00843024|516590328|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
143283795|NCT00843024|516590329|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
143283796|NCT00843024|516590330|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
143283797|NCT00843024|516590331|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
143283798|NCT00843024|516590332|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
143283799|NCT00843024|516590327|FG000|Double-blind Treatment Phase|Physician Decision|0|||
143283800|NCT00843024|516590328|FG001|Double-blind Treatment Phase|Physician Decision|0|||
143283801|NCT00843024|516590329|FG002|Double-blind Treatment Phase|Physician Decision|0|||
143283802|NCT00843024|516590330|FG003|Double-blind Treatment Phase|Physician Decision|3|||
143283803|NCT00843024|516590331|FG004|Double-blind Treatment Phase|Physician Decision|1|||
143283804|NCT00843024|516590332|FG005|Double-blind Treatment Phase|Physician Decision|1|||
143283805|NCT00843024|516590327|FG000|Double-blind Treatment Phase|Adverse Event|0|||
143283806|NCT00843024|516590328|FG001|Double-blind Treatment Phase|Adverse Event|0|||
143373284|NCT00716144|516911416|FG000|Overall Study|Adverse Event|0|||
143373285|NCT00716144|516911417|FG001|Overall Study|Adverse Event|0|||
143373286|NCT00716144|516911418|FG002|Overall Study|Adverse Event|0|||
143373287|NCT00716144|516911419|FG003|Overall Study|Adverse Event|2|||
143373288|NCT00716144|516911416|FG000|Overall Study|Non-compliance|1|||
143373289|NCT00716144|516911417|FG001|Overall Study|Non-compliance|0|||
143373290|NCT00716144|516911418|FG002|Overall Study|Non-compliance|0|||
143373291|NCT00716144|516911419|FG003|Overall Study|Non-compliance|0|||
143373292|NCT00716144|516911416|FG000|Overall Study|Protocol Violation|2|||
143373293|NCT00716144|516911417|FG001|Overall Study|Protocol Violation|0|||
143373294|NCT00716144|516911418|FG002|Overall Study|Protocol Violation|1|||
143373295|NCT00716144|516911419|FG003|Overall Study|Protocol Violation|0|||
143373296|NCT00716144|516911416|FG000|Overall Study|Physician Decision|0|||
143283807|NCT00843024|516590329|FG002|Double-blind Treatment Phase|Adverse Event|0|||
143283808|NCT00843024|516590330|FG003|Double-blind Treatment Phase|Adverse Event|0|||
143283809|NCT00843024|516590331|FG004|Double-blind Treatment Phase|Adverse Event|1|||
143283810|NCT00843024|516590332|FG005|Double-blind Treatment Phase|Adverse Event|1|||
143283811|NCT00843024|516590327|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
143283812|NCT00843024|516590328|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
143283813|NCT00843024|516590329|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
143283814|NCT00843024|516590330|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
143283815|NCT00843024|516590331|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
143283816|NCT00843024|516590332|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
143283817|NCT05201703|516590333|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
143283818|NCT05201703|516590334|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
143283819|NCT05201703|516590333|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
143283820|NCT05201703|516590334|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
143283821|NCT02006719|516590335|FG000|Overall Study|Withdrawal by Subject|10|||
143283822|NCT02006719|516590336|FG001|Overall Study|Withdrawal by Subject|2|||
143283823|NCT02006719|516590335|FG000|Overall Study|Lost to Follow-up|5|||
143283824|NCT02006719|516590336|FG001|Overall Study|Lost to Follow-up|1|||
143283825|NCT02006719|516590335|FG000|Overall Study|Protocol Violation|2|||
143283826|NCT02006719|516590336|FG001|Overall Study|Protocol Violation|0|||
143283827|NCT02006719|516590335|FG000|Overall Study|Adverse Event|1|||
143283828|NCT02006719|516590336|FG001|Overall Study|Adverse Event|1|||
143283829|NCT02006719|516590335|FG000|Overall Study|Other/Unknown|0|||
143283830|NCT02006719|516590336|FG001|Overall Study|Other/Unknown|1|||
143283831|NCT02439138|516590338|FG000|Overall Study|Adverse Event|1|||
143283832|NCT02439138|516590338|FG000|Overall Study|PI decision to terminate the study|2|||
143283833|NCT02615145|516590343|FG000|Overall Study|Did Not Start Treatment|0|||
143283834|NCT02615145|516590344|FG001|Overall Study|Did Not Start Treatment|0|||
143283835|NCT02615145|516590345|FG002|Overall Study|Did Not Start Treatment|1|||
143283836|NCT02615145|516590346|FG003|Overall Study|Did Not Start Treatment|1|||
143283837|NCT02615145|516590343|FG000|Overall Study|Failure to Return|20|||
143283838|NCT02615145|516590344|FG001|Overall Study|Failure to Return|10|||
143283839|NCT02615145|516590345|FG002|Overall Study|Failure to Return|7|||
143283840|NCT02615145|516590346|FG003|Overall Study|Failure to Return|0|||
143283841|NCT02615145|516590343|FG000|Overall Study|Death|2|||
143283842|NCT02615145|516590344|FG001|Overall Study|Death|3|||
143283843|NCT02615145|516590345|FG002|Overall Study|Death|0|||
143283844|NCT02615145|516590346|FG003|Overall Study|Death|0|||
143283845|NCT02615145|516590343|FG000|Overall Study|Other, Not Specified|5|||
143283846|NCT02615145|516590344|FG001|Overall Study|Other, Not Specified|2|||
143283847|NCT02615145|516590345|FG002|Overall Study|Other, Not Specified|0|||
143283848|NCT02615145|516590346|FG003|Overall Study|Other, Not Specified|0|||
143283849|NCT01737697|516590347|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
143283850|NCT01737697|516590348|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
143283851|NCT01737697|516590349|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
143283852|NCT01737697|516590350|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
143283853|NCT01737697|516590351|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
143283854|NCT01737697|516590352|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
143283855|NCT01737697|516590353|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
143283856|NCT01737697|516590354|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
143283857|NCT01737697|516590355|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
143283858|NCT01737697|516590356|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
143283859|NCT01737697|516590357|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
143283860|NCT01737697|516590358|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
143283861|NCT01737697|516590359|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
143283862|NCT01737697|516590360|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
143283863|NCT01737697|516590361|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
143283864|NCT01737697|516590347|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
143283865|NCT01737697|516590348|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
143283866|NCT01737697|516590349|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
143283867|NCT01737697|516590350|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
143283868|NCT01737697|516590351|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
143283869|NCT01737697|516590352|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
143283870|NCT01737697|516590353|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
143283871|NCT01737697|516590354|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
143283872|NCT01737697|516590355|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
143283873|NCT01737697|516590356|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
143283874|NCT01737697|516590357|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
143283875|NCT01737697|516590358|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
143283876|NCT01737697|516590359|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
143283877|NCT01737697|516590360|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
143283878|NCT01737697|516590361|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
143283879|NCT01737697|516590347|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
143283880|NCT01737697|516590348|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
143283881|NCT01737697|516590349|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
143283882|NCT01737697|516590350|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
143283883|NCT01737697|516590351|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
143283884|NCT01737697|516590352|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
143283885|NCT01737697|516590353|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
143283886|NCT01737697|516590354|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
143283887|NCT01737697|516590355|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
143283888|NCT01737697|516590356|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
143283889|NCT01737697|516590357|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
143283890|NCT01737697|516590358|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
143283891|NCT01737697|516590359|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
143283892|NCT01737697|516590360|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
143283893|NCT01737697|516590361|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
143283894|NCT01737697|516590347|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
143283895|NCT01737697|516590348|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
143283896|NCT01737697|516590349|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
143283897|NCT01737697|516590350|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
143283898|NCT01737697|516590351|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
143283899|NCT01737697|516590352|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
143283900|NCT01737697|516590353|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
143283901|NCT01737697|516590354|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
143283902|NCT01737697|516590355|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
143283903|NCT01737697|516590356|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
143283904|NCT01737697|516590357|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
143283905|NCT01737697|516590358|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
143283906|NCT01737697|516590359|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
143283907|NCT01737697|516590360|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
143283908|NCT01737697|516590361|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
143283909|NCT01737697|516590347|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
143283910|NCT01737697|516590348|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
143283911|NCT01737697|516590349|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
143283912|NCT01737697|516590350|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
143283913|NCT01737697|516590351|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
143283914|NCT01737697|516590352|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
143283915|NCT01737697|516590353|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
143283916|NCT01737697|516590354|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
143283917|NCT01737697|516590355|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
143283918|NCT01737697|516590356|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
143283919|NCT01737697|516590357|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
143283920|NCT01737697|516590358|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
143283921|NCT01737697|516590359|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
143283922|NCT01737697|516590360|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
143283923|NCT01737697|516590361|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
143283924|NCT01737697|516590347|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
143283925|NCT01737697|516590348|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
143283926|NCT01737697|516590349|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
143283927|NCT01737697|516590350|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
143283928|NCT01737697|516590351|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
143283929|NCT01737697|516590352|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
143283930|NCT01737697|516590353|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
143283931|NCT01737697|516590354|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
143283932|NCT01737697|516590355|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
143283933|NCT01737697|516590356|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
143283934|NCT01737697|516590357|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
143283935|NCT01737697|516590358|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
143283936|NCT01737697|516590359|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
143283937|NCT01737697|516590360|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
143283938|NCT01737697|516590361|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
143283939|NCT01737697|516590347|FG000|Subacute Phase|Adverse Event|0|||
143283940|NCT01737697|516590348|FG001|Subacute Phase|Adverse Event|0|||
143283941|NCT01737697|516590349|FG002|Subacute Phase|Adverse Event|0|||
143283942|NCT01737697|516590350|FG003|Subacute Phase|Adverse Event|0|||
143283943|NCT01737697|516590351|FG004|Subacute Phase|Adverse Event|0|||
143283944|NCT01737697|516590352|FG005|Subacute Phase|Adverse Event|1|||
143283945|NCT01737697|516590353|FG006|Subacute Phase|Adverse Event|1|||
143283946|NCT01737697|516590354|FG007|Subacute Phase|Adverse Event|1|||
143283947|NCT01737697|516590355|FG008|Subacute Phase|Adverse Event|1|||
143283948|NCT01737697|516590356|FG009|Subacute Phase|Adverse Event|1|||
143283949|NCT01737697|516590357|FG010|Subacute Phase|Adverse Event|4|||
143283950|NCT01737697|516590358|FG011|Subacute Phase|Adverse Event|1|||
143283951|NCT01737697|516590359|FG012|Subacute Phase|Adverse Event|1|||
143283952|NCT01737697|516590360|FG013|Subacute Phase|Adverse Event|0|||
143283953|NCT01737697|516590361|FG014|Subacute Phase|Adverse Event|0|||
143283954|NCT01737697|516590347|FG000|Subacute Phase|Withdrawal by Subject|0|||
143283955|NCT01737697|516590348|FG001|Subacute Phase|Withdrawal by Subject|0|||
143283956|NCT01737697|516590349|FG002|Subacute Phase|Withdrawal by Subject|0|||
143283957|NCT01737697|516590350|FG003|Subacute Phase|Withdrawal by Subject|0|||
143283958|NCT01737697|516590351|FG004|Subacute Phase|Withdrawal by Subject|0|||
143283959|NCT01737697|516590352|FG005|Subacute Phase|Withdrawal by Subject|1|||
143283960|NCT01737697|516590353|FG006|Subacute Phase|Withdrawal by Subject|0|||
143283961|NCT01737697|516590354|FG007|Subacute Phase|Withdrawal by Subject|2|||
143283962|NCT01737697|516590355|FG008|Subacute Phase|Withdrawal by Subject|0|||
143283963|NCT01737697|516590356|FG009|Subacute Phase|Withdrawal by Subject|1|||
143283964|NCT01737697|516590357|FG010|Subacute Phase|Withdrawal by Subject|0|||
143283965|NCT01737697|516590358|FG011|Subacute Phase|Withdrawal by Subject|1|||
143283966|NCT01737697|516590359|FG012|Subacute Phase|Withdrawal by Subject|1|||
143283967|NCT01737697|516590360|FG013|Subacute Phase|Withdrawal by Subject|1|||
143283968|NCT01737697|516590361|FG014|Subacute Phase|Withdrawal by Subject|0|||
143283969|NCT01737697|516590347|FG000|Subacute Phase|Lost to Follow-up|0|||
143283970|NCT01737697|516590348|FG001|Subacute Phase|Lost to Follow-up|0|||
143283971|NCT01737697|516590349|FG002|Subacute Phase|Lost to Follow-up|0|||
143283972|NCT01737697|516590350|FG003|Subacute Phase|Lost to Follow-up|0|||
143283973|NCT01737697|516590351|FG004|Subacute Phase|Lost to Follow-up|0|||
143283974|NCT01737697|516590352|FG005|Subacute Phase|Lost to Follow-up|0|||
143283975|NCT01737697|516590353|FG006|Subacute Phase|Lost to Follow-up|0|||
143283976|NCT01737697|516590354|FG007|Subacute Phase|Lost to Follow-up|0|||
143283977|NCT01737697|516590355|FG008|Subacute Phase|Lost to Follow-up|0|||
143283978|NCT01737697|516590356|FG009|Subacute Phase|Lost to Follow-up|0|||
143283979|NCT01737697|516590357|FG010|Subacute Phase|Lost to Follow-up|0|||
143283980|NCT01737697|516590358|FG011|Subacute Phase|Lost to Follow-up|0|||
143283981|NCT01737697|516590359|FG012|Subacute Phase|Lost to Follow-up|0|||
143283982|NCT01737697|516590360|FG013|Subacute Phase|Lost to Follow-up|0|||
143283983|NCT01737697|516590361|FG014|Subacute Phase|Lost to Follow-up|1|||
143283984|NCT01737697|516590347|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
143283985|NCT01737697|516590348|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
143373297|NCT00716144|516911417|FG001|Overall Study|Physician Decision|1|||
143373298|NCT00716144|516911418|FG002|Overall Study|Physician Decision|2|||
143373299|NCT00716144|516911419|FG003|Overall Study|Physician Decision|2|||
143283986|NCT01737697|516590349|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
143283987|NCT01737697|516590350|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
143283988|NCT01737697|516590351|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
143283989|NCT01737697|516590352|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
143283990|NCT01737697|516590353|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
143283991|NCT01737697|516590354|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
143373300|NCT00716144|516911416|FG000|Overall Study|Intercurrent illness|0|||
143283992|NCT01737697|516590355|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
143283993|NCT01737697|516590356|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
143283994|NCT01737697|516590357|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
143283995|NCT01737697|516590358|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
143283996|NCT01737697|516590359|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
143283997|NCT01737697|516590360|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
143283998|NCT01737697|516590361|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
143283999|NCT01737697|516590347|FG000|Subacute Phase|Protocol Violation|0|||
143284000|NCT01737697|516590348|FG001|Subacute Phase|Protocol Violation|0|||
143284001|NCT01737697|516590349|FG002|Subacute Phase|Protocol Violation|0|||
143284002|NCT01737697|516590350|FG003|Subacute Phase|Protocol Violation|0|||
143284003|NCT01737697|516590351|FG004|Subacute Phase|Protocol Violation|0|||
143284004|NCT01737697|516590352|FG005|Subacute Phase|Protocol Violation|1|||
143284005|NCT01737697|516590353|FG006|Subacute Phase|Protocol Violation|0|||
143284006|NCT01737697|516590354|FG007|Subacute Phase|Protocol Violation|0|||
143284007|NCT01737697|516590355|FG008|Subacute Phase|Protocol Violation|0|||
143284008|NCT01737697|516590356|FG009|Subacute Phase|Protocol Violation|0|||
143284009|NCT01737697|516590357|FG010|Subacute Phase|Protocol Violation|1|||
143284010|NCT01737697|516590358|FG011|Subacute Phase|Protocol Violation|0|||
143284011|NCT01737697|516590359|FG012|Subacute Phase|Protocol Violation|0|||
143284012|NCT01737697|516590360|FG013|Subacute Phase|Protocol Violation|0|||
143284013|NCT01737697|516590361|FG014|Subacute Phase|Protocol Violation|0|||
143284014|NCT01737697|516590347|FG000|Subacute Phase|Physician Decision|0|||
143284015|NCT01737697|516590348|FG001|Subacute Phase|Physician Decision|0|||
143284016|NCT01737697|516590349|FG002|Subacute Phase|Physician Decision|0|||
143284017|NCT01737697|516590350|FG003|Subacute Phase|Physician Decision|0|||
143284018|NCT01737697|516590351|FG004|Subacute Phase|Physician Decision|0|||
143284019|NCT01737697|516590352|FG005|Subacute Phase|Physician Decision|0|||
143284020|NCT01737697|516590353|FG006|Subacute Phase|Physician Decision|0|||
143284021|NCT01737697|516590354|FG007|Subacute Phase|Physician Decision|0|||
143284022|NCT01737697|516590355|FG008|Subacute Phase|Physician Decision|1|||
143284023|NCT01737697|516590356|FG009|Subacute Phase|Physician Decision|0|||
143284024|NCT01737697|516590357|FG010|Subacute Phase|Physician Decision|0|||
143284025|NCT01737697|516590358|FG011|Subacute Phase|Physician Decision|0|||
143284026|NCT01737697|516590359|FG012|Subacute Phase|Physician Decision|0|||
143284027|NCT01737697|516590360|FG013|Subacute Phase|Physician Decision|0|||
143284028|NCT01737697|516590361|FG014|Subacute Phase|Physician Decision|0|||
143284029|NCT01737697|516590347|FG000|Subacute Phase|Death|0|||
143284030|NCT01737697|516590348|FG001|Subacute Phase|Death|0|||
143284031|NCT01737697|516590349|FG002|Subacute Phase|Death|0|||
143284032|NCT01737697|516590350|FG003|Subacute Phase|Death|0|||
143284033|NCT01737697|516590351|FG004|Subacute Phase|Death|0|||
143284034|NCT01737697|516590352|FG005|Subacute Phase|Death|0|||
143284035|NCT01737697|516590353|FG006|Subacute Phase|Death|0|||
143284036|NCT01737697|516590354|FG007|Subacute Phase|Death|0|||
143284037|NCT01737697|516590355|FG008|Subacute Phase|Death|0|||
143284038|NCT01737697|516590356|FG009|Subacute Phase|Death|0|||
143284039|NCT01737697|516590357|FG010|Subacute Phase|Death|1|||
143284040|NCT01737697|516590358|FG011|Subacute Phase|Death|0|||
143284041|NCT01737697|516590359|FG012|Subacute Phase|Death|0|||
143284042|NCT01737697|516590360|FG013|Subacute Phase|Death|0|||
143284043|NCT01737697|516590361|FG014|Subacute Phase|Death|0|||
143284044|NCT03648983|516590362|FG000|Overall Study|Study was terminated due to PI departure|95|||
143284045|NCT01866930|516590363|FG000|Treatment Period|Other|1|||
143284046|NCT01866930|516590364|FG001|Treatment Period|Other|0|||
143284047|NCT01866930|516590363|FG000|Treatment Period|Death|0|||
143284048|NCT01866930|516590364|FG001|Treatment Period|Death|2|||
143284049|NCT01866930|516590363|FG000|Treatment Period|Poor/non compliance|0|||
143284050|NCT01866930|516590364|FG001|Treatment Period|Poor/non compliance|2|||
143284051|NCT01866930|516590363|FG000|Treatment Period|No longer meets study criteria|0|||
143284052|NCT01866930|516590364|FG001|Treatment Period|No longer meets study criteria|1|||
143284053|NCT01866930|516590363|FG000|Treatment Period|Withdrawal by Subject|2|||
143284054|NCT01866930|516590364|FG001|Treatment Period|Withdrawal by Subject|8|||
143284055|NCT01866930|516590363|FG000|Treatment Period|Lack of Efficacy|1|||
143284056|NCT01866930|516590364|FG001|Treatment Period|Lack of Efficacy|9|||
143284057|NCT01866930|516590363|FG000|Treatment Period|Adverse Event|4|||
143284058|NCT01866930|516590364|FG001|Treatment Period|Adverse Event|12|||
143284059|NCT01866930|516590363|FG000|Treatment Period|Lost to Follow-up|1|||
143284060|NCT01866930|516590364|FG001|Treatment Period|Lost to Follow-up|1|||
143373301|NCT00716144|516911417|FG001|Overall Study|Intercurrent illness|0|||
143284061|NCT01866930|516590363|FG000|Follow-up Period|Lost to Follow-up|1|||
143284062|NCT01866930|516590364|FG001|Follow-up Period|Lost to Follow-up|1|||
143284063|NCT01866930|516590363|FG000|Follow-up Period|Other|1|||
143284064|NCT01866930|516590364|FG001|Follow-up Period|Other|5|||
143284065|NCT01866930|516590363|FG000|Follow-up Period|No longer required per protocol|1|||
143284066|NCT01866930|516590364|FG001|Follow-up Period|No longer required per protocol|0|||
143284067|NCT01866930|516590363|FG000|Follow-up Period|Withdrawal by Subject|3|||
143284068|NCT01866930|516590364|FG001|Follow-up Period|Withdrawal by Subject|3|||
143373302|NCT00716144|516911418|FG002|Overall Study|Intercurrent illness|1|||
143284069|NCT00279305|516590367|FG000|Overall Study|Pregnancy|1|||
143284070|NCT00279305|516590368|FG001|Overall Study|Pregnancy|0|||
143284071|NCT00279305|516590367|FG000|Overall Study|Withdrawal by Subject|2|||
143284072|NCT00279305|516590368|FG001|Overall Study|Withdrawal by Subject|0|||
143284073|NCT00279305|516590367|FG000|Overall Study|Dificulting establishing IV|1|||
143284074|NCT00279305|516590368|FG001|Overall Study|Dificulting establishing IV|0|||
143284075|NCT00279305|516590367|FG000|Overall Study|FDA Safety Alert|4|||
143284076|NCT00279305|516590368|FG001|Overall Study|FDA Safety Alert|1|||
143284077|NCT00558558|516590371|FG000|Overall Study|Unable to swallow|1|||
143284078|NCT00558558|516590371|FG000|Overall Study|Withdrawal by Subject|1|||
143284079|NCT00558558|516590371|FG000|Overall Study|Lack of Efficacy|4|||
143284080|NCT02549937|516590372|FG000|Overall Study|Death|0|||
143284081|NCT02549937|516590373|FG001|Overall Study|Death|1|||
143284082|NCT02549937|516590374|FG002|Overall Study|Death|0|||
143284083|NCT02549937|516590375|FG003|Overall Study|Death|1|||
143284084|NCT02549937|516590376|FG004|Overall Study|Death|0|||
143284085|NCT02549937|516590377|FG005|Overall Study|Death|8|||
143284086|NCT02549937|516590378|FG006|Overall Study|Death|0|||
143284087|NCT02549937|516590379|FG007|Overall Study|Death|0|||
143284088|NCT02549937|516590380|FG008|Overall Study|Death|19|||
143284089|NCT02549937|516590372|FG000|Overall Study|No follow up required|3|||
143284090|NCT02549937|516590373|FG001|Overall Study|No follow up required|6|||
143284091|NCT02549937|516590374|FG002|Overall Study|No follow up required|3|||
143284092|NCT02549937|516590375|FG003|Overall Study|No follow up required|8|||
143284093|NCT02549937|516590376|FG004|Overall Study|No follow up required|12|||
143284094|NCT02549937|516590377|FG005|Overall Study|No follow up required|21|||
143284095|NCT02549937|516590378|FG006|Overall Study|No follow up required|9|||
143284096|NCT02549937|516590379|FG007|Overall Study|No follow up required|11|||
143284097|NCT02549937|516590380|FG008|Overall Study|No follow up required|0|||
143284098|NCT02549937|516590372|FG000|Overall Study|Other|0|||
143284099|NCT02549937|516590373|FG001|Overall Study|Other|0|||
143284100|NCT02549937|516590374|FG002|Overall Study|Other|0|||
143284101|NCT02549937|516590375|FG003|Overall Study|Other|0|||
143284102|NCT02549937|516590376|FG004|Overall Study|Other|1|||
143284103|NCT02549937|516590377|FG005|Overall Study|Other|0|||
143284104|NCT02549937|516590378|FG006|Overall Study|Other|3|||
143284105|NCT02549937|516590379|FG007|Overall Study|Other|2|||
143284106|NCT02549937|516590380|FG008|Overall Study|Other|3|||
143284107|NCT02549937|516590372|FG000|Overall Study|Lost to Follow-up|0|||
143284108|NCT02549937|516590373|FG001|Overall Study|Lost to Follow-up|0|||
143284109|NCT02549937|516590374|FG002|Overall Study|Lost to Follow-up|0|||
143284110|NCT02549937|516590375|FG003|Overall Study|Lost to Follow-up|0|||
143284111|NCT02549937|516590376|FG004|Overall Study|Lost to Follow-up|0|||
143284112|NCT02549937|516590377|FG005|Overall Study|Lost to Follow-up|0|||
143284113|NCT02549937|516590378|FG006|Overall Study|Lost to Follow-up|0|||
143284114|NCT02549937|516590379|FG007|Overall Study|Lost to Follow-up|0|||
143284115|NCT02549937|516590380|FG008|Overall Study|Lost to Follow-up|3|||
143284116|NCT02549937|516590372|FG000|Overall Study|Withdrawal by Subject|0|||
143284117|NCT02549937|516590373|FG001|Overall Study|Withdrawal by Subject|0|||
143284118|NCT02549937|516590374|FG002|Overall Study|Withdrawal by Subject|0|||
143284119|NCT02549937|516590375|FG003|Overall Study|Withdrawal by Subject|0|||
143284120|NCT02549937|516590376|FG004|Overall Study|Withdrawal by Subject|0|||
143284121|NCT02549937|516590377|FG005|Overall Study|Withdrawal by Subject|1|||
143284122|NCT02549937|516590378|FG006|Overall Study|Withdrawal by Subject|4|||
143284123|NCT02549937|516590379|FG007|Overall Study|Withdrawal by Subject|3|||
143284124|NCT02549937|516590380|FG008|Overall Study|Withdrawal by Subject|2|||
143284125|NCT02549937|516590372|FG000|Overall Study|Sponsor Decision|0|||
143284126|NCT02549937|516590373|FG001|Overall Study|Sponsor Decision|0|||
143284127|NCT02549937|516590374|FG002|Overall Study|Sponsor Decision|0|||
143284128|NCT02549937|516590375|FG003|Overall Study|Sponsor Decision|0|||
143284129|NCT02549937|516590376|FG004|Overall Study|Sponsor Decision|0|||
143284130|NCT02549937|516590377|FG005|Overall Study|Sponsor Decision|0|||
143284131|NCT02549937|516590378|FG006|Overall Study|Sponsor Decision|0|||
143284132|NCT02549937|516590379|FG007|Overall Study|Sponsor Decision|0|||
143284133|NCT02549937|516590380|FG008|Overall Study|Sponsor Decision|6|||
143284134|NCT03930797|516590381|FG000|Overall Study|Lost to Follow-up|3|||
143284135|NCT03930797|516590382|FG001|Overall Study|Lost to Follow-up|10|||
143284136|NCT00662012|516590383|FG000|Overall Study|Lost to Follow-up|85|||
143284137|NCT00662012|516590383|FG000|Overall Study|Death|1|||
143284138|NCT00662012|516590383|FG000|Overall Study|Withdrawal by Subject|1|||
143284139|NCT04656691|516590389|FG000|Overall Study|Adverse Event|1|||
143284140|NCT04023526|516592406|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
143284141|NCT04023526|516592407|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
143284142|NCT04023526|516592406|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
143284143|NCT04023526|516592407|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
143284144|NCT03761277|516592417|FG000|Enrollment to Implant|Screen Failure|17|||
143284145|NCT03761277|516592417|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
143284146|NCT03761277|516592417|FG000|Enrollment to Implant|Physician Decision|2|||
143284147|NCT03761277|516592417|FG000|Enrollment to Implant|Site Closure|3|||
143284148|NCT03761277|516592417|FG000|Enrollment to Implant|Sponsor Request|2|||
143284149|NCT03761277|516592417|FG000|Post-Implant to 6 Months|Adverse Event|2|||
143284150|NCT03761277|516592417|FG000|Post-Implant to 6 Months|Death|1|||
143284151|NCT03761277|516592417|FG000|Post-Implant to 6 Months|Site Closure|2|||
143284152|NCT03761277|516592417|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
143284153|NCT03761277|516592417|FG000|6 Months to 12 Months|Physician Decision|2|||
143284154|NCT03761277|516592417|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
143284155|NCT00903695|516592418|FG000|Overall Study|medical exclusion after 1st testing|1|||
143284156|NCT00903695|516592419|FG001|Overall Study|medical exclusion after 1st testing|0|||
143284157|NCT00903695|516592418|FG000|Overall Study|lung cancer|1|||
143284158|NCT00903695|516592419|FG001|Overall Study|lung cancer|0|||
143284159|NCT00684307|516592421|FG000|Overall Study|Adverse Event|11|||
143284160|NCT00684307|516592422|FG001|Overall Study|Adverse Event|6|||
143284161|NCT00684307|516592423|FG002|Overall Study|Adverse Event|15|||
143284162|NCT00684307|516592424|FG003|Overall Study|Adverse Event|16|||
143284163|NCT00684307|516592425|FG004|Overall Study|Adverse Event|8|||
143284164|NCT00684307|516592421|FG000|Overall Study|Development of increasing Liver Function|0|||
143284165|NCT00684307|516592422|FG001|Overall Study|Development of increasing Liver Function|2|||
143284166|NCT00684307|516592423|FG002|Overall Study|Development of increasing Liver Function|0|||
143284167|NCT00684307|516592424|FG003|Overall Study|Development of increasing Liver Function|1|||
143284168|NCT00684307|516592425|FG004|Overall Study|Development of increasing Liver Function|0|||
143284169|NCT00684307|516592421|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
143284170|NCT00684307|516592422|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
143284171|NCT00684307|516592423|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
143284172|NCT00684307|516592424|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
143284173|NCT00684307|516592425|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
143284174|NCT00684307|516592421|FG000|Overall Study|Incorrect enrolment or randomization|4|||
143284175|NCT00684307|516592422|FG001|Overall Study|Incorrect enrolment or randomization|0|||
143284176|NCT00684307|516592423|FG002|Overall Study|Incorrect enrolment or randomization|0|||
143284177|NCT00684307|516592424|FG003|Overall Study|Incorrect enrolment or randomization|0|||
143284178|NCT00684307|516592425|FG004|Overall Study|Incorrect enrolment or randomization|0|||
143284179|NCT00684307|516592421|FG000|Overall Study|Interupted IP for more than 7 days|0|||
143284180|NCT00684307|516592422|FG001|Overall Study|Interupted IP for more than 7 days|4|||
143284181|NCT00684307|516592423|FG002|Overall Study|Interupted IP for more than 7 days|1|||
143284182|NCT00684307|516592424|FG003|Overall Study|Interupted IP for more than 7 days|3|||
143284183|NCT00684307|516592425|FG004|Overall Study|Interupted IP for more than 7 days|3|||
143284184|NCT00684307|516592421|FG000|Overall Study|Severe non compliance to protocol|1|||
143284185|NCT00684307|516592422|FG001|Overall Study|Severe non compliance to protocol|0|||
143284186|NCT00684307|516592423|FG002|Overall Study|Severe non compliance to protocol|0|||
143284187|NCT00684307|516592424|FG003|Overall Study|Severe non compliance to protocol|1|||
143284188|NCT00684307|516592425|FG004|Overall Study|Severe non compliance to protocol|2|||
143284189|NCT00684307|516592421|FG000|Overall Study|Participant not willing to continue|7|||
143284190|NCT00684307|516592422|FG001|Overall Study|Participant not willing to continue|10|||
143284191|NCT00684307|516592423|FG002|Overall Study|Participant not willing to continue|11|||
143284192|NCT00684307|516592424|FG003|Overall Study|Participant not willing to continue|5|||
143284193|NCT00684307|516592425|FG004|Overall Study|Participant not willing to continue|8|||
143284194|NCT00684307|516592421|FG000|Overall Study|Criteria from the CSR|0|||
143284195|NCT00684307|516592422|FG001|Overall Study|Criteria from the CSR|0|||
143284196|NCT00684307|516592423|FG002|Overall Study|Criteria from the CSR|1|||
143284197|NCT00684307|516592424|FG003|Overall Study|Criteria from the CSR|3|||
143284198|NCT00684307|516592425|FG004|Overall Study|Criteria from the CSR|3|||
143284199|NCT00543140|516592426|FG000|Overall Study|Lost to Follow-up|33|||
143284200|NCT00543140|516592426|FG000|Overall Study|Withdrawal by Subject|13|||
143284201|NCT00543140|516592426|FG000|Overall Study|Protocol Violation|10|||
143284202|NCT00543140|516592426|FG000|Overall Study|Insufficient weight loss|10|||
143284203|NCT00543140|516592426|FG000|Overall Study|SAE leading to explant of SAGB|3|||
143284204|NCT00543140|516592426|FG000|Overall Study|Death|1|||
143284205|NCT00543140|516592426|FG000|Overall Study|Subject moved|1|||
143284206|NCT00543140|516592426|FG000|Overall Study|Conversion to different procedure|1|||
143284207|NCT00578812|516592427|FG000|Overall Study|Not treated|6|||
143284208|NCT00578812|516592428|FG001|Overall Study|Not treated|7|||
143284209|NCT04532164|516592430|FG000|Overall Study|Adverse Event|1|||
143284210|NCT04532164|516592430|FG000|Overall Study|Protocol Violation|5|||
143284211|NCT04532164|516592430|FG000|Overall Study|Lost to Follow-up|1|||
143284212|NCT04532164|516592430|FG000|Overall Study|Found to be Ineligible|3|||
143284213|NCT04532164|516592430|FG000|Overall Study|Withdrawal by Subject|14|||
143284214|NCT02483520|516592431|FG000|Overall Study|Lost to Follow-up|3|||
143284215|NCT02483520|516592432|FG001|Overall Study|Lost to Follow-up|4|||
143284216|NCT02483520|516592431|FG000|Overall Study|Withdrawal by Subject|4|||
143284217|NCT02483520|516592432|FG001|Overall Study|Withdrawal by Subject|14|||
143284218|NCT02483520|516592431|FG000|Overall Study|Hospitalized|2|||
143284219|NCT02483520|516592432|FG001|Overall Study|Hospitalized|3|||
143284220|NCT02483520|516592431|FG000|Overall Study|Moved to LTC|2|||
143284221|NCT02483520|516592432|FG001|Overall Study|Moved to LTC|3|||
143284222|NCT01104493|516592434|FG000|Overall Study|Lost to Follow-up|0|||
143284223|NCT01104493|516592435|FG001|Overall Study|Lost to Follow-up|2|||
143284224|NCT00727025|516592438|FG000|Overall Study|Physician Decision|23|||
143284225|NCT01218204|516592439|FG000|Part B Washout|Adverse Event|0|||
143284226|NCT01218204|516592440|FG001|Part B Washout|Adverse Event|1|||
143284227|NCT01218204|516592441|FG002|Part B Washout|Adverse Event|0|||
143284228|NCT01218204|516592442|FG003|Part B Washout|Adverse Event|0|||
143284229|NCT01218204|516592439|FG000|Part B Washout|Lost to Follow-up|0|||
143284230|NCT01218204|516592440|FG001|Part B Washout|Lost to Follow-up|2|||
143284231|NCT01218204|516592441|FG002|Part B Washout|Lost to Follow-up|0|||
143284232|NCT01218204|516592442|FG003|Part B Washout|Lost to Follow-up|0|||
143284233|NCT01218204|516592439|FG000|Part B Washout|Physician Decision|0|||
143284234|NCT01218204|516592440|FG001|Part B Washout|Physician Decision|14|||
143284235|NCT01218204|516592441|FG002|Part B Washout|Physician Decision|0|||
143284236|NCT01218204|516592442|FG003|Part B Washout|Physician Decision|0|||
143284237|NCT01218204|516592439|FG000|Part B Washout|Withdrawal by Subject|0|||
143284238|NCT01218204|516592440|FG001|Part B Washout|Withdrawal by Subject|14|||
143284239|NCT01218204|516592441|FG002|Part B Washout|Withdrawal by Subject|0|||
143284240|NCT01218204|516592442|FG003|Part B Washout|Withdrawal by Subject|0|||
143284241|NCT01218204|516592439|FG000|Part B Washout|Reached defined stopping criteria|0|||
143284242|NCT01218204|516592440|FG001|Part B Washout|Reached defined stopping criteria|2|||
143284243|NCT01218204|516592441|FG002|Part B Washout|Reached defined stopping criteria|0|||
143284244|NCT01218204|516592442|FG003|Part B Washout|Reached defined stopping criteria|0|||
143284245|NCT01218204|516592439|FG000|Part B Washout|Did not meet continuation criteria|0|||
143284246|NCT01218204|516592440|FG001|Part B Washout|Did not meet continuation criteria|112|||
143284247|NCT01218204|516592441|FG002|Part B Washout|Did not meet continuation criteria|0|||
143284248|NCT01218204|516592442|FG003|Part B Washout|Did not meet continuation criteria|0|||
143284249|NCT01218204|516592439|FG000|Part B Run-in|Adverse Event|0|||
143284250|NCT01218204|516592440|FG001|Part B Run-in|Adverse Event|0|||
143284251|NCT01218204|516592441|FG002|Part B Run-in|Adverse Event|1|||
143284252|NCT01218204|516592442|FG003|Part B Run-in|Adverse Event|0|||
143284253|NCT01218204|516592439|FG000|Part B Run-in|Protocol Violation|0|||
143284254|NCT01218204|516592440|FG001|Part B Run-in|Protocol Violation|0|||
143284255|NCT01218204|516592441|FG002|Part B Run-in|Protocol Violation|2|||
143284256|NCT01218204|516592442|FG003|Part B Run-in|Protocol Violation|0|||
143284257|NCT01218204|516592439|FG000|Part B Run-in|Withdrawal by Subject|0|||
143284258|NCT01218204|516592440|FG001|Part B Run-in|Withdrawal by Subject|0|||
143284259|NCT01218204|516592441|FG002|Part B Run-in|Withdrawal by Subject|3|||
143284260|NCT01218204|516592442|FG003|Part B Run-in|Withdrawal by Subject|0|||
143284261|NCT01218204|516592439|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
143284262|NCT01218204|516592440|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
143284263|NCT01218204|516592441|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
143284264|NCT01218204|516592442|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
143284265|NCT01218204|516592439|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
143284266|NCT01218204|516592440|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
143284267|NCT01218204|516592441|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
143284268|NCT01218204|516592442|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
143284269|NCT00743340|516592443|FG000|Overall Study|Study medication non-compliance|1|||
143284270|NCT00743340|516592443|FG000|Overall Study|Lost to Follow-up|1|||
143284271|NCT00743340|516592443|FG000|Overall Study|Withdrawal from the Study|5|||
143284272|NCT00743340|516592443|FG000|Overall Study|Protocol Violation|1|||
143284273|NCT00743340|516592443|FG000|Overall Study|Virologic failure|8|||
143284274|NCT00743340|516592443|FG000|Overall Study|Pregnancy|1|||
143284275|NCT00743340|516592443|FG000|Overall Study|Rolled over to other Gilead Study|23|||
143284276|NCT00743340|516592443|FG000|Overall Study|Participant Relocated|1|||
143284277|NCT00127660|516592444|FG000|Overall Study|Protocol Violation|3|||
143284278|NCT00127660|516592445|FG001|Overall Study|Protocol Violation|3|||
143284279|NCT00127660|516592446|FG002|Overall Study|Protocol Violation|5|||
143284280|NCT00127660|516592447|FG003|Overall Study|Protocol Violation|0|||
143284281|NCT04605484|516592450|FG000|Overall Study|Lost to Follow-up|0|||
143284282|NCT04605484|516592451|FG001|Overall Study|Lost to Follow-up|1|||
143284283|NCT04605484|516592452|FG002|Overall Study|Lost to Follow-up|1|||
143284284|NCT04605484|516592450|FG000|Overall Study|Other|0|||
143284285|NCT04605484|516592451|FG001|Overall Study|Other|1|||
143284286|NCT04605484|516592452|FG002|Overall Study|Other|0|||
143284287|NCT00660309|516592455|FG000|Overall Study|Adverse Event|2|||
143284288|NCT00660309|516592456|FG001|Overall Study|Adverse Event|0|||
143284289|NCT00660309|516592455|FG000|Overall Study|Withdrawal by Subject|0|||
143284290|NCT00660309|516592456|FG001|Overall Study|Withdrawal by Subject|3|||
143284291|NCT02573311|516592459|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
143284292|NCT02573311|516592460|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
143284293|NCT02573311|516592459|FG000|Disposition for Part 2|Physician Decision|25|||
143284294|NCT02573311|516592460|FG001|Disposition for Part 2|Physician Decision|7|||
143284295|NCT02573311|516592459|FG000|Disposition for Part 2|Adverse Event|36|||
143284296|NCT02573311|516592460|FG001|Disposition for Part 2|Adverse Event|5|||
143284297|NCT02573311|516592459|FG000|Disposition for Part 2|Lost to Follow-up|76|||
143284298|NCT02573311|516592460|FG001|Disposition for Part 2|Lost to Follow-up|7|||
143284299|NCT02573311|516592459|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
143284300|NCT02573311|516592460|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
143284301|NCT02573311|516592459|FG000|Disposition for Part 2|Investigator decision|0|||
143284302|NCT02573311|516592460|FG001|Disposition for Part 2|Investigator decision|1|||
143284303|NCT02573311|516592459|FG000|Disposition for Part 2|Other than specified above|13|||
143284304|NCT02573311|516592460|FG001|Disposition for Part 2|Other than specified above|3|||
143284305|NCT04171531|516592462|FG000|Overall Study|Lost to Follow-up|4|||
143284306|NCT04171531|516592463|FG001|Overall Study|Lost to Follow-up|5|||
143284307|NCT04171531|516592462|FG000|Overall Study|Consent only through 6 months|1|||
143284308|NCT04171531|516592463|FG001|Overall Study|Consent only through 6 months|1|||
143284309|NCT04171531|516592462|FG000|Overall Study|Insurance did not cover procedure|0|||
143284310|NCT04171531|516592463|FG001|Overall Study|Insurance did not cover procedure|1|||
143284311|NCT04171531|516592462|FG000|Overall Study|Physician Decision|0|||
143284312|NCT04171531|516592463|FG001|Overall Study|Physician Decision|3|||
143284313|NCT04171531|516592462|FG000|Overall Study|Withdrawal by Subject|1|||
143284314|NCT04171531|516592463|FG001|Overall Study|Withdrawal by Subject|5|||
143284315|NCT04862585|516592467|FG000|Overall Study|two subjects withdrew due to perceived side effects of premedications|2|||
143284316|NCT04862585|516592468|FG001|Overall Study|two subjects withdrew due to perceived side effects of premedications|0|||
143284317|NCT04862585|516592467|FG000|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|2|||
143284318|NCT04862585|516592468|FG001|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|3|||
143284319|NCT04862585|516592467|FG000|Overall Study|one subject discontinued paclitaxel due to toxicity|0|||
143284320|NCT04862585|516592468|FG001|Overall Study|one subject discontinued paclitaxel due to toxicity|1|||
143284321|NCT04862585|516592467|FG000|Overall Study|one withdrew without providing a reason|0|||
143284322|NCT04862585|516592468|FG001|Overall Study|one withdrew without providing a reason|1|||
143284323|NCT03366337|516592471|FG000|Overall Study|Lost to Follow-up|1|||
143284324|NCT03366337|516592472|FG001|Overall Study|Lost to Follow-up|0|||
143284325|NCT03366337|516592473|FG002|Overall Study|Lost to Follow-up|1|||
143284326|NCT03366337|516592474|FG003|Overall Study|Lost to Follow-up|0|||
143284327|NCT03366337|516592471|FG000|Overall Study|Withdrawal by Subject|2|||
143284328|NCT03366337|516592472|FG001|Overall Study|Withdrawal by Subject|0|||
143284329|NCT03366337|516592473|FG002|Overall Study|Withdrawal by Subject|1|||
143284330|NCT03366337|516592474|FG003|Overall Study|Withdrawal by Subject|1|||
143284331|NCT05288062|516592475|FG000|Overall Study|Ineligible|0|||
143284332|NCT05288062|516592476|FG001|Overall Study|Ineligible|0|||
143284333|NCT05288062|516592477|FG002|Overall Study|Ineligible|1|||
143284334|NCT05288062|516592478|FG003|Overall Study|Ineligible|0|||
143284335|NCT05288062|516592475|FG000|Overall Study|Withdrawal by Subject|0|||
143284336|NCT05288062|516592476|FG001|Overall Study|Withdrawal by Subject|0|||
143284337|NCT05288062|516592477|FG002|Overall Study|Withdrawal by Subject|1|||
143284338|NCT05288062|516592478|FG003|Overall Study|Withdrawal by Subject|0|||
143284339|NCT01537393|516592482|FG000|Overall Study|Exclude prior to study|32|||
143284340|NCT01537393|516592483|FG001|Overall Study|Exclude prior to study|44|||
143284341|NCT01537393|516592482|FG000|Overall Study|Death|20|||
143284342|NCT01537393|516592483|FG001|Overall Study|Death|32|||
143284343|NCT01537393|516592482|FG000|Overall Study|Withdrawal by Subject|18|||
143284344|NCT01537393|516592483|FG001|Overall Study|Withdrawal by Subject|17|||
143284345|NCT01537393|516592482|FG000|Overall Study|Lost to Follow-up|53|||
143284346|NCT01537393|516592483|FG001|Overall Study|Lost to Follow-up|48|||
143284347|NCT01537393|516592482|FG000|Overall Study|Failure - Regrafted|28|||
143284348|NCT01537393|516592483|FG001|Overall Study|Failure - Regrafted|43|||
143284349|NCT01537393|516592482|FG000|Overall Study|Failure - Not regrafted|2|||
143284350|NCT01537393|516592483|FG001|Overall Study|Failure - Not regrafted|6|||
143284351|NCT01537393|516592482|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
143284352|NCT01537393|516592483|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
143284353|NCT01697566|516592484|FG000|Overall Study|Withdrawal by Subject|0|||
143284354|NCT01697566|516592485|FG001|Overall Study|Withdrawal by Subject|0|||
143284355|NCT01697566|516592486|FG002|Overall Study|Withdrawal by Subject|1|||
143284356|NCT01697566|516592487|FG003|Overall Study|Withdrawal by Subject|1|||
143284357|NCT01697566|516592484|FG000|Overall Study|Final biopsy not obtained|0|||
143284358|NCT01697566|516592485|FG001|Overall Study|Final biopsy not obtained|0|||
143284359|NCT01697566|516592486|FG002|Overall Study|Final biopsy not obtained|1|||
143284360|NCT01697566|516592487|FG003|Overall Study|Final biopsy not obtained|0|||
143284361|NCT00459953|516592488|FG000|Overall Study|not analyzed-household member in study|1|||
143284362|NCT00459953|516592489|FG001|Overall Study|not analyzed-household member in study|1|||
143284363|NCT01447433|516592490|FG000|Overall Study|Lost to Follow-up|0|||
143284364|NCT01447433|516592491|FG001|Overall Study|Lost to Follow-up|2|||
143284365|NCT01447433|516592490|FG000|Overall Study|Withdrawal by Subject|3|||
143284366|NCT01447433|516592491|FG001|Overall Study|Withdrawal by Subject|3|||
143284367|NCT01447433|516592490|FG000|Overall Study|Protocol Violation|1|||
143284368|NCT01447433|516592491|FG001|Overall Study|Protocol Violation|1|||
143284369|NCT01578187|516592492|FG000|Usability Phase|Withdrawal by Subject|1|||
143284370|NCT01370356|516592497|FG000|Overall Study|Death|1|||
143284371|NCT01370356|516592498|FG001|Overall Study|Death|0|||
143284372|NCT01370356|516592497|FG000|Overall Study|Lack of Efficacy|6|||
143284373|NCT01370356|516592498|FG001|Overall Study|Lack of Efficacy|28|||
143284374|NCT01370356|516592497|FG000|Overall Study|Lost to Follow-up|76|||
143284375|NCT01370356|516592498|FG001|Overall Study|Lost to Follow-up|81|||
143284376|NCT01370356|516592497|FG000|Overall Study|Withdrawal by Subject|54|||
143284377|NCT01370356|516592498|FG001|Overall Study|Withdrawal by Subject|59|||
143284378|NCT01370356|516592497|FG000|Overall Study|Reason not specified|39|||
143284379|NCT01370356|516592498|FG001|Overall Study|Reason not specified|43|||
143284380|NCT01370356|516592497|FG000|Overall Study|Protocol Violation|3|||
143284381|NCT01370356|516592498|FG001|Overall Study|Protocol Violation|3|||
143284382|NCT01370356|516592497|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
143284383|NCT01370356|516592498|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
143284384|NCT01370356|516592497|FG000|Overall Study|AE Not Related to Study Drug|1|||
143284385|NCT01370356|516592498|FG001|Overall Study|AE Not Related to Study Drug|4|||
143284386|NCT01709162|516592501|FG000|Overall Study|Disease progression|3|||
143284387|NCT01709162|516592502|FG001|Overall Study|Disease progression|3|||
143284388|NCT01709162|516592501|FG000|Overall Study|Study drug toxicity|2|||
143284389|NCT01709162|516592502|FG001|Overall Study|Study drug toxicity|0|||
143284390|NCT01709162|516592501|FG000|Overall Study|Administrative reason by sponsor|0|||
143284391|NCT01709162|516592502|FG001|Overall Study|Administrative reason by sponsor|1|||
143284392|NCT01709162|516592501|FG000|Overall Study|Other|1|||
143284393|NCT01709162|516592502|FG001|Overall Study|Other|0|||
143284394|NCT01709162|516592501|FG000|Overall Study|Withdrawal by Subject|0|||
143284395|NCT01709162|516592502|FG001|Overall Study|Withdrawal by Subject|1|||
143284396|NCT01874054|516592503|FG000|Overall Study|Withdrawal by Subject|3|||
143284397|NCT01874054|516592503|FG000|Overall Study|Study Termination by Sponsor|42|||
143284398|NCT01874054|516592503|FG000|Overall Study|Lost to Follow-up|5|||
143284399|NCT01874054|516592503|FG000|Overall Study|Death|5|||
143284400|NCT01233258|516592504|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
143284401|NCT01233258|516592505|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
143284402|NCT01233258|516592506|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
143284403|NCT01233258|516592507|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
143284404|NCT01233258|516592508|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
143284405|NCT01233258|516592509|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
143284406|NCT01233258|516592504|FG000|First Intervention (6 Months)|Protocol Violation|0|||
143284407|NCT01233258|516592505|FG001|First Intervention (6 Months)|Protocol Violation|0|||
143284408|NCT01233258|516592506|FG002|First Intervention (6 Months)|Protocol Violation|1|||
143284409|NCT01233258|516592507|FG003|First Intervention (6 Months)|Protocol Violation|0|||
143284410|NCT01233258|516592508|FG004|First Intervention (6 Months)|Protocol Violation|0|||
143284411|NCT01233258|516592509|FG005|First Intervention (6 Months)|Protocol Violation|0|||
143284412|NCT01233258|516592504|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
143284413|NCT01233258|516592505|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
143284414|NCT01233258|516592506|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
143284415|NCT01233258|516592507|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
143284416|NCT01233258|516592508|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
143284417|NCT01233258|516592509|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
143284418|NCT01217801|516592512|FG000|Period 1|Protocol Violation|1|||
143284419|NCT01217801|516592513|FG001|Period 1|Protocol Violation|1|||
143284420|NCT01217801|516592512|FG000|Period 1|Withdrawal by Subject|0|||
143284421|NCT01217801|516592513|FG001|Period 1|Withdrawal by Subject|1|||
143284422|NCT03129100|516592514|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
143284423|NCT03129100|516592515|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
143284424|NCT03129100|516592516|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
143284425|NCT03129100|516592517|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
143284426|NCT03129100|516592518|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
143284427|NCT03129100|516592519|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
143284428|NCT03129100|516592520|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
143284429|NCT03129100|516592521|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
143284430|NCT03129100|516592522|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
143284431|NCT03129100|516592523|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
143284432|NCT03129100|516592524|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
143284433|NCT03129100|516592525|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
143284434|NCT03129100|516592526|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
143284435|NCT03129100|516592527|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
143284436|NCT03129100|516592528|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
143284437|NCT03129100|516592529|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
143284438|NCT03129100|516592530|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
143284439|NCT03129100|516592531|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
143284440|NCT03129100|516592532|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
143284441|NCT03129100|516592533|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
143284442|NCT03129100|516592534|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
143284443|NCT03129100|516592535|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
143284444|NCT03129100|516592536|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
143284445|NCT03129100|516592537|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
143284446|NCT03129100|516592538|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
143284447|NCT03129100|516592539|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
143284448|NCT03129100|516592514|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
143284449|NCT03129100|516592515|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
143284450|NCT03129100|516592516|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
143284451|NCT03129100|516592517|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
143284452|NCT03129100|516592518|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
143284453|NCT03129100|516592519|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
143284454|NCT03129100|516592520|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
143284455|NCT03129100|516592521|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
143284456|NCT03129100|516592522|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
143284457|NCT03129100|516592523|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
143284458|NCT03129100|516592524|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
143284459|NCT03129100|516592525|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
143284460|NCT03129100|516592526|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
143284461|NCT03129100|516592527|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
143284462|NCT03129100|516592528|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
143284463|NCT03129100|516592529|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
143284464|NCT03129100|516592530|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
143284465|NCT03129100|516592531|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
143284466|NCT03129100|516592532|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
143284467|NCT03129100|516592533|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
143284468|NCT03129100|516592534|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
143284469|NCT03129100|516592535|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
143284470|NCT03129100|516592536|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
143284471|NCT03129100|516592537|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
143284472|NCT03129100|516592538|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
143284473|NCT03129100|516592539|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
143284474|NCT03129100|516592514|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
143284475|NCT03129100|516592515|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
143284476|NCT03129100|516592516|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
143284477|NCT03129100|516592517|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
143284478|NCT03129100|516592518|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
143284479|NCT03129100|516592519|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
143284480|NCT03129100|516592520|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
143284481|NCT03129100|516592521|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
143284482|NCT03129100|516592522|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
143284483|NCT03129100|516592523|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
143284484|NCT03129100|516592524|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
143284485|NCT03129100|516592525|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
143284486|NCT03129100|516592526|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
143284487|NCT03129100|516592527|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
143284488|NCT03129100|516592528|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
143284489|NCT03129100|516592529|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
143284490|NCT03129100|516592530|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
143284491|NCT03129100|516592531|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
143284492|NCT03129100|516592532|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
143284493|NCT03129100|516592533|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
143284494|NCT03129100|516592534|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
143284495|NCT03129100|516592535|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
143284496|NCT03129100|516592536|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
143284497|NCT03129100|516592537|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
143284498|NCT03129100|516592538|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
143284499|NCT03129100|516592539|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
143284500|NCT03129100|516592514|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
143284501|NCT03129100|516592515|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
143284502|NCT03129100|516592516|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
143284503|NCT03129100|516592517|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
143284504|NCT03129100|516592518|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
143284505|NCT03129100|516592519|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
143284506|NCT03129100|516592520|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
143284507|NCT03129100|516592521|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
143284508|NCT03129100|516592522|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
143284509|NCT03129100|516592523|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
143284510|NCT03129100|516592524|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
143284511|NCT03129100|516592525|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
143284512|NCT03129100|516592526|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
143284513|NCT03129100|516592527|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
143284514|NCT03129100|516592528|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
143284515|NCT03129100|516592529|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
143284516|NCT03129100|516592530|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
143284517|NCT03129100|516592531|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
143284518|NCT03129100|516592532|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
143284519|NCT03129100|516592533|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
143284520|NCT03129100|516592534|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
143284521|NCT03129100|516592535|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
143284522|NCT03129100|516592536|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
143284523|NCT03129100|516592537|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
143284524|NCT03129100|516592538|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
143284525|NCT03129100|516592539|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
143284526|NCT03129100|516592514|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
143284527|NCT03129100|516592515|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
143284528|NCT03129100|516592516|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
143284529|NCT03129100|516592517|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
143284530|NCT03129100|516592518|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
143284531|NCT03129100|516592519|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
143284532|NCT03129100|516592520|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
143284533|NCT03129100|516592521|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
143284534|NCT03129100|516592522|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
143284535|NCT03129100|516592523|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
143284536|NCT03129100|516592524|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
143284537|NCT03129100|516592525|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
143284538|NCT03129100|516592526|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
143284539|NCT03129100|516592527|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
143284540|NCT03129100|516592528|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
143284541|NCT03129100|516592529|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
143284542|NCT03129100|516592530|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
143284543|NCT03129100|516592531|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
143284544|NCT03129100|516592532|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
143284545|NCT03129100|516592533|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
143284546|NCT03129100|516592534|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
143284547|NCT03129100|516592535|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
143284548|NCT03129100|516592536|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
143284549|NCT03129100|516592537|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
143284550|NCT03129100|516592538|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
143284551|NCT03129100|516592539|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
143284552|NCT03129100|516592514|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
143284553|NCT03129100|516592515|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
143284554|NCT03129100|516592516|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
143284555|NCT03129100|516592517|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
143284556|NCT03129100|516592518|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
143284557|NCT03129100|516592519|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
143284558|NCT03129100|516592520|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
143284559|NCT03129100|516592521|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
143284560|NCT03129100|516592522|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
143284561|NCT03129100|516592523|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
143284562|NCT03129100|516592524|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
143284563|NCT03129100|516592525|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
143284564|NCT03129100|516592526|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
143284565|NCT03129100|516592527|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
143284566|NCT03129100|516592528|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
143284567|NCT03129100|516592529|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
143284568|NCT03129100|516592530|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
143284569|NCT03129100|516592531|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
143284570|NCT03129100|516592532|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
143284571|NCT03129100|516592533|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
143284572|NCT03129100|516592534|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
143284573|NCT03129100|516592535|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
143373303|NCT00716144|516911419|FG003|Overall Study|Intercurrent illness|0|||
143284574|NCT03129100|516592536|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
143284575|NCT03129100|516592537|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
143284576|NCT03129100|516592538|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
143284577|NCT03129100|516592539|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
143284578|NCT03129100|516592514|FG000|Period2 Extension Period (Group A and B)|Death|0|||
143284579|NCT03129100|516592515|FG001|Period2 Extension Period (Group A and B)|Death|0|||
143284580|NCT03129100|516592516|FG002|Period2 Extension Period (Group A and B)|Death|1|||
143284581|NCT03129100|516592517|FG003|Period2 Extension Period (Group A and B)|Death|0|||
143284582|NCT03129100|516592518|FG004|Period2 Extension Period (Group A and B)|Death|0|||
143284583|NCT03129100|516592519|FG005|Period2 Extension Period (Group A and B)|Death|0|||
143284584|NCT03129100|516592520|FG006|Period2 Extension Period (Group A and B)|Death|0|||
143284585|NCT03129100|516592521|FG007|Period2 Extension Period (Group A and B)|Death|0|||
143284586|NCT03129100|516592522|FG008|Period2 Extension Period (Group A and B)|Death|0|||
143284587|NCT03129100|516592523|FG009|Period2 Extension Period (Group A and B)|Death|0|||
143284588|NCT03129100|516592524|FG010|Period2 Extension Period (Group A and B)|Death|0|||
143284589|NCT03129100|516592525|FG011|Period2 Extension Period (Group A and B)|Death|0|||
143284590|NCT03129100|516592526|FG012|Period2 Extension Period (Group A and B)|Death|0|||
143284591|NCT03129100|516592527|FG013|Period2 Extension Period (Group A and B)|Death|0|||
143284592|NCT03129100|516592528|FG014|Period2 Extension Period (Group A and B)|Death|0|||
143284593|NCT03129100|516592529|FG015|Period2 Extension Period (Group A and B)|Death|0|||
143284594|NCT03129100|516592530|FG016|Period2 Extension Period (Group A and B)|Death|0|||
143284595|NCT03129100|516592531|FG017|Period2 Extension Period (Group A and B)|Death|0|||
143284596|NCT03129100|516592532|FG018|Period2 Extension Period (Group A and B)|Death|0|||
143284597|NCT03129100|516592533|FG019|Period2 Extension Period (Group A and B)|Death|0|||
143284598|NCT03129100|516592534|FG020|Period2 Extension Period (Group A and B)|Death|0|||
143284599|NCT03129100|516592535|FG021|Period2 Extension Period (Group A and B)|Death|0|||
143284600|NCT03129100|516592536|FG022|Period2 Extension Period (Group A and B)|Death|0|||
143284601|NCT03129100|516592537|FG023|Period2 Extension Period (Group A and B)|Death|0|||
143284602|NCT03129100|516592538|FG024|Period2 Extension Period (Group A and B)|Death|0|||
143284603|NCT03129100|516592539|FG025|Period2 Extension Period (Group A and B)|Death|0|||
143284604|NCT03129100|516592514|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
143284605|NCT03129100|516592515|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
143284606|NCT03129100|516592516|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
143284607|NCT03129100|516592517|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
143284608|NCT03129100|516592518|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
143284609|NCT03129100|516592519|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
143284610|NCT03129100|516592520|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
143284611|NCT03129100|516592521|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
143284612|NCT03129100|516592522|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
143284613|NCT03129100|516592523|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
143284614|NCT03129100|516592524|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
143284615|NCT03129100|516592525|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
143284616|NCT03129100|516592526|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
143284617|NCT03129100|516592527|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
143284618|NCT03129100|516592528|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
143284619|NCT03129100|516592529|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
143284620|NCT03129100|516592530|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
143284621|NCT03129100|516592531|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
143284622|NCT03129100|516592532|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
143284623|NCT03129100|516592533|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
143284624|NCT03129100|516592534|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
143284625|NCT03129100|516592535|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
143284626|NCT03129100|516592536|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
143284627|NCT03129100|516592537|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
143284628|NCT03129100|516592538|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
143284629|NCT03129100|516592539|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
143284630|NCT03129100|516592514|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
143284631|NCT03129100|516592515|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
143284632|NCT03129100|516592516|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
143284633|NCT03129100|516592517|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
143284634|NCT03129100|516592518|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
143284635|NCT03129100|516592519|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
143284636|NCT03129100|516592520|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
143284637|NCT03129100|516592521|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
143284638|NCT03129100|516592522|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
143284639|NCT03129100|516592523|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
143284640|NCT03129100|516592524|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
143284641|NCT03129100|516592525|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
143284642|NCT03129100|516592526|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
143284643|NCT03129100|516592527|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
143284644|NCT03129100|516592528|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
143284645|NCT03129100|516592529|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
143284646|NCT03129100|516592530|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
143284647|NCT03129100|516592531|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
143284648|NCT03129100|516592532|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
143284649|NCT03129100|516592533|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
143284650|NCT03129100|516592534|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
143284651|NCT03129100|516592535|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
143284652|NCT03129100|516592536|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
143284653|NCT03129100|516592537|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
143284654|NCT03129100|516592538|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
143284655|NCT03129100|516592539|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
143284656|NCT03129100|516592514|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
143284657|NCT03129100|516592515|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
143284658|NCT03129100|516592516|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
143284659|NCT03129100|516592517|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
143284660|NCT03129100|516592518|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
143284661|NCT03129100|516592519|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
143284662|NCT03129100|516592520|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
143284663|NCT03129100|516592521|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
143284664|NCT03129100|516592522|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
143284665|NCT03129100|516592523|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
143284666|NCT03129100|516592524|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
143284667|NCT03129100|516592525|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
143284668|NCT03129100|516592526|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
143284669|NCT03129100|516592527|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
143284670|NCT03129100|516592528|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
143284671|NCT03129100|516592529|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
143284672|NCT03129100|516592530|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
143373304|NCT00716144|516911416|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
143373305|NCT00716144|516911417|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
143373306|NCT00716144|516911418|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
143373307|NCT00716144|516911419|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
143373308|NCT00716144|516911416|FG000|Overall Study|Adverse event: left foot pain|0|||
143373309|NCT00716144|516911417|FG001|Overall Study|Adverse event: left foot pain|1|||
143373310|NCT00716144|516911418|FG002|Overall Study|Adverse event: left foot pain|0|||
143373311|NCT00716144|516911419|FG003|Overall Study|Adverse event: left foot pain|0|||
143373312|NCT00716144|516911416|FG000|Overall Study|Clinical Depression|0|||
143373313|NCT00716144|516911417|FG001|Overall Study|Clinical Depression|1|||
143373314|NCT00716144|516911418|FG002|Overall Study|Clinical Depression|0|||
143373315|NCT00716144|516911419|FG003|Overall Study|Clinical Depression|0|||
143373316|NCT02808338|516911427|FG000|Screening|Screen Failure|10|||
143373317|NCT02808338|516911427|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
143373318|NCT02808338|516911427|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
143373319|NCT03383146|516911433|FG000|Overall Study|Screen Failure|1|||
143373320|NCT03383146|516911434|FG001|Overall Study|Screen Failure|0|||
143373321|NCT03383146|516911433|FG000|Overall Study|Adverse Event|6|||
143373322|NCT03383146|516911434|FG001|Overall Study|Adverse Event|18|||
143284673|NCT03129100|516592531|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
143284674|NCT03129100|516592532|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
143284675|NCT03129100|516592533|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
143284676|NCT03129100|516592534|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
143284677|NCT03129100|516592535|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
143284678|NCT03129100|516592536|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
143284679|NCT03129100|516592537|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
143284680|NCT03129100|516592538|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
143284681|NCT03129100|516592539|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
143284682|NCT03129100|516592514|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
143284683|NCT03129100|516592515|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
143373323|NCT03383146|516911433|FG000|Overall Study|Lack of Efficacy|0|||
143373324|NCT03383146|516911434|FG001|Overall Study|Lack of Efficacy|3|||
143284684|NCT03129100|516592516|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
143284685|NCT03129100|516592517|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
143284686|NCT03129100|516592518|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
143284687|NCT03129100|516592519|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
143373325|NCT03383146|516911433|FG000|Overall Study|Withdrawal by Subject|20|||
143373326|NCT03383146|516911434|FG001|Overall Study|Withdrawal by Subject|36|||
143284688|NCT03129100|516592520|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
143284689|NCT03129100|516592521|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
143284690|NCT03129100|516592522|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
143284691|NCT03129100|516592523|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
143284692|NCT03129100|516592524|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
143284693|NCT03129100|516592525|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
143284694|NCT03129100|516592526|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
143284695|NCT03129100|516592527|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
143284696|NCT03129100|516592528|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
143284697|NCT03129100|516592529|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
143284698|NCT03129100|516592530|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
143284699|NCT03129100|516592531|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
143284700|NCT03129100|516592532|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
143284701|NCT03129100|516592533|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
143284702|NCT03129100|516592534|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
143284703|NCT03129100|516592535|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
143284704|NCT03129100|516592536|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
143284705|NCT03129100|516592537|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
143284706|NCT03129100|516592538|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
143284707|NCT03129100|516592539|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
143284708|NCT03129100|516592514|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
143284709|NCT03129100|516592515|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
143284710|NCT03129100|516592516|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
143284711|NCT03129100|516592517|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
143284712|NCT03129100|516592518|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
143284713|NCT03129100|516592519|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
143284714|NCT03129100|516592520|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
143284715|NCT03129100|516592521|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
143284716|NCT03129100|516592522|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
143284717|NCT03129100|516592523|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
143284718|NCT03129100|516592524|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
143284719|NCT03129100|516592525|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
143284720|NCT03129100|516592526|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
143284721|NCT03129100|516592527|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
143284722|NCT03129100|516592528|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
143284723|NCT03129100|516592529|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
143284724|NCT03129100|516592530|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
143284725|NCT03129100|516592531|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
143284726|NCT03129100|516592532|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
143284727|NCT03129100|516592533|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
143284728|NCT03129100|516592534|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
143284729|NCT03129100|516592535|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
143284730|NCT03129100|516592536|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
143284731|NCT03129100|516592537|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
143284732|NCT03129100|516592538|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
143373327|NCT03383146|516911433|FG000|Overall Study|Lost to Follow-up|5|||
143373328|NCT03383146|516911434|FG001|Overall Study|Lost to Follow-up|15|||
143373329|NCT03383146|516911433|FG000|Overall Study|Death|0|||
143373330|NCT03383146|516911434|FG001|Overall Study|Death|2|||
143373331|NCT03383146|516911433|FG000|Overall Study|Physician Decision|0|||
143373332|NCT03383146|516911434|FG001|Overall Study|Physician Decision|1|||
143373333|NCT03383146|516911433|FG000|Overall Study|Protocol Deviation|1|||
143373334|NCT03383146|516911434|FG001|Overall Study|Protocol Deviation|8|||
143373335|NCT03383146|516911433|FG000|Overall Study|Study Terminated by the Sponsor|48|||
143373336|NCT03383146|516911434|FG001|Overall Study|Study Terminated by the Sponsor|95|||
143373337|NCT03383146|516911433|FG000|Overall Study|Reason not Specified|4|||
143373338|NCT03383146|516911434|FG001|Overall Study|Reason not Specified|6|||
143373339|NCT00639002|516911435|FG000|Overall Study|Death|1|||
143373340|NCT00639002|516911435|FG000|Overall Study|Adverse Event|1|||
143373341|NCT00639002|516911435|FG000|Overall Study|Protocol Violation|1|||
143373342|NCT00639002|516911435|FG000|Overall Study|Disease progression|3|||
143373343|NCT00639002|516911435|FG000|Overall Study|Physician Decision|6|||
143373344|NCT00639002|516911435|FG000|Overall Study|Lack of Efficacy|1|||
143373345|NCT01317420|516911440|FG000|Overall Study|Progressive disease according to RECIST|2|||
143373346|NCT01317420|516911441|FG001|Overall Study|Progressive disease according to RECIST|3|||
143373347|NCT01317420|516911442|FG002|Overall Study|Progressive disease according to RECIST|3|||
143284733|NCT03129100|516592539|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
143284734|NCT03129100|516592514|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
143284735|NCT03129100|516592515|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
143284736|NCT03129100|516592516|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
143284737|NCT03129100|516592517|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
143284738|NCT03129100|516592518|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
143284739|NCT03129100|516592519|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
143284740|NCT03129100|516592520|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
143284741|NCT03129100|516592521|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
143284742|NCT03129100|516592522|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
143284743|NCT03129100|516592523|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
143284744|NCT03129100|516592524|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
143284745|NCT03129100|516592525|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
143284746|NCT03129100|516592526|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
143284747|NCT03129100|516592527|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
143284748|NCT03129100|516592528|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
143284749|NCT03129100|516592529|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
143284750|NCT03129100|516592530|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
143284751|NCT03129100|516592531|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
143284752|NCT03129100|516592532|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
143284753|NCT03129100|516592533|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
143284754|NCT03129100|516592534|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
143284755|NCT03129100|516592535|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
143284756|NCT03129100|516592536|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
143284757|NCT03129100|516592537|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
143284758|NCT03129100|516592538|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
143284759|NCT03129100|516592539|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
143284760|NCT03129100|516592514|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
143284761|NCT03129100|516592515|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
143284762|NCT03129100|516592516|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
143284763|NCT03129100|516592517|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
143284764|NCT03129100|516592518|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
143284765|NCT03129100|516592519|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
143284766|NCT03129100|516592520|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
143284767|NCT03129100|516592521|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
143284768|NCT03129100|516592522|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
143284769|NCT03129100|516592523|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
143284770|NCT03129100|516592524|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
143284771|NCT03129100|516592525|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
143284772|NCT03129100|516592526|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
143284773|NCT03129100|516592527|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
143284774|NCT03129100|516592528|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
143284775|NCT03129100|516592529|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
143284776|NCT03129100|516592530|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
143284777|NCT03129100|516592531|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
143284778|NCT03129100|516592532|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
143284779|NCT03129100|516592533|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
143284780|NCT03129100|516592534|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
143284781|NCT03129100|516592535|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
143284782|NCT03129100|516592536|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
143284783|NCT03129100|516592537|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
143284784|NCT03129100|516592538|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
143284785|NCT03129100|516592539|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
143284786|NCT03129100|516592514|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
143284787|NCT03129100|516592515|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
143284788|NCT03129100|516592516|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
143284789|NCT03129100|516592517|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
143284790|NCT03129100|516592518|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
143284791|NCT03129100|516592519|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
143284792|NCT03129100|516592520|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
143284793|NCT03129100|516592521|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
143284794|NCT03129100|516592522|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
143284795|NCT03129100|516592523|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
143284796|NCT03129100|516592524|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
143284797|NCT03129100|516592525|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
143284798|NCT03129100|516592526|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
143284799|NCT03129100|516592527|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
143284800|NCT03129100|516592528|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
143284801|NCT03129100|516592529|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
143284802|NCT03129100|516592530|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
143284803|NCT03129100|516592531|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
143284804|NCT03129100|516592532|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
143284805|NCT03129100|516592533|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
143284806|NCT03129100|516592534|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
143284807|NCT03129100|516592535|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
143284808|NCT03129100|516592536|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
143284809|NCT03129100|516592537|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
143284810|NCT03129100|516592538|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
143284811|NCT03129100|516592539|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
143284812|NCT03129100|516592514|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
143284813|NCT03129100|516592515|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
143284814|NCT03129100|516592516|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
143284815|NCT03129100|516592517|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
143284816|NCT03129100|516592518|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
143284817|NCT03129100|516592519|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
143284818|NCT03129100|516592520|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
143284819|NCT03129100|516592521|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
143284820|NCT03129100|516592522|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
143284821|NCT03129100|516592523|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
143284822|NCT03129100|516592524|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
143284823|NCT03129100|516592525|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
143284824|NCT03129100|516592526|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
143284825|NCT03129100|516592527|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
143284826|NCT03129100|516592528|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
143284827|NCT03129100|516592529|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
143284828|NCT03129100|516592530|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
143284829|NCT03129100|516592531|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
143284830|NCT03129100|516592532|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
143284831|NCT03129100|516592533|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
143284832|NCT03129100|516592534|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
143284833|NCT03129100|516592535|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
143284834|NCT03129100|516592536|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
143284835|NCT03129100|516592537|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
143284836|NCT03129100|516592538|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
143284837|NCT03129100|516592539|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
143284838|NCT03129100|516592514|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
143284839|NCT03129100|516592515|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
143284840|NCT03129100|516592516|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
143284841|NCT03129100|516592517|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
143284842|NCT03129100|516592518|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
143284843|NCT03129100|516592519|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
143284844|NCT03129100|516592520|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
143284845|NCT03129100|516592521|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
143284846|NCT03129100|516592522|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
143284847|NCT03129100|516592523|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
143284848|NCT03129100|516592524|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
143284849|NCT03129100|516592525|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
143284850|NCT03129100|516592526|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
143373348|NCT01317420|516911443|FG003|Overall Study|Progressive disease according to RECIST|3|||
143373349|NCT01317420|516911444|FG004|Overall Study|Progressive disease according to RECIST|3|||
143373350|NCT01317420|516911445|FG005|Overall Study|Progressive disease according to RECIST|3|||
143373351|NCT01317420|516911446|FG006|Overall Study|Progressive disease according to RECIST|3|||
143373352|NCT01317420|516911447|FG007|Overall Study|Progressive disease according to RECIST|3|||
143373353|NCT01317420|516911448|FG008|Overall Study|Progressive disease according to RECIST|3|||
143284851|NCT03129100|516592527|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
143284852|NCT03129100|516592528|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
143284853|NCT03129100|516592529|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
143284854|NCT03129100|516592530|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
143284855|NCT03129100|516592531|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
143284856|NCT03129100|516592532|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
143284857|NCT03129100|516592533|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
143284858|NCT03129100|516592534|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
143284859|NCT03129100|516592535|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
143284860|NCT03129100|516592536|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
143284861|NCT03129100|516592537|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
143284862|NCT03129100|516592538|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
143284863|NCT03129100|516592539|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
143284864|NCT03129100|516592514|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
143284865|NCT03129100|516592515|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
143284866|NCT03129100|516592516|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
143284867|NCT03129100|516592517|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
143284868|NCT03129100|516592518|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
143284869|NCT03129100|516592519|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
143284870|NCT03129100|516592520|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
143284871|NCT03129100|516592521|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
143284872|NCT03129100|516592522|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
143284873|NCT03129100|516592523|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
143284874|NCT03129100|516592524|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
143284875|NCT03129100|516592525|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
143284876|NCT03129100|516592526|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
143284877|NCT03129100|516592527|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
143284878|NCT03129100|516592528|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
143284879|NCT03129100|516592529|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
143284880|NCT03129100|516592530|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
143284881|NCT03129100|516592531|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
143284882|NCT03129100|516592532|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
143284883|NCT03129100|516592533|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
143284884|NCT03129100|516592534|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
143284885|NCT03129100|516592535|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
143284886|NCT03129100|516592536|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
143284887|NCT03129100|516592537|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
143284888|NCT03129100|516592538|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
143284889|NCT03129100|516592539|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
143284890|NCT03129100|516592514|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
143284891|NCT03129100|516592515|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
143284892|NCT03129100|516592516|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
143284893|NCT03129100|516592517|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
143284894|NCT03129100|516592518|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
143284895|NCT03129100|516592519|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
143284896|NCT03129100|516592520|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
143284897|NCT03129100|516592521|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
143284898|NCT03129100|516592522|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
143284899|NCT03129100|516592523|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
143284900|NCT03129100|516592524|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
143284901|NCT03129100|516592525|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
143284902|NCT03129100|516592526|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
143284903|NCT03129100|516592527|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
143284904|NCT03129100|516592528|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
143284905|NCT03129100|516592529|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
143284906|NCT03129100|516592530|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
143284907|NCT03129100|516592531|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
143284908|NCT03129100|516592532|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
143284909|NCT03129100|516592533|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
143284910|NCT03129100|516592534|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
143284911|NCT03129100|516592535|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
143284912|NCT03129100|516592536|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
143284913|NCT03129100|516592537|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
143284914|NCT03129100|516592538|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
143284915|NCT03129100|516592539|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
143284916|NCT03129100|516592514|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
143284917|NCT03129100|516592515|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
143284918|NCT03129100|516592516|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
143284919|NCT03129100|516592517|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
143284920|NCT03129100|516592518|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
143284921|NCT03129100|516592519|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
143284922|NCT03129100|516592520|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
143284923|NCT03129100|516592521|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
143284924|NCT03129100|516592522|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
143284925|NCT03129100|516592523|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
143284926|NCT03129100|516592524|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
143284927|NCT03129100|516592525|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
143284928|NCT03129100|516592526|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
143284929|NCT03129100|516592527|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
143284930|NCT03129100|516592528|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
143284931|NCT03129100|516592529|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
143284932|NCT03129100|516592530|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
143284933|NCT03129100|516592531|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
143284934|NCT03129100|516592532|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
143284935|NCT03129100|516592533|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
143284936|NCT03129100|516592534|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
143284937|NCT03129100|516592535|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
143284938|NCT03129100|516592536|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
143284939|NCT03129100|516592537|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
143284940|NCT03129100|516592538|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
143284941|NCT03129100|516592539|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
143284942|NCT03129100|516592514|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
143284943|NCT03129100|516592515|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
143284944|NCT03129100|516592516|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
143284945|NCT03129100|516592517|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
143284946|NCT03129100|516592518|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
143284947|NCT03129100|516592519|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
143284948|NCT03129100|516592520|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
143284949|NCT03129100|516592521|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
143284950|NCT03129100|516592522|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
143284951|NCT03129100|516592523|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
143284952|NCT03129100|516592524|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
143284953|NCT03129100|516592525|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
143284954|NCT03129100|516592526|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
143284955|NCT03129100|516592527|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
143284956|NCT03129100|516592528|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
143284957|NCT03129100|516592529|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
143284958|NCT03129100|516592530|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
143284959|NCT03129100|516592531|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
143284960|NCT03129100|516592532|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
143284961|NCT03129100|516592533|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
143284962|NCT03129100|516592534|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
143284963|NCT03129100|516592535|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
143284964|NCT03129100|516592536|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
143284965|NCT03129100|516592537|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
143284966|NCT03129100|516592538|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
143284967|NCT03129100|516592539|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
143284968|NCT03129100|516592514|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
143284969|NCT03129100|516592515|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
143284970|NCT03129100|516592516|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
143284971|NCT03129100|516592517|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
143284972|NCT03129100|516592518|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
143284973|NCT03129100|516592519|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
143284974|NCT03129100|516592520|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
143284975|NCT03129100|516592521|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
143284976|NCT03129100|516592522|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
143284977|NCT03129100|516592523|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
143284978|NCT03129100|516592524|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
143284979|NCT03129100|516592525|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
143284980|NCT03129100|516592526|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
143284981|NCT03129100|516592527|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
143284982|NCT03129100|516592528|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
143284983|NCT03129100|516592529|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
143284984|NCT03129100|516592530|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
143284985|NCT03129100|516592531|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
143284986|NCT03129100|516592532|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
143284987|NCT03129100|516592533|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
143284988|NCT03129100|516592534|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
143284989|NCT03129100|516592535|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
143284990|NCT03129100|516592536|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
143284991|NCT03129100|516592537|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
143284992|NCT03129100|516592538|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
143284993|NCT03129100|516592539|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
143284994|NCT03129100|516592514|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
143284995|NCT03129100|516592515|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
143284996|NCT03129100|516592516|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
143284997|NCT03129100|516592517|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
143284998|NCT03129100|516592518|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
143284999|NCT03129100|516592519|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
143285000|NCT03129100|516592520|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
143285001|NCT03129100|516592521|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
143285002|NCT03129100|516592522|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
143285003|NCT03129100|516592523|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
143285004|NCT03129100|516592524|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
143285005|NCT03129100|516592525|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
143285006|NCT03129100|516592526|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
143285007|NCT03129100|516592527|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
143285008|NCT03129100|516592528|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
143285009|NCT03129100|516592529|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
143285010|NCT03129100|516592530|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
143285011|NCT03129100|516592531|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
143285012|NCT03129100|516592532|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
143285013|NCT03129100|516592533|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
143285014|NCT03129100|516592534|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
143285015|NCT03129100|516592535|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
143285016|NCT03129100|516592536|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
143285017|NCT03129100|516592537|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
143285018|NCT03129100|516592538|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
143285019|NCT03129100|516592539|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
143285020|NCT03129100|516592514|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
143285021|NCT03129100|516592515|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
143285022|NCT03129100|516592516|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
143285023|NCT03129100|516592517|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
143285024|NCT03129100|516592518|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
143285025|NCT03129100|516592519|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
143285026|NCT03129100|516592520|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
143285027|NCT03129100|516592521|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
143285028|NCT03129100|516592522|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
143285029|NCT03129100|516592523|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
143285030|NCT03129100|516592524|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
143285031|NCT03129100|516592525|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
143285032|NCT03129100|516592526|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
143285033|NCT03129100|516592527|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
143285034|NCT03129100|516592528|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
143285035|NCT03129100|516592529|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
143285036|NCT03129100|516592530|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
143285037|NCT03129100|516592531|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
143285038|NCT03129100|516592532|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
143285039|NCT03129100|516592533|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
143285040|NCT03129100|516592534|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
143285041|NCT03129100|516592535|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
143285042|NCT03129100|516592536|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
143285043|NCT03129100|516592537|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
143285044|NCT03129100|516592538|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
143285045|NCT03129100|516592539|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
143285046|NCT03129100|516592514|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
143285047|NCT03129100|516592515|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
143285048|NCT03129100|516592516|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
143285049|NCT03129100|516592517|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
143285050|NCT03129100|516592518|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
143285051|NCT03129100|516592519|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
143285052|NCT03129100|516592520|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
143285053|NCT03129100|516592521|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
143285054|NCT03129100|516592522|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
143285055|NCT03129100|516592523|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
143285056|NCT03129100|516592524|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
143285057|NCT03129100|516592525|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
143285058|NCT03129100|516592526|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
143285059|NCT03129100|516592527|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
143285060|NCT03129100|516592528|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
143285061|NCT03129100|516592529|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
143285062|NCT03129100|516592530|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
143285063|NCT03129100|516592531|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
143285064|NCT03129100|516592532|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
143285065|NCT03129100|516592533|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
143285066|NCT03129100|516592534|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
143285067|NCT03129100|516592535|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
143285068|NCT03129100|516592536|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
143285069|NCT03129100|516592537|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
143285070|NCT03129100|516592538|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
143285071|NCT03129100|516592539|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
143285072|NCT03129100|516592514|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
143285073|NCT03129100|516592515|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
143285074|NCT03129100|516592516|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
143285075|NCT03129100|516592517|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
143285076|NCT03129100|516592518|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
143285077|NCT03129100|516592519|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
143285078|NCT03129100|516592520|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
143285079|NCT03129100|516592521|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
143285080|NCT03129100|516592522|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
143285081|NCT03129100|516592523|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
143285082|NCT03129100|516592524|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
143285083|NCT03129100|516592525|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
143285084|NCT03129100|516592526|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
143285085|NCT03129100|516592527|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
143285086|NCT03129100|516592528|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
143285087|NCT03129100|516592529|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
143285088|NCT03129100|516592530|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
143285089|NCT03129100|516592531|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
143285090|NCT03129100|516592532|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
143285091|NCT03129100|516592533|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
143285092|NCT03129100|516592534|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
143285093|NCT03129100|516592535|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
143285094|NCT03129100|516592536|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
143285095|NCT03129100|516592537|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
143285096|NCT03129100|516592538|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
143285097|NCT03129100|516592539|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
143285098|NCT03129100|516592514|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
143285099|NCT03129100|516592515|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
143285100|NCT03129100|516592516|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
143285101|NCT03129100|516592517|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
143285102|NCT03129100|516592518|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
143285103|NCT03129100|516592519|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
143285104|NCT03129100|516592520|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
143285105|NCT03129100|516592521|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
143285106|NCT03129100|516592522|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
143285107|NCT03129100|516592523|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
143285108|NCT03129100|516592524|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
143285109|NCT03129100|516592525|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
143285110|NCT03129100|516592526|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
143285111|NCT03129100|516592527|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
143285112|NCT03129100|516592528|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
143285113|NCT03129100|516592529|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
143285114|NCT03129100|516592530|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
143285115|NCT03129100|516592531|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
143285116|NCT03129100|516592532|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
143285117|NCT03129100|516592533|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
143285118|NCT03129100|516592534|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
143285119|NCT03129100|516592535|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
143285120|NCT03129100|516592536|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
143285121|NCT03129100|516592537|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
143285122|NCT03129100|516592538|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
143285123|NCT03129100|516592539|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
143285124|NCT03129100|516592514|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
143285125|NCT03129100|516592515|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
143285126|NCT03129100|516592516|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
143285127|NCT03129100|516592517|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
143285128|NCT03129100|516592518|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
143285129|NCT03129100|516592519|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
143285130|NCT03129100|516592520|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
143285131|NCT03129100|516592521|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
143285132|NCT03129100|516592522|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
143285133|NCT03129100|516592523|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
143285134|NCT03129100|516592524|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
143285135|NCT03129100|516592525|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
143285136|NCT03129100|516592526|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
143285137|NCT03129100|516592527|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
143285138|NCT03129100|516592528|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
143285139|NCT03129100|516592529|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
143285140|NCT03129100|516592530|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
143285141|NCT03129100|516592531|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
143285142|NCT03129100|516592532|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
143285143|NCT03129100|516592533|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
143285144|NCT03129100|516592534|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
143285145|NCT03129100|516592535|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
143285146|NCT03129100|516592536|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
143285147|NCT03129100|516592537|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
143285148|NCT03129100|516592538|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
143285149|NCT03129100|516592539|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
143285150|NCT02756013|516592540|FG000|Overall Study|Adverse Event|1|||
143285151|NCT02756013|516592540|FG000|Overall Study|Hypersensitivity|1|||
143285152|NCT01032837|516592542|FG000|Overall Study|Adverse event/internal illness|0|||
143285153|NCT01032837|516592543|FG001|Overall Study|Adverse event/internal illness|1|||
143285154|NCT01032837|516592544|FG002|Overall Study|Adverse event/internal illness|0|||
143285155|NCT01032837|516592545|FG003|Overall Study|Adverse event/internal illness|1|||
143285156|NCT01032837|516592542|FG000|Overall Study|Withdrew consent|0|||
143285157|NCT01032837|516592543|FG001|Overall Study|Withdrew consent|2|||
143285158|NCT01032837|516592544|FG002|Overall Study|Withdrew consent|0|||
143285159|NCT01032837|516592545|FG003|Overall Study|Withdrew consent|1|||
143285160|NCT01032837|516592542|FG000|Overall Study|Failed to return|0|||
143285161|NCT01032837|516592543|FG001|Overall Study|Failed to return|0|||
143285162|NCT01032837|516592544|FG002|Overall Study|Failed to return|1|||
143285163|NCT01032837|516592545|FG003|Overall Study|Failed to return|0|||
143285164|NCT01032837|516592542|FG000|Overall Study|Refused treatment|0|||
143285165|NCT01032837|516592543|FG001|Overall Study|Refused treatment|0|||
143285166|NCT01032837|516592544|FG002|Overall Study|Refused treatment|0|||
143285167|NCT01032837|516592545|FG003|Overall Study|Refused treatment|1|||
143285168|NCT01197560|516592546|FG000|Overall Study|Adverse Event|6|||
143285169|NCT01197560|516592547|FG001|Overall Study|Adverse Event|8|||
143285170|NCT01197560|516592546|FG000|Overall Study|Death|3|||
143285171|NCT01197560|516592547|FG001|Overall Study|Death|5|||
143285172|NCT01197560|516592546|FG000|Overall Study|Withdrawal by Subject|1|||
143285173|NCT01197560|516592547|FG001|Overall Study|Withdrawal by Subject|1|||
143285174|NCT01197560|516592546|FG000|Overall Study|Disease progression|40|||
143285175|NCT01197560|516592547|FG001|Overall Study|Disease progression|35|||
143285176|NCT01197560|516592546|FG000|Overall Study|Miscellaneous|4|||
143285177|NCT01197560|516592547|FG001|Overall Study|Miscellaneous|3|||
143285178|NCT01197560|516592546|FG000|Overall Study|Missing|0|||
143285179|NCT01197560|516592547|FG001|Overall Study|Missing|1|||
143285180|NCT00006237|516592548|FG000|Overall Study|Adverse Event|39|||
143285181|NCT00006237|516592549|FG001|Overall Study|Adverse Event|29|||
143285182|NCT00006237|516592548|FG000|Overall Study|Death|1|||
143285183|NCT00006237|516592549|FG001|Overall Study|Death|0|||
143285184|NCT00006237|516592548|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
143285185|NCT00006237|516592549|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
143285186|NCT00006237|516592548|FG000|Overall Study|Progression/relapse|54|||
143285187|NCT00006237|516592549|FG001|Overall Study|Progression/relapse|2|||
143285188|NCT00006237|516592548|FG000|Overall Study|Not eligible|9|||
143285189|NCT00006237|516592549|FG001|Overall Study|Not eligible|20|||
143285190|NCT00006237|516592548|FG000|Overall Study|Withdrawal by Subject|0|||
143285191|NCT00006237|516592549|FG001|Overall Study|Withdrawal by Subject|1|||
143285192|NCT00006237|516592548|FG000|Overall Study|Not protocol specified|14|||
143285193|NCT00006237|516592549|FG001|Overall Study|Not protocol specified|5|||
143285194|NCT03727347|516592550|FG000|Overall Study|Withdrawal by Subject|2|||
143285195|NCT03727347|516592550|FG000|Overall Study|Lost to Follow-up|1|||
143285196|NCT01846416|516592555|FG000|Treatment Phase|Death|2|||
143285197|NCT01846416|516592556|FG001|Treatment Phase|Death|9|||
143285198|NCT01846416|516592557|FG002|Treatment Phase|Death|1|||
143285199|NCT01846416|516592555|FG000|Treatment Phase|Withdrawal by Subject|2|||
143285200|NCT01846416|516592556|FG001|Treatment Phase|Withdrawal by Subject|4|||
143285201|NCT01846416|516592557|FG002|Treatment Phase|Withdrawal by Subject|2|||
143285202|NCT01846416|516592555|FG000|Treatment Phase|Other|1|||
143285203|NCT01846416|516592556|FG001|Treatment Phase|Other|5|||
143285204|NCT01846416|516592557|FG002|Treatment Phase|Other|1|||
143285205|NCT01846416|516592555|FG000|Treatment Phase|Physician Decision|1|||
143285206|NCT01846416|516592556|FG001|Treatment Phase|Physician Decision|2|||
143285207|NCT01846416|516592557|FG002|Treatment Phase|Physician Decision|0|||
143285208|NCT01846416|516592555|FG000|Treatment Phase|Adverse Event|3|||
143285209|NCT01846416|516592556|FG001|Treatment Phase|Adverse Event|4|||
143285210|NCT01846416|516592557|FG002|Treatment Phase|Adverse Event|0|||
143285211|NCT01846416|516592555|FG000|Treatment Phase|Non-compliance|0|||
143285212|NCT01846416|516592556|FG001|Treatment Phase|Non-compliance|2|||
143285213|NCT01846416|516592557|FG002|Treatment Phase|Non-compliance|0|||
143285214|NCT01846416|516592555|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
143285215|NCT01846416|516592556|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
143285216|NCT01846416|516592557|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
143285217|NCT01846416|516592555|FG000|Treatment Phase|Progressive Disease|21|||
143285218|NCT01846416|516592556|FG001|Treatment Phase|Progressive Disease|63|||
143285219|NCT01846416|516592557|FG002|Treatment Phase|Progressive Disease|9|||
143285220|NCT01846416|516592555|FG000|Survival Follow-up|Death|21|||
143285221|NCT01846416|516592556|FG001|Survival Follow-up|Death|62|||
143285222|NCT01846416|516592557|FG002|Survival Follow-up|Death|9|||
143285223|NCT01846416|516592555|FG000|Survival Follow-up|Lost to Follow-up|0|||
143285224|NCT01846416|516592556|FG001|Survival Follow-up|Lost to Follow-up|2|||
143285225|NCT01846416|516592557|FG002|Survival Follow-up|Lost to Follow-up|2|||
143285226|NCT01846416|516592555|FG000|Survival Follow-up|Withdrawal by Subject|2|||
143285227|NCT01846416|516592556|FG001|Survival Follow-up|Withdrawal by Subject|7|||
143285228|NCT01846416|516592557|FG002|Survival Follow-up|Withdrawal by Subject|0|||
143373354|NCT01317420|516911449|FG009|Overall Study|Progressive disease according to RECIST|2|||
143285229|NCT01846416|516592555|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
143285230|NCT01846416|516592556|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
143285231|NCT01846416|516592557|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
143285232|NCT01846416|516592555|FG000|Survival Follow-up|Other|3|||
143285233|NCT01846416|516592556|FG001|Survival Follow-up|Other|1|||
143285234|NCT01846416|516592557|FG002|Survival Follow-up|Other|1|||
143285235|NCT00211510|516592558|FG000|Overall Study|Physician Decision|3|||
143285236|NCT00211510|516592559|FG001|Overall Study|Physician Decision|1|||
143285237|NCT00211510|516592558|FG000|Overall Study|Withdrawal by Subject|3|||
143285238|NCT00211510|516592559|FG001|Overall Study|Withdrawal by Subject|1|||
143285239|NCT01487200|516592560|FG000|Overall Study|Withdrawal by Subject|0|||
143285240|NCT01487200|516592561|FG001|Overall Study|Withdrawal by Subject|1|||
143285241|NCT01487200|516592562|FG002|Overall Study|Withdrawal by Subject|0|||
143285242|NCT01487200|516592563|FG003|Overall Study|Withdrawal by Subject|0|||
143285243|NCT02837783|516592564|FG000|Overall Study|Adverse Event|1|||
143285244|NCT02837783|516592565|FG001|Overall Study|Adverse Event|0|||
143285245|NCT02837783|516592564|FG000|Overall Study|Other, Not Specified|1|||
143285246|NCT02837783|516592565|FG001|Overall Study|Other, Not Specified|2|||
143285247|NCT01962896|516592566|FG000|Overall Study|Lack of Efficacy|4|||
143285248|NCT02207244|516592569|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
143285249|NCT02207244|516592570|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
143285250|NCT02207244|516592571|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
143285251|NCT02207244|516592572|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
143285252|NCT02207244|516592573|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
143285253|NCT02207244|516592574|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
143285254|NCT02207244|516592575|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
143285255|NCT02207244|516592576|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
143285256|NCT02207244|516592577|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
143285257|NCT02207244|516592578|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
143285258|NCT02207244|516592579|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
143285259|NCT02207244|516592569|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
143285260|NCT02207244|516592570|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
143285261|NCT02207244|516592571|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
143285262|NCT02207244|516592572|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
143285263|NCT02207244|516592573|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
143285264|NCT02207244|516592574|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
143285265|NCT02207244|516592575|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
143285266|NCT02207244|516592576|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
143285267|NCT02207244|516592577|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
143285268|NCT02207244|516592578|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
143285269|NCT02207244|516592579|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
143285270|NCT02207244|516592569|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
143285271|NCT02207244|516592570|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
143285272|NCT02207244|516592571|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
143285273|NCT02207244|516592572|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
143285274|NCT02207244|516592573|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
143285275|NCT02207244|516592574|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
143285276|NCT02207244|516592575|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
143285277|NCT02207244|516592576|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
143285278|NCT02207244|516592577|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
143285279|NCT02207244|516592578|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
143285280|NCT02207244|516592579|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
143285281|NCT02207244|516592569|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
143285282|NCT02207244|516592570|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
143285283|NCT02207244|516592571|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
143285284|NCT02207244|516592572|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
143285285|NCT02207244|516592573|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
143285286|NCT02207244|516592574|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
143285287|NCT02207244|516592575|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
143285288|NCT02207244|516592576|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
143285289|NCT02207244|516592577|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
143285290|NCT02207244|516592578|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
143285291|NCT02207244|516592579|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
143285292|NCT02207244|516592569|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
143285293|NCT02207244|516592570|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
143285294|NCT02207244|516592571|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
143285295|NCT02207244|516592572|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
143285296|NCT02207244|516592573|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
143285297|NCT02207244|516592574|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
143373355|NCT01317420|516911450|FG010|Overall Study|Progressive disease according to RECIST|3|||
143373356|NCT01317420|516911451|FG011|Overall Study|Progressive disease according to RECIST|11|||
143285298|NCT02207244|516592575|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
143285299|NCT02207244|516592576|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
143285300|NCT02207244|516592577|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
143285301|NCT02207244|516592578|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
143285302|NCT02207244|516592579|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
143285303|NCT02207244|516592569|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
143285304|NCT02207244|516592570|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
143285305|NCT02207244|516592571|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
143285306|NCT02207244|516592572|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
143285307|NCT02207244|516592573|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
143285308|NCT02207244|516592574|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
143285309|NCT02207244|516592575|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
143285310|NCT02207244|516592576|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
143285311|NCT02207244|516592577|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
143285312|NCT02207244|516592578|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
143285313|NCT02207244|516592579|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
143285314|NCT02207244|516592569|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
143285315|NCT02207244|516592570|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
143285316|NCT02207244|516592571|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
143285317|NCT02207244|516592572|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
143285318|NCT02207244|516592573|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
143285319|NCT02207244|516592574|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
143285320|NCT02207244|516592575|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
143285321|NCT02207244|516592576|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
143285322|NCT02207244|516592577|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
143285323|NCT02207244|516592578|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
143285324|NCT02207244|516592579|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
143285325|NCT02207244|516592569|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
143285326|NCT02207244|516592570|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
143285327|NCT02207244|516592571|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
143285328|NCT02207244|516592572|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
143285329|NCT02207244|516592573|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
143285330|NCT02207244|516592574|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
143285331|NCT02207244|516592575|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
143285332|NCT02207244|516592576|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
143285333|NCT02207244|516592577|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
143285334|NCT02207244|516592578|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
143285335|NCT02207244|516592579|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
143285336|NCT02207244|516592569|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
143285337|NCT02207244|516592570|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
143285338|NCT02207244|516592571|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
143285339|NCT02207244|516592572|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
143285340|NCT02207244|516592573|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
143285341|NCT02207244|516592574|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
143285342|NCT02207244|516592575|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
143285343|NCT02207244|516592576|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
143285344|NCT02207244|516592577|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
143285345|NCT02207244|516592578|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
143285346|NCT02207244|516592579|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
143285347|NCT02207244|516592569|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
143285348|NCT02207244|516592570|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
143285349|NCT02207244|516592571|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
143285350|NCT02207244|516592572|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
143285351|NCT02207244|516592573|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
143285352|NCT02207244|516592574|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
143285353|NCT02207244|516592575|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
143285354|NCT02207244|516592576|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
143285355|NCT02207244|516592577|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
143285356|NCT02207244|516592578|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
143285357|NCT02207244|516592579|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
143373357|NCT01317420|516911452|FG012|Overall Study|Progressive disease according to RECIST|16|||
143373358|NCT01317420|516911440|FG000|Overall Study|Other adverse event|1|||
143373359|NCT01317420|516911441|FG001|Overall Study|Other adverse event|0|||
143373360|NCT01317420|516911442|FG002|Overall Study|Other adverse event|0|||
143373361|NCT01317420|516911443|FG003|Overall Study|Other adverse event|0|||
143373362|NCT01317420|516911444|FG004|Overall Study|Other adverse event|0|||
143373363|NCT01317420|516911445|FG005|Overall Study|Other adverse event|0|||
143373364|NCT01317420|516911446|FG006|Overall Study|Other adverse event|0|||
143373365|NCT01317420|516911447|FG007|Overall Study|Other adverse event|0|||
143373366|NCT01317420|516911448|FG008|Overall Study|Other adverse event|0|||
143373367|NCT01317420|516911449|FG009|Overall Study|Other adverse event|0|||
143373368|NCT01317420|516911450|FG010|Overall Study|Other adverse event|0|||
143373369|NCT01317420|516911451|FG011|Overall Study|Other adverse event|0|||
143373370|NCT01317420|516911452|FG012|Overall Study|Other adverse event|2|||
143285358|NCT02207244|516592569|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
143285359|NCT02207244|516592570|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
143285360|NCT02207244|516592571|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
143285361|NCT02207244|516592572|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
143285362|NCT02207244|516592573|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
143285363|NCT02207244|516592574|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
143285364|NCT02207244|516592575|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
143285365|NCT02207244|516592576|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
143285366|NCT02207244|516592577|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
143285367|NCT02207244|516592578|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
143285368|NCT02207244|516592579|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
143285369|NCT02207244|516592569|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
143285370|NCT02207244|516592570|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
143285371|NCT02207244|516592571|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
143285372|NCT02207244|516592572|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
143285373|NCT02207244|516592573|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
143285374|NCT02207244|516592574|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
143285375|NCT02207244|516592575|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
143285376|NCT02207244|516592576|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
143285377|NCT02207244|516592577|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
143285378|NCT02207244|516592578|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
143285379|NCT02207244|516592579|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
143285380|NCT02207244|516592569|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
143285381|NCT02207244|516592570|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
143285382|NCT02207244|516592571|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
143285383|NCT02207244|516592572|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
143285384|NCT02207244|516592573|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
143285385|NCT02207244|516592574|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
143285386|NCT02207244|516592575|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
143285387|NCT02207244|516592576|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
143285388|NCT02207244|516592577|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
143285389|NCT02207244|516592578|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
143285390|NCT02207244|516592579|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
143285391|NCT02207244|516592569|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
143285392|NCT02207244|516592570|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
143285393|NCT02207244|516592571|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
143285394|NCT02207244|516592572|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
143285395|NCT02207244|516592573|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
143285396|NCT02207244|516592574|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
143285397|NCT02207244|516592575|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
143285398|NCT02207244|516592576|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
143285399|NCT02207244|516592577|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
143285400|NCT02207244|516592578|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
143285401|NCT02207244|516592579|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
143285402|NCT02207244|516592569|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
143285403|NCT02207244|516592570|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
143285404|NCT02207244|516592571|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
143285405|NCT02207244|516592572|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
143373371|NCT01317420|516911440|FG000|Overall Study|Non-compliant with protocol|0|||
143285406|NCT02207244|516592573|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
143285407|NCT02207244|516592574|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
143285408|NCT02207244|516592575|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
143285409|NCT02207244|516592576|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
143285410|NCT02207244|516592577|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
143285411|NCT02207244|516592578|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
143285412|NCT02207244|516592579|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
143285413|NCT02207244|516592569|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
143285414|NCT02207244|516592570|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
143285415|NCT02207244|516592571|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
143285416|NCT02207244|516592572|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
143285417|NCT02207244|516592573|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
143285418|NCT02207244|516592574|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
143373372|NCT01317420|516911441|FG001|Overall Study|Non-compliant with protocol|0|||
143373373|NCT01317420|516911442|FG002|Overall Study|Non-compliant with protocol|0|||
143373374|NCT01317420|516911443|FG003|Overall Study|Non-compliant with protocol|0|||
143373375|NCT01317420|516911444|FG004|Overall Study|Non-compliant with protocol|0|||
143373376|NCT01317420|516911445|FG005|Overall Study|Non-compliant with protocol|0|||
143373377|NCT01317420|516911446|FG006|Overall Study|Non-compliant with protocol|0|||
143373378|NCT01317420|516911447|FG007|Overall Study|Non-compliant with protocol|0|||
143373379|NCT01317420|516911448|FG008|Overall Study|Non-compliant with protocol|0|||
143373380|NCT01317420|516911449|FG009|Overall Study|Non-compliant with protocol|0|||
143373381|NCT01317420|516911450|FG010|Overall Study|Non-compliant with protocol|0|||
143373382|NCT01317420|516911451|FG011|Overall Study|Non-compliant with protocol|0|||
143373383|NCT01317420|516911452|FG012|Overall Study|Non-compliant with protocol|1|||
143373384|NCT01317420|516911440|FG000|Overall Study|Refused to cont. taking trial medication|0|||
143373385|NCT01317420|516911441|FG001|Overall Study|Refused to cont. taking trial medication|0|||
143373386|NCT01317420|516911442|FG002|Overall Study|Refused to cont. taking trial medication|0|||
143373387|NCT01317420|516911443|FG003|Overall Study|Refused to cont. taking trial medication|0|||
143373388|NCT01317420|516911444|FG004|Overall Study|Refused to cont. taking trial medication|0|||
143373389|NCT01317420|516911445|FG005|Overall Study|Refused to cont. taking trial medication|0|||
143373390|NCT01317420|516911446|FG006|Overall Study|Refused to cont. taking trial medication|0|||
143373391|NCT01317420|516911447|FG007|Overall Study|Refused to cont. taking trial medication|0|||
143373392|NCT01317420|516911448|FG008|Overall Study|Refused to cont. taking trial medication|0|||
143373393|NCT01317420|516911449|FG009|Overall Study|Refused to cont. taking trial medication|0|||
143373394|NCT01317420|516911450|FG010|Overall Study|Refused to cont. taking trial medication|0|||
143373395|NCT01317420|516911451|FG011|Overall Study|Refused to cont. taking trial medication|0|||
143373396|NCT01317420|516911452|FG012|Overall Study|Refused to cont. taking trial medication|1|||
143373397|NCT01317420|516911440|FG000|Overall Study|Reason other than those specified|0|||
143373398|NCT01317420|516911441|FG001|Overall Study|Reason other than those specified|0|||
143373399|NCT01317420|516911442|FG002|Overall Study|Reason other than those specified|0|||
143373400|NCT01317420|516911443|FG003|Overall Study|Reason other than those specified|0|||
143373401|NCT01317420|516911444|FG004|Overall Study|Reason other than those specified|0|||
143373402|NCT01317420|516911445|FG005|Overall Study|Reason other than those specified|0|||
143373403|NCT01317420|516911446|FG006|Overall Study|Reason other than those specified|0|||
143373404|NCT01317420|516911447|FG007|Overall Study|Reason other than those specified|0|||
143373405|NCT01317420|516911448|FG008|Overall Study|Reason other than those specified|0|||
143373406|NCT01317420|516911449|FG009|Overall Study|Reason other than those specified|1|||
143373407|NCT01317420|516911450|FG010|Overall Study|Reason other than those specified|0|||
143373408|NCT01317420|516911451|FG011|Overall Study|Reason other than those specified|0|||
143373409|NCT01317420|516911452|FG012|Overall Study|Reason other than those specified|0|||
143373410|NCT05686421|516911453|FG000|Overall Study|Screen failure|22|||
143373411|NCT05686421|516911454|FG001|Overall Study|Screen failure|0|||
143373412|NCT05686421|516911455|FG002|Overall Study|Screen failure|0|||
143373413|NCT05686421|516911456|FG003|Overall Study|Screen failure|0|||
143373414|NCT00857649|516911457|FG000|Overall Study|Adverse Event|15|||
143373415|NCT00857649|516911458|FG001|Overall Study|Adverse Event|10|||
143373416|NCT00857649|516911457|FG000|Overall Study|Non-compliance|1|||
143373417|NCT00857649|516911458|FG001|Overall Study|Non-compliance|1|||
143373418|NCT00857649|516911457|FG000|Overall Study|Protocol Violation|2|||
143373419|NCT00857649|516911458|FG001|Overall Study|Protocol Violation|2|||
143373420|NCT00857649|516911457|FG000|Overall Study|Withdrawal of Consent|10|||
143373421|NCT00857649|516911458|FG001|Overall Study|Withdrawal of Consent|7|||
143373422|NCT00857649|516911457|FG000|Overall Study|Nursing Home Placement|2|||
143373423|NCT00857649|516911458|FG001|Overall Study|Nursing Home Placement|9|||
143373424|NCT00857649|516911457|FG000|Overall Study|Other Reasons|1|||
143285419|NCT02207244|516592575|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
143285420|NCT02207244|516592576|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
143285421|NCT02207244|516592577|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
143285422|NCT02207244|516592578|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
143285423|NCT02207244|516592579|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
143285424|NCT02207244|516592569|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
143285425|NCT02207244|516592570|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
143285426|NCT02207244|516592571|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
143285427|NCT02207244|516592572|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
143285428|NCT02207244|516592573|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
143285429|NCT02207244|516592574|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
143285430|NCT02207244|516592575|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
143285431|NCT02207244|516592576|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
143285432|NCT02207244|516592577|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
143285433|NCT02207244|516592578|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
143285434|NCT02207244|516592579|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
143285435|NCT02207244|516592569|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
143285436|NCT02207244|516592570|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
143285437|NCT02207244|516592571|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
143285438|NCT02207244|516592572|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
143285439|NCT02207244|516592573|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
143285440|NCT02207244|516592574|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
143285441|NCT02207244|516592575|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
143285442|NCT02207244|516592576|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
143285443|NCT02207244|516592577|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
143285444|NCT02207244|516592578|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
143285445|NCT02207244|516592579|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
143285446|NCT02207244|516592569|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
143285447|NCT02207244|516592570|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
143285448|NCT02207244|516592571|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
143285449|NCT02207244|516592572|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
143285450|NCT02207244|516592573|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
143285451|NCT02207244|516592574|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
143285452|NCT02207244|516592575|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
143285453|NCT02207244|516592576|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
143285454|NCT02207244|516592577|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
143285455|NCT02207244|516592578|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
143285456|NCT02207244|516592579|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
143285457|NCT02207244|516592569|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
143285458|NCT02207244|516592570|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
143285459|NCT02207244|516592571|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
143285460|NCT02207244|516592572|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
143285461|NCT02207244|516592573|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
143285462|NCT02207244|516592574|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
143285463|NCT02207244|516592575|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
143285464|NCT02207244|516592576|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
143285465|NCT02207244|516592577|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
143285466|NCT02207244|516592578|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
143285467|NCT02207244|516592579|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
143285468|NCT02207244|516592569|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
143285469|NCT02207244|516592570|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
143285470|NCT02207244|516592571|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
143285471|NCT02207244|516592572|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
143285472|NCT02207244|516592573|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
143285473|NCT02207244|516592574|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
143285474|NCT02207244|516592575|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
143285475|NCT02207244|516592576|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
143285476|NCT02207244|516592577|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
143285477|NCT02207244|516592578|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
143285478|NCT02207244|516592579|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
143285479|NCT02207244|516592569|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
143285480|NCT02207244|516592570|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
143285481|NCT02207244|516592571|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
143285482|NCT02207244|516592572|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
143373425|NCT00857649|516911458|FG001|Overall Study|Other Reasons|3|||
143285483|NCT02207244|516592573|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
143285484|NCT02207244|516592574|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
143285485|NCT02207244|516592575|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
143285486|NCT02207244|516592576|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
143285487|NCT02207244|516592577|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
143285488|NCT02207244|516592578|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
143285489|NCT02207244|516592579|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
143285490|NCT02207244|516592569|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
143285491|NCT02207244|516592570|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
143285492|NCT02207244|516592571|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
143285493|NCT02207244|516592572|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
143285494|NCT02207244|516592573|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
143285495|NCT02207244|516592574|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
143285496|NCT02207244|516592575|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
143285497|NCT02207244|516592576|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
143285498|NCT02207244|516592577|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
143285499|NCT02207244|516592578|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
143285500|NCT02207244|516592579|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
143285501|NCT02207244|516592569|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
143285502|NCT02207244|516592570|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
143285503|NCT02207244|516592571|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
143285504|NCT02207244|516592572|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
143285505|NCT02207244|516592573|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
143285506|NCT02207244|516592574|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
143285507|NCT02207244|516592575|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
143285508|NCT02207244|516592576|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
143285509|NCT02207244|516592577|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
143285510|NCT02207244|516592578|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
143285511|NCT02207244|516592579|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
143285512|NCT02207244|516592569|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
143285513|NCT02207244|516592570|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
143285514|NCT02207244|516592571|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
143285515|NCT02207244|516592572|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
143285516|NCT02207244|516592573|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
143285517|NCT02207244|516592574|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
143285518|NCT02207244|516592575|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
143285519|NCT02207244|516592576|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
143285520|NCT02207244|516592577|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
143285521|NCT02207244|516592578|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
143285522|NCT02207244|516592579|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
143285523|NCT02207244|516592569|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
143285524|NCT02207244|516592570|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
143285525|NCT02207244|516592571|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
143285526|NCT02207244|516592572|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
143285527|NCT02207244|516592573|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
143285528|NCT02207244|516592574|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
143285529|NCT02207244|516592575|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
143285530|NCT02207244|516592576|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
143285531|NCT02207244|516592577|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
143285532|NCT02207244|516592578|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
143285533|NCT02207244|516592579|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
143285534|NCT02207244|516592569|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
143285535|NCT02207244|516592570|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
143285536|NCT02207244|516592571|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
143285537|NCT02207244|516592572|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
143285538|NCT02207244|516592573|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
143285539|NCT02207244|516592574|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
143285540|NCT02207244|516592575|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
143285541|NCT02207244|516592576|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
143373426|NCT05190419|516911459|FG000|Overall Study|Lack of Efficacy|8|||
143373427|NCT05190419|516911460|FG001|Overall Study|Lack of Efficacy|0|||
143285542|NCT02207244|516592577|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
143285543|NCT02207244|516592578|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
143285544|NCT02207244|516592579|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
143285545|NCT02207244|516592569|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
143285546|NCT02207244|516592570|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
143285547|NCT02207244|516592571|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
143285548|NCT02207244|516592572|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
143285549|NCT02207244|516592573|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
143285550|NCT02207244|516592574|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
143285551|NCT02207244|516592575|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
143285552|NCT02207244|516592576|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
143285553|NCT02207244|516592577|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
143285554|NCT02207244|516592578|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
143285555|NCT02207244|516592579|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
143285556|NCT02207244|516592569|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
143285557|NCT02207244|516592570|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
143285558|NCT02207244|516592571|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
143285559|NCT02207244|516592572|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
143285560|NCT02207244|516592573|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
143285561|NCT02207244|516592574|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
143285562|NCT02207244|516592575|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
143285563|NCT02207244|516592576|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
143285564|NCT02207244|516592577|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
143285565|NCT02207244|516592578|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
143285566|NCT02207244|516592579|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
143285567|NCT02216591|516592580|FG000|Overall Study|Lost to Follow-up|0|||
143285568|NCT02216591|516592581|FG001|Overall Study|Lost to Follow-up|1|||
143285569|NCT02521870|516592583|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
143285570|NCT02521870|516592584|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
143285571|NCT02521870|516592585|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
143285572|NCT02521870|516592586|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
143285573|NCT02521870|516592587|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
143285574|NCT02521870|516592588|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
143285575|NCT02521870|516592589|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
143285576|NCT02521870|516592590|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
143285577|NCT02521870|516592591|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
143285578|NCT02521870|516592592|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
143285579|NCT02521870|516592593|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
143285580|NCT02521870|516592594|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
143373428|NCT05190419|516911461|FG002|Overall Study|Lack of Efficacy|1|||
143373429|NCT05190419|516911462|FG003|Overall Study|Lack of Efficacy|0|||
143373430|NCT05190419|516911459|FG000|Overall Study|Withdrawal by Subject|7|||
143373431|NCT05190419|516911460|FG001|Overall Study|Withdrawal by Subject|1|||
143373432|NCT05190419|516911461|FG002|Overall Study|Withdrawal by Subject|2|||
143373433|NCT05190419|516911462|FG003|Overall Study|Withdrawal by Subject|2|||
143373434|NCT05190419|516911459|FG000|Overall Study|Adverse Event|2|||
143373435|NCT05190419|516911460|FG001|Overall Study|Adverse Event|10|||
143373436|NCT05190419|516911461|FG002|Overall Study|Adverse Event|11|||
143373437|NCT05190419|516911462|FG003|Overall Study|Adverse Event|21|||
143373438|NCT05190419|516911459|FG000|Overall Study|Lost to Follow-up|1|||
143373439|NCT05190419|516911460|FG001|Overall Study|Lost to Follow-up|2|||
143373440|NCT05190419|516911461|FG002|Overall Study|Lost to Follow-up|3|||
143373441|NCT05190419|516911462|FG003|Overall Study|Lost to Follow-up|1|||
143373442|NCT05190419|516911459|FG000|Overall Study|Other|1|||
143373443|NCT05190419|516911460|FG001|Overall Study|Other|1|||
143373444|NCT05190419|516911461|FG002|Overall Study|Other|0|||
143373445|NCT05190419|516911462|FG003|Overall Study|Other|3|||
143373446|NCT00367055|516911466|FG000|Overall Study|Adverse Event|6|||
143373447|NCT00367055|516911467|FG001|Overall Study|Adverse Event|3|||
143373448|NCT00367055|516911466|FG000|Overall Study|Patient's Willing|3|||
143373449|NCT00367055|516911467|FG001|Overall Study|Patient's Willing|2|||
143373450|NCT00367055|516911466|FG000|Overall Study|Lack of Efficacy|1|||
143373451|NCT00367055|516911467|FG001|Overall Study|Lack of Efficacy|2|||
143373452|NCT00367055|516911466|FG000|Overall Study|Lost to Follow-up|1|||
143373453|NCT00367055|516911467|FG001|Overall Study|Lost to Follow-up|1|||
143373454|NCT00367055|516911466|FG000|Overall Study|Protocol Violation|0|||
143373455|NCT00367055|516911467|FG001|Overall Study|Protocol Violation|1|||
143373456|NCT00367055|516911466|FG000|Overall Study|Stopping Criterion Met|0|||
143373457|NCT00367055|516911467|FG001|Overall Study|Stopping Criterion Met|1|||
143373458|NCT00367055|516911466|FG000|Overall Study|Participant Living too Far from Hospital|0|||
143285581|NCT02521870|516592583|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
143285582|NCT02521870|516592584|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
143285583|NCT02521870|516592585|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
143373459|NCT00367055|516911467|FG001|Overall Study|Participant Living too Far from Hospital|1|||
143373460|NCT04707313|516911468|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
143285584|NCT02521870|516592586|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
143285585|NCT02521870|516592587|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
143285586|NCT02521870|516592588|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
143285587|NCT02521870|516592589|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
143285588|NCT02521870|516592590|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
143285589|NCT02521870|516592591|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
143285590|NCT02521870|516592592|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
143285591|NCT02521870|516592593|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
143285592|NCT02521870|516592594|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
143285593|NCT02521870|516592583|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
143285594|NCT02521870|516592584|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
143285595|NCT02521870|516592585|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
143285596|NCT02521870|516592586|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
143285597|NCT02521870|516592587|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
143285598|NCT02521870|516592588|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
143285599|NCT02521870|516592589|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
143285600|NCT02521870|516592590|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
143285601|NCT02521870|516592591|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
143285602|NCT02521870|516592592|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
143285603|NCT02521870|516592593|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
143285604|NCT02521870|516592594|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
143285605|NCT02521870|516592583|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
143285606|NCT02521870|516592584|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
143285607|NCT02521870|516592585|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
143285608|NCT02521870|516592586|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
143285609|NCT02521870|516592587|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
143285610|NCT02521870|516592588|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
143285611|NCT02521870|516592589|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
143285612|NCT02521870|516592590|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
143285613|NCT02521870|516592591|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
143285614|NCT02521870|516592592|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
143285615|NCT02521870|516592593|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
143285616|NCT02521870|516592594|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
143285617|NCT02521870|516592583|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
143285618|NCT02521870|516592584|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
143285619|NCT02521870|516592585|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
143285620|NCT02521870|516592586|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
143285621|NCT02521870|516592587|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
143285622|NCT02521870|516592588|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
143285623|NCT02521870|516592589|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
143285624|NCT02521870|516592590|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
143285625|NCT02521870|516592591|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
143285626|NCT02521870|516592592|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
143285627|NCT02521870|516592593|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
143285628|NCT02521870|516592594|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
143285629|NCT02521870|516592583|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
143285630|NCT02521870|516592584|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
143285631|NCT02521870|516592585|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
143285632|NCT02521870|516592586|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
143285633|NCT02521870|516592587|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
143285634|NCT02521870|516592588|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
143285635|NCT02521870|516592589|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
143285636|NCT02521870|516592590|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
143285637|NCT02521870|516592591|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
143285638|NCT02521870|516592592|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
143285639|NCT02521870|516592593|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
143285640|NCT02521870|516592594|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
143285641|NCT02521870|516592583|FG000|Phase 2: Dose Expansion|Death|0|||
143285642|NCT02521870|516592584|FG001|Phase 2: Dose Expansion|Death|0|||
143285643|NCT02521870|516592585|FG002|Phase 2: Dose Expansion|Death|0|||
143285644|NCT02521870|516592586|FG003|Phase 2: Dose Expansion|Death|0|||
143285645|NCT02521870|516592587|FG004|Phase 2: Dose Expansion|Death|1|||
143285646|NCT02521870|516592588|FG005|Phase 2: Dose Expansion|Death|1|||
143285647|NCT02521870|516592589|FG006|Phase 2: Dose Expansion|Death|3|||
143285648|NCT02521870|516592590|FG007|Phase 2: Dose Expansion|Death|1|||
143285649|NCT02521870|516592591|FG008|Phase 2: Dose Expansion|Death|1|||
143285650|NCT02521870|516592592|FG009|Phase 2: Dose Expansion|Death|5|||
143285651|NCT02521870|516592593|FG010|Phase 2: Dose Expansion|Death|2|||
143285652|NCT02521870|516592594|FG011|Phase 2: Dose Expansion|Death|2|||
143285653|NCT02521870|516592583|FG000|Phase 2: Dose Expansion|Other|0|||
143285654|NCT02521870|516592584|FG001|Phase 2: Dose Expansion|Other|0|||
143285655|NCT02521870|516592585|FG002|Phase 2: Dose Expansion|Other|0|||
143285656|NCT02521870|516592586|FG003|Phase 2: Dose Expansion|Other|0|||
143285657|NCT02521870|516592587|FG004|Phase 2: Dose Expansion|Other|10|||
143285658|NCT02521870|516592588|FG005|Phase 2: Dose Expansion|Other|3|||
143285659|NCT02521870|516592589|FG006|Phase 2: Dose Expansion|Other|2|||
143285660|NCT02521870|516592590|FG007|Phase 2: Dose Expansion|Other|0|||
143285661|NCT02521870|516592591|FG008|Phase 2: Dose Expansion|Other|10|||
143285662|NCT02521870|516592592|FG009|Phase 2: Dose Expansion|Other|5|||
143285663|NCT02521870|516592593|FG010|Phase 2: Dose Expansion|Other|1|||
143285664|NCT02521870|516592594|FG011|Phase 2: Dose Expansion|Other|7|||
143285665|NCT02521870|516592583|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
143285666|NCT02521870|516592584|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
143285667|NCT02521870|516592585|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
143285668|NCT02521870|516592586|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
143285669|NCT02521870|516592587|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
143285670|NCT02521870|516592588|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
143285671|NCT02521870|516592589|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
143285672|NCT02521870|516592590|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
143285673|NCT02521870|516592591|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
143285674|NCT02521870|516592592|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
143285675|NCT02521870|516592593|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
143285676|NCT02521870|516592594|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
143285677|NCT02521870|516592583|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
143285678|NCT02521870|516592584|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
143285679|NCT02521870|516592585|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
143285680|NCT02521870|516592586|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
143285681|NCT02521870|516592587|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
143285682|NCT02521870|516592588|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
143285683|NCT02521870|516592589|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
143285684|NCT02521870|516592590|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
143285685|NCT02521870|516592591|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
143285686|NCT02521870|516592592|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
143285687|NCT02521870|516592593|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
143285688|NCT02521870|516592594|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
143285689|NCT04404361|516592596|FG000|Overall Study|Death|12|||
143285690|NCT04404361|516592597|FG001|Overall Study|Death|12|||
143285691|NCT04404361|516592596|FG000|Overall Study|Withdrawal by Subject|13|||
143285692|NCT04404361|516592597|FG001|Overall Study|Withdrawal by Subject|5|||
143285693|NCT04404361|516592596|FG000|Overall Study|Lost to Follow-up|6|||
143285694|NCT04404361|516592597|FG001|Overall Study|Lost to Follow-up|3|||
143285695|NCT04404361|516592596|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
143285696|NCT04404361|516592597|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
143285697|NCT02862171|516592598|FG000|Overall Study|Death|1|||
143285698|NCT02862171|516592598|FG000|Overall Study|Lost to Follow-up|13|||
143285699|NCT02862171|516592598|FG000|Overall Study|Withdrawal by Subject|57|||
143285700|NCT02862171|516592598|FG000|Overall Study|Non-compliance|4|||
143285701|NCT02862171|516592598|FG000|Overall Study|HIV-1 seroconversion|18|||
143285702|NCT02144012|516592600|FG000|Overall Study|Adverse Event|1|||
143285703|NCT02144012|516592601|FG001|Overall Study|Adverse Event|0|||
143285704|NCT02144012|516592600|FG000|Overall Study|Death|1|||
143285705|NCT02144012|516592601|FG001|Overall Study|Death|0|||
143285706|NCT02144012|516592600|FG000|Overall Study|Withdrawal by Subject|11|||
143285707|NCT02144012|516592601|FG001|Overall Study|Withdrawal by Subject|3|||
143285708|NCT02144012|516592600|FG000|Overall Study|Study Terminated by Sponsor|18|||
143285709|NCT02144012|516592601|FG001|Overall Study|Study Terminated by Sponsor|12|||
143285710|NCT02144012|516592600|FG000|Overall Study|Other|3|||
143285711|NCT02144012|516592601|FG001|Overall Study|Other|0|||
143285712|NCT02846779|516592604|FG000|Overall Study|Lost Enrollment|83|||
143285713|NCT02846779|516592605|FG001|Overall Study|Lost Enrollment|82|||
143285714|NCT02846779|516592606|FG002|Overall Study|Lost Enrollment|86|||
143285715|NCT02846779|516592604|FG000|Overall Study|Less than 31 days of follow-up|56|||
143285716|NCT02846779|516592605|FG001|Overall Study|Less than 31 days of follow-up|45|||
143285717|NCT02846779|516592606|FG002|Overall Study|Less than 31 days of follow-up|52|||
143285718|NCT02324569|516594371|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
143285719|NCT02324569|516594372|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
143285720|NCT02324569|516594371|FG000|Overall Study|Voluntary Withdrawal|3|||
143285721|NCT02324569|516594372|FG001|Overall Study|Voluntary Withdrawal|6|||
143285722|NCT02324569|516594371|FG000|Overall Study|Lack of Efficacy|2|||
143285723|NCT02324569|516594372|FG001|Overall Study|Lack of Efficacy|3|||
143285724|NCT02324569|516594371|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
143285725|NCT02324569|516594372|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
143285726|NCT02324569|516594371|FG000|Overall Study|Inconvenient Schedule|2|||
143285727|NCT02324569|516594372|FG001|Overall Study|Inconvenient Schedule|0|||
143285728|NCT01943292|516594373|FG000|Overall Study|Withdrawal by Subject|1|||
143285729|NCT01943292|516594374|FG001|Overall Study|Withdrawal by Subject|0|||
143285730|NCT01943292|516594375|FG002|Overall Study|Withdrawal by Subject|0|||
143285731|NCT00638378|516594376|FG000|Overall Study|Death|2|||
143285732|NCT00638378|516594376|FG000|Overall Study|Adverse Event|1|||
143285733|NCT00638378|516594376|FG000|Overall Study|Disease progression|15|||
143285734|NCT00638378|516594376|FG000|Overall Study|Physician Decision|4|||
143285735|NCT00996216|516594377|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
143285736|NCT00996216|516594377|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
143285737|NCT00996216|516594377|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
143285738|NCT01342796|516594383|FG000|Overall Study|Withdrawal by Subject|2|||
143285739|NCT01342796|516594384|FG001|Overall Study|Withdrawal by Subject|0|||
143285740|NCT01342796|516594383|FG000|Overall Study|Lost to Follow-up|0|||
143285741|NCT01342796|516594384|FG001|Overall Study|Lost to Follow-up|3|||
143285742|NCT01342796|516594383|FG000|Overall Study|Inappropriate enrollment|1|||
143285743|NCT01342796|516594384|FG001|Overall Study|Inappropriate enrollment|0|||
143285744|NCT01599234|516594394|FG000|Overall Study|Adverse Event|9|||
143285745|NCT01599234|516594395|FG001|Overall Study|Adverse Event|5|||
143285746|NCT01599234|516594394|FG000|Overall Study|Withdrawal by Subject|2|||
143285747|NCT01599234|516594395|FG001|Overall Study|Withdrawal by Subject|1|||
143285748|NCT01599234|516594394|FG000|Overall Study|Lost to Follow-up|1|||
143285749|NCT01599234|516594395|FG001|Overall Study|Lost to Follow-up|2|||
143285750|NCT01599234|516594394|FG000|Overall Study|Lack of Efficacy|2|||
143285751|NCT01599234|516594395|FG001|Overall Study|Lack of Efficacy|4|||
143285752|NCT01599234|516594394|FG000|Overall Study|Unable to operate spray|1|||
143285753|NCT01599234|516594395|FG001|Overall Study|Unable to operate spray|0|||
143285754|NCT01599234|516594394|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
143285755|NCT01599234|516594395|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
143285756|NCT01599234|516594394|FG000|Overall Study|Death|1|||
143285757|NCT01599234|516594395|FG001|Overall Study|Death|0|||
143285758|NCT01599234|516594394|FG000|Overall Study|Patient would not stop driving|1|||
143285759|NCT01599234|516594395|FG001|Overall Study|Patient would not stop driving|0|||
143285760|NCT01599234|516594394|FG000|Overall Study|Contra-indication discovered|0|||
143285761|NCT01599234|516594395|FG001|Overall Study|Contra-indication discovered|1|||
143285762|NCT01599234|516594394|FG000|Overall Study|Pregnancy|0|||
143285763|NCT01599234|516594395|FG001|Overall Study|Pregnancy|1|||
143285764|NCT03902574|516594404|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
143285765|NCT03902574|516594405|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
143285766|NCT03902574|516594406|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
143285767|NCT04492618|516594409|FG000|Overall Study|Withdrawal by Subject|1|||
143285768|NCT03521934|516594410|FG000|Overall Study|Death|65|||
143285769|NCT03521934|516594411|FG001|Overall Study|Death|73|||
143285770|NCT03521934|516594410|FG000|Overall Study|Withdrawal by Subject|18|||
143285771|NCT03521934|516594411|FG001|Overall Study|Withdrawal by Subject|23|||
143285772|NCT03521934|516594410|FG000|Overall Study|Site Terminated by Sponsor|39|||
143285773|NCT03521934|516594411|FG001|Overall Study|Site Terminated by Sponsor|35|||
143285774|NCT03521934|516594410|FG000|Overall Study|Study Terminated by Sponsor|483|||
143285775|NCT03521934|516594411|FG001|Overall Study|Study Terminated by Sponsor|477|||
143285776|NCT03521934|516594410|FG000|Overall Study|Reason not Specified|3|||
143285777|NCT03521934|516594411|FG001|Overall Study|Reason not Specified|6|||
143285778|NCT02101060|516594412|FG000|Overall Study|Adverse Event|1|||
143285779|NCT02101060|516594413|FG001|Overall Study|Adverse Event|0|||
143285780|NCT02101060|516594412|FG000|Overall Study|Withdrawal by Subject|1|||
143285781|NCT02101060|516594413|FG001|Overall Study|Withdrawal by Subject|1|||
143285782|NCT02101060|516594412|FG000|Overall Study|Lost to Follow-up|3|||
143285783|NCT02101060|516594413|FG001|Overall Study|Lost to Follow-up|3|||
143285784|NCT04166435|516594414|FG000|Overall Study|2 patients ineligible for response|2|||
143285785|NCT01425281|516594422|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
143285786|NCT01425281|516594423|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
143285787|NCT01425281|516594422|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
143285788|NCT01425281|516594423|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
143285789|NCT01425281|516594422|FG000|At 180-day Clinical Follow-up|Death|0|||
143285790|NCT01425281|516594423|FG001|At 180-day Clinical Follow-up|Death|1|||
143285791|NCT01425281|516594422|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
143285792|NCT01425281|516594423|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
143285793|NCT01425281|516594422|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
143285794|NCT01425281|516594423|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
143285795|NCT01425281|516594422|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
143285796|NCT01425281|516594423|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
143285797|NCT01425281|516594422|FG000|At 2-year Clinical Follow-up|Death|2|||
143285798|NCT01425281|516594423|FG001|At 2-year Clinical Follow-up|Death|0|||
143285799|NCT01425281|516594422|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
143285800|NCT01425281|516594423|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
143285801|NCT01425281|516594422|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
143285802|NCT01425281|516594423|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
143285803|NCT01425281|516594422|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
143285804|NCT01425281|516594423|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
143285805|NCT01425281|516594422|FG000|At 3-year Clinical Follow-up|Death|2|||
143285806|NCT01425281|516594423|FG001|At 3-year Clinical Follow-up|Death|3|||
143285807|NCT01425281|516594422|FG000|At 4-year Clinical Follow-up|Death|7|||
143285808|NCT01425281|516594423|FG001|At 4-year Clinical Follow-up|Death|3|||
143285809|NCT01425281|516594422|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
143285810|NCT01425281|516594423|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
143285811|NCT01425281|516594422|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
143285812|NCT01425281|516594423|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
143285813|NCT01425281|516594422|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
143285814|NCT01425281|516594423|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
143285815|NCT01425281|516594422|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
143285816|NCT01425281|516594423|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
143285817|NCT01425281|516594422|FG000|At 5-year Clinical Follow-up|Death|2|||
143285818|NCT01425281|516594423|FG001|At 5-year Clinical Follow-up|Death|0|||
143285819|NCT01425281|516594422|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
143285820|NCT01425281|516594423|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
143285821|NCT01425281|516594422|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
143285822|NCT01425281|516594423|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
143285823|NCT01425281|516594422|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
143285824|NCT01425281|516594423|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
143285825|NCT01987505|516594424|FG000|Overall Study|Other|9|||
143285826|NCT01987505|516594424|FG000|Overall Study|Withdrawal by Subject|2|||
143285827|NCT01987505|516594424|FG000|Overall Study|Other Reason|2|||
143285828|NCT01987505|516594424|FG000|Overall Study|Lost to Follow-up|15|||
143285829|NCT01987505|516594424|FG000|Overall Study|Investigator Decision|2|||
143285830|NCT01987505|516594424|FG000|Overall Study|Death|4|||
143285831|NCT01833520|516594425|FG000|Overall Study|Lack of Efficacy|3|||
143285832|NCT01833520|516594426|FG001|Overall Study|Lack of Efficacy|3|||
143285833|NCT01833520|516594427|FG002|Overall Study|Lack of Efficacy|8|||
143285834|NCT01833520|516594428|FG003|Overall Study|Lack of Efficacy|3|||
143285835|NCT05131646|516594429|FG000|Overall Study|Withdrawal by Subject|1|||
143285836|NCT05131646|516594430|FG001|Overall Study|Withdrawal by Subject|0|||
143285837|NCT05131646|516594431|FG002|Overall Study|Withdrawal by Subject|0|||
143285838|NCT03266107|516594432|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
143285839|NCT03266107|516594432|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
143285840|NCT03266107|516594432|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
143285841|NCT03266107|516594432|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
143285842|NCT03454997|516594433|FG000|Overall Study|Staff Coach - Left Oranization|1|||
143285843|NCT03454997|516594434|FG001|Overall Study|Staff Coach - Left Oranization|1|||
143285844|NCT03454997|516594433|FG000|Overall Study|Staff Coach - Withdrawal by Site|0|||
143285845|NCT03454997|516594434|FG001|Overall Study|Staff Coach - Withdrawal by Site|2|||
143285846|NCT03454997|516594433|FG000|Overall Study|Staff Coach - Withdrawal by subject|0|||
143285847|NCT03454997|516594434|FG001|Overall Study|Staff Coach - Withdrawal by subject|1|||
143285848|NCT03454997|516594433|FG000|Overall Study|Staff Coach - Lost to follow-up|0|||
143285849|NCT03454997|516594434|FG001|Overall Study|Staff Coach - Lost to follow-up|1|||
143285850|NCT03454997|516594433|FG000|Overall Study|Client with SMI - Lost to follow-up|2|||
143285851|NCT03454997|516594434|FG001|Overall Study|Client with SMI - Lost to follow-up|1|||
143285852|NCT03454997|516594433|FG000|Overall Study|Client with SMI - Left organization|0|||
143285853|NCT03454997|516594434|FG001|Overall Study|Client with SMI - Left organization|1|||
143285854|NCT03454997|516594433|FG000|Overall Study|Client with SMI - Withdrawal by site|0|||
143285855|NCT03454997|516594434|FG001|Overall Study|Client with SMI - Withdrawal by site|11|||
143285856|NCT01191801|516594437|FG000|Overall Study|Death|36|||
143285857|NCT01191801|516594438|FG001|Overall Study|Death|12|||
143285858|NCT01191801|516594437|FG000|Overall Study|Lack of Efficacy|176|||
143285859|NCT01191801|516594438|FG001|Overall Study|Lack of Efficacy|258|||
143285860|NCT01191801|516594437|FG000|Overall Study|Adverse Event|9|||
143285861|NCT01191801|516594438|FG001|Overall Study|Adverse Event|8|||
143285862|NCT01191801|516594437|FG000|Overall Study|Protocol Violation|2|||
143285863|NCT01191801|516594438|FG001|Overall Study|Protocol Violation|4|||
143285864|NCT01191801|516594437|FG000|Overall Study|Physician Decision|47|||
143285865|NCT01191801|516594438|FG001|Overall Study|Physician Decision|24|||
143285866|NCT01191801|516594437|FG000|Overall Study|Withdrawal by Subject|1|||
143285867|NCT01191801|516594438|FG001|Overall Study|Withdrawal by Subject|4|||
143285868|NCT01191801|516594437|FG000|Overall Study|Not Provided|45|||
143285869|NCT01191801|516594438|FG001|Overall Study|Not Provided|27|||
143285870|NCT01111149|516594439|FG000|Overall Study|Protocol Violation|1|||
143285871|NCT01111149|516594440|FG001|Overall Study|Protocol Violation|1|||
143285872|NCT01111149|516594441|FG002|Overall Study|Protocol Violation|2|||
143285873|NCT01111149|516594439|FG000|Overall Study|Withdrawal by Subject|1|||
143285874|NCT01111149|516594440|FG001|Overall Study|Withdrawal by Subject|0|||
143285875|NCT01111149|516594441|FG002|Overall Study|Withdrawal by Subject|2|||
143285876|NCT02794883|516594445|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
143285877|NCT02794883|516594446|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
143285878|NCT02794883|516594447|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
143285879|NCT02794883|516594445|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
143285880|NCT02794883|516594446|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
143285881|NCT02794883|516594447|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
143285882|NCT02794883|516594445|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
143285883|NCT02794883|516594446|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
143285884|NCT02794883|516594447|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
143285885|NCT02794883|516594445|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
143285886|NCT02794883|516594446|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
143285887|NCT02794883|516594447|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
143285888|NCT02794883|516594445|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
143285889|NCT02794883|516594446|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
143285890|NCT02794883|516594447|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
143285891|NCT02794883|516594445|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
143285892|NCT02794883|516594446|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
143285893|NCT02794883|516594447|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
143285894|NCT02794883|516594445|FG000|Follow-up Period (up to 2 Years)|Death|12|||
143285895|NCT02794883|516594446|FG001|Follow-up Period (up to 2 Years)|Death|10|||
143285896|NCT02794883|516594447|FG002|Follow-up Period (up to 2 Years)|Death|10|||
143285897|NCT01727297|516594450|FG000|Overall Study|Death|13|||
143285898|NCT01727297|516594451|FG001|Overall Study|Death|0|||
143285899|NCT01727297|516594450|FG000|Overall Study|Protocol Violation|1|||
143285900|NCT01727297|516594451|FG001|Overall Study|Protocol Violation|10|||
143285901|NCT01727297|516594450|FG000|Overall Study|Adverse Event|3|||
143285902|NCT01727297|516594451|FG001|Overall Study|Adverse Event|1|||
143285903|NCT01727297|516594450|FG000|Overall Study|Lost to Follow-up|11|||
143285904|NCT01727297|516594451|FG001|Overall Study|Lost to Follow-up|0|||
143285905|NCT01727297|516594450|FG000|Overall Study|Withdrawal by Subject|26|||
143285906|NCT01727297|516594451|FG001|Overall Study|Withdrawal by Subject|27|||
143285907|NCT01727297|516594450|FG000|Overall Study|Physician Decision|19|||
143285908|NCT01727297|516594451|FG001|Overall Study|Physician Decision|5|||
143285909|NCT01727297|516594450|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
143285910|NCT01727297|516594451|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
143285911|NCT02042183|516594452|FG000|Overall Study|Physician Decision|7|||
143285912|NCT02042183|516594453|FG001|Overall Study|Physician Decision|2|||
143285913|NCT02042183|516594452|FG000|Overall Study|Lack of Efficacy|4|||
143285914|NCT02042183|516594453|FG001|Overall Study|Lack of Efficacy|3|||
143285915|NCT02042183|516594452|FG000|Overall Study|Non-compliance with Study Drug|2|||
143285916|NCT02042183|516594453|FG001|Overall Study|Non-compliance with Study Drug|3|||
143285917|NCT02042183|516594452|FG000|Overall Study|Adverse Event|17|||
143285918|NCT02042183|516594453|FG001|Overall Study|Adverse Event|6|||
143285919|NCT02042183|516594452|FG000|Overall Study|Other|3|||
143285920|NCT02042183|516594453|FG001|Overall Study|Other|3|||
143285921|NCT02042183|516594452|FG000|Overall Study|Withdrawal by Subject|21|||
143285922|NCT02042183|516594453|FG001|Overall Study|Withdrawal by Subject|16|||
143285923|NCT02042183|516594452|FG000|Overall Study|Site Terminated by Sponsor|2|||
143285924|NCT02042183|516594453|FG001|Overall Study|Site Terminated by Sponsor|1|||
143285925|NCT02042183|516594452|FG000|Overall Study|Lost to Follow-up|9|||
143285926|NCT02042183|516594453|FG001|Overall Study|Lost to Follow-up|2|||
143285927|NCT01192516|516594456|FG000|Overall Study|Lost to Follow-up|7|||
143285928|NCT01192516|516594457|FG001|Overall Study|Lost to Follow-up|10|||
143285929|NCT01192516|516594458|FG002|Overall Study|Lost to Follow-up|7|||
143285930|NCT01192516|516594456|FG000|Overall Study|Withdrawal by Subject|4|||
143285931|NCT01192516|516594457|FG001|Overall Study|Withdrawal by Subject|4|||
143285932|NCT01192516|516594458|FG002|Overall Study|Withdrawal by Subject|1|||
143285933|NCT01192516|516594456|FG000|Overall Study|started new treatment|5|||
143285934|NCT01192516|516594457|FG001|Overall Study|started new treatment|1|||
143285935|NCT01192516|516594458|FG002|Overall Study|started new treatment|0|||
143285936|NCT01192516|516594456|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
143285937|NCT01192516|516594457|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
143285938|NCT01192516|516594458|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
143285939|NCT02266225|516594472|FG000|Overall Study|Lost to Follow-up|2|||
143285940|NCT02266225|516594472|FG000|Overall Study|Death|1|||
143285941|NCT02266225|516594472|FG000|Overall Study|Withdrawal by Subject|13|||
143285942|NCT03018704|516594473|FG000|Overall Study|Lost to Follow-up|1|||
143285943|NCT03018704|516594474|FG001|Overall Study|Lost to Follow-up|1|||
143285944|NCT00320411|516594475|FG000|Overall Study|No investigational product admin.|4|||
143285945|NCT04448171|516594476|FG000|Overall Study|Procedure Cancelled|1|||
143285946|NCT04448171|516594477|FG001|Overall Study|Procedure Cancelled|0|||
143285947|NCT04448171|516594476|FG000|Overall Study|Protocol Violation|1|||
143285948|NCT04448171|516594477|FG001|Overall Study|Protocol Violation|0|||
143285949|NCT01025752|516594478|FG000|Overall Study|Lost to Follow-up|7|||
143285950|NCT01025752|516594479|FG001|Overall Study|Lost to Follow-up|10|||
143285951|NCT01025752|516594478|FG000|Overall Study|Physician Decision|1|||
143285952|NCT01025752|516594479|FG001|Overall Study|Physician Decision|3|||
143285953|NCT00211809|516594482|FG000|Overall Study|Lack of Efficacy|1|||
143285954|NCT00211809|516594482|FG000|Overall Study|Lost to Follow-up|2|||
143285955|NCT00211809|516594482|FG000|Overall Study|Pregnancy|1|||
143285956|NCT00211809|516594482|FG000|Overall Study|side effects|2|||
143285957|NCT01417234|516594483|FG000|Overall Study|Subject non-compliant|3|||
143285958|NCT00023764|516594484|FG000|Overall Study|Other|1|||
143285959|NCT00023764|516594484|FG000|Overall Study|Adverse Event|4|||
143373461|NCT04707313|516911469|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
143285960|NCT00023764|516594484|FG000|Overall Study|Withdrawal by Subject|1|||
143285961|NCT00023764|516594484|FG000|Overall Study|Progression of disease|6|||
143285962|NCT00023764|516594484|FG000|Overall Study|patient received other treatment|1|||
143285963|NCT00023764|516594484|FG000|Overall Study|delay in obtaining staging images|1|||
143285964|NCT00753415|516594489|FG000|Part A|Disease progression|1|||
143285965|NCT00753415|516594490|FG001|Part A|Disease progression|0|||
143285966|NCT00753415|516594491|FG002|Part A|Disease progression|1|||
143285967|NCT00753415|516594492|FG003|Part A|Disease progression|2|||
143285968|NCT00753415|516594493|FG004|Part A|Disease progression|0|||
143285969|NCT00753415|516594494|FG005|Part A|Disease progression|0|||
143285970|NCT00753415|516594495|FG006|Part A|Disease progression|0|||
143285971|NCT00753415|516594496|FG007|Part A|Disease progression|0|||
143285972|NCT00753415|516594497|FG008|Part A|Disease progression|0|||
143285973|NCT00753415|516594498|FG009|Part A|Disease progression|0|||
143285974|NCT00753415|516594489|FG000|Part A|Withdrawal by Subject|0|||
143285975|NCT00753415|516594490|FG001|Part A|Withdrawal by Subject|0|||
143285976|NCT00753415|516594491|FG002|Part A|Withdrawal by Subject|1|||
143285977|NCT00753415|516594492|FG003|Part A|Withdrawal by Subject|0|||
143285978|NCT00753415|516594493|FG004|Part A|Withdrawal by Subject|0|||
143285979|NCT00753415|516594494|FG005|Part A|Withdrawal by Subject|0|||
143285980|NCT00753415|516594495|FG006|Part A|Withdrawal by Subject|0|||
143285981|NCT00753415|516594496|FG007|Part A|Withdrawal by Subject|0|||
143285982|NCT00753415|516594497|FG008|Part A|Withdrawal by Subject|0|||
143285983|NCT00753415|516594498|FG009|Part A|Withdrawal by Subject|0|||
143285984|NCT00753415|516594489|FG000|Part B|Lost to Follow-up|0|||
143285985|NCT00753415|516594490|FG001|Part B|Lost to Follow-up|0|||
143285986|NCT00753415|516594491|FG002|Part B|Lost to Follow-up|0|||
143285987|NCT00753415|516594492|FG003|Part B|Lost to Follow-up|0|||
143285988|NCT00753415|516594493|FG004|Part B|Lost to Follow-up|0|||
143285989|NCT00753415|516594494|FG005|Part B|Lost to Follow-up|0|||
143285990|NCT00753415|516594495|FG006|Part B|Lost to Follow-up|0|||
143285991|NCT00753415|516594496|FG007|Part B|Lost to Follow-up|1|||
143285992|NCT00753415|516594497|FG008|Part B|Lost to Follow-up|1|||
143285993|NCT00753415|516594498|FG009|Part B|Lost to Follow-up|0|||
143285994|NCT00753415|516594489|FG000|Part B|Disease progression|0|||
143285995|NCT00753415|516594490|FG001|Part B|Disease progression|0|||
143285996|NCT00753415|516594491|FG002|Part B|Disease progression|0|||
143285997|NCT00753415|516594492|FG003|Part B|Disease progression|0|||
143285998|NCT00753415|516594493|FG004|Part B|Disease progression|0|||
143285999|NCT00753415|516594494|FG005|Part B|Disease progression|0|||
143286000|NCT00753415|516594495|FG006|Part B|Disease progression|0|||
143286001|NCT00753415|516594496|FG007|Part B|Disease progression|0|||
143286002|NCT00753415|516594497|FG008|Part B|Disease progression|2|||
143286003|NCT00753415|516594498|FG009|Part B|Disease progression|1|||
143286004|NCT04212650|516594499|FG000|Overall Study|Withdrawal by Subject|1|||
143286005|NCT04212650|516594500|FG001|Overall Study|Withdrawal by Subject|0|||
143286006|NCT00887978|516594506|FG000|Overall Study|Adverse Event|18|||
143286007|NCT00887978|516594507|FG001|Overall Study|Adverse Event|5|||
143286008|NCT00887978|516594506|FG000|Overall Study|Clinical Worsening|4|||
143286009|NCT00887978|516594507|FG001|Overall Study|Clinical Worsening|4|||
143286010|NCT00887978|516594506|FG000|Overall Study|Death|2|||
143286011|NCT00887978|516594507|FG001|Overall Study|Death|3|||
143286012|NCT00887978|516594506|FG000|Overall Study|Withdrawal by Subject|1|||
143286013|NCT00887978|516594507|FG001|Overall Study|Withdrawal by Subject|2|||
143286014|NCT00887978|516594506|FG000|Overall Study|Lost to Follow-up|0|||
143286015|NCT00887978|516594507|FG001|Overall Study|Lost to Follow-up|1|||
143286016|NCT05425745|516594517|FG000|Overall Study|Withdrawal of Consent|3|||
143286017|NCT05425745|516594518|FG001|Overall Study|Withdrawal of Consent|3|||
143286018|NCT05425745|516594517|FG000|Overall Study|Death|2|||
143286019|NCT05425745|516594518|FG001|Overall Study|Death|3|||
143286020|NCT05425745|516594517|FG000|Overall Study|Lost to Follow-up|1|||
143286021|NCT05425745|516594518|FG001|Overall Study|Lost to Follow-up|2|||
143286022|NCT05425745|516594517|FG000|Overall Study|Adverse Event|0|||
143286023|NCT05425745|516594518|FG001|Overall Study|Adverse Event|1|||
143286024|NCT05425745|516594517|FG000|Overall Study|Did not return for end of study visit|0|||
143286025|NCT05425745|516594518|FG001|Overall Study|Did not return for end of study visit|1|||
143286026|NCT05425745|516594517|FG000|Overall Study|End of study visit completed by phone|1|||
143286027|NCT05425745|516594518|FG001|Overall Study|End of study visit completed by phone|0|||
143286028|NCT05425745|516594517|FG000|Overall Study|Subject decision|1|||
143286029|NCT05425745|516594518|FG001|Overall Study|Subject decision|0|||
143286030|NCT00911820|516596097|FG000|Overall Study|RECIST progression|12|||
143286031|NCT00911820|516596098|FG001|Overall Study|RECIST progression|8|||
143286032|NCT00911820|516596097|FG000|Overall Study|Adverse Event|8|||
143286033|NCT00911820|516596098|FG001|Overall Study|Adverse Event|8|||
143286034|NCT00911820|516596097|FG000|Overall Study|Clinical Progression|7|||
143286035|NCT00911820|516596098|FG001|Overall Study|Clinical Progression|5|||
143286036|NCT00911820|516596097|FG000|Overall Study|Physician Decision|5|||
143286037|NCT00911820|516596098|FG001|Overall Study|Physician Decision|9|||
143286038|NCT00911820|516596097|FG000|Overall Study|Decline in Performance Status|4|||
143286039|NCT00911820|516596098|FG001|Overall Study|Decline in Performance Status|2|||
143286040|NCT00911820|516596097|FG000|Overall Study|Withdrawal by Subject|3|||
143286041|NCT00911820|516596098|FG001|Overall Study|Withdrawal by Subject|4|||
143286042|NCT00911820|516596097|FG000|Overall Study|Death|1|||
143286043|NCT00911820|516596098|FG001|Overall Study|Death|2|||
143286044|NCT00911820|516596097|FG000|Overall Study|Pursue surgery|1|||
143286045|NCT00911820|516596098|FG001|Overall Study|Pursue surgery|1|||
143286046|NCT00911820|516596097|FG000|Overall Study|Pursue Radiation|1|||
143286047|NCT00911820|516596098|FG001|Overall Study|Pursue Radiation|0|||
143286048|NCT00911820|516596097|FG000|Overall Study|Still on Therapy|2|||
143286049|NCT00911820|516596098|FG001|Overall Study|Still on Therapy|2|||
143286050|NCT00911820|516596097|FG000|Overall Study|Pathology Not Confirmed|1|||
143286051|NCT00911820|516596098|FG001|Overall Study|Pathology Not Confirmed|0|||
143286052|NCT00911820|516596097|FG000|Overall Study|Withdraw before Receive Treatment|0|||
143286053|NCT00911820|516596098|FG001|Overall Study|Withdraw before Receive Treatment|2|||
143286054|NCT00630396|516596106|FG000|Overall Study|Death|4|||
143286055|NCT00630396|516596106|FG000|Overall Study|Lost to Follow-up|3|||
143286056|NCT02430311|516596107|FG000|Part A|Adverse Event|0|||
143286057|NCT02430311|516596108|FG001|Part A|Adverse Event|1|||
143286058|NCT02430311|516596107|FG000|Part A|Withdrawal by Subject|1|||
143286059|NCT02430311|516596108|FG001|Part A|Withdrawal by Subject|0|||
143286060|NCT02430311|516596107|FG000|Part B|Meet study-specific withdrawal criteria|6|||
143286061|NCT02430311|516596108|FG001|Part B|Meet study-specific withdrawal criteria|6|||
143286062|NCT02430311|516596107|FG000|Part B|Withdrawal by Subject|2|||
143286063|NCT02430311|516596108|FG001|Part B|Withdrawal by Subject|2|||
143286064|NCT02430311|516596107|FG000|Part B|Adverse Event|1|||
143286065|NCT02430311|516596108|FG001|Part B|Adverse Event|0|||
143286066|NCT02430311|516596107|FG000|Part B|Death|1|||
143286067|NCT02430311|516596108|FG001|Part B|Death|0|||
143286068|NCT04160091|516596111|FG000|Overall Study|Terminated by Sponsor|7|||
143286069|NCT04160091|516596112|FG001|Overall Study|Terminated by Sponsor|3|||
143286070|NCT04160091|516596113|FG002|Overall Study|Terminated by Sponsor|5|||
143286071|NCT04160091|516596114|FG003|Overall Study|Terminated by Sponsor|2|||
143286072|NCT04160091|516596111|FG000|Overall Study|Noncompliance|0|||
143286073|NCT04160091|516596112|FG001|Overall Study|Noncompliance|0|||
143286074|NCT04160091|516596113|FG002|Overall Study|Noncompliance|0|||
143286075|NCT04160091|516596114|FG003|Overall Study|Noncompliance|1|||
143286076|NCT04160091|516596111|FG000|Overall Study|Withdrawal by Subject|0|||
143286077|NCT04160091|516596112|FG001|Overall Study|Withdrawal by Subject|0|||
143286078|NCT04160091|516596113|FG002|Overall Study|Withdrawal by Subject|0|||
143286079|NCT04160091|516596114|FG003|Overall Study|Withdrawal by Subject|1|||
143286080|NCT00309387|516596119|FG000|Overall Study|Death|72|||
143286081|NCT00309387|516596120|FG001|Overall Study|Death|73|||
143286082|NCT00309387|516596119|FG000|Overall Study|Lost to Follow-up|70|||
143286083|NCT00309387|516596120|FG001|Overall Study|Lost to Follow-up|86|||
143286084|NCT00381095|516596121|FG000|Overall Study|Death|3|||
143286085|NCT00381095|516596122|FG001|Overall Study|Death|4|||
143286086|NCT00381095|516596121|FG000|Overall Study|Lack of Efficacy|2|||
143286087|NCT00381095|516596122|FG001|Overall Study|Lack of Efficacy|4|||
143286088|NCT00381095|516596121|FG000|Overall Study|Other|2|||
143286089|NCT00381095|516596122|FG001|Overall Study|Other|2|||
143286090|NCT00381095|516596121|FG000|Overall Study|Protocol Violation|1|||
143286091|NCT00381095|516596122|FG001|Overall Study|Protocol Violation|1|||
143286092|NCT00381095|516596121|FG000|Overall Study|Withdrawal by Subject|3|||
143286093|NCT00381095|516596122|FG001|Overall Study|Withdrawal by Subject|3|||
143286094|NCT00381095|516596121|FG000|Overall Study|Adverse Event|2|||
143286095|NCT00381095|516596122|FG001|Overall Study|Adverse Event|7|||
143286096|NCT03489720|516596124|FG000|Overall Study|Withdrawal by Subject|2|||
143286097|NCT03489720|516596125|FG001|Overall Study|Withdrawal by Subject|0|||
143286098|NCT02485301|516596126|FG000|Overall Study|Serious Adverse Events|2|||
143286099|NCT02485301|516596127|FG001|Overall Study|Serious Adverse Events|1|||
143286100|NCT02485301|516596126|FG000|Overall Study|Protocol Violation|0|||
143286101|NCT02485301|516596127|FG001|Overall Study|Protocol Violation|1|||
143286102|NCT02485301|516596126|FG000|Overall Study|Withdrawal by Subject|6|||
143286103|NCT02485301|516596127|FG001|Overall Study|Withdrawal by Subject|7|||
143286104|NCT02485301|516596126|FG000|Overall Study|Migrated/moved from study area|10|||
143286105|NCT02485301|516596127|FG001|Overall Study|Migrated/moved from study area|19|||
143286106|NCT02485301|516596126|FG000|Overall Study|Lost to Follow-up|17|||
143286107|NCT02485301|516596127|FG001|Overall Study|Lost to Follow-up|17|||
143286108|NCT02485301|516596126|FG000|Overall Study|Other|3|||
143286109|NCT02485301|516596127|FG001|Overall Study|Other|4|||
143286110|NCT00085631|516596134|FG000|Overall Study|Missing Data|4|||
143286111|NCT00085631|516596135|FG001|Overall Study|Missing Data|11|||
143286112|NCT00085631|516596136|FG002|Overall Study|Missing Data|7|||
143286113|NCT00411645|516596137|FG000|Overall Study|Consent Withdrawn|13|||
143286114|NCT00411645|516596138|FG001|Overall Study|Consent Withdrawn|22|||
143286115|NCT00411645|516596137|FG000|Overall Study|Death|56|||
143286116|NCT00411645|516596138|FG001|Overall Study|Death|135|||
143286117|NCT00411645|516596137|FG000|Overall Study|Investigator/Sponsor Decision|10|||
143286118|NCT00411645|516596138|FG001|Overall Study|Investigator/Sponsor Decision|7|||
143286119|NCT00411645|516596137|FG000|Overall Study|Lost to Follow-up|2|||
143286120|NCT00411645|516596138|FG001|Overall Study|Lost to Follow-up|0|||
143286121|NCT02495168|516596139|FG000|Overall Study|Other than Specified|18|||
143286122|NCT02495168|516596140|FG001|Overall Study|Other than Specified|22|||
143286123|NCT02495168|516596141|FG002|Overall Study|Other than Specified|5|||
143286124|NCT02495168|516596139|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
143286125|NCT02495168|516596140|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
143286126|NCT02495168|516596141|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
143286127|NCT02495168|516596139|FG000|Overall Study|Physician Decision|1|||
143286128|NCT02495168|516596140|FG001|Overall Study|Physician Decision|1|||
143286129|NCT02495168|516596141|FG002|Overall Study|Physician Decision|0|||
143286130|NCT02495168|516596139|FG000|Overall Study|Lost to Follow-up|10|||
143286131|NCT02495168|516596140|FG001|Overall Study|Lost to Follow-up|6|||
143286132|NCT02495168|516596141|FG002|Overall Study|Lost to Follow-up|1|||
143286133|NCT02495168|516596139|FG000|Overall Study|Withdrawal by Subject|1|||
143286134|NCT02495168|516596140|FG001|Overall Study|Withdrawal by Subject|4|||
143286135|NCT02495168|516596141|FG002|Overall Study|Withdrawal by Subject|2|||
143286136|NCT02495168|516596139|FG000|Overall Study|Protocol Violation|0|||
143286137|NCT02495168|516596140|FG001|Overall Study|Protocol Violation|10|||
143286138|NCT02495168|516596141|FG002|Overall Study|Protocol Violation|1|||
143286139|NCT02495168|516596139|FG000|Overall Study|Adverse Event|4|||
143286140|NCT02495168|516596140|FG001|Overall Study|Adverse Event|8|||
143286141|NCT02495168|516596141|FG002|Overall Study|Adverse Event|3|||
143286142|NCT02495168|516596139|FG000|Overall Study|Lack of Efficacy|0|||
143286143|NCT02495168|516596140|FG001|Overall Study|Lack of Efficacy|0|||
143286144|NCT02495168|516596141|FG002|Overall Study|Lack of Efficacy|3|||
143286145|NCT00814164|516596160|FG000|Overall Study|Progression|7|||
143286146|NCT00814164|516596160|FG000|Overall Study|not stated|7|||
143286147|NCT00814164|516596160|FG000|Overall Study|Death|5|||
143286148|NCT01980992|516596161|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
143286149|NCT01980992|516596162|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
143286150|NCT01980992|516596161|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
143286151|NCT01980992|516596162|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
143286152|NCT01980992|516596161|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
143286153|NCT01980992|516596162|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
143286154|NCT01980992|516596161|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
143286155|NCT01980992|516596162|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
143373462|NCT04707313|516911470|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
143373463|NCT04707313|516911471|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
143373464|NCT04707313|516911472|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
143373465|NCT04707313|516911473|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
143373466|NCT04707313|516911474|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
143373467|NCT04707313|516911475|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
143373468|NCT04707313|516911476|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
143373469|NCT04707313|516911477|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
143373470|NCT04707313|516911478|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
143373471|NCT04707313|516911479|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
143373472|NCT04707313|516911480|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
143373473|NCT04707313|516911468|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
143373474|NCT04707313|516911469|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
143373475|NCT04707313|516911470|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
143373476|NCT04707313|516911471|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
143373477|NCT04707313|516911472|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
143286156|NCT01980992|516596161|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
143286157|NCT01980992|516596162|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
143286158|NCT01980992|516596161|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
143286159|NCT01980992|516596162|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
143286160|NCT00299975|516596163|FG000|Overall Study|Adverse Event|1|||
143286161|NCT00299975|516596164|FG001|Overall Study|Adverse Event|0|||
143286162|NCT00299975|516596165|FG002|Overall Study|Adverse Event|2|||
143286163|NCT00299975|516596163|FG000|Overall Study|Pregnancy|0|||
143286164|NCT00299975|516596164|FG001|Overall Study|Pregnancy|0|||
143286165|NCT00299975|516596165|FG002|Overall Study|Pregnancy|1|||
143286166|NCT00299975|516596163|FG000|Overall Study|Lack of Efficacy|1|||
143286167|NCT00299975|516596164|FG001|Overall Study|Lack of Efficacy|0|||
143286168|NCT00299975|516596165|FG002|Overall Study|Lack of Efficacy|1|||
143286169|NCT00299975|516596163|FG000|Overall Study|Lost to Follow-up|1|||
143286170|NCT00299975|516596164|FG001|Overall Study|Lost to Follow-up|0|||
143286171|NCT00299975|516596165|FG002|Overall Study|Lost to Follow-up|0|||
143286172|NCT00299975|516596163|FG000|Overall Study|Withdrawal by Subject|0|||
143286173|NCT00299975|516596164|FG001|Overall Study|Withdrawal by Subject|1|||
143286174|NCT00299975|516596165|FG002|Overall Study|Withdrawal by Subject|3|||
143286175|NCT00299975|516596163|FG000|Overall Study|Physician Decision|0|||
143286176|NCT00299975|516596164|FG001|Overall Study|Physician Decision|0|||
143286177|NCT00299975|516596165|FG002|Overall Study|Physician Decision|1|||
143286178|NCT05228132|516596171|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
143286179|NCT05228132|516596171|FG000|Overall Study|Adverse Event|3|||
143286180|NCT05228132|516596171|FG000|Overall Study|Lost to Follow-up|1|||
143286181|NCT05228132|516596171|FG000|Overall Study|Arteriovenous-fistula mature|1|||
143286182|NCT00420927|516596172|FG000|Period 1|Adverse Event|19|||
143286183|NCT00420927|516596173|FG001|Period 1|Adverse Event|15|||
143286184|NCT00420927|516596174|FG002|Period 1|Adverse Event|0|||
143286185|NCT00420927|516596175|FG003|Period 1|Adverse Event|0|||
143286186|NCT00420927|516596176|FG004|Period 1|Adverse Event|0|||
143286187|NCT00420927|516596177|FG005|Period 1|Adverse Event|0|||
143286188|NCT00420927|516596178|FG006|Period 1|Adverse Event|0|||
143286189|NCT00420927|516596172|FG000|Period 1|Withdrawal by Subject|7|||
143286190|NCT00420927|516596173|FG001|Period 1|Withdrawal by Subject|12|||
143286191|NCT00420927|516596174|FG002|Period 1|Withdrawal by Subject|0|||
143286192|NCT00420927|516596175|FG003|Period 1|Withdrawal by Subject|0|||
143286193|NCT00420927|516596176|FG004|Period 1|Withdrawal by Subject|0|||
143286194|NCT00420927|516596177|FG005|Period 1|Withdrawal by Subject|0|||
143286195|NCT00420927|516596178|FG006|Period 1|Withdrawal by Subject|0|||
143286196|NCT00420927|516596172|FG000|Period 1|Lost to Follow-up|8|||
143286197|NCT00420927|516596173|FG001|Period 1|Lost to Follow-up|6|||
143286198|NCT00420927|516596174|FG002|Period 1|Lost to Follow-up|0|||
143286199|NCT00420927|516596175|FG003|Period 1|Lost to Follow-up|0|||
143286200|NCT00420927|516596176|FG004|Period 1|Lost to Follow-up|0|||
143286201|NCT00420927|516596177|FG005|Period 1|Lost to Follow-up|0|||
143286202|NCT00420927|516596178|FG006|Period 1|Lost to Follow-up|0|||
143286203|NCT00420927|516596172|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
143286204|NCT00420927|516596173|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
143286205|NCT00420927|516596174|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
143286206|NCT00420927|516596175|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
143286207|NCT00420927|516596176|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
143286208|NCT00420927|516596177|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
143286209|NCT00420927|516596178|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
143286210|NCT00420927|516596172|FG000|Period 1|Death|2|||
143286211|NCT00420927|516596173|FG001|Period 1|Death|0|||
143286212|NCT00420927|516596174|FG002|Period 1|Death|0|||
143286213|NCT00420927|516596175|FG003|Period 1|Death|0|||
143286214|NCT00420927|516596176|FG004|Period 1|Death|0|||
143286215|NCT00420927|516596177|FG005|Period 1|Death|0|||
143286216|NCT00420927|516596178|FG006|Period 1|Death|0|||
143286217|NCT00420927|516596172|FG000|Period 1|Subject moved/relocated|0|||
143286218|NCT00420927|516596173|FG001|Period 1|Subject moved/relocated|2|||
143286219|NCT00420927|516596174|FG002|Period 1|Subject moved/relocated|0|||
143286220|NCT00420927|516596175|FG003|Period 1|Subject moved/relocated|0|||
143286221|NCT00420927|516596176|FG004|Period 1|Subject moved/relocated|0|||
143286222|NCT00420927|516596177|FG005|Period 1|Subject moved/relocated|0|||
143286223|NCT00420927|516596178|FG006|Period 1|Subject moved/relocated|0|||
143286224|NCT00420927|516596172|FG000|Period 1|Noncompliant with study drug|1|||
143286225|NCT00420927|516596173|FG001|Period 1|Noncompliant with study drug|1|||
143286226|NCT00420927|516596174|FG002|Period 1|Noncompliant with study drug|0|||
143286227|NCT00420927|516596175|FG003|Period 1|Noncompliant with study drug|0|||
143286228|NCT00420927|516596176|FG004|Period 1|Noncompliant with study drug|0|||
143286229|NCT00420927|516596177|FG005|Period 1|Noncompliant with study drug|0|||
143286230|NCT00420927|516596178|FG006|Period 1|Noncompliant with study drug|0|||
143286231|NCT00420927|516596172|FG000|Period 1|Randomization error|1|||
143286232|NCT00420927|516596173|FG001|Period 1|Randomization error|0|||
143286233|NCT00420927|516596174|FG002|Period 1|Randomization error|0|||
143286234|NCT00420927|516596175|FG003|Period 1|Randomization error|0|||
143286235|NCT00420927|516596176|FG004|Period 1|Randomization error|0|||
143286236|NCT00420927|516596177|FG005|Period 1|Randomization error|0|||
143286237|NCT00420927|516596178|FG006|Period 1|Randomization error|0|||
143286238|NCT00420927|516596172|FG000|Period 1|Suspected tuberculosis/positive test|1|||
143286239|NCT00420927|516596173|FG001|Period 1|Suspected tuberculosis/positive test|1|||
143286240|NCT00420927|516596174|FG002|Period 1|Suspected tuberculosis/positive test|0|||
143286241|NCT00420927|516596175|FG003|Period 1|Suspected tuberculosis/positive test|0|||
143286242|NCT00420927|516596176|FG004|Period 1|Suspected tuberculosis/positive test|0|||
143286243|NCT00420927|516596177|FG005|Period 1|Suspected tuberculosis/positive test|0|||
143286244|NCT00420927|516596178|FG006|Period 1|Suspected tuberculosis/positive test|0|||
143286245|NCT00420927|516596172|FG000|Period 1|Study site closure|0|||
143286246|NCT00420927|516596173|FG001|Period 1|Study site closure|1|||
143286247|NCT00420927|516596174|FG002|Period 1|Study site closure|0|||
143286248|NCT00420927|516596175|FG003|Period 1|Study site closure|0|||
143286249|NCT00420927|516596176|FG004|Period 1|Study site closure|0|||
143286250|NCT00420927|516596177|FG005|Period 1|Study site closure|0|||
143286251|NCT00420927|516596178|FG006|Period 1|Study site closure|0|||
143286252|NCT00420927|516596172|FG000|Period 1|Subject received new diagnosis|0|||
143286253|NCT00420927|516596173|FG001|Period 1|Subject received new diagnosis|2|||
143286254|NCT00420927|516596174|FG002|Period 1|Subject received new diagnosis|0|||
143286255|NCT00420927|516596175|FG003|Period 1|Subject received new diagnosis|0|||
143286256|NCT00420927|516596176|FG004|Period 1|Subject received new diagnosis|0|||
143286257|NCT00420927|516596177|FG005|Period 1|Subject received new diagnosis|0|||
143286258|NCT00420927|516596178|FG006|Period 1|Subject received new diagnosis|0|||
143286259|NCT00420927|516596172|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
143286260|NCT00420927|516596173|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
143286261|NCT00420927|516596174|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
143286262|NCT00420927|516596175|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
143286263|NCT00420927|516596176|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
143286264|NCT00420927|516596177|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
143286265|NCT00420927|516596178|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
143286266|NCT00420927|516596172|FG000|Period 1|Failed to meet entry criteria|8|||
143286267|NCT00420927|516596173|FG001|Period 1|Failed to meet entry criteria|7|||
143286268|NCT00420927|516596174|FG002|Period 1|Failed to meet entry criteria|0|||
143373478|NCT04707313|516911473|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
143286269|NCT00420927|516596175|FG003|Period 1|Failed to meet entry criteria|0|||
143286270|NCT00420927|516596176|FG004|Period 1|Failed to meet entry criteria|0|||
143286271|NCT00420927|516596177|FG005|Period 1|Failed to meet entry criteria|0|||
143286272|NCT00420927|516596178|FG006|Period 1|Failed to meet entry criteria|0|||
143286273|NCT00420927|516596172|FG000|Period 1|Took prohibited medication|1|||
143286274|NCT00420927|516596173|FG001|Period 1|Took prohibited medication|3|||
143286275|NCT00420927|516596174|FG002|Period 1|Took prohibited medication|0|||
143373479|NCT04707313|516911474|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
143286276|NCT00420927|516596175|FG003|Period 1|Took prohibited medication|0|||
143286277|NCT00420927|516596176|FG004|Period 1|Took prohibited medication|0|||
143286278|NCT00420927|516596177|FG005|Period 1|Took prohibited medication|0|||
143286279|NCT00420927|516596178|FG006|Period 1|Took prohibited medication|0|||
143286280|NCT00420927|516596172|FG000|Period 2|Adverse Event|0|||
143286281|NCT00420927|516596173|FG001|Period 2|Adverse Event|0|||
143286282|NCT00420927|516596174|FG002|Period 2|Adverse Event|7|||
143286283|NCT00420927|516596175|FG003|Period 2|Adverse Event|3|||
143286284|NCT00420927|516596176|FG004|Period 2|Adverse Event|17|||
143286285|NCT00420927|516596177|FG005|Period 2|Adverse Event|6|||
143286286|NCT00420927|516596178|FG006|Period 2|Adverse Event|20|||
143286287|NCT00420927|516596172|FG000|Period 2|Withdrawal by Subject|0|||
143286288|NCT00420927|516596173|FG001|Period 2|Withdrawal by Subject|0|||
143286289|NCT00420927|516596174|FG002|Period 2|Withdrawal by Subject|1|||
143286290|NCT00420927|516596175|FG003|Period 2|Withdrawal by Subject|3|||
143286291|NCT00420927|516596176|FG004|Period 2|Withdrawal by Subject|11|||
143286292|NCT00420927|516596177|FG005|Period 2|Withdrawal by Subject|2|||
143286293|NCT00420927|516596178|FG006|Period 2|Withdrawal by Subject|12|||
143286294|NCT00420927|516596172|FG000|Period 2|Lost to Follow-up|0|||
143286295|NCT00420927|516596173|FG001|Period 2|Lost to Follow-up|0|||
143286296|NCT00420927|516596174|FG002|Period 2|Lost to Follow-up|2|||
143286297|NCT00420927|516596175|FG003|Period 2|Lost to Follow-up|2|||
143286298|NCT00420927|516596176|FG004|Period 2|Lost to Follow-up|6|||
143286299|NCT00420927|516596177|FG005|Period 2|Lost to Follow-up|3|||
143286300|NCT00420927|516596178|FG006|Period 2|Lost to Follow-up|9|||
143286301|NCT00420927|516596172|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
143286302|NCT00420927|516596173|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
143286303|NCT00420927|516596174|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
143286304|NCT00420927|516596175|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
143286305|NCT00420927|516596176|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
143286306|NCT00420927|516596177|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
143286307|NCT00420927|516596178|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
143286308|NCT00420927|516596172|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
143286309|NCT00420927|516596173|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
143286310|NCT00420927|516596174|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
143286311|NCT00420927|516596175|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
143286312|NCT00420927|516596176|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
143286313|NCT00420927|516596177|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
143286314|NCT00420927|516596178|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
143286315|NCT00420927|516596172|FG000|Period 2|Subject unable to find transportation|0|||
143286316|NCT00420927|516596173|FG001|Period 2|Subject unable to find transportation|0|||
143286317|NCT00420927|516596174|FG002|Period 2|Subject unable to find transportation|0|||
143286318|NCT00420927|516596175|FG003|Period 2|Subject unable to find transportation|0|||
143286319|NCT00420927|516596176|FG004|Period 2|Subject unable to find transportation|0|||
143286320|NCT00420927|516596177|FG005|Period 2|Subject unable to find transportation|0|||
143286321|NCT00420927|516596178|FG006|Period 2|Subject unable to find transportation|1|||
143286322|NCT00420927|516596172|FG000|Period 2|Physician Decision|0|||
143286323|NCT00420927|516596173|FG001|Period 2|Physician Decision|0|||
143286324|NCT00420927|516596174|FG002|Period 2|Physician Decision|0|||
143286325|NCT00420927|516596175|FG003|Period 2|Physician Decision|0|||
143286326|NCT00420927|516596176|FG004|Period 2|Physician Decision|1|||
143286327|NCT00420927|516596177|FG005|Period 2|Physician Decision|1|||
143286328|NCT00420927|516596178|FG006|Period 2|Physician Decision|0|||
143286329|NCT00420927|516596172|FG000|Period 2|Sponsor decision|0|||
143286330|NCT00420927|516596173|FG001|Period 2|Sponsor decision|0|||
143286331|NCT00420927|516596174|FG002|Period 2|Sponsor decision|1|||
143286332|NCT00420927|516596175|FG003|Period 2|Sponsor decision|0|||
143286333|NCT00420927|516596176|FG004|Period 2|Sponsor decision|0|||
143286334|NCT00420927|516596177|FG005|Period 2|Sponsor decision|0|||
143286335|NCT00420927|516596178|FG006|Period 2|Sponsor decision|1|||
143286336|NCT00420927|516596172|FG000|Period 2|Randomization error|0|||
143286337|NCT00420927|516596173|FG001|Period 2|Randomization error|0|||
143286338|NCT00420927|516596174|FG002|Period 2|Randomization error|0|||
143286339|NCT00420927|516596175|FG003|Period 2|Randomization error|0|||
143286340|NCT00420927|516596176|FG004|Period 2|Randomization error|1|||
143286341|NCT00420927|516596177|FG005|Period 2|Randomization error|1|||
143286342|NCT00420927|516596178|FG006|Period 2|Randomization error|0|||
143286343|NCT00420927|516596172|FG000|Period 2|Noncompliant with study drug|0|||
143286344|NCT00420927|516596173|FG001|Period 2|Noncompliant with study drug|0|||
143286345|NCT00420927|516596174|FG002|Period 2|Noncompliant with study drug|0|||
143286346|NCT00420927|516596175|FG003|Period 2|Noncompliant with study drug|1|||
143286347|NCT00420927|516596176|FG004|Period 2|Noncompliant with study drug|0|||
143286348|NCT00420927|516596177|FG005|Period 2|Noncompliant with study drug|0|||
143286349|NCT00420927|516596178|FG006|Period 2|Noncompliant with study drug|2|||
143286350|NCT00420927|516596172|FG000|Period 2|Methotrexate intolerance|0|||
143286351|NCT00420927|516596173|FG001|Period 2|Methotrexate intolerance|0|||
143286352|NCT00420927|516596174|FG002|Period 2|Methotrexate intolerance|0|||
143286353|NCT00420927|516596175|FG003|Period 2|Methotrexate intolerance|0|||
143286354|NCT00420927|516596176|FG004|Period 2|Methotrexate intolerance|0|||
143286355|NCT00420927|516596177|FG005|Period 2|Methotrexate intolerance|0|||
143286356|NCT00420927|516596178|FG006|Period 2|Methotrexate intolerance|1|||
143286357|NCT00420927|516596172|FG000|Period 2|Took prohibited medication|0|||
143286358|NCT00420927|516596173|FG001|Period 2|Took prohibited medication|0|||
143286359|NCT00420927|516596174|FG002|Period 2|Took prohibited medication|0|||
143286360|NCT00420927|516596175|FG003|Period 2|Took prohibited medication|0|||
143286361|NCT00420927|516596176|FG004|Period 2|Took prohibited medication|1|||
143286362|NCT00420927|516596177|FG005|Period 2|Took prohibited medication|0|||
143286363|NCT00420927|516596178|FG006|Period 2|Took prohibited medication|0|||
143286364|NCT00642460|516596181|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
143286365|NCT00642460|516596182|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
143286366|NCT00642460|516596183|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
143286367|NCT00642460|516596184|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
143286368|NCT00642460|516596185|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
143286369|NCT00642460|516596186|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
143286370|NCT00642460|516596181|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
143286371|NCT00642460|516596182|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
143286372|NCT00642460|516596183|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
143286373|NCT00642460|516596184|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
143286374|NCT00642460|516596185|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
143286375|NCT00642460|516596186|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
143286376|NCT00642460|516596181|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
143286377|NCT00642460|516596182|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
143286378|NCT00642460|516596183|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
143286379|NCT00642460|516596184|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
143286380|NCT00642460|516596185|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
143286381|NCT00642460|516596186|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
143286382|NCT00642460|516596181|FG000|Part II: Open-Label Up to Week 92|Death|0|||
143286383|NCT00642460|516596182|FG001|Part II: Open-Label Up to Week 92|Death|1|||
143286384|NCT00642460|516596183|FG002|Part II: Open-Label Up to Week 92|Death|0|||
143286385|NCT00642460|516596184|FG003|Part II: Open-Label Up to Week 92|Death|2|||
143286386|NCT00642460|516596185|FG004|Part II: Open-Label Up to Week 92|Death|0|||
143286387|NCT00642460|516596186|FG005|Part II: Open-Label Up to Week 92|Death|0|||
143286388|NCT00642460|516596181|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
143286389|NCT00642460|516596182|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
143286390|NCT00642460|516596183|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
143286391|NCT00642460|516596184|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
143286392|NCT00642460|516596185|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
143286393|NCT00642460|516596186|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
143286394|NCT00642460|516596181|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
143286395|NCT00642460|516596182|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
143286396|NCT00642460|516596183|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
143286397|NCT00642460|516596184|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
143286398|NCT00642460|516596185|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
143286399|NCT00642460|516596186|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
143286400|NCT00642460|516596181|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
143286401|NCT00642460|516596182|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
143286402|NCT00642460|516596183|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
143286403|NCT00642460|516596184|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
143286404|NCT00642460|516596185|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
143286405|NCT00642460|516596186|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
143286406|NCT00642460|516596181|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
143286407|NCT00642460|516596182|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
143286408|NCT00642460|516596183|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
143286409|NCT00642460|516596184|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
143286410|NCT00642460|516596185|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
143286411|NCT00642460|516596186|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
143286412|NCT00642460|516596181|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
143286413|NCT00642460|516596182|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
143286414|NCT00642460|516596183|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
143286415|NCT00642460|516596184|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
143286416|NCT00642460|516596185|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
143286417|NCT00642460|516596186|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
143286418|NCT00642460|516596181|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
143286419|NCT00642460|516596182|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
143286420|NCT00642460|516596183|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
143286421|NCT00642460|516596184|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
143286422|NCT00642460|516596185|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
143286423|NCT00642460|516596186|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
143286424|NCT00642460|516596181|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
143286425|NCT00642460|516596182|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
143286426|NCT00642460|516596183|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
143286427|NCT00642460|516596184|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
143286428|NCT00642460|516596185|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
143286429|NCT00642460|516596186|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
143286430|NCT00642460|516596181|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
143286431|NCT00642460|516596182|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
143286432|NCT00642460|516596183|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
143286433|NCT00642460|516596184|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
143286434|NCT00642460|516596185|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
143286435|NCT00642460|516596186|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
143286436|NCT00642460|516596181|FG000|Part III: Open-Label Up to Week 260|Other|0|||
143286437|NCT00642460|516596182|FG001|Part III: Open-Label Up to Week 260|Other|0|||
143286438|NCT00642460|516596183|FG002|Part III: Open-Label Up to Week 260|Other|0|||
143286439|NCT00642460|516596184|FG003|Part III: Open-Label Up to Week 260|Other|0|||
143286440|NCT00642460|516596185|FG004|Part III: Open-Label Up to Week 260|Other|2|||
143286441|NCT00642460|516596186|FG005|Part III: Open-Label Up to Week 260|Other|2|||
143286442|NCT00642460|516596181|FG000|Part III: Open-Label Up to Week 260|Death|0|||
143286443|NCT00642460|516596182|FG001|Part III: Open-Label Up to Week 260|Death|0|||
143286444|NCT00642460|516596183|FG002|Part III: Open-Label Up to Week 260|Death|0|||
143286445|NCT00642460|516596184|FG003|Part III: Open-Label Up to Week 260|Death|0|||
143286446|NCT00642460|516596185|FG004|Part III: Open-Label Up to Week 260|Death|0|||
143286447|NCT00642460|516596186|FG005|Part III: Open-Label Up to Week 260|Death|3|||
143286448|NCT00642460|516596181|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
143286449|NCT00642460|516596182|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
143286450|NCT00642460|516596183|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
143286451|NCT00642460|516596184|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
143286452|NCT00642460|516596185|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
143286453|NCT00642460|516596186|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
143286454|NCT00642460|516596181|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
143286455|NCT00642460|516596182|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
143286456|NCT00642460|516596183|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
143286457|NCT00642460|516596184|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
143286458|NCT00642460|516596185|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
143286459|NCT00642460|516596186|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
143286460|NCT02088047|516596189|FG000|Overall Study|Withdrawal by Subject|1|||
143286461|NCT02088047|516596190|FG001|Overall Study|Withdrawal by Subject|0|||
143286462|NCT00496470|516596193|FG000|Overall Study|Adverse Event|8|||
143286463|NCT00496470|516596194|FG001|Overall Study|Adverse Event|10|||
143286464|NCT00496470|516596193|FG000|Overall Study|Withdrawal by Subject|5|||
143286465|NCT00496470|516596194|FG001|Overall Study|Withdrawal by Subject|12|||
143286466|NCT00496470|516596193|FG000|Overall Study|Incorrectly enrolled|13|||
143286467|NCT00496470|516596194|FG001|Overall Study|Incorrectly enrolled|5|||
143286468|NCT00496470|516596193|FG000|Overall Study|Other reason|0|||
143286469|NCT00496470|516596194|FG001|Overall Study|Other reason|2|||
143286470|NCT00729651|516596196|FG000|Overall Study|Withdrawal by Subject|5|||
143286471|NCT00729651|516596197|FG001|Overall Study|Withdrawal by Subject|6|||
143286472|NCT00729651|516596196|FG000|Overall Study|Lost to Follow-up|5|||
143286473|NCT00729651|516596197|FG001|Overall Study|Lost to Follow-up|4|||
143286474|NCT00729651|516596196|FG000|Overall Study|Protocol Violation|0|||
143286475|NCT00729651|516596197|FG001|Overall Study|Protocol Violation|1|||
143286476|NCT00729651|516596196|FG000|Overall Study|Adverse Event|7|||
143286477|NCT00729651|516596197|FG001|Overall Study|Adverse Event|3|||
143286478|NCT00729651|516596196|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
143286479|NCT00729651|516596197|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
143286480|NCT00729651|516596196|FG000|Overall Study|Subject's private reason|2|||
143286481|NCT00729651|516596197|FG001|Overall Study|Subject's private reason|0|||
143286482|NCT01218243|516596198|FG000|Overall Study|Lack of Efficacy|1|||
143286483|NCT01218243|516596199|FG001|Overall Study|Lack of Efficacy|1|||
143286484|NCT01218243|516596198|FG000|Overall Study|Lost to Follow-up|3|||
143286485|NCT01218243|516596199|FG001|Overall Study|Lost to Follow-up|3|||
143286486|NCT01218243|516596198|FG000|Overall Study|Protocol Violation|5|||
143286487|NCT01218243|516596199|FG001|Overall Study|Protocol Violation|10|||
143286488|NCT01637272|516596202|FG000|Overall Study|Adverse Event|6|||
143286489|NCT01637272|516596202|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
143286490|NCT01637272|516596202|FG000|Overall Study|Withdrawal by Subject|3|||
143286491|NCT01637272|516596202|FG000|Overall Study|Lost to Follow-up|2|||
143286492|NCT01637272|516596202|FG000|Overall Study|completed core, did not enter ext. phase|4|||
143286493|NCT01637272|516596202|FG000|Overall Study|Administrative problems|1|||
143286494|NCT01637272|516596202|FG000|Overall Study|Protocol Violation|2|||
143286495|NCT01844518|516596203|FG000|Overall Study|Adverse Event|7|||
143286496|NCT01844518|516596204|FG001|Overall Study|Adverse Event|1|||
143286497|NCT01844518|516596203|FG000|Overall Study|Lack of Efficacy|17|||
143286498|NCT01844518|516596204|FG001|Overall Study|Lack of Efficacy|5|||
143286499|NCT01844518|516596203|FG000|Overall Study|Participant's request to discontinue|4|||
143286500|NCT01844518|516596204|FG001|Overall Study|Participant's request to discontinue|1|||
143286501|NCT01844518|516596203|FG000|Overall Study|Poor/Non-compliance|1|||
143286502|NCT01844518|516596204|FG001|Overall Study|Poor/Non-compliance|0|||
143286503|NCT01844518|516596203|FG000|Overall Study|No Longer Met Study Criteria|2|||
143286504|NCT01844518|516596204|FG001|Overall Study|No Longer Met Study Criteria|0|||
143286505|NCT01844518|516596203|FG000|Overall Study|Withdrawal by Subject|9|||
143286506|NCT01844518|516596204|FG001|Overall Study|Withdrawal by Subject|0|||
143286507|NCT01844518|516596203|FG000|Overall Study|Pregnancy|1|||
143286508|NCT01844518|516596204|FG001|Overall Study|Pregnancy|0|||
143286509|NCT01496612|516596205|FG000|1st Intervention|Adverse Event|1|||
143286510|NCT01496612|516596206|FG001|1st Intervention|Adverse Event|0|||
143286511|NCT01496612|516596205|FG000|1st Intervention|Withdrawal by Subject|1|||
143286512|NCT01496612|516596206|FG001|1st Intervention|Withdrawal by Subject|0|||
143286513|NCT00291577|516596207|FG000|Overall Study|Adverse Event|1|||
143286514|NCT00291577|516596207|FG000|Overall Study|Other|4|||
143286515|NCT00291577|516596207|FG000|Overall Study|Withdrawal by Subject|2|||
143286516|NCT00291577|516596207|FG000|Overall Study|Lack of Efficacy|14|||
143286517|NCT01587001|516596214|FG000|Overall Study|Lost to Follow-up|2|||
143286518|NCT01587001|516596215|FG001|Overall Study|Lost to Follow-up|0|||
143286519|NCT01587001|516596214|FG000|Overall Study|Insufficient samples to complete testing|4|||
143286520|NCT01587001|516596215|FG001|Overall Study|Insufficient samples to complete testing|1|||
143286521|NCT00833794|516596218|FG000|Open-label Phase|Adverse Event|225|||
143286522|NCT00833794|516596219|FG001|Open-label Phase|Adverse Event|0|||
143286523|NCT00833794|516596218|FG000|Open-label Phase|Lack of Efficacy|28|||
143286524|NCT00833794|516596219|FG001|Open-label Phase|Lack of Efficacy|0|||
143286525|NCT00833794|516596218|FG000|Open-label Phase|Withdrawal by Subject|48|||
143286526|NCT00833794|516596219|FG001|Open-label Phase|Withdrawal by Subject|0|||
143286527|NCT00833794|516596218|FG000|Open-label Phase|Physician Decision|20|||
143286528|NCT00833794|516596219|FG001|Open-label Phase|Physician Decision|0|||
143286529|NCT00833794|516596218|FG000|Open-label Phase|Administrative reason|1|||
143286530|NCT00833794|516596219|FG001|Open-label Phase|Administrative reason|0|||
143286531|NCT00833794|516596218|FG000|Open-label Phase|Protocol Violation|47|||
143286532|NCT00833794|516596219|FG001|Open-label Phase|Protocol Violation|0|||
143286533|NCT00833794|516596218|FG000|Open-label Phase|Did not complete wash-out period|12|||
143286534|NCT00833794|516596219|FG001|Open-label Phase|Did not complete wash-out period|0|||
143286535|NCT00833794|516596218|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
143286536|NCT00833794|516596219|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
143286537|NCT00833794|516596218|FG000|Double-blind Phase|Adverse Event|44|||
143286538|NCT00833794|516596219|FG001|Double-blind Phase|Adverse Event|11|||
143286539|NCT00833794|516596218|FG000|Double-blind Phase|Lack of Efficacy|34|||
143286540|NCT00833794|516596219|FG001|Double-blind Phase|Lack of Efficacy|22|||
143286541|NCT00833794|516596218|FG000|Double-blind Phase|Withdrawal by Subject|23|||
143286542|NCT00833794|516596219|FG001|Double-blind Phase|Withdrawal by Subject|6|||
143286543|NCT00833794|516596218|FG000|Double-blind Phase|Physician Decision|4|||
143286544|NCT00833794|516596219|FG001|Double-blind Phase|Physician Decision|7|||
143286545|NCT00833794|516596218|FG000|Double-blind Phase|Administrative reason|1|||
143286546|NCT00833794|516596219|FG001|Double-blind Phase|Administrative reason|3|||
143286547|NCT01950741|516596224|FG000|Overall Study|Lost to Follow-up|1|||
143286548|NCT01950741|516596224|FG000|Overall Study|Death|1|||
143286549|NCT01950741|516596224|FG000|Overall Study|Withdrawal by Subject|1|||
143286550|NCT00471328|516596225|FG000|Core Phase|Adverse Event|18|||
143286551|NCT00471328|516596226|FG001|Core Phase|Adverse Event|6|||
143286552|NCT00471328|516596225|FG000|Core Phase|Death|8|||
143286553|NCT00471328|516596226|FG001|Core Phase|Death|4|||
143286554|NCT00471328|516596225|FG000|Core Phase|Withdrawal by Subject|2|||
143286555|NCT00471328|516596226|FG001|Core Phase|Withdrawal by Subject|2|||
143286556|NCT00471328|516596225|FG000|Core Phase|Abnormal laboratory value|1|||
143286557|NCT00471328|516596226|FG001|Core Phase|Abnormal laboratory value|0|||
143286558|NCT00471328|516596225|FG000|Core Phase|Disease Progression|78|||
143286559|NCT00471328|516596226|FG001|Core Phase|Disease Progression|53|||
143286560|NCT00471328|516596225|FG000|Core Phase|Administrative Problem|0|||
143286561|NCT00471328|516596226|FG001|Core Phase|Administrative Problem|1|||
143286562|NCT00471328|516596225|FG000|Core Phase|Protocol Deviation|0|||
143286563|NCT00471328|516596226|FG001|Core Phase|Protocol Deviation|1|||
143286564|NCT00471328|516596225|FG000|Extension Phase|Adverse Event|3|||
143286565|NCT00471328|516596226|FG001|Extension Phase|Adverse Event|12|||
143286566|NCT00471328|516596225|FG000|Extension Phase|Withdrawal by Subject|0|||
143286567|NCT00471328|516596226|FG001|Extension Phase|Withdrawal by Subject|2|||
143286568|NCT00471328|516596225|FG000|Extension Phase|Death|1|||
143286569|NCT00471328|516596226|FG001|Extension Phase|Death|7|||
143286570|NCT00471328|516596225|FG000|Extension Phase|Protocol Deviation|3|||
143286571|NCT00471328|516596226|FG001|Extension Phase|Protocol Deviation|1|||
143286572|NCT00471328|516596225|FG000|Extension Phase|Treatment duration as per protocol|0|||
143286573|NCT00471328|516596226|FG001|Extension Phase|Treatment duration as per protocol|1|||
143286574|NCT00471328|516596225|FG000|Extension Phase|Disease Progression|32|||
143286575|NCT00471328|516596226|FG001|Extension Phase|Disease Progression|44|||
143286576|NCT00471328|516596225|FG000|Extension Phase|New cancer Therapy|1|||
143286577|NCT00471328|516596226|FG001|Extension Phase|New cancer Therapy|0|||
143286578|NCT00471328|516596225|FG000|Extension Phase|Administrative Problem|1|||
143286579|NCT00471328|516596226|FG001|Extension Phase|Administrative Problem|0|||
143286580|NCT00519831|516596227|FG000|Overall Study|Adverse Event|3|||
143286581|NCT02854631|516596228|FG000|Overall Study|Adverse Event|1|||
143286582|NCT02854631|516596229|FG001|Overall Study|Adverse Event|2|||
143286583|NCT02854631|516596228|FG000|Overall Study|Withdrew Consent|3|||
143286584|NCT02854631|516596229|FG001|Overall Study|Withdrew Consent|2|||
143286585|NCT02854631|516596228|FG000|Overall Study|Investigator's Discretion|2|||
143286586|NCT02854631|516596229|FG001|Overall Study|Investigator's Discretion|0|||
143286587|NCT02854631|516596228|FG000|Overall Study|Death|12|||
143286588|NCT02854631|516596229|FG001|Overall Study|Death|8|||
143286589|NCT02854631|516596228|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
143286590|NCT02854631|516596229|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
143286591|NCT02854631|516596228|FG000|Overall Study|Protocol Violation|0|||
143286592|NCT02854631|516596229|FG001|Overall Study|Protocol Violation|1|||
143286593|NCT02854631|516596228|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
143286594|NCT02854631|516596229|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
143286595|NCT02854631|516596228|FG000|Overall Study|Lost to Follow-up|4|||
143286596|NCT02854631|516596229|FG001|Overall Study|Lost to Follow-up|2|||
143286597|NCT04051008|516596230|FG000|Overall Study|Withdrawal by Subject|2|||
143286598|NCT04051008|516596231|FG001|Overall Study|Withdrawal by Subject|0|||
143286599|NCT04051008|516596232|FG002|Overall Study|Withdrawal by Subject|1|||
143286600|NCT03200860|516596233|FG000|Overall Study|Withdrawal by Subject|1|||
143286601|NCT03200860|516596234|FG001|Overall Study|Withdrawal by Subject|0|||
143286602|NCT00844896|516596235|FG000|Overall Study|Lost to Follow-up|12|||
143286603|NCT00844896|516596236|FG001|Overall Study|Lost to Follow-up|16|||
143286604|NCT00844896|516596235|FG000|Overall Study|Parents did not have time to complete|0|||
143286605|NCT00844896|516596236|FG001|Overall Study|Parents did not have time to complete|1|||
143286606|NCT02233647|516596237|FG000|Overall Study|Adverse Event|1|||
143286607|NCT02700815|516597875|FG000|Overall Study|Adverse Event|0|||
143286608|NCT02700815|516597876|FG001|Overall Study|Adverse Event|6|||
143286609|NCT02700815|516597877|FG002|Overall Study|Adverse Event|2|||
143286610|NCT02700815|516597878|FG003|Overall Study|Adverse Event|3|||
143286611|NCT02700815|516597875|FG000|Overall Study|Lack of Efficacy|0|||
143286612|NCT02700815|516597876|FG001|Overall Study|Lack of Efficacy|0|||
143286613|NCT02700815|516597877|FG002|Overall Study|Lack of Efficacy|1|||
143286614|NCT02700815|516597878|FG003|Overall Study|Lack of Efficacy|2|||
143286615|NCT02700815|516597875|FG000|Overall Study|Lost to Follow-up|1|||
143286616|NCT02700815|516597876|FG001|Overall Study|Lost to Follow-up|0|||
143286617|NCT02700815|516597877|FG002|Overall Study|Lost to Follow-up|0|||
143286618|NCT02700815|516597878|FG003|Overall Study|Lost to Follow-up|1|||
143286619|NCT02700815|516597875|FG000|Overall Study|Refusal to continue medication|0|||
143286620|NCT02700815|516597876|FG001|Overall Study|Refusal to continue medication|1|||
143286621|NCT02700815|516597877|FG002|Overall Study|Refusal to continue medication|0|||
143286622|NCT02700815|516597878|FG003|Overall Study|Refusal to continue medication|1|||
143286623|NCT02700815|516597875|FG000|Overall Study|Withdrawal by Subject|0|||
143286624|NCT02700815|516597876|FG001|Overall Study|Withdrawal by Subject|0|||
143286625|NCT02700815|516597877|FG002|Overall Study|Withdrawal by Subject|1|||
143286626|NCT02700815|516597878|FG003|Overall Study|Withdrawal by Subject|0|||
143286627|NCT02239978|516597882|FG000|Overall Study|Withdrawal by Subject|2|||
143373480|NCT04707313|516911475|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
143286628|NCT02239978|516597883|FG001|Overall Study|Withdrawal by Subject|0|||
143286629|NCT01852110|516597895|FG000|Overall Study|Adverse Event|12|||
143286630|NCT01852110|516597896|FG001|Overall Study|Adverse Event|5|||
143286631|NCT01852110|516597897|FG002|Overall Study|Adverse Event|0|||
143286632|NCT01852110|516597898|FG003|Overall Study|Adverse Event|0|||
143286633|NCT01852110|516597899|FG004|Overall Study|Adverse Event|0|||
143286634|NCT01852110|516597900|FG005|Overall Study|Adverse Event|0|||
143286635|NCT01852110|516597895|FG000|Overall Study|Lost to Follow-up|1|||
143286636|NCT01852110|516597896|FG001|Overall Study|Lost to Follow-up|3|||
143286637|NCT01852110|516597897|FG002|Overall Study|Lost to Follow-up|0|||
143286638|NCT01852110|516597898|FG003|Overall Study|Lost to Follow-up|0|||
143286639|NCT01852110|516597899|FG004|Overall Study|Lost to Follow-up|0|||
143286640|NCT01852110|516597900|FG005|Overall Study|Lost to Follow-up|0|||
143286641|NCT01852110|516597895|FG000|Overall Study|Non-compliance with Study Drug|2|||
143286642|NCT01852110|516597896|FG001|Overall Study|Non-compliance with Study Drug|1|||
143286643|NCT01852110|516597897|FG002|Overall Study|Non-compliance with Study Drug|0|||
143286644|NCT01852110|516597898|FG003|Overall Study|Non-compliance with Study Drug|0|||
143286645|NCT01852110|516597899|FG004|Overall Study|Non-compliance with Study Drug|0|||
143286646|NCT01852110|516597900|FG005|Overall Study|Non-compliance with Study Drug|0|||
143286647|NCT01852110|516597895|FG000|Overall Study|Physician Decision|1|||
143286648|NCT01852110|516597896|FG001|Overall Study|Physician Decision|0|||
143286649|NCT01852110|516597897|FG002|Overall Study|Physician Decision|0|||
143286650|NCT01852110|516597898|FG003|Overall Study|Physician Decision|0|||
143286651|NCT01852110|516597899|FG004|Overall Study|Physician Decision|0|||
143286652|NCT01852110|516597900|FG005|Overall Study|Physician Decision|0|||
143286653|NCT01852110|516597895|FG000|Overall Study|Protocol Violation|0|||
143286654|NCT01852110|516597896|FG001|Overall Study|Protocol Violation|1|||
143286655|NCT01852110|516597897|FG002|Overall Study|Protocol Violation|0|||
143286656|NCT01852110|516597898|FG003|Overall Study|Protocol Violation|0|||
143286657|NCT01852110|516597899|FG004|Overall Study|Protocol Violation|0|||
143286658|NCT01852110|516597900|FG005|Overall Study|Protocol Violation|0|||
143286659|NCT01852110|516597895|FG000|Overall Study|Study Terminated by Sponsor|30|||
143286660|NCT01852110|516597896|FG001|Overall Study|Study Terminated by Sponsor|32|||
143286661|NCT01852110|516597897|FG002|Overall Study|Study Terminated by Sponsor|0|||
143286662|NCT01852110|516597898|FG003|Overall Study|Study Terminated by Sponsor|0|||
143286663|NCT01852110|516597899|FG004|Overall Study|Study Terminated by Sponsor|0|||
143286664|NCT01852110|516597900|FG005|Overall Study|Study Terminated by Sponsor|0|||
143286665|NCT01852110|516597895|FG000|Overall Study|Withdrawal by Subject|4|||
143286666|NCT01852110|516597896|FG001|Overall Study|Withdrawal by Subject|4|||
143286667|NCT01852110|516597897|FG002|Overall Study|Withdrawal by Subject|0|||
143286668|NCT01852110|516597898|FG003|Overall Study|Withdrawal by Subject|0|||
143286669|NCT01852110|516597899|FG004|Overall Study|Withdrawal by Subject|0|||
143286670|NCT01852110|516597900|FG005|Overall Study|Withdrawal by Subject|0|||
143286671|NCT00793403|516597901|FG000|Overall Study|Other|73|||
143286672|NCT00759031|516597906|FG000|First Intervention (1 Day)|Physician Decision|1|||
143286673|NCT00759031|516597907|FG001|First Intervention (1 Day)|Physician Decision|0|||
143286674|NCT00759031|516597906|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
143286675|NCT00759031|516597907|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
143286676|NCT00759031|516597906|FG000|First Intervention (1 Day)|Screening failure|1|||
143286677|NCT00759031|516597907|FG001|First Intervention (1 Day)|Screening failure|0|||
143286678|NCT01327885|516597908|FG000|Overall Study|Disease progression-according to RECIST|173|||
143286679|NCT01327885|516597909|FG001|Overall Study|Disease progression-according to RECIST|165|||
143286680|NCT01327885|516597908|FG000|Overall Study|Clinical progression|24|||
143286681|NCT01327885|516597909|FG001|Overall Study|Clinical progression|27|||
143286682|NCT01327885|516597908|FG000|Overall Study|Adverse Event|14|||
143286683|NCT01327885|516597909|FG001|Overall Study|Adverse Event|10|||
143286684|NCT01327885|516597908|FG000|Overall Study|Subject choice|5|||
143286685|NCT01327885|516597909|FG001|Overall Study|Subject choice|10|||
143286686|NCT01327885|516597908|FG000|Overall Study|Other|8|||
143286687|NCT01327885|516597909|FG001|Overall Study|Other|6|||
143286688|NCT01327885|516597908|FG000|Overall Study|Withdrawal of consent from study|3|||
143286689|NCT01327885|516597909|FG001|Overall Study|Withdrawal of consent from study|4|||
143286690|NCT01327885|516597908|FG000|Overall Study|Not treated|1|||
143286691|NCT01327885|516597909|FG001|Overall Study|Not treated|1|||
143286692|NCT01327885|516597908|FG000|Overall Study|Administrative decision|0|||
143286693|NCT01327885|516597909|FG001|Overall Study|Administrative decision|1|||
143286694|NCT03138889|516597910|FG000|Overall Study|Withdrawal by Subject|5|||
143286695|NCT03138889|516597911|FG001|Overall Study|Withdrawal by Subject|5|||
143286696|NCT03138889|516597912|FG002|Overall Study|Withdrawal by Subject|0|||
143286697|NCT03138889|516597913|FG003|Overall Study|Withdrawal by Subject|2|||
143286698|NCT03138889|516597914|FG004|Overall Study|Withdrawal by Subject|1|||
143286699|NCT03138889|516597915|FG005|Overall Study|Withdrawal by Subject|3|||
143286700|NCT03138889|516597916|FG006|Overall Study|Withdrawal by Subject|0|||
143286701|NCT03138889|516597917|FG007|Overall Study|Withdrawal by Subject|1|||
143286702|NCT00105482|516597918|FG000|Overall Study|Adverse Event|1|||
143286703|NCT00105482|516597919|FG001|Overall Study|Adverse Event|1|||
143286704|NCT00105482|516597918|FG000|Overall Study|Lost to Follow-up|26|||
143286705|NCT00105482|516597919|FG001|Overall Study|Lost to Follow-up|17|||
143286706|NCT00105482|516597918|FG000|Overall Study|Withdrawal by Subject|0|||
143286707|NCT00105482|516597919|FG001|Overall Study|Withdrawal by Subject|1|||
143286708|NCT00105482|516597918|FG000|Overall Study|Lost Interest|29|||
143286709|NCT00105482|516597919|FG001|Overall Study|Lost Interest|32|||
143286710|NCT00105482|516597918|FG000|Overall Study|Scheduling Conflict|2|||
143286711|NCT00105482|516597919|FG001|Overall Study|Scheduling Conflict|3|||
143286712|NCT00105482|516597918|FG000|Overall Study|Withdrawn by PI|1|||
143286713|NCT00105482|516597919|FG001|Overall Study|Withdrawn by PI|1|||
143286714|NCT01349790|516597920|FG000|Overall Study|Investigator Judgement|3|||
143286715|NCT01349790|516597920|FG000|Overall Study|Death|2|||
143286716|NCT01349790|516597920|FG000|Overall Study|Withdrawal by Patient|2|||
143286717|NCT01349790|516597920|FG000|Overall Study|Adverse Event|1|||
143286718|NCT01349790|516597920|FG000|Overall Study|Lost to Follow-up|1|||
143286719|NCT02573350|516597921|FG000|Overall Study|Lost to Follow-up|2|||
143286720|NCT02573350|516597922|FG001|Overall Study|Lost to Follow-up|1|||
143286721|NCT02573350|516597921|FG000|Overall Study|Adverse Event|3|||
143286722|NCT02573350|516597922|FG001|Overall Study|Adverse Event|4|||
143286723|NCT02573350|516597921|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
143286724|NCT02573350|516597922|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
143286725|NCT02573350|516597921|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
143286726|NCT02573350|516597922|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
143286727|NCT02573350|516597921|FG000|Overall Study|Subject withdrew consent to participate|6|||
143286728|NCT02573350|516597922|FG001|Overall Study|Subject withdrew consent to participate|1|||
143286729|NCT02573350|516597921|FG000|Overall Study|Protocol Deviation|1|||
143286730|NCT02573350|516597922|FG001|Overall Study|Protocol Deviation|1|||
143286731|NCT02708121|516597923|FG000|Overall Study|Withdrawn by Study Team|1|||
143286732|NCT02708121|516597924|FG001|Overall Study|Withdrawn by Study Team|1|||
143286733|NCT02708121|516597923|FG000|Overall Study|Withdrawal by Subject|0|||
143286734|NCT02708121|516597924|FG001|Overall Study|Withdrawal by Subject|4|||
143286735|NCT02547649|516597927|FG000|Overall Study|Lost to Follow-up|3|||
143286736|NCT02547649|516597928|FG001|Overall Study|Lost to Follow-up|1|||
143286737|NCT02547649|516597929|FG002|Overall Study|Lost to Follow-up|1|||
143286738|NCT02547649|516597927|FG000|Overall Study|Not vaccinated|0|||
143286739|NCT02547649|516597928|FG001|Overall Study|Not vaccinated|0|||
143286740|NCT02547649|516597929|FG002|Overall Study|Not vaccinated|1|||
143286741|NCT02547649|516597927|FG000|Overall Study|Withdrawal by Subject|0|||
143286742|NCT02547649|516597928|FG001|Overall Study|Withdrawal by Subject|4|||
143286743|NCT02547649|516597929|FG002|Overall Study|Withdrawal by Subject|2|||
143286744|NCT01750242|516597932|FG000|Overall Study|Unreadable Images|3|||
143286745|NCT03765918|516597935|FG000|Overall Study|Death|109|||
143286746|NCT03765918|516597936|FG001|Overall Study|Death|127|||
143286747|NCT03765918|516597935|FG000|Overall Study|Lost to Follow-up|2|||
143286748|NCT03765918|516597936|FG001|Overall Study|Lost to Follow-up|3|||
143286749|NCT03765918|516597935|FG000|Overall Study|Withdrawal by Subject|12|||
143286750|NCT03765918|516597936|FG001|Overall Study|Withdrawal by Subject|16|||
143286751|NCT03765918|516597935|FG000|Overall Study|Participants Ongoing|240|||
143286752|NCT03765918|516597936|FG001|Overall Study|Participants Ongoing|205|||
143286753|NCT04202965|516597937|FG000|Overall Study|Adverse Event|3|||
143286754|NCT04202965|516597937|FG000|Overall Study|Did not meet inclusion criteria|1|||
143286755|NCT00006903|516597938|FG000|Overall Study|Still receiving treatment|0|||
143286756|NCT00006903|516597939|FG001|Overall Study|Still receiving treatment|0|||
143286757|NCT00006903|516597940|FG002|Overall Study|Still receiving treatment|1|||
143286758|NCT00006903|516597938|FG000|Overall Study|Refused further treatment|0|||
143286759|NCT00006903|516597939|FG001|Overall Study|Refused further treatment|2|||
143286760|NCT00006903|516597940|FG002|Overall Study|Refused further treatment|1|||
143286761|NCT00006903|516597938|FG000|Overall Study|Adverse Event|0|||
143286762|NCT00006903|516597939|FG001|Overall Study|Adverse Event|0|||
143286763|NCT00006903|516597940|FG002|Overall Study|Adverse Event|1|||
143286764|NCT00006903|516597938|FG000|Overall Study|Death|0|||
143286765|NCT00006903|516597939|FG001|Overall Study|Death|1|||
143286766|NCT00006903|516597940|FG002|Overall Study|Death|0|||
143286767|NCT00006903|516597938|FG000|Overall Study|Patient never treated|0|||
143286768|NCT00006903|516597939|FG001|Overall Study|Patient never treated|0|||
143286769|NCT00006903|516597940|FG002|Overall Study|Patient never treated|1|||
143286770|NCT00006903|516597938|FG000|Overall Study|Ineligible|10|||
143286771|NCT00006903|516597939|FG001|Overall Study|Ineligible|1|||
143286772|NCT00006903|516597940|FG002|Overall Study|Ineligible|2|||
143286773|NCT01909674|516597941|FG000|Overall Study|Withdrawal by Subject|5|||
143286774|NCT01909674|516597942|FG001|Overall Study|Withdrawal by Subject|2|||
143286775|NCT02969369|516597943|FG000|Study|Adverse Event|1|||
143286776|NCT02969369|516597944|FG001|Study|Adverse Event|6|||
143286777|NCT02969369|516597943|FG000|Study|Lack of Efficacy|0|||
143286778|NCT02969369|516597944|FG001|Study|Lack of Efficacy|1|||
143286779|NCT02969369|516597943|FG000|Study|Lost to Follow-up|0|||
143286780|NCT02969369|516597944|FG001|Study|Lost to Follow-up|1|||
143286781|NCT02969369|516597943|FG000|Study|Withdrawal by Subject|3|||
143286782|NCT02969369|516597944|FG001|Study|Withdrawal by Subject|5|||
143286783|NCT02969369|516597943|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
143286784|NCT02969369|516597944|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
143286785|NCT02969369|516597943|FG000|Double-blind Period|Adverse Event|1|||
143286786|NCT02969369|516597944|FG001|Double-blind Period|Adverse Event|5|||
143286787|NCT02969369|516597943|FG000|Double-blind Period|Lost to Follow-up|0|||
143286788|NCT02969369|516597944|FG001|Double-blind Period|Lost to Follow-up|1|||
143286789|NCT02969369|516597943|FG000|Double-blind Period|Withdrawal by Subject|2|||
143286790|NCT02969369|516597944|FG001|Double-blind Period|Withdrawal by Subject|3|||
143286791|NCT02969369|516597943|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
143286792|NCT02969369|516597944|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
143286793|NCT02969369|516597943|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
143286794|NCT02969369|516597944|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
143286795|NCT02969369|516597943|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
143286796|NCT02969369|516597944|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
143286797|NCT02969369|516597943|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
143286798|NCT02969369|516597944|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
143286799|NCT01484197|516597946|FG000|Treatment Period 1|Adverse Event|1|||
143286800|NCT01484197|516597947|FG001|Treatment Period 1|Adverse Event|0|||
143286801|NCT01484197|516597948|FG002|Treatment Period 1|Adverse Event|0|||
143286802|NCT01484197|516597949|FG003|Treatment Period 1|Adverse Event|0|||
143286803|NCT01484197|516597946|FG000|Treatment Period 2|Subject withdrew consent|0|||
143286804|NCT01484197|516597947|FG001|Treatment Period 2|Subject withdrew consent|0|||
143286805|NCT01484197|516597948|FG002|Treatment Period 2|Subject withdrew consent|0|||
143286806|NCT01484197|516597949|FG003|Treatment Period 2|Subject withdrew consent|1|||
143286807|NCT01169493|516597954|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
143286808|NCT01169493|516597955|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
143286809|NCT01169493|516597956|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
143286810|NCT01169493|516597957|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
143286811|NCT01169493|516597958|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
143286812|NCT01169493|516597959|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
143286813|NCT01169493|516597954|FG000|Period 3 (6 Months)|Adverse Event|0|||
143286814|NCT01169493|516597955|FG001|Period 3 (6 Months)|Adverse Event|1|||
143286815|NCT01169493|516597956|FG002|Period 3 (6 Months)|Adverse Event|0|||
143286816|NCT01169493|516597957|FG003|Period 3 (6 Months)|Adverse Event|0|||
143286817|NCT01169493|516597958|FG004|Period 3 (6 Months)|Adverse Event|0|||
143286818|NCT01169493|516597959|FG005|Period 3 (6 Months)|Adverse Event|0|||
143286819|NCT01169493|516597954|FG000|Period 3 (6 Months)|Physician Decision|0|||
143286820|NCT01169493|516597955|FG001|Period 3 (6 Months)|Physician Decision|1|||
143286821|NCT01169493|516597956|FG002|Period 3 (6 Months)|Physician Decision|1|||
143286822|NCT01169493|516597957|FG003|Period 3 (6 Months)|Physician Decision|0|||
143286823|NCT01169493|516597958|FG004|Period 3 (6 Months)|Physician Decision|0|||
143286824|NCT01169493|516597959|FG005|Period 3 (6 Months)|Physician Decision|0|||
143286825|NCT03167411|516597960|FG000|Overall Study|Adverse Event|0|||
143286826|NCT03167411|516597961|FG001|Overall Study|Adverse Event|1|||
143286827|NCT02627144|516597964|FG000|Overall Study|Serious adverse event|32|||
143286828|NCT02627144|516597964|FG000|Overall Study|Cancer progression|171|||
143286829|NCT02627144|516597964|FG000|Overall Study|Death from cancer|20|||
143286830|NCT02627144|516597964|FG000|Overall Study|Death from other cause|8|||
143373481|NCT04707313|516911476|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
143373482|NCT04707313|516911477|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
143373483|NCT04707313|516911478|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
143373484|NCT04707313|516911479|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
143373485|NCT04707313|516911480|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
143373486|NCT04707313|516911468|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
143373487|NCT04707313|516911469|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
143373488|NCT04707313|516911470|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
143373489|NCT04707313|516911471|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
143373490|NCT04707313|516911472|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
143373491|NCT04707313|516911473|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
143373492|NCT04707313|516911474|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
143373493|NCT04707313|516911475|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
143373494|NCT04707313|516911476|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
143373495|NCT04707313|516911477|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
143373496|NCT04707313|516911478|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
143373497|NCT04707313|516911479|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
143373498|NCT04707313|516911480|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
143373499|NCT04707313|516911468|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
143373500|NCT04707313|516911469|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
143373501|NCT04707313|516911470|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
143373502|NCT04707313|516911471|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
143373503|NCT04707313|516911472|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
143373504|NCT04707313|516911473|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
143373505|NCT04707313|516911474|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
143373506|NCT04707313|516911475|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
143373507|NCT04707313|516911476|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
143373508|NCT04707313|516911477|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
143373509|NCT04707313|516911478|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
143373510|NCT04707313|516911479|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
143373511|NCT04707313|516911480|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
143286831|NCT02627144|516597964|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
143286832|NCT02627144|516597964|FG000|Overall Study|Administrative reasons|65|||
143286833|NCT02627144|516597964|FG000|Overall Study|Lost to Follow-up|8|||
143286834|NCT02627144|516597964|FG000|Overall Study|Enrolled, not treated|6|||
143286835|NCT02627144|516597964|FG000|Overall Study|Other|17|||
143286836|NCT02651922|516597969|FG000|Overall Study|due to exclusion criteria|2|||
143286837|NCT02557646|516597970|FG000|Overall Study|Adverse Event|40|||
143286838|NCT02557646|516597970|FG000|Overall Study|Death|1|||
143286839|NCT02557646|516597970|FG000|Overall Study|Lack of Efficacy|186|||
143286840|NCT02557646|516597970|FG000|Overall Study|Withdrawal by Subject|18|||
143286841|NCT02557646|516597970|FG000|Overall Study|Lost to Follow-up|17|||
143286842|NCT02557646|516597970|FG000|Overall Study|Other|14|||
143286843|NCT01217814|516597971|FG000|Overall Study|Adverse Event|1|||
143286844|NCT01217814|516597972|FG001|Overall Study|Adverse Event|1|||
143286845|NCT01217814|516597973|FG002|Overall Study|Adverse Event|0|||
143286846|NCT01217814|516597971|FG000|Overall Study|Lack of Efficacy|0|||
143286847|NCT01217814|516597972|FG001|Overall Study|Lack of Efficacy|0|||
143286848|NCT01217814|516597973|FG002|Overall Study|Lack of Efficacy|1|||
143286849|NCT00496054|516597978|FG000|Overall Study|Adverse Event|1|||
143286850|NCT00496054|516597978|FG000|Overall Study|Lost to Follow-up|7|||
143286851|NCT00458211|516597983|FG000|Overall Study|Lack of Efficacy|12|||
143286852|NCT00458211|516597983|FG000|Overall Study|Withdrawal by Subject|2|||
143286853|NCT00458211|516597983|FG000|Overall Study|Protocol Violation|2|||
143286854|NCT04342897|516597984|FG000|Overall Study|Death|7|||
143286855|NCT04342897|516597985|FG001|Overall Study|Death|4|||
143286856|NCT04342897|516597984|FG000|Overall Study|Lost to Follow-up|6|||
143286857|NCT04342897|516597985|FG001|Overall Study|Lost to Follow-up|6|||
143286858|NCT04342897|516597984|FG000|Overall Study|Withdrawal by Subject|1|||
143286859|NCT04342897|516597985|FG001|Overall Study|Withdrawal by Subject|2|||
143286860|NCT00621153|516597989|FG000|Overall Study|Safety Reason|8|||
143286861|NCT00621153|516597990|FG001|Overall Study|Safety Reason|7|||
143286862|NCT00621153|516597989|FG000|Overall Study|Adverse Event|3|||
143286863|NCT00621153|516597990|FG001|Overall Study|Adverse Event|2|||
143286864|NCT00621153|516597989|FG000|Overall Study|Lost to Follow-up|5|||
143286865|NCT00621153|516597990|FG001|Overall Study|Lost to Follow-up|1|||
143286866|NCT00621153|516597989|FG000|Overall Study|Withdrawal by Subject|4|||
143286867|NCT00621153|516597990|FG001|Overall Study|Withdrawal by Subject|5|||
143286868|NCT02634320|516597992|FG000|Overall Study|Adverse Event|2|||
143286869|NCT02634320|516597992|FG000|Overall Study|Lost to Follow-up|3|||
143286870|NCT02634320|516597992|FG000|Overall Study|Moved out of area|2|||
143286871|NCT02634320|516597992|FG000|Overall Study|Out of window for study visits|1|||
143286872|NCT02634320|516597992|FG000|Overall Study|Protocol Violation|1|||
143286873|NCT02634320|516597992|FG000|Overall Study|Withdrawal by Subject|5|||
143286874|NCT02634320|516597992|FG000|Overall Study|Lack of Efficacy|2|||
143286875|NCT00838578|516597997|FG000|Overall Study|Protocol Violation|2|||
143286876|NCT00598832|516597998|FG000|Overall Study|Lack of Efficacy|3|||
143286877|NCT00598832|516597999|FG001|Overall Study|Lack of Efficacy|7|||
143286878|NCT00598832|516597998|FG000|Overall Study|Adverse Event|6|||
143286879|NCT00598832|516597999|FG001|Overall Study|Adverse Event|2|||
143286880|NCT00598832|516597998|FG000|Overall Study|Withdrawal by Subject|25|||
143286881|NCT00598832|516597999|FG001|Overall Study|Withdrawal by Subject|36|||
143286882|NCT00598832|516597998|FG000|Overall Study|Protocol Violation|0|||
143286883|NCT00598832|516597999|FG001|Overall Study|Protocol Violation|2|||
143286884|NCT00598832|516597998|FG000|Overall Study|Lost to Follow-up|24|||
143286885|NCT00598832|516597999|FG001|Overall Study|Lost to Follow-up|29|||
143286886|NCT00598832|516597998|FG000|Overall Study|Pregnancy|2|||
143286887|NCT00598832|516597999|FG001|Overall Study|Pregnancy|2|||
143286888|NCT00598832|516597998|FG000|Overall Study|Physician Decision|1|||
143286889|NCT00598832|516597999|FG001|Overall Study|Physician Decision|4|||
143286890|NCT00598832|516597998|FG000|Overall Study|Non compliance|1|||
143286891|NCT00598832|516597999|FG001|Overall Study|Non compliance|0|||
143286892|NCT00357968|516598000|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
143286893|NCT00357968|516598001|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
143286894|NCT00357968|516598000|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
143286895|NCT00357968|516598001|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
143286896|NCT03919799|516598006|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
143286897|NCT03919799|516598007|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
143286898|NCT03919799|516598008|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
143286899|NCT03919799|516598009|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
143286900|NCT03919799|516598010|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
143286901|NCT03919799|516598006|FG000|DB Period (28 Weeks)|Adverse Event|1|||
143286902|NCT03919799|516598007|FG001|DB Period (28 Weeks)|Adverse Event|1|||
143286903|NCT03919799|516598008|FG002|DB Period (28 Weeks)|Adverse Event|1|||
143286904|NCT03919799|516598009|FG003|DB Period (28 Weeks)|Adverse Event|0|||
143286905|NCT03919799|516598010|FG004|DB Period (28 Weeks)|Adverse Event|0|||
143286906|NCT03919799|516598006|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
143286907|NCT03919799|516598007|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
143286908|NCT03919799|516598008|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
143286909|NCT03919799|516598009|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
143286910|NCT03919799|516598010|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
143286911|NCT03919799|516598006|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
143286912|NCT03919799|516598007|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
143286913|NCT03919799|516598008|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
143286914|NCT03919799|516598009|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
143286915|NCT03919799|516598010|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
143286916|NCT03919799|516598006|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
143286917|NCT03919799|516598007|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
143286918|NCT03919799|516598008|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
143286919|NCT03919799|516598009|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
143286920|NCT03919799|516598010|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
143286921|NCT02142959|516598011|FG000|Overall Study|Adverse Event|1|||
143286922|NCT02142959|516598012|FG001|Overall Study|Adverse Event|0|||
143286923|NCT02142959|516598013|FG002|Overall Study|Adverse Event|0|||
143286924|NCT02142959|516598011|FG000|Overall Study|Death|0|||
143286925|NCT02142959|516598012|FG001|Overall Study|Death|1|||
143286926|NCT02142959|516598013|FG002|Overall Study|Death|0|||
143286927|NCT02142959|516598011|FG000|Overall Study|Withdrawal by Subject|3|||
143286928|NCT02142959|516598012|FG001|Overall Study|Withdrawal by Subject|1|||
143286929|NCT02142959|516598013|FG002|Overall Study|Withdrawal by Subject|3|||
143286930|NCT02142959|516598011|FG000|Overall Study|Administrative Reasons|1|||
143286931|NCT02142959|516598012|FG001|Overall Study|Administrative Reasons|0|||
143286932|NCT02142959|516598013|FG002|Overall Study|Administrative Reasons|1|||
143286933|NCT02142959|516598011|FG000|Overall Study|Missing|0|||
143286934|NCT02142959|516598012|FG001|Overall Study|Missing|1|||
143286935|NCT02142959|516598013|FG002|Overall Study|Missing|0|||
143286936|NCT02142959|516598011|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
143286937|NCT02142959|516598012|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
143286938|NCT02142959|516598013|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
143286939|NCT02142959|516598011|FG000|Overall Study|Patient didn't complete end of study visit|0|||
143286940|NCT02142959|516598012|FG001|Overall Study|Patient didn't complete end of study visit|0|||
143286941|NCT02142959|516598013|FG002|Overall Study|Patient didn't complete end of study visit|1|||
143286942|NCT03547687|516598014|FG000|Overall Study|Withdrawal by Subject|1|||
143286943|NCT03547687|516598014|FG000|Overall Study|Death|1|||
143286944|NCT00679302|516598015|FG000|Overall Study|Lost to Follow-up|8|||
143286945|NCT00679302|516598016|FG001|Overall Study|Lost to Follow-up|4|||
143286946|NCT01482884|516598021|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
143286947|NCT01482884|516598022|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
143286948|NCT01482884|516598021|FG000|Overall Study|Protocol Violation|1|||
143286949|NCT01482884|516598022|FG001|Overall Study|Protocol Violation|0|||
143286950|NCT01482884|516598021|FG000|Overall Study|Lost to Follow-up|2|||
143286951|NCT01482884|516598022|FG001|Overall Study|Lost to Follow-up|2|||
143286952|NCT01482884|516598021|FG000|Overall Study|Lack of Efficacy|0|||
143286953|NCT01482884|516598022|FG001|Overall Study|Lack of Efficacy|1|||
143286954|NCT01482884|516598021|FG000|Overall Study|Adverse Event|2|||
143286955|NCT01482884|516598022|FG001|Overall Study|Adverse Event|1|||
143286956|NCT01482884|516598021|FG000|Overall Study|Withdrawal by Subject|8|||
143286957|NCT01482884|516598022|FG001|Overall Study|Withdrawal by Subject|13|||
143286958|NCT00439244|516598025|FG000|Overall Study|Adverse Event|5|||
143286959|NCT00439244|516598026|FG001|Overall Study|Adverse Event|2|||
143286960|NCT00439244|516598027|FG002|Overall Study|Adverse Event|3|||
143286961|NCT00439244|516598025|FG000|Overall Study|Withdrawal by Subject|3|||
143286962|NCT00439244|516598026|FG001|Overall Study|Withdrawal by Subject|1|||
143286963|NCT00439244|516598027|FG002|Overall Study|Withdrawal by Subject|2|||
143286964|NCT00439244|516598025|FG000|Overall Study|Lost to Follow-up|2|||
143286965|NCT00439244|516598026|FG001|Overall Study|Lost to Follow-up|1|||
143286966|NCT00439244|516598027|FG002|Overall Study|Lost to Follow-up|2|||
143286967|NCT00439244|516598025|FG000|Overall Study|Death|0|||
143286968|NCT00439244|516598026|FG001|Overall Study|Death|1|||
143286969|NCT00439244|516598027|FG002|Overall Study|Death|0|||
143286970|NCT00439244|516598025|FG000|Overall Study|Protocol Violation|0|||
143286971|NCT00439244|516598026|FG001|Overall Study|Protocol Violation|1|||
143286972|NCT00439244|516598027|FG002|Overall Study|Protocol Violation|0|||
143286973|NCT00439244|516598025|FG000|Overall Study|Administrative problems|1|||
143286974|NCT00439244|516598026|FG001|Overall Study|Administrative problems|0|||
143286975|NCT00439244|516598027|FG002|Overall Study|Administrative problems|0|||
143286976|NCT01753856|516598028|FG000|Overall Study|Adverse Event|1|||
143286977|NCT01753856|516598029|FG001|Overall Study|Adverse Event|0|||
143286978|NCT01753856|516598028|FG000|Overall Study|Withdrawal by Subject|0|||
143286979|NCT01753856|516598029|FG001|Overall Study|Withdrawal by Subject|2|||
143286980|NCT01753856|516598028|FG000|Overall Study|Sponsor Decision|2|||
143286981|NCT01753856|516598029|FG001|Overall Study|Sponsor Decision|0|||
143286982|NCT04600921|516598032|FG000|Overall Study|Withdrawal by Subject|3|||
143286983|NCT04600921|516598033|FG001|Overall Study|Withdrawal by Subject|5|||
143286984|NCT04600921|516598032|FG000|Overall Study|Death|0|||
143286985|NCT04600921|516598033|FG001|Overall Study|Death|1|||
143373512|NCT04707313|516911468|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
143373513|NCT04707313|516911469|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
143373514|NCT04707313|516911470|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
143373515|NCT04707313|516911471|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
143373516|NCT04707313|516911472|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
143373517|NCT04707313|516911473|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
143373518|NCT04707313|516911474|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
143373519|NCT04707313|516911475|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
143373520|NCT04707313|516911476|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
143373521|NCT04707313|516911477|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
143373522|NCT04707313|516911478|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
143373523|NCT04707313|516911479|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
143373524|NCT04707313|516911480|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
143373525|NCT04707313|516911468|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
143373526|NCT04707313|516911469|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
143373527|NCT04707313|516911470|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
143373528|NCT04707313|516911471|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
143373529|NCT04707313|516911472|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
143373530|NCT04707313|516911473|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
143373531|NCT04707313|516911474|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
143373532|NCT04707313|516911475|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
143373533|NCT04707313|516911476|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
143373534|NCT04707313|516911477|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
143373535|NCT04707313|516911478|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
143373536|NCT04707313|516911479|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
143373537|NCT04707313|516911480|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
143373538|NCT04707313|516911468|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
143373539|NCT04707313|516911469|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
143373540|NCT04707313|516911470|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
143373541|NCT04707313|516911471|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
143373542|NCT04707313|516911472|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
143373543|NCT04707313|516911473|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
143373544|NCT04707313|516911474|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
143373545|NCT04707313|516911475|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
143373546|NCT04707313|516911476|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
143373547|NCT04707313|516911477|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
143373548|NCT04707313|516911478|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
143373549|NCT04707313|516911479|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
143373550|NCT04707313|516911480|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
143373551|NCT04707313|516911468|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
143373552|NCT04707313|516911469|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
143286986|NCT00842712|516599638|FG000|Safety Run-in Part|Adverse Event|0|||
143286987|NCT00842712|516599639|FG001|Safety Run-in Part|Adverse Event|1|||
143286988|NCT00842712|516599640|FG002|Safety Run-in Part|Adverse Event|0|||
143286989|NCT00842712|516599641|FG003|Safety Run-in Part|Adverse Event|0|||
143286990|NCT00842712|516599642|FG004|Safety Run-in Part|Adverse Event|0|||
143286991|NCT00842712|516599643|FG005|Safety Run-in Part|Adverse Event|0|||
143286992|NCT00842712|516599644|FG006|Safety Run-in Part|Adverse Event|0|||
143286993|NCT00842712|516599638|FG000|Safety Run-in Part|Progressive disease|3|||
143286994|NCT00842712|516599639|FG001|Safety Run-in Part|Progressive disease|1|||
143286995|NCT00842712|516599640|FG002|Safety Run-in Part|Progressive disease|0|||
143286996|NCT00842712|516599641|FG003|Safety Run-in Part|Progressive disease|1|||
143286997|NCT00842712|516599642|FG004|Safety Run-in Part|Progressive disease|0|||
143286998|NCT00842712|516599643|FG005|Safety Run-in Part|Progressive disease|0|||
143286999|NCT00842712|516599644|FG006|Safety Run-in Part|Progressive disease|0|||
143287000|NCT00842712|516599638|FG000|Randomized Part|Randomized but not treated|0|||
143287001|NCT00842712|516599639|FG001|Randomized Part|Randomized but not treated|0|||
143287002|NCT00842712|516599640|FG002|Randomized Part|Randomized but not treated|0|||
143287003|NCT00842712|516599641|FG003|Randomized Part|Randomized but not treated|0|||
143287004|NCT00842712|516599642|FG004|Randomized Part|Randomized but not treated|0|||
143287005|NCT00842712|516599643|FG005|Randomized Part|Randomized but not treated|1|||
143287006|NCT00842712|516599644|FG006|Randomized Part|Randomized but not treated|4|||
143287007|NCT00842712|516599638|FG000|Randomized Part|Ongoing at cut-off date|0|||
143287008|NCT00842712|516599639|FG001|Randomized Part|Ongoing at cut-off date|0|||
143287009|NCT00842712|516599640|FG002|Randomized Part|Ongoing at cut-off date|0|||
143287010|NCT00842712|516599641|FG003|Randomized Part|Ongoing at cut-off date|0|||
143287011|NCT00842712|516599642|FG004|Randomized Part|Ongoing at cut-off date|0|||
143287012|NCT00842712|516599643|FG005|Randomized Part|Ongoing at cut-off date|0|||
143287013|NCT00842712|516599644|FG006|Randomized Part|Ongoing at cut-off date|2|||
143287014|NCT00410046|516599645|FG000|Overall Study|Adverse Event|3|||
143287015|NCT00410046|516599645|FG000|Overall Study|Withdrawal by Subject|1|||
143287016|NCT00410046|516599645|FG000|Overall Study|Lost to Follow-up|1|||
143287017|NCT02141282|516599646|FG000|Overall Study|Adverse event, not related to progression|8|||
143287018|NCT02141282|516599647|FG001|Overall Study|Adverse event, not related to progression|1|||
143287019|NCT02141282|516599648|FG002|Overall Study|Adverse event, not related to progression|3|||
143287020|NCT02141282|516599649|FG003|Overall Study|Adverse event, not related to progression|1|||
143287021|NCT02141282|516599646|FG000|Overall Study|Adverse event, related to progression|1|||
143287022|NCT02141282|516599647|FG001|Overall Study|Adverse event, related to progression|0|||
143287023|NCT02141282|516599648|FG002|Overall Study|Adverse event, related to progression|2|||
143287024|NCT02141282|516599649|FG003|Overall Study|Adverse event, related to progression|0|||
143287025|NCT02141282|516599646|FG000|Overall Study|COVID-19 infection|1|||
143287026|NCT02141282|516599647|FG001|Overall Study|COVID-19 infection|0|||
143287027|NCT02141282|516599648|FG002|Overall Study|COVID-19 infection|0|||
143287028|NCT02141282|516599649|FG003|Overall Study|COVID-19 infection|0|||
143287029|NCT02141282|516599646|FG000|Overall Study|Lost to Follow-up|0|||
143287030|NCT02141282|516599647|FG001|Overall Study|Lost to Follow-up|0|||
143287031|NCT02141282|516599648|FG002|Overall Study|Lost to Follow-up|4|||
143287032|NCT02141282|516599649|FG003|Overall Study|Lost to Follow-up|2|||
143287033|NCT02141282|516599646|FG000|Overall Study|Other, not specified|14|||
143287034|NCT02141282|516599647|FG001|Overall Study|Other, not specified|11|||
143287035|NCT02141282|516599648|FG002|Overall Study|Other, not specified|23|||
143287036|NCT02141282|516599649|FG003|Overall Study|Other, not specified|9|||
143287037|NCT02141282|516599646|FG000|Overall Study|Progressive disease, Richter's|4|||
143287038|NCT02141282|516599647|FG001|Overall Study|Progressive disease, Richter's|1|||
143287039|NCT02141282|516599648|FG002|Overall Study|Progressive disease, Richter's|1|||
143287040|NCT02141282|516599649|FG003|Overall Study|Progressive disease, Richter's|1|||
143287041|NCT02141282|516599646|FG000|Overall Study|Progressive disease per protocol|12|||
143287042|NCT02141282|516599647|FG001|Overall Study|Progressive disease per protocol|7|||
143287043|NCT02141282|516599648|FG002|Overall Study|Progressive disease per protocol|9|||
143287044|NCT02141282|516599649|FG003|Overall Study|Progressive disease per protocol|2|||
143287045|NCT02141282|516599646|FG000|Overall Study|Stem cell transplant|1|||
143287046|NCT02141282|516599647|FG001|Overall Study|Stem cell transplant|0|||
143287047|NCT02141282|516599648|FG002|Overall Study|Stem cell transplant|1|||
143287048|NCT02141282|516599649|FG003|Overall Study|Stem cell transplant|0|||
143287049|NCT02141282|516599646|FG000|Overall Study|Study terminated by Sponsor|0|||
143287050|NCT02141282|516599647|FG001|Overall Study|Study terminated by Sponsor|1|||
143287051|NCT02141282|516599648|FG002|Overall Study|Study terminated by Sponsor|0|||
143287052|NCT02141282|516599649|FG003|Overall Study|Study terminated by Sponsor|0|||
143287053|NCT02141282|516599646|FG000|Overall Study|Subject non-compliance|0|||
143287054|NCT02141282|516599647|FG001|Overall Study|Subject non-compliance|0|||
143287055|NCT02141282|516599648|FG002|Overall Study|Subject non-compliance|1|||
143287056|NCT02141282|516599649|FG003|Overall Study|Subject non-compliance|0|||
143287057|NCT02141282|516599646|FG000|Overall Study|Withdrew consent|2|||
143287058|NCT02141282|516599647|FG001|Overall Study|Withdrew consent|0|||
143287059|NCT02141282|516599648|FG002|Overall Study|Withdrew consent|4|||
143287060|NCT02141282|516599649|FG003|Overall Study|Withdrew consent|0|||
143287061|NCT01752907|516599651|FG000|Overall Study|Withdrawal by Subject|4|||
143287062|NCT01752907|516599652|FG001|Overall Study|Withdrawal by Subject|10|||
143287063|NCT01752907|516599651|FG000|Overall Study|Lost to Follow-up|2|||
143287064|NCT01752907|516599652|FG001|Overall Study|Lost to Follow-up|1|||
143287065|NCT01752907|516599651|FG000|Overall Study|Decision by Sponsor|6|||
143287066|NCT01752907|516599652|FG001|Overall Study|Decision by Sponsor|9|||
143287067|NCT03098550|516599653|FG000|Overall Study|Disease Progression|30|||
143287068|NCT03098550|516599654|FG001|Overall Study|Disease Progression|19|||
143287069|NCT03098550|516599655|FG002|Overall Study|Disease Progression|41|||
143287070|NCT03098550|516599653|FG000|Overall Study|Study Drug Toxicity|2|||
143287071|NCT03098550|516599654|FG001|Overall Study|Study Drug Toxicity|1|||
143287072|NCT03098550|516599655|FG002|Overall Study|Study Drug Toxicity|0|||
143287073|NCT03098550|516599653|FG000|Overall Study|Death|1|||
143287074|NCT03098550|516599654|FG001|Overall Study|Death|0|||
143287075|NCT03098550|516599655|FG002|Overall Study|Death|0|||
143287076|NCT03098550|516599653|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
143287077|NCT03098550|516599654|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
143287078|NCT03098550|516599655|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
143287079|NCT03098550|516599653|FG000|Overall Study|Administrative reason by sponsor|0|||
143287080|NCT03098550|516599654|FG001|Overall Study|Administrative reason by sponsor|0|||
143287081|NCT03098550|516599655|FG002|Overall Study|Administrative reason by sponsor|1|||
143287082|NCT03098550|516599653|FG000|Overall Study|Other reasons|2|||
143287083|NCT03098550|516599654|FG001|Overall Study|Other reasons|0|||
143287084|NCT03098550|516599655|FG002|Overall Study|Other reasons|0|||
143287085|NCT02310568|516599656|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
143287086|NCT02310568|516599657|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
143287087|NCT02310568|516599658|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
143287088|NCT02310568|516599659|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
143287089|NCT02310568|516599660|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
143287090|NCT02310568|516599656|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
143287091|NCT02310568|516599657|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
143287092|NCT02310568|516599658|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
143287093|NCT02310568|516599659|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
143287094|NCT02310568|516599660|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
143287095|NCT02310568|516599656|FG000|Stage 1 ( 4 Weeks)|Other|1|||
143287096|NCT02310568|516599657|FG001|Stage 1 ( 4 Weeks)|Other|1|||
143287097|NCT02310568|516599658|FG002|Stage 1 ( 4 Weeks)|Other|0|||
143287098|NCT02310568|516599659|FG003|Stage 1 ( 4 Weeks)|Other|0|||
143287099|NCT02310568|516599660|FG004|Stage 1 ( 4 Weeks)|Other|0|||
143287100|NCT02310568|516599656|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
143287101|NCT02310568|516599657|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
143287102|NCT02310568|516599658|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
143287103|NCT02310568|516599659|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
143287104|NCT02310568|516599660|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
143287105|NCT02310568|516599656|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
143287106|NCT02310568|516599657|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
143287107|NCT02310568|516599658|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
143287108|NCT02310568|516599659|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
143287109|NCT02310568|516599660|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
143287110|NCT02310568|516599656|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
143287111|NCT02310568|516599657|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
143287112|NCT02310568|516599658|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
143287113|NCT02310568|516599659|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
143287114|NCT02310568|516599660|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
143287115|NCT02310568|516599656|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
143287116|NCT02310568|516599657|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
143287117|NCT02310568|516599658|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
143287118|NCT02310568|516599659|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
143287119|NCT02310568|516599660|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
143287120|NCT02310568|516599656|FG000|Stage 2 (4 Weeks)|Other|0|||
143287121|NCT02310568|516599657|FG001|Stage 2 (4 Weeks)|Other|1|||
143287122|NCT02310568|516599658|FG002|Stage 2 (4 Weeks)|Other|1|||
143287123|NCT02310568|516599659|FG003|Stage 2 (4 Weeks)|Other|0|||
143287124|NCT02310568|516599660|FG004|Stage 2 (4 Weeks)|Other|0|||
143287125|NCT02310568|516599656|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
143287126|NCT02310568|516599657|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
143287127|NCT02310568|516599658|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
143287128|NCT02310568|516599659|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
143287129|NCT02310568|516599660|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
143287130|NCT02310568|516599656|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
143287131|NCT02310568|516599657|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
143287132|NCT02310568|516599658|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
143287133|NCT02310568|516599659|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
143287134|NCT02310568|516599660|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
143287135|NCT02310568|516599656|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
143287136|NCT02310568|516599657|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
143287137|NCT02310568|516599658|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
143287138|NCT02310568|516599659|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
143287139|NCT02310568|516599660|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
143287140|NCT01384760|516599661|FG000|Overall Study|Lost to Follow-up|0|||
143287141|NCT01384760|516599662|FG001|Overall Study|Lost to Follow-up|6|||
143287142|NCT01384760|516599661|FG000|Overall Study|Protocol Violation|16|||
143287143|NCT01384760|516599662|FG001|Overall Study|Protocol Violation|0|||
143287144|NCT00963547|516599666|FG000|Overall Study|Adverse Event|0|||
143287145|NCT00963547|516599667|FG001|Overall Study|Adverse Event|1|||
143287146|NCT00963547|516599668|FG002|Overall Study|Adverse Event|0|||
143287147|NCT00963547|516599669|FG003|Overall Study|Adverse Event|1|||
143287148|NCT00963547|516599670|FG004|Overall Study|Adverse Event|0|||
143287149|NCT00963547|516599671|FG005|Overall Study|Adverse Event|0|||
143287150|NCT00963547|516599672|FG006|Overall Study|Adverse Event|0|||
143287151|NCT00963547|516599666|FG000|Overall Study|Physician Decision|1|||
143287152|NCT00963547|516599667|FG001|Overall Study|Physician Decision|1|||
143287153|NCT00963547|516599668|FG002|Overall Study|Physician Decision|0|||
143287154|NCT00963547|516599669|FG003|Overall Study|Physician Decision|0|||
143287155|NCT00963547|516599670|FG004|Overall Study|Physician Decision|0|||
143287156|NCT00963547|516599671|FG005|Overall Study|Physician Decision|0|||
143287157|NCT00963547|516599672|FG006|Overall Study|Physician Decision|0|||
143287158|NCT00963547|516599666|FG000|Overall Study|Progressive Disease|3|||
143287159|NCT00963547|516599667|FG001|Overall Study|Progressive Disease|8|||
143287160|NCT00963547|516599668|FG002|Overall Study|Progressive Disease|9|||
143287161|NCT00963547|516599669|FG003|Overall Study|Progressive Disease|5|||
143287162|NCT00963547|516599670|FG004|Overall Study|Progressive Disease|0|||
143287163|NCT00963547|516599671|FG005|Overall Study|Progressive Disease|0|||
143287164|NCT00963547|516599672|FG006|Overall Study|Progressive Disease|0|||
143287165|NCT00963547|516599666|FG000|Overall Study|Withdrawal by Subject|0|||
143287166|NCT00963547|516599667|FG001|Overall Study|Withdrawal by Subject|0|||
143287167|NCT00963547|516599668|FG002|Overall Study|Withdrawal by Subject|3|||
143287168|NCT00963547|516599669|FG003|Overall Study|Withdrawal by Subject|0|||
143287169|NCT00963547|516599670|FG004|Overall Study|Withdrawal by Subject|0|||
143287170|NCT00963547|516599671|FG005|Overall Study|Withdrawal by Subject|0|||
143287171|NCT00963547|516599672|FG006|Overall Study|Withdrawal by Subject|0|||
143287172|NCT00963547|516599666|FG000|Overall Study|Reason Unknown|0|||
143287173|NCT00963547|516599667|FG001|Overall Study|Reason Unknown|1|||
143287174|NCT00963547|516599668|FG002|Overall Study|Reason Unknown|0|||
143287175|NCT00963547|516599669|FG003|Overall Study|Reason Unknown|0|||
143287176|NCT00963547|516599670|FG004|Overall Study|Reason Unknown|0|||
143287177|NCT00963547|516599671|FG005|Overall Study|Reason Unknown|0|||
143287178|NCT00963547|516599672|FG006|Overall Study|Reason Unknown|0|||
143287179|NCT02990910|516599680|FG000|Overall Study|Lack of Efficacy|6|||
143287180|NCT02990910|516599681|FG001|Overall Study|Lack of Efficacy|10|||
143287181|NCT01549860|516599682|FG000|Overall Study|Withdrawal by Subject|1|||
143287182|NCT01549860|516599683|FG001|Overall Study|Withdrawal by Subject|0|||
143287183|NCT01549860|516599682|FG000|Overall Study|Physician Decision|1|||
143287184|NCT01549860|516599683|FG001|Overall Study|Physician Decision|1|||
143287185|NCT01366521|516599684|FG000|Overall Study|Adverse Event|1|||
143287186|NCT01366521|516599685|FG001|Overall Study|Adverse Event|0|||
143287187|NCT01366521|516599686|FG002|Overall Study|Adverse Event|0|||
143287188|NCT01366521|516599687|FG003|Overall Study|Adverse Event|0|||
143287189|NCT01366521|516599684|FG000|Overall Study|Protocol Violation|0|||
143287190|NCT01366521|516599685|FG001|Overall Study|Protocol Violation|0|||
143287191|NCT01366521|516599686|FG002|Overall Study|Protocol Violation|1|||
143287192|NCT01366521|516599687|FG003|Overall Study|Protocol Violation|0|||
143287193|NCT01366521|516599684|FG000|Overall Study|Physician Decision|0|||
143287194|NCT01366521|516599685|FG001|Overall Study|Physician Decision|0|||
143287195|NCT01366521|516599686|FG002|Overall Study|Physician Decision|1|||
143287196|NCT01366521|516599687|FG003|Overall Study|Physician Decision|0|||
143287197|NCT01366521|516599684|FG000|Overall Study|Withdrawal by Subject|0|||
143287198|NCT01366521|516599685|FG001|Overall Study|Withdrawal by Subject|1|||
143287199|NCT01366521|516599686|FG002|Overall Study|Withdrawal by Subject|0|||
143287200|NCT01366521|516599687|FG003|Overall Study|Withdrawal by Subject|0|||
143287201|NCT00660023|516599688|FG000|Overall Study|Adverse Event|2|||
143287202|NCT00660023|516599688|FG000|Overall Study|Death|8|||
143287203|NCT00660023|516599688|FG000|Overall Study|Blood Transfusion|5|||
143287204|NCT00660023|516599688|FG000|Overall Study|Renal Transplantation|3|||
143287205|NCT00660023|516599688|FG000|Overall Study|Withdrawal by Subject|1|||
143287206|NCT00660023|516599688|FG000|Overall Study|Missed Pregnancy Test|1|||
143287207|NCT00660023|516599688|FG000|Overall Study|Other Screening Failure|9|||
143287208|NCT04180488|516599689|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
143287209|NCT04180488|516599690|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
143287210|NCT04180488|516599691|FG002|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
143287211|NCT04180488|516599692|FG003|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
143287212|NCT04180488|516599693|FG004|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
143287213|NCT04180488|516599694|FG005|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
143287214|NCT04180488|516599689|FG000|Overall Study|Withdrawal by Subject|8|||
143287215|NCT04180488|516599690|FG001|Overall Study|Withdrawal by Subject|4|||
143287216|NCT04180488|516599691|FG002|Overall Study|Withdrawal by Subject|5|||
143287217|NCT04180488|516599692|FG003|Overall Study|Withdrawal by Subject|2|||
143287218|NCT04180488|516599693|FG004|Overall Study|Withdrawal by Subject|8|||
143287219|NCT04180488|516599694|FG005|Overall Study|Withdrawal by Subject|6|||
143287220|NCT04180488|516599689|FG000|Overall Study|Adverse Event|3|||
143287221|NCT04180488|516599690|FG001|Overall Study|Adverse Event|2|||
143287222|NCT04180488|516599691|FG002|Overall Study|Adverse Event|0|||
143287223|NCT04180488|516599692|FG003|Overall Study|Adverse Event|0|||
143287224|NCT04180488|516599693|FG004|Overall Study|Adverse Event|0|||
143287225|NCT04180488|516599694|FG005|Overall Study|Adverse Event|0|||
143287226|NCT04180488|516599689|FG000|Overall Study|Poor compliance to protocol|0|||
143287227|NCT04180488|516599690|FG001|Overall Study|Poor compliance to protocol|0|||
143287228|NCT04180488|516599691|FG002|Overall Study|Poor compliance to protocol|1|||
143287229|NCT04180488|516599692|FG003|Overall Study|Poor compliance to protocol|0|||
143287230|NCT04180488|516599693|FG004|Overall Study|Poor compliance to protocol|0|||
143287231|NCT04180488|516599694|FG005|Overall Study|Poor compliance to protocol|0|||
143287232|NCT03506815|516599695|FG000|Overall Study|Adverse Event|8|||
143287233|NCT03506815|516599696|FG001|Overall Study|Adverse Event|0|||
143287234|NCT03506815|516599695|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
143287235|NCT03506815|516599696|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
143287236|NCT03506815|516599695|FG000|Overall Study|Protocol Violation|1|||
143287237|NCT03506815|516599696|FG001|Overall Study|Protocol Violation|0|||
143287238|NCT03506815|516599695|FG000|Overall Study|Elective Surgery|1|||
143287239|NCT03506815|516599696|FG001|Overall Study|Elective Surgery|0|||
143287240|NCT04016285|516599700|FG000|Overall Study|Did not progress to surgery|2|||
143287241|NCT04016285|516599701|FG001|Overall Study|Did not progress to surgery|5|||
143287242|NCT04016285|516599700|FG000|Overall Study|Failed to collect outcome data|5|||
143287243|NCT04016285|516599701|FG001|Overall Study|Failed to collect outcome data|3|||
143287244|NCT00284050|516599702|FG000|Overall Study|Adverse Event|1|||
143287245|NCT00284050|516599703|FG001|Overall Study|Adverse Event|1|||
143287246|NCT00284050|516599704|FG002|Overall Study|Adverse Event|1|||
143287247|NCT00284050|516599702|FG000|Overall Study|Lack of Efficacy|0|||
143287248|NCT00284050|516599703|FG001|Overall Study|Lack of Efficacy|1|||
143287249|NCT00284050|516599704|FG002|Overall Study|Lack of Efficacy|3|||
143287250|NCT00284050|516599702|FG000|Overall Study|Protocol Violation|0|||
143287251|NCT00284050|516599703|FG001|Overall Study|Protocol Violation|1|||
143287252|NCT00284050|516599704|FG002|Overall Study|Protocol Violation|2|||
143287253|NCT00284050|516599702|FG000|Overall Study|Withdrawal by Subject|2|||
143287254|NCT00284050|516599703|FG001|Overall Study|Withdrawal by Subject|2|||
143287255|NCT00284050|516599704|FG002|Overall Study|Withdrawal by Subject|2|||
143287256|NCT00284050|516599702|FG000|Overall Study|Lost to Follow-up|1|||
143287257|NCT00284050|516599703|FG001|Overall Study|Lost to Follow-up|0|||
143287258|NCT00284050|516599704|FG002|Overall Study|Lost to Follow-up|1|||
143287259|NCT00284050|516599702|FG000|Overall Study|Death|1|||
143287260|NCT00284050|516599703|FG001|Overall Study|Death|0|||
143287261|NCT00284050|516599704|FG002|Overall Study|Death|0|||
143287262|NCT01906008|516599715|FG000|Overall Study|Lost to Follow-up|2|||
143287263|NCT01906008|516599716|FG001|Overall Study|Lost to Follow-up|0|||
143287264|NCT01906008|516599715|FG000|Overall Study|Oxaliplatin toxicity|2|||
143287265|NCT01906008|516599716|FG001|Overall Study|Oxaliplatin toxicity|0|||
143287266|NCT01906008|516599715|FG000|Overall Study|Protocol Violation|0|||
143287267|NCT01906008|516599716|FG001|Overall Study|Protocol Violation|1|||
143287268|NCT01906008|516599715|FG000|Overall Study|Withdrawal by Subject|1|||
143287269|NCT01906008|516599716|FG001|Overall Study|Withdrawal by Subject|5|||
143287270|NCT01906008|516599715|FG000|Overall Study|Did not start study med|3|||
143287271|NCT01906008|516599716|FG001|Overall Study|Did not start study med|4|||
143287272|NCT01906008|516599715|FG000|Overall Study|Oxaliplatin stops|10|||
143287273|NCT01906008|516599716|FG001|Overall Study|Oxaliplatin stops|8|||
143287274|NCT01906008|516599715|FG000|Overall Study|Hospice|1|||
143287275|NCT01906008|516599716|FG001|Overall Study|Hospice|0|||
143287276|NCT01906008|516599715|FG000|Overall Study|Physician Decision|3|||
143287277|NCT01906008|516599716|FG001|Overall Study|Physician Decision|3|||
143287278|NCT01906008|516599715|FG000|Overall Study|Lack of compliance of study med|5|||
143287279|NCT01906008|516599716|FG001|Overall Study|Lack of compliance of study med|3|||
143287280|NCT01906008|516599715|FG000|Overall Study|Adverse Event|0|||
143287281|NCT01906008|516599716|FG001|Overall Study|Adverse Event|3|||
143287282|NCT02117648|516599717|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
143287283|NCT02117648|516599717|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
143287284|NCT02117648|516599717|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
143287285|NCT02117648|516599717|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
143287286|NCT02117648|516599717|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
143287287|NCT02117648|516599717|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
143287288|NCT02117648|516599717|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
143287289|NCT02117648|516599717|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
143287290|NCT02117648|516599717|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
143287291|NCT02117648|516599717|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
143287292|NCT02117648|516599717|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
143287293|NCT00171730|516599719|FG000|Overall Study|Adverse Event|3|||
143287294|NCT00171730|516599719|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
143287295|NCT00171730|516599719|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
143287296|NCT00171730|516599719|FG000|Overall Study|Withdrawal by Subject|3|||
143287297|NCT05025241|516599720|FG000|Screening|Failed Screening|5|||
143287298|NCT05025241|516599720|FG000|Treatment and Follow Up|Adverse Event|3|||
143287299|NCT01366209|516599721|FG000|Overall Study|Adverse Event|6|||
143287300|NCT01366209|516599722|FG001|Overall Study|Adverse Event|7|||
143287301|NCT01366209|516599721|FG000|Overall Study|Withdrawal by Subject|4|||
143287302|NCT01366209|516599722|FG001|Overall Study|Withdrawal by Subject|4|||
143287303|NCT01366209|516599721|FG000|Overall Study|Death|12|||
143287304|NCT01366209|516599722|FG001|Overall Study|Death|19|||
143287305|NCT01366209|516599721|FG000|Overall Study|Lung transplantation|6|||
143287306|NCT01366209|516599722|FG001|Overall Study|Lung transplantation|1|||
143287307|NCT01366209|516599721|FG000|Overall Study|Lost to Follow-up|2|||
143287308|NCT01366209|516599722|FG001|Overall Study|Lost to Follow-up|1|||
143287309|NCT01366209|516599721|FG000|Overall Study|Physician Decision|1|||
143287310|NCT01366209|516599722|FG001|Overall Study|Physician Decision|0|||
143287311|NCT01366209|516599721|FG000|Overall Study|Sponsors decision|0|||
143287312|NCT01366209|516599722|FG001|Overall Study|Sponsors decision|1|||
143287313|NCT01366209|516599721|FG000|Overall Study|Withdrew consent|4|||
143287314|NCT01366209|516599722|FG001|Overall Study|Withdrew consent|3|||
143287315|NCT01053221|516599723|FG000|Overall Study|The study was closed prematurely|5|||
143287316|NCT01053221|516599724|FG001|Overall Study|The study was closed prematurely|9|||
143287317|NCT02220205|516599725|FG000|Overall Study|Withdrawal by Subject|1|||
143287318|NCT02220205|516599726|FG001|Overall Study|Withdrawal by Subject|0|||
143287319|NCT01465997|516599727|FG000|Overall Study|Adverse Event|12|||
143287320|NCT01465997|516599728|FG001|Overall Study|Adverse Event|22|||
143287321|NCT01465997|516599727|FG000|Overall Study|Lack of Efficacy|13|||
143287322|NCT01465997|516599728|FG001|Overall Study|Lack of Efficacy|1|||
143287323|NCT01465997|516599727|FG000|Overall Study|Protocol Violation|1|||
143287324|NCT01465997|516599728|FG001|Overall Study|Protocol Violation|4|||
143287325|NCT01465997|516599727|FG000|Overall Study|Lost to Follow-up|6|||
143287326|NCT01465997|516599728|FG001|Overall Study|Lost to Follow-up|9|||
143287327|NCT01465997|516599727|FG000|Overall Study|Withdrawal by Subject|32|||
143287328|NCT01465997|516599728|FG001|Overall Study|Withdrawal by Subject|35|||
143287329|NCT01465997|516599727|FG000|Overall Study|investigator's decision|1|||
143287330|NCT01465997|516599728|FG001|Overall Study|investigator's decision|1|||
143287331|NCT01465997|516599727|FG000|Overall Study|Death|0|||
143287332|NCT01465997|516599728|FG001|Overall Study|Death|1|||
143287333|NCT01465997|516599727|FG000|Overall Study|sponsor's decision|1|||
143287334|NCT01465997|516599728|FG001|Overall Study|sponsor's decision|1|||
143287335|NCT01465997|516599727|FG000|Overall Study|subject withdrew consent|1|||
143287336|NCT01465997|516599728|FG001|Overall Study|subject withdrew consent|0|||
143287337|NCT01465997|516599727|FG000|Overall Study|local lab unblinded site|1|||
143287338|NCT01465997|516599728|FG001|Overall Study|local lab unblinded site|0|||
143287339|NCT01465997|516599727|FG000|Overall Study|withdrew before follow-up|0|||
143287340|NCT01465997|516599728|FG001|Overall Study|withdrew before follow-up|13|||
143287341|NCT01465997|516599727|FG000|Overall Study|decision by site staff|0|||
143287342|NCT01465997|516599728|FG001|Overall Study|decision by site staff|1|||
143287343|NCT01465997|516599727|FG000|Overall Study|subject left participation SP0993|0|||
143287344|NCT01465997|516599728|FG001|Overall Study|subject left participation SP0993|1|||
143287345|NCT02246660|516599729|FG000|Overall Study|Withdrawal by Subject|0|||
143287346|NCT02246660|516599730|FG001|Overall Study|Withdrawal by Subject|1|||
143287347|NCT02246660|516599731|FG002|Overall Study|Withdrawal by Subject|0|||
143287348|NCT02246660|516599729|FG000|Overall Study|Death|0|||
143287349|NCT02246660|516599730|FG001|Overall Study|Death|0|||
143287350|NCT02246660|516599731|FG002|Overall Study|Death|1|||
143287351|NCT03552198|516599732|FG000|Overall Study|Lost to Follow-up|42|||
143287352|NCT03552198|516599733|FG001|Overall Study|Lost to Follow-up|48|||
143287353|NCT03552198|516599734|FG002|Overall Study|Lost to Follow-up|15|||
143287354|NCT03552198|516599735|FG003|Overall Study|Lost to Follow-up|19|||
143287355|NCT03552198|516599732|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
143287356|NCT03552198|516599733|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
143287357|NCT03552198|516599734|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
143287358|NCT03552198|516599735|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
143287359|NCT03552198|516599732|FG000|Overall Study|Did not receive air alerts|1|||
143287360|NCT03552198|516599733|FG001|Overall Study|Did not receive air alerts|0|||
143287361|NCT03552198|516599734|FG002|Overall Study|Did not receive air alerts|0|||
143287362|NCT03552198|516599735|FG003|Overall Study|Did not receive air alerts|1|||
143287363|NCT06149247|516599736|FG000|Overall Study|Adverse Event|0|||
143287364|NCT06149247|516599737|FG001|Overall Study|Adverse Event|1|||
143287365|NCT00855920|516599738|FG000|Overall Study|Protocol Violation|0|||
143287366|NCT00855920|516599739|FG001|Overall Study|Protocol Violation|0|||
143287367|NCT00855920|516599740|FG002|Overall Study|Protocol Violation|2|||
143287368|NCT00855920|516599738|FG000|Overall Study|Adverse Event|2|||
143287369|NCT00855920|516599739|FG001|Overall Study|Adverse Event|1|||
143287370|NCT00855920|516599740|FG002|Overall Study|Adverse Event|1|||
143287371|NCT00855920|516599738|FG000|Overall Study|Lack of Efficacy|2|||
143287372|NCT00855920|516599739|FG001|Overall Study|Lack of Efficacy|2|||
143287373|NCT00855920|516599740|FG002|Overall Study|Lack of Efficacy|2|||
143287374|NCT00855920|516599738|FG000|Overall Study|Withdrawal by Subject|2|||
143287375|NCT00855920|516599739|FG001|Overall Study|Withdrawal by Subject|3|||
143287376|NCT00855920|516599740|FG002|Overall Study|Withdrawal by Subject|2|||
143287377|NCT00855920|516599738|FG000|Overall Study|Lost to Follow-up|1|||
143287378|NCT00855920|516599739|FG001|Overall Study|Lost to Follow-up|0|||
143287379|NCT00855920|516599740|FG002|Overall Study|Lost to Follow-up|2|||
143287380|NCT00855920|516599738|FG000|Overall Study|Death|0|||
143287381|NCT00855920|516599739|FG001|Overall Study|Death|1|||
143287382|NCT00855920|516599740|FG002|Overall Study|Death|0|||
143287383|NCT00855920|516599738|FG000|Overall Study|Decision by the sponsor|0|||
143287384|NCT00855920|516599739|FG001|Overall Study|Decision by the sponsor|1|||
143287385|NCT00855920|516599740|FG002|Overall Study|Decision by the sponsor|1|||
143287386|NCT00855920|516599738|FG000|Overall Study|Other than specified above|1|||
143287387|NCT00855920|516599739|FG001|Overall Study|Other than specified above|1|||
143287388|NCT00855920|516599740|FG002|Overall Study|Other than specified above|1|||
143287389|NCT01666782|516599741|FG000|Overall Study|Received 2 doses of vaccine|0|||
143287390|NCT01666782|516599742|FG001|Overall Study|Received 2 doses of vaccine|1|||
143287391|NCT01666782|516599741|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
143287392|NCT01666782|516599742|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
143287393|NCT01756898|516599756|FG000|Overall Study|Adverse Event|7|||
143287394|NCT01756898|516599757|FG001|Overall Study|Adverse Event|1|||
143287395|NCT01756898|516599758|FG002|Overall Study|Adverse Event|0|||
143287396|NCT01756898|516599759|FG003|Overall Study|Adverse Event|0|||
143287397|NCT01756898|516599756|FG000|Overall Study|Lack of Efficacy|4|||
143287398|NCT01756898|516599757|FG001|Overall Study|Lack of Efficacy|7|||
143287399|NCT01756898|516599758|FG002|Overall Study|Lack of Efficacy|6|||
143287400|NCT01756898|516599759|FG003|Overall Study|Lack of Efficacy|6|||
143287401|NCT01756898|516599756|FG000|Overall Study|Lost to Follow-up|2|||
143287402|NCT01756898|516599757|FG001|Overall Study|Lost to Follow-up|4|||
143287403|NCT01756898|516599758|FG002|Overall Study|Lost to Follow-up|2|||
143287404|NCT01756898|516599759|FG003|Overall Study|Lost to Follow-up|3|||
143287405|NCT01756898|516599756|FG000|Overall Study|Protocol Violation|1|||
143287406|NCT01756898|516599757|FG001|Overall Study|Protocol Violation|2|||
143287407|NCT01756898|516599758|FG002|Overall Study|Protocol Violation|2|||
143287408|NCT01756898|516599759|FG003|Overall Study|Protocol Violation|1|||
143287409|NCT01756898|516599756|FG000|Overall Study|Withdrew Consent|5|||
143287410|NCT01756898|516599757|FG001|Overall Study|Withdrew Consent|3|||
143287411|NCT01756898|516599758|FG002|Overall Study|Withdrew Consent|5|||
143287412|NCT01756898|516599759|FG003|Overall Study|Withdrew Consent|6|||
143287413|NCT01756898|516599756|FG000|Overall Study|Other|0|||
143287414|NCT01756898|516599757|FG001|Overall Study|Other|2|||
143287415|NCT01756898|516599758|FG002|Overall Study|Other|2|||
143287416|NCT01756898|516599759|FG003|Overall Study|Other|0|||
143287417|NCT01500694|516599760|FG000|Overall Study|Adverse Event|4|||
143287418|NCT01500694|516599761|FG001|Overall Study|Adverse Event|3|||
143287419|NCT01500694|516599760|FG000|Overall Study|Protocol Violation|0|||
143287420|NCT01500694|516599761|FG001|Overall Study|Protocol Violation|1|||
143287421|NCT01500694|516599760|FG000|Overall Study|Withdrawal by Subject|23|||
143287422|NCT01500694|516599761|FG001|Overall Study|Withdrawal by Subject|14|||
143287423|NCT01500694|516599760|FG000|Overall Study|Lost to Follow-up|2|||
143287424|NCT01500694|516599761|FG001|Overall Study|Lost to Follow-up|3|||
143287425|NCT01500694|516599760|FG000|Overall Study|Lack of Efficacy|14|||
143287426|NCT01500694|516599761|FG001|Overall Study|Lack of Efficacy|5|||
143287427|NCT01500694|516599760|FG000|Overall Study|Other|9|||
143287428|NCT01500694|516599761|FG001|Overall Study|Other|3|||
143287429|NCT03572062|516599762|FG000|Overall Study|Adverse Event|0|||
143287430|NCT03572062|516599763|FG001|Overall Study|Adverse Event|0|||
143287431|NCT03572062|516599764|FG002|Overall Study|Adverse Event|0|||
143287432|NCT03572062|516599765|FG003|Overall Study|Adverse Event|0|||
143287433|NCT03572062|516599766|FG004|Overall Study|Adverse Event|0|||
143287434|NCT03572062|516599767|FG005|Overall Study|Adverse Event|0|||
143287435|NCT03572062|516599768|FG006|Overall Study|Adverse Event|0|||
143287436|NCT03572062|516599769|FG007|Overall Study|Adverse Event|0|||
143287437|NCT03572062|516599770|FG008|Overall Study|Adverse Event|1|||
143287438|NCT03572062|516599771|FG009|Overall Study|Adverse Event|3|||
143287439|NCT03572062|516599762|FG000|Overall Study|Death|0|||
143287440|NCT03572062|516599763|FG001|Overall Study|Death|0|||
143287441|NCT03572062|516599764|FG002|Overall Study|Death|0|||
143287442|NCT03572062|516599765|FG003|Overall Study|Death|0|||
143287443|NCT03572062|516599766|FG004|Overall Study|Death|0|||
143287444|NCT03572062|516599767|FG005|Overall Study|Death|1|||
143287445|NCT03572062|516599768|FG006|Overall Study|Death|0|||
143287446|NCT03572062|516599769|FG007|Overall Study|Death|0|||
143287447|NCT03572062|516599770|FG008|Overall Study|Death|0|||
143287448|NCT03572062|516599771|FG009|Overall Study|Death|0|||
143287449|NCT03572062|516599762|FG000|Overall Study|Lost to Follow-up|0|||
143287450|NCT03572062|516599763|FG001|Overall Study|Lost to Follow-up|0|||
143373553|NCT04707313|516911470|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
143373554|NCT04707313|516911471|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
143373555|NCT04707313|516911472|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
143373556|NCT04707313|516911473|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
143373557|NCT04707313|516911474|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
143373558|NCT04707313|516911475|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
143373559|NCT04707313|516911476|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
143373560|NCT04707313|516911477|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
143373561|NCT04707313|516911478|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
143373562|NCT04707313|516911479|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
143373563|NCT04707313|516911480|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
143373564|NCT04707313|516911468|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
143373565|NCT04707313|516911469|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
143373566|NCT04707313|516911470|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
143373567|NCT04707313|516911471|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
143373568|NCT04707313|516911472|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
143373569|NCT04707313|516911473|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
143373570|NCT04707313|516911474|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
143373571|NCT04707313|516911475|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
143373572|NCT04707313|516911476|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
143373573|NCT04707313|516911477|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
143373574|NCT04707313|516911478|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
143373575|NCT04707313|516911479|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
143373576|NCT04707313|516911480|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
143373577|NCT04707313|516911468|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
143373578|NCT04707313|516911469|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
143373579|NCT04707313|516911470|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
143373580|NCT04707313|516911471|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
143373581|NCT04707313|516911472|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
143373582|NCT04707313|516911473|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
143373583|NCT04707313|516911474|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
143373584|NCT04707313|516911475|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
143373585|NCT04707313|516911476|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
143373586|NCT04707313|516911477|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
143373587|NCT04707313|516911478|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
143373588|NCT04707313|516911479|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
143373589|NCT04707313|516911480|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
143373590|NCT04707313|516911468|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
143373591|NCT04707313|516911469|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
143373592|NCT04707313|516911470|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
143373593|NCT04707313|516911471|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
143373594|NCT04707313|516911472|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
143373595|NCT04707313|516911473|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
143287451|NCT03572062|516599764|FG002|Overall Study|Lost to Follow-up|0|||
143287452|NCT03572062|516599765|FG003|Overall Study|Lost to Follow-up|0|||
143287453|NCT03572062|516599766|FG004|Overall Study|Lost to Follow-up|0|||
143287454|NCT03572062|516599767|FG005|Overall Study|Lost to Follow-up|1|||
143373596|NCT04707313|516911474|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
143373597|NCT04707313|516911475|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
143373598|NCT04707313|516911476|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
143373599|NCT04707313|516911477|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
143287455|NCT03572062|516599768|FG006|Overall Study|Lost to Follow-up|1|||
143287456|NCT03572062|516599769|FG007|Overall Study|Lost to Follow-up|0|||
143287457|NCT03572062|516599770|FG008|Overall Study|Lost to Follow-up|0|||
143287458|NCT03572062|516599771|FG009|Overall Study|Lost to Follow-up|0|||
143287459|NCT03572062|516599762|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
143373600|NCT04707313|516911478|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
143373601|NCT04707313|516911479|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
143373602|NCT04707313|516911480|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
143373603|NCT04707313|516911468|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
143373604|NCT04707313|516911469|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
143373605|NCT04707313|516911470|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
143373606|NCT04707313|516911471|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
143373607|NCT04707313|516911472|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
143373608|NCT04707313|516911473|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
143373609|NCT04707313|516911474|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
143373610|NCT04707313|516911475|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
143373611|NCT04707313|516911476|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
143373612|NCT04707313|516911477|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
143373613|NCT04707313|516911478|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
143373614|NCT04707313|516911479|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
143373615|NCT04707313|516911480|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
143373616|NCT04707313|516911468|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
143373617|NCT04707313|516911469|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
143373618|NCT04707313|516911470|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
143373619|NCT04707313|516911471|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
143373620|NCT04707313|516911472|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
143373621|NCT04707313|516911473|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
143373622|NCT04707313|516911474|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
143373623|NCT04707313|516911475|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
143373624|NCT04707313|516911476|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
143373625|NCT04707313|516911477|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
143373626|NCT04707313|516911478|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
143373627|NCT04707313|516911479|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
143373628|NCT04707313|516911480|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
143373629|NCT04707313|516911468|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
143373630|NCT04707313|516911469|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
143373631|NCT04707313|516911470|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
143373632|NCT04707313|516911471|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
143373633|NCT04707313|516911472|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
143373634|NCT04707313|516911473|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
143373635|NCT04707313|516911474|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
143373636|NCT04707313|516911475|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
143373637|NCT04707313|516911476|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
143373638|NCT04707313|516911477|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
143373639|NCT04707313|516911478|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
143287460|NCT03572062|516599763|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
143287461|NCT03572062|516599764|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
143287462|NCT03572062|516599765|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
143287463|NCT03572062|516599766|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
143287464|NCT03572062|516599767|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
143287465|NCT03572062|516599768|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
143287466|NCT03572062|516599769|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
143287467|NCT03572062|516599770|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
143287468|NCT03572062|516599771|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
143287469|NCT03572062|516599762|FG000|Overall Study|Study Terminated By Sponsor|0|||
143287470|NCT03572062|516599763|FG001|Overall Study|Study Terminated By Sponsor|0|||
143287471|NCT03572062|516599764|FG002|Overall Study|Study Terminated By Sponsor|0|||
143287472|NCT03572062|516599765|FG003|Overall Study|Study Terminated By Sponsor|0|||
143287473|NCT03572062|516599766|FG004|Overall Study|Study Terminated By Sponsor|0|||
143287474|NCT03572062|516599767|FG005|Overall Study|Study Terminated By Sponsor|0|||
143287475|NCT03572062|516599768|FG006|Overall Study|Study Terminated By Sponsor|0|||
143287476|NCT03572062|516599769|FG007|Overall Study|Study Terminated By Sponsor|0|||
143287477|NCT03572062|516599770|FG008|Overall Study|Study Terminated By Sponsor|29|||
143287478|NCT03572062|516599771|FG009|Overall Study|Study Terminated By Sponsor|27|||
143287479|NCT03572062|516599762|FG000|Overall Study|Physician Decision|0|||
143287480|NCT03572062|516599763|FG001|Overall Study|Physician Decision|0|||
143287481|NCT03572062|516599764|FG002|Overall Study|Physician Decision|0|||
143287482|NCT03572062|516599765|FG003|Overall Study|Physician Decision|0|||
143287483|NCT03572062|516599766|FG004|Overall Study|Physician Decision|0|||
143287484|NCT03572062|516599767|FG005|Overall Study|Physician Decision|0|||
143287485|NCT03572062|516599768|FG006|Overall Study|Physician Decision|0|||
143287486|NCT03572062|516599769|FG007|Overall Study|Physician Decision|0|||
143287487|NCT03572062|516599770|FG008|Overall Study|Physician Decision|1|||
143287488|NCT03572062|516599771|FG009|Overall Study|Physician Decision|0|||
143287489|NCT03572062|516599762|FG000|Overall Study|Withdrawal by Subject|0|||
143287490|NCT03572062|516599763|FG001|Overall Study|Withdrawal by Subject|0|||
143287491|NCT03572062|516599764|FG002|Overall Study|Withdrawal by Subject|0|||
143287492|NCT03572062|516599765|FG003|Overall Study|Withdrawal by Subject|0|||
143287493|NCT03572062|516599766|FG004|Overall Study|Withdrawal by Subject|0|||
143287494|NCT03572062|516599767|FG005|Overall Study|Withdrawal by Subject|0|||
143287495|NCT03572062|516599768|FG006|Overall Study|Withdrawal by Subject|0|||
143287496|NCT03572062|516599769|FG007|Overall Study|Withdrawal by Subject|0|||
143287497|NCT03572062|516599770|FG008|Overall Study|Withdrawal by Subject|0|||
143287498|NCT03572062|516599771|FG009|Overall Study|Withdrawal by Subject|1|||
143287499|NCT03572062|516599762|FG000|Overall Study|Randomized But Not Treated|0|||
143287500|NCT03572062|516599763|FG001|Overall Study|Randomized But Not Treated|0|||
143287501|NCT03572062|516599764|FG002|Overall Study|Randomized But Not Treated|0|||
143287502|NCT03572062|516599765|FG003|Overall Study|Randomized But Not Treated|0|||
143287503|NCT03572062|516599766|FG004|Overall Study|Randomized But Not Treated|1|||
143287504|NCT03572062|516599767|FG005|Overall Study|Randomized But Not Treated|2|||
143287505|NCT03572062|516599768|FG006|Overall Study|Randomized But Not Treated|0|||
143287506|NCT03572062|516599769|FG007|Overall Study|Randomized But Not Treated|1|||
143287507|NCT03572062|516599770|FG008|Overall Study|Randomized But Not Treated|0|||
143287508|NCT03572062|516599771|FG009|Overall Study|Randomized But Not Treated|0|||
143287509|NCT01691781|516599772|FG000|Overall Study|Withdrawal by Subject|4|||
143287510|NCT01691781|516599773|FG001|Overall Study|Withdrawal by Subject|3|||
143287511|NCT01691781|516599772|FG000|Overall Study|Physician Decision|1|||
143287512|NCT01691781|516599773|FG001|Overall Study|Physician Decision|1|||
143287513|NCT01691781|516599772|FG000|Overall Study|Protocol Violation|2|||
143287514|NCT01691781|516599773|FG001|Overall Study|Protocol Violation|2|||
143287515|NCT01691781|516599772|FG000|Overall Study|Adverse Event|0|||
143287516|NCT01691781|516599773|FG001|Overall Study|Adverse Event|1|||
143287517|NCT01918085|516599774|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
143287518|NCT01918085|516599775|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
143287519|NCT02132130|516599776|FG000|Overall Study|Lost to Follow-up|0|||
143287520|NCT02132130|516599777|FG001|Overall Study|Lost to Follow-up|2|||
143287521|NCT02132130|516599778|FG002|Overall Study|Lost to Follow-up|0|||
143287522|NCT02132130|516599779|FG003|Overall Study|Lost to Follow-up|0|||
143287523|NCT02132130|516599776|FG000|Overall Study|Withdrawal by Subject|0|||
143287524|NCT02132130|516599777|FG001|Overall Study|Withdrawal by Subject|0|||
143287525|NCT02132130|516599778|FG002|Overall Study|Withdrawal by Subject|0|||
143287526|NCT02132130|516599779|FG003|Overall Study|Withdrawal by Subject|1|||
143287527|NCT02760069|516599782|FG000|Overall Study|Withdrawal by Subject|0|||
143287528|NCT02760069|516599783|FG001|Overall Study|Withdrawal by Subject|1|||
143373640|NCT04707313|516911479|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
143373641|NCT04707313|516911480|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
143373642|NCT02459899|516911481|FG000|Overall Study|Adverse Event|1|||
143373643|NCT02459899|516911482|FG001|Overall Study|Adverse Event|1|||
143373644|NCT02459899|516911483|FG002|Overall Study|Adverse Event|0|||
143373645|NCT02459899|516911484|FG003|Overall Study|Adverse Event|0|||
143373646|NCT02459899|516911481|FG000|Overall Study|Lost to Follow-up|1|||
143373647|NCT02459899|516911482|FG001|Overall Study|Lost to Follow-up|2|||
143373648|NCT02459899|516911483|FG002|Overall Study|Lost to Follow-up|0|||
143373649|NCT02459899|516911484|FG003|Overall Study|Lost to Follow-up|1|||
143373650|NCT02459899|516911481|FG000|Overall Study|Non-compliance with the treatment|0|||
143373651|NCT02459899|516911482|FG001|Overall Study|Non-compliance with the treatment|0|||
143373652|NCT02459899|516911483|FG002|Overall Study|Non-compliance with the treatment|0|||
143373653|NCT02459899|516911484|FG003|Overall Study|Non-compliance with the treatment|1|||
143373654|NCT02459899|516911481|FG000|Overall Study|Withdrawal by Subject|1|||
143373655|NCT02459899|516911482|FG001|Overall Study|Withdrawal by Subject|3|||
143373656|NCT02459899|516911483|FG002|Overall Study|Withdrawal by Subject|0|||
143287529|NCT02760069|516599784|FG002|Overall Study|Withdrawal by Subject|1|||
143287530|NCT00646776|516599794|FG000|Overall Study|Adverse Event|1|||
143287531|NCT00646776|516599795|FG001|Overall Study|Adverse Event|9|||
143287532|NCT00646776|516599794|FG000|Overall Study|Investigator discretion|0|||
143287533|NCT00646776|516599795|FG001|Overall Study|Investigator discretion|4|||
143287534|NCT00600483|516599798|FG000|Overall Study|Lost to Follow-up|26|||
143373657|NCT02459899|516911484|FG003|Overall Study|Withdrawal by Subject|0|||
143373658|NCT00940992|516911488|FG000|Overall Study|Adverse Event|2|||
143373659|NCT00940992|516911489|FG001|Overall Study|Adverse Event|0|||
143373660|NCT00940992|516911490|FG002|Overall Study|Adverse Event|1|||
143373661|NCT00940992|516911488|FG000|Overall Study|subject request|2|||
143373662|NCT00940992|516911489|FG001|Overall Study|subject request|1|||
143373663|NCT00940992|516911490|FG002|Overall Study|subject request|0|||
143373664|NCT00940992|516911488|FG000|Overall Study|Lost to Follow-up|0|||
143373665|NCT00940992|516911489|FG001|Overall Study|Lost to Follow-up|1|||
143287535|NCT00600483|516599799|FG001|Overall Study|Lost to Follow-up|47|||
143287536|NCT00600483|516599798|FG000|Overall Study|Randomized but not treated|10|||
143287537|NCT00600483|516599799|FG001|Overall Study|Randomized but not treated|0|||
143287538|NCT03031678|516599814|FG000|Overall Study|Study closed prior to completion|1|||
143287539|NCT05475236|516599816|FG000|Overall Study|Withdrawal by Subject|0|||
143287540|NCT05475236|516599817|FG001|Overall Study|Withdrawal by Subject|1|||
143287541|NCT00477971|516599818|FG000|Overall Study|Disease progression|6|||
143373666|NCT00940992|516911490|FG002|Overall Study|Lost to Follow-up|1|||
143373667|NCT00324038|516911499|FG000|Overall Study|Adverse Event|38|||
143373668|NCT00324038|516911500|FG001|Overall Study|Adverse Event|23|||
143373669|NCT00324038|516911499|FG000|Overall Study|Lack of Efficacy|5|||
143373670|NCT00324038|516911500|FG001|Overall Study|Lack of Efficacy|13|||
143373671|NCT00324038|516911499|FG000|Overall Study|Lost to Follow-up|0|||
143373672|NCT00324038|516911500|FG001|Overall Study|Lost to Follow-up|2|||
143373673|NCT00324038|516911499|FG000|Overall Study|Other|6|||
143373674|NCT00324038|516911500|FG001|Overall Study|Other|13|||
143373675|NCT03070483|516911501|FG000|Overall Study|Lost to Follow-up|2|||
143373676|NCT02770248|516911504|FG000|Overall Study|Adverse Event|0|||
143373677|NCT02770248|516911505|FG001|Overall Study|Adverse Event|1|||
143373678|NCT02770248|516911504|FG000|Overall Study|Randomized in error, prior to treatment|0|||
143373679|NCT02770248|516911505|FG001|Overall Study|Randomized in error, prior to treatment|1|||
143373680|NCT01579916|516911506|FG000|Overall Study|Lost to Follow-up|6|||
143373681|NCT01579916|516911507|FG001|Overall Study|Lost to Follow-up|1|||
143373682|NCT01579916|516911506|FG000|Overall Study|Withdrawal by Subject|1|||
143373683|NCT01579916|516911507|FG001|Overall Study|Withdrawal by Subject|1|||
143373684|NCT01579916|516911506|FG000|Overall Study|Death|1|||
143373685|NCT01579916|516911507|FG001|Overall Study|Death|0|||
143373686|NCT02041104|516911508|FG000|Overall Study|Lost to Follow-up|1|||
143373687|NCT02041104|516911509|FG001|Overall Study|Lost to Follow-up|4|||
143373688|NCT02041104|516911508|FG000|Overall Study|discomfort during OGTT|0|||
143373689|NCT02041104|516911509|FG001|Overall Study|discomfort during OGTT|3|||
143373690|NCT02106442|516911510|FG000|Overall Study|Case Report Forms Uncollected|7|||
143373691|NCT02106442|516911510|FG000|Overall Study|Protocol Deviation|30|||
143373692|NCT00849147|516911512|FG000|Overall Study|Withdrawal by Subject|1|||
143373693|NCT00849147|516911512|FG000|Overall Study|Protocol Violation|2|||
143373694|NCT00849147|516911512|FG000|Overall Study|Disease Relapse/Progression|2|||
143373695|NCT05328297|516913546|FG000|Overall Study|Adverse Event|5|||
143373696|NCT05328297|516913547|FG001|Overall Study|Adverse Event|7|||
143373697|NCT05328297|516913546|FG000|Overall Study|Withdrawal by Subject|4|||
143373698|NCT05328297|516913547|FG001|Overall Study|Withdrawal by Subject|3|||
143373699|NCT05328297|516913546|FG000|Overall Study|Lack of Efficacy|1|||
143373700|NCT05328297|516913547|FG001|Overall Study|Lack of Efficacy|0|||
143373701|NCT05328297|516913546|FG000|Overall Study|Lost to Follow-up|1|||
143373702|NCT05328297|516913547|FG001|Overall Study|Lost to Follow-up|0|||
143373703|NCT05328297|516913546|FG000|Overall Study|Protocol Violation|1|||
143373704|NCT05328297|516913547|FG001|Overall Study|Protocol Violation|0|||
143287542|NCT00477971|516599819|FG001|Overall Study|Disease progression|0|||
143287543|NCT00477971|516599818|FG000|Overall Study|Withdrawal by Subject|3|||
143287544|NCT00477971|516599819|FG001|Overall Study|Withdrawal by Subject|1|||
143287545|NCT00477971|516599818|FG000|Overall Study|Adverse Event|3|||
143287546|NCT00477971|516599819|FG001|Overall Study|Adverse Event|0|||
143287547|NCT00477971|516599818|FG000|Overall Study|Death|2|||
143287548|NCT00477971|516599819|FG001|Overall Study|Death|4|||
143287549|NCT00477971|516599818|FG000|Overall Study|Alternative treatment|3|||
143287550|NCT00477971|516599819|FG001|Overall Study|Alternative treatment|1|||
143287551|NCT01774968|516599820|FG000|Overall Study|Adverse Event|4|||
143287552|NCT01774968|516599821|FG001|Overall Study|Adverse Event|4|||
143287553|NCT01774968|516599820|FG000|Overall Study|Death|0|||
143287554|NCT01774968|516599821|FG001|Overall Study|Death|1|||
143287555|NCT01774968|516599820|FG000|Overall Study|Lost to Follow-up|1|||
143287556|NCT01774968|516599821|FG001|Overall Study|Lost to Follow-up|3|||
143287557|NCT01774968|516599820|FG000|Overall Study|Physician Decision|5|||
143287558|NCT01774968|516599821|FG001|Overall Study|Physician Decision|1|||
143287559|NCT01774968|516599820|FG000|Overall Study|Protocol Violation|14|||
143287560|NCT01774968|516599821|FG001|Overall Study|Protocol Violation|13|||
143287561|NCT01774968|516599820|FG000|Overall Study|Sponsor Decision|0|||
143287562|NCT01774968|516599821|FG001|Overall Study|Sponsor Decision|2|||
143287563|NCT01774968|516599820|FG000|Overall Study|Withdrawal by Subject|6|||
143287564|NCT01774968|516599821|FG001|Overall Study|Withdrawal by Subject|11|||
143373705|NCT05328297|516913546|FG000|Overall Study|Randomized but not treated|1|||
143287565|NCT04847557|516599824|FG000|Overall Study|Adverse Event|1|||
143287566|NCT04847557|516599825|FG001|Overall Study|Adverse Event|0|||
143287567|NCT04847557|516599824|FG000|Overall Study|Death|19|||
143373706|NCT05328297|516913547|FG001|Overall Study|Randomized but not treated|1|||
143373707|NCT00768664|516913548|FG000|Overall Study|Death|57|||
143373708|NCT00768664|516913548|FG000|Overall Study|Lost to Follow-up|2|||
143287568|NCT04847557|516599825|FG001|Overall Study|Death|15|||
143287569|NCT04847557|516599824|FG000|Overall Study|Lost to Follow-up|3|||
143287570|NCT04847557|516599825|FG001|Overall Study|Lost to Follow-up|6|||
143287571|NCT04847557|516599824|FG000|Overall Study|Physician Decision|1|||
143287572|NCT04847557|516599825|FG001|Overall Study|Physician Decision|0|||
143287573|NCT04847557|516599824|FG000|Overall Study|Protocol Violation|0|||
143373709|NCT00768664|516913548|FG000|Overall Study|Other|9|||
143373710|NCT00768664|516913548|FG000|Overall Study|Participant refused|1|||
143373711|NCT00708032|516913551|FG000|Overall Study|Adverse Event|0|||
143373712|NCT00708032|516913552|FG001|Overall Study|Adverse Event|2|||
143373713|NCT00708032|516913551|FG000|Overall Study|Lost to Follow-up|1|||
143373714|NCT00708032|516913552|FG001|Overall Study|Lost to Follow-up|2|||
143287574|NCT04847557|516599825|FG001|Overall Study|Protocol Violation|1|||
143287575|NCT04847557|516599824|FG000|Overall Study|Withdrawal by Subject|8|||
143287576|NCT04847557|516599825|FG001|Overall Study|Withdrawal by Subject|14|||
143287577|NCT04419714|516599826|FG000|Overall Study|Technical Fault|5|||
143287578|NCT04419714|516599826|FG000|Overall Study|Protocol Deviation|2|||
143287579|NCT04419714|516599826|FG000|Overall Study|Withdrawal by Subject|1|||
143287580|NCT00793598|516601856|FG000|Overall Study|Patient Request|0|||
143287581|NCT00793598|516601857|FG001|Overall Study|Patient Request|1|||
143287582|NCT00793598|516601858|FG002|Overall Study|Patient Request|0|||
143287583|NCT00793598|516601859|FG003|Overall Study|Patient Request|0|||
143287584|NCT00793598|516601860|FG004|Overall Study|Patient Request|0|||
143287585|NCT00793598|516601861|FG005|Overall Study|Patient Request|0|||
143287586|NCT00793598|516601862|FG006|Overall Study|Patient Request|0|||
143287587|NCT00793598|516601863|FG007|Overall Study|Patient Request|0|||
143287588|NCT00793598|516601856|FG000|Overall Study|Protocol Violation|0|||
143287589|NCT00793598|516601857|FG001|Overall Study|Protocol Violation|0|||
143287590|NCT00793598|516601858|FG002|Overall Study|Protocol Violation|0|||
143287591|NCT00793598|516601859|FG003|Overall Study|Protocol Violation|0|||
143287592|NCT00793598|516601860|FG004|Overall Study|Protocol Violation|0|||
143287593|NCT00793598|516601861|FG005|Overall Study|Protocol Violation|0|||
143287594|NCT00793598|516601862|FG006|Overall Study|Protocol Violation|0|||
143287595|NCT00793598|516601863|FG007|Overall Study|Protocol Violation|1|||
143287596|NCT00793598|516601856|FG000|Overall Study|Subject not dosed|0|||
143287597|NCT00793598|516601857|FG001|Overall Study|Subject not dosed|0|||
143287598|NCT00793598|516601858|FG002|Overall Study|Subject not dosed|0|||
143287599|NCT00793598|516601859|FG003|Overall Study|Subject not dosed|0|||
143287600|NCT00793598|516601860|FG004|Overall Study|Subject not dosed|0|||
143287601|NCT00793598|516601861|FG005|Overall Study|Subject not dosed|1|||
143287602|NCT00793598|516601862|FG006|Overall Study|Subject not dosed|0|||
143287603|NCT00793598|516601863|FG007|Overall Study|Subject not dosed|0|||
143287604|NCT02762266|516601864|FG000|Overall Study|Physician Decision|2|||
143287605|NCT02762266|516601865|FG001|Overall Study|Physician Decision|0|||
143287606|NCT02961751|516601868|FG000|Overall Study|Lost to Follow-up|11|||
143287607|NCT02961751|516601868|FG000|Overall Study|Physician Decision|2|||
143287608|NCT02961751|516601868|FG000|Overall Study|Not Eligible at Enrollment|1|||
143287609|NCT02961751|516601868|FG000|Overall Study|Protocol Violation|1|||
143287610|NCT03909295|516601869|FG000|Overall Study|Adverse Event|2|||
143287611|NCT03909295|516601869|FG000|Overall Study|Study terminated by sponsor|50|||
143287612|NCT03312933|516601876|FG000|Overall Study|Protocol Violation|15|||
143287613|NCT03312933|516601876|FG000|Overall Study|Lost to Follow-up|36|||
143287614|NCT03312933|516601876|FG000|Overall Study|Withdrawal by Subject|3|||
143287615|NCT02989194|516601882|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
143287616|NCT02989194|516601883|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
143287617|NCT02989194|516601884|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
143287618|NCT02989194|516601882|FG000|Overall Study|Lost to Follow-up|0|||
143287619|NCT02989194|516601883|FG001|Overall Study|Lost to Follow-up|1|||
143287620|NCT02989194|516601884|FG002|Overall Study|Lost to Follow-up|0|||
143287621|NCT02989194|516601882|FG000|Overall Study|Withdrawal by Subject|0|||
143287622|NCT02989194|516601883|FG001|Overall Study|Withdrawal by Subject|1|||
143287623|NCT02989194|516601884|FG002|Overall Study|Withdrawal by Subject|0|||
143287624|NCT02692716|516601886|FG000|Overall Study|Lost to Follow-up|2|||
143287625|NCT02692716|516601887|FG001|Overall Study|Lost to Follow-up|5|||
143287626|NCT02692716|516601886|FG000|Overall Study|Withdrawal by Subject|3|||
143287627|NCT02692716|516601887|FG001|Overall Study|Withdrawal by Subject|1|||
143287628|NCT02899988|516601892|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
143287629|NCT02899988|516601893|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
143287630|NCT02899988|516601894|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
143287631|NCT02899988|516601895|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
143287632|NCT02899988|516601896|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
143287633|NCT02899988|516601897|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
143287634|NCT02899988|516601898|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
143287635|NCT02899988|516601899|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
143287636|NCT02899988|516601900|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
143287637|NCT02899988|516601901|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
143287638|NCT02899988|516601902|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
143287639|NCT02899988|516601892|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
143287640|NCT02899988|516601893|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
143287641|NCT02899988|516601894|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
143287642|NCT02899988|516601895|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
143287643|NCT02899988|516601896|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
143287644|NCT02899988|516601897|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
143287645|NCT02899988|516601898|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
143287646|NCT02899988|516601899|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
143287647|NCT02899988|516601900|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
143287648|NCT02899988|516601901|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
143287649|NCT02899988|516601902|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
143287650|NCT02899988|516601892|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
143287651|NCT02899988|516601893|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
143287652|NCT02899988|516601894|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
143287653|NCT02899988|516601895|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
143287654|NCT02899988|516601896|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
143287655|NCT02899988|516601897|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
143287656|NCT02899988|516601898|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
143287657|NCT02899988|516601899|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
143287658|NCT02899988|516601900|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
143287659|NCT02899988|516601901|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
143287660|NCT02899988|516601902|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
143287661|NCT02899988|516601892|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
143287662|NCT02899988|516601893|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
143287663|NCT02899988|516601894|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
143287664|NCT02899988|516601895|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
143287665|NCT02899988|516601896|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
143287666|NCT02899988|516601897|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
143287667|NCT02899988|516601898|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
143287668|NCT02899988|516601899|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
143287669|NCT02899988|516601900|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
143287670|NCT02899988|516601901|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
143287671|NCT02899988|516601902|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
143287672|NCT02899988|516601892|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
143287673|NCT02899988|516601893|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
143287674|NCT02899988|516601894|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
143287675|NCT02899988|516601895|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
143287676|NCT02899988|516601896|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
143287677|NCT02899988|516601897|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
143287678|NCT02899988|516601898|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
143287679|NCT02899988|516601899|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
143287680|NCT02899988|516601900|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
143287681|NCT02899988|516601901|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
143287682|NCT02899988|516601902|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
143287683|NCT02899988|516601892|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
143287684|NCT02899988|516601893|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
143287685|NCT02899988|516601894|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
143287686|NCT02899988|516601895|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
143287687|NCT02899988|516601896|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
143287688|NCT02899988|516601897|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
143287689|NCT02899988|516601898|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
143287690|NCT02899988|516601899|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
143287691|NCT02899988|516601900|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
143287692|NCT02899988|516601901|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
143287693|NCT02899988|516601902|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
143287694|NCT00856284|516601907|FG000|Overall Study|Hyperglycemic rescue|231|||
143287695|NCT00856284|516601908|FG001|Overall Study|Hyperglycemic rescue|201|||
143287696|NCT00856284|516601909|FG002|Overall Study|Hyperglycemic rescue|235|||
143287697|NCT00856284|516601907|FG000|Overall Study|Adverse Event|60|||
143287698|NCT00856284|516601908|FG001|Overall Study|Adverse Event|74|||
143287699|NCT00856284|516601909|FG002|Overall Study|Adverse Event|82|||
143287700|NCT00856284|516601907|FG000|Overall Study|Major protocol deviation|24|||
143287701|NCT00856284|516601908|FG001|Overall Study|Major protocol deviation|16|||
143287702|NCT00856284|516601909|FG002|Overall Study|Major protocol deviation|15|||
143287703|NCT00856284|516601907|FG000|Overall Study|Lost to Follow-up|20|||
143287704|NCT00856284|516601908|FG001|Overall Study|Lost to Follow-up|22|||
143287705|NCT00856284|516601909|FG002|Overall Study|Lost to Follow-up|28|||
143287706|NCT00856284|516601907|FG000|Overall Study|Voluntary withdrawal|48|||
143287707|NCT00856284|516601908|FG001|Overall Study|Voluntary withdrawal|52|||
143287708|NCT00856284|516601909|FG002|Overall Study|Voluntary withdrawal|62|||
143287709|NCT00856284|516601907|FG000|Overall Study|Pregnancy|1|||
143287710|NCT00856284|516601908|FG001|Overall Study|Pregnancy|2|||
143287711|NCT00856284|516601909|FG002|Overall Study|Pregnancy|0|||
143287712|NCT00856284|516601907|FG000|Overall Study|Investigator discretion|9|||
143287713|NCT00856284|516601908|FG001|Overall Study|Investigator discretion|8|||
143287714|NCT00856284|516601909|FG002|Overall Study|Investigator discretion|10|||
143287715|NCT00856284|516601907|FG000|Overall Study|Other|15|||
143287716|NCT00856284|516601908|FG001|Overall Study|Other|17|||
143287717|NCT00856284|516601909|FG002|Overall Study|Other|14|||
143287718|NCT00856284|516601907|FG000|Overall Study|Randomized in error|0|||
143287719|NCT00856284|516601908|FG001|Overall Study|Randomized in error|0|||
143287720|NCT00856284|516601909|FG002|Overall Study|Randomized in error|1|||
143287721|NCT03824912|516601916|FG000|Overall Study|Lost to Follow-up|18|||
143287722|NCT03824912|516601917|FG001|Overall Study|Lost to Follow-up|15|||
143287723|NCT03824912|516601918|FG002|Overall Study|Lost to Follow-up|8|||
143287724|NCT03824912|516601916|FG000|Overall Study|Negative Baseline Culture Result|118|||
143287725|NCT03824912|516601917|FG001|Overall Study|Negative Baseline Culture Result|112|||
143287726|NCT03824912|516601918|FG002|Overall Study|Negative Baseline Culture Result|57|||
143287727|NCT03824912|516601916|FG000|Overall Study|Non-Compliance with Study Drug|0|||
143287728|NCT03824912|516601917|FG001|Overall Study|Non-Compliance with Study Drug|0|||
143287729|NCT03824912|516601918|FG002|Overall Study|Non-Compliance with Study Drug|1|||
143287730|NCT03824912|516601916|FG000|Overall Study|Protocol Violation|1|||
143287731|NCT03824912|516601917|FG001|Overall Study|Protocol Violation|4|||
143287732|NCT03824912|516601918|FG002|Overall Study|Protocol Violation|1|||
143287733|NCT03824912|516601916|FG000|Overall Study|Withdrawal by Subject|3|||
143287734|NCT03824912|516601917|FG001|Overall Study|Withdrawal by Subject|2|||
143287735|NCT03824912|516601918|FG002|Overall Study|Withdrawal by Subject|1|||
143287736|NCT03824912|516601916|FG000|Overall Study|Participation in another study|0|||
143287737|NCT03824912|516601917|FG001|Overall Study|Participation in another study|1|||
143287738|NCT03824912|516601918|FG002|Overall Study|Participation in another study|0|||
143287739|NCT02511184|516601919|FG000|Overall Study|Death|1|||
143287740|NCT02511184|516601920|FG001|Overall Study|Death|0|||
143287741|NCT02511184|516601919|FG000|Overall Study|Lost to Follow-up|0|||
143287742|NCT02511184|516601920|FG001|Overall Study|Lost to Follow-up|1|||
143287743|NCT02511184|516601919|FG000|Overall Study|Study terminated by sponsor|1|||
143287744|NCT02511184|516601920|FG001|Overall Study|Study terminated by sponsor|5|||
143287745|NCT02511184|516601919|FG000|Overall Study|Withdrawal by Subject|0|||
143287746|NCT02511184|516601920|FG001|Overall Study|Withdrawal by Subject|1|||
143287747|NCT04271605|516601921|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
143287748|NCT01059825|516601925|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
143287749|NCT01059825|516601926|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
143287750|NCT01059825|516601927|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
143287751|NCT01059825|516601928|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
143287752|NCT01059825|516601929|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
143287753|NCT01059825|516601930|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
143287754|NCT01059825|516601931|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
143287755|NCT01059825|516601925|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
143287756|NCT01059825|516601926|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
143287757|NCT01059825|516601927|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
143287758|NCT01059825|516601928|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
143287759|NCT01059825|516601929|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
143287760|NCT01059825|516601930|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
143287761|NCT01059825|516601931|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
143287762|NCT01059825|516601925|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
143287763|NCT01059825|516601926|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
143287764|NCT01059825|516601927|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
143287765|NCT01059825|516601928|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
143287766|NCT01059825|516601929|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
143287767|NCT01059825|516601930|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
143287768|NCT01059825|516601931|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
143287769|NCT01059825|516601925|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
143287770|NCT01059825|516601926|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
143287771|NCT01059825|516601927|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
143287772|NCT01059825|516601928|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
143287773|NCT01059825|516601929|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
143287774|NCT01059825|516601930|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
143287775|NCT01059825|516601931|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
143287776|NCT01059825|516601925|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
143287777|NCT01059825|516601926|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
143287778|NCT01059825|516601927|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
143287779|NCT01059825|516601928|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
143287780|NCT01059825|516601929|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
143287781|NCT01059825|516601930|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
143287782|NCT01059825|516601931|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
143287783|NCT01059825|516601925|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
143287784|NCT01059825|516601926|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
143287785|NCT01059825|516601927|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
143287786|NCT01059825|516601928|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
143287787|NCT01059825|516601929|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
143287788|NCT01059825|516601930|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
143373715|NCT00708032|516913551|FG000|Overall Study|Pregnancy|0|||
143287789|NCT01059825|516601931|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
143287790|NCT01059825|516601925|FG000|Treatment Period|Lost to Follow-up|2|||
143287791|NCT01059825|516601926|FG001|Treatment Period|Lost to Follow-up|1|||
143287792|NCT01059825|516601927|FG002|Treatment Period|Lost to Follow-up|0|||
143287793|NCT01059825|516601928|FG003|Treatment Period|Lost to Follow-up|1|||
143287794|NCT01059825|516601929|FG004|Treatment Period|Lost to Follow-up|2|||
143287795|NCT01059825|516601930|FG005|Treatment Period|Lost to Follow-up|0|||
143287796|NCT01059825|516601931|FG006|Treatment Period|Lost to Follow-up|0|||
143287797|NCT01059825|516601925|FG000|Treatment Period|Withdrawal by Subject|3|||
143287798|NCT01059825|516601926|FG001|Treatment Period|Withdrawal by Subject|0|||
143287799|NCT01059825|516601927|FG002|Treatment Period|Withdrawal by Subject|1|||
143287800|NCT01059825|516601928|FG003|Treatment Period|Withdrawal by Subject|5|||
143287801|NCT01059825|516601929|FG004|Treatment Period|Withdrawal by Subject|4|||
143287802|NCT01059825|516601930|FG005|Treatment Period|Withdrawal by Subject|1|||
143287803|NCT01059825|516601931|FG006|Treatment Period|Withdrawal by Subject|0|||
143287804|NCT01059825|516601925|FG000|Treatment Period|Other reason not specified|1|||
143287805|NCT01059825|516601926|FG001|Treatment Period|Other reason not specified|2|||
143287806|NCT01059825|516601927|FG002|Treatment Period|Other reason not specified|1|||
143287807|NCT01059825|516601928|FG003|Treatment Period|Other reason not specified|2|||
143287808|NCT01059825|516601929|FG004|Treatment Period|Other reason not specified|0|||
143287809|NCT01059825|516601930|FG005|Treatment Period|Other reason not specified|0|||
143287810|NCT01059825|516601931|FG006|Treatment Period|Other reason not specified|0|||
143287811|NCT01059825|516601925|FG000|Treatment Period|Protocol Violation|0|||
143287812|NCT01059825|516601926|FG001|Treatment Period|Protocol Violation|0|||
143287813|NCT01059825|516601927|FG002|Treatment Period|Protocol Violation|1|||
143287814|NCT01059825|516601928|FG003|Treatment Period|Protocol Violation|1|||
143287815|NCT01059825|516601929|FG004|Treatment Period|Protocol Violation|1|||
143287816|NCT01059825|516601930|FG005|Treatment Period|Protocol Violation|1|||
143287817|NCT01059825|516601931|FG006|Treatment Period|Protocol Violation|0|||
143287818|NCT01059825|516601925|FG000|Treatment Period|Adverse event related to study drug|1|||
143287819|NCT01059825|516601926|FG001|Treatment Period|Adverse event related to study drug|0|||
143287820|NCT01059825|516601927|FG002|Treatment Period|Adverse event related to study drug|1|||
143287821|NCT01059825|516601928|FG003|Treatment Period|Adverse event related to study drug|1|||
143287822|NCT01059825|516601929|FG004|Treatment Period|Adverse event related to study drug|0|||
143287823|NCT01059825|516601930|FG005|Treatment Period|Adverse event related to study drug|0|||
143287824|NCT01059825|516601931|FG006|Treatment Period|Adverse event related to study drug|0|||
143287825|NCT01059825|516601925|FG000|Treatment Period|Insufficient clinical response|3|||
143287826|NCT01059825|516601926|FG001|Treatment Period|Insufficient clinical response|0|||
143287827|NCT01059825|516601927|FG002|Treatment Period|Insufficient clinical response|0|||
143287828|NCT01059825|516601928|FG003|Treatment Period|Insufficient clinical response|0|||
143287829|NCT01059825|516601929|FG004|Treatment Period|Insufficient clinical response|0|||
143287830|NCT01059825|516601930|FG005|Treatment Period|Insufficient clinical response|0|||
143287831|NCT01059825|516601931|FG006|Treatment Period|Insufficient clinical response|0|||
143287832|NCT01059825|516601925|FG000|Treatment Period|Adverse event not related to study drug|0|||
143287833|NCT01059825|516601926|FG001|Treatment Period|Adverse event not related to study drug|1|||
143287834|NCT01059825|516601927|FG002|Treatment Period|Adverse event not related to study drug|2|||
143287835|NCT01059825|516601928|FG003|Treatment Period|Adverse event not related to study drug|1|||
143287836|NCT01059825|516601929|FG004|Treatment Period|Adverse event not related to study drug|1|||
143287837|NCT01059825|516601930|FG005|Treatment Period|Adverse event not related to study drug|1|||
143287838|NCT01059825|516601931|FG006|Treatment Period|Adverse event not related to study drug|0|||
143287839|NCT02041286|516601932|FG000|Overall Study|Adverse Event|1|||
143287840|NCT03342690|516601941|FG000|Overall Study|Missing Information|9|||
143287841|NCT03342690|516601941|FG000|Overall Study|Protocol Violation|16|||
143287842|NCT02289690|516601946|FG000|Overall Study|Adverse Event Related to Progression|0|||
143287843|NCT02289690|516601947|FG001|Overall Study|Adverse Event Related to Progression|1|||
143287844|NCT02289690|516601948|FG002|Overall Study|Adverse Event Related to Progression|1|||
143287845|NCT02289690|516601949|FG003|Overall Study|Adverse Event Related to Progression|0|||
143287846|NCT02289690|516601950|FG004|Overall Study|Adverse Event Related to Progression|1|||
143287847|NCT02289690|516601951|FG005|Overall Study|Adverse Event Related to Progression|0|||
143287848|NCT02289690|516601952|FG006|Overall Study|Adverse Event Related to Progression|1|||
143287849|NCT02289690|516601953|FG007|Overall Study|Adverse Event Related to Progression|0|||
143287850|NCT02289690|516601954|FG008|Overall Study|Adverse Event Related to Progression|0|||
143287851|NCT02289690|516601955|FG009|Overall Study|Adverse Event Related to Progression|0|||
143287852|NCT02289690|516601946|FG000|Overall Study|Withdrawal by Subject|1|||
143287853|NCT02289690|516601947|FG001|Overall Study|Withdrawal by Subject|0|||
143287854|NCT02289690|516601948|FG002|Overall Study|Withdrawal by Subject|0|||
143287855|NCT02289690|516601949|FG003|Overall Study|Withdrawal by Subject|0|||
143287856|NCT02289690|516601950|FG004|Overall Study|Withdrawal by Subject|1|||
143287857|NCT02289690|516601951|FG005|Overall Study|Withdrawal by Subject|1|||
143287858|NCT02289690|516601952|FG006|Overall Study|Withdrawal by Subject|0|||
143287859|NCT02289690|516601953|FG007|Overall Study|Withdrawal by Subject|0|||
143287860|NCT02289690|516601954|FG008|Overall Study|Withdrawal by Subject|4|||
143287861|NCT02289690|516601955|FG009|Overall Study|Withdrawal by Subject|2|||
143287862|NCT02289690|516601946|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
143287863|NCT02289690|516601947|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
143287864|NCT02289690|516601948|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
143287865|NCT02289690|516601949|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
143287866|NCT02289690|516601950|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
143287867|NCT02289690|516601951|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
143287868|NCT02289690|516601952|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
143287869|NCT02289690|516601953|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
143287870|NCT02289690|516601954|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
143287871|NCT02289690|516601955|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
143287872|NCT02289690|516601946|FG000|Overall Study|Lost to Follow-up|0|||
143287873|NCT02289690|516601947|FG001|Overall Study|Lost to Follow-up|0|||
143287874|NCT02289690|516601948|FG002|Overall Study|Lost to Follow-up|0|||
143287875|NCT02289690|516601949|FG003|Overall Study|Lost to Follow-up|0|||
143287876|NCT02289690|516601950|FG004|Overall Study|Lost to Follow-up|0|||
143287877|NCT02289690|516601951|FG005|Overall Study|Lost to Follow-up|0|||
143287878|NCT02289690|516601952|FG006|Overall Study|Lost to Follow-up|0|||
143287879|NCT02289690|516601953|FG007|Overall Study|Lost to Follow-up|1|||
143287880|NCT02289690|516601954|FG008|Overall Study|Lost to Follow-up|0|||
143287881|NCT02289690|516601955|FG009|Overall Study|Lost to Follow-up|2|||
143287882|NCT02289690|516601946|FG000|Overall Study|Death|0|||
143287883|NCT02289690|516601947|FG001|Overall Study|Death|0|||
143287884|NCT02289690|516601948|FG002|Overall Study|Death|0|||
143287885|NCT02289690|516601949|FG003|Overall Study|Death|0|||
143287886|NCT02289690|516601950|FG004|Overall Study|Death|0|||
143287887|NCT02289690|516601951|FG005|Overall Study|Death|0|||
143287888|NCT02289690|516601952|FG006|Overall Study|Death|0|||
143287889|NCT02289690|516601953|FG007|Overall Study|Death|49|||
143287890|NCT02289690|516601954|FG008|Overall Study|Death|45|||
143287891|NCT02289690|516601955|FG009|Overall Study|Death|41|||
143287892|NCT02289690|516601946|FG000|Overall Study|Sponsor Discontinued Study|0|||
143287893|NCT02289690|516601947|FG001|Overall Study|Sponsor Discontinued Study|0|||
143287894|NCT02289690|516601948|FG002|Overall Study|Sponsor Discontinued Study|0|||
143287895|NCT02289690|516601949|FG003|Overall Study|Sponsor Discontinued Study|0|||
143287896|NCT02289690|516601950|FG004|Overall Study|Sponsor Discontinued Study|0|||
143287897|NCT02289690|516601951|FG005|Overall Study|Sponsor Discontinued Study|0|||
143287898|NCT02289690|516601952|FG006|Overall Study|Sponsor Discontinued Study|0|||
143287899|NCT02289690|516601953|FG007|Overall Study|Sponsor Discontinued Study|9|||
143287900|NCT02289690|516601954|FG008|Overall Study|Sponsor Discontinued Study|7|||
143287901|NCT02289690|516601955|FG009|Overall Study|Sponsor Discontinued Study|15|||
143287902|NCT02289690|516601946|FG000|Overall Study|Other|0|||
143287903|NCT02289690|516601947|FG001|Overall Study|Other|0|||
143287904|NCT02289690|516601948|FG002|Overall Study|Other|0|||
143287905|NCT02289690|516601949|FG003|Overall Study|Other|1|||
143287906|NCT02289690|516601950|FG004|Overall Study|Other|1|||
143287907|NCT02289690|516601951|FG005|Overall Study|Other|0|||
143287908|NCT02289690|516601952|FG006|Overall Study|Other|1|||
143287909|NCT02289690|516601953|FG007|Overall Study|Other|2|||
143287910|NCT02289690|516601954|FG008|Overall Study|Other|3|||
143287911|NCT02289690|516601955|FG009|Overall Study|Other|1|||
143287912|NCT02085785|516601958|FG000|Overall Study|Withdrawal by Subject|2|||
143287913|NCT02085785|516601959|FG001|Overall Study|Withdrawal by Subject|1|||
143287914|NCT02085785|516601958|FG000|Overall Study|Lost to Follow-up|0|||
143287915|NCT02085785|516601959|FG001|Overall Study|Lost to Follow-up|1|||
143287916|NCT00779467|516601960|FG000|Overall Study|Lack of Efficacy|11|||
143287917|NCT00779467|516601961|FG001|Overall Study|Lack of Efficacy|2|||
143287918|NCT00779467|516601962|FG002|Overall Study|Lack of Efficacy|6|||
143287919|NCT00779467|516601963|FG003|Overall Study|Lack of Efficacy|11|||
143287920|NCT00779467|516601960|FG000|Overall Study|failed inclusion criteria|3|||
143287921|NCT00779467|516601961|FG001|Overall Study|failed inclusion criteria|3|||
143287922|NCT00779467|516601962|FG002|Overall Study|failed inclusion criteria|1|||
143287923|NCT00779467|516601963|FG003|Overall Study|failed inclusion criteria|2|||
143287924|NCT00779467|516601960|FG000|Overall Study|missing data|1|||
143287925|NCT00779467|516601961|FG001|Overall Study|missing data|0|||
143287926|NCT00779467|516601962|FG002|Overall Study|missing data|1|||
143287927|NCT00779467|516601963|FG003|Overall Study|missing data|4|||
143287928|NCT00779467|516601960|FG000|Overall Study|technical issue|0|||
143287929|NCT00779467|516601961|FG001|Overall Study|technical issue|0|||
143287930|NCT00779467|516601962|FG002|Overall Study|technical issue|2|||
143287931|NCT00779467|516601963|FG003|Overall Study|technical issue|1|||
143287932|NCT00779467|516601960|FG000|Overall Study|unavailable research staff|0|||
143287933|NCT00779467|516601961|FG001|Overall Study|unavailable research staff|0|||
143287934|NCT00779467|516601962|FG002|Overall Study|unavailable research staff|0|||
143287935|NCT00779467|516601963|FG003|Overall Study|unavailable research staff|1|||
143287936|NCT04626297|516601964|FG000|Overall Study|Adverse Event|5|||
143287937|NCT04626297|516601965|FG001|Overall Study|Adverse Event|3|||
143287938|NCT04626297|516601964|FG000|Overall Study|Lost to Follow-up|7|||
143287939|NCT04626297|516601965|FG001|Overall Study|Lost to Follow-up|3|||
143287940|NCT04626297|516601964|FG000|Overall Study|Protocol Violation|5|||
143287941|NCT04626297|516601965|FG001|Overall Study|Protocol Violation|1|||
143287942|NCT04626297|516601964|FG000|Overall Study|Withdrawal by Subject|20|||
143287943|NCT04626297|516601965|FG001|Overall Study|Withdrawal by Subject|6|||
143287944|NCT04626297|516601964|FG000|Overall Study|Sponsor decision|2|||
143287945|NCT04626297|516601965|FG001|Overall Study|Sponsor decision|1|||
143287946|NCT04118166|516601966|FG000|Overall Study|Adverse Event|1|||
143287947|NCT02254486|516601969|FG000|Overall Study|Adverse Event|1|||
143287948|NCT02254486|516601970|FG001|Overall Study|Adverse Event|1|||
143287949|NCT02254486|516601969|FG000|Overall Study|Lack of Efficacy|1|||
143287950|NCT02254486|516601970|FG001|Overall Study|Lack of Efficacy|0|||
143287951|NCT02254486|516601969|FG000|Overall Study|Lost to Follow-up|2|||
143287952|NCT02254486|516601970|FG001|Overall Study|Lost to Follow-up|4|||
143287953|NCT02254486|516601969|FG000|Overall Study|Protocol Violation|1|||
143287954|NCT02254486|516601970|FG001|Overall Study|Protocol Violation|2|||
143287955|NCT02254486|516601969|FG000|Overall Study|Withdrawal by Subject|17|||
143287956|NCT02254486|516601970|FG001|Overall Study|Withdrawal by Subject|15|||
143287957|NCT02254486|516601969|FG000|Overall Study|GFR<60mL/min|16|||
143287958|NCT02254486|516601970|FG001|Overall Study|GFR<60mL/min|21|||
143287959|NCT02254486|516601969|FG000|Overall Study|Various|12|||
143287960|NCT02254486|516601970|FG001|Overall Study|Various|12|||
143287961|NCT01350414|516601977|FG000|Overall Study|Lost to Follow-up|13|||
143287962|NCT01350414|516601977|FG000|Overall Study|Withdrawal by Subject|4|||
143287963|NCT01350414|516601977|FG000|Overall Study|Physician Decision|2|||
143287964|NCT02743520|516601978|FG000|Overall Study|Withdrawal by Subject|1|||
143287965|NCT01749514|516601979|FG000|Overall Study|Lost to Follow-up|0|||
143287966|NCT01749514|516601980|FG001|Overall Study|Lost to Follow-up|0|||
143287967|NCT01749514|516601981|FG002|Overall Study|Lost to Follow-up|0|||
143287968|NCT01749514|516601982|FG003|Overall Study|Lost to Follow-up|0|||
143287969|NCT01749514|516601983|FG004|Overall Study|Lost to Follow-up|0|||
143287970|NCT01749514|516601984|FG005|Overall Study|Lost to Follow-up|0|||
143287971|NCT01749514|516601985|FG006|Overall Study|Lost to Follow-up|0|||
143287972|NCT01749514|516601986|FG007|Overall Study|Lost to Follow-up|1|||
143287973|NCT01749514|516601979|FG000|Overall Study|Withdrawal by Subject|0|||
143287974|NCT01749514|516601980|FG001|Overall Study|Withdrawal by Subject|0|||
143287975|NCT01749514|516601981|FG002|Overall Study|Withdrawal by Subject|0|||
143287976|NCT01749514|516601982|FG003|Overall Study|Withdrawal by Subject|0|||
143287977|NCT01749514|516601983|FG004|Overall Study|Withdrawal by Subject|0|||
143287978|NCT01749514|516601984|FG005|Overall Study|Withdrawal by Subject|1|||
143287979|NCT01749514|516601985|FG006|Overall Study|Withdrawal by Subject|0|||
143287980|NCT01749514|516601986|FG007|Overall Study|Withdrawal by Subject|1|||
143287981|NCT01749514|516601979|FG000|Overall Study|Not Reported|0|||
143287982|NCT01749514|516601980|FG001|Overall Study|Not Reported|0|||
143287983|NCT01749514|516601981|FG002|Overall Study|Not Reported|0|||
143287984|NCT01749514|516601982|FG003|Overall Study|Not Reported|0|||
143287985|NCT01749514|516601983|FG004|Overall Study|Not Reported|0|||
143287986|NCT01749514|516601984|FG005|Overall Study|Not Reported|0|||
143287987|NCT01749514|516601985|FG006|Overall Study|Not Reported|0|||
143287988|NCT01749514|516601986|FG007|Overall Study|Not Reported|5|||
143287989|NCT02509156|516601987|FG000|Randomized Phase|Death|1|||
143287990|NCT02509156|516601988|FG001|Randomized Phase|Death|0|||
143287991|NCT02509156|516601987|FG000|Randomized Phase|Withdrawal by Subject|1|||
143287992|NCT02509156|516601988|FG001|Randomized Phase|Withdrawal by Subject|1|||
143287993|NCT03042533|516601989|FG000|Overall Study|MD left program|1|||
143287994|NCT03042533|516601990|FG001|Overall Study|MD left program|4|||
143287995|NCT03042533|516601991|FG002|Overall Study|MD left program|1|||
143287996|NCT02551731|516601992|FG000|Overall Study|Withdrawal by Subject|2|||
143287997|NCT00010374|516601993|FG000|Overall Study|False positive phrenic nerve test|1|||
143287998|NCT02268084|516601994|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
143287999|NCT02268084|516601995|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
143288000|NCT02268084|516601994|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
143288001|NCT02268084|516601995|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
143288002|NCT02007109|516601996|FG000|Overall Study|Diary not returned or excluded|102|||
143288003|NCT02007109|516601996|FG000|Overall Study|Excluded - Age<7yo|9|||
143288004|NCT00687323|516601997|FG000|Overall Study|Death|25|||
143288005|NCT00687323|516601997|FG000|Overall Study|Withdrawal by Subject|1|||
143288006|NCT00687323|516601997|FG000|Overall Study|Excluded from efficacy evaluations|6|||
143288007|NCT00687323|516601997|FG000|Overall Study|Screen failure|148|||
143288008|NCT03655691|516601999|FG000|Overall Study|Adverse Event|0|||
143288009|NCT03655691|516602000|FG001|Overall Study|Adverse Event|0|||
143288010|NCT03655691|516602001|FG002|Overall Study|Adverse Event|1|||
143288011|NCT03655691|516601999|FG000|Overall Study|Lost to Follow-up|1|||
143288012|NCT03655691|516602000|FG001|Overall Study|Lost to Follow-up|1|||
143288013|NCT03655691|516602001|FG002|Overall Study|Lost to Follow-up|2|||
143288014|NCT03655691|516601999|FG000|Overall Study|Protocol Violation|0|||
143288015|NCT03655691|516602000|FG001|Overall Study|Protocol Violation|1|||
143288016|NCT03655691|516602001|FG002|Overall Study|Protocol Violation|0|||
143288017|NCT03655691|516601999|FG000|Overall Study|Withdrawal by Subject|1|||
143288018|NCT03655691|516602000|FG001|Overall Study|Withdrawal by Subject|1|||
143288019|NCT03655691|516602001|FG002|Overall Study|Withdrawal by Subject|0|||
143288020|NCT04557371|516602006|FG000|Overall Study|Covid-19-related|0|||
143288021|NCT04557371|516602007|FG001|Overall Study|Covid-19-related|1|||
143288022|NCT04557371|516602008|FG002|Overall Study|Covid-19-related|0|||
143288023|NCT04557371|516602006|FG000|Overall Study|Withdrawal by Subject|0|||
143288024|NCT04557371|516602007|FG001|Overall Study|Withdrawal by Subject|1|||
143288025|NCT04557371|516602008|FG002|Overall Study|Withdrawal by Subject|0|||
143288026|NCT04557371|516602006|FG000|Overall Study|Adverse Event|1|||
143288027|NCT04557371|516602007|FG001|Overall Study|Adverse Event|0|||
143288028|NCT04557371|516602008|FG002|Overall Study|Adverse Event|0|||
143288029|NCT03694821|516602009|FG000|Overall Study|Study terminated|4|||
143288030|NCT03694821|516602010|FG001|Overall Study|Study terminated|8|||
143288031|NCT03694821|516602011|FG002|Overall Study|Study terminated|4|||
143288032|NCT04102020|516602012|FG000|Overall Study|Adverse Event|1|||
143288033|NCT04102020|516602013|FG001|Overall Study|Adverse Event|0|||
143288034|NCT04102020|516602014|FG002|Overall Study|Adverse Event|0|||
143288035|NCT04102020|516602015|FG003|Overall Study|Adverse Event|1|||
143288036|NCT04102020|516602016|FG004|Overall Study|Adverse Event|0|||
143288037|NCT04102020|516602012|FG000|Overall Study|Withdrawal by Subject|0|||
143288038|NCT04102020|516602013|FG001|Overall Study|Withdrawal by Subject|1|||
143288039|NCT04102020|516602014|FG002|Overall Study|Withdrawal by Subject|1|||
143288040|NCT04102020|516602015|FG003|Overall Study|Withdrawal by Subject|1|||
143288041|NCT04102020|516602016|FG004|Overall Study|Withdrawal by Subject|1|||
143288042|NCT04102020|516602012|FG000|Overall Study|Death|1|||
143288043|NCT04102020|516602013|FG001|Overall Study|Death|4|||
143288044|NCT04102020|516602014|FG002|Overall Study|Death|1|||
143288045|NCT04102020|516602015|FG003|Overall Study|Death|1|||
143288046|NCT04102020|516602016|FG004|Overall Study|Death|0|||
143288047|NCT04102020|516602012|FG000|Overall Study|Physician Decision|1|||
143288048|NCT04102020|516602013|FG001|Overall Study|Physician Decision|2|||
143288049|NCT04102020|516602014|FG002|Overall Study|Physician Decision|2|||
143288050|NCT04102020|516602015|FG003|Overall Study|Physician Decision|0|||
143288051|NCT04102020|516602016|FG004|Overall Study|Physician Decision|1|||
143288052|NCT04102020|516602012|FG000|Overall Study|COVID-19 Infection|1|||
143288053|NCT04102020|516602013|FG001|Overall Study|COVID-19 Infection|0|||
143288054|NCT04102020|516602014|FG002|Overall Study|COVID-19 Infection|0|||
143288055|NCT04102020|516602015|FG003|Overall Study|COVID-19 Infection|0|||
143288056|NCT04102020|516602016|FG004|Overall Study|COVID-19 Infection|0|||
143288057|NCT04102020|516602012|FG000|Overall Study|Not disclosed|5|||
143288058|NCT04102020|516602013|FG001|Overall Study|Not disclosed|3|||
143288059|NCT04102020|516602014|FG002|Overall Study|Not disclosed|8|||
143288060|NCT04102020|516602015|FG003|Overall Study|Not disclosed|0|||
143288061|NCT04102020|516602016|FG004|Overall Study|Not disclosed|1|||
143288062|NCT04102020|516602012|FG000|Overall Study|MIssing|1|||
143288063|NCT04102020|516602013|FG001|Overall Study|MIssing|0|||
143288064|NCT04102020|516602014|FG002|Overall Study|MIssing|1|||
143288065|NCT04102020|516602015|FG003|Overall Study|MIssing|1|||
143288066|NCT04102020|516602016|FG004|Overall Study|MIssing|1|||
143288067|NCT04102020|516602012|FG000|Overall Study|Continuing in ongoing study|13|||
143288068|NCT04102020|516602013|FG001|Overall Study|Continuing in ongoing study|13|||
143373716|NCT00708032|516913552|FG001|Overall Study|Pregnancy|1|||
143288069|NCT04102020|516602014|FG002|Overall Study|Continuing in ongoing study|7|||
143288070|NCT04102020|516602015|FG003|Overall Study|Continuing in ongoing study|26|||
143288071|NCT04102020|516602016|FG004|Overall Study|Continuing in ongoing study|12|||
143288072|NCT05109442|516602017|FG000|Overall Study|Withdrawal by Subject|0|||
143288073|NCT05109442|516602018|FG001|Overall Study|Withdrawal by Subject|0|||
143288074|NCT05109442|516602019|FG002|Overall Study|Withdrawal by Subject|1|||
143288075|NCT05109442|516602020|FG003|Overall Study|Withdrawal by Subject|0|||
143288076|NCT05109442|516602021|FG004|Overall Study|Withdrawal by Subject|0|||
143373717|NCT00708032|516913551|FG000|Overall Study|Poor vision|0|||
143288077|NCT05109442|516602022|FG005|Overall Study|Withdrawal by Subject|0|||
143288078|NCT05109442|516602017|FG000|Overall Study|Adverse Event|0|||
143288079|NCT05109442|516602018|FG001|Overall Study|Adverse Event|1|||
143288080|NCT05109442|516602019|FG002|Overall Study|Adverse Event|5|||
143288081|NCT05109442|516602020|FG003|Overall Study|Adverse Event|0|||
143288082|NCT05109442|516602021|FG004|Overall Study|Adverse Event|0|||
143288083|NCT05109442|516602022|FG005|Overall Study|Adverse Event|2|||
143288084|NCT05109442|516602017|FG000|Overall Study|Death|0|||
143288085|NCT05109442|516602018|FG001|Overall Study|Death|0|||
143288086|NCT05109442|516602019|FG002|Overall Study|Death|4|||
143288087|NCT05109442|516602020|FG003|Overall Study|Death|0|||
143288088|NCT05109442|516602021|FG004|Overall Study|Death|0|||
143288089|NCT05109442|516602022|FG005|Overall Study|Death|1|||
143288090|NCT05109442|516602017|FG000|Overall Study|Physician Decision|1|||
143288091|NCT05109442|516602018|FG001|Overall Study|Physician Decision|0|||
143288092|NCT05109442|516602019|FG002|Overall Study|Physician Decision|1|||
143288093|NCT05109442|516602020|FG003|Overall Study|Physician Decision|0|||
143288094|NCT05109442|516602021|FG004|Overall Study|Physician Decision|0|||
143288095|NCT05109442|516602022|FG005|Overall Study|Physician Decision|2|||
143288096|NCT05109442|516602017|FG000|Overall Study|Other than listed|0|||
143288097|NCT05109442|516602018|FG001|Overall Study|Other than listed|0|||
143288098|NCT05109442|516602019|FG002|Overall Study|Other than listed|9|||
143288099|NCT05109442|516602020|FG003|Overall Study|Other than listed|2|||
143288100|NCT05109442|516602021|FG004|Overall Study|Other than listed|0|||
143288101|NCT05109442|516602022|FG005|Overall Study|Other than listed|8|||
143288102|NCT05109442|516602017|FG000|Overall Study|Lack of Efficacy|3|||
143288103|NCT05109442|516602018|FG001|Overall Study|Lack of Efficacy|5|||
143288104|NCT05109442|516602019|FG002|Overall Study|Lack of Efficacy|29|||
143288105|NCT05109442|516602020|FG003|Overall Study|Lack of Efficacy|10|||
143288106|NCT05109442|516602021|FG004|Overall Study|Lack of Efficacy|11|||
143288107|NCT05109442|516602022|FG005|Overall Study|Lack of Efficacy|17|||
143288108|NCT01405456|516602027|FG000|Overall Study|Lost to Follow-up|2|||
143288109|NCT01405456|516602028|FG001|Overall Study|Lost to Follow-up|1|||
143288110|NCT01405456|516602027|FG000|Overall Study|Physician Decision|1|||
143288111|NCT01405456|516602028|FG001|Overall Study|Physician Decision|0|||
143288112|NCT05355805|516602029|FG000|Overall Study|Lost to Follow-up|6|||
143288113|NCT05355805|516602030|FG001|Overall Study|Lost to Follow-up|11|||
143288114|NCT05355805|516602031|FG002|Overall Study|Lost to Follow-up|10|||
143288115|NCT05355805|516602032|FG003|Overall Study|Lost to Follow-up|6|||
143288116|NCT05355805|516602029|FG000|Overall Study|Decision by Sponsor|0|||
143288117|NCT05355805|516602030|FG001|Overall Study|Decision by Sponsor|0|||
143288118|NCT05355805|516602031|FG002|Overall Study|Decision by Sponsor|1|||
143288119|NCT05355805|516602032|FG003|Overall Study|Decision by Sponsor|0|||
143288120|NCT05355805|516602029|FG000|Overall Study|Withdrawal by Subject|7|||
143288121|NCT05355805|516602030|FG001|Overall Study|Withdrawal by Subject|14|||
143288122|NCT05355805|516602031|FG002|Overall Study|Withdrawal by Subject|15|||
143288123|NCT05355805|516602032|FG003|Overall Study|Withdrawal by Subject|13|||
143288124|NCT05353985|516602033|FG000|Overall Study|Adverse Event|5|||
143288125|NCT05353985|516602034|FG001|Overall Study|Adverse Event|7|||
143288126|NCT05353985|516602033|FG000|Overall Study|Lost to Follow-up|1|||
143288127|NCT05353985|516602034|FG001|Overall Study|Lost to Follow-up|1|||
143288128|NCT05353985|516602033|FG000|Overall Study|Protocol Violation|1|||
143288129|NCT05353985|516602034|FG001|Overall Study|Protocol Violation|0|||
143288130|NCT05353985|516602033|FG000|Overall Study|Withdrawal by Subject|13|||
143288131|NCT05353985|516602034|FG001|Overall Study|Withdrawal by Subject|17|||
143288132|NCT05353985|516602033|FG000|Overall Study|Reason Not Specified|1|||
143288133|NCT05353985|516602034|FG001|Overall Study|Reason Not Specified|0|||
143288134|NCT05353985|516602033|FG000|Overall Study|Randomized in Error & Not Treated|0|||
143288135|NCT05353985|516602034|FG001|Overall Study|Randomized in Error & Not Treated|1|||
143288136|NCT01325584|516602037|FG000|Overall Study|Death|1|||
143288137|NCT00524368|516603695|FG000|Overall Study|Adverse Event|10|||
143288138|NCT00524368|516603696|FG001|Overall Study|Adverse Event|12|||
143288139|NCT00524368|516603695|FG000|Overall Study|Lost to Follow-up|9|||
143288140|NCT00524368|516603696|FG001|Overall Study|Lost to Follow-up|13|||
143288141|NCT00524368|516603695|FG000|Overall Study|Withdrawal by Subject|4|||
143288142|NCT00524368|516603696|FG001|Overall Study|Withdrawal by Subject|5|||
143288143|NCT00524368|516603695|FG000|Overall Study|Non-compliant|8|||
143288144|NCT00524368|516603696|FG001|Overall Study|Non-compliant|9|||
143288145|NCT00524368|516603695|FG000|Overall Study|Reached a Virologic Endpoint|3|||
143288146|NCT00524368|516603696|FG001|Overall Study|Reached a Virologic Endpoint|2|||
143288147|NCT00524368|516603695|FG000|Overall Study|Sponsor's Decision|2|||
143288148|NCT00524368|516603696|FG001|Overall Study|Sponsor's Decision|0|||
143288149|NCT00524368|516603695|FG000|Overall Study|Ineligible to Continue the study|2|||
143373718|NCT00708032|516913552|FG001|Overall Study|Poor vision|6|||
143288150|NCT00524368|516603696|FG001|Overall Study|Ineligible to Continue the study|5|||
143288151|NCT00524368|516603695|FG000|Overall Study|Other|3|||
143288152|NCT00524368|516603696|FG001|Overall Study|Other|2|||
143288153|NCT01955733|516603697|FG000|Period 1|Lost to Follow-up|1|||
143288154|NCT01955733|516603698|FG001|Period 1|Lost to Follow-up|0|||
143288155|NCT01955733|516603699|FG002|Period 1|Lost to Follow-up|0|||
143288156|NCT01955733|516603697|FG000|Period 2|Adverse Event|1|||
143288157|NCT01955733|516603698|FG001|Period 2|Adverse Event|0|||
143288158|NCT01955733|516603699|FG002|Period 2|Adverse Event|0|||
143288159|NCT01955733|516603697|FG000|Period 2|Physician Decision|0|||
143288160|NCT01955733|516603698|FG001|Period 2|Physician Decision|0|||
143288161|NCT01955733|516603699|FG002|Period 2|Physician Decision|1|||
143288162|NCT01955733|516603697|FG000|Period 2|Withdrawal by Subject|1|||
143288163|NCT01955733|516603698|FG001|Period 2|Withdrawal by Subject|3|||
143288164|NCT01955733|516603699|FG002|Period 2|Withdrawal by Subject|2|||
143288165|NCT01955733|516603697|FG000|Period 2|Study terminated by sponsor|8|||
143288166|NCT01955733|516603698|FG001|Period 2|Study terminated by sponsor|14|||
143288167|NCT01955733|516603699|FG002|Period 2|Study terminated by sponsor|16|||
143288168|NCT01955733|516603697|FG000|Period 2|Lost to Follow-up|2|||
143288169|NCT01955733|516603698|FG001|Period 2|Lost to Follow-up|0|||
143288170|NCT01955733|516603699|FG002|Period 2|Lost to Follow-up|0|||
143288171|NCT01955733|516603697|FG000|Period 2|Other not defined above|0|||
143288172|NCT01955733|516603698|FG001|Period 2|Other not defined above|2|||
143288173|NCT01955733|516603699|FG002|Period 2|Other not defined above|2|||
143288174|NCT00482612|516603716|FG000|In-treatment Period|No study medication administered|0|||
143288175|NCT00482612|516603717|FG001|In-treatment Period|No study medication administered|0|||
143288176|NCT00482612|516603718|FG002|In-treatment Period|No study medication administered|1|||
143288177|NCT00482612|516603719|FG003|In-treatment Period|No study medication administered|0|||
143288178|NCT00482612|516603716|FG000|Follow-up Period|Other|4|||
143288179|NCT00482612|516603717|FG001|Follow-up Period|Other|2|||
143288180|NCT00482612|516603718|FG002|Follow-up Period|Other|1|||
143288181|NCT00482612|516603719|FG003|Follow-up Period|Other|2|||
143288182|NCT00482612|516603716|FG000|Follow-up Period|Lack of compliance|0|||
143288183|NCT00482612|516603717|FG001|Follow-up Period|Lack of compliance|0|||
143288184|NCT00482612|516603718|FG002|Follow-up Period|Lack of compliance|1|||
143288185|NCT00482612|516603719|FG003|Follow-up Period|Lack of compliance|0|||
143288186|NCT00482612|516603716|FG000|Follow-up Period|Lost to Follow-up|0|||
143288187|NCT00482612|516603717|FG001|Follow-up Period|Lost to Follow-up|4|||
143288188|NCT00482612|516603718|FG002|Follow-up Period|Lost to Follow-up|2|||
143288189|NCT00482612|516603719|FG003|Follow-up Period|Lost to Follow-up|1|||
143288190|NCT00482612|516603716|FG000|Follow-up Period|Adverse Event|4|||
143288191|NCT00482612|516603717|FG001|Follow-up Period|Adverse Event|7|||
143288192|NCT00482612|516603718|FG002|Follow-up Period|Adverse Event|9|||
143288193|NCT00482612|516603719|FG003|Follow-up Period|Adverse Event|0|||
143288194|NCT00482612|516603716|FG000|Follow-up Period|Lack of Efficacy|2|||
143288195|NCT00482612|516603717|FG001|Follow-up Period|Lack of Efficacy|0|||
143288196|NCT00482612|516603718|FG002|Follow-up Period|Lack of Efficacy|1|||
143288197|NCT00482612|516603719|FG003|Follow-up Period|Lack of Efficacy|0|||
143288198|NCT00482612|516603716|FG000|Follow-up Period|Withdrawal by Subject|3|||
143288199|NCT00482612|516603717|FG001|Follow-up Period|Withdrawal by Subject|5|||
143288200|NCT00482612|516603718|FG002|Follow-up Period|Withdrawal by Subject|7|||
143288201|NCT00482612|516603719|FG003|Follow-up Period|Withdrawal by Subject|2|||
143288202|NCT00482612|516603716|FG000|Follow-up Period|Reasons not related to trial|1|||
143288203|NCT00482612|516603717|FG001|Follow-up Period|Reasons not related to trial|0|||
143288204|NCT00482612|516603718|FG002|Follow-up Period|Reasons not related to trial|1|||
143288205|NCT00482612|516603719|FG003|Follow-up Period|Reasons not related to trial|3|||
143288206|NCT00464087|516603723|FG000|Overall Study|No PCI per inclusion criteria|0|||
143288207|NCT00464087|516603724|FG001|Overall Study|No PCI per inclusion criteria|0|||
143288208|NCT00464087|516603725|FG002|Overall Study|No PCI per inclusion criteria|29|||
143288209|NCT00418314|516603727|FG000|Overall Study|Withdrawal by Subject|1|||
143288210|NCT00418314|516603728|FG001|Overall Study|Withdrawal by Subject|2|||
143288211|NCT01224431|516603729|FG000|Overall Study|not randomized|0|||
143288212|NCT01224431|516603730|FG001|Overall Study|not randomized|4|||
143288213|NCT01224431|516603729|FG000|Overall Study|no video record|0|||
143288214|NCT01224431|516603730|FG001|Overall Study|no video record|1|||
143288215|NCT02057406|516603731|FG000|Overall Study|Physician Decision|0|||
143288216|NCT02057406|516603732|FG001|Overall Study|Physician Decision|0|||
143288217|NCT02057406|516603733|FG002|Overall Study|Physician Decision|2|||
143288218|NCT02057406|516603731|FG000|Overall Study|Withdrawal by Subject|0|||
143288219|NCT02057406|516603732|FG001|Overall Study|Withdrawal by Subject|2|||
143288220|NCT02057406|516603733|FG002|Overall Study|Withdrawal by Subject|0|||
143288221|NCT02057406|516603731|FG000|Overall Study|Lost to Follow-up|0|||
143288222|NCT02057406|516603732|FG001|Overall Study|Lost to Follow-up|0|||
143288223|NCT02057406|516603733|FG002|Overall Study|Lost to Follow-up|1|||
143288224|NCT02057406|516603731|FG000|Overall Study|Death|1|||
143288225|NCT02057406|516603732|FG001|Overall Study|Death|0|||
143288226|NCT02057406|516603733|FG002|Overall Study|Death|0|||
143288227|NCT02057406|516603731|FG000|Overall Study|Protocol Violation|0|||
143288228|NCT02057406|516603732|FG001|Overall Study|Protocol Violation|1|||
143288229|NCT02057406|516603733|FG002|Overall Study|Protocol Violation|0|||
143288230|NCT02057406|516603731|FG000|Overall Study|Patient transportation issues|0|||
143288231|NCT02057406|516603732|FG001|Overall Study|Patient transportation issues|0|||
143288232|NCT02057406|516603733|FG002|Overall Study|Patient transportation issues|1|||
143288233|NCT03654651|516603735|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
143288234|NCT03654651|516603736|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
143288235|NCT01401283|516603737|FG000|Overall Study|surgery cancelled|5|||
143288236|NCT01401283|516603738|FG001|Overall Study|surgery cancelled|8|||
143288237|NCT01401283|516603737|FG000|Overall Study|preoperative arrhythmia|5|||
143288238|NCT01401283|516603738|FG001|Overall Study|preoperative arrhythmia|0|||
143288239|NCT01401283|516603737|FG000|Overall Study|no central venous access|0|||
143288240|NCT01401283|516603738|FG001|Overall Study|no central venous access|1|||
143288241|NCT01401283|516603737|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
143288242|NCT01401283|516603738|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
143288243|NCT02433483|516603739|FG000|Overall Study|Unacceptable toxicity|1|||
143288244|NCT02433483|516603739|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
143288245|NCT00372112|516603742|FG000|Overall Study|Adverse Event|0|||
143288246|NCT00372112|516603743|FG001|Overall Study|Adverse Event|1|||
143288247|NCT00372112|516603744|FG002|Overall Study|Adverse Event|1|||
143288248|NCT00372112|516603745|FG003|Overall Study|Adverse Event|1|||
143288249|NCT00372112|516603742|FG000|Overall Study|Withdrawal by Subject|0|||
143288250|NCT00372112|516603743|FG001|Overall Study|Withdrawal by Subject|0|||
143288251|NCT00372112|516603744|FG002|Overall Study|Withdrawal by Subject|2|||
143288252|NCT00372112|516603745|FG003|Overall Study|Withdrawal by Subject|1|||
143288253|NCT00372112|516603742|FG000|Overall Study|Exacerbation|0|||
143288254|NCT00372112|516603743|FG001|Overall Study|Exacerbation|0|||
143288255|NCT00372112|516603744|FG002|Overall Study|Exacerbation|0|||
143288256|NCT00372112|516603745|FG003|Overall Study|Exacerbation|1|||
143288257|NCT00372112|516603742|FG000|Overall Study|PR >240 at Visit 3|0|||
143288258|NCT00372112|516603743|FG001|Overall Study|PR >240 at Visit 3|0|||
143288259|NCT00372112|516603744|FG002|Overall Study|PR >240 at Visit 3|0|||
143288260|NCT00372112|516603745|FG003|Overall Study|PR >240 at Visit 3|1|||
143288261|NCT00372112|516603742|FG000|Overall Study|Hepatitis B|1|||
143288262|NCT00372112|516603743|FG001|Overall Study|Hepatitis B|0|||
143288263|NCT00372112|516603744|FG002|Overall Study|Hepatitis B|0|||
143288264|NCT00372112|516603745|FG003|Overall Study|Hepatitis B|0|||
143288265|NCT00372112|516603742|FG000|Overall Study|Other-protocol violation|0|||
143288266|NCT00372112|516603743|FG001|Overall Study|Other-protocol violation|0|||
143288267|NCT00372112|516603744|FG002|Overall Study|Other-protocol violation|1|||
143288268|NCT00372112|516603745|FG003|Overall Study|Other-protocol violation|0|||
143288269|NCT01678911|516603746|FG000|Second Intervention|Lost to Follow-up|2|||
143288270|NCT01678911|516603747|FG001|Second Intervention|Lost to Follow-up|0|||
143288271|NCT04649060|516603748|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
143288272|NCT04649060|516603749|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
143288273|NCT04649060|516603748|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
143288274|NCT04649060|516603749|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
143288275|NCT04649060|516603748|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
143288276|NCT04649060|516603749|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
143288277|NCT04649060|516603748|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
143288278|NCT04649060|516603749|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
143288279|NCT04649060|516603748|FG000|Arm A/Arm B Treatment|Patient Request|1|||
143288280|NCT04649060|516603749|FG001|Arm A/Arm B Treatment|Patient Request|0|||
143288281|NCT04649060|516603748|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
143288282|NCT04649060|516603749|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
143288283|NCT04649060|516603748|FG000|Arm A/Arm B Treatment|Other|1|||
143288284|NCT04649060|516603749|FG001|Arm A/Arm B Treatment|Other|0|||
143288285|NCT04649060|516603748|FG000|Crossover (Arm B)|Adverse Event|0|||
143288286|NCT04649060|516603749|FG001|Crossover (Arm B)|Adverse Event|1|||
143288287|NCT04649060|516603748|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
143288288|NCT04649060|516603749|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
143288289|NCT02706691|516603750|FG000|Overall Study|Adverse Event|1|||
143288290|NCT00356369|516603751|FG000|Active Phase|Withdrawal by Subject|2|||
143288291|NCT00356369|516603752|FG001|Active Phase|Withdrawal by Subject|1|||
143288292|NCT00137046|516603753|FG000|Overall Study|Death|2|||
143288293|NCT00137046|516603754|FG001|Overall Study|Death|1|||
143288294|NCT00137046|516603753|FG000|Overall Study|Adverse Event|16|||
143288295|NCT00137046|516603754|FG001|Overall Study|Adverse Event|5|||
143288296|NCT00137046|516603753|FG000|Overall Study|Laboratory Abnormality|2|||
143288297|NCT00137046|516603754|FG001|Overall Study|Laboratory Abnormality|0|||
143288298|NCT00137046|516603753|FG000|Overall Study|Lack of Efficacy|13|||
143288299|NCT00137046|516603754|FG001|Overall Study|Lack of Efficacy|1|||
143288300|NCT00137046|516603753|FG000|Overall Study|Lost to Follow-up|8|||
143288301|NCT00137046|516603754|FG001|Overall Study|Lost to Follow-up|24|||
143288302|NCT00137046|516603753|FG000|Overall Study|Other|23|||
143288303|NCT00137046|516603754|FG001|Overall Study|Other|19|||
143288304|NCT00137046|516603753|FG000|Overall Study|Withdrawal by Subject|33|||
143288305|NCT00137046|516603754|FG001|Overall Study|Withdrawal by Subject|42|||
143288306|NCT00137046|516603753|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
143288307|NCT00137046|516603754|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
143288308|NCT00137046|516603753|FG000|Overall Study|Withdrew prior to study treatment|1|||
143288309|NCT00137046|516603754|FG001|Overall Study|Withdrew prior to study treatment|1|||
143288310|NCT02532972|516603756|FG000|Overall Study|Withdrawal by Subject|1|||
143288311|NCT02859454|516603759|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
143288312|NCT04294472|516603760|FG000|Overall Study|Adverse Event|0|||
143288313|NCT04294472|516603761|FG001|Overall Study|Adverse Event|1|||
143288314|NCT04294472|516603762|FG002|Overall Study|Adverse Event|1|||
143288315|NCT04294472|516603760|FG000|Overall Study|Randomized but not treated|0|||
143288316|NCT04294472|516603761|FG001|Overall Study|Randomized but not treated|1|||
143288317|NCT04294472|516603762|FG002|Overall Study|Randomized but not treated|1|||
143288318|NCT03944954|516603763|FG000|Overall Study|Withdrawal by Subject|22|||
143288319|NCT03944954|516603764|FG001|Overall Study|Withdrawal by Subject|4|||
143288320|NCT03944954|516603763|FG000|Overall Study|Lost to Follow-up|18|||
143288321|NCT03944954|516603764|FG001|Overall Study|Lost to Follow-up|0|||
143288322|NCT03944954|516603763|FG000|Overall Study|Failed Medical Screening|7|||
143288323|NCT03944954|516603764|FG001|Overall Study|Failed Medical Screening|0|||
143288324|NCT05227027|516603767|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
143288325|NCT05227027|516603768|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
143288326|NCT02603419|516603769|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
143288327|NCT02603419|516603770|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
143288328|NCT02603419|516603771|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
143288329|NCT02603419|516603772|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
143288330|NCT02603419|516603773|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
143288331|NCT02603419|516603774|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
143288332|NCT02603419|516603769|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
143288333|NCT02603419|516603770|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
143288334|NCT02603419|516603771|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
143288335|NCT02603419|516603772|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
143288336|NCT02603419|516603773|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
143288337|NCT02603419|516603774|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
143288338|NCT02603419|516603769|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
143288339|NCT02603419|516603770|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
143288340|NCT02603419|516603771|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
143288341|NCT02603419|516603772|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
143288342|NCT02603419|516603773|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
143288343|NCT02603419|516603774|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
143288344|NCT02603419|516603769|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
143288345|NCT02603419|516603770|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
143288346|NCT02603419|516603771|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
143288347|NCT02603419|516603772|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
143288348|NCT02603419|516603773|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
143288349|NCT02603419|516603774|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
143288350|NCT02603419|516603769|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
143288351|NCT02603419|516603770|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
143288352|NCT02603419|516603771|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
143288353|NCT02603419|516603772|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
143288354|NCT02603419|516603773|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
143288355|NCT02603419|516603774|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
143288356|NCT02603419|516603769|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
143288357|NCT02603419|516603770|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
143288358|NCT02603419|516603771|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
143288359|NCT02603419|516603772|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
143288360|NCT02603419|516603773|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
143288361|NCT02603419|516603774|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
143288362|NCT02603419|516603769|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
143288363|NCT02603419|516603770|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
143288364|NCT02603419|516603771|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
143288365|NCT02603419|516603772|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
143288366|NCT02603419|516603773|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
143288367|NCT02603419|516603774|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
143288368|NCT02603419|516603769|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
143288369|NCT02603419|516603770|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
143288370|NCT02603419|516603771|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
143288371|NCT02603419|516603772|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
143288372|NCT02603419|516603773|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
143288373|NCT02603419|516603774|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
143288374|NCT02603419|516603769|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
143288375|NCT02603419|516603770|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
143288376|NCT02603419|516603771|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
143288377|NCT02603419|516603772|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
143288378|NCT02603419|516603773|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
143288379|NCT02603419|516603774|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
143288380|NCT02603419|516603769|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
143288381|NCT02603419|516603770|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
143288382|NCT02603419|516603771|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
143288383|NCT02603419|516603772|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
143288384|NCT02603419|516603773|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
143288385|NCT02603419|516603774|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
143288386|NCT02925494|516603775|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
143373719|NCT00708032|516913551|FG000|Overall Study|Visit out of range at month 12|4|||
143288387|NCT02925494|516603776|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
143288388|NCT02925494|516603777|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
143288389|NCT02925494|516603778|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
143288390|NCT02925494|516603775|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
143288391|NCT02925494|516603776|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
143288392|NCT02925494|516603777|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
143288393|NCT02925494|516603778|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
143288394|NCT02925494|516603775|FG000|Post-Treatment Follow-Up Period|Other|1|||
143288395|NCT02925494|516603776|FG001|Post-Treatment Follow-Up Period|Other|4|||
143288396|NCT02925494|516603777|FG002|Post-Treatment Follow-Up Period|Other|3|||
143288397|NCT02925494|516603778|FG003|Post-Treatment Follow-Up Period|Other|6|||
143288398|NCT02925494|516603775|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
143288399|NCT02925494|516603776|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
143288400|NCT02925494|516603777|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
143288401|NCT02925494|516603778|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
143288402|NCT02925494|516603775|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
143288403|NCT02925494|516603776|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
143288404|NCT02925494|516603777|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
143288405|NCT02925494|516603778|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
143288406|NCT02925494|516603775|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
143288407|NCT02925494|516603776|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
143288408|NCT02925494|516603777|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
143288409|NCT02925494|516603778|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
143288410|NCT02925494|516603775|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
143288411|NCT02925494|516603776|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
143288412|NCT02925494|516603777|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
143288413|NCT02925494|516603778|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
143288414|NCT03334448|516603782|FG000|Washout|Personal Reason|0|||
143288415|NCT03334448|516603783|FG001|Washout|Personal Reason|1|||
143288416|NCT03334448|516603784|FG002|Washout|Personal Reason|0|||
143288417|NCT03334448|516603785|FG003|Washout|Personal Reason|0|||
143288418|NCT03334448|516603782|FG000|Washout|Protocol Violation|0|||
143288419|NCT03334448|516603783|FG001|Washout|Protocol Violation|0|||
143288420|NCT03334448|516603784|FG002|Washout|Protocol Violation|0|||
143288421|NCT03334448|516603785|FG003|Washout|Protocol Violation|1|||
143288422|NCT02496611|516603790|FG000|Overall Study|Lost to Follow-up|2|||
143288423|NCT02496611|516603791|FG001|Overall Study|Lost to Follow-up|1|||
143288424|NCT02496611|516603790|FG000|Overall Study|Withdrawal by Subject|5|||
143288425|NCT02496611|516603791|FG001|Overall Study|Withdrawal by Subject|2|||
143288426|NCT02850965|516603792|FG000|Overall Study|Other than listed|3|||
143288427|NCT02850965|516603793|FG001|Overall Study|Other than listed|4|||
143288428|NCT02850965|516603792|FG000|Overall Study|Protocol Violation|0|||
143288429|NCT02850965|516603793|FG001|Overall Study|Protocol Violation|2|||
143288430|NCT02850965|516603792|FG000|Overall Study|Lost to Follow-up|5|||
143288431|NCT02850965|516603793|FG001|Overall Study|Lost to Follow-up|3|||
143288432|NCT02850965|516603792|FG000|Overall Study|Lack of Efficacy|4|||
143288433|NCT02850965|516603793|FG001|Overall Study|Lack of Efficacy|8|||
143288434|NCT02850965|516603792|FG000|Overall Study|Adverse Event|3|||
143288435|NCT02850965|516603793|FG001|Overall Study|Adverse Event|2|||
143288436|NCT02850965|516603792|FG000|Overall Study|Withdrawal by Subject|3|||
143288437|NCT02850965|516603793|FG001|Overall Study|Withdrawal by Subject|4|||
143288438|NCT02850965|516603792|FG000|Overall Study|Physician Decision|0|||
143288439|NCT02850965|516603793|FG001|Overall Study|Physician Decision|1|||
143288440|NCT02850965|516603792|FG000|Overall Study|Randomized but not treated|0|||
143288441|NCT02850965|516603793|FG001|Overall Study|Randomized but not treated|1|||
143288442|NCT02788357|516603797|FG000|Overall Study|Lost to Follow-up|3|||
143288443|NCT02788357|516603798|FG001|Overall Study|Lost to Follow-up|0|||
143288444|NCT01365910|516603799|FG000|Overall Study|Withdrawal by Subject|7|||
143288445|NCT01365910|516603799|FG000|Overall Study|disease progression|18|||
143288446|NCT01365910|516603799|FG000|Overall Study|Adverse Event|3|||
143288447|NCT01365910|516603799|FG000|Overall Study|other complicating disease|1|||
143288448|NCT01365910|516603799|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
143288449|NCT00371137|516603800|FG000|Overall Study|Adverse Event|20|||
143288450|NCT00371137|516603801|FG001|Overall Study|Adverse Event|35|||
143288451|NCT00371137|516603802|FG002|Overall Study|Adverse Event|42|||
143288452|NCT00371137|516603800|FG000|Overall Study|Withdrawal by Subject|11|||
143288453|NCT00371137|516603801|FG001|Overall Study|Withdrawal by Subject|10|||
143288454|NCT00371137|516603802|FG002|Overall Study|Withdrawal by Subject|15|||
143288455|NCT00371137|516603800|FG000|Overall Study|Lost to Follow-up|6|||
143288456|NCT00371137|516603801|FG001|Overall Study|Lost to Follow-up|3|||
143288457|NCT00371137|516603802|FG002|Overall Study|Lost to Follow-up|5|||
143288458|NCT00371137|516603800|FG000|Overall Study|Lack of Efficacy|30|||
143288459|NCT00371137|516603801|FG001|Overall Study|Lack of Efficacy|12|||
143288460|NCT00371137|516603802|FG002|Overall Study|Lack of Efficacy|13|||
143288461|NCT00371137|516603800|FG000|Overall Study|Sponsor Decision|2|||
143288462|NCT00371137|516603801|FG001|Overall Study|Sponsor Decision|1|||
143288463|NCT00371137|516603802|FG002|Overall Study|Sponsor Decision|2|||
143288464|NCT00371137|516603800|FG000|Overall Study|Physician Decision|1|||
143288465|NCT00371137|516603801|FG001|Overall Study|Physician Decision|1|||
143288466|NCT00371137|516603802|FG002|Overall Study|Physician Decision|1|||
143288467|NCT00371137|516603800|FG000|Overall Study|Protocol Violation|2|||
143288468|NCT00371137|516603801|FG001|Overall Study|Protocol Violation|1|||
143288469|NCT00371137|516603802|FG002|Overall Study|Protocol Violation|1|||
143288470|NCT02013791|516603803|FG000|Period 1|Lost to Follow-up|0|||
143288471|NCT02013791|516603804|FG001|Period 1|Lost to Follow-up|0|||
143288472|NCT02013791|516603805|FG002|Period 1|Lost to Follow-up|0|||
143288473|NCT02013791|516603806|FG003|Period 1|Lost to Follow-up|1|||
143288474|NCT02013791|516603807|FG004|Period 1|Lost to Follow-up|0|||
143288475|NCT02013791|516603808|FG005|Period 1|Lost to Follow-up|0|||
143288476|NCT02013791|516603809|FG006|Period 1|Lost to Follow-up|1|||
143288477|NCT02013791|516603810|FG007|Period 1|Lost to Follow-up|1|||
143288478|NCT02013791|516603811|FG008|Period 1|Lost to Follow-up|0|||
143288479|NCT02013791|516603803|FG000|Period 1|Other Miscellaneous Reasons|0|||
143288480|NCT02013791|516603804|FG001|Period 1|Other Miscellaneous Reasons|2|||
143288481|NCT02013791|516603805|FG002|Period 1|Other Miscellaneous Reasons|0|||
143288482|NCT02013791|516603806|FG003|Period 1|Other Miscellaneous Reasons|0|||
143288483|NCT02013791|516603807|FG004|Period 1|Other Miscellaneous Reasons|0|||
143288484|NCT02013791|516603808|FG005|Period 1|Other Miscellaneous Reasons|0|||
143288485|NCT02013791|516603809|FG006|Period 1|Other Miscellaneous Reasons|0|||
143288486|NCT02013791|516603810|FG007|Period 1|Other Miscellaneous Reasons|0|||
143288487|NCT02013791|516603811|FG008|Period 1|Other Miscellaneous Reasons|0|||
143288488|NCT02289417|516603812|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
143288489|NCT02289417|516603813|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
143288490|NCT02289417|516603814|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
143288491|NCT02289417|516603815|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
143288492|NCT02289417|516603816|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
143288493|NCT02289417|516603817|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
143288494|NCT02289417|516603818|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
143288495|NCT02289417|516603819|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
143288496|NCT02289417|516603820|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
143288497|NCT02289417|516603812|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
143288498|NCT02289417|516603813|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
143288499|NCT02289417|516603814|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
143288500|NCT02289417|516603815|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
143288501|NCT02289417|516603816|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
143288502|NCT02289417|516603817|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
143288503|NCT02289417|516603818|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
143288504|NCT02289417|516603819|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
143288505|NCT02289417|516603820|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
143288506|NCT02289417|516603812|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
143288507|NCT02289417|516603813|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
143288508|NCT02289417|516603814|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
143288509|NCT02289417|516603815|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
143288510|NCT02289417|516603816|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
143288511|NCT02289417|516603817|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
143288512|NCT02289417|516603818|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
143288513|NCT02289417|516603819|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
143288514|NCT02289417|516603820|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
143288515|NCT02289417|516603812|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
143288516|NCT02289417|516603813|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
143288517|NCT02289417|516603814|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
143288518|NCT02289417|516603815|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
143288519|NCT02289417|516603816|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
143288520|NCT02289417|516603817|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
143288521|NCT02289417|516603818|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
143288522|NCT02289417|516603819|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
143288523|NCT02289417|516603820|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
143288524|NCT02289417|516603812|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
143288525|NCT02289417|516603813|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
143288526|NCT02289417|516603814|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
143288527|NCT02289417|516603815|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
143288528|NCT02289417|516603816|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
143288529|NCT02289417|516603817|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
143288530|NCT02289417|516603818|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
143288531|NCT02289417|516603819|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
143288532|NCT02289417|516603820|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
143288533|NCT02289417|516603812|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
143288534|NCT02289417|516603813|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
143288535|NCT02289417|516603814|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
143288536|NCT02289417|516603815|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
143288537|NCT02289417|516603816|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
143288538|NCT02289417|516603817|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
143288539|NCT02289417|516603818|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
143288540|NCT02289417|516603819|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
143288541|NCT02289417|516603820|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
143288542|NCT02289417|516603812|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
143288543|NCT02289417|516603813|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
143288544|NCT02289417|516603814|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
143288545|NCT02289417|516603815|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
143288546|NCT02289417|516603816|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
143288547|NCT02289417|516603817|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
143288548|NCT02289417|516603818|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
143288549|NCT02289417|516603819|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
143288550|NCT02289417|516603820|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
143288551|NCT02289417|516603812|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
143288552|NCT02289417|516603813|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
143288553|NCT02289417|516603814|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
143288554|NCT02289417|516603815|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
143288555|NCT02289417|516603816|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
143288556|NCT02289417|516603817|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
143288557|NCT02289417|516603818|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
143288558|NCT02289417|516603819|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
143288559|NCT02289417|516603820|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
143288560|NCT02289417|516603812|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
143288561|NCT02289417|516603813|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
143288562|NCT02289417|516603814|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
143288563|NCT02289417|516603815|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
143288564|NCT02289417|516603816|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
143288565|NCT02289417|516603817|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
143288566|NCT02289417|516603818|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
143288567|NCT02289417|516603819|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
143288568|NCT02289417|516603820|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
143288569|NCT02289417|516603812|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
143288570|NCT02289417|516603813|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
143288571|NCT02289417|516603814|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
143288572|NCT02289417|516603815|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
143288573|NCT02289417|516603816|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
143288574|NCT02289417|516603817|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
143288575|NCT02289417|516603818|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
143288576|NCT02289417|516603819|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
143288577|NCT02289417|516603820|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
143288578|NCT02289417|516603812|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
143288579|NCT02289417|516603813|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
143288580|NCT02289417|516603814|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
143288581|NCT02289417|516603815|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
143288582|NCT02289417|516603816|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
143288583|NCT02289417|516603817|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
143288584|NCT02289417|516603818|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
143288585|NCT02289417|516603819|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
143288586|NCT02289417|516603820|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
143288587|NCT02289417|516603812|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
143288588|NCT02289417|516603813|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
143288589|NCT02289417|516603814|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
143288590|NCT02289417|516603815|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
143288591|NCT02289417|516603816|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
143288592|NCT02289417|516603817|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
143288593|NCT02289417|516603818|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
143288594|NCT02289417|516603819|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
143288595|NCT02289417|516603820|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
143288596|NCT02289417|516603812|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
143288597|NCT02289417|516603813|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
143288598|NCT02289417|516603814|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
143288599|NCT02289417|516603815|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
143288600|NCT02289417|516603816|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
143288601|NCT02289417|516603817|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
143288602|NCT02289417|516603818|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
143288603|NCT02289417|516603819|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
143288604|NCT02289417|516603820|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
143288605|NCT02289417|516603812|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
143288606|NCT02289417|516603813|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
143288607|NCT02289417|516603814|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
143288608|NCT02289417|516603815|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
143288609|NCT02289417|516603816|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
143288610|NCT02289417|516603817|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
143288611|NCT02289417|516603818|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
143288612|NCT02289417|516603819|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
143288613|NCT02289417|516603820|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
143288614|NCT02725710|516603821|FG000|Overall Study|Lost to Follow-up|1|||
143288615|NCT02725710|516603822|FG001|Overall Study|Lost to Follow-up|0|||
143288616|NCT04786990|516603827|FG000|Overall Study|Withdrawal by Subject|1|||
143288617|NCT04786990|516603827|FG000|Overall Study|Adverse Event|1|||
143288618|NCT04786990|516603827|FG000|Overall Study|Lost to Follow-up|1|||
143288619|NCT04786990|516603827|FG000|Overall Study|Noncompliance|1|||
143288620|NCT04786990|516603827|FG000|Overall Study|Unable to complete site visits|1|||
143288621|NCT04786990|516603827|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
143288622|NCT01782222|516603828|FG000|Overall Study|Adverse Event|4|||
143288623|NCT01782222|516603829|FG001|Overall Study|Adverse Event|5|||
143288624|NCT01782222|516603830|FG002|Overall Study|Adverse Event|3|||
143288625|NCT01782222|516603828|FG000|Overall Study|Lack of Efficacy|2|||
143288626|NCT01782222|516603829|FG001|Overall Study|Lack of Efficacy|1|||
143288627|NCT01782222|516603830|FG002|Overall Study|Lack of Efficacy|0|||
143288628|NCT01782222|516603828|FG000|Overall Study|Protocol Violation|1|||
143288629|NCT01782222|516603829|FG001|Overall Study|Protocol Violation|0|||
143288630|NCT01782222|516603830|FG002|Overall Study|Protocol Violation|0|||
143288631|NCT01782222|516603828|FG000|Overall Study|Withdrawal by Subject|1|||
143288632|NCT01782222|516603829|FG001|Overall Study|Withdrawal by Subject|4|||
143288633|NCT01782222|516603830|FG002|Overall Study|Withdrawal by Subject|1|||
143288634|NCT01782222|516603828|FG000|Overall Study|Moved to other state|0|||
143288635|NCT01782222|516603829|FG001|Overall Study|Moved to other state|1|||
143288636|NCT01782222|516603830|FG002|Overall Study|Moved to other state|0|||
143288637|NCT01858389|516603835|FG000|Overall Study|Death|1|||
143288638|NCT01858389|516603836|FG001|Overall Study|Death|3|||
143288639|NCT01858389|516603835|FG000|Overall Study|Study terminated by sponsor|0|||
143288640|NCT01858389|516603836|FG001|Overall Study|Study terminated by sponsor|2|||
143288641|NCT01858389|516603835|FG000|Overall Study|Withdrawal by Subject|0|||
143288642|NCT01858389|516603836|FG001|Overall Study|Withdrawal by Subject|1|||
143288643|NCT01858389|516603835|FG000|Overall Study|Progressive disease|10|||
143288644|NCT01858389|516603836|FG001|Overall Study|Progressive disease|11|||
143288645|NCT01858389|516603835|FG000|Overall Study|Other|2|||
143288646|NCT01858389|516603836|FG001|Overall Study|Other|4|||
143288647|NCT01858389|516603835|FG000|Overall Study|Adverse Event|3|||
143288648|NCT01858389|516603836|FG001|Overall Study|Adverse Event|1|||
143288649|NCT01858389|516603835|FG000|Overall Study|Did not receive treatment|0|||
143288650|NCT01858389|516603836|FG001|Overall Study|Did not receive treatment|3|||
143288651|NCT03310775|516603840|FG000|Overall Study|Lost to Follow-up|2|||
143288652|NCT03310775|516603841|FG001|Overall Study|Lost to Follow-up|3|||
143288653|NCT03310775|516603840|FG000|Overall Study|aggravation of depression|0|||
143288654|NCT03310775|516603841|FG001|Overall Study|aggravation of depression|1|||
143288655|NCT02547454|516603842|FG000|Overall Study|Due to hemodialysis|53|||
143288656|NCT02547454|516603842|FG000|Overall Study|Due to transplantation|1|||
143288657|NCT02547454|516603842|FG000|Overall Study|Due to no further need to treat|4|||
143288658|NCT02547454|516603842|FG000|Overall Study|Death|38|||
143288659|NCT02547454|516603842|FG000|Overall Study|Lost to Follow-up|26|||
143288660|NCT02547454|516603842|FG000|Overall Study|Other|39|||
143288661|NCT02547454|516603842|FG000|Overall Study|No data|11|||
143288662|NCT00580606|516603843|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
143288663|NCT00580606|516603844|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
143288664|NCT00580606|516603843|FG000|Open Label (OL)|Withdrawal by Subject|4|||
143288665|NCT00580606|516603844|FG001|Open Label (OL)|Withdrawal by Subject|6|||
143288666|NCT00580606|516603843|FG000|Open Label (OL)|Dosing Symptoms|0|||
143288667|NCT00580606|516603844|FG001|Open Label (OL)|Dosing Symptoms|1|||
143288668|NCT00580606|516603843|FG000|Open Label (OL)|Lost to Follow-up|0|||
143288669|NCT00580606|516603844|FG001|Open Label (OL)|Lost to Follow-up|1|||
143288670|NCT00580606|516603843|FG000|Open Label (OL)|Pregnancy|0|||
143288671|NCT00580606|516603844|FG001|Open Label (OL)|Pregnancy|1|||
143288672|NCT00580606|516603843|FG000|Open Label (OL)|Non-compliance|2|||
143288673|NCT00580606|516603844|FG001|Open Label (OL)|Non-compliance|0|||
143288674|NCT00580606|516603843|FG000|Open Label (OL)|Physician Decision|1|||
143288675|NCT00580606|516603844|FG001|Open Label (OL)|Physician Decision|1|||
143288676|NCT00580606|516603843|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
143288677|NCT00580606|516603844|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
143288678|NCT03278613|516603848|FG000|Overall Study|Lost to Follow-up|3|||
143288679|NCT03278613|516603849|FG001|Overall Study|Lost to Follow-up|1|||
143288680|NCT04221009|516605693|FG000|Overall Study|Withdrawal by Subject|4|||
143288681|NCT02154490|516605694|FG000|Overall Study|No tissue submitted|23|||
143288682|NCT02154490|516605694|FG000|Overall Study|No biomarker results|167|||
143288683|NCT02154490|516605694|FG000|Overall Study|Not assigned to a sub-study|270|||
143288684|NCT02154490|516605694|FG000|Overall Study|Did not register to a sub-study|749|||
143288685|NCT02373202|516605695|FG000|Overall Study|Adverse Event|2|||
143288686|NCT02373202|516605696|FG001|Overall Study|Adverse Event|5|||
143288687|NCT02373202|516605697|FG002|Overall Study|Adverse Event|2|||
143288688|NCT02373202|516605698|FG003|Overall Study|Adverse Event|1|||
143288689|NCT02373202|516605695|FG000|Overall Study|Lack of Efficacy|0|||
143288690|NCT02373202|516605696|FG001|Overall Study|Lack of Efficacy|0|||
143288691|NCT02373202|516605697|FG002|Overall Study|Lack of Efficacy|1|||
143288692|NCT02373202|516605698|FG003|Overall Study|Lack of Efficacy|0|||
143288693|NCT02373202|516605695|FG000|Overall Study|Other|0|||
143288694|NCT02373202|516605696|FG001|Overall Study|Other|1|||
143288695|NCT02373202|516605697|FG002|Overall Study|Other|0|||
143288696|NCT02373202|516605698|FG003|Overall Study|Other|0|||
143288697|NCT03010254|516605699|FG000|Overall Study|Adverse Event|0|||
143288698|NCT03010254|516605700|FG001|Overall Study|Adverse Event|1|||
143288699|NCT03010254|516605699|FG000|Overall Study|Lost to Follow-up|4|||
143288700|NCT03010254|516605700|FG001|Overall Study|Lost to Follow-up|0|||
143288701|NCT03010254|516605699|FG000|Overall Study|Withdrawal by Subject|1|||
143288702|NCT03010254|516605700|FG001|Overall Study|Withdrawal by Subject|1|||
143288703|NCT03010254|516605699|FG000|Overall Study|Other|2|||
143288704|NCT03010254|516605700|FG001|Overall Study|Other|3|||
143288705|NCT01404325|516605707|FG000|Overall Study|Lost to Follow-up|1|||
143288706|NCT01404325|516605708|FG001|Overall Study|Lost to Follow-up|0|||
143288707|NCT01404325|516605707|FG000|Overall Study|Death|2|||
143288708|NCT01404325|516605708|FG001|Overall Study|Death|0|||
143288709|NCT01404325|516605707|FG000|Overall Study|Graft loss/Retransplantation|1|||
143288710|NCT01404325|516605708|FG001|Overall Study|Graft loss/Retransplantation|0|||
143288711|NCT01404325|516605707|FG000|Overall Study|non-specified reason|0|||
143288712|NCT01404325|516605708|FG001|Overall Study|non-specified reason|2|||
143288713|NCT01986855|516605709|FG000|Overall Study|Adverse Event|1|||
143288714|NCT01986855|516605710|FG001|Overall Study|Adverse Event|0|||
143288715|NCT01986855|516605711|FG002|Overall Study|Adverse Event|0|||
143288716|NCT01986855|516605709|FG000|Overall Study|Death|3|||
143288717|NCT01986855|516605710|FG001|Overall Study|Death|4|||
143288718|NCT01986855|516605711|FG002|Overall Study|Death|4|||
143288719|NCT01986855|516605709|FG000|Overall Study|Lost to Follow-up|2|||
143288720|NCT01986855|516605710|FG001|Overall Study|Lost to Follow-up|1|||
143288721|NCT01986855|516605711|FG002|Overall Study|Lost to Follow-up|0|||
143288722|NCT01986855|516605709|FG000|Overall Study|Screen Failure|0|||
143288723|NCT01986855|516605710|FG001|Overall Study|Screen Failure|1|||
143288724|NCT01986855|516605711|FG002|Overall Study|Screen Failure|0|||
143288725|NCT01986855|516605709|FG000|Overall Study|Participant Moved|0|||
143288726|NCT01986855|516605710|FG001|Overall Study|Participant Moved|0|||
143288727|NCT01986855|516605711|FG002|Overall Study|Participant Moved|2|||
143288728|NCT01986855|516605709|FG000|Overall Study|Withdrawal by Subject|7|||
143288729|NCT01986855|516605710|FG001|Overall Study|Withdrawal by Subject|8|||
143288730|NCT01986855|516605711|FG002|Overall Study|Withdrawal by Subject|5|||
143288731|NCT02064868|516605715|FG000|Overall Study|Lost to Follow-up|14|||
143288732|NCT02064868|516605716|FG001|Overall Study|Lost to Follow-up|8|||
143288733|NCT02064868|516605715|FG000|Overall Study|Physician Decision|1|||
143288734|NCT02064868|516605716|FG001|Overall Study|Physician Decision|0|||
143288735|NCT02064868|516605715|FG000|Overall Study|Withdrawal by Subject|14|||
143288736|NCT02064868|516605716|FG001|Overall Study|Withdrawal by Subject|3|||
143288737|NCT02064868|516605715|FG000|Overall Study|Technical Problems or Missing|5|||
143288738|NCT02064868|516605716|FG001|Overall Study|Technical Problems or Missing|2|||
143288739|NCT02670083|516605717|FG000|Overall Study|Adverse Event|16|||
143288740|NCT02670083|516605718|FG001|Overall Study|Adverse Event|13|||
143288741|NCT02670083|516605717|FG000|Overall Study|Death|4|||
143288742|NCT02670083|516605718|FG001|Overall Study|Death|6|||
143288743|NCT02670083|516605717|FG000|Overall Study|Lost to Follow-up|2|||
143288744|NCT02670083|516605718|FG001|Overall Study|Lost to Follow-up|2|||
143288745|NCT02670083|516605717|FG000|Overall Study|Multiple Reasons|9|||
143288746|NCT02670083|516605718|FG001|Overall Study|Multiple Reasons|9|||
143288747|NCT02670083|516605717|FG000|Overall Study|Physician Decision|0|||
143288748|NCT02670083|516605718|FG001|Overall Study|Physician Decision|2|||
143288749|NCT02670083|516605717|FG000|Overall Study|Study Terminated By Sponsor|257|||
143288750|NCT02670083|516605718|FG001|Overall Study|Study Terminated By Sponsor|254|||
143288751|NCT02670083|516605717|FG000|Overall Study|Symptomatic Deterioration|0|||
143288752|NCT02670083|516605718|FG001|Overall Study|Symptomatic Deterioration|2|||
143288753|NCT02670083|516605717|FG000|Overall Study|Withdrawal by Subject|32|||
143288754|NCT02670083|516605718|FG001|Overall Study|Withdrawal by Subject|31|||
143288755|NCT02670083|516605717|FG000|Overall Study|Non-Compliance With Study Drug|1|||
143288756|NCT02670083|516605718|FG001|Overall Study|Non-Compliance With Study Drug|0|||
143288757|NCT02425046|516605723|FG000|Overall Study|Lost to Follow-up|52|||
143288758|NCT02425046|516605724|FG001|Overall Study|Lost to Follow-up|50|||
143288759|NCT02425046|516605725|FG002|Overall Study|Lost to Follow-up|56|||
143288760|NCT02425046|516605723|FG000|Overall Study|Withdrawal by Subject|16|||
143288761|NCT02425046|516605724|FG001|Overall Study|Withdrawal by Subject|12|||
143288762|NCT02425046|516605725|FG002|Overall Study|Withdrawal by Subject|0|||
143288763|NCT03562481|516605726|FG000|First Intervention|Lost to Follow-up|1|||
143288764|NCT03562481|516605727|FG001|First Intervention|Lost to Follow-up|0|||
143288765|NCT02904512|516605731|FG000|Overall Study|Withdrawal by Subject|1|||
143288766|NCT02904512|516605732|FG001|Overall Study|Withdrawal by Subject|0|||
143288767|NCT02904512|516605731|FG000|Overall Study|Transferred to ICU|1|||
143288768|NCT02904512|516605732|FG001|Overall Study|Transferred to ICU|0|||
143288769|NCT02904512|516605731|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
143288770|NCT02904512|516605732|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
143288771|NCT01963403|516605745|FG000|Overall Study|Lost to Follow-up|2|||
143288772|NCT01963403|516605746|FG001|Overall Study|Lost to Follow-up|3|||
143288773|NCT01963403|516605745|FG000|Overall Study|Implant removal|0|||
143288774|NCT01963403|516605746|FG001|Overall Study|Implant removal|1|||
143288775|NCT00549302|516605751|FG000|Double-Blind|Death|2|||
143288776|NCT00549302|516605752|FG001|Double-Blind|Death|9|||
143288777|NCT00549302|516605753|FG002|Double-Blind|Death|0|||
143288778|NCT00549302|516605751|FG000|Double-Blind|Adverse Event|3|||
143288779|NCT00549302|516605752|FG001|Double-Blind|Adverse Event|16|||
143288780|NCT00549302|516605753|FG002|Double-Blind|Adverse Event|0|||
143288781|NCT00549302|516605751|FG000|Double-Blind|Withdrawal by Subject|3|||
143288782|NCT00549302|516605752|FG001|Double-Blind|Withdrawal by Subject|8|||
143288783|NCT00549302|516605753|FG002|Double-Blind|Withdrawal by Subject|0|||
143288784|NCT00549302|516605751|FG000|Double-Blind|Investigator Decision|1|||
143288785|NCT00549302|516605752|FG001|Double-Blind|Investigator Decision|5|||
143288786|NCT00549302|516605753|FG002|Double-Blind|Investigator Decision|0|||
143288787|NCT00549302|516605751|FG000|Double-Blind|Sponsor Decision|0|||
143288788|NCT00549302|516605752|FG001|Double-Blind|Sponsor Decision|1|||
143288789|NCT00549302|516605753|FG002|Double-Blind|Sponsor Decision|0|||
143288790|NCT00549302|516605751|FG000|Double-Blind|Lost to Follow-up|1|||
143288791|NCT00549302|516605752|FG001|Double-Blind|Lost to Follow-up|2|||
143288792|NCT00549302|516605753|FG002|Double-Blind|Lost to Follow-up|0|||
143288793|NCT00549302|516605751|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
143288794|NCT00549302|516605752|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
143288795|NCT00549302|516605753|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
143288796|NCT00549302|516605751|FG000|Double-Blind|New condition or starts new therapy|0|||
143288797|NCT00549302|516605752|FG001|Double-Blind|New condition or starts new therapy|2|||
143288798|NCT00549302|516605753|FG002|Double-Blind|New condition or starts new therapy|0|||
143288799|NCT00549302|516605751|FG000|Open-Label|Adverse Event|0|||
143288800|NCT00549302|516605752|FG001|Open-Label|Adverse Event|0|||
143288801|NCT00549302|516605753|FG002|Open-Label|Adverse Event|11|||
143288802|NCT00549302|516605751|FG000|Open-Label|Death|0|||
143288803|NCT00549302|516605752|FG001|Open-Label|Death|0|||
143288804|NCT00549302|516605753|FG002|Open-Label|Death|40|||
143288805|NCT00549302|516605751|FG000|Open-Label|Investigator Decision|0|||
143288806|NCT00549302|516605752|FG001|Open-Label|Investigator Decision|0|||
143288807|NCT00549302|516605753|FG002|Open-Label|Investigator Decision|5|||
143288808|NCT00549302|516605751|FG000|Open-Label|Lost to Follow-up|0|||
143288809|NCT00549302|516605752|FG001|Open-Label|Lost to Follow-up|0|||
143288810|NCT00549302|516605753|FG002|Open-Label|Lost to Follow-up|2|||
143288811|NCT00549302|516605751|FG000|Open-Label|Other|0|||
143288812|NCT00549302|516605752|FG001|Open-Label|Other|0|||
143288813|NCT00549302|516605753|FG002|Open-Label|Other|3|||
143288814|NCT00549302|516605751|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
143288815|NCT00549302|516605752|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
143288816|NCT00549302|516605753|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
143288817|NCT00549302|516605751|FG000|Open-Label|Withdrawal by Subject|0|||
143288818|NCT00549302|516605752|FG001|Open-Label|Withdrawal by Subject|0|||
143288819|NCT00549302|516605753|FG002|Open-Label|Withdrawal by Subject|6|||
143288820|NCT03585504|516605754|FG000|Overall Study|Lost to Follow-up|26|||
143288821|NCT03585504|516605755|FG001|Overall Study|Lost to Follow-up|29|||
143288822|NCT01414114|516605756|FG000|Overall Study|Adverse Event|2|||
143288823|NCT01414114|516605756|FG000|Overall Study|Withdrawal by Subject|1|||
143288824|NCT01414114|516605756|FG000|Overall Study|Other|2|||
143288825|NCT05620563|516605757|FG000|Overall Study|Adverse Event|3|||
143288826|NCT05620563|516605758|FG001|Overall Study|Adverse Event|1|||
143288827|NCT05620563|516605757|FG000|Overall Study|Lost to Follow-up|0|||
143288828|NCT05620563|516605758|FG001|Overall Study|Lost to Follow-up|2|||
143288829|NCT05620563|516605757|FG000|Overall Study|Protocol Deviation|1|||
143288830|NCT05620563|516605758|FG001|Overall Study|Protocol Deviation|2|||
143288831|NCT05620563|516605757|FG000|Overall Study|Withdrawal by Subject|3|||
143288832|NCT05620563|516605758|FG001|Overall Study|Withdrawal by Subject|3|||
143288833|NCT05620563|516605757|FG000|Overall Study|Physician Decision|0|||
143288834|NCT05620563|516605758|FG001|Overall Study|Physician Decision|1|||
143288835|NCT03590041|516605762|FG000|Overall Study|Protocol Violation|4|||
143288836|NCT03590041|516605763|FG001|Overall Study|Protocol Violation|3|||
143288837|NCT03590041|516605762|FG000|Overall Study|No session data recorded|14|||
143288838|NCT03590041|516605763|FG001|Overall Study|No session data recorded|2|||
143288839|NCT02692703|516605764|FG000|Overall Study|Lost to Follow-up|1|||
143288840|NCT02692703|516605764|FG000|Overall Study|Other|1|||
143288841|NCT00865124|516605765|FG000|Overall Study|Physician Decision|2|||
143288842|NCT00865124|516605766|FG001|Overall Study|Physician Decision|1|||
143288843|NCT00865124|516605767|FG002|Overall Study|Physician Decision|0|||
143288844|NCT00865124|516605765|FG000|Overall Study|Withdrawn consent|2|||
143288845|NCT00865124|516605766|FG001|Overall Study|Withdrawn consent|0|||
143288846|NCT00865124|516605767|FG002|Overall Study|Withdrawn consent|0|||
143288847|NCT03247530|516605770|FG000|Overall Study|Withdrawal by caregiver|19|||
143288848|NCT03247530|516605771|FG001|Overall Study|Withdrawal by caregiver|8|||
143288849|NCT03247530|516605772|FG002|Overall Study|Withdrawal by caregiver|10|||
143288850|NCT03247530|516605770|FG000|Overall Study|Lost to Follow-up|3|||
143288851|NCT03247530|516605771|FG001|Overall Study|Lost to Follow-up|9|||
143288852|NCT03247530|516605772|FG002|Overall Study|Lost to Follow-up|6|||
143288853|NCT03247530|516605770|FG000|Overall Study|Adverse Event|2|||
143288854|NCT03247530|516605771|FG001|Overall Study|Adverse Event|5|||
143288855|NCT03247530|516605772|FG002|Overall Study|Adverse Event|2|||
143288856|NCT03247530|516605770|FG000|Overall Study|Failure to follow procedure|1|||
143288857|NCT03247530|516605771|FG001|Overall Study|Failure to follow procedure|1|||
143288858|NCT03247530|516605772|FG002|Overall Study|Failure to follow procedure|1|||
143288859|NCT03247530|516605770|FG000|Overall Study|Withdrawal by Subject|1|||
143288860|NCT03247530|516605771|FG001|Overall Study|Withdrawal by Subject|1|||
143288861|NCT03247530|516605772|FG002|Overall Study|Withdrawal by Subject|0|||
143288862|NCT03247530|516605770|FG000|Overall Study|Study medication misuse|0|||
143288863|NCT03247530|516605771|FG001|Overall Study|Study medication misuse|1|||
143288864|NCT03247530|516605772|FG002|Overall Study|Study medication misuse|0|||
143288865|NCT03247530|516605770|FG000|Overall Study|Other, multiple categories|1|||
143288866|NCT03247530|516605771|FG001|Overall Study|Other, multiple categories|3|||
143288867|NCT03247530|516605772|FG002|Overall Study|Other, multiple categories|1|||
143288868|NCT01979016|516605774|FG000|Overall Study|Withdrawal by Subject|2|||
143288869|NCT01979016|516605775|FG001|Overall Study|Withdrawal by Subject|0|||
143288870|NCT01979016|516605774|FG000|Overall Study|Adverse Event|0|||
143288871|NCT01979016|516605775|FG001|Overall Study|Adverse Event|1|||
143288872|NCT04983264|516605777|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
143288873|NCT04983264|516605778|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
143288874|NCT04983264|516605779|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
143288875|NCT04983264|516605777|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
143288876|NCT04983264|516605778|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
143288877|NCT04983264|516605779|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
143288878|NCT01124422|516605781|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
143288879|NCT01124422|516605782|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
143288880|NCT01124422|516605783|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
143288881|NCT01124422|516605781|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
143288882|NCT01124422|516605782|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
143288883|NCT01124422|516605783|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
143288884|NCT01124422|516605781|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
143288885|NCT01124422|516605782|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
143288886|NCT01124422|516605783|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
143288887|NCT01124422|516605781|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
143288888|NCT01124422|516605782|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
143288889|NCT01124422|516605783|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
143288890|NCT01124422|516605781|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
143288891|NCT01124422|516605782|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
143288892|NCT01124422|516605783|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
143288893|NCT01124422|516605781|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
143288894|NCT01124422|516605782|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
143288895|NCT01124422|516605783|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
143288896|NCT01124422|516605781|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
143288897|NCT01124422|516605782|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
143288898|NCT01124422|516605783|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
143288899|NCT01124422|516605781|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
143288900|NCT01124422|516605782|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
143288901|NCT01124422|516605783|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
143288902|NCT01124422|516605781|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
143373720|NCT00708032|516913552|FG001|Overall Study|Visit out of range at month 12|1|||
143288903|NCT01124422|516605782|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
143288904|NCT01124422|516605783|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
143288905|NCT01124422|516605781|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
143288906|NCT01124422|516605782|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
143288907|NCT01124422|516605783|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
143288908|NCT00938639|516605784|FG000|Overall Study|Moved away from study area|0|||
143288909|NCT00938639|516605785|FG001|Overall Study|Moved away from study area|1|||
143288910|NCT00938639|516605784|FG000|Overall Study|Lost to Follow-up|1|||
143288911|NCT00938639|516605785|FG001|Overall Study|Lost to Follow-up|2|||
143288912|NCT00938639|516605784|FG000|Overall Study|Family issues|1|||
143288913|NCT00938639|516605785|FG001|Overall Study|Family issues|1|||
143288914|NCT00938639|516605784|FG000|Overall Study|Participant noncompliance|1|||
143288915|NCT00938639|516605785|FG001|Overall Study|Participant noncompliance|0|||
143288916|NCT04326231|516605791|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
143288917|NCT03303079|516605792|FG000|Overall Study|Adverse Event|0|||
143288918|NCT03303079|516605793|FG001|Overall Study|Adverse Event|1|||
143288919|NCT03303079|516605794|FG002|Overall Study|Adverse Event|3|||
143288920|NCT03303079|516605792|FG000|Overall Study|Protocol Violation|5|||
143288921|NCT03303079|516605793|FG001|Overall Study|Protocol Violation|4|||
143288922|NCT03303079|516605794|FG002|Overall Study|Protocol Violation|7|||
143288923|NCT03303079|516605792|FG000|Overall Study|Withdrawal by Subject|2|||
143288924|NCT03303079|516605793|FG001|Overall Study|Withdrawal by Subject|4|||
143288925|NCT03303079|516605794|FG002|Overall Study|Withdrawal by Subject|2|||
143288926|NCT03303079|516605792|FG000|Overall Study|Other than specified|0|||
143288927|NCT03303079|516605793|FG001|Overall Study|Other than specified|2|||
143288928|NCT03303079|516605794|FG002|Overall Study|Other than specified|0|||
143288929|NCT01919723|516605795|FG000|Overall Study|Blood Samples Hemolyzed|2|||
143288930|NCT01919723|516605796|FG001|Overall Study|Blood Samples Hemolyzed|2|||
143288931|NCT04502589|516605797|FG000|Overall Study|Physician Decision|1|||
143288932|NCT04502589|516605798|FG001|Overall Study|Physician Decision|0|||
143288933|NCT00110149|516605804|FG000|Overall Study|Physician Decision|3|||
143288934|NCT00996307|516605808|FG000|Overall Study|Adverse Event|0|||
143288935|NCT00996307|516605809|FG001|Overall Study|Adverse Event|1|||
143288936|NCT00996307|516605810|FG002|Overall Study|Adverse Event|0|||
143288937|NCT00996307|516605811|FG003|Overall Study|Adverse Event|0|||
143288938|NCT00996307|516605808|FG000|Overall Study|Withdrawal by Subject|3|||
143288939|NCT00996307|516605809|FG001|Overall Study|Withdrawal by Subject|2|||
143288940|NCT00996307|516605810|FG002|Overall Study|Withdrawal by Subject|5|||
143288941|NCT00996307|516605811|FG003|Overall Study|Withdrawal by Subject|5|||
143288942|NCT00996307|516605808|FG000|Overall Study|Lost to Follow-up|13|||
143288943|NCT00996307|516605809|FG001|Overall Study|Lost to Follow-up|13|||
143288944|NCT00996307|516605810|FG002|Overall Study|Lost to Follow-up|7|||
143288945|NCT00996307|516605811|FG003|Overall Study|Lost to Follow-up|15|||
143288946|NCT00996307|516605808|FG000|Overall Study|Administrative reason|0|||
143288947|NCT00996307|516605809|FG001|Overall Study|Administrative reason|1|||
143288948|NCT00996307|516605810|FG002|Overall Study|Administrative reason|0|||
143288949|NCT00996307|516605811|FG003|Overall Study|Administrative reason|0|||
143288950|NCT00996307|516605808|FG000|Overall Study|Unable to classify|4|||
143288951|NCT00996307|516605809|FG001|Overall Study|Unable to classify|0|||
143288952|NCT00996307|516605810|FG002|Overall Study|Unable to classify|2|||
143288953|NCT00996307|516605811|FG003|Overall Study|Unable to classify|1|||
143288954|NCT02170051|516605812|FG000|Overall Study|Withdrawal by Subject|10|||
143288955|NCT02170051|516605813|FG001|Overall Study|Withdrawal by Subject|10|||
143288956|NCT02170051|516605812|FG000|Overall Study|Lost to Follow-up|1|||
143288957|NCT02170051|516605813|FG001|Overall Study|Lost to Follow-up|3|||
143288958|NCT03798483|516605814|FG000|Overall Study|Lost to Follow-up|2|||
143288959|NCT00276744|516605815|FG000|PART A|Reason unknown|98|||
143288960|NCT03978520|516605818|FG000|Overall Study|Adverse Event|2|||
143288961|NCT03978520|516605819|FG001|Overall Study|Adverse Event|5|||
143288962|NCT03978520|516605820|FG002|Overall Study|Adverse Event|3|||
143288963|NCT03978520|516605821|FG003|Overall Study|Adverse Event|5|||
143288964|NCT03978520|516605822|FG004|Overall Study|Adverse Event|6|||
143288965|NCT03978520|516605818|FG000|Overall Study|Withdrawal by Subject|10|||
143288966|NCT03978520|516605819|FG001|Overall Study|Withdrawal by Subject|4|||
143288967|NCT03978520|516605820|FG002|Overall Study|Withdrawal by Subject|5|||
143288968|NCT03978520|516605821|FG003|Overall Study|Withdrawal by Subject|6|||
143288969|NCT03978520|516605822|FG004|Overall Study|Withdrawal by Subject|5|||
143288970|NCT03978520|516605818|FG000|Overall Study|Lost to Follow-up|2|||
143288971|NCT03978520|516605819|FG001|Overall Study|Lost to Follow-up|2|||
143288972|NCT03978520|516605820|FG002|Overall Study|Lost to Follow-up|2|||
143288973|NCT03978520|516605821|FG003|Overall Study|Lost to Follow-up|0|||
143288974|NCT03978520|516605822|FG004|Overall Study|Lost to Follow-up|1|||
143288975|NCT03978520|516605818|FG000|Overall Study|COVID-19 infection|0|||
143288976|NCT03978520|516605819|FG001|Overall Study|COVID-19 infection|1|||
143288977|NCT03978520|516605820|FG002|Overall Study|COVID-19 infection|0|||
143288978|NCT03978520|516605821|FG003|Overall Study|COVID-19 infection|0|||
143288979|NCT03978520|516605822|FG004|Overall Study|COVID-19 infection|0|||
143288980|NCT03978520|516605818|FG000|Overall Study|Other, not specified|9|||
143288981|NCT03978520|516605819|FG001|Overall Study|Other, not specified|4|||
143288982|NCT03978520|516605820|FG002|Overall Study|Other, not specified|1|||
143288983|NCT03978520|516605821|FG003|Overall Study|Other, not specified|1|||
143288984|NCT03978520|516605822|FG004|Overall Study|Other, not specified|2|||
143288985|NCT03978520|516605818|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
143288986|NCT03978520|516605819|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
143288987|NCT03978520|516605820|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
143288988|NCT03978520|516605821|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
143288989|NCT03978520|516605822|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
143288990|NCT01605877|516605823|FG000|Overall Study|Withdrawal by Subject|1|||
143288991|NCT01835587|516605826|FG000|Overall Study|Disease Recurrence or Relapse|0|||
143288992|NCT01835587|516605827|FG001|Overall Study|Disease Recurrence or Relapse|3|||
143288993|NCT01835587|516605828|FG002|Overall Study|Disease Recurrence or Relapse|0|||
143288994|NCT01835587|516605829|FG003|Overall Study|Disease Recurrence or Relapse|3|||
143288995|NCT01835587|516605826|FG000|Overall Study|Withdrawal by Subject|2|||
143288996|NCT01835587|516605827|FG001|Overall Study|Withdrawal by Subject|0|||
143288997|NCT01835587|516605828|FG002|Overall Study|Withdrawal by Subject|0|||
143288998|NCT01835587|516605829|FG003|Overall Study|Withdrawal by Subject|3|||
143288999|NCT01835587|516605826|FG000|Overall Study|Adverse Event|0|||
143289000|NCT01835587|516605827|FG001|Overall Study|Adverse Event|0|||
143289001|NCT01835587|516605828|FG002|Overall Study|Adverse Event|2|||
143289002|NCT01835587|516605829|FG003|Overall Study|Adverse Event|2|||
143289003|NCT01835587|516605826|FG000|Overall Study|Death|0|||
143289004|NCT01835587|516605827|FG001|Overall Study|Death|0|||
143289005|NCT01835587|516605828|FG002|Overall Study|Death|0|||
143289006|NCT01835587|516605829|FG003|Overall Study|Death|1|||
143289007|NCT01835587|516605826|FG000|Overall Study|Miscellaneous|0|||
143289008|NCT01835587|516605827|FG001|Overall Study|Miscellaneous|1|||
143289009|NCT01835587|516605828|FG002|Overall Study|Miscellaneous|0|||
143289010|NCT01835587|516605829|FG003|Overall Study|Miscellaneous|0|||
143289011|NCT00126568|516605832|FG000|Overall Study|Death|2|||
143289012|NCT03064451|516605833|FG000|Overall Study|Lost to Follow-up|1|||
143289013|NCT03064451|516605833|FG000|Overall Study|Mapping Failure|4|||
143289014|NCT03064451|516605833|FG000|Overall Study|Exited prior to procedure|8|||
143289015|NCT03064451|516605833|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
143289016|NCT00897104|516605834|FG000|Overall Study|Lost to Follow-up|12|||
143289017|NCT00897104|516605835|FG001|Overall Study|Lost to Follow-up|17|||
143289018|NCT00897104|516605836|FG002|Overall Study|Lost to Follow-up|2|||
143289019|NCT00897104|516605834|FG000|Overall Study|Pregnancy|0|||
143289020|NCT00897104|516605835|FG001|Overall Study|Pregnancy|1|||
143289021|NCT00897104|516605836|FG002|Overall Study|Pregnancy|0|||
143289022|NCT00897104|516605834|FG000|Overall Study|Protocol Violation|0|||
143289023|NCT00897104|516605835|FG001|Overall Study|Protocol Violation|1|||
143289024|NCT00897104|516605836|FG002|Overall Study|Protocol Violation|0|||
143289025|NCT00897104|516605834|FG000|Overall Study|Withdrawal by Subject|23|||
143289026|NCT00897104|516605835|FG001|Overall Study|Withdrawal by Subject|27|||
143289027|NCT00897104|516605836|FG002|Overall Study|Withdrawal by Subject|3|||
143289028|NCT00897104|516605834|FG000|Overall Study|Abnormal Prestudy Labs|2|||
143289029|NCT00897104|516605835|FG001|Overall Study|Abnormal Prestudy Labs|0|||
143289030|NCT00897104|516605836|FG002|Overall Study|Abnormal Prestudy Labs|0|||
143289031|NCT00897104|516605834|FG000|Overall Study|Abnormal Baseline ECG|2|||
143289032|NCT00897104|516605835|FG001|Overall Study|Abnormal Baseline ECG|2|||
143289033|NCT00897104|516605836|FG002|Overall Study|Abnormal Baseline ECG|0|||
143289034|NCT00897104|516605834|FG000|Overall Study|Need for Concom. Med.|0|||
143289035|NCT00897104|516605835|FG001|Overall Study|Need for Concom. Med.|1|||
143289036|NCT00897104|516605836|FG002|Overall Study|Need for Concom. Med.|1|||
143289037|NCT00897104|516605834|FG000|Overall Study|Lack of Migraine Attack|20|||
143289038|NCT00897104|516605835|FG001|Overall Study|Lack of Migraine Attack|22|||
143289039|NCT00897104|516605836|FG002|Overall Study|Lack of Migraine Attack|1|||
143289040|NCT00897104|516605834|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
143289041|NCT00897104|516605835|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
143289042|NCT00897104|516605836|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
143289043|NCT00897104|516605834|FG000|Overall Study|Other|3|||
143289044|NCT00897104|516605835|FG001|Overall Study|Other|0|||
143289045|NCT00897104|516605836|FG002|Overall Study|Other|0|||
143289046|NCT00897104|516605834|FG000|Overall Study|Protocol Violation|1|||
143289047|NCT00897104|516605835|FG001|Overall Study|Protocol Violation|0|||
143289048|NCT00897104|516605836|FG002|Overall Study|Protocol Violation|0|||
143289049|NCT00897104|516605834|FG000|Overall Study|Withdrawal by Subject|0|||
143289050|NCT00897104|516605835|FG001|Overall Study|Withdrawal by Subject|0|||
143289051|NCT00897104|516605836|FG002|Overall Study|Withdrawal by Subject|1|||
143289052|NCT00434330|516605837|FG000|Overall Study|Adverse Event|0|||
143289053|NCT00434330|516605838|FG001|Overall Study|Adverse Event|0|||
143289054|NCT00434330|516605839|FG002|Overall Study|Adverse Event|1|||
143289055|NCT00434330|516605840|FG003|Overall Study|Adverse Event|0|||
143289056|NCT00434330|516605841|FG004|Overall Study|Adverse Event|0|||
143289057|NCT00434330|516605842|FG005|Overall Study|Adverse Event|0|||
143289058|NCT00434330|516605837|FG000|Overall Study|Death|1|||
143289059|NCT00434330|516605838|FG001|Overall Study|Death|0|||
143289060|NCT00434330|516605839|FG002|Overall Study|Death|0|||
143289061|NCT00434330|516605840|FG003|Overall Study|Death|0|||
143289062|NCT00434330|516605841|FG004|Overall Study|Death|1|||
143289063|NCT00434330|516605842|FG005|Overall Study|Death|1|||
143289064|NCT00434330|516605837|FG000|Overall Study|Withdrawal by Subject|0|||
143289065|NCT00434330|516605838|FG001|Overall Study|Withdrawal by Subject|0|||
143289066|NCT00434330|516605839|FG002|Overall Study|Withdrawal by Subject|1|||
143289067|NCT00434330|516605840|FG003|Overall Study|Withdrawal by Subject|1|||
143289068|NCT00434330|516605841|FG004|Overall Study|Withdrawal by Subject|0|||
143289069|NCT00434330|516605842|FG005|Overall Study|Withdrawal by Subject|0|||
143289070|NCT00434330|516605837|FG000|Overall Study|Renal transplant|0|||
143289071|NCT00434330|516605838|FG001|Overall Study|Renal transplant|0|||
143289072|NCT00434330|516605839|FG002|Overall Study|Renal transplant|0|||
143289073|NCT00434330|516605840|FG003|Overall Study|Renal transplant|1|||
143289074|NCT00434330|516605841|FG004|Overall Study|Renal transplant|0|||
143289075|NCT00434330|516605842|FG005|Overall Study|Renal transplant|0|||
143289076|NCT00434330|516605837|FG000|Overall Study|Subject Not Compliant With Study|0|||
143289077|NCT00434330|516605838|FG001|Overall Study|Subject Not Compliant With Study|0|||
143289078|NCT00434330|516605839|FG002|Overall Study|Subject Not Compliant With Study|1|||
143289079|NCT00434330|516605840|FG003|Overall Study|Subject Not Compliant With Study|0|||
143289080|NCT00434330|516605841|FG004|Overall Study|Subject Not Compliant With Study|0|||
143289081|NCT00434330|516605842|FG005|Overall Study|Subject Not Compliant With Study|0|||
143289082|NCT00750204|516605843|FG000|Overall Study|study halted prematurely|1|||
143289083|NCT00750204|516605844|FG001|Overall Study|study halted prematurely|1|||
143289084|NCT04853225|516605845|FG000|Overall Study|Withdrawal by Subject|81|||
143289085|NCT04853225|516605846|FG001|Overall Study|Withdrawal by Subject|4|||
143289086|NCT04853225|516605847|FG002|Overall Study|Withdrawal by Subject|1|||
143289087|NCT04853225|516605845|FG000|Overall Study|Physician Decision|12|||
143289088|NCT04853225|516605846|FG001|Overall Study|Physician Decision|4|||
143289089|NCT04853225|516605847|FG002|Overall Study|Physician Decision|1|||
143289090|NCT04853225|516605845|FG000|Overall Study|Lost to Follow-up|50|||
143289091|NCT04853225|516605846|FG001|Overall Study|Lost to Follow-up|0|||
143289092|NCT04853225|516605847|FG002|Overall Study|Lost to Follow-up|0|||
143289093|NCT04853225|516605845|FG000|Overall Study|Other|102|||
143289094|NCT04853225|516605846|FG001|Overall Study|Other|11|||
143289095|NCT04853225|516605847|FG002|Overall Study|Other|5|||
143289096|NCT04853225|516605845|FG000|Overall Study|Not included in the Full Population due to Investigator discretion|1|||
143289097|NCT04853225|516605846|FG001|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
143289098|NCT04853225|516605847|FG002|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
143289099|NCT04853225|516605845|FG000|Overall Study|Not included in the Full Population due to withdrew consent|1|||
143289100|NCT04853225|516605846|FG001|Overall Study|Not included in the Full Population due to withdrew consent|0|||
143289101|NCT04853225|516605847|FG002|Overall Study|Not included in the Full Population due to withdrew consent|0|||
143289102|NCT03918447|516605848|FG000|Overall Study|Death|1|||
143289103|NCT03918447|516605849|FG001|Overall Study|Death|0|||
143289104|NCT03918447|516605848|FG000|Overall Study|Lost to Follow-up|13|||
143289105|NCT03918447|516605849|FG001|Overall Study|Lost to Follow-up|6|||
143289106|NCT03918447|516605848|FG000|Overall Study|Withdrawal by Subject|19|||
143289107|NCT03918447|516605849|FG001|Overall Study|Withdrawal by Subject|17|||
143289108|NCT03918447|516605848|FG000|Overall Study|Study Terminated by Sponsor|195|||
143289109|NCT03918447|516605849|FG001|Overall Study|Study Terminated by Sponsor|197|||
143289110|NCT03918447|516605848|FG000|Overall Study|Reason not Specified|0|||
143289111|NCT03918447|516605849|FG001|Overall Study|Reason not Specified|1|||
143289112|NCT01411228|516607579|FG000|Overall Study|Lost to Follow-up|0|||
143289113|NCT01411228|516607580|FG001|Overall Study|Lost to Follow-up|0|||
143289114|NCT01411228|516607581|FG002|Overall Study|Lost to Follow-up|1|||
143289115|NCT01411228|516607579|FG000|Overall Study|Withdrawal by Subject|1|||
143289116|NCT01411228|516607580|FG001|Overall Study|Withdrawal by Subject|0|||
143289117|NCT01411228|516607581|FG002|Overall Study|Withdrawal by Subject|0|||
143289118|NCT00848081|516607582|FG000|Overall Study|Adverse Event|6|||
143289119|NCT00848081|516607583|FG001|Overall Study|Adverse Event|7|||
143289120|NCT00848081|516607582|FG000|Overall Study|Protocol Violation|8|||
143289121|NCT00848081|516607583|FG001|Overall Study|Protocol Violation|5|||
143289122|NCT00848081|516607582|FG000|Overall Study|Lost to Follow-up|1|||
143289123|NCT00848081|516607583|FG001|Overall Study|Lost to Follow-up|0|||
143289124|NCT00848081|516607582|FG000|Overall Study|Physician Decision|0|||
143289125|NCT00848081|516607583|FG001|Overall Study|Physician Decision|3|||
143289126|NCT00848081|516607582|FG000|Overall Study|Withdrawal by Subject|5|||
143289127|NCT00848081|516607583|FG001|Overall Study|Withdrawal by Subject|3|||
143289128|NCT00609492|516607584|FG000|Overall Study|Withdrawal by Subject|0|||
143289129|NCT00609492|516607585|FG001|Overall Study|Withdrawal by Subject|2|||
143289130|NCT00609492|516607586|FG002|Overall Study|Withdrawal by Subject|3|||
143289131|NCT00609492|516607584|FG000|Overall Study|Lost to Follow-up|1|||
143289132|NCT00609492|516607585|FG001|Overall Study|Lost to Follow-up|1|||
143289133|NCT00609492|516607586|FG002|Overall Study|Lost to Follow-up|4|||
143289134|NCT00720434|516607587|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
143289135|NCT00720434|516607588|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
143289136|NCT00720434|516607589|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
143289137|NCT00720434|516607590|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
143289138|NCT00720434|516607587|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
143289139|NCT00720434|516607588|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
143289140|NCT00720434|516607589|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
143289141|NCT00720434|516607590|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
143289142|NCT00720434|516607587|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
143289143|NCT00720434|516607588|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
143289144|NCT00720434|516607589|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
143289145|NCT00720434|516607590|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
143289146|NCT00720434|516607587|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
143289147|NCT00720434|516607588|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
143289148|NCT00720434|516607589|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
143289149|NCT00720434|516607590|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
143289150|NCT00720434|516607587|FG000|Open-Label Period (Week 5-72)|Other|4|||
143289151|NCT00720434|516607588|FG001|Open-Label Period (Week 5-72)|Other|3|||
143289152|NCT00720434|516607589|FG002|Open-Label Period (Week 5-72)|Other|3|||
143289153|NCT00720434|516607590|FG003|Open-Label Period (Week 5-72)|Other|2|||
143289154|NCT02782780|516607591|FG000|Overall Study|dropped out after randomization.|7|||
143289155|NCT02782780|516607592|FG001|Overall Study|dropped out after randomization.|5|||
143289156|NCT02782780|516607591|FG000|Overall Study|Protocol Violation|0|||
143289157|NCT02782780|516607592|FG001|Overall Study|Protocol Violation|2|||
143289158|NCT00644995|516607596|FG000|Overall Study|Lost to Follow-up|1|||
143289159|NCT00644995|516607597|FG001|Overall Study|Lost to Follow-up|4|||
143289160|NCT00644995|516607596|FG000|Overall Study|Refused|1|||
143289161|NCT00644995|516607597|FG001|Overall Study|Refused|0|||
143289162|NCT00460408|516607598|FG000|Overall Study|Adverse Event|1|||
143289163|NCT00460408|516607599|FG001|Overall Study|Adverse Event|0|||
143289164|NCT00460408|516607600|FG002|Overall Study|Adverse Event|0|||
143289165|NCT00460408|516607601|FG003|Overall Study|Adverse Event|0|||
143289166|NCT00460408|516607598|FG000|Overall Study|Death|7|||
143289167|NCT00460408|516607599|FG001|Overall Study|Death|0|||
143289168|NCT00460408|516607600|FG002|Overall Study|Death|0|||
143289169|NCT00460408|516607601|FG003|Overall Study|Death|0|||
143289170|NCT00460408|516607598|FG000|Overall Study|Lost to Follow-up|11|||
143289171|NCT00460408|516607599|FG001|Overall Study|Lost to Follow-up|0|||
143289172|NCT00460408|516607600|FG002|Overall Study|Lost to Follow-up|1|||
143289173|NCT00460408|516607601|FG003|Overall Study|Lost to Follow-up|0|||
143289174|NCT00460408|516607598|FG000|Overall Study|Withdrawal by Subject|31|||
143289175|NCT00460408|516607599|FG001|Overall Study|Withdrawal by Subject|0|||
143289176|NCT00460408|516607600|FG002|Overall Study|Withdrawal by Subject|0|||
143289177|NCT00460408|516607601|FG003|Overall Study|Withdrawal by Subject|0|||
143289178|NCT00460408|516607598|FG000|Overall Study|Insufficient clinical response|5|||
143289179|NCT00460408|516607599|FG001|Overall Study|Insufficient clinical response|1|||
143289180|NCT00460408|516607600|FG002|Overall Study|Insufficient clinical response|5|||
143289181|NCT00460408|516607601|FG003|Overall Study|Insufficient clinical response|0|||
143289182|NCT00460408|516607598|FG000|Overall Study|Other|12|||
143289183|NCT00460408|516607599|FG001|Overall Study|Other|2|||
143289184|NCT00460408|516607600|FG002|Overall Study|Other|0|||
143289185|NCT00460408|516607601|FG003|Overall Study|Other|0|||
143373721|NCT00708032|516913551|FG000|Overall Study|Did not meet protocol criteria|1|||
143289186|NCT03315208|516607602|FG000|Overall Study|Lost to Follow-up|11|||
143289187|NCT03315208|516607603|FG001|Overall Study|Lost to Follow-up|6|||
143289188|NCT03315208|516607602|FG000|Overall Study|Withdrawal by Subject|2|||
143289189|NCT03315208|516607603|FG001|Overall Study|Withdrawal by Subject|0|||
143289190|NCT02875860|516607604|FG000|Overall Study|Withdrawal by Subject|0|||
143289191|NCT02875860|516607605|FG001|Overall Study|Withdrawal by Subject|1|||
143289192|NCT01156311|516607612|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
143289193|NCT01156311|516607613|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
143289194|NCT01156311|516607614|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
143289195|NCT01156311|516607615|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
143289196|NCT01156311|516607612|FG000|2-Month Monotherapy Period|Physician Decision|0|||
143289197|NCT01156311|516607613|FG001|2-Month Monotherapy Period|Physician Decision|1|||
143289198|NCT01156311|516607614|FG002|2-Month Monotherapy Period|Physician Decision|0|||
143289199|NCT01156311|516607615|FG003|2-Month Monotherapy Period|Physician Decision|0|||
143289200|NCT01156311|516607612|FG000|2-Month Monotherapy Period|Other|1|||
143289201|NCT01156311|516607613|FG001|2-Month Monotherapy Period|Other|0|||
143289202|NCT01156311|516607614|FG002|2-Month Monotherapy Period|Other|0|||
143289203|NCT01156311|516607615|FG003|2-Month Monotherapy Period|Other|0|||
143289204|NCT01156311|516607612|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
143289205|NCT01156311|516607613|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
143289206|NCT01156311|516607614|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
143289207|NCT01156311|516607615|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
143289208|NCT01156311|516607612|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
143289209|NCT01156311|516607613|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
143289210|NCT01156311|516607614|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
143289211|NCT01156311|516607615|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
143289212|NCT01156311|516607612|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
143289213|NCT01156311|516607613|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
143289214|NCT01156311|516607614|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
143289215|NCT01156311|516607615|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
143289216|NCT01156311|516607612|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
143289217|NCT01156311|516607613|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
143289218|NCT01156311|516607614|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
143289219|NCT01156311|516607615|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
143289220|NCT01156311|516607612|FG000|6-month Add-on Therapy Period|Other|0|||
143289221|NCT01156311|516607613|FG001|6-month Add-on Therapy Period|Other|0|||
143289222|NCT01156311|516607614|FG002|6-month Add-on Therapy Period|Other|1|||
143289223|NCT01156311|516607615|FG003|6-month Add-on Therapy Period|Other|2|||
143289224|NCT01741701|516607618|FG000|Overall Study|Adverse Event|5|||
143289225|NCT01741701|516607619|FG001|Overall Study|Adverse Event|1|||
143289226|NCT01741701|516607618|FG000|Overall Study|Withdrawal by Subject|0|||
143289227|NCT01741701|516607619|FG001|Overall Study|Withdrawal by Subject|1|||
143289228|NCT03033394|516607640|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
143289229|NCT03033394|516607640|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
143289230|NCT03033394|516607640|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
143289231|NCT03033394|516607640|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
143289232|NCT03033394|516607640|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
143289233|NCT01830972|516607642|FG000|Part II|Withdrawal by Subject|2|||
143289234|NCT01830972|516607643|FG001|Part II|Withdrawal by Subject|2|||
143289235|NCT01830972|516607642|FG000|Part III|Withdrawal by Subject|1|||
143289236|NCT01830972|516607643|FG001|Part III|Withdrawal by Subject|0|||
143289237|NCT01830972|516607642|FG000|Part III|Noncompliance|1|||
143289238|NCT01830972|516607643|FG001|Part III|Noncompliance|0|||
143289239|NCT01830972|516607642|FG000|Part IV|Withdrawal by Subject|2|||
143289240|NCT01830972|516607643|FG001|Part IV|Withdrawal by Subject|1|||
143289241|NCT01830972|516607642|FG000|Part IV|Non-Compliance|1|||
143289242|NCT01830972|516607643|FG001|Part IV|Non-Compliance|0|||
143289243|NCT02670837|516607646|FG000|Overall Study|Death|2|||
143289244|NCT02670837|516607647|FG001|Overall Study|Death|0|||
143289245|NCT02670837|516607648|FG002|Overall Study|Death|0|||
143289246|NCT01985867|516607649|FG000|Overall Study|Lost to Follow-up|3|||
143289247|NCT01985867|516607650|FG001|Overall Study|Lost to Follow-up|4|||
143289248|NCT01985867|516607649|FG000|Overall Study|Adverse Event|3|||
143289249|NCT01985867|516607650|FG001|Overall Study|Adverse Event|2|||
143289250|NCT01985867|516607649|FG000|Overall Study|Lack of Efficacy|1|||
143289251|NCT01985867|516607650|FG001|Overall Study|Lack of Efficacy|0|||
143289252|NCT02205814|516607656|FG000|Overall Study|Lost to Follow-up|0|||
143289253|NCT02205814|516607657|FG001|Overall Study|Lost to Follow-up|0|||
143289254|NCT02205814|516607658|FG002|Overall Study|Lost to Follow-up|0|||
143289255|NCT02205814|516607659|FG003|Overall Study|Lost to Follow-up|1|||
143289256|NCT02205814|516607656|FG000|Overall Study|Lack of Efficacy|1|||
143289257|NCT02205814|516607657|FG001|Overall Study|Lack of Efficacy|0|||
143289258|NCT02205814|516607658|FG002|Overall Study|Lack of Efficacy|1|||
143289259|NCT02205814|516607659|FG003|Overall Study|Lack of Efficacy|1|||
143289260|NCT02205814|516607656|FG000|Overall Study|Physician Decision|0|||
143289261|NCT02205814|516607657|FG001|Overall Study|Physician Decision|0|||
143289262|NCT02205814|516607658|FG002|Overall Study|Physician Decision|1|||
143289263|NCT02205814|516607659|FG003|Overall Study|Physician Decision|0|||
143289264|NCT02205814|516607656|FG000|Overall Study|Protocol Violation|1|||
143289265|NCT02205814|516607657|FG001|Overall Study|Protocol Violation|0|||
143289266|NCT02205814|516607658|FG002|Overall Study|Protocol Violation|0|||
143289267|NCT02205814|516607659|FG003|Overall Study|Protocol Violation|1|||
143289268|NCT02205814|516607656|FG000|Overall Study|Withdrawal by Subject|0|||
143289269|NCT02205814|516607657|FG001|Overall Study|Withdrawal by Subject|1|||
143289270|NCT02205814|516607658|FG002|Overall Study|Withdrawal by Subject|2|||
143289271|NCT02205814|516607659|FG003|Overall Study|Withdrawal by Subject|1|||
143289272|NCT02205814|516607656|FG000|Overall Study|not compliant with study procedures|0|||
143289273|NCT02205814|516607657|FG001|Overall Study|not compliant with study procedures|0|||
143289274|NCT02205814|516607658|FG002|Overall Study|not compliant with study procedures|1|||
143289275|NCT02205814|516607659|FG003|Overall Study|not compliant with study procedures|0|||
143289276|NCT01426373|516607660|FG000|Overall Study|Adverse Event|6|||
143289277|NCT01426373|516607660|FG000|Overall Study|Lost to Follow-up|14|||
143289278|NCT01426373|516607660|FG000|Overall Study|Participant Convenience|10|||
143289279|NCT01426373|516607660|FG000|Overall Study|Miscellaneous Reasons|4|||
143289280|NCT04952402|516607661|FG000|Overall Study|Lost to Follow-up|1|||
143289281|NCT04952402|516607662|FG001|Overall Study|Lost to Follow-up|3|||
143289282|NCT04952402|516607661|FG000|Overall Study|Lack Of Venous Access|0|||
143289283|NCT04952402|516607662|FG001|Overall Study|Lack Of Venous Access|1|||
143289284|NCT00143403|516607663|FG000|Overall Study|Adverse Event|3|||
143289285|NCT00143403|516607664|FG001|Overall Study|Adverse Event|8|||
143289286|NCT00143403|516607663|FG000|Overall Study|Death|1|||
143289287|NCT00143403|516607664|FG001|Overall Study|Death|0|||
143289288|NCT00143403|516607663|FG000|Overall Study|Withdrawal by Subject|3|||
143289289|NCT00143403|516607664|FG001|Overall Study|Withdrawal by Subject|12|||
143289290|NCT00143403|516607663|FG000|Overall Study|Relapse|15|||
143289291|NCT00143403|516607664|FG001|Overall Study|Relapse|7|||
143289292|NCT00143403|516607663|FG000|Overall Study|Protocol Violation|2|||
143289293|NCT00143403|516607664|FG001|Overall Study|Protocol Violation|2|||
143289294|NCT00143403|516607663|FG000|Overall Study|specified by site|4|||
143289295|NCT00143403|516607664|FG001|Overall Study|specified by site|9|||
143289296|NCT00143403|516607663|FG000|Overall Study|Randomized Not Treated|7|||
143289297|NCT00143403|516607664|FG001|Overall Study|Randomized Not Treated|8|||
143289298|NCT00514540|516607665|FG000|First-Line Chemo|Withdrawal by Subject|1|||
143289299|NCT00514540|516607665|FG000|First-Line Chemo|Protocol Violation|7|||
143289300|NCT00514540|516607665|FG000|Second-Line|Physician/Patient Decision|31|||
143289301|NCT01996982|516607668|FG000|Overall Study|PI/team left institution|7|||
143289302|NCT01574326|516607669|FG000|Overall Study|Randomized but not treated|0|||
143289303|NCT01574326|516607670|FG001|Overall Study|Randomized but not treated|1|||
143289304|NCT01574326|516607669|FG000|Overall Study|Withdrawal by Participant|2|||
143289305|NCT01574326|516607670|FG001|Overall Study|Withdrawal by Participant|4|||
143289306|NCT01574326|516607669|FG000|Overall Study|Physician Decision|5|||
143289307|NCT01574326|516607670|FG001|Overall Study|Physician Decision|3|||
143289308|NCT01574326|516607669|FG000|Overall Study|Adverse Event|1|||
143289309|NCT01574326|516607670|FG001|Overall Study|Adverse Event|3|||
143289310|NCT01574326|516607669|FG000|Overall Study|Other: Mainly kidney transplant|8|||
143289311|NCT01574326|516607670|FG001|Overall Study|Other: Mainly kidney transplant|8|||
143289312|NCT00160251|516607691|FG000|Prior to Amendment 2|Adverse Event|2|||
143289313|NCT00160251|516607692|FG001|Prior to Amendment 2|Adverse Event|1|||
143289314|NCT00160251|516607693|FG002|Prior to Amendment 2|Adverse Event|3|||
143289315|NCT00160251|516607694|FG003|Prior to Amendment 2|Adverse Event|1|||
143289316|NCT00160251|516607695|FG004|Prior to Amendment 2|Adverse Event|1|||
143289317|NCT00160251|516607696|FG005|Prior to Amendment 2|Adverse Event|1|||
143289318|NCT00160251|516607697|FG006|Prior to Amendment 2|Adverse Event|1|||
143289319|NCT00160251|516607698|FG007|Prior to Amendment 2|Adverse Event|0|||
143289320|NCT00160251|516607691|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
143289321|NCT00160251|516607692|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
143289322|NCT00160251|516607693|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
143289323|NCT00160251|516607694|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
143289324|NCT00160251|516607695|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
143289325|NCT00160251|516607696|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
143289326|NCT00160251|516607697|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
143289327|NCT00160251|516607698|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
143289328|NCT00160251|516607691|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
143289329|NCT00160251|516607692|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
143289330|NCT00160251|516607693|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
143289331|NCT00160251|516607694|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
143289332|NCT00160251|516607695|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
143289333|NCT00160251|516607696|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
143289334|NCT00160251|516607697|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
143289335|NCT00160251|516607698|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
143289336|NCT00160251|516607691|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
143289337|NCT00160251|516607692|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
143289338|NCT00160251|516607693|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
143289339|NCT00160251|516607694|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
143289340|NCT00160251|516607695|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
143289341|NCT00160251|516607696|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
143289342|NCT00160251|516607697|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
143289343|NCT00160251|516607698|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
143289344|NCT00160251|516607691|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
143289345|NCT00160251|516607692|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
143289346|NCT00160251|516607693|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
143289347|NCT00160251|516607694|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
143289348|NCT00160251|516607695|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
143289349|NCT00160251|516607696|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
143289350|NCT00160251|516607697|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
143289351|NCT00160251|516607698|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
143289352|NCT00160251|516607691|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
143289353|NCT00160251|516607692|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
143289354|NCT00160251|516607693|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
143289355|NCT00160251|516607694|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
143289356|NCT00160251|516607695|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
143289357|NCT00160251|516607696|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
143289358|NCT00160251|516607697|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
143289359|NCT00160251|516607698|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
143289360|NCT00160251|516607691|FG000|Post-amendment 2|Adverse Event|0|||
143289361|NCT00160251|516607692|FG001|Post-amendment 2|Adverse Event|0|||
143289362|NCT00160251|516607693|FG002|Post-amendment 2|Adverse Event|0|||
143289363|NCT00160251|516607694|FG003|Post-amendment 2|Adverse Event|0|||
143289364|NCT00160251|516607695|FG004|Post-amendment 2|Adverse Event|0|||
143289365|NCT00160251|516607696|FG005|Post-amendment 2|Adverse Event|0|||
143289366|NCT00160251|516607697|FG006|Post-amendment 2|Adverse Event|0|||
143289367|NCT00160251|516607698|FG007|Post-amendment 2|Adverse Event|20|||
143289368|NCT00160251|516607691|FG000|Post-amendment 2|Lack of Efficacy|0|||
143289369|NCT00160251|516607692|FG001|Post-amendment 2|Lack of Efficacy|0|||
143289370|NCT00160251|516607693|FG002|Post-amendment 2|Lack of Efficacy|0|||
143289371|NCT00160251|516607694|FG003|Post-amendment 2|Lack of Efficacy|0|||
143289372|NCT00160251|516607695|FG004|Post-amendment 2|Lack of Efficacy|0|||
143289373|NCT00160251|516607696|FG005|Post-amendment 2|Lack of Efficacy|0|||
143289374|NCT00160251|516607697|FG006|Post-amendment 2|Lack of Efficacy|0|||
143289375|NCT00160251|516607698|FG007|Post-amendment 2|Lack of Efficacy|24|||
143289376|NCT00160251|516607691|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
143289377|NCT00160251|516607692|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
143289378|NCT00160251|516607693|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
143289379|NCT00160251|516607694|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
143289380|NCT00160251|516607695|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
143289381|NCT00160251|516607696|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
143289382|NCT00160251|516607697|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
143289383|NCT00160251|516607698|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
143289384|NCT01574612|516607701|FG000|Overall Study|Adverse Event|3|||
143289385|NCT01574612|516607701|FG000|Overall Study|non compliant with drug|2|||
143289386|NCT01574612|516607701|FG000|Overall Study|Withdrawal by Subject|1|||
143289387|NCT01574612|516607701|FG000|Overall Study|Lost to Follow-up|2|||
143289388|NCT00582166|516607702|FG000|Overall Study|Death|1|||
143289389|NCT00582166|516607702|FG000|Overall Study|Ineligible pathology|1|||
143289390|NCT01606436|516607703|FG000|Overall Study|Withdrawal by Subject|0|||
143289391|NCT01606436|516607704|FG001|Overall Study|Withdrawal by Subject|0|||
143289392|NCT01606436|516607705|FG002|Overall Study|Withdrawal by Subject|1|||
143289393|NCT01606436|516607706|FG003|Overall Study|Withdrawal by Subject|1|||
143373722|NCT00708032|516913552|FG001|Overall Study|Did not meet protocol criteria|2|||
143373723|NCT00708032|516913551|FG000|Overall Study|Protocol Violation|4|||
143289394|NCT01606436|516607707|FG004|Overall Study|Withdrawal by Subject|1|||
143289395|NCT01606436|516607708|FG005|Overall Study|Withdrawal by Subject|0|||
143289396|NCT01606436|516607703|FG000|Overall Study|Adverse Event|0|||
143289397|NCT01606436|516607704|FG001|Overall Study|Adverse Event|0|||
143289398|NCT01606436|516607705|FG002|Overall Study|Adverse Event|1|||
143289399|NCT01606436|516607706|FG003|Overall Study|Adverse Event|0|||
143373724|NCT00708032|516913552|FG001|Overall Study|Protocol Violation|1|||
143289400|NCT01606436|516607707|FG004|Overall Study|Adverse Event|0|||
143289401|NCT01606436|516607708|FG005|Overall Study|Adverse Event|0|||
143289402|NCT01606436|516607703|FG000|Overall Study|Sponsor Decision|0|||
143289403|NCT01606436|516607704|FG001|Overall Study|Sponsor Decision|0|||
143289404|NCT01606436|516607705|FG002|Overall Study|Sponsor Decision|0|||
143289405|NCT01606436|516607706|FG003|Overall Study|Sponsor Decision|1|||
143289406|NCT01606436|516607707|FG004|Overall Study|Sponsor Decision|0|||
143289407|NCT01606436|516607708|FG005|Overall Study|Sponsor Decision|0|||
143289408|NCT03235154|516607710|FG000|Overall Study|Withdrawal by Subject|1|||
143289409|NCT03235154|516607710|FG000|Overall Study|Adverse Event|1|||
143289410|NCT03235154|516607710|FG000|Overall Study|Lost to Follow-up|2|||
143289411|NCT01922089|516607711|FG000|Overall Study|Adverse Event|18|||
143289412|NCT01922089|516607712|FG001|Overall Study|Adverse Event|13|||
143289413|NCT01922089|516607711|FG000|Overall Study|Protocol Deviation|10|||
143289414|NCT01922089|516607712|FG001|Overall Study|Protocol Deviation|7|||
143289415|NCT01922089|516607711|FG000|Overall Study|Withdrawal by Subject|3|||
143289416|NCT01922089|516607712|FG001|Overall Study|Withdrawal by Subject|4|||
143289417|NCT01922089|516607711|FG000|Overall Study|administrative problems|4|||
143289418|NCT01922089|516607712|FG001|Overall Study|administrative problems|1|||
143289419|NCT01922089|516607711|FG000|Overall Study|Physician Decision|2|||
143289420|NCT01922089|516607712|FG001|Overall Study|Physician Decision|3|||
143289421|NCT01922089|516607711|FG000|Overall Study|Death|2|||
143289422|NCT01922089|516607712|FG001|Overall Study|Death|1|||
143289423|NCT01922089|516607711|FG000|Overall Study|Lost to Follow-up|0|||
143289424|NCT01922089|516607712|FG001|Overall Study|Lost to Follow-up|1|||
143289425|NCT01683383|516607715|FG000|Overall Study|Infant was not transported|1|||
143289426|NCT01683383|516607716|FG001|Overall Study|Infant was not transported|0|||
143289427|NCT02326025|516607717|FG000|Overall Study|Adverse Event|3|||
143289428|NCT02326025|516607718|FG001|Overall Study|Adverse Event|0|||
143289429|NCT02326025|516607717|FG000|Overall Study|Physician Decision|1|||
143289430|NCT02326025|516607718|FG001|Overall Study|Physician Decision|2|||
143289431|NCT02326025|516607717|FG000|Overall Study|Physician and Participant Decision|1|||
143289432|NCT02326025|516607718|FG001|Overall Study|Physician and Participant Decision|0|||
143289433|NCT02326025|516607717|FG000|Overall Study|Withdrawal by Subject|0|||
143289434|NCT02326025|516607718|FG001|Overall Study|Withdrawal by Subject|2|||
143289435|NCT02326025|516607717|FG000|Overall Study|Protocol Violation|0|||
143289436|NCT02326025|516607718|FG001|Overall Study|Protocol Violation|1|||
143289437|NCT00640601|516607719|FG000|Overall Study|Adverse Event|43|||
143289438|NCT00640601|516607719|FG000|Overall Study|Withdrawal by Subject|20|||
143289439|NCT00640601|516607719|FG000|Overall Study|Protocol Violation|6|||
143289440|NCT00640601|516607719|FG000|Overall Study|Lack of Efficacy|16|||
143289441|NCT00640601|516607719|FG000|Overall Study|Lost to Follow-up|9|||
143289442|NCT00640601|516607719|FG000|Overall Study|Physician Decision|8|||
143289443|NCT00640601|516607719|FG000|Overall Study|treatment naive, combination therapy|10|||
143289444|NCT00230607|516607721|FG000|Overall Study|Other|3|||
143289445|NCT00203996|516607722|FG000|Overall Study|Lost to Follow-up|0|||
143289446|NCT00203996|516607723|FG001|Overall Study|Lost to Follow-up|0|||
143289447|NCT00203996|516607724|FG002|Overall Study|Lost to Follow-up|0|||
143289448|NCT00203996|516607725|FG003|Overall Study|Lost to Follow-up|1|||
143289449|NCT00203996|516607726|FG004|Overall Study|Lost to Follow-up|0|||
143289450|NCT00203996|516607727|FG005|Overall Study|Lost to Follow-up|0|||
143289451|NCT00203996|516607728|FG006|Overall Study|Lost to Follow-up|0|||
143289452|NCT00203996|516607729|FG007|Overall Study|Lost to Follow-up|0|||
143289453|NCT00203996|516607730|FG008|Overall Study|Lost to Follow-up|0|||
143289454|NCT00203996|516607731|FG009|Overall Study|Lost to Follow-up|0|||
143289455|NCT00203996|516607722|FG000|Overall Study|Protocol Violation|0|||
143289456|NCT00203996|516607723|FG001|Overall Study|Protocol Violation|0|||
143289457|NCT00203996|516607724|FG002|Overall Study|Protocol Violation|0|||
143289458|NCT00203996|516607725|FG003|Overall Study|Protocol Violation|6|||
143289459|NCT00203996|516607726|FG004|Overall Study|Protocol Violation|1|||
143289460|NCT00203996|516607727|FG005|Overall Study|Protocol Violation|0|||
143289461|NCT00203996|516607728|FG006|Overall Study|Protocol Violation|0|||
143289462|NCT00203996|516607729|FG007|Overall Study|Protocol Violation|0|||
143289463|NCT00203996|516607730|FG008|Overall Study|Protocol Violation|0|||
143289464|NCT00203996|516607731|FG009|Overall Study|Protocol Violation|0|||
143289465|NCT00203996|516607722|FG000|Overall Study|Physician Decision|0|||
143289466|NCT00203996|516607723|FG001|Overall Study|Physician Decision|0|||
143289467|NCT00203996|516607724|FG002|Overall Study|Physician Decision|0|||
143289468|NCT00203996|516607725|FG003|Overall Study|Physician Decision|2|||
143289469|NCT00203996|516607726|FG004|Overall Study|Physician Decision|0|||
143289470|NCT00203996|516607727|FG005|Overall Study|Physician Decision|0|||
143289471|NCT00203996|516607728|FG006|Overall Study|Physician Decision|0|||
143289472|NCT00203996|516607729|FG007|Overall Study|Physician Decision|0|||
143289473|NCT00203996|516607730|FG008|Overall Study|Physician Decision|0|||
143289474|NCT00203996|516607731|FG009|Overall Study|Physician Decision|1|||
143289475|NCT00203996|516607722|FG000|Overall Study|CPAP machine malfunction|0|||
143289476|NCT00203996|516607723|FG001|Overall Study|CPAP machine malfunction|0|||
143289477|NCT00203996|516607724|FG002|Overall Study|CPAP machine malfunction|0|||
143289478|NCT00203996|516607725|FG003|Overall Study|CPAP machine malfunction|1|||
143289479|NCT00203996|516607726|FG004|Overall Study|CPAP machine malfunction|0|||
143289480|NCT00203996|516607727|FG005|Overall Study|CPAP machine malfunction|0|||
143289481|NCT00203996|516607728|FG006|Overall Study|CPAP machine malfunction|0|||
143289482|NCT00203996|516607729|FG007|Overall Study|CPAP machine malfunction|0|||
143289483|NCT00203996|516607730|FG008|Overall Study|CPAP machine malfunction|0|||
143289484|NCT00203996|516607731|FG009|Overall Study|CPAP machine malfunction|0|||
143289485|NCT00203996|516607722|FG000|Overall Study|Scheduling issue|0|||
143289486|NCT00203996|516607723|FG001|Overall Study|Scheduling issue|0|||
143289487|NCT00203996|516607724|FG002|Overall Study|Scheduling issue|0|||
143289488|NCT00203996|516607725|FG003|Overall Study|Scheduling issue|0|||
143289489|NCT00203996|516607726|FG004|Overall Study|Scheduling issue|0|||
143289490|NCT00203996|516607727|FG005|Overall Study|Scheduling issue|0|||
143289491|NCT00203996|516607728|FG006|Overall Study|Scheduling issue|0|||
143289492|NCT00203996|516607729|FG007|Overall Study|Scheduling issue|2|||
143289493|NCT00203996|516607730|FG008|Overall Study|Scheduling issue|0|||
143289494|NCT00203996|516607731|FG009|Overall Study|Scheduling issue|0|||
143289495|NCT01937559|516607736|FG000|Overall Study|Physician Decision|3|||
143289496|NCT01937559|516607737|FG001|Overall Study|Physician Decision|3|||
143289497|NCT01937559|516607738|FG002|Overall Study|Physician Decision|0|||
143289498|NCT01937559|516607736|FG000|Overall Study|Withdrawal by Subject|6|||
143289499|NCT01937559|516607737|FG001|Overall Study|Withdrawal by Subject|4|||
143289500|NCT01937559|516607738|FG002|Overall Study|Withdrawal by Subject|0|||
143289501|NCT01937559|516607736|FG000|Overall Study|screen fail|2|||
143289502|NCT01937559|516607737|FG001|Overall Study|screen fail|4|||
143289503|NCT01937559|516607738|FG002|Overall Study|screen fail|0|||
143289504|NCT02167893|516607739|FG000|Overall Study|Investigator transferred|85|||
143289505|NCT02167893|516607739|FG000|Overall Study|Investigator health reasons|10|||
143289506|NCT02167893|516607739|FG000|Overall Study|Case report forms not collected|68|||
143289507|NCT04818840|516607740|FG000|Overall Study|Lost to Follow-up|0|||
143289508|NCT04818840|516607741|FG001|Overall Study|Lost to Follow-up|5|||
143289509|NCT04818840|516607740|FG000|Overall Study|Physician Decision|1|||
143289510|NCT04818840|516607741|FG001|Overall Study|Physician Decision|0|||
143289511|NCT04818840|516607740|FG000|Overall Study|Site Terminated by Sponsor|0|||
143289512|NCT04818840|516607741|FG001|Overall Study|Site Terminated by Sponsor|3|||
143289513|NCT04818840|516607740|FG000|Overall Study|Study Terminated by Sponsor|43|||
143289514|NCT04818840|516607741|FG001|Overall Study|Study Terminated by Sponsor|7|||
143289515|NCT04818840|516607740|FG000|Overall Study|Withdrawal by Subject|0|||
143289516|NCT04818840|516607741|FG001|Overall Study|Withdrawal by Subject|1|||
143289517|NCT01413191|516609579|FG000|Overall Study|Lost to Follow-up|5|||
143289518|NCT01413191|516609579|FG000|Overall Study|Disease Progression|5|||
143289519|NCT01413191|516609579|FG000|Overall Study|Death|1|||
143289520|NCT02289898|516609580|FG000|Overall Study|Death|5|||
143289521|NCT02289898|516609581|FG001|Overall Study|Death|4|||
143289522|NCT02289898|516609582|FG002|Overall Study|Death|3|||
143289523|NCT02289898|516609580|FG000|Overall Study|Physician Decision|2|||
143289524|NCT02289898|516609581|FG001|Overall Study|Physician Decision|5|||
143289525|NCT02289898|516609582|FG002|Overall Study|Physician Decision|2|||
143289526|NCT02289898|516609580|FG000|Overall Study|Withdrawal by Subject|0|||
143289527|NCT02289898|516609581|FG001|Overall Study|Withdrawal by Subject|4|||
143289528|NCT02289898|516609582|FG002|Overall Study|Withdrawal by Subject|1|||
143289529|NCT02289898|516609580|FG000|Overall Study|Adverse Event|3|||
143289530|NCT02289898|516609581|FG001|Overall Study|Adverse Event|5|||
143289531|NCT02289898|516609582|FG002|Overall Study|Adverse Event|5|||
143289532|NCT02289898|516609580|FG000|Overall Study|Disease progression|34|||
143289533|NCT02289898|516609581|FG001|Overall Study|Disease progression|28|||
143289534|NCT02289898|516609582|FG002|Overall Study|Disease progression|34|||
143289535|NCT02289898|516609580|FG000|Overall Study|Use of another anticancer therapy|0|||
143289536|NCT02289898|516609581|FG001|Overall Study|Use of another anticancer therapy|0|||
143289537|NCT02289898|516609582|FG002|Overall Study|Use of another anticancer therapy|1|||
143289538|NCT02289898|516609580|FG000|Overall Study|Other|8|||
143289539|NCT02289898|516609581|FG001|Overall Study|Other|7|||
143289540|NCT02289898|516609582|FG002|Overall Study|Other|10|||
143289541|NCT00885105|516609583|FG000|Overall Study|Withdrawal by Subject|0|||
143289542|NCT00885105|516609584|FG001|Overall Study|Withdrawal by Subject|8|||
143289543|NCT00885105|516609583|FG000|Overall Study|Adverse Event|1|||
143289544|NCT00885105|516609584|FG001|Overall Study|Adverse Event|0|||
143289545|NCT00885105|516609583|FG000|Overall Study|Protocol Violation|0|||
143373725|NCT00708032|516913551|FG000|Overall Study|Withdrawal by Subject|0|||
143373726|NCT00708032|516913552|FG001|Overall Study|Withdrawal by Subject|1|||
143373727|NCT00941655|516913561|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
143289546|NCT00885105|516609584|FG001|Overall Study|Protocol Violation|2|||
143289547|NCT03519932|516609585|FG000|First Intervention|Adverse Event|1|||
143289548|NCT03519932|516609586|FG001|First Intervention|Adverse Event|3|||
143289549|NCT00267046|516609587|FG000|Overall Study|Disease progression|4|||
143289550|NCT00267046|516609588|FG001|Overall Study|Disease progression|2|||
143289551|NCT00267046|516609587|FG000|Overall Study|Chemotoxicity|2|||
143289552|NCT00267046|516609588|FG001|Overall Study|Chemotoxicity|0|||
143289553|NCT00267046|516609587|FG000|Overall Study|Open-label palifermin|2|||
143289554|NCT00267046|516609588|FG001|Overall Study|Open-label palifermin|7|||
143289555|NCT00267046|516609587|FG000|Overall Study|Surgery|3|||
143289556|NCT00267046|516609588|FG001|Overall Study|Surgery|1|||
143289557|NCT00267046|516609587|FG000|Overall Study|Withdrawal by Subject|1|||
143289558|NCT00267046|516609588|FG001|Overall Study|Withdrawal by Subject|0|||
143289559|NCT00267046|516609587|FG000|Overall Study|Radiation|0|||
143289560|NCT00267046|516609588|FG001|Overall Study|Radiation|1|||
143289561|NCT00142584|516609589|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
143289562|NCT00142584|516609590|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
143289563|NCT00142584|516609589|FG000|Overall Study|Withdrawal by Subject|30|||
143289564|NCT00142584|516609590|FG001|Overall Study|Withdrawal by Subject|16|||
143289565|NCT00142584|516609589|FG000|Overall Study|Lost to Follow-up|22|||
143289566|NCT00142584|516609590|FG001|Overall Study|Lost to Follow-up|12|||
143289567|NCT00142584|516609589|FG000|Overall Study|Adverse Event|14|||
143289568|NCT00142584|516609590|FG001|Overall Study|Adverse Event|5|||
143289569|NCT00142584|516609589|FG000|Overall Study|Protocol Violation|4|||
143289570|NCT00142584|516609590|FG001|Overall Study|Protocol Violation|7|||
143289571|NCT00142584|516609589|FG000|Overall Study|Treatment Failure|2|||
143289572|NCT00142584|516609590|FG001|Overall Study|Treatment Failure|0|||
143289573|NCT01276353|516609599|FG000|Double-blind|Adverse Event|2|||
143289574|NCT01276353|516609600|FG001|Double-blind|Adverse Event|0|||
143289575|NCT01276353|516609599|FG000|Double-blind|Withdrawal by Subject|1|||
143289576|NCT01276353|516609600|FG001|Double-blind|Withdrawal by Subject|0|||
143289577|NCT01276353|516609599|FG000|Extension|Adverse Event|2|||
143289578|NCT01276353|516609600|FG001|Extension|Adverse Event|5|||
143289579|NCT01276353|516609599|FG000|Extension|Withdrawal by Subject|1|||
143289580|NCT01276353|516609600|FG001|Extension|Withdrawal by Subject|2|||
143289581|NCT01276353|516609599|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
143289582|NCT01276353|516609600|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
143289583|NCT01276353|516609599|FG000|Extension|Physician Decision|1|||
143289584|NCT01276353|516609600|FG001|Extension|Physician Decision|0|||
143289585|NCT01276353|516609599|FG000|Extension|Prohibited concomitant medications|0|||
143289586|NCT01276353|516609600|FG001|Extension|Prohibited concomitant medications|1|||
143289587|NCT00553514|516609601|FG000|Overall Study|Protocol deviation|0|||
143289588|NCT00553514|516609602|FG001|Overall Study|Protocol deviation|0|||
143289589|NCT00553514|516609603|FG002|Overall Study|Protocol deviation|0|||
143289590|NCT00553514|516609604|FG003|Overall Study|Protocol deviation|1|||
143289591|NCT00553514|516609605|FG004|Overall Study|Protocol deviation|0|||
143289592|NCT00553514|516609601|FG000|Overall Study|Lack of ovarian response|4|||
143289593|NCT00553514|516609602|FG001|Overall Study|Lack of ovarian response|5|||
143289594|NCT00553514|516609603|FG002|Overall Study|Lack of ovarian response|5|||
143289595|NCT00553514|516609604|FG003|Overall Study|Lack of ovarian response|5|||
143289596|NCT00553514|516609605|FG004|Overall Study|Lack of ovarian response|6|||
143289597|NCT00553514|516609601|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
143289598|NCT00553514|516609602|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
143289599|NCT00553514|516609603|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
143289600|NCT00553514|516609604|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
143289601|NCT00553514|516609605|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
143289602|NCT00553514|516609601|FG000|Overall Study|Risk of multiple pregnancy|0|||
143289603|NCT00553514|516609602|FG001|Overall Study|Risk of multiple pregnancy|2|||
143289604|NCT00553514|516609603|FG002|Overall Study|Risk of multiple pregnancy|0|||
143289605|NCT00553514|516609604|FG003|Overall Study|Risk of multiple pregnancy|1|||
143289606|NCT00553514|516609605|FG004|Overall Study|Risk of multiple pregnancy|0|||
143289607|NCT00553514|516609601|FG000|Overall Study|Other|1|||
143289608|NCT00553514|516609602|FG001|Overall Study|Other|1|||
143289609|NCT00553514|516609603|FG002|Overall Study|Other|0|||
143289610|NCT00553514|516609604|FG003|Overall Study|Other|0|||
143289611|NCT00553514|516609605|FG004|Overall Study|Other|1|||
143289612|NCT01285310|516609608|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
143289613|NCT01285310|516609609|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
143289614|NCT01285310|516609610|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
143289615|NCT01285310|516609611|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
143289616|NCT01285310|516609612|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
143289617|NCT01285310|516609608|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
143289618|NCT01285310|516609609|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
143289619|NCT01285310|516609610|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
143289620|NCT01285310|516609611|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
143289621|NCT01285310|516609612|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
143289622|NCT01285310|516609608|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
143289623|NCT01285310|516609609|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
143289624|NCT01285310|516609610|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
143289625|NCT01285310|516609611|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
143289626|NCT01285310|516609612|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
143289627|NCT01285310|516609608|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
143289628|NCT01285310|516609609|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
143289629|NCT01285310|516609610|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
143289630|NCT01285310|516609611|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
143289631|NCT01285310|516609612|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
143289632|NCT01285310|516609608|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
143289633|NCT01285310|516609609|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
143289634|NCT01285310|516609610|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
143289635|NCT01285310|516609611|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
143289636|NCT01285310|516609612|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
143289637|NCT01285310|516609608|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
143289638|NCT01285310|516609609|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
143289639|NCT01285310|516609610|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
143289640|NCT01285310|516609611|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
143289641|NCT01285310|516609612|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
143289642|NCT01285310|516609608|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
143289643|NCT01285310|516609609|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
143289644|NCT01285310|516609610|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
143289645|NCT01285310|516609611|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
143289646|NCT01285310|516609612|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
143289647|NCT01285310|516609608|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
143289648|NCT01285310|516609609|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
143289649|NCT01285310|516609610|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
143289650|NCT01285310|516609611|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
143289651|NCT01285310|516609612|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
143289652|NCT01285310|516609608|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
143289653|NCT01285310|516609609|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
143289654|NCT01285310|516609610|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
143289655|NCT01285310|516609611|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
143289656|NCT01285310|516609612|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
143289657|NCT01285310|516609608|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
143289658|NCT01285310|516609609|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
143289659|NCT01285310|516609610|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
143289660|NCT01285310|516609611|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
143289661|NCT01285310|516609612|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
143289662|NCT01285310|516609608|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
143289663|NCT01285310|516609609|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
143289664|NCT01285310|516609610|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
143289665|NCT01285310|516609611|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
143289666|NCT01285310|516609612|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
143289667|NCT01285310|516609608|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
143289668|NCT01285310|516609609|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
143289669|NCT01285310|516609610|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
143289670|NCT01285310|516609611|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
143289671|NCT01285310|516609612|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
143289672|NCT00587639|516609615|FG000|Overall Study|Withdrawal by Subject|1|||
143289673|NCT00533845|516609618|FG000|Overall Study|Physician Decision|1|||
143289674|NCT00533845|516609619|FG001|Overall Study|Physician Decision|0|||
143289675|NCT04997161|516609631|FG000|Overall Study|Study terminated by sponsor|3|||
143289676|NCT01442675|516609632|FG000|Overall Study|Protocol Violation|6|||
143289677|NCT01442675|516609632|FG000|Overall Study|Lost to Follow-up|2|||
143289678|NCT01442675|516609632|FG000|Overall Study|Withdrawal by Subject|4|||
143289679|NCT00752232|516609633|FG000|Overall Study|Protocol Violation|0|||
143289680|NCT00752232|516609634|FG001|Overall Study|Protocol Violation|0|||
143289681|NCT00752232|516609635|FG002|Overall Study|Protocol Violation|0|||
143289682|NCT00752232|516609636|FG003|Overall Study|Protocol Violation|0|||
143289683|NCT00752232|516609637|FG004|Overall Study|Protocol Violation|0|||
143289684|NCT00752232|516609638|FG005|Overall Study|Protocol Violation|1|||
143289685|NCT00752232|516609639|FG006|Overall Study|Protocol Violation|0|||
143289686|NCT00752232|516609633|FG000|Overall Study|Caregiver request|2|||
143289687|NCT00752232|516609634|FG001|Overall Study|Caregiver request|0|||
143289688|NCT00752232|516609635|FG002|Overall Study|Caregiver request|0|||
143289689|NCT00752232|516609636|FG003|Overall Study|Caregiver request|0|||
143289690|NCT00752232|516609637|FG004|Overall Study|Caregiver request|1|||
143289691|NCT00752232|516609638|FG005|Overall Study|Caregiver request|0|||
143373728|NCT00941655|516913562|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
143289692|NCT00752232|516609639|FG006|Overall Study|Caregiver request|0|||
143289693|NCT00752232|516609633|FG000|Overall Study|Investigator request|0|||
143289694|NCT00752232|516609634|FG001|Overall Study|Investigator request|0|||
143289695|NCT00752232|516609635|FG002|Overall Study|Investigator request|0|||
143289696|NCT00752232|516609636|FG003|Overall Study|Investigator request|0|||
143289697|NCT00752232|516609637|FG004|Overall Study|Investigator request|1|||
143289698|NCT00752232|516609638|FG005|Overall Study|Investigator request|0|||
143289699|NCT00752232|516609639|FG006|Overall Study|Investigator request|0|||
143289700|NCT00752232|516609633|FG000|Overall Study|Subject request|0|||
143289701|NCT00752232|516609634|FG001|Overall Study|Subject request|0|||
143289702|NCT00752232|516609635|FG002|Overall Study|Subject request|1|||
143289703|NCT00752232|516609636|FG003|Overall Study|Subject request|0|||
143289704|NCT00752232|516609637|FG004|Overall Study|Subject request|0|||
143289705|NCT00752232|516609638|FG005|Overall Study|Subject request|0|||
143289706|NCT00752232|516609639|FG006|Overall Study|Subject request|0|||
143289707|NCT00752232|516609633|FG000|Overall Study|Group home admission|0|||
143289708|NCT00752232|516609634|FG001|Overall Study|Group home admission|0|||
143289709|NCT00752232|516609635|FG002|Overall Study|Group home admission|0|||
143289710|NCT00752232|516609636|FG003|Overall Study|Group home admission|1|||
143289711|NCT00752232|516609637|FG004|Overall Study|Group home admission|0|||
143289712|NCT00752232|516609638|FG005|Overall Study|Group home admission|0|||
143289713|NCT00752232|516609639|FG006|Overall Study|Group home admission|0|||
143289714|NCT00752232|516609633|FG000|Overall Study|Caregiver could not attend the subject|0|||
143289715|NCT00752232|516609634|FG001|Overall Study|Caregiver could not attend the subject|0|||
143289716|NCT00752232|516609635|FG002|Overall Study|Caregiver could not attend the subject|0|||
143289717|NCT00752232|516609636|FG003|Overall Study|Caregiver could not attend the subject|0|||
143289718|NCT00752232|516609637|FG004|Overall Study|Caregiver could not attend the subject|1|||
143289719|NCT00752232|516609638|FG005|Overall Study|Caregiver could not attend the subject|0|||
143289720|NCT00752232|516609639|FG006|Overall Study|Caregiver could not attend the subject|0|||
143289721|NCT00555321|516609642|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
143289722|NCT00555321|516609643|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
143289723|NCT00555321|516609644|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
143289724|NCT00555321|516609645|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
143289725|NCT00555321|516609646|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
143289726|NCT00555321|516609642|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
143289727|NCT00555321|516609643|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
143289728|NCT00555321|516609644|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
143289729|NCT00555321|516609645|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
143289730|NCT00555321|516609646|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
143289731|NCT00555321|516609642|FG000|Treatment Phase up to 12-months|Death|2|||
143289732|NCT00555321|516609643|FG001|Treatment Phase up to 12-months|Death|1|||
143289733|NCT00555321|516609644|FG002|Treatment Phase up to 12-months|Death|4|||
143289734|NCT00555321|516609645|FG003|Treatment Phase up to 12-months|Death|0|||
143289735|NCT00555321|516609646|FG004|Treatment Phase up to 12-months|Death|0|||
143289736|NCT00555321|516609642|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
143289737|NCT00555321|516609643|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
143289738|NCT00555321|516609644|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
143289739|NCT00555321|516609645|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
143289740|NCT00555321|516609646|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
143289741|NCT00555321|516609642|FG000|Treatment Phase up to 12-months|Other Reason|1|||
143289742|NCT00555321|516609643|FG001|Treatment Phase up to 12-months|Other Reason|3|||
143289743|NCT00555321|516609644|FG002|Treatment Phase up to 12-months|Other Reason|2|||
143289744|NCT00555321|516609645|FG003|Treatment Phase up to 12-months|Other Reason|0|||
143289745|NCT00555321|516609646|FG004|Treatment Phase up to 12-months|Other Reason|0|||
143289746|NCT00555321|516609642|FG000|Treatment Phase up to 12-months|Never treated|2|||
143289747|NCT00555321|516609643|FG001|Treatment Phase up to 12-months|Never treated|3|||
143289748|NCT00555321|516609644|FG002|Treatment Phase up to 12-months|Never treated|1|||
143289749|NCT00555321|516609645|FG003|Treatment Phase up to 12-months|Never treated|0|||
143289750|NCT00555321|516609646|FG004|Treatment Phase up to 12-months|Never treated|4|||
143289751|NCT00555321|516609642|FG000|Long-term Extension Phase|Adverse Event|2|||
143289752|NCT00555321|516609643|FG001|Long-term Extension Phase|Adverse Event|5|||
143289753|NCT00555321|516609644|FG002|Long-term Extension Phase|Adverse Event|2|||
143289754|NCT00555321|516609645|FG003|Long-term Extension Phase|Adverse Event|1|||
143289755|NCT00555321|516609646|FG004|Long-term Extension Phase|Adverse Event|0|||
143289756|NCT00555321|516609642|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
143289757|NCT00555321|516609643|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
143289758|NCT00555321|516609644|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
143289759|NCT00555321|516609645|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
143289760|NCT00555321|516609646|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
143289761|NCT00555321|516609642|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
143289762|NCT00555321|516609643|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
143289763|NCT00555321|516609644|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
143289764|NCT00555321|516609645|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
143289765|NCT00555321|516609646|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
143289766|NCT00555321|516609642|FG000|Long-term Extension Phase|Death|2|||
143289767|NCT00555321|516609643|FG001|Long-term Extension Phase|Death|0|||
143289768|NCT00555321|516609644|FG002|Long-term Extension Phase|Death|0|||
143289769|NCT00555321|516609645|FG003|Long-term Extension Phase|Death|3|||
143289770|NCT00555321|516609646|FG004|Long-term Extension Phase|Death|0|||
143289771|NCT00555321|516609642|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
143289772|NCT00555321|516609643|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
143289773|NCT00555321|516609644|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
143289774|NCT00555321|516609645|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
143289775|NCT00555321|516609646|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
143289776|NCT00555321|516609642|FG000|Long-term Extension Phase|Other Reason|1|||
143289777|NCT00555321|516609643|FG001|Long-term Extension Phase|Other Reason|0|||
143289778|NCT00555321|516609644|FG002|Long-term Extension Phase|Other Reason|2|||
143289779|NCT00555321|516609645|FG003|Long-term Extension Phase|Other Reason|0|||
143289780|NCT00555321|516609646|FG004|Long-term Extension Phase|Other Reason|0|||
143289781|NCT00005937|516609647|FG000|Overall Study|Lack of Efficacy|5|||
143289782|NCT01288469|516609648|FG000|Overall Study|Adverse Event|4|||
143289783|NCT01288469|516609649|FG001|Overall Study|Adverse Event|1|||
143289784|NCT01288469|516609650|FG002|Overall Study|Adverse Event|1|||
143289785|NCT01288469|516609648|FG000|Overall Study|Poor compliance to protocol|0|||
143289786|NCT01288469|516609649|FG001|Overall Study|Poor compliance to protocol|1|||
143289787|NCT01288469|516609650|FG002|Overall Study|Poor compliance to protocol|0|||
143289788|NCT01288469|516609648|FG000|Overall Study|Participant Moved|1|||
143289789|NCT01288469|516609649|FG001|Overall Study|Participant Moved|0|||
143289790|NCT01288469|516609650|FG002|Overall Study|Participant Moved|0|||
143289791|NCT01288469|516609648|FG000|Overall Study|Consent withdrawn by subject|1|||
143289792|NCT01288469|516609649|FG001|Overall Study|Consent withdrawn by subject|1|||
143289793|NCT01288469|516609650|FG002|Overall Study|Consent withdrawn by subject|1|||
143289794|NCT01288469|516609648|FG000|Overall Study|Exclusion criteria finally met|1|||
143289795|NCT01288469|516609649|FG001|Overall Study|Exclusion criteria finally met|0|||
143289796|NCT01288469|516609650|FG002|Overall Study|Exclusion criteria finally met|0|||
143289797|NCT00563381|516609652|FG000|Overall Study|Adverse Event|264|||
143289798|NCT00563381|516609653|FG001|Overall Study|Adverse Event|292|||
143289799|NCT00563381|516609652|FG000|Overall Study|Protocol Violation|66|||
143289800|NCT00563381|516609653|FG001|Overall Study|Protocol Violation|74|||
143289801|NCT00563381|516609652|FG000|Overall Study|Lost to Follow-up|7|||
143289802|NCT00563381|516609653|FG001|Overall Study|Lost to Follow-up|15|||
143289803|NCT00563381|516609652|FG000|Overall Study|Withdrawal by Subject|192|||
143289804|NCT00563381|516609653|FG001|Overall Study|Withdrawal by Subject|209|||
143289805|NCT00563381|516609652|FG000|Overall Study|Lack of Efficacy|32|||
143289806|NCT00563381|516609653|FG001|Overall Study|Lack of Efficacy|24|||
143289807|NCT00563381|516609652|FG000|Overall Study|Individual different reasons|24|||
143289808|NCT00563381|516609653|FG001|Overall Study|Individual different reasons|34|||
143289809|NCT02452398|516609658|FG000|Overall Study|Adverse Event|1|||
143289810|NCT02452398|516609658|FG000|Overall Study|Lost to Follow-up|28|||
143289811|NCT02452398|516609658|FG000|Overall Study|Physician Decision|2|||
143289812|NCT02452398|516609658|FG000|Overall Study|Withdrawal by Subject|6|||
143289813|NCT02452398|516609658|FG000|Overall Study|Moved away|4|||
143289814|NCT02407704|516609659|FG000|Overall Study|Lost to Follow-up|0|||
143289815|NCT02407704|516609660|FG001|Overall Study|Lost to Follow-up|0|||
143289816|NCT02407704|516609661|FG002|Overall Study|Lost to Follow-up|0|||
143289817|NCT02407704|516609662|FG003|Overall Study|Lost to Follow-up|2|||
143289818|NCT02407704|516609659|FG000|Overall Study|Protocol Violation|0|||
143289819|NCT02407704|516609660|FG001|Overall Study|Protocol Violation|0|||
143289820|NCT02407704|516609661|FG002|Overall Study|Protocol Violation|0|||
143289821|NCT02407704|516609662|FG003|Overall Study|Protocol Violation|1|||
143289822|NCT02407704|516609659|FG000|Overall Study|Withdrawal by Subject|0|||
143289823|NCT02407704|516609660|FG001|Overall Study|Withdrawal by Subject|0|||
143289824|NCT02407704|516609661|FG002|Overall Study|Withdrawal by Subject|1|||
143289825|NCT02407704|516609662|FG003|Overall Study|Withdrawal by Subject|0|||
143289826|NCT01957644|516609663|FG000|Overall Study|Adverse Event|4|||
143289827|NCT01957644|516609664|FG001|Overall Study|Adverse Event|2|||
143289828|NCT01957644|516609665|FG002|Overall Study|Adverse Event|0|||
143289829|NCT01957644|516609666|FG003|Overall Study|Adverse Event|0|||
143289830|NCT01957644|516609667|FG004|Overall Study|Adverse Event|1|||
143289831|NCT01957644|516609663|FG000|Overall Study|Progressive disease / relapse|0|||
143289832|NCT01957644|516609664|FG001|Overall Study|Progressive disease / relapse|1|||
143289833|NCT01957644|516609665|FG002|Overall Study|Progressive disease / relapse|0|||
143289834|NCT01957644|516609666|FG003|Overall Study|Progressive disease / relapse|1|||
143289835|NCT01957644|516609667|FG004|Overall Study|Progressive disease / relapse|0|||
143289836|NCT01957644|516609663|FG000|Overall Study|Other reason|1|||
143289837|NCT01957644|516609664|FG001|Overall Study|Other reason|2|||
143289838|NCT01957644|516609665|FG002|Overall Study|Other reason|1|||
143289839|NCT01957644|516609666|FG003|Overall Study|Other reason|1|||
143289840|NCT01957644|516609667|FG004|Overall Study|Other reason|0|||
143289841|NCT01957644|516609663|FG000|Overall Study|Withdrawal by Subject|1|||
143289842|NCT01957644|516609664|FG001|Overall Study|Withdrawal by Subject|0|||
143289843|NCT01957644|516609665|FG002|Overall Study|Withdrawal by Subject|0|||
143289844|NCT01957644|516609666|FG003|Overall Study|Withdrawal by Subject|0|||
143289845|NCT01957644|516609667|FG004|Overall Study|Withdrawal by Subject|0|||
143289846|NCT01957644|516609663|FG000|Overall Study|Protocol Violation|0|||
143289847|NCT01957644|516609664|FG001|Overall Study|Protocol Violation|1|||
143289848|NCT01957644|516609665|FG002|Overall Study|Protocol Violation|0|||
143289849|NCT01957644|516609666|FG003|Overall Study|Protocol Violation|0|||
143289850|NCT01957644|516609667|FG004|Overall Study|Protocol Violation|0|||
143289851|NCT02730455|516609668|FG000|Overall Study|Death|5|||
143289852|NCT02730455|516609669|FG001|Overall Study|Death|6|||
143289853|NCT02730455|516609670|FG002|Overall Study|Death|4|||
143289854|NCT02730455|516609668|FG000|Overall Study|Consent withdrawn|2|||
143289855|NCT02730455|516609669|FG001|Overall Study|Consent withdrawn|4|||
143289856|NCT02730455|516609670|FG002|Overall Study|Consent withdrawn|1|||
143289857|NCT02730455|516609668|FG000|Overall Study|Lost to Follow-up|3|||
143289858|NCT02730455|516609669|FG001|Overall Study|Lost to Follow-up|1|||
143289859|NCT02730455|516609670|FG002|Overall Study|Lost to Follow-up|4|||
143289860|NCT02730455|516609668|FG000|Overall Study|Other|1|||
143289861|NCT02730455|516609669|FG001|Overall Study|Other|1|||
143289862|NCT02730455|516609670|FG002|Overall Study|Other|2|||
143289863|NCT02730455|516609668|FG000|Overall Study|Other|2|||
143289864|NCT02730455|516609669|FG001|Overall Study|Other|2|||
143289865|NCT02730455|516609670|FG002|Overall Study|Other|0|||
143289866|NCT00748033|516609677|FG000|Overall Study|Adverse Event|0|||
143289867|NCT00748033|516609678|FG001|Overall Study|Adverse Event|1|||
143289868|NCT01018186|516609679|FG000|2-week Run-in Period|Protocol Violation|1|||
143289869|NCT01018186|516609680|FG001|2-week Run-in Period|Protocol Violation|0|||
143289870|NCT01018186|516609681|FG002|2-week Run-in Period|Protocol Violation|0|||
143289871|NCT01018186|516609682|FG003|2-week Run-in Period|Protocol Violation|0|||
143289872|NCT01018186|516609679|FG000|2-week Run-in Period|Lost to Follow-up|2|||
143289873|NCT01018186|516609680|FG001|2-week Run-in Period|Lost to Follow-up|0|||
143289874|NCT01018186|516609681|FG002|2-week Run-in Period|Lost to Follow-up|0|||
143289875|NCT01018186|516609682|FG003|2-week Run-in Period|Lost to Follow-up|0|||
143289876|NCT01018186|516609679|FG000|2-week Run-in Period|Physician Decision|3|||
143289877|NCT01018186|516609680|FG001|2-week Run-in Period|Physician Decision|0|||
143289878|NCT01018186|516609681|FG002|2-week Run-in Period|Physician Decision|0|||
143289879|NCT01018186|516609682|FG003|2-week Run-in Period|Physician Decision|0|||
143289880|NCT01018186|516609679|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
143289881|NCT01018186|516609680|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
143289882|NCT01018186|516609681|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
143289883|NCT01018186|516609682|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
143289884|NCT01018186|516609679|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
143289885|NCT01018186|516609680|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
143289886|NCT01018186|516609681|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
143289887|NCT01018186|516609682|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
143289888|NCT01018186|516609679|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
143289889|NCT01018186|516609680|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
143289890|NCT01018186|516609681|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
143289891|NCT01018186|516609682|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
143289892|NCT01018186|516609679|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
143289893|NCT01018186|516609680|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
143289894|NCT01018186|516609681|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
143289895|NCT01018186|516609682|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
143289896|NCT01018186|516609679|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
143289897|NCT01018186|516609680|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
143289898|NCT01018186|516609681|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
143289899|NCT01018186|516609682|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
143289900|NCT01018186|516609679|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
143289901|NCT01018186|516609680|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
143289902|NCT01018186|516609681|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
143289903|NCT01018186|516609682|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
143289904|NCT01018186|516609679|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
143289905|NCT01018186|516609680|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
143289906|NCT01018186|516609681|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
143289907|NCT01018186|516609682|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
143289908|NCT01018186|516609679|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
143289909|NCT01018186|516609680|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
143289910|NCT01018186|516609681|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
143289911|NCT01018186|516609682|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
143289912|NCT01018186|516609679|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
143289913|NCT01018186|516609680|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
143289914|NCT01018186|516609681|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
143289915|NCT01018186|516609682|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
143289916|NCT03049280|516609683|FG000|Overall Study|Physician Decision|1|||
143289917|NCT00001723|516609686|FG000|Overall Study|Lack of Efficacy|6|||
143289918|NCT00001723|516609687|FG001|Overall Study|Lack of Efficacy|7|||
143289919|NCT00001723|516609686|FG000|Overall Study|Lack of family interest|4|||
143289920|NCT00001723|516609687|FG001|Overall Study|Lack of family interest|5|||
143289921|NCT00001723|516609686|FG000|Overall Study|Lost to Follow-up|2|||
143289922|NCT00001723|516609687|FG001|Overall Study|Lost to Follow-up|2|||
143289923|NCT00001723|516609686|FG000|Overall Study|medication intolerance|1|||
143289924|NCT00001723|516609687|FG001|Overall Study|medication intolerance|2|||
143289925|NCT00536198|516609688|FG000|Overall Study|Lost to Follow-up|15|||
143289926|NCT00536198|516609689|FG001|Overall Study|Lost to Follow-up|14|||
143289927|NCT00536198|516609688|FG000|Overall Study|Withdrawal by Subject|16|||
143289928|NCT00536198|516609689|FG001|Overall Study|Withdrawal by Subject|12|||
143289929|NCT00536198|516609688|FG000|Overall Study|Adverse Event|2|||
143289930|NCT00536198|516609689|FG001|Overall Study|Adverse Event|2|||
143289931|NCT00536198|516609688|FG000|Overall Study|Rescue|3|||
143289932|NCT00536198|516609689|FG001|Overall Study|Rescue|9|||
143289933|NCT00536198|516609688|FG000|Overall Study|Pregnancy|1|||
143289934|NCT00536198|516609689|FG001|Overall Study|Pregnancy|1|||
143289935|NCT00536198|516609688|FG000|Overall Study|Protocol Violation|0|||
143289936|NCT00536198|516609689|FG001|Overall Study|Protocol Violation|1|||
143289937|NCT02643082|516609690|FG000|Period 1|Adverse Event|1|||
143289938|NCT02643082|516609691|FG001|Period 1|Adverse Event|0|||
143289939|NCT01867021|516609692|FG000|Overall Study|Adverse Event|0|||
143289940|NCT01867021|516609693|FG001|Overall Study|Adverse Event|1|||
143289941|NCT01867021|516609692|FG000|Overall Study|Not Eligible|0|||
143289942|NCT01867021|516609693|FG001|Overall Study|Not Eligible|1|||
143289943|NCT01867021|516609692|FG000|Overall Study|Death|1|||
143289944|NCT01867021|516609693|FG001|Overall Study|Death|0|||
143289945|NCT01867021|516609692|FG000|Overall Study|Lost to Follow-up|0|||
143289946|NCT01867021|516609693|FG001|Overall Study|Lost to Follow-up|2|||
143289947|NCT01867021|516609692|FG000|Overall Study|Withdrawal by Subject|1|||
143289948|NCT01867021|516609693|FG001|Overall Study|Withdrawal by Subject|6|||
143289949|NCT00881712|516609694|FG000|Overall Study|Death|1|||
143289950|NCT00881712|516609695|FG001|Overall Study|Death|0|||
143289951|NCT00881712|516609696|FG002|Overall Study|Death|0|||
143289952|NCT00881712|516609694|FG000|Overall Study|Withdrawal by Subject|1|||
143289953|NCT00881712|516609695|FG001|Overall Study|Withdrawal by Subject|0|||
143289954|NCT00881712|516609696|FG002|Overall Study|Withdrawal by Subject|0|||
143289955|NCT01324999|516609697|FG000|Overall Study|Adverse Event|3|||
143289956|NCT01324999|516609697|FG000|Overall Study|Withdrawal by Subject|2|||
143289957|NCT02505867|516609699|FG000|Overall Study|Lack of Efficacy|6|||
143289958|NCT02505867|516609700|FG001|Overall Study|Lack of Efficacy|6|||
143289959|NCT03681405|516609701|FG000|Overall Study|Found to be ineligible after randomized|1|||
143289960|NCT03681405|516609702|FG001|Overall Study|Found to be ineligible after randomized|0|||
143289961|NCT02860169|516609708|FG000|Part A|Withdrawal by Subject|1|||
143289962|NCT02860169|516609708|FG000|Part A|Other (Screening failure)|6|||
143289963|NCT02860169|516609708|FG000|Part A|Other (Survey not completed)|3|||
143289964|NCT02860169|516609708|FG000|Part A|Other (did not completed consent)|1|||
143289965|NCT02860169|516609708|FG000|Part B|Other (Screening failure)|10|||
143289966|NCT02860169|516609708|FG000|Part B|Withdrawal by Subject|1|||
143289967|NCT02860169|516609708|FG000|Part C|Other (Screening failure)|1|||
143289968|NCT00165776|516609709|FG000|Overall Study|Lack of Efficacy|0|||
143289969|NCT00165776|516609710|FG001|Overall Study|Lack of Efficacy|0|||
143289970|NCT00165776|516609711|FG002|Overall Study|Lack of Efficacy|0|||
143289971|NCT00165776|516609712|FG003|Overall Study|Lack of Efficacy|1|||
143289972|NCT00165776|516609709|FG000|Overall Study|Withdrawal by Subject|4|||
143289973|NCT00165776|516609710|FG001|Overall Study|Withdrawal by Subject|1|||
143289974|NCT00165776|516609711|FG002|Overall Study|Withdrawal by Subject|2|||
143289975|NCT00165776|516609712|FG003|Overall Study|Withdrawal by Subject|0|||
143289976|NCT00165776|516609709|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
143289977|NCT00165776|516609710|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
143289978|NCT00165776|516609711|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
143289979|NCT00165776|516609712|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
143289980|NCT01648205|516609720|FG000|Placebo|Pregnancy|1|||
143289981|NCT01648205|516609720|FG000|Placebo|Withdrawal by Subject|1|||
143289982|NCT01648205|516609720|FG000|Placebo|Protocol Violation|2|||
143289983|NCT01648205|516609720|FG000|Ranolazine|Death|1|||
143289984|NCT01648205|516609720|FG000|Ranolazine|Withdrawal by Subject|1|||
143289985|NCT01648205|516609720|FG000|Ranolazine|Protocol Violation|3|||
143289986|NCT01428453|516609721|FG000|Overall Study|Adverse Event|2|||
143289987|NCT01428453|516609722|FG001|Overall Study|Adverse Event|7|||
143289988|NCT01428453|516609721|FG000|Overall Study|Protocol Violation|1|||
143289989|NCT01428453|516609722|FG001|Overall Study|Protocol Violation|0|||
143289990|NCT01428453|516609721|FG000|Overall Study|Lost to Follow-up|0|||
143289991|NCT01428453|516609722|FG001|Overall Study|Lost to Follow-up|1|||
143289992|NCT01428453|516609721|FG000|Overall Study|Withdrawal by Subject|3|||
143289993|NCT01428453|516609722|FG001|Overall Study|Withdrawal by Subject|1|||
143289994|NCT01996709|516609723|FG000|Overall Study|Withdrawal by Subject|1|||
143289995|NCT01996709|516609724|FG001|Overall Study|Withdrawal by Subject|0|||
143289996|NCT01996709|516609723|FG000|Overall Study|Lost to Follow-up|3|||
143289997|NCT01996709|516609724|FG001|Overall Study|Lost to Follow-up|0|||
143289998|NCT01996709|516609723|FG000|Overall Study|Subject Non-Compliant|1|||
143289999|NCT01996709|516609724|FG001|Overall Study|Subject Non-Compliant|0|||
143290000|NCT01996709|516609723|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
143290001|NCT01996709|516609724|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
143290002|NCT03789318|516609727|FG000|Overall Study|Adverse Event|0|||
143290003|NCT03789318|516609728|FG001|Overall Study|Adverse Event|0|||
143290004|NCT03789318|516609729|FG002|Overall Study|Adverse Event|1|||
143290005|NCT03789318|516609730|FG003|Overall Study|Adverse Event|1|||
143290006|NCT03789318|516609731|FG004|Overall Study|Adverse Event|0|||
143290007|NCT03789318|516609727|FG000|Overall Study|Lost to Follow-up|0|||
143290008|NCT03789318|516609728|FG001|Overall Study|Lost to Follow-up|0|||
143290009|NCT03789318|516609729|FG002|Overall Study|Lost to Follow-up|1|||
143290010|NCT03789318|516609730|FG003|Overall Study|Lost to Follow-up|0|||
143290011|NCT03789318|516609731|FG004|Overall Study|Lost to Follow-up|0|||
143290012|NCT03789318|516609727|FG000|Overall Study|Withdrawal by Subject|0|||
143290013|NCT03789318|516609728|FG001|Overall Study|Withdrawal by Subject|0|||
143290014|NCT03789318|516609729|FG002|Overall Study|Withdrawal by Subject|1|||
143290015|NCT03789318|516609730|FG003|Overall Study|Withdrawal by Subject|0|||
143290016|NCT03789318|516609731|FG004|Overall Study|Withdrawal by Subject|0|||
143290017|NCT00850564|516609732|FG000|Overall Study|Withdrawal by Subject|2|||
143290018|NCT00733408|516611798|FG000|Overall Study|Adverse Event|4|||
143290019|NCT00531232|516611799|FG000|Overall Study|Investigator decision|0|||
143290020|NCT00531232|516611800|FG001|Overall Study|Investigator decision|0|||
143290021|NCT00531232|516611801|FG002|Overall Study|Investigator decision|4|||
143290022|NCT00531232|516611799|FG000|Overall Study|Participants refused further treatment|0|||
143290023|NCT00531232|516611800|FG001|Overall Study|Participants refused further treatment|1|||
143290024|NCT00531232|516611801|FG002|Overall Study|Participants refused further treatment|2|||
143290025|NCT00531232|516611799|FG000|Overall Study|Adverse events (AEs)|1|||
143290026|NCT00531232|516611800|FG001|Overall Study|Adverse events (AEs)|2|||
143290027|NCT00531232|516611801|FG002|Overall Study|Adverse events (AEs)|2|||
143290028|NCT00531232|516611799|FG000|Overall Study|Treatment failure|1|||
143290029|NCT00531232|516611800|FG001|Overall Study|Treatment failure|3|||
143290030|NCT00531232|516611801|FG002|Overall Study|Treatment failure|7|||
143290031|NCT00531232|516611799|FG000|Overall Study|Disease recurrence|0|||
143290032|NCT00531232|516611800|FG001|Overall Study|Disease recurrence|0|||
143290033|NCT00531232|516611801|FG002|Overall Study|Disease recurrence|1|||
143290034|NCT00531232|516611799|FG000|Overall Study|Deceased|2|||
143290035|NCT00531232|516611800|FG001|Overall Study|Deceased|2|||
143290036|NCT00531232|516611801|FG002|Overall Study|Deceased|2|||
143290037|NCT00531232|516611799|FG000|Overall Study|Withdrawal by Subject|0|||
143290038|NCT00531232|516611800|FG001|Overall Study|Withdrawal by Subject|1|||
143290039|NCT00531232|516611801|FG002|Overall Study|Withdrawal by Subject|2|||
143290040|NCT00531232|516611799|FG000|Overall Study|Other|0|||
143290041|NCT00531232|516611800|FG001|Overall Study|Other|0|||
143290042|NCT00531232|516611801|FG002|Overall Study|Other|5|||
143290043|NCT01438424|516611802|FG000|Overall Study|Continuing treatment|29|||
143290044|NCT01438424|516611802|FG000|Overall Study|Minimal virologic response|95|||
143290045|NCT01438424|516611802|FG000|Overall Study|Not identified|55|||
143290046|NCT01438424|516611802|FG000|Overall Study|Withdrawal by Subject|104|||
143290047|NCT01438424|516611802|FG000|Overall Study|Progression of chronic hepatitis B|22|||
143290048|NCT01438424|516611802|FG000|Overall Study|Death|22|||
143290049|NCT01438424|516611802|FG000|Overall Study|Adverse Event|17|||
143290050|NCT01438424|516611802|FG000|Overall Study|Lost to Follow-up|17|||
143290051|NCT01438424|516611802|FG000|Overall Study|Abnormal laboratory test result|14|||
143290052|NCT01438424|516611802|FG000|Overall Study|Need for drug prohibited by protocol|14|||
143290053|NCT01438424|516611802|FG000|Overall Study|Pregnancy|7|||
143290054|NCT01438424|516611802|FG000|Overall Study|No longer met inclusion criteria|1|||
143290055|NCT01438424|516611802|FG000|Overall Study|Participant noncompliance|20|||
143290056|NCT04232124|516611803|FG000|Overall Study|Lost to Follow-up|3|||
143290057|NCT02329730|516611809|FG000|Overall Study|Protocol Violation|0|||
143290058|NCT02329730|516611810|FG001|Overall Study|Protocol Violation|0|||
143290059|NCT02329730|516611811|FG002|Overall Study|Protocol Violation|0|||
143290060|NCT02329730|516611812|FG003|Overall Study|Protocol Violation|0|||
143290061|NCT02329730|516611813|FG004|Overall Study|Protocol Violation|2|||
143290062|NCT02329730|516611814|FG005|Overall Study|Protocol Violation|2|||
143290063|NCT02329730|516611815|FG006|Overall Study|Protocol Violation|0|||
143290064|NCT02329730|516611816|FG007|Overall Study|Protocol Violation|0|||
143290065|NCT02329730|516611817|FG008|Overall Study|Protocol Violation|0|||
143290066|NCT02329730|516611818|FG009|Overall Study|Protocol Violation|0|||
143290067|NCT02329730|516611819|FG010|Overall Study|Protocol Violation|0|||
143290068|NCT02329730|516611820|FG011|Overall Study|Protocol Violation|0|||
143290069|NCT02329730|516611809|FG000|Overall Study|Withdrawal by Subject|0|||
143290070|NCT02329730|516611810|FG001|Overall Study|Withdrawal by Subject|0|||
143290071|NCT02329730|516611811|FG002|Overall Study|Withdrawal by Subject|0|||
143290072|NCT02329730|516611812|FG003|Overall Study|Withdrawal by Subject|0|||
143290073|NCT02329730|516611813|FG004|Overall Study|Withdrawal by Subject|1|||
143290074|NCT02329730|516611814|FG005|Overall Study|Withdrawal by Subject|0|||
143290075|NCT02329730|516611815|FG006|Overall Study|Withdrawal by Subject|1|||
143290076|NCT02329730|516611816|FG007|Overall Study|Withdrawal by Subject|1|||
143290077|NCT02329730|516611817|FG008|Overall Study|Withdrawal by Subject|1|||
143290078|NCT02329730|516611818|FG009|Overall Study|Withdrawal by Subject|1|||
143290079|NCT02329730|516611819|FG010|Overall Study|Withdrawal by Subject|0|||
143290080|NCT02329730|516611820|FG011|Overall Study|Withdrawal by Subject|0|||
143290081|NCT02345850|516611823|FG000|Overall Study|Not transplanted|10|||
143290082|NCT02345850|516611824|FG001|Overall Study|Not transplanted|5|||
143290083|NCT02345850|516611825|FG002|Overall Study|Not transplanted|4|||
143290084|NCT02345850|516611823|FG000|Overall Study|Lost to Follow-up|2|||
143290085|NCT02345850|516611824|FG001|Overall Study|Lost to Follow-up|3|||
143290086|NCT02345850|516611825|FG002|Overall Study|Lost to Follow-up|2|||
143290087|NCT02345850|516611823|FG000|Overall Study|Withdrawal by Subject|1|||
143290088|NCT02345850|516611824|FG001|Overall Study|Withdrawal by Subject|0|||
143290089|NCT02345850|516611825|FG002|Overall Study|Withdrawal by Subject|0|||
143290090|NCT02392247|516611826|FG000|Overall Study|Withdrawal by Subject|1|||
143290091|NCT02392247|516611826|FG000|Overall Study|Surgery cancelled; no data|1|||
143290092|NCT01991067|516611828|FG000|Overall Study|Lost to Follow-up|6|||
143290093|NCT01991067|516611829|FG001|Overall Study|Lost to Follow-up|5|||
143290094|NCT02068443|516611832|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
143290095|NCT02068443|516611833|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
143290096|NCT02068443|516611834|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
143290097|NCT02068443|516611832|FG000|Overall Study|Voluntary Withdrawal|4|||
143290098|NCT02068443|516611833|FG001|Overall Study|Voluntary Withdrawal|0|||
143290099|NCT02068443|516611834|FG002|Overall Study|Voluntary Withdrawal|1|||
143290100|NCT02068443|516611832|FG000|Overall Study|Lack of Efficacy|2|||
143290101|NCT02068443|516611833|FG001|Overall Study|Lack of Efficacy|1|||
143290102|NCT02068443|516611834|FG002|Overall Study|Lack of Efficacy|0|||
143290103|NCT02068443|516611832|FG000|Overall Study|Other Reason Not Specified|1|||
143290104|NCT02068443|516611833|FG001|Overall Study|Other Reason Not Specified|0|||
143290105|NCT02068443|516611834|FG002|Overall Study|Other Reason Not Specified|0|||
143290106|NCT00664742|516611835|FG000|Overall Study|Withdrawn due to adverse events|3|||
143290107|NCT00664742|516611835|FG000|Overall Study|Withdrawal by Subject|31|||
143290108|NCT00664742|516611835|FG000|Overall Study|Lost to Follow-up|92|||
143290109|NCT04317066|516611836|FG000|Overall Study|Sponsor decision|5|||
143290110|NCT04317066|516611836|FG000|Overall Study|Death|2|||
143290111|NCT02014597|516611839|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
143290112|NCT02014597|516611840|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
143290113|NCT02825992|516611841|FG000|Overall Study|Withdrawal by Subject|4|||
143290114|NCT02825992|516611841|FG000|Overall Study|Lost to Follow-up|2|||
143290115|NCT02825992|516611841|FG000|Overall Study|Procedure terminated|2|||
143290116|NCT02279173|516611843|FG000|Overall Study|Protocol-specified Criteria|67|||
143290117|NCT02279173|516611843|FG000|Overall Study|Withdrawal by Subject|20|||
143290118|NCT02279173|516611843|FG000|Overall Study|Decision by Sponsor|4|||
143290119|NCT02279173|516611843|FG000|Overall Study|Lost to Follow-up|3|||
143290120|NCT01164956|516611844|FG000|Overall Study|Side Effects|1|||
143290121|NCT01164956|516611845|FG001|Overall Study|Side Effects|0|||
143290122|NCT01164956|516611846|FG002|Overall Study|Side Effects|1|||
143290123|NCT00931762|516611847|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
143290124|NCT00931762|516611847|FG000|Overall Study|Administrative Problems|5|||
143290125|NCT00931762|516611847|FG000|Overall Study|Death|1|||
143290126|NCT00931762|516611847|FG000|Overall Study|Disease Progression|3|||
143290127|NCT00931762|516611847|FG000|Overall Study|Adverse Event (s)|11|||
143290128|NCT00931762|516611847|FG000|Overall Study|Subject withdrew consent|13|||
143290129|NCT01320085|516611848|FG000|Overall Study|Disease Progression|26|||
143290130|NCT01320085|516611849|FG001|Overall Study|Disease Progression|93|||
143290131|NCT01320085|516611850|FG002|Overall Study|Disease Progression|17|||
143290132|NCT01320085|516611848|FG000|Overall Study|Adverse Event|12|||
143290133|NCT01320085|516611849|FG001|Overall Study|Adverse Event|20|||
143290134|NCT01320085|516611850|FG002|Overall Study|Adverse Event|5|||
143290135|NCT01320085|516611848|FG000|Overall Study|Withdrawal by Subject|2|||
143290136|NCT01320085|516611849|FG001|Overall Study|Withdrawal by Subject|4|||
143290137|NCT01320085|516611850|FG002|Overall Study|Withdrawal by Subject|1|||
143290138|NCT01320085|516611848|FG000|Overall Study|Protocol Deviation|1|||
143290139|NCT01320085|516611849|FG001|Overall Study|Protocol Deviation|0|||
143290140|NCT01320085|516611850|FG002|Overall Study|Protocol Deviation|1|||
143290141|NCT01320085|516611848|FG000|Overall Study|Administrative problems|0|||
143290142|NCT01320085|516611849|FG001|Overall Study|Administrative problems|0|||
143290143|NCT01320085|516611850|FG002|Overall Study|Administrative problems|1|||
143290144|NCT01702454|516611851|FG000|Overall Study|Consent withdrawal|0|||
143290145|NCT01702454|516611852|FG001|Overall Study|Consent withdrawal|1|||
143290146|NCT01702454|516611851|FG000|Overall Study|Migrated/moved from study area|0|||
143290147|NCT01702454|516611852|FG001|Overall Study|Migrated/moved from study area|1|||
143290148|NCT01702454|516611851|FG000|Overall Study|Lost to Follow-up|3|||
143290149|NCT01702454|516611852|FG001|Overall Study|Lost to Follow-up|6|||
143290150|NCT00710710|516611853|FG000|Overall Study|Consent withdrawn|2|||
143290151|NCT00710710|516611854|FG001|Overall Study|Consent withdrawn|2|||
143290152|NCT00710710|516611853|FG000|Overall Study|Protocol Violation|0|||
143290153|NCT00710710|516611854|FG001|Overall Study|Protocol Violation|1|||
143290154|NCT00710710|516611853|FG000|Overall Study|Adverse Event|3|||
143290155|NCT00710710|516611854|FG001|Overall Study|Adverse Event|3|||
143290156|NCT00710710|516611853|FG000|Overall Study|Progressive disease|40|||
143290157|NCT00710710|516611854|FG001|Overall Study|Progressive disease|38|||
143290158|NCT03510884|516611855|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
143290159|NCT03510884|516611856|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
143290160|NCT03510884|516611857|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
143290161|NCT03510884|516611858|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
143290162|NCT03510884|516611855|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
143290163|NCT03510884|516611856|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
143290164|NCT03510884|516611857|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
143290165|NCT03510884|516611858|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
143290166|NCT03510884|516611855|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
143290167|NCT03510884|516611856|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
143290168|NCT03510884|516611857|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
143290169|NCT03510884|516611858|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
143290170|NCT03510884|516611855|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
143290171|NCT03510884|516611856|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
143290172|NCT03510884|516611857|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
143290173|NCT03510884|516611858|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
143290174|NCT03510884|516611855|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
143290175|NCT03510884|516611856|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
143290176|NCT03510884|516611857|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
143290177|NCT03510884|516611858|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
143290178|NCT03510884|516611855|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
143290179|NCT03510884|516611856|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
143290180|NCT03510884|516611857|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
143290181|NCT03510884|516611858|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
143290182|NCT03510884|516611855|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
143290183|NCT03510884|516611856|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
143290184|NCT03510884|516611857|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
143290185|NCT03510884|516611858|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
143290186|NCT03510884|516611855|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
143290187|NCT03510884|516611856|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
143290188|NCT03510884|516611857|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
143290189|NCT03510884|516611858|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
143290190|NCT03510884|516611855|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
143290191|NCT03510884|516611856|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
143290192|NCT03510884|516611857|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
143290193|NCT03510884|516611858|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
143290194|NCT03510884|516611855|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
143290195|NCT03510884|516611856|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
143290196|NCT03510884|516611857|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
143290197|NCT03510884|516611858|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
143290198|NCT00589914|516611859|FG000|Overall Study|Adverse Event|19|||
143290199|NCT00589914|516611860|FG001|Overall Study|Adverse Event|10|||
143290200|NCT00589914|516611859|FG000|Overall Study|Death|2|||
143290201|NCT00589914|516611860|FG001|Overall Study|Death|0|||
143290202|NCT00589914|516611859|FG000|Overall Study|Lack of Efficacy|40|||
143290203|NCT00589914|516611860|FG001|Overall Study|Lack of Efficacy|43|||
143290204|NCT00589914|516611859|FG000|Overall Study|Lost to Follow-up|11|||
143290205|NCT00589914|516611860|FG001|Overall Study|Lost to Follow-up|18|||
143290206|NCT00589914|516611859|FG000|Overall Study|Pregnancy|1|||
143290207|NCT00589914|516611860|FG001|Overall Study|Pregnancy|0|||
143290208|NCT00589914|516611859|FG000|Overall Study|Withdrawal by Subject|55|||
143290209|NCT00589914|516611860|FG001|Overall Study|Withdrawal by Subject|49|||
143290210|NCT00589914|516611859|FG000|Overall Study|Other|22|||
143290211|NCT00589914|516611860|FG001|Overall Study|Other|17|||
143290212|NCT02564042|516611866|FG000|Overall Study|Adverse Event|4|||
143290213|NCT02564042|516611867|FG001|Overall Study|Adverse Event|4|||
143290214|NCT02564042|516611868|FG002|Overall Study|Adverse Event|3|||
143290215|NCT02564042|516611869|FG003|Overall Study|Adverse Event|0|||
143290216|NCT02564042|516611870|FG004|Overall Study|Adverse Event|0|||
143290217|NCT02564042|516611871|FG005|Overall Study|Adverse Event|1|||
143290218|NCT02564042|516611866|FG000|Overall Study|Lost to Follow-up|1|||
143290219|NCT02564042|516611867|FG001|Overall Study|Lost to Follow-up|1|||
143290220|NCT02564042|516611868|FG002|Overall Study|Lost to Follow-up|1|||
143290221|NCT02564042|516611869|FG003|Overall Study|Lost to Follow-up|0|||
143290222|NCT02564042|516611870|FG004|Overall Study|Lost to Follow-up|1|||
143290223|NCT02564042|516611871|FG005|Overall Study|Lost to Follow-up|1|||
143290224|NCT02564042|516611866|FG000|Overall Study|Physician Decision|1|||
143290225|NCT02564042|516611867|FG001|Overall Study|Physician Decision|0|||
143290226|NCT02564042|516611868|FG002|Overall Study|Physician Decision|0|||
143290227|NCT02564042|516611869|FG003|Overall Study|Physician Decision|1|||
143290228|NCT02564042|516611870|FG004|Overall Study|Physician Decision|0|||
143290229|NCT02564042|516611871|FG005|Overall Study|Physician Decision|0|||
143290230|NCT02564042|516611866|FG000|Overall Study|Withdrawal by Subject|5|||
143290231|NCT02564042|516611867|FG001|Overall Study|Withdrawal by Subject|3|||
143290232|NCT02564042|516611868|FG002|Overall Study|Withdrawal by Subject|2|||
143290233|NCT02564042|516611869|FG003|Overall Study|Withdrawal by Subject|2|||
143290234|NCT02564042|516611870|FG004|Overall Study|Withdrawal by Subject|10|||
143290235|NCT02564042|516611871|FG005|Overall Study|Withdrawal by Subject|12|||
143290236|NCT02066233|516611878|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
143290237|NCT02066233|516611879|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
143290238|NCT00103142|516611880|FG000|Overall Study|Adverse Event|1|||
143290239|NCT00103142|516611881|FG001|Overall Study|Adverse Event|0|||
143290240|NCT00103142|516611880|FG000|Overall Study|Progression of disease|2|||
143290241|NCT00103142|516611881|FG001|Overall Study|Progression of disease|1|||
143290242|NCT02772081|516611882|FG000|Overall Study|Physician Decision|1|||
143290243|NCT02772081|516611883|FG001|Overall Study|Physician Decision|1|||
143290244|NCT02772081|516611882|FG000|Overall Study|Death|1|||
143290245|NCT02772081|516611883|FG001|Overall Study|Death|1|||
143290246|NCT01402544|516611888|FG000|Overall Study|Withdrawal by Subject|6|||
143290247|NCT01828281|516611889|FG000|Overall Study|Withdrawal by Subject|1|||
143290248|NCT01828281|516611890|FG001|Overall Study|Withdrawal by Subject|0|||
143290249|NCT01442493|516611891|FG000|Overall Study|withdrawn from study|3|||
143290250|NCT01442493|516611892|FG001|Overall Study|withdrawn from study|2|||
143290251|NCT01986985|516611893|FG000|Overall Study|Withdrawal by Subject|4|||
143290252|NCT01986985|516611893|FG000|Overall Study|Scan not completed due to malfunction|3|||
143290253|NCT01083576|516611896|FG000|Overall Study|Treatment Failure|6|||
143290254|NCT01083576|516611897|FG001|Overall Study|Treatment Failure|1|||
143290255|NCT02005445|516611898|FG000|Overall Study|Dual study enrollment|0|||
143290256|NCT02005445|516611899|FG001|Overall Study|Dual study enrollment|1|||
143290257|NCT00759954|516611900|FG000|Overall Study|Personal reason|1|||
143290258|NCT00759954|516611901|FG001|Overall Study|Personal reason|0|||
143290259|NCT00759954|516611900|FG000|Overall Study|Adverse Event|1|||
143290260|NCT00759954|516611901|FG001|Overall Study|Adverse Event|2|||
143290261|NCT02709785|516611905|FG000|Overall Study|Withdrawal by Subject|1|||
143290262|NCT02709785|516611906|FG001|Overall Study|Withdrawal by Subject|2|||
143290263|NCT02709785|516611907|FG002|Overall Study|Withdrawal by Subject|1|||
143290264|NCT01961323|516611908|FG000|Overall Study|Withdrawal by Subject|7|||
143290265|NCT01961323|516611908|FG000|Overall Study|Lost to Follow-up|8|||
143290266|NCT01961323|516611908|FG000|Overall Study|screen failure|34|||
143290267|NCT01881776|516611910|FG000|Overall Study|Lost to Follow-up|1|||
143290268|NCT01881776|516611911|FG001|Overall Study|Lost to Follow-up|2|||
143290269|NCT01881776|516611912|FG002|Overall Study|Lost to Follow-up|1|||
143290270|NCT01881776|516611910|FG000|Overall Study|Protocol Violation|0|||
143290271|NCT01881776|516611911|FG001|Overall Study|Protocol Violation|2|||
143290272|NCT01881776|516611912|FG002|Overall Study|Protocol Violation|1|||
143290273|NCT02320149|516611913|FG000|Overall Study|Adverse Event|3|||
143290274|NCT02320149|516611914|FG001|Overall Study|Adverse Event|7|||
143373729|NCT00941655|516913561|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
143290275|NCT02320149|516611913|FG000|Overall Study|Withdrawal of Consent|28|||
143290276|NCT02320149|516611914|FG001|Overall Study|Withdrawal of Consent|32|||
143290277|NCT02320149|516611913|FG000|Overall Study|Lost to Follow-up|21|||
143290278|NCT02320149|516611914|FG001|Overall Study|Lost to Follow-up|34|||
143290279|NCT02320149|516611913|FG000|Overall Study|Protocol Violation|2|||
143290280|NCT02320149|516611914|FG001|Overall Study|Protocol Violation|1|||
143290281|NCT02320149|516611913|FG000|Overall Study|Noncompliance with Study Treatment|7|||
143290282|NCT02320149|516611914|FG001|Overall Study|Noncompliance with Study Treatment|2|||
143290283|NCT02320149|516611913|FG000|Overall Study|Lack of Efficacy|0|||
143290284|NCT02320149|516611914|FG001|Overall Study|Lack of Efficacy|1|||
143290285|NCT02320149|516611913|FG000|Overall Study|Other Miscellaneous Reasons|2|||
143290286|NCT02320149|516611914|FG001|Overall Study|Other Miscellaneous Reasons|3|||
143290287|NCT00022633|516611915|FG000|Overall Study|Adverse Event|11|||
143290288|NCT00022633|516611916|FG001|Overall Study|Adverse Event|1|||
143290289|NCT00022633|516611915|FG000|Overall Study|Refusal unrelated to adverse event|1|||
143290290|NCT00022633|516611916|FG001|Overall Study|Refusal unrelated to adverse event|0|||
143290291|NCT00022633|516611915|FG000|Overall Study|Progression/relapse|9|||
143290292|NCT00022633|516611916|FG001|Overall Study|Progression/relapse|2|||
143290293|NCT00022633|516611915|FG000|Overall Study|Death|4|||
143290294|NCT00022633|516611916|FG001|Overall Study|Death|0|||
143290295|NCT00022633|516611915|FG000|Overall Study|Other - not protocol specified|3|||
143290296|NCT00022633|516611916|FG001|Overall Study|Other - not protocol specified|2|||
143290297|NCT00022633|516611915|FG000|Overall Study|Ineligible|4|||
143290298|NCT00022633|516611916|FG001|Overall Study|Ineligible|0|||
143290299|NCT00487747|516611917|FG000|Overall Study|Adverse Event|1|||
143290300|NCT00487747|516611917|FG000|Overall Study|Lost to Follow-up|9|||
143290301|NCT00487747|516611917|FG000|Overall Study|Lack of Efficacy|1|||
143290302|NCT01359449|516611918|FG000|Overall Study|Lost to Follow-up|1|||
143290303|NCT01359449|516611919|FG001|Overall Study|Lost to Follow-up|0|||
143290304|NCT01359449|516611918|FG000|Overall Study|Protocol Violation|0|||
143290305|NCT01359449|516611919|FG001|Overall Study|Protocol Violation|2|||
143290306|NCT01359449|516611918|FG000|Overall Study|Withdrawal by Subject|3|||
143290307|NCT01359449|516611919|FG001|Overall Study|Withdrawal by Subject|2|||
143290308|NCT01829191|516611920|FG000|Overall Study|Relocation|0|||
143290309|NCT01829191|516611921|FG001|Overall Study|Relocation|1|||
143290310|NCT01829191|516611920|FG000|Overall Study|Lens discomfort|0|||
143290311|NCT01829191|516611921|FG001|Overall Study|Lens discomfort|3|||
143290312|NCT01829191|516611920|FG000|Overall Study|Lens handling difficulty|1|||
143290313|NCT01829191|516611921|FG001|Overall Study|Lens handling difficulty|4|||
143290314|NCT01829191|516611920|FG000|Overall Study|Protocol Violation|4|||
143290315|NCT01829191|516611921|FG001|Overall Study|Protocol Violation|1|||
143290316|NCT01829191|516611920|FG000|Overall Study|Withdrawal by Subject|2|||
143290317|NCT01829191|516611921|FG001|Overall Study|Withdrawal by Subject|3|||
143290318|NCT01829191|516611920|FG000|Overall Study|Lost to Follow-up|0|||
143290319|NCT01829191|516611921|FG001|Overall Study|Lost to Follow-up|1|||
143290320|NCT01829191|516611920|FG000|Overall Study|Subject was fit for ortho - k|0|||
143290321|NCT01829191|516611921|FG001|Overall Study|Subject was fit for ortho - k|1|||
143290322|NCT00726661|516611922|FG000|Overall Study|Lost to Follow-up|36|||
143290323|NCT00726661|516611923|FG001|Overall Study|Lost to Follow-up|11|||
143290324|NCT00726661|516611922|FG000|Overall Study|Withdrawal by Subject|17|||
143290325|NCT00726661|516611923|FG001|Overall Study|Withdrawal by Subject|13|||
143290326|NCT00726661|516611922|FG000|Overall Study|Trial terminated by sponsor|214|||
143290327|NCT00726661|516611923|FG001|Overall Study|Trial terminated by sponsor|187|||
143290328|NCT00726661|516611922|FG000|Overall Study|Death|475|||
143290329|NCT00726661|516611923|FG001|Overall Study|Death|159|||
143290330|NCT00726661|516611922|FG000|Overall Study|Physician Decision|25|||
143290331|NCT00726661|516611923|FG001|Overall Study|Physician Decision|13|||
143290332|NCT00726661|516611922|FG000|Overall Study|Other|47|||
143290333|NCT00726661|516611923|FG001|Overall Study|Other|35|||
143290334|NCT04044716|516611931|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
143290335|NCT04044716|516611932|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
143290336|NCT04044716|516611933|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
143290337|NCT04044716|516611931|FG000|Overall Study|Lost to Follow-up|2|||
143290338|NCT04044716|516611932|FG001|Overall Study|Lost to Follow-up|3|||
143290339|NCT04044716|516611933|FG002|Overall Study|Lost to Follow-up|0|||
143290340|NCT02743871|516611934|FG000|Overall Study|Lost to Follow-up|0|||
143290341|NCT02743871|516611935|FG001|Overall Study|Lost to Follow-up|0|||
143290342|NCT02743871|516611936|FG002|Overall Study|Lost to Follow-up|0|||
143290343|NCT02743871|516611937|FG003|Overall Study|Lost to Follow-up|1|||
143290344|NCT02743871|516611938|FG004|Overall Study|Lost to Follow-up|0|||
143290345|NCT02743871|516611939|FG005|Overall Study|Lost to Follow-up|0|||
143290346|NCT02743871|516611940|FG006|Overall Study|Lost to Follow-up|1|||
143290347|NCT02743871|516611941|FG007|Overall Study|Lost to Follow-up|0|||
143290348|NCT02743871|516611942|FG008|Overall Study|Lost to Follow-up|0|||
143290349|NCT02743871|516611943|FG009|Overall Study|Lost to Follow-up|0|||
143290350|NCT02743871|516611944|FG010|Overall Study|Lost to Follow-up|0|||
143290351|NCT02743871|516611945|FG011|Overall Study|Lost to Follow-up|2|||
143290352|NCT02743871|516611946|FG012|Overall Study|Lost to Follow-up|0|||
143290353|NCT02743871|516611947|FG013|Overall Study|Lost to Follow-up|0|||
143290354|NCT02743871|516611934|FG000|Overall Study|Withdrawal by Subject|0|||
143290355|NCT02743871|516611935|FG001|Overall Study|Withdrawal by Subject|0|||
143290356|NCT02743871|516611936|FG002|Overall Study|Withdrawal by Subject|0|||
143290357|NCT02743871|516611937|FG003|Overall Study|Withdrawal by Subject|0|||
143290358|NCT02743871|516611938|FG004|Overall Study|Withdrawal by Subject|0|||
143290359|NCT02743871|516611939|FG005|Overall Study|Withdrawal by Subject|0|||
143290360|NCT02743871|516611940|FG006|Overall Study|Withdrawal by Subject|0|||
143290361|NCT02743871|516611941|FG007|Overall Study|Withdrawal by Subject|0|||
143290362|NCT02743871|516611942|FG008|Overall Study|Withdrawal by Subject|0|||
143290363|NCT02743871|516611943|FG009|Overall Study|Withdrawal by Subject|0|||
143290364|NCT02743871|516611944|FG010|Overall Study|Withdrawal by Subject|1|||
143290365|NCT02743871|516611945|FG011|Overall Study|Withdrawal by Subject|0|||
143290366|NCT02743871|516611946|FG012|Overall Study|Withdrawal by Subject|12|||
143290367|NCT02743871|516611947|FG013|Overall Study|Withdrawal by Subject|6|||
143290368|NCT02743871|516611934|FG000|Overall Study|Adverse Event|1|||
143290369|NCT02743871|516611935|FG001|Overall Study|Adverse Event|0|||
143290370|NCT02743871|516611936|FG002|Overall Study|Adverse Event|0|||
143290371|NCT02743871|516611937|FG003|Overall Study|Adverse Event|0|||
143290372|NCT02743871|516611938|FG004|Overall Study|Adverse Event|0|||
143290373|NCT02743871|516611939|FG005|Overall Study|Adverse Event|0|||
143290374|NCT02743871|516611940|FG006|Overall Study|Adverse Event|0|||
143290375|NCT02743871|516611941|FG007|Overall Study|Adverse Event|0|||
143290376|NCT02743871|516611942|FG008|Overall Study|Adverse Event|0|||
143290377|NCT02743871|516611943|FG009|Overall Study|Adverse Event|0|||
143290378|NCT02743871|516611944|FG010|Overall Study|Adverse Event|0|||
143290379|NCT02743871|516611945|FG011|Overall Study|Adverse Event|0|||
143290380|NCT02743871|516611946|FG012|Overall Study|Adverse Event|0|||
143290381|NCT02743871|516611947|FG013|Overall Study|Adverse Event|0|||
143290382|NCT02743871|516611934|FG000|Overall Study|Other|0|||
143290383|NCT02743871|516611935|FG001|Overall Study|Other|0|||
143290384|NCT02743871|516611936|FG002|Overall Study|Other|0|||
143290385|NCT02743871|516611937|FG003|Overall Study|Other|0|||
143290386|NCT02743871|516611938|FG004|Overall Study|Other|0|||
143290387|NCT02743871|516611939|FG005|Overall Study|Other|0|||
143290388|NCT02743871|516611940|FG006|Overall Study|Other|0|||
143290389|NCT02743871|516611941|FG007|Overall Study|Other|0|||
143290390|NCT02743871|516611942|FG008|Overall Study|Other|0|||
143290391|NCT02743871|516611943|FG009|Overall Study|Other|0|||
143290392|NCT02743871|516611944|FG010|Overall Study|Other|0|||
143290393|NCT02743871|516611945|FG011|Overall Study|Other|1|||
143290394|NCT02743871|516611946|FG012|Overall Study|Other|1|||
143290395|NCT02743871|516611947|FG013|Overall Study|Other|1|||
143290396|NCT02743871|516611934|FG000|Overall Study|Protocol Violation|0|||
143290397|NCT02743871|516611935|FG001|Overall Study|Protocol Violation|0|||
143290398|NCT02743871|516611936|FG002|Overall Study|Protocol Violation|0|||
143290399|NCT02743871|516611937|FG003|Overall Study|Protocol Violation|0|||
143290400|NCT02743871|516611938|FG004|Overall Study|Protocol Violation|0|||
143290401|NCT02743871|516611939|FG005|Overall Study|Protocol Violation|0|||
143290402|NCT02743871|516611940|FG006|Overall Study|Protocol Violation|0|||
143290403|NCT02743871|516611941|FG007|Overall Study|Protocol Violation|0|||
143290404|NCT02743871|516611942|FG008|Overall Study|Protocol Violation|0|||
143290405|NCT02743871|516611943|FG009|Overall Study|Protocol Violation|0|||
143290406|NCT02743871|516611944|FG010|Overall Study|Protocol Violation|0|||
143290407|NCT02743871|516611945|FG011|Overall Study|Protocol Violation|0|||
143290408|NCT02743871|516611946|FG012|Overall Study|Protocol Violation|2|||
143290409|NCT02743871|516611947|FG013|Overall Study|Protocol Violation|0|||
143290410|NCT02480114|516611948|FG000|Overall Study|Not completing surveys|3|||
143290411|NCT02480114|516611949|FG001|Overall Study|Not completing surveys|2|||
143373730|NCT00941655|516913562|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
143373731|NCT00941655|516913561|FG000|Overall Study|progressed while on chemo|0|||
143290412|NCT02480114|516611948|FG000|Overall Study|Withdrawal by Subject|2|||
143290413|NCT02480114|516611949|FG001|Overall Study|Withdrawal by Subject|4|||
143290414|NCT02480114|516611948|FG000|Overall Study|Disease progression|3|||
143290415|NCT02480114|516611949|FG001|Overall Study|Disease progression|0|||
143290416|NCT02480114|516611948|FG000|Overall Study|Improper completion of survey|1|||
143290417|NCT02480114|516611949|FG001|Overall Study|Improper completion of survey|1|||
143290418|NCT02480114|516611948|FG000|Overall Study|Not eligible|0|||
143290419|NCT02480114|516611949|FG001|Overall Study|Not eligible|1|||
143290420|NCT00512707|516611950|FG000|Overall Study|Lost to Follow-up|5|||
143290421|NCT00512707|516611951|FG001|Overall Study|Lost to Follow-up|11|||
143290422|NCT00512707|516611950|FG000|Overall Study|Developed skin irritation|2|||
143290423|NCT00512707|516611951|FG001|Overall Study|Developed skin irritation|1|||
143290424|NCT00512707|516611950|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
143290425|NCT00512707|516611951|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
143373732|NCT00941655|516913562|FG001|Overall Study|progressed while on chemo|2|||
143373733|NCT00941655|516913561|FG000|Overall Study|refused further treatment|0|||
143290426|NCT00512707|516611950|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
143290427|NCT00512707|516611951|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
143290428|NCT01317160|516611952|FG000|Overall Study|Incorrect inclusion|1|||
143290429|NCT01317160|516611953|FG001|Overall Study|Incorrect inclusion|1|||
143290430|NCT01317160|516611952|FG000|Overall Study|Lost to Follow-up|3|||
143290431|NCT01317160|516611953|FG001|Overall Study|Lost to Follow-up|3|||
143290432|NCT01317160|516611952|FG000|Overall Study|Withdrawal by Subject|0|||
143290433|NCT01317160|516611953|FG001|Overall Study|Withdrawal by Subject|2|||
143290434|NCT00224055|516613464|FG000|Overall Study|Adverse Event|9|||
143290435|NCT00224055|516613465|FG001|Overall Study|Adverse Event|3|||
143290436|NCT00224055|516613464|FG000|Overall Study|Lost to Follow-up|1|||
143290437|NCT00224055|516613465|FG001|Overall Study|Lost to Follow-up|2|||
143290438|NCT00224055|516613464|FG000|Overall Study|Protocol Violation|1|||
143290439|NCT00224055|516613465|FG001|Overall Study|Protocol Violation|1|||
143290440|NCT00224055|516613464|FG000|Overall Study|Inclusion Violation|3|||
143290441|NCT00224055|516613465|FG001|Overall Study|Inclusion Violation|6|||
143290442|NCT00224055|516613464|FG000|Overall Study|Withdrawal by Subject|0|||
143290443|NCT00224055|516613465|FG001|Overall Study|Withdrawal by Subject|2|||
143290444|NCT00224055|516613464|FG000|Overall Study|Other|1|||
143290445|NCT00224055|516613465|FG001|Overall Study|Other|0|||
143290446|NCT02618434|516613466|FG000|Overall Study|Withdrawal by Subject|0|||
143290447|NCT02618434|516613467|FG001|Overall Study|Withdrawal by Subject|2|||
143290448|NCT02618434|516613468|FG002|Overall Study|Withdrawal by Subject|3|||
143290449|NCT02618434|516613466|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
143290450|NCT02618434|516613467|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
143290451|NCT02618434|516613468|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
143290452|NCT02618434|516613466|FG000|Overall Study|Lost to Follow-up|3|||
143290453|NCT02618434|516613467|FG001|Overall Study|Lost to Follow-up|1|||
143290454|NCT02618434|516613468|FG002|Overall Study|Lost to Follow-up|3|||
143290455|NCT02618434|516613466|FG000|Overall Study|Adverse Event|1|||
143290456|NCT02618434|516613467|FG001|Overall Study|Adverse Event|0|||
143290457|NCT02618434|516613468|FG002|Overall Study|Adverse Event|12|||
143290458|NCT02618434|516613466|FG000|Overall Study|Physician Decision|0|||
143290459|NCT02618434|516613467|FG001|Overall Study|Physician Decision|1|||
143290460|NCT02618434|516613468|FG002|Overall Study|Physician Decision|0|||
143290461|NCT02618434|516613466|FG000|Overall Study|Protocol Violation|0|||
143290462|NCT02618434|516613467|FG001|Overall Study|Protocol Violation|0|||
143290463|NCT02618434|516613468|FG002|Overall Study|Protocol Violation|1|||
143290464|NCT02618434|516613466|FG000|Overall Study|Other, Multiple categories|1|||
143290465|NCT02618434|516613467|FG001|Overall Study|Other, Multiple categories|1|||
143290466|NCT02618434|516613468|FG002|Overall Study|Other, Multiple categories|1|||
143290467|NCT02051608|516613471|FG000|Part 1: Double Blind Treatment|Death|3|||
143290468|NCT02051608|516613472|FG001|Part 1: Double Blind Treatment|Death|3|||
143290469|NCT02051608|516613473|FG002|Part 1: Double Blind Treatment|Death|0|||
143290470|NCT02051608|516613474|FG003|Part 1: Double Blind Treatment|Death|0|||
143290471|NCT02051608|516613471|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
143290472|NCT02051608|516613472|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
143290473|NCT02051608|516613473|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
143290474|NCT02051608|516613474|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
143290475|NCT02051608|516613471|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
143290476|NCT02051608|516613472|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
143290477|NCT02051608|516613473|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
143290478|NCT02051608|516613474|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
143290479|NCT02051608|516613471|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
143290480|NCT02051608|516613472|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
143290481|NCT02051608|516613473|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
143290482|NCT02051608|516613474|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
143290483|NCT02051608|516613471|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
143290484|NCT02051608|516613472|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
143290485|NCT02051608|516613473|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
143290486|NCT02051608|516613474|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
143290487|NCT02051608|516613471|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
143290488|NCT02051608|516613472|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
143290489|NCT02051608|516613473|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
143290490|NCT02051608|516613474|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
143290491|NCT02051608|516613471|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
143290492|NCT02051608|516613472|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
143290493|NCT02051608|516613473|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
143290494|NCT02051608|516613474|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
143290495|NCT02051608|516613471|FG000|Part 1: Double Blind Treatment|Other|6|||
143290496|NCT02051608|516613472|FG001|Part 1: Double Blind Treatment|Other|3|||
143290497|NCT02051608|516613473|FG002|Part 1: Double Blind Treatment|Other|0|||
143290498|NCT02051608|516613474|FG003|Part 1: Double Blind Treatment|Other|0|||
143290499|NCT02051608|516613471|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
143290500|NCT02051608|516613472|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
143290501|NCT02051608|516613473|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
143290502|NCT02051608|516613474|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
143290503|NCT02051608|516613471|FG000|Part 2: Open-label Extension|Adverse Event|0|||
143290504|NCT02051608|516613472|FG001|Part 2: Open-label Extension|Adverse Event|0|||
143290505|NCT02051608|516613473|FG002|Part 2: Open-label Extension|Adverse Event|6|||
143290506|NCT02051608|516613474|FG003|Part 2: Open-label Extension|Adverse Event|8|||
143290507|NCT02051608|516613471|FG000|Part 2: Open-label Extension|Death|0|||
143290508|NCT02051608|516613472|FG001|Part 2: Open-label Extension|Death|0|||
143290509|NCT02051608|516613473|FG002|Part 2: Open-label Extension|Death|7|||
143290510|NCT02051608|516613474|FG003|Part 2: Open-label Extension|Death|4|||
143290511|NCT02051608|516613471|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
143290512|NCT02051608|516613472|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
143290513|NCT02051608|516613473|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
143290514|NCT02051608|516613474|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
143290515|NCT02051608|516613471|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
143290516|NCT02051608|516613472|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
143290517|NCT02051608|516613473|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
143290518|NCT02051608|516613474|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
143290519|NCT02051608|516613471|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
143290520|NCT02051608|516613472|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
143290521|NCT02051608|516613473|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
143290522|NCT02051608|516613474|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
143290523|NCT02051608|516613471|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
143290524|NCT02051608|516613472|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
143290525|NCT02051608|516613473|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
143290526|NCT02051608|516613474|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
143290527|NCT02051608|516613471|FG000|Part 2: Open-label Extension|Physician Decision|0|||
143290528|NCT02051608|516613472|FG001|Part 2: Open-label Extension|Physician Decision|0|||
143290529|NCT02051608|516613473|FG002|Part 2: Open-label Extension|Physician Decision|8|||
143290530|NCT02051608|516613474|FG003|Part 2: Open-label Extension|Physician Decision|5|||
143290531|NCT02051608|516613471|FG000|Part 2: Open-label Extension|Other|0|||
143290532|NCT02051608|516613472|FG001|Part 2: Open-label Extension|Other|0|||
143290533|NCT02051608|516613473|FG002|Part 2: Open-label Extension|Other|9|||
143290534|NCT02051608|516613474|FG003|Part 2: Open-label Extension|Other|9|||
143290535|NCT02036294|516613475|FG000|Overall Study|Death|7|||
143290536|NCT02036294|516613476|FG001|Overall Study|Death|8|||
143290537|NCT02036294|516613475|FG000|Overall Study|Withdrawal by Subject|2|||
143290538|NCT02036294|516613476|FG001|Overall Study|Withdrawal by Subject|3|||
143290539|NCT02927431|516613477|FG000|Overall Study|Withdrawal by Subject|0|||
143290540|NCT02927431|516613478|FG001|Overall Study|Withdrawal by Subject|0|||
143290541|NCT02927431|516613479|FG002|Overall Study|Withdrawal by Subject|1|||
143290542|NCT00673465|516613482|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
143290543|NCT00673465|516613483|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
143290544|NCT00673465|516613484|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
143290545|NCT00673465|516613485|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
143290546|NCT00673465|516613486|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
143290547|NCT00673465|516613487|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
143290548|NCT00673465|516613488|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
143290549|NCT00673465|516613489|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
143290550|NCT00673465|516613490|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
143290551|NCT00673465|516613491|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
143290552|NCT00673465|516613492|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
143290553|NCT00673465|516613493|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
143290554|NCT00673465|516613482|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
143290555|NCT00673465|516613483|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
143290556|NCT00673465|516613484|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
143290557|NCT00673465|516613485|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
143290558|NCT00673465|516613486|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
143290559|NCT00673465|516613487|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
143290560|NCT00673465|516613488|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
143290561|NCT00673465|516613489|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
143290562|NCT00673465|516613490|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
143290563|NCT00673465|516613491|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
143290564|NCT00673465|516613492|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
143290565|NCT00673465|516613493|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
143290566|NCT00429104|516613494|FG000|Overall Study|Protocol Violation|1|||
143290567|NCT01907815|516613495|FG000|Overall Study|Withdrawal by Subject|1|||
143290568|NCT01907815|516613496|FG001|Overall Study|Withdrawal by Subject|0|||
143290569|NCT01195415|516613497|FG000|Overall Study|No repeat biopsy due to progression|2|||
143290570|NCT02485574|516613504|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
143290571|NCT01408914|516613505|FG000|Overall Study|Could not complete tx in protocol period|5|||
143290572|NCT01408914|516613506|FG001|Overall Study|Could not complete tx in protocol period|5|||
143290573|NCT01408914|516613507|FG002|Overall Study|Could not complete tx in protocol period|6|||
143290574|NCT01408914|516613505|FG000|Overall Study|Lost to Follow-up|4|||
143290575|NCT01408914|516613506|FG001|Overall Study|Lost to Follow-up|1|||
143290576|NCT01408914|516613507|FG002|Overall Study|Lost to Follow-up|2|||
143290577|NCT01408914|516613505|FG000|Overall Study|Physician Decision|1|||
143290578|NCT01408914|516613506|FG001|Overall Study|Physician Decision|1|||
143290579|NCT01408914|516613507|FG002|Overall Study|Physician Decision|0|||
143290580|NCT01408914|516613505|FG000|Overall Study|Withdrawal by Subject|1|||
143290581|NCT01408914|516613506|FG001|Overall Study|Withdrawal by Subject|0|||
143290582|NCT01408914|516613507|FG002|Overall Study|Withdrawal by Subject|1|||
143290583|NCT01408914|516613505|FG000|Overall Study|Moved out of study jurisdiction|1|||
143290584|NCT01408914|516613506|FG001|Overall Study|Moved out of study jurisdiction|1|||
143290585|NCT01408914|516613507|FG002|Overall Study|Moved out of study jurisdiction|0|||
143290586|NCT01408914|516613505|FG000|Overall Study|Late exclusion|0|||
143290587|NCT01408914|516613506|FG001|Overall Study|Late exclusion|3|||
143290588|NCT01408914|516613507|FG002|Overall Study|Late exclusion|3|||
143290589|NCT01408914|516613505|FG000|Overall Study|Change in local TB/HIV norms|0|||
143290590|NCT01408914|516613506|FG001|Overall Study|Change in local TB/HIV norms|1|||
143290591|NCT01408914|516613507|FG002|Overall Study|Change in local TB/HIV norms|1|||
143290592|NCT01957553|516613512|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
143290593|NCT01957553|516613513|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
143290594|NCT01957553|516613512|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
143290595|NCT01957553|516613513|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
143290596|NCT01957553|516613512|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
143290597|NCT01957553|516613513|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
143290598|NCT01957553|516613512|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
143290599|NCT01957553|516613513|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
143290600|NCT01957553|516613512|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
143290601|NCT01957553|516613513|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
143290602|NCT01957553|516613512|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
143290603|NCT01957553|516613513|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
143290604|NCT01957553|516613512|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
143290605|NCT01957553|516613513|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
143290606|NCT01957553|516613512|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
143290607|NCT01957553|516613513|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
143290608|NCT01957553|516613512|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
143290609|NCT01957553|516613513|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
143290610|NCT02733367|516613514|FG000|Overall Study|Withdrawal by Subject|6|||
143290611|NCT01348347|516613515|FG000|Overall Study|Withdrawal by Subject|1|||
143290612|NCT01348347|516613516|FG001|Overall Study|Withdrawal by Subject|1|||
143290613|NCT01348347|516613517|FG002|Overall Study|Withdrawal by Subject|1|||
143290614|NCT01348347|516613515|FG000|Overall Study|Progressive disease|2|||
143290615|NCT01348347|516613516|FG001|Overall Study|Progressive disease|5|||
143290616|NCT01348347|516613517|FG002|Overall Study|Progressive disease|5|||
143290617|NCT00191789|516613520|FG000|Overall Study|Adverse Event|5|||
143373734|NCT00941655|516913562|FG001|Overall Study|refused further treatment|1|||
143373735|NCT00941655|516913561|FG000|Overall Study|withdrew consent|0|||
143373736|NCT00941655|516913562|FG001|Overall Study|withdrew consent|1|||
143373737|NCT00941655|516913561|FG000|Overall Study|non-compliant|0|||
143373738|NCT00941655|516913562|FG001|Overall Study|non-compliant|1|||
143373739|NCT02477670|516913563|FG000|Stage 1|Adverse Event|2|||
143373740|NCT02477670|516913564|FG001|Stage 1|Adverse Event|7|||
143373741|NCT02477670|516913565|FG002|Stage 1|Adverse Event|0|||
143290618|NCT00191789|516613520|FG000|Overall Study|Patient: Satisfactory Response|5|||
143290619|NCT00191789|516613520|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
143290620|NCT00191789|516613520|FG000|Overall Study|Withdrawal by Subject|4|||
143290621|NCT00191789|516613520|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
143290622|NCT00191789|516613520|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
143290623|NCT00191789|516613520|FG000|Overall Study|Death - Not Study-Drug Related|1|||
143290624|NCT03060629|516613529|FG000|Overall Study|Death|4|||
143373742|NCT02477670|516913566|FG003|Stage 1|Adverse Event|0|||
143290625|NCT03060629|516613530|FG001|Overall Study|Death|5|||
143373743|NCT02477670|516913567|FG004|Stage 1|Adverse Event|0|||
143373744|NCT02477670|516913568|FG005|Stage 1|Adverse Event|0|||
143373745|NCT02477670|516913569|FG006|Stage 1|Adverse Event|0|||
143290626|NCT03060629|516613529|FG000|Overall Study|Withdrawal by Subject|50|||
143290627|NCT03060629|516613530|FG001|Overall Study|Withdrawal by Subject|35|||
143290628|NCT03060629|516613529|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
143290629|NCT03060629|516613530|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
143290630|NCT03060629|516613529|FG000|Overall Study|Participant Relocate|15|||
143290631|NCT03060629|516613530|FG001|Overall Study|Participant Relocate|15|||
143290632|NCT03060629|516613529|FG000|Overall Study|Unable to Contact Participant|34|||
143290633|NCT03060629|516613530|FG001|Overall Study|Unable to Contact Participant|23|||
143290634|NCT03060629|516613529|FG000|Overall Study|Investigator Decision|7|||
143290635|NCT03060629|516613530|FG001|Overall Study|Investigator Decision|7|||
143290636|NCT03060629|516613529|FG000|Overall Study|Study Terminated by Sponsor|1100|||
143290637|NCT03060629|516613530|FG001|Overall Study|Study Terminated by Sponsor|1123|||
143290638|NCT03060629|516613529|FG000|Overall Study|Other|4|||
143290639|NCT03060629|516613530|FG001|Overall Study|Other|4|||
143290640|NCT01862874|516613531|FG000|Overall Study|Randomized not treated|1|||
143290641|NCT01862874|516613532|FG001|Overall Study|Randomized not treated|0|||
143290642|NCT01862874|516613531|FG000|Overall Study|Adverse Event|0|||
143290643|NCT01862874|516613532|FG001|Overall Study|Adverse Event|3|||
143290644|NCT01862874|516613531|FG000|Overall Study|Lost to Follow-up|26|||
143290645|NCT01862874|516613532|FG001|Overall Study|Lost to Follow-up|29|||
143290646|NCT01862874|516613531|FG000|Overall Study|Physician Decision|5|||
143290647|NCT01862874|516613532|FG001|Overall Study|Physician Decision|3|||
143290648|NCT01862874|516613531|FG000|Overall Study|Withdrawn by parent/guardian|1|||
143290649|NCT01862874|516613532|FG001|Overall Study|Withdrawn by parent/guardian|1|||
143290650|NCT01862874|516613531|FG000|Overall Study|Withdrawal by Subject|46|||
143290651|NCT01862874|516613532|FG001|Overall Study|Withdrawal by Subject|40|||
143290652|NCT01862874|516613531|FG000|Overall Study|Death|0|||
143290653|NCT01862874|516613532|FG001|Overall Study|Death|1|||
143290654|NCT01714635|516613537|FG000|Overall Study|Discontinued|1|||
143290655|NCT01714635|516613538|FG001|Overall Study|Discontinued|0|||
143290656|NCT01714635|516613539|FG002|Overall Study|Discontinued|2|||
143290657|NCT01714635|516613537|FG000|Overall Study|Missed 6-month exam|1|||
143290658|NCT01714635|516613538|FG001|Overall Study|Missed 6-month exam|0|||
143290659|NCT01714635|516613539|FG002|Overall Study|Missed 6-month exam|0|||
143290660|NCT03672747|516613541|FG000|Overall Study|Lost to Follow-up|1|||
143290661|NCT03672747|516613542|FG001|Overall Study|Lost to Follow-up|1|||
143290662|NCT03672747|516613543|FG002|Overall Study|Lost to Follow-up|2|||
143290663|NCT03672747|516613544|FG003|Overall Study|Lost to Follow-up|2|||
143290664|NCT03672747|516613545|FG004|Overall Study|Lost to Follow-up|2|||
143290665|NCT03672747|516613546|FG005|Overall Study|Lost to Follow-up|1|||
143290666|NCT04285879|516613547|FG000|Overall Study|Lost to Follow-up|1|||
143290667|NCT04285879|516613548|FG001|Overall Study|Lost to Follow-up|8|||
143290668|NCT04285879|516613547|FG000|Overall Study|medical/surgical exclusion|16|||
143290669|NCT04285879|516613548|FG001|Overall Study|medical/surgical exclusion|0|||
143290670|NCT01782495|516613555|FG000|Overall Study|Adverse Event|0|||
143290671|NCT01782495|516613556|FG001|Overall Study|Adverse Event|0|||
143290672|NCT01782495|516613557|FG002|Overall Study|Adverse Event|0|||
143290673|NCT01782495|516613558|FG003|Overall Study|Adverse Event|0|||
143290674|NCT01782495|516613559|FG004|Overall Study|Adverse Event|0|||
143290675|NCT01782495|516613560|FG005|Overall Study|Adverse Event|0|||
143290676|NCT01782495|516613561|FG006|Overall Study|Adverse Event|0|||
143290677|NCT01782495|516613562|FG007|Overall Study|Adverse Event|2|||
143290678|NCT01782495|516613563|FG008|Overall Study|Adverse Event|0|||
143290679|NCT01782495|516613564|FG009|Overall Study|Adverse Event|0|||
143290680|NCT01782495|516613565|FG010|Overall Study|Adverse Event|0|||
143290681|NCT01782495|516613555|FG000|Overall Study|Withdrew Consent|0|||
143290682|NCT01782495|516613556|FG001|Overall Study|Withdrew Consent|1|||
143290683|NCT01782495|516613557|FG002|Overall Study|Withdrew Consent|0|||
143290684|NCT01782495|516613558|FG003|Overall Study|Withdrew Consent|0|||
143290685|NCT01782495|516613559|FG004|Overall Study|Withdrew Consent|0|||
143290686|NCT01782495|516613560|FG005|Overall Study|Withdrew Consent|0|||
143290687|NCT01782495|516613561|FG006|Overall Study|Withdrew Consent|0|||
143290688|NCT01782495|516613562|FG007|Overall Study|Withdrew Consent|1|||
143290689|NCT01782495|516613563|FG008|Overall Study|Withdrew Consent|0|||
143290690|NCT01782495|516613564|FG009|Overall Study|Withdrew Consent|0|||
143290691|NCT01782495|516613565|FG010|Overall Study|Withdrew Consent|0|||
143290692|NCT01927367|516613566|FG000|Overall Study|Withdrawal by Subject|7|||
143290693|NCT01927367|516613567|FG001|Overall Study|Withdrawal by Subject|4|||
143290694|NCT01927367|516613566|FG000|Overall Study|No baseline data|0|||
143290695|NCT01927367|516613567|FG001|Overall Study|No baseline data|1|||
143290696|NCT00071513|516613570|FG000|Intervention Component|Withdrawal by Subject|2|||
143290697|NCT00071513|516613571|FG001|Intervention Component|Withdrawal by Subject|3|||
143290698|NCT00071513|516613570|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
143290699|NCT00071513|516613571|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
143290700|NCT01958008|516613574|FG000|Overall Study|Worsening of disease under study|0|||
143290701|NCT01958008|516613575|FG001|Overall Study|Worsening of disease under study|0|||
143290702|NCT01958008|516613576|FG002|Overall Study|Worsening of disease under study|1|||
143290703|NCT01958008|516613577|FG003|Overall Study|Worsening of disease under study|0|||
143290704|NCT01958008|516613574|FG000|Overall Study|Other adverse event|1|||
143290705|NCT01958008|516613575|FG001|Overall Study|Other adverse event|0|||
143290706|NCT01958008|516613576|FG002|Overall Study|Other adverse event|0|||
143290707|NCT01958008|516613577|FG003|Overall Study|Other adverse event|0|||
143290708|NCT03667924|516613578|FG000|Baseline Completed|Lost to Follow-up|0|||
143290709|NCT03667924|516613579|FG001|Baseline Completed|Lost to Follow-up|2|||
143290710|NCT03667924|516613580|FG002|Baseline Completed|Lost to Follow-up|0|||
143290711|NCT03667924|516613578|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
143290712|NCT03667924|516613579|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
143290713|NCT03667924|516613580|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
143290714|NCT03667924|516613578|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
143290715|NCT03667924|516613579|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
143290716|NCT03667924|516613580|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
143290717|NCT03667924|516613578|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
143290718|NCT03667924|516613579|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
143290719|NCT03667924|516613580|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
143290720|NCT03667924|516613578|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
143290721|NCT03667924|516613579|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
143290722|NCT03667924|516613580|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
143290723|NCT03667924|516613578|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
143290724|NCT03667924|516613579|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
143290725|NCT03667924|516613580|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
143290726|NCT03667924|516613578|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
143290727|NCT03667924|516613579|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
143290728|NCT03667924|516613580|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
143290729|NCT03358290|516613581|FG000|Overall Study|Study discontinued by Sponsor|0|||
143290730|NCT03358290|516613582|FG001|Overall Study|Study discontinued by Sponsor|1|||
143290731|NCT03358290|516613583|FG002|Overall Study|Study discontinued by Sponsor|1|||
143290732|NCT03358290|516613584|FG003|Overall Study|Study discontinued by Sponsor|0|||
143290733|NCT03358290|516613585|FG004|Overall Study|Study discontinued by Sponsor|0|||
143290734|NCT03358290|516613581|FG000|Overall Study|Adverse Event|0|||
143290735|NCT03358290|516613582|FG001|Overall Study|Adverse Event|0|||
143290736|NCT03358290|516613583|FG002|Overall Study|Adverse Event|1|||
143290737|NCT03358290|516613584|FG003|Overall Study|Adverse Event|2|||
143290738|NCT03358290|516613585|FG004|Overall Study|Adverse Event|0|||
143290739|NCT03358290|516613581|FG000|Overall Study|Withdrawal by Subject|0|||
143290740|NCT03358290|516613582|FG001|Overall Study|Withdrawal by Subject|0|||
143290741|NCT03358290|516613583|FG002|Overall Study|Withdrawal by Subject|0|||
143290742|NCT03358290|516613584|FG003|Overall Study|Withdrawal by Subject|0|||
143290743|NCT03358290|516613585|FG004|Overall Study|Withdrawal by Subject|1|||
143290744|NCT02999854|516613587|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
143290745|NCT02999854|516613588|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
143290746|NCT02999854|516613587|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
143290747|NCT02999854|516613588|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
143290748|NCT02999854|516613587|FG000|Active Study Phase (up to 18 Months)|Death|7|||
143290749|NCT02999854|516613588|FG001|Active Study Phase (up to 18 Months)|Death|5|||
143290750|NCT02999854|516613587|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
143290751|NCT02999854|516613588|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
143290752|NCT02999854|516613587|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
143290753|NCT02999854|516613588|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
143290754|NCT02999854|516613587|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
143290755|NCT02999854|516613588|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
143290756|NCT02999854|516613587|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
143290757|NCT02999854|516613588|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
143290758|NCT02999854|516613587|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
143290759|NCT02999854|516613588|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
143290760|NCT02848651|516613589|FG000|Overall Study|Death|85|||
143290761|NCT02848651|516613589|FG000|Overall Study|Lost to Follow-up|1|||
143290762|NCT02848651|516613589|FG000|Overall Study|Non-Compliance|1|||
143373746|NCT02477670|516913563|FG000|Stage 1|Lost to Follow-up|0|||
143290763|NCT02848651|516613589|FG000|Overall Study|Symptomatic Deterioration|1|||
143290764|NCT02848651|516613589|FG000|Overall Study|Physician Decision|4|||
143290765|NCT02848651|516613589|FG000|Overall Study|Withdrawal by Subject|14|||
143290766|NCT04140292|516613590|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
143290767|NCT04140292|516613591|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
143290768|NCT00662363|516613594|FG000|Overall Study|Withdrawal by Subject|6|||
143290769|NCT00662363|516613595|FG001|Overall Study|Withdrawal by Subject|5|||
143290770|NCT00662363|516613594|FG000|Overall Study|Adverse Event|0|||
143290771|NCT00662363|516613595|FG001|Overall Study|Adverse Event|3|||
143290772|NCT00662363|516613594|FG000|Overall Study|Discharged early from rehab|4|||
143290773|NCT00662363|516613595|FG001|Overall Study|Discharged early from rehab|1|||
143290774|NCT00662363|516613594|FG000|Overall Study|Protocol Violation|1|||
143290775|NCT00662363|516613595|FG001|Overall Study|Protocol Violation|1|||
143290776|NCT03700671|516613599|FG000|Overall Study|Lack of Efficacy|1|||
143290777|NCT03700671|516613600|FG001|Overall Study|Lack of Efficacy|2|||
143290778|NCT04405037|516613601|FG000|Overall Study|Withdrawal by Subject|1|||
143290779|NCT04405037|516613602|FG001|Overall Study|Withdrawal by Subject|0|||
143290780|NCT04405037|516613601|FG000|Overall Study|Screen Failure- Received Alvimopan Preoperatively|1|||
143290781|NCT04405037|516613602|FG001|Overall Study|Screen Failure- Received Alvimopan Preoperatively|0|||
143290782|NCT01853826|516615322|FG000|Overall Study|Patients who switched to commercial drug|11|||
143290783|NCT01853826|516615322|FG000|Overall Study|Patient refused to continue medication|21|||
143290784|NCT01853826|516615322|FG000|Overall Study|Lost to Follow-up|2|||
143290785|NCT01853826|516615322|FG000|Overall Study|Non-compliant with protocol|4|||
143290786|NCT01853826|516615322|FG000|Overall Study|Other adverse events (AE)|62|||
143290787|NCT01853826|516615322|FG000|Overall Study|Worsening or AE of underlying cancer disease|24|||
143290788|NCT01853826|516615322|FG000|Overall Study|Progressive disease|342|||
143290789|NCT01853826|516615322|FG000|Overall Study|Other than listed|13|||
143290790|NCT01853826|516615322|FG000|Overall Study|Not treated - not signed privacy informed consent|2|||
143290791|NCT03653637|516615323|FG000|Overall Study|Death|1|||
143290792|NCT03653637|516615324|FG001|Overall Study|Death|3|||
143290793|NCT03653637|516615323|FG000|Overall Study|Lost to Follow-up|29|||
143290794|NCT03653637|516615324|FG001|Overall Study|Lost to Follow-up|30|||
143290795|NCT03653637|516615323|FG000|Overall Study|Physician Decision|1|||
143290796|NCT03653637|516615324|FG001|Overall Study|Physician Decision|1|||
143290797|NCT03653637|516615323|FG000|Overall Study|Withdrawal by Subject|7|||
143290798|NCT03653637|516615324|FG001|Overall Study|Withdrawal by Subject|4|||
143290799|NCT05661942|516615326|FG000|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|2|||
143290800|NCT05661942|516615327|FG001|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|7|||
143290801|NCT02927080|516615328|FG000|Overall Study|Withdrawal by Subject|0|||
143290802|NCT02927080|516615329|FG001|Overall Study|Withdrawal by Subject|0|||
143290803|NCT02927080|516615330|FG002|Overall Study|Withdrawal by Subject|0|||
143290804|NCT02927080|516615331|FG003|Overall Study|Withdrawal by Subject|0|||
143290805|NCT02927080|516615332|FG004|Overall Study|Withdrawal by Subject|1|||
143290806|NCT02927080|516615333|FG005|Overall Study|Withdrawal by Subject|0|||
143290807|NCT02927080|516615334|FG006|Overall Study|Withdrawal by Subject|1|||
143290808|NCT02927080|516615335|FG007|Overall Study|Withdrawal by Subject|1|||
143290809|NCT02927080|516615336|FG008|Overall Study|Withdrawal by Subject|0|||
143290810|NCT02927080|516615337|FG009|Overall Study|Withdrawal by Subject|2|||
143290811|NCT02927080|516615328|FG000|Overall Study|Willingness to comply with protocol|0|||
143290812|NCT02927080|516615329|FG001|Overall Study|Willingness to comply with protocol|0|||
143290813|NCT02927080|516615330|FG002|Overall Study|Willingness to comply with protocol|0|||
143290814|NCT02927080|516615331|FG003|Overall Study|Willingness to comply with protocol|0|||
143290815|NCT02927080|516615332|FG004|Overall Study|Willingness to comply with protocol|0|||
143290816|NCT02927080|516615333|FG005|Overall Study|Willingness to comply with protocol|0|||
143290817|NCT02927080|516615334|FG006|Overall Study|Willingness to comply with protocol|0|||
143290818|NCT02927080|516615335|FG007|Overall Study|Willingness to comply with protocol|0|||
143290819|NCT02927080|516615336|FG008|Overall Study|Willingness to comply with protocol|0|||
143290820|NCT02927080|516615337|FG009|Overall Study|Willingness to comply with protocol|1|||
143290821|NCT02927080|516615328|FG000|Overall Study|Study terminated by Sponsor|0|||
143290822|NCT02927080|516615329|FG001|Overall Study|Study terminated by Sponsor|0|||
143290823|NCT02927080|516615330|FG002|Overall Study|Study terminated by Sponsor|0|||
143373747|NCT02477670|516913564|FG001|Stage 1|Lost to Follow-up|2|||
143290824|NCT02927080|516615331|FG003|Overall Study|Study terminated by Sponsor|0|||
143290825|NCT02927080|516615332|FG004|Overall Study|Study terminated by Sponsor|0|||
143290826|NCT02927080|516615333|FG005|Overall Study|Study terminated by Sponsor|0|||
143290827|NCT02927080|516615334|FG006|Overall Study|Study terminated by Sponsor|6|||
143290828|NCT02927080|516615335|FG007|Overall Study|Study terminated by Sponsor|7|||
143290829|NCT02927080|516615336|FG008|Overall Study|Study terminated by Sponsor|2|||
143290830|NCT02927080|516615337|FG009|Overall Study|Study terminated by Sponsor|3|||
143290831|NCT02927080|516615328|FG000|Overall Study|Adverse Event|0|||
143290832|NCT02927080|516615329|FG001|Overall Study|Adverse Event|1|||
143290833|NCT02927080|516615330|FG002|Overall Study|Adverse Event|0|||
143290834|NCT02927080|516615331|FG003|Overall Study|Adverse Event|0|||
143290835|NCT02927080|516615332|FG004|Overall Study|Adverse Event|0|||
143290836|NCT02927080|516615333|FG005|Overall Study|Adverse Event|0|||
143290837|NCT02927080|516615334|FG006|Overall Study|Adverse Event|0|||
143290838|NCT02927080|516615335|FG007|Overall Study|Adverse Event|1|||
143290839|NCT02927080|516615336|FG008|Overall Study|Adverse Event|0|||
143290840|NCT02927080|516615337|FG009|Overall Study|Adverse Event|1|||
143290841|NCT02927080|516615328|FG000|Overall Study|Other|0|||
143290842|NCT02927080|516615329|FG001|Overall Study|Other|0|||
143290843|NCT02927080|516615330|FG002|Overall Study|Other|0|||
143290844|NCT02927080|516615331|FG003|Overall Study|Other|0|||
143290845|NCT02927080|516615332|FG004|Overall Study|Other|0|||
143290846|NCT02927080|516615333|FG005|Overall Study|Other|0|||
143290847|NCT02927080|516615334|FG006|Overall Study|Other|1|||
143290848|NCT02927080|516615335|FG007|Overall Study|Other|0|||
143290849|NCT02927080|516615336|FG008|Overall Study|Other|1|||
143290850|NCT02927080|516615337|FG009|Overall Study|Other|0|||
143290851|NCT05126901|516615338|FG000|Overall Study|Withdrawal by Subject|1|||
143290852|NCT05126901|516615339|FG001|Overall Study|Withdrawal by Subject|1|||
143290853|NCT05126901|516615340|FG002|Overall Study|Withdrawal by Subject|4|||
143290854|NCT05126901|516615338|FG000|Overall Study|Adverse Event|0|||
143290855|NCT05126901|516615339|FG001|Overall Study|Adverse Event|0|||
143290856|NCT05126901|516615340|FG002|Overall Study|Adverse Event|1|||
143290857|NCT05126901|516615338|FG000|Overall Study|Lost to Follow-up|0|||
143290858|NCT05126901|516615339|FG001|Overall Study|Lost to Follow-up|2|||
143290859|NCT05126901|516615340|FG002|Overall Study|Lost to Follow-up|0|||
143290860|NCT00754624|516615341|FG000|Overall Study|Adverse Event|16|||
143290861|NCT00754624|516615341|FG000|Overall Study|Death|1|||
143290862|NCT00754624|516615341|FG000|Overall Study|Physician Decision|8|||
143290863|NCT00754624|516615341|FG000|Overall Study|Protocol Violation|1|||
143290864|NCT00754624|516615341|FG000|Overall Study|Withdrawal by Subject|28|||
143290865|NCT00754624|516615341|FG000|Overall Study|Various|12|||
143290866|NCT00754624|516615341|FG000|Overall Study|Lost to Follow-up|3|||
143290867|NCT04067544|516615342|FG000|Overall Study|Unforeseen recruitment issues due to Coronavirus Disease (COVID)-19 pandemic|1|||
143290868|NCT01529346|516615345|FG000|Overall Study|Lost to Follow-up|2|||
143290869|NCT01529346|516615346|FG001|Overall Study|Lost to Follow-up|0|||
143290870|NCT01529346|516615347|FG002|Overall Study|Lost to Follow-up|1|||
143290871|NCT01529346|516615348|FG003|Overall Study|Lost to Follow-up|0|||
143290872|NCT01529346|516615349|FG004|Overall Study|Lost to Follow-up|0|||
143290873|NCT01529346|516615345|FG000|Overall Study|Other|0|||
143290874|NCT01529346|516615346|FG001|Overall Study|Other|1|||
143290875|NCT01529346|516615347|FG002|Overall Study|Other|1|||
143290876|NCT01529346|516615348|FG003|Overall Study|Other|0|||
143290877|NCT01529346|516615349|FG004|Overall Study|Other|0|||
143290878|NCT02282020|516615350|FG000|Overall Study|Objective Disease Progression|128|||
143290879|NCT02282020|516615351|FG001|Overall Study|Objective Disease Progression|30|||
143290880|NCT02282020|516615350|FG000|Overall Study|Adverse Event|18|||
143290881|NCT02282020|516615351|FG001|Overall Study|Adverse Event|15|||
143290882|NCT02282020|516615350|FG000|Overall Study|Withdrawal by Subject|7|||
143290883|NCT02282020|516615351|FG001|Overall Study|Withdrawal by Subject|10|||
143290884|NCT02282020|516615350|FG000|Overall Study|Miscellaneous|5|||
143290885|NCT02282020|516615351|FG001|Overall Study|Miscellaneous|19|||
143290886|NCT02282020|516615350|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
143290887|NCT02282020|516615351|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
143290888|NCT02282020|516615350|FG000|Overall Study|Developed Discontinuation Criteria|0|||
143290889|NCT02282020|516615351|FG001|Overall Study|Developed Discontinuation Criteria|2|||
143290890|NCT02282020|516615350|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
143373748|NCT02477670|516913565|FG002|Stage 1|Lost to Follow-up|0|||
143290891|NCT02282020|516615351|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
143290892|NCT01500629|516615352|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
143290893|NCT01500629|516615353|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
143290894|NCT01499667|516615354|FG000|Overall Study|administrative problems|4|||
143290895|NCT01499667|516615355|FG001|Overall Study|administrative problems|5|||
143290896|NCT01499667|516615356|FG002|Overall Study|administrative problems|5|||
143290897|NCT01499667|516615354|FG000|Overall Study|Protocol Violation|1|||
143290898|NCT01499667|516615355|FG001|Overall Study|Protocol Violation|3|||
143290899|NCT01499667|516615356|FG002|Overall Study|Protocol Violation|2|||
143290900|NCT01499667|516615354|FG000|Overall Study|Adverse Event|0|||
143290901|NCT01499667|516615355|FG001|Overall Study|Adverse Event|2|||
143290902|NCT01499667|516615356|FG002|Overall Study|Adverse Event|2|||
143290903|NCT01499667|516615354|FG000|Overall Study|Withdrawal by Subject|2|||
143290904|NCT01499667|516615355|FG001|Overall Study|Withdrawal by Subject|1|||
143290905|NCT01499667|516615356|FG002|Overall Study|Withdrawal by Subject|1|||
143290906|NCT01499667|516615354|FG000|Overall Study|Lack of Efficacy|2|||
143290907|NCT01499667|516615355|FG001|Overall Study|Lack of Efficacy|0|||
143290908|NCT01499667|516615356|FG002|Overall Study|Lack of Efficacy|0|||
143290909|NCT01084174|516615357|FG000|Overall Study|gastrointestinal symptoms|1|||
143290910|NCT01084174|516615358|FG001|Overall Study|gastrointestinal symptoms|1|||
143290911|NCT01084174|516615357|FG000|Overall Study|Eosinophilic esophagitis|0|||
143290912|NCT01084174|516615358|FG001|Overall Study|Eosinophilic esophagitis|1|||
143290913|NCT01084174|516615357|FG000|Overall Study|Anaphylaxis|0|||
143290914|NCT01084174|516615358|FG001|Overall Study|Anaphylaxis|1|||
143290915|NCT01084174|516615357|FG000|Overall Study|Participant noncompliance|0|||
143290916|NCT01084174|516615358|FG001|Overall Study|Participant noncompliance|1|||
143290917|NCT01594125|516615359|FG000|Overall Study|Withdrawal by Subject|1|||
143290918|NCT01594125|516615360|FG001|Overall Study|Withdrawal by Subject|0|||
143290919|NCT01594125|516615361|FG002|Overall Study|Withdrawal by Subject|0|||
143290920|NCT01594125|516615362|FG003|Overall Study|Withdrawal by Subject|1|||
143290921|NCT01594125|516615363|FG004|Overall Study|Withdrawal by Subject|0|||
143290922|NCT01594125|516615359|FG000|Overall Study|Progressive Disease|3|||
143290923|NCT01594125|516615360|FG001|Overall Study|Progressive Disease|12|||
143290924|NCT01594125|516615361|FG002|Overall Study|Progressive Disease|3|||
143290925|NCT01594125|516615362|FG003|Overall Study|Progressive Disease|3|||
143290926|NCT01594125|516615363|FG004|Overall Study|Progressive Disease|7|||
143290927|NCT01484873|516615364|FG000|Overall Study|Withdrawal by Subject|2|||
143290928|NCT01356966|516615365|FG000|Overall Study|Withdrawal by Subject|1|||
143290929|NCT01356966|516615366|FG001|Overall Study|Withdrawal by Subject|2|||
143290930|NCT01356966|516615365|FG000|Overall Study|Physician Decision|1|||
143290931|NCT01356966|516615366|FG001|Overall Study|Physician Decision|0|||
143290932|NCT01549392|516615367|FG000|Overall Study|Withdrawal by Subject|1|||
143290933|NCT01549392|516615368|FG001|Overall Study|Withdrawal by Subject|0|||
143290934|NCT02743806|516615369|FG000|Overall Study|Adverse Event|9|||
143290935|NCT02743806|516615369|FG000|Overall Study|Lost to Follow-up|8|||
143290936|NCT02743806|516615369|FG000|Overall Study|Voluntary Withdrawal|54|||
143290937|NCT02743806|516615369|FG000|Overall Study|Study Termination|65|||
143290938|NCT02743806|516615369|FG000|Overall Study|Pregnancy|6|||
143290939|NCT02743806|516615369|FG000|Overall Study|No Longer Clinically Benefiting|27|||
143290940|NCT02743806|516615369|FG000|Overall Study|Reason Not Specified|12|||
143290941|NCT00849381|516615370|FG000|Overall Study|Adverse Event|1|||
143290942|NCT00849381|516615370|FG000|Overall Study|Lost to Follow-up|129|||
143290943|NCT00849381|516615370|FG000|Overall Study|Protocol Violation|5|||
143290944|NCT00849381|516615370|FG000|Overall Study|Withdrawal by Subject|6|||
143290945|NCT00849381|516615370|FG000|Overall Study|Other|4|||
143290946|NCT00460031|516615376|FG000|Overall Study|Adverse Event|5|||
143290947|NCT00460031|516615376|FG000|Overall Study|Withdrawal by Subject|5|||
143290948|NCT00460031|516615376|FG000|Overall Study|Death|1|||
143290949|NCT04429061|516615377|FG000|Overall Study|Lost to Follow-up|62|||
143290950|NCT04429061|516615378|FG001|Overall Study|Lost to Follow-up|87|||
143290951|NCT04429061|516615377|FG000|Overall Study|Withdrawal by Subject|3|||
143290952|NCT04429061|516615378|FG001|Overall Study|Withdrawal by Subject|4|||
143290953|NCT01988103|516615383|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
143290954|NCT01988103|516615384|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
143290955|NCT01988103|516615385|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
143290956|NCT01988103|516615386|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
143290957|NCT01988103|516615387|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
143290958|NCT01988103|516615383|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
143290959|NCT01988103|516615384|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
143290960|NCT01988103|516615385|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
143290961|NCT01988103|516615386|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
143290962|NCT01988103|516615387|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
143290963|NCT01988103|516615383|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
143290964|NCT01988103|516615384|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
143290965|NCT01988103|516615385|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
143290966|NCT01988103|516615386|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
143290967|NCT01988103|516615387|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
143290968|NCT01988103|516615383|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
143290969|NCT01988103|516615384|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
143290970|NCT01988103|516615385|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
143290971|NCT01988103|516615386|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
143290972|NCT01988103|516615387|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
143290973|NCT01988103|516615383|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
143290974|NCT01988103|516615384|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
143290975|NCT01988103|516615385|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
143290976|NCT01988103|516615386|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
143290977|NCT01988103|516615387|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
143290978|NCT01988103|516615383|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
143290979|NCT01988103|516615384|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
143290980|NCT01988103|516615385|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
143290981|NCT01988103|516615386|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
143290982|NCT01988103|516615387|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
143290983|NCT01988103|516615383|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
143290984|NCT01988103|516615384|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
143290985|NCT01988103|516615385|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
143290986|NCT01988103|516615386|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
143290987|NCT01988103|516615387|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
143290988|NCT05492942|516615388|FG000|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|10|||
143290989|NCT05492942|516615389|FG001|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|7|||
143290990|NCT05492942|516615390|FG002|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|8|||
143290991|NCT05492942|516615391|FG003|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|13|||
143290992|NCT02506153|516615392|FG000|Overall Study|Adverse Event|359|||
143290993|NCT02506153|516615393|FG001|Overall Study|Adverse Event|114|||
143290994|NCT02506153|516615392|FG000|Overall Study|Refused unrelated to adverse event|127|||
143290995|NCT02506153|516615393|FG001|Overall Study|Refused unrelated to adverse event|18|||
143290996|NCT02506153|516615392|FG000|Overall Study|Progression/relapse|91|||
143290997|NCT02506153|516615393|FG001|Overall Study|Progression/relapse|136|||
143290998|NCT02506153|516615392|FG000|Overall Study|Death|2|||
143290999|NCT02506153|516615393|FG001|Overall Study|Death|1|||
143291000|NCT02506153|516615392|FG000|Overall Study|Other - not protocol specified|23|||
143291001|NCT02506153|516615393|FG001|Overall Study|Other - not protocol specified|12|||
143291002|NCT00311623|516615401|FG000|Overall Study|Physician Decision|0|||
143291003|NCT00311623|516615402|FG001|Overall Study|Physician Decision|0|||
143291004|NCT00311623|516615403|FG002|Overall Study|Physician Decision|2|||
143291005|NCT05682326|516615404|FG000|Overall Study|Withdrawal by Subject|1|||
143291006|NCT05682326|516615405|FG001|Overall Study|Withdrawal by Subject|0|||
143291007|NCT03070782|516615407|FG000|Overall Study|Adverse Event|3|||
143291008|NCT03070782|516615408|FG001|Overall Study|Adverse Event|0|||
143291009|NCT03070782|516615409|FG002|Overall Study|Adverse Event|3|||
143291010|NCT03070782|516615410|FG003|Overall Study|Adverse Event|1|||
143291011|NCT03070782|516615411|FG004|Overall Study|Adverse Event|6|||
143291012|NCT03070782|516615412|FG005|Overall Study|Adverse Event|2|||
143291013|NCT03070782|516615407|FG000|Overall Study|Withdrawal by Subject|2|||
143291014|NCT03070782|516615408|FG001|Overall Study|Withdrawal by Subject|1|||
143291015|NCT03070782|516615409|FG002|Overall Study|Withdrawal by Subject|1|||
143291016|NCT03070782|516615410|FG003|Overall Study|Withdrawal by Subject|0|||
143291017|NCT03070782|516615411|FG004|Overall Study|Withdrawal by Subject|4|||
143291018|NCT03070782|516615412|FG005|Overall Study|Withdrawal by Subject|3|||
143291019|NCT03070782|516615407|FG000|Overall Study|Reason Not Specified|2|||
143291020|NCT03070782|516615408|FG001|Overall Study|Reason Not Specified|0|||
143291021|NCT03070782|516615409|FG002|Overall Study|Reason Not Specified|0|||
143291022|NCT03070782|516615410|FG003|Overall Study|Reason Not Specified|1|||
143291023|NCT03070782|516615411|FG004|Overall Study|Reason Not Specified|2|||
143291024|NCT03070782|516615412|FG005|Overall Study|Reason Not Specified|1|||
143291025|NCT03070782|516615407|FG000|Overall Study|Ineligibility|0|||
143291026|NCT03070782|516615408|FG001|Overall Study|Ineligibility|0|||
143291027|NCT03070782|516615409|FG002|Overall Study|Ineligibility|0|||
143291028|NCT03070782|516615410|FG003|Overall Study|Ineligibility|1|||
143291029|NCT03070782|516615411|FG004|Overall Study|Ineligibility|0|||
143291030|NCT03070782|516615412|FG005|Overall Study|Ineligibility|1|||
143291031|NCT03070782|516615407|FG000|Overall Study|Pregnancy|0|||
143291032|NCT03070782|516615408|FG001|Overall Study|Pregnancy|0|||
143291033|NCT03070782|516615409|FG002|Overall Study|Pregnancy|0|||
143291034|NCT03070782|516615410|FG003|Overall Study|Pregnancy|1|||
143291035|NCT03070782|516615411|FG004|Overall Study|Pregnancy|0|||
143291036|NCT03070782|516615412|FG005|Overall Study|Pregnancy|0|||
143291037|NCT03070782|516615407|FG000|Overall Study|Investigator Judgement|0|||
143291038|NCT03070782|516615408|FG001|Overall Study|Investigator Judgement|0|||
143291039|NCT03070782|516615409|FG002|Overall Study|Investigator Judgement|0|||
143291040|NCT03070782|516615410|FG003|Overall Study|Investigator Judgement|1|||
143291041|NCT03070782|516615411|FG004|Overall Study|Investigator Judgement|0|||
143291042|NCT03070782|516615412|FG005|Overall Study|Investigator Judgement|0|||
143291043|NCT01314443|516615413|FG000|Overall Study|Withdrawal by Subject|2|||
143291044|NCT01314443|516615414|FG001|Overall Study|Withdrawal by Subject|1|||
143291045|NCT01314443|516615415|FG002|Overall Study|Withdrawal by Subject|1|||
143291046|NCT01314443|516615416|FG003|Overall Study|Withdrawal by Subject|1|||
143291047|NCT01314443|516615413|FG000|Overall Study|Protocol Violation|2|||
143291048|NCT01314443|516615414|FG001|Overall Study|Protocol Violation|2|||
143291049|NCT01314443|516615415|FG002|Overall Study|Protocol Violation|1|||
143291050|NCT01314443|516615416|FG003|Overall Study|Protocol Violation|1|||
143291051|NCT06133348|516615417|FG000|Overall Study|Death|3|||
143291052|NCT06133348|516615417|FG000|Overall Study|Lost to Follow-up|1|||
143291053|NCT06133348|516615417|FG000|Overall Study|Physician Decision|1|||
143291054|NCT06133348|516615417|FG000|Overall Study|Withdrawal by Subject|5|||
143291055|NCT02567435|516615421|FG000|Overall Study|Death|1|||
143291056|NCT02567435|516615422|FG001|Overall Study|Death|1|||
143291057|NCT02567435|516615423|FG002|Overall Study|Death|0|||
143291058|NCT02567435|516615424|FG003|Overall Study|Death|0|||
143291059|NCT02567435|516615421|FG000|Overall Study|Ineligible|1|||
143291060|NCT02567435|516615422|FG001|Overall Study|Ineligible|3|||
143291061|NCT02567435|516615423|FG002|Overall Study|Ineligible|0|||
143291062|NCT02567435|516615424|FG003|Overall Study|Ineligible|0|||
143291063|NCT02567435|516615421|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
143291064|NCT02567435|516615422|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
143291065|NCT02567435|516615423|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
143291066|NCT02567435|516615424|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
143291067|NCT00241280|516615428|FG000|Overall Study|Adverse Event|2|||
143291068|NCT00241280|516615429|FG001|Overall Study|Adverse Event|6|||
143291069|NCT00241280|516615428|FG000|Overall Study|Discomfort|11|||
143291070|NCT00241280|516615429|FG001|Overall Study|Discomfort|16|||
143291071|NCT00241280|516615428|FG000|Overall Study|Pregnancy|1|||
143291072|NCT00241280|516615429|FG001|Overall Study|Pregnancy|5|||
143291073|NCT00241280|516615428|FG000|Overall Study|Lost to Follow-up|5|||
143291074|NCT00241280|516615429|FG001|Overall Study|Lost to Follow-up|8|||
143291075|NCT00241280|516615428|FG000|Overall Study|Withdrawal by Subject|7|||
143291076|NCT00241280|516615429|FG001|Overall Study|Withdrawal by Subject|4|||
143291077|NCT00241280|516615428|FG000|Overall Study|Protocol Violation|4|||
143291078|NCT00241280|516615429|FG001|Overall Study|Protocol Violation|10|||
143291079|NCT00241280|516615428|FG000|Overall Study|Relocation|4|||
143291080|NCT00241280|516615429|FG001|Overall Study|Relocation|4|||
143291081|NCT00241280|516615428|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
143291082|NCT00241280|516615429|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
143291083|NCT00241280|516615428|FG000|Overall Study|Unsatisfactory Visual Response|1|||
143291084|NCT00241280|516615429|FG001|Overall Study|Unsatisfactory Visual Response|1|||
143291085|NCT00241280|516615428|FG000|Overall Study|Diabetic|1|||
143291086|NCT00241280|516615429|FG001|Overall Study|Diabetic|0|||
143291087|NCT00241280|516615428|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
143291088|NCT00241280|516615429|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
143291089|NCT00241280|516615428|FG000|Overall Study|Dispensed incorrect test article|1|||
143291090|NCT00241280|516615429|FG001|Overall Study|Dispensed incorrect test article|2|||
143291091|NCT00241280|516615428|FG000|Overall Study|Unacceptable Fit|0|||
143291092|NCT00241280|516615429|FG001|Overall Study|Unacceptable Fit|1|||
143291093|NCT00241280|516615428|FG000|Overall Study|Scheduling Conflict|0|||
143291094|NCT00241280|516615429|FG001|Overall Study|Scheduling Conflict|2|||
143291095|NCT00241280|516615428|FG000|Overall Study|History of Ocular Surgery|0|||
143291096|NCT00241280|516615429|FG001|Overall Study|History of Ocular Surgery|1|||
143291097|NCT00241280|516615428|FG000|Overall Study|Coating on Lens|1|||
143291098|NCT00241280|516615429|FG001|Overall Study|Coating on Lens|0|||
143291099|NCT00241280|516615428|FG000|Overall Study|Excessive Dryness|0|||
143291100|NCT00241280|516615429|FG001|Overall Study|Excessive Dryness|1|||
143291101|NCT01634360|516615430|FG000|Overall Study|Adverse Event|10|||
143291102|NCT01634360|516615431|FG001|Overall Study|Adverse Event|34|||
143291103|NCT01634360|516615430|FG000|Overall Study|subject withdrew consent|13|||
143291104|NCT01634360|516615431|FG001|Overall Study|subject withdrew consent|23|||
143291105|NCT01634360|516615430|FG000|Overall Study|Protocol Violation|1|||
143291106|NCT01634360|516615431|FG001|Overall Study|Protocol Violation|1|||
143291107|NCT01634360|516615430|FG000|Overall Study|Lack of Efficacy|4|||
143291108|NCT01634360|516615431|FG001|Overall Study|Lack of Efficacy|14|||
143291109|NCT01634360|516615430|FG000|Overall Study|Other|3|||
143291110|NCT01634360|516615431|FG001|Overall Study|Other|20|||
143291111|NCT01634360|516615430|FG000|Overall Study|Study termination by sponsor|18|||
143291112|NCT01634360|516615431|FG001|Overall Study|Study termination by sponsor|44|||
143291113|NCT03428360|516615432|FG000|Overall Study|Informed consent withdrawn|5|||
143291114|NCT03428360|516615432|FG000|Overall Study|Withdrawal by Subject|4|||
143291115|NCT03428360|516615432|FG000|Overall Study|Lost to Follow-up|5|||
143291116|NCT03428360|516615432|FG000|Overall Study|Physician Decision|2|||
143291117|NCT03428360|516615432|FG000|Overall Study|Informed consent withdrawn|5|||
143291118|NCT03428360|516615432|FG000|Overall Study|Study terminated by sponsor|10|||
143291119|NCT03428360|516615432|FG000|Overall Study|Non-compliant with study|1|||
143291120|NCT03428360|516615432|FG000|Overall Study|Non-compliant with study drug|3|||
143291121|NCT03428360|516615432|FG000|Overall Study|Death|3|||
143291122|NCT03428360|516615432|FG000|Overall Study|Adverse Event|1|||
143291123|NCT03428360|516615432|FG000|Overall Study|Not on antiepileptic drug|1|||
143291124|NCT01244425|516615433|FG000|Overall Study|Withdrawal by Subject|2|||
143291125|NCT01244425|516615434|FG001|Overall Study|Withdrawal by Subject|2|||
143291126|NCT01244425|516615433|FG000|Overall Study|Adverse Event|1|||
143291127|NCT01244425|516615434|FG001|Overall Study|Adverse Event|1|||
143291128|NCT00368355|516615435|FG000|Overall Study|Adverse Event|1|||
143291129|NCT00368355|516615436|FG001|Overall Study|Adverse Event|0|||
143291130|NCT00368355|516615435|FG000|Overall Study|Death|2|||
143291131|NCT00368355|516615436|FG001|Overall Study|Death|4|||
143291132|NCT00368355|516615435|FG000|Overall Study|Relapse|6|||
143291133|NCT00368355|516615436|FG001|Overall Study|Relapse|10|||
143291134|NCT00368355|516615435|FG000|Overall Study|Subsequent transplant|0|||
143291135|NCT00368355|516615436|FG001|Overall Study|Subsequent transplant|3|||
143291136|NCT00368355|516615435|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
143291137|NCT00368355|516615436|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
143291138|NCT01013701|516615445|FG000|Overall Study|study prematurely terminated|7|||
143291139|NCT03241342|516615446|FG000|Overall Study|Adverse Event|5|||
143291140|NCT03241342|516615447|FG001|Overall Study|Adverse Event|8|||
143291141|NCT03241342|516615448|FG002|Overall Study|Adverse Event|4|||
143291142|NCT03241342|516615446|FG000|Overall Study|Lack of Efficacy|0|||
143291143|NCT03241342|516615447|FG001|Overall Study|Lack of Efficacy|0|||
143291144|NCT03241342|516615448|FG002|Overall Study|Lack of Efficacy|1|||
143291145|NCT03241342|516615446|FG000|Overall Study|noncompliance with study drug|2|||
143291146|NCT03241342|516615447|FG001|Overall Study|noncompliance with study drug|1|||
143291147|NCT03241342|516615448|FG002|Overall Study|noncompliance with study drug|1|||
143291148|NCT03241342|516615446|FG000|Overall Study|sponsor decision|0|||
143291149|NCT03241342|516615447|FG001|Overall Study|sponsor decision|1|||
143291150|NCT03241342|516615448|FG002|Overall Study|sponsor decision|2|||
143291151|NCT03241342|516615446|FG000|Overall Study|not reported|15|||
143291152|NCT03241342|516615447|FG001|Overall Study|not reported|21|||
143291153|NCT03241342|516615448|FG002|Overall Study|not reported|19|||
143291154|NCT00556712|516615450|FG000|Overall Study|Adverse Event|7|||
143291155|NCT00556712|516615451|FG001|Overall Study|Adverse Event|19|||
143291156|NCT00556712|516615450|FG000|Overall Study|Death|5|||
143291157|NCT00556712|516615451|FG001|Overall Study|Death|10|||
143291158|NCT00556712|516615450|FG000|Overall Study|Progressive Disease|383|||
143291159|NCT00556712|516615451|FG001|Overall Study|Progressive Disease|320|||
143291160|NCT00556712|516615450|FG000|Overall Study|Protocol Violation|3|||
143291161|NCT00556712|516615451|FG001|Overall Study|Protocol Violation|2|||
143291162|NCT00556712|516615450|FG000|Overall Study|Refused Treatment|17|||
143291163|NCT00556712|516615451|FG001|Overall Study|Refused Treatment|16|||
143291164|NCT00556712|516615450|FG000|Overall Study|Failure to Return|2|||
143291165|NCT00556712|516615451|FG001|Overall Study|Failure to Return|3|||
143291166|NCT00556712|516615450|FG000|Overall Study|Other|2|||
143291167|NCT00556712|516615451|FG001|Overall Study|Other|2|||
143291168|NCT00556712|516615450|FG000|Overall Study|Ongoing at Data Cutoff|32|||
143291169|NCT00556712|516615451|FG001|Overall Study|Ongoing at Data Cutoff|66|||
143291170|NCT01059799|516615454|FG000|Overall Study|Adverse Event|2|||
143291171|NCT01059799|516615455|FG001|Overall Study|Adverse Event|3|||
143291172|NCT01059799|516615454|FG000|Overall Study|Lack of Efficacy|1|||
143291173|NCT01059799|516615455|FG001|Overall Study|Lack of Efficacy|0|||
143291174|NCT01059799|516615454|FG000|Overall Study|Protocol Violation|3|||
143373749|NCT02477670|516913566|FG003|Stage 1|Lost to Follow-up|0|||
143373750|NCT02477670|516913567|FG004|Stage 1|Lost to Follow-up|0|||
143291175|NCT01059799|516615455|FG001|Overall Study|Protocol Violation|2|||
143291176|NCT01059799|516615454|FG000|Overall Study|Withdrawal criteria|13|||
143291177|NCT01059799|516615455|FG001|Overall Study|Withdrawal criteria|2|||
143291178|NCT01059799|516615454|FG000|Overall Study|Other|12|||
143291179|NCT01059799|516615455|FG001|Overall Study|Other|3|||
143291180|NCT01905657|516615457|FG000|Overall Study|Adverse Event|23|||
143291181|NCT01905657|516615458|FG001|Overall Study|Adverse Event|17|||
143291182|NCT01905657|516615459|FG002|Overall Study|Adverse Event|18|||
143291183|NCT01905657|516615457|FG000|Overall Study|Clinical Progression|103|||
143291184|NCT01905657|516615458|FG001|Overall Study|Clinical Progression|78|||
143291185|NCT01905657|516615459|FG002|Overall Study|Clinical Progression|59|||
143291186|NCT01905657|516615457|FG000|Overall Study|Death|40|||
143291187|NCT01905657|516615458|FG001|Overall Study|Death|43|||
143291188|NCT01905657|516615459|FG002|Overall Study|Death|47|||
143291189|NCT01905657|516615457|FG000|Overall Study|Excluded Medication|13|||
143291190|NCT01905657|516615458|FG001|Overall Study|Excluded Medication|16|||
143291191|NCT01905657|516615459|FG002|Overall Study|Excluded Medication|9|||
143291192|NCT01905657|516615457|FG000|Overall Study|Lost to Follow-up|1|||
143373751|NCT02477670|516913568|FG005|Stage 1|Lost to Follow-up|0|||
143373752|NCT02477670|516913569|FG006|Stage 1|Lost to Follow-up|0|||
143291193|NCT01905657|516615458|FG001|Overall Study|Lost to Follow-up|2|||
143291194|NCT01905657|516615459|FG002|Overall Study|Lost to Follow-up|1|||
143291195|NCT01905657|516615457|FG000|Overall Study|Physician Decision|5|||
143291196|NCT01905657|516615458|FG001|Overall Study|Physician Decision|8|||
143291197|NCT01905657|516615459|FG002|Overall Study|Physician Decision|12|||
143291198|NCT01905657|516615457|FG000|Overall Study|Protocol Violation|2|||
143291199|NCT01905657|516615458|FG001|Overall Study|Protocol Violation|1|||
143291200|NCT01905657|516615459|FG002|Overall Study|Protocol Violation|1|||
143291201|NCT01905657|516615457|FG000|Overall Study|Screen Failure|0|||
143291202|NCT01905657|516615458|FG001|Overall Study|Screen Failure|1|||
143291203|NCT01905657|516615459|FG002|Overall Study|Screen Failure|0|||
143291204|NCT01905657|516615457|FG000|Overall Study|Withdrawal by Subject|15|||
143291205|NCT01905657|516615458|FG001|Overall Study|Withdrawal by Subject|21|||
143291206|NCT01905657|516615459|FG002|Overall Study|Withdrawal by Subject|53|||
143291207|NCT01905657|516615457|FG000|Overall Study|Sponsor Decision|1|||
143291208|NCT01905657|516615458|FG001|Overall Study|Sponsor Decision|0|||
143291209|NCT01905657|516615459|FG002|Overall Study|Sponsor Decision|0|||
143291210|NCT02744391|516615460|FG000|Overall Study|Lost to Follow-up|9|||
143291211|NCT02744391|516615460|FG000|Overall Study|Physician Decision|2|||
143291212|NCT02744391|516615460|FG000|Overall Study|Withdrawal by Subject|3|||
143291213|NCT01535053|516615465|FG000|Overall Study|Ineligible|1|||
143291214|NCT01535053|516615466|FG001|Overall Study|Ineligible|2|||
143291215|NCT01031069|516615467|FG000|Overall Study|Serious Adverse Event|0|||
143291216|NCT01031069|516615468|FG001|Overall Study|Serious Adverse Event|1|||
143291217|NCT01031069|516615469|FG002|Overall Study|Serious Adverse Event|0|||
143291218|NCT01031069|516615470|FG003|Overall Study|Serious Adverse Event|0|||
143291219|NCT01031069|516615467|FG000|Overall Study|Withdrawal by Subject|2|||
143291220|NCT01031069|516615468|FG001|Overall Study|Withdrawal by Subject|3|||
143291221|NCT01031069|516615469|FG002|Overall Study|Withdrawal by Subject|18|||
143291222|NCT01031069|516615470|FG003|Overall Study|Withdrawal by Subject|18|||
143291223|NCT01031069|516615467|FG000|Overall Study|Migrated/moved from study area|1|||
143291224|NCT01031069|516615468|FG001|Overall Study|Migrated/moved from study area|2|||
143291225|NCT01031069|516615469|FG002|Overall Study|Migrated/moved from study area|1|||
143291226|NCT01031069|516615470|FG003|Overall Study|Migrated/moved from study area|1|||
143291227|NCT01031069|516615467|FG000|Overall Study|Lost to Follow-up|9|||
143291228|NCT01031069|516615468|FG001|Overall Study|Lost to Follow-up|5|||
143291229|NCT01031069|516615469|FG002|Overall Study|Lost to Follow-up|21|||
143291230|NCT01031069|516615470|FG003|Overall Study|Lost to Follow-up|15|||
143291231|NCT01031069|516615467|FG000|Overall Study|Other|0|||
143291232|NCT01031069|516615468|FG001|Overall Study|Other|0|||
143291233|NCT01031069|516615469|FG002|Overall Study|Other|1|||
143291234|NCT01031069|516615470|FG003|Overall Study|Other|0|||
143291235|NCT03032705|516615472|FG000|Overall Study|Lost to Follow-up|16|||
143291236|NCT03032705|516615473|FG001|Overall Study|Lost to Follow-up|17|||
143291237|NCT03032705|516615472|FG000|Overall Study|did not quality|6|||
143291238|NCT03032705|516615473|FG001|Overall Study|did not quality|6|||
143291239|NCT02180867|516615474|FG000|Overall Study|Adverse Event|3|||
143291240|NCT02180867|516615475|FG001|Overall Study|Adverse Event|4|||
143291241|NCT02180867|516615476|FG002|Overall Study|Adverse Event|1|||
143291242|NCT02180867|516615477|FG003|Overall Study|Adverse Event|5|||
143291243|NCT02180867|516615478|FG004|Overall Study|Adverse Event|0|||
143291244|NCT02180867|516615479|FG005|Overall Study|Adverse Event|0|||
143291245|NCT02180867|516615480|FG006|Overall Study|Adverse Event|0|||
143291246|NCT02180867|516615474|FG000|Overall Study|Death|0|||
143291247|NCT02180867|516615475|FG001|Overall Study|Death|0|||
143291248|NCT02180867|516615476|FG002|Overall Study|Death|0|||
143291249|NCT02180867|516615477|FG003|Overall Study|Death|0|||
143291250|NCT02180867|516615478|FG004|Overall Study|Death|1|||
143291251|NCT02180867|516615479|FG005|Overall Study|Death|0|||
143291252|NCT02180867|516615480|FG006|Overall Study|Death|0|||
143291253|NCT02180867|516615474|FG000|Overall Study|Lack of Efficacy|0|||
143373753|NCT02477670|516913563|FG000|Stage 1|Withdrawal by Subject|1|||
143291254|NCT02180867|516615475|FG001|Overall Study|Lack of Efficacy|2|||
143291255|NCT02180867|516615476|FG002|Overall Study|Lack of Efficacy|0|||
143373754|NCT02477670|516913564|FG001|Stage 1|Withdrawal by Subject|2|||
143291256|NCT02180867|516615477|FG003|Overall Study|Lack of Efficacy|1|||
143291257|NCT02180867|516615478|FG004|Overall Study|Lack of Efficacy|6|||
143373755|NCT02477670|516913565|FG002|Stage 1|Withdrawal by Subject|0|||
143291258|NCT02180867|516615479|FG005|Overall Study|Lack of Efficacy|0|||
143291259|NCT02180867|516615480|FG006|Overall Study|Lack of Efficacy|1|||
143291260|NCT02180867|516615474|FG000|Overall Study|Physician Decision|1|||
143291261|NCT02180867|516615475|FG001|Overall Study|Physician Decision|3|||
143291262|NCT02180867|516615476|FG002|Overall Study|Physician Decision|1|||
143291263|NCT02180867|516615477|FG003|Overall Study|Physician Decision|10|||
143291264|NCT02180867|516615478|FG004|Overall Study|Physician Decision|9|||
143291265|NCT02180867|516615479|FG005|Overall Study|Physician Decision|3|||
143373756|NCT02477670|516913566|FG003|Stage 1|Withdrawal by Subject|0|||
143291266|NCT02180867|516615480|FG006|Overall Study|Physician Decision|4|||
143291267|NCT02180867|516615474|FG000|Overall Study|Withdrawal by Subject|0|||
143291268|NCT02180867|516615475|FG001|Overall Study|Withdrawal by Subject|0|||
143291269|NCT02180867|516615476|FG002|Overall Study|Withdrawal by Subject|0|||
143291270|NCT02180867|516615477|FG003|Overall Study|Withdrawal by Subject|1|||
143291271|NCT02180867|516615478|FG004|Overall Study|Withdrawal by Subject|1|||
143291272|NCT02180867|516615479|FG005|Overall Study|Withdrawal by Subject|0|||
143291273|NCT02180867|516615480|FG006|Overall Study|Withdrawal by Subject|0|||
143291274|NCT02180867|516615474|FG000|Overall Study|Ineligible|1|||
143291275|NCT02180867|516615475|FG001|Overall Study|Ineligible|2|||
143291276|NCT02180867|516615476|FG002|Overall Study|Ineligible|0|||
143291277|NCT02180867|516615477|FG003|Overall Study|Ineligible|3|||
143291278|NCT02180867|516615478|FG004|Overall Study|Ineligible|5|||
143291279|NCT02180867|516615479|FG005|Overall Study|Ineligible|0|||
143291280|NCT02180867|516615480|FG006|Overall Study|Ineligible|0|||
143291281|NCT02180867|516615474|FG000|Overall Study|Repeat Eligibility Studies|0|||
143291282|NCT02180867|516615475|FG001|Overall Study|Repeat Eligibility Studies|0|||
143291283|NCT02180867|516615476|FG002|Overall Study|Repeat Eligibility Studies|0|||
143291284|NCT02180867|516615477|FG003|Overall Study|Repeat Eligibility Studies|0|||
143291285|NCT02180867|516615478|FG004|Overall Study|Repeat Eligibility Studies|1|||
143291286|NCT02180867|516615479|FG005|Overall Study|Repeat Eligibility Studies|0|||
143291287|NCT02180867|516615480|FG006|Overall Study|Repeat Eligibility Studies|0|||
143291288|NCT02180867|516615474|FG000|Overall Study|Refusal of further protocol therapy|1|||
143291289|NCT02180867|516615475|FG001|Overall Study|Refusal of further protocol therapy|0|||
143291290|NCT02180867|516615476|FG002|Overall Study|Refusal of further protocol therapy|2|||
143291291|NCT02180867|516615477|FG003|Overall Study|Refusal of further protocol therapy|6|||
143291292|NCT02180867|516615478|FG004|Overall Study|Refusal of further protocol therapy|4|||
143291293|NCT02180867|516615479|FG005|Overall Study|Refusal of further protocol therapy|0|||
143291294|NCT02180867|516615480|FG006|Overall Study|Refusal of further protocol therapy|0|||
143291295|NCT03578367|516615481|FG000|Overall Study|Adverse Event|0|||
143291296|NCT03578367|516615482|FG001|Overall Study|Adverse Event|3|||
143291297|NCT03578367|516615483|FG002|Overall Study|Adverse Event|0|||
143291298|NCT03578367|516615484|FG003|Overall Study|Adverse Event|5|||
143291299|NCT03578367|516615481|FG000|Overall Study|Withdrawal by Subject|2|||
143291300|NCT03578367|516615482|FG001|Overall Study|Withdrawal by Subject|2|||
143291301|NCT03578367|516615483|FG002|Overall Study|Withdrawal by Subject|1|||
143291302|NCT03578367|516615484|FG003|Overall Study|Withdrawal by Subject|3|||
143291303|NCT03578367|516615481|FG000|Overall Study|Physician Decision|0|||
143291304|NCT03578367|516615482|FG001|Overall Study|Physician Decision|0|||
143291305|NCT03578367|516615483|FG002|Overall Study|Physician Decision|14|||
143291306|NCT03578367|516615484|FG003|Overall Study|Physician Decision|0|||
143291307|NCT03578367|516615481|FG000|Overall Study|Death|1|||
143291308|NCT03578367|516615482|FG001|Overall Study|Death|0|||
143291309|NCT03578367|516615483|FG002|Overall Study|Death|0|||
143291310|NCT03578367|516615484|FG003|Overall Study|Death|0|||
143291311|NCT03578367|516615481|FG000|Overall Study|Not treated|0|||
143291312|NCT03578367|516615482|FG001|Overall Study|Not treated|0|||
143291313|NCT03578367|516615483|FG002|Overall Study|Not treated|1|||
143291314|NCT03578367|516615484|FG003|Overall Study|Not treated|0|||
143291315|NCT02664441|516617316|FG000|Randomization|Withdrawal by Subject|0|||
143291316|NCT02664441|516617317|FG001|Randomization|Withdrawal by Subject|1|||
143291317|NCT02664441|516617316|FG000|36-week Randomized Trial|Adverse Event|2|||
143291318|NCT02664441|516617317|FG001|36-week Randomized Trial|Adverse Event|0|||
143291319|NCT02664441|516617316|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
143291320|NCT02664441|516617317|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
143291321|NCT02664441|516617316|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
143291322|NCT02664441|516617317|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
143291323|NCT02664441|516617316|FG000|18-week Open Label Extension|Adverse Event|1|||
143291324|NCT02664441|516617317|FG001|18-week Open Label Extension|Adverse Event|0|||
143291325|NCT02664441|516617316|FG000|18-week Open Label Extension|Physician Decision|1|||
143291326|NCT02664441|516617317|FG001|18-week Open Label Extension|Physician Decision|0|||
143291327|NCT02664441|516617316|FG000|18-week Open Label Extension|Death|1|||
143291328|NCT02664441|516617317|FG001|18-week Open Label Extension|Death|0|||
143291329|NCT02664441|516617316|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
143291330|NCT02664441|516617317|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
143291331|NCT05040386|516617318|FG000|Overall Study|Withdrawal by Subject|1|||
143291332|NCT05040386|516617319|FG001|Overall Study|Withdrawal by Subject|0|||
143291333|NCT05040386|516617320|FG002|Overall Study|Withdrawal by Subject|1|||
143291334|NCT05040386|516617321|FG003|Overall Study|Withdrawal by Subject|0|||
143291335|NCT05040386|516617318|FG000|Overall Study|Lost to Follow-up|0|||
143291336|NCT05040386|516617319|FG001|Overall Study|Lost to Follow-up|0|||
143291337|NCT05040386|516617320|FG002|Overall Study|Lost to Follow-up|1|||
143291338|NCT05040386|516617321|FG003|Overall Study|Lost to Follow-up|0|||
143291339|NCT00082355|516617322|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
143291340|NCT00082355|516617322|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
143291341|NCT00082355|516617322|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
143291342|NCT02598076|516617325|FG000|Overall Study|Lost to Follow-up|2|||
143291343|NCT02598076|516617326|FG001|Overall Study|Lost to Follow-up|3|||
143291344|NCT01946425|516617328|FG000|Overall Study|Protocol Violation|1|||
143291345|NCT01946425|516617329|FG001|Overall Study|Protocol Violation|0|||
143291346|NCT01946425|516617328|FG000|Overall Study|Withdrawal by Subject|1|||
143291347|NCT01946425|516617329|FG001|Overall Study|Withdrawal by Subject|0|||
143291348|NCT03103919|516617332|FG000|Overall Study|Adverse Event|2|||
143291349|NCT03103919|516617333|FG001|Overall Study|Adverse Event|2|||
143291350|NCT03998189|516617334|FG000|Overall Study|Lack of Efficacy|0|||
143291351|NCT03998189|516617335|FG001|Overall Study|Lack of Efficacy|1|||
143291352|NCT03454893|516617338|FG000|Overall Study|Study Terminated by the Sponsor|5|||
143291353|NCT03454893|516617338|FG000|Overall Study|Did not pass screening|4|||
143291354|NCT04876274|516617339|FG000|Overall Study|Lost to Follow-up|9|||
143291355|NCT04876274|516617340|FG001|Overall Study|Lost to Follow-up|12|||
143291356|NCT03414424|516617341|FG000|Overall Study|Screened out after consent|0|||
143291357|NCT03414424|516617342|FG001|Overall Study|Screened out after consent|2|||
143291358|NCT03414424|516617341|FG000|Overall Study|Lost to Follow-up|0|||
143291359|NCT03414424|516617342|FG001|Overall Study|Lost to Follow-up|1|||
143291360|NCT03527966|516617343|FG000|Overall Study|Lost to Follow-up|3|||
143291361|NCT03527966|516617344|FG001|Overall Study|Lost to Follow-up|0|||
143291362|NCT01948050|516617345|FG000|Overall Study|Withdrawal by Subject|0|||
143291363|NCT01948050|516617346|FG001|Overall Study|Withdrawal by Subject|1|||
143291364|NCT02288559|516617347|FG000|Overall Study|Adverse Event|1|||
143291365|NCT02288559|516617348|FG001|Overall Study|Adverse Event|1|||
143291366|NCT02288559|516617349|FG002|Overall Study|Adverse Event|5|||
143291367|NCT02288559|516617350|FG003|Overall Study|Adverse Event|0|||
143291368|NCT02288559|516617347|FG000|Overall Study|Death|0|||
143291369|NCT02288559|516617348|FG001|Overall Study|Death|0|||
143291370|NCT02288559|516617349|FG002|Overall Study|Death|1|||
143291371|NCT02288559|516617350|FG003|Overall Study|Death|0|||
143291372|NCT02288559|516617347|FG000|Overall Study|Lost to Follow-up|0|||
143291373|NCT02288559|516617348|FG001|Overall Study|Lost to Follow-up|0|||
143291374|NCT02288559|516617349|FG002|Overall Study|Lost to Follow-up|0|||
143291375|NCT02288559|516617350|FG003|Overall Study|Lost to Follow-up|1|||
143291376|NCT02288559|516617347|FG000|Overall Study|Withdrawal by Subject|0|||
143291377|NCT02288559|516617348|FG001|Overall Study|Withdrawal by Subject|0|||
143291378|NCT02288559|516617349|FG002|Overall Study|Withdrawal by Subject|2|||
143291379|NCT02288559|516617350|FG003|Overall Study|Withdrawal by Subject|1|||
143291380|NCT02288559|516617347|FG000|Overall Study|Reason Not Specified|0|||
143291381|NCT02288559|516617348|FG001|Overall Study|Reason Not Specified|0|||
143291382|NCT02288559|516617349|FG002|Overall Study|Reason Not Specified|3|||
143291383|NCT02288559|516617350|FG003|Overall Study|Reason Not Specified|0|||
143291384|NCT00558025|516617351|FG000|Overall Study|Adverse Event|1|||
143291385|NCT00558025|516617352|FG001|Overall Study|Adverse Event|1|||
143291386|NCT00558025|516617351|FG000|Overall Study|Withdrawal by Subject|2|||
143291387|NCT00558025|516617352|FG001|Overall Study|Withdrawal by Subject|2|||
143291388|NCT00558025|516617351|FG000|Overall Study|Protocol Violation|1|||
143291389|NCT00558025|516617352|FG001|Overall Study|Protocol Violation|0|||
143291390|NCT00449540|516617354|FG000|Pretreatment Phase|No migraine experienced|66|||
143291391|NCT00449540|516617355|FG001|Pretreatment Phase|No migraine experienced|0|||
143291392|NCT00449540|516617356|FG002|Pretreatment Phase|No migraine experienced|0|||
143291393|NCT00449540|516617354|FG000|Treatment Phase|did not experience or treat migraine|0|||
143291394|NCT00449540|516617355|FG001|Treatment Phase|did not experience or treat migraine|20|||
143291395|NCT00449540|516617356|FG002|Treatment Phase|did not experience or treat migraine|17|||
143291396|NCT04545866|516617357|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|1|||
143291397|NCT04545866|516617358|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
143373757|NCT02477670|516913567|FG004|Stage 1|Withdrawal by Subject|0|||
143373758|NCT02477670|516913568|FG005|Stage 1|Withdrawal by Subject|0|||
143373759|NCT02477670|516913569|FG006|Stage 1|Withdrawal by Subject|0|||
143291398|NCT04545866|516617357|FG000|Overall Study|Withdrawal by Physician|1|||
143291399|NCT04545866|516617358|FG001|Overall Study|Withdrawal by Physician|0|||
143291400|NCT05247866|516617359|FG000|Overall Study|Adverse Event|2|||
143291401|NCT05247866|516617359|FG000|Overall Study|Lack of Efficacy|1|||
143291402|NCT05247866|516617359|FG000|Overall Study|Protocol Violation|1|||
143291403|NCT05247866|516617359|FG000|Overall Study|Withdrawal by Subject|3|||
143291404|NCT04463719|516617362|FG000|Overall Study|Exclusion criteria identified during clinical visit|2|||
143291405|NCT04463719|516617363|FG001|Overall Study|Exclusion criteria identified during clinical visit|2|||
143291406|NCT04463719|516617364|FG002|Overall Study|Exclusion criteria identified during clinical visit|0|||
143291407|NCT00333866|516617367|FG000|Overall Study|Adverse Event|23|||
143291408|NCT00333866|516617368|FG001|Overall Study|Adverse Event|37|||
143291409|NCT00333866|516617369|FG002|Overall Study|Adverse Event|38|||
143291410|NCT00333866|516617370|FG003|Overall Study|Adverse Event|47|||
143291411|NCT00333866|516617367|FG000|Overall Study|Other|3|||
143291412|NCT00333866|516617368|FG001|Overall Study|Other|2|||
143291413|NCT00333866|516617369|FG002|Overall Study|Other|2|||
143291414|NCT00333866|516617370|FG003|Overall Study|Other|2|||
143291415|NCT00333866|516617367|FG000|Overall Study|Lack of Efficacy|8|||
143291416|NCT00333866|516617368|FG001|Overall Study|Lack of Efficacy|6|||
143291417|NCT00333866|516617369|FG002|Overall Study|Lack of Efficacy|3|||
143291418|NCT00333866|516617370|FG003|Overall Study|Lack of Efficacy|5|||
143291419|NCT00333866|516617367|FG000|Overall Study|Lost to Follow-up|1|||
143291420|NCT00333866|516617368|FG001|Overall Study|Lost to Follow-up|2|||
143291421|NCT00333866|516617369|FG002|Overall Study|Lost to Follow-up|2|||
143291422|NCT00333866|516617370|FG003|Overall Study|Lost to Follow-up|2|||
143291423|NCT00333866|516617367|FG000|Overall Study|Withdrawal by Subject|8|||
143291424|NCT00333866|516617368|FG001|Overall Study|Withdrawal by Subject|14|||
143291425|NCT00333866|516617369|FG002|Overall Study|Withdrawal by Subject|4|||
143291426|NCT00333866|516617370|FG003|Overall Study|Withdrawal by Subject|9|||
143291427|NCT00333866|516617367|FG000|Overall Study|Randomized but not Treated|5|||
143291428|NCT00333866|516617368|FG001|Overall Study|Randomized but not Treated|3|||
143291429|NCT00333866|516617369|FG002|Overall Study|Randomized but not Treated|2|||
143291430|NCT00333866|516617370|FG003|Overall Study|Randomized but not Treated|1|||
143291431|NCT06073119|516617371|FG000|Overall Study|Adverse Event|1|||
143291432|NCT06073119|516617372|FG001|Overall Study|Adverse Event|3|||
143291433|NCT06073119|516617373|FG002|Overall Study|Adverse Event|0|||
143291434|NCT06073119|516617374|FG003|Overall Study|Adverse Event|0|||
143291435|NCT06073119|516617375|FG004|Overall Study|Adverse Event|1|||
143291436|NCT06073119|516617376|FG005|Overall Study|Adverse Event|0|||
143291437|NCT06073119|516617371|FG000|Overall Study|Non-compliance with study schedule|1|||
143291438|NCT06073119|516617372|FG001|Overall Study|Non-compliance with study schedule|0|||
143291439|NCT06073119|516617373|FG002|Overall Study|Non-compliance with study schedule|0|||
143291440|NCT06073119|516617374|FG003|Overall Study|Non-compliance with study schedule|0|||
143291441|NCT06073119|516617375|FG004|Overall Study|Non-compliance with study schedule|1|||
143291442|NCT06073119|516617376|FG005|Overall Study|Non-compliance with study schedule|0|||
143291443|NCT06073119|516617371|FG000|Overall Study|Withdrawal by Subject|4|||
143291444|NCT06073119|516617372|FG001|Overall Study|Withdrawal by Subject|4|||
143291445|NCT06073119|516617373|FG002|Overall Study|Withdrawal by Subject|3|||
143291446|NCT06073119|516617374|FG003|Overall Study|Withdrawal by Subject|5|||
143291447|NCT06073119|516617375|FG004|Overall Study|Withdrawal by Subject|3|||
143291448|NCT06073119|516617376|FG005|Overall Study|Withdrawal by Subject|1|||
143291449|NCT06073119|516617371|FG000|Overall Study|Other|2|||
143291450|NCT06073119|516617372|FG001|Overall Study|Other|4|||
143291451|NCT06073119|516617373|FG002|Overall Study|Other|1|||
143291452|NCT06073119|516617374|FG003|Overall Study|Other|0|||
143291453|NCT06073119|516617375|FG004|Overall Study|Other|1|||
143291454|NCT06073119|516617376|FG005|Overall Study|Other|0|||
143291455|NCT02393547|516617379|FG000|Overall Study|Adverse Event|2|||
143291456|NCT02393547|516617379|FG000|Overall Study|Withdrawal by Subject|3|||
143291457|NCT02393547|516617379|FG000|Overall Study|Lost to Follow-up|1|||
143291458|NCT02979522|516617380|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
143291459|NCT02979522|516617381|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
143291460|NCT02979522|516617380|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
143291461|NCT02979522|516617381|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
143291462|NCT05185089|516617382|FG000|First Intervention (4 weeks)|Adverse Event|0|||
143291463|NCT05185089|516617383|FG001|First Intervention (4 weeks)|Adverse Event|0|||
143291464|NCT05185089|516617384|FG002|First Intervention (4 weeks)|Adverse Event|0|||
143291465|NCT05185089|516617385|FG003|First Intervention (4 weeks)|Adverse Event|1|||
143291466|NCT05185089|516617382|FG000|Second Intervention (4 weeks)|Death|0|||
143291467|NCT05185089|516617383|FG001|Second Intervention (4 weeks)|Death|1|||
143291468|NCT05185089|516617384|FG002|Second Intervention (4 weeks)|Death|0|||
143291469|NCT05185089|516617385|FG003|Second Intervention (4 weeks)|Death|0|||
143291470|NCT05185089|516617382|FG000|Second Intervention (4 weeks)|Adverse Event|1|||
143291471|NCT05185089|516617383|FG001|Second Intervention (4 weeks)|Adverse Event|0|||
143291472|NCT05185089|516617384|FG002|Second Intervention (4 weeks)|Adverse Event|0|||
143291473|NCT05185089|516617385|FG003|Second Intervention (4 weeks)|Adverse Event|0|||
143291474|NCT00667368|516617386|FG000|Overall Study|Lost to Follow-up|176|||
143291475|NCT00667368|516617387|FG001|Overall Study|Lost to Follow-up|155|||
143291476|NCT00667368|516617386|FG000|Overall Study|Discontinued early|24|||
143291477|NCT00667368|516617387|FG001|Overall Study|Discontinued early|17|||
143291478|NCT05582889|516617389|FG000|Overall Study|Health event|3|||
143291479|NCT05582889|516617390|FG001|Overall Study|Health event|2|||
143291480|NCT05582889|516617389|FG000|Overall Study|Lost to Follow-up|2|||
143291481|NCT05582889|516617390|FG001|Overall Study|Lost to Follow-up|4|||
143291482|NCT06112756|516617391|FG000|Overall Study|Withdrawal by Subject|0|||
143291483|NCT06112756|516617392|FG001|Overall Study|Withdrawal by Subject|2|||
143291484|NCT06112756|516617391|FG000|Overall Study|Subject took an out of state job and had to early terminate|1|||
143291485|NCT06112756|516617392|FG001|Overall Study|Subject took an out of state job and had to early terminate|0|||
143291486|NCT06112756|516617391|FG000|Overall Study|Adverse Event|2|||
143291487|NCT06112756|516617392|FG001|Overall Study|Adverse Event|2|||
143291488|NCT04551092|516617393|FG000|Overall Study|Lost to Follow-up|7|||
143291489|NCT04551092|516617393|FG000|Overall Study|Withdrawal by Subject|4|||
143291490|NCT01712490|516617394|FG000|Overall Study|Ongoing|601|||
143291491|NCT01712490|516617395|FG001|Overall Study|Ongoing|586|||
143291492|NCT01712490|516617394|FG000|Overall Study|Other|11|||
143291493|NCT01712490|516617395|FG001|Overall Study|Other|11|||
143291494|NCT01712490|516617394|FG000|Overall Study|Withdrawal by Subject|36|||
143291495|NCT01712490|516617395|FG001|Overall Study|Withdrawal by Subject|44|||
143291496|NCT01712490|516617394|FG000|Overall Study|Lost to Follow-up|16|||
143291497|NCT01712490|516617395|FG001|Overall Study|Lost to Follow-up|29|||
143291498|NCT06079320|516617396|FG000|Follow up Phase|Lost to Follow-up|1|||
143291499|NCT06079320|516617397|FG001|Follow up Phase|Lost to Follow-up|0|||
143291500|NCT01129960|516617398|FG000|Overall Study|Withdrawal by Subject|3|||
143291501|NCT01129960|516617399|FG001|Overall Study|Withdrawal by Subject|0|||
143291502|NCT01129960|516617400|FG002|Overall Study|Withdrawal by Subject|3|||
143291503|NCT01129960|516617401|FG003|Overall Study|Withdrawal by Subject|2|||
143291504|NCT01129960|516617398|FG000|Overall Study|Lack of Efficacy|1|||
143291505|NCT01129960|516617399|FG001|Overall Study|Lack of Efficacy|1|||
143291506|NCT01129960|516617400|FG002|Overall Study|Lack of Efficacy|1|||
143291507|NCT01129960|516617401|FG003|Overall Study|Lack of Efficacy|1|||
143291508|NCT01129960|516617398|FG000|Overall Study|Adverse Event|23|||
143291509|NCT01129960|516617399|FG001|Overall Study|Adverse Event|16|||
143291510|NCT01129960|516617400|FG002|Overall Study|Adverse Event|16|||
143291511|NCT01129960|516617401|FG003|Overall Study|Adverse Event|7|||
143291512|NCT01129960|516617398|FG000|Overall Study|Protocol Violation|1|||
143291513|NCT01129960|516617399|FG001|Overall Study|Protocol Violation|2|||
143291514|NCT01129960|516617400|FG002|Overall Study|Protocol Violation|3|||
143291515|NCT01129960|516617401|FG003|Overall Study|Protocol Violation|0|||
143291516|NCT01129960|516617398|FG000|Overall Study|Lost to Follow-up|0|||
143291517|NCT01129960|516617399|FG001|Overall Study|Lost to Follow-up|2|||
143291518|NCT01129960|516617400|FG002|Overall Study|Lost to Follow-up|3|||
143291519|NCT01129960|516617401|FG003|Overall Study|Lost to Follow-up|3|||
143291520|NCT01129960|516617398|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
143291521|NCT01129960|516617399|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
143291522|NCT01129960|516617400|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
143291523|NCT01129960|516617401|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
143291524|NCT01129960|516617398|FG000|Overall Study|Physician Decision|1|||
143291525|NCT01129960|516617399|FG001|Overall Study|Physician Decision|0|||
143291526|NCT01129960|516617400|FG002|Overall Study|Physician Decision|0|||
143291527|NCT01129960|516617401|FG003|Overall Study|Physician Decision|0|||
143291528|NCT01129960|516617398|FG000|Overall Study|Pregnancy|1|||
143291529|NCT01129960|516617399|FG001|Overall Study|Pregnancy|0|||
143291530|NCT01129960|516617400|FG002|Overall Study|Pregnancy|0|||
143291531|NCT01129960|516617401|FG003|Overall Study|Pregnancy|0|||
143291532|NCT03198234|516617402|FG000|Overall Study|Relapse of primary disease|0|||
143291533|NCT03198234|516617403|FG001|Overall Study|Relapse of primary disease|1|||
143291534|NCT03198234|516617404|FG002|Overall Study|Relapse of primary disease|0|||
143291535|NCT03228537|516617405|FG000|Neoadjuvant|Adverse Event|2|||
143291536|NCT03228537|516617405|FG000|Neoadjuvant|Progression/Relapse|4|||
143291537|NCT03228537|516617405|FG000|Neoadjuvant|Death|1|||
143291538|NCT03228537|516617405|FG000|Surgery|Death|1|||
143291539|NCT03228537|516617405|FG000|Surgery|Other - Not Protocol Specified|2|||
143291540|NCT03228537|516617405|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
143291541|NCT03228537|516617405|FG000|Maintenance|Progression/Relapse|10|||
143291542|NCT04900220|516617406|FG000|Overall Study|Lost to Follow-up|1|||
143291543|NCT04900220|516617407|FG001|Overall Study|Lost to Follow-up|1|||
143291544|NCT02622321|516617408|FG000|Overall Study|Withdrawal by Subject|2|||
143291545|NCT02622321|516617409|FG001|Overall Study|Withdrawal by Subject|0|||
143291546|NCT02622321|516617410|FG002|Overall Study|Withdrawal by Subject|0|||
143291547|NCT02622321|516617411|FG003|Overall Study|Withdrawal by Subject|0|||
143291548|NCT02622321|516617408|FG000|Overall Study|Death|0|||
143291549|NCT02622321|516617409|FG001|Overall Study|Death|0|||
143291550|NCT02622321|516617410|FG002|Overall Study|Death|1|||
143291551|NCT02622321|516617411|FG003|Overall Study|Death|0|||
143291552|NCT02622321|516617408|FG000|Overall Study|Physician Decision|1|||
143291553|NCT02622321|516617409|FG001|Overall Study|Physician Decision|0|||
143291554|NCT02622321|516617410|FG002|Overall Study|Physician Decision|0|||
143291555|NCT02622321|516617411|FG003|Overall Study|Physician Decision|0|||
143291556|NCT00965718|516617412|FG000|Overall Study|Withdrawal by Subject|4|||
143291557|NCT02028065|516617414|FG000|Randomization Through Start Treatment|Not treated|1|||
143291558|NCT02028065|516617415|FG001|Randomization Through Start Treatment|Not treated|3|||
143291559|NCT02028065|516617416|FG002|Randomization Through Start Treatment|Not treated|3|||
143291560|NCT02028065|516617414|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
143291561|NCT02028065|516617415|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
143291562|NCT02028065|516617416|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
143291563|NCT02028065|516617414|FG000|Treatment Through Study Completion|Physician Decision|1|||
143291564|NCT02028065|516617415|FG001|Treatment Through Study Completion|Physician Decision|0|||
143291565|NCT02028065|516617416|FG002|Treatment Through Study Completion|Physician Decision|0|||
143291566|NCT02028065|516617414|FG000|Treatment Through Study Completion|Protocol Violation|1|||
143291567|NCT02028065|516617415|FG001|Treatment Through Study Completion|Protocol Violation|4|||
143291568|NCT02028065|516617416|FG002|Treatment Through Study Completion|Protocol Violation|0|||
143291569|NCT02028065|516617414|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
143291570|NCT02028065|516617415|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
143291571|NCT02028065|516617416|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
143291572|NCT02028065|516617414|FG000|Treatment Through Study Completion|Adverse Event|3|||
143291573|NCT02028065|516617415|FG001|Treatment Through Study Completion|Adverse Event|3|||
143291574|NCT02028065|516617416|FG002|Treatment Through Study Completion|Adverse Event|5|||
143291575|NCT01414855|516617419|FG000|Overall Study|Death|17|||
143291576|NCT01414855|516617419|FG000|Overall Study|Lost to Follow-up|5|||
143291577|NCT01414855|516617419|FG000|Overall Study|Withdrawal by Subject|7|||
143291578|NCT04851314|516617423|FG000|Overall Study|Unable to complete research set-up procedures|0|||
143291579|NCT04851314|516617424|FG001|Overall Study|Unable to complete research set-up procedures|2|||
143291580|NCT04851314|516617423|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
143291581|NCT04851314|516617424|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
143291582|NCT02260921|516617431|FG000|Overall Study|Adverse Event|1|||
143291583|NCT02260921|516617432|FG001|Overall Study|Adverse Event|0|||
143291584|NCT02260921|516617431|FG000|Overall Study|Lost to Follow-up|4|||
143291585|NCT02260921|516617432|FG001|Overall Study|Lost to Follow-up|3|||
143291586|NCT02260921|516617431|FG000|Overall Study|Withdraw Consent|4|||
143291587|NCT02260921|516617432|FG001|Overall Study|Withdraw Consent|1|||
143291588|NCT02260921|516617431|FG000|Overall Study|Death|1|||
143291589|NCT02260921|516617432|FG001|Overall Study|Death|0|||
143291590|NCT02260921|516617431|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
143291591|NCT02260921|516617432|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
143291592|NCT03266094|516617435|FG000|Overall Study|Lost to Follow-up|1|||
143291593|NCT03266094|516617435|FG000|Overall Study|Withdrawal by Subject|1|||
143291594|NCT01962207|516617442|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
143291595|NCT01962207|516617443|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
143291596|NCT01962207|516617444|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
143291597|NCT01962207|516617445|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
143291598|NCT01962207|516617442|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
143291599|NCT01962207|516617443|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
143291600|NCT01962207|516617444|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
143291601|NCT01962207|516617445|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
143291602|NCT01962207|516617442|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
143291603|NCT01962207|516617443|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
143291604|NCT01962207|516617444|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
143291605|NCT01962207|516617445|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
143291606|NCT01962207|516617442|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
143291607|NCT01962207|516617443|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
143291608|NCT01962207|516617444|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
143291609|NCT01962207|516617445|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
143291610|NCT01962207|516617442|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
143291611|NCT01962207|516617443|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
143291612|NCT01962207|516617444|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
143291613|NCT01962207|516617445|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
143291614|NCT01962207|516617442|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
143291615|NCT01962207|516617443|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
143291616|NCT01962207|516617444|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
143291617|NCT01962207|516617445|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
143291618|NCT02289079|516617449|FG000|Overall Study|Physician Decision|2|||
143291619|NCT02289079|516617450|FG001|Overall Study|Physician Decision|0|||
143291620|NCT02289079|516617449|FG000|Overall Study|Lost to Follow-up|0|||
143291621|NCT02289079|516617450|FG001|Overall Study|Lost to Follow-up|1|||
143291622|NCT03036072|516617451|FG000|Overall Study|Death|0|||
143291623|NCT03036072|516617452|FG001|Overall Study|Death|1|||
143291624|NCT03036072|516617451|FG000|Overall Study|Withdrawal by Subject|0|||
143291625|NCT03036072|516617452|FG001|Overall Study|Withdrawal by Subject|1|||
143291626|NCT03036072|516617451|FG000|Overall Study|Physician Decision|0|||
143291627|NCT03036072|516617452|FG001|Overall Study|Physician Decision|1|||
143291628|NCT02671422|516617453|FG000|Overall Study|Lost to Follow-up|1|||
143291629|NCT02671422|516617453|FG000|Overall Study|Adverse Event|68|||
143291630|NCT02671422|516617453|FG000|Overall Study|Lack of Efficacy|1|||
143291631|NCT02671422|516617453|FG000|Overall Study|Lost to Follow-up|4|||
143291632|NCT02671422|516617453|FG000|Overall Study|Withdrawal by Subject|7|||
143291633|NCT02671422|516617453|FG000|Overall Study|Progressive Disease|156|||
143291634|NCT02671422|516617453|FG000|Overall Study|Worsening of Disease|4|||
143291635|NCT02671422|516617453|FG000|Overall Study|Sponsor decision|5|||
143291636|NCT02671422|516617453|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
143291637|NCT02671422|516617453|FG000|Overall Study|Not treated with Vargatef®|3|||
143291638|NCT02671422|516617453|FG000|Overall Study|Other not defined above|3|||
143291639|NCT02484729|516617454|FG000|Overall Study|Failure of IntelliCap Error|0|||
143291640|NCT02484729|516617455|FG001|Overall Study|Failure of IntelliCap Error|0|||
143291641|NCT02484729|516617456|FG002|Overall Study|Failure of IntelliCap Error|0|||
143291642|NCT02484729|516617457|FG003|Overall Study|Failure of IntelliCap Error|0|||
143291643|NCT02484729|516617458|FG004|Overall Study|Failure of IntelliCap Error|0|||
143291644|NCT02484729|516617459|FG005|Overall Study|Failure of IntelliCap Error|0|||
143291645|NCT02484729|516617460|FG006|Overall Study|Failure of IntelliCap Error|0|||
143291646|NCT02484729|516617461|FG007|Overall Study|Failure of IntelliCap Error|0|||
143291647|NCT02484729|516617462|FG008|Overall Study|Failure of IntelliCap Error|0|||
143291648|NCT02484729|516617463|FG009|Overall Study|Failure of IntelliCap Error|1|||
143291649|NCT04772755|516617464|FG000|Overall Study|Withdrawal by Subject|1|||
143291650|NCT04772755|516617465|FG001|Overall Study|Withdrawal by Subject|0|||
143291651|NCT04772755|516617464|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
143291652|NCT04772755|516617465|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
143291653|NCT04080297|516617466|FG000|Overall Study|Adverse Event|1|||
143291654|NCT04080297|516617467|FG001|Overall Study|Adverse Event|3|||
143291655|NCT04080297|516617466|FG000|Overall Study|concurrent illness|1|||
143291656|NCT04080297|516617467|FG001|Overall Study|concurrent illness|0|||
143291657|NCT05838742|516617468|FG000|Overall Study|Adverse Event|2|||
143291658|NCT05838742|516617469|FG001|Overall Study|Adverse Event|0|||
143291659|NCT05838742|516617470|FG002|Overall Study|Adverse Event|1|||
143291660|NCT05838742|516617471|FG003|Overall Study|Adverse Event|0|||
143291661|NCT05838742|516617472|FG004|Overall Study|Adverse Event|1|||
143291662|NCT05838742|516617468|FG000|Overall Study|Lost to Follow-up|1|||
143291663|NCT05838742|516617469|FG001|Overall Study|Lost to Follow-up|1|||
143291664|NCT05838742|516617470|FG002|Overall Study|Lost to Follow-up|1|||
143291665|NCT05838742|516617471|FG003|Overall Study|Lost to Follow-up|0|||
143291666|NCT05838742|516617472|FG004|Overall Study|Lost to Follow-up|0|||
143291667|NCT05838742|516617468|FG000|Overall Study|Physician Decision|0|||
143291668|NCT05838742|516617469|FG001|Overall Study|Physician Decision|0|||
143291669|NCT05838742|516617470|FG002|Overall Study|Physician Decision|0|||
143291670|NCT05838742|516617471|FG003|Overall Study|Physician Decision|0|||
143291671|NCT05838742|516617472|FG004|Overall Study|Physician Decision|1|||
143291672|NCT05838742|516617468|FG000|Overall Study|Withdrawal by Subject|8|||
143291673|NCT05838742|516617469|FG001|Overall Study|Withdrawal by Subject|3|||
143291674|NCT05838742|516617470|FG002|Overall Study|Withdrawal by Subject|3|||
143291675|NCT05838742|516617471|FG003|Overall Study|Withdrawal by Subject|1|||
143291676|NCT05838742|516617472|FG004|Overall Study|Withdrawal by Subject|4|||
143291677|NCT05838742|516617468|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|68|||
143291678|NCT05838742|516617469|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
143291679|NCT05838742|516617470|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|33|||
143291680|NCT05838742|516617471|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
143291681|NCT05838742|516617472|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|32|||
143291682|NCT05838742|516617468|FG000|Overall Study|Lack of Efficacy|0|||
143291683|NCT05838742|516617469|FG001|Overall Study|Lack of Efficacy|0|||
143291684|NCT05838742|516617470|FG002|Overall Study|Lack of Efficacy|0|||
143291685|NCT05838742|516617471|FG003|Overall Study|Lack of Efficacy|1|||
143291686|NCT05838742|516617472|FG004|Overall Study|Lack of Efficacy|0|||
143291687|NCT05838742|516617468|FG000|Overall Study|Randomized, not treated|2|||
143291688|NCT05838742|516617469|FG001|Overall Study|Randomized, not treated|1|||
143291689|NCT05838742|516617470|FG002|Overall Study|Randomized, not treated|0|||
143291690|NCT05838742|516617471|FG003|Overall Study|Randomized, not treated|1|||
143291691|NCT05838742|516617472|FG004|Overall Study|Randomized, not treated|0|||
143291692|NCT05371509|516617473|FG000|Overall Study|Physician Decision|1|||
143291693|NCT05371509|516617474|FG001|Overall Study|Physician Decision|0|||
143291694|NCT03851302|516617477|FG000|Screening (1 Day)|Withdrawal by Subject|0|||
143291695|NCT03851302|516617478|FG001|Screening (1 Day)|Withdrawal by Subject|0|||
143291696|NCT03851302|516617479|FG002|Screening (1 Day)|Withdrawal by Subject|0|||
143291697|NCT03851302|516617480|FG003|Screening (1 Day)|Withdrawal by Subject|1|||
143291698|NCT03851302|516617481|FG004|Screening (1 Day)|Withdrawal by Subject|0|||
143291699|NCT03851302|516617482|FG005|Screening (1 Day)|Withdrawal by Subject|0|||
143291700|NCT03851302|516617477|FG000|Screening (1 Day)|Screened out|0|||
143291701|NCT03851302|516617478|FG001|Screening (1 Day)|Screened out|0|||
143291702|NCT03851302|516617479|FG002|Screening (1 Day)|Screened out|1|||
143291703|NCT03851302|516617480|FG003|Screening (1 Day)|Screened out|1|||
143291704|NCT03851302|516617481|FG004|Screening (1 Day)|Screened out|0|||
143291705|NCT03851302|516617482|FG005|Screening (1 Day)|Screened out|0|||
143291706|NCT03851302|516617477|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
143291707|NCT03851302|516617478|FG001|First Intervention (1 Day)|Withdrawal by Subject|0|||
143291708|NCT03851302|516617479|FG002|First Intervention (1 Day)|Withdrawal by Subject|0|||
143291709|NCT03851302|516617480|FG003|First Intervention (1 Day)|Withdrawal by Subject|0|||
143291710|NCT03851302|516617481|FG004|First Intervention (1 Day)|Withdrawal by Subject|0|||
143291711|NCT03851302|516617482|FG005|First Intervention (1 Day)|Withdrawal by Subject|0|||
143291712|NCT02081690|516619183|FG000|Overall Study|Death|3|||
143291713|NCT02081690|516619183|FG000|Overall Study|Physician Decision|3|||
143291714|NCT02081690|516619183|FG000|Overall Study|Withdrawal by Subject|1|||
143291715|NCT00982488|516619186|FG000|Overall Study|Administrative reason by sponsor|81|||
143291716|NCT00982488|516619187|FG001|Overall Study|Administrative reason by sponsor|3|||
143291717|NCT00982488|516619188|FG002|Overall Study|Administrative reason by sponsor|11|||
143291718|NCT00982488|516619189|FG003|Overall Study|Administrative reason by sponsor|0|||
143291719|NCT00982488|516619190|FG004|Overall Study|Administrative reason by sponsor|0|||
143291720|NCT00982488|516619186|FG000|Overall Study|Adverse event unrelated to study drug|5|||
143291721|NCT00982488|516619187|FG001|Overall Study|Adverse event unrelated to study drug|1|||
143291722|NCT00982488|516619188|FG002|Overall Study|Adverse event unrelated to study drug|0|||
143291723|NCT00982488|516619189|FG003|Overall Study|Adverse event unrelated to study drug|0|||
143291724|NCT00982488|516619190|FG004|Overall Study|Adverse event unrelated to study drug|0|||
143291725|NCT00982488|516619186|FG000|Overall Study|Death|11|||
143291726|NCT00982488|516619187|FG001|Overall Study|Death|0|||
143291727|NCT00982488|516619188|FG002|Overall Study|Death|2|||
143291728|NCT00982488|516619189|FG003|Overall Study|Death|0|||
143291729|NCT00982488|516619190|FG004|Overall Study|Death|0|||
143291730|NCT00982488|516619186|FG000|Overall Study|Disease progression|30|||
143291731|NCT00982488|516619187|FG001|Overall Study|Disease progression|5|||
143291732|NCT00982488|516619188|FG002|Overall Study|Disease progression|10|||
143291733|NCT00982488|516619189|FG003|Overall Study|Disease progression|1|||
143291734|NCT00982488|516619190|FG004|Overall Study|Disease progression|1|||
143291735|NCT00982488|516619186|FG000|Overall Study|Lost to Follow-up|1|||
143291736|NCT00982488|516619187|FG001|Overall Study|Lost to Follow-up|0|||
143291737|NCT00982488|516619188|FG002|Overall Study|Lost to Follow-up|0|||
143291738|NCT00982488|516619189|FG003|Overall Study|Lost to Follow-up|0|||
143291739|NCT00982488|516619190|FG004|Overall Study|Lost to Follow-up|0|||
143291740|NCT00982488|516619186|FG000|Overall Study|Maximum clinical benefit|1|||
143291741|NCT00982488|516619187|FG001|Overall Study|Maximum clinical benefit|1|||
143291742|NCT00982488|516619188|FG002|Overall Study|Maximum clinical benefit|1|||
143291743|NCT00982488|516619189|FG003|Overall Study|Maximum clinical benefit|0|||
143291744|NCT00982488|516619190|FG004|Overall Study|Maximum clinical benefit|0|||
143291745|NCT00982488|516619186|FG000|Overall Study|Other|15|||
143291746|NCT00982488|516619187|FG001|Overall Study|Other|1|||
143291747|NCT00982488|516619188|FG002|Overall Study|Other|3|||
143291748|NCT00982488|516619189|FG003|Overall Study|Other|1|||
143291749|NCT00982488|516619190|FG004|Overall Study|Other|0|||
143291750|NCT00982488|516619186|FG000|Overall Study|Poor compliance/noncompliance|0|||
143291751|NCT00982488|516619187|FG001|Overall Study|Poor compliance/noncompliance|1|||
143291752|NCT00982488|516619188|FG002|Overall Study|Poor compliance/noncompliance|0|||
143291753|NCT00982488|516619189|FG003|Overall Study|Poor compliance/noncompliance|0|||
143291754|NCT00982488|516619190|FG004|Overall Study|Poor compliance/noncompliance|0|||
143291755|NCT00982488|516619186|FG000|Overall Study|Stem cell transplant|2|||
143291756|NCT00982488|516619187|FG001|Overall Study|Stem cell transplant|0|||
143291757|NCT00982488|516619188|FG002|Overall Study|Stem cell transplant|0|||
143291758|NCT00982488|516619189|FG003|Overall Study|Stem cell transplant|1|||
143291759|NCT00982488|516619190|FG004|Overall Study|Stem cell transplant|0|||
143291760|NCT00982488|516619186|FG000|Overall Study|Study drug toxicity|34|||
143291761|NCT00982488|516619187|FG001|Overall Study|Study drug toxicity|1|||
143291762|NCT00982488|516619188|FG002|Overall Study|Study drug toxicity|6|||
143291763|NCT00982488|516619189|FG003|Overall Study|Study drug toxicity|0|||
143291764|NCT00982488|516619190|FG004|Overall Study|Study drug toxicity|0|||
143291765|NCT00982488|516619186|FG000|Overall Study|Withdrawal by Subject|5|||
143291766|NCT00982488|516619187|FG001|Overall Study|Withdrawal by Subject|1|||
143291767|NCT00982488|516619188|FG002|Overall Study|Withdrawal by Subject|1|||
143291768|NCT00982488|516619189|FG003|Overall Study|Withdrawal by Subject|0|||
143291769|NCT00982488|516619190|FG004|Overall Study|Withdrawal by Subject|0|||
143291770|NCT04203238|516619191|FG000|Overall Study|Withdrawal by Subject|1|||
143291771|NCT04203238|516619192|FG001|Overall Study|Withdrawal by Subject|1|||
143291772|NCT04203238|516619191|FG000|Overall Study|Covid-19|3|||
143291773|NCT04203238|516619192|FG001|Overall Study|Covid-19|0|||
143373760|NCT02477670|516913563|FG000|Stage 1|Non-compliance with Study Drug|1|||
143291774|NCT01134783|516619194|FG000|Overall Study|Pregnancy|16|||
143291775|NCT01134783|516619195|FG001|Overall Study|Pregnancy|8|||
143291776|NCT01134783|516619194|FG000|Overall Study|Withdrawal by Subject|15|||
143291777|NCT01134783|516619195|FG001|Overall Study|Withdrawal by Subject|9|||
143291778|NCT01134783|516619194|FG000|Overall Study|Lost to Follow-up|5|||
143373761|NCT02477670|516913564|FG001|Stage 1|Non-compliance with Study Drug|2|||
143291779|NCT01134783|516619195|FG001|Overall Study|Lost to Follow-up|20|||
143291780|NCT00001596|516619196|FG000|Overall Study|Death|1|||
143291781|NCT00001596|516619197|FG001|Overall Study|Death|0|||
143291782|NCT00001596|516619196|FG000|Overall Study|Withdrawal by Subject|3|||
143291783|NCT00001596|516619197|FG001|Overall Study|Withdrawal by Subject|1|||
143291784|NCT00001596|516619196|FG000|Overall Study|Study Termination|12|||
143291785|NCT00001596|516619197|FG001|Overall Study|Study Termination|9|||
143291786|NCT00001596|516619196|FG000|Overall Study|Adverse Event|1|||
143291787|NCT00001596|516619197|FG001|Overall Study|Adverse Event|0|||
143291788|NCT00180414|516619206|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
143291789|NCT00180414|516619207|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
143291790|NCT00463346|516619209|FG000|Overall Study|Withdrawal by Subject|3|||
143291791|NCT00463346|516619210|FG001|Overall Study|Withdrawal by Subject|3|||
143291792|NCT01572909|516619211|FG000|Overall Study|Adverse Event|7|||
143291793|NCT01572909|516619212|FG001|Overall Study|Adverse Event|2|||
143291794|NCT01572909|516619211|FG000|Overall Study|Death|3|||
143291795|NCT01572909|516619212|FG001|Overall Study|Death|1|||
143291796|NCT01572909|516619211|FG000|Overall Study|Lost to Follow-up|8|||
143291797|NCT01572909|516619212|FG001|Overall Study|Lost to Follow-up|7|||
143291798|NCT01572909|516619211|FG000|Overall Study|Physician Decision|1|||
143291799|NCT01572909|516619212|FG001|Overall Study|Physician Decision|1|||
143291800|NCT01572909|516619211|FG000|Overall Study|Technical Issues|1|||
143291801|NCT01572909|516619212|FG001|Overall Study|Technical Issues|0|||
143291802|NCT01572909|516619211|FG000|Overall Study|Withdrawal by Subject|12|||
143291803|NCT01572909|516619212|FG001|Overall Study|Withdrawal by Subject|11|||
143291804|NCT01572909|516619211|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
143291805|NCT01572909|516619212|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
143291806|NCT03641651|516619217|FG000|Overall Study|organizational issues at one study site|1|||
143291807|NCT00951665|516619218|FG000|Phase 1b|Adverse Event|2|||
143291808|NCT00951665|516619219|FG001|Phase 1b|Adverse Event|1|||
143291809|NCT00951665|516619220|FG002|Phase 1b|Adverse Event|0|||
143291810|NCT00951665|516619221|FG003|Phase 1b|Adverse Event|1|||
143291811|NCT00951665|516619222|FG004|Phase 1b|Adverse Event|0|||
143291812|NCT00951665|516619223|FG005|Phase 1b|Adverse Event|0|||
143291813|NCT00951665|516619218|FG000|Phase 1b|Death|1|||
143291814|NCT00951665|516619219|FG001|Phase 1b|Death|0|||
143291815|NCT00951665|516619220|FG002|Phase 1b|Death|2|||
143291816|NCT00951665|516619221|FG003|Phase 1b|Death|0|||
143291817|NCT00951665|516619222|FG004|Phase 1b|Death|0|||
143291818|NCT00951665|516619223|FG005|Phase 1b|Death|0|||
143291819|NCT00951665|516619218|FG000|Phase 1b|Physician Decision|4|||
143291820|NCT00951665|516619219|FG001|Phase 1b|Physician Decision|0|||
143291821|NCT00951665|516619220|FG002|Phase 1b|Physician Decision|1|||
143291822|NCT00951665|516619221|FG003|Phase 1b|Physician Decision|0|||
143291823|NCT00951665|516619222|FG004|Phase 1b|Physician Decision|0|||
143291824|NCT00951665|516619223|FG005|Phase 1b|Physician Decision|0|||
143291825|NCT00951665|516619218|FG000|Phase 1b|Withdrawal by Subject|0|||
143291826|NCT00951665|516619219|FG001|Phase 1b|Withdrawal by Subject|1|||
143291827|NCT00951665|516619220|FG002|Phase 1b|Withdrawal by Subject|0|||
143291828|NCT00951665|516619221|FG003|Phase 1b|Withdrawal by Subject|0|||
143291829|NCT00951665|516619222|FG004|Phase 1b|Withdrawal by Subject|0|||
143291830|NCT00951665|516619223|FG005|Phase 1b|Withdrawal by Subject|0|||
143291831|NCT00951665|516619218|FG000|Phase 1b|Disease Progression|13|||
143291832|NCT00951665|516619219|FG001|Phase 1b|Disease Progression|2|||
143291833|NCT00951665|516619220|FG002|Phase 1b|Disease Progression|14|||
143291834|NCT00951665|516619221|FG003|Phase 1b|Disease Progression|0|||
143291835|NCT00951665|516619222|FG004|Phase 1b|Disease Progression|0|||
143291836|NCT00951665|516619223|FG005|Phase 1b|Disease Progression|0|||
143291837|NCT00951665|516619218|FG000|Phase 1b|Protocol Violation|2|||
143291838|NCT00951665|516619219|FG001|Phase 1b|Protocol Violation|0|||
143291839|NCT00951665|516619220|FG002|Phase 1b|Protocol Violation|0|||
143291840|NCT00951665|516619221|FG003|Phase 1b|Protocol Violation|0|||
143291841|NCT00951665|516619222|FG004|Phase 1b|Protocol Violation|0|||
143291842|NCT00951665|516619223|FG005|Phase 1b|Protocol Violation|0|||
143291843|NCT00951665|516619218|FG000|Phase 2a|Adverse Event|0|||
143291844|NCT00951665|516619219|FG001|Phase 2a|Adverse Event|0|||
143291845|NCT00951665|516619220|FG002|Phase 2a|Adverse Event|0|||
143291846|NCT00951665|516619221|FG003|Phase 2a|Adverse Event|0|||
143291847|NCT00951665|516619222|FG004|Phase 2a|Adverse Event|2|||
143291848|NCT00951665|516619223|FG005|Phase 2a|Adverse Event|0|||
143291849|NCT00951665|516619218|FG000|Phase 2a|Death|0|||
143291850|NCT00951665|516619219|FG001|Phase 2a|Death|0|||
143291851|NCT00951665|516619220|FG002|Phase 2a|Death|0|||
143291852|NCT00951665|516619221|FG003|Phase 2a|Death|0|||
143291853|NCT00951665|516619222|FG004|Phase 2a|Death|1|||
143291854|NCT00951665|516619223|FG005|Phase 2a|Death|1|||
143291855|NCT00951665|516619218|FG000|Phase 2a|Lost to Follow-up|0|||
143291856|NCT00951665|516619219|FG001|Phase 2a|Lost to Follow-up|0|||
143291857|NCT00951665|516619220|FG002|Phase 2a|Lost to Follow-up|0|||
143291858|NCT00951665|516619221|FG003|Phase 2a|Lost to Follow-up|0|||
143291859|NCT00951665|516619222|FG004|Phase 2a|Lost to Follow-up|1|||
143291860|NCT00951665|516619223|FG005|Phase 2a|Lost to Follow-up|0|||
143291861|NCT00951665|516619218|FG000|Phase 2a|Physician Decision|0|||
143291862|NCT00951665|516619219|FG001|Phase 2a|Physician Decision|0|||
143291863|NCT00951665|516619220|FG002|Phase 2a|Physician Decision|0|||
143291864|NCT00951665|516619221|FG003|Phase 2a|Physician Decision|0|||
143291865|NCT00951665|516619222|FG004|Phase 2a|Physician Decision|0|||
143291866|NCT00951665|516619223|FG005|Phase 2a|Physician Decision|1|||
143291867|NCT00951665|516619218|FG000|Phase 2a|Withdrawal by Subject|0|||
143291868|NCT00951665|516619219|FG001|Phase 2a|Withdrawal by Subject|0|||
143291869|NCT00951665|516619220|FG002|Phase 2a|Withdrawal by Subject|0|||
143291870|NCT00951665|516619221|FG003|Phase 2a|Withdrawal by Subject|0|||
143291871|NCT00951665|516619222|FG004|Phase 2a|Withdrawal by Subject|2|||
143291872|NCT00951665|516619223|FG005|Phase 2a|Withdrawal by Subject|0|||
143291873|NCT00951665|516619218|FG000|Phase 2a|Disease Progression|0|||
143291874|NCT00951665|516619219|FG001|Phase 2a|Disease Progression|0|||
143291875|NCT00951665|516619220|FG002|Phase 2a|Disease Progression|0|||
143291876|NCT00951665|516619221|FG003|Phase 2a|Disease Progression|0|||
143291877|NCT00951665|516619222|FG004|Phase 2a|Disease Progression|6|||
143291878|NCT00951665|516619223|FG005|Phase 2a|Disease Progression|5|||
143291879|NCT02723084|516619224|FG000|Overall Study|Withdrawal by Subject|1|||
143291880|NCT02723084|516619225|FG001|Overall Study|Withdrawal by Subject|1|||
143291881|NCT02723084|516619224|FG000|Overall Study|Lost to Follow-up|3|||
143291882|NCT02723084|516619225|FG001|Overall Study|Lost to Follow-up|0|||
143291883|NCT05024058|516619226|FG000|Treatment|Study terminated by sponsor|5|||
143291884|NCT05024058|516619227|FG001|Treatment|Study terminated by sponsor|6|||
143291885|NCT05024058|516619228|FG002|Treatment|Study terminated by sponsor|4|||
143291886|NCT05024058|516619229|FG003|Treatment|Study terminated by sponsor|2|||
143291887|NCT05024058|516619230|FG004|Treatment|Study terminated by sponsor|3|||
143291888|NCT05024058|516619231|FG005|Treatment|Study terminated by sponsor|3|||
143291889|NCT05024058|516619232|FG006|Treatment|Study terminated by sponsor|1|||
143291890|NCT05024058|516619233|FG007|Treatment|Study terminated by sponsor|3|||
143291891|NCT05024058|516619234|FG008|Treatment|Study terminated by sponsor|6|||
143291892|NCT05024058|516619235|FG009|Treatment|Study terminated by sponsor|6|||
143291893|NCT05024058|516619226|FG000|Follow-up|Withdrawal by Subject|1|||
143291894|NCT05024058|516619227|FG001|Follow-up|Withdrawal by Subject|0|||
143291895|NCT05024058|516619228|FG002|Follow-up|Withdrawal by Subject|1|||
143291896|NCT05024058|516619229|FG003|Follow-up|Withdrawal by Subject|0|||
143291897|NCT05024058|516619230|FG004|Follow-up|Withdrawal by Subject|0|||
143291898|NCT05024058|516619231|FG005|Follow-up|Withdrawal by Subject|0|||
143291899|NCT05024058|516619232|FG006|Follow-up|Withdrawal by Subject|0|||
143291900|NCT05024058|516619233|FG007|Follow-up|Withdrawal by Subject|1|||
143291901|NCT05024058|516619234|FG008|Follow-up|Withdrawal by Subject|0|||
143291902|NCT05024058|516619235|FG009|Follow-up|Withdrawal by Subject|1|||
143291903|NCT02734810|516619240|FG000|Overall Study|Adverse Event|1|||
143291904|NCT02734810|516619241|FG001|Overall Study|Adverse Event|0|||
143291905|NCT02734810|516619240|FG000|Overall Study|Lack of Efficacy|1|||
143291906|NCT02734810|516619241|FG001|Overall Study|Lack of Efficacy|0|||
143291907|NCT00127712|516619242|FG000|Overall Study|Adverse Event|3|||
143291908|NCT00127712|516619243|FG001|Overall Study|Adverse Event|0|||
143291909|NCT00127712|516619242|FG000|Overall Study|Lack of GI access to continue|2|||
143291910|NCT00127712|516619243|FG001|Overall Study|Lack of GI access to continue|0|||
143291911|NCT00715078|516619247|FG000|Overall Study|Death|29|||
143291912|NCT00715078|516619248|FG001|Overall Study|Death|36|||
143291913|NCT00715078|516619249|FG002|Overall Study|Death|36|||
143291914|NCT00715078|516619247|FG000|Overall Study|Withdrawal by Subject|1|||
143291915|NCT00715078|516619248|FG001|Overall Study|Withdrawal by Subject|0|||
143291916|NCT00715078|516619249|FG002|Overall Study|Withdrawal by Subject|1|||
143291917|NCT00715078|516619247|FG000|Overall Study|Unable to start due to disease prog.|0|||
143291918|NCT00715078|516619248|FG001|Overall Study|Unable to start due to disease prog.|0|||
143291919|NCT00715078|516619249|FG002|Overall Study|Unable to start due to disease prog.|1|||
143291920|NCT00157950|516619250|FG000|Overall Study|Death|1|||
143291921|NCT00157950|516619251|FG001|Overall Study|Death|0|||
143291922|NCT02892760|516619252|FG000|Overall Study|Withdrawal by Subject|3|||
143291923|NCT00386776|516619257|FG000|Overall Study|Withdrawal by Subject|8|||
143291924|NCT02673489|516619258|FG000|Treatment Period|Lost to Follow-up|3|||
143291925|NCT02673489|516619259|FG001|Treatment Period|Lost to Follow-up|0|||
143291926|NCT02673489|516619258|FG000|Treatment Period|Participant request to discontinue|1|||
143291927|NCT02673489|516619259|FG001|Treatment Period|Participant request to discontinue|1|||
143291928|NCT02673489|516619258|FG000|Treatment Period|Participant moved to another province|1|||
143291929|NCT02673489|516619259|FG001|Treatment Period|Participant moved to another province|0|||
143291930|NCT02673489|516619258|FG000|Treatment Period|Participant was incarcerated|0|||
143291931|NCT02673489|516619259|FG001|Treatment Period|Participant was incarcerated|1|||
143291932|NCT02673489|516619258|FG000|Treatment Period|Adverse Event|0|||
143291933|NCT02673489|516619259|FG001|Treatment Period|Adverse Event|1|||
143291934|NCT02673489|516619258|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
143291935|NCT02673489|516619259|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
143291936|NCT02673489|516619258|FG000|Follow Up Period|Unable to return for follow-up|0|||
143291937|NCT02673489|516619259|FG001|Follow Up Period|Unable to return for follow-up|1|||
143291938|NCT02335489|516619260|FG000|Overall Study|Sponsor terminated study|4|||
143291939|NCT02335489|516619260|FG000|Overall Study|Lost to Follow-up|1|||
143291940|NCT02335489|516619260|FG000|Overall Study|Withdrawal by Subject|2|||
143291941|NCT02335489|516619260|FG000|Overall Study|Physician Decision|2|||
143291942|NCT02335489|516619260|FG000|Overall Study|Lack of Efficacy|1|||
143291943|NCT00759863|516619261|FG000|Overall Study|Death, moved, or lost contact|20|||
143291944|NCT00759863|516619262|FG001|Overall Study|Death, moved, or lost contact|18|||
143291945|NCT00503308|516619266|FG000|Overall Study|Protocol Violation|2|||
143291946|NCT00503308|516619267|FG001|Overall Study|Protocol Violation|1|||
143291947|NCT00531050|516619268|FG000|Part 1: Period 1|Adverse Event|0|||
143291948|NCT00531050|516619269|FG001|Part 1: Period 1|Adverse Event|1|||
143291949|NCT00531050|516619270|FG002|Part 1: Period 1|Adverse Event|0|||
143291950|NCT00531050|516619271|FG003|Part 1: Period 1|Adverse Event|0|||
143291951|NCT00531050|516619272|FG004|Part 1: Period 1|Adverse Event|0|||
143291952|NCT00531050|516619273|FG005|Part 1: Period 1|Adverse Event|0|||
143291953|NCT00531050|516619268|FG000|Part 1: Period 1|Protocol Deviation|0|||
143291954|NCT00531050|516619269|FG001|Part 1: Period 1|Protocol Deviation|0|||
143291955|NCT00531050|516619270|FG002|Part 1: Period 1|Protocol Deviation|0|||
143291956|NCT00531050|516619271|FG003|Part 1: Period 1|Protocol Deviation|1|||
143291957|NCT00531050|516619272|FG004|Part 1: Period 1|Protocol Deviation|0|||
143291958|NCT00531050|516619273|FG005|Part 1: Period 1|Protocol Deviation|0|||
143291959|NCT00531050|516619268|FG000|Part 1: Period 3|Adverse Event|1|||
143291960|NCT00531050|516619269|FG001|Part 1: Period 3|Adverse Event|0|||
143291961|NCT00531050|516619270|FG002|Part 1: Period 3|Adverse Event|0|||
143291962|NCT00531050|516619271|FG003|Part 1: Period 3|Adverse Event|0|||
143291963|NCT00531050|516619272|FG004|Part 1: Period 3|Adverse Event|0|||
143291964|NCT00531050|516619273|FG005|Part 1: Period 3|Adverse Event|0|||
143291965|NCT00531050|516619268|FG000|Part 2: Period 1|Adverse Event|0|||
143291966|NCT00531050|516619269|FG001|Part 2: Period 1|Adverse Event|0|||
143291967|NCT00531050|516619270|FG002|Part 2: Period 1|Adverse Event|0|||
143291968|NCT00531050|516619271|FG003|Part 2: Period 1|Adverse Event|0|||
143291969|NCT00531050|516619272|FG004|Part 2: Period 1|Adverse Event|0|||
143291970|NCT00531050|516619273|FG005|Part 2: Period 1|Adverse Event|1|||
143291971|NCT00531050|516619268|FG000|Part 2: Period 3|Abnormal test procedure|1|||
143291972|NCT00531050|516619269|FG001|Part 2: Period 3|Abnormal test procedure|0|||
143291973|NCT00531050|516619270|FG002|Part 2: Period 3|Abnormal test procedure|0|||
143291974|NCT00531050|516619271|FG003|Part 2: Period 3|Abnormal test procedure|0|||
143291975|NCT00531050|516619272|FG004|Part 2: Period 3|Abnormal test procedure|0|||
143291976|NCT00531050|516619273|FG005|Part 2: Period 3|Abnormal test procedure|1|||
143291977|NCT02233309|516619274|FG000|Overall Study|Physician Decision|5|||
143291978|NCT00799487|516619276|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
143291979|NCT00799487|516619277|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
143291980|NCT00799487|516619278|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
143291981|NCT00799487|516619276|FG000|Dose Adjustment Period|Adverse Event|2|||
143291982|NCT00799487|516619277|FG001|Dose Adjustment Period|Adverse Event|0|||
143291983|NCT00799487|516619278|FG002|Dose Adjustment Period|Adverse Event|0|||
143291984|NCT00799487|516619276|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
143291985|NCT00799487|516619277|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
143291986|NCT00799487|516619278|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
143291987|NCT00799487|516619276|FG000|Dose Adjustment Period|Investigator Discretion|2|||
143291988|NCT00799487|516619277|FG001|Dose Adjustment Period|Investigator Discretion|0|||
143291989|NCT00799487|516619278|FG002|Dose Adjustment Period|Investigator Discretion|0|||
143291990|NCT00799487|516619276|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
143291991|NCT00799487|516619277|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
143291992|NCT00799487|516619278|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
143291993|NCT00799487|516619276|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
143291994|NCT00799487|516619277|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
143291995|NCT00799487|516619278|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
143291996|NCT00799487|516619276|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
143291997|NCT00799487|516619277|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
143291998|NCT00799487|516619278|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
143291999|NCT00799487|516619276|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
143292000|NCT00799487|516619277|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
143292001|NCT00799487|516619278|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
143292002|NCT00799487|516619276|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
143292003|NCT00799487|516619277|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
143292004|NCT00799487|516619278|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
143292005|NCT00799487|516619276|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
143292006|NCT00799487|516619277|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
143292007|NCT00799487|516619278|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
143292008|NCT00799487|516619276|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
143292009|NCT00799487|516619277|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
143292010|NCT00799487|516619278|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
143292011|NCT00799487|516619276|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
143292012|NCT00799487|516619277|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
143292013|NCT00799487|516619278|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
143292014|NCT00232817|516619279|FG000|Overall Study|Protocol Violation|2|||
143292015|NCT00232817|516619280|FG001|Overall Study|Protocol Violation|1|||
143292016|NCT04481750|516619281|FG000|Period 1 (Fasted)|Adverse Event|0|||
143292017|NCT04481750|516619282|FG001|Period 1 (Fasted)|Adverse Event|0|||
143292018|NCT04481750|516619283|FG002|Period 1 (Fasted)|Adverse Event|1|||
143292019|NCT04481750|516619284|FG003|Period 1 (Fasted)|Adverse Event|0|||
143292020|NCT04481750|516619285|FG004|Period 1 (Fasted)|Adverse Event|0|||
143292021|NCT04481750|516619286|FG005|Period 1 (Fasted)|Adverse Event|0|||
143292022|NCT04481750|516619287|FG006|Period 1 (Fasted)|Adverse Event|0|||
143292023|NCT04481750|516619288|FG007|Period 1 (Fasted)|Adverse Event|0|||
143292024|NCT04481750|516619289|FG008|Period 1 (Fasted)|Adverse Event|0|||
143292025|NCT04481750|516619290|FG009|Period 1 (Fasted)|Adverse Event|0|||
143292026|NCT04481750|516619291|FG010|Period 1 (Fasted)|Adverse Event|0|||
143292027|NCT03263442|516619292|FG000|Inpatient Phase|Death|1|||
143292028|NCT03263442|516619293|FG001|Inpatient Phase|Death|0|||
143292029|NCT03263442|516619292|FG000|Inpatient Phase|Withdrawal by Subject|1|||
143292030|NCT03263442|516619293|FG001|Inpatient Phase|Withdrawal by Subject|0|||
143292031|NCT03263442|516619292|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
143292032|NCT03263442|516619293|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
143292033|NCT03263442|516619292|FG000|1-month Follow-Up|Lost to Follow-up|1|||
143292034|NCT03263442|516619293|FG001|1-month Follow-Up|Lost to Follow-up|0|||
143292035|NCT03263442|516619292|FG000|3-month Follow-Up|Lost to Follow-up|1|||
143292036|NCT03263442|516619293|FG001|3-month Follow-Up|Lost to Follow-up|3|||
143292037|NCT03263442|516619292|FG000|6-month Follow-Up|Lost to Follow-up|2|||
143292038|NCT03263442|516619293|FG001|6-month Follow-Up|Lost to Follow-up|2|||
143292039|NCT01463878|516619294|FG000|Overall Study|no longer met criteria for tube feed|2|||
143292040|NCT01463878|516619295|FG001|Overall Study|no longer met criteria for tube feed|2|||
143292041|NCT03804879|516619296|FG000|Overall Study|Adverse Event|3|||
143292042|NCT03804879|516619297|FG001|Overall Study|Adverse Event|0|||
143292043|NCT03804879|516619296|FG000|Overall Study|Study Terminated By Sponsor|10|||
143292044|NCT03804879|516619297|FG001|Overall Study|Study Terminated By Sponsor|12|||
143292045|NCT03804879|516619296|FG000|Overall Study|Withdrawal by Subject|3|||
143292046|NCT03804879|516619297|FG001|Overall Study|Withdrawal by Subject|1|||
143292047|NCT02436889|516619298|FG000|Overall Study|No improvement in symptoms|1|||
143292048|NCT02436889|516619299|FG001|Overall Study|No improvement in symptoms|0|||
143292049|NCT02436889|516619298|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
143292050|NCT02436889|516619299|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
143292051|NCT01034462|516619300|FG000|Overall Study|Adverse Event|7|||
143292052|NCT01034462|516619301|FG001|Overall Study|Adverse Event|17|||
143292053|NCT01034462|516619300|FG000|Overall Study|Lack of Efficacy|4|||
143292054|NCT01034462|516619301|FG001|Overall Study|Lack of Efficacy|4|||
143292055|NCT01034462|516619300|FG000|Overall Study|Protocol Violation|10|||
143292056|NCT01034462|516619301|FG001|Overall Study|Protocol Violation|7|||
143292057|NCT01034462|516619300|FG000|Overall Study|Withdrawal by Subject|9|||
143292058|NCT01034462|516619301|FG001|Overall Study|Withdrawal by Subject|8|||
143292059|NCT01034462|516619300|FG000|Overall Study|Lost to Follow-up|14|||
143292060|NCT01034462|516619301|FG001|Overall Study|Lost to Follow-up|16|||
143292061|NCT01034462|516619300|FG000|Overall Study|Other reasons|1|||
143292062|NCT01034462|516619301|FG001|Overall Study|Other reasons|2|||
143292063|NCT04273217|516619302|FG000|Overall Study|Lost to Follow-up|0|||
143292064|NCT04273217|516619303|FG001|Overall Study|Lost to Follow-up|0|||
143292065|NCT04273217|516619304|FG002|Overall Study|Lost to Follow-up|0|||
143292066|NCT04273217|516619305|FG003|Overall Study|Lost to Follow-up|0|||
143292067|NCT04273217|516619306|FG004|Overall Study|Lost to Follow-up|0|||
143292068|NCT04273217|516619307|FG005|Overall Study|Lost to Follow-up|1|||
143292069|NCT04273217|516619302|FG000|Overall Study|Participant non-compliance|0|||
143292070|NCT04273217|516619303|FG001|Overall Study|Participant non-compliance|0|||
143292071|NCT04273217|516619304|FG002|Overall Study|Participant non-compliance|0|||
143292072|NCT04273217|516619305|FG003|Overall Study|Participant non-compliance|0|||
143292073|NCT04273217|516619306|FG004|Overall Study|Participant non-compliance|1|||
143292074|NCT04273217|516619307|FG005|Overall Study|Participant non-compliance|0|||
143292075|NCT04273217|516619302|FG000|Overall Study|Positive urine drug screen|1|||
143292076|NCT04273217|516619303|FG001|Overall Study|Positive urine drug screen|0|||
143292077|NCT04273217|516619304|FG002|Overall Study|Positive urine drug screen|1|||
143292078|NCT04273217|516619305|FG003|Overall Study|Positive urine drug screen|0|||
143292079|NCT04273217|516619306|FG004|Overall Study|Positive urine drug screen|0|||
143292080|NCT04273217|516619307|FG005|Overall Study|Positive urine drug screen|1|||
143292081|NCT03720470|516619308|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
143292082|NCT03720470|516619309|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
143292083|NCT03720470|516619310|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
143292084|NCT03720470|516619311|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
143292085|NCT03720470|516619312|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
143292086|NCT03720470|516619313|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
143292087|NCT03720470|516619308|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
143292088|NCT03720470|516619309|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
143292089|NCT03720470|516619310|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
143292090|NCT03720470|516619311|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
143292091|NCT03720470|516619312|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
143292092|NCT03720470|516619313|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
143292093|NCT03720470|516619308|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
143292094|NCT03720470|516619309|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
143292095|NCT03720470|516619310|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
143292096|NCT03720470|516619311|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
143292097|NCT03720470|516619312|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
143292098|NCT03720470|516619313|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
143292099|NCT03720470|516619308|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
143292100|NCT03720470|516619309|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
143292101|NCT03720470|516619310|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
143292102|NCT03720470|516619311|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
143292103|NCT03720470|516619312|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
143292104|NCT03720470|516619313|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
143292105|NCT03720470|516619308|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
143292106|NCT03720470|516619309|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
143292107|NCT03720470|516619310|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
143373762|NCT02477670|516913565|FG002|Stage 1|Non-compliance with Study Drug|0|||
143292108|NCT03720470|516619311|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
143292109|NCT03720470|516619312|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
143292110|NCT03720470|516619313|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
143292111|NCT03720470|516619308|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
143292112|NCT03720470|516619309|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
143373763|NCT02477670|516913566|FG003|Stage 1|Non-compliance with Study Drug|0|||
143292113|NCT03720470|516619310|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
143292114|NCT03720470|516619311|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
143292115|NCT03720470|516619312|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
143292116|NCT03720470|516619313|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
143292117|NCT03720470|516619308|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
143292118|NCT03720470|516619309|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
143292119|NCT03720470|516619310|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
143292120|NCT03720470|516619311|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
143292121|NCT03720470|516619312|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
143292122|NCT03720470|516619313|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
143292123|NCT03720470|516619308|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
143292124|NCT03720470|516619309|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
143292125|NCT03720470|516619310|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
143292126|NCT03720470|516619311|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
143292127|NCT03720470|516619312|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
143292128|NCT03720470|516619313|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
143292129|NCT03720470|516619308|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
143292130|NCT03720470|516619309|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
143292131|NCT03720470|516619310|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
143292132|NCT03720470|516619311|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
143292133|NCT03720470|516619312|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
143292134|NCT03720470|516619313|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
143292135|NCT03720470|516619308|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
143292136|NCT03720470|516619309|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
143292137|NCT03720470|516619310|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
143292138|NCT03720470|516619311|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
143292139|NCT03720470|516619312|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
143292140|NCT03720470|516619313|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
143292141|NCT03720470|516619308|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
143292142|NCT03720470|516619309|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
143292143|NCT03720470|516619310|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
143292144|NCT03720470|516619311|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
143292145|NCT03720470|516619312|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
143292146|NCT03720470|516619313|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
143292147|NCT03720470|516619308|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
143292148|NCT03720470|516619309|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
143292149|NCT03720470|516619310|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
143292150|NCT03720470|516619311|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
143292151|NCT03720470|516619312|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
143292152|NCT03720470|516619313|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
143292153|NCT03720470|516619308|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
143292154|NCT03720470|516619309|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
143292155|NCT03720470|516619310|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
143292156|NCT03720470|516619311|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
143292157|NCT03720470|516619312|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
143292158|NCT03720470|516619313|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
143292159|NCT03720470|516619308|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
143292160|NCT03720470|516619309|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
143292161|NCT03720470|516619310|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
143292162|NCT03720470|516619311|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
143292163|NCT03720470|516619312|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
143292164|NCT03720470|516619313|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
143292165|NCT03720470|516619308|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
143292166|NCT03720470|516619309|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
143292167|NCT03720470|516619310|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
143292168|NCT03720470|516619311|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
143292169|NCT03720470|516619312|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
143292170|NCT03720470|516619313|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
143292171|NCT03720470|516619308|FG000|Treatment Period: Final 4 Weeks|Other|0|||
143292172|NCT03720470|516619309|FG001|Treatment Period: Final 4 Weeks|Other|1|||
143292173|NCT03720470|516619310|FG002|Treatment Period: Final 4 Weeks|Other|0|||
143292174|NCT03720470|516619311|FG003|Treatment Period: Final 4 Weeks|Other|2|||
143292175|NCT03720470|516619312|FG004|Treatment Period: Final 4 Weeks|Other|1|||
143292176|NCT03720470|516619313|FG005|Treatment Period: Final 4 Weeks|Other|0|||
143292177|NCT04532099|516619314|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
143292178|NCT04532099|516619315|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
143292179|NCT04532099|516619316|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
143292180|NCT00330616|516619319|FG000|Overall Study|Adverse Event|13|||
143292181|NCT00330616|516619319|FG000|Overall Study|Lack of Efficacy|1|||
143292182|NCT00330616|516619319|FG000|Overall Study|Lost to Follow-up|2|||
143292183|NCT00330616|516619319|FG000|Overall Study|Withdrawal by Subject|4|||
143292184|NCT00330616|516619319|FG000|Overall Study|Other|1|||
143292185|NCT02642042|516619322|FG000|Overall Study|Adverse Event|22|||
143292186|NCT02642042|516619322|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
143292187|NCT02642042|516619322|FG000|Overall Study|Progression/Relapse|28|||
143292188|NCT02642042|516619322|FG000|Overall Study|Death|1|||
143292189|NCT02642042|516619322|FG000|Overall Study|Not Protocol Specified|2|||
143292190|NCT01333059|516619323|FG000|Overall Study|Physician Decision|3|||
143292191|NCT01333059|516619324|FG001|Overall Study|Physician Decision|3|||
143292192|NCT01333059|516619323|FG000|Overall Study|Protocol Violation|3|||
143292193|NCT01333059|516619324|FG001|Overall Study|Protocol Violation|0|||
143292194|NCT04903626|516619325|FG000|Overall Study|Lost to Follow-up|6|||
143292195|NCT04903626|516619325|FG000|Overall Study|Withdrawal by Subject|1|||
143292196|NCT04903626|516619325|FG000|Overall Study|Other, Not Specified|1|||
143292197|NCT03035409|516619326|FG000|Overall Study|Adverse Event|5|||
143292198|NCT03035409|516619326|FG000|Overall Study|Death|2|||
143292199|NCT03035409|516619326|FG000|Overall Study|Withdrawal by Subject|2|||
143292200|NCT03035409|516619326|FG000|Overall Study|Non compliance|4|||
143292201|NCT03035409|516619326|FG000|Overall Study|Patient was jittery|1|||
143292202|NCT03035409|516619326|FG000|Overall Study|Did not like Questionnaire|1|||
143292203|NCT03035409|516619326|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
143292204|NCT03035409|516619326|FG000|Overall Study|Did not like taking drugs|1|||
143292205|NCT00927784|516619327|FG000|Overall Study|Death|1|||
143292206|NCT00927784|516619328|FG001|Overall Study|Death|0|||
143292207|NCT00927784|516619327|FG000|Overall Study|Withdrawal by Subject|1|||
143292208|NCT00927784|516619328|FG001|Overall Study|Withdrawal by Subject|0|||
143292209|NCT02056340|516619329|FG000|Overall Study|Lost to Follow-up|5|||
143292210|NCT02056340|516619330|FG001|Overall Study|Lost to Follow-up|5|||
143292211|NCT02056340|516619329|FG000|Overall Study|Withdrawal by Subject|2|||
143292212|NCT02056340|516619330|FG001|Overall Study|Withdrawal by Subject|6|||
143292213|NCT01085591|516619332|FG000|Overall Study|Adverse Event|0|||
143292214|NCT01085591|516619333|FG001|Overall Study|Adverse Event|1|||
143292215|NCT01085591|516619334|FG002|Overall Study|Adverse Event|3|||
143292216|NCT01085591|516619332|FG000|Overall Study|Physician Decision|1|||
143292217|NCT01085591|516619333|FG001|Overall Study|Physician Decision|0|||
143292218|NCT01085591|516619334|FG002|Overall Study|Physician Decision|1|||
143292219|NCT01085591|516619332|FG000|Overall Study|Withdrawal by Subject|0|||
143292220|NCT01085591|516619333|FG001|Overall Study|Withdrawal by Subject|2|||
143292221|NCT01085591|516619334|FG002|Overall Study|Withdrawal by Subject|1|||
143292222|NCT01085591|516619332|FG000|Overall Study|Lost to Follow-up|0|||
143292223|NCT01085591|516619333|FG001|Overall Study|Lost to Follow-up|1|||
143292224|NCT01085591|516619334|FG002|Overall Study|Lost to Follow-up|1|||
143292225|NCT01085591|516619332|FG000|Overall Study|Protocol Violation|1|||
143292226|NCT01085591|516619333|FG001|Overall Study|Protocol Violation|1|||
143292227|NCT01085591|516619334|FG002|Overall Study|Protocol Violation|1|||
143292228|NCT01085591|516619332|FG000|Overall Study|Other|0|||
143292229|NCT01085591|516619333|FG001|Overall Study|Other|1|||
143292230|NCT01085591|516619334|FG002|Overall Study|Other|0|||
143292231|NCT01085591|516619332|FG000|Overall Study|Not Properly Consented|1|||
143292232|NCT01085591|516619333|FG001|Overall Study|Not Properly Consented|0|||
143292233|NCT01085591|516619334|FG002|Overall Study|Not Properly Consented|0|||
143292234|NCT05119569|516619335|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
143292235|NCT05119569|516619336|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
143292236|NCT05119569|516619337|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
143292237|NCT05119569|516619338|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
143292238|NCT05119569|516619335|FG000|Double Blind Treatment Phase|Adverse Event|6|||
143292239|NCT05119569|516619336|FG001|Double Blind Treatment Phase|Adverse Event|0|||
143292240|NCT05119569|516619337|FG002|Double Blind Treatment Phase|Adverse Event|0|||
143292241|NCT05119569|516619338|FG003|Double Blind Treatment Phase|Adverse Event|0|||
143292242|NCT05119569|516619335|FG000|Open Label Extension Phase|Ongoing in the study|0|||
143292243|NCT05119569|516619336|FG001|Open Label Extension Phase|Ongoing in the study|0|||
143292244|NCT05119569|516619337|FG002|Open Label Extension Phase|Ongoing in the study|65|||
143292245|NCT05119569|516619338|FG003|Open Label Extension Phase|Ongoing in the study|34|||
143292246|NCT02623439|516619341|FG000|Overall Study|Withdrawal by Subject|1|||
143292247|NCT02623439|516619341|FG000|Overall Study|Screen Failure|1|||
143292248|NCT02839707|516619342|FG000|Phase I|Not eligible for analysis|9|||
143292249|NCT02839707|516619343|FG001|Phase I|Not eligible for analysis|0|||
143292250|NCT02839707|516619344|FG002|Phase I|Not eligible for analysis|0|||
143292251|NCT02839707|516619342|FG000|Phase II|Not treated according to protocol|4|||
143292252|NCT02839707|516619343|FG001|Phase II|Not treated according to protocol|0|||
143292253|NCT02839707|516619344|FG002|Phase II|Not treated according to protocol|2|||
143292254|NCT02839707|516619342|FG000|Phase III|Not treated according to protocol|0|||
143292255|NCT02839707|516619343|FG001|Phase III|Not treated according to protocol|0|||
143292256|NCT02839707|516619344|FG002|Phase III|Not treated according to protocol|4|||
143292257|NCT02890355|516619345|FG000|Overall Study|Adverse Event|5|||
143292258|NCT02890355|516619346|FG001|Overall Study|Adverse Event|5|||
143292259|NCT02890355|516619345|FG000|Overall Study|Refusal unrelated to adverse event|5|||
143292260|NCT02890355|516619346|FG001|Overall Study|Refusal unrelated to adverse event|10|||
143292261|NCT02890355|516619345|FG000|Overall Study|Progression/relapse|46|||
143292262|NCT02890355|516619346|FG001|Overall Study|Progression/relapse|39|||
143292263|NCT02890355|516619345|FG000|Overall Study|Not protocol specified|3|||
143292264|NCT02890355|516619346|FG001|Overall Study|Not protocol specified|4|||
143292265|NCT04434092|516619347|FG000|Primary Treatment Period:Baseline-Week24|Physician Decision|2|||
143292266|NCT04434092|516619348|FG001|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
143292267|NCT04434092|516619349|FG002|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
143292268|NCT04434092|516619347|FG000|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|2|||
143292269|NCT04434092|516619348|FG001|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
143292270|NCT04434092|516619349|FG002|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
143292271|NCT04434092|516619347|FG000|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|1|||
143292272|NCT04434092|516619348|FG001|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
143292273|NCT04434092|516619349|FG002|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
143292274|NCT04434092|516619347|FG000|Primary Treatment Period:Baseline-Week24|Death|1|||
143292275|NCT04434092|516619348|FG001|Primary Treatment Period:Baseline-Week24|Death|1|||
143292276|NCT04434092|516619349|FG002|Primary Treatment Period:Baseline-Week24|Death|0|||
143292277|NCT04434092|516619347|FG000|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|127|||
143292278|NCT04434092|516619348|FG001|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|65|||
143292279|NCT04434092|516619349|FG002|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|6|||
143292280|NCT04434092|516619347|FG000|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
143292281|NCT04434092|516619348|FG001|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
143292282|NCT04434092|516619349|FG002|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|0|||
143292283|NCT04434092|516619347|FG000|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
143292284|NCT04434092|516619348|FG001|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|1|||
143292285|NCT04434092|516619349|FG002|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
143292286|NCT04779489|516620892|FG000|Overall Study|Physician Decision|1|||
143292287|NCT00415909|516620897|FG000|Overall Study|Withdrawal by Subject|2|||
143292288|NCT00415909|516620897|FG000|Overall Study|Death|1|||
143292289|NCT00407563|516620900|FG000|Overall Study|Patient continues on treatment|1|||
143292290|NCT02450903|516620901|FG000|Overall Study|Adverse Event|3|||
143292291|NCT02450903|516620901|FG000|Overall Study|Progressive disease|15|||
143292292|NCT02450903|516620901|FG000|Overall Study|Switched to commercial drug|1|||
143292293|NCT02450903|516620901|FG000|Overall Study|Subject/guardian decision|1|||
143292294|NCT00588848|516620904|FG000|Overall Study|Physician Decision|0|||
143292295|NCT00588848|516620905|FG001|Overall Study|Physician Decision|3|||
143292296|NCT00249444|516620906|FG000|Overall Study|Lost to Follow-up|2|||
143292297|NCT00249444|516620907|FG001|Overall Study|Lost to Follow-up|2|||
143292298|NCT00249444|516620906|FG000|Overall Study|non-compliant|9|||
143292299|NCT00249444|516620907|FG001|Overall Study|non-compliant|11|||
143292300|NCT00249444|516620906|FG000|Overall Study|Adverse Event|1|||
143292301|NCT00249444|516620907|FG001|Overall Study|Adverse Event|1|||
143292302|NCT00249444|516620906|FG000|Overall Study|life event|0|||
143292303|NCT00249444|516620907|FG001|Overall Study|life event|1|||
143292304|NCT02902965|516620908|FG000|Overall Study|Withdrawal by Subject|10|||
143292305|NCT00293254|516620909|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
143292306|NCT00293254|516620910|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
143292307|NCT00293254|516620909|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
143292308|NCT00293254|516620910|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
143292309|NCT00293254|516620909|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
143292310|NCT00293254|516620910|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
143292311|NCT00293254|516620909|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
143292312|NCT00293254|516620910|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
143292313|NCT00293254|516620909|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
143292314|NCT00293254|516620910|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
143292315|NCT00293254|516620909|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
143292316|NCT00293254|516620910|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
143292317|NCT00293254|516620909|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
143292318|NCT00293254|516620910|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
143292319|NCT00293254|516620909|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
143292320|NCT00293254|516620910|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
143292321|NCT00293254|516620909|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
143292322|NCT00293254|516620910|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
143292323|NCT00293254|516620909|FG000|Extension - Double-Blind Week 49-156|Death|4|||
143373764|NCT02477670|516913567|FG004|Stage 1|Non-compliance with Study Drug|0|||
143292324|NCT00293254|516620910|FG001|Extension - Double-Blind Week 49-156|Death|1|||
143292325|NCT00293254|516620909|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
143292326|NCT00293254|516620910|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
143292327|NCT00293254|516620909|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
143292328|NCT00293254|516620910|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
143292329|NCT00293254|516620909|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
143292330|NCT00293254|516620910|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
143292331|NCT00293254|516620909|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
143292332|NCT00293254|516620910|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
143292333|NCT00293254|516620909|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
143292334|NCT00293254|516620910|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
143292335|NCT00293254|516620909|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
143292336|NCT00293254|516620910|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
143292337|NCT00293254|516620909|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
143292338|NCT00293254|516620910|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
143292339|NCT00293254|516620909|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
143292340|NCT00293254|516620910|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
143292341|NCT00293254|516620909|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
143292342|NCT00293254|516620910|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
143292343|NCT00293254|516620909|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
143292344|NCT00293254|516620910|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
143292345|NCT00293254|516620909|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
143292346|NCT00293254|516620910|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
143292347|NCT00293254|516620909|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
143292348|NCT00293254|516620910|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
143292349|NCT00293254|516620909|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
143292350|NCT00293254|516620910|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
143292351|NCT00293254|516620909|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
143292352|NCT00293254|516620910|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
143292353|NCT00293254|516620909|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
143292354|NCT00293254|516620910|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
143292355|NCT00293254|516620909|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
143292356|NCT00293254|516620910|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
143292357|NCT00293254|516620909|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
143292358|NCT00293254|516620910|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
143292359|NCT02259582|516620911|FG000|Overall Study|Physician Decision|0|||
143292360|NCT02259582|516620912|FG001|Overall Study|Physician Decision|1|||
143292361|NCT02259582|516620913|FG002|Overall Study|Physician Decision|0|||
143292362|NCT02259582|516620911|FG000|Overall Study|Death|0|||
143292363|NCT02259582|516620912|FG001|Overall Study|Death|0|||
143292364|NCT02259582|516620913|FG002|Overall Study|Death|1|||
143292365|NCT02259582|516620911|FG000|Overall Study|Adverse Event|1|||
143292366|NCT02259582|516620912|FG001|Overall Study|Adverse Event|0|||
143292367|NCT02259582|516620913|FG002|Overall Study|Adverse Event|1|||
143292368|NCT02259582|516620911|FG000|Overall Study|Withdrawal by Subject|0|||
143292369|NCT02259582|516620912|FG001|Overall Study|Withdrawal by Subject|0|||
143292370|NCT02259582|516620913|FG002|Overall Study|Withdrawal by Subject|1|||
143292371|NCT02259582|516620911|FG000|Overall Study|Disease progression|14|||
143292372|NCT02259582|516620912|FG001|Overall Study|Disease progression|15|||
143292373|NCT02259582|516620913|FG002|Overall Study|Disease progression|17|||
143292374|NCT02259582|516620911|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
143292375|NCT02259582|516620912|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
143292376|NCT02259582|516620913|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
143292377|NCT00412854|516620917|FG000|Overall Study|Withdrawn due to adverse events|1|||
143292378|NCT00412854|516620918|FG001|Overall Study|Withdrawn due to adverse events|5|||
143292379|NCT00412854|516620917|FG000|Overall Study|Withdrawn for other reasons|13|||
143292380|NCT00412854|516620918|FG001|Overall Study|Withdrawn for other reasons|11|||
143292381|NCT03045081|516620919|FG000|Overall Study|Withdrawal by Subject|6|||
143292382|NCT03045081|516620920|FG001|Overall Study|Withdrawal by Subject|11|||
143292383|NCT00708643|516620921|FG000|Overall Study|Adverse Event|0|||
143292384|NCT00708643|516620922|FG001|Overall Study|Adverse Event|1|||
143292385|NCT00065507|516620925|FG000|Overall Study|Death|16|||
143292386|NCT00065507|516620926|FG001|Overall Study|Death|17|||
143292387|NCT00065507|516620925|FG000|Overall Study|Adverse Event|4|||
143292388|NCT00065507|516620926|FG001|Overall Study|Adverse Event|3|||
143292389|NCT00065507|516620925|FG000|Overall Study|Lack of Efficacy|0|||
143292390|NCT00065507|516620926|FG001|Overall Study|Lack of Efficacy|6|||
143292391|NCT00065507|516620925|FG000|Overall Study|Poor/Non-compliance|3|||
143292392|NCT00065507|516620926|FG001|Overall Study|Poor/Non-compliance|2|||
143292393|NCT00065507|516620925|FG000|Overall Study|Lost to Follow-up|3|||
143292394|NCT00065507|516620926|FG001|Overall Study|Lost to Follow-up|0|||
143292395|NCT00065507|516620925|FG000|Overall Study|Subject Withdrew Consent|2|||
143292396|NCT00065507|516620926|FG001|Overall Study|Subject Withdrew Consent|1|||
143292397|NCT00065507|516620925|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
143292398|NCT00065507|516620926|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
143292399|NCT00100815|516620927|FG000|Overall Study|Progression|24|||
143292400|NCT00100815|516620927|FG000|Overall Study|Adverse Event|18|||
143292401|NCT00100815|516620927|FG000|Overall Study|Death|4|||
143292402|NCT00100815|516620927|FG000|Overall Study|Other|3|||
143292403|NCT00227903|516620928|FG000|Overall Study|Withdrawal by Subject|2|||
143292404|NCT00227903|516620929|FG001|Overall Study|Withdrawal by Subject|5|||
143292405|NCT00227903|516620928|FG000|Overall Study|Subject moved out of area|1|||
143292406|NCT00227903|516620929|FG001|Overall Study|Subject moved out of area|2|||
143292407|NCT00227903|516620928|FG000|Overall Study|Lost to Follow-up|1|||
143292408|NCT00227903|516620929|FG001|Overall Study|Lost to Follow-up|3|||
143292409|NCT00227903|516620928|FG000|Overall Study|Miscarriage|1|||
143292410|NCT00227903|516620929|FG001|Overall Study|Miscarriage|0|||
143292411|NCT00723892|516620930|FG000|Overall Study|Participant not tracked|33|||
143292412|NCT00723892|516620931|FG001|Overall Study|Participant not tracked|35|||
143292413|NCT00723892|516620930|FG000|Overall Study|Virological criterion|24|||
143292414|NCT00723892|516620931|FG001|Overall Study|Virological criterion|9|||
143292415|NCT00723892|516620930|FG000|Overall Study|Withdrawal by Subject|6|||
143292416|NCT00723892|516620931|FG001|Overall Study|Withdrawal by Subject|9|||
143292417|NCT00723892|516620930|FG000|Overall Study|End planned|11|||
143292418|NCT00723892|516620931|FG001|Overall Study|End planned|7|||
143292419|NCT00723892|516620930|FG000|Overall Study|Bad tolerance|5|||
143292420|NCT00723892|516620931|FG001|Overall Study|Bad tolerance|5|||
143292421|NCT00723892|516620930|FG000|Overall Study|Multiple reasons|17|||
143292422|NCT00723892|516620931|FG001|Overall Study|Multiple reasons|12|||
143292423|NCT00723892|516620930|FG000|Overall Study|Other|6|||
143292424|NCT00723892|516620931|FG001|Overall Study|Other|3|||
143292425|NCT00723892|516620930|FG000|Overall Study|Study end|1|||
143292426|NCT00723892|516620931|FG001|Overall Study|Study end|3|||
143292427|NCT00723892|516620930|FG000|Overall Study|Weight loss|1|||
143292428|NCT00723892|516620931|FG001|Overall Study|Weight loss|3|||
143292429|NCT00723892|516620930|FG000|Overall Study|Alcohol abuse|0|||
143292430|NCT00723892|516620931|FG001|Overall Study|Alcohol abuse|1|||
143292431|NCT00723892|516620930|FG000|Overall Study|Intercurrent infection|2|||
143292432|NCT00723892|516620931|FG001|Overall Study|Intercurrent infection|0|||
143292433|NCT00723892|516620930|FG000|Overall Study|Drug addiction|1|||
143292434|NCT00723892|516620931|FG001|Overall Study|Drug addiction|0|||
143292435|NCT00498602|516620938|FG000|Overall Study|Death|0|||
143292436|NCT00498602|516620939|FG001|Overall Study|Death|0|||
143292437|NCT00498602|516620940|FG002|Overall Study|Death|0|||
143292438|NCT00498602|516620941|FG003|Overall Study|Death|0|||
143292439|NCT00498602|516620942|FG004|Overall Study|Death|0|||
143292440|NCT00498602|516620943|FG005|Overall Study|Death|1|||
143292441|NCT00498602|516620944|FG006|Overall Study|Death|0|||
143292442|NCT00498602|516620938|FG000|Overall Study|Lack of Efficacy|1|||
143292443|NCT00498602|516620939|FG001|Overall Study|Lack of Efficacy|0|||
143292444|NCT00498602|516620940|FG002|Overall Study|Lack of Efficacy|0|||
143292445|NCT00498602|516620941|FG003|Overall Study|Lack of Efficacy|0|||
143292446|NCT00498602|516620942|FG004|Overall Study|Lack of Efficacy|0|||
143292447|NCT00498602|516620943|FG005|Overall Study|Lack of Efficacy|0|||
143292448|NCT00498602|516620944|FG006|Overall Study|Lack of Efficacy|0|||
143292449|NCT00498602|516620938|FG000|Overall Study|Lost to Follow-up|0|||
143292450|NCT00498602|516620939|FG001|Overall Study|Lost to Follow-up|2|||
143292451|NCT00498602|516620940|FG002|Overall Study|Lost to Follow-up|0|||
143292452|NCT00498602|516620941|FG003|Overall Study|Lost to Follow-up|2|||
143292453|NCT00498602|516620942|FG004|Overall Study|Lost to Follow-up|0|||
143292454|NCT00498602|516620943|FG005|Overall Study|Lost to Follow-up|0|||
143292455|NCT00498602|516620944|FG006|Overall Study|Lost to Follow-up|0|||
143292456|NCT00498602|516620938|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
143292457|NCT00498602|516620939|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
143292458|NCT00498602|516620940|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
143292459|NCT00498602|516620941|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
143292460|NCT00498602|516620942|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
143292461|NCT00498602|516620943|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
143292462|NCT00498602|516620944|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
143292463|NCT00498602|516620938|FG000|Overall Study|AE not related to Study Drug|1|||
143292464|NCT00498602|516620939|FG001|Overall Study|AE not related to Study Drug|3|||
143292465|NCT00498602|516620940|FG002|Overall Study|AE not related to Study Drug|0|||
143292466|NCT00498602|516620941|FG003|Overall Study|AE not related to Study Drug|0|||
143292467|NCT00498602|516620942|FG004|Overall Study|AE not related to Study Drug|2|||
143292468|NCT00498602|516620943|FG005|Overall Study|AE not related to Study Drug|2|||
143292469|NCT00498602|516620944|FG006|Overall Study|AE not related to Study Drug|1|||
143292470|NCT00498602|516620938|FG000|Overall Study|Caregiver Request|2|||
143292471|NCT00498602|516620939|FG001|Overall Study|Caregiver Request|2|||
143292472|NCT00498602|516620940|FG002|Overall Study|Caregiver Request|2|||
143292473|NCT00498602|516620941|FG003|Overall Study|Caregiver Request|0|||
143292474|NCT00498602|516620942|FG004|Overall Study|Caregiver Request|1|||
143292475|NCT00498602|516620943|FG005|Overall Study|Caregiver Request|2|||
143292476|NCT00498602|516620944|FG006|Overall Study|Caregiver Request|0|||
143292477|NCT00498602|516620938|FG000|Overall Study|Investigator Request|0|||
143292478|NCT00498602|516620939|FG001|Overall Study|Investigator Request|0|||
143292479|NCT00498602|516620940|FG002|Overall Study|Investigator Request|1|||
143292480|NCT00498602|516620941|FG003|Overall Study|Investigator Request|0|||
143292481|NCT00498602|516620942|FG004|Overall Study|Investigator Request|0|||
143292482|NCT00498602|516620943|FG005|Overall Study|Investigator Request|0|||
143292483|NCT00498602|516620944|FG006|Overall Study|Investigator Request|0|||
143292484|NCT00498602|516620938|FG000|Overall Study|Subject Request|3|||
143292485|NCT00498602|516620939|FG001|Overall Study|Subject Request|0|||
143292486|NCT00498602|516620940|FG002|Overall Study|Subject Request|1|||
143292487|NCT00498602|516620941|FG003|Overall Study|Subject Request|1|||
143292488|NCT00498602|516620942|FG004|Overall Study|Subject Request|1|||
143292489|NCT00498602|516620943|FG005|Overall Study|Subject Request|4|||
143292490|NCT00498602|516620944|FG006|Overall Study|Subject Request|1|||
143292491|NCT00498602|516620938|FG000|Overall Study|Other|2|||
143292492|NCT00498602|516620939|FG001|Overall Study|Other|3|||
143292493|NCT00498602|516620940|FG002|Overall Study|Other|1|||
143292494|NCT00498602|516620941|FG003|Overall Study|Other|0|||
143292495|NCT00498602|516620942|FG004|Overall Study|Other|0|||
143292496|NCT00498602|516620943|FG005|Overall Study|Other|3|||
143373765|NCT02477670|516913568|FG005|Stage 1|Non-compliance with Study Drug|0|||
143373766|NCT02477670|516913569|FG006|Stage 1|Non-compliance with Study Drug|0|||
143373767|NCT02477670|516913563|FG000|Stage 2|Adverse Event|0|||
143292497|NCT00498602|516620944|FG006|Overall Study|Other|0|||
143292498|NCT01113801|516620948|FG000|Overall Study|Adverse Event|4|||
143292499|NCT01113801|516620949|FG001|Overall Study|Adverse Event|0|||
143292500|NCT01113801|516620950|FG002|Overall Study|Adverse Event|2|||
143373768|NCT02477670|516913564|FG001|Stage 2|Adverse Event|0|||
143373769|NCT02477670|516913565|FG002|Stage 2|Adverse Event|1|||
143292501|NCT01113801|516620951|FG003|Overall Study|Adverse Event|6|||
143292502|NCT01113801|516620948|FG000|Overall Study|Death|4|||
143292503|NCT01113801|516620949|FG001|Overall Study|Death|5|||
143292504|NCT01113801|516620950|FG002|Overall Study|Death|3|||
143292505|NCT01113801|516620951|FG003|Overall Study|Death|4|||
143292506|NCT01113801|516620948|FG000|Overall Study|Protocol Violation|0|||
143292507|NCT01113801|516620949|FG001|Overall Study|Protocol Violation|1|||
143292508|NCT01113801|516620950|FG002|Overall Study|Protocol Violation|0|||
143292509|NCT01113801|516620951|FG003|Overall Study|Protocol Violation|0|||
143292510|NCT01113801|516620948|FG000|Overall Study|Withdrawal by Subject|9|||
143292511|NCT01113801|516620949|FG001|Overall Study|Withdrawal by Subject|7|||
143292512|NCT01113801|516620950|FG002|Overall Study|Withdrawal by Subject|7|||
143292513|NCT01113801|516620951|FG003|Overall Study|Withdrawal by Subject|8|||
143292514|NCT01113801|516620948|FG000|Overall Study|Physician Decision|2|||
143292515|NCT01113801|516620949|FG001|Overall Study|Physician Decision|2|||
143292516|NCT01113801|516620950|FG002|Overall Study|Physician Decision|3|||
143292517|NCT01113801|516620951|FG003|Overall Study|Physician Decision|3|||
143292518|NCT01113801|516620948|FG000|Overall Study|Sponsor Decision|15|||
143292519|NCT01113801|516620949|FG001|Overall Study|Sponsor Decision|21|||
143292520|NCT01113801|516620950|FG002|Overall Study|Sponsor Decision|20|||
143292521|NCT01113801|516620951|FG003|Overall Study|Sponsor Decision|15|||
143292522|NCT01113801|516620948|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
143292523|NCT01113801|516620949|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
143292524|NCT01113801|516620950|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
143292525|NCT01113801|516620951|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
143292526|NCT01949051|516620954|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
143292527|NCT01949051|516620955|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
143292528|NCT01949051|516620956|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
143292529|NCT01949051|516620957|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
143292530|NCT01949051|516620958|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
143292531|NCT01949051|516620959|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
143292532|NCT01949051|516620954|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
143292533|NCT01949051|516620955|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
143292534|NCT01949051|516620956|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
143292535|NCT01949051|516620957|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
143292536|NCT01949051|516620958|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
143292537|NCT01949051|516620959|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
143292538|NCT01949051|516620954|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
143292539|NCT01949051|516620955|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
143292540|NCT01949051|516620956|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
143292541|NCT01949051|516620957|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
143292542|NCT01949051|516620958|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
143292543|NCT01949051|516620959|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
143292544|NCT01949051|516620954|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
143292545|NCT01949051|516620955|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
143292546|NCT01949051|516620956|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
143292547|NCT01949051|516620957|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
143292548|NCT01949051|516620958|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
143292549|NCT01949051|516620959|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
143292550|NCT01949051|516620954|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
143292551|NCT01949051|516620955|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
143292552|NCT01949051|516620956|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
143292553|NCT01949051|516620957|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
143292554|NCT01949051|516620958|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
143292555|NCT01949051|516620959|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
143292556|NCT01506479|516620961|FG000|Overall Study|Lost to Follow-up|1|||
143292557|NCT01506479|516620962|FG001|Overall Study|Lost to Follow-up|2|||
143292558|NCT01506479|516620963|FG002|Overall Study|Lost to Follow-up|2|||
143292559|NCT01506479|516620961|FG000|Overall Study|Withdrawal by Subject|1|||
143292560|NCT01506479|516620962|FG001|Overall Study|Withdrawal by Subject|2|||
143292561|NCT01506479|516620963|FG002|Overall Study|Withdrawal by Subject|1|||
143292562|NCT01506479|516620961|FG000|Overall Study|Missing assessment|1|||
143292563|NCT01506479|516620962|FG001|Overall Study|Missing assessment|0|||
143292564|NCT01506479|516620963|FG002|Overall Study|Missing assessment|0|||
143292565|NCT01506479|516620961|FG000|Overall Study|Adverse Event|0|||
143292566|NCT01506479|516620962|FG001|Overall Study|Adverse Event|1|||
143292567|NCT01506479|516620963|FG002|Overall Study|Adverse Event|0|||
143292568|NCT01846507|516620964|FG000|Overall Study|Lost to Follow-up|4|||
143292569|NCT01846507|516620964|FG000|Overall Study|Protocol Violation|1|||
143292570|NCT01846507|516620964|FG000|Overall Study|Missing data|2|||
143292571|NCT01782859|516620965|FG000|Overall Study|Protocol Violation|6|||
143292572|NCT01782859|516620966|FG001|Overall Study|Protocol Violation|6|||
143292573|NCT01782859|516620965|FG000|Overall Study|Withdrawal by Subject|0|||
143292574|NCT01782859|516620966|FG001|Overall Study|Withdrawal by Subject|1|||
143292575|NCT00268996|516620972|FG000|Overall Study|Adverse Event|11|||
143292576|NCT00268996|516620973|FG001|Overall Study|Adverse Event|7|||
143292577|NCT00268996|516620972|FG000|Overall Study|Lost to Follow-up|3|||
143292578|NCT00268996|516620973|FG001|Overall Study|Lost to Follow-up|1|||
143292579|NCT00268996|516620972|FG000|Overall Study|Withdrawal by Subject|5|||
143292580|NCT00268996|516620973|FG001|Overall Study|Withdrawal by Subject|11|||
143292581|NCT00268996|516620972|FG000|Overall Study|Non-compliance|1|||
143292582|NCT00268996|516620973|FG001|Overall Study|Non-compliance|0|||
143292583|NCT00268996|516620972|FG000|Overall Study|Other|1|||
143292584|NCT00268996|516620973|FG001|Overall Study|Other|1|||
143292585|NCT02956486|516620974|FG000|Core Phase|Adverse Event|51|||
143292586|NCT02956486|516620975|FG001|Core Phase|Adverse Event|88|||
143292587|NCT02956486|516620976|FG002|Core Phase|Adverse Event|0|||
143292588|NCT02956486|516620974|FG000|Core Phase|Lost to Follow-up|8|||
143292589|NCT02956486|516620975|FG001|Core Phase|Lost to Follow-up|6|||
143292590|NCT02956486|516620976|FG002|Core Phase|Lost to Follow-up|0|||
143292591|NCT02956486|516620974|FG000|Core Phase|Inadequate therapeutic effect|4|||
143292592|NCT02956486|516620975|FG001|Core Phase|Inadequate therapeutic effect|5|||
143292593|NCT02956486|516620976|FG002|Core Phase|Inadequate therapeutic effect|0|||
143292594|NCT02956486|516620974|FG000|Core Phase|Withdrawal by Subject|101|||
143292595|NCT02956486|516620975|FG001|Core Phase|Withdrawal by Subject|104|||
143292596|NCT02956486|516620976|FG002|Core Phase|Withdrawal by Subject|0|||
143292597|NCT02956486|516620974|FG000|Core Phase|Study terminated by sponsor|888|||
143292598|NCT02956486|516620975|FG001|Core Phase|Study terminated by sponsor|848|||
143292599|NCT02956486|516620976|FG002|Core Phase|Study terminated by sponsor|0|||
143292600|NCT02956486|516620974|FG000|Core Phase|Other|27|||
143292601|NCT02956486|516620975|FG001|Core Phase|Other|18|||
143292602|NCT02956486|516620976|FG002|Core Phase|Other|0|||
143292603|NCT02956486|516620974|FG000|Core Phase|Not treated|0|||
143292604|NCT02956486|516620975|FG001|Core Phase|Not treated|3|||
143292605|NCT02956486|516620976|FG002|Core Phase|Not treated|0|||
143292606|NCT02956486|516620974|FG000|Extension Phase|Adverse Event|0|||
143292607|NCT02956486|516620975|FG001|Extension Phase|Adverse Event|0|||
143292608|NCT02956486|516620976|FG002|Extension Phase|Adverse Event|2|||
143292609|NCT02956486|516620974|FG000|Extension Phase|Study terminated by sponsor|0|||
143292610|NCT02956486|516620975|FG001|Extension Phase|Study terminated by sponsor|0|||
143292611|NCT02956486|516620976|FG002|Extension Phase|Study terminated by sponsor|16|||
143292612|NCT02956486|516620974|FG000|Extension Phase|Not Treated|0|||
143292613|NCT02956486|516620975|FG001|Extension Phase|Not Treated|0|||
143292614|NCT02956486|516620976|FG002|Extension Phase|Not Treated|1|||
143292615|NCT03325075|516620979|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
143292616|NCT03325075|516620980|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
143292617|NCT03325075|516620981|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
143292618|NCT03325075|516620982|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
143292619|NCT03325075|516620979|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
143292620|NCT03325075|516620980|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
143292621|NCT03325075|516620981|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
143292622|NCT03325075|516620982|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
143292623|NCT03325075|516620979|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
143292624|NCT03325075|516620980|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
143292625|NCT03325075|516620981|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
143292626|NCT03325075|516620982|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
143292627|NCT00422591|516620983|FG000|Overall Study|Physician Decision|4|||
143292628|NCT00422591|516620983|FG000|Overall Study|Withdrawal by Subject|2|||
143292629|NCT02377466|516620984|FG000|Overall Study|Other: Randomized and not treated|0|||
143292630|NCT02377466|516620985|FG001|Overall Study|Other: Randomized and not treated|2|||
143292631|NCT04210310|516620986|FG000|Overall Study|Lost to Follow-up|32|||
143292632|NCT04210310|516620987|FG001|Overall Study|Lost to Follow-up|1|||
143292633|NCT01585194|516620988|FG000|Overall Study|Withdrawal by Subject|1|||
143292634|NCT01585194|516620988|FG000|Overall Study|Physician Decision|2|||
143292635|NCT01585194|516620988|FG000|Overall Study|Lack of insurance|1|||
143292636|NCT01187043|516620996|FG000|Overall Study|Adverse Event|0|||
143292637|NCT01187043|516620997|FG001|Overall Study|Adverse Event|0|||
143292638|NCT01187043|516620998|FG002|Overall Study|Adverse Event|0|||
143292639|NCT01187043|516620999|FG003|Overall Study|Adverse Event|0|||
143292640|NCT01187043|516621000|FG004|Overall Study|Adverse Event|1|||
143292641|NCT01187043|516620996|FG000|Overall Study|Unable to make scheduled visits|1|||
143292642|NCT01187043|516620997|FG001|Overall Study|Unable to make scheduled visits|0|||
143292643|NCT01187043|516620998|FG002|Overall Study|Unable to make scheduled visits|4|||
143292644|NCT01187043|516620999|FG003|Overall Study|Unable to make scheduled visits|0|||
143292645|NCT01187043|516621000|FG004|Overall Study|Unable to make scheduled visits|1|||
143292646|NCT00467259|516621001|FG000|Overall Study|Adverse Event|24|||
143292647|NCT00467259|516621002|FG001|Overall Study|Adverse Event|90|||
143292648|NCT00467259|516621001|FG000|Overall Study|Protocol Violation|1|||
143292649|NCT00467259|516621002|FG001|Overall Study|Protocol Violation|7|||
143292650|NCT00467259|516621001|FG000|Overall Study|Withdrawal by Subject|34|||
143292651|NCT00467259|516621002|FG001|Overall Study|Withdrawal by Subject|108|||
143292652|NCT00467259|516621001|FG000|Overall Study|Physician Decision|0|||
143292653|NCT00467259|516621002|FG001|Overall Study|Physician Decision|2|||
143292654|NCT00467259|516621001|FG000|Overall Study|Lost to Follow-up|14|||
143292655|NCT00467259|516621002|FG001|Overall Study|Lost to Follow-up|34|||
143292656|NCT00467259|516621001|FG000|Overall Study|Site Closed|2|||
143292657|NCT00467259|516621002|FG001|Overall Study|Site Closed|1|||
143292658|NCT01405742|516621003|FG000|Overall Study|Lost to Follow-up|1|||
143292659|NCT01405742|516621004|FG001|Overall Study|Lost to Follow-up|0|||
143292660|NCT00867009|516621005|FG000|Induction Period|Nonserious Adverse Event|5|||
143292661|NCT00867009|516621005|FG000|Induction Period|Serious Adverse Event|10|||
143292662|NCT00867009|516621005|FG000|Induction Period|Death due to serious adverse event|6|||
143292663|NCT00867009|516621005|FG000|Induction Period|Death due to Study Disease|4|||
143292664|NCT00867009|516621005|FG000|Induction Period|Protocol Violation|1|||
143292665|NCT00867009|516621005|FG000|Induction Period|Withdrawal by Subject|8|||
143292666|NCT00867009|516621005|FG000|Induction Period|Physician Decision|3|||
143292667|NCT00867009|516621005|FG000|Induction Period|Progressive Disease (PD)|25|||
143292668|NCT00867009|516621005|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
143292669|NCT03473808|516621008|FG000|Overall Study|Withdrawal by Subject|1|||
143292670|NCT03171415|516621009|FG000|Overall Study|Lost to Follow-up|0|||
143292671|NCT03171415|516621010|FG001|Overall Study|Lost to Follow-up|0|||
143292672|NCT03171415|516621011|FG002|Overall Study|Lost to Follow-up|0|||
143292673|NCT03171415|516621012|FG003|Overall Study|Lost to Follow-up|0|||
143292674|NCT03171415|516621013|FG004|Overall Study|Lost to Follow-up|2|||
143292675|NCT04059094|516621014|FG000|Overall Study|Adverse Event|0|||
143292676|NCT04059094|516621015|FG001|Overall Study|Adverse Event|0|||
143292677|NCT04059094|516621016|FG002|Overall Study|Adverse Event|0|||
143292678|NCT04059094|516621017|FG003|Overall Study|Adverse Event|0|||
143373770|NCT02477670|516913566|FG003|Stage 2|Adverse Event|0|||
143373771|NCT02477670|516913567|FG004|Stage 2|Adverse Event|0|||
143292679|NCT04059094|516621018|FG004|Overall Study|Adverse Event|1|||
143292680|NCT04059094|516621014|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
143292681|NCT04059094|516621015|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
143292682|NCT04059094|516621016|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
143292683|NCT04059094|516621017|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
143292684|NCT04059094|516621018|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
143292685|NCT01339429|516621019|FG000|Overall Study|Withdrawal by Subject|1|||
143292686|NCT01339429|516621019|FG000|Overall Study|Physician Decision|3|||
143292687|NCT00459667|516621024|FG000|Overall Study|Adverse Event|9|||
143292688|NCT00459667|516621025|FG001|Overall Study|Adverse Event|12|||
143292689|NCT00459667|516621026|FG002|Overall Study|Adverse Event|8|||
143292690|NCT00459667|516621024|FG000|Overall Study|Lost to Follow-up|5|||
143292691|NCT00459667|516621025|FG001|Overall Study|Lost to Follow-up|9|||
143292692|NCT00459667|516621026|FG002|Overall Study|Lost to Follow-up|3|||
143292693|NCT00459667|516621024|FG000|Overall Study|Pregnancy|1|||
143292694|NCT00459667|516621025|FG001|Overall Study|Pregnancy|1|||
143292695|NCT00459667|516621026|FG002|Overall Study|Pregnancy|1|||
143292696|NCT00459667|516621024|FG000|Overall Study|Protocol Violation|1|||
143292697|NCT00459667|516621025|FG001|Overall Study|Protocol Violation|0|||
143292698|NCT00459667|516621026|FG002|Overall Study|Protocol Violation|0|||
143292699|NCT00459667|516621024|FG000|Overall Study|Withdrawal by Subject|3|||
143292700|NCT00459667|516621025|FG001|Overall Study|Withdrawal by Subject|5|||
143292701|NCT00459667|516621026|FG002|Overall Study|Withdrawal by Subject|5|||
143292702|NCT00459667|516621024|FG000|Overall Study|Other disease modifying treatment|1|||
143292703|NCT00459667|516621025|FG001|Overall Study|Other disease modifying treatment|2|||
143292704|NCT00459667|516621026|FG002|Overall Study|Other disease modifying treatment|1|||
143292705|NCT00459667|516621024|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
143292706|NCT00459667|516621025|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
143292707|NCT00459667|516621026|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
143292708|NCT00459667|516621024|FG000|Overall Study|No treatment administered|6|||
143373772|NCT02477670|516913568|FG005|Stage 2|Adverse Event|0|||
143373773|NCT02477670|516913569|FG006|Stage 2|Adverse Event|0|||
143292709|NCT00459667|516621025|FG001|Overall Study|No treatment administered|3|||
143292710|NCT00459667|516621026|FG002|Overall Study|No treatment administered|1|||
143292711|NCT00396591|516621027|FG000|Overall Study|Disease Progression|13|||
143292712|NCT00396591|516621027|FG000|Overall Study|Adverse Event|2|||
143292713|NCT00396591|516621027|FG000|Overall Study|Participant request|1|||
143292714|NCT01846611|516621034|FG000|Overall Study|Lost to Follow-up|4|||
143292715|NCT01846611|516621035|FG001|Overall Study|Lost to Follow-up|6|||
143292716|NCT01846611|516621034|FG000|Overall Study|Withdrawal by Subject|15|||
143292717|NCT01846611|516621035|FG001|Overall Study|Withdrawal by Subject|19|||
143292718|NCT01846611|516621034|FG000|Overall Study|Other|19|||
143292719|NCT01846611|516621035|FG001|Overall Study|Other|18|||
143292720|NCT00847704|516621036|FG000|Overall Study|Withdrawal by Subject|1|||
143292721|NCT02111850|516621039|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
143292722|NCT02111850|516621040|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
143292723|NCT02111850|516621041|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
143292724|NCT02111850|516621042|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
143292725|NCT02111850|516621043|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
143373774|NCT02477670|516913563|FG000|Stage 2|Antipsychotic Medication Changed|0|||
143373775|NCT02477670|516913564|FG001|Stage 2|Antipsychotic Medication Changed|0|||
143373776|NCT02477670|516913565|FG002|Stage 2|Antipsychotic Medication Changed|1|||
143292726|NCT02111850|516621044|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
143292727|NCT02111850|516621045|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
143292728|NCT02111850|516621046|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
143292729|NCT02111850|516621047|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
143373777|NCT02477670|516913566|FG003|Stage 2|Antipsychotic Medication Changed|0|||
143373778|NCT02477670|516913567|FG004|Stage 2|Antipsychotic Medication Changed|0|||
143292730|NCT02111850|516621048|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
143292731|NCT02111850|516621049|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
143292732|NCT04484142|516621050|FG000|Overall Study|Adverse Event|13|||
143292733|NCT04484142|516621050|FG000|Overall Study|Progressive Disease|87|||
143292734|NCT04484142|516621050|FG000|Overall Study|Clinical Progression|10|||
143292735|NCT04484142|516621050|FG000|Overall Study|Withdrawal by Subject|6|||
143292736|NCT04484142|516621050|FG000|Overall Study|Physician Decision|1|||
143292737|NCT01409564|516622665|FG000|Overall Study|low medication compliance|4|||
143292738|NCT01409564|516622666|FG001|Overall Study|low medication compliance|3|||
143292739|NCT01409564|516622665|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
143292740|NCT01409564|516622666|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
143292741|NCT00225251|516622667|FG000|Overall Study|Withdrawal by Subject|1|||
143292742|NCT00225251|516622668|FG001|Overall Study|Withdrawal by Subject|1|||
143292743|NCT03045328|516622669|FG000|Overall Study|Withdrawal by Subject|2|||
143292744|NCT00592839|516622677|FG000|Overall Study|Withdrawal by Subject|1|||
143292745|NCT00592839|516622678|FG001|Overall Study|Withdrawal by Subject|1|||
143292746|NCT00592839|516622679|FG002|Overall Study|Withdrawal by Subject|3|||
143292747|NCT00592839|516622677|FG000|Overall Study|Protocol Violation|1|||
143292748|NCT00592839|516622678|FG001|Overall Study|Protocol Violation|1|||
143292749|NCT00592839|516622679|FG002|Overall Study|Protocol Violation|2|||
143292750|NCT00592839|516622677|FG000|Overall Study|Adverse Event|0|||
143292751|NCT00592839|516622678|FG001|Overall Study|Adverse Event|1|||
143292752|NCT00592839|516622679|FG002|Overall Study|Adverse Event|0|||
143292753|NCT00592839|516622677|FG000|Overall Study|Lost to Follow-up|0|||
143292754|NCT00592839|516622678|FG001|Overall Study|Lost to Follow-up|1|||
143292755|NCT00592839|516622679|FG002|Overall Study|Lost to Follow-up|1|||
143292756|NCT01313767|516622680|FG000|Overall Study|Adverse Event|1|||
143292757|NCT01313767|516622681|FG001|Overall Study|Adverse Event|0|||
143292758|NCT01313767|516622680|FG000|Overall Study|Lost to Follow-up|1|||
143292759|NCT01313767|516622681|FG001|Overall Study|Lost to Follow-up|0|||
143292760|NCT01313767|516622680|FG000|Overall Study|Withdrawal by Subject|2|||
143292761|NCT01313767|516622681|FG001|Overall Study|Withdrawal by Subject|1|||
143292762|NCT01313767|516622680|FG000|Overall Study|Protocol Violation|3|||
143292763|NCT01313767|516622681|FG001|Overall Study|Protocol Violation|1|||
143292764|NCT01287897|516622685|FG000|Overall Study|Adverse Event|5|||
143292765|NCT01287897|516622686|FG001|Overall Study|Adverse Event|3|||
143292766|NCT01287897|516622687|FG002|Overall Study|Adverse Event|6|||
143292767|NCT01287897|516622688|FG003|Overall Study|Adverse Event|4|||
143292768|NCT01287897|516622685|FG000|Overall Study|Lack of Efficacy|2|||
143292769|NCT01287897|516622686|FG001|Overall Study|Lack of Efficacy|0|||
143292770|NCT01287897|516622687|FG002|Overall Study|Lack of Efficacy|0|||
143292771|NCT01287897|516622688|FG003|Overall Study|Lack of Efficacy|0|||
143292772|NCT01287897|516622685|FG000|Overall Study|Protocol Violation|1|||
143292773|NCT01287897|516622686|FG001|Overall Study|Protocol Violation|1|||
143292774|NCT01287897|516622687|FG002|Overall Study|Protocol Violation|0|||
143292775|NCT01287897|516622688|FG003|Overall Study|Protocol Violation|1|||
143292776|NCT01287897|516622685|FG000|Overall Study|Lost to Follow-up|0|||
143292777|NCT01287897|516622686|FG001|Overall Study|Lost to Follow-up|0|||
143292778|NCT01287897|516622687|FG002|Overall Study|Lost to Follow-up|2|||
143292779|NCT01287897|516622688|FG003|Overall Study|Lost to Follow-up|0|||
143292780|NCT01287897|516622685|FG000|Overall Study|Withdrawal by Subject|1|||
143292781|NCT01287897|516622686|FG001|Overall Study|Withdrawal by Subject|5|||
143292782|NCT01287897|516622687|FG002|Overall Study|Withdrawal by Subject|3|||
143292783|NCT01287897|516622688|FG003|Overall Study|Withdrawal by Subject|2|||
143292784|NCT01287897|516622685|FG000|Overall Study|Not consented properly|0|||
143292785|NCT01287897|516622686|FG001|Overall Study|Not consented properly|1|||
143292786|NCT01287897|516622687|FG002|Overall Study|Not consented properly|0|||
143292787|NCT01287897|516622688|FG003|Overall Study|Not consented properly|0|||
143292788|NCT01287897|516622685|FG000|Overall Study|Not meeting entrance criteria|1|||
143292789|NCT01287897|516622686|FG001|Overall Study|Not meeting entrance criteria|1|||
143292790|NCT01287897|516622687|FG002|Overall Study|Not meeting entrance criteria|0|||
143292791|NCT01287897|516622688|FG003|Overall Study|Not meeting entrance criteria|0|||
143292792|NCT01287897|516622685|FG000|Overall Study|Other|1|||
143292793|NCT01287897|516622686|FG001|Overall Study|Other|0|||
143292794|NCT01287897|516622687|FG002|Overall Study|Other|1|||
143292795|NCT01287897|516622688|FG003|Overall Study|Other|0|||
143292796|NCT04483011|516622698|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
143292797|NCT04483011|516622699|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
143292798|NCT00475176|516622700|FG000|Overall Study|Adverse Event|2|||
143292799|NCT00475176|516622700|FG000|Overall Study|Withdrawal by Subject|1|||
143292800|NCT00475176|516622700|FG000|Overall Study|Protocol Violation|1|||
143292801|NCT01853046|516622701|FG000|Overall Study|Withdrawal by Subject|1|||
143292802|NCT01853046|516622702|FG001|Overall Study|Withdrawal by Subject|1|||
143292803|NCT01853046|516622701|FG000|Overall Study|Adverse Event|4|||
143292804|NCT01853046|516622702|FG001|Overall Study|Adverse Event|2|||
143292805|NCT01853046|516622701|FG000|Overall Study|Disease progression|13|||
143292806|NCT01853046|516622702|FG001|Overall Study|Disease progression|3|||
143292807|NCT00708162|516622706|FG000|Randomized Phase|Randomized but Not Treated|7|||
143292808|NCT00708162|516622707|FG001|Randomized Phase|Randomized but Not Treated|5|||
143292809|NCT00708162|516622706|FG000|Randomized Phase|Participant Noncompliance|40|||
143292810|NCT00708162|516622707|FG001|Randomized Phase|Participant Noncompliance|32|||
143292811|NCT00708162|516622706|FG000|Randomized Phase|Lost to Follow-up|34|||
143292812|NCT00708162|516622707|FG001|Randomized Phase|Lost to Follow-up|34|||
143292813|NCT00708162|516622706|FG000|Randomized Phase|Withdrew Consent|31|||
143292814|NCT00708162|516622707|FG001|Randomized Phase|Withdrew Consent|22|||
143292815|NCT00708162|516622706|FG000|Randomized Phase|Lack of Efficacy|14|||
143292816|NCT00708162|516622707|FG001|Randomized Phase|Lack of Efficacy|19|||
143292817|NCT00708162|516622706|FG000|Randomized Phase|Protocol Violation|10|||
143292818|NCT00708162|516622707|FG001|Randomized Phase|Protocol Violation|11|||
143292819|NCT00708162|516622706|FG000|Randomized Phase|Adverse Event|8|||
143292820|NCT00708162|516622707|FG001|Randomized Phase|Adverse Event|12|||
143292821|NCT00708162|516622706|FG000|Randomized Phase|Investigator's Discretion|7|||
143292822|NCT00708162|516622707|FG001|Randomized Phase|Investigator's Discretion|10|||
143292823|NCT00708162|516622706|FG000|Randomized Phase|Death|2|||
143292824|NCT00708162|516622707|FG001|Randomized Phase|Death|9|||
143292825|NCT00708162|516622706|FG000|Randomized Phase|Pregnancy|3|||
143292826|NCT00708162|516622707|FG001|Randomized Phase|Pregnancy|0|||
143292827|NCT00708162|516622706|FG000|Open-Label Phase|Lost to Follow-up|10|||
143292828|NCT00708162|516622707|FG001|Open-Label Phase|Lost to Follow-up|8|||
143292829|NCT00708162|516622706|FG000|Open-Label Phase|Withdrew Consent|12|||
143292830|NCT00708162|516622707|FG001|Open-Label Phase|Withdrew Consent|6|||
143292831|NCT00708162|516622706|FG000|Open-Label Phase|Participant Noncompliance|7|||
143292832|NCT00708162|516622707|FG001|Open-Label Phase|Participant Noncompliance|7|||
143292833|NCT00708162|516622706|FG000|Open-Label Phase|Lack of Efficacy|7|||
143292834|NCT00708162|516622707|FG001|Open-Label Phase|Lack of Efficacy|4|||
143292835|NCT00708162|516622706|FG000|Open-Label Phase|Investigator's Discretion|3|||
143292836|NCT00708162|516622707|FG001|Open-Label Phase|Investigator's Discretion|2|||
143292837|NCT00708162|516622706|FG000|Open-Label Phase|Death|3|||
143292838|NCT00708162|516622707|FG001|Open-Label Phase|Death|1|||
143292839|NCT00708162|516622706|FG000|Open-Label Phase|Adverse Event|1|||
143292840|NCT00708162|516622707|FG001|Open-Label Phase|Adverse Event|2|||
143292841|NCT00708162|516622706|FG000|Open-Label Phase|Other|1|||
143292842|NCT00708162|516622707|FG001|Open-Label Phase|Other|0|||
143292843|NCT03318315|516622709|FG000|Overall Study|Lost to Follow-up|3|||
143292844|NCT03318315|516622710|FG001|Overall Study|Lost to Follow-up|2|||
143292845|NCT03318315|516622711|FG002|Overall Study|Lost to Follow-up|1|||
143292846|NCT03318315|516622709|FG000|Overall Study|Protocol Violation|1|||
143292847|NCT03318315|516622710|FG001|Overall Study|Protocol Violation|1|||
143292848|NCT03318315|516622711|FG002|Overall Study|Protocol Violation|1|||
143292849|NCT03318315|516622709|FG000|Overall Study|Withdrawal by Subject|0|||
143292850|NCT03318315|516622710|FG001|Overall Study|Withdrawal by Subject|0|||
143292851|NCT03318315|516622711|FG002|Overall Study|Withdrawal by Subject|2|||
143292852|NCT02611778|516622712|FG000|Overall Study|Withdrawal by Subject|2|||
143292853|NCT02611778|516622713|FG001|Overall Study|Withdrawal by Subject|8|||
143292854|NCT02611778|516622712|FG000|Overall Study|Adverse Event|1|||
143292855|NCT02611778|516622713|FG001|Overall Study|Adverse Event|2|||
143292856|NCT02611778|516622712|FG000|Overall Study|Death|2|||
143292857|NCT02611778|516622713|FG001|Overall Study|Death|1|||
143292858|NCT02611778|516622712|FG000|Overall Study|Protocol Violation|1|||
143292859|NCT02611778|516622713|FG001|Overall Study|Protocol Violation|0|||
143292860|NCT02611778|516622712|FG000|Overall Study|Lost to Follow-up|3|||
143292861|NCT02611778|516622713|FG001|Overall Study|Lost to Follow-up|1|||
143292862|NCT02611778|516622712|FG000|Overall Study|Need for alternative treatment|1|||
143292863|NCT02611778|516622713|FG001|Overall Study|Need for alternative treatment|0|||
143292864|NCT02611778|516622712|FG000|Overall Study|Other Reason|2|||
143292865|NCT02611778|516622713|FG001|Overall Study|Other Reason|1|||
143292866|NCT02746874|516622714|FG000|Overall Study|Withdrawal by Subject|0|||
143292867|NCT02746874|516622715|FG001|Overall Study|Withdrawal by Subject|1|||
143292868|NCT02746874|516622714|FG000|Overall Study|Surgery Date Changed|0|||
143292869|NCT02746874|516622715|FG001|Overall Study|Surgery Date Changed|2|||
143292870|NCT00276159|516622718|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
143292871|NCT01382446|516622727|FG000|Overall Study|Withdrawal by Subject|0|||
143292872|NCT01382446|516622728|FG001|Overall Study|Withdrawal by Subject|1|||
143292873|NCT01382446|516622727|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
143292874|NCT01382446|516622728|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
143292875|NCT03402386|516622729|FG000|Overall Study|Adverse Event|3|||
143292876|NCT03402386|516622729|FG000|Overall Study|Physician Decision|1|||
143292877|NCT03402386|516622729|FG000|Overall Study|Difficult to control Hb|2|||
143292878|NCT01896531|516622732|FG000|Overall Study|Death|57|||
143292879|NCT01896531|516622733|FG001|Overall Study|Death|59|||
143292880|NCT01896531|516622732|FG000|Overall Study|Lost to Follow-up|3|||
143292881|NCT01896531|516622733|FG001|Overall Study|Lost to Follow-up|0|||
143292882|NCT01896531|516622732|FG000|Overall Study|Non-compliance|0|||
143292883|NCT01896531|516622733|FG001|Overall Study|Non-compliance|1|||
143292884|NCT01896531|516622732|FG000|Overall Study|Study Ended by Sponsor|7|||
143292885|NCT01896531|516622733|FG001|Overall Study|Study Ended by Sponsor|20|||
143292886|NCT01896531|516622732|FG000|Overall Study|Withdrawal by Subject|3|||
143292887|NCT01896531|516622733|FG001|Overall Study|Withdrawal by Subject|2|||
143292888|NCT01896531|516622732|FG000|Overall Study|Death Prior to Treatment|1|||
143292889|NCT01896531|516622733|FG001|Overall Study|Death Prior to Treatment|0|||
143292890|NCT00495170|516622736|FG000|Overall Study|Lost to Follow-up|9|||
143292891|NCT00495170|516622736|FG000|Overall Study|Withdrawal by Subject|3|||
143292892|NCT00495170|516622736|FG000|Overall Study|Inappropriate staging|8|||
143292893|NCT00255047|516622741|FG000|Overall Study|Serious Adverse Events|2|||
143292894|NCT00255047|516622742|FG001|Overall Study|Serious Adverse Events|1|||
143292895|NCT00255047|516622743|FG002|Overall Study|Serious Adverse Events|2|||
143292896|NCT00255047|516622744|FG003|Overall Study|Serious Adverse Events|1|||
143292897|NCT00255047|516622741|FG000|Overall Study|Adverse Event|0|||
143292898|NCT00255047|516622742|FG001|Overall Study|Adverse Event|3|||
143292899|NCT00255047|516622743|FG002|Overall Study|Adverse Event|2|||
143292900|NCT00255047|516622744|FG003|Overall Study|Adverse Event|1|||
143292901|NCT00255047|516622741|FG000|Overall Study|Protocol Violation|13|||
143292902|NCT00255047|516622742|FG001|Overall Study|Protocol Violation|13|||
143292903|NCT00255047|516622743|FG002|Overall Study|Protocol Violation|16|||
143292904|NCT00255047|516622744|FG003|Overall Study|Protocol Violation|20|||
143292905|NCT00255047|516622741|FG000|Overall Study|Lost to Follow-up|9|||
143292906|NCT00255047|516622742|FG001|Overall Study|Lost to Follow-up|8|||
143292907|NCT00255047|516622743|FG002|Overall Study|Lost to Follow-up|5|||
143292908|NCT00255047|516622744|FG003|Overall Study|Lost to Follow-up|6|||
143292909|NCT00255047|516622741|FG000|Overall Study|Withdrawal by Subject|24|||
143292910|NCT00255047|516622742|FG001|Overall Study|Withdrawal by Subject|23|||
143292911|NCT00255047|516622743|FG002|Overall Study|Withdrawal by Subject|25|||
143292912|NCT00255047|516622744|FG003|Overall Study|Withdrawal by Subject|18|||
143292913|NCT00811473|516622745|FG000|Overall Study|Adverse Event|3|||
143292914|NCT00811473|516622746|FG001|Overall Study|Adverse Event|12|||
143292915|NCT00811473|516622745|FG000|Overall Study|Lost to Follow-up|5|||
143292916|NCT00811473|516622746|FG001|Overall Study|Lost to Follow-up|1|||
143292917|NCT00811473|516622745|FG000|Overall Study|Withdrawal by Subject|2|||
143292918|NCT00811473|516622746|FG001|Overall Study|Withdrawal by Subject|4|||
143292919|NCT00811473|516622745|FG000|Overall Study|Severe non-compliance to protocol|2|||
143292920|NCT00811473|516622746|FG001|Overall Study|Severe non-compliance to protocol|4|||
143292921|NCT00811473|516622745|FG000|Overall Study|Lack of therapeutic response|4|||
143292922|NCT00811473|516622746|FG001|Overall Study|Lack of therapeutic response|1|||
143292923|NCT00811473|516622745|FG000|Overall Study|Condition under investigation worsened|1|||
143292924|NCT00811473|516622746|FG001|Overall Study|Condition under investigation worsened|3|||
143292925|NCT00811473|516622745|FG000|Overall Study|Other 2|4|||
143292926|NCT00811473|516622746|FG001|Overall Study|Other 2|1|||
143292927|NCT00811473|516622745|FG000|Overall Study|Incorrect Enrollment|1|||
143292928|NCT00811473|516622746|FG001|Overall Study|Incorrect Enrollment|0|||
143292929|NCT00811473|516622745|FG000|Overall Study|Safety Reasons|1|||
143292930|NCT00811473|516622746|FG001|Overall Study|Safety Reasons|0|||
143292931|NCT01119131|516622756|FG000|Overall Study|Adverse Event|1|||
143292932|NCT01119131|516622757|FG001|Overall Study|Adverse Event|1|||
143292933|NCT01119131|516622758|FG002|Overall Study|Adverse Event|1|||
143292934|NCT01119131|516622756|FG000|Overall Study|Non-Compliance|1|||
143292935|NCT01119131|516622757|FG001|Overall Study|Non-Compliance|0|||
143292936|NCT01119131|516622758|FG002|Overall Study|Non-Compliance|4|||
143292937|NCT01119131|516622756|FG000|Overall Study|Physician Decision|0|||
143292938|NCT01119131|516622757|FG001|Overall Study|Physician Decision|0|||
143292939|NCT01119131|516622758|FG002|Overall Study|Physician Decision|1|||
143292940|NCT00732615|516622759|FG000|Overall Study|Withdrawal by Subject|3|||
143292941|NCT00732615|516622760|FG001|Overall Study|Withdrawal by Subject|1|||
143292942|NCT00732615|516622759|FG000|Overall Study|Lost to Follow-up|0|||
143292943|NCT00732615|516622760|FG001|Overall Study|Lost to Follow-up|1|||
143292944|NCT00732615|516622759|FG000|Overall Study|Adverse Event|0|||
143292945|NCT00732615|516622760|FG001|Overall Study|Adverse Event|2|||
143292946|NCT00732615|516622759|FG000|Overall Study|Physician Decision|3|||
143292947|NCT00732615|516622760|FG001|Overall Study|Physician Decision|0|||
143292948|NCT00732615|516622759|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
143292949|NCT00732615|516622760|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
143292950|NCT00993291|516622761|FG000|Overall Study|Withdrawal by Subject|1|||
143292951|NCT00003492|516622762|FG000|Overall Study|Not evaluable|6|||
143292952|NCT03566823|516622763|FG000|Overall Study|Lack of Efficacy|0|||
143292953|NCT03566823|516622764|FG001|Overall Study|Lack of Efficacy|1|||
143292954|NCT03566823|516622765|FG002|Overall Study|Lack of Efficacy|0|||
143292955|NCT03566823|516622763|FG000|Overall Study|Withdrawal by Subject|1|||
143292956|NCT03566823|516622764|FG001|Overall Study|Withdrawal by Subject|2|||
143292957|NCT03566823|516622765|FG002|Overall Study|Withdrawal by Subject|0|||
143292958|NCT03566823|516622763|FG000|Overall Study|Adverse Event|1|||
143292959|NCT03566823|516622764|FG001|Overall Study|Adverse Event|0|||
143292960|NCT03566823|516622765|FG002|Overall Study|Adverse Event|2|||
143292961|NCT01528254|516622766|FG000|Overall Study|Administrative problems|96|||
143292962|NCT01528254|516622767|FG001|Overall Study|Administrative problems|94|||
143292963|NCT01528254|516622766|FG000|Overall Study|Adverse Event|28|||
143292964|NCT01528254|516622767|FG001|Overall Study|Adverse Event|44|||
143292965|NCT01528254|516622766|FG000|Overall Study|Lost to Follow-up|17|||
143292966|NCT01528254|516622767|FG001|Overall Study|Lost to Follow-up|24|||
143292967|NCT01528254|516622766|FG000|Overall Study|Death|13|||
143292968|NCT01528254|516622767|FG001|Overall Study|Death|9|||
143292969|NCT01528254|516622766|FG000|Overall Study|Protocol deviation|9|||
143292970|NCT01528254|516622767|FG001|Overall Study|Protocol deviation|19|||
143292971|NCT01528254|516622766|FG000|Overall Study|New therapy for study indication|8|||
143292972|NCT01528254|516622767|FG001|Overall Study|New therapy for study indication|6|||
143292973|NCT01528254|516622766|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
143292974|NCT01528254|516622767|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
143292975|NCT01528254|516622766|FG000|Overall Study|Withdrawal by Subject|5|||
143292976|NCT01528254|516622767|FG001|Overall Study|Withdrawal by Subject|4|||
143292977|NCT01528254|516622766|FG000|Overall Study|Abnormal laboratory value(s)|3|||
143292978|NCT01528254|516622767|FG001|Overall Study|Abnormal laboratory value(s)|7|||
143292979|NCT01528254|516622766|FG000|Overall Study|Abnormal test procedure result(s)|1|||
143292980|NCT01528254|516622767|FG001|Overall Study|Abnormal test procedure result(s)|0|||
143292981|NCT01528254|516622766|FG000|Overall Study|No longer requires study drug|1|||
143292982|NCT01528254|516622767|FG001|Overall Study|No longer requires study drug|1|||
143292983|NCT04446377|516622768|FG000|Overall Study|Withdrawal by Subject|6|||
143292984|NCT04446377|516622769|FG001|Overall Study|Withdrawal by Subject|1|||
143292985|NCT04446377|516622768|FG000|Overall Study|Physician Decision|1|||
143292986|NCT04446377|516622769|FG001|Overall Study|Physician Decision|1|||
143292987|NCT04446377|516622768|FG000|Overall Study|Lost to Follow-up|0|||
143292988|NCT04446377|516622769|FG001|Overall Study|Lost to Follow-up|2|||
143292989|NCT04446377|516622768|FG000|Overall Study|Not eligible|0|||
143292990|NCT04446377|516622769|FG001|Overall Study|Not eligible|1|||
143292991|NCT02763189|516622770|FG000|Overall Study|Device failure|0|||
143292992|NCT02763189|516622771|FG001|Overall Study|Device failure|2|||
143292993|NCT01414075|516622772|FG000|Overall Study|Adverse Event|1|||
143292994|NCT01414075|516622773|FG001|Overall Study|Adverse Event|0|||
143292995|NCT01414075|516622774|FG002|Overall Study|Adverse Event|1|||
143292996|NCT01414075|516622775|FG003|Overall Study|Adverse Event|0|||
143292997|NCT01414075|516622772|FG000|Overall Study|Death|1|||
143292998|NCT01414075|516622773|FG001|Overall Study|Death|0|||
143292999|NCT01414075|516622774|FG002|Overall Study|Death|0|||
143293000|NCT01414075|516622775|FG003|Overall Study|Death|1|||
143293001|NCT01414075|516622772|FG000|Overall Study|Withdrawal by Subject|0|||
143293002|NCT01414075|516622773|FG001|Overall Study|Withdrawal by Subject|0|||
143293003|NCT01414075|516622774|FG002|Overall Study|Withdrawal by Subject|0|||
143293004|NCT01414075|516622775|FG003|Overall Study|Withdrawal by Subject|1|||
143293005|NCT01414075|516622772|FG000|Overall Study|Other than specified|1|||
143293006|NCT01414075|516622773|FG001|Overall Study|Other than specified|0|||
143293007|NCT01414075|516622774|FG002|Overall Study|Other than specified|1|||
143293008|NCT01414075|516622775|FG003|Overall Study|Other than specified|0|||
143293009|NCT02810392|516622776|FG000|Overall Study|Subject too ill to continue|1|||
143293010|NCT02810392|516622777|FG001|Overall Study|Subject too ill to continue|0|||
143293011|NCT02810392|516622776|FG000|Overall Study|COVID 19 research restrictions|0|||
143293012|NCT02810392|516622777|FG001|Overall Study|COVID 19 research restrictions|1|||
143293013|NCT00573534|516622778|FG000|Overall Study|oppositional behavior|3|||
143293014|NCT02457910|516622783|FG000|Overall Study|Withdrawal by Subject|0|||
143293015|NCT02457910|516622784|FG001|Overall Study|Withdrawal by Subject|0|||
143293016|NCT02457910|516622785|FG002|Overall Study|Withdrawal by Subject|0|||
143293017|NCT02457910|516622786|FG003|Overall Study|Withdrawal by Subject|0|||
143293018|NCT02457910|516622787|FG004|Overall Study|Withdrawal by Subject|0|||
143293019|NCT02457910|516622788|FG005|Overall Study|Withdrawal by Subject|1|||
143293020|NCT02457910|516622783|FG000|Overall Study|Adverse Event|0|||
143293021|NCT02457910|516622784|FG001|Overall Study|Adverse Event|2|||
143293022|NCT02457910|516622785|FG002|Overall Study|Adverse Event|1|||
143293023|NCT02457910|516622786|FG003|Overall Study|Adverse Event|1|||
143293024|NCT02457910|516622787|FG004|Overall Study|Adverse Event|1|||
143293025|NCT02457910|516622788|FG005|Overall Study|Adverse Event|3|||
143293026|NCT02457910|516622783|FG000|Overall Study|Disease progression|3|||
143293027|NCT02457910|516622784|FG001|Overall Study|Disease progression|3|||
143293028|NCT02457910|516622785|FG002|Overall Study|Disease progression|1|||
143293029|NCT02457910|516622786|FG003|Overall Study|Disease progression|1|||
143293030|NCT02457910|516622787|FG004|Overall Study|Disease progression|4|||
143293031|NCT02457910|516622788|FG005|Overall Study|Disease progression|6|||
143293032|NCT02457910|516622783|FG000|Overall Study|Other complicating illness|0|||
143293033|NCT02457910|516622784|FG001|Overall Study|Other complicating illness|0|||
143293034|NCT02457910|516622785|FG002|Overall Study|Other complicating illness|0|||
143293035|NCT02457910|516622786|FG003|Overall Study|Other complicating illness|0|||
143293036|NCT02457910|516622787|FG004|Overall Study|Other complicating illness|0|||
143293037|NCT02457910|516622788|FG005|Overall Study|Other complicating illness|1|||
143293038|NCT02457910|516622783|FG000|Overall Study|Death|0|||
143293039|NCT02457910|516622784|FG001|Overall Study|Death|0|||
143293040|NCT02457910|516622785|FG002|Overall Study|Death|1|||
143293041|NCT02457910|516622786|FG003|Overall Study|Death|0|||
143293042|NCT02457910|516622787|FG004|Overall Study|Death|0|||
143293043|NCT02457910|516622788|FG005|Overall Study|Death|0|||
143293044|NCT02196558|516622789|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
143293045|NCT02196558|516622790|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
143293046|NCT02196558|516622791|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
143293047|NCT02196558|516622789|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
143293048|NCT02196558|516622790|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
143373779|NCT02477670|516913568|FG005|Stage 2|Antipsychotic Medication Changed|0|||
143373780|NCT02477670|516913569|FG006|Stage 2|Antipsychotic Medication Changed|0|||
143373781|NCT02477670|516913563|FG000|Stage 2|Withdrawal by Subject|0|||
143293049|NCT02196558|516622791|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
143293050|NCT02196558|516622789|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
143293051|NCT02196558|516622790|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
143293052|NCT02196558|516622791|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
143293053|NCT02196558|516622789|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
143293054|NCT02196558|516622790|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
143293055|NCT02196558|516622791|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
143293056|NCT02196558|516622789|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
143293057|NCT02196558|516622790|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
143293058|NCT02196558|516622791|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
143293059|NCT02107482|516622792|FG000|Overall Study|inconveinence|2|||
143293060|NCT02107482|516622792|FG000|Overall Study|Lost to Follow-up|1|||
143293061|NCT02107482|516622792|FG000|Overall Study|Lack of Efficacy|1|||
143293062|NCT04868890|516622793|FG000|Overall Study|Death|2|||
143293063|NCT04868890|516622794|FG001|Overall Study|Death|1|||
143293064|NCT04868890|516622793|FG000|Overall Study|Withdrawal by Subject|1|||
143293065|NCT04868890|516622794|FG001|Overall Study|Withdrawal by Subject|5|||
143293066|NCT03128892|516622799|FG000|Overall Study|Withdrawal by Subject|2|||
143293067|NCT03128892|516622799|FG000|Overall Study|Physician Decision|1|||
143293068|NCT01850524|516622800|FG000|Overall Study|Lost to Follow-up|5|||
143293069|NCT01850524|516622801|FG001|Overall Study|Lost to Follow-up|10|||
143293070|NCT01850524|516622800|FG000|Overall Study|Withdrawal by Subject|24|||
143293071|NCT01850524|516622801|FG001|Overall Study|Withdrawal by Subject|22|||
143293072|NCT01850524|516622800|FG000|Overall Study|Reason not Specified|142|||
143293073|NCT01850524|516622801|FG001|Overall Study|Reason not Specified|141|||
143293074|NCT00883116|516622809|FG000|Overall Study|Adverse event unrelated to study drug|5|||
143293075|NCT00883116|516622810|FG001|Overall Study|Adverse event unrelated to study drug|10|||
143293076|NCT00883116|516622809|FG000|Overall Study|Death|6|||
143293077|NCT00883116|516622810|FG001|Overall Study|Death|2|||
143293078|NCT00883116|516622809|FG000|Overall Study|Disease progression|130|||
143293079|NCT00883116|516622810|FG001|Overall Study|Disease progression|128|||
143293080|NCT00883116|516622809|FG000|Overall Study|Lost to Follow-up|0|||
143373782|NCT02477670|516913564|FG001|Stage 2|Withdrawal by Subject|0|||
143293081|NCT00883116|516622810|FG001|Overall Study|Lost to Follow-up|1|||
143293082|NCT00883116|516622809|FG000|Overall Study|Maximum clinical benefit|13|||
143293083|NCT00883116|516622810|FG001|Overall Study|Maximum clinical benefit|46|||
143293084|NCT00883116|516622809|FG000|Overall Study|Not identified|3|||
143293085|NCT00883116|516622810|FG001|Overall Study|Not identified|6|||
143293086|NCT00883116|516622809|FG000|Overall Study|Study drug toxicity|36|||
143293087|NCT00883116|516622810|FG001|Overall Study|Study drug toxicity|16|||
143293088|NCT00883116|516622809|FG000|Overall Study|Withdrawal by Subject|14|||
143293089|NCT00883116|516622810|FG001|Overall Study|Withdrawal by Subject|8|||
143293090|NCT00883116|516622809|FG000|Overall Study|No longer meets study criteria|2|||
143293091|NCT00883116|516622810|FG001|Overall Study|No longer meets study criteria|2|||
143293092|NCT03061331|516622811|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
143293093|NCT03061331|516622812|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
143293094|NCT01980875|516622813|FG000|Overall Study|Withdrew Consent|1|||
143293095|NCT01980875|516622814|FG001|Overall Study|Withdrew Consent|1|||
143293096|NCT01980875|516622815|FG002|Overall Study|Withdrew Consent|1|||
143293097|NCT01980875|516622813|FG000|Overall Study|Study Terminated by Sponsor|7|||
143293098|NCT01980875|516622814|FG001|Overall Study|Study Terminated by Sponsor|24|||
143293099|NCT01980875|516622815|FG002|Overall Study|Study Terminated by Sponsor|22|||
143293100|NCT01980875|516622813|FG000|Overall Study|Lost to Follow-up|0|||
143293101|NCT01980875|516622814|FG001|Overall Study|Lost to Follow-up|0|||
143293102|NCT01980875|516622815|FG002|Overall Study|Lost to Follow-up|1|||
143293103|NCT00665847|516622816|FG000|Overall Study|Adverse Event|8|||
143293104|NCT00665847|516622816|FG000|Overall Study|Withdrawal by Subject|2|||
143293105|NCT00665847|516622816|FG000|Overall Study|Subject non-compliant|8|||
143293106|NCT00665847|516622816|FG000|Overall Study|Subject reached a virologic endpoint|4|||
143293107|NCT00665847|516622816|FG000|Overall Study|Resistance to TMC125|1|||
143293108|NCT00665847|516622816|FG000|Overall Study|Subject ineligible to continue the trial|1|||
143293109|NCT00665847|516622816|FG000|Overall Study|Switch to Commercial Medication|1|||
143293110|NCT01189812|516622822|FG000|Overall Study|Withdrawal by Subject|2|||
143293111|NCT01189812|516622823|FG001|Overall Study|Withdrawal by Subject|3|||
143293112|NCT01189812|516622822|FG000|Overall Study|Adverse Event|1|||
143293113|NCT01189812|516622823|FG001|Overall Study|Adverse Event|0|||
143293114|NCT01189812|516622822|FG000|Overall Study|Out of Window|4|||
143293115|NCT01189812|516622823|FG001|Overall Study|Out of Window|3|||
143293116|NCT01189812|516622822|FG000|Overall Study|Moved out of State|1|||
143293117|NCT01189812|516622823|FG001|Overall Study|Moved out of State|2|||
143293118|NCT02200445|516622825|FG000|Overall Study|Lack of Efficacy|1|||
143293119|NCT02200445|516622826|FG001|Overall Study|Lack of Efficacy|2|||
143293120|NCT02200445|516622827|FG002|Overall Study|Lack of Efficacy|2|||
143293121|NCT02200445|516622825|FG000|Overall Study|Adverse Event|0|||
143293122|NCT02200445|516622826|FG001|Overall Study|Adverse Event|2|||
143293123|NCT02200445|516622827|FG002|Overall Study|Adverse Event|0|||
143293124|NCT03334903|516622828|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
143293125|NCT03334903|516622829|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
143293126|NCT03334903|516622828|FG000|Overall Study|Protocol Violation|1|||
143293127|NCT03334903|516622829|FG001|Overall Study|Protocol Violation|3|||
143293128|NCT03334903|516622828|FG000|Overall Study|Surgery postponed|1|||
143293129|NCT03334903|516622829|FG001|Overall Study|Surgery postponed|0|||
143293130|NCT03334903|516622828|FG000|Overall Study|Adverse Event|1|||
143293131|NCT03334903|516622829|FG001|Overall Study|Adverse Event|1|||
143293132|NCT03334903|516622828|FG000|Overall Study|Withdrawal by Subject|0|||
143293133|NCT03334903|516622829|FG001|Overall Study|Withdrawal by Subject|1|||
143293134|NCT02879305|516622830|FG000|Overall Study|Investigator Site Closed|55|||
143293135|NCT02879305|516622831|FG001|Overall Study|Investigator Site Closed|57|||
143293136|NCT02879305|516622830|FG000|Overall Study|Withdrawal by Subject|44|||
143293137|NCT02879305|516622831|FG001|Overall Study|Withdrawal by Subject|42|||
143293138|NCT02879305|516622830|FG000|Overall Study|Lost to Follow-up|17|||
143293139|NCT02879305|516622831|FG001|Overall Study|Lost to Follow-up|12|||
143293140|NCT02879305|516622830|FG000|Overall Study|Other|1|||
143293141|NCT02879305|516622831|FG001|Overall Study|Other|0|||
143293142|NCT01199289|516625357|FG000|Overall Study|Ineligibility determined|2|||
143293143|NCT01199289|516625358|FG001|Overall Study|Ineligibility determined|1|||
143293144|NCT01199289|516625359|FG002|Overall Study|Ineligibility determined|0|||
143293145|NCT01199289|516625360|FG003|Overall Study|Ineligibility determined|0|||
143293146|NCT01199289|516625357|FG000|Overall Study|Protocol Violation|1|||
143293147|NCT01199289|516625358|FG001|Overall Study|Protocol Violation|0|||
143293148|NCT01199289|516625359|FG002|Overall Study|Protocol Violation|0|||
143293149|NCT01199289|516625360|FG003|Overall Study|Protocol Violation|1|||
143293150|NCT01199289|516625357|FG000|Overall Study|Noncompliance|1|||
143293151|NCT01199289|516625358|FG001|Overall Study|Noncompliance|0|||
143293152|NCT01199289|516625359|FG002|Overall Study|Noncompliance|2|||
143293153|NCT01199289|516625360|FG003|Overall Study|Noncompliance|0|||
143293154|NCT01199289|516625357|FG000|Overall Study|Adverse Event|0|||
143293155|NCT01199289|516625358|FG001|Overall Study|Adverse Event|3|||
143293156|NCT01199289|516625359|FG002|Overall Study|Adverse Event|1|||
143293157|NCT01199289|516625360|FG003|Overall Study|Adverse Event|4|||
143373783|NCT02477670|516913565|FG002|Stage 2|Withdrawal by Subject|0|||
143293158|NCT01199289|516625357|FG000|Overall Study|Full consent withdrawn|2|||
143293159|NCT01199289|516625358|FG001|Overall Study|Full consent withdrawn|2|||
143293160|NCT01199289|516625359|FG002|Overall Study|Full consent withdrawn|2|||
143293161|NCT01199289|516625360|FG003|Overall Study|Full consent withdrawn|3|||
143293162|NCT01199289|516625357|FG000|Overall Study|Administrative decision|0|||
143293163|NCT01199289|516625358|FG001|Overall Study|Administrative decision|0|||
143293164|NCT01199289|516625359|FG002|Overall Study|Administrative decision|0|||
143293165|NCT01199289|516625360|FG003|Overall Study|Administrative decision|1|||
143293166|NCT01199289|516625357|FG000|Overall Study|Lost to Follow-up|0|||
143293167|NCT01199289|516625358|FG001|Overall Study|Lost to Follow-up|0|||
143293168|NCT01199289|516625359|FG002|Overall Study|Lost to Follow-up|0|||
143293169|NCT01199289|516625360|FG003|Overall Study|Lost to Follow-up|1|||
143293170|NCT01199289|516625357|FG000|Overall Study|Protocol-specified criteria|3|||
143293171|NCT01199289|516625358|FG001|Overall Study|Protocol-specified criteria|0|||
143293172|NCT01199289|516625359|FG002|Overall Study|Protocol-specified criteria|0|||
143293173|NCT01199289|516625360|FG003|Overall Study|Protocol-specified criteria|1|||
143293174|NCT01199289|516625357|FG000|Overall Study|Pregnancy|0|||
143293175|NCT01199289|516625358|FG001|Overall Study|Pregnancy|1|||
143293176|NCT01199289|516625359|FG002|Overall Study|Pregnancy|0|||
143293177|NCT01199289|516625360|FG003|Overall Study|Pregnancy|1|||
143293178|NCT02636868|516625361|FG000|Overall Study|Death|0|||
143293179|NCT02636868|516625362|FG001|Overall Study|Death|1|||
143293180|NCT02636868|516625363|FG002|Overall Study|Death|2|||
143293181|NCT03220217|516625364|FG000|Overall Study|Withdrawal by Subject|0|||
143293182|NCT03220217|516625365|FG001|Overall Study|Withdrawal by Subject|1|||
143293183|NCT03220217|516625366|FG002|Overall Study|Withdrawal by Subject|0|||
143293184|NCT03220217|516625364|FG000|Overall Study|Subject Missed Procedure|0|||
143293185|NCT03220217|516625365|FG001|Overall Study|Subject Missed Procedure|0|||
143293186|NCT03220217|516625366|FG002|Overall Study|Subject Missed Procedure|1|||
143293187|NCT00903617|516625368|FG000|Overall Study|Adverse Event|0|||
143293188|NCT00903617|516625369|FG001|Overall Study|Adverse Event|1|||
143293189|NCT00903617|516625370|FG002|Overall Study|Adverse Event|1|||
143293190|NCT00903617|516625371|FG003|Overall Study|Adverse Event|0|||
143293191|NCT00903617|516625368|FG000|Overall Study|Protocol-defined stopping criteria|0|||
143293192|NCT00903617|516625369|FG001|Overall Study|Protocol-defined stopping criteria|2|||
143293193|NCT00903617|516625370|FG002|Overall Study|Protocol-defined stopping criteria|0|||
143293194|NCT00903617|516625371|FG003|Overall Study|Protocol-defined stopping criteria|0|||
143293195|NCT00903617|516625368|FG000|Overall Study|Lost to Follow-up|2|||
143293196|NCT00903617|516625369|FG001|Overall Study|Lost to Follow-up|0|||
143293197|NCT00903617|516625370|FG002|Overall Study|Lost to Follow-up|1|||
143293198|NCT00903617|516625371|FG003|Overall Study|Lost to Follow-up|1|||
143293199|NCT00903617|516625368|FG000|Overall Study|Withdrawal by Subject|1|||
143293200|NCT00903617|516625369|FG001|Overall Study|Withdrawal by Subject|2|||
143293201|NCT00903617|516625370|FG002|Overall Study|Withdrawal by Subject|3|||
143293202|NCT00903617|516625371|FG003|Overall Study|Withdrawal by Subject|0|||
143293203|NCT01104636|516625372|FG000|Overall Study|Lack of Efficacy|43|||
143293204|NCT01104636|516625372|FG000|Overall Study|Lost to Follow-up|24|||
143293205|NCT01104636|516625372|FG000|Overall Study|Withdrawal by Subject|4|||
143293206|NCT01104636|516625372|FG000|Overall Study|Other|43|||
143293207|NCT01104636|516625372|FG000|Overall Study|Study terminated by sponsor|1|||
143293208|NCT01104636|516625372|FG000|Overall Study|Pregnancy|2|||
143293209|NCT01104636|516625372|FG000|Overall Study|Adverse Event|40|||
143293210|NCT01104636|516625372|FG000|Overall Study|Ongoing|21|||
143293211|NCT03055260|516625373|FG000|Overall Study|Withdrawal by Subject|1|||
143293212|NCT03055260|516625374|FG001|Overall Study|Withdrawal by Subject|0|||
143293213|NCT02507505|516625375|FG000|Overall Study|Withdrawal by Subject|13|||
143293214|NCT02507505|516625376|FG001|Overall Study|Withdrawal by Subject|11|||
143293215|NCT02507505|516625375|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
143293216|NCT02507505|516625376|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
143293217|NCT02507505|516625375|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
143293218|NCT02507505|516625376|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
143293219|NCT02507505|516625375|FG000|Overall Study|Death before receipt of anesthesia|0|||
143293220|NCT02507505|516625376|FG001|Overall Study|Death before receipt of anesthesia|1|||
143293221|NCT00967798|516625377|FG000|Overall Study|Withdrawal by Subject|5|||
143293222|NCT00967798|516625378|FG001|Overall Study|Withdrawal by Subject|2|||
143293223|NCT00967798|516625377|FG000|Overall Study|Lost to Follow-up|4|||
143293224|NCT00967798|516625378|FG001|Overall Study|Lost to Follow-up|1|||
143293225|NCT00254540|516625379|FG000|Overall Study|Adverse Event|6|||
143293226|NCT00254540|516625380|FG001|Overall Study|Adverse Event|7|||
143293227|NCT00254540|516625379|FG000|Overall Study|Lack of Efficacy|13|||
143293228|NCT00254540|516625380|FG001|Overall Study|Lack of Efficacy|13|||
143293229|NCT00254540|516625379|FG000|Overall Study|Death|0|||
143373784|NCT02477670|516913566|FG003|Stage 2|Withdrawal by Subject|1|||
143293230|NCT00254540|516625380|FG001|Overall Study|Death|1|||
143293231|NCT00254540|516625379|FG000|Overall Study|Laboratory Test Abnormality|0|||
143293232|NCT00254540|516625380|FG001|Overall Study|Laboratory Test Abnormality|1|||
143293233|NCT03518073|516625381|FG000|Overall Study|Adverse Event|2|||
143293234|NCT03518073|516625382|FG001|Overall Study|Adverse Event|4|||
143293235|NCT03518073|516625383|FG002|Overall Study|Adverse Event|2|||
143293236|NCT03518073|516625381|FG000|Overall Study|Death|2|||
143293237|NCT03518073|516625382|FG001|Overall Study|Death|1|||
143293238|NCT03518073|516625383|FG002|Overall Study|Death|3|||
143293239|NCT03518073|516625381|FG000|Overall Study|Lost to Follow-up|1|||
143293240|NCT03518073|516625382|FG001|Overall Study|Lost to Follow-up|0|||
143293241|NCT03518073|516625383|FG002|Overall Study|Lost to Follow-up|1|||
143293242|NCT03518073|516625381|FG000|Overall Study|Physician Decision|5|||
143293243|NCT03518073|516625382|FG001|Overall Study|Physician Decision|0|||
143293244|NCT03518073|516625383|FG002|Overall Study|Physician Decision|2|||
143293245|NCT03518073|516625381|FG000|Overall Study|Progressive disease|1|||
143293246|NCT03518073|516625382|FG001|Overall Study|Progressive disease|1|||
143293247|NCT03518073|516625383|FG002|Overall Study|Progressive disease|1|||
143293248|NCT03518073|516625381|FG000|Overall Study|Protocol Violation|1|||
143293249|NCT03518073|516625382|FG001|Overall Study|Protocol Violation|0|||
143293250|NCT03518073|516625383|FG002|Overall Study|Protocol Violation|0|||
143293251|NCT03518073|516625381|FG000|Overall Study|Withdrawal by Subject|30|||
143293252|NCT03518073|516625382|FG001|Overall Study|Withdrawal by Subject|34|||
143293253|NCT03518073|516625383|FG002|Overall Study|Withdrawal by Subject|29|||
143293254|NCT03518073|516625381|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
143293255|NCT03518073|516625382|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
143293256|NCT03518073|516625383|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
143293257|NCT03518073|516625381|FG000|Overall Study|Covid-19|1|||
143293258|NCT03518073|516625382|FG001|Overall Study|Covid-19|2|||
143293259|NCT03518073|516625383|FG002|Overall Study|Covid-19|1|||
143293260|NCT03020407|516625384|FG000|Overall Study|Withdrawal by Subject|2|||
143293261|NCT03020407|516625385|FG001|Overall Study|Withdrawal by Subject|1|||
143293262|NCT03020407|516625384|FG000|Overall Study|Lost to Follow-up|2|||
143293263|NCT03020407|516625385|FG001|Overall Study|Lost to Follow-up|3|||
143293264|NCT03020407|516625384|FG000|Overall Study|Protocol Violation|0|||
143293265|NCT03020407|516625385|FG001|Overall Study|Protocol Violation|1|||
143293266|NCT02699554|516625386|FG000|Overall Study|Lost to Follow-up|9|||
143293267|NCT00788151|516625387|FG000|Overall Study|Other adverse event|0|||
143293268|NCT00788151|516625388|FG001|Overall Study|Other adverse event|2|||
143293269|NCT00788151|516625387|FG000|Overall Study|Protocol Violation|0|||
143293270|NCT00788151|516625388|FG001|Overall Study|Protocol Violation|1|||
143293271|NCT00788151|516625387|FG000|Overall Study|Withdrawal by Subject|13|||
143293272|NCT00788151|516625388|FG001|Overall Study|Withdrawal by Subject|6|||
143293273|NCT00788151|516625387|FG000|Overall Study|Enrolled but not treated|1|||
143293274|NCT00788151|516625388|FG001|Overall Study|Enrolled but not treated|1|||
143293275|NCT00503009|516625389|FG000|Overall Study|Protocol Violation|1|||
143293276|NCT00503009|516625390|FG001|Overall Study|Protocol Violation|0|||
143293277|NCT00503009|516625391|FG002|Overall Study|Protocol Violation|1|||
143293278|NCT00503009|516625389|FG000|Overall Study|Withdrawal by Subject|0|||
143293279|NCT00503009|516625390|FG001|Overall Study|Withdrawal by Subject|1|||
143293280|NCT00503009|516625391|FG002|Overall Study|Withdrawal by Subject|1|||
143293281|NCT00503009|516625389|FG000|Overall Study|Physician Decision|0|||
143293282|NCT00503009|516625390|FG001|Overall Study|Physician Decision|1|||
143293283|NCT00503009|516625391|FG002|Overall Study|Physician Decision|1|||
143293284|NCT01349803|516625393|FG000|Overall Study|Adverse Event|0|||
143293285|NCT01349803|516625394|FG001|Overall Study|Adverse Event|0|||
143293286|NCT01349803|516625395|FG002|Overall Study|Adverse Event|0|||
143293287|NCT01349803|516625396|FG003|Overall Study|Adverse Event|2|||
143293288|NCT01349803|516625393|FG000|Overall Study|Withdrawal by Subject|1|||
143293289|NCT01349803|516625394|FG001|Overall Study|Withdrawal by Subject|0|||
143293290|NCT01349803|516625395|FG002|Overall Study|Withdrawal by Subject|0|||
143293291|NCT01349803|516625396|FG003|Overall Study|Withdrawal by Subject|0|||
143293292|NCT01349803|516625393|FG000|Overall Study|Protocol-specified criteria|0|||
143293293|NCT01349803|516625394|FG001|Overall Study|Protocol-specified criteria|1|||
143293294|NCT01349803|516625395|FG002|Overall Study|Protocol-specified criteria|3|||
143293295|NCT01349803|516625396|FG003|Overall Study|Protocol-specified criteria|0|||
143293296|NCT02169739|516625397|FG000|Overall Study|Lost to Follow-up|0|||
143293297|NCT02169739|516625398|FG001|Overall Study|Lost to Follow-up|4|||
143293298|NCT03635957|516625399|FG000|Run-In Period|Lost to Follow-up|1|||
143293299|NCT03635957|516625399|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
143293300|NCT00350636|516625400|FG000|Overall Study|Adverse Event|19|||
143293301|NCT00350636|516625401|FG001|Overall Study|Adverse Event|13|||
143293302|NCT00350636|516625400|FG000|Overall Study|Protocol Violation|1|||
143293303|NCT00350636|516625401|FG001|Overall Study|Protocol Violation|3|||
143293304|NCT00350636|516625400|FG000|Overall Study|Withdrawal by Subject|13|||
143293305|NCT00350636|516625401|FG001|Overall Study|Withdrawal by Subject|17|||
143293306|NCT00350636|516625400|FG000|Overall Study|Lost to Follow-up|9|||
143293307|NCT00350636|516625401|FG001|Overall Study|Lost to Follow-up|8|||
143293308|NCT00350636|516625400|FG000|Overall Study|Physician Decision|0|||
143293309|NCT00350636|516625401|FG001|Overall Study|Physician Decision|2|||
143293310|NCT00350636|516625400|FG000|Overall Study|Other|1|||
143293311|NCT00350636|516625401|FG001|Overall Study|Other|2|||
143293312|NCT01710033|516625402|FG000|Stage 2|Adverse Event|0|||
143293313|NCT01710033|516625403|FG001|Stage 2|Adverse Event|0|||
143293314|NCT01710033|516625404|FG002|Stage 2|Adverse Event|0|||
143293315|NCT01710033|516625405|FG003|Stage 2|Adverse Event|0|||
143293316|NCT01710033|516625406|FG004|Stage 2|Adverse Event|1|||
143293317|NCT01647282|516625412|FG000|Overall Study|Physician Decision|7|||
143293318|NCT01647282|516625413|FG001|Overall Study|Physician Decision|5|||
143293319|NCT01042236|516625414|FG000|Treatment Period 1|Adverse Event|0|||
143293320|NCT01042236|516625415|FG001|Treatment Period 1|Adverse Event|1|||
143293321|NCT01042236|516625416|FG002|Treatment Period 1|Adverse Event|0|||
143293322|NCT01042236|516625417|FG003|Treatment Period 1|Adverse Event|0|||
143293323|NCT01042236|516625418|FG004|Treatment Period 1|Adverse Event|1|||
143293324|NCT01042236|516625419|FG005|Treatment Period 1|Adverse Event|0|||
143293325|NCT01042236|516625414|FG000|Treatment Period 3|Adverse Event|0|||
143293326|NCT01042236|516625415|FG001|Treatment Period 3|Adverse Event|0|||
143293327|NCT01042236|516625416|FG002|Treatment Period 3|Adverse Event|0|||
143293328|NCT01042236|516625417|FG003|Treatment Period 3|Adverse Event|1|||
143293329|NCT01042236|516625418|FG004|Treatment Period 3|Adverse Event|0|||
143293330|NCT01042236|516625419|FG005|Treatment Period 3|Adverse Event|0|||
143293331|NCT01042236|516625414|FG000|Treatment Period 3|Protocol Violation|0|||
143293332|NCT01042236|516625415|FG001|Treatment Period 3|Protocol Violation|0|||
143293333|NCT01042236|516625416|FG002|Treatment Period 3|Protocol Violation|0|||
143293334|NCT01042236|516625417|FG003|Treatment Period 3|Protocol Violation|1|||
143293335|NCT01042236|516625418|FG004|Treatment Period 3|Protocol Violation|0|||
143293336|NCT01042236|516625419|FG005|Treatment Period 3|Protocol Violation|0|||
143293337|NCT01475331|516625423|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
143293338|NCT01475331|516625424|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
143293339|NCT01475331|516625423|FG000|Overall Study|excessive main duct communication|1|||
143293340|NCT01475331|516625424|FG001|Overall Study|excessive main duct communication|1|||
143293341|NCT01475331|516625423|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
143293342|NCT01475331|516625424|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
143293343|NCT01475331|516625423|FG000|Overall Study|Sign of malignancy during the procedure|2|||
143293344|NCT01475331|516625424|FG001|Overall Study|Sign of malignancy during the procedure|0|||
143293345|NCT01475331|516625423|FG000|Overall Study|cyst found to be prohibitively small|0|||
143293346|NCT01475331|516625424|FG001|Overall Study|cyst found to be prohibitively small|1|||
143293347|NCT01525550|516625425|FG000|Overall Study|Lost to Follow-up|8|||
143293348|NCT01525550|516625426|FG001|Overall Study|Lost to Follow-up|2|||
143293349|NCT01525550|516625425|FG000|Overall Study|Death|19|||
143293350|NCT01525550|516625426|FG001|Overall Study|Death|28|||
143293351|NCT01525550|516625425|FG000|Overall Study|Other|0|||
143293352|NCT01525550|516625426|FG001|Overall Study|Other|4|||
143293353|NCT01525550|516625425|FG000|Overall Study|Sponsor's Decision|30|||
143293354|NCT01525550|516625426|FG001|Overall Study|Sponsor's Decision|11|||
143293355|NCT01525550|516625425|FG000|Overall Study|Withdrawal by Subject|4|||
143293356|NCT01525550|516625426|FG001|Overall Study|Withdrawal by Subject|0|||
143293357|NCT00462761|516625428|FG000|Overall Study|Adverse Event|6|||
143293358|NCT00462761|516625428|FG000|Overall Study|Withdrawal by Subject|9|||
143293359|NCT00462761|516625428|FG000|Overall Study|Physician Decision|5|||
143293360|NCT00462761|516625428|FG000|Overall Study|Disease progression|43|||
143293361|NCT00462761|516625428|FG000|Overall Study|Death|12|||
143293362|NCT00462761|516625428|FG000|Overall Study|Other|1|||
143373785|NCT02477670|516913567|FG004|Stage 2|Withdrawal by Subject|0|||
143293363|NCT02877082|516625429|FG000|Overall Study|Trial was closed early|5|||
143293364|NCT01244906|516625430|FG000|Overall Study|Death|2|||
143293365|NCT01244906|516625430|FG000|Overall Study|Progression of disease post treatment|6|||
143293366|NCT03480750|516625431|FG000|Overall Study|Withdrawal by Subject|0|||
143293367|NCT03480750|516625432|FG001|Overall Study|Withdrawal by Subject|1|||
143293368|NCT03480750|516625433|FG002|Overall Study|Withdrawal by Subject|0|||
143293369|NCT03480750|516625434|FG003|Overall Study|Withdrawal by Subject|0|||
143293370|NCT03480750|516625435|FG004|Overall Study|Withdrawal by Subject|0|||
143293371|NCT03480750|516625436|FG005|Overall Study|Withdrawal by Subject|0|||
143293372|NCT03480750|516625431|FG000|Overall Study|The interruption in Trientine shippment|0|||
143293373|NCT03480750|516625432|FG001|Overall Study|The interruption in Trientine shippment|0|||
143293374|NCT03480750|516625433|FG002|Overall Study|The interruption in Trientine shippment|0|||
143293375|NCT03480750|516625434|FG003|Overall Study|The interruption in Trientine shippment|0|||
143293376|NCT03480750|516625435|FG004|Overall Study|The interruption in Trientine shippment|0|||
143293377|NCT03480750|516625436|FG005|Overall Study|The interruption in Trientine shippment|1|||
143293378|NCT01163279|516625439|FG000|Overall Study|Withdrawal by Subject|2|||
143293379|NCT01163279|516625440|FG001|Overall Study|Withdrawal by Subject|0|||
143293380|NCT02232425|516625441|FG000|Overall Study|Lost to Follow-up|6|||
143293381|NCT02232425|516625442|FG001|Overall Study|Lost to Follow-up|2|||
143293382|NCT02232425|516625441|FG000|Overall Study|Adverse Event|2|||
143293383|NCT02232425|516625442|FG001|Overall Study|Adverse Event|0|||
143293384|NCT02232425|516625441|FG000|Overall Study|Withdrawal by Subject|5|||
143293385|NCT02232425|516625442|FG001|Overall Study|Withdrawal by Subject|6|||
143293386|NCT02232425|516625441|FG000|Overall Study|Lack of Efficacy|1|||
143293387|NCT02232425|516625442|FG001|Overall Study|Lack of Efficacy|0|||
143293388|NCT00665353|516625443|FG000|Study Step 1|Adverse Event|1|||
143293389|NCT00665353|516625443|FG000|Study Step 1|Withdrawal by Subject|2|||
143293390|NCT00665353|516625443|FG000|Study Step 2|Lost to Follow-up|2|||
143293391|NCT00665353|516625443|FG000|Study Step 2|Lack of Efficacy|12|||
143293392|NCT01601626|516625444|FG000|Overall Study|Death|1|||
143293393|NCT01601626|516625445|FG001|Overall Study|Death|1|||
143293394|NCT01601626|516625446|FG002|Overall Study|Death|1|||
143293395|NCT01601626|516625444|FG000|Overall Study|Lost to Follow-up|1|||
143293396|NCT01601626|516625445|FG001|Overall Study|Lost to Follow-up|2|||
143293397|NCT01601626|516625446|FG002|Overall Study|Lost to Follow-up|0|||
143293398|NCT01601626|516625444|FG000|Overall Study|Unable to Get to Clinic|0|||
143293399|NCT01601626|516625445|FG001|Overall Study|Unable to Get to Clinic|1|||
143293400|NCT01601626|516625446|FG002|Overall Study|Unable to Get to Clinic|0|||
143293401|NCT01601626|516625444|FG000|Overall Study|Withdrawal by Subject|0|||
143293402|NCT01601626|516625445|FG001|Overall Study|Withdrawal by Subject|1|||
143293403|NCT01601626|516625446|FG002|Overall Study|Withdrawal by Subject|1|||
143293404|NCT01601626|516625444|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
143293405|NCT01601626|516625445|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
143293406|NCT01601626|516625446|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
143293407|NCT02632552|516625448|FG000|Overall Study|Lost to Follow-up|14|||
143293408|NCT02632552|516625449|FG001|Overall Study|Lost to Follow-up|8|||
143293409|NCT02632552|516625448|FG000|Overall Study|Withdrawal by Subject|2|||
143293410|NCT02632552|516625449|FG001|Overall Study|Withdrawal by Subject|0|||
143293411|NCT02632552|516625448|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
143293412|NCT02632552|516625449|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
143293413|NCT04191499|516625453|FG000|Overall Study|Adverse Event|1|||
143293414|NCT04191499|516625454|FG001|Overall Study|Adverse Event|0|||
143293415|NCT04191499|516625453|FG000|Overall Study|Death|42|||
143293416|NCT04191499|516625454|FG001|Overall Study|Death|55|||
143293417|NCT04191499|516625453|FG000|Overall Study|Lost to Follow-up|4|||
143293418|NCT04191499|516625454|FG001|Overall Study|Lost to Follow-up|1|||
143293419|NCT04191499|516625453|FG000|Overall Study|Physician Decision|1|||
143293420|NCT04191499|516625454|FG001|Overall Study|Physician Decision|0|||
143293421|NCT04191499|516625453|FG000|Overall Study|Progressive Disease|1|||
143293422|NCT04191499|516625454|FG001|Overall Study|Progressive Disease|0|||
143293423|NCT04191499|516625453|FG000|Overall Study|Symptomatic Deterioration|1|||
143293424|NCT04191499|516625454|FG001|Overall Study|Symptomatic Deterioration|0|||
143293425|NCT04191499|516625453|FG000|Overall Study|Withdrawal by Subject|7|||
143293426|NCT04191499|516625454|FG001|Overall Study|Withdrawal by Subject|11|||
143293427|NCT04191499|516625453|FG000|Overall Study|Ongoing in the study|104|||
143293428|NCT04191499|516625454|FG001|Overall Study|Ongoing in the study|97|||
143293429|NCT00680745|516625455|FG000|Overall Study|Withdrawal by Subject|8|||
143293430|NCT00680745|516625456|FG001|Overall Study|Withdrawal by Subject|3|||
143293431|NCT00680745|516625457|FG002|Overall Study|Withdrawal by Subject|2|||
143293432|NCT00680745|516625458|FG003|Overall Study|Withdrawal by Subject|8|||
143293433|NCT00680745|516625455|FG000|Overall Study|Lost to Follow-up|0|||
143293434|NCT00680745|516625456|FG001|Overall Study|Lost to Follow-up|1|||
143293435|NCT00680745|516625457|FG002|Overall Study|Lost to Follow-up|1|||
143293436|NCT00680745|516625458|FG003|Overall Study|Lost to Follow-up|0|||
143293437|NCT00680745|516625455|FG000|Overall Study|Death|1|||
143293438|NCT00680745|516625456|FG001|Overall Study|Death|0|||
143293439|NCT00680745|516625457|FG002|Overall Study|Death|1|||
143293440|NCT00680745|516625458|FG003|Overall Study|Death|0|||
143293441|NCT00680745|516625455|FG000|Overall Study|Adverse Event|5|||
143293442|NCT00680745|516625456|FG001|Overall Study|Adverse Event|3|||
143293443|NCT00680745|516625457|FG002|Overall Study|Adverse Event|3|||
143293444|NCT00680745|516625458|FG003|Overall Study|Adverse Event|3|||
143293445|NCT00680745|516625455|FG000|Overall Study|Poor/Non-compliance|0|||
143293446|NCT00680745|516625456|FG001|Overall Study|Poor/Non-compliance|3|||
143293447|NCT00680745|516625457|FG002|Overall Study|Poor/Non-compliance|0|||
143293448|NCT00680745|516625458|FG003|Overall Study|Poor/Non-compliance|0|||
143293449|NCT00680745|516625455|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
143293450|NCT00680745|516625456|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
143293451|NCT00680745|516625457|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
143293452|NCT00680745|516625458|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
143293453|NCT00680745|516625455|FG000|Overall Study|False Treatment|0|||
143293454|NCT00680745|516625456|FG001|Overall Study|False Treatment|1|||
143293455|NCT00680745|516625457|FG002|Overall Study|False Treatment|3|||
143293456|NCT00680745|516625458|FG003|Overall Study|False Treatment|0|||
143293457|NCT00737282|516625469|FG000|Overall Study|Study prematurely terminated|175|||
143293458|NCT02049957|516625470|FG000|Overall Study|Progressive Disease|5|||
143293459|NCT02049957|516625471|FG001|Overall Study|Progressive Disease|4|||
143293460|NCT02049957|516625472|FG002|Overall Study|Progressive Disease|2|||
143293461|NCT02049957|516625473|FG003|Overall Study|Progressive Disease|2|||
143293462|NCT02049957|516625474|FG004|Overall Study|Progressive Disease|6|||
143293463|NCT02049957|516625475|FG005|Overall Study|Progressive Disease|35|||
143293464|NCT02049957|516625476|FG006|Overall Study|Progressive Disease|7|||
143293465|NCT02049957|516625477|FG007|Overall Study|Progressive Disease|26|||
143293466|NCT02049957|516625478|FG008|Overall Study|Progressive Disease|6|||
143293467|NCT02049957|516625470|FG000|Overall Study|Adverse Event|1|||
143293468|NCT02049957|516625471|FG001|Overall Study|Adverse Event|1|||
143293469|NCT02049957|516625472|FG002|Overall Study|Adverse Event|1|||
143293470|NCT02049957|516625473|FG003|Overall Study|Adverse Event|0|||
143293471|NCT02049957|516625474|FG004|Overall Study|Adverse Event|0|||
143293472|NCT02049957|516625475|FG005|Overall Study|Adverse Event|5|||
143293473|NCT02049957|516625476|FG006|Overall Study|Adverse Event|0|||
143293474|NCT02049957|516625477|FG007|Overall Study|Adverse Event|6|||
143293475|NCT02049957|516625478|FG008|Overall Study|Adverse Event|1|||
143293476|NCT02049957|516625470|FG000|Overall Study|Study Terminated by Sponsor|0|||
143293477|NCT02049957|516625471|FG001|Overall Study|Study Terminated by Sponsor|1|||
143293478|NCT02049957|516625472|FG002|Overall Study|Study Terminated by Sponsor|0|||
143293479|NCT02049957|516625473|FG003|Overall Study|Study Terminated by Sponsor|0|||
143293480|NCT02049957|516625474|FG004|Overall Study|Study Terminated by Sponsor|0|||
143293481|NCT02049957|516625475|FG005|Overall Study|Study Terminated by Sponsor|0|||
143293482|NCT02049957|516625476|FG006|Overall Study|Study Terminated by Sponsor|1|||
143293483|NCT02049957|516625477|FG007|Overall Study|Study Terminated by Sponsor|0|||
143293484|NCT02049957|516625478|FG008|Overall Study|Study Terminated by Sponsor|0|||
143293485|NCT02049957|516625470|FG000|Overall Study|Withdrawal by Subject|0|||
143293486|NCT02049957|516625471|FG001|Overall Study|Withdrawal by Subject|0|||
143293487|NCT02049957|516625472|FG002|Overall Study|Withdrawal by Subject|0|||
143293488|NCT02049957|516625473|FG003|Overall Study|Withdrawal by Subject|1|||
143293489|NCT02049957|516625474|FG004|Overall Study|Withdrawal by Subject|0|||
143293490|NCT02049957|516625475|FG005|Overall Study|Withdrawal by Subject|2|||
143293491|NCT02049957|516625476|FG006|Overall Study|Withdrawal by Subject|0|||
143293492|NCT02049957|516625477|FG007|Overall Study|Withdrawal by Subject|3|||
143293493|NCT02049957|516625478|FG008|Overall Study|Withdrawal by Subject|1|||
143293494|NCT02049957|516625470|FG000|Overall Study|Physician Decision|0|||
143293495|NCT02049957|516625471|FG001|Overall Study|Physician Decision|0|||
143293496|NCT02049957|516625472|FG002|Overall Study|Physician Decision|0|||
143293497|NCT02049957|516625473|FG003|Overall Study|Physician Decision|0|||
143293498|NCT02049957|516625474|FG004|Overall Study|Physician Decision|0|||
143293499|NCT02049957|516625475|FG005|Overall Study|Physician Decision|1|||
143293500|NCT02049957|516625476|FG006|Overall Study|Physician Decision|0|||
143293501|NCT02049957|516625477|FG007|Overall Study|Physician Decision|0|||
143293502|NCT02049957|516625478|FG008|Overall Study|Physician Decision|0|||
143293503|NCT03557151|516625479|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
143293504|NCT03557151|516625480|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
143293505|NCT03557151|516625479|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
143293506|NCT03557151|516625480|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
143293507|NCT03557151|516625479|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
143293508|NCT03557151|516625480|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
143293509|NCT00840294|516625482|FG000|Overall Study|Withdrawal by Subject|2|||
143373786|NCT02477670|516913568|FG005|Stage 2|Withdrawal by Subject|0|||
143293510|NCT00840294|516625483|FG001|Overall Study|Withdrawal by Subject|1|||
143293511|NCT00840294|516625482|FG000|Overall Study|Protocol Violation|1|||
143293512|NCT00840294|516625483|FG001|Overall Study|Protocol Violation|3|||
143293513|NCT00840294|516625482|FG000|Overall Study|Illness|0|||
143293514|NCT00840294|516625483|FG001|Overall Study|Illness|1|||
143293515|NCT02669433|516625484|FG000|Overall Study|Protocol Violation|0|||
143293516|NCT02669433|516625485|FG001|Overall Study|Protocol Violation|4|||
143293517|NCT02669433|516625486|FG002|Overall Study|Protocol Violation|1|||
143293518|NCT02669433|516625484|FG000|Overall Study|Disease Progression|1|||
143293519|NCT02669433|516625485|FG001|Overall Study|Disease Progression|0|||
143293520|NCT02669433|516625486|FG002|Overall Study|Disease Progression|0|||
143293521|NCT02669433|516625484|FG000|Overall Study|Physician Decision|1|||
143293522|NCT02669433|516625485|FG001|Overall Study|Physician Decision|1|||
143293523|NCT02669433|516625486|FG002|Overall Study|Physician Decision|0|||
143293524|NCT02669433|516625484|FG000|Overall Study|Adverse Event|6|||
143293525|NCT02669433|516625485|FG001|Overall Study|Adverse Event|7|||
143293526|NCT02669433|516625486|FG002|Overall Study|Adverse Event|10|||
143293527|NCT02669433|516625484|FG000|Overall Study|Sponsor Termination|1|||
143293528|NCT02669433|516625485|FG001|Overall Study|Sponsor Termination|0|||
143293529|NCT02669433|516625486|FG002|Overall Study|Sponsor Termination|1|||
143293530|NCT02669433|516625484|FG000|Overall Study|Withdrawal by Subject|5|||
143293531|NCT02669433|516625485|FG001|Overall Study|Withdrawal by Subject|1|||
143293532|NCT02669433|516625486|FG002|Overall Study|Withdrawal by Subject|0|||
143293533|NCT02669433|516625484|FG000|Overall Study|Withdrawal by Caregiver|1|||
143293534|NCT02669433|516625485|FG001|Overall Study|Withdrawal by Caregiver|0|||
143293535|NCT02669433|516625486|FG002|Overall Study|Withdrawal by Caregiver|2|||
143293536|NCT02669433|516625484|FG000|Overall Study|Death|0|||
143293537|NCT02669433|516625485|FG001|Overall Study|Death|1|||
143293538|NCT02669433|516625486|FG002|Overall Study|Death|1|||
143293539|NCT00576927|516625487|FG000|Clinical Assessment|Lack of Efficacy|24|||
143293540|NCT00576927|516625487|FG000|Clinical Assessment|Death|1|||
143293541|NCT00576927|516625487|FG000|Clinical Assessment|Withdrawal by Subject|10|||
143293542|NCT00576927|516625487|FG000|Clinical Assessment|Physician Decision|1|||
143293543|NCT00576927|516625487|FG000|Baseline|Physician Decision|9|||
143293544|NCT00576927|516625487|FG000|Baseline|Medication Change by PCP of subject|1|||
143293545|NCT00576927|516625487|FG000|Baseline|Withdrawal by Subject|3|||
143293546|NCT00576927|516625487|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
143293547|NCT00576927|516625487|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
143293548|NCT00576927|516625487|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
143293549|NCT00576927|516625487|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
143293550|NCT00576927|516625487|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
143293551|NCT03715764|516625489|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
143293552|NCT03715764|516625490|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
143293553|NCT03715764|516625489|FG000|3 Month Follow-up|Lost to Follow-up|2|||
143293554|NCT03715764|516625490|FG001|3 Month Follow-up|Lost to Follow-up|2|||
143293555|NCT03715764|516625489|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
143293556|NCT03715764|516625490|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
143293557|NCT03715764|516625489|FG000|6 Month Follow-up|Lost to Follow-up|3|||
143293558|NCT03715764|516625490|FG001|6 Month Follow-up|Lost to Follow-up|0|||
143293559|NCT03715764|516625489|FG000|12 Month Follow-up|Lost to Follow-up|2|||
143293560|NCT03715764|516625490|FG001|12 Month Follow-up|Lost to Follow-up|3|||
143293561|NCT03715764|516625489|FG000|12 Month Follow-up|Pregnancy|0|||
143293562|NCT03715764|516625490|FG001|12 Month Follow-up|Pregnancy|1|||
143293563|NCT03715764|516625489|FG000|12 Month Follow-up|Surgery|2|||
143293564|NCT03715764|516625490|FG001|12 Month Follow-up|Surgery|0|||
143293565|NCT03715764|516625489|FG000|12 Month Follow-up|Wrong address|1|||
143293566|NCT03715764|516625490|FG001|12 Month Follow-up|Wrong address|0|||
143293567|NCT03715764|516625489|FG000|12 Month Follow-up|No symptoms|1|||
143293568|NCT03715764|516625490|FG001|12 Month Follow-up|No symptoms|0|||
143293569|NCT03715764|516625489|FG000|12 Month Follow-up|Changed primary care centre|0|||
143293570|NCT03715764|516625490|FG001|12 Month Follow-up|Changed primary care centre|1|||
143293571|NCT01361464|516625493|FG000|Overall Study|Death|1|||
143293572|NCT01361464|516625493|FG000|Overall Study|Withdrawal by Subject|2|||
143293573|NCT00818662|516625494|FG000|Overall Study|Adverse Event|5|||
143293574|NCT00818662|516625495|FG001|Overall Study|Adverse Event|14|||
143293575|NCT00818662|516625496|FG002|Overall Study|Adverse Event|4|||
143293576|NCT00818662|516625497|FG003|Overall Study|Adverse Event|3|||
143293577|NCT00818662|516625494|FG000|Overall Study|Withdrawal by Subject|5|||
143293578|NCT00818662|516625495|FG001|Overall Study|Withdrawal by Subject|4|||
143293579|NCT00818662|516625496|FG002|Overall Study|Withdrawal by Subject|2|||
143293580|NCT00818662|516625497|FG003|Overall Study|Withdrawal by Subject|2|||
143293581|NCT00818662|516625494|FG000|Overall Study|Death|1|||
143293582|NCT00818662|516625495|FG001|Overall Study|Death|3|||
143293583|NCT00818662|516625496|FG002|Overall Study|Death|0|||
143293584|NCT00818662|516625497|FG003|Overall Study|Death|0|||
143293585|NCT00818662|516625494|FG000|Overall Study|Physician Decision|1|||
143293586|NCT00818662|516625495|FG001|Overall Study|Physician Decision|0|||
143293587|NCT00818662|516625496|FG002|Overall Study|Physician Decision|0|||
143293588|NCT00818662|516625497|FG003|Overall Study|Physician Decision|0|||
143293589|NCT00818662|516625494|FG000|Overall Study|Lost to Follow-up|0|||
143293590|NCT00818662|516625495|FG001|Overall Study|Lost to Follow-up|0|||
143293591|NCT00818662|516625496|FG002|Overall Study|Lost to Follow-up|0|||
143293592|NCT00818662|516625497|FG003|Overall Study|Lost to Follow-up|1|||
143293593|NCT00818662|516625494|FG000|Overall Study|Unwilling or Unable to Participate|4|||
143293594|NCT00818662|516625495|FG001|Overall Study|Unwilling or Unable to Participate|6|||
143293595|NCT00818662|516625496|FG002|Overall Study|Unwilling or Unable to Participate|2|||
143293596|NCT00818662|516625497|FG003|Overall Study|Unwilling or Unable to Participate|4|||
143293597|NCT00818662|516625494|FG000|Overall Study|Protocol Violation|1|||
143293598|NCT00818662|516625495|FG001|Overall Study|Protocol Violation|1|||
143293599|NCT00818662|516625496|FG002|Overall Study|Protocol Violation|0|||
143293600|NCT00818662|516625497|FG003|Overall Study|Protocol Violation|0|||
143293601|NCT00818662|516625494|FG000|Overall Study|Requires a Prohibited Medication|1|||
143293602|NCT00818662|516625495|FG001|Overall Study|Requires a Prohibited Medication|0|||
143293603|NCT00818662|516625496|FG002|Overall Study|Requires a Prohibited Medication|0|||
143293604|NCT00818662|516625497|FG003|Overall Study|Requires a Prohibited Medication|0|||
143293605|NCT00818662|516625494|FG000|Overall Study|Safety Risk|1|||
143293606|NCT00818662|516625495|FG001|Overall Study|Safety Risk|1|||
143293607|NCT00818662|516625496|FG002|Overall Study|Safety Risk|0|||
143293608|NCT00818662|516625497|FG003|Overall Study|Safety Risk|1|||
143293609|NCT00818662|516625494|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
143293610|NCT00818662|516625495|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
143293611|NCT00818662|516625496|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
143293612|NCT00818662|516625497|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
143293613|NCT00818662|516625494|FG000|Overall Study|Participant's health declined|0|||
143293614|NCT00818662|516625495|FG001|Overall Study|Participant's health declined|0|||
143293615|NCT00818662|516625496|FG002|Overall Study|Participant's health declined|0|||
143293616|NCT00818662|516625497|FG003|Overall Study|Participant's health declined|1|||
143293617|NCT00818662|516625494|FG000|Overall Study|Caregiver to pursue other treatment|0|||
143293618|NCT00818662|516625495|FG001|Overall Study|Caregiver to pursue other treatment|1|||
143293619|NCT00818662|516625496|FG002|Overall Study|Caregiver to pursue other treatment|0|||
143293620|NCT00818662|516625497|FG003|Overall Study|Caregiver to pursue other treatment|0|||
143293621|NCT00818662|516625494|FG000|Overall Study|Moving out of state|0|||
143293622|NCT00818662|516625495|FG001|Overall Study|Moving out of state|0|||
143293623|NCT00818662|516625496|FG002|Overall Study|Moving out of state|0|||
143293624|NCT00818662|516625497|FG003|Overall Study|Moving out of state|1|||
143293625|NCT00818662|516625494|FG000|Overall Study|Declined move to another study site|1|||
143293626|NCT00818662|516625495|FG001|Overall Study|Declined move to another study site|0|||
143293627|NCT00818662|516625496|FG002|Overall Study|Declined move to another study site|0|||
143293628|NCT00818662|516625497|FG003|Overall Study|Declined move to another study site|0|||
143293629|NCT00818662|516625494|FG000|Overall Study|Change in living situation|0|||
143293630|NCT00818662|516625495|FG001|Overall Study|Change in living situation|0|||
143293631|NCT00818662|516625496|FG002|Overall Study|Change in living situation|0|||
143293632|NCT00818662|516625497|FG003|Overall Study|Change in living situation|1|||
143293633|NCT00818662|516625494|FG000|Overall Study|Study partner decision|0|||
143293634|NCT00818662|516625495|FG001|Overall Study|Study partner decision|0|||
143293635|NCT00818662|516625496|FG002|Overall Study|Study partner decision|0|||
143293636|NCT00818662|516625497|FG003|Overall Study|Study partner decision|1|||
143293637|NCT00818662|516625494|FG000|Overall Study|Admitted to long term nursing care|0|||
143293638|NCT00818662|516625495|FG001|Overall Study|Admitted to long term nursing care|1|||
143293639|NCT00818662|516625496|FG002|Overall Study|Admitted to long term nursing care|0|||
143293640|NCT00818662|516625497|FG003|Overall Study|Admitted to long term nursing care|0|||
143293641|NCT01106898|516625498|FG000|Overall Study|Adverse Event|6|||
143293642|NCT03021265|516625499|FG000|Overall Study|Adverse Event|29|||
143293643|NCT03021265|516625499|FG000|Overall Study|Lack of Efficacy|3|||
143293644|NCT03021265|516625499|FG000|Overall Study|Improved|17|||
143293645|NCT03021265|516625499|FG000|Overall Study|Lost to Follow-up|67|||
143293646|NCT03021265|516625499|FG000|Overall Study|No reason given|2|||
143293647|NCT03021265|516625499|FG000|Overall Study|No visit since the first visit|4|||
143293648|NCT01472081|516625500|FG000|Overall Study|Continuing treatment at time of analysis|1|||
143293649|NCT01472081|516625501|FG001|Overall Study|Continuing treatment at time of analysis|4|||
143293650|NCT01472081|516625502|FG002|Overall Study|Continuing treatment at time of analysis|1|||
143293651|NCT01472081|516625503|FG003|Overall Study|Continuing treatment at time of analysis|8|||
143293652|NCT01472081|516625504|FG004|Overall Study|Continuing treatment at time of analysis|9|||
143293653|NCT01472081|516625505|FG005|Overall Study|Continuing treatment at time of analysis|0|||
143293654|NCT01472081|516625500|FG000|Overall Study|Disease Progression|4|||
143293655|NCT01472081|516625501|FG001|Overall Study|Disease Progression|10|||
143293656|NCT01472081|516625502|FG002|Overall Study|Disease Progression|12|||
143293657|NCT01472081|516625503|FG003|Overall Study|Disease Progression|31|||
143293658|NCT01472081|516625504|FG004|Overall Study|Disease Progression|22|||
143293659|NCT01472081|516625505|FG005|Overall Study|Disease Progression|3|||
143293660|NCT01472081|516625500|FG000|Overall Study|Study drug toxicity|2|||
143293661|NCT01472081|516625501|FG001|Overall Study|Study drug toxicity|9|||
143293662|NCT01472081|516625502|FG002|Overall Study|Study drug toxicity|4|||
143293663|NCT01472081|516625503|FG003|Overall Study|Study drug toxicity|6|||
143293664|NCT01472081|516625504|FG004|Overall Study|Study drug toxicity|13|||
143293665|NCT01472081|516625505|FG005|Overall Study|Study drug toxicity|2|||
143293666|NCT01472081|516625500|FG000|Overall Study|Death|0|||
143293667|NCT01472081|516625501|FG001|Overall Study|Death|0|||
143293668|NCT01472081|516625502|FG002|Overall Study|Death|0|||
143293669|NCT01472081|516625503|FG003|Overall Study|Death|0|||
143293670|NCT01472081|516625504|FG004|Overall Study|Death|1|||
143293671|NCT01472081|516625505|FG005|Overall Study|Death|0|||
143293672|NCT01472081|516625500|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
143293673|NCT01472081|516625501|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
143293674|NCT01472081|516625502|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
143293675|NCT01472081|516625503|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
143293676|NCT01472081|516625504|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
143293677|NCT01472081|516625505|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
143293678|NCT01472081|516625500|FG000|Overall Study|Withdrawal by Subject|0|||
143293679|NCT01472081|516625501|FG001|Overall Study|Withdrawal by Subject|0|||
143293680|NCT01472081|516625502|FG002|Overall Study|Withdrawal by Subject|0|||
143293681|NCT01472081|516625503|FG003|Overall Study|Withdrawal by Subject|0|||
143293682|NCT01472081|516625504|FG004|Overall Study|Withdrawal by Subject|0|||
143293683|NCT01472081|516625505|FG005|Overall Study|Withdrawal by Subject|1|||
143293684|NCT01472081|516625500|FG000|Overall Study|Poor/non-compliance|0|||
143293685|NCT01472081|516625501|FG001|Overall Study|Poor/non-compliance|0|||
143293686|NCT01472081|516625502|FG002|Overall Study|Poor/non-compliance|1|||
143293687|NCT01472081|516625503|FG003|Overall Study|Poor/non-compliance|0|||
143293688|NCT01472081|516625504|FG004|Overall Study|Poor/non-compliance|1|||
143293689|NCT01472081|516625505|FG005|Overall Study|Poor/non-compliance|0|||
143293690|NCT01472081|516625500|FG000|Overall Study|No longer meets study criteria|0|||
143293691|NCT01472081|516625501|FG001|Overall Study|No longer meets study criteria|0|||
143293692|NCT01472081|516625502|FG002|Overall Study|No longer meets study criteria|1|||
143293693|NCT01472081|516625503|FG003|Overall Study|No longer meets study criteria|0|||
143293694|NCT01472081|516625504|FG004|Overall Study|No longer meets study criteria|0|||
143293695|NCT01472081|516625505|FG005|Overall Study|No longer meets study criteria|0|||
143293696|NCT01472081|516625500|FG000|Overall Study|Subject request to discontinue treatment|0|||
143293697|NCT01472081|516625501|FG001|Overall Study|Subject request to discontinue treatment|3|||
143293698|NCT01472081|516625502|FG002|Overall Study|Subject request to discontinue treatment|1|||
143293699|NCT01472081|516625503|FG003|Overall Study|Subject request to discontinue treatment|1|||
143293700|NCT01472081|516625504|FG004|Overall Study|Subject request to discontinue treatment|0|||
143293701|NCT01472081|516625505|FG005|Overall Study|Subject request to discontinue treatment|0|||
143293702|NCT01705652|516625507|FG000|Overall Study|Adverse Event|1|||
143373787|NCT02477670|516913569|FG006|Stage 2|Withdrawal by Subject|0|||
143293703|NCT01705652|516625508|FG001|Overall Study|Adverse Event|0|||
143293704|NCT01705652|516625507|FG000|Overall Study|Withdrawal by Subject|1|||
143293705|NCT01705652|516625508|FG001|Overall Study|Withdrawal by Subject|2|||
143293706|NCT01705652|516625507|FG000|Overall Study|non-compliance|1|||
143293707|NCT01705652|516625508|FG001|Overall Study|non-compliance|1|||
143293708|NCT01698801|516625509|FG000|Treatment Phase|Adverse Event|4|||
143293709|NCT01698801|516625509|FG000|Treatment Phase|Protocol Violation|1|||
143293710|NCT01698801|516625509|FG000|Treatment Phase|Other|4|||
143293711|NCT01698801|516625509|FG000|Treatment Phase|Withdrawal by Subject|1|||
143293712|NCT01698801|516625509|FG000|Treatment Phase|Disease progression|1|||
143293713|NCT01698801|516625509|FG000|Follow Up Phase|Withdrawal by Subject|1|||
143293714|NCT01698801|516625509|FG000|Follow Up Phase|Death|4|||
143293715|NCT00541034|516625510|FG000|Overall Study|Non-Compliance|3|||
143293716|NCT01614067|516625512|FG000|Overall Study|Pregnancy|1|||
143293717|NCT01614067|516625513|FG001|Overall Study|Pregnancy|0|||
143293718|NCT01614067|516625512|FG000|Overall Study|Physician Decision|6|||
143293719|NCT01614067|516625513|FG001|Overall Study|Physician Decision|5|||
143293720|NCT01614067|516625512|FG000|Overall Study|Withdrawal by Subject|0|||
143293721|NCT01614067|516625513|FG001|Overall Study|Withdrawal by Subject|1|||
143293722|NCT01614067|516625512|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
143293723|NCT01614067|516625513|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
143293724|NCT01505868|516625514|FG000|Overall Study|Withdrawal by Subject|1|||
143293725|NCT01505868|516625515|FG001|Overall Study|Withdrawal by Subject|0|||
143293726|NCT01505868|516625516|FG002|Overall Study|Withdrawal by Subject|0|||
143293727|NCT01505868|516625517|FG003|Overall Study|Withdrawal by Subject|0|||
143293728|NCT01505868|516625518|FG004|Overall Study|Withdrawal by Subject|0|||
143293729|NCT00680043|516625519|FG000|Overall Study|Withdrawal by Subject|1|||
143293730|NCT00680043|516625520|FG001|Overall Study|Withdrawal by Subject|0|||
143293731|NCT00680043|516625521|FG002|Overall Study|Withdrawal by Subject|0|||
143293732|NCT00680043|516625519|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
143293733|NCT00680043|516625520|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
143293734|NCT00680043|516625521|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
143293735|NCT00680043|516625519|FG000|Overall Study|Renal Transplant|1|||
143293736|NCT00680043|516625520|FG001|Overall Study|Renal Transplant|0|||
143293737|NCT00680043|516625521|FG002|Overall Study|Renal Transplant|4|||
143293738|NCT02625259|516625525|FG000|First Intervention (Day 1)|Other|0|||
143293739|NCT02625259|516625526|FG001|First Intervention (Day 1)|Other|0|||
143293740|NCT02625259|516625527|FG002|First Intervention (Day 1)|Other|1|||
143293741|NCT02625259|516625528|FG003|First Intervention (Day 1)|Other|0|||
143293742|NCT02625259|516625529|FG004|First Intervention (Day 1)|Other|0|||
143293743|NCT02625259|516625525|FG000|First Intervention (Day 1)|Adverse Event|2|||
143293744|NCT02625259|516625526|FG001|First Intervention (Day 1)|Adverse Event|1|||
143293745|NCT02625259|516625527|FG002|First Intervention (Day 1)|Adverse Event|0|||
143293746|NCT02625259|516625528|FG003|First Intervention (Day 1)|Adverse Event|0|||
143293747|NCT02625259|516625529|FG004|First Intervention (Day 1)|Adverse Event|0|||
143293748|NCT02625259|516625525|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
143293749|NCT02625259|516625526|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
143293750|NCT02625259|516625527|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
143293751|NCT02625259|516625528|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
143293752|NCT02625259|516625529|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
143293753|NCT02998840|516625530|FG000|Overall Study|Lost to Follow-up|1|||
143293754|NCT02998840|516625531|FG001|Overall Study|Lost to Follow-up|1|||
143293755|NCT02998840|516625532|FG002|Overall Study|Lost to Follow-up|2|||
143293756|NCT02998840|516625533|FG003|Overall Study|Lost to Follow-up|3|||
143293757|NCT02998840|516625530|FG000|Overall Study|Withdrawal by Subject|1|||
143293758|NCT02998840|516625531|FG001|Overall Study|Withdrawal by Subject|1|||
143293759|NCT02998840|516625532|FG002|Overall Study|Withdrawal by Subject|0|||
143293760|NCT02998840|516625533|FG003|Overall Study|Withdrawal by Subject|1|||
143293761|NCT02998840|516625530|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
143293762|NCT02998840|516625531|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
143293763|NCT02998840|516625532|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
143293764|NCT02998840|516625533|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
143293765|NCT00513474|516625534|FG000|Overall Study|Death|6|||
143293766|NCT00513474|516625535|FG001|Overall Study|Death|9|||
143293767|NCT00513474|516625534|FG000|Overall Study|Participant Withdrew Consent|1|||
143293768|NCT00513474|516625535|FG001|Overall Study|Participant Withdrew Consent|0|||
143293769|NCT01686633|516625536|FG000|Overall Study|Lack of Efficacy|33|||
143293770|NCT01686633|516625537|FG001|Overall Study|Lack of Efficacy|13|||
143293771|NCT01686633|516625538|FG002|Overall Study|Lack of Efficacy|11|||
143293772|NCT01686633|516625536|FG000|Overall Study|Withdrawal by Subject|8|||
143293773|NCT01686633|516625537|FG001|Overall Study|Withdrawal by Subject|8|||
143293774|NCT01686633|516625538|FG002|Overall Study|Withdrawal by Subject|5|||
143293775|NCT01686633|516625536|FG000|Overall Study|Physician Decision|3|||
143293776|NCT01686633|516625537|FG001|Overall Study|Physician Decision|4|||
143293777|NCT01686633|516625538|FG002|Overall Study|Physician Decision|4|||
143293778|NCT01686633|516625536|FG000|Overall Study|Adverse Event|4|||
143293779|NCT01686633|516625537|FG001|Overall Study|Adverse Event|3|||
143293780|NCT01686633|516625538|FG002|Overall Study|Adverse Event|3|||
143293781|NCT01686633|516625536|FG000|Overall Study|Protocol Violation|2|||
143293782|NCT01686633|516625537|FG001|Overall Study|Protocol Violation|3|||
143293783|NCT01686633|516625538|FG002|Overall Study|Protocol Violation|0|||
143293784|NCT01686633|516625536|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
143293785|NCT01686633|516625537|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
143293786|NCT01686633|516625538|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
143293787|NCT01686633|516625536|FG000|Overall Study|Lost to Follow-up|0|||
143293788|NCT01686633|516625537|FG001|Overall Study|Lost to Follow-up|1|||
143293789|NCT01686633|516625538|FG002|Overall Study|Lost to Follow-up|1|||
143293790|NCT00195676|516625539|FG000|Period O - Open-label Treatment|Adverse Event|82|||
143293791|NCT00195676|516625539|FG000|Period O - Open-label Treatment|Death|6|||
143293792|NCT00195676|516625539|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
143293793|NCT00195676|516625539|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
143293794|NCT00195676|516625539|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
143293795|NCT00195676|516625539|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
143293796|NCT00195676|516625539|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
143293797|NCT00195676|516625539|FG000|Period O - Open-label Treatment|Other reasons|68|||
143293798|NCT00195676|516625539|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
143293799|NCT00195676|516625539|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
143293800|NCT00195676|516625539|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
143293801|NCT00195676|516625539|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
143293802|NCT00195676|516625539|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
143293803|NCT00195676|516625539|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
143293804|NCT00195676|516625539|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
143293805|NCT00195676|516625539|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
143293806|NCT00195676|516625539|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
143293807|NCT00195676|516625539|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
143293808|NCT00195676|516625539|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
143293809|NCT00195676|516625539|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
143293810|NCT00195676|516625539|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
143293811|NCT03564145|516625541|FG000|Overall Study|Adverse Event|4|||
143293812|NCT03564145|516625541|FG000|Overall Study|Lost to Follow-up|21|||
143293813|NCT03564145|516625541|FG000|Overall Study|Protocol Violation|2|||
143293814|NCT03564145|516625541|FG000|Overall Study|Withdrawal by Subject|48|||
143293815|NCT03564145|516625541|FG000|Overall Study|Study Terminated by Sponsor|146|||
143293816|NCT03564145|516625541|FG000|Overall Study|Physician Decision|1|||
143293817|NCT03564145|516625541|FG000|Overall Study|Other Than Specified|1|||
143293818|NCT03564145|516625541|FG000|Overall Study|Pregnancy|1|||
143293819|NCT04702997|516625542|FG000|Overall Study|Withdrawal by Subject|1|||
143293820|NCT04702997|516625543|FG001|Overall Study|Withdrawal by Subject|1|||
143293821|NCT01386554|516625549|FG000|Overall Study|Lost to Follow-up|0|||
143293822|NCT01386554|516625550|FG001|Overall Study|Lost to Follow-up|0|||
143293823|NCT01386554|516625551|FG002|Overall Study|Lost to Follow-up|1|||
143293824|NCT01386554|516625549|FG000|Overall Study|Adverse Event|2|||
143293825|NCT01386554|516625550|FG001|Overall Study|Adverse Event|5|||
143293826|NCT01386554|516625551|FG002|Overall Study|Adverse Event|2|||
143293827|NCT01386554|516625549|FG000|Overall Study|Progressive disease|1|||
143293828|NCT01386554|516625550|FG001|Overall Study|Progressive disease|2|||
143293829|NCT01386554|516625551|FG002|Overall Study|Progressive disease|2|||
143293830|NCT01386554|516625549|FG000|Overall Study|Administration of live vaccines|0|||
143293831|NCT01386554|516625550|FG001|Overall Study|Administration of live vaccines|1|||
143293832|NCT01386554|516625551|FG002|Overall Study|Administration of live vaccines|0|||
143293833|NCT01386554|516625549|FG000|Overall Study|Investigator discretion|0|||
143293834|NCT01386554|516625550|FG001|Overall Study|Investigator discretion|0|||
143293835|NCT01386554|516625551|FG002|Overall Study|Investigator discretion|1|||
143293836|NCT01386554|516625549|FG000|Overall Study|Reason not collected|0|||
143293837|NCT01386554|516625550|FG001|Overall Study|Reason not collected|1|||
143293838|NCT01386554|516625551|FG002|Overall Study|Reason not collected|0|||
143293839|NCT02759471|516625552|FG000|Overall Study|discomfort|2|||
143293840|NCT02554812|516625553|FG000|Overall Study|Adverse Event|2|||
143293841|NCT02554812|516625554|FG001|Overall Study|Adverse Event|5|||
143293842|NCT02554812|516625555|FG002|Overall Study|Adverse Event|3|||
143293843|NCT02554812|516625556|FG003|Overall Study|Adverse Event|0|||
143293844|NCT02554812|516625557|FG004|Overall Study|Adverse Event|5|||
143293845|NCT02554812|516625558|FG005|Overall Study|Adverse Event|0|||
143293846|NCT02554812|516625559|FG006|Overall Study|Adverse Event|1|||
143293847|NCT02554812|516625560|FG007|Overall Study|Adverse Event|6|||
143293848|NCT02554812|516625561|FG008|Overall Study|Adverse Event|2|||
143293849|NCT02554812|516625562|FG009|Overall Study|Adverse Event|2|||
143293850|NCT02554812|516625563|FG010|Overall Study|Adverse Event|1|||
143293851|NCT02554812|516625564|FG011|Overall Study|Adverse Event|2|||
143293852|NCT02554812|516625565|FG012|Overall Study|Adverse Event|0|||
143293853|NCT02554812|516625566|FG013|Overall Study|Adverse Event|3|||
143293854|NCT02554812|516625567|FG014|Overall Study|Adverse Event|2|||
143293855|NCT02554812|516625568|FG015|Overall Study|Adverse Event|1|||
143293856|NCT02554812|516625569|FG016|Overall Study|Adverse Event|0|||
143293857|NCT02554812|516625570|FG017|Overall Study|Adverse Event|1|||
143293858|NCT02554812|516625571|FG018|Overall Study|Adverse Event|0|||
143293859|NCT02554812|516625572|FG019|Overall Study|Adverse Event|0|||
143293860|NCT02554812|516625573|FG020|Overall Study|Adverse Event|0|||
143293861|NCT02554812|516625574|FG021|Overall Study|Adverse Event|2|||
143293862|NCT02554812|516625575|FG022|Overall Study|Adverse Event|1|||
143293863|NCT02554812|516625576|FG023|Overall Study|Adverse Event|1|||
143293864|NCT02554812|516625577|FG024|Overall Study|Adverse Event|1|||
143293865|NCT02554812|516625578|FG025|Overall Study|Adverse Event|2|||
143293866|NCT02554812|516625579|FG026|Overall Study|Adverse Event|1|||
143293867|NCT02554812|516625553|FG000|Overall Study|Death|1|||
143293868|NCT02554812|516625554|FG001|Overall Study|Death|2|||
143293869|NCT02554812|516625555|FG002|Overall Study|Death|2|||
143293870|NCT02554812|516625556|FG003|Overall Study|Death|2|||
143293871|NCT02554812|516625557|FG004|Overall Study|Death|0|||
143293872|NCT02554812|516625558|FG005|Overall Study|Death|1|||
143293873|NCT02554812|516625559|FG006|Overall Study|Death|1|||
143293874|NCT02554812|516625560|FG007|Overall Study|Death|1|||
143293875|NCT02554812|516625561|FG008|Overall Study|Death|0|||
143293876|NCT02554812|516625562|FG009|Overall Study|Death|0|||
143293877|NCT02554812|516625563|FG010|Overall Study|Death|0|||
143293878|NCT02554812|516625564|FG011|Overall Study|Death|0|||
143293879|NCT02554812|516625565|FG012|Overall Study|Death|0|||
143293880|NCT02554812|516625566|FG013|Overall Study|Death|0|||
143293881|NCT02554812|516625567|FG014|Overall Study|Death|1|||
143293882|NCT02554812|516625568|FG015|Overall Study|Death|1|||
143293883|NCT02554812|516625569|FG016|Overall Study|Death|1|||
143293884|NCT02554812|516625570|FG017|Overall Study|Death|0|||
143293885|NCT02554812|516625571|FG018|Overall Study|Death|1|||
143293886|NCT02554812|516625572|FG019|Overall Study|Death|2|||
143293887|NCT02554812|516625573|FG020|Overall Study|Death|0|||
143293888|NCT02554812|516625574|FG021|Overall Study|Death|1|||
143293889|NCT02554812|516625575|FG022|Overall Study|Death|1|||
143293890|NCT02554812|516625576|FG023|Overall Study|Death|0|||
143293891|NCT02554812|516625577|FG024|Overall Study|Death|0|||
143293892|NCT02554812|516625578|FG025|Overall Study|Death|0|||
143293893|NCT02554812|516625579|FG026|Overall Study|Death|0|||
143293894|NCT02554812|516625553|FG000|Overall Study|Lost to Follow-up|0|||
143293895|NCT02554812|516625554|FG001|Overall Study|Lost to Follow-up|1|||
143293896|NCT02554812|516625555|FG002|Overall Study|Lost to Follow-up|0|||
143293897|NCT02554812|516625556|FG003|Overall Study|Lost to Follow-up|0|||
143293898|NCT02554812|516625557|FG004|Overall Study|Lost to Follow-up|0|||
143293899|NCT02554812|516625558|FG005|Overall Study|Lost to Follow-up|0|||
143293900|NCT02554812|516625559|FG006|Overall Study|Lost to Follow-up|0|||
143293901|NCT02554812|516625560|FG007|Overall Study|Lost to Follow-up|0|||
143293902|NCT02554812|516625561|FG008|Overall Study|Lost to Follow-up|0|||
143293903|NCT02554812|516625562|FG009|Overall Study|Lost to Follow-up|0|||
143293904|NCT02554812|516625563|FG010|Overall Study|Lost to Follow-up|0|||
143293905|NCT02554812|516625564|FG011|Overall Study|Lost to Follow-up|0|||
143293906|NCT02554812|516625565|FG012|Overall Study|Lost to Follow-up|0|||
143293907|NCT02554812|516625566|FG013|Overall Study|Lost to Follow-up|0|||
143293908|NCT02554812|516625567|FG014|Overall Study|Lost to Follow-up|0|||
143293909|NCT02554812|516625568|FG015|Overall Study|Lost to Follow-up|0|||
143293910|NCT02554812|516625569|FG016|Overall Study|Lost to Follow-up|0|||
143293911|NCT02554812|516625570|FG017|Overall Study|Lost to Follow-up|0|||
143293912|NCT02554812|516625571|FG018|Overall Study|Lost to Follow-up|0|||
143293913|NCT02554812|516625572|FG019|Overall Study|Lost to Follow-up|0|||
143293914|NCT02554812|516625573|FG020|Overall Study|Lost to Follow-up|0|||
143293915|NCT02554812|516625574|FG021|Overall Study|Lost to Follow-up|0|||
143293916|NCT02554812|516625575|FG022|Overall Study|Lost to Follow-up|0|||
143293917|NCT02554812|516625576|FG023|Overall Study|Lost to Follow-up|0|||
143293918|NCT02554812|516625577|FG024|Overall Study|Lost to Follow-up|0|||
143293919|NCT02554812|516625578|FG025|Overall Study|Lost to Follow-up|0|||
143293920|NCT02554812|516625579|FG026|Overall Study|Lost to Follow-up|0|||
143293921|NCT02554812|516625553|FG000|Overall Study|Global deterioration of health status|4|||
143293922|NCT02554812|516625554|FG001|Overall Study|Global deterioration of health status|3|||
143293923|NCT02554812|516625555|FG002|Overall Study|Global deterioration of health status|3|||
143293924|NCT02554812|516625556|FG003|Overall Study|Global deterioration of health status|2|||
143293925|NCT02554812|516625557|FG004|Overall Study|Global deterioration of health status|5|||
143293926|NCT02554812|516625558|FG005|Overall Study|Global deterioration of health status|0|||
143293927|NCT02554812|516625559|FG006|Overall Study|Global deterioration of health status|2|||
143293928|NCT02554812|516625560|FG007|Overall Study|Global deterioration of health status|1|||
143293929|NCT02554812|516625561|FG008|Overall Study|Global deterioration of health status|1|||
143293930|NCT02554812|516625562|FG009|Overall Study|Global deterioration of health status|1|||
143293931|NCT02554812|516625563|FG010|Overall Study|Global deterioration of health status|2|||
143293932|NCT02554812|516625564|FG011|Overall Study|Global deterioration of health status|1|||
143293933|NCT02554812|516625565|FG012|Overall Study|Global deterioration of health status|0|||
143293934|NCT02554812|516625566|FG013|Overall Study|Global deterioration of health status|0|||
143293935|NCT02554812|516625567|FG014|Overall Study|Global deterioration of health status|0|||
143293936|NCT02554812|516625568|FG015|Overall Study|Global deterioration of health status|1|||
143293937|NCT02554812|516625569|FG016|Overall Study|Global deterioration of health status|0|||
143293938|NCT02554812|516625570|FG017|Overall Study|Global deterioration of health status|0|||
143293939|NCT02554812|516625571|FG018|Overall Study|Global deterioration of health status|0|||
143293940|NCT02554812|516625572|FG019|Overall Study|Global deterioration of health status|0|||
143293941|NCT02554812|516625573|FG020|Overall Study|Global deterioration of health status|0|||
143293942|NCT02554812|516625574|FG021|Overall Study|Global deterioration of health status|0|||
143293943|NCT02554812|516625575|FG022|Overall Study|Global deterioration of health status|0|||
143293944|NCT02554812|516625576|FG023|Overall Study|Global deterioration of health status|0|||
143293945|NCT02554812|516625577|FG024|Overall Study|Global deterioration of health status|0|||
143293946|NCT02554812|516625578|FG025|Overall Study|Global deterioration of health status|0|||
143293947|NCT02554812|516625579|FG026|Overall Study|Global deterioration of health status|0|||
143293948|NCT02554812|516625553|FG000|Overall Study|Progressive disease|20|||
143293949|NCT02554812|516625554|FG001|Overall Study|Progressive disease|16|||
143293950|NCT02554812|516625555|FG002|Overall Study|Progressive disease|19|||
143293951|NCT02554812|516625556|FG003|Overall Study|Progressive disease|18|||
143293952|NCT02554812|516625557|FG004|Overall Study|Progressive disease|21|||
143293953|NCT02554812|516625558|FG005|Overall Study|Progressive disease|15|||
143293954|NCT02554812|516625559|FG006|Overall Study|Progressive disease|6|||
143293955|NCT02554812|516625560|FG007|Overall Study|Progressive disease|13|||
143293956|NCT02554812|516625561|FG008|Overall Study|Progressive disease|6|||
143293957|NCT02554812|516625562|FG009|Overall Study|Progressive disease|6|||
143293958|NCT02554812|516625563|FG010|Overall Study|Progressive disease|8|||
143293959|NCT02554812|516625564|FG011|Overall Study|Progressive disease|8|||
143293960|NCT02554812|516625565|FG012|Overall Study|Progressive disease|6|||
143293961|NCT02554812|516625566|FG013|Overall Study|Progressive disease|10|||
143293962|NCT02554812|516625567|FG014|Overall Study|Progressive disease|20|||
143293963|NCT02554812|516625568|FG015|Overall Study|Progressive disease|6|||
143293964|NCT02554812|516625569|FG016|Overall Study|Progressive disease|3|||
143293965|NCT02554812|516625570|FG017|Overall Study|Progressive disease|3|||
143293966|NCT02554812|516625571|FG018|Overall Study|Progressive disease|11|||
143293967|NCT02554812|516625572|FG019|Overall Study|Progressive disease|7|||
143293968|NCT02554812|516625573|FG020|Overall Study|Progressive disease|11|||
143293969|NCT02554812|516625574|FG021|Overall Study|Progressive disease|6|||
143293970|NCT02554812|516625575|FG022|Overall Study|Progressive disease|9|||
143293971|NCT02554812|516625576|FG023|Overall Study|Progressive disease|9|||
143293972|NCT02554812|516625577|FG024|Overall Study|Progressive disease|4|||
143293973|NCT02554812|516625578|FG025|Overall Study|Progressive disease|5|||
143293974|NCT02554812|516625579|FG026|Overall Study|Progressive disease|5|||
143293975|NCT02554812|516625553|FG000|Overall Study|Other|0|||
143293976|NCT02554812|516625554|FG001|Overall Study|Other|0|||
143293977|NCT02554812|516625555|FG002|Overall Study|Other|2|||
143293978|NCT02554812|516625556|FG003|Overall Study|Other|3|||
143293979|NCT02554812|516625557|FG004|Overall Study|Other|2|||
143293980|NCT02554812|516625558|FG005|Overall Study|Other|1|||
143293981|NCT02554812|516625559|FG006|Overall Study|Other|0|||
143293982|NCT02554812|516625560|FG007|Overall Study|Other|0|||
143293983|NCT02554812|516625561|FG008|Overall Study|Other|1|||
143293984|NCT02554812|516625562|FG009|Overall Study|Other|1|||
143293985|NCT02554812|516625563|FG010|Overall Study|Other|0|||
143293986|NCT02554812|516625564|FG011|Overall Study|Other|0|||
143293987|NCT02554812|516625565|FG012|Overall Study|Other|1|||
143293988|NCT02554812|516625566|FG013|Overall Study|Other|0|||
143293989|NCT02554812|516625567|FG014|Overall Study|Other|1|||
143293990|NCT02554812|516625568|FG015|Overall Study|Other|0|||
143293991|NCT02554812|516625569|FG016|Overall Study|Other|0|||
143293992|NCT02554812|516625570|FG017|Overall Study|Other|0|||
143293993|NCT02554812|516625571|FG018|Overall Study|Other|0|||
143293994|NCT02554812|516625572|FG019|Overall Study|Other|0|||
143293995|NCT02554812|516625573|FG020|Overall Study|Other|0|||
143293996|NCT02554812|516625574|FG021|Overall Study|Other|2|||
143293997|NCT02554812|516625575|FG022|Overall Study|Other|0|||
143293998|NCT02554812|516625576|FG023|Overall Study|Other|0|||
143293999|NCT02554812|516625577|FG024|Overall Study|Other|0|||
143294000|NCT02554812|516625578|FG025|Overall Study|Other|0|||
143294001|NCT02554812|516625579|FG026|Overall Study|Other|0|||
143294002|NCT02554812|516625553|FG000|Overall Study|Withdrawal by Subject|1|||
143294003|NCT02554812|516625554|FG001|Overall Study|Withdrawal by Subject|0|||
143294004|NCT02554812|516625555|FG002|Overall Study|Withdrawal by Subject|0|||
143294005|NCT02554812|516625556|FG003|Overall Study|Withdrawal by Subject|2|||
143294006|NCT02554812|516625557|FG004|Overall Study|Withdrawal by Subject|2|||
143294007|NCT02554812|516625558|FG005|Overall Study|Withdrawal by Subject|3|||
143294008|NCT02554812|516625559|FG006|Overall Study|Withdrawal by Subject|0|||
143294009|NCT02554812|516625560|FG007|Overall Study|Withdrawal by Subject|0|||
143294010|NCT02554812|516625561|FG008|Overall Study|Withdrawal by Subject|1|||
143294011|NCT02554812|516625562|FG009|Overall Study|Withdrawal by Subject|1|||
143294012|NCT02554812|516625563|FG010|Overall Study|Withdrawal by Subject|0|||
143294013|NCT02554812|516625564|FG011|Overall Study|Withdrawal by Subject|1|||
143294014|NCT02554812|516625565|FG012|Overall Study|Withdrawal by Subject|1|||
143294015|NCT02554812|516625566|FG013|Overall Study|Withdrawal by Subject|1|||
143294016|NCT02554812|516625567|FG014|Overall Study|Withdrawal by Subject|1|||
143294017|NCT02554812|516625568|FG015|Overall Study|Withdrawal by Subject|1|||
143294018|NCT02554812|516625569|FG016|Overall Study|Withdrawal by Subject|3|||
143294019|NCT02554812|516625570|FG017|Overall Study|Withdrawal by Subject|1|||
143294020|NCT02554812|516625571|FG018|Overall Study|Withdrawal by Subject|0|||
143294021|NCT02554812|516625572|FG019|Overall Study|Withdrawal by Subject|2|||
143294022|NCT02554812|516625573|FG020|Overall Study|Withdrawal by Subject|0|||
143294023|NCT02554812|516625574|FG021|Overall Study|Withdrawal by Subject|1|||
143294024|NCT02554812|516625575|FG022|Overall Study|Withdrawal by Subject|0|||
143294025|NCT02554812|516625576|FG023|Overall Study|Withdrawal by Subject|1|||
143294026|NCT02554812|516625577|FG024|Overall Study|Withdrawal by Subject|0|||
143294027|NCT02554812|516625578|FG025|Overall Study|Withdrawal by Subject|0|||
143294028|NCT02554812|516625579|FG026|Overall Study|Withdrawal by Subject|1|||
143294029|NCT02554812|516625553|FG000|Overall Study|Physician Decision|1|||
143294030|NCT02554812|516625554|FG001|Overall Study|Physician Decision|0|||
143294031|NCT02554812|516625555|FG002|Overall Study|Physician Decision|0|||
143294032|NCT02554812|516625556|FG003|Overall Study|Physician Decision|1|||
143294033|NCT02554812|516625557|FG004|Overall Study|Physician Decision|0|||
143294034|NCT02554812|516625558|FG005|Overall Study|Physician Decision|1|||
143294035|NCT02554812|516625559|FG006|Overall Study|Physician Decision|0|||
143294036|NCT02554812|516625560|FG007|Overall Study|Physician Decision|0|||
143294037|NCT02554812|516625561|FG008|Overall Study|Physician Decision|0|||
143294038|NCT02554812|516625562|FG009|Overall Study|Physician Decision|0|||
143294039|NCT02554812|516625563|FG010|Overall Study|Physician Decision|1|||
143294040|NCT02554812|516625564|FG011|Overall Study|Physician Decision|0|||
143294041|NCT02554812|516625565|FG012|Overall Study|Physician Decision|0|||
143294042|NCT02554812|516625566|FG013|Overall Study|Physician Decision|0|||
143294043|NCT02554812|516625567|FG014|Overall Study|Physician Decision|0|||
143294044|NCT02554812|516625568|FG015|Overall Study|Physician Decision|0|||
143294045|NCT02554812|516625569|FG016|Overall Study|Physician Decision|1|||
143294046|NCT02554812|516625570|FG017|Overall Study|Physician Decision|1|||
143294047|NCT02554812|516625571|FG018|Overall Study|Physician Decision|0|||
143294048|NCT02554812|516625572|FG019|Overall Study|Physician Decision|1|||
143294049|NCT02554812|516625573|FG020|Overall Study|Physician Decision|1|||
143294050|NCT02554812|516625574|FG021|Overall Study|Physician Decision|0|||
143294051|NCT02554812|516625575|FG022|Overall Study|Physician Decision|1|||
143294052|NCT02554812|516625576|FG023|Overall Study|Physician Decision|0|||
143294053|NCT02554812|516625577|FG024|Overall Study|Physician Decision|0|||
143294054|NCT02554812|516625578|FG025|Overall Study|Physician Decision|0|||
143294055|NCT02554812|516625579|FG026|Overall Study|Physician Decision|0|||
143294056|NCT02554812|516625553|FG000|Overall Study|Study terminated by sponsor|0|||
143294057|NCT02554812|516625554|FG001|Overall Study|Study terminated by sponsor|0|||
143294058|NCT02554812|516625555|FG002|Overall Study|Study terminated by sponsor|0|||
143294059|NCT02554812|516625556|FG003|Overall Study|Study terminated by sponsor|0|||
143294060|NCT02554812|516625557|FG004|Overall Study|Study terminated by sponsor|0|||
143294061|NCT02554812|516625558|FG005|Overall Study|Study terminated by sponsor|0|||
143294062|NCT02554812|516625559|FG006|Overall Study|Study terminated by sponsor|0|||
143294063|NCT02554812|516625560|FG007|Overall Study|Study terminated by sponsor|0|||
143294064|NCT02554812|516625561|FG008|Overall Study|Study terminated by sponsor|0|||
143294065|NCT02554812|516625562|FG009|Overall Study|Study terminated by sponsor|0|||
143294066|NCT02554812|516625563|FG010|Overall Study|Study terminated by sponsor|0|||
143294067|NCT02554812|516625564|FG011|Overall Study|Study terminated by sponsor|0|||
143294068|NCT02554812|516625565|FG012|Overall Study|Study terminated by sponsor|0|||
143294069|NCT02554812|516625566|FG013|Overall Study|Study terminated by sponsor|0|||
143294070|NCT02554812|516625567|FG014|Overall Study|Study terminated by sponsor|0|||
143294071|NCT02554812|516625568|FG015|Overall Study|Study terminated by sponsor|0|||
143294072|NCT02554812|516625569|FG016|Overall Study|Study terminated by sponsor|0|||
143294073|NCT02554812|516625570|FG017|Overall Study|Study terminated by sponsor|0|||
143294074|NCT02554812|516625571|FG018|Overall Study|Study terminated by sponsor|0|||
143294075|NCT02554812|516625572|FG019|Overall Study|Study terminated by sponsor|0|||
143294076|NCT02554812|516625573|FG020|Overall Study|Study terminated by sponsor|0|||
143294077|NCT02554812|516625574|FG021|Overall Study|Study terminated by sponsor|0|||
143294078|NCT02554812|516625575|FG022|Overall Study|Study terminated by sponsor|0|||
143294079|NCT02554812|516625576|FG023|Overall Study|Study terminated by sponsor|0|||
143294080|NCT02554812|516625577|FG024|Overall Study|Study terminated by sponsor|1|||
143294081|NCT02554812|516625578|FG025|Overall Study|Study terminated by sponsor|0|||
143294082|NCT02554812|516625579|FG026|Overall Study|Study terminated by sponsor|0|||
143294083|NCT02554812|516625553|FG000|Overall Study|No longer meets eligibility criteria|0|||
143294084|NCT02554812|516625554|FG001|Overall Study|No longer meets eligibility criteria|1|||
143294085|NCT02554812|516625555|FG002|Overall Study|No longer meets eligibility criteria|0|||
143294086|NCT02554812|516625556|FG003|Overall Study|No longer meets eligibility criteria|0|||
143294087|NCT02554812|516625557|FG004|Overall Study|No longer meets eligibility criteria|0|||
143294088|NCT02554812|516625558|FG005|Overall Study|No longer meets eligibility criteria|0|||
143294089|NCT02554812|516625559|FG006|Overall Study|No longer meets eligibility criteria|0|||
143294090|NCT02554812|516625560|FG007|Overall Study|No longer meets eligibility criteria|0|||
143294091|NCT02554812|516625561|FG008|Overall Study|No longer meets eligibility criteria|0|||
143294092|NCT02554812|516625562|FG009|Overall Study|No longer meets eligibility criteria|0|||
143294093|NCT02554812|516625563|FG010|Overall Study|No longer meets eligibility criteria|0|||
143294094|NCT02554812|516625564|FG011|Overall Study|No longer meets eligibility criteria|0|||
143294095|NCT02554812|516625565|FG012|Overall Study|No longer meets eligibility criteria|0|||
143294096|NCT02554812|516625566|FG013|Overall Study|No longer meets eligibility criteria|0|||
143294097|NCT02554812|516625567|FG014|Overall Study|No longer meets eligibility criteria|0|||
143294098|NCT02554812|516625568|FG015|Overall Study|No longer meets eligibility criteria|0|||
143294099|NCT02554812|516625569|FG016|Overall Study|No longer meets eligibility criteria|0|||
143294100|NCT02554812|516625570|FG017|Overall Study|No longer meets eligibility criteria|0|||
143294101|NCT02554812|516625571|FG018|Overall Study|No longer meets eligibility criteria|0|||
143294102|NCT02554812|516625572|FG019|Overall Study|No longer meets eligibility criteria|0|||
143294103|NCT02554812|516625573|FG020|Overall Study|No longer meets eligibility criteria|0|||
143294104|NCT02554812|516625574|FG021|Overall Study|No longer meets eligibility criteria|0|||
143294105|NCT02554812|516625575|FG022|Overall Study|No longer meets eligibility criteria|0|||
143294106|NCT02554812|516625576|FG023|Overall Study|No longer meets eligibility criteria|0|||
143294107|NCT02554812|516625577|FG024|Overall Study|No longer meets eligibility criteria|0|||
143294108|NCT02554812|516625578|FG025|Overall Study|No longer meets eligibility criteria|0|||
143294109|NCT02554812|516625579|FG026|Overall Study|No longer meets eligibility criteria|0|||
143294110|NCT03204981|516627585|FG000|Overall Study|Physician Decision|2|||
143294111|NCT03204981|516627585|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
143294112|NCT00397982|516627589|FG000|Overall Study|Withdrawal by Subject|1|||
143294113|NCT00397982|516627589|FG000|Overall Study|Adverse Event|1|||
143294114|NCT00397982|516627589|FG000|Overall Study|noncompliance|1|||
143294115|NCT00397982|516627589|FG000|Overall Study|Unrelated health issues|1|||
143294116|NCT04244786|516627590|FG000|Overall Study|Adverse Event|0|||
143294117|NCT04244786|516627591|FG001|Overall Study|Adverse Event|0|||
143294118|NCT04244786|516627592|FG002|Overall Study|Adverse Event|2|||
143294119|NCT04244786|516627590|FG000|Overall Study|Withdrawal by Subject|0|||
143294120|NCT04244786|516627591|FG001|Overall Study|Withdrawal by Subject|0|||
143294121|NCT04244786|516627592|FG002|Overall Study|Withdrawal by Subject|5|||
143294122|NCT00613938|516627593|FG000|Overall Study|Withdrawal by Subject|2|||
143294123|NCT00613938|516627594|FG001|Overall Study|Withdrawal by Subject|4|||
143294124|NCT00613938|516627595|FG002|Overall Study|Withdrawal by Subject|9|||
143294125|NCT00613938|516627596|FG003|Overall Study|Withdrawal by Subject|9|||
143294126|NCT00613938|516627593|FG000|Overall Study|Adverse Event|1|||
143294127|NCT00613938|516627594|FG001|Overall Study|Adverse Event|4|||
143294128|NCT00613938|516627595|FG002|Overall Study|Adverse Event|8|||
143294129|NCT00613938|516627596|FG003|Overall Study|Adverse Event|5|||
143294130|NCT00613938|516627593|FG000|Overall Study|Lack of Efficacy|16|||
143294131|NCT00613938|516627594|FG001|Overall Study|Lack of Efficacy|18|||
143294132|NCT00613938|516627595|FG002|Overall Study|Lack of Efficacy|5|||
143294133|NCT00613938|516627596|FG003|Overall Study|Lack of Efficacy|9|||
143294134|NCT00613938|516627593|FG000|Overall Study|Other|1|||
143294135|NCT00613938|516627594|FG001|Overall Study|Other|2|||
143294136|NCT00613938|516627595|FG002|Overall Study|Other|1|||
143294137|NCT00613938|516627596|FG003|Overall Study|Other|3|||
143294138|NCT03025542|516627597|FG000|Overall Study|Adverse Event|0|||
143294139|NCT03025542|516627598|FG001|Overall Study|Adverse Event|2|||
143294140|NCT03025542|516627597|FG000|Overall Study|Lost to Follow-up|1|||
143294141|NCT03025542|516627598|FG001|Overall Study|Lost to Follow-up|0|||
143294142|NCT03025542|516627597|FG000|Overall Study|Withdrawal by Subject|1|||
143294143|NCT03025542|516627598|FG001|Overall Study|Withdrawal by Subject|0|||
143294144|NCT00488345|516627599|FG000|Overall Study|Adverse Event|0|||
143294145|NCT00488345|516627600|FG001|Overall Study|Adverse Event|1|||
143294146|NCT00488345|516627601|FG002|Overall Study|Adverse Event|1|||
143294147|NCT00488345|516627599|FG000|Overall Study|Unable to administer antibiotics at home|0|||
143294148|NCT00488345|516627600|FG001|Overall Study|Unable to administer antibiotics at home|1|||
143294149|NCT00488345|516627601|FG002|Overall Study|Unable to administer antibiotics at home|0|||
143294150|NCT00488345|516627599|FG000|Overall Study|Institutional Review Board review|0|||
143294151|NCT00488345|516627600|FG001|Overall Study|Institutional Review Board review|0|||
143294152|NCT00488345|516627601|FG002|Overall Study|Institutional Review Board review|1|||
143294153|NCT00488345|516627599|FG000|Overall Study|Surgical team recommendation|0|||
143294154|NCT00488345|516627600|FG001|Overall Study|Surgical team recommendation|1|||
143294155|NCT00488345|516627601|FG002|Overall Study|Surgical team recommendation|0|||
143294156|NCT00488345|516627599|FG000|Overall Study|Parent/legal guardian request|0|||
143294157|NCT00488345|516627600|FG001|Overall Study|Parent/legal guardian request|1|||
143294158|NCT00488345|516627601|FG002|Overall Study|Parent/legal guardian request|1|||
143294159|NCT01706003|516627605|FG000|Overall Study|Withdrawal by Subject|2|||
143294160|NCT01706003|516627606|FG001|Overall Study|Withdrawal by Subject|0|||
143294161|NCT01706003|516627605|FG000|Overall Study|Not scheduled|3|||
143294162|NCT01706003|516627606|FG001|Overall Study|Not scheduled|0|||
143294163|NCT01706003|516627605|FG000|Overall Study|Lost to Follow-up|6|||
143294164|NCT01706003|516627606|FG001|Overall Study|Lost to Follow-up|4|||
143294165|NCT00696696|516627609|FG000|Overall Study|Adverse Event|5|||
143294166|NCT00696696|516627609|FG000|Overall Study|Withdrawal by Subject|8|||
143294167|NCT00696696|516627609|FG000|Overall Study|Physician Decision|2|||
143294168|NCT00696696|516627609|FG000|Overall Study|Death|3|||
143294169|NCT05608005|516627610|FG000|Overall Study|Adverse Event|2|||
143294170|NCT05608005|516627611|FG001|Overall Study|Adverse Event|1|||
143294171|NCT05608005|516627612|FG002|Overall Study|Adverse Event|3|||
143294172|NCT05608005|516627610|FG000|Overall Study|Protocol Violation|2|||
143373788|NCT00004124|516913574|FG000|Overall Study|Received no protocol therapy|12|||
143294173|NCT05608005|516627611|FG001|Overall Study|Protocol Violation|3|||
143294174|NCT05608005|516627612|FG002|Overall Study|Protocol Violation|0|||
143294175|NCT05608005|516627610|FG000|Overall Study|Withdrawal by Subject|10|||
143294176|NCT05608005|516627611|FG001|Overall Study|Withdrawal by Subject|12|||
143294177|NCT05608005|516627612|FG002|Overall Study|Withdrawal by Subject|4|||
143294178|NCT05608005|516627610|FG000|Overall Study|Lost to Follow-up|25|||
143294179|NCT05608005|516627611|FG001|Overall Study|Lost to Follow-up|27|||
143294180|NCT05608005|516627612|FG002|Overall Study|Lost to Follow-up|15|||
143294181|NCT05608005|516627610|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
143294182|NCT05608005|516627611|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
143294183|NCT05608005|516627612|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
143294184|NCT00936910|516627615|FG000|Overall Study|Lack of Efficacy|3|||
143294185|NCT01485640|516627616|FG000|Overall Study|Adverse Event|10|||
143294186|NCT01485640|516627616|FG000|Overall Study|Lack of Efficacy|2|||
143294187|NCT01485640|516627616|FG000|Overall Study|Protocol Violation|1|||
143294188|NCT01485640|516627616|FG000|Overall Study|Withdrawal by Subject|14|||
143294189|NCT01485640|516627616|FG000|Overall Study|Terminated by Sponsor|95|||
143294190|NCT01585428|516627618|FG000|Overall Study|Death during treatment|1|||
143294191|NCT01585428|516627619|FG001|Overall Study|Death during treatment|0|||
143294192|NCT02355691|516627622|FG000|Overall Study|Loss of Research Personnel|7|||
143294193|NCT02355691|516627623|FG001|Overall Study|Loss of Research Personnel|9|||
143294194|NCT03683758|516627627|FG000|Overall Study|Non-study commitment conflict|1|||
143294195|NCT03683758|516627628|FG001|Overall Study|Non-study commitment conflict|3|||
143294196|NCT03683758|516627627|FG000|Overall Study|Illness preventing participation|1|||
143294197|NCT03683758|516627628|FG001|Overall Study|Illness preventing participation|0|||
143294198|NCT03683758|516627627|FG000|Overall Study|Adverse Event|1|||
143294199|NCT03683758|516627628|FG001|Overall Study|Adverse Event|0|||
143294200|NCT02411292|516627630|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
143294201|NCT02411292|516627630|FG000|Overall Study|Death|2|||
143294202|NCT02411292|516627630|FG000|Overall Study|Lost to Follow-up|3|||
143294203|NCT00303498|516627631|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
143294204|NCT00303498|516627632|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
143294205|NCT00303498|516627631|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
143294206|NCT00303498|516627632|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
143294207|NCT00303498|516627631|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
143294208|NCT00303498|516627632|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
143294209|NCT00303498|516627631|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
143294210|NCT00303498|516627632|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
143294211|NCT00303498|516627631|FG000|Run-In-Phase (10 Weeks)|Other|4|||
143294212|NCT00303498|516627632|FG001|Run-In-Phase (10 Weeks)|Other|1|||
143294213|NCT00303498|516627631|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
143294214|NCT00303498|516627632|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
143294215|NCT00303498|516627631|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
143294216|NCT00303498|516627632|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
143294217|NCT00303498|516627631|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
143294218|NCT00303498|516627632|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
143294219|NCT00303498|516627631|FG000|Maintenance Phase (24 Weeks)|Death|1|||
143294220|NCT00303498|516627632|FG001|Maintenance Phase (24 Weeks)|Death|0|||
143294221|NCT00303498|516627631|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
143294222|NCT00303498|516627632|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
143294223|NCT00303498|516627631|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
143294224|NCT00303498|516627632|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
143294225|NCT00303498|516627631|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
143294226|NCT00303498|516627632|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
143294227|NCT00303498|516627631|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
143294228|NCT00303498|516627632|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
143294229|NCT00303498|516627631|FG000|Maintenance Phase (24 Weeks)|Other|1|||
143294230|NCT00303498|516627632|FG001|Maintenance Phase (24 Weeks)|Other|0|||
143294231|NCT00303498|516627631|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
143294232|NCT00303498|516627632|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
143294233|NCT00303498|516627631|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
143294234|NCT00303498|516627632|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
143294235|NCT00453921|516627633|FG000|Overall Study|Withdrawal by Subject|1|||
143294236|NCT00453921|516627634|FG001|Overall Study|Withdrawal by Subject|1|||
143294237|NCT00453921|516627635|FG002|Overall Study|Withdrawal by Subject|1|||
143294238|NCT00453921|516627636|FG003|Overall Study|Withdrawal by Subject|1|||
143294239|NCT00453921|516627633|FG000|Overall Study|Lost to Follow-up|0|||
143294240|NCT00453921|516627634|FG001|Overall Study|Lost to Follow-up|0|||
143294241|NCT00453921|516627635|FG002|Overall Study|Lost to Follow-up|1|||
143294242|NCT00453921|516627636|FG003|Overall Study|Lost to Follow-up|0|||
143294243|NCT02132767|516627638|FG000|Overall Study|Death|3|||
143294244|NCT02132767|516627639|FG001|Overall Study|Death|2|||
143294245|NCT02132767|516627638|FG000|Overall Study|Withdrawal by Subject|10|||
143294246|NCT02132767|516627639|FG001|Overall Study|Withdrawal by Subject|9|||
143294247|NCT02132767|516627638|FG000|Overall Study|Lost to Follow-up|4|||
143294248|NCT02132767|516627639|FG001|Overall Study|Lost to Follow-up|4|||
143294249|NCT02436356|516627647|FG000|Overall Study|Excluded by MRI Screening|0|||
143294250|NCT02436356|516627648|FG001|Overall Study|Excluded by MRI Screening|0|||
143294251|NCT02436356|516627649|FG002|Overall Study|Excluded by MRI Screening|2|||
143294252|NCT02436356|516627647|FG000|Overall Study|Lost to Follow-up|0|||
143294253|NCT02436356|516627648|FG001|Overall Study|Lost to Follow-up|1|||
143294254|NCT02436356|516627649|FG002|Overall Study|Lost to Follow-up|0|||
143294255|NCT02436356|516627647|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
143294256|NCT02436356|516627648|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
143294257|NCT02436356|516627649|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
143294258|NCT02436356|516627647|FG000|Overall Study|Excluded due to other medical conditions|3|||
143294259|NCT02436356|516627648|FG001|Overall Study|Excluded due to other medical conditions|0|||
143294260|NCT02436356|516627649|FG002|Overall Study|Excluded due to other medical conditions|0|||
143294261|NCT02436356|516627647|FG000|Overall Study|Withdrawal by Subject|1|||
143294262|NCT02436356|516627648|FG001|Overall Study|Withdrawal by Subject|0|||
143294263|NCT02436356|516627649|FG002|Overall Study|Withdrawal by Subject|0|||
143294264|NCT04577118|516627654|FG000|Overall Study|Withdrawal by Subject|4|||
143294265|NCT00810407|516627655|FG000|Overall Study|Protocol Violation|3|||
143294266|NCT00810407|516627655|FG000|Overall Study|No Visit After First Day of Treatment|3|||
143294267|NCT02968563|516627656|FG000|Overall Study|Adverse Event|0|||
143294268|NCT02968563|516627657|FG001|Overall Study|Adverse Event|6|||
143294269|NCT02968563|516627656|FG000|Overall Study|Death|1|||
143294270|NCT02968563|516627657|FG001|Overall Study|Death|1|||
143294271|NCT02968563|516627656|FG000|Overall Study|Lost to Follow-up|0|||
143294272|NCT02968563|516627657|FG001|Overall Study|Lost to Follow-up|1|||
143294273|NCT03287804|516627661|FG000|Overall Study|Death|1|||
143294274|NCT03287804|516627661|FG000|Overall Study|Physician Decision|2|||
143294275|NCT03287804|516627661|FG000|Overall Study|Progressive disease|8|||
143294276|NCT04008030|516627664|FG000|Pre-Treatment|Withdrawal by Subject|0|||
143294277|NCT04008030|516627665|FG001|Pre-Treatment|Withdrawal by Subject|0|||
143294278|NCT04008030|516627666|FG002|Pre-Treatment|Withdrawal by Subject|9|||
143294279|NCT04008030|516627664|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
143294280|NCT04008030|516627665|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
143294281|NCT04008030|516627666|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
143294282|NCT04008030|516627664|FG000|Pre-Treatment|Other reasons|0|||
143294283|NCT04008030|516627665|FG001|Pre-Treatment|Other reasons|1|||
143294284|NCT04008030|516627666|FG002|Pre-Treatment|Other reasons|6|||
143294285|NCT04008030|516627664|FG000|Treatment|Withdrawal by Subject|1|||
143294286|NCT04008030|516627665|FG001|Treatment|Withdrawal by Subject|1|||
143294287|NCT04008030|516627666|FG002|Treatment|Withdrawal by Subject|1|||
143294288|NCT04008030|516627664|FG000|Treatment|Death|2|||
143294289|NCT04008030|516627665|FG001|Treatment|Death|4|||
143294290|NCT04008030|516627666|FG002|Treatment|Death|0|||
143294291|NCT04008030|516627664|FG000|Treatment|Pregnancy|0|||
143294292|NCT04008030|516627665|FG001|Treatment|Pregnancy|1|||
143294293|NCT04008030|516627666|FG002|Treatment|Pregnancy|0|||
143294294|NCT04008030|516627664|FG000|Treatment|Participant no longer meets study criteria|0|||
143294295|NCT04008030|516627665|FG001|Treatment|Participant no longer meets study criteria|1|||
143294296|NCT04008030|516627666|FG002|Treatment|Participant no longer meets study criteria|0|||
143294297|NCT04008030|516627664|FG000|Treatment|Other reasons|5|||
143294298|NCT04008030|516627665|FG001|Treatment|Other reasons|13|||
143294299|NCT04008030|516627666|FG002|Treatment|Other reasons|6|||
143294300|NCT04008030|516627664|FG000|Treatment|Disease Progression|137|||
143294301|NCT04008030|516627665|FG001|Treatment|Disease Progression|82|||
143294302|NCT04008030|516627666|FG002|Treatment|Disease Progression|85|||
143294303|NCT04008030|516627664|FG000|Treatment|Study drug toxicity|28|||
143294304|NCT04008030|516627665|FG001|Treatment|Study drug toxicity|48|||
143294305|NCT04008030|516627666|FG002|Treatment|Study drug toxicity|8|||
143294306|NCT04008030|516627664|FG000|Treatment|Adverse Event unrelated to study drug|28|||
143294307|NCT04008030|516627665|FG001|Treatment|Adverse Event unrelated to study drug|22|||
143294308|NCT04008030|516627666|FG002|Treatment|Adverse Event unrelated to study drug|6|||
143294309|NCT04008030|516627664|FG000|Treatment|Maximum Clinical Benefit|0|||
143294310|NCT04008030|516627665|FG001|Treatment|Maximum Clinical Benefit|1|||
143294311|NCT04008030|516627666|FG002|Treatment|Maximum Clinical Benefit|9|||
143294312|NCT04008030|516627664|FG000|Treatment|On-going treatment|13|||
143294313|NCT04008030|516627665|FG001|Treatment|On-going treatment|20|||
143294314|NCT04008030|516627666|FG002|Treatment|On-going treatment|0|||
143294315|NCT03108027|516627673|FG000|Period 1|Subject/Guardian Decision|0|||
143294316|NCT03108027|516627674|FG001|Period 1|Subject/Guardian Decision|0|||
143294317|NCT03108027|516627675|FG002|Period 1|Subject/Guardian Decision|0|||
143294318|NCT03108027|516627676|FG003|Period 1|Subject/Guardian Decision|2|||
143294319|NCT03108027|516627677|FG004|Period 1|Subject/Guardian Decision|0|||
143294320|NCT03108027|516627678|FG005|Period 1|Subject/Guardian Decision|0|||
143294321|NCT03108027|516627673|FG000|Period 3|Adverse Event|0|||
143294322|NCT03108027|516627674|FG001|Period 3|Adverse Event|1|||
143294323|NCT03108027|516627675|FG002|Period 3|Adverse Event|0|||
143294324|NCT03108027|516627676|FG003|Period 3|Adverse Event|0|||
143294325|NCT03108027|516627677|FG004|Period 3|Adverse Event|0|||
143294326|NCT03108027|516627678|FG005|Period 3|Adverse Event|0|||
143294327|NCT02426892|516627679|FG000|Overall Study|Adverse Event|2|||
143294328|NCT02426892|516627679|FG000|Overall Study|Lack of Efficacy|17|||
143294329|NCT02426892|516627679|FG000|Overall Study|Withdrawal by Subject|1|||
143294330|NCT02574247|516627680|FG000|Overall Study|Withdrawal by Subject|1|||
143294331|NCT02574247|516627681|FG001|Overall Study|Withdrawal by Subject|0|||
143294332|NCT02574247|516627682|FG002|Overall Study|Withdrawal by Subject|0|||
143294333|NCT02574247|516627680|FG000|Overall Study|Did not meet inclusion criteria|4|||
143294334|NCT02574247|516627681|FG001|Overall Study|Did not meet inclusion criteria|3|||
143294335|NCT02574247|516627682|FG002|Overall Study|Did not meet inclusion criteria|5|||
143294336|NCT03178773|516627683|FG000|Overall Study|Death|0|||
143294337|NCT03178773|516627684|FG001|Overall Study|Death|1|||
143294338|NCT03178773|516627683|FG000|Overall Study|Lost to Follow-up|29|||
143294339|NCT03178773|516627684|FG001|Overall Study|Lost to Follow-up|25|||
143294340|NCT03178773|516627683|FG000|Overall Study|Withdrawal by Subject|10|||
143294341|NCT03178773|516627684|FG001|Overall Study|Withdrawal by Subject|14|||
143294342|NCT00770289|516627686|FG000|Overall Study|Other|6|||
143294343|NCT02733991|516627687|FG000|Overall Study|Adverse Event|1|||
143294344|NCT02733991|516627688|FG001|Overall Study|Adverse Event|0|||
143294345|NCT02733991|516627687|FG000|Overall Study|Withdrawal by Subject|0|||
143294346|NCT02733991|516627688|FG001|Overall Study|Withdrawal by Subject|5|||
143294347|NCT02659631|516627690|FG000|Overall Study|Lost to Follow-up|0|||
143294348|NCT02659631|516627691|FG001|Overall Study|Lost to Follow-up|0|||
143294349|NCT02659631|516627692|FG002|Overall Study|Lost to Follow-up|2|||
143294350|NCT02659631|516627693|FG003|Overall Study|Lost to Follow-up|0|||
143294351|NCT02659631|516627694|FG004|Overall Study|Lost to Follow-up|0|||
143294352|NCT02659631|516627695|FG005|Overall Study|Lost to Follow-up|1|||
143294353|NCT02659631|516627696|FG006|Overall Study|Lost to Follow-up|0|||
143294354|NCT02659631|516627697|FG007|Overall Study|Lost to Follow-up|0|||
143294355|NCT02659631|516627698|FG008|Overall Study|Lost to Follow-up|0|||
143294356|NCT02659631|516627699|FG009|Overall Study|Lost to Follow-up|0|||
143294357|NCT02659631|516627690|FG000|Overall Study|Withdrawal prior to treatment|0|||
143294358|NCT02659631|516627691|FG001|Overall Study|Withdrawal prior to treatment|0|||
143294359|NCT02659631|516627692|FG002|Overall Study|Withdrawal prior to treatment|0|||
143294360|NCT02659631|516627693|FG003|Overall Study|Withdrawal prior to treatment|0|||
143294361|NCT02659631|516627694|FG004|Overall Study|Withdrawal prior to treatment|1|||
143294362|NCT02659631|516627695|FG005|Overall Study|Withdrawal prior to treatment|0|||
143294363|NCT02659631|516627696|FG006|Overall Study|Withdrawal prior to treatment|0|||
143294364|NCT02659631|516627697|FG007|Overall Study|Withdrawal prior to treatment|0|||
143294365|NCT02659631|516627698|FG008|Overall Study|Withdrawal prior to treatment|0|||
143294366|NCT02659631|516627699|FG009|Overall Study|Withdrawal prior to treatment|0|||
143294367|NCT02659631|516627690|FG000|Overall Study|Participant refused further follow-up|0|||
143294368|NCT02659631|516627691|FG001|Overall Study|Participant refused further follow-up|0|||
143294369|NCT02659631|516627692|FG002|Overall Study|Participant refused further follow-up|0|||
143294370|NCT02659631|516627693|FG003|Overall Study|Participant refused further follow-up|1|||
143294371|NCT02659631|516627694|FG004|Overall Study|Participant refused further follow-up|0|||
143294372|NCT02659631|516627695|FG005|Overall Study|Participant refused further follow-up|0|||
143294373|NCT02659631|516627696|FG006|Overall Study|Participant refused further follow-up|0|||
143294374|NCT02659631|516627697|FG007|Overall Study|Participant refused further follow-up|0|||
143294375|NCT02659631|516627698|FG008|Overall Study|Participant refused further follow-up|1|||
143294376|NCT02659631|516627699|FG009|Overall Study|Participant refused further follow-up|0|||
143294377|NCT02659631|516627690|FG000|Overall Study|Death (follow-up phase)|1|||
143294378|NCT02659631|516627691|FG001|Overall Study|Death (follow-up phase)|2|||
143294379|NCT02659631|516627692|FG002|Overall Study|Death (follow-up phase)|1|||
143294380|NCT02659631|516627693|FG003|Overall Study|Death (follow-up phase)|1|||
143294381|NCT02659631|516627694|FG004|Overall Study|Death (follow-up phase)|3|||
143294382|NCT02659631|516627695|FG005|Overall Study|Death (follow-up phase)|2|||
143294383|NCT02659631|516627696|FG006|Overall Study|Death (follow-up phase)|0|||
143294384|NCT02659631|516627697|FG007|Overall Study|Death (follow-up phase)|3|||
143294385|NCT02659631|516627698|FG008|Overall Study|Death (follow-up phase)|1|||
143294386|NCT02659631|516627699|FG009|Overall Study|Death (follow-up phase)|0|||
143294387|NCT02659631|516627690|FG000|Overall Study|Death (treatment phase)|0|||
143294388|NCT02659631|516627691|FG001|Overall Study|Death (treatment phase)|0|||
143294389|NCT02659631|516627692|FG002|Overall Study|Death (treatment phase)|0|||
143294390|NCT02659631|516627693|FG003|Overall Study|Death (treatment phase)|0|||
143294391|NCT02659631|516627694|FG004|Overall Study|Death (treatment phase)|1|||
143294392|NCT02659631|516627695|FG005|Overall Study|Death (treatment phase)|0|||
143294393|NCT02659631|516627696|FG006|Overall Study|Death (treatment phase)|1|||
143294394|NCT02659631|516627697|FG007|Overall Study|Death (treatment phase)|0|||
143294395|NCT02659631|516627698|FG008|Overall Study|Death (treatment phase)|0|||
143294396|NCT02659631|516627699|FG009|Overall Study|Death (treatment phase)|0|||
143294397|NCT01928329|516627700|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
143294398|NCT01928329|516627701|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
143294399|NCT01928329|516627700|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
143294400|NCT01928329|516627701|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
143294401|NCT01928329|516627700|FG000|Overall Study|Adverse Event|5|||
143294402|NCT01928329|516627701|FG001|Overall Study|Adverse Event|3|||
143294403|NCT01928329|516627700|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
143294404|NCT01928329|516627701|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
143294405|NCT01928329|516627700|FG000|Overall Study|Withdrawal by Subject|1|||
143294406|NCT01928329|516627701|FG001|Overall Study|Withdrawal by Subject|5|||
143294407|NCT01928329|516627700|FG000|Overall Study|Physician Decision|1|||
143294408|NCT01928329|516627701|FG001|Overall Study|Physician Decision|1|||
143294409|NCT02617511|516627702|FG000|Overall Study|Withdrawal by Subject|1|||
143294410|NCT02617511|516627703|FG001|Overall Study|Withdrawal by Subject|0|||
143294411|NCT02141997|516627704|FG000|Overall Study|Adverse Event|0|||
143294412|NCT02141997|516627705|FG001|Overall Study|Adverse Event|2|||
143294413|NCT02141997|516627706|FG002|Overall Study|Adverse Event|0|||
143294414|NCT02141997|516627707|FG003|Overall Study|Adverse Event|1|||
143294415|NCT02141997|516627704|FG000|Overall Study|Participant noncompliance|1|||
143294416|NCT02141997|516627705|FG001|Overall Study|Participant noncompliance|0|||
143294417|NCT02141997|516627706|FG002|Overall Study|Participant noncompliance|0|||
143294418|NCT02141997|516627707|FG003|Overall Study|Participant noncompliance|0|||
143294419|NCT02141997|516627704|FG000|Overall Study|Withdrew consent|1|||
143294420|NCT02141997|516627705|FG001|Overall Study|Withdrew consent|0|||
143294421|NCT02141997|516627706|FG002|Overall Study|Withdrew consent|3|||
143294422|NCT02141997|516627707|FG003|Overall Study|Withdrew consent|0|||
143294423|NCT02141997|516627704|FG000|Overall Study|Other|1|||
143294424|NCT02141997|516627705|FG001|Overall Study|Other|4|||
143294425|NCT02141997|516627706|FG002|Overall Study|Other|0|||
143294426|NCT02141997|516627707|FG003|Overall Study|Other|0|||
143294427|NCT00451321|516627712|FG000|Overall Study|Lost to Follow-up|3|||
143294428|NCT00451321|516627713|FG001|Overall Study|Lost to Follow-up|3|||
143294429|NCT00451321|516627714|FG002|Overall Study|Lost to Follow-up|1|||
143294430|NCT00451321|516627715|FG003|Overall Study|Lost to Follow-up|3|||
143294431|NCT00451321|516627716|FG004|Overall Study|Lost to Follow-up|0|||
143294432|NCT00451321|516627717|FG005|Overall Study|Lost to Follow-up|1|||
143294433|NCT00451321|516627718|FG006|Overall Study|Lost to Follow-up|0|||
143294434|NCT00451321|516627719|FG007|Overall Study|Lost to Follow-up|0|||
143294435|NCT00451321|516627712|FG000|Overall Study|Withdrawal by Subject|3|||
143294436|NCT00451321|516627713|FG001|Overall Study|Withdrawal by Subject|1|||
143294437|NCT00451321|516627714|FG002|Overall Study|Withdrawal by Subject|0|||
143294438|NCT00451321|516627715|FG003|Overall Study|Withdrawal by Subject|4|||
143294439|NCT00451321|516627716|FG004|Overall Study|Withdrawal by Subject|0|||
143294440|NCT00451321|516627717|FG005|Overall Study|Withdrawal by Subject|0|||
143294441|NCT00451321|516627718|FG006|Overall Study|Withdrawal by Subject|0|||
143294442|NCT00451321|516627719|FG007|Overall Study|Withdrawal by Subject|0|||
143294443|NCT00451321|516627712|FG000|Overall Study|Study closed/terminated|1|||
143294444|NCT00451321|516627713|FG001|Overall Study|Study closed/terminated|1|||
143294445|NCT00451321|516627714|FG002|Overall Study|Study closed/terminated|17|||
143294446|NCT00451321|516627715|FG003|Overall Study|Study closed/terminated|5|||
143294447|NCT00451321|516627716|FG004|Overall Study|Study closed/terminated|7|||
143294448|NCT00451321|516627717|FG005|Overall Study|Study closed/terminated|7|||
143294449|NCT00451321|516627718|FG006|Overall Study|Study closed/terminated|5|||
143294450|NCT00451321|516627719|FG007|Overall Study|Study closed/terminated|3|||
143294451|NCT00451321|516627712|FG000|Overall Study|Sponsor decision to amend protocol|0|||
143294452|NCT00451321|516627713|FG001|Overall Study|Sponsor decision to amend protocol|0|||
143294453|NCT00451321|516627714|FG002|Overall Study|Sponsor decision to amend protocol|0|||
143294454|NCT00451321|516627715|FG003|Overall Study|Sponsor decision to amend protocol|0|||
143294455|NCT00451321|516627716|FG004|Overall Study|Sponsor decision to amend protocol|0|||
143294456|NCT00451321|516627717|FG005|Overall Study|Sponsor decision to amend protocol|1|||
143294457|NCT00451321|516627718|FG006|Overall Study|Sponsor decision to amend protocol|1|||
143294458|NCT00451321|516627719|FG007|Overall Study|Sponsor decision to amend protocol|3|||
143294459|NCT00909389|516627723|FG000|Overall Study|Adverse Event|6|||
143294460|NCT00909389|516627723|FG000|Overall Study|Death|4|||
143294461|NCT00909389|516627723|FG000|Overall Study|Poor Compliance|16|||
143294462|NCT00909389|516627723|FG000|Overall Study|Lost to Follow-up|4|||
143294463|NCT00909389|516627723|FG000|Overall Study|No Information|103|||
143294464|NCT00877383|516627737|FG000|Overall Study|Adverse Event|13|||
143294465|NCT00877383|516627738|FG001|Overall Study|Adverse Event|14|||
143294466|NCT00877383|516627737|FG000|Overall Study|Lost to Follow-up|5|||
143294467|NCT00877383|516627738|FG001|Overall Study|Lost to Follow-up|3|||
143294468|NCT00877383|516627737|FG000|Overall Study|Subject withdrew consent|3|||
143294469|NCT00877383|516627738|FG001|Overall Study|Subject withdrew consent|12|||
143294470|NCT00877383|516627737|FG000|Overall Study|Subject no longer requires study drug|2|||
143294471|NCT00877383|516627738|FG001|Overall Study|Subject no longer requires study drug|0|||
143294472|NCT00877383|516627737|FG000|Overall Study|Administrative problems|2|||
143294473|NCT00877383|516627738|FG001|Overall Study|Administrative problems|0|||
143294474|NCT00877383|516627737|FG000|Overall Study|Protocol deviation|2|||
143294475|NCT00877383|516627738|FG001|Overall Study|Protocol deviation|6|||
143294476|NCT00877383|516627737|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
143294477|NCT00877383|516627738|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
143294478|NCT00877383|516627737|FG000|Overall Study|Death|1|||
143294479|NCT00877383|516627738|FG001|Overall Study|Death|2|||
143294480|NCT00459108|516627739|FG000|Overall Study|Withdrawal by Subject|5|||
143294481|NCT00459108|516627739|FG000|Overall Study|Adverse Event|3|||
143294482|NCT00459108|516627739|FG000|Overall Study|Death|2|||
143294483|NCT00459108|516627739|FG000|Overall Study|Progression|1|||
143294484|NCT02157298|516627742|FG000|Overall Study|Adverse Event|1|||
143294485|NCT02157298|516627743|FG001|Overall Study|Adverse Event|0|||
143294486|NCT02157298|516627742|FG000|Overall Study|Subject no longer meets study criteria|1|||
143294487|NCT02157298|516627743|FG001|Overall Study|Subject no longer meets study criteria|2|||
143294488|NCT02157298|516627742|FG000|Overall Study|Poor/Non-compliance|1|||
143294489|NCT02157298|516627743|FG001|Overall Study|Poor/Non-compliance|0|||
143294490|NCT02157298|516627742|FG000|Overall Study|Withdrawal by Subject|1|||
143294491|NCT02157298|516627743|FG001|Overall Study|Withdrawal by Subject|0|||
143294492|NCT01722071|516627744|FG000|Overall Study|Protocol Violation|1|||
143294493|NCT01722071|516627745|FG001|Overall Study|Protocol Violation|0|||
143294494|NCT01338493|516627746|FG000|Enrolled|Withdrawal by Subject|1|||
143294495|NCT01338493|516627746|FG000|Enrolled|Patient not implanted|4|||
143294496|NCT01338493|516627746|FG000|Discharge|Death|1|||
143294497|NCT01338493|516627746|FG000|Discharge|Missed visit|1|||
143294498|NCT01338493|516627746|FG000|6 Months Follow up|Lost to Follow-up|11|||
143294499|NCT01338493|516627746|FG000|6 Months Follow up|Missed visit|8|||
143294500|NCT01338493|516627746|FG000|12 Months Follow up|Lost to Follow-up|9|||
143294501|NCT00656474|516627747|FG000|Overall Study|Other Reason|1|||
143294502|NCT02062879|516627748|FG000|Overall Study|Withdrawal by Subject|4|||
143294503|NCT02062879|516627749|FG001|Overall Study|Withdrawal by Subject|1|||
143294504|NCT00353262|516627750|FG000|Overall Study|Adverse Event|8|||
143294505|NCT00353262|516627750|FG000|Overall Study|Withdrawal by Subject|2|||
143294506|NCT00353262|516627750|FG000|Overall Study|Insufficient Therapeutic Response|13|||
143294507|NCT00353262|516627750|FG000|Overall Study|Progression|1|||
143294508|NCT00353262|516627750|FG000|Overall Study|Surgery|4|||
143294509|NCT00353262|516627750|FG000|Overall Study|Break from Chemotherapy|1|||
143294510|NCT05286307|516627751|FG000|Overall Study|Incomplete outcome assessments|2|||
143294511|NCT05286307|516627752|FG001|Overall Study|Incomplete outcome assessments|1|||
143294512|NCT05286307|516627751|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
143294513|NCT05286307|516627752|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
143294514|NCT05286307|516627751|FG000|Overall Study|Lost to follow up at 6 months|25|||
143294515|NCT05286307|516627752|FG001|Overall Study|Lost to follow up at 6 months|35|||
143294516|NCT05286307|516627751|FG000|Overall Study|Study medication not available|1|||
143294517|NCT05286307|516627752|FG001|Overall Study|Study medication not available|1|||
143294518|NCT01103284|516627753|FG000|Overall Study|Death|2|||
143294519|NCT01103284|516627754|FG001|Overall Study|Death|0|||
143294520|NCT01103284|516627753|FG000|Overall Study|Lost to Follow-up|9|||
143294521|NCT01103284|516627754|FG001|Overall Study|Lost to Follow-up|10|||
143294522|NCT01103284|516627753|FG000|Overall Study|Pregnancy|3|||
143294523|NCT01103284|516627754|FG001|Overall Study|Pregnancy|1|||
143294524|NCT01103284|516627753|FG000|Overall Study|Protocol Violation|12|||
143294525|NCT01103284|516627754|FG001|Overall Study|Protocol Violation|5|||
143294526|NCT01103284|516627753|FG000|Overall Study|Adverse Event|0|||
143294527|NCT01103284|516627754|FG001|Overall Study|Adverse Event|5|||
143294528|NCT01103284|516627753|FG000|Overall Study|Withdrawal by Subject|14|||
143294529|NCT01103284|516627754|FG001|Overall Study|Withdrawal by Subject|18|||
143294530|NCT01103284|516627753|FG000|Overall Study|Dermal Hypersensitivity|0|||
143294531|NCT01103284|516627754|FG001|Overall Study|Dermal Hypersensitivity|1|||
143294532|NCT01103284|516627753|FG000|Overall Study|Termination by the Sponsor|0|||
143294533|NCT01103284|516627754|FG001|Overall Study|Termination by the Sponsor|1|||
143294534|NCT01103284|516627753|FG000|Overall Study|Not described|2|||
143294535|NCT01103284|516627754|FG001|Overall Study|Not described|1|||
143294536|NCT01103284|516627753|FG000|Overall Study|Missing CRF entries for study completion|0|||
143294537|NCT01103284|516627754|FG001|Overall Study|Missing CRF entries for study completion|2|||
143294538|NCT00587561|516629060|FG000|Overall Study|Lost to Follow-up|6|||
143294539|NCT00587561|516629061|FG001|Overall Study|Lost to Follow-up|4|||
143294540|NCT03274687|516629062|FG000|Overall Study|Protocol Violation|1|||
143294541|NCT03274687|516629063|FG001|Overall Study|Protocol Violation|1|||
143294542|NCT00623727|516629064|FG000|Double Blind (DB)|Adverse Event|1|||
143294543|NCT00623727|516629065|FG001|Double Blind (DB)|Adverse Event|3|||
143294544|NCT00623727|516629064|FG000|Double Blind (DB)|Physician Decision|0|||
143294545|NCT00623727|516629065|FG001|Double Blind (DB)|Physician Decision|1|||
143294546|NCT00623727|516629064|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
143294547|NCT00623727|516629065|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
143294548|NCT00623727|516629064|FG000|Double Blind (DB)|Lack of Efficacy|2|||
143294549|NCT00623727|516629065|FG001|Double Blind (DB)|Lack of Efficacy|2|||
143294550|NCT00623727|516629064|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
143294551|NCT00623727|516629065|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
143294552|NCT00623727|516629064|FG000|Double Blind (DB)|Lost to Follow-up|1|||
143294553|NCT00623727|516629065|FG001|Double Blind (DB)|Lost to Follow-up|1|||
143294554|NCT00623727|516629064|FG000|Double Blind (DB)|Protocol Violation|2|||
143294555|NCT00623727|516629065|FG001|Double Blind (DB)|Protocol Violation|2|||
143294556|NCT00623727|516629064|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
143294557|NCT00623727|516629065|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
143294558|NCT00623727|516629064|FG000|Open Label Follow-up|Study termination|0|||
143294559|NCT00623727|516629065|FG001|Open Label Follow-up|Study termination|6|||
143294560|NCT00623727|516629064|FG000|Open Label Follow-up|Participant convenience|0|||
143294561|NCT00623727|516629065|FG001|Open Label Follow-up|Participant convenience|1|||
143294562|NCT03745937|516629066|FG000|Overall Study|Withdrawal by Subject|0|||
143294563|NCT03745937|516629067|FG001|Overall Study|Withdrawal by Subject|0|||
143294564|NCT03745937|516629068|FG002|Overall Study|Withdrawal by Subject|0|||
143294565|NCT03745937|516629069|FG003|Overall Study|Withdrawal by Subject|1|||
143294566|NCT03745937|516629066|FG000|Overall Study|Not-specifed|0|||
143294567|NCT03745937|516629067|FG001|Overall Study|Not-specifed|1|||
143294568|NCT03745937|516629068|FG002|Overall Study|Not-specifed|0|||
143294569|NCT03745937|516629069|FG003|Overall Study|Not-specifed|1|||
143294570|NCT00312494|516629071|FG000|Overall Study|Randomized; not treated with study drug|9|||
143294571|NCT00312494|516629072|FG001|Overall Study|Randomized; not treated with study drug|10|||
143373789|NCT00004124|516913575|FG001|Overall Study|Received no protocol therapy|20|||
143373790|NCT02983617|516913578|FG000|Overall Study|Adverse Event|0|||
143373791|NCT02983617|516913579|FG001|Overall Study|Adverse Event|7|||
143373792|NCT02983617|516913578|FG000|Overall Study|Death|0|||
143373793|NCT02983617|516913579|FG001|Overall Study|Death|1|||
143294572|NCT00312494|516629073|FG002|Overall Study|Randomized; not treated with study drug|5|||
143294573|NCT00312494|516629071|FG000|Overall Study|Adverse Event|33|||
143294574|NCT00312494|516629072|FG001|Overall Study|Adverse Event|15|||
143294575|NCT00312494|516629073|FG002|Overall Study|Adverse Event|11|||
143294576|NCT00312494|516629071|FG000|Overall Study|Lack of Efficacy|4|||
143294577|NCT00312494|516629072|FG001|Overall Study|Lack of Efficacy|6|||
143294578|NCT00312494|516629073|FG002|Overall Study|Lack of Efficacy|8|||
143294579|NCT00312494|516629071|FG000|Overall Study|Laboratory abnormality|1|||
143294580|NCT00312494|516629072|FG001|Overall Study|Laboratory abnormality|0|||
143294581|NCT00312494|516629073|FG002|Overall Study|Laboratory abnormality|0|||
143294582|NCT00312494|516629071|FG000|Overall Study|Lost to Follow-up|8|||
143294583|NCT00312494|516629072|FG001|Overall Study|Lost to Follow-up|8|||
143294584|NCT00312494|516629073|FG002|Overall Study|Lost to Follow-up|8|||
143294585|NCT00312494|516629071|FG000|Overall Study|Withdrawal by Subject|6|||
143294586|NCT00312494|516629072|FG001|Overall Study|Withdrawal by Subject|9|||
143294587|NCT00312494|516629073|FG002|Overall Study|Withdrawal by Subject|10|||
143294588|NCT00312494|516629071|FG000|Overall Study|Other|10|||
143294589|NCT00312494|516629072|FG001|Overall Study|Other|10|||
143294590|NCT00312494|516629073|FG002|Overall Study|Other|1|||
143294591|NCT00501293|516629074|FG000|Optimization Period|Enrolled in error|1|||
143294592|NCT00501293|516629075|FG001|Optimization Period|Enrolled in error|0|||
143294593|NCT00501293|516629074|FG000|Maintenance Period|Withdrawal by Subject|14|||
143294594|NCT00501293|516629075|FG001|Maintenance Period|Withdrawal by Subject|13|||
143294595|NCT00501293|516629074|FG000|Maintenance Period|Lost to Follow-up|12|||
143294596|NCT00501293|516629075|FG001|Maintenance Period|Lost to Follow-up|7|||
143294597|NCT00501293|516629074|FG000|Maintenance Period|Adverse Event|6|||
143294598|NCT00501293|516629075|FG001|Maintenance Period|Adverse Event|6|||
143294599|NCT00501293|516629074|FG000|Maintenance Period|Protocol Violation|2|||
143294600|NCT00501293|516629075|FG001|Maintenance Period|Protocol Violation|1|||
143294601|NCT00501293|516629074|FG000|Maintenance Period|Lack of Efficacy|4|||
143294602|NCT00501293|516629075|FG001|Maintenance Period|Lack of Efficacy|1|||
143294603|NCT00501293|516629074|FG000|Maintenance Period|Noncompliant with study medication|5|||
143294604|NCT00501293|516629075|FG001|Maintenance Period|Noncompliant with study medication|0|||
143294605|NCT00501293|516629074|FG000|Maintenance Period|Went into rehabilitation|1|||
143294606|NCT00501293|516629075|FG001|Maintenance Period|Went into rehabilitation|0|||
143294607|NCT00501293|516629074|FG000|Maintenance Period|Would not wear patch|1|||
143294608|NCT00501293|516629075|FG001|Maintenance Period|Would not wear patch|0|||
143294609|NCT00501293|516629074|FG000|Maintenance Period|Application site reaction|1|||
143294610|NCT00501293|516629075|FG001|Maintenance Period|Application site reaction|0|||
143294611|NCT02642614|516629078|FG000|Overall Study|Adverse Event|1|||
143294612|NCT02642614|516629079|FG001|Overall Study|Adverse Event|1|||
143294613|NCT02642614|516629080|FG002|Overall Study|Adverse Event|2|||
143294614|NCT02642614|516629081|FG003|Overall Study|Adverse Event|2|||
143373794|NCT02983617|516913578|FG000|Overall Study|Investigator's Discretion|0|||
143294615|NCT02642614|516629078|FG000|Overall Study|Lost to Follow-up|1|||
143294616|NCT02642614|516629079|FG001|Overall Study|Lost to Follow-up|0|||
143294617|NCT02642614|516629080|FG002|Overall Study|Lost to Follow-up|0|||
143294618|NCT02642614|516629081|FG003|Overall Study|Lost to Follow-up|0|||
143294619|NCT02642614|516629078|FG000|Overall Study|Withdrawal by Subject|1|||
143294620|NCT02642614|516629079|FG001|Overall Study|Withdrawal by Subject|1|||
143294621|NCT02642614|516629080|FG002|Overall Study|Withdrawal by Subject|0|||
143294622|NCT02642614|516629081|FG003|Overall Study|Withdrawal by Subject|0|||
143294623|NCT03182829|516629082|FG000|Overall Study|Protocol Violation|12|||
143294624|NCT03182829|516629083|FG001|Overall Study|Protocol Violation|12|||
143294625|NCT03182829|516629082|FG000|Overall Study|Other|4|||
143294626|NCT03182829|516629083|FG001|Overall Study|Other|3|||
143294627|NCT03316131|516629084|FG000|Treatment Period 2|Protocol deviation|1|||
143294628|NCT03316131|516629085|FG001|Treatment Period 2|Protocol deviation|0|||
143294629|NCT02057198|516629089|FG000|Overall Study|Death|0|||
143294630|NCT02057198|516629090|FG001|Overall Study|Death|0|||
143294631|NCT02057198|516629091|FG002|Overall Study|Death|1|||
143294632|NCT02057198|516629089|FG000|Overall Study|Discharged early; lost to followup|0|||
143294633|NCT02057198|516629090|FG001|Overall Study|Discharged early; lost to followup|1|||
143294634|NCT02057198|516629091|FG002|Overall Study|Discharged early; lost to followup|0|||
143294635|NCT02345811|516629093|FG000|First Intervention|Withdrawal by Subject|1|||
143294636|NCT02345811|516629094|FG001|First Intervention|Withdrawal by Subject|1|||
143294637|NCT02522286|516629095|FG000|Overall Study|Withdrawal by Subject|3|||
143294638|NCT02522286|516629096|FG001|Overall Study|Withdrawal by Subject|0|||
143294639|NCT02522286|516629097|FG002|Overall Study|Withdrawal by Subject|0|||
143294640|NCT02522286|516629098|FG003|Overall Study|Withdrawal by Subject|3|||
143294641|NCT02489344|516629100|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
143294642|NCT02489344|516629100|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
143294643|NCT02489344|516629100|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
143294644|NCT02489344|516629100|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
143294645|NCT00605813|516629101|FG000|Overall Study|Protocol Violation|25|||
143294646|NCT01172847|516629104|FG000|Overall Study|Withdrawal by Subject|3|||
143294647|NCT00174915|516629107|FG000|Overall Study|Lost to Follow-up|19|||
143294648|NCT00174915|516629108|FG001|Overall Study|Lost to Follow-up|17|||
143294649|NCT00174915|516629109|FG002|Overall Study|Lost to Follow-up|9|||
143294650|NCT00174915|516629110|FG003|Overall Study|Lost to Follow-up|17|||
143294651|NCT00174915|516629111|FG004|Overall Study|Lost to Follow-up|10|||
143294652|NCT00174915|516629107|FG000|Overall Study|Adverse Event|18|||
143294653|NCT00174915|516629108|FG001|Overall Study|Adverse Event|16|||
143294654|NCT00174915|516629109|FG002|Overall Study|Adverse Event|11|||
143294655|NCT00174915|516629110|FG003|Overall Study|Adverse Event|18|||
143294656|NCT00174915|516629111|FG004|Overall Study|Adverse Event|5|||
143294657|NCT00174915|516629107|FG000|Overall Study|Personal Reason(s)|16|||
143294658|NCT00174915|516629108|FG001|Overall Study|Personal Reason(s)|16|||
143294659|NCT00174915|516629109|FG002|Overall Study|Personal Reason(s)|9|||
143294660|NCT00174915|516629110|FG003|Overall Study|Personal Reason(s)|9|||
143294661|NCT00174915|516629111|FG004|Overall Study|Personal Reason(s)|9|||
143294662|NCT00174915|516629107|FG000|Overall Study|Other|15|||
143294663|NCT00174915|516629108|FG001|Overall Study|Other|8|||
143294664|NCT00174915|516629109|FG002|Overall Study|Other|6|||
143294665|NCT00174915|516629110|FG003|Overall Study|Other|5|||
143294666|NCT00174915|516629111|FG004|Overall Study|Other|3|||
143294667|NCT00174915|516629107|FG000|Overall Study|Gout Flare|13|||
143294668|NCT00174915|516629108|FG001|Overall Study|Gout Flare|6|||
143294669|NCT00174915|516629109|FG002|Overall Study|Gout Flare|8|||
143294670|NCT00174915|516629110|FG003|Overall Study|Gout Flare|1|||
143294671|NCT00174915|516629111|FG004|Overall Study|Gout Flare|0|||
143294672|NCT00174915|516629107|FG000|Overall Study|Protocol Violation|6|||
143294673|NCT00174915|516629108|FG001|Overall Study|Protocol Violation|3|||
143294674|NCT00174915|516629109|FG002|Overall Study|Protocol Violation|3|||
143294675|NCT00174915|516629110|FG003|Overall Study|Protocol Violation|6|||
143294676|NCT00174915|516629111|FG004|Overall Study|Protocol Violation|3|||
143294677|NCT00174915|516629107|FG000|Overall Study|Therapeutic Failure|6|||
143294678|NCT00174915|516629108|FG001|Overall Study|Therapeutic Failure|3|||
143294679|NCT00174915|516629109|FG002|Overall Study|Therapeutic Failure|2|||
143294680|NCT00174915|516629110|FG003|Overall Study|Therapeutic Failure|1|||
143294681|NCT00174915|516629111|FG004|Overall Study|Therapeutic Failure|3|||
143294682|NCT03060447|516629116|FG000|Overall Study|Withdrawal by Subject|2|||
143294683|NCT03060447|516629117|FG001|Overall Study|Withdrawal by Subject|0|||
143294684|NCT00573755|516629118|FG000|Overall Study|Still receiving treatment|1|||
143294685|NCT00573755|516629119|FG001|Overall Study|Still receiving treatment|0|||
143294686|NCT01870583|516629120|FG000|Overall Study|Protocol Violation|0|||
143294687|NCT01870583|516629121|FG001|Overall Study|Protocol Violation|5|||
143294688|NCT01870583|516629122|FG002|Overall Study|Protocol Violation|3|||
143294689|NCT01870583|516629120|FG000|Overall Study|Lost to Follow-up|11|||
143294690|NCT01870583|516629121|FG001|Overall Study|Lost to Follow-up|13|||
143294691|NCT01870583|516629122|FG002|Overall Study|Lost to Follow-up|5|||
143294692|NCT00778700|516629129|FG000|Overall Study|Adverse Event|6|||
143294693|NCT00778700|516629130|FG001|Overall Study|Adverse Event|1|||
143294694|NCT00778700|516629131|FG002|Overall Study|Adverse Event|3|||
143294695|NCT00778700|516629132|FG003|Overall Study|Adverse Event|5|||
143294696|NCT00778700|516629129|FG000|Overall Study|Protocol Violation|1|||
143294697|NCT00778700|516629130|FG001|Overall Study|Protocol Violation|1|||
143294698|NCT00778700|516629131|FG002|Overall Study|Protocol Violation|0|||
143294699|NCT00778700|516629132|FG003|Overall Study|Protocol Violation|0|||
143294700|NCT00778700|516629129|FG000|Overall Study|Subject Withdrew Consent|6|||
143294701|NCT00778700|516629130|FG001|Overall Study|Subject Withdrew Consent|4|||
143294702|NCT00778700|516629131|FG002|Overall Study|Subject Withdrew Consent|1|||
143294703|NCT00778700|516629132|FG003|Overall Study|Subject Withdrew Consent|4|||
143294704|NCT00778700|516629129|FG000|Overall Study|Lost to Follow-up|3|||
143294705|NCT00778700|516629130|FG001|Overall Study|Lost to Follow-up|1|||
143294706|NCT00778700|516629131|FG002|Overall Study|Lost to Follow-up|0|||
143294707|NCT00778700|516629132|FG003|Overall Study|Lost to Follow-up|1|||
143294708|NCT00778700|516629129|FG000|Overall Study|Reason not Specified|2|||
143294709|NCT00778700|516629130|FG001|Overall Study|Reason not Specified|0|||
143294710|NCT00778700|516629131|FG002|Overall Study|Reason not Specified|1|||
143294711|NCT00778700|516629132|FG003|Overall Study|Reason not Specified|3|||
143294712|NCT00778700|516629129|FG000|Overall Study|Other|0|||
143294713|NCT00778700|516629130|FG001|Overall Study|Other|0|||
143294714|NCT00778700|516629131|FG002|Overall Study|Other|1|||
143294715|NCT00778700|516629132|FG003|Overall Study|Other|0|||
143294716|NCT03914326|516629133|FG000|Overall Study|Withdrawal by Subject|27|||
143294717|NCT03914326|516629134|FG001|Overall Study|Withdrawal by Subject|34|||
143294718|NCT03914326|516629133|FG000|Overall Study|Lost to Follow-up|43|||
143294719|NCT03914326|516629134|FG001|Overall Study|Lost to Follow-up|51|||
143294720|NCT03914326|516629133|FG000|Overall Study|Randomised more than once|0|||
143294721|NCT03914326|516629134|FG001|Overall Study|Randomised more than once|1|||
143294722|NCT00546637|516629135|FG000|Overall Study|Adverse Event|46|||
143294723|NCT00546637|516629136|FG001|Overall Study|Adverse Event|20|||
143294724|NCT00546637|516629135|FG000|Overall Study|Lack of Efficacy|5|||
143294725|NCT00546637|516629136|FG001|Overall Study|Lack of Efficacy|5|||
143294726|NCT00546637|516629135|FG000|Overall Study|Lost to Follow-up|2|||
143294727|NCT00546637|516629136|FG001|Overall Study|Lost to Follow-up|2|||
143294728|NCT00546637|516629135|FG000|Overall Study|Other|10|||
143294729|NCT00546637|516629136|FG001|Overall Study|Other|12|||
143294730|NCT00546637|516629135|FG000|Overall Study|Withdrawal by Subject|7|||
143294731|NCT00546637|516629136|FG001|Overall Study|Withdrawal by Subject|9|||
143294732|NCT00546637|516629135|FG000|Overall Study|Randomized, but not treated|3|||
143294733|NCT00546637|516629136|FG001|Overall Study|Randomized, but not treated|1|||
143294734|NCT03274440|516629137|FG000|Overall Study|Time commitment too great|1|||
143294735|NCT03274440|516629138|FG001|Overall Study|Time commitment too great|0|||
143294736|NCT03274440|516629139|FG002|Overall Study|Time commitment too great|0|||
143294737|NCT03274440|516629140|FG003|Overall Study|Time commitment too great|1|||
143294738|NCT03274440|516629141|FG004|Overall Study|Time commitment too great|0|||
143294739|NCT03274440|516629142|FG005|Overall Study|Time commitment too great|0|||
143294740|NCT00450450|516629143|FG000|Overall Study|Death|1|||
143294741|NCT00450450|516629144|FG001|Overall Study|Death|3|||
143294742|NCT00450450|516629143|FG000|Overall Study|Relapse|2|||
143294743|NCT00450450|516629144|FG001|Overall Study|Relapse|0|||
143294744|NCT00450450|516629143|FG000|Overall Study|Missing Data|2|||
143294745|NCT00450450|516629144|FG001|Overall Study|Missing Data|0|||
143294746|NCT04267133|516629145|FG000|Overall Study|Withdrawal by Subject|1|||
143294747|NCT04267133|516629145|FG000|Overall Study|Adverse Event|4|||
143294748|NCT02369341|516629146|FG000|Overall Study|Migrated/moved from study area|1|||
143294749|NCT02369341|516629147|FG001|Overall Study|Migrated/moved from study area|0|||
143294750|NCT00674661|516629149|FG000|Overall Study|Other|5|||
143294751|NCT00674661|516629150|FG001|Overall Study|Other|7|||
143294752|NCT00674661|516629149|FG000|Overall Study|Lost to Follow-up|6|||
143294753|NCT00674661|516629150|FG001|Overall Study|Lost to Follow-up|3|||
143294754|NCT00674661|516629149|FG000|Overall Study|Withdrawal by Subject|0|||
143294755|NCT00674661|516629150|FG001|Overall Study|Withdrawal by Subject|5|||
143294756|NCT00003901|516629151|FG000|Overall Study|Adverse Event|1|||
143294757|NCT00003901|516629151|FG000|Overall Study|Withdrawal by Subject|1|||
143294758|NCT00003901|516629151|FG000|Overall Study|Ineligible|6|||
143294759|NCT00003901|516629151|FG000|Overall Study|CT Scan not within protocol requirement|2|||
143294760|NCT00003901|516629151|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
143294761|NCT00003901|516629151|FG000|Overall Study|Medical problems|6|||
143373795|NCT02983617|516913579|FG001|Overall Study|Investigator's Discretion|1|||
143373796|NCT02027558|516913582|FG000|Overall Study|Death|0|||
143373797|NCT02027558|516913583|FG001|Overall Study|Death|1|||
143373798|NCT02027558|516913582|FG000|Overall Study|Withdrawal by Subject|2|||
143373799|NCT02027558|516913583|FG001|Overall Study|Withdrawal by Subject|0|||
143373800|NCT02027558|516913582|FG000|Overall Study|Lost to Follow-up|4|||
143373801|NCT02027558|516913583|FG001|Overall Study|Lost to Follow-up|1|||
143373802|NCT02027558|516913582|FG000|Overall Study|Refused assessment|3|||
143373803|NCT02027558|516913583|FG001|Overall Study|Refused assessment|0|||
143373804|NCT02698891|516913588|FG000|Overall Study|Withdrawal by Subject|2|||
143373805|NCT02698891|516913588|FG000|Overall Study|deemed ineligible|1|||
143373806|NCT02698891|516913588|FG000|Overall Study|Adverse Event|9|||
143373807|NCT00516386|516913589|FG000|Overall Study|not interested in the study|4|||
143373808|NCT00516386|516913589|FG000|Overall Study|Lost to Follow-up|2|||
143373809|NCT00114244|516913590|FG000|Overall Study|Adverse Event|2|||
143373810|NCT00114244|516913591|FG001|Overall Study|Adverse Event|5|||
143373811|NCT00114244|516913590|FG000|Overall Study|Withdrawal by Subject|0|||
143373812|NCT00114244|516913591|FG001|Overall Study|Withdrawal by Subject|2|||
143373813|NCT00711958|516913592|FG000|Overall Study|Withdrawal by Subject|6|||
143373814|NCT00711958|516913593|FG001|Overall Study|Withdrawal by Subject|8|||
143373815|NCT00711958|516913592|FG000|Overall Study|Lack of Efficacy|3|||
143373816|NCT00711958|516913593|FG001|Overall Study|Lack of Efficacy|1|||
143373817|NCT00711958|516913592|FG000|Overall Study|Clinical deterioration|1|||
143373818|NCT00711958|516913593|FG001|Overall Study|Clinical deterioration|0|||
143373819|NCT00711958|516913592|FG000|Overall Study|Adverse Event|9|||
143373820|NCT00711958|516913593|FG001|Overall Study|Adverse Event|7|||
143373821|NCT00711958|516913592|FG000|Overall Study|Protocol Violation|1|||
143373822|NCT00711958|516913593|FG001|Overall Study|Protocol Violation|0|||
143294762|NCT02707991|516629152|FG000|Overall Study|Protocol Violation|1|||
143294763|NCT02707991|516629153|FG001|Overall Study|Protocol Violation|0|||
143294764|NCT02707991|516629152|FG000|Overall Study|Became ineligible|0|||
143294765|NCT02707991|516629153|FG001|Overall Study|Became ineligible|1|||
143294766|NCT02268864|516629154|FG000|Overall Study|Withdrawal by Subject|2|||
143294767|NCT02268864|516629155|FG001|Overall Study|Withdrawal by Subject|0|||
143294768|NCT02268864|516629156|FG002|Overall Study|Withdrawal by Subject|0|||
143294769|NCT02268864|516629154|FG000|Overall Study|Death|0|||
143294770|NCT02268864|516629155|FG001|Overall Study|Death|1|||
143294771|NCT02268864|516629156|FG002|Overall Study|Death|0|||
143294772|NCT00857220|516629157|FG000|Overall Study|Adverse Event|35|||
143294773|NCT00857220|516629157|FG000|Overall Study|Death|1|||
143294774|NCT00857220|516629157|FG000|Overall Study|Lack of Efficacy|11|||
143294775|NCT00857220|516629157|FG000|Overall Study|Lost to Follow-up|30|||
143373823|NCT00711958|516913592|FG000|Overall Study|Lost to Follow-up|2|||
143294776|NCT00857220|516629157|FG000|Overall Study|Physician Decision|4|||
143294777|NCT00857220|516629157|FG000|Overall Study|Protocol Violation|16|||
143373824|NCT00711958|516913593|FG001|Overall Study|Lost to Follow-up|2|||
143373825|NCT00711958|516913592|FG000|Overall Study|Death|10|||
143373826|NCT00711958|516913593|FG001|Overall Study|Death|5|||
143373827|NCT00711958|516913592|FG000|Overall Study|Progression of disease|1|||
143373828|NCT00711958|516913593|FG001|Overall Study|Progression of disease|0|||
143373829|NCT01111526|516913594|FG000|Overall Study|GVHD Disease Progression|0|||
143373830|NCT01111526|516913595|FG001|Overall Study|GVHD Disease Progression|1|||
143294778|NCT00857220|516629157|FG000|Overall Study|Withdrawal by Subject|67|||
143294779|NCT00857220|516629157|FG000|Overall Study|Clinical Hold|6|||
143294780|NCT00857220|516629157|FG000|Overall Study|Site Closed|5|||
143294781|NCT00857220|516629157|FG000|Overall Study|Miscellaneous|8|||
143294782|NCT03187262|516629158|FG000|Induction|Lack of Efficacy|2|||
143294783|NCT03187262|516629158|FG000|Induction|Progressive Disease|4|||
143294784|NCT03187262|516629158|FG000|Consolidation|Progressive Disease|5|||
143294785|NCT01496313|516629159|FG000|Randomized Period (up to 14 Months)|Adverse Event|1|||
143294786|NCT01496313|516629160|FG001|Randomized Period (up to 14 Months)|Adverse Event|5|||
143294787|NCT01496313|516629161|FG002|Randomized Period (up to 14 Months)|Adverse Event|0|||
143294788|NCT01496313|516629162|FG003|Randomized Period (up to 14 Months)|Adverse Event|0|||
143294789|NCT01496313|516629163|FG004|Randomized Period (up to 14 Months)|Adverse Event|0|||
143294790|NCT01496313|516629164|FG005|Randomized Period (up to 14 Months)|Adverse Event|0|||
143294791|NCT01496313|516629159|FG000|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|2|||
143294792|NCT01496313|516629160|FG001|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|3|||
143294793|NCT01496313|516629161|FG002|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
143294794|NCT01496313|516629162|FG003|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
143294795|NCT01496313|516629163|FG004|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
143294796|NCT01496313|516629164|FG005|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
143294797|NCT01496313|516629159|FG000|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
143294798|NCT01496313|516629160|FG001|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|2|||
143294799|NCT01496313|516629161|FG002|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
143294800|NCT01496313|516629162|FG003|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
143294801|NCT01496313|516629163|FG004|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
143294802|NCT01496313|516629164|FG005|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
143294803|NCT01496313|516629159|FG000|Randomized Period (up to 14 Months)|Participant Decision|1|||
143294804|NCT01496313|516629160|FG001|Randomized Period (up to 14 Months)|Participant Decision|3|||
143294805|NCT01496313|516629161|FG002|Randomized Period (up to 14 Months)|Participant Decision|0|||
143294806|NCT01496313|516629162|FG003|Randomized Period (up to 14 Months)|Participant Decision|0|||
143294807|NCT01496313|516629163|FG004|Randomized Period (up to 14 Months)|Participant Decision|0|||
143294808|NCT01496313|516629164|FG005|Randomized Period (up to 14 Months)|Participant Decision|0|||
143294809|NCT01496313|516629159|FG000|Randomized Period (up to 14 Months)|Other|1|||
143294810|NCT01496313|516629160|FG001|Randomized Period (up to 14 Months)|Other|2|||
143294811|NCT01496313|516629161|FG002|Randomized Period (up to 14 Months)|Other|0|||
143294812|NCT01496313|516629162|FG003|Randomized Period (up to 14 Months)|Other|0|||
143294813|NCT01496313|516629163|FG004|Randomized Period (up to 14 Months)|Other|0|||
143294814|NCT01496313|516629164|FG005|Randomized Period (up to 14 Months)|Other|0|||
143294815|NCT01496313|516629159|FG000|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
143294816|NCT01496313|516629160|FG001|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
143294817|NCT01496313|516629161|FG002|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
143294818|NCT01496313|516629162|FG003|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
143294819|NCT01496313|516629163|FG004|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
143294820|NCT01496313|516629164|FG005|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|1|||
143294821|NCT01496313|516629159|FG000|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
143294822|NCT01496313|516629160|FG001|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
143294823|NCT01496313|516629161|FG002|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
143294824|NCT01496313|516629162|FG003|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
143294825|NCT01496313|516629163|FG004|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
143294826|NCT01496313|516629164|FG005|Open-Label Period (Month 14 to 2 Years)|Participant Decision|3|||
143294827|NCT01496313|516629159|FG000|Open-Label Period (Month 14 to 2 Years)|Other|0|||
143294828|NCT01496313|516629160|FG001|Open-Label Period (Month 14 to 2 Years)|Other|0|||
143294829|NCT01496313|516629161|FG002|Open-Label Period (Month 14 to 2 Years)|Other|2|||
143294830|NCT01496313|516629162|FG003|Open-Label Period (Month 14 to 2 Years)|Other|2|||
143294831|NCT01496313|516629163|FG004|Open-Label Period (Month 14 to 2 Years)|Other|1|||
143294832|NCT01496313|516629164|FG005|Open-Label Period (Month 14 to 2 Years)|Other|7|||
143294833|NCT00597766|516629170|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
143294834|NCT00597766|516629171|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
143294835|NCT00597766|516629172|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
143294836|NCT00597766|516629170|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
143294837|NCT00597766|516629171|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
143294838|NCT00597766|516629172|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
143294839|NCT03045887|516630938|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
143294840|NCT03045887|516630939|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
143294841|NCT03045887|516630940|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
143294842|NCT03045887|516630941|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
143294843|NCT03045887|516630942|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
143294844|NCT03045887|516630943|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
143294845|NCT03045887|516630944|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
143294846|NCT03045887|516630945|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
143294847|NCT03045887|516630946|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
143294848|NCT03045887|516630947|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
143294849|NCT03045887|516630938|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
143294850|NCT03045887|516630939|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
143294851|NCT03045887|516630940|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
143294852|NCT03045887|516630941|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
143294853|NCT03045887|516630942|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
143294854|NCT03045887|516630943|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
143294855|NCT03045887|516630944|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
143294856|NCT03045887|516630945|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
143294857|NCT03045887|516630946|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
143294858|NCT03045887|516630947|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
143294859|NCT03045887|516630938|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
143294860|NCT03045887|516630939|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
143294861|NCT03045887|516630940|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
143294862|NCT03045887|516630941|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
143294863|NCT03045887|516630942|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
143294864|NCT03045887|516630943|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
143294865|NCT03045887|516630944|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
143294866|NCT03045887|516630945|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
143294867|NCT03045887|516630946|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
143294868|NCT03045887|516630947|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
143294869|NCT03045887|516630938|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
143294870|NCT03045887|516630939|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
143294871|NCT03045887|516630940|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
143294872|NCT03045887|516630941|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
143294873|NCT03045887|516630942|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
143294874|NCT03045887|516630943|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
143294875|NCT03045887|516630944|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
143294876|NCT03045887|516630945|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
143294877|NCT03045887|516630946|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
143294878|NCT03045887|516630947|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
143294879|NCT03045887|516630938|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
143294880|NCT03045887|516630939|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
143294881|NCT03045887|516630940|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
143294882|NCT03045887|516630941|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
143294883|NCT03045887|516630942|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
143294884|NCT03045887|516630943|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
143294885|NCT03045887|516630944|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
143294886|NCT03045887|516630945|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
143294887|NCT03045887|516630946|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
143294888|NCT03045887|516630947|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
143294889|NCT03227029|516630948|FG000|Overall Study|Child Wheezed (no treatment)|0|||
143294890|NCT03227029|516630949|FG001|Overall Study|Child Wheezed (no treatment)|1|||
143294891|NCT03227029|516630950|FG002|Overall Study|Child Wheezed (no treatment)|0|||
143294892|NCT03227029|516630948|FG000|Overall Study|No post RSV season visit due to COVID|3|||
143294893|NCT03227029|516630949|FG001|Overall Study|No post RSV season visit due to COVID|3|||
143294894|NCT03227029|516630950|FG002|Overall Study|No post RSV season visit due to COVID|2|||
143294895|NCT03227029|516630948|FG000|Overall Study|Not able to get to clinic|0|||
143294896|NCT03227029|516630949|FG001|Overall Study|Not able to get to clinic|0|||
143294897|NCT03227029|516630950|FG002|Overall Study|Not able to get to clinic|1|||
143294898|NCT03227029|516630948|FG000|Overall Study|Withdrawal by Subject|1|||
143294899|NCT03227029|516630949|FG001|Overall Study|Withdrawal by Subject|0|||
143294900|NCT03227029|516630950|FG002|Overall Study|Withdrawal by Subject|0|||
143294901|NCT03227029|516630948|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
143294902|NCT03227029|516630949|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
143294903|NCT03227029|516630950|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
143294904|NCT01291173|516630951|FG000|Overall Study|Adverse Event|0|||
143294905|NCT01291173|516630952|FG001|Overall Study|Adverse Event|3|||
143294906|NCT01291173|516630953|FG002|Overall Study|Adverse Event|1|||
143294907|NCT01291173|516630954|FG003|Overall Study|Adverse Event|3|||
143294908|NCT01291173|516630951|FG000|Overall Study|Protocol Violation|7|||
143294909|NCT01291173|516630952|FG001|Overall Study|Protocol Violation|2|||
143294910|NCT01291173|516630953|FG002|Overall Study|Protocol Violation|2|||
143294911|NCT01291173|516630954|FG003|Overall Study|Protocol Violation|5|||
143294912|NCT01291173|516630951|FG000|Overall Study|Withdrawal by Subject|6|||
143294913|NCT01291173|516630952|FG001|Overall Study|Withdrawal by Subject|4|||
143294914|NCT01291173|516630953|FG002|Overall Study|Withdrawal by Subject|4|||
143294915|NCT01291173|516630954|FG003|Overall Study|Withdrawal by Subject|2|||
143294916|NCT01291173|516630951|FG000|Overall Study|Lost to Follow-up|4|||
143294917|NCT01291173|516630952|FG001|Overall Study|Lost to Follow-up|6|||
143294918|NCT01291173|516630953|FG002|Overall Study|Lost to Follow-up|3|||
143294919|NCT01291173|516630954|FG003|Overall Study|Lost to Follow-up|2|||
143294920|NCT01291173|516630951|FG000|Overall Study|Unable to meet visit schedule|0|||
143294921|NCT01291173|516630952|FG001|Overall Study|Unable to meet visit schedule|0|||
143294922|NCT01291173|516630953|FG002|Overall Study|Unable to meet visit schedule|1|||
143294923|NCT01291173|516630954|FG003|Overall Study|Unable to meet visit schedule|0|||
143294924|NCT01291173|516630951|FG000|Overall Study|Lack of compliance|0|||
143294925|NCT01291173|516630952|FG001|Overall Study|Lack of compliance|0|||
143294926|NCT01291173|516630953|FG002|Overall Study|Lack of compliance|0|||
143294927|NCT01291173|516630954|FG003|Overall Study|Lack of compliance|1|||
143294928|NCT01291173|516630951|FG000|Overall Study|Subject was unblinded|0|||
143294929|NCT01291173|516630952|FG001|Overall Study|Subject was unblinded|0|||
143294930|NCT01291173|516630953|FG002|Overall Study|Subject was unblinded|1|||
143294931|NCT01291173|516630954|FG003|Overall Study|Subject was unblinded|0|||
143294932|NCT01291173|516630951|FG000|Overall Study|Excluded therapy|0|||
143294933|NCT01291173|516630952|FG001|Overall Study|Excluded therapy|0|||
143294934|NCT01291173|516630953|FG002|Overall Study|Excluded therapy|1|||
143294935|NCT01291173|516630954|FG003|Overall Study|Excluded therapy|0|||
143294936|NCT00390858|516630955|FG000|Overall Study|Adverse Event|6|||
143294937|NCT00390858|516630956|FG001|Overall Study|Adverse Event|2|||
143294938|NCT00390858|516630955|FG000|Overall Study|Lack of Efficacy|0|||
143294939|NCT00390858|516630956|FG001|Overall Study|Lack of Efficacy|1|||
143294940|NCT00390858|516630955|FG000|Overall Study|Withdrawal by Subject|3|||
143294941|NCT00390858|516630956|FG001|Overall Study|Withdrawal by Subject|4|||
143294942|NCT04984993|516630957|FG000|Overall Study|Withdrawal by Subject|8|||
143294943|NCT04984993|516630958|FG001|Overall Study|Withdrawal by Subject|2|||
143294944|NCT04984993|516630957|FG000|Overall Study|Lost to Follow-up|2|||
143294945|NCT04984993|516630958|FG001|Overall Study|Lost to Follow-up|2|||
143294946|NCT04984993|516630957|FG000|Overall Study|Both patients moved to another country|4|||
143294947|NCT04984993|516630958|FG001|Overall Study|Both patients moved to another country|0|||
143294948|NCT02024867|516630961|FG000|Overall Study|Protocol Violation|3|||
143294949|NCT02024867|516630962|FG001|Overall Study|Protocol Violation|3|||
143294950|NCT02024867|516630961|FG000|Overall Study|Lost to Follow-up|6|||
143294951|NCT02024867|516630962|FG001|Overall Study|Lost to Follow-up|4|||
143294952|NCT02865187|516630963|FG000|Overall Study|Lost to Follow-up|12|||
143294953|NCT02865187|516630964|FG001|Overall Study|Lost to Follow-up|7|||
143294954|NCT02865187|516630963|FG000|Overall Study|Adverse Event|1|||
143294955|NCT02865187|516630964|FG001|Overall Study|Adverse Event|0|||
143294956|NCT01110707|516630965|FG000|Overall Study|Protocol Violation|0|||
143294957|NCT01110707|516630966|FG001|Overall Study|Protocol Violation|3|||
143294958|NCT03698994|516630968|FG000|Overall Study|Adverse Event|2|||
143294959|NCT03698994|516630968|FG000|Overall Study|Death|1|||
143294960|NCT03698994|516630968|FG000|Overall Study|Physician Decision|1|||
143294961|NCT03698994|516630968|FG000|Overall Study|Withdrawal by Subject|3|||
143294962|NCT03698994|516630968|FG000|Overall Study|Progressive Disease|12|||
143294963|NCT02612428|516630969|FG000|VTL-308|Death|14|||
143294964|NCT02612428|516630970|FG001|VTL-308|Death|16|||
143294965|NCT02612428|516630969|FG000|VTL-308|Withdrawal by Subject|0|||
143294966|NCT02612428|516630970|FG001|VTL-308|Withdrawal by Subject|1|||
143294967|NCT02612428|516630969|FG000|VTL-308E|Death|9|||
143294968|NCT02612428|516630970|FG001|VTL-308E|Death|7|||
143294969|NCT02612428|516630969|FG000|VTL-308E|Lost to Follow-up|2|||
143294970|NCT02612428|516630970|FG001|VTL-308E|Lost to Follow-up|0|||
143294971|NCT00742001|516630971|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
143294972|NCT00742001|516630972|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
143294973|NCT00742001|516630973|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
143294974|NCT00137423|516630974|FG000|Overall Study|Adverse Event|7|||
143294975|NCT00137423|516630975|FG001|Overall Study|Adverse Event|9|||
143294976|NCT00137423|516630974|FG000|Overall Study|consent withdrawn|1|||
143294977|NCT00137423|516630975|FG001|Overall Study|consent withdrawn|1|||
143294978|NCT00137423|516630974|FG000|Overall Study|Lack of Efficacy|31|||
143294979|NCT00137423|516630975|FG001|Overall Study|Lack of Efficacy|33|||
143294980|NCT00137423|516630974|FG000|Overall Study|Death|0|||
143294981|NCT00137423|516630975|FG001|Overall Study|Death|1|||
143294982|NCT02604212|516630977|FG000|Overall Study|Study Terminated by Sponsor|2|||
143294983|NCT02604212|516630978|FG001|Overall Study|Study Terminated by Sponsor|1|||
143294984|NCT02604212|516630979|FG002|Overall Study|Study Terminated by Sponsor|3|||
143294985|NCT02604212|516630980|FG003|Overall Study|Study Terminated by Sponsor|3|||
143294986|NCT02604212|516630977|FG000|Overall Study|Withdrawal by Subject|0|||
143294987|NCT02604212|516630978|FG001|Overall Study|Withdrawal by Subject|0|||
143294988|NCT02604212|516630979|FG002|Overall Study|Withdrawal by Subject|1|||
143294989|NCT02604212|516630980|FG003|Overall Study|Withdrawal by Subject|0|||
143294990|NCT02580357|516630981|FG000|Overall Study|Lost to Follow-up|2|||
143373831|NCT01111526|516913596|FG002|Overall Study|GVHD Disease Progression|2|||
143373832|NCT04424641|516913599|FG000|Overall Study|Death|1|||
143373833|NCT04424641|516913600|FG001|Overall Study|Death|2|||
143373834|NCT04424641|516913601|FG002|Overall Study|Death|3|||
143373835|NCT04424641|516913602|FG003|Overall Study|Death|0|||
143373836|NCT04424641|516913603|FG004|Overall Study|Death|3|||
143373837|NCT04424641|516913604|FG005|Overall Study|Death|0|||
143373838|NCT04424641|516913605|FG006|Overall Study|Death|1|||
143373839|NCT04424641|516913606|FG007|Overall Study|Death|2|||
143294991|NCT02580357|516630982|FG001|Overall Study|Lost to Follow-up|0|||
143294992|NCT02580357|516630983|FG002|Overall Study|Lost to Follow-up|0|||
143294993|NCT02580357|516630981|FG000|Overall Study|Protocol Violation|1|||
143294994|NCT02580357|516630982|FG001|Overall Study|Protocol Violation|0|||
143294995|NCT02580357|516630983|FG002|Overall Study|Protocol Violation|0|||
143294996|NCT02064166|516630984|FG000|Overall Study|Adverse Event|1|||
143294997|NCT02064166|516630985|FG001|Overall Study|Adverse Event|0|||
143294998|NCT01166763|516630991|FG000|Overall Study|Withdrawal by Subject|3|||
143294999|NCT04339296|516630992|FG000|Overall Study|Refuse to participate after allocation|1|||
143295000|NCT04339296|516630993|FG001|Overall Study|Refuse to participate after allocation|1|||
143295001|NCT04339296|516630992|FG000|Overall Study|Withdrew after completion of baseline|2|||
143295002|NCT04339296|516630993|FG001|Overall Study|Withdrew after completion of baseline|1|||
143295003|NCT04339296|516630992|FG000|Overall Study|Lost to Follow-up|0|||
143295004|NCT04339296|516630993|FG001|Overall Study|Lost to Follow-up|4|||
143295005|NCT04339296|516630992|FG000|Overall Study|Discontinued intervention|5|||
143295006|NCT04339296|516630993|FG001|Overall Study|Discontinued intervention|3|||
143295007|NCT01909479|516630994|FG000|From Baseline to Week 26|Adverse Event|3|||
143295008|NCT01909479|516630995|FG001|From Baseline to Week 26|Adverse Event|2|||
143295009|NCT01909479|516630994|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
143295010|NCT01909479|516630995|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
143295011|NCT01909479|516630994|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
143295012|NCT01909479|516630995|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
143295013|NCT01909479|516630994|FG000|26 - 52 Weeks|Adverse Event|0|||
143295014|NCT01909479|516630995|FG001|26 - 52 Weeks|Adverse Event|1|||
143295015|NCT01909479|516630994|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
143295016|NCT01909479|516630995|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
143295017|NCT01909479|516630994|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
143295018|NCT01909479|516630995|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
143295019|NCT01909479|516630994|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
143295020|NCT01909479|516630995|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
143295021|NCT01909479|516630994|FG000|52 Weeks to End of Study|Adverse Event|2|||
143295022|NCT01909479|516630995|FG001|52 Weeks to End of Study|Adverse Event|1|||
143295023|NCT01909479|516630994|FG000|52 Weeks to End of Study|Death|0|||
143295024|NCT01909479|516630995|FG001|52 Weeks to End of Study|Death|1|||
143295025|NCT01909479|516630994|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
143295026|NCT01909479|516630995|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
143295027|NCT01909479|516630994|FG000|52 Weeks to End of Study|Protocol Violation|1|||
143295028|NCT01909479|516630995|FG001|52 Weeks to End of Study|Protocol Violation|0|||
143295029|NCT01909479|516630994|FG000|52 Weeks to End of Study|Progressive disease|1|||
143295030|NCT01909479|516630995|FG001|52 Weeks to End of Study|Progressive disease|1|||
143295031|NCT01909479|516630994|FG000|52 Weeks to End of Study|Personal reasons|2|||
143295032|NCT01909479|516630995|FG001|52 Weeks to End of Study|Personal reasons|1|||
143295033|NCT01909479|516630994|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
143295034|NCT01909479|516630995|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
143295035|NCT01909479|516630994|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
143295036|NCT01909479|516630995|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
143295037|NCT01909479|516630994|FG000|52 Weeks to End of Study|Lack of contact|1|||
143295038|NCT01909479|516630995|FG001|52 Weeks to End of Study|Lack of contact|0|||
143295039|NCT01909479|516630994|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
143295040|NCT01909479|516630995|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
143295041|NCT01909479|516630994|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
143295042|NCT01909479|516630995|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
143295043|NCT01214629|516631002|FG000|Overall Study|Progressive Disease|1|||
143373840|NCT04424641|516913599|FG000|Overall Study|Sponsor decision|0|||
143373841|NCT04424641|516913600|FG001|Overall Study|Sponsor decision|2|||
143373842|NCT04424641|516913601|FG002|Overall Study|Sponsor decision|3|||
143373843|NCT04424641|516913602|FG003|Overall Study|Sponsor decision|7|||
143373844|NCT04424641|516913603|FG004|Overall Study|Sponsor decision|2|||
143295044|NCT01214629|516631003|FG001|Overall Study|Progressive Disease|1|||
143295045|NCT01214629|516631004|FG002|Overall Study|Progressive Disease|0|||
143295046|NCT01214629|516631005|FG003|Overall Study|Progressive Disease|1|||
143295047|NCT01214629|516631006|FG004|Overall Study|Progressive Disease|2|||
143295048|NCT01214629|516631007|FG005|Overall Study|Progressive Disease|3|||
143373845|NCT04424641|516913604|FG005|Overall Study|Sponsor decision|2|||
143295049|NCT01214629|516631008|FG006|Overall Study|Progressive Disease|1|||
143373846|NCT04424641|516913605|FG006|Overall Study|Sponsor decision|3|||
143373847|NCT04424641|516913606|FG007|Overall Study|Sponsor decision|4|||
143295050|NCT01214629|516631009|FG007|Overall Study|Progressive Disease|1|||
143295051|NCT01214629|516631010|FG008|Overall Study|Progressive Disease|1|||
143295052|NCT01214629|516631011|FG009|Overall Study|Progressive Disease|5|||
143295053|NCT01214629|516631012|FG010|Overall Study|Progressive Disease|1|||
143295054|NCT01214629|516631002|FG000|Overall Study|Adverse Event|0|||
143295055|NCT01214629|516631003|FG001|Overall Study|Adverse Event|0|||
143295056|NCT01214629|516631004|FG002|Overall Study|Adverse Event|0|||
143295057|NCT01214629|516631005|FG003|Overall Study|Adverse Event|1|||
143295058|NCT01214629|516631006|FG004|Overall Study|Adverse Event|0|||
143295059|NCT01214629|516631007|FG005|Overall Study|Adverse Event|1|||
143295060|NCT01214629|516631008|FG006|Overall Study|Adverse Event|0|||
143295061|NCT01214629|516631009|FG007|Overall Study|Adverse Event|0|||
143295062|NCT01214629|516631010|FG008|Overall Study|Adverse Event|0|||
143295063|NCT01214629|516631011|FG009|Overall Study|Adverse Event|1|||
143295064|NCT01214629|516631012|FG010|Overall Study|Adverse Event|0|||
143295065|NCT01214629|516631002|FG000|Overall Study|Physician Decision|0|||
143295066|NCT01214629|516631003|FG001|Overall Study|Physician Decision|0|||
143295067|NCT01214629|516631004|FG002|Overall Study|Physician Decision|0|||
143295068|NCT01214629|516631005|FG003|Overall Study|Physician Decision|0|||
143295069|NCT01214629|516631006|FG004|Overall Study|Physician Decision|0|||
143295070|NCT01214629|516631007|FG005|Overall Study|Physician Decision|0|||
143295071|NCT01214629|516631008|FG006|Overall Study|Physician Decision|0|||
143295072|NCT01214629|516631009|FG007|Overall Study|Physician Decision|0|||
143295073|NCT01214629|516631010|FG008|Overall Study|Physician Decision|0|||
143295074|NCT01214629|516631011|FG009|Overall Study|Physician Decision|0|||
143295075|NCT01214629|516631012|FG010|Overall Study|Physician Decision|1|||
143295076|NCT01214629|516631002|FG000|Overall Study|Withdrawal by Subject|0|||
143295077|NCT01214629|516631003|FG001|Overall Study|Withdrawal by Subject|0|||
143295078|NCT01214629|516631004|FG002|Overall Study|Withdrawal by Subject|0|||
143295079|NCT01214629|516631005|FG003|Overall Study|Withdrawal by Subject|0|||
143295080|NCT01214629|516631006|FG004|Overall Study|Withdrawal by Subject|0|||
143295081|NCT01214629|516631007|FG005|Overall Study|Withdrawal by Subject|0|||
143295082|NCT01214629|516631008|FG006|Overall Study|Withdrawal by Subject|0|||
143295083|NCT01214629|516631009|FG007|Overall Study|Withdrawal by Subject|0|||
143295084|NCT01214629|516631010|FG008|Overall Study|Withdrawal by Subject|0|||
143295085|NCT01214629|516631011|FG009|Overall Study|Withdrawal by Subject|1|||
143295086|NCT01214629|516631012|FG010|Overall Study|Withdrawal by Subject|0|||
143295087|NCT01829230|516631025|FG000|Overall Study|Protocol Violation|0|||
143295088|NCT01829230|516631026|FG001|Overall Study|Protocol Violation|2|||
143295089|NCT01829230|516631025|FG000|Overall Study|Withdrawal by Subject|0|||
143295090|NCT01829230|516631026|FG001|Overall Study|Withdrawal by Subject|1|||
143295091|NCT01829230|516631025|FG000|Overall Study|Lost to Follow-up|1|||
143295092|NCT01829230|516631026|FG001|Overall Study|Lost to Follow-up|1|||
143295093|NCT00553150|516631032|FG000|Overall Study|Withdrawal by Subject|0|||
143295094|NCT00553150|516631033|FG001|Overall Study|Withdrawal by Subject|0|||
143295095|NCT00553150|516631034|FG002|Overall Study|Withdrawal by Subject|0|||
143295096|NCT00553150|516631035|FG003|Overall Study|Withdrawal by Subject|2|||
143295097|NCT00553150|516631032|FG000|Overall Study|Protocol Violation|0|||
143295098|NCT00553150|516631033|FG001|Overall Study|Protocol Violation|0|||
143295099|NCT00553150|516631034|FG002|Overall Study|Protocol Violation|0|||
143295100|NCT00553150|516631035|FG003|Overall Study|Protocol Violation|1|||
143295101|NCT00553150|516631032|FG000|Overall Study|Ineligible|0|||
143295102|NCT00553150|516631033|FG001|Overall Study|Ineligible|0|||
143295103|NCT00553150|516631034|FG002|Overall Study|Ineligible|0|||
143295104|NCT00553150|516631035|FG003|Overall Study|Ineligible|1|||
143295105|NCT00511667|516631036|FG000|Overall Study|Adverse Event|1|||
143295106|NCT00511667|516631037|FG001|Overall Study|Adverse Event|0|||
143295107|NCT00511667|516631036|FG000|Overall Study|Protocol Violation|1|||
143295108|NCT00511667|516631037|FG001|Overall Study|Protocol Violation|1|||
143295109|NCT00511667|516631036|FG000|Overall Study|Withdrawal by Subject|2|||
143295110|NCT00511667|516631037|FG001|Overall Study|Withdrawal by Subject|0|||
143295111|NCT00511667|516631036|FG000|Overall Study|Site terminated|6|||
143295112|NCT00511667|516631037|FG001|Overall Study|Site terminated|1|||
143295113|NCT00511667|516631036|FG000|Overall Study|Other|2|||
143295114|NCT00511667|516631037|FG001|Overall Study|Other|1|||
143295115|NCT00056407|516631038|FG000|Overall Study|Adverse Event|282|||
143295116|NCT00056407|516631039|FG001|Overall Study|Adverse Event|364|||
143295117|NCT00056407|516631038|FG000|Overall Study|Withdrawal by Subject|377|||
143295118|NCT00056407|516631039|FG001|Overall Study|Withdrawal by Subject|361|||
143295119|NCT00056407|516631038|FG000|Overall Study|Lost to Follow-up|123|||
143295120|NCT00056407|516631039|FG001|Overall Study|Lost to Follow-up|113|||
143295121|NCT00056407|516631038|FG000|Overall Study|Protocol Violation|104|||
143295122|NCT00056407|516631039|FG001|Overall Study|Protocol Violation|95|||
143295123|NCT00056407|516631038|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
143295124|NCT00056407|516631039|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
143295125|NCT00056407|516631038|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
143295126|NCT00056407|516631039|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
143295127|NCT00056407|516631038|FG000|Overall Study|Missing|25|||
143295128|NCT00056407|516631039|FG001|Overall Study|Missing|34|||
143295129|NCT00616655|516631040|FG000|Overall Study|Adverse Event|10|||
143295130|NCT00616655|516631041|FG001|Overall Study|Adverse Event|7|||
143295131|NCT00616655|516631042|FG002|Overall Study|Adverse Event|12|||
143295132|NCT00616655|516631040|FG000|Overall Study|Lack of Efficacy|5|||
143295133|NCT00616655|516631041|FG001|Overall Study|Lack of Efficacy|5|||
143295134|NCT00616655|516631042|FG002|Overall Study|Lack of Efficacy|5|||
143295135|NCT00616655|516631040|FG000|Overall Study|Lost to Follow-up|3|||
143295136|NCT00616655|516631041|FG001|Overall Study|Lost to Follow-up|12|||
143295137|NCT00616655|516631042|FG002|Overall Study|Lost to Follow-up|10|||
143295138|NCT00616655|516631040|FG000|Overall Study|Protocol Violation|2|||
143295139|NCT00616655|516631041|FG001|Overall Study|Protocol Violation|4|||
143295140|NCT00616655|516631042|FG002|Overall Study|Protocol Violation|3|||
143295141|NCT00616655|516631040|FG000|Overall Study|Withdrawal by Subject|9|||
143295142|NCT00616655|516631041|FG001|Overall Study|Withdrawal by Subject|7|||
143295143|NCT00616655|516631042|FG002|Overall Study|Withdrawal by Subject|11|||
143295144|NCT00616655|516631040|FG000|Overall Study|Does not meet in/ex criteria|0|||
143295145|NCT00616655|516631041|FG001|Overall Study|Does not meet in/ex criteria|0|||
143295146|NCT00616655|516631042|FG002|Overall Study|Does not meet in/ex criteria|2|||
143295147|NCT00616655|516631040|FG000|Overall Study|Other|6|||
143295148|NCT00616655|516631041|FG001|Overall Study|Other|6|||
143295149|NCT00616655|516631042|FG002|Overall Study|Other|5|||
143295150|NCT03761147|516631043|FG000|Overall Study|Withdrawal by Subject|6|||
143295151|NCT03761147|516631044|FG001|Overall Study|Withdrawal by Subject|1|||
143295152|NCT03761147|516631043|FG000|Overall Study|Adverse Event|1|||
143295153|NCT03761147|516631044|FG001|Overall Study|Adverse Event|3|||
143295154|NCT03605303|516631045|FG000|Period 1|Study Terminated|2|||
143295155|NCT03605303|516631046|FG001|Period 1|Study Terminated|1|||
143295156|NCT00309842|516631047|FG000|Overall Study|Lost to Follow-up|1|||
143295157|NCT03204305|516631050|FG000|Overall Study|Lost to Follow-up|6|||
143295158|NCT03204305|516631051|FG001|Overall Study|Lost to Follow-up|4|||
143295159|NCT03204305|516631052|FG002|Overall Study|Lost to Follow-up|0|||
143295160|NCT03204305|516631053|FG003|Overall Study|Lost to Follow-up|0|||
143295161|NCT03204305|516631050|FG000|Overall Study|Physician Decision|1|||
143295162|NCT03204305|516631051|FG001|Overall Study|Physician Decision|0|||
143295163|NCT03204305|516631052|FG002|Overall Study|Physician Decision|0|||
143295164|NCT03204305|516631053|FG003|Overall Study|Physician Decision|0|||
143295165|NCT03204305|516631050|FG000|Overall Study|failure to place arterial line|2|||
143295166|NCT03204305|516631051|FG001|Overall Study|failure to place arterial line|1|||
143295167|NCT03204305|516631052|FG002|Overall Study|failure to place arterial line|0|||
143295168|NCT03204305|516631053|FG003|Overall Study|failure to place arterial line|0|||
143295169|NCT03204305|516631050|FG000|Overall Study|Withdrawal by Subject|2|||
143295170|NCT03204305|516631051|FG001|Overall Study|Withdrawal by Subject|0|||
143295171|NCT03204305|516631052|FG002|Overall Study|Withdrawal by Subject|0|||
143295172|NCT03204305|516631053|FG003|Overall Study|Withdrawal by Subject|0|||
143295173|NCT01165554|516631054|FG000|Overall Study|Withdrawal by Subject|23|||
143295174|NCT02626520|516631058|FG000|Overall Study|Physician Decision|1|||
143295175|NCT02626520|516631059|FG001|Overall Study|Physician Decision|1|||
143373848|NCT04424641|516913599|FG000|Overall Study|Withdrawal by Subject|0|||
143373849|NCT04424641|516913600|FG001|Overall Study|Withdrawal by Subject|0|||
143373850|NCT04424641|516913601|FG002|Overall Study|Withdrawal by Subject|0|||
143373851|NCT04424641|516913602|FG003|Overall Study|Withdrawal by Subject|0|||
143373852|NCT04424641|516913603|FG004|Overall Study|Withdrawal by Subject|1|||
143373853|NCT04424641|516913604|FG005|Overall Study|Withdrawal by Subject|0|||
143373854|NCT04424641|516913605|FG006|Overall Study|Withdrawal by Subject|0|||
143373855|NCT04424641|516913606|FG007|Overall Study|Withdrawal by Subject|0|||
143373856|NCT04424641|516913599|FG000|Overall Study|Other|0|||
143295176|NCT02626520|516631058|FG000|Overall Study|Adverse Event|0|||
143295177|NCT02626520|516631059|FG001|Overall Study|Adverse Event|4|||
143295178|NCT02626520|516631058|FG000|Overall Study|Lack of Efficacy|0|||
143295179|NCT02626520|516631059|FG001|Overall Study|Lack of Efficacy|2|||
143295180|NCT02626520|516631058|FG000|Overall Study|Did not start protocol therapy|0|||
143295181|NCT02626520|516631059|FG001|Overall Study|Did not start protocol therapy|2|||
143295182|NCT02626520|516631058|FG000|Overall Study|Study terminated|0|||
143295183|NCT02626520|516631059|FG001|Overall Study|Study terminated|1|||
143295184|NCT00535223|516631060|FG000|Overall Study|Withdrawal by Subject|4|||
143295185|NCT00535223|516631061|FG001|Overall Study|Withdrawal by Subject|1|||
143295186|NCT02953314|516631062|FG000|Overall Study|Adverse Event|0|||
143295187|NCT02953314|516631063|FG001|Overall Study|Adverse Event|1|||
143295188|NCT02953314|516631062|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
143295189|NCT02953314|516631063|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
143295190|NCT00492115|516631064|FG000|Overall Study|Withdrawal by Subject|3|||
143295191|NCT00492115|516631065|FG001|Overall Study|Withdrawal by Subject|4|||
143295192|NCT02045797|516631066|FG000|Overall Study|Adverse Event|3|||
143295193|NCT02045797|516631067|FG001|Overall Study|Adverse Event|1|||
143295194|NCT02045797|516631068|FG002|Overall Study|Adverse Event|0|||
143295195|NCT02045797|516631066|FG000|Overall Study|Lack of Efficacy|1|||
143295196|NCT02045797|516631067|FG001|Overall Study|Lack of Efficacy|0|||
143295197|NCT02045797|516631068|FG002|Overall Study|Lack of Efficacy|0|||
143295198|NCT02045797|516631066|FG000|Overall Study|Lost to Follow-up|2|||
143295199|NCT02045797|516631067|FG001|Overall Study|Lost to Follow-up|3|||
143295200|NCT02045797|516631068|FG002|Overall Study|Lost to Follow-up|1|||
143295201|NCT02045797|516631066|FG000|Overall Study|Physician Decision|0|||
143295202|NCT02045797|516631067|FG001|Overall Study|Physician Decision|1|||
143295203|NCT02045797|516631068|FG002|Overall Study|Physician Decision|0|||
143295204|NCT02045797|516631066|FG000|Overall Study|Withdrawal by Subject|1|||
143295205|NCT02045797|516631067|FG001|Overall Study|Withdrawal by Subject|2|||
143373857|NCT04424641|516913600|FG001|Overall Study|Other|0|||
143295206|NCT02045797|516631068|FG002|Overall Study|Withdrawal by Subject|0|||
143295207|NCT00101907|516631072|FG000|Overall Study|Adverse Event|1|||
143295208|NCT00101907|516631073|FG001|Overall Study|Adverse Event|0|||
143295209|NCT00101907|516631074|FG002|Overall Study|Adverse Event|0|||
143295210|NCT00101907|516631075|FG003|Overall Study|Adverse Event|0|||
143295211|NCT00101907|516631076|FG004|Overall Study|Adverse Event|0|||
143295212|NCT00101907|516631077|FG005|Overall Study|Adverse Event|0|||
143295213|NCT00101907|516631072|FG000|Overall Study|Death|0|||
143295214|NCT00101907|516631073|FG001|Overall Study|Death|1|||
143373858|NCT04424641|516913601|FG002|Overall Study|Other|1|||
143373859|NCT04424641|516913602|FG003|Overall Study|Other|0|||
143295215|NCT00101907|516631074|FG002|Overall Study|Death|0|||
143295216|NCT00101907|516631075|FG003|Overall Study|Death|0|||
143295217|NCT00101907|516631076|FG004|Overall Study|Death|3|||
143295218|NCT00101907|516631077|FG005|Overall Study|Death|0|||
143295219|NCT00101907|516631072|FG000|Overall Study|Physician Decision|0|||
143295220|NCT00101907|516631073|FG001|Overall Study|Physician Decision|0|||
143295221|NCT00101907|516631074|FG002|Overall Study|Physician Decision|0|||
143295222|NCT00101907|516631075|FG003|Overall Study|Physician Decision|1|||
143295223|NCT00101907|516631076|FG004|Overall Study|Physician Decision|1|||
143295224|NCT00101907|516631077|FG005|Overall Study|Physician Decision|0|||
143295225|NCT00101907|516631072|FG000|Overall Study|Withdrawal by Subject|1|||
143295226|NCT00101907|516631073|FG001|Overall Study|Withdrawal by Subject|0|||
143295227|NCT00101907|516631074|FG002|Overall Study|Withdrawal by Subject|1|||
143295228|NCT00101907|516631075|FG003|Overall Study|Withdrawal by Subject|0|||
143295229|NCT00101907|516631076|FG004|Overall Study|Withdrawal by Subject|1|||
143295230|NCT00101907|516631077|FG005|Overall Study|Withdrawal by Subject|0|||
143295231|NCT01765153|516631078|FG000|Training Phase 1|Format of intervention differed|1|||
143295232|NCT01765153|516631079|FG001|Training Phase 1|Format of intervention differed|0|||
143295233|NCT01765153|516631078|FG000|Training Phase 1|Poor participation in intervention|0|||
143295234|NCT01765153|516631079|FG001|Training Phase 1|Poor participation in intervention|1|||
143295235|NCT01765153|516631078|FG000|Rest Phase 1|Withdrawal by Subject|0|||
143295236|NCT01765153|516631079|FG001|Rest Phase 1|Withdrawal by Subject|1|||
143295237|NCT01765153|516631078|FG000|Training Phase 2|Withdrawal by Subject|0|||
143295238|NCT01765153|516631079|FG001|Training Phase 2|Withdrawal by Subject|1|||
143295239|NCT01765153|516631078|FG000|Rest Phase 2|Lost to Follow-up|2|||
143295240|NCT01765153|516631079|FG001|Rest Phase 2|Lost to Follow-up|1|||
143295241|NCT03915496|516631082|FG000|Overall Study|Adverse Event|2|||
143295242|NCT03915496|516631083|FG001|Overall Study|Adverse Event|1|||
143295243|NCT03915496|516631084|FG002|Overall Study|Adverse Event|2|||
143295244|NCT02663674|516631085|FG000|Overall Study|Lost to Follow-up|5|||
143295245|NCT02663674|516631086|FG001|Overall Study|Lost to Follow-up|4|||
143295246|NCT02663674|516631085|FG000|Overall Study|Withdrawal by Subject|1|||
143295247|NCT02663674|516631086|FG001|Overall Study|Withdrawal by Subject|4|||
143295248|NCT02663674|516631085|FG000|Overall Study|Physician Decision|1|||
143295249|NCT02663674|516631086|FG001|Overall Study|Physician Decision|1|||
143295250|NCT02663674|516631085|FG000|Overall Study|Other Event (Health Related)|0|||
143295251|NCT02663674|516631086|FG001|Overall Study|Other Event (Health Related)|1|||
143295252|NCT02472795|516631087|FG000|Overall Study|Adverse Event|0|||
143295253|NCT02472795|516631088|FG001|Overall Study|Adverse Event|1|||
143295254|NCT02472795|516631089|FG002|Overall Study|Adverse Event|0|||
143295255|NCT02472795|516631090|FG003|Overall Study|Adverse Event|0|||
143295256|NCT02472795|516631091|FG004|Overall Study|Adverse Event|2|||
143295257|NCT02472795|516631087|FG000|Overall Study|Withdrawal by Subject|0|||
143295258|NCT02472795|516631088|FG001|Overall Study|Withdrawal by Subject|0|||
143295259|NCT02472795|516631089|FG002|Overall Study|Withdrawal by Subject|0|||
143295260|NCT02472795|516631090|FG003|Overall Study|Withdrawal by Subject|0|||
143295261|NCT02472795|516631091|FG004|Overall Study|Withdrawal by Subject|1|||
143295262|NCT01372501|516632190|FG000|Overall Study|Adverse Event|4|||
143295263|NCT01372501|516632190|FG000|Overall Study|Device migration|1|||
143295264|NCT01074450|516632197|FG000|First Intervention|Emesis in Dosing Interval|0|||
143295265|NCT01074450|516632198|FG001|First Intervention|Emesis in Dosing Interval|2|||
143295266|NCT01074450|516632197|FG000|Second Intervention|Protocol Violation|1|||
143295267|NCT01074450|516632198|FG001|Second Intervention|Protocol Violation|0|||
143295268|NCT01074450|516632197|FG000|Second Intervention|Physician Decision|0|||
143295269|NCT01074450|516632198|FG001|Second Intervention|Physician Decision|1|||
143295270|NCT02728895|516632199|FG000|Overall Study|Other|1|||
143295271|NCT02728895|516632200|FG001|Overall Study|Other|2|||
143295272|NCT02728895|516632199|FG000|Overall Study|Withdrawal by Subject|0|||
143295273|NCT02728895|516632200|FG001|Overall Study|Withdrawal by Subject|3|||
143295274|NCT03164928|516632202|FG000|Overall Study|Lost to Follow-up|1|||
143295275|NCT03164928|516632203|FG001|Overall Study|Lost to Follow-up|0|||
143295276|NCT01998737|516632204|FG000|Overall Study|Corrupted database|23|||
143295277|NCT01998737|516632205|FG001|Overall Study|Corrupted database|0|||
143295278|NCT00326950|516632206|FG000|Overall Study|Progressive Disease|1|||
143295279|NCT05407675|516632213|FG000|Overall Study|Withdrawal by Subject|0|||
143295280|NCT05407675|516632214|FG001|Overall Study|Withdrawal by Subject|2|||
143295281|NCT05407675|516632215|FG002|Overall Study|Withdrawal by Subject|3|||
143295282|NCT05407675|516632216|FG003|Overall Study|Withdrawal by Subject|5|||
143295283|NCT05407675|516632217|FG004|Overall Study|Withdrawal by Subject|0|||
143295284|NCT05407675|516632218|FG005|Overall Study|Withdrawal by Subject|2|||
143295285|NCT05407675|516632219|FG006|Overall Study|Withdrawal by Subject|0|||
143295286|NCT05407675|516632220|FG007|Overall Study|Withdrawal by Subject|0|||
143295287|NCT05407675|516632221|FG008|Overall Study|Withdrawal by Subject|2|||
143295288|NCT05407675|516632222|FG009|Overall Study|Withdrawal by Subject|0|||
143295289|NCT05407675|516632223|FG010|Overall Study|Withdrawal by Subject|1|||
143295290|NCT05407675|516632224|FG011|Overall Study|Withdrawal by Subject|0|||
143295291|NCT05407675|516632225|FG012|Overall Study|Withdrawal by Subject|0|||
143295292|NCT05407675|516632213|FG000|Overall Study|Site terminated by sponsor|0|||
143295293|NCT05407675|516632214|FG001|Overall Study|Site terminated by sponsor|0|||
143295294|NCT05407675|516632215|FG002|Overall Study|Site terminated by sponsor|1|||
143295295|NCT05407675|516632216|FG003|Overall Study|Site terminated by sponsor|0|||
143295296|NCT05407675|516632217|FG004|Overall Study|Site terminated by sponsor|2|||
143295297|NCT05407675|516632218|FG005|Overall Study|Site terminated by sponsor|0|||
143295298|NCT05407675|516632219|FG006|Overall Study|Site terminated by sponsor|1|||
143295299|NCT05407675|516632220|FG007|Overall Study|Site terminated by sponsor|0|||
143295300|NCT05407675|516632221|FG008|Overall Study|Site terminated by sponsor|0|||
143295301|NCT05407675|516632222|FG009|Overall Study|Site terminated by sponsor|2|||
143295302|NCT05407675|516632223|FG010|Overall Study|Site terminated by sponsor|2|||
143295303|NCT05407675|516632224|FG011|Overall Study|Site terminated by sponsor|2|||
143295304|NCT05407675|516632225|FG012|Overall Study|Site terminated by sponsor|1|||
143295305|NCT05407675|516632213|FG000|Overall Study|Disease Progression|0|||
143295306|NCT05407675|516632214|FG001|Overall Study|Disease Progression|0|||
143295307|NCT05407675|516632215|FG002|Overall Study|Disease Progression|0|||
143295308|NCT05407675|516632216|FG003|Overall Study|Disease Progression|0|||
143295309|NCT05407675|516632217|FG004|Overall Study|Disease Progression|0|||
143295310|NCT05407675|516632218|FG005|Overall Study|Disease Progression|0|||
143295311|NCT05407675|516632219|FG006|Overall Study|Disease Progression|0|||
143295312|NCT05407675|516632220|FG007|Overall Study|Disease Progression|0|||
143295313|NCT05407675|516632221|FG008|Overall Study|Disease Progression|0|||
143295314|NCT05407675|516632222|FG009|Overall Study|Disease Progression|0|||
143295315|NCT05407675|516632223|FG010|Overall Study|Disease Progression|1|||
143295316|NCT05407675|516632224|FG011|Overall Study|Disease Progression|0|||
143295317|NCT05407675|516632225|FG012|Overall Study|Disease Progression|0|||
143295318|NCT05407675|516632213|FG000|Overall Study|Physician Decision|0|||
143295319|NCT05407675|516632214|FG001|Overall Study|Physician Decision|0|||
143295320|NCT05407675|516632215|FG002|Overall Study|Physician Decision|0|||
143295321|NCT05407675|516632216|FG003|Overall Study|Physician Decision|0|||
143295322|NCT05407675|516632217|FG004|Overall Study|Physician Decision|0|||
143295323|NCT05407675|516632218|FG005|Overall Study|Physician Decision|0|||
143295324|NCT05407675|516632219|FG006|Overall Study|Physician Decision|0|||
143295325|NCT05407675|516632220|FG007|Overall Study|Physician Decision|0|||
143295326|NCT05407675|516632221|FG008|Overall Study|Physician Decision|0|||
143295327|NCT05407675|516632222|FG009|Overall Study|Physician Decision|0|||
143295328|NCT05407675|516632223|FG010|Overall Study|Physician Decision|1|||
143295329|NCT05407675|516632224|FG011|Overall Study|Physician Decision|0|||
143295330|NCT05407675|516632225|FG012|Overall Study|Physician Decision|0|||
143295331|NCT05407675|516632213|FG000|Overall Study|Other reasons|0|||
143295332|NCT05407675|516632214|FG001|Overall Study|Other reasons|0|||
143295333|NCT05407675|516632215|FG002|Overall Study|Other reasons|0|||
143295334|NCT05407675|516632216|FG003|Overall Study|Other reasons|0|||
143295335|NCT05407675|516632217|FG004|Overall Study|Other reasons|0|||
143295336|NCT05407675|516632218|FG005|Overall Study|Other reasons|0|||
143295337|NCT05407675|516632219|FG006|Overall Study|Other reasons|0|||
143295338|NCT05407675|516632220|FG007|Overall Study|Other reasons|0|||
143295339|NCT05407675|516632221|FG008|Overall Study|Other reasons|1|||
143295340|NCT05407675|516632222|FG009|Overall Study|Other reasons|1|||
143295341|NCT05407675|516632223|FG010|Overall Study|Other reasons|1|||
143295342|NCT05407675|516632224|FG011|Overall Study|Other reasons|1|||
143295343|NCT05407675|516632225|FG012|Overall Study|Other reasons|0|||
143295344|NCT05407675|516632213|FG000|Overall Study|Death|3|||
143295345|NCT05407675|516632214|FG001|Overall Study|Death|4|||
143295346|NCT05407675|516632215|FG002|Overall Study|Death|3|||
143295347|NCT05407675|516632216|FG003|Overall Study|Death|6|||
143295348|NCT05407675|516632217|FG004|Overall Study|Death|0|||
143295349|NCT05407675|516632218|FG005|Overall Study|Death|2|||
143295350|NCT05407675|516632219|FG006|Overall Study|Death|4|||
143295351|NCT05407675|516632220|FG007|Overall Study|Death|2|||
143295352|NCT05407675|516632221|FG008|Overall Study|Death|2|||
143295353|NCT05407675|516632222|FG009|Overall Study|Death|4|||
143295354|NCT05407675|516632223|FG010|Overall Study|Death|2|||
143295355|NCT05407675|516632224|FG011|Overall Study|Death|1|||
143295356|NCT05407675|516632225|FG012|Overall Study|Death|0|||
143295357|NCT05407675|516632213|FG000|Overall Study|Adverse Event|0|||
143295358|NCT05407675|516632214|FG001|Overall Study|Adverse Event|0|||
143295359|NCT05407675|516632215|FG002|Overall Study|Adverse Event|0|||
143295360|NCT05407675|516632216|FG003|Overall Study|Adverse Event|0|||
143295361|NCT05407675|516632217|FG004|Overall Study|Adverse Event|1|||
143295362|NCT05407675|516632218|FG005|Overall Study|Adverse Event|0|||
143295363|NCT05407675|516632219|FG006|Overall Study|Adverse Event|0|||
143295364|NCT05407675|516632220|FG007|Overall Study|Adverse Event|0|||
143295365|NCT05407675|516632221|FG008|Overall Study|Adverse Event|0|||
143295366|NCT05407675|516632222|FG009|Overall Study|Adverse Event|0|||
143295367|NCT05407675|516632223|FG010|Overall Study|Adverse Event|0|||
143295368|NCT05407675|516632224|FG011|Overall Study|Adverse Event|1|||
143295369|NCT05407675|516632225|FG012|Overall Study|Adverse Event|0|||
143295370|NCT05407675|516632213|FG000|Overall Study|Ongoing Treatment|0|||
143295371|NCT05407675|516632214|FG001|Overall Study|Ongoing Treatment|0|||
143373860|NCT04424641|516913603|FG004|Overall Study|Other|0|||
143373861|NCT04424641|516913604|FG005|Overall Study|Other|0|||
143373862|NCT04424641|516913605|FG006|Overall Study|Other|0|||
143373863|NCT04424641|516913606|FG007|Overall Study|Other|0|||
143373864|NCT02694978|516913615|FG000|Overall Study|Adverse Event|10|||
143373865|NCT02694978|516913616|FG001|Overall Study|Adverse Event|9|||
143373866|NCT02694978|516913615|FG000|Overall Study|Withdrawal by Subject|22|||
143373867|NCT02694978|516913616|FG001|Overall Study|Withdrawal by Subject|19|||
143373868|NCT02694978|516913615|FG000|Overall Study|Lost to Follow-up|14|||
143373869|NCT02694978|516913616|FG001|Overall Study|Lost to Follow-up|17|||
143373870|NCT02694978|516913615|FG000|Overall Study|Death|4|||
143373871|NCT02694978|516913616|FG001|Overall Study|Death|1|||
143373872|NCT02694978|516913615|FG000|Overall Study|Other-Decision of Participant|6|||
143373873|NCT02694978|516913616|FG001|Overall Study|Other-Decision of Participant|1|||
143295372|NCT05407675|516632215|FG002|Overall Study|Ongoing Treatment|0|||
143373874|NCT02694978|516913615|FG000|Overall Study|Other-Investigator's decision|1|||
143373875|NCT02694978|516913616|FG001|Overall Study|Other-Investigator's decision|0|||
143295373|NCT05407675|516632216|FG003|Overall Study|Ongoing Treatment|0|||
143295374|NCT05407675|516632217|FG004|Overall Study|Ongoing Treatment|0|||
143295375|NCT05407675|516632218|FG005|Overall Study|Ongoing Treatment|0|||
143295376|NCT05407675|516632219|FG006|Overall Study|Ongoing Treatment|0|||
143295377|NCT05407675|516632220|FG007|Overall Study|Ongoing Treatment|0|||
143295378|NCT05407675|516632221|FG008|Overall Study|Ongoing Treatment|1|||
143295379|NCT05407675|516632222|FG009|Overall Study|Ongoing Treatment|0|||
143295380|NCT05407675|516632223|FG010|Overall Study|Ongoing Treatment|0|||
143295381|NCT05407675|516632224|FG011|Overall Study|Ongoing Treatment|0|||
143295382|NCT05407675|516632225|FG012|Overall Study|Ongoing Treatment|0|||
143295383|NCT04105998|516632226|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
143295384|NCT04105998|516632227|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
143295385|NCT01050257|516632228|FG000|Overall Study|Adverse Event|4|||
143295386|NCT01050257|516632229|FG001|Overall Study|Adverse Event|4|||
143295387|NCT01050257|516632230|FG002|Overall Study|Adverse Event|2|||
143295388|NCT01050257|516632228|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
143295389|NCT01050257|516632229|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
143295390|NCT01050257|516632230|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
143295391|NCT01050257|516632228|FG000|Overall Study|Withdrawal by Subject|0|||
143295392|NCT01050257|516632229|FG001|Overall Study|Withdrawal by Subject|3|||
143295393|NCT01050257|516632230|FG002|Overall Study|Withdrawal by Subject|0|||
143295394|NCT01050257|516632228|FG000|Overall Study|No reason specified|0|||
143295395|NCT01050257|516632229|FG001|Overall Study|No reason specified|0|||
143295396|NCT01050257|516632230|FG002|Overall Study|No reason specified|2|||
143295397|NCT01050257|516632228|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
143295398|NCT01050257|516632229|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
143295399|NCT01050257|516632230|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
143295400|NCT01050257|516632228|FG000|Overall Study|Violation criteria|0|||
143295401|NCT01050257|516632229|FG001|Overall Study|Violation criteria|1|||
143295402|NCT01050257|516632230|FG002|Overall Study|Violation criteria|0|||
143295403|NCT01050257|516632228|FG000|Overall Study|Failure to return|0|||
143295404|NCT01050257|516632229|FG001|Overall Study|Failure to return|2|||
143295405|NCT01050257|516632230|FG002|Overall Study|Failure to return|0|||
143295406|NCT01050257|516632228|FG000|Overall Study|Death|0|||
143295407|NCT01050257|516632229|FG001|Overall Study|Death|0|||
143295408|NCT01050257|516632230|FG002|Overall Study|Death|1|||
143295409|NCT00171223|516632231|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
143295410|NCT00171223|516632232|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
143295411|NCT00171223|516632233|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
143295412|NCT00171223|516632231|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
143295413|NCT00171223|516632232|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
143295414|NCT00171223|516632233|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
143295415|NCT00171223|516632231|FG000|Overall Study|Abnormal Procedure|1|||
143295416|NCT00171223|516632232|FG001|Overall Study|Abnormal Procedure|0|||
143295417|NCT00171223|516632233|FG002|Overall Study|Abnormal Procedure|0|||
143295418|NCT00171223|516632231|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
143295419|NCT00171223|516632232|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
143295420|NCT00171223|516632233|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
143295421|NCT00171223|516632231|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
143295422|NCT00171223|516632232|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
143295423|NCT00171223|516632233|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
143295424|NCT00171223|516632231|FG000|Overall Study|Protocol Violation|2|||
143295425|NCT00171223|516632232|FG001|Overall Study|Protocol Violation|2|||
143295426|NCT00171223|516632233|FG002|Overall Study|Protocol Violation|3|||
143295427|NCT00171223|516632231|FG000|Overall Study|Participant Withdrew Consent|12|||
143295428|NCT00171223|516632232|FG001|Overall Study|Participant Withdrew Consent|21|||
143295429|NCT00171223|516632233|FG002|Overall Study|Participant Withdrew Consent|15|||
143295430|NCT00171223|516632231|FG000|Overall Study|Lost to Follow-up|5|||
143295431|NCT00171223|516632232|FG001|Overall Study|Lost to Follow-up|2|||
143295432|NCT00171223|516632233|FG002|Overall Study|Lost to Follow-up|3|||
143295433|NCT00171223|516632231|FG000|Overall Study|Administrative Problems|4|||
143295434|NCT00171223|516632232|FG001|Overall Study|Administrative Problems|7|||
143295435|NCT00171223|516632233|FG002|Overall Study|Administrative Problems|6|||
143295436|NCT00171223|516632231|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
143295437|NCT00171223|516632232|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
143295438|NCT00171223|516632233|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
143295439|NCT00171223|516632231|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
143295440|NCT00171223|516632232|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
143295441|NCT00171223|516632233|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
143295442|NCT00278109|516632235|FG000|Overall Study|Adverse Event|3|||
143295443|NCT00278109|516632235|FG000|Overall Study|social circumstances|1|||
143295444|NCT00383149|516632245|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
143295445|NCT00383149|516632245|FG000|Overall Study|Death|2|||
143295446|NCT00383149|516632245|FG000|Overall Study|Disease Progression|38|||
143295447|NCT00383149|516632245|FG000|Overall Study|Lost to Follow-up|1|||
143295448|NCT00383149|516632245|FG000|Overall Study|Other|1|||
143295449|NCT00383149|516632245|FG000|Overall Study|Study Drug Toxicity|4|||
143295450|NCT00383149|516632245|FG000|Overall Study|Request to Discontinue Treatment|4|||
143295451|NCT00383149|516632245|FG000|Overall Study|Participant Withdrew Consent|1|||
143295452|NCT00453544|516632248|FG000|Overall Study|Withdrawal by Subject|1|||
143295453|NCT00453544|516632249|FG001|Overall Study|Withdrawal by Subject|0|||
143295454|NCT00453544|516632250|FG002|Overall Study|Withdrawal by Subject|0|||
143295455|NCT00453544|516632251|FG003|Overall Study|Withdrawal by Subject|0|||
143295456|NCT00453544|516632248|FG000|Overall Study|Primary outcome measure not completed|1|||
143295457|NCT00453544|516632249|FG001|Overall Study|Primary outcome measure not completed|1|||
143295458|NCT00453544|516632250|FG002|Overall Study|Primary outcome measure not completed|0|||
143295459|NCT00453544|516632251|FG003|Overall Study|Primary outcome measure not completed|1|||
143295460|NCT03721276|516632254|FG000|Overall Study|Lost to Follow-up|5|||
143295461|NCT03721276|516632255|FG001|Overall Study|Lost to Follow-up|3|||
143295462|NCT03721276|516632254|FG000|Overall Study|Adverse Event|0|||
143295463|NCT03721276|516632255|FG001|Overall Study|Adverse Event|1|||
143295464|NCT00450333|516632256|FG000|Overall Study|Study terminated|47|||
143295465|NCT00450333|516632257|FG001|Overall Study|Study terminated|54|||
143295466|NCT00450333|516632258|FG002|Overall Study|Study terminated|16|||
143295467|NCT00450333|516632259|FG003|Overall Study|Study terminated|21|||
143295468|NCT00450333|516632256|FG000|Overall Study|Adverse Event|1|||
143295469|NCT00450333|516632257|FG001|Overall Study|Adverse Event|7|||
143295470|NCT00450333|516632258|FG002|Overall Study|Adverse Event|2|||
143295471|NCT00450333|516632259|FG003|Overall Study|Adverse Event|2|||
143295472|NCT00450333|516632256|FG000|Overall Study|Protocol Violation|1|||
143295473|NCT00450333|516632257|FG001|Overall Study|Protocol Violation|0|||
143295474|NCT00450333|516632258|FG002|Overall Study|Protocol Violation|1|||
143295475|NCT00450333|516632259|FG003|Overall Study|Protocol Violation|0|||
143295476|NCT00450333|516632256|FG000|Overall Study|Withdrawal by Subject|1|||
143295477|NCT00450333|516632257|FG001|Overall Study|Withdrawal by Subject|0|||
143295478|NCT00450333|516632258|FG002|Overall Study|Withdrawal by Subject|3|||
143295479|NCT00450333|516632259|FG003|Overall Study|Withdrawal by Subject|0|||
143295480|NCT00450333|516632256|FG000|Overall Study|Kidney transplant|1|||
143295481|NCT00450333|516632257|FG001|Overall Study|Kidney transplant|0|||
143295482|NCT00450333|516632258|FG002|Overall Study|Kidney transplant|1|||
143295483|NCT00450333|516632259|FG003|Overall Study|Kidney transplant|3|||
143295484|NCT00450333|516632256|FG000|Overall Study|Death|3|||
143295485|NCT00450333|516632257|FG001|Overall Study|Death|2|||
143295486|NCT00450333|516632258|FG002|Overall Study|Death|2|||
143295487|NCT00450333|516632259|FG003|Overall Study|Death|2|||
143295488|NCT01340898|516632260|FG000|Primary Phase|Serious Adverse Events|0|||
143295489|NCT01340898|516632261|FG001|Primary Phase|Serious Adverse Events|0|||
143295490|NCT01340898|516632262|FG002|Primary Phase|Serious Adverse Events|1|||
143295491|NCT01340898|516632260|FG000|Primary Phase|Withdrawal by Subject|8|||
143295492|NCT01340898|516632261|FG001|Primary Phase|Withdrawal by Subject|7|||
143295493|NCT01340898|516632262|FG002|Primary Phase|Withdrawal by Subject|5|||
143295494|NCT01340898|516632260|FG000|Primary Phase|Migrated/moved from study area|4|||
143295495|NCT01340898|516632261|FG001|Primary Phase|Migrated/moved from study area|1|||
143295496|NCT01340898|516632262|FG002|Primary Phase|Migrated/moved from study area|0|||
143295497|NCT01340898|516632260|FG000|Primary Phase|Lost to Follow-up|4|||
143295498|NCT01340898|516632261|FG001|Primary Phase|Lost to Follow-up|1|||
143295499|NCT01340898|516632262|FG002|Primary Phase|Lost to Follow-up|0|||
143295500|NCT01340898|516632260|FG000|Booster Phase|Withdrawal by Subject|3|||
143295501|NCT01340898|516632261|FG001|Booster Phase|Withdrawal by Subject|0|||
143295502|NCT01340898|516632262|FG002|Booster Phase|Withdrawal by Subject|4|||
143295503|NCT01340898|516632260|FG000|Booster Phase|Migrated/moved from study area|3|||
143295504|NCT01340898|516632261|FG001|Booster Phase|Migrated/moved from study area|0|||
143295505|NCT01340898|516632262|FG002|Booster Phase|Migrated/moved from study area|0|||
143295506|NCT01340898|516632260|FG000|Booster Phase|Lost to Follow-up|4|||
143295507|NCT01340898|516632261|FG001|Booster Phase|Lost to Follow-up|2|||
143295508|NCT01340898|516632262|FG002|Booster Phase|Lost to Follow-up|3|||
143295509|NCT02375113|516632264|FG000|Overall Study|Undisclosed Reason(s).|1|||
143295510|NCT02375113|516632265|FG001|Overall Study|Undisclosed Reason(s).|1|||
143295511|NCT02375113|516632264|FG000|Overall Study|Poor adherence (<70%).|1|||
143295512|NCT02375113|516632265|FG001|Overall Study|Poor adherence (<70%).|0|||
143295513|NCT02375113|516632264|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
143295514|NCT02375113|516632265|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
143295515|NCT00416078|516632268|FG000|Overall Study|Death|3|||
143295516|NCT00416078|516632269|FG001|Overall Study|Death|4|||
143295517|NCT00416078|516632268|FG000|Overall Study|Withdrawal by Subject|3|||
143295518|NCT00416078|516632269|FG001|Overall Study|Withdrawal by Subject|2|||
143295519|NCT00416078|516632268|FG000|Overall Study|Physician Decision|1|||
143295520|NCT00416078|516632269|FG001|Overall Study|Physician Decision|0|||
143295521|NCT00416078|516632268|FG000|Overall Study|Lost to Follow-up|4|||
143295522|NCT00416078|516632269|FG001|Overall Study|Lost to Follow-up|2|||
143295523|NCT03855280|516632271|FG000|Treatment Phase|Adverse Event|1|||
143295524|NCT03855280|516632271|FG000|Treatment Phase|Withdrawal by Subject|1|||
143295525|NCT03855280|516632271|FG000|Continuation Phase|Protocol Violation|1|||
143295526|NCT03855280|516632271|FG000|Continuation Phase|Adverse Event|1|||
143295527|NCT03855280|516632271|FG000|Continuation Phase|Sponsor Concluded Study|1|||
143295528|NCT00969150|516632275|FG000|Overall Study|Adverse Event|4|||
143295529|NCT00969150|516632276|FG001|Overall Study|Adverse Event|14|||
143295530|NCT00969150|516632275|FG000|Overall Study|Lack of Efficacy|1|||
143295531|NCT00969150|516632276|FG001|Overall Study|Lack of Efficacy|1|||
143295532|NCT00969150|516632275|FG000|Overall Study|Protocol Violation|9|||
143295533|NCT00969150|516632276|FG001|Overall Study|Protocol Violation|12|||
143295534|NCT00969150|516632275|FG000|Overall Study|Withdrawal by Subject|13|||
143295535|NCT00969150|516632276|FG001|Overall Study|Withdrawal by Subject|9|||
143295536|NCT00969150|516632275|FG000|Overall Study|Lost to Follow-up|5|||
143295537|NCT00969150|516632276|FG001|Overall Study|Lost to Follow-up|4|||
143295538|NCT00969150|516632275|FG000|Overall Study|Other reasons|1|||
143295539|NCT00969150|516632276|FG001|Overall Study|Other reasons|0|||
143295540|NCT00461682|516632277|FG000|Overall Study|Protocol Violation|1|||
143295541|NCT04501666|516632281|FG000|Overall Study|Physician Decision|0|||
143295542|NCT04501666|516632282|FG001|Overall Study|Physician Decision|1|||
143295543|NCT04501666|516632281|FG000|Overall Study|Adverse Event|12|||
143295544|NCT04501666|516632282|FG001|Overall Study|Adverse Event|4|||
143295545|NCT04501666|516632281|FG000|Overall Study|Subject's request|10|||
143295546|NCT04501666|516632282|FG001|Overall Study|Subject's request|6|||
143295547|NCT04501666|516632281|FG000|Overall Study|Protocol Deviation|2|||
143295548|NCT04501666|516632282|FG001|Overall Study|Protocol Deviation|1|||
143295549|NCT04501666|516632281|FG000|Overall Study|Other-- site permanently closing|0|||
143295550|NCT04501666|516632282|FG001|Overall Study|Other-- site permanently closing|1|||
143295551|NCT04128267|516632283|FG000|Overall Study|Withdrawal by Subject|6|||
143295552|NCT04128267|516632283|FG000|Overall Study|Death|2|||
143295553|NCT04128267|516632283|FG000|Overall Study|Disease progression|1|||
143295554|NCT04128267|516632283|FG000|Overall Study|Participant had other medical issues|4|||
143295555|NCT04128267|516632283|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
143295556|NCT01026792|516632284|FG000|Overall Study|Protocol Violation|1|||
143295557|NCT04166513|516632287|FG000|Behavioral Assessment 1|Withdrawal by Subject|0|||
143295558|NCT04166513|516632288|FG001|Behavioral Assessment 1|Withdrawal by Subject|1|||
143295559|NCT04166513|516632289|FG002|Behavioral Assessment 1|Withdrawal by Subject|0|||
143295560|NCT04166513|516632290|FG003|Behavioral Assessment 1|Withdrawal by Subject|0|||
143295561|NCT04166513|516632287|FG000|Behavioral Assessment 1|Investigator Withdrawn|0|||
143295562|NCT04166513|516632288|FG001|Behavioral Assessment 1|Investigator Withdrawn|0|||
143295563|NCT04166513|516632289|FG002|Behavioral Assessment 1|Investigator Withdrawn|0|||
143295564|NCT04166513|516632290|FG003|Behavioral Assessment 1|Investigator Withdrawn|1|||
143295565|NCT04166513|516632287|FG000|Therapy Cycle B|Withdrawal by Subject|0|||
143295566|NCT04166513|516632288|FG001|Therapy Cycle B|Withdrawal by Subject|1|||
143295567|NCT04166513|516632289|FG002|Therapy Cycle B|Withdrawal by Subject|0|||
143295568|NCT04166513|516632290|FG003|Therapy Cycle B|Withdrawal by Subject|0|||
143295569|NCT04166513|516632287|FG000|Behavioral Assessment 4|Lost to Follow-up|1|||
143295570|NCT04166513|516632288|FG001|Behavioral Assessment 4|Lost to Follow-up|0|||
143295571|NCT04166513|516632289|FG002|Behavioral Assessment 4|Lost to Follow-up|1|||
143295572|NCT04166513|516632290|FG003|Behavioral Assessment 4|Lost to Follow-up|1|||
143295573|NCT04166513|516632287|FG000|Behavioral Assessment 4|Withdrawal by Subject|2|||
143295574|NCT04166513|516632288|FG001|Behavioral Assessment 4|Withdrawal by Subject|2|||
143295575|NCT04166513|516632289|FG002|Behavioral Assessment 4|Withdrawal by Subject|1|||
143295576|NCT04166513|516632290|FG003|Behavioral Assessment 4|Withdrawal by Subject|0|||
143295577|NCT04219891|516632292|FG000|Overall Study|Lost to Follow-up|3|||
143295578|NCT04219891|516632292|FG000|Overall Study|Withdrawal by Subject|2|||
143295579|NCT00597012|516632293|FG000|Overall Study|Death|1|||
143295580|NCT00597012|516632294|FG001|Overall Study|Death|1|||
143295581|NCT00597012|516632293|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
143295582|NCT00597012|516632294|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
143295583|NCT00597012|516632293|FG000|Overall Study|Withdrawal by Subject|7|||
143295584|NCT00597012|516632294|FG001|Overall Study|Withdrawal by Subject|4|||
143295585|NCT00597012|516632293|FG000|Overall Study|Ineligible|2|||
143295586|NCT00597012|516632294|FG001|Overall Study|Ineligible|0|||
143295587|NCT00597012|516632293|FG000|Overall Study|Lost to Follow-up|0|||
143295588|NCT00597012|516632294|FG001|Overall Study|Lost to Follow-up|2|||
143295589|NCT01786629|516633218|FG000|Overall Study|Lack of Efficacy|0|||
143295590|NCT01786629|516633219|FG001|Overall Study|Lack of Efficacy|4|||
143295591|NCT01786629|516633218|FG000|Overall Study|Adverse Event|0|||
143295592|NCT01786629|516633219|FG001|Overall Study|Adverse Event|1|||
143295593|NCT04568590|516633220|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
143295594|NCT04708886|516633223|FG000|Year 2: Alendronate|Withdrawal by Subject|1|||
143295595|NCT04708886|516633223|FG000|Year 2: Alendronate|Lost to Follow-up|1|||
143373876|NCT02694978|516913615|FG000|Overall Study|Other-Unable to be reached|0|||
143295596|NCT00202644|516633224|FG000|Overall Study|Adverse Event|12|||
143295597|NCT00202644|516633225|FG001|Overall Study|Adverse Event|13|||
143295598|NCT00202644|516633224|FG000|Overall Study|Withdrawal by Subject|8|||
143295599|NCT00202644|516633225|FG001|Overall Study|Withdrawal by Subject|6|||
143295600|NCT00202644|516633224|FG000|Overall Study|Lack of Efficacy|6|||
143295601|NCT00202644|516633225|FG001|Overall Study|Lack of Efficacy|6|||
143295602|NCT00202644|516633224|FG000|Overall Study|Lost to Follow-up|0|||
143295603|NCT00202644|516633225|FG001|Overall Study|Lost to Follow-up|1|||
143295604|NCT00202644|516633224|FG000|Overall Study|Other|9|||
143295605|NCT00202644|516633225|FG001|Overall Study|Other|1|||
143295606|NCT02750592|516633231|FG000|Overall Study|Adverse Event|3|||
143295607|NCT02750592|516633231|FG000|Overall Study|Lack of Efficacy|2|||
143295608|NCT03232281|516633232|FG000|Overall Study|Adverse Event|1|||
143295609|NCT03232281|516633233|FG001|Overall Study|Adverse Event|1|||
143295610|NCT03232281|516633232|FG000|Overall Study|Withdrawal by Subject|5|||
143295611|NCT03232281|516633233|FG001|Overall Study|Withdrawal by Subject|4|||
143295612|NCT03232281|516633232|FG000|Overall Study|Protocol Deviation|1|||
143295613|NCT03232281|516633233|FG001|Overall Study|Protocol Deviation|1|||
143295614|NCT02981342|516633236|FG000|Overall Study|Adverse Event|0|||
143295615|NCT02981342|516633237|FG001|Overall Study|Adverse Event|0|||
143295616|NCT02981342|516633238|FG002|Overall Study|Adverse Event|0|||
143295617|NCT02981342|516633239|FG003|Overall Study|Adverse Event|1|||
143295618|NCT02981342|516633236|FG000|Overall Study|Death|0|||
143295619|NCT02981342|516633237|FG001|Overall Study|Death|9|||
143295620|NCT02981342|516633238|FG002|Overall Study|Death|9|||
143295621|NCT02981342|516633239|FG003|Overall Study|Death|4|||
143295622|NCT02981342|516633236|FG000|Overall Study|Withdrawal by Subject|0|||
143295623|NCT02981342|516633237|FG001|Overall Study|Withdrawal by Subject|0|||
143295624|NCT02981342|516633238|FG002|Overall Study|Withdrawal by Subject|3|||
143295625|NCT02981342|516633239|FG003|Overall Study|Withdrawal by Subject|1|||
143295626|NCT02981342|516633236|FG000|Overall Study|Study closed by sponsor|0|||
143295627|NCT02981342|516633237|FG001|Overall Study|Study closed by sponsor|0|||
143295628|NCT02981342|516633238|FG002|Overall Study|Study closed by sponsor|1|||
143295629|NCT02981342|516633239|FG003|Overall Study|Study closed by sponsor|1|||
143295630|NCT02981342|516633236|FG000|Overall Study|Randomized, Never Treated|0|||
143295631|NCT02981342|516633237|FG001|Overall Study|Randomized, Never Treated|1|||
143295632|NCT02981342|516633238|FG002|Overall Study|Randomized, Never Treated|0|||
143295633|NCT02981342|516633239|FG003|Overall Study|Randomized, Never Treated|7|||
143295634|NCT02981342|516633236|FG000|Overall Study|Lost to Follow-up|0|||
143295635|NCT02981342|516633237|FG001|Overall Study|Lost to Follow-up|1|||
143295636|NCT02981342|516633238|FG002|Overall Study|Lost to Follow-up|0|||
143295637|NCT02981342|516633239|FG003|Overall Study|Lost to Follow-up|0|||
143295638|NCT01132482|516633240|FG000|Overall Study|Adverse Event|1|||
143295639|NCT01132482|516633241|FG001|Overall Study|Adverse Event|0|||
143295640|NCT05333900|516633242|FG000|Overall Study|Protocol Violation|0|||
143295641|NCT05333900|516633243|FG001|Overall Study|Protocol Violation|1|||
143295642|NCT05333900|516633242|FG000|Overall Study|Withdrawal by Subject|0|||
143295643|NCT05333900|516633243|FG001|Overall Study|Withdrawal by Subject|1|||
143295644|NCT05333900|516633242|FG000|Overall Study|COVID-19 Pandemic|1|||
143295645|NCT05333900|516633243|FG001|Overall Study|COVID-19 Pandemic|1|||
143295646|NCT01277523|516633244|FG000|Overall Study|Adverse Event|1|||
143295647|NCT01277523|516633245|FG001|Overall Study|Adverse Event|0|||
143373877|NCT02694978|516913616|FG001|Overall Study|Other-Unable to be reached|1|||
143373878|NCT02694978|516913615|FG000|Overall Study|Other-Protocol noncompliant|2|||
143295648|NCT01277523|516633246|FG002|Overall Study|Adverse Event|0|||
143295649|NCT01277523|516633244|FG000|Overall Study|Protocol Violation|2|||
143295650|NCT01277523|516633245|FG001|Overall Study|Protocol Violation|0|||
143295651|NCT01277523|516633246|FG002|Overall Study|Protocol Violation|0|||
143295652|NCT01277523|516633244|FG000|Overall Study|Other Reason not Defined|0|||
143295653|NCT01277523|516633245|FG001|Overall Study|Other Reason not Defined|1|||
143295654|NCT01277523|516633246|FG002|Overall Study|Other Reason not Defined|0|||
143295655|NCT03724812|516633247|FG000|Overall Study|Missed Visit|1|||
143295656|NCT03724812|516633247|FG000|Overall Study|Death|2|||
143295657|NCT03724812|516633247|FG000|Overall Study|Withdrawal by Subject|1|||
143295658|NCT01851720|516633248|FG000|Overall Study|Lost to Follow-up|0|||
143295659|NCT01851720|516633249|FG001|Overall Study|Lost to Follow-up|1|||
143295660|NCT02389998|516633256|FG000|Overall Study|car accident|1|||
143295661|NCT02389998|516633257|FG001|Overall Study|car accident|0|||
143295662|NCT03525574|516633258|FG000|Overall Study|Adverse Event|15|||
143295663|NCT03525574|516633259|FG001|Overall Study|Adverse Event|0|||
143295664|NCT03525574|516633258|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
143295665|NCT03525574|516633259|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
143295666|NCT03525574|516633258|FG000|Overall Study|Lost to Follow-up|4|||
143295667|NCT03525574|516633259|FG001|Overall Study|Lost to Follow-up|0|||
143295668|NCT03525574|516633258|FG000|Overall Study|Commercial drug is Available for participant|48|||
143295669|NCT03525574|516633259|FG001|Overall Study|Commercial drug is Available for participant|0|||
143295670|NCT03525574|516633258|FG000|Overall Study|Death|1|||
143295671|NCT03525574|516633259|FG001|Overall Study|Death|0|||
143295672|NCT03525574|516633258|FG000|Overall Study|Other non-compliance|2|||
143295673|NCT03525574|516633259|FG001|Overall Study|Other non-compliance|0|||
143295674|NCT03525574|516633258|FG000|Overall Study|Physician Decision|6|||
143295675|NCT03525574|516633259|FG001|Overall Study|Physician Decision|0|||
143295676|NCT03525574|516633258|FG000|Overall Study|Other|58|||
143295677|NCT03525574|516633259|FG001|Overall Study|Other|0|||
143295678|NCT03525574|516633258|FG000|Overall Study|Enrolled but never dosed|1|||
143295679|NCT03525574|516633259|FG001|Overall Study|Enrolled but never dosed|0|||
143295680|NCT03525574|516633258|FG000|Overall Study|Not enrolled in 105 study|0|||
143295681|NCT03525574|516633259|FG001|Overall Study|Not enrolled in 105 study|3|||
143295682|NCT01770379|516633262|FG000|Overall Study|Technical issues|1|||
143295683|NCT01770379|516633263|FG001|Overall Study|Technical issues|0|||
143295684|NCT01770379|516633264|FG002|Overall Study|Technical issues|0|||
143295685|NCT01770379|516633262|FG000|Overall Study|Withdrawal by Subject|7|||
143295686|NCT01770379|516633263|FG001|Overall Study|Withdrawal by Subject|10|||
143295687|NCT01770379|516633264|FG002|Overall Study|Withdrawal by Subject|7|||
143295688|NCT01770379|516633262|FG000|Overall Study|study terminated by sponsor|22|||
143295689|NCT01770379|516633263|FG001|Overall Study|study terminated by sponsor|23|||
143295690|NCT01770379|516633264|FG002|Overall Study|study terminated by sponsor|22|||
143295691|NCT01770379|516633262|FG000|Overall Study|Protocol Violation|0|||
143295692|NCT01770379|516633263|FG001|Overall Study|Protocol Violation|1|||
143295693|NCT01770379|516633264|FG002|Overall Study|Protocol Violation|1|||
143295694|NCT01770379|516633262|FG000|Overall Study|Physician Decision|0|||
143295695|NCT01770379|516633263|FG001|Overall Study|Physician Decision|1|||
143295696|NCT01770379|516633264|FG002|Overall Study|Physician Decision|2|||
143295697|NCT01770379|516633262|FG000|Overall Study|Lost to Follow-up|0|||
143295698|NCT01770379|516633263|FG001|Overall Study|Lost to Follow-up|0|||
143295699|NCT01770379|516633264|FG002|Overall Study|Lost to Follow-up|2|||
143295700|NCT01770379|516633262|FG000|Overall Study|Lack of Efficacy|8|||
143295701|NCT01770379|516633263|FG001|Overall Study|Lack of Efficacy|6|||
143295702|NCT01770379|516633264|FG002|Overall Study|Lack of Efficacy|6|||
143295703|NCT01770379|516633262|FG000|Overall Study|Adverse Event|1|||
143295704|NCT01770379|516633263|FG001|Overall Study|Adverse Event|3|||
143295705|NCT01770379|516633264|FG002|Overall Study|Adverse Event|2|||
143373879|NCT02694978|516913616|FG001|Overall Study|Other-Protocol noncompliant|1|||
143373880|NCT02694978|516913615|FG000|Overall Study|Other-Personal reasons|3|||
143373881|NCT02694978|516913616|FG001|Overall Study|Other-Personal reasons|3|||
143373882|NCT02694978|516913615|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
143373883|NCT02694978|516913616|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
143373884|NCT01613716|516913617|FG000|Overall Study|screen failures|3|||
143373885|NCT01613716|516913617|FG000|Overall Study|Lost to Follow-up|4|||
143373886|NCT01171625|516913618|FG000|Overall Study|On-Protocol|67|||
143373887|NCT01171625|516913618|FG000|Overall Study|Death|38|||
143373888|NCT01171625|516913618|FG000|Overall Study|Withdrawal by Subject|31|||
143373889|NCT01171625|516913618|FG000|Overall Study|Explanted|10|||
143373890|NCT01171625|516913618|FG000|Overall Study|Lost to Follow-up|5|||
143373891|NCT01171625|516913618|FG000|Overall Study|Patient received valve-in-valve|3|||
143295706|NCT02769247|516633269|FG000|Overall Study|Withdrawal by Subject|1|||
143295707|NCT02769247|516633270|FG001|Overall Study|Withdrawal by Subject|0|||
143295708|NCT02769247|516633271|FG002|Overall Study|Withdrawal by Subject|0|||
143295709|NCT02769247|516633272|FG003|Overall Study|Withdrawal by Subject|1|||
143373892|NCT01171625|516913618|FG000|Overall Study|Other|1|||
143373893|NCT01171625|516913618|FG000|Overall Study|Consented but did not receive device|25|||
143373894|NCT03262935|516913619|FG000|Overall Study|Withdrawal by Subject|6|||
143373895|NCT03262935|516913620|FG001|Overall Study|Withdrawal by Subject|7|||
143373896|NCT03262935|516913619|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
143295710|NCT02769247|516633269|FG000|Overall Study|Protocol Violation|0|||
143295711|NCT02769247|516633270|FG001|Overall Study|Protocol Violation|0|||
143295712|NCT02769247|516633271|FG002|Overall Study|Protocol Violation|1|||
143295713|NCT02769247|516633272|FG003|Overall Study|Protocol Violation|0|||
143295714|NCT02769247|516633269|FG000|Overall Study|Physician Decision|1|||
143295715|NCT02769247|516633270|FG001|Overall Study|Physician Decision|0|||
143295716|NCT02769247|516633271|FG002|Overall Study|Physician Decision|0|||
143295717|NCT02769247|516633272|FG003|Overall Study|Physician Decision|0|||
143295718|NCT02710045|516633289|FG000|Overall Study|Death|1|||
143295719|NCT02710045|516633290|FG001|Overall Study|Death|2|||
143295720|NCT02710045|516633291|FG002|Overall Study|Death|0|||
143295721|NCT02710045|516633289|FG000|Overall Study|Withdrawal by Subject|6|||
143295722|NCT02710045|516633290|FG001|Overall Study|Withdrawal by Subject|6|||
143295723|NCT02710045|516633291|FG002|Overall Study|Withdrawal by Subject|2|||
143295724|NCT02710045|516633289|FG000|Overall Study|Protocol Violation|1|||
143295725|NCT02710045|516633290|FG001|Overall Study|Protocol Violation|2|||
143295726|NCT02710045|516633291|FG002|Overall Study|Protocol Violation|3|||
143295727|NCT02710045|516633289|FG000|Overall Study|Lost to Follow-up|3|||
143295728|NCT02710045|516633290|FG001|Overall Study|Lost to Follow-up|6|||
143295729|NCT02710045|516633291|FG002|Overall Study|Lost to Follow-up|7|||
143295730|NCT02710045|516633289|FG000|Overall Study|Physician Decision|0|||
143295731|NCT02710045|516633290|FG001|Overall Study|Physician Decision|0|||
143295732|NCT02710045|516633291|FG002|Overall Study|Physician Decision|1|||
143295733|NCT02710045|516633289|FG000|Overall Study|Poor Attendance|0|||
143295734|NCT02710045|516633290|FG001|Overall Study|Poor Attendance|1|||
143295735|NCT02710045|516633291|FG002|Overall Study|Poor Attendance|0|||
143295736|NCT04499781|516633292|FG000|Overall Study|Lost to Follow-up|2|||
143295737|NCT04499781|516633293|FG001|Overall Study|Lost to Follow-up|3|||
143295738|NCT04499781|516633292|FG000|Overall Study|Withdrawal by Subject|2|||
143295739|NCT04499781|516633293|FG001|Overall Study|Withdrawal by Subject|0|||
143295740|NCT01275833|516633294|FG000|Overall Study|Study terminated|1|||
143373897|NCT03262935|516913620|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
143373898|NCT03262935|516913619|FG000|Overall Study|Death|181|||
143295741|NCT01275833|516633295|FG001|Overall Study|Study terminated|1|||
143295742|NCT02118012|516633296|FG000|Overall Study|Adverse Event|0|||
143295743|NCT02118012|516633297|FG001|Overall Study|Adverse Event|1|||
143295744|NCT02118012|516633296|FG000|Overall Study|Physician Decision|0|||
143295745|NCT02118012|516633297|FG001|Overall Study|Physician Decision|1|||
143295746|NCT04519645|516633302|FG000|Enrollment Period (Up to 36 Hours)|Adverse Event|1|||
143295747|NCT04519645|516633303|FG001|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
143295748|NCT04519645|516633304|FG002|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
143295749|NCT04519645|516633302|FG000|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|1|||
143295750|NCT04519645|516633303|FG001|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
143295751|NCT04519645|516633304|FG002|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
143295752|NCT04519645|516633302|FG000|Enrollment Period (Up to 36 Hours)|Protocol Violation|1|||
143373899|NCT03262935|516913620|FG001|Overall Study|Death|94|||
143373900|NCT03262935|516913619|FG000|Overall Study|Lost to Follow-up|9|||
143373901|NCT03262935|516913620|FG001|Overall Study|Lost to Follow-up|4|||
143373902|NCT03262935|516913619|FG000|Overall Study|Other reason|5|||
143373903|NCT03262935|516913620|FG001|Overall Study|Other reason|0|||
143373904|NCT00743444|516913621|FG000|First Intervention|Catheter placement problems|0|||
143373905|NCT00743444|516913622|FG001|First Intervention|Catheter placement problems|1|||
143373906|NCT00743444|516913621|FG000|Washout Period|Adverse Event|0|||
143295753|NCT04519645|516633303|FG001|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
143295754|NCT04519645|516633304|FG002|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
143295755|NCT04519645|516633302|FG000|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
143295756|NCT04519645|516633303|FG001|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|1|||
143295757|NCT04519645|516633304|FG002|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
143295758|NCT04447755|516633312|FG000|Overall Study|Death|9|||
143295759|NCT04447755|516633313|FG001|Overall Study|Death|16|||
143295760|NCT04447755|516633314|FG002|Overall Study|Death|8|||
143295761|NCT04447755|516633315|FG003|Overall Study|Death|9|||
143295762|NCT04447755|516633316|FG004|Overall Study|Death|8|||
143295763|NCT04447755|516633317|FG005|Overall Study|Death|9|||
143295764|NCT04447755|516633318|FG006|Overall Study|Death|55|||
143295765|NCT04447755|516633312|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
143295766|NCT04447755|516633313|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
143295767|NCT04447755|516633314|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
143295768|NCT04447755|516633315|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
143295769|NCT04447755|516633316|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
143295770|NCT04447755|516633317|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
143295771|NCT04447755|516633318|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
143295772|NCT04447755|516633312|FG000|Overall Study|Sponsor Decision|0|||
143295773|NCT04447755|516633313|FG001|Overall Study|Sponsor Decision|0|||
143295774|NCT04447755|516633314|FG002|Overall Study|Sponsor Decision|0|||
143295775|NCT04447755|516633315|FG003|Overall Study|Sponsor Decision|0|||
143295776|NCT04447755|516633316|FG004|Overall Study|Sponsor Decision|1|||
143295777|NCT04447755|516633317|FG005|Overall Study|Sponsor Decision|0|||
143295778|NCT04447755|516633318|FG006|Overall Study|Sponsor Decision|10|||
143295779|NCT04447755|516633312|FG000|Overall Study|Lost to Follow-up|0|||
143295780|NCT04447755|516633313|FG001|Overall Study|Lost to Follow-up|0|||
143295781|NCT04447755|516633314|FG002|Overall Study|Lost to Follow-up|0|||
143295782|NCT04447755|516633315|FG003|Overall Study|Lost to Follow-up|0|||
143295783|NCT04447755|516633316|FG004|Overall Study|Lost to Follow-up|0|||
143295784|NCT04447755|516633317|FG005|Overall Study|Lost to Follow-up|0|||
143295785|NCT04447755|516633318|FG006|Overall Study|Lost to Follow-up|1|||
143295786|NCT00670800|516634812|FG000|Overall Study|2 controls were insulin resistant|0|||
143295787|NCT00670800|516634813|FG001|Overall Study|2 controls were insulin resistant|2|||
143295788|NCT00227305|516634819|FG000|Overall Study|Adverse Event|40|||
143295789|NCT00227305|516634819|FG000|Overall Study|Withdrawal by Subject|42|||
143295790|NCT00227305|516634819|FG000|Overall Study|Lost to Follow-up|33|||
143295791|NCT00227305|516634819|FG000|Overall Study|Study specific discontinuation|13|||
143295792|NCT00227305|516634819|FG000|Overall Study|MOVED OUT OF AREA|3|||
143295793|NCT00227305|516634819|FG000|Overall Study|Lack of Efficacy|7|||
143295794|NCT00227305|516634819|FG000|Overall Study|Physician Decision|3|||
143295795|NCT00227305|516634819|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
143295796|NCT00227305|516634819|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
143295797|NCT00227305|516634819|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
143295798|NCT03742037|516634822|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
143295799|NCT03742037|516634823|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
143295800|NCT03742037|516634824|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
143295801|NCT03742037|516634825|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
143295802|NCT03742037|516634826|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
143373907|NCT00743444|516913622|FG001|Washout Period|Adverse Event|1|||
143373908|NCT02567656|516913625|FG000|Overall Study|Premature discontinuation due to PD|1|||
143373909|NCT02567656|516913626|FG001|Overall Study|Premature discontinuation due to PD|1|||
143373910|NCT02567656|516913627|FG002|Overall Study|Premature discontinuation due to PD|2|||
143373911|NCT02567656|516913628|FG003|Overall Study|Premature discontinuation due to PD|0|||
143373912|NCT02567656|516913629|FG004|Overall Study|Premature discontinuation due to PD|0|||
143295803|NCT03742037|516634827|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
143295804|NCT03742037|516634828|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
143295805|NCT03742037|516634822|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
143295806|NCT03742037|516634823|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
143295807|NCT03742037|516634824|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
143295808|NCT03742037|516634825|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
143295809|NCT03742037|516634826|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
143295810|NCT03742037|516634827|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
143373913|NCT02567656|516913630|FG005|Overall Study|Premature discontinuation due to PD|0|||
143373914|NCT03622580|516913631|FG000|Overall Study|Death|16|||
143295811|NCT03742037|516634828|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
143295812|NCT03742037|516634822|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
143295813|NCT03742037|516634823|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
143295814|NCT03742037|516634824|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
143295815|NCT03742037|516634825|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
143295816|NCT03742037|516634826|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
143295817|NCT03742037|516634827|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
143295818|NCT03742037|516634828|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
143295819|NCT03742037|516634822|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
143295820|NCT03742037|516634823|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
143295821|NCT03742037|516634824|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
143295822|NCT03742037|516634825|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
143295823|NCT03742037|516634826|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
143295824|NCT03742037|516634827|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
143295825|NCT03742037|516634828|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
143295826|NCT03742037|516634822|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
143295827|NCT03742037|516634823|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
143295828|NCT03742037|516634824|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
143295829|NCT03742037|516634825|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
143295830|NCT03742037|516634826|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
143295831|NCT03742037|516634827|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
143295832|NCT03742037|516634828|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
143295833|NCT03742037|516634822|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
143295834|NCT03742037|516634823|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
143295835|NCT03742037|516634824|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
143295836|NCT03742037|516634825|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
143295837|NCT03742037|516634826|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
143295838|NCT03742037|516634827|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
143295839|NCT03742037|516634828|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
143295840|NCT03742037|516634822|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
143295841|NCT03742037|516634823|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
143295842|NCT03742037|516634824|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
143295843|NCT03742037|516634825|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
143295844|NCT03742037|516634826|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
143295845|NCT03742037|516634827|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
143295846|NCT03742037|516634828|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
143295847|NCT03742037|516634822|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
143295848|NCT03742037|516634823|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
143295849|NCT03742037|516634824|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
143295850|NCT03742037|516634825|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
143295851|NCT03742037|516634826|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
143295852|NCT03742037|516634827|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
143295853|NCT03742037|516634828|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
143295854|NCT03742037|516634822|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
143295855|NCT03742037|516634823|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
143295856|NCT03742037|516634824|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
143295857|NCT03742037|516634825|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
143295858|NCT03742037|516634826|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
143295859|NCT03742037|516634827|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
143295860|NCT03742037|516634828|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
143295861|NCT03742037|516634822|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
143295862|NCT03742037|516634823|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
143295863|NCT03742037|516634824|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
143295864|NCT03742037|516634825|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
143295865|NCT03742037|516634826|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
143295866|NCT03742037|516634827|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
143295867|NCT03742037|516634828|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
143295868|NCT03742037|516634822|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
143295869|NCT03742037|516634823|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
143295870|NCT03742037|516634824|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
143295871|NCT03742037|516634825|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
143295872|NCT03742037|516634826|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
143295873|NCT03742037|516634827|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
143295874|NCT03742037|516634828|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
143295875|NCT03742037|516634822|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
143295876|NCT03742037|516634823|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
143295877|NCT03742037|516634824|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
143295878|NCT03742037|516634825|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
143295879|NCT03742037|516634826|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
143295880|NCT03742037|516634827|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
143295881|NCT03742037|516634828|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
143295882|NCT03742037|516634822|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
143295883|NCT03742037|516634823|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
143295884|NCT03742037|516634824|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
143295885|NCT03742037|516634825|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
143295886|NCT03742037|516634826|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
143295887|NCT03742037|516634827|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
143295888|NCT03742037|516634828|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
143295889|NCT03742037|516634822|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
143295890|NCT03742037|516634823|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
143295891|NCT03742037|516634824|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
143295892|NCT03742037|516634825|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
143295893|NCT03742037|516634826|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
143295894|NCT03742037|516634827|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
143295895|NCT03742037|516634828|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
143295896|NCT03742037|516634822|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
143295897|NCT03742037|516634823|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
143295898|NCT03742037|516634824|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
143295899|NCT03742037|516634825|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
143295900|NCT03742037|516634826|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
143295901|NCT03742037|516634827|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
143295902|NCT03742037|516634828|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
143295903|NCT00619801|516634829|FG000|Overall Study|Lack of Efficacy|0|||
143295904|NCT00619801|516634830|FG001|Overall Study|Lack of Efficacy|1|||
143295905|NCT00619801|516634829|FG000|Overall Study|Withdrawal by Subject|1|||
143295906|NCT00619801|516634830|FG001|Overall Study|Withdrawal by Subject|1|||
143295907|NCT00619801|516634829|FG000|Overall Study|Loss of efficacy|0|||
143295908|NCT00619801|516634830|FG001|Overall Study|Loss of efficacy|1|||
143295909|NCT00642941|516634840|FG000|Overall Study|Physician Decision|3|||
143295910|NCT00642941|516634841|FG001|Overall Study|Physician Decision|1|||
143295911|NCT00642941|516634842|FG002|Overall Study|Physician Decision|0|||
143295912|NCT00642941|516634843|FG003|Overall Study|Physician Decision|0|||
143295913|NCT00642941|516634844|FG004|Overall Study|Physician Decision|0|||
143295914|NCT00642941|516634845|FG005|Overall Study|Physician Decision|0|||
143295915|NCT00642941|516634846|FG006|Overall Study|Physician Decision|1|||
143295916|NCT00642941|516634847|FG007|Overall Study|Physician Decision|0|||
143295917|NCT00642941|516634848|FG008|Overall Study|Physician Decision|0|||
143295918|NCT00642941|516634849|FG009|Overall Study|Physician Decision|1|||
143295919|NCT00642941|516634850|FG010|Overall Study|Physician Decision|0|||
143295920|NCT00642941|516634851|FG011|Overall Study|Physician Decision|1|||
143295921|NCT00642941|516634840|FG000|Overall Study|Death|4|||
143295922|NCT00642941|516634841|FG001|Overall Study|Death|0|||
143295923|NCT00642941|516634842|FG002|Overall Study|Death|1|||
143295924|NCT00642941|516634843|FG003|Overall Study|Death|1|||
143295925|NCT00642941|516634844|FG004|Overall Study|Death|2|||
143295926|NCT00642941|516634845|FG005|Overall Study|Death|1|||
143295927|NCT00642941|516634846|FG006|Overall Study|Death|0|||
143295928|NCT00642941|516634847|FG007|Overall Study|Death|0|||
143295929|NCT00642941|516634848|FG008|Overall Study|Death|0|||
143295930|NCT00642941|516634849|FG009|Overall Study|Death|0|||
143295931|NCT00642941|516634850|FG010|Overall Study|Death|0|||
143295932|NCT00642941|516634851|FG011|Overall Study|Death|1|||
143295933|NCT00642941|516634840|FG000|Overall Study|Study closed by Sponsor|0|||
143295934|NCT00642941|516634841|FG001|Overall Study|Study closed by Sponsor|1|||
143295935|NCT00642941|516634842|FG002|Overall Study|Study closed by Sponsor|0|||
143295936|NCT00642941|516634843|FG003|Overall Study|Study closed by Sponsor|0|||
143295937|NCT00642941|516634844|FG004|Overall Study|Study closed by Sponsor|0|||
143295938|NCT00642941|516634845|FG005|Overall Study|Study closed by Sponsor|0|||
143295939|NCT00642941|516634846|FG006|Overall Study|Study closed by Sponsor|0|||
143295940|NCT00642941|516634847|FG007|Overall Study|Study closed by Sponsor|0|||
143295941|NCT00642941|516634848|FG008|Overall Study|Study closed by Sponsor|0|||
143295942|NCT00642941|516634849|FG009|Overall Study|Study closed by Sponsor|0|||
143295943|NCT00642941|516634850|FG010|Overall Study|Study closed by Sponsor|0|||
143295944|NCT00642941|516634851|FG011|Overall Study|Study closed by Sponsor|0|||
143295945|NCT00642941|516634840|FG000|Overall Study|Withdrawal by Subject|1|||
143295946|NCT00642941|516634841|FG001|Overall Study|Withdrawal by Subject|0|||
143295947|NCT00642941|516634842|FG002|Overall Study|Withdrawal by Subject|0|||
143295948|NCT00642941|516634843|FG003|Overall Study|Withdrawal by Subject|2|||
143295949|NCT00642941|516634844|FG004|Overall Study|Withdrawal by Subject|0|||
143295950|NCT00642941|516634845|FG005|Overall Study|Withdrawal by Subject|0|||
143295951|NCT00642941|516634846|FG006|Overall Study|Withdrawal by Subject|2|||
143295952|NCT00642941|516634847|FG007|Overall Study|Withdrawal by Subject|0|||
143295953|NCT00642941|516634848|FG008|Overall Study|Withdrawal by Subject|1|||
143295954|NCT00642941|516634849|FG009|Overall Study|Withdrawal by Subject|0|||
143295955|NCT00642941|516634850|FG010|Overall Study|Withdrawal by Subject|0|||
143295956|NCT00642941|516634851|FG011|Overall Study|Withdrawal by Subject|1|||
143295957|NCT00642941|516634840|FG000|Overall Study|Protocol Violation|0|||
143295958|NCT00642941|516634841|FG001|Overall Study|Protocol Violation|0|||
143295959|NCT00642941|516634842|FG002|Overall Study|Protocol Violation|0|||
143295960|NCT00642941|516634843|FG003|Overall Study|Protocol Violation|0|||
143295961|NCT00642941|516634844|FG004|Overall Study|Protocol Violation|0|||
143295962|NCT00642941|516634845|FG005|Overall Study|Protocol Violation|0|||
143295963|NCT00642941|516634846|FG006|Overall Study|Protocol Violation|1|||
143295964|NCT00642941|516634847|FG007|Overall Study|Protocol Violation|0|||
143295965|NCT00642941|516634848|FG008|Overall Study|Protocol Violation|0|||
143295966|NCT00642941|516634849|FG009|Overall Study|Protocol Violation|0|||
143295967|NCT00642941|516634850|FG010|Overall Study|Protocol Violation|0|||
143295968|NCT00642941|516634851|FG011|Overall Study|Protocol Violation|0|||
143295969|NCT00642941|516634840|FG000|Overall Study|Adverse Event|1|||
143295970|NCT00642941|516634841|FG001|Overall Study|Adverse Event|1|||
143295971|NCT00642941|516634842|FG002|Overall Study|Adverse Event|0|||
143295972|NCT00642941|516634843|FG003|Overall Study|Adverse Event|0|||
143295973|NCT00642941|516634844|FG004|Overall Study|Adverse Event|0|||
143295974|NCT00642941|516634845|FG005|Overall Study|Adverse Event|0|||
143295975|NCT00642941|516634846|FG006|Overall Study|Adverse Event|1|||
143295976|NCT00642941|516634847|FG007|Overall Study|Adverse Event|1|||
143295977|NCT00642941|516634848|FG008|Overall Study|Adverse Event|0|||
143295978|NCT00642941|516634849|FG009|Overall Study|Adverse Event|1|||
143295979|NCT00642941|516634850|FG010|Overall Study|Adverse Event|0|||
143295980|NCT00642941|516634851|FG011|Overall Study|Adverse Event|0|||
143295981|NCT00642941|516634840|FG000|Overall Study|Other|1|||
143295982|NCT00642941|516634841|FG001|Overall Study|Other|1|||
143295983|NCT00642941|516634842|FG002|Overall Study|Other|1|||
143373915|NCT03622580|516913632|FG001|Overall Study|Death|21|||
143373916|NCT03622580|516913633|FG002|Overall Study|Death|13|||
143373917|NCT03622580|516913631|FG000|Overall Study|Adverse Event|6|||
143373918|NCT03622580|516913632|FG001|Overall Study|Adverse Event|6|||
143373919|NCT03622580|516913633|FG002|Overall Study|Adverse Event|5|||
143373920|NCT03622580|516913631|FG000|Overall Study|Withdrawal by Subject|12|||
143373921|NCT03622580|516913632|FG001|Overall Study|Withdrawal by Subject|7|||
143373922|NCT03622580|516913633|FG002|Overall Study|Withdrawal by Subject|19|||
143373923|NCT03622580|516913631|FG000|Overall Study|Lost to Follow-up|12|||
143373924|NCT03622580|516913632|FG001|Overall Study|Lost to Follow-up|9|||
143373925|NCT03622580|516913633|FG002|Overall Study|Lost to Follow-up|9|||
143373926|NCT03622580|516913631|FG000|Overall Study|Protocol Violation|1|||
143373927|NCT03622580|516913632|FG001|Overall Study|Protocol Violation|0|||
143373928|NCT03622580|516913633|FG002|Overall Study|Protocol Violation|1|||
143373929|NCT03622580|516913631|FG000|Overall Study|Physician Decision|3|||
143373930|NCT03622580|516913632|FG001|Overall Study|Physician Decision|0|||
143373931|NCT03622580|516913633|FG002|Overall Study|Physician Decision|1|||
143373932|NCT03622580|516913631|FG000|Overall Study|Pregnancy|0|||
143373933|NCT03622580|516913632|FG001|Overall Study|Pregnancy|1|||
143373934|NCT03622580|516913633|FG002|Overall Study|Pregnancy|0|||
143373935|NCT03622580|516913631|FG000|Overall Study|Lack of Efficacy|0|||
143373936|NCT03622580|516913632|FG001|Overall Study|Lack of Efficacy|0|||
143373937|NCT03622580|516913633|FG002|Overall Study|Lack of Efficacy|1|||
143373938|NCT03622580|516913631|FG000|Overall Study|Other|2|||
143373939|NCT03622580|516913632|FG001|Overall Study|Other|0|||
143373940|NCT03622580|516913633|FG002|Overall Study|Other|3|||
143373941|NCT00813904|516913634|FG000|Overall Study|Death|1|||
143373942|NCT01405924|516913637|FG000|Overall Study|Protocol Violation|8|||
143373943|NCT01405924|516913637|FG000|Overall Study|Missing/Incomplete Data|2|||
143373944|NCT02441036|516913640|FG000|Overall Study|No tissue resected|0|||
143373945|NCT02441036|516913641|FG001|Overall Study|No tissue resected|1|||
143373946|NCT02441036|516913642|FG002|Overall Study|No tissue resected|0|||
143373947|NCT02441036|516913643|FG003|Overall Study|No tissue resected|1|||
143373948|NCT02441036|516913644|FG004|Overall Study|No tissue resected|0|||
143295984|NCT00642941|516634843|FG003|Overall Study|Other|1|||
143295985|NCT00642941|516634844|FG004|Overall Study|Other|0|||
143295986|NCT00642941|516634845|FG005|Overall Study|Other|1|||
143295987|NCT00642941|516634846|FG006|Overall Study|Other|0|||
143295988|NCT00642941|516634847|FG007|Overall Study|Other|1|||
143295989|NCT00642941|516634848|FG008|Overall Study|Other|0|||
143295990|NCT00642941|516634849|FG009|Overall Study|Other|0|||
143295991|NCT00642941|516634850|FG010|Overall Study|Other|0|||
143295992|NCT00642941|516634851|FG011|Overall Study|Other|1|||
143295993|NCT00642941|516634840|FG000|Overall Study|Disease progression|60|||
143295994|NCT00642941|516634841|FG001|Overall Study|Disease progression|50|||
143295995|NCT00642941|516634842|FG002|Overall Study|Disease progression|5|||
143295996|NCT00642941|516634843|FG003|Overall Study|Disease progression|36|||
143295997|NCT00642941|516634844|FG004|Overall Study|Disease progression|23|||
143295998|NCT00642941|516634845|FG005|Overall Study|Disease progression|39|||
143295999|NCT00642941|516634846|FG006|Overall Study|Disease progression|18|||
143296000|NCT00642941|516634847|FG007|Overall Study|Disease progression|12|||
143296001|NCT00642941|516634848|FG008|Overall Study|Disease progression|10|||
143296002|NCT00642941|516634849|FG009|Overall Study|Disease progression|7|||
143296003|NCT00642941|516634850|FG010|Overall Study|Disease progression|12|||
143296004|NCT00642941|516634851|FG011|Overall Study|Disease progression|7|||
143296005|NCT03051607|516634852|FG000|Overall Study|Adverse Event|66|||
143373949|NCT00770965|516913645|FG000|Safety Set|Withdrawal by Subject|0|||
143373950|NCT00770965|516913646|FG001|Safety Set|Withdrawal by Subject|0|||
143373951|NCT00770965|516913647|FG002|Safety Set|Withdrawal by Subject|0|||
143373952|NCT00770965|516913648|FG003|Safety Set|Withdrawal by Subject|1|||
143373953|NCT00770965|516913645|FG000|Safety Set|Protocol deviation|0|||
143373954|NCT00770965|516913646|FG001|Safety Set|Protocol deviation|0|||
143373955|NCT00770965|516913647|FG002|Safety Set|Protocol deviation|1|||
143373956|NCT00770965|516913648|FG003|Safety Set|Protocol deviation|0|||
143373957|NCT00770965|516913645|FG000|Excluded Set|Administrative problems|14|||
143296006|NCT03338855|516634854|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
143296007|NCT03338855|516634855|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
143296008|NCT03447990|516634856|FG000|Overall Study|Withdrawal by Subject|0|||
143296009|NCT03447990|516634857|FG001|Overall Study|Withdrawal by Subject|0|||
143296010|NCT03447990|516634858|FG002|Overall Study|Withdrawal by Subject|0|||
143296011|NCT03447990|516634859|FG003|Overall Study|Withdrawal by Subject|0|||
143296012|NCT03447990|516634860|FG004|Overall Study|Withdrawal by Subject|0|||
143296013|NCT03447990|516634861|FG005|Overall Study|Withdrawal by Subject|0|||
143296014|NCT03447990|516634862|FG006|Overall Study|Withdrawal by Subject|1|||
143296015|NCT00455429|516634863|FG000|Overall Study|Study Terminated by Sponsor|0|||
143296016|NCT00455429|516634864|FG001|Overall Study|Study Terminated by Sponsor|0|||
143296017|NCT00455429|516634865|FG002|Overall Study|Study Terminated by Sponsor|0|||
143296018|NCT00455429|516634866|FG003|Overall Study|Study Terminated by Sponsor|3|||
143296019|NCT00455429|516634863|FG000|Overall Study|Lost to Follow-up|1|||
143296020|NCT00455429|516634864|FG001|Overall Study|Lost to Follow-up|0|||
143296021|NCT00455429|516634865|FG002|Overall Study|Lost to Follow-up|0|||
143296022|NCT00455429|516634866|FG003|Overall Study|Lost to Follow-up|3|||
143296023|NCT00455429|516634863|FG000|Overall Study|Withdrawal by Subject|0|||
143296024|NCT00455429|516634864|FG001|Overall Study|Withdrawal by Subject|1|||
143296025|NCT00455429|516634865|FG002|Overall Study|Withdrawal by Subject|1|||
143296026|NCT00455429|516634866|FG003|Overall Study|Withdrawal by Subject|0|||
143296027|NCT00455429|516634863|FG000|Overall Study|Lack of Efficacy|0|||
143296028|NCT00455429|516634864|FG001|Overall Study|Lack of Efficacy|1|||
143296029|NCT00455429|516634865|FG002|Overall Study|Lack of Efficacy|0|||
143296030|NCT00455429|516634866|FG003|Overall Study|Lack of Efficacy|1|||
143296031|NCT00455429|516634863|FG000|Overall Study|Adverse Event|0|||
143296032|NCT00455429|516634864|FG001|Overall Study|Adverse Event|1|||
143373958|NCT00770965|516913646|FG001|Excluded Set|Administrative problems|12|||
143373959|NCT00770965|516913647|FG002|Excluded Set|Administrative problems|12|||
143373960|NCT00770965|516913648|FG003|Excluded Set|Administrative problems|10|||
143373961|NCT00770965|516913645|FG000|Excluded Set|Withdrawal by Subject|1|||
143373962|NCT00770965|516913646|FG001|Excluded Set|Withdrawal by Subject|1|||
143373963|NCT00770965|516913647|FG002|Excluded Set|Withdrawal by Subject|2|||
143373964|NCT00770965|516913648|FG003|Excluded Set|Withdrawal by Subject|3|||
143373965|NCT00612586|516913649|FG000|Overall Study|Adverse Event|6|||
143373966|NCT00612586|516913650|FG001|Overall Study|Adverse Event|2|||
143373967|NCT00612586|516913649|FG000|Overall Study|Death|1|||
143373968|NCT00612586|516913650|FG001|Overall Study|Death|0|||
143373969|NCT00612586|516913649|FG000|Overall Study|Entry Criteria Not Met|0|||
143373970|NCT00612586|516913650|FG001|Overall Study|Entry Criteria Not Met|2|||
143373971|NCT00612586|516913649|FG000|Overall Study|Withdrawal by Subject|7|||
143373972|NCT00612586|516913650|FG001|Overall Study|Withdrawal by Subject|9|||
143373973|NCT00612586|516913649|FG000|Overall Study|Physician Decision|1|||
143373974|NCT00612586|516913650|FG001|Overall Study|Physician Decision|2|||
143373975|NCT00612586|516913649|FG000|Overall Study|Sponsor Decision|1|||
143373976|NCT00612586|516913650|FG001|Overall Study|Sponsor Decision|1|||
143373977|NCT00612586|516913649|FG000|Overall Study|Progressive Disease|26|||
143373978|NCT00612586|516913650|FG001|Overall Study|Progressive Disease|24|||
143373979|NCT00612586|516913649|FG000|Overall Study|Randomized and Not Treated|1|||
143373980|NCT00612586|516913650|FG001|Overall Study|Randomized and Not Treated|1|||
143373981|NCT01505881|516913651|FG000|Overall Study|Adverse Event|0|||
143373982|NCT01505881|516913652|FG001|Overall Study|Adverse Event|1|||
143373983|NCT01505881|516913651|FG000|Overall Study|Lost to Follow-up|2|||
143373984|NCT01505881|516913652|FG001|Overall Study|Lost to Follow-up|0|||
143373985|NCT01505881|516913651|FG000|Overall Study|Withdrawal by Subject|2|||
143373986|NCT01505881|516913652|FG001|Overall Study|Withdrawal by Subject|0|||
143373987|NCT01194154|516913653|FG000|Overall Study|Adverse Event|12|||
143373988|NCT01194154|516913654|FG001|Overall Study|Adverse Event|7|||
143373989|NCT01194154|516913653|FG000|Overall Study|Lost to Follow-up|2|||
143373990|NCT01194154|516913654|FG001|Overall Study|Lost to Follow-up|3|||
143373991|NCT01194154|516913653|FG000|Overall Study|Protocol Violation|0|||
143373992|NCT01194154|516913654|FG001|Overall Study|Protocol Violation|1|||
143373993|NCT01194154|516913653|FG000|Overall Study|Withdrawal by Subject|5|||
143373994|NCT01194154|516913654|FG001|Overall Study|Withdrawal by Subject|6|||
143373995|NCT01194154|516913653|FG000|Overall Study|Blood pressure increase|5|||
143373996|NCT01194154|516913654|FG001|Overall Study|Blood pressure increase|3|||
143373997|NCT01194154|516913653|FG000|Overall Study|Hemoglobin decrease|0|||
143373998|NCT01194154|516913654|FG001|Overall Study|Hemoglobin decrease|1|||
143373999|NCT01194154|516913653|FG000|Overall Study|Hemoglobin increase|12|||
143374000|NCT01194154|516913654|FG001|Overall Study|Hemoglobin increase|3|||
143374001|NCT01194154|516913653|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
143374002|NCT01194154|516913654|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
143374003|NCT01194154|516913653|FG000|Overall Study|Treatment with prohibited medication|4|||
143374004|NCT01194154|516913654|FG001|Overall Study|Treatment with prohibited medication|5|||
143374005|NCT01194154|516913653|FG000|Overall Study|Other|4|||
143296033|NCT00455429|516634865|FG002|Overall Study|Adverse Event|0|||
143296034|NCT00455429|516634866|FG003|Overall Study|Adverse Event|3|||
143296035|NCT00455429|516634863|FG000|Overall Study|Randomly assigned but not treated|0|||
143296036|NCT00455429|516634864|FG001|Overall Study|Randomly assigned but not treated|0|||
143296037|NCT00455429|516634865|FG002|Overall Study|Randomly assigned but not treated|0|||
143296038|NCT00455429|516634866|FG003|Overall Study|Randomly assigned but not treated|2|||
143296039|NCT00455429|516634863|FG000|Overall Study|Personal Reason|1|||
143296040|NCT00455429|516634864|FG001|Overall Study|Personal Reason|0|||
143296041|NCT00455429|516634865|FG002|Overall Study|Personal Reason|0|||
143296042|NCT00455429|516634866|FG003|Overall Study|Personal Reason|0|||
143296043|NCT00455429|516634863|FG000|Overall Study|Non-compliance|0|||
143296044|NCT00455429|516634864|FG001|Overall Study|Non-compliance|0|||
143296045|NCT00455429|516634865|FG002|Overall Study|Non-compliance|0|||
143296046|NCT00455429|516634866|FG003|Overall Study|Non-compliance|1|||
143296047|NCT00455429|516634863|FG000|Overall Study|Other|0|||
143296048|NCT00455429|516634864|FG001|Overall Study|Other|2|||
143296049|NCT00455429|516634865|FG002|Overall Study|Other|0|||
143296050|NCT00455429|516634866|FG003|Overall Study|Other|1|||
143296051|NCT00238121|516634877|FG000|Overall Study|Withdrawal by Subject|1|||
143374006|NCT01194154|516913654|FG001|Overall Study|Other|0|||
143374007|NCT01194154|516913653|FG000|Overall Study|Did not receive study medication|2|||
143296052|NCT00238121|516634878|FG001|Overall Study|Withdrawal by Subject|1|||
143296053|NCT00238121|516634877|FG000|Overall Study|Adverse Event|2|||
143296054|NCT00238121|516634878|FG001|Overall Study|Adverse Event|1|||
143374008|NCT01194154|516913654|FG001|Overall Study|Did not receive study medication|4|||
143374009|NCT01596504|516913655|FG000|Overall Study|Participant's Private Reason|0|||
143374010|NCT01596504|516913656|FG001|Overall Study|Participant's Private Reason|1|||
143374011|NCT01596504|516913657|FG002|Overall Study|Participant's Private Reason|0|||
143374012|NCT01596504|516913655|FG000|Overall Study|Adverse Event|1|||
143296055|NCT00484939|516634879|FG000|Overall Study|Death|9|||
143296056|NCT00484939|516634880|FG001|Overall Study|Death|13|||
143296057|NCT00484939|516634879|FG000|Overall Study|Adverse Event|22|||
143296058|NCT00484939|516634880|FG001|Overall Study|Adverse Event|12|||
143296059|NCT00484939|516634879|FG000|Overall Study|Patient Withdrew Consent|19|||
143296060|NCT00484939|516634880|FG001|Overall Study|Patient Withdrew Consent|10|||
143296061|NCT00484939|516634879|FG000|Overall Study|Protocol Violation|3|||
143296062|NCT00484939|516634880|FG001|Overall Study|Protocol Violation|3|||
143296063|NCT00484939|516634879|FG000|Overall Study|Lost to Follow-up|0|||
143296064|NCT00484939|516634880|FG001|Overall Study|Lost to Follow-up|3|||
143296065|NCT00484939|516634879|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
143296066|NCT00484939|516634880|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
143296067|NCT00484939|516634879|FG000|Overall Study|Disease progression|67|||
143296068|NCT00484939|516634880|FG001|Overall Study|Disease progression|88|||
143296069|NCT00484939|516634879|FG000|Overall Study|Screen Failure|2|||
143296070|NCT00484939|516634880|FG001|Overall Study|Screen Failure|2|||
143296071|NCT00484939|516634879|FG000|Overall Study|Reason Not Specified|11|||
143296072|NCT00484939|516634880|FG001|Overall Study|Reason Not Specified|6|||
143296073|NCT04948450|516634881|FG000|Overall Study|Return home|1|||
143296074|NCT04948450|516634882|FG001|Overall Study|Return home|3|||
143296075|NCT01474876|516634886|FG000|Overall Study|Adverse Event|11|||
143296076|NCT01474876|516634887|FG001|Overall Study|Adverse Event|5|||
143296077|NCT01474876|516634888|FG002|Overall Study|Adverse Event|0|||
143296078|NCT01474876|516634886|FG000|Overall Study|Serious Adverse Event|2|||
143296079|NCT01474876|516634887|FG001|Overall Study|Serious Adverse Event|3|||
143296080|NCT01474876|516634888|FG002|Overall Study|Serious Adverse Event|0|||
143296081|NCT01474876|516634886|FG000|Overall Study|Lost to Follow-up|5|||
143296082|NCT01474876|516634887|FG001|Overall Study|Lost to Follow-up|4|||
143296083|NCT01474876|516634888|FG002|Overall Study|Lost to Follow-up|0|||
143296084|NCT01474876|516634886|FG000|Overall Study|Investigator's decision|28|||
143296085|NCT01474876|516634887|FG001|Overall Study|Investigator's decision|6|||
143296086|NCT01474876|516634888|FG002|Overall Study|Investigator's decision|0|||
143296087|NCT01474876|516634886|FG000|Overall Study|Patient's request|19|||
143296088|NCT01474876|516634887|FG001|Overall Study|Patient's request|5|||
143296089|NCT01474876|516634888|FG002|Overall Study|Patient's request|0|||
143296090|NCT01474876|516634886|FG000|Overall Study|Investigator's decision and pt request|1|||
143296091|NCT01474876|516634887|FG001|Overall Study|Investigator's decision and pt request|0|||
143296092|NCT01474876|516634888|FG002|Overall Study|Investigator's decision and pt request|0|||
143296093|NCT01523886|516634892|FG000|Overall Study|surgery cancelled|0|||
143296094|NCT01523886|516634893|FG001|Overall Study|surgery cancelled|1|||
143296095|NCT01173718|516634906|FG000|Overall Study|Death|17|||
143296096|NCT01173718|516634906|FG000|Overall Study|Abandonment of study graft|27|||
143296097|NCT01367158|516634907|FG000|Overall Study|Withdrew consent|0|||
143296098|NCT01367158|516634908|FG001|Overall Study|Withdrew consent|2|||
143296099|NCT01367158|516634909|FG002|Overall Study|Withdrew consent|1|||
143296100|NCT01367158|516634910|FG003|Overall Study|Withdrew consent|0|||
143296101|NCT01367158|516634911|FG004|Overall Study|Withdrew consent|2|||
143296102|NCT01367158|516634912|FG005|Overall Study|Withdrew consent|0|||
143296103|NCT01367158|516634913|FG006|Overall Study|Withdrew consent|0|||
143296104|NCT01367158|516634914|FG007|Overall Study|Withdrew consent|1|||
143296105|NCT01367158|516634915|FG008|Overall Study|Withdrew consent|0|||
143296106|NCT01367158|516634916|FG009|Overall Study|Withdrew consent|0|||
143296107|NCT01367158|516634917|FG010|Overall Study|Withdrew consent|0|||
143296108|NCT01367158|516634907|FG000|Overall Study|Lost to Follow-up|0|||
143296109|NCT01367158|516634908|FG001|Overall Study|Lost to Follow-up|0|||
143296110|NCT01367158|516634909|FG002|Overall Study|Lost to Follow-up|0|||
143296111|NCT01367158|516634910|FG003|Overall Study|Lost to Follow-up|1|||
143296112|NCT01367158|516634911|FG004|Overall Study|Lost to Follow-up|0|||
143296113|NCT01367158|516634912|FG005|Overall Study|Lost to Follow-up|2|||
143296114|NCT01367158|516634913|FG006|Overall Study|Lost to Follow-up|0|||
143296115|NCT01367158|516634914|FG007|Overall Study|Lost to Follow-up|1|||
143296116|NCT01367158|516634915|FG008|Overall Study|Lost to Follow-up|0|||
143296117|NCT01367158|516634916|FG009|Overall Study|Lost to Follow-up|0|||
143296118|NCT01367158|516634917|FG010|Overall Study|Lost to Follow-up|1|||
143296119|NCT01367158|516634907|FG000|Overall Study|Protocol Violation|0|||
143296120|NCT01367158|516634908|FG001|Overall Study|Protocol Violation|1|||
143296121|NCT01367158|516634909|FG002|Overall Study|Protocol Violation|0|||
143296122|NCT01367158|516634910|FG003|Overall Study|Protocol Violation|0|||
143296123|NCT01367158|516634911|FG004|Overall Study|Protocol Violation|0|||
143296124|NCT01367158|516634912|FG005|Overall Study|Protocol Violation|0|||
143296125|NCT01367158|516634913|FG006|Overall Study|Protocol Violation|0|||
143296126|NCT01367158|516634914|FG007|Overall Study|Protocol Violation|0|||
143296127|NCT01367158|516634915|FG008|Overall Study|Protocol Violation|0|||
143296128|NCT01367158|516634916|FG009|Overall Study|Protocol Violation|0|||
143296129|NCT01367158|516634917|FG010|Overall Study|Protocol Violation|0|||
143296130|NCT02226003|516634918|FG000|Overall Study|Lost to Follow-up|2|||
143296131|NCT02226003|516634919|FG001|Overall Study|Lost to Follow-up|1|||
143296132|NCT02226003|516634920|FG002|Overall Study|Lost to Follow-up|3|||
143296133|NCT02226003|516634918|FG000|Overall Study|Withdrawal by Subject|0|||
143296134|NCT02226003|516634919|FG001|Overall Study|Withdrawal by Subject|0|||
143296135|NCT02226003|516634920|FG002|Overall Study|Withdrawal by Subject|3|||
143296136|NCT01499563|516634923|FG000|Overall Study|Withdrawal by Subject|10|||
143296137|NCT01499563|516634924|FG001|Overall Study|Withdrawal by Subject|11|||
143296138|NCT01499563|516634925|FG002|Overall Study|Withdrawal by Subject|7|||
143296139|NCT01499563|516634926|FG003|Overall Study|Withdrawal by Subject|8|||
143296140|NCT01499563|516634923|FG000|Overall Study|Physician Decision|2|||
143296141|NCT01499563|516634924|FG001|Overall Study|Physician Decision|1|||
143296142|NCT01499563|516634925|FG002|Overall Study|Physician Decision|3|||
143296143|NCT01499563|516634926|FG003|Overall Study|Physician Decision|0|||
143296144|NCT01499563|516634923|FG000|Overall Study|Specific Request of Sponsor or Investigator|2|||
143296145|NCT01499563|516634924|FG001|Overall Study|Specific Request of Sponsor or Investigator|0|||
143296146|NCT01499563|516634925|FG002|Overall Study|Specific Request of Sponsor or Investigator|1|||
143296147|NCT01499563|516634926|FG003|Overall Study|Specific Request of Sponsor or Investigator|1|||
143296148|NCT01499563|516634923|FG000|Overall Study|Adverse Event|2|||
143296149|NCT01499563|516634924|FG001|Overall Study|Adverse Event|0|||
143296150|NCT01499563|516634925|FG002|Overall Study|Adverse Event|1|||
143296151|NCT01499563|516634926|FG003|Overall Study|Adverse Event|3|||
143296152|NCT01499563|516634923|FG000|Overall Study|Lack of Efficacy|0|||
143296153|NCT01499563|516634924|FG001|Overall Study|Lack of Efficacy|1|||
143296154|NCT01499563|516634925|FG002|Overall Study|Lack of Efficacy|6|||
143296155|NCT01499563|516634926|FG003|Overall Study|Lack of Efficacy|3|||
143296156|NCT01499563|516634923|FG000|Overall Study|Other|8|||
143296157|NCT01499563|516634924|FG001|Overall Study|Other|6|||
143296158|NCT01499563|516634925|FG002|Overall Study|Other|6|||
143296159|NCT01499563|516634926|FG003|Overall Study|Other|4|||
143296160|NCT03658538|516634929|FG000|Overall Study|Death|2|||
143296161|NCT03658538|516634930|FG001|Overall Study|Death|1|||
143296162|NCT03658538|516634929|FG000|Overall Study|Cancer diagnosis|1|||
143296163|NCT03658538|516634930|FG001|Overall Study|Cancer diagnosis|0|||
143296164|NCT03658538|516634929|FG000|Overall Study|Change residence|1|||
143296165|NCT03658538|516634930|FG001|Overall Study|Change residence|2|||
143296166|NCT03658538|516634929|FG000|Overall Study|Lost to Follow-up|3|||
143296167|NCT03658538|516634930|FG001|Overall Study|Lost to Follow-up|3|||
143296168|NCT03658538|516634929|FG000|Overall Study|Unblinded|2|||
143296169|NCT03658538|516634930|FG001|Overall Study|Unblinded|3|||
143296170|NCT03658538|516634929|FG000|Overall Study|Physician Decision|0|||
143296171|NCT03658538|516634930|FG001|Overall Study|Physician Decision|1|||
143296172|NCT03658538|516634929|FG000|Overall Study|Incomplete clinical visit at 6 months due to illness|1|||
143296173|NCT03658538|516634930|FG001|Overall Study|Incomplete clinical visit at 6 months due to illness|0|||
143296174|NCT03658538|516634929|FG000|Overall Study|Evicted from home|1|||
143296175|NCT03658538|516634930|FG001|Overall Study|Evicted from home|0|||
143296176|NCT03279692|516634931|FG000|Overall Study|Withdrawal by Subject|1|||
143296177|NCT05198843|516634934|FG000|Overall Study|Lack of Efficacy|1|||
143296178|NCT02921776|516634936|FG000|Overall Study|patient deterioration, fatigue|2|||
143296179|NCT02921776|516634937|FG001|Overall Study|patient deterioration, fatigue|6|||
143296180|NCT02921776|516634938|FG002|Overall Study|patient deterioration, fatigue|0|||
143296181|NCT02921776|516634939|FG003|Overall Study|patient deterioration, fatigue|0|||
143296182|NCT02921776|516634940|FG004|Overall Study|patient deterioration, fatigue|0|||
143296183|NCT02921776|516634941|FG005|Overall Study|patient deterioration, fatigue|0|||
143296184|NCT02921776|516634942|FG006|Overall Study|patient deterioration, fatigue|0|||
143296185|NCT02921776|516634943|FG007|Overall Study|patient deterioration, fatigue|0|||
143296186|NCT02921776|516634936|FG000|Overall Study|Withdrawal by Subject|0|||
143296187|NCT02921776|516634937|FG001|Overall Study|Withdrawal by Subject|2|||
143296188|NCT02921776|516634938|FG002|Overall Study|Withdrawal by Subject|0|||
143296189|NCT02921776|516634939|FG003|Overall Study|Withdrawal by Subject|1|||
143296190|NCT02921776|516634940|FG004|Overall Study|Withdrawal by Subject|1|||
143296191|NCT02921776|516634941|FG005|Overall Study|Withdrawal by Subject|0|||
143296192|NCT02921776|516634942|FG006|Overall Study|Withdrawal by Subject|8|||
143296193|NCT02921776|516634943|FG007|Overall Study|Withdrawal by Subject|1|||
143296194|NCT02921776|516634936|FG000|Overall Study|Death|0|||
143296195|NCT02921776|516634937|FG001|Overall Study|Death|0|||
143296196|NCT02921776|516634938|FG002|Overall Study|Death|0|||
143296197|NCT02921776|516634939|FG003|Overall Study|Death|2|||
143296198|NCT02921776|516634940|FG004|Overall Study|Death|0|||
143296199|NCT02921776|516634941|FG005|Overall Study|Death|0|||
143296200|NCT02921776|516634942|FG006|Overall Study|Death|0|||
143296201|NCT02921776|516634943|FG007|Overall Study|Death|0|||
143296202|NCT02921776|516634936|FG000|Overall Study|extubation or early discharge|0|||
143296203|NCT02921776|516634937|FG001|Overall Study|extubation or early discharge|0|||
143296204|NCT02921776|516634938|FG002|Overall Study|extubation or early discharge|0|||
143296205|NCT02921776|516634939|FG003|Overall Study|extubation or early discharge|5|||
143296206|NCT02921776|516634940|FG004|Overall Study|extubation or early discharge|5|||
143296207|NCT02921776|516634941|FG005|Overall Study|extubation or early discharge|0|||
143296208|NCT02921776|516634942|FG006|Overall Study|extubation or early discharge|0|||
143296209|NCT02921776|516634943|FG007|Overall Study|extubation or early discharge|0|||
143296210|NCT02921776|516634936|FG000|Overall Study|Lost to Follow-up|0|||
143296211|NCT02921776|516634937|FG001|Overall Study|Lost to Follow-up|0|||
143296212|NCT02921776|516634938|FG002|Overall Study|Lost to Follow-up|0|||
143296213|NCT02921776|516634939|FG003|Overall Study|Lost to Follow-up|0|||
143296214|NCT02921776|516634940|FG004|Overall Study|Lost to Follow-up|0|||
143296215|NCT02921776|516634941|FG005|Overall Study|Lost to Follow-up|2|||
143296216|NCT02921776|516634942|FG006|Overall Study|Lost to Follow-up|3|||
143296217|NCT02921776|516634943|FG007|Overall Study|Lost to Follow-up|6|||
143296218|NCT04537234|516634945|FG000|Overall Study|Withdrawal by Subject|2|||
143296219|NCT04537234|516634946|FG001|Overall Study|Withdrawal by Subject|0|||
143296220|NCT00410761|516636486|FG000|Randomized Treatment Period|Adverse Event|34|||
143296221|NCT00410761|516636487|FG001|Randomized Treatment Period|Adverse Event|3|||
143296222|NCT00410761|516636486|FG000|Randomized Treatment Period|Objective Disease Progression|103|||
143296223|NCT00410761|516636487|FG001|Randomized Treatment Period|Objective Disease Progression|68|||
143296224|NCT00410761|516636486|FG000|Randomized Treatment Period|Withdrawal by Subject|11|||
143296225|NCT00410761|516636487|FG001|Randomized Treatment Period|Withdrawal by Subject|6|||
143296226|NCT00410761|516636486|FG000|Randomized Treatment Period|Other|69|||
143296227|NCT00410761|516636487|FG001|Randomized Treatment Period|Other|21|||
143296228|NCT00410761|516636486|FG000|Randomized Treatment Period|Randomized but did not Receive Treatment|0|||
143296229|NCT00410761|516636487|FG001|Randomized Treatment Period|Randomized but did not Receive Treatment|1|||
143296230|NCT00410761|516636486|FG000|Open-Label Treatment Period|Adverse Event|13|||
143296231|NCT00410761|516636487|FG001|Open-Label Treatment Period|Adverse Event|15|||
143296232|NCT00410761|516636486|FG000|Open-Label Treatment Period|Objective Disease Progression|42|||
143296233|NCT00410761|516636487|FG001|Open-Label Treatment Period|Objective Disease Progression|27|||
143296234|NCT00410761|516636486|FG000|Open-Label Treatment Period|Withdrawal by Subject|8|||
143296235|NCT00410761|516636487|FG001|Open-Label Treatment Period|Withdrawal by Subject|7|||
143296236|NCT00410761|516636486|FG000|Open-Label Treatment Period|Other|18|||
143296237|NCT00410761|516636487|FG001|Open-Label Treatment Period|Other|9|||
143296238|NCT03712904|516636489|FG000|Overall Study|Death|0|||
143296239|NCT03712904|516636490|FG001|Overall Study|Death|1|||
143296240|NCT03712904|516636489|FG000|Overall Study|Withdrawal by Subject|0|||
143296241|NCT03712904|516636490|FG001|Overall Study|Withdrawal by Subject|1|||
143296242|NCT03712904|516636489|FG000|Overall Study|progression/eye removed before 2 years (unable to complete testing)|1|||
143296243|NCT03712904|516636490|FG001|Overall Study|progression/eye removed before 2 years (unable to complete testing)|0|||
143296244|NCT00542919|516636496|FG000|Overall Study|Adverse Event|1|||
143296245|NCT00542919|516636497|FG001|Overall Study|Adverse Event|5|||
143296246|NCT00542919|516636498|FG002|Overall Study|Adverse Event|1|||
143296247|NCT00542919|516636496|FG000|Overall Study|Withdrawal by Subject|1|||
143296248|NCT00542919|516636497|FG001|Overall Study|Withdrawal by Subject|0|||
143296249|NCT00542919|516636498|FG002|Overall Study|Withdrawal by Subject|3|||
143296250|NCT00542919|516636496|FG000|Overall Study|Physician Decision|2|||
143296251|NCT00542919|516636497|FG001|Overall Study|Physician Decision|2|||
143296252|NCT00542919|516636498|FG002|Overall Study|Physician Decision|1|||
143296253|NCT00542919|516636496|FG000|Overall Study|Sponsor Decision|1|||
143296254|NCT00542919|516636497|FG001|Overall Study|Sponsor Decision|0|||
143296255|NCT00542919|516636498|FG002|Overall Study|Sponsor Decision|0|||
143296256|NCT00542919|516636496|FG000|Overall Study|Lost to Follow-up|2|||
143296257|NCT00542919|516636497|FG001|Overall Study|Lost to Follow-up|0|||
143296258|NCT00542919|516636498|FG002|Overall Study|Lost to Follow-up|1|||
143296259|NCT01394523|516636501|FG000|Overall Study|Unable to place block|1|||
143296260|NCT01394523|516636502|FG001|Overall Study|Unable to place block|0|||
143296261|NCT01394523|516636503|FG002|Overall Study|Unable to place block|0|||
143296262|NCT02432846|516636504|FG000|Overall Study (4 Arms/Strata)|Death|3|||
143296263|NCT02432846|516636505|FG001|Overall Study (4 Arms/Strata)|Death|2|||
143296264|NCT02432846|516636506|FG002|Overall Study (4 Arms/Strata)|Death|4|||
143296265|NCT02432846|516636507|FG003|Overall Study (4 Arms/Strata)|Death|3|||
143296266|NCT02432846|516636508|FG004|Overall Study (4 Arms/Strata)|Death|0|||
143296267|NCT02432846|516636509|FG005|Overall Study (4 Arms/Strata)|Death|0|||
143296268|NCT02432846|516636504|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
143296269|NCT02432846|516636505|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
143296270|NCT02432846|516636506|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
143296271|NCT02432846|516636507|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
143296272|NCT02432846|516636508|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
143296273|NCT02432846|516636509|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
143296274|NCT02432846|516636504|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
143296275|NCT02432846|516636505|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
143296276|NCT02432846|516636506|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
143296277|NCT02432846|516636507|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
143296278|NCT02432846|516636508|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
143296279|NCT02432846|516636509|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
143296280|NCT02432846|516636504|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
143296281|NCT02432846|516636505|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
143296282|NCT02432846|516636506|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
143296283|NCT02432846|516636507|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
143296284|NCT02432846|516636508|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
143296285|NCT02432846|516636509|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
143296286|NCT02432846|516636504|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
143374013|NCT01596504|516913656|FG001|Overall Study|Adverse Event|2|||
143374014|NCT01596504|516913657|FG002|Overall Study|Adverse Event|1|||
143374015|NCT01596504|516913655|FG000|Overall Study|Withdrawal by Subject|1|||
143374016|NCT01596504|516913656|FG001|Overall Study|Withdrawal by Subject|0|||
143296287|NCT02432846|516636505|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
143296288|NCT02432846|516636506|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
143296289|NCT02432846|516636507|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
143296290|NCT02432846|516636508|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
143296291|NCT02432846|516636509|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
143296292|NCT02432846|516636504|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
143296293|NCT02432846|516636505|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
143296294|NCT02432846|516636506|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
143296295|NCT02432846|516636507|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
143296296|NCT02432846|516636508|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
143296297|NCT02432846|516636509|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
143296298|NCT02432846|516636504|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
143296299|NCT02432846|516636505|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
143296300|NCT02432846|516636506|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
143296301|NCT02432846|516636507|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
143296302|NCT02432846|516636508|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
143296303|NCT02432846|516636509|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
143296304|NCT02432846|516636504|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
143296305|NCT02432846|516636505|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
143296306|NCT02432846|516636506|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
143296307|NCT02432846|516636507|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
143296308|NCT02432846|516636508|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
143296309|NCT02432846|516636509|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
143296310|NCT02432846|516636504|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
143296311|NCT02432846|516636505|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
143296312|NCT02432846|516636506|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
143296313|NCT02432846|516636507|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
143296314|NCT02432846|516636508|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
143296315|NCT02432846|516636509|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
143296316|NCT02432846|516636504|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
143296317|NCT02432846|516636505|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
143296318|NCT02432846|516636506|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
143296319|NCT02432846|516636507|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
143296320|NCT02432846|516636508|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
143296321|NCT02432846|516636509|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
143296322|NCT02432846|516636504|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
143296323|NCT02432846|516636505|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
143296324|NCT02432846|516636506|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
143296325|NCT02432846|516636507|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
143296326|NCT02432846|516636508|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
143296327|NCT02432846|516636509|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
143296328|NCT02432846|516636504|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
143296329|NCT02432846|516636505|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
143296330|NCT02432846|516636506|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
143296331|NCT02432846|516636507|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
143296332|NCT02432846|516636508|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
143296333|NCT02432846|516636509|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
143296334|NCT02432846|516636504|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
143296335|NCT02432846|516636505|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
143296336|NCT02432846|516636506|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
143296337|NCT02432846|516636507|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
143296338|NCT02432846|516636508|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
143296339|NCT02432846|516636509|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
143296340|NCT02432846|516636504|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
143296341|NCT02432846|516636505|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
143296342|NCT02432846|516636506|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
143296343|NCT02432846|516636507|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
143374017|NCT01596504|516913657|FG002|Overall Study|Withdrawal by Subject|0|||
143374018|NCT01901276|516913658|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
143374019|NCT01901276|516913659|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
143374020|NCT00395018|516913660|FG000|On-Treatment|Death|4|||
143374021|NCT00395018|516913660|FG000|On-Treatment|Other Reason|2|||
143374022|NCT00395018|516913660|FG000|On-Treatment|Poor/non-compliance|2|||
143374023|NCT00395018|516913660|FG000|On-Treatment|Subject no longer meets study criteria|2|||
143374024|NCT00395018|516913660|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
143296344|NCT02432846|516636508|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
143296345|NCT02432846|516636509|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
143296346|NCT01912287|516636510|FG000|Overall Study|Ineligible|1|||
143296347|NCT01912287|516636511|FG001|Overall Study|Ineligible|0|||
143296348|NCT01912287|516636512|FG002|Overall Study|Ineligible|1|||
143296349|NCT01912287|516636510|FG000|Overall Study|No-show|0|||
143296350|NCT01912287|516636511|FG001|Overall Study|No-show|0|||
143296351|NCT01912287|516636512|FG002|Overall Study|No-show|1|||
143296352|NCT01912287|516636510|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
143296353|NCT01912287|516636511|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
143296354|NCT01912287|516636512|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
143296355|NCT01912287|516636510|FG000|Overall Study|Felt treatment no longer needed|0|||
143296356|NCT01912287|516636511|FG001|Overall Study|Felt treatment no longer needed|1|||
143296357|NCT01912287|516636512|FG002|Overall Study|Felt treatment no longer needed|0|||
143296358|NCT01912287|516636510|FG000|Overall Study|Life circumstances|4|||
143296359|NCT01912287|516636511|FG001|Overall Study|Life circumstances|2|||
143296360|NCT01912287|516636512|FG002|Overall Study|Life circumstances|0|||
143296361|NCT01912287|516636510|FG000|Overall Study|Lost Interest|1|||
143296362|NCT01912287|516636511|FG001|Overall Study|Lost Interest|0|||
143296363|NCT01912287|516636512|FG002|Overall Study|Lost Interest|0|||
143296364|NCT01912287|516636510|FG000|Overall Study|Uknown reason - subject drop out|5|||
143296365|NCT01912287|516636511|FG001|Overall Study|Uknown reason - subject drop out|7|||
143296366|NCT01912287|516636512|FG002|Overall Study|Uknown reason - subject drop out|3|||
143296367|NCT01912287|516636510|FG000|Overall Study|Missed Assesment|1|||
143296368|NCT01912287|516636511|FG001|Overall Study|Missed Assesment|1|||
143296369|NCT01912287|516636512|FG002|Overall Study|Missed Assesment|1|||
143296370|NCT01912287|516636510|FG000|Overall Study|Scheduling/change in availability|17|||
143296371|NCT01912287|516636511|FG001|Overall Study|Scheduling/change in availability|10|||
143296372|NCT01912287|516636512|FG002|Overall Study|Scheduling/change in availability|8|||
143296373|NCT03226392|516636513|FG000|Overall Study|Protocol Deviation|1|||
143296374|NCT03226392|516636514|FG001|Overall Study|Protocol Deviation|0|||
143296375|NCT03226392|516636513|FG000|Overall Study|Physician Decision|1|||
143296376|NCT03226392|516636514|FG001|Overall Study|Physician Decision|0|||
143374025|NCT00395018|516913660|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
143296377|NCT03226392|516636513|FG000|Overall Study|Lost to Follow-up|1|||
143296378|NCT03226392|516636514|FG001|Overall Study|Lost to Follow-up|0|||
143296379|NCT03226392|516636513|FG000|Overall Study|Adverse Event|1|||
143296380|NCT03226392|516636514|FG001|Overall Study|Adverse Event|0|||
143296381|NCT03226392|516636513|FG000|Overall Study|Technical Problems|0|||
143296382|NCT03226392|516636514|FG001|Overall Study|Technical Problems|2|||
143296383|NCT03226392|516636513|FG000|Overall Study|Subject/Guardian Decision|7|||
143296384|NCT03226392|516636514|FG001|Overall Study|Subject/Guardian Decision|6|||
143296385|NCT04788953|516636518|FG000|Overall Study|Adverse Event|1|||
143296386|NCT04788953|516636519|FG001|Overall Study|Adverse Event|1|||
143296387|NCT04788953|516636518|FG000|Overall Study|Withdrawal by Subject|1|||
143296388|NCT04788953|516636519|FG001|Overall Study|Withdrawal by Subject|0|||
143296389|NCT04788953|516636518|FG000|Overall Study|Protocol Violation|0|||
143296390|NCT04788953|516636519|FG001|Overall Study|Protocol Violation|1|||
143296391|NCT00937157|516636520|FG000|Overall Study|Pregnancy|1|||
143296392|NCT00937157|516636520|FG000|Overall Study|Lost to Follow-up|3|||
143296393|NCT00469092|516636521|FG000|Overall Study|Adverse Event|5|||
143296394|NCT00469092|516636522|FG001|Overall Study|Adverse Event|4|||
143296395|NCT00469092|516636521|FG000|Overall Study|Lack of Efficacy|1|||
143296396|NCT00469092|516636522|FG001|Overall Study|Lack of Efficacy|0|||
143296397|NCT00469092|516636521|FG000|Overall Study|Lost to Follow-up|1|||
143296398|NCT00469092|516636522|FG001|Overall Study|Lost to Follow-up|2|||
143296399|NCT00469092|516636521|FG000|Overall Study|Protocol Violation|3|||
143296400|NCT00469092|516636522|FG001|Overall Study|Protocol Violation|3|||
143296401|NCT00469092|516636521|FG000|Overall Study|Withdrawal by Subject|4|||
143296402|NCT00469092|516636522|FG001|Overall Study|Withdrawal by Subject|4|||
143296403|NCT00469092|516636521|FG000|Overall Study|Withdrawal Criteria|3|||
143296404|NCT00469092|516636522|FG001|Overall Study|Withdrawal Criteria|4|||
143296405|NCT00469092|516636521|FG000|Overall Study|Incorrectly Randomised|4|||
143296406|NCT00469092|516636522|FG001|Overall Study|Incorrectly Randomised|3|||
143296407|NCT00469092|516636521|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
143296408|NCT00469092|516636522|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
143296409|NCT00469092|516636521|FG000|Overall Study|Use of lipid lowering drug|1|||
143296410|NCT00469092|516636522|FG001|Overall Study|Use of lipid lowering drug|0|||
143296411|NCT00469092|516636521|FG000|Overall Study|Hypoglycaemic Episodes|1|||
143296412|NCT00469092|516636522|FG001|Overall Study|Hypoglycaemic Episodes|1|||
143296413|NCT00469092|516636521|FG000|Overall Study|Abnormal lab value|1|||
143296414|NCT00469092|516636522|FG001|Overall Study|Abnormal lab value|0|||
143296415|NCT00469092|516636521|FG000|Overall Study|Use of Corticosteroid|1|||
143296416|NCT00469092|516636522|FG001|Overall Study|Use of Corticosteroid|0|||
143296417|NCT02150954|516636523|FG000|Overall Study|Protocol Violation|1|||
143296418|NCT02150954|516636524|FG001|Overall Study|Protocol Violation|0|||
143296419|NCT01998633|516636525|FG000|Overall Study|Death|1|||
143296420|NCT02631850|516636526|FG000|Treatment Period|Lost to Follow-up|0|||
143296421|NCT02631850|516636527|FG001|Treatment Period|Lost to Follow-up|1|||
143296422|NCT02631850|516636528|FG002|Treatment Period|Lost to Follow-up|0|||
143296423|NCT02631850|516636529|FG003|Treatment Period|Lost to Follow-up|0|||
143296424|NCT02631850|516636526|FG000|Treatment Period|Protocol Violation|1|||
143296425|NCT02631850|516636527|FG001|Treatment Period|Protocol Violation|0|||
143296426|NCT02631850|516636528|FG002|Treatment Period|Protocol Violation|0|||
143296427|NCT02631850|516636529|FG003|Treatment Period|Protocol Violation|0|||
143296428|NCT02631850|516636526|FG000|Treatment Period|Withdrawal by Subject|0|||
143296429|NCT02631850|516636527|FG001|Treatment Period|Withdrawal by Subject|5|||
143296430|NCT02631850|516636528|FG002|Treatment Period|Withdrawal by Subject|2|||
143296431|NCT02631850|516636529|FG003|Treatment Period|Withdrawal by Subject|2|||
143296432|NCT02631850|516636526|FG000|Treatment Period|Adverse Event|1|||
143296433|NCT02631850|516636527|FG001|Treatment Period|Adverse Event|0|||
143296434|NCT02631850|516636528|FG002|Treatment Period|Adverse Event|2|||
143296435|NCT02631850|516636529|FG003|Treatment Period|Adverse Event|3|||
143296436|NCT02631850|516636526|FG000|Treatment Period|Family medical issue|1|||
143296437|NCT02631850|516636527|FG001|Treatment Period|Family medical issue|0|||
143296438|NCT02631850|516636528|FG002|Treatment Period|Family medical issue|0|||
143296439|NCT02631850|516636529|FG003|Treatment Period|Family medical issue|0|||
143296440|NCT02631850|516636526|FG000|6 Month Follow up|Lost to Follow-up|5|||
143296441|NCT02631850|516636527|FG001|6 Month Follow up|Lost to Follow-up|8|||
143296442|NCT02631850|516636528|FG002|6 Month Follow up|Lost to Follow-up|3|||
143296443|NCT02631850|516636529|FG003|6 Month Follow up|Lost to Follow-up|5|||
143296444|NCT02631850|516636526|FG000|6 Month Follow up|Withdrawal by Subject|1|||
143296445|NCT02631850|516636527|FG001|6 Month Follow up|Withdrawal by Subject|0|||
143296446|NCT02631850|516636528|FG002|6 Month Follow up|Withdrawal by Subject|0|||
143296447|NCT02631850|516636529|FG003|6 Month Follow up|Withdrawal by Subject|2|||
143296448|NCT02631850|516636526|FG000|6 Month Follow up|Adverse Event|1|||
143296449|NCT02631850|516636527|FG001|6 Month Follow up|Adverse Event|4|||
143296450|NCT02631850|516636528|FG002|6 Month Follow up|Adverse Event|1|||
143296451|NCT02631850|516636529|FG003|6 Month Follow up|Adverse Event|3|||
143296452|NCT02631850|516636526|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
143296453|NCT02631850|516636527|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
143296454|NCT02631850|516636528|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
143296455|NCT02631850|516636529|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
143296456|NCT01462084|516636532|FG000|Overall Study|Withdrawal by Subject|1|||
143296457|NCT01462084|516636533|FG001|Overall Study|Withdrawal by Subject|0|||
143296458|NCT01462084|516636532|FG000|Overall Study|Protocol Violation|1|||
143296459|NCT01462084|516636533|FG001|Overall Study|Protocol Violation|1|||
143296460|NCT03992781|516636534|FG000|Overall Study|Lost to Follow-up|5|||
143296461|NCT03992781|516636534|FG000|Overall Study|Adverse Event|1|||
143296462|NCT03992781|516636534|FG000|Overall Study|Lack of Efficacy|5|||
143296463|NCT00518323|516636535|FG000|Overall Study|Lack of Efficacy|14|||
143296464|NCT00518323|516636536|FG001|Overall Study|Lack of Efficacy|2|||
143296465|NCT00518323|516636537|FG002|Overall Study|Lack of Efficacy|4|||
143296466|NCT00518323|516636538|FG003|Overall Study|Lack of Efficacy|20|||
143296467|NCT00518323|516636535|FG000|Overall Study|Withdrawal by Subject|1|||
143296468|NCT00518323|516636536|FG001|Overall Study|Withdrawal by Subject|2|||
143296469|NCT00518323|516636537|FG002|Overall Study|Withdrawal by Subject|4|||
143296470|NCT00518323|516636538|FG003|Overall Study|Withdrawal by Subject|2|||
143296471|NCT00518323|516636535|FG000|Overall Study|Lost to Follow-up|0|||
143296472|NCT00518323|516636536|FG001|Overall Study|Lost to Follow-up|2|||
143296473|NCT00518323|516636537|FG002|Overall Study|Lost to Follow-up|1|||
143296474|NCT00518323|516636538|FG003|Overall Study|Lost to Follow-up|3|||
143296475|NCT00518323|516636535|FG000|Overall Study|Adverse Event|1|||
143296476|NCT00518323|516636536|FG001|Overall Study|Adverse Event|1|||
143296477|NCT00518323|516636537|FG002|Overall Study|Adverse Event|1|||
143296478|NCT00518323|516636538|FG003|Overall Study|Adverse Event|0|||
143296479|NCT00518323|516636535|FG000|Overall Study|Prohibited medication and others|3|||
143296480|NCT00518323|516636536|FG001|Overall Study|Prohibited medication and others|1|||
143296481|NCT00518323|516636537|FG002|Overall Study|Prohibited medication and others|1|||
143296482|NCT00518323|516636538|FG003|Overall Study|Prohibited medication and others|0|||
143296483|NCT01086540|516636539|FG000|Overall Study|Death|3|||
143296484|NCT01086540|516636540|FG001|Overall Study|Death|1|||
143296485|NCT01086540|516636539|FG000|Overall Study|Physician Decision|2|||
143296486|NCT01086540|516636540|FG001|Overall Study|Physician Decision|1|||
143296487|NCT01086540|516636539|FG000|Overall Study|Addition of new therapy for PAH|1|||
143296488|NCT01086540|516636540|FG001|Overall Study|Addition of new therapy for PAH|0|||
143296489|NCT02278263|516636542|FG000|Overall Study|Protocol Violation|7|||
143296490|NCT02278263|516636543|FG001|Overall Study|Protocol Violation|0|||
143296491|NCT02278263|516636544|FG002|Overall Study|Protocol Violation|9|||
143296492|NCT03880019|516636545|FG000|Overall Study|Competing disease|1|||
143296493|NCT02092662|516636546|FG000|Overall Study|Lost to Follow-up|13|||
143296494|NCT02092662|516636547|FG001|Overall Study|Lost to Follow-up|0|||
143296495|NCT01132547|516636548|FG000|Overall Study|Withdrawal by Subject|3|||
143296496|NCT01132547|516636549|FG001|Overall Study|Withdrawal by Subject|1|||
143296497|NCT01132547|516636548|FG000|Overall Study|Death|1|||
143296498|NCT01132547|516636549|FG001|Overall Study|Death|0|||
143296499|NCT05811234|516636550|FG000|Overall Study|Loss of Effectiveness|2|||
143296500|NCT05811234|516636550|FG000|Overall Study|Adverse Event|4|||
143296501|NCT05811234|516636550|FG000|Overall Study|Pregnancy|1|||
143296502|NCT05811234|516636550|FG000|Overall Study|Disease progression|1|||
143296503|NCT05811234|516636550|FG000|Overall Study|Withdrawal by Subject|4|||
143296504|NCT05811234|516636550|FG000|Overall Study|Lost to Follow-up|13|||
143296505|NCT05811234|516636550|FG000|Overall Study|Personal reason, or the patient stops taking the study treatment|1|||
143296506|NCT03424265|516636555|FG000|Overall Study|screening failure|1|||
143296507|NCT03424265|516636556|FG001|Overall Study|screening failure|0|||
143374026|NCT00395018|516913660|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
143374027|NCT02314117|516913661|FG000|Overall Study|Lost to Follow-up|9|||
143374028|NCT02314117|516913662|FG001|Overall Study|Lost to Follow-up|14|||
143374029|NCT02314117|516913661|FG000|Overall Study|Withdrawal by Subject|3|||
143374030|NCT02314117|516913662|FG001|Overall Study|Withdrawal by Subject|2|||
143374031|NCT00909363|516913663|FG000|Overall Study|Withdrawal by Subject|1|||
143374032|NCT00909363|516913664|FG001|Overall Study|Withdrawal by Subject|0|||
143374033|NCT00909363|516913665|FG002|Overall Study|Withdrawal by Subject|0|||
143374034|NCT00909363|516913663|FG000|Overall Study|Lack of Efficacy|1|||
143374035|NCT00909363|516913664|FG001|Overall Study|Lack of Efficacy|0|||
143374036|NCT00909363|516913665|FG002|Overall Study|Lack of Efficacy|0|||
143374037|NCT02954848|516913666|FG000|Overall Study|Randomized but Not Treated|0|||
143374038|NCT02954848|516913667|FG001|Overall Study|Randomized but Not Treated|1|||
143374039|NCT02954848|516913666|FG000|Overall Study|Adverse Event|2|||
143374040|NCT02954848|516913667|FG001|Overall Study|Adverse Event|3|||
143374041|NCT02954848|516913666|FG000|Overall Study|Withdrawal by Participant|0|||
143374042|NCT02954848|516913667|FG001|Overall Study|Withdrawal by Participant|1|||
143374043|NCT02000817|516913668|FG000|Overall Study|Withdrawal by Subject|2|||
143374044|NCT02000817|516913669|FG001|Overall Study|Withdrawal by Subject|0|||
143374045|NCT02000817|516913670|FG002|Overall Study|Withdrawal by Subject|0|||
143374046|NCT02000817|516913671|FG003|Overall Study|Withdrawal by Subject|0|||
143374047|NCT02000817|516913668|FG000|Overall Study|Adverse Event|0|||
143374048|NCT02000817|516913669|FG001|Overall Study|Adverse Event|1|||
143374049|NCT02000817|516913670|FG002|Overall Study|Adverse Event|0|||
143374050|NCT02000817|516913671|FG003|Overall Study|Adverse Event|0|||
143374051|NCT02000817|516913668|FG000|Overall Study|Lost to Follow-up|0|||
143374052|NCT02000817|516913669|FG001|Overall Study|Lost to Follow-up|0|||
143374053|NCT02000817|516913670|FG002|Overall Study|Lost to Follow-up|1|||
143374054|NCT02000817|516913671|FG003|Overall Study|Lost to Follow-up|0|||
143374055|NCT05382104|516913672|FG000|Period 2 (2 Days)|Adverse Event|0|||
143374056|NCT05382104|516913673|FG001|Period 2 (2 Days)|Adverse Event|1|||
143374057|NCT05382104|516913674|FG002|Period 2 (2 Days)|Adverse Event|0|||
143374058|NCT05382104|516913675|FG003|Period 2 (2 Days)|Adverse Event|0|||
143296508|NCT03424265|516636555|FG000|Overall Study|Withdrawal by Subject|0|||
143374059|NCT05382104|516913676|FG004|Period 2 (2 Days)|Adverse Event|0|||
143374060|NCT05382104|516913677|FG005|Period 2 (2 Days)|Adverse Event|0|||
143374061|NCT05082025|516913679|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 1 full cycle of treatment)|1|||
143374062|NCT01585558|516913681|FG000|Overall Study|Withdrawal by Subject|4|||
143296509|NCT03424265|516636556|FG001|Overall Study|Withdrawal by Subject|2|||
143296510|NCT00894322|516636568|FG000|Overall Study|Withdrawal by Subject|1|||
143296511|NCT00894322|516636569|FG001|Overall Study|Withdrawal by Subject|0|||
143296512|NCT00894322|516636570|FG002|Overall Study|Withdrawal by Subject|0|||
143296513|NCT02738450|516636578|FG000|Overall Study|Withdrawal by Subject|0|||
143296514|NCT02738450|516636579|FG001|Overall Study|Withdrawal by Subject|2|||
143296515|NCT02738450|516636580|FG002|Overall Study|Withdrawal by Subject|0|||
143296516|NCT03251079|516636581|FG000|Overall Study|Withdrawal by Subject|1|||
143296517|NCT00733746|516636585|FG000|Overall Study|Ineligible|5|||
143374063|NCT01585558|516913682|FG001|Overall Study|Withdrawal by Subject|5|||
143296518|NCT02113956|516636586|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
143296519|NCT02113956|516636587|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
143296520|NCT02113956|516636586|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
143296521|NCT02113956|516636587|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
143296522|NCT02113956|516636586|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
143296523|NCT02113956|516636587|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
143296524|NCT02446990|516636588|FG000|Overall Study|Death|485|||
143296525|NCT02446990|516636589|FG001|Overall Study|Death|458|||
143296526|NCT02446990|516636588|FG000|Overall Study|Lost to Follow-up|3|||
143296527|NCT02446990|516636589|FG001|Overall Study|Lost to Follow-up|1|||
143296528|NCT02446990|516636588|FG000|Overall Study|Physician Decision|1|||
143296529|NCT02446990|516636589|FG001|Overall Study|Physician Decision|0|||
143296530|NCT02446990|516636588|FG000|Overall Study|Withdrawal by Subject|231|||
143296531|NCT02446990|516636589|FG001|Overall Study|Withdrawal by Subject|199|||
143296532|NCT01064401|516636590|FG000|Overall Study|Adverse Event|47|||
143296533|NCT01064401|516636591|FG001|Overall Study|Adverse Event|56|||
143296534|NCT01064401|516636590|FG000|Overall Study|Lack of Efficacy|46|||
143296535|NCT01064401|516636591|FG001|Overall Study|Lack of Efficacy|23|||
143296536|NCT01064401|516636590|FG000|Overall Study|Lost to Follow-up|12|||
143296537|NCT01064401|516636591|FG001|Overall Study|Lost to Follow-up|9|||
143296538|NCT01064401|516636590|FG000|Overall Study|Consent Withdrawn|98|||
143296539|NCT01064401|516636591|FG001|Overall Study|Consent Withdrawn|80|||
143296540|NCT01064401|516636590|FG000|Overall Study|Investigator Decision|4|||
143296541|NCT01064401|516636591|FG001|Overall Study|Investigator Decision|6|||
143296542|NCT01064401|516636590|FG000|Overall Study|Death|4|||
143296543|NCT01064401|516636591|FG001|Overall Study|Death|0|||
143296544|NCT01064401|516636590|FG000|Overall Study|Pregnancy|4|||
143296545|NCT01064401|516636591|FG001|Overall Study|Pregnancy|7|||
143296546|NCT01064401|516636590|FG000|Overall Study|Noncompliance|7|||
143296547|NCT01064401|516636591|FG001|Overall Study|Noncompliance|8|||
143296548|NCT01064401|516636590|FG000|Overall Study|Site Closure|4|||
143296549|NCT01064401|516636591|FG001|Overall Study|Site Closure|5|||
143296550|NCT01064401|516636590|FG000|Overall Study|Other|2|||
143296551|NCT01064401|516636591|FG001|Overall Study|Other|1|||
143296552|NCT03158051|516636592|FG000|Overall Study|Lost to Follow-up|41|||
143296553|NCT03158051|516636593|FG001|Overall Study|Lost to Follow-up|47|||
143296554|NCT03158051|516636592|FG000|Overall Study|Physician Decision|6|||
143296555|NCT03158051|516636593|FG001|Overall Study|Physician Decision|7|||
143296556|NCT03158051|516636592|FG000|Overall Study|Withdrawal by Subject|24|||
143296557|NCT03158051|516636593|FG001|Overall Study|Withdrawal by Subject|15|||
143296558|NCT03158051|516636592|FG000|Overall Study|Death|0|||
143296559|NCT03158051|516636593|FG001|Overall Study|Death|1|||
143296560|NCT02738151|516636594|FG000|Overall Study|Randomized but not treated|4|||
143296561|NCT02738151|516636595|FG001|Overall Study|Randomized but not treated|1|||
143296562|NCT02738151|516636594|FG000|Overall Study|Adverse Event|4|||
143296563|NCT02738151|516636595|FG001|Overall Study|Adverse Event|5|||
143296564|NCT02738151|516636594|FG000|Overall Study|Hypoglycemia|0|||
143296565|NCT02738151|516636595|FG001|Overall Study|Hypoglycemia|1|||
143296566|NCT02738151|516636594|FG000|Overall Study|Poor Compliance to Protocol|4|||
143296567|NCT02738151|516636595|FG001|Overall Study|Poor Compliance to Protocol|3|||
143296568|NCT02738151|516636594|FG000|Overall Study|Other than specified above|11|||
143296569|NCT02738151|516636595|FG001|Overall Study|Other than specified above|21|||
143296570|NCT02588833|516636596|FG000|Part 1|Withdrawal by Subject|1|||
143296571|NCT02588833|516636597|FG001|Part 1|Withdrawal by Subject|0|||
143296572|NCT02588833|516636596|FG000|Part 2A|Physician Decision|0|||
143296573|NCT02588833|516636597|FG001|Part 2A|Physician Decision|1|||
143296574|NCT02588833|516636596|FG000|Part 2A|Withdrawal by Subject|0|||
143296575|NCT02588833|516636597|FG001|Part 2A|Withdrawal by Subject|1|||
143296576|NCT02588833|516636596|FG000|Part 2B|Adverse Event|0|||
143296577|NCT02588833|516636597|FG001|Part 2B|Adverse Event|1|||
143296578|NCT02588833|516636596|FG000|Part 2C|Adverse Event|0|||
143296579|NCT02588833|516636597|FG001|Part 2C|Adverse Event|1|||
143296580|NCT02588833|516636596|FG000|Part 2C|Withdrawal by Subject|0|||
143296581|NCT02588833|516636597|FG001|Part 2C|Withdrawal by Subject|1|||
143296582|NCT02588833|516636596|FG000|Part 3 (Safety Follow-up)|Other|0|||
143296583|NCT02588833|516636597|FG001|Part 3 (Safety Follow-up)|Other|2|||
143296584|NCT03333044|516636601|FG000|Overall Study|Pregnancy|1|||
143296585|NCT03333044|516636602|FG001|Overall Study|Pregnancy|0|||
143296586|NCT03333044|516636603|FG002|Overall Study|Pregnancy|0|||
143296587|NCT03333044|516636601|FG000|Overall Study|Lost to Follow-up|0|||
143296588|NCT03333044|516636602|FG001|Overall Study|Lost to Follow-up|14|||
143296589|NCT03333044|516636603|FG002|Overall Study|Lost to Follow-up|6|||
143296590|NCT03649711|516636606|FG000|Overall Study|Adverse Event|0|||
143296591|NCT03649711|516636607|FG001|Overall Study|Adverse Event|1|||
143296592|NCT03649711|516636608|FG002|Overall Study|Adverse Event|0|||
143296593|NCT03649711|516636606|FG000|Overall Study|Kidney Transplant|1|||
143296594|NCT03649711|516636607|FG001|Overall Study|Kidney Transplant|0|||
143296595|NCT03649711|516636608|FG002|Overall Study|Kidney Transplant|0|||
143296596|NCT00296374|516636612|FG000|Overall Study|Adverse Event|14|||
143296597|NCT00296374|516636613|FG001|Overall Study|Adverse Event|10|||
143374064|NCT01585558|516913683|FG002|Overall Study|Withdrawal by Subject|8|||
143374065|NCT01585558|516913681|FG000|Overall Study|Lost to Follow-up|2|||
143374066|NCT01585558|516913682|FG001|Overall Study|Lost to Follow-up|0|||
143374067|NCT01585558|516913683|FG002|Overall Study|Lost to Follow-up|3|||
143374068|NCT01585558|516913681|FG000|Overall Study|Adverse Event|3|||
143374069|NCT01585558|516913682|FG001|Overall Study|Adverse Event|4|||
143374070|NCT01585558|516913683|FG002|Overall Study|Adverse Event|1|||
143374071|NCT01585558|516913681|FG000|Overall Study|Protocol Violation|4|||
143296598|NCT00296374|516636614|FG002|Overall Study|Adverse Event|7|||
143296599|NCT00296374|516636612|FG000|Overall Study|Withdrawal by Subject|3|||
143296600|NCT00296374|516636613|FG001|Overall Study|Withdrawal by Subject|5|||
143296601|NCT00296374|516636614|FG002|Overall Study|Withdrawal by Subject|11|||
143296602|NCT00296374|516636612|FG000|Overall Study|Incorrect enrollment|3|||
143296603|NCT00296374|516636613|FG001|Overall Study|Incorrect enrollment|3|||
143296604|NCT00296374|516636614|FG002|Overall Study|Incorrect enrollment|4|||
143296605|NCT00296374|516636612|FG000|Overall Study|Protocol Violation|1|||
143296606|NCT00296374|516636613|FG001|Overall Study|Protocol Violation|2|||
143296607|NCT00296374|516636614|FG002|Overall Study|Protocol Violation|3|||
143296608|NCT00296374|516636612|FG000|Overall Study|Lost to Follow-up|3|||
143296609|NCT00296374|516636613|FG001|Overall Study|Lost to Follow-up|1|||
143374072|NCT01585558|516913682|FG001|Overall Study|Protocol Violation|3|||
143374073|NCT01585558|516913683|FG002|Overall Study|Protocol Violation|2|||
143374074|NCT01585558|516913681|FG000|Overall Study|Lack of Efficacy|0|||
143374075|NCT01585558|516913682|FG001|Overall Study|Lack of Efficacy|0|||
143374076|NCT01585558|516913683|FG002|Overall Study|Lack of Efficacy|1|||
143374077|NCT00361283|516913684|FG000|Overall Study|Lost to Follow-up|27|||
143374078|NCT00961636|516913687|FG000|Overall Study|Adverse Event|35|||
143374079|NCT00961636|516913688|FG001|Overall Study|Adverse Event|54|||
143374080|NCT00961636|516913689|FG002|Overall Study|Adverse Event|13|||
143374081|NCT00961636|516913687|FG000|Overall Study|Flushing Symptoms|29|||
143374082|NCT00961636|516913688|FG001|Overall Study|Flushing Symptoms|46|||
143374083|NCT00961636|516913689|FG002|Overall Study|Flushing Symptoms|3|||
143374084|NCT00961636|516913687|FG000|Overall Study|Lost to Follow-up|2|||
143374085|NCT00961636|516913688|FG001|Overall Study|Lost to Follow-up|3|||
143374086|NCT00961636|516913689|FG002|Overall Study|Lost to Follow-up|1|||
143374087|NCT00961636|516913687|FG000|Overall Study|Physician Decision|3|||
143374088|NCT00961636|516913688|FG001|Overall Study|Physician Decision|1|||
143374089|NCT00961636|516913689|FG002|Overall Study|Physician Decision|1|||
143374090|NCT00961636|516913687|FG000|Overall Study|Protocol Violation|9|||
143374091|NCT00961636|516913688|FG001|Overall Study|Protocol Violation|5|||
143374092|NCT00961636|516913689|FG002|Overall Study|Protocol Violation|1|||
143374093|NCT00961636|516913687|FG000|Overall Study|Withdrawal by Subject|29|||
143374094|NCT00961636|516913688|FG001|Overall Study|Withdrawal by Subject|22|||
143374095|NCT00961636|516913689|FG002|Overall Study|Withdrawal by Subject|13|||
143374096|NCT00688519|516913690|FG000|Overall Study|Adverse Event|2|||
143374097|NCT00688519|516913691|FG001|Overall Study|Adverse Event|3|||
143374098|NCT00688519|516913690|FG000|Overall Study|Lost to Follow-up|3|||
143374099|NCT00688519|516913691|FG001|Overall Study|Lost to Follow-up|3|||
143374100|NCT00688519|516913690|FG000|Overall Study|Lack of Efficacy|3|||
143374101|NCT00688519|516913691|FG001|Overall Study|Lack of Efficacy|1|||
143374102|NCT00688519|516913690|FG000|Overall Study|Withdrawal by Subject|7|||
143374103|NCT00688519|516913691|FG001|Overall Study|Withdrawal by Subject|6|||
143374104|NCT00688519|516913690|FG000|Overall Study|Prohibited medication|1|||
143374105|NCT00688519|516913691|FG001|Overall Study|Prohibited medication|0|||
143374106|NCT00688519|516913690|FG000|Overall Study|Non-compliance|0|||
143296610|NCT00296374|516636614|FG002|Overall Study|Lost to Follow-up|1|||
143296611|NCT00296374|516636612|FG000|Overall Study|Relocated to another state|1|||
143296612|NCT00296374|516636613|FG001|Overall Study|Relocated to another state|0|||
143296613|NCT00296374|516636614|FG002|Overall Study|Relocated to another state|0|||
143296614|NCT00296374|516636612|FG000|Overall Study|Stopped drug before end of study visit|0|||
143296615|NCT00296374|516636613|FG001|Overall Study|Stopped drug before end of study visit|1|||
143296616|NCT00296374|516636614|FG002|Overall Study|Stopped drug before end of study visit|0|||
143296617|NCT00296374|516636612|FG000|Overall Study|Nephrologist introduced ACE|0|||
143296618|NCT00296374|516636613|FG001|Overall Study|Nephrologist introduced ACE|1|||
143296619|NCT00296374|516636614|FG002|Overall Study|Nephrologist introduced ACE|0|||
143296620|NCT00296374|516636612|FG000|Overall Study|Pregnancy|0|||
143296621|NCT00296374|516636613|FG001|Overall Study|Pregnancy|0|||
143296622|NCT00296374|516636614|FG002|Overall Study|Pregnancy|2|||
143296623|NCT00296374|516636612|FG000|Overall Study|Other|0|||
143296624|NCT00296374|516636613|FG001|Overall Study|Other|0|||
143296625|NCT00296374|516636614|FG002|Overall Study|Other|1|||
143296626|NCT01721330|516636615|FG000|Overall Study|Withdrawal by Subject|0|||
143296627|NCT01721330|516636616|FG001|Overall Study|Withdrawal by Subject|1|||
143296628|NCT04318080|516638786|FG000|Overall Study|Study closed by sponsor|10|||
143296629|NCT04318080|516638787|FG001|Overall Study|Study closed by sponsor|22|||
143296630|NCT04318080|516638786|FG000|Overall Study|Death|3|||
143296631|NCT04318080|516638787|FG001|Overall Study|Death|9|||
143296632|NCT04318080|516638786|FG000|Overall Study|Withdrawal by Subject|1|||
143296633|NCT04318080|516638787|FG001|Overall Study|Withdrawal by Subject|0|||
143296634|NCT04318080|516638786|FG000|Overall Study|Protocol Deviation|1|||
143296635|NCT04318080|516638787|FG001|Overall Study|Protocol Deviation|0|||
143296636|NCT06308822|516638788|FG000|Overall Study|Mutation Status Not Confirmed|17|||
143296637|NCT06308822|516638788|FG000|Overall Study|Adverse Event|1|||
143296638|NCT06308822|516638788|FG000|Overall Study|Death|5|||
143296639|NCT06308822|516638788|FG000|Overall Study|Disease progression|8|||
143296640|NCT06308822|516638788|FG000|Overall Study|Withdrawal by Subject|1|||
143296641|NCT06308822|516638788|FG000|Overall Study|Physician Decision|3|||
143296642|NCT02926924|516638789|FG000|Overall Study|withdrawal - reason unknown|0|||
143296643|NCT02926924|516638790|FG001|Overall Study|withdrawal - reason unknown|1|||
143296644|NCT04734652|516638796|FG000|Overall Study|Withdrawal by Subject|2|||
143296645|NCT04734652|516638797|FG001|Overall Study|Withdrawal by Subject|0|||
143296646|NCT04734652|516638796|FG000|Overall Study|Death|0|||
143296647|NCT04734652|516638797|FG001|Overall Study|Death|1|||
143296648|NCT01852942|516638799|FG000|Overall Study|Physician Decision|1|||
143296649|NCT01852942|516638800|FG001|Overall Study|Physician Decision|0|||
143296650|NCT01852942|516638799|FG000|Overall Study|Death|1|||
143296651|NCT01852942|516638800|FG001|Overall Study|Death|1|||
143296652|NCT01852942|516638799|FG000|Overall Study|Withdrawal by Subject|2|||
143296653|NCT01852942|516638800|FG001|Overall Study|Withdrawal by Subject|3|||
143296654|NCT01852942|516638799|FG000|Overall Study|Lost to Follow-up|1|||
143296655|NCT01852942|516638800|FG001|Overall Study|Lost to Follow-up|2|||
143296656|NCT01921179|516638801|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
143296657|NCT01921179|516638802|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
143296658|NCT01921179|516638801|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
143296659|NCT01921179|516638802|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
143296660|NCT01190254|516638807|FG000|Overall Study|Adverse Event|3|||
143296661|NCT01190254|516638808|FG001|Overall Study|Adverse Event|6|||
143296662|NCT01190254|516638809|FG002|Overall Study|Adverse Event|8|||
143296663|NCT01190254|516638807|FG000|Overall Study|Lack of Efficacy|7|||
143296664|NCT01190254|516638808|FG001|Overall Study|Lack of Efficacy|4|||
143296665|NCT01190254|516638809|FG002|Overall Study|Lack of Efficacy|5|||
143296666|NCT01190254|516638807|FG000|Overall Study|Lost to Follow-up|4|||
143296667|NCT01190254|516638808|FG001|Overall Study|Lost to Follow-up|2|||
143296668|NCT01190254|516638809|FG002|Overall Study|Lost to Follow-up|0|||
143296669|NCT01190254|516638807|FG000|Overall Study|Withdrawal by Subject|4|||
143296670|NCT01190254|516638808|FG001|Overall Study|Withdrawal by Subject|5|||
143296671|NCT01190254|516638809|FG002|Overall Study|Withdrawal by Subject|7|||
143296672|NCT01190254|516638807|FG000|Overall Study|Protocol Violation|2|||
143296673|NCT01190254|516638808|FG001|Overall Study|Protocol Violation|0|||
143296674|NCT01190254|516638809|FG002|Overall Study|Protocol Violation|2|||
143296675|NCT01190254|516638807|FG000|Overall Study|Did not meet protocol eligibility|1|||
143296676|NCT01190254|516638808|FG001|Overall Study|Did not meet protocol eligibility|0|||
143296677|NCT01190254|516638809|FG002|Overall Study|Did not meet protocol eligibility|0|||
143296678|NCT04146545|516638810|FG000|Overall Study|deemed ineligible after randomization|1|||
143296679|NCT04146545|516638811|FG001|Overall Study|deemed ineligible after randomization|0|||
143374107|NCT00688519|516913691|FG001|Overall Study|Non-compliance|1|||
143296680|NCT01729754|516638812|FG000|Part 1|Adverse Event|2|||
143296681|NCT01729754|516638813|FG001|Part 1|Adverse Event|0|||
143296682|NCT01729754|516638814|FG002|Part 1|Adverse Event|0|||
143296683|NCT01729754|516638815|FG003|Part 1|Adverse Event|1|||
143296684|NCT01729754|516638816|FG004|Part 1|Adverse Event|0|||
143296685|NCT01729754|516638817|FG005|Part 1|Adverse Event|0|||
143296686|NCT01729754|516638818|FG006|Part 1|Adverse Event|2|||
143296687|NCT01729754|516638819|FG007|Part 1|Adverse Event|0|||
143296688|NCT01729754|516638820|FG008|Part 1|Adverse Event|0|||
143296689|NCT01729754|516638821|FG009|Part 1|Adverse Event|5|||
143296690|NCT01729754|516638812|FG000|Part 1|Lack of Efficacy|1|||
143296691|NCT01729754|516638813|FG001|Part 1|Lack of Efficacy|0|||
143296692|NCT01729754|516638814|FG002|Part 1|Lack of Efficacy|0|||
143296693|NCT01729754|516638815|FG003|Part 1|Lack of Efficacy|0|||
143296694|NCT01729754|516638816|FG004|Part 1|Lack of Efficacy|0|||
143296695|NCT01729754|516638817|FG005|Part 1|Lack of Efficacy|0|||
143296696|NCT01729754|516638818|FG006|Part 1|Lack of Efficacy|2|||
143296697|NCT01729754|516638819|FG007|Part 1|Lack of Efficacy|0|||
143296698|NCT01729754|516638820|FG008|Part 1|Lack of Efficacy|0|||
143296699|NCT01729754|516638821|FG009|Part 1|Lack of Efficacy|0|||
143296700|NCT01729754|516638812|FG000|Part 1|Lost to Follow-up|1|||
143296701|NCT01729754|516638813|FG001|Part 1|Lost to Follow-up|0|||
143296702|NCT01729754|516638814|FG002|Part 1|Lost to Follow-up|0|||
143296703|NCT01729754|516638815|FG003|Part 1|Lost to Follow-up|2|||
143296704|NCT01729754|516638816|FG004|Part 1|Lost to Follow-up|0|||
143296705|NCT01729754|516638817|FG005|Part 1|Lost to Follow-up|0|||
143296706|NCT01729754|516638818|FG006|Part 1|Lost to Follow-up|3|||
143296707|NCT01729754|516638819|FG007|Part 1|Lost to Follow-up|0|||
143296708|NCT01729754|516638820|FG008|Part 1|Lost to Follow-up|0|||
143296709|NCT01729754|516638821|FG009|Part 1|Lost to Follow-up|3|||
143296710|NCT01729754|516638812|FG000|Part 1|Non-compliance with Study Drug|1|||
143296711|NCT01729754|516638813|FG001|Part 1|Non-compliance with Study Drug|0|||
143296712|NCT01729754|516638814|FG002|Part 1|Non-compliance with Study Drug|0|||
143296713|NCT01729754|516638815|FG003|Part 1|Non-compliance with Study Drug|0|||
143296714|NCT01729754|516638816|FG004|Part 1|Non-compliance with Study Drug|0|||
143296715|NCT01729754|516638817|FG005|Part 1|Non-compliance with Study Drug|0|||
143296716|NCT01729754|516638818|FG006|Part 1|Non-compliance with Study Drug|0|||
143296717|NCT01729754|516638819|FG007|Part 1|Non-compliance with Study Drug|0|||
143296718|NCT01729754|516638820|FG008|Part 1|Non-compliance with Study Drug|0|||
143296719|NCT01729754|516638821|FG009|Part 1|Non-compliance with Study Drug|0|||
143296720|NCT01729754|516638812|FG000|Part 1|Physician Decision|0|||
143296721|NCT01729754|516638813|FG001|Part 1|Physician Decision|0|||
143296722|NCT01729754|516638814|FG002|Part 1|Physician Decision|0|||
143296723|NCT01729754|516638815|FG003|Part 1|Physician Decision|0|||
143296724|NCT01729754|516638816|FG004|Part 1|Physician Decision|0|||
143296725|NCT01729754|516638817|FG005|Part 1|Physician Decision|0|||
143296726|NCT01729754|516638818|FG006|Part 1|Physician Decision|0|||
143296727|NCT01729754|516638819|FG007|Part 1|Physician Decision|0|||
143296728|NCT01729754|516638820|FG008|Part 1|Physician Decision|0|||
143296729|NCT01729754|516638821|FG009|Part 1|Physician Decision|4|||
143296730|NCT01729754|516638812|FG000|Part 1|Pregnancy|0|||
143296731|NCT01729754|516638813|FG001|Part 1|Pregnancy|0|||
143296732|NCT01729754|516638814|FG002|Part 1|Pregnancy|0|||
143296733|NCT01729754|516638815|FG003|Part 1|Pregnancy|1|||
143296734|NCT01729754|516638816|FG004|Part 1|Pregnancy|0|||
143296735|NCT01729754|516638817|FG005|Part 1|Pregnancy|0|||
143296736|NCT01729754|516638818|FG006|Part 1|Pregnancy|0|||
143296737|NCT01729754|516638819|FG007|Part 1|Pregnancy|0|||
143296738|NCT01729754|516638820|FG008|Part 1|Pregnancy|0|||
143296739|NCT01729754|516638821|FG009|Part 1|Pregnancy|1|||
143296740|NCT01729754|516638812|FG000|Part 1|Progressive Disease|0|||
143296741|NCT01729754|516638813|FG001|Part 1|Progressive Disease|0|||
143296742|NCT01729754|516638814|FG002|Part 1|Progressive Disease|0|||
143296743|NCT01729754|516638815|FG003|Part 1|Progressive Disease|0|||
143296744|NCT01729754|516638816|FG004|Part 1|Progressive Disease|0|||
143296745|NCT01729754|516638817|FG005|Part 1|Progressive Disease|0|||
143296746|NCT01729754|516638818|FG006|Part 1|Progressive Disease|0|||
143296747|NCT01729754|516638819|FG007|Part 1|Progressive Disease|0|||
143296748|NCT01729754|516638820|FG008|Part 1|Progressive Disease|0|||
143296749|NCT01729754|516638821|FG009|Part 1|Progressive Disease|1|||
143296750|NCT01729754|516638812|FG000|Part 1|Protocol Violation|2|||
143296751|NCT01729754|516638813|FG001|Part 1|Protocol Violation|0|||
143296752|NCT01729754|516638814|FG002|Part 1|Protocol Violation|0|||
143296753|NCT01729754|516638815|FG003|Part 1|Protocol Violation|1|||
143296754|NCT01729754|516638816|FG004|Part 1|Protocol Violation|0|||
143296755|NCT01729754|516638817|FG005|Part 1|Protocol Violation|0|||
143296756|NCT01729754|516638818|FG006|Part 1|Protocol Violation|1|||
143296757|NCT01729754|516638819|FG007|Part 1|Protocol Violation|0|||
143296758|NCT01729754|516638820|FG008|Part 1|Protocol Violation|0|||
143296759|NCT01729754|516638821|FG009|Part 1|Protocol Violation|0|||
143296760|NCT01729754|516638812|FG000|Part 1|Withdrawal by Subject|5|||
143296761|NCT01729754|516638813|FG001|Part 1|Withdrawal by Subject|0|||
143296762|NCT01729754|516638814|FG002|Part 1|Withdrawal by Subject|0|||
143296763|NCT01729754|516638815|FG003|Part 1|Withdrawal by Subject|7|||
143296764|NCT01729754|516638816|FG004|Part 1|Withdrawal by Subject|0|||
143296765|NCT01729754|516638817|FG005|Part 1|Withdrawal by Subject|0|||
143296766|NCT01729754|516638818|FG006|Part 1|Withdrawal by Subject|5|||
143296767|NCT01729754|516638819|FG007|Part 1|Withdrawal by Subject|0|||
143296768|NCT01729754|516638820|FG008|Part 1|Withdrawal by Subject|0|||
143296769|NCT01729754|516638821|FG009|Part 1|Withdrawal by Subject|6|||
143296770|NCT01729754|516638812|FG000|Part 1|Other Protocol Specified Criteria|2|||
143296771|NCT01729754|516638813|FG001|Part 1|Other Protocol Specified Criteria|0|||
143296772|NCT01729754|516638814|FG002|Part 1|Other Protocol Specified Criteria|0|||
143296773|NCT01729754|516638815|FG003|Part 1|Other Protocol Specified Criteria|0|||
143296774|NCT01729754|516638816|FG004|Part 1|Other Protocol Specified Criteria|0|||
143296775|NCT01729754|516638817|FG005|Part 1|Other Protocol Specified Criteria|0|||
143296776|NCT01729754|516638818|FG006|Part 1|Other Protocol Specified Criteria|1|||
143296777|NCT01729754|516638819|FG007|Part 1|Other Protocol Specified Criteria|0|||
143296778|NCT01729754|516638820|FG008|Part 1|Other Protocol Specified Criteria|0|||
143296779|NCT01729754|516638821|FG009|Part 1|Other Protocol Specified Criteria|4|||
143296780|NCT01729754|516638812|FG000|Part 2|Adverse Event|2|||
143296781|NCT01729754|516638813|FG001|Part 2|Adverse Event|0|||
143296782|NCT01729754|516638814|FG002|Part 2|Adverse Event|0|||
143296783|NCT01729754|516638815|FG003|Part 2|Adverse Event|0|||
143296784|NCT01729754|516638816|FG004|Part 2|Adverse Event|0|||
143296785|NCT01729754|516638817|FG005|Part 2|Adverse Event|0|||
143296786|NCT01729754|516638818|FG006|Part 2|Adverse Event|0|||
143296787|NCT01729754|516638819|FG007|Part 2|Adverse Event|0|||
143296788|NCT01729754|516638820|FG008|Part 2|Adverse Event|1|||
143296789|NCT01729754|516638821|FG009|Part 2|Adverse Event|2|||
143296790|NCT01729754|516638812|FG000|Part 2|Lack of Efficacy|0|||
143296791|NCT01729754|516638813|FG001|Part 2|Lack of Efficacy|0|||
143296792|NCT01729754|516638814|FG002|Part 2|Lack of Efficacy|0|||
143296793|NCT01729754|516638815|FG003|Part 2|Lack of Efficacy|0|||
143296794|NCT01729754|516638816|FG004|Part 2|Lack of Efficacy|0|||
143296795|NCT01729754|516638817|FG005|Part 2|Lack of Efficacy|0|||
143296796|NCT01729754|516638818|FG006|Part 2|Lack of Efficacy|0|||
143296797|NCT01729754|516638819|FG007|Part 2|Lack of Efficacy|0|||
143296798|NCT01729754|516638820|FG008|Part 2|Lack of Efficacy|2|||
143296799|NCT01729754|516638821|FG009|Part 2|Lack of Efficacy|2|||
143296800|NCT01729754|516638812|FG000|Part 2|Lost to Follow-up|0|||
143296801|NCT01729754|516638813|FG001|Part 2|Lost to Follow-up|0|||
143296802|NCT01729754|516638814|FG002|Part 2|Lost to Follow-up|0|||
143296803|NCT01729754|516638815|FG003|Part 2|Lost to Follow-up|2|||
143296804|NCT01729754|516638816|FG004|Part 2|Lost to Follow-up|0|||
143296805|NCT01729754|516638817|FG005|Part 2|Lost to Follow-up|0|||
143296806|NCT01729754|516638818|FG006|Part 2|Lost to Follow-up|0|||
143296807|NCT01729754|516638819|FG007|Part 2|Lost to Follow-up|1|||
143296808|NCT01729754|516638820|FG008|Part 2|Lost to Follow-up|0|||
143296809|NCT01729754|516638821|FG009|Part 2|Lost to Follow-up|2|||
143296810|NCT01729754|516638812|FG000|Part 2|Non-Compliance with Study Drug|0|||
143296811|NCT01729754|516638813|FG001|Part 2|Non-Compliance with Study Drug|0|||
143296812|NCT01729754|516638814|FG002|Part 2|Non-Compliance with Study Drug|0|||
143296813|NCT01729754|516638815|FG003|Part 2|Non-Compliance with Study Drug|0|||
143296814|NCT01729754|516638816|FG004|Part 2|Non-Compliance with Study Drug|0|||
143296815|NCT01729754|516638817|FG005|Part 2|Non-Compliance with Study Drug|0|||
143296816|NCT01729754|516638818|FG006|Part 2|Non-Compliance with Study Drug|0|||
143296817|NCT01729754|516638819|FG007|Part 2|Non-Compliance with Study Drug|0|||
143296818|NCT01729754|516638820|FG008|Part 2|Non-Compliance with Study Drug|0|||
143296819|NCT01729754|516638821|FG009|Part 2|Non-Compliance with Study Drug|1|||
143296820|NCT01729754|516638812|FG000|Part 2|Pregnancy|0|||
143296821|NCT01729754|516638813|FG001|Part 2|Pregnancy|0|||
143296822|NCT01729754|516638814|FG002|Part 2|Pregnancy|0|||
143296823|NCT01729754|516638815|FG003|Part 2|Pregnancy|1|||
143296824|NCT01729754|516638816|FG004|Part 2|Pregnancy|0|||
143296825|NCT01729754|516638817|FG005|Part 2|Pregnancy|0|||
143296826|NCT01729754|516638818|FG006|Part 2|Pregnancy|0|||
143296827|NCT01729754|516638819|FG007|Part 2|Pregnancy|0|||
143296828|NCT01729754|516638820|FG008|Part 2|Pregnancy|0|||
143296829|NCT01729754|516638821|FG009|Part 2|Pregnancy|1|||
143296830|NCT01729754|516638812|FG000|Part 2|Withdrawal by Subject|3|||
143296831|NCT01729754|516638813|FG001|Part 2|Withdrawal by Subject|0|||
143296832|NCT01729754|516638814|FG002|Part 2|Withdrawal by Subject|0|||
143296833|NCT01729754|516638815|FG003|Part 2|Withdrawal by Subject|2|||
143296834|NCT01729754|516638816|FG004|Part 2|Withdrawal by Subject|0|||
143296835|NCT01729754|516638817|FG005|Part 2|Withdrawal by Subject|0|||
143296836|NCT01729754|516638818|FG006|Part 2|Withdrawal by Subject|0|||
143296837|NCT01729754|516638819|FG007|Part 2|Withdrawal by Subject|1|||
143296838|NCT01729754|516638820|FG008|Part 2|Withdrawal by Subject|1|||
143296839|NCT01729754|516638821|FG009|Part 2|Withdrawal by Subject|4|||
143296840|NCT01729754|516638812|FG000|Part 2|Other Protocol Specified Criteria|1|||
143296841|NCT01729754|516638813|FG001|Part 2|Other Protocol Specified Criteria|0|||
143296842|NCT01729754|516638814|FG002|Part 2|Other Protocol Specified Criteria|0|||
143296843|NCT01729754|516638815|FG003|Part 2|Other Protocol Specified Criteria|0|||
143296844|NCT01729754|516638816|FG004|Part 2|Other Protocol Specified Criteria|0|||
143296845|NCT01729754|516638817|FG005|Part 2|Other Protocol Specified Criteria|0|||
143296846|NCT01729754|516638818|FG006|Part 2|Other Protocol Specified Criteria|0|||
143296847|NCT01729754|516638819|FG007|Part 2|Other Protocol Specified Criteria|1|||
143296848|NCT01729754|516638820|FG008|Part 2|Other Protocol Specified Criteria|0|||
143296849|NCT01729754|516638821|FG009|Part 2|Other Protocol Specified Criteria|0|||
143296850|NCT01729754|516638812|FG000|Part 3|Adverse Event|0|||
143296851|NCT01729754|516638813|FG001|Part 3|Adverse Event|0|||
143296852|NCT01729754|516638814|FG002|Part 3|Adverse Event|1|||
143296853|NCT01729754|516638815|FG003|Part 3|Adverse Event|0|||
143296854|NCT01729754|516638816|FG004|Part 3|Adverse Event|0|||
143296855|NCT01729754|516638817|FG005|Part 3|Adverse Event|5|||
143296856|NCT01729754|516638818|FG006|Part 3|Adverse Event|0|||
143296857|NCT01729754|516638819|FG007|Part 3|Adverse Event|0|||
143296858|NCT01729754|516638820|FG008|Part 3|Adverse Event|0|||
143296859|NCT01729754|516638821|FG009|Part 3|Adverse Event|3|||
143296860|NCT01729754|516638812|FG000|Part 3|Death|0|||
143296861|NCT01729754|516638813|FG001|Part 3|Death|0|||
143296862|NCT01729754|516638814|FG002|Part 3|Death|0|||
143296863|NCT01729754|516638815|FG003|Part 3|Death|0|||
143296864|NCT01729754|516638816|FG004|Part 3|Death|0|||
143296865|NCT01729754|516638817|FG005|Part 3|Death|2|||
143296866|NCT01729754|516638818|FG006|Part 3|Death|0|||
143296867|NCT01729754|516638819|FG007|Part 3|Death|0|||
143296868|NCT01729754|516638820|FG008|Part 3|Death|0|||
143296869|NCT01729754|516638821|FG009|Part 3|Death|0|||
143296870|NCT01729754|516638812|FG000|Part 3|Lack of Efficacy|0|||
143296871|NCT01729754|516638813|FG001|Part 3|Lack of Efficacy|0|||
143296872|NCT01729754|516638814|FG002|Part 3|Lack of Efficacy|0|||
143296873|NCT01729754|516638815|FG003|Part 3|Lack of Efficacy|0|||
143296874|NCT01729754|516638816|FG004|Part 3|Lack of Efficacy|2|||
143296875|NCT01729754|516638817|FG005|Part 3|Lack of Efficacy|0|||
143296876|NCT01729754|516638818|FG006|Part 3|Lack of Efficacy|0|||
143296877|NCT01729754|516638819|FG007|Part 3|Lack of Efficacy|0|||
143296878|NCT01729754|516638820|FG008|Part 3|Lack of Efficacy|0|||
143374108|NCT00688519|516913690|FG000|Overall Study|Subject moved out of state|1|||
143374109|NCT00688519|516913691|FG001|Overall Study|Subject moved out of state|0|||
143374110|NCT00688519|516913690|FG000|Overall Study|Investigator decision|1|||
143374111|NCT00688519|516913691|FG001|Overall Study|Investigator decision|0|||
143296879|NCT01729754|516638821|FG009|Part 3|Lack of Efficacy|4|||
143296880|NCT01729754|516638812|FG000|Part 3|Lost to Follow-up|0|||
143296881|NCT01729754|516638813|FG001|Part 3|Lost to Follow-up|1|||
143296882|NCT01729754|516638814|FG002|Part 3|Lost to Follow-up|2|||
143296883|NCT01729754|516638815|FG003|Part 3|Lost to Follow-up|0|||
143296884|NCT01729754|516638816|FG004|Part 3|Lost to Follow-up|0|||
143296885|NCT01729754|516638817|FG005|Part 3|Lost to Follow-up|3|||
143296886|NCT01729754|516638818|FG006|Part 3|Lost to Follow-up|0|||
143296887|NCT01729754|516638819|FG007|Part 3|Lost to Follow-up|0|||
143296888|NCT01729754|516638820|FG008|Part 3|Lost to Follow-up|1|||
143296889|NCT01729754|516638821|FG009|Part 3|Lost to Follow-up|0|||
143296890|NCT01729754|516638812|FG000|Part 3|Physician Decision|0|||
143296891|NCT01729754|516638813|FG001|Part 3|Physician Decision|0|||
143296892|NCT01729754|516638814|FG002|Part 3|Physician Decision|1|||
143296893|NCT01729754|516638815|FG003|Part 3|Physician Decision|0|||
143296894|NCT01729754|516638816|FG004|Part 3|Physician Decision|0|||
143296895|NCT01729754|516638817|FG005|Part 3|Physician Decision|0|||
143296896|NCT01729754|516638818|FG006|Part 3|Physician Decision|0|||
143296897|NCT01729754|516638819|FG007|Part 3|Physician Decision|0|||
143296898|NCT01729754|516638820|FG008|Part 3|Physician Decision|0|||
143296899|NCT01729754|516638821|FG009|Part 3|Physician Decision|0|||
143296900|NCT01729754|516638812|FG000|Part 3|Withdrawal by Subject|0|||
143296901|NCT01729754|516638813|FG001|Part 3|Withdrawal by Subject|4|||
143296902|NCT01729754|516638814|FG002|Part 3|Withdrawal by Subject|1|||
143296903|NCT01729754|516638815|FG003|Part 3|Withdrawal by Subject|0|||
143296904|NCT01729754|516638816|FG004|Part 3|Withdrawal by Subject|2|||
143296905|NCT01729754|516638817|FG005|Part 3|Withdrawal by Subject|1|||
143296906|NCT01729754|516638818|FG006|Part 3|Withdrawal by Subject|0|||
143296907|NCT01729754|516638819|FG007|Part 3|Withdrawal by Subject|2|||
143296908|NCT01729754|516638820|FG008|Part 3|Withdrawal by Subject|0|||
143296909|NCT01729754|516638821|FG009|Part 3|Withdrawal by Subject|0|||
143296910|NCT01729754|516638812|FG000|Part 3|Other Protocol Specified Criteria|0|||
143296911|NCT01729754|516638813|FG001|Part 3|Other Protocol Specified Criteria|0|||
143296912|NCT01729754|516638814|FG002|Part 3|Other Protocol Specified Criteria|0|||
143296913|NCT01729754|516638815|FG003|Part 3|Other Protocol Specified Criteria|0|||
143296914|NCT01729754|516638816|FG004|Part 3|Other Protocol Specified Criteria|0|||
143296915|NCT01729754|516638817|FG005|Part 3|Other Protocol Specified Criteria|2|||
143296916|NCT01729754|516638818|FG006|Part 3|Other Protocol Specified Criteria|0|||
143296917|NCT01729754|516638819|FG007|Part 3|Other Protocol Specified Criteria|1|||
143296918|NCT01729754|516638820|FG008|Part 3|Other Protocol Specified Criteria|0|||
143296919|NCT01729754|516638821|FG009|Part 3|Other Protocol Specified Criteria|0|||
143296920|NCT00773292|516638822|FG000|Treatment 48 Weeks|Adverse Event|1|||
143296921|NCT00773292|516638822|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
143296922|NCT02385266|516638823|FG000|Overall Study|Withdrawal by Subject|1|||
143296923|NCT02385266|516638824|FG001|Overall Study|Withdrawal by Subject|3|||
143296924|NCT00491387|516638828|FG000|Overall Study|study terminated|20|||
143296925|NCT00413192|516638831|FG000|Overall Study|Disease progression|26|||
143296926|NCT00413192|516638832|FG001|Overall Study|Disease progression|31|||
143296927|NCT00413192|516638833|FG002|Overall Study|Disease progression|16|||
143296928|NCT00413192|516638834|FG003|Overall Study|Disease progression|25|||
143296929|NCT00413192|516638831|FG000|Overall Study|Toxicity|3|||
143296930|NCT00413192|516638832|FG001|Overall Study|Toxicity|2|||
143296931|NCT00413192|516638833|FG002|Overall Study|Toxicity|2|||
143296932|NCT00413192|516638834|FG003|Overall Study|Toxicity|2|||
143296933|NCT00413192|516638831|FG000|Overall Study|Withdrawal by Subject|3|||
143296934|NCT00413192|516638832|FG001|Overall Study|Withdrawal by Subject|5|||
143296935|NCT00413192|516638833|FG002|Overall Study|Withdrawal by Subject|0|||
143296936|NCT00413192|516638834|FG003|Overall Study|Withdrawal by Subject|1|||
143296937|NCT00413192|516638831|FG000|Overall Study|Intercurrent illness|0|||
143296938|NCT00413192|516638832|FG001|Overall Study|Intercurrent illness|0|||
143296939|NCT00413192|516638833|FG002|Overall Study|Intercurrent illness|0|||
143296940|NCT00413192|516638834|FG003|Overall Study|Intercurrent illness|1|||
143296941|NCT00413192|516638831|FG000|Overall Study|Intercurrent death|0|||
143296942|NCT00413192|516638832|FG001|Overall Study|Intercurrent death|1|||
143296943|NCT00413192|516638833|FG002|Overall Study|Intercurrent death|0|||
143296944|NCT00413192|516638834|FG003|Overall Study|Intercurrent death|0|||
143296945|NCT00413192|516638831|FG000|Overall Study|Other|5|||
143296946|NCT00413192|516638832|FG001|Overall Study|Other|1|||
143296947|NCT00413192|516638833|FG002|Overall Study|Other|1|||
143296948|NCT00413192|516638834|FG003|Overall Study|Other|2|||
143296949|NCT00413192|516638831|FG000|Overall Study|Not treated|0|||
143296950|NCT00413192|516638832|FG001|Overall Study|Not treated|0|||
143296951|NCT00413192|516638833|FG002|Overall Study|Not treated|0|||
143296952|NCT00413192|516638834|FG003|Overall Study|Not treated|1|||
143296953|NCT03814746|516638835|FG000|Overall Study|Participant decision|9|||
143296954|NCT03814746|516638836|FG001|Overall Study|Participant decision|6|||
143296955|NCT03814746|516638837|FG002|Overall Study|Participant decision|15|||
143296956|NCT03814746|516638835|FG000|Overall Study|Physician Decision|2|||
143296957|NCT03814746|516638836|FG001|Overall Study|Physician Decision|2|||
143296958|NCT03814746|516638837|FG002|Overall Study|Physician Decision|4|||
143296959|NCT03814746|516638835|FG000|Overall Study|Death|2|||
143296960|NCT03814746|516638836|FG001|Overall Study|Death|2|||
143296961|NCT03814746|516638837|FG002|Overall Study|Death|2|||
143296962|NCT03814746|516638835|FG000|Overall Study|Adverse Event|2|||
143296963|NCT03814746|516638836|FG001|Overall Study|Adverse Event|2|||
143296964|NCT03814746|516638837|FG002|Overall Study|Adverse Event|1|||
143296965|NCT03814746|516638835|FG000|Overall Study|Lost to Follow-up|2|||
143296966|NCT03814746|516638836|FG001|Overall Study|Lost to Follow-up|1|||
143296967|NCT03814746|516638837|FG002|Overall Study|Lost to Follow-up|2|||
143296968|NCT03814746|516638835|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
143296969|NCT03814746|516638836|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
143296970|NCT03814746|516638837|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
143296971|NCT03814746|516638835|FG000|Overall Study|Pregnancy|0|||
143296972|NCT03814746|516638836|FG001|Overall Study|Pregnancy|1|||
143296973|NCT03814746|516638837|FG002|Overall Study|Pregnancy|1|||
143296974|NCT03814746|516638835|FG000|Overall Study|Protocol Violation|1|||
143296975|NCT03814746|516638836|FG001|Overall Study|Protocol Violation|0|||
143296976|NCT03814746|516638837|FG002|Overall Study|Protocol Violation|0|||
143296977|NCT01996826|516638840|FG000|Overall Study|Lost to Follow-up|6|||
143296978|NCT01996826|516638841|FG001|Overall Study|Lost to Follow-up|2|||
143296979|NCT01996826|516638840|FG000|Overall Study|Physician Decision|1|||
143296980|NCT01996826|516638841|FG001|Overall Study|Physician Decision|1|||
143296981|NCT00695396|516638842|FG000|Overall Study|Study Closed Prematurely|5|||
143374112|NCT00688519|516913690|FG000|Overall Study|Subject moved out of area|1|||
143374113|NCT00688519|516913691|FG001|Overall Study|Subject moved out of area|0|||
143374114|NCT00688519|516913690|FG000|Overall Study|Pregnancy|0|||
143374115|NCT00688519|516913691|FG001|Overall Study|Pregnancy|1|||
143374116|NCT01063517|516913692|FG000|Overall Study|Consent withdrawal|1|||
143374117|NCT01063517|516913693|FG001|Overall Study|Consent withdrawal|0|||
143374118|NCT01063517|516913692|FG000|Overall Study|Study reached data cut-off|19|||
143374119|NCT01063517|516913693|FG001|Overall Study|Study reached data cut-off|7|||
143374120|NCT01063517|516913692|FG000|Overall Study|Lost to Follow-up|4|||
143374121|NCT01063517|516913693|FG001|Overall Study|Lost to Follow-up|3|||
143374122|NCT01063517|516913692|FG000|Overall Study|Withdrawal by Subject|1|||
143374123|NCT01063517|516913693|FG001|Overall Study|Withdrawal by Subject|2|||
143374124|NCT01063517|516913692|FG000|Overall Study|Death|33|||
143374125|NCT01063517|516913693|FG001|Overall Study|Death|48|||
143374126|NCT00617201|516913694|FG000|Overall Study|Lost to Follow-up|9|||
143374127|NCT00617201|516913695|FG001|Overall Study|Lost to Follow-up|13|||
143374128|NCT01350804|516913696|FG000|Core Study|Withdrawal by Subject|11|||
143374129|NCT01350804|516913697|FG001|Core Study|Withdrawal by Subject|17|||
143374130|NCT01350804|516913698|FG002|Core Study|Withdrawal by Subject|16|||
143374131|NCT01350804|516913699|FG003|Core Study|Withdrawal by Subject|7|||
143374132|NCT01350804|516913696|FG000|Core Study|Study terminated by Sponsor|0|||
143374133|NCT01350804|516913697|FG001|Core Study|Study terminated by Sponsor|0|||
143374134|NCT01350804|516913698|FG002|Core Study|Study terminated by Sponsor|0|||
143374135|NCT01350804|516913699|FG003|Core Study|Study terminated by Sponsor|2|||
143374136|NCT01350804|516913696|FG000|Core Study|Protocol deviation|1|||
143374137|NCT01350804|516913697|FG001|Core Study|Protocol deviation|0|||
143374138|NCT01350804|516913698|FG002|Core Study|Protocol deviation|1|||
143374139|NCT01350804|516913699|FG003|Core Study|Protocol deviation|0|||
143374140|NCT01350804|516913696|FG000|Core Study|Physician Decision|1|||
143374141|NCT01350804|516913697|FG001|Core Study|Physician Decision|0|||
143374142|NCT01350804|516913698|FG002|Core Study|Physician Decision|1|||
143374143|NCT01350804|516913699|FG003|Core Study|Physician Decision|3|||
143374144|NCT01350804|516913696|FG000|Core Study|Lost to Follow-up|3|||
143374145|NCT01350804|516913697|FG001|Core Study|Lost to Follow-up|0|||
143374146|NCT01350804|516913698|FG002|Core Study|Lost to Follow-up|2|||
143374147|NCT01350804|516913699|FG003|Core Study|Lost to Follow-up|1|||
143374148|NCT01350804|516913696|FG000|Core Study|Lack of Efficacy|16|||
143374149|NCT01350804|516913697|FG001|Core Study|Lack of Efficacy|19|||
143374150|NCT01350804|516913698|FG002|Core Study|Lack of Efficacy|18|||
143374151|NCT01350804|516913699|FG003|Core Study|Lack of Efficacy|5|||
143374152|NCT01350804|516913696|FG000|Core Study|Death|1|||
143374153|NCT01350804|516913697|FG001|Core Study|Death|1|||
143374154|NCT01350804|516913698|FG002|Core Study|Death|1|||
143374155|NCT01350804|516913699|FG003|Core Study|Death|0|||
143374156|NCT01350804|516913696|FG000|Core Study|Adverse Event|8|||
143374157|NCT01350804|516913697|FG001|Core Study|Adverse Event|10|||
143374158|NCT01350804|516913698|FG002|Core Study|Adverse Event|8|||
143374159|NCT01350804|516913699|FG003|Core Study|Adverse Event|8|||
143374160|NCT01350804|516913696|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
143374161|NCT01350804|516913697|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
143374162|NCT01350804|516913698|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
143374163|NCT01350804|516913699|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
143374164|NCT01350804|516913696|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
143374165|NCT01350804|516913697|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
143374166|NCT01350804|516913698|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
143374167|NCT01350804|516913699|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
143374168|NCT01350804|516913696|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
143374169|NCT01350804|516913697|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
143374170|NCT01350804|516913698|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
143374171|NCT01350804|516913699|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
143374172|NCT01350804|516913696|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
143374173|NCT01350804|516913697|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
143374174|NCT01350804|516913698|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
143374175|NCT01350804|516913699|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
143374176|NCT01350804|516913696|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
143374177|NCT01350804|516913697|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
143374178|NCT01350804|516913698|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
143374179|NCT01350804|516913699|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
143374180|NCT01350804|516913696|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
143374181|NCT01350804|516913697|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
143374182|NCT01350804|516913698|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
143374183|NCT01350804|516913699|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
143374184|NCT04513522|516915363|FG000|Overall Study|Other reasons|1|||
143374185|NCT04513522|516915363|FG000|Overall Study|Adverse event unrelated to study drug|9|||
143374186|NCT04513522|516915363|FG000|Overall Study|Study drug toxicity|14|||
143374187|NCT04513522|516915363|FG000|Overall Study|Disease progression|39|||
143374188|NCT04513522|516915363|FG000|Overall Study|Participants withdrew consent|2|||
143374189|NCT05219253|516915375|FG000|Overall Study|Withdrawal by Subject|1|||
143374190|NCT05219253|516915376|FG001|Overall Study|Withdrawal by Subject|2|||
143296982|NCT00695396|516638843|FG001|Overall Study|Study Closed Prematurely|6|||
143296983|NCT00695396|516638844|FG002|Overall Study|Study Closed Prematurely|8|||
143296984|NCT00695396|516638842|FG000|Overall Study|Withdrawal by Subject|2|||
143296985|NCT00695396|516638843|FG001|Overall Study|Withdrawal by Subject|2|||
143296986|NCT00695396|516638844|FG002|Overall Study|Withdrawal by Subject|0|||
143296987|NCT00483379|516638845|FG000|Treatment Period|Adverse Event|1|||
143296988|NCT00483379|516638846|FG001|Treatment Period|Adverse Event|0|||
143296989|NCT00483379|516638845|FG000|Treatment Period|Withdrawal by Subject|1|||
143296990|NCT00483379|516638846|FG001|Treatment Period|Withdrawal by Subject|0|||
143296991|NCT00371254|516638848|FG000|Overall Study|Disease progression|13|||
143296992|NCT00371254|516638849|FG001|Overall Study|Disease progression|13|||
143296993|NCT00371254|516638848|FG000|Overall Study|Study drug toxicity|3|||
143296994|NCT00371254|516638849|FG001|Overall Study|Study drug toxicity|5|||
143296995|NCT00371254|516638848|FG000|Overall Study|Subject request|5|||
143296996|NCT00371254|516638849|FG001|Overall Study|Subject request|0|||
143296997|NCT00371254|516638848|FG000|Overall Study|Investigator Decision|2|||
143296998|NCT00371254|516638849|FG001|Overall Study|Investigator Decision|0|||
143296999|NCT00371254|516638848|FG000|Overall Study|Adverse event unrelated to study drug|0|||
143297000|NCT00371254|516638849|FG001|Overall Study|Adverse event unrelated to study drug|1|||
143297001|NCT00371254|516638848|FG000|Overall Study|Lost to Follow-up|0|||
143297002|NCT00371254|516638849|FG001|Overall Study|Lost to Follow-up|1|||
143297003|NCT00371254|516638848|FG000|Overall Study|Withdrawal by Subject|0|||
143297004|NCT00371254|516638849|FG001|Overall Study|Withdrawal by Subject|1|||
143297005|NCT03311659|516638854|FG000|Overall Study|Protocol Violation|1|||
143297006|NCT01179477|516638857|FG000|Overall Study|Death|542|||
143297007|NCT01179477|516638857|FG000|Overall Study|Unsuccessful implant|80|||
143297008|NCT01179477|516638857|FG000|Overall Study|Non-death withdrawal|438|||
143297009|NCT01179477|516638857|FG000|Overall Study|Did not complete final visit|27|||
143297010|NCT04327388|516638859|FG000|Overall Study|Adverse Event|17|||
143297011|NCT04327388|516638860|FG001|Overall Study|Adverse Event|18|||
143297012|NCT04327388|516638861|FG002|Overall Study|Adverse Event|9|||
143297013|NCT04327388|516638859|FG000|Overall Study|Other|1|||
143297014|NCT04327388|516638860|FG001|Overall Study|Other|2|||
143297015|NCT04327388|516638861|FG002|Overall Study|Other|0|||
143297016|NCT04327388|516638859|FG000|Overall Study|Randomized and not treated|2|||
143297017|NCT04327388|516638860|FG001|Overall Study|Randomized and not treated|0|||
143297018|NCT04327388|516638861|FG002|Overall Study|Randomized and not treated|2|||
143297019|NCT04053023|516638862|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
143297020|NCT04053023|516638863|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
143297021|NCT00071760|516638865|FG000|Overall Study|Adverse Event|2|||
143297022|NCT00071760|516638866|FG001|Overall Study|Adverse Event|1|||
143297023|NCT00071760|516638865|FG000|Overall Study|Lost to Follow-up|0|||
143297024|NCT00071760|516638866|FG001|Overall Study|Lost to Follow-up|3|||
143297025|NCT00071760|516638865|FG000|Overall Study|Protocol Violation|1|||
143297026|NCT00071760|516638866|FG001|Overall Study|Protocol Violation|0|||
143297027|NCT00071760|516638865|FG000|Overall Study|Withdrawal by Subject|0|||
143297028|NCT00071760|516638866|FG001|Overall Study|Withdrawal by Subject|1|||
143297029|NCT00071760|516638865|FG000|Overall Study|Insufficient Viral Load Response|1|||
143297030|NCT00071760|516638866|FG001|Overall Study|Insufficient Viral Load Response|1|||
143297031|NCT00071760|516638865|FG000|Overall Study|Lack of availability of RTV|1|||
143297032|NCT00071760|516638866|FG001|Overall Study|Lack of availability of RTV|0|||
143297033|NCT00071760|516638865|FG000|Overall Study|Physician Decision|2|||
143297034|NCT00071760|516638866|FG001|Overall Study|Physician Decision|1|||
143297035|NCT00071760|516638865|FG000|Overall Study|Relocation|0|||
143297036|NCT00071760|516638866|FG001|Overall Study|Relocation|1|||
143297037|NCT01558752|516638870|FG000|Overall Study|Physician Decision|2|||
143297038|NCT01558752|516638871|FG001|Overall Study|Physician Decision|0|||
143297039|NCT04387435|516638872|FG000|Overall Study|Physician Decision|1|||
143297040|NCT00391274|516638877|FG000|Overall Study|Death Due to Study Disease|55|||
143297041|NCT00391274|516638878|FG001|Overall Study|Death Due to Study Disease|45|||
143297042|NCT00391274|516638877|FG000|Overall Study|Lost to Follow-up|0|||
143297043|NCT00391274|516638878|FG001|Overall Study|Lost to Follow-up|3|||
143297044|NCT00391274|516638877|FG000|Overall Study|Physician Decision|4|||
143297045|NCT00391274|516638878|FG001|Overall Study|Physician Decision|2|||
143297046|NCT00391274|516638877|FG000|Overall Study|Withdrawal by Subject|0|||
143297047|NCT00391274|516638878|FG001|Overall Study|Withdrawal by Subject|3|||
143297048|NCT00391274|516638877|FG000|Overall Study|Death Due to Adverse Event|1|||
143297049|NCT00391274|516638878|FG001|Overall Study|Death Due to Adverse Event|3|||
143297050|NCT00391274|516638877|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
143297051|NCT00391274|516638878|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
143297052|NCT00391274|516638877|FG000|Overall Study|Death Not Study Related|0|||
143374191|NCT03086369|516915377|FG000|Overall Study|Lost to Follow-up|1|||
143297053|NCT00391274|516638878|FG001|Overall Study|Death Not Study Related|1|||
143297054|NCT03559257|516638881|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
143297055|NCT03559257|516638882|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
143297056|NCT03559257|516638881|FG000|Double Blind Treatment Period|Protocol Violation|1|||
143297057|NCT03559257|516638882|FG001|Double Blind Treatment Period|Protocol Violation|4|||
143297058|NCT03559257|516638881|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
143297059|NCT03559257|516638882|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
143297060|NCT03559257|516638881|FG000|Double Blind Treatment Period|Adverse Event|0|||
143297061|NCT03559257|516638882|FG001|Double Blind Treatment Period|Adverse Event|1|||
143297062|NCT03559257|516638881|FG000|Double Blind Treatment Period|Screen Failure|0|||
143297063|NCT03559257|516638882|FG001|Double Blind Treatment Period|Screen Failure|1|||
143297064|NCT03559257|516638881|FG000|Open-label Treatment Period|Adverse Event|1|||
143297065|NCT03559257|516638882|FG001|Open-label Treatment Period|Adverse Event|4|||
143297066|NCT03559257|516638881|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
143297067|NCT03559257|516638882|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
143297068|NCT03559257|516638881|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
143297069|NCT03559257|516638882|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
143297070|NCT03559257|516638881|FG000|Open-label Treatment Period|Protocol Violation|2|||
143297071|NCT03559257|516638882|FG001|Open-label Treatment Period|Protocol Violation|0|||
143297072|NCT03559257|516638881|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
143297073|NCT03559257|516638882|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
143297074|NCT03559257|516638881|FG000|Open-label Treatment Period|Physician Decision|0|||
143297075|NCT03559257|516638882|FG001|Open-label Treatment Period|Physician Decision|1|||
143297076|NCT03630120|516638884|FG000|Overall Study|Disease progression|0|||
143297077|NCT03630120|516638885|FG001|Overall Study|Disease progression|1|||
143297078|NCT03630120|516638886|FG002|Overall Study|Disease progression|1|||
143297079|NCT03630120|516638887|FG003|Overall Study|Disease progression|1|||
143297080|NCT01387347|516638888|FG000|Overall Study|Lost to Follow-up|2|||
143297081|NCT01387347|516638889|FG001|Overall Study|Lost to Follow-up|1|||
143297082|NCT01519960|516638890|FG000|Overall Study|Withdrawal from the study|26|||
143297083|NCT01519960|516638891|FG001|Overall Study|Withdrawal from the study|22|||
143374192|NCT03086369|516915378|FG001|Overall Study|Lost to Follow-up|0|||
143297084|NCT01519960|516638892|FG002|Overall Study|Withdrawal from the study|5|||
143297085|NCT00423150|516638897|FG000|Overall Study|Adverse Event|11|||
143297086|NCT00423150|516638897|FG000|Overall Study|Progression of disease being studied|69|||
143297087|NCT00423150|516638897|FG000|Overall Study|Withdrawal by Subject|1|||
143297088|NCT00423150|516638897|FG000|Overall Study|Non-compliance with protocol|1|||
143297089|NCT00423150|516638897|FG000|Overall Study|Administrative|4|||
143297090|NCT01603459|516638900|FG000|Overall Study|Adverse Event|5|||
143297091|NCT01603459|516638900|FG000|Overall Study|Withdrawal by Subject|5|||
143297092|NCT01603459|516638900|FG000|Overall Study|Lost to Follow-up|3|||
143297093|NCT01603459|516638900|FG000|Overall Study|Predefined discontinuation criteria|3|||
143297094|NCT01603459|516638900|FG000|Overall Study|Non-compliance|1|||
143297095|NCT01603459|516638900|FG000|Overall Study|Administrative reason|1|||
143297096|NCT00399360|516638901|FG000|Overall Study|Lost to Follow-up|2|||
143297097|NCT00399360|516638902|FG001|Overall Study|Lost to Follow-up|1|||
143297098|NCT00399360|516638903|FG002|Overall Study|Lost to Follow-up|2|||
143297099|NCT00399360|516638904|FG003|Overall Study|Lost to Follow-up|4|||
143297100|NCT00399360|516638901|FG000|Overall Study|Adverse Event|0|||
143297101|NCT00399360|516638902|FG001|Overall Study|Adverse Event|0|||
143297102|NCT00399360|516638903|FG002|Overall Study|Adverse Event|1|||
143297103|NCT00399360|516638904|FG003|Overall Study|Adverse Event|0|||
143297104|NCT00399360|516638901|FG000|Overall Study|Withdrawal by Subject|0|||
143297105|NCT00399360|516638902|FG001|Overall Study|Withdrawal by Subject|2|||
143297106|NCT00399360|516638903|FG002|Overall Study|Withdrawal by Subject|0|||
143297107|NCT00399360|516638904|FG003|Overall Study|Withdrawal by Subject|2|||
143297108|NCT02335099|516638906|FG000|Treatment|Withdrawal by Subject|1|||
143297109|NCT02335099|516638907|FG001|Treatment|Withdrawal by Subject|3|||
143297110|NCT02335099|516638906|FG000|Treatment|Lost to Follow-up|2|||
143297111|NCT02335099|516638907|FG001|Treatment|Lost to Follow-up|0|||
143297112|NCT02335099|516638906|FG000|Treatment|Death|1|||
143297113|NCT02335099|516638907|FG001|Treatment|Death|0|||
143297114|NCT02335099|516638906|FG000|Treatment|Adverse Event|1|||
143297115|NCT02335099|516638907|FG001|Treatment|Adverse Event|2|||
143297116|NCT02335099|516638906|FG000|Follow-up|Death|0|||
143297117|NCT02335099|516638907|FG001|Follow-up|Death|1|||
143297118|NCT01288287|516638908|FG000|Overall Study|Lost to Follow-up|8|||
143297119|NCT01288287|516638908|FG000|Overall Study|Withdrawal by Subject|4|||
143297120|NCT01288287|516638908|FG000|Overall Study|Lack of Efficacy|13|||
143297121|NCT01288287|516638908|FG000|Overall Study|Other Reason|13|||
143297122|NCT01288287|516638908|FG000|Overall Study|Unknown Reason|1|||
143297123|NCT01288287|516638908|FG000|Overall Study|Unknown Status|7|||
143297124|NCT03519347|516638909|FG000|Interventional Crossover Period 1|Death|0|||
143297125|NCT03519347|516638910|FG001|Interventional Crossover Period 1|Death|0|||
143297126|NCT03519347|516638911|FG002|Interventional Crossover Period 1|Death|0|||
143297127|NCT03519347|516638912|FG003|Interventional Crossover Period 1|Death|1|||
143297128|NCT01412021|516638921|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
143297129|NCT01412021|516638921|FG000|Overall Study|Treatment Prior to Approval|3|||
143297130|NCT01412021|516638921|FG000|Overall Study|Transferred to Other Hospital|9|||
143297131|NCT01374087|516638926|FG000|Overall Study|Adverse Event|1|||
143297132|NCT01374087|516638927|FG001|Overall Study|Adverse Event|0|||
143297133|NCT01374087|516638926|FG000|Overall Study|Disease progression|2|||
143297134|NCT01374087|516638927|FG001|Overall Study|Disease progression|2|||
143297135|NCT01374087|516638926|FG000|Overall Study|Study discontinued|13|||
143297136|NCT01374087|516638927|FG001|Overall Study|Study discontinued|13|||
143297137|NCT00449644|516638930|FG000|Overall Study|Adverse Event|0|||
143297138|NCT00449644|516638931|FG001|Overall Study|Adverse Event|0|||
143297139|NCT00449644|516638932|FG002|Overall Study|Adverse Event|3|||
143297140|NCT00449644|516638933|FG003|Overall Study|Adverse Event|5|||
143297141|NCT00449644|516638930|FG000|Overall Study|Death|1|||
143297142|NCT00449644|516638931|FG001|Overall Study|Death|0|||
143297143|NCT00449644|516638932|FG002|Overall Study|Death|6|||
143297144|NCT00449644|516638933|FG003|Overall Study|Death|1|||
143297145|NCT00449644|516638930|FG000|Overall Study|Lost to Follow-up|1|||
143297146|NCT00449644|516638931|FG001|Overall Study|Lost to Follow-up|1|||
143297147|NCT00449644|516638932|FG002|Overall Study|Lost to Follow-up|5|||
143297148|NCT00449644|516638933|FG003|Overall Study|Lost to Follow-up|3|||
143297149|NCT00449644|516638930|FG000|Overall Study|Pregnancy|0|||
143297150|NCT00449644|516638931|FG001|Overall Study|Pregnancy|0|||
143297151|NCT00449644|516638932|FG002|Overall Study|Pregnancy|3|||
143297152|NCT00449644|516638933|FG003|Overall Study|Pregnancy|2|||
143297153|NCT00449644|516638930|FG000|Overall Study|Protocol Violation|4|||
143297154|NCT00449644|516638931|FG001|Overall Study|Protocol Violation|4|||
143297155|NCT00449644|516638932|FG002|Overall Study|Protocol Violation|3|||
143297156|NCT00449644|516638933|FG003|Overall Study|Protocol Violation|7|||
143297157|NCT00449644|516638930|FG000|Overall Study|Withdrawal by Subject|3|||
143297158|NCT00449644|516638931|FG001|Overall Study|Withdrawal by Subject|4|||
143297159|NCT00449644|516638932|FG002|Overall Study|Withdrawal by Subject|6|||
143297160|NCT00449644|516638933|FG003|Overall Study|Withdrawal by Subject|7|||
143297161|NCT00449644|516638930|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
143297162|NCT00449644|516638931|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
143297163|NCT00449644|516638932|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
143297164|NCT00449644|516638933|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
143297165|NCT00449644|516638930|FG000|Overall Study|Other|1|||
143297166|NCT00449644|516638931|FG001|Overall Study|Other|4|||
143297167|NCT00449644|516638932|FG002|Overall Study|Other|1|||
143297168|NCT00449644|516638933|FG003|Overall Study|Other|0|||
143297169|NCT00449644|516638930|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
143297170|NCT00449644|516638931|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
143297171|NCT00449644|516638932|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
143297172|NCT00449644|516638933|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
143297173|NCT00529542|516638934|FG000|Overall Study|Withdrawal by Subject|1|||
143297174|NCT00529542|516638935|FG001|Overall Study|Withdrawal by Subject|0|||
143297175|NCT00529542|516638934|FG000|Overall Study|Lost to Follow-up|0|||
143297176|NCT00529542|516638935|FG001|Overall Study|Lost to Follow-up|1|||
143297177|NCT02291055|516638940|FG000|Overall Study|Death|2|||
143297178|NCT02291055|516638941|FG001|Overall Study|Death|2|||
143297179|NCT02291055|516638942|FG002|Overall Study|Death|5|||
143297180|NCT02291055|516638943|FG003|Overall Study|Death|8|||
143297181|NCT02291055|516638944|FG004|Overall Study|Death|12|||
143297182|NCT02291055|516638940|FG000|Overall Study|Lost to Follow-up|0|||
143297183|NCT02291055|516638941|FG001|Overall Study|Lost to Follow-up|0|||
143297184|NCT02291055|516638942|FG002|Overall Study|Lost to Follow-up|0|||
143297185|NCT02291055|516638943|FG003|Overall Study|Lost to Follow-up|1|||
143297186|NCT02291055|516638944|FG004|Overall Study|Lost to Follow-up|2|||
143297187|NCT02291055|516638940|FG000|Overall Study|Withdrawal by Subject|3|||
143297188|NCT02291055|516638941|FG001|Overall Study|Withdrawal by Subject|1|||
143297189|NCT02291055|516638942|FG002|Overall Study|Withdrawal by Subject|1|||
143297190|NCT02291055|516638943|FG003|Overall Study|Withdrawal by Subject|5|||
143297191|NCT02291055|516638944|FG004|Overall Study|Withdrawal by Subject|10|||
143297192|NCT02291055|516638940|FG000|Overall Study|Progressive Disease|0|||
143297193|NCT02291055|516638941|FG001|Overall Study|Progressive Disease|0|||
143297194|NCT02291055|516638942|FG002|Overall Study|Progressive Disease|1|||
143297195|NCT02291055|516638943|FG003|Overall Study|Progressive Disease|4|||
143297196|NCT02291055|516638944|FG004|Overall Study|Progressive Disease|2|||
143297197|NCT02291055|516638940|FG000|Overall Study|Study Terminated by Sponsor|0|||
143297198|NCT02291055|516638941|FG001|Overall Study|Study Terminated by Sponsor|0|||
143297199|NCT02291055|516638942|FG002|Overall Study|Study Terminated by Sponsor|0|||
143297200|NCT02291055|516638943|FG003|Overall Study|Study Terminated by Sponsor|5|||
143297201|NCT02291055|516638944|FG004|Overall Study|Study Terminated by Sponsor|1|||
143297202|NCT02291055|516638940|FG000|Overall Study|Other|0|||
143297203|NCT02291055|516638941|FG001|Overall Study|Other|2|||
143297204|NCT02291055|516638942|FG002|Overall Study|Other|1|||
143297205|NCT02291055|516638943|FG003|Overall Study|Other|4|||
143297206|NCT02291055|516638944|FG004|Overall Study|Other|0|||
143297207|NCT07114198|516638956|FG000|Overall Study|Protocol Violation|1|||
143297208|NCT07114198|516638957|FG001|Overall Study|Protocol Violation|1|||
143297209|NCT04729127|516640638|FG000|Overall Study|Suspended/Terminated EI Services|4|||
143297210|NCT04729127|516640639|FG001|Overall Study|Suspended/Terminated EI Services|0|||
143297211|NCT04729127|516640640|FG002|Overall Study|Suspended/Terminated EI Services|4|||
143297212|NCT04729127|516640641|FG003|Overall Study|Suspended/Terminated EI Services|6|||
143297213|NCT04729127|516640642|FG004|Overall Study|Suspended/Terminated EI Services|0|||
143297214|NCT04729127|516640643|FG005|Overall Study|Suspended/Terminated EI Services|6|||
143297215|NCT04729127|516640644|FG006|Overall Study|Suspended/Terminated EI Services|2|||
143297216|NCT04729127|516640645|FG007|Overall Study|Suspended/Terminated EI Services|0|||
143297217|NCT04729127|516640646|FG008|Overall Study|Suspended/Terminated EI Services|2|||
143297218|NCT04729127|516640638|FG000|Overall Study|Withdrawal by Subject|1|||
143297219|NCT04729127|516640639|FG001|Overall Study|Withdrawal by Subject|0|||
143297220|NCT04729127|516640640|FG002|Overall Study|Withdrawal by Subject|1|||
143297221|NCT04729127|516640641|FG003|Overall Study|Withdrawal by Subject|0|||
143297222|NCT04729127|516640642|FG004|Overall Study|Withdrawal by Subject|0|||
143297223|NCT04729127|516640643|FG005|Overall Study|Withdrawal by Subject|0|||
143297224|NCT04729127|516640644|FG006|Overall Study|Withdrawal by Subject|0|||
143297225|NCT04729127|516640645|FG007|Overall Study|Withdrawal by Subject|0|||
143297226|NCT04729127|516640646|FG008|Overall Study|Withdrawal by Subject|0|||
143297227|NCT04729127|516640638|FG000|Overall Study|Switched Agency/Setting|1|||
143297228|NCT04729127|516640639|FG001|Overall Study|Switched Agency/Setting|0|||
143297229|NCT04729127|516640640|FG002|Overall Study|Switched Agency/Setting|1|||
143297230|NCT04729127|516640641|FG003|Overall Study|Switched Agency/Setting|1|||
143297231|NCT04729127|516640642|FG004|Overall Study|Switched Agency/Setting|0|||
143297232|NCT04729127|516640643|FG005|Overall Study|Switched Agency/Setting|1|||
143297233|NCT04729127|516640644|FG006|Overall Study|Switched Agency/Setting|1|||
143297234|NCT04729127|516640645|FG007|Overall Study|Switched Agency/Setting|0|||
143297235|NCT04729127|516640646|FG008|Overall Study|Switched Agency/Setting|1|||
143297236|NCT00887354|516640647|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
143374193|NCT03086369|516915379|FG002|Overall Study|Lost to Follow-up|0|||
143374194|NCT03086369|516915380|FG003|Overall Study|Lost to Follow-up|2|||
143374195|NCT03086369|516915381|FG004|Overall Study|Lost to Follow-up|1|||
143374196|NCT03086369|516915377|FG000|Overall Study|Physician Decision|0|||
143374197|NCT03086369|516915378|FG001|Overall Study|Physician Decision|0|||
143374198|NCT03086369|516915379|FG002|Overall Study|Physician Decision|0|||
143374199|NCT03086369|516915380|FG003|Overall Study|Physician Decision|1|||
143374200|NCT03086369|516915381|FG004|Overall Study|Physician Decision|2|||
143374201|NCT03086369|516915377|FG000|Overall Study|Withdrawal by Subject|0|||
143374202|NCT03086369|516915378|FG001|Overall Study|Withdrawal by Subject|0|||
143374203|NCT03086369|516915379|FG002|Overall Study|Withdrawal by Subject|0|||
143374204|NCT03086369|516915380|FG003|Overall Study|Withdrawal by Subject|5|||
143374205|NCT03086369|516915381|FG004|Overall Study|Withdrawal by Subject|3|||
143374206|NCT03086369|516915377|FG000|Overall Study|Progressive Disease|0|||
143374207|NCT03086369|516915378|FG001|Overall Study|Progressive Disease|0|||
143374208|NCT03086369|516915379|FG002|Overall Study|Progressive Disease|0|||
143374209|NCT03086369|516915380|FG003|Overall Study|Progressive Disease|1|||
143374210|NCT03086369|516915381|FG004|Overall Study|Progressive Disease|1|||
143374211|NCT04668339|516915382|FG000|Overall Study|Physician Decision|1|||
143374212|NCT04668339|516915383|FG001|Overall Study|Physician Decision|0|||
143374213|NCT04668339|516915384|FG002|Overall Study|Physician Decision|1|||
143374214|NCT04668339|516915385|FG003|Overall Study|Physician Decision|1|||
143374215|NCT04668339|516915382|FG000|Overall Study|Lost to Follow-up|14|||
143374216|NCT04668339|516915383|FG001|Overall Study|Lost to Follow-up|12|||
143374217|NCT04668339|516915384|FG002|Overall Study|Lost to Follow-up|8|||
143374218|NCT04668339|516915385|FG003|Overall Study|Lost to Follow-up|5|||
143374219|NCT04668339|516915382|FG000|Overall Study|Adverse Event|0|||
143374220|NCT04668339|516915383|FG001|Overall Study|Adverse Event|0|||
143374221|NCT04668339|516915384|FG002|Overall Study|Adverse Event|1|||
143374222|NCT04668339|516915385|FG003|Overall Study|Adverse Event|0|||
143374223|NCT04668339|516915382|FG000|Overall Study|Other than specified|3|||
143374224|NCT04668339|516915383|FG001|Overall Study|Other than specified|0|||
143374225|NCT04668339|516915384|FG002|Overall Study|Other than specified|1|||
143374226|NCT04668339|516915385|FG003|Overall Study|Other than specified|0|||
143374227|NCT04668339|516915382|FG000|Overall Study|Participant unblinded between Day 98 and 198|6|||
143374228|NCT04668339|516915383|FG001|Overall Study|Participant unblinded between Day 98 and 198|5|||
143374229|NCT04668339|516915384|FG002|Overall Study|Participant unblinded between Day 98 and 198|4|||
143374230|NCT04668339|516915385|FG003|Overall Study|Participant unblinded between Day 98 and 198|91|||
143374231|NCT04668339|516915382|FG000|Overall Study|Vaccine not Administered|0|||
143374232|NCT04668339|516915383|FG001|Overall Study|Vaccine not Administered|0|||
143374233|NCT04668339|516915384|FG002|Overall Study|Vaccine not Administered|1|||
143374234|NCT04668339|516915385|FG003|Overall Study|Vaccine not Administered|0|||
143374235|NCT04668339|516915382|FG000|Overall Study|Protocol Violation|18|||
143374236|NCT04668339|516915383|FG001|Overall Study|Protocol Violation|23|||
143374237|NCT04668339|516915384|FG002|Overall Study|Protocol Violation|12|||
143374238|NCT04668339|516915385|FG003|Overall Study|Protocol Violation|20|||
143374239|NCT04668339|516915382|FG000|Overall Study|Withdrawal by Subject|45|||
143374240|NCT04668339|516915383|FG001|Overall Study|Withdrawal by Subject|46|||
143374241|NCT04668339|516915384|FG002|Overall Study|Withdrawal by Subject|46|||
143374242|NCT04668339|516915385|FG003|Overall Study|Withdrawal by Subject|27|||
143374243|NCT04668339|516915382|FG000|Overall Study|Study Terminated by Sponsor|59|||
143374244|NCT04668339|516915383|FG001|Overall Study|Study Terminated by Sponsor|59|||
143374245|NCT04668339|516915384|FG002|Overall Study|Study Terminated by Sponsor|71|||
143374246|NCT04668339|516915385|FG003|Overall Study|Study Terminated by Sponsor|1|||
143374247|NCT03622593|516915389|FG000|Overall Study|Withdrawal by Subject|11|||
143374248|NCT03622593|516915390|FG001|Overall Study|Withdrawal by Subject|9|||
143374249|NCT03622593|516915391|FG002|Overall Study|Withdrawal by Subject|13|||
143374250|NCT03622593|516915389|FG000|Overall Study|Death|12|||
143374251|NCT03622593|516915390|FG001|Overall Study|Death|9|||
143374252|NCT03622593|516915391|FG002|Overall Study|Death|10|||
143374253|NCT03622593|516915389|FG000|Overall Study|Lost to Follow-up|11|||
143374254|NCT03622593|516915390|FG001|Overall Study|Lost to Follow-up|5|||
143374255|NCT03622593|516915391|FG002|Overall Study|Lost to Follow-up|8|||
143374256|NCT03622593|516915389|FG000|Overall Study|Adverse Event|4|||
143297237|NCT00887354|516640648|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
143297238|NCT00887354|516640647|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
143297239|NCT00887354|516640648|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
143297240|NCT00887354|516640647|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
143297241|NCT00887354|516640648|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
143297242|NCT00887354|516640647|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
143297243|NCT00887354|516640648|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
143297244|NCT00887354|516640647|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
143297245|NCT00887354|516640648|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
143297246|NCT00887354|516640647|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
143297247|NCT00887354|516640648|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
143297248|NCT00887354|516640647|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
143297249|NCT00887354|516640648|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
143297250|NCT00887354|516640647|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
143297251|NCT00887354|516640648|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
143297252|NCT00887354|516640647|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
143297253|NCT00887354|516640648|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
143297254|NCT00887354|516640647|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
143297255|NCT00887354|516640648|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
143297256|NCT00887354|516640647|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
143297257|NCT00887354|516640648|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
143297258|NCT00887354|516640647|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
143297259|NCT00887354|516640648|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
143297260|NCT00887354|516640647|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
143297261|NCT00887354|516640648|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
143297262|NCT00887354|516640647|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
143297263|NCT00887354|516640648|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
143297264|NCT00887354|516640647|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
143297265|NCT00887354|516640648|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
143297266|NCT01955161|516640651|FG000|Overall Study|Withdrawal before treatment|2|||
143297267|NCT01955161|516640652|FG001|Overall Study|Withdrawal before treatment|0|||
143297268|NCT01955161|516640653|FG002|Overall Study|Withdrawal before treatment|1|||
143297269|NCT01955161|516640651|FG000|Overall Study|Adverse Event|10|||
143297270|NCT01955161|516640652|FG001|Overall Study|Adverse Event|14|||
143297271|NCT01955161|516640653|FG002|Overall Study|Adverse Event|15|||
143297272|NCT01955161|516640651|FG000|Overall Study|Death|1|||
143297273|NCT01955161|516640652|FG001|Overall Study|Death|1|||
143297274|NCT01955161|516640653|FG002|Overall Study|Death|3|||
143297275|NCT01955161|516640651|FG000|Overall Study|Withdrawal by Subject|9|||
143297276|NCT01955161|516640652|FG001|Overall Study|Withdrawal by Subject|8|||
143297277|NCT01955161|516640653|FG002|Overall Study|Withdrawal by Subject|12|||
143297278|NCT01955161|516640651|FG000|Overall Study|Protocol Violation|2|||
143297279|NCT01955161|516640652|FG001|Overall Study|Protocol Violation|0|||
143297280|NCT01955161|516640653|FG002|Overall Study|Protocol Violation|0|||
143297281|NCT01955161|516640651|FG000|Overall Study|Other reason: physician decision|0|||
143297282|NCT01955161|516640652|FG001|Overall Study|Other reason: physician decision|1|||
143297283|NCT01955161|516640653|FG002|Overall Study|Other reason: physician decision|1|||
143297284|NCT01955161|516640651|FG000|Overall Study|Other reason: disallowed medication|1|||
143297285|NCT01955161|516640652|FG001|Overall Study|Other reason: disallowed medication|0|||
143297286|NCT01955161|516640653|FG002|Overall Study|Other reason: disallowed medication|1|||
143297287|NCT01955161|516640651|FG000|Overall Study|Other reason: caregiver unavailable|1|||
143297288|NCT01955161|516640652|FG001|Overall Study|Other reason: caregiver unavailable|0|||
143297289|NCT01955161|516640653|FG002|Overall Study|Other reason: caregiver unavailable|0|||
143297290|NCT01955161|516640651|FG000|Overall Study|Other reason: moved to nursing home|0|||
143297291|NCT01955161|516640652|FG001|Overall Study|Other reason: moved to nursing home|1|||
143297292|NCT01955161|516640653|FG002|Overall Study|Other reason: moved to nursing home|0|||
143297293|NCT01955161|516640651|FG000|Overall Study|Other reason: insufficient compliance|0|||
143297294|NCT01955161|516640652|FG001|Overall Study|Other reason: insufficient compliance|0|||
143297295|NCT01955161|516640653|FG002|Overall Study|Other reason: insufficient compliance|1|||
143297296|NCT01955161|516640651|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
143297297|NCT01955161|516640652|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
143297298|NCT01955161|516640653|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
143374257|NCT03622593|516915390|FG001|Overall Study|Adverse Event|5|||
143374258|NCT03622593|516915391|FG002|Overall Study|Adverse Event|6|||
143297299|NCT01955161|516640651|FG000|Overall Study|Other reason: patient's will|0|||
143297300|NCT01955161|516640652|FG001|Overall Study|Other reason: patient's will|0|||
143297301|NCT01955161|516640653|FG002|Overall Study|Other reason: patient's will|1|||
143297302|NCT03388138|516640657|FG000|Overall Study|Protocol Violation|1|||
143297303|NCT03388138|516640658|FG001|Overall Study|Protocol Violation|0|||
143297304|NCT01528072|516640659|FG000|Overall Study|Withdrawal by Subject|5|||
143297305|NCT01528072|516640659|FG000|Overall Study|Physician Decision|1|||
143297306|NCT01528072|516640659|FG000|Overall Study|Determined not eligible by AEAC|1|||
143297307|NCT01528072|516640659|FG000|Overall Study|Missed Visit|2|||
143297308|NCT01528072|516640659|FG000|Overall Study|Lost to Follow-up|5|||
143297309|NCT01528072|516640659|FG000|Overall Study|Explanted|2|||
143297310|NCT01528072|516640659|FG000|Overall Study|Site Closure|4|||
143297311|NCT01528072|516640659|FG000|Overall Study|Death|2|||
143297312|NCT01528072|516640659|FG000|Overall Study|Early Termination of Study|52|||
143297313|NCT01859494|516640662|FG000|Overall Study|Adverse Event|1|||
143297314|NCT04741074|516640665|FG000|Overall Study|Withdrawal by Subject|1|||
143297315|NCT04741074|516640666|FG001|Overall Study|Withdrawal by Subject|1|||
143297316|NCT04741074|516640665|FG000|Overall Study|Study terminated prematurely|1|||
143297317|NCT04741074|516640666|FG001|Overall Study|Study terminated prematurely|0|||
143297318|NCT02357901|516640671|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
143297319|NCT02357901|516640672|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
143297320|NCT02357901|516640673|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
143297321|NCT02357901|516640674|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
143297322|NCT02357901|516640671|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
143297323|NCT02357901|516640672|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
143297324|NCT02357901|516640673|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
143297325|NCT02357901|516640674|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
143297326|NCT02357901|516640671|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
143297327|NCT02357901|516640672|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
143297328|NCT02357901|516640673|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
143297329|NCT02357901|516640674|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
143297330|NCT02357901|516640671|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
143297331|NCT02357901|516640672|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
143297332|NCT02357901|516640673|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
143297333|NCT02357901|516640674|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
143297334|NCT02357901|516640671|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
143297335|NCT02357901|516640672|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
143297336|NCT02357901|516640673|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
143297337|NCT02357901|516640674|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
143297338|NCT02357901|516640671|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
143297339|NCT02357901|516640672|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
143297340|NCT02357901|516640673|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
143297341|NCT02357901|516640674|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
143297342|NCT02357901|516640671|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
143297343|NCT02357901|516640672|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
143297344|NCT02357901|516640673|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
143297345|NCT02357901|516640674|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
143297346|NCT02357901|516640671|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
143297347|NCT02357901|516640672|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
143297348|NCT02357901|516640673|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
143297349|NCT02357901|516640674|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
143297350|NCT02357901|516640671|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
143297351|NCT02357901|516640672|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
143297352|NCT02357901|516640673|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
143297353|NCT02357901|516640674|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
143374259|NCT03622593|516915389|FG000|Overall Study|Physician Decision|2|||
143297354|NCT02357901|516640671|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
143297355|NCT02357901|516640672|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
143297356|NCT02357901|516640673|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
143297357|NCT02357901|516640674|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
143297358|NCT02357901|516640671|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
143297359|NCT02357901|516640672|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
143297360|NCT02357901|516640673|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
143297361|NCT02357901|516640674|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
143297362|NCT01514760|516640681|FG000|Overall Study|Lost to Follow-up|2|||
143297363|NCT01266460|516640682|FG000|Overall Study|Adverse Event|3|||
143297364|NCT01266460|516640682|FG000|Overall Study|Withdrawal by Subject|5|||
143297365|NCT01266460|516640682|FG000|Overall Study|Disease Progression|18|||
143297366|NCT01266460|516640682|FG000|Overall Study|Not otherwise specified|8|||
143297367|NCT00536107|516640687|FG000|Overall Study|Death|5|||
143297368|NCT00536107|516640688|FG001|Overall Study|Death|1|||
143297369|NCT00536107|516640687|FG000|Overall Study|Incorrect enrolment|1|||
143297370|NCT00536107|516640688|FG001|Overall Study|Incorrect enrolment|0|||
143297371|NCT00536107|516640687|FG000|Overall Study|Withdrawal by Subject|0|||
143297372|NCT00536107|516640688|FG001|Overall Study|Withdrawal by Subject|1|||
143297373|NCT00536107|516640687|FG000|Overall Study|Study Termination|2|||
143297374|NCT00536107|516640688|FG001|Overall Study|Study Termination|4|||
143297375|NCT02337907|516640689|FG000|Overall Study|Other than listed|1|||
143297376|NCT02337907|516640690|FG001|Overall Study|Other than listed|0|||
143297377|NCT02337907|516640691|FG002|Overall Study|Other than listed|0|||
143297378|NCT02337907|516640692|FG003|Overall Study|Other than listed|1|||
143297379|NCT02337907|516640693|FG004|Overall Study|Other than listed|1|||
143297380|NCT02337907|516640694|FG005|Overall Study|Other than listed|0|||
143297381|NCT02337907|516640689|FG000|Overall Study|Withdrawal by Subject|2|||
143297382|NCT02337907|516640690|FG001|Overall Study|Withdrawal by Subject|3|||
143297383|NCT02337907|516640691|FG002|Overall Study|Withdrawal by Subject|0|||
143297384|NCT02337907|516640692|FG003|Overall Study|Withdrawal by Subject|2|||
143297385|NCT02337907|516640693|FG004|Overall Study|Withdrawal by Subject|5|||
143297386|NCT02337907|516640694|FG005|Overall Study|Withdrawal by Subject|0|||
143297387|NCT02337907|516640689|FG000|Overall Study|Lost to Follow-up|0|||
143297388|NCT02337907|516640690|FG001|Overall Study|Lost to Follow-up|0|||
143297389|NCT02337907|516640691|FG002|Overall Study|Lost to Follow-up|0|||
143297390|NCT02337907|516640692|FG003|Overall Study|Lost to Follow-up|0|||
143297391|NCT02337907|516640693|FG004|Overall Study|Lost to Follow-up|0|||
143374260|NCT03622593|516915390|FG001|Overall Study|Physician Decision|1|||
143374261|NCT03622593|516915391|FG002|Overall Study|Physician Decision|6|||
143374262|NCT03622593|516915389|FG000|Overall Study|Other|2|||
143374263|NCT03622593|516915390|FG001|Overall Study|Other|2|||
143374264|NCT03622593|516915391|FG002|Overall Study|Other|3|||
143374265|NCT03622593|516915389|FG000|Overall Study|Protocol Violation|0|||
143374266|NCT03622593|516915390|FG001|Overall Study|Protocol Violation|0|||
143374267|NCT03622593|516915391|FG002|Overall Study|Protocol Violation|1|||
143374268|NCT03622593|516915389|FG000|Overall Study|Pregnancy|0|||
143374269|NCT03622593|516915390|FG001|Overall Study|Pregnancy|0|||
143374270|NCT03622593|516915391|FG002|Overall Study|Pregnancy|1|||
143374271|NCT01393119|516915392|FG000|Overall Study|Adverse Event|1|||
143374272|NCT01393119|516915393|FG001|Overall Study|Adverse Event|1|||
143374273|NCT01393119|516915394|FG002|Overall Study|Adverse Event|0|||
143374274|NCT01393119|516915395|FG003|Overall Study|Adverse Event|1|||
143374275|NCT01393119|516915392|FG000|Overall Study|Withdrawal by Subject|0|||
143374276|NCT01393119|516915393|FG001|Overall Study|Withdrawal by Subject|1|||
143374277|NCT01393119|516915394|FG002|Overall Study|Withdrawal by Subject|1|||
143374278|NCT01393119|516915395|FG003|Overall Study|Withdrawal by Subject|0|||
143374279|NCT01393119|516915392|FG000|Overall Study|Lack of Efficacy|1|||
143374280|NCT01393119|516915393|FG001|Overall Study|Lack of Efficacy|0|||
143374281|NCT01393119|516915394|FG002|Overall Study|Lack of Efficacy|2|||
143374282|NCT01393119|516915395|FG003|Overall Study|Lack of Efficacy|1|||
143374283|NCT01393119|516915392|FG000|Overall Study|Protocol Violation|0|||
143374284|NCT01393119|516915393|FG001|Overall Study|Protocol Violation|0|||
143374285|NCT01393119|516915394|FG002|Overall Study|Protocol Violation|1|||
143374286|NCT01393119|516915395|FG003|Overall Study|Protocol Violation|0|||
143374287|NCT01393119|516915392|FG000|Overall Study|Death|0|||
143374288|NCT01393119|516915393|FG001|Overall Study|Death|0|||
143374289|NCT01393119|516915394|FG002|Overall Study|Death|0|||
143374290|NCT01393119|516915395|FG003|Overall Study|Death|1|||
143374291|NCT01393119|516915392|FG000|Overall Study|Randomized but Not treated|1|||
143374292|NCT01393119|516915393|FG001|Overall Study|Randomized but Not treated|0|||
143374293|NCT01393119|516915394|FG002|Overall Study|Randomized but Not treated|1|||
143374294|NCT01393119|516915395|FG003|Overall Study|Randomized but Not treated|1|||
143374295|NCT01393119|516915392|FG000|Overall Study|Sponsor Termination of Study|11|||
143374296|NCT01393119|516915393|FG001|Overall Study|Sponsor Termination of Study|12|||
143374297|NCT01393119|516915394|FG002|Overall Study|Sponsor Termination of Study|9|||
143374298|NCT01393119|516915395|FG003|Overall Study|Sponsor Termination of Study|12|||
143374299|NCT01580293|516915396|FG000|Part A_Main Trial|Adverse Event|0|||
143374300|NCT01580293|516915397|FG001|Part A_Main Trial|Adverse Event|2|||
143374301|NCT01580293|516915398|FG002|Part A_Main Trial|Adverse Event|0|||
143374302|NCT01580293|516915396|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
143374303|NCT01580293|516915397|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
143374304|NCT01580293|516915398|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
143374305|NCT01580293|516915396|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
143374306|NCT01580293|516915397|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
143374307|NCT01580293|516915398|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
143374308|NCT01580293|516915396|FG000|Part A_Extension|Adverse Event|0|||
143374309|NCT01580293|516915397|FG001|Part A_Extension|Adverse Event|2|||
143374310|NCT01580293|516915398|FG002|Part A_Extension|Adverse Event|0|||
143374311|NCT01580293|516915396|FG000|Part A_Extension|Withdrawal by Subject|0|||
143374312|NCT01580293|516915397|FG001|Part A_Extension|Withdrawal by Subject|3|||
143374313|NCT01580293|516915398|FG002|Part A_Extension|Withdrawal by Subject|0|||
143374314|NCT01580293|516915396|FG000|Part A_Extension|Lost to Follow-up|0|||
143374315|NCT01580293|516915397|FG001|Part A_Extension|Lost to Follow-up|1|||
143374316|NCT01580293|516915398|FG002|Part A_Extension|Lost to Follow-up|0|||
143374317|NCT01580293|516915396|FG000|Part A_Extension|Other Reason|0|||
143374318|NCT01580293|516915397|FG001|Part A_Extension|Other Reason|1|||
143374319|NCT01580293|516915398|FG002|Part A_Extension|Other Reason|0|||
143374320|NCT01580293|516915396|FG000|Part A_Extension|Completed Japan only|0|||
143374321|NCT01580293|516915397|FG001|Part A_Extension|Completed Japan only|5|||
143374322|NCT01580293|516915398|FG002|Part A_Extension|Completed Japan only|0|||
143374323|NCT01580293|516915396|FG000|Part B|Withdrawal by Subject|0|||
143374324|NCT01580293|516915397|FG001|Part B|Withdrawal by Subject|0|||
143374325|NCT01580293|516915398|FG002|Part B|Withdrawal by Subject|1|||
143374326|NCT01580293|516915396|FG000|Part B|Other reason|0|||
143374327|NCT01580293|516915397|FG001|Part B|Other reason|0|||
143374328|NCT01580293|516915398|FG002|Part B|Other reason|1|||
143297392|NCT02337907|516640694|FG005|Overall Study|Lost to Follow-up|1|||
143297393|NCT02337907|516640689|FG000|Overall Study|Adverse Event|1|||
143297394|NCT02337907|516640690|FG001|Overall Study|Adverse Event|1|||
143297395|NCT02337907|516640691|FG002|Overall Study|Adverse Event|1|||
143297396|NCT02337907|516640692|FG003|Overall Study|Adverse Event|1|||
143297397|NCT02337907|516640693|FG004|Overall Study|Adverse Event|4|||
143374329|NCT01134562|516915401|FG000|Overall Study|Adverse Event|0|||
143297398|NCT02337907|516640694|FG005|Overall Study|Adverse Event|0|||
143297399|NCT01592344|516640697|FG000|Overall Study|Adverse Event|1|||
143297400|NCT01592344|516640698|FG001|Overall Study|Adverse Event|1|||
143297401|NCT01592344|516640697|FG000|Overall Study|Lack of Efficacy|1|||
143297402|NCT01592344|516640698|FG001|Overall Study|Lack of Efficacy|0|||
143297403|NCT01592344|516640697|FG000|Overall Study|not available at primary outcome visit|2|||
143297404|NCT01592344|516640698|FG001|Overall Study|not available at primary outcome visit|4|||
143297405|NCT03165110|516640700|FG000|Overall Study|Anroid phone software incompatibility|1|||
143297406|NCT00730912|516640703|FG000|Overall Study|Discontinued|0|||
143297407|NCT00730912|516640704|FG001|Overall Study|Discontinued|0|||
143297408|NCT00730912|516640705|FG002|Overall Study|Discontinued|1|||
143297409|NCT00613015|516640706|FG000|Overall Study|Lost to Follow-up|0|||
143297410|NCT00613015|516640707|FG001|Overall Study|Lost to Follow-up|1|||
143297411|NCT00613015|516640708|FG002|Overall Study|Lost to Follow-up|3|||
143297412|NCT00613015|516640709|FG003|Overall Study|Lost to Follow-up|3|||
143297413|NCT00613015|516640710|FG004|Overall Study|Lost to Follow-up|2|||
143297414|NCT00613015|516640711|FG005|Overall Study|Lost to Follow-up|3|||
143297415|NCT00561080|516640714|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
143297416|NCT00561080|516640715|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
143297417|NCT00561080|516640716|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
143297418|NCT00561080|516640714|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
143297419|NCT00561080|516640715|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
143297420|NCT00561080|516640716|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
143297421|NCT00561080|516640714|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
143297422|NCT00561080|516640715|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
143297423|NCT00561080|516640716|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
143297424|NCT00561080|516640714|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
143297425|NCT00561080|516640715|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
143297426|NCT00561080|516640716|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
143297427|NCT00561080|516640714|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
143297428|NCT00561080|516640715|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
143297429|NCT00561080|516640716|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
143297430|NCT00561080|516640714|FG000|Vaccination Period (up to Month 4)|Other|0|||
143297431|NCT00561080|516640715|FG001|Vaccination Period (up to Month 4)|Other|2|||
143297432|NCT00561080|516640716|FG002|Vaccination Period (up to Month 4)|Other|1|||
143297433|NCT00561080|516640714|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
143297434|NCT00561080|516640715|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
143297435|NCT00561080|516640716|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
143297436|NCT00561080|516640714|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
143297437|NCT00561080|516640715|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
143297438|NCT00561080|516640716|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
143297439|NCT00561080|516640714|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
143297440|NCT00561080|516640715|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
143297441|NCT00561080|516640716|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
143297442|NCT00561080|516640714|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
143297443|NCT00561080|516640715|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
143297444|NCT00561080|516640716|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
143297445|NCT02951156|516640717|FG000|Overall Study|Death|3|||
143297446|NCT02951156|516640718|FG001|Overall Study|Death|8|||
143297447|NCT02951156|516640719|FG002|Overall Study|Death|5|||
143297448|NCT02951156|516640717|FG000|Overall Study|Progressive disease|1|||
143297449|NCT02951156|516640718|FG001|Overall Study|Progressive disease|0|||
143297450|NCT02951156|516640719|FG002|Overall Study|Progressive disease|1|||
143297451|NCT02951156|516640717|FG000|Overall Study|Withdrawal by Subject|0|||
143297452|NCT02951156|516640718|FG001|Overall Study|Withdrawal by Subject|0|||
143297453|NCT02951156|516640719|FG002|Overall Study|Withdrawal by Subject|1|||
143297454|NCT02951156|516640717|FG000|Overall Study|Study terminated by sponsor|0|||
143297455|NCT02951156|516640718|FG001|Overall Study|Study terminated by sponsor|0|||
143297456|NCT02951156|516640719|FG002|Overall Study|Study terminated by sponsor|1|||
143297457|NCT02951156|516640717|FG000|Overall Study|Other|5|||
143297458|NCT02951156|516640718|FG001|Overall Study|Other|1|||
143297459|NCT02951156|516640719|FG002|Overall Study|Other|2|||
143297460|NCT04351087|516640720|FG000|Overall Study|Lost to Follow-up|7|||
143297461|NCT04351087|516640721|FG001|Overall Study|Lost to Follow-up|3|||
143297462|NCT04351087|516640720|FG000|Overall Study|Withdrawal by Subject|3|||
143297463|NCT04351087|516640721|FG001|Overall Study|Withdrawal by Subject|4|||
143297464|NCT04351087|516640720|FG000|Overall Study|Lack of Efficacy|3|||
143297465|NCT04351087|516640721|FG001|Overall Study|Lack of Efficacy|2|||
143297466|NCT01641692|516640722|FG000|Treatment Period 1|Adverse Event|1|||
143297467|NCT01641692|516640723|FG001|Treatment Period 1|Adverse Event|0|||
143297468|NCT01641692|516640724|FG002|Treatment Period 1|Adverse Event|0|||
143297469|NCT01641692|516640725|FG003|Treatment Period 1|Adverse Event|0|||
143297470|NCT01641692|516640726|FG004|Treatment Period 1|Adverse Event|0|||
143297471|NCT01641692|516640727|FG005|Treatment Period 1|Adverse Event|0|||
143297472|NCT01641692|516640728|FG006|Treatment Period 1|Adverse Event|0|||
143297473|NCT01641692|516640729|FG007|Treatment Period 1|Adverse Event|0|||
143297474|NCT01641692|516640722|FG000|Treatment Period 1|Lack of Efficacy|0|||
143297475|NCT01641692|516640723|FG001|Treatment Period 1|Lack of Efficacy|0|||
143297476|NCT01641692|516640724|FG002|Treatment Period 1|Lack of Efficacy|0|||
143297477|NCT01641692|516640725|FG003|Treatment Period 1|Lack of Efficacy|0|||
143297478|NCT01641692|516640726|FG004|Treatment Period 1|Lack of Efficacy|0|||
143297479|NCT01641692|516640727|FG005|Treatment Period 1|Lack of Efficacy|0|||
143297480|NCT01641692|516640728|FG006|Treatment Period 1|Lack of Efficacy|0|||
143297481|NCT01641692|516640729|FG007|Treatment Period 1|Lack of Efficacy|1|||
143297482|NCT01641692|516640722|FG000|Treatment Period 1|Protocol Violation|1|||
143297483|NCT01641692|516640723|FG001|Treatment Period 1|Protocol Violation|0|||
143297484|NCT01641692|516640724|FG002|Treatment Period 1|Protocol Violation|0|||
143297485|NCT01641692|516640725|FG003|Treatment Period 1|Protocol Violation|0|||
143297486|NCT01641692|516640726|FG004|Treatment Period 1|Protocol Violation|2|||
143297487|NCT01641692|516640727|FG005|Treatment Period 1|Protocol Violation|0|||
143297488|NCT01641692|516640728|FG006|Treatment Period 1|Protocol Violation|0|||
143297489|NCT01641692|516640729|FG007|Treatment Period 1|Protocol Violation|0|||
143297490|NCT01641692|516640722|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
143297491|NCT01641692|516640723|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
143297492|NCT01641692|516640724|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
143297493|NCT01641692|516640725|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
143297494|NCT01641692|516640726|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
143297495|NCT01641692|516640727|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
143297496|NCT01641692|516640728|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
143297497|NCT01641692|516640729|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
143297498|NCT01641692|516640722|FG000|Treatment Period 1|Lost to Follow-up|0|||
143297499|NCT01641692|516640723|FG001|Treatment Period 1|Lost to Follow-up|0|||
143297500|NCT01641692|516640724|FG002|Treatment Period 1|Lost to Follow-up|1|||
143297501|NCT01641692|516640725|FG003|Treatment Period 1|Lost to Follow-up|0|||
143297502|NCT01641692|516640726|FG004|Treatment Period 1|Lost to Follow-up|0|||
143297503|NCT01641692|516640727|FG005|Treatment Period 1|Lost to Follow-up|0|||
143297504|NCT01641692|516640728|FG006|Treatment Period 1|Lost to Follow-up|0|||
143297505|NCT01641692|516640729|FG007|Treatment Period 1|Lost to Follow-up|0|||
143297506|NCT01641692|516640722|FG000|Treatment Period 1|Physician Decision|0|||
143297507|NCT01641692|516640723|FG001|Treatment Period 1|Physician Decision|0|||
143297508|NCT01641692|516640724|FG002|Treatment Period 1|Physician Decision|0|||
143297509|NCT01641692|516640725|FG003|Treatment Period 1|Physician Decision|0|||
143297510|NCT01641692|516640726|FG004|Treatment Period 1|Physician Decision|1|||
143297511|NCT01641692|516640727|FG005|Treatment Period 1|Physician Decision|0|||
143297512|NCT01641692|516640728|FG006|Treatment Period 1|Physician Decision|0|||
143297513|NCT01641692|516640729|FG007|Treatment Period 1|Physician Decision|0|||
143297514|NCT01641692|516640722|FG000|Treatment Period 1|Withdrawal by Subject|0|||
143374330|NCT01134562|516915402|FG001|Overall Study|Adverse Event|1|||
143374331|NCT01134562|516915403|FG002|Overall Study|Adverse Event|0|||
143374332|NCT01134562|516915404|FG003|Overall Study|Adverse Event|0|||
143374333|NCT01134562|516915405|FG004|Overall Study|Adverse Event|0|||
143374334|NCT02544152|516915406|FG000|Overall Study|Adverse Event|0|||
143374335|NCT02544152|516915407|FG001|Overall Study|Adverse Event|4|||
143374336|NCT02544152|516915406|FG000|Overall Study|Withdrawal by Subject|0|||
143374337|NCT02544152|516915407|FG001|Overall Study|Withdrawal by Subject|3|||
143374338|NCT02544152|516915406|FG000|Overall Study|Other|1|||
143374339|NCT02544152|516915407|FG001|Overall Study|Other|0|||
143374340|NCT00423098|516915408|FG000|Overall Study|Adverse Event|1|||
143374341|NCT00423098|516915409|FG001|Overall Study|Adverse Event|2|||
143374342|NCT00423098|516915408|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
143374343|NCT00423098|516915409|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
143374344|NCT00423098|516915408|FG000|Overall Study|Administrative problems|0|||
143374345|NCT00423098|516915409|FG001|Overall Study|Administrative problems|1|||
143374346|NCT00423098|516915408|FG000|Overall Study|Death|2|||
143374347|NCT00423098|516915409|FG001|Overall Study|Death|0|||
143374348|NCT02320123|516915413|FG000|Overall Study|Lost to Follow-up|4|||
143374349|NCT02320123|516915414|FG001|Overall Study|Lost to Follow-up|6|||
143374350|NCT02320123|516915413|FG000|Overall Study|Death|6|||
143374351|NCT02320123|516915414|FG001|Overall Study|Death|5|||
143374352|NCT04480827|516915416|FG000|Overall Study|Adverse Event|0|||
143374353|NCT04480827|516915417|FG001|Overall Study|Adverse Event|0|||
143374354|NCT04480827|516915418|FG002|Overall Study|Adverse Event|0|||
143374355|NCT04480827|516915419|FG003|Overall Study|Adverse Event|0|||
143374356|NCT04480827|516915420|FG004|Overall Study|Adverse Event|0|||
143374357|NCT04480827|516915421|FG005|Overall Study|Adverse Event|1|||
143374358|NCT04480827|516915422|FG006|Overall Study|Adverse Event|0|||
143374359|NCT01759264|516915423|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
143374360|NCT01759264|516915423|FG000|Overall Study|Adverse Event|1|||
143374361|NCT01759264|516915423|FG000|Overall Study|Other|2|||
143374362|NCT01759264|516915423|FG000|Overall Study|Lost to Follow-up|2|||
143374363|NCT01759264|516915423|FG000|Overall Study|Withdrawal by Subject|3|||
143374364|NCT01759264|516915423|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
143374365|NCT02383472|516915424|FG000|Overall Study|Withdrawal by Subject|1|||
143374366|NCT02383472|516915425|FG001|Overall Study|Withdrawal by Subject|1|||
143374367|NCT01337635|516915428|FG000|Overall Study|Lost to Follow-up|0|||
143374368|NCT01337635|516915429|FG001|Overall Study|Lost to Follow-up|1|||
143374369|NCT04439799|516915434|FG000|Overall Study|Lost to Follow-up|6|||
143374370|NCT04439799|516915435|FG001|Overall Study|Lost to Follow-up|6|||
143374371|NCT04439799|516915434|FG000|Overall Study|Withdrawal by Subject|2|||
143374372|NCT04439799|516915435|FG001|Overall Study|Withdrawal by Subject|6|||
143374373|NCT04439799|516915434|FG000|Overall Study|Adverse Event|2|||
143374374|NCT04439799|516915435|FG001|Overall Study|Adverse Event|5|||
143374375|NCT05641311|516915440|FG000|Dosing Period 1|Adverse Event|1|||
143374376|NCT05641311|516915441|FG001|Dosing Period 1|Adverse Event|0|||
143374377|NCT00922207|516915444|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
143374378|NCT00922207|516915445|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
143374379|NCT00922207|516915446|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
143374380|NCT00922207|516915444|FG000|Overall Study|Insufficient Therapeutic Response|0|||
143374381|NCT00922207|516915445|FG001|Overall Study|Insufficient Therapeutic Response|0|||
143374382|NCT00922207|516915446|FG002|Overall Study|Insufficient Therapeutic Response|1|||
143374383|NCT00922207|516915444|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
143374384|NCT00922207|516915445|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
143374385|NCT00922207|516915446|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
143297515|NCT01641692|516640723|FG001|Treatment Period 1|Withdrawal by Subject|0|||
143297516|NCT01641692|516640724|FG002|Treatment Period 1|Withdrawal by Subject|0|||
143297517|NCT01641692|516640725|FG003|Treatment Period 1|Withdrawal by Subject|0|||
143297518|NCT01641692|516640726|FG004|Treatment Period 1|Withdrawal by Subject|0|||
143297519|NCT01641692|516640727|FG005|Treatment Period 1|Withdrawal by Subject|2|||
143297520|NCT01641692|516640728|FG006|Treatment Period 1|Withdrawal by Subject|0|||
143297521|NCT01641692|516640729|FG007|Treatment Period 1|Withdrawal by Subject|1|||
143297522|NCT01641692|516640722|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
143297523|NCT01641692|516640723|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
143297524|NCT01641692|516640724|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
143297525|NCT01641692|516640725|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
143297526|NCT01641692|516640726|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
143297527|NCT01641692|516640727|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
143297528|NCT01641692|516640728|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
143297529|NCT01641692|516640729|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
143297530|NCT01641692|516640722|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
143297531|NCT01641692|516640723|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
143297532|NCT01641692|516640724|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
143297533|NCT01641692|516640725|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
143297534|NCT01641692|516640726|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
143297535|NCT01641692|516640727|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
143297536|NCT01641692|516640728|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
143297537|NCT01641692|516640729|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
143297538|NCT01641692|516640722|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
143297539|NCT01641692|516640723|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
143297540|NCT01641692|516640724|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
143297541|NCT01641692|516640725|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
143297542|NCT01641692|516640726|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
143297543|NCT01641692|516640727|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
143297544|NCT01641692|516640728|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
143297545|NCT01641692|516640729|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
143297546|NCT01641692|516640722|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
143297547|NCT01641692|516640723|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
143297548|NCT01641692|516640724|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
143297549|NCT01641692|516640725|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
143297550|NCT01641692|516640726|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
143297551|NCT01641692|516640727|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
143297552|NCT01641692|516640728|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
143297553|NCT01641692|516640729|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
143297554|NCT01641692|516640722|FG000|Treatment Period 2|Lack of Efficacy|1|||
143297555|NCT01641692|516640723|FG001|Treatment Period 2|Lack of Efficacy|0|||
143297556|NCT01641692|516640724|FG002|Treatment Period 2|Lack of Efficacy|0|||
143297557|NCT01641692|516640725|FG003|Treatment Period 2|Lack of Efficacy|0|||
143297558|NCT01641692|516640726|FG004|Treatment Period 2|Lack of Efficacy|0|||
143297559|NCT01641692|516640727|FG005|Treatment Period 2|Lack of Efficacy|0|||
143297560|NCT01641692|516640728|FG006|Treatment Period 2|Lack of Efficacy|0|||
143297561|NCT01641692|516640729|FG007|Treatment Period 2|Lack of Efficacy|0|||
143297562|NCT01641692|516640722|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
143297563|NCT01641692|516640723|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
143297564|NCT01641692|516640724|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
143297565|NCT01641692|516640725|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
143297566|NCT01641692|516640726|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
143297567|NCT01641692|516640727|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
143297568|NCT01641692|516640728|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
143297569|NCT01641692|516640729|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
143297570|NCT01641692|516640722|FG000|Treatment Period 2|Lost to Follow-up|0|||
143297571|NCT01641692|516640723|FG001|Treatment Period 2|Lost to Follow-up|0|||
143297572|NCT01641692|516640724|FG002|Treatment Period 2|Lost to Follow-up|0|||
143297573|NCT01641692|516640725|FG003|Treatment Period 2|Lost to Follow-up|0|||
143297574|NCT01641692|516640726|FG004|Treatment Period 2|Lost to Follow-up|0|||
143297575|NCT01641692|516640727|FG005|Treatment Period 2|Lost to Follow-up|1|||
143297576|NCT01641692|516640728|FG006|Treatment Period 2|Lost to Follow-up|0|||
143297577|NCT01641692|516640729|FG007|Treatment Period 2|Lost to Follow-up|0|||
143297578|NCT01641692|516640722|FG000|Treatment Period 2|Withdrawal by Subject|1|||
143297579|NCT01641692|516640723|FG001|Treatment Period 2|Withdrawal by Subject|0|||
143297580|NCT01641692|516640724|FG002|Treatment Period 2|Withdrawal by Subject|0|||
143297581|NCT01641692|516640725|FG003|Treatment Period 2|Withdrawal by Subject|0|||
143297582|NCT01641692|516640726|FG004|Treatment Period 2|Withdrawal by Subject|0|||
143374386|NCT00922207|516915444|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
143297583|NCT01641692|516640727|FG005|Treatment Period 2|Withdrawal by Subject|1|||
143297584|NCT01641692|516640728|FG006|Treatment Period 2|Withdrawal by Subject|0|||
143297585|NCT01641692|516640729|FG007|Treatment Period 2|Withdrawal by Subject|1|||
143297586|NCT01641692|516640722|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
143297587|NCT01641692|516640723|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
143297588|NCT01641692|516640724|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
143297589|NCT01641692|516640725|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
143297590|NCT01641692|516640726|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
143297591|NCT01641692|516640727|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
143297592|NCT01641692|516640728|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
143297593|NCT01641692|516640729|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
143297594|NCT01641692|516640722|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
143297595|NCT01641692|516640723|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
143297596|NCT01641692|516640724|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
143297597|NCT01641692|516640725|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
143297598|NCT01641692|516640726|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
143297599|NCT01641692|516640727|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
143297600|NCT01641692|516640728|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
143297601|NCT01641692|516640729|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
143297602|NCT01641692|516640722|FG000|Treatment Period 3|Adverse Event|0|||
143297603|NCT01641692|516640723|FG001|Treatment Period 3|Adverse Event|0|||
143297604|NCT01641692|516640724|FG002|Treatment Period 3|Adverse Event|0|||
143297605|NCT01641692|516640725|FG003|Treatment Period 3|Adverse Event|0|||
143297606|NCT01641692|516640726|FG004|Treatment Period 3|Adverse Event|0|||
143297607|NCT01641692|516640727|FG005|Treatment Period 3|Adverse Event|0|||
143297608|NCT01641692|516640728|FG006|Treatment Period 3|Adverse Event|1|||
143297609|NCT01641692|516640729|FG007|Treatment Period 3|Adverse Event|0|||
143297610|NCT01641692|516640722|FG000|Treatment Period 3|Protocol Violation|0|||
143297611|NCT01641692|516640723|FG001|Treatment Period 3|Protocol Violation|0|||
143297612|NCT01641692|516640724|FG002|Treatment Period 3|Protocol Violation|1|||
143297613|NCT01641692|516640725|FG003|Treatment Period 3|Protocol Violation|0|||
143297614|NCT01641692|516640726|FG004|Treatment Period 3|Protocol Violation|0|||
143297615|NCT01641692|516640727|FG005|Treatment Period 3|Protocol Violation|0|||
143297616|NCT01641692|516640728|FG006|Treatment Period 3|Protocol Violation|0|||
143297617|NCT01641692|516640729|FG007|Treatment Period 3|Protocol Violation|0|||
143297618|NCT01641692|516640722|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
143297619|NCT01641692|516640723|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
143297620|NCT01641692|516640724|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
143297621|NCT01641692|516640725|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
143297622|NCT01641692|516640726|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
143297623|NCT01641692|516640727|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
143297624|NCT01641692|516640728|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
143297625|NCT01641692|516640729|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
143297626|NCT01641692|516640722|FG000|Treatment Period 3|Lost to Follow-up|0|||
143297627|NCT01641692|516640723|FG001|Treatment Period 3|Lost to Follow-up|1|||
143297628|NCT01641692|516640724|FG002|Treatment Period 3|Lost to Follow-up|0|||
143297629|NCT01641692|516640725|FG003|Treatment Period 3|Lost to Follow-up|0|||
143297630|NCT01641692|516640726|FG004|Treatment Period 3|Lost to Follow-up|0|||
143297631|NCT01641692|516640727|FG005|Treatment Period 3|Lost to Follow-up|0|||
143297632|NCT01641692|516640728|FG006|Treatment Period 3|Lost to Follow-up|0|||
143297633|NCT01641692|516640729|FG007|Treatment Period 3|Lost to Follow-up|0|||
143297634|NCT01641692|516640722|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
143297635|NCT01641692|516640723|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
143297636|NCT01641692|516640724|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
143297637|NCT01641692|516640725|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
143297638|NCT01641692|516640726|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
143297639|NCT01641692|516640727|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
143297640|NCT01641692|516640728|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
143297641|NCT01641692|516640729|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
143297642|NCT01641692|516640722|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
143297643|NCT01641692|516640723|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
143297644|NCT01641692|516640724|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
143297645|NCT01641692|516640725|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
143297646|NCT01641692|516640726|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
143297647|NCT01641692|516640727|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
143297648|NCT01641692|516640728|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
143297649|NCT01641692|516640729|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
143297650|NCT02515045|516640730|FG000|Overall Study|Adverse Event|0|||
143297651|NCT02515045|516640731|FG001|Overall Study|Adverse Event|3|||
143297652|NCT02515045|516640732|FG002|Overall Study|Adverse Event|3|||
143297653|NCT02515045|516640730|FG000|Overall Study|Lost to Follow-up|0|||
143297654|NCT02515045|516640731|FG001|Overall Study|Lost to Follow-up|1|||
143297655|NCT02515045|516640732|FG002|Overall Study|Lost to Follow-up|1|||
143297656|NCT03255382|516640733|FG000|Overall Study|Adverse Event|3|||
143297657|NCT03255382|516640734|FG001|Overall Study|Adverse Event|0|||
143297658|NCT03255382|516640733|FG000|Overall Study|Lost to Follow-up|2|||
143297659|NCT03255382|516640734|FG001|Overall Study|Lost to Follow-up|0|||
143297660|NCT03255382|516640733|FG000|Overall Study|Withdrawal by Subject|2|||
143297661|NCT03255382|516640734|FG001|Overall Study|Withdrawal by Subject|0|||
143297662|NCT03255382|516640733|FG000|Overall Study|Other|6|||
143297663|NCT03255382|516640734|FG001|Overall Study|Other|0|||
143297664|NCT02221284|516640737|FG000|Overall Study|Case Report Forms Uncollected|56|||
143297665|NCT02221284|516640737|FG000|Overall Study|Protocol Deviation|5|||
143297666|NCT03839212|516640743|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
143297667|NCT00679263|516640744|FG000|Visit 2/Dose 1|Adverse Event|1|||
143297668|NCT00679263|516640745|FG001|Visit 2/Dose 1|Adverse Event|0|||
143297669|NCT00679263|516640746|FG002|Visit 2/Dose 1|Adverse Event|0|||
143297670|NCT00679263|516640744|FG000|Visit 2/Dose 1|subject not compliance|1|||
143297671|NCT00679263|516640745|FG001|Visit 2/Dose 1|subject not compliance|1|||
143297672|NCT00679263|516640746|FG002|Visit 2/Dose 1|subject not compliance|0|||
143297673|NCT05104567|516640747|FG000|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
143297674|NCT05104567|516640748|FG001|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|1|||
143297675|NCT05104567|516640749|FG002|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
143297676|NCT05104567|516640750|FG003|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
143297677|NCT05104567|516640751|FG004|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
143297678|NCT05104567|516640752|FG005|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
143297679|NCT05104567|516640753|FG006|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
143297680|NCT05104567|516640747|FG000|Overall Study|Adverse event: Not related to COVID-19|0|||
143297681|NCT05104567|516640748|FG001|Overall Study|Adverse event: Not related to COVID-19|5|||
143297682|NCT05104567|516640749|FG002|Overall Study|Adverse event: Not related to COVID-19|3|||
143297683|NCT05104567|516640750|FG003|Overall Study|Adverse event: Not related to COVID-19|1|||
143297684|NCT05104567|516640751|FG004|Overall Study|Adverse event: Not related to COVID-19|3|||
143297685|NCT05104567|516640752|FG005|Overall Study|Adverse event: Not related to COVID-19|2|||
143297686|NCT05104567|516640753|FG006|Overall Study|Adverse event: Not related to COVID-19|0|||
143297687|NCT05104567|516640747|FG000|Overall Study|Progressive disease|3|||
143297688|NCT05104567|516640748|FG001|Overall Study|Progressive disease|13|||
143297689|NCT05104567|516640749|FG002|Overall Study|Progressive disease|13|||
143297690|NCT05104567|516640750|FG003|Overall Study|Progressive disease|17|||
143297691|NCT05104567|516640751|FG004|Overall Study|Progressive disease|17|||
143297692|NCT05104567|516640752|FG005|Overall Study|Progressive disease|28|||
143297693|NCT05104567|516640753|FG006|Overall Study|Progressive disease|24|||
143297694|NCT05104567|516640747|FG000|Overall Study|Withdrawal by Subject|1|||
143297695|NCT05104567|516640748|FG001|Overall Study|Withdrawal by Subject|1|||
143297696|NCT05104567|516640749|FG002|Overall Study|Withdrawal by Subject|2|||
143297697|NCT05104567|516640750|FG003|Overall Study|Withdrawal by Subject|0|||
143297698|NCT05104567|516640751|FG004|Overall Study|Withdrawal by Subject|0|||
143297699|NCT05104567|516640752|FG005|Overall Study|Withdrawal by Subject|0|||
143297700|NCT05104567|516640753|FG006|Overall Study|Withdrawal by Subject|0|||
143297701|NCT05104567|516640747|FG000|Overall Study|Other|1|||
143297702|NCT05104567|516640748|FG001|Overall Study|Other|1|||
143297703|NCT05104567|516640749|FG002|Overall Study|Other|1|||
143297704|NCT05104567|516640750|FG003|Overall Study|Other|0|||
143297705|NCT05104567|516640751|FG004|Overall Study|Other|0|||
143297706|NCT05104567|516640752|FG005|Overall Study|Other|0|||
143297707|NCT05104567|516640753|FG006|Overall Study|Other|0|||
143297708|NCT01464346|516640757|FG000|Overall Study|Withdrawal by Subject|0|||
143297709|NCT01464346|516640758|FG001|Overall Study|Withdrawal by Subject|0|||
143297710|NCT01464346|516640759|FG002|Overall Study|Withdrawal by Subject|1|||
143297711|NCT02295995|516640760|FG000|Overall Study|Lost to Follow-up|5|||
143297712|NCT02295995|516640761|FG001|Overall Study|Lost to Follow-up|1|||
143297713|NCT01498458|516640763|FG000|Overall Study|Adverse Event|4|||
143297714|NCT01498458|516640763|FG000|Overall Study|Physician Decision|3|||
143297715|NCT02005250|516640764|FG000|Overall Study|Lost to Follow-up|15|||
143297716|NCT02005250|516640765|FG001|Overall Study|Lost to Follow-up|5|||
143297717|NCT03188094|516640770|FG000|Overall Study|Screen failure|1|||
143297718|NCT03188094|516640771|FG001|Overall Study|Screen failure|0|||
143297719|NCT03188094|516640772|FG002|Overall Study|Screen failure|0|||
143297720|NCT03188094|516640770|FG000|Overall Study|Pregnancy|3|||
143297721|NCT03188094|516640771|FG001|Overall Study|Pregnancy|0|||
143297722|NCT03188094|516640772|FG002|Overall Study|Pregnancy|0|||
143297723|NCT03188094|516640770|FG000|Overall Study|Ineligible|1|||
143297724|NCT03188094|516640771|FG001|Overall Study|Ineligible|0|||
143297725|NCT03188094|516640772|FG002|Overall Study|Ineligible|0|||
143297726|NCT03188094|516640770|FG000|Overall Study|Lost to Follow-up|0|||
143297727|NCT03188094|516640771|FG001|Overall Study|Lost to Follow-up|0|||
143297728|NCT03188094|516640772|FG002|Overall Study|Lost to Follow-up|17|||
143297729|NCT04007094|516640773|FG000|Overall Study|Lost to Follow-up|1|||
143297730|NCT04007094|516640774|FG001|Overall Study|Lost to Follow-up|1|||
143297731|NCT04350788|516640780|FG000|Overall Study|Lost to Follow-up|6|||
143297732|NCT04350788|516640781|FG001|Overall Study|Lost to Follow-up|2|||
143297733|NCT04350788|516640780|FG000|Overall Study|Withdrawal by Subject|2|||
143297734|NCT04350788|516640781|FG001|Overall Study|Withdrawal by Subject|4|||
143297735|NCT04350788|516640780|FG000|Overall Study|Protocol Violation|4|||
143297736|NCT04350788|516640781|FG001|Overall Study|Protocol Violation|0|||
143297737|NCT01581307|516640782|FG000|Overall Study|Withdrawal by Subject|1|||
143297738|NCT00378209|516640785|FG000|Overall Study|Progressive disease|11|||
143297739|NCT00378209|516640785|FG000|Overall Study|Adverse Event|3|||
143297740|NCT00378209|516640785|FG000|Overall Study|Initiation of non-protocol therapy|3|||
143297741|NCT00378209|516640785|FG000|Overall Study|Physician Decision|3|||
143297742|NCT00378209|516640785|FG000|Overall Study|Death|1|||
143297743|NCT00378209|516640785|FG000|Overall Study|Treatment delay|1|||
143297744|NCT02070744|516640786|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
143297745|NCT02070744|516640787|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
143297746|NCT02070744|516640788|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
143297747|NCT02070744|516640789|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
143297748|NCT02070744|516640790|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
143297749|NCT02070744|516640786|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
143297750|NCT02070744|516640787|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
143297751|NCT02070744|516640788|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
143297752|NCT02070744|516640789|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
143297753|NCT02070744|516640790|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
143297754|NCT02070744|516640786|FG000|OLE Phase (48 Weeks)|Other|0|||
143297755|NCT02070744|516640787|FG001|OLE Phase (48 Weeks)|Other|0|||
143297756|NCT02070744|516640788|FG002|OLE Phase (48 Weeks)|Other|0|||
143297757|NCT02070744|516640789|FG003|OLE Phase (48 Weeks)|Other|0|||
143297758|NCT02070744|516640790|FG004|OLE Phase (48 Weeks)|Other|1|||
143297759|NCT01894581|516640791|FG000|Overall Study|Withdrawal by Subject|2|||
143297760|NCT01894581|516640792|FG001|Overall Study|Withdrawal by Subject|3|||
143297761|NCT01894581|516640791|FG000|Overall Study|Screen Failure|3|||
143297762|NCT01894581|516640792|FG001|Overall Study|Screen Failure|4|||
143297763|NCT03795298|516640796|FG000|Overall Study|Death|34|||
143297764|NCT03795298|516640797|FG001|Overall Study|Death|29|||
143297765|NCT03795298|516640796|FG000|Overall Study|Death > 1095 day (not included in endpoint analyses)|1|||
143297766|NCT03795298|516640797|FG001|Overall Study|Death > 1095 day (not included in endpoint analyses)|2|||
143297767|NCT03795298|516640796|FG000|Overall Study|Lost to Follow-up|28|||
143297768|NCT03795298|516640797|FG001|Overall Study|Lost to Follow-up|17|||
143297769|NCT03795298|516640796|FG000|Overall Study|Physician Decision|5|||
143297770|NCT03795298|516640797|FG001|Overall Study|Physician Decision|4|||
143297771|NCT03795298|516640796|FG000|Overall Study|Withdrawal by Subject|43|||
143297772|NCT03795298|516640797|FG001|Overall Study|Withdrawal by Subject|28|||
143297773|NCT03795298|516640796|FG000|Overall Study|Reason not reported|7|||
143297774|NCT03795298|516640797|FG001|Overall Study|Reason not reported|9|||
143297775|NCT04199117|516640798|FG000|Overall Study|Withdrawal by Subject|3|||
143297776|NCT04199117|516640799|FG001|Overall Study|Withdrawal by Subject|0|||
143297777|NCT04199117|516640800|FG002|Overall Study|Withdrawal by Subject|0|||
143297778|NCT04199117|516640801|FG003|Overall Study|Withdrawal by Subject|1|||
143297779|NCT04199117|516640802|FG004|Overall Study|Withdrawal by Subject|1|||
143297780|NCT04199117|516640803|FG005|Overall Study|Withdrawal by Subject|0|||
143297781|NCT04199117|516640804|FG006|Overall Study|Withdrawal by Subject|0|||
143297782|NCT04199117|516640805|FG007|Overall Study|Withdrawal by Subject|2|||
143297783|NCT04199117|516640806|FG008|Overall Study|Withdrawal by Subject|0|||
143297784|NCT04199117|516640807|FG009|Overall Study|Withdrawal by Subject|0|||
143297785|NCT04199117|516640808|FG010|Overall Study|Withdrawal by Subject|1|||
143297786|NCT04199117|516640809|FG011|Overall Study|Withdrawal by Subject|1|||
143297787|NCT04199117|516640810|FG012|Overall Study|Withdrawal by Subject|2|||
143297788|NCT04199117|516640811|FG013|Overall Study|Withdrawal by Subject|1|||
143297789|NCT04199117|516640812|FG014|Overall Study|Withdrawal by Subject|1|||
143297790|NCT04199117|516640813|FG015|Overall Study|Withdrawal by Subject|1|||
143297791|NCT04199117|516640798|FG000|Overall Study|Death|1|||
143297792|NCT04199117|516640799|FG001|Overall Study|Death|1|||
143297793|NCT04199117|516640800|FG002|Overall Study|Death|0|||
143297794|NCT04199117|516640801|FG003|Overall Study|Death|0|||
143297795|NCT04199117|516640802|FG004|Overall Study|Death|0|||
143297796|NCT04199117|516640803|FG005|Overall Study|Death|0|||
143297797|NCT04199117|516640804|FG006|Overall Study|Death|0|||
143297798|NCT04199117|516640805|FG007|Overall Study|Death|0|||
143297799|NCT04199117|516640806|FG008|Overall Study|Death|0|||
143297800|NCT04199117|516640807|FG009|Overall Study|Death|0|||
143297801|NCT04199117|516640808|FG010|Overall Study|Death|0|||
143297802|NCT04199117|516640809|FG011|Overall Study|Death|1|||
143297803|NCT04199117|516640810|FG012|Overall Study|Death|0|||
143297804|NCT04199117|516640811|FG013|Overall Study|Death|1|||
143297805|NCT04199117|516640812|FG014|Overall Study|Death|0|||
143297806|NCT04199117|516640813|FG015|Overall Study|Death|0|||
143297807|NCT04199117|516640798|FG000|Overall Study|Withdrawal by PI|0|||
143297808|NCT04199117|516640799|FG001|Overall Study|Withdrawal by PI|0|||
143297809|NCT04199117|516640800|FG002|Overall Study|Withdrawal by PI|0|||
143297810|NCT04199117|516640801|FG003|Overall Study|Withdrawal by PI|0|||
143297811|NCT04199117|516640802|FG004|Overall Study|Withdrawal by PI|0|||
143297812|NCT04199117|516640803|FG005|Overall Study|Withdrawal by PI|0|||
143297813|NCT04199117|516640804|FG006|Overall Study|Withdrawal by PI|0|||
143297814|NCT04199117|516640805|FG007|Overall Study|Withdrawal by PI|0|||
143297815|NCT04199117|516640806|FG008|Overall Study|Withdrawal by PI|0|||
143297816|NCT04199117|516640807|FG009|Overall Study|Withdrawal by PI|0|||
143297817|NCT04199117|516640808|FG010|Overall Study|Withdrawal by PI|0|||
143297818|NCT04199117|516640809|FG011|Overall Study|Withdrawal by PI|0|||
143297819|NCT04199117|516640810|FG012|Overall Study|Withdrawal by PI|1|||
143297820|NCT04199117|516640811|FG013|Overall Study|Withdrawal by PI|0|||
143297821|NCT04199117|516640812|FG014|Overall Study|Withdrawal by PI|0|||
143297822|NCT04199117|516640813|FG015|Overall Study|Withdrawal by PI|0|||
143297823|NCT05478252|516640814|FG000|Overall Study|Withdrawal by Subject|2|||
143297824|NCT05478252|516640815|FG001|Overall Study|Withdrawal by Subject|3|||
143297825|NCT05478252|516640814|FG000|Overall Study|Lost to Follow-up|4|||
143297826|NCT05478252|516640815|FG001|Overall Study|Lost to Follow-up|2|||
143297827|NCT05478252|516640814|FG000|Overall Study|Physician Decision|1|||
143297828|NCT05478252|516640815|FG001|Overall Study|Physician Decision|1|||
143297829|NCT05478252|516640814|FG000|Overall Study|Death|1|||
143297830|NCT05478252|516640815|FG001|Overall Study|Death|0|||
143297831|NCT01816893|516640820|FG000|Washout Period|Withdrawal by Subject|2|||
143297832|NCT01816893|516640821|FG001|Washout Period|Withdrawal by Subject|0|||
143297833|NCT04439253|516643482|FG000|Overall Study|Adverse Event|1|||
143297834|NCT04439253|516643482|FG000|Overall Study|Disease progression|2|||
143297835|NCT04439253|516643482|FG000|Overall Study|Complicating disease|1|||
143297836|NCT03971695|516643483|FG000|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
143297837|NCT03971695|516643484|FG001|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
143297838|NCT03971695|516643485|FG002|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
143297839|NCT03971695|516643486|FG003|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
143297840|NCT03971695|516643487|FG004|End of Part I and Part II - Washout|Did not participate in part II of study|9|||
143297841|NCT03971695|516643488|FG005|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
143297842|NCT03971695|516643489|FG006|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
143297843|NCT03971695|516643490|FG007|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
143297844|NCT03971695|516643491|FG008|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
143297845|NCT03971695|516643492|FG009|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
143297846|NCT03971695|516643493|FG010|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
143297847|NCT03971695|516643494|FG011|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
143297848|NCT03971695|516643495|FG012|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
143297849|NCT00939809|516643496|FG000|Overall Study|Adverse Event|2|||
143297850|NCT00939809|516643496|FG000|Overall Study|Death|1|||
143297851|NCT04447417|516643497|FG000|Overall Study|Withdrawal by Subject|1|||
143297852|NCT04447417|516643498|FG001|Overall Study|Withdrawal by Subject|0|||
143297853|NCT04447417|516643497|FG000|Overall Study|Failure to meet inclusion criteria|1|||
143297854|NCT04447417|516643498|FG001|Overall Study|Failure to meet inclusion criteria|0|||
143297855|NCT04447417|516643497|FG000|Overall Study|Lost to Follow-up|1|||
143297856|NCT04447417|516643498|FG001|Overall Study|Lost to Follow-up|0|||
143297857|NCT00858442|516643503|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
143297858|NCT00858442|516643504|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
143297859|NCT02155738|516643507|FG000|Overall Study|Missing critical information|1|||
143297860|NCT02155738|516643508|FG001|Overall Study|Missing critical information|0|||
143297861|NCT02155738|516643509|FG002|Overall Study|Missing critical information|0|||
143297862|NCT02155738|516643510|FG003|Overall Study|Missing critical information|1|||
143297863|NCT02016625|516643511|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
143297864|NCT02016625|516643512|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
143297865|NCT02016625|516643511|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
143297866|NCT02016625|516643512|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
143297867|NCT02016625|516643511|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
143297868|NCT02016625|516643512|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
143297869|NCT02356783|516643514|FG000|Overall Study|Lost to Follow-up|1|||
143297870|NCT02356783|516643515|FG001|Overall Study|Lost to Follow-up|3|||
143297871|NCT02603809|516643516|FG000|Overall Study|Withdrawal by Subject|4|||
143297872|NCT02603809|516643517|FG001|Overall Study|Withdrawal by Subject|1|||
143297873|NCT02603809|516643518|FG002|Overall Study|Withdrawal by Subject|2|||
143297874|NCT02603809|516643519|FG003|Overall Study|Withdrawal by Subject|3|||
143297875|NCT02603809|516643520|FG004|Overall Study|Withdrawal by Subject|3|||
143297876|NCT02603809|516643521|FG005|Overall Study|Withdrawal by Subject|4|||
143297877|NCT02603809|516643516|FG000|Overall Study|Lost to Follow-up|2|||
143297878|NCT02603809|516643517|FG001|Overall Study|Lost to Follow-up|3|||
143297879|NCT02603809|516643518|FG002|Overall Study|Lost to Follow-up|1|||
143297880|NCT02603809|516643519|FG003|Overall Study|Lost to Follow-up|4|||
143297881|NCT02603809|516643520|FG004|Overall Study|Lost to Follow-up|2|||
143297882|NCT02603809|516643521|FG005|Overall Study|Lost to Follow-up|2|||
143297883|NCT02603809|516643516|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
143297884|NCT02603809|516643517|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
143297885|NCT02603809|516643518|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
143297886|NCT02603809|516643519|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
143297887|NCT02603809|516643520|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
143297888|NCT02603809|516643521|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
143297889|NCT02603809|516643516|FG000|Overall Study|Physician Decision|0|||
143297890|NCT02603809|516643517|FG001|Overall Study|Physician Decision|0|||
143297891|NCT02603809|516643518|FG002|Overall Study|Physician Decision|0|||
143297892|NCT02603809|516643519|FG003|Overall Study|Physician Decision|1|||
143297893|NCT02603809|516643520|FG004|Overall Study|Physician Decision|2|||
143297894|NCT02603809|516643521|FG005|Overall Study|Physician Decision|1|||
143297895|NCT02603809|516643516|FG000|Overall Study|Adverse Event|3|||
143297896|NCT02603809|516643517|FG001|Overall Study|Adverse Event|0|||
143297897|NCT02603809|516643518|FG002|Overall Study|Adverse Event|2|||
143297898|NCT02603809|516643519|FG003|Overall Study|Adverse Event|2|||
143297899|NCT02603809|516643520|FG004|Overall Study|Adverse Event|1|||
143297900|NCT02603809|516643521|FG005|Overall Study|Adverse Event|1|||
143297901|NCT02603809|516643516|FG000|Overall Study|Lack of Efficacy|0|||
143297902|NCT02603809|516643517|FG001|Overall Study|Lack of Efficacy|1|||
143297903|NCT02603809|516643518|FG002|Overall Study|Lack of Efficacy|0|||
143297904|NCT02603809|516643519|FG003|Overall Study|Lack of Efficacy|0|||
143297905|NCT02603809|516643520|FG004|Overall Study|Lack of Efficacy|0|||
143297906|NCT02603809|516643521|FG005|Overall Study|Lack of Efficacy|1|||
143297907|NCT00380978|516643523|FG000|Overall Study|Refused allocated intervention|0|||
143297908|NCT00380978|516643524|FG001|Overall Study|Refused allocated intervention|6|||
143297909|NCT00380978|516643523|FG000|Overall Study|Wrong study envelope|0|||
143297910|NCT00380978|516643524|FG001|Overall Study|Wrong study envelope|2|||
143297911|NCT00380978|516643523|FG000|Overall Study|Allocation prior to analgesia request|1|||
143297912|NCT00380978|516643524|FG001|Overall Study|Allocation prior to analgesia request|2|||
143297913|NCT00380978|516643523|FG000|Overall Study|Parous patient|1|||
143297914|NCT00380978|516643524|FG001|Overall Study|Parous patient|0|||
143297915|NCT01466348|516643525|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
143297916|NCT01466348|516643526|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
143297917|NCT03970733|516643529|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
143297918|NCT03970733|516643530|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
143297919|NCT03970733|516643531|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
143297920|NCT03970733|516643532|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
143297921|NCT03970733|516643533|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
143297922|NCT03970733|516643529|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
143297923|NCT03970733|516643530|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
143297924|NCT03970733|516643531|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
143297925|NCT03970733|516643532|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
143297926|NCT03970733|516643533|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
143297927|NCT03970733|516643529|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
143297928|NCT03970733|516643530|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
143297929|NCT03970733|516643531|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
143297930|NCT03970733|516643532|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
143297931|NCT03970733|516643533|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
143297932|NCT03970733|516643529|FG000|Main Study Phase (18 Months)|Other|1|||
143297933|NCT03970733|516643530|FG001|Main Study Phase (18 Months)|Other|1|||
143297934|NCT03970733|516643531|FG002|Main Study Phase (18 Months)|Other|0|||
143297935|NCT03970733|516643532|FG003|Main Study Phase (18 Months)|Other|0|||
143297936|NCT03970733|516643533|FG004|Main Study Phase (18 Months)|Other|0|||
143297937|NCT03970733|516643529|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
143297938|NCT03970733|516643530|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
143297939|NCT03970733|516643531|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
143297940|NCT03970733|516643532|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
143297941|NCT03970733|516643533|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
143297942|NCT02784821|516643537|FG000|Overall Study|Death|0|||
143297943|NCT02784821|516643538|FG001|Overall Study|Death|5|||
143297944|NCT02784821|516643539|FG002|Overall Study|Death|4|||
143297945|NCT02784821|516643540|FG003|Overall Study|Death|5|||
143297946|NCT01139450|516643541|FG000|Overall Study|Withdrawal by Subject|7|||
143297947|NCT01139450|516643542|FG001|Overall Study|Withdrawal by Subject|10|||
143374387|NCT00922207|516915445|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
143297948|NCT01139450|516643543|FG002|Overall Study|Withdrawal by Subject|13|||
143297949|NCT01139450|516643541|FG000|Overall Study|Lack of Efficacy|3|||
143374388|NCT00922207|516915446|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
143374389|NCT00922207|516915444|FG000|Overall Study|Withdrew Consent|2|||
143374390|NCT00922207|516915445|FG001|Overall Study|Withdrew Consent|5|||
143374391|NCT00922207|516915446|FG002|Overall Study|Withdrew Consent|2|||
143374392|NCT00922207|516915444|FG000|Overall Study|Abnormality of Laboratory Test|0|||
143374393|NCT00922207|516915445|FG001|Overall Study|Abnormality of Laboratory Test|1|||
143374394|NCT00922207|516915446|FG002|Overall Study|Abnormality of Laboratory Test|1|||
143374395|NCT01802632|516915447|FG000|Overall Study|Death|28|||
143374396|NCT01802632|516915448|FG001|Overall Study|Death|1|||
143374397|NCT01802632|516915449|FG002|Overall Study|Death|38|||
143374398|NCT01802632|516915450|FG003|Overall Study|Death|0|||
143374399|NCT01802632|516915451|FG004|Overall Study|Death|2|||
143374400|NCT01802632|516915452|FG005|Overall Study|Death|0|||
143374401|NCT01802632|516915447|FG000|Overall Study|Withdrawal by Subject|4|||
143374402|NCT01802632|516915448|FG001|Overall Study|Withdrawal by Subject|2|||
143374403|NCT01802632|516915449|FG002|Overall Study|Withdrawal by Subject|7|||
143374404|NCT01802632|516915450|FG003|Overall Study|Withdrawal by Subject|3|||
143374405|NCT01802632|516915451|FG004|Overall Study|Withdrawal by Subject|0|||
143374406|NCT01802632|516915452|FG005|Overall Study|Withdrawal by Subject|1|||
143374407|NCT01802632|516915447|FG000|Overall Study|Objective Disease Progression|1|||
143374408|NCT01802632|516915448|FG001|Overall Study|Objective Disease Progression|12|||
143374409|NCT01802632|516915449|FG002|Overall Study|Objective Disease Progression|104|||
143374410|NCT01802632|516915450|FG003|Overall Study|Objective Disease Progression|6|||
143374411|NCT01802632|516915451|FG004|Overall Study|Objective Disease Progression|4|||
143374412|NCT01802632|516915452|FG005|Overall Study|Objective Disease Progression|4|||
143374413|NCT01802632|516915447|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
143374414|NCT01802632|516915448|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
143374415|NCT01802632|516915449|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
143374416|NCT01802632|516915450|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
143374417|NCT01802632|516915451|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
143374418|NCT01802632|516915452|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
143374419|NCT01802632|516915447|FG000|Overall Study|Other (not specified)|0|||
143374420|NCT01802632|516915448|FG001|Overall Study|Other (not specified)|0|||
143374421|NCT01802632|516915449|FG002|Overall Study|Other (not specified)|7|||
143374422|NCT01802632|516915450|FG003|Overall Study|Other (not specified)|1|||
143374423|NCT01802632|516915451|FG004|Overall Study|Other (not specified)|0|||
143374424|NCT01802632|516915452|FG005|Overall Study|Other (not specified)|1|||
143374425|NCT02705586|516915462|FG000|Overall Study|Health Issues|2|||
143374426|NCT02705586|516915462|FG000|Overall Study|Transportation Difficulties|5|||
143374427|NCT02705586|516915462|FG000|Overall Study|Vacation/Planned Absence|1|||
143374428|NCT02045836|516915466|FG000|Overall Study|Adverse Event|4|||
143374429|NCT02045836|516915467|FG001|Overall Study|Adverse Event|4|||
143374430|NCT02045836|516915466|FG000|Overall Study|Withdrawal by Subject|1|||
143374431|NCT02045836|516915467|FG001|Overall Study|Withdrawal by Subject|1|||
143374432|NCT02045836|516915466|FG000|Overall Study|Lost to Follow-up|4|||
143374433|NCT02045836|516915467|FG001|Overall Study|Lost to Follow-up|7|||
143374434|NCT02045836|516915466|FG000|Overall Study|Migrated from study area|0|||
143374435|NCT02045836|516915467|FG001|Overall Study|Migrated from study area|2|||
143374436|NCT03920215|516915469|FG000|Overall Study|Lost to Follow-up|1|||
143374437|NCT03920215|516915470|FG001|Overall Study|Lost to Follow-up|2|||
143297950|NCT01139450|516643542|FG001|Overall Study|Lack of Efficacy|1|||
143297951|NCT01139450|516643543|FG002|Overall Study|Lack of Efficacy|8|||
143297952|NCT01139450|516643541|FG000|Overall Study|Protocol Violation|6|||
143374438|NCT03920215|516915471|FG002|Overall Study|Lost to Follow-up|0|||
143374439|NCT03920215|516915472|FG003|Overall Study|Lost to Follow-up|0|||
143374440|NCT03920215|516915469|FG000|Overall Study|Death|0|||
143374441|NCT03920215|516915470|FG001|Overall Study|Death|0|||
143374442|NCT03920215|516915471|FG002|Overall Study|Death|0|||
143374443|NCT03920215|516915472|FG003|Overall Study|Death|1|||
143374444|NCT02798835|516915473|FG000|Overall Study|Protocol Violation|0|||
143297953|NCT01139450|516643542|FG001|Overall Study|Protocol Violation|5|||
143297954|NCT01139450|516643543|FG002|Overall Study|Protocol Violation|2|||
143374445|NCT02798835|516915474|FG001|Overall Study|Protocol Violation|0|||
143297955|NCT01139450|516643541|FG000|Overall Study|Lost to Follow-up|9|||
143297956|NCT01139450|516643542|FG001|Overall Study|Lost to Follow-up|7|||
143297957|NCT01139450|516643543|FG002|Overall Study|Lost to Follow-up|11|||
143297958|NCT01139450|516643541|FG000|Overall Study|Administrative|0|||
143297959|NCT01139450|516643542|FG001|Overall Study|Administrative|0|||
143297960|NCT01139450|516643543|FG002|Overall Study|Administrative|1|||
143297961|NCT01139450|516643541|FG000|Overall Study|Adverse Event|2|||
143297962|NCT01139450|516643542|FG001|Overall Study|Adverse Event|2|||
143297963|NCT01139450|516643543|FG002|Overall Study|Adverse Event|3|||
143297964|NCT02794103|516643544|FG000|Overall Study|Loss to follow up due to high sedation|3|||
143297965|NCT04608500|516643545|FG000|Overall Study|Adverse Event|2|||
143297966|NCT04608500|516643546|FG001|Overall Study|Adverse Event|0|||
143297967|NCT04608500|516643545|FG000|Overall Study|Lost to Follow-up|15|||
143297968|NCT04608500|516643546|FG001|Overall Study|Lost to Follow-up|9|||
143297969|NCT04608500|516643545|FG000|Overall Study|Participant request|11|||
143297970|NCT04608500|516643546|FG001|Overall Study|Participant request|7|||
143297971|NCT04608500|516643545|FG000|Overall Study|Protocol Violation|1|||
143297972|NCT04608500|516643546|FG001|Overall Study|Protocol Violation|0|||
143297973|NCT04608500|516643545|FG000|Overall Study|Other|6|||
143297974|NCT04608500|516643546|FG001|Overall Study|Other|2|||
143297975|NCT01881230|516643558|FG000|Overall Study|Death|2|||
143297976|NCT01881230|516643559|FG001|Overall Study|Death|0|||
143297977|NCT01881230|516643560|FG002|Overall Study|Death|1|||
143297978|NCT01881230|516643558|FG000|Overall Study|Adverse Event|9|||
143297979|NCT01881230|516643559|FG001|Overall Study|Adverse Event|13|||
143297980|NCT01881230|516643560|FG002|Overall Study|Adverse Event|12|||
143297981|NCT01881230|516643558|FG000|Overall Study|Progressive Disease|31|||
143297982|NCT01881230|516643559|FG001|Overall Study|Progressive Disease|35|||
143297983|NCT01881230|516643560|FG002|Overall Study|Progressive Disease|36|||
143297984|NCT01881230|516643558|FG000|Overall Study|Symptomatic Deterioration|3|||
143297985|NCT01881230|516643559|FG001|Overall Study|Symptomatic Deterioration|3|||
143297986|NCT01881230|516643560|FG002|Overall Study|Symptomatic Deterioration|1|||
143297987|NCT01881230|516643558|FG000|Overall Study|Withdrawal by Subject|6|||
143297988|NCT01881230|516643559|FG001|Overall Study|Withdrawal by Subject|4|||
143297989|NCT01881230|516643560|FG002|Overall Study|Withdrawal by Subject|6|||
143297990|NCT01881230|516643558|FG000|Overall Study|Physician Decision|4|||
143297991|NCT01881230|516643559|FG001|Overall Study|Physician Decision|3|||
143297992|NCT01881230|516643560|FG002|Overall Study|Physician Decision|6|||
143297993|NCT01881230|516643558|FG000|Overall Study|Non-Compliance with Study Drug|1|||
143297994|NCT01881230|516643559|FG001|Overall Study|Non-Compliance with Study Drug|2|||
143297995|NCT01881230|516643560|FG002|Overall Study|Non-Compliance with Study Drug|0|||
143297996|NCT01881230|516643558|FG000|Overall Study|Given Commercially Available Drug|0|||
143297997|NCT01881230|516643559|FG001|Overall Study|Given Commercially Available Drug|0|||
143297998|NCT01881230|516643560|FG002|Overall Study|Given Commercially Available Drug|2|||
143297999|NCT01881230|516643558|FG000|Overall Study|Protocol Violation|1|||
143298000|NCT01881230|516643559|FG001|Overall Study|Protocol Violation|1|||
143298001|NCT01881230|516643560|FG002|Overall Study|Protocol Violation|0|||
143298002|NCT01881230|516643558|FG000|Overall Study|Miscellaneous|3|||
143298003|NCT01881230|516643559|FG001|Overall Study|Miscellaneous|3|||
143298004|NCT01881230|516643560|FG002|Overall Study|Miscellaneous|0|||
143298005|NCT01881230|516643558|FG000|Overall Study|Untreated: Other|0|||
143298006|NCT01881230|516643559|FG001|Overall Study|Untreated: Other|0|||
143298007|NCT01881230|516643560|FG002|Overall Study|Untreated: Other|1|||
143298008|NCT01881230|516643558|FG000|Overall Study|Untreated: Death|0|||
143298009|NCT01881230|516643559|FG001|Overall Study|Untreated: Death|0|||
143298010|NCT01881230|516643560|FG002|Overall Study|Untreated: Death|1|||
143298011|NCT01881230|516643558|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
143298012|NCT01881230|516643559|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
143298013|NCT01881230|516643560|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
143298014|NCT00112502|516643561|FG000|Overall Study|Withdrawal by Subject|0|||
143298015|NCT00112502|516643562|FG001|Overall Study|Withdrawal by Subject|1|||
143298016|NCT00112502|516643563|FG002|Overall Study|Withdrawal by Subject|1|||
143298017|NCT00112502|516643564|FG003|Overall Study|Withdrawal by Subject|4|||
143298018|NCT00112502|516643565|FG004|Overall Study|Withdrawal by Subject|2|||
143298019|NCT00112502|516643566|FG005|Overall Study|Withdrawal by Subject|5|||
143298020|NCT00112502|516643567|FG006|Overall Study|Withdrawal by Subject|3|||
143298021|NCT00112502|516643568|FG007|Overall Study|Withdrawal by Subject|7|||
143298022|NCT02747420|516643569|FG000|Overall Study|Lost to Follow-up|4|||
143298023|NCT02747420|516643570|FG001|Overall Study|Lost to Follow-up|2|||
143298024|NCT02747420|516643569|FG000|Overall Study|Withdrawal by Subject|3|||
143298025|NCT02747420|516643570|FG001|Overall Study|Withdrawal by Subject|2|||
143298026|NCT05129488|516643571|FG000|Overall Study|Protocol Violation|3|||
143298027|NCT02608268|516643572|FG000|Overall Study|Adverse Event|0|||
143298028|NCT02608268|516643573|FG001|Overall Study|Adverse Event|0|||
143298029|NCT02608268|516643574|FG002|Overall Study|Adverse Event|1|||
143298030|NCT02608268|516643575|FG003|Overall Study|Adverse Event|0|||
143298031|NCT02608268|516643576|FG004|Overall Study|Adverse Event|0|||
143298032|NCT02608268|516643577|FG005|Overall Study|Adverse Event|0|||
143298033|NCT02608268|516643578|FG006|Overall Study|Adverse Event|0|||
143298034|NCT02608268|516643579|FG007|Overall Study|Adverse Event|0|||
143298035|NCT02608268|516643580|FG008|Overall Study|Adverse Event|0|||
143298036|NCT02608268|516643581|FG009|Overall Study|Adverse Event|0|||
143298037|NCT02608268|516643582|FG010|Overall Study|Adverse Event|0|||
143298038|NCT02608268|516643583|FG011|Overall Study|Adverse Event|0|||
143298039|NCT02608268|516643584|FG012|Overall Study|Adverse Event|2|||
143298040|NCT02608268|516643585|FG013|Overall Study|Adverse Event|0|||
143298041|NCT02608268|516643586|FG014|Overall Study|Adverse Event|0|||
143298042|NCT02608268|516643587|FG015|Overall Study|Adverse Event|0|||
143298043|NCT02608268|516643588|FG016|Overall Study|Adverse Event|0|||
143298044|NCT02608268|516643589|FG017|Overall Study|Adverse Event|0|||
143298045|NCT02608268|516643590|FG018|Overall Study|Adverse Event|0|||
143298046|NCT02608268|516643591|FG019|Overall Study|Adverse Event|0|||
143298047|NCT02608268|516643592|FG020|Overall Study|Adverse Event|1|||
143298048|NCT02608268|516643593|FG021|Overall Study|Adverse Event|1|||
143298049|NCT02608268|516643594|FG022|Overall Study|Adverse Event|0|||
143298050|NCT02608268|516643595|FG023|Overall Study|Adverse Event|0|||
143298051|NCT02608268|516643596|FG024|Overall Study|Adverse Event|1|||
143298052|NCT02608268|516643597|FG025|Overall Study|Adverse Event|0|||
143298053|NCT02608268|516643598|FG026|Overall Study|Adverse Event|0|||
143298054|NCT02608268|516643599|FG027|Overall Study|Adverse Event|0|||
143298055|NCT02608268|516643600|FG028|Overall Study|Adverse Event|1|||
143298056|NCT02608268|516643601|FG029|Overall Study|Adverse Event|0|||
143298057|NCT02608268|516643572|FG000|Overall Study|Death|1|||
143298058|NCT02608268|516643573|FG001|Overall Study|Death|0|||
143298059|NCT02608268|516643574|FG002|Overall Study|Death|0|||
143298060|NCT02608268|516643575|FG003|Overall Study|Death|0|||
143298061|NCT02608268|516643576|FG004|Overall Study|Death|0|||
143298062|NCT02608268|516643577|FG005|Overall Study|Death|0|||
143298063|NCT02608268|516643578|FG006|Overall Study|Death|0|||
143298064|NCT02608268|516643579|FG007|Overall Study|Death|0|||
143298065|NCT02608268|516643580|FG008|Overall Study|Death|1|||
143298066|NCT02608268|516643581|FG009|Overall Study|Death|1|||
143298067|NCT02608268|516643582|FG010|Overall Study|Death|0|||
143298068|NCT02608268|516643583|FG011|Overall Study|Death|0|||
143298069|NCT02608268|516643584|FG012|Overall Study|Death|0|||
143298070|NCT02608268|516643585|FG013|Overall Study|Death|0|||
143298071|NCT02608268|516643586|FG014|Overall Study|Death|0|||
143298072|NCT02608268|516643587|FG015|Overall Study|Death|1|||
143298073|NCT02608268|516643588|FG016|Overall Study|Death|0|||
143298074|NCT02608268|516643589|FG017|Overall Study|Death|1|||
143298075|NCT02608268|516643590|FG018|Overall Study|Death|0|||
143298076|NCT02608268|516643591|FG019|Overall Study|Death|1|||
143298077|NCT02608268|516643592|FG020|Overall Study|Death|1|||
143298078|NCT02608268|516643593|FG021|Overall Study|Death|0|||
143298079|NCT02608268|516643594|FG022|Overall Study|Death|0|||
143298080|NCT02608268|516643595|FG023|Overall Study|Death|0|||
143298081|NCT02608268|516643596|FG024|Overall Study|Death|1|||
143298082|NCT02608268|516643597|FG025|Overall Study|Death|2|||
143298083|NCT02608268|516643598|FG026|Overall Study|Death|0|||
143298084|NCT02608268|516643599|FG027|Overall Study|Death|1|||
143298085|NCT02608268|516643600|FG028|Overall Study|Death|4|||
143298086|NCT02608268|516643601|FG029|Overall Study|Death|0|||
143298087|NCT02608268|516643572|FG000|Overall Study|Physician Decision|0|||
143298088|NCT02608268|516643573|FG001|Overall Study|Physician Decision|0|||
143298089|NCT02608268|516643574|FG002|Overall Study|Physician Decision|0|||
143298090|NCT02608268|516643575|FG003|Overall Study|Physician Decision|0|||
143298091|NCT02608268|516643576|FG004|Overall Study|Physician Decision|0|||
143298092|NCT02608268|516643577|FG005|Overall Study|Physician Decision|0|||
143298093|NCT02608268|516643578|FG006|Overall Study|Physician Decision|0|||
143298094|NCT02608268|516643579|FG007|Overall Study|Physician Decision|0|||
143298095|NCT02608268|516643580|FG008|Overall Study|Physician Decision|0|||
143298096|NCT02608268|516643581|FG009|Overall Study|Physician Decision|0|||
143298097|NCT02608268|516643582|FG010|Overall Study|Physician Decision|1|||
143298098|NCT02608268|516643583|FG011|Overall Study|Physician Decision|0|||
143298099|NCT02608268|516643584|FG012|Overall Study|Physician Decision|0|||
143298100|NCT02608268|516643585|FG013|Overall Study|Physician Decision|1|||
143298101|NCT02608268|516643586|FG014|Overall Study|Physician Decision|0|||
143298102|NCT02608268|516643587|FG015|Overall Study|Physician Decision|0|||
143298103|NCT02608268|516643588|FG016|Overall Study|Physician Decision|0|||
143298104|NCT02608268|516643589|FG017|Overall Study|Physician Decision|0|||
143298105|NCT02608268|516643590|FG018|Overall Study|Physician Decision|0|||
143298106|NCT02608268|516643591|FG019|Overall Study|Physician Decision|0|||
143298107|NCT02608268|516643592|FG020|Overall Study|Physician Decision|0|||
143298108|NCT02608268|516643593|FG021|Overall Study|Physician Decision|0|||
143298109|NCT02608268|516643594|FG022|Overall Study|Physician Decision|1|||
143298110|NCT02608268|516643595|FG023|Overall Study|Physician Decision|1|||
143298111|NCT02608268|516643596|FG024|Overall Study|Physician Decision|1|||
143298112|NCT02608268|516643597|FG025|Overall Study|Physician Decision|0|||
143298113|NCT02608268|516643598|FG026|Overall Study|Physician Decision|0|||
143298114|NCT02608268|516643599|FG027|Overall Study|Physician Decision|2|||
143298115|NCT02608268|516643600|FG028|Overall Study|Physician Decision|1|||
143298116|NCT02608268|516643601|FG029|Overall Study|Physician Decision|1|||
143298117|NCT02608268|516643572|FG000|Overall Study|Progressive disease|12|||
143298118|NCT02608268|516643573|FG001|Overall Study|Progressive disease|8|||
143298119|NCT02608268|516643574|FG002|Overall Study|Progressive disease|13|||
143298120|NCT02608268|516643575|FG003|Overall Study|Progressive disease|5|||
143298121|NCT02608268|516643576|FG004|Overall Study|Progressive disease|2|||
143298122|NCT02608268|516643577|FG005|Overall Study|Progressive disease|4|||
143298123|NCT02608268|516643578|FG006|Overall Study|Progressive disease|6|||
143298124|NCT02608268|516643579|FG007|Overall Study|Progressive disease|2|||
143298125|NCT02608268|516643580|FG008|Overall Study|Progressive disease|5|||
143298126|NCT02608268|516643581|FG009|Overall Study|Progressive disease|6|||
143298127|NCT02608268|516643582|FG010|Overall Study|Progressive disease|5|||
143298128|NCT02608268|516643583|FG011|Overall Study|Progressive disease|5|||
143298129|NCT02608268|516643584|FG012|Overall Study|Progressive disease|4|||
143298130|NCT02608268|516643585|FG013|Overall Study|Progressive disease|11|||
143298131|NCT02608268|516643586|FG014|Overall Study|Progressive disease|6|||
143298132|NCT02608268|516643587|FG015|Overall Study|Progressive disease|3|||
143298133|NCT02608268|516643588|FG016|Overall Study|Progressive disease|5|||
143298134|NCT02608268|516643589|FG017|Overall Study|Progressive disease|5|||
143298135|NCT02608268|516643590|FG018|Overall Study|Progressive disease|5|||
143298136|NCT02608268|516643591|FG019|Overall Study|Progressive disease|2|||
143298137|NCT02608268|516643592|FG020|Overall Study|Progressive disease|10|||
143298138|NCT02608268|516643593|FG021|Overall Study|Progressive disease|4|||
143298139|NCT02608268|516643594|FG022|Overall Study|Progressive disease|5|||
143298140|NCT02608268|516643595|FG023|Overall Study|Progressive disease|5|||
143298141|NCT02608268|516643596|FG024|Overall Study|Progressive disease|3|||
143298142|NCT02608268|516643597|FG025|Overall Study|Progressive disease|11|||
143298143|NCT02608268|516643598|FG026|Overall Study|Progressive disease|16|||
143298144|NCT02608268|516643599|FG027|Overall Study|Progressive disease|11|||
143298145|NCT02608268|516643600|FG028|Overall Study|Progressive disease|10|||
143298146|NCT02608268|516643601|FG029|Overall Study|Progressive disease|15|||
143298147|NCT02608268|516643572|FG000|Overall Study|Subject/guardian decision|1|||
143298148|NCT02608268|516643573|FG001|Overall Study|Subject/guardian decision|1|||
143298149|NCT02608268|516643574|FG002|Overall Study|Subject/guardian decision|2|||
143298150|NCT02608268|516643575|FG003|Overall Study|Subject/guardian decision|0|||
143298151|NCT02608268|516643576|FG004|Overall Study|Subject/guardian decision|0|||
143298152|NCT02608268|516643577|FG005|Overall Study|Subject/guardian decision|0|||
143298153|NCT02608268|516643578|FG006|Overall Study|Subject/guardian decision|0|||
143374446|NCT02798835|516915475|FG002|Overall Study|Protocol Violation|3|||
143374447|NCT03024606|516915480|FG000|Overall Study|Withdrawal by Subject|9|||
143374448|NCT03024606|516915481|FG001|Overall Study|Withdrawal by Subject|10|||
143374449|NCT02547922|516915488|FG000|Overall Study|Withdrawal by Subject|9|||
143374450|NCT02547922|516915489|FG001|Overall Study|Withdrawal by Subject|6|||
143374451|NCT02547922|516915490|FG002|Overall Study|Withdrawal by Subject|10|||
143374452|NCT02547922|516915488|FG000|Overall Study|Adverse Event|3|||
143374453|NCT02547922|516915489|FG001|Overall Study|Adverse Event|1|||
143374454|NCT02547922|516915490|FG002|Overall Study|Adverse Event|2|||
143374455|NCT02547922|516915488|FG000|Overall Study|Lost to Follow-up|1|||
143374456|NCT02547922|516915489|FG001|Overall Study|Lost to Follow-up|0|||
143374457|NCT02547922|516915490|FG002|Overall Study|Lost to Follow-up|0|||
143374458|NCT02547922|516915488|FG000|Overall Study|Lack of Efficacy|5|||
143374459|NCT02547922|516915489|FG001|Overall Study|Lack of Efficacy|7|||
143374460|NCT02547922|516915490|FG002|Overall Study|Lack of Efficacy|4|||
143374461|NCT02547922|516915488|FG000|Overall Study|Death|1|||
143374462|NCT02547922|516915489|FG001|Overall Study|Death|0|||
143374463|NCT02547922|516915490|FG002|Overall Study|Death|0|||
143374464|NCT02547922|516915488|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
143374465|NCT02547922|516915489|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
143374466|NCT02547922|516915490|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
143374467|NCT02547922|516915488|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
143374468|NCT02547922|516915489|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
143298154|NCT02608268|516643579|FG007|Overall Study|Subject/guardian decision|0|||
143298155|NCT02608268|516643580|FG008|Overall Study|Subject/guardian decision|2|||
143298156|NCT02608268|516643581|FG009|Overall Study|Subject/guardian decision|2|||
143298157|NCT02608268|516643582|FG010|Overall Study|Subject/guardian decision|0|||
143298158|NCT02608268|516643583|FG011|Overall Study|Subject/guardian decision|1|||
143298159|NCT02608268|516643584|FG012|Overall Study|Subject/guardian decision|0|||
143298160|NCT02608268|516643585|FG013|Overall Study|Subject/guardian decision|1|||
143298161|NCT02608268|516643586|FG014|Overall Study|Subject/guardian decision|0|||
143298162|NCT02608268|516643587|FG015|Overall Study|Subject/guardian decision|1|||
143298163|NCT02608268|516643588|FG016|Overall Study|Subject/guardian decision|0|||
143298164|NCT02608268|516643589|FG017|Overall Study|Subject/guardian decision|0|||
143298165|NCT02608268|516643590|FG018|Overall Study|Subject/guardian decision|1|||
143298166|NCT02608268|516643591|FG019|Overall Study|Subject/guardian decision|0|||
143298167|NCT02608268|516643592|FG020|Overall Study|Subject/guardian decision|0|||
143298168|NCT02608268|516643593|FG021|Overall Study|Subject/guardian decision|0|||
143298169|NCT02608268|516643594|FG022|Overall Study|Subject/guardian decision|1|||
143298170|NCT02608268|516643595|FG023|Overall Study|Subject/guardian decision|0|||
143298171|NCT02608268|516643596|FG024|Overall Study|Subject/guardian decision|0|||
143298172|NCT02608268|516643597|FG025|Overall Study|Subject/guardian decision|1|||
143298173|NCT02608268|516643598|FG026|Overall Study|Subject/guardian decision|1|||
143298174|NCT02608268|516643599|FG027|Overall Study|Subject/guardian decision|1|||
143298175|NCT02608268|516643600|FG028|Overall Study|Subject/guardian decision|1|||
143298176|NCT02608268|516643601|FG029|Overall Study|Subject/guardian decision|0|||
143298177|NCT01030523|516643602|FG000|Initial Study (5 Years)|Death|1|||
143298178|NCT01030523|516643603|FG001|Initial Study (5 Years)|Death|0|||
143298179|NCT01030523|516643602|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
143298180|NCT01030523|516643603|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
143298181|NCT01030523|516643602|FG000|Initial Study (5 Years)|Implant failure|1|||
143298182|NCT01030523|516643603|FG001|Initial Study (5 Years)|Implant failure|0|||
143298183|NCT01030523|516643602|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
143298184|NCT01030523|516643603|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
143298185|NCT01030523|516643602|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
143298186|NCT01030523|516643603|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
143298187|NCT01030523|516643602|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
143298188|NCT01030523|516643603|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
143298189|NCT03662542|516643608|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
143298190|NCT03662542|516643609|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
143298191|NCT03662542|516643610|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
143298192|NCT03662542|516643611|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
143374469|NCT02547922|516915490|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
143374470|NCT02547922|516915488|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
143374471|NCT02547922|516915489|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
143374472|NCT02547922|516915490|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
143374473|NCT02547922|516915488|FG000|Overall Study|Physician Decision|2|||
143298193|NCT03662542|516643612|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
143298194|NCT03662542|516643613|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
143298195|NCT03662542|516643614|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
143298196|NCT03662542|516643615|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
143298197|NCT03662542|516643616|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
143298198|NCT03662542|516643608|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
143298199|NCT03662542|516643609|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
143298200|NCT03662542|516643610|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
143298201|NCT03662542|516643611|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
143298202|NCT03662542|516643612|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
143298203|NCT03662542|516643613|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
143298204|NCT03662542|516643614|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
143298205|NCT03662542|516643615|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
143298206|NCT03662542|516643616|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
143298207|NCT03662542|516643608|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
143298208|NCT03662542|516643609|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
143298209|NCT03662542|516643610|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
143298210|NCT03662542|516643611|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
143298211|NCT03662542|516643612|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
143298212|NCT03662542|516643613|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
143298213|NCT03662542|516643614|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
143298214|NCT03662542|516643615|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
143298215|NCT03662542|516643616|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
143298216|NCT03662542|516643608|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
143298217|NCT03662542|516643609|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
143298218|NCT03662542|516643610|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
143298219|NCT03662542|516643611|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
143298220|NCT03662542|516643612|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
143298221|NCT03662542|516643613|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
143298222|NCT03662542|516643614|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
143298223|NCT03662542|516643615|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
143298224|NCT03662542|516643616|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
143298225|NCT03662542|516643608|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
143298226|NCT03662542|516643609|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
143298227|NCT03662542|516643610|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
143298228|NCT03662542|516643611|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
143298229|NCT03662542|516643612|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
143298230|NCT03662542|516643613|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
143298231|NCT03662542|516643614|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
143298232|NCT03662542|516643615|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
143298233|NCT03662542|516643616|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
143298234|NCT03662542|516643608|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
143298235|NCT03662542|516643609|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
143298236|NCT03662542|516643610|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
143298237|NCT03662542|516643611|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
143298238|NCT03662542|516643612|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
143298239|NCT03662542|516643613|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
143298240|NCT03662542|516643614|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
143298241|NCT03662542|516643615|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
143298242|NCT03662542|516643616|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
143298243|NCT03662542|516643608|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
143298244|NCT03662542|516643609|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
143298245|NCT03662542|516643610|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
143298246|NCT03662542|516643611|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
143298247|NCT03662542|516643612|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
143298248|NCT03662542|516643613|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
143298249|NCT03662542|516643614|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
143298250|NCT03662542|516643615|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
143298251|NCT03662542|516643616|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
143298252|NCT03662542|516643608|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
143298253|NCT03662542|516643609|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
143298254|NCT03662542|516643610|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
143374474|NCT02547922|516915489|FG001|Overall Study|Physician Decision|1|||
143298255|NCT03662542|516643611|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
143298256|NCT03662542|516643612|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
143298257|NCT03662542|516643613|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
143298258|NCT03662542|516643614|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
143298259|NCT03662542|516643615|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
143298260|NCT03662542|516643616|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
143298261|NCT03662542|516643608|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
143298262|NCT03662542|516643609|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
143298263|NCT03662542|516643610|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
143298264|NCT03662542|516643611|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
143298265|NCT03662542|516643612|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
143298266|NCT03662542|516643613|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
143298267|NCT03662542|516643614|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
143298268|NCT03662542|516643615|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
143298269|NCT03662542|516643616|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
143298270|NCT03662542|516643608|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
143298271|NCT03662542|516643609|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
143298272|NCT03662542|516643610|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
143298273|NCT03662542|516643611|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
143298274|NCT03662542|516643612|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
143298275|NCT03662542|516643613|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
143298276|NCT03662542|516643614|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
143298277|NCT03662542|516643615|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
143298278|NCT03662542|516643616|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
143298279|NCT03662542|516643608|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
143298280|NCT03662542|516643609|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
143298281|NCT03662542|516643610|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
143298282|NCT03662542|516643611|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
143298283|NCT03662542|516643612|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
143298284|NCT03662542|516643613|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
143298285|NCT03662542|516643614|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
143298286|NCT03662542|516643615|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
143298287|NCT03662542|516643616|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
143298288|NCT03662542|516643608|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
143298289|NCT03662542|516643609|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
143298290|NCT03662542|516643610|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
143298291|NCT03662542|516643611|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
143298292|NCT03662542|516643612|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
143298293|NCT03662542|516643613|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
143298294|NCT03662542|516643614|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
143298295|NCT03662542|516643615|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
143298296|NCT03662542|516643616|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
143298297|NCT03662542|516643608|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
143298298|NCT03662542|516643609|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
143298299|NCT03662542|516643610|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
143298300|NCT03662542|516643611|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
143298301|NCT03662542|516643612|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
143298302|NCT03662542|516643613|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
143298303|NCT03662542|516643614|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
143298304|NCT03662542|516643615|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
143298305|NCT03662542|516643616|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
143298306|NCT01217060|516643618|FG000|Overall Study|Withdrawal by Subject|1|||
143298307|NCT04014075|516643631|FG000|Overall Study|Progressive Disease|53|||
143298308|NCT04014075|516643631|FG000|Overall Study|Adverse Event|15|||
143298309|NCT04014075|516643631|FG000|Overall Study|Clinical Progression|4|||
143298310|NCT04014075|516643631|FG000|Overall Study|Death|2|||
143298311|NCT04014075|516643631|FG000|Overall Study|Withdrawal by Subject|2|||
143298312|NCT04014075|516643631|FG000|Overall Study|Miscellaneous|2|||
143298313|NCT04014075|516643631|FG000|Overall Study|Physician Decision|1|||
143298314|NCT05089682|516643639|FG000|Overall Study|Withdrawal by Subject|2|||
143298315|NCT03329690|516643642|FG000|Overall Study|Progressive disease per RECIST|85|||
143298316|NCT03329690|516643643|FG001|Overall Study|Progressive disease per RECIST|44|||
143298317|NCT03329690|516643644|FG002|Overall Study|Progressive disease per RECIST|6|||
143298318|NCT03329690|516643645|FG003|Overall Study|Progressive disease per RECIST|16|||
143298319|NCT03329690|516643646|FG004|Overall Study|Progressive disease per RECIST|20|||
143374475|NCT02547922|516915490|FG002|Overall Study|Physician Decision|2|||
143298320|NCT03329690|516643642|FG000|Overall Study|Clinical progression|7|||
143298321|NCT03329690|516643643|FG001|Overall Study|Clinical progression|4|||
143298322|NCT03329690|516643644|FG002|Overall Study|Clinical progression|1|||
143298323|NCT03329690|516643645|FG003|Overall Study|Clinical progression|1|||
143298324|NCT03329690|516643646|FG004|Overall Study|Clinical progression|1|||
143298325|NCT03329690|516643642|FG000|Overall Study|Adverse Event|22|||
143298326|NCT03329690|516643643|FG001|Overall Study|Adverse Event|4|||
143298327|NCT03329690|516643644|FG002|Overall Study|Adverse Event|0|||
143298328|NCT03329690|516643645|FG003|Overall Study|Adverse Event|1|||
143298329|NCT03329690|516643646|FG004|Overall Study|Adverse Event|2|||
143298330|NCT03329690|516643642|FG000|Overall Study|Death|2|||
143298331|NCT03329690|516643643|FG001|Overall Study|Death|0|||
143298332|NCT03329690|516643644|FG002|Overall Study|Death|0|||
143298333|NCT03329690|516643645|FG003|Overall Study|Death|1|||
143298334|NCT03329690|516643646|FG004|Overall Study|Death|0|||
143298335|NCT03329690|516643642|FG000|Overall Study|Withdrawal by Subject|2|||
143298336|NCT03329690|516643643|FG001|Overall Study|Withdrawal by Subject|3|||
143298337|NCT03329690|516643644|FG002|Overall Study|Withdrawal by Subject|0|||
143298338|NCT03329690|516643645|FG003|Overall Study|Withdrawal by Subject|1|||
143298339|NCT03329690|516643646|FG004|Overall Study|Withdrawal by Subject|0|||
143298340|NCT03329690|516643642|FG000|Overall Study|Physician Decision|1|||
143298341|NCT03329690|516643643|FG001|Overall Study|Physician Decision|0|||
143298342|NCT03329690|516643644|FG002|Overall Study|Physician Decision|0|||
143298343|NCT03329690|516643645|FG003|Overall Study|Physician Decision|0|||
143298344|NCT03329690|516643646|FG004|Overall Study|Physician Decision|1|||
143298345|NCT03329690|516643642|FG000|Overall Study|Miscellaneous|6|||
143298346|NCT03329690|516643643|FG001|Overall Study|Miscellaneous|0|||
143298347|NCT03329690|516643644|FG002|Overall Study|Miscellaneous|0|||
143298348|NCT03329690|516643645|FG003|Overall Study|Miscellaneous|0|||
143298349|NCT03329690|516643646|FG004|Overall Study|Miscellaneous|0|||
143298350|NCT03329690|516643642|FG000|Overall Study|Did not receive treatment|1|||
143298351|NCT03329690|516643643|FG001|Overall Study|Did not receive treatment|0|||
143298352|NCT03329690|516643644|FG002|Overall Study|Did not receive treatment|0|||
143298353|NCT03329690|516643645|FG003|Overall Study|Did not receive treatment|1|||
143298354|NCT03329690|516643646|FG004|Overall Study|Did not receive treatment|0|||
143298355|NCT01817725|516643647|FG000|Overall Study|Withdrawal by Subject|1|||
143298356|NCT02073279|516643653|FG000|Double-blind Period|Adverse Event|1|||
143298357|NCT02073279|516643654|FG001|Double-blind Period|Adverse Event|1|||
143298358|NCT02073279|516643653|FG000|Double-blind Period|Switched to another treatment|1|||
143298359|NCT02073279|516643654|FG001|Double-blind Period|Switched to another treatment|2|||
143298360|NCT02073279|516643653|FG000|Double-blind Period|Protocol Violation|0|||
143298361|NCT02073279|516643654|FG001|Double-blind Period|Protocol Violation|1|||
143298362|NCT02073279|516643653|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
143298363|NCT02073279|516643654|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
143298364|NCT02073279|516643653|FG000|Double-blind Period|Withdrawal by Subject|2|||
143298365|NCT02073279|516643654|FG001|Double-blind Period|Withdrawal by Subject|2|||
143298366|NCT02073279|516643653|FG000|Open-label Extension Period|Adverse Event|1|||
143298367|NCT02073279|516643654|FG001|Open-label Extension Period|Adverse Event|0|||
143298368|NCT02073279|516643653|FG000|Open-label Extension Period|Lack of Efficacy|1|||
143298369|NCT02073279|516643654|FG001|Open-label Extension Period|Lack of Efficacy|0|||
143298370|NCT02073279|516643653|FG000|Open-label Extension Period|Lost to Follow-up|0|||
143298371|NCT02073279|516643654|FG001|Open-label Extension Period|Lost to Follow-up|4|||
143298372|NCT02073279|516643653|FG000|Open-label Extension Period|Switched to another treatment|1|||
143298373|NCT02073279|516643654|FG001|Open-label Extension Period|Switched to another treatment|4|||
143298374|NCT02073279|516643653|FG000|Open-label Extension Period|Protocol Violation|0|||
143298375|NCT02073279|516643654|FG001|Open-label Extension Period|Protocol Violation|1|||
143298376|NCT02073279|516643653|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
143298377|NCT02073279|516643654|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
143298378|NCT02073279|516643653|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
143298379|NCT02073279|516643654|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
143298380|NCT01994629|516643655|FG000|Overall Study|Withdrawal by Subject|1|||
143298381|NCT01994629|516643656|FG001|Overall Study|Withdrawal by Subject|0|||
143298382|NCT01994629|516643655|FG000|Overall Study|Lost to Follow-up|0|||
143298383|NCT01994629|516643656|FG001|Overall Study|Lost to Follow-up|3|||
143298384|NCT03338062|516643657|FG000|Overall Study|Alternative Therapy|1|||
143298385|NCT03338062|516643658|FG001|Overall Study|Alternative Therapy|0|||
143298386|NCT04340362|516643662|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
143298387|NCT00975481|516643665|FG000|Second Intervention Period|Adverse Event|2|||
143298388|NCT00975481|516643666|FG001|Second Intervention Period|Adverse Event|1|||
143298389|NCT00975481|516643667|FG002|Second Intervention Period|Adverse Event|0|||
143374476|NCT02547922|516915488|FG000|Overall Study|Patients did not receive IP|1|||
143298390|NCT00975481|516643668|FG003|Second Intervention Period|Adverse Event|0|||
143298391|NCT00975481|516643669|FG004|Second Intervention Period|Adverse Event|0|||
143298392|NCT00975481|516643670|FG005|Second Intervention Period|Adverse Event|0|||
143298393|NCT00975481|516643665|FG000|Second Intervention Period|Withdrawal by Subject|0|||
143298394|NCT00975481|516643666|FG001|Second Intervention Period|Withdrawal by Subject|0|||
143298395|NCT00975481|516643667|FG002|Second Intervention Period|Withdrawal by Subject|1|||
143298396|NCT00975481|516643668|FG003|Second Intervention Period|Withdrawal by Subject|0|||
143298397|NCT00975481|516643669|FG004|Second Intervention Period|Withdrawal by Subject|0|||
143298398|NCT00975481|516643670|FG005|Second Intervention Period|Withdrawal by Subject|0|||
143298399|NCT00975481|516643665|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
143298400|NCT00975481|516643666|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
143298401|NCT00975481|516643667|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
143298402|NCT00975481|516643668|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
143298403|NCT00975481|516643669|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
143298404|NCT00975481|516643670|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
143298405|NCT00975481|516643665|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
143298406|NCT00975481|516643666|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
143298407|NCT00975481|516643667|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
143298408|NCT00975481|516643668|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
143298409|NCT00975481|516643669|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
143298410|NCT00975481|516643670|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
143298411|NCT01092182|516643672|FG000|Overall Study|Death|0|||
143298412|NCT01092182|516643673|FG001|Overall Study|Death|5|||
143298413|NCT01092182|516643674|FG002|Overall Study|Death|3|||
143298414|NCT01092182|516643672|FG000|Overall Study|participant safety|1|||
143298415|NCT01092182|516643673|FG001|Overall Study|participant safety|2|||
143298416|NCT01092182|516643674|FG002|Overall Study|participant safety|0|||
143298417|NCT01092182|516643672|FG000|Overall Study|Physician Decision|0|||
143298418|NCT01092182|516643673|FG001|Overall Study|Physician Decision|6|||
143298419|NCT01092182|516643674|FG002|Overall Study|Physician Decision|0|||
143298420|NCT01092182|516643672|FG000|Overall Study|Did not meet criteria|0|||
143298421|NCT01092182|516643673|FG001|Overall Study|Did not meet criteria|0|||
143298422|NCT01092182|516643674|FG002|Overall Study|Did not meet criteria|25|||
143298423|NCT01092182|516643672|FG000|Overall Study|Non-compliance|0|||
143298424|NCT01092182|516643673|FG001|Overall Study|Non-compliance|3|||
143298425|NCT01092182|516643674|FG002|Overall Study|Non-compliance|0|||
143298426|NCT01092182|516643672|FG000|Overall Study|Participant refused follow-up|0|||
143298427|NCT01092182|516643673|FG001|Overall Study|Participant refused follow-up|2|||
143298428|NCT01092182|516643674|FG002|Overall Study|Participant refused follow-up|0|||
143298429|NCT05517382|516643675|FG000|Overall Study|Lost to Follow-up|0|||
143298430|NCT05517382|516643676|FG001|Overall Study|Lost to Follow-up|1|||
143298431|NCT01166178|516643678|FG000|Overall Study|Withdrawal by Subject|1|||
143298432|NCT01166178|516643679|FG001|Overall Study|Withdrawal by Subject|0|||
143298433|NCT01166178|516643678|FG000|Overall Study|Study was terminated|20|||
143298434|NCT01166178|516643679|FG001|Overall Study|Study was terminated|8|||
143298435|NCT00271947|516643684|FG000|Overall Study|Lost to Follow-up|1|||
143298436|NCT01522365|516643687|FG000|Overall Study|Withdrawal by Subject|1|||
143298437|NCT01522365|516643688|FG001|Overall Study|Withdrawal by Subject|1|||
143298438|NCT01522365|516643687|FG000|Overall Study|Lost to Follow-up|1|||
143298439|NCT01522365|516643688|FG001|Overall Study|Lost to Follow-up|1|||
143298440|NCT00651755|516643689|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
143298441|NCT00651755|516643690|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
143298442|NCT00651755|516643689|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
143298443|NCT00651755|516643690|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
143298444|NCT00624052|516643691|FG000|Overall Study|Adverse Event|7|||
143298445|NCT00624052|516643692|FG001|Overall Study|Adverse Event|6|||
143298446|NCT00624052|516643693|FG002|Overall Study|Adverse Event|0|||
143298447|NCT00624052|516643694|FG003|Overall Study|Adverse Event|3|||
143298448|NCT00624052|516643691|FG000|Overall Study|Lack of Efficacy|1|||
143298449|NCT00624052|516643692|FG001|Overall Study|Lack of Efficacy|1|||
143298450|NCT00624052|516643693|FG002|Overall Study|Lack of Efficacy|0|||
143298451|NCT00624052|516643694|FG003|Overall Study|Lack of Efficacy|0|||
143298452|NCT00624052|516643691|FG000|Overall Study|Lost to Follow-up|2|||
143298453|NCT00624052|516643692|FG001|Overall Study|Lost to Follow-up|3|||
143298454|NCT00624052|516643693|FG002|Overall Study|Lost to Follow-up|1|||
143298455|NCT00624052|516643694|FG003|Overall Study|Lost to Follow-up|0|||
143298456|NCT00624052|516643691|FG000|Overall Study|Non compliant with the protocol|2|||
143298457|NCT00624052|516643692|FG001|Overall Study|Non compliant with the protocol|1|||
143298458|NCT00624052|516643693|FG002|Overall Study|Non compliant with the protocol|1|||
143298459|NCT00624052|516643694|FG003|Overall Study|Non compliant with the protocol|1|||
143298460|NCT00624052|516643691|FG000|Overall Study|Consent withdrawn|3|||
143298461|NCT00624052|516643692|FG001|Overall Study|Consent withdrawn|1|||
143298462|NCT00624052|516643693|FG002|Overall Study|Consent withdrawn|1|||
143298463|NCT00624052|516643694|FG003|Overall Study|Consent withdrawn|0|||
143298464|NCT00624052|516643691|FG000|Overall Study|Changed job/ran out if meds|0|||
143298465|NCT00624052|516643692|FG001|Overall Study|Changed job/ran out if meds|2|||
143298466|NCT00624052|516643693|FG002|Overall Study|Changed job/ran out if meds|0|||
143298467|NCT00624052|516643694|FG003|Overall Study|Changed job/ran out if meds|0|||
143298468|NCT02466555|516643695|FG000|Overall Study|Lost to Follow-up|2|||
143298469|NCT04170348|516643696|FG000|Overall Study|Lost to Follow-up|2|||
143298470|NCT04170348|516643697|FG001|Overall Study|Lost to Follow-up|2|||
143298471|NCT04170348|516643696|FG000|Overall Study|Withdrawal by Subject|1|||
143298472|NCT04170348|516643697|FG001|Overall Study|Withdrawal by Subject|5|||
143298473|NCT04170348|516643696|FG000|Overall Study|Non-adherence|1|||
143298474|NCT04170348|516643697|FG001|Overall Study|Non-adherence|1|||
143298475|NCT04170348|516643696|FG000|Overall Study|Adverse Event|1|||
143298476|NCT04170348|516643697|FG001|Overall Study|Adverse Event|0|||
143298477|NCT01120756|516643698|FG000|Overall Study|Withdrawal by Subject|1|||
143298478|NCT01120756|516643699|FG001|Overall Study|Withdrawal by Subject|1|||
143298479|NCT00698581|516643703|FG000|Overall Study|Lack of Efficacy|23|||
143298480|NCT00698581|516643704|FG001|Overall Study|Lack of Efficacy|11|||
143298481|NCT00698581|516643703|FG000|Overall Study|Withdrawal by Subject|6|||
143298482|NCT00698581|516643704|FG001|Overall Study|Withdrawal by Subject|0|||
143298483|NCT00698581|516643703|FG000|Overall Study|Other reason|9|||
143298484|NCT00698581|516643704|FG001|Overall Study|Other reason|1|||
143298485|NCT00698581|516643703|FG000|Overall Study|SAE, non-fatal|1|||
143298486|NCT00698581|516643704|FG001|Overall Study|SAE, non-fatal|0|||
143298487|NCT00698581|516643703|FG000|Overall Study|AE, non-serious non-fatal|4|||
143298488|NCT00698581|516643704|FG001|Overall Study|AE, non-serious non-fatal|0|||
143298489|NCT00698581|516643703|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
143298490|NCT00698581|516643704|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
143298491|NCT00698581|516643703|FG000|Overall Study|AE of unknown type|1|||
143298492|NCT00698581|516643704|FG001|Overall Study|AE of unknown type|0|||
143298493|NCT03760146|516643705|FG000|Overall Study|Adverse Event|11|||
143298494|NCT03760146|516643706|FG001|Overall Study|Adverse Event|8|||
143298495|NCT03760146|516643707|FG002|Overall Study|Adverse Event|0|||
143298496|NCT03760146|516643708|FG003|Overall Study|Adverse Event|0|||
143298497|NCT03760146|516643709|FG004|Overall Study|Adverse Event|0|||
143298498|NCT03760146|516643710|FG005|Overall Study|Adverse Event|0|||
143298499|NCT03760146|516643705|FG000|Overall Study|Death|1|||
143298500|NCT03760146|516643706|FG001|Overall Study|Death|0|||
143298501|NCT03760146|516643707|FG002|Overall Study|Death|0|||
143298502|NCT03760146|516643708|FG003|Overall Study|Death|0|||
143298503|NCT03760146|516643709|FG004|Overall Study|Death|0|||
143298504|NCT03760146|516643710|FG005|Overall Study|Death|0|||
143298505|NCT03760146|516643705|FG000|Overall Study|Lost to Follow-up|41|||
143298506|NCT03760146|516643706|FG001|Overall Study|Lost to Follow-up|28|||
143298507|NCT03760146|516643707|FG002|Overall Study|Lost to Follow-up|9|||
143298508|NCT03760146|516643708|FG003|Overall Study|Lost to Follow-up|2|||
143298509|NCT03760146|516643709|FG004|Overall Study|Lost to Follow-up|14|||
143298510|NCT03760146|516643710|FG005|Overall Study|Lost to Follow-up|8|||
143298511|NCT03760146|516643705|FG000|Overall Study|No longer met eligibility criteria|3|||
143298512|NCT03760146|516643706|FG001|Overall Study|No longer met eligibility criteria|9|||
143298513|NCT03760146|516643707|FG002|Overall Study|No longer met eligibility criteria|0|||
143374477|NCT02547922|516915489|FG001|Overall Study|Patients did not receive IP|1|||
143298514|NCT03760146|516643708|FG003|Overall Study|No longer met eligibility criteria|0|||
143298515|NCT03760146|516643709|FG004|Overall Study|No longer met eligibility criteria|1|||
143298516|NCT03760146|516643710|FG005|Overall Study|No longer met eligibility criteria|0|||
143298517|NCT03760146|516643705|FG000|Overall Study|Protocol Violation|21|||
143298518|NCT03760146|516643706|FG001|Overall Study|Protocol Violation|13|||
143298519|NCT03760146|516643707|FG002|Overall Study|Protocol Violation|1|||
143298520|NCT03760146|516643708|FG003|Overall Study|Protocol Violation|0|||
143298521|NCT03760146|516643709|FG004|Overall Study|Protocol Violation|1|||
143298522|NCT03760146|516643710|FG005|Overall Study|Protocol Violation|0|||
143298523|NCT03760146|516643705|FG000|Overall Study|Withdrawal by Subject|19|||
143298524|NCT03760146|516643706|FG001|Overall Study|Withdrawal by Subject|20|||
143298525|NCT03760146|516643707|FG002|Overall Study|Withdrawal by Subject|1|||
143298526|NCT03760146|516643708|FG003|Overall Study|Withdrawal by Subject|0|||
143298527|NCT03760146|516643709|FG004|Overall Study|Withdrawal by Subject|1|||
143298528|NCT03760146|516643710|FG005|Overall Study|Withdrawal by Subject|0|||
143298529|NCT01082965|516643711|FG000|Overall Study|Protocol Violation|0|||
143298530|NCT01082965|516643712|FG001|Overall Study|Protocol Violation|1|||
143298531|NCT01082965|516643711|FG000|Overall Study|Other|1|||
143298532|NCT01082965|516643712|FG001|Overall Study|Other|1|||
143298533|NCT02587065|516643713|FG000|Overall Study|Adverse Event|14|||
143298534|NCT02587065|516643713|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
143298535|NCT02587065|516643713|FG000|Overall Study|Non-adherence to the Protocol|3|||
143298536|NCT02587065|516643713|FG000|Overall Study|Discontinuation of Study Medication|2|||
143298537|NCT02587065|516643713|FG000|Overall Study|Reason not Specified|3|||
143298538|NCT01536379|516645143|FG000|Overall Study|Adverse Event|1|||
143298539|NCT01536379|516645144|FG001|Overall Study|Adverse Event|2|||
143298540|NCT01536379|516645143|FG000|Overall Study|Withdrawal by Subject|1|||
143298541|NCT01536379|516645144|FG001|Overall Study|Withdrawal by Subject|1|||
143298542|NCT01290666|516645146|FG000|Overall Study|Lost to Follow-up|11|||
143298543|NCT01290666|516645146|FG000|Overall Study|Withdrawal by Subject|23|||
143298544|NCT01290666|516645146|FG000|Overall Study|Early Termination of Study|4|||
143298545|NCT03538158|516645147|FG000|Overall Study|Lost to Follow-up|13|||
143298546|NCT03538158|516645148|FG001|Overall Study|Lost to Follow-up|7|||
143298547|NCT03538158|516645147|FG000|Overall Study|Withdrawal by Subject|2|||
143298548|NCT03538158|516645148|FG001|Overall Study|Withdrawal by Subject|1|||
143298549|NCT00772707|516645151|FG000|Overall Study|Withdrawn|3|||
143298550|NCT01454570|516645152|FG000|Overall Study|Withdrawal by Subject|2|||
143298551|NCT01454570|516645152|FG000|Overall Study|Screen Failure|7|||
143298552|NCT02246673|516645156|FG000|Overall Study|Sponsor Decision|1|||
143298553|NCT02246673|516645157|FG001|Overall Study|Sponsor Decision|0|||
143298554|NCT02246673|516645158|FG002|Overall Study|Sponsor Decision|0|||
143298555|NCT02246673|516645159|FG003|Overall Study|Sponsor Decision|0|||
143298556|NCT02246673|516645160|FG004|Overall Study|Sponsor Decision|0|||
143298557|NCT02246673|516645156|FG000|Overall Study|Withdrawal by Subject|0|||
143298558|NCT02246673|516645157|FG001|Overall Study|Withdrawal by Subject|0|||
143298559|NCT02246673|516645158|FG002|Overall Study|Withdrawal by Subject|0|||
143298560|NCT02246673|516645159|FG003|Overall Study|Withdrawal by Subject|0|||
143298561|NCT02246673|516645160|FG004|Overall Study|Withdrawal by Subject|1|||
143298562|NCT02246673|516645156|FG000|Overall Study|Lost to Follow-up|0|||
143298563|NCT02246673|516645157|FG001|Overall Study|Lost to Follow-up|0|||
143298564|NCT02246673|516645158|FG002|Overall Study|Lost to Follow-up|0|||
143298565|NCT02246673|516645159|FG003|Overall Study|Lost to Follow-up|1|||
143298566|NCT02246673|516645160|FG004|Overall Study|Lost to Follow-up|0|||
143298567|NCT02246673|516645156|FG000|Overall Study|Protocol Violation|0|||
143298568|NCT02246673|516645157|FG001|Overall Study|Protocol Violation|0|||
143298569|NCT02246673|516645158|FG002|Overall Study|Protocol Violation|0|||
143298570|NCT02246673|516645159|FG003|Overall Study|Protocol Violation|1|||
143298571|NCT02246673|516645160|FG004|Overall Study|Protocol Violation|0|||
143298572|NCT02914769|516645161|FG000|Overall Study|Protocol Violation|3|||
143298573|NCT02914769|516645162|FG001|Overall Study|Protocol Violation|2|||
143298574|NCT02914769|516645161|FG000|Overall Study|Withdrawal by Subject|0|||
143298575|NCT02914769|516645162|FG001|Overall Study|Withdrawal by Subject|1|||
143298576|NCT00099437|516645163|FG000|Overall Study|Lost to Follow-up|30|||
143298577|NCT00099437|516645164|FG001|Overall Study|Lost to Follow-up|33|||
143298578|NCT00099437|516645163|FG000|Overall Study|Death|293|||
143298579|NCT00099437|516645164|FG001|Overall Study|Death|261|||
143298580|NCT00099437|516645163|FG000|Overall Study|Withdrawal by Subject|6|||
143298581|NCT00099437|516645164|FG001|Overall Study|Withdrawal by Subject|10|||
143298582|NCT00099437|516645163|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
143298583|NCT00099437|516645164|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
143298584|NCT02488681|516645165|FG000|Overall Study|Implant unsuccessful|7|||
143298585|NCT05413369|516645166|FG000|Overall Study|Adverse Event|1|||
143298586|NCT05413369|516645167|FG001|Overall Study|Adverse Event|1|||
143298587|NCT05413369|516645166|FG000|Overall Study|Withdrawal by Subject|13|||
143298588|NCT05413369|516645167|FG001|Overall Study|Withdrawal by Subject|4|||
143298589|NCT05413369|516645166|FG000|Overall Study|Non-compliance with study schedule|2|||
143298590|NCT05413369|516645167|FG001|Overall Study|Non-compliance with study schedule|1|||
143298591|NCT05413369|516645166|FG000|Overall Study|Other|1|||
143298592|NCT05413369|516645167|FG001|Overall Study|Other|1|||
143298593|NCT02809677|516645169|FG000|Overall Study|Withdrawal by Subject|8|||
143298594|NCT00720057|516645170|FG000|Overall Study|Lost to Follow-up|0|||
143298595|NCT00720057|516645171|FG001|Overall Study|Lost to Follow-up|2|||
143298596|NCT00720057|516645170|FG000|Overall Study|Protocol Violation|1|||
143298597|NCT00720057|516645171|FG001|Overall Study|Protocol Violation|0|||
143298598|NCT00720057|516645170|FG000|Overall Study|Withdrawal by Subject|0|||
143298599|NCT00720057|516645171|FG001|Overall Study|Withdrawal by Subject|1|||
143298600|NCT04969224|516645176|FG000|Overall Study|Adverse Event|1|||
143298601|NCT04969224|516645176|FG000|Overall Study|Enrolled but never dosed|1|||
143298602|NCT05172544|516645177|FG000|Overall Study|Withdrawal by Subject|1|||
143298603|NCT05172544|516645178|FG001|Overall Study|Withdrawal by Subject|0|||
143298604|NCT05172544|516645179|FG002|Overall Study|Withdrawal by Subject|0|||
143298605|NCT05172544|516645177|FG000|Overall Study|Physician Decision|0|||
143298606|NCT05172544|516645178|FG001|Overall Study|Physician Decision|0|||
143298607|NCT05172544|516645179|FG002|Overall Study|Physician Decision|1|||
143298608|NCT04256785|516645180|FG000|Overall Study|Adverse Event|8|||
143298609|NCT04256785|516645181|FG001|Overall Study|Adverse Event|6|||
143298610|NCT04256785|516645180|FG000|Overall Study|Lack of Efficacy|3|||
143298611|NCT04256785|516645181|FG001|Overall Study|Lack of Efficacy|4|||
143298612|NCT04256785|516645180|FG000|Overall Study|Lost to Follow-up|7|||
143298613|NCT04256785|516645181|FG001|Overall Study|Lost to Follow-up|7|||
143298614|NCT04256785|516645180|FG000|Overall Study|Protocol Violation|1|||
143298615|NCT04256785|516645181|FG001|Overall Study|Protocol Violation|0|||
143298616|NCT04256785|516645180|FG000|Overall Study|Withdrawal by Subject|4|||
143298617|NCT04256785|516645181|FG001|Overall Study|Withdrawal by Subject|1|||
143298618|NCT04256785|516645180|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
143298619|NCT04256785|516645181|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
143298620|NCT01170091|516645182|FG000|Overall Study|Missing efficacy evaluation|3|||
143298621|NCT01170091|516645182|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
143298622|NCT00271609|516645183|FG000|Overall Study|Adverse Event|11|||
143298623|NCT00271609|516645184|FG001|Overall Study|Adverse Event|3|||
143298624|NCT00271609|516645183|FG000|Overall Study|Withdrawal by Subject|2|||
143298625|NCT00271609|516645184|FG001|Overall Study|Withdrawal by Subject|0|||
143298626|NCT02188589|516645185|FG000|Overall Study|Withdrawal by Subject|5|||
143298627|NCT03341533|516645186|FG000|Overall Study|Withdrawal by Subject|1|||
143298628|NCT03341533|516645187|FG001|Overall Study|Withdrawal by Subject|1|||
143298629|NCT03341533|516645186|FG000|Overall Study|Not eligible after randomization|2|||
143298630|NCT03341533|516645187|FG001|Overall Study|Not eligible after randomization|1|||
143298631|NCT01675128|516645188|FG000|Overall Study|Disease progression on study|1|||
143298632|NCT01675128|516645189|FG001|Overall Study|Disease progression on study|1|||
143298633|NCT01675128|516645190|FG002|Overall Study|Disease progression on study|1|||
143298634|NCT01675128|516645188|FG000|Overall Study|Refused further treatment|1|||
143298635|NCT01675128|516645189|FG001|Overall Study|Refused further treatment|0|||
143298636|NCT01675128|516645190|FG002|Overall Study|Refused further treatment|0|||
143298637|NCT01675128|516645188|FG000|Overall Study|Pulmonary complication; off study|0|||
143298638|NCT01675128|516645189|FG001|Overall Study|Pulmonary complication; off study|1|||
143298639|NCT01675128|516645190|FG002|Overall Study|Pulmonary complication; off study|0|||
143298640|NCT03526458|516645191|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
143298641|NCT03526458|516645192|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
143298642|NCT03526458|516645191|FG000|Overall Study|Stone passed, surgery cancelled|2|||
143298643|NCT03526458|516645192|FG001|Overall Study|Stone passed, surgery cancelled|1|||
143298644|NCT03526458|516645191|FG000|Overall Study|Withdrawal by Subject|1|||
143298645|NCT03526458|516645192|FG001|Overall Study|Withdrawal by Subject|0|||
143298646|NCT03526458|516645191|FG000|Overall Study|Physician Decision|2|||
143298647|NCT03526458|516645192|FG001|Overall Study|Physician Decision|1|||
143298648|NCT03526458|516645191|FG000|Overall Study|Lack of equipment|1|||
143298649|NCT03526458|516645192|FG001|Overall Study|Lack of equipment|1|||
143298650|NCT03011307|516645193|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
143298651|NCT03011307|516645194|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
143298652|NCT03011307|516645193|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
143298653|NCT03011307|516645194|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
143298654|NCT03011307|516645193|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
143298655|NCT03011307|516645194|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
143298656|NCT01782664|516645195|FG000|Overall Study|Adverse Event|2|||
143298657|NCT01782664|516645196|FG001|Overall Study|Adverse Event|2|||
143298658|NCT01782664|516645197|FG002|Overall Study|Adverse Event|2|||
143298659|NCT01782664|516645198|FG003|Overall Study|Adverse Event|2|||
143298660|NCT01782664|516645199|FG004|Overall Study|Adverse Event|0|||
143298661|NCT01782664|516645200|FG005|Overall Study|Adverse Event|0|||
143298662|NCT01782664|516645195|FG000|Overall Study|Lack of Efficacy|2|||
143298663|NCT01782664|516645196|FG001|Overall Study|Lack of Efficacy|0|||
143298664|NCT01782664|516645197|FG002|Overall Study|Lack of Efficacy|2|||
143298665|NCT01782664|516645198|FG003|Overall Study|Lack of Efficacy|2|||
143298666|NCT01782664|516645199|FG004|Overall Study|Lack of Efficacy|0|||
143298667|NCT01782664|516645200|FG005|Overall Study|Lack of Efficacy|0|||
143298668|NCT01782664|516645195|FG000|Overall Study|Protocol Violation|0|||
143298669|NCT01782664|516645196|FG001|Overall Study|Protocol Violation|1|||
143298670|NCT01782664|516645197|FG002|Overall Study|Protocol Violation|0|||
143298671|NCT01782664|516645198|FG003|Overall Study|Protocol Violation|1|||
143298672|NCT01782664|516645199|FG004|Overall Study|Protocol Violation|0|||
143298673|NCT01782664|516645200|FG005|Overall Study|Protocol Violation|0|||
143298674|NCT01782664|516645195|FG000|Overall Study|Withdrawal by Subject|2|||
143298675|NCT01782664|516645196|FG001|Overall Study|Withdrawal by Subject|2|||
143298676|NCT01782664|516645197|FG002|Overall Study|Withdrawal by Subject|0|||
143298677|NCT01782664|516645198|FG003|Overall Study|Withdrawal by Subject|0|||
143298678|NCT01782664|516645199|FG004|Overall Study|Withdrawal by Subject|0|||
143298679|NCT01782664|516645200|FG005|Overall Study|Withdrawal by Subject|0|||
143298680|NCT02642432|516645203|FG000|Overall Study|Adverse Event|2|||
143298681|NCT02642432|516645203|FG000|Overall Study|Withdrew Consent|1|||
143298682|NCT02642432|516645203|FG000|Overall Study|Lost to Follow-up|2|||
143298683|NCT02642432|516645203|FG000|Overall Study|Other|3|||
143298684|NCT03999892|516645204|FG000|Overall Study|Lost to Follow-up|1|||
143298685|NCT02447081|516645205|FG000|Overall Study|Death|161|||
143298686|NCT02447081|516645205|FG000|Overall Study|Lost to Follow-up|36|||
143298687|NCT02447081|516645205|FG000|Overall Study|Visit not completed|17|||
143298688|NCT02447081|516645205|FG000|Overall Study|unsuccessful implant procedure|10|||
143298689|NCT05778786|516645206|FG000|Period 1|COVID-19 Related|3|||
143298690|NCT05778786|516645207|FG001|Period 1|COVID-19 Related|3|||
143298691|NCT05778786|516645206|FG000|Period 1|Withdrew Consent during Study|1|||
143298692|NCT05778786|516645207|FG001|Period 1|Withdrew Consent during Study|0|||
143298693|NCT05778786|516645206|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
143298694|NCT05778786|516645207|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
143298695|NCT05778786|516645206|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
143298696|NCT05778786|516645207|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
143298697|NCT01848756|516645210|FG000|Overall Study|Adverse Event|1|||
143298698|NCT01848756|516645210|FG000|Overall Study|Withdrawal by Subject|1|||
143298699|NCT01848756|516645210|FG000|Overall Study|Enrolled in Error|1|||
143298700|NCT03245008|516645211|FG000|Overall Study|Adverse Event|15|||
143298701|NCT03245008|516645212|FG001|Overall Study|Adverse Event|18|||
143298702|NCT03245008|516645213|FG002|Overall Study|Adverse Event|15|||
143298703|NCT03245008|516645214|FG003|Overall Study|Adverse Event|0|||
143298704|NCT03245008|516645215|FG004|Overall Study|Adverse Event|1|||
143298705|NCT03245008|516645211|FG000|Overall Study|Lack of Efficacy|0|||
143298706|NCT03245008|516645212|FG001|Overall Study|Lack of Efficacy|1|||
143298707|NCT03245008|516645213|FG002|Overall Study|Lack of Efficacy|0|||
143298708|NCT03245008|516645214|FG003|Overall Study|Lack of Efficacy|0|||
143298709|NCT03245008|516645215|FG004|Overall Study|Lack of Efficacy|0|||
143298710|NCT03245008|516645211|FG000|Overall Study|Lost to Follow-up|4|||
143298711|NCT03245008|516645212|FG001|Overall Study|Lost to Follow-up|1|||
143298712|NCT03245008|516645213|FG002|Overall Study|Lost to Follow-up|0|||
143298713|NCT03245008|516645214|FG003|Overall Study|Lost to Follow-up|0|||
143298714|NCT03245008|516645215|FG004|Overall Study|Lost to Follow-up|1|||
143298715|NCT03245008|516645211|FG000|Overall Study|Physician Decision|1|||
143298716|NCT03245008|516645212|FG001|Overall Study|Physician Decision|3|||
143298717|NCT03245008|516645213|FG002|Overall Study|Physician Decision|4|||
143298718|NCT03245008|516645214|FG003|Overall Study|Physician Decision|0|||
143298719|NCT03245008|516645215|FG004|Overall Study|Physician Decision|0|||
143298720|NCT03245008|516645211|FG000|Overall Study|Protocol Violation|0|||
143298721|NCT03245008|516645212|FG001|Overall Study|Protocol Violation|1|||
143298722|NCT03245008|516645213|FG002|Overall Study|Protocol Violation|0|||
143298723|NCT03245008|516645214|FG003|Overall Study|Protocol Violation|0|||
143298724|NCT03245008|516645215|FG004|Overall Study|Protocol Violation|0|||
143298725|NCT03245008|516645211|FG000|Overall Study|Withdrawal by Subject|20|||
143298726|NCT03245008|516645212|FG001|Overall Study|Withdrawal by Subject|19|||
143298727|NCT03245008|516645213|FG002|Overall Study|Withdrawal by Subject|11|||
143298728|NCT03245008|516645214|FG003|Overall Study|Withdrawal by Subject|0|||
143298729|NCT03245008|516645215|FG004|Overall Study|Withdrawal by Subject|0|||
143298730|NCT03245008|516645211|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
143298731|NCT03245008|516645212|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
143298732|NCT03245008|516645213|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
143298733|NCT03245008|516645214|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
143298734|NCT03245008|516645215|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
143298735|NCT03245008|516645211|FG000|Overall Study|Failure to meet randomization criteria|0|||
143298736|NCT03245008|516645212|FG001|Overall Study|Failure to meet randomization criteria|1|||
143298737|NCT03245008|516645213|FG002|Overall Study|Failure to meet randomization criteria|0|||
143298738|NCT03245008|516645214|FG003|Overall Study|Failure to meet randomization criteria|1|||
143298739|NCT03245008|516645215|FG004|Overall Study|Failure to meet randomization criteria|0|||
143298740|NCT02075658|516645216|FG000|Overall Study|Physician Decision|2|||
143298741|NCT02075658|516645217|FG001|Overall Study|Physician Decision|2|||
143298742|NCT01286012|516645218|FG000|Overall Study|Adverse Event|3|||
143298743|NCT01286012|516645219|FG001|Overall Study|Adverse Event|3|||
143298744|NCT01286012|516645218|FG000|Overall Study|Death|2|||
143298745|NCT01286012|516645219|FG001|Overall Study|Death|3|||
143298746|NCT01286012|516645218|FG000|Overall Study|Protocol Violation|1|||
143298747|NCT01286012|516645219|FG001|Overall Study|Protocol Violation|1|||
143298748|NCT01286012|516645218|FG000|Overall Study|Withdrawal by Subject|4|||
143298749|NCT01286012|516645219|FG001|Overall Study|Withdrawal by Subject|4|||
143298750|NCT01286012|516645218|FG000|Overall Study|Physician Decision|2|||
143298751|NCT01286012|516645219|FG001|Overall Study|Physician Decision|0|||
143298752|NCT01286012|516645218|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
143298753|NCT01286012|516645219|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
143298754|NCT02406651|516645222|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
143298755|NCT00718328|516645227|FG000|Overall Study|Lost to Follow-up|1|||
143298756|NCT00718328|516645228|FG001|Overall Study|Lost to Follow-up|0|||
143298757|NCT02865915|516645229|FG000|Overall Study|Pregnancy|1|||
143298758|NCT02865915|516645230|FG001|Overall Study|Pregnancy|0|||
143298759|NCT02865915|516645229|FG000|Overall Study|Withdrawal by Subject|1|||
143298760|NCT02865915|516645230|FG001|Overall Study|Withdrawal by Subject|1|||
143298761|NCT02865915|516645229|FG000|Overall Study|Adverse Event|0|||
143298762|NCT02865915|516645230|FG001|Overall Study|Adverse Event|4|||
143298763|NCT02865915|516645229|FG000|Overall Study|Lost to Follow-up|0|||
143298764|NCT02865915|516645230|FG001|Overall Study|Lost to Follow-up|1|||
143298765|NCT02865915|516645229|FG000|Overall Study|Protocol Violation|0|||
143298766|NCT02865915|516645230|FG001|Overall Study|Protocol Violation|1|||
143298767|NCT02865915|516645229|FG000|Overall Study|Study terminated by sponsor|23|||
143298768|NCT02865915|516645230|FG001|Overall Study|Study terminated by sponsor|18|||
143298769|NCT02865915|516645229|FG000|Overall Study|Dosing group discontinued|0|||
143298770|NCT02865915|516645230|FG001|Overall Study|Dosing group discontinued|5|||
143298771|NCT00663052|516645233|FG000|Overall Study|Adverse Event|6|||
143298772|NCT00663052|516645234|FG001|Overall Study|Adverse Event|3|||
143298773|NCT00663052|516645233|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
143298774|NCT00663052|516645234|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
143298775|NCT00663052|516645233|FG000|Overall Study|Protocol Violation|1|||
143298776|NCT00663052|516645234|FG001|Overall Study|Protocol Violation|0|||
143298777|NCT00663052|516645233|FG000|Overall Study|Withdrawal by Subject|2|||
143298778|NCT00663052|516645234|FG001|Overall Study|Withdrawal by Subject|5|||
143298779|NCT00663052|516645233|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
143298780|NCT00663052|516645234|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
143298781|NCT00663052|516645233|FG000|Overall Study|Other|0|||
143298782|NCT00663052|516645234|FG001|Overall Study|Other|1|||
143298783|NCT01602380|516645238|FG000|Overall Study|Death|147|||
143298784|NCT01602380|516645239|FG001|Overall Study|Death|145|||
143298785|NCT01602380|516645238|FG000|Overall Study|Withdrawal by Subject|39|||
143298786|NCT01602380|516645239|FG001|Overall Study|Withdrawal by Subject|41|||
143298787|NCT01602380|516645238|FG000|Overall Study|Lost to Follow-up|15|||
143298788|NCT01602380|516645239|FG001|Overall Study|Lost to Follow-up|12|||
143298789|NCT01602380|516645238|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
143298790|NCT01602380|516645239|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
143298791|NCT01602380|516645238|FG000|Overall Study|Other|2|||
143298792|NCT01602380|516645239|FG001|Overall Study|Other|0|||
143298793|NCT05041322|516645250|FG000|Baseline|Withdrawal by Subject|1|||
143298794|NCT05041322|516645251|FG001|Baseline|Withdrawal by Subject|0|||
143298795|NCT05041322|516645250|FG000|Treatment 1 (14 Days)|Adverse Event|1|||
143298796|NCT05041322|516645251|FG001|Treatment 1 (14 Days)|Adverse Event|0|||
143298797|NCT05041322|516645250|FG000|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
143298798|NCT05041322|516645251|FG001|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
143298799|NCT01252940|516645252|FG000|Main Study Phase|Randomized but not treated|4|||
143298800|NCT01252940|516645253|FG001|Main Study Phase|Randomized but not treated|2|||
143298801|NCT01252940|516645252|FG000|Main Study Phase|Adverse Event|3|||
143298802|NCT01252940|516645253|FG001|Main Study Phase|Adverse Event|1|||
143298803|NCT01252940|516645252|FG000|Main Study Phase|Lack of Efficacy|1|||
143298804|NCT01252940|516645253|FG001|Main Study Phase|Lack of Efficacy|0|||
143298805|NCT01252940|516645252|FG000|Main Study Phase|Lost to Follow-up|6|||
143298806|NCT01252940|516645253|FG001|Main Study Phase|Lost to Follow-up|1|||
143298807|NCT01252940|516645252|FG000|Main Study Phase|Physician Decision|1|||
143298808|NCT01252940|516645253|FG001|Main Study Phase|Physician Decision|0|||
143298809|NCT01252940|516645252|FG000|Main Study Phase|Protocol Violation|4|||
143298810|NCT01252940|516645253|FG001|Main Study Phase|Protocol Violation|2|||
143298811|NCT01252940|516645252|FG000|Main Study Phase|Withdrawal by Subject|6|||
143298812|NCT01252940|516645253|FG001|Main Study Phase|Withdrawal by Subject|5|||
143298813|NCT01252940|516645252|FG000|Main Study Phase|Subject Non-compliance|1|||
143298814|NCT01252940|516645253|FG001|Main Study Phase|Subject Non-compliance|1|||
143298815|NCT01252940|516645252|FG000|Extension Phase|Adverse Event|2|||
143298816|NCT01252940|516645253|FG001|Extension Phase|Adverse Event|1|||
143298817|NCT01252940|516645252|FG000|Extension Phase|Lack of Efficacy|1|||
143298818|NCT01252940|516645253|FG001|Extension Phase|Lack of Efficacy|0|||
143298819|NCT01252940|516645252|FG000|Extension Phase|Lost to Follow-up|5|||
143298820|NCT01252940|516645253|FG001|Extension Phase|Lost to Follow-up|0|||
143298821|NCT01252940|516645252|FG000|Extension Phase|Physician Decision|0|||
143298822|NCT01252940|516645253|FG001|Extension Phase|Physician Decision|1|||
143298823|NCT01252940|516645252|FG000|Extension Phase|Subject Non-compliance|1|||
143298824|NCT01252940|516645253|FG001|Extension Phase|Subject Non-compliance|0|||
143298825|NCT01252940|516645252|FG000|Extension Phase|Withdrawal by Subject|1|||
143298826|NCT01252940|516645253|FG001|Extension Phase|Withdrawal by Subject|1|||
143298827|NCT04383743|516645254|FG000|Overall Study|Withdrawal by Subject|1|||
143298828|NCT04383743|516645254|FG000|Overall Study|Adverse Event|1|||
143298829|NCT04814433|516645257|FG000|Overall Study|Survey not returned|4|||
143298830|NCT04814433|516645258|FG001|Overall Study|Survey not returned|8|||
143298831|NCT04814433|516645259|FG002|Overall Study|Survey not returned|4|||
143298832|NCT04814433|516645260|FG003|Overall Study|Survey not returned|5|||
143298833|NCT03482791|516645261|FG000|Overall Study|Patient did not start treatment due to physician decision|1|||
143298834|NCT03482791|516645262|FG001|Overall Study|Patient did not start treatment due to physician decision|0|||
143298835|NCT01239368|516646646|FG000|Overall Study|Principal investigator discretion|1|||
143298836|NCT01239368|516646647|FG001|Overall Study|Principal investigator discretion|0|||
143298837|NCT01239368|516646648|FG002|Overall Study|Principal investigator discretion|0|||
143298838|NCT01239368|516646649|FG003|Overall Study|Principal investigator discretion|0|||
143298839|NCT01239368|516646650|FG004|Overall Study|Principal investigator discretion|1|||
143298840|NCT01239368|516646651|FG005|Overall Study|Principal investigator discretion|2|||
143298841|NCT01239368|516646652|FG006|Overall Study|Principal investigator discretion|0|||
143298842|NCT01239368|516646653|FG007|Overall Study|Principal investigator discretion|0|||
143298843|NCT01239368|516646654|FG008|Overall Study|Principal investigator discretion|0|||
143298844|NCT01239368|516646655|FG009|Overall Study|Principal investigator discretion|1|||
143298845|NCT01239368|516646646|FG000|Overall Study|Disease progression on study|1|||
143298846|NCT01239368|516646647|FG001|Overall Study|Disease progression on study|1|||
143298847|NCT01239368|516646648|FG002|Overall Study|Disease progression on study|1|||
143298848|NCT01239368|516646649|FG003|Overall Study|Disease progression on study|1|||
143298849|NCT01239368|516646650|FG004|Overall Study|Disease progression on study|4|||
143298850|NCT01239368|516646651|FG005|Overall Study|Disease progression on study|2|||
143298851|NCT01239368|516646652|FG006|Overall Study|Disease progression on study|5|||
143374478|NCT02547922|516915490|FG002|Overall Study|Patients did not receive IP|0|||
143298852|NCT01239368|516646653|FG007|Overall Study|Disease progression on study|0|||
143298853|NCT01239368|516646654|FG008|Overall Study|Disease progression on study|0|||
143298854|NCT01239368|516646655|FG009|Overall Study|Disease progression on study|2|||
143298855|NCT01239368|516646646|FG000|Overall Study|Refused further treatment|0|||
143298856|NCT01239368|516646647|FG001|Overall Study|Refused further treatment|0|||
143298857|NCT01239368|516646648|FG002|Overall Study|Refused further treatment|0|||
143298858|NCT01239368|516646649|FG003|Overall Study|Refused further treatment|0|||
143298859|NCT01239368|516646650|FG004|Overall Study|Refused further treatment|0|||
143298860|NCT01239368|516646651|FG005|Overall Study|Refused further treatment|0|||
143374479|NCT00102063|516915495|FG000|Overall Study|Lack of Efficacy|5|||
143374480|NCT00102063|516915496|FG001|Overall Study|Lack of Efficacy|1|||
143374481|NCT00102063|516915497|FG002|Overall Study|Lack of Efficacy|1|||
143374482|NCT00102063|516915495|FG000|Overall Study|Adverse Event|7|||
143374483|NCT00102063|516915496|FG001|Overall Study|Adverse Event|4|||
143298861|NCT01239368|516646652|FG006|Overall Study|Refused further treatment|0|||
143298862|NCT01239368|516646653|FG007|Overall Study|Refused further treatment|0|||
143298863|NCT01239368|516646654|FG008|Overall Study|Refused further treatment|0|||
143298864|NCT01239368|516646655|FG009|Overall Study|Refused further treatment|1|||
143298865|NCT01239368|516646646|FG000|Overall Study|Death|0|||
143298866|NCT01239368|516646647|FG001|Overall Study|Death|0|||
143298867|NCT01239368|516646648|FG002|Overall Study|Death|0|||
143298868|NCT01239368|516646649|FG003|Overall Study|Death|0|||
143298869|NCT01239368|516646650|FG004|Overall Study|Death|0|||
143298870|NCT01239368|516646651|FG005|Overall Study|Death|0|||
143298871|NCT01239368|516646652|FG006|Overall Study|Death|1|||
143298872|NCT01239368|516646653|FG007|Overall Study|Death|0|||
143298873|NCT01239368|516646654|FG008|Overall Study|Death|0|||
143298874|NCT01239368|516646655|FG009|Overall Study|Death|0|||
143298875|NCT04709575|516646656|FG000|Overall Study|Withdrawal by Subject|6|||
143298876|NCT04709575|516646657|FG001|Overall Study|Withdrawal by Subject|2|||
143298877|NCT04709575|516646656|FG000|Overall Study|Lost to Follow-up|2|||
143298878|NCT04709575|516646657|FG001|Overall Study|Lost to Follow-up|2|||
143298879|NCT04709575|516646656|FG000|Overall Study|Adverse Event|1|||
143298880|NCT04709575|516646657|FG001|Overall Study|Adverse Event|0|||
143298881|NCT04709575|516646656|FG000|Overall Study|Protocol Violation|1|||
143298882|NCT04709575|516646657|FG001|Overall Study|Protocol Violation|1|||
143298883|NCT00192504|516646660|FG000|Overall Study|Lost to Follow-up|1|||
143298884|NCT00192504|516646661|FG001|Overall Study|Lost to Follow-up|0|||
143298885|NCT00192504|516646662|FG002|Overall Study|Lost to Follow-up|0|||
143298886|NCT00192504|516646663|FG003|Overall Study|Lost to Follow-up|0|||
143298887|NCT00192504|516646660|FG000|Overall Study|Dosing window missed|0|||
143298888|NCT00192504|516646661|FG001|Overall Study|Dosing window missed|0|||
143298889|NCT00192504|516646662|FG002|Overall Study|Dosing window missed|1|||
143298890|NCT00192504|516646663|FG003|Overall Study|Dosing window missed|0|||
143298891|NCT03989440|516646664|FG000|Overall Study|COVID-19 travel restrictions|0|||
143298892|NCT03989440|516646665|FG001|Overall Study|COVID-19 travel restrictions|0|||
143298893|NCT03989440|516646666|FG002|Overall Study|COVID-19 travel restrictions|1|||
143298894|NCT03989440|516646667|FG003|Overall Study|COVID-19 travel restrictions|0|||
143298895|NCT03989440|516646668|FG004|Overall Study|COVID-19 travel restrictions|0|||
143298896|NCT03989440|516646669|FG005|Overall Study|COVID-19 travel restrictions|0|||
143298897|NCT03989440|516646664|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
143298898|NCT03989440|516646665|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
143298899|NCT03989440|516646666|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
143298900|NCT03989440|516646667|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
143298901|NCT03989440|516646668|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
143298902|NCT03989440|516646669|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
143298903|NCT02189473|516646670|FG000|Overall Study|Death|22|||
143298904|NCT02189473|516646671|FG001|Overall Study|Death|23|||
143298905|NCT02189473|516646670|FG000|Overall Study|Lost to Follow-up|1|||
143298906|NCT02189473|516646671|FG001|Overall Study|Lost to Follow-up|2|||
143298907|NCT01327300|516646676|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
143298908|NCT01327300|516646677|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
143298909|NCT02082210|516646678|FG000|Overall Study|Death|0|||
143298910|NCT02082210|516646679|FG001|Overall Study|Death|0|||
143298911|NCT02082210|516646680|FG002|Overall Study|Death|1|||
143298912|NCT02082210|516646681|FG003|Overall Study|Death|1|||
143298913|NCT02082210|516646682|FG004|Overall Study|Death|1|||
143298914|NCT02082210|516646683|FG005|Overall Study|Death|0|||
143298915|NCT02082210|516646678|FG000|Overall Study|Withdrawal by Subject|0|||
143298916|NCT02082210|516646679|FG001|Overall Study|Withdrawal by Subject|0|||
143298917|NCT02082210|516646680|FG002|Overall Study|Withdrawal by Subject|0|||
143298918|NCT02082210|516646681|FG003|Overall Study|Withdrawal by Subject|1|||
143298919|NCT02082210|516646682|FG004|Overall Study|Withdrawal by Subject|2|||
143298920|NCT02082210|516646683|FG005|Overall Study|Withdrawal by Subject|2|||
143298921|NCT02082210|516646678|FG000|Overall Study|Clinical Progression|0|||
143298922|NCT02082210|516646679|FG001|Overall Study|Clinical Progression|0|||
143374484|NCT00102063|516915497|FG002|Overall Study|Adverse Event|2|||
143298923|NCT02082210|516646680|FG002|Overall Study|Clinical Progression|0|||
143298924|NCT02082210|516646681|FG003|Overall Study|Clinical Progression|1|||
143298925|NCT02082210|516646682|FG004|Overall Study|Clinical Progression|0|||
143298926|NCT02082210|516646683|FG005|Overall Study|Clinical Progression|0|||
143298927|NCT02082210|516646678|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
143298928|NCT02082210|516646679|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
143298929|NCT02082210|516646680|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
143374485|NCT00102063|516915495|FG000|Overall Study|Withdrawal by Subject|4|||
143374486|NCT00102063|516915496|FG001|Overall Study|Withdrawal by Subject|12|||
143374487|NCT00102063|516915497|FG002|Overall Study|Withdrawal by Subject|5|||
143374488|NCT00102063|516915495|FG000|Overall Study|Lost to Follow-up|0|||
143298930|NCT02082210|516646681|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
143298931|NCT02082210|516646682|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
143374489|NCT00102063|516915496|FG001|Overall Study|Lost to Follow-up|0|||
143374490|NCT00102063|516915497|FG002|Overall Study|Lost to Follow-up|1|||
143298932|NCT02082210|516646683|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
143298933|NCT02082210|516646678|FG000|Overall Study|Physician Decision|0|||
143298934|NCT02082210|516646679|FG001|Overall Study|Physician Decision|0|||
143298935|NCT02082210|516646680|FG002|Overall Study|Physician Decision|1|||
143298936|NCT02082210|516646681|FG003|Overall Study|Physician Decision|1|||
143298937|NCT02082210|516646682|FG004|Overall Study|Physician Decision|0|||
143298938|NCT02082210|516646683|FG005|Overall Study|Physician Decision|0|||
143298939|NCT01727141|516646693|FG000|Overall Study|Physician Decision|0|||
143298940|NCT01727141|516646694|FG001|Overall Study|Physician Decision|1|||
143298941|NCT01727141|516646695|FG002|Overall Study|Physician Decision|0|||
143298942|NCT01727141|516646696|FG003|Overall Study|Physician Decision|2|||
143298943|NCT01727141|516646693|FG000|Overall Study|Lost to Follow-up|0|||
143298944|NCT01727141|516646694|FG001|Overall Study|Lost to Follow-up|2|||
143298945|NCT01727141|516646695|FG002|Overall Study|Lost to Follow-up|0|||
143298946|NCT01727141|516646696|FG003|Overall Study|Lost to Follow-up|0|||
143298947|NCT01727141|516646693|FG000|Overall Study|Death|0|||
143298948|NCT01727141|516646694|FG001|Overall Study|Death|1|||
143298949|NCT01727141|516646695|FG002|Overall Study|Death|1|||
143298950|NCT01727141|516646696|FG003|Overall Study|Death|1|||
143298951|NCT01727141|516646693|FG000|Overall Study|Protocol deviation|1|||
143298952|NCT01727141|516646694|FG001|Overall Study|Protocol deviation|1|||
143298953|NCT01727141|516646695|FG002|Overall Study|Protocol deviation|0|||
143298954|NCT01727141|516646696|FG003|Overall Study|Protocol deviation|1|||
143298955|NCT01727141|516646693|FG000|Overall Study|Withdrawal by Subject|4|||
143298956|NCT01727141|516646694|FG001|Overall Study|Withdrawal by Subject|4|||
143298957|NCT01727141|516646695|FG002|Overall Study|Withdrawal by Subject|2|||
143298958|NCT01727141|516646696|FG003|Overall Study|Withdrawal by Subject|11|||
143298959|NCT02603432|516646697|FG000|Overall Study|Adverse Event|1|||
143298960|NCT02603432|516646698|FG001|Overall Study|Adverse Event|0|||
143298961|NCT02603432|516646697|FG000|Overall Study|Death|221|||
143298962|NCT02603432|516646698|FG001|Overall Study|Death|242|||
143298963|NCT02603432|516646697|FG000|Overall Study|Lost to Follow-up|3|||
143298964|NCT02603432|516646698|FG001|Overall Study|Lost to Follow-up|9|||
143298965|NCT02603432|516646697|FG000|Overall Study|Progressive Disease|7|||
143298966|NCT02603432|516646698|FG001|Overall Study|Progressive Disease|5|||
143298967|NCT02603432|516646697|FG000|Overall Study|Withdrawal by Subject|12|||
143298968|NCT02603432|516646698|FG001|Overall Study|Withdrawal by Subject|18|||
143298969|NCT02603432|516646697|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
143298970|NCT02603432|516646698|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
143298971|NCT02603432|516646697|FG000|Overall Study|Study terminated by sponsor|74|||
143298972|NCT02603432|516646698|FG001|Overall Study|Study terminated by sponsor|75|||
143298973|NCT02603432|516646697|FG000|Overall Study|Other|13|||
143298974|NCT02603432|516646698|FG001|Overall Study|Other|0|||
143298975|NCT02584504|516646699|FG000|Double-blind Treatment|Participant withdrew consent|0|||
143298976|NCT02584504|516646700|FG001|Double-blind Treatment|Participant withdrew consent|0|||
143298977|NCT02584504|516646701|FG002|Double-blind Treatment|Participant withdrew consent|1|||
143298978|NCT02584504|516646699|FG000|Double-blind Treatment|Adverse Event|0|||
143298979|NCT02584504|516646700|FG001|Double-blind Treatment|Adverse Event|1|||
143298980|NCT02584504|516646701|FG002|Double-blind Treatment|Adverse Event|0|||
143298981|NCT02584504|516646699|FG000|Double-blind Treatment|Family Matter|0|||
143298982|NCT02584504|516646700|FG001|Double-blind Treatment|Family Matter|1|||
143298983|NCT02584504|516646701|FG002|Double-blind Treatment|Family Matter|0|||
143298984|NCT02584504|516646699|FG000|Open-label Treatment|Participant withdrew consent|0|||
143298985|NCT02584504|516646700|FG001|Open-label Treatment|Participant withdrew consent|0|||
143298986|NCT02584504|516646701|FG002|Open-label Treatment|Participant withdrew consent|4|||
143298987|NCT02584504|516646699|FG000|Open-label Treatment|Adverse Event|2|||
143298988|NCT02584504|516646700|FG001|Open-label Treatment|Adverse Event|2|||
143298989|NCT02584504|516646701|FG002|Open-label Treatment|Adverse Event|3|||
143298990|NCT02584504|516646699|FG000|Open-label Treatment|Physician Decision|0|||
143298991|NCT02584504|516646700|FG001|Open-label Treatment|Physician Decision|1|||
143298992|NCT02584504|516646701|FG002|Open-label Treatment|Physician Decision|0|||
143298993|NCT02584504|516646699|FG000|Open-label Treatment|Entered but not treated|0|||
143298994|NCT02584504|516646700|FG001|Open-label Treatment|Entered but not treated|1|||
143374491|NCT00102063|516915495|FG000|Overall Study|Protocol Violation|0|||
143298995|NCT02584504|516646701|FG002|Open-label Treatment|Entered but not treated|1|||
143298996|NCT01652664|516646702|FG000|Overall Study|Treatment Failure|5|||
143298997|NCT01652664|516646703|FG001|Overall Study|Treatment Failure|1|||
143298998|NCT01652664|516646702|FG000|Overall Study|Inadequate IOP control|1|||
143298999|NCT01652664|516646703|FG001|Overall Study|Inadequate IOP control|0|||
143299000|NCT00581776|516646704|FG000|Overall Study|Disease progression or no response|3|||
143299001|NCT02063854|516646708|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
143299002|NCT02063854|516646709|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
143299003|NCT02063854|516646710|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
143299004|NCT02063854|516646711|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
143299005|NCT02063854|516646712|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
143299006|NCT02063854|516646713|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
143299007|NCT02063854|516646714|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
143299008|NCT02063854|516646708|FG000|Overall Study|Major Protocol Deviation|0|||
143299009|NCT02063854|516646709|FG001|Overall Study|Major Protocol Deviation|0|||
143299010|NCT02063854|516646710|FG002|Overall Study|Major Protocol Deviation|3|||
143299011|NCT02063854|516646711|FG003|Overall Study|Major Protocol Deviation|0|||
143299012|NCT02063854|516646712|FG004|Overall Study|Major Protocol Deviation|0|||
143299013|NCT02063854|516646713|FG005|Overall Study|Major Protocol Deviation|0|||
143299014|NCT02063854|516646714|FG006|Overall Study|Major Protocol Deviation|0|||
143374492|NCT00102063|516915496|FG001|Overall Study|Protocol Violation|1|||
143374493|NCT00102063|516915497|FG002|Overall Study|Protocol Violation|1|||
143374494|NCT02739035|516915501|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
143374495|NCT02739035|516915502|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
143374496|NCT02739035|516915501|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
143374497|NCT02739035|516915502|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
143374498|NCT02739035|516915501|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
143374499|NCT02739035|516915502|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
143374500|NCT02739035|516915501|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
143374501|NCT02739035|516915502|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
143374502|NCT00539292|516915508|FG000|Overall Study|Physician Decision|1|||
143374503|NCT00539292|516915509|FG001|Overall Study|Physician Decision|0|||
143374504|NCT00630786|516915510|FG000|Overall Study|Physician Decision|0|||
143374505|NCT00630786|516915511|FG001|Overall Study|Physician Decision|0|||
143374506|NCT00630786|516915512|FG002|Overall Study|Physician Decision|1|||
143374507|NCT00630786|516915510|FG000|Overall Study|Withdrawal by Subject|0|||
143374508|NCT00630786|516915511|FG001|Overall Study|Withdrawal by Subject|1|||
143374509|NCT00630786|516915512|FG002|Overall Study|Withdrawal by Subject|1|||
143374510|NCT00630786|516915510|FG000|Overall Study|Lost to Follow-up|0|||
143374511|NCT00630786|516915511|FG001|Overall Study|Lost to Follow-up|1|||
143374512|NCT00630786|516915512|FG002|Overall Study|Lost to Follow-up|0|||
143374513|NCT00630786|516915510|FG000|Overall Study|Other|1|||
143374514|NCT00630786|516915511|FG001|Overall Study|Other|0|||
143374515|NCT00630786|516915512|FG002|Overall Study|Other|0|||
143374516|NCT02020616|516915516|FG000|Overall Study|Adverse Event|0|||
143374517|NCT02020616|516915517|FG001|Overall Study|Adverse Event|0|||
143374518|NCT02020616|516915518|FG002|Overall Study|Adverse Event|0|||
143374519|NCT02020616|516915519|FG003|Overall Study|Adverse Event|0|||
143374520|NCT02020616|516915520|FG004|Overall Study|Adverse Event|0|||
143374521|NCT02020616|516915521|FG005|Overall Study|Adverse Event|1|||
143374522|NCT02020616|516915522|FG006|Overall Study|Adverse Event|1|||
143374523|NCT02020616|516915516|FG000|Overall Study|Physician Decision|0|||
143374524|NCT02020616|516915517|FG001|Overall Study|Physician Decision|0|||
143374525|NCT02020616|516915518|FG002|Overall Study|Physician Decision|0|||
143374526|NCT02020616|516915519|FG003|Overall Study|Physician Decision|0|||
143374527|NCT02020616|516915520|FG004|Overall Study|Physician Decision|0|||
143374528|NCT02020616|516915521|FG005|Overall Study|Physician Decision|1|||
143374529|NCT02020616|516915522|FG006|Overall Study|Physician Decision|2|||
143374530|NCT02020616|516915516|FG000|Overall Study|Withdrawal by Subject|0|||
143374531|NCT02020616|516915517|FG001|Overall Study|Withdrawal by Subject|0|||
143374532|NCT02020616|516915518|FG002|Overall Study|Withdrawal by Subject|1|||
143299015|NCT02063854|516646708|FG000|Overall Study|Voluntary Withdrawal|2|||
143299016|NCT02063854|516646709|FG001|Overall Study|Voluntary Withdrawal|0|||
143299017|NCT02063854|516646710|FG002|Overall Study|Voluntary Withdrawal|8|||
143299018|NCT02063854|516646711|FG003|Overall Study|Voluntary Withdrawal|1|||
143299019|NCT02063854|516646712|FG004|Overall Study|Voluntary Withdrawal|3|||
143374533|NCT02020616|516915519|FG003|Overall Study|Withdrawal by Subject|0|||
143374534|NCT02020616|516915520|FG004|Overall Study|Withdrawal by Subject|0|||
143374535|NCT02020616|516915521|FG005|Overall Study|Withdrawal by Subject|1|||
143374536|NCT02020616|516915522|FG006|Overall Study|Withdrawal by Subject|1|||
143374537|NCT02020616|516915516|FG000|Overall Study|Lost to Follow-up|0|||
143374538|NCT02020616|516915517|FG001|Overall Study|Lost to Follow-up|1|||
143374539|NCT02020616|516915518|FG002|Overall Study|Lost to Follow-up|0|||
143374540|NCT02020616|516915519|FG003|Overall Study|Lost to Follow-up|1|||
143374541|NCT02020616|516915520|FG004|Overall Study|Lost to Follow-up|1|||
143374542|NCT02020616|516915521|FG005|Overall Study|Lost to Follow-up|1|||
143374543|NCT02020616|516915522|FG006|Overall Study|Lost to Follow-up|0|||
143299020|NCT02063854|516646713|FG005|Overall Study|Voluntary Withdrawal|6|||
143299021|NCT02063854|516646714|FG006|Overall Study|Voluntary Withdrawal|1|||
143299022|NCT02063854|516646708|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
143299023|NCT02063854|516646709|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
143299024|NCT02063854|516646710|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
143299025|NCT02063854|516646711|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
143299026|NCT02063854|516646712|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
143299027|NCT02063854|516646713|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
143299028|NCT02063854|516646714|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
143299029|NCT02063854|516646708|FG000|Overall Study|Reason Not Specified|1|||
143299030|NCT02063854|516646709|FG001|Overall Study|Reason Not Specified|0|||
143299031|NCT02063854|516646710|FG002|Overall Study|Reason Not Specified|0|||
143299032|NCT02063854|516646711|FG003|Overall Study|Reason Not Specified|0|||
143299033|NCT02063854|516646712|FG004|Overall Study|Reason Not Specified|0|||
143299034|NCT02063854|516646713|FG005|Overall Study|Reason Not Specified|0|||
143299035|NCT02063854|516646714|FG006|Overall Study|Reason Not Specified|0|||
143299036|NCT02063854|516646708|FG000|Overall Study|Did Not Receive Study Drug|0|||
143299037|NCT02063854|516646709|FG001|Overall Study|Did Not Receive Study Drug|0|||
143299038|NCT02063854|516646710|FG002|Overall Study|Did Not Receive Study Drug|0|||
143299039|NCT02063854|516646711|FG003|Overall Study|Did Not Receive Study Drug|0|||
143299040|NCT02063854|516646712|FG004|Overall Study|Did Not Receive Study Drug|0|||
143299041|NCT02063854|516646713|FG005|Overall Study|Did Not Receive Study Drug|1|||
143299042|NCT02063854|516646714|FG006|Overall Study|Did Not Receive Study Drug|0|||
143299043|NCT02255981|516646717|FG000|Overall Study|Lost to Follow-up|3|||
143299044|NCT02255981|516646717|FG000|Overall Study|Withdrawal by Subject|1|||
143299045|NCT01046682|516646718|FG000|Overall Study|Adverse Event|2|||
143299046|NCT01046682|516646719|FG001|Overall Study|Adverse Event|0|||
143299047|NCT03425331|516646724|FG000|Overall Study|Withdrawal by Subject|1|||
143299048|NCT03425331|516646724|FG000|Overall Study|Death|1|||
143299049|NCT03425331|516646724|FG000|Overall Study|Adverse Event|1|||
143299050|NCT03425331|516646724|FG000|Overall Study|Disease Progression|2|||
143299051|NCT02418468|516646728|FG000|Overall Study|Adverse Event|1|||
143299052|NCT02418468|516646729|FG001|Overall Study|Adverse Event|0|||
143299053|NCT02418468|516646728|FG000|Overall Study|Withdrawal of informed consent|1|||
143299054|NCT02418468|516646729|FG001|Overall Study|Withdrawal of informed consent|1|||
143299055|NCT04356963|516646733|FG000|First Session|Withdrawal by Subject|1|||
143299056|NCT04356963|516646733|FG000|Second Session|Withdrawal by Subject|3|||
143299057|NCT04356963|516646733|FG000|Second Session|Lost to Follow-up|1|||
143299058|NCT04356963|516646733|FG000|Third Session|Lost to Follow-up|6|||
143299059|NCT04356963|516646733|FG000|Third Session|Withdrawal by Subject|1|||
143299060|NCT00909779|516646735|FG000|Overall Study|Adverse Event|53|||
143299061|NCT00909779|516646736|FG001|Overall Study|Adverse Event|55|||
143299062|NCT00909779|516646735|FG000|Overall Study|Lack of Efficacy|7|||
143299063|NCT00909779|516646736|FG001|Overall Study|Lack of Efficacy|4|||
143299064|NCT00909779|516646735|FG000|Overall Study|Lost to Follow-up|19|||
143299065|NCT00909779|516646736|FG001|Overall Study|Lost to Follow-up|15|||
143299066|NCT00909779|516646735|FG000|Overall Study|Physician Decision|8|||
143299067|NCT00909779|516646736|FG001|Overall Study|Physician Decision|2|||
143374544|NCT02020616|516915516|FG000|Overall Study|Early Termination Criteria Met|0|||
143299068|NCT00909779|516646735|FG000|Overall Study|Protocol Violation|2|||
143299069|NCT00909779|516646736|FG001|Overall Study|Protocol Violation|5|||
143299070|NCT00909779|516646735|FG000|Overall Study|Withdrawal by Subject|116|||
143299071|NCT00909779|516646736|FG001|Overall Study|Withdrawal by Subject|80|||
143299072|NCT00909779|516646735|FG000|Overall Study|Site Ceasing Operation|2|||
143299073|NCT00909779|516646736|FG001|Overall Study|Site Ceasing Operation|2|||
143299074|NCT00909779|516646735|FG000|Overall Study|Medical Monitor Decision|1|||
143299075|NCT00909779|516646736|FG001|Overall Study|Medical Monitor Decision|0|||
143299076|NCT00909779|516646735|FG000|Overall Study|Noncompliance|1|||
143299077|NCT00909779|516646736|FG001|Overall Study|Noncompliance|1|||
143299078|NCT00909779|516646735|FG000|Overall Study|Randomized in error|1|||
143299079|NCT00909779|516646736|FG001|Overall Study|Randomized in error|1|||
143299080|NCT02410954|516646739|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
143299081|NCT02410954|516646740|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
143299082|NCT02410954|516646739|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
143299083|NCT02410954|516646740|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
143299084|NCT02738333|516646741|FG000|Overall Study|Death|1|||
143299085|NCT02738333|516646742|FG001|Overall Study|Death|0|||
143299086|NCT02738333|516646743|FG002|Overall Study|Death|0|||
143299087|NCT02738333|516646741|FG000|Overall Study|Lost to Follow-up|1|||
143299088|NCT02738333|516646742|FG001|Overall Study|Lost to Follow-up|0|||
143299089|NCT02738333|516646743|FG002|Overall Study|Lost to Follow-up|0|||
143299090|NCT00949325|516646744|FG000|Overall Study|Adverse Event|0|||
143299091|NCT00949325|516646745|FG001|Overall Study|Adverse Event|2|||
143299092|NCT00949325|516646746|FG002|Overall Study|Adverse Event|0|||
143299093|NCT00791518|516646747|FG000|Overall Study|Protocol Violation|93|||
143299094|NCT01498952|516646752|FG000|Overall Study|Death|2|||
143299095|NCT01498952|516646753|FG001|Overall Study|Death|2|||
143299096|NCT01498952|516646754|FG002|Overall Study|Death|0|||
143299097|NCT01498952|516646755|FG003|Overall Study|Death|0|||
143299098|NCT01498952|516646756|FG004|Overall Study|Death|0|||
143299099|NCT05533632|516646757|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
143299100|NCT05533632|516646757|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
143299101|NCT05533632|516646757|FG000|Overall Study|Lost to Follow-up|1|||
143374545|NCT02020616|516915517|FG001|Overall Study|Early Termination Criteria Met|0|||
143299102|NCT05533632|516646757|FG000|Overall Study|Withdrawal by Subject|4|||
143299103|NCT05533632|516646757|FG000|Overall Study|Adverse Event|4|||
143299104|NCT02726074|516646758|FG000|Overall Study|Withdrawal by Subject|4|||
143374546|NCT02020616|516915518|FG002|Overall Study|Early Termination Criteria Met|1|||
143299105|NCT02726074|516646758|FG000|Overall Study|Adverse Event|14|||
143299106|NCT02726074|516646758|FG000|Overall Study|Protocol Violation|3|||
143299107|NCT02726074|516646758|FG000|Overall Study|Lost to Follow-up|2|||
143299108|NCT02726074|516646758|FG000|Overall Study|Others|3|||
143374547|NCT02020616|516915519|FG003|Overall Study|Early Termination Criteria Met|0|||
143374548|NCT02020616|516915520|FG004|Overall Study|Early Termination Criteria Met|0|||
143374549|NCT02020616|516915521|FG005|Overall Study|Early Termination Criteria Met|1|||
143374550|NCT02020616|516915522|FG006|Overall Study|Early Termination Criteria Met|0|||
143374551|NCT02020616|516915516|FG000|Overall Study|Randomized in Error|0|||
143374552|NCT02020616|516915517|FG001|Overall Study|Randomized in Error|0|||
143374553|NCT02020616|516915518|FG002|Overall Study|Randomized in Error|0|||
143374554|NCT02020616|516915519|FG003|Overall Study|Randomized in Error|1|||
143374555|NCT02020616|516915520|FG004|Overall Study|Randomized in Error|0|||
143374556|NCT02020616|516915521|FG005|Overall Study|Randomized in Error|0|||
143374557|NCT02020616|516915522|FG006|Overall Study|Randomized in Error|0|||
143374558|NCT02020616|516915516|FG000|Overall Study|Lack of Efficacy|0|||
143374559|NCT02020616|516915517|FG001|Overall Study|Lack of Efficacy|0|||
143374560|NCT02020616|516915518|FG002|Overall Study|Lack of Efficacy|0|||
143374561|NCT02020616|516915519|FG003|Overall Study|Lack of Efficacy|0|||
143374562|NCT02020616|516915520|FG004|Overall Study|Lack of Efficacy|1|||
143374563|NCT02020616|516915521|FG005|Overall Study|Lack of Efficacy|0|||
143374564|NCT02020616|516915522|FG006|Overall Study|Lack of Efficacy|0|||
143374565|NCT02031471|516915525|FG000|24 Week Treatment Period|Adverse Event|6|||
143374566|NCT02031471|516915525|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
143374567|NCT02031471|516915525|FG000|24 Week Treatment Period|Protocol Violation|1|||
143374568|NCT02031471|516915525|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
143374569|NCT02031471|516915525|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
143374570|NCT02031471|516915525|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
143374571|NCT02031471|516915525|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
143374572|NCT00997386|516915526|FG000|Overall Study|Death|7|||
143374573|NCT03544515|516917232|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
143374574|NCT03544515|516917233|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
143374575|NCT03544515|516917232|FG000|Overall Study|Lost to Follow-up|2|||
143374576|NCT03544515|516917233|FG001|Overall Study|Lost to Follow-up|0|||
143374577|NCT02013830|516917237|FG000|Overall Study|Adverse Event|3|||
143374578|NCT02013830|516917237|FG000|Overall Study|Death|1|||
143374579|NCT02013830|516917237|FG000|Overall Study|Insufficient therapeutic response|25|||
143374580|NCT02013830|516917237|FG000|Overall Study|Refused treatment|1|||
143374581|NCT00818454|516917238|FG000|Treatment Period 1|Adverse Event|0|||
143374582|NCT00818454|516917239|FG001|Treatment Period 1|Adverse Event|1|||
143374583|NCT00818454|516917240|FG002|Treatment Period 1|Adverse Event|0|||
143374584|NCT00818454|516917241|FG003|Treatment Period 1|Adverse Event|0|||
143374585|NCT00818454|516917238|FG000|Treatment Period 1|Other|3|||
143374586|NCT00818454|516917239|FG001|Treatment Period 1|Other|0|||
143299109|NCT00579826|516646759|FG000|Overall Study|Withdrawal by Subject|5|||
143299110|NCT00579826|516646760|FG001|Overall Study|Withdrawal by Subject|3|||
143299111|NCT01679002|516646761|FG000|Overall Study|Adverse Event|1|||
143299112|NCT01679002|516646762|FG001|Overall Study|Adverse Event|1|||
143299113|NCT01679002|516646763|FG002|Overall Study|Adverse Event|0|||
143299114|NCT00454987|516646767|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
143299115|NCT00454987|516646768|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
143299116|NCT00454987|516646769|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
143299117|NCT00454987|516646767|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
143299118|NCT00454987|516646768|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
143299119|NCT00454987|516646769|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
143299120|NCT00454987|516646767|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
143299121|NCT00454987|516646768|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
143299122|NCT00454987|516646769|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
143299123|NCT01176266|516646770|FG000|Overall Study|Death|6|||
143299124|NCT01176266|516646770|FG000|Overall Study|Withdrawal by Subject|3|||
143374587|NCT00818454|516917240|FG002|Treatment Period 1|Other|0|||
143374588|NCT00818454|516917241|FG003|Treatment Period 1|Other|0|||
143374589|NCT00818454|516917238|FG000|Washout Period of 1 Week|Adverse Event|1|||
143374590|NCT00818454|516917239|FG001|Washout Period of 1 Week|Adverse Event|1|||
143374591|NCT00818454|516917240|FG002|Washout Period of 1 Week|Adverse Event|0|||
143374592|NCT00818454|516917241|FG003|Washout Period of 1 Week|Adverse Event|0|||
143374593|NCT00818454|516917238|FG000|Washout Period of 1 Week|Protocol Violation|2|||
143299125|NCT04829318|516646771|FG000|Overall Study|Adverse Event|6|||
143299126|NCT04829318|516646771|FG000|Overall Study|Death|1|||
143299127|NCT04829318|516646771|FG000|Overall Study|Lost to Follow-up|1|||
143299128|NCT04829318|516646771|FG000|Overall Study|Physician Decision|1|||
143299129|NCT04829318|516646771|FG000|Overall Study|Withdrawal by Subject|19|||
143299130|NCT04829318|516646771|FG000|Overall Study|Site terminated by sponsor|1|||
143374594|NCT00818454|516917239|FG001|Washout Period of 1 Week|Protocol Violation|0|||
143374595|NCT00818454|516917240|FG002|Washout Period of 1 Week|Protocol Violation|0|||
143374596|NCT00818454|516917241|FG003|Washout Period of 1 Week|Protocol Violation|0|||
143299131|NCT04829318|516646771|FG000|Overall Study|Sponsor decision|5|||
143299132|NCT04829318|516646771|FG000|Overall Study|Other|1|||
143299133|NCT00728130|516646772|FG000|Overall Study|Withdrawal by Subject|1|||
143299134|NCT00728130|516646772|FG000|Overall Study|Paperwork not completed in time|1|||
143299135|NCT00728130|516646772|FG000|Overall Study|Physician Decision|1|||
143299136|NCT00304356|516646776|FG000|Nitazoxanide|Physician Decision|5|||
143299137|NCT00304356|516646776|FG000|Nitazoxanide|Physician Decision|1|||
143299138|NCT00304356|516646776|FG000|Nitazoxanide|number is 0|1|||
143299139|NCT00304356|516646776|FG000|Nitazoxanide|Physician Decision|1|||
143299140|NCT00304356|516646776|FG000|Nitazoxanide|Physician Decision|1|||
143299141|NCT00304356|516646776|FG000|Nitazoxanide|Physician Decision|1|||
143299142|NCT04120974|516646780|FG000|Overall Study|Death|1|||
143299143|NCT04120974|516646780|FG000|Overall Study|Physician Decision|1|||
143299144|NCT04120974|516646780|FG000|Overall Study|Lost to Follow-up|6|||
143299145|NCT00973479|516646783|FG000|Overall Study|Lost to Follow-up|0|||
143299146|NCT00973479|516646784|FG001|Overall Study|Lost to Follow-up|3|||
143299147|NCT00973479|516646783|FG000|Overall Study|Death|2|||
143299148|NCT00973479|516646784|FG001|Overall Study|Death|2|||
143299149|NCT00973479|516646783|FG000|Overall Study|Withdrawal by Subject|15|||
143299150|NCT00973479|516646784|FG001|Overall Study|Withdrawal by Subject|16|||
143299151|NCT00973479|516646783|FG000|Overall Study|Lack of Efficacy|5|||
143299152|NCT00973479|516646784|FG001|Overall Study|Lack of Efficacy|7|||
143299153|NCT00973479|516646783|FG000|Overall Study|Adverse Event|12|||
143299154|NCT00973479|516646784|FG001|Overall Study|Adverse Event|32|||
143299155|NCT00973479|516646783|FG000|Overall Study|Protocol Violation|2|||
143299156|NCT00973479|516646784|FG001|Overall Study|Protocol Violation|2|||
143299157|NCT00973479|516646783|FG000|Overall Study|Other|1|||
143299158|NCT00973479|516646784|FG001|Overall Study|Other|7|||
143299159|NCT05075850|516646785|FG000|Overall Study|Did not completed follow-up questionnaires|34|||
143299160|NCT01265849|516646786|FG000|Overall Study|Randomized//Treatment not initiated|1|||
143299161|NCT01265849|516646787|FG001|Overall Study|Randomized//Treatment not initiated|4|||
143299162|NCT01265849|516646788|FG002|Overall Study|Randomized//Treatment not initiated|0|||
143299163|NCT01265849|516646786|FG000|Overall Study|Physician Decision|1|||
143299164|NCT01265849|516646787|FG001|Overall Study|Physician Decision|2|||
143299165|NCT01265849|516646788|FG002|Overall Study|Physician Decision|0|||
143299166|NCT01265849|516646786|FG000|Overall Study|Lost to Follow-up|18|||
143299167|NCT01265849|516646787|FG001|Overall Study|Lost to Follow-up|15|||
143299168|NCT01265849|516646788|FG002|Overall Study|Lost to Follow-up|5|||
143299169|NCT01265849|516646786|FG000|Overall Study|Not otherwise specified|1|||
143299170|NCT01265849|516646787|FG001|Overall Study|Not otherwise specified|6|||
143299171|NCT01265849|516646788|FG002|Overall Study|Not otherwise specified|1|||
143299172|NCT01265849|516646786|FG000|Overall Study|Withdrawal by Subject|25|||
143299173|NCT01265849|516646787|FG001|Overall Study|Withdrawal by Subject|34|||
143299174|NCT01265849|516646788|FG002|Overall Study|Withdrawal by Subject|13|||
143299175|NCT03194321|516646790|FG000|Overall Study|Withdrawal by Subject|1|||
143299176|NCT03194321|516646790|FG000|Overall Study|Lost to Follow-up|1|||
143299177|NCT03194321|516646790|FG000|Overall Study|Travel for Follow-up|1|||
143299178|NCT03181399|516648657|FG000|6 Months on Treatment|Protocol non-compliance|7|||
143299179|NCT03181399|516648657|FG000|6 Months on Treatment|Adverse Event|4|||
143299180|NCT03181399|516648657|FG000|6 Months on Treatment|Tried alternative treatment|2|||
143299181|NCT03181399|516648657|FG000|6 Months on Treatment|Lost to Follow-up|2|||
143299182|NCT03181399|516648657|FG000|6 Months on Treatment|Personal reasons|1|||
143299183|NCT03181399|516648657|FG000|3 Months Off-treatment|Parent unable to travel|1|||
143299184|NCT00702403|516648658|FG000|From Consent to Engraftment|Progressive leukemia|6|||
143299185|NCT00702403|516648658|FG000|From Consent to Engraftment|Critically ill|2|||
143299186|NCT00702403|516648658|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
143299187|NCT00702403|516648658|FG000|From Consent to Engraftment|Myocardial infarction|1|||
143299188|NCT00702403|516648658|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
143299189|NCT00702403|516648658|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
143299190|NCT00702403|516648658|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
143299191|NCT00702403|516648658|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
143299192|NCT00702403|516648658|FG000|From Engraftment to Study Completion|Non-compliance|2|||
143299193|NCT00702403|516648658|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
143299194|NCT00702403|516648658|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
143299195|NCT00702403|516648658|FG000|From Engraftment to Study Completion|Suicide|1|||
143299196|NCT00702403|516648658|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
143299197|NCT00702403|516648658|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
143299198|NCT00702403|516648658|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
143299199|NCT01254227|516648659|FG000|Overall Study|Withdrawal by Subject|6|||
143299200|NCT01254227|516648659|FG000|Overall Study|Lost to Follow-up|6|||
143299201|NCT01254227|516648659|FG000|Overall Study|Adverse Event|5|||
143299202|NCT01254227|516648659|FG000|Overall Study|Abnormal test procedure result|5|||
143299203|NCT01254227|516648659|FG000|Overall Study|Administrative problems|2|||
143299204|NCT01254227|516648659|FG000|Overall Study|Death|1|||
143299205|NCT01254227|516648659|FG000|Overall Study|Protocol deviation|1|||
143299206|NCT05123222|516648660|FG000|Overall Study|Lost to Follow-up|2|||
143299207|NCT05123222|516648661|FG001|Overall Study|Lost to Follow-up|0|||
143299208|NCT05123222|516648662|FG002|Overall Study|Lost to Follow-up|0|||
143299209|NCT05123222|516648663|FG003|Overall Study|Lost to Follow-up|0|||
143299210|NCT05123222|516648660|FG000|Overall Study|Protocol Violation|0|||
143299211|NCT05123222|516648661|FG001|Overall Study|Protocol Violation|0|||
143299212|NCT05123222|516648662|FG002|Overall Study|Protocol Violation|1|||
143299213|NCT05123222|516648663|FG003|Overall Study|Protocol Violation|0|||
143299214|NCT00914810|516648666|FG000|Overall Study|Withdrawal by Subject|1|||
143299215|NCT00914810|516648667|FG001|Overall Study|Withdrawal by Subject|0|||
143299216|NCT00914810|516648666|FG000|Overall Study|Relocated out of state|1|||
143299217|NCT00914810|516648667|FG001|Overall Study|Relocated out of state|0|||
143299218|NCT00914810|516648666|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
143299219|NCT00914810|516648667|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
143299220|NCT00265343|516648668|FG000|Overall Study|Adverse Event|10|||
143299221|NCT00265343|516648669|FG001|Overall Study|Adverse Event|7|||
143299222|NCT00265343|516648668|FG000|Overall Study|Withdrawal by Subject|3|||
143299223|NCT00265343|516648669|FG001|Overall Study|Withdrawal by Subject|9|||
143299224|NCT00265343|516648668|FG000|Overall Study|Other|8|||
143299225|NCT00265343|516648669|FG001|Overall Study|Other|3|||
143299226|NCT00706641|516648670|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
143299227|NCT00706641|516648670|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
143299228|NCT00706641|516648670|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
143299229|NCT04782856|516648674|FG000|Overall Study|Withdrawal by Subject|0|||
143299230|NCT04782856|516648675|FG001|Overall Study|Withdrawal by Subject|1|||
143299231|NCT02535741|516648676|FG000|Overall Study|Adverse Event|3|||
143299232|NCT02535741|516648676|FG000|Overall Study|Withdrawal by Subject|9|||
143299233|NCT02535741|516648676|FG000|Overall Study|Lost to Follow-up|10|||
143299234|NCT02535741|516648676|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
143299235|NCT02535741|516648676|FG000|Overall Study|Missing data|6|||
143299236|NCT00798369|516648677|FG000|Overall Study|Subject withdrew consent|0|||
143299237|NCT00798369|516648678|FG001|Overall Study|Subject withdrew consent|0|||
143299238|NCT00798369|516648679|FG002|Overall Study|Subject withdrew consent|1|||
143299239|NCT00798369|516648680|FG003|Overall Study|Subject withdrew consent|1|||
143299240|NCT00798369|516648681|FG004|Overall Study|Subject withdrew consent|0|||
143299241|NCT00798369|516648682|FG005|Overall Study|Subject withdrew consent|2|||
143299242|NCT00798369|516648677|FG000|Overall Study|Lost to Follow-up|1|||
143299243|NCT00798369|516648678|FG001|Overall Study|Lost to Follow-up|1|||
143299244|NCT00798369|516648679|FG002|Overall Study|Lost to Follow-up|1|||
143299245|NCT00798369|516648680|FG003|Overall Study|Lost to Follow-up|0|||
143299246|NCT00798369|516648681|FG004|Overall Study|Lost to Follow-up|1|||
143299247|NCT00798369|516648682|FG005|Overall Study|Lost to Follow-up|0|||
143299248|NCT00798369|516648677|FG000|Overall Study|Adminstrative problems|0|||
143299249|NCT00798369|516648678|FG001|Overall Study|Adminstrative problems|0|||
143299250|NCT00798369|516648679|FG002|Overall Study|Adminstrative problems|0|||
143299251|NCT00798369|516648680|FG003|Overall Study|Adminstrative problems|0|||
143299252|NCT00798369|516648681|FG004|Overall Study|Adminstrative problems|0|||
143299253|NCT00798369|516648682|FG005|Overall Study|Adminstrative problems|1|||
143299254|NCT04475588|516648683|FG000|Overall Study|Adverse Event|2|||
143299255|NCT04475588|516648684|FG001|Overall Study|Adverse Event|0|||
143299256|NCT03020823|516648685|FG000|Overall Study|Physician Decision|4|||
143299257|NCT03020823|516648685|FG000|Overall Study|Lack of Efficacy|4|||
143299258|NCT03020823|516648685|FG000|Overall Study|Adverse Event|2|||
143299259|NCT03739112|516648687|FG000|Overall Study|Adverse Event|2|||
143299260|NCT03739112|516648688|FG001|Overall Study|Adverse Event|2|||
143299261|NCT03739112|516648687|FG000|Overall Study|Withdrawal by Subject|38|||
143299262|NCT03739112|516648688|FG001|Overall Study|Withdrawal by Subject|19|||
143299263|NCT03739112|516648687|FG000|Overall Study|Lost to Follow-up|31|||
143299264|NCT03739112|516648688|FG001|Overall Study|Lost to Follow-up|33|||
143299265|NCT03739112|516648687|FG000|Overall Study|Protocol Deviation|12|||
143299266|NCT03739112|516648688|FG001|Overall Study|Protocol Deviation|9|||
143299267|NCT03739112|516648687|FG000|Overall Study|Physician Decision|1|||
143299268|NCT03739112|516648688|FG001|Overall Study|Physician Decision|0|||
143299269|NCT03739112|516648687|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
143299270|NCT03739112|516648688|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
143299271|NCT03739112|516648687|FG000|Overall Study|Site went on hold|65|||
143299272|NCT03739112|516648688|FG001|Overall Study|Site went on hold|67|||
143299273|NCT03739112|516648687|FG000|Overall Study|Other than specified|8|||
143299274|NCT03739112|516648688|FG001|Overall Study|Other than specified|5|||
143299275|NCT03739112|516648687|FG000|Overall Study|Randomized but not vaccinated|31|||
143299276|NCT03739112|516648688|FG001|Overall Study|Randomized but not vaccinated|25|||
143299277|NCT00588822|516648689|FG000|Overall Study|progression of disease|8|||
143299278|NCT04762680|516648691|FG000|Phase 2|Adverse Event|0|||
143299279|NCT04762680|516648692|FG001|Phase 2|Adverse Event|1|||
143299280|NCT04762680|516648693|FG002|Phase 2|Adverse Event|0|||
143299281|NCT04762680|516648694|FG003|Phase 2|Adverse Event|0|||
143299282|NCT04762680|516648695|FG004|Phase 2|Adverse Event|0|||
143299283|NCT04762680|516648696|FG005|Phase 2|Adverse Event|0|||
143299284|NCT04762680|516648697|FG006|Phase 2|Adverse Event|0|||
143299285|NCT04762680|516648698|FG007|Phase 2|Adverse Event|0|||
143299286|NCT04762680|516648699|FG008|Phase 2|Adverse Event|0|||
143299287|NCT04762680|516648700|FG009|Phase 2|Adverse Event|0|||
143299288|NCT04762680|516648701|FG010|Phase 2|Adverse Event|0|||
143299289|NCT04762680|516648702|FG011|Phase 2|Adverse Event|0|||
143299290|NCT04762680|516648703|FG012|Phase 2|Adverse Event|0|||
143299291|NCT04762680|516648704|FG013|Phase 2|Adverse Event|0|||
143299292|NCT04762680|516648705|FG014|Phase 2|Adverse Event|0|||
143299293|NCT04762680|516648706|FG015|Phase 2|Adverse Event|0|||
143299294|NCT04762680|516648707|FG016|Phase 2|Adverse Event|0|||
143299295|NCT04762680|516648708|FG017|Phase 2|Adverse Event|0|||
143299296|NCT04762680|516648709|FG018|Phase 2|Adverse Event|0|||
143299297|NCT04762680|516648710|FG019|Phase 2|Adverse Event|0|||
143299298|NCT04762680|516648711|FG020|Phase 2|Adverse Event|0|||
143299299|NCT04762680|516648712|FG021|Phase 2|Adverse Event|0|||
143299300|NCT04762680|516648691|FG000|Phase 2|Protocol Violation|5|||
143299301|NCT04762680|516648692|FG001|Phase 2|Protocol Violation|5|||
143299302|NCT04762680|516648693|FG002|Phase 2|Protocol Violation|1|||
143299303|NCT04762680|516648694|FG003|Phase 2|Protocol Violation|0|||
143299304|NCT04762680|516648695|FG004|Phase 2|Protocol Violation|0|||
143299305|NCT04762680|516648696|FG005|Phase 2|Protocol Violation|0|||
143299306|NCT04762680|516648697|FG006|Phase 2|Protocol Violation|0|||
143299307|NCT04762680|516648698|FG007|Phase 2|Protocol Violation|0|||
143299308|NCT04762680|516648699|FG008|Phase 2|Protocol Violation|0|||
143299309|NCT04762680|516648700|FG009|Phase 2|Protocol Violation|0|||
143299310|NCT04762680|516648701|FG010|Phase 2|Protocol Violation|0|||
143299311|NCT04762680|516648702|FG011|Phase 2|Protocol Violation|0|||
143299312|NCT04762680|516648703|FG012|Phase 2|Protocol Violation|0|||
143299313|NCT04762680|516648704|FG013|Phase 2|Protocol Violation|0|||
143299314|NCT04762680|516648705|FG014|Phase 2|Protocol Violation|0|||
143299315|NCT04762680|516648706|FG015|Phase 2|Protocol Violation|0|||
143299316|NCT04762680|516648707|FG016|Phase 2|Protocol Violation|0|||
143299317|NCT04762680|516648708|FG017|Phase 2|Protocol Violation|0|||
143299318|NCT04762680|516648709|FG018|Phase 2|Protocol Violation|0|||
143299319|NCT04762680|516648710|FG019|Phase 2|Protocol Violation|0|||
143299320|NCT04762680|516648711|FG020|Phase 2|Protocol Violation|0|||
143299321|NCT04762680|516648712|FG021|Phase 2|Protocol Violation|0|||
143299322|NCT04762680|516648691|FG000|Phase 2|Withdrawal by Subject|23|||
143299323|NCT04762680|516648692|FG001|Phase 2|Withdrawal by Subject|21|||
143299324|NCT04762680|516648693|FG002|Phase 2|Withdrawal by Subject|28|||
143299325|NCT04762680|516648694|FG003|Phase 2|Withdrawal by Subject|0|||
143299326|NCT04762680|516648695|FG004|Phase 2|Withdrawal by Subject|0|||
143299327|NCT04762680|516648696|FG005|Phase 2|Withdrawal by Subject|0|||
143299328|NCT04762680|516648697|FG006|Phase 2|Withdrawal by Subject|0|||
143299329|NCT04762680|516648698|FG007|Phase 2|Withdrawal by Subject|0|||
143299330|NCT04762680|516648699|FG008|Phase 2|Withdrawal by Subject|0|||
143299331|NCT04762680|516648700|FG009|Phase 2|Withdrawal by Subject|0|||
143299332|NCT04762680|516648701|FG010|Phase 2|Withdrawal by Subject|0|||
143299333|NCT04762680|516648702|FG011|Phase 2|Withdrawal by Subject|0|||
143299334|NCT04762680|516648703|FG012|Phase 2|Withdrawal by Subject|0|||
143299335|NCT04762680|516648704|FG013|Phase 2|Withdrawal by Subject|0|||
143299336|NCT04762680|516648705|FG014|Phase 2|Withdrawal by Subject|0|||
143299337|NCT04762680|516648706|FG015|Phase 2|Withdrawal by Subject|0|||
143299338|NCT04762680|516648707|FG016|Phase 2|Withdrawal by Subject|0|||
143299339|NCT04762680|516648708|FG017|Phase 2|Withdrawal by Subject|0|||
143299340|NCT04762680|516648709|FG018|Phase 2|Withdrawal by Subject|0|||
143299341|NCT04762680|516648710|FG019|Phase 2|Withdrawal by Subject|0|||
143299342|NCT04762680|516648711|FG020|Phase 2|Withdrawal by Subject|0|||
143299343|NCT04762680|516648712|FG021|Phase 2|Withdrawal by Subject|0|||
143299344|NCT04762680|516648691|FG000|Phase 2|Lost to Follow-up|14|||
143299345|NCT04762680|516648692|FG001|Phase 2|Lost to Follow-up|8|||
143299346|NCT04762680|516648693|FG002|Phase 2|Lost to Follow-up|9|||
143299347|NCT04762680|516648694|FG003|Phase 2|Lost to Follow-up|0|||
143299348|NCT04762680|516648695|FG004|Phase 2|Lost to Follow-up|0|||
143299349|NCT04762680|516648696|FG005|Phase 2|Lost to Follow-up|0|||
143299350|NCT04762680|516648697|FG006|Phase 2|Lost to Follow-up|0|||
143299351|NCT04762680|516648698|FG007|Phase 2|Lost to Follow-up|0|||
143299352|NCT04762680|516648699|FG008|Phase 2|Lost to Follow-up|0|||
143299353|NCT04762680|516648700|FG009|Phase 2|Lost to Follow-up|0|||
143299354|NCT04762680|516648701|FG010|Phase 2|Lost to Follow-up|0|||
143299355|NCT04762680|516648702|FG011|Phase 2|Lost to Follow-up|0|||
143299356|NCT04762680|516648703|FG012|Phase 2|Lost to Follow-up|0|||
143299357|NCT04762680|516648704|FG013|Phase 2|Lost to Follow-up|0|||
143299358|NCT04762680|516648705|FG014|Phase 2|Lost to Follow-up|0|||
143299359|NCT04762680|516648706|FG015|Phase 2|Lost to Follow-up|0|||
143299360|NCT04762680|516648707|FG016|Phase 2|Lost to Follow-up|0|||
143299361|NCT04762680|516648708|FG017|Phase 2|Lost to Follow-up|0|||
143299362|NCT04762680|516648709|FG018|Phase 2|Lost to Follow-up|0|||
143299363|NCT04762680|516648710|FG019|Phase 2|Lost to Follow-up|0|||
143299364|NCT04762680|516648711|FG020|Phase 2|Lost to Follow-up|0|||
143299365|NCT04762680|516648712|FG021|Phase 2|Lost to Follow-up|0|||
143299366|NCT04762680|516648691|FG000|Phase 3|Adverse Event|0|||
143299367|NCT04762680|516648692|FG001|Phase 3|Adverse Event|0|||
143299368|NCT04762680|516648693|FG002|Phase 3|Adverse Event|0|||
143299369|NCT04762680|516648694|FG003|Phase 3|Adverse Event|1|||
143299370|NCT04762680|516648695|FG004|Phase 3|Adverse Event|0|||
143299371|NCT04762680|516648696|FG005|Phase 3|Adverse Event|0|||
143299372|NCT04762680|516648697|FG006|Phase 3|Adverse Event|0|||
143299373|NCT04762680|516648698|FG007|Phase 3|Adverse Event|0|||
143299374|NCT04762680|516648699|FG008|Phase 3|Adverse Event|0|||
143299375|NCT04762680|516648700|FG009|Phase 3|Adverse Event|0|||
143299376|NCT04762680|516648701|FG010|Phase 3|Adverse Event|0|||
143299377|NCT04762680|516648702|FG011|Phase 3|Adverse Event|0|||
143299378|NCT04762680|516648703|FG012|Phase 3|Adverse Event|0|||
143299379|NCT04762680|516648704|FG013|Phase 3|Adverse Event|0|||
143299380|NCT04762680|516648705|FG014|Phase 3|Adverse Event|0|||
143299381|NCT04762680|516648706|FG015|Phase 3|Adverse Event|0|||
143299382|NCT04762680|516648707|FG016|Phase 3|Adverse Event|0|||
143299383|NCT04762680|516648708|FG017|Phase 3|Adverse Event|3|||
143299384|NCT04762680|516648709|FG018|Phase 3|Adverse Event|0|||
143299385|NCT04762680|516648710|FG019|Phase 3|Adverse Event|0|||
143299386|NCT04762680|516648711|FG020|Phase 3|Adverse Event|0|||
143299387|NCT04762680|516648712|FG021|Phase 3|Adverse Event|0|||
143299388|NCT04762680|516648691|FG000|Phase 3|Protocol Violation|0|||
143299389|NCT04762680|516648692|FG001|Phase 3|Protocol Violation|0|||
143299390|NCT04762680|516648693|FG002|Phase 3|Protocol Violation|0|||
143299391|NCT04762680|516648694|FG003|Phase 3|Protocol Violation|4|||
143299392|NCT04762680|516648695|FG004|Phase 3|Protocol Violation|1|||
143299393|NCT04762680|516648696|FG005|Phase 3|Protocol Violation|5|||
143299394|NCT04762680|516648697|FG006|Phase 3|Protocol Violation|1|||
143299395|NCT04762680|516648698|FG007|Phase 3|Protocol Violation|0|||
143299396|NCT04762680|516648699|FG008|Phase 3|Protocol Violation|0|||
143299397|NCT04762680|516648700|FG009|Phase 3|Protocol Violation|0|||
143299398|NCT04762680|516648701|FG010|Phase 3|Protocol Violation|0|||
143299399|NCT04762680|516648702|FG011|Phase 3|Protocol Violation|2|||
143299400|NCT04762680|516648703|FG012|Phase 3|Protocol Violation|3|||
143299401|NCT04762680|516648704|FG013|Phase 3|Protocol Violation|0|||
143299402|NCT04762680|516648705|FG014|Phase 3|Protocol Violation|0|||
143299403|NCT04762680|516648706|FG015|Phase 3|Protocol Violation|1|||
143299404|NCT04762680|516648707|FG016|Phase 3|Protocol Violation|0|||
143299405|NCT04762680|516648708|FG017|Phase 3|Protocol Violation|10|||
143299406|NCT04762680|516648709|FG018|Phase 3|Protocol Violation|0|||
143299407|NCT04762680|516648710|FG019|Phase 3|Protocol Violation|0|||
143299408|NCT04762680|516648711|FG020|Phase 3|Protocol Violation|0|||
143299409|NCT04762680|516648712|FG021|Phase 3|Protocol Violation|0|||
143299410|NCT04762680|516648691|FG000|Phase 3|Withdrawal by Subject|0|||
143299411|NCT04762680|516648692|FG001|Phase 3|Withdrawal by Subject|0|||
143299412|NCT04762680|516648693|FG002|Phase 3|Withdrawal by Subject|0|||
143299413|NCT04762680|516648694|FG003|Phase 3|Withdrawal by Subject|13|||
143299414|NCT04762680|516648695|FG004|Phase 3|Withdrawal by Subject|17|||
143299415|NCT04762680|516648696|FG005|Phase 3|Withdrawal by Subject|12|||
143299416|NCT04762680|516648697|FG006|Phase 3|Withdrawal by Subject|8|||
143299417|NCT04762680|516648698|FG007|Phase 3|Withdrawal by Subject|3|||
143299418|NCT04762680|516648699|FG008|Phase 3|Withdrawal by Subject|2|||
143299419|NCT04762680|516648700|FG009|Phase 3|Withdrawal by Subject|4|||
143299420|NCT04762680|516648701|FG010|Phase 3|Withdrawal by Subject|3|||
143299421|NCT04762680|516648702|FG011|Phase 3|Withdrawal by Subject|1|||
143299422|NCT04762680|516648703|FG012|Phase 3|Withdrawal by Subject|3|||
143299423|NCT04762680|516648704|FG013|Phase 3|Withdrawal by Subject|2|||
143299424|NCT04762680|516648705|FG014|Phase 3|Withdrawal by Subject|1|||
143299425|NCT04762680|516648706|FG015|Phase 3|Withdrawal by Subject|4|||
143299426|NCT04762680|516648707|FG016|Phase 3|Withdrawal by Subject|6|||
143299427|NCT04762680|516648708|FG017|Phase 3|Withdrawal by Subject|32|||
143299428|NCT04762680|516648709|FG018|Phase 3|Withdrawal by Subject|0|||
143299429|NCT04762680|516648710|FG019|Phase 3|Withdrawal by Subject|0|||
143299430|NCT04762680|516648711|FG020|Phase 3|Withdrawal by Subject|0|||
143299431|NCT04762680|516648712|FG021|Phase 3|Withdrawal by Subject|0|||
143299432|NCT04762680|516648691|FG000|Phase 3|Lost to Follow-up|0|||
143299433|NCT04762680|516648692|FG001|Phase 3|Lost to Follow-up|0|||
143299434|NCT04762680|516648693|FG002|Phase 3|Lost to Follow-up|0|||
143299435|NCT04762680|516648694|FG003|Phase 3|Lost to Follow-up|9|||
143299436|NCT04762680|516648695|FG004|Phase 3|Lost to Follow-up|22|||
143299437|NCT04762680|516648696|FG005|Phase 3|Lost to Follow-up|24|||
143299438|NCT04762680|516648697|FG006|Phase 3|Lost to Follow-up|2|||
143299439|NCT04762680|516648698|FG007|Phase 3|Lost to Follow-up|4|||
143299440|NCT04762680|516648699|FG008|Phase 3|Lost to Follow-up|6|||
143299441|NCT04762680|516648700|FG009|Phase 3|Lost to Follow-up|4|||
143299442|NCT04762680|516648701|FG010|Phase 3|Lost to Follow-up|3|||
143299443|NCT04762680|516648702|FG011|Phase 3|Lost to Follow-up|0|||
143299444|NCT04762680|516648703|FG012|Phase 3|Lost to Follow-up|5|||
143299445|NCT04762680|516648704|FG013|Phase 3|Lost to Follow-up|4|||
143299446|NCT04762680|516648705|FG014|Phase 3|Lost to Follow-up|6|||
143299447|NCT04762680|516648706|FG015|Phase 3|Lost to Follow-up|1|||
143299448|NCT04762680|516648707|FG016|Phase 3|Lost to Follow-up|1|||
143299449|NCT04762680|516648708|FG017|Phase 3|Lost to Follow-up|66|||
143299450|NCT04762680|516648709|FG018|Phase 3|Lost to Follow-up|0|||
143299451|NCT04762680|516648710|FG019|Phase 3|Lost to Follow-up|0|||
143299452|NCT04762680|516648711|FG020|Phase 3|Lost to Follow-up|0|||
143299453|NCT04762680|516648712|FG021|Phase 3|Lost to Follow-up|0|||
143299454|NCT04762680|516648691|FG000|Phase 3 - Exploratory|Withdrawal by Subject|0|||
143299455|NCT04762680|516648692|FG001|Phase 3 - Exploratory|Withdrawal by Subject|0|||
143299456|NCT04762680|516648693|FG002|Phase 3 - Exploratory|Withdrawal by Subject|0|||
143299457|NCT04762680|516648694|FG003|Phase 3 - Exploratory|Withdrawal by Subject|0|||
143299458|NCT04762680|516648695|FG004|Phase 3 - Exploratory|Withdrawal by Subject|0|||
143299459|NCT04762680|516648696|FG005|Phase 3 - Exploratory|Withdrawal by Subject|0|||
143299460|NCT04762680|516648697|FG006|Phase 3 - Exploratory|Withdrawal by Subject|0|||
143299461|NCT04762680|516648698|FG007|Phase 3 - Exploratory|Withdrawal by Subject|0|||
143299462|NCT04762680|516648699|FG008|Phase 3 - Exploratory|Withdrawal by Subject|0|||
143299463|NCT04762680|516648700|FG009|Phase 3 - Exploratory|Withdrawal by Subject|0|||
143299464|NCT04762680|516648701|FG010|Phase 3 - Exploratory|Withdrawal by Subject|0|||
143299465|NCT04762680|516648702|FG011|Phase 3 - Exploratory|Withdrawal by Subject|0|||
143299466|NCT04762680|516648703|FG012|Phase 3 - Exploratory|Withdrawal by Subject|0|||
143299467|NCT04762680|516648704|FG013|Phase 3 - Exploratory|Withdrawal by Subject|0|||
143299468|NCT04762680|516648705|FG014|Phase 3 - Exploratory|Withdrawal by Subject|0|||
143299469|NCT04762680|516648706|FG015|Phase 3 - Exploratory|Withdrawal by Subject|0|||
143299470|NCT04762680|516648707|FG016|Phase 3 - Exploratory|Withdrawal by Subject|0|||
143299471|NCT04762680|516648708|FG017|Phase 3 - Exploratory|Withdrawal by Subject|0|||
143299472|NCT04762680|516648709|FG018|Phase 3 - Exploratory|Withdrawal by Subject|0|||
143299473|NCT04762680|516648710|FG019|Phase 3 - Exploratory|Withdrawal by Subject|0|||
143299474|NCT04762680|516648711|FG020|Phase 3 - Exploratory|Withdrawal by Subject|0|||
143299475|NCT04762680|516648712|FG021|Phase 3 - Exploratory|Withdrawal by Subject|1|||
143299476|NCT04762680|516648691|FG000|Phase 3 - Exploratory|Lost to Follow-up|0|||
143299477|NCT04762680|516648692|FG001|Phase 3 - Exploratory|Lost to Follow-up|0|||
143299478|NCT04762680|516648693|FG002|Phase 3 - Exploratory|Lost to Follow-up|0|||
143299479|NCT04762680|516648694|FG003|Phase 3 - Exploratory|Lost to Follow-up|0|||
143299480|NCT04762680|516648695|FG004|Phase 3 - Exploratory|Lost to Follow-up|0|||
143299481|NCT04762680|516648696|FG005|Phase 3 - Exploratory|Lost to Follow-up|0|||
143299482|NCT04762680|516648697|FG006|Phase 3 - Exploratory|Lost to Follow-up|0|||
143299483|NCT04762680|516648698|FG007|Phase 3 - Exploratory|Lost to Follow-up|0|||
143299484|NCT04762680|516648699|FG008|Phase 3 - Exploratory|Lost to Follow-up|0|||
143299485|NCT04762680|516648700|FG009|Phase 3 - Exploratory|Lost to Follow-up|0|||
143299486|NCT04762680|516648701|FG010|Phase 3 - Exploratory|Lost to Follow-up|0|||
143299487|NCT04762680|516648702|FG011|Phase 3 - Exploratory|Lost to Follow-up|0|||
143299488|NCT04762680|516648703|FG012|Phase 3 - Exploratory|Lost to Follow-up|0|||
143299489|NCT04762680|516648704|FG013|Phase 3 - Exploratory|Lost to Follow-up|0|||
143299490|NCT04762680|516648705|FG014|Phase 3 - Exploratory|Lost to Follow-up|0|||
143299491|NCT04762680|516648706|FG015|Phase 3 - Exploratory|Lost to Follow-up|0|||
143299492|NCT04762680|516648707|FG016|Phase 3 - Exploratory|Lost to Follow-up|0|||
143299493|NCT04762680|516648708|FG017|Phase 3 - Exploratory|Lost to Follow-up|0|||
143299494|NCT04762680|516648709|FG018|Phase 3 - Exploratory|Lost to Follow-up|0|||
143299495|NCT04762680|516648710|FG019|Phase 3 - Exploratory|Lost to Follow-up|1|||
143299496|NCT04762680|516648711|FG020|Phase 3 - Exploratory|Lost to Follow-up|0|||
143299497|NCT04762680|516648712|FG021|Phase 3 - Exploratory|Lost to Follow-up|0|||
143299498|NCT04307446|516648714|FG000|Overall Study|Lost to Follow-up|2|||
143299499|NCT04307446|516648715|FG001|Overall Study|Lost to Follow-up|0|||
143299500|NCT01063764|516648716|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
143299501|NCT01063764|516648716|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
143299502|NCT01063764|516648716|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
143299503|NCT01063764|516648716|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
143299504|NCT01063764|516648716|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
143299505|NCT01063764|516648716|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
143299506|NCT01063764|516648716|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
143299507|NCT03257631|516648717|FG000|Overall Study|Death|1|||
143299508|NCT03257631|516648718|FG001|Overall Study|Death|0|||
143374597|NCT00818454|516917238|FG000|Washout Period of 1 Week|Other|1|||
143299509|NCT03257631|516648719|FG002|Overall Study|Death|1|||
143299510|NCT03257631|516648720|FG003|Overall Study|Death|1|||
143299511|NCT03257631|516648717|FG000|Overall Study|Progressive Disease|10|||
143299512|NCT03257631|516648718|FG001|Overall Study|Progressive Disease|9|||
143299513|NCT03257631|516648719|FG002|Overall Study|Progressive Disease|17|||
143299514|NCT03257631|516648720|FG003|Overall Study|Progressive Disease|8|||
143299515|NCT03257631|516648717|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
143374598|NCT00818454|516917239|FG001|Washout Period of 1 Week|Other|2|||
143299516|NCT03257631|516648718|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
143299517|NCT03257631|516648719|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
143299518|NCT03257631|516648720|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
143299519|NCT03257631|516648717|FG000|Overall Study|Adverse Event|0|||
143299520|NCT03257631|516648718|FG001|Overall Study|Adverse Event|0|||
143299521|NCT03257631|516648719|FG002|Overall Study|Adverse Event|2|||
143299522|NCT03257631|516648720|FG003|Overall Study|Adverse Event|0|||
143299523|NCT00697515|516648721|FG000|Dose Optimization Period|Adverse Event|4|||
143299524|NCT00697515|516648722|FG001|Dose Optimization Period|Adverse Event|0|||
143299525|NCT00697515|516648721|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
143299526|NCT00697515|516648722|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
143299527|NCT00697515|516648721|FG000|Dose Optimization Period|Lost to Follow-up|2|||
143299528|NCT00697515|516648722|FG001|Dose Optimization Period|Lost to Follow-up|0|||
143299529|NCT00697515|516648721|FG000|Dose Optimization Period|sponsor request|2|||
143299530|NCT00697515|516648722|FG001|Dose Optimization Period|sponsor request|0|||
143299531|NCT00697515|516648721|FG000|Dose Optimization Period|called to active duty|1|||
143299532|NCT00697515|516648722|FG001|Dose Optimization Period|called to active duty|0|||
143299533|NCT00697515|516648721|FG000|Dose Optimization Period|elevated QTc|1|||
143299534|NCT00697515|516648722|FG001|Dose Optimization Period|elevated QTc|0|||
143299535|NCT00697515|516648721|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
143299536|NCT00697515|516648722|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
143299537|NCT00697515|516648721|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
143299538|NCT00697515|516648722|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
143299539|NCT00697515|516648721|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
143299540|NCT00697515|516648722|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
143299541|NCT00697515|516648721|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
143299542|NCT00697515|516648722|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
143299543|NCT02436759|516648723|FG000|Overall Study|Adverse Event|3|||
143299544|NCT02436759|516648724|FG001|Overall Study|Adverse Event|0|||
143299545|NCT02436759|516648723|FG000|Overall Study|Protocol Violation|1|||
143299546|NCT02436759|516648724|FG001|Overall Study|Protocol Violation|0|||
143299547|NCT02436759|516648723|FG000|Overall Study|Withdrawal by Subject|0|||
143299548|NCT02436759|516648724|FG001|Overall Study|Withdrawal by Subject|1|||
143299549|NCT02529137|516648727|FG000|Overall Study|Discontinuation for different reasons|8|||
143299550|NCT00297037|516648730|FG000|Overall Study|Withdrawal by Subject|2|||
143299551|NCT00297037|516648731|FG001|Overall Study|Withdrawal by Subject|0|||
143299552|NCT04461015|516648732|FG000|Overall Study|IV access lost during the study|0|||
143299553|NCT04461015|516648733|FG001|Overall Study|IV access lost during the study|1|||
143299554|NCT04461015|516648732|FG000|Overall Study|Withdrawal by Subject|0|||
143299555|NCT04461015|516648733|FG001|Overall Study|Withdrawal by Subject|1|||
143299556|NCT00930579|516648738|FG000|Overall Study|Withdrawal by Subject|1|||
143299557|NCT00930579|516648738|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
143299558|NCT02864251|516648742|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
143299559|NCT02864251|516648743|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
143299560|NCT02864251|516648744|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
143299561|NCT02864251|516648742|FG000|Pre-Treatment|Withdrawal by Participant|0|||
143299562|NCT02864251|516648743|FG001|Pre-Treatment|Withdrawal by Participant|0|||
143299563|NCT02864251|516648744|FG002|Pre-Treatment|Withdrawal by Participant|4|||
143299564|NCT02864251|516648742|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
143299565|NCT02864251|516648743|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
143299566|NCT02864251|516648744|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
143299567|NCT02864251|516648742|FG000|Pre-Treatment|Other Reasons|0|||
143299568|NCT02864251|516648743|FG001|Pre-Treatment|Other Reasons|1|||
143299569|NCT02864251|516648744|FG002|Pre-Treatment|Other Reasons|1|||
143299570|NCT02864251|516648742|FG000|Treatment|Disease Progression|109|||
143299571|NCT02864251|516648743|FG001|Treatment|Disease Progression|52|||
143299572|NCT02864251|516648744|FG002|Treatment|Disease Progression|101|||
143299573|NCT02864251|516648742|FG000|Treatment|Study Drug Toxicity|9|||
143299574|NCT02864251|516648743|FG001|Treatment|Study Drug Toxicity|4|||
143299575|NCT02864251|516648744|FG002|Treatment|Study Drug Toxicity|10|||
143299576|NCT02864251|516648742|FG000|Treatment|Death|0|||
143299577|NCT02864251|516648743|FG001|Treatment|Death|2|||
143374599|NCT00818454|516917240|FG002|Washout Period of 1 Week|Other|0|||
143374600|NCT00818454|516917241|FG003|Washout Period of 1 Week|Other|0|||
143374601|NCT00818454|516917238|FG000|Treatment Period 2|Other|2|||
143374602|NCT00818454|516917239|FG001|Treatment Period 2|Other|1|||
143299578|NCT02864251|516648744|FG002|Treatment|Death|3|||
143299579|NCT02864251|516648742|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
143299580|NCT02864251|516648743|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
143299581|NCT02864251|516648744|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
143299582|NCT02864251|516648742|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
143299583|NCT02864251|516648743|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
143374603|NCT00818454|516917240|FG002|Treatment Period 2|Other|0|||
143299584|NCT02864251|516648744|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
143299585|NCT02864251|516648742|FG000|Treatment|Withdrawal by Participant|8|||
143299586|NCT02864251|516648743|FG001|Treatment|Withdrawal by Participant|5|||
143299587|NCT02864251|516648744|FG002|Treatment|Withdrawal by Participant|13|||
143299588|NCT02864251|516648742|FG000|Treatment|Maximum Clinical Benefit|1|||
143299589|NCT02864251|516648743|FG001|Treatment|Maximum Clinical Benefit|0|||
143299590|NCT02864251|516648744|FG002|Treatment|Maximum Clinical Benefit|1|||
143299591|NCT02864251|516648742|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
143299592|NCT02864251|516648743|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
143299593|NCT02864251|516648744|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
143299594|NCT02864251|516648742|FG000|Treatment|Other Reasons|1|||
143299595|NCT02864251|516648743|FG001|Treatment|Other Reasons|1|||
143299596|NCT02864251|516648744|FG002|Treatment|Other Reasons|4|||
143299597|NCT02864251|516648742|FG000|Treatment|Administrative Reason by Sponsor|1|||
143299598|NCT02864251|516648743|FG001|Treatment|Administrative Reason by Sponsor|0|||
143299599|NCT02864251|516648744|FG002|Treatment|Administrative Reason by Sponsor|0|||
143299600|NCT03506373|516648745|FG000|Overall Study|Adverse Event|6|||
143299601|NCT03506373|516648745|FG000|Overall Study|Withdrawal by Subject|2|||
143299602|NCT03506373|516648745|FG000|Overall Study|Disease progression|5|||
143299603|NCT03506373|516648745|FG000|Overall Study|Other|3|||
143299604|NCT00107198|516648746|FG000|Overall Study|Lack of Efficacy|28|||
143299605|NCT00107198|516648746|FG000|Overall Study|Lost to Follow-up|12|||
143299606|NCT00107198|516648746|FG000|Overall Study|Protocol Violation|1|||
143299607|NCT00107198|516648746|FG000|Overall Study|Withdrawal by Subject|6|||
143299608|NCT00107198|516648746|FG000|Overall Study|Ineligible|5|||
143299609|NCT02625090|516648747|FG000|Overall Study|Participant wants to be pregnant|2|||
143299610|NCT02625090|516648747|FG000|Overall Study|For the Promoter|1|||
143299611|NCT02625090|516648747|FG000|Overall Study|Sponsor's Decision|9|||
143299612|NCT02625090|516648747|FG000|Overall Study|Somnolence|1|||
143299613|NCT02625090|516648747|FG000|Overall Study|Study terminated by Sponsor|7|||
143299614|NCT02625090|516648747|FG000|Overall Study|Negative Benefit/Risk|1|||
143299615|NCT02625090|516648747|FG000|Overall Study|Protocol Deviation|2|||
143299616|NCT02625090|516648747|FG000|Overall Study|Lack of Efficacy|16|||
143299617|NCT02625090|516648747|FG000|Overall Study|Adverse Event|3|||
143299618|NCT02250443|516648748|FG000|Overall Study|Administrative problems|7|||
143299619|NCT02250443|516648748|FG000|Overall Study|Adverse Event|3|||
143299620|NCT01549964|516648749|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
143299621|NCT01549964|516648750|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
143299622|NCT01549964|516648751|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
143299623|NCT01549964|516648752|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
143299624|NCT01549964|516648749|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
143299625|NCT01549964|516648750|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
143299626|NCT01549964|516648751|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
143299627|NCT01549964|516648752|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
143299628|NCT01549964|516648749|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
143299629|NCT01549964|516648750|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
143299630|NCT01549964|516648751|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
143299631|NCT01549964|516648752|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
143299632|NCT01549964|516648749|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
143299633|NCT01549964|516648750|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
143299634|NCT01549964|516648751|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
143299635|NCT01549964|516648752|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
143299636|NCT01549964|516648749|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
143299637|NCT01549964|516648750|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
143299638|NCT01549964|516648751|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
143299639|NCT01549964|516648752|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
143299640|NCT01549964|516648749|FG000|24-Week Treatment Period|Other|1|||
143299641|NCT01549964|516648750|FG001|24-Week Treatment Period|Other|0|||
143299642|NCT01549964|516648751|FG002|24-Week Treatment Period|Other|1|||
143299643|NCT01549964|516648752|FG003|24-Week Treatment Period|Other|0|||
143299644|NCT01549964|516648749|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
143299645|NCT01549964|516648750|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
143299646|NCT01549964|516648751|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
143299647|NCT01549964|516648752|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
143299648|NCT01549964|516648749|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
143299649|NCT01549964|516648750|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
143299650|NCT01549964|516648751|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
143299651|NCT01549964|516648752|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
143299652|NCT01549964|516648749|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
143299653|NCT01549964|516648750|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
143299654|NCT01549964|516648751|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
143299655|NCT01549964|516648752|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
143299656|NCT01549964|516648749|FG000|80-Week Extension Period|Pregnancy|0|||
143299657|NCT01549964|516648750|FG001|80-Week Extension Period|Pregnancy|0|||
143299658|NCT01549964|516648751|FG002|80-Week Extension Period|Pregnancy|1|||
143299659|NCT01549964|516648752|FG003|80-Week Extension Period|Pregnancy|0|||
143299660|NCT01549964|516648749|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
143299661|NCT01549964|516648750|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
143299662|NCT01549964|516648751|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
143299663|NCT01549964|516648752|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
143299664|NCT01549964|516648749|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
143299665|NCT01549964|516648750|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
143299666|NCT01549964|516648751|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
143299667|NCT01549964|516648752|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
143299668|NCT01549964|516648749|FG000|80-Week Extension Period|Lost to Follow-up|1|||
143299669|NCT01549964|516648750|FG001|80-Week Extension Period|Lost to Follow-up|0|||
143299670|NCT01549964|516648751|FG002|80-Week Extension Period|Lost to Follow-up|2|||
143299671|NCT01549964|516648752|FG003|80-Week Extension Period|Lost to Follow-up|1|||
143299672|NCT01549964|516648749|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
143299673|NCT01549964|516648750|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
143299674|NCT01549964|516648751|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
143299675|NCT01549964|516648752|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
143299676|NCT00751348|516648760|FG000|Overall Study|Withdrawal by Subject|5|||
143299677|NCT00751348|516648761|FG001|Overall Study|Withdrawal by Subject|2|||
143299678|NCT00751348|516648760|FG000|Overall Study|Migration from study area|1|||
143299679|NCT00751348|516648761|FG001|Overall Study|Migration from study area|0|||
143299680|NCT04191382|516648765|FG000|Overall Study|Withdrawal by Subject|1|||
143299681|NCT04191382|516648766|FG001|Overall Study|Withdrawal by Subject|0|||
143299682|NCT04191382|516648767|FG002|Overall Study|Withdrawal by Subject|0|||
143299683|NCT05237206|516648768|FG000|Overall Study|screen failure-did not receive treatment|8|||
143299684|NCT05237206|516648768|FG000|Overall Study|did not receive treatment|3|||
143299685|NCT03054870|516648771|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
143299686|NCT03054870|516648771|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
143299687|NCT00643682|516648772|FG000|Overall Study|did not keep appointment|522|||
143299688|NCT00643682|516648773|FG001|Overall Study|did not keep appointment|509|||
143299689|NCT03755414|516648774|FG000|Overall Study|Did not continue with treatment due to low donor collection|2|||
143299690|NCT03755414|516648775|FG001|Overall Study|Did not continue with treatment due to low donor collection|1|||
143299691|NCT03755414|516648776|FG002|Overall Study|Did not continue with treatment due to low donor collection|0|||
143299692|NCT03755414|516648774|FG000|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
143299693|NCT03755414|516648775|FG001|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
143299694|NCT03755414|516648776|FG002|Overall Study|Recipient did not continue with treatment due to low donor cell collection|2|||
143299695|NCT03755414|516648774|FG000|Overall Study|Non-compliance|0|||
143299696|NCT03755414|516648775|FG001|Overall Study|Non-compliance|1|||
143299697|NCT03755414|516648776|FG002|Overall Study|Non-compliance|0|||
143299698|NCT02153112|516648777|FG000|Overall Study|Adverse Event|0|||
143299699|NCT02153112|516648778|FG001|Overall Study|Adverse Event|0|||
143299700|NCT02153112|516648779|FG002|Overall Study|Adverse Event|1|||
143299701|NCT02153112|516648780|FG003|Overall Study|Adverse Event|0|||
143299702|NCT02153112|516648781|FG004|Overall Study|Adverse Event|0|||
143299703|NCT02153112|516648782|FG005|Overall Study|Adverse Event|0|||
143299704|NCT02153112|516648783|FG006|Overall Study|Adverse Event|0|||
143299705|NCT02153112|516648784|FG007|Overall Study|Adverse Event|0|||
143299706|NCT02153112|516648785|FG008|Overall Study|Adverse Event|0|||
143299707|NCT02153112|516648786|FG009|Overall Study|Adverse Event|0|||
143299708|NCT02153112|516648777|FG000|Overall Study|Lost to Follow-up|1|||
143299709|NCT02153112|516648778|FG001|Overall Study|Lost to Follow-up|1|||
143299710|NCT02153112|516648779|FG002|Overall Study|Lost to Follow-up|0|||
143299711|NCT02153112|516648780|FG003|Overall Study|Lost to Follow-up|0|||
143299712|NCT02153112|516648781|FG004|Overall Study|Lost to Follow-up|2|||
143299713|NCT02153112|516648782|FG005|Overall Study|Lost to Follow-up|1|||
143299714|NCT02153112|516648783|FG006|Overall Study|Lost to Follow-up|1|||
143299715|NCT02153112|516648784|FG007|Overall Study|Lost to Follow-up|0|||
143299716|NCT02153112|516648785|FG008|Overall Study|Lost to Follow-up|1|||
143299717|NCT02153112|516648786|FG009|Overall Study|Lost to Follow-up|1|||
143299718|NCT02153112|516648777|FG000|Overall Study|Withdrawal by Subject|3|||
143299719|NCT02153112|516648778|FG001|Overall Study|Withdrawal by Subject|1|||
143299720|NCT02153112|516648779|FG002|Overall Study|Withdrawal by Subject|2|||
143299721|NCT02153112|516648780|FG003|Overall Study|Withdrawal by Subject|2|||
143299722|NCT02153112|516648781|FG004|Overall Study|Withdrawal by Subject|1|||
143299723|NCT02153112|516648782|FG005|Overall Study|Withdrawal by Subject|1|||
143299724|NCT02153112|516648783|FG006|Overall Study|Withdrawal by Subject|7|||
143299725|NCT02153112|516648784|FG007|Overall Study|Withdrawal by Subject|2|||
143299726|NCT02153112|516648785|FG008|Overall Study|Withdrawal by Subject|13|||
143299727|NCT02153112|516648786|FG009|Overall Study|Withdrawal by Subject|12|||
143299728|NCT02153112|516648777|FG000|Overall Study|Reason not Specified|0|||
143299729|NCT02153112|516648778|FG001|Overall Study|Reason not Specified|0|||
143299730|NCT02153112|516648779|FG002|Overall Study|Reason not Specified|0|||
143299731|NCT02153112|516648780|FG003|Overall Study|Reason not Specified|0|||
143299732|NCT02153112|516648781|FG004|Overall Study|Reason not Specified|0|||
143299733|NCT02153112|516648782|FG005|Overall Study|Reason not Specified|0|||
143299734|NCT02153112|516648783|FG006|Overall Study|Reason not Specified|0|||
143299735|NCT02153112|516648784|FG007|Overall Study|Reason not Specified|0|||
143299736|NCT02153112|516648785|FG008|Overall Study|Reason not Specified|1|||
143299737|NCT02153112|516648786|FG009|Overall Study|Reason not Specified|1|||
143299738|NCT00003641|516648789|FG000|Overall Study|Withdrawal by Subject|0|||
143299739|NCT00003641|516648790|FG001|Overall Study|Withdrawal by Subject|100|||
143299740|NCT00003641|516648789|FG000|Overall Study|Adverse Event|0|||
143299741|NCT00003641|516648790|FG001|Overall Study|Adverse Event|38|||
143299742|NCT00003641|516648789|FG000|Overall Study|Disease progression|0|||
143299743|NCT00003641|516648790|FG001|Overall Study|Disease progression|2|||
143299744|NCT00003641|516648789|FG000|Overall Study|Unknown/missing|0|||
143299745|NCT00003641|516648790|FG001|Overall Study|Unknown/missing|22|||
143299746|NCT00003641|516648789|FG000|Overall Study|Should not receive interferon therapy|2|||
143299747|NCT00003641|516648790|FG001|Overall Study|Should not receive interferon therapy|0|||
143299748|NCT00003641|516648789|FG000|Overall Study|Never started interferon|567|||
143299749|NCT00003641|516648790|FG001|Overall Study|Never started interferon|12|||
143299750|NCT03886220|516648794|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
143299751|NCT03886220|516648795|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
143299752|NCT03886220|516648794|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
143299753|NCT03886220|516648795|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
143299754|NCT03886220|516648794|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
143299755|NCT03886220|516648795|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
143299756|NCT02068222|516648798|FG000|Overall Study|Lost to Follow-up|1|||
143299757|NCT00281684|516648801|FG000|Overall Study|Lost to Follow-up|0|||
143299758|NCT00281684|516648802|FG001|Overall Study|Lost to Follow-up|0|||
143299759|NCT00281684|516648803|FG002|Overall Study|Lost to Follow-up|1|||
143299760|NCT00281684|516648804|FG003|Overall Study|Lost to Follow-up|0|||
143299761|NCT00281684|516648801|FG000|Overall Study|Withdrawal by Subject|1|||
143299762|NCT00281684|516648802|FG001|Overall Study|Withdrawal by Subject|0|||
143299763|NCT00281684|516648803|FG002|Overall Study|Withdrawal by Subject|0|||
143299764|NCT00281684|516648804|FG003|Overall Study|Withdrawal by Subject|0|||
143299765|NCT01559012|516648807|FG000|Overall Study|Withdrawal by Subject|0|||
143299766|NCT01559012|516648808|FG001|Overall Study|Withdrawal by Subject|1|||
143299767|NCT00946712|516648809|FG000|Overall Study|Adverse Event|118|||
143299768|NCT00946712|516648810|FG001|Overall Study|Adverse Event|124|||
143299769|NCT00946712|516648809|FG000|Overall Study|Disease progression|308|||
143299770|NCT00946712|516648810|FG001|Overall Study|Disease progression|404|||
143299771|NCT00946712|516648809|FG000|Overall Study|Death|21|||
143299772|NCT00946712|516648810|FG001|Overall Study|Death|22|||
143299773|NCT00946712|516648809|FG000|Overall Study|No treatment given|25|||
143299774|NCT00946712|516648810|FG001|Overall Study|No treatment given|29|||
143299775|NCT00946712|516648809|FG000|Overall Study|Other reasons|61|||
143299776|NCT00946712|516648810|FG001|Overall Study|Other reasons|73|||
143299777|NCT00946712|516648809|FG000|Overall Study|On Treatment|0|||
143299778|NCT00946712|516648810|FG001|Overall Study|On Treatment|4|||
143299779|NCT00946712|516648809|FG000|Overall Study|Ineligible|14|||
143299780|NCT00946712|516648810|FG001|Overall Study|Ineligible|6|||
143299781|NCT00302458|516648811|FG000|Overall Study|Lost to Follow-up|1|||
143299782|NCT00302458|516648811|FG000|Overall Study|Ineligible after screening|1|||
143299783|NCT00302458|516648811|FG000|Overall Study|Withdrawal by Subject|1|||
143299784|NCT00853723|516648815|FG000|Overall Study|Adverse Event|3|||
143299785|NCT00853723|516648816|FG001|Overall Study|Adverse Event|4|||
143299786|NCT00853723|516648817|FG002|Overall Study|Adverse Event|1|||
143299787|NCT00853723|516648815|FG000|Overall Study|Withdrawal by Subject|2|||
143299788|NCT00853723|516648816|FG001|Overall Study|Withdrawal by Subject|1|||
143299789|NCT00853723|516648817|FG002|Overall Study|Withdrawal by Subject|0|||
143299790|NCT00853723|516648815|FG000|Overall Study|Protocol Violation|1|||
143299791|NCT00853723|516648816|FG001|Overall Study|Protocol Violation|2|||
143299792|NCT00853723|516648817|FG002|Overall Study|Protocol Violation|1|||
143299793|NCT01531387|516648818|FG000|Overall Study|Early termination of study|11|||
143299794|NCT01531387|516648819|FG001|Overall Study|Early termination of study|11|||
143299795|NCT00445965|516648820|FG000|Overall Study|Adverse Event|2|||
143299796|NCT00445965|516648820|FG000|Overall Study|Physician Decision|1|||
143299797|NCT00445965|516648820|FG000|Overall Study|Enrolled but not treated|1|||
143299798|NCT00445965|516648820|FG000|Overall Study|Removed due to progressive disease|29|||
143299799|NCT02867709|516648821|FG000|Treatment Period|Adverse Event|1|||
143299800|NCT02867709|516648822|FG001|Treatment Period|Adverse Event|1|||
143299801|NCT02867709|516648823|FG002|Treatment Period|Adverse Event|2|||
143299802|NCT02867709|516648821|FG000|Treatment Period|Withdrawal of Consent|7|||
143299803|NCT02867709|516648822|FG001|Treatment Period|Withdrawal of Consent|9|||
143299804|NCT02867709|516648823|FG002|Treatment Period|Withdrawal of Consent|8|||
143299805|NCT02867709|516648821|FG000|Treatment Period|Lost to Follow-up|17|||
143299806|NCT02867709|516648822|FG001|Treatment Period|Lost to Follow-up|20|||
143299807|NCT02867709|516648823|FG002|Treatment Period|Lost to Follow-up|20|||
143299808|NCT02867709|516648821|FG000|Treatment Period|Lack of Qualifying Event|42|||
143299809|NCT02867709|516648822|FG001|Treatment Period|Lack of Qualifying Event|55|||
143299810|NCT02867709|516648823|FG002|Treatment Period|Lack of Qualifying Event|42|||
143299811|NCT02867709|516648821|FG000|Treatment Period|Protocol Violation|3|||
143299812|NCT02867709|516648822|FG001|Treatment Period|Protocol Violation|2|||
143299813|NCT02867709|516648823|FG002|Treatment Period|Protocol Violation|3|||
143299814|NCT02867709|516648821|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
143299815|NCT02867709|516648822|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
143299816|NCT02867709|516648823|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
143299817|NCT02867709|516648821|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
143299818|NCT02867709|516648822|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
143299819|NCT02867709|516648823|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
143299820|NCT02867709|516648821|FG000|Safety Follow-up Period|Pregnancy|0|||
143299821|NCT02867709|516648822|FG001|Safety Follow-up Period|Pregnancy|1|||
143299822|NCT02867709|516648823|FG002|Safety Follow-up Period|Pregnancy|0|||
143299823|NCT02867709|516648821|FG000|Safety Follow-up Period|Protocol Violation|0|||
143299824|NCT02867709|516648822|FG001|Safety Follow-up Period|Protocol Violation|1|||
143299825|NCT02867709|516648823|FG002|Safety Follow-up Period|Protocol Violation|1|||
143299826|NCT03878446|516648824|FG000|Overall Study|Withdrawn by parent or guardian|1|||
143299827|NCT03878446|516648825|FG001|Overall Study|Withdrawn by parent or guardian|0|||
143299828|NCT03878446|516648826|FG002|Overall Study|Withdrawn by parent or guardian|0|||
143299829|NCT03878446|516648827|FG003|Overall Study|Withdrawn by parent or guardian|0|||
143299830|NCT03878446|516648828|FG004|Overall Study|Withdrawn by parent or guardian|0|||
143299831|NCT03265249|516650197|FG000|Overall Study|Withdrawal by Subject|0|||
143299832|NCT03265249|516650198|FG001|Overall Study|Withdrawal by Subject|1|||
143299833|NCT01614990|516650199|FG000|Overall Study|Protocol Violation|1|||
143299834|NCT01614990|516650200|FG001|Overall Study|Protocol Violation|1|||
143299835|NCT02255500|516650201|FG000|Overall Study|Withdrawal by Subject|1|||
143299836|NCT02255500|516650202|FG001|Overall Study|Withdrawal by Subject|0|||
143299837|NCT03102918|516650203|FG000|Overall Study|Protocol Violation|1|||
143299838|NCT03102918|516650204|FG001|Overall Study|Protocol Violation|0|||
143299839|NCT04765358|516650205|FG000|Overall Study|Withdrawal by Subject|1|||
143299840|NCT00952341|516650207|FG000|Cycle 1|Adverse Event|4|||
143299841|NCT00952341|516650208|FG001|Cycle 1|Adverse Event|1|||
143299842|NCT00952341|516650207|FG000|Cycle 1|Withdrawal by Subject|3|||
143299843|NCT00952341|516650208|FG001|Cycle 1|Withdrawal by Subject|8|||
143299844|NCT00952341|516650207|FG000|Cycle 1|Protocol Violation|2|||
143299845|NCT00952341|516650208|FG001|Cycle 1|Protocol Violation|1|||
143299846|NCT00952341|516650207|FG000|Cycle 1|Lost to Follow-up|11|||
143299847|NCT00952341|516650208|FG001|Cycle 1|Lost to Follow-up|2|||
143299848|NCT00952341|516650207|FG000|Cycle 1|Physician Decision|0|||
143299849|NCT00952341|516650208|FG001|Cycle 1|Physician Decision|1|||
143299850|NCT00952341|516650207|FG000|Cycle 2|Withdrawal by Subject|1|||
143299851|NCT00952341|516650208|FG001|Cycle 2|Withdrawal by Subject|1|||
143299852|NCT00952341|516650207|FG000|Cycle 2|Protocol Violation|1|||
143299853|NCT00952341|516650208|FG001|Cycle 2|Protocol Violation|0|||
143299854|NCT00952341|516650207|FG000|Cycle 2|Lost to Follow-up|6|||
143299855|NCT00952341|516650208|FG001|Cycle 2|Lost to Follow-up|9|||
143299856|NCT00952341|516650207|FG000|Cycle 2|Physician Decision|1|||
143299857|NCT00952341|516650208|FG001|Cycle 2|Physician Decision|1|||
143299858|NCT00952341|516650207|FG000|Cycle 2|Progressive Disease|0|||
143299859|NCT00952341|516650208|FG001|Cycle 2|Progressive Disease|1|||
143299860|NCT01413360|516650215|FG000|Overall Study|Lost to Follow-up|2|||
143374604|NCT00818454|516917241|FG003|Treatment Period 2|Other|0|||
143374605|NCT00818454|516917238|FG000|Treatment Period 3|Adverse Event|0|||
143374606|NCT00818454|516917239|FG001|Treatment Period 3|Adverse Event|0|||
143299861|NCT01413360|516650215|FG000|Overall Study|Adverse Event|1|||
143299862|NCT02120950|516650216|FG000|Overall Study|Adverse Event|5|||
143299863|NCT02120950|516650217|FG001|Overall Study|Adverse Event|4|||
143299864|NCT02120950|516650218|FG002|Overall Study|Adverse Event|3|||
143299865|NCT02120950|516650216|FG000|Overall Study|Death|3|||
143299866|NCT02120950|516650217|FG001|Overall Study|Death|0|||
143299867|NCT02120950|516650218|FG002|Overall Study|Death|1|||
143299868|NCT02120950|516650216|FG000|Overall Study|Withdrawal by Subject|6|||
143299869|NCT02120950|516650217|FG001|Overall Study|Withdrawal by Subject|3|||
143299870|NCT02120950|516650218|FG002|Overall Study|Withdrawal by Subject|2|||
143299871|NCT02120950|516650216|FG000|Overall Study|Protocol Violation|1|||
143299872|NCT02120950|516650217|FG001|Overall Study|Protocol Violation|1|||
143299873|NCT02120950|516650218|FG002|Overall Study|Protocol Violation|7|||
143299874|NCT02120950|516650216|FG000|Overall Study|Other reasons|5|||
143299875|NCT02120950|516650217|FG001|Overall Study|Other reasons|4|||
143299876|NCT02120950|516650218|FG002|Overall Study|Other reasons|1|||
143299877|NCT02120950|516650216|FG000|Overall Study|Lost to Follow-up|0|||
143299878|NCT02120950|516650217|FG001|Overall Study|Lost to Follow-up|2|||
143299879|NCT02120950|516650218|FG002|Overall Study|Lost to Follow-up|1|||
143299880|NCT01852812|516650221|FG000|Overall Study|Adverse Event|0|||
143299881|NCT01852812|516650222|FG001|Overall Study|Adverse Event|0|||
143299882|NCT01852812|516650223|FG002|Overall Study|Adverse Event|1|||
143299883|NCT01852812|516650221|FG000|Overall Study|Non-compliance With Study Drug|0|||
143299884|NCT01852812|516650222|FG001|Overall Study|Non-compliance With Study Drug|1|||
143299885|NCT01852812|516650223|FG002|Overall Study|Non-compliance With Study Drug|0|||
143299886|NCT02290821|516650226|FG000|Overall Study|Withdrawal by Subject|1|||
143299887|NCT02290821|516650227|FG001|Overall Study|Withdrawal by Subject|1|||
143299888|NCT02290821|516650226|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
143299889|NCT02290821|516650227|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
143299890|NCT02290821|516650226|FG000|Overall Study|Lost to Follow-up|3|||
143299891|NCT02290821|516650227|FG001|Overall Study|Lost to Follow-up|2|||
143299892|NCT02438722|516650228|FG000|Overall Study|Adverse Event|12|||
143299893|NCT02438722|516650229|FG001|Overall Study|Adverse Event|9|||
143299894|NCT02438722|516650228|FG000|Overall Study|Refusal unrelated to AE|2|||
143299895|NCT02438722|516650229|FG001|Overall Study|Refusal unrelated to AE|5|||
143299896|NCT02438722|516650228|FG000|Overall Study|Disease progression/relapse|46|||
143299897|NCT02438722|516650229|FG001|Overall Study|Disease progression/relapse|51|||
143299898|NCT02438722|516650228|FG000|Overall Study|Death|0|||
143299899|NCT02438722|516650229|FG001|Overall Study|Death|3|||
143299900|NCT02438722|516650228|FG000|Overall Study|Physician Decision|2|||
143299901|NCT02438722|516650229|FG001|Overall Study|Physician Decision|2|||
143299902|NCT02438722|516650228|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
143299903|NCT02438722|516650229|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
143299904|NCT02438722|516650228|FG000|Overall Study|Withdrawal by Subject|0|||
143299905|NCT02438722|516650229|FG001|Overall Study|Withdrawal by Subject|1|||
143299906|NCT02438722|516650228|FG000|Overall Study|On protocol treatment|15|||
143299907|NCT02438722|516650229|FG001|Overall Study|On protocol treatment|14|||
143299908|NCT02438722|516650228|FG000|Overall Study|Did not receive protocol treatment|5|||
143299909|NCT02438722|516650229|FG001|Overall Study|Did not receive protocol treatment|0|||
143299910|NCT01520363|516650230|FG000|Overall Study|Withdrawal by Subject|2|||
143299911|NCT01520363|516650231|FG001|Overall Study|Withdrawal by Subject|0|||
143299912|NCT02205333|516650233|FG000|Overall Study|Death|5|||
143299913|NCT02205333|516650234|FG001|Overall Study|Death|6|||
143299914|NCT02205333|516650235|FG002|Overall Study|Death|2|||
143299915|NCT02205333|516650236|FG003|Overall Study|Death|6|||
143299916|NCT02205333|516650237|FG004|Overall Study|Death|5|||
143299917|NCT02205333|516650238|FG005|Overall Study|Death|3|||
143299918|NCT02205333|516650239|FG006|Overall Study|Death|3|||
143299919|NCT02205333|516650240|FG007|Overall Study|Death|2|||
143299920|NCT02205333|516650241|FG008|Overall Study|Death|0|||
143299921|NCT02205333|516650233|FG000|Overall Study|Withdrawal by Subject|1|||
143299922|NCT02205333|516650234|FG001|Overall Study|Withdrawal by Subject|0|||
143299923|NCT02205333|516650235|FG002|Overall Study|Withdrawal by Subject|0|||
143299924|NCT02205333|516650236|FG003|Overall Study|Withdrawal by Subject|1|||
143299925|NCT02205333|516650237|FG004|Overall Study|Withdrawal by Subject|0|||
143299926|NCT02205333|516650238|FG005|Overall Study|Withdrawal by Subject|0|||
143299927|NCT02205333|516650239|FG006|Overall Study|Withdrawal by Subject|2|||
143299928|NCT02205333|516650240|FG007|Overall Study|Withdrawal by Subject|0|||
143299929|NCT02205333|516650241|FG008|Overall Study|Withdrawal by Subject|0|||
143299930|NCT01476696|516650244|FG000|Overall Study|Sponsor decision|2|||
143299931|NCT01476696|516650245|FG001|Overall Study|Sponsor decision|1|||
143299932|NCT01476696|516650246|FG002|Overall Study|Sponsor decision|0|||
143299933|NCT01476696|516650244|FG000|Overall Study|Withdrawal by Subject|1|||
143299934|NCT01476696|516650245|FG001|Overall Study|Withdrawal by Subject|0|||
143299935|NCT01476696|516650246|FG002|Overall Study|Withdrawal by Subject|0|||
143299936|NCT02009046|516650248|FG000|Overall Study|Lost to Follow-up|256|||
143299937|NCT02009046|516650249|FG001|Overall Study|Lost to Follow-up|206|||
143299938|NCT03965962|516650255|FG000|Overall Study|Adverse Event|1|||
143299939|NCT03965962|516650256|FG001|Overall Study|Adverse Event|0|||
143299940|NCT03965962|516650257|FG002|Overall Study|Adverse Event|0|||
143299941|NCT03965962|516650258|FG003|Overall Study|Adverse Event|0|||
143299942|NCT03965962|516650255|FG000|Overall Study|Protocol Violation|21|||
143299943|NCT03965962|516650256|FG001|Overall Study|Protocol Violation|4|||
143299944|NCT03965962|516650257|FG002|Overall Study|Protocol Violation|10|||
143299945|NCT03965962|516650258|FG003|Overall Study|Protocol Violation|5|||
143299946|NCT03965962|516650255|FG000|Overall Study|Lost to Follow-up|0|||
143299947|NCT03965962|516650256|FG001|Overall Study|Lost to Follow-up|1|||
143299948|NCT03965962|516650257|FG002|Overall Study|Lost to Follow-up|0|||
143299949|NCT03965962|516650258|FG003|Overall Study|Lost to Follow-up|0|||
143299950|NCT03965962|516650255|FG000|Overall Study|Withdrawal by Subject|3|||
143299951|NCT03965962|516650256|FG001|Overall Study|Withdrawal by Subject|0|||
143299952|NCT03965962|516650257|FG002|Overall Study|Withdrawal by Subject|0|||
143299953|NCT03965962|516650258|FG003|Overall Study|Withdrawal by Subject|1|||
143299954|NCT02154581|516650266|FG000|Overall Study|Lost to Follow-up|7|||
143299955|NCT02154581|516650267|FG001|Overall Study|Lost to Follow-up|8|||
143299956|NCT00741039|516650268|FG000|Overall Study|Patient non-compliance|2|||
143299957|NCT00741039|516650269|FG001|Overall Study|Patient non-compliance|0|||
143299958|NCT00878709|516650270|FG000|Overall Study|Withdrawal by Subject|197|||
143299959|NCT00878709|516650271|FG001|Overall Study|Withdrawal by Subject|120|||
143299960|NCT00878709|516650270|FG000|Overall Study|Lost to Follow-up|35|||
143299961|NCT00878709|516650271|FG001|Overall Study|Lost to Follow-up|33|||
143299962|NCT00878709|516650270|FG000|Overall Study|Other Reasons|93|||
143299963|NCT00878709|516650271|FG001|Overall Study|Other Reasons|84|||
143299964|NCT01712854|516650272|FG000|Overall Study|Physician Decision|1|||
143299965|NCT02225743|516650273|FG000|Overall Study|Withdrawal by Subject|18|||
143299966|NCT00768300|516650276|FG000|Overall Study|Randomized but not treated|1|||
143299967|NCT00768300|516650277|FG001|Overall Study|Randomized but not treated|1|||
143299968|NCT00768300|516650276|FG000|Overall Study|Adverse Event|10|||
143299969|NCT00768300|516650277|FG001|Overall Study|Adverse Event|2|||
143299970|NCT00768300|516650276|FG000|Overall Study|Protocol Violation|6|||
143299971|NCT00768300|516650277|FG001|Overall Study|Protocol Violation|1|||
143299972|NCT00768300|516650276|FG000|Overall Study|Withdrawal by Subject|13|||
143299973|NCT00768300|516650277|FG001|Overall Study|Withdrawal by Subject|7|||
143299974|NCT00768300|516650276|FG000|Overall Study|Physician Decision|2|||
143299975|NCT00768300|516650277|FG001|Overall Study|Physician Decision|3|||
143299976|NCT00768300|516650276|FG000|Overall Study|Study discontinued by Sponsor|271|||
143299977|NCT00768300|516650277|FG001|Overall Study|Study discontinued by Sponsor|140|||
143299978|NCT00768300|516650276|FG000|Overall Study|Death|21|||
143299979|NCT00768300|516650277|FG001|Overall Study|Death|5|||
143299980|NCT00768300|516650276|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
143299981|NCT00768300|516650277|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
143299982|NCT00768300|516650276|FG000|Overall Study|Screen failure following randomization|1|||
143299983|NCT00768300|516650277|FG001|Overall Study|Screen failure following randomization|0|||
143299984|NCT00768300|516650276|FG000|Overall Study|Received lung transplant|1|||
143299985|NCT00768300|516650277|FG001|Overall Study|Received lung transplant|1|||
143299986|NCT00768300|516650276|FG000|Overall Study|Lost to Follow-up|0|||
143299987|NCT00768300|516650277|FG001|Overall Study|Lost to Follow-up|1|||
143299988|NCT00768300|516650276|FG000|Overall Study|Began prohibited concomitant medication|0|||
143299989|NCT00768300|516650277|FG001|Overall Study|Began prohibited concomitant medication|1|||
143299990|NCT00768300|516650276|FG000|Overall Study|Treated but never dosed with Study drug|1|||
143299991|NCT00768300|516650277|FG001|Overall Study|Treated but never dosed with Study drug|0|||
143299992|NCT00768300|516650276|FG000|Overall Study|Missing data|1|||
143299993|NCT00768300|516650277|FG001|Overall Study|Missing data|0|||
143374607|NCT00818454|516917240|FG002|Treatment Period 3|Adverse Event|0|||
143374608|NCT00818454|516917241|FG003|Treatment Period 3|Adverse Event|1|||
143374609|NCT03557008|516917242|FG000|Overall Study|Withdrawal by Subject|2|||
143374610|NCT03557008|516917243|FG001|Overall Study|Withdrawal by Subject|2|||
143374611|NCT03557008|516917242|FG000|Overall Study|Early termination from study|3|||
143374612|NCT03557008|516917243|FG001|Overall Study|Early termination from study|1|||
143374613|NCT02296424|516917246|FG000|Part 1|New therapy for study indication|0|||
143374614|NCT02296424|516917247|FG001|Part 1|New therapy for study indication|1|||
143374615|NCT02296424|516917248|FG002|Part 1|New therapy for study indication|0|||
143374616|NCT02296424|516917249|FG003|Part 1|New therapy for study indication|0|||
143299994|NCT00322842|516650278|FG000|Overall Study|Withdrawal by Subject|0|||
143299995|NCT00322842|516650279|FG001|Overall Study|Withdrawal by Subject|1|||
143299996|NCT00322842|516650278|FG000|Overall Study|Lost to Follow-up|0|||
143299997|NCT00322842|516650279|FG001|Overall Study|Lost to Follow-up|1|||
143374617|NCT02296424|516917246|FG000|Part 1|Protocol Violation|0|||
143374618|NCT02296424|516917247|FG001|Part 1|Protocol Violation|1|||
143299998|NCT00322842|516650278|FG000|Overall Study|Refused transplant|1|||
143299999|NCT00322842|516650279|FG001|Overall Study|Refused transplant|0|||
143300000|NCT00322842|516650278|FG000|Overall Study|Death|1|||
143300001|NCT00322842|516650279|FG001|Overall Study|Death|0|||
143300002|NCT03082599|516650282|FG000|Overall Study|Lost to Follow-up|1|||
143300003|NCT03082599|516650283|FG001|Overall Study|Lost to Follow-up|0|||
143300004|NCT00832585|516650296|FG000|Overall Study|Withdrawal by Subject|1|||
143300005|NCT00832585|516650296|FG000|Overall Study|Lost to Follow-up|1|||
143300006|NCT02677987|516650298|FG000|Overall Study|Withdrawal by Subject|3|||
143300007|NCT02677987|516650299|FG001|Overall Study|Withdrawal by Subject|0|||
143300008|NCT02677987|516650298|FG000|Overall Study|Lost to Follow-up|1|||
143300009|NCT02677987|516650299|FG001|Overall Study|Lost to Follow-up|0|||
143300010|NCT00673179|516650301|FG000|Overall Study|Toxicity/Complications|3|||
143300011|NCT00673179|516650302|FG001|Overall Study|Toxicity/Complications|0|||
143300012|NCT03642717|516650303|FG000|Overall Study|Lost to Follow-up|2|||
143300013|NCT03642717|516650303|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
143300014|NCT03642717|516650303|FG000|Overall Study|Taken study drug prior to contract date|3|||
143300015|NCT04056195|516650304|FG000|Overall Study|Adverse Event|1|||
143300016|NCT04056195|516650305|FG001|Overall Study|Adverse Event|0|||
143300017|NCT04056195|516650306|FG002|Overall Study|Adverse Event|0|||
143374619|NCT02296424|516917248|FG002|Part 1|Protocol Violation|0|||
143374620|NCT02296424|516917249|FG003|Part 1|Protocol Violation|0|||
143374621|NCT02296424|516917246|FG000|Part 1|Withdrawal by Subject|0|||
143374622|NCT02296424|516917247|FG001|Part 1|Withdrawal by Subject|2|||
143374623|NCT02296424|516917248|FG002|Part 1|Withdrawal by Subject|0|||
143374624|NCT02296424|516917249|FG003|Part 1|Withdrawal by Subject|0|||
143374625|NCT02296424|516917246|FG000|Part 1|Study terminated by sponsor|0|||
143374626|NCT02296424|516917247|FG001|Part 1|Study terminated by sponsor|1|||
143374627|NCT02296424|516917248|FG002|Part 1|Study terminated by sponsor|0|||
143374628|NCT02296424|516917249|FG003|Part 1|Study terminated by sponsor|0|||
143374629|NCT02296424|516917246|FG000|Part 1|Adverse Event|2|||
143374630|NCT02296424|516917247|FG001|Part 1|Adverse Event|11|||
143374631|NCT02296424|516917248|FG002|Part 1|Adverse Event|0|||
143300018|NCT04056195|516650304|FG000|Overall Study|Withdrawal by Subject|0|||
143300019|NCT04056195|516650305|FG001|Overall Study|Withdrawal by Subject|1|||
143300020|NCT04056195|516650306|FG002|Overall Study|Withdrawal by Subject|1|||
143300021|NCT04056195|516650304|FG000|Overall Study|Physician Decision|1|||
143300022|NCT04056195|516650305|FG001|Overall Study|Physician Decision|1|||
143300023|NCT04056195|516650306|FG002|Overall Study|Physician Decision|1|||
143300024|NCT05497284|516650307|FG000|Overall Study|Adverse Event|1|||
143300025|NCT05497284|516650308|FG001|Overall Study|Adverse Event|0|||
143300026|NCT05497284|516650307|FG000|Overall Study|Physician Decision|0|||
143374632|NCT02296424|516917249|FG003|Part 1|Adverse Event|0|||
143374633|NCT02296424|516917246|FG000|Part 1|Lack of Efficacy|5|||
143374634|NCT02296424|516917247|FG001|Part 1|Lack of Efficacy|17|||
143300027|NCT05497284|516650308|FG001|Overall Study|Physician Decision|1|||
143300028|NCT05497284|516650307|FG000|Overall Study|Study terminated by sponsor|7|||
143300029|NCT05497284|516650308|FG001|Overall Study|Study terminated by sponsor|4|||
143300030|NCT05497284|516650307|FG000|Overall Study|Subject Decision|0|||
143300031|NCT05497284|516650308|FG001|Overall Study|Subject Decision|1|||
143300032|NCT05760300|516650309|FG000|Overall Study|Adverse Event|0|||
143300033|NCT05760300|516650310|FG001|Overall Study|Adverse Event|0|||
143300034|NCT05760300|516650311|FG002|Overall Study|Adverse Event|1|||
143300035|NCT05760300|516650312|FG003|Overall Study|Adverse Event|0|||
143374635|NCT02296424|516917248|FG002|Part 1|Lack of Efficacy|0|||
143374636|NCT02296424|516917249|FG003|Part 1|Lack of Efficacy|0|||
143300036|NCT05760300|516650309|FG000|Overall Study|Participant Decision|1|||
143300037|NCT05760300|516650310|FG001|Overall Study|Participant Decision|0|||
143374637|NCT02296424|516917246|FG000|Part 1|16 directly started part II|16|||
143300038|NCT05760300|516650311|FG002|Overall Study|Participant Decision|0|||
143300039|NCT05760300|516650312|FG003|Overall Study|Participant Decision|0|||
143300040|NCT03615105|516650313|FG000|Overall Study|Protocol Violation|1|||
143300041|NCT03615105|516650314|FG001|Overall Study|Protocol Violation|0|||
143300042|NCT03615105|516650315|FG002|Overall Study|Protocol Violation|0|||
143300043|NCT03615105|516650313|FG000|Overall Study|Death|0|||
143300044|NCT03615105|516650314|FG001|Overall Study|Death|2|||
143300045|NCT03615105|516650315|FG002|Overall Study|Death|0|||
143300046|NCT03313804|516650316|FG000|Treatment|Death|5|||
143300047|NCT03313804|516650316|FG000|Treatment|still on treatment|2|||
143300048|NCT03313804|516650316|FG000|Follow Up|still on follow up|3|||
143300049|NCT01502423|516650317|FG000|Overall Study|Withdrawal by Subject|0|||
143300050|NCT01502423|516650318|FG001|Overall Study|Withdrawal by Subject|1|||
143300051|NCT04690751|516650320|FG000|Overall Study|Protocol Violation|0|||
143300052|NCT04690751|516650321|FG001|Overall Study|Protocol Violation|1|||
143300053|NCT04690751|516650322|FG002|Overall Study|Protocol Violation|0|||
143300054|NCT04690751|516650323|FG003|Overall Study|Protocol Violation|1|||
143300055|NCT04690751|516650324|FG004|Overall Study|Protocol Violation|2|||
143300056|NCT04690751|516650325|FG005|Overall Study|Protocol Violation|0|||
143300057|NCT04690751|516650320|FG000|Overall Study|Adverse Event|0|||
143300058|NCT04690751|516650321|FG001|Overall Study|Adverse Event|0|||
143300059|NCT04690751|516650322|FG002|Overall Study|Adverse Event|1|||
143300060|NCT04690751|516650323|FG003|Overall Study|Adverse Event|0|||
143300061|NCT04690751|516650324|FG004|Overall Study|Adverse Event|0|||
143300062|NCT04690751|516650325|FG005|Overall Study|Adverse Event|0|||
143300063|NCT04690751|516650320|FG000|Overall Study|Positive urine drug screen test|0|||
143300064|NCT04690751|516650321|FG001|Overall Study|Positive urine drug screen test|0|||
143300065|NCT04690751|516650322|FG002|Overall Study|Positive urine drug screen test|0|||
143300066|NCT04690751|516650323|FG003|Overall Study|Positive urine drug screen test|0|||
143300067|NCT04690751|516650324|FG004|Overall Study|Positive urine drug screen test|1|||
143300068|NCT04690751|516650325|FG005|Overall Study|Positive urine drug screen test|0|||
143300069|NCT01344161|516650326|FG000|Overall Study|Lost to Follow-up|4|||
143300070|NCT01344161|516650327|FG001|Overall Study|Lost to Follow-up|1|||
143300071|NCT01344161|516650326|FG000|Overall Study|Pregnancy|0|||
143300072|NCT01344161|516650327|FG001|Overall Study|Pregnancy|1|||
143300073|NCT01344161|516650326|FG000|Overall Study|Protocol Violation|1|||
143300074|NCT01344161|516650327|FG001|Overall Study|Protocol Violation|1|||
143300075|NCT04364620|516650328|FG000|Overall Study|Disease Progression|20|||
143300076|NCT04364620|516650328|FG000|Overall Study|Adverse Event|5|||
143300077|NCT04364620|516650328|FG000|Overall Study|Physician Decision|4|||
143300078|NCT04364620|516650328|FG000|Overall Study|Death|3|||
143300079|NCT04364620|516650328|FG000|Overall Study|Other|2|||
143300080|NCT04364620|516650328|FG000|Overall Study|Withdrawal by Subject|1|||
143374638|NCT02296424|516917247|FG001|Part 1|16 directly started part II|0|||
143300081|NCT01545817|516652004|FG000|Pazopanib|Disease progression|51|||
143300082|NCT01545817|516652005|FG001|Pazopanib|Disease progression|0|||
143300083|NCT01545817|516652004|FG000|Pazopanib|Adverse Event|19|||
143300084|NCT01545817|516652005|FG001|Pazopanib|Adverse Event|0|||
143300085|NCT01545817|516652004|FG000|Pazopanib|Other reason|4|||
143300086|NCT01545817|516652005|FG001|Pazopanib|Other reason|0|||
143300087|NCT01545817|516652004|FG000|Everolimus|Other reason|0|||
143300088|NCT01545817|516652005|FG001|Everolimus|Other reason|7|||
143300089|NCT01545817|516652004|FG000|Everolimus|Disease progression|0|||
143300090|NCT01545817|516652005|FG001|Everolimus|Disease progression|25|||
143300091|NCT01545817|516652004|FG000|Everolimus|Adverse Event|0|||
143300092|NCT01545817|516652005|FG001|Everolimus|Adverse Event|6|||
143300093|NCT02967692|516652006|FG000|Overall Study|Progressive disease|3|||
143300094|NCT02967692|516652007|FG001|Overall Study|Progressive disease|15|||
143300095|NCT02967692|516652008|FG002|Overall Study|Progressive disease|114|||
143300096|NCT02967692|516652009|FG003|Overall Study|Progressive disease|151|||
143300097|NCT02967692|516652006|FG000|Overall Study|Subject/guardian decision|1|||
143300098|NCT02967692|516652007|FG001|Overall Study|Subject/guardian decision|1|||
143300099|NCT02967692|516652008|FG002|Overall Study|Subject/guardian decision|14|||
143300100|NCT02967692|516652009|FG003|Overall Study|Subject/guardian decision|22|||
143300101|NCT02967692|516652006|FG000|Overall Study|Death|0|||
143300102|NCT02967692|516652007|FG001|Overall Study|Death|1|||
143300103|NCT02967692|516652008|FG002|Overall Study|Death|13|||
143300104|NCT02967692|516652009|FG003|Overall Study|Death|13|||
143300105|NCT02967692|516652006|FG000|Overall Study|Protocol deviation|1|||
143300106|NCT02967692|516652007|FG001|Overall Study|Protocol deviation|0|||
143300107|NCT02967692|516652008|FG002|Overall Study|Protocol deviation|1|||
143300108|NCT02967692|516652009|FG003|Overall Study|Protocol deviation|1|||
143300109|NCT02967692|516652006|FG000|Overall Study|Lost to Follow-up|0|||
143300110|NCT02967692|516652007|FG001|Overall Study|Lost to Follow-up|0|||
143300111|NCT02967692|516652008|FG002|Overall Study|Lost to Follow-up|1|||
143300112|NCT02967692|516652009|FG003|Overall Study|Lost to Follow-up|0|||
143300113|NCT02967692|516652006|FG000|Overall Study|Physician Decision|0|||
143300114|NCT02967692|516652007|FG001|Overall Study|Physician Decision|0|||
143300115|NCT02967692|516652008|FG002|Overall Study|Physician Decision|22|||
143300116|NCT02967692|516652009|FG003|Overall Study|Physician Decision|13|||
143300117|NCT02967692|516652006|FG000|Overall Study|Adverse Event|2|||
143300118|NCT02967692|516652007|FG001|Overall Study|Adverse Event|9|||
143300119|NCT02967692|516652008|FG002|Overall Study|Adverse Event|60|||
143300120|NCT02967692|516652009|FG003|Overall Study|Adverse Event|28|||
143300121|NCT02967692|516652006|FG000|Overall Study|Study terminated by sponsor|2|||
143300122|NCT02967692|516652007|FG001|Overall Study|Study terminated by sponsor|1|||
143300123|NCT02967692|516652008|FG002|Overall Study|Study terminated by sponsor|42|||
143300124|NCT02967692|516652009|FG003|Overall Study|Study terminated by sponsor|37|||
143300125|NCT00066066|516652010|FG000|Overall Study|Lost to Follow-up|6|||
143300126|NCT00066066|516652011|FG001|Overall Study|Lost to Follow-up|4|||
143300127|NCT00066066|516652012|FG002|Overall Study|Lost to Follow-up|7|||
143300128|NCT00066066|516652013|FG003|Overall Study|Lost to Follow-up|4|||
143300129|NCT00066066|516652014|FG004|Overall Study|Lost to Follow-up|3|||
143300130|NCT00066066|516652015|FG005|Overall Study|Lost to Follow-up|5|||
143300131|NCT00156533|516652022|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
143300132|NCT00156533|516652023|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
143300133|NCT00156533|516652024|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
143300134|NCT00156533|516652025|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
143300135|NCT00156533|516652022|FG000|Overall Study|Withdrawal by Subject|1|||
143300136|NCT00156533|516652023|FG001|Overall Study|Withdrawal by Subject|0|||
143300137|NCT00156533|516652024|FG002|Overall Study|Withdrawal by Subject|0|||
143300138|NCT00156533|516652025|FG003|Overall Study|Withdrawal by Subject|1|||
143300139|NCT00156533|516652022|FG000|Overall Study|Failed Screening|1|||
143300140|NCT00156533|516652023|FG001|Overall Study|Failed Screening|0|||
143300141|NCT00156533|516652024|FG002|Overall Study|Failed Screening|1|||
143300142|NCT00156533|516652025|FG003|Overall Study|Failed Screening|1|||
143300143|NCT01541969|516652026|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
143300144|NCT01541969|516652027|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
143300145|NCT01541969|516652026|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
143300146|NCT01541969|516652027|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
143300147|NCT01541969|516652026|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
143300148|NCT01541969|516652027|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
143300149|NCT01541969|516652026|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
143300150|NCT01541969|516652027|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
143300151|NCT01541969|516652026|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
143300152|NCT01541969|516652027|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
143300153|NCT01541969|516652026|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
143300154|NCT01541969|516652027|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
143300155|NCT01541969|516652026|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
143300156|NCT01541969|516652027|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
143300157|NCT01541969|516652026|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
143300158|NCT01541969|516652027|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
143300159|NCT01541969|516652026|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
143300160|NCT01541969|516652027|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
143300161|NCT01541969|516652026|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
143300162|NCT01541969|516652027|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
143300163|NCT01365507|516652028|FG000|Overall Study|Withdrawal Criteria|8|||
143300164|NCT01365507|516652029|FG001|Overall Study|Withdrawal Criteria|5|||
143300165|NCT01365507|516652028|FG000|Overall Study|Unclassified|1|||
143300166|NCT01365507|516652029|FG001|Overall Study|Unclassified|4|||
143300167|NCT01012622|516652036|FG000|Overall Study|Withdrawal by Subject|6|||
143300168|NCT01012622|516652036|FG000|Overall Study|Lost to Follow-up|5|||
143300169|NCT01012622|516652036|FG000|Overall Study|Adverse Event|7|||
143300170|NCT01012622|516652036|FG000|Overall Study|non-compliance with the drug|9|||
143300171|NCT01012622|516652036|FG000|Overall Study|Other|1|||
143300172|NCT01012622|516652036|FG000|Overall Study|screening failure|1|||
143300173|NCT01012622|516652036|FG000|Overall Study|withdrawal of consent by a parent|2|||
143300174|NCT04254978|516652037|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
143300175|NCT04254978|516652037|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
143300176|NCT04254978|516652037|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
143300177|NCT04254978|516652037|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
143300178|NCT04254978|516652037|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
143300179|NCT04254978|516652037|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
143300180|NCT02520011|516652038|FG000|Overall Study|Adverse Event|0|||
143300181|NCT02520011|516652039|FG001|Overall Study|Adverse Event|1|||
143300182|NCT02520011|516652040|FG002|Overall Study|Adverse Event|2|||
143300183|NCT02520011|516652038|FG000|Overall Study|Death|0|||
143300184|NCT02520011|516652039|FG001|Overall Study|Death|8|||
143300185|NCT02520011|516652040|FG002|Overall Study|Death|1|||
143300186|NCT02520011|516652038|FG000|Overall Study|Lack of Efficacy|4|||
143300187|NCT02520011|516652039|FG001|Overall Study|Lack of Efficacy|26|||
143300188|NCT02520011|516652040|FG002|Overall Study|Lack of Efficacy|4|||
143300189|NCT02520011|516652038|FG000|Overall Study|Physician Decision|0|||
143300190|NCT02520011|516652039|FG001|Overall Study|Physician Decision|2|||
143300191|NCT02520011|516652040|FG002|Overall Study|Physician Decision|0|||
143300192|NCT02520011|516652038|FG000|Overall Study|Withdrawal by Subject|1|||
143300193|NCT02520011|516652039|FG001|Overall Study|Withdrawal by Subject|3|||
143300194|NCT02520011|516652040|FG002|Overall Study|Withdrawal by Subject|0|||
143300195|NCT02520011|516652038|FG000|Overall Study|Protocol Deviation|0|||
143300196|NCT02520011|516652039|FG001|Overall Study|Protocol Deviation|1|||
143300197|NCT02520011|516652040|FG002|Overall Study|Protocol Deviation|0|||
143300198|NCT02520011|516652038|FG000|Overall Study|Patient went to hospice|0|||
143300199|NCT02520011|516652039|FG001|Overall Study|Patient went to hospice|1|||
143300200|NCT02520011|516652040|FG002|Overall Study|Patient went to hospice|0|||
143300201|NCT02520011|516652038|FG000|Overall Study|Progressive disease following response|0|||
143300202|NCT02520011|516652039|FG001|Overall Study|Progressive disease following response|4|||
143300203|NCT02520011|516652040|FG002|Overall Study|Progressive disease following response|2|||
143300204|NCT02515942|516652041|FG000|Overall Study|Adverse Event|5|||
143300205|NCT02515942|516652042|FG001|Overall Study|Adverse Event|0|||
143300206|NCT02515942|516652043|FG002|Overall Study|Adverse Event|0|||
143300207|NCT02515942|516652041|FG000|Overall Study|Death|0|||
143300208|NCT02515942|516652042|FG001|Overall Study|Death|0|||
143300209|NCT02515942|516652043|FG002|Overall Study|Death|1|||
143300210|NCT02515942|516652041|FG000|Overall Study|Lack of Efficacy|0|||
143300211|NCT02515942|516652042|FG001|Overall Study|Lack of Efficacy|0|||
143300212|NCT02515942|516652043|FG002|Overall Study|Lack of Efficacy|1|||
143300213|NCT02515942|516652041|FG000|Overall Study|Lost to Follow-up|2|||
143300214|NCT02515942|516652042|FG001|Overall Study|Lost to Follow-up|0|||
143300215|NCT02515942|516652043|FG002|Overall Study|Lost to Follow-up|0|||
143300216|NCT02515942|516652041|FG000|Overall Study|Withdrawal by Subject|0|||
143300217|NCT02515942|516652042|FG001|Overall Study|Withdrawal by Subject|3|||
143300218|NCT02515942|516652043|FG002|Overall Study|Withdrawal by Subject|2|||
143300219|NCT00277212|516652047|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
143300220|NCT00277212|516652048|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
143300221|NCT00277212|516652049|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
143300222|NCT00277212|516652047|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
143300223|NCT00277212|516652048|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
143300224|NCT00277212|516652049|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
143300225|NCT00277212|516652047|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
143300226|NCT00277212|516652048|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
143300227|NCT00277212|516652049|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
143300228|NCT00277212|516652047|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
143300229|NCT00277212|516652048|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
143300230|NCT00277212|516652049|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
143300231|NCT00277212|516652047|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
143300232|NCT00277212|516652048|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
143300233|NCT00277212|516652049|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
143300234|NCT00277212|516652047|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
143300235|NCT00277212|516652048|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
143300236|NCT00277212|516652049|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
143300237|NCT00277212|516652047|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
143300238|NCT00277212|516652048|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
143300239|NCT00277212|516652049|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
143300240|NCT00277212|516652047|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
143300241|NCT00277212|516652048|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
143300242|NCT00277212|516652049|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
143300243|NCT00277212|516652047|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
143300244|NCT00277212|516652048|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
143300245|NCT00277212|516652049|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
143300246|NCT00277212|516652047|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
143300247|NCT00277212|516652048|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
143300248|NCT00277212|516652049|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
143300249|NCT00277212|516652047|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
143300250|NCT00277212|516652048|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
143300251|NCT00277212|516652049|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
143300252|NCT00277212|516652047|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
143300253|NCT00277212|516652048|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
143300254|NCT00277212|516652049|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
143300255|NCT00277212|516652047|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
143300256|NCT00277212|516652048|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
143300257|NCT00277212|516652049|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
143300258|NCT00277212|516652047|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
143300259|NCT00277212|516652048|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
143300260|NCT00277212|516652049|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
143300261|NCT00277212|516652047|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
143300262|NCT00277212|516652048|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
143300263|NCT00277212|516652049|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
143300264|NCT00277212|516652047|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
143300265|NCT00277212|516652048|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
143300266|NCT00277212|516652049|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
143300267|NCT00277212|516652047|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
143300268|NCT00277212|516652048|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
143300269|NCT00277212|516652049|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
143300270|NCT00277212|516652047|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
143300271|NCT00277212|516652048|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
143300272|NCT00277212|516652049|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
143300273|NCT00902564|516652050|FG000|Overall Study|Withdrawal by Subject|2|||
143300274|NCT03336216|516652056|FG000|Randomization|Not reported|2|||
143300275|NCT03336216|516652057|FG001|Randomization|Not reported|0|||
143300276|NCT03336216|516652058|FG002|Randomization|Not reported|1|||
143300277|NCT03336216|516652059|FG003|Randomization|Not reported|0|||
143300278|NCT03336216|516652056|FG000|Randomization|Other reasons|1|||
143300279|NCT03336216|516652057|FG001|Randomization|Other reasons|1|||
143300280|NCT03336216|516652058|FG002|Randomization|Other reasons|1|||
143300281|NCT03336216|516652059|FG003|Randomization|Other reasons|0|||
143300282|NCT03336216|516652056|FG000|Randomization|Participant no longer meets study criteria|0|||
143300283|NCT03336216|516652057|FG001|Randomization|Participant no longer meets study criteria|2|||
143300284|NCT03336216|516652058|FG002|Randomization|Participant no longer meets study criteria|4|||
143300285|NCT03336216|516652059|FG003|Randomization|Participant no longer meets study criteria|1|||
143300286|NCT03336216|516652056|FG000|Randomization|Lost to Follow-up|1|||
143300287|NCT03336216|516652057|FG001|Randomization|Lost to Follow-up|0|||
143300288|NCT03336216|516652058|FG002|Randomization|Lost to Follow-up|0|||
143300289|NCT03336216|516652059|FG003|Randomization|Lost to Follow-up|0|||
143300290|NCT03336216|516652056|FG000|Randomization|Participant withdrew consent|9|||
143300291|NCT03336216|516652057|FG001|Randomization|Participant withdrew consent|1|||
143300292|NCT03336216|516652058|FG002|Randomization|Participant withdrew consent|0|||
143300293|NCT03336216|516652059|FG003|Randomization|Participant withdrew consent|0|||
143300294|NCT03336216|516652056|FG000|Randomization|Adverse Event|1|||
143300295|NCT03336216|516652057|FG001|Randomization|Adverse Event|1|||
143300296|NCT03336216|516652058|FG002|Randomization|Adverse Event|0|||
143300297|NCT03336216|516652059|FG003|Randomization|Adverse Event|0|||
143300298|NCT03336216|516652056|FG000|Treatment|Adverse Event|2|||
143300299|NCT03336216|516652057|FG001|Treatment|Adverse Event|3|||
143300300|NCT03336216|516652058|FG002|Treatment|Adverse Event|4|||
143374639|NCT02296424|516917248|FG002|Part 1|16 directly started part II|0|||
143374640|NCT02296424|516917249|FG003|Part 1|16 directly started part II|0|||
143374641|NCT02296424|516917246|FG000|Part 2|Lack of Efficacy|0|||
143374642|NCT02296424|516917247|FG001|Part 2|Lack of Efficacy|0|||
143374643|NCT02296424|516917248|FG002|Part 2|Lack of Efficacy|1|||
143374644|NCT02296424|516917249|FG003|Part 2|Lack of Efficacy|0|||
143374645|NCT02296424|516917246|FG000|Part 2|Adverse Event|0|||
143374646|NCT02296424|516917247|FG001|Part 2|Adverse Event|0|||
143374647|NCT02296424|516917248|FG002|Part 2|Adverse Event|1|||
143374648|NCT02296424|516917249|FG003|Part 2|Adverse Event|0|||
143374649|NCT02296424|516917246|FG000|Part 2|Lost to Follow-up|0|||
143374650|NCT02296424|516917247|FG001|Part 2|Lost to Follow-up|0|||
143374651|NCT02296424|516917248|FG002|Part 2|Lost to Follow-up|1|||
143300301|NCT03336216|516652059|FG003|Treatment|Adverse Event|4|||
143300302|NCT03336216|516652056|FG000|Treatment|Participant request to discontinue treatment|2|||
143300303|NCT03336216|516652057|FG001|Treatment|Participant request to discontinue treatment|1|||
143300304|NCT03336216|516652058|FG002|Treatment|Participant request to discontinue treatment|2|||
143300305|NCT03336216|516652059|FG003|Treatment|Participant request to discontinue treatment|2|||
143300306|NCT03336216|516652056|FG000|Treatment|Participant withdrew consent|7|||
143300307|NCT03336216|516652057|FG001|Treatment|Participant withdrew consent|2|||
143300308|NCT03336216|516652058|FG002|Treatment|Participant withdrew consent|3|||
143300309|NCT03336216|516652059|FG003|Treatment|Participant withdrew consent|2|||
143300310|NCT03336216|516652056|FG000|Treatment|Death|2|||
143374652|NCT02296424|516917249|FG003|Part 2|Lost to Follow-up|0|||
143300311|NCT03336216|516652057|FG001|Treatment|Death|3|||
143300312|NCT03336216|516652058|FG002|Treatment|Death|3|||
143374653|NCT00186186|516917250|FG000|Overall Study|Lack of Efficacy|3|||
143374654|NCT00186186|516917250|FG000|Overall Study|Withdrawal by Subject|3|||
143374655|NCT00186186|516917250|FG000|Overall Study|Not reported as to reason|2|||
143300313|NCT03336216|516652059|FG003|Treatment|Death|4|||
143300314|NCT03336216|516652056|FG000|Treatment|Participant no longer meets study criteria|0|||
143300315|NCT03336216|516652057|FG001|Treatment|Participant no longer meets study criteria|1|||
143300316|NCT03336216|516652058|FG002|Treatment|Participant no longer meets study criteria|0|||
143300317|NCT03336216|516652059|FG003|Treatment|Participant no longer meets study criteria|0|||
143300318|NCT03336216|516652056|FG000|Treatment|Other reasons|2|||
143300319|NCT03336216|516652057|FG001|Treatment|Other reasons|0|||
143374656|NCT00807144|516917251|FG000|Overall Study|Lost to Follow-up|0|||
143374657|NCT00807144|516917252|FG001|Overall Study|Lost to Follow-up|1|||
143300320|NCT03336216|516652058|FG002|Treatment|Other reasons|0|||
143300321|NCT03336216|516652059|FG003|Treatment|Other reasons|3|||
143300322|NCT03336216|516652056|FG000|Treatment|Disease progression|23|||
143300323|NCT03336216|516652057|FG001|Treatment|Disease progression|34|||
143300324|NCT03336216|516652058|FG002|Treatment|Disease progression|33|||
143300325|NCT03336216|516652059|FG003|Treatment|Disease progression|26|||
143300326|NCT03336216|516652056|FG000|Treatment|Study drug toxicity|0|||
143300327|NCT03336216|516652057|FG001|Treatment|Study drug toxicity|3|||
143300328|NCT03336216|516652058|FG002|Treatment|Study drug toxicity|2|||
143300329|NCT03336216|516652059|FG003|Treatment|Study drug toxicity|0|||
143300330|NCT03336216|516652056|FG000|Treatment|Adverse Event unrelated to study drug|1|||
143300331|NCT03336216|516652057|FG001|Treatment|Adverse Event unrelated to study drug|1|||
143300332|NCT03336216|516652058|FG002|Treatment|Adverse Event unrelated to study drug|1|||
143300333|NCT03336216|516652059|FG003|Treatment|Adverse Event unrelated to study drug|0|||
143300334|NCT03336216|516652056|FG000|Treatment|Disease Recurrence|1|||
143300335|NCT03336216|516652057|FG001|Treatment|Disease Recurrence|0|||
143300336|NCT03336216|516652058|FG002|Treatment|Disease Recurrence|0|||
143300337|NCT03336216|516652059|FG003|Treatment|Disease Recurrence|0|||
143300338|NCT03239470|516652060|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
143300339|NCT03239470|516652061|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
143300340|NCT00922766|516652062|FG000|Overall Study|Death|3|||
143300341|NCT00922766|516652062|FG000|Overall Study|Withdrawal by Subject|2|||
143300342|NCT00922766|516652062|FG000|Overall Study|Other|1|||
143300343|NCT00922766|516652062|FG000|Overall Study|Adverse Event|1|||
143300344|NCT02510794|516652068|FG000|Overall Study|Adverse Event|0|||
143300345|NCT02510794|516652069|FG001|Overall Study|Adverse Event|1|||
143300346|NCT02510794|516652070|FG002|Overall Study|Adverse Event|0|||
143300347|NCT02510794|516652071|FG003|Overall Study|Adverse Event|0|||
143300348|NCT02510794|516652068|FG000|Overall Study|Death|1|||
143300349|NCT02510794|516652069|FG001|Overall Study|Death|2|||
143300350|NCT02510794|516652070|FG002|Overall Study|Death|1|||
143300351|NCT02510794|516652071|FG003|Overall Study|Death|1|||
143300352|NCT02510794|516652068|FG000|Overall Study|Lack of Efficacy|3|||
143300353|NCT02510794|516652069|FG001|Overall Study|Lack of Efficacy|1|||
143300354|NCT02510794|516652070|FG002|Overall Study|Lack of Efficacy|1|||
143300355|NCT02510794|516652071|FG003|Overall Study|Lack of Efficacy|0|||
143300356|NCT02510794|516652068|FG000|Overall Study|Participant moved out of the area|0|||
143300357|NCT02510794|516652069|FG001|Overall Study|Participant moved out of the area|0|||
143300358|NCT02510794|516652070|FG002|Overall Study|Participant moved out of the area|0|||
143300359|NCT02510794|516652071|FG003|Overall Study|Participant moved out of the area|1|||
143300360|NCT02510794|516652068|FG000|Overall Study|Physician Decision|3|||
143300361|NCT02510794|516652069|FG001|Overall Study|Physician Decision|0|||
143300362|NCT02510794|516652070|FG002|Overall Study|Physician Decision|0|||
143300363|NCT02510794|516652071|FG003|Overall Study|Physician Decision|0|||
143300364|NCT02510794|516652068|FG000|Overall Study|Protocol Violation|0|||
143300365|NCT02510794|516652069|FG001|Overall Study|Protocol Violation|0|||
143300366|NCT02510794|516652070|FG002|Overall Study|Protocol Violation|1|||
143300367|NCT02510794|516652071|FG003|Overall Study|Protocol Violation|0|||
143300368|NCT02510794|516652068|FG000|Overall Study|Withdrawal by Subject|1|||
143300369|NCT02510794|516652069|FG001|Overall Study|Withdrawal by Subject|2|||
143300370|NCT02510794|516652070|FG002|Overall Study|Withdrawal by Subject|4|||
143300371|NCT02510794|516652071|FG003|Overall Study|Withdrawal by Subject|3|||
143300372|NCT01649375|516652072|FG000|Up to Week 16|Adverse Event|2|||
143300373|NCT01649375|516652073|FG001|Up to Week 16|Adverse Event|5|||
143300374|NCT01649375|516652074|FG002|Up to Week 16|Adverse Event|4|||
143300375|NCT01649375|516652075|FG003|Up to Week 16|Adverse Event|0|||
143300376|NCT01649375|516652076|FG004|Up to Week 16|Adverse Event|0|||
143300377|NCT01649375|516652072|FG000|Up to Week 16|Lack of Efficacy|0|||
143300378|NCT01649375|516652073|FG001|Up to Week 16|Lack of Efficacy|0|||
143300379|NCT01649375|516652074|FG002|Up to Week 16|Lack of Efficacy|1|||
143300380|NCT01649375|516652075|FG003|Up to Week 16|Lack of Efficacy|0|||
143300381|NCT01649375|516652076|FG004|Up to Week 16|Lack of Efficacy|0|||
143374658|NCT01113931|516917255|FG000|Overall Study|Adverse Event|2|||
143300382|NCT01649375|516652072|FG000|Up to Week 16|Physician Decision|0|||
143300383|NCT01649375|516652073|FG001|Up to Week 16|Physician Decision|0|||
143300384|NCT01649375|516652074|FG002|Up to Week 16|Physician Decision|1|||
143300385|NCT01649375|516652075|FG003|Up to Week 16|Physician Decision|0|||
143300386|NCT01649375|516652076|FG004|Up to Week 16|Physician Decision|0|||
143300387|NCT01649375|516652072|FG000|Up to Week 16|Withdrawal by Subject|2|||
143300388|NCT01649375|516652073|FG001|Up to Week 16|Withdrawal by Subject|1|||
143300389|NCT01649375|516652074|FG002|Up to Week 16|Withdrawal by Subject|2|||
143300390|NCT01649375|516652075|FG003|Up to Week 16|Withdrawal by Subject|0|||
143300391|NCT01649375|516652076|FG004|Up to Week 16|Withdrawal by Subject|0|||
143300392|NCT01649375|516652072|FG000|Up to Week 16|Death|1|||
143300393|NCT01649375|516652073|FG001|Up to Week 16|Death|0|||
143300394|NCT01649375|516652074|FG002|Up to Week 16|Death|0|||
143300395|NCT01649375|516652075|FG003|Up to Week 16|Death|0|||
143300396|NCT01649375|516652076|FG004|Up to Week 16|Death|0|||
143300397|NCT01649375|516652072|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
143300398|NCT01649375|516652073|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
143300399|NCT01649375|516652074|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
143300400|NCT01649375|516652075|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
143300401|NCT01649375|516652076|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
143300402|NCT01649375|516652072|FG000|Week 16 up to Week 260|Non-compliance|0|||
143300403|NCT01649375|516652073|FG001|Week 16 up to Week 260|Non-compliance|1|||
143300404|NCT01649375|516652074|FG002|Week 16 up to Week 260|Non-compliance|0|||
143300405|NCT01649375|516652075|FG003|Week 16 up to Week 260|Non-compliance|1|||
143300406|NCT01649375|516652076|FG004|Week 16 up to Week 260|Non-compliance|0|||
143300407|NCT01649375|516652072|FG000|Week 16 up to Week 260|Physician Decision|0|||
143300408|NCT01649375|516652073|FG001|Week 16 up to Week 260|Physician Decision|2|||
143300409|NCT01649375|516652074|FG002|Week 16 up to Week 260|Physician Decision|0|||
143300410|NCT01649375|516652075|FG003|Week 16 up to Week 260|Physician Decision|0|||
143300411|NCT01649375|516652076|FG004|Week 16 up to Week 260|Physician Decision|0|||
143300412|NCT01649375|516652072|FG000|Week 16 up to Week 260|Technical issues|0|||
143300413|NCT01649375|516652073|FG001|Week 16 up to Week 260|Technical issues|1|||
143300414|NCT01649375|516652074|FG002|Week 16 up to Week 260|Technical issues|0|||
143300415|NCT01649375|516652075|FG003|Week 16 up to Week 260|Technical issues|1|||
143300416|NCT01649375|516652076|FG004|Week 16 up to Week 260|Technical issues|0|||
143300417|NCT01649375|516652072|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
143300418|NCT01649375|516652073|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
143300419|NCT01649375|516652074|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
143300420|NCT01649375|516652075|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
143300421|NCT01649375|516652076|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
143300422|NCT01649375|516652072|FG000|Week 16 up to Week 260|Death|1|||
143300423|NCT01649375|516652073|FG001|Week 16 up to Week 260|Death|1|||
143300424|NCT01649375|516652074|FG002|Week 16 up to Week 260|Death|0|||
143300425|NCT01649375|516652075|FG003|Week 16 up to Week 260|Death|0|||
143300426|NCT01649375|516652076|FG004|Week 16 up to Week 260|Death|0|||
143300427|NCT01649375|516652072|FG000|Week 16 up to Week 260|Adverse Event|5|||
143300428|NCT01649375|516652073|FG001|Week 16 up to Week 260|Adverse Event|2|||
143300429|NCT01649375|516652074|FG002|Week 16 up to Week 260|Adverse Event|0|||
143300430|NCT01649375|516652075|FG003|Week 16 up to Week 260|Adverse Event|3|||
143300431|NCT01649375|516652076|FG004|Week 16 up to Week 260|Adverse Event|2|||
143300432|NCT01124604|516652077|FG000|Overall Study|Adverse Event|10|||
143300433|NCT01124604|516652078|FG001|Overall Study|Adverse Event|1|||
143300434|NCT01124604|516652077|FG000|Overall Study|Lack of Efficacy|1|||
143300435|NCT01124604|516652078|FG001|Overall Study|Lack of Efficacy|0|||
143300436|NCT01124604|516652077|FG000|Overall Study|Withdrawal by Subject|4|||
143300437|NCT01124604|516652078|FG001|Overall Study|Withdrawal by Subject|0|||
143300438|NCT01124604|516652077|FG000|Overall Study|Disease Progression|0|||
143300439|NCT01124604|516652078|FG001|Overall Study|Disease Progression|1|||
143300440|NCT02066467|516652081|FG000|Overall Study|Did not undergo implant procedure|24|||
143300441|NCT02066467|516652081|FG000|Overall Study|Attempted to implant withoput success|43|||
143300442|NCT02066467|516652081|FG000|Overall Study|Consent ineligible|1|||
143300443|NCT02066467|516652081|FG000|Overall Study|Death|54|||
143300444|NCT02066467|516652081|FG000|Overall Study|Lost to Follow-up|51|||
143300445|NCT02066467|516652081|FG000|Overall Study|Adverse Event|20|||
143300446|NCT02066467|516652081|FG000|Overall Study|Withdrawal by Subject|16|||
143300447|NCT02066467|516652081|FG000|Overall Study|Physician Decision|2|||
143300448|NCT02066467|516652081|FG000|Overall Study|Not defined|4|||
143300449|NCT01316276|516652082|FG000|Overall Study|Death|1|||
143300450|NCT01316276|516652082|FG000|Overall Study|Adverse Event|19|||
143300451|NCT01316276|516652082|FG000|Overall Study|Withdrawal of consent|24|||
143300452|NCT01316276|516652082|FG000|Overall Study|Lost to Follow-up|1|||
143300453|NCT01316276|516652082|FG000|Overall Study|Other|22|||
143374659|NCT01113931|516917256|FG001|Overall Study|Adverse Event|2|||
143374660|NCT01113931|516917255|FG000|Overall Study|Physician Decision|0|||
143374661|NCT01113931|516917256|FG001|Overall Study|Physician Decision|2|||
143300454|NCT02596854|516652083|FG000|Overall Study|Withdrawn|8|||
143300455|NCT05352815|516652084|FG000|Overall Study|Withdrawal by Subject|28|||
143300456|NCT05352815|516652085|FG001|Overall Study|Withdrawal by Subject|24|||
143300457|NCT05352815|516652084|FG000|Overall Study|Lost to Follow-up|4|||
143300458|NCT05352815|516652085|FG001|Overall Study|Lost to Follow-up|7|||
143300459|NCT05352815|516652084|FG000|Overall Study|Death|2|||
143300460|NCT05352815|516652085|FG001|Overall Study|Death|3|||
143300461|NCT05352815|516652084|FG000|Overall Study|Site closure|1|||
143300462|NCT05352815|516652085|FG001|Overall Study|Site closure|0|||
143300463|NCT02759120|516652088|FG000|Overall Study|Death|34|||
143300464|NCT02759120|516652089|FG001|Overall Study|Death|36|||
143300465|NCT02759120|516652088|FG000|Overall Study|Lost to Follow-up|4|||
143300466|NCT02759120|516652089|FG001|Overall Study|Lost to Follow-up|7|||
143300467|NCT02759120|516652088|FG000|Overall Study|Physician Decision|3|||
143300468|NCT02759120|516652089|FG001|Overall Study|Physician Decision|0|||
143300469|NCT02759120|516652088|FG000|Overall Study|Withdrawal by Subject|28|||
143300470|NCT02759120|516652089|FG001|Overall Study|Withdrawal by Subject|15|||
143300471|NCT02759120|516652088|FG000|Overall Study|Moved out of area|3|||
143300472|NCT02759120|516652089|FG001|Overall Study|Moved out of area|4|||
143300473|NCT02759120|516652088|FG000|Overall Study|Lung transplant|3|||
143300474|NCT02759120|516652089|FG001|Overall Study|Lung transplant|5|||
143300475|NCT02759120|516652088|FG000|Overall Study|Other reason not completed|10|||
143300476|NCT02759120|516652089|FG001|Overall Study|Other reason not completed|12|||
143300477|NCT00464568|516652092|FG000|Overall Study|Adverse Event|2|||
143300478|NCT00507442|516652095|FG000|Overall Study|Adverse Event|8|||
143300479|NCT00507442|516652096|FG001|Overall Study|Adverse Event|11|||
143300480|NCT00507442|516652097|FG002|Overall Study|Adverse Event|4|||
143300481|NCT00507442|516652098|FG003|Overall Study|Adverse Event|1|||
143300482|NCT00507442|516652095|FG000|Overall Study|Protocol Violation|0|||
143300483|NCT00507442|516652096|FG001|Overall Study|Protocol Violation|1|||
143300484|NCT00507442|516652097|FG002|Overall Study|Protocol Violation|0|||
143300485|NCT00507442|516652098|FG003|Overall Study|Protocol Violation|0|||
143300486|NCT00507442|516652095|FG000|Overall Study|Lost to Follow-up|0|||
143300487|NCT00507442|516652096|FG001|Overall Study|Lost to Follow-up|0|||
143300488|NCT00507442|516652097|FG002|Overall Study|Lost to Follow-up|1|||
143300489|NCT00507442|516652098|FG003|Overall Study|Lost to Follow-up|0|||
143300490|NCT00507442|516652095|FG000|Overall Study|Physician Decision|0|||
143300491|NCT00507442|516652096|FG001|Overall Study|Physician Decision|2|||
143300492|NCT00507442|516652097|FG002|Overall Study|Physician Decision|4|||
143300493|NCT00507442|516652098|FG003|Overall Study|Physician Decision|1|||
143300494|NCT00507442|516652095|FG000|Overall Study|Progressive Disease|2|||
143300495|NCT00507442|516652096|FG001|Overall Study|Progressive Disease|4|||
143300496|NCT00507442|516652097|FG002|Overall Study|Progressive Disease|2|||
143300497|NCT00507442|516652098|FG003|Overall Study|Progressive Disease|0|||
143300498|NCT00507442|516652095|FG000|Overall Study|Withdrawal by Subject|4|||
143300499|NCT00507442|516652096|FG001|Overall Study|Withdrawal by Subject|4|||
143300500|NCT00507442|516652097|FG002|Overall Study|Withdrawal by Subject|2|||
143300501|NCT00507442|516652098|FG003|Overall Study|Withdrawal by Subject|1|||
143300502|NCT00507442|516652095|FG000|Overall Study|Other|2|||
143300503|NCT00507442|516652096|FG001|Overall Study|Other|5|||
143300504|NCT00507442|516652097|FG002|Overall Study|Other|2|||
143300505|NCT00507442|516652098|FG003|Overall Study|Other|2|||
143300506|NCT02672423|516652099|FG000|Period 1|Adverse Event|0|||
143300507|NCT02672423|516652100|FG001|Period 1|Adverse Event|0|||
143300508|NCT02672423|516652101|FG002|Period 1|Adverse Event|0|||
143300509|NCT02672423|516652102|FG003|Period 1|Adverse Event|0|||
143300510|NCT02672423|516652103|FG004|Period 1|Adverse Event|1|||
143300511|NCT02672423|516652104|FG005|Period 1|Adverse Event|0|||
143300512|NCT02672423|516652105|FG006|Period 1|Adverse Event|0|||
143300513|NCT02672423|516652106|FG007|Period 1|Adverse Event|0|||
143300514|NCT02672423|516652107|FG008|Period 1|Adverse Event|0|||
143300515|NCT02672423|516652108|FG009|Period 1|Adverse Event|0|||
143300516|NCT02672423|516652099|FG000|Period 2|Withdrawal by Subject|0|||
143300517|NCT02672423|516652100|FG001|Period 2|Withdrawal by Subject|0|||
143300518|NCT02672423|516652101|FG002|Period 2|Withdrawal by Subject|1|||
143300519|NCT02672423|516652102|FG003|Period 2|Withdrawal by Subject|0|||
143300520|NCT02672423|516652103|FG004|Period 2|Withdrawal by Subject|0|||
143300521|NCT02672423|516652104|FG005|Period 2|Withdrawal by Subject|0|||
143300522|NCT02672423|516652105|FG006|Period 2|Withdrawal by Subject|0|||
143300523|NCT02672423|516652106|FG007|Period 2|Withdrawal by Subject|0|||
143300524|NCT02672423|516652107|FG008|Period 2|Withdrawal by Subject|0|||
143300525|NCT02672423|516652108|FG009|Period 2|Withdrawal by Subject|0|||
143300526|NCT02672423|516652099|FG000|Period 3|Withdrawal by Subject|0|||
143300527|NCT02672423|516652100|FG001|Period 3|Withdrawal by Subject|0|||
143300528|NCT02672423|516652101|FG002|Period 3|Withdrawal by Subject|0|||
143300529|NCT02672423|516652102|FG003|Period 3|Withdrawal by Subject|0|||
143300530|NCT02672423|516652103|FG004|Period 3|Withdrawal by Subject|0|||
143300531|NCT02672423|516652104|FG005|Period 3|Withdrawal by Subject|0|||
143300532|NCT02672423|516652105|FG006|Period 3|Withdrawal by Subject|0|||
143300533|NCT02672423|516652106|FG007|Period 3|Withdrawal by Subject|1|||
143300534|NCT02672423|516652107|FG008|Period 3|Withdrawal by Subject|0|||
143300535|NCT02672423|516652108|FG009|Period 3|Withdrawal by Subject|0|||
143300536|NCT02672423|516652099|FG000|Period 3|Physician Decision|0|||
143300537|NCT02672423|516652100|FG001|Period 3|Physician Decision|0|||
143300538|NCT02672423|516652101|FG002|Period 3|Physician Decision|0|||
143300539|NCT02672423|516652102|FG003|Period 3|Physician Decision|0|||
143300540|NCT02672423|516652103|FG004|Period 3|Physician Decision|0|||
143300541|NCT02672423|516652104|FG005|Period 3|Physician Decision|1|||
143300542|NCT02672423|516652105|FG006|Period 3|Physician Decision|0|||
143300543|NCT02672423|516652106|FG007|Period 3|Physician Decision|0|||
143300544|NCT02672423|516652107|FG008|Period 3|Physician Decision|0|||
143300545|NCT02672423|516652108|FG009|Period 3|Physician Decision|0|||
143300546|NCT00885755|516652119|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
143300547|NCT00885755|516652120|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
143300548|NCT00885755|516652121|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
143300549|NCT00885755|516652119|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
143300550|NCT00885755|516652120|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
143300551|NCT00885755|516652121|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
143300552|NCT00885755|516652119|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
143300553|NCT00885755|516652120|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
143300554|NCT00885755|516652121|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
143300555|NCT00885755|516652119|FG000|Part I: Trastuzumab+Taxane|Death|0|||
143300556|NCT00885755|516652120|FG001|Part I: Trastuzumab+Taxane|Death|0|||
143300557|NCT00885755|516652121|FG002|Part I: Trastuzumab+Taxane|Death|1|||
143300558|NCT00885755|516652119|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
143300559|NCT00885755|516652120|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
143300560|NCT00885755|516652121|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
143300561|NCT04343521|516652122|FG000|Overall Study|Adverse Event|0|||
143300562|NCT04343521|516652123|FG001|Overall Study|Adverse Event|2|||
143300563|NCT04343521|516652122|FG000|Overall Study|Death|1|||
143300564|NCT04343521|516652123|FG001|Overall Study|Death|2|||
143300565|NCT04343521|516652122|FG000|Overall Study|Lost to follow-up due to moving from the cluster|327|||
143300566|NCT04343521|516652123|FG001|Overall Study|Lost to follow-up due to moving from the cluster|393|||
143300567|NCT04343521|516652122|FG000|Overall Study|Withdrawal by Subject|70|||
143300568|NCT04343521|516652123|FG001|Overall Study|Withdrawal by Subject|95|||
143300569|NCT04343521|516652122|FG000|Overall Study|Withdrawal by study team|6|||
143300570|NCT04343521|516652123|FG001|Overall Study|Withdrawal by study team|12|||
143300571|NCT02939560|516652129|FG000|Overall Study|Withdrawal by Subject|2|||
143300572|NCT02939560|516652129|FG000|Overall Study|Protocol Violation|1|||
143300573|NCT03340025|516652130|FG000|Overall Study|Lost to Follow-up|2|||
143300574|NCT03340025|516652131|FG001|Overall Study|Lost to Follow-up|2|||
143300575|NCT02420691|516652134|FG000|Overall Study|Adverse Event|3|||
143300576|NCT02420691|516652134|FG000|Overall Study|Withdrawal by Subject|3|||
143300577|NCT03897179|516652137|FG000|Overall Study|Withdrawal by Subject|1|||
143300578|NCT00704535|516652138|FG000|Overall Study|Adverse Event|2|||
143300579|NCT00704535|516652138|FG000|Overall Study|Death|2|||
143300580|NCT00704535|516652138|FG000|Overall Study|Lost to Follow-up|8|||
143300581|NCT00704535|516652138|FG000|Overall Study|Protocol Violation|10|||
143300582|NCT00704535|516652138|FG000|Overall Study|Completed status not on Case Report Form|124|||
143300583|NCT05694546|516652140|FG000|Overall Study|Lost to Follow-up|11|||
143300584|NCT02424383|516652141|FG000|Overall Study|Withdrawal by Subject|32|||
143300585|NCT02424383|516652141|FG000|Overall Study|Death|170|||
143300586|NCT02424383|516652141|FG000|Overall Study|Sponsor's decision|3|||
143300587|NCT02424383|516652141|FG000|Overall Study|Investigator's decision|44|||
143300588|NCT02424383|516652141|FG000|Overall Study|Lost to Follow-up|81|||
143300589|NCT02424383|516652141|FG000|Overall Study|Other|7|||
143300590|NCT02424383|516652141|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
143300591|NCT01251380|516652145|FG000|Overall Study|Other (Not otherwise specified)|12|||
143300592|NCT01251380|516652145|FG000|Overall Study|Withdrawal by Subject|6|||
143300593|NCT01251380|516652145|FG000|Overall Study|Lack of Efficacy|1|||
143300594|NCT01251380|516652145|FG000|Overall Study|Adverse Event|1|||
143300595|NCT01251380|516652145|FG000|Overall Study|Lost to Follow-up|2|||
143300596|NCT01154218|516652146|FG000|Third Intervention Period|Adverse Event|0|||
143300597|NCT01154218|516652147|FG001|Third Intervention Period|Adverse Event|1|||
143300598|NCT01154218|516652148|FG002|Third Intervention Period|Adverse Event|0|||
143300599|NCT01154218|516652149|FG003|Third Intervention Period|Adverse Event|0|||
143300600|NCT01154218|516652146|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
143300601|NCT01154218|516652147|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
143300602|NCT01154218|516652148|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
143300603|NCT01154218|516652149|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
143300604|NCT01154218|516652146|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
143300605|NCT01154218|516652147|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
143300606|NCT01154218|516652148|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
143300607|NCT01154218|516652149|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
143300608|NCT00362115|516652152|FG000|Overall Study|Adverse Event|0|||
143300609|NCT00362115|516652153|FG001|Overall Study|Adverse Event|1|||
143300610|NCT00362115|516652154|FG002|Overall Study|Adverse Event|1|||
143300611|NCT00362115|516652155|FG003|Overall Study|Adverse Event|1|||
143300612|NCT00362115|516652156|FG004|Overall Study|Adverse Event|2|||
143300613|NCT00362115|516652157|FG005|Overall Study|Adverse Event|2|||
143300614|NCT00362115|516652158|FG006|Overall Study|Adverse Event|1|||
143300615|NCT00362115|516652152|FG000|Overall Study|Protocol Violation|0|||
143300616|NCT00362115|516652153|FG001|Overall Study|Protocol Violation|0|||
143300617|NCT00362115|516652154|FG002|Overall Study|Protocol Violation|0|||
143300618|NCT00362115|516652155|FG003|Overall Study|Protocol Violation|0|||
143300619|NCT00362115|516652156|FG004|Overall Study|Protocol Violation|0|||
143300620|NCT00362115|516652157|FG005|Overall Study|Protocol Violation|1|||
143300621|NCT00362115|516652158|FG006|Overall Study|Protocol Violation|0|||
143300622|NCT00362115|516652152|FG000|Overall Study|Lost to Follow-up|0|||
143300623|NCT00362115|516652153|FG001|Overall Study|Lost to Follow-up|1|||
143300624|NCT00362115|516652154|FG002|Overall Study|Lost to Follow-up|0|||
143300625|NCT00362115|516652155|FG003|Overall Study|Lost to Follow-up|0|||
143300626|NCT00362115|516652156|FG004|Overall Study|Lost to Follow-up|2|||
143300627|NCT00362115|516652157|FG005|Overall Study|Lost to Follow-up|0|||
143300628|NCT00362115|516652158|FG006|Overall Study|Lost to Follow-up|1|||
143300629|NCT00362115|516652152|FG000|Overall Study|Withdrawal by Subject|1|||
143300630|NCT00362115|516652153|FG001|Overall Study|Withdrawal by Subject|3|||
143300631|NCT00362115|516652154|FG002|Overall Study|Withdrawal by Subject|1|||
143300632|NCT00362115|516652155|FG003|Overall Study|Withdrawal by Subject|0|||
143300633|NCT00362115|516652156|FG004|Overall Study|Withdrawal by Subject|1|||
143300634|NCT00362115|516652157|FG005|Overall Study|Withdrawal by Subject|3|||
143300635|NCT00362115|516652158|FG006|Overall Study|Withdrawal by Subject|4|||
143300636|NCT00362115|516652152|FG000|Overall Study|Lack of Efficacy|1|||
143300637|NCT00362115|516652153|FG001|Overall Study|Lack of Efficacy|0|||
143300638|NCT00362115|516652154|FG002|Overall Study|Lack of Efficacy|5|||
143300639|NCT00362115|516652155|FG003|Overall Study|Lack of Efficacy|2|||
143300640|NCT00362115|516652156|FG004|Overall Study|Lack of Efficacy|2|||
143300641|NCT00362115|516652157|FG005|Overall Study|Lack of Efficacy|0|||
143300642|NCT00362115|516652158|FG006|Overall Study|Lack of Efficacy|3|||
143300643|NCT00362115|516652152|FG000|Overall Study|Physician Decision|0|||
143300644|NCT00362115|516652153|FG001|Overall Study|Physician Decision|0|||
143300645|NCT00362115|516652154|FG002|Overall Study|Physician Decision|0|||
143300646|NCT00362115|516652155|FG003|Overall Study|Physician Decision|0|||
143300647|NCT00362115|516652156|FG004|Overall Study|Physician Decision|0|||
143300648|NCT00362115|516652157|FG005|Overall Study|Physician Decision|0|||
143300649|NCT00362115|516652158|FG006|Overall Study|Physician Decision|3|||
143300650|NCT00362115|516652152|FG000|Overall Study|Other|0|||
143300651|NCT00362115|516652153|FG001|Overall Study|Other|1|||
143300652|NCT00362115|516652154|FG002|Overall Study|Other|0|||
143300653|NCT00362115|516652155|FG003|Overall Study|Other|1|||
143300654|NCT00362115|516652156|FG004|Overall Study|Other|0|||
143300655|NCT00362115|516652157|FG005|Overall Study|Other|1|||
143300656|NCT00362115|516652158|FG006|Overall Study|Other|0|||
143300657|NCT00567892|516652163|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
143300658|NCT00567892|516652164|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
143300659|NCT00567892|516652165|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
143300660|NCT00567892|516652166|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
143300661|NCT00567892|516652163|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
143300662|NCT00567892|516652164|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
143300663|NCT00567892|516652165|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
143300664|NCT00567892|516652166|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
143300665|NCT00699972|516653947|FG000|Overall Study|Adverse Event|7|||
143300666|NCT00699972|516653948|FG001|Overall Study|Adverse Event|9|||
143300667|NCT00699972|516653949|FG002|Overall Study|Adverse Event|24|||
143300668|NCT00699972|516653947|FG000|Overall Study|Lost to Follow-up|0|||
143300669|NCT00699972|516653948|FG001|Overall Study|Lost to Follow-up|2|||
143300670|NCT00699972|516653949|FG002|Overall Study|Lost to Follow-up|0|||
143300671|NCT00699972|516653947|FG000|Overall Study|Withdrawal by Subject|3|||
143300672|NCT00699972|516653948|FG001|Overall Study|Withdrawal by Subject|7|||
143300673|NCT00699972|516653949|FG002|Overall Study|Withdrawal by Subject|4|||
143300674|NCT00699972|516653947|FG000|Overall Study|Lack of Efficacy|2|||
143300675|NCT00699972|516653948|FG001|Overall Study|Lack of Efficacy|0|||
143300676|NCT00699972|516653949|FG002|Overall Study|Lack of Efficacy|2|||
143300677|NCT00699972|516653947|FG000|Overall Study|Administrative/Other|3|||
143300678|NCT00699972|516653948|FG001|Overall Study|Administrative/Other|1|||
143300679|NCT00699972|516653949|FG002|Overall Study|Administrative/Other|4|||
143300680|NCT00699972|516653947|FG000|Overall Study|Randomized, Not Treated|1|||
143300681|NCT00699972|516653948|FG001|Overall Study|Randomized, Not Treated|0|||
143300682|NCT00699972|516653949|FG002|Overall Study|Randomized, Not Treated|1|||
143300683|NCT02268409|516653950|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
143300684|NCT02268409|516653950|FG000|Overall Study|Death|1|||
143300685|NCT02268409|516653950|FG000|Overall Study|Lost to Follow-up|1|||
143300686|NCT02268409|516653950|FG000|Overall Study|Protocol Violation|3|||
143300687|NCT02268409|516653950|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
143300688|NCT02268409|516653950|FG000|Overall Study|Withdrawal by Subject|5|||
143300689|NCT04865354|516653953|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
143300690|NCT04865354|516653954|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
143300691|NCT04865354|516653953|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
143300692|NCT04865354|516653954|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
143300693|NCT04865354|516653953|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
143300694|NCT04865354|516653954|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
143300695|NCT03873987|516653955|FG000|Overall Study|Adverse Event|1|||
143300696|NCT03873987|516653956|FG001|Overall Study|Adverse Event|0|||
143300697|NCT03873987|516653955|FG000|Overall Study|staff was unable to start a new IV line|1|||
143300698|NCT03873987|516653956|FG001|Overall Study|staff was unable to start a new IV line|0|||
143300699|NCT03873987|516653955|FG000|Overall Study|Lost to Follow-up|0|||
143300700|NCT03873987|516653956|FG001|Overall Study|Lost to Follow-up|1|||
143300701|NCT01465022|516653957|FG000|Overall Study|Lost to Follow-up|15|||
143300702|NCT01465022|516653958|FG001|Overall Study|Lost to Follow-up|14|||
143300703|NCT01465022|516653959|FG002|Overall Study|Lost to Follow-up|0|||
143300704|NCT01465022|516653957|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
143300705|NCT01465022|516653958|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
143300706|NCT01465022|516653959|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
143300707|NCT01465022|516653957|FG000|Overall Study|Not Randomized|0|||
143300708|NCT01465022|516653958|FG001|Overall Study|Not Randomized|0|||
143300709|NCT01465022|516653959|FG002|Overall Study|Not Randomized|70|||
143300710|NCT00666757|516653962|FG000|Overall Study|Lost to Follow-up|39|||
143300711|NCT00666757|516653963|FG001|Overall Study|Lost to Follow-up|35|||
143300712|NCT00666757|516653962|FG000|Overall Study|Protocol Violation|23|||
143300713|NCT00666757|516653963|FG001|Overall Study|Protocol Violation|24|||
143300714|NCT00666757|516653962|FG000|Overall Study|Adverse Event|22|||
143300715|NCT00666757|516653963|FG001|Overall Study|Adverse Event|12|||
143300716|NCT00666757|516653962|FG000|Overall Study|Withdrawal by Subject|13|||
143300717|NCT00666757|516653963|FG001|Overall Study|Withdrawal by Subject|17|||
143300718|NCT00666757|516653962|FG000|Overall Study|Lack of Efficacy|3|||
143300719|NCT00666757|516653963|FG001|Overall Study|Lack of Efficacy|6|||
143300720|NCT00666757|516653962|FG000|Overall Study|Physician Decision|0|||
143300721|NCT00666757|516653963|FG001|Overall Study|Physician Decision|2|||
143300722|NCT00666757|516653962|FG000|Overall Study|Sponsor decision|0|||
143300723|NCT00666757|516653963|FG001|Overall Study|Sponsor decision|1|||
143300724|NCT01231581|516653964|FG000|Overall Study|Lost to Follow-up|2|||
143300725|NCT01231581|516653965|FG001|Overall Study|Lost to Follow-up|2|||
143300726|NCT01231581|516653964|FG000|Overall Study|Withdrawal by Subject|6|||
143300727|NCT01231581|516653965|FG001|Overall Study|Withdrawal by Subject|9|||
143300728|NCT01231581|516653964|FG000|Overall Study|Study Closed/Terminated|6|||
143300729|NCT01231581|516653965|FG001|Overall Study|Study Closed/Terminated|5|||
143300730|NCT01231581|516653964|FG000|Overall Study|Death|65|||
143300731|NCT01231581|516653965|FG001|Overall Study|Death|64|||
143300732|NCT01231581|516653964|FG000|Overall Study|Ongoing|1|||
143300733|NCT01231581|516653965|FG001|Overall Study|Ongoing|0|||
143300734|NCT05954052|516653966|FG000|Overall Study|Adverse Event|1|||
143300735|NCT01957462|516653967|FG000|Test Period 1|Withdrawal by Subject|1|||
143300736|NCT01957462|516653968|FG001|Test Period 1|Withdrawal by Subject|0|||
143300737|NCT01957462|516653967|FG000|Test Period 1|Adverse Event|1|||
143300738|NCT01957462|516653968|FG001|Test Period 1|Adverse Event|0|||
143300739|NCT03616912|516653969|FG000|Overall Study|Adverse Event|17|||
143300740|NCT03616912|516653970|FG001|Overall Study|Adverse Event|21|||
143300741|NCT03616912|516653971|FG002|Overall Study|Adverse Event|9|||
143300742|NCT03616912|516653972|FG003|Overall Study|Adverse Event|0|||
143300743|NCT03616912|516653973|FG004|Overall Study|Adverse Event|0|||
143300744|NCT03616912|516653974|FG005|Overall Study|Adverse Event|0|||
143374662|NCT01113931|516917255|FG000|Overall Study|Lost to Follow-up|12|||
143300745|NCT03616912|516653969|FG000|Overall Study|Death|1|||
143300746|NCT03616912|516653970|FG001|Overall Study|Death|1|||
143300747|NCT03616912|516653971|FG002|Overall Study|Death|0|||
143300748|NCT03616912|516653972|FG003|Overall Study|Death|0|||
143300749|NCT03616912|516653973|FG004|Overall Study|Death|0|||
143300750|NCT03616912|516653974|FG005|Overall Study|Death|0|||
143300751|NCT03616912|516653969|FG000|Overall Study|Lack of Efficacy|13|||
143300752|NCT03616912|516653970|FG001|Overall Study|Lack of Efficacy|6|||
143300753|NCT03616912|516653971|FG002|Overall Study|Lack of Efficacy|8|||
143300754|NCT03616912|516653972|FG003|Overall Study|Lack of Efficacy|4|||
143300755|NCT03616912|516653973|FG004|Overall Study|Lack of Efficacy|5|||
143300756|NCT03616912|516653974|FG005|Overall Study|Lack of Efficacy|1|||
143300757|NCT03616912|516653969|FG000|Overall Study|Lost to Follow-up|1|||
143300758|NCT03616912|516653970|FG001|Overall Study|Lost to Follow-up|2|||
143300759|NCT03616912|516653971|FG002|Overall Study|Lost to Follow-up|3|||
143300760|NCT03616912|516653972|FG003|Overall Study|Lost to Follow-up|0|||
143300761|NCT03616912|516653973|FG004|Overall Study|Lost to Follow-up|0|||
143300762|NCT03616912|516653974|FG005|Overall Study|Lost to Follow-up|0|||
143300763|NCT03616912|516653969|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
143300764|NCT03616912|516653970|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
143300765|NCT03616912|516653971|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
143300766|NCT03616912|516653972|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
143300767|NCT03616912|516653973|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
143300768|NCT03616912|516653974|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
143300769|NCT03616912|516653969|FG000|Overall Study|Withdrawal by Subject|12|||
143300770|NCT03616912|516653970|FG001|Overall Study|Withdrawal by Subject|12|||
143300771|NCT03616912|516653971|FG002|Overall Study|Withdrawal by Subject|15|||
143300772|NCT03616912|516653972|FG003|Overall Study|Withdrawal by Subject|2|||
143300773|NCT03616912|516653973|FG004|Overall Study|Withdrawal by Subject|0|||
143300774|NCT03616912|516653974|FG005|Overall Study|Withdrawal by Subject|2|||
143300775|NCT03616912|516653969|FG000|Overall Study|Study Terminated by Sponsor|0|||
143300776|NCT03616912|516653970|FG001|Overall Study|Study Terminated by Sponsor|0|||
143300777|NCT03616912|516653971|FG002|Overall Study|Study Terminated by Sponsor|0|||
143300778|NCT03616912|516653972|FG003|Overall Study|Study Terminated by Sponsor|10|||
143300779|NCT03616912|516653973|FG004|Overall Study|Study Terminated by Sponsor|9|||
143300780|NCT03616912|516653974|FG005|Overall Study|Study Terminated by Sponsor|11|||
143300781|NCT03616912|516653969|FG000|Overall Study|Protocol Deviation|1|||
143300782|NCT03616912|516653970|FG001|Overall Study|Protocol Deviation|1|||
143300783|NCT03616912|516653971|FG002|Overall Study|Protocol Deviation|0|||
143300784|NCT03616912|516653972|FG003|Overall Study|Protocol Deviation|0|||
143300785|NCT03616912|516653973|FG004|Overall Study|Protocol Deviation|0|||
143300786|NCT03616912|516653974|FG005|Overall Study|Protocol Deviation|0|||
143300787|NCT03616912|516653969|FG000|Overall Study|Pregnancy|1|||
143300788|NCT03616912|516653970|FG001|Overall Study|Pregnancy|0|||
143300789|NCT03616912|516653971|FG002|Overall Study|Pregnancy|4|||
143300790|NCT03616912|516653972|FG003|Overall Study|Pregnancy|0|||
143300791|NCT03616912|516653973|FG004|Overall Study|Pregnancy|0|||
143300792|NCT03616912|516653974|FG005|Overall Study|Pregnancy|0|||
143300793|NCT03616912|516653969|FG000|Overall Study|Protocol Violation|1|||
143300794|NCT03616912|516653970|FG001|Overall Study|Protocol Violation|0|||
143300795|NCT03616912|516653971|FG002|Overall Study|Protocol Violation|2|||
143300796|NCT03616912|516653972|FG003|Overall Study|Protocol Violation|0|||
143300797|NCT03616912|516653973|FG004|Overall Study|Protocol Violation|0|||
143300798|NCT03616912|516653974|FG005|Overall Study|Protocol Violation|0|||
143300799|NCT03616912|516653969|FG000|Overall Study|Physician Decision|2|||
143300800|NCT03616912|516653970|FG001|Overall Study|Physician Decision|0|||
143300801|NCT03616912|516653971|FG002|Overall Study|Physician Decision|0|||
143300802|NCT03616912|516653972|FG003|Overall Study|Physician Decision|0|||
143300803|NCT03616912|516653973|FG004|Overall Study|Physician Decision|1|||
143300804|NCT03616912|516653974|FG005|Overall Study|Physician Decision|0|||
143300805|NCT03616912|516653969|FG000|Overall Study|Randomized But Never Treated|0|||
143300806|NCT03616912|516653970|FG001|Overall Study|Randomized But Never Treated|2|||
143300807|NCT03616912|516653971|FG002|Overall Study|Randomized But Never Treated|0|||
143374663|NCT01113931|516917256|FG001|Overall Study|Lost to Follow-up|9|||
143300808|NCT03616912|516653972|FG003|Overall Study|Randomized But Never Treated|0|||
143300809|NCT03616912|516653973|FG004|Overall Study|Randomized But Never Treated|0|||
143300810|NCT03616912|516653974|FG005|Overall Study|Randomized But Never Treated|0|||
143300811|NCT01723163|516653977|FG000|Treatment Phase|Withdrawal by Subject|14|||
143300812|NCT01723163|516653978|FG001|Treatment Phase|Withdrawal by Subject|6|||
143300813|NCT01723163|516653977|FG000|Treatment Phase|Withdrawal by PI|5|||
143300814|NCT01723163|516653978|FG001|Treatment Phase|Withdrawal by PI|1|||
143300815|NCT01723163|516653977|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
143374664|NCT01113931|516917255|FG000|Overall Study|Various|2|||
143300816|NCT01723163|516653978|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
143300817|NCT01723163|516653977|FG000|3-Month Follow-up|Unable to Contact|12|||
143300818|NCT01723163|516653978|FG001|3-Month Follow-up|Unable to Contact|19|||
143300819|NCT01723163|516653977|FG000|6-Month Follow-up|Death|1|||
143300820|NCT01723163|516653978|FG001|6-Month Follow-up|Death|0|||
143374665|NCT01113931|516917256|FG001|Overall Study|Various|4|||
143300821|NCT01723163|516653977|FG000|6-Month Follow-up|Unable to Contact|17|||
143300822|NCT01723163|516653978|FG001|6-Month Follow-up|Unable to Contact|15|||
143300823|NCT01723163|516653977|FG000|12-Month Follow-up|Death|1|||
143300824|NCT01723163|516653978|FG001|12-Month Follow-up|Death|0|||
143300825|NCT01723163|516653977|FG000|12-Month Follow-up|Unable to Contact|23|||
143300826|NCT01723163|516653978|FG001|12-Month Follow-up|Unable to Contact|28|||
143300827|NCT01856790|516653981|FG000|Closed Loop Control|Withdrawal by Subject|2|||
143300828|NCT01856790|516653981|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
143300829|NCT02474199|516653983|FG000|Overall Study|Lost to Follow-up|1|||
143300830|NCT02474199|516653984|FG001|Overall Study|Lost to Follow-up|0|||
143300831|NCT02474199|516653985|FG002|Overall Study|Lost to Follow-up|0|||
143300832|NCT02474199|516653986|FG003|Overall Study|Lost to Follow-up|0|||
143300833|NCT02474199|516653983|FG000|Overall Study|Withdrawal by Subject|1|||
143300834|NCT02474199|516653984|FG001|Overall Study|Withdrawal by Subject|2|||
143300835|NCT02474199|516653985|FG002|Overall Study|Withdrawal by Subject|0|||
143300836|NCT02474199|516653986|FG003|Overall Study|Withdrawal by Subject|1|||
143300837|NCT02474199|516653983|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
143300838|NCT02474199|516653984|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
143300839|NCT02474199|516653985|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
143300840|NCT02474199|516653986|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
143300841|NCT02474199|516653983|FG000|Overall Study|Did not meet eligibility criteria|0|||
143300842|NCT02474199|516653984|FG001|Overall Study|Did not meet eligibility criteria|0|||
143300843|NCT02474199|516653985|FG002|Overall Study|Did not meet eligibility criteria|2|||
143300844|NCT02474199|516653986|FG003|Overall Study|Did not meet eligibility criteria|2|||
143300845|NCT02731729|516653987|FG000|Overall Study|Death|2|||
143300846|NCT02731729|516653988|FG001|Overall Study|Death|2|||
143300847|NCT02731729|516653987|FG000|Overall Study|Study terminated by Sponsor|6|||
143300848|NCT02731729|516653988|FG001|Overall Study|Study terminated by Sponsor|6|||
143300849|NCT02731729|516653987|FG000|Overall Study|Withdrawal by Subject|1|||
143300850|NCT02731729|516653988|FG001|Overall Study|Withdrawal by Subject|0|||
143300851|NCT00159588|516653989|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
143300852|NCT00159588|516653990|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
143300853|NCT00159588|516653991|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
143300854|NCT01660711|516653992|FG000|Overall Study|Adverse Event|7|||
143300855|NCT01660711|516653992|FG000|Overall Study|Withdrawal by Subject|1|||
143300856|NCT03446040|516653993|FG000|Overall Study|Disease progression|3|||
143300857|NCT03446040|516653994|FG001|Overall Study|Disease progression|3|||
143300858|NCT03446040|516653995|FG002|Overall Study|Disease progression|3|||
143300859|NCT03446040|516653996|FG003|Overall Study|Disease progression|4|||
143300860|NCT03446040|516653997|FG004|Overall Study|Disease progression|4|||
143300861|NCT03446040|516653998|FG005|Overall Study|Disease progression|6|||
143300862|NCT03446040|516653999|FG006|Overall Study|Disease progression|3|||
143300863|NCT03446040|516654000|FG007|Overall Study|Disease progression|4|||
143300864|NCT03446040|516654001|FG008|Overall Study|Disease progression|2|||
143300865|NCT03446040|516654002|FG009|Overall Study|Disease progression|4|||
143300866|NCT03446040|516654003|FG010|Overall Study|Disease progression|9|||
143300867|NCT03446040|516654004|FG011|Overall Study|Disease progression|3|||
143300868|NCT03446040|516654005|FG012|Overall Study|Disease progression|7|||
143300869|NCT03446040|516654006|FG013|Overall Study|Disease progression|7|||
143300870|NCT03446040|516653993|FG000|Overall Study|Study drug toxicity|0|||
143300871|NCT03446040|516653994|FG001|Overall Study|Study drug toxicity|0|||
143374666|NCT01113931|516917255|FG000|Overall Study|Withdrawal by Subject|3|||
143374667|NCT01113931|516917256|FG001|Overall Study|Withdrawal by Subject|0|||
143374668|NCT01307267|516917257|FG000|Overall Study|Death|4|||
143374669|NCT01307267|516917258|FG001|Overall Study|Death|3|||
143374670|NCT01307267|516917259|FG002|Overall Study|Death|5|||
143374671|NCT01307267|516917260|FG003|Overall Study|Death|3|||
143374672|NCT01307267|516917261|FG004|Overall Study|Death|1|||
143300872|NCT03446040|516653995|FG002|Overall Study|Study drug toxicity|0|||
143300873|NCT03446040|516653996|FG003|Overall Study|Study drug toxicity|0|||
143300874|NCT03446040|516653997|FG004|Overall Study|Study drug toxicity|0|||
143300875|NCT03446040|516653998|FG005|Overall Study|Study drug toxicity|0|||
143300876|NCT03446040|516653999|FG006|Overall Study|Study drug toxicity|0|||
143300877|NCT03446040|516654000|FG007|Overall Study|Study drug toxicity|0|||
143300878|NCT03446040|516654001|FG008|Overall Study|Study drug toxicity|1|||
143300879|NCT03446040|516654002|FG009|Overall Study|Study drug toxicity|0|||
143300880|NCT03446040|516654003|FG010|Overall Study|Study drug toxicity|0|||
143300881|NCT03446040|516654004|FG011|Overall Study|Study drug toxicity|0|||
143300882|NCT03446040|516654005|FG012|Overall Study|Study drug toxicity|0|||
143300883|NCT03446040|516654006|FG013|Overall Study|Study drug toxicity|0|||
143300884|NCT03446040|516653993|FG000|Overall Study|Adverse Event|0|||
143374673|NCT01307267|516917262|FG005|Overall Study|Death|26|||
143300885|NCT03446040|516653994|FG001|Overall Study|Adverse Event|0|||
143300886|NCT03446040|516653995|FG002|Overall Study|Adverse Event|0|||
143300887|NCT03446040|516653996|FG003|Overall Study|Adverse Event|0|||
143374674|NCT01307267|516917263|FG006|Overall Study|Death|2|||
143374675|NCT01307267|516917264|FG007|Overall Study|Death|2|||
143374676|NCT01307267|516917265|FG008|Overall Study|Death|21|||
143300888|NCT03446040|516653997|FG004|Overall Study|Adverse Event|0|||
143300889|NCT03446040|516653998|FG005|Overall Study|Adverse Event|2|||
143300890|NCT03446040|516653999|FG006|Overall Study|Adverse Event|0|||
143300891|NCT03446040|516654000|FG007|Overall Study|Adverse Event|0|||
143300892|NCT03446040|516654001|FG008|Overall Study|Adverse Event|1|||
143300893|NCT03446040|516654002|FG009|Overall Study|Adverse Event|0|||
143300894|NCT03446040|516654003|FG010|Overall Study|Adverse Event|0|||
143300895|NCT03446040|516654004|FG011|Overall Study|Adverse Event|0|||
143300896|NCT03446040|516654005|FG012|Overall Study|Adverse Event|0|||
143300897|NCT03446040|516654006|FG013|Overall Study|Adverse Event|0|||
143300898|NCT03446040|516653993|FG000|Overall Study|Death|0|||
143300899|NCT03446040|516653994|FG001|Overall Study|Death|0|||
143300900|NCT03446040|516653995|FG002|Overall Study|Death|0|||
143300901|NCT03446040|516653996|FG003|Overall Study|Death|0|||
143300902|NCT03446040|516653997|FG004|Overall Study|Death|0|||
143300903|NCT03446040|516653998|FG005|Overall Study|Death|0|||
143300904|NCT03446040|516653999|FG006|Overall Study|Death|0|||
143300905|NCT03446040|516654000|FG007|Overall Study|Death|0|||
143300906|NCT03446040|516654001|FG008|Overall Study|Death|0|||
143300907|NCT03446040|516654002|FG009|Overall Study|Death|0|||
143300908|NCT03446040|516654003|FG010|Overall Study|Death|1|||
143300909|NCT03446040|516654004|FG011|Overall Study|Death|0|||
143300910|NCT03446040|516654005|FG012|Overall Study|Death|0|||
143300911|NCT03446040|516654006|FG013|Overall Study|Death|2|||
143300912|NCT03446040|516653993|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
143300913|NCT03446040|516653994|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
143300914|NCT03446040|516653995|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
143300915|NCT03446040|516653996|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
143300916|NCT03446040|516653997|FG004|Overall Study|Participant requested to discontinue study treatment|0|||
143300917|NCT03446040|516653998|FG005|Overall Study|Participant requested to discontinue study treatment|0|||
143300918|NCT03446040|516653999|FG006|Overall Study|Participant requested to discontinue study treatment|0|||
143300919|NCT03446040|516654000|FG007|Overall Study|Participant requested to discontinue study treatment|0|||
143300920|NCT03446040|516654001|FG008|Overall Study|Participant requested to discontinue study treatment|0|||
143300921|NCT03446040|516654002|FG009|Overall Study|Participant requested to discontinue study treatment|0|||
143300922|NCT03446040|516654003|FG010|Overall Study|Participant requested to discontinue study treatment|0|||
143300923|NCT03446040|516654004|FG011|Overall Study|Participant requested to discontinue study treatment|1|||
143300924|NCT03446040|516654005|FG012|Overall Study|Participant requested to discontinue study treatment|0|||
143300925|NCT03446040|516654006|FG013|Overall Study|Participant requested to discontinue study treatment|0|||
143300926|NCT03446040|516653993|FG000|Overall Study|Participant withdrew consent|0|||
143300927|NCT03446040|516653994|FG001|Overall Study|Participant withdrew consent|0|||
143300928|NCT03446040|516653995|FG002|Overall Study|Participant withdrew consent|0|||
143300929|NCT03446040|516653996|FG003|Overall Study|Participant withdrew consent|0|||
143300930|NCT03446040|516653997|FG004|Overall Study|Participant withdrew consent|0|||
143300931|NCT03446040|516653998|FG005|Overall Study|Participant withdrew consent|1|||
143300932|NCT03446040|516653999|FG006|Overall Study|Participant withdrew consent|0|||
143300933|NCT03446040|516654000|FG007|Overall Study|Participant withdrew consent|1|||
143300934|NCT03446040|516654001|FG008|Overall Study|Participant withdrew consent|0|||
143300935|NCT03446040|516654002|FG009|Overall Study|Participant withdrew consent|0|||
143300936|NCT03446040|516654003|FG010|Overall Study|Participant withdrew consent|0|||
143300937|NCT03446040|516654004|FG011|Overall Study|Participant withdrew consent|0|||
143300938|NCT03446040|516654005|FG012|Overall Study|Participant withdrew consent|0|||
143300939|NCT03446040|516654006|FG013|Overall Study|Participant withdrew consent|0|||
143300940|NCT03446040|516653993|FG000|Overall Study|Not reported|0|||
143300941|NCT03446040|516653994|FG001|Overall Study|Not reported|0|||
143300942|NCT03446040|516653995|FG002|Overall Study|Not reported|1|||
143300943|NCT03446040|516653996|FG003|Overall Study|Not reported|0|||
143300944|NCT03446040|516653997|FG004|Overall Study|Not reported|0|||
143300945|NCT03446040|516653998|FG005|Overall Study|Not reported|0|||
143300946|NCT03446040|516653999|FG006|Overall Study|Not reported|0|||
143300947|NCT03446040|516654000|FG007|Overall Study|Not reported|0|||
143300948|NCT03446040|516654001|FG008|Overall Study|Not reported|0|||
143300949|NCT03446040|516654002|FG009|Overall Study|Not reported|0|||
143300950|NCT03446040|516654003|FG010|Overall Study|Not reported|0|||
143300951|NCT03446040|516654004|FG011|Overall Study|Not reported|0|||
143300952|NCT03446040|516654005|FG012|Overall Study|Not reported|0|||
143300953|NCT03446040|516654006|FG013|Overall Study|Not reported|0|||
143300954|NCT00456521|516654007|FG000|Overall Study|Adverse Event|150|||
143300955|NCT00456521|516654008|FG001|Overall Study|Adverse Event|25|||
143300956|NCT00456521|516654007|FG000|Overall Study|Withdrawal by Subject|43|||
143300957|NCT00456521|516654008|FG001|Overall Study|Withdrawal by Subject|24|||
143300958|NCT00456521|516654007|FG000|Overall Study|Lost to Follow-up|22|||
143300959|NCT00456521|516654008|FG001|Overall Study|Lost to Follow-up|17|||
143300960|NCT00456521|516654007|FG000|Overall Study|Lack of Efficacy|3|||
143300961|NCT00456521|516654008|FG001|Overall Study|Lack of Efficacy|6|||
143300962|NCT00456521|516654007|FG000|Overall Study|Protocol Violation|4|||
143300963|NCT00456521|516654008|FG001|Overall Study|Protocol Violation|0|||
143300964|NCT00456521|516654007|FG000|Overall Study|Pregnancy|1|||
143300965|NCT00456521|516654008|FG001|Overall Study|Pregnancy|1|||
143300966|NCT00456521|516654007|FG000|Overall Study|Drug non-compliance, moved, other|26|||
143300967|NCT00456521|516654008|FG001|Overall Study|Drug non-compliance, moved, other|11|||
143300968|NCT00605475|516654009|FG000|Overall Study|Abnormal Laboratory Values|0|||
143300969|NCT00605475|516654010|FG001|Overall Study|Abnormal Laboratory Values|0|||
143300970|NCT00605475|516654011|FG002|Overall Study|Abnormal Laboratory Values|0|||
143300971|NCT00605475|516654012|FG003|Overall Study|Abnormal Laboratory Values|0|||
143300972|NCT00605475|516654013|FG004|Overall Study|Abnormal Laboratory Values|0|||
143300973|NCT00605475|516654014|FG005|Overall Study|Abnormal Laboratory Values|0|||
143300974|NCT00605475|516654015|FG006|Overall Study|Abnormal Laboratory Values|0|||
143300975|NCT00605475|516654016|FG007|Overall Study|Abnormal Laboratory Values|0|||
143300976|NCT00605475|516654017|FG008|Overall Study|Abnormal Laboratory Values|1|||
143300977|NCT00605475|516654018|FG009|Overall Study|Abnormal Laboratory Values|0|||
143300978|NCT00605475|516654009|FG000|Overall Study|Administrative problems|0|||
143300979|NCT00605475|516654010|FG001|Overall Study|Administrative problems|0|||
143300980|NCT00605475|516654011|FG002|Overall Study|Administrative problems|0|||
143300981|NCT00605475|516654012|FG003|Overall Study|Administrative problems|0|||
143300982|NCT00605475|516654013|FG004|Overall Study|Administrative problems|0|||
143300983|NCT00605475|516654014|FG005|Overall Study|Administrative problems|0|||
143300984|NCT00605475|516654015|FG006|Overall Study|Administrative problems|1|||
143300985|NCT00605475|516654016|FG007|Overall Study|Administrative problems|0|||
143300986|NCT00605475|516654017|FG008|Overall Study|Administrative problems|0|||
143300987|NCT00605475|516654018|FG009|Overall Study|Administrative problems|0|||
143300988|NCT00605475|516654009|FG000|Overall Study|Lost to Follow-up|0|||
143300989|NCT00605475|516654010|FG001|Overall Study|Lost to Follow-up|0|||
143300990|NCT00605475|516654011|FG002|Overall Study|Lost to Follow-up|0|||
143300991|NCT00605475|516654012|FG003|Overall Study|Lost to Follow-up|0|||
143300992|NCT00605475|516654013|FG004|Overall Study|Lost to Follow-up|0|||
143300993|NCT00605475|516654014|FG005|Overall Study|Lost to Follow-up|0|||
143300994|NCT00605475|516654015|FG006|Overall Study|Lost to Follow-up|0|||
143300995|NCT00605475|516654016|FG007|Overall Study|Lost to Follow-up|0|||
143300996|NCT00605475|516654017|FG008|Overall Study|Lost to Follow-up|1|||
143300997|NCT00605475|516654018|FG009|Overall Study|Lost to Follow-up|1|||
143300998|NCT00605475|516654009|FG000|Overall Study|Protocol Violation|0|||
143300999|NCT00605475|516654010|FG001|Overall Study|Protocol Violation|0|||
143301000|NCT00605475|516654011|FG002|Overall Study|Protocol Violation|0|||
143301001|NCT00605475|516654012|FG003|Overall Study|Protocol Violation|0|||
143301002|NCT00605475|516654013|FG004|Overall Study|Protocol Violation|1|||
143301003|NCT00605475|516654014|FG005|Overall Study|Protocol Violation|0|||
143301004|NCT00605475|516654015|FG006|Overall Study|Protocol Violation|0|||
143301005|NCT00605475|516654016|FG007|Overall Study|Protocol Violation|0|||
143301006|NCT00605475|516654017|FG008|Overall Study|Protocol Violation|0|||
143301007|NCT00605475|516654018|FG009|Overall Study|Protocol Violation|0|||
143301008|NCT00605475|516654009|FG000|Overall Study|Withdrawal by Subject|0|||
143301009|NCT00605475|516654010|FG001|Overall Study|Withdrawal by Subject|0|||
143301010|NCT00605475|516654011|FG002|Overall Study|Withdrawal by Subject|0|||
143301011|NCT00605475|516654012|FG003|Overall Study|Withdrawal by Subject|0|||
143301012|NCT00605475|516654013|FG004|Overall Study|Withdrawal by Subject|0|||
143301013|NCT00605475|516654014|FG005|Overall Study|Withdrawal by Subject|2|||
143301014|NCT00605475|516654015|FG006|Overall Study|Withdrawal by Subject|0|||
143301015|NCT00605475|516654016|FG007|Overall Study|Withdrawal by Subject|0|||
143301016|NCT00605475|516654017|FG008|Overall Study|Withdrawal by Subject|0|||
143301017|NCT00605475|516654018|FG009|Overall Study|Withdrawal by Subject|1|||
143301018|NCT03056755|516654024|FG000|Treatment- Core Phase|Progressive disease|89|||
143301019|NCT03056755|516654025|FG001|Treatment- Core Phase|Progressive disease|88|||
143301020|NCT03056755|516654026|FG002|Treatment- Core Phase|Progressive disease|90|||
143301021|NCT03056755|516654024|FG000|Treatment- Core Phase|Adverse Event|20|||
143301022|NCT03056755|516654025|FG001|Treatment- Core Phase|Adverse Event|14|||
143301023|NCT03056755|516654026|FG002|Treatment- Core Phase|Adverse Event|13|||
143301024|NCT03056755|516654024|FG000|Treatment- Core Phase|Physician Decision|7|||
143301025|NCT03056755|516654025|FG001|Treatment- Core Phase|Physician Decision|13|||
143301026|NCT03056755|516654026|FG002|Treatment- Core Phase|Physician Decision|5|||
143301027|NCT03056755|516654024|FG000|Treatment- Core Phase|Subject/guardian decision|5|||
143301028|NCT03056755|516654025|FG001|Treatment- Core Phase|Subject/guardian decision|8|||
143301029|NCT03056755|516654026|FG002|Treatment- Core Phase|Subject/guardian decision|4|||
143301030|NCT03056755|516654024|FG000|Treatment- Core Phase|Death|3|||
143301031|NCT03056755|516654025|FG001|Treatment- Core Phase|Death|2|||
143301032|NCT03056755|516654026|FG002|Treatment- Core Phase|Death|4|||
143301033|NCT03056755|516654024|FG000|Treatment- Core Phase|Protocol deviation|1|||
143301034|NCT03056755|516654025|FG001|Treatment- Core Phase|Protocol deviation|1|||
143301035|NCT03056755|516654026|FG002|Treatment- Core Phase|Protocol deviation|0|||
143301036|NCT03056755|516654024|FG000|Treatment- Core Phase|Technical problems|1|||
143301037|NCT03056755|516654025|FG001|Treatment- Core Phase|Technical problems|0|||
143301038|NCT03056755|516654026|FG002|Treatment- Core Phase|Technical problems|0|||
143301039|NCT03056755|516654024|FG000|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
143301040|NCT03056755|516654025|FG001|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
143301041|NCT03056755|516654026|FG002|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|2|||
143301042|NCT03056755|516654024|FG000|Post-treatment Efficacy - Core Phase|Progressive disease|11|||
143301043|NCT03056755|516654025|FG001|Post-treatment Efficacy - Core Phase|Progressive disease|9|||
143301044|NCT03056755|516654026|FG002|Post-treatment Efficacy - Core Phase|Progressive disease|5|||
143301045|NCT03056755|516654024|FG000|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
143301046|NCT03056755|516654025|FG001|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
143301047|NCT03056755|516654026|FG002|Post-treatment Efficacy - Core Phase|Adverse Event|0|||
143301048|NCT03056755|516654024|FG000|Post-treatment Efficacy - Core Phase|Death|1|||
143301049|NCT03056755|516654025|FG001|Post-treatment Efficacy - Core Phase|Death|3|||
143301050|NCT03056755|516654026|FG002|Post-treatment Efficacy - Core Phase|Death|0|||
143301051|NCT00405587|516654027|FG000|Overall Study|Death|0|||
143301052|NCT00405587|516654028|FG001|Overall Study|Death|0|||
143301053|NCT00405587|516654029|FG002|Overall Study|Death|0|||
143301054|NCT00405587|516654030|FG003|Overall Study|Death|1|||
143301055|NCT00405587|516654027|FG000|Overall Study|Disease Progression|22|||
143301056|NCT00405587|516654028|FG001|Overall Study|Disease Progression|23|||
143301057|NCT00405587|516654029|FG002|Overall Study|Disease Progression|21|||
143301058|NCT00405587|516654030|FG003|Overall Study|Disease Progression|17|||
143301059|NCT00405587|516654027|FG000|Overall Study|Physician Decision|3|||
143301060|NCT00405587|516654028|FG001|Overall Study|Physician Decision|2|||
143301061|NCT00405587|516654029|FG002|Overall Study|Physician Decision|0|||
143374677|NCT01307267|516917266|FG009|Overall Study|Death|2|||
143374678|NCT01307267|516917267|FG010|Overall Study|Death|3|||
143374679|NCT01307267|516917268|FG011|Overall Study|Death|9|||
143374680|NCT01307267|516917269|FG012|Overall Study|Death|0|||
143374681|NCT01307267|516917270|FG013|Overall Study|Death|0|||
143374682|NCT01307267|516917271|FG014|Overall Study|Death|0|||
143374683|NCT01307267|516917272|FG015|Overall Study|Death|0|||
143374684|NCT01307267|516917273|FG016|Overall Study|Death|1|||
143374685|NCT01307267|516917274|FG017|Overall Study|Death|1|||
143374686|NCT01307267|516917275|FG018|Overall Study|Death|2|||
143374687|NCT01307267|516917276|FG019|Overall Study|Death|8|||
143374688|NCT01307267|516917277|FG020|Overall Study|Death|1|||
143374689|NCT01307267|516917278|FG021|Overall Study|Death|2|||
143374690|NCT01307267|516917279|FG022|Overall Study|Death|2|||
143374691|NCT01307267|516917257|FG000|Overall Study|Lost to Follow-up|0|||
143374692|NCT01307267|516917258|FG001|Overall Study|Lost to Follow-up|0|||
143374693|NCT01307267|516917259|FG002|Overall Study|Lost to Follow-up|0|||
143374694|NCT01307267|516917260|FG003|Overall Study|Lost to Follow-up|0|||
143374695|NCT01307267|516917261|FG004|Overall Study|Lost to Follow-up|0|||
143374696|NCT01307267|516917262|FG005|Overall Study|Lost to Follow-up|7|||
143374697|NCT01307267|516917263|FG006|Overall Study|Lost to Follow-up|0|||
143374698|NCT01307267|516917264|FG007|Overall Study|Lost to Follow-up|0|||
143374699|NCT01307267|516917265|FG008|Overall Study|Lost to Follow-up|1|||
143374700|NCT01307267|516917266|FG009|Overall Study|Lost to Follow-up|2|||
143374701|NCT01307267|516917267|FG010|Overall Study|Lost to Follow-up|1|||
143374702|NCT01307267|516917268|FG011|Overall Study|Lost to Follow-up|0|||
143374703|NCT01307267|516917269|FG012|Overall Study|Lost to Follow-up|0|||
143374704|NCT01307267|516917270|FG013|Overall Study|Lost to Follow-up|0|||
143374705|NCT01307267|516917271|FG014|Overall Study|Lost to Follow-up|0|||
143374706|NCT01307267|516917272|FG015|Overall Study|Lost to Follow-up|0|||
143374707|NCT01307267|516917273|FG016|Overall Study|Lost to Follow-up|0|||
143374708|NCT01307267|516917274|FG017|Overall Study|Lost to Follow-up|0|||
143374709|NCT01307267|516917275|FG018|Overall Study|Lost to Follow-up|0|||
143374710|NCT01307267|516917276|FG019|Overall Study|Lost to Follow-up|2|||
143374711|NCT01307267|516917277|FG020|Overall Study|Lost to Follow-up|0|||
143374712|NCT01307267|516917278|FG021|Overall Study|Lost to Follow-up|0|||
143374713|NCT01307267|516917279|FG022|Overall Study|Lost to Follow-up|0|||
143374714|NCT01307267|516917257|FG000|Overall Study|Withdrawal by Subject|0|||
143374715|NCT01307267|516917258|FG001|Overall Study|Withdrawal by Subject|0|||
143374716|NCT01307267|516917259|FG002|Overall Study|Withdrawal by Subject|0|||
143374717|NCT01307267|516917260|FG003|Overall Study|Withdrawal by Subject|0|||
143374718|NCT01307267|516917261|FG004|Overall Study|Withdrawal by Subject|0|||
143374719|NCT01307267|516917262|FG005|Overall Study|Withdrawal by Subject|1|||
143374720|NCT01307267|516917263|FG006|Overall Study|Withdrawal by Subject|0|||
143374721|NCT01307267|516917264|FG007|Overall Study|Withdrawal by Subject|1|||
143374722|NCT01307267|516917265|FG008|Overall Study|Withdrawal by Subject|5|||
143374723|NCT01307267|516917266|FG009|Overall Study|Withdrawal by Subject|1|||
143374724|NCT01307267|516917267|FG010|Overall Study|Withdrawal by Subject|1|||
143374725|NCT01307267|516917268|FG011|Overall Study|Withdrawal by Subject|1|||
143374726|NCT01307267|516917269|FG012|Overall Study|Withdrawal by Subject|0|||
143374727|NCT01307267|516917270|FG013|Overall Study|Withdrawal by Subject|0|||
143374728|NCT01307267|516917271|FG014|Overall Study|Withdrawal by Subject|0|||
143374729|NCT01307267|516917272|FG015|Overall Study|Withdrawal by Subject|0|||
143374730|NCT01307267|516917273|FG016|Overall Study|Withdrawal by Subject|0|||
143374731|NCT01307267|516917274|FG017|Overall Study|Withdrawal by Subject|0|||
143301062|NCT00405587|516654030|FG003|Overall Study|Physician Decision|0|||
143301063|NCT00405587|516654027|FG000|Overall Study|Adverse Event|1|||
143374732|NCT01307267|516917275|FG018|Overall Study|Withdrawal by Subject|0|||
143301064|NCT00405587|516654028|FG001|Overall Study|Adverse Event|0|||
143374733|NCT01307267|516917276|FG019|Overall Study|Withdrawal by Subject|3|||
143301065|NCT00405587|516654029|FG002|Overall Study|Adverse Event|0|||
143301066|NCT00405587|516654030|FG003|Overall Study|Adverse Event|0|||
143374734|NCT01307267|516917277|FG020|Overall Study|Withdrawal by Subject|0|||
143374735|NCT01307267|516917278|FG021|Overall Study|Withdrawal by Subject|0|||
143374736|NCT01307267|516917279|FG022|Overall Study|Withdrawal by Subject|0|||
143374737|NCT01307267|516917257|FG000|Overall Study|Other|0|||
143301067|NCT00405587|516654027|FG000|Overall Study|Lost to Follow-up|0|||
143374738|NCT01307267|516917258|FG001|Overall Study|Other|0|||
143374739|NCT01307267|516917259|FG002|Overall Study|Other|0|||
143374740|NCT01307267|516917260|FG003|Overall Study|Other|0|||
143374741|NCT01307267|516917261|FG004|Overall Study|Other|0|||
143374742|NCT01307267|516917262|FG005|Overall Study|Other|7|||
143374743|NCT01307267|516917263|FG006|Overall Study|Other|0|||
143301068|NCT00405587|516654028|FG001|Overall Study|Lost to Follow-up|1|||
143374744|NCT01307267|516917264|FG007|Overall Study|Other|1|||
143374745|NCT01307267|516917265|FG008|Overall Study|Other|3|||
143374746|NCT01307267|516917266|FG009|Overall Study|Other|0|||
143374747|NCT01307267|516917267|FG010|Overall Study|Other|1|||
143374748|NCT01307267|516917268|FG011|Overall Study|Other|1|||
143374749|NCT01307267|516917269|FG012|Overall Study|Other|1|||
143374750|NCT01307267|516917270|FG013|Overall Study|Other|0|||
143374751|NCT01307267|516917271|FG014|Overall Study|Other|2|||
143301069|NCT00405587|516654029|FG002|Overall Study|Lost to Follow-up|1|||
143301070|NCT00405587|516654030|FG003|Overall Study|Lost to Follow-up|0|||
143301071|NCT00405587|516654027|FG000|Overall Study|Radiation induced necrosis|0|||
143301072|NCT00405587|516654028|FG001|Overall Study|Radiation induced necrosis|1|||
143301073|NCT00405587|516654029|FG002|Overall Study|Radiation induced necrosis|0|||
143301074|NCT00405587|516654030|FG003|Overall Study|Radiation induced necrosis|0|||
143301075|NCT00405587|516654027|FG000|Overall Study|Withdrawal by Subject|0|||
143301076|NCT00405587|516654028|FG001|Overall Study|Withdrawal by Subject|0|||
143301077|NCT00405587|516654029|FG002|Overall Study|Withdrawal by Subject|0|||
143301078|NCT00405587|516654030|FG003|Overall Study|Withdrawal by Subject|2|||
143301079|NCT00405587|516654027|FG000|Overall Study|Participant not dosed|0|||
143301080|NCT00405587|516654028|FG001|Overall Study|Participant not dosed|1|||
143301081|NCT00405587|516654029|FG002|Overall Study|Participant not dosed|0|||
143301082|NCT00405587|516654030|FG003|Overall Study|Participant not dosed|0|||
143301083|NCT03406858|516654031|FG000|Overall Study|Failure to receive treatment drug.|1|||
143374752|NCT01307267|516917272|FG015|Overall Study|Other|1|||
143374753|NCT01307267|516917273|FG016|Overall Study|Other|0|||
143301084|NCT03406858|516654031|FG000|Overall Study|ineligible|1|||
143301085|NCT06027866|516654032|FG000|Overall Study|Withdrawal by Subject|2|||
143374754|NCT01307267|516917274|FG017|Overall Study|Other|0|||
143374755|NCT01307267|516917275|FG018|Overall Study|Other|0|||
143374756|NCT01307267|516917276|FG019|Overall Study|Other|19|||
143374757|NCT01307267|516917277|FG020|Overall Study|Other|2|||
143374758|NCT01307267|516917278|FG021|Overall Study|Other|3|||
143374759|NCT01307267|516917279|FG022|Overall Study|Other|2|||
143374760|NCT04956575|516917283|FG000|Overall Study|Death|1|||
143374761|NCT04956575|516917284|FG001|Overall Study|Death|0|||
143301086|NCT02419742|516654035|FG000|Overall Study|Adverse Event|2|||
143374762|NCT04956575|516917285|FG002|Overall Study|Death|0|||
143301087|NCT02419742|516654036|FG001|Overall Study|Adverse Event|0|||
143301088|NCT02419742|516654035|FG000|Overall Study|Disease Progression|0|||
143301089|NCT02419742|516654036|FG001|Overall Study|Disease Progression|1|||
143301090|NCT02419742|516654035|FG000|Overall Study|Withdrew Consent|2|||
143301091|NCT02419742|516654036|FG001|Overall Study|Withdrew Consent|1|||
143301092|NCT02419742|516654035|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
143301093|NCT02419742|516654036|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
143301094|NCT05071183|516654038|FG000|Overall Study|Death|1|||
143301095|NCT05071183|516654039|FG001|Overall Study|Death|2|||
143301096|NCT05071183|516654040|FG002|Overall Study|Death|0|||
143301097|NCT05071183|516654038|FG000|Overall Study|Other Reasons|1|||
143301098|NCT05071183|516654039|FG001|Overall Study|Other Reasons|3|||
143301099|NCT05071183|516654040|FG002|Overall Study|Other Reasons|2|||
143301100|NCT01480076|516654042|FG000|Overall Study|Run-in Failure|52|||
143301101|NCT01480076|516654042|FG000|Overall Study|Adverse Event|39|||
143301102|NCT01480076|516654042|FG000|Overall Study|Death|2|||
143301103|NCT01480076|516654042|FG000|Overall Study|Disease Progression|5|||
143301104|NCT01480076|516654042|FG000|Overall Study|Non-compliance With Study Protocol|15|||
143301105|NCT01480076|516654042|FG000|Overall Study|Withdrawal by Subject|105|||
143301106|NCT01480076|516654042|FG000|Overall Study|Lost to Follow-up|7|||
143301107|NCT01480076|516654042|FG000|Overall Study|Investigator Decision|13|||
143301108|NCT01480076|516654042|FG000|Overall Study|Other|52|||
143301109|NCT02503332|516654043|FG000|Overall Study|Adverse Event|17|||
143301110|NCT02503332|516654044|FG001|Overall Study|Adverse Event|5|||
143301111|NCT02503332|516654045|FG002|Overall Study|Adverse Event|3|||
142941516|NCT00064701|515324682|FG002|One Year Post-transplant|Adverse Event|37|||
143301112|NCT02503332|516654046|FG003|Overall Study|Adverse Event|1|||
143301113|NCT02503332|516654043|FG000|Overall Study|Investigator's Decision|5|||
143301114|NCT02503332|516654044|FG001|Overall Study|Investigator's Decision|1|||
143301115|NCT02503332|516654045|FG002|Overall Study|Investigator's Decision|0|||
143301116|NCT02503332|516654046|FG003|Overall Study|Investigator's Decision|0|||
143301117|NCT02503332|516654043|FG000|Overall Study|Sponsor's Decision|1|||
143301118|NCT02503332|516654044|FG001|Overall Study|Sponsor's Decision|0|||
143301119|NCT02503332|516654045|FG002|Overall Study|Sponsor's Decision|0|||
143301120|NCT02503332|516654046|FG003|Overall Study|Sponsor's Decision|1|||
143301121|NCT02503332|516654043|FG000|Overall Study|Subject Request|6|||
143301122|NCT02503332|516654044|FG001|Overall Study|Subject Request|5|||
143301123|NCT02503332|516654045|FG002|Overall Study|Subject Request|2|||
143301124|NCT02503332|516654046|FG003|Overall Study|Subject Request|1|||
143301125|NCT02503332|516654043|FG000|Overall Study|Death|0|||
143301126|NCT02503332|516654044|FG001|Overall Study|Death|2|||
143301127|NCT02503332|516654045|FG002|Overall Study|Death|2|||
143301128|NCT02503332|516654046|FG003|Overall Study|Death|0|||
143301129|NCT02503332|516654043|FG000|Overall Study|Other|5|||
143301130|NCT02503332|516654044|FG001|Overall Study|Other|6|||
143301131|NCT02503332|516654045|FG002|Overall Study|Other|1|||
143301132|NCT02503332|516654046|FG003|Overall Study|Other|1|||
143301133|NCT01589445|516654049|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
143301134|NCT01589445|516654049|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
143301135|NCT01589445|516654049|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
143301136|NCT01589445|516654049|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
143301137|NCT01589445|516654049|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
143301138|NCT01589445|516654049|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
143301139|NCT01589445|516654049|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
143301140|NCT01589445|516654049|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
143301141|NCT01589445|516654049|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
143301142|NCT01589445|516654049|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
143301143|NCT00325754|516654050|FG000|Overall Study|Adverse Event|4|||
143301144|NCT00325754|516654051|FG001|Overall Study|Adverse Event|1|||
143301145|NCT01358357|516654054|FG000|Open Label Phase|Adverse Event|0|||
143301146|NCT01358357|516654055|FG001|Open Label Phase|Adverse Event|0|||
143301147|NCT01358357|516654056|FG002|Open Label Phase|Adverse Event|59|||
143301148|NCT01358357|516654054|FG000|Open Label Phase|Lack of Efficacy|0|||
143301149|NCT01358357|516654055|FG001|Open Label Phase|Lack of Efficacy|0|||
143301150|NCT01358357|516654056|FG002|Open Label Phase|Lack of Efficacy|107|||
143301151|NCT01358357|516654054|FG000|Open Label Phase|Lost to Follow-up|0|||
143301152|NCT01358357|516654055|FG001|Open Label Phase|Lost to Follow-up|0|||
143301153|NCT01358357|516654056|FG002|Open Label Phase|Lost to Follow-up|76|||
143301154|NCT01358357|516654054|FG000|Open Label Phase|Protocol Violation|0|||
143301155|NCT01358357|516654055|FG001|Open Label Phase|Protocol Violation|0|||
143301156|NCT01358357|516654056|FG002|Open Label Phase|Protocol Violation|45|||
143301157|NCT01358357|516654054|FG000|Open Label Phase|Withdrawal by Subject|0|||
143301158|NCT01358357|516654055|FG001|Open Label Phase|Withdrawal by Subject|0|||
143301159|NCT01358357|516654056|FG002|Open Label Phase|Withdrawal by Subject|112|||
143301160|NCT01358357|516654054|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
143301161|NCT01358357|516654055|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
143301162|NCT01358357|516654056|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
143301163|NCT01358357|516654054|FG000|Open Label Phase|Terminated at study completion|0|||
143301164|NCT01358357|516654055|FG001|Open Label Phase|Terminated at study completion|0|||
143301165|NCT01358357|516654056|FG002|Open Label Phase|Terminated at study completion|5|||
143301166|NCT01358357|516654054|FG000|Open Label Phase|Mood episode|0|||
143301167|NCT01358357|516654055|FG001|Open Label Phase|Mood episode|0|||
143301168|NCT01358357|516654056|FG002|Open Label Phase|Mood episode|42|||
143301169|NCT01358357|516654054|FG000|Double-Blind Phase|Adverse Event|8|||
143301170|NCT01358357|516654055|FG001|Double-Blind Phase|Adverse Event|5|||
143301171|NCT01358357|516654056|FG002|Double-Blind Phase|Adverse Event|0|||
143301172|NCT01358357|516654054|FG000|Double-Blind Phase|Lost to Follow-up|5|||
143301173|NCT01358357|516654055|FG001|Double-Blind Phase|Lost to Follow-up|7|||
143301174|NCT01358357|516654056|FG002|Double-Blind Phase|Lost to Follow-up|0|||
143301175|NCT01358357|516654054|FG000|Double-Blind Phase|Protocol Violation|1|||
143301176|NCT01358357|516654055|FG001|Double-Blind Phase|Protocol Violation|11|||
143301177|NCT01358357|516654056|FG002|Double-Blind Phase|Protocol Violation|0|||
143301178|NCT01358357|516654054|FG000|Double-Blind Phase|Protocol Violation|16|||
143301179|NCT01358357|516654055|FG001|Double-Blind Phase|Protocol Violation|12|||
143301180|NCT01358357|516654056|FG002|Double-Blind Phase|Protocol Violation|0|||
143301181|NCT01358357|516654054|FG000|Double-Blind Phase|Terminated at study completion|2|||
143301182|NCT01358357|516654055|FG001|Double-Blind Phase|Terminated at study completion|0|||
143301183|NCT01358357|516654056|FG002|Double-Blind Phase|Terminated at study completion|0|||
143301184|NCT01358357|516654054|FG000|Double-Blind Phase|Recurrence of mood event|48|||
143301185|NCT01358357|516654055|FG001|Double-Blind Phase|Recurrence of mood event|64|||
143301186|NCT01358357|516654056|FG002|Double-Blind Phase|Recurrence of mood event|0|||
143301187|NCT01358357|516654054|FG000|Double-Blind Phase|Administrative|0|||
143301188|NCT01358357|516654055|FG001|Double-Blind Phase|Administrative|1|||
143301189|NCT01358357|516654056|FG002|Double-Blind Phase|Administrative|0|||
143301190|NCT01826487|516654057|FG000|Overall Study|Adverse Event|1|||
143301191|NCT01826487|516654058|FG001|Overall Study|Adverse Event|1|||
143301192|NCT01826487|516654057|FG000|Overall Study|Lost to Follow-up|1|||
143301193|NCT01826487|516654058|FG001|Overall Study|Lost to Follow-up|0|||
143301194|NCT01826487|516654057|FG000|Overall Study|Withdrawal by Subject|1|||
143301195|NCT01826487|516654058|FG001|Overall Study|Withdrawal by Subject|3|||
143301196|NCT01826487|516654057|FG000|Overall Study|Protocol Violation|1|||
143301197|NCT01826487|516654058|FG001|Overall Study|Protocol Violation|1|||
143301198|NCT03979638|516654067|FG000|Period 1|Physician Decision|1|||
143301199|NCT03979638|516654068|FG001|Period 1|Physician Decision|1|||
143301200|NCT03979638|516654067|FG000|Period 1|Withdrawal by Subject|4|||
143301201|NCT03979638|516654068|FG001|Period 1|Withdrawal by Subject|3|||
143301202|NCT03979638|516654067|FG000|Period 1|Study terminated by Sponsor|1|||
143301203|NCT03979638|516654068|FG001|Period 1|Study terminated by Sponsor|3|||
143301204|NCT03979638|516654067|FG000|Period 1|Protocol Violation|1|||
143301205|NCT03979638|516654068|FG001|Period 1|Protocol Violation|0|||
143301206|NCT03979638|516654067|FG000|Period 2|Study terminated by Sponsor|1|||
143301207|NCT03979638|516654068|FG001|Period 2|Study terminated by Sponsor|1|||
143301208|NCT04248933|516654073|FG000|Overall Study|Lost to Follow-up|9|||
143301209|NCT04248933|516654073|FG000|Overall Study|Withdrawal by Subject|2|||
143301210|NCT00578942|516654074|FG000|Overall Study|Lost to Follow-up|1|||
143301211|NCT00600938|516654077|FG000|Core Study|Abnormal test procedure result(s)|3|||
143301212|NCT00600938|516654078|FG001|Core Study|Abnormal test procedure result(s)|2|||
143301213|NCT00600938|516654079|FG002|Core Study|Abnormal test procedure result(s)|0|||
143301214|NCT00600938|516654080|FG003|Core Study|Abnormal test procedure result(s)|0|||
143301215|NCT00600938|516654077|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
143301216|NCT00600938|516654078|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
143301217|NCT00600938|516654079|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
143301218|NCT00600938|516654080|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
143301219|NCT00600938|516654077|FG000|Core Study|Patient withdrew consent|7|||
143301220|NCT00600938|516654078|FG001|Core Study|Patient withdrew consent|12|||
143301221|NCT00600938|516654079|FG002|Core Study|Patient withdrew consent|0|||
143301222|NCT00600938|516654080|FG003|Core Study|Patient withdrew consent|0|||
143301223|NCT00600938|516654077|FG000|Core Study|Lost to Follow-up|3|||
143301224|NCT00600938|516654078|FG001|Core Study|Lost to Follow-up|2|||
143301225|NCT00600938|516654079|FG002|Core Study|Lost to Follow-up|0|||
143301226|NCT00600938|516654080|FG003|Core Study|Lost to Follow-up|0|||
143301227|NCT00600938|516654077|FG000|Core Study|Death|1|||
143301228|NCT00600938|516654078|FG001|Core Study|Death|1|||
143301229|NCT00600938|516654079|FG002|Core Study|Death|0|||
143301230|NCT00600938|516654080|FG003|Core Study|Death|0|||
143301231|NCT00600938|516654077|FG000|Core Study|Protocol Violation|1|||
143301232|NCT00600938|516654078|FG001|Core Study|Protocol Violation|2|||
143301233|NCT00600938|516654079|FG002|Core Study|Protocol Violation|0|||
143301234|NCT00600938|516654080|FG003|Core Study|Protocol Violation|0|||
143301235|NCT00600938|516654077|FG000|Extension Study|Adverse Event|1|||
143301236|NCT00600938|516654078|FG001|Extension Study|Adverse Event|0|||
143301237|NCT00600938|516654079|FG002|Extension Study|Adverse Event|2|||
143301238|NCT00600938|516654080|FG003|Extension Study|Adverse Event|0|||
143301239|NCT00600938|516654077|FG000|Extension Study|Abnormal test procedure results|0|||
143301240|NCT00600938|516654078|FG001|Extension Study|Abnormal test procedure results|1|||
143301241|NCT00600938|516654079|FG002|Extension Study|Abnormal test procedure results|1|||
143301242|NCT00600938|516654080|FG003|Extension Study|Abnormal test procedure results|1|||
143301243|NCT00600938|516654077|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
143301244|NCT00600938|516654078|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
143301245|NCT00600938|516654079|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
143301246|NCT00600938|516654080|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
143301247|NCT00600938|516654077|FG000|Extension Study|Withdrawal by Subject|2|||
143301248|NCT00600938|516654078|FG001|Extension Study|Withdrawal by Subject|2|||
143301249|NCT00600938|516654079|FG002|Extension Study|Withdrawal by Subject|3|||
143301250|NCT00600938|516654080|FG003|Extension Study|Withdrawal by Subject|0|||
143301251|NCT00600938|516654077|FG000|Extension Study|Lost to Follow-up|1|||
143301252|NCT00600938|516654078|FG001|Extension Study|Lost to Follow-up|1|||
143301253|NCT00600938|516654079|FG002|Extension Study|Lost to Follow-up|2|||
143301254|NCT00600938|516654080|FG003|Extension Study|Lost to Follow-up|0|||
143301255|NCT00600938|516654077|FG000|Extension Study|Death|1|||
143301256|NCT00600938|516654078|FG001|Extension Study|Death|0|||
143301257|NCT00600938|516654079|FG002|Extension Study|Death|0|||
143301258|NCT00600938|516654080|FG003|Extension Study|Death|0|||
143301259|NCT04220411|516654081|FG000|Overall Study|Adverse Event|0|||
143301260|NCT04220411|516654082|FG001|Overall Study|Adverse Event|0|||
143301261|NCT04220411|516654083|FG002|Overall Study|Adverse Event|0|||
143301262|NCT04220411|516654084|FG003|Overall Study|Adverse Event|1|||
143301263|NCT02680639|516654085|FG000|Screening Period|Screen Failure|7|||
143301264|NCT02680639|516654086|FG001|Screening Period|Screen Failure|0|||
143301265|NCT02680639|516654087|FG002|Screening Period|Screen Failure|0|||
143301266|NCT00323115|516654091|FG000|Vaccine Administration|Adverse Event|1|||
143301267|NCT00323115|516654091|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
143301268|NCT02946047|516654092|FG000|Overall Study|Adverse Event|1|||
143301269|NCT02946047|516654093|FG001|Overall Study|Adverse Event|0|||
143301270|NCT02946047|516654094|FG002|Overall Study|Adverse Event|0|||
143301271|NCT02946047|516654095|FG003|Overall Study|Adverse Event|0|||
143301272|NCT02496533|516654096|FG000|Overall Study|Lack of data on outcome|3|||
143301273|NCT02496533|516654097|FG001|Overall Study|Lack of data on outcome|0|||
143301274|NCT02496533|516654096|FG000|Overall Study|Patient did not complete all measures|0|||
143301275|NCT02496533|516654097|FG001|Overall Study|Patient did not complete all measures|4|||
143301276|NCT02496533|516654096|FG000|Overall Study|Late for radiologic testing|0|||
143301277|NCT02496533|516654097|FG001|Overall Study|Late for radiologic testing|2|||
143301278|NCT04439318|516654098|FG000|Overall Study|Ineligible|1|||
143301279|NCT04439318|516654098|FG000|Overall Study|Never Started Treatment|3|||
143301280|NCT04439318|516654098|FG000|Overall Study|Adverse Event|10|||
143301281|NCT04439318|516654098|FG000|Overall Study|Death|2|||
143301282|NCT04439318|516654098|FG000|Overall Study|Disease Progression|25|||
143301283|NCT04439318|516654098|FG000|Overall Study|Other Complicating Disease|2|||
143301284|NCT04439318|516654098|FG000|Overall Study|Withdrawal by Subject|4|||
143301285|NCT04439318|516654098|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
143301286|NCT04439318|516654098|FG000|Overall Study|Non-Compliance|1|||
143301287|NCT04439318|516654098|FG000|Overall Study|Still on Treatment|1|||
143301288|NCT01921829|516655801|FG000|Overall Study|Withdrawal by Subject|0|||
143301289|NCT01921829|516655802|FG001|Overall Study|Withdrawal by Subject|1|||
143301290|NCT01762943|516655803|FG000|Overall Study|Physician Decision|1|||
143301291|NCT01762943|516655804|FG001|Overall Study|Physician Decision|1|||
143301292|NCT01762943|516655803|FG000|Overall Study|Protocol Violation|1|||
143301293|NCT01762943|516655804|FG001|Overall Study|Protocol Violation|0|||
143301294|NCT01762943|516655803|FG000|Overall Study|Withdrawal by Subject|2|||
143301295|NCT01762943|516655804|FG001|Overall Study|Withdrawal by Subject|1|||
143301296|NCT00539838|516655805|FG000|Overall Study|Fail to return|2|||
143301297|NCT00539838|516655806|FG001|Overall Study|Fail to return|0|||
143301298|NCT00539838|516655807|FG002|Overall Study|Fail to return|0|||
143301299|NCT00539838|516655805|FG000|Overall Study|Withdrawal by Subject|0|||
143301300|NCT00539838|516655806|FG001|Overall Study|Withdrawal by Subject|4|||
143301301|NCT00539838|516655807|FG002|Overall Study|Withdrawal by Subject|0|||
143301302|NCT00539838|516655805|FG000|Overall Study|Death|0|||
143301303|NCT00539838|516655806|FG001|Overall Study|Death|2|||
143301304|NCT00539838|516655807|FG002|Overall Study|Death|0|||
143301305|NCT00539838|516655805|FG000|Overall Study|Did not cooperate|1|||
143301306|NCT00539838|516655806|FG001|Overall Study|Did not cooperate|0|||
143301307|NCT00539838|516655807|FG002|Overall Study|Did not cooperate|1|||
143301308|NCT00539838|516655805|FG000|Overall Study|Administrative|4|||
143301309|NCT00539838|516655806|FG001|Overall Study|Administrative|0|||
143301310|NCT00539838|516655807|FG002|Overall Study|Administrative|8|||
143301311|NCT02658890|516655813|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301312|NCT02658890|516655814|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301313|NCT02658890|516655815|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301314|NCT02658890|516655816|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301315|NCT02658890|516655817|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301316|NCT02658890|516655818|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301317|NCT02658890|516655819|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301318|NCT02658890|516655820|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301319|NCT02658890|516655821|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
143301320|NCT02658890|516655822|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301321|NCT02658890|516655823|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301322|NCT02658890|516655824|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301323|NCT02658890|516655825|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301324|NCT02658890|516655826|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301325|NCT02658890|516655827|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301326|NCT02658890|516655828|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301327|NCT02658890|516655829|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301328|NCT02658890|516655830|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301329|NCT02658890|516655831|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301330|NCT02658890|516655832|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301331|NCT02658890|516655833|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301332|NCT02658890|516655834|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301333|NCT02658890|516655835|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301334|NCT02658890|516655836|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301335|NCT02658890|516655837|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143374763|NCT04956575|516917286|FG003|Overall Study|Death|0|||
143374764|NCT04956575|516917287|FG004|Overall Study|Death|0|||
143301336|NCT02658890|516655838|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301337|NCT02658890|516655839|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301338|NCT02658890|516655813|FG000|Treatment Phase|Adverse Event|0|||
143301339|NCT02658890|516655814|FG001|Treatment Phase|Adverse Event|1|||
143301340|NCT02658890|516655815|FG002|Treatment Phase|Adverse Event|2|||
143301341|NCT02658890|516655816|FG003|Treatment Phase|Adverse Event|2|||
143301342|NCT02658890|516655817|FG004|Treatment Phase|Adverse Event|1|||
143301343|NCT02658890|516655818|FG005|Treatment Phase|Adverse Event|0|||
143301344|NCT02658890|516655819|FG006|Treatment Phase|Adverse Event|0|||
143301345|NCT02658890|516655820|FG007|Treatment Phase|Adverse Event|2|||
143301346|NCT02658890|516655821|FG008|Treatment Phase|Adverse Event|1|||
143301347|NCT02658890|516655822|FG009|Treatment Phase|Adverse Event|2|||
143301348|NCT02658890|516655823|FG010|Treatment Phase|Adverse Event|3|||
143301349|NCT02658890|516655824|FG011|Treatment Phase|Adverse Event|0|||
143301350|NCT02658890|516655825|FG012|Treatment Phase|Adverse Event|1|||
143301351|NCT02658890|516655826|FG013|Treatment Phase|Adverse Event|4|||
143301352|NCT02658890|516655827|FG014|Treatment Phase|Adverse Event|0|||
143301353|NCT02658890|516655828|FG015|Treatment Phase|Adverse Event|0|||
143301354|NCT02658890|516655829|FG016|Treatment Phase|Adverse Event|0|||
143301355|NCT02658890|516655830|FG017|Treatment Phase|Adverse Event|0|||
143301356|NCT02658890|516655831|FG018|Treatment Phase|Adverse Event|5|||
143301357|NCT02658890|516655832|FG019|Treatment Phase|Adverse Event|1|||
143301358|NCT02658890|516655833|FG020|Treatment Phase|Adverse Event|3|||
143301359|NCT02658890|516655834|FG021|Treatment Phase|Adverse Event|0|||
143301360|NCT02658890|516655835|FG022|Treatment Phase|Adverse Event|5|||
143301361|NCT02658890|516655836|FG023|Treatment Phase|Adverse Event|0|||
143301362|NCT02658890|516655837|FG024|Treatment Phase|Adverse Event|0|||
143301363|NCT02658890|516655838|FG025|Treatment Phase|Adverse Event|2|||
143301364|NCT02658890|516655839|FG026|Treatment Phase|Adverse Event|1|||
143301365|NCT02658890|516655813|FG000|Treatment Phase|Death|0|||
143301366|NCT02658890|516655814|FG001|Treatment Phase|Death|0|||
143301367|NCT02658890|516655815|FG002|Treatment Phase|Death|0|||
143301368|NCT02658890|516655816|FG003|Treatment Phase|Death|0|||
143301369|NCT02658890|516655817|FG004|Treatment Phase|Death|0|||
143301370|NCT02658890|516655818|FG005|Treatment Phase|Death|0|||
143301371|NCT02658890|516655819|FG006|Treatment Phase|Death|0|||
143301372|NCT02658890|516655820|FG007|Treatment Phase|Death|0|||
143301373|NCT02658890|516655821|FG008|Treatment Phase|Death|0|||
143301374|NCT02658890|516655822|FG009|Treatment Phase|Death|0|||
143301375|NCT02658890|516655823|FG010|Treatment Phase|Death|0|||
143301376|NCT02658890|516655824|FG011|Treatment Phase|Death|0|||
143301377|NCT02658890|516655825|FG012|Treatment Phase|Death|0|||
143301378|NCT02658890|516655826|FG013|Treatment Phase|Death|0|||
143301379|NCT02658890|516655827|FG014|Treatment Phase|Death|0|||
143301380|NCT02658890|516655828|FG015|Treatment Phase|Death|0|||
143301381|NCT02658890|516655829|FG016|Treatment Phase|Death|0|||
143301382|NCT02658890|516655830|FG017|Treatment Phase|Death|0|||
143301383|NCT02658890|516655831|FG018|Treatment Phase|Death|1|||
143301384|NCT02658890|516655832|FG019|Treatment Phase|Death|0|||
143301385|NCT02658890|516655833|FG020|Treatment Phase|Death|0|||
143301386|NCT02658890|516655834|FG021|Treatment Phase|Death|0|||
143301387|NCT02658890|516655835|FG022|Treatment Phase|Death|0|||
143301388|NCT02658890|516655836|FG023|Treatment Phase|Death|0|||
143301389|NCT02658890|516655837|FG024|Treatment Phase|Death|0|||
143301390|NCT02658890|516655838|FG025|Treatment Phase|Death|0|||
143301391|NCT02658890|516655839|FG026|Treatment Phase|Death|0|||
143301392|NCT02658890|516655813|FG000|Treatment Phase|Lost to Follow-up|0|||
143301393|NCT02658890|516655814|FG001|Treatment Phase|Lost to Follow-up|0|||
143301394|NCT02658890|516655815|FG002|Treatment Phase|Lost to Follow-up|0|||
143301395|NCT02658890|516655816|FG003|Treatment Phase|Lost to Follow-up|0|||
143301396|NCT02658890|516655817|FG004|Treatment Phase|Lost to Follow-up|0|||
143301397|NCT02658890|516655818|FG005|Treatment Phase|Lost to Follow-up|0|||
143301398|NCT02658890|516655819|FG006|Treatment Phase|Lost to Follow-up|1|||
143301399|NCT02658890|516655820|FG007|Treatment Phase|Lost to Follow-up|0|||
143301400|NCT02658890|516655821|FG008|Treatment Phase|Lost to Follow-up|0|||
143301401|NCT02658890|516655822|FG009|Treatment Phase|Lost to Follow-up|0|||
143301402|NCT02658890|516655823|FG010|Treatment Phase|Lost to Follow-up|0|||
143301403|NCT02658890|516655824|FG011|Treatment Phase|Lost to Follow-up|0|||
143301404|NCT02658890|516655825|FG012|Treatment Phase|Lost to Follow-up|0|||
143301405|NCT02658890|516655826|FG013|Treatment Phase|Lost to Follow-up|0|||
143301406|NCT02658890|516655827|FG014|Treatment Phase|Lost to Follow-up|0|||
143301407|NCT02658890|516655828|FG015|Treatment Phase|Lost to Follow-up|0|||
143301408|NCT02658890|516655829|FG016|Treatment Phase|Lost to Follow-up|0|||
143301409|NCT02658890|516655830|FG017|Treatment Phase|Lost to Follow-up|0|||
143301410|NCT02658890|516655831|FG018|Treatment Phase|Lost to Follow-up|0|||
143301411|NCT02658890|516655832|FG019|Treatment Phase|Lost to Follow-up|0|||
143301412|NCT02658890|516655833|FG020|Treatment Phase|Lost to Follow-up|0|||
143301413|NCT02658890|516655834|FG021|Treatment Phase|Lost to Follow-up|0|||
143301414|NCT02658890|516655835|FG022|Treatment Phase|Lost to Follow-up|0|||
143301415|NCT02658890|516655836|FG023|Treatment Phase|Lost to Follow-up|0|||
143301416|NCT02658890|516655837|FG024|Treatment Phase|Lost to Follow-up|0|||
143301417|NCT02658890|516655838|FG025|Treatment Phase|Lost to Follow-up|0|||
143301418|NCT02658890|516655839|FG026|Treatment Phase|Lost to Follow-up|0|||
143301419|NCT02658890|516655813|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
143301420|NCT02658890|516655814|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
143301421|NCT02658890|516655815|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
143301422|NCT02658890|516655816|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
143301423|NCT02658890|516655817|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
143301424|NCT02658890|516655818|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
143301425|NCT02658890|516655819|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
143301426|NCT02658890|516655820|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
143301427|NCT02658890|516655821|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
143301428|NCT02658890|516655822|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
143301429|NCT02658890|516655823|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
143301430|NCT02658890|516655824|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
143301431|NCT02658890|516655825|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
143301432|NCT02658890|516655826|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
143301433|NCT02658890|516655827|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
143301434|NCT02658890|516655828|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
143301435|NCT02658890|516655829|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
143301436|NCT02658890|516655830|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
143301437|NCT02658890|516655831|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
143301438|NCT02658890|516655832|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
143301439|NCT02658890|516655833|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
143301440|NCT02658890|516655834|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
143301441|NCT02658890|516655835|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
143301442|NCT02658890|516655836|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
143301443|NCT02658890|516655837|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
143301444|NCT02658890|516655838|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
143301445|NCT02658890|516655839|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
143301446|NCT02658890|516655813|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
143301447|NCT02658890|516655814|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
143301448|NCT02658890|516655815|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
143301449|NCT02658890|516655816|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
143301450|NCT02658890|516655817|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
143301451|NCT02658890|516655818|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
143301452|NCT02658890|516655819|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
143301453|NCT02658890|516655820|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
143301454|NCT02658890|516655821|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
143301455|NCT02658890|516655822|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
143301456|NCT02658890|516655823|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
143301457|NCT02658890|516655824|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
143301458|NCT02658890|516655825|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
143301459|NCT02658890|516655826|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
143301460|NCT02658890|516655827|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
143301461|NCT02658890|516655828|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
143301462|NCT02658890|516655829|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
143301463|NCT02658890|516655830|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
143301464|NCT02658890|516655831|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
143301465|NCT02658890|516655832|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
143301466|NCT02658890|516655833|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
143301467|NCT02658890|516655834|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
143301468|NCT02658890|516655835|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
143301469|NCT02658890|516655836|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
143301470|NCT02658890|516655837|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
143301471|NCT02658890|516655838|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
143301472|NCT02658890|516655839|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
143301473|NCT02658890|516655813|FG000|Treatment Phase|Other Reasons|0|||
143301474|NCT02658890|516655814|FG001|Treatment Phase|Other Reasons|0|||
143301475|NCT02658890|516655815|FG002|Treatment Phase|Other Reasons|0|||
143301476|NCT02658890|516655816|FG003|Treatment Phase|Other Reasons|0|||
143301477|NCT02658890|516655817|FG004|Treatment Phase|Other Reasons|0|||
143301478|NCT02658890|516655818|FG005|Treatment Phase|Other Reasons|0|||
143301479|NCT02658890|516655819|FG006|Treatment Phase|Other Reasons|1|||
143301480|NCT02658890|516655820|FG007|Treatment Phase|Other Reasons|0|||
143301481|NCT02658890|516655821|FG008|Treatment Phase|Other Reasons|1|||
143301482|NCT02658890|516655822|FG009|Treatment Phase|Other Reasons|0|||
143301483|NCT02658890|516655823|FG010|Treatment Phase|Other Reasons|0|||
143301484|NCT02658890|516655824|FG011|Treatment Phase|Other Reasons|0|||
143301485|NCT02658890|516655825|FG012|Treatment Phase|Other Reasons|0|||
143301486|NCT02658890|516655826|FG013|Treatment Phase|Other Reasons|2|||
143301487|NCT02658890|516655827|FG014|Treatment Phase|Other Reasons|0|||
143301488|NCT02658890|516655828|FG015|Treatment Phase|Other Reasons|0|||
143301489|NCT02658890|516655829|FG016|Treatment Phase|Other Reasons|0|||
143301490|NCT02658890|516655830|FG017|Treatment Phase|Other Reasons|0|||
143301491|NCT02658890|516655831|FG018|Treatment Phase|Other Reasons|1|||
143301492|NCT02658890|516655832|FG019|Treatment Phase|Other Reasons|0|||
143301493|NCT02658890|516655833|FG020|Treatment Phase|Other Reasons|0|||
143301494|NCT02658890|516655834|FG021|Treatment Phase|Other Reasons|0|||
143301495|NCT02658890|516655835|FG022|Treatment Phase|Other Reasons|0|||
143301496|NCT02658890|516655836|FG023|Treatment Phase|Other Reasons|0|||
143301497|NCT02658890|516655837|FG024|Treatment Phase|Other Reasons|1|||
143301498|NCT02658890|516655838|FG025|Treatment Phase|Other Reasons|0|||
143301499|NCT02658890|516655839|FG026|Treatment Phase|Other Reasons|1|||
143301500|NCT02658890|516655813|FG000|Treatment Phase|Progressive Disease|6|||
143301501|NCT02658890|516655814|FG001|Treatment Phase|Progressive Disease|7|||
143301502|NCT02658890|516655815|FG002|Treatment Phase|Progressive Disease|6|||
143301503|NCT02658890|516655816|FG003|Treatment Phase|Progressive Disease|12|||
143301504|NCT02658890|516655817|FG004|Treatment Phase|Progressive Disease|6|||
143301505|NCT02658890|516655818|FG005|Treatment Phase|Progressive Disease|18|||
143301506|NCT02658890|516655819|FG006|Treatment Phase|Progressive Disease|12|||
143301507|NCT02658890|516655820|FG007|Treatment Phase|Progressive Disease|19|||
143301508|NCT02658890|516655821|FG008|Treatment Phase|Progressive Disease|26|||
143301509|NCT02658890|516655822|FG009|Treatment Phase|Progressive Disease|8|||
143301510|NCT02658890|516655823|FG010|Treatment Phase|Progressive Disease|7|||
143301511|NCT02658890|516655824|FG011|Treatment Phase|Progressive Disease|9|||
143301512|NCT02658890|516655825|FG012|Treatment Phase|Progressive Disease|8|||
143301513|NCT02658890|516655826|FG013|Treatment Phase|Progressive Disease|29|||
143301514|NCT02658890|516655827|FG014|Treatment Phase|Progressive Disease|6|||
143301515|NCT02658890|516655828|FG015|Treatment Phase|Progressive Disease|2|||
143301516|NCT02658890|516655829|FG016|Treatment Phase|Progressive Disease|32|||
143301517|NCT02658890|516655830|FG017|Treatment Phase|Progressive Disease|14|||
143301518|NCT02658890|516655831|FG018|Treatment Phase|Progressive Disease|40|||
143301519|NCT02658890|516655832|FG019|Treatment Phase|Progressive Disease|32|||
143301520|NCT02658890|516655833|FG020|Treatment Phase|Progressive Disease|19|||
143301521|NCT02658890|516655834|FG021|Treatment Phase|Progressive Disease|30|||
143301522|NCT02658890|516655835|FG022|Treatment Phase|Progressive Disease|15|||
143301523|NCT02658890|516655836|FG023|Treatment Phase|Progressive Disease|0|||
143301524|NCT02658890|516655837|FG024|Treatment Phase|Progressive Disease|0|||
143301525|NCT02658890|516655838|FG025|Treatment Phase|Progressive Disease|14|||
143301526|NCT02658890|516655839|FG026|Treatment Phase|Progressive Disease|11|||
143301527|NCT02658890|516655813|FG000|Treatment Phase|Study Drug Toxicity|0|||
143301528|NCT02658890|516655814|FG001|Treatment Phase|Study Drug Toxicity|0|||
143301529|NCT02658890|516655815|FG002|Treatment Phase|Study Drug Toxicity|2|||
143301530|NCT02658890|516655816|FG003|Treatment Phase|Study Drug Toxicity|0|||
143301531|NCT02658890|516655817|FG004|Treatment Phase|Study Drug Toxicity|0|||
143301532|NCT02658890|516655818|FG005|Treatment Phase|Study Drug Toxicity|0|||
143301533|NCT02658890|516655819|FG006|Treatment Phase|Study Drug Toxicity|0|||
143301534|NCT02658890|516655820|FG007|Treatment Phase|Study Drug Toxicity|0|||
143301535|NCT02658890|516655821|FG008|Treatment Phase|Study Drug Toxicity|3|||
143301536|NCT02658890|516655822|FG009|Treatment Phase|Study Drug Toxicity|0|||
143301537|NCT02658890|516655823|FG010|Treatment Phase|Study Drug Toxicity|1|||
143301538|NCT02658890|516655824|FG011|Treatment Phase|Study Drug Toxicity|1|||
143301539|NCT02658890|516655825|FG012|Treatment Phase|Study Drug Toxicity|2|||
143301540|NCT02658890|516655826|FG013|Treatment Phase|Study Drug Toxicity|9|||
143301541|NCT02658890|516655827|FG014|Treatment Phase|Study Drug Toxicity|0|||
143301542|NCT02658890|516655828|FG015|Treatment Phase|Study Drug Toxicity|1|||
143301543|NCT02658890|516655829|FG016|Treatment Phase|Study Drug Toxicity|1|||
143301544|NCT02658890|516655830|FG017|Treatment Phase|Study Drug Toxicity|0|||
143301545|NCT02658890|516655831|FG018|Treatment Phase|Study Drug Toxicity|8|||
143301546|NCT02658890|516655832|FG019|Treatment Phase|Study Drug Toxicity|3|||
143301547|NCT02658890|516655833|FG020|Treatment Phase|Study Drug Toxicity|2|||
143301548|NCT02658890|516655834|FG021|Treatment Phase|Study Drug Toxicity|0|||
143301549|NCT02658890|516655835|FG022|Treatment Phase|Study Drug Toxicity|8|||
143301550|NCT02658890|516655836|FG023|Treatment Phase|Study Drug Toxicity|0|||
143301551|NCT02658890|516655837|FG024|Treatment Phase|Study Drug Toxicity|0|||
143301552|NCT02658890|516655838|FG025|Treatment Phase|Study Drug Toxicity|2|||
143301553|NCT02658890|516655839|FG026|Treatment Phase|Study Drug Toxicity|0|||
143301554|NCT02658890|516655813|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301555|NCT02658890|516655814|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301556|NCT02658890|516655815|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301557|NCT02658890|516655816|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
143301558|NCT02658890|516655817|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301559|NCT02658890|516655818|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301560|NCT02658890|516655819|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301561|NCT02658890|516655820|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301562|NCT02658890|516655821|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301563|NCT02658890|516655822|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
143301564|NCT02658890|516655823|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301565|NCT02658890|516655824|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301566|NCT02658890|516655825|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301567|NCT02658890|516655826|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301568|NCT02658890|516655827|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301569|NCT02658890|516655828|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301570|NCT02658890|516655829|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301571|NCT02658890|516655830|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301572|NCT02658890|516655831|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
143301573|NCT02658890|516655832|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301574|NCT02658890|516655833|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301575|NCT02658890|516655834|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301576|NCT02658890|516655835|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
143301577|NCT02658890|516655836|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301578|NCT02658890|516655837|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301579|NCT02658890|516655838|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301580|NCT02658890|516655839|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
143301581|NCT02658890|516655813|FG000|Treatment Phase|Withdrawal by Subject|0|||
143301582|NCT02658890|516655814|FG001|Treatment Phase|Withdrawal by Subject|1|||
143301583|NCT02658890|516655815|FG002|Treatment Phase|Withdrawal by Subject|0|||
143301584|NCT02658890|516655816|FG003|Treatment Phase|Withdrawal by Subject|0|||
143301585|NCT02658890|516655817|FG004|Treatment Phase|Withdrawal by Subject|0|||
143301586|NCT02658890|516655818|FG005|Treatment Phase|Withdrawal by Subject|0|||
143301587|NCT02658890|516655819|FG006|Treatment Phase|Withdrawal by Subject|1|||
143301588|NCT02658890|516655820|FG007|Treatment Phase|Withdrawal by Subject|0|||
143301589|NCT02658890|516655821|FG008|Treatment Phase|Withdrawal by Subject|0|||
143301590|NCT02658890|516655822|FG009|Treatment Phase|Withdrawal by Subject|1|||
143301591|NCT02658890|516655823|FG010|Treatment Phase|Withdrawal by Subject|0|||
143301592|NCT02658890|516655824|FG011|Treatment Phase|Withdrawal by Subject|0|||
143301593|NCT02658890|516655825|FG012|Treatment Phase|Withdrawal by Subject|1|||
143301594|NCT02658890|516655826|FG013|Treatment Phase|Withdrawal by Subject|3|||
143301595|NCT02658890|516655827|FG014|Treatment Phase|Withdrawal by Subject|0|||
143301596|NCT02658890|516655828|FG015|Treatment Phase|Withdrawal by Subject|0|||
143301597|NCT02658890|516655829|FG016|Treatment Phase|Withdrawal by Subject|1|||
143301598|NCT02658890|516655830|FG017|Treatment Phase|Withdrawal by Subject|0|||
143301599|NCT02658890|516655831|FG018|Treatment Phase|Withdrawal by Subject|4|||
143301600|NCT02658890|516655832|FG019|Treatment Phase|Withdrawal by Subject|3|||
143301601|NCT02658890|516655833|FG020|Treatment Phase|Withdrawal by Subject|0|||
143301602|NCT02658890|516655834|FG021|Treatment Phase|Withdrawal by Subject|4|||
143301603|NCT02658890|516655835|FG022|Treatment Phase|Withdrawal by Subject|1|||
143301604|NCT02658890|516655836|FG023|Treatment Phase|Withdrawal by Subject|1|||
143301605|NCT02658890|516655837|FG024|Treatment Phase|Withdrawal by Subject|0|||
143301606|NCT02658890|516655838|FG025|Treatment Phase|Withdrawal by Subject|0|||
143301607|NCT02658890|516655839|FG026|Treatment Phase|Withdrawal by Subject|0|||
143301608|NCT03090100|516655840|FG000|Overall Study|Adverse Event|9|||
143301609|NCT03090100|516655841|FG001|Overall Study|Adverse Event|11|||
143301610|NCT03090100|516655840|FG000|Overall Study|Pregnancy|1|||
143301611|NCT03090100|516655841|FG001|Overall Study|Pregnancy|1|||
143301612|NCT03090100|516655840|FG000|Overall Study|Lack of Efficacy|2|||
143301613|NCT03090100|516655841|FG001|Overall Study|Lack of Efficacy|7|||
143301614|NCT03090100|516655840|FG000|Overall Study|Lost to Follow-up|2|||
143301615|NCT03090100|516655841|FG001|Overall Study|Lost to Follow-up|2|||
143301616|NCT03090100|516655840|FG000|Overall Study|Withdrawal by Subject|7|||
143301617|NCT03090100|516655841|FG001|Overall Study|Withdrawal by Subject|19|||
143301618|NCT03090100|516655840|FG000|Overall Study|Protocol Violation|2|||
143301619|NCT03090100|516655841|FG001|Overall Study|Protocol Violation|6|||
143301620|NCT03090100|516655840|FG000|Overall Study|Non-compliance|2|||
143301621|NCT03090100|516655841|FG001|Overall Study|Non-compliance|0|||
143301622|NCT03090100|516655840|FG000|Overall Study|Other|2|||
143301623|NCT03090100|516655841|FG001|Overall Study|Other|2|||
143301624|NCT01344447|516655844|FG000|Overall Study|Adverse Event|1|||
143301625|NCT01344447|516655844|FG000|Overall Study|Protocol Violation|1|||
143301626|NCT01344447|516655844|FG000|Overall Study|Withdrawal by Subject|1|||
143301627|NCT01344447|516655844|FG000|Overall Study|The contrast was not seen|1|||
143374765|NCT04956575|516917288|FG005|Overall Study|Death|0|||
143301628|NCT01344447|516655844|FG000|Overall Study|Physician Decision|1|||
143301629|NCT01344447|516655844|FG000|Overall Study|MRA unsuccessful|1|||
143301630|NCT01344447|516655844|FG000|Overall Study|Bolus tracking failed|1|||
143301631|NCT01344447|516655844|FG000|Overall Study|Error of power injector|1|||
143301632|NCT00076011|516655848|FG000|Overall Study|Death|1|||
143301633|NCT00076011|516655848|FG000|Overall Study|Adverse Event|10|||
143301634|NCT00076011|516655848|FG000|Overall Study|Lack of Efficacy|25|||
143301635|NCT00076011|516655848|FG000|Overall Study|Withdrawal by Subject|1|||
143374766|NCT04956575|516917289|FG006|Overall Study|Death|0|||
143374767|NCT04956575|516917290|FG007|Overall Study|Death|1|||
143374768|NCT04956575|516917291|FG008|Overall Study|Death|0|||
143374769|NCT04956575|516917292|FG009|Overall Study|Death|1|||
143374770|NCT04956575|516917293|FG010|Overall Study|Death|0|||
143374771|NCT04956575|516917294|FG011|Overall Study|Death|0|||
143374772|NCT04956575|516917283|FG000|Overall Study|Lost to Follow-up|3|||
143374773|NCT04956575|516917284|FG001|Overall Study|Lost to Follow-up|4|||
143374774|NCT04956575|516917285|FG002|Overall Study|Lost to Follow-up|2|||
143374775|NCT04956575|516917286|FG003|Overall Study|Lost to Follow-up|3|||
143374776|NCT04956575|516917287|FG004|Overall Study|Lost to Follow-up|1|||
143374777|NCT04956575|516917288|FG005|Overall Study|Lost to Follow-up|10|||
143374778|NCT04956575|516917289|FG006|Overall Study|Lost to Follow-up|11|||
143374779|NCT04956575|516917290|FG007|Overall Study|Lost to Follow-up|7|||
143374780|NCT04956575|516917291|FG008|Overall Study|Lost to Follow-up|4|||
143301636|NCT00076011|516655848|FG000|Overall Study|Study terminated by sponsor|3|||
143301637|NCT00076011|516655848|FG000|Overall Study|Other|11|||
143301638|NCT00076011|516655848|FG000|Overall Study|Ongoing|1|||
143301639|NCT03314584|516655849|FG000|Overall Study|Withdrawal by Subject|3|||
143301640|NCT03314584|516655850|FG001|Overall Study|Withdrawal by Subject|3|||
143301641|NCT03314584|516655849|FG000|Overall Study|Lost to Follow-up|4|||
143301642|NCT03314584|516655850|FG001|Overall Study|Lost to Follow-up|0|||
143301643|NCT03615326|516655858|FG000|Overall Study|Death|266|||
143301644|NCT03615326|516655859|FG001|Overall Study|Death|286|||
143301645|NCT03615326|516655860|FG002|Overall Study|Death|14|||
143301646|NCT03615326|516655861|FG003|Overall Study|Death|17|||
143301647|NCT03615326|516655858|FG000|Overall Study|Lost to Follow-up|0|||
143301648|NCT03615326|516655859|FG001|Overall Study|Lost to Follow-up|1|||
143301649|NCT03615326|516655860|FG002|Overall Study|Lost to Follow-up|0|||
143301650|NCT03615326|516655861|FG003|Overall Study|Lost to Follow-up|0|||
143301651|NCT03615326|516655858|FG000|Overall Study|Withdrawal by Subject|1|||
143301652|NCT03615326|516655859|FG001|Overall Study|Withdrawal by Subject|3|||
143301653|NCT03615326|516655860|FG002|Overall Study|Withdrawal by Subject|0|||
143301654|NCT03615326|516655861|FG003|Overall Study|Withdrawal by Subject|0|||
143301655|NCT03615326|516655858|FG000|Overall Study|Participants Ongoing|83|||
143301656|NCT03615326|516655859|FG001|Overall Study|Participants Ongoing|58|||
143301657|NCT03615326|516655860|FG002|Overall Study|Participants Ongoing|6|||
143301658|NCT03615326|516655861|FG003|Overall Study|Participants Ongoing|3|||
143301659|NCT01505608|516655868|FG000|Phase I|Lack of Efficacy|0|||
143301660|NCT01505608|516655869|FG001|Phase I|Lack of Efficacy|4|||
143301661|NCT01505608|516655868|FG000|Phase I|Adverse Event|0|||
143301662|NCT01505608|516655869|FG001|Phase I|Adverse Event|1|||
143301663|NCT01505608|516655868|FG000|Phase I|Withdrawal by Subject|0|||
143301664|NCT01505608|516655869|FG001|Phase I|Withdrawal by Subject|1|||
143301665|NCT01505608|516655868|FG000|Phase II|Lack of Efficacy|2|||
143301666|NCT01505608|516655869|FG001|Phase II|Lack of Efficacy|1|||
143301667|NCT01505608|516655868|FG000|Phase II|Protocol Violation|0|||
143301668|NCT01505608|516655869|FG001|Phase II|Protocol Violation|1|||
143301669|NCT03969992|516655873|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|1|||
143301670|NCT03969992|516655874|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|0|||
143301671|NCT03969992|516655875|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|3|||
143301672|NCT03969992|516655873|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
143301673|NCT03969992|516655874|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Death|3|||
143301674|NCT03969992|516655875|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
143301675|NCT03969992|516655873|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|12|||
143301676|NCT03969992|516655874|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|8|||
143301677|NCT03969992|516655875|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|9|||
143301678|NCT03969992|516655873|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
143301679|NCT03969992|516655874|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
143301680|NCT03969992|516655875|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|1|||
143301681|NCT03969992|516655873|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|3|||
143301682|NCT03969992|516655874|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|1|||
143301683|NCT03969992|516655875|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|0|||
143301684|NCT02063737|516655876|FG000|Overall Study|Lost to Follow-up|11|||
143301685|NCT02063737|516655877|FG001|Overall Study|Lost to Follow-up|4|||
143301686|NCT00439556|516655878|FG000|Overall Study|Patient was taken off study for non-comp|0|||
143301687|NCT00439556|516655879|FG001|Overall Study|Patient was taken off study for non-comp|1|||
143301688|NCT00439556|516655880|FG002|Overall Study|Patient was taken off study for non-comp|0|||
143301689|NCT01324388|516655883|FG000|Part 1 of Study|Adverse Event|2|||
143374781|NCT04956575|516917292|FG009|Overall Study|Lost to Follow-up|2|||
143374782|NCT04956575|516917293|FG010|Overall Study|Lost to Follow-up|3|||
143374783|NCT04956575|516917294|FG011|Overall Study|Lost to Follow-up|8|||
143374784|NCT04956575|516917283|FG000|Overall Study|Withdrawal by Subject|1|||
143374785|NCT04956575|516917284|FG001|Overall Study|Withdrawal by Subject|2|||
143374786|NCT04956575|516917285|FG002|Overall Study|Withdrawal by Subject|1|||
143374787|NCT04956575|516917286|FG003|Overall Study|Withdrawal by Subject|4|||
143374788|NCT04956575|516917287|FG004|Overall Study|Withdrawal by Subject|2|||
143301690|NCT01324388|516655884|FG001|Part 1 of Study|Adverse Event|0|||
143301691|NCT01324388|516655885|FG002|Part 1 of Study|Adverse Event|0|||
143301692|NCT01324388|516655886|FG003|Part 1 of Study|Adverse Event|0|||
143301693|NCT01324388|516655883|FG000|Part 1 of Study|Protocol Violation|1|||
143301694|NCT01324388|516655884|FG001|Part 1 of Study|Protocol Violation|2|||
143301695|NCT01324388|516655885|FG002|Part 1 of Study|Protocol Violation|0|||
143301696|NCT01324388|516655886|FG003|Part 1 of Study|Protocol Violation|0|||
143301697|NCT01324388|516655883|FG000|Part 1 of Study|Physician Decision|1|||
143301698|NCT01324388|516655884|FG001|Part 1 of Study|Physician Decision|0|||
143301699|NCT01324388|516655885|FG002|Part 1 of Study|Physician Decision|0|||
143301700|NCT01324388|516655886|FG003|Part 1 of Study|Physician Decision|0|||
143301701|NCT01324388|516655883|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
143301702|NCT01324388|516655884|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
143301703|NCT01324388|516655885|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
143301704|NCT01324388|516655886|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
143301705|NCT01324388|516655883|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
143301706|NCT01324388|516655884|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
143301707|NCT01324388|516655885|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
143301708|NCT01324388|516655886|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
143301709|NCT01408030|516655888|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
143301710|NCT01408030|516655889|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
143301711|NCT01408030|516655890|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
143301712|NCT01408030|516655891|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
143301713|NCT01408030|516655888|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
143301714|NCT01408030|516655889|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
143301715|NCT01408030|516655890|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
143301716|NCT01408030|516655891|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
143301717|NCT01408030|516655888|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
143301718|NCT01408030|516655889|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
143301719|NCT01408030|516655890|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
143301720|NCT01408030|516655891|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
143301721|NCT01408030|516655888|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
143301722|NCT01408030|516655889|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
143301723|NCT01408030|516655890|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
143301724|NCT01408030|516655891|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
143301725|NCT01408030|516655888|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
143301726|NCT01408030|516655889|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
143301727|NCT01408030|516655890|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
143301728|NCT01408030|516655891|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
143301729|NCT01408030|516655888|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
143301730|NCT01408030|516655889|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
143301731|NCT01408030|516655890|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
143301732|NCT01408030|516655891|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
143301733|NCT01408030|516655888|FG000|Observation Phase (Off Drug)|Other|1|||
143301734|NCT01408030|516655889|FG001|Observation Phase (Off Drug)|Other|1|||
143301735|NCT01408030|516655890|FG002|Observation Phase (Off Drug)|Other|1|||
143301736|NCT01408030|516655891|FG003|Observation Phase (Off Drug)|Other|1|||
143301737|NCT00108160|516655892|FG000|Overall Study|Lost to Follow-up|25|||
143301738|NCT00108160|516655893|FG001|Overall Study|Lost to Follow-up|12|||
143301739|NCT00108160|516655892|FG000|Overall Study|Death|1|||
143301740|NCT00108160|516655893|FG001|Overall Study|Death|2|||
143301741|NCT00108160|516655892|FG000|Overall Study|Withdrawal by Subject|4|||
143301742|NCT00108160|516655893|FG001|Overall Study|Withdrawal by Subject|2|||
143301743|NCT00108160|516655892|FG000|Overall Study|Protocol Violation|9|||
143301744|NCT00108160|516655893|FG001|Overall Study|Protocol Violation|5|||
143301745|NCT00768144|516655896|FG000|Overall Study|Adverse Event|13|||
143301746|NCT00768144|516655896|FG000|Overall Study|Progressive Disease|21|||
143301747|NCT00768144|516655896|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
143301748|NCT00768144|516655896|FG000|Overall Study|Pt Withdrew Consent|1|||
143301749|NCT01150123|516655897|FG000|Overall Study|Withdrawal by Subject|1|||
143301750|NCT01150123|516655898|FG001|Overall Study|Withdrawal by Subject|1|||
143301751|NCT01150123|516655899|FG002|Overall Study|Withdrawal by Subject|2|||
143301752|NCT01150123|516655900|FG003|Overall Study|Withdrawal by Subject|1|||
143301753|NCT01150123|516655901|FG004|Overall Study|Withdrawal by Subject|1|||
143301754|NCT01150123|516655902|FG005|Overall Study|Withdrawal by Subject|1|||
143301755|NCT01150123|516655903|FG006|Overall Study|Withdrawal by Subject|0|||
143301756|NCT01150123|516655904|FG007|Overall Study|Withdrawal by Subject|3|||
143301757|NCT01150123|516655905|FG008|Overall Study|Withdrawal by Subject|2|||
143301758|NCT01150123|516655906|FG009|Overall Study|Withdrawal by Subject|0|||
143301759|NCT01150123|516655907|FG010|Overall Study|Withdrawal by Subject|1|||
143301760|NCT01150123|516655908|FG011|Overall Study|Withdrawal by Subject|0|||
143301761|NCT01150123|516655909|FG012|Overall Study|Withdrawal by Subject|1|||
143301762|NCT01150123|516655910|FG013|Overall Study|Withdrawal by Subject|0|||
143301763|NCT01150123|516655911|FG014|Overall Study|Withdrawal by Subject|0|||
143301764|NCT01150123|516655912|FG015|Overall Study|Withdrawal by Subject|1|||
143301765|NCT01150123|516655913|FG016|Overall Study|Withdrawal by Subject|0|||
143301766|NCT01150123|516655914|FG017|Overall Study|Withdrawal by Subject|1|||
143301767|NCT01150123|516655897|FG000|Overall Study|Lost to Follow-up|2|||
143301768|NCT01150123|516655898|FG001|Overall Study|Lost to Follow-up|1|||
143301769|NCT01150123|516655899|FG002|Overall Study|Lost to Follow-up|2|||
143301770|NCT01150123|516655900|FG003|Overall Study|Lost to Follow-up|2|||
143301771|NCT01150123|516655901|FG004|Overall Study|Lost to Follow-up|2|||
143301772|NCT01150123|516655902|FG005|Overall Study|Lost to Follow-up|5|||
143301773|NCT01150123|516655903|FG006|Overall Study|Lost to Follow-up|0|||
143301774|NCT01150123|516655904|FG007|Overall Study|Lost to Follow-up|0|||
143301775|NCT01150123|516655905|FG008|Overall Study|Lost to Follow-up|3|||
143301776|NCT01150123|516655906|FG009|Overall Study|Lost to Follow-up|1|||
143301777|NCT01150123|516655907|FG010|Overall Study|Lost to Follow-up|1|||
143301778|NCT01150123|516655908|FG011|Overall Study|Lost to Follow-up|1|||
143301779|NCT01150123|516655909|FG012|Overall Study|Lost to Follow-up|2|||
143301780|NCT01150123|516655910|FG013|Overall Study|Lost to Follow-up|0|||
143301781|NCT01150123|516655911|FG014|Overall Study|Lost to Follow-up|0|||
143301782|NCT01150123|516655912|FG015|Overall Study|Lost to Follow-up|0|||
143301783|NCT01150123|516655913|FG016|Overall Study|Lost to Follow-up|0|||
143301784|NCT01150123|516655914|FG017|Overall Study|Lost to Follow-up|0|||
143301785|NCT02171260|516655919|FG000|Overall Study|Death|0|||
143301786|NCT02171260|516655920|FG001|Overall Study|Death|0|||
143301787|NCT02171260|516655921|FG002|Overall Study|Death|0|||
143301788|NCT02171260|516655922|FG003|Overall Study|Death|1|||
143301789|NCT02171260|516655919|FG000|Overall Study|Physician Decision|1|||
143301790|NCT02171260|516655920|FG001|Overall Study|Physician Decision|0|||
143301791|NCT02171260|516655921|FG002|Overall Study|Physician Decision|1|||
143301792|NCT02171260|516655922|FG003|Overall Study|Physician Decision|0|||
143301793|NCT02171260|516655919|FG000|Overall Study|Withdrawal by Subject|1|||
143301794|NCT02171260|516655920|FG001|Overall Study|Withdrawal by Subject|0|||
143301795|NCT02171260|516655921|FG002|Overall Study|Withdrawal by Subject|0|||
143301796|NCT02171260|516655922|FG003|Overall Study|Withdrawal by Subject|0|||
143301797|NCT02171260|516655919|FG000|Overall Study|Evidence of progressive disease|4|||
143301798|NCT02171260|516655920|FG001|Overall Study|Evidence of progressive disease|6|||
143301799|NCT02171260|516655921|FG002|Overall Study|Evidence of progressive disease|4|||
143374789|NCT04956575|516917288|FG005|Overall Study|Withdrawal by Subject|8|||
143374790|NCT04956575|516917289|FG006|Overall Study|Withdrawal by Subject|5|||
143374791|NCT04956575|516917290|FG007|Overall Study|Withdrawal by Subject|1|||
143374792|NCT04956575|516917291|FG008|Overall Study|Withdrawal by Subject|1|||
143374793|NCT04956575|516917292|FG009|Overall Study|Withdrawal by Subject|0|||
143301800|NCT02171260|516655922|FG003|Overall Study|Evidence of progressive disease|4|||
143301801|NCT00323492|516655923|FG000|Study Phase 1|Adverse Event|2|||
143301802|NCT00323492|516655924|FG001|Study Phase 1|Adverse Event|0|||
143301803|NCT00323492|516655925|FG002|Study Phase 1|Adverse Event|0|||
143301804|NCT00323492|516655923|FG000|Study Phase 2|Adverse Event|1|||
143301805|NCT00323492|516655924|FG001|Study Phase 2|Adverse Event|0|||
143301806|NCT00323492|516655925|FG002|Study Phase 2|Adverse Event|0|||
143301807|NCT00323492|516655923|FG000|Study Phase 2|Physician Decision|1|||
143301808|NCT00323492|516655924|FG001|Study Phase 2|Physician Decision|0|||
143374794|NCT04956575|516917293|FG010|Overall Study|Withdrawal by Subject|3|||
143374795|NCT04956575|516917294|FG011|Overall Study|Withdrawal by Subject|1|||
143374796|NCT03593876|516917295|FG000|Overall Study|Withdrawal by Subject|1|||
143301809|NCT00323492|516655925|FG002|Study Phase 2|Physician Decision|0|||
143301810|NCT00323492|516655923|FG000|Study Phase 2|Lost to Follow-up|1|||
143301811|NCT00323492|516655924|FG001|Study Phase 2|Lost to Follow-up|0|||
143301812|NCT00323492|516655925|FG002|Study Phase 2|Lost to Follow-up|0|||
143301813|NCT00323492|516655923|FG000|Study Phase 2|Withdrawal by Subject|0|||
143301814|NCT00323492|516655924|FG001|Study Phase 2|Withdrawal by Subject|1|||
143301815|NCT00323492|516655925|FG002|Study Phase 2|Withdrawal by Subject|0|||
143301816|NCT00323492|516655923|FG000|Study Phase 2|Noncompliance with study schedule|0|||
143301817|NCT00323492|516655924|FG001|Study Phase 2|Noncompliance with study schedule|0|||
143301818|NCT00323492|516655925|FG002|Study Phase 2|Noncompliance with study schedule|1|||
143301819|NCT00323492|516655923|FG000|Study Phase 2|Protocol Violation|1|||
143374797|NCT03593876|516917295|FG000|Overall Study|Discharged home before intervention completion|2|||
143374798|NCT00854906|516917301|FG000|Overall Study|One person had no ocular history|1|||
143374799|NCT00071799|516917302|FG000|Overall Study|Adverse Event|19|||
143301820|NCT00323492|516655924|FG001|Study Phase 2|Protocol Violation|0|||
143301821|NCT00323492|516655925|FG002|Study Phase 2|Protocol Violation|0|||
143301822|NCT02486042|516655926|FG000|Overall Study|Physician Decision|1|||
143301823|NCT02486042|516655927|FG001|Overall Study|Physician Decision|7|||
143301824|NCT02486042|516655926|FG000|Overall Study|Hospital transfer|2|||
143301825|NCT02486042|516655927|FG001|Overall Study|Hospital transfer|2|||
143301826|NCT02486042|516655926|FG000|Overall Study|Withdrawal by Subject|0|||
143301827|NCT02486042|516655927|FG001|Overall Study|Withdrawal by Subject|2|||
143301828|NCT01466387|516655928|FG000|Overall Study|Adverse Event|0|||
143301829|NCT01466387|516655929|FG001|Overall Study|Adverse Event|0|||
143301830|NCT01466387|516655930|FG002|Overall Study|Adverse Event|1|||
143301831|NCT01466387|516655931|FG003|Overall Study|Adverse Event|1|||
143301832|NCT01466387|516655932|FG004|Overall Study|Adverse Event|0|||
143301833|NCT01466387|516655933|FG005|Overall Study|Adverse Event|0|||
143301834|NCT01466387|516655928|FG000|Overall Study|Lost to Follow-up|0|||
143301835|NCT01466387|516655929|FG001|Overall Study|Lost to Follow-up|0|||
143301836|NCT01466387|516655930|FG002|Overall Study|Lost to Follow-up|0|||
143301837|NCT01466387|516655931|FG003|Overall Study|Lost to Follow-up|0|||
143301838|NCT01466387|516655932|FG004|Overall Study|Lost to Follow-up|0|||
143301839|NCT01466387|516655933|FG005|Overall Study|Lost to Follow-up|1|||
143301840|NCT01466387|516655928|FG000|Overall Study|Protocol Violation|1|||
143301841|NCT01466387|516655929|FG001|Overall Study|Protocol Violation|0|||
143301842|NCT01466387|516655930|FG002|Overall Study|Protocol Violation|0|||
143301843|NCT01466387|516655931|FG003|Overall Study|Protocol Violation|1|||
143301844|NCT01466387|516655932|FG004|Overall Study|Protocol Violation|0|||
143301845|NCT01466387|516655933|FG005|Overall Study|Protocol Violation|0|||
143301846|NCT01319877|516655934|FG000|Overall Study|Lost to Follow-up|100|||
143301847|NCT01319877|516655935|FG001|Overall Study|Lost to Follow-up|37|||
143301848|NCT01319877|516655934|FG000|Overall Study|Physician Decision|2|||
143301849|NCT01319877|516655935|FG001|Overall Study|Physician Decision|0|||
143301850|NCT01319877|516655934|FG000|Overall Study|Disease Progression|2|||
143301851|NCT01319877|516655935|FG001|Overall Study|Disease Progression|2|||
143301852|NCT01319877|516655934|FG000|Overall Study|Withdrawal by Subject|0|||
143301853|NCT01319877|516655935|FG001|Overall Study|Withdrawal by Subject|1|||
143301854|NCT01319877|516655934|FG000|Overall Study|Reason Not Specified|4|||
143301855|NCT01319877|516655935|FG001|Overall Study|Reason Not Specified|5|||
143301856|NCT02347189|516655938|FG000|Overall Study|No implant attempted of study device|9|||
143301857|NCT02347189|516655938|FG000|Overall Study|No primary outcome data available|2|||
143301858|NCT00735878|516655939|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
143301859|NCT00735878|516655940|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
143301860|NCT00735878|516655941|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
143301861|NCT04404855|516655942|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
143301862|NCT04404855|516655943|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
143301863|NCT03320564|516655944|FG000|Overall Study|Protocol Violation|1|||
143301864|NCT00352846|516655945|FG000|Overall Study|Disease progression|0|||
143301865|NCT00352846|516655946|FG001|Overall Study|Disease progression|2|||
143301866|NCT00352846|516655945|FG000|Overall Study|Withdrawal by Subject|3|||
143301867|NCT00352846|516655946|FG001|Overall Study|Withdrawal by Subject|8|||
143301868|NCT00352846|516655945|FG000|Overall Study|Ineligible|3|||
143301869|NCT00352846|516655946|FG001|Overall Study|Ineligible|2|||
143301870|NCT00352846|516655945|FG000|Overall Study|Non-compliance|2|||
143301871|NCT00352846|516655946|FG001|Overall Study|Non-compliance|0|||
143301872|NCT00352846|516655945|FG000|Overall Study|Death|0|||
143301873|NCT00352846|516655946|FG001|Overall Study|Death|1|||
143301874|NCT00788827|516655947|FG000|Overall Study|Lack of Efficacy|2|||
143301875|NCT01527682|516655948|FG000|Overall Study|Protocol Violation|8|||
143301876|NCT04668950|516655953|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
143301877|NCT04668950|516655954|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
143301878|NCT04668950|516655953|FG000|Overall Study|Could not confirm started study medication|15|||
143374800|NCT00071799|516917303|FG001|Overall Study|Adverse Event|10|||
143301879|NCT04668950|516655954|FG001|Overall Study|Could not confirm started study medication|15|||
143301880|NCT04668950|516655953|FG000|Overall Study|Could not confirm baseline status|6|||
143301881|NCT04668950|516655954|FG001|Overall Study|Could not confirm baseline status|2|||
143301882|NCT04668950|516655953|FG000|Overall Study|Drop out and did not start medication|15|||
143301883|NCT04668950|516655954|FG001|Overall Study|Drop out and did not start medication|17|||
143301884|NCT04668950|516655953|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
143301885|NCT04668950|516655954|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
143301886|NCT04668950|516655953|FG000|Overall Study|Other|2|||
143301887|NCT04668950|516655954|FG001|Overall Study|Other|4|||
143301888|NCT03200899|516655955|FG000|Overall Study|Lost to Follow-up|10|||
143301889|NCT03200899|516655956|FG001|Overall Study|Lost to Follow-up|23|||
143301890|NCT01400516|516655968|FG000|Primary Trial|Withdrawal by Subject|0|||
143301891|NCT01400516|516655969|FG001|Primary Trial|Withdrawal by Subject|2|||
143301892|NCT00549562|516655972|FG000|Overall Study|Adverse Event|1|||
143301893|NCT00549562|516655972|FG000|Overall Study|Lack of Efficacy|1|||
143301894|NCT04365556|516655976|FG000|Overall Study|No longer eligible due to treatment plan|1|||
143301895|NCT04365556|516655977|FG001|Overall Study|No longer eligible due to treatment plan|0|||
143301896|NCT04365556|516655976|FG000|Overall Study|Lost to Follow-up|3|||
143301897|NCT04365556|516655977|FG001|Overall Study|Lost to Follow-up|2|||
143301898|NCT00489853|516657720|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
143301899|NCT00489853|516657721|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
143301900|NCT00489853|516657722|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
143301901|NCT00489853|516657720|FG000|Wash-out Period 1|Adverse Event|0|||
143301902|NCT00489853|516657721|FG001|Wash-out Period 1|Adverse Event|1|||
143301903|NCT00489853|516657722|FG002|Wash-out Period 1|Adverse Event|1|||
143301904|NCT00489853|516657720|FG000|Wash-out Period 1|Protocol Violation|0|||
143301905|NCT00489853|516657721|FG001|Wash-out Period 1|Protocol Violation|1|||
143301906|NCT00489853|516657722|FG002|Wash-out Period 1|Protocol Violation|1|||
143301907|NCT00489853|516657720|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
143301908|NCT00489853|516657721|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
143301909|NCT00489853|516657722|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
143301910|NCT00489853|516657720|FG000|Wash-out Period 2|Adverse Event|1|||
143301911|NCT00489853|516657721|FG001|Wash-out Period 2|Adverse Event|1|||
143301912|NCT00489853|516657722|FG002|Wash-out Period 2|Adverse Event|0|||
143301913|NCT00489853|516657720|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
143301914|NCT00489853|516657721|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
143301915|NCT00489853|516657722|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
143301916|NCT00489853|516657720|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
143301917|NCT00489853|516657721|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
143301918|NCT00489853|516657722|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
143301919|NCT00004888|516657728|FG000|Overall Study|Adverse Event|5|||
143301920|NCT00004888|516657729|FG001|Overall Study|Adverse Event|10|||
143301921|NCT00004888|516657728|FG000|Overall Study|Withdrawal by Subject|0|||
143301922|NCT00004888|516657729|FG001|Overall Study|Withdrawal by Subject|3|||
143301923|NCT00004888|516657728|FG000|Overall Study|Physician Decision|1|||
143301924|NCT00004888|516657729|FG001|Overall Study|Physician Decision|1|||
143301925|NCT00004888|516657728|FG000|Overall Study|Progressive Disease|4|||
143301926|NCT00004888|516657729|FG001|Overall Study|Progressive Disease|9|||
143301927|NCT00004888|516657728|FG000|Overall Study|Death without progressive disease|0|||
143301928|NCT00004888|516657729|FG001|Overall Study|Death without progressive disease|1|||
143301929|NCT00004888|516657728|FG000|Overall Study|Toxic death|1|||
143301930|NCT00004888|516657729|FG001|Overall Study|Toxic death|0|||
143301931|NCT02579265|516657730|FG000|Overall Study|Weaned off earlier than 28 days|44|||
143301932|NCT02579265|516657731|FG001|Overall Study|Weaned off earlier than 28 days|43|||
143301933|NCT02579265|516657730|FG000|Overall Study|Adverse Event|2|||
143301934|NCT02579265|516657731|FG001|Overall Study|Adverse Event|0|||
143301935|NCT02579265|516657730|FG000|Overall Study|Any other reason not specified|0|||
143301936|NCT02579265|516657731|FG001|Overall Study|Any other reason not specified|2|||
143301937|NCT02579265|516657730|FG000|Overall Study|Withdrawal by Subject|2|||
143301938|NCT02579265|516657731|FG001|Overall Study|Withdrawal by Subject|0|||
143301939|NCT02579265|516657730|FG000|Overall Study|Physician Decision|1|||
143301940|NCT02579265|516657731|FG001|Overall Study|Physician Decision|0|||
143301941|NCT02579265|516657730|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
143301942|NCT02579265|516657731|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
143301943|NCT02174848|516657732|FG000|Overall Study|Adverse Event|2|||
143301944|NCT02174848|516657733|FG001|Overall Study|Adverse Event|1|||
143301945|NCT02174848|516657732|FG000|Overall Study|Withdrawal by Subject|3|||
143301946|NCT02174848|516657733|FG001|Overall Study|Withdrawal by Subject|3|||
143301947|NCT02174848|516657732|FG000|Overall Study|Lost to Follow-up|0|||
143301948|NCT02174848|516657733|FG001|Overall Study|Lost to Follow-up|1|||
143301949|NCT02174848|516657732|FG000|Overall Study|Worsening of disease|1|||
143301950|NCT02174848|516657733|FG001|Overall Study|Worsening of disease|1|||
143301951|NCT02174848|516657732|FG000|Overall Study|Unable to comply with study requirements|1|||
143301952|NCT02174848|516657733|FG001|Overall Study|Unable to comply with study requirements|0|||
143301953|NCT04091646|516657737|FG000|Overall Study|Adverse Event|2|||
143301954|NCT04091646|516657738|FG001|Overall Study|Adverse Event|1|||
143301955|NCT04091646|516657737|FG000|Overall Study|Lost to Follow-up|6|||
143301956|NCT04091646|516657738|FG001|Overall Study|Lost to Follow-up|2|||
143301957|NCT04091646|516657737|FG000|Overall Study|Protocol Violation|0|||
143301958|NCT04091646|516657738|FG001|Overall Study|Protocol Violation|1|||
143301959|NCT04091646|516657737|FG000|Overall Study|Withdrawal by Subject|4|||
143301960|NCT04091646|516657738|FG001|Overall Study|Withdrawal by Subject|1|||
143301961|NCT04091646|516657737|FG000|Overall Study|Participant Incarcerated|1|||
143301962|NCT04091646|516657738|FG001|Overall Study|Participant Incarcerated|0|||
143301963|NCT02532647|516657739|FG000|Overall Study|Did not receive trial medication|1|||
143301964|NCT02532647|516657740|FG001|Overall Study|Did not receive trial medication|0|||
143301965|NCT02532647|516657741|FG002|Overall Study|Did not receive trial medication|1|||
143301966|NCT02439320|516657746|FG000|Overall Study|Adverse Event|0|||
143301967|NCT02439320|516657747|FG001|Overall Study|Adverse Event|2|||
143301968|NCT02439320|516657748|FG002|Overall Study|Adverse Event|0|||
143301969|NCT02439320|516657746|FG000|Overall Study|Lost to Follow-up|37|||
143301970|NCT02439320|516657747|FG001|Overall Study|Lost to Follow-up|34|||
143301971|NCT02439320|516657748|FG002|Overall Study|Lost to Follow-up|42|||
143301972|NCT02439320|516657746|FG000|Overall Study|Death|0|||
143301973|NCT02439320|516657747|FG001|Overall Study|Death|1|||
143301974|NCT02439320|516657748|FG002|Overall Study|Death|0|||
143301975|NCT02439320|516657746|FG000|Overall Study|Noncompliance with Protocol|10|||
143301976|NCT02439320|516657747|FG001|Overall Study|Noncompliance with Protocol|11|||
143301977|NCT02439320|516657748|FG002|Overall Study|Noncompliance with Protocol|7|||
143301978|NCT02439320|516657746|FG000|Overall Study|Pregnancy|0|||
143301979|NCT02439320|516657747|FG001|Overall Study|Pregnancy|1|||
143301980|NCT02439320|516657748|FG002|Overall Study|Pregnancy|1|||
143301981|NCT02439320|516657746|FG000|Overall Study|Withdrawal by Subject|12|||
143301982|NCT02439320|516657747|FG001|Overall Study|Withdrawal by Subject|16|||
143301983|NCT02439320|516657748|FG002|Overall Study|Withdrawal by Subject|14|||
143301984|NCT02439320|516657746|FG000|Overall Study|Physician Decision|2|||
143301985|NCT02439320|516657747|FG001|Overall Study|Physician Decision|1|||
143301986|NCT02439320|516657748|FG002|Overall Study|Physician Decision|0|||
143301987|NCT02439320|516657746|FG000|Overall Study|Sponsor Request|0|||
143301988|NCT02439320|516657747|FG001|Overall Study|Sponsor Request|2|||
143301989|NCT02439320|516657748|FG002|Overall Study|Sponsor Request|1|||
143301990|NCT02439320|516657746|FG000|Overall Study|Randomization Failure|35|||
143301991|NCT02439320|516657747|FG001|Overall Study|Randomization Failure|46|||
143301992|NCT02439320|516657748|FG002|Overall Study|Randomization Failure|34|||
143301993|NCT03343483|516657753|FG000|Overall Study|Death|0|||
143301994|NCT03343483|516657754|FG001|Overall Study|Death|3|||
143301995|NCT03343483|516657753|FG000|Overall Study|Lost to Follow-up|9|||
143301996|NCT03343483|516657754|FG001|Overall Study|Lost to Follow-up|13|||
143301997|NCT03343483|516657753|FG000|Overall Study|Withdrawal by Subject|8|||
143301998|NCT03343483|516657754|FG001|Overall Study|Withdrawal by Subject|17|||
143301999|NCT00600756|516657755|FG000|Analysis After 6 Months|Adverse Event|43|||
143302000|NCT00600756|516657756|FG001|Analysis After 6 Months|Adverse Event|33|||
143302001|NCT00600756|516657755|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
143302002|NCT00600756|516657756|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
143302003|NCT00600756|516657755|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
143302004|NCT00600756|516657756|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
143302005|NCT00600756|516657755|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
143302006|NCT00600756|516657756|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
143302007|NCT00600756|516657755|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
143302008|NCT00600756|516657756|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
143302009|NCT00600756|516657755|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
143302010|NCT00600756|516657756|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
143302011|NCT00600756|516657755|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
143302012|NCT00600756|516657756|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
143302013|NCT00600756|516657755|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
143302014|NCT00600756|516657756|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
143374801|NCT00071799|516917302|FG000|Overall Study|Protocol Violation|1|||
143374802|NCT00071799|516917303|FG001|Overall Study|Protocol Violation|7|||
143302015|NCT00600756|516657755|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
143302016|NCT00600756|516657756|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
143302017|NCT00600756|516657755|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
143302018|NCT00600756|516657756|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
143374803|NCT00071799|516917302|FG000|Overall Study|Lost to Follow-up|1|||
143302019|NCT00600756|516657755|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
143302020|NCT00600756|516657756|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
143302021|NCT00600756|516657755|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
143302022|NCT00600756|516657756|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
143302023|NCT00600756|516657755|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
143302024|NCT00600756|516657756|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
143302025|NCT00600756|516657755|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
143302026|NCT00600756|516657756|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
143302027|NCT01405963|516657758|FG000|Overall Study|Moved Away|2|||
143302028|NCT01405963|516657759|FG001|Overall Study|Moved Away|0|||
143302029|NCT01405963|516657758|FG000|Overall Study|Adverse Event|0|||
143302030|NCT01405963|516657759|FG001|Overall Study|Adverse Event|1|||
143302031|NCT01405963|516657758|FG000|Overall Study|Lost to Follow-up|0|||
143302032|NCT01405963|516657759|FG001|Overall Study|Lost to Follow-up|1|||
143302033|NCT01498640|516657760|FG000|Overall Study|Lost to Follow-up|1|||
143302034|NCT01498640|516657760|FG000|Overall Study|Death|1|||
143302035|NCT01498640|516657760|FG000|Overall Study|Other|3|||
143302036|NCT01737047|516657761|FG000|Overall Study|Death|10|||
143302037|NCT01737047|516657762|FG001|Overall Study|Death|0|||
143302038|NCT01737047|516657763|FG002|Overall Study|Death|1|||
143302039|NCT01737047|516657761|FG000|Overall Study|Withdrawal by Subject|17|||
143302040|NCT01737047|516657762|FG001|Overall Study|Withdrawal by Subject|11|||
143302041|NCT01737047|516657763|FG002|Overall Study|Withdrawal by Subject|4|||
143302042|NCT00129129|516657764|FG000|Primary Phase|Adverse Event|2|||
143302043|NCT00129129|516657765|FG001|Primary Phase|Adverse Event|1|||
143302044|NCT00129129|516657766|FG002|Primary Phase|Adverse Event|0|||
143302045|NCT00129129|516657767|FG003|Primary Phase|Adverse Event|0|||
143302046|NCT00129129|516657768|FG004|Primary Phase|Adverse Event|0|||
143302047|NCT00129129|516657764|FG000|Primary Phase|Withdrawal by Subject|12|||
143302048|NCT00129129|516657765|FG001|Primary Phase|Withdrawal by Subject|10|||
143302049|NCT00129129|516657766|FG002|Primary Phase|Withdrawal by Subject|0|||
143374804|NCT00071799|516917303|FG001|Overall Study|Lost to Follow-up|1|||
143374805|NCT00071799|516917302|FG000|Overall Study|Withdrawal by Subject|15|||
143302050|NCT00129129|516657767|FG003|Primary Phase|Withdrawal by Subject|0|||
143374806|NCT00071799|516917303|FG001|Overall Study|Withdrawal by Subject|37|||
143374807|NCT00071799|516917302|FG000|Overall Study|Physician Decision|0|||
143374808|NCT00071799|516917303|FG001|Overall Study|Physician Decision|2|||
143374809|NCT00071799|516917302|FG000|Overall Study|Lack of Efficacy|11|||
143374810|NCT00071799|516917303|FG001|Overall Study|Lack of Efficacy|18|||
143374811|NCT00071799|516917302|FG000|Overall Study|Disease Progression|23|||
143374812|NCT00071799|516917303|FG001|Overall Study|Disease Progression|20|||
143374813|NCT00071799|516917302|FG000|Overall Study|Different Central+Local Pathology Review|0|||
143374814|NCT00071799|516917303|FG001|Overall Study|Different Central+Local Pathology Review|1|||
143374815|NCT00071799|516917302|FG000|Overall Study|Not Documented|0|||
143374816|NCT00071799|516917303|FG001|Overall Study|Not Documented|2|||
143374817|NCT00814346|516917304|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
143374818|NCT00814346|516917305|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
143374819|NCT00814346|516917304|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
143374820|NCT00814346|516917305|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
143374821|NCT00814346|516917304|FG000|Open Phase (17 Months)|Adverse Event|5|||
143374822|NCT00814346|516917305|FG001|Open Phase (17 Months)|Adverse Event|0|||
143374823|NCT00814346|516917304|FG000|Open Phase (17 Months)|Consent|2|||
143374824|NCT00814346|516917305|FG001|Open Phase (17 Months)|Consent|0|||
143374825|NCT00814346|516917304|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
143374826|NCT00814346|516917305|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
143302051|NCT00129129|516657768|FG004|Primary Phase|Withdrawal by Subject|0|||
143302052|NCT00129129|516657764|FG000|Primary Phase|Migration from study area|1|||
143302053|NCT00129129|516657765|FG001|Primary Phase|Migration from study area|3|||
143302054|NCT00129129|516657766|FG002|Primary Phase|Migration from study area|0|||
143302055|NCT00129129|516657767|FG003|Primary Phase|Migration from study area|0|||
143302056|NCT00129129|516657768|FG004|Primary Phase|Migration from study area|0|||
143302057|NCT00129129|516657764|FG000|Primary Phase|Lost to Follow-up|8|||
143302058|NCT00129129|516657765|FG001|Primary Phase|Lost to Follow-up|6|||
143302059|NCT00129129|516657766|FG002|Primary Phase|Lost to Follow-up|0|||
143302060|NCT00129129|516657767|FG003|Primary Phase|Lost to Follow-up|0|||
143302061|NCT00129129|516657768|FG004|Primary Phase|Lost to Follow-up|0|||
143302062|NCT00129129|516657764|FG000|Primary Phase|Other|2|||
143302063|NCT00129129|516657765|FG001|Primary Phase|Other|5|||
143302064|NCT00129129|516657766|FG002|Primary Phase|Other|0|||
143302065|NCT00129129|516657767|FG003|Primary Phase|Other|0|||
143302066|NCT00129129|516657768|FG004|Primary Phase|Other|0|||
143302067|NCT00129129|516657764|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
143302068|NCT00129129|516657765|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
143302069|NCT00129129|516657766|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
143302070|NCT00129129|516657767|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
143302071|NCT00129129|516657768|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
143302072|NCT00129129|516657764|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
143302073|NCT00129129|516657765|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
143302074|NCT00129129|516657766|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
143302075|NCT00129129|516657767|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
143374827|NCT00814346|516917304|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
143374828|NCT00814346|516917305|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
143374829|NCT05136443|516917307|FG000|Overall Study|Lost to Follow-up|2|||
143374830|NCT05136443|516917307|FG000|Overall Study|Adverse Event|2|||
143374831|NCT03959241|516917314|FG000|Overall Study|Withdrawal by Subject|7|||
143374832|NCT03959241|516917315|FG001|Overall Study|Withdrawal by Subject|8|||
143374833|NCT03959241|516917314|FG000|Overall Study|Lost to Follow-up|1|||
143374834|NCT03959241|516917315|FG001|Overall Study|Lost to Follow-up|0|||
143374835|NCT03959241|516917314|FG000|Overall Study|Move to Hospice Care|1|||
143374836|NCT03959241|516917315|FG001|Overall Study|Move to Hospice Care|0|||
143302076|NCT00129129|516657768|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
143302077|NCT00129129|516657764|FG000|Fourth Dose Phase|Migration from study area|0|||
143302078|NCT00129129|516657765|FG001|Fourth Dose Phase|Migration from study area|0|||
143302079|NCT00129129|516657766|FG002|Fourth Dose Phase|Migration from study area|0|||
143302080|NCT00129129|516657767|FG003|Fourth Dose Phase|Migration from study area|0|||
143302081|NCT00129129|516657768|FG004|Fourth Dose Phase|Migration from study area|2|||
143302082|NCT00129129|516657764|FG000|Fourth Dose Phase|Other|0|||
143302083|NCT00129129|516657765|FG001|Fourth Dose Phase|Other|0|||
143302084|NCT00129129|516657766|FG002|Fourth Dose Phase|Other|0|||
143302085|NCT00129129|516657767|FG003|Fourth Dose Phase|Other|1|||
143302086|NCT00129129|516657768|FG004|Fourth Dose Phase|Other|1|||
143302087|NCT00129129|516657764|FG000|Fourth Dose Phase|Protocol Violation|0|||
143302088|NCT00129129|516657765|FG001|Fourth Dose Phase|Protocol Violation|0|||
143302089|NCT00129129|516657766|FG002|Fourth Dose Phase|Protocol Violation|0|||
143302090|NCT00129129|516657767|FG003|Fourth Dose Phase|Protocol Violation|1|||
143302091|NCT00129129|516657768|FG004|Fourth Dose Phase|Protocol Violation|0|||
143302092|NCT03089606|516657769|FG000|Overall Study|Progression after Cycle 1|1|||
143302093|NCT00335972|516657770|FG000|Overall Study|not given treatments|0|||
143302094|NCT00335972|516657771|FG001|Overall Study|not given treatments|3|||
143302095|NCT02802592|516657776|FG000|Overall Study|Study terminated due to loss of funding|4|||
143302096|NCT02882854|516657779|FG000|Overall Study|Lost to Follow-up|1|||
143302097|NCT02882854|516657780|FG001|Overall Study|Lost to Follow-up|2|||
143302098|NCT02882854|516657779|FG000|Overall Study|Physician Decision|0|||
143302099|NCT02882854|516657780|FG001|Overall Study|Physician Decision|1|||
143302100|NCT02039674|516657781|FG000|Overall Study|Adverse Event|0|||
143302101|NCT02039674|516657782|FG001|Overall Study|Adverse Event|0|||
143302102|NCT02039674|516657783|FG002|Overall Study|Adverse Event|0|||
143302103|NCT02039674|516657784|FG003|Overall Study|Adverse Event|1|||
143302104|NCT02039674|516657785|FG004|Overall Study|Adverse Event|0|||
143302105|NCT02039674|516657786|FG005|Overall Study|Adverse Event|0|||
143302106|NCT02039674|516657787|FG006|Overall Study|Adverse Event|0|||
143302107|NCT02039674|516657788|FG007|Overall Study|Adverse Event|0|||
143302108|NCT02039674|516657789|FG008|Overall Study|Adverse Event|2|||
143302109|NCT02039674|516657790|FG009|Overall Study|Adverse Event|1|||
143302110|NCT02039674|516657791|FG010|Overall Study|Adverse Event|0|||
143302111|NCT02039674|516657792|FG011|Overall Study|Adverse Event|2|||
143302112|NCT02039674|516657793|FG012|Overall Study|Adverse Event|3|||
143302113|NCT02039674|516657794|FG013|Overall Study|Adverse Event|1|||
143302114|NCT02039674|516657781|FG000|Overall Study|Death|2|||
143302115|NCT02039674|516657782|FG001|Overall Study|Death|0|||
143302116|NCT02039674|516657783|FG002|Overall Study|Death|2|||
143302117|NCT02039674|516657784|FG003|Overall Study|Death|3|||
143302118|NCT02039674|516657785|FG004|Overall Study|Death|0|||
143302119|NCT02039674|516657786|FG005|Overall Study|Death|0|||
143302120|NCT02039674|516657787|FG006|Overall Study|Death|1|||
143302121|NCT02039674|516657788|FG007|Overall Study|Death|0|||
143302122|NCT02039674|516657789|FG008|Overall Study|Death|2|||
143302123|NCT02039674|516657790|FG009|Overall Study|Death|0|||
143302124|NCT02039674|516657791|FG010|Overall Study|Death|1|||
143302125|NCT02039674|516657792|FG011|Overall Study|Death|3|||
143302126|NCT02039674|516657793|FG012|Overall Study|Death|2|||
143302127|NCT02039674|516657794|FG013|Overall Study|Death|8|||
143302128|NCT02039674|516657781|FG000|Overall Study|Excluded Medication|1|||
143302129|NCT02039674|516657782|FG001|Overall Study|Excluded Medication|1|||
143302130|NCT02039674|516657783|FG002|Overall Study|Excluded Medication|0|||
143302131|NCT02039674|516657784|FG003|Overall Study|Excluded Medication|1|||
143302132|NCT02039674|516657785|FG004|Overall Study|Excluded Medication|0|||
143302133|NCT02039674|516657786|FG005|Overall Study|Excluded Medication|1|||
143302134|NCT02039674|516657787|FG006|Overall Study|Excluded Medication|0|||
143302135|NCT02039674|516657788|FG007|Overall Study|Excluded Medication|0|||
143302136|NCT02039674|516657789|FG008|Overall Study|Excluded Medication|2|||
143302137|NCT02039674|516657790|FG009|Overall Study|Excluded Medication|3|||
143302138|NCT02039674|516657791|FG010|Overall Study|Excluded Medication|5|||
143302139|NCT02039674|516657792|FG011|Overall Study|Excluded Medication|6|||
143302140|NCT02039674|516657793|FG012|Overall Study|Excluded Medication|8|||
143302141|NCT02039674|516657794|FG013|Overall Study|Excluded Medication|3|||
143302142|NCT02039674|516657781|FG000|Overall Study|Lost to Follow-up|0|||
143302143|NCT02039674|516657782|FG001|Overall Study|Lost to Follow-up|0|||
143302144|NCT02039674|516657783|FG002|Overall Study|Lost to Follow-up|0|||
143302145|NCT02039674|516657784|FG003|Overall Study|Lost to Follow-up|0|||
143302146|NCT02039674|516657785|FG004|Overall Study|Lost to Follow-up|1|||
143302147|NCT02039674|516657786|FG005|Overall Study|Lost to Follow-up|1|||
143302148|NCT02039674|516657787|FG006|Overall Study|Lost to Follow-up|0|||
143302149|NCT02039674|516657788|FG007|Overall Study|Lost to Follow-up|0|||
143302150|NCT02039674|516657789|FG008|Overall Study|Lost to Follow-up|0|||
143302151|NCT02039674|516657790|FG009|Overall Study|Lost to Follow-up|0|||
143302152|NCT02039674|516657791|FG010|Overall Study|Lost to Follow-up|0|||
143302153|NCT02039674|516657792|FG011|Overall Study|Lost to Follow-up|2|||
143302154|NCT02039674|516657793|FG012|Overall Study|Lost to Follow-up|2|||
143302155|NCT02039674|516657794|FG013|Overall Study|Lost to Follow-up|1|||
143302156|NCT02039674|516657781|FG000|Overall Study|Physician Decision|0|||
143302157|NCT02039674|516657782|FG001|Overall Study|Physician Decision|0|||
143302158|NCT02039674|516657783|FG002|Overall Study|Physician Decision|0|||
143302159|NCT02039674|516657784|FG003|Overall Study|Physician Decision|0|||
143302160|NCT02039674|516657785|FG004|Overall Study|Physician Decision|0|||
143302161|NCT02039674|516657786|FG005|Overall Study|Physician Decision|0|||
143302162|NCT02039674|516657787|FG006|Overall Study|Physician Decision|0|||
143374837|NCT03959241|516917314|FG000|Overall Study|Screen Failure|1|||
143374838|NCT03959241|516917315|FG001|Overall Study|Screen Failure|0|||
143374839|NCT03959241|516917314|FG000|Overall Study|Disease Relapse|0|||
143374840|NCT03959241|516917315|FG001|Overall Study|Disease Relapse|1|||
143374841|NCT03959241|516917314|FG000|Overall Study|Off Study|1|||
143374842|NCT03959241|516917315|FG001|Overall Study|Off Study|0|||
143374843|NCT00831415|516917316|FG000|Overall Study|Adverse Event|14|||
143374844|NCT00831415|516917316|FG000|Overall Study|Failed to return|3|||
143374845|NCT00831415|516917316|FG000|Overall Study|Physician Decision|6|||
143374846|NCT00831415|516917316|FG000|Overall Study|Lost to Follow-up|9|||
143374847|NCT00831415|516917316|FG000|Overall Study|Protocol Violation|3|||
143302163|NCT02039674|516657788|FG007|Overall Study|Physician Decision|0|||
143302164|NCT02039674|516657789|FG008|Overall Study|Physician Decision|0|||
143302165|NCT02039674|516657790|FG009|Overall Study|Physician Decision|0|||
143302166|NCT02039674|516657791|FG010|Overall Study|Physician Decision|0|||
143302167|NCT02039674|516657792|FG011|Overall Study|Physician Decision|1|||
143302168|NCT02039674|516657793|FG012|Overall Study|Physician Decision|1|||
143302169|NCT02039674|516657794|FG013|Overall Study|Physician Decision|0|||
143302170|NCT02039674|516657781|FG000|Overall Study|Progressive Disease|8|||
143302171|NCT02039674|516657782|FG001|Overall Study|Progressive Disease|8|||
143302172|NCT02039674|516657783|FG002|Overall Study|Progressive Disease|6|||
143302173|NCT02039674|516657784|FG003|Overall Study|Progressive Disease|7|||
143302174|NCT02039674|516657785|FG004|Overall Study|Progressive Disease|9|||
143302175|NCT02039674|516657786|FG005|Overall Study|Progressive Disease|10|||
143302176|NCT02039674|516657787|FG006|Overall Study|Progressive Disease|1|||
143302177|NCT02039674|516657788|FG007|Overall Study|Progressive Disease|3|||
143302178|NCT02039674|516657789|FG008|Overall Study|Progressive Disease|6|||
143302179|NCT02039674|516657790|FG009|Overall Study|Progressive Disease|4|||
143302180|NCT02039674|516657791|FG010|Overall Study|Progressive Disease|0|||
143302181|NCT02039674|516657792|FG011|Overall Study|Progressive Disease|34|||
143302182|NCT02039674|516657793|FG012|Overall Study|Progressive Disease|34|||
143302183|NCT02039674|516657794|FG013|Overall Study|Progressive Disease|18|||
143302184|NCT02039674|516657781|FG000|Overall Study|Withdrawal by Subject|1|||
143302185|NCT02039674|516657782|FG001|Overall Study|Withdrawal by Subject|2|||
143302186|NCT02039674|516657783|FG002|Overall Study|Withdrawal by Subject|3|||
143302187|NCT02039674|516657784|FG003|Overall Study|Withdrawal by Subject|0|||
143302188|NCT02039674|516657785|FG004|Overall Study|Withdrawal by Subject|1|||
143302189|NCT02039674|516657786|FG005|Overall Study|Withdrawal by Subject|0|||
143302190|NCT02039674|516657787|FG006|Overall Study|Withdrawal by Subject|0|||
143302191|NCT02039674|516657788|FG007|Overall Study|Withdrawal by Subject|0|||
143302192|NCT02039674|516657789|FG008|Overall Study|Withdrawal by Subject|0|||
143302193|NCT02039674|516657790|FG009|Overall Study|Withdrawal by Subject|1|||
143302194|NCT02039674|516657791|FG010|Overall Study|Withdrawal by Subject|1|||
143302195|NCT02039674|516657792|FG011|Overall Study|Withdrawal by Subject|4|||
143302196|NCT02039674|516657793|FG012|Overall Study|Withdrawal by Subject|6|||
143302197|NCT02039674|516657794|FG013|Overall Study|Withdrawal by Subject|2|||
143302198|NCT02039674|516657781|FG000|Overall Study|Clinical Progression|0|||
143302199|NCT02039674|516657782|FG001|Overall Study|Clinical Progression|0|||
143302200|NCT02039674|516657783|FG002|Overall Study|Clinical Progression|0|||
143302201|NCT02039674|516657784|FG003|Overall Study|Clinical Progression|0|||
143302202|NCT02039674|516657785|FG004|Overall Study|Clinical Progression|0|||
143302203|NCT02039674|516657786|FG005|Overall Study|Clinical Progression|0|||
143302204|NCT02039674|516657787|FG006|Overall Study|Clinical Progression|1|||
143302205|NCT02039674|516657788|FG007|Overall Study|Clinical Progression|0|||
143302206|NCT02039674|516657789|FG008|Overall Study|Clinical Progression|0|||
143302207|NCT02039674|516657790|FG009|Overall Study|Clinical Progression|0|||
143302208|NCT02039674|516657791|FG010|Overall Study|Clinical Progression|0|||
143302209|NCT02039674|516657792|FG011|Overall Study|Clinical Progression|0|||
143302210|NCT02039674|516657793|FG012|Overall Study|Clinical Progression|1|||
143302211|NCT02039674|516657794|FG013|Overall Study|Clinical Progression|0|||
143302212|NCT02039674|516657781|FG000|Overall Study|Sponsor Decision|1|||
143302213|NCT02039674|516657782|FG001|Overall Study|Sponsor Decision|1|||
143302214|NCT02039674|516657783|FG002|Overall Study|Sponsor Decision|1|||
143302215|NCT02039674|516657784|FG003|Overall Study|Sponsor Decision|1|||
143302216|NCT02039674|516657785|FG004|Overall Study|Sponsor Decision|1|||
143302217|NCT02039674|516657786|FG005|Overall Study|Sponsor Decision|0|||
143374848|NCT00831415|516917316|FG000|Overall Study|Withdrawal by Subject|35|||
143374849|NCT00831415|516917316|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
143374850|NCT00831415|516917316|FG000|Overall Study|Death|1|||
143374851|NCT01290224|516917317|FG000|Overall Study|Adverse Event|1|||
143302218|NCT02039674|516657787|FG006|Overall Study|Sponsor Decision|0|||
143302219|NCT02039674|516657788|FG007|Overall Study|Sponsor Decision|0|||
143302220|NCT02039674|516657789|FG008|Overall Study|Sponsor Decision|0|||
143302221|NCT02039674|516657790|FG009|Overall Study|Sponsor Decision|3|||
143302222|NCT02039674|516657791|FG010|Overall Study|Sponsor Decision|0|||
143302223|NCT02039674|516657792|FG011|Overall Study|Sponsor Decision|8|||
143302224|NCT02039674|516657793|FG012|Overall Study|Sponsor Decision|5|||
143302225|NCT02039674|516657794|FG013|Overall Study|Sponsor Decision|0|||
143302226|NCT02039674|516657781|FG000|Overall Study|Other|0|||
143302227|NCT02039674|516657782|FG001|Overall Study|Other|0|||
143302228|NCT02039674|516657783|FG002|Overall Study|Other|0|||
143302229|NCT02039674|516657784|FG003|Overall Study|Other|0|||
143302230|NCT02039674|516657785|FG004|Overall Study|Other|0|||
143302231|NCT02039674|516657786|FG005|Overall Study|Other|0|||
143302232|NCT02039674|516657787|FG006|Overall Study|Other|0|||
143302233|NCT02039674|516657788|FG007|Overall Study|Other|0|||
143302234|NCT02039674|516657789|FG008|Overall Study|Other|0|||
143302235|NCT02039674|516657790|FG009|Overall Study|Other|0|||
143302236|NCT02039674|516657791|FG010|Overall Study|Other|0|||
143302237|NCT02039674|516657792|FG011|Overall Study|Other|0|||
143302238|NCT02039674|516657793|FG012|Overall Study|Other|1|||
143302239|NCT02039674|516657794|FG013|Overall Study|Other|0|||
143302240|NCT02136576|516657795|FG000|Overall Study|Lost to Follow-up|2|||
143302241|NCT02136576|516657796|FG001|Overall Study|Lost to Follow-up|0|||
143302242|NCT02136576|516657797|FG002|Overall Study|Lost to Follow-up|0|||
143302243|NCT02197806|516657798|FG000|Overall Study|Adverse Event|0|||
143302244|NCT02197806|516657799|FG001|Overall Study|Adverse Event|1|||
143302245|NCT02197806|516657800|FG002|Overall Study|Adverse Event|0|||
143302246|NCT02197806|516657801|FG003|Overall Study|Adverse Event|1|||
143302247|NCT00537381|516657802|FG000|Overall Study|Adverse Event|13|||
143302248|NCT00537381|516657803|FG001|Overall Study|Adverse Event|9|||
143302249|NCT00537381|516657802|FG000|Overall Study|Death|3|||
143302250|NCT00537381|516657803|FG001|Overall Study|Death|3|||
143302251|NCT00537381|516657802|FG000|Overall Study|Withdrawal by Subject|5|||
143302252|NCT00537381|516657803|FG001|Overall Study|Withdrawal by Subject|14|||
143302253|NCT00537381|516657802|FG000|Overall Study|Physician Decision|7|||
143302254|NCT00537381|516657803|FG001|Overall Study|Physician Decision|6|||
143302255|NCT00537381|516657802|FG000|Overall Study|Disease Progression|9|||
143302256|NCT00537381|516657803|FG001|Overall Study|Disease Progression|18|||
143302257|NCT00537381|516657802|FG000|Overall Study|Sponsor decision|14|||
143302258|NCT00537381|516657803|FG001|Overall Study|Sponsor decision|9|||
143302259|NCT00537381|516657802|FG000|Overall Study|Other|5|||
143302260|NCT00537381|516657803|FG001|Overall Study|Other|3|||
143302261|NCT02590939|516657804|FG000|Overall Study|Withdrawal by Subject|3|||
143302262|NCT02590939|516657805|FG001|Overall Study|Withdrawal by Subject|1|||
143302263|NCT02590939|516657804|FG000|Overall Study|Failed the nociceptive test|2|||
143302264|NCT02590939|516657805|FG001|Overall Study|Failed the nociceptive test|1|||
143302265|NCT03065244|516657806|FG000|Overall Study|Lost to Follow-up|1|||
143302266|NCT03065244|516657807|FG001|Overall Study|Lost to Follow-up|1|||
143302267|NCT03065244|516657806|FG000|Overall Study|Diagnosed with a different disease|1|||
143302268|NCT03065244|516657807|FG001|Overall Study|Diagnosed with a different disease|1|||
143302269|NCT03065244|516657806|FG000|Overall Study|Protocol Violation|0|||
143302270|NCT03065244|516657807|FG001|Overall Study|Protocol Violation|1|||
143302271|NCT03065244|516657806|FG000|Overall Study|Withdrawal by Subject|1|||
143302272|NCT03065244|516657807|FG001|Overall Study|Withdrawal by Subject|1|||
143302273|NCT03774433|516657808|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
143302274|NCT02385084|516657810|FG000|Period 2|Protocol Violation|0|||
143374852|NCT01290224|516917317|FG000|Overall Study|Refused Further Treatment|4|||
143374853|NCT03861767|516917318|FG000|Overall Study|Withdrawal by Subject|2|||
143374854|NCT03861767|516917319|FG001|Overall Study|Withdrawal by Subject|1|||
143302275|NCT02385084|516657811|FG001|Period 2|Protocol Violation|0|||
143302276|NCT02385084|516657812|FG002|Period 2|Protocol Violation|1|||
143302277|NCT02385084|516657813|FG003|Period 2|Protocol Violation|0|||
143302278|NCT02385084|516657814|FG004|Period 2|Protocol Violation|0|||
143302279|NCT02385084|516657815|FG005|Period 2|Protocol Violation|0|||
143302280|NCT05045144|516657816|FG000|Overall Study|Lost to Follow-up|3|||
143302281|NCT05045144|516657817|FG001|Overall Study|Lost to Follow-up|2|||
143302282|NCT05045144|516657818|FG002|Overall Study|Lost to Follow-up|3|||
143302283|NCT05045144|516657819|FG003|Overall Study|Lost to Follow-up|5|||
143302284|NCT05045144|516657820|FG004|Overall Study|Lost to Follow-up|13|||
143302285|NCT05045144|516657816|FG000|Overall Study|Withdrawal by Subject|0|||
143302286|NCT05045144|516657817|FG001|Overall Study|Withdrawal by Subject|1|||
143374855|NCT03861767|516917320|FG002|Overall Study|Withdrawal by Subject|0|||
143374856|NCT03861767|516917321|FG003|Overall Study|Withdrawal by Subject|5|||
143374857|NCT03861767|516917322|FG004|Overall Study|Withdrawal by Subject|2|||
143374858|NCT03861767|516917323|FG005|Overall Study|Withdrawal by Subject|1|||
143374859|NCT03861767|516917324|FG006|Overall Study|Withdrawal by Subject|3|||
143374860|NCT03861767|516917325|FG007|Overall Study|Withdrawal by Subject|1|||
143374861|NCT03861767|516917326|FG008|Overall Study|Withdrawal by Subject|0|||
143374862|NCT03861767|516917327|FG009|Overall Study|Withdrawal by Subject|5|||
143374863|NCT00346333|516917328|FG000|Overall Study|Death|1|||
143374864|NCT00346333|516917329|FG001|Overall Study|Death|0|||
143302287|NCT05045144|516657818|FG002|Overall Study|Withdrawal by Subject|0|||
143302288|NCT05045144|516657819|FG003|Overall Study|Withdrawal by Subject|0|||
143302289|NCT05045144|516657820|FG004|Overall Study|Withdrawal by Subject|0|||
143302290|NCT05045144|516657816|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143302291|NCT05045144|516657817|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143302292|NCT05045144|516657818|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
143302293|NCT05045144|516657819|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143302294|NCT05045144|516657820|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
143302295|NCT02965703|516657826|FG000|Overall Study|Withdrawal by Subject|6|||
143302296|NCT02965703|516657827|FG001|Overall Study|Withdrawal by Subject|3|||
143302297|NCT02965703|516657828|FG002|Overall Study|Withdrawal by Subject|1|||
143302298|NCT02965703|516657826|FG000|Overall Study|Protocol Violation|1|||
143302299|NCT02965703|516657827|FG001|Overall Study|Protocol Violation|0|||
143302300|NCT02965703|516657828|FG002|Overall Study|Protocol Violation|0|||
143302301|NCT02965703|516657826|FG000|Overall Study|Adverse Event|1|||
143302302|NCT02965703|516657827|FG001|Overall Study|Adverse Event|1|||
143302303|NCT02965703|516657828|FG002|Overall Study|Adverse Event|0|||
143302304|NCT02965703|516657826|FG000|Overall Study|Lost to Follow-up|2|||
143302305|NCT02965703|516657827|FG001|Overall Study|Lost to Follow-up|1|||
143302306|NCT02965703|516657828|FG002|Overall Study|Lost to Follow-up|1|||
143302307|NCT02081079|516657829|FG000|Overall Study|Lack of Efficacy|3|||
143302308|NCT02081079|516657830|FG001|Overall Study|Lack of Efficacy|2|||
143302309|NCT02081079|516657829|FG000|Overall Study|Lost to Follow-up|1|||
143302310|NCT02081079|516657830|FG001|Overall Study|Lost to Follow-up|0|||
143302311|NCT00744627|516657831|FG000|Overall Study|Adverse Event|6|||
143302312|NCT00744627|516657832|FG001|Overall Study|Adverse Event|9|||
143302313|NCT00744627|516657831|FG000|Overall Study|Lack of Efficacy|7|||
143302314|NCT00744627|516657832|FG001|Overall Study|Lack of Efficacy|3|||
143302315|NCT00744627|516657831|FG000|Overall Study|Noncompliance|0|||
143302316|NCT00744627|516657832|FG001|Overall Study|Noncompliance|1|||
143302317|NCT00744627|516657831|FG000|Overall Study|Protocol Deviations|0|||
143302318|NCT00744627|516657832|FG001|Overall Study|Protocol Deviations|2|||
143302319|NCT00744627|516657831|FG000|Overall Study|Voluntary Withdrawal|9|||
143302320|NCT00744627|516657832|FG001|Overall Study|Voluntary Withdrawal|6|||
143302321|NCT00744627|516657831|FG000|Overall Study|Lost to Follow-up|2|||
143302322|NCT00744627|516657832|FG001|Overall Study|Lost to Follow-up|1|||
143374865|NCT00346333|516917328|FG000|Overall Study|unwilling or unable to continue|4|||
143374866|NCT00346333|516917329|FG001|Overall Study|unwilling or unable to continue|8|||
143302323|NCT00744627|516657831|FG000|Overall Study|Other|1|||
143302324|NCT00744627|516657832|FG001|Overall Study|Other|0|||
143302325|NCT02968979|516657833|FG000|Overall Study|Protocol Violation|7|||
143302326|NCT02968979|516657833|FG000|Overall Study|Withdrawal by Subject|1|||
143302327|NCT00729183|516657834|FG000|Overall Study|Adverse Event|11|||
143302328|NCT00729183|516657835|FG001|Overall Study|Adverse Event|5|||
143302329|NCT00729183|516657834|FG000|Overall Study|Lack of Efficacy|0|||
143302330|NCT00729183|516657835|FG001|Overall Study|Lack of Efficacy|1|||
143374867|NCT03184558|516917330|FG000|Overall Study|Withdrawal by Subject|2|||
143374868|NCT03184558|516917330|FG000|Overall Study|Death|16|||
143374869|NCT03184558|516917330|FG000|Overall Study|Lost to Follow-up|2|||
143374870|NCT03184558|516917330|FG000|Overall Study|Other|9|||
143302331|NCT00729183|516657834|FG000|Overall Study|Lost to Follow-up|3|||
143302332|NCT00729183|516657835|FG001|Overall Study|Lost to Follow-up|1|||
143302333|NCT00729183|516657834|FG000|Overall Study|Physician Decision|1|||
143302334|NCT00729183|516657835|FG001|Overall Study|Physician Decision|1|||
143302335|NCT00729183|516657834|FG000|Overall Study|Protocol Violation|1|||
143302336|NCT00729183|516657835|FG001|Overall Study|Protocol Violation|0|||
143302337|NCT00729183|516657834|FG000|Overall Study|Withdrawal by Subject|9|||
143302338|NCT00729183|516657835|FG001|Overall Study|Withdrawal by Subject|7|||
143302339|NCT03745144|516657842|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
143302340|NCT03745144|516657843|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
143302341|NCT03745144|516657844|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
143302342|NCT03745144|516657842|FG000|Period 1|Other|0|||
143302343|NCT03745144|516657843|FG001|Period 1|Other|0|||
143302344|NCT03745144|516657844|FG002|Period 1|Other|1|||
143302345|NCT01359254|516657845|FG000|Overall Study|Death|1|||
143302346|NCT01359254|516657846|FG001|Overall Study|Death|0|||
143302347|NCT01124643|516657857|FG000|Overall Study|Death|1|||
143302348|NCT02678676|516657860|FG000|Overall Study|Death|619|||
143302349|NCT02678676|516657861|FG001|Overall Study|Death|649|||
143302350|NCT02678676|516657860|FG000|Overall Study|Withdrawal by Subject|13|||
143302351|NCT02678676|516657861|FG001|Overall Study|Withdrawal by Subject|5|||
143302352|NCT02678676|516657860|FG000|Overall Study|Lost to Follow-up|171|||
143302353|NCT02678676|516657861|FG001|Overall Study|Lost to Follow-up|151|||
143302354|NCT02678676|516657860|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
143302355|NCT02678676|516657861|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
143374871|NCT03460756|516917331|FG000|Overall Study|Adverse Event|0|||
143302356|NCT00851799|516657862|FG000|Overall Study|Death|1|||
143302357|NCT00851799|516657863|FG001|Overall Study|Death|0|||
143302358|NCT00851799|516657864|FG002|Overall Study|Death|1|||
143302359|NCT00851799|516657862|FG000|Overall Study|Lost to Follow-up|5|||
143302360|NCT00851799|516657863|FG001|Overall Study|Lost to Follow-up|3|||
143302361|NCT00851799|516657864|FG002|Overall Study|Lost to Follow-up|10|||
143302362|NCT00851799|516657862|FG000|Overall Study|Not able to get to clinic|8|||
143302363|NCT00851799|516657863|FG001|Overall Study|Not able to get to clinic|5|||
143302364|NCT00851799|516657864|FG002|Overall Study|Not able to get to clinic|9|||
143302365|NCT00851799|516657862|FG000|Overall Study|Not willing to adhere to requirements|1|||
143302366|NCT00851799|516657863|FG001|Overall Study|Not willing to adhere to requirements|2|||
143302367|NCT00851799|516657864|FG002|Overall Study|Not willing to adhere to requirements|2|||
143302368|NCT00851799|516657862|FG000|Overall Study|Withdrew consent prior study completion|1|||
143302369|NCT00851799|516657863|FG001|Overall Study|Withdrew consent prior study completion|2|||
143302370|NCT00851799|516657864|FG002|Overall Study|Withdrew consent prior study completion|1|||
143302371|NCT00851799|516657862|FG000|Overall Study|Severe Debilitation|0|||
143302372|NCT00851799|516657863|FG001|Overall Study|Severe Debilitation|1|||
143302373|NCT00851799|516657864|FG002|Overall Study|Severe Debilitation|0|||
143302374|NCT00851799|516657862|FG000|Overall Study|Completed protocol due to pregnancy|0|||
143302375|NCT00851799|516657863|FG001|Overall Study|Completed protocol due to pregnancy|0|||
143302376|NCT00851799|516657864|FG002|Overall Study|Completed protocol due to pregnancy|1|||
143302377|NCT01342510|516657865|FG000|Overall Study|Protocol Violation|12|||
143302378|NCT01342510|516657866|FG001|Overall Study|Protocol Violation|6|||
143302379|NCT01342510|516657867|FG002|Overall Study|Protocol Violation|13|||
143302380|NCT01342510|516657868|FG003|Overall Study|Protocol Violation|11|||
143302381|NCT01449526|516657869|FG000|Overall Study|Lost to Follow-up|1|||
143302382|NCT01449526|516657870|FG001|Overall Study|Lost to Follow-up|2|||
143302383|NCT01449526|516657869|FG000|Overall Study|Withdrawal by Subject|1|||
143302384|NCT01449526|516657870|FG001|Overall Study|Withdrawal by Subject|1|||
143302385|NCT01449526|516657869|FG000|Overall Study|Symptoms/complaints|0|||
143302386|NCT01449526|516657870|FG001|Overall Study|Symptoms/complaints|1|||
143302387|NCT01449526|516657869|FG000|Overall Study|Lack of Motivation|0|||
143302388|NCT01449526|516657870|FG001|Overall Study|Lack of Motivation|1|||
143302389|NCT01449526|516657869|FG000|Overall Study|Cannot maintain visits|0|||
143302390|NCT01449526|516657870|FG001|Overall Study|Cannot maintain visits|1|||
143302391|NCT04837131|516657874|FG000|Overall Study|Death|1|||
143302392|NCT04837131|516657874|FG000|Overall Study|Withdrawal by Subject|1|||
143302393|NCT04837131|516657874|FG000|Overall Study|Adverse Event|1|||
143302394|NCT04837131|516657874|FG000|Overall Study|Protocol Violation|1|||
143302395|NCT05756790|516657875|FG000|Overall Study|Withdrawal by Subject|1|||
143302396|NCT05756790|516657876|FG001|Overall Study|Withdrawal by Subject|1|||
143302397|NCT05756790|516657877|FG002|Overall Study|Withdrawal by Subject|1|||
143302398|NCT05756790|516657878|FG003|Overall Study|Withdrawal by Subject|1|||
143302399|NCT05756790|516657879|FG004|Overall Study|Withdrawal by Subject|0|||
143302400|NCT05756790|516657880|FG005|Overall Study|Withdrawal by Subject|0|||
143302401|NCT05756790|516657875|FG000|Overall Study|Protocol Violation|0|||
143302402|NCT05756790|516657876|FG001|Overall Study|Protocol Violation|0|||
143302403|NCT05756790|516657877|FG002|Overall Study|Protocol Violation|1|||
143302404|NCT05756790|516657878|FG003|Overall Study|Protocol Violation|1|||
143302405|NCT05756790|516657879|FG004|Overall Study|Protocol Violation|0|||
143302406|NCT05756790|516657880|FG005|Overall Study|Protocol Violation|0|||
143302407|NCT05756790|516657875|FG000|Overall Study|Ineligible|0|||
143302408|NCT05756790|516657876|FG001|Overall Study|Ineligible|0|||
143302409|NCT05756790|516657877|FG002|Overall Study|Ineligible|0|||
143302410|NCT05756790|516657878|FG003|Overall Study|Ineligible|0|||
143302411|NCT05756790|516657879|FG004|Overall Study|Ineligible|2|||
143302412|NCT05756790|516657880|FG005|Overall Study|Ineligible|2|||
143302413|NCT00502697|516659507|FG000|Overall Study|Withdrawal by Subject|3|||
143302414|NCT00502697|516659508|FG001|Overall Study|Withdrawal by Subject|1|||
143302415|NCT00502697|516659507|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
143302416|NCT00502697|516659508|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
143302417|NCT00502697|516659507|FG000|Overall Study|found not to meet eligibility criteria|3|||
143302418|NCT00502697|516659508|FG001|Overall Study|found not to meet eligibility criteria|4|||
143302419|NCT00502697|516659507|FG000|Overall Study|did not meet assignment criteria|4|||
143302420|NCT00502697|516659508|FG001|Overall Study|did not meet assignment criteria|2|||
143302421|NCT03256552|516659513|FG000|Overall Study|Protocol Violation|1|||
143302422|NCT03256552|516659513|FG000|Overall Study|Physician Decision|1|||
143302423|NCT03256552|516659513|FG000|Overall Study|Adverse Event|1|||
143302424|NCT03256552|516659513|FG000|Overall Study|Withdrawal by Subject|2|||
143302425|NCT05083442|516659518|FG000|Overall Study|Lost to Follow-up|1|||
143302426|NCT05083442|516659519|FG001|Overall Study|Lost to Follow-up|0|||
143302427|NCT05083442|516659518|FG000|Overall Study|Lack of Efficacy|0|||
143302428|NCT05083442|516659519|FG001|Overall Study|Lack of Efficacy|1|||
143302429|NCT05083442|516659518|FG000|Overall Study|Withdrawal by Subject|1|||
143302430|NCT05083442|516659519|FG001|Overall Study|Withdrawal by Subject|3|||
143302431|NCT05083442|516659518|FG000|Overall Study|scheduling difficulties|1|||
143302432|NCT05083442|516659519|FG001|Overall Study|scheduling difficulties|2|||
143302433|NCT00136084|516659523|FG000|Overall Study|Death|12|||
143302434|NCT00136084|516659524|FG001|Overall Study|Death|5|||
143302435|NCT00136084|516659523|FG000|Overall Study|Unacceptable toxicity|8|||
143302436|NCT00136084|516659524|FG001|Overall Study|Unacceptable toxicity|11|||
143302437|NCT00136084|516659523|FG000|Overall Study|Relapse|20|||
143374872|NCT03460756|516917332|FG001|Overall Study|Adverse Event|0|||
143374873|NCT03460756|516917333|FG002|Overall Study|Adverse Event|0|||
143374874|NCT03460756|516917334|FG003|Overall Study|Adverse Event|1|||
143374875|NCT03460756|516917331|FG000|Overall Study|Lack of Efficacy|0|||
143374876|NCT03460756|516917332|FG001|Overall Study|Lack of Efficacy|0|||
143374877|NCT03460756|516917333|FG002|Overall Study|Lack of Efficacy|0|||
143374878|NCT03460756|516917334|FG003|Overall Study|Lack of Efficacy|2|||
143374879|NCT03460756|516917331|FG000|Overall Study|Lost to Follow-up|0|||
143374880|NCT03460756|516917332|FG001|Overall Study|Lost to Follow-up|1|||
143374881|NCT03460756|516917333|FG002|Overall Study|Lost to Follow-up|2|||
143374882|NCT03460756|516917334|FG003|Overall Study|Lost to Follow-up|1|||
143374883|NCT03460756|516917331|FG000|Overall Study|Pregnancy|0|||
143374884|NCT03460756|516917332|FG001|Overall Study|Pregnancy|0|||
143374885|NCT03460756|516917333|FG002|Overall Study|Pregnancy|0|||
143374886|NCT03460756|516917334|FG003|Overall Study|Pregnancy|1|||
143374887|NCT03460756|516917331|FG000|Overall Study|Protocol Violation|0|||
143374888|NCT03460756|516917332|FG001|Overall Study|Protocol Violation|0|||
143374889|NCT03460756|516917333|FG002|Overall Study|Protocol Violation|0|||
143374890|NCT03460756|516917334|FG003|Overall Study|Protocol Violation|1|||
143374891|NCT03460756|516917331|FG000|Overall Study|Withdrawal by Subject|0|||
143374892|NCT03460756|516917332|FG001|Overall Study|Withdrawal by Subject|4|||
143374893|NCT03460756|516917333|FG002|Overall Study|Withdrawal by Subject|7|||
143374894|NCT03460756|516917334|FG003|Overall Study|Withdrawal by Subject|3|||
143374895|NCT03192046|516917337|FG000|Overall Study|Withdrawal by Subject|1|||
143374896|NCT03192046|516917338|FG001|Overall Study|Withdrawal by Subject|1|||
143374897|NCT00762606|516917339|FG000|Overall Study|Lost to Follow-up|18|||
143374898|NCT00762606|516917340|FG001|Overall Study|Lost to Follow-up|13|||
143374899|NCT00842257|516917343|FG000|Overall Study|Adverse Event|1|||
143374900|NCT01147341|516917344|FG000|Double Blind Period|Lack of Efficacy|1|||
143374901|NCT01147341|516917345|FG001|Double Blind Period|Lack of Efficacy|1|||
143374902|NCT01147341|516917344|FG000|Double Blind Period|Withdrawal by Subject|0|||
143374903|NCT01147341|516917345|FG001|Double Blind Period|Withdrawal by Subject|1|||
143374904|NCT01147341|516917344|FG000|Open Label Period|Lack of Efficacy|3|||
143374905|NCT01147341|516917345|FG001|Open Label Period|Lack of Efficacy|0|||
143374906|NCT01147341|516917344|FG000|Open Label Period|Subject moved|1|||
143374907|NCT01147341|516917345|FG001|Open Label Period|Subject moved|0|||
143374908|NCT04177394|516917351|FG000|Overall Study|Death|16|||
143374909|NCT04177394|516917351|FG000|Overall Study|Withdrawal by Subject|19|||
143374910|NCT04177394|516917351|FG000|Overall Study|Missed visits|61|||
143374911|NCT04177394|516917351|FG000|Overall Study|Expected Visits|15|||
143374912|NCT00256243|516917352|FG000|Overall Study|Lost to Follow-up|2|||
143374913|NCT00256243|516917352|FG000|Overall Study|Death|7|||
143374914|NCT00256243|516917352|FG000|Overall Study|Not treated|1|||
143374915|NCT00373529|516917353|FG000|Overall Study|Physician Decision|19|||
143374916|NCT00373529|516917353|FG000|Overall Study|Withdrawal by Subject|7|||
143374917|NCT00373529|516917353|FG000|Overall Study|Adverse Event|7|||
143374918|NCT00373529|516917353|FG000|Overall Study|Treatment failure|36|||
143374919|NCT00373529|516917353|FG000|Overall Study|Disease recurrence|10|||
143374920|NCT00373529|516917353|FG000|Overall Study|Death|16|||
143374921|NCT00373529|516917353|FG000|Overall Study|Need for treatment prohibited by study|1|||
143374922|NCT00373529|516917353|FG000|Overall Study|Other|8|||
143374923|NCT00373529|516917353|FG000|Overall Study|Failed independent confirmation of AML|3|||
143374924|NCT00373529|516917353|FG000|Overall Study|Consent violation|1|||
143374925|NCT00442117|516917354|FG000|Overall Study|Adverse Event|3|||
143374926|NCT00442117|516917355|FG001|Overall Study|Adverse Event|2|||
143374927|NCT00442117|516917354|FG000|Overall Study|Lack of Efficacy|2|||
143374928|NCT00442117|516917355|FG001|Overall Study|Lack of Efficacy|6|||
143374929|NCT00442117|516917354|FG000|Overall Study|Lost to Follow-up|1|||
143374930|NCT00442117|516917355|FG001|Overall Study|Lost to Follow-up|2|||
143374931|NCT00442117|516917354|FG000|Overall Study|Withdrawal by Subject|2|||
143374932|NCT00442117|516917355|FG001|Overall Study|Withdrawal by Subject|2|||
143374933|NCT00442117|516917354|FG000|Overall Study|Major Deviation|25|||
143374934|NCT00442117|516917355|FG001|Overall Study|Major Deviation|20|||
143374935|NCT00442117|516917354|FG000|Overall Study|Non compliance with protocol|3|||
143374936|NCT00442117|516917355|FG001|Overall Study|Non compliance with protocol|5|||
143374937|NCT00442117|516917354|FG000|Overall Study|Met Withdrawal Criteria|2|||
143374938|NCT00442117|516917355|FG001|Overall Study|Met Withdrawal Criteria|1|||
143374939|NCT00841035|516917358|FG000|Phase 1 Overall Study|Physician Decision|13|||
143374940|NCT02994654|516917367|FG000|Overall Study|Lost to Follow-up|1|||
143374941|NCT01266265|516918900|FG000|Overall Study|Death|95|||
143374942|NCT01266265|516918901|FG001|Overall Study|Death|73|||
143374943|NCT01266265|516918900|FG000|Overall Study|Lost to Follow-up|23|||
143374944|NCT01266265|516918901|FG001|Overall Study|Lost to Follow-up|28|||
143374945|NCT01266265|516918900|FG000|Overall Study|Withdrawal by Subject|13|||
143374946|NCT01266265|516918901|FG001|Overall Study|Withdrawal by Subject|11|||
143374947|NCT01266265|516918900|FG000|Overall Study|Respiratory-related adverse event|2|||
143374948|NCT01266265|516918901|FG001|Overall Study|Respiratory-related adverse event|1|||
143374949|NCT01266265|516918900|FG000|Overall Study|Transferred care to another provider|22|||
143374950|NCT01266265|516918901|FG001|Overall Study|Transferred care to another provider|28|||
143374951|NCT01266265|516918900|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
143374952|NCT01266265|516918901|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
143374953|NCT01266265|516918900|FG000|Overall Study|Enrolled in another clinical study|15|||
143374954|NCT01266265|516918901|FG001|Overall Study|Enrolled in another clinical study|26|||
143374955|NCT01266265|516918900|FG000|Overall Study|Non-compliance|8|||
143374956|NCT01266265|516918901|FG001|Overall Study|Non-compliance|5|||
143374957|NCT01266265|516918900|FG000|Overall Study|Lung transplant|6|||
143374958|NCT01266265|516918901|FG001|Overall Study|Lung transplant|5|||
143374959|NCT01266265|516918900|FG000|Overall Study|Site closed early|4|||
143374960|NCT01266265|516918901|FG001|Overall Study|Site closed early|3|||
143374961|NCT01266265|516918900|FG000|Overall Study|Clinical worsening|1|||
143374962|NCT01266265|516918901|FG001|Overall Study|Clinical worsening|1|||
143374963|NCT00465816|516918902|FG000|Overall Study|Lost to Follow-up|0|||
143374964|NCT00465816|516918903|FG001|Overall Study|Lost to Follow-up|0|||
143374965|NCT00465816|516918904|FG002|Overall Study|Lost to Follow-up|2|||
143374966|NCT04218110|516918905|FG000|Overall Study|Withdrawal by Subject|0|||
143374967|NCT04218110|516918906|FG001|Overall Study|Withdrawal by Subject|0|||
143374968|NCT04218110|516918907|FG002|Overall Study|Withdrawal by Subject|0|||
143374969|NCT04218110|516918908|FG003|Overall Study|Withdrawal by Subject|1|||
143374970|NCT00002842|516918909|FG000|Overall Study|ineligible for surgical resection|27|||
143374971|NCT02015546|516918910|FG000|Overall Study|Withdrawal by Subject|1|||
143374972|NCT02015546|516918911|FG001|Overall Study|Withdrawal by Subject|1|||
143374973|NCT02015546|516918912|FG002|Overall Study|Withdrawal by Subject|1|||
143374974|NCT02015546|516918910|FG000|Overall Study|Screem Failure|2|||
143374975|NCT02015546|516918911|FG001|Overall Study|Screem Failure|1|||
143374976|NCT02015546|516918912|FG002|Overall Study|Screem Failure|3|||
143374977|NCT01426269|516918915|FG000|Period 1: 12 Weeks|Adverse Event|5|||
143374978|NCT01426269|516918916|FG001|Period 1: 12 Weeks|Adverse Event|0|||
143374979|NCT01426269|516918917|FG002|Period 1: 12 Weeks|Adverse Event|0|||
143374980|NCT01426269|516918915|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
143374981|NCT01426269|516918916|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
143374982|NCT01426269|516918917|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
143302438|NCT00136084|516659524|FG001|Overall Study|Relapse|23|||
143302439|NCT00136084|516659523|FG000|Overall Study|Lost to Follow-up|2|||
143302440|NCT00136084|516659524|FG001|Overall Study|Lost to Follow-up|0|||
143302441|NCT00136084|516659523|FG000|Overall Study|No Response|1|||
143302442|NCT00136084|516659524|FG001|Overall Study|No Response|2|||
143302443|NCT00136084|516659523|FG000|Overall Study|Withdrawal by Subject|5|||
143302444|NCT00136084|516659524|FG001|Overall Study|Withdrawal by Subject|1|||
143302445|NCT00644969|516659525|FG000|Treatment Phase|Randomized, not treated|1|||
143302446|NCT00644969|516659526|FG001|Treatment Phase|Randomized, not treated|0|||
143302447|NCT00644969|516659525|FG000|Treatment Phase|Adverse Event|3|||
143302448|NCT00644969|516659526|FG001|Treatment Phase|Adverse Event|0|||
143302449|NCT00644969|516659525|FG000|Treatment Phase|Withdrawal by Subject|4|||
143302450|NCT00644969|516659526|FG001|Treatment Phase|Withdrawal by Subject|0|||
143302451|NCT00644969|516659525|FG000|Treatment Phase|Lost to Follow-up|2|||
143302452|NCT00644969|516659526|FG001|Treatment Phase|Lost to Follow-up|2|||
143302453|NCT00644969|516659525|FG000|Treatment Phase|Other|4|||
143302454|NCT00644969|516659526|FG001|Treatment Phase|Other|1|||
143302455|NCT00644969|516659525|FG000|Post Treatment Phase|Death|1|||
143302456|NCT00644969|516659526|FG001|Post Treatment Phase|Death|0|||
143302457|NCT00644969|516659525|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
143302458|NCT00644969|516659526|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
143302459|NCT00644969|516659525|FG000|Post Treatment Phase|Lost to Follow-up|4|||
143302460|NCT00644969|516659526|FG001|Post Treatment Phase|Lost to Follow-up|1|||
143302461|NCT00644969|516659525|FG000|Post Treatment Phase|Other|1|||
143302462|NCT00644969|516659526|FG001|Post Treatment Phase|Other|0|||
143302463|NCT02449239|516659527|FG000|Induction Phase|Lack of Efficacy|64|||
143302464|NCT02449239|516659527|FG000|Induction Phase|Adverse Event|1|||
143302465|NCT02449239|516659527|FG000|Induction Phase|Lost to Follow-up|1|||
143302466|NCT02449239|516659527|FG000|Induction Phase|Protocol Violation|1|||
143302467|NCT02449239|516659527|FG000|Induction Phase|Physician Decision|1|||
143302468|NCT02449239|516659527|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
143302469|NCT02449239|516659527|FG000|Induction Phase|Withdrawal by Subject|1|||
143302470|NCT02449239|516659527|FG000|Maintenance Month 3|Lack of Efficacy|14|||
143302471|NCT02449239|516659527|FG000|Maintenance Month 6|Lack of Efficacy|10|||
143302472|NCT02449239|516659527|FG000|Maintenance Month 6|Adverse Event|2|||
143302473|NCT02449239|516659527|FG000|Maintenance Month 6|Physician Decision|1|||
143302474|NCT02449239|516659527|FG000|Maintenance Month 9|Lack of Efficacy|2|||
143302475|NCT02449239|516659527|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
143302476|NCT02449239|516659527|FG000|Maintenance Month 12|Lack of Efficacy|5|||
143302477|NCT02449239|516659527|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
143302478|NCT02449239|516659527|FG000|Maintenance Month 12|Subject moved from area|1|||
143302479|NCT02449239|516659527|FG000|Maintenance Month 15|Lack of Efficacy|1|||
143302480|NCT02449239|516659527|FG000|Maintenance Month 21|Lack of Efficacy|1|||
143302481|NCT02449239|516659527|FG000|Maintenance Month 21|Sponsor decision|1|||
143302482|NCT03509675|516659528|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
143374983|NCT01426269|516918915|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
143374984|NCT01426269|516918916|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
143374985|NCT01426269|516918917|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
143374986|NCT01426269|516918915|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
143302483|NCT03509675|516659529|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
143302484|NCT03509675|516659528|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
143302485|NCT03509675|516659529|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
143302486|NCT03509675|516659528|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
143302487|NCT03509675|516659529|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
143302488|NCT03509675|516659528|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
143302489|NCT03509675|516659529|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
143302490|NCT05620576|516659532|FG000|Overall Study|Adverse Event|1|||
143302491|NCT05620576|516659533|FG001|Overall Study|Adverse Event|1|||
143302492|NCT05620576|516659532|FG000|Overall Study|Lost to Follow-up|3|||
143302493|NCT05620576|516659533|FG001|Overall Study|Lost to Follow-up|1|||
143302494|NCT05620576|516659532|FG000|Overall Study|Physician Decision|0|||
143302495|NCT05620576|516659533|FG001|Overall Study|Physician Decision|1|||
143302496|NCT05620576|516659532|FG000|Overall Study|Protocol Deviation|1|||
143302497|NCT05620576|516659533|FG001|Overall Study|Protocol Deviation|1|||
143302498|NCT05620576|516659532|FG000|Overall Study|Withdrawal by Subject|2|||
143302499|NCT05620576|516659533|FG001|Overall Study|Withdrawal by Subject|3|||
143302500|NCT01023581|516659534|FG000|Overall Study|Adverse Event|4|||
143302501|NCT01023581|516659535|FG001|Overall Study|Adverse Event|4|||
143302502|NCT01023581|516659536|FG002|Overall Study|Adverse Event|7|||
143302503|NCT01023581|516659537|FG003|Overall Study|Adverse Event|3|||
143302504|NCT01023581|516659538|FG004|Overall Study|Adverse Event|2|||
143302505|NCT01023581|516659539|FG005|Overall Study|Adverse Event|5|||
143302506|NCT01023581|516659540|FG006|Overall Study|Adverse Event|11|||
143302507|NCT01023581|516659534|FG000|Overall Study|Major protocol deviation|2|||
143302508|NCT01023581|516659535|FG001|Overall Study|Major protocol deviation|0|||
143302509|NCT01023581|516659536|FG002|Overall Study|Major protocol deviation|3|||
143302510|NCT01023581|516659537|FG003|Overall Study|Major protocol deviation|0|||
143302511|NCT01023581|516659538|FG004|Overall Study|Major protocol deviation|0|||
143302512|NCT01023581|516659539|FG005|Overall Study|Major protocol deviation|0|||
143302513|NCT01023581|516659540|FG006|Overall Study|Major protocol deviation|0|||
143302514|NCT01023581|516659534|FG000|Overall Study|Lost to Follow-up|4|||
143302515|NCT01023581|516659535|FG001|Overall Study|Lost to Follow-up|8|||
143302516|NCT01023581|516659536|FG002|Overall Study|Lost to Follow-up|7|||
143302517|NCT01023581|516659537|FG003|Overall Study|Lost to Follow-up|2|||
143302518|NCT01023581|516659538|FG004|Overall Study|Lost to Follow-up|5|||
143302519|NCT01023581|516659539|FG005|Overall Study|Lost to Follow-up|2|||
143302520|NCT01023581|516659540|FG006|Overall Study|Lost to Follow-up|2|||
143302521|NCT01023581|516659534|FG000|Overall Study|Withdrawal by Subject|13|||
143302522|NCT01023581|516659535|FG001|Overall Study|Withdrawal by Subject|8|||
143302523|NCT01023581|516659536|FG002|Overall Study|Withdrawal by Subject|16|||
143302524|NCT01023581|516659537|FG003|Overall Study|Withdrawal by Subject|10|||
143302525|NCT01023581|516659538|FG004|Overall Study|Withdrawal by Subject|6|||
143302526|NCT01023581|516659539|FG005|Overall Study|Withdrawal by Subject|8|||
143302527|NCT01023581|516659540|FG006|Overall Study|Withdrawal by Subject|5|||
143302528|NCT01023581|516659534|FG000|Overall Study|Pregnancy|0|||
143302529|NCT01023581|516659535|FG001|Overall Study|Pregnancy|0|||
143302530|NCT01023581|516659536|FG002|Overall Study|Pregnancy|0|||
143302531|NCT01023581|516659537|FG003|Overall Study|Pregnancy|2|||
143302532|NCT01023581|516659538|FG004|Overall Study|Pregnancy|0|||
143302533|NCT01023581|516659539|FG005|Overall Study|Pregnancy|1|||
143302534|NCT01023581|516659540|FG006|Overall Study|Pregnancy|0|||
143302535|NCT01023581|516659534|FG000|Overall Study|Lack of Efficacy|9|||
143302536|NCT01023581|516659535|FG001|Overall Study|Lack of Efficacy|3|||
143302537|NCT01023581|516659536|FG002|Overall Study|Lack of Efficacy|6|||
143302538|NCT01023581|516659537|FG003|Overall Study|Lack of Efficacy|2|||
143302539|NCT01023581|516659538|FG004|Overall Study|Lack of Efficacy|1|||
143302540|NCT01023581|516659539|FG005|Overall Study|Lack of Efficacy|2|||
143302541|NCT01023581|516659540|FG006|Overall Study|Lack of Efficacy|1|||
143302542|NCT01023581|516659534|FG000|Overall Study|Physician Decision|2|||
143302543|NCT01023581|516659535|FG001|Overall Study|Physician Decision|0|||
143302544|NCT01023581|516659536|FG002|Overall Study|Physician Decision|2|||
143302545|NCT01023581|516659537|FG003|Overall Study|Physician Decision|1|||
143302546|NCT01023581|516659538|FG004|Overall Study|Physician Decision|1|||
143302547|NCT01023581|516659539|FG005|Overall Study|Physician Decision|1|||
143302548|NCT01023581|516659540|FG006|Overall Study|Physician Decision|1|||
143302549|NCT01023581|516659534|FG000|Overall Study|Other|1|||
143302550|NCT01023581|516659535|FG001|Overall Study|Other|0|||
143302551|NCT01023581|516659536|FG002|Overall Study|Other|1|||
143302552|NCT01023581|516659537|FG003|Overall Study|Other|0|||
143302553|NCT01023581|516659538|FG004|Overall Study|Other|1|||
143302554|NCT01023581|516659539|FG005|Overall Study|Other|0|||
143302555|NCT01023581|516659540|FG006|Overall Study|Other|0|||
143302556|NCT02622828|516659541|FG000|Overall Study|participant withdrew|3|||
143302557|NCT02780804|516659545|FG000|Overall Study|Death|1|||
143302558|NCT02780804|516659546|FG001|Overall Study|Death|0|||
143302559|NCT02780804|516659547|FG002|Overall Study|Death|0|||
143302560|NCT02780804|516659545|FG000|Overall Study|Lack of Efficacy|5|||
143302561|NCT02780804|516659546|FG001|Overall Study|Lack of Efficacy|8|||
143302562|NCT02780804|516659547|FG002|Overall Study|Lack of Efficacy|4|||
143302563|NCT02780804|516659545|FG000|Overall Study|Physician Decision|0|||
143302564|NCT02780804|516659546|FG001|Overall Study|Physician Decision|0|||
143302565|NCT02780804|516659547|FG002|Overall Study|Physician Decision|2|||
143302566|NCT02780804|516659545|FG000|Overall Study|Withdrawal by Subject|0|||
143302567|NCT02780804|516659546|FG001|Overall Study|Withdrawal by Subject|1|||
143302568|NCT02780804|516659547|FG002|Overall Study|Withdrawal by Subject|0|||
143302569|NCT02256891|516659552|FG000|Overall Study|Death|0|||
143302570|NCT02256891|516659553|FG001|Overall Study|Death|2|||
143302571|NCT02256891|516659552|FG000|Overall Study|Lost to Follow-up|0|||
143302572|NCT02256891|516659553|FG001|Overall Study|Lost to Follow-up|3|||
143302573|NCT02256891|516659552|FG000|Overall Study|Physician Decision|7|||
143302574|NCT02256891|516659553|FG001|Overall Study|Physician Decision|3|||
143302575|NCT02256891|516659552|FG000|Overall Study|Screen Fail|5|||
143302576|NCT02256891|516659553|FG001|Overall Study|Screen Fail|4|||
143302577|NCT02256891|516659552|FG000|Overall Study|Equipment Malfunction|0|||
143302578|NCT02256891|516659553|FG001|Overall Study|Equipment Malfunction|1|||
143302579|NCT04920123|516659558|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
143302580|NCT04920123|516659559|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
143302581|NCT04920123|516659560|FG002|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
143302582|NCT06134817|516659574|FG000|Overall Study|Physician Departure - termination of study|1|||
143302583|NCT00278954|516659575|FG000|Overall Study|Adverse Event|3|||
143374987|NCT01426269|516918916|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
143374988|NCT01426269|516918917|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
143302584|NCT00278954|516659575|FG000|Overall Study|Lost to Follow-up|1|||
143302585|NCT00278954|516659575|FG000|Overall Study|Withdrawal by Subject|1|||
143302586|NCT02046148|516659581|FG000|Overall Study|Lost to Follow-up|1|||
143302587|NCT02046148|516659582|FG001|Overall Study|Lost to Follow-up|1|||
143302588|NCT02046148|516659581|FG000|Overall Study|Withdrawal by Subject|0|||
143302589|NCT02046148|516659582|FG001|Overall Study|Withdrawal by Subject|2|||
143302590|NCT02211131|516659592|FG000|Overall Study|Death|26|||
143302591|NCT02211131|516659593|FG001|Overall Study|Death|16|||
143302592|NCT02211131|516659592|FG000|Overall Study|Lost to Follow-up|4|||
143302593|NCT02211131|516659593|FG001|Overall Study|Lost to Follow-up|3|||
143302594|NCT02211131|516659592|FG000|Overall Study|Decision by Sponsor|1|||
143302595|NCT02211131|516659593|FG001|Overall Study|Decision by Sponsor|1|||
143302596|NCT02211131|516659592|FG000|Overall Study|Withdrawal by Subject|3|||
143302597|NCT02211131|516659593|FG001|Overall Study|Withdrawal by Subject|8|||
143374989|NCT01426269|516918915|FG000|Period 1: 12 Weeks|Pregnancy|1|||
143302598|NCT01928862|516659596|FG000|Overall Study|Lost to Follow-up|1|||
143302599|NCT01928862|516659597|FG001|Overall Study|Lost to Follow-up|0|||
143302600|NCT01928862|516659598|FG002|Overall Study|Lost to Follow-up|0|||
143302601|NCT01928862|516659599|FG003|Overall Study|Lost to Follow-up|0|||
143302602|NCT01928862|516659600|FG004|Overall Study|Lost to Follow-up|1|||
143302603|NCT01752855|516659601|FG000|Overall Study|Adverse Event|1|||
143302604|NCT01752855|516659602|FG001|Overall Study|Adverse Event|0|||
143302605|NCT01752855|516659601|FG000|Overall Study|Withdrew Consent|0|||
143302606|NCT01752855|516659602|FG001|Overall Study|Withdrew Consent|2|||
143302607|NCT01752855|516659601|FG000|Overall Study|Lack of Efficacy|0|||
143302608|NCT01752855|516659602|FG001|Overall Study|Lack of Efficacy|2|||
143302609|NCT01478321|516659603|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
143302610|NCT01478321|516659603|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
143302611|NCT01478321|516659603|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
143302612|NCT01478321|516659603|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
143302613|NCT01478321|516659603|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
143302614|NCT01478321|516659603|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
143302615|NCT01478321|516659603|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
143302616|NCT01478321|516659603|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
143302617|NCT03168464|516659612|FG000|Overall Study|Death|9|||
143302618|NCT03168464|516659612|FG000|Overall Study|Progression of disease|6|||
143302619|NCT04649164|516659613|FG000|Overall Study|Withdrawal by Subject|1|||
143302620|NCT04649164|516659614|FG001|Overall Study|Withdrawal by Subject|1|||
143302621|NCT04649164|516659615|FG002|Overall Study|Withdrawal by Subject|2|||
143302622|NCT04649164|516659613|FG000|Overall Study|Participant's care recipient expired|0|||
143302623|NCT04649164|516659614|FG001|Overall Study|Participant's care recipient expired|0|||
143302624|NCT04649164|516659615|FG002|Overall Study|Participant's care recipient expired|2|||
143302625|NCT02053753|516659616|FG000|Overall Study|Withdrawal by Subject|2|||
143302626|NCT02053753|516659617|FG001|Overall Study|Withdrawal by Subject|4|||
143302627|NCT02053753|516659616|FG000|Overall Study|Decision by Sponsor|1|||
143302628|NCT02053753|516659617|FG001|Overall Study|Decision by Sponsor|1|||
143302629|NCT02053753|516659616|FG000|Overall Study|Lost to Follow-up|4|||
143302630|NCT02053753|516659617|FG001|Overall Study|Lost to Follow-up|3|||
143302631|NCT00634088|516659620|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
143302632|NCT00634088|516659621|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
143302633|NCT00634088|516659622|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
143302634|NCT00634088|516659623|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
143302635|NCT00634088|516659620|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
143302636|NCT00634088|516659621|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
143302637|NCT00634088|516659622|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
143302638|NCT00634088|516659623|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
143302639|NCT00634088|516659620|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
143302640|NCT00634088|516659621|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
143302641|NCT00634088|516659622|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
143302642|NCT00634088|516659623|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
143302643|NCT00634088|516659620|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
143302644|NCT00634088|516659621|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
143302645|NCT00634088|516659622|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
143302646|NCT00634088|516659623|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
143302647|NCT00634088|516659620|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
143302648|NCT00634088|516659621|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
143302649|NCT00634088|516659622|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
143302650|NCT00634088|516659623|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
143302651|NCT00634088|516659620|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
143302652|NCT00634088|516659621|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
143302653|NCT00634088|516659622|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
143302654|NCT00634088|516659623|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
143302655|NCT01488097|516659628|FG000|Overall Study|Lost to Follow-up|1|||
143302656|NCT01577758|516659629|FG000|Dose Escalation Phase|Adverse Event|0|||
143302657|NCT01577758|516659630|FG001|Dose Escalation Phase|Adverse Event|0|||
143302658|NCT01577758|516659631|FG002|Dose Escalation Phase|Adverse Event|0|||
143302659|NCT01577758|516659632|FG003|Dose Escalation Phase|Adverse Event|0|||
143302660|NCT01577758|516659633|FG004|Dose Escalation Phase|Adverse Event|0|||
143302661|NCT01577758|516659634|FG005|Dose Escalation Phase|Adverse Event|2|||
143302662|NCT01577758|516659635|FG006|Dose Escalation Phase|Adverse Event|1|||
143302663|NCT01577758|516659636|FG007|Dose Escalation Phase|Adverse Event|0|||
143302664|NCT01577758|516659629|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
143302665|NCT01577758|516659630|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
143302666|NCT01577758|516659631|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
143302667|NCT01577758|516659632|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
143302668|NCT01577758|516659633|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
143302669|NCT01577758|516659634|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
143302670|NCT01577758|516659635|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
143302671|NCT01577758|516659636|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
143302672|NCT01577758|516659629|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
143302673|NCT01577758|516659630|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
143302674|NCT01577758|516659631|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
143302675|NCT01577758|516659632|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
143302676|NCT01577758|516659633|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
143302677|NCT01577758|516659634|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
143302678|NCT01577758|516659635|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
143302679|NCT01577758|516659636|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
143302680|NCT01577758|516659629|FG000|Dose Escalation Phase|Progression Disease|2|||
143302681|NCT01577758|516659630|FG001|Dose Escalation Phase|Progression Disease|2|||
143302682|NCT01577758|516659631|FG002|Dose Escalation Phase|Progression Disease|1|||
143302683|NCT01577758|516659632|FG003|Dose Escalation Phase|Progression Disease|2|||
143302684|NCT01577758|516659633|FG004|Dose Escalation Phase|Progression Disease|5|||
143302685|NCT01577758|516659634|FG005|Dose Escalation Phase|Progression Disease|0|||
143302686|NCT01577758|516659635|FG006|Dose Escalation Phase|Progression Disease|0|||
143302687|NCT01577758|516659636|FG007|Dose Escalation Phase|Progression Disease|0|||
143302688|NCT01577758|516659629|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
143302689|NCT01577758|516659630|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
143302690|NCT01577758|516659631|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
143302691|NCT01577758|516659632|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
143302692|NCT01577758|516659633|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
143302693|NCT01577758|516659634|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
143302694|NCT01577758|516659635|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
143302695|NCT01577758|516659636|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
143302696|NCT01577758|516659629|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
143302697|NCT01577758|516659630|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
143302698|NCT01577758|516659631|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
143302699|NCT01577758|516659632|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
143302700|NCT01577758|516659633|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
143302701|NCT01577758|516659634|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
143302702|NCT01577758|516659635|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
143302703|NCT01577758|516659636|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
143302704|NCT01577758|516659629|FG000|mCRC Expansion Phase|Progression Disease|0|||
143302705|NCT01577758|516659630|FG001|mCRC Expansion Phase|Progression Disease|0|||
143302706|NCT01577758|516659631|FG002|mCRC Expansion Phase|Progression Disease|0|||
143302707|NCT01577758|516659632|FG003|mCRC Expansion Phase|Progression Disease|0|||
143302708|NCT01577758|516659633|FG004|mCRC Expansion Phase|Progression Disease|0|||
143302709|NCT01577758|516659634|FG005|mCRC Expansion Phase|Progression Disease|0|||
143302710|NCT01577758|516659635|FG006|mCRC Expansion Phase|Progression Disease|0|||
143302711|NCT01577758|516659636|FG007|mCRC Expansion Phase|Progression Disease|19|||
143302712|NCT02404350|516659639|FG000|Overall Study|Adverse Event|2|||
143302713|NCT02404350|516659640|FG001|Overall Study|Adverse Event|2|||
143302714|NCT02404350|516659641|FG002|Overall Study|Adverse Event|3|||
143302715|NCT02404350|516659642|FG003|Overall Study|Adverse Event|9|||
143302716|NCT02404350|516659639|FG000|Overall Study|Lack of Efficacy|3|||
143302717|NCT02404350|516659640|FG001|Overall Study|Lack of Efficacy|1|||
143302718|NCT02404350|516659641|FG002|Overall Study|Lack of Efficacy|0|||
143302719|NCT02404350|516659642|FG003|Overall Study|Lack of Efficacy|3|||
143302720|NCT02404350|516659639|FG000|Overall Study|Lost to Follow-up|2|||
143302721|NCT02404350|516659640|FG001|Overall Study|Lost to Follow-up|0|||
143302722|NCT02404350|516659641|FG002|Overall Study|Lost to Follow-up|0|||
143302723|NCT02404350|516659642|FG003|Overall Study|Lost to Follow-up|1|||
143302724|NCT02404350|516659639|FG000|Overall Study|Physician Decision|1|||
143302725|NCT02404350|516659640|FG001|Overall Study|Physician Decision|0|||
143302726|NCT02404350|516659641|FG002|Overall Study|Physician Decision|0|||
143302727|NCT02404350|516659642|FG003|Overall Study|Physician Decision|2|||
143302728|NCT02404350|516659639|FG000|Overall Study|Pregnancy|0|||
143302729|NCT02404350|516659640|FG001|Overall Study|Pregnancy|0|||
143302730|NCT02404350|516659641|FG002|Overall Study|Pregnancy|0|||
143302731|NCT02404350|516659642|FG003|Overall Study|Pregnancy|1|||
143302732|NCT02404350|516659639|FG000|Overall Study|Withdrawal by Subject|7|||
143302733|NCT02404350|516659640|FG001|Overall Study|Withdrawal by Subject|3|||
143302734|NCT02404350|516659641|FG002|Overall Study|Withdrawal by Subject|3|||
143302735|NCT02404350|516659642|FG003|Overall Study|Withdrawal by Subject|19|||
143302736|NCT02404350|516659639|FG000|Overall Study|Due to Non-compliance with treatment|0|||
143302737|NCT02404350|516659640|FG001|Overall Study|Due to Non-compliance with treatment|0|||
143302738|NCT02404350|516659641|FG002|Overall Study|Due to Non-compliance with treatment|0|||
143302739|NCT02404350|516659642|FG003|Overall Study|Due to Non-compliance with treatment|1|||
143302740|NCT02404350|516659639|FG000|Overall Study|Due to Technical problems|0|||
143302741|NCT02404350|516659640|FG001|Overall Study|Due to Technical problems|0|||
143302742|NCT02404350|516659641|FG002|Overall Study|Due to Technical problems|0|||
143302743|NCT02404350|516659642|FG003|Overall Study|Due to Technical problems|1|||
143302744|NCT02140567|516659647|FG000|Overall Study|Problems with recording equipment|6|||
143302745|NCT01062555|516659655|FG000|Phase 1|Death|10|||
143302746|NCT01062555|516659656|FG001|Phase 1|Death|17|||
143302747|NCT01062555|516659657|FG002|Phase 1|Death|0|||
143302748|NCT01062555|516659658|FG003|Phase 1|Death|0|||
143302749|NCT01062555|516659655|FG000|Phase 1|Graft Failure|12|||
143302750|NCT01062555|516659656|FG001|Phase 1|Graft Failure|8|||
143302751|NCT01062555|516659657|FG002|Phase 1|Graft Failure|0|||
143302752|NCT01062555|516659658|FG003|Phase 1|Graft Failure|0|||
143302753|NCT01062555|516659655|FG000|Phase 1|Withdrawal by Subject|1|||
143302754|NCT01062555|516659656|FG001|Phase 1|Withdrawal by Subject|1|||
143302755|NCT01062555|516659657|FG002|Phase 1|Withdrawal by Subject|0|||
143302756|NCT01062555|516659658|FG003|Phase 1|Withdrawal by Subject|0|||
143302757|NCT01062555|516659655|FG000|Phase 2|Death|0|||
143302758|NCT01062555|516659656|FG001|Phase 2|Death|0|||
143302759|NCT01062555|516659657|FG002|Phase 2|Death|8|||
143302760|NCT01062555|516659658|FG003|Phase 2|Death|3|||
143302761|NCT01062555|516659655|FG000|Phase 2|Graft failure|0|||
143302762|NCT01062555|516659656|FG001|Phase 2|Graft failure|0|||
143302763|NCT01062555|516659657|FG002|Phase 2|Graft failure|7|||
143302764|NCT01062555|516659658|FG003|Phase 2|Graft failure|4|||
143302765|NCT01062555|516659655|FG000|Phase 2|Withdrawal by Subject|0|||
143302766|NCT01062555|516659656|FG001|Phase 2|Withdrawal by Subject|0|||
143302767|NCT01062555|516659657|FG002|Phase 2|Withdrawal by Subject|0|||
143302768|NCT01062555|516659658|FG003|Phase 2|Withdrawal by Subject|7|||
143302769|NCT01062555|516659655|FG000|Phase 2|Protocol Violation|0|||
143302770|NCT01062555|516659656|FG001|Phase 2|Protocol Violation|0|||
143302771|NCT01062555|516659657|FG002|Phase 2|Protocol Violation|0|||
143302772|NCT01062555|516659658|FG003|Phase 2|Protocol Violation|3|||
143302773|NCT01062555|516659655|FG000|Phase 2|Physician Decision|0|||
143302774|NCT01062555|516659656|FG001|Phase 2|Physician Decision|0|||
143302775|NCT01062555|516659657|FG002|Phase 2|Physician Decision|0|||
143302776|NCT01062555|516659658|FG003|Phase 2|Physician Decision|17|||
143302777|NCT03560531|516659659|FG000|Overall Study|Death|4|||
143302778|NCT03560531|516659660|FG001|Overall Study|Death|1|||
143302779|NCT03560531|516659661|FG002|Overall Study|Death|1|||
143302780|NCT03560531|516659662|FG003|Overall Study|Death|2|||
143302781|NCT03560531|516659663|FG004|Overall Study|Death|6|||
143302782|NCT03560531|516659664|FG005|Overall Study|Death|1|||
143302783|NCT03560531|516659665|FG006|Overall Study|Death|4|||
143302784|NCT03560531|516659666|FG007|Overall Study|Death|8|||
143302785|NCT03560531|516659667|FG008|Overall Study|Death|1|||
143302786|NCT03560531|516659668|FG009|Overall Study|Death|3|||
143302787|NCT03560531|516659669|FG010|Overall Study|Death|2|||
143302788|NCT03560531|516659670|FG011|Overall Study|Death|0|||
143302789|NCT03560531|516659671|FG012|Overall Study|Death|4|||
143302790|NCT03560531|516659672|FG013|Overall Study|Death|1|||
143302791|NCT03560531|516659659|FG000|Overall Study|Lost to Follow-up|1|||
143302792|NCT03560531|516659660|FG001|Overall Study|Lost to Follow-up|1|||
143302793|NCT03560531|516659661|FG002|Overall Study|Lost to Follow-up|0|||
143302794|NCT03560531|516659662|FG003|Overall Study|Lost to Follow-up|0|||
143302795|NCT03560531|516659663|FG004|Overall Study|Lost to Follow-up|0|||
143302796|NCT03560531|516659664|FG005|Overall Study|Lost to Follow-up|0|||
143302797|NCT03560531|516659665|FG006|Overall Study|Lost to Follow-up|1|||
143302798|NCT03560531|516659666|FG007|Overall Study|Lost to Follow-up|0|||
143302799|NCT03560531|516659667|FG008|Overall Study|Lost to Follow-up|0|||
143302800|NCT03560531|516659668|FG009|Overall Study|Lost to Follow-up|0|||
143302801|NCT03560531|516659669|FG010|Overall Study|Lost to Follow-up|0|||
143302802|NCT03560531|516659670|FG011|Overall Study|Lost to Follow-up|0|||
143302803|NCT03560531|516659671|FG012|Overall Study|Lost to Follow-up|0|||
143302804|NCT03560531|516659672|FG013|Overall Study|Lost to Follow-up|0|||
143302805|NCT03560531|516659659|FG000|Overall Study|Withdrawal by Subject|1|||
143302806|NCT03560531|516659660|FG001|Overall Study|Withdrawal by Subject|0|||
143302807|NCT03560531|516659661|FG002|Overall Study|Withdrawal by Subject|0|||
143302808|NCT03560531|516659662|FG003|Overall Study|Withdrawal by Subject|0|||
143302809|NCT03560531|516659663|FG004|Overall Study|Withdrawal by Subject|0|||
143302810|NCT03560531|516659664|FG005|Overall Study|Withdrawal by Subject|0|||
143302811|NCT03560531|516659665|FG006|Overall Study|Withdrawal by Subject|0|||
143302812|NCT03560531|516659666|FG007|Overall Study|Withdrawal by Subject|3|||
143302813|NCT03560531|516659667|FG008|Overall Study|Withdrawal by Subject|2|||
143302814|NCT03560531|516659668|FG009|Overall Study|Withdrawal by Subject|0|||
143302815|NCT03560531|516659669|FG010|Overall Study|Withdrawal by Subject|0|||
143302816|NCT03560531|516659670|FG011|Overall Study|Withdrawal by Subject|0|||
143302817|NCT03560531|516659671|FG012|Overall Study|Withdrawal by Subject|2|||
143302818|NCT03560531|516659672|FG013|Overall Study|Withdrawal by Subject|0|||
143302819|NCT03560531|516659659|FG000|Overall Study|Study end per-protocol|1|||
143302820|NCT03560531|516659660|FG001|Overall Study|Study end per-protocol|1|||
143302821|NCT03560531|516659661|FG002|Overall Study|Study end per-protocol|2|||
143302822|NCT03560531|516659662|FG003|Overall Study|Study end per-protocol|0|||
143302823|NCT03560531|516659663|FG004|Overall Study|Study end per-protocol|1|||
143302824|NCT03560531|516659664|FG005|Overall Study|Study end per-protocol|0|||
143302825|NCT03560531|516659665|FG006|Overall Study|Study end per-protocol|0|||
143302826|NCT03560531|516659666|FG007|Overall Study|Study end per-protocol|0|||
143302827|NCT03560531|516659667|FG008|Overall Study|Study end per-protocol|0|||
143302828|NCT03560531|516659668|FG009|Overall Study|Study end per-protocol|0|||
143302829|NCT03560531|516659669|FG010|Overall Study|Study end per-protocol|0|||
143302830|NCT03560531|516659670|FG011|Overall Study|Study end per-protocol|0|||
143302831|NCT03560531|516659671|FG012|Overall Study|Study end per-protocol|0|||
143302832|NCT03560531|516659672|FG013|Overall Study|Study end per-protocol|0|||
143302833|NCT03560531|516659659|FG000|Overall Study|Early study termination by sponsor|9|||
143302834|NCT03560531|516659660|FG001|Overall Study|Early study termination by sponsor|0|||
143302835|NCT03560531|516659661|FG002|Overall Study|Early study termination by sponsor|0|||
143302836|NCT03560531|516659662|FG003|Overall Study|Early study termination by sponsor|4|||
143302837|NCT03560531|516659663|FG004|Overall Study|Early study termination by sponsor|8|||
143302838|NCT03560531|516659664|FG005|Overall Study|Early study termination by sponsor|2|||
143302839|NCT03560531|516659665|FG006|Overall Study|Early study termination by sponsor|5|||
143302840|NCT03560531|516659666|FG007|Overall Study|Early study termination by sponsor|64|||
143302841|NCT03560531|516659667|FG008|Overall Study|Early study termination by sponsor|7|||
143302842|NCT03560531|516659668|FG009|Overall Study|Early study termination by sponsor|2|||
143302843|NCT03560531|516659669|FG010|Overall Study|Early study termination by sponsor|16|||
143302844|NCT03560531|516659670|FG011|Overall Study|Early study termination by sponsor|2|||
143302845|NCT03560531|516659671|FG012|Overall Study|Early study termination by sponsor|6|||
143302846|NCT03560531|516659672|FG013|Overall Study|Early study termination by sponsor|2|||
143302847|NCT01471379|516659673|FG000|Overall Study|Adverse Event|1|||
143302848|NCT01471379|516659674|FG001|Overall Study|Adverse Event|0|||
143302849|NCT01471379|516659675|FG002|Overall Study|Adverse Event|0|||
143302850|NCT01471379|516659673|FG000|Overall Study|Study terminated|0|||
143302851|NCT01471379|516659674|FG001|Overall Study|Study terminated|1|||
143302852|NCT01471379|516659675|FG002|Overall Study|Study terminated|0|||
143302853|NCT02028988|516659676|FG000|Overall Study|Withdrawal by Subject|2|||
143302854|NCT01063595|516659677|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
143302855|NCT01063595|516659678|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
143302856|NCT01063595|516659677|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
143302857|NCT01063595|516659678|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
143302858|NCT01063595|516659677|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
143302859|NCT01063595|516659678|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
143302860|NCT01063595|516659677|FG000|First Intervention|Adverse Event|1|||
143302861|NCT01063595|516659678|FG001|First Intervention|Adverse Event|4|||
143302862|NCT01063595|516659677|FG000|First Intervention|Withdrawal by Subject|1|||
143302863|NCT01063595|516659678|FG001|First Intervention|Withdrawal by Subject|0|||
143302864|NCT01063595|516659677|FG000|First Intervention|Reason not Specified|0|||
143302865|NCT01063595|516659678|FG001|First Intervention|Reason not Specified|1|||
143302866|NCT00747435|516659679|FG000|Overall Study|Lost to Follow-up|2|||
143302867|NCT00747435|516659679|FG000|Overall Study|Withdrawal by Subject|3|||
143302868|NCT00747435|516659679|FG000|Overall Study|Still undergoing follow up|1|||
143302869|NCT00589108|516661408|FG000|Overall Study|Lost to Follow-up|1|||
143302870|NCT00589108|516661409|FG001|Overall Study|Lost to Follow-up|1|||
143302871|NCT00589108|516661410|FG002|Overall Study|Lost to Follow-up|1|||
143302872|NCT00589108|516661408|FG000|Overall Study|Death|3|||
143302873|NCT00589108|516661409|FG001|Overall Study|Death|3|||
143302874|NCT00589108|516661410|FG002|Overall Study|Death|4|||
143302875|NCT01176292|516661415|FG000|Overall Study|Lost to Follow-up|2|||
143302876|NCT01176292|516661416|FG001|Overall Study|Lost to Follow-up|4|||
143302877|NCT01176292|516661415|FG000|Overall Study|Adverse Event|1|||
143302878|NCT01176292|516661416|FG001|Overall Study|Adverse Event|1|||
143302879|NCT01176292|516661415|FG000|Overall Study|Physician Decision|0|||
143302880|NCT01176292|516661416|FG001|Overall Study|Physician Decision|2|||
143302881|NCT01176292|516661415|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
143302882|NCT01176292|516661416|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
143302883|NCT00997503|516661417|FG000|Overall Study|Death|53|||
143302884|NCT00997503|516661417|FG000|Overall Study|Withdrawal by Subject|76|||
143302885|NCT00997503|516661417|FG000|Overall Study|Lost to Follow-up|33|||
143302886|NCT00997503|516661417|FG000|Overall Study|Adverse Event|3|||
143302887|NCT00997503|516661417|FG000|Overall Study|Physician Decision|10|||
143302888|NCT00997503|516661417|FG000|Overall Study|Missed 12-month follow-up|85|||
143302889|NCT00997503|516661417|FG000|Overall Study|Other reason|13|||
143302890|NCT00380393|516661418|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
143302891|NCT00380393|516661419|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
143302892|NCT00380393|516661418|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
143302893|NCT00380393|516661419|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
143302894|NCT00380393|516661418|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
143302895|NCT00380393|516661419|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
143302896|NCT00380393|516661418|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
143302897|NCT00380393|516661419|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
143302898|NCT00380393|516661418|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
143302899|NCT00380393|516661419|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
143302900|NCT00380393|516661418|FG000|Month 14|Withdrawal by Subject|9|||
143302901|NCT00380393|516661419|FG001|Month 14|Withdrawal by Subject|7|||
143302902|NCT00380393|516661418|FG000|Month 14|Death|1|||
143302903|NCT00380393|516661419|FG001|Month 14|Death|0|||
143302904|NCT00380393|516661418|FG000|Month 14|Lost to Follow-up|0|||
143302905|NCT00380393|516661419|FG001|Month 14|Lost to Follow-up|1|||
143302906|NCT00380393|516661418|FG000|Month 14|Migrated/moved from study area|39|||
143302907|NCT00380393|516661419|FG001|Month 14|Migrated/moved from study area|42|||
143302908|NCT00380393|516661418|FG000|Month 14|Protocol Violation|2|||
143302909|NCT00380393|516661419|FG001|Month 14|Protocol Violation|0|||
143302910|NCT00380393|516661418|FG000|Month 14|Others|6|||
143302911|NCT00380393|516661419|FG001|Month 14|Others|6|||
143302912|NCT00218296|516661420|FG000|Overall Study|Lost to Follow-up|9|||
143302913|NCT00218296|516661421|FG001|Overall Study|Lost to Follow-up|7|||
143302914|NCT00218296|516661420|FG000|Overall Study|Withdrawal by Subject|36|||
143302915|NCT00218296|516661421|FG001|Overall Study|Withdrawal by Subject|47|||
143302916|NCT00218296|516661420|FG000|Overall Study|Randomized but did not enter treatment|66|||
143302917|NCT00218296|516661421|FG001|Overall Study|Randomized but did not enter treatment|67|||
143302918|NCT02586493|516661424|FG000|Overall Study|Adverse Event|4|||
143302919|NCT02586493|516661424|FG000|Overall Study|Protocol Violation|6|||
143302920|NCT02586493|516661424|FG000|Overall Study|Lost to Follow-up|1|||
143302921|NCT02586493|516661424|FG000|Overall Study|Withdrawal by Subject|1|||
143302922|NCT05664490|516661431|FG000|Overall Study|Withdrawal by Subject|0|||
143374990|NCT01426269|516918916|FG001|Period 1: 12 Weeks|Pregnancy|0|||
143374991|NCT01426269|516918917|FG002|Period 1: 12 Weeks|Pregnancy|0|||
143374992|NCT01426269|516918915|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
143302923|NCT05664490|516661432|FG001|Overall Study|Withdrawal by Subject|1|||
143302924|NCT05664490|516661431|FG000|Overall Study|Lost to Follow-up|14|||
143374993|NCT01426269|516918916|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
143302925|NCT05664490|516661432|FG001|Overall Study|Lost to Follow-up|22|||
143302926|NCT05442554|516661433|FG000|Overall Study|Adverse Event|1|||
143302927|NCT01990495|516661441|FG000|Overall Study|Physician Decision|5|||
143302928|NCT01990495|516661442|FG001|Overall Study|Physician Decision|4|||
143302929|NCT03412084|516661443|FG000|Overall Study|Withdrawal by Subject|2|||
143302930|NCT03412084|516661444|FG001|Overall Study|Withdrawal by Subject|0|||
143302931|NCT03412084|516661443|FG000|Overall Study|Participant moved|1|||
143302932|NCT03412084|516661444|FG001|Overall Study|Participant moved|0|||
143302933|NCT03412084|516661443|FG000|Overall Study|Lost to Follow-up|1|||
143302934|NCT03412084|516661444|FG001|Overall Study|Lost to Follow-up|1|||
143302935|NCT02972632|516661445|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
143302936|NCT02972632|516661445|FG000|Overall Study|Lost to Follow-up|4|||
143302937|NCT02972632|516661445|FG000|Overall Study|Voluntary Withdrawal|10|||
143302938|NCT02023151|516661446|FG000|Overall Study|Lost to Follow-up|4|||
143302939|NCT04064294|516661447|FG000|Overall Study|Adverse Event|1|||
143302940|NCT04064294|516661448|FG001|Overall Study|Adverse Event|0|||
143302941|NCT04064294|516661449|FG002|Overall Study|Adverse Event|0|||
143302942|NCT03450707|516661450|FG000|Overall Study|Outside enrollment window|4|||
143302943|NCT03450707|516661451|FG001|Overall Study|Outside enrollment window|1|||
143302944|NCT03450707|516661450|FG000|Overall Study|Death|1|||
143302945|NCT03450707|516661451|FG001|Overall Study|Death|0|||
143302946|NCT03450707|516661450|FG000|Overall Study|Indication for thiamine|1|||
143302947|NCT03450707|516661451|FG001|Overall Study|Indication for thiamine|1|||
143302948|NCT03450707|516661450|FG000|Overall Study|Evidence of traumatic brain injury|1|||
143302949|NCT03450707|516661451|FG001|Overall Study|Evidence of traumatic brain injury|0|||
143302950|NCT03450707|516661450|FG000|Overall Study|Following commands|0|||
143302951|NCT03450707|516661451|FG001|Overall Study|Following commands|3|||
143302952|NCT03450707|516661450|FG000|Overall Study|Lactate < 3.5|0|||
143302953|NCT03450707|516661451|FG001|Overall Study|Lactate < 3.5|2|||
143302954|NCT03450707|516661450|FG000|Overall Study|Rearrest with ECMO|0|||
143302955|NCT03450707|516661451|FG001|Overall Study|Rearrest with ECMO|1|||
143302956|NCT03450707|516661450|FG000|Overall Study|Indication for thiamine + head CT results|0|||
143302957|NCT03450707|516661451|FG001|Overall Study|Indication for thiamine + head CT results|1|||
143302958|NCT03450707|516661450|FG000|Overall Study|Family/patient goals of care|0|||
143302959|NCT03450707|516661451|FG001|Overall Study|Family/patient goals of care|1|||
143302960|NCT02932904|516661458|FG000|Overall Study|Reason not Specified|1|||
143302961|NCT02932904|516661459|FG001|Overall Study|Reason not Specified|0|||
143302962|NCT02932904|516661460|FG002|Overall Study|Reason not Specified|2|||
143302963|NCT02932904|516661461|FG003|Overall Study|Reason not Specified|2|||
143302964|NCT02932904|516661458|FG000|Overall Study|Noncompliance with Study Drug|2|||
143302965|NCT02932904|516661459|FG001|Overall Study|Noncompliance with Study Drug|3|||
143302966|NCT02932904|516661460|FG002|Overall Study|Noncompliance with Study Drug|3|||
143302967|NCT02932904|516661461|FG003|Overall Study|Noncompliance with Study Drug|4|||
143302968|NCT02932904|516661458|FG000|Overall Study|Pregnancy|0|||
143302969|NCT02932904|516661459|FG001|Overall Study|Pregnancy|1|||
143302970|NCT02932904|516661460|FG002|Overall Study|Pregnancy|1|||
143302971|NCT02932904|516661461|FG003|Overall Study|Pregnancy|0|||
143302972|NCT02932904|516661458|FG000|Overall Study|Study Termination|0|||
143302973|NCT02932904|516661459|FG001|Overall Study|Study Termination|1|||
143302974|NCT02932904|516661460|FG002|Overall Study|Study Termination|0|||
143302975|NCT02932904|516661461|FG003|Overall Study|Study Termination|0|||
143302976|NCT02932904|516661458|FG000|Overall Study|Voluntary Withdrawal|2|||
143302977|NCT02932904|516661459|FG001|Overall Study|Voluntary Withdrawal|1|||
143302978|NCT02932904|516661460|FG002|Overall Study|Voluntary Withdrawal|4|||
143302979|NCT02932904|516661461|FG003|Overall Study|Voluntary Withdrawal|2|||
143302980|NCT02932904|516661458|FG000|Overall Study|Lost to Follow-up|5|||
143302981|NCT02932904|516661459|FG001|Overall Study|Lost to Follow-up|3|||
143302982|NCT02932904|516661460|FG002|Overall Study|Lost to Follow-up|6|||
143302983|NCT02932904|516661461|FG003|Overall Study|Lost to Follow-up|0|||
143302984|NCT02932904|516661458|FG000|Overall Study|Significant Protocol Deviation|2|||
143302985|NCT02932904|516661459|FG001|Overall Study|Significant Protocol Deviation|3|||
143302986|NCT02932904|516661460|FG002|Overall Study|Significant Protocol Deviation|6|||
143302987|NCT02932904|516661461|FG003|Overall Study|Significant Protocol Deviation|1|||
143302988|NCT02932904|516661458|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
143302989|NCT02932904|516661459|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
143302990|NCT02932904|516661460|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
143302991|NCT02932904|516661461|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
143302992|NCT02932904|516661458|FG000|Overall Study|Randomized But Not Treated|1|||
143302993|NCT02932904|516661459|FG001|Overall Study|Randomized But Not Treated|1|||
143302994|NCT02932904|516661460|FG002|Overall Study|Randomized But Not Treated|0|||
143302995|NCT02932904|516661461|FG003|Overall Study|Randomized But Not Treated|2|||
143302996|NCT00337103|516661465|FG000|Overall Study|Progressive Disease|414|||
143302997|NCT00337103|516661466|FG001|Overall Study|Progressive Disease|410|||
143302998|NCT00337103|516661465|FG000|Overall Study|Adverse Event|45|||
143302999|NCT00337103|516661466|FG001|Overall Study|Adverse Event|59|||
143303000|NCT00337103|516661465|FG000|Overall Study|Subject Choice|34|||
143303001|NCT00337103|516661466|FG001|Overall Study|Subject Choice|27|||
143303002|NCT00337103|516661465|FG000|Overall Study|Clinical Progression|27|||
143303003|NCT00337103|516661466|FG001|Overall Study|Clinical Progression|24|||
143303004|NCT00337103|516661465|FG000|Overall Study|Physician Decision|15|||
143303005|NCT00337103|516661466|FG001|Overall Study|Physician Decision|14|||
143303006|NCT00337103|516661465|FG000|Overall Study|Withdrawal by Subject|8|||
143303007|NCT00337103|516661466|FG001|Overall Study|Withdrawal by Subject|5|||
143303008|NCT00337103|516661465|FG000|Overall Study|Other|5|||
143303009|NCT00337103|516661466|FG001|Overall Study|Other|6|||
143303010|NCT00337103|516661465|FG000|Overall Study|Entry Criteria Not Met|4|||
143303011|NCT00337103|516661466|FG001|Overall Study|Entry Criteria Not Met|1|||
143303012|NCT00337103|516661465|FG000|Overall Study|Lost to Follow-up|1|||
143303013|NCT00337103|516661466|FG001|Overall Study|Lost to Follow-up|2|||
143303014|NCT00337103|516661465|FG000|Overall Study|Death|1|||
143303015|NCT00337103|516661466|FG001|Overall Study|Death|0|||
143303016|NCT02016482|516661467|FG000|Period A|Adverse Event|3|||
143303017|NCT02016482|516661468|FG001|Period A|Adverse Event|5|||
143303018|NCT02016482|516661467|FG000|Period A|Withdrawal by Subject|3|||
143303019|NCT02016482|516661468|FG001|Period A|Withdrawal by Subject|4|||
143303020|NCT02016482|516661467|FG000|Period A|Lost to Follow-up|3|||
143303021|NCT02016482|516661468|FG001|Period A|Lost to Follow-up|3|||
143303022|NCT02016482|516661467|FG000|Period A|Lack of Efficacy|2|||
143303023|NCT02016482|516661468|FG001|Period A|Lack of Efficacy|1|||
143303024|NCT02016482|516661467|FG000|Period A|Other|3|||
143303025|NCT02016482|516661468|FG001|Period A|Other|0|||
143303026|NCT02016482|516661467|FG000|Period A|Protocol Violation|0|||
143303027|NCT02016482|516661468|FG001|Period A|Protocol Violation|1|||
143303028|NCT02016482|516661467|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
143303029|NCT02016482|516661468|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
143303030|NCT02016482|516661467|FG000|Period B|Withdrawal by Subject|1|||
143303031|NCT02016482|516661468|FG001|Period B|Withdrawal by Subject|1|||
143303032|NCT02016482|516661467|FG000|Period B|Lost to Follow-up|2|||
143303033|NCT02016482|516661468|FG001|Period B|Lost to Follow-up|0|||
143303034|NCT02016482|516661467|FG000|Period B|Lack of Efficacy|6|||
143303035|NCT02016482|516661468|FG001|Period B|Lack of Efficacy|4|||
143303036|NCT02016482|516661467|FG000|Period B|Other|4|||
143303037|NCT02016482|516661468|FG001|Period B|Other|0|||
143303038|NCT02016482|516661467|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
143303039|NCT02016482|516661468|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
143303040|NCT01289847|516661469|FG000|Overall Study|Patient could not comply with visits|1|||
143303041|NCT03975647|516661480|FG000|Overall Study|Death|71|||
143303042|NCT03975647|516661481|FG001|Overall Study|Death|63|||
143303043|NCT03975647|516661480|FG000|Overall Study|Lost to Follow-up|2|||
143303044|NCT03975647|516661481|FG001|Overall Study|Lost to Follow-up|2|||
143303045|NCT03975647|516661480|FG000|Overall Study|Subject withdrawal of consent|7|||
143303046|NCT03975647|516661481|FG001|Overall Study|Subject withdrawal of consent|11|||
143303047|NCT01293240|516661482|FG000|Overall Study|Noncompliance|2|||
143303048|NCT05389657|516661492|FG000|Overall Study|Lost to Follow-up|7|||
143303049|NCT05389657|516661493|FG001|Overall Study|Lost to Follow-up|8|||
143303050|NCT03261947|516661494|FG000|Overall Study|Death|10|||
143303051|NCT03261947|516661495|FG001|Overall Study|Death|13|||
143303052|NCT03261947|516661496|FG002|Overall Study|Death|17|||
143303053|NCT03261947|516661497|FG003|Overall Study|Death|12|||
143303054|NCT03261947|516661498|FG004|Overall Study|Death|8|||
143303055|NCT03261947|516661494|FG000|Overall Study|Lost to Follow-up|0|||
143303056|NCT03261947|516661495|FG001|Overall Study|Lost to Follow-up|0|||
143303057|NCT03261947|516661496|FG002|Overall Study|Lost to Follow-up|2|||
143303058|NCT03261947|516661497|FG003|Overall Study|Lost to Follow-up|1|||
143303059|NCT03261947|516661498|FG004|Overall Study|Lost to Follow-up|0|||
143303060|NCT03261947|516661494|FG000|Overall Study|Withdrawal by Subject|0|||
143303061|NCT03261947|516661495|FG001|Overall Study|Withdrawal by Subject|0|||
143303062|NCT03261947|516661496|FG002|Overall Study|Withdrawal by Subject|3|||
143303063|NCT03261947|516661497|FG003|Overall Study|Withdrawal by Subject|0|||
143303064|NCT03261947|516661498|FG004|Overall Study|Withdrawal by Subject|1|||
143303065|NCT03261947|516661494|FG000|Overall Study|Site Terminated by Sponsor|0|||
143303066|NCT03261947|516661495|FG001|Overall Study|Site Terminated by Sponsor|0|||
143303067|NCT03261947|516661496|FG002|Overall Study|Site Terminated by Sponsor|4|||
143303068|NCT03261947|516661497|FG003|Overall Study|Site Terminated by Sponsor|7|||
143303069|NCT03261947|516661498|FG004|Overall Study|Site Terminated by Sponsor|5|||
143303070|NCT03261947|516661494|FG000|Overall Study|Reason not Specified|2|||
143303071|NCT03261947|516661495|FG001|Overall Study|Reason not Specified|0|||
143303072|NCT03261947|516661496|FG002|Overall Study|Reason not Specified|4|||
143303073|NCT03261947|516661497|FG003|Overall Study|Reason not Specified|1|||
143303074|NCT03261947|516661498|FG004|Overall Study|Reason not Specified|3|||
143303075|NCT00228917|516661499|FG000|Overall Study|Migrated/moved from study area|0|||
143303076|NCT00228917|516661500|FG001|Overall Study|Migrated/moved from study area|0|||
143303077|NCT00228917|516661501|FG002|Overall Study|Migrated/moved from study area|0|||
143303078|NCT00228917|516661502|FG003|Overall Study|Migrated/moved from study area|0|||
143303079|NCT00228917|516661503|FG004|Overall Study|Migrated/moved from study area|0|||
143303080|NCT00228917|516661504|FG005|Overall Study|Migrated/moved from study area|2|||
143303081|NCT00228917|516661505|FG006|Overall Study|Migrated/moved from study area|0|||
143303082|NCT00228917|516661506|FG007|Overall Study|Migrated/moved from study area|0|||
143303083|NCT00409617|516661507|FG000|Overall Study|Adverse Event|57|||
143303084|NCT00409617|516661507|FG000|Overall Study|Lack of Efficacy|54|||
143374994|NCT01426269|516918917|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
143374995|NCT01426269|516918915|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
143374996|NCT01426269|516918916|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
143374997|NCT01426269|516918917|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
143374998|NCT01426269|516918915|FG000|Period 2: 40 Weeks|Adverse Event|0|||
143374999|NCT01426269|516918916|FG001|Period 2: 40 Weeks|Adverse Event|1|||
143375000|NCT01426269|516918917|FG002|Period 2: 40 Weeks|Adverse Event|2|||
143375001|NCT01426269|516918915|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
143375002|NCT01426269|516918916|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
143375003|NCT01426269|516918917|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
143375004|NCT01426269|516918915|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
143375005|NCT01426269|516918916|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
143375006|NCT01426269|516918917|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
143375007|NCT01426269|516918915|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
143375008|NCT01426269|516918916|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
143375009|NCT01426269|516918917|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
143375010|NCT01426269|516918915|FG000|Period 2: 40 Weeks|Site closed|0|||
143303085|NCT00409617|516661507|FG000|Overall Study|Lost to Follow-up|2|||
143303086|NCT00409617|516661507|FG000|Overall Study|Protocol Violation|24|||
143303087|NCT00409617|516661507|FG000|Overall Study|Withdrawal by Subject|8|||
143303088|NCT00409617|516661507|FG000|Overall Study|Administrative reasons|1|||
143303089|NCT00409617|516661507|FG000|Overall Study|Not described|14|||
143303090|NCT04372602|516661517|FG000|Overall Study|Withdrawal by Subject|1|||
143303091|NCT04372602|516661518|FG001|Overall Study|Withdrawal by Subject|1|||
143303092|NCT04372602|516661517|FG000|Overall Study|Adverse Event|0|||
143303093|NCT04372602|516661518|FG001|Overall Study|Adverse Event|1|||
143303094|NCT04372602|516661517|FG000|Overall Study|Transitioned to comfort care|0|||
143303095|NCT04372602|516661518|FG001|Overall Study|Transitioned to comfort care|1|||
143303096|NCT02739269|516661531|FG000|Overall Study|Protocol Violation|5|||
143303097|NCT02739269|516661532|FG001|Overall Study|Protocol Violation|0|||
143303098|NCT02739269|516661531|FG000|Overall Study|Cycle cancellation|2|||
143303099|NCT02739269|516661532|FG001|Overall Study|Cycle cancellation|2|||
143303100|NCT02739269|516661531|FG000|Overall Study|Withdrawal by Subject|0|||
143303101|NCT02739269|516661532|FG001|Overall Study|Withdrawal by Subject|2|||
143303102|NCT01354496|516661533|FG000|Period 1|Adverse Event|0|||
143303103|NCT01354496|516661534|FG001|Period 1|Adverse Event|0|||
143303104|NCT01354496|516661535|FG002|Period 1|Adverse Event|1|||
143303105|NCT01354496|516661536|FG003|Period 1|Adverse Event|0|||
143303106|NCT01354496|516661537|FG004|Period 1|Adverse Event|0|||
143303107|NCT01354496|516661538|FG005|Period 1|Adverse Event|0|||
143303108|NCT01354496|516661533|FG000|Period 1|Physician Decision|0|||
143303109|NCT01354496|516661534|FG001|Period 1|Physician Decision|0|||
143303110|NCT01354496|516661535|FG002|Period 1|Physician Decision|1|||
143303111|NCT01354496|516661536|FG003|Period 1|Physician Decision|0|||
143303112|NCT01354496|516661537|FG004|Period 1|Physician Decision|0|||
143303113|NCT01354496|516661538|FG005|Period 1|Physician Decision|0|||
143303114|NCT01354496|516661533|FG000|Period 2|Adverse Event|0|||
143303115|NCT01354496|516661534|FG001|Period 2|Adverse Event|0|||
143303116|NCT01354496|516661535|FG002|Period 2|Adverse Event|0|||
143303117|NCT01354496|516661536|FG003|Period 2|Adverse Event|1|||
143303118|NCT01354496|516661537|FG004|Period 2|Adverse Event|0|||
143303119|NCT01354496|516661538|FG005|Period 2|Adverse Event|0|||
143303120|NCT01354496|516661533|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
143303121|NCT01354496|516661534|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
143303122|NCT01354496|516661535|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
143303123|NCT01354496|516661536|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
143303124|NCT01354496|516661537|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
143303125|NCT01354496|516661538|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
143303126|NCT01524692|516661541|FG000|Overall Study|Withdrawal by Subject|3|||
143303127|NCT03190889|516661542|FG000|Overall Study|Lost to Follow-up|7|||
143303128|NCT03190889|516661543|FG001|Overall Study|Lost to Follow-up|7|||
143303129|NCT03190889|516661544|FG002|Overall Study|Lost to Follow-up|3|||
143303130|NCT03190889|516661542|FG000|Overall Study|Withdrawal by Subject|1|||
143303131|NCT03190889|516661543|FG001|Overall Study|Withdrawal by Subject|1|||
143303132|NCT03190889|516661544|FG002|Overall Study|Withdrawal by Subject|2|||
143303133|NCT03190889|516661542|FG000|Overall Study|Did not complete protocol|4|||
143303134|NCT03190889|516661543|FG001|Overall Study|Did not complete protocol|9|||
143303135|NCT03190889|516661544|FG002|Overall Study|Did not complete protocol|0|||
143303136|NCT03190889|516661542|FG000|Overall Study|COVID-19|1|||
143303137|NCT03190889|516661543|FG001|Overall Study|COVID-19|0|||
143303138|NCT03190889|516661544|FG002|Overall Study|COVID-19|2|||
143303139|NCT00680901|516661546|FG000|Overall Study|Ongoing: On Study Treatment|1|||
143303140|NCT00680901|516661547|FG001|Overall Study|Ongoing: On Study Treatment|0|||
143303141|NCT00680901|516661546|FG000|Overall Study|Ongoing: In Follow Up|1|||
143303142|NCT00680901|516661547|FG001|Overall Study|Ongoing: In Follow Up|0|||
143303143|NCT00680901|516661546|FG000|Overall Study|Adverse Event|1|||
143303144|NCT00680901|516661547|FG001|Overall Study|Adverse Event|1|||
143303145|NCT00680901|516661546|FG000|Overall Study|Lost to Follow-up|3|||
143303146|NCT00680901|516661547|FG001|Overall Study|Lost to Follow-up|5|||
143303147|NCT00680901|516661546|FG000|Overall Study|Subject decided to withdraw from the study|4|||
143303148|NCT00680901|516661547|FG001|Overall Study|Subject decided to withdraw from the study|15|||
143303149|NCT00680901|516661546|FG000|Overall Study|Sponsor decision|1|||
143303150|NCT00680901|516661547|FG001|Overall Study|Sponsor decision|0|||
143303151|NCT00680901|516661546|FG000|Overall Study|Physician Decision|0|||
143303152|NCT00680901|516661547|FG001|Overall Study|Physician Decision|2|||
143303153|NCT00680901|516661546|FG000|Overall Study|Subject reached protocol defined stopping criteria|1|||
143303154|NCT00680901|516661547|FG001|Overall Study|Subject reached protocol defined stopping criteria|0|||
143303155|NCT00680901|516661546|FG000|Overall Study|Other protocol defined stopping criteria|17|||
143303156|NCT00680901|516661547|FG001|Overall Study|Other protocol defined stopping criteria|17|||
143303157|NCT03717480|516661548|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
143303158|NCT01708174|516661549|FG000|Treatment Period|Withdrawal by Subject|1|||
143303159|NCT01708174|516661550|FG001|Treatment Period|Withdrawal by Subject|0|||
143303160|NCT01708174|516661551|FG002|Treatment Period|Withdrawal by Subject|0|||
143303161|NCT01708174|516661549|FG000|Treatment Period|Progressive disease|0|||
143303162|NCT01708174|516661550|FG001|Treatment Period|Progressive disease|1|||
143303163|NCT01708174|516661551|FG002|Treatment Period|Progressive disease|0|||
143303164|NCT01708174|516661549|FG000|Treatment Period|Death|0|||
143303165|NCT01708174|516661550|FG001|Treatment Period|Death|0|||
143303166|NCT01708174|516661551|FG002|Treatment Period|Death|1|||
143303167|NCT01708174|516661549|FG000|Treatment Period|Adverse Event|0|||
143303168|NCT01708174|516661550|FG001|Treatment Period|Adverse Event|1|||
143303169|NCT01708174|516661551|FG002|Treatment Period|Adverse Event|0|||
143303170|NCT01894152|516661552|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
143303171|NCT00923559|516661553|FG000|Overall Study|Lost to Follow-up|2|||
143303172|NCT00923559|516661554|FG001|Overall Study|Lost to Follow-up|3|||
143303173|NCT01774786|516661555|FG000|Overall Study|Death|300|||
143303174|NCT01774786|516661556|FG001|Overall Study|Death|319|||
143303175|NCT01774786|516661555|FG000|Overall Study|Lost to Follow-up|6|||
143303176|NCT01774786|516661556|FG001|Overall Study|Lost to Follow-up|7|||
143303177|NCT01774786|516661555|FG000|Overall Study|Withdrawal by Subject|18|||
143303178|NCT01774786|516661556|FG001|Overall Study|Withdrawal by Subject|14|||
143303179|NCT01774786|516661555|FG000|Overall Study|Physician Decision|2|||
143303180|NCT01774786|516661556|FG001|Overall Study|Physician Decision|0|||
143303181|NCT01774786|516661555|FG000|Overall Study|Non-compliance|0|||
143303182|NCT01774786|516661556|FG001|Overall Study|Non-compliance|1|||
143303183|NCT01774786|516661555|FG000|Overall Study|Reason Not Specified|2|||
143303184|NCT01774786|516661556|FG001|Overall Study|Reason Not Specified|5|||
143303185|NCT00075582|516661557|FG000|Overall Study|Adverse Event|3|||
143303186|NCT00075582|516661558|FG001|Overall Study|Adverse Event|1|||
143303187|NCT00075582|516661557|FG000|Overall Study|Lack of Efficacy|4|||
143303188|NCT00075582|516661558|FG001|Overall Study|Lack of Efficacy|8|||
143303189|NCT00075582|516661557|FG000|Overall Study|Physician Decision|5|||
143303190|NCT00075582|516661558|FG001|Overall Study|Physician Decision|8|||
143303191|NCT00075582|516661557|FG000|Overall Study|Withdrawal by Subject|2|||
143303192|NCT00075582|516661558|FG001|Overall Study|Withdrawal by Subject|2|||
143303193|NCT00075582|516661557|FG000|Overall Study|Ineligible for study|36|||
143303194|NCT00075582|516661558|FG001|Overall Study|Ineligible for study|16|||
143303195|NCT02268812|516661559|FG000|Overall Study|Adverse Event|8|||
143303196|NCT02268812|516661560|FG001|Overall Study|Adverse Event|26|||
143303197|NCT02268812|516661561|FG002|Overall Study|Adverse Event|7|||
143303198|NCT02268812|516661562|FG003|Overall Study|Adverse Event|10|||
143303199|NCT02268812|516661559|FG000|Overall Study|Protocol deviation|0|||
143303200|NCT02268812|516661560|FG001|Overall Study|Protocol deviation|0|||
143303201|NCT02268812|516661561|FG002|Overall Study|Protocol deviation|1|||
143303202|NCT02268812|516661562|FG003|Overall Study|Protocol deviation|0|||
143303203|NCT02268812|516661559|FG000|Overall Study|Withdrawal by Subject|0|||
143303204|NCT02268812|516661560|FG001|Overall Study|Withdrawal by Subject|1|||
143303205|NCT02268812|516661561|FG002|Overall Study|Withdrawal by Subject|0|||
143303206|NCT02268812|516661562|FG003|Overall Study|Withdrawal by Subject|0|||
143303207|NCT02268812|516661559|FG000|Overall Study|Physician Decision|3|||
143303208|NCT02268812|516661560|FG001|Overall Study|Physician Decision|1|||
143303209|NCT02268812|516661561|FG002|Overall Study|Physician Decision|0|||
143303210|NCT02268812|516661562|FG003|Overall Study|Physician Decision|1|||
143303211|NCT02268812|516661559|FG000|Overall Study|Other|5|||
143303212|NCT02268812|516661560|FG001|Overall Study|Other|4|||
143303213|NCT02268812|516661561|FG002|Overall Study|Other|1|||
143303214|NCT02268812|516661562|FG003|Overall Study|Other|3|||
143303215|NCT04544293|516661563|FG000|Double-blind|Adverse Event|2|||
143303216|NCT04544293|516661564|FG001|Double-blind|Adverse Event|1|||
143303217|NCT04544293|516661563|FG000|Double-blind|Pregnancy|0|||
143303218|NCT04544293|516661564|FG001|Double-blind|Pregnancy|1|||
143303219|NCT04544293|516661563|FG000|Double-blind|Lost to Follow-up|0|||
143303220|NCT04544293|516661564|FG001|Double-blind|Lost to Follow-up|1|||
143375011|NCT01426269|516918916|FG001|Period 2: 40 Weeks|Site closed|6|||
143303221|NCT04544293|516661563|FG000|Open-Label Extension|Study ongoing|79|||
143303222|NCT04544293|516661564|FG001|Open-Label Extension|Study ongoing|81|||
143303223|NCT01951157|516661565|FG000|Overall Study|Progressive Disease|12|||
143303224|NCT01951157|516661566|FG001|Overall Study|Progressive Disease|13|||
143303225|NCT01951157|516661567|FG002|Overall Study|Progressive Disease|10|||
143303226|NCT01951157|516661565|FG000|Overall Study|Treatment-unrelated AE|1|||
143303227|NCT01951157|516661566|FG001|Overall Study|Treatment-unrelated AE|0|||
143303228|NCT01951157|516661567|FG002|Overall Study|Treatment-unrelated AE|3|||
143303229|NCT01951157|516661565|FG000|Overall Study|Study Termination|0|||
143303230|NCT01951157|516661566|FG001|Overall Study|Study Termination|0|||
143303231|NCT01951157|516661567|FG002|Overall Study|Study Termination|1|||
143303232|NCT01951157|516661565|FG000|Overall Study|Physician Decision|5|||
143303233|NCT01951157|516661566|FG001|Overall Study|Physician Decision|3|||
143303234|NCT01951157|516661567|FG002|Overall Study|Physician Decision|2|||
143303235|NCT01951157|516661565|FG000|Overall Study|Non-treatmentrelated death|2|||
143303236|NCT01951157|516661566|FG001|Overall Study|Non-treatmentrelated death|2|||
143303237|NCT01951157|516661567|FG002|Overall Study|Non-treatmentrelated death|2|||
143303238|NCT01951157|516661565|FG000|Overall Study|No treated|0|||
143303239|NCT01951157|516661566|FG001|Overall Study|No treated|1|||
143303240|NCT01951157|516661567|FG002|Overall Study|No treated|0|||
143303241|NCT01951157|516661565|FG000|Overall Study|Treatment-related AE|2|||
143303242|NCT01951157|516661566|FG001|Overall Study|Treatment-related AE|0|||
143303243|NCT01951157|516661567|FG002|Overall Study|Treatment-related AE|4|||
143303244|NCT01951157|516661565|FG000|Overall Study|Consent withdrawn by subject|0|||
143303245|NCT01951157|516661566|FG001|Overall Study|Consent withdrawn by subject|1|||
143303246|NCT01951157|516661567|FG002|Overall Study|Consent withdrawn by subject|3|||
143303247|NCT01951157|516661565|FG000|Overall Study|Treatment-related death|0|||
143303248|NCT01951157|516661566|FG001|Overall Study|Treatment-related death|2|||
143303249|NCT01951157|516661567|FG002|Overall Study|Treatment-related death|0|||
143303250|NCT02268786|516661569|FG000|Overall Study|No Euploid Embryos available|42|||
143303251|NCT02268786|516661570|FG001|Overall Study|No Euploid Embryos available|0|||
143303252|NCT02268786|516661569|FG000|Overall Study|Withdrawal by Subject|7|||
143303253|NCT02268786|516661570|FG001|Overall Study|Withdrawal by Subject|14|||
143303254|NCT02268786|516661569|FG000|Overall Study|Thaw Failure|6|||
143303255|NCT02268786|516661570|FG001|Overall Study|Thaw Failure|4|||
143303256|NCT02268786|516661569|FG000|Overall Study|Protocol Violation|1|||
143303257|NCT02268786|516661570|FG001|Overall Study|Protocol Violation|0|||
143303258|NCT04809220|516661573|FG000|Overall Study|Adverse Event|4|||
143303259|NCT04809220|516661574|FG001|Overall Study|Adverse Event|0|||
143303260|NCT04809220|516661573|FG000|Overall Study|Death|1|||
143303261|NCT04809220|516661574|FG001|Overall Study|Death|0|||
143303262|NCT04809220|516661573|FG000|Overall Study|Lost to Follow-up|3|||
143303263|NCT04809220|516661574|FG001|Overall Study|Lost to Follow-up|0|||
143303264|NCT04809220|516661573|FG000|Overall Study|Physician Decision|0|||
143303265|NCT04809220|516661574|FG001|Overall Study|Physician Decision|1|||
143303266|NCT04809220|516661573|FG000|Overall Study|Withdrawal by Subject|9|||
143303267|NCT04809220|516661574|FG001|Overall Study|Withdrawal by Subject|5|||
143303268|NCT04809220|516661573|FG000|Overall Study|Due to long-term overseas business trips|1|||
143303269|NCT04809220|516661574|FG001|Overall Study|Due to long-term overseas business trips|0|||
143303270|NCT01933048|516662795|FG000|Overall Study|Lost to Follow-up|15|||
143303271|NCT01933048|516662796|FG001|Overall Study|Lost to Follow-up|18|||
143303272|NCT01933048|516662795|FG000|Overall Study|personal reasons|1|||
143303273|NCT01933048|516662796|FG001|Overall Study|personal reasons|1|||
143303274|NCT01933048|516662795|FG000|Overall Study|Protocol Violation|7|||
143303275|NCT01933048|516662796|FG001|Overall Study|Protocol Violation|8|||
143303276|NCT01933048|516662795|FG000|Overall Study|Physician Decision|1|||
143303277|NCT01933048|516662796|FG001|Overall Study|Physician Decision|0|||
143303278|NCT01933048|516662795|FG000|Overall Study|unknown reasons|1|||
143303279|NCT01933048|516662796|FG001|Overall Study|unknown reasons|1|||
143303280|NCT02476968|516662797|FG000|Overall Study|Other|0|||
143303281|NCT02476968|516662798|FG001|Overall Study|Other|2|||
143303282|NCT02476968|516662799|FG002|Overall Study|Other|0|||
143303283|NCT02476968|516662797|FG000|Overall Study|Lost to Follow-up|10|||
143303284|NCT02476968|516662798|FG001|Overall Study|Lost to Follow-up|0|||
143303285|NCT02476968|516662799|FG002|Overall Study|Lost to Follow-up|1|||
143303286|NCT02476968|516662797|FG000|Overall Study|Death|48|||
143303287|NCT02476968|516662798|FG001|Overall Study|Death|8|||
143303288|NCT02476968|516662799|FG002|Overall Study|Death|1|||
143303289|NCT02476968|516662797|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
143303290|NCT02476968|516662798|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
143303291|NCT02476968|516662799|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
143303292|NCT02476968|516662797|FG000|Overall Study|Patient decision|37|||
143303293|NCT02476968|516662798|FG001|Overall Study|Patient decision|8|||
143303294|NCT02476968|516662799|FG002|Overall Study|Patient decision|0|||
143303295|NCT01859507|516662800|FG000|Overall Study|left the country|4|||
143303296|NCT04476030|516662801|FG000|Overall Study|Withdrawal by Subject|20|||
143303297|NCT04476030|516662802|FG001|Overall Study|Withdrawal by Subject|16|||
143303298|NCT04476030|516662801|FG000|Overall Study|Adverse Event|10|||
143303299|NCT04476030|516662802|FG001|Overall Study|Adverse Event|11|||
143303300|NCT04476030|516662801|FG000|Overall Study|Lost to Follow-up|7|||
143303301|NCT04476030|516662802|FG001|Overall Study|Lost to Follow-up|4|||
143303302|NCT04476030|516662801|FG000|Overall Study|Physician Decision|1|||
143303303|NCT04476030|516662802|FG001|Overall Study|Physician Decision|1|||
143303304|NCT04476030|516662801|FG000|Overall Study|Protocol Deviation|2|||
143303305|NCT04476030|516662802|FG001|Overall Study|Protocol Deviation|0|||
143303306|NCT04476030|516662801|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
143303307|NCT04476030|516662802|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
143303308|NCT04476030|516662801|FG000|Overall Study|Randomized but not Dosed|2|||
143303309|NCT04476030|516662802|FG001|Overall Study|Randomized but not Dosed|8|||
143303310|NCT02404311|516662803|FG000|Part A: Month 0-18|Death|2|||
143303311|NCT02404311|516662804|FG001|Part A: Month 0-18|Death|0|||
143303312|NCT02404311|516662805|FG002|Part A: Month 0-18|Death|0|||
143303313|NCT02404311|516662806|FG003|Part A: Month 0-18|Death|0|||
143303314|NCT02404311|516662807|FG004|Part A: Month 0-18|Death|0|||
143303315|NCT02404311|516662803|FG000|Part A: Month 0-18|Physician Decision|1|||
143303316|NCT02404311|516662804|FG001|Part A: Month 0-18|Physician Decision|0|||
143303317|NCT02404311|516662805|FG002|Part A: Month 0-18|Physician Decision|0|||
143303318|NCT02404311|516662806|FG003|Part A: Month 0-18|Physician Decision|0|||
143303319|NCT02404311|516662807|FG004|Part A: Month 0-18|Physician Decision|0|||
143303320|NCT02404311|516662803|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
143303321|NCT02404311|516662804|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
143303322|NCT02404311|516662805|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
143303323|NCT02404311|516662806|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
143303324|NCT02404311|516662807|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
143303325|NCT02404311|516662803|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
143303326|NCT02404311|516662804|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
143303327|NCT02404311|516662805|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
143303328|NCT02404311|516662806|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
143303329|NCT02404311|516662807|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
143303330|NCT02404311|516662803|FG000|Part A: Month 0-18|HIV Infection|6|||
143303331|NCT02404311|516662804|FG001|Part A: Month 0-18|HIV Infection|2|||
143303332|NCT02404311|516662805|FG002|Part A: Month 0-18|HIV Infection|0|||
143303333|NCT02404311|516662806|FG003|Part A: Month 0-18|HIV Infection|0|||
143303334|NCT02404311|516662807|FG004|Part A: Month 0-18|HIV Infection|0|||
143303335|NCT02404311|516662803|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
143303336|NCT02404311|516662804|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
143303337|NCT02404311|516662805|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
143303338|NCT02404311|516662806|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
143303339|NCT02404311|516662807|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
143303340|NCT04171414|516662818|FG000|Overall Study|Death|1|||
143303341|NCT04171414|516662818|FG000|Overall Study|Withdrawal by Subject|1|||
143303342|NCT00481195|516662819|FG000|Overall Study|Adverse Event|16|||
143303343|NCT00481195|516662820|FG001|Overall Study|Adverse Event|11|||
143303344|NCT00481195|516662819|FG000|Overall Study|Lack of Efficacy|1|||
143303345|NCT00481195|516662820|FG001|Overall Study|Lack of Efficacy|3|||
143303346|NCT00481195|516662819|FG000|Overall Study|Lost to Follow-up|4|||
143303347|NCT00481195|516662820|FG001|Overall Study|Lost to Follow-up|6|||
143303348|NCT00481195|516662819|FG000|Overall Study|Physician Decision|3|||
143303349|NCT00481195|516662820|FG001|Overall Study|Physician Decision|1|||
143303350|NCT00481195|516662819|FG000|Overall Study|Protocol Violation|10|||
143303351|NCT00481195|516662820|FG001|Overall Study|Protocol Violation|7|||
143303352|NCT00481195|516662819|FG000|Overall Study|Withdrawal by Subject|3|||
143303353|NCT00481195|516662820|FG001|Overall Study|Withdrawal by Subject|9|||
143303354|NCT00481195|516662819|FG000|Overall Study|Miscellaneous|2|||
143303355|NCT00481195|516662820|FG001|Overall Study|Miscellaneous|2|||
143303356|NCT02872116|516662823|FG000|Pre-Treatment|Disease Progression|0|||
143303357|NCT02872116|516662824|FG001|Pre-Treatment|Disease Progression|1|||
143303358|NCT02872116|516662825|FG002|Pre-Treatment|Disease Progression|0|||
143303359|NCT02872116|516662823|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
143303360|NCT02872116|516662824|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
143303361|NCT02872116|516662825|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
143303362|NCT02872116|516662823|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
143303363|NCT02872116|516662824|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
143303364|NCT02872116|516662825|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
143303365|NCT02872116|516662823|FG000|Pre-Treatment|Participant withdrew consent|2|||
143303366|NCT02872116|516662824|FG001|Pre-Treatment|Participant withdrew consent|20|||
143303367|NCT02872116|516662825|FG002|Pre-Treatment|Participant withdrew consent|3|||
143303368|NCT02872116|516662823|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
143303369|NCT02872116|516662824|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
143303370|NCT02872116|516662825|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
143303371|NCT02872116|516662823|FG000|Pre-Treatment|Other reasons|1|||
143303372|NCT02872116|516662824|FG001|Pre-Treatment|Other reasons|2|||
143303373|NCT02872116|516662825|FG002|Pre-Treatment|Other reasons|2|||
143303374|NCT02872116|516662823|FG000|Treatment|Death|121|||
143303375|NCT02872116|516662824|FG001|Treatment|Death|94|||
143303376|NCT02872116|516662825|FG002|Treatment|Death|68|||
143303377|NCT02872116|516662823|FG000|Treatment|Lost to Follow-up|5|||
143303378|NCT02872116|516662824|FG001|Treatment|Lost to Follow-up|7|||
143303379|NCT02872116|516662825|FG002|Treatment|Lost to Follow-up|3|||
143303380|NCT02872116|516662823|FG000|Treatment|Participant withdrew consent|20|||
143303381|NCT02872116|516662824|FG001|Treatment|Participant withdrew consent|40|||
143303382|NCT02872116|516662825|FG002|Treatment|Participant withdrew consent|8|||
143303383|NCT02872116|516662823|FG000|Treatment|Other reasons|13|||
143303384|NCT02872116|516662824|FG001|Treatment|Other reasons|12|||
143303385|NCT02872116|516662825|FG002|Treatment|Other reasons|5|||
143303386|NCT03161483|516662829|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
143303387|NCT03161483|516662830|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
143303388|NCT03161483|516662831|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
143303389|NCT03161483|516662832|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
143303390|NCT03161483|516662829|FG000|Treatment Period|Death|1|||
143303391|NCT03161483|516662830|FG001|Treatment Period|Death|0|||
143303392|NCT03161483|516662831|FG002|Treatment Period|Death|0|||
143303393|NCT03161483|516662832|FG003|Treatment Period|Death|0|||
143303394|NCT03161483|516662829|FG000|Treatment Period|Adverse Event|5|||
143303395|NCT03161483|516662830|FG001|Treatment Period|Adverse Event|2|||
143303396|NCT03161483|516662831|FG002|Treatment Period|Adverse Event|1|||
143303397|NCT03161483|516662832|FG003|Treatment Period|Adverse Event|11|||
143303398|NCT03161483|516662829|FG000|Treatment Period|Pregnancy|1|||
143303399|NCT03161483|516662830|FG001|Treatment Period|Pregnancy|0|||
143303400|NCT03161483|516662831|FG002|Treatment Period|Pregnancy|0|||
143303401|NCT03161483|516662832|FG003|Treatment Period|Pregnancy|0|||
143303402|NCT03161483|516662829|FG000|Treatment Period|Lack of Efficacy|0|||
143303403|NCT03161483|516662830|FG001|Treatment Period|Lack of Efficacy|0|||
143303404|NCT03161483|516662831|FG002|Treatment Period|Lack of Efficacy|0|||
143303405|NCT03161483|516662832|FG003|Treatment Period|Lack of Efficacy|1|||
143303406|NCT03161483|516662829|FG000|Treatment Period|Withdrawal by Subject|2|||
143303407|NCT03161483|516662830|FG001|Treatment Period|Withdrawal by Subject|5|||
143303408|NCT03161483|516662831|FG002|Treatment Period|Withdrawal by Subject|2|||
143303409|NCT03161483|516662832|FG003|Treatment Period|Withdrawal by Subject|6|||
143303410|NCT03161483|516662829|FG000|Treatment Period|Lost to Follow-up|0|||
143303411|NCT03161483|516662830|FG001|Treatment Period|Lost to Follow-up|0|||
143303412|NCT03161483|516662831|FG002|Treatment Period|Lost to Follow-up|0|||
143303413|NCT03161483|516662832|FG003|Treatment Period|Lost to Follow-up|1|||
143303414|NCT03161483|516662829|FG000|Treatment Period|Protocol Violation|0|||
143303415|NCT03161483|516662830|FG001|Treatment Period|Protocol Violation|0|||
143303416|NCT03161483|516662831|FG002|Treatment Period|Protocol Violation|0|||
143303417|NCT03161483|516662832|FG003|Treatment Period|Protocol Violation|1|||
143303418|NCT03161483|516662829|FG000|Treatment Period|Other reasons|1|||
143303419|NCT03161483|516662830|FG001|Treatment Period|Other reasons|1|||
143303420|NCT03161483|516662831|FG002|Treatment Period|Other reasons|0|||
143303421|NCT03161483|516662832|FG003|Treatment Period|Other reasons|0|||
143303422|NCT01364428|516662834|FG000|Overall Study|Adverse Event|1|||
143303423|NCT01364428|516662835|FG001|Overall Study|Adverse Event|2|||
143303424|NCT01364428|516662834|FG000|Overall Study|Protocol Violation|2|||
143303425|NCT01364428|516662835|FG001|Overall Study|Protocol Violation|0|||
143303426|NCT01364428|516662834|FG000|Overall Study|Withdrawal Criteria|14|||
143303427|NCT01364428|516662835|FG001|Overall Study|Withdrawal Criteria|10|||
143303428|NCT01364428|516662834|FG000|Overall Study|Other|3|||
143303429|NCT01364428|516662835|FG001|Overall Study|Other|3|||
143303430|NCT01073865|516662837|FG000|Overall Study|Reasons other than below|19|||
143303431|NCT01073865|516662838|FG001|Overall Study|Reasons other than below|31|||
143303432|NCT01073865|516662837|FG000|Overall Study|Lost to Follow-up|1|||
143303433|NCT01073865|516662838|FG001|Overall Study|Lost to Follow-up|1|||
143303434|NCT01073865|516662837|FG000|Overall Study|Death|3|||
143303435|NCT01073865|516662838|FG001|Overall Study|Death|2|||
143303436|NCT01073865|516662837|FG000|Overall Study|Withdrawal by Subject|5|||
143303437|NCT01073865|516662838|FG001|Overall Study|Withdrawal by Subject|5|||
143303438|NCT02547129|516662842|FG000|Overall Study|Difficulty with ongoing infection|1|||
143303439|NCT02547129|516662843|FG001|Overall Study|Difficulty with ongoing infection|0|||
143303440|NCT03925324|516662844|FG000|Overall Study|Death|1|||
143303441|NCT03925324|516662845|FG001|Overall Study|Death|1|||
143303442|NCT00805766|516662846|FG000|Screening Period|Adverse Event|1|||
143303443|NCT00805766|516662846|FG000|Screening Period|Lack of Efficacy|2|||
143303444|NCT00805766|516662846|FG000|Screening Period|Pregnancy|1|||
143303445|NCT00805766|516662846|FG000|Screening Period|Responder|2|||
143303446|NCT00805766|516662846|FG000|Increased Dose Period|Adverse Event|4|||
143303447|NCT00805766|516662846|FG000|Increased Dose Period|Lack of Efficacy|7|||
143303448|NCT00805766|516662846|FG000|Increased Dose Period|Pregnancy|1|||
143303449|NCT00805766|516662846|FG000|Increased Dose Period|Withdrawal by Subject|1|||
143303450|NCT01256593|516662847|FG000|Overall Study|Protocol Violation|26|||
143303451|NCT01256593|516662847|FG000|Overall Study|No Drug Administration Information|2|||
143303452|NCT01256593|516662847|FG000|Overall Study|No Visit After Treatment|186|||
143303453|NCT03373383|516662853|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
143303454|NCT03373383|516662854|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
143303455|NCT03373383|516662855|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
143303456|NCT03373383|516662856|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
143303457|NCT03373383|516662857|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
143303458|NCT03373383|516662853|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
143303459|NCT03373383|516662854|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
143303460|NCT03373383|516662855|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
143303461|NCT03373383|516662856|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
143303462|NCT03373383|516662857|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
143303463|NCT03373383|516662853|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
143303464|NCT03373383|516662854|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
143303465|NCT03373383|516662855|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
143303466|NCT03373383|516662856|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
143303467|NCT03373383|516662857|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
143303468|NCT03373383|516662853|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
143303469|NCT03373383|516662854|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
143303470|NCT03373383|516662855|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
143303471|NCT03373383|516662856|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
143303472|NCT03373383|516662857|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
143303473|NCT03373383|516662853|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
143303474|NCT03373383|516662854|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
143303475|NCT03373383|516662855|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
143303476|NCT03373383|516662856|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
143303477|NCT03373383|516662857|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
143303478|NCT03373383|516662853|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
143303479|NCT03373383|516662854|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
143303480|NCT03373383|516662855|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
143303481|NCT03373383|516662856|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
143303482|NCT03373383|516662857|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
143303483|NCT03373383|516662853|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
143303484|NCT03373383|516662854|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
143303485|NCT03373383|516662855|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
143303486|NCT03373383|516662856|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
143303487|NCT03373383|516662857|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
143303488|NCT03373383|516662853|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
143303489|NCT03373383|516662854|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
143303490|NCT03373383|516662855|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
143303491|NCT03373383|516662856|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
143303492|NCT03373383|516662857|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
143303493|NCT03373383|516662853|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
143303494|NCT03373383|516662854|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
143303495|NCT03373383|516662855|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
143303496|NCT03373383|516662856|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
143303497|NCT03373383|516662857|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
143303498|NCT02871739|516662858|FG000|Overall Study|Lost to Follow-up|3|||
143303499|NCT02871739|516662859|FG001|Overall Study|Lost to Follow-up|2|||
143375012|NCT01426269|516918917|FG002|Period 2: 40 Weeks|Site closed|5|||
143375013|NCT01426269|516918915|FG000|Period 2: 40 Weeks|Relapsed|0|||
143375014|NCT01426269|516918916|FG001|Period 2: 40 Weeks|Relapsed|9|||
143375015|NCT01426269|516918917|FG002|Period 2: 40 Weeks|Relapsed|18|||
143375016|NCT00799396|516918919|FG000|Clopidogrel Treatment|Adverse Event|6|||
143375017|NCT00799396|516918919|FG000|Clopidogrel Treatment|Physician Decision|5|||
143375018|NCT00799396|516918919|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
143375019|NCT00799396|516918919|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
143375020|NCT00799396|516918919|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
143375021|NCT01867216|516918920|FG000|Overall Study|Withdrawal by Subject|2|||
143375022|NCT01867216|516918921|FG001|Overall Study|Withdrawal by Subject|0|||
143375023|NCT01867216|516918922|FG002|Overall Study|Withdrawal by Subject|0|||
143375024|NCT01867216|516918923|FG003|Overall Study|Withdrawal by Subject|0|||
143375025|NCT01867216|516918924|FG004|Overall Study|Withdrawal by Subject|1|||
143375026|NCT01867216|516918925|FG005|Overall Study|Withdrawal by Subject|0|||
143375027|NCT01867216|516918926|FG006|Overall Study|Withdrawal by Subject|1|||
143375028|NCT01867216|516918920|FG000|Overall Study|Physician Decision|1|||
143375029|NCT01867216|516918921|FG001|Overall Study|Physician Decision|0|||
143375030|NCT01867216|516918922|FG002|Overall Study|Physician Decision|0|||
143375031|NCT01867216|516918923|FG003|Overall Study|Physician Decision|0|||
143375032|NCT01867216|516918924|FG004|Overall Study|Physician Decision|0|||
143375033|NCT01867216|516918925|FG005|Overall Study|Physician Decision|0|||
143375034|NCT01867216|516918926|FG006|Overall Study|Physician Decision|0|||
143375035|NCT01867216|516918920|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
143375036|NCT01867216|516918921|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
143375037|NCT01867216|516918922|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
143375038|NCT01867216|516918923|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
143375039|NCT01867216|516918924|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
143375040|NCT01867216|516918925|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
143375041|NCT01867216|516918926|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
143375042|NCT01765543|516918937|FG000|Overall Study|Death|1|||
143375043|NCT01765543|516918937|FG000|Overall Study|Withdrawal by Subject|2|||
143375044|NCT03454529|516918938|FG000|Overall Study|Did not receive treatment|6|||
143375045|NCT03454529|516918938|FG000|Overall Study|Received < 80% doses|1|||
143375046|NCT00507689|516918939|FG000|Pre-Randomization Period|Adverse Event|1|||
143375047|NCT00507689|516918940|FG001|Pre-Randomization Period|Adverse Event|0|||
143375048|NCT00507689|516918939|FG000|Pre-Randomization Period|Physician Decision|1|||
143375049|NCT00507689|516918940|FG001|Pre-Randomization Period|Physician Decision|0|||
143375050|NCT00507689|516918939|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
143375051|NCT00507689|516918940|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
143375052|NCT00507689|516918939|FG000|Randomized Period|Adverse Event|1|||
143375053|NCT00507689|516918940|FG001|Randomized Period|Adverse Event|1|||
143375054|NCT00507689|516918939|FG000|Randomized Period|Withdrawal by Subject|0|||
143375055|NCT00507689|516918940|FG001|Randomized Period|Withdrawal by Subject|1|||
143375056|NCT00424762|516918948|FG000|Overall Study|Withdrawal by Subject|18|||
143375057|NCT00424762|516918949|FG001|Overall Study|Withdrawal by Subject|19|||
143375058|NCT00424762|516918948|FG000|Overall Study|Lost to Follow-up|2|||
143375059|NCT00424762|516918949|FG001|Overall Study|Lost to Follow-up|3|||
143375060|NCT01145885|516918950|FG000|Overall Study|Progressive Disease|7|||
143375061|NCT00723450|516918951|FG000|Open-Label Phase|Adverse Event|26|||
143375062|NCT00723450|516918952|FG001|Open-Label Phase|Adverse Event|0|||
143375063|NCT00723450|516918953|FG002|Open-Label Phase|Adverse Event|0|||
143375064|NCT00723450|516918951|FG000|Open-Label Phase|Lack of Efficacy|18|||
143375065|NCT00723450|516918952|FG001|Open-Label Phase|Lack of Efficacy|0|||
143375066|NCT00723450|516918953|FG002|Open-Label Phase|Lack of Efficacy|0|||
143375067|NCT00723450|516918951|FG000|Open-Label Phase|Protocol Violation|35|||
142941517|NCT00064701|515324680|FG000|One Year Post-transplant|Rejection|0|||
143375068|NCT00723450|516918952|FG001|Open-Label Phase|Protocol Violation|0|||
143375069|NCT00723450|516918953|FG002|Open-Label Phase|Protocol Violation|0|||
143375070|NCT00723450|516918951|FG000|Open-Label Phase|Lost to Follow-up|7|||
143375071|NCT00723450|516918952|FG001|Open-Label Phase|Lost to Follow-up|0|||
143375072|NCT00723450|516918953|FG002|Open-Label Phase|Lost to Follow-up|0|||
143375073|NCT00723450|516918951|FG000|Open-Label Phase|Physician Decision|2|||
143303500|NCT02871739|516662860|FG002|Overall Study|Lost to Follow-up|0|||
143303501|NCT02871739|516662861|FG003|Overall Study|Lost to Follow-up|2|||
143303502|NCT00594464|516662862|FG000|Overall Study|Withdrawal by Subject|1|||
143303503|NCT00594464|516662862|FG000|Overall Study|Delay in operation|2|||
143303504|NCT02907359|516662863|FG000|Overall Study|Death|234|||
143303505|NCT02907359|516662864|FG001|Overall Study|Death|117|||
143303506|NCT02907359|516662863|FG000|Overall Study|Withdrawal by Subject|6|||
143303507|NCT02907359|516662864|FG001|Overall Study|Withdrawal by Subject|11|||
143303508|NCT02907359|516662863|FG000|Overall Study|Lost to Follow-up|1|||
143303509|NCT02907359|516662864|FG001|Overall Study|Lost to Follow-up|0|||
143303510|NCT01085097|516662869|FG000|Overall Study|Adverse Event|0|||
143303511|NCT01085097|516662870|FG001|Overall Study|Adverse Event|0|||
143303512|NCT01085097|516662871|FG002|Overall Study|Adverse Event|2|||
143303513|NCT01085097|516662869|FG000|Overall Study|Treatment failure|2|||
143303514|NCT01085097|516662870|FG001|Overall Study|Treatment failure|0|||
143303515|NCT01085097|516662871|FG002|Overall Study|Treatment failure|0|||
143303516|NCT04371380|516662874|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
143303517|NCT04371380|516662875|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
143303518|NCT04371380|516662876|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
143303519|NCT06049043|516662877|FG000|Overall Study|Lost to Follow-up|11|||
143303520|NCT06049043|516662878|FG001|Overall Study|Lost to Follow-up|9|||
143303521|NCT01709695|516662881|FG000|Overall Study|Withdrawal by Subject|1|||
143303522|NCT01709695|516662882|FG001|Overall Study|Withdrawal by Subject|1|||
143303523|NCT04007523|516662883|FG000|Overall Study|Withdrawal by Subject|0|||
143303524|NCT04007523|516662884|FG001|Overall Study|Withdrawal by Subject|1|||
143303525|NCT04007523|516662885|FG002|Overall Study|Withdrawal by Subject|1|||
143303526|NCT04007523|516662886|FG003|Overall Study|Withdrawal by Subject|0|||
143303527|NCT04007523|516662883|FG000|Overall Study|ICU Transfer|0|||
143303528|NCT04007523|516662884|FG001|Overall Study|ICU Transfer|1|||
143303529|NCT04007523|516662885|FG002|Overall Study|ICU Transfer|0|||
143303530|NCT04007523|516662886|FG003|Overall Study|ICU Transfer|0|||
143303531|NCT04007523|516662883|FG000|Overall Study|COVID hospital closure|0|||
143303532|NCT04007523|516662884|FG001|Overall Study|COVID hospital closure|0|||
143303533|NCT04007523|516662885|FG002|Overall Study|COVID hospital closure|1|||
143303534|NCT04007523|516662886|FG003|Overall Study|COVID hospital closure|2|||
143303535|NCT04007523|516662883|FG000|Overall Study|Surgery cancelled|0|||
143303536|NCT04007523|516662884|FG001|Overall Study|Surgery cancelled|0|||
143303537|NCT04007523|516662885|FG002|Overall Study|Surgery cancelled|1|||
143303538|NCT04007523|516662886|FG003|Overall Study|Surgery cancelled|1|||
143303539|NCT00500292|516662887|FG000|Overall Study|Adverse Event|3|||
143303540|NCT00500292|516662888|FG001|Overall Study|Adverse Event|6|||
143303541|NCT00500292|516662889|FG002|Overall Study|Adverse Event|4|||
143303542|NCT00500292|516662887|FG000|Overall Study|Condition under investigation worsened|21|||
143303543|NCT00500292|516662888|FG001|Overall Study|Condition under investigation worsened|23|||
143303544|NCT00500292|516662889|FG002|Overall Study|Condition under investigation worsened|19|||
143303545|NCT00500292|516662887|FG000|Overall Study|Withdrawal by Subject|0|||
143303546|NCT00500292|516662888|FG001|Overall Study|Withdrawal by Subject|1|||
143303547|NCT00500292|516662889|FG002|Overall Study|Withdrawal by Subject|0|||
143303548|NCT00500292|516662887|FG000|Overall Study|Other|1|||
143303549|NCT00500292|516662888|FG001|Overall Study|Other|1|||
143303550|NCT00500292|516662889|FG002|Overall Study|Other|4|||
143303551|NCT02120794|516662893|FG000|Overall Study|Withdrawal by Subject|43|||
143303552|NCT02120794|516662893|FG000|Overall Study|Adverse Event|10|||
143303553|NCT02120794|516662893|FG000|Overall Study|Physician Decision|4|||
143303554|NCT02120794|516662893|FG000|Overall Study|Due to insurance coverage|1|||
143303555|NCT00994240|516662895|FG000|Overall Study|Lost to Follow-up|3|||
143303556|NCT00994240|516662896|FG001|Overall Study|Lost to Follow-up|2|||
143303557|NCT00994240|516662895|FG000|Overall Study|Withdrawal by Subject|1|||
143303558|NCT00994240|516662896|FG001|Overall Study|Withdrawal by Subject|0|||
143303559|NCT00994240|516662895|FG000|Overall Study|study termination|2|||
143303560|NCT00994240|516662896|FG001|Overall Study|study termination|3|||
143303561|NCT01200797|516662897|FG000|Overall Study|symptomatic deterioration|2|||
143303562|NCT01200797|516662897|FG000|Overall Study|Adverse Event|4|||
143303563|NCT01200797|516662897|FG000|Overall Study|Disease Progression|13|||
143303564|NCT03608774|516662902|FG000|Overall Study|Lost to Follow-up|5|||
143375074|NCT00723450|516918952|FG001|Open-Label Phase|Physician Decision|0|||
143375075|NCT00723450|516918953|FG002|Open-Label Phase|Physician Decision|0|||
143375076|NCT00723450|516918951|FG000|Open-Label Phase|Withdrawal by Subject|37|||
143303565|NCT03608774|516662903|FG001|Overall Study|Lost to Follow-up|5|||
143375077|NCT00723450|516918952|FG001|Open-Label Phase|Withdrawal by Subject|0|||
143375078|NCT00723450|516918953|FG002|Open-Label Phase|Withdrawal by Subject|0|||
143303566|NCT03608774|516662902|FG000|Overall Study|Withdrawal by Subject|1|||
143303567|NCT03608774|516662903|FG001|Overall Study|Withdrawal by Subject|0|||
143303568|NCT03608774|516662902|FG000|Overall Study|Protocol Violation|1|||
143303569|NCT03608774|516662903|FG001|Overall Study|Protocol Violation|0|||
143303570|NCT03608774|516662902|FG000|Overall Study|Not eligible at enrollment|0|||
143303571|NCT03608774|516662903|FG001|Overall Study|Not eligible at enrollment|1|||
143303572|NCT03608774|516662902|FG000|Overall Study|Health related event|0|||
143303573|NCT03608774|516662903|FG001|Overall Study|Health related event|1|||
143303574|NCT00642668|516662904|FG000|Overall Study|Lost to Follow-up|1|||
143303575|NCT00642668|516662904|FG000|Overall Study|Adverse Event|2|||
143303576|NCT00642668|516662904|FG000|Overall Study|Death|2|||
143303577|NCT00642668|516662904|FG000|Overall Study|Insufficient Therapeutic Response|1|||
143303578|NCT00642668|516662904|FG000|Overall Study|Failure to Return|1|||
143303579|NCT00642668|516662904|FG000|Overall Study|Dialysis Initiation|5|||
143303580|NCT00642668|516662904|FG000|Overall Study|Blood Transfusion|2|||
143303581|NCT00896337|516662905|FG000|Overall Study|Death|7|||
143303582|NCT00896337|516662905|FG000|Overall Study|Withdrawal by Subject|7|||
143303583|NCT00896337|516662905|FG000|Overall Study|Lost to Follow-up|11|||
143303584|NCT01586819|516662906|FG000|Overall Study|Withdrawal by Subject|1|||
143303585|NCT01586819|516662907|FG001|Overall Study|Withdrawal by Subject|0|||
143303586|NCT02910167|516662915|FG000|Overall Study|Adverse Event|1|||
143303587|NCT02910167|516662915|FG000|Overall Study|Lost to Follow-up|18|||
143303588|NCT04059146|516662916|FG000|Overall Study|Withdrawal by Subject|0|||
143303589|NCT04059146|516662917|FG001|Overall Study|Withdrawal by Subject|1|||
143303590|NCT00082433|516662918|FG000|Overall Study|Adverse Event|12|||
143303591|NCT00082433|516662919|FG001|Overall Study|Adverse Event|17|||
143303592|NCT00082433|516662918|FG000|Overall Study|Death|8|||
143303593|NCT00082433|516662919|FG001|Overall Study|Death|18|||
143303594|NCT00082433|516662918|FG000|Overall Study|Disease Progression/Relapse|270|||
143303595|NCT00082433|516662919|FG001|Overall Study|Disease Progression/Relapse|388|||
143303596|NCT00082433|516662918|FG000|Overall Study|Physician Decision|50|||
143303597|NCT00082433|516662919|FG001|Overall Study|Physician Decision|61|||
143303598|NCT00082433|516662918|FG000|Overall Study|Lost to Follow-up|1|||
143303599|NCT00082433|516662919|FG001|Overall Study|Lost to Follow-up|2|||
143303600|NCT00082433|516662918|FG000|Overall Study|Study Drug Toxicity|179|||
143303601|NCT00082433|516662919|FG001|Overall Study|Study Drug Toxicity|66|||
143303602|NCT00082433|516662918|FG000|Overall Study|Withdrawal by Subject|55|||
143303603|NCT00082433|516662919|FG001|Overall Study|Withdrawal by Subject|30|||
143303604|NCT00082433|516662918|FG000|Overall Study|Still On Treatment|2|||
143303605|NCT00082433|516662919|FG001|Overall Study|Still On Treatment|1|||
143303606|NCT00082433|516662918|FG000|Overall Study|Not Treated|12|||
143303607|NCT00082433|516662919|FG001|Overall Study|Not Treated|11|||
143303608|NCT00082433|516662918|FG000|Overall Study|Ineligible|2|||
143303609|NCT00082433|516662919|FG001|Overall Study|Ineligible|1|||
143303610|NCT00082433|516662918|FG000|Overall Study|Noncompliance|2|||
143303611|NCT00082433|516662919|FG001|Overall Study|Noncompliance|1|||
143303612|NCT00082433|516662918|FG000|Overall Study|New primary cancer|1|||
143303613|NCT00082433|516662919|FG001|Overall Study|New primary cancer|0|||
143303614|NCT00082433|516662918|FG000|Overall Study|Impending surgery|0|||
143303615|NCT00082433|516662919|FG001|Overall Study|Impending surgery|1|||
143303616|NCT01796197|516662922|FG000|Overall Study|Lost to Follow-up|1|||
143303617|NCT01796197|516662922|FG000|Overall Study|Lack of Efficacy|1|||
143303618|NCT00427635|516664184|FG000|Treatment Phase|Withdrawal by Subject|1|||
143303619|NCT00427635|516664185|FG001|Treatment Phase|Withdrawal by Subject|0|||
143303620|NCT00427635|516664184|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
143303621|NCT00427635|516664185|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
143303622|NCT02042924|516664186|FG000|Overall Study|Early Death|1|||
143303623|NCT04033003|516664187|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
143303624|NCT04033003|516664188|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
143303625|NCT04033003|516664187|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
143303626|NCT04033003|516664188|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
143303627|NCT04033003|516664187|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
143303628|NCT04033003|516664188|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
143303629|NCT04033003|516664187|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
143303630|NCT04033003|516664188|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
143303631|NCT04033003|516664187|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
143303632|NCT04033003|516664188|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
143303633|NCT04033003|516664187|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
143303634|NCT04033003|516664188|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
143303635|NCT04033003|516664187|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
143303636|NCT04033003|516664188|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
143303637|NCT04033003|516664187|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
143375079|NCT00723450|516918951|FG000|Randomized Phase|Adverse Event|0|||
143375080|NCT00723450|516918952|FG001|Randomized Phase|Adverse Event|26|||
143303638|NCT04033003|516664188|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
143303639|NCT04033003|516664187|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
143303640|NCT04033003|516664188|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
143303641|NCT04033003|516664187|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
143303642|NCT04033003|516664188|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
143303643|NCT04033003|516664187|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
143303644|NCT04033003|516664188|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
143303645|NCT04033003|516664187|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
143303646|NCT04033003|516664188|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
143303647|NCT04033003|516664187|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
143303648|NCT04033003|516664188|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
143303649|NCT01714310|516664189|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
143303650|NCT01714310|516664190|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
143303651|NCT01714310|516664191|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
143303652|NCT01714310|516664189|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
143303653|NCT01714310|516664190|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
143303654|NCT01714310|516664191|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
143303655|NCT01714310|516664189|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
143303656|NCT01714310|516664190|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
143303657|NCT01714310|516664191|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
143303658|NCT01714310|516664189|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
143303659|NCT01714310|516664190|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
143303660|NCT01714310|516664191|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
143303661|NCT02487394|516664192|FG000|Phase 1|Withdrawal by Subject|0|||
143303662|NCT02487394|516664193|FG001|Phase 1|Withdrawal by Subject|1|||
143303663|NCT00826267|516664198|FG000|Overall Study|Other Adverse Event|1|||
143303664|NCT00826267|516664199|FG001|Overall Study|Other Adverse Event|0|||
143303665|NCT00826267|516664200|FG002|Overall Study|Other Adverse Event|0|||
143303666|NCT01675882|516664217|FG000|Overall Study|Adverse Event|0|||
143303667|NCT01675882|516664218|FG001|Overall Study|Adverse Event|2|||
143303668|NCT01675882|516664219|FG002|Overall Study|Adverse Event|1|||
143303669|NCT01675882|516664220|FG003|Overall Study|Adverse Event|0|||
143303670|NCT01675882|516664217|FG000|Overall Study|Participant unwilling to continue|2|||
143303671|NCT01675882|516664218|FG001|Overall Study|Participant unwilling to continue|4|||
143303672|NCT01675882|516664219|FG002|Overall Study|Participant unwilling to continue|2|||
143303673|NCT01675882|516664220|FG003|Overall Study|Participant unwilling to continue|1|||
143303674|NCT01675882|516664217|FG000|Overall Study|Lost to Follow-up|0|||
143303675|NCT01675882|516664218|FG001|Overall Study|Lost to Follow-up|1|||
143303676|NCT01675882|516664219|FG002|Overall Study|Lost to Follow-up|0|||
143303677|NCT01675882|516664220|FG003|Overall Study|Lost to Follow-up|0|||
143303678|NCT01675882|516664217|FG000|Overall Study|Non-compliance|0|||
143303679|NCT01675882|516664218|FG001|Overall Study|Non-compliance|0|||
143303680|NCT01675882|516664219|FG002|Overall Study|Non-compliance|0|||
143303681|NCT01675882|516664220|FG003|Overall Study|Non-compliance|1|||
143303682|NCT02711800|516664224|FG000|Overall Study|Lost to Follow-up|1|||
143303683|NCT02711800|516664224|FG000|Overall Study|Withdrawal by Subject|1|||
143303684|NCT04238728|516664245|FG000|Overall Study|Withdrawal by Subject|1|||
143303685|NCT04238728|516664245|FG000|Overall Study|Lost to Follow-up|2|||
143303686|NCT01907828|516664247|FG000|Overall Study|Exclusion criteria not met|0|||
143303687|NCT01907828|516664248|FG001|Overall Study|Exclusion criteria not met|1|||
143303688|NCT01907828|516664247|FG000|Overall Study|Withdrawal by Subject|3|||
143303689|NCT01907828|516664248|FG001|Overall Study|Withdrawal by Subject|4|||
143303690|NCT01907828|516664247|FG000|Overall Study|Lost to Follow-up|3|||
143303691|NCT01907828|516664248|FG001|Overall Study|Lost to Follow-up|0|||
143303692|NCT01907828|516664247|FG000|Overall Study|Participant refused 24-month follow-up|1|||
143303693|NCT01907828|516664248|FG001|Overall Study|Participant refused 24-month follow-up|0|||
143303694|NCT01907828|516664247|FG000|Overall Study|Participant met exclusion criteria|0|||
143303695|NCT01907828|516664248|FG001|Overall Study|Participant met exclusion criteria|1|||
143303696|NCT00743652|516664254|FG000|Overall Study|Parent/Legal Guardian Request|3|||
143303697|NCT00743652|516664255|FG001|Overall Study|Parent/Legal Guardian Request|2|||
143303698|NCT00743652|516664256|FG002|Overall Study|Parent/Legal Guardian Request|2|||
143303699|NCT00743652|516664257|FG003|Overall Study|Parent/Legal Guardian Request|2|||
143303700|NCT00743652|516664258|FG004|Overall Study|Parent/Legal Guardian Request|0|||
143303701|NCT00743652|516664254|FG000|Overall Study|Adverse Event|3|||
143303702|NCT00743652|516664255|FG001|Overall Study|Adverse Event|0|||
143303703|NCT00743652|516664256|FG002|Overall Study|Adverse Event|0|||
143303704|NCT00743652|516664257|FG003|Overall Study|Adverse Event|0|||
143303705|NCT00743652|516664258|FG004|Overall Study|Adverse Event|0|||
143303706|NCT00743652|516664254|FG000|Overall Study|Death|2|||
143303707|NCT00743652|516664255|FG001|Overall Study|Death|0|||
143303708|NCT00743652|516664256|FG002|Overall Study|Death|0|||
143303709|NCT00743652|516664257|FG003|Overall Study|Death|0|||
143303710|NCT00743652|516664258|FG004|Overall Study|Death|0|||
143303711|NCT00743652|516664254|FG000|Overall Study|Investigator Request|0|||
143303712|NCT00743652|516664255|FG001|Overall Study|Investigator Request|0|||
143303713|NCT00743652|516664256|FG002|Overall Study|Investigator Request|0|||
143303714|NCT00743652|516664257|FG003|Overall Study|Investigator Request|2|||
143303715|NCT00743652|516664258|FG004|Overall Study|Investigator Request|0|||
143303716|NCT00743652|516664254|FG000|Overall Study|Other|1|||
143303717|NCT00743652|516664255|FG001|Overall Study|Other|1|||
143303718|NCT00743652|516664256|FG002|Overall Study|Other|0|||
143303719|NCT00743652|516664257|FG003|Overall Study|Other|0|||
143303720|NCT00743652|516664258|FG004|Overall Study|Other|0|||
143303721|NCT00743652|516664254|FG000|Overall Study|Lost to Follow-up|1|||
143303722|NCT00743652|516664255|FG001|Overall Study|Lost to Follow-up|0|||
143303723|NCT00743652|516664256|FG002|Overall Study|Lost to Follow-up|0|||
143303724|NCT00743652|516664257|FG003|Overall Study|Lost to Follow-up|0|||
143303725|NCT00743652|516664258|FG004|Overall Study|Lost to Follow-up|0|||
143303726|NCT00794196|516664260|FG000|Overall Study|Lost to Follow-up|5|||
143303727|NCT00794196|516664261|FG001|Overall Study|Lost to Follow-up|23|||
143303728|NCT04414553|516664262|FG000|Overall Study|Lost to Follow-up|20|||
143303729|NCT02129803|516664265|FG000|Overall Study|Protocol Violation|4|||
143303730|NCT02129803|516664266|FG001|Overall Study|Protocol Violation|0|||
143303731|NCT02129803|516664265|FG000|Overall Study|Physician Decision|0|||
143303732|NCT02129803|516664266|FG001|Overall Study|Physician Decision|1|||
143303733|NCT02129803|516664265|FG000|Overall Study|Difficulty sleeping|1|||
143303734|NCT02129803|516664266|FG001|Overall Study|Difficulty sleeping|0|||
143303735|NCT02129803|516664265|FG000|Overall Study|Morning headache|0|||
143303736|NCT02129803|516664266|FG001|Overall Study|Morning headache|1|||
143303737|NCT02129803|516664265|FG000|Overall Study|Withdrawal by Subject|1|||
143303738|NCT02129803|516664266|FG001|Overall Study|Withdrawal by Subject|1|||
143303739|NCT00149747|516664271|FG000|Overall Study|Death|1|||
143303740|NCT00149747|516664272|FG001|Overall Study|Death|0|||
143303741|NCT00149747|516664271|FG000|Overall Study|Withdrawal by Subject|3|||
143303742|NCT00149747|516664272|FG001|Overall Study|Withdrawal by Subject|3|||
143303743|NCT03818516|516664273|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
143303744|NCT03742141|516664274|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
143303745|NCT00850395|516664275|FG000|Overall Study|Death|1|||
143303746|NCT00850395|516664275|FG000|Overall Study|Adverse Event|1|||
143303747|NCT00850395|516664275|FG000|Overall Study|Insufficient clinical response|3|||
143303748|NCT00850395|516664275|FG000|Overall Study|Other|5|||
143303749|NCT00405548|516664276|FG000|Overall Study|Cognitive Memory problems on study day|1|||
143303750|NCT00405548|516664277|FG001|Overall Study|Cognitive Memory problems on study day|0|||
143303751|NCT00405548|516664276|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
143303752|NCT00405548|516664277|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
143303753|NCT00405548|516664276|FG000|Overall Study|Unable to self-administer shots|1|||
143303754|NCT00405548|516664277|FG001|Overall Study|Unable to self-administer shots|0|||
143303755|NCT00405548|516664276|FG000|Overall Study|Venous access failed during study day|1|||
143303756|NCT00405548|516664277|FG001|Overall Study|Venous access failed during study day|0|||
143303757|NCT00405548|516664276|FG000|Overall Study|Withdrawal by Subject|1|||
143375081|NCT00723450|516918953|FG002|Randomized Phase|Adverse Event|17|||
143303758|NCT00405548|516664277|FG001|Overall Study|Withdrawal by Subject|0|||
143303759|NCT02741700|516664282|FG000|Overall Study|Lost to Follow-up|17|||
143303760|NCT02741700|516664283|FG001|Overall Study|Lost to Follow-up|8|||
143303761|NCT02741700|516664282|FG000|Overall Study|Withdrawal by Subject|2|||
143303762|NCT02741700|516664283|FG001|Overall Study|Withdrawal by Subject|5|||
143303763|NCT02741700|516664282|FG000|Overall Study|Physician Decision|3|||
143303764|NCT02741700|516664283|FG001|Overall Study|Physician Decision|0|||
143303765|NCT02741700|516664282|FG000|Overall Study|Moved out of State|0|||
143303766|NCT02741700|516664283|FG001|Overall Study|Moved out of State|1|||
143303767|NCT02741700|516664282|FG000|Overall Study|Death|4|||
143303768|NCT02741700|516664283|FG001|Overall Study|Death|5|||
143303769|NCT01177540|516664284|FG000|Overall Study|Adverse Event|1|||
143303770|NCT01177540|516664285|FG001|Overall Study|Adverse Event|0|||
143303771|NCT01418937|516664289|FG000|Overall Study|Lost to Follow-up|5|||
143303772|NCT01418937|516664289|FG000|Overall Study|Protocol Violation|1|||
143303773|NCT01418937|516664289|FG000|Overall Study|Pregnancy|1|||
143303774|NCT01418937|516664289|FG000|Overall Study|Withdrawal by Subject|1|||
143303775|NCT01623596|516664290|FG000|Overall Study|Abnormal laboratory values|2|||
143303776|NCT01623596|516664291|FG001|Overall Study|Abnormal laboratory values|0|||
143303777|NCT01623596|516664290|FG000|Overall Study|Administrative problems|9|||
143303778|NCT01623596|516664291|FG001|Overall Study|Administrative problems|13|||
143303779|NCT01623596|516664290|FG000|Overall Study|Adverse Event|20|||
143303780|NCT01623596|516664291|FG001|Overall Study|Adverse Event|29|||
143303781|NCT01623596|516664290|FG000|Overall Study|Death|0|||
143303782|NCT01623596|516664291|FG001|Overall Study|Death|2|||
143303783|NCT01623596|516664290|FG000|Overall Study|Lost to Follow-up|12|||
143303784|NCT01623596|516664291|FG001|Overall Study|Lost to Follow-up|16|||
143303785|NCT01623596|516664290|FG000|Overall Study|Withdrawal by Subject|13|||
143303786|NCT01623596|516664291|FG001|Overall Study|Withdrawal by Subject|31|||
143303787|NCT01623596|516664290|FG000|Overall Study|Patient no longer requires study drug|1|||
143303788|NCT01623596|516664291|FG001|Overall Study|Patient no longer requires study drug|0|||
143303789|NCT01623596|516664290|FG000|Overall Study|Protocol Violation|0|||
143303790|NCT01623596|516664291|FG001|Overall Study|Protocol Violation|6|||
143303791|NCT01623596|516664290|FG000|Overall Study|Lack of Efficacy|5|||
143303792|NCT01623596|516664291|FG001|Overall Study|Lack of Efficacy|3|||
143303793|NCT01324349|516664292|FG000|Overall Study|Death|1|||
143303794|NCT01324349|516664293|FG001|Overall Study|Death|1|||
143303795|NCT01324349|516664292|FG000|Overall Study|Withdrawal by Subject|0|||
143303796|NCT01324349|516664293|FG001|Overall Study|Withdrawal by Subject|1|||
143303797|NCT01070316|516664294|FG000|Extension Phase|Lack of Efficacy|3|||
143303798|NCT01070316|516664294|FG000|Extension Phase|Withdrawal by Subject|1|||
143303799|NCT00748215|516664295|FG000|Overall Study|Withdrawal by Subject|7|||
143303800|NCT00748215|516664296|FG001|Overall Study|Withdrawal by Subject|7|||
143303801|NCT00748215|516664295|FG000|Overall Study|Treatment change|2|||
143303802|NCT00748215|516664296|FG001|Overall Study|Treatment change|1|||
143303803|NCT00748215|516664295|FG000|Overall Study|Change in patient condition|0|||
143303804|NCT00748215|516664296|FG001|Overall Study|Change in patient condition|3|||
143303805|NCT00748215|516664295|FG000|Overall Study|Non-compliant|0|||
143303806|NCT00748215|516664296|FG001|Overall Study|Non-compliant|2|||
143303807|NCT00748215|516664295|FG000|Overall Study|Adverse Event|0|||
143303808|NCT00748215|516664296|FG001|Overall Study|Adverse Event|5|||
143303809|NCT01132495|516664304|FG000|Overall Study|Various reasons|40|||
143303810|NCT01132495|516664305|FG001|Overall Study|Various reasons|38|||
143303811|NCT01132495|516664306|FG002|Overall Study|Various reasons|20|||
143303812|NCT01132495|516664307|FG003|Overall Study|Various reasons|12|||
143303813|NCT04097821|516664310|FG000|Overall Study|Subject Decision|0|||
143303814|NCT04097821|516664311|FG001|Overall Study|Subject Decision|0|||
143303815|NCT04097821|516664312|FG002|Overall Study|Subject Decision|0|||
143303816|NCT04097821|516664313|FG003|Overall Study|Subject Decision|1|||
143303817|NCT04097821|516664314|FG004|Overall Study|Subject Decision|2|||
143303818|NCT04097821|516664315|FG005|Overall Study|Subject Decision|2|||
143303819|NCT04097821|516664316|FG006|Overall Study|Subject Decision|0|||
143303820|NCT04097821|516664317|FG007|Overall Study|Subject Decision|1|||
143303821|NCT04097821|516664310|FG000|Overall Study|Death|0|||
143303822|NCT04097821|516664311|FG001|Overall Study|Death|0|||
143303823|NCT04097821|516664312|FG002|Overall Study|Death|3|||
143303824|NCT04097821|516664313|FG003|Overall Study|Death|1|||
143303825|NCT04097821|516664314|FG004|Overall Study|Death|0|||
143303826|NCT04097821|516664315|FG005|Overall Study|Death|0|||
143303827|NCT04097821|516664316|FG006|Overall Study|Death|0|||
143303828|NCT04097821|516664317|FG007|Overall Study|Death|0|||
143303829|NCT04097821|516664310|FG000|Overall Study|Physician Decision|1|||
143303830|NCT04097821|516664311|FG001|Overall Study|Physician Decision|2|||
143303831|NCT04097821|516664312|FG002|Overall Study|Physician Decision|0|||
143303832|NCT04097821|516664313|FG003|Overall Study|Physician Decision|0|||
143303833|NCT04097821|516664314|FG004|Overall Study|Physician Decision|0|||
143303834|NCT04097821|516664315|FG005|Overall Study|Physician Decision|0|||
143303835|NCT04097821|516664316|FG006|Overall Study|Physician Decision|0|||
143303836|NCT04097821|516664317|FG007|Overall Study|Physician Decision|0|||
143303837|NCT04097821|516664310|FG000|Overall Study|Adverse Event|0|||
143303838|NCT04097821|516664311|FG001|Overall Study|Adverse Event|0|||
143303839|NCT04097821|516664312|FG002|Overall Study|Adverse Event|1|||
143303840|NCT04097821|516664313|FG003|Overall Study|Adverse Event|1|||
143303841|NCT04097821|516664314|FG004|Overall Study|Adverse Event|0|||
143303842|NCT04097821|516664315|FG005|Overall Study|Adverse Event|0|||
143303843|NCT04097821|516664316|FG006|Overall Study|Adverse Event|0|||
143303844|NCT04097821|516664317|FG007|Overall Study|Adverse Event|0|||
143303845|NCT04097821|516664310|FG000|Overall Study|New Therapy For Study Indication|0|||
143303846|NCT04097821|516664311|FG001|Overall Study|New Therapy For Study Indication|0|||
143303847|NCT04097821|516664312|FG002|Overall Study|New Therapy For Study Indication|0|||
143303848|NCT04097821|516664313|FG003|Overall Study|New Therapy For Study Indication|0|||
143303849|NCT04097821|516664314|FG004|Overall Study|New Therapy For Study Indication|0|||
143303850|NCT04097821|516664315|FG005|Overall Study|New Therapy For Study Indication|0|||
143303851|NCT04097821|516664316|FG006|Overall Study|New Therapy For Study Indication|1|||
143303852|NCT04097821|516664317|FG007|Overall Study|New Therapy For Study Indication|0|||
143303853|NCT02776917|516664318|FG000|Overall Study|Screen failures. One subject ended treatment early due to disease related symptoms|7|||
143303854|NCT03026257|516666187|FG000|Overall Study|Adverse Event|3|||
143303855|NCT03026257|516666188|FG001|Overall Study|Adverse Event|0|||
143303856|NCT03026257|516666189|FG002|Overall Study|Adverse Event|0|||
143303857|NCT03026257|516666190|FG003|Overall Study|Adverse Event|0|||
143303858|NCT03026257|516666191|FG004|Overall Study|Adverse Event|0|||
143303859|NCT03026257|516666192|FG005|Overall Study|Adverse Event|0|||
143303860|NCT03026257|516666187|FG000|Overall Study|Lost to Follow-up|1|||
143303861|NCT03026257|516666188|FG001|Overall Study|Lost to Follow-up|0|||
143303862|NCT03026257|516666189|FG002|Overall Study|Lost to Follow-up|0|||
143303863|NCT03026257|516666190|FG003|Overall Study|Lost to Follow-up|0|||
143303864|NCT03026257|516666191|FG004|Overall Study|Lost to Follow-up|0|||
143303865|NCT03026257|516666192|FG005|Overall Study|Lost to Follow-up|0|||
143303866|NCT03026257|516666187|FG000|Overall Study|Protocol Violation|1|||
143303867|NCT03026257|516666188|FG001|Overall Study|Protocol Violation|0|||
143303868|NCT03026257|516666189|FG002|Overall Study|Protocol Violation|0|||
143303869|NCT03026257|516666190|FG003|Overall Study|Protocol Violation|1|||
143303870|NCT03026257|516666191|FG004|Overall Study|Protocol Violation|1|||
143303871|NCT03026257|516666192|FG005|Overall Study|Protocol Violation|0|||
143303872|NCT03026257|516666187|FG000|Overall Study|Withdrawal by Subject|1|||
143303873|NCT03026257|516666188|FG001|Overall Study|Withdrawal by Subject|1|||
143303874|NCT03026257|516666189|FG002|Overall Study|Withdrawal by Subject|0|||
143303875|NCT03026257|516666190|FG003|Overall Study|Withdrawal by Subject|0|||
143303876|NCT03026257|516666191|FG004|Overall Study|Withdrawal by Subject|0|||
143303877|NCT03026257|516666192|FG005|Overall Study|Withdrawal by Subject|0|||
143303878|NCT02181556|516666194|FG000|Overall Study|Withdrawal by Subject|1|||
143303879|NCT04380857|516666195|FG000|Overall Study|Lost to Follow-up|3|||
143303880|NCT04380857|516666196|FG001|Overall Study|Lost to Follow-up|3|||
143303881|NCT02558790|516666197|FG000|Overall Study|Lost to Follow-up|2|||
143303882|NCT02558790|516666197|FG000|Overall Study|Physician Decision|1|||
143303883|NCT02558790|516666197|FG000|Overall Study|Withdrawal by Subject|1|||
143303884|NCT02558790|516666197|FG000|Overall Study|Screen Fail|3|||
143375082|NCT00723450|516918951|FG000|Randomized Phase|Lack of Efficacy|0|||
143303885|NCT00838201|516666198|FG000|Overall Study|Investigator decision, or other reasons|2|||
143303886|NCT00838201|516666199|FG001|Overall Study|Investigator decision, or other reasons|3|||
143303887|NCT00838201|516666198|FG000|Overall Study|Noncompliance|0|||
143303888|NCT00838201|516666199|FG001|Overall Study|Noncompliance|1|||
143303889|NCT00838201|516666198|FG000|Overall Study|Administrative decision|1|||
143303890|NCT00838201|516666199|FG001|Overall Study|Administrative decision|2|||
143303891|NCT00838201|516666198|FG000|Overall Study|Disease progression|3|||
143303892|NCT00838201|516666199|FG001|Overall Study|Disease progression|3|||
143303893|NCT00838201|516666198|FG000|Overall Study|Consent withdrawn|16|||
143303894|NCT00838201|516666199|FG001|Overall Study|Consent withdrawn|19|||
143303895|NCT00838201|516666198|FG000|Overall Study|Lost to Follow-up|4|||
143303896|NCT00838201|516666199|FG001|Overall Study|Lost to Follow-up|3|||
143303897|NCT00838201|516666198|FG000|Overall Study|Adverse Event|5|||
143303898|NCT00838201|516666199|FG001|Overall Study|Adverse Event|9|||
143303899|NCT00838201|516666198|FG000|Overall Study|Death|11|||
143303900|NCT00838201|516666199|FG001|Overall Study|Death|13|||
143303901|NCT01888497|516666200|FG000|Washout Period 1|Withdrawal by Subject|0|||
143303902|NCT01888497|516666201|FG001|Washout Period 1|Withdrawal by Subject|0|||
143303903|NCT01888497|516666202|FG002|Washout Period 1|Withdrawal by Subject|1|||
143303904|NCT01888497|516666203|FG003|Washout Period 1|Withdrawal by Subject|1|||
143303905|NCT01888497|516666200|FG000|Washout Period 2|Adverse Event|0|||
143303906|NCT01888497|516666201|FG001|Washout Period 2|Adverse Event|0|||
143303907|NCT01888497|516666202|FG002|Washout Period 2|Adverse Event|0|||
143303908|NCT01888497|516666203|FG003|Washout Period 2|Adverse Event|1|||
143303909|NCT01888497|516666200|FG000|Washout Period 2|Withdrawal by Subject|0|||
143303910|NCT01888497|516666201|FG001|Washout Period 2|Withdrawal by Subject|0|||
143303911|NCT01888497|516666202|FG002|Washout Period 2|Withdrawal by Subject|0|||
143303912|NCT01888497|516666203|FG003|Washout Period 2|Withdrawal by Subject|1|||
143303913|NCT03711162|516666204|FG000|Overall Study|Adverse Event|5|||
143303914|NCT03711162|516666205|FG001|Overall Study|Adverse Event|2|||
143303915|NCT03711162|516666206|FG002|Overall Study|Adverse Event|4|||
143303916|NCT03711162|516666204|FG000|Overall Study|Death|11|||
143303917|NCT03711162|516666205|FG001|Overall Study|Death|7|||
143303918|NCT03711162|516666206|FG002|Overall Study|Death|8|||
143303919|NCT03711162|516666204|FG000|Overall Study|Lost to Follow-up|1|||
143303920|NCT03711162|516666205|FG001|Overall Study|Lost to Follow-up|0|||
143303921|NCT03711162|516666206|FG002|Overall Study|Lost to Follow-up|1|||
143303922|NCT03711162|516666204|FG000|Overall Study|Study Terminated by Sponsor|139|||
143303923|NCT03711162|516666205|FG001|Overall Study|Study Terminated by Sponsor|152|||
143303924|NCT03711162|516666206|FG002|Overall Study|Study Terminated by Sponsor|146|||
143303925|NCT03711162|516666204|FG000|Overall Study|Withdrawal by Subject|17|||
143303926|NCT03711162|516666205|FG001|Overall Study|Withdrawal by Subject|10|||
143303927|NCT03711162|516666206|FG002|Overall Study|Withdrawal by Subject|10|||
143303928|NCT03711162|516666204|FG000|Overall Study|Miscellaneous|1|||
143303929|NCT03711162|516666205|FG001|Overall Study|Miscellaneous|2|||
143303930|NCT03711162|516666206|FG002|Overall Study|Miscellaneous|2|||
143303931|NCT03711162|516666204|FG000|Overall Study|Not Treated|1|||
143303932|NCT03711162|516666205|FG001|Overall Study|Not Treated|0|||
143303933|NCT03711162|516666206|FG002|Overall Study|Not Treated|1|||
143303934|NCT03711162|516666204|FG000|Overall Study|Physician Decision|0|||
143303935|NCT03711162|516666205|FG001|Overall Study|Physician Decision|2|||
143303936|NCT03711162|516666206|FG002|Overall Study|Physician Decision|0|||
143303937|NCT03711162|516666204|FG000|Overall Study|Lack of Efficacy|0|||
143303938|NCT03711162|516666205|FG001|Overall Study|Lack of Efficacy|0|||
143303939|NCT03711162|516666206|FG002|Overall Study|Lack of Efficacy|2|||
143303940|NCT03711162|516666204|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
143303941|NCT03711162|516666205|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
143303942|NCT03711162|516666206|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
143303943|NCT03240133|516666207|FG000|Overall Study|Withdrawal by Subject|0|||
143303944|NCT03240133|516666208|FG001|Overall Study|Withdrawal by Subject|1|||
143303945|NCT03240133|516666209|FG002|Overall Study|Withdrawal by Subject|0|||
143303946|NCT03240133|516666207|FG000|Overall Study|Adverse Event|1|||
143303947|NCT03240133|516666208|FG001|Overall Study|Adverse Event|1|||
143303948|NCT03240133|516666209|FG002|Overall Study|Adverse Event|0|||
143303949|NCT03240133|516666207|FG000|Overall Study|Rash|1|||
143303950|NCT03240133|516666208|FG001|Overall Study|Rash|0|||
143303951|NCT03240133|516666209|FG002|Overall Study|Rash|0|||
143303952|NCT03240133|516666207|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
143303953|NCT03240133|516666208|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
143303954|NCT03240133|516666209|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
143303955|NCT03240133|516666207|FG000|Overall Study|Intercurrent illness.|0|||
143303956|NCT03240133|516666208|FG001|Overall Study|Intercurrent illness.|1|||
143303957|NCT03240133|516666209|FG002|Overall Study|Intercurrent illness.|0|||
143303958|NCT03240133|516666207|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
143303959|NCT03240133|516666208|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
143303960|NCT03240133|516666209|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
143303961|NCT00097721|516666213|FG000|Overall Study|Adverse Event|8|||
143303962|NCT00097721|516666214|FG001|Overall Study|Adverse Event|1|||
143303963|NCT00097721|516666213|FG000|Overall Study|Withdrawal by Subject|6|||
143375083|NCT00723450|516918952|FG001|Randomized Phase|Lack of Efficacy|11|||
143303964|NCT00097721|516666214|FG001|Overall Study|Withdrawal by Subject|1|||
143303965|NCT00097721|516666213|FG000|Overall Study|Progressive Disease|55|||
143303966|NCT00097721|516666214|FG001|Overall Study|Progressive Disease|27|||
143303967|NCT00097721|516666213|FG000|Overall Study|Physician Decision|1|||
143303968|NCT00097721|516666214|FG001|Overall Study|Physician Decision|3|||
143303969|NCT00097721|516666213|FG000|Overall Study|Reason not given|1|||
143303970|NCT00097721|516666214|FG001|Overall Study|Reason not given|1|||
143303971|NCT00314574|516666218|FG000|Overall Study|Death|3|||
143303972|NCT00314574|516666219|FG001|Overall Study|Death|0|||
143303973|NCT00314574|516666218|FG000|Overall Study|Adverse Event|11|||
143303974|NCT00314574|516666219|FG001|Overall Study|Adverse Event|16|||
143303975|NCT00314574|516666218|FG000|Overall Study|Lost to Follow-up|19|||
143303976|NCT00314574|516666219|FG001|Overall Study|Lost to Follow-up|25|||
143303977|NCT00314574|516666218|FG000|Overall Study|Withdrawal by Subject|33|||
143303978|NCT00314574|516666219|FG001|Overall Study|Withdrawal by Subject|22|||
143303979|NCT00314574|516666218|FG000|Overall Study|Physician Decision|22|||
143303980|NCT00314574|516666219|FG001|Overall Study|Physician Decision|15|||
143303981|NCT00314574|516666218|FG000|Overall Study|Pregnancy|6|||
143303982|NCT00314574|516666219|FG001|Overall Study|Pregnancy|4|||
143303983|NCT00314574|516666218|FG000|Overall Study|Data unknown at database lock|0|||
143303984|NCT00314574|516666219|FG001|Overall Study|Data unknown at database lock|1|||
143303985|NCT00449956|516666220|FG000|Overall Study|Adverse Event|7|||
143303986|NCT00449956|516666221|FG001|Overall Study|Adverse Event|1|||
143303987|NCT00449956|516666222|FG002|Overall Study|Adverse Event|6|||
143303988|NCT00449956|516666220|FG000|Overall Study|Lack of Efficacy|0|||
143303989|NCT00449956|516666221|FG001|Overall Study|Lack of Efficacy|0|||
143303990|NCT00449956|516666222|FG002|Overall Study|Lack of Efficacy|1|||
143303991|NCT00449956|516666220|FG000|Overall Study|Protocol Violation|1|||
143303992|NCT00449956|516666221|FG001|Overall Study|Protocol Violation|1|||
143303993|NCT00449956|516666222|FG002|Overall Study|Protocol Violation|1|||
143303994|NCT00449956|516666220|FG000|Overall Study|Withdrawal by Subject|0|||
143303995|NCT00449956|516666221|FG001|Overall Study|Withdrawal by Subject|1|||
143303996|NCT00449956|516666222|FG002|Overall Study|Withdrawal by Subject|0|||
143303997|NCT00449956|516666220|FG000|Overall Study|Physician Decision|2|||
143303998|NCT00449956|516666221|FG001|Overall Study|Physician Decision|1|||
143303999|NCT00449956|516666222|FG002|Overall Study|Physician Decision|1|||
143304000|NCT00004412|516666225|FG000|Randomized Period|Moved to Crossover Period|3|||
143304001|NCT00004412|516666226|FG001|Randomized Period|Moved to Crossover Period|0|||
143304002|NCT00004412|516666227|FG002|Randomized Period|Moved to Crossover Period|0|||
143304003|NCT03144180|516666232|FG000|Overall Study|STAT Delivery|1|||
143304004|NCT03144180|516666233|FG001|Overall Study|STAT Delivery|1|||
143304005|NCT03144180|516666232|FG000|Overall Study|Provider forgot to fill out forms|1|||
143304006|NCT03144180|516666233|FG001|Overall Study|Provider forgot to fill out forms|3|||
143304007|NCT03144180|516666232|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
143304008|NCT03144180|516666233|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
143304009|NCT03144180|516666232|FG000|Overall Study|Scrub tech removed tube cap|0|||
143375084|NCT00723450|516918953|FG002|Randomized Phase|Lack of Efficacy|11|||
143304010|NCT03144180|516666233|FG001|Overall Study|Scrub tech removed tube cap|1|||
143304011|NCT03387813|516666236|FG000|Overall Study|Death|40|||
143304012|NCT03387813|516666237|FG001|Overall Study|Death|37|||
143304013|NCT03387813|516666238|FG002|Overall Study|Death|190|||
143304014|NCT03387813|516666236|FG000|Overall Study|Withdrawal by Subject|9|||
143304015|NCT03387813|516666237|FG001|Overall Study|Withdrawal by Subject|19|||
143304016|NCT03387813|516666238|FG002|Overall Study|Withdrawal by Subject|32|||
143304017|NCT03387813|516666236|FG000|Overall Study|Lost to Follow-up|3|||
143304018|NCT03387813|516666237|FG001|Overall Study|Lost to Follow-up|9|||
143304019|NCT03387813|516666238|FG002|Overall Study|Lost to Follow-up|15|||
143304020|NCT03387813|516666236|FG000|Overall Study|Non-Compliance|6|||
143304021|NCT03387813|516666237|FG001|Overall Study|Non-Compliance|6|||
143304022|NCT03387813|516666238|FG002|Overall Study|Non-Compliance|31|||
143304023|NCT03387813|516666236|FG000|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|7|||
143304024|NCT03387813|516666237|FG001|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|10|||
143304025|NCT03387813|516666238|FG002|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|14|||
143304026|NCT04327999|516666241|FG000|Overall Study|Protocol Violation|1|||
143304027|NCT02346136|516666246|FG000|Overall Study|Withdrawal by Subject|7|||
143304028|NCT02346136|516666247|FG001|Overall Study|Withdrawal by Subject|5|||
143304029|NCT02346136|516666246|FG000|Overall Study|Death|1|||
143304030|NCT02346136|516666247|FG001|Overall Study|Death|0|||
143304031|NCT02346136|516666246|FG000|Overall Study|Study termination|14|||
143304032|NCT02346136|516666247|FG001|Overall Study|Study termination|18|||
143304033|NCT03735667|516666248|FG000|1 Year PE Main Randomized and Roll-in|Death|40|||
143304034|NCT03735667|516666249|FG001|1 Year PE Main Randomized and Roll-in|Death|31|||
143304035|NCT03735667|516666250|FG002|1 Year PE Main Randomized and Roll-in|Death|7|||
143304036|NCT03735667|516666248|FG000|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|3|||
143304037|NCT03735667|516666249|FG001|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|2|||
143304038|NCT03735667|516666250|FG002|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|0|||
143304039|NCT03735667|516666248|FG000|1 Year PE Main Randomized and Roll-in|Physician Decision|4|||
143304040|NCT03735667|516666249|FG001|1 Year PE Main Randomized and Roll-in|Physician Decision|2|||
143304041|NCT03735667|516666250|FG002|1 Year PE Main Randomized and Roll-in|Physician Decision|0|||
143304042|NCT03735667|516666248|FG000|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|27|||
143304043|NCT03735667|516666249|FG001|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|24|||
143304044|NCT03735667|516666250|FG002|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|2|||
143304045|NCT03735667|516666248|FG000|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|28|||
143304046|NCT03735667|516666249|FG001|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|29|||
143304047|NCT03735667|516666250|FG002|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|9|||
143304048|NCT03735667|516666248|FG000|1 Year PE Main Randomized and Roll-in|Other|1|||
143304049|NCT03735667|516666249|FG001|1 Year PE Main Randomized and Roll-in|Other|2|||
143304050|NCT03735667|516666250|FG002|1 Year PE Main Randomized and Roll-in|Other|0|||
143304051|NCT03735667|516666248|FG000|4D-CT Substudy (Subset of Main RCT)|Death|8|||
143304052|NCT03735667|516666249|FG001|4D-CT Substudy (Subset of Main RCT)|Death|5|||
143304053|NCT03735667|516666250|FG002|4D-CT Substudy (Subset of Main RCT)|Death|0|||
143304054|NCT03735667|516666248|FG000|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
143304055|NCT03735667|516666249|FG001|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
143304056|NCT03735667|516666250|FG002|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|0|||
143304057|NCT03735667|516666248|FG000|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|1|||
143304058|NCT03735667|516666249|FG001|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
143304059|NCT03735667|516666250|FG002|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
143304060|NCT03735667|516666248|FG000|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
143304061|NCT03735667|516666249|FG001|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
143304062|NCT03735667|516666250|FG002|4D-CT Substudy (Subset of Main RCT)|Physician Decision|0|||
143304063|NCT03735667|516666248|FG000|4D-CT Substudy (Subset of Main RCT)|Other|0|||
143304064|NCT03735667|516666249|FG001|4D-CT Substudy (Subset of Main RCT)|Other|1|||
143304065|NCT03735667|516666250|FG002|4D-CT Substudy (Subset of Main RCT)|Other|0|||
143304066|NCT03735667|516666248|FG000|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
143304067|NCT03735667|516666249|FG001|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
143304068|NCT03735667|516666250|FG002|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|0|||
143304069|NCT02308735|516666252|FG000|Overall Study|Physician Decision|2|||
143304070|NCT02308735|516666253|FG001|Overall Study|Physician Decision|0|||
143304071|NCT02308735|516666254|FG002|Overall Study|Physician Decision|0|||
143304072|NCT02308735|516666255|FG003|Overall Study|Physician Decision|2|||
143304073|NCT03792672|516666256|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
143304074|NCT03792672|516666257|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
143304075|NCT03792672|516666258|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
143304076|NCT03792672|516666259|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
143304077|NCT03792672|516666260|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
143304078|NCT03792672|516666261|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
143304079|NCT03792672|516666256|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
143304080|NCT03792672|516666257|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
143304081|NCT03792672|516666258|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
143304082|NCT03792672|516666259|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
143304083|NCT03792672|516666260|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
143304084|NCT03792672|516666261|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
143304085|NCT03792672|516666256|FG000|Treatment Period 4 (2 Days)|Other|1|||
143304086|NCT03792672|516666257|FG001|Treatment Period 4 (2 Days)|Other|0|||
143304087|NCT03792672|516666258|FG002|Treatment Period 4 (2 Days)|Other|0|||
143304088|NCT03792672|516666259|FG003|Treatment Period 4 (2 Days)|Other|0|||
143304089|NCT03792672|516666260|FG004|Treatment Period 4 (2 Days)|Other|0|||
143304090|NCT03792672|516666261|FG005|Treatment Period 4 (2 Days)|Other|0|||
143304091|NCT00453999|516666262|FG000|Overall Study|Adverse Event|1|||
143304092|NCT00453999|516666263|FG001|Overall Study|Adverse Event|2|||
143304093|NCT00453999|516666264|FG002|Overall Study|Adverse Event|1|||
143304094|NCT00453999|516666262|FG000|Overall Study|Lost to Follow-up|0|||
143304095|NCT00453999|516666263|FG001|Overall Study|Lost to Follow-up|1|||
143304096|NCT00453999|516666264|FG002|Overall Study|Lost to Follow-up|1|||
143304097|NCT00453999|516666262|FG000|Overall Study|Withdrawal by Subject|2|||
143304098|NCT00453999|516666263|FG001|Overall Study|Withdrawal by Subject|1|||
143304099|NCT00453999|516666264|FG002|Overall Study|Withdrawal by Subject|1|||
143304100|NCT00453999|516666262|FG000|Overall Study|Subject Request|2|||
143304101|NCT00453999|516666263|FG001|Overall Study|Subject Request|1|||
143304102|NCT00453999|516666264|FG002|Overall Study|Subject Request|0|||
143304103|NCT00006478|516666272|FG000|Overall Study|Vaccine could not be produced|1|||
143304104|NCT00006478|516666272|FG000|Overall Study|Physician Decision|6|||
143304105|NCT04960228|516666287|FG000|Overall Study|Withdrawal by Subject|216|||
143304106|NCT04960228|516666288|FG001|Overall Study|Withdrawal by Subject|35|||
143304107|NCT04960228|516666287|FG000|Overall Study|Failed attention check|69|||
143304108|NCT04960228|516666288|FG001|Overall Study|Failed attention check|148|||
143304109|NCT04960228|516666287|FG000|Overall Study|Flagged for response quality by Dynata|3|||
143304110|NCT04960228|516666288|FG001|Overall Study|Flagged for response quality by Dynata|3|||
143304111|NCT01987427|516666289|FG000|Overall Study|Adverse Event|4|||
143304112|NCT01987427|516666290|FG001|Overall Study|Adverse Event|2|||
143304113|NCT01987427|516666291|FG002|Overall Study|Adverse Event|8|||
143304114|NCT01987427|516666289|FG000|Overall Study|Lost to Follow-up|6|||
143304115|NCT01987427|516666290|FG001|Overall Study|Lost to Follow-up|6|||
143304116|NCT01987427|516666291|FG002|Overall Study|Lost to Follow-up|9|||
143304117|NCT01987427|516666289|FG000|Overall Study|Withdrawal by Subject|2|||
143304118|NCT01987427|516666290|FG001|Overall Study|Withdrawal by Subject|1|||
143304119|NCT01987427|516666291|FG002|Overall Study|Withdrawal by Subject|3|||
143304120|NCT01987427|516666289|FG000|Overall Study|Lack of Efficacy|1|||
143304121|NCT01987427|516666290|FG001|Overall Study|Lack of Efficacy|0|||
143304122|NCT01987427|516666291|FG002|Overall Study|Lack of Efficacy|0|||
143304123|NCT01987427|516666289|FG000|Overall Study|Other|1|||
143304124|NCT01987427|516666290|FG001|Overall Study|Other|1|||
143304125|NCT01987427|516666291|FG002|Overall Study|Other|0|||
143304126|NCT02159521|516666292|FG000|Overall Study|Enrolled but not treated|3|||
143304127|NCT02159521|516666292|FG000|Overall Study|Withdrawal by Subject|7|||
143304128|NCT02159521|516666292|FG000|Overall Study|Lost to Follow-up|6|||
143304129|NCT02159521|516666292|FG000|Overall Study|Death|1|||
143304130|NCT02159521|516666292|FG000|Overall Study|Other than specified|1|||
143304131|NCT03131440|516666297|FG000|Overall Study|Withdrawal by Subject|1|||
143304132|NCT03131440|516666298|FG001|Overall Study|Withdrawal by Subject|3|||
143304133|NCT03131440|516666299|FG002|Overall Study|Withdrawal by Subject|0|||
143304134|NCT03131440|516666300|FG003|Overall Study|Withdrawal by Subject|0|||
143304135|NCT03131440|516666301|FG004|Overall Study|Withdrawal by Subject|1|||
143304136|NCT03131440|516666302|FG005|Overall Study|Withdrawal by Subject|0|||
143304137|NCT03131440|516666303|FG006|Overall Study|Withdrawal by Subject|0|||
143304138|NCT03131440|516666304|FG007|Overall Study|Withdrawal by Subject|1|||
143304139|NCT03131440|516666305|FG008|Overall Study|Withdrawal by Subject|1|||
143304140|NCT03131440|516666306|FG009|Overall Study|Withdrawal by Subject|1|||
143304141|NCT03131440|516666307|FG010|Overall Study|Withdrawal by Subject|0|||
143304142|NCT03131440|516666308|FG011|Overall Study|Withdrawal by Subject|1|||
143304143|NCT03131440|516666309|FG012|Overall Study|Withdrawal by Subject|1|||
143304144|NCT03131440|516666310|FG013|Overall Study|Withdrawal by Subject|0|||
143304145|NCT03131440|516666311|FG014|Overall Study|Withdrawal by Subject|1|||
143304146|NCT03131440|516666312|FG015|Overall Study|Withdrawal by Subject|0|||
143304147|NCT03131440|516666313|FG016|Overall Study|Withdrawal by Subject|0|||
143304148|NCT03131440|516666314|FG017|Overall Study|Withdrawal by Subject|0|||
143304149|NCT03131440|516666315|FG018|Overall Study|Withdrawal by Subject|1|||
143304150|NCT03131440|516666316|FG019|Overall Study|Withdrawal by Subject|0|||
143304151|NCT03131440|516666317|FG020|Overall Study|Withdrawal by Subject|1|||
143304152|NCT03131440|516666318|FG021|Overall Study|Withdrawal by Subject|1|||
143304153|NCT03131440|516666319|FG022|Overall Study|Withdrawal by Subject|1|||
143304154|NCT03131440|516666320|FG023|Overall Study|Withdrawal by Subject|0|||
143304155|NCT03131440|516666321|FG024|Overall Study|Withdrawal by Subject|0|||
143304156|NCT03131440|516666322|FG025|Overall Study|Withdrawal by Subject|0|||
143304157|NCT03131440|516666323|FG026|Overall Study|Withdrawal by Subject|0|||
143304158|NCT03131440|516666324|FG027|Overall Study|Withdrawal by Subject|0|||
143304159|NCT03131440|516666325|FG028|Overall Study|Withdrawal by Subject|0|||
143304160|NCT03131440|516666326|FG029|Overall Study|Withdrawal by Subject|0|||
143304161|NCT03131440|516666327|FG030|Overall Study|Withdrawal by Subject|1|||
143304162|NCT03131440|516666328|FG031|Overall Study|Withdrawal by Subject|0|||
143304163|NCT03131440|516666297|FG000|Overall Study|Lost to Follow-up|0|||
143304164|NCT03131440|516666298|FG001|Overall Study|Lost to Follow-up|0|||
143304165|NCT03131440|516666299|FG002|Overall Study|Lost to Follow-up|0|||
143304166|NCT03131440|516666300|FG003|Overall Study|Lost to Follow-up|0|||
143304167|NCT03131440|516666301|FG004|Overall Study|Lost to Follow-up|0|||
143304168|NCT03131440|516666302|FG005|Overall Study|Lost to Follow-up|1|||
143304169|NCT03131440|516666303|FG006|Overall Study|Lost to Follow-up|0|||
143304170|NCT03131440|516666304|FG007|Overall Study|Lost to Follow-up|0|||
143304171|NCT03131440|516666305|FG008|Overall Study|Lost to Follow-up|0|||
143304172|NCT03131440|516666306|FG009|Overall Study|Lost to Follow-up|0|||
143304173|NCT03131440|516666307|FG010|Overall Study|Lost to Follow-up|0|||
143304174|NCT03131440|516666308|FG011|Overall Study|Lost to Follow-up|0|||
143304175|NCT03131440|516666309|FG012|Overall Study|Lost to Follow-up|0|||
143304176|NCT03131440|516666310|FG013|Overall Study|Lost to Follow-up|0|||
143304177|NCT03131440|516666311|FG014|Overall Study|Lost to Follow-up|0|||
143304178|NCT03131440|516666312|FG015|Overall Study|Lost to Follow-up|0|||
143304179|NCT03131440|516666313|FG016|Overall Study|Lost to Follow-up|0|||
143304180|NCT03131440|516666314|FG017|Overall Study|Lost to Follow-up|0|||
143304181|NCT03131440|516666315|FG018|Overall Study|Lost to Follow-up|0|||
143304182|NCT03131440|516666316|FG019|Overall Study|Lost to Follow-up|2|||
143304183|NCT03131440|516666317|FG020|Overall Study|Lost to Follow-up|1|||
143304184|NCT03131440|516666318|FG021|Overall Study|Lost to Follow-up|0|||
143304185|NCT03131440|516666319|FG022|Overall Study|Lost to Follow-up|1|||
143304186|NCT03131440|516666320|FG023|Overall Study|Lost to Follow-up|0|||
143304187|NCT03131440|516666321|FG024|Overall Study|Lost to Follow-up|1|||
143304188|NCT03131440|516666322|FG025|Overall Study|Lost to Follow-up|0|||
143304189|NCT03131440|516666323|FG026|Overall Study|Lost to Follow-up|0|||
143304190|NCT03131440|516666324|FG027|Overall Study|Lost to Follow-up|2|||
143304191|NCT03131440|516666325|FG028|Overall Study|Lost to Follow-up|0|||
143304192|NCT03131440|516666326|FG029|Overall Study|Lost to Follow-up|2|||
143304193|NCT03131440|516666327|FG030|Overall Study|Lost to Follow-up|0|||
143304194|NCT03131440|516666328|FG031|Overall Study|Lost to Follow-up|0|||
143304195|NCT03131440|516666297|FG000|Overall Study|Death|0|||
143304196|NCT03131440|516666298|FG001|Overall Study|Death|0|||
143304197|NCT03131440|516666299|FG002|Overall Study|Death|0|||
143304198|NCT03131440|516666300|FG003|Overall Study|Death|0|||
143304199|NCT03131440|516666301|FG004|Overall Study|Death|0|||
143304200|NCT03131440|516666302|FG005|Overall Study|Death|0|||
143304201|NCT03131440|516666303|FG006|Overall Study|Death|0|||
143304202|NCT03131440|516666304|FG007|Overall Study|Death|0|||
143304203|NCT03131440|516666305|FG008|Overall Study|Death|0|||
143304204|NCT03131440|516666306|FG009|Overall Study|Death|0|||
143304205|NCT03131440|516666307|FG010|Overall Study|Death|0|||
143304206|NCT03131440|516666308|FG011|Overall Study|Death|0|||
143304207|NCT03131440|516666309|FG012|Overall Study|Death|0|||
143304208|NCT03131440|516666310|FG013|Overall Study|Death|0|||
143304209|NCT03131440|516666311|FG014|Overall Study|Death|0|||
143304210|NCT03131440|516666312|FG015|Overall Study|Death|0|||
143304211|NCT03131440|516666313|FG016|Overall Study|Death|0|||
143304212|NCT03131440|516666314|FG017|Overall Study|Death|0|||
143304213|NCT03131440|516666315|FG018|Overall Study|Death|0|||
143304214|NCT03131440|516666316|FG019|Overall Study|Death|0|||
143304215|NCT03131440|516666317|FG020|Overall Study|Death|0|||
143304216|NCT03131440|516666318|FG021|Overall Study|Death|0|||
143304217|NCT03131440|516666319|FG022|Overall Study|Death|0|||
143304218|NCT03131440|516666320|FG023|Overall Study|Death|0|||
143304219|NCT03131440|516666321|FG024|Overall Study|Death|0|||
143304220|NCT03131440|516666322|FG025|Overall Study|Death|1|||
143304221|NCT03131440|516666323|FG026|Overall Study|Death|0|||
143304222|NCT03131440|516666324|FG027|Overall Study|Death|0|||
143304223|NCT03131440|516666325|FG028|Overall Study|Death|0|||
143304224|NCT03131440|516666326|FG029|Overall Study|Death|0|||
143304225|NCT03131440|516666327|FG030|Overall Study|Death|0|||
143304226|NCT03131440|516666328|FG031|Overall Study|Death|0|||
143304227|NCT00746941|516666331|FG000|Overall Study|Death|2|||
143304228|NCT00746941|516666332|FG001|Overall Study|Death|0|||
143304229|NCT00746941|516666333|FG002|Overall Study|Death|0|||
143304230|NCT00746941|516666334|FG003|Overall Study|Death|6|||
143304231|NCT00746941|516666331|FG000|Overall Study|Physician Decision|0|||
143304232|NCT00746941|516666332|FG001|Overall Study|Physician Decision|0|||
143304233|NCT00746941|516666333|FG002|Overall Study|Physician Decision|2|||
143304234|NCT00746941|516666334|FG003|Overall Study|Physician Decision|0|||
143304235|NCT00746941|516666331|FG000|Overall Study|Withdrawal by Subject|3|||
143304236|NCT00746941|516666332|FG001|Overall Study|Withdrawal by Subject|0|||
143304237|NCT00746941|516666333|FG002|Overall Study|Withdrawal by Subject|0|||
143304238|NCT00746941|516666334|FG003|Overall Study|Withdrawal by Subject|2|||
143304239|NCT00746941|516666331|FG000|Overall Study|Other, reason not provided|2|||
143304240|NCT00746941|516666332|FG001|Overall Study|Other, reason not provided|4|||
143304241|NCT00746941|516666333|FG002|Overall Study|Other, reason not provided|0|||
143304242|NCT00746941|516666334|FG003|Overall Study|Other, reason not provided|4|||
143304243|NCT00746941|516666331|FG000|Overall Study|Adverse Event|0|||
143304244|NCT00746941|516666332|FG001|Overall Study|Adverse Event|0|||
143304245|NCT00746941|516666333|FG002|Overall Study|Adverse Event|0|||
143304246|NCT00746941|516666334|FG003|Overall Study|Adverse Event|1|||
143304247|NCT03316885|516666338|FG000|Overall Study|Adverse Event|1|||
143304248|NCT03316885|516666338|FG000|Overall Study|Death|10|||
143304249|NCT03316885|516666338|FG000|Overall Study|Lost to Follow-up|4|||
143304250|NCT03316885|516666338|FG000|Overall Study|Withdrawal by Subject|9|||
143304251|NCT03316885|516666338|FG000|Overall Study|COVID related|8|||
143304252|NCT02376166|516666341|FG000|Overall Study|Adverse Event|1|||
143304253|NCT02376166|516666341|FG000|Overall Study|Discontinued metformin early|2|||
143304254|NCT01640366|516666345|FG000|Overall Study|Withdrawal by Subject|1|||
143304255|NCT01640366|516666345|FG000|Overall Study|Protocol Violation|16|||
143304256|NCT01640366|516666345|FG000|Overall Study|Lost to Follow-up|5|||
143304257|NCT04251221|516666348|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
143304258|NCT04251221|516666349|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
143304259|NCT00329407|516666350|FG000|Overall Study|Withdrawal by Subject|1|||
143304260|NCT00978068|516666351|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
143304261|NCT00978068|516666352|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
143304262|NCT00978068|516666351|FG000|Overall Study|Death|1|||
143304263|NCT00978068|516666352|FG001|Overall Study|Death|2|||
143304264|NCT00978068|516666351|FG000|Overall Study|Lost to Follow-up|1|||
143304265|NCT00978068|516666352|FG001|Overall Study|Lost to Follow-up|2|||
143304266|NCT00978068|516666351|FG000|Overall Study|Physician Decision|0|||
143304267|NCT00978068|516666352|FG001|Overall Study|Physician Decision|1|||
143304268|NCT00978068|516666351|FG000|Overall Study|Unable to Comply with Study|0|||
143304269|NCT00978068|516666352|FG001|Overall Study|Unable to Comply with Study|2|||
143304270|NCT01712256|516666359|FG000|Overall Study|Lost to Follow-up|1|||
143304271|NCT00962104|516666360|FG000|Overall Study|Adverse Event|10|||
143304272|NCT00962104|516666361|FG001|Overall Study|Adverse Event|3|||
143304273|NCT00962104|516666360|FG000|Overall Study|Entry Criteria Not Met|1|||
143304274|NCT00962104|516666361|FG001|Overall Study|Entry Criteria Not Met|2|||
143304275|NCT00962104|516666360|FG000|Overall Study|Lack of Efficacy|0|||
143304276|NCT00962104|516666361|FG001|Overall Study|Lack of Efficacy|1|||
143304277|NCT00962104|516666360|FG000|Overall Study|Lost to Follow-up|10|||
143304278|NCT00962104|516666361|FG001|Overall Study|Lost to Follow-up|4|||
143304279|NCT00962104|516666360|FG000|Overall Study|Physician Decision|1|||
143304280|NCT00962104|516666361|FG001|Overall Study|Physician Decision|0|||
143304281|NCT00962104|516666360|FG000|Overall Study|Protocol Violation|6|||
143304282|NCT00962104|516666361|FG001|Overall Study|Protocol Violation|8|||
143304283|NCT00962104|516666360|FG000|Overall Study|Sponsor Decision|0|||
143304284|NCT00962104|516666361|FG001|Overall Study|Sponsor Decision|1|||
143304285|NCT00962104|516666360|FG000|Overall Study|Withdrawal by Subject|10|||
143304286|NCT00962104|516666361|FG001|Overall Study|Withdrawal by Subject|6|||
143304287|NCT00962104|516666360|FG000|Overall Study|Other|2|||
143304288|NCT00962104|516666361|FG001|Overall Study|Other|0|||
143304289|NCT02013167|516666362|FG000|Overall Study|Withdrawal by Subject|15|||
143304290|NCT02013167|516666363|FG001|Overall Study|Withdrawal by Subject|14|||
143304291|NCT02013167|516666362|FG000|Overall Study|Sponsor Decision|1|||
143304292|NCT02013167|516666363|FG001|Overall Study|Sponsor Decision|3|||
143304293|NCT02013167|516666362|FG000|Overall Study|Lost to Follow-up|0|||
143304294|NCT02013167|516666363|FG001|Overall Study|Lost to Follow-up|1|||
143304295|NCT02013167|516666362|FG000|Overall Study|Death|85|||
143304296|NCT02013167|516666363|FG001|Overall Study|Death|160|||
143304297|NCT00842348|516666364|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
143304298|NCT00842348|516666365|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
143304299|NCT00842348|516666364|FG000|Study 729|Disease progression/death|19|||
143304300|NCT00842348|516666365|FG001|Study 729|Disease progression/death|30|||
143304301|NCT00842348|516666364|FG000|Study 729|Adverse Event|1|||
143304302|NCT00842348|516666365|FG001|Study 729|Adverse Event|1|||
143304303|NCT00842348|516666364|FG000|Study 729|Protocol Violation|1|||
143304304|NCT00842348|516666365|FG001|Study 729|Protocol Violation|1|||
143304305|NCT00842348|516666364|FG000|Study 729|Withdrawal by Subject|2|||
143304306|NCT00842348|516666365|FG001|Study 729|Withdrawal by Subject|4|||
143304307|NCT00842348|516666364|FG000|Study 729|Due to Sponsor stopping the study|1|||
143304308|NCT00842348|516666365|FG001|Study 729|Due to Sponsor stopping the study|1|||
143304309|NCT00842348|516666364|FG000|Study 729|Due to non-availability of IP|0|||
143304310|NCT00842348|516666365|FG001|Study 729|Due to non-availability of IP|1|||
143304311|NCT00842348|516666364|FG000|Study 729|Sponsor's decision|1|||
143304312|NCT00842348|516666365|FG001|Study 729|Sponsor's decision|0|||
143304313|NCT00842348|516666364|FG000|Study 729|Surgical resection|1|||
143304314|NCT00842348|516666365|FG001|Study 729|Surgical resection|0|||
143304315|NCT00026793|516666368|FG000|Overall Study|Death on study due to underlying disease|4|||
143304316|NCT00026793|516666368|FG000|Overall Study|Physician Decision|2|||
143304317|NCT00026793|516666368|FG000|Overall Study|Off study|2|||
143304318|NCT04151290|516666370|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
143304319|NCT02276612|516666372|FG000|Overall Study|Death|1|||
143304320|NCT02276612|516666373|FG001|Overall Study|Death|0|||
143304321|NCT02276612|516666372|FG000|Overall Study|Pregnancy|1|||
143304322|NCT02276612|516666373|FG001|Overall Study|Pregnancy|0|||
143304323|NCT02276612|516666372|FG000|Overall Study|Withdrew Consent|1|||
143304324|NCT02276612|516666373|FG001|Overall Study|Withdrew Consent|0|||
143304325|NCT02276612|516666372|FG000|Overall Study|Lost to Follow-up|1|||
143304326|NCT02276612|516666373|FG001|Overall Study|Lost to Follow-up|0|||
143304327|NCT02196324|516666374|FG000|Overall Study|Withdrawal by Subject|8|||
143304328|NCT02196324|516666375|FG001|Overall Study|Withdrawal by Subject|4|||
143304329|NCT02196324|516666374|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
143304330|NCT02196324|516666375|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
143304331|NCT02196324|516666374|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
143304332|NCT02196324|516666375|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
143304333|NCT02196324|516666374|FG000|Overall Study|Other|1|||
143304334|NCT02196324|516666375|FG001|Overall Study|Other|0|||
143304335|NCT01380184|516666376|FG000|Part 1 (19 Days)|Adverse Event|1|||
143304336|NCT01380184|516666376|FG000|Part 2|Adverse Event|5|||
143304337|NCT01380184|516666376|FG000|Part 2|Disease Progression|8|||
143304338|NCT01380184|516666376|FG000|Part 2|Lost to Follow-up|1|||
143304339|NCT04243538|516666377|FG000|Overall Study|Withdrawal by Subject|0|||
143304340|NCT04243538|516666378|FG001|Overall Study|Withdrawal by Subject|2|||
143304341|NCT04243538|516666377|FG000|Overall Study|Lost to Follow-up|0|||
143304342|NCT04243538|516666378|FG001|Overall Study|Lost to Follow-up|3|||
143304343|NCT00655564|516666379|FG000|Overall Study|Adverse Event|1|||
143304344|NCT00655564|516666379|FG000|Overall Study|Lost to Follow-up|1|||
143304345|NCT00655564|516666379|FG000|Overall Study|Desired Alternate Therapy|1|||
143304346|NCT01077804|516666381|FG000|Overall Study|Unreachable|102|||
143304347|NCT01077804|516666381|FG000|Overall Study|Refused to continue|79|||
143304348|NCT01077804|516666381|FG000|Overall Study|Other|18|||
143304349|NCT02620046|516666382|FG000|Overall Study|Adverse Event|22|||
143304350|NCT02620046|516666383|FG001|Overall Study|Adverse Event|42|||
143304351|NCT02620046|516666382|FG000|Overall Study|Lost to Follow-up|4|||
143304352|NCT02620046|516666383|FG001|Overall Study|Lost to Follow-up|10|||
143304353|NCT02620046|516666382|FG000|Overall Study|Withdrawal by Subject|36|||
143304354|NCT02620046|516666383|FG001|Overall Study|Withdrawal by Subject|66|||
143304355|NCT02620046|516666382|FG000|Overall Study|Site Termination|3|||
143304356|NCT02620046|516666383|FG001|Overall Study|Site Termination|3|||
143304357|NCT02620046|516666382|FG000|Overall Study|Pregnancy|3|||
143304358|NCT02620046|516666383|FG001|Overall Study|Pregnancy|7|||
143304359|NCT02620046|516666382|FG000|Overall Study|Lack of Efficacy|81|||
143304360|NCT02620046|516666383|FG001|Overall Study|Lack of Efficacy|146|||
143304361|NCT02620046|516666382|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
143304362|NCT02620046|516666383|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
143304363|NCT02620046|516666382|FG000|Overall Study|Reason Not Specified|13|||
143304364|NCT02620046|516666383|FG001|Overall Study|Reason Not Specified|21|||
143304365|NCT02620046|516666382|FG000|Overall Study|Significant Protocol Deviation|0|||
143304366|NCT02620046|516666383|FG001|Overall Study|Significant Protocol Deviation|1|||
143304367|NCT00574405|516668021|FG000|Overall Study|Withdrawal by Subject|3|||
143304368|NCT00574405|516668022|FG001|Overall Study|Withdrawal by Subject|2|||
143304369|NCT04615949|516668028|FG000|Overall Study|Withdrawal by Subject|2|||
143304370|NCT04615949|516668029|FG001|Overall Study|Withdrawal by Subject|4|||
143304371|NCT04615949|516668028|FG000|Overall Study|Lost to Follow-up|2|||
143304372|NCT04615949|516668029|FG001|Overall Study|Lost to Follow-up|2|||
143304373|NCT04615949|516668028|FG000|Overall Study|Death|0|||
143304374|NCT04615949|516668029|FG001|Overall Study|Death|2|||
143304375|NCT03036566|516668030|FG000|Overall Study|Lost to Follow-up|3|||
143304376|NCT01852292|516668031|FG000|Overall Study|Untreated - did not receive study drug|3|||
143304377|NCT01852292|516668032|FG001|Overall Study|Untreated - did not receive study drug|1|||
143304378|NCT01852292|516668031|FG000|Overall Study|Death|9|||
143304379|NCT01852292|516668032|FG001|Overall Study|Death|8|||
143304380|NCT01852292|516668031|FG000|Overall Study|Patient/guardian decision|8|||
143304381|NCT01852292|516668032|FG001|Overall Study|Patient/guardian decision|4|||
143304382|NCT01852292|516668031|FG000|Overall Study|Adverse Event|8|||
143304383|NCT01852292|516668032|FG001|Overall Study|Adverse Event|11|||
143304384|NCT01852292|516668031|FG000|Overall Study|Physician Decision|6|||
143304385|NCT01852292|516668032|FG001|Overall Study|Physician Decision|2|||
143304386|NCT01852292|516668031|FG000|Overall Study|Protocol Violation|2|||
143304387|NCT01852292|516668032|FG001|Overall Study|Protocol Violation|0|||
143304388|NCT01852292|516668031|FG000|Overall Study|Non-compliance with study treatment|1|||
143304389|NCT01852292|516668032|FG001|Overall Study|Non-compliance with study treatment|0|||
143304390|NCT01852292|516668031|FG000|Overall Study|Study terminated by Sponsor|0|||
143304391|NCT01852292|516668032|FG001|Overall Study|Study terminated by Sponsor|1|||
143304392|NCT01852292|516668031|FG000|Overall Study|Progressive disease|42|||
143304393|NCT01852292|516668032|FG001|Overall Study|Progressive disease|52|||
143304394|NCT01572038|516668036|FG000|Overall Study|Death|648|||
143304395|NCT01572038|516668036|FG000|Overall Study|Withdrawal by Subject|204|||
143304396|NCT01572038|516668036|FG000|Overall Study|Lost to Follow-up|81|||
143304397|NCT01572038|516668036|FG000|Overall Study|Physician Decision|20|||
143304398|NCT01572038|516668036|FG000|Overall Study|Patient Decision|14|||
143304399|NCT01572038|516668036|FG000|Overall Study|Progressive Disease|8|||
143304400|NCT01572038|516668036|FG000|Overall Study|Site Closed Before Completing Form|6|||
143304401|NCT01572038|516668036|FG000|Overall Study|Enrolled into Another Trial|3|||
143304402|NCT01572038|516668036|FG000|Overall Study|Participated in Another Trial|3|||
143304403|NCT01572038|516668036|FG000|Overall Study|Termination by Sponsor|2|||
143304404|NCT01572038|516668036|FG000|Overall Study|Patient Deterioration|1|||
143304405|NCT01572038|516668036|FG000|Overall Study|Sponsor Decision|1|||
143304406|NCT04152447|516668037|FG000|Overall Study|Lost to Follow-up|1|||
143304407|NCT04152447|516668038|FG001|Overall Study|Lost to Follow-up|0|||
143304408|NCT04152447|516668037|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
143304409|NCT04152447|516668038|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
143304410|NCT04152447|516668037|FG000|Overall Study|Withdrawal by Subject|0|||
143304411|NCT04152447|516668038|FG001|Overall Study|Withdrawal by Subject|1|||
143304412|NCT04152447|516668037|FG000|Overall Study|Found ineligible after enrolling|1|||
143304413|NCT04152447|516668038|FG001|Overall Study|Found ineligible after enrolling|1|||
143304414|NCT04152447|516668037|FG000|Overall Study|Did not receive VR headset in time.|0|||
143304415|NCT04152447|516668038|FG001|Overall Study|Did not receive VR headset in time.|2|||
143304416|NCT03034954|516668047|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
143304417|NCT03034954|516668048|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
143304418|NCT01275066|516668055|FG000|Overall Study|Withdrawal by Subject|0|||
143304419|NCT01275066|516668056|FG001|Overall Study|Withdrawal by Subject|0|||
143304420|NCT01275066|516668057|FG002|Overall Study|Withdrawal by Subject|1|||
143304421|NCT01275066|516668055|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
143304422|NCT01275066|516668056|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
143304423|NCT01275066|516668057|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
143304424|NCT00394212|516668060|FG000|Overall Study|Lost to Follow-up|3|||
143304425|NCT00394212|516668061|FG001|Overall Study|Lost to Follow-up|0|||
143304426|NCT00394212|516668060|FG000|Overall Study|Withdrawal by Subject|4|||
143304427|NCT00394212|516668061|FG001|Overall Study|Withdrawal by Subject|1|||
143304428|NCT00588445|516668062|FG000|Overall Study|Protocol Violation|1|||
143304429|NCT00588445|516668062|FG000|Overall Study|Withdrawal by Subject|3|||
143304430|NCT00588445|516668062|FG000|Overall Study|Disease Progression|1|||
143304431|NCT00588445|516668062|FG000|Overall Study|Not Treated|10|||
143304432|NCT00116831|516668065|FG000|Overall Study|Adverse Event|14|||
143304433|NCT00116831|516668066|FG001|Overall Study|Adverse Event|16|||
143304434|NCT00116831|516668065|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
143304435|NCT00116831|516668066|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
143304436|NCT00116831|516668065|FG000|Overall Study|Lost to Follow-up|8|||
143304437|NCT00116831|516668066|FG001|Overall Study|Lost to Follow-up|6|||
143304438|NCT00116831|516668065|FG000|Overall Study|Protocol Violation|3|||
143304439|NCT00116831|516668066|FG001|Overall Study|Protocol Violation|6|||
143304440|NCT00116831|516668065|FG000|Overall Study|Hypoglycaemic events|1|||
143304441|NCT00116831|516668066|FG001|Overall Study|Hypoglycaemic events|0|||
143304442|NCT00116831|516668065|FG000|Overall Study|Low haemoglobin on screening|1|||
143304443|NCT00116831|516668066|FG001|Overall Study|Low haemoglobin on screening|0|||
143304444|NCT00116831|516668065|FG000|Overall Study|Withdrawn investigational product|1|||
143304445|NCT00116831|516668066|FG001|Overall Study|Withdrawn investigational product|0|||
143304446|NCT00116831|516668065|FG000|Overall Study|Withdrawal by Subject|32|||
143304447|NCT00116831|516668066|FG001|Overall Study|Withdrawal by Subject|32|||
143304448|NCT00116831|516668065|FG000|Overall Study|Insufficient therapeutic effect|0|||
143304449|NCT00116831|516668066|FG001|Overall Study|Insufficient therapeutic effect|1|||
143304450|NCT00116831|516668065|FG000|Overall Study|Missing data for participant|1|||
143304451|NCT00116831|516668066|FG001|Overall Study|Missing data for participant|0|||
143304452|NCT02945410|516668067|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
143304453|NCT02945410|516668068|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
143304454|NCT02945410|516668069|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
143304455|NCT02945410|516668070|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
143304456|NCT02945410|516668071|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
143304457|NCT02945410|516668072|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
143304458|NCT02945410|516668067|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
143304459|NCT02945410|516668068|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
143304460|NCT02945410|516668069|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
143304461|NCT02945410|516668070|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
143304462|NCT02945410|516668071|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
143304463|NCT02945410|516668072|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
143304464|NCT02945410|516668067|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
143304465|NCT02945410|516668068|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
143304466|NCT02945410|516668069|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
143304467|NCT02945410|516668070|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
143304468|NCT02945410|516668071|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
143304469|NCT02945410|516668072|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
143304470|NCT04904185|516668073|FG000|Overall Study|Expansion failure|1|||
143304471|NCT04904185|516668074|FG001|Overall Study|Expansion failure|0|||
143304472|NCT04904185|516668073|FG000|Overall Study|Late response on prior treatment|1|||
143304473|NCT04904185|516668074|FG001|Overall Study|Late response on prior treatment|0|||
143304474|NCT00110812|516668077|FG000|Main Study|Death|0|||
143304475|NCT00110812|516668078|FG001|Main Study|Death|0|||
143304476|NCT00110812|516668079|FG002|Main Study|Death|2|||
143304477|NCT00110812|516668077|FG000|Main Study|Withdrawal by Subject|0|||
143304478|NCT00110812|516668078|FG001|Main Study|Withdrawal by Subject|0|||
143304479|NCT00110812|516668079|FG002|Main Study|Withdrawal by Subject|1|||
143304480|NCT00110812|516668077|FG000|Main Study|Lost to Follow-up|8|||
143304481|NCT00110812|516668078|FG001|Main Study|Lost to Follow-up|11|||
143304482|NCT00110812|516668079|FG002|Main Study|Lost to Follow-up|10|||
143304483|NCT00110812|516668077|FG000|Extended Follow-up|Death|1|||
143304484|NCT00110812|516668078|FG001|Extended Follow-up|Death|0|||
143304485|NCT00110812|516668079|FG002|Extended Follow-up|Death|3|||
143304486|NCT00110812|516668077|FG000|Extended Follow-up|Withdrawal by Subject|0|||
143304487|NCT00110812|516668078|FG001|Extended Follow-up|Withdrawal by Subject|1|||
143304488|NCT00110812|516668079|FG002|Extended Follow-up|Withdrawal by Subject|0|||
143304489|NCT00110812|516668077|FG000|Extended Follow-up|Lost to Follow-up|1|||
143304490|NCT00110812|516668078|FG001|Extended Follow-up|Lost to Follow-up|3|||
143304491|NCT00110812|516668079|FG002|Extended Follow-up|Lost to Follow-up|1|||
143304492|NCT01344369|516668080|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
143304493|NCT01344369|516668081|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
143304494|NCT01344369|516668080|FG000|Washout of 28 Days|Physician Decision|0|||
143304495|NCT01344369|516668081|FG001|Washout of 28 Days|Physician Decision|1|||
143304496|NCT01344369|516668080|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
143304497|NCT01344369|516668081|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
143304498|NCT02342704|516668084|FG000|Overall Study|Physician Decision|0|||
143304499|NCT02342704|516668085|FG001|Overall Study|Physician Decision|3|||
143304500|NCT02342704|516668084|FG000|Overall Study|Sponsor Termination|49|||
143304501|NCT02342704|516668085|FG001|Overall Study|Sponsor Termination|43|||
143304502|NCT02342704|516668084|FG000|Overall Study|Other|0|||
143304503|NCT02342704|516668085|FG001|Overall Study|Other|1|||
143304504|NCT02342704|516668084|FG000|Overall Study|Withdrawal by Subject|1|||
143304505|NCT02342704|516668085|FG001|Overall Study|Withdrawal by Subject|0|||
143304506|NCT02342704|516668084|FG000|Overall Study|Lost to Follow-up|2|||
143304507|NCT02342704|516668085|FG001|Overall Study|Lost to Follow-up|1|||
143304508|NCT02342704|516668084|FG000|Overall Study|Adverse Event|1|||
143304509|NCT02342704|516668085|FG001|Overall Study|Adverse Event|3|||
143304510|NCT03100825|516668086|FG000|Overall Study|Participant/Guardian Decision|7|||
143304511|NCT03100825|516668086|FG000|Overall Study|Physician Decision|1|||
143304512|NCT00735371|516668089|FG000|Overall Study|Adverse Event|3|||
143304513|NCT00735371|516668090|FG001|Overall Study|Adverse Event|3|||
143304514|NCT00735371|516668091|FG002|Overall Study|Adverse Event|4|||
143304515|NCT00735371|516668092|FG003|Overall Study|Adverse Event|1|||
143304516|NCT00735371|516668089|FG000|Overall Study|Protocol Violation|2|||
143304517|NCT00735371|516668090|FG001|Overall Study|Protocol Violation|2|||
143304518|NCT00735371|516668091|FG002|Overall Study|Protocol Violation|0|||
143304519|NCT00735371|516668092|FG003|Overall Study|Protocol Violation|3|||
143304520|NCT00735371|516668089|FG000|Overall Study|Withdrawal by Subject|0|||
143304521|NCT00735371|516668090|FG001|Overall Study|Withdrawal by Subject|2|||
143304522|NCT00735371|516668091|FG002|Overall Study|Withdrawal by Subject|2|||
143304523|NCT00735371|516668092|FG003|Overall Study|Withdrawal by Subject|0|||
143304524|NCT00735371|516668089|FG000|Overall Study|Lost to Follow-up|1|||
143304525|NCT00735371|516668090|FG001|Overall Study|Lost to Follow-up|1|||
143304526|NCT00735371|516668091|FG002|Overall Study|Lost to Follow-up|3|||
143304527|NCT00735371|516668092|FG003|Overall Study|Lost to Follow-up|1|||
143304528|NCT00735371|516668089|FG000|Overall Study|Lack of Efficacy|4|||
143304529|NCT00735371|516668090|FG001|Overall Study|Lack of Efficacy|2|||
143304530|NCT00735371|516668091|FG002|Overall Study|Lack of Efficacy|0|||
143304531|NCT00735371|516668092|FG003|Overall Study|Lack of Efficacy|4|||
143304532|NCT00735371|516668089|FG000|Overall Study|Sponsor Decision|3|||
143304533|NCT00735371|516668090|FG001|Overall Study|Sponsor Decision|1|||
143304534|NCT00735371|516668091|FG002|Overall Study|Sponsor Decision|0|||
143304535|NCT00735371|516668092|FG003|Overall Study|Sponsor Decision|1|||
143304536|NCT00735371|516668089|FG000|Overall Study|Protocol Violation|0|||
143304537|NCT00735371|516668090|FG001|Overall Study|Protocol Violation|1|||
143304538|NCT00735371|516668091|FG002|Overall Study|Protocol Violation|2|||
143304539|NCT00735371|516668092|FG003|Overall Study|Protocol Violation|0|||
143304540|NCT00735371|516668089|FG000|Overall Study|Prior Vyvanse Exposure|1|||
143304541|NCT00735371|516668090|FG001|Overall Study|Prior Vyvanse Exposure|1|||
143304542|NCT00735371|516668091|FG002|Overall Study|Prior Vyvanse Exposure|0|||
143304543|NCT00735371|516668092|FG003|Overall Study|Prior Vyvanse Exposure|0|||
143304544|NCT00735371|516668089|FG000|Overall Study|Exclusion criteria|1|||
143304545|NCT00735371|516668090|FG001|Overall Study|Exclusion criteria|0|||
143304546|NCT00735371|516668091|FG002|Overall Study|Exclusion criteria|0|||
143304547|NCT00735371|516668092|FG003|Overall Study|Exclusion criteria|0|||
143304548|NCT01604343|516668095|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
143304549|NCT01604343|516668096|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
143304550|NCT01604343|516668097|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
143304551|NCT01604343|516668098|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
143304552|NCT01604343|516668099|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
143304553|NCT01604343|516668095|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
143304554|NCT01604343|516668096|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
143304555|NCT01604343|516668097|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
143304556|NCT01604343|516668098|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
143304557|NCT01604343|516668099|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
143304558|NCT01604343|516668095|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
143304559|NCT01604343|516668096|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
143304560|NCT01604343|516668097|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
143304561|NCT01604343|516668098|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
143304562|NCT01604343|516668099|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
143304563|NCT01604343|516668095|FG000|Prior to W52 Administration(Through W52)|Death|5|||
143304564|NCT01604343|516668096|FG001|Prior to W52 Administration(Through W52)|Death|0|||
143304565|NCT01604343|516668097|FG002|Prior to W52 Administration(Through W52)|Death|2|||
143304566|NCT01604343|516668098|FG003|Prior to W52 Administration(Through W52)|Death|0|||
143304567|NCT01604343|516668099|FG004|Prior to W52 Administration(Through W52)|Death|4|||
143304568|NCT01604343|516668095|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
143304569|NCT01604343|516668096|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
143304570|NCT01604343|516668097|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
143304571|NCT01604343|516668098|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
143304572|NCT01604343|516668099|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
143304573|NCT01604343|516668095|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
143304574|NCT01604343|516668096|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
143304575|NCT01604343|516668097|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
143304576|NCT01604343|516668098|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
143304577|NCT01604343|516668099|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
143304578|NCT01604343|516668095|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
143304579|NCT01604343|516668096|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
143304580|NCT01604343|516668097|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
143304581|NCT01604343|516668098|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
143304582|NCT01604343|516668099|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
143304583|NCT01604343|516668095|FG000|Prior to W52 Administration(Through W52)|Other|15|||
143304584|NCT01604343|516668096|FG001|Prior to W52 Administration(Through W52)|Other|0|||
143304585|NCT01604343|516668097|FG002|Prior to W52 Administration(Through W52)|Other|10|||
143304586|NCT01604343|516668098|FG003|Prior to W52 Administration(Through W52)|Other|0|||
143304587|NCT01604343|516668099|FG004|Prior to W52 Administration(Through W52)|Other|6|||
143304588|NCT01604343|516668095|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
143304589|NCT01604343|516668096|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
143304590|NCT01604343|516668097|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
143304591|NCT01604343|516668098|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
143304592|NCT01604343|516668099|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
143304593|NCT01604343|516668095|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
143304594|NCT01604343|516668096|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
143304595|NCT01604343|516668097|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
143304596|NCT01604343|516668098|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
143304597|NCT01604343|516668099|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
143304598|NCT01604343|516668095|FG000|Week 52 to Week 104|Adverse Event|0|||
143304599|NCT01604343|516668096|FG001|Week 52 to Week 104|Adverse Event|12|||
143304600|NCT01604343|516668097|FG002|Week 52 to Week 104|Adverse Event|26|||
143304601|NCT01604343|516668098|FG003|Week 52 to Week 104|Adverse Event|21|||
143304602|NCT01604343|516668099|FG004|Week 52 to Week 104|Adverse Event|27|||
143304603|NCT01604343|516668095|FG000|Week 52 to Week 104|Death|0|||
143304604|NCT01604343|516668096|FG001|Week 52 to Week 104|Death|4|||
143304605|NCT01604343|516668097|FG002|Week 52 to Week 104|Death|2|||
143304606|NCT01604343|516668098|FG003|Week 52 to Week 104|Death|5|||
143304607|NCT01604343|516668099|FG004|Week 52 to Week 104|Death|0|||
143304608|NCT01604343|516668095|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
143304609|NCT01604343|516668096|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
143304610|NCT01604343|516668097|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
143304611|NCT01604343|516668098|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
143304612|NCT01604343|516668099|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
143304613|NCT01604343|516668095|FG000|Week 52 to Week 104|Physician Decision|0|||
143304614|NCT01604343|516668096|FG001|Week 52 to Week 104|Physician Decision|1|||
143304615|NCT01604343|516668097|FG002|Week 52 to Week 104|Physician Decision|0|||
143304616|NCT01604343|516668098|FG003|Week 52 to Week 104|Physician Decision|0|||
143304617|NCT01604343|516668099|FG004|Week 52 to Week 104|Physician Decision|2|||
143304618|NCT01604343|516668095|FG000|Week 52 to Week 104|Pregnancy|0|||
143304619|NCT01604343|516668096|FG001|Week 52 to Week 104|Pregnancy|0|||
143304620|NCT01604343|516668097|FG002|Week 52 to Week 104|Pregnancy|1|||
143304621|NCT01604343|516668098|FG003|Week 52 to Week 104|Pregnancy|2|||
143304622|NCT01604343|516668099|FG004|Week 52 to Week 104|Pregnancy|1|||
143304623|NCT01604343|516668095|FG000|Week 52 to Week 104|Other|0|||
143304624|NCT01604343|516668096|FG001|Week 52 to Week 104|Other|11|||
143304625|NCT01604343|516668097|FG002|Week 52 to Week 104|Other|11|||
143304626|NCT01604343|516668098|FG003|Week 52 to Week 104|Other|6|||
143304627|NCT01604343|516668099|FG004|Week 52 to Week 104|Other|3|||
143304628|NCT01604343|516668095|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
143304629|NCT01604343|516668096|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
143304630|NCT01604343|516668097|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
143304631|NCT01604343|516668098|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
143304632|NCT01604343|516668099|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
143304633|NCT01604343|516668095|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
143304634|NCT01604343|516668096|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
143304635|NCT01604343|516668097|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
143304636|NCT01604343|516668098|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
143304637|NCT01604343|516668099|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
143304638|NCT01604343|516668095|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
143304639|NCT01604343|516668096|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
143304640|NCT01604343|516668097|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
143304641|NCT01604343|516668098|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
143304642|NCT01604343|516668099|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
143304643|NCT00436748|516668102|FG000|Overall Study|Ineligibility Determined|1|||
143304644|NCT00436748|516668103|FG001|Overall Study|Ineligibility Determined|1|||
143304645|NCT00436748|516668102|FG000|Overall Study|Adverse Event|0|||
143304646|NCT00436748|516668103|FG001|Overall Study|Adverse Event|2|||
143304647|NCT00436748|516668102|FG000|Overall Study|Consent Withdrawn|1|||
143304648|NCT00436748|516668103|FG001|Overall Study|Consent Withdrawn|4|||
143304649|NCT00436748|516668102|FG000|Overall Study|Administrative Decision|1|||
143304650|NCT00436748|516668103|FG001|Overall Study|Administrative Decision|0|||
143304651|NCT00436748|516668102|FG000|Overall Study|Lost to Follow-up|0|||
143304652|NCT00436748|516668103|FG001|Overall Study|Lost to Follow-up|1|||
143304653|NCT00436748|516668102|FG000|Overall Study|Protocol-specified Criteria|5|||
143304654|NCT00436748|516668103|FG001|Overall Study|Protocol-specified Criteria|4|||
143304655|NCT00436748|516668102|FG000|Overall Study|Other|3|||
143304656|NCT00436748|516668103|FG001|Overall Study|Other|0|||
143304657|NCT01610791|516668104|FG000|Overall Study|Lost to Follow-up|7|||
143304658|NCT01610791|516668104|FG000|Overall Study|Adverse Event|6|||
143304659|NCT01610791|516668104|FG000|Overall Study|Physician Decision|1|||
143304660|NCT01610791|516668104|FG000|Overall Study|Adverse event and Investigator decision|1|||
143304661|NCT01610791|516668104|FG000|Overall Study|Death|1|||
143304662|NCT01610791|516668104|FG000|Overall Study|Not determined|5|||
143304663|NCT00578175|516668108|FG000|Overall Study|Adverse Event|0|||
143304664|NCT00578175|516668109|FG001|Overall Study|Adverse Event|1|||
143304665|NCT00578175|516668110|FG002|Overall Study|Adverse Event|1|||
143304666|NCT00578175|516668108|FG000|Overall Study|Other reasons|70|||
143304667|NCT00578175|516668109|FG001|Overall Study|Other reasons|42|||
143304668|NCT00578175|516668110|FG002|Overall Study|Other reasons|23|||
143304669|NCT01203072|516668114|FG000|Overall Study|Adverse Event|5|||
143304670|NCT01203072|516668115|FG001|Overall Study|Adverse Event|3|||
143304671|NCT01203072|516668116|FG002|Overall Study|Adverse Event|2|||
143304672|NCT01203072|516668117|FG003|Overall Study|Adverse Event|4|||
143304673|NCT01203072|516668118|FG004|Overall Study|Adverse Event|2|||
143304674|NCT01203072|516668114|FG000|Overall Study|Lack of Efficacy|1|||
143304675|NCT01203072|516668115|FG001|Overall Study|Lack of Efficacy|0|||
143304676|NCT01203072|516668116|FG002|Overall Study|Lack of Efficacy|0|||
143304677|NCT01203072|516668117|FG003|Overall Study|Lack of Efficacy|0|||
143304678|NCT01203072|516668118|FG004|Overall Study|Lack of Efficacy|0|||
143304679|NCT01203072|516668114|FG000|Overall Study|Lost to Follow-up|0|||
143304680|NCT01203072|516668115|FG001|Overall Study|Lost to Follow-up|1|||
143304681|NCT01203072|516668116|FG002|Overall Study|Lost to Follow-up|0|||
143304682|NCT01203072|516668117|FG003|Overall Study|Lost to Follow-up|0|||
143304683|NCT01203072|516668118|FG004|Overall Study|Lost to Follow-up|0|||
143304684|NCT01203072|516668114|FG000|Overall Study|Protocol Violation|2|||
143304685|NCT01203072|516668115|FG001|Overall Study|Protocol Violation|0|||
143304686|NCT01203072|516668116|FG002|Overall Study|Protocol Violation|0|||
143304687|NCT01203072|516668117|FG003|Overall Study|Protocol Violation|0|||
143304688|NCT01203072|516668118|FG004|Overall Study|Protocol Violation|1|||
143304689|NCT01203072|516668114|FG000|Overall Study|Withdrawal by Subject|2|||
143304690|NCT01203072|516668115|FG001|Overall Study|Withdrawal by Subject|2|||
143304691|NCT01203072|516668116|FG002|Overall Study|Withdrawal by Subject|1|||
143304692|NCT01203072|516668117|FG003|Overall Study|Withdrawal by Subject|2|||
143304693|NCT01203072|516668118|FG004|Overall Study|Withdrawal by Subject|3|||
143304694|NCT02272413|516668119|FG000|Randomized Through Treatment Start|Not treated|3|||
143304695|NCT02272413|516668120|FG001|Randomized Through Treatment Start|Not treated|5|||
143304696|NCT02272413|516668119|FG000|Pre-switch Period|Adverse Event|38|||
143304697|NCT02272413|516668120|FG001|Pre-switch Period|Adverse Event|37|||
143304698|NCT02272413|516668119|FG000|Pre-switch Period|Death|26|||
143375085|NCT00723450|516918951|FG000|Randomized Phase|Protocol Violation|0|||
143375086|NCT00723450|516918952|FG001|Randomized Phase|Protocol Violation|9|||
143375087|NCT00723450|516918953|FG002|Randomized Phase|Protocol Violation|13|||
143375088|NCT00723450|516918951|FG000|Randomized Phase|Lost to Follow-up|0|||
143375089|NCT00723450|516918952|FG001|Randomized Phase|Lost to Follow-up|2|||
143375090|NCT00723450|516918953|FG002|Randomized Phase|Lost to Follow-up|3|||
143375091|NCT00723450|516918951|FG000|Randomized Phase|Physician Decision|0|||
143375092|NCT00723450|516918952|FG001|Randomized Phase|Physician Decision|3|||
143375093|NCT00723450|516918953|FG002|Randomized Phase|Physician Decision|1|||
143375094|NCT00723450|516918951|FG000|Randomized Phase|Withdrawal by Subject|0|||
143375095|NCT00723450|516918952|FG001|Randomized Phase|Withdrawal by Subject|14|||
143375096|NCT00723450|516918953|FG002|Randomized Phase|Withdrawal by Subject|22|||
143375097|NCT03299816|516918954|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
143375098|NCT03299816|516918955|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
143375099|NCT03299816|516918954|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
143375100|NCT03299816|516918955|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
143375101|NCT03299816|516918954|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
143375102|NCT03299816|516918955|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
143375103|NCT00367991|516918956|FG000|Overall Study|Withdrawal by Subject|1|||
143375104|NCT00367991|516918957|FG001|Overall Study|Withdrawal by Subject|1|||
143375105|NCT00367991|516918956|FG000|Overall Study|Adverse Event|1|||
143375106|NCT00367991|516918957|FG001|Overall Study|Adverse Event|1|||
143375107|NCT02969863|516918967|FG000|Overall Study|Physician Decision|1|||
143375108|NCT02969863|516918968|FG001|Overall Study|Physician Decision|0|||
143375109|NCT02969863|516918969|FG002|Overall Study|Physician Decision|0|||
143375110|NCT02969863|516918970|FG003|Overall Study|Physician Decision|0|||
143375111|NCT02969863|516918971|FG004|Overall Study|Physician Decision|0|||
143304699|NCT02272413|516668120|FG001|Pre-switch Period|Death|26|||
143304700|NCT02272413|516668119|FG000|Pre-switch Period|Withdrawal by Subject|27|||
143304701|NCT02272413|516668120|FG001|Pre-switch Period|Withdrawal by Subject|15|||
143304702|NCT02272413|516668119|FG000|Pre-switch Period|Physician Decision|6|||
143304703|NCT02272413|516668120|FG001|Pre-switch Period|Physician Decision|18|||
143304704|NCT02272413|516668119|FG000|Pre-switch Period|Progressive disease|185|||
143304705|NCT02272413|516668120|FG001|Pre-switch Period|Progressive disease|173|||
143304706|NCT02272413|516668119|FG000|Pre-switch Period|Lost to Follow-up|0|||
143304707|NCT02272413|516668120|FG001|Pre-switch Period|Lost to Follow-up|2|||
143304708|NCT02272413|516668119|FG000|Pre-switch Period|Protocol Violation|1|||
143304709|NCT02272413|516668120|FG001|Pre-switch Period|Protocol Violation|0|||
143304710|NCT02272413|516668119|FG000|Pre-switch Period|Other than listed|10|||
143304711|NCT02272413|516668120|FG001|Pre-switch Period|Other than listed|11|||
143304712|NCT02272413|516668119|FG000|Post-switch Period|Adverse Event|4|||
143304713|NCT02272413|516668120|FG001|Post-switch Period|Adverse Event|4|||
143304714|NCT02272413|516668119|FG000|Post-switch Period|Death|3|||
143304715|NCT02272413|516668120|FG001|Post-switch Period|Death|2|||
143304716|NCT02272413|516668119|FG000|Post-switch Period|Withdrawal by Subject|1|||
143304717|NCT02272413|516668120|FG001|Post-switch Period|Withdrawal by Subject|2|||
143304718|NCT02272413|516668119|FG000|Post-switch Period|Physician Decision|1|||
143304719|NCT02272413|516668120|FG001|Post-switch Period|Physician Decision|1|||
143304720|NCT02272413|516668119|FG000|Post-switch Period|Progressive disease|21|||
143304721|NCT02272413|516668120|FG001|Post-switch Period|Progressive disease|21|||
143304722|NCT02272413|516668119|FG000|Post-switch Period|Study terminated by sponsor|8|||
143304723|NCT02272413|516668120|FG001|Post-switch Period|Study terminated by sponsor|11|||
143304724|NCT02272413|516668119|FG000|Post-switch Period|Other than listed|4|||
143304725|NCT02272413|516668120|FG001|Post-switch Period|Other than listed|5|||
143304726|NCT02286193|516668121|FG000|Overall Study|Referred: CRS unable to make contact|62|||
143304727|NCT02286193|516668121|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
143304728|NCT02286193|516668121|FG000|Overall Study|Referred: Declined service|38|||
143304729|NCT01446965|516668122|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
143304730|NCT01446965|516668123|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
143304731|NCT01446965|516668122|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
143304732|NCT01446965|516668123|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
143304733|NCT02871375|516668124|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
143304734|NCT02871375|516668125|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
143304735|NCT01988571|516668126|FG000|Overall Study|Death|3|||
143304736|NCT01988571|516668127|FG001|Overall Study|Death|1|||
143304737|NCT01988571|516668126|FG000|Overall Study|Physician Decision|2|||
143304738|NCT01988571|516668127|FG001|Overall Study|Physician Decision|1|||
143304739|NCT01988571|516668126|FG000|Overall Study|Lost to Follow-up|3|||
143304740|NCT01988571|516668127|FG001|Overall Study|Lost to Follow-up|0|||
143304741|NCT01988571|516668126|FG000|Overall Study|Withdrawal by Subject|31|||
143304742|NCT01988571|516668127|FG001|Overall Study|Withdrawal by Subject|33|||
143304743|NCT01417481|516668128|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
143304744|NCT01417481|516668129|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
143304745|NCT00829296|516668130|FG000|Overall Study|Adverse Event|5|||
143304746|NCT00829296|516668131|FG001|Overall Study|Adverse Event|4|||
143304747|NCT03029624|516668132|FG000|Overall Study|Adverse Event|1|||
143304748|NCT03029624|516668132|FG000|Overall Study|Withdrawal by Subject|1|||
143304749|NCT03029624|516668132|FG000|Overall Study|Lack of Efficacy|1|||
143304750|NCT03029624|516668132|FG000|Overall Study|MRI need|2|||
143304751|NCT00694369|516668135|FG000|Overall Study|Adverse Event|0|||
143304752|NCT00694369|516668136|FG001|Overall Study|Adverse Event|1|||
143304753|NCT00694369|516668137|FG002|Overall Study|Adverse Event|0|||
143304754|NCT00694369|516668138|FG003|Overall Study|Adverse Event|1|||
143304755|NCT00694369|516668139|FG004|Overall Study|Adverse Event|3|||
143304756|NCT00694369|516668135|FG000|Overall Study|Lost to Follow-up|0|||
143304757|NCT00694369|516668136|FG001|Overall Study|Lost to Follow-up|0|||
143304758|NCT00694369|516668137|FG002|Overall Study|Lost to Follow-up|1|||
143304759|NCT00694369|516668138|FG003|Overall Study|Lost to Follow-up|1|||
143304760|NCT00694369|516668139|FG004|Overall Study|Lost to Follow-up|0|||
143304761|NCT00694369|516668135|FG000|Overall Study|Physician Decision|0|||
143304762|NCT00694369|516668136|FG001|Overall Study|Physician Decision|0|||
143304763|NCT00694369|516668137|FG002|Overall Study|Physician Decision|0|||
143304764|NCT00694369|516668138|FG003|Overall Study|Physician Decision|0|||
143304765|NCT00694369|516668139|FG004|Overall Study|Physician Decision|1|||
143304766|NCT00694369|516668135|FG000|Overall Study|Protocol Violation|0|||
143304767|NCT00694369|516668136|FG001|Overall Study|Protocol Violation|1|||
143304768|NCT00694369|516668137|FG002|Overall Study|Protocol Violation|0|||
143304769|NCT00694369|516668138|FG003|Overall Study|Protocol Violation|0|||
143304770|NCT00694369|516668139|FG004|Overall Study|Protocol Violation|0|||
143304771|NCT00694369|516668135|FG000|Overall Study|Withdrawal by Subject|1|||
143304772|NCT00694369|516668136|FG001|Overall Study|Withdrawal by Subject|1|||
143304773|NCT00694369|516668137|FG002|Overall Study|Withdrawal by Subject|1|||
143304774|NCT00694369|516668138|FG003|Overall Study|Withdrawal by Subject|1|||
143304775|NCT00694369|516668139|FG004|Overall Study|Withdrawal by Subject|2|||
143304776|NCT00907374|516668148|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
143304777|NCT00907374|516668149|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
143304778|NCT00785486|516668150|FG000|Midazolam Alone|Withdrawal by Subject|1|||
143304779|NCT01183975|516668151|FG000|Overall Study|Lost to Follow-up|73|||
143304780|NCT00811577|516668154|FG000|Overall Study|Lost to Follow-up|7|||
143304781|NCT00811577|516668155|FG001|Overall Study|Lost to Follow-up|1|||
143304782|NCT00811577|516668154|FG000|Overall Study|Withdrawal by Subject|3|||
143304783|NCT00811577|516668155|FG001|Overall Study|Withdrawal by Subject|0|||
143304784|NCT01644175|516668158|FG000|Overall Study|Randomized But Not Treated|0|||
143304785|NCT01644175|516668159|FG001|Overall Study|Randomized But Not Treated|2|||
143304786|NCT01644175|516668158|FG000|Overall Study|Adverse Event|8|||
143304787|NCT01644175|516668159|FG001|Overall Study|Adverse Event|13|||
143304788|NCT01644175|516668158|FG000|Overall Study|Death|1|||
143304789|NCT01644175|516668159|FG001|Overall Study|Death|2|||
143304790|NCT01644175|516668158|FG000|Overall Study|Poor compliance to protocol|9|||
143304791|NCT01644175|516668159|FG001|Overall Study|Poor compliance to protocol|10|||
143304792|NCT01644175|516668158|FG000|Overall Study|Physician Decision|1|||
143304793|NCT01644175|516668159|FG001|Overall Study|Physician Decision|2|||
143304794|NCT01644175|516668158|FG000|Overall Study|Participant Moved|1|||
143304795|NCT01644175|516668159|FG001|Overall Study|Participant Moved|2|||
143304796|NCT01644175|516668158|FG000|Overall Study|Consent withdrawn by participant|3|||
143304797|NCT01644175|516668159|FG001|Overall Study|Consent withdrawn by participant|4|||
143304798|NCT01644175|516668158|FG000|Overall Study|Related to Autoinjector Administration|2|||
143304799|NCT01644175|516668159|FG001|Overall Study|Related to Autoinjector Administration|1|||
143304800|NCT01644175|516668158|FG000|Overall Study|Last visit outside protocol visit window|4|||
143304801|NCT01644175|516668159|FG001|Overall Study|Last visit outside protocol visit window|11|||
143304802|NCT01644175|516668158|FG000|Overall Study|Selection criteria finally not met|0|||
143304803|NCT01644175|516668159|FG001|Overall Study|Selection criteria finally not met|1|||
143304804|NCT01644175|516668158|FG000|Overall Study|Site closure|2|||
143304805|NCT01644175|516668159|FG001|Overall Study|Site closure|2|||
143304806|NCT01644175|516668158|FG000|Overall Study|Lost to Follow-up|1|||
143304807|NCT01644175|516668159|FG001|Overall Study|Lost to Follow-up|0|||
143304808|NCT01644175|516668158|FG000|Overall Study|Other than specified above|0|||
143304809|NCT01644175|516668159|FG001|Overall Study|Other than specified above|3|||
143304810|NCT02818777|516668163|FG000|Overall Study|Adverse Event|3|||
143304811|NCT00856908|516668183|FG000|Overall Study|Lost to Follow-up|1|||
143304812|NCT00856908|516668184|FG001|Overall Study|Lost to Follow-up|0|||
143304813|NCT00344773|516668188|FG000|Overall Study|Adverse Event|2|||
143304814|NCT00344773|516668188|FG000|Overall Study|Objective Disease Progression|16|||
143304815|NCT00344773|516668188|FG000|Overall Study|Withdrawal by Subject|1|||
143304816|NCT00344773|516668188|FG000|Overall Study|Not Eligible for the study|2|||
143304817|NCT00244712|516668189|FG000|Overall Study|Adverse Event|20|||
143304818|NCT00244712|516668190|FG001|Overall Study|Adverse Event|21|||
143304819|NCT00244712|516668189|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
143304820|NCT00244712|516668190|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
143304821|NCT00244712|516668189|FG000|Overall Study|Lack of Compliance|10|||
143304822|NCT00244712|516668190|FG001|Overall Study|Lack of Compliance|11|||
143304823|NCT00244712|516668189|FG000|Overall Study|Lost to Follow-up|45|||
143304824|NCT00244712|516668190|FG001|Overall Study|Lost to Follow-up|52|||
143304825|NCT00244712|516668189|FG000|Overall Study|Withdrawal by Subject|13|||
143304826|NCT00244712|516668190|FG001|Overall Study|Withdrawal by Subject|23|||
143304827|NCT00244712|516668189|FG000|Overall Study|Protocol Violation, disease progression|13|||
143304828|NCT00244712|516668190|FG001|Overall Study|Protocol Violation, disease progression|11|||
143304829|NCT02917031|516668196|FG000|Overall Study|Reason not specified|7|||
143304830|NCT02917031|516668197|FG001|Overall Study|Reason not specified|5|||
143304831|NCT02917031|516668198|FG002|Overall Study|Reason not specified|6|||
143304832|NCT02917031|516668196|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
143304833|NCT02917031|516668197|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
143304834|NCT02917031|516668198|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
143304835|NCT02917031|516668196|FG000|Overall Study|Withdrawal by Subject|3|||
143304836|NCT02917031|516668197|FG001|Overall Study|Withdrawal by Subject|3|||
143304837|NCT02917031|516668198|FG002|Overall Study|Withdrawal by Subject|0|||
143304838|NCT02917031|516668196|FG000|Overall Study|Physician Decision|1|||
143304839|NCT02917031|516668197|FG001|Overall Study|Physician Decision|0|||
143304840|NCT02917031|516668198|FG002|Overall Study|Physician Decision|0|||
143304841|NCT02917031|516668196|FG000|Overall Study|Adverse Event|4|||
143304842|NCT02917031|516668197|FG001|Overall Study|Adverse Event|1|||
143304843|NCT02917031|516668198|FG002|Overall Study|Adverse Event|5|||
143304844|NCT02917031|516668196|FG000|Overall Study|Death|2|||
143304845|NCT02917031|516668197|FG001|Overall Study|Death|3|||
143304846|NCT02917031|516668198|FG002|Overall Study|Death|4|||
143304847|NCT00403273|516670562|FG000|Overall Study|Lost to Follow-up|3|||
143304848|NCT00403273|516670563|FG001|Overall Study|Lost to Follow-up|2|||
143304849|NCT00403273|516670562|FG000|Overall Study|Physician Decision|0|||
143304850|NCT00403273|516670563|FG001|Overall Study|Physician Decision|1|||
143304851|NCT00403273|516670562|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
143304852|NCT00403273|516670563|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
143304853|NCT01336738|516670565|FG000|Overall Study|Adverse Event|0|||
143304854|NCT01336738|516670566|FG001|Overall Study|Adverse Event|3|||
143304855|NCT01336738|516670567|FG002|Overall Study|Adverse Event|2|||
143304856|NCT01336738|516670568|FG003|Overall Study|Adverse Event|1|||
143304857|NCT01336738|516670569|FG004|Overall Study|Adverse Event|3|||
143304858|NCT01336738|516670565|FG000|Overall Study|Lost to Follow-up|2|||
143304859|NCT01336738|516670566|FG001|Overall Study|Lost to Follow-up|1|||
143304860|NCT01336738|516670567|FG002|Overall Study|Lost to Follow-up|2|||
143304861|NCT01336738|516670568|FG003|Overall Study|Lost to Follow-up|2|||
143304862|NCT01336738|516670569|FG004|Overall Study|Lost to Follow-up|2|||
143304863|NCT01336738|516670565|FG000|Overall Study|Did not meet entrance criteria|0|||
143304864|NCT01336738|516670566|FG001|Overall Study|Did not meet entrance criteria|1|||
143304865|NCT01336738|516670567|FG002|Overall Study|Did not meet entrance criteria|0|||
143304866|NCT01336738|516670568|FG003|Overall Study|Did not meet entrance criteria|0|||
143304867|NCT01336738|516670569|FG004|Overall Study|Did not meet entrance criteria|0|||
143304868|NCT01336738|516670565|FG000|Overall Study|Protocol Violation|0|||
143304869|NCT01336738|516670566|FG001|Overall Study|Protocol Violation|1|||
143304870|NCT01336738|516670567|FG002|Overall Study|Protocol Violation|0|||
143304871|NCT01336738|516670568|FG003|Overall Study|Protocol Violation|0|||
143304872|NCT01336738|516670569|FG004|Overall Study|Protocol Violation|0|||
143304873|NCT01336738|516670565|FG000|Overall Study|Withdrawal by Subject|2|||
143304874|NCT01336738|516670566|FG001|Overall Study|Withdrawal by Subject|0|||
143304875|NCT01336738|516670567|FG002|Overall Study|Withdrawal by Subject|2|||
143304876|NCT01336738|516670568|FG003|Overall Study|Withdrawal by Subject|1|||
143304877|NCT01336738|516670569|FG004|Overall Study|Withdrawal by Subject|1|||
143304878|NCT01336738|516670565|FG000|Overall Study|Other|3|||
143304879|NCT01336738|516670566|FG001|Overall Study|Other|3|||
143304880|NCT01336738|516670567|FG002|Overall Study|Other|2|||
143304881|NCT01336738|516670568|FG003|Overall Study|Other|3|||
143304882|NCT01336738|516670569|FG004|Overall Study|Other|4|||
143304883|NCT01083433|516670570|FG000|Overall Study|Lost to Follow-up|2|||
143304884|NCT01083433|516670571|FG001|Overall Study|Lost to Follow-up|1|||
143304885|NCT01083433|516670572|FG002|Overall Study|Lost to Follow-up|1|||
143304886|NCT01083433|516670570|FG000|Overall Study|Withdrawal by Subject|0|||
143304887|NCT01083433|516670571|FG001|Overall Study|Withdrawal by Subject|5|||
143304888|NCT01083433|516670572|FG002|Overall Study|Withdrawal by Subject|3|||
143304889|NCT01083433|516670570|FG000|Overall Study|Pregnancy|0|||
143304890|NCT01083433|516670571|FG001|Overall Study|Pregnancy|0|||
143304891|NCT01083433|516670572|FG002|Overall Study|Pregnancy|1|||
143304892|NCT01581593|516670573|FG000|Overall Study|Withdrawal by Subject|1|||
143304893|NCT04982029|516670574|FG000|Overall Study|Lost to Follow-up|2|||
143304894|NCT04982029|516670575|FG001|Overall Study|Lost to Follow-up|3|||
143304895|NCT03264404|516670576|FG000|Overall Study|Death|2|||
143304896|NCT03264404|516670576|FG000|Overall Study|Physician Decision|1|||
143304897|NCT03264404|516670576|FG000|Overall Study|Disease Progression|28|||
143304898|NCT03264404|516670576|FG000|Overall Study|Adverse Event|1|||
143304899|NCT03264404|516670576|FG000|Overall Study|Off study prior to treatment|2|||
143304900|NCT05458856|516670577|FG000|Overall Study|Withdrawal by Subject|5|||
143304901|NCT05458856|516670577|FG000|Overall Study|Death|4|||
143304902|NCT05458856|516670577|FG000|Overall Study|Protocol Deviation|3|||
143304903|NCT05458856|516670577|FG000|Overall Study|Physician Decision|1|||
143304904|NCT02919670|516670578|FG000|Overall Study|Only 17 participants met compliance|43|||
143304905|NCT02919670|516670579|FG001|Overall Study|Only 17 participants met compliance|39|||
143304906|NCT00240071|516670580|FG000|Overall Study|Withdrawal by Subject|3|||
143304907|NCT01641367|516670591|FG000|Cohorts|Death|18|||
143304908|NCT01641367|516670592|FG001|Cohorts|Death|1|||
143304909|NCT01641367|516670593|FG002|Cohorts|Death|2|||
143304910|NCT01641367|516670594|FG003|Cohorts|Death|0|||
143304911|NCT01641367|516670595|FG004|Cohorts|Death|1|||
143304912|NCT01641367|516670596|FG005|Cohorts|Death|1|||
143304913|NCT01641367|516670597|FG006|Cohorts|Death|0|||
143304914|NCT01641367|516670598|FG007|Cohorts|Death|0|||
143304915|NCT01641367|516670591|FG000|Cohorts|Lost to Follow-up|16|||
143304916|NCT01641367|516670592|FG001|Cohorts|Lost to Follow-up|0|||
143304917|NCT01641367|516670593|FG002|Cohorts|Lost to Follow-up|2|||
143304918|NCT01641367|516670594|FG003|Cohorts|Lost to Follow-up|0|||
143304919|NCT01641367|516670595|FG004|Cohorts|Lost to Follow-up|2|||
143304920|NCT01641367|516670596|FG005|Cohorts|Lost to Follow-up|0|||
143375112|NCT02969863|516918972|FG005|Overall Study|Physician Decision|0|||
143304921|NCT01641367|516670597|FG006|Cohorts|Lost to Follow-up|0|||
143304922|NCT01641367|516670598|FG007|Cohorts|Lost to Follow-up|0|||
143375113|NCT01135511|516918974|FG000|Overall Study|Adverse Event|0|||
143304923|NCT01641367|516670591|FG000|Randomized Adherence Intervention|Death|0|||
143304924|NCT01641367|516670592|FG001|Randomized Adherence Intervention|Death|0|||
143304925|NCT01641367|516670593|FG002|Randomized Adherence Intervention|Death|0|||
143304926|NCT01641367|516670594|FG003|Randomized Adherence Intervention|Death|0|||
143304927|NCT01641367|516670595|FG004|Randomized Adherence Intervention|Death|0|||
143375114|NCT01135511|516918975|FG001|Overall Study|Adverse Event|1|||
143375115|NCT01135511|516918976|FG002|Overall Study|Adverse Event|2|||
143375116|NCT01135511|516918977|FG003|Overall Study|Adverse Event|0|||
143375117|NCT01135511|516918978|FG004|Overall Study|Adverse Event|0|||
143375118|NCT01135511|516918979|FG005|Overall Study|Adverse Event|1|||
143375119|NCT01135511|516918980|FG006|Overall Study|Adverse Event|0|||
143375120|NCT01135511|516918981|FG007|Overall Study|Adverse Event|1|||
143375121|NCT01135511|516918982|FG008|Overall Study|Adverse Event|0|||
143375122|NCT01135511|516918974|FG000|Overall Study|Lack of Efficacy|0|||
143375123|NCT01135511|516918975|FG001|Overall Study|Lack of Efficacy|1|||
143375124|NCT01135511|516918976|FG002|Overall Study|Lack of Efficacy|1|||
143375125|NCT01135511|516918977|FG003|Overall Study|Lack of Efficacy|2|||
143375126|NCT01135511|516918978|FG004|Overall Study|Lack of Efficacy|0|||
143375127|NCT01135511|516918979|FG005|Overall Study|Lack of Efficacy|0|||
143375128|NCT01135511|516918980|FG006|Overall Study|Lack of Efficacy|0|||
143375129|NCT01135511|516918981|FG007|Overall Study|Lack of Efficacy|0|||
143375130|NCT01135511|516918982|FG008|Overall Study|Lack of Efficacy|0|||
143375131|NCT01135511|516918974|FG000|Overall Study|Protocol Violation|0|||
143375132|NCT01135511|516918975|FG001|Overall Study|Protocol Violation|0|||
143375133|NCT01135511|516918976|FG002|Overall Study|Protocol Violation|3|||
143375134|NCT01135511|516918977|FG003|Overall Study|Protocol Violation|0|||
143375135|NCT01135511|516918978|FG004|Overall Study|Protocol Violation|0|||
143375136|NCT01135511|516918979|FG005|Overall Study|Protocol Violation|0|||
143375137|NCT01135511|516918980|FG006|Overall Study|Protocol Violation|0|||
143375138|NCT01135511|516918981|FG007|Overall Study|Protocol Violation|0|||
143375139|NCT01135511|516918982|FG008|Overall Study|Protocol Violation|0|||
143375140|NCT01135511|516918974|FG000|Overall Study|Pregnancy|0|||
143375141|NCT01135511|516918975|FG001|Overall Study|Pregnancy|0|||
143375142|NCT01135511|516918976|FG002|Overall Study|Pregnancy|0|||
143375143|NCT01135511|516918977|FG003|Overall Study|Pregnancy|1|||
143375144|NCT01135511|516918978|FG004|Overall Study|Pregnancy|0|||
143375145|NCT01135511|516918979|FG005|Overall Study|Pregnancy|0|||
143375146|NCT01135511|516918980|FG006|Overall Study|Pregnancy|0|||
143375147|NCT01135511|516918981|FG007|Overall Study|Pregnancy|0|||
143375148|NCT01135511|516918982|FG008|Overall Study|Pregnancy|0|||
143375149|NCT01135511|516918974|FG000|Overall Study|could not visit the clinic|0|||
143375150|NCT01135511|516918975|FG001|Overall Study|could not visit the clinic|1|||
143375151|NCT01135511|516918976|FG002|Overall Study|could not visit the clinic|2|||
143375152|NCT01135511|516918977|FG003|Overall Study|could not visit the clinic|0|||
143375153|NCT01135511|516918978|FG004|Overall Study|could not visit the clinic|0|||
143375154|NCT01135511|516918979|FG005|Overall Study|could not visit the clinic|0|||
143304928|NCT01641367|516670596|FG005|Randomized Adherence Intervention|Death|0|||
143304929|NCT01641367|516670597|FG006|Randomized Adherence Intervention|Death|11|||
143304930|NCT01641367|516670598|FG007|Randomized Adherence Intervention|Death|12|||
143304931|NCT01641367|516670591|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
143304932|NCT01641367|516670592|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
143304933|NCT01641367|516670593|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
143304934|NCT01641367|516670594|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
143304935|NCT01641367|516670595|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
143304936|NCT01641367|516670596|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
143304937|NCT01641367|516670597|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
143304938|NCT01641367|516670598|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
143304939|NCT00782210|516670599|FG000|Overall Study|Adverse Event|21|||
143304940|NCT00782210|516670600|FG001|Overall Study|Adverse Event|17|||
143304941|NCT00782210|516670601|FG002|Overall Study|Adverse Event|16|||
143304942|NCT00782210|516670599|FG000|Overall Study|Lost to Follow-up|2|||
143304943|NCT00782210|516670600|FG001|Overall Study|Lost to Follow-up|1|||
143304944|NCT00782210|516670601|FG002|Overall Study|Lost to Follow-up|2|||
143304945|NCT00782210|516670599|FG000|Overall Study|Withdrawal by Subject|11|||
143304946|NCT00782210|516670600|FG001|Overall Study|Withdrawal by Subject|8|||
143304947|NCT00782210|516670601|FG002|Overall Study|Withdrawal by Subject|11|||
143304948|NCT00782210|516670599|FG000|Overall Study|Non compliance with protocol|0|||
143304949|NCT00782210|516670600|FG001|Overall Study|Non compliance with protocol|3|||
143304950|NCT00782210|516670601|FG002|Overall Study|Non compliance with protocol|2|||
143304951|NCT00782210|516670599|FG000|Overall Study|Lack of Efficacy|13|||
143304952|NCT00782210|516670600|FG001|Overall Study|Lack of Efficacy|4|||
143304953|NCT00782210|516670601|FG002|Overall Study|Lack of Efficacy|1|||
143304954|NCT00782210|516670599|FG000|Overall Study|Other reason not described above|3|||
143304955|NCT00782210|516670600|FG001|Overall Study|Other reason not described above|2|||
143304956|NCT00782210|516670601|FG002|Overall Study|Other reason not described above|3|||
143304957|NCT00850200|516670604|FG000|Overall Study|Physician Decision|2|||
143304958|NCT00850200|516670604|FG000|Overall Study|Did not recieve treatment|2|||
143304959|NCT00850200|516670604|FG000|Overall Study|Withdrawal by Subject|1|||
143304960|NCT00048542|516670615|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
143304961|NCT00048542|516670616|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
143304962|NCT00048542|516670617|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
143304963|NCT00048542|516670618|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
143304964|NCT00048542|516670619|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
143304965|NCT00048542|516670620|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
143304966|NCT00048542|516670621|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
143304967|NCT00048542|516670622|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
143304968|NCT00048542|516670615|FG000|Double-Blind Phase|Protocol Violation|0|||
143304969|NCT00048542|516670616|FG001|Double-Blind Phase|Protocol Violation|0|||
143304970|NCT00048542|516670617|FG002|Double-Blind Phase|Protocol Violation|1|||
143304971|NCT00048542|516670618|FG003|Double-Blind Phase|Protocol Violation|0|||
143304972|NCT00048542|516670619|FG004|Double-Blind Phase|Protocol Violation|0|||
143304973|NCT00048542|516670620|FG005|Double-Blind Phase|Protocol Violation|0|||
143304974|NCT00048542|516670621|FG006|Double-Blind Phase|Protocol Violation|0|||
143304975|NCT00048542|516670622|FG007|Double-Blind Phase|Protocol Violation|0|||
143304976|NCT00048542|516670615|FG000|Double-Blind Phase|Sponsor request or decision|2|||
143304977|NCT00048542|516670616|FG001|Double-Blind Phase|Sponsor request or decision|0|||
143304978|NCT00048542|516670617|FG002|Double-Blind Phase|Sponsor request or decision|0|||
143304979|NCT00048542|516670618|FG003|Double-Blind Phase|Sponsor request or decision|0|||
143304980|NCT00048542|516670619|FG004|Double-Blind Phase|Sponsor request or decision|0|||
143304981|NCT00048542|516670620|FG005|Double-Blind Phase|Sponsor request or decision|0|||
143304982|NCT00048542|516670621|FG006|Double-Blind Phase|Sponsor request or decision|0|||
143304983|NCT00048542|516670622|FG007|Double-Blind Phase|Sponsor request or decision|0|||
143304984|NCT00048542|516670615|FG000|Double-Blind Phase|Randomized in error|1|||
143304985|NCT00048542|516670616|FG001|Double-Blind Phase|Randomized in error|0|||
143304986|NCT00048542|516670617|FG002|Double-Blind Phase|Randomized in error|0|||
143304987|NCT00048542|516670618|FG003|Double-Blind Phase|Randomized in error|0|||
143304988|NCT00048542|516670619|FG004|Double-Blind Phase|Randomized in error|0|||
143304989|NCT00048542|516670620|FG005|Double-Blind Phase|Randomized in error|0|||
143304990|NCT00048542|516670621|FG006|Double-Blind Phase|Randomized in error|0|||
143304991|NCT00048542|516670622|FG007|Double-Blind Phase|Randomized in error|0|||
143304992|NCT00048542|516670615|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
143304993|NCT00048542|516670616|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
143304994|NCT00048542|516670617|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
143304995|NCT00048542|516670618|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
143304996|NCT00048542|516670619|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
143304997|NCT00048542|516670620|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
143304998|NCT00048542|516670621|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
143304999|NCT00048542|516670622|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
143305000|NCT00048542|516670615|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
143305001|NCT00048542|516670616|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
143305002|NCT00048542|516670617|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
143305003|NCT00048542|516670618|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
143305004|NCT00048542|516670619|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
143305005|NCT00048542|516670620|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
143305006|NCT00048542|516670621|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
143305007|NCT00048542|516670622|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
143305008|NCT00048542|516670615|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
143305009|NCT00048542|516670616|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
143305010|NCT00048542|516670617|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
143305011|NCT00048542|516670618|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
143305012|NCT00048542|516670619|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
143305013|NCT00048542|516670620|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
143305014|NCT00048542|516670621|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
143305015|NCT00048542|516670622|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
143305016|NCT00048542|516670615|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
143305017|NCT00048542|516670616|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
143305018|NCT00048542|516670617|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
143305019|NCT00048542|516670618|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
143305020|NCT00048542|516670619|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
143305021|NCT00048542|516670620|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
143305022|NCT00048542|516670621|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
143305023|NCT00048542|516670622|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
143305024|NCT00048542|516670615|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
143305025|NCT00048542|516670616|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
143305026|NCT00048542|516670617|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
143305027|NCT00048542|516670618|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
143305028|NCT00048542|516670619|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
143305029|NCT00048542|516670620|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
143305030|NCT00048542|516670621|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
143305031|NCT00048542|516670622|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
143305032|NCT00048542|516670615|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
143305033|NCT00048542|516670616|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
143305034|NCT00048542|516670617|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
143305035|NCT00048542|516670618|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
143305036|NCT00048542|516670619|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
143305037|NCT00048542|516670620|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
143305038|NCT00048542|516670621|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
143305039|NCT00048542|516670622|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
143305040|NCT00048542|516670615|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
143305041|NCT00048542|516670616|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
143305042|NCT00048542|516670617|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
143305043|NCT00048542|516670618|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
143305044|NCT00048542|516670619|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
143305045|NCT00048542|516670620|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
143305046|NCT00048542|516670621|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
143305047|NCT00048542|516670622|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
143305048|NCT00048542|516670615|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
143305049|NCT00048542|516670616|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
143305050|NCT00048542|516670617|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
143305051|NCT00048542|516670618|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
143305052|NCT00048542|516670619|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
143305053|NCT00048542|516670620|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
143305054|NCT00048542|516670621|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
143305055|NCT00048542|516670622|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
143305056|NCT00048542|516670615|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
143305057|NCT00048542|516670616|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
143305058|NCT00048542|516670617|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
143305059|NCT00048542|516670618|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
143305060|NCT00048542|516670619|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
143305061|NCT00048542|516670620|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
143305062|NCT00048542|516670621|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
143305063|NCT00048542|516670622|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
143305064|NCT00048542|516670615|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
143305065|NCT00048542|516670616|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
143305066|NCT00048542|516670617|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
143305067|NCT00048542|516670618|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
143305068|NCT00048542|516670619|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
143305069|NCT00048542|516670620|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
143305070|NCT00048542|516670621|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
143305071|NCT00048542|516670622|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
143305072|NCT00048542|516670615|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
143305073|NCT00048542|516670616|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
143305074|NCT00048542|516670617|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
143305075|NCT00048542|516670618|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
143305076|NCT00048542|516670619|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
143305077|NCT00048542|516670620|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
143305078|NCT00048542|516670621|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
143305079|NCT00048542|516670622|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
143305080|NCT02086110|516670623|FG000|Overall Study|Withdrawal by Subject|1|||
143305081|NCT02086110|516670624|FG001|Overall Study|Withdrawal by Subject|1|||
143305082|NCT01869192|516670625|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
143305083|NCT01869192|516670626|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
143305084|NCT01869192|516670625|FG000|Postoperative Chemotherapy|Physician Decision|0|||
143305085|NCT01869192|516670626|FG001|Postoperative Chemotherapy|Physician Decision|2|||
143305086|NCT00423891|516670635|FG000|Enrolled|Withdrawal by Subject|0|||
143305087|NCT00423891|516670636|FG001|Enrolled|Withdrawal by Subject|0|||
143305088|NCT00423891|516670637|FG002|Enrolled|Withdrawal by Subject|1|||
143305089|NCT00423891|516670635|FG000|Enrolled|Lost to Follow-up|0|||
143305090|NCT00423891|516670636|FG001|Enrolled|Lost to Follow-up|0|||
143305091|NCT00423891|516670637|FG002|Enrolled|Lost to Follow-up|1|||
143305092|NCT00423891|516670635|FG000|Enrolled|No longer met criteria|11|||
143305093|NCT00423891|516670636|FG001|Enrolled|No longer met criteria|2|||
143305094|NCT00423891|516670637|FG002|Enrolled|No longer met criteria|1|||
143305095|NCT00423891|516670635|FG000|Treatment|Withdrawal by Subject|1|||
143305096|NCT00423891|516670636|FG001|Treatment|Withdrawal by Subject|0|||
143305097|NCT00423891|516670637|FG002|Treatment|Withdrawal by Subject|0|||
143305098|NCT00423891|516670635|FG000|Treatment|Lost to Follow-up|1|||
143305099|NCT00423891|516670636|FG001|Treatment|Lost to Follow-up|0|||
143305100|NCT00423891|516670637|FG002|Treatment|Lost to Follow-up|0|||
143305101|NCT00423891|516670635|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
143305102|NCT00423891|516670636|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
143305103|NCT00423891|516670637|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
143305104|NCT00423891|516670635|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
143305105|NCT00423891|516670636|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
143305106|NCT00423891|516670637|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
143305107|NCT02852265|516670638|FG000|3-month Follow-up|Lost to Follow-up|1|||
143305108|NCT02852265|516670639|FG001|3-month Follow-up|Lost to Follow-up|1|||
143305109|NCT01828034|516670642|FG000|Overall Study|Withdrawal by Subject|0|||
143305110|NCT01828034|516670643|FG001|Overall Study|Withdrawal by Subject|0|||
143305111|NCT01828034|516670644|FG002|Overall Study|Withdrawal by Subject|0|||
143305112|NCT01828034|516670645|FG003|Overall Study|Withdrawal by Subject|1|||
143305113|NCT01800916|516670646|FG000|Test Period 1 (1 Week)|Convex product user|0|||
143305114|NCT01800916|516670647|FG001|Test Period 1 (1 Week)|Convex product user|0|||
143305115|NCT01800916|516670648|FG002|Test Period 1 (1 Week)|Convex product user|0|||
143305116|NCT01800916|516670649|FG003|Test Period 1 (1 Week)|Convex product user|1|||
143305117|NCT01800916|516670650|FG004|Test Period 1 (1 Week)|Convex product user|0|||
143305118|NCT01800916|516670651|FG005|Test Period 1 (1 Week)|Convex product user|0|||
143305119|NCT01800916|516670652|FG006|Test Period 1 (1 Week)|Convex product user|0|||
143305120|NCT01800916|516670653|FG007|Test Period 1 (1 Week)|Convex product user|0|||
143305121|NCT01800916|516670654|FG008|Test Period 1 (1 Week)|Convex product user|0|||
143305122|NCT01800916|516670646|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
143305123|NCT01800916|516670647|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
143305124|NCT01800916|516670648|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
143305125|NCT01800916|516670649|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
143305126|NCT01800916|516670650|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
143305127|NCT01800916|516670651|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
143305128|NCT01800916|516670652|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
143305129|NCT01800916|516670653|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
143305130|NCT01800916|516670654|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
143305131|NCT01232296|516670655|FG000|Overall Study|Adverse Event|24|||
143305132|NCT01232296|516670656|FG001|Overall Study|Adverse Event|12|||
143305133|NCT01232296|516670655|FG000|Overall Study|Physician Decision|1|||
143305134|NCT01232296|516670656|FG001|Overall Study|Physician Decision|1|||
143305135|NCT01232296|516670655|FG000|Overall Study|Progressive disease|43|||
143305136|NCT01232296|516670656|FG001|Overall Study|Progressive disease|61|||
143305137|NCT01232296|516670655|FG000|Overall Study|Study terminated by sponsor|0|||
143305138|NCT01232296|516670656|FG001|Overall Study|Study terminated by sponsor|1|||
143305139|NCT01232296|516670655|FG000|Overall Study|Technical problems|3|||
143305140|NCT01232296|516670656|FG001|Overall Study|Technical problems|0|||
143305141|NCT01232296|516670655|FG000|Overall Study|Subject/guardian decision|10|||
143305142|NCT01232296|516670656|FG001|Overall Study|Subject/guardian decision|2|||
143305143|NCT01232296|516670655|FG000|Overall Study|Death|1|||
143305144|NCT01232296|516670656|FG001|Overall Study|Death|6|||
143305145|NCT01479621|516670663|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
143305146|NCT01479621|516670664|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
143305147|NCT01479621|516670665|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
143305148|NCT01479621|516670666|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
143305149|NCT01479621|516670667|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
143305150|NCT01479621|516670668|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
143305151|NCT01479621|516670669|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
143305152|NCT01479621|516670663|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
143305153|NCT01479621|516670664|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
143305154|NCT01479621|516670665|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
143305155|NCT01479621|516670666|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
143305156|NCT01479621|516670667|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
143305157|NCT01479621|516670668|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
143305158|NCT01479621|516670669|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
143305159|NCT01479621|516670663|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
143305160|NCT01479621|516670664|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
143305161|NCT01479621|516670665|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
143305162|NCT01479621|516670666|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
143305163|NCT01479621|516670667|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
143305164|NCT01479621|516670668|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
143305165|NCT01479621|516670669|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
143305166|NCT01479621|516670663|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
143305167|NCT01479621|516670664|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
143305168|NCT01479621|516670665|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
143305169|NCT01479621|516670666|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
143305170|NCT01479621|516670667|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
143305171|NCT01479621|516670668|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
143305172|NCT01479621|516670669|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
143305173|NCT01479621|516670663|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
143305174|NCT01479621|516670664|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
143305175|NCT01479621|516670665|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
143305176|NCT01479621|516670666|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
143305177|NCT01479621|516670667|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
143305178|NCT01479621|516670668|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
143305179|NCT01479621|516670669|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
143305180|NCT01479621|516670663|FG000|Treatment Period|Adverse Event|0|||
143305181|NCT01479621|516670664|FG001|Treatment Period|Adverse Event|0|||
143305182|NCT01479621|516670665|FG002|Treatment Period|Adverse Event|0|||
143305183|NCT01479621|516670666|FG003|Treatment Period|Adverse Event|0|||
143305184|NCT01479621|516670667|FG004|Treatment Period|Adverse Event|1|||
143305185|NCT01479621|516670668|FG005|Treatment Period|Adverse Event|2|||
143305186|NCT01479621|516670669|FG006|Treatment Period|Adverse Event|2|||
143305187|NCT01479621|516670663|FG000|Treatment Period|Withdrawal by Subject|0|||
143305188|NCT01479621|516670664|FG001|Treatment Period|Withdrawal by Subject|4|||
143305189|NCT01479621|516670665|FG002|Treatment Period|Withdrawal by Subject|2|||
143305190|NCT01479621|516670666|FG003|Treatment Period|Withdrawal by Subject|2|||
143305191|NCT01479621|516670667|FG004|Treatment Period|Withdrawal by Subject|5|||
143305192|NCT01479621|516670668|FG005|Treatment Period|Withdrawal by Subject|5|||
143305193|NCT01479621|516670669|FG006|Treatment Period|Withdrawal by Subject|1|||
143305194|NCT01479621|516670663|FG000|Treatment Period|Physician Decision|0|||
143305195|NCT01479621|516670664|FG001|Treatment Period|Physician Decision|0|||
143305196|NCT01479621|516670665|FG002|Treatment Period|Physician Decision|0|||
143305197|NCT01479621|516670666|FG003|Treatment Period|Physician Decision|0|||
143305198|NCT01479621|516670667|FG004|Treatment Period|Physician Decision|1|||
143305199|NCT01479621|516670668|FG005|Treatment Period|Physician Decision|1|||
143305200|NCT01479621|516670669|FG006|Treatment Period|Physician Decision|0|||
143305201|NCT01479621|516670663|FG000|Treatment Period|Non-compliance to study drug|0|||
143305202|NCT01479621|516670664|FG001|Treatment Period|Non-compliance to study drug|1|||
143305203|NCT01479621|516670665|FG002|Treatment Period|Non-compliance to study drug|0|||
143305204|NCT01479621|516670666|FG003|Treatment Period|Non-compliance to study drug|0|||
143305205|NCT01479621|516670667|FG004|Treatment Period|Non-compliance to study drug|0|||
143305206|NCT01479621|516670668|FG005|Treatment Period|Non-compliance to study drug|0|||
143305207|NCT01479621|516670669|FG006|Treatment Period|Non-compliance to study drug|1|||
143305208|NCT01479621|516670663|FG000|Treatment Period|Protocol Violation|0|||
143305209|NCT01479621|516670664|FG001|Treatment Period|Protocol Violation|9|||
143305210|NCT01479621|516670665|FG002|Treatment Period|Protocol Violation|6|||
143305211|NCT01479621|516670666|FG003|Treatment Period|Protocol Violation|5|||
143305212|NCT01479621|516670667|FG004|Treatment Period|Protocol Violation|2|||
143305213|NCT01479621|516670668|FG005|Treatment Period|Protocol Violation|10|||
143305214|NCT01479621|516670669|FG006|Treatment Period|Protocol Violation|6|||
143305215|NCT01479621|516670663|FG000|Treatment Period|Pregnancy|0|||
143305216|NCT01479621|516670664|FG001|Treatment Period|Pregnancy|0|||
143305217|NCT01479621|516670665|FG002|Treatment Period|Pregnancy|2|||
143305218|NCT01479621|516670666|FG003|Treatment Period|Pregnancy|0|||
143305219|NCT01479621|516670667|FG004|Treatment Period|Pregnancy|0|||
143305220|NCT01479621|516670668|FG005|Treatment Period|Pregnancy|0|||
143305221|NCT01479621|516670669|FG006|Treatment Period|Pregnancy|0|||
143305222|NCT01479621|516670663|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
143305223|NCT01479621|516670664|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
143375155|NCT01135511|516918980|FG006|Overall Study|could not visit the clinic|0|||
143375156|NCT01135511|516918981|FG007|Overall Study|could not visit the clinic|0|||
143305224|NCT01479621|516670665|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
143305225|NCT01479621|516670666|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
143305226|NCT01479621|516670667|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
143305227|NCT01479621|516670668|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
143305228|NCT01479621|516670669|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
143305229|NCT01479621|516670663|FG000|Treatment Period|Lost to Follow-up|0|||
143375157|NCT01135511|516918982|FG008|Overall Study|could not visit the clinic|0|||
143375158|NCT01135511|516918974|FG000|Overall Study|noncompliance with study drug taken|0|||
143375159|NCT01135511|516918975|FG001|Overall Study|noncompliance with study drug taken|0|||
143375160|NCT01135511|516918976|FG002|Overall Study|noncompliance with study drug taken|0|||
143375161|NCT01135511|516918977|FG003|Overall Study|noncompliance with study drug taken|0|||
143375162|NCT01135511|516918978|FG004|Overall Study|noncompliance with study drug taken|1|||
143375163|NCT01135511|516918979|FG005|Overall Study|noncompliance with study drug taken|0|||
143375164|NCT01135511|516918980|FG006|Overall Study|noncompliance with study drug taken|0|||
143375165|NCT01135511|516918981|FG007|Overall Study|noncompliance with study drug taken|0|||
143375166|NCT01135511|516918982|FG008|Overall Study|noncompliance with study drug taken|0|||
143375167|NCT01135511|516918974|FG000|Overall Study|Withdrawal by Subject|0|||
143375168|NCT01135511|516918975|FG001|Overall Study|Withdrawal by Subject|0|||
143375169|NCT01135511|516918976|FG002|Overall Study|Withdrawal by Subject|0|||
143375170|NCT01135511|516918977|FG003|Overall Study|Withdrawal by Subject|0|||
143375171|NCT01135511|516918978|FG004|Overall Study|Withdrawal by Subject|0|||
143375172|NCT01135511|516918979|FG005|Overall Study|Withdrawal by Subject|0|||
143375173|NCT01135511|516918980|FG006|Overall Study|Withdrawal by Subject|1|||
143375174|NCT01135511|516918981|FG007|Overall Study|Withdrawal by Subject|0|||
143375175|NCT01135511|516918982|FG008|Overall Study|Withdrawal by Subject|1|||
143305230|NCT01479621|516670664|FG001|Treatment Period|Lost to Follow-up|0|||
143305231|NCT01479621|516670665|FG002|Treatment Period|Lost to Follow-up|1|||
143305232|NCT01479621|516670666|FG003|Treatment Period|Lost to Follow-up|0|||
143305233|NCT01479621|516670667|FG004|Treatment Period|Lost to Follow-up|2|||
143305234|NCT01479621|516670668|FG005|Treatment Period|Lost to Follow-up|2|||
143305235|NCT01479621|516670669|FG006|Treatment Period|Lost to Follow-up|1|||
143305236|NCT01479621|516670663|FG000|Treatment Period|Met stopping criteria|0|||
143305237|NCT01479621|516670664|FG001|Treatment Period|Met stopping criteria|8|||
143305238|NCT01479621|516670665|FG002|Treatment Period|Met stopping criteria|7|||
143305239|NCT01479621|516670666|FG003|Treatment Period|Met stopping criteria|4|||
143305240|NCT01479621|516670667|FG004|Treatment Period|Met stopping criteria|9|||
143305241|NCT01479621|516670668|FG005|Treatment Period|Met stopping criteria|20|||
143305242|NCT01479621|516670669|FG006|Treatment Period|Met stopping criteria|6|||
143305243|NCT00606892|516670678|FG000|First Intervention|Protocol Violation|1|||
143305244|NCT00606892|516670679|FG001|First Intervention|Protocol Violation|4|||
143305245|NCT04225923|516670680|FG000|Overall Study|Protocol Violation|1|||
143305246|NCT04225923|516670681|FG001|Overall Study|Protocol Violation|0|||
143305247|NCT04225923|516670682|FG002|Overall Study|Protocol Violation|1|||
143305248|NCT04225923|516670680|FG000|Overall Study|Withdrawal by Subject|4|||
143305249|NCT04225923|516670681|FG001|Overall Study|Withdrawal by Subject|1|||
143305250|NCT04225923|516670682|FG002|Overall Study|Withdrawal by Subject|3|||
143305251|NCT04225923|516670680|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
143305252|NCT04225923|516670681|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
143305253|NCT04225923|516670682|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
143305254|NCT00855309|516670683|FG000|Overall Study|patient never recieved drug|1|||
143305255|NCT00855309|516670684|FG001|Overall Study|patient never recieved drug|0|||
143305256|NCT01585766|516670685|FG000|Overall Study|Withdrawal by Subject|0|||
143305257|NCT01585766|516670686|FG001|Overall Study|Withdrawal by Subject|1|||
143305258|NCT01585766|516670687|FG002|Overall Study|Withdrawal by Subject|1|||
143305259|NCT01585766|516670688|FG003|Overall Study|Withdrawal by Subject|0|||
143305260|NCT01585766|516670689|FG004|Overall Study|Withdrawal by Subject|0|||
143305261|NCT01585766|516670690|FG005|Overall Study|Withdrawal by Subject|0|||
143305262|NCT01585766|516670685|FG000|Overall Study|Death|0|||
143305263|NCT01585766|516670686|FG001|Overall Study|Death|1|||
143305264|NCT01585766|516670687|FG002|Overall Study|Death|0|||
143305265|NCT01585766|516670688|FG003|Overall Study|Death|0|||
143305266|NCT01585766|516670689|FG004|Overall Study|Death|0|||
143305267|NCT01585766|516670690|FG005|Overall Study|Death|0|||
143375176|NCT02880241|516918983|FG000|Overall Study|Lack of Efficacy|1|||
143375177|NCT02880241|516918984|FG001|Overall Study|Lack of Efficacy|0|||
143375178|NCT02880241|516918985|FG002|Overall Study|Lack of Efficacy|0|||
143375179|NCT02880241|516918986|FG003|Overall Study|Lack of Efficacy|0|||
143375180|NCT02880241|516918987|FG004|Overall Study|Lack of Efficacy|0|||
143375181|NCT02880241|516918988|FG005|Overall Study|Lack of Efficacy|0|||
143375182|NCT00057837|516918989|FG000|Overall Study|Progression/relapse|12|||
143375183|NCT00057837|516918990|FG001|Overall Study|Progression/relapse|14|||
143375184|NCT00057837|516918989|FG000|Overall Study|Adverse Event|2|||
143375185|NCT00057837|516918990|FG001|Overall Study|Adverse Event|12|||
143375186|NCT00057837|516918989|FG000|Overall Study|Death|5|||
143375187|NCT00057837|516918990|FG001|Overall Study|Death|4|||
143375188|NCT00057837|516918989|FG000|Overall Study|Withdrawal by Subject|5|||
143375189|NCT00057837|516918990|FG001|Overall Study|Withdrawal by Subject|3|||
143375190|NCT00057837|516918989|FG000|Overall Study|Alternative therapy|0|||
143375191|NCT00057837|516918990|FG001|Overall Study|Alternative therapy|1|||
143375192|NCT00057837|516918989|FG000|Overall Study|Other complicating disease|2|||
143375193|NCT00057837|516918990|FG001|Overall Study|Other complicating disease|1|||
143375194|NCT00057837|516918989|FG000|Overall Study|Physician Decision|1|||
143375195|NCT00057837|516918990|FG001|Overall Study|Physician Decision|0|||
143375196|NCT00057837|516918989|FG000|Overall Study|Ineligible|3|||
143375197|NCT00057837|516918990|FG001|Overall Study|Ineligible|3|||
143375198|NCT00057837|516918989|FG000|Overall Study|Never started treatment|1|||
143375199|NCT00057837|516918990|FG001|Overall Study|Never started treatment|1|||
143375200|NCT05001945|516918992|FG000|Overall Study|Adverse Event|0|||
143375201|NCT05001945|516918993|FG001|Overall Study|Adverse Event|0|||
143375202|NCT05001945|516918994|FG002|Overall Study|Adverse Event|0|||
143375203|NCT05001945|516918995|FG003|Overall Study|Adverse Event|1|||
143375204|NCT05001945|516918996|FG004|Overall Study|Adverse Event|0|||
143375205|NCT05001945|516918997|FG005|Overall Study|Adverse Event|0|||
143375206|NCT05001945|516918998|FG006|Overall Study|Adverse Event|0|||
143375207|NCT05001945|516918999|FG007|Overall Study|Adverse Event|0|||
143375208|NCT05001945|516918992|FG000|Overall Study|Lost to Follow-up|0|||
143375209|NCT05001945|516918993|FG001|Overall Study|Lost to Follow-up|1|||
143375210|NCT05001945|516918994|FG002|Overall Study|Lost to Follow-up|1|||
143375211|NCT05001945|516918995|FG003|Overall Study|Lost to Follow-up|2|||
143375212|NCT05001945|516918996|FG004|Overall Study|Lost to Follow-up|0|||
143375213|NCT05001945|516918997|FG005|Overall Study|Lost to Follow-up|1|||
143375214|NCT05001945|516918998|FG006|Overall Study|Lost to Follow-up|0|||
143375215|NCT05001945|516918999|FG007|Overall Study|Lost to Follow-up|0|||
143375216|NCT05001945|516918992|FG000|Overall Study|Protocol Violation|1|||
143375217|NCT05001945|516918993|FG001|Overall Study|Protocol Violation|0|||
143375218|NCT05001945|516918994|FG002|Overall Study|Protocol Violation|1|||
143375219|NCT05001945|516918995|FG003|Overall Study|Protocol Violation|1|||
143305268|NCT01585766|516670685|FG000|Overall Study|Physician Decision|0|||
143305269|NCT01585766|516670686|FG001|Overall Study|Physician Decision|0|||
143305270|NCT01585766|516670687|FG002|Overall Study|Physician Decision|1|||
143305271|NCT01585766|516670688|FG003|Overall Study|Physician Decision|0|||
143305272|NCT01585766|516670689|FG004|Overall Study|Physician Decision|0|||
143305273|NCT01585766|516670690|FG005|Overall Study|Physician Decision|0|||
143305274|NCT04116710|516670691|FG000|Overall Study|Death|4|||
143305275|NCT04116710|516670692|FG001|Overall Study|Death|6|||
143305276|NCT04116710|516670693|FG002|Overall Study|Death|3|||
143305277|NCT04116710|516670694|FG003|Overall Study|Death|1|||
143305278|NCT04116710|516670691|FG000|Overall Study|Withdrawal by Subject|0|||
143305279|NCT04116710|516670692|FG001|Overall Study|Withdrawal by Subject|0|||
143305280|NCT04116710|516670693|FG002|Overall Study|Withdrawal by Subject|0|||
143305281|NCT04116710|516670694|FG003|Overall Study|Withdrawal by Subject|1|||
143305282|NCT02319031|516670695|FG000|Treatment Period|Death|1|||
143305283|NCT02319031|516670696|FG001|Treatment Period|Death|0|||
143305284|NCT01371656|516670702|FG000|Overall Study|Death|7|||
143305285|NCT01371656|516670703|FG001|Overall Study|Death|4|||
143305286|NCT01371656|516670702|FG000|Overall Study|Physician Decision|46|||
143305287|NCT01371656|516670703|FG001|Overall Study|Physician Decision|7|||
143305288|NCT01371656|516670702|FG000|Overall Study|Withdrawal by Subject|7|||
143305289|NCT01371656|516670703|FG001|Overall Study|Withdrawal by Subject|0|||
143305290|NCT01371656|516670702|FG000|Overall Study|Ineligible|4|||
143305291|NCT01371656|516670703|FG001|Overall Study|Ineligible|3|||
143305292|NCT00696137|516670704|FG000|Overall Study|Withdrawal by Subject|2|||
143375220|NCT05001945|516918996|FG004|Overall Study|Protocol Violation|0|||
143305293|NCT01465464|516670710|FG000|Overall Study|Adverse Event|96|||
143305294|NCT01465464|516670711|FG001|Overall Study|Adverse Event|49|||
143305295|NCT01465464|516670710|FG000|Overall Study|Lack of Efficacy|139|||
143305296|NCT01465464|516670711|FG001|Overall Study|Lack of Efficacy|190|||
143305297|NCT01465464|516670710|FG000|Overall Study|Physician Decision|13|||
143375221|NCT05001945|516918997|FG005|Overall Study|Protocol Violation|1|||
143375222|NCT05001945|516918998|FG006|Overall Study|Protocol Violation|0|||
143375223|NCT05001945|516918999|FG007|Overall Study|Protocol Violation|0|||
143375224|NCT05001945|516918992|FG000|Overall Study|Withdrawal by Subject|0|||
143375225|NCT05001945|516918993|FG001|Overall Study|Withdrawal by Subject|0|||
143375226|NCT05001945|516918994|FG002|Overall Study|Withdrawal by Subject|0|||
143375227|NCT05001945|516918995|FG003|Overall Study|Withdrawal by Subject|1|||
143375228|NCT05001945|516918996|FG004|Overall Study|Withdrawal by Subject|1|||
143305298|NCT01465464|516670711|FG001|Overall Study|Physician Decision|5|||
143305299|NCT01465464|516670710|FG000|Overall Study|Protocol Violation|1|||
143305300|NCT01465464|516670711|FG001|Overall Study|Protocol Violation|1|||
143305301|NCT01465464|516670710|FG000|Overall Study|Withdrawal by Subject|46|||
143305302|NCT01465464|516670711|FG001|Overall Study|Withdrawal by Subject|30|||
143305303|NCT01465464|516670710|FG000|Overall Study|Other|9|||
143305304|NCT01465464|516670711|FG001|Overall Study|Other|3|||
143305305|NCT01465464|516670710|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
143305306|NCT01465464|516670711|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
143305307|NCT00775437|516670717|FG000|Overall Study|Loss of efficacy|2|||
143305308|NCT00775437|516670717|FG000|Overall Study|Withdrawal by Subject|3|||
143305309|NCT00775437|516670717|FG000|Overall Study|Lost to Follow-up|1|||
143305310|NCT04180020|516670718|FG000|Overall Study|missed visit|18|||
143305311|NCT04180020|516670719|FG001|Overall Study|missed visit|16|||
143305312|NCT04180020|516670718|FG000|Overall Study|Death|2|||
143305313|NCT04180020|516670719|FG001|Overall Study|Death|3|||
143305314|NCT04180020|516670718|FG000|Overall Study|Withdrawal by Subject|1|||
143305315|NCT04180020|516670719|FG001|Overall Study|Withdrawal by Subject|5|||
143305316|NCT04180020|516670718|FG000|Overall Study|incarcerated|1|||
143305317|NCT04180020|516670719|FG001|Overall Study|incarcerated|1|||
143305318|NCT04180020|516670718|FG000|Overall Study|Physician Decision|0|||
143305319|NCT04180020|516670719|FG001|Overall Study|Physician Decision|2|||
143305320|NCT02244580|516670724|FG000|Overall Study|No cancer tissues available|241|||
143305321|NCT02442778|516670725|FG000|Overall Study|Adverse Event|2|||
143305322|NCT02442778|516670726|FG001|Overall Study|Adverse Event|6|||
143305323|NCT02442778|516670727|FG002|Overall Study|Adverse Event|6|||
143305324|NCT02442778|516670725|FG000|Overall Study|Death|0|||
143305325|NCT02442778|516670726|FG001|Overall Study|Death|2|||
143305326|NCT02442778|516670727|FG002|Overall Study|Death|0|||
143305327|NCT02442778|516670725|FG000|Overall Study|Lack of Efficacy|1|||
143305328|NCT02442778|516670726|FG001|Overall Study|Lack of Efficacy|0|||
143305329|NCT02442778|516670727|FG002|Overall Study|Lack of Efficacy|0|||
143305330|NCT02442778|516670725|FG000|Overall Study|Lost to Follow-up|1|||
143305331|NCT02442778|516670726|FG001|Overall Study|Lost to Follow-up|1|||
143305332|NCT02442778|516670727|FG002|Overall Study|Lost to Follow-up|1|||
143305333|NCT02442778|516670725|FG000|Overall Study|Non-compliance with study drug|2|||
143305334|NCT02442778|516670726|FG001|Overall Study|Non-compliance with study drug|0|||
143305335|NCT02442778|516670727|FG002|Overall Study|Non-compliance with study drug|1|||
143305336|NCT02442778|516670725|FG000|Overall Study|Physician Decision|1|||
143305337|NCT02442778|516670726|FG001|Overall Study|Physician Decision|1|||
143305338|NCT02442778|516670727|FG002|Overall Study|Physician Decision|1|||
143305339|NCT02442778|516670725|FG000|Overall Study|Protocol Deviation|3|||
143305340|NCT02442778|516670726|FG001|Overall Study|Protocol Deviation|0|||
143305341|NCT02442778|516670727|FG002|Overall Study|Protocol Deviation|1|||
143305342|NCT02442778|516670725|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
143305343|NCT02442778|516670726|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
143305344|NCT02442778|516670727|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
143305345|NCT02442778|516670725|FG000|Overall Study|Withdrawal by Subject|4|||
143305346|NCT02442778|516670726|FG001|Overall Study|Withdrawal by Subject|4|||
143305347|NCT02442778|516670727|FG002|Overall Study|Withdrawal by Subject|3|||
143305348|NCT02442778|516670725|FG000|Overall Study|Reason not specified|1|||
143305349|NCT02442778|516670726|FG001|Overall Study|Reason not specified|4|||
143305350|NCT02442778|516670727|FG002|Overall Study|Reason not specified|0|||
143305351|NCT04964128|516670728|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
143305352|NCT04964128|516670728|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
143305353|NCT01148511|516670730|FG000|Exposed to Study Drug|Protocol Violation|2|||
143305354|NCT01148511|516670731|FG001|Exposed to Study Drug|Protocol Violation|0|||
143305355|NCT01148511|516670732|FG002|Exposed to Study Drug|Protocol Violation|0|||
143305356|NCT01148511|516670730|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
143305357|NCT01148511|516670731|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
143305358|NCT01148511|516670732|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
143305359|NCT01148511|516670730|FG000|Randomized|Adverse Event|0|||
143305360|NCT01148511|516670731|FG001|Randomized|Adverse Event|1|||
143305361|NCT01148511|516670732|FG002|Randomized|Adverse Event|0|||
143305362|NCT01148511|516670730|FG000|Randomized|Protocol Violation|0|||
143305363|NCT01148511|516670731|FG001|Randomized|Protocol Violation|2|||
143305364|NCT01148511|516670732|FG002|Randomized|Protocol Violation|1|||
143305365|NCT01148511|516670730|FG000|Randomized|Lost to Follow-up|0|||
143305366|NCT01148511|516670731|FG001|Randomized|Lost to Follow-up|1|||
143305367|NCT01148511|516670732|FG002|Randomized|Lost to Follow-up|1|||
143305368|NCT01148511|516670730|FG000|Randomized|Consent withdrawal|0|||
143305369|NCT01148511|516670731|FG001|Randomized|Consent withdrawal|5|||
143305370|NCT01148511|516670732|FG002|Randomized|Consent withdrawal|3|||
143305371|NCT01148511|516670730|FG000|Randomized|Other|0|||
143305372|NCT01148511|516670731|FG001|Randomized|Other|1|||
143305373|NCT01148511|516670732|FG002|Randomized|Other|1|||
143305374|NCT04258605|516670736|FG000|Overall Study|Death|1|||
143305375|NCT04258605|516670737|FG001|Overall Study|Death|0|||
143305376|NCT04258605|516670736|FG000|Overall Study|Early study termination|21|||
143305377|NCT04258605|516670737|FG001|Overall Study|Early study termination|2|||
143305378|NCT01113879|516670742|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
143305379|NCT01113879|516670743|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
143305380|NCT03323658|516670744|FG000|Overall Study|Adverse Event|0|||
143305381|NCT03323658|516670745|FG001|Overall Study|Adverse Event|1|||
143305382|NCT03323658|516670746|FG002|Overall Study|Adverse Event|0|||
143305383|NCT03913091|516670747|FG000|Overall Study|Lost to Follow-up|18|||
143305384|NCT03913091|516670748|FG001|Overall Study|Lost to Follow-up|11|||
143305385|NCT03913091|516670747|FG000|Overall Study|Required additional meds/surgery|1|||
143305386|NCT03913091|516670748|FG001|Overall Study|Required additional meds/surgery|2|||
143305387|NCT03913091|516670747|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
143305388|NCT03913091|516670748|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
143305389|NCT04536727|516670749|FG000|Overall Study|Lost to Follow-up|1|||
143305390|NCT04536727|516670750|FG001|Overall Study|Lost to Follow-up|1|||
143305391|NCT04536727|516670749|FG000|Overall Study|Death|0|||
143305392|NCT04536727|516670750|FG001|Overall Study|Death|1|||
143305393|NCT00500370|516670762|FG000|Overall Study|Adverse Event|9|||
143305394|NCT00500370|516670763|FG001|Overall Study|Adverse Event|3|||
143305395|NCT00500370|516670762|FG000|Overall Study|Lost to Follow-up|10|||
143305396|NCT00500370|516670763|FG001|Overall Study|Lost to Follow-up|10|||
143305397|NCT00500370|516670762|FG000|Overall Study|Protocol Violation|2|||
143305398|NCT00500370|516670763|FG001|Overall Study|Protocol Violation|4|||
143305399|NCT00500370|516670762|FG000|Overall Study|Sponsor Decision|2|||
143305400|NCT00500370|516670763|FG001|Overall Study|Sponsor Decision|0|||
143305401|NCT00500370|516670762|FG000|Overall Study|Subject Decision|10|||
143305402|NCT00500370|516670763|FG001|Overall Study|Subject Decision|17|||
143305403|NCT05627518|516670764|FG000|Treatment Period 1|Adverse Event|0|||
143305404|NCT05627518|516670765|FG001|Treatment Period 1|Adverse Event|0|||
143305405|NCT05627518|516670766|FG002|Treatment Period 1|Adverse Event|1|||
143305406|NCT05627518|516670767|FG003|Treatment Period 1|Adverse Event|0|||
143305407|NCT05627518|516670768|FG004|Treatment Period 1|Adverse Event|0|||
143305408|NCT05627518|516670769|FG005|Treatment Period 1|Adverse Event|0|||
143305409|NCT05627518|516670770|FG006|Treatment Period 1|Adverse Event|0|||
143305410|NCT05627518|516670771|FG007|Treatment Period 1|Adverse Event|1|||
143305411|NCT05627518|516670764|FG000|Treatment Period 1|Withdrawal by Subject|0|||
143305412|NCT05627518|516670765|FG001|Treatment Period 1|Withdrawal by Subject|0|||
143305413|NCT05627518|516670766|FG002|Treatment Period 1|Withdrawal by Subject|1|||
143305414|NCT05627518|516670767|FG003|Treatment Period 1|Withdrawal by Subject|0|||
143305415|NCT05627518|516670768|FG004|Treatment Period 1|Withdrawal by Subject|0|||
143305416|NCT05627518|516670769|FG005|Treatment Period 1|Withdrawal by Subject|1|||
143305417|NCT05627518|516670770|FG006|Treatment Period 1|Withdrawal by Subject|0|||
143305418|NCT05627518|516670771|FG007|Treatment Period 1|Withdrawal by Subject|0|||
143305419|NCT05627518|516670764|FG000|Treatment Period 1|Protocol Violation|0|||
143305420|NCT05627518|516670765|FG001|Treatment Period 1|Protocol Violation|0|||
143305421|NCT05627518|516670766|FG002|Treatment Period 1|Protocol Violation|0|||
143305422|NCT05627518|516670767|FG003|Treatment Period 1|Protocol Violation|0|||
143305423|NCT05627518|516670768|FG004|Treatment Period 1|Protocol Violation|0|||
143305424|NCT05627518|516670769|FG005|Treatment Period 1|Protocol Violation|0|||
143305425|NCT05627518|516670770|FG006|Treatment Period 1|Protocol Violation|6|||
143305426|NCT05627518|516670771|FG007|Treatment Period 1|Protocol Violation|6|||
143305427|NCT05627518|516670764|FG000|Treatment Period 2|Adverse Event|1|||
143305428|NCT05627518|516670765|FG001|Treatment Period 2|Adverse Event|0|||
143305429|NCT05627518|516670766|FG002|Treatment Period 2|Adverse Event|0|||
143305430|NCT05627518|516670767|FG003|Treatment Period 2|Adverse Event|0|||
143305431|NCT05627518|516670768|FG004|Treatment Period 2|Adverse Event|0|||
143305432|NCT05627518|516670769|FG005|Treatment Period 2|Adverse Event|0|||
143375229|NCT05001945|516918997|FG005|Overall Study|Withdrawal by Subject|1|||
143375230|NCT05001945|516918998|FG006|Overall Study|Withdrawal by Subject|0|||
143375231|NCT05001945|516918999|FG007|Overall Study|Withdrawal by Subject|1|||
143305433|NCT05627518|516670770|FG006|Treatment Period 2|Adverse Event|0|||
143305434|NCT05627518|516670771|FG007|Treatment Period 2|Adverse Event|0|||
143305435|NCT05627518|516670764|FG000|Treatment Period 2|Withdrawal by Subject|1|||
143305436|NCT05627518|516670765|FG001|Treatment Period 2|Withdrawal by Subject|0|||
143305437|NCT05627518|516670766|FG002|Treatment Period 2|Withdrawal by Subject|0|||
143305438|NCT05627518|516670767|FG003|Treatment Period 2|Withdrawal by Subject|0|||
143305439|NCT05627518|516670768|FG004|Treatment Period 2|Withdrawal by Subject|0|||
143305440|NCT05627518|516670769|FG005|Treatment Period 2|Withdrawal by Subject|0|||
143375232|NCT05001945|516918992|FG000|Overall Study|Not specified by Investigator|0|||
143305441|NCT05627518|516670770|FG006|Treatment Period 2|Withdrawal by Subject|0|||
143305442|NCT05627518|516670771|FG007|Treatment Period 2|Withdrawal by Subject|0|||
143305443|NCT04804813|516670772|FG000|Overall Study|Protocol Violation|2|||
143305444|NCT04804813|516670773|FG001|Overall Study|Protocol Violation|0|||
143305445|NCT04804813|516670772|FG000|Overall Study|Withdrawal by Subject|1|||
143305446|NCT04804813|516670773|FG001|Overall Study|Withdrawal by Subject|0|||
143305447|NCT03003520|516672605|FG000|Overall Study|Adverse Event|9|||
143305448|NCT03003520|516672606|FG001|Overall Study|Adverse Event|0|||
143305449|NCT03003520|516672605|FG000|Overall Study|Death|1|||
143305450|NCT03003520|516672606|FG001|Overall Study|Death|0|||
143305451|NCT03003520|516672605|FG000|Overall Study|Other reasons|4|||
143305452|NCT03003520|516672606|FG001|Overall Study|Other reasons|0|||
143305453|NCT03003520|516672605|FG000|Overall Study|Withdrawal by Subject|6|||
143305454|NCT03003520|516672606|FG001|Overall Study|Withdrawal by Subject|0|||
143305455|NCT03003520|516672605|FG000|Overall Study|Progressive disease|9|||
143305456|NCT03003520|516672606|FG001|Overall Study|Progressive disease|1|||
143305457|NCT01332149|516672607|FG000|Overall Study|Adverse Event|11|||
143305458|NCT01332149|516672608|FG001|Overall Study|Adverse Event|9|||
143305459|NCT01332149|516672607|FG000|Overall Study|Other unspecified|5|||
143305460|NCT01332149|516672608|FG001|Overall Study|Other unspecified|7|||
143305461|NCT01332149|516672607|FG000|Overall Study|Protocol Violation|1|||
143305462|NCT01332149|516672608|FG001|Overall Study|Protocol Violation|3|||
143305463|NCT01332149|516672607|FG000|Overall Study|Withdrawal by Subject|4|||
143305464|NCT01332149|516672608|FG001|Overall Study|Withdrawal by Subject|5|||
143305465|NCT01332149|516672607|FG000|Overall Study|Lost to Follow-up|1|||
143305466|NCT01332149|516672608|FG001|Overall Study|Lost to Follow-up|1|||
143305467|NCT01332149|516672607|FG000|Overall Study|Insufficient clinical response|4|||
143305468|NCT01332149|516672608|FG001|Overall Study|Insufficient clinical response|7|||
143305469|NCT01332149|516672607|FG000|Overall Study|Did not meet entrance criteria|3|||
143305470|NCT01332149|516672608|FG001|Overall Study|Did not meet entrance criteria|4|||
143305471|NCT01332149|516672607|FG000|Overall Study|Randomized but not treated|1|||
143305472|NCT01332149|516672608|FG001|Overall Study|Randomized but not treated|2|||
143305473|NCT02565381|516672609|FG000|Overall Study|Lost to Follow-up|1|||
143305474|NCT02565381|516672610|FG001|Overall Study|Lost to Follow-up|0|||
143305475|NCT02565381|516672611|FG002|Overall Study|Lost to Follow-up|1|||
143305476|NCT01914666|516672619|FG000|Treatment Period|Lack of Efficacy|0|||
143305477|NCT01914666|516672620|FG001|Treatment Period|Lack of Efficacy|0|||
143305478|NCT01914666|516672621|FG002|Treatment Period|Lack of Efficacy|2|||
143305479|NCT01914666|516672619|FG000|Treatment Period|Adverse Event|10|||
143305480|NCT01914666|516672620|FG001|Treatment Period|Adverse Event|4|||
143305481|NCT01914666|516672621|FG002|Treatment Period|Adverse Event|2|||
143305482|NCT01914666|516672619|FG000|Treatment Period|Withdrawal by Subject|3|||
143305483|NCT01914666|516672620|FG001|Treatment Period|Withdrawal by Subject|2|||
143305484|NCT01914666|516672621|FG002|Treatment Period|Withdrawal by Subject|2|||
143305485|NCT01914666|516672619|FG000|Treatment Period|Physician Decision|0|||
143305486|NCT01914666|516672620|FG001|Treatment Period|Physician Decision|0|||
143305487|NCT01914666|516672621|FG002|Treatment Period|Physician Decision|2|||
143305488|NCT02586012|516672622|FG000|Overall Study|Withdrawal by Subject|1|||
143305489|NCT02586012|516672623|FG001|Overall Study|Withdrawal by Subject|1|||
143305490|NCT02586012|516672624|FG002|Overall Study|Withdrawal by Subject|0|||
143305491|NCT02586012|516672625|FG003|Overall Study|Withdrawal by Subject|1|||
143305492|NCT02586012|516672626|FG004|Overall Study|Withdrawal by Subject|0|||
143305493|NCT02586012|516672627|FG005|Overall Study|Withdrawal by Subject|2|||
143305494|NCT02586012|516672622|FG000|Overall Study|Protocol Violation|0|||
143305495|NCT02586012|516672623|FG001|Overall Study|Protocol Violation|0|||
143305496|NCT02586012|516672624|FG002|Overall Study|Protocol Violation|0|||
143305497|NCT02586012|516672625|FG003|Overall Study|Protocol Violation|0|||
143305498|NCT02586012|516672626|FG004|Overall Study|Protocol Violation|0|||
143305499|NCT02586012|516672627|FG005|Overall Study|Protocol Violation|1|||
143305500|NCT02586012|516672622|FG000|Overall Study|study terminated|0|||
143305501|NCT02586012|516672623|FG001|Overall Study|study terminated|2|||
143305502|NCT02586012|516672624|FG002|Overall Study|study terminated|1|||
143305503|NCT02586012|516672625|FG003|Overall Study|study terminated|1|||
143305504|NCT02586012|516672626|FG004|Overall Study|study terminated|1|||
143305505|NCT02586012|516672627|FG005|Overall Study|study terminated|0|||
143305506|NCT02388737|516672629|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
143305507|NCT02388737|516672630|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
143305508|NCT02388737|516672631|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
143305509|NCT02388737|516672629|FG000|Overall Study|Major Protocol Deviation|18|||
143305510|NCT02388737|516672630|FG001|Overall Study|Major Protocol Deviation|25|||
143305511|NCT02388737|516672631|FG002|Overall Study|Major Protocol Deviation|22|||
143305512|NCT02388737|516672629|FG000|Overall Study|Lost to Follow-up|5|||
143305513|NCT02388737|516672630|FG001|Overall Study|Lost to Follow-up|1|||
143305514|NCT02388737|516672631|FG002|Overall Study|Lost to Follow-up|4|||
143305515|NCT02388737|516672629|FG000|Overall Study|Voluntary Withdrawal|10|||
143375233|NCT05001945|516918993|FG001|Overall Study|Not specified by Investigator|3|||
143375234|NCT05001945|516918994|FG002|Overall Study|Not specified by Investigator|0|||
143375235|NCT05001945|516918995|FG003|Overall Study|Not specified by Investigator|0|||
143375236|NCT05001945|516918996|FG004|Overall Study|Not specified by Investigator|1|||
143375237|NCT05001945|516918997|FG005|Overall Study|Not specified by Investigator|0|||
143375238|NCT05001945|516918998|FG006|Overall Study|Not specified by Investigator|0|||
143375239|NCT05001945|516918999|FG007|Overall Study|Not specified by Investigator|0|||
143375240|NCT02570711|516919000|FG000|Overall Study|Death|1|||
143375241|NCT02570711|516919001|FG001|Overall Study|Death|0|||
143375242|NCT02570711|516919000|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
143375243|NCT02570711|516919001|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
143375244|NCT02425111|516919002|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
143375245|NCT02425111|516919002|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
143375246|NCT02425111|516919002|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
143375247|NCT02425111|516919002|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
143375248|NCT02425111|516919002|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
143375249|NCT02425111|516919002|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
143375250|NCT00585533|516919003|FG000|Overall Study|objective or symptomatic progression|9|||
143375251|NCT00545077|516919004|FG000|Overall Study|Treatment not received|5|||
143375252|NCT00545077|516919005|FG001|Overall Study|Treatment not received|1|||
143375253|NCT00545077|516919004|FG000|Overall Study|Disease Progression|131|||
143375254|NCT00545077|516919005|FG001|Overall Study|Disease Progression|98|||
143375255|NCT00545077|516919004|FG000|Overall Study|Withdrawal by Subject|3|||
143375256|NCT00545077|516919005|FG001|Overall Study|Withdrawal by Subject|14|||
143375257|NCT00545077|516919004|FG000|Overall Study|Physician Decision|6|||
143375258|NCT00545077|516919005|FG001|Overall Study|Physician Decision|3|||
143375259|NCT00545077|516919004|FG000|Overall Study|Lost to Follow-up|2|||
143375260|NCT00545077|516919005|FG001|Overall Study|Lost to Follow-up|0|||
143375261|NCT00545077|516919004|FG000|Overall Study|Protocol Violation|1|||
143375262|NCT00545077|516919005|FG001|Overall Study|Protocol Violation|0|||
143375263|NCT00545077|516919004|FG000|Overall Study|Adverse Event|0|||
143375264|NCT00545077|516919005|FG001|Overall Study|Adverse Event|31|||
143375265|NCT00545077|516919004|FG000|Overall Study|Death|0|||
143375266|NCT00545077|516919005|FG001|Overall Study|Death|8|||
143375267|NCT00360698|516919006|FG000|Run-In|Physician Decision|0|||
143375268|NCT00360698|516919007|FG001|Run-In|Physician Decision|1|||
143375269|NCT00360698|516919006|FG000|Run-In|Withdrawal by Subject|0|||
143375270|NCT00360698|516919007|FG001|Run-In|Withdrawal by Subject|2|||
143375271|NCT00360698|516919006|FG000|Run-In|Non compliance with treatment procedure|0|||
143375272|NCT00360698|516919007|FG001|Run-In|Non compliance with treatment procedure|1|||
143375273|NCT00360698|516919006|FG000|Run-In|Sponsor request|0|||
143375274|NCT00360698|516919007|FG001|Run-In|Sponsor request|2|||
143375275|NCT00360698|516919006|FG000|Run-In|Patient did not meet inclusion criteria|0|||
143375276|NCT00360698|516919007|FG001|Run-In|Patient did not meet inclusion criteria|1|||
143375277|NCT00360698|516919006|FG000|Run-In|Patient personal reasons|0|||
143375278|NCT00360698|516919007|FG001|Run-In|Patient personal reasons|2|||
143375279|NCT00360698|516919006|FG000|Run-In|Need of insulin with meals|0|||
143375280|NCT00360698|516919007|FG001|Run-In|Need of insulin with meals|1|||
143375281|NCT00360698|516919006|FG000|Treatment Period|Non compliance with treatment procedure|1|||
143375282|NCT00360698|516919007|FG001|Treatment Period|Non compliance with treatment procedure|0|||
143375283|NCT00360698|516919006|FG000|Treatment Period|Early termination by error|0|||
143375284|NCT00360698|516919007|FG001|Treatment Period|Early termination by error|1|||
143375285|NCT04975308|516919008|FG000|Overall Study|Withdrawal by Subject|6|||
143375286|NCT04975308|516919009|FG001|Overall Study|Withdrawal by Subject|16|||
143375287|NCT04975308|516919010|FG002|Overall Study|Withdrawal by Subject|6|||
143375288|NCT04975308|516919008|FG000|Overall Study|Physician Decision|0|||
143375289|NCT04975308|516919009|FG001|Overall Study|Physician Decision|3|||
143305516|NCT02388737|516672630|FG001|Overall Study|Voluntary Withdrawal|18|||
143305517|NCT02388737|516672631|FG002|Overall Study|Voluntary Withdrawal|17|||
143305518|NCT02388737|516672629|FG000|Overall Study|Lack of Efficacy|3|||
143305519|NCT02388737|516672630|FG001|Overall Study|Lack of Efficacy|0|||
143305520|NCT02388737|516672631|FG002|Overall Study|Lack of Efficacy|3|||
143305521|NCT02388737|516672629|FG000|Overall Study|Reason Not Specified|5|||
143305522|NCT02388737|516672630|FG001|Overall Study|Reason Not Specified|5|||
143305523|NCT02388737|516672631|FG002|Overall Study|Reason Not Specified|4|||
143305524|NCT01920932|516672632|FG000|Overall Study|Death|1|||
143305525|NCT01920932|516672632|FG000|Overall Study|Withdrawal of consent|1|||
143375290|NCT04975308|516919010|FG002|Overall Study|Physician Decision|1|||
143375291|NCT04975308|516919008|FG000|Overall Study|Adverse Event|10|||
143375292|NCT04975308|516919009|FG001|Overall Study|Adverse Event|1|||
143375293|NCT04975308|516919010|FG002|Overall Study|Adverse Event|12|||
143375294|NCT04975308|516919008|FG000|Overall Study|On study treatment (Ongoing)|65|||
143305526|NCT03299842|516672633|FG000|Overall Study|Caregiver withdrew consent|2|||
143305527|NCT03299842|516672633|FG000|Overall Study|Child would not keep the watch on|3|||
143375295|NCT04975308|516919009|FG001|Overall Study|On study treatment (Ongoing)|43|||
143375296|NCT04975308|516919010|FG002|Overall Study|On study treatment (Ongoing)|75|||
143305528|NCT00071812|516672634|FG000|24-Week Double-Blind Period|Adverse Event|2|||
143305529|NCT00071812|516672635|FG001|24-Week Double-Blind Period|Adverse Event|3|||
143305530|NCT00071812|516672636|FG002|24-Week Double-Blind Period|Adverse Event|4|||
143305531|NCT00071812|516672637|FG003|24-Week Double-Blind Period|Adverse Event|4|||
143305532|NCT00071812|516672634|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
143305533|NCT00071812|516672635|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
143305534|NCT00071812|516672636|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
143305535|NCT00071812|516672637|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
143305536|NCT00071812|516672634|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
143305537|NCT00071812|516672635|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
143305538|NCT00071812|516672636|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
143305539|NCT00071812|516672637|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
143305540|NCT00071812|516672634|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
143305541|NCT00071812|516672635|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
143305542|NCT00071812|516672636|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
143305543|NCT00071812|516672637|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
143305544|NCT00071812|516672634|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
143305545|NCT00071812|516672635|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
143305546|NCT00071812|516672636|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
143305547|NCT00071812|516672637|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
143305548|NCT00071812|516672634|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
143305549|NCT00071812|516672635|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
143305550|NCT00071812|516672636|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
143305551|NCT00071812|516672637|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
143305552|NCT00071812|516672634|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
143305553|NCT00071812|516672635|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
143305554|NCT00071812|516672636|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
143305555|NCT00071812|516672637|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
143305556|NCT00071812|516672634|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
143305557|NCT00071812|516672635|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
143305558|NCT00071812|516672636|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
143305559|NCT00071812|516672637|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
143305560|NCT00071812|516672634|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
143305561|NCT00071812|516672635|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
143305562|NCT00071812|516672636|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
143305563|NCT00071812|516672637|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
143305564|NCT00071812|516672634|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
143305565|NCT00071812|516672635|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
143305566|NCT00071812|516672636|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
143305567|NCT00071812|516672637|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
143305568|NCT01816139|516672638|FG000|Overall Study|Adverse Event|6|||
143305569|NCT01816139|516672639|FG001|Overall Study|Adverse Event|8|||
143305570|NCT01816139|516672638|FG000|Overall Study|Lack of Efficacy|1|||
143305571|NCT01816139|516672639|FG001|Overall Study|Lack of Efficacy|2|||
143305572|NCT01816139|516672638|FG000|Overall Study|Lost to Follow-up|5|||
143305573|NCT01816139|516672639|FG001|Overall Study|Lost to Follow-up|3|||
143305574|NCT01816139|516672638|FG000|Overall Study|Withdrew Consent|6|||
143305575|NCT01816139|516672639|FG001|Overall Study|Withdrew Consent|4|||
143305576|NCT01816139|516672638|FG000|Overall Study|Protocol Violation|6|||
143305577|NCT01816139|516672639|FG001|Overall Study|Protocol Violation|3|||
143305578|NCT01816139|516672638|FG000|Overall Study|Reason not Specified|4|||
143305579|NCT01816139|516672639|FG001|Overall Study|Reason not Specified|2|||
143305580|NCT04013191|516672640|FG000|Overall Study|Adverse Event|1|||
143305581|NCT04013191|516672641|FG001|Overall Study|Adverse Event|0|||
143305582|NCT00358527|516672646|FG000|Overall Study|Adverse Event|4|||
143305583|NCT00358527|516672647|FG001|Overall Study|Adverse Event|0|||
143305584|NCT00358527|516672646|FG000|Overall Study|Withdrawal by Subject|1|||
143305585|NCT00358527|516672647|FG001|Overall Study|Withdrawal by Subject|1|||
143305586|NCT00358527|516672646|FG000|Overall Study|Non-compliance with protocol|6|||
143305587|NCT00358527|516672647|FG001|Overall Study|Non-compliance with protocol|1|||
143305588|NCT00358527|516672646|FG000|Overall Study|Administrative|2|||
143305589|NCT00358527|516672647|FG001|Overall Study|Administrative|1|||
143305590|NCT00749463|516672648|FG000|Overall Study|Adverse Event|0|||
143305591|NCT00749463|516672649|FG001|Overall Study|Adverse Event|4|||
143305592|NCT00749463|516672650|FG002|Overall Study|Adverse Event|1|||
143375297|NCT04975308|516919008|FG000|Overall Study|Protocol Deviation|4|||
143375298|NCT04975308|516919009|FG001|Overall Study|Protocol Deviation|3|||
143375299|NCT04975308|516919010|FG002|Overall Study|Protocol Deviation|2|||
143375300|NCT02709655|516919011|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
143305593|NCT00749463|516672648|FG000|Overall Study|Withdrawal by Subject|1|||
143375301|NCT02709655|516919012|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
143305594|NCT00749463|516672649|FG001|Overall Study|Withdrawal by Subject|0|||
143375302|NCT02709655|516919013|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
143375303|NCT02709655|516919014|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
143375304|NCT02709655|516919015|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
143375305|NCT02709655|516919011|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
143375306|NCT02709655|516919012|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
143375307|NCT02709655|516919013|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
143375308|NCT02709655|516919014|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
143375309|NCT02709655|516919015|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
143375310|NCT02709655|516919011|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
143375311|NCT02709655|516919012|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
143375312|NCT02709655|516919013|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
143375313|NCT02709655|516919014|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
143375314|NCT02709655|516919015|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
143375315|NCT02709655|516919011|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
143375316|NCT02709655|516919012|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
143375317|NCT02709655|516919013|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
143375318|NCT02709655|516919014|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
143375319|NCT02709655|516919015|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
143375320|NCT02709655|516919011|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
143375321|NCT02709655|516919012|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
143375322|NCT02709655|516919013|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
143375323|NCT02709655|516919014|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
143375324|NCT02709655|516919015|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
143375325|NCT02709655|516919011|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
143375326|NCT02709655|516919012|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
143375327|NCT02709655|516919013|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
143375328|NCT02709655|516919014|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
143375329|NCT02709655|516919015|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
143375330|NCT02709655|516919011|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
143375331|NCT02709655|516919012|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
143375332|NCT02709655|516919013|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
143375333|NCT02709655|516919014|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
143375334|NCT02709655|516919015|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
143375335|NCT02709655|516919011|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
143375336|NCT02709655|516919012|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
143375337|NCT02709655|516919013|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
143375338|NCT02709655|516919014|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
143375339|NCT02709655|516919015|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
143375340|NCT02709655|516919011|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
143375341|NCT02709655|516919012|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
143375342|NCT02709655|516919013|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
143305595|NCT00749463|516672650|FG002|Overall Study|Withdrawal by Subject|0|||
143305596|NCT00913744|516672652|FG000|Overall Study|Adverse Event|2|||
143305597|NCT00913744|516672653|FG001|Overall Study|Adverse Event|0|||
143305598|NCT00913744|516672652|FG000|Overall Study|Withdrawal by Subject|2|||
143305599|NCT00913744|516672653|FG001|Overall Study|Withdrawal by Subject|1|||
143305600|NCT00913744|516672652|FG000|Overall Study|Death|1|||
143305601|NCT00913744|516672653|FG001|Overall Study|Death|0|||
143305602|NCT01886833|516672654|FG000|Overall Study|IgA not available from both periods|204|||
143305603|NCT01454726|516672657|FG000|Overall Study|Withdrawal by Subject|0|||
143305604|NCT01454726|516672658|FG001|Overall Study|Withdrawal by Subject|1|||
143305605|NCT02223767|516672662|FG000|Overall Study|Withdrawal by Subject|4|||
143305606|NCT02223767|516672663|FG001|Overall Study|Withdrawal by Subject|4|||
143305607|NCT00934544|516672666|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
143305608|NCT00934544|516672667|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
143305609|NCT00934544|516672668|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
143305610|NCT00934544|516672666|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
143305611|NCT00934544|516672667|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
143305612|NCT00934544|516672668|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
143305613|NCT00934544|516672666|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
143305614|NCT00934544|516672667|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
143305615|NCT00934544|516672668|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
143305616|NCT00934544|516672666|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
143375343|NCT02709655|516919014|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
143375344|NCT02709655|516919015|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
143305617|NCT00934544|516672667|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
143305618|NCT00934544|516672668|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
143305619|NCT00934544|516672666|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
143375345|NCT02709655|516919011|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
143305620|NCT00934544|516672667|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
143305621|NCT00934544|516672668|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
143305622|NCT00934544|516672666|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
143305623|NCT00934544|516672667|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
143305624|NCT00934544|516672668|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
143305625|NCT00934544|516672666|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
143305626|NCT00934544|516672667|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
143305627|NCT00934544|516672668|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
143305628|NCT00934544|516672666|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
143305629|NCT00934544|516672667|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
143305630|NCT00934544|516672668|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
143305631|NCT00934544|516672666|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
143305632|NCT00934544|516672667|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
143305633|NCT00934544|516672668|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
143305634|NCT00934544|516672666|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
143305635|NCT00934544|516672667|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
143305636|NCT00934544|516672668|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
143305637|NCT00934544|516672666|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
143305638|NCT00934544|516672667|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
143305639|NCT00934544|516672668|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
143305640|NCT00934544|516672666|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
143305641|NCT00934544|516672667|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
143305642|NCT00934544|516672668|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
143305643|NCT00934544|516672666|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
143305644|NCT00934544|516672667|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
143305645|NCT00934544|516672668|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
143305646|NCT00934544|516672666|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
143305647|NCT00934544|516672667|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
143305648|NCT00934544|516672668|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
143305649|NCT00934544|516672666|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
143305650|NCT00934544|516672667|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
143305651|NCT00934544|516672668|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
143305652|NCT00934544|516672666|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
143305653|NCT00934544|516672667|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
143305654|NCT00934544|516672668|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
143305655|NCT01218516|516672669|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
143305656|NCT01218516|516672670|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
143305657|NCT01218516|516672671|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
143305658|NCT01218516|516672672|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
143305659|NCT01218516|516672669|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
143305660|NCT01218516|516672670|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
143305661|NCT01218516|516672671|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
143305662|NCT01218516|516672672|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
143305663|NCT01218516|516672669|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
143305664|NCT01218516|516672670|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
143305665|NCT01218516|516672671|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
143305666|NCT01218516|516672672|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
143305667|NCT01218516|516672669|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
143305668|NCT01218516|516672670|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
143305669|NCT01218516|516672671|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
143305670|NCT01218516|516672672|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
143305671|NCT01218516|516672669|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
143305672|NCT01218516|516672670|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
143305673|NCT01218516|516672671|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
143305674|NCT01218516|516672672|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
143305675|NCT01218516|516672669|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
143305676|NCT01218516|516672670|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
143305677|NCT01218516|516672671|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
143305678|NCT01218516|516672672|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
143305679|NCT01218516|516672669|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
143305680|NCT01218516|516672670|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
143305681|NCT01218516|516672671|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
143305682|NCT01218516|516672672|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
143305683|NCT01218516|516672669|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
143305684|NCT01218516|516672670|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
143305685|NCT01218516|516672671|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
143305686|NCT01218516|516672672|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
143305687|NCT01218516|516672669|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
143305688|NCT01218516|516672670|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
143305689|NCT01218516|516672671|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
143305690|NCT01218516|516672672|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
143305691|NCT01218516|516672669|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
143305692|NCT01218516|516672670|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
143305693|NCT01218516|516672671|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
143305694|NCT01218516|516672672|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
143305695|NCT01218516|516672669|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
143305696|NCT01218516|516672670|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
143305697|NCT01218516|516672671|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
143305698|NCT01218516|516672672|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
143305699|NCT01218516|516672669|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
143305700|NCT01218516|516672670|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
143305701|NCT01218516|516672671|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
143305702|NCT01218516|516672672|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
143305703|NCT02118428|516672673|FG000|Overall Study|Physician Decision|0|||
143305704|NCT02118428|516672674|FG001|Overall Study|Physician Decision|1|||
143305705|NCT02118428|516672675|FG002|Overall Study|Physician Decision|0|||
143305706|NCT02118428|516672673|FG000|Overall Study|Withdrawal by Subject|2|||
143305707|NCT02118428|516672674|FG001|Overall Study|Withdrawal by Subject|2|||
143305708|NCT02118428|516672675|FG002|Overall Study|Withdrawal by Subject|0|||
143305709|NCT02118428|516672673|FG000|Overall Study|Death|7|||
143305710|NCT02118428|516672674|FG001|Overall Study|Death|5|||
143305711|NCT02118428|516672675|FG002|Overall Study|Death|0|||
143305712|NCT02118428|516672673|FG000|Overall Study|Lost to Follow-up|3|||
143305713|NCT02118428|516672674|FG001|Overall Study|Lost to Follow-up|1|||
143305714|NCT02118428|516672675|FG002|Overall Study|Lost to Follow-up|0|||
143305715|NCT02118428|516672673|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
143305716|NCT02118428|516672674|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
143305717|NCT02118428|516672675|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
143305718|NCT00654381|516672679|FG000|1st Stage|Adverse Event|3|||
143305719|NCT00654381|516672680|FG001|1st Stage|Adverse Event|3|||
143305720|NCT00654381|516672681|FG002|1st Stage|Adverse Event|3|||
143305721|NCT00654381|516672682|FG003|1st Stage|Adverse Event|3|||
143305722|NCT00654381|516672683|FG004|1st Stage|Adverse Event|2|||
143305723|NCT00654381|516672684|FG005|1st Stage|Adverse Event|1|||
143305724|NCT00654381|516672679|FG000|1st Stage|Withdrawal by Subject|0|||
143305725|NCT00654381|516672680|FG001|1st Stage|Withdrawal by Subject|0|||
143305726|NCT00654381|516672681|FG002|1st Stage|Withdrawal by Subject|0|||
143305727|NCT00654381|516672682|FG003|1st Stage|Withdrawal by Subject|1|||
143305728|NCT00654381|516672683|FG004|1st Stage|Withdrawal by Subject|0|||
143305729|NCT00654381|516672684|FG005|1st Stage|Withdrawal by Subject|1|||
143305730|NCT00654381|516672679|FG000|1st Stage|Investigator's decision|0|||
143305731|NCT00654381|516672680|FG001|1st Stage|Investigator's decision|0|||
143305732|NCT00654381|516672681|FG002|1st Stage|Investigator's decision|0|||
143305733|NCT00654381|516672682|FG003|1st Stage|Investigator's decision|1|||
143305734|NCT00654381|516672683|FG004|1st Stage|Investigator's decision|0|||
143305735|NCT00654381|516672684|FG005|1st Stage|Investigator's decision|0|||
143305736|NCT00654381|516672679|FG000|2nd Stage|Adverse Event|2|||
143305737|NCT00654381|516672680|FG001|2nd Stage|Adverse Event|0|||
143305738|NCT00654381|516672681|FG002|2nd Stage|Adverse Event|2|||
143305739|NCT00654381|516672682|FG003|2nd Stage|Adverse Event|3|||
143305740|NCT00654381|516672683|FG004|2nd Stage|Adverse Event|7|||
143305741|NCT00654381|516672684|FG005|2nd Stage|Adverse Event|2|||
143305742|NCT00654381|516672679|FG000|2nd Stage|Withdrawal by Subject|0|||
143305743|NCT00654381|516672680|FG001|2nd Stage|Withdrawal by Subject|0|||
143305744|NCT00654381|516672681|FG002|2nd Stage|Withdrawal by Subject|0|||
143305745|NCT00654381|516672682|FG003|2nd Stage|Withdrawal by Subject|0|||
143305746|NCT00654381|516672683|FG004|2nd Stage|Withdrawal by Subject|1|||
143305747|NCT00654381|516672684|FG005|2nd Stage|Withdrawal by Subject|1|||
143305748|NCT00654381|516672679|FG000|2nd Stage|Investigator's decision|0|||
143305749|NCT00654381|516672680|FG001|2nd Stage|Investigator's decision|0|||
143305750|NCT00654381|516672681|FG002|2nd Stage|Investigator's decision|1|||
143305751|NCT00654381|516672682|FG003|2nd Stage|Investigator's decision|1|||
143305752|NCT00654381|516672683|FG004|2nd Stage|Investigator's decision|0|||
143305753|NCT00654381|516672684|FG005|2nd Stage|Investigator's decision|0|||
143305754|NCT00654381|516672679|FG000|Extension Stage|Adverse Event|1|||
143305755|NCT00654381|516672680|FG001|Extension Stage|Adverse Event|2|||
143305756|NCT00654381|516672681|FG002|Extension Stage|Adverse Event|9|||
143305757|NCT00654381|516672682|FG003|Extension Stage|Adverse Event|7|||
143305758|NCT00654381|516672683|FG004|Extension Stage|Adverse Event|1|||
143305759|NCT00654381|516672684|FG005|Extension Stage|Adverse Event|1|||
143305760|NCT00654381|516672679|FG000|Extension Stage|Protocol Violation|0|||
143305761|NCT00654381|516672680|FG001|Extension Stage|Protocol Violation|0|||
143305762|NCT00654381|516672681|FG002|Extension Stage|Protocol Violation|0|||
143305763|NCT00654381|516672682|FG003|Extension Stage|Protocol Violation|1|||
143305764|NCT00654381|516672683|FG004|Extension Stage|Protocol Violation|0|||
143305765|NCT00654381|516672684|FG005|Extension Stage|Protocol Violation|0|||
143305766|NCT00654381|516672679|FG000|Extension Stage|Lack of Efficacy|0|||
143305767|NCT00654381|516672680|FG001|Extension Stage|Lack of Efficacy|0|||
143305768|NCT00654381|516672681|FG002|Extension Stage|Lack of Efficacy|1|||
143305769|NCT00654381|516672682|FG003|Extension Stage|Lack of Efficacy|0|||
143305770|NCT00654381|516672683|FG004|Extension Stage|Lack of Efficacy|0|||
143305771|NCT00654381|516672684|FG005|Extension Stage|Lack of Efficacy|0|||
143305772|NCT00654381|516672679|FG000|Extension Stage|Withdrawal by Subject|0|||
143305773|NCT00654381|516672680|FG001|Extension Stage|Withdrawal by Subject|0|||
143305774|NCT00654381|516672681|FG002|Extension Stage|Withdrawal by Subject|1|||
143305775|NCT00654381|516672682|FG003|Extension Stage|Withdrawal by Subject|1|||
143305776|NCT00654381|516672683|FG004|Extension Stage|Withdrawal by Subject|1|||
143305777|NCT00654381|516672684|FG005|Extension Stage|Withdrawal by Subject|1|||
143305778|NCT00654381|516672679|FG000|Extension Stage|Closure of the trial site|0|||
143305779|NCT00654381|516672680|FG001|Extension Stage|Closure of the trial site|0|||
143305780|NCT00654381|516672681|FG002|Extension Stage|Closure of the trial site|0|||
143305781|NCT00654381|516672682|FG003|Extension Stage|Closure of the trial site|0|||
143305782|NCT00654381|516672683|FG004|Extension Stage|Closure of the trial site|1|||
143305783|NCT00654381|516672684|FG005|Extension Stage|Closure of the trial site|1|||
143305784|NCT00994448|516672686|FG000|Overall Study|Adverse Event|1|||
143305785|NCT00994448|516672687|FG001|Overall Study|Adverse Event|0|||
143305786|NCT00994448|516672686|FG000|Overall Study|Lost to Follow-up|5|||
143305787|NCT00994448|516672687|FG001|Overall Study|Lost to Follow-up|1|||
143305788|NCT00994448|516672686|FG000|Overall Study|Withdrawal by Subject|1|||
143305789|NCT00994448|516672687|FG001|Overall Study|Withdrawal by Subject|1|||
143305790|NCT00994448|516672686|FG000|Overall Study|Physician Decision|1|||
143305791|NCT00994448|516672687|FG001|Overall Study|Physician Decision|0|||
143305792|NCT04164901|516672690|FG000|Overall Study|Withdrawal by Subject|4|||
143305793|NCT04164901|516672691|FG001|Overall Study|Withdrawal by Subject|4|||
143305794|NCT02775344|516672692|FG000|Overall Study|No ovarian cyst identified|3|||
143305795|NCT02775344|516672693|FG001|Overall Study|No ovarian cyst identified|2|||
143305796|NCT04627064|516672695|FG000|Overall Study|Progressive disease|8|||
143305797|NCT04627064|516672696|FG001|Overall Study|Progressive disease|0|||
143305798|NCT04627064|516672695|FG000|Overall Study|Withdrawal by Subject|2|||
143305799|NCT04627064|516672696|FG001|Overall Study|Withdrawal by Subject|0|||
143305800|NCT04627064|516672695|FG000|Overall Study|Physician Decision|1|||
143305801|NCT04627064|516672696|FG001|Overall Study|Physician Decision|0|||
143305802|NCT04098458|516672699|FG000|Overall Study|Death|1|||
143305803|NCT04098458|516672699|FG000|Overall Study|did not meet study inclusion criteria|3|||
143305804|NCT00006489|516672700|FG000|Overall Study|Adverse Event|3|||
143305805|NCT00006489|516672701|FG001|Overall Study|Adverse Event|2|||
143305806|NCT00006489|516672702|FG002|Overall Study|Adverse Event|4|||
143305807|NCT00006489|516672703|FG003|Overall Study|Adverse Event|3|||
143305808|NCT00006489|516672700|FG000|Overall Study|Withdrawal by Subject|10|||
143305809|NCT00006489|516672701|FG001|Overall Study|Withdrawal by Subject|9|||
143305810|NCT00006489|516672702|FG002|Overall Study|Withdrawal by Subject|9|||
143305811|NCT00006489|516672703|FG003|Overall Study|Withdrawal by Subject|6|||
143305812|NCT00006489|516672700|FG000|Overall Study|Scheduling Conflict|0|||
143305813|NCT00006489|516672701|FG001|Overall Study|Scheduling Conflict|3|||
143305814|NCT00006489|516672702|FG002|Overall Study|Scheduling Conflict|2|||
143305815|NCT00006489|516672703|FG003|Overall Study|Scheduling Conflict|1|||
143305816|NCT00006489|516672700|FG000|Overall Study|Death|0|||
143305817|NCT00006489|516672701|FG001|Overall Study|Death|0|||
143305818|NCT00006489|516672702|FG002|Overall Study|Death|0|||
143305819|NCT00006489|516672703|FG003|Overall Study|Death|1|||
143305820|NCT02126969|516672704|FG000|Overall Study|Withdrawal by Subject|1|||
143305821|NCT02126969|516672705|FG001|Overall Study|Withdrawal by Subject|2|||
143305822|NCT01533246|516672706|FG000|Overall Study|Adverse Event|1|||
143305823|NCT01533246|516672706|FG000|Overall Study|Withdrawal by Subject|1|||
143305824|NCT00354172|516672707|FG000|Overall Study|Did not receive transplant|1|||
143305825|NCT00582933|516672710|FG000|Overall Study|Physician Decision|3|||
143305826|NCT02689258|516672711|FG000|Overall Study|Subject Non-Compliance|0|||
143305827|NCT02689258|516672712|FG001|Overall Study|Subject Non-Compliance|1|||
143305828|NCT02689258|516672713|FG002|Overall Study|Subject Non-Compliance|0|||
143305829|NCT02689258|516672714|FG003|Overall Study|Subject Non-Compliance|0|||
143305830|NCT02689258|516672715|FG004|Overall Study|Subject Non-Compliance|0|||
143305831|NCT02689258|516672716|FG005|Overall Study|Subject Non-Compliance|0|||
143305832|NCT02689258|516672717|FG006|Overall Study|Subject Non-Compliance|0|||
143305833|NCT02689258|516672718|FG007|Overall Study|Subject Non-Compliance|0|||
143305834|NCT02689258|516672719|FG008|Overall Study|Subject Non-Compliance|0|||
143305835|NCT02689258|516672720|FG009|Overall Study|Subject Non-Compliance|0|||
143305836|NCT02689258|516672721|FG010|Overall Study|Subject Non-Compliance|0|||
143305837|NCT02689258|516672722|FG011|Overall Study|Subject Non-Compliance|0|||
143305838|NCT02689258|516672711|FG000|Overall Study|Subject Refusal to Continue|0|||
143305839|NCT02689258|516672712|FG001|Overall Study|Subject Refusal to Continue|1|||
143305840|NCT02689258|516672713|FG002|Overall Study|Subject Refusal to Continue|0|||
143305841|NCT02689258|516672714|FG003|Overall Study|Subject Refusal to Continue|0|||
143305842|NCT02689258|516672715|FG004|Overall Study|Subject Refusal to Continue|0|||
143305843|NCT02689258|516672716|FG005|Overall Study|Subject Refusal to Continue|0|||
143305844|NCT02689258|516672717|FG006|Overall Study|Subject Refusal to Continue|0|||
143305845|NCT02689258|516672718|FG007|Overall Study|Subject Refusal to Continue|0|||
143305846|NCT02689258|516672719|FG008|Overall Study|Subject Refusal to Continue|1|||
143305847|NCT02689258|516672720|FG009|Overall Study|Subject Refusal to Continue|0|||
143305848|NCT02689258|516672721|FG010|Overall Study|Subject Refusal to Continue|0|||
143305849|NCT02689258|516672722|FG011|Overall Study|Subject Refusal to Continue|1|||
143305850|NCT02689258|516672711|FG000|Overall Study|Other|0|||
143305851|NCT02689258|516672712|FG001|Overall Study|Other|2|||
143305852|NCT02689258|516672713|FG002|Overall Study|Other|0|||
143305853|NCT02689258|516672714|FG003|Overall Study|Other|0|||
143305854|NCT02689258|516672715|FG004|Overall Study|Other|1|||
143305855|NCT02689258|516672716|FG005|Overall Study|Other|0|||
143305856|NCT02689258|516672717|FG006|Overall Study|Other|0|||
143305857|NCT02689258|516672718|FG007|Overall Study|Other|0|||
143305858|NCT02689258|516672719|FG008|Overall Study|Other|1|||
143305859|NCT02689258|516672720|FG009|Overall Study|Other|0|||
143305860|NCT02689258|516672721|FG010|Overall Study|Other|0|||
143305861|NCT02689258|516672722|FG011|Overall Study|Other|0|||
143305862|NCT04753164|516672723|FG000|Overall Study|Adverse Event|0|||
143305863|NCT04753164|516672724|FG001|Overall Study|Adverse Event|2|||
143305864|NCT04753164|516672723|FG000|Overall Study|Withdrawal by Subject|9|||
143305865|NCT04753164|516672724|FG001|Overall Study|Withdrawal by Subject|7|||
143305866|NCT04753164|516672723|FG000|Overall Study|Lost to Follow-up|6|||
143305867|NCT04753164|516672724|FG001|Overall Study|Lost to Follow-up|6|||
143305868|NCT04753164|516672723|FG000|Overall Study|Other|12|||
143305869|NCT04753164|516672724|FG001|Overall Study|Other|5|||
143305870|NCT01116232|516672728|FG000|Overall Study|Progressive diease|4|||
143305871|NCT03554291|516672729|FG000|Overall Study|Death|2|||
143305872|NCT03554291|516672730|FG001|Overall Study|Death|1|||
143305873|NCT03554291|516672729|FG000|Overall Study|Lost to Follow-up|1|||
143305874|NCT03554291|516672730|FG001|Overall Study|Lost to Follow-up|0|||
143305875|NCT03554291|516672729|FG000|Overall Study|Withdrawal by Subject|1|||
143375346|NCT02709655|516919012|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
143375347|NCT02709655|516919013|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
143375348|NCT02709655|516919014|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
143375349|NCT02709655|516919015|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
143375350|NCT02709655|516919011|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
143375351|NCT02709655|516919012|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
143375352|NCT02709655|516919013|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
143375353|NCT02709655|516919014|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
143375354|NCT02709655|516919015|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
143375355|NCT02709655|516919011|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
143375356|NCT02709655|516919012|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
143375357|NCT02709655|516919013|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
143375358|NCT02709655|516919014|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
143375359|NCT02709655|516919015|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
143375360|NCT02709655|516919011|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
143375361|NCT02709655|516919012|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
143375362|NCT02709655|516919013|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
143375363|NCT02709655|516919014|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
143375364|NCT02709655|516919015|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
143375365|NCT02709655|516919011|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
143375366|NCT02709655|516919012|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
143375367|NCT02709655|516919013|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
143375368|NCT02709655|516919014|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
143375369|NCT02709655|516919015|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
143375370|NCT02709655|516919011|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
143375371|NCT02709655|516919012|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
143375372|NCT02709655|516919013|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
143375373|NCT02709655|516919014|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
143375374|NCT02709655|516919015|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
143375375|NCT02709655|516919011|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
143375376|NCT02709655|516919012|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
143375377|NCT02709655|516919013|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
143375378|NCT02709655|516919014|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
143375379|NCT02709655|516919015|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
143375380|NCT01179334|516919016|FG000|Treatment Period|Adverse Event|1|||
143375381|NCT01179334|516919017|FG001|Treatment Period|Adverse Event|0|||
143375382|NCT01179334|516919016|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
143375383|NCT01179334|516919017|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
143375384|NCT01179334|516919016|FG000|Long-term Extension (LTE) Period|Death|3|||
143375385|NCT01179334|516919017|FG001|Long-term Extension (LTE) Period|Death|0|||
143375386|NCT01179334|516919016|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
143375387|NCT01179334|516919017|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
143375388|NCT00258895|516919018|FG000|Overall Study|Lost to Follow-up|3|||
143375389|NCT00258895|516919019|FG001|Overall Study|Lost to Follow-up|1|||
143375390|NCT00258895|516919018|FG000|Overall Study|Protocol Violation|6|||
143375391|NCT00258895|516919019|FG001|Overall Study|Protocol Violation|2|||
143375392|NCT00258895|516919018|FG000|Overall Study|Withdrawal by Subject|1|||
143305876|NCT03554291|516672730|FG001|Overall Study|Withdrawal by Subject|0|||
143305877|NCT03554291|516672729|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
143305878|NCT03554291|516672730|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
143305879|NCT01228747|516672731|FG000|Overall Study|Adverse Event|8|||
143305880|NCT01228747|516672732|FG001|Overall Study|Adverse Event|4|||
143305881|NCT01228747|516672731|FG000|Overall Study|Lack of Efficacy|40|||
143305882|NCT01228747|516672732|FG001|Overall Study|Lack of Efficacy|27|||
143305883|NCT01228747|516672731|FG000|Overall Study|Protocol Violation|6|||
143305884|NCT01228747|516672732|FG001|Overall Study|Protocol Violation|5|||
143305885|NCT01228747|516672731|FG000|Overall Study|Lost to Follow-up|4|||
143305886|NCT01228747|516672732|FG001|Overall Study|Lost to Follow-up|3|||
143305887|NCT01228747|516672731|FG000|Overall Study|Withdrawal by Subject|5|||
143305888|NCT01228747|516672732|FG001|Overall Study|Withdrawal by Subject|1|||
143305889|NCT01228747|516672731|FG000|Overall Study|Other Reason|2|||
143305890|NCT01228747|516672732|FG001|Overall Study|Other Reason|5|||
143305891|NCT02036502|516672733|FG000|Part 1:Dose Determination/Escalation|Death|3|||
143305892|NCT02036502|516672734|FG001|Part 1:Dose Determination/Escalation|Death|2|||
143305893|NCT02036502|516672735|FG002|Part 1:Dose Determination/Escalation|Death|0|||
143305894|NCT02036502|516672736|FG003|Part 1:Dose Determination/Escalation|Death|0|||
143305895|NCT02036502|516672737|FG004|Part 1:Dose Determination/Escalation|Death|0|||
143305896|NCT02036502|516672738|FG005|Part 1:Dose Determination/Escalation|Death|0|||
143305897|NCT02036502|516672739|FG006|Part 1:Dose Determination/Escalation|Death|0|||
143305898|NCT02036502|516672740|FG007|Part 1:Dose Determination/Escalation|Death|0|||
143305899|NCT02036502|516672733|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
143305900|NCT02036502|516672734|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
143305901|NCT02036502|516672735|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
143305902|NCT02036502|516672736|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
143305903|NCT02036502|516672737|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
143305904|NCT02036502|516672738|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
143305905|NCT02036502|516672739|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
143305906|NCT02036502|516672740|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
143305907|NCT02036502|516672733|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
143305908|NCT02036502|516672734|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
143305909|NCT02036502|516672735|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
143305910|NCT02036502|516672736|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
143305911|NCT02036502|516672737|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
143305912|NCT02036502|516672738|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
143305913|NCT02036502|516672739|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
143305914|NCT02036502|516672740|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
143305915|NCT02036502|516672733|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
143375393|NCT00258895|516919019|FG001|Overall Study|Withdrawal by Subject|0|||
143305916|NCT02036502|516672734|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
143305917|NCT02036502|516672735|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
143375394|NCT00547118|516919020|FG000|Overall Study|Did not qualify prior to starting drug|1|||
143375395|NCT00547118|516919021|FG001|Overall Study|Did not qualify prior to starting drug|1|||
143375396|NCT00547118|516919020|FG000|Overall Study|Study suspended|7|||
143375397|NCT00547118|516919021|FG001|Overall Study|Study suspended|8|||
143375398|NCT02248480|516919024|FG000|Overall Study|Lack of Efficacy|4|||
143375399|NCT02248480|516919025|FG001|Overall Study|Lack of Efficacy|6|||
143375400|NCT02248480|516919024|FG000|Overall Study|Adverse Event|11|||
143375401|NCT02248480|516919025|FG001|Overall Study|Adverse Event|2|||
143375402|NCT02248480|516919024|FG000|Overall Study|Withdrawal by Subject|2|||
143375403|NCT02248480|516919025|FG001|Overall Study|Withdrawal by Subject|4|||
143375404|NCT02248480|516919024|FG000|Overall Study|Entry Criteria Not Met|0|||
143375405|NCT02248480|516919025|FG001|Overall Study|Entry Criteria Not Met|1|||
143375406|NCT02248480|516919024|FG000|Overall Study|Other:Physician Decision|0|||
143375407|NCT02248480|516919025|FG001|Overall Study|Other:Physician Decision|1|||
143375408|NCT00834834|516919026|FG000|Overall Study|Withdrawal by Subject|4|||
143375409|NCT00834834|516919027|FG001|Overall Study|Withdrawal by Subject|3|||
143375410|NCT04009577|516919028|FG000|Core Study|Adverse Event|1|||
143375411|NCT04009577|516919029|FG001|Core Study|Adverse Event|0|||
143305918|NCT02036502|516672736|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
143305919|NCT02036502|516672737|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
143305920|NCT02036502|516672738|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
143305921|NCT02036502|516672739|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
143305922|NCT02036502|516672740|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
143305923|NCT02036502|516672733|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
143305924|NCT02036502|516672734|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
143305925|NCT02036502|516672735|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
143305926|NCT02036502|516672736|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
143305927|NCT02036502|516672737|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
143375412|NCT04009577|516919030|FG002|Core Study|Adverse Event|2|||
143375413|NCT04009577|516919031|FG003|Core Study|Adverse Event|4|||
143375414|NCT04009577|516919028|FG000|Core Study|Withdrawal by Subject|0|||
143305928|NCT02036502|516672738|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
143375415|NCT04009577|516919029|FG001|Core Study|Withdrawal by Subject|0|||
143305929|NCT02036502|516672739|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
143305930|NCT02036502|516672740|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
143305931|NCT02036502|516672733|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
143305932|NCT02036502|516672734|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
143305933|NCT02036502|516672735|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
143305934|NCT02036502|516672736|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
143305935|NCT02036502|516672737|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
143305936|NCT02036502|516672738|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
143305937|NCT02036502|516672739|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
143305938|NCT02036502|516672740|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
143305939|NCT02036502|516672733|FG000|Part 2:Dose Confirmation|Death|0|||
143305940|NCT02036502|516672734|FG001|Part 2:Dose Confirmation|Death|0|||
143305941|NCT02036502|516672735|FG002|Part 2:Dose Confirmation|Death|1|||
143305942|NCT02036502|516672736|FG003|Part 2:Dose Confirmation|Death|0|||
143305943|NCT02036502|516672737|FG004|Part 2:Dose Confirmation|Death|0|||
143305944|NCT02036502|516672738|FG005|Part 2:Dose Confirmation|Death|0|||
143305945|NCT02036502|516672739|FG006|Part 2:Dose Confirmation|Death|0|||
143305946|NCT02036502|516672740|FG007|Part 2:Dose Confirmation|Death|0|||
143305947|NCT02036502|516672733|FG000|Part 2:Dose Confirmation|Not treated|0|||
143305948|NCT02036502|516672734|FG001|Part 2:Dose Confirmation|Not treated|0|||
143305949|NCT02036502|516672735|FG002|Part 2:Dose Confirmation|Not treated|0|||
143305950|NCT02036502|516672736|FG003|Part 2:Dose Confirmation|Not treated|1|||
143305951|NCT02036502|516672737|FG004|Part 2:Dose Confirmation|Not treated|0|||
143305952|NCT02036502|516672738|FG005|Part 2:Dose Confirmation|Not treated|0|||
143305953|NCT02036502|516672739|FG006|Part 2:Dose Confirmation|Not treated|0|||
143305954|NCT02036502|516672740|FG007|Part 2:Dose Confirmation|Not treated|0|||
143305955|NCT02036502|516672733|FG000|Part 3:Dose Expansion|Adverse Event|0|||
143305956|NCT02036502|516672734|FG001|Part 3:Dose Expansion|Adverse Event|0|||
143305957|NCT02036502|516672735|FG002|Part 3:Dose Expansion|Adverse Event|0|||
143305958|NCT02036502|516672736|FG003|Part 3:Dose Expansion|Adverse Event|0|||
143305959|NCT02036502|516672737|FG004|Part 3:Dose Expansion|Adverse Event|0|||
143305960|NCT02036502|516672738|FG005|Part 3:Dose Expansion|Adverse Event|4|||
143305961|NCT02036502|516672739|FG006|Part 3:Dose Expansion|Adverse Event|0|||
143305962|NCT02036502|516672740|FG007|Part 3:Dose Expansion|Adverse Event|2|||
143305963|NCT02036502|516672733|FG000|Part 3:Dose Expansion|Death|0|||
143305964|NCT02036502|516672734|FG001|Part 3:Dose Expansion|Death|0|||
143305965|NCT02036502|516672735|FG002|Part 3:Dose Expansion|Death|0|||
143305966|NCT02036502|516672736|FG003|Part 3:Dose Expansion|Death|0|||
143305967|NCT02036502|516672737|FG004|Part 3:Dose Expansion|Death|0|||
143305968|NCT02036502|516672738|FG005|Part 3:Dose Expansion|Death|24|||
143305969|NCT02036502|516672739|FG006|Part 3:Dose Expansion|Death|0|||
143305970|NCT02036502|516672740|FG007|Part 3:Dose Expansion|Death|3|||
143305971|NCT02036502|516672733|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
143305972|NCT02036502|516672734|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
143305973|NCT02036502|516672735|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
143305974|NCT02036502|516672736|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
143305975|NCT02036502|516672737|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
143305976|NCT02036502|516672738|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
143305977|NCT02036502|516672739|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
143305978|NCT02036502|516672740|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
143305979|NCT02036502|516672733|FG000|Part 3:Dose Expansion|Physician Decision|0|||
143305980|NCT02036502|516672734|FG001|Part 3:Dose Expansion|Physician Decision|0|||
143305981|NCT02036502|516672735|FG002|Part 3:Dose Expansion|Physician Decision|0|||
143305982|NCT02036502|516672736|FG003|Part 3:Dose Expansion|Physician Decision|0|||
143305983|NCT02036502|516672737|FG004|Part 3:Dose Expansion|Physician Decision|0|||
143305984|NCT02036502|516672738|FG005|Part 3:Dose Expansion|Physician Decision|1|||
143305985|NCT02036502|516672739|FG006|Part 3:Dose Expansion|Physician Decision|0|||
143305986|NCT02036502|516672740|FG007|Part 3:Dose Expansion|Physician Decision|0|||
143305987|NCT02036502|516672733|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
143305988|NCT02036502|516672734|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
143305989|NCT02036502|516672735|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
143305990|NCT02036502|516672736|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
143305991|NCT02036502|516672737|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
143305992|NCT02036502|516672738|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
143305993|NCT02036502|516672739|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
143305994|NCT02036502|516672740|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
143305995|NCT02036502|516672733|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
143305996|NCT02036502|516672734|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
143305997|NCT02036502|516672735|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
143305998|NCT02036502|516672736|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
143305999|NCT02036502|516672737|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
143306000|NCT02036502|516672738|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
143306001|NCT02036502|516672739|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
143306002|NCT02036502|516672740|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
143306003|NCT02036502|516672733|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
143375416|NCT04009577|516919030|FG002|Core Study|Withdrawal by Subject|2|||
143375417|NCT04009577|516919031|FG003|Core Study|Withdrawal by Subject|0|||
143375418|NCT04009577|516919028|FG000|Core Study|Other|0|||
143306004|NCT02036502|516672734|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
143306005|NCT02036502|516672735|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
143306006|NCT02036502|516672736|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
143306007|NCT02036502|516672737|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
143306008|NCT02036502|516672738|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
143306009|NCT02036502|516672739|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
143306010|NCT02036502|516672740|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
143306011|NCT02036502|516672733|FG000|Part 3:Dose Expansion|Not Treated|0|||
143306012|NCT02036502|516672734|FG001|Part 3:Dose Expansion|Not Treated|0|||
143306013|NCT02036502|516672735|FG002|Part 3:Dose Expansion|Not Treated|0|||
143306014|NCT02036502|516672736|FG003|Part 3:Dose Expansion|Not Treated|0|||
143306015|NCT02036502|516672737|FG004|Part 3:Dose Expansion|Not Treated|0|||
143306016|NCT02036502|516672738|FG005|Part 3:Dose Expansion|Not Treated|2|||
143306017|NCT02036502|516672739|FG006|Part 3:Dose Expansion|Not Treated|0|||
143306018|NCT02036502|516672740|FG007|Part 3:Dose Expansion|Not Treated|0|||
143306019|NCT01068509|516672746|FG000|Overall Study|Death|0|||
143306020|NCT01068509|516672747|FG001|Overall Study|Death|0|||
143306021|NCT01068509|516672748|FG002|Overall Study|Death|1|||
143306022|NCT01068509|516672746|FG000|Overall Study|Disease Progression|5|||
143306023|NCT01068509|516672747|FG001|Overall Study|Disease Progression|20|||
143306024|NCT01068509|516672748|FG002|Overall Study|Disease Progression|18|||
143306025|NCT01068509|516672746|FG000|Overall Study|Lost to Follow-up|1|||
143306026|NCT01068509|516672747|FG001|Overall Study|Lost to Follow-up|0|||
143306027|NCT01068509|516672748|FG002|Overall Study|Lost to Follow-up|0|||
143306028|NCT01068509|516672746|FG000|Overall Study|Withdrew Consent|0|||
143306029|NCT01068509|516672747|FG001|Overall Study|Withdrew Consent|1|||
143306030|NCT01068509|516672748|FG002|Overall Study|Withdrew Consent|2|||
143306031|NCT01068509|516672746|FG000|Overall Study|Reason Not Specified|0|||
143306032|NCT01068509|516672747|FG001|Overall Study|Reason Not Specified|1|||
143306033|NCT01068509|516672748|FG002|Overall Study|Reason Not Specified|0|||
143306034|NCT02357940|516672753|FG000|Overall Study|Adverse Event|0|||
143306035|NCT02357940|516672754|FG001|Overall Study|Adverse Event|1|||
143306036|NCT02357940|516672753|FG000|Overall Study|Investigator's judgement|0|||
143306037|NCT02357940|516672754|FG001|Overall Study|Investigator's judgement|1|||
143306038|NCT02641379|516672755|FG000|Overall Study|Exclusion criterion during screening|1|||
143306039|NCT02641379|516672756|FG001|Overall Study|Exclusion criterion during screening|0|||
143306040|NCT02641379|516672757|FG002|Overall Study|Exclusion criterion during screening|0|||
143306041|NCT02641379|516672758|FG003|Overall Study|Exclusion criterion during screening|1|||
143306042|NCT02641379|516672759|FG004|Overall Study|Exclusion criterion during screening|2|||
143306043|NCT02641379|516672760|FG005|Overall Study|Exclusion criterion during screening|0|||
143306044|NCT02641379|516672761|FG006|Overall Study|Exclusion criterion during screening|0|||
143306045|NCT02641379|516672762|FG007|Overall Study|Exclusion criterion during screening|0|||
143306046|NCT02641379|516672763|FG008|Overall Study|Exclusion criterion during screening|0|||
143306047|NCT02641379|516672764|FG009|Overall Study|Exclusion criterion during screening|0|||
143306048|NCT02641379|516672765|FG010|Overall Study|Exclusion criterion during screening|0|||
143306049|NCT02641379|516672755|FG000|Overall Study|Withdrawal of informed consent|0|||
143306050|NCT02641379|516672756|FG001|Overall Study|Withdrawal of informed consent|1|||
143306051|NCT02641379|516672757|FG002|Overall Study|Withdrawal of informed consent|0|||
143306052|NCT02641379|516672758|FG003|Overall Study|Withdrawal of informed consent|0|||
143306053|NCT02641379|516672759|FG004|Overall Study|Withdrawal of informed consent|0|||
143306054|NCT02641379|516672760|FG005|Overall Study|Withdrawal of informed consent|0|||
143306055|NCT02641379|516672761|FG006|Overall Study|Withdrawal of informed consent|0|||
143306056|NCT02641379|516672762|FG007|Overall Study|Withdrawal of informed consent|1|||
143306057|NCT02641379|516672763|FG008|Overall Study|Withdrawal of informed consent|0|||
143306058|NCT02641379|516672764|FG009|Overall Study|Withdrawal of informed consent|0|||
143306059|NCT02641379|516672765|FG010|Overall Study|Withdrawal of informed consent|0|||
143306060|NCT02641379|516672755|FG000|Overall Study|Adverse Event|7|||
143306061|NCT02641379|516672756|FG001|Overall Study|Adverse Event|8|||
143306062|NCT02641379|516672757|FG002|Overall Study|Adverse Event|2|||
143306063|NCT02641379|516672758|FG003|Overall Study|Adverse Event|2|||
143306064|NCT02641379|516672759|FG004|Overall Study|Adverse Event|5|||
143306065|NCT02641379|516672760|FG005|Overall Study|Adverse Event|1|||
143306066|NCT02641379|516672761|FG006|Overall Study|Adverse Event|5|||
143306067|NCT02641379|516672762|FG007|Overall Study|Adverse Event|0|||
143375419|NCT04009577|516919029|FG001|Core Study|Other|0|||
143375420|NCT04009577|516919030|FG002|Core Study|Other|0|||
143306068|NCT02641379|516672763|FG008|Overall Study|Adverse Event|1|||
143306069|NCT02641379|516672764|FG009|Overall Study|Adverse Event|1|||
143306070|NCT02641379|516672765|FG010|Overall Study|Adverse Event|5|||
143306071|NCT02641379|516672755|FG000|Overall Study|Lack of Efficacy|0|||
143306072|NCT02641379|516672756|FG001|Overall Study|Lack of Efficacy|0|||
143306073|NCT02641379|516672757|FG002|Overall Study|Lack of Efficacy|2|||
143375421|NCT04009577|516919031|FG003|Core Study|Other|1|||
143375422|NCT04009577|516919028|FG000|Extension Phase|Adverse Event|0|||
143375423|NCT04009577|516919029|FG001|Extension Phase|Adverse Event|0|||
143375424|NCT04009577|516919030|FG002|Extension Phase|Adverse Event|0|||
143375425|NCT04009577|516919031|FG003|Extension Phase|Adverse Event|1|||
143375426|NCT04009577|516919028|FG000|Extension Phase|Inadequate therapeutic effect|0|||
143375427|NCT04009577|516919029|FG001|Extension Phase|Inadequate therapeutic effect|0|||
143375428|NCT04009577|516919030|FG002|Extension Phase|Inadequate therapeutic effect|1|||
143375429|NCT04009577|516919031|FG003|Extension Phase|Inadequate therapeutic effect|0|||
143375430|NCT04009577|516919028|FG000|Extension Phase|Withdrawal by Subject|0|||
143375431|NCT04009577|516919029|FG001|Extension Phase|Withdrawal by Subject|0|||
143375432|NCT04009577|516919030|FG002|Extension Phase|Withdrawal by Subject|1|||
143375433|NCT04009577|516919031|FG003|Extension Phase|Withdrawal by Subject|0|||
143375434|NCT04009577|516919028|FG000|Extension Phase|Not Treated|0|||
143375435|NCT04009577|516919029|FG001|Extension Phase|Not Treated|0|||
143375436|NCT04009577|516919030|FG002|Extension Phase|Not Treated|2|||
143375437|NCT04009577|516919031|FG003|Extension Phase|Not Treated|0|||
143375438|NCT00305695|516919036|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
143375439|NCT00305695|516919037|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
143375440|NCT00305695|516919036|FG000|Overall Study|Did not have baseline scan|1|||
143375441|NCT00305695|516919037|FG001|Overall Study|Did not have baseline scan|1|||
143375442|NCT00658996|516919038|FG000|First Intervention|Positive slit lamp finding|1|||
143375443|NCT00658996|516919039|FG001|First Intervention|Positive slit lamp finding|0|||
143375444|NCT00658996|516919038|FG000|First Intervention|Lack of lenses|0|||
143375445|NCT00658996|516919039|FG001|First Intervention|Lack of lenses|1|||
143375446|NCT00658996|516919038|FG000|Crossover Period|Physician Decision|1|||
143375447|NCT00658996|516919039|FG001|Crossover Period|Physician Decision|0|||
143375448|NCT00658996|516919038|FG000|Crossover Period|Ineligible|1|||
143375449|NCT00658996|516919039|FG001|Crossover Period|Ineligible|1|||
143375450|NCT00658996|516919038|FG000|Second Intervention|Developed a stye on upper lid|1|||
143375451|NCT00658996|516919039|FG001|Second Intervention|Developed a stye on upper lid|0|||
143375452|NCT00658996|516919038|FG000|Second Intervention|Positive slit lamp finding|0|||
143375453|NCT00658996|516919039|FG001|Second Intervention|Positive slit lamp finding|1|||
143375454|NCT01810263|516919046|FG000|Overall Study|Lost to Follow-up|8|||
143375455|NCT01810263|516919047|FG001|Overall Study|Lost to Follow-up|7|||
143375456|NCT01390402|516919048|FG000|Overall Study|Death|1|||
143375457|NCT01390402|516919048|FG000|Overall Study|Disease Progression|4|||
143375458|NCT01353963|516919049|FG000|Overall Study|Adverse Event|2|||
143375459|NCT01121549|516919050|FG000|Overall Study|Adverse Event|10|||
143375460|NCT01121549|516919050|FG000|Overall Study|Lack of Efficacy|11|||
143375461|NCT01121549|516919050|FG000|Overall Study|Lost to Follow-up|12|||
143375462|NCT01121549|516919050|FG000|Overall Study|Did not meet entrance criteria|9|||
143375463|NCT01121549|516919050|FG000|Overall Study|Study terminated by sponsor|197|||
143375464|NCT01121549|516919050|FG000|Overall Study|Pregnancy|1|||
143375465|NCT01121549|516919050|FG000|Overall Study|Protocol Violation|33|||
143375466|NCT01121549|516919050|FG000|Overall Study|Withdrawal by Subject|16|||
143375467|NCT01121549|516919050|FG000|Overall Study|Other|58|||
143375468|NCT04789408|516919051|FG000|Overall Study|Death|4|||
143375469|NCT04789408|516919052|FG001|Overall Study|Death|3|||
143375470|NCT04789408|516919053|FG002|Overall Study|Death|6|||
143375471|NCT04789408|516919051|FG000|Overall Study|Did not meet eligibility criteria|1|||
143375472|NCT04789408|516919052|FG001|Overall Study|Did not meet eligibility criteria|0|||
143375473|NCT04789408|516919053|FG002|Overall Study|Did not meet eligibility criteria|0|||
143375474|NCT04789408|516919051|FG000|Overall Study|Participant withdrawal of consent from further follow-up|0|||
143375475|NCT04789408|516919052|FG001|Overall Study|Participant withdrawal of consent from further follow-up|0|||
143375476|NCT04789408|516919053|FG002|Overall Study|Participant withdrawal of consent from further follow-up|1|||
143375477|NCT03215927|516920422|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
143375478|NCT03215927|516920423|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
143375479|NCT03215927|516920422|FG000|Open Label Extension|Adverse Event|1|||
143375480|NCT03215927|516920423|FG001|Open Label Extension|Adverse Event|0|||
143375481|NCT03215927|516920422|FG000|Open Label Extension|Lack of Efficacy|1|||
143375482|NCT03215927|516920423|FG001|Open Label Extension|Lack of Efficacy|0|||
143375483|NCT03215927|516920422|FG000|Open Label Extension|Death|0|||
143375484|NCT03215927|516920423|FG001|Open Label Extension|Death|1|||
143375485|NCT03779048|516920426|FG000|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|8|||
143375486|NCT03779048|516920427|FG001|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
143375487|NCT03779048|516920428|FG002|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
143375488|NCT03779048|516920426|FG000|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|5|||
143306074|NCT02641379|516672758|FG003|Overall Study|Lack of Efficacy|0|||
143306075|NCT02641379|516672759|FG004|Overall Study|Lack of Efficacy|0|||
143306076|NCT02641379|516672760|FG005|Overall Study|Lack of Efficacy|2|||
143306077|NCT02641379|516672761|FG006|Overall Study|Lack of Efficacy|0|||
143306078|NCT02641379|516672762|FG007|Overall Study|Lack of Efficacy|5|||
143306079|NCT02641379|516672763|FG008|Overall Study|Lack of Efficacy|0|||
143306080|NCT02641379|516672764|FG009|Overall Study|Lack of Efficacy|0|||
143306081|NCT02641379|516672765|FG010|Overall Study|Lack of Efficacy|0|||
143306082|NCT02641379|516672755|FG000|Overall Study|Participant unable to attend study visit|4|||
143306083|NCT02641379|516672756|FG001|Overall Study|Participant unable to attend study visit|10|||
143306084|NCT02641379|516672757|FG002|Overall Study|Participant unable to attend study visit|1|||
143306085|NCT02641379|516672758|FG003|Overall Study|Participant unable to attend study visit|2|||
143306086|NCT02641379|516672759|FG004|Overall Study|Participant unable to attend study visit|5|||
143306087|NCT02641379|516672760|FG005|Overall Study|Participant unable to attend study visit|1|||
143306088|NCT02641379|516672761|FG006|Overall Study|Participant unable to attend study visit|1|||
143306089|NCT02641379|516672762|FG007|Overall Study|Participant unable to attend study visit|1|||
143306090|NCT02641379|516672763|FG008|Overall Study|Participant unable to attend study visit|0|||
143306091|NCT02641379|516672764|FG009|Overall Study|Participant unable to attend study visit|2|||
143306092|NCT02641379|516672765|FG010|Overall Study|Participant unable to attend study visit|0|||
143306093|NCT02641379|516672755|FG000|Overall Study|Participant's compliance|0|||
143306094|NCT02641379|516672756|FG001|Overall Study|Participant's compliance|1|||
143306095|NCT02641379|516672757|FG002|Overall Study|Participant's compliance|0|||
143306096|NCT02641379|516672758|FG003|Overall Study|Participant's compliance|1|||
143306097|NCT02641379|516672759|FG004|Overall Study|Participant's compliance|0|||
143306098|NCT02641379|516672760|FG005|Overall Study|Participant's compliance|2|||
143306099|NCT02641379|516672761|FG006|Overall Study|Participant's compliance|0|||
143306100|NCT02641379|516672762|FG007|Overall Study|Participant's compliance|0|||
143306101|NCT02641379|516672763|FG008|Overall Study|Participant's compliance|1|||
143306102|NCT02641379|516672764|FG009|Overall Study|Participant's compliance|1|||
143306103|NCT02641379|516672765|FG010|Overall Study|Participant's compliance|1|||
143306104|NCT02641379|516672755|FG000|Overall Study|Participant cannot be reached|4|||
143306105|NCT02641379|516672756|FG001|Overall Study|Participant cannot be reached|4|||
143306106|NCT02641379|516672757|FG002|Overall Study|Participant cannot be reached|0|||
143306107|NCT02641379|516672758|FG003|Overall Study|Participant cannot be reached|8|||
143306108|NCT02641379|516672759|FG004|Overall Study|Participant cannot be reached|2|||
143306109|NCT02641379|516672760|FG005|Overall Study|Participant cannot be reached|1|||
143306110|NCT02641379|516672761|FG006|Overall Study|Participant cannot be reached|0|||
143306111|NCT02641379|516672762|FG007|Overall Study|Participant cannot be reached|1|||
143306112|NCT02641379|516672763|FG008|Overall Study|Participant cannot be reached|0|||
143306113|NCT02641379|516672764|FG009|Overall Study|Participant cannot be reached|2|||
143306114|NCT02641379|516672765|FG010|Overall Study|Participant cannot be reached|1|||
143306115|NCT02641379|516672755|FG000|Overall Study|PCR positive at Week 24|15|||
143306116|NCT02641379|516672756|FG001|Overall Study|PCR positive at Week 24|21|||
143306117|NCT02641379|516672757|FG002|Overall Study|PCR positive at Week 24|62|||
143306118|NCT02641379|516672758|FG003|Overall Study|PCR positive at Week 24|0|||
143306119|NCT02641379|516672759|FG004|Overall Study|PCR positive at Week 24|0|||
143306120|NCT02641379|516672760|FG005|Overall Study|PCR positive at Week 24|6|||
143306121|NCT02641379|516672761|FG006|Overall Study|PCR positive at Week 24|3|||
143306122|NCT02641379|516672762|FG007|Overall Study|PCR positive at Week 24|8|||
143306123|NCT02641379|516672763|FG008|Overall Study|PCR positive at Week 24|0|||
143306124|NCT02641379|516672764|FG009|Overall Study|PCR positive at Week 24|1|||
143306125|NCT02641379|516672765|FG010|Overall Study|PCR positive at Week 24|0|||
143306126|NCT02641379|516672755|FG000|Overall Study|PCR positive at follow up 2|1|||
143306127|NCT02641379|516672756|FG001|Overall Study|PCR positive at follow up 2|0|||
143306128|NCT02641379|516672757|FG002|Overall Study|PCR positive at follow up 2|0|||
143306129|NCT02641379|516672758|FG003|Overall Study|PCR positive at follow up 2|0|||
143306130|NCT02641379|516672759|FG004|Overall Study|PCR positive at follow up 2|0|||
143306131|NCT02641379|516672760|FG005|Overall Study|PCR positive at follow up 2|0|||
143306132|NCT02641379|516672761|FG006|Overall Study|PCR positive at follow up 2|0|||
143306133|NCT02641379|516672762|FG007|Overall Study|PCR positive at follow up 2|0|||
143306134|NCT02641379|516672763|FG008|Overall Study|PCR positive at follow up 2|0|||
143306135|NCT02641379|516672764|FG009|Overall Study|PCR positive at follow up 2|0|||
143306136|NCT02641379|516672765|FG010|Overall Study|PCR positive at follow up 2|0|||
143306137|NCT02641379|516672755|FG000|Overall Study|Participant showed relapse|1|||
143306138|NCT02641379|516672756|FG001|Overall Study|Participant showed relapse|0|||
143306139|NCT02641379|516672757|FG002|Overall Study|Participant showed relapse|0|||
143306140|NCT02641379|516672758|FG003|Overall Study|Participant showed relapse|0|||
143306141|NCT02641379|516672759|FG004|Overall Study|Participant showed relapse|0|||
143306142|NCT02641379|516672760|FG005|Overall Study|Participant showed relapse|0|||
143306143|NCT02641379|516672761|FG006|Overall Study|Participant showed relapse|1|||
143306144|NCT02641379|516672762|FG007|Overall Study|Participant showed relapse|0|||
143306145|NCT02641379|516672763|FG008|Overall Study|Participant showed relapse|0|||
143306146|NCT02641379|516672764|FG009|Overall Study|Participant showed relapse|0|||
143306147|NCT02641379|516672765|FG010|Overall Study|Participant showed relapse|0|||
143306148|NCT02641379|516672755|FG000|Overall Study|Participant stopped study/treatment|1|||
143306149|NCT02641379|516672756|FG001|Overall Study|Participant stopped study/treatment|3|||
143306150|NCT02641379|516672757|FG002|Overall Study|Participant stopped study/treatment|1|||
143306151|NCT02641379|516672758|FG003|Overall Study|Participant stopped study/treatment|0|||
143306152|NCT02641379|516672759|FG004|Overall Study|Participant stopped study/treatment|0|||
143306153|NCT02641379|516672760|FG005|Overall Study|Participant stopped study/treatment|1|||
143306154|NCT02641379|516672761|FG006|Overall Study|Participant stopped study/treatment|2|||
143306155|NCT02641379|516672762|FG007|Overall Study|Participant stopped study/treatment|0|||
143306156|NCT02641379|516672763|FG008|Overall Study|Participant stopped study/treatment|1|||
143306157|NCT02641379|516672764|FG009|Overall Study|Participant stopped study/treatment|0|||
143306158|NCT02641379|516672765|FG010|Overall Study|Participant stopped study/treatment|0|||
143306159|NCT02641379|516672755|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
143306160|NCT02641379|516672756|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
143306161|NCT02641379|516672757|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
143306162|NCT02641379|516672758|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
143306163|NCT02641379|516672759|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
143306164|NCT02641379|516672760|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
143306165|NCT02641379|516672761|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
143306166|NCT02641379|516672762|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
143306167|NCT02641379|516672763|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
143306168|NCT02641379|516672764|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
143306169|NCT02641379|516672765|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
143306170|NCT02641379|516672755|FG000|Overall Study|Financial problems|0|||
143306171|NCT02641379|516672756|FG001|Overall Study|Financial problems|1|||
143306172|NCT02641379|516672757|FG002|Overall Study|Financial problems|0|||
143306173|NCT02641379|516672758|FG003|Overall Study|Financial problems|0|||
143306174|NCT02641379|516672759|FG004|Overall Study|Financial problems|0|||
143306175|NCT02641379|516672760|FG005|Overall Study|Financial problems|0|||
143306176|NCT02641379|516672761|FG006|Overall Study|Financial problems|0|||
143306177|NCT02641379|516672762|FG007|Overall Study|Financial problems|0|||
143306178|NCT02641379|516672763|FG008|Overall Study|Financial problems|0|||
143306179|NCT02641379|516672764|FG009|Overall Study|Financial problems|0|||
143306180|NCT02641379|516672765|FG010|Overall Study|Financial problems|0|||
143306181|NCT02641379|516672755|FG000|Overall Study|PCR positive at Week 68|0|||
143306182|NCT02641379|516672756|FG001|Overall Study|PCR positive at Week 68|1|||
143306183|NCT02641379|516672757|FG002|Overall Study|PCR positive at Week 68|0|||
143306184|NCT02641379|516672758|FG003|Overall Study|PCR positive at Week 68|0|||
143306185|NCT02641379|516672759|FG004|Overall Study|PCR positive at Week 68|0|||
143306186|NCT02641379|516672760|FG005|Overall Study|PCR positive at Week 68|0|||
143306187|NCT02641379|516672761|FG006|Overall Study|PCR positive at Week 68|0|||
143306188|NCT02641379|516672762|FG007|Overall Study|PCR positive at Week 68|0|||
143306189|NCT02641379|516672763|FG008|Overall Study|PCR positive at Week 68|0|||
143306190|NCT02641379|516672764|FG009|Overall Study|PCR positive at Week 68|0|||
143306191|NCT02641379|516672765|FG010|Overall Study|PCR positive at Week 68|0|||
143306192|NCT02641379|516672755|FG000|Overall Study|PCR positive at Week 48|0|||
143306193|NCT02641379|516672756|FG001|Overall Study|PCR positive at Week 48|1|||
143306194|NCT02641379|516672757|FG002|Overall Study|PCR positive at Week 48|0|||
143306195|NCT02641379|516672758|FG003|Overall Study|PCR positive at Week 48|0|||
143306196|NCT02641379|516672759|FG004|Overall Study|PCR positive at Week 48|0|||
143306197|NCT02641379|516672760|FG005|Overall Study|PCR positive at Week 48|0|||
143306198|NCT02641379|516672761|FG006|Overall Study|PCR positive at Week 48|0|||
143306199|NCT02641379|516672762|FG007|Overall Study|PCR positive at Week 48|0|||
143306200|NCT02641379|516672763|FG008|Overall Study|PCR positive at Week 48|0|||
143306201|NCT02641379|516672764|FG009|Overall Study|PCR positive at Week 48|0|||
143306202|NCT02641379|516672765|FG010|Overall Study|PCR positive at Week 48|0|||
143306203|NCT02641379|516672755|FG000|Overall Study|PCR not performed at Week 12|0|||
143306204|NCT02641379|516672756|FG001|Overall Study|PCR not performed at Week 12|0|||
143306205|NCT02641379|516672757|FG002|Overall Study|PCR not performed at Week 12|1|||
143306206|NCT02641379|516672758|FG003|Overall Study|PCR not performed at Week 12|0|||
143306207|NCT02641379|516672759|FG004|Overall Study|PCR not performed at Week 12|0|||
143306208|NCT02641379|516672760|FG005|Overall Study|PCR not performed at Week 12|0|||
143306209|NCT02641379|516672761|FG006|Overall Study|PCR not performed at Week 12|0|||
143306210|NCT02641379|516672762|FG007|Overall Study|PCR not performed at Week 12|0|||
143306211|NCT02641379|516672763|FG008|Overall Study|PCR not performed at Week 12|0|||
143306212|NCT02641379|516672764|FG009|Overall Study|PCR not performed at Week 12|0|||
143306213|NCT02641379|516672765|FG010|Overall Study|PCR not performed at Week 12|0|||
143306214|NCT02641379|516672755|FG000|Overall Study|No PCR at baseline|0|||
143306215|NCT02641379|516672756|FG001|Overall Study|No PCR at baseline|0|||
143306216|NCT02641379|516672757|FG002|Overall Study|No PCR at baseline|1|||
143306217|NCT02641379|516672758|FG003|Overall Study|No PCR at baseline|0|||
143306218|NCT02641379|516672759|FG004|Overall Study|No PCR at baseline|0|||
143306219|NCT02641379|516672760|FG005|Overall Study|No PCR at baseline|0|||
143306220|NCT02641379|516672761|FG006|Overall Study|No PCR at baseline|0|||
143306221|NCT02641379|516672762|FG007|Overall Study|No PCR at baseline|0|||
143306222|NCT02641379|516672763|FG008|Overall Study|No PCR at baseline|0|||
143306223|NCT02641379|516672764|FG009|Overall Study|No PCR at baseline|0|||
143306224|NCT02641379|516672765|FG010|Overall Study|No PCR at baseline|0|||
143306225|NCT02641379|516672755|FG000|Overall Study|PCR positive at Week 28|0|||
143306226|NCT02641379|516672756|FG001|Overall Study|PCR positive at Week 28|0|||
143306227|NCT02641379|516672757|FG002|Overall Study|PCR positive at Week 28|1|||
143306228|NCT02641379|516672758|FG003|Overall Study|PCR positive at Week 28|0|||
143306229|NCT02641379|516672759|FG004|Overall Study|PCR positive at Week 28|0|||
143306230|NCT02641379|516672760|FG005|Overall Study|PCR positive at Week 28|0|||
143306231|NCT02641379|516672761|FG006|Overall Study|PCR positive at Week 28|0|||
143306232|NCT02641379|516672762|FG007|Overall Study|PCR positive at Week 28|0|||
143306233|NCT02641379|516672763|FG008|Overall Study|PCR positive at Week 28|0|||
143306234|NCT02641379|516672764|FG009|Overall Study|PCR positive at Week 28|0|||
143306235|NCT02641379|516672765|FG010|Overall Study|PCR positive at Week 28|0|||
143306236|NCT02641379|516672755|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
143306237|NCT02641379|516672756|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
143306238|NCT02641379|516672757|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
143306239|NCT02641379|516672758|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
143306240|NCT02641379|516672759|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
143306241|NCT02641379|516672760|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
143306242|NCT02641379|516672761|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
143306243|NCT02641379|516672762|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
143306244|NCT02641379|516672763|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
143306245|NCT02641379|516672764|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
143306246|NCT02641379|516672765|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
143306247|NCT02641379|516672755|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
143306248|NCT02641379|516672756|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
143306249|NCT02641379|516672757|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
143306250|NCT02641379|516672758|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
143306251|NCT02641379|516672759|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
143306252|NCT02641379|516672760|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
143306253|NCT02641379|516672761|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
143306254|NCT02641379|516672762|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
143306255|NCT02641379|516672763|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
143306256|NCT02641379|516672764|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
143306257|NCT02641379|516672765|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
143306258|NCT02641379|516672755|FG000|Overall Study|Baseline viral load unavailable|0|||
143306259|NCT02641379|516672756|FG001|Overall Study|Baseline viral load unavailable|0|||
143306260|NCT02641379|516672757|FG002|Overall Study|Baseline viral load unavailable|0|||
143306261|NCT02641379|516672758|FG003|Overall Study|Baseline viral load unavailable|1|||
143306262|NCT02641379|516672759|FG004|Overall Study|Baseline viral load unavailable|0|||
143306263|NCT02641379|516672760|FG005|Overall Study|Baseline viral load unavailable|0|||
143306264|NCT02641379|516672761|FG006|Overall Study|Baseline viral load unavailable|0|||
143306265|NCT02641379|516672762|FG007|Overall Study|Baseline viral load unavailable|0|||
143306266|NCT02641379|516672763|FG008|Overall Study|Baseline viral load unavailable|0|||
143306267|NCT02641379|516672764|FG009|Overall Study|Baseline viral load unavailable|0|||
143306268|NCT02641379|516672765|FG010|Overall Study|Baseline viral load unavailable|0|||
143306269|NCT02641379|516672755|FG000|Overall Study|Blood could not be drawn|0|||
143306270|NCT02641379|516672756|FG001|Overall Study|Blood could not be drawn|0|||
143306271|NCT02641379|516672757|FG002|Overall Study|Blood could not be drawn|0|||
143306272|NCT02641379|516672758|FG003|Overall Study|Blood could not be drawn|0|||
143306273|NCT02641379|516672759|FG004|Overall Study|Blood could not be drawn|1|||
143306274|NCT02641379|516672760|FG005|Overall Study|Blood could not be drawn|0|||
143306275|NCT02641379|516672761|FG006|Overall Study|Blood could not be drawn|0|||
143306276|NCT02641379|516672762|FG007|Overall Study|Blood could not be drawn|0|||
143306277|NCT02641379|516672763|FG008|Overall Study|Blood could not be drawn|0|||
143306278|NCT02641379|516672764|FG009|Overall Study|Blood could not be drawn|0|||
143306279|NCT02641379|516672765|FG010|Overall Study|Blood could not be drawn|0|||
143306280|NCT02641379|516672755|FG000|Overall Study|Protocol Violation|0|||
143306281|NCT02641379|516672756|FG001|Overall Study|Protocol Violation|0|||
143306282|NCT02641379|516672757|FG002|Overall Study|Protocol Violation|0|||
143306283|NCT02641379|516672758|FG003|Overall Study|Protocol Violation|0|||
143306284|NCT02641379|516672759|FG004|Overall Study|Protocol Violation|2|||
143306285|NCT02641379|516672760|FG005|Overall Study|Protocol Violation|0|||
143306286|NCT02641379|516672761|FG006|Overall Study|Protocol Violation|0|||
143306287|NCT02641379|516672762|FG007|Overall Study|Protocol Violation|0|||
143306288|NCT02641379|516672763|FG008|Overall Study|Protocol Violation|1|||
143306289|NCT02641379|516672764|FG009|Overall Study|Protocol Violation|0|||
143306290|NCT02641379|516672765|FG010|Overall Study|Protocol Violation|0|||
143306291|NCT02641379|516672755|FG000|Overall Study|Participation in sili rescue study|0|||
143306292|NCT02641379|516672756|FG001|Overall Study|Participation in sili rescue study|0|||
143306293|NCT02641379|516672757|FG002|Overall Study|Participation in sili rescue study|0|||
143306294|NCT02641379|516672758|FG003|Overall Study|Participation in sili rescue study|0|||
143306295|NCT02641379|516672759|FG004|Overall Study|Participation in sili rescue study|0|||
143306296|NCT02641379|516672760|FG005|Overall Study|Participation in sili rescue study|1|||
143306297|NCT02641379|516672761|FG006|Overall Study|Participation in sili rescue study|0|||
143306298|NCT02641379|516672762|FG007|Overall Study|Participation in sili rescue study|0|||
143306299|NCT02641379|516672763|FG008|Overall Study|Participation in sili rescue study|0|||
143306300|NCT02641379|516672764|FG009|Overall Study|Participation in sili rescue study|0|||
143306301|NCT02641379|516672765|FG010|Overall Study|Participation in sili rescue study|0|||
143306302|NCT02641379|516672755|FG000|Overall Study|Lost to Follow-up|0|||
143306303|NCT02641379|516672756|FG001|Overall Study|Lost to Follow-up|0|||
143306304|NCT02641379|516672757|FG002|Overall Study|Lost to Follow-up|0|||
143306305|NCT02641379|516672758|FG003|Overall Study|Lost to Follow-up|0|||
143306306|NCT02641379|516672759|FG004|Overall Study|Lost to Follow-up|0|||
143306307|NCT02641379|516672760|FG005|Overall Study|Lost to Follow-up|0|||
143306308|NCT02641379|516672761|FG006|Overall Study|Lost to Follow-up|0|||
143306309|NCT02641379|516672762|FG007|Overall Study|Lost to Follow-up|0|||
143306310|NCT02641379|516672763|FG008|Overall Study|Lost to Follow-up|1|||
143306311|NCT02641379|516672764|FG009|Overall Study|Lost to Follow-up|0|||
143306312|NCT02641379|516672765|FG010|Overall Study|Lost to Follow-up|0|||
143306313|NCT02641379|516672755|FG000|Overall Study|Source data not found|0|||
143306314|NCT02641379|516672756|FG001|Overall Study|Source data not found|0|||
143306315|NCT02641379|516672757|FG002|Overall Study|Source data not found|0|||
143306316|NCT02641379|516672758|FG003|Overall Study|Source data not found|0|||
143306317|NCT02641379|516672759|FG004|Overall Study|Source data not found|0|||
143306318|NCT02641379|516672760|FG005|Overall Study|Source data not found|1|||
143306319|NCT02641379|516672761|FG006|Overall Study|Source data not found|0|||
143306320|NCT02641379|516672762|FG007|Overall Study|Source data not found|0|||
143306321|NCT02641379|516672763|FG008|Overall Study|Source data not found|0|||
143306322|NCT02641379|516672764|FG009|Overall Study|Source data not found|0|||
143306323|NCT02641379|516672765|FG010|Overall Study|Source data not found|0|||
143306324|NCT02641379|516672755|FG000|Overall Study|Participant showed weight reduction|0|||
143306325|NCT02641379|516672756|FG001|Overall Study|Participant showed weight reduction|0|||
143306326|NCT02641379|516672757|FG002|Overall Study|Participant showed weight reduction|0|||
143306327|NCT02641379|516672758|FG003|Overall Study|Participant showed weight reduction|0|||
143306328|NCT02641379|516672759|FG004|Overall Study|Participant showed weight reduction|0|||
143306329|NCT02641379|516672760|FG005|Overall Study|Participant showed weight reduction|0|||
143306330|NCT02641379|516672761|FG006|Overall Study|Participant showed weight reduction|0|||
143306331|NCT02641379|516672762|FG007|Overall Study|Participant showed weight reduction|1|||
143306332|NCT02641379|516672763|FG008|Overall Study|Participant showed weight reduction|0|||
143306333|NCT02641379|516672764|FG009|Overall Study|Participant showed weight reduction|0|||
143306334|NCT02641379|516672765|FG010|Overall Study|Participant showed weight reduction|0|||
143306335|NCT02641379|516672755|FG000|Overall Study|Non-response Week 12|0|||
143306336|NCT02641379|516672756|FG001|Overall Study|Non-response Week 12|0|||
143306337|NCT02641379|516672757|FG002|Overall Study|Non-response Week 12|0|||
143306338|NCT02641379|516672758|FG003|Overall Study|Non-response Week 12|0|||
143306339|NCT02641379|516672759|FG004|Overall Study|Non-response Week 12|0|||
143306340|NCT02641379|516672760|FG005|Overall Study|Non-response Week 12|0|||
143306341|NCT02641379|516672761|FG006|Overall Study|Non-response Week 12|0|||
143306342|NCT02641379|516672762|FG007|Overall Study|Non-response Week 12|1|||
143306343|NCT02641379|516672763|FG008|Overall Study|Non-response Week 12|0|||
143375489|NCT03779048|516920427|FG001|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
143375490|NCT03779048|516920428|FG002|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
143375491|NCT03779048|516920426|FG000|Phase 2: Randomized Trial|Lost to Follow-up|0|||
143375492|NCT03779048|516920427|FG001|Phase 2: Randomized Trial|Lost to Follow-up|2|||
143375493|NCT03779048|516920428|FG002|Phase 2: Randomized Trial|Lost to Follow-up|2|||
143375494|NCT00493649|516920430|FG000|Overall Study|Adverse Event|44|||
143375495|NCT00493649|516920430|FG000|Overall Study|Patient Request|21|||
143375496|NCT00493649|516920430|FG000|Overall Study|Investigator Request|2|||
143375497|NCT00493649|516920430|FG000|Overall Study|Disease Progression|1|||
143375498|NCT00493649|516920430|FG000|Overall Study|Lost to Follow-up|1|||
143375499|NCT00493649|516920430|FG000|Overall Study|Other|13|||
143306344|NCT02641379|516672764|FG009|Overall Study|Non-response Week 12|0|||
143306345|NCT02641379|516672765|FG010|Overall Study|Non-response Week 12|0|||
143306346|NCT02641379|516672755|FG000|Overall Study|No 2 Log drop at Week 12|0|||
143306347|NCT02641379|516672756|FG001|Overall Study|No 2 Log drop at Week 12|0|||
143306348|NCT02641379|516672757|FG002|Overall Study|No 2 Log drop at Week 12|0|||
143306349|NCT02641379|516672758|FG003|Overall Study|No 2 Log drop at Week 12|0|||
143306350|NCT02641379|516672759|FG004|Overall Study|No 2 Log drop at Week 12|0|||
143306351|NCT02641379|516672760|FG005|Overall Study|No 2 Log drop at Week 12|0|||
143306352|NCT02641379|516672761|FG006|Overall Study|No 2 Log drop at Week 12|0|||
143306353|NCT02641379|516672762|FG007|Overall Study|No 2 Log drop at Week 12|0|||
143306354|NCT02641379|516672763|FG008|Overall Study|No 2 Log drop at Week 12|0|||
143306355|NCT02641379|516672764|FG009|Overall Study|No 2 Log drop at Week 12|0|||
143306356|NCT02641379|516672765|FG010|Overall Study|No 2 Log drop at Week 12|1|||
143306357|NCT02641379|516672755|FG000|Overall Study|Negative PCR result|0|||
143306358|NCT02641379|516672756|FG001|Overall Study|Negative PCR result|0|||
143306359|NCT02641379|516672757|FG002|Overall Study|Negative PCR result|0|||
143306360|NCT02641379|516672758|FG003|Overall Study|Negative PCR result|0|||
143306361|NCT02641379|516672759|FG004|Overall Study|Negative PCR result|0|||
143306362|NCT02641379|516672760|FG005|Overall Study|Negative PCR result|0|||
143306363|NCT02641379|516672761|FG006|Overall Study|Negative PCR result|0|||
143306364|NCT02641379|516672762|FG007|Overall Study|Negative PCR result|0|||
143306365|NCT02641379|516672763|FG008|Overall Study|Negative PCR result|0|||
143306366|NCT02641379|516672764|FG009|Overall Study|Negative PCR result|1|||
143306367|NCT02641379|516672765|FG010|Overall Study|Negative PCR result|0|||
143306368|NCT02641379|516672755|FG000|Overall Study|Participant's PCR high|0|||
143306369|NCT02641379|516672756|FG001|Overall Study|Participant's PCR high|0|||
143306370|NCT02641379|516672757|FG002|Overall Study|Participant's PCR high|0|||
143306371|NCT02641379|516672758|FG003|Overall Study|Participant's PCR high|0|||
143306372|NCT02641379|516672759|FG004|Overall Study|Participant's PCR high|0|||
143306373|NCT02641379|516672760|FG005|Overall Study|Participant's PCR high|0|||
143306374|NCT02641379|516672761|FG006|Overall Study|Participant's PCR high|0|||
143306375|NCT02641379|516672762|FG007|Overall Study|Participant's PCR high|1|||
143306376|NCT02641379|516672763|FG008|Overall Study|Participant's PCR high|0|||
143306377|NCT02641379|516672764|FG009|Overall Study|Participant's PCR high|0|||
143306378|NCT02641379|516672765|FG010|Overall Study|Participant's PCR high|0|||
143306379|NCT02641379|516672755|FG000|Overall Study|Participant treated after Week 24|0|||
143306380|NCT02641379|516672756|FG001|Overall Study|Participant treated after Week 24|0|||
143306381|NCT02641379|516672757|FG002|Overall Study|Participant treated after Week 24|0|||
143306382|NCT02641379|516672758|FG003|Overall Study|Participant treated after Week 24|0|||
143306383|NCT02641379|516672759|FG004|Overall Study|Participant treated after Week 24|0|||
143306384|NCT02641379|516672760|FG005|Overall Study|Participant treated after Week 24|0|||
143306385|NCT02641379|516672761|FG006|Overall Study|Participant treated after Week 24|0|||
143306386|NCT02641379|516672762|FG007|Overall Study|Participant treated after Week 24|0|||
143306387|NCT02641379|516672763|FG008|Overall Study|Participant treated after Week 24|1|||
143375500|NCT01662336|516920443|FG000|Overall Study|Adverse Event|1|||
143306388|NCT02641379|516672764|FG009|Overall Study|Participant treated after Week 24|0|||
143306389|NCT02641379|516672765|FG010|Overall Study|Participant treated after Week 24|0|||
143306390|NCT02641379|516672755|FG000|Overall Study|Missing PCR result at Week 8|0|||
143306391|NCT02641379|516672756|FG001|Overall Study|Missing PCR result at Week 8|0|||
143306392|NCT02641379|516672757|FG002|Overall Study|Missing PCR result at Week 8|0|||
143375501|NCT01662336|516920443|FG000|Overall Study|No longer on LPV/r|30|||
143306393|NCT02641379|516672758|FG003|Overall Study|Missing PCR result at Week 8|0|||
143306394|NCT02641379|516672759|FG004|Overall Study|Missing PCR result at Week 8|0|||
143306395|NCT02641379|516672760|FG005|Overall Study|Missing PCR result at Week 8|0|||
143306396|NCT02641379|516672761|FG006|Overall Study|Missing PCR result at Week 8|0|||
143306397|NCT02641379|516672762|FG007|Overall Study|Missing PCR result at Week 8|0|||
143306398|NCT02641379|516672763|FG008|Overall Study|Missing PCR result at Week 8|0|||
143306399|NCT02641379|516672764|FG009|Overall Study|Missing PCR result at Week 8|1|||
143306400|NCT02641379|516672765|FG010|Overall Study|Missing PCR result at Week 8|0|||
143306401|NCT02641379|516672755|FG000|Overall Study|PCR positive|0|||
143306402|NCT02641379|516672756|FG001|Overall Study|PCR positive|0|||
143306403|NCT02641379|516672757|FG002|Overall Study|PCR positive|0|||
143306404|NCT02641379|516672758|FG003|Overall Study|PCR positive|0|||
143306405|NCT02641379|516672759|FG004|Overall Study|PCR positive|0|||
143306406|NCT02641379|516672760|FG005|Overall Study|PCR positive|0|||
143306407|NCT02641379|516672761|FG006|Overall Study|PCR positive|1|||
143306408|NCT02641379|516672762|FG007|Overall Study|PCR positive|0|||
143306409|NCT02641379|516672763|FG008|Overall Study|PCR positive|0|||
143306410|NCT02641379|516672764|FG009|Overall Study|PCR positive|0|||
143306411|NCT02641379|516672765|FG010|Overall Study|PCR positive|0|||
143306412|NCT01165138|516672766|FG000|Overall Study|Adverse Event|0|||
143306413|NCT01165138|516672767|FG001|Overall Study|Adverse Event|1|||
143306414|NCT01165138|516672768|FG002|Overall Study|Adverse Event|0|||
143306415|NCT01165138|516672769|FG003|Overall Study|Adverse Event|2|||
143306416|NCT01165138|516672766|FG000|Overall Study|Lack of Efficacy|0|||
143306417|NCT01165138|516672767|FG001|Overall Study|Lack of Efficacy|32|||
143306418|NCT01165138|516672768|FG002|Overall Study|Lack of Efficacy|6|||
143306419|NCT01165138|516672769|FG003|Overall Study|Lack of Efficacy|7|||
143306420|NCT01165138|516672766|FG000|Overall Study|Protocol Violation|0|||
143306421|NCT01165138|516672767|FG001|Overall Study|Protocol Violation|7|||
143306422|NCT01165138|516672768|FG002|Overall Study|Protocol Violation|0|||
143306423|NCT01165138|516672769|FG003|Overall Study|Protocol Violation|2|||
143306424|NCT01165138|516672766|FG000|Overall Study|Lost to Follow-up|0|||
143306425|NCT01165138|516672767|FG001|Overall Study|Lost to Follow-up|0|||
143306426|NCT01165138|516672768|FG002|Overall Study|Lost to Follow-up|1|||
143306427|NCT01165138|516672769|FG003|Overall Study|Lost to Follow-up|2|||
143306428|NCT01165138|516672766|FG000|Overall Study|Physician Decision|0|||
143306429|NCT01165138|516672767|FG001|Overall Study|Physician Decision|6|||
143306430|NCT01165138|516672768|FG002|Overall Study|Physician Decision|7|||
143306431|NCT01165138|516672769|FG003|Overall Study|Physician Decision|6|||
143306432|NCT01165138|516672766|FG000|Overall Study|Withdrawal by Subject|0|||
143306433|NCT01165138|516672767|FG001|Overall Study|Withdrawal by Subject|6|||
143306434|NCT01165138|516672768|FG002|Overall Study|Withdrawal by Subject|6|||
143306435|NCT01165138|516672769|FG003|Overall Study|Withdrawal by Subject|3|||
143306436|NCT03274986|516672774|FG000|Overall Study|Withdrawal by Subject|0|||
143306437|NCT03274986|516672775|FG001|Overall Study|Withdrawal by Subject|1|||
143306438|NCT03274986|516672774|FG000|Overall Study|Lost to Follow-up|0|||
143306439|NCT03274986|516672775|FG001|Overall Study|Lost to Follow-up|1|||
143306440|NCT02357147|516672776|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
143306441|NCT02357147|516672777|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
143306442|NCT02357147|516672776|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
143306443|NCT02357147|516672777|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
143306444|NCT02357147|516672776|FG000|Combination Treatment Phase|Investigator Discretion|1|||
143306445|NCT02357147|516672777|FG001|Combination Treatment Phase|Investigator Discretion|1|||
143306446|NCT02357147|516672776|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
143306447|NCT02357147|516672777|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
143306448|NCT02357147|516672776|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
143306449|NCT02357147|516672777|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
143306450|NCT02357147|516672776|FG000|Combination Treatment Phase|Adverse Event|12|||
143306451|NCT02357147|516672777|FG001|Combination Treatment Phase|Adverse Event|4|||
143306452|NCT02357147|516672776|FG000|Combination Treatment Phase|Death|1|||
143306453|NCT02357147|516672777|FG001|Combination Treatment Phase|Death|1|||
143306454|NCT02357147|516672776|FG000|Combination Treatment Phase|Sponsor Decision|0|||
143306455|NCT02357147|516672777|FG001|Combination Treatment Phase|Sponsor Decision|12|||
143306456|NCT02357147|516672776|FG000|Combination Treatment Phase|Other|1|||
143306457|NCT02357147|516672777|FG001|Combination Treatment Phase|Other|0|||
143306458|NCT02357147|516672776|FG000|Combination Treatment Phase|Not treated|0|||
143306459|NCT02357147|516672777|FG001|Combination Treatment Phase|Not treated|2|||
143306460|NCT02357147|516672776|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
143306461|NCT02357147|516672777|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
143306462|NCT02357147|516672776|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
143306463|NCT02357147|516672777|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
143306464|NCT02357147|516672776|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
143375502|NCT01662336|516920443|FG000|Overall Study|Other|29|||
143375503|NCT01662336|516920443|FG000|Overall Study|Withdrawal by Subject|6|||
143375504|NCT02189252|516920444|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
143375505|NCT02189252|516920445|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
143375506|NCT02189252|516920446|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
143375507|NCT02189252|516920447|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
143375508|NCT02189252|516920444|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
143375509|NCT02189252|516920445|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
143306465|NCT02357147|516672777|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
143375510|NCT02189252|516920446|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
143375511|NCT02189252|516920447|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
143375512|NCT04603924|516920448|FG000|Overall Study|Not Dosed|2|||
143375513|NCT04603924|516920449|FG001|Overall Study|Not Dosed|1|||
143375514|NCT04603924|516920448|FG000|Overall Study|Withdrawal by Subject|6|||
143306466|NCT02357147|516672776|FG000|Maintenance Treatment Phase|Adverse Event|0|||
143306467|NCT02357147|516672777|FG001|Maintenance Treatment Phase|Adverse Event|3|||
143306468|NCT02357147|516672776|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
143306469|NCT02357147|516672777|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
143306470|NCT02357147|516672776|FG000|Maintenance Treatment Phase|Not Treated|1|||
143306471|NCT02357147|516672777|FG001|Maintenance Treatment Phase|Not Treated|0|||
143306472|NCT03962543|516672780|FG000|Treatment Phase|Death|0|||
143306473|NCT03962543|516672781|FG001|Treatment Phase|Death|1|||
143306474|NCT03962543|516672780|FG000|Treatment Phase|Withdrawal by Subject|3|||
143306475|NCT03962543|516672781|FG001|Treatment Phase|Withdrawal by Subject|0|||
143306476|NCT03962543|516672780|FG000|Treatment Phase|Adverse Event|3|||
143306477|NCT03962543|516672781|FG001|Treatment Phase|Adverse Event|12|||
143306478|NCT03962543|516672780|FG000|Treatment Phase|Lost to Follow-up|1|||
143306479|NCT03962543|516672781|FG001|Treatment Phase|Lost to Follow-up|2|||
143306480|NCT03962543|516672780|FG000|Treatment Phase|Radiographic PD|9|||
143306481|NCT03962543|516672781|FG001|Treatment Phase|Radiographic PD|3|||
143306482|NCT03962543|516672780|FG000|Treatment Phase|Participant Decision|3|||
143306483|NCT03962543|516672781|FG001|Treatment Phase|Participant Decision|8|||
143306484|NCT03962543|516672780|FG000|Treatment Phase|Received procedure not compatible with MRI|0|||
143306485|NCT03962543|516672781|FG001|Treatment Phase|Received procedure not compatible with MRI|1|||
143306486|NCT03962543|516672780|FG000|Treatment Phase|Ongoing in the Treatment Phase|4|||
143306487|NCT03962543|516672781|FG001|Treatment Phase|Ongoing in the Treatment Phase|0|||
143306488|NCT03962543|516672780|FG000|Long Term Follow-Up Phase|Withdrawal by Subject|0|||
143306489|NCT03962543|516672781|FG001|Long Term Follow-Up Phase|Withdrawal by Subject|1|||
143306490|NCT03962543|516672780|FG000|Long Term Follow-Up Phase|Adverse Event|1|||
143306491|NCT03962543|516672781|FG001|Long Term Follow-Up Phase|Adverse Event|0|||
143306492|NCT03962543|516672780|FG000|Long Term Follow-Up Phase|Physician Decision|0|||
143306493|NCT03962543|516672781|FG001|Long Term Follow-Up Phase|Physician Decision|1|||
143375515|NCT04603924|516920449|FG001|Overall Study|Withdrawal by Subject|6|||
143375516|NCT04603924|516920448|FG000|Overall Study|Adverse Event|2|||
143375517|NCT04603924|516920449|FG001|Overall Study|Adverse Event|2|||
143306494|NCT03962543|516672780|FG000|Long Term Follow-Up Phase|Radiographic PD|1|||
143306495|NCT03962543|516672781|FG001|Long Term Follow-Up Phase|Radiographic PD|0|||
143306496|NCT03962543|516672780|FG000|Long Term Follow-Up Phase|Sponsor Request|1|||
143306497|NCT03962543|516672781|FG001|Long Term Follow-Up Phase|Sponsor Request|0|||
143306498|NCT03962543|516672780|FG000|Long Term Follow-Up Phase|Participant Decision|0|||
143306499|NCT03962543|516672781|FG001|Long Term Follow-Up Phase|Participant Decision|1|||
143306500|NCT03962543|516672780|FG000|Long Term Follow-Up Phase|Positive pregnancy test|0|||
143306501|NCT03962543|516672781|FG001|Long Term Follow-Up Phase|Positive pregnancy test|1|||
143306502|NCT03962543|516672780|FG000|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|25|||
143306503|NCT03962543|516672781|FG001|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|22|||
143306504|NCT00560950|516672782|FG000|Overall Study|Lost to Follow-up|1|||
143306505|NCT00560950|516672783|FG001|Overall Study|Lost to Follow-up|0|||
143306506|NCT03568942|516674392|FG000|Overall Study|Family emergency|1|||
143306507|NCT03568942|516674392|FG000|Overall Study|Lost to Follow-up|1|||
143306508|NCT04200248|516674396|FG000|Overall Study|Personal reasons|0|||
143306509|NCT04200248|516674397|FG001|Overall Study|Personal reasons|0|||
143306510|NCT04200248|516674398|FG002|Overall Study|Personal reasons|1|||
143306511|NCT04200248|516674396|FG000|Overall Study|Discontinued prior to treatment|3|||
143306512|NCT04200248|516674397|FG001|Overall Study|Discontinued prior to treatment|3|||
143306513|NCT04200248|516674398|FG002|Overall Study|Discontinued prior to treatment|2|||
143306514|NCT02433834|516674402|FG000|Overall Study|Protocol-specified criteria|7|||
143306515|NCT02433834|516674402|FG000|Overall Study|Protocol Violation|3|||
143306516|NCT02433834|516674402|FG000|Overall Study|Lost to Follow-up|6|||
143306517|NCT02433834|516674402|FG000|Overall Study|Withdrawal by Subject|14|||
143306518|NCT02433834|516674402|FG000|Overall Study|Adverse Event|6|||
143306519|NCT02433834|516674402|FG000|Overall Study|Physician Decision|1|||
143306520|NCT00302003|516674403|FG000|Overall Study|Lack of Efficacy|62|||
143306521|NCT00302003|516674403|FG000|Overall Study|Lost to Follow-up|1|||
143306522|NCT00302003|516674403|FG000|Overall Study|Physician Decision|2|||
143306523|NCT00302003|516674403|FG000|Overall Study|Withdrawal by Subject|5|||
143306524|NCT00302003|516674403|FG000|Overall Study|Ineligible|9|||
143306525|NCT00302003|516674403|FG000|Overall Study|Protocol Violation|1|||
143306526|NCT01539226|516674404|FG000|Overall Study|Withdrawal by Subject|24|||
143306527|NCT01539226|516674405|FG001|Overall Study|Withdrawal by Subject|54|||
143306528|NCT01539226|516674404|FG000|Overall Study|Lost to Follow-up|20|||
143306529|NCT01539226|516674405|FG001|Overall Study|Lost to Follow-up|54|||
143306530|NCT01539226|516674404|FG000|Overall Study|Death|1|||
143306531|NCT01539226|516674405|FG001|Overall Study|Death|2|||
143306532|NCT01539226|516674404|FG000|Overall Study|Adverse Event|2|||
143306533|NCT01539226|516674405|FG001|Overall Study|Adverse Event|0|||
143306534|NCT01539226|516674404|FG000|Overall Study|Pregnancy|13|||
143306535|NCT01539226|516674405|FG001|Overall Study|Pregnancy|29|||
143306536|NCT01539226|516674404|FG000|Overall Study|inappropriate enrollment|0|||
143306537|NCT01539226|516674405|FG001|Overall Study|inappropriate enrollment|1|||
143306538|NCT01539226|516674404|FG000|Overall Study|Multiple Reasons|3|||
143306539|NCT01539226|516674405|FG001|Overall Study|Multiple Reasons|1|||
143306540|NCT01539226|516674404|FG000|Overall Study|not HIV seroconversion-related|93|||
143306541|NCT01539226|516674405|FG001|Overall Study|not HIV seroconversion-related|176|||
143306542|NCT01539226|516674404|FG000|Overall Study|HIV seroconversion-related|55|||
143306543|NCT01539226|516674405|FG001|Overall Study|HIV seroconversion-related|80|||
143306544|NCT01539226|516674404|FG000|Overall Study|Non-compliance|6|||
143306545|NCT01539226|516674405|FG001|Overall Study|Non-compliance|8|||
143306546|NCT00283439|516674406|FG000|Overall Study|Adverse Event|0|||
143306547|NCT00283439|516674407|FG001|Overall Study|Adverse Event|0|||
143306548|NCT00283439|516674408|FG002|Overall Study|Adverse Event|0|||
143306549|NCT00283439|516674409|FG003|Overall Study|Adverse Event|1|||
143306550|NCT00283439|516674406|FG000|Overall Study|Death|0|||
143306551|NCT00283439|516674407|FG001|Overall Study|Death|0|||
143306552|NCT00283439|516674408|FG002|Overall Study|Death|1|||
143306553|NCT00283439|516674409|FG003|Overall Study|Death|0|||
143306554|NCT00283439|516674406|FG000|Overall Study|Disease progression|0|||
143306555|NCT00283439|516674407|FG001|Overall Study|Disease progression|1|||
143306556|NCT00283439|516674408|FG002|Overall Study|Disease progression|0|||
143306557|NCT00283439|516674409|FG003|Overall Study|Disease progression|0|||
143306558|NCT00283439|516674406|FG000|Overall Study|Requirement for alternative therapy|1|||
143306559|NCT00283439|516674407|FG001|Overall Study|Requirement for alternative therapy|2|||
143306560|NCT00283439|516674408|FG002|Overall Study|Requirement for alternative therapy|5|||
143306561|NCT00283439|516674409|FG003|Overall Study|Requirement for alternative therapy|2|||
143306562|NCT00283439|516674406|FG000|Overall Study|Stem cell transplant|6|||
143306563|NCT00283439|516674407|FG001|Overall Study|Stem cell transplant|6|||
143306564|NCT00283439|516674408|FG002|Overall Study|Stem cell transplant|4|||
143306565|NCT00283439|516674409|FG003|Overall Study|Stem cell transplant|3|||
143306566|NCT00283439|516674406|FG000|Overall Study|Treatment discontinued|0|||
143306567|NCT00283439|516674407|FG001|Overall Study|Treatment discontinued|2|||
143306568|NCT00283439|516674408|FG002|Overall Study|Treatment discontinued|1|||
143306569|NCT00283439|516674409|FG003|Overall Study|Treatment discontinued|3|||
143306570|NCT00283439|516674406|FG000|Overall Study|Other|1|||
143306571|NCT00283439|516674407|FG001|Overall Study|Other|0|||
143306572|NCT00283439|516674408|FG002|Overall Study|Other|0|||
143306573|NCT00283439|516674409|FG003|Overall Study|Other|0|||
143306574|NCT01632891|516674412|FG000|Overall Study|Lost to Follow-up|0|||
143306575|NCT01632891|516674413|FG001|Overall Study|Lost to Follow-up|1|||
143306576|NCT01632891|516674412|FG000|Overall Study|Withdrawal by Subject|1|||
143306577|NCT01632891|516674413|FG001|Overall Study|Withdrawal by Subject|0|||
143306578|NCT00333229|516674414|FG000|Overall Study|Lack of Efficacy|0|||
143306579|NCT00333229|516674415|FG001|Overall Study|Lack of Efficacy|1|||
143306580|NCT01466270|516674417|FG000|Overall Study|Withdrawal by Subject|4|||
143306581|NCT01466270|516674418|FG001|Overall Study|Withdrawal by Subject|1|||
143306582|NCT01466270|516674417|FG000|Overall Study|Physician Decision|1|||
143306583|NCT01466270|516674418|FG001|Overall Study|Physician Decision|0|||
143306584|NCT01466270|516674417|FG000|Overall Study|Lost to Follow-up|1|||
143306585|NCT01466270|516674418|FG001|Overall Study|Lost to Follow-up|3|||
143306586|NCT01466270|516674417|FG000|Overall Study|Progression|1|||
143306587|NCT01466270|516674418|FG001|Overall Study|Progression|0|||
143306588|NCT01466270|516674417|FG000|Overall Study|Toxicity|4|||
143306589|NCT01466270|516674418|FG001|Overall Study|Toxicity|1|||
143306590|NCT01466270|516674417|FG000|Overall Study|Multiple|1|||
143306591|NCT01466270|516674418|FG001|Overall Study|Multiple|1|||
143306592|NCT04206293|516674427|FG000|Overall Study|Consent withdrawal|1|||
143306593|NCT05358821|516674430|FG000|Overall Study|Withdrawal by Subject|0|||
143306594|NCT05358821|516674431|FG001|Overall Study|Withdrawal by Subject|1|||
143306595|NCT05358821|516674432|FG002|Overall Study|Withdrawal by Subject|0|||
143306596|NCT05358821|516674430|FG000|Overall Study|Withdrawal of Consent|0|||
143306597|NCT05358821|516674431|FG001|Overall Study|Withdrawal of Consent|0|||
143306598|NCT05358821|516674432|FG002|Overall Study|Withdrawal of Consent|1|||
143306599|NCT04476017|516674433|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
143306600|NCT04476017|516674434|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
143306601|NCT02704364|516674435|FG000|Overall Study|Adverse Event|1|||
143306602|NCT02704364|516674436|FG001|Overall Study|Adverse Event|1|||
143306603|NCT02704364|516674437|FG002|Overall Study|Adverse Event|0|||
143306604|NCT02704364|516674435|FG000|Overall Study|Noncompliance with study drug|1|||
143306605|NCT02704364|516674436|FG001|Overall Study|Noncompliance with study drug|1|||
143306606|NCT02704364|516674437|FG002|Overall Study|Noncompliance with study drug|0|||
143306607|NCT02704364|516674435|FG000|Overall Study|Other|0|||
143306608|NCT02704364|516674436|FG001|Overall Study|Other|1|||
143306609|NCT02704364|516674437|FG002|Overall Study|Other|1|||
143306610|NCT00846742|516674438|FG000|Overall Study|Withdrawal by Subject|1|||
143306611|NCT03909165|516674442|FG000|Overall Study|Physician Decision|0|||
143306612|NCT03909165|516674443|FG001|Overall Study|Physician Decision|1|||
143306613|NCT03909165|516674444|FG002|Overall Study|Physician Decision|0|||
143306614|NCT03909165|516674445|FG003|Overall Study|Physician Decision|0|||
143306615|NCT03909165|516674446|FG004|Overall Study|Physician Decision|0|||
143306616|NCT03909165|516674442|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
143306617|NCT03909165|516674443|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
143306618|NCT03909165|516674444|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
143306619|NCT03909165|516674445|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
143306620|NCT03909165|516674446|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
143306621|NCT03909165|516674442|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
143306622|NCT03909165|516674443|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
143306623|NCT03909165|516674444|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
143306624|NCT03909165|516674445|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
143306625|NCT03909165|516674446|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
143306626|NCT03909165|516674442|FG000|Overall Study|Previous Drug Exposure|0|||
143306627|NCT03909165|516674443|FG001|Overall Study|Previous Drug Exposure|0|||
143306628|NCT03909165|516674444|FG002|Overall Study|Previous Drug Exposure|1|||
143306629|NCT03909165|516674445|FG003|Overall Study|Previous Drug Exposure|0|||
143306630|NCT03909165|516674446|FG004|Overall Study|Previous Drug Exposure|0|||
143306631|NCT03909165|516674442|FG000|Overall Study|Early Discharge|1|||
143306632|NCT03909165|516674443|FG001|Overall Study|Early Discharge|0|||
143306633|NCT03909165|516674444|FG002|Overall Study|Early Discharge|0|||
143306634|NCT03909165|516674445|FG003|Overall Study|Early Discharge|0|||
143306635|NCT03909165|516674446|FG004|Overall Study|Early Discharge|0|||
143306636|NCT00235872|516674447|FG000|Overall Study|Adverse Event|34|||
143306637|NCT00235872|516674447|FG000|Overall Study|Death|1|||
143306638|NCT00235872|516674447|FG000|Overall Study|Lost to Follow-up|1|||
143306639|NCT00235872|516674447|FG000|Overall Study|Withdrawal by Subject|50|||
143306640|NCT00235872|516674447|FG000|Overall Study|Administrative reason|61|||
143306641|NCT00414661|516674453|FG000|Overall Study|Death|2|||
143306642|NCT00414661|516674454|FG001|Overall Study|Death|5|||
143306643|NCT00414661|516674455|FG002|Overall Study|Death|0|||
143306644|NCT00414661|516674456|FG003|Overall Study|Death|0|||
143306645|NCT00414661|516674453|FG000|Overall Study|Lost to Follow-up|1|||
143306646|NCT00414661|516674454|FG001|Overall Study|Lost to Follow-up|4|||
143306647|NCT00414661|516674455|FG002|Overall Study|Lost to Follow-up|0|||
143306648|NCT00414661|516674456|FG003|Overall Study|Lost to Follow-up|1|||
143306649|NCT00414661|516674453|FG000|Overall Study|Withdrawal by Subject|5|||
143306650|NCT00414661|516674454|FG001|Overall Study|Withdrawal by Subject|2|||
143306651|NCT00414661|516674455|FG002|Overall Study|Withdrawal by Subject|2|||
143306652|NCT00414661|516674456|FG003|Overall Study|Withdrawal by Subject|2|||
143306653|NCT00414661|516674453|FG000|Overall Study|Other|6|||
143306654|NCT00414661|516674454|FG001|Overall Study|Other|3|||
143306655|NCT00414661|516674455|FG002|Overall Study|Other|0|||
143306656|NCT00414661|516674456|FG003|Overall Study|Other|0|||
143306657|NCT00937547|516674457|FG000|Overall Study|misdiagnosis|1|||
143306658|NCT00937547|516674458|FG001|Overall Study|misdiagnosis|6|||
143306659|NCT00937547|516674459|FG002|Overall Study|misdiagnosis|7|||
143306660|NCT01234467|516674460|FG000|Overall Study|Adverse Event|3|||
143306661|NCT01234467|516674460|FG000|Overall Study|Death|2|||
143306662|NCT01234467|516674460|FG000|Overall Study|Withdrawal by Subject|2|||
143306663|NCT01234467|516674460|FG000|Overall Study|Disease Progression|2|||
143306664|NCT01234467|516674460|FG000|Overall Study|Clinical deterioration|1|||
143306665|NCT01234467|516674460|FG000|Overall Study|Physician Decision|1|||
143306666|NCT01234467|516674460|FG000|Overall Study|Other complicating disease (stroke)|1|||
143306667|NCT00559962|516674461|FG000|Overall Study|Adverse Event|1|||
143306668|NCT00559962|516674462|FG001|Overall Study|Adverse Event|7|||
143306669|NCT00559962|516674463|FG002|Overall Study|Adverse Event|8|||
143306670|NCT00559962|516674464|FG003|Overall Study|Adverse Event|5|||
143306671|NCT00559962|516674465|FG004|Overall Study|Adverse Event|11|||
143306672|NCT00559962|516674466|FG005|Overall Study|Adverse Event|4|||
143306673|NCT00559962|516674467|FG006|Overall Study|Adverse Event|4|||
143306674|NCT00559962|516674468|FG007|Overall Study|Adverse Event|2|||
143306675|NCT00559962|516674461|FG000|Overall Study|Lost to Follow-up|0|||
143306676|NCT00559962|516674462|FG001|Overall Study|Lost to Follow-up|1|||
143306677|NCT00559962|516674463|FG002|Overall Study|Lost to Follow-up|0|||
143306678|NCT00559962|516674464|FG003|Overall Study|Lost to Follow-up|0|||
143306679|NCT00559962|516674465|FG004|Overall Study|Lost to Follow-up|0|||
143306680|NCT00559962|516674466|FG005|Overall Study|Lost to Follow-up|0|||
143306681|NCT00559962|516674467|FG006|Overall Study|Lost to Follow-up|0|||
143306682|NCT00559962|516674468|FG007|Overall Study|Lost to Follow-up|0|||
143306683|NCT00559962|516674461|FG000|Overall Study|Withdrawal by Subject|1|||
143306684|NCT00559962|516674462|FG001|Overall Study|Withdrawal by Subject|1|||
143306685|NCT00559962|516674463|FG002|Overall Study|Withdrawal by Subject|2|||
143306686|NCT00559962|516674464|FG003|Overall Study|Withdrawal by Subject|0|||
143306687|NCT00559962|516674465|FG004|Overall Study|Withdrawal by Subject|3|||
143306688|NCT00559962|516674466|FG005|Overall Study|Withdrawal by Subject|1|||
143306689|NCT00559962|516674467|FG006|Overall Study|Withdrawal by Subject|0|||
143306690|NCT00559962|516674468|FG007|Overall Study|Withdrawal by Subject|2|||
143306691|NCT00559962|516674461|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
143306692|NCT00559962|516674462|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
143306693|NCT00559962|516674463|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
143306694|NCT00559962|516674464|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
143306695|NCT00559962|516674465|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
143306696|NCT00559962|516674466|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
143306697|NCT00559962|516674467|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
143306698|NCT00559962|516674468|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
143306699|NCT01461096|516674470|FG000|Overall Study|Death|3|||
143306700|NCT01461096|516674471|FG001|Overall Study|Death|6|||
143306701|NCT01461096|516674470|FG000|Overall Study|Severe debilitation, unable to continue|1|||
143306702|NCT01461096|516674471|FG001|Overall Study|Severe debilitation, unable to continue|1|||
143306703|NCT01461096|516674470|FG000|Overall Study|Subj not able to get to clinic|15|||
143306704|NCT01461096|516674471|FG001|Overall Study|Subj not able to get to clinic|13|||
143306705|NCT01461096|516674470|FG000|Overall Study|Site is closing|27|||
143306706|NCT01461096|516674471|FG001|Overall Study|Site is closing|30|||
143306707|NCT01461096|516674470|FG000|Overall Study|Withdrawal by Subject|5|||
143306708|NCT01461096|516674471|FG001|Overall Study|Withdrawal by Subject|3|||
143306709|NCT01461096|516674470|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
143306710|NCT01461096|516674471|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
143306711|NCT01461096|516674470|FG000|Overall Study|Lost to Follow-up|8|||
143306712|NCT01461096|516674471|FG001|Overall Study|Lost to Follow-up|4|||
143306713|NCT04889625|516674472|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
143306714|NCT04889625|516674473|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
143306715|NCT04889625|516674472|FG000|Period 1|Subject out of window|0|||
143306716|NCT04889625|516674473|FG001|Period 1|Subject out of window|1|||
143306717|NCT04889625|516674472|FG000|Period 1|Wrong add power dispensed|0|||
143306718|NCT04889625|516674473|FG001|Period 1|Wrong add power dispensed|1|||
143306719|NCT04889625|516674472|FG000|Period 1|Discontinued due to fitting guide error|1|||
143306720|NCT04889625|516674473|FG001|Period 1|Discontinued due to fitting guide error|1|||
143306721|NCT04889625|516674472|FG000|Period 2|Test article no longer available|1|||
143306722|NCT04889625|516674473|FG001|Period 2|Test article no longer available|0|||
143306723|NCT04889625|516674472|FG000|Period 2|Incorrect lens dispensed|1|||
143306724|NCT04889625|516674473|FG001|Period 2|Incorrect lens dispensed|0|||
143306725|NCT04889625|516674472|FG000|Period 2|Wrong add power dispensed|0|||
143306726|NCT04889625|516674473|FG001|Period 2|Wrong add power dispensed|1|||
143306727|NCT00404352|516674485|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
143306728|NCT00404352|516674486|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
143306729|NCT00404352|516674487|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
143306730|NCT00404352|516674488|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
143306731|NCT00404352|516674489|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
143306732|NCT00404352|516674490|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
143306733|NCT00404352|516674491|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
143306734|NCT00404352|516674492|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
143306735|NCT00404352|516674493|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
143306736|NCT00404352|516674485|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
143306737|NCT00404352|516674486|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
143306738|NCT00404352|516674487|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
143306739|NCT00404352|516674488|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
143306740|NCT00404352|516674489|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
143306741|NCT00404352|516674490|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
143306742|NCT00404352|516674491|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
143306743|NCT00404352|516674492|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
143306744|NCT00404352|516674493|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
143306745|NCT00404352|516674485|FG000|Double Blind (up to 24 Month)|Death|0|||
143306746|NCT00404352|516674486|FG001|Double Blind (up to 24 Month)|Death|0|||
143306747|NCT00404352|516674487|FG002|Double Blind (up to 24 Month)|Death|1|||
143306748|NCT00404352|516674488|FG003|Double Blind (up to 24 Month)|Death|0|||
143306749|NCT00404352|516674489|FG004|Double Blind (up to 24 Month)|Death|0|||
143306750|NCT00404352|516674490|FG005|Double Blind (up to 24 Month)|Death|0|||
143306751|NCT00404352|516674491|FG006|Double Blind (up to 24 Month)|Death|0|||
143306752|NCT00404352|516674492|FG007|Double Blind (up to 24 Month)|Death|0|||
143306753|NCT00404352|516674493|FG008|Double Blind (up to 24 Month)|Death|0|||
143306754|NCT00404352|516674485|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
143306755|NCT00404352|516674486|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
143306756|NCT00404352|516674487|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
143306757|NCT00404352|516674488|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
143306758|NCT00404352|516674489|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
143306759|NCT00404352|516674490|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
143306760|NCT00404352|516674491|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
143306761|NCT00404352|516674492|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
143306762|NCT00404352|516674493|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
143306763|NCT00404352|516674485|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
143306764|NCT00404352|516674486|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
143306765|NCT00404352|516674487|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
143306766|NCT00404352|516674488|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
143306767|NCT00404352|516674489|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
143306768|NCT00404352|516674490|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
143306769|NCT00404352|516674491|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
143306770|NCT00404352|516674492|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
143306771|NCT00404352|516674493|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
143306772|NCT00404352|516674485|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
143306773|NCT00404352|516674486|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
143306774|NCT00404352|516674487|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
143306775|NCT00404352|516674488|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
143306776|NCT00404352|516674489|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
143306777|NCT00404352|516674490|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
143306778|NCT00404352|516674491|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
143306779|NCT00404352|516674492|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
143306780|NCT00404352|516674493|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
143306781|NCT00404352|516674485|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
143375518|NCT03762668|516920450|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
143375519|NCT03762668|516920451|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
143375520|NCT00516321|516920452|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
143375521|NCT00516321|516920453|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
143375522|NCT00516321|516920454|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
143375523|NCT00516321|516920452|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
143375524|NCT00516321|516920453|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
143375525|NCT00516321|516920454|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
143375526|NCT00516321|516920452|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
143375527|NCT00516321|516920453|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
143375528|NCT00516321|516920454|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
143306782|NCT00404352|516674486|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
143306783|NCT00404352|516674487|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
143306784|NCT00404352|516674488|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
143306785|NCT00404352|516674489|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
143306786|NCT00404352|516674490|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
143306787|NCT00404352|516674491|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
143306788|NCT00404352|516674492|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
143306789|NCT00404352|516674493|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
143306790|NCT00404352|516674485|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
143306791|NCT00404352|516674486|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
143306792|NCT00404352|516674487|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
143306793|NCT00404352|516674488|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
143306794|NCT00404352|516674489|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
143306795|NCT00404352|516674490|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
143306796|NCT00404352|516674491|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
143306797|NCT00404352|516674492|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
143306798|NCT00404352|516674493|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
143306799|NCT00404352|516674485|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
143306800|NCT00404352|516674486|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
143306801|NCT00404352|516674487|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
143306802|NCT00404352|516674488|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
143306803|NCT00404352|516674489|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
143306804|NCT00404352|516674490|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
143306805|NCT00404352|516674491|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
143306806|NCT00404352|516674492|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
143306807|NCT00404352|516674493|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
143306808|NCT00404352|516674485|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
143306809|NCT00404352|516674486|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
143306810|NCT00404352|516674487|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
143306811|NCT00404352|516674488|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
143306812|NCT00404352|516674489|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
143306813|NCT00404352|516674490|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
143306814|NCT00404352|516674491|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
143306815|NCT00404352|516674492|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
143306816|NCT00404352|516674493|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
143306817|NCT00404352|516674485|FG000|Double Blind (up to 24 Month)|Other|0|||
143306818|NCT00404352|516674486|FG001|Double Blind (up to 24 Month)|Other|1|||
143306819|NCT00404352|516674487|FG002|Double Blind (up to 24 Month)|Other|0|||
143306820|NCT00404352|516674488|FG003|Double Blind (up to 24 Month)|Other|0|||
143306821|NCT00404352|516674489|FG004|Double Blind (up to 24 Month)|Other|0|||
143306822|NCT00404352|516674490|FG005|Double Blind (up to 24 Month)|Other|0|||
143306823|NCT00404352|516674491|FG006|Double Blind (up to 24 Month)|Other|0|||
143306824|NCT00404352|516674492|FG007|Double Blind (up to 24 Month)|Other|0|||
143306825|NCT00404352|516674493|FG008|Double Blind (up to 24 Month)|Other|0|||
143306826|NCT00404352|516674485|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
143306827|NCT00404352|516674486|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
143306828|NCT00404352|516674487|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
143306829|NCT00404352|516674488|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
143306830|NCT00404352|516674489|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
143306831|NCT00404352|516674490|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
143306832|NCT00404352|516674491|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
143306833|NCT00404352|516674492|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
143306834|NCT00404352|516674493|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
143306835|NCT00404352|516674485|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
143306836|NCT00404352|516674486|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
143306837|NCT00404352|516674487|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
143306838|NCT00404352|516674488|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
143306839|NCT00404352|516674489|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
143306840|NCT00404352|516674490|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
143306841|NCT00404352|516674491|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
143306842|NCT00404352|516674492|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
143306843|NCT00404352|516674493|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
143306844|NCT00404352|516674485|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
143306845|NCT00404352|516674486|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
143306846|NCT00404352|516674487|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
143306847|NCT00404352|516674488|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
143306848|NCT00404352|516674489|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
143306849|NCT00404352|516674490|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
143306850|NCT00404352|516674491|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
143306851|NCT00404352|516674492|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
143306852|NCT00404352|516674493|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
143306853|NCT00404352|516674485|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
143306854|NCT00404352|516674486|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
143306855|NCT00404352|516674487|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
143306856|NCT00404352|516674488|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
143306857|NCT00404352|516674489|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
143306858|NCT00404352|516674490|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
143306859|NCT00404352|516674491|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
143306860|NCT00404352|516674492|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
143306861|NCT00404352|516674493|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
143306862|NCT00404352|516674485|FG000|Open Label (up to 24 Month)|Disease progression|0|||
143306863|NCT00404352|516674486|FG001|Open Label (up to 24 Month)|Disease progression|0|||
143306864|NCT00404352|516674487|FG002|Open Label (up to 24 Month)|Disease progression|0|||
143306865|NCT00404352|516674488|FG003|Open Label (up to 24 Month)|Disease progression|1|||
143306866|NCT00404352|516674489|FG004|Open Label (up to 24 Month)|Disease progression|0|||
143306867|NCT00404352|516674490|FG005|Open Label (up to 24 Month)|Disease progression|0|||
143306868|NCT00404352|516674491|FG006|Open Label (up to 24 Month)|Disease progression|0|||
143306869|NCT00404352|516674492|FG007|Open Label (up to 24 Month)|Disease progression|0|||
143306870|NCT00404352|516674493|FG008|Open Label (up to 24 Month)|Disease progression|0|||
143306871|NCT00404352|516674485|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
143306872|NCT00404352|516674486|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
143306873|NCT00404352|516674487|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
143306874|NCT00404352|516674488|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
143306875|NCT00404352|516674489|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
143306876|NCT00404352|516674490|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
143306877|NCT00404352|516674491|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
143306878|NCT00404352|516674492|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
143306879|NCT00404352|516674493|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
143306880|NCT00404352|516674485|FG000|Open Label Extension (up to 36 Months)|Other|0|||
143306881|NCT00404352|516674486|FG001|Open Label Extension (up to 36 Months)|Other|0|||
143306882|NCT00404352|516674487|FG002|Open Label Extension (up to 36 Months)|Other|0|||
143306883|NCT00404352|516674488|FG003|Open Label Extension (up to 36 Months)|Other|0|||
143306884|NCT00404352|516674489|FG004|Open Label Extension (up to 36 Months)|Other|0|||
143306885|NCT00404352|516674490|FG005|Open Label Extension (up to 36 Months)|Other|0|||
143306886|NCT00404352|516674491|FG006|Open Label Extension (up to 36 Months)|Other|0|||
143306887|NCT00404352|516674492|FG007|Open Label Extension (up to 36 Months)|Other|0|||
143306888|NCT00404352|516674493|FG008|Open Label Extension (up to 36 Months)|Other|2|||
143306889|NCT04370691|516674494|FG000|Overall Study|Pending visit|48|||
143306890|NCT04370691|516674494|FG000|Overall Study|Have Not Reached Lower Window|15|||
143306891|NCT04370691|516674494|FG000|Overall Study|Termination|14|||
143306892|NCT04370691|516674494|FG000|Overall Study|Missed or Overdue|10|||
143306893|NCT03047135|516674498|FG000|Overall Study|Still being treated|3|||
143306894|NCT00323414|516674499|FG000|Overall Study|Withdrawal by Subject|0|||
143306895|NCT00323414|516674500|FG001|Overall Study|Withdrawal by Subject|1|||
143306896|NCT05619692|516674503|FG000|Overall Study|Adverse Event|2|||
143306897|NCT05619692|516674504|FG001|Overall Study|Adverse Event|2|||
143306898|NCT05619692|516674503|FG000|Overall Study|Withdrawal by Participant|3|||
143306899|NCT05619692|516674504|FG001|Overall Study|Withdrawal by Participant|4|||
143375529|NCT00516321|516920452|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
143375530|NCT00516321|516920453|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
143375531|NCT00516321|516920454|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
143375532|NCT00516321|516920452|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
143375533|NCT00516321|516920453|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
143375534|NCT00516321|516920454|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
143375535|NCT00516321|516920452|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
143375536|NCT00516321|516920453|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
143375537|NCT00516321|516920454|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
143375538|NCT00516321|516920452|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
143375539|NCT00516321|516920453|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
143375540|NCT00516321|516920454|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
143306900|NCT05619692|516674503|FG000|Overall Study|Lost to Follow-up|2|||
143306901|NCT05619692|516674504|FG001|Overall Study|Lost to Follow-up|1|||
143306902|NCT05619692|516674503|FG000|Overall Study|Randomized but not treated|1|||
143306903|NCT05619692|516674504|FG001|Overall Study|Randomized but not treated|3|||
143306904|NCT03216850|516674506|FG000|Overall Study|Pre-analytical error|6|||
143306905|NCT00603746|516674507|FG000|Overall Study|Adverse Event|2|||
143306906|NCT00603746|516674508|FG001|Overall Study|Adverse Event|3|||
143306907|NCT00603746|516674509|FG002|Overall Study|Adverse Event|0|||
143306908|NCT00603746|516674510|FG003|Overall Study|Adverse Event|1|||
143375541|NCT00516321|516920452|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
143306909|NCT00603746|516674511|FG004|Overall Study|Adverse Event|0|||
143306910|NCT00603746|516674512|FG005|Overall Study|Adverse Event|4|||
143306911|NCT00603746|516674507|FG000|Overall Study|Lack of Efficacy|34|||
143306912|NCT00603746|516674508|FG001|Overall Study|Lack of Efficacy|11|||
143306913|NCT00603746|516674509|FG002|Overall Study|Lack of Efficacy|6|||
143306914|NCT00603746|516674510|FG003|Overall Study|Lack of Efficacy|11|||
143306915|NCT00603746|516674511|FG004|Overall Study|Lack of Efficacy|12|||
143306916|NCT00603746|516674512|FG005|Overall Study|Lack of Efficacy|8|||
143306917|NCT00603746|516674507|FG000|Overall Study|Protocol Violation|0|||
143306918|NCT00603746|516674508|FG001|Overall Study|Protocol Violation|3|||
143306919|NCT00603746|516674509|FG002|Overall Study|Protocol Violation|1|||
143306920|NCT00603746|516674510|FG003|Overall Study|Protocol Violation|0|||
143306921|NCT00603746|516674511|FG004|Overall Study|Protocol Violation|1|||
143306922|NCT00603746|516674512|FG005|Overall Study|Protocol Violation|0|||
143306923|NCT00603746|516674507|FG000|Overall Study|Lost to Follow-up|0|||
143306924|NCT00603746|516674508|FG001|Overall Study|Lost to Follow-up|1|||
143306925|NCT00603746|516674509|FG002|Overall Study|Lost to Follow-up|1|||
143306926|NCT00603746|516674510|FG003|Overall Study|Lost to Follow-up|0|||
143306927|NCT00603746|516674511|FG004|Overall Study|Lost to Follow-up|0|||
143306928|NCT00603746|516674512|FG005|Overall Study|Lost to Follow-up|0|||
143306929|NCT00603746|516674507|FG000|Overall Study|Physician Decision|1|||
143306930|NCT00603746|516674508|FG001|Overall Study|Physician Decision|0|||
143306931|NCT00603746|516674509|FG002|Overall Study|Physician Decision|0|||
143306932|NCT00603746|516674510|FG003|Overall Study|Physician Decision|0|||
143306933|NCT00603746|516674511|FG004|Overall Study|Physician Decision|1|||
143306934|NCT00603746|516674512|FG005|Overall Study|Physician Decision|0|||
143306935|NCT00603746|516674507|FG000|Overall Study|Withdrawal by Subject|1|||
143306936|NCT00603746|516674508|FG001|Overall Study|Withdrawal by Subject|0|||
143306937|NCT00603746|516674509|FG002|Overall Study|Withdrawal by Subject|0|||
143306938|NCT00603746|516674510|FG003|Overall Study|Withdrawal by Subject|1|||
143306939|NCT00603746|516674511|FG004|Overall Study|Withdrawal by Subject|3|||
143306940|NCT00603746|516674512|FG005|Overall Study|Withdrawal by Subject|1|||
143306941|NCT01524627|516674517|FG000|Overall Study|Physician Decision|0|||
143306942|NCT01524627|516674518|FG001|Overall Study|Physician Decision|1|||
143306943|NCT01524627|516674517|FG000|Overall Study|Lost to Follow-up|1|||
143306944|NCT01524627|516674518|FG001|Overall Study|Lost to Follow-up|1|||
143306945|NCT00969553|516674519|FG000|Overall Study|Progressive disease (PD)|2|||
143306946|NCT00969553|516674520|FG001|Overall Study|Progressive disease (PD)|2|||
143306947|NCT00969553|516674521|FG002|Overall Study|Progressive disease (PD)|6|||
143306948|NCT00969553|516674522|FG003|Overall Study|Progressive disease (PD)|9|||
143306949|NCT00969553|516674523|FG004|Overall Study|Progressive disease (PD)|2|||
143306950|NCT00969553|516674524|FG005|Overall Study|Progressive disease (PD)|4|||
143306951|NCT00969553|516674525|FG006|Overall Study|Progressive disease (PD)|2|||
143306952|NCT00969553|516674526|FG007|Overall Study|Progressive disease (PD)|12|||
143306953|NCT00969553|516674527|FG008|Overall Study|Progressive disease (PD)|3|||
143306954|NCT00969553|516674519|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
143306955|NCT00969553|516674520|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
143306956|NCT00969553|516674521|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
143306957|NCT00969553|516674522|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
143306958|NCT00969553|516674523|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
143306959|NCT00969553|516674524|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
143306960|NCT00969553|516674525|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
143306961|NCT00969553|516674526|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
143306962|NCT00969553|516674527|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
143306963|NCT00969553|516674519|FG000|Overall Study|Other Adverse Event|0|||
143306964|NCT00969553|516674520|FG001|Overall Study|Other Adverse Event|0|||
143306965|NCT00969553|516674521|FG002|Overall Study|Other Adverse Event|0|||
143306966|NCT00969553|516674522|FG003|Overall Study|Other Adverse Event|1|||
143306967|NCT00969553|516674523|FG004|Overall Study|Other Adverse Event|0|||
143306968|NCT00969553|516674524|FG005|Overall Study|Other Adverse Event|0|||
143306969|NCT00969553|516674525|FG006|Overall Study|Other Adverse Event|1|||
143306970|NCT00969553|516674526|FG007|Overall Study|Other Adverse Event|0|||
143306971|NCT00969553|516674527|FG008|Overall Study|Other Adverse Event|0|||
143306972|NCT00969553|516674519|FG000|Overall Study|Refused cont. medication|1|||
143306973|NCT00969553|516674520|FG001|Overall Study|Refused cont. medication|1|||
143306974|NCT00969553|516674521|FG002|Overall Study|Refused cont. medication|0|||
143306975|NCT00969553|516674522|FG003|Overall Study|Refused cont. medication|2|||
143306976|NCT00969553|516674523|FG004|Overall Study|Refused cont. medication|0|||
143306977|NCT00969553|516674524|FG005|Overall Study|Refused cont. medication|0|||
143306978|NCT00969553|516674525|FG006|Overall Study|Refused cont. medication|0|||
143306979|NCT00969553|516674526|FG007|Overall Study|Refused cont. medication|1|||
143306980|NCT00969553|516674527|FG008|Overall Study|Refused cont. medication|0|||
143306981|NCT00969553|516674519|FG000|Overall Study|Not specified above|0|||
143306982|NCT00969553|516674520|FG001|Overall Study|Not specified above|0|||
143306983|NCT00969553|516674521|FG002|Overall Study|Not specified above|0|||
143306984|NCT00969553|516674522|FG003|Overall Study|Not specified above|4|||
143306985|NCT00969553|516674523|FG004|Overall Study|Not specified above|0|||
143306986|NCT00969553|516674524|FG005|Overall Study|Not specified above|0|||
143306987|NCT00969553|516674525|FG006|Overall Study|Not specified above|1|||
143306988|NCT00969553|516674526|FG007|Overall Study|Not specified above|1|||
143306989|NCT00969553|516674527|FG008|Overall Study|Not specified above|0|||
143306990|NCT00615056|516674528|FG000|Overall Study|Death|31|||
143306991|NCT00615056|516674529|FG001|Overall Study|Death|31|||
143306992|NCT00615056|516674530|FG002|Overall Study|Death|21|||
143306993|NCT00615056|516674531|FG003|Overall Study|Death|23|||
143306994|NCT00615056|516674528|FG000|Overall Study|Lost to Follow-up|1|||
143306995|NCT00615056|516674529|FG001|Overall Study|Lost to Follow-up|2|||
143306996|NCT00615056|516674530|FG002|Overall Study|Lost to Follow-up|4|||
143306997|NCT00615056|516674531|FG003|Overall Study|Lost to Follow-up|5|||
143306998|NCT00615056|516674528|FG000|Overall Study|Other|13|||
143306999|NCT00615056|516674529|FG001|Overall Study|Other|15|||
143307000|NCT00615056|516674530|FG002|Overall Study|Other|10|||
143307001|NCT00615056|516674531|FG003|Overall Study|Other|7|||
143307002|NCT00615056|516674528|FG000|Overall Study|Objective progression or relapse|0|||
143307003|NCT00615056|516674529|FG001|Overall Study|Objective progression or relapse|2|||
143307004|NCT00615056|516674530|FG002|Overall Study|Objective progression or relapse|0|||
143307005|NCT00615056|516674531|FG003|Overall Study|Objective progression or relapse|0|||
143307006|NCT00615056|516674528|FG000|Overall Study|Withdrawal by Subject|0|||
143307007|NCT00615056|516674529|FG001|Overall Study|Withdrawal by Subject|1|||
143307008|NCT00615056|516674530|FG002|Overall Study|Withdrawal by Subject|1|||
143307009|NCT00615056|516674531|FG003|Overall Study|Withdrawal by Subject|0|||
143307010|NCT00615056|516674528|FG000|Overall Study|Discontinued by Sponsor|1|||
143307011|NCT00615056|516674529|FG001|Overall Study|Discontinued by Sponsor|0|||
143307012|NCT00615056|516674530|FG002|Overall Study|Discontinued by Sponsor|0|||
143307013|NCT00615056|516674531|FG003|Overall Study|Discontinued by Sponsor|0|||
143307014|NCT00615056|516674528|FG000|Overall Study|Randomized but not treated|3|||
143307015|NCT00615056|516674529|FG001|Overall Study|Randomized but not treated|0|||
143307016|NCT00615056|516674530|FG002|Overall Study|Randomized but not treated|0|||
143307017|NCT00615056|516674531|FG003|Overall Study|Randomized but not treated|0|||
143307018|NCT00717769|516674532|FG000|Overall Study|Adverse Event|9|||
143307019|NCT00717769|516674533|FG001|Overall Study|Adverse Event|6|||
143307020|NCT00717769|516674534|FG002|Overall Study|Adverse Event|1|||
143307021|NCT00717769|516674532|FG000|Overall Study|Lack of compliance|0|||
143307022|NCT00717769|516674533|FG001|Overall Study|Lack of compliance|2|||
143307023|NCT00717769|516674534|FG002|Overall Study|Lack of compliance|0|||
143307024|NCT00717769|516674532|FG000|Overall Study|Lost to Follow-up|3|||
143307025|NCT00717769|516674533|FG001|Overall Study|Lost to Follow-up|4|||
143307026|NCT00717769|516674534|FG002|Overall Study|Lost to Follow-up|0|||
143307027|NCT00717769|516674532|FG000|Overall Study|Lack of Efficacy|1|||
143307028|NCT00717769|516674533|FG001|Overall Study|Lack of Efficacy|2|||
143307029|NCT00717769|516674534|FG002|Overall Study|Lack of Efficacy|0|||
143307030|NCT00717769|516674532|FG000|Overall Study|Protocol Violation|0|||
143307031|NCT00717769|516674533|FG001|Overall Study|Protocol Violation|2|||
143307032|NCT00717769|516674534|FG002|Overall Study|Protocol Violation|0|||
143307033|NCT00717769|516674532|FG000|Overall Study|Sponsor decision|1|||
143307034|NCT00717769|516674533|FG001|Overall Study|Sponsor decision|0|||
143307035|NCT00717769|516674534|FG002|Overall Study|Sponsor decision|10|||
143307036|NCT00717769|516674532|FG000|Overall Study|Withdrew consent|2|||
143307037|NCT00717769|516674533|FG001|Overall Study|Withdrew consent|2|||
143307038|NCT00717769|516674534|FG002|Overall Study|Withdrew consent|0|||
143307039|NCT00692770|516674542|FG000|Overall Study|Protocol Violation|2|||
143307040|NCT00692770|516674543|FG001|Overall Study|Protocol Violation|7|||
143307041|NCT00692770|516674542|FG000|Overall Study|Withdrawal by Subject|97|||
143307042|NCT00692770|516674543|FG001|Overall Study|Withdrawal by Subject|36|||
143307043|NCT00692770|516674542|FG000|Overall Study|Adverse Event|136|||
143307044|NCT00692770|516674543|FG001|Overall Study|Adverse Event|41|||
143307045|NCT00692770|516674542|FG000|Overall Study|Death|10|||
143307046|NCT00692770|516674543|FG001|Overall Study|Death|5|||
143307047|NCT00692770|516674542|FG000|Overall Study|Lost to Follow-up|7|||
143307048|NCT00692770|516674543|FG001|Overall Study|Lost to Follow-up|3|||
143307049|NCT00692770|516674542|FG000|Overall Study|Non-compliant with study medication|11|||
143307050|NCT00692770|516674543|FG001|Overall Study|Non-compliant with study medication|5|||
143307051|NCT00692770|516674542|FG000|Overall Study|Progression by clinical judgment|2|||
143307052|NCT00692770|516674543|FG001|Overall Study|Progression by clinical judgment|3|||
143307053|NCT00692770|516674542|FG000|Overall Study|Physician decision not protocol driven|10|||
143307054|NCT00692770|516674543|FG001|Overall Study|Physician decision not protocol driven|14|||
143307055|NCT00692770|516674542|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
143307056|NCT00692770|516674543|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
143307057|NCT00692770|516674542|FG000|Overall Study|Protocol driven decision point|3|||
143307058|NCT00692770|516674543|FG001|Overall Study|Protocol driven decision point|7|||
143307059|NCT00692770|516674542|FG000|Overall Study|Completed all planned assessments|79|||
143307060|NCT00692770|516674543|FG001|Overall Study|Completed all planned assessments|101|||
143307061|NCT00692770|516674542|FG000|Overall Study|Radiological and clinical progression|8|||
143307062|NCT00692770|516674543|FG001|Overall Study|Radiological and clinical progression|8|||
143307063|NCT00692770|516674542|FG000|Overall Study|Clinical endpoint reached|16|||
143307064|NCT00692770|516674543|FG001|Overall Study|Clinical endpoint reached|43|||
143307065|NCT00692770|516674542|FG000|Overall Study|Study terminated by sponsor|2|||
143307066|NCT00692770|516674543|FG001|Overall Study|Study terminated by sponsor|2|||
143307067|NCT00692770|516674542|FG000|Overall Study|Randomized but not treated|3|||
143307068|NCT00692770|516674543|FG001|Overall Study|Randomized but not treated|4|||
143307069|NCT04327986|516674545|FG000|Overall Study|Physician Decision|2|||
143307070|NCT04327986|516674546|FG001|Overall Study|Physician Decision|0|||
143307071|NCT04327986|516674547|FG002|Overall Study|Physician Decision|0|||
143307072|NCT04327986|516674545|FG000|Overall Study|Death|1|||
143307073|NCT04327986|516674546|FG001|Overall Study|Death|0|||
143375542|NCT00516321|516920453|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
143307074|NCT04327986|516674547|FG002|Overall Study|Death|0|||
143307075|NCT04248816|516674549|FG000|Overall Study|Ineligible post-randomization|7|||
143307076|NCT04248816|516674550|FG001|Overall Study|Ineligible post-randomization|21|||
143307077|NCT04248816|516674551|FG002|Overall Study|Ineligible post-randomization|25|||
143307078|NCT03350503|516674552|FG000|Overall Study|Adverse Event|5|||
143307079|NCT03350503|516674552|FG000|Overall Study|Withdrawal by Subject|5|||
143307080|NCT03350503|516674552|FG000|Overall Study|Continuation impossible due to move|4|||
143307081|NCT03350503|516674552|FG000|Overall Study|Physician Decision|3|||
143307082|NCT01399593|516674556|FG000|Overall Study|Physician Decision|1|||
143307083|NCT01399593|516674557|FG001|Overall Study|Physician Decision|0|||
143307084|NCT01399593|516674556|FG000|Overall Study|Adverse Event|1|||
143307085|NCT01399593|516674557|FG001|Overall Study|Adverse Event|0|||
143307086|NCT01399593|516674556|FG000|Overall Study|Death|1|||
143307087|NCT01399593|516674557|FG001|Overall Study|Death|1|||
143307088|NCT01399593|516674556|FG000|Overall Study|Transplantectomy|0|||
143307089|NCT01399593|516674557|FG001|Overall Study|Transplantectomy|1|||
143307090|NCT02970968|516676031|FG000|Overall Study|Withdrawal by Subject|3|||
143307091|NCT02970968|516676032|FG001|Overall Study|Withdrawal by Subject|3|||
143307092|NCT02970968|516676031|FG000|Overall Study|Adverse Event|1|||
143307093|NCT02970968|516676032|FG001|Overall Study|Adverse Event|2|||
143307094|NCT02970968|516676031|FG000|Overall Study|Lost to Follow-up|1|||
143307095|NCT02970968|516676032|FG001|Overall Study|Lost to Follow-up|1|||
143307096|NCT02970968|516676031|FG000|Overall Study|Non-Compliance|0|||
143307097|NCT02970968|516676032|FG001|Overall Study|Non-Compliance|1|||
143307098|NCT05308901|516676033|FG000|Overall Study|Death|6|||
143307099|NCT03252522|516676034|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
143307100|NCT03252522|516676035|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
143307101|NCT03252522|516676036|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
143307102|NCT03252522|516676034|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
143307103|NCT03252522|516676035|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
143307104|NCT03252522|516676036|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
143307105|NCT03252522|516676034|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
143307106|NCT03252522|516676035|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
143307107|NCT03252522|516676036|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
143307108|NCT03252522|516676034|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
143307109|NCT03252522|516676035|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
143307110|NCT03252522|516676036|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
143307111|NCT03252522|516676034|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
143307112|NCT03252522|516676035|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
143307113|NCT03252522|516676036|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
143307114|NCT03252522|516676034|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
143307115|NCT03252522|516676035|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
143307116|NCT03252522|516676036|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
143307117|NCT03252522|516676034|FG000|Phase 2: Open Label|Adverse Event|0|||
143307118|NCT03252522|516676035|FG001|Phase 2: Open Label|Adverse Event|0|||
143307119|NCT03252522|516676036|FG002|Phase 2: Open Label|Adverse Event|2|||
143307120|NCT03252522|516676034|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
143307121|NCT03252522|516676035|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
143307122|NCT03252522|516676036|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
143307123|NCT01940120|516676040|FG000|Overall Study|Death|40|||
143307124|NCT01940120|516676040|FG000|Overall Study|Withdrawal by Subject|8|||
143307125|NCT03277846|516676041|FG000|Overall Study|Inpatient stay too brief|12|||
143307126|NCT03277846|516676042|FG001|Overall Study|Inpatient stay too brief|11|||
143307127|NCT02554656|516676043|FG000|Overall Study|Protocol Violation|3|||
143307128|NCT03240575|516676044|FG000|Overall Study|Adverse Event|0|||
143307129|NCT03240575|516676045|FG001|Overall Study|Adverse Event|2|||
143307130|NCT03240575|516676046|FG002|Overall Study|Adverse Event|0|||
143307131|NCT03240575|516676047|FG003|Overall Study|Adverse Event|1|||
143307132|NCT03240575|516676044|FG000|Overall Study|Withdrawal by Subject|2|||
143307133|NCT03240575|516676045|FG001|Overall Study|Withdrawal by Subject|11|||
143307134|NCT03240575|516676046|FG002|Overall Study|Withdrawal by Subject|0|||
143307135|NCT03240575|516676047|FG003|Overall Study|Withdrawal by Subject|1|||
143307136|NCT03240575|516676044|FG000|Overall Study|Other|0|||
143307137|NCT03240575|516676045|FG001|Overall Study|Other|1|||
143307138|NCT03240575|516676046|FG002|Overall Study|Other|0|||
143307139|NCT03240575|516676047|FG003|Overall Study|Other|0|||
143307140|NCT04144166|516676050|FG000|Overall Study|Discharged before study start|1|||
143307141|NCT04144166|516676050|FG000|Overall Study|Pregnancy|1|||
143307142|NCT04144166|516676050|FG000|Overall Study|Nail polish could not be removed from finger|1|||
143307143|NCT00697346|516676051|FG000|Overall Study|Adverse Event|4|||
143307144|NCT00697346|516676052|FG001|Overall Study|Adverse Event|5|||
143307145|NCT00697346|516676053|FG002|Overall Study|Adverse Event|0|||
143307146|NCT00697346|516676051|FG000|Overall Study|Progressive Disease|19|||
143307147|NCT00697346|516676052|FG001|Overall Study|Progressive Disease|18|||
143307148|NCT00697346|516676053|FG002|Overall Study|Progressive Disease|0|||
143307149|NCT00697346|516676051|FG000|Overall Study|Symptomatic Deterioration|0|||
143307150|NCT00697346|516676052|FG001|Overall Study|Symptomatic Deterioration|1|||
143307151|NCT00697346|516676053|FG002|Overall Study|Symptomatic Deterioration|0|||
143307152|NCT00697346|516676051|FG000|Overall Study|Withdrawal by Subject|2|||
143307153|NCT00697346|516676052|FG001|Overall Study|Withdrawal by Subject|2|||
143375543|NCT00516321|516920454|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
143307154|NCT00697346|516676053|FG002|Overall Study|Withdrawal by Subject|0|||
143307155|NCT00697346|516676051|FG000|Overall Study|Reason not Specified|3|||
143307156|NCT00697346|516676052|FG001|Overall Study|Reason not Specified|0|||
143307157|NCT00697346|516676053|FG002|Overall Study|Reason not Specified|1|||
143307158|NCT04145895|516676054|FG000|Overall Study|Physician Decision|2|||
143307159|NCT04145895|516676055|FG001|Overall Study|Physician Decision|0|||
143307160|NCT04145895|516676054|FG000|Overall Study|Withdrawal by Subject|0|||
143307161|NCT04145895|516676055|FG001|Overall Study|Withdrawal by Subject|2|||
143307162|NCT01236755|516676056|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
143307163|NCT01236755|516676056|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
143307164|NCT01236755|516676056|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
143307165|NCT01236755|516676056|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
143307166|NCT01481116|516676057|FG000|Overall Study|Adverse Event|26|||
143307167|NCT01481116|516676058|FG001|Overall Study|Adverse Event|26|||
143307168|NCT01481116|516676059|FG002|Overall Study|Adverse Event|42|||
143307169|NCT01481116|516676057|FG000|Overall Study|Major Protocol Deviation|3|||
143307170|NCT01481116|516676058|FG001|Overall Study|Major Protocol Deviation|7|||
143307171|NCT01481116|516676059|FG002|Overall Study|Major Protocol Deviation|1|||
143307172|NCT01481116|516676057|FG000|Overall Study|Lost to Follow-up|8|||
143307173|NCT01481116|516676058|FG001|Overall Study|Lost to Follow-up|12|||
143307174|NCT01481116|516676059|FG002|Overall Study|Lost to Follow-up|11|||
143307175|NCT01481116|516676057|FG000|Overall Study|Withdrawal by Subject|37|||
143307176|NCT01481116|516676058|FG001|Overall Study|Withdrawal by Subject|33|||
143307177|NCT01481116|516676059|FG002|Overall Study|Withdrawal by Subject|37|||
143307178|NCT01481116|516676057|FG000|Overall Study|Study Termination|730|||
143307179|NCT01481116|516676058|FG001|Overall Study|Study Termination|729|||
143307180|NCT01481116|516676059|FG002|Overall Study|Study Termination|713|||
143307181|NCT01481116|516676057|FG000|Overall Study|Pregnancy|0|||
143307182|NCT01481116|516676058|FG001|Overall Study|Pregnancy|0|||
143307183|NCT01481116|516676059|FG002|Overall Study|Pregnancy|1|||
143307184|NCT01481116|516676057|FG000|Overall Study|Lack of Efficacy|3|||
143307185|NCT01481116|516676058|FG001|Overall Study|Lack of Efficacy|3|||
143307186|NCT01481116|516676059|FG002|Overall Study|Lack of Efficacy|1|||
143307187|NCT01481116|516676057|FG000|Overall Study|Contraindications|1|||
143307188|NCT01481116|516676058|FG001|Overall Study|Contraindications|1|||
143307189|NCT01481116|516676059|FG002|Overall Study|Contraindications|0|||
143307190|NCT01481116|516676057|FG000|Overall Study|Other|1|||
143307191|NCT01481116|516676058|FG001|Overall Study|Other|1|||
143307192|NCT01481116|516676059|FG002|Overall Study|Other|0|||
143307193|NCT01481116|516676057|FG000|Overall Study|Participant Started Taking Glipizide|1|||
143307194|NCT01481116|516676058|FG001|Overall Study|Participant Started Taking Glipizide|0|||
143307195|NCT01481116|516676059|FG002|Overall Study|Participant Started Taking Glipizide|0|||
143307196|NCT01481116|516676057|FG000|Overall Study|Participant Moved Out of Area|2|||
143307197|NCT01481116|516676058|FG001|Overall Study|Participant Moved Out of Area|0|||
143307198|NCT01481116|516676059|FG002|Overall Study|Participant Moved Out of Area|1|||
143307199|NCT01481116|516676057|FG000|Overall Study|Participant Moved Out of Country|1|||
143307200|NCT01481116|516676058|FG001|Overall Study|Participant Moved Out of Country|0|||
143307201|NCT01481116|516676059|FG002|Overall Study|Participant Moved Out of Country|1|||
143307202|NCT01481116|516676057|FG000|Overall Study|Investigator Decision|3|||
143307203|NCT01481116|516676058|FG001|Overall Study|Investigator Decision|2|||
143307204|NCT01481116|516676059|FG002|Overall Study|Investigator Decision|1|||
143307205|NCT01481116|516676057|FG000|Overall Study|Sponsor Decision|0|||
143307206|NCT01481116|516676058|FG001|Overall Study|Sponsor Decision|1|||
143307207|NCT01481116|516676059|FG002|Overall Study|Sponsor Decision|3|||
143307208|NCT01481116|516676057|FG000|Overall Study|Non-Compliant With Study Drug|0|||
143307209|NCT01481116|516676058|FG001|Overall Study|Non-Compliant With Study Drug|1|||
143307210|NCT01481116|516676059|FG002|Overall Study|Non-Compliant With Study Drug|1|||
143307211|NCT01481116|516676057|FG000|Overall Study|Investigator's Discretion|2|||
143307212|NCT01481116|516676058|FG001|Overall Study|Investigator's Discretion|0|||
143375544|NCT00516321|516920452|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
143307213|NCT01481116|516676059|FG002|Overall Study|Investigator's Discretion|0|||
143307214|NCT01481116|516676057|FG000|Overall Study|Death|2|||
143307215|NCT01481116|516676058|FG001|Overall Study|Death|1|||
143307216|NCT01481116|516676059|FG002|Overall Study|Death|0|||
143307217|NCT01481116|516676057|FG000|Overall Study|Hypoglycemic Event|4|||
143307218|NCT01481116|516676058|FG001|Overall Study|Hypoglycemic Event|0|||
143307219|NCT01481116|516676059|FG002|Overall Study|Hypoglycemic Event|0|||
143307220|NCT00805935|516676060|FG000|Overall Study|Stimulation Failure|1|||
143307221|NCT00805935|516676061|FG001|Overall Study|Stimulation Failure|5|||
143307222|NCT00805935|516676062|FG002|Overall Study|Stimulation Failure|2|||
143307223|NCT00805935|516676063|FG003|Overall Study|Stimulation Failure|2|||
143307224|NCT00805935|516676060|FG000|Overall Study|Cycle cancelled|0|||
143307225|NCT00805935|516676061|FG001|Overall Study|Cycle cancelled|0|||
143307226|NCT00805935|516676062|FG002|Overall Study|Cycle cancelled|2|||
143307227|NCT00805935|516676063|FG003|Overall Study|Cycle cancelled|0|||
143307228|NCT00805935|516676060|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
143307229|NCT00805935|516676061|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
143307230|NCT00805935|516676062|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
143307231|NCT00805935|516676063|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
143307232|NCT00805935|516676060|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
143307233|NCT00805935|516676061|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
143307234|NCT00805935|516676062|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
143375545|NCT00516321|516920453|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
143307235|NCT00805935|516676063|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
143307236|NCT00805935|516676060|FG000|Overall Study|Lost to Follow-up|1|||
143307237|NCT00805935|516676061|FG001|Overall Study|Lost to Follow-up|0|||
143375546|NCT00516321|516920454|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
143307238|NCT00805935|516676062|FG002|Overall Study|Lost to Follow-up|0|||
143307239|NCT00805935|516676063|FG003|Overall Study|Lost to Follow-up|0|||
143307240|NCT00805935|516676060|FG000|Overall Study|No positive serum pregnancy|8|||
143307241|NCT00805935|516676061|FG001|Overall Study|No positive serum pregnancy|7|||
143307242|NCT00805935|516676062|FG002|Overall Study|No positive serum pregnancy|6|||
143307243|NCT00805935|516676063|FG003|Overall Study|No positive serum pregnancy|5|||
143307244|NCT00805935|516676060|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
143307245|NCT00805935|516676061|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
143307246|NCT00805935|516676062|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
143307247|NCT00805935|516676063|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
143307248|NCT00805935|516676060|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
143307249|NCT00805935|516676061|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
143307250|NCT00805935|516676062|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
143307251|NCT00805935|516676063|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
143307252|NCT00805935|516676060|FG000|Overall Study|Biochemical pregnancy|0|||
143307253|NCT00805935|516676061|FG001|Overall Study|Biochemical pregnancy|1|||
143307254|NCT00805935|516676062|FG002|Overall Study|Biochemical pregnancy|0|||
143307255|NCT00805935|516676063|FG003|Overall Study|Biochemical pregnancy|0|||
143307256|NCT00805935|516676060|FG000|Overall Study|Chemical pregnancy|0|||
143307257|NCT00805935|516676061|FG001|Overall Study|Chemical pregnancy|5|||
143307258|NCT00805935|516676062|FG002|Overall Study|Chemical pregnancy|3|||
143307259|NCT00805935|516676063|FG003|Overall Study|Chemical pregnancy|2|||
143307260|NCT00805935|516676060|FG000|Overall Study|Ectopic pregnancy|0|||
143307261|NCT00805935|516676061|FG001|Overall Study|Ectopic pregnancy|0|||
143307262|NCT00805935|516676062|FG002|Overall Study|Ectopic pregnancy|1|||
143307263|NCT00805935|516676063|FG003|Overall Study|Ectopic pregnancy|0|||
143307264|NCT00805935|516676060|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
143307265|NCT00805935|516676061|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
143307266|NCT00805935|516676062|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
143307267|NCT00805935|516676063|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
143307268|NCT02347527|516676064|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
143307269|NCT02347527|516676065|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
143307270|NCT02347527|516676066|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
143307271|NCT02347527|516676067|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
143307272|NCT02347527|516676064|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
143307273|NCT02347527|516676065|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
143307274|NCT02347527|516676066|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
143307275|NCT02347527|516676067|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
143307276|NCT02347527|516676064|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
143307277|NCT02347527|516676065|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
143307278|NCT02347527|516676066|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
143307279|NCT02347527|516676067|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
143307280|NCT02347527|516676064|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
143307281|NCT02347527|516676065|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
143307282|NCT02347527|516676066|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
143307283|NCT02347527|516676067|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
143307284|NCT02347527|516676064|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
143307285|NCT02347527|516676065|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
143307286|NCT02347527|516676066|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
143307287|NCT02347527|516676067|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
143307288|NCT02643251|516676068|FG000|Overall Study|Adverse Event|3|||
143307289|NCT02643251|516676069|FG001|Overall Study|Adverse Event|1|||
143307290|NCT02643251|516676068|FG000|Overall Study|Withdrawal by Subject|2|||
143307291|NCT02643251|516676069|FG001|Overall Study|Withdrawal by Subject|0|||
143307292|NCT02643251|516676068|FG000|Overall Study|Lost to Follow-up|4|||
143307293|NCT02643251|516676069|FG001|Overall Study|Lost to Follow-up|1|||
143307294|NCT02643251|516676068|FG000|Overall Study|Protocol Violation|1|||
143307295|NCT02643251|516676069|FG001|Overall Study|Protocol Violation|0|||
143307296|NCT02643251|516676068|FG000|Overall Study|PI Decision to terminate patient|1|||
143307297|NCT02643251|516676069|FG001|Overall Study|PI Decision to terminate patient|0|||
143307298|NCT02821962|516676070|FG000|Overall Study|Lost to Follow-up|2|||
143307299|NCT02821962|516676071|FG001|Overall Study|Lost to Follow-up|0|||
143307300|NCT00706966|516676077|FG000|Overall Study|Adverse Event|1|||
143307301|NCT03400332|516676080|FG000|Pre-Treatment|Other reasons|0|||
143307302|NCT03400332|516676081|FG001|Pre-Treatment|Other reasons|0|||
143307303|NCT03400332|516676082|FG002|Pre-Treatment|Other reasons|0|||
143307304|NCT03400332|516676083|FG003|Pre-Treatment|Other reasons|0|||
143375547|NCT00516321|516920452|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
143375548|NCT00516321|516920453|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
143375549|NCT00516321|516920454|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
143375550|NCT00516321|516920452|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
143375551|NCT00516321|516920453|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
143375552|NCT00516321|516920454|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
143375553|NCT02139046|516920455|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
143307305|NCT03400332|516676084|FG004|Pre-Treatment|Other reasons|0|||
143307306|NCT03400332|516676085|FG005|Pre-Treatment|Other reasons|0|||
143307307|NCT03400332|516676086|FG006|Pre-Treatment|Other reasons|0|||
143307308|NCT03400332|516676087|FG007|Pre-Treatment|Other reasons|0|||
143307309|NCT03400332|516676088|FG008|Pre-Treatment|Other reasons|1|||
143307310|NCT03400332|516676080|FG000|Pre-Treatment|No longer met study criteria|0|||
143307311|NCT03400332|516676081|FG001|Pre-Treatment|No longer met study criteria|0|||
143307312|NCT03400332|516676082|FG002|Pre-Treatment|No longer met study criteria|0|||
143307313|NCT03400332|516676083|FG003|Pre-Treatment|No longer met study criteria|0|||
143307314|NCT03400332|516676084|FG004|Pre-Treatment|No longer met study criteria|0|||
143307315|NCT03400332|516676085|FG005|Pre-Treatment|No longer met study criteria|0|||
143307316|NCT03400332|516676086|FG006|Pre-Treatment|No longer met study criteria|0|||
143307317|NCT03400332|516676087|FG007|Pre-Treatment|No longer met study criteria|0|||
143307318|NCT03400332|516676088|FG008|Pre-Treatment|No longer met study criteria|1|||
143307319|NCT03400332|516676080|FG000|Pre-Treatment|Withdrawal by Subject|0|||
143307320|NCT03400332|516676081|FG001|Pre-Treatment|Withdrawal by Subject|0|||
143307321|NCT03400332|516676082|FG002|Pre-Treatment|Withdrawal by Subject|0|||
143307322|NCT03400332|516676083|FG003|Pre-Treatment|Withdrawal by Subject|0|||
143307323|NCT03400332|516676084|FG004|Pre-Treatment|Withdrawal by Subject|0|||
143307324|NCT03400332|516676085|FG005|Pre-Treatment|Withdrawal by Subject|0|||
143307325|NCT03400332|516676086|FG006|Pre-Treatment|Withdrawal by Subject|0|||
143307326|NCT03400332|516676087|FG007|Pre-Treatment|Withdrawal by Subject|0|||
143307327|NCT03400332|516676088|FG008|Pre-Treatment|Withdrawal by Subject|1|||
143307328|NCT03400332|516676080|FG000|Treatment|Participant withdrew consent|2|||
143307329|NCT03400332|516676081|FG001|Treatment|Participant withdrew consent|2|||
143307330|NCT03400332|516676082|FG002|Treatment|Participant withdrew consent|0|||
143307331|NCT03400332|516676083|FG003|Treatment|Participant withdrew consent|0|||
143307332|NCT03400332|516676084|FG004|Treatment|Participant withdrew consent|3|||
143307333|NCT03400332|516676085|FG005|Treatment|Participant withdrew consent|3|||
143307334|NCT03400332|516676086|FG006|Treatment|Participant withdrew consent|1|||
143307335|NCT03400332|516676087|FG007|Treatment|Participant withdrew consent|1|||
143307336|NCT03400332|516676088|FG008|Treatment|Participant withdrew consent|1|||
143307337|NCT03400332|516676080|FG000|Treatment|Other reasons|0|||
143375554|NCT02139046|516920456|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
143307338|NCT03400332|516676081|FG001|Treatment|Other reasons|1|||
143307339|NCT03400332|516676082|FG002|Treatment|Other reasons|1|||
143307340|NCT03400332|516676083|FG003|Treatment|Other reasons|0|||
143307341|NCT03400332|516676084|FG004|Treatment|Other reasons|3|||
143307342|NCT03400332|516676085|FG005|Treatment|Other reasons|1|||
143307343|NCT03400332|516676086|FG006|Treatment|Other reasons|2|||
143307344|NCT03400332|516676087|FG007|Treatment|Other reasons|0|||
143307345|NCT03400332|516676088|FG008|Treatment|Other reasons|1|||
143307346|NCT03400332|516676080|FG000|Treatment|Lost to Follow-up|0|||
143307347|NCT03400332|516676081|FG001|Treatment|Lost to Follow-up|1|||
143307348|NCT03400332|516676082|FG002|Treatment|Lost to Follow-up|0|||
143307349|NCT03400332|516676083|FG003|Treatment|Lost to Follow-up|0|||
143307350|NCT03400332|516676084|FG004|Treatment|Lost to Follow-up|0|||
143307351|NCT03400332|516676085|FG005|Treatment|Lost to Follow-up|0|||
143307352|NCT03400332|516676086|FG006|Treatment|Lost to Follow-up|0|||
143307353|NCT03400332|516676087|FG007|Treatment|Lost to Follow-up|0|||
143307354|NCT03400332|516676088|FG008|Treatment|Lost to Follow-up|0|||
143307355|NCT03400332|516676080|FG000|Treatment|Death|3|||
143307356|NCT03400332|516676081|FG001|Treatment|Death|1|||
143307357|NCT03400332|516676082|FG002|Treatment|Death|2|||
143307358|NCT03400332|516676083|FG003|Treatment|Death|3|||
143307359|NCT03400332|516676084|FG004|Treatment|Death|6|||
143307360|NCT03400332|516676085|FG005|Treatment|Death|2|||
143307361|NCT03400332|516676086|FG006|Treatment|Death|1|||
143307362|NCT03400332|516676087|FG007|Treatment|Death|3|||
143307363|NCT03400332|516676088|FG008|Treatment|Death|6|||
143307364|NCT03837899|516676091|FG000|Overall Study|Death|6|||
143307365|NCT03837899|516676092|FG001|Overall Study|Death|8|||
143307366|NCT03837899|516676093|FG002|Overall Study|Death|3|||
143307367|NCT03837899|516676094|FG003|Overall Study|Death|7|||
143307368|NCT03837899|516676095|FG004|Overall Study|Death|8|||
143307369|NCT03837899|516676096|FG005|Overall Study|Death|7|||
143307370|NCT03837899|516676091|FG000|Overall Study|Moved to post-trial access program|0|||
143307371|NCT03837899|516676092|FG001|Overall Study|Moved to post-trial access program|1|||
143307372|NCT03837899|516676093|FG002|Overall Study|Moved to post-trial access program|0|||
143307373|NCT03837899|516676094|FG003|Overall Study|Moved to post-trial access program|0|||
143307374|NCT03837899|516676095|FG004|Overall Study|Moved to post-trial access program|0|||
143307375|NCT03837899|516676096|FG005|Overall Study|Moved to post-trial access program|0|||
143307376|NCT03837899|516676091|FG000|Overall Study|Other|0|||
143307377|NCT03837899|516676092|FG001|Overall Study|Other|0|||
143307378|NCT03837899|516676093|FG002|Overall Study|Other|0|||
143307379|NCT03837899|516676094|FG003|Overall Study|Other|0|||
143307380|NCT03837899|516676095|FG004|Overall Study|Other|0|||
143307381|NCT03837899|516676096|FG005|Overall Study|Other|2|||
143307382|NCT03837899|516676091|FG000|Overall Study|Lost to Follow-up|0|||
143307383|NCT03837899|516676092|FG001|Overall Study|Lost to Follow-up|1|||
143375555|NCT02139046|516920457|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
143307384|NCT03837899|516676093|FG002|Overall Study|Lost to Follow-up|0|||
143307385|NCT03837899|516676094|FG003|Overall Study|Lost to Follow-up|0|||
143307386|NCT03837899|516676095|FG004|Overall Study|Lost to Follow-up|0|||
143307387|NCT03837899|516676096|FG005|Overall Study|Lost to Follow-up|0|||
143307388|NCT03837899|516676091|FG000|Overall Study|Withdrawal by Subject|0|||
143307389|NCT03837899|516676092|FG001|Overall Study|Withdrawal by Subject|0|||
143307390|NCT03837899|516676093|FG002|Overall Study|Withdrawal by Subject|0|||
143307391|NCT03837899|516676094|FG003|Overall Study|Withdrawal by Subject|1|||
143307392|NCT03837899|516676095|FG004|Overall Study|Withdrawal by Subject|0|||
143307393|NCT03837899|516676096|FG005|Overall Study|Withdrawal by Subject|0|||
143307394|NCT03837899|516676091|FG000|Overall Study|Study specific discontinuation criteria|0|||
143307395|NCT03837899|516676092|FG001|Overall Study|Study specific discontinuation criteria|1|||
143307396|NCT03837899|516676093|FG002|Overall Study|Study specific discontinuation criteria|0|||
143307397|NCT03837899|516676094|FG003|Overall Study|Study specific discontinuation criteria|0|||
143307398|NCT03837899|516676095|FG004|Overall Study|Study specific discontinuation criteria|3|||
143307399|NCT03837899|516676096|FG005|Overall Study|Study specific discontinuation criteria|1|||
143307400|NCT04011410|516676097|FG000|Overall Study|Withdrawal by Subject|1|||
143307401|NCT01398956|516676098|FG000|Overall Study|Withdrawal by Subject|4|||
143307402|NCT01398956|516676098|FG000|Overall Study|AE, non-serious non-fatal|4|||
143307403|NCT01398956|516676098|FG000|Overall Study|Withdrawal Criteria No.3|1|||
143307404|NCT01398956|516676098|FG000|Overall Study|Subject moved a long distance|1|||
143307405|NCT01393405|516676101|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
143307406|NCT01393405|516676102|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
143307407|NCT01393405|516676103|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
143307408|NCT01393405|516676101|FG000|Induction Period (week1-16)|Adverse Event|16|||
143307409|NCT01393405|516676102|FG001|Induction Period (week1-16)|Adverse Event|0|||
143307410|NCT01393405|516676103|FG002|Induction Period (week1-16)|Adverse Event|0|||
143307411|NCT01393405|516676101|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
143307412|NCT01393405|516676102|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
143307413|NCT01393405|516676103|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
143307414|NCT01393405|516676101|FG000|Maintenance Period Week|Lack of Efficacy|0|||
143307415|NCT01393405|516676102|FG001|Maintenance Period Week|Lack of Efficacy|22|||
143307416|NCT01393405|516676103|FG002|Maintenance Period Week|Lack of Efficacy|22|||
143307417|NCT01393405|516676101|FG000|Maintenance Period Week|Adverse Event|0|||
143307418|NCT01393405|516676102|FG001|Maintenance Period Week|Adverse Event|5|||
143307419|NCT01393405|516676103|FG002|Maintenance Period Week|Adverse Event|2|||
143307420|NCT01393405|516676101|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
143307421|NCT01393405|516676102|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
143307422|NCT01393405|516676103|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
143307423|NCT01393405|516676101|FG000|Maintenance Period Week|Lost to Follow-up|0|||
143307424|NCT01393405|516676102|FG001|Maintenance Period Week|Lost to Follow-up|1|||
143307425|NCT01393405|516676103|FG002|Maintenance Period Week|Lost to Follow-up|0|||
143307426|NCT04365699|516676106|FG000|Overall Study|Death|2|||
143307427|NCT04365699|516676107|FG001|Overall Study|Death|5|||
143307428|NCT04365699|516676108|FG002|Overall Study|Death|15|||
143307429|NCT02321462|516676111|FG000|Overall Study|Withdrawal by Subject|5|||
143307430|NCT02321462|516676112|FG001|Overall Study|Withdrawal by Subject|2|||
143307431|NCT02321462|516676111|FG000|Overall Study|Subject withdrawn before any treatment|1|||
143307432|NCT02321462|516676112|FG001|Overall Study|Subject withdrawn before any treatment|1|||
143307433|NCT00834912|516676120|FG000|Treatment Period 1|Adverse Event|0|||
143307434|NCT00834912|516676121|FG001|Treatment Period 1|Adverse Event|1|||
143307435|NCT00834912|516676122|FG002|Treatment Period 1|Adverse Event|0|||
143307436|NCT00834912|516676123|FG003|Treatment Period 1|Adverse Event|1|||
143307437|NCT00834912|516676124|FG004|Treatment Period 1|Adverse Event|0|||
143307438|NCT00834912|516676125|FG005|Treatment Period 1|Adverse Event|0|||
143307439|NCT00834912|516676120|FG000|Treatment Period 2|Withdrawal by Subject|0|||
143307440|NCT00834912|516676121|FG001|Treatment Period 2|Withdrawal by Subject|0|||
143307441|NCT00834912|516676122|FG002|Treatment Period 2|Withdrawal by Subject|1|||
143307442|NCT00834912|516676123|FG003|Treatment Period 2|Withdrawal by Subject|0|||
143307443|NCT00834912|516676124|FG004|Treatment Period 2|Withdrawal by Subject|1|||
143307444|NCT00834912|516676125|FG005|Treatment Period 2|Withdrawal by Subject|0|||
143307445|NCT03044197|516676126|FG000|Overall Study|Withdrawal by Subject|3|||
143307446|NCT03044197|516676127|FG001|Overall Study|Withdrawal by Subject|1|||
143307447|NCT00262067|516676133|FG000|Overall Study|Death|190|||
143307448|NCT00262067|516676134|FG001|Overall Study|Death|89|||
143307449|NCT00262067|516676135|FG002|Overall Study|Death|186|||
143307450|NCT00262067|516676136|FG003|Overall Study|Death|99|||
143307451|NCT00262067|516676133|FG000|Overall Study|Lost to Follow-up|5|||
143307452|NCT00262067|516676134|FG001|Overall Study|Lost to Follow-up|4|||
143307453|NCT00262067|516676135|FG002|Overall Study|Lost to Follow-up|7|||
143307454|NCT00262067|516676136|FG003|Overall Study|Lost to Follow-up|5|||
143307455|NCT00262067|516676133|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
143307456|NCT00262067|516676134|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
143307457|NCT00262067|516676135|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
143307458|NCT00262067|516676136|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
143307459|NCT00262067|516676133|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
143307460|NCT00262067|516676134|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
143307461|NCT00262067|516676135|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
143307462|NCT00262067|516676136|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
143307463|NCT03829046|516676137|FG000|Overall Study|Withdrawal by Subject|1|||
143307464|NCT03829046|516676138|FG001|Overall Study|Withdrawal by Subject|0|||
143307465|NCT02849548|516676141|FG000|Overall Study|Lost to Follow-up|1|||
143307466|NCT02849548|516676142|FG001|Overall Study|Lost to Follow-up|2|||
143307467|NCT02849548|516676141|FG000|Overall Study|Protocol Violation|1|||
143307468|NCT02849548|516676142|FG001|Overall Study|Protocol Violation|0|||
143307469|NCT00714259|516676143|FG000|Overall Study|Death|2|||
143307470|NCT00256698|516676146|FG000|Overall Study|Withdrawal by Subject|7|||
143307471|NCT00256698|516676147|FG001|Overall Study|Withdrawal by Subject|7|||
143307472|NCT00256698|516676146|FG000|Overall Study|Adverse Event|13|||
143307473|NCT00256698|516676147|FG001|Overall Study|Adverse Event|6|||
143307474|NCT00256698|516676146|FG000|Overall Study|Protocol Violation|6|||
143307475|NCT00256698|516676147|FG001|Overall Study|Protocol Violation|5|||
143307476|NCT00256698|516676146|FG000|Overall Study|Lost to Follow-up|1|||
143307477|NCT00256698|516676147|FG001|Overall Study|Lost to Follow-up|3|||
143307478|NCT00256698|516676146|FG000|Overall Study|disease progression|97|||
143307479|NCT00256698|516676147|FG001|Overall Study|disease progression|105|||
143307480|NCT00256698|516676146|FG000|Overall Study|still ongoing at data cut-off|41|||
143307481|NCT00256698|516676147|FG001|Overall Study|still ongoing at data cut-off|46|||
143307482|NCT00256698|516676146|FG000|Overall Study|withdrawn due to osteoporosis|1|||
143307483|NCT00256698|516676147|FG001|Overall Study|withdrawn due to osteoporosis|0|||
143307484|NCT00256698|516676146|FG000|Overall Study|Prematurely Discontinued|1|||
143307485|NCT00256698|516676147|FG001|Overall Study|Prematurely Discontinued|0|||
143307486|NCT04477304|516676149|FG000|Overall Study|No valid opioid prescriptions during study timeframe|47|||
143307487|NCT04477304|516676150|FG001|Overall Study|No valid opioid prescriptions during study timeframe|26|||
143307488|NCT00773175|516677916|FG000|Overall Study|Adverse Event|2|||
143307489|NCT00773175|516677917|FG001|Overall Study|Adverse Event|0|||
143307490|NCT00773175|516677916|FG000|Overall Study|Consent Withdrawn|0|||
143307491|NCT00773175|516677917|FG001|Overall Study|Consent Withdrawn|2|||
143307492|NCT04482179|516677918|FG000|Overall Study|Death|1|||
143307493|NCT04482179|516677919|FG001|Overall Study|Death|0|||
143307494|NCT04482179|516677918|FG000|Overall Study|Withdrawal by Subject|1|||
143307495|NCT04482179|516677919|FG001|Overall Study|Withdrawal by Subject|0|||
143307496|NCT05723770|516677920|FG000|Overall Study|Lost to Follow-up|4|||
143307497|NCT05723770|516677920|FG000|Overall Study|Withdrawal by Subject|2|||
143307498|NCT04127786|516677923|FG000|Primary Series|Adverse Event|1|||
143307499|NCT04127786|516677924|FG001|Primary Series|Adverse Event|0|||
143307500|NCT04127786|516677925|FG002|Primary Series|Adverse Event|0|||
143307501|NCT04127786|516677926|FG003|Primary Series|Adverse Event|1|||
143307502|NCT04127786|516677927|FG004|Primary Series|Adverse Event|0|||
143307503|NCT04127786|516677928|FG005|Primary Series|Adverse Event|1|||
143307504|NCT04127786|516677923|FG000|Primary Series|Protocol Violation|5|||
143307505|NCT04127786|516677924|FG001|Primary Series|Protocol Violation|3|||
143307506|NCT04127786|516677925|FG002|Primary Series|Protocol Violation|4|||
143307507|NCT04127786|516677926|FG003|Primary Series|Protocol Violation|3|||
143307508|NCT04127786|516677927|FG004|Primary Series|Protocol Violation|2|||
143307509|NCT04127786|516677928|FG005|Primary Series|Protocol Violation|0|||
143307510|NCT04127786|516677923|FG000|Primary Series|Withdrawal by Subject|0|||
143307511|NCT04127786|516677924|FG001|Primary Series|Withdrawal by Subject|0|||
143307512|NCT04127786|516677925|FG002|Primary Series|Withdrawal by Subject|0|||
143307513|NCT04127786|516677926|FG003|Primary Series|Withdrawal by Subject|1|||
143307514|NCT04127786|516677927|FG004|Primary Series|Withdrawal by Subject|0|||
143307515|NCT04127786|516677928|FG005|Primary Series|Withdrawal by Subject|0|||
143307516|NCT04127786|516677923|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
143307517|NCT04127786|516677924|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
143307518|NCT04127786|516677925|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
143307519|NCT04127786|516677926|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
143307520|NCT04127786|516677927|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
143307521|NCT04127786|516677928|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
143307522|NCT04127786|516677923|FG000|Booster Phase|Withdrawal by Subject|2|||
143307523|NCT04127786|516677924|FG001|Booster Phase|Withdrawal by Subject|0|||
143307524|NCT04127786|516677925|FG002|Booster Phase|Withdrawal by Subject|0|||
143307525|NCT04127786|516677926|FG003|Booster Phase|Withdrawal by Subject|0|||
143307526|NCT04127786|516677927|FG004|Booster Phase|Withdrawal by Subject|0|||
143307527|NCT04127786|516677928|FG005|Booster Phase|Withdrawal by Subject|0|||
143307528|NCT01904604|516677929|FG000|Overall Study|Withdrew before receiving dosing|0|||
143307529|NCT01904604|516677930|FG001|Overall Study|Withdrew before receiving dosing|1|||
143307530|NCT01904604|516677931|FG002|Overall Study|Withdrew before receiving dosing|0|||
143307531|NCT01904604|516677929|FG000|Overall Study|Non-compliance|1|||
143307532|NCT01904604|516677930|FG001|Overall Study|Non-compliance|0|||
143307533|NCT01904604|516677931|FG002|Overall Study|Non-compliance|0|||
143307534|NCT01904604|516677929|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
143307535|NCT01904604|516677930|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
143307536|NCT01904604|516677931|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
143307537|NCT01904604|516677929|FG000|Overall Study|Patch site reactions|1|||
143307538|NCT01904604|516677930|FG001|Overall Study|Patch site reactions|1|||
143307539|NCT01904604|516677931|FG002|Overall Study|Patch site reactions|0|||
143307540|NCT01904604|516677929|FG000|Overall Study|Increased syncope|0|||
143307541|NCT01904604|516677930|FG001|Overall Study|Increased syncope|1|||
143307542|NCT01904604|516677931|FG002|Overall Study|Increased syncope|0|||
143307543|NCT01904604|516677929|FG000|Overall Study|Unrelated illness|0|||
143307544|NCT01904604|516677930|FG001|Overall Study|Unrelated illness|1|||
143307545|NCT01904604|516677931|FG002|Overall Study|Unrelated illness|0|||
143307546|NCT01904604|516677929|FG000|Overall Study|Passed Week 52 OFC|1|||
143307547|NCT01904604|516677930|FG001|Overall Study|Passed Week 52 OFC|0|||
143307548|NCT01904604|516677931|FG002|Overall Study|Passed Week 52 OFC|0|||
143307549|NCT01904604|516677929|FG000|Overall Study|Withdrawal by Subject|1|||
143307550|NCT01904604|516677930|FG001|Overall Study|Withdrawal by Subject|2|||
143307551|NCT01904604|516677931|FG002|Overall Study|Withdrawal by Subject|0|||
143307552|NCT01904604|516677929|FG000|Overall Study|Participant Relocated|1|||
143307553|NCT01904604|516677930|FG001|Overall Study|Participant Relocated|1|||
143307554|NCT01904604|516677931|FG002|Overall Study|Participant Relocated|1|||
143307555|NCT01904604|516677929|FG000|Overall Study|Lost to Follow-up|0|||
143307556|NCT01904604|516677930|FG001|Overall Study|Lost to Follow-up|0|||
143307557|NCT01904604|516677931|FG002|Overall Study|Lost to Follow-up|1|||
143307558|NCT01945489|516677934|FG000|Cycle 1|Adverse Event|2|||
143307559|NCT01945489|516677935|FG001|Cycle 1|Adverse Event|0|||
143307560|NCT01945489|516677934|FG000|Cycle 1|Lost to Follow-up|4|||
143307561|NCT01945489|516677935|FG001|Cycle 1|Lost to Follow-up|0|||
143307562|NCT01945489|516677934|FG000|Cycle 1|Personal Reasons|4|||
143307563|NCT01945489|516677935|FG001|Cycle 1|Personal Reasons|2|||
143307564|NCT01945489|516677934|FG000|Cycle 1|Protocol Violation|0|||
143307565|NCT01945489|516677935|FG001|Cycle 1|Protocol Violation|1|||
143307566|NCT01945489|516677934|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
143307567|NCT01945489|516677935|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
143307568|NCT01945489|516677934|FG000|Cycle 2|Adverse Event|1|||
143307569|NCT01945489|516677935|FG001|Cycle 2|Adverse Event|0|||
143307570|NCT01945489|516677934|FG000|Cycle 2|Lost to Follow-up|0|||
143307571|NCT01945489|516677935|FG001|Cycle 2|Lost to Follow-up|1|||
143307572|NCT03569371|516677941|FG000|Overall Study|Lack of Efficacy|1|||
143307573|NCT03569371|516677941|FG000|Overall Study|Lost to Follow-up|1|||
143307574|NCT03569371|516677941|FG000|Overall Study|Adverse Event|1|||
143307575|NCT03643562|516677944|FG000|Overall Study|Adverse Event|1|||
143307576|NCT03643562|516677945|FG001|Overall Study|Adverse Event|0|||
143307577|NCT03643562|516677944|FG000|Overall Study|Lack of Efficacy|0|||
143307578|NCT03643562|516677945|FG001|Overall Study|Lack of Efficacy|1|||
143307579|NCT03643562|516677944|FG000|Overall Study|Physician Decision|0|||
143307580|NCT03643562|516677945|FG001|Overall Study|Physician Decision|1|||
143307581|NCT03643562|516677944|FG000|Overall Study|Study Terminated by Sponsor|2|||
143307582|NCT03643562|516677945|FG001|Overall Study|Study Terminated by Sponsor|10|||
143307583|NCT03643562|516677944|FG000|Overall Study|Withdrawal by Subject|2|||
143307584|NCT03643562|516677945|FG001|Overall Study|Withdrawal by Subject|2|||
143307585|NCT03643562|516677944|FG000|Overall Study|Other than specified|3|||
143307586|NCT03643562|516677945|FG001|Overall Study|Other than specified|2|||
143307587|NCT01982253|516677946|FG000|Overall Study|Withdrawal by Subject|1|||
143307588|NCT01982253|516677947|FG001|Overall Study|Withdrawal by Subject|0|||
143307589|NCT01982253|516677948|FG002|Overall Study|Withdrawal by Subject|0|||
143307590|NCT01982253|516677946|FG000|Overall Study|Study terminated by sponsor|1|||
143307591|NCT01982253|516677947|FG001|Overall Study|Study terminated by sponsor|4|||
143307592|NCT01982253|516677948|FG002|Overall Study|Study terminated by sponsor|4|||
143307593|NCT03848845|516677949|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
143307594|NCT03848845|516677950|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
143307595|NCT03848845|516677951|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
143307596|NCT03848845|516677952|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
143307597|NCT03848845|516677949|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
143307598|NCT03848845|516677950|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
143307599|NCT03848845|516677951|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
143307600|NCT03848845|516677952|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
143307601|NCT03848845|516677949|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
143307602|NCT03848845|516677950|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
143307603|NCT03848845|516677951|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
143307604|NCT03848845|516677952|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
143307605|NCT03848845|516677949|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
143307606|NCT03848845|516677950|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
143307607|NCT03848845|516677951|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
143307608|NCT03848845|516677952|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
143307609|NCT01944059|516677953|FG000|Overall Study|Lost to Follow-up|1|||
143307610|NCT01944059|516677953|FG000|Overall Study|Physician Decision|3|||
143307611|NCT01944059|516677953|FG000|Overall Study|Withdrawal by Subject|1|||
143307612|NCT01944059|516677953|FG000|Overall Study|Adverse Event|2|||
143307613|NCT05923229|516677965|FG000|Overall Study|Withdrawal by Subject|3|||
143307614|NCT05923229|516677966|FG001|Overall Study|Withdrawal by Subject|0|||
143307615|NCT05923229|516677965|FG000|Overall Study|Health related|2|||
143307616|NCT05923229|516677966|FG001|Overall Study|Health related|1|||
143307617|NCT03064126|516677967|FG000|Overall Study|Death|40|||
143307618|NCT03064126|516677968|FG001|Overall Study|Death|16|||
143307619|NCT03064126|516677969|FG002|Overall Study|Death|4|||
143307620|NCT03064126|516677970|FG003|Overall Study|Death|2|||
143307621|NCT03064126|516677967|FG000|Overall Study|Withdrawal by Subject|17|||
143307622|NCT03064126|516677968|FG001|Overall Study|Withdrawal by Subject|9|||
143307623|NCT03064126|516677969|FG002|Overall Study|Withdrawal by Subject|0|||
143307624|NCT03064126|516677970|FG003|Overall Study|Withdrawal by Subject|2|||
143307625|NCT03064126|516677967|FG000|Overall Study|Lost to Follow-up|7|||
143307626|NCT03064126|516677968|FG001|Overall Study|Lost to Follow-up|3|||
143307627|NCT03064126|516677969|FG002|Overall Study|Lost to Follow-up|0|||
143307628|NCT03064126|516677970|FG003|Overall Study|Lost to Follow-up|0|||
143307629|NCT03064126|516677967|FG000|Overall Study|Adverse Event|2|||
143307630|NCT03064126|516677968|FG001|Overall Study|Adverse Event|0|||
143307631|NCT03064126|516677969|FG002|Overall Study|Adverse Event|0|||
143307632|NCT03064126|516677970|FG003|Overall Study|Adverse Event|0|||
143307633|NCT03064126|516677967|FG000|Overall Study|Physician Decision|3|||
143307634|NCT03064126|516677968|FG001|Overall Study|Physician Decision|0|||
143307635|NCT03064126|516677969|FG002|Overall Study|Physician Decision|0|||
143307636|NCT03064126|516677970|FG003|Overall Study|Physician Decision|0|||
143307637|NCT03064126|516677967|FG000|Overall Study|Other reason for early termination|3|||
143307638|NCT03064126|516677968|FG001|Overall Study|Other reason for early termination|2|||
143307639|NCT03064126|516677969|FG002|Overall Study|Other reason for early termination|0|||
143307640|NCT03064126|516677970|FG003|Overall Study|Other reason for early termination|0|||
143307641|NCT03064126|516677967|FG000|Overall Study|Missed Visit|3|||
143307642|NCT03064126|516677968|FG001|Overall Study|Missed Visit|1|||
143307643|NCT03064126|516677969|FG002|Overall Study|Missed Visit|0|||
143307644|NCT03064126|516677970|FG003|Overall Study|Missed Visit|0|||
143307645|NCT05288556|516677974|FG000|Overall Study|Protocol Violation|1|||
143307646|NCT05288556|516677974|FG000|Overall Study|Withdrawal by Subject|1|||
143307647|NCT02465528|516677975|FG000|Overall Study|Progressive disease|0|||
143307648|NCT02465528|516677976|FG001|Overall Study|Progressive disease|2|||
143307649|NCT02465528|516677977|FG002|Overall Study|Progressive disease|9|||
143307650|NCT02465528|516677978|FG003|Overall Study|Progressive disease|4|||
143307651|NCT02465528|516677975|FG000|Overall Study|Study terminated by sponsor|1|||
143307652|NCT02465528|516677976|FG001|Overall Study|Study terminated by sponsor|2|||
143307653|NCT02465528|516677977|FG002|Overall Study|Study terminated by sponsor|0|||
143307654|NCT02465528|516677978|FG003|Overall Study|Study terminated by sponsor|0|||
143307655|NCT02465528|516677975|FG000|Overall Study|Withdrawal by Subject|0|||
143307656|NCT02465528|516677976|FG001|Overall Study|Withdrawal by Subject|0|||
143307657|NCT02465528|516677977|FG002|Overall Study|Withdrawal by Subject|2|||
143307658|NCT02465528|516677978|FG003|Overall Study|Withdrawal by Subject|0|||
143307659|NCT02465528|516677975|FG000|Overall Study|Adverse Event|0|||
143307660|NCT02465528|516677976|FG001|Overall Study|Adverse Event|0|||
143307661|NCT02465528|516677977|FG002|Overall Study|Adverse Event|0|||
143307662|NCT02465528|516677978|FG003|Overall Study|Adverse Event|1|||
143307663|NCT02465528|516677975|FG000|Overall Study|Physician Decision|0|||
143307664|NCT02465528|516677976|FG001|Overall Study|Physician Decision|0|||
143307665|NCT02465528|516677977|FG002|Overall Study|Physician Decision|1|||
143307666|NCT02465528|516677978|FG003|Overall Study|Physician Decision|0|||
143307667|NCT05040152|516677981|FG000|Overall Study|Withdrawal by Subject|5|||
143307668|NCT05040152|516677982|FG001|Overall Study|Withdrawal by Subject|0|||
143375556|NCT02139046|516920458|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
143375557|NCT02139046|516920459|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
143375558|NCT02139046|516920455|FG000|Overall Study|Major Protocol Deviation|9|||
143307669|NCT05040152|516677981|FG000|Overall Study|Lost to Follow-up|0|||
143307670|NCT05040152|516677982|FG001|Overall Study|Lost to Follow-up|2|||
143307671|NCT03907683|516677983|FG000|Overall Study|Pregnancy|1|||
143307672|NCT03907683|516677983|FG000|Overall Study|Withdrawal by Subject|1|||
143307673|NCT01428193|516677984|FG000|Overall Study|Physician Decision|1|||
143307674|NCT01428193|516677984|FG000|Overall Study|Elevated screening liver enzymes|1|||
143307675|NCT02552316|516677985|FG000|Overall Study|Withdrawal by Subject|1|||
143375559|NCT02139046|516920456|FG001|Overall Study|Major Protocol Deviation|10|||
143375560|NCT02139046|516920457|FG002|Overall Study|Major Protocol Deviation|16|||
143307676|NCT02552316|516677985|FG000|Overall Study|Withdrawal due to non-compliance|1|||
143307677|NCT02659020|516677986|FG000|Overall Study|Adverse Event|0|||
143307678|NCT02659020|516677987|FG001|Overall Study|Adverse Event|0|||
143307679|NCT02659020|516677988|FG002|Overall Study|Adverse Event|0|||
143307680|NCT02659020|516677989|FG003|Overall Study|Adverse Event|2|||
143307681|NCT02659020|516677990|FG004|Overall Study|Adverse Event|0|||
143307682|NCT02659020|516677991|FG005|Overall Study|Adverse Event|0|||
143307683|NCT02659020|516677992|FG006|Overall Study|Adverse Event|2|||
143307684|NCT02659020|516677986|FG000|Overall Study|Lost to Follow-up|1|||
143307685|NCT02659020|516677987|FG001|Overall Study|Lost to Follow-up|2|||
143307686|NCT02659020|516677988|FG002|Overall Study|Lost to Follow-up|1|||
143307687|NCT02659020|516677989|FG003|Overall Study|Lost to Follow-up|6|||
143307688|NCT02659020|516677990|FG004|Overall Study|Lost to Follow-up|1|||
143307689|NCT02659020|516677991|FG005|Overall Study|Lost to Follow-up|5|||
143307690|NCT02659020|516677992|FG006|Overall Study|Lost to Follow-up|0|||
143307691|NCT02659020|516677986|FG000|Overall Study|Physician Decision|0|||
143307692|NCT02659020|516677987|FG001|Overall Study|Physician Decision|0|||
143307693|NCT02659020|516677988|FG002|Overall Study|Physician Decision|0|||
143307694|NCT02659020|516677989|FG003|Overall Study|Physician Decision|1|||
143307695|NCT02659020|516677990|FG004|Overall Study|Physician Decision|1|||
143307696|NCT02659020|516677991|FG005|Overall Study|Physician Decision|0|||
143307697|NCT02659020|516677992|FG006|Overall Study|Physician Decision|1|||
143307698|NCT02659020|516677986|FG000|Overall Study|Withdrawal by Subject|2|||
143307699|NCT02659020|516677987|FG001|Overall Study|Withdrawal by Subject|1|||
143307700|NCT02659020|516677988|FG002|Overall Study|Withdrawal by Subject|0|||
143307701|NCT02659020|516677989|FG003|Overall Study|Withdrawal by Subject|3|||
143307702|NCT02659020|516677990|FG004|Overall Study|Withdrawal by Subject|3|||
143307703|NCT02659020|516677991|FG005|Overall Study|Withdrawal by Subject|6|||
143307704|NCT02659020|516677992|FG006|Overall Study|Withdrawal by Subject|3|||
143307705|NCT02659020|516677986|FG000|Overall Study|Progressive Disease|0|||
143307706|NCT02659020|516677987|FG001|Overall Study|Progressive Disease|0|||
143307707|NCT02659020|516677988|FG002|Overall Study|Progressive Disease|0|||
143307708|NCT02659020|516677989|FG003|Overall Study|Progressive Disease|4|||
143307709|NCT02659020|516677990|FG004|Overall Study|Progressive Disease|1|||
143307710|NCT02659020|516677991|FG005|Overall Study|Progressive Disease|0|||
143307711|NCT02659020|516677992|FG006|Overall Study|Progressive Disease|2|||
143307712|NCT01077960|516677995|FG000|Overall Study|Adverse Event|6|||
143307713|NCT01077960|516677995|FG000|Overall Study|Protocol Violation|3|||
143307714|NCT01077960|516677995|FG000|Overall Study|Lost to Follow-up|5|||
143307715|NCT01077960|516677995|FG000|Overall Study|Subject decision|1|||
143307716|NCT01077960|516677995|FG000|Overall Study|Reason unspecified|1|||
143307717|NCT02457598|516677996|FG000|Overall Study|Progressive Disease|2|||
143307718|NCT02457598|516677997|FG001|Overall Study|Progressive Disease|2|||
143307719|NCT02457598|516677998|FG002|Overall Study|Progressive Disease|1|||
143307720|NCT02457598|516677999|FG003|Overall Study|Progressive Disease|11|||
143307721|NCT02457598|516678000|FG004|Overall Study|Progressive Disease|7|||
143307722|NCT02457598|516678001|FG005|Overall Study|Progressive Disease|3|||
143307723|NCT02457598|516678002|FG006|Overall Study|Progressive Disease|2|||
143307724|NCT02457598|516678003|FG007|Overall Study|Progressive Disease|1|||
143307725|NCT02457598|516678004|FG008|Overall Study|Progressive Disease|1|||
143307726|NCT02457598|516678005|FG009|Overall Study|Progressive Disease|2|||
143307727|NCT02457598|516678006|FG010|Overall Study|Progressive Disease|45|||
143307728|NCT02457598|516678007|FG011|Overall Study|Progressive Disease|6|||
143307729|NCT02457598|516678008|FG012|Overall Study|Progressive Disease|2|||
143307730|NCT02457598|516678009|FG013|Overall Study|Progressive Disease|2|||
143307731|NCT02457598|516678010|FG014|Overall Study|Progressive Disease|10|||
143307732|NCT02457598|516678011|FG015|Overall Study|Progressive Disease|1|||
143307733|NCT02457598|516678012|FG016|Overall Study|Progressive Disease|1|||
143307734|NCT02457598|516677996|FG000|Overall Study|Investigator's Discretion|0|||
143307735|NCT02457598|516677997|FG001|Overall Study|Investigator's Discretion|2|||
143307736|NCT02457598|516677998|FG002|Overall Study|Investigator's Discretion|2|||
143307737|NCT02457598|516677999|FG003|Overall Study|Investigator's Discretion|2|||
143307738|NCT02457598|516678000|FG004|Overall Study|Investigator's Discretion|0|||
143307739|NCT02457598|516678001|FG005|Overall Study|Investigator's Discretion|0|||
143307740|NCT02457598|516678002|FG006|Overall Study|Investigator's Discretion|0|||
143307741|NCT02457598|516678003|FG007|Overall Study|Investigator's Discretion|1|||
143307742|NCT02457598|516678004|FG008|Overall Study|Investigator's Discretion|2|||
143307743|NCT02457598|516678005|FG009|Overall Study|Investigator's Discretion|0|||
143307744|NCT02457598|516678006|FG010|Overall Study|Investigator's Discretion|10|||
143307745|NCT02457598|516678007|FG011|Overall Study|Investigator's Discretion|2|||
143307746|NCT02457598|516678008|FG012|Overall Study|Investigator's Discretion|2|||
143307747|NCT02457598|516678009|FG013|Overall Study|Investigator's Discretion|1|||
143307748|NCT02457598|516678010|FG014|Overall Study|Investigator's Discretion|5|||
143307749|NCT02457598|516678011|FG015|Overall Study|Investigator's Discretion|0|||
143307750|NCT02457598|516678012|FG016|Overall Study|Investigator's Discretion|0|||
143307751|NCT02457598|516677996|FG000|Overall Study|Study Terminated by Sponsor|0|||
143307752|NCT02457598|516677997|FG001|Overall Study|Study Terminated by Sponsor|1|||
143307753|NCT02457598|516677998|FG002|Overall Study|Study Terminated by Sponsor|0|||
143307754|NCT02457598|516677999|FG003|Overall Study|Study Terminated by Sponsor|4|||
143307755|NCT02457598|516678000|FG004|Overall Study|Study Terminated by Sponsor|1|||
143307756|NCT02457598|516678001|FG005|Overall Study|Study Terminated by Sponsor|0|||
143307757|NCT02457598|516678002|FG006|Overall Study|Study Terminated by Sponsor|1|||
143307758|NCT02457598|516678003|FG007|Overall Study|Study Terminated by Sponsor|0|||
143307759|NCT02457598|516678004|FG008|Overall Study|Study Terminated by Sponsor|0|||
143307760|NCT02457598|516678005|FG009|Overall Study|Study Terminated by Sponsor|0|||
143307761|NCT02457598|516678006|FG010|Overall Study|Study Terminated by Sponsor|4|||
143307762|NCT02457598|516678007|FG011|Overall Study|Study Terminated by Sponsor|0|||
143375561|NCT02139046|516920458|FG003|Overall Study|Major Protocol Deviation|12|||
143307763|NCT02457598|516678008|FG012|Overall Study|Study Terminated by Sponsor|1|||
143307764|NCT02457598|516678009|FG013|Overall Study|Study Terminated by Sponsor|0|||
143307765|NCT02457598|516678010|FG014|Overall Study|Study Terminated by Sponsor|8|||
143307766|NCT02457598|516678011|FG015|Overall Study|Study Terminated by Sponsor|1|||
143307767|NCT02457598|516678012|FG016|Overall Study|Study Terminated by Sponsor|0|||
143307768|NCT02457598|516677996|FG000|Overall Study|Adverse Event|0|||
143307769|NCT02457598|516677997|FG001|Overall Study|Adverse Event|1|||
143307770|NCT02457598|516677998|FG002|Overall Study|Adverse Event|1|||
143307771|NCT02457598|516677999|FG003|Overall Study|Adverse Event|4|||
143307772|NCT02457598|516678000|FG004|Overall Study|Adverse Event|1|||
143307773|NCT02457598|516678001|FG005|Overall Study|Adverse Event|0|||
143307774|NCT02457598|516678002|FG006|Overall Study|Adverse Event|0|||
143307775|NCT02457598|516678003|FG007|Overall Study|Adverse Event|1|||
143375562|NCT02139046|516920459|FG004|Overall Study|Major Protocol Deviation|6|||
143375563|NCT02139046|516920455|FG000|Overall Study|Lost to Follow-up|13|||
143307776|NCT02457598|516678004|FG008|Overall Study|Adverse Event|0|||
143307777|NCT02457598|516678005|FG009|Overall Study|Adverse Event|1|||
143307778|NCT02457598|516678006|FG010|Overall Study|Adverse Event|6|||
143307779|NCT02457598|516678007|FG011|Overall Study|Adverse Event|0|||
143307780|NCT02457598|516678008|FG012|Overall Study|Adverse Event|0|||
143307781|NCT02457598|516678009|FG013|Overall Study|Adverse Event|1|||
143307782|NCT02457598|516678010|FG014|Overall Study|Adverse Event|2|||
143307783|NCT02457598|516678011|FG015|Overall Study|Adverse Event|0|||
143307784|NCT02457598|516678012|FG016|Overall Study|Adverse Event|0|||
143307785|NCT02457598|516677996|FG000|Overall Study|Death|0|||
143307786|NCT02457598|516677997|FG001|Overall Study|Death|0|||
143307787|NCT02457598|516677998|FG002|Overall Study|Death|0|||
143307788|NCT02457598|516677999|FG003|Overall Study|Death|3|||
143307789|NCT02457598|516678000|FG004|Overall Study|Death|0|||
143307790|NCT02457598|516678001|FG005|Overall Study|Death|1|||
143307791|NCT02457598|516678002|FG006|Overall Study|Death|0|||
143307792|NCT02457598|516678003|FG007|Overall Study|Death|0|||
143307793|NCT02457598|516678004|FG008|Overall Study|Death|0|||
143307794|NCT02457598|516678005|FG009|Overall Study|Death|0|||
143307795|NCT02457598|516678006|FG010|Overall Study|Death|3|||
143307796|NCT02457598|516678007|FG011|Overall Study|Death|0|||
143307797|NCT02457598|516678008|FG012|Overall Study|Death|0|||
143307798|NCT02457598|516678009|FG013|Overall Study|Death|1|||
143307799|NCT02457598|516678010|FG014|Overall Study|Death|2|||
143307800|NCT02457598|516678011|FG015|Overall Study|Death|0|||
143307801|NCT02457598|516678012|FG016|Overall Study|Death|1|||
143307802|NCT02457598|516677996|FG000|Overall Study|Transition to the MHRA's Special Scheme|0|||
143307803|NCT02457598|516677997|FG001|Overall Study|Transition to the MHRA's Special Scheme|2|||
143307804|NCT02457598|516677998|FG002|Overall Study|Transition to the MHRA's Special Scheme|0|||
143307805|NCT02457598|516677999|FG003|Overall Study|Transition to the MHRA's Special Scheme|1|||
143307806|NCT02457598|516678000|FG004|Overall Study|Transition to the MHRA's Special Scheme|0|||
143307807|NCT02457598|516678001|FG005|Overall Study|Transition to the MHRA's Special Scheme|0|||
143307808|NCT02457598|516678002|FG006|Overall Study|Transition to the MHRA's Special Scheme|0|||
143307809|NCT02457598|516678003|FG007|Overall Study|Transition to the MHRA's Special Scheme|1|||
143307810|NCT02457598|516678004|FG008|Overall Study|Transition to the MHRA's Special Scheme|0|||
143307811|NCT02457598|516678005|FG009|Overall Study|Transition to the MHRA's Special Scheme|0|||
143307812|NCT02457598|516678006|FG010|Overall Study|Transition to the MHRA's Special Scheme|4|||
143307813|NCT02457598|516678007|FG011|Overall Study|Transition to the MHRA's Special Scheme|0|||
143307814|NCT02457598|516678008|FG012|Overall Study|Transition to the MHRA's Special Scheme|0|||
143307815|NCT02457598|516678009|FG013|Overall Study|Transition to the MHRA's Special Scheme|0|||
143307816|NCT02457598|516678010|FG014|Overall Study|Transition to the MHRA's Special Scheme|1|||
143307817|NCT02457598|516678011|FG015|Overall Study|Transition to the MHRA's Special Scheme|1|||
143307818|NCT02457598|516678012|FG016|Overall Study|Transition to the MHRA's Special Scheme|1|||
143307819|NCT02457598|516677996|FG000|Overall Study|Withdrew Consent|0|||
143307820|NCT02457598|516677997|FG001|Overall Study|Withdrew Consent|0|||
143307821|NCT02457598|516677998|FG002|Overall Study|Withdrew Consent|0|||
143307822|NCT02457598|516677999|FG003|Overall Study|Withdrew Consent|0|||
143307823|NCT02457598|516678000|FG004|Overall Study|Withdrew Consent|0|||
143307824|NCT02457598|516678001|FG005|Overall Study|Withdrew Consent|0|||
143307825|NCT02457598|516678002|FG006|Overall Study|Withdrew Consent|0|||
143307826|NCT02457598|516678003|FG007|Overall Study|Withdrew Consent|2|||
143307827|NCT02457598|516678004|FG008|Overall Study|Withdrew Consent|0|||
143307828|NCT02457598|516678005|FG009|Overall Study|Withdrew Consent|0|||
143307829|NCT02457598|516678006|FG010|Overall Study|Withdrew Consent|3|||
143307830|NCT02457598|516678007|FG011|Overall Study|Withdrew Consent|0|||
143307831|NCT02457598|516678008|FG012|Overall Study|Withdrew Consent|0|||
143307832|NCT02457598|516678009|FG013|Overall Study|Withdrew Consent|1|||
143307833|NCT02457598|516678010|FG014|Overall Study|Withdrew Consent|0|||
143307834|NCT02457598|516678011|FG015|Overall Study|Withdrew Consent|0|||
143307835|NCT02457598|516678012|FG016|Overall Study|Withdrew Consent|0|||
143307836|NCT02457598|516677996|FG000|Overall Study|Unacceptable Toxicity|0|||
143307837|NCT02457598|516677997|FG001|Overall Study|Unacceptable Toxicity|0|||
143307838|NCT02457598|516677998|FG002|Overall Study|Unacceptable Toxicity|0|||
143307839|NCT02457598|516677999|FG003|Overall Study|Unacceptable Toxicity|0|||
143307840|NCT02457598|516678000|FG004|Overall Study|Unacceptable Toxicity|0|||
143307841|NCT02457598|516678001|FG005|Overall Study|Unacceptable Toxicity|0|||
143307842|NCT02457598|516678002|FG006|Overall Study|Unacceptable Toxicity|0|||
143307843|NCT02457598|516678003|FG007|Overall Study|Unacceptable Toxicity|0|||
143307844|NCT02457598|516678004|FG008|Overall Study|Unacceptable Toxicity|0|||
143307845|NCT02457598|516678005|FG009|Overall Study|Unacceptable Toxicity|0|||
143307846|NCT02457598|516678006|FG010|Overall Study|Unacceptable Toxicity|1|||
143307847|NCT02457598|516678007|FG011|Overall Study|Unacceptable Toxicity|0|||
143307848|NCT02457598|516678008|FG012|Overall Study|Unacceptable Toxicity|1|||
143307849|NCT02457598|516678009|FG013|Overall Study|Unacceptable Toxicity|1|||
143307850|NCT02457598|516678010|FG014|Overall Study|Unacceptable Toxicity|1|||
143307851|NCT02457598|516678011|FG015|Overall Study|Unacceptable Toxicity|0|||
143307852|NCT02457598|516678012|FG016|Overall Study|Unacceptable Toxicity|0|||
143307853|NCT02457598|516677996|FG000|Overall Study|Intercurrent Illness|0|||
143307854|NCT02457598|516677997|FG001|Overall Study|Intercurrent Illness|0|||
143307855|NCT02457598|516677998|FG002|Overall Study|Intercurrent Illness|0|||
143307856|NCT02457598|516677999|FG003|Overall Study|Intercurrent Illness|0|||
143307857|NCT02457598|516678000|FG004|Overall Study|Intercurrent Illness|0|||
143307858|NCT02457598|516678001|FG005|Overall Study|Intercurrent Illness|0|||
143307859|NCT02457598|516678002|FG006|Overall Study|Intercurrent Illness|0|||
143307860|NCT02457598|516678003|FG007|Overall Study|Intercurrent Illness|0|||
143307861|NCT02457598|516678004|FG008|Overall Study|Intercurrent Illness|0|||
143307862|NCT02457598|516678005|FG009|Overall Study|Intercurrent Illness|0|||
143307863|NCT02457598|516678006|FG010|Overall Study|Intercurrent Illness|1|||
143307864|NCT02457598|516678007|FG011|Overall Study|Intercurrent Illness|0|||
143307865|NCT02457598|516678008|FG012|Overall Study|Intercurrent Illness|0|||
143307866|NCT02457598|516678009|FG013|Overall Study|Intercurrent Illness|0|||
143307867|NCT02457598|516678010|FG014|Overall Study|Intercurrent Illness|0|||
143307868|NCT02457598|516678011|FG015|Overall Study|Intercurrent Illness|0|||
143307869|NCT02457598|516678012|FG016|Overall Study|Intercurrent Illness|0|||
143307870|NCT02457598|516677996|FG000|Overall Study|Protocol Violation|0|||
143307871|NCT02457598|516677997|FG001|Overall Study|Protocol Violation|0|||
143307872|NCT02457598|516677998|FG002|Overall Study|Protocol Violation|0|||
143307873|NCT02457598|516677999|FG003|Overall Study|Protocol Violation|0|||
143307874|NCT02457598|516678000|FG004|Overall Study|Protocol Violation|0|||
143307875|NCT02457598|516678001|FG005|Overall Study|Protocol Violation|0|||
143307876|NCT02457598|516678002|FG006|Overall Study|Protocol Violation|0|||
143307877|NCT02457598|516678003|FG007|Overall Study|Protocol Violation|0|||
143307878|NCT02457598|516678004|FG008|Overall Study|Protocol Violation|0|||
143307879|NCT02457598|516678005|FG009|Overall Study|Protocol Violation|0|||
143307880|NCT02457598|516678006|FG010|Overall Study|Protocol Violation|1|||
143307881|NCT02457598|516678007|FG011|Overall Study|Protocol Violation|0|||
143307882|NCT02457598|516678008|FG012|Overall Study|Protocol Violation|0|||
143307883|NCT02457598|516678009|FG013|Overall Study|Protocol Violation|0|||
143307884|NCT02457598|516678010|FG014|Overall Study|Protocol Violation|0|||
143307885|NCT02457598|516678011|FG015|Overall Study|Protocol Violation|0|||
143307886|NCT02457598|516678012|FG016|Overall Study|Protocol Violation|0|||
143307887|NCT02703636|516678022|FG000|Overall Study|Adverse Event|14|||
143307888|NCT02703636|516678022|FG000|Overall Study|Study stopped by sponsor|1|||
143307889|NCT02703636|516678022|FG000|Overall Study|Withdrawal by Subject|1|||
143307890|NCT04334460|516678031|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
143307891|NCT04334460|516678032|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
143307892|NCT04334460|516678031|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
143307893|NCT04334460|516678032|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
143307894|NCT03778931|516678035|FG000|Overall Study|Withdrawal by Subject|12|||
143307895|NCT03778931|516678036|FG001|Overall Study|Withdrawal by Subject|25|||
143307896|NCT03778931|516678035|FG000|Overall Study|Physician Decision|1|||
143307897|NCT03778931|516678036|FG001|Overall Study|Physician Decision|3|||
143307898|NCT03778931|516678035|FG000|Overall Study|Participant Noncompliance|1|||
143307899|NCT03778931|516678036|FG001|Overall Study|Participant Noncompliance|1|||
143307900|NCT03778931|516678035|FG000|Overall Study|Lost to Follow-up|4|||
143307901|NCT03778931|516678036|FG001|Overall Study|Lost to Follow-up|1|||
143375564|NCT02139046|516920456|FG001|Overall Study|Lost to Follow-up|16|||
143307902|NCT03778931|516678035|FG000|Overall Study|Death|69|||
143375565|NCT02139046|516920457|FG002|Overall Study|Lost to Follow-up|16|||
143375566|NCT02139046|516920458|FG003|Overall Study|Lost to Follow-up|18|||
143375567|NCT02139046|516920459|FG004|Overall Study|Lost to Follow-up|13|||
143375568|NCT02139046|516920455|FG000|Overall Study|Voluntary Withdrawal|20|||
143375569|NCT02139046|516920456|FG001|Overall Study|Voluntary Withdrawal|8|||
143375570|NCT02139046|516920457|FG002|Overall Study|Voluntary Withdrawal|10|||
143307903|NCT03778931|516678036|FG001|Overall Study|Death|79|||
143307904|NCT02130765|516678041|FG000|Overall Study|Did not receive treatment|4|||
143307905|NCT02130765|516678042|FG001|Overall Study|Did not receive treatment|0|||
143307906|NCT02130765|516678043|FG002|Overall Study|Did not receive treatment|0|||
143307907|NCT02130765|516678044|FG003|Overall Study|Did not receive treatment|0|||
143307908|NCT01537783|516678053|FG000|Overall Study|Lost to Follow-up|11|||
143307909|NCT01537783|516678054|FG001|Overall Study|Lost to Follow-up|2|||
143307910|NCT01554618|516678055|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
143307911|NCT01554618|516678056|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
143307912|NCT01554618|516678055|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
143307913|NCT01554618|516678056|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
143375571|NCT02139046|516920458|FG003|Overall Study|Voluntary Withdrawal|15|||
143307914|NCT01554618|516678055|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
143307915|NCT01554618|516678056|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
143307916|NCT01554618|516678055|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
143307917|NCT01554618|516678056|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
143307918|NCT01554618|516678055|FG000|Open-Label Extension Period|Physician Decision|0|||
143307919|NCT01554618|516678056|FG001|Open-Label Extension Period|Physician Decision|1|||
143307920|NCT01554618|516678055|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
143307921|NCT01554618|516678056|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
143307922|NCT00477672|516678057|FG000|Overall Study|Adverse Event|3|||
143307923|NCT00477672|516678058|FG001|Overall Study|Adverse Event|5|||
143307924|NCT00477672|516678059|FG002|Overall Study|Adverse Event|6|||
143307925|NCT00477672|516678057|FG000|Overall Study|Death|0|||
143307926|NCT00477672|516678058|FG001|Overall Study|Death|1|||
143307927|NCT00477672|516678059|FG002|Overall Study|Death|0|||
143307928|NCT00477672|516678057|FG000|Overall Study|Disease progression|0|||
143307929|NCT00477672|516678058|FG001|Overall Study|Disease progression|1|||
143307930|NCT00477672|516678059|FG002|Overall Study|Disease progression|0|||
143307931|NCT00477672|516678057|FG000|Overall Study|Physician Decision|1|||
143307932|NCT00477672|516678058|FG001|Overall Study|Physician Decision|0|||
143307933|NCT00477672|516678059|FG002|Overall Study|Physician Decision|0|||
143307934|NCT00477672|516678057|FG000|Overall Study|Protocol noncompliance|0|||
143307935|NCT00477672|516678058|FG001|Overall Study|Protocol noncompliance|2|||
143307936|NCT00477672|516678059|FG002|Overall Study|Protocol noncompliance|0|||
143307937|NCT00477672|516678057|FG000|Overall Study|Consent withdrawn|2|||
143307938|NCT00477672|516678058|FG001|Overall Study|Consent withdrawn|5|||
143307939|NCT00477672|516678059|FG002|Overall Study|Consent withdrawn|10|||
143307940|NCT00477672|516678057|FG000|Overall Study|Discretion of Sponsor|1|||
143307941|NCT00477672|516678058|FG001|Overall Study|Discretion of Sponsor|2|||
143307942|NCT00477672|516678059|FG002|Overall Study|Discretion of Sponsor|0|||
143307943|NCT02722928|516678062|FG000|Overall Study|Standard CT was not as required per prot|5|||
143307944|NCT02722928|516678063|FG001|Overall Study|Standard CT was not as required per prot|13|||
143307945|NCT02722928|516678062|FG000|Overall Study|Required Intraoperative MRI|5|||
143307946|NCT02722928|516678063|FG001|Overall Study|Required Intraoperative MRI|7|||
143307947|NCT02275481|516678064|FG000|Overall Study|Death|2|||
143307948|NCT02275481|516678065|FG001|Overall Study|Death|1|||
143307949|NCT02275481|516678064|FG000|Overall Study|Lost to Follow-up|2|||
143307950|NCT02275481|516678065|FG001|Overall Study|Lost to Follow-up|0|||
143307951|NCT02275481|516678064|FG000|Overall Study|Withdrawal by Subject|3|||
143307952|NCT02275481|516678065|FG001|Overall Study|Withdrawal by Subject|0|||
143307953|NCT02275481|516678064|FG000|Overall Study|all other reasons combined|2|||
143307954|NCT02275481|516678065|FG001|Overall Study|all other reasons combined|1|||
143307955|NCT02275481|516678064|FG000|Overall Study|Physician Decision|0|||
143307956|NCT02275481|516678065|FG001|Overall Study|Physician Decision|1|||
143307957|NCT01838642|516678067|FG000|Overall Study|Died on study|1|||
143307958|NCT01215227|516678071|FG000|Overall Study|Adverse Event|11|||
143307959|NCT01215227|516678072|FG001|Overall Study|Adverse Event|11|||
143307960|NCT01215227|516678073|FG002|Overall Study|Adverse Event|4|||
143307961|NCT01215227|516678074|FG003|Overall Study|Adverse Event|8|||
143307962|NCT01215227|516678075|FG004|Overall Study|Adverse Event|7|||
143307963|NCT01215227|516678076|FG005|Overall Study|Adverse Event|6|||
143307964|NCT01215227|516678071|FG000|Overall Study|Treatment Failure|8|||
143307965|NCT01215227|516678072|FG001|Overall Study|Treatment Failure|4|||
143307966|NCT01215227|516678073|FG002|Overall Study|Treatment Failure|1|||
143307967|NCT01215227|516678074|FG003|Overall Study|Treatment Failure|5|||
143307968|NCT01215227|516678075|FG004|Overall Study|Treatment Failure|1|||
143307969|NCT01215227|516678076|FG005|Overall Study|Treatment Failure|1|||
143307970|NCT01215227|516678071|FG000|Overall Study|Lost to Follow-up|1|||
143307971|NCT01215227|516678072|FG001|Overall Study|Lost to Follow-up|4|||
143307972|NCT01215227|516678073|FG002|Overall Study|Lost to Follow-up|1|||
143307973|NCT01215227|516678074|FG003|Overall Study|Lost to Follow-up|1|||
143307974|NCT01215227|516678075|FG004|Overall Study|Lost to Follow-up|1|||
143307975|NCT01215227|516678076|FG005|Overall Study|Lost to Follow-up|2|||
143307976|NCT01215227|516678071|FG000|Overall Study|Subject Withdrew Consent|16|||
143307977|NCT01215227|516678072|FG001|Overall Study|Subject Withdrew Consent|20|||
143307978|NCT01215227|516678073|FG002|Overall Study|Subject Withdrew Consent|7|||
143307979|NCT01215227|516678074|FG003|Overall Study|Subject Withdrew Consent|10|||
143307980|NCT01215227|516678075|FG004|Overall Study|Subject Withdrew Consent|11|||
143307981|NCT01215227|516678076|FG005|Overall Study|Subject Withdrew Consent|8|||
143307982|NCT01215227|516678071|FG000|Overall Study|Non-Compliance With Protocol|2|||
143307983|NCT01215227|516678072|FG001|Overall Study|Non-Compliance With Protocol|6|||
143307984|NCT01215227|516678073|FG002|Overall Study|Non-Compliance With Protocol|1|||
143307985|NCT01215227|516678074|FG003|Overall Study|Non-Compliance With Protocol|0|||
143307986|NCT01215227|516678075|FG004|Overall Study|Non-Compliance With Protocol|0|||
143307987|NCT01215227|516678076|FG005|Overall Study|Non-Compliance With Protocol|0|||
143307988|NCT01215227|516678071|FG000|Overall Study|Administrative|83|||
143307989|NCT01215227|516678072|FG001|Overall Study|Administrative|73|||
143307990|NCT01215227|516678073|FG002|Overall Study|Administrative|42|||
143307991|NCT01215227|516678074|FG003|Overall Study|Administrative|24|||
143307992|NCT01215227|516678075|FG004|Overall Study|Administrative|28|||
143307993|NCT01215227|516678076|FG005|Overall Study|Administrative|40|||
143307994|NCT01215227|516678071|FG000|Overall Study|Missing Status|0|||
143307995|NCT01215227|516678072|FG001|Overall Study|Missing Status|1|||
143307996|NCT01215227|516678073|FG002|Overall Study|Missing Status|0|||
143307997|NCT01215227|516678074|FG003|Overall Study|Missing Status|0|||
143307998|NCT01215227|516678075|FG004|Overall Study|Missing Status|0|||
143307999|NCT01215227|516678076|FG005|Overall Study|Missing Status|0|||
143308000|NCT01215227|516678071|FG000|Overall Study|Randomized but not treated|0|||
143308001|NCT01215227|516678072|FG001|Overall Study|Randomized but not treated|0|||
143308002|NCT01215227|516678073|FG002|Overall Study|Randomized but not treated|1|||
143308003|NCT01215227|516678074|FG003|Overall Study|Randomized but not treated|1|||
143308004|NCT01215227|516678075|FG004|Overall Study|Randomized but not treated|0|||
143308005|NCT01215227|516678076|FG005|Overall Study|Randomized but not treated|1|||
143308006|NCT00291668|516678077|FG000|Overall Study|Lack of Efficacy|1|||
143308007|NCT00291668|516678078|FG001|Overall Study|Lack of Efficacy|0|||
143308008|NCT00291668|516678079|FG002|Overall Study|Lack of Efficacy|0|||
143308009|NCT00291668|516678077|FG000|Overall Study|SAE, non-fatal|1|||
143308010|NCT00291668|516678078|FG001|Overall Study|SAE, non-fatal|1|||
143308011|NCT00291668|516678079|FG002|Overall Study|SAE, non-fatal|1|||
143308012|NCT00291668|516678077|FG000|Overall Study|AE, non-serious non-fatal|1|||
143308013|NCT00291668|516678078|FG001|Overall Study|AE, non-serious non-fatal|0|||
143308014|NCT00291668|516678079|FG002|Overall Study|AE, non-serious non-fatal|0|||
143308015|NCT00291668|516678077|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
143308016|NCT00291668|516678078|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
143308017|NCT00291668|516678079|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
143308018|NCT00313612|516678082|FG000|Overall Study|Patient never received treatment|0|||
143308019|NCT00313612|516678083|FG001|Overall Study|Patient never received treatment|1|||
143308020|NCT00451035|516678084|FG000|Overall Study|Disease progression|11|||
143308021|NCT00451035|516678084|FG000|Overall Study|Death|3|||
143308022|NCT00451035|516678084|FG000|Overall Study|New anti-neoplastic therapy|3|||
143308023|NCT01557400|516678085|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
143308024|NCT01557400|516678085|FG000|Overall Study|Adverse Event|3|||
143308025|NCT01557400|516678085|FG000|Overall Study|Lost to Follow-up|5|||
143308026|NCT01557400|516678085|FG000|Overall Study|Withdrawal by Subject|9|||
143308027|NCT02777125|516678086|FG000|Overall Study|Consent form violation|14|||
143308028|NCT02777125|516678087|FG001|Overall Study|Consent form violation|12|||
143308029|NCT02777125|516678086|FG000|Overall Study|Assent form violation|21|||
143308030|NCT02777125|516678087|FG001|Overall Study|Assent form violation|23|||
143308031|NCT02777125|516678086|FG000|Overall Study|Protocol Violation|8|||
143308032|NCT02777125|516678087|FG001|Overall Study|Protocol Violation|12|||
143308033|NCT05084053|516679580|FG000|Epoch 1: Up to 6 Months|Withdrawal by Subject|1|||
143308034|NCT05084053|516679581|FG001|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
143308035|NCT05084053|516679582|FG002|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
143308036|NCT05084053|516679583|FG003|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
143308037|NCT05084053|516679580|FG000|Epoch 1: Up to 6 Months|Physician Decision|1|||
143308038|NCT05084053|516679581|FG001|Epoch 1: Up to 6 Months|Physician Decision|0|||
143308039|NCT05084053|516679582|FG002|Epoch 1: Up to 6 Months|Physician Decision|0|||
143375572|NCT02139046|516920459|FG004|Overall Study|Voluntary Withdrawal|16|||
143375573|NCT02139046|516920455|FG000|Overall Study|Lack of Efficacy|0|||
143308040|NCT05084053|516679583|FG003|Epoch 1: Up to 6 Months|Physician Decision|0|||
143308041|NCT05084053|516679580|FG000|Epoch 2: Up to 6 Months|Physician Decision|0|||
143308042|NCT05084053|516679581|FG001|Epoch 2: Up to 6 Months|Physician Decision|0|||
143308043|NCT05084053|516679582|FG002|Epoch 2: Up to 6 Months|Physician Decision|1|||
143308044|NCT05084053|516679583|FG003|Epoch 2: Up to 6 Months|Physician Decision|0|||
143308045|NCT05168475|516679584|FG000|Period 1|Protocol Violation|1|||
143308046|NCT05168475|516679584|FG000|Period 1|IMP shortage|2|||
143308047|NCT05168475|516679584|FG000|Period 1|Not randomised|2|||
143308048|NCT05168475|516679584|FG000|Period 2|IMP shortage|1|||
143308049|NCT00503841|516679585|FG000|Overall Study|All screen failures|44|||
143308050|NCT01302964|516679590|FG000|Overall Study|Adverse Event|1|||
143308051|NCT01302964|516679591|FG001|Overall Study|Adverse Event|0|||
143308052|NCT00596011|516679593|FG000|Overall Study|Withdrawal by Subject|2|||
143308053|NCT00596011|516679594|FG001|Overall Study|Withdrawal by Subject|3|||
143308054|NCT00596011|516679593|FG000|Overall Study|Adverse Event|11|||
143308055|NCT00596011|516679594|FG001|Overall Study|Adverse Event|7|||
143308056|NCT02365636|516679597|FG000|Overall Study|Adverse Event|3|||
143308057|NCT02365636|516679598|FG001|Overall Study|Adverse Event|3|||
143308058|NCT02365636|516679599|FG002|Overall Study|Adverse Event|2|||
143308059|NCT02365636|516679597|FG000|Overall Study|Protocol Violation|1|||
143308060|NCT02365636|516679598|FG001|Overall Study|Protocol Violation|4|||
143308061|NCT02365636|516679599|FG002|Overall Study|Protocol Violation|0|||
143308062|NCT02365636|516679597|FG000|Overall Study|Lost to Follow-up|0|||
143308063|NCT02365636|516679598|FG001|Overall Study|Lost to Follow-up|0|||
143375574|NCT02139046|516920456|FG001|Overall Study|Lack of Efficacy|1|||
143375575|NCT02139046|516920457|FG002|Overall Study|Lack of Efficacy|2|||
143375576|NCT02139046|516920458|FG003|Overall Study|Lack of Efficacy|1|||
143308064|NCT02365636|516679599|FG002|Overall Study|Lost to Follow-up|1|||
143308065|NCT02365636|516679597|FG000|Overall Study|Other|2|||
143308066|NCT02365636|516679598|FG001|Overall Study|Other|0|||
143308067|NCT02365636|516679599|FG002|Overall Study|Other|0|||
143375577|NCT02139046|516920459|FG004|Overall Study|Lack of Efficacy|2|||
143308068|NCT00355238|516679600|FG000|Overall Study|Adverse event unrelated to study drug|2|||
143308069|NCT00355238|516679601|FG001|Overall Study|Adverse event unrelated to study drug|2|||
143308070|NCT00355238|516679602|FG002|Overall Study|Adverse event unrelated to study drug|0|||
143308071|NCT00355238|516679603|FG003|Overall Study|Adverse event unrelated to study drug|1|||
143308072|NCT00355238|516679600|FG000|Overall Study|Death|1|||
143308073|NCT00355238|516679601|FG001|Overall Study|Death|0|||
143308074|NCT00355238|516679602|FG002|Overall Study|Death|0|||
143308075|NCT00355238|516679603|FG003|Overall Study|Death|0|||
143308076|NCT00355238|516679600|FG000|Overall Study|Disease progression|37|||
143308077|NCT00355238|516679601|FG001|Overall Study|Disease progression|36|||
143308078|NCT00355238|516679602|FG002|Overall Study|Disease progression|16|||
143308079|NCT00355238|516679603|FG003|Overall Study|Disease progression|11|||
143308080|NCT00355238|516679600|FG000|Overall Study|Study drug toxicity|11|||
143308081|NCT00355238|516679601|FG001|Overall Study|Study drug toxicity|7|||
143308082|NCT00355238|516679602|FG002|Overall Study|Study drug toxicity|5|||
143308083|NCT00355238|516679603|FG003|Overall Study|Study drug toxicity|2|||
143308084|NCT00355238|516679600|FG000|Overall Study|Participant withdrew consent|3|||
143308085|NCT00355238|516679601|FG001|Overall Study|Participant withdrew consent|1|||
143308086|NCT00355238|516679602|FG002|Overall Study|Participant withdrew consent|0|||
143308087|NCT00355238|516679603|FG003|Overall Study|Participant withdrew consent|0|||
143308088|NCT00355238|516679600|FG000|Overall Study|Participant request to discontinue study treatment|1|||
143308089|NCT00355238|516679601|FG001|Overall Study|Participant request to discontinue study treatment|0|||
143308090|NCT00355238|516679602|FG002|Overall Study|Participant request to discontinue study treatment|1|||
143308091|NCT00355238|516679603|FG003|Overall Study|Participant request to discontinue study treatment|0|||
143308092|NCT01454934|516679606|FG000|Overall Study|Clinical progression|28|||
143308093|NCT01454934|516679607|FG001|Overall Study|Clinical progression|25|||
143308094|NCT01454934|516679606|FG000|Overall Study|Other|6|||
143308095|NCT01454934|516679607|FG001|Overall Study|Other|17|||
143308096|NCT01454934|516679606|FG000|Overall Study|Adverse Event|28|||
143308097|NCT01454934|516679607|FG001|Overall Study|Adverse Event|24|||
143308098|NCT01454934|516679606|FG000|Overall Study|Withdrawn consent|2|||
143308099|NCT01454934|516679607|FG001|Overall Study|Withdrawn consent|5|||
143308100|NCT01454934|516679606|FG000|Overall Study|Withdrawal by Subject|11|||
143308101|NCT01454934|516679607|FG001|Overall Study|Withdrawal by Subject|15|||
143308102|NCT01454934|516679606|FG000|Overall Study|Disease progression|194|||
143308103|NCT01454934|516679607|FG001|Overall Study|Disease progression|181|||
143308104|NCT01454934|516679606|FG000|Overall Study|Lost to Follow-up|0|||
143308105|NCT01454934|516679607|FG001|Overall Study|Lost to Follow-up|1|||
143308106|NCT01454934|516679606|FG000|Overall Study|Not treated|1|||
143308107|NCT01454934|516679607|FG001|Overall Study|Not treated|2|||
143308108|NCT00430092|516679608|FG000|Overall Study|Adverse Event|0|||
143308109|NCT00430092|516679609|FG001|Overall Study|Adverse Event|0|||
143308110|NCT00430092|516679610|FG002|Overall Study|Adverse Event|1|||
143308111|NCT00430092|516679608|FG000|Overall Study|Lack of Efficacy|5|||
143308112|NCT00430092|516679609|FG001|Overall Study|Lack of Efficacy|2|||
143308113|NCT00430092|516679610|FG002|Overall Study|Lack of Efficacy|54|||
143308114|NCT00430092|516679608|FG000|Overall Study|Lost to Follow-up|1|||
143308115|NCT00430092|516679609|FG001|Overall Study|Lost to Follow-up|0|||
143308116|NCT00430092|516679610|FG002|Overall Study|Lost to Follow-up|0|||
143308117|NCT00430092|516679608|FG000|Overall Study|Protocol Violation|0|||
143308118|NCT00430092|516679609|FG001|Overall Study|Protocol Violation|1|||
143308119|NCT00430092|516679610|FG002|Overall Study|Protocol Violation|1|||
143308120|NCT00430092|516679608|FG000|Overall Study|Withdrawal by Subject|0|||
143308121|NCT00430092|516679609|FG001|Overall Study|Withdrawal by Subject|1|||
143308122|NCT00430092|516679610|FG002|Overall Study|Withdrawal by Subject|1|||
143308123|NCT03752619|516679613|FG000|Overall Study|Lost to Follow-up|2|||
143308124|NCT03752619|516679614|FG001|Overall Study|Lost to Follow-up|1|||
143308125|NCT03752619|516679613|FG000|Overall Study|Withdrawal by Subject|1|||
143308126|NCT03752619|516679614|FG001|Overall Study|Withdrawal by Subject|1|||
143308127|NCT03752619|516679613|FG000|Overall Study|Adverse Event|0|||
143308128|NCT03752619|516679614|FG001|Overall Study|Adverse Event|1|||
143308129|NCT02075840|516679617|FG000|Overall Study|Withdrawal by Subject|13|||
143308130|NCT02075840|516679618|FG001|Overall Study|Withdrawal by Subject|22|||
143308131|NCT02075840|516679617|FG000|Overall Study|Reason not specified|1|||
143308132|NCT02075840|516679618|FG001|Overall Study|Reason not specified|0|||
143308133|NCT02075840|516679617|FG000|Overall Study|Adverse Event|0|||
143308134|NCT02075840|516679618|FG001|Overall Study|Adverse Event|2|||
143308135|NCT02075840|516679617|FG000|Overall Study|Death|35|||
143308136|NCT02075840|516679618|FG001|Overall Study|Death|40|||
143308137|NCT02075840|516679617|FG000|Overall Study|Lost to Follow-up|3|||
143308138|NCT02075840|516679618|FG001|Overall Study|Lost to Follow-up|2|||
143308139|NCT02075840|516679617|FG000|Overall Study|Physician Decision|1|||
143308140|NCT02075840|516679618|FG001|Overall Study|Physician Decision|3|||
143308141|NCT02075840|516679617|FG000|Overall Study|Ongoing at CCOD|99|||
143308142|NCT02075840|516679618|FG001|Overall Study|Ongoing at CCOD|82|||
143308143|NCT03795610|516679619|FG000|Overall Study|Screen Failure (Did not meet inclusion/exclusion)|4|||
143308144|NCT03795610|516679619|FG000|Overall Study|Withdrawal by Subject|1|||
143308145|NCT03795610|516679619|FG000|Overall Study|Screen Failure (Unknown)|1|||
143308146|NCT02018458|516679628|FG000|Overall Study|Death|4|||
143308147|NCT03762083|516679631|FG000|Overall Study|Withdrawal by Subject|2|||
143308148|NCT03762083|516679631|FG000|Overall Study|Physician Decision|1|||
143308149|NCT00116558|516679632|FG000|Overall Study|Death|11|||
143308150|NCT00116558|516679633|FG001|Overall Study|Death|5|||
143308151|NCT00116558|516679634|FG002|Overall Study|Death|3|||
143308152|NCT00116558|516679632|FG000|Overall Study|Withdrawal by Subject|17|||
143308153|NCT00116558|516679633|FG001|Overall Study|Withdrawal by Subject|3|||
143308154|NCT00116558|516679634|FG002|Overall Study|Withdrawal by Subject|12|||
143308155|NCT00116558|516679632|FG000|Overall Study|disease progression|3|||
143308156|NCT00116558|516679633|FG001|Overall Study|disease progression|7|||
143308157|NCT00116558|516679634|FG002|Overall Study|disease progression|18|||
143308158|NCT02027844|516679635|FG000|Overall Study|Withdrawal by Subject|3|||
143308159|NCT02027844|516679636|FG001|Overall Study|Withdrawal by Subject|2|||
143308160|NCT02027844|516679637|FG002|Overall Study|Withdrawal by Subject|1|||
143308161|NCT02027844|516679635|FG000|Overall Study|Lost to Follow-up|0|||
143308162|NCT02027844|516679636|FG001|Overall Study|Lost to Follow-up|2|||
143308163|NCT02027844|516679637|FG002|Overall Study|Lost to Follow-up|1|||
143308164|NCT02027844|516679635|FG000|Overall Study|Protocol Violation|0|||
143308165|NCT02027844|516679636|FG001|Overall Study|Protocol Violation|2|||
143308166|NCT02027844|516679637|FG002|Overall Study|Protocol Violation|0|||
143308167|NCT02027844|516679635|FG000|Overall Study|Incomlete data|2|||
143308168|NCT02027844|516679636|FG001|Overall Study|Incomlete data|0|||
143308169|NCT02027844|516679637|FG002|Overall Study|Incomlete data|0|||
143308170|NCT00378014|516679638|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
143308171|NCT00378014|516679639|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
143308172|NCT00378014|516679638|FG000|Core (Randomization to Month 11)|Graft loss|1|||
143308173|NCT00378014|516679639|FG001|Core (Randomization to Month 11)|Graft loss|2|||
143308174|NCT00378014|516679638|FG000|Core (Randomization to Month 11)|Death|5|||
143308175|NCT00378014|516679639|FG001|Core (Randomization to Month 11)|Death|3|||
143308176|NCT00378014|516679638|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
143308177|NCT00378014|516679639|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
143308178|NCT00378014|516679638|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
143308179|NCT00378014|516679639|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
143308180|NCT00378014|516679638|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
143308181|NCT00378014|516679639|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
143308182|NCT00378014|516679638|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
143308183|NCT00378014|516679639|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
143308184|NCT00378014|516679638|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
143308185|NCT00378014|516679639|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
143308186|NCT00378014|516679638|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
143308187|NCT00378014|516679639|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
143308188|NCT00378014|516679638|FG000|Extension (Month 12 to Month 59)|Death|1|||
143308189|NCT00378014|516679639|FG001|Extension (Month 12 to Month 59)|Death|2|||
143308190|NCT00378014|516679638|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
143308191|NCT00378014|516679639|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
143308192|NCT00378014|516679638|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
143308193|NCT00378014|516679639|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
143308194|NCT00378014|516679638|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
143308195|NCT00378014|516679639|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
143308196|NCT00378014|516679638|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
143308197|NCT00378014|516679639|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
143308198|NCT00357370|516679640|FG000|Cohort 2|Lack of Efficacy|0|||
143308199|NCT00357370|516679641|FG001|Cohort 2|Lack of Efficacy|2|||
143308200|NCT00357370|516679642|FG002|Cohort 2|Lack of Efficacy|1|||
143308201|NCT00357370|516679640|FG000|Cohort 2|Adverse Event|1|||
143308202|NCT00357370|516679641|FG001|Cohort 2|Adverse Event|1|||
143308203|NCT00357370|516679642|FG002|Cohort 2|Adverse Event|1|||
143308204|NCT00357370|516679640|FG000|Cohort 2|Lost to Follow-up|0|||
143308205|NCT00357370|516679641|FG001|Cohort 2|Lost to Follow-up|1|||
143308206|NCT00357370|516679642|FG002|Cohort 2|Lost to Follow-up|0|||
143308207|NCT00357370|516679640|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
143308208|NCT00357370|516679641|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
143308209|NCT00357370|516679642|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
143308210|NCT00357370|516679640|FG000|Cohort 2|Withdrawal by Subject|0|||
143308211|NCT00357370|516679641|FG001|Cohort 2|Withdrawal by Subject|2|||
143308212|NCT00357370|516679642|FG002|Cohort 2|Withdrawal by Subject|0|||
143308213|NCT00727714|516679647|FG000|Overall Study|Lost to Follow-up|2|||
143308214|NCT04382911|516679652|FG000|Overall Study|unable to be imaged prior to surgery|2|||
143308215|NCT02043015|516679662|FG000|Overall Study|Lost to Follow-up|4|||
143308216|NCT02043015|516679662|FG000|Overall Study|Withdrawal by Subject|4|||
143308217|NCT02043015|516679662|FG000|Overall Study|Removed once target enrollment reached|15|||
143308218|NCT02043015|516679662|FG000|Overall Study|Participant moved away from study city|4|||
143308219|NCT02043015|516679662|FG000|Overall Study|Incarceration|1|||
143308220|NCT04049760|516679664|FG000|Overall Study|Withdrawal by Subject|1|||
143308221|NCT04697628|516679665|FG000|Overall Study|Withdrawal by Subject|17|||
143308222|NCT04697628|516679666|FG001|Overall Study|Withdrawal by Subject|23|||
143308223|NCT04697628|516679665|FG000|Overall Study|Lost to Follow-up|0|||
143308224|NCT04697628|516679666|FG001|Overall Study|Lost to Follow-up|4|||
143308225|NCT04697628|516679665|FG000|Overall Study|On-going in study|122|||
143308226|NCT04697628|516679666|FG001|Overall Study|On-going in study|91|||
143308227|NCT00974571|516679667|FG000|Overall Study|Adverse Event|31|||
143308228|NCT00974571|516679668|FG001|Overall Study|Adverse Event|4|||
143308229|NCT00974571|516679669|FG002|Overall Study|Adverse Event|27|||
143308230|NCT00974571|516679667|FG000|Overall Study|Lack of Efficacy|3|||
143308231|NCT00974571|516679668|FG001|Overall Study|Lack of Efficacy|2|||
143308232|NCT00974571|516679669|FG002|Overall Study|Lack of Efficacy|9|||
143308233|NCT00974571|516679667|FG000|Overall Study|Lost to Follow-up|2|||
143308234|NCT00974571|516679668|FG001|Overall Study|Lost to Follow-up|1|||
143308235|NCT00974571|516679669|FG002|Overall Study|Lost to Follow-up|2|||
143308236|NCT00974571|516679667|FG000|Overall Study|Protocol Violation|13|||
143308237|NCT00974571|516679668|FG001|Overall Study|Protocol Violation|4|||
143308238|NCT00974571|516679669|FG002|Overall Study|Protocol Violation|18|||
143308239|NCT00974571|516679667|FG000|Overall Study|Withdrawal by Subject|14|||
143308240|NCT00974571|516679668|FG001|Overall Study|Withdrawal by Subject|5|||
143308241|NCT00974571|516679669|FG002|Overall Study|Withdrawal by Subject|16|||
143308242|NCT00974571|516679667|FG000|Overall Study|Patient Moved|1|||
143308243|NCT00974571|516679668|FG001|Overall Study|Patient Moved|0|||
143308244|NCT00974571|516679669|FG002|Overall Study|Patient Moved|1|||
143308245|NCT00974571|516679667|FG000|Overall Study|Other|4|||
143308246|NCT00974571|516679668|FG001|Overall Study|Other|0|||
143308247|NCT00974571|516679669|FG002|Overall Study|Other|10|||
143308248|NCT00393939|516679670|FG000|Overall Study|Protocol Violation|1|||
143308249|NCT00393939|516679671|FG001|Overall Study|Protocol Violation|1|||
143308250|NCT00393939|516679670|FG000|Overall Study|Lost to Follow-up|2|||
143308251|NCT00393939|516679671|FG001|Overall Study|Lost to Follow-up|4|||
143308252|NCT00393939|516679670|FG000|Overall Study|Death|10|||
143308253|NCT00393939|516679671|FG001|Overall Study|Death|4|||
143308254|NCT00393939|516679670|FG000|Overall Study|Sponsor|5|||
143308255|NCT00393939|516679671|FG001|Overall Study|Sponsor|13|||
143308256|NCT00393939|516679670|FG000|Overall Study|Objective progression or relapse|239|||
143308257|NCT00393939|516679671|FG001|Overall Study|Objective progression or relapse|223|||
143308258|NCT00393939|516679670|FG000|Overall Study|Withdrawal by Subject|2|||
143308259|NCT00393939|516679671|FG001|Overall Study|Withdrawal by Subject|7|||
143308260|NCT00393939|516679670|FG000|Overall Study|Other|37|||
143308261|NCT00393939|516679671|FG001|Overall Study|Other|45|||
143308262|NCT01494610|516679672|FG000|Period 1|Withdrawal by Subject|1|||
143308263|NCT01494610|516679673|FG001|Period 1|Withdrawal by Subject|1|||
143308264|NCT01494610|516679672|FG000|Period 3|Adverse Event|1|||
143308265|NCT01494610|516679673|FG001|Period 3|Adverse Event|0|||
143308266|NCT01494610|516679672|FG000|Period 3|Withdrawal by Subject|1|||
143308267|NCT01494610|516679673|FG001|Period 3|Withdrawal by Subject|0|||
143308268|NCT01494610|516679672|FG000|Period 4|Protocol Violation|1|||
143308269|NCT01494610|516679673|FG001|Period 4|Protocol Violation|0|||
143308270|NCT02385799|516679674|FG000|Overall Study|Lost to Follow-up|1|||
143308271|NCT02385799|516679675|FG001|Overall Study|Lost to Follow-up|2|||
143308272|NCT02385799|516679674|FG000|Overall Study|Adverse Event|4|||
143308273|NCT02385799|516679675|FG001|Overall Study|Adverse Event|2|||
143308274|NCT02385799|516679674|FG000|Overall Study|Withdrawal by Subject|0|||
143308275|NCT02385799|516679675|FG001|Overall Study|Withdrawal by Subject|4|||
143308276|NCT00547703|516679676|FG000|Overall Study|Lost to Follow-up|1|||
143308277|NCT00547703|516679677|FG001|Overall Study|Lost to Follow-up|0|||
143308278|NCT03995953|516679680|FG000|Overall Study|Death|3|||
143308279|NCT03995953|516679681|FG001|Overall Study|Death|0|||
143308280|NCT03995953|516679682|FG002|Overall Study|Death|3|||
143308281|NCT03995953|516679683|FG003|Overall Study|Death|0|||
143308282|NCT03995953|516679684|FG004|Overall Study|Death|3|||
143308283|NCT03995953|516679685|FG005|Overall Study|Death|0|||
143308284|NCT03995953|516679686|FG006|Overall Study|Death|0|||
143308285|NCT03995953|516679687|FG007|Overall Study|Death|0|||
143308286|NCT03995953|516679688|FG008|Overall Study|Death|1|||
143308287|NCT03995953|516679689|FG009|Overall Study|Death|0|||
143308288|NCT03995953|516679690|FG010|Overall Study|Death|0|||
143308289|NCT03995953|516679691|FG011|Overall Study|Death|0|||
143308290|NCT03995953|516679680|FG000|Overall Study|Lost to Follow-up|6|||
143308291|NCT03995953|516679681|FG001|Overall Study|Lost to Follow-up|54|||
143308292|NCT03995953|516679682|FG002|Overall Study|Lost to Follow-up|3|||
143308293|NCT03995953|516679683|FG003|Overall Study|Lost to Follow-up|32|||
143308294|NCT03995953|516679684|FG004|Overall Study|Lost to Follow-up|5|||
143308295|NCT03995953|516679685|FG005|Overall Study|Lost to Follow-up|44|||
143308296|NCT03995953|516679686|FG006|Overall Study|Lost to Follow-up|0|||
143308297|NCT03995953|516679687|FG007|Overall Study|Lost to Follow-up|31|||
143308298|NCT03995953|516679688|FG008|Overall Study|Lost to Follow-up|8|||
143308299|NCT03995953|516679689|FG009|Overall Study|Lost to Follow-up|36|||
143308300|NCT03995953|516679690|FG010|Overall Study|Lost to Follow-up|5|||
143308301|NCT03995953|516679691|FG011|Overall Study|Lost to Follow-up|41|||
143308302|NCT03995953|516679680|FG000|Overall Study|Withdrawal by Subject|4|||
143308303|NCT03995953|516679681|FG001|Overall Study|Withdrawal by Subject|0|||
143308304|NCT03995953|516679682|FG002|Overall Study|Withdrawal by Subject|1|||
143308305|NCT03995953|516679683|FG003|Overall Study|Withdrawal by Subject|0|||
143308306|NCT03995953|516679684|FG004|Overall Study|Withdrawal by Subject|1|||
143308307|NCT03995953|516679685|FG005|Overall Study|Withdrawal by Subject|0|||
143308308|NCT03995953|516679686|FG006|Overall Study|Withdrawal by Subject|1|||
143308309|NCT03995953|516679687|FG007|Overall Study|Withdrawal by Subject|0|||
143308310|NCT03995953|516679688|FG008|Overall Study|Withdrawal by Subject|3|||
143308311|NCT03995953|516679689|FG009|Overall Study|Withdrawal by Subject|0|||
143308312|NCT03995953|516679690|FG010|Overall Study|Withdrawal by Subject|3|||
143308313|NCT03995953|516679691|FG011|Overall Study|Withdrawal by Subject|0|||
143308314|NCT03995953|516679680|FG000|Overall Study|Health Issues|0|||
143308315|NCT03995953|516679681|FG001|Overall Study|Health Issues|0|||
143308316|NCT03995953|516679682|FG002|Overall Study|Health Issues|0|||
143308317|NCT03995953|516679683|FG003|Overall Study|Health Issues|0|||
143308318|NCT03995953|516679684|FG004|Overall Study|Health Issues|1|||
143308319|NCT03995953|516679685|FG005|Overall Study|Health Issues|0|||
143308320|NCT03995953|516679686|FG006|Overall Study|Health Issues|0|||
143308321|NCT03995953|516679687|FG007|Overall Study|Health Issues|0|||
143308322|NCT03995953|516679688|FG008|Overall Study|Health Issues|4|||
143308323|NCT03995953|516679689|FG009|Overall Study|Health Issues|0|||
143308324|NCT03995953|516679690|FG010|Overall Study|Health Issues|0|||
143308325|NCT03995953|516679691|FG011|Overall Study|Health Issues|0|||
143308326|NCT03995953|516679680|FG000|Overall Study|Relocated|11|||
143308327|NCT03995953|516679681|FG001|Overall Study|Relocated|0|||
143308328|NCT03995953|516679682|FG002|Overall Study|Relocated|16|||
143308329|NCT03995953|516679683|FG003|Overall Study|Relocated|0|||
143308330|NCT03995953|516679684|FG004|Overall Study|Relocated|14|||
143308331|NCT03995953|516679685|FG005|Overall Study|Relocated|0|||
143308332|NCT03995953|516679686|FG006|Overall Study|Relocated|16|||
143308333|NCT03995953|516679687|FG007|Overall Study|Relocated|0|||
143308334|NCT03995953|516679688|FG008|Overall Study|Relocated|14|||
143308335|NCT03995953|516679689|FG009|Overall Study|Relocated|0|||
143308336|NCT03995953|516679690|FG010|Overall Study|Relocated|15|||
143308337|NCT03995953|516679691|FG011|Overall Study|Relocated|0|||
143308338|NCT02161718|516679694|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
143308339|NCT02161718|516679695|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
143308340|NCT02161718|516679696|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
143308341|NCT02161718|516679694|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
143308342|NCT02161718|516679695|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
143308343|NCT02161718|516679696|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
143308344|NCT02161718|516679694|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
143308345|NCT02161718|516679695|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
143308346|NCT02161718|516679696|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
143308347|NCT02161718|516679694|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
143308348|NCT02161718|516679695|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
143308349|NCT02161718|516679696|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
143308350|NCT02161718|516679694|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
143308351|NCT02161718|516679695|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
143308352|NCT02161718|516679696|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
143308353|NCT02161718|516679694|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
143308354|NCT02161718|516679695|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
143308355|NCT02161718|516679696|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
143308356|NCT02161718|516679694|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
143308357|NCT02161718|516679695|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
143308358|NCT02161718|516679696|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
143308359|NCT02161718|516679694|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
143308360|NCT02161718|516679695|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
143308361|NCT02161718|516679696|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
143308362|NCT02161718|516679694|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
143308363|NCT02161718|516679695|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
143308364|NCT02161718|516679696|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
143308365|NCT02161718|516679694|FG000|Post- Randomization Period|Lost to Follow-up|0|||
143308366|NCT02161718|516679695|FG001|Post- Randomization Period|Lost to Follow-up|9|||
143308367|NCT02161718|516679696|FG002|Post- Randomization Period|Lost to Follow-up|15|||
143308368|NCT02161718|516679694|FG000|Post- Randomization Period|Adverse Event|0|||
143308369|NCT02161718|516679695|FG001|Post- Randomization Period|Adverse Event|9|||
143308370|NCT02161718|516679696|FG002|Post- Randomization Period|Adverse Event|10|||
143308371|NCT02161718|516679694|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
143308372|NCT02161718|516679695|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
143308373|NCT02161718|516679696|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
143308374|NCT02161718|516679694|FG000|Post- Randomization Period|Physician Decision|0|||
143308375|NCT02161718|516679695|FG001|Post- Randomization Period|Physician Decision|2|||
143308376|NCT02161718|516679696|FG002|Post- Randomization Period|Physician Decision|4|||
143308377|NCT02161718|516679694|FG000|Post- Randomization Period|Protocol Violation|0|||
143308378|NCT02161718|516679695|FG001|Post- Randomization Period|Protocol Violation|2|||
143308379|NCT02161718|516679696|FG002|Post- Randomization Period|Protocol Violation|3|||
143308380|NCT02161718|516679694|FG000|Post- Randomization Period|Lack of Efficacy|0|||
143308381|NCT02161718|516679695|FG001|Post- Randomization Period|Lack of Efficacy|0|||
143308382|NCT02161718|516679696|FG002|Post- Randomization Period|Lack of Efficacy|1|||
143308383|NCT02161718|516679694|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
143308384|NCT02161718|516679695|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
143308385|NCT02161718|516679696|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
143308386|NCT02161718|516679694|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
143308387|NCT02161718|516679695|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
143308388|NCT02161718|516679696|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
143308389|NCT02161718|516679694|FG000|Post- Randomization Period|Relocation|0|||
143308390|NCT02161718|516679695|FG001|Post- Randomization Period|Relocation|3|||
143308391|NCT02161718|516679696|FG002|Post- Randomization Period|Relocation|0|||
143308392|NCT01256710|516679700|FG000|Overall Study|Death|449|||
143308393|NCT01256710|516679700|FG000|Overall Study|System Explant|67|||
143308394|NCT01256710|516679700|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
143308395|NCT01256710|516679700|FG000|Overall Study|Lost to Follow-up|67|||
143308396|NCT01256710|516679700|FG000|Overall Study|Withdrawal by Subject|29|||
143308397|NCT01256710|516679700|FG000|Overall Study|Physician Decision|9|||
143308398|NCT01256710|516679700|FG000|Overall Study|Subject Noncompliance|2|||
143308399|NCT01256710|516679700|FG000|Overall Study|Study Terminated by Sponsor|273|||
143308400|NCT01205165|516679702|FG000|Overall Study|Lost to Follow-up|2|||
143308401|NCT02681302|516679705|FG000|Overall Study|Withdrawal by Subject|1|||
143308402|NCT02681302|516679706|FG001|Overall Study|Withdrawal by Subject|1|||
143308403|NCT02681302|516679707|FG002|Overall Study|Withdrawal by Subject|0|||
143308404|NCT02681302|516679708|FG003|Overall Study|Withdrawal by Subject|0|||
143308405|NCT02681302|516679709|FG004|Overall Study|Withdrawal by Subject|1|||
143308406|NCT02681302|516679710|FG005|Overall Study|Withdrawal by Subject|0|||
143308407|NCT02681302|516679705|FG000|Overall Study|Screen Failure|2|||
143308408|NCT02681302|516679706|FG001|Overall Study|Screen Failure|4|||
143308409|NCT02681302|516679707|FG002|Overall Study|Screen Failure|2|||
143308410|NCT02681302|516679708|FG003|Overall Study|Screen Failure|0|||
143308411|NCT02681302|516679709|FG004|Overall Study|Screen Failure|1|||
143308412|NCT02681302|516679710|FG005|Overall Study|Screen Failure|1|||
143308413|NCT02681302|516679705|FG000|Overall Study|Discontinued Due to Updated FDA Risks|0|||
143308414|NCT02681302|516679706|FG001|Overall Study|Discontinued Due to Updated FDA Risks|0|||
143308415|NCT02681302|516679707|FG002|Overall Study|Discontinued Due to Updated FDA Risks|0|||
143308416|NCT02681302|516679708|FG003|Overall Study|Discontinued Due to Updated FDA Risks|0|||
143308417|NCT02681302|516679709|FG004|Overall Study|Discontinued Due to Updated FDA Risks|0|||
143308418|NCT02681302|516679710|FG005|Overall Study|Discontinued Due to Updated FDA Risks|1|||
143308419|NCT02942017|516679711|FG000|Overall Study|Adverse Event|0|||
143308420|NCT02942017|516679712|FG001|Overall Study|Adverse Event|1|||
143308421|NCT02942017|516679711|FG000|Overall Study|Withdrawal by Subject|0|||
143308422|NCT02942017|516679712|FG001|Overall Study|Withdrawal by Subject|1|||
143308423|NCT02942017|516679711|FG000|Overall Study|Lost to Follow-up|1|||
143308424|NCT02942017|516679712|FG001|Overall Study|Lost to Follow-up|1|||
143308425|NCT02942017|516679711|FG000|Overall Study|Randomized but not dosed|1|||
143308426|NCT02942017|516679712|FG001|Overall Study|Randomized but not dosed|3|||
143308427|NCT04399161|516679713|FG000|Overall Study|Withdrawal by Subject|1|||
143308428|NCT04399161|516679714|FG001|Overall Study|Withdrawal by Subject|0|||
143308429|NCT04399161|516679715|FG002|Overall Study|Withdrawal by Subject|2|||
143308430|NCT04399161|516679713|FG000|Overall Study|Protocol Violation|1|||
143308431|NCT04399161|516679714|FG001|Overall Study|Protocol Violation|2|||
143308432|NCT04399161|516679715|FG002|Overall Study|Protocol Violation|0|||
143308433|NCT03417141|516679716|FG000|Overall Study|Withdrawal by Subject|1|||
143308434|NCT03417141|516679716|FG000|Overall Study|Protocol Violation|3|||
143308435|NCT00458484|516679717|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
143308436|NCT00458484|516679718|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
143308437|NCT00458484|516679719|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
143308438|NCT00458484|516679720|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
143308439|NCT00458484|516679721|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
143308440|NCT00458484|516679722|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
143308441|NCT00458484|516679723|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
143308442|NCT01434290|516679731|FG000|Overall Study|Protocol Violation|6|||
143308443|NCT01434290|516679732|FG001|Overall Study|Protocol Violation|3|||
143308444|NCT01434290|516679731|FG000|Overall Study|No protocol treatment|2|||
143308445|NCT01434290|516679732|FG001|Overall Study|No protocol treatment|4|||
143308446|NCT02281552|516679733|FG000|Overall Study|Medication error|1|||
143308447|NCT02281552|516679734|FG001|Overall Study|Medication error|0|||
143308448|NCT02281552|516679733|FG000|Overall Study|Insufficient clinical response|0|||
143308449|NCT02281552|516679734|FG001|Overall Study|Insufficient clinical response|1|||
143308450|NCT02281552|516679733|FG000|Overall Study|Adverse Event|3|||
143308451|NCT02281552|516679734|FG001|Overall Study|Adverse Event|9|||
143308452|NCT03465878|516679735|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
143308453|NCT03465878|516679736|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
143308454|NCT03465878|516679737|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
143308455|NCT03465878|516679738|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
143308456|NCT03465878|516679735|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
143308457|NCT03465878|516679736|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
143308458|NCT03465878|516679737|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
143308459|NCT03465878|516679738|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
143308460|NCT03465878|516679735|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
143308461|NCT03465878|516679736|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
143308462|NCT03465878|516679737|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
143308463|NCT03465878|516679738|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
143308464|NCT02540954|516679739|FG000|Overall Study|Physician Decision|3|||
143308465|NCT02540954|516679740|FG001|Overall Study|Physician Decision|1|||
143308466|NCT02540954|516679739|FG000|Overall Study|Withdrawal by Subject|6|||
143308467|NCT02540954|516679740|FG001|Overall Study|Withdrawal by Subject|5|||
143308468|NCT02540954|516679739|FG000|Overall Study|Lost to Follow-up|1|||
143308469|NCT02540954|516679740|FG001|Overall Study|Lost to Follow-up|1|||
143308470|NCT02540954|516679739|FG000|Overall Study|Adverse Event|4|||
143308471|NCT02540954|516679740|FG001|Overall Study|Adverse Event|2|||
143308472|NCT02540954|516679739|FG000|Overall Study|Death|0|||
143308473|NCT02540954|516679740|FG001|Overall Study|Death|3|||
143308474|NCT02540954|516679739|FG000|Overall Study|Treatment failure|1|||
143308475|NCT02540954|516679740|FG001|Overall Study|Treatment failure|0|||
143308476|NCT02540954|516679739|FG000|Overall Study|Other reason|4|||
143308477|NCT02540954|516679740|FG001|Overall Study|Other reason|2|||
143308478|NCT00213148|516679741|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
143308479|NCT00213148|516679742|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
143308480|NCT00213148|516679743|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
143308481|NCT00213148|516679744|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
143308482|NCT00213148|516679745|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
143308483|NCT00213148|516679741|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
143308484|NCT00213148|516679742|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
143308485|NCT00213148|516679743|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
143308486|NCT00213148|516679744|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
143308487|NCT00213148|516679745|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
143308488|NCT00213148|516679741|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
143308489|NCT00213148|516679742|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
143308490|NCT00213148|516679743|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
143308491|NCT00213148|516679744|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
143308492|NCT00213148|516679745|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
143308493|NCT00213148|516679741|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
143308494|NCT00213148|516679742|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
143308495|NCT00213148|516679743|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
143308496|NCT00213148|516679744|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
143308497|NCT00213148|516679745|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
143308498|NCT00213148|516679741|FG000|Cycle 1 (1 Month)|Other|3|||
143308499|NCT00213148|516679742|FG001|Cycle 1 (1 Month)|Other|0|||
143308500|NCT00213148|516679743|FG002|Cycle 1 (1 Month)|Other|2|||
143308501|NCT00213148|516679744|FG003|Cycle 1 (1 Month)|Other|2|||
143308502|NCT00213148|516679745|FG004|Cycle 1 (1 Month)|Other|7|||
143308503|NCT00213148|516679741|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
143375578|NCT02139046|516920455|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
143375579|NCT02139046|516920456|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
143375580|NCT02139046|516920457|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
143375581|NCT02139046|516920458|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
143375582|NCT02139046|516920459|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
143375583|NCT02139046|516920455|FG000|Overall Study|Other Miscellaneous Reasons|10|||
143308504|NCT00213148|516679742|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
143308505|NCT00213148|516679743|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
143308506|NCT00213148|516679744|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
143308507|NCT00213148|516679745|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
143308508|NCT00213148|516679741|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
143308509|NCT00213148|516679742|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
143308510|NCT00213148|516679743|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
143308511|NCT00213148|516679744|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
143308512|NCT00213148|516679745|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
143308513|NCT00213148|516679741|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
143308514|NCT00213148|516679742|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
143308515|NCT00213148|516679743|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
143308516|NCT00213148|516679744|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
143308517|NCT00213148|516679745|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
143308518|NCT00213148|516679741|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
143308519|NCT00213148|516679742|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
143308520|NCT00213148|516679743|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
143308521|NCT00213148|516679744|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
143308522|NCT00213148|516679745|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
143308523|NCT00213148|516679741|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
143308524|NCT00213148|516679742|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
143308525|NCT00213148|516679743|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
143308526|NCT00213148|516679744|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
143308527|NCT00213148|516679745|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
143308528|NCT00213148|516679741|FG000|Cycle 2 (1 Month)|Other|2|||
143308529|NCT00213148|516679742|FG001|Cycle 2 (1 Month)|Other|1|||
143308530|NCT00213148|516679743|FG002|Cycle 2 (1 Month)|Other|2|||
143308531|NCT00213148|516679744|FG003|Cycle 2 (1 Month)|Other|8|||
143308532|NCT00213148|516679745|FG004|Cycle 2 (1 Month)|Other|7|||
143308533|NCT00213148|516679741|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
143308534|NCT00213148|516679742|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
143308535|NCT00213148|516679743|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
143308536|NCT00213148|516679744|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
143308537|NCT00213148|516679745|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
143308538|NCT00213148|516679741|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
143308539|NCT00213148|516679742|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
143308540|NCT00213148|516679743|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
143308541|NCT00213148|516679744|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
143308542|NCT00213148|516679745|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
143308543|NCT00213148|516679741|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
143308544|NCT00213148|516679742|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
143308545|NCT00213148|516679743|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
143308546|NCT00213148|516679744|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
143308547|NCT00213148|516679745|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
143308548|NCT00213148|516679741|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
143308549|NCT00213148|516679742|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
143308550|NCT00213148|516679743|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
143308551|NCT00213148|516679744|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
143308552|NCT00213148|516679745|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
143308553|NCT00213148|516679741|FG000|Cycle 3 (1 Month)|Other|0|||
143308554|NCT00213148|516679742|FG001|Cycle 3 (1 Month)|Other|0|||
143308555|NCT00213148|516679743|FG002|Cycle 3 (1 Month)|Other|1|||
143308556|NCT00213148|516679744|FG003|Cycle 3 (1 Month)|Other|1|||
143308557|NCT00213148|516679745|FG004|Cycle 3 (1 Month)|Other|0|||
143308558|NCT02283788|516679749|FG000|Overall Study|Adverse Event|1|||
143308559|NCT02283788|516679750|FG001|Overall Study|Adverse Event|3|||
143308560|NCT02283788|516679751|FG002|Overall Study|Adverse Event|5|||
143308561|NCT02283788|516679752|FG003|Overall Study|Adverse Event|1|||
143308562|NCT02283788|516679749|FG000|Overall Study|Withdrawal by Subject|0|||
143375584|NCT02139046|516920456|FG001|Overall Study|Other Miscellaneous Reasons|9|||
143375585|NCT02139046|516920457|FG002|Overall Study|Other Miscellaneous Reasons|4|||
143375586|NCT02139046|516920458|FG003|Overall Study|Other Miscellaneous Reasons|9|||
143375587|NCT02139046|516920459|FG004|Overall Study|Other Miscellaneous Reasons|12|||
143375588|NCT05876949|516920460|FG000|Overall Study|Withdrawal by Subject|1|||
143375589|NCT05876949|516920461|FG001|Overall Study|Withdrawal by Subject|3|||
143375590|NCT05876949|516920460|FG000|Overall Study|Physician Decision|0|||
143308563|NCT02283788|516679750|FG001|Overall Study|Withdrawal by Subject|1|||
143308564|NCT02283788|516679751|FG002|Overall Study|Withdrawal by Subject|0|||
143308565|NCT02283788|516679752|FG003|Overall Study|Withdrawal by Subject|1|||
143308566|NCT01589822|516681744|FG000|Overall Study|Withdrawal by Subject|1|||
143308567|NCT01589822|516681745|FG001|Overall Study|Withdrawal by Subject|2|||
143308568|NCT01589822|516681746|FG002|Overall Study|Withdrawal by Subject|0|||
143308569|NCT01589822|516681744|FG000|Overall Study|Death|1|||
143308570|NCT01589822|516681745|FG001|Overall Study|Death|0|||
143308571|NCT01589822|516681746|FG002|Overall Study|Death|0|||
143308572|NCT01589822|516681744|FG000|Overall Study|Missed 90 day visit|2|||
143308573|NCT01589822|516681745|FG001|Overall Study|Missed 90 day visit|1|||
143308574|NCT01589822|516681746|FG002|Overall Study|Missed 90 day visit|1|||
143308575|NCT01140477|516681747|FG000|Overall Study|Lost to Follow-up|4|||
143308576|NCT01140477|516681748|FG001|Overall Study|Lost to Follow-up|0|||
143308577|NCT01140477|516681747|FG000|Overall Study|Withdrawal by Subject|1|||
143308578|NCT01140477|516681748|FG001|Overall Study|Withdrawal by Subject|4|||
143308579|NCT01140477|516681747|FG000|Overall Study|Surgical complication preventing implant|2|||
143375591|NCT05876949|516920461|FG001|Overall Study|Physician Decision|2|||
143308580|NCT01140477|516681748|FG001|Overall Study|Surgical complication preventing implant|0|||
143308581|NCT01140477|516681747|FG000|Overall Study|Death|1|||
143308582|NCT01140477|516681748|FG001|Overall Study|Death|1|||
143308583|NCT01140477|516681747|FG000|Overall Study|Subject explanted|0|||
143308584|NCT01140477|516681748|FG001|Overall Study|Subject explanted|1|||
143308585|NCT02789176|516681749|FG000|Overall Study|Death|0|||
143375592|NCT05876949|516920460|FG000|Overall Study|Death|0|||
143375593|NCT05876949|516920461|FG001|Overall Study|Death|1|||
143375594|NCT02252042|516920466|FG000|Overall Study|Adverse Event|9|||
143375595|NCT02252042|516920467|FG001|Overall Study|Adverse Event|6|||
143375596|NCT02252042|516920466|FG000|Overall Study|Death|209|||
143375597|NCT02252042|516920467|FG001|Overall Study|Death|217|||
143375598|NCT02252042|516920466|FG000|Overall Study|Physician Decision|0|||
143375599|NCT02252042|516920467|FG001|Overall Study|Physician Decision|2|||
143375600|NCT02252042|516920466|FG000|Overall Study|Transferred to Extension Study|7|||
143375601|NCT02252042|516920467|FG001|Overall Study|Transferred to Extension Study|1|||
143375602|NCT02252042|516920466|FG000|Overall Study|Did Not Continue on Extension Study|7|||
143375603|NCT02252042|516920467|FG001|Overall Study|Did Not Continue on Extension Study|2|||
143375604|NCT02252042|516920466|FG000|Overall Study|Withdrawal by Subject|15|||
143375605|NCT02252042|516920467|FG001|Overall Study|Withdrawal by Subject|20|||
143375606|NCT02613871|516920470|FG000|Overall Study|Death|2|||
143375607|NCT02613871|516920470|FG000|Overall Study|Withdrew Consent|1|||
143308586|NCT02789176|516681750|FG001|Overall Study|Death|0|||
143308587|NCT02789176|516681751|FG002|Overall Study|Death|3|||
143308588|NCT02789176|516681752|FG003|Overall Study|Death|0|||
143308589|NCT02789176|516681749|FG000|Overall Study|Withdrawal by Subject|0|||
143308590|NCT02789176|516681750|FG001|Overall Study|Withdrawal by Subject|0|||
143308591|NCT02789176|516681751|FG002|Overall Study|Withdrawal by Subject|1|||
143308592|NCT02789176|516681752|FG003|Overall Study|Withdrawal by Subject|0|||
143308593|NCT02789176|516681749|FG000|Overall Study|Lost to Follow-up|8|||
143308594|NCT02789176|516681750|FG001|Overall Study|Lost to Follow-up|2|||
143308595|NCT02789176|516681751|FG002|Overall Study|Lost to Follow-up|6|||
143308596|NCT02789176|516681752|FG003|Overall Study|Lost to Follow-up|1|||
143308597|NCT03325166|516681758|FG000|Overall Study|Adverse Event|1|||
143308598|NCT01633944|516681759|FG000|Open-label Titration Phase|Adverse Event|109|||
143308599|NCT01633944|516681760|FG001|Open-label Titration Phase|Adverse Event|0|||
143308600|NCT01633944|516681761|FG002|Open-label Titration Phase|Adverse Event|0|||
143308601|NCT01633944|516681759|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
143308602|NCT01633944|516681760|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
143308603|NCT01633944|516681761|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
143308604|NCT01633944|516681759|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
143308605|NCT01633944|516681760|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
143308606|NCT01633944|516681761|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
143375608|NCT01786564|516920471|FG000|Overall Study|Lost to Follow-up|47|||
143375609|NCT01786564|516920471|FG000|Overall Study|Ineligible|17|||
143375610|NCT00494442|516920472|FG000|Overall Study|Death|1|||
143308607|NCT01633944|516681759|FG000|Open-label Titration Phase|Protocol Violation|24|||
143308608|NCT01633944|516681760|FG001|Open-label Titration Phase|Protocol Violation|0|||
143308609|NCT01633944|516681761|FG002|Open-label Titration Phase|Protocol Violation|0|||
143308610|NCT01633944|516681759|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
143308611|NCT01633944|516681760|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
143375611|NCT00494442|516920473|FG001|Overall Study|Death|1|||
143375612|NCT00494442|516920472|FG000|Overall Study|Lack of Efficacy|16|||
143375613|NCT00494442|516920473|FG001|Overall Study|Lack of Efficacy|10|||
143375614|NCT00494442|516920472|FG000|Overall Study|Adverse Event|0|||
143308612|NCT01633944|516681761|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
143308613|NCT01633944|516681759|FG000|Open-label Titration Phase|Other|68|||
143308614|NCT01633944|516681760|FG001|Open-label Titration Phase|Other|0|||
143308615|NCT01633944|516681761|FG002|Open-label Titration Phase|Other|0|||
143308616|NCT01633944|516681759|FG000|Double-blind Treatment Phase|Adverse Event|0|||
143308617|NCT01633944|516681760|FG001|Double-blind Treatment Phase|Adverse Event|13|||
143308618|NCT01633944|516681761|FG002|Double-blind Treatment Phase|Adverse Event|7|||
143308619|NCT01633944|516681759|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
143308620|NCT01633944|516681760|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
143308621|NCT01633944|516681761|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
143308622|NCT01633944|516681759|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
143308623|NCT01633944|516681760|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
143308624|NCT01633944|516681761|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
143308625|NCT01633944|516681759|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
143308626|NCT01633944|516681760|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
143308627|NCT01633944|516681761|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
143308628|NCT01633944|516681759|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
143308629|NCT01633944|516681760|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
143308630|NCT01633944|516681761|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
143308631|NCT01633944|516681759|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
143308632|NCT01633944|516681760|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
143308633|NCT01633944|516681761|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
143308634|NCT01633944|516681759|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
143308635|NCT01633944|516681760|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
143308636|NCT01633944|516681761|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
143308637|NCT01633944|516681759|FG000|Double-blind Treatment Phase|Other|0|||
143308638|NCT01633944|516681760|FG001|Double-blind Treatment Phase|Other|7|||
143308639|NCT01633944|516681761|FG002|Double-blind Treatment Phase|Other|0|||
143308640|NCT00463060|516681762|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
143308641|NCT00463060|516681762|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
143308642|NCT01400841|516681763|FG000|Initial Study Phase (6 Months)|Death|1|||
143308643|NCT01400841|516681763|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
143308644|NCT00910715|516681766|FG000|Overall Study|Lost to Follow-up|22|||
143308645|NCT00910715|516681767|FG001|Overall Study|Lost to Follow-up|26|||
143308646|NCT00910715|516681768|FG002|Overall Study|Lost to Follow-up|0|||
143308647|NCT00770120|516681769|FG000|Overall Study|Progression|31|||
143308648|NCT00770120|516681769|FG000|Overall Study|Adverse Event|11|||
143308649|NCT00770120|516681769|FG000|Overall Study|Not Protocol Specified|11|||
143308650|NCT00770120|516681769|FG000|Overall Study|Death|3|||
143308651|NCT00770120|516681769|FG000|Overall Study|Withdrawal by Subject|2|||
143308652|NCT00770120|516681769|FG000|Overall Study|Ineligible|1|||
143308653|NCT00770120|516681769|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
143308654|NCT00770120|516681769|FG000|Overall Study|Reason under Review|1|||
143308655|NCT01782313|516681770|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
143308656|NCT01782313|516681770|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
143308657|NCT01782313|516681770|FG000|Treated Cycle 3|Progressive Disease|21|||
143308658|NCT01782313|516681770|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
143308659|NCT01782313|516681770|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
143308660|NCT01782313|516681770|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
143308661|NCT01782313|516681770|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
143308662|NCT01782313|516681770|FG000|Survival Follow up|Lost to Follow-up|1|||
143308663|NCT04649151|516681775|FG000|Overall Study|Pregnancy|0|||
143308664|NCT04649151|516681776|FG001|Overall Study|Pregnancy|0|||
143308665|NCT04649151|516681777|FG002|Overall Study|Pregnancy|0|||
143375615|NCT00494442|516920473|FG001|Overall Study|Adverse Event|2|||
143375616|NCT00494442|516920472|FG000|Overall Study|Physician Decision|0|||
143375617|NCT00494442|516920473|FG001|Overall Study|Physician Decision|1|||
143375618|NCT00494442|516920472|FG000|Overall Study|Non-compliance|0|||
143375619|NCT00494442|516920473|FG001|Overall Study|Non-compliance|1|||
143375620|NCT00494442|516920472|FG000|Overall Study|Intercurrent illness|0|||
143375621|NCT00494442|516920473|FG001|Overall Study|Intercurrent illness|1|||
143375622|NCT01241292|516920476|FG000|Overall Study|Administrative Reason by Sponsor|1|||
143375623|NCT01241292|516920477|FG001|Overall Study|Administrative Reason by Sponsor|0|||
143375624|NCT01241292|516920476|FG000|Overall Study|Disease Progression|2|||
143375625|NCT01241292|516920477|FG001|Overall Study|Disease Progression|0|||
143375626|NCT01241292|516920476|FG000|Overall Study|Study Drug Toxicity|0|||
143375627|NCT01241292|516920477|FG001|Overall Study|Study Drug Toxicity|1|||
143308666|NCT04649151|516681778|FG003|Overall Study|Pregnancy|0|||
143308667|NCT04649151|516681779|FG004|Overall Study|Pregnancy|3|||
143308668|NCT04649151|516681775|FG000|Overall Study|Physician Decision|10|||
143375628|NCT01241292|516920476|FG000|Overall Study|Participant Discontinued Treatment|0|||
143375629|NCT01241292|516920477|FG001|Overall Study|Participant Discontinued Treatment|2|||
143308669|NCT04649151|516681776|FG001|Overall Study|Physician Decision|0|||
143308670|NCT04649151|516681777|FG002|Overall Study|Physician Decision|0|||
143308671|NCT04649151|516681778|FG003|Overall Study|Physician Decision|1|||
143308672|NCT04649151|516681779|FG004|Overall Study|Physician Decision|1|||
143308673|NCT04649151|516681775|FG000|Overall Study|Protocol Deviation|25|||
143308674|NCT04649151|516681776|FG001|Overall Study|Protocol Deviation|3|||
143308675|NCT04649151|516681777|FG002|Overall Study|Protocol Deviation|0|||
143308676|NCT04649151|516681778|FG003|Overall Study|Protocol Deviation|0|||
143308677|NCT04649151|516681779|FG004|Overall Study|Protocol Deviation|0|||
143308678|NCT04649151|516681775|FG000|Overall Study|Received another COVID-19 vaccine under EUA|495|||
143308679|NCT04649151|516681776|FG001|Overall Study|Received another COVID-19 vaccine under EUA|730|||
143308680|NCT04649151|516681777|FG002|Overall Study|Received another COVID-19 vaccine under EUA|0|||
143308681|NCT04649151|516681778|FG003|Overall Study|Received another COVID-19 vaccine under EUA|0|||
143308682|NCT04649151|516681779|FG004|Overall Study|Received another COVID-19 vaccine under EUA|0|||
143308683|NCT04649151|516681775|FG000|Overall Study|Withdrawal by Subject|370|||
143308684|NCT04649151|516681776|FG001|Overall Study|Withdrawal by Subject|113|||
143308685|NCT04649151|516681777|FG002|Overall Study|Withdrawal by Subject|2|||
143308686|NCT04649151|516681778|FG003|Overall Study|Withdrawal by Subject|7|||
143308687|NCT04649151|516681779|FG004|Overall Study|Withdrawal by Subject|15|||
143308688|NCT04649151|516681775|FG000|Overall Study|Adverse Event|1|||
143308689|NCT04649151|516681776|FG001|Overall Study|Adverse Event|0|||
143308690|NCT04649151|516681777|FG002|Overall Study|Adverse Event|0|||
143308691|NCT04649151|516681778|FG003|Overall Study|Adverse Event|0|||
143308692|NCT04649151|516681779|FG004|Overall Study|Adverse Event|0|||
143308693|NCT04649151|516681775|FG000|Overall Study|Lost to Follow-up|256|||
143308694|NCT04649151|516681776|FG001|Overall Study|Lost to Follow-up|29|||
143308695|NCT04649151|516681777|FG002|Overall Study|Lost to Follow-up|10|||
143308696|NCT04649151|516681778|FG003|Overall Study|Lost to Follow-up|3|||
143308697|NCT04649151|516681779|FG004|Overall Study|Lost to Follow-up|6|||
143308698|NCT04649151|516681775|FG000|Overall Study|Other than specified|59|||
143308699|NCT04649151|516681776|FG001|Overall Study|Other than specified|294|||
143308700|NCT04649151|516681777|FG002|Overall Study|Other than specified|0|||
143308701|NCT04649151|516681778|FG003|Overall Study|Other than specified|0|||
143308702|NCT04649151|516681779|FG004|Overall Study|Other than specified|4|||
143308703|NCT04649151|516681775|FG000|Overall Study|Death|0|||
143308704|NCT04649151|516681776|FG001|Overall Study|Death|0|||
143308705|NCT04649151|516681777|FG002|Overall Study|Death|0|||
143308706|NCT04649151|516681778|FG003|Overall Study|Death|0|||
143308707|NCT04649151|516681779|FG004|Overall Study|Death|1|||
143308708|NCT02975934|516681780|FG000|Treatment Phase|Never initiated study drug|0|||
143308709|NCT02975934|516681781|FG001|Treatment Phase|Never initiated study drug|5|||
143308710|NCT02975934|516681782|FG002|Treatment Phase|Never initiated study drug|0|||
143308711|NCT00433654|516681785|FG000|Overall Study|Death|4|||
143308712|NCT00433654|516681786|FG001|Overall Study|Death|0|||
143308713|NCT00433654|516681785|FG000|Overall Study|Missed visit|6|||
143308714|NCT00433654|516681786|FG001|Overall Study|Missed visit|3|||
143308715|NCT00433654|516681785|FG000|Overall Study|Subject not yet due for visit|4|||
143308716|NCT00433654|516681786|FG001|Overall Study|Subject not yet due for visit|0|||
143308717|NCT00433654|516681785|FG000|Overall Study|Withdrawal by Subject|1|||
143308718|NCT00433654|516681786|FG001|Overall Study|Withdrawal by Subject|2|||
143308719|NCT01143090|516681787|FG000|Overall Study|Lack of Efficacy|2|||
143308720|NCT01143090|516681787|FG000|Overall Study|Adverse Event|17|||
143308721|NCT01143090|516681787|FG000|Overall Study|Lost to Follow-up|9|||
143308722|NCT01143090|516681787|FG000|Overall Study|Protocol Violation|2|||
143308723|NCT01143090|516681787|FG000|Overall Study|Withdrawal by Subject|18|||
143308724|NCT01143090|516681787|FG000|Overall Study|Non-compliance with study drug|1|||
143308725|NCT01143090|516681787|FG000|Overall Study|Failure to meet eligibility criteria|1|||
143308726|NCT01143090|516681787|FG000|Overall Study|Administrative|1|||
143308727|NCT03491150|516681788|FG000|Overall Study|Adverse Event|1|||
143308728|NCT03491150|516681789|FG001|Overall Study|Adverse Event|0|||
143308729|NCT03491150|516681788|FG000|Overall Study|Study Terminated by Sponsor|74|||
143308730|NCT03491150|516681789|FG001|Overall Study|Study Terminated by Sponsor|70|||
143308731|NCT03491150|516681788|FG000|Overall Study|Other|0|||
143308732|NCT03491150|516681789|FG001|Overall Study|Other|1|||
143308733|NCT03491150|516681788|FG000|Overall Study|Withdrawal by Subject|1|||
143308734|NCT03491150|516681789|FG001|Overall Study|Withdrawal by Subject|2|||
143308735|NCT00325234|516681793|FG000|Overall Study|Adverse Event|10|||
143308736|NCT00325234|516681794|FG001|Overall Study|Adverse Event|7|||
143308737|NCT00325234|516681793|FG000|Overall Study|Death due to Study Disease|1|||
143308738|NCT00325234|516681794|FG001|Overall Study|Death due to Study Disease|0|||
143308739|NCT00325234|516681793|FG000|Overall Study|Entry Criteria Not Met|1|||
143308740|NCT00325234|516681794|FG001|Overall Study|Entry Criteria Not Met|2|||
143308741|NCT00325234|516681793|FG000|Overall Study|Subject Decision|6|||
143308742|NCT00325234|516681794|FG001|Overall Study|Subject Decision|8|||
143308743|NCT00325234|516681793|FG000|Overall Study|Physician Decision|17|||
143308744|NCT00325234|516681794|FG001|Overall Study|Physician Decision|12|||
143308745|NCT00325234|516681793|FG000|Overall Study|Progressive Disease|34|||
143308746|NCT00325234|516681794|FG001|Overall Study|Progressive Disease|37|||
143308747|NCT02644967|516681800|FG000|Overall Study|Death|26|||
143308748|NCT02644967|516681800|FG000|Overall Study|Physician Decision|1|||
143308749|NCT02644967|516681800|FG000|Overall Study|Withdrawal by Subject|2|||
143308750|NCT02644967|516681800|FG000|Overall Study|Protocol Violation|1|||
143308751|NCT02644967|516681800|FG000|Overall Study|Progressive Disease|1|||
143308752|NCT02644967|516681800|FG000|Overall Study|Study Terminated by Sponsor|4|||
143308753|NCT02287896|516681801|FG000|Second Injection Visit|Withdrawal by Subject|0|||
143308754|NCT02287896|516681802|FG001|Second Injection Visit|Withdrawal by Subject|1|||
143308755|NCT05179421|516681803|FG000|First Infusion Day|Adverse Event|1|||
143308756|NCT05179421|516681804|FG001|First Infusion Day|Adverse Event|0|||
143308757|NCT03746522|516681805|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
143308758|NCT03746522|516681806|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
143308759|NCT03746522|516681807|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
143308760|NCT03746522|516681805|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
143308761|NCT03746522|516681806|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
143308762|NCT03746522|516681807|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
143308763|NCT03746522|516681805|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
143308764|NCT03746522|516681806|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
143308765|NCT03746522|516681807|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
143308766|NCT03746522|516681805|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
143308767|NCT03746522|516681806|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
143308768|NCT03746522|516681807|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
143308769|NCT03746522|516681805|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
143308770|NCT03746522|516681806|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
143308771|NCT03746522|516681807|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
143308772|NCT01639040|516681808|FG000|Overall Study|Adverse Event|1|||
143308773|NCT01639040|516681809|FG001|Overall Study|Adverse Event|0|||
143308774|NCT00486265|516681813|FG000|Overall Study|Adverse Event|1|||
143308775|NCT00486265|516681813|FG000|Overall Study|Lack of Efficacy|8|||
143308776|NCT01452412|516681814|FG000|Overall Study|Withdrawal by Subject|15|||
143308777|NCT01452412|516681815|FG001|Overall Study|Withdrawal by Subject|11|||
143308778|NCT01452412|516681814|FG000|Overall Study|Adverse Event|4|||
143308779|NCT01452412|516681815|FG001|Overall Study|Adverse Event|3|||
143308780|NCT01452412|516681814|FG000|Overall Study|Lost to Follow-up|5|||
143308781|NCT01452412|516681815|FG001|Overall Study|Lost to Follow-up|3|||
143308782|NCT01452412|516681814|FG000|Overall Study|Death|1|||
143308783|NCT01452412|516681815|FG001|Overall Study|Death|0|||
143308784|NCT01452412|516681814|FG000|Overall Study|Initiated dialysis|1|||
143308785|NCT01452412|516681815|FG001|Overall Study|Initiated dialysis|0|||
143308786|NCT01452412|516681814|FG000|Overall Study|Other|2|||
143308787|NCT01452412|516681815|FG001|Overall Study|Other|0|||
143308788|NCT05132127|516681816|FG000|Overall Study|Adverse Event|1|||
143308789|NCT03013543|516681817|FG000|Overall Study|Withdrawal by Subject|0|||
143308790|NCT03013543|516681818|FG001|Overall Study|Withdrawal by Subject|2|||
143308791|NCT03013543|516681819|FG002|Overall Study|Withdrawal by Subject|0|||
143308792|NCT03013543|516681820|FG003|Overall Study|Withdrawal by Subject|5|||
143308793|NCT03013543|516681821|FG004|Overall Study|Withdrawal by Subject|6|||
143308794|NCT03013543|516681822|FG005|Overall Study|Withdrawal by Subject|2|||
143308795|NCT03013543|516681823|FG006|Overall Study|Withdrawal by Subject|3|||
143308796|NCT03013543|516681824|FG007|Overall Study|Withdrawal by Subject|1|||
143308797|NCT03013543|516681825|FG008|Overall Study|Withdrawal by Subject|0|||
143308798|NCT03013543|516681826|FG009|Overall Study|Withdrawal by Subject|4|||
143308799|NCT03013543|516681817|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
143308800|NCT03013543|516681818|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
143308801|NCT03013543|516681819|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
143308802|NCT03013543|516681820|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
143308803|NCT03013543|516681821|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
143308804|NCT03013543|516681822|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
143308805|NCT03013543|516681823|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
143308806|NCT03013543|516681824|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
143308807|NCT03013543|516681825|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
143308808|NCT03013543|516681826|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
143308809|NCT03013543|516681817|FG000|Overall Study|Other|0|||
143308810|NCT03013543|516681818|FG001|Overall Study|Other|0|||
143308811|NCT03013543|516681819|FG002|Overall Study|Other|2|||
143308812|NCT03013543|516681820|FG003|Overall Study|Other|0|||
143308813|NCT03013543|516681821|FG004|Overall Study|Other|2|||
143308814|NCT03013543|516681822|FG005|Overall Study|Other|0|||
143308815|NCT03013543|516681823|FG006|Overall Study|Other|0|||
143308816|NCT03013543|516681824|FG007|Overall Study|Other|0|||
143308817|NCT03013543|516681825|FG008|Overall Study|Other|1|||
143308818|NCT03013543|516681826|FG009|Overall Study|Other|0|||
143308819|NCT03013543|516681817|FG000|Overall Study|Adverse Event|0|||
143308820|NCT03013543|516681818|FG001|Overall Study|Adverse Event|0|||
143308821|NCT03013543|516681819|FG002|Overall Study|Adverse Event|0|||
143308822|NCT03013543|516681820|FG003|Overall Study|Adverse Event|3|||
143308823|NCT03013543|516681821|FG004|Overall Study|Adverse Event|2|||
143308824|NCT03013543|516681822|FG005|Overall Study|Adverse Event|1|||
143308825|NCT03013543|516681823|FG006|Overall Study|Adverse Event|3|||
143308826|NCT03013543|516681824|FG007|Overall Study|Adverse Event|8|||
143308827|NCT03013543|516681825|FG008|Overall Study|Adverse Event|0|||
143308828|NCT03013543|516681826|FG009|Overall Study|Adverse Event|2|||
143308829|NCT03013543|516681817|FG000|Overall Study|Death|0|||
143308830|NCT03013543|516681818|FG001|Overall Study|Death|0|||
143308831|NCT03013543|516681819|FG002|Overall Study|Death|0|||
143308832|NCT03013543|516681820|FG003|Overall Study|Death|1|||
143308833|NCT03013543|516681821|FG004|Overall Study|Death|0|||
143308834|NCT03013543|516681822|FG005|Overall Study|Death|0|||
143375630|NCT03034915|516920480|FG000|Overall Study|Adverse Event|29|||
143308835|NCT03013543|516681823|FG006|Overall Study|Death|0|||
143308836|NCT03013543|516681824|FG007|Overall Study|Death|0|||
143308837|NCT03013543|516681825|FG008|Overall Study|Death|0|||
143308838|NCT03013543|516681826|FG009|Overall Study|Death|0|||
143308839|NCT03013543|516681817|FG000|Overall Study|Lack of Efficacy|0|||
143308840|NCT03013543|516681818|FG001|Overall Study|Lack of Efficacy|0|||
143308841|NCT03013543|516681819|FG002|Overall Study|Lack of Efficacy|0|||
143375631|NCT03034915|516920481|FG001|Overall Study|Adverse Event|32|||
143308842|NCT03013543|516681820|FG003|Overall Study|Lack of Efficacy|1|||
143308843|NCT03013543|516681821|FG004|Overall Study|Lack of Efficacy|0|||
143308844|NCT03013543|516681822|FG005|Overall Study|Lack of Efficacy|0|||
143308845|NCT03013543|516681823|FG006|Overall Study|Lack of Efficacy|0|||
143308846|NCT03013543|516681824|FG007|Overall Study|Lack of Efficacy|0|||
143375632|NCT03034915|516920482|FG002|Overall Study|Adverse Event|22|||
143308847|NCT03013543|516681825|FG008|Overall Study|Lack of Efficacy|0|||
143308848|NCT03013543|516681826|FG009|Overall Study|Lack of Efficacy|0|||
143308849|NCT03013543|516681817|FG000|Overall Study|Lost to Follow-up|0|||
143308850|NCT03013543|516681818|FG001|Overall Study|Lost to Follow-up|0|||
143308851|NCT03013543|516681819|FG002|Overall Study|Lost to Follow-up|0|||
143308852|NCT03013543|516681820|FG003|Overall Study|Lost to Follow-up|1|||
143308853|NCT03013543|516681821|FG004|Overall Study|Lost to Follow-up|0|||
143308854|NCT03013543|516681822|FG005|Overall Study|Lost to Follow-up|0|||
143308855|NCT03013543|516681823|FG006|Overall Study|Lost to Follow-up|1|||
143308856|NCT03013543|516681824|FG007|Overall Study|Lost to Follow-up|0|||
143308857|NCT03013543|516681825|FG008|Overall Study|Lost to Follow-up|0|||
143308858|NCT03013543|516681826|FG009|Overall Study|Lost to Follow-up|2|||
143308859|NCT03013543|516681817|FG000|Overall Study|Non-Compliance With Study Drug|0|||
143308860|NCT03013543|516681818|FG001|Overall Study|Non-Compliance With Study Drug|0|||
143308861|NCT03013543|516681819|FG002|Overall Study|Non-Compliance With Study Drug|0|||
143308862|NCT03013543|516681820|FG003|Overall Study|Non-Compliance With Study Drug|0|||
143308863|NCT03013543|516681821|FG004|Overall Study|Non-Compliance With Study Drug|0|||
143308864|NCT03013543|516681822|FG005|Overall Study|Non-Compliance With Study Drug|0|||
143308865|NCT03013543|516681823|FG006|Overall Study|Non-Compliance With Study Drug|0|||
143308866|NCT03013543|516681824|FG007|Overall Study|Non-Compliance With Study Drug|0|||
143308867|NCT03013543|516681825|FG008|Overall Study|Non-Compliance With Study Drug|1|||
143308868|NCT03013543|516681826|FG009|Overall Study|Non-Compliance With Study Drug|0|||
143308869|NCT03013543|516681817|FG000|Overall Study|Physician Decision|0|||
143308870|NCT03013543|516681818|FG001|Overall Study|Physician Decision|0|||
143308871|NCT03013543|516681819|FG002|Overall Study|Physician Decision|0|||
143308872|NCT03013543|516681820|FG003|Overall Study|Physician Decision|0|||
143308873|NCT03013543|516681821|FG004|Overall Study|Physician Decision|1|||
143375633|NCT03034915|516920480|FG000|Overall Study|Lost to Follow-up|5|||
143375634|NCT03034915|516920481|FG001|Overall Study|Lost to Follow-up|13|||
143375635|NCT03034915|516920482|FG002|Overall Study|Lost to Follow-up|3|||
143375636|NCT03034915|516920480|FG000|Overall Study|Withdrawal by Subject|29|||
143375637|NCT03034915|516920481|FG001|Overall Study|Withdrawal by Subject|46|||
143375638|NCT03034915|516920482|FG002|Overall Study|Withdrawal by Subject|41|||
143375639|NCT03034915|516920480|FG000|Overall Study|Protocol Deviation|2|||
143375640|NCT03034915|516920481|FG001|Overall Study|Protocol Deviation|14|||
143375641|NCT03034915|516920482|FG002|Overall Study|Protocol Deviation|7|||
143375642|NCT03034915|516920480|FG000|Overall Study|Lack of Efficacy|8|||
143375643|NCT03034915|516920481|FG001|Overall Study|Lack of Efficacy|16|||
143375644|NCT03034915|516920482|FG002|Overall Study|Lack of Efficacy|18|||
143375645|NCT03034915|516920480|FG000|Overall Study|Site closed|2|||
143375646|NCT03034915|516920481|FG001|Overall Study|Site closed|2|||
143375647|NCT03034915|516920482|FG002|Overall Study|Site closed|4|||
143375648|NCT03034915|516920480|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
143375649|NCT03034915|516920481|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
143375650|NCT03034915|516920482|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
143375651|NCT03034915|516920480|FG000|Overall Study|Physician Decision|1|||
143375652|NCT03034915|516920481|FG001|Overall Study|Physician Decision|5|||
143375653|NCT03034915|516920482|FG002|Overall Study|Physician Decision|2|||
143375654|NCT01831791|516920483|FG000|Overall Study|Withdrawal by Subject|10|||
143375655|NCT01254019|516920484|FG000|Overall Study|Adverse Event|0|||
143375656|NCT01254019|516920485|FG001|Overall Study|Adverse Event|2|||
143375657|NCT01254019|516920484|FG000|Overall Study|Protocol Violation|1|||
143375658|NCT01254019|516920485|FG001|Overall Study|Protocol Violation|0|||
143375659|NCT01254019|516920484|FG000|Overall Study|Withdrawal by Subject|0|||
143375660|NCT01254019|516920485|FG001|Overall Study|Withdrawal by Subject|2|||
143375661|NCT03061474|516920486|FG000|Overall Study|Adverse Event|2|||
143375662|NCT03061474|516920487|FG001|Overall Study|Adverse Event|0|||
143375663|NCT03061474|516920486|FG000|Overall Study|Safety Risk|0|||
143375664|NCT03061474|516920487|FG001|Overall Study|Safety Risk|1|||
143375665|NCT03061474|516920486|FG000|Overall Study|Participant unwilling or unable to participate|0|||
143375666|NCT03061474|516920487|FG001|Overall Study|Participant unwilling or unable to participate|2|||
143375667|NCT03061474|516920486|FG000|Overall Study|Lost to Follow-up|0|||
143375668|NCT03061474|516920487|FG001|Overall Study|Lost to Follow-up|1|||
143375669|NCT00845832|516920488|FG000|Treatment Period|Adverse Event|0|||
143308874|NCT03013543|516681822|FG005|Overall Study|Physician Decision|0|||
143308875|NCT03013543|516681823|FG006|Overall Study|Physician Decision|0|||
143375670|NCT00845832|516920489|FG001|Treatment Period|Adverse Event|2|||
143375671|NCT00845832|516920490|FG002|Treatment Period|Adverse Event|0|||
143375672|NCT00845832|516920488|FG000|Treatment Period|Protocol Violation|1|||
143375673|NCT00845832|516920489|FG001|Treatment Period|Protocol Violation|1|||
143375674|NCT00845832|516920490|FG002|Treatment Period|Protocol Violation|0|||
143375675|NCT00845832|516920488|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
143375676|NCT00845832|516920489|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
143375677|NCT00845832|516920490|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
143308876|NCT03013543|516681824|FG007|Overall Study|Physician Decision|0|||
143308877|NCT03013543|516681825|FG008|Overall Study|Physician Decision|0|||
143375678|NCT00845832|516920488|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
143375679|NCT00845832|516920489|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
143375680|NCT00845832|516920490|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
143375681|NCT01391130|516920491|FG000|Overall Study|Withdrawal by Subject|3|||
143375682|NCT01391130|516920492|FG001|Overall Study|Withdrawal by Subject|2|||
143375683|NCT01391130|516920491|FG000|Overall Study|Physician Decision|2|||
143308878|NCT03013543|516681826|FG009|Overall Study|Physician Decision|0|||
143308879|NCT03013543|516681817|FG000|Overall Study|Protocol Violation|0|||
143308880|NCT03013543|516681818|FG001|Overall Study|Protocol Violation|0|||
143308881|NCT03013543|516681819|FG002|Overall Study|Protocol Violation|0|||
143308882|NCT03013543|516681820|FG003|Overall Study|Protocol Violation|0|||
143308883|NCT03013543|516681821|FG004|Overall Study|Protocol Violation|0|||
143308884|NCT03013543|516681822|FG005|Overall Study|Protocol Violation|0|||
143308885|NCT03013543|516681823|FG006|Overall Study|Protocol Violation|0|||
143308886|NCT03013543|516681824|FG007|Overall Study|Protocol Violation|0|||
143308887|NCT03013543|516681825|FG008|Overall Study|Protocol Violation|0|||
143308888|NCT03013543|516681826|FG009|Overall Study|Protocol Violation|1|||
143308889|NCT01120210|516681828|FG000|MAIN INFUSION|Adverse Event|1|||
143308890|NCT01120210|516681829|FG001|MAIN INFUSION|Adverse Event|0|||
143308891|NCT01120210|516681828|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
143308892|NCT01120210|516681829|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
143308893|NCT01403974|516681834|FG000|Overall Study|Progressive disease according to RECIST|3|||
143308894|NCT01403974|516681835|FG001|Overall Study|Progressive disease according to RECIST|3|||
143308895|NCT01403974|516681836|FG002|Overall Study|Progressive disease according to RECIST|2|||
143308896|NCT01403974|516681837|FG003|Overall Study|Progressive disease according to RECIST|3|||
143308897|NCT01403974|516681838|FG004|Overall Study|Progressive disease according to RECIST|3|||
143308898|NCT01403974|516681839|FG005|Overall Study|Progressive disease according to RECIST|2|||
143308899|NCT01403974|516681840|FG006|Overall Study|Progressive disease according to RECIST|3|||
143308900|NCT01403974|516681841|FG007|Overall Study|Progressive disease according to RECIST|2|||
143308901|NCT01403974|516681842|FG008|Overall Study|Progressive disease according to RECIST|6|||
143308902|NCT01403974|516681843|FG009|Overall Study|Progressive disease according to RECIST|2|||
143308903|NCT01403974|516681844|FG010|Overall Study|Progressive disease according to RECIST|3|||
143308904|NCT01403974|516681845|FG011|Overall Study|Progressive disease according to RECIST|2|||
143308905|NCT01403974|516681846|FG012|Overall Study|Progressive disease according to RECIST|2|||
143308906|NCT01403974|516681847|FG013|Overall Study|Progressive disease according to RECIST|3|||
143308907|NCT01403974|516681848|FG014|Overall Study|Progressive disease according to RECIST|1|||
143308908|NCT01403974|516681849|FG015|Overall Study|Progressive disease according to RECIST|8|||
143308909|NCT01403974|516681834|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
143308910|NCT01403974|516681835|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
143308911|NCT01403974|516681836|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
143375684|NCT01391130|516920492|FG001|Overall Study|Physician Decision|3|||
143375685|NCT01391130|516920491|FG000|Overall Study|Did not Receive Drug|1|||
143308912|NCT01403974|516681837|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
143308913|NCT01403974|516681838|FG004|Overall Study|Dose limiting toxicity (DLT)|0|||
143308914|NCT01403974|516681839|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
143308915|NCT01403974|516681840|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
143308916|NCT01403974|516681841|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
143308917|NCT01403974|516681842|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
143308918|NCT01403974|516681843|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
143308919|NCT01403974|516681844|FG010|Overall Study|Dose limiting toxicity (DLT)|0|||
143308920|NCT01403974|516681845|FG011|Overall Study|Dose limiting toxicity (DLT)|0|||
143308921|NCT01403974|516681846|FG012|Overall Study|Dose limiting toxicity (DLT)|0|||
143308922|NCT01403974|516681847|FG013|Overall Study|Dose limiting toxicity (DLT)|0|||
143308923|NCT01403974|516681848|FG014|Overall Study|Dose limiting toxicity (DLT)|0|||
143308924|NCT01403974|516681849|FG015|Overall Study|Dose limiting toxicity (DLT)|0|||
143308925|NCT01403974|516681834|FG000|Overall Study|Refused to continue study medication|0|||
143308926|NCT01403974|516681835|FG001|Overall Study|Refused to continue study medication|0|||
143375686|NCT01391130|516920492|FG001|Overall Study|Did not Receive Drug|1|||
143308927|NCT01403974|516681836|FG002|Overall Study|Refused to continue study medication|0|||
143308928|NCT01403974|516681837|FG003|Overall Study|Refused to continue study medication|0|||
143375687|NCT00668863|516920493|FG000|Overall Study|Objective Progression or Relapse|42|||
143308929|NCT01403974|516681838|FG004|Overall Study|Refused to continue study medication|0|||
143308930|NCT01403974|516681839|FG005|Overall Study|Refused to continue study medication|1|||
143308931|NCT01403974|516681840|FG006|Overall Study|Refused to continue study medication|0|||
143308932|NCT01403974|516681841|FG007|Overall Study|Refused to continue study medication|0|||
143308933|NCT01403974|516681842|FG008|Overall Study|Refused to continue study medication|1|||
143308934|NCT01403974|516681843|FG009|Overall Study|Refused to continue study medication|0|||
143308935|NCT01403974|516681844|FG010|Overall Study|Refused to continue study medication|1|||
143308936|NCT01403974|516681845|FG011|Overall Study|Refused to continue study medication|0|||
143308937|NCT01403974|516681846|FG012|Overall Study|Refused to continue study medication|0|||
143308938|NCT01403974|516681847|FG013|Overall Study|Refused to continue study medication|0|||
143308939|NCT01403974|516681848|FG014|Overall Study|Refused to continue study medication|0|||
143308940|NCT01403974|516681849|FG015|Overall Study|Refused to continue study medication|4|||
143308941|NCT01403974|516681834|FG000|Overall Study|Adverse Event|0|||
143308942|NCT01403974|516681835|FG001|Overall Study|Adverse Event|0|||
143308943|NCT01403974|516681836|FG002|Overall Study|Adverse Event|1|||
143308944|NCT01403974|516681837|FG003|Overall Study|Adverse Event|0|||
143308945|NCT01403974|516681838|FG004|Overall Study|Adverse Event|0|||
143308946|NCT01403974|516681839|FG005|Overall Study|Adverse Event|0|||
143308947|NCT01403974|516681840|FG006|Overall Study|Adverse Event|0|||
143308948|NCT01403974|516681841|FG007|Overall Study|Adverse Event|1|||
143308949|NCT01403974|516681842|FG008|Overall Study|Adverse Event|0|||
143308950|NCT01403974|516681843|FG009|Overall Study|Adverse Event|0|||
143308951|NCT01403974|516681844|FG010|Overall Study|Adverse Event|0|||
143308952|NCT01403974|516681845|FG011|Overall Study|Adverse Event|0|||
143308953|NCT01403974|516681846|FG012|Overall Study|Adverse Event|1|||
143308954|NCT01403974|516681847|FG013|Overall Study|Adverse Event|0|||
143308955|NCT01403974|516681848|FG014|Overall Study|Adverse Event|0|||
143308956|NCT01403974|516681849|FG015|Overall Study|Adverse Event|0|||
143308957|NCT01403974|516681834|FG000|Overall Study|Other than specified|0|||
143308958|NCT01403974|516681835|FG001|Overall Study|Other than specified|0|||
143308959|NCT01403974|516681836|FG002|Overall Study|Other than specified|0|||
143308960|NCT01403974|516681837|FG003|Overall Study|Other than specified|0|||
143308961|NCT01403974|516681838|FG004|Overall Study|Other than specified|0|||
143308962|NCT01403974|516681839|FG005|Overall Study|Other than specified|0|||
143308963|NCT01403974|516681840|FG006|Overall Study|Other than specified|0|||
143308964|NCT01403974|516681841|FG007|Overall Study|Other than specified|0|||
143308965|NCT01403974|516681842|FG008|Overall Study|Other than specified|0|||
143308966|NCT01403974|516681843|FG009|Overall Study|Other than specified|1|||
143308967|NCT01403974|516681844|FG010|Overall Study|Other than specified|0|||
143308968|NCT01403974|516681845|FG011|Overall Study|Other than specified|1|||
143308969|NCT01403974|516681846|FG012|Overall Study|Other than specified|0|||
143308970|NCT01403974|516681847|FG013|Overall Study|Other than specified|0|||
143308971|NCT01403974|516681848|FG014|Overall Study|Other than specified|0|||
143308972|NCT01403974|516681849|FG015|Overall Study|Other than specified|0|||
143308973|NCT02948842|516681852|FG000|Overall Study|Withdrawal by Subject|4|||
143308974|NCT01736696|516681854|FG000|Overall Study|Withdrawal by Subject|0|||
143308975|NCT01736696|516681855|FG001|Overall Study|Withdrawal by Subject|0|||
143308976|NCT01736696|516681856|FG002|Overall Study|Withdrawal by Subject|1|||
143308977|NCT01736696|516681857|FG003|Overall Study|Withdrawal by Subject|0|||
143308978|NCT01736696|516681858|FG004|Overall Study|Withdrawal by Subject|0|||
143308979|NCT01736696|516681859|FG005|Overall Study|Withdrawal by Subject|0|||
143308980|NCT01736696|516681860|FG006|Overall Study|Withdrawal by Subject|0|||
143308981|NCT00838565|516681861|FG000|Overall Study|Withdrawal by Subject|0|||
143308982|NCT00838565|516681862|FG001|Overall Study|Withdrawal by Subject|0|||
143308983|NCT00838565|516681863|FG002|Overall Study|Withdrawal by Subject|1|||
143308984|NCT00838565|516681864|FG003|Overall Study|Withdrawal by Subject|0|||
143308985|NCT00838565|516681865|FG004|Overall Study|Withdrawal by Subject|0|||
143308986|NCT00838565|516681866|FG005|Overall Study|Withdrawal by Subject|2|||
143308987|NCT00838565|516681861|FG000|Overall Study|Other|0|||
143308988|NCT00838565|516681862|FG001|Overall Study|Other|2|||
143308989|NCT00838565|516681863|FG002|Overall Study|Other|0|||
143308990|NCT00838565|516681864|FG003|Overall Study|Other|0|||
143308991|NCT00838565|516681865|FG004|Overall Study|Other|0|||
143308992|NCT00838565|516681866|FG005|Overall Study|Other|0|||
143308993|NCT00838565|516681861|FG000|Overall Study|Randomized but not Treated|0|||
143308994|NCT00838565|516681862|FG001|Overall Study|Randomized but not Treated|1|||
143308995|NCT00838565|516681863|FG002|Overall Study|Randomized but not Treated|0|||
143308996|NCT00838565|516681864|FG003|Overall Study|Randomized but not Treated|0|||
143308997|NCT00838565|516681865|FG004|Overall Study|Randomized but not Treated|0|||
143308998|NCT00838565|516681866|FG005|Overall Study|Randomized but not Treated|0|||
143308999|NCT03571516|516681867|FG000|Overall Study|Severe diarrhea|1|||
143309000|NCT03571516|516681868|FG001|Overall Study|Severe diarrhea|0|||
143309001|NCT03571516|516681867|FG000|Overall Study|Withdrawal by Subject|0|||
143309002|NCT03571516|516681868|FG001|Overall Study|Withdrawal by Subject|1|||
143309003|NCT01224639|516681869|FG000|Overall Study|Withdrawal by Subject|0|||
143309004|NCT01224639|516681870|FG001|Overall Study|Withdrawal by Subject|0|||
143309005|NCT01224639|516681871|FG002|Overall Study|Withdrawal by Subject|0|||
143309006|NCT01224639|516681872|FG003|Overall Study|Withdrawal by Subject|0|||
143309007|NCT01224639|516681873|FG004|Overall Study|Withdrawal by Subject|2|||
143309008|NCT01224639|516681874|FG005|Overall Study|Withdrawal by Subject|0|||
143309009|NCT01224639|516681875|FG006|Overall Study|Withdrawal by Subject|1|||
143309010|NCT01224639|516681876|FG007|Overall Study|Withdrawal by Subject|1|||
143309011|NCT01224639|516681869|FG000|Overall Study|Adverse Event|0|||
143309012|NCT01224639|516681870|FG001|Overall Study|Adverse Event|0|||
143309013|NCT01224639|516681871|FG002|Overall Study|Adverse Event|0|||
143309014|NCT01224639|516681872|FG003|Overall Study|Adverse Event|0|||
143309015|NCT01224639|516681873|FG004|Overall Study|Adverse Event|0|||
143309016|NCT01224639|516681874|FG005|Overall Study|Adverse Event|0|||
143309017|NCT01224639|516681875|FG006|Overall Study|Adverse Event|0|||
143309018|NCT01224639|516681876|FG007|Overall Study|Adverse Event|1|||
143309019|NCT04656132|516681879|FG000|Overall Study|Lost to Follow-up|4|||
143309020|NCT04656132|516681879|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
143309021|NCT04019041|516681880|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
143309022|NCT04019041|516681881|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
143309023|NCT04019041|516681882|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
143309024|NCT04019041|516681883|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
143309025|NCT04019041|516681884|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
143309026|NCT04019041|516681885|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
143309027|NCT04019041|516681880|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
143309028|NCT04019041|516681881|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
143309029|NCT04019041|516681882|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
143309030|NCT04019041|516681883|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
143309031|NCT04019041|516681884|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
143309032|NCT04019041|516681885|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
143309033|NCT04019041|516681880|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
143309034|NCT04019041|516681881|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
143309035|NCT04019041|516681882|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
143309036|NCT04019041|516681883|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
143309037|NCT04019041|516681884|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
143309038|NCT04019041|516681885|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
143309039|NCT04019041|516681880|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
143309040|NCT04019041|516681881|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
143309041|NCT04019041|516681882|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
143309042|NCT04019041|516681883|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
143309043|NCT04019041|516681884|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
143309044|NCT04019041|516681885|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
143309045|NCT04019041|516681880|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
143309046|NCT04019041|516681881|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
143309047|NCT04019041|516681882|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
143309048|NCT04019041|516681883|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
143309049|NCT04019041|516681884|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
143309050|NCT04019041|516681885|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
143309051|NCT04019041|516681880|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
143309052|NCT04019041|516681881|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
143309053|NCT04019041|516681882|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
143309054|NCT04019041|516681883|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
143309055|NCT04019041|516681884|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
143309056|NCT04019041|516681885|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
143309057|NCT04019041|516681880|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
143309058|NCT04019041|516681881|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
143309059|NCT04019041|516681882|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
143309060|NCT04019041|516681883|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
143309061|NCT04019041|516681884|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
143309062|NCT04019041|516681885|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
143309063|NCT04019041|516681880|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
143309064|NCT04019041|516681881|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
143309065|NCT04019041|516681882|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
143309066|NCT04019041|516681883|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
143309067|NCT04019041|516681884|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
143309068|NCT04019041|516681885|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
143309069|NCT04019041|516681880|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
143309070|NCT04019041|516681881|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
143309071|NCT04019041|516681882|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
143309072|NCT04019041|516681883|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
143309073|NCT04019041|516681884|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
143309074|NCT04019041|516681885|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
143309075|NCT03925727|516681887|FG000|Overall Study|Adverse Event|4|||
143309076|NCT03925727|516681888|FG001|Overall Study|Adverse Event|0|||
143309077|NCT03925727|516681889|FG002|Overall Study|Adverse Event|3|||
143309078|NCT03925727|516681887|FG000|Overall Study|Protocol Violation|1|||
143309079|NCT03925727|516681888|FG001|Overall Study|Protocol Violation|2|||
143309080|NCT03925727|516681889|FG002|Overall Study|Protocol Violation|2|||
143309081|NCT03925727|516681887|FG000|Overall Study|Withdrawal by Subject|3|||
143309082|NCT03925727|516681888|FG001|Overall Study|Withdrawal by Subject|2|||
143309083|NCT03925727|516681889|FG002|Overall Study|Withdrawal by Subject|4|||
143309084|NCT03925727|516681887|FG000|Overall Study|Administrative Reasons|3|||
143309085|NCT03925727|516681888|FG001|Overall Study|Administrative Reasons|1|||
143309086|NCT03925727|516681889|FG002|Overall Study|Administrative Reasons|2|||
143309087|NCT03925727|516681887|FG000|Overall Study|Randomized in error or Disqualified|8|||
143309088|NCT03925727|516681888|FG001|Overall Study|Randomized in error or Disqualified|1|||
143309089|NCT03925727|516681889|FG002|Overall Study|Randomized in error or Disqualified|7|||
143309090|NCT01393743|516681890|FG000|Core Study|Adverse Event|5|||
143309091|NCT01393743|516681891|FG001|Core Study|Adverse Event|9|||
143309092|NCT01393743|516681892|FG002|Core Study|Adverse Event|0|||
143309093|NCT01393743|516681890|FG000|Core Study|Lost to Follow-up|1|||
143309094|NCT01393743|516681891|FG001|Core Study|Lost to Follow-up|1|||
143309095|NCT01393743|516681892|FG002|Core Study|Lost to Follow-up|0|||
143309096|NCT01393743|516681890|FG000|Core Study|Participant's Choice|2|||
143309097|NCT01393743|516681891|FG001|Core Study|Participant's Choice|3|||
143309098|NCT01393743|516681892|FG002|Core Study|Participant's Choice|0|||
143309099|NCT01393743|516681890|FG000|Core Study|Inadequate therapeutic effect|2|||
143309100|NCT01393743|516681891|FG001|Core Study|Inadequate therapeutic effect|0|||
143309101|NCT01393743|516681892|FG002|Core Study|Inadequate therapeutic effect|0|||
143309102|NCT01393743|516681890|FG000|Extension Phase|Adverse Event|0|||
143309103|NCT01393743|516681891|FG001|Extension Phase|Adverse Event|0|||
143309104|NCT01393743|516681892|FG002|Extension Phase|Adverse Event|12|||
143309105|NCT01393743|516681890|FG000|Extension Phase|Lost to Follow-up|0|||
143309106|NCT01393743|516681891|FG001|Extension Phase|Lost to Follow-up|0|||
143309107|NCT01393743|516681892|FG002|Extension Phase|Lost to Follow-up|2|||
143309108|NCT01393743|516681890|FG000|Extension Phase|Participant choice|0|||
143309109|NCT01393743|516681891|FG001|Extension Phase|Participant choice|0|||
143309110|NCT01393743|516681892|FG002|Extension Phase|Participant choice|16|||
143309111|NCT01393743|516681890|FG000|Extension Phase|Inadequate therapeutic effect|0|||
143309112|NCT01393743|516681891|FG001|Extension Phase|Inadequate therapeutic effect|0|||
143309113|NCT01393743|516681892|FG002|Extension Phase|Inadequate therapeutic effect|7|||
143309114|NCT01393743|516681890|FG000|Extension Phase|Withdrawal by Subject|0|||
143309115|NCT01393743|516681891|FG001|Extension Phase|Withdrawal by Subject|0|||
143309116|NCT01393743|516681892|FG002|Extension Phase|Withdrawal by Subject|8|||
143309117|NCT01393743|516681890|FG000|Extension Phase|Pregnancy|0|||
143309118|NCT01393743|516681891|FG001|Extension Phase|Pregnancy|0|||
143309119|NCT01393743|516681892|FG002|Extension Phase|Pregnancy|1|||
143309120|NCT01393743|516681890|FG000|Extension Phase|Other|0|||
143309121|NCT01393743|516681891|FG001|Extension Phase|Other|0|||
143309122|NCT01393743|516681892|FG002|Extension Phase|Other|14|||
143309123|NCT00314366|516681893|FG000|Overall Study|not treated due to patient medical condi|1|||
143309124|NCT00314366|516681894|FG001|Overall Study|not treated due to patient medical condi|0|||
143309125|NCT02469610|516681903|FG000|Overall Study|Death|1|||
143309126|NCT02469610|516681904|FG001|Overall Study|Death|0|||
143309127|NCT02469610|516681903|FG000|Overall Study|Lost to Follow-up|1|||
143309128|NCT02469610|516681904|FG001|Overall Study|Lost to Follow-up|0|||
143309129|NCT02469610|516681903|FG000|Overall Study|exclusion criteria|2|||
143309130|NCT02469610|516681904|FG001|Overall Study|exclusion criteria|1|||
143309131|NCT01574352|516681905|FG000|Overall Study|Withdrawal by Subject|6|||
143309132|NCT01574352|516681906|FG001|Overall Study|Withdrawal by Subject|13|||
143309133|NCT01574352|516681905|FG000|Overall Study|Injury in non-camp related sport|1|||
143309134|NCT01574352|516681906|FG001|Overall Study|Injury in non-camp related sport|0|||
143309135|NCT00660348|516681907|FG000|Overall Study|Withdrawal by Subject|1|||
143309136|NCT00660348|516681908|FG001|Overall Study|Withdrawal by Subject|0|||
143309137|NCT01282424|516681912|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
143309138|NCT01282424|516681912|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
143309139|NCT01282424|516681912|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
143309140|NCT01282424|516681912|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
143309141|NCT01282424|516681912|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
143309142|NCT01282424|516681912|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
143309143|NCT01282424|516681912|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
143309144|NCT01282424|516681912|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
143309145|NCT02741115|516681913|FG000|Overall Study|Adverse Event|1|||
143309146|NCT02741115|516681914|FG001|Overall Study|Adverse Event|0|||
143309147|NCT02741115|516681913|FG000|Overall Study|Lost to Follow-up|7|||
143309148|NCT02741115|516681914|FG001|Overall Study|Lost to Follow-up|4|||
143309149|NCT02741115|516681913|FG000|Overall Study|Withdrawal by Subject|4|||
143309150|NCT02741115|516681914|FG001|Overall Study|Withdrawal by Subject|2|||
143309151|NCT06425458|516681917|FG000|Overall Study|Removed by study team|2|||
143309152|NCT06425458|516681917|FG000|Overall Study|Lost to Follow-up|5|||
143309153|NCT03508219|516681918|FG000|Overall Study|Death|2|||
143309154|NCT03508219|516681918|FG000|Overall Study|Withdrawal by Subject|1|||
143309155|NCT03508219|516681918|FG000|Overall Study|Lost to Follow-up|4|||
143309156|NCT03508219|516681918|FG000|Overall Study|Missed visit|2|||
143309157|NCT03945981|516681919|FG000|Overall Study|Lost to Follow-up|12|||
143309158|NCT03945981|516681919|FG000|Overall Study|Physician Decision|4|||
143309159|NCT03945981|516681919|FG000|Overall Study|Withdrawal by Subject|6|||
143309160|NCT03945981|516681919|FG000|Overall Study|Protocol Violation|1|||
143309161|NCT00445328|516681920|FG000|Overall Study|Death|0|||
143309162|NCT00445328|516681921|FG001|Overall Study|Death|1|||
143309163|NCT00445328|516681920|FG000|Overall Study|Adverse Event|0|||
143309164|NCT00445328|516681921|FG001|Overall Study|Adverse Event|3|||
143309165|NCT00445328|516681920|FG000|Overall Study|Other|0|||
143309166|NCT00445328|516681921|FG001|Overall Study|Other|2|||
143309167|NCT00445328|516681920|FG000|Overall Study|Withdrawal by Subject|2|||
143309168|NCT00445328|516681921|FG001|Overall Study|Withdrawal by Subject|0|||
143309169|NCT00445328|516681920|FG000|Overall Study|Protocol Violation|1|||
143309170|NCT00445328|516681921|FG001|Overall Study|Protocol Violation|0|||
143309171|NCT00316199|516681922|FG000|Overall Study|Adverse Event|2|||
143309172|NCT00316199|516681922|FG000|Overall Study|Death|8|||
143309173|NCT00316199|516681922|FG000|Overall Study|Lost to Follow-up|2|||
143309174|NCT03316872|516681924|FG000|Overall Study|Death|1|||
143309175|NCT06023394|516681927|FG000|Overall Study|Surgery was not performed laparoscopically|4|||
143309176|NCT06023394|516681928|FG001|Overall Study|Surgery was not performed laparoscopically|2|||
143309177|NCT06023394|516681927|FG000|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|0|||
143309178|NCT06023394|516681928|FG001|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|3|||
143309179|NCT06023394|516681927|FG000|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|1|||
143309180|NCT06023394|516681928|FG001|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|0|||
143309181|NCT06023394|516681927|FG000|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
143309182|NCT06023394|516681928|FG001|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
143309183|NCT01101841|516683624|FG000|Overall Study|Adverse Event|15|||
143309184|NCT01101841|516683625|FG001|Overall Study|Adverse Event|15|||
143309185|NCT01101841|516683624|FG000|Overall Study|Lost to Follow-up|9|||
143309186|NCT01101841|516683625|FG001|Overall Study|Lost to Follow-up|3|||
143309187|NCT01101841|516683624|FG000|Overall Study|Withdrawal by Subject|21|||
143309188|NCT01101841|516683625|FG001|Overall Study|Withdrawal by Subject|40|||
143309189|NCT01101841|516683624|FG000|Overall Study|Protocol Violation|1|||
143309190|NCT01101841|516683625|FG001|Overall Study|Protocol Violation|1|||
143309191|NCT01101841|516683624|FG000|Overall Study|Physician Decision|0|||
143309192|NCT01101841|516683625|FG001|Overall Study|Physician Decision|2|||
143309193|NCT01101841|516683624|FG000|Overall Study|Lack of Efficacy|0|||
143309194|NCT01101841|516683625|FG001|Overall Study|Lack of Efficacy|2|||
143309195|NCT01101841|516683624|FG000|Overall Study|Other|0|||
143309196|NCT01101841|516683625|FG001|Overall Study|Other|1|||
143309197|NCT01101841|516683624|FG000|Overall Study|Suicidality Tracking Scale|3|||
143309198|NCT01101841|516683625|FG001|Overall Study|Suicidality Tracking Scale|1|||
143309199|NCT01101841|516683624|FG000|Overall Study|Eligibility Criteria|1|||
143309200|NCT01101841|516683625|FG001|Overall Study|Eligibility Criteria|2|||
143309201|NCT00653224|516683628|FG000|Overall Study|Adverse Event|2|||
143309202|NCT00653224|516683629|FG001|Overall Study|Adverse Event|1|||
143309203|NCT00653224|516683628|FG000|Overall Study|Lack of Efficacy|1|||
143309204|NCT00653224|516683629|FG001|Overall Study|Lack of Efficacy|2|||
143309205|NCT00653224|516683628|FG000|Overall Study|Loss of efficacy|1|||
143309206|NCT00653224|516683629|FG001|Overall Study|Loss of efficacy|0|||
143309207|NCT00653224|516683628|FG000|Overall Study|Lost to Follow-up|1|||
143309208|NCT00653224|516683629|FG001|Overall Study|Lost to Follow-up|0|||
143309209|NCT00653224|516683628|FG000|Overall Study|Other|2|||
143309210|NCT00653224|516683629|FG001|Overall Study|Other|4|||
143309211|NCT02896400|516683630|FG000|1 Month Follow-up|Lost to Follow-up|7|||
143309212|NCT02896400|516683631|FG001|1 Month Follow-up|Lost to Follow-up|7|||
143309213|NCT02896400|516683632|FG002|1 Month Follow-up|Lost to Follow-up|5|||
143309214|NCT02896400|516683633|FG003|1 Month Follow-up|Lost to Follow-up|8|||
143309215|NCT02896400|516683634|FG004|1 Month Follow-up|Lost to Follow-up|9|||
143309216|NCT02896400|516683635|FG005|1 Month Follow-up|Lost to Follow-up|6|||
143309217|NCT02896400|516683636|FG006|1 Month Follow-up|Lost to Follow-up|5|||
143309218|NCT02896400|516683637|FG007|1 Month Follow-up|Lost to Follow-up|6|||
143309219|NCT02896400|516683638|FG008|1 Month Follow-up|Lost to Follow-up|4|||
143309220|NCT02896400|516683639|FG009|1 Month Follow-up|Lost to Follow-up|7|||
143309221|NCT02896400|516683640|FG010|1 Month Follow-up|Lost to Follow-up|5|||
143309222|NCT02896400|516683641|FG011|1 Month Follow-up|Lost to Follow-up|5|||
143309223|NCT02896400|516683642|FG012|1 Month Follow-up|Lost to Follow-up|3|||
143309224|NCT02896400|516683643|FG013|1 Month Follow-up|Lost to Follow-up|4|||
143309225|NCT02896400|516683644|FG014|1 Month Follow-up|Lost to Follow-up|1|||
143309226|NCT02896400|516683645|FG015|1 Month Follow-up|Lost to Follow-up|2|||
143309227|NCT02896400|516683630|FG000|1 Month Follow-up|Death|0|||
143309228|NCT02896400|516683631|FG001|1 Month Follow-up|Death|0|||
143309229|NCT02896400|516683632|FG002|1 Month Follow-up|Death|0|||
143309230|NCT02896400|516683633|FG003|1 Month Follow-up|Death|0|||
143309231|NCT02896400|516683634|FG004|1 Month Follow-up|Death|0|||
143309232|NCT02896400|516683635|FG005|1 Month Follow-up|Death|0|||
143309233|NCT02896400|516683636|FG006|1 Month Follow-up|Death|0|||
143309234|NCT02896400|516683637|FG007|1 Month Follow-up|Death|0|||
143309235|NCT02896400|516683638|FG008|1 Month Follow-up|Death|0|||
143309236|NCT02896400|516683639|FG009|1 Month Follow-up|Death|0|||
143309237|NCT02896400|516683640|FG010|1 Month Follow-up|Death|0|||
143309238|NCT02896400|516683641|FG011|1 Month Follow-up|Death|0|||
143309239|NCT02896400|516683642|FG012|1 Month Follow-up|Death|0|||
143309240|NCT02896400|516683643|FG013|1 Month Follow-up|Death|0|||
143309241|NCT02896400|516683644|FG014|1 Month Follow-up|Death|0|||
143309242|NCT02896400|516683645|FG015|1 Month Follow-up|Death|1|||
143309243|NCT02896400|516683630|FG000|3 Month Follow-up|Lost to Follow-up|6|||
143309244|NCT02896400|516683631|FG001|3 Month Follow-up|Lost to Follow-up|3|||
143309245|NCT02896400|516683632|FG002|3 Month Follow-up|Lost to Follow-up|6|||
143309246|NCT02896400|516683633|FG003|3 Month Follow-up|Lost to Follow-up|11|||
143309247|NCT02896400|516683634|FG004|3 Month Follow-up|Lost to Follow-up|12|||
143309248|NCT02896400|516683635|FG005|3 Month Follow-up|Lost to Follow-up|6|||
143309249|NCT02896400|516683636|FG006|3 Month Follow-up|Lost to Follow-up|4|||
143309250|NCT02896400|516683637|FG007|3 Month Follow-up|Lost to Follow-up|3|||
143309251|NCT02896400|516683638|FG008|3 Month Follow-up|Lost to Follow-up|6|||
143309252|NCT02896400|516683639|FG009|3 Month Follow-up|Lost to Follow-up|5|||
143309253|NCT02896400|516683640|FG010|3 Month Follow-up|Lost to Follow-up|6|||
143309254|NCT02896400|516683641|FG011|3 Month Follow-up|Lost to Follow-up|6|||
143309255|NCT02896400|516683642|FG012|3 Month Follow-up|Lost to Follow-up|3|||
143309256|NCT02896400|516683643|FG013|3 Month Follow-up|Lost to Follow-up|5|||
143309257|NCT02896400|516683644|FG014|3 Month Follow-up|Lost to Follow-up|3|||
143309258|NCT02896400|516683645|FG015|3 Month Follow-up|Lost to Follow-up|2|||
143309259|NCT02896400|516683630|FG000|3 Month Follow-up|Death|0|||
143309260|NCT02896400|516683631|FG001|3 Month Follow-up|Death|0|||
143309261|NCT02896400|516683632|FG002|3 Month Follow-up|Death|0|||
143309262|NCT02896400|516683633|FG003|3 Month Follow-up|Death|0|||
143309263|NCT02896400|516683634|FG004|3 Month Follow-up|Death|0|||
143309264|NCT02896400|516683635|FG005|3 Month Follow-up|Death|0|||
143309265|NCT02896400|516683636|FG006|3 Month Follow-up|Death|0|||
143309266|NCT02896400|516683637|FG007|3 Month Follow-up|Death|0|||
143309267|NCT02896400|516683638|FG008|3 Month Follow-up|Death|0|||
143309268|NCT02896400|516683639|FG009|3 Month Follow-up|Death|0|||
143309269|NCT02896400|516683640|FG010|3 Month Follow-up|Death|0|||
143309270|NCT02896400|516683641|FG011|3 Month Follow-up|Death|0|||
143309271|NCT02896400|516683642|FG012|3 Month Follow-up|Death|0|||
143309272|NCT02896400|516683643|FG013|3 Month Follow-up|Death|1|||
143309273|NCT02896400|516683644|FG014|3 Month Follow-up|Death|1|||
143309274|NCT02896400|516683645|FG015|3 Month Follow-up|Death|0|||
143309275|NCT02896400|516683630|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
143309276|NCT02896400|516683631|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
143309277|NCT02896400|516683632|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
143375688|NCT00668863|516920493|FG000|Overall Study|Adverse Event|13|||
143309278|NCT02896400|516683633|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
143309279|NCT02896400|516683634|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
143309280|NCT02896400|516683635|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
143309281|NCT02896400|516683636|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
143309282|NCT02896400|516683637|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
143309283|NCT02896400|516683638|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
143309284|NCT02896400|516683639|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
143375689|NCT00668863|516920493|FG000|Overall Study|Study Terminated by Sponsor|8|||
143375690|NCT00668863|516920493|FG000|Overall Study|Global Deterioration of Health Status|4|||
143375691|NCT00668863|516920493|FG000|Overall Study|Withdrawal by Subject|1|||
143375692|NCT00668863|516920493|FG000|Overall Study|Surgery|1|||
143375693|NCT00668863|516920493|FG000|Overall Study|Subject's work scheduling problem|1|||
143375694|NCT00668863|516920493|FG000|Overall Study|Physician Decision|1|||
143375695|NCT00869323|516920496|FG000|Maintenance Therapy|concurrent illness|1|||
143375696|NCT01068743|516920499|FG000|Period 3|Adverse Event|0|||
143375697|NCT01068743|516920500|FG001|Period 3|Adverse Event|1|||
143375698|NCT01068743|516920501|FG002|Period 3|Adverse Event|0|||
143375699|NCT01068743|516920502|FG003|Period 3|Adverse Event|0|||
143375700|NCT02537522|516920505|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
143309285|NCT02896400|516683640|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
143309286|NCT02896400|516683641|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
143309287|NCT02896400|516683642|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
143309288|NCT02896400|516683643|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
143309289|NCT02896400|516683644|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
143309290|NCT02896400|516683645|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
143309291|NCT02896400|516683630|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
143309292|NCT02896400|516683631|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
143309293|NCT02896400|516683632|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
143309294|NCT02896400|516683633|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
143309295|NCT02896400|516683634|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
143309296|NCT02896400|516683635|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
143309297|NCT02896400|516683636|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
143309298|NCT02896400|516683637|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
143309299|NCT02896400|516683638|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
143309300|NCT02896400|516683639|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
143309301|NCT02896400|516683640|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
143309302|NCT02896400|516683641|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
143309303|NCT02896400|516683642|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
143309304|NCT02896400|516683643|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
143309305|NCT02896400|516683644|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
143309306|NCT02896400|516683645|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
143309307|NCT00634647|516683646|FG000|Overall Study|death on study|3|||
143309308|NCT00634647|516683646|FG000|Overall Study|refused further treatment|3|||
143309309|NCT00634647|516683646|FG000|Overall Study|declined to participate before treatment|1|||
143309310|NCT02984020|516683647|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
143309311|NCT02984020|516683647|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
143309312|NCT02984020|516683647|FG000|Overall Study|Other significant protocol violation|2|||
143309313|NCT01359592|516683648|FG000|Initial Registration|Adverse Event|1|||
143309314|NCT01359592|516683649|FG001|Initial Registration|Adverse Event|0|||
143309315|NCT01359592|516683650|FG002|Initial Registration|Adverse Event|0|||
143309316|NCT01359592|516683651|FG003|Initial Registration|Adverse Event|0|||
143309317|NCT01359592|516683648|FG000|Initial Registration|Death|1|||
143309318|NCT01359592|516683649|FG001|Initial Registration|Death|0|||
143309319|NCT01359592|516683650|FG002|Initial Registration|Death|0|||
143309320|NCT01359592|516683651|FG003|Initial Registration|Death|0|||
143309321|NCT01359592|516683648|FG000|Initial Registration|Other reason not protocol specified|1|||
143309322|NCT01359592|516683649|FG001|Initial Registration|Other reason not protocol specified|0|||
143309323|NCT01359592|516683650|FG002|Initial Registration|Other reason not protocol specified|0|||
143309324|NCT01359592|516683651|FG003|Initial Registration|Other reason not protocol specified|0|||
143309325|NCT01359592|516683648|FG000|Initial Registration|Ineligible|26|||
143309326|NCT01359592|516683649|FG001|Initial Registration|Ineligible|0|||
143309327|NCT01359592|516683650|FG002|Initial Registration|Ineligible|0|||
143309328|NCT01359592|516683651|FG003|Initial Registration|Ineligible|0|||
143309329|NCT01359592|516683648|FG000|PET-Directed Therapy|Adverse Event|0|||
143309330|NCT01359592|516683649|FG001|PET-Directed Therapy|Adverse Event|0|||
143309331|NCT01359592|516683650|FG002|PET-Directed Therapy|Adverse Event|1|||
143309332|NCT01359592|516683651|FG003|PET-Directed Therapy|Adverse Event|0|||
143309333|NCT01359592|516683648|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
143309334|NCT01359592|516683649|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
143309335|NCT01359592|516683650|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
143309336|NCT01359592|516683651|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
143309337|NCT01359592|516683648|FG000|PET-Directed Therapy|Ineligible|0|||
143309338|NCT01359592|516683649|FG001|PET-Directed Therapy|Ineligible|0|||
143309339|NCT01359592|516683650|FG002|PET-Directed Therapy|Ineligible|24|||
143375701|NCT02537522|516920506|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
143375702|NCT02537522|516920507|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
143375703|NCT02537522|516920508|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
143375704|NCT02537522|516920505|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
143375705|NCT02537522|516920506|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
143375706|NCT02537522|516920507|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
143375707|NCT02537522|516920508|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
143375708|NCT02537522|516920505|FG000|Phase I - Contralateral|incorrect randomization|0|||
143375709|NCT02537522|516920506|FG001|Phase I - Contralateral|incorrect randomization|1|||
143375710|NCT02537522|516920507|FG002|Phase I - Contralateral|incorrect randomization|0|||
143375711|NCT02537522|516920508|FG003|Phase I - Contralateral|incorrect randomization|0|||
143375712|NCT02537522|516920505|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
143375713|NCT02537522|516920506|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
143375714|NCT02537522|516920507|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
143309340|NCT01359592|516683651|FG003|PET-Directed Therapy|Ineligible|0|||
143309341|NCT00640510|516683652|FG000|Overall Study|Lack of Efficacy|0|||
143309342|NCT00640510|516683653|FG001|Overall Study|Lack of Efficacy|1|||
143375715|NCT02537522|516920508|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
143375716|NCT02537522|516920505|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
143375717|NCT02537522|516920506|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
143375718|NCT02537522|516920507|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
143375719|NCT02537522|516920508|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
143309343|NCT00640510|516683652|FG000|Overall Study|Protocol Violation|1|||
143309344|NCT00640510|516683653|FG001|Overall Study|Protocol Violation|0|||
143309345|NCT00640510|516683652|FG000|Overall Study|Physician Decision|0|||
143309346|NCT00640510|516683653|FG001|Overall Study|Physician Decision|1|||
143309347|NCT00348556|516683654|FG000|Overall Study|Adverse Event|1|||
143309348|NCT00192075|516683655|FG000|Overall Study|Disease Progression|23|||
143309349|NCT00192075|516683656|FG001|Overall Study|Disease Progression|6|||
143309350|NCT00192075|516683655|FG000|Overall Study|Adverse Event|1|||
143309351|NCT00192075|516683656|FG001|Overall Study|Adverse Event|3|||
143309352|NCT00192075|516683655|FG000|Overall Study|Death|0|||
143309353|NCT00192075|516683656|FG001|Overall Study|Death|1|||
143309354|NCT00192075|516683655|FG000|Overall Study|Lack of Efficacy|0|||
143309355|NCT00192075|516683656|FG001|Overall Study|Lack of Efficacy|0|||
143309356|NCT00192075|516683655|FG000|Overall Study|Physician Decision|3|||
143309357|NCT00192075|516683656|FG001|Overall Study|Physician Decision|0|||
143309358|NCT00192075|516683655|FG000|Overall Study|Withdrawal by Subject|5|||
143309359|NCT00192075|516683656|FG001|Overall Study|Withdrawal by Subject|5|||
143309360|NCT00192075|516683655|FG000|Overall Study|Patient Non-Compliance|0|||
143309361|NCT00192075|516683656|FG001|Overall Study|Patient Non-Compliance|1|||
143309362|NCT00192075|516683655|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
143309363|NCT00192075|516683656|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
143309364|NCT00192075|516683655|FG000|Overall Study|Other|5|||
143309365|NCT00192075|516683656|FG001|Overall Study|Other|2|||
143309366|NCT00779675|516683657|FG000|Treatment Period|Adverse Event|87|||
143309367|NCT00779675|516683657|FG000|Treatment Period|Treatment Failure|80|||
143309368|NCT00779675|516683657|FG000|Treatment Period|Transferred to Another Study|38|||
143309369|NCT00779675|516683657|FG000|Treatment Period|Lost to Follow-up|23|||
143309370|NCT00779675|516683657|FG000|Treatment Period|Withdrawal by Subject|46|||
143309371|NCT00779675|516683657|FG000|Treatment Period|Protocol Violation|54|||
143309372|NCT00779675|516683657|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
143309373|NCT00779675|516683657|FG000|Treatment Period|Administrative|3|||
143309374|NCT00779675|516683657|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
143309375|NCT00779675|516683657|FG000|Extended Treatment Period|Protocol Violation|13|||
143309376|NCT00779675|516683657|FG000|Extended Treatment Period|Adverse Event|6|||
143309377|NCT00779675|516683657|FG000|Extended Treatment Period|Treatment Failure|11|||
143309378|NCT00779675|516683657|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
143309379|NCT00779675|516683657|FG000|Extended Treatment Period|Lost to Follow-up|6|||
143309380|NCT01440322|516683658|FG000|Overall Study|Discomfort|2|||
143309381|NCT01440322|516683659|FG001|Overall Study|Discomfort|0|||
143309382|NCT01440322|516683658|FG000|Overall Study|Biomicroscopy|1|||
143309383|NCT01440322|516683659|FG001|Overall Study|Biomicroscopy|0|||
143309384|NCT01440322|516683658|FG000|Overall Study|Symptoms and Problems|1|||
143309385|NCT01440322|516683659|FG001|Overall Study|Symptoms and Problems|0|||
143309386|NCT01440322|516683658|FG000|Overall Study|Unacceptable Subjective Vision|1|||
143309387|NCT01440322|516683659|FG001|Overall Study|Unacceptable Subjective Vision|0|||
143309388|NCT01440322|516683658|FG000|Overall Study|Other Product Related|1|||
143309389|NCT01440322|516683659|FG001|Overall Study|Other Product Related|0|||
143309390|NCT01440322|516683658|FG000|Overall Study|Unrelated Medical Problem|0|||
143309391|NCT01440322|516683659|FG001|Overall Study|Unrelated Medical Problem|1|||
143309392|NCT01440322|516683658|FG000|Overall Study|Other Non-Product Related|1|||
143309393|NCT01440322|516683659|FG001|Overall Study|Other Non-Product Related|0|||
143309394|NCT01956110|516683669|FG000|Overall Study|Protocol Violation|25|||
143309395|NCT01956110|516683670|FG001|Overall Study|Protocol Violation|11|||
143309396|NCT01956110|516683669|FG000|Overall Study|Adverse Event|9|||
143309397|NCT01956110|516683670|FG001|Overall Study|Adverse Event|10|||
143309398|NCT01956110|516683669|FG000|Overall Study|Personal reasons|1|||
143309399|NCT01956110|516683670|FG001|Overall Study|Personal reasons|1|||
143309400|NCT00701129|516683674|FG000|Overall Study|Death|2|||
143309401|NCT02412631|516683675|FG000|Overall Study|Adverse Event|1|||
143309402|NCT02412631|516683676|FG001|Overall Study|Adverse Event|2|||
143309403|NCT02412631|516683675|FG000|Overall Study|Lost to Follow-up|5|||
143309404|NCT02412631|516683676|FG001|Overall Study|Lost to Follow-up|9|||
143309405|NCT02412631|516683675|FG000|Overall Study|Withdrawal by Subject|9|||
143309406|NCT02412631|516683676|FG001|Overall Study|Withdrawal by Subject|3|||
143309407|NCT02412631|516683675|FG000|Overall Study|Early stop by FDA|5|||
143309408|NCT02412631|516683676|FG001|Overall Study|Early stop by FDA|2|||
143309409|NCT02412631|516683675|FG000|Overall Study|Unspecified reason|6|||
143309410|NCT02412631|516683676|FG001|Overall Study|Unspecified reason|8|||
143309411|NCT02884089|516683684|FG000|Period 1|Dosing error|2|||
143309412|NCT02884089|516683685|FG001|Period 1|Dosing error|2|||
143309413|NCT02884089|516683686|FG002|Period 1|Dosing error|0|||
143309414|NCT02884089|516683687|FG003|Period 1|Dosing error|0|||
143309415|NCT02884089|516683684|FG000|Washout Period 1|Lost to Follow-up|0|||
143309416|NCT02884089|516683685|FG001|Washout Period 1|Lost to Follow-up|1|||
143309417|NCT02884089|516683686|FG002|Washout Period 1|Lost to Follow-up|0|||
143309418|NCT02884089|516683687|FG003|Washout Period 1|Lost to Follow-up|1|||
143309419|NCT02884089|516683684|FG000|Washout Period 1|Withdrawal by Subject|0|||
143309420|NCT02884089|516683685|FG001|Washout Period 1|Withdrawal by Subject|1|||
143375720|NCT02202499|516920509|FG000|Overall Study|Cancer diagnosis|0|||
143375721|NCT02202499|516920510|FG001|Overall Study|Cancer diagnosis|0|||
143375722|NCT02202499|516920511|FG002|Overall Study|Cancer diagnosis|1|||
143375723|NCT02202499|516920509|FG000|Overall Study|Moved from area|0|||
143375724|NCT02202499|516920510|FG001|Overall Study|Moved from area|0|||
143375725|NCT02202499|516920511|FG002|Overall Study|Moved from area|1|||
143375726|NCT02202499|516920509|FG000|Overall Study|Declined before randomization|1|||
143375727|NCT02202499|516920510|FG001|Overall Study|Declined before randomization|0|||
143375728|NCT02202499|516920511|FG002|Overall Study|Declined before randomization|0|||
143375729|NCT02202499|516920509|FG000|Overall Study|Auto accident|1|||
143375730|NCT02202499|516920510|FG001|Overall Study|Auto accident|0|||
143375731|NCT02202499|516920511|FG002|Overall Study|Auto accident|0|||
143375732|NCT03260140|516920512|FG000|Overall Study|Death|4|||
143375733|NCT03260140|516920513|FG001|Overall Study|Death|1|||
143375734|NCT03260140|516920512|FG000|Overall Study|Withdrawal by Subject|1|||
143375735|NCT03260140|516920513|FG001|Overall Study|Withdrawal by Subject|4|||
143375736|NCT00463788|516920514|FG000|Overall Study|Progressive Disease|86|||
143375737|NCT00463788|516920515|FG001|Overall Study|Progressive Disease|42|||
143375738|NCT00463788|516920514|FG000|Overall Study|Adverse Event|6|||
143375739|NCT00463788|516920515|FG001|Overall Study|Adverse Event|2|||
143375740|NCT00463788|516920514|FG000|Overall Study|Withdrawal by Subject|6|||
143375741|NCT00463788|516920515|FG001|Overall Study|Withdrawal by Subject|2|||
143375742|NCT00463788|516920514|FG000|Overall Study|Death|4|||
143309421|NCT02884089|516683686|FG002|Washout Period 1|Withdrawal by Subject|0|||
143309422|NCT02884089|516683687|FG003|Washout Period 1|Withdrawal by Subject|0|||
143309423|NCT02884089|516683684|FG000|Period 2|Adverse Event|1|||
143309424|NCT02884089|516683685|FG001|Period 2|Adverse Event|0|||
143309425|NCT02884089|516683686|FG002|Period 2|Adverse Event|0|||
143309426|NCT02884089|516683687|FG003|Period 2|Adverse Event|0|||
143309427|NCT02884089|516683684|FG000|Period 3|Withdrawal by Subject|0|||
143309428|NCT02884089|516683685|FG001|Period 3|Withdrawal by Subject|0|||
143309429|NCT02884089|516683686|FG002|Period 3|Withdrawal by Subject|1|||
143309430|NCT02884089|516683687|FG003|Period 3|Withdrawal by Subject|0|||
143309431|NCT02884089|516683684|FG000|Washout Period 3|Withdrawal by Subject|0|||
143309432|NCT02884089|516683685|FG001|Washout Period 3|Withdrawal by Subject|0|||
143309433|NCT02884089|516683686|FG002|Washout Period 3|Withdrawal by Subject|1|||
143309434|NCT02884089|516683687|FG003|Washout Period 3|Withdrawal by Subject|0|||
143309435|NCT02884089|516683684|FG000|Washout Period 3|Lost to Follow-up|0|||
143309436|NCT02884089|516683685|FG001|Washout Period 3|Lost to Follow-up|0|||
143309437|NCT02884089|516683686|FG002|Washout Period 3|Lost to Follow-up|0|||
143309438|NCT02884089|516683687|FG003|Washout Period 3|Lost to Follow-up|1|||
143309439|NCT02884089|516683684|FG000|Period 4|Withdrawal by Subject|0|||
143309440|NCT02884089|516683685|FG001|Period 4|Withdrawal by Subject|1|||
143309441|NCT02884089|516683686|FG002|Period 4|Withdrawal by Subject|0|||
143309442|NCT02884089|516683687|FG003|Period 4|Withdrawal by Subject|0|||
143309443|NCT02884089|516683684|FG000|Period 4|Lost to Follow-up|1|||
143309444|NCT02884089|516683685|FG001|Period 4|Lost to Follow-up|0|||
143309445|NCT02884089|516683686|FG002|Period 4|Lost to Follow-up|0|||
143309446|NCT02884089|516683687|FG003|Period 4|Lost to Follow-up|0|||
143309447|NCT02884089|516683684|FG000|Follow-up Visit|Withdrawal by Subject|1|||
143309448|NCT02884089|516683685|FG001|Follow-up Visit|Withdrawal by Subject|0|||
143309449|NCT02884089|516683686|FG002|Follow-up Visit|Withdrawal by Subject|0|||
143309450|NCT02884089|516683687|FG003|Follow-up Visit|Withdrawal by Subject|1|||
143309451|NCT01631474|516683688|FG000|Overall Study|Lost to Follow-up|8|||
143309452|NCT01631474|516683689|FG001|Overall Study|Lost to Follow-up|5|||
143309453|NCT01631474|516683690|FG002|Overall Study|Lost to Follow-up|7|||
143309454|NCT01631474|516683691|FG003|Overall Study|Lost to Follow-up|5|||
143309455|NCT01631474|516683692|FG004|Overall Study|Lost to Follow-up|5|||
143309456|NCT01631474|516683688|FG000|Overall Study|Withdrawal by Subject|4|||
143309457|NCT01631474|516683689|FG001|Overall Study|Withdrawal by Subject|4|||
143309458|NCT01631474|516683690|FG002|Overall Study|Withdrawal by Subject|2|||
143309459|NCT01631474|516683691|FG003|Overall Study|Withdrawal by Subject|6|||
143309460|NCT01631474|516683692|FG004|Overall Study|Withdrawal by Subject|5|||
143309461|NCT01631474|516683688|FG000|Overall Study|Lack of Efficacy|2|||
143309462|NCT01631474|516683689|FG001|Overall Study|Lack of Efficacy|2|||
143309463|NCT01631474|516683690|FG002|Overall Study|Lack of Efficacy|0|||
143309464|NCT01631474|516683691|FG003|Overall Study|Lack of Efficacy|0|||
143375743|NCT00463788|516920515|FG001|Overall Study|Death|3|||
143375744|NCT00463788|516920514|FG000|Overall Study|Symptomatic Deterioration|2|||
143375745|NCT00463788|516920515|FG001|Overall Study|Symptomatic Deterioration|3|||
143375746|NCT00463788|516920514|FG000|Overall Study|Lost to Follow-up|1|||
143375747|NCT00463788|516920515|FG001|Overall Study|Lost to Follow-up|0|||
143309465|NCT01631474|516683692|FG004|Overall Study|Lack of Efficacy|2|||
143375748|NCT00463788|516920514|FG000|Overall Study|Protocol Violation|0|||
143375749|NCT00463788|516920515|FG001|Overall Study|Protocol Violation|1|||
143375750|NCT00463788|516920514|FG000|Overall Study|Other|3|||
143375751|NCT00463788|516920515|FG001|Overall Study|Other|0|||
143309466|NCT01631474|516683688|FG000|Overall Study|Noncompliance with Study Drug|0|||
143375752|NCT00463788|516920514|FG000|Overall Study|Randomized but not treated|1|||
143375753|NCT00463788|516920515|FG001|Overall Study|Randomized but not treated|1|||
143375754|NCT01692938|516920524|FG000|Overall Study|Protocol Deviation|1|||
143375755|NCT01692938|516920525|FG001|Overall Study|Protocol Deviation|1|||
143375756|NCT01692938|516920524|FG000|Overall Study|Study completed prior to site completion|3|||
143375757|NCT01692938|516920525|FG001|Overall Study|Study completed prior to site completion|3|||
143375758|NCT05283395|516920528|FG000|Overall Study|Adverse Event|4|||
143375759|NCT05283395|516920529|FG001|Overall Study|Adverse Event|4|||
143375760|NCT05283395|516920530|FG002|Overall Study|Adverse Event|0|||
143375761|NCT05283395|516920528|FG000|Overall Study|Patient Lost to Follow-Up|0|||
143375762|NCT05283395|516920529|FG001|Overall Study|Patient Lost to Follow-Up|0|||
143375763|NCT05283395|516920530|FG002|Overall Study|Patient Lost to Follow-Up|1|||
143375764|NCT05283395|516920528|FG000|Overall Study|Patient Withdrawal|2|||
143309467|NCT01631474|516683689|FG001|Overall Study|Noncompliance with Study Drug|0|||
143309468|NCT01631474|516683690|FG002|Overall Study|Noncompliance with Study Drug|0|||
143309469|NCT01631474|516683691|FG003|Overall Study|Noncompliance with Study Drug|0|||
143309470|NCT01631474|516683692|FG004|Overall Study|Noncompliance with Study Drug|1|||
143309471|NCT01631474|516683688|FG000|Overall Study|Adverse Event|0|||
143309472|NCT01631474|516683689|FG001|Overall Study|Adverse Event|1|||
143309473|NCT01631474|516683690|FG002|Overall Study|Adverse Event|0|||
143309474|NCT01631474|516683691|FG003|Overall Study|Adverse Event|0|||
143309475|NCT01631474|516683692|FG004|Overall Study|Adverse Event|0|||
143309476|NCT01467076|516683693|FG000|Overall Study|Lost to Follow-up|1|||
143309477|NCT01467076|516683694|FG001|Overall Study|Lost to Follow-up|0|||
143309478|NCT01467076|516683695|FG002|Overall Study|Lost to Follow-up|0|||
143309479|NCT03354429|516683696|FG000|Overall Study|Withdrawal by Subject|8|||
143309480|NCT03354429|516683697|FG001|Overall Study|Withdrawal by Subject|7|||
143309481|NCT03354429|516683696|FG000|Overall Study|Lost to Follow-up|1|||
143309482|NCT03354429|516683697|FG001|Overall Study|Lost to Follow-up|0|||
143309483|NCT02624284|516683698|FG000|Overall Study|Withdrawal by Subject|3|||
143375765|NCT05283395|516920529|FG001|Overall Study|Patient Withdrawal|4|||
143375766|NCT05283395|516920530|FG002|Overall Study|Patient Withdrawal|2|||
143375767|NCT05283395|516920528|FG000|Overall Study|Investigator Decision|1|||
143375768|NCT05283395|516920529|FG001|Overall Study|Investigator Decision|0|||
143375769|NCT05283395|516920530|FG002|Overall Study|Investigator Decision|1|||
143375770|NCT05283395|516920528|FG000|Overall Study|Enrolled in error|0|||
143375771|NCT05283395|516920529|FG001|Overall Study|Enrolled in error|0|||
143375772|NCT05283395|516920530|FG002|Overall Study|Enrolled in error|1|||
143375773|NCT01063972|516920531|FG000|Overall Study|Death|12|||
143375774|NCT01063972|516920532|FG001|Overall Study|Death|11|||
143375775|NCT01063972|516920531|FG000|Overall Study|Incarcerated|2|||
143375776|NCT01063972|516920532|FG001|Overall Study|Incarcerated|1|||
143375777|NCT00712335|516920533|FG000|Overall Study|Withdrawal by Subject|0|||
143375778|NCT00712335|516920534|FG001|Overall Study|Withdrawal by Subject|7|||
143375779|NCT00712335|516920535|FG002|Overall Study|Withdrawal by Subject|2|||
143375780|NCT00712335|516920536|FG003|Overall Study|Withdrawal by Subject|3|||
143375781|NCT00712335|516920537|FG004|Overall Study|Withdrawal by Subject|0|||
143375782|NCT00712335|516920533|FG000|Overall Study|Lost to Follow-up|2|||
143375783|NCT00712335|516920534|FG001|Overall Study|Lost to Follow-up|5|||
143375784|NCT00712335|516920535|FG002|Overall Study|Lost to Follow-up|0|||
143375785|NCT00712335|516920536|FG003|Overall Study|Lost to Follow-up|1|||
143375786|NCT00712335|516920537|FG004|Overall Study|Lost to Follow-up|0|||
143375787|NCT00712335|516920533|FG000|Overall Study|Protocol Violation|1|||
143375788|NCT00712335|516920534|FG001|Overall Study|Protocol Violation|2|||
143375789|NCT00712335|516920535|FG002|Overall Study|Protocol Violation|1|||
143375790|NCT00712335|516920536|FG003|Overall Study|Protocol Violation|0|||
143375791|NCT00712335|516920537|FG004|Overall Study|Protocol Violation|0|||
143375792|NCT00712335|516920533|FG000|Overall Study|Lack of Efficacy|0|||
143375793|NCT00712335|516920534|FG001|Overall Study|Lack of Efficacy|0|||
143375794|NCT00712335|516920535|FG002|Overall Study|Lack of Efficacy|1|||
143375795|NCT00712335|516920536|FG003|Overall Study|Lack of Efficacy|1|||
143375796|NCT00712335|516920537|FG004|Overall Study|Lack of Efficacy|0|||
143375797|NCT00712335|516920533|FG000|Overall Study|Other Reason|0|||
143375798|NCT00712335|516920534|FG001|Overall Study|Other Reason|3|||
143375799|NCT00712335|516920535|FG002|Overall Study|Other Reason|1|||
143375800|NCT00712335|516920536|FG003|Overall Study|Other Reason|0|||
143375801|NCT00712335|516920537|FG004|Overall Study|Other Reason|0|||
143375802|NCT03401112|516920538|FG000|Overall Study|Adverse Event|1|||
143309484|NCT02624284|516683699|FG001|Overall Study|Withdrawal by Subject|6|||
143309485|NCT02624284|516683700|FG002|Overall Study|Withdrawal by Subject|3|||
143309486|NCT02624284|516683698|FG000|Overall Study|Protocol Violation|9|||
143375803|NCT03401112|516920539|FG001|Overall Study|Adverse Event|2|||
143375804|NCT03401112|516920540|FG002|Overall Study|Adverse Event|3|||
143375805|NCT03401112|516920541|FG003|Overall Study|Adverse Event|2|||
143375806|NCT03401112|516920542|FG004|Overall Study|Adverse Event|0|||
143375807|NCT03401112|516920538|FG000|Overall Study|Lost to Follow-up|1|||
143375808|NCT03401112|516920539|FG001|Overall Study|Lost to Follow-up|0|||
143375809|NCT03401112|516920540|FG002|Overall Study|Lost to Follow-up|0|||
143309487|NCT02624284|516683699|FG001|Overall Study|Protocol Violation|10|||
143309488|NCT02624284|516683700|FG002|Overall Study|Protocol Violation|7|||
143309489|NCT02624284|516683698|FG000|Overall Study|Revealed exclusionary condition|2|||
143309490|NCT02624284|516683699|FG001|Overall Study|Revealed exclusionary condition|2|||
143309491|NCT02624284|516683700|FG002|Overall Study|Revealed exclusionary condition|0|||
143309492|NCT02624284|516683698|FG000|Overall Study|Adverse Event|0|||
143309493|NCT02624284|516683699|FG001|Overall Study|Adverse Event|0|||
143309494|NCT02624284|516683700|FG002|Overall Study|Adverse Event|1|||
143309495|NCT00958776|516683701|FG000|Overall Study|Adverse Event|0|||
143309496|NCT00958776|516683702|FG001|Overall Study|Adverse Event|1|||
143309497|NCT00958776|516683701|FG000|Overall Study|Physician Decision|1|||
143309498|NCT00958776|516683702|FG001|Overall Study|Physician Decision|0|||
143309499|NCT00958776|516683701|FG000|Overall Study|Lost to Follow-up|2|||
143309500|NCT00958776|516683702|FG001|Overall Study|Lost to Follow-up|6|||
143309501|NCT00958776|516683701|FG000|Overall Study|Withdrawal by Subject|7|||
143309502|NCT00958776|516683702|FG001|Overall Study|Withdrawal by Subject|16|||
143309503|NCT00958776|516683701|FG000|Overall Study|Protocol Violation|1|||
143309504|NCT00958776|516683702|FG001|Overall Study|Protocol Violation|1|||
143309505|NCT00958776|516683701|FG000|Overall Study|Death|2|||
143309506|NCT00958776|516683702|FG001|Overall Study|Death|1|||
143309507|NCT00958776|516683701|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
143309508|NCT00958776|516683702|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
143309509|NCT00958776|516683701|FG000|Overall Study|Missing|1|||
143309510|NCT00958776|516683702|FG001|Overall Study|Missing|1|||
143309511|NCT00480636|516683703|FG000|Overall Study|Death|12|||
143309512|NCT00480636|516683703|FG000|Overall Study|Lost to Follow-up|4|||
143309513|NCT00480636|516683703|FG000|Overall Study|Other|2|||
143309514|NCT00480636|516683703|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
143309515|NCT02583256|516683704|FG000|Overall Study|Withdrawal by Subject|0|||
143309516|NCT02583256|516683705|FG001|Overall Study|Withdrawal by Subject|1|||
143309517|NCT02583256|516683706|FG002|Overall Study|Withdrawal by Subject|1|||
143309518|NCT02583256|516683707|FG003|Overall Study|Withdrawal by Subject|0|||
143309519|NCT02583256|516683704|FG000|Overall Study|Lost to Follow-up|1|||
143309520|NCT02583256|516683705|FG001|Overall Study|Lost to Follow-up|1|||
143309521|NCT02583256|516683706|FG002|Overall Study|Lost to Follow-up|0|||
143309522|NCT02583256|516683707|FG003|Overall Study|Lost to Follow-up|1|||
143309523|NCT02583256|516683704|FG000|Overall Study|Administrative/Other|2|||
143309524|NCT02583256|516683705|FG001|Overall Study|Administrative/Other|0|||
143309525|NCT02583256|516683706|FG002|Overall Study|Administrative/Other|1|||
143309526|NCT02583256|516683707|FG003|Overall Study|Administrative/Other|2|||
143309527|NCT02506816|516683718|FG000|Overall Study|Adverse Event|3|||
143309528|NCT02177266|516683719|FG000|Overall Study|Adverse Event|0|||
143309529|NCT02177266|516683720|FG001|Overall Study|Adverse Event|1|||
143309530|NCT02177266|516683719|FG000|Overall Study|Withdrawal by Subject|1|||
143309531|NCT02177266|516683720|FG001|Overall Study|Withdrawal by Subject|0|||
143309532|NCT03019627|516683722|FG000|Overall Study|Adverse Event|8|||
143309533|NCT03019627|516683723|FG001|Overall Study|Adverse Event|0|||
143309534|NCT03019627|516683722|FG000|Overall Study|Unrelated to adverse event|1|||
143309535|NCT03019627|516683723|FG001|Overall Study|Unrelated to adverse event|3|||
143309536|NCT03019627|516683722|FG000|Overall Study|Lost to Follow-up|2|||
143309537|NCT03019627|516683723|FG001|Overall Study|Lost to Follow-up|1|||
143309538|NCT03019627|516683722|FG000|Overall Study|not compliance|2|||
143309539|NCT03019627|516683723|FG001|Overall Study|not compliance|2|||
143309540|NCT03019627|516683722|FG000|Overall Study|Other|2|||
143309541|NCT03019627|516683723|FG001|Overall Study|Other|2|||
143309542|NCT03364049|516683724|FG000|Overall Study|Death|6|||
143309543|NCT03364049|516683725|FG001|Overall Study|Death|4|||
143309544|NCT03364049|516683726|FG002|Overall Study|Death|5|||
143309545|NCT03364049|516683727|FG003|Overall Study|Death|14|||
143309546|NCT03364049|516683724|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
143309547|NCT03364049|516683725|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
143309548|NCT03364049|516683726|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
143309549|NCT03364049|516683727|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
143309550|NCT03364049|516683724|FG000|Overall Study|Withdrawal by Subject|0|||
143309551|NCT03364049|516683725|FG001|Overall Study|Withdrawal by Subject|1|||
143309552|NCT03364049|516683726|FG002|Overall Study|Withdrawal by Subject|1|||
143309553|NCT03364049|516683727|FG003|Overall Study|Withdrawal by Subject|1|||
143309554|NCT00546715|516683728|FG000|Overall Study|Withdrawal by Subject|0|||
143309555|NCT00546715|516683729|FG001|Overall Study|Withdrawal by Subject|1|||
143309556|NCT00546715|516683730|FG002|Overall Study|Withdrawal by Subject|0|||
143309557|NCT00546715|516683731|FG003|Overall Study|Withdrawal by Subject|0|||
143309558|NCT00418691|516683732|FG000|Overall Study|Lost to Follow-up|1|||
143309559|NCT00418691|516683733|FG001|Overall Study|Lost to Follow-up|2|||
143309560|NCT00418691|516683734|FG002|Overall Study|Lost to Follow-up|3|||
143309561|NCT00418691|516683732|FG000|Overall Study|Started new medication voiding entry|0|||
143309562|NCT00418691|516683733|FG001|Overall Study|Started new medication voiding entry|0|||
143309563|NCT00418691|516683734|FG002|Overall Study|Started new medication voiding entry|1|||
143309564|NCT00418691|516683732|FG000|Overall Study|Progressive Disease|1|||
143309565|NCT00418691|516683733|FG001|Overall Study|Progressive Disease|0|||
143309566|NCT00418691|516683734|FG002|Overall Study|Progressive Disease|1|||
143309567|NCT01802775|516683737|FG000|Overall Study|Death|0|||
143309568|NCT01802775|516683738|FG001|Overall Study|Death|3|||
143309569|NCT01802775|516683737|FG000|Overall Study|Reason not provided|0|||
143309570|NCT01802775|516683738|FG001|Overall Study|Reason not provided|1|||
143309571|NCT01802775|516683737|FG000|Overall Study|Physician Decision|1|||
143309572|NCT01802775|516683738|FG001|Overall Study|Physician Decision|0|||
143309573|NCT01802775|516683737|FG000|Overall Study|Adverse Event|1|||
143309574|NCT01802775|516683738|FG001|Overall Study|Adverse Event|1|||
143309575|NCT01802775|516683737|FG000|Overall Study|Withdrawal by Subject|3|||
143309576|NCT01802775|516683738|FG001|Overall Study|Withdrawal by Subject|5|||
143309577|NCT01802775|516683737|FG000|Overall Study|Lost to Follow-up|1|||
143309578|NCT01802775|516683738|FG001|Overall Study|Lost to Follow-up|2|||
143309579|NCT01067352|516683741|FG000|Overall Study|Withdrawal by Subject|1|||
143309580|NCT01067352|516683742|FG001|Overall Study|Withdrawal by Subject|2|||
143309581|NCT01067352|516683743|FG002|Overall Study|Withdrawal by Subject|1|||
143309582|NCT01067352|516683741|FG000|Overall Study|Physician Decision|0|||
143309583|NCT01067352|516683742|FG001|Overall Study|Physician Decision|1|||
143309584|NCT01067352|516683743|FG002|Overall Study|Physician Decision|0|||
143309585|NCT01096784|516683744|FG000|Overall Study|Withdrawal by Subject|2|||
143309586|NCT01096784|516683745|FG001|Overall Study|Withdrawal by Subject|1|||
143309587|NCT01096784|516683744|FG000|Overall Study|Adverse Event|11|||
143309588|NCT01096784|516683745|FG001|Overall Study|Adverse Event|9|||
143309589|NCT01096784|516683744|FG000|Overall Study|Protocol Deviation|2|||
143309590|NCT01096784|516683745|FG001|Overall Study|Protocol Deviation|2|||
143309591|NCT01096784|516683744|FG000|Overall Study|Administrative Decision|0|||
143309592|NCT01096784|516683745|FG001|Overall Study|Administrative Decision|1|||
143309593|NCT01096784|516683744|FG000|Overall Study|Other Unspecified|0|||
143309594|NCT01096784|516683745|FG001|Overall Study|Other Unspecified|1|||
143309595|NCT03761628|516683746|FG000|Overall Study|Withdrawal by Subject|3|||
143309596|NCT03761628|516683746|FG000|Overall Study|Physician Decision|1|||
143309597|NCT03761628|516683746|FG000|Overall Study|Pregnancy|1|||
143309598|NCT03761628|516683746|FG000|Overall Study|Lost to Follow-up|1|||
143309599|NCT03362502|516683748|FG000|Overall Study|Death|0|||
143309600|NCT03362502|516683749|FG001|Overall Study|Death|0|||
143309601|NCT03362502|516683750|FG002|Overall Study|Death|1|||
143309602|NCT01526889|516683753|FG000|Treatment Period|Adverse Event|2|||
143309603|NCT01526889|516683754|FG001|Treatment Period|Adverse Event|0|||
143309604|NCT01526889|516683753|FG000|Treatment Extension Period|Administrative problems|1|||
143309605|NCT01526889|516683754|FG001|Treatment Extension Period|Administrative problems|0|||
143309606|NCT01110915|516683755|FG000|Overall Study|Death|2|||
143309607|NCT01110915|516683756|FG001|Overall Study|Death|1|||
143309608|NCT01110915|516683755|FG000|Overall Study|Lost to Follow-up|1|||
143309609|NCT01110915|516683756|FG001|Overall Study|Lost to Follow-up|0|||
143309610|NCT01110915|516683755|FG000|Overall Study|Withdrawal by Subject|7|||
143309611|NCT01110915|516683756|FG001|Overall Study|Withdrawal by Subject|1|||
143309612|NCT02350309|516683757|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
143309613|NCT02350309|516683758|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
143375810|NCT03401112|516920541|FG003|Overall Study|Lost to Follow-up|0|||
143309614|NCT02350309|516683759|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
143309615|NCT02350309|516683760|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
143309616|NCT02350309|516683761|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
143309617|NCT02350309|516683762|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
143309618|NCT02350309|516683757|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
143309619|NCT02350309|516683758|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
143309620|NCT02350309|516683759|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
143309621|NCT02350309|516683760|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
143309622|NCT02350309|516683761|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
143309623|NCT02350309|516683762|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
143309624|NCT02253810|516683763|FG000|Overall Study|Withdrawal by Subject|2|||
143309625|NCT02253810|516683764|FG001|Overall Study|Withdrawal by Subject|1|||
143309626|NCT02253810|516683763|FG000|Overall Study|Unknown concomitant procedure|3|||
143309627|NCT02253810|516683764|FG001|Overall Study|Unknown concomitant procedure|2|||
143309628|NCT01806896|516683766|FG000|Overall Study|Adverse Event|2|||
143309629|NCT01806896|516683767|FG001|Overall Study|Adverse Event|0|||
143309630|NCT01806896|516683766|FG000|Overall Study|Other|1|||
143309631|NCT01806896|516683767|FG001|Overall Study|Other|0|||
143309632|NCT02434770|516683768|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
143309633|NCT02434770|516683769|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
143309634|NCT02434770|516683770|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
143309635|NCT02434770|516683768|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
143309636|NCT02434770|516683769|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
143309637|NCT02434770|516683770|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
143309638|NCT02434770|516683768|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
143309639|NCT02434770|516683769|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
143309640|NCT02434770|516683770|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
143309641|NCT02434770|516683768|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
143309642|NCT02434770|516683769|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
143309643|NCT02434770|516683770|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
143309644|NCT02434770|516683768|FG000|Week 1 to Week 18|Death|1|||
143309645|NCT02434770|516683769|FG001|Week 1 to Week 18|Death|0|||
143309646|NCT02434770|516683770|FG002|Week 1 to Week 18|Death|0|||
143309647|NCT02434770|516683768|FG000|Week 18 to Week|Lost to Follow-up|2|||
143309648|NCT02434770|516683769|FG001|Week 18 to Week|Lost to Follow-up|2|||
143309649|NCT02434770|516683770|FG002|Week 18 to Week|Lost to Follow-up|1|||
143309650|NCT02434770|516683768|FG000|Week 18 to Week|Withdrawal by Subject|0|||
143309651|NCT02434770|516683769|FG001|Week 18 to Week|Withdrawal by Subject|0|||
143309652|NCT02434770|516683770|FG002|Week 18 to Week|Withdrawal by Subject|2|||
143309653|NCT02434770|516683768|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
143309654|NCT02434770|516683769|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
143309655|NCT02434770|516683770|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
143309656|NCT00245765|516683771|FG000|Overall Study|Adverse Event|1|||
143309657|NCT00245765|516683772|FG001|Overall Study|Adverse Event|1|||
143309658|NCT00245765|516683773|FG002|Overall Study|Adverse Event|0|||
143309659|NCT00245765|516683771|FG000|Overall Study|Lack of Efficacy|14|||
143309660|NCT00245765|516683772|FG001|Overall Study|Lack of Efficacy|7|||
143309661|NCT00245765|516683773|FG002|Overall Study|Lack of Efficacy|0|||
143309662|NCT00245765|516683771|FG000|Overall Study|Lost to Follow-up|1|||
143309663|NCT00245765|516683772|FG001|Overall Study|Lost to Follow-up|2|||
143309664|NCT00245765|516683773|FG002|Overall Study|Lost to Follow-up|0|||
143309665|NCT00245765|516683771|FG000|Overall Study|Withdrawal by Subject|1|||
143309666|NCT00245765|516683772|FG001|Overall Study|Withdrawal by Subject|0|||
143309667|NCT00245765|516683773|FG002|Overall Study|Withdrawal by Subject|3|||
143309668|NCT00245765|516683771|FG000|Overall Study|Other reason|2|||
143309669|NCT00245765|516683772|FG001|Overall Study|Other reason|0|||
143309670|NCT00245765|516683773|FG002|Overall Study|Other reason|1|||
143309671|NCT00245765|516683771|FG000|Overall Study|Other|13|||
143309672|NCT00245765|516683772|FG001|Overall Study|Other|4|||
143309673|NCT00245765|516683773|FG002|Overall Study|Other|4|||
143309674|NCT03080961|516683774|FG000|Overall Study|Withdrawal by Subject|3|||
143309675|NCT00528528|516683777|FG000|Overall Study|Lost to Follow-up|0|||
143309676|NCT00528528|516683778|FG001|Overall Study|Lost to Follow-up|0|||
143309677|NCT00528528|516683779|FG002|Overall Study|Lost to Follow-up|1|||
143309678|NCT00528528|516683780|FG003|Overall Study|Lost to Follow-up|1|||
143309679|NCT00528528|516683777|FG000|Overall Study|Ineligible to continue the trial|0|||
143309680|NCT00528528|516683778|FG001|Overall Study|Ineligible to continue the trial|0|||
143309681|NCT00528528|516683779|FG002|Overall Study|Ineligible to continue the trial|0|||
143309682|NCT00528528|516683780|FG003|Overall Study|Ineligible to continue the trial|1|||
143309683|NCT00528528|516683777|FG000|Overall Study|Other|0|||
143309684|NCT00528528|516683778|FG001|Overall Study|Other|1|||
143309685|NCT00528528|516683779|FG002|Overall Study|Other|0|||
143309686|NCT00528528|516683780|FG003|Overall Study|Other|0|||
143309687|NCT00528528|516683777|FG000|Overall Study|Withdrawal by Subject|3|||
143309688|NCT00528528|516683778|FG001|Overall Study|Withdrawal by Subject|2|||
143309689|NCT00528528|516683779|FG002|Overall Study|Withdrawal by Subject|1|||
143309690|NCT00528528|516683780|FG003|Overall Study|Withdrawal by Subject|1|||
143309691|NCT00528528|516683777|FG000|Overall Study|Ongoing participant|0|||
143309692|NCT00528528|516683778|FG001|Overall Study|Ongoing participant|0|||
143309693|NCT00528528|516683779|FG002|Overall Study|Ongoing participant|1|||
143309694|NCT00528528|516683780|FG003|Overall Study|Ongoing participant|0|||
143309695|NCT04602624|516683781|FG000|Overall Study|Protocol Deviation|1|||
143309696|NCT04602624|516683781|FG000|Overall Study|Withdrawal by Participant|1|||
143309697|NCT04466891|516683784|FG000|Overall Study|Death|60|||
143309698|NCT04466891|516683785|FG001|Overall Study|Death|6|||
143309699|NCT04466891|516683784|FG000|Overall Study|Withdrawal by Subject|8|||
143309700|NCT04466891|516683785|FG001|Overall Study|Withdrawal by Subject|1|||
143309701|NCT04466891|516683784|FG000|Overall Study|Study terminated by sponsor|5|||
143309702|NCT04466891|516683785|FG001|Overall Study|Study terminated by sponsor|0|||
143309703|NCT04466891|516683784|FG000|Overall Study|Lost to Follow-up|2|||
143309704|NCT04466891|516683785|FG001|Overall Study|Lost to Follow-up|0|||
143309705|NCT04466891|516683784|FG000|Overall Study|Transitioned to Named Patient Supply (NPS) program|5|||
143309706|NCT04466891|516683785|FG001|Overall Study|Transitioned to Named Patient Supply (NPS) program|0|||
143309707|NCT00590954|516683786|FG000|Overall Study|Inevaluable|2|||
143309708|NCT02782949|516683787|FG000|Overall Study|Protocol Violation|1|||
143309709|NCT02782949|516683788|FG001|Overall Study|Protocol Violation|0|||
143309710|NCT02782949|516683787|FG000|Overall Study|Withdrawal by Subject|0|||
143309711|NCT02782949|516683788|FG001|Overall Study|Withdrawal by Subject|1|||
143309712|NCT00667342|516685118|FG000|Overall Study|Protocol Violation|1|||
143309713|NCT00667342|516685119|FG001|Overall Study|Protocol Violation|0|||
143309714|NCT00667342|516685120|FG002|Overall Study|Protocol Violation|0|||
143309715|NCT00667342|516685118|FG000|Overall Study|Withdrawal by Subject|1|||
143309716|NCT00667342|516685119|FG001|Overall Study|Withdrawal by Subject|0|||
143309717|NCT00667342|516685120|FG002|Overall Study|Withdrawal by Subject|0|||
143309718|NCT00667342|516685118|FG000|Overall Study|Physician Decision|3|||
143309719|NCT00667342|516685119|FG001|Overall Study|Physician Decision|0|||
143309720|NCT00667342|516685120|FG002|Overall Study|Physician Decision|0|||
143309721|NCT00667342|516685118|FG000|Overall Study|Relapse or tumor progression|9|||
143309722|NCT00667342|516685119|FG001|Overall Study|Relapse or tumor progression|0|||
143309723|NCT00667342|516685120|FG002|Overall Study|Relapse or tumor progression|7|||
143309724|NCT00667342|516685118|FG000|Overall Study|Adverse Event|0|||
143309725|NCT00667342|516685119|FG001|Overall Study|Adverse Event|0|||
143309726|NCT00667342|516685120|FG002|Overall Study|Adverse Event|1|||
143309727|NCT00667342|516685118|FG000|Overall Study|Ineligible|0|||
143309728|NCT00667342|516685119|FG001|Overall Study|Ineligible|0|||
143309729|NCT00667342|516685120|FG002|Overall Study|Ineligible|1|||
143309730|NCT01896895|516685121|FG000|Double-blind MP|Physician Decision|0|||
143309731|NCT01896895|516685122|FG001|Double-blind MP|Physician Decision|0|||
143309732|NCT01896895|516685123|FG002|Double-blind MP|Physician Decision|1|||
143309733|NCT01896895|516685124|FG003|Double-blind MP|Physician Decision|0|||
143309734|NCT01896895|516685121|FG000|Double-blind MP|Withdrawal by Subject|0|||
143309735|NCT01896895|516685122|FG001|Double-blind MP|Withdrawal by Subject|2|||
143309736|NCT01896895|516685123|FG002|Double-blind MP|Withdrawal by Subject|1|||
143309737|NCT01896895|516685124|FG003|Double-blind MP|Withdrawal by Subject|0|||
143309738|NCT01896895|516685121|FG000|Double-blind MP|Lost to Follow-up|1|||
143309739|NCT01896895|516685122|FG001|Double-blind MP|Lost to Follow-up|0|||
143309740|NCT01896895|516685123|FG002|Double-blind MP|Lost to Follow-up|1|||
143309741|NCT01896895|516685124|FG003|Double-blind MP|Lost to Follow-up|0|||
143309742|NCT01207778|516685125|FG000|Overall Study|Lost to Follow-up|0|||
143309743|NCT01207778|516685126|FG001|Overall Study|Lost to Follow-up|3|||
143309744|NCT01207778|516685127|FG002|Overall Study|Lost to Follow-up|3|||
143309745|NCT01433263|516685130|FG000|Overall Study|Adverse Event|3|||
143309746|NCT01433263|516685131|FG001|Overall Study|Adverse Event|1|||
143309747|NCT01433263|516685130|FG000|Overall Study|Death|5|||
143309748|NCT01433263|516685131|FG001|Overall Study|Death|3|||
143309749|NCT01433263|516685130|FG000|Overall Study|Lost to Follow-up|0|||
143309750|NCT01433263|516685131|FG001|Overall Study|Lost to Follow-up|1|||
143309751|NCT01433263|516685130|FG000|Overall Study|Protocol Deviation|1|||
143309752|NCT01433263|516685131|FG001|Overall Study|Protocol Deviation|0|||
143309753|NCT01433263|516685130|FG000|Overall Study|Withdrawal by Subject|10|||
143309754|NCT01433263|516685131|FG001|Overall Study|Withdrawal by Subject|7|||
143309755|NCT00293384|516685134|FG000|Overall Study|Non-compliance|2|||
143309756|NCT00293384|516685134|FG000|Overall Study|Missed dosage/study drug|1|||
143309757|NCT00293384|516685134|FG000|Overall Study|Ineligible|2|||
143309758|NCT03107988|516685135|FG000|Overall Study|Adverse Event|0|||
143309759|NCT03107988|516685136|FG001|Overall Study|Adverse Event|0|||
143309760|NCT03107988|516685137|FG002|Overall Study|Adverse Event|0|||
143309761|NCT03107988|516685138|FG003|Overall Study|Adverse Event|1|||
143309762|NCT03107988|516685139|FG004|Overall Study|Adverse Event|0|||
143309763|NCT03107988|516685140|FG005|Overall Study|Adverse Event|1|||
143309764|NCT03107988|516685141|FG006|Overall Study|Adverse Event|0|||
143309765|NCT03107988|516685142|FG007|Overall Study|Adverse Event|1|||
143309766|NCT03107988|516685143|FG008|Overall Study|Adverse Event|0|||
143309767|NCT03107988|516685144|FG009|Overall Study|Adverse Event|0|||
143309768|NCT03107988|516685145|FG010|Overall Study|Adverse Event|0|||
143309769|NCT03107988|516685146|FG011|Overall Study|Adverse Event|0|||
143309770|NCT03107988|516685147|FG012|Overall Study|Adverse Event|0|||
143309771|NCT03107988|516685135|FG000|Overall Study|Disease Progression or Relapse|1|||
143309772|NCT03107988|516685136|FG001|Overall Study|Disease Progression or Relapse|2|||
143309773|NCT03107988|516685137|FG002|Overall Study|Disease Progression or Relapse|2|||
143309774|NCT03107988|516685138|FG003|Overall Study|Disease Progression or Relapse|5|||
143309775|NCT03107988|516685139|FG004|Overall Study|Disease Progression or Relapse|1|||
143309776|NCT03107988|516685140|FG005|Overall Study|Disease Progression or Relapse|1|||
143309777|NCT03107988|516685141|FG006|Overall Study|Disease Progression or Relapse|0|||
143309778|NCT03107988|516685142|FG007|Overall Study|Disease Progression or Relapse|0|||
143309779|NCT03107988|516685143|FG008|Overall Study|Disease Progression or Relapse|0|||
143309780|NCT03107988|516685144|FG009|Overall Study|Disease Progression or Relapse|1|||
143309781|NCT03107988|516685145|FG010|Overall Study|Disease Progression or Relapse|4|||
143309782|NCT03107988|516685146|FG011|Overall Study|Disease Progression or Relapse|0|||
143309783|NCT03107988|516685147|FG012|Overall Study|Disease Progression or Relapse|0|||
143309784|NCT03107988|516685135|FG000|Overall Study|Ineligible|0|||
143309785|NCT03107988|516685136|FG001|Overall Study|Ineligible|0|||
143309786|NCT03107988|516685137|FG002|Overall Study|Ineligible|0|||
143309787|NCT03107988|516685138|FG003|Overall Study|Ineligible|0|||
143309788|NCT03107988|516685139|FG004|Overall Study|Ineligible|0|||
143309789|NCT03107988|516685140|FG005|Overall Study|Ineligible|0|||
143309790|NCT03107988|516685141|FG006|Overall Study|Ineligible|0|||
143309791|NCT03107988|516685142|FG007|Overall Study|Ineligible|0|||
143309792|NCT03107988|516685143|FG008|Overall Study|Ineligible|1|||
143309793|NCT03107988|516685144|FG009|Overall Study|Ineligible|0|||
143309794|NCT03107988|516685145|FG010|Overall Study|Ineligible|0|||
143309795|NCT03107988|516685146|FG011|Overall Study|Ineligible|0|||
143309796|NCT03107988|516685147|FG012|Overall Study|Ineligible|0|||
143309797|NCT04709237|516685149|FG000|Overall Study|Lost to Follow-up|1|||
143309798|NCT04709237|516685150|FG001|Overall Study|Lost to Follow-up|0|||
143309799|NCT04709237|516685151|FG002|Overall Study|Lost to Follow-up|0|||
143309800|NCT02610192|516685152|FG000|Overall Study|Received other treatment|8|||
143309801|NCT02610192|516685152|FG000|Overall Study|Physician Decision|1|||
143309802|NCT00145509|516685157|FG000|Overall Study|Adverse Event|10|||
143309803|NCT00145509|516685158|FG001|Overall Study|Adverse Event|3|||
143309804|NCT00145509|516685157|FG000|Overall Study|Lack of Efficacy|3|||
143309805|NCT00145509|516685158|FG001|Overall Study|Lack of Efficacy|1|||
143309806|NCT00145509|516685157|FG000|Overall Study|Lost to Follow-up|5|||
143309807|NCT00145509|516685158|FG001|Overall Study|Lost to Follow-up|9|||
143309808|NCT00145509|516685157|FG000|Overall Study|Withdrew Consent|2|||
143309809|NCT00145509|516685158|FG001|Overall Study|Withdrew Consent|7|||
143309810|NCT00145509|516685157|FG000|Overall Study|Reason not provided|2|||
143309811|NCT00145509|516685158|FG001|Overall Study|Reason not provided|1|||
143309812|NCT00419562|516685161|FG000|Overall Study|Lost to Follow-up|12|||
143309813|NCT00419562|516685162|FG001|Overall Study|Lost to Follow-up|13|||
143309814|NCT00419562|516685161|FG000|Overall Study|Withdrawal by Subject|20|||
143309815|NCT00419562|516685162|FG001|Overall Study|Withdrawal by Subject|18|||
143309816|NCT00419562|516685161|FG000|Overall Study|Participant Institutionalized|1|||
143309817|NCT00419562|516685162|FG001|Overall Study|Participant Institutionalized|0|||
143309818|NCT00749775|516685167|FG000|Overall Study|Protocol Violation|24|||
143309819|NCT00749775|516685167|FG000|Overall Study|Lost to Follow-up|36|||
143309820|NCT00749775|516685167|FG000|Overall Study|No visit after first day of treatment|44|||
143309821|NCT00749775|516685167|FG000|Overall Study|No drug administration|3|||
143309822|NCT04300296|516685168|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
143309823|NCT04300296|516685169|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
143309824|NCT04300296|516685170|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
143309825|NCT04300296|516685171|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
143309826|NCT04300296|516685172|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
143309827|NCT04300296|516685173|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
143309828|NCT04300296|516685168|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
143309829|NCT04300296|516685169|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
143309830|NCT04300296|516685170|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
143309831|NCT04300296|516685171|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
143309832|NCT04300296|516685172|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
143309833|NCT04300296|516685173|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
143309834|NCT04300296|516685168|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
143309835|NCT04300296|516685169|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
143309836|NCT04300296|516685170|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
143375811|NCT03401112|516920542|FG004|Overall Study|Lost to Follow-up|0|||
143309837|NCT04300296|516685171|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
143309838|NCT04300296|516685172|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
143309839|NCT04300296|516685173|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
143309840|NCT04300296|516685168|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
143309841|NCT04300296|516685169|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
143309842|NCT04300296|516685170|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
143309843|NCT04300296|516685171|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
143309844|NCT04300296|516685172|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
143309845|NCT04300296|516685173|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
143309846|NCT04300296|516685168|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
143309847|NCT04300296|516685169|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
143309848|NCT04300296|516685170|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
143309849|NCT04300296|516685171|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
143309850|NCT04300296|516685172|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
143309851|NCT04300296|516685173|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
143309852|NCT04300296|516685168|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
143309853|NCT04300296|516685169|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
143309854|NCT04300296|516685170|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
143309855|NCT04300296|516685171|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
143309856|NCT04300296|516685172|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
143309857|NCT04300296|516685173|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
143309858|NCT04300296|516685168|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
143309859|NCT04300296|516685169|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
143309860|NCT04300296|516685170|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
143309861|NCT04300296|516685171|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
143309862|NCT04300296|516685172|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
143309863|NCT04300296|516685173|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
143309864|NCT06034496|516685176|FG000|Overall Study|Did not meet minimum stimulation threshold|2|||
143309865|NCT06034496|516685177|FG001|Overall Study|Did not meet minimum stimulation threshold|1|||
143309866|NCT06034496|516685176|FG000|Overall Study|Withdrawal by Subject|5|||
143309867|NCT06034496|516685177|FG001|Overall Study|Withdrawal by Subject|4|||
143309868|NCT04033159|516685201|FG000|Washout Period|Physician Decision|0|||
143309869|NCT04033159|516685202|FG001|Washout Period|Physician Decision|1|||
143309870|NCT04033159|516685203|FG002|Washout Period|Physician Decision|0|||
143309871|NCT04033159|516685201|FG000|Washout Period|Study terminated by Sponsor|0|||
143309872|NCT04033159|516685202|FG001|Washout Period|Study terminated by Sponsor|7|||
143309873|NCT04033159|516685203|FG002|Washout Period|Study terminated by Sponsor|0|||
143309874|NCT04033159|516685201|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
143309875|NCT04033159|516685202|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
143309876|NCT04033159|516685203|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
143309877|NCT03277261|516685210|FG000|Overall Study|Adverse Event|17|||
143309878|NCT03277261|516685211|FG001|Overall Study|Adverse Event|1|||
143309879|NCT03277261|516685210|FG000|Overall Study|Participant Withdrawal of Consent|6|||
143309880|NCT03277261|516685211|FG001|Overall Study|Participant Withdrawal of Consent|15|||
143309881|NCT03277261|516685210|FG000|Overall Study|Investigator / Sponsor Decision|4|||
143309882|NCT03277261|516685211|FG001|Overall Study|Investigator / Sponsor Decision|2|||
143309883|NCT03277261|516685210|FG000|Overall Study|Pregnancy|2|||
143309884|NCT03277261|516685211|FG001|Overall Study|Pregnancy|0|||
143309885|NCT03277261|516685210|FG000|Overall Study|Lost to Follow-up|2|||
143309886|NCT03277261|516685211|FG001|Overall Study|Lost to Follow-up|2|||
143309887|NCT03277261|516685210|FG000|Overall Study|Lack of Efficacy|2|||
143309888|NCT03277261|516685211|FG001|Overall Study|Lack of Efficacy|2|||
143309889|NCT03277261|516685210|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
143309890|NCT03277261|516685211|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
143309891|NCT00499603|516685212|FG000|Overall Study|Adverse Event|0|||
143309892|NCT00499603|516685213|FG001|Overall Study|Adverse Event|1|||
143309893|NCT03323099|516685214|FG000|Overall Study|Withdrawal by Subject|6|||
143309894|NCT03323099|516685215|FG001|Overall Study|Withdrawal by Subject|12|||
143309895|NCT03323099|516685214|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
143309896|NCT03323099|516685215|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
143309897|NCT05220397|516685216|FG000|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
143375812|NCT03401112|516920538|FG000|Overall Study|Noncompliance|1|||
143309898|NCT05220397|516685217|FG001|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
143309899|NCT05220397|516685218|FG002|Second Janssen Vaccine Administration|Withdrawal by Subject|8|||
143309900|NCT05220397|516685219|FG003|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
143309901|NCT05220397|516685220|FG004|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
143309902|NCT01502644|516685221|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
143309903|NCT01502644|516685222|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
143309904|NCT01502644|516685223|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
143309905|NCT01502644|516685224|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
143309906|NCT01502644|516685221|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
143309907|NCT01502644|516685222|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
143309908|NCT01502644|516685223|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
143309909|NCT01502644|516685224|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
143309910|NCT01502644|516685221|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
143309911|NCT01502644|516685222|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
143309912|NCT01502644|516685223|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
143309913|NCT01502644|516685224|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
143309914|NCT01502644|516685221|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
143309915|NCT01502644|516685222|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
143309916|NCT01502644|516685223|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
143309917|NCT01502644|516685224|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
143309918|NCT01502644|516685221|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
143309919|NCT01502644|516685222|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
143309920|NCT01502644|516685223|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
143309921|NCT01502644|516685224|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
143309922|NCT00006184|516685227|FG000|Overall Study|Death|1|||
143309923|NCT00006184|516685228|FG001|Overall Study|Death|0|||
143309924|NCT00207142|516685236|FG000|Induction Phase|Adverse Event|9|||
143309925|NCT00207142|516685237|FG001|Induction Phase|Adverse Event|0|||
143309926|NCT00207142|516685238|FG002|Induction Phase|Adverse Event|0|||
143309927|NCT00207142|516685239|FG003|Induction Phase|Adverse Event|0|||
143309928|NCT00207142|516685236|FG000|Induction Phase|Death|1|||
143309929|NCT00207142|516685237|FG001|Induction Phase|Death|0|||
143309930|NCT00207142|516685238|FG002|Induction Phase|Death|0|||
143309931|NCT00207142|516685239|FG003|Induction Phase|Death|0|||
143309932|NCT00207142|516685236|FG000|Induction Phase|Lack of Efficacy|1|||
143309933|NCT00207142|516685237|FG001|Induction Phase|Lack of Efficacy|0|||
143309934|NCT00207142|516685238|FG002|Induction Phase|Lack of Efficacy|0|||
143309935|NCT00207142|516685239|FG003|Induction Phase|Lack of Efficacy|0|||
143309936|NCT00207142|516685236|FG000|Induction Phase|Lost to Follow-up|5|||
143309937|NCT00207142|516685237|FG001|Induction Phase|Lost to Follow-up|0|||
143309938|NCT00207142|516685238|FG002|Induction Phase|Lost to Follow-up|0|||
143309939|NCT00207142|516685239|FG003|Induction Phase|Lost to Follow-up|0|||
143309940|NCT00207142|516685236|FG000|Induction Phase|Physician Decision|2|||
143309941|NCT00207142|516685237|FG001|Induction Phase|Physician Decision|0|||
143309942|NCT00207142|516685238|FG002|Induction Phase|Physician Decision|0|||
143309943|NCT00207142|516685239|FG003|Induction Phase|Physician Decision|0|||
143309944|NCT00207142|516685236|FG000|Induction Phase|Poor/noncompliance|2|||
143309945|NCT00207142|516685237|FG001|Induction Phase|Poor/noncompliance|0|||
143309946|NCT00207142|516685238|FG002|Induction Phase|Poor/noncompliance|0|||
143309947|NCT00207142|516685239|FG003|Induction Phase|Poor/noncompliance|0|||
143309948|NCT00207142|516685236|FG000|Induction Phase|Pregnancy|1|||
143309949|NCT00207142|516685237|FG001|Induction Phase|Pregnancy|0|||
143309950|NCT00207142|516685238|FG002|Induction Phase|Pregnancy|0|||
143309951|NCT00207142|516685239|FG003|Induction Phase|Pregnancy|0|||
143309952|NCT00207142|516685236|FG000|Induction Phase|Subject no longer meets study criteria|3|||
143309953|NCT00207142|516685237|FG001|Induction Phase|Subject no longer meets study criteria|0|||
143309954|NCT00207142|516685238|FG002|Induction Phase|Subject no longer meets study criteria|0|||
143309955|NCT00207142|516685239|FG003|Induction Phase|Subject no longer meets study criteria|0|||
143309956|NCT00207142|516685236|FG000|Induction Phase|Withdrawal by Subject|4|||
143309957|NCT00207142|516685237|FG001|Induction Phase|Withdrawal by Subject|0|||
143309958|NCT00207142|516685238|FG002|Induction Phase|Withdrawal by Subject|0|||
143309959|NCT00207142|516685239|FG003|Induction Phase|Withdrawal by Subject|0|||
143309960|NCT00207142|516685236|FG000|Induction Phase|Incarceration|1|||
143309961|NCT00207142|516685237|FG001|Induction Phase|Incarceration|0|||
143309962|NCT00207142|516685238|FG002|Induction Phase|Incarceration|0|||
143309963|NCT00207142|516685239|FG003|Induction Phase|Incarceration|0|||
143309964|NCT00207142|516685236|FG000|Induction Phase|Missing lab data|1|||
143309965|NCT00207142|516685237|FG001|Induction Phase|Missing lab data|0|||
143309966|NCT00207142|516685238|FG002|Induction Phase|Missing lab data|0|||
143309967|NCT00207142|516685239|FG003|Induction Phase|Missing lab data|0|||
143309968|NCT00207142|516685236|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
143309969|NCT00207142|516685237|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
143309970|NCT00207142|516685238|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
143309971|NCT00207142|516685239|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
143309972|NCT00207142|516685236|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
143309973|NCT00207142|516685237|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
143309974|NCT00207142|516685238|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
143309975|NCT00207142|516685239|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
143309976|NCT00207142|516685236|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
143309977|NCT00207142|516685237|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
143309978|NCT00207142|516685238|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
143309979|NCT00207142|516685239|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
143309980|NCT00207142|516685236|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
143309981|NCT00207142|516685237|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
143309982|NCT00207142|516685238|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
143309983|NCT00207142|516685239|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
143309984|NCT00207142|516685236|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
143309985|NCT00207142|516685237|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
143309986|NCT00207142|516685238|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
143309987|NCT00207142|516685239|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
143309988|NCT00207142|516685236|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
143309989|NCT00207142|516685237|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
143309990|NCT00207142|516685238|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
143309991|NCT00207142|516685239|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
143309992|NCT00207142|516685236|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
143309993|NCT00207142|516685237|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
143309994|NCT00207142|516685238|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
143309995|NCT00207142|516685239|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
143309996|NCT00207142|516685236|FG000|Maintenance Phase/Rescue Phase|Death|0|||
143309997|NCT00207142|516685237|FG001|Maintenance Phase/Rescue Phase|Death|0|||
143309998|NCT00207142|516685238|FG002|Maintenance Phase/Rescue Phase|Death|0|||
143309999|NCT00207142|516685239|FG003|Maintenance Phase/Rescue Phase|Death|1|||
143310000|NCT00207142|516685236|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
143310001|NCT00207142|516685237|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
143310002|NCT00207142|516685238|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
143310003|NCT00207142|516685239|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
143310004|NCT01857063|516685240|FG000|Period 1 (7 Days)|Adverse Event|0|||
143310005|NCT01857063|516685241|FG001|Period 1 (7 Days)|Adverse Event|1|||
143310006|NCT01857063|516685240|FG000|Period 1 (7 Days)|Physician Decision|1|||
143310007|NCT01857063|516685241|FG001|Period 1 (7 Days)|Physician Decision|0|||
143310008|NCT01857063|516685240|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
143310009|NCT01857063|516685241|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
143310010|NCT01857063|516685240|FG000|Period 2 (7 Days)|Adverse Event|2|||
143375813|NCT03401112|516920539|FG001|Overall Study|Noncompliance|2|||
143310011|NCT01857063|516685241|FG001|Period 2 (7 Days)|Adverse Event|1|||
143310012|NCT01857063|516685240|FG000|Period 2 (7 Days)|Physician Decision|1|||
143310013|NCT01857063|516685241|FG001|Period 2 (7 Days)|Physician Decision|1|||
143310014|NCT01857063|516685240|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
143310015|NCT01857063|516685241|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
143310016|NCT00058825|516685244|FG000|Overall Study|Relapse|9|||
143310017|NCT00058825|516685244|FG000|Overall Study|Progressive Disease|5|||
143310018|NCT00058825|516685244|FG000|Overall Study|Graft Failure|5|||
143310019|NCT00058825|516685244|FG000|Overall Study|Death|3|||
143310020|NCT05059600|516685245|FG000|Overall Study|Enrolled but not Treated|10|||
143310021|NCT01455012|516685250|FG000|Overall Study|Adverse Event|0|||
143310022|NCT01455012|516685251|FG001|Overall Study|Adverse Event|2|||
143310023|NCT01455012|516685250|FG000|Overall Study|Lack of Efficacy|6|||
143310024|NCT01455012|516685251|FG001|Overall Study|Lack of Efficacy|1|||
143310025|NCT01455012|516685250|FG000|Overall Study|Withdrawal by Subject|3|||
143310026|NCT01455012|516685251|FG001|Overall Study|Withdrawal by Subject|1|||
143310027|NCT01455012|516685250|FG000|Overall Study|Unknown reason|2|||
143310028|NCT01455012|516685251|FG001|Overall Study|Unknown reason|0|||
143310029|NCT04552587|516685252|FG000|Overall Study|Lost to Follow-up|4|||
143310030|NCT01822132|516685253|FG000|Overall Study|Lost to Follow-up|4|||
143310031|NCT01822132|516685254|FG001|Overall Study|Lost to Follow-up|2|||
143310032|NCT02519712|516685255|FG000|Overall Study|Disease Relapse|1|||
143310033|NCT02519712|516685255|FG000|Overall Study|Disease Progression|1|||
143310034|NCT02519712|516685255|FG000|Overall Study|Accruals are donors|2|||
143310035|NCT00613509|516685256|FG000|Cycle 1|Adverse Event|2|||
143310036|NCT00613509|516685257|FG001|Cycle 1|Adverse Event|1|||
143310037|NCT00613509|516685256|FG000|Cycle 1|Disease Progression|2|||
143310038|NCT00613509|516685257|FG001|Cycle 1|Disease Progression|6|||
143310039|NCT00613509|516685256|FG000|Cycle 1|Unacceptable Toxicity|1|||
143310040|NCT00613509|516685257|FG001|Cycle 1|Unacceptable Toxicity|0|||
143310041|NCT00613509|516685256|FG000|Cycle 1|Other administrative reason|0|||
143310042|NCT00613509|516685257|FG001|Cycle 1|Other administrative reason|1|||
143310043|NCT03400033|516685259|FG000|Overall Study|Withdrawal by Subject|1|||
143310044|NCT03400033|516685260|FG001|Overall Study|Withdrawal by Subject|2|||
143310045|NCT01723228|516685262|FG000|Overall Study|Adverse Event|2|||
143310046|NCT01723228|516685263|FG001|Overall Study|Adverse Event|6|||
143310047|NCT01723228|516685262|FG000|Overall Study|Withdrawal by Subject|2|||
143310048|NCT01723228|516685263|FG001|Overall Study|Withdrawal by Subject|1|||
143310049|NCT01723228|516685262|FG000|Overall Study|Protocol Violation|0|||
143310050|NCT01723228|516685263|FG001|Overall Study|Protocol Violation|2|||
143310051|NCT01723228|516685262|FG000|Overall Study|Lost to Follow-up|2|||
143310052|NCT01723228|516685263|FG001|Overall Study|Lost to Follow-up|1|||
143310053|NCT01723228|516685262|FG000|Overall Study|Other|2|||
143310054|NCT01723228|516685263|FG001|Overall Study|Other|1|||
143310055|NCT01387607|516685269|FG000|Overall Study|Adverse Event|23|||
143310056|NCT01387607|516685270|FG001|Overall Study|Adverse Event|11|||
143310057|NCT01387607|516685269|FG000|Overall Study|Lack of Efficacy|8|||
143310058|NCT01387607|516685270|FG001|Overall Study|Lack of Efficacy|6|||
143310059|NCT01387607|516685269|FG000|Overall Study|Lost to Follow-up|2|||
143310060|NCT01387607|516685270|FG001|Overall Study|Lost to Follow-up|1|||
143310061|NCT01387607|516685269|FG000|Overall Study|No longer meets eligibility criteria|0|||
143310062|NCT01387607|516685270|FG001|Overall Study|No longer meets eligibility criteria|1|||
143310063|NCT01387607|516685269|FG000|Overall Study|Protocol Violation|1|||
143310064|NCT01387607|516685270|FG001|Overall Study|Protocol Violation|5|||
143310065|NCT01387607|516685269|FG000|Overall Study|Withdrawal by Subject|13|||
143310066|NCT01387607|516685270|FG001|Overall Study|Withdrawal by Subject|14|||
143310067|NCT01387607|516685269|FG000|Overall Study|Other|1|||
143310068|NCT01387607|516685270|FG001|Overall Study|Other|1|||
143310069|NCT01387607|516685269|FG000|Overall Study|Randomized, not treated|3|||
143310070|NCT01387607|516685270|FG001|Overall Study|Randomized, not treated|6|||
143310071|NCT04074317|516685271|FG000|Third Period|Withdrawal by Subject|0|||
143310072|NCT04074317|516685272|FG001|Third Period|Withdrawal by Subject|0|||
143310073|NCT04074317|516685273|FG002|Third Period|Withdrawal by Subject|0|||
143310074|NCT04074317|516685274|FG003|Third Period|Withdrawal by Subject|1|||
143310075|NCT04074317|516685275|FG004|Third Period|Withdrawal by Subject|0|||
143310076|NCT04074317|516685276|FG005|Third Period|Withdrawal by Subject|0|||
143310077|NCT03091192|516685277|FG000|Overall Study|Study terminated by sponsor|21|||
143310078|NCT03091192|516685278|FG001|Overall Study|Study terminated by sponsor|14|||
143310079|NCT03091192|516685277|FG000|Overall Study|Death|9|||
143310080|NCT03091192|516685278|FG001|Overall Study|Death|13|||
143310081|NCT03091192|516685277|FG000|Overall Study|Withdrawal by Subject|2|||
143310082|NCT03091192|516685278|FG001|Overall Study|Withdrawal by Subject|0|||
143310083|NCT03091192|516685277|FG000|Overall Study|Lost to Follow-up|1|||
143310084|NCT03091192|516685278|FG001|Overall Study|Lost to Follow-up|0|||
143310085|NCT03548584|516686870|FG000|Overall Study|Lost to Follow-up|0|||
143310086|NCT03548584|516686871|FG001|Overall Study|Lost to Follow-up|0|||
143310087|NCT03548584|516686872|FG002|Overall Study|Lost to Follow-up|1|||
143310088|NCT03548584|516686870|FG000|Overall Study|Adverse Event|1|||
143310089|NCT03548584|516686871|FG001|Overall Study|Adverse Event|11|||
143310090|NCT03548584|516686872|FG002|Overall Study|Adverse Event|5|||
143310091|NCT03548584|516686870|FG000|Overall Study|Site Terminated by Sponsor|1|||
143310092|NCT03548584|516686871|FG001|Overall Study|Site Terminated by Sponsor|3|||
143310093|NCT03548584|516686872|FG002|Overall Study|Site Terminated by Sponsor|2|||
143310094|NCT03548584|516686870|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
143310095|NCT03548584|516686871|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
143310096|NCT03548584|516686872|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
143310097|NCT03548584|516686870|FG000|Overall Study|Lack of Efficacy|0|||
143310098|NCT03548584|516686871|FG001|Overall Study|Lack of Efficacy|1|||
143310099|NCT03548584|516686872|FG002|Overall Study|Lack of Efficacy|0|||
143310100|NCT03548584|516686870|FG000|Overall Study|Non-compliance with Study Drug|0|||
143310101|NCT03548584|516686871|FG001|Overall Study|Non-compliance with Study Drug|1|||
143310102|NCT03548584|516686872|FG002|Overall Study|Non-compliance with Study Drug|0|||
143310103|NCT03548584|516686870|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
143310104|NCT03548584|516686871|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
143310105|NCT03548584|516686872|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
143310106|NCT04269161|516686873|FG000|Overall Study|Change of modality and no longer eligible|3|||
143310107|NCT04269161|516686874|FG001|Overall Study|Change of modality and no longer eligible|3|||
143310108|NCT04269161|516686873|FG000|Overall Study|Required procedure outside of NICU|1|||
143310109|NCT04269161|516686874|FG001|Overall Study|Required procedure outside of NICU|0|||
143310110|NCT04269161|516686873|FG000|Overall Study|Equipment issue|1|||
143310111|NCT04269161|516686874|FG001|Overall Study|Equipment issue|1|||
143310112|NCT01677195|516686875|FG000|Overall Study|Lost to Follow-up|14|||
143310113|NCT01677195|516686876|FG001|Overall Study|Lost to Follow-up|22|||
143310114|NCT01677195|516686877|FG002|Overall Study|Lost to Follow-up|22|||
143310115|NCT01677195|516686875|FG000|Overall Study|Withdrawal by Subject|1|||
143310116|NCT01677195|516686876|FG001|Overall Study|Withdrawal by Subject|0|||
143310117|NCT01677195|516686877|FG002|Overall Study|Withdrawal by Subject|1|||
143310118|NCT01677195|516686875|FG000|Overall Study|Adverse Event|6|||
143310119|NCT01677195|516686876|FG001|Overall Study|Adverse Event|4|||
143310120|NCT01677195|516686877|FG002|Overall Study|Adverse Event|1|||
143310121|NCT01677195|516686875|FG000|Overall Study|Physician Decision|1|||
143310122|NCT01677195|516686876|FG001|Overall Study|Physician Decision|2|||
143310123|NCT01677195|516686877|FG002|Overall Study|Physician Decision|2|||
143310124|NCT01677195|516686875|FG000|Overall Study|Pregnancy|0|||
143310125|NCT01677195|516686876|FG001|Overall Study|Pregnancy|1|||
143310126|NCT01677195|516686877|FG002|Overall Study|Pregnancy|0|||
143310127|NCT01677195|516686875|FG000|Overall Study|Protocol Violation|7|||
143310128|NCT01677195|516686876|FG001|Overall Study|Protocol Violation|3|||
143310129|NCT01677195|516686877|FG002|Overall Study|Protocol Violation|4|||
143310130|NCT04368429|516686878|FG000|Overall Study|Adverse Event|1|||
143310131|NCT04368429|516686879|FG001|Overall Study|Adverse Event|0|||
143310132|NCT03633396|516686882|FG000|Overall Study|Withdrawal by Subject|4|||
143310133|NCT03633396|516686883|FG001|Overall Study|Withdrawal by Subject|4|||
143310134|NCT03633396|516686882|FG000|Overall Study|Adverse Event|1|||
143310135|NCT03633396|516686883|FG001|Overall Study|Adverse Event|1|||
143310136|NCT03633396|516686882|FG000|Overall Study|Lack of Efficacy|1|||
143310137|NCT03633396|516686883|FG001|Overall Study|Lack of Efficacy|0|||
143310138|NCT03633396|516686882|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
143310139|NCT03633396|516686883|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
143310140|NCT01012817|516686884|FG000|Overall Study|Withdrawal by Subject|0|||
143310141|NCT01012817|516686885|FG001|Overall Study|Withdrawal by Subject|0|||
143310142|NCT01012817|516686886|FG002|Overall Study|Withdrawal by Subject|0|||
143310143|NCT01012817|516686887|FG003|Overall Study|Withdrawal by Subject|1|||
143310144|NCT01012817|516686888|FG004|Overall Study|Withdrawal by Subject|0|||
143310145|NCT01012817|516686889|FG005|Overall Study|Withdrawal by Subject|0|||
143310146|NCT01012817|516686890|FG006|Overall Study|Withdrawal by Subject|0|||
143310147|NCT01012817|516686891|FG007|Overall Study|Withdrawal by Subject|1|||
143310148|NCT01012817|516686892|FG008|Overall Study|Withdrawal by Subject|0|||
143310149|NCT01012817|516686893|FG009|Overall Study|Withdrawal by Subject|0|||
143310150|NCT01012817|516686894|FG010|Overall Study|Withdrawal by Subject|1|||
143310151|NCT01012817|516686895|FG011|Overall Study|Withdrawal by Subject|1|||
143310152|NCT01012817|516686896|FG012|Overall Study|Withdrawal by Subject|0|||
143310153|NCT01012817|516686897|FG013|Overall Study|Withdrawal by Subject|1|||
143310154|NCT01012817|516686884|FG000|Overall Study|Adverse Event|0|||
143310155|NCT01012817|516686885|FG001|Overall Study|Adverse Event|0|||
143310156|NCT01012817|516686886|FG002|Overall Study|Adverse Event|0|||
143310157|NCT01012817|516686887|FG003|Overall Study|Adverse Event|0|||
143310158|NCT01012817|516686888|FG004|Overall Study|Adverse Event|0|||
143310159|NCT01012817|516686889|FG005|Overall Study|Adverse Event|1|||
143310160|NCT01012817|516686890|FG006|Overall Study|Adverse Event|0|||
143310161|NCT01012817|516686891|FG007|Overall Study|Adverse Event|0|||
143310162|NCT01012817|516686892|FG008|Overall Study|Adverse Event|0|||
143310163|NCT01012817|516686893|FG009|Overall Study|Adverse Event|0|||
143310164|NCT01012817|516686894|FG010|Overall Study|Adverse Event|1|||
143310165|NCT01012817|516686895|FG011|Overall Study|Adverse Event|0|||
143310166|NCT01012817|516686896|FG012|Overall Study|Adverse Event|0|||
143310167|NCT01012817|516686897|FG013|Overall Study|Adverse Event|1|||
143310168|NCT03756558|516686898|FG000|Overall Study|Death|1|||
143310169|NCT03756558|516686898|FG000|Overall Study|Lost to Follow-up|2|||
143310170|NCT03756558|516686898|FG000|Overall Study|Withdrawal by Subject|2|||
143310171|NCT02472756|516686899|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
143310172|NCT02472756|516686899|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
143310173|NCT02472756|516686899|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
143310174|NCT02472756|516686899|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
143310175|NCT02472756|516686899|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
143310176|NCT02143414|516686900|FG000|Induction|Adverse Event|1|||
143310177|NCT02143414|516686901|FG001|Induction|Adverse Event|2|||
143310178|NCT02143414|516686900|FG000|Induction|Death|1|||
143310179|NCT02143414|516686901|FG001|Induction|Death|2|||
143310180|NCT02143414|516686900|FG000|Induction|Patient refusal|1|||
143310181|NCT02143414|516686901|FG001|Induction|Patient refusal|1|||
143310182|NCT02143414|516686900|FG000|Induction|Refractory|1|||
143310183|NCT02143414|516686901|FG001|Induction|Refractory|0|||
143310184|NCT02143414|516686900|FG000|Induction|Began alternative treatment|1|||
143310185|NCT02143414|516686901|FG001|Induction|Began alternative treatment|0|||
143310186|NCT02143414|516686900|FG000|Induction|Ineligible for postremission|5|||
143310187|NCT02143414|516686901|FG001|Induction|Ineligible for postremission|1|||
143310188|NCT02143414|516686900|FG000|Post-remission|Adverse Event|0|||
143310189|NCT02143414|516686901|FG001|Post-remission|Adverse Event|2|||
143310190|NCT02143414|516686900|FG000|Post-remission|Disease progression/relapse|5|||
143310191|NCT02143414|516686901|FG001|Post-remission|Disease progression/relapse|0|||
143310192|NCT02143414|516686900|FG000|Maintenance|Adverse Event|4|||
143310193|NCT02143414|516686901|FG001|Maintenance|Adverse Event|6|||
143310194|NCT02143414|516686900|FG000|Maintenance|Disease progression/relapse|3|||
143310195|NCT02143414|516686901|FG001|Maintenance|Disease progression/relapse|2|||
143310196|NCT02143414|516686900|FG000|Maintenance|Patient refusal|2|||
143310197|NCT02143414|516686901|FG001|Maintenance|Patient refusal|1|||
143310198|NCT02143414|516686900|FG000|Maintenance|Physician Decision|1|||
143310199|NCT02143414|516686901|FG001|Maintenance|Physician Decision|0|||
143310200|NCT02143414|516686900|FG000|Maintenance|Death|0|||
143310201|NCT02143414|516686901|FG001|Maintenance|Death|1|||
143310202|NCT02143414|516686900|FG000|Maintenance|On protocol treatment|0|||
143310203|NCT02143414|516686901|FG001|Maintenance|On protocol treatment|6|||
143310204|NCT00110266|516686905|FG000|Overall Study|Adverse Event|27|||
143310205|NCT00110266|516686905|FG000|Overall Study|Abnormal laboratory value|15|||
143310206|NCT00110266|516686905|FG000|Overall Study|Withdrawal by Subject|16|||
143310207|NCT00110266|516686905|FG000|Overall Study|Death|17|||
143310208|NCT00110266|516686905|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
143375814|NCT03401112|516920540|FG002|Overall Study|Noncompliance|3|||
143375815|NCT03401112|516920541|FG003|Overall Study|Noncompliance|0|||
143375816|NCT03401112|516920542|FG004|Overall Study|Noncompliance|0|||
143375817|NCT03401112|516920538|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
143375818|NCT03401112|516920539|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
143375819|NCT03401112|516920540|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
143375820|NCT03401112|516920541|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
143375821|NCT03401112|516920542|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
143375822|NCT03401112|516920538|FG000|Overall Study|Withdrawal by Subject|0|||
143375823|NCT03401112|516920539|FG001|Overall Study|Withdrawal by Subject|3|||
143375824|NCT03401112|516920540|FG002|Overall Study|Withdrawal by Subject|2|||
143375825|NCT03401112|516920541|FG003|Overall Study|Withdrawal by Subject|1|||
143375826|NCT03401112|516920542|FG004|Overall Study|Withdrawal by Subject|0|||
143375827|NCT03401112|516920538|FG000|Overall Study|Physician Decision|0|||
143375828|NCT03401112|516920539|FG001|Overall Study|Physician Decision|0|||
143375829|NCT03401112|516920540|FG002|Overall Study|Physician Decision|0|||
143375830|NCT03401112|516920541|FG003|Overall Study|Physician Decision|2|||
143375831|NCT03401112|516920542|FG004|Overall Study|Physician Decision|0|||
143375832|NCT03401112|516920538|FG000|Overall Study|Study was Terminated by Sponsor|0|||
143375833|NCT03401112|516920539|FG001|Overall Study|Study was Terminated by Sponsor|0|||
143375834|NCT03401112|516920540|FG002|Overall Study|Study was Terminated by Sponsor|0|||
143375835|NCT03401112|516920541|FG003|Overall Study|Study was Terminated by Sponsor|1|||
143375836|NCT03401112|516920542|FG004|Overall Study|Study was Terminated by Sponsor|0|||
143375837|NCT03401112|516920538|FG000|Overall Study|Day 1 Assessment not Done|1|||
143375838|NCT03401112|516920539|FG001|Overall Study|Day 1 Assessment not Done|0|||
143375839|NCT03401112|516920540|FG002|Overall Study|Day 1 Assessment not Done|0|||
143375840|NCT03401112|516920541|FG003|Overall Study|Day 1 Assessment not Done|0|||
143375841|NCT03401112|516920542|FG004|Overall Study|Day 1 Assessment not Done|0|||
143375842|NCT03401112|516920538|FG000|Overall Study|Not Dosed|0|||
143375843|NCT03401112|516920539|FG001|Overall Study|Not Dosed|0|||
143375844|NCT03401112|516920540|FG002|Overall Study|Not Dosed|1|||
143375845|NCT03401112|516920541|FG003|Overall Study|Not Dosed|0|||
143375846|NCT03401112|516920542|FG004|Overall Study|Not Dosed|0|||
143375847|NCT03401112|516920538|FG000|Overall Study|Missed Clinical Visit|0|||
143375848|NCT03401112|516920539|FG001|Overall Study|Missed Clinical Visit|0|||
143310209|NCT00110266|516686905|FG000|Overall Study|Participant condition no longer requires study drug|1|||
143310210|NCT00978731|516686906|FG000|Overall Study|Death|4|||
143310211|NCT00978731|516686907|FG001|Overall Study|Death|1|||
143310212|NCT00978731|516686908|FG002|Overall Study|Death|1|||
143310213|NCT00978731|516686909|FG003|Overall Study|Death|0|||
143310214|NCT00978731|516686906|FG000|Overall Study|Lost to Follow-up|0|||
143310215|NCT00978731|516686907|FG001|Overall Study|Lost to Follow-up|0|||
143310216|NCT00978731|516686908|FG002|Overall Study|Lost to Follow-up|0|||
143310217|NCT00978731|516686909|FG003|Overall Study|Lost to Follow-up|1|||
143375849|NCT03401112|516920540|FG002|Overall Study|Missed Clinical Visit|1|||
143375850|NCT03401112|516920541|FG003|Overall Study|Missed Clinical Visit|0|||
143375851|NCT03401112|516920542|FG004|Overall Study|Missed Clinical Visit|0|||
143375852|NCT03401112|516920538|FG000|Overall Study|Missed Doses|0|||
143375853|NCT03401112|516920539|FG001|Overall Study|Missed Doses|0|||
143310218|NCT00978731|516686906|FG000|Overall Study|Adverse Event|5|||
143310219|NCT00978731|516686907|FG001|Overall Study|Adverse Event|2|||
143310220|NCT00978731|516686908|FG002|Overall Study|Adverse Event|0|||
143310221|NCT00978731|516686909|FG003|Overall Study|Adverse Event|0|||
143310222|NCT00978731|516686906|FG000|Overall Study|Participant's request|1|||
143310223|NCT00978731|516686907|FG001|Overall Study|Participant's request|0|||
143310224|NCT00978731|516686908|FG002|Overall Study|Participant's request|0|||
143310225|NCT00978731|516686909|FG003|Overall Study|Participant's request|0|||
143310226|NCT00978731|516686906|FG000|Overall Study|Administrative reason|3|||
143310227|NCT00978731|516686907|FG001|Overall Study|Administrative reason|3|||
143310228|NCT00978731|516686908|FG002|Overall Study|Administrative reason|1|||
143310229|NCT00978731|516686909|FG003|Overall Study|Administrative reason|0|||
143310230|NCT00978731|516686906|FG000|Overall Study|Deterioration without progression|0|||
143310231|NCT00978731|516686907|FG001|Overall Study|Deterioration without progression|1|||
143310232|NCT00978731|516686908|FG002|Overall Study|Deterioration without progression|0|||
143310233|NCT00978731|516686909|FG003|Overall Study|Deterioration without progression|0|||
143310234|NCT00978731|516686906|FG000|Overall Study|Disease progression/relapse|5|||
143310235|NCT00978731|516686907|FG001|Overall Study|Disease progression/relapse|4|||
143310236|NCT00978731|516686908|FG002|Overall Study|Disease progression/relapse|2|||
143310237|NCT00978731|516686909|FG003|Overall Study|Disease progression/relapse|2|||
143310238|NCT00978731|516686906|FG000|Overall Study|Study closure|3|||
143310239|NCT00978731|516686907|FG001|Overall Study|Study closure|4|||
143310240|NCT00978731|516686908|FG002|Overall Study|Study closure|1|||
143310241|NCT00978731|516686909|FG003|Overall Study|Study closure|1|||
143310242|NCT00978731|516686906|FG000|Overall Study|No response|1|||
143375854|NCT03401112|516920540|FG002|Overall Study|Missed Doses|1|||
143375855|NCT03401112|516920541|FG003|Overall Study|Missed Doses|0|||
143375856|NCT03401112|516920542|FG004|Overall Study|Missed Doses|0|||
143375857|NCT01264679|516920543|FG000|Overall Study|Participation in Another Clinical Trial|1|||
143375858|NCT01264679|516920543|FG000|Overall Study|Physician Decision|1|||
143375859|NCT01264679|516920543|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
143375860|NCT01264679|516920543|FG000|Overall Study|Withdrawal by Subject|1|||
143375861|NCT03482011|516920544|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
143375862|NCT03482011|516920545|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
143375863|NCT03482011|516920546|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
143375864|NCT03482011|516920547|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
143375865|NCT03482011|516920548|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
143375866|NCT03482011|516920549|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
143375867|NCT03482011|516920550|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
143375868|NCT03482011|516920551|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
143375869|NCT03482011|516920544|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
143375870|NCT03482011|516920545|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
143375871|NCT03482011|516920546|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
143375872|NCT03482011|516920547|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
143375873|NCT03482011|516920548|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
143375874|NCT03482011|516920549|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
143375875|NCT03482011|516920550|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
143375876|NCT03482011|516920551|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
143375877|NCT03482011|516920544|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
143375878|NCT03482011|516920545|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
143375879|NCT03482011|516920546|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
143375880|NCT03482011|516920547|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
143375881|NCT03482011|516920548|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
143375882|NCT03482011|516920549|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
143375883|NCT03482011|516920550|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
143375884|NCT03482011|516920551|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
143375885|NCT03482011|516920544|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
143375886|NCT03482011|516920545|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
143375887|NCT03482011|516920546|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
143310243|NCT00978731|516686907|FG001|Overall Study|No response|0|||
143310244|NCT00978731|516686908|FG002|Overall Study|No response|0|||
143310245|NCT00978731|516686909|FG003|Overall Study|No response|0|||
143310246|NCT01700179|516686910|FG000|Overall Study|Physician Decision|2|||
143310247|NCT00646204|516686911|FG000|Overall Study|Adverse Event|3|||
143310248|NCT00646204|516686912|FG001|Overall Study|Adverse Event|0|||
143310249|NCT00646204|516686911|FG000|Overall Study|Withdrawal by Subject|1|||
143310250|NCT00646204|516686912|FG001|Overall Study|Withdrawal by Subject|0|||
143375888|NCT03482011|516920547|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
143375889|NCT03482011|516920548|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
143375890|NCT03482011|516920549|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
143375891|NCT03482011|516920550|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
143375892|NCT03482011|516920551|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
143310251|NCT01344057|516686916|FG000|Overall Study|Premature Withdrawal|1|||
143310252|NCT00326612|516686917|FG000|Overall Study|They did not have a seizure requiring tx|129|||
143310253|NCT00326612|516686918|FG001|Overall Study|They did not have a seizure requiring tx|137|||
143310254|NCT02896127|516686919|FG000|COMPLETED WEEK 52|Adverse Event|9|||
143310255|NCT02896127|516686920|FG001|COMPLETED WEEK 52|Adverse Event|2|||
143310256|NCT02896127|516686919|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
143310257|NCT02896127|516686920|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
143310258|NCT02896127|516686919|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
143310259|NCT02896127|516686920|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
143310260|NCT02896127|516686919|FG000|COMPLETED WEEK 52|Physician Decision|1|||
143310261|NCT02896127|516686920|FG001|COMPLETED WEEK 52|Physician Decision|1|||
143310262|NCT02896127|516686919|FG000|COMPLETED WEEK 52|Pregnancy|2|||
143310263|NCT02896127|516686920|FG001|COMPLETED WEEK 52|Pregnancy|0|||
143375893|NCT03482011|516920544|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
143310264|NCT02896127|516686919|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
143310265|NCT02896127|516686920|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
143310266|NCT02896127|516686919|FG000|COMPLETED WEEK 52|Technical problems|1|||
143310267|NCT02896127|516686920|FG001|COMPLETED WEEK 52|Technical problems|0|||
143310268|NCT02896127|516686919|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
143310269|NCT02896127|516686920|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
143310270|NCT02896127|516686919|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
143310271|NCT02896127|516686920|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
143310272|NCT02896127|516686919|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
143310273|NCT02896127|516686920|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
143310274|NCT02896127|516686919|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
143310275|NCT02896127|516686920|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
143310276|NCT02896127|516686919|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
143310277|NCT02896127|516686920|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
143310278|NCT00326911|516686921|FG000|Overall Study|Hospitalization prior to treatment|0|||
143310279|NCT00326911|516686922|FG001|Overall Study|Hospitalization prior to treatment|1|||
143310280|NCT00326911|516686921|FG000|Overall Study|Physician decision prior to treatment|1|||
143310281|NCT00326911|516686922|FG001|Overall Study|Physician decision prior to treatment|0|||
143310282|NCT00326911|516686921|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
143310283|NCT00326911|516686922|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
143310284|NCT04537806|516686930|FG000|Overall Study|Randomized but not treated|1|||
143310285|NCT04537806|516686931|FG001|Overall Study|Randomized but not treated|0|||
143310286|NCT04537806|516686930|FG000|Overall Study|Adverse Event|1|||
143310287|NCT04537806|516686931|FG001|Overall Study|Adverse Event|1|||
143310288|NCT02477020|516686935|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
143310289|NCT02477020|516686936|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
143310290|NCT02477020|516686935|FG000|Overall Study|Voluntary Withdrawal|7|||
143310291|NCT02477020|516686936|FG001|Overall Study|Voluntary Withdrawal|16|||
143310292|NCT02477020|516686935|FG000|Overall Study|Reason not Specified|3|||
143310293|NCT02477020|516686936|FG001|Overall Study|Reason not Specified|1|||
143310294|NCT02477020|516686935|FG000|Overall Study|Lack of Efficacy|14|||
143310295|NCT02477020|516686936|FG001|Overall Study|Lack of Efficacy|5|||
143310296|NCT01465802|516686937|FG000|Overall Study|Study terminated by sponsor|1|||
143310297|NCT01465802|516686938|FG001|Overall Study|Study terminated by sponsor|0|||
143310298|NCT01465802|516686939|FG002|Overall Study|Study terminated by sponsor|0|||
143310299|NCT01465802|516686940|FG003|Overall Study|Study terminated by sponsor|1|||
143310300|NCT01465802|516686941|FG004|Overall Study|Study terminated by sponsor|7|||
143310301|NCT01465802|516686937|FG000|Overall Study|Withdrawal by Subject|7|||
143310302|NCT01465802|516686938|FG001|Overall Study|Withdrawal by Subject|7|||
143310303|NCT01465802|516686939|FG002|Overall Study|Withdrawal by Subject|0|||
143310304|NCT01465802|516686940|FG003|Overall Study|Withdrawal by Subject|8|||
143310305|NCT01465802|516686941|FG004|Overall Study|Withdrawal by Subject|1|||
143310306|NCT01465802|516686937|FG000|Overall Study|Lost to Follow-up|1|||
143310307|NCT01465802|516686938|FG001|Overall Study|Lost to Follow-up|1|||
143310308|NCT01465802|516686939|FG002|Overall Study|Lost to Follow-up|0|||
143310309|NCT01465802|516686940|FG003|Overall Study|Lost to Follow-up|0|||
143310310|NCT01465802|516686941|FG004|Overall Study|Lost to Follow-up|0|||
143310311|NCT01465802|516686937|FG000|Overall Study|Reason not specified|9|||
143310312|NCT01465802|516686938|FG001|Overall Study|Reason not specified|4|||
143310313|NCT01465802|516686939|FG002|Overall Study|Reason not specified|0|||
143310314|NCT01465802|516686940|FG003|Overall Study|Reason not specified|10|||
143310315|NCT01465802|516686941|FG004|Overall Study|Reason not specified|2|||
143310316|NCT01465802|516686937|FG000|Overall Study|Death|15|||
143310317|NCT01465802|516686938|FG001|Overall Study|Death|12|||
143310318|NCT01465802|516686939|FG002|Overall Study|Death|0|||
143310319|NCT01465802|516686940|FG003|Overall Study|Death|10|||
143310320|NCT01465802|516686941|FG004|Overall Study|Death|2|||
143310321|NCT01340976|516686942|FG000|Overall Study|Physician Decision|2|||
143310322|NCT01340976|516686943|FG001|Overall Study|Physician Decision|0|||
143310323|NCT01340976|516686944|FG002|Overall Study|Physician Decision|1|||
143310324|NCT01340976|516686945|FG003|Overall Study|Physician Decision|1|||
143310325|NCT01340976|516686946|FG004|Overall Study|Physician Decision|1|||
143310326|NCT01340976|516686947|FG005|Overall Study|Physician Decision|0|||
143310327|NCT01340976|516686942|FG000|Overall Study|Death|0|||
143310328|NCT01340976|516686943|FG001|Overall Study|Death|1|||
143310329|NCT01340976|516686944|FG002|Overall Study|Death|0|||
143310330|NCT01340976|516686945|FG003|Overall Study|Death|0|||
143310331|NCT01340976|516686946|FG004|Overall Study|Death|0|||
143310332|NCT01340976|516686947|FG005|Overall Study|Death|0|||
143310333|NCT01340976|516686942|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
143310334|NCT01340976|516686943|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
143310335|NCT01340976|516686944|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
143310336|NCT01340976|516686945|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
143310337|NCT01340976|516686946|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
143310338|NCT01340976|516686947|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
143310339|NCT01340976|516686942|FG000|Overall Study|Withdrawal by Subject|0|||
143310340|NCT01340976|516686943|FG001|Overall Study|Withdrawal by Subject|0|||
143310341|NCT01340976|516686944|FG002|Overall Study|Withdrawal by Subject|0|||
143310342|NCT01340976|516686945|FG003|Overall Study|Withdrawal by Subject|1|||
143310343|NCT01340976|516686946|FG004|Overall Study|Withdrawal by Subject|1|||
143310344|NCT01340976|516686947|FG005|Overall Study|Withdrawal by Subject|0|||
143310345|NCT01340976|516686942|FG000|Overall Study|Other anemia treatment|1|||
143310346|NCT01340976|516686943|FG001|Overall Study|Other anemia treatment|0|||
143310347|NCT01340976|516686944|FG002|Overall Study|Other anemia treatment|2|||
143310348|NCT01340976|516686945|FG003|Overall Study|Other anemia treatment|1|||
143310349|NCT01340976|516686946|FG004|Overall Study|Other anemia treatment|0|||
143310350|NCT01340976|516686947|FG005|Overall Study|Other anemia treatment|1|||
143310351|NCT01340976|516686942|FG000|Overall Study|Adverse Event|0|||
143310352|NCT01340976|516686943|FG001|Overall Study|Adverse Event|1|||
143310353|NCT01340976|516686944|FG002|Overall Study|Adverse Event|0|||
143310354|NCT01340976|516686945|FG003|Overall Study|Adverse Event|0|||
143310355|NCT01340976|516686946|FG004|Overall Study|Adverse Event|0|||
143310356|NCT01340976|516686947|FG005|Overall Study|Adverse Event|0|||
143310357|NCT02953821|516686948|FG000|Overall Study|Adverse Event|0|||
143310358|NCT02953821|516686949|FG001|Overall Study|Adverse Event|4|||
143310359|NCT02953821|516686948|FG000|Overall Study|Death|1|||
143310360|NCT02953821|516686949|FG001|Overall Study|Death|0|||
143310361|NCT02953821|516686948|FG000|Overall Study|Progressive Disease|5|||
143310362|NCT02953821|516686949|FG001|Overall Study|Progressive Disease|1|||
143310363|NCT02953821|516686948|FG000|Overall Study|Lost to Follow-up|2|||
143310364|NCT02953821|516686949|FG001|Overall Study|Lost to Follow-up|0|||
143310365|NCT02953821|516686948|FG000|Overall Study|Physician Decision|1|||
143310366|NCT02953821|516686949|FG001|Overall Study|Physician Decision|1|||
143310367|NCT02953821|516686948|FG000|Overall Study|Withdrawal by Subject|3|||
143310368|NCT02953821|516686949|FG001|Overall Study|Withdrawal by Subject|3|||
143310369|NCT02953821|516686948|FG000|Overall Study|Change of address|0|||
143310370|NCT02953821|516686949|FG001|Overall Study|Change of address|1|||
143310371|NCT02953821|516686948|FG000|Overall Study|Lack of Efficacy|1|||
143310372|NCT02953821|516686949|FG001|Overall Study|Lack of Efficacy|0|||
143310373|NCT02953821|516686948|FG000|Overall Study|Out of state for indeterminate time|0|||
143310374|NCT02953821|516686949|FG001|Overall Study|Out of state for indeterminate time|1|||
143310375|NCT02953821|516686948|FG000|Overall Study|No improvement|0|||
143310376|NCT02953821|516686949|FG001|Overall Study|No improvement|1|||
143310377|NCT02953821|516686948|FG000|Overall Study|Refused follow-up visit|2|||
143310378|NCT02953821|516686949|FG001|Overall Study|Refused follow-up visit|1|||
143310379|NCT02103478|516686950|FG000|Overall Study|Adverse Event|0|||
143310380|NCT02103478|516686951|FG001|Overall Study|Adverse Event|0|||
143310381|NCT02103478|516686952|FG002|Overall Study|Adverse Event|1|||
143310382|NCT02103478|516686953|FG003|Overall Study|Adverse Event|1|||
143310383|NCT02103478|516686954|FG004|Overall Study|Adverse Event|2|||
143310384|NCT02103478|516686955|FG005|Overall Study|Adverse Event|1|||
143310385|NCT02103478|516686956|FG006|Overall Study|Adverse Event|0|||
143310386|NCT02103478|516686957|FG007|Overall Study|Adverse Event|0|||
143310387|NCT02103478|516686958|FG008|Overall Study|Adverse Event|0|||
143310388|NCT02103478|516686950|FG000|Overall Study|Death|2|||
143310389|NCT02103478|516686951|FG001|Overall Study|Death|2|||
143310390|NCT02103478|516686952|FG002|Overall Study|Death|1|||
143310391|NCT02103478|516686953|FG003|Overall Study|Death|1|||
143310392|NCT02103478|516686954|FG004|Overall Study|Death|5|||
143310393|NCT02103478|516686955|FG005|Overall Study|Death|15|||
143375894|NCT03482011|516920545|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
143310394|NCT02103478|516686956|FG006|Overall Study|Death|14|||
143310395|NCT02103478|516686957|FG007|Overall Study|Death|10|||
143310396|NCT02103478|516686958|FG008|Overall Study|Death|11|||
143310397|NCT02103478|516686950|FG000|Overall Study|Progressive Disease|2|||
143310398|NCT02103478|516686951|FG001|Overall Study|Progressive Disease|1|||
143310399|NCT02103478|516686952|FG002|Overall Study|Progressive Disease|2|||
143310400|NCT02103478|516686953|FG003|Overall Study|Progressive Disease|0|||
143310401|NCT02103478|516686954|FG004|Overall Study|Progressive Disease|9|||
143310402|NCT02103478|516686955|FG005|Overall Study|Progressive Disease|1|||
143310403|NCT02103478|516686956|FG006|Overall Study|Progressive Disease|2|||
143310404|NCT02103478|516686957|FG007|Overall Study|Progressive Disease|0|||
143310405|NCT02103478|516686958|FG008|Overall Study|Progressive Disease|1|||
143310406|NCT02103478|516686950|FG000|Overall Study|Withdrawal by Subject|2|||
143310407|NCT02103478|516686951|FG001|Overall Study|Withdrawal by Subject|0|||
143310408|NCT02103478|516686952|FG002|Overall Study|Withdrawal by Subject|0|||
143310409|NCT02103478|516686953|FG003|Overall Study|Withdrawal by Subject|4|||
143310410|NCT02103478|516686954|FG004|Overall Study|Withdrawal by Subject|0|||
143310411|NCT02103478|516686955|FG005|Overall Study|Withdrawal by Subject|0|||
143310412|NCT02103478|516686956|FG006|Overall Study|Withdrawal by Subject|1|||
143310413|NCT02103478|516686957|FG007|Overall Study|Withdrawal by Subject|1|||
143310414|NCT02103478|516686958|FG008|Overall Study|Withdrawal by Subject|0|||
143310415|NCT02103478|516686950|FG000|Overall Study|Lost to Follow-up|0|||
143310416|NCT02103478|516686951|FG001|Overall Study|Lost to Follow-up|0|||
143310417|NCT02103478|516686952|FG002|Overall Study|Lost to Follow-up|0|||
143310418|NCT02103478|516686953|FG003|Overall Study|Lost to Follow-up|0|||
143310419|NCT02103478|516686954|FG004|Overall Study|Lost to Follow-up|0|||
143310420|NCT02103478|516686955|FG005|Overall Study|Lost to Follow-up|0|||
143310421|NCT02103478|516686956|FG006|Overall Study|Lost to Follow-up|0|||
143310422|NCT02103478|516686957|FG007|Overall Study|Lost to Follow-up|1|||
143310423|NCT02103478|516686958|FG008|Overall Study|Lost to Follow-up|0|||
143310424|NCT02103478|516686950|FG000|Overall Study|Other|1|||
143310425|NCT02103478|516686951|FG001|Overall Study|Other|3|||
143310426|NCT02103478|516686952|FG002|Overall Study|Other|2|||
143310427|NCT02103478|516686953|FG003|Overall Study|Other|0|||
143310428|NCT02103478|516686954|FG004|Overall Study|Other|3|||
143310429|NCT02103478|516686955|FG005|Overall Study|Other|8|||
143310430|NCT02103478|516686956|FG006|Overall Study|Other|8|||
143310431|NCT02103478|516686957|FG007|Overall Study|Other|4|||
143310432|NCT02103478|516686958|FG008|Overall Study|Other|2|||
143310433|NCT00723606|516686959|FG000|Overall Study|Adverse Event|2|||
143310434|NCT00723606|516686960|FG001|Overall Study|Adverse Event|5|||
143310435|NCT00723606|516686959|FG000|Overall Study|Other|2|||
143310436|NCT00723606|516686960|FG001|Overall Study|Other|0|||
143310437|NCT00723606|516686959|FG000|Overall Study|Withdrawal by Subject|0|||
143310438|NCT00723606|516686960|FG001|Overall Study|Withdrawal by Subject|2|||
143310439|NCT00976898|516686961|FG000|Overall Study|Protocol Violation|1|||
143310440|NCT00976898|516686961|FG000|Overall Study|Adverse Event|1|||
143310441|NCT00976898|516686961|FG000|Overall Study|Physician Decision|1|||
143310442|NCT00976898|516686961|FG000|Overall Study|Liver Transplant|1|||
143310443|NCT00976898|516686961|FG000|Overall Study|Progressive Disease|1|||
143310444|NCT05107128|516686962|FG000|Overall Study|Adverse Event|2|||
143310445|NCT05107128|516686963|FG001|Overall Study|Adverse Event|0|||
143310446|NCT05107128|516686962|FG000|Overall Study|Withdrawal by Subject|3|||
143310447|NCT05107128|516686963|FG001|Overall Study|Withdrawal by Subject|3|||
143310448|NCT05107128|516686962|FG000|Overall Study|Withdrawal of Consent|0|||
143310449|NCT05107128|516686963|FG001|Overall Study|Withdrawal of Consent|1|||
143310450|NCT05107128|516686962|FG000|Overall Study|Reason Not Specified|2|||
143310451|NCT05107128|516686963|FG001|Overall Study|Reason Not Specified|0|||
143310452|NCT05459129|516686966|FG000|Overall Study|Death|1|||
143310453|NCT05459129|516686967|FG001|Overall Study|Death|0|||
143310454|NCT05459129|516686966|FG000|Overall Study|Study Terminated By Sponsor|5|||
143310455|NCT05459129|516686967|FG001|Overall Study|Study Terminated By Sponsor|6|||
143310456|NCT04182100|516686968|FG000|Overall Study|Adverse Event|1|||
143310457|NCT04182100|516686968|FG000|Overall Study|Withdrawal by Subject|1|||
143310458|NCT04530552|516686970|FG000|Overall Study|Physician Decision|0|||
143310459|NCT04530552|516686971|FG001|Overall Study|Physician Decision|1|||
143310460|NCT04530552|516686970|FG000|Overall Study|Withdrawal by Subject|0|||
143310461|NCT04530552|516686971|FG001|Overall Study|Withdrawal by Subject|1|||
143310462|NCT04530552|516686970|FG000|Overall Study|Adverse Event|0|||
143310463|NCT04530552|516686971|FG001|Overall Study|Adverse Event|1|||
143310464|NCT04530552|516686970|FG000|Overall Study|No surgery|0|||
143310465|NCT04530552|516686971|FG001|Overall Study|No surgery|1|||
143310466|NCT02052739|516686972|FG000|Overall Study|Withdrew due to Adverse Event|3|||
143310467|NCT02052739|516686973|FG001|Overall Study|Withdrew due to Adverse Event|0|||
143310468|NCT02052739|516686972|FG000|Overall Study|Participant Died|2|||
143310469|NCT02052739|516686973|FG001|Overall Study|Participant Died|1|||
143310470|NCT00670228|516686974|FG000|Overall Study|Adverse Event|1|||
143310471|NCT00670228|516686975|FG001|Overall Study|Adverse Event|0|||
143310472|NCT00670228|516686974|FG000|Overall Study|Death or MACE|0|||
143310473|NCT00670228|516686975|FG001|Overall Study|Death or MACE|1|||
143310474|NCT00670228|516686974|FG000|Overall Study|Not treated|2|||
143310475|NCT00670228|516686975|FG001|Overall Study|Not treated|2|||
143310476|NCT00670228|516686974|FG000|Overall Study|Not meeting the selection criteria|2|||
143310477|NCT00670228|516686975|FG001|Overall Study|Not meeting the selection criteria|0|||
143310478|NCT05267054|516686976|FG000|Overall Study|Death|13|||
143375895|NCT03482011|516920546|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
143310479|NCT05267054|516686977|FG001|Overall Study|Death|14|||
143310480|NCT05267054|516686976|FG000|Overall Study|Study Ended by Sponsor|9|||
143310481|NCT05267054|516686977|FG001|Overall Study|Study Ended by Sponsor|13|||
143375896|NCT03482011|516920547|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
143310482|NCT05267054|516686976|FG000|Overall Study|Lost to Follow-up|1|||
143310483|NCT05267054|516686977|FG001|Overall Study|Lost to Follow-up|1|||
143310484|NCT05267054|516686976|FG000|Overall Study|Withdrawal by Subject|1|||
143310485|NCT05267054|516686977|FG001|Overall Study|Withdrawal by Subject|1|||
143310486|NCT01552226|516686978|FG000|Overall Study|Withdrawal by Subject|4|||
143310487|NCT01552226|516686979|FG001|Overall Study|Withdrawal by Subject|4|||
143310488|NCT00637195|516686980|FG000|Overall Study|Lost to Follow-up|1|||
143310489|NCT00637195|516686981|FG001|Overall Study|Lost to Follow-up|0|||
143310490|NCT00637195|516686980|FG000|Overall Study|Other|2|||
143310491|NCT00637195|516686981|FG001|Overall Study|Other|0|||
143310492|NCT00637195|516686980|FG000|Overall Study|Withdrawal by Subject|0|||
143310493|NCT00637195|516686981|FG001|Overall Study|Withdrawal by Subject|1|||
143310494|NCT02388997|516686982|FG000|Overall Study|Adverse Event|1|||
143310495|NCT02388997|516686983|FG001|Overall Study|Adverse Event|2|||
143310496|NCT02388997|516686982|FG000|Overall Study|Withdrawal by Subject|2|||
143310497|NCT02388997|516686983|FG001|Overall Study|Withdrawal by Subject|1|||
143310498|NCT02388997|516686982|FG000|Overall Study|Lung function exclusion criteria|0|||
143310499|NCT02388997|516686983|FG001|Overall Study|Lung function exclusion criteria|2|||
143310500|NCT02388997|516686982|FG000|Overall Study|Tested positive for virus during run-in|0|||
143310501|NCT02388997|516686983|FG001|Overall Study|Tested positive for virus during run-in|1|||
143310502|NCT00376168|516686989|FG000|Overall Study|Adverse Event|1|||
143310503|NCT00376168|516686990|FG001|Overall Study|Adverse Event|1|||
143310504|NCT00376168|516686989|FG000|Overall Study|Pregnancy|1|||
143310505|NCT00376168|516686990|FG001|Overall Study|Pregnancy|0|||
143310506|NCT01020019|516686991|FG000|Overall Study|Lost to Follow-up|21|||
143310507|NCT01020019|516686992|FG001|Overall Study|Lost to Follow-up|18|||
143310508|NCT01020019|516686991|FG000|Overall Study|Adverse Event|1|||
143310509|NCT01020019|516686992|FG001|Overall Study|Adverse Event|5|||
143310510|NCT01020019|516686991|FG000|Overall Study|not interested in treatment|4|||
143310511|NCT01020019|516686992|FG001|Overall Study|not interested in treatment|4|||
143310512|NCT01020019|516686991|FG000|Overall Study|moving|0|||
143310513|NCT01020019|516686992|FG001|Overall Study|moving|2|||
143310514|NCT04115358|516686993|FG000|Overall Study|exfoliation|0|||
143310515|NCT04115358|516686994|FG001|Overall Study|exfoliation|0|||
143310516|NCT04115358|516686995|FG002|Overall Study|exfoliation|1|||
143310517|NCT02346240|516686996|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
143310518|NCT02346240|516686997|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
143310519|NCT02346240|516686998|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
143310520|NCT02346240|516686999|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
143310521|NCT02346240|516687000|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
143310522|NCT02346240|516687001|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
143310523|NCT02346240|516687002|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
143310524|NCT02346240|516687003|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
143310525|NCT02346240|516687004|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
143310526|NCT02346240|516687005|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
143310527|NCT02346240|516687006|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
143310528|NCT02346240|516687007|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
143310529|NCT02346240|516687008|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
143310530|NCT02346240|516687009|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
143310531|NCT02346240|516687010|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
143310532|NCT02346240|516687011|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
143310533|NCT02346240|516687012|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
143310534|NCT02346240|516687013|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
143310535|NCT02346240|516687014|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
143310536|NCT02346240|516687015|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
143310537|NCT02346240|516687016|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
143310538|NCT02346240|516687017|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
143310539|NCT02346240|516687018|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
143310540|NCT02346240|516687019|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
143310541|NCT02346240|516686996|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
143310542|NCT02346240|516686997|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
143375897|NCT03482011|516920548|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
143375898|NCT03482011|516920549|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
143310543|NCT02346240|516686998|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
143310544|NCT02346240|516686999|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
143310545|NCT02346240|516687000|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
143310546|NCT02346240|516687001|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
143310547|NCT02346240|516687002|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
143310548|NCT02346240|516687003|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
143310549|NCT02346240|516687004|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
143310550|NCT02346240|516687005|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
143310551|NCT02346240|516687006|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
143310552|NCT02346240|516687007|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
143310553|NCT02346240|516687008|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
143310554|NCT02346240|516687009|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
143310555|NCT02346240|516687010|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
143310556|NCT02346240|516687011|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
143310557|NCT02346240|516687012|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
143310558|NCT02346240|516687013|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
143310559|NCT02346240|516687014|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
143310560|NCT02346240|516687015|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
143310561|NCT02346240|516687016|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
143310562|NCT02346240|516687017|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
143310563|NCT02346240|516687018|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
143310564|NCT02346240|516687019|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
143310565|NCT02346240|516686996|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
143310566|NCT02346240|516686997|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
143310567|NCT02346240|516686998|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
143310568|NCT02346240|516686999|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
143310569|NCT02346240|516687000|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
143310570|NCT02346240|516687001|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
143310571|NCT02346240|516687002|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
143310572|NCT02346240|516687003|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
143310573|NCT02346240|516687004|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
143310574|NCT02346240|516687005|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
143310575|NCT02346240|516687006|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
143310576|NCT02346240|516687007|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
143310577|NCT02346240|516687008|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
143310578|NCT02346240|516687009|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
143310579|NCT02346240|516687010|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
143310580|NCT02346240|516687011|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
143310581|NCT02346240|516687012|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
143310582|NCT02346240|516687013|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
143310583|NCT02346240|516687014|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
143310584|NCT02346240|516687015|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
143310585|NCT02346240|516687016|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
143310586|NCT02346240|516687017|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
143310587|NCT02346240|516687018|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
143310588|NCT02346240|516687019|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
143310589|NCT02346240|516686996|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
143310590|NCT02346240|516686997|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
143310591|NCT02346240|516686998|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
143310592|NCT02346240|516686999|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
143310593|NCT02346240|516687000|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
143310594|NCT02346240|516687001|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
143310595|NCT02346240|516687002|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
143310596|NCT02346240|516687003|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
143310597|NCT02346240|516687004|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
143310598|NCT02346240|516687005|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
143310599|NCT02346240|516687006|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
143310600|NCT02346240|516687007|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
143310601|NCT02346240|516687008|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
143310602|NCT02346240|516687009|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
143310603|NCT02346240|516687010|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
143310604|NCT02346240|516687011|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
143310605|NCT02346240|516687012|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
143310606|NCT02346240|516687013|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
143310607|NCT02346240|516687014|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
143310608|NCT02346240|516687015|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
143310609|NCT02346240|516687016|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
143310610|NCT02346240|516687017|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
143310611|NCT02346240|516687018|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
143310612|NCT02346240|516687019|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
143310613|NCT02346240|516686996|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
143310614|NCT02346240|516686997|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
143310615|NCT02346240|516686998|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
143310616|NCT02346240|516686999|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
143310617|NCT02346240|516687000|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
143310618|NCT02346240|516687001|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
143310619|NCT02346240|516687002|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
143310620|NCT02346240|516687003|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
143310621|NCT02346240|516687004|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
143310622|NCT02346240|516687005|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
143310623|NCT02346240|516687006|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
143310624|NCT02346240|516687007|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
143310625|NCT02346240|516687008|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
143310626|NCT02346240|516687009|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
143310627|NCT02346240|516687010|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
143310628|NCT02346240|516687011|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
143310629|NCT02346240|516687012|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
143310630|NCT02346240|516687013|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
143310631|NCT02346240|516687014|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
143310632|NCT02346240|516687015|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
143310633|NCT02346240|516687016|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
143310634|NCT02346240|516687017|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
143310635|NCT02346240|516687018|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
143310636|NCT02346240|516687019|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
143310637|NCT02346240|516686996|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
143310638|NCT02346240|516686997|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
143310639|NCT02346240|516686998|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
143310640|NCT02346240|516686999|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
143310641|NCT02346240|516687000|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
143310642|NCT02346240|516687001|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
143310643|NCT02346240|516687002|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
143310644|NCT02346240|516687003|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
143310645|NCT02346240|516687004|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
143310646|NCT02346240|516687005|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
143310647|NCT02346240|516687006|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
143310648|NCT02346240|516687007|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
143310649|NCT02346240|516687008|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
143310650|NCT02346240|516687009|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
143310651|NCT02346240|516687010|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
143310652|NCT02346240|516687011|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
143310653|NCT02346240|516687012|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
143310654|NCT02346240|516687013|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
143310655|NCT02346240|516687014|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
143310656|NCT02346240|516687015|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
143310657|NCT02346240|516687016|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
143310658|NCT02346240|516687017|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
143310659|NCT02346240|516687018|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
143310660|NCT02346240|516687019|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
143310661|NCT02346240|516686996|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
143310662|NCT02346240|516686997|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
143310663|NCT02346240|516686998|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
143310664|NCT02346240|516686999|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
143310665|NCT02346240|516687000|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
143310666|NCT02346240|516687001|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
143310667|NCT02346240|516687002|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
143310668|NCT02346240|516687003|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
143310669|NCT02346240|516687004|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
143310670|NCT02346240|516687005|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
143310671|NCT02346240|516687006|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
143310672|NCT02346240|516687007|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
143310673|NCT02346240|516687008|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
143310674|NCT02346240|516687009|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
143310675|NCT02346240|516687010|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
143310676|NCT02346240|516687011|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
143310677|NCT02346240|516687012|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
143310678|NCT02346240|516687013|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
143310679|NCT02346240|516687014|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
143310680|NCT02346240|516687015|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
143310681|NCT02346240|516687016|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
143310682|NCT02346240|516687017|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
143310683|NCT02346240|516687018|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
143310684|NCT02346240|516687019|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
143310685|NCT02346240|516686996|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143310686|NCT02346240|516686997|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143310687|NCT02346240|516686998|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143310688|NCT02346240|516686999|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143310689|NCT02346240|516687000|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143310690|NCT02346240|516687001|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143310691|NCT02346240|516687002|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143310692|NCT02346240|516687003|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
143310693|NCT02346240|516687004|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
143310694|NCT02346240|516687005|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143310695|NCT02346240|516687006|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143310696|NCT02346240|516687007|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143310697|NCT02346240|516687008|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143310698|NCT02346240|516687009|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
143310699|NCT02346240|516687010|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
143310700|NCT02346240|516687011|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
143310701|NCT02346240|516687012|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
143310702|NCT02346240|516687013|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143310703|NCT02346240|516687014|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143310704|NCT02346240|516687015|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143310705|NCT02346240|516687016|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143310706|NCT02346240|516687017|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143310707|NCT02346240|516687018|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143310708|NCT02346240|516687019|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
143310709|NCT02346240|516686996|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
143310710|NCT02346240|516686997|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
143310711|NCT02346240|516686998|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
143310712|NCT02346240|516686999|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
143310713|NCT02346240|516687000|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
143310714|NCT02346240|516687001|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
143310715|NCT02346240|516687002|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
143310716|NCT02346240|516687003|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
143310717|NCT02346240|516687004|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
143310718|NCT02346240|516687005|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
143310719|NCT02346240|516687006|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
143310720|NCT02346240|516687007|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
143310721|NCT02346240|516687008|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
143310722|NCT02346240|516687009|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
143310723|NCT02346240|516687010|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
143310724|NCT02346240|516687011|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
143310725|NCT02346240|516687012|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
143310726|NCT02346240|516687013|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
143310727|NCT02346240|516687014|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
143310728|NCT02346240|516687015|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
143310729|NCT02346240|516687016|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
143310730|NCT02346240|516687017|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
143310731|NCT02346240|516687018|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
143310732|NCT02346240|516687019|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
143310733|NCT02346240|516686996|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143310734|NCT02346240|516686997|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143310735|NCT02346240|516686998|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143310736|NCT02346240|516686999|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143310737|NCT02346240|516687000|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143310738|NCT02346240|516687001|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143310739|NCT02346240|516687002|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143310740|NCT02346240|516687003|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143310741|NCT02346240|516687004|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143310742|NCT02346240|516687005|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143310743|NCT02346240|516687006|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143310744|NCT02346240|516687007|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143310745|NCT02346240|516687008|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143310746|NCT02346240|516687009|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143310747|NCT02346240|516687010|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
143310748|NCT02346240|516687011|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143310749|NCT02346240|516687012|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143310750|NCT02346240|516687013|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143310751|NCT02346240|516687014|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143310752|NCT02346240|516687015|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143310753|NCT02346240|516687016|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143310754|NCT02346240|516687017|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143310755|NCT02346240|516687018|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143310756|NCT02346240|516687019|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
143310757|NCT02346240|516686996|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
143310758|NCT02346240|516686997|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
143310759|NCT02346240|516686998|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
143310760|NCT02346240|516686999|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
143310761|NCT02346240|516687000|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
143310762|NCT02346240|516687001|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
143310763|NCT02346240|516687002|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
143310764|NCT02346240|516687003|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
143310765|NCT02346240|516687004|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
143310766|NCT02346240|516687005|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
143310767|NCT02346240|516687006|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
143310768|NCT02346240|516687007|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
143310769|NCT02346240|516687008|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
143310770|NCT02346240|516687009|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
143310771|NCT02346240|516687010|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
143310772|NCT02346240|516687011|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
143310773|NCT02346240|516687012|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
143310774|NCT02346240|516687013|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
143310775|NCT02346240|516687014|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
143310776|NCT02346240|516687015|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
143310777|NCT02346240|516687016|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
143310778|NCT02346240|516687017|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
143310779|NCT02346240|516687018|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
143310780|NCT02346240|516687019|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
143310781|NCT02346240|516686996|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
143310782|NCT02346240|516686997|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
143310783|NCT02346240|516686998|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
143310784|NCT02346240|516686999|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
143310785|NCT02346240|516687000|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
143310786|NCT02346240|516687001|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
143310787|NCT02346240|516687002|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
143310788|NCT02346240|516687003|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
143310789|NCT02346240|516687004|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
143310790|NCT02346240|516687005|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
143310791|NCT02346240|516687006|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
143310792|NCT02346240|516687007|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
143310793|NCT02346240|516687008|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
143310794|NCT02346240|516687009|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
143310795|NCT02346240|516687010|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
143310796|NCT02346240|516687011|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
143310797|NCT02346240|516687012|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
143310798|NCT02346240|516687013|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
143310799|NCT02346240|516687014|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
143310800|NCT02346240|516687015|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
143310801|NCT02346240|516687016|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
143310802|NCT02346240|516687017|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
143310803|NCT02346240|516687018|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
143310804|NCT02346240|516687019|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
143310805|NCT02346240|516686996|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
143310806|NCT02346240|516686997|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
143310807|NCT02346240|516686998|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
143310808|NCT02346240|516686999|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
143310809|NCT02346240|516687000|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
143310810|NCT02346240|516687001|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
143310811|NCT02346240|516687002|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
143310812|NCT02346240|516687003|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
143310813|NCT02346240|516687004|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
143310814|NCT02346240|516687005|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
143375899|NCT03482011|516920550|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
143375900|NCT03482011|516920551|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
143375901|NCT03482011|516920544|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
143375902|NCT03482011|516920545|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
143375903|NCT03482011|516920546|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
143375904|NCT03482011|516920547|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
143375905|NCT03482011|516920548|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
143375906|NCT03482011|516920549|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
143375907|NCT03482011|516920550|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
143375908|NCT03482011|516920551|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
143375909|NCT03482011|516920544|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
143375910|NCT03482011|516920545|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
143375911|NCT03482011|516920546|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
143375912|NCT03482011|516920547|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
143375913|NCT03482011|516920548|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
143375914|NCT03482011|516920549|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
143375915|NCT03482011|516920550|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
143375916|NCT03482011|516920551|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
143375917|NCT03482011|516920544|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
143375918|NCT03482011|516920545|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
143375919|NCT03482011|516920546|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
143375920|NCT03482011|516920547|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
143375921|NCT03482011|516920548|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
143375922|NCT03482011|516920549|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
143375923|NCT03482011|516920550|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
143375924|NCT03482011|516920551|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
143375925|NCT03482011|516920544|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
143375926|NCT03482011|516920545|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
143375927|NCT03482011|516920546|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
143375928|NCT03482011|516920547|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
143375929|NCT03482011|516920548|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
143375930|NCT03482011|516920549|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
143375931|NCT03482011|516920550|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
143375932|NCT03482011|516920551|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
143375933|NCT03482011|516920544|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
143375934|NCT03482011|516920545|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
143375935|NCT03482011|516920546|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
143310815|NCT02346240|516687006|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
143310816|NCT02346240|516687007|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
143310817|NCT02346240|516687008|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
143310818|NCT02346240|516687009|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
143310819|NCT02346240|516687010|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
143310820|NCT02346240|516687011|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
143310821|NCT02346240|516687012|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
143310822|NCT02346240|516687013|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
143375936|NCT03482011|516920547|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
143375937|NCT03482011|516920548|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
143375938|NCT03482011|516920549|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
143375939|NCT03482011|516920550|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
143375940|NCT03482011|516920551|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
143375941|NCT03482011|516920544|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
143375942|NCT03482011|516920545|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
143375943|NCT03482011|516920546|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
143375944|NCT03482011|516920547|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
143375945|NCT03482011|516920548|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
143375946|NCT03482011|516920549|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
143375947|NCT03482011|516920550|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
143375948|NCT03482011|516920551|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
143375949|NCT03482011|516920544|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
143375950|NCT03482011|516920545|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
143375951|NCT03482011|516920546|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
143375952|NCT03482011|516920547|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
143375953|NCT03482011|516920548|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
143375954|NCT03482011|516920549|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
143375955|NCT03482011|516920550|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
143375956|NCT03482011|516920551|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
143375957|NCT03482011|516920544|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
143375958|NCT03482011|516920545|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
143310823|NCT02346240|516687014|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
143310824|NCT02346240|516687015|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
143310825|NCT02346240|516687016|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
143310826|NCT02346240|516687017|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
143310827|NCT02346240|516687018|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
143310828|NCT02346240|516687019|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
143310829|NCT02346240|516686996|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
143310830|NCT02346240|516686997|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
143310831|NCT02346240|516686998|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
143310832|NCT02346240|516686999|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
143310833|NCT02346240|516687000|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
143310834|NCT02346240|516687001|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
143310835|NCT02346240|516687002|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
143310836|NCT02346240|516687003|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
143310837|NCT02346240|516687004|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
143310838|NCT02346240|516687005|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
143310839|NCT02346240|516687006|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
143310840|NCT02346240|516687007|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
143310841|NCT02346240|516687008|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
143310842|NCT02346240|516687009|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
143310843|NCT02346240|516687010|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
143310844|NCT02346240|516687011|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
143310845|NCT02346240|516687012|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
143310846|NCT02346240|516687013|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
143310847|NCT02346240|516687014|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
143310848|NCT02346240|516687015|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
143310849|NCT02346240|516687016|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
143310850|NCT02346240|516687017|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
143310851|NCT02346240|516687018|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
143310852|NCT02346240|516687019|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
143310853|NCT02346240|516686996|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
143310854|NCT02346240|516686997|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
143310855|NCT02346240|516686998|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
143310856|NCT02346240|516686999|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
143310857|NCT02346240|516687000|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
143310858|NCT02346240|516687001|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
143310859|NCT02346240|516687002|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
143310860|NCT02346240|516687003|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
143310861|NCT02346240|516687004|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
143310862|NCT02346240|516687005|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
143310863|NCT02346240|516687006|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
143310864|NCT02346240|516687007|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
143310865|NCT02346240|516687008|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
143310866|NCT02346240|516687009|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
143310867|NCT02346240|516687010|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
143310868|NCT02346240|516687011|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
143310869|NCT02346240|516687012|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
143310870|NCT02346240|516687013|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
143310871|NCT02346240|516687014|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
143310872|NCT02346240|516687015|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
143310873|NCT02346240|516687016|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
143310874|NCT02346240|516687017|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
143310875|NCT02346240|516687018|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
143310876|NCT02346240|516687019|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
143310877|NCT02346240|516686996|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
143310878|NCT02346240|516686997|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
143310879|NCT02346240|516686998|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
143310880|NCT02346240|516686999|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
143375959|NCT03482011|516920546|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
143375960|NCT03482011|516920547|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
143375961|NCT03482011|516920548|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
143375962|NCT03482011|516920549|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
143375963|NCT03482011|516920550|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
143375964|NCT03482011|516920551|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
143375965|NCT03482011|516920544|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
143375966|NCT03482011|516920545|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
143375967|NCT03482011|516920546|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
143375968|NCT03482011|516920547|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
143375969|NCT03482011|516920548|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
143375970|NCT03482011|516920549|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
143375971|NCT03482011|516920550|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
143375972|NCT03482011|516920551|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
143375973|NCT03482011|516920544|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
143310881|NCT02346240|516687000|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
143310882|NCT02346240|516687001|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
143310883|NCT02346240|516687002|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
143310884|NCT02346240|516687003|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
143310885|NCT02346240|516687004|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
143310886|NCT02346240|516687005|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
143310887|NCT02346240|516687006|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
143310888|NCT02346240|516687007|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
143310889|NCT02346240|516687008|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
143310890|NCT02346240|516687009|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
143310891|NCT02346240|516687010|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
143310892|NCT02346240|516687011|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
143310893|NCT02346240|516687012|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
143310894|NCT02346240|516687013|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
143310895|NCT02346240|516687014|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
143310896|NCT02346240|516687015|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
143310897|NCT02346240|516687016|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
143310898|NCT02346240|516687017|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
143310899|NCT02346240|516687018|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
143310900|NCT02346240|516687019|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
143310901|NCT02346240|516686996|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
143310902|NCT02346240|516686997|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
143310903|NCT02346240|516686998|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
143310904|NCT02346240|516686999|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
143310905|NCT02346240|516687000|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
143310906|NCT02346240|516687001|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
143310907|NCT02346240|516687002|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
143375974|NCT03482011|516920545|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
143310908|NCT02346240|516687003|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
143310909|NCT02346240|516687004|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
143310910|NCT02346240|516687005|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
143310911|NCT02346240|516687006|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
143310912|NCT02346240|516687007|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
143310913|NCT02346240|516687008|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
143310914|NCT02346240|516687009|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
143310915|NCT02346240|516687010|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
143310916|NCT02346240|516687011|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
143310917|NCT02346240|516687012|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
143310918|NCT02346240|516687013|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
143310919|NCT02346240|516687014|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
143310920|NCT02346240|516687015|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
143310921|NCT02346240|516687016|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
143375975|NCT03482011|516920546|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
143310922|NCT02346240|516687017|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
143310923|NCT02346240|516687018|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
143310924|NCT02346240|516687019|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
143310925|NCT02346240|516686996|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
143310926|NCT02346240|516686997|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
143310927|NCT02346240|516686998|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
143310928|NCT02346240|516686999|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
143310929|NCT02346240|516687000|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
143310930|NCT02346240|516687001|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
143310931|NCT02346240|516687002|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
143310932|NCT02346240|516687003|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
143310933|NCT02346240|516687004|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
143310934|NCT02346240|516687005|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
143310935|NCT02346240|516687006|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
143310936|NCT02346240|516687007|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
143310937|NCT02346240|516687008|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
143310938|NCT02346240|516687009|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
143310939|NCT02346240|516687010|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
143310940|NCT02346240|516687011|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
143310941|NCT02346240|516687012|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
143310942|NCT02346240|516687013|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
143310943|NCT02346240|516687014|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
143310944|NCT02346240|516687015|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
143310945|NCT02346240|516687016|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
143310946|NCT02346240|516687017|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
143310947|NCT02346240|516687018|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
143310948|NCT02346240|516687019|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
143310949|NCT02346240|516686996|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
143310950|NCT02346240|516686997|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
143310951|NCT02346240|516686998|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
143310952|NCT02346240|516686999|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
143310953|NCT02346240|516687000|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
143310954|NCT02346240|516687001|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
143310955|NCT02346240|516687002|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
143310956|NCT02346240|516687003|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
143310957|NCT02346240|516687004|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
143310958|NCT02346240|516687005|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
143310959|NCT02346240|516687006|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
143310960|NCT02346240|516687007|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
143310961|NCT02346240|516687008|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
143310962|NCT02346240|516687009|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
143310963|NCT02346240|516687010|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
143310964|NCT02346240|516687011|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
143310965|NCT02346240|516687012|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
143310966|NCT02346240|516687013|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
143310967|NCT02346240|516687014|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
143310968|NCT02346240|516687015|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
143310969|NCT02346240|516687016|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
143310970|NCT02346240|516687017|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
143310971|NCT02346240|516687018|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
143310972|NCT02346240|516687019|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
143310973|NCT02346240|516686996|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
143310974|NCT02346240|516686997|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
143310975|NCT02346240|516686998|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
143310976|NCT02346240|516686999|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
143310977|NCT02346240|516687000|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
143310978|NCT02346240|516687001|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
143310979|NCT02346240|516687002|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
143310980|NCT02346240|516687003|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
143310981|NCT02346240|516687004|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
143310982|NCT02346240|516687005|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
143310983|NCT02346240|516687006|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
143310984|NCT02346240|516687007|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
143310985|NCT02346240|516687008|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
143310986|NCT02346240|516687009|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
143310987|NCT02346240|516687010|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
143310988|NCT02346240|516687011|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
143310989|NCT02346240|516687012|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
143310990|NCT02346240|516687013|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
143310991|NCT02346240|516687014|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
143310992|NCT02346240|516687015|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
143310993|NCT02346240|516687016|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
143310994|NCT02346240|516687017|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
143310995|NCT02346240|516687018|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
143310996|NCT02346240|516687019|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
143310997|NCT02346240|516686996|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
143310998|NCT02346240|516686997|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
143310999|NCT02346240|516686998|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
143311000|NCT02346240|516686999|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
143311001|NCT02346240|516687000|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
143311002|NCT02346240|516687001|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
143311003|NCT02346240|516687002|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
143311004|NCT02346240|516687003|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
143311005|NCT02346240|516687004|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
143311006|NCT02346240|516687005|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
143311007|NCT02346240|516687006|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
143311008|NCT02346240|516687007|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
143311009|NCT02346240|516687008|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
143311010|NCT02346240|516687009|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
143311011|NCT02346240|516687010|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
143311012|NCT02346240|516687011|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
143311013|NCT02346240|516687012|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
143311014|NCT02346240|516687013|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
143311015|NCT02346240|516687014|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
143311016|NCT02346240|516687015|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
143311017|NCT02346240|516687016|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
143311018|NCT02346240|516687017|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
143311019|NCT02346240|516687018|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
143311020|NCT02346240|516687019|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
143311021|NCT02346240|516686996|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143311022|NCT02346240|516686997|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143311023|NCT02346240|516686998|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143311024|NCT02346240|516686999|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143311025|NCT02346240|516687000|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143311026|NCT02346240|516687001|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143311027|NCT02346240|516687002|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143311028|NCT02346240|516687003|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143311029|NCT02346240|516687004|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143311030|NCT02346240|516687005|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143311031|NCT02346240|516687006|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143311032|NCT02346240|516687007|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143311033|NCT02346240|516687008|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143311034|NCT02346240|516687009|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143311035|NCT02346240|516687010|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143311036|NCT02346240|516687011|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143311037|NCT02346240|516687012|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143311038|NCT02346240|516687013|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143311039|NCT02346240|516687014|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
143311040|NCT02346240|516687015|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143311041|NCT02346240|516687016|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143311042|NCT02346240|516687017|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
143311043|NCT02346240|516687018|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143311044|NCT02346240|516687019|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
143311045|NCT02346240|516686996|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
143311046|NCT02346240|516686997|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
143311047|NCT02346240|516686998|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
143311048|NCT02346240|516686999|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
143311049|NCT02346240|516687000|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
143311050|NCT02346240|516687001|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
143311051|NCT02346240|516687002|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
143311052|NCT02346240|516687003|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
143311053|NCT02346240|516687004|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
143311054|NCT02346240|516687005|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
143375976|NCT03482011|516920547|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
143375977|NCT03482011|516920548|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
143375978|NCT03482011|516920549|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
143375979|NCT03482011|516920550|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
143375980|NCT03482011|516920551|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
143375981|NCT03475316|516920552|FG000|6 Month Intervention|Adverse Event|2|||
143311055|NCT02346240|516687006|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
143375982|NCT03475316|516920553|FG001|6 Month Intervention|Adverse Event|1|||
143375983|NCT03475316|516920552|FG000|6 Month Intervention|Withdrawal by Subject|2|||
143311056|NCT02346240|516687007|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
143311057|NCT02346240|516687008|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
143311058|NCT02346240|516687009|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
143311059|NCT02346240|516687010|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
143311060|NCT02346240|516687011|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
143311061|NCT02346240|516687012|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
143311062|NCT02346240|516687013|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
143311063|NCT02346240|516687014|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
143311064|NCT02346240|516687015|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
143311065|NCT02346240|516687016|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
143311066|NCT02346240|516687017|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
143311067|NCT02346240|516687018|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
143311068|NCT02346240|516687019|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
143311069|NCT02346240|516686996|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143311070|NCT02346240|516686997|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143311071|NCT02346240|516686998|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143311072|NCT02346240|516686999|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143311073|NCT02346240|516687000|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143311074|NCT02346240|516687001|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143311075|NCT02346240|516687002|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143311076|NCT02346240|516687003|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143311077|NCT02346240|516687004|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143311078|NCT02346240|516687005|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143311079|NCT02346240|516687006|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143311080|NCT02346240|516687007|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143311081|NCT02346240|516687008|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143311082|NCT02346240|516687009|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143311083|NCT02346240|516687010|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143311084|NCT02346240|516687011|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143311085|NCT02346240|516687012|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143311086|NCT02346240|516687013|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
143311087|NCT02346240|516687014|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
143311088|NCT02346240|516687015|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
143311089|NCT02346240|516687016|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
143311090|NCT02346240|516687017|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
143311091|NCT02346240|516687018|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
143311092|NCT02346240|516687019|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
143311093|NCT02346240|516686996|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143311094|NCT02346240|516686997|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143311095|NCT02346240|516686998|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143311096|NCT02346240|516686999|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143311097|NCT02346240|516687000|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143311098|NCT02346240|516687001|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143311099|NCT02346240|516687002|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143311100|NCT02346240|516687003|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143311101|NCT02346240|516687004|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143311102|NCT02346240|516687005|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143311103|NCT02346240|516687006|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143311104|NCT02346240|516687007|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143311105|NCT02346240|516687008|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143311106|NCT02346240|516687009|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143311107|NCT02346240|516687010|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143311108|NCT02346240|516687011|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143311109|NCT02346240|516687012|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143311110|NCT02346240|516687013|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143311111|NCT02346240|516687014|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
143311112|NCT02346240|516687015|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
143311113|NCT02346240|516687016|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
143311114|NCT02346240|516687017|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
143311115|NCT02346240|516687018|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
143311116|NCT02346240|516687019|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
143311117|NCT02346240|516686996|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
143311118|NCT02346240|516686997|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
143311119|NCT02346240|516686998|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
143311120|NCT02346240|516686999|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
143311121|NCT02346240|516687000|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
143311122|NCT02346240|516687001|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
143311123|NCT02346240|516687002|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
143311124|NCT02346240|516687003|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
143311125|NCT02346240|516687004|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
143311126|NCT02346240|516687005|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
143311127|NCT02346240|516687006|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
143311128|NCT02346240|516687007|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
143311129|NCT02346240|516687008|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
143311130|NCT02346240|516687009|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
143311131|NCT02346240|516687010|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
143311132|NCT02346240|516687011|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
143311133|NCT02346240|516687012|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
143311134|NCT02346240|516687013|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
143311135|NCT02346240|516687014|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
143311136|NCT02346240|516687015|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
143311137|NCT02346240|516687016|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
143311138|NCT02346240|516687017|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
143311139|NCT02346240|516687018|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
143311140|NCT02346240|516687019|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
143311141|NCT02346240|516686996|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
143311142|NCT02346240|516686997|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
143311143|NCT02346240|516686998|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
143311144|NCT02346240|516686999|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
143311145|NCT02346240|516687000|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
143311146|NCT02346240|516687001|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
143311147|NCT02346240|516687002|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
143311148|NCT02346240|516687003|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
143311149|NCT02346240|516687004|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
143311150|NCT02346240|516687005|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
143311151|NCT02346240|516687006|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
143311152|NCT02346240|516687007|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
143311153|NCT02346240|516687008|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
143311154|NCT02346240|516687009|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
143311155|NCT02346240|516687010|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
143375984|NCT03475316|516920553|FG001|6 Month Intervention|Withdrawal by Subject|0|||
143375985|NCT03475316|516920552|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
143311156|NCT02346240|516687011|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
143311157|NCT02346240|516687012|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
143311158|NCT02346240|516687013|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
143311159|NCT02346240|516687014|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
143311160|NCT02346240|516687015|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
143311161|NCT02346240|516687016|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
143311162|NCT02346240|516687017|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
143311163|NCT02346240|516687018|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
143311164|NCT02346240|516687019|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
143311165|NCT02114879|516687020|FG000|Overall Study|Withdrawal by Subject|9|||
143311166|NCT02114879|516687021|FG001|Overall Study|Withdrawal by Subject|5|||
143311167|NCT02114879|516687020|FG000|Overall Study|Death|6|||
143311168|NCT02114879|516687021|FG001|Overall Study|Death|11|||
143311169|NCT02114879|516687020|FG000|Overall Study|Lost to Follow-up|4|||
143311170|NCT02114879|516687021|FG001|Overall Study|Lost to Follow-up|6|||
143311171|NCT02114879|516687020|FG000|Overall Study|Physician Decision|0|||
143311172|NCT02114879|516687021|FG001|Overall Study|Physician Decision|2|||
143311173|NCT02152995|516687022|FG000|Overall Study|Withdrawal by Subject|1|||
143311174|NCT02152995|516687023|FG001|Overall Study|Withdrawal by Subject|0|||
143311175|NCT01365273|516687024|FG000|Overall Study|Lost to Follow-up|1|||
143311176|NCT01365273|516687025|FG001|Overall Study|Lost to Follow-up|0|||
143311177|NCT01365273|516687024|FG000|Overall Study|Protocol Violation|0|||
143311178|NCT01365273|516687025|FG001|Overall Study|Protocol Violation|1|||
143311179|NCT01365273|516687024|FG000|Overall Study|Physician Decision|1|||
143311180|NCT01365273|516687025|FG001|Overall Study|Physician Decision|0|||
143311181|NCT01524770|516687027|FG000|First Intervention|Withdrawal by Subject|1|||
143311182|NCT01524770|516687028|FG001|First Intervention|Withdrawal by Subject|0|||
143311183|NCT01524770|516687027|FG000|First Intervention|Adverse Event|1|||
143311184|NCT01524770|516687028|FG001|First Intervention|Adverse Event|1|||
143311185|NCT01524770|516687027|FG000|First Intervention|Protocol Violation|1|||
143311186|NCT01524770|516687028|FG001|First Intervention|Protocol Violation|0|||
143311187|NCT00989833|516687030|FG000|Overall Study|Lost to Follow-up|0|||
143311188|NCT00989833|516687031|FG001|Overall Study|Lost to Follow-up|1|||
143311189|NCT00989833|516687032|FG002|Overall Study|Lost to Follow-up|0|||
143311190|NCT00989833|516687030|FG000|Overall Study|Protocol Violation|1|||
143311191|NCT00989833|516687031|FG001|Overall Study|Protocol Violation|2|||
143311192|NCT00989833|516687032|FG002|Overall Study|Protocol Violation|1|||
143311193|NCT00989833|516687030|FG000|Overall Study|Withdrawal by Subject|0|||
143311194|NCT00989833|516687031|FG001|Overall Study|Withdrawal by Subject|0|||
143311195|NCT00989833|516687032|FG002|Overall Study|Withdrawal by Subject|1|||
143311196|NCT00989833|516687030|FG000|Overall Study|Incorrectly randomized|1|||
143311197|NCT00989833|516687031|FG001|Overall Study|Incorrectly randomized|0|||
143311198|NCT00989833|516687032|FG002|Overall Study|Incorrectly randomized|0|||
143311199|NCT02167256|516687033|FG000|Overall Study|Adverse Event|13|||
143311200|NCT02167256|516687034|FG001|Overall Study|Adverse Event|6|||
143311201|NCT02167256|516687033|FG000|Overall Study|Withdrawal by Subject|4|||
143311202|NCT02167256|516687034|FG001|Overall Study|Withdrawal by Subject|4|||
143311203|NCT02167256|516687033|FG000|Overall Study|non-compliance|3|||
143311204|NCT02167256|516687034|FG001|Overall Study|non-compliance|0|||
143311205|NCT02167256|516687033|FG000|Overall Study|Study partner unable to participate|1|||
143311206|NCT02167256|516687034|FG001|Overall Study|Study partner unable to participate|0|||
143311207|NCT00689481|516687038|FG000|Overall Study|Adverse Event|7|||
143311208|NCT00689481|516687039|FG001|Overall Study|Adverse Event|1|||
143311209|NCT00689481|516687038|FG000|Overall Study|Lost to Follow-up|4|||
143311210|NCT00689481|516687039|FG001|Overall Study|Lost to Follow-up|3|||
143311211|NCT00689481|516687038|FG000|Overall Study|Lack of Efficacy|4|||
143311212|NCT00689481|516687039|FG001|Overall Study|Lack of Efficacy|3|||
143311213|NCT00689481|516687038|FG000|Overall Study|Non-compliance with study treatment|1|||
143311214|NCT00689481|516687039|FG001|Overall Study|Non-compliance with study treatment|1|||
143311215|NCT00689481|516687038|FG000|Overall Study|Withdrawal by Subject|8|||
143311216|NCT00689481|516687039|FG001|Overall Study|Withdrawal by Subject|4|||
143311217|NCT00689481|516687038|FG000|Overall Study|Excluded medication started during study|0|||
143311218|NCT00689481|516687039|FG001|Overall Study|Excluded medication started during study|1|||
143311219|NCT00689481|516687038|FG000|Overall Study|Subject early term, left on vacation|0|||
143311220|NCT00689481|516687039|FG001|Overall Study|Subject early term, left on vacation|1|||
143311221|NCT03195478|516687042|FG000|Overall Study|Disease Progression|5|||
143311222|NCT03195478|516687043|FG001|Overall Study|Disease Progression|4|||
143311223|NCT03195478|516687044|FG002|Overall Study|Disease Progression|6|||
143311224|NCT03195478|516687045|FG003|Overall Study|Disease Progression|1|||
143311225|NCT03195478|516687042|FG000|Overall Study|Study Drug Toxicity|2|||
143311226|NCT03195478|516687043|FG001|Overall Study|Study Drug Toxicity|0|||
143311227|NCT03195478|516687044|FG002|Overall Study|Study Drug Toxicity|0|||
143311228|NCT03195478|516687045|FG003|Overall Study|Study Drug Toxicity|1|||
143311229|NCT03195478|516687042|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
143311230|NCT03195478|516687043|FG001|Overall Study|Participant requested to discontinue study treatment|1|||
143311231|NCT03195478|516687044|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
143311232|NCT03195478|516687045|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
143311233|NCT03195478|516687042|FG000|Overall Study|Participant Withdrew Consent|1|||
143311234|NCT03195478|516687043|FG001|Overall Study|Participant Withdrew Consent|0|||
143311235|NCT03195478|516687044|FG002|Overall Study|Participant Withdrew Consent|0|||
143311236|NCT03195478|516687045|FG003|Overall Study|Participant Withdrew Consent|0|||
143311237|NCT03195478|516687042|FG000|Overall Study|Maximum Clinical benefit|0|||
143311238|NCT03195478|516687043|FG001|Overall Study|Maximum Clinical benefit|0|||
143311239|NCT03195478|516687044|FG002|Overall Study|Maximum Clinical benefit|1|||
143311240|NCT03195478|516687045|FG003|Overall Study|Maximum Clinical benefit|0|||
143311241|NCT03195478|516687042|FG000|Overall Study|Other Reasons|0|||
143311242|NCT03195478|516687043|FG001|Overall Study|Other Reasons|0|||
143311243|NCT03195478|516687044|FG002|Overall Study|Other Reasons|1|||
143311244|NCT03195478|516687045|FG003|Overall Study|Other Reasons|0|||
143311245|NCT05044234|516688433|FG000|Overall Study|Lost to Follow-up|2|||
143311246|NCT05044234|516688434|FG001|Overall Study|Lost to Follow-up|1|||
143311247|NCT05044234|516688435|FG002|Overall Study|Lost to Follow-up|1|||
143311248|NCT05044234|516688436|FG003|Overall Study|Lost to Follow-up|2|||
143311249|NCT05044234|516688433|FG000|Overall Study|Withdrawal by Subject|6|||
143311250|NCT05044234|516688434|FG001|Overall Study|Withdrawal by Subject|4|||
143311251|NCT05044234|516688435|FG002|Overall Study|Withdrawal by Subject|5|||
143311252|NCT05044234|516688436|FG003|Overall Study|Withdrawal by Subject|8|||
143311253|NCT05044234|516688433|FG000|Overall Study|Study terminated by Sponsor|21|||
143311254|NCT05044234|516688434|FG001|Overall Study|Study terminated by Sponsor|21|||
143311255|NCT05044234|516688435|FG002|Overall Study|Study terminated by Sponsor|20|||
143311256|NCT05044234|516688436|FG003|Overall Study|Study terminated by Sponsor|14|||
143311257|NCT05044234|516688433|FG000|Overall Study|Other, not specified|0|||
143311258|NCT05044234|516688434|FG001|Overall Study|Other, not specified|0|||
143311259|NCT05044234|516688435|FG002|Overall Study|Other, not specified|1|||
143311260|NCT05044234|516688436|FG003|Overall Study|Other, not specified|2|||
143311261|NCT05044234|516688433|FG000|Overall Study|Delayed data entry|0|||
143311262|NCT05044234|516688434|FG001|Overall Study|Delayed data entry|0|||
143311263|NCT05044234|516688435|FG002|Overall Study|Delayed data entry|0|||
143311264|NCT05044234|516688436|FG003|Overall Study|Delayed data entry|1|||
143311265|NCT00279708|516688437|FG000|Overall Study|Withdrawal by Subject|2|||
143311266|NCT00279708|516688438|FG001|Overall Study|Withdrawal by Subject|3|||
143311267|NCT00279708|516688437|FG000|Overall Study|Adverse Event|1|||
143311268|NCT00279708|516688438|FG001|Overall Study|Adverse Event|1|||
143311269|NCT02940691|516688439|FG000|Overall Study|Lost to Follow-up|5|||
143311270|NCT02940691|516688439|FG000|Overall Study|Incarceration|1|||
143311271|NCT03912233|516688440|FG000|Overall Study|Adverse Event|1|||
143311272|NCT03912233|516688441|FG001|Overall Study|Adverse Event|0|||
143311273|NCT03912233|516688442|FG002|Overall Study|Adverse Event|0|||
143311274|NCT03912233|516688443|FG003|Overall Study|Adverse Event|0|||
143311275|NCT03912233|516688444|FG004|Overall Study|Adverse Event|0|||
143311276|NCT03912233|516688445|FG005|Overall Study|Adverse Event|0|||
143311277|NCT03912233|516688440|FG000|Overall Study|Physician Decision|1|||
143311278|NCT03912233|516688441|FG001|Overall Study|Physician Decision|0|||
143311279|NCT03912233|516688442|FG002|Overall Study|Physician Decision|0|||
143311280|NCT03912233|516688443|FG003|Overall Study|Physician Decision|0|||
143311281|NCT03912233|516688444|FG004|Overall Study|Physician Decision|0|||
143311282|NCT03912233|516688445|FG005|Overall Study|Physician Decision|0|||
143311283|NCT03912233|516688440|FG000|Overall Study|Other|0|||
143311284|NCT03912233|516688441|FG001|Overall Study|Other|0|||
143311285|NCT03912233|516688442|FG002|Overall Study|Other|0|||
143375986|NCT03475316|516920553|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
143311286|NCT03912233|516688443|FG003|Overall Study|Other|0|||
143311287|NCT03912233|516688444|FG004|Overall Study|Other|7|||
143311288|NCT03912233|516688445|FG005|Overall Study|Other|12|||
143311289|NCT00519649|516688447|FG000|Overall Study|Withdrawal by Subject|1|||
143311290|NCT00501540|516688448|FG000|Overall Study|Death|5|||
143311291|NCT04879745|516688449|FG000|Overall Study|Lost to Follow-up|4|||
143311292|NCT04879745|516688450|FG001|Overall Study|Lost to Follow-up|1|||
143311293|NCT03219333|516688451|FG000|Overall Study|Withdrawal by Subject|9|||
143311294|NCT03219333|516688452|FG001|Overall Study|Withdrawal by Subject|4|||
143375987|NCT03475316|516920552|FG000|9 Months|Study stopped due to COVID pandemic|3|||
143375988|NCT03475316|516920553|FG001|9 Months|Study stopped due to COVID pandemic|4|||
143375989|NCT00424645|516920554|FG000|Overall Study|Death|1|||
143311295|NCT03219333|516688451|FG000|Overall Study|Lost to Follow-up|1|||
143375990|NCT00424645|516920555|FG001|Overall Study|Death|0|||
143375991|NCT00468052|516920556|FG000|Overall Study|Protocol Violation|7|||
143375992|NCT00468052|516920557|FG001|Overall Study|Protocol Violation|8|||
143375993|NCT01909778|516920562|FG000|Overall Study|failed screening|1|||
143375994|NCT00919763|516920563|FG000|Overall Study|Adverse Event|7|||
143375995|NCT00919763|516920564|FG001|Overall Study|Adverse Event|1|||
143375996|NCT00919763|516920563|FG000|Overall Study|Lost to Follow-up|1|||
143311296|NCT03219333|516688452|FG001|Overall Study|Lost to Follow-up|1|||
143311297|NCT03219333|516688451|FG000|Overall Study|Death|104|||
143311298|NCT03219333|516688452|FG001|Overall Study|Death|72|||
143311299|NCT03219333|516688451|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
143311300|NCT03219333|516688452|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
143311301|NCT03219333|516688451|FG000|Overall Study|Other|2|||
143311302|NCT03219333|516688452|FG001|Overall Study|Other|2|||
143311303|NCT02566759|516688453|FG000|All Parts|Withdrawal by Subject|0|||
143311304|NCT02566759|516688454|FG001|All Parts|Withdrawal by Subject|1|||
143311305|NCT02566759|516688455|FG002|All Parts|Withdrawal by Subject|0|||
143311306|NCT02566759|516688456|FG003|All Parts|Withdrawal by Subject|0|||
143311307|NCT02566759|516688457|FG004|All Parts|Withdrawal by Subject|0|||
143311308|NCT02566759|516688458|FG005|All Parts|Withdrawal by Subject|0|||
143375997|NCT00919763|516920564|FG001|Overall Study|Lost to Follow-up|0|||
143375998|NCT00919763|516920563|FG000|Overall Study|Protocol Violation|1|||
143311309|NCT02566759|516688459|FG006|All Parts|Withdrawal by Subject|0|||
143375999|NCT00919763|516920564|FG001|Overall Study|Protocol Violation|1|||
143376000|NCT00919763|516920563|FG000|Overall Study|Withdrawal by Subject|3|||
143311310|NCT02566759|516688460|FG007|All Parts|Withdrawal by Subject|0|||
143311311|NCT02566759|516688461|FG008|All Parts|Withdrawal by Subject|0|||
143311312|NCT02566759|516688462|FG009|All Parts|Withdrawal by Subject|0|||
143311313|NCT02566759|516688463|FG010|All Parts|Withdrawal by Subject|0|||
143311314|NCT02566759|516688464|FG011|All Parts|Withdrawal by Subject|0|||
143311315|NCT02566759|516688465|FG012|All Parts|Withdrawal by Subject|0|||
143311316|NCT02566759|516688466|FG013|All Parts|Withdrawal by Subject|0|||
143311317|NCT02566759|516688467|FG014|All Parts|Withdrawal by Subject|0|||
143311318|NCT02566759|516688468|FG015|All Parts|Withdrawal by Subject|0|||
143311319|NCT02566759|516688469|FG016|All Parts|Withdrawal by Subject|0|||
143311320|NCT02566759|516688453|FG000|All Parts|Adverse Event|0|||
143311321|NCT02566759|516688454|FG001|All Parts|Adverse Event|0|||
143311322|NCT02566759|516688455|FG002|All Parts|Adverse Event|0|||
143311323|NCT02566759|516688456|FG003|All Parts|Adverse Event|0|||
143311324|NCT02566759|516688457|FG004|All Parts|Adverse Event|0|||
143311325|NCT02566759|516688458|FG005|All Parts|Adverse Event|0|||
143311326|NCT02566759|516688459|FG006|All Parts|Adverse Event|0|||
143311327|NCT02566759|516688460|FG007|All Parts|Adverse Event|0|||
143311328|NCT02566759|516688461|FG008|All Parts|Adverse Event|0|||
143311329|NCT02566759|516688462|FG009|All Parts|Adverse Event|0|||
143311330|NCT02566759|516688463|FG010|All Parts|Adverse Event|0|||
143311331|NCT02566759|516688464|FG011|All Parts|Adverse Event|0|||
143311332|NCT02566759|516688465|FG012|All Parts|Adverse Event|1|||
143311333|NCT02566759|516688466|FG013|All Parts|Adverse Event|3|||
143311334|NCT02566759|516688467|FG014|All Parts|Adverse Event|0|||
143311335|NCT02566759|516688468|FG015|All Parts|Adverse Event|0|||
143311336|NCT02566759|516688469|FG016|All Parts|Adverse Event|0|||
143311337|NCT02566759|516688453|FG000|All Parts|Other|0|||
143311338|NCT02566759|516688454|FG001|All Parts|Other|0|||
143311339|NCT02566759|516688455|FG002|All Parts|Other|0|||
143311340|NCT02566759|516688456|FG003|All Parts|Other|0|||
143311341|NCT02566759|516688457|FG004|All Parts|Other|0|||
143311342|NCT02566759|516688458|FG005|All Parts|Other|0|||
143311343|NCT02566759|516688459|FG006|All Parts|Other|0|||
143311344|NCT02566759|516688460|FG007|All Parts|Other|0|||
143311345|NCT02566759|516688461|FG008|All Parts|Other|0|||
143311346|NCT02566759|516688462|FG009|All Parts|Other|0|||
143311347|NCT02566759|516688463|FG010|All Parts|Other|0|||
143311348|NCT02566759|516688464|FG011|All Parts|Other|0|||
143311349|NCT02566759|516688465|FG012|All Parts|Other|0|||
143311350|NCT02566759|516688466|FG013|All Parts|Other|2|||
143311351|NCT02566759|516688467|FG014|All Parts|Other|0|||
143311352|NCT02566759|516688468|FG015|All Parts|Other|0|||
143311353|NCT02566759|516688469|FG016|All Parts|Other|0|||
143311354|NCT02566759|516688453|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
143311355|NCT02566759|516688454|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
143311356|NCT02566759|516688455|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
143311357|NCT02566759|516688456|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
143311358|NCT02566759|516688457|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
143311359|NCT02566759|516688458|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
143311360|NCT02566759|516688459|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
143311361|NCT02566759|516688460|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
143311362|NCT02566759|516688461|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
143311363|NCT02566759|516688462|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
143311364|NCT02566759|516688463|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
143311365|NCT02566759|516688464|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
143311366|NCT02566759|516688465|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
143311367|NCT02566759|516688466|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
143311368|NCT02566759|516688467|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
143311369|NCT02566759|516688468|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
143311370|NCT02566759|516688469|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
143311371|NCT02504372|516688470|FG000|Overall Study|Death|136|||
143311372|NCT02504372|516688471|FG001|Overall Study|Death|154|||
143311373|NCT02504372|516688470|FG000|Overall Study|Lost to Follow-up|0|||
143311374|NCT02504372|516688471|FG001|Overall Study|Lost to Follow-up|2|||
143311375|NCT02504372|516688470|FG000|Overall Study|Withdrawal of consent|25|||
143311376|NCT02504372|516688471|FG001|Overall Study|Withdrawal of consent|16|||
143311377|NCT02504372|516688470|FG000|Overall Study|Participants ongoing|429|||
143311378|NCT02504372|516688471|FG001|Overall Study|Participants ongoing|415|||
143311379|NCT03604692|516688476|FG000|Overall Study|Investigator's Decision|0|||
143311380|NCT03604692|516688477|FG001|Overall Study|Investigator's Decision|0|||
143311381|NCT03604692|516688478|FG002|Overall Study|Investigator's Decision|0|||
143311382|NCT03604692|516688479|FG003|Overall Study|Investigator's Decision|1|||
143311383|NCT03604692|516688480|FG004|Overall Study|Investigator's Decision|0|||
143311384|NCT03604692|516688481|FG005|Overall Study|Investigator's Decision|7|||
143311385|NCT03604692|516688476|FG000|Overall Study|Withdrawal by Subject|0|||
143311386|NCT03604692|516688477|FG001|Overall Study|Withdrawal by Subject|0|||
143311387|NCT03604692|516688478|FG002|Overall Study|Withdrawal by Subject|0|||
143311388|NCT03604692|516688479|FG003|Overall Study|Withdrawal by Subject|0|||
143311389|NCT03604692|516688480|FG004|Overall Study|Withdrawal by Subject|0|||
143311390|NCT03604692|516688481|FG005|Overall Study|Withdrawal by Subject|2|||
143311391|NCT03604692|516688476|FG000|Overall Study|Progressive Disease|1|||
143311392|NCT03604692|516688477|FG001|Overall Study|Progressive Disease|0|||
143311393|NCT03604692|516688478|FG002|Overall Study|Progressive Disease|1|||
143311394|NCT03604692|516688479|FG003|Overall Study|Progressive Disease|0|||
143311395|NCT03604692|516688480|FG004|Overall Study|Progressive Disease|3|||
143311396|NCT03604692|516688481|FG005|Overall Study|Progressive Disease|4|||
143311397|NCT03604692|516688476|FG000|Overall Study|Difficulty Coming into Site|0|||
143311398|NCT03604692|516688477|FG001|Overall Study|Difficulty Coming into Site|0|||
143311399|NCT03604692|516688478|FG002|Overall Study|Difficulty Coming into Site|0|||
143311400|NCT03604692|516688479|FG003|Overall Study|Difficulty Coming into Site|0|||
143311401|NCT03604692|516688480|FG004|Overall Study|Difficulty Coming into Site|0|||
143311402|NCT03604692|516688481|FG005|Overall Study|Difficulty Coming into Site|1|||
143311403|NCT03604692|516688476|FG000|Overall Study|Death|0|||
143311404|NCT03604692|516688477|FG001|Overall Study|Death|0|||
143311405|NCT03604692|516688478|FG002|Overall Study|Death|1|||
143311406|NCT03604692|516688479|FG003|Overall Study|Death|0|||
143311407|NCT03604692|516688480|FG004|Overall Study|Death|0|||
143311408|NCT03604692|516688481|FG005|Overall Study|Death|0|||
143311409|NCT03604692|516688476|FG000|Overall Study|Drug Intolerance|0|||
143311410|NCT03604692|516688477|FG001|Overall Study|Drug Intolerance|0|||
143311411|NCT03604692|516688478|FG002|Overall Study|Drug Intolerance|0|||
143311412|NCT03604692|516688479|FG003|Overall Study|Drug Intolerance|1|||
143311413|NCT03604692|516688480|FG004|Overall Study|Drug Intolerance|0|||
143311414|NCT03604692|516688481|FG005|Overall Study|Drug Intolerance|0|||
143311415|NCT03604692|516688476|FG000|Overall Study|Noncompliance with follow-up visit|0|||
143311416|NCT03604692|516688477|FG001|Overall Study|Noncompliance with follow-up visit|0|||
143311417|NCT03604692|516688478|FG002|Overall Study|Noncompliance with follow-up visit|0|||
143311418|NCT03604692|516688479|FG003|Overall Study|Noncompliance with follow-up visit|1|||
143311419|NCT03604692|516688480|FG004|Overall Study|Noncompliance with follow-up visit|0|||
143311420|NCT03604692|516688481|FG005|Overall Study|Noncompliance with follow-up visit|0|||
143311421|NCT03604692|516688476|FG000|Overall Study|Not Treated|0|||
143311422|NCT03604692|516688477|FG001|Overall Study|Not Treated|0|||
143311423|NCT03604692|516688478|FG002|Overall Study|Not Treated|0|||
143311424|NCT03604692|516688479|FG003|Overall Study|Not Treated|0|||
143311425|NCT03604692|516688480|FG004|Overall Study|Not Treated|1|||
143311426|NCT03604692|516688481|FG005|Overall Study|Not Treated|0|||
143311427|NCT04958109|516688483|FG000|Overall Study|Withdrawal by Subject|0|||
143311428|NCT04958109|516688484|FG001|Overall Study|Withdrawal by Subject|1|||
143311429|NCT04958109|516688483|FG000|Overall Study|Lost to Follow-up|0|||
143311430|NCT04958109|516688484|FG001|Overall Study|Lost to Follow-up|1|||
143311431|NCT02214121|516688485|FG000|Part A|Patient decision|2|||
143311432|NCT02214121|516688486|FG001|Part A|Patient decision|0|||
143311433|NCT02214121|516688487|FG002|Part A|Patient decision|0|||
143311434|NCT02214121|516688485|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
143311435|NCT02214121|516688486|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
143311436|NCT02214121|516688487|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
143311437|NCT02214121|516688485|FG000|Part A|Other|1|||
143311438|NCT02214121|516688486|FG001|Part A|Other|0|||
143311439|NCT02214121|516688487|FG002|Part A|Other|0|||
143311440|NCT02214121|516688485|FG000|Part B|Patient decision|0|||
143311441|NCT02214121|516688486|FG001|Part B|Patient decision|1|||
143311442|NCT02214121|516688487|FG002|Part B|Patient decision|0|||
143311443|NCT02214121|516688485|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
143311444|NCT02214121|516688486|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
143311445|NCT02214121|516688487|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
143311446|NCT02214121|516688485|FG000|Part B|Lost to Follow-up|0|||
143311447|NCT02214121|516688486|FG001|Part B|Lost to Follow-up|0|||
143311448|NCT02214121|516688487|FG002|Part B|Lost to Follow-up|1|||
143311449|NCT00715793|516688488|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
143311450|NCT00715793|516688489|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
143311451|NCT00715793|516688488|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
143311452|NCT00715793|516688489|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
143311453|NCT01573624|516688490|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
143311454|NCT01573624|516688491|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
143311455|NCT01573624|516688492|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
143311456|NCT01573624|516688493|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
143311457|NCT01573624|516688494|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
143311458|NCT01573624|516688495|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
143311459|NCT01573624|516688496|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
143311460|NCT01573624|516688490|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
143311461|NCT01573624|516688491|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
143311462|NCT01573624|516688492|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
143311463|NCT01573624|516688493|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
143311464|NCT01573624|516688494|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
143311465|NCT01573624|516688495|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
143311466|NCT01573624|516688496|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
143311467|NCT01573624|516688490|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
143311468|NCT01573624|516688491|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
143311469|NCT01573624|516688492|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
143311470|NCT01573624|516688493|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
143311471|NCT01573624|516688494|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
143311472|NCT01573624|516688495|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
143311473|NCT01573624|516688496|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
143311474|NCT01573624|516688490|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
143311475|NCT01573624|516688491|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
143311476|NCT01573624|516688492|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
143311477|NCT01573624|516688493|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
143311478|NCT01573624|516688494|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
143311479|NCT01573624|516688495|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
143311480|NCT01573624|516688496|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
143311481|NCT01573624|516688490|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
143311482|NCT01573624|516688491|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
143311483|NCT01573624|516688492|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
143311484|NCT01573624|516688493|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
143311485|NCT01573624|516688494|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
143311486|NCT01573624|516688495|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
143311487|NCT01573624|516688496|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
143311488|NCT01573624|516688490|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
143311489|NCT01573624|516688491|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
143311490|NCT01573624|516688492|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
143311491|NCT01573624|516688493|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
143311492|NCT01573624|516688494|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
143311493|NCT01573624|516688495|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
143311494|NCT01573624|516688496|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
143311495|NCT01573624|516688490|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
143311496|NCT01573624|516688491|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
143311497|NCT01573624|516688492|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
143311498|NCT01573624|516688493|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
143311499|NCT01573624|516688494|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
143311500|NCT01573624|516688495|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
143311501|NCT01573624|516688496|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
143311502|NCT01573624|516688490|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
143311503|NCT01573624|516688491|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
143311504|NCT01573624|516688492|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
143311505|NCT01573624|516688493|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
143311506|NCT01573624|516688494|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
143311507|NCT01573624|516688495|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
143311508|NCT01573624|516688496|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
143311509|NCT01573624|516688490|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
143311510|NCT01573624|516688491|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
143311511|NCT01573624|516688492|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
143311512|NCT01573624|516688493|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
143311513|NCT01573624|516688494|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
143311514|NCT01573624|516688495|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
143311515|NCT01573624|516688496|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
143311516|NCT01573624|516688490|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
143311517|NCT01573624|516688491|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
143311518|NCT01573624|516688492|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
143311519|NCT01573624|516688493|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
143311520|NCT01573624|516688494|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
143311521|NCT01573624|516688495|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
143311522|NCT01573624|516688496|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
143311523|NCT01573624|516688490|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
143311524|NCT01573624|516688491|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
143311525|NCT01573624|516688492|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
143311526|NCT01573624|516688493|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
143311527|NCT01573624|516688494|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
143311528|NCT01573624|516688495|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
143311529|NCT01573624|516688496|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
143311530|NCT01573624|516688490|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
143311531|NCT01573624|516688491|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
143311532|NCT01573624|516688492|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
143311533|NCT01573624|516688493|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
143311534|NCT01573624|516688494|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
143311535|NCT01573624|516688495|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
143311536|NCT01573624|516688496|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
143311537|NCT01573624|516688490|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
143311538|NCT01573624|516688491|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
143311539|NCT01573624|516688492|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
143311540|NCT01573624|516688493|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
143311541|NCT01573624|516688494|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
143311542|NCT01573624|516688495|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
143311543|NCT01573624|516688496|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
143311544|NCT01573624|516688490|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
143311545|NCT01573624|516688491|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
143311546|NCT01573624|516688492|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
143311547|NCT01573624|516688493|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
143311548|NCT01573624|516688494|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
143311549|NCT01573624|516688495|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
143311550|NCT01573624|516688496|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
143311551|NCT01573624|516688490|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
143311552|NCT01573624|516688491|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
143311553|NCT01573624|516688492|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
143311554|NCT01573624|516688493|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
143311555|NCT01573624|516688494|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
143311556|NCT01573624|516688495|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
143311557|NCT01573624|516688496|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
143311558|NCT01573624|516688490|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
143311559|NCT01573624|516688491|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
143311560|NCT01573624|516688492|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
143311561|NCT01573624|516688493|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
143311562|NCT01573624|516688494|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
143311563|NCT01573624|516688495|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
143311564|NCT01573624|516688496|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
143311565|NCT01573624|516688490|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
143311566|NCT01573624|516688491|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
143311567|NCT01573624|516688492|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
143311568|NCT01573624|516688493|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
143311569|NCT01573624|516688494|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
143311570|NCT01573624|516688495|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
143311571|NCT01573624|516688496|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
143311572|NCT01573624|516688490|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
143311573|NCT01573624|516688491|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
143311574|NCT01573624|516688492|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
143311575|NCT01573624|516688493|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
143311576|NCT01573624|516688494|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
143311577|NCT01573624|516688495|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
143311578|NCT01573624|516688496|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
143311579|NCT01573624|516688490|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
143311580|NCT01573624|516688491|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
143311581|NCT01573624|516688492|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
143311582|NCT01573624|516688493|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
143311583|NCT01573624|516688494|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
143311584|NCT01573624|516688495|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
143311585|NCT01573624|516688496|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
143311586|NCT01573624|516688490|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
143311587|NCT01573624|516688491|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
143311588|NCT01573624|516688492|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
143311589|NCT01573624|516688493|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
143311590|NCT01573624|516688494|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
143311591|NCT01573624|516688495|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
143311592|NCT01573624|516688496|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
143311593|NCT01573624|516688490|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
143376001|NCT00919763|516920564|FG001|Overall Study|Withdrawal by Subject|1|||
143376002|NCT00919763|516920563|FG000|Overall Study|Non-compliance|0|||
143376003|NCT00919763|516920564|FG001|Overall Study|Non-compliance|1|||
143311594|NCT01573624|516688491|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
143311595|NCT01573624|516688492|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
143311596|NCT01573624|516688493|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
143311597|NCT01573624|516688494|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
143311598|NCT01573624|516688495|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
143311599|NCT01573624|516688496|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
143311600|NCT01573624|516688490|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
143311601|NCT01573624|516688491|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
143311602|NCT01573624|516688492|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
143311603|NCT01573624|516688493|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
143311604|NCT01573624|516688494|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
143311605|NCT01573624|516688495|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
143311606|NCT01573624|516688496|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
143311607|NCT01573624|516688490|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
143311608|NCT01573624|516688491|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
143311609|NCT01573624|516688492|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
143311610|NCT01573624|516688493|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
143311611|NCT01573624|516688494|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
143311612|NCT01573624|516688495|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
143311613|NCT01573624|516688496|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
143311614|NCT01573624|516688490|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
143311615|NCT01573624|516688491|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
143311616|NCT01573624|516688492|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
143311617|NCT01573624|516688493|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
143311618|NCT01573624|516688494|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
143311619|NCT01573624|516688495|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
143311620|NCT01573624|516688496|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
143311621|NCT01573624|516688490|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
143311622|NCT01573624|516688491|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
143311623|NCT01573624|516688492|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
143311624|NCT01573624|516688493|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
143311625|NCT01573624|516688494|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
143311626|NCT01573624|516688495|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
143311627|NCT01573624|516688496|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
143311628|NCT01573624|516688490|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
143311629|NCT01573624|516688491|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
143311630|NCT01573624|516688492|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
143311631|NCT01573624|516688493|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
143311632|NCT01573624|516688494|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
143311633|NCT01573624|516688495|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
143311634|NCT01573624|516688496|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
143311635|NCT01573624|516688490|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
143376004|NCT02471755|516920565|FG000|Overall Study|Withdrawal by Subject|1|||
143376005|NCT02471755|516920566|FG001|Overall Study|Withdrawal by Subject|0|||
143376006|NCT02471755|516920565|FG000|Overall Study|Lost to Follow-up|0|||
143376007|NCT02471755|516920566|FG001|Overall Study|Lost to Follow-up|1|||
143376008|NCT01595321|516920570|FG000|Overall Study|Adverse Event|1|||
143376009|NCT01595321|516920571|FG001|Overall Study|Adverse Event|1|||
143311636|NCT01573624|516688491|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
143311637|NCT01573624|516688492|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
143311638|NCT01573624|516688493|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
143311639|NCT01573624|516688494|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
143311640|NCT01573624|516688495|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
143311641|NCT01573624|516688496|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
143311642|NCT02115282|516688497|FG000|Overall Study|Disease progression during treatment|216|||
143311643|NCT02115282|516688498|FG001|Overall Study|Disease progression during treatment|229|||
143311644|NCT02115282|516688497|FG000|Overall Study|Adverse Event|49|||
143311645|NCT02115282|516688498|FG001|Overall Study|Adverse Event|23|||
143311646|NCT02115282|516688497|FG000|Overall Study|Death|1|||
143311647|NCT02115282|516688498|FG001|Overall Study|Death|3|||
143311648|NCT02115282|516688497|FG000|Overall Study|Alternative therapy|1|||
143311649|NCT02115282|516688498|FG001|Overall Study|Alternative therapy|1|||
143311650|NCT02115282|516688497|FG000|Overall Study|Complicating disease|0|||
143311651|NCT02115282|516688498|FG001|Overall Study|Complicating disease|3|||
143311652|NCT02115282|516688497|FG000|Overall Study|Withdrawal by Subject|12|||
143311653|NCT02115282|516688498|FG001|Overall Study|Withdrawal by Subject|10|||
143311654|NCT02115282|516688497|FG000|Overall Study|Symptomatic progression/deterioration|7|||
143311655|NCT02115282|516688498|FG001|Overall Study|Symptomatic progression/deterioration|18|||
143311656|NCT02115282|516688497|FG000|Overall Study|Non-compliance|5|||
143311657|NCT02115282|516688498|FG001|Overall Study|Non-compliance|1|||
143311658|NCT02115282|516688497|FG000|Overall Study|Protocol Violation|2|||
143311659|NCT02115282|516688498|FG001|Overall Study|Protocol Violation|2|||
143311660|NCT02115282|516688497|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
143311661|NCT02115282|516688498|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
143311662|NCT02115282|516688497|FG000|Overall Study|Not start protocol therapy|9|||
143311663|NCT02115282|516688498|FG001|Overall Study|Not start protocol therapy|10|||
143311664|NCT04907032|516688504|FG000|Overall Study|Withdrawal by Subject|7|||
143311665|NCT04907032|516688505|FG001|Overall Study|Withdrawal by Subject|1|||
143311666|NCT04847674|516688514|FG000|Overall Study|Withdrawal by Subject|0|||
143311667|NCT04847674|516688515|FG001|Overall Study|Withdrawal by Subject|1|||
143311668|NCT04847674|516688516|FG002|Overall Study|Withdrawal by Subject|0|||
143311669|NCT04847674|516688514|FG000|Overall Study|Lost to Follow-up|0|||
143311670|NCT04847674|516688515|FG001|Overall Study|Lost to Follow-up|0|||
143311671|NCT04847674|516688516|FG002|Overall Study|Lost to Follow-up|2|||
143311672|NCT04847674|516688514|FG000|Overall Study|Other than specified|21|||
143311673|NCT04847674|516688515|FG001|Overall Study|Other than specified|20|||
143311674|NCT04847674|516688516|FG002|Overall Study|Other than specified|20|||
143311675|NCT02705820|516688517|FG000|Overall Study|Death|2|||
143311676|NCT02705820|516688517|FG000|Overall Study|Disease Progression|34|||
143311677|NCT02705820|516688517|FG000|Overall Study|Clinical Deterioration|3|||
143311678|NCT00677807|516688518|FG000|Overall Study|Adverse Event|4|||
143311679|NCT00677807|516688519|FG001|Overall Study|Adverse Event|1|||
143311680|NCT00677807|516688520|FG002|Overall Study|Adverse Event|6|||
143311681|NCT00677807|516688518|FG000|Overall Study|Lack of Efficacy|0|||
143311682|NCT00677807|516688519|FG001|Overall Study|Lack of Efficacy|0|||
143311683|NCT00677807|516688520|FG002|Overall Study|Lack of Efficacy|2|||
143311684|NCT00677807|516688518|FG000|Overall Study|Participant no longer needs study drug|0|||
143311685|NCT00677807|516688519|FG001|Overall Study|Participant no longer needs study drug|0|||
143311686|NCT00677807|516688520|FG002|Overall Study|Participant no longer needs study drug|1|||
143311687|NCT00677807|516688518|FG000|Overall Study|Withdrawal by Subject|10|||
143311688|NCT00677807|516688519|FG001|Overall Study|Withdrawal by Subject|3|||
143311689|NCT00677807|516688520|FG002|Overall Study|Withdrawal by Subject|6|||
143311690|NCT00677807|516688518|FG000|Overall Study|Lost to Follow-up|2|||
143311691|NCT00677807|516688519|FG001|Overall Study|Lost to Follow-up|2|||
143311692|NCT00677807|516688520|FG002|Overall Study|Lost to Follow-up|2|||
143311693|NCT00677807|516688518|FG000|Overall Study|Administrative problems|1|||
143311694|NCT00677807|516688519|FG001|Overall Study|Administrative problems|1|||
143376010|NCT01595321|516920572|FG002|Overall Study|Adverse Event|1|||
143311695|NCT00677807|516688520|FG002|Overall Study|Administrative problems|2|||
143311696|NCT00677807|516688518|FG000|Overall Study|Death|0|||
143311697|NCT00677807|516688519|FG001|Overall Study|Death|1|||
143311698|NCT00677807|516688520|FG002|Overall Study|Death|1|||
143311699|NCT00677807|516688518|FG000|Overall Study|Protocol Deviation|1|||
143311700|NCT00677807|516688519|FG001|Overall Study|Protocol Deviation|3|||
143311701|NCT00677807|516688520|FG002|Overall Study|Protocol Deviation|0|||
143311702|NCT00006916|516688526|FG000|Overall Study|Device not inserted|4|||
143311703|NCT00006916|516688526|FG000|Overall Study|Complication of device insertion|1|||
143311704|NCT00558103|516688527|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
143311705|NCT00558103|516688528|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
143311706|NCT00558103|516688529|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
143311707|NCT00558103|516688530|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
143311708|NCT00558103|516688531|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
143311709|NCT00558103|516688532|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
143311710|NCT00558103|516688527|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
143311711|NCT00558103|516688528|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
143311712|NCT00558103|516688529|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
143311713|NCT00558103|516688530|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
143311714|NCT00558103|516688531|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
143311715|NCT00558103|516688532|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
143311716|NCT00558103|516688527|FG000|Randomized Treatment Phase|Disease Progression|1|||
143311717|NCT00558103|516688528|FG001|Randomized Treatment Phase|Disease Progression|0|||
143311718|NCT00558103|516688529|FG002|Randomized Treatment Phase|Disease Progression|1|||
143311719|NCT00558103|516688530|FG003|Randomized Treatment Phase|Disease Progression|0|||
143311720|NCT00558103|516688531|FG004|Randomized Treatment Phase|Disease Progression|0|||
143311721|NCT00558103|516688532|FG005|Randomized Treatment Phase|Disease Progression|0|||
143311722|NCT00558103|516688527|FG000|Randomized Treatment Phase|Adverse Event|0|||
143311723|NCT00558103|516688528|FG001|Randomized Treatment Phase|Adverse Event|0|||
143311724|NCT00558103|516688529|FG002|Randomized Treatment Phase|Adverse Event|0|||
143311725|NCT00558103|516688530|FG003|Randomized Treatment Phase|Adverse Event|1|||
143311726|NCT00558103|516688531|FG004|Randomized Treatment Phase|Adverse Event|1|||
143311727|NCT00558103|516688532|FG005|Randomized Treatment Phase|Adverse Event|0|||
143311728|NCT00558103|516688527|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
143311729|NCT00558103|516688528|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
143311730|NCT00558103|516688529|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
143311731|NCT00558103|516688530|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
143311732|NCT00558103|516688531|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
143311733|NCT00558103|516688532|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
143311734|NCT00558103|516688527|FG000|Monotherapy Extension Phase|Disease Progression|0|||
143311735|NCT00558103|516688528|FG001|Monotherapy Extension Phase|Disease Progression|0|||
143311736|NCT00558103|516688529|FG002|Monotherapy Extension Phase|Disease Progression|0|||
143311737|NCT00558103|516688530|FG003|Monotherapy Extension Phase|Disease Progression|0|||
143311738|NCT00558103|516688531|FG004|Monotherapy Extension Phase|Disease Progression|0|||
143311739|NCT00558103|516688532|FG005|Monotherapy Extension Phase|Disease Progression|8|||
143311740|NCT00308711|516688534|FG000|Overall Study|Withdrawal by Subject|1|||
143311741|NCT00308711|516688535|FG001|Overall Study|Withdrawal by Subject|0|||
143311742|NCT00308711|516688536|FG002|Overall Study|Withdrawal by Subject|1|||
143311743|NCT00308711|516688534|FG000|Overall Study|Protocol Violation|0|||
143311744|NCT00308711|516688535|FG001|Overall Study|Protocol Violation|1|||
143311745|NCT00308711|516688536|FG002|Overall Study|Protocol Violation|1|||
143311746|NCT00308711|516688534|FG000|Overall Study|Lost to Follow-up|0|||
143311747|NCT00308711|516688535|FG001|Overall Study|Lost to Follow-up|1|||
143311748|NCT00308711|516688536|FG002|Overall Study|Lost to Follow-up|0|||
143311749|NCT00308711|516688534|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
143311750|NCT00308711|516688535|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
143311751|NCT00308711|516688536|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
143311752|NCT00308711|516688534|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
143311753|NCT00308711|516688535|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
143311754|NCT00308711|516688536|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
143311755|NCT01420081|516688537|FG000|Overall Study|Death|1|||
143311756|NCT01420081|516688538|FG001|Overall Study|Death|0|||
143311757|NCT01420081|516688539|FG002|Overall Study|Death|8|||
143311758|NCT01420081|516688540|FG003|Overall Study|Death|0|||
143311759|NCT01420081|516688541|FG004|Overall Study|Death|7|||
143311760|NCT01420081|516688542|FG005|Overall Study|Death|12|||
143311761|NCT01420081|516688543|FG006|Overall Study|Death|0|||
143311762|NCT01420081|516688544|FG007|Overall Study|Death|1|||
143311763|NCT01420081|516688545|FG008|Overall Study|Death|1|||
143311764|NCT01420081|516688537|FG000|Overall Study|Lost to Follow-up|0|||
143311765|NCT01420081|516688538|FG001|Overall Study|Lost to Follow-up|0|||
143311766|NCT01420081|516688539|FG002|Overall Study|Lost to Follow-up|0|||
143311767|NCT01420081|516688540|FG003|Overall Study|Lost to Follow-up|0|||
143311768|NCT01420081|516688541|FG004|Overall Study|Lost to Follow-up|1|||
143311769|NCT01420081|516688542|FG005|Overall Study|Lost to Follow-up|1|||
143311770|NCT01420081|516688543|FG006|Overall Study|Lost to Follow-up|0|||
143311771|NCT01420081|516688544|FG007|Overall Study|Lost to Follow-up|0|||
143311772|NCT01420081|516688545|FG008|Overall Study|Lost to Follow-up|0|||
143311773|NCT01420081|516688537|FG000|Overall Study|Study Terminated by Sponsor|2|||
143311774|NCT01420081|516688538|FG001|Overall Study|Study Terminated by Sponsor|1|||
143311775|NCT01420081|516688539|FG002|Overall Study|Study Terminated by Sponsor|1|||
143311776|NCT01420081|516688540|FG003|Overall Study|Study Terminated by Sponsor|3|||
143311777|NCT01420081|516688541|FG004|Overall Study|Study Terminated by Sponsor|11|||
143311778|NCT01420081|516688542|FG005|Overall Study|Study Terminated by Sponsor|7|||
143311779|NCT01420081|516688543|FG006|Overall Study|Study Terminated by Sponsor|3|||
143311780|NCT01420081|516688544|FG007|Overall Study|Study Terminated by Sponsor|2|||
143311781|NCT01420081|516688545|FG008|Overall Study|Study Terminated by Sponsor|2|||
143311782|NCT01420081|516688537|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
143311783|NCT01420081|516688538|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
143311784|NCT01420081|516688539|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
143311785|NCT01420081|516688540|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
143311786|NCT01420081|516688541|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
143311787|NCT01420081|516688542|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
143311788|NCT01420081|516688543|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
143311789|NCT01420081|516688544|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
143311790|NCT01420081|516688545|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
143311791|NCT01420081|516688537|FG000|Overall Study|Other Reasons|0|||
143311792|NCT01420081|516688538|FG001|Overall Study|Other Reasons|0|||
143311793|NCT01420081|516688539|FG002|Overall Study|Other Reasons|1|||
143311794|NCT01420081|516688540|FG003|Overall Study|Other Reasons|0|||
143311795|NCT01420081|516688541|FG004|Overall Study|Other Reasons|0|||
143311796|NCT01420081|516688542|FG005|Overall Study|Other Reasons|0|||
143311797|NCT01420081|516688543|FG006|Overall Study|Other Reasons|0|||
143311798|NCT01420081|516688544|FG007|Overall Study|Other Reasons|0|||
143311799|NCT01420081|516688545|FG008|Overall Study|Other Reasons|0|||
143311800|NCT00414388|516688546|FG000|Overall Study|Adverse Event|1|||
143311801|NCT03467425|516688547|FG000|Overall Study|Adverse Event|9|||
143311802|NCT03467425|516688548|FG001|Overall Study|Adverse Event|9|||
143311803|NCT03467425|516688547|FG000|Overall Study|Lack of Efficacy|3|||
143311804|NCT03467425|516688548|FG001|Overall Study|Lack of Efficacy|1|||
143311805|NCT03467425|516688547|FG000|Overall Study|Protocol Violation|0|||
143311806|NCT03467425|516688548|FG001|Overall Study|Protocol Violation|1|||
143311807|NCT03467425|516688547|FG000|Overall Study|Lost to Follow-up|18|||
143311808|NCT03467425|516688548|FG001|Overall Study|Lost to Follow-up|25|||
143311809|NCT03467425|516688547|FG000|Overall Study|Physician Decision|2|||
143311810|NCT03467425|516688548|FG001|Overall Study|Physician Decision|1|||
143311811|NCT03467425|516688547|FG000|Overall Study|Withdrawal by Subject|15|||
143311812|NCT03467425|516688548|FG001|Overall Study|Withdrawal by Subject|17|||
143311813|NCT02318693|516688550|FG000|Overall Study|Protocol Violation|0|||
143311814|NCT02318693|516688551|FG001|Overall Study|Protocol Violation|1|||
143311815|NCT01864291|516688552|FG000|Overall Study|need for revision surgery|2|||
143311816|NCT03337724|516688557|FG000|Overall Study|Reason not Specified|12|||
143311817|NCT03337724|516688558|FG001|Overall Study|Reason not Specified|21|||
143311818|NCT03337724|516688559|FG002|Overall Study|Reason not Specified|9|||
143311819|NCT03337724|516688560|FG003|Overall Study|Reason not Specified|9|||
143311820|NCT03337724|516688561|FG004|Overall Study|Reason not Specified|29|||
143311821|NCT03337724|516688557|FG000|Overall Study|Withdrawal by Subject|13|||
143311822|NCT03337724|516688558|FG001|Overall Study|Withdrawal by Subject|15|||
143311823|NCT03337724|516688559|FG002|Overall Study|Withdrawal by Subject|4|||
143311824|NCT03337724|516688560|FG003|Overall Study|Withdrawal by Subject|15|||
143311825|NCT03337724|516688561|FG004|Overall Study|Withdrawal by Subject|6|||
143311826|NCT03337724|516688557|FG000|Overall Study|Protocol Deviation|0|||
143311827|NCT03337724|516688558|FG001|Overall Study|Protocol Deviation|1|||
143311828|NCT03337724|516688559|FG002|Overall Study|Protocol Deviation|1|||
143311829|NCT03337724|516688560|FG003|Overall Study|Protocol Deviation|1|||
143311830|NCT03337724|516688561|FG004|Overall Study|Protocol Deviation|0|||
143311831|NCT03337724|516688557|FG000|Overall Study|Adverse Event|1|||
143311832|NCT03337724|516688558|FG001|Overall Study|Adverse Event|1|||
143311833|NCT03337724|516688559|FG002|Overall Study|Adverse Event|0|||
143311834|NCT03337724|516688560|FG003|Overall Study|Adverse Event|1|||
143311835|NCT03337724|516688561|FG004|Overall Study|Adverse Event|0|||
143311836|NCT03337724|516688557|FG000|Overall Study|Death|40|||
143311837|NCT03337724|516688558|FG001|Overall Study|Death|89|||
143311838|NCT03337724|516688559|FG002|Overall Study|Death|43|||
143311839|NCT03337724|516688560|FG003|Overall Study|Death|76|||
143311840|NCT03337724|516688561|FG004|Overall Study|Death|50|||
143311841|NCT03337724|516688557|FG000|Overall Study|Lost to Follow-up|5|||
143311842|NCT03337724|516688558|FG001|Overall Study|Lost to Follow-up|5|||
143311843|NCT03337724|516688559|FG002|Overall Study|Lost to Follow-up|4|||
143311844|NCT03337724|516688560|FG003|Overall Study|Lost to Follow-up|7|||
143311845|NCT03337724|516688561|FG004|Overall Study|Lost to Follow-up|4|||
143311846|NCT03337724|516688557|FG000|Overall Study|Physician Decision|16|||
143311847|NCT03337724|516688558|FG001|Overall Study|Physician Decision|34|||
143311848|NCT03337724|516688559|FG002|Overall Study|Physician Decision|14|||
143311849|NCT03337724|516688560|FG003|Overall Study|Physician Decision|34|||
143311850|NCT03337724|516688561|FG004|Overall Study|Physician Decision|13|||
143311851|NCT03337724|516688557|FG000|Overall Study|Progressive Disease|0|||
143311852|NCT03337724|516688558|FG001|Overall Study|Progressive Disease|2|||
143311853|NCT03337724|516688559|FG002|Overall Study|Progressive Disease|1|||
143311854|NCT03337724|516688560|FG003|Overall Study|Progressive Disease|2|||
143311855|NCT03337724|516688561|FG004|Overall Study|Progressive Disease|0|||
143311856|NCT03337724|516688557|FG000|Overall Study|Symptomatic Deterioration|0|||
143311857|NCT03337724|516688558|FG001|Overall Study|Symptomatic Deterioration|0|||
143311858|NCT03337724|516688559|FG002|Overall Study|Symptomatic Deterioration|0|||
143311859|NCT03337724|516688560|FG003|Overall Study|Symptomatic Deterioration|1|||
143311860|NCT03337724|516688561|FG004|Overall Study|Symptomatic Deterioration|0|||
143311861|NCT00773097|516688562|FG000|Overall Study|Withdrawal by Subject|1|||
143311862|NCT00773097|516688562|FG000|Overall Study|Physician Decision|6|||
143311863|NCT05645432|516688565|FG000|Overall Study|Withdrawal by Subject|1|||
143311864|NCT00533949|516690392|FG000|Overall Study|Protocol Violation|12|||
143311865|NCT00533949|516690393|FG001|Overall Study|Protocol Violation|12|||
143311866|NCT00533949|516690394|FG002|Overall Study|Protocol Violation|9|||
143311867|NCT00533949|516690395|FG003|Overall Study|Protocol Violation|9|||
143311868|NCT00533949|516690392|FG000|Overall Study|Withdrawal by Subject|3|||
143311869|NCT00533949|516690393|FG001|Overall Study|Withdrawal by Subject|2|||
143311870|NCT00533949|516690394|FG002|Overall Study|Withdrawal by Subject|1|||
143311871|NCT00533949|516690395|FG003|Overall Study|Withdrawal by Subject|1|||
143311872|NCT00727194|516690396|FG000|Screening Period|Low QMG scores|0|||
143311873|NCT00727194|516690397|FG001|Screening Period|Low QMG scores|0|||
143311874|NCT00727194|516690398|FG002|Screening Period|Low QMG scores|6|||
143311875|NCT00727194|516690396|FG000|Screening Period|Lacked AChR antibodies|0|||
143311876|NCT00727194|516690397|FG001|Screening Period|Lacked AChR antibodies|0|||
143311877|NCT00727194|516690398|FG002|Screening Period|Lacked AChR antibodies|5|||
143311878|NCT00727194|516690396|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
143311879|NCT00727194|516690397|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
143311880|NCT00727194|516690398|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
143311881|NCT00727194|516690396|FG000|Screening Period|Severe infections|0|||
143311882|NCT00727194|516690397|FG001|Screening Period|Severe infections|0|||
143311883|NCT00727194|516690398|FG002|Screening Period|Severe infections|2|||
143311884|NCT00727194|516690396|FG000|Screening Period|History of thymoma|0|||
143311885|NCT00727194|516690397|FG001|Screening Period|History of thymoma|0|||
143311886|NCT00727194|516690398|FG002|Screening Period|History of thymoma|1|||
143311887|NCT00727194|516690396|FG000|Treatment Period 2|Lack of Efficacy|0|||
143311888|NCT00727194|516690397|FG001|Treatment Period 2|Lack of Efficacy|1|||
143311889|NCT00727194|516690398|FG002|Treatment Period 2|Lack of Efficacy|0|||
143311890|NCT00023673|516690404|FG000|Overall Study|Ineligible / no protocol treatment|0|||
143311891|NCT00023673|516690405|FG001|Overall Study|Ineligible / no protocol treatment|0|||
143311892|NCT00023673|516690406|FG002|Overall Study|Ineligible / no protocol treatment|0|||
143311893|NCT00023673|516690407|FG003|Overall Study|Ineligible / no protocol treatment|1|||
143311894|NCT00023673|516690404|FG000|Overall Study|Patient withdrew consent|0|||
143311895|NCT00023673|516690405|FG001|Overall Study|Patient withdrew consent|0|||
143311896|NCT00023673|516690406|FG002|Overall Study|Patient withdrew consent|0|||
143311897|NCT00023673|516690407|FG003|Overall Study|Patient withdrew consent|1|||
143311898|NCT03285646|516690413|FG000|Overall Study|Adverse Event|1|||
143311899|NCT03285646|516690414|FG001|Overall Study|Adverse Event|0|||
143311900|NCT03285646|516690413|FG000|Overall Study|Withdrawal by Subject|10|||
143311901|NCT03285646|516690414|FG001|Overall Study|Withdrawal by Subject|2|||
143311902|NCT03285646|516690413|FG000|Overall Study|Lost to Follow-up|2|||
143311903|NCT03285646|516690414|FG001|Overall Study|Lost to Follow-up|1|||
143311904|NCT03285646|516690413|FG000|Overall Study|Investigator/Sponsor Decision|0|||
143311905|NCT03285646|516690414|FG001|Overall Study|Investigator/Sponsor Decision|1|||
143311906|NCT00548808|516690415|FG000|Overall Study|Lost to Follow-up|9|||
143311907|NCT00548808|516690416|FG001|Overall Study|Lost to Follow-up|3|||
143311908|NCT00548808|516690415|FG000|Overall Study|Protocol Violation|8|||
143376011|NCT01595321|516920570|FG000|Overall Study|Lack of Efficacy|0|||
143376012|NCT01595321|516920571|FG001|Overall Study|Lack of Efficacy|0|||
143311909|NCT00548808|516690416|FG001|Overall Study|Protocol Violation|8|||
143311910|NCT00548808|516690415|FG000|Overall Study|Withdrawal by Subject|8|||
143311911|NCT00548808|516690416|FG001|Overall Study|Withdrawal by Subject|4|||
143311912|NCT00548808|516690415|FG000|Overall Study|Physician Decision|6|||
143311913|NCT00548808|516690416|FG001|Overall Study|Physician Decision|3|||
143311914|NCT00548808|516690415|FG000|Overall Study|Adverse Event|4|||
143311915|NCT00548808|516690416|FG001|Overall Study|Adverse Event|5|||
143311916|NCT00548808|516690415|FG000|Overall Study|Death|2|||
143311917|NCT00548808|516690416|FG001|Overall Study|Death|0|||
143311918|NCT00548808|516690415|FG000|Overall Study|Entry Criteria Not Met|2|||
143311919|NCT00548808|516690416|FG001|Overall Study|Entry Criteria Not Met|2|||
143311920|NCT00548808|516690415|FG000|Overall Study|Lack of Efficacy|2|||
143311921|NCT00548808|516690416|FG001|Overall Study|Lack of Efficacy|0|||
143311922|NCT00548808|516690415|FG000|Overall Study|Sponsor Decision|1|||
143311923|NCT00548808|516690416|FG001|Overall Study|Sponsor Decision|1|||
143311924|NCT01023659|516690417|FG000|Overall Study|Lost to Follow-up|73|||
143311925|NCT01023659|516690418|FG001|Overall Study|Lost to Follow-up|228|||
143311926|NCT01023659|516690419|FG002|Overall Study|Lost to Follow-up|99|||
143311927|NCT02331446|516690420|FG000|Overall Study|Lost to Follow-up|2|||
143311928|NCT02331446|516690421|FG001|Overall Study|Lost to Follow-up|1|||
143311929|NCT02331446|516690422|FG002|Overall Study|Lost to Follow-up|0|||
143311930|NCT02331446|516690423|FG003|Overall Study|Lost to Follow-up|1|||
143311931|NCT02331446|516690420|FG000|Overall Study|Personal Problem|2|||
143311932|NCT02331446|516690421|FG001|Overall Study|Personal Problem|0|||
143311933|NCT02331446|516690422|FG002|Overall Study|Personal Problem|0|||
143311934|NCT02331446|516690423|FG003|Overall Study|Personal Problem|0|||
143311935|NCT02331446|516690420|FG000|Overall Study|Disease|0|||
143311936|NCT02331446|516690421|FG001|Overall Study|Disease|2|||
143311937|NCT02331446|516690422|FG002|Overall Study|Disease|2|||
143311938|NCT02331446|516690423|FG003|Overall Study|Disease|1|||
143311939|NCT02331446|516690420|FG000|Overall Study|Physician Decision|0|||
143311940|NCT02331446|516690421|FG001|Overall Study|Physician Decision|1|||
143311941|NCT02331446|516690422|FG002|Overall Study|Physician Decision|0|||
143311942|NCT02331446|516690423|FG003|Overall Study|Physician Decision|1|||
143311943|NCT02331446|516690420|FG000|Overall Study|Lost before baseline analysis|0|||
143311944|NCT02331446|516690421|FG001|Overall Study|Lost before baseline analysis|1|||
143311945|NCT02331446|516690422|FG002|Overall Study|Lost before baseline analysis|1|||
143311946|NCT02331446|516690423|FG003|Overall Study|Lost before baseline analysis|0|||
143311947|NCT01049919|516690425|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
143311948|NCT01049919|516690426|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
143311949|NCT01049919|516690425|FG000|Overall Study|Withdrawal by Subject|5|||
143311950|NCT01049919|516690426|FG001|Overall Study|Withdrawal by Subject|0|||
143311951|NCT01049919|516690425|FG000|Overall Study|Lost to Follow-up|6|||
143311952|NCT01049919|516690426|FG001|Overall Study|Lost to Follow-up|1|||
143311953|NCT01049919|516690425|FG000|Overall Study|Physician Decision|2|||
143311954|NCT01049919|516690426|FG001|Overall Study|Physician Decision|0|||
143311955|NCT01049919|516690425|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
143311956|NCT01049919|516690426|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
143311957|NCT01049919|516690425|FG000|Overall Study|Early study termination by sponsor.|2|||
143311958|NCT01049919|516690426|FG001|Overall Study|Early study termination by sponsor.|0|||
143311959|NCT01126541|516690427|FG000|Overall Study|Adverse Event|0|||
143311960|NCT01126541|516690428|FG001|Overall Study|Adverse Event|2|||
143311961|NCT01126541|516690429|FG002|Overall Study|Adverse Event|4|||
143311962|NCT01126541|516690427|FG000|Overall Study|Death|0|||
143311963|NCT01126541|516690428|FG001|Overall Study|Death|1|||
143311964|NCT01126541|516690429|FG002|Overall Study|Death|0|||
143311965|NCT01126541|516690427|FG000|Overall Study|Lack of Efficacy|6|||
143311966|NCT01126541|516690428|FG001|Overall Study|Lack of Efficacy|1|||
143311967|NCT01126541|516690429|FG002|Overall Study|Lack of Efficacy|11|||
143311968|NCT01126541|516690427|FG000|Overall Study|Lost to Follow-up|1|||
143311969|NCT01126541|516690428|FG001|Overall Study|Lost to Follow-up|2|||
143311970|NCT01126541|516690429|FG002|Overall Study|Lost to Follow-up|2|||
143311971|NCT01126541|516690427|FG000|Overall Study|Withdrawal by Subject|2|||
143311972|NCT01126541|516690428|FG001|Overall Study|Withdrawal by Subject|5|||
143311973|NCT01126541|516690429|FG002|Overall Study|Withdrawal by Subject|6|||
143311974|NCT01126541|516690427|FG000|Overall Study|Protocol Violation|0|||
143311975|NCT01126541|516690428|FG001|Overall Study|Protocol Violation|0|||
143311976|NCT01126541|516690429|FG002|Overall Study|Protocol Violation|1|||
143311977|NCT01126541|516690427|FG000|Overall Study|Administrative reason or other|1|||
143311978|NCT01126541|516690428|FG001|Overall Study|Administrative reason or other|1|||
143311979|NCT01126541|516690429|FG002|Overall Study|Administrative reason or other|2|||
143311980|NCT02984995|516690430|FG000|Overall Study|Required stem cell transplant|13|||
143311981|NCT02984995|516690431|FG001|Overall Study|Required stem cell transplant|2|||
143311982|NCT02984995|516690430|FG000|Overall Study|Progressive disease|11|||
143311983|NCT02984995|516690431|FG001|Overall Study|Progressive disease|1|||
143311984|NCT02984995|516690430|FG000|Overall Study|Adverse Event|1|||
143311985|NCT02984995|516690431|FG001|Overall Study|Adverse Event|0|||
143311986|NCT01401530|516690432|FG000|Overall Study|Disease Progression|1|||
143311987|NCT01401530|516690433|FG001|Overall Study|Disease Progression|2|||
143311988|NCT01401530|516690434|FG002|Overall Study|Disease Progression|1|||
143311989|NCT01401530|516690432|FG000|Overall Study|Adverse Event|1|||
143311990|NCT01401530|516690433|FG001|Overall Study|Adverse Event|1|||
143311991|NCT01401530|516690434|FG002|Overall Study|Adverse Event|1|||
143311992|NCT01401530|516690432|FG000|Overall Study|Participant Choice|1|||
143311993|NCT01401530|516690433|FG001|Overall Study|Participant Choice|2|||
143311994|NCT01401530|516690434|FG002|Overall Study|Participant Choice|1|||
143311995|NCT01401530|516690432|FG000|Overall Study|Physician Decision|0|||
143311996|NCT01401530|516690433|FG001|Overall Study|Physician Decision|1|||
143311997|NCT01401530|516690434|FG002|Overall Study|Physician Decision|0|||
143311998|NCT01470469|516690435|FG000|Overall Study|Withdrawal by Subject|4|||
143311999|NCT01470469|516690436|FG001|Overall Study|Withdrawal by Subject|6|||
143312000|NCT01470469|516690435|FG000|Overall Study|Lack of Efficacy|1|||
143312001|NCT01470469|516690436|FG001|Overall Study|Lack of Efficacy|7|||
143312002|NCT01470469|516690435|FG000|Overall Study|Adverse Event|0|||
143312003|NCT01470469|516690436|FG001|Overall Study|Adverse Event|7|||
143312004|NCT01470469|516690435|FG000|Overall Study|Lost to Follow-up|2|||
143312005|NCT01470469|516690436|FG001|Overall Study|Lost to Follow-up|2|||
143312006|NCT01470469|516690435|FG000|Overall Study|Protocol Violation|1|||
143312007|NCT01470469|516690436|FG001|Overall Study|Protocol Violation|1|||
143312008|NCT01470469|516690435|FG000|Overall Study|Other|2|||
143312009|NCT01470469|516690436|FG001|Overall Study|Other|1|||
143312010|NCT03670810|516690437|FG000|Main Study|Adverse Event|37|||
143312011|NCT03670810|516690438|FG001|Main Study|Adverse Event|38|||
143312012|NCT03670810|516690439|FG002|Main Study|Adverse Event|3|||
143312013|NCT03670810|516690440|FG003|Main Study|Adverse Event|4|||
143312014|NCT03670810|516690441|FG004|Main Study|Adverse Event|4|||
143312015|NCT03670810|516690442|FG005|Main Study|Adverse Event|5|||
143312016|NCT03670810|516690443|FG006|Main Study|Adverse Event|0|||
143312017|NCT03670810|516690444|FG007|Main Study|Adverse Event|0|||
143312018|NCT03670810|516690445|FG008|Main Study|Adverse Event|0|||
143312019|NCT03670810|516690437|FG000|Main Study|Lack of Efficacy|8|||
143312020|NCT03670810|516690438|FG001|Main Study|Lack of Efficacy|9|||
143312021|NCT03670810|516690439|FG002|Main Study|Lack of Efficacy|3|||
143312022|NCT03670810|516690440|FG003|Main Study|Lack of Efficacy|4|||
143312023|NCT03670810|516690441|FG004|Main Study|Lack of Efficacy|0|||
143312024|NCT03670810|516690442|FG005|Main Study|Lack of Efficacy|0|||
143312025|NCT03670810|516690443|FG006|Main Study|Lack of Efficacy|0|||
143312026|NCT03670810|516690444|FG007|Main Study|Lack of Efficacy|0|||
143312027|NCT03670810|516690445|FG008|Main Study|Lack of Efficacy|0|||
143312028|NCT03670810|516690437|FG000|Main Study|Lost to Follow-up|9|||
143312029|NCT03670810|516690438|FG001|Main Study|Lost to Follow-up|7|||
143312030|NCT03670810|516690439|FG002|Main Study|Lost to Follow-up|4|||
143312031|NCT03670810|516690440|FG003|Main Study|Lost to Follow-up|6|||
143312032|NCT03670810|516690441|FG004|Main Study|Lost to Follow-up|1|||
143312033|NCT03670810|516690442|FG005|Main Study|Lost to Follow-up|0|||
143312034|NCT03670810|516690443|FG006|Main Study|Lost to Follow-up|0|||
143312035|NCT03670810|516690444|FG007|Main Study|Lost to Follow-up|0|||
143312036|NCT03670810|516690445|FG008|Main Study|Lost to Follow-up|0|||
143312037|NCT03670810|516690437|FG000|Main Study|Non-compliance with Study Drug|0|||
143312038|NCT03670810|516690438|FG001|Main Study|Non-compliance with Study Drug|2|||
143312039|NCT03670810|516690439|FG002|Main Study|Non-compliance with Study Drug|3|||
143312040|NCT03670810|516690440|FG003|Main Study|Non-compliance with Study Drug|0|||
143312041|NCT03670810|516690441|FG004|Main Study|Non-compliance with Study Drug|0|||
143312042|NCT03670810|516690442|FG005|Main Study|Non-compliance with Study Drug|0|||
143312043|NCT03670810|516690443|FG006|Main Study|Non-compliance with Study Drug|0|||
143312044|NCT03670810|516690444|FG007|Main Study|Non-compliance with Study Drug|1|||
143312045|NCT03670810|516690445|FG008|Main Study|Non-compliance with Study Drug|0|||
143312046|NCT03670810|516690437|FG000|Main Study|Physician Decision|3|||
143312047|NCT03670810|516690438|FG001|Main Study|Physician Decision|0|||
143312048|NCT03670810|516690439|FG002|Main Study|Physician Decision|1|||
143312049|NCT03670810|516690440|FG003|Main Study|Physician Decision|0|||
143312050|NCT03670810|516690441|FG004|Main Study|Physician Decision|0|||
143312051|NCT03670810|516690442|FG005|Main Study|Physician Decision|0|||
143312052|NCT03670810|516690443|FG006|Main Study|Physician Decision|1|||
143312053|NCT03670810|516690444|FG007|Main Study|Physician Decision|1|||
143312054|NCT03670810|516690445|FG008|Main Study|Physician Decision|0|||
143312055|NCT03670810|516690437|FG000|Main Study|Pregnancy|1|||
143312056|NCT03670810|516690438|FG001|Main Study|Pregnancy|2|||
143312057|NCT03670810|516690439|FG002|Main Study|Pregnancy|0|||
143312058|NCT03670810|516690440|FG003|Main Study|Pregnancy|0|||
143312059|NCT03670810|516690441|FG004|Main Study|Pregnancy|0|||
143312060|NCT03670810|516690442|FG005|Main Study|Pregnancy|0|||
143312061|NCT03670810|516690443|FG006|Main Study|Pregnancy|0|||
143312062|NCT03670810|516690444|FG007|Main Study|Pregnancy|0|||
143312063|NCT03670810|516690445|FG008|Main Study|Pregnancy|0|||
143312064|NCT03670810|516690437|FG000|Main Study|Protocol Deviation|2|||
143312065|NCT03670810|516690438|FG001|Main Study|Protocol Deviation|12|||
143312066|NCT03670810|516690439|FG002|Main Study|Protocol Deviation|8|||
143312067|NCT03670810|516690440|FG003|Main Study|Protocol Deviation|4|||
143312068|NCT03670810|516690441|FG004|Main Study|Protocol Deviation|0|||
143312069|NCT03670810|516690442|FG005|Main Study|Protocol Deviation|0|||
143312070|NCT03670810|516690443|FG006|Main Study|Protocol Deviation|0|||
143312071|NCT03670810|516690444|FG007|Main Study|Protocol Deviation|0|||
143312072|NCT03670810|516690445|FG008|Main Study|Protocol Deviation|0|||
143312073|NCT03670810|516690437|FG000|Main Study|Withdrawal by Subject|21|||
143312074|NCT03670810|516690438|FG001|Main Study|Withdrawal by Subject|21|||
143312075|NCT03670810|516690439|FG002|Main Study|Withdrawal by Subject|8|||
143312076|NCT03670810|516690440|FG003|Main Study|Withdrawal by Subject|9|||
143312077|NCT03670810|516690441|FG004|Main Study|Withdrawal by Subject|5|||
143312078|NCT03670810|516690442|FG005|Main Study|Withdrawal by Subject|2|||
143312079|NCT03670810|516690443|FG006|Main Study|Withdrawal by Subject|1|||
143312080|NCT03670810|516690444|FG007|Main Study|Withdrawal by Subject|1|||
143312081|NCT03670810|516690445|FG008|Main Study|Withdrawal by Subject|0|||
143312082|NCT03670810|516690437|FG000|Main Study|Participant did not want to take the three other treatments|1|||
143312083|NCT03670810|516690438|FG001|Main Study|Participant did not want to take the three other treatments|0|||
143312084|NCT03670810|516690439|FG002|Main Study|Participant did not want to take the three other treatments|0|||
143312085|NCT03670810|516690440|FG003|Main Study|Participant did not want to take the three other treatments|0|||
143312086|NCT03670810|516690441|FG004|Main Study|Participant did not want to take the three other treatments|0|||
143312087|NCT03670810|516690442|FG005|Main Study|Participant did not want to take the three other treatments|0|||
143312088|NCT03670810|516690443|FG006|Main Study|Participant did not want to take the three other treatments|0|||
143312089|NCT03670810|516690444|FG007|Main Study|Participant did not want to take the three other treatments|0|||
143312090|NCT03670810|516690445|FG008|Main Study|Participant did not want to take the three other treatments|0|||
143312091|NCT03670810|516690437|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
143312092|NCT03670810|516690438|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
143312093|NCT03670810|516690439|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
143312094|NCT03670810|516690440|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
143312095|NCT03670810|516690441|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
143312096|NCT03670810|516690442|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
143312097|NCT03670810|516690443|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
143312098|NCT03670810|516690444|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
143312099|NCT03670810|516690445|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
143312100|NCT03670810|516690437|FG000|Main Study|Travel and Coronavirus issues|0|||
143312101|NCT03670810|516690438|FG001|Main Study|Travel and Coronavirus issues|0|||
143312102|NCT03670810|516690439|FG002|Main Study|Travel and Coronavirus issues|0|||
143312103|NCT03670810|516690440|FG003|Main Study|Travel and Coronavirus issues|1|||
143312104|NCT03670810|516690441|FG004|Main Study|Travel and Coronavirus issues|0|||
143312105|NCT03670810|516690442|FG005|Main Study|Travel and Coronavirus issues|0|||
143312106|NCT03670810|516690443|FG006|Main Study|Travel and Coronavirus issues|0|||
143312107|NCT03670810|516690444|FG007|Main Study|Travel and Coronavirus issues|0|||
143312108|NCT03670810|516690445|FG008|Main Study|Travel and Coronavirus issues|0|||
143312109|NCT03670810|516690437|FG000|Open Label Extension|Protocol Deviation|0|||
143312110|NCT03670810|516690438|FG001|Open Label Extension|Protocol Deviation|0|||
143312111|NCT03670810|516690439|FG002|Open Label Extension|Protocol Deviation|0|||
143312112|NCT03670810|516690440|FG003|Open Label Extension|Protocol Deviation|0|||
143312113|NCT03670810|516690441|FG004|Open Label Extension|Protocol Deviation|0|||
143312114|NCT03670810|516690442|FG005|Open Label Extension|Protocol Deviation|0|||
143312115|NCT03670810|516690443|FG006|Open Label Extension|Protocol Deviation|0|||
143312116|NCT03670810|516690444|FG007|Open Label Extension|Protocol Deviation|0|||
143312117|NCT03670810|516690445|FG008|Open Label Extension|Protocol Deviation|5|||
143312118|NCT03670810|516690437|FG000|Open Label Extension|Death|0|||
143312119|NCT03670810|516690438|FG001|Open Label Extension|Death|0|||
143312120|NCT03670810|516690439|FG002|Open Label Extension|Death|0|||
143312121|NCT03670810|516690440|FG003|Open Label Extension|Death|0|||
143312122|NCT03670810|516690441|FG004|Open Label Extension|Death|0|||
143312123|NCT03670810|516690442|FG005|Open Label Extension|Death|0|||
143312124|NCT03670810|516690443|FG006|Open Label Extension|Death|0|||
143312125|NCT03670810|516690444|FG007|Open Label Extension|Death|0|||
143312126|NCT03670810|516690445|FG008|Open Label Extension|Death|1|||
143312127|NCT03670810|516690437|FG000|Open Label Extension|COVID-19|0|||
143312128|NCT03670810|516690438|FG001|Open Label Extension|COVID-19|0|||
143312129|NCT03670810|516690439|FG002|Open Label Extension|COVID-19|0|||
143312130|NCT03670810|516690440|FG003|Open Label Extension|COVID-19|0|||
143312131|NCT03670810|516690441|FG004|Open Label Extension|COVID-19|0|||
143312132|NCT03670810|516690442|FG005|Open Label Extension|COVID-19|0|||
143312133|NCT03670810|516690443|FG006|Open Label Extension|COVID-19|0|||
143376013|NCT01595321|516920572|FG002|Overall Study|Lack of Efficacy|4|||
143376014|NCT00686855|516921615|FG000|Overall Study|Lost to Follow-up|1|||
143376015|NCT00686855|516921616|FG001|Overall Study|Lost to Follow-up|0|||
143312134|NCT03670810|516690444|FG007|Open Label Extension|COVID-19|0|||
143312135|NCT03670810|516690445|FG008|Open Label Extension|COVID-19|1|||
143312136|NCT03670810|516690437|FG000|Open Label Extension|Lack of Efficacy|0|||
143312137|NCT03670810|516690438|FG001|Open Label Extension|Lack of Efficacy|0|||
143312138|NCT03670810|516690439|FG002|Open Label Extension|Lack of Efficacy|0|||
143312139|NCT03670810|516690440|FG003|Open Label Extension|Lack of Efficacy|0|||
143312140|NCT03670810|516690441|FG004|Open Label Extension|Lack of Efficacy|0|||
143312141|NCT03670810|516690442|FG005|Open Label Extension|Lack of Efficacy|0|||
143312142|NCT03670810|516690443|FG006|Open Label Extension|Lack of Efficacy|0|||
143312143|NCT03670810|516690444|FG007|Open Label Extension|Lack of Efficacy|0|||
143312144|NCT03670810|516690445|FG008|Open Label Extension|Lack of Efficacy|39|||
143312145|NCT03670810|516690437|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
143312146|NCT03670810|516690438|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
143312147|NCT03670810|516690439|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
143312148|NCT03670810|516690440|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
143312149|NCT03670810|516690441|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
143312150|NCT03670810|516690442|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
143312151|NCT03670810|516690443|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
143312152|NCT03670810|516690444|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
143312153|NCT03670810|516690445|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
143312154|NCT03670810|516690437|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
143312155|NCT03670810|516690438|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
143312156|NCT03670810|516690439|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
143312157|NCT03670810|516690440|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
143312158|NCT03670810|516690441|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
143312159|NCT03670810|516690442|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
143312160|NCT03670810|516690443|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
143376016|NCT00686855|516921615|FG000|Overall Study|Progressive GVHD|0|||
143376017|NCT00686855|516921616|FG001|Overall Study|Progressive GVHD|1|||
143376018|NCT02731755|516921617|FG000|First Intervention|Withdrawal by Subject|0|||
143376019|NCT02731755|516921618|FG001|First Intervention|Withdrawal by Subject|2|||
143376020|NCT01582100|516921627|FG000|Overall Study|Adverse Event|1|||
143376021|NCT01582100|516921627|FG000|Overall Study|Withdrawal by Subject|1|||
143376022|NCT01040689|516921628|FG000|Overall Study|Adverse Event|0|||
143376023|NCT01040689|516921629|FG001|Overall Study|Adverse Event|0|||
143376024|NCT01040689|516921630|FG002|Overall Study|Adverse Event|2|||
143376025|NCT01040689|516921631|FG003|Overall Study|Adverse Event|4|||
143376026|NCT01040689|516921628|FG000|Overall Study|Lack of Efficacy|0|||
143376027|NCT01040689|516921629|FG001|Overall Study|Lack of Efficacy|0|||
143376028|NCT01040689|516921630|FG002|Overall Study|Lack of Efficacy|1|||
143376029|NCT01040689|516921631|FG003|Overall Study|Lack of Efficacy|0|||
143312161|NCT03670810|516690444|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
143312162|NCT03670810|516690445|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
143312163|NCT03670810|516690437|FG000|Open Label Extension|Withdrawal by Subject|0|||
143312164|NCT03670810|516690438|FG001|Open Label Extension|Withdrawal by Subject|0|||
143312165|NCT03670810|516690439|FG002|Open Label Extension|Withdrawal by Subject|0|||
143312166|NCT03670810|516690440|FG003|Open Label Extension|Withdrawal by Subject|0|||
143312167|NCT03670810|516690441|FG004|Open Label Extension|Withdrawal by Subject|0|||
143312168|NCT03670810|516690442|FG005|Open Label Extension|Withdrawal by Subject|0|||
143312169|NCT03670810|516690443|FG006|Open Label Extension|Withdrawal by Subject|0|||
143312170|NCT03670810|516690444|FG007|Open Label Extension|Withdrawal by Subject|0|||
143312171|NCT03670810|516690445|FG008|Open Label Extension|Withdrawal by Subject|46|||
143312172|NCT03670810|516690437|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
143312173|NCT03670810|516690438|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
143312174|NCT03670810|516690439|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
143312175|NCT03670810|516690440|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
143312176|NCT03670810|516690441|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
143312177|NCT03670810|516690442|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
143312178|NCT03670810|516690443|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
143312179|NCT03670810|516690444|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
143312180|NCT03670810|516690445|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
143312181|NCT03670810|516690437|FG000|Open Label Extension|Physician Decision|0|||
143312182|NCT03670810|516690438|FG001|Open Label Extension|Physician Decision|0|||
143312183|NCT03670810|516690439|FG002|Open Label Extension|Physician Decision|0|||
143312184|NCT03670810|516690440|FG003|Open Label Extension|Physician Decision|0|||
143312185|NCT03670810|516690441|FG004|Open Label Extension|Physician Decision|0|||
143312186|NCT03670810|516690442|FG005|Open Label Extension|Physician Decision|0|||
143312187|NCT03670810|516690443|FG006|Open Label Extension|Physician Decision|0|||
143312188|NCT03670810|516690444|FG007|Open Label Extension|Physician Decision|0|||
143312189|NCT03670810|516690445|FG008|Open Label Extension|Physician Decision|2|||
143312190|NCT03670810|516690437|FG000|Open Label Extension|Non-compliance with study drug|0|||
143312191|NCT03670810|516690438|FG001|Open Label Extension|Non-compliance with study drug|0|||
143312192|NCT03670810|516690439|FG002|Open Label Extension|Non-compliance with study drug|0|||
143312193|NCT03670810|516690440|FG003|Open Label Extension|Non-compliance with study drug|0|||
143312194|NCT03670810|516690441|FG004|Open Label Extension|Non-compliance with study drug|0|||
143312195|NCT03670810|516690442|FG005|Open Label Extension|Non-compliance with study drug|0|||
143312196|NCT03670810|516690443|FG006|Open Label Extension|Non-compliance with study drug|0|||
143312197|NCT03670810|516690444|FG007|Open Label Extension|Non-compliance with study drug|0|||
143312198|NCT03670810|516690445|FG008|Open Label Extension|Non-compliance with study drug|5|||
143312199|NCT03670810|516690437|FG000|Open Label Extension|Pregnancy|0|||
143312200|NCT03670810|516690438|FG001|Open Label Extension|Pregnancy|0|||
143312201|NCT03670810|516690439|FG002|Open Label Extension|Pregnancy|0|||
143312202|NCT03670810|516690440|FG003|Open Label Extension|Pregnancy|0|||
143312203|NCT03670810|516690441|FG004|Open Label Extension|Pregnancy|0|||
143312204|NCT03670810|516690442|FG005|Open Label Extension|Pregnancy|0|||
143312205|NCT03670810|516690443|FG006|Open Label Extension|Pregnancy|0|||
143312206|NCT03670810|516690444|FG007|Open Label Extension|Pregnancy|0|||
143312207|NCT03670810|516690445|FG008|Open Label Extension|Pregnancy|3|||
143312208|NCT03670810|516690437|FG000|Open Label Extension|Adverse Event|0|||
143312209|NCT03670810|516690438|FG001|Open Label Extension|Adverse Event|0|||
143312210|NCT03670810|516690439|FG002|Open Label Extension|Adverse Event|0|||
143312211|NCT03670810|516690440|FG003|Open Label Extension|Adverse Event|0|||
143312212|NCT03670810|516690441|FG004|Open Label Extension|Adverse Event|0|||
143312213|NCT03670810|516690442|FG005|Open Label Extension|Adverse Event|0|||
143312214|NCT03670810|516690443|FG006|Open Label Extension|Adverse Event|0|||
143312215|NCT03670810|516690444|FG007|Open Label Extension|Adverse Event|0|||
143312216|NCT03670810|516690445|FG008|Open Label Extension|Adverse Event|24|||
143312217|NCT03670810|516690437|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
143312218|NCT03670810|516690438|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
143312219|NCT03670810|516690439|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
143312220|NCT03670810|516690440|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
143312221|NCT03670810|516690441|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
143312222|NCT03670810|516690442|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
143312223|NCT03670810|516690443|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
143312224|NCT03670810|516690444|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
143312225|NCT03670810|516690445|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
143312226|NCT03670810|516690437|FG000|Open Label Extension|Lost to Follow-up|0|||
143312227|NCT03670810|516690438|FG001|Open Label Extension|Lost to Follow-up|0|||
143312228|NCT03670810|516690439|FG002|Open Label Extension|Lost to Follow-up|0|||
143312229|NCT03670810|516690440|FG003|Open Label Extension|Lost to Follow-up|0|||
143312230|NCT03670810|516690441|FG004|Open Label Extension|Lost to Follow-up|0|||
143312231|NCT03670810|516690442|FG005|Open Label Extension|Lost to Follow-up|0|||
143312232|NCT03670810|516690443|FG006|Open Label Extension|Lost to Follow-up|0|||
143312233|NCT03670810|516690444|FG007|Open Label Extension|Lost to Follow-up|0|||
143312234|NCT03670810|516690445|FG008|Open Label Extension|Lost to Follow-up|23|||
143312235|NCT04304001|516690448|FG000|Overall Study|Lost to Follow-up|13|||
143312236|NCT04304001|516690449|FG001|Overall Study|Lost to Follow-up|9|||
143312237|NCT00813124|516690456|FG000|Overall Study|Death|2|||
143312238|NCT00813124|516690456|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
143312239|NCT00813124|516690456|FG000|Overall Study|Withdrawal by Subject|1|||
143312240|NCT00079274|516690459|FG000|Overall Study|Withdrawal by Subject|111|||
143312241|NCT00079274|516690460|FG001|Overall Study|Withdrawal by Subject|10|||
143312242|NCT00079274|516690461|FG002|Overall Study|Withdrawal by Subject|12|||
143312243|NCT00079274|516690462|FG003|Overall Study|Withdrawal by Subject|163|||
143312244|NCT00079274|516690463|FG004|Overall Study|Withdrawal by Subject|7|||
143312245|NCT00079274|516690464|FG005|Overall Study|Withdrawal by Subject|8|||
143312246|NCT00079274|516690465|FG006|Overall Study|Withdrawal by Subject|0|||
143312247|NCT00079274|516690459|FG000|Overall Study|Adverse Event|130|||
143312248|NCT00079274|516690460|FG001|Overall Study|Adverse Event|8|||
143312249|NCT00079274|516690461|FG002|Overall Study|Adverse Event|8|||
143312250|NCT00079274|516690462|FG003|Overall Study|Adverse Event|184|||
143312251|NCT00079274|516690463|FG004|Overall Study|Adverse Event|7|||
143312252|NCT00079274|516690464|FG005|Overall Study|Adverse Event|8|||
143312253|NCT00079274|516690465|FG006|Overall Study|Adverse Event|0|||
143312254|NCT00079274|516690459|FG000|Overall Study|Recurrence|21|||
143312255|NCT00079274|516690460|FG001|Overall Study|Recurrence|0|||
143312256|NCT00079274|516690461|FG002|Overall Study|Recurrence|1|||
143312257|NCT00079274|516690462|FG003|Overall Study|Recurrence|15|||
143312258|NCT00079274|516690463|FG004|Overall Study|Recurrence|0|||
143312259|NCT00079274|516690464|FG005|Overall Study|Recurrence|2|||
143312260|NCT00079274|516690465|FG006|Overall Study|Recurrence|0|||
143312261|NCT00079274|516690459|FG000|Overall Study|Alternate Treatment|6|||
143312262|NCT00079274|516690460|FG001|Overall Study|Alternate Treatment|1|||
143312263|NCT00079274|516690461|FG002|Overall Study|Alternate Treatment|0|||
143312264|NCT00079274|516690462|FG003|Overall Study|Alternate Treatment|3|||
143312265|NCT00079274|516690463|FG004|Overall Study|Alternate Treatment|0|||
143312266|NCT00079274|516690464|FG005|Overall Study|Alternate Treatment|0|||
143312267|NCT00079274|516690465|FG006|Overall Study|Alternate Treatment|0|||
143312268|NCT00079274|516690459|FG000|Overall Study|Other Medical Problems|6|||
143312269|NCT00079274|516690460|FG001|Overall Study|Other Medical Problems|1|||
143312270|NCT00079274|516690461|FG002|Overall Study|Other Medical Problems|0|||
143312271|NCT00079274|516690462|FG003|Overall Study|Other Medical Problems|7|||
143312272|NCT00079274|516690463|FG004|Overall Study|Other Medical Problems|0|||
143312273|NCT00079274|516690464|FG005|Overall Study|Other Medical Problems|0|||
143312274|NCT00079274|516690465|FG006|Overall Study|Other Medical Problems|0|||
143312275|NCT00079274|516690459|FG000|Overall Study|Death|4|||
143312276|NCT00079274|516690460|FG001|Overall Study|Death|0|||
143312277|NCT00079274|516690461|FG002|Overall Study|Death|1|||
143312278|NCT00079274|516690462|FG003|Overall Study|Death|15|||
143312279|NCT00079274|516690463|FG004|Overall Study|Death|0|||
143312280|NCT00079274|516690464|FG005|Overall Study|Death|0|||
143312281|NCT00079274|516690465|FG006|Overall Study|Death|0|||
143312282|NCT00079274|516690459|FG000|Overall Study|Cytogenetic resistance|0|||
143312283|NCT00079274|516690460|FG001|Overall Study|Cytogenetic resistance|0|||
143312284|NCT00079274|516690461|FG002|Overall Study|Cytogenetic resistance|0|||
143312285|NCT00079274|516690462|FG003|Overall Study|Cytogenetic resistance|2|||
143312286|NCT00079274|516690463|FG004|Overall Study|Cytogenetic resistance|0|||
143312287|NCT00079274|516690464|FG005|Overall Study|Cytogenetic resistance|0|||
143312288|NCT00079274|516690465|FG006|Overall Study|Cytogenetic resistance|0|||
143312289|NCT00079274|516690459|FG000|Overall Study|Other|43|||
143312290|NCT00079274|516690460|FG001|Overall Study|Other|7|||
143312291|NCT00079274|516690461|FG002|Overall Study|Other|5|||
143312292|NCT00079274|516690462|FG003|Overall Study|Other|55|||
143312293|NCT00079274|516690463|FG004|Overall Study|Other|1|||
143312294|NCT00079274|516690464|FG005|Overall Study|Other|2|||
143312295|NCT00079274|516690465|FG006|Overall Study|Other|0|||
143312296|NCT00767676|516690466|FG000|Overall Study|Investigator error|54|||
143312297|NCT00617240|516690469|FG000|Overall Study|Lack of Efficacy|1|||
143312298|NCT00617240|516690470|FG001|Overall Study|Lack of Efficacy|0|||
143312299|NCT01611259|516690471|FG000|Overall Study|Physician Decision|1|||
143312300|NCT01611259|516690471|FG000|Overall Study|Lack of Efficacy|2|||
143312301|NCT01611259|516690471|FG000|Overall Study|Adverse Event|4|||
143312302|NCT01611259|516690471|FG000|Overall Study|Withdrawal by Subject|7|||
143312303|NCT03969212|516690472|FG000|Overall Study|Adverse Event|1|||
143312304|NCT03969212|516690473|FG001|Overall Study|Adverse Event|0|||
143312305|NCT03969212|516690474|FG002|Overall Study|Adverse Event|0|||
143312306|NCT03969212|516690475|FG003|Overall Study|Adverse Event|0|||
143312307|NCT03969212|516690472|FG000|Overall Study|Lost to Follow-up|2|||
143312308|NCT03969212|516690473|FG001|Overall Study|Lost to Follow-up|2|||
143312309|NCT03969212|516690474|FG002|Overall Study|Lost to Follow-up|2|||
143312310|NCT03969212|516690475|FG003|Overall Study|Lost to Follow-up|2|||
143312311|NCT03969212|516690472|FG000|Overall Study|Protocol Violation|0|||
143312312|NCT03969212|516690473|FG001|Overall Study|Protocol Violation|0|||
143312313|NCT03969212|516690474|FG002|Overall Study|Protocol Violation|0|||
143312314|NCT03969212|516690475|FG003|Overall Study|Protocol Violation|1|||
143312315|NCT03969212|516690472|FG000|Overall Study|Withdrawal by Subject|7|||
143312316|NCT03969212|516690473|FG001|Overall Study|Withdrawal by Subject|13|||
143312317|NCT03969212|516690474|FG002|Overall Study|Withdrawal by Subject|5|||
143312318|NCT03969212|516690475|FG003|Overall Study|Withdrawal by Subject|11|||
143312319|NCT03969212|516690472|FG000|Overall Study|Physician Decision|0|||
143312320|NCT03969212|516690473|FG001|Overall Study|Physician Decision|0|||
143312321|NCT03969212|516690474|FG002|Overall Study|Physician Decision|1|||
143312322|NCT03969212|516690475|FG003|Overall Study|Physician Decision|0|||
143312323|NCT03969212|516690472|FG000|Overall Study|Reason not Specified|22|||
143312324|NCT03969212|516690473|FG001|Overall Study|Reason not Specified|23|||
143312325|NCT03969212|516690474|FG002|Overall Study|Reason not Specified|28|||
143312326|NCT03969212|516690475|FG003|Overall Study|Reason not Specified|26|||
143312327|NCT00280566|516690479|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
143312328|NCT00280566|516690480|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
143312329|NCT00280566|516690481|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
143312330|NCT00280566|516690479|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
143312331|NCT00280566|516690480|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
143312332|NCT00280566|516690481|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
143312333|NCT00280566|516690479|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
143312334|NCT00280566|516690480|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
143312335|NCT00280566|516690481|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
143312336|NCT00280566|516690479|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
143312337|NCT00280566|516690480|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
143312338|NCT00280566|516690481|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
143312339|NCT00280566|516690479|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
143312340|NCT00280566|516690480|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
143312341|NCT00280566|516690481|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
143312342|NCT00280566|516690479|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
143312343|NCT00280566|516690480|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
143312344|NCT00280566|516690481|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
143312345|NCT00280566|516690479|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
143312346|NCT00280566|516690480|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
143312347|NCT00280566|516690481|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
143312348|NCT00280566|516690479|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
143312349|NCT00280566|516690480|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
143312350|NCT00280566|516690481|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
143312351|NCT00280566|516690479|FG000|Period 2 Double Blind|Adverse Event|0|||
143312352|NCT00280566|516690480|FG001|Period 2 Double Blind|Adverse Event|11|||
143312353|NCT00280566|516690481|FG002|Period 2 Double Blind|Adverse Event|15|||
143312354|NCT00280566|516690479|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
143312355|NCT00280566|516690480|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
143312356|NCT00280566|516690481|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
143312357|NCT00280566|516690479|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
143312358|NCT00280566|516690480|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
143312359|NCT00280566|516690481|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
143312360|NCT00280566|516690479|FG000|Period 2 Double Blind|miscellaneous|0|||
143376030|NCT01040689|516921628|FG000|Overall Study|Lost to Follow-up|1|||
143376031|NCT01040689|516921629|FG001|Overall Study|Lost to Follow-up|0|||
143312361|NCT00280566|516690480|FG001|Period 2 Double Blind|miscellaneous|10|||
143312362|NCT00280566|516690481|FG002|Period 2 Double Blind|miscellaneous|5|||
143312363|NCT01147653|516690482|FG000|Year 2|Withdrawal by Subject|2|||
143312364|NCT01147653|516690483|FG001|Year 2|Withdrawal by Subject|3|||
143312365|NCT00353366|516690484|FG000|Overall Study|Adverse Event|8|||
143312366|NCT00353366|516690484|FG000|Overall Study|Protocol Violation|12|||
143312367|NCT00353366|516690484|FG000|Overall Study|Withdrawal by Subject|12|||
143312368|NCT00353366|516690484|FG000|Overall Study|Lost to Follow-up|92|||
143312369|NCT00353366|516690484|FG000|Overall Study|Other|19|||
143312370|NCT01302392|516690485|FG000|Overall Study|Lost to Follow-up|1|||
143312371|NCT01302392|516690486|FG001|Overall Study|Lost to Follow-up|0|||
143312372|NCT01302392|516690485|FG000|Overall Study|Withdrawal by Subject|6|||
143312373|NCT01302392|516690486|FG001|Overall Study|Withdrawal by Subject|1|||
143312374|NCT00259857|516690487|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
143312375|NCT00259857|516690488|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
143312376|NCT00259857|516690487|FG000|24 Months Treatment|Lost to Follow-up|0|||
143312377|NCT00259857|516690488|FG001|24 Months Treatment|Lost to Follow-up|3|||
143312378|NCT01469065|516690495|FG000|Overall Study|Lack of Efficacy|0|||
143312379|NCT01469065|516690496|FG001|Overall Study|Lack of Efficacy|0|||
143312380|NCT01469065|516690497|FG002|Overall Study|Lack of Efficacy|0|||
143312381|NCT01469065|516690498|FG003|Overall Study|Lack of Efficacy|0|||
143312382|NCT01469065|516690499|FG004|Overall Study|Lack of Efficacy|1|||
143312383|NCT01469065|516690495|FG000|Overall Study|Other|0|||
143312384|NCT01469065|516690496|FG001|Overall Study|Other|1|||
143312385|NCT01469065|516690497|FG002|Overall Study|Other|0|||
143312386|NCT01469065|516690498|FG003|Overall Study|Other|0|||
143312387|NCT01469065|516690499|FG004|Overall Study|Other|0|||
143312388|NCT05091528|516690505|FG000|Overall Study|Study Termination by Sponsor|0|||
143312389|NCT05091528|516690506|FG001|Overall Study|Study Termination by Sponsor|1|||
143312390|NCT05091528|516690507|FG002|Overall Study|Study Termination by Sponsor|0|||
143312391|NCT05091528|516690508|FG003|Overall Study|Study Termination by Sponsor|1|||
143312392|NCT02375672|516690509|FG000|Overall Study|remain on follow up|20|||
143312393|NCT03921411|516690510|FG000|Overall Study|Withdrawal by Subject|1|||
143312394|NCT03921411|516690510|FG000|Overall Study|Protocol Deviation|2|||
143312395|NCT03921411|516690510|FG000|Overall Study|Enrolled, but never treated|2|||
143312396|NCT02098109|516690511|FG000|Overall Study|Protocol Violation|3|||
143312397|NCT02098109|516690512|FG001|Overall Study|Protocol Violation|0|||
143312398|NCT01541826|516690513|FG000|Overall Study|Lost to Follow-up|2|||
143312399|NCT01541826|516690514|FG001|Overall Study|Lost to Follow-up|3|||
143312400|NCT01541826|516690515|FG002|Overall Study|Lost to Follow-up|0|||
143312401|NCT01541826|516690513|FG000|Overall Study|Withdrawal by Subject|2|||
143312402|NCT01541826|516690514|FG001|Overall Study|Withdrawal by Subject|0|||
143312403|NCT01541826|516690515|FG002|Overall Study|Withdrawal by Subject|0|||
143312404|NCT01482767|516690519|FG000|Overall Study|Death|1|||
143312405|NCT01482767|516690520|FG001|Overall Study|Death|1|||
143312406|NCT01482767|516690519|FG000|Overall Study|Withdrawal by Subject|7|||
143312407|NCT01482767|516690520|FG001|Overall Study|Withdrawal by Subject|5|||
143312408|NCT01482767|516690519|FG000|Overall Study|Lost to Follow-up|12|||
143312409|NCT01482767|516690520|FG001|Overall Study|Lost to Follow-up|6|||
143312410|NCT01482767|516690519|FG000|Overall Study|Adverse Event|0|||
143312411|NCT01482767|516690520|FG001|Overall Study|Adverse Event|3|||
143312412|NCT01482767|516690519|FG000|Overall Study|Site closure|22|||
143312413|NCT01482767|516690520|FG001|Overall Study|Site closure|14|||
143312414|NCT01482767|516690519|FG000|Overall Study|Non-adherence to study requirements|4|||
143376032|NCT01040689|516921630|FG002|Overall Study|Lost to Follow-up|0|||
143312415|NCT01482767|516690520|FG001|Overall Study|Non-adherence to study requirements|7|||
143312416|NCT01482767|516690519|FG000|Overall Study|Alternate HCV treatment|7|||
143312417|NCT01482767|516690520|FG001|Overall Study|Alternate HCV treatment|8|||
143312418|NCT01482767|516690519|FG000|Overall Study|Ineligible|0|||
143312419|NCT01482767|516690520|FG001|Overall Study|Ineligible|5|||
143312420|NCT01482767|516690519|FG000|Overall Study|Nurse error|1|||
143312421|NCT01482767|516690520|FG001|Overall Study|Nurse error|0|||
143312422|NCT00025883|516690523|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
143312423|NCT00025883|516690523|FG000|Overall Study|no baseline data|1|||
143312424|NCT00025883|516690523|FG000|Overall Study|Death|1|||
143312425|NCT00025883|516690523|FG000|Overall Study|Adverse Event|1|||
143312426|NCT00025883|516690523|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
143312427|NCT03591575|516690524|FG000|Overall Study|Adverse Event|2|||
143312428|NCT03591575|516690525|FG001|Overall Study|Adverse Event|0|||
143312429|NCT03591575|516690524|FG000|Overall Study|Withdrawal by Subject|4|||
143312430|NCT03591575|516690525|FG001|Overall Study|Withdrawal by Subject|1|||
143312431|NCT00218543|516690526|FG000|Overall Study|Lost to Follow-up|8|||
143312432|NCT00218543|516690526|FG000|Overall Study|relocated|1|||
143312433|NCT00218543|516690526|FG000|Overall Study|Withdrawal by Subject|1|||
143312434|NCT00218543|516690526|FG000|Overall Study|Physician Decision|3|||
143312435|NCT00218543|516690526|FG000|Overall Study|Adverse Event|2|||
143312436|NCT02448875|516690527|FG000|Overall Study|Adverse Event|2|||
143312437|NCT02448875|516690528|FG001|Overall Study|Adverse Event|1|||
143312438|NCT02448875|516690529|FG002|Overall Study|Adverse Event|0|||
143312439|NCT02448875|516690527|FG000|Overall Study|Lost to Follow-up|1|||
143312440|NCT02448875|516690528|FG001|Overall Study|Lost to Follow-up|0|||
143312441|NCT02448875|516690529|FG002|Overall Study|Lost to Follow-up|0|||
143312442|NCT02448875|516690527|FG000|Overall Study|Investigator Decision|3|||
143312443|NCT02448875|516690528|FG001|Overall Study|Investigator Decision|0|||
143312444|NCT02448875|516690529|FG002|Overall Study|Investigator Decision|1|||
143312445|NCT02448875|516690527|FG000|Overall Study|Withdrawal by Subject|1|||
143312446|NCT02448875|516690528|FG001|Overall Study|Withdrawal by Subject|0|||
143312447|NCT02448875|516690529|FG002|Overall Study|Withdrawal by Subject|0|||
143312448|NCT04084769|516690534|FG000|Overall Study|Protocol Violation|1|||
143312449|NCT04084769|516690535|FG001|Overall Study|Protocol Violation|3|||
143312450|NCT04084769|516690536|FG002|Overall Study|Protocol Violation|0|||
143312451|NCT04084769|516690537|FG003|Overall Study|Protocol Violation|1|||
143312452|NCT04084769|516690534|FG000|Overall Study|Withdrawal by Subject|0|||
143312453|NCT04084769|516690535|FG001|Overall Study|Withdrawal by Subject|1|||
143312454|NCT04084769|516690536|FG002|Overall Study|Withdrawal by Subject|0|||
143312455|NCT04084769|516690537|FG003|Overall Study|Withdrawal by Subject|0|||
143312456|NCT04084769|516690534|FG000|Overall Study|Withdrawal by parent/guardian|1|||
143312457|NCT04084769|516690535|FG001|Overall Study|Withdrawal by parent/guardian|0|||
143312458|NCT04084769|516690536|FG002|Overall Study|Withdrawal by parent/guardian|0|||
143312459|NCT04084769|516690537|FG003|Overall Study|Withdrawal by parent/guardian|1|||
143312460|NCT04084769|516690534|FG000|Overall Study|Lost to Follow-up|2|||
143312461|NCT04084769|516690535|FG001|Overall Study|Lost to Follow-up|0|||
143312462|NCT04084769|516690536|FG002|Overall Study|Lost to Follow-up|0|||
143312463|NCT04084769|516690537|FG003|Overall Study|Lost to Follow-up|0|||
143312464|NCT03238911|516690538|FG000|Overall Study|Withdrawal by Subject|1|||
143312465|NCT03238911|516690539|FG001|Overall Study|Withdrawal by Subject|2|||
143312466|NCT03238911|516690538|FG000|Overall Study|Lost to Follow-up|2|||
143312467|NCT03238911|516690539|FG001|Overall Study|Lost to Follow-up|1|||
143312468|NCT02239536|516690540|FG000|Overall Study|Non-neoplastic polyp|23|||
143312469|NCT02239536|516690541|FG001|Overall Study|Non-neoplastic polyp|17|||
143312470|NCT04740034|516690545|FG000|Overall Study|Death|0|||
143312471|NCT04740034|516690546|FG001|Overall Study|Death|1|||
143312472|NCT04740034|516690547|FG002|Overall Study|Death|2|||
143312473|NCT04740034|516690548|FG003|Overall Study|Death|3|||
143312474|NCT04740034|516690549|FG004|Overall Study|Death|4|||
143312475|NCT04740034|516690550|FG005|Overall Study|Death|4|||
143312476|NCT04740034|516690551|FG006|Overall Study|Death|2|||
143312477|NCT04740034|516690552|FG007|Overall Study|Death|2|||
143312478|NCT04740034|516690553|FG008|Overall Study|Death|2|||
143312479|NCT04740034|516690554|FG009|Overall Study|Death|4|||
143312480|NCT04740034|516690555|FG010|Overall Study|Death|0|||
143312481|NCT04740034|516690545|FG000|Overall Study|Lost to Follow-up|0|||
143312482|NCT04740034|516690546|FG001|Overall Study|Lost to Follow-up|0|||
143312483|NCT04740034|516690547|FG002|Overall Study|Lost to Follow-up|0|||
143312484|NCT04740034|516690548|FG003|Overall Study|Lost to Follow-up|1|||
143312485|NCT04740034|516690549|FG004|Overall Study|Lost to Follow-up|2|||
143312486|NCT04740034|516690550|FG005|Overall Study|Lost to Follow-up|2|||
143312487|NCT04740034|516690551|FG006|Overall Study|Lost to Follow-up|0|||
143312488|NCT04740034|516690552|FG007|Overall Study|Lost to Follow-up|0|||
143312489|NCT04740034|516690553|FG008|Overall Study|Lost to Follow-up|0|||
143312490|NCT04740034|516690554|FG009|Overall Study|Lost to Follow-up|1|||
143312491|NCT04740034|516690555|FG010|Overall Study|Lost to Follow-up|0|||
143312492|NCT04740034|516690545|FG000|Overall Study|Withdrawal by Subject|1|||
143312493|NCT04740034|516690546|FG001|Overall Study|Withdrawal by Subject|0|||
143312494|NCT04740034|516690547|FG002|Overall Study|Withdrawal by Subject|0|||
143312495|NCT04740034|516690548|FG003|Overall Study|Withdrawal by Subject|0|||
143312496|NCT04740034|516690549|FG004|Overall Study|Withdrawal by Subject|0|||
143312497|NCT04740034|516690550|FG005|Overall Study|Withdrawal by Subject|0|||
143312498|NCT04740034|516690551|FG006|Overall Study|Withdrawal by Subject|0|||
143312499|NCT04740034|516690552|FG007|Overall Study|Withdrawal by Subject|1|||
143312500|NCT04740034|516690553|FG008|Overall Study|Withdrawal by Subject|0|||
143312501|NCT04740034|516690554|FG009|Overall Study|Withdrawal by Subject|1|||
143312502|NCT04740034|516690555|FG010|Overall Study|Withdrawal by Subject|0|||
143312503|NCT04740034|516690545|FG000|Overall Study|Decision by sponsor|0|||
143312504|NCT04740034|516690546|FG001|Overall Study|Decision by sponsor|0|||
143312505|NCT04740034|516690547|FG002|Overall Study|Decision by sponsor|1|||
143312506|NCT04740034|516690548|FG003|Overall Study|Decision by sponsor|0|||
143312507|NCT04740034|516690549|FG004|Overall Study|Decision by sponsor|0|||
143312508|NCT04740034|516690550|FG005|Overall Study|Decision by sponsor|0|||
143312509|NCT04740034|516690551|FG006|Overall Study|Decision by sponsor|1|||
143312510|NCT04740034|516690552|FG007|Overall Study|Decision by sponsor|2|||
143312511|NCT04740034|516690553|FG008|Overall Study|Decision by sponsor|1|||
143312512|NCT04740034|516690554|FG009|Overall Study|Decision by sponsor|1|||
143312513|NCT04740034|516690555|FG010|Overall Study|Decision by sponsor|2|||
143312514|NCT02742103|516692528|FG000|Overall Study|Protocol Violation|1|||
143312515|NCT02742103|516692529|FG001|Overall Study|Protocol Violation|0|||
143312516|NCT02742103|516692528|FG000|Overall Study|Death|2|||
143312517|NCT02742103|516692529|FG001|Overall Study|Death|2|||
143312518|NCT02742103|516692528|FG000|Overall Study|Adverse Event|1|||
143312519|NCT02742103|516692529|FG001|Overall Study|Adverse Event|0|||
143312520|NCT02742103|516692528|FG000|Overall Study|Moved to another town|0|||
143312521|NCT02742103|516692529|FG001|Overall Study|Moved to another town|1|||
143312522|NCT02742103|516692528|FG000|Overall Study|Withdrawal by Subject|5|||
143312523|NCT02742103|516692529|FG001|Overall Study|Withdrawal by Subject|2|||
143312524|NCT04346615|516692532|FG000|Overall Study|Lost to Follow-up|0|||
143312525|NCT04346615|516692533|FG001|Overall Study|Lost to Follow-up|2|||
143312526|NCT04346615|516692532|FG000|Overall Study|Withdrawal by Subject|1|||
143312527|NCT04346615|516692533|FG001|Overall Study|Withdrawal by Subject|0|||
143312528|NCT04346615|516692532|FG000|Overall Study|Death|5|||
143312529|NCT04346615|516692533|FG001|Overall Study|Death|1|||
143312530|NCT04346615|516692532|FG000|Overall Study|Other|0|||
143312531|NCT04346615|516692533|FG001|Overall Study|Other|2|||
143312532|NCT04346615|516692532|FG000|Overall Study|Randomized not treated|1|||
143312533|NCT04346615|516692533|FG001|Overall Study|Randomized not treated|0|||
143312534|NCT00991302|516692538|FG000|Overall Study|Death|0|||
143312535|NCT00991302|516692539|FG001|Overall Study|Death|1|||
143312536|NCT00991302|516692538|FG000|Overall Study|Lost to Follow-up|14|||
143312537|NCT00991302|516692539|FG001|Overall Study|Lost to Follow-up|12|||
143312538|NCT01709318|516692540|FG000|Overall Study|Adverse Event|3|||
143312539|NCT01709318|516692541|FG001|Overall Study|Adverse Event|4|||
143312540|NCT01709318|516692542|FG002|Overall Study|Adverse Event|2|||
143312541|NCT01709318|516692543|FG003|Overall Study|Adverse Event|2|||
143312542|NCT01709318|516692544|FG004|Overall Study|Adverse Event|0|||
143312543|NCT01709318|516692545|FG005|Overall Study|Adverse Event|1|||
143312544|NCT01709318|516692546|FG006|Overall Study|Adverse Event|2|||
143312545|NCT01709318|516692540|FG000|Overall Study|Lost to Follow-up|2|||
143312546|NCT01709318|516692541|FG001|Overall Study|Lost to Follow-up|0|||
143312547|NCT01709318|516692542|FG002|Overall Study|Lost to Follow-up|0|||
143312548|NCT01709318|516692543|FG003|Overall Study|Lost to Follow-up|0|||
143312549|NCT01709318|516692544|FG004|Overall Study|Lost to Follow-up|1|||
143312550|NCT01709318|516692545|FG005|Overall Study|Lost to Follow-up|1|||
143312551|NCT01709318|516692546|FG006|Overall Study|Lost to Follow-up|1|||
143312552|NCT01709318|516692540|FG000|Overall Study|Non-compliance with Study Drug|0|||
143312553|NCT01709318|516692541|FG001|Overall Study|Non-compliance with Study Drug|2|||
143312554|NCT01709318|516692542|FG002|Overall Study|Non-compliance with Study Drug|1|||
143312555|NCT01709318|516692543|FG003|Overall Study|Non-compliance with Study Drug|1|||
143312556|NCT01709318|516692544|FG004|Overall Study|Non-compliance with Study Drug|0|||
143312557|NCT01709318|516692545|FG005|Overall Study|Non-compliance with Study Drug|0|||
143312558|NCT01709318|516692546|FG006|Overall Study|Non-compliance with Study Drug|2|||
143312559|NCT01709318|516692540|FG000|Overall Study|Physician Decision|0|||
143312560|NCT01709318|516692541|FG001|Overall Study|Physician Decision|0|||
143312561|NCT01709318|516692542|FG002|Overall Study|Physician Decision|0|||
143312562|NCT01709318|516692543|FG003|Overall Study|Physician Decision|0|||
143312563|NCT01709318|516692544|FG004|Overall Study|Physician Decision|0|||
143312564|NCT01709318|516692545|FG005|Overall Study|Physician Decision|0|||
143312565|NCT01709318|516692546|FG006|Overall Study|Physician Decision|1|||
143312566|NCT01709318|516692540|FG000|Overall Study|Pregnancy|0|||
143312567|NCT01709318|516692541|FG001|Overall Study|Pregnancy|0|||
143312568|NCT01709318|516692542|FG002|Overall Study|Pregnancy|0|||
143312569|NCT01709318|516692543|FG003|Overall Study|Pregnancy|0|||
143312570|NCT01709318|516692544|FG004|Overall Study|Pregnancy|1|||
143312571|NCT01709318|516692545|FG005|Overall Study|Pregnancy|0|||
143312572|NCT01709318|516692546|FG006|Overall Study|Pregnancy|0|||
143312573|NCT01709318|516692540|FG000|Overall Study|Protocol Violation|0|||
143312574|NCT01709318|516692541|FG001|Overall Study|Protocol Violation|0|||
143312575|NCT01709318|516692542|FG002|Overall Study|Protocol Violation|0|||
143312576|NCT01709318|516692543|FG003|Overall Study|Protocol Violation|0|||
143312577|NCT01709318|516692544|FG004|Overall Study|Protocol Violation|2|||
143312578|NCT01709318|516692545|FG005|Overall Study|Protocol Violation|0|||
143312579|NCT01709318|516692546|FG006|Overall Study|Protocol Violation|1|||
143312580|NCT01709318|516692540|FG000|Overall Study|Technical Problems|1|||
143312581|NCT01709318|516692541|FG001|Overall Study|Technical Problems|0|||
143312582|NCT01709318|516692542|FG002|Overall Study|Technical Problems|0|||
143312583|NCT01709318|516692543|FG003|Overall Study|Technical Problems|0|||
143312584|NCT01709318|516692544|FG004|Overall Study|Technical Problems|0|||
143312585|NCT01709318|516692545|FG005|Overall Study|Technical Problems|0|||
143312586|NCT01709318|516692546|FG006|Overall Study|Technical Problems|0|||
143312587|NCT01709318|516692540|FG000|Overall Study|Withdrawal by Subject|3|||
143312588|NCT01709318|516692541|FG001|Overall Study|Withdrawal by Subject|0|||
143312589|NCT01709318|516692542|FG002|Overall Study|Withdrawal by Subject|3|||
143312590|NCT01709318|516692543|FG003|Overall Study|Withdrawal by Subject|3|||
143312591|NCT01709318|516692544|FG004|Overall Study|Withdrawal by Subject|0|||
143312592|NCT01709318|516692545|FG005|Overall Study|Withdrawal by Subject|2|||
143312593|NCT01709318|516692546|FG006|Overall Study|Withdrawal by Subject|4|||
143312594|NCT01709318|516692540|FG000|Overall Study|Other Protocol Specified Criteria|0|||
143312595|NCT01709318|516692541|FG001|Overall Study|Other Protocol Specified Criteria|1|||
143312596|NCT01709318|516692542|FG002|Overall Study|Other Protocol Specified Criteria|0|||
143312597|NCT01709318|516692543|FG003|Overall Study|Other Protocol Specified Criteria|0|||
143312598|NCT01709318|516692544|FG004|Overall Study|Other Protocol Specified Criteria|0|||
143312599|NCT01709318|516692545|FG005|Overall Study|Other Protocol Specified Criteria|0|||
143312600|NCT01709318|516692546|FG006|Overall Study|Other Protocol Specified Criteria|0|||
143312601|NCT03370341|516692547|FG000|Overall Study|Lost to Follow-up|0|||
143312602|NCT03370341|516692548|FG001|Overall Study|Lost to Follow-up|1|||
143312603|NCT01707004|516692549|FG000|Overall Study|Physician Decision|3|||
143312604|NCT02573324|516692551|FG000|Overall Study|Withdrawal by Subject|26|||
143312605|NCT02573324|516692552|FG001|Overall Study|Withdrawal by Subject|23|||
143312606|NCT02573324|516692553|FG002|Overall Study|Withdrawal by Subject|3|||
143312607|NCT02573324|516692551|FG000|Overall Study|Lost to Follow-up|4|||
143312608|NCT02573324|516692552|FG001|Overall Study|Lost to Follow-up|5|||
143312609|NCT02573324|516692553|FG002|Overall Study|Lost to Follow-up|0|||
143312610|NCT02573324|516692551|FG000|Overall Study|Study Terminated by Sponsor|107|||
143312611|NCT02573324|516692552|FG001|Overall Study|Study Terminated by Sponsor|89|||
143312612|NCT02573324|516692553|FG002|Overall Study|Study Terminated by Sponsor|2|||
143312613|NCT02573324|516692551|FG000|Overall Study|Death|182|||
143312614|NCT02573324|516692552|FG001|Overall Study|Death|200|||
143312615|NCT02573324|516692553|FG002|Overall Study|Death|1|||
143312616|NCT02573324|516692551|FG000|Overall Study|Other, Not Specified|20|||
143312617|NCT02573324|516692552|FG001|Overall Study|Other, Not Specified|27|||
143312618|NCT02573324|516692553|FG002|Overall Study|Other, Not Specified|0|||
143312619|NCT02573324|516692551|FG000|Overall Study|Unknown Reason|2|||
143312620|NCT02573324|516692552|FG001|Overall Study|Unknown Reason|0|||
143312621|NCT02573324|516692553|FG002|Overall Study|Unknown Reason|0|||
143312622|NCT01607905|516692555|FG000|Overall Study|Withdrawal by participant|7|||
143312623|NCT01607905|516692556|FG001|Overall Study|Withdrawal by participant|2|||
143312624|NCT01607905|516692557|FG002|Overall Study|Withdrawal by participant|4|||
143312625|NCT01607905|516692558|FG003|Overall Study|Withdrawal by participant|6|||
143312626|NCT01607905|516692559|FG004|Overall Study|Withdrawal by participant|0|||
143312627|NCT01607905|516692560|FG005|Overall Study|Withdrawal by participant|4|||
143312628|NCT01607905|516692561|FG006|Overall Study|Withdrawal by participant|12|||
143312629|NCT01607905|516692555|FG000|Overall Study|Incidence or severity of AEs|5|||
143312630|NCT01607905|516692556|FG001|Overall Study|Incidence or severity of AEs|1|||
143312631|NCT01607905|516692557|FG002|Overall Study|Incidence or severity of AEs|1|||
143312632|NCT01607905|516692558|FG003|Overall Study|Incidence or severity of AEs|3|||
143312633|NCT01607905|516692559|FG004|Overall Study|Incidence or severity of AEs|0|||
143312634|NCT01607905|516692560|FG005|Overall Study|Incidence or severity of AEs|2|||
143312635|NCT01607905|516692561|FG006|Overall Study|Incidence or severity of AEs|8|||
143312636|NCT01607905|516692555|FG000|Overall Study|Disease progression|44|||
143312637|NCT01607905|516692556|FG001|Overall Study|Disease progression|16|||
143312638|NCT01607905|516692557|FG002|Overall Study|Disease progression|15|||
143312639|NCT01607905|516692558|FG003|Overall Study|Disease progression|11|||
143312640|NCT01607905|516692559|FG004|Overall Study|Disease progression|6|||
143312641|NCT01607905|516692560|FG005|Overall Study|Disease progression|7|||
143312642|NCT01607905|516692561|FG006|Overall Study|Disease progression|21|||
143312643|NCT01607905|516692555|FG000|Overall Study|Non-compliance with study procedures|0|||
143312644|NCT01607905|516692556|FG001|Overall Study|Non-compliance with study procedures|0|||
143312645|NCT01607905|516692557|FG002|Overall Study|Non-compliance with study procedures|0|||
143312646|NCT01607905|516692558|FG003|Overall Study|Non-compliance with study procedures|0|||
143312647|NCT01607905|516692559|FG004|Overall Study|Non-compliance with study procedures|0|||
143312648|NCT01607905|516692560|FG005|Overall Study|Non-compliance with study procedures|0|||
143312649|NCT01607905|516692561|FG006|Overall Study|Non-compliance with study procedures|1|||
143312650|NCT01607905|516692555|FG000|Overall Study|Death|1|||
143312651|NCT01607905|516692556|FG001|Overall Study|Death|1|||
143312652|NCT01607905|516692557|FG002|Overall Study|Death|1|||
143312653|NCT01607905|516692558|FG003|Overall Study|Death|1|||
143376033|NCT01040689|516921631|FG003|Overall Study|Lost to Follow-up|0|||
143312654|NCT01607905|516692559|FG004|Overall Study|Death|0|||
143312655|NCT01607905|516692560|FG005|Overall Study|Death|0|||
143312656|NCT01607905|516692561|FG006|Overall Study|Death|3|||
143312657|NCT01607905|516692555|FG000|Overall Study|Other treatments become available|1|||
143312658|NCT01607905|516692556|FG001|Overall Study|Other treatments become available|0|||
143312659|NCT01607905|516692557|FG002|Overall Study|Other treatments become available|0|||
143312660|NCT01607905|516692558|FG003|Overall Study|Other treatments become available|0|||
143312661|NCT01607905|516692559|FG004|Overall Study|Other treatments become available|0|||
143312662|NCT01607905|516692560|FG005|Overall Study|Other treatments become available|0|||
143312663|NCT01607905|516692561|FG006|Overall Study|Other treatments become available|1|||
143312664|NCT01607905|516692555|FG000|Overall Study|Investigator discretion|0|||
143312665|NCT01607905|516692556|FG001|Overall Study|Investigator discretion|0|||
143312666|NCT01607905|516692557|FG002|Overall Study|Investigator discretion|0|||
143312667|NCT01607905|516692558|FG003|Overall Study|Investigator discretion|0|||
143312668|NCT01607905|516692559|FG004|Overall Study|Investigator discretion|0|||
143312669|NCT01607905|516692560|FG005|Overall Study|Investigator discretion|1|||
143312670|NCT01607905|516692561|FG006|Overall Study|Investigator discretion|0|||
143312671|NCT01607905|516692555|FG000|Overall Study|Other|1|||
143312672|NCT01607905|516692556|FG001|Overall Study|Other|0|||
143312673|NCT01607905|516692557|FG002|Overall Study|Other|0|||
143312674|NCT01607905|516692558|FG003|Overall Study|Other|0|||
143312675|NCT01607905|516692559|FG004|Overall Study|Other|0|||
143312676|NCT01607905|516692560|FG005|Overall Study|Other|0|||
143312677|NCT01607905|516692561|FG006|Overall Study|Other|1|||
143312678|NCT01607905|516692555|FG000|Overall Study|Randomized but not treated|1|||
143312679|NCT01607905|516692556|FG001|Overall Study|Randomized but not treated|0|||
143312680|NCT01607905|516692557|FG002|Overall Study|Randomized but not treated|0|||
143312681|NCT01607905|516692558|FG003|Overall Study|Randomized but not treated|0|||
143312682|NCT01607905|516692559|FG004|Overall Study|Randomized but not treated|1|||
143312683|NCT01607905|516692560|FG005|Overall Study|Randomized but not treated|1|||
143312684|NCT01607905|516692561|FG006|Overall Study|Randomized but not treated|0|||
143312685|NCT02349711|516692563|FG000|Overall Study|Withdrawal by Subject|2|||
143312686|NCT02349711|516692564|FG001|Overall Study|Withdrawal by Subject|1|||
143312687|NCT02349711|516692563|FG000|Overall Study|Lost to Follow-up|1|||
143312688|NCT02349711|516692564|FG001|Overall Study|Lost to Follow-up|1|||
143312689|NCT01105533|516692570|FG000|Overall Study|Death|0|||
143312690|NCT01105533|516692571|FG001|Overall Study|Death|0|||
143312691|NCT01105533|516692572|FG002|Overall Study|Death|0|||
143312692|NCT01105533|516692573|FG003|Overall Study|Death|0|||
143312693|NCT01105533|516692574|FG004|Overall Study|Death|1|||
143312694|NCT01105533|516692575|FG005|Overall Study|Death|0|||
143312695|NCT01105533|516692576|FG006|Overall Study|Death|0|||
143312696|NCT01105533|516692577|FG007|Overall Study|Death|0|||
143312697|NCT01105533|516692578|FG008|Overall Study|Death|0|||
143312698|NCT01105533|516692570|FG000|Overall Study|Lack of Efficacy|1|||
143312699|NCT01105533|516692571|FG001|Overall Study|Lack of Efficacy|1|||
143312700|NCT01105533|516692572|FG002|Overall Study|Lack of Efficacy|3|||
143312701|NCT01105533|516692573|FG003|Overall Study|Lack of Efficacy|3|||
143312702|NCT01105533|516692574|FG004|Overall Study|Lack of Efficacy|4|||
143312703|NCT01105533|516692575|FG005|Overall Study|Lack of Efficacy|5|||
143312704|NCT01105533|516692576|FG006|Overall Study|Lack of Efficacy|3|||
143312705|NCT01105533|516692577|FG007|Overall Study|Lack of Efficacy|2|||
143312706|NCT01105533|516692578|FG008|Overall Study|Lack of Efficacy|9|||
143312707|NCT01105533|516692570|FG000|Overall Study|Adverse Event|0|||
143312708|NCT01105533|516692571|FG001|Overall Study|Adverse Event|0|||
143312709|NCT01105533|516692572|FG002|Overall Study|Adverse Event|0|||
143312710|NCT01105533|516692573|FG003|Overall Study|Adverse Event|0|||
143312711|NCT01105533|516692574|FG004|Overall Study|Adverse Event|1|||
143312712|NCT01105533|516692575|FG005|Overall Study|Adverse Event|2|||
143312713|NCT01105533|516692576|FG006|Overall Study|Adverse Event|2|||
143312714|NCT01105533|516692577|FG007|Overall Study|Adverse Event|0|||
143312715|NCT01105533|516692578|FG008|Overall Study|Adverse Event|1|||
143312716|NCT01105533|516692570|FG000|Overall Study|Other|0|||
143312717|NCT01105533|516692571|FG001|Overall Study|Other|0|||
143312718|NCT01105533|516692572|FG002|Overall Study|Other|0|||
143312719|NCT01105533|516692573|FG003|Overall Study|Other|0|||
143312720|NCT01105533|516692574|FG004|Overall Study|Other|1|||
143312721|NCT01105533|516692575|FG005|Overall Study|Other|0|||
143312722|NCT01105533|516692576|FG006|Overall Study|Other|3|||
143312723|NCT01105533|516692577|FG007|Overall Study|Other|1|||
143312724|NCT01105533|516692578|FG008|Overall Study|Other|2|||
143312725|NCT01105533|516692570|FG000|Overall Study|Physician Decision|0|||
143312726|NCT01105533|516692571|FG001|Overall Study|Physician Decision|0|||
143312727|NCT01105533|516692572|FG002|Overall Study|Physician Decision|0|||
143312728|NCT01105533|516692573|FG003|Overall Study|Physician Decision|0|||
143312729|NCT01105533|516692574|FG004|Overall Study|Physician Decision|0|||
143312730|NCT01105533|516692575|FG005|Overall Study|Physician Decision|0|||
143312731|NCT01105533|516692576|FG006|Overall Study|Physician Decision|0|||
143312732|NCT01105533|516692577|FG007|Overall Study|Physician Decision|1|||
143312733|NCT01105533|516692578|FG008|Overall Study|Physician Decision|0|||
143312734|NCT02096835|516692579|FG000|Overall Study|Withdrawal by Subject|1|||
143312735|NCT02096835|516692580|FG001|Overall Study|Withdrawal by Subject|0|||
143312736|NCT02096835|516692581|FG002|Overall Study|Withdrawal by Subject|0|||
143312737|NCT02096835|516692579|FG000|Overall Study|converted to open procedures|1|||
143312738|NCT02096835|516692580|FG001|Overall Study|converted to open procedures|0|||
143312739|NCT02096835|516692581|FG002|Overall Study|converted to open procedures|0|||
143312740|NCT02096835|516692579|FG000|Overall Study|Lost to Follow-up|1|||
143312741|NCT02096835|516692580|FG001|Overall Study|Lost to Follow-up|0|||
143312742|NCT02096835|516692581|FG002|Overall Study|Lost to Follow-up|1|||
143312743|NCT03892889|516692582|FG000|Overall Study|Adverse Event|17|||
143312744|NCT03892889|516692582|FG000|Overall Study|Lack of Efficacy|1|||
143312745|NCT03892889|516692582|FG000|Overall Study|Lost to Follow-up|46|||
143312746|NCT03892889|516692582|FG000|Overall Study|Non-compliance with study drug|22|||
143312747|NCT03892889|516692582|FG000|Overall Study|Pregnancy|1|||
143312748|NCT03892889|516692582|FG000|Overall Study|Protocol Deviation|3|||
143312749|NCT03892889|516692582|FG000|Overall Study|Withdrawal by Subject|50|||
143312750|NCT03892889|516692582|FG000|Overall Study|Withdrawal by Caregiver|1|||
143312751|NCT03892889|516692582|FG000|Overall Study|Study Terminated by Sponsor|50|||
143312752|NCT03892889|516692582|FG000|Overall Study|Physician Decision|8|||
143312753|NCT03892889|516692582|FG000|Overall Study|Reason not Specified|5|||
143312754|NCT02453594|516692583|FG000|Overall Study|Protocol Violation|0|||
143312755|NCT02453594|516692584|FG001|Overall Study|Protocol Violation|0|||
143312756|NCT02453594|516692585|FG002|Overall Study|Protocol Violation|1|||
143312757|NCT02453594|516692583|FG000|Overall Study|Cohort Was Closed|17|||
143312758|NCT02453594|516692584|FG001|Overall Study|Cohort Was Closed|21|||
143312759|NCT02453594|516692585|FG002|Overall Study|Cohort Was Closed|14|||
143312760|NCT02453594|516692583|FG000|Overall Study|Death|20|||
143312761|NCT02453594|516692584|FG001|Overall Study|Death|24|||
143312762|NCT02453594|516692585|FG002|Overall Study|Death|16|||
143312763|NCT02453594|516692583|FG000|Overall Study|Lost to Follow-up|6|||
143312764|NCT02453594|516692584|FG001|Overall Study|Lost to Follow-up|14|||
143312765|NCT02453594|516692585|FG002|Overall Study|Lost to Follow-up|2|||
143312766|NCT02453594|516692583|FG000|Overall Study|Physician Decision|2|||
143312767|NCT02453594|516692584|FG001|Overall Study|Physician Decision|4|||
143312768|NCT02453594|516692585|FG002|Overall Study|Physician Decision|0|||
143312769|NCT02453594|516692583|FG000|Overall Study|Site Terminated by Sponsor|1|||
143312770|NCT02453594|516692584|FG001|Overall Study|Site Terminated by Sponsor|0|||
143312771|NCT02453594|516692585|FG002|Overall Study|Site Terminated by Sponsor|1|||
143312772|NCT02453594|516692583|FG000|Overall Study|Transitioned to Extension Study|16|||
143312773|NCT02453594|516692584|FG001|Overall Study|Transitioned to Extension Study|9|||
143312774|NCT02453594|516692585|FG002|Overall Study|Transitioned to Extension Study|16|||
143312775|NCT02453594|516692583|FG000|Overall Study|Withdrawal by Subject|7|||
143312776|NCT02453594|516692584|FG001|Overall Study|Withdrawal by Subject|9|||
143312777|NCT02453594|516692585|FG002|Overall Study|Withdrawal by Subject|11|||
143312778|NCT02097134|516692586|FG000|Overall Study|Physician Decision|4|||
143312779|NCT02097134|516692586|FG000|Overall Study|Non-Protocol Therapy|1|||
143312780|NCT02097134|516692586|FG000|Overall Study|Progressive Disease|3|||
143312781|NCT02097134|516692586|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
143312782|NCT00679341|516692592|FG000|Overall Study|Disease progression|42|||
143312783|NCT00679341|516692593|FG001|Overall Study|Disease progression|36|||
143312784|NCT00679341|516692592|FG000|Overall Study|Adverse Event|5|||
143312785|NCT00679341|516692593|FG001|Overall Study|Adverse Event|6|||
143312786|NCT00679341|516692592|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
143312787|NCT00679341|516692593|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
143312788|NCT00679341|516692592|FG000|Overall Study|Death|1|||
143312789|NCT00679341|516692593|FG001|Overall Study|Death|1|||
143312790|NCT00679341|516692592|FG000|Overall Study|Other|1|||
143312791|NCT00679341|516692593|FG001|Overall Study|Other|0|||
143312792|NCT00679341|516692592|FG000|Overall Study|Physician Decision|1|||
143312793|NCT00679341|516692593|FG001|Overall Study|Physician Decision|0|||
143312794|NCT00679341|516692592|FG000|Overall Study|Not treated|0|||
143312795|NCT00679341|516692593|FG001|Overall Study|Not treated|2|||
143312796|NCT00679341|516692592|FG000|Overall Study|Physician/patient decision to withdraw|0|||
143312797|NCT00679341|516692593|FG001|Overall Study|Physician/patient decision to withdraw|6|||
143312798|NCT00306592|516692596|FG000|Overall Study|Adverse Event|8|||
143312799|NCT00306592|516692597|FG001|Overall Study|Adverse Event|15|||
143312800|NCT00306592|516692596|FG000|Overall Study|Lost to Follow-up|1|||
143312801|NCT00306592|516692597|FG001|Overall Study|Lost to Follow-up|0|||
143312802|NCT00306592|516692596|FG000|Overall Study|Noncompliance|0|||
143312803|NCT00306592|516692597|FG001|Overall Study|Noncompliance|2|||
143312804|NCT00306592|516692596|FG000|Overall Study|Persistent Antibodies|6|||
143312805|NCT00306592|516692597|FG001|Overall Study|Persistent Antibodies|3|||
143312806|NCT00306592|516692596|FG000|Overall Study|Voluntary|10|||
143312807|NCT00306592|516692597|FG001|Overall Study|Voluntary|6|||
143312808|NCT00306592|516692596|FG000|Overall Study|Other|5|||
143312809|NCT00306592|516692597|FG001|Overall Study|Other|10|||
143312810|NCT00306592|516692596|FG000|Overall Study|Other|1|||
143312811|NCT00306592|516692597|FG001|Overall Study|Other|2|||
143312812|NCT00306592|516692596|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
143312813|NCT00306592|516692597|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
143312814|NCT04101526|516692601|FG000|Overall Study|Did not complete all sleep diary entries|0|||
143312815|NCT04101526|516692602|FG001|Overall Study|Did not complete all sleep diary entries|1|||
143312816|NCT02488629|516692603|FG000|Overall Study|Lack of Efficacy|3|||
143312817|NCT02488629|516692604|FG001|Overall Study|Lack of Efficacy|1|||
143312818|NCT02488629|516692605|FG002|Overall Study|Lack of Efficacy|0|||
143312819|NCT02488629|516692606|FG003|Overall Study|Lack of Efficacy|0|||
143312820|NCT02488629|516692603|FG000|Overall Study|Withdrawal by Subject|0|||
143312821|NCT02488629|516692604|FG001|Overall Study|Withdrawal by Subject|1|||
143312822|NCT02488629|516692605|FG002|Overall Study|Withdrawal by Subject|0|||
143312823|NCT02488629|516692606|FG003|Overall Study|Withdrawal by Subject|0|||
143312824|NCT02652624|516692607|FG000|Randomized Phase|Pregnancy|3|||
143312825|NCT02652624|516692608|FG001|Randomized Phase|Pregnancy|1|||
143312826|NCT02652624|516692607|FG000|Randomized Phase|Investigator's Discretion|0|||
143312827|NCT02652624|516692608|FG001|Randomized Phase|Investigator's Discretion|2|||
143312828|NCT02652624|516692607|FG000|Randomized Phase|Death|0|||
143312829|NCT02652624|516692608|FG001|Randomized Phase|Death|1|||
143312830|NCT02652624|516692607|FG000|Randomized Phase|Lost to Follow-up|0|||
143312831|NCT02652624|516692608|FG001|Randomized Phase|Lost to Follow-up|1|||
143312832|NCT02652624|516692607|FG000|Extension Phase|Lost to Follow-up|3|||
143312833|NCT02652624|516692608|FG001|Extension Phase|Lost to Follow-up|1|||
143312834|NCT02652624|516692607|FG000|Extension Phase|Pregnancy|1|||
143312835|NCT02652624|516692608|FG001|Extension Phase|Pregnancy|1|||
143312836|NCT02652624|516692607|FG000|Extension Phase|Adverse Event|0|||
143312837|NCT02652624|516692608|FG001|Extension Phase|Adverse Event|1|||
143312838|NCT02652624|516692607|FG000|Extension Phase|Withdrew Consent|0|||
143312839|NCT02652624|516692608|FG001|Extension Phase|Withdrew Consent|1|||
143312840|NCT00654628|516692609|FG000|6-week Active Treatment Period|Adverse Event|9|||
143312841|NCT00654628|516692609|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
143312842|NCT00654628|516692609|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
143312843|NCT00654628|516692609|FG000|6-week Active Treatment Period|Out of window period|1|||
143312844|NCT00654628|516692609|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
143312845|NCT00654628|516692609|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
143312846|NCT00912405|516692612|FG000|Overall Study|Lost to Follow-up|5|||
143312847|NCT00953329|516692613|FG000|Overall Study|Lack of Efficacy|1|||
143312848|NCT01434823|516692614|FG000|Overall Study|Incomplete data in medical record|4|||
143312849|NCT01434823|516692615|FG001|Overall Study|Incomplete data in medical record|7|||
143312850|NCT01797536|516692616|FG000|Overall Study|Adverse Event|0|||
143312851|NCT01797536|516692617|FG001|Overall Study|Adverse Event|1|||
143312852|NCT01797536|516692618|FG002|Overall Study|Adverse Event|0|||
143312853|NCT01797536|516692619|FG003|Overall Study|Adverse Event|0|||
143312854|NCT03592641|516692628|FG000|Overall Study|Withdrawal by Subject|1|||
143312855|NCT00436280|516692629|FG000|Period 1: Induction|Adverse Event|8|||
143312856|NCT00436280|516692629|FG000|Period 1: Induction|Progressive Disease|12|||
143312857|NCT00436280|516692629|FG000|Period 1: Induction|Stable Disease|6|||
143312858|NCT00436280|516692629|FG000|Period 1: Induction|Withdrawal by Subject|1|||
143312859|NCT00436280|516692629|FG000|Period 1: Induction|Death|1|||
143312860|NCT00436280|516692629|FG000|Period 2: Consolidation|Adverse Event|1|||
143312861|NCT00436280|516692629|FG000|Period 2: Consolidation|Progressive Disease|10|||
143312862|NCT00436280|516692629|FG000|Period 2: Consolidation|Stable Disease|1|||
143312863|NCT00436280|516692629|FG000|Period 2: Consolidation|Physician Decision|2|||
143312864|NCT00436280|516692629|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
143312865|NCT00436280|516692629|FG000|Period 2: Consolidation|Death|1|||
143312866|NCT00436280|516692629|FG000|Period 3: Maintenance|Adverse Event|6|||
143312867|NCT00436280|516692629|FG000|Period 3: Maintenance|Progressive Disease|12|||
143312868|NCT01532687|516692635|FG000|Overall Study|Death|2|||
143312869|NCT01532687|516692636|FG001|Overall Study|Death|0|||
143312870|NCT01532687|516692635|FG000|Overall Study|Adverse Event|6|||
143312871|NCT01532687|516692636|FG001|Overall Study|Adverse Event|1|||
143312872|NCT01532687|516692635|FG000|Overall Study|Withdrawal by Subject|1|||
143312873|NCT01532687|516692636|FG001|Overall Study|Withdrawal by Subject|0|||
143312874|NCT01532687|516692635|FG000|Overall Study|Physician Decision|2|||
143312875|NCT01532687|516692636|FG001|Overall Study|Physician Decision|1|||
143312876|NCT01532687|516692635|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
143312877|NCT01532687|516692636|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
143312878|NCT00403455|516692637|FG000|Overall Study|Withdrawal by Subject|1|||
143312879|NCT03160703|516692638|FG000|Overall Study|Withdrawal by Subject|0|||
143312880|NCT03160703|516692639|FG001|Overall Study|Withdrawal by Subject|0|||
143312881|NCT03160703|516692640|FG002|Overall Study|Withdrawal by Subject|0|||
143312882|NCT03160703|516692641|FG003|Overall Study|Withdrawal by Subject|1|||
143312883|NCT01513291|516692648|FG000|Treatment Period|Adverse Event|8|||
143312884|NCT01513291|516692649|FG001|Treatment Period|Adverse Event|4|||
143312885|NCT01513291|516692650|FG002|Treatment Period|Adverse Event|0|||
143312886|NCT01513291|516692651|FG003|Treatment Period|Adverse Event|0|||
143312887|NCT01513291|516692652|FG004|Treatment Period|Adverse Event|0|||
143312888|NCT01513291|516692648|FG000|Treatment Period|Lack of Efficacy|3|||
143312889|NCT01513291|516692649|FG001|Treatment Period|Lack of Efficacy|0|||
143312890|NCT01513291|516692650|FG002|Treatment Period|Lack of Efficacy|0|||
143312891|NCT01513291|516692651|FG003|Treatment Period|Lack of Efficacy|0|||
143312892|NCT01513291|516692652|FG004|Treatment Period|Lack of Efficacy|0|||
143312893|NCT01513291|516692648|FG000|Treatment Period|Lost to Follow-up|2|||
143312894|NCT01513291|516692649|FG001|Treatment Period|Lost to Follow-up|3|||
143312895|NCT01513291|516692650|FG002|Treatment Period|Lost to Follow-up|0|||
143312896|NCT01513291|516692651|FG003|Treatment Period|Lost to Follow-up|0|||
143312897|NCT01513291|516692652|FG004|Treatment Period|Lost to Follow-up|0|||
143312898|NCT01513291|516692648|FG000|Treatment Period|Physician Decision|1|||
143312899|NCT01513291|516692649|FG001|Treatment Period|Physician Decision|0|||
143312900|NCT01513291|516692650|FG002|Treatment Period|Physician Decision|0|||
143312901|NCT01513291|516692651|FG003|Treatment Period|Physician Decision|0|||
143312902|NCT01513291|516692652|FG004|Treatment Period|Physician Decision|0|||
143312903|NCT01513291|516692648|FG000|Treatment Period|Protocol Violation|1|||
143312904|NCT01513291|516692649|FG001|Treatment Period|Protocol Violation|2|||
143312905|NCT01513291|516692650|FG002|Treatment Period|Protocol Violation|0|||
143312906|NCT01513291|516692651|FG003|Treatment Period|Protocol Violation|0|||
143312907|NCT01513291|516692652|FG004|Treatment Period|Protocol Violation|0|||
143312908|NCT01513291|516692648|FG000|Treatment Period|Withdrawal by Subject|8|||
143312909|NCT01513291|516692649|FG001|Treatment Period|Withdrawal by Subject|5|||
143312910|NCT01513291|516692650|FG002|Treatment Period|Withdrawal by Subject|0|||
143312911|NCT01513291|516692651|FG003|Treatment Period|Withdrawal by Subject|0|||
143312912|NCT01513291|516692652|FG004|Treatment Period|Withdrawal by Subject|0|||
143312913|NCT01513291|516692648|FG000|Treatment Period|Randomized not treated|0|||
143312914|NCT01513291|516692649|FG001|Treatment Period|Randomized not treated|2|||
143312915|NCT01513291|516692650|FG002|Treatment Period|Randomized not treated|0|||
143312916|NCT01513291|516692651|FG003|Treatment Period|Randomized not treated|0|||
143312917|NCT01513291|516692652|FG004|Treatment Period|Randomized not treated|0|||
143312918|NCT01513291|516692648|FG000|Run-out Period|Lost to Follow-up|0|||
143312919|NCT01513291|516692649|FG001|Run-out Period|Lost to Follow-up|0|||
143312920|NCT01513291|516692650|FG002|Run-out Period|Lost to Follow-up|0|||
143312921|NCT01513291|516692651|FG003|Run-out Period|Lost to Follow-up|1|||
143312922|NCT01513291|516692652|FG004|Run-out Period|Lost to Follow-up|0|||
143312923|NCT01513291|516692648|FG000|Run-out Period|Withdrawal by Subject|0|||
143312924|NCT01513291|516692649|FG001|Run-out Period|Withdrawal by Subject|0|||
143312925|NCT01513291|516692650|FG002|Run-out Period|Withdrawal by Subject|0|||
143312926|NCT01513291|516692651|FG003|Run-out Period|Withdrawal by Subject|1|||
143312927|NCT01513291|516692652|FG004|Run-out Period|Withdrawal by Subject|0|||
143312928|NCT01358981|516692653|FG000|Period 1|Withdrawal by Subject|0|||
143312929|NCT01358981|516692654|FG001|Period 1|Withdrawal by Subject|0|||
143312930|NCT01358981|516692655|FG002|Period 1|Withdrawal by Subject|0|||
143312931|NCT01358981|516692656|FG003|Period 1|Withdrawal by Subject|1|||
143312932|NCT01358981|516692657|FG004|Period 1|Withdrawal by Subject|0|||
143312933|NCT01358981|516692658|FG005|Period 1|Withdrawal by Subject|0|||
143312934|NCT01358981|516692659|FG006|Period 1|Withdrawal by Subject|0|||
143312935|NCT03728582|516692660|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
143312936|NCT03728582|516692661|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
143312937|NCT03728582|516692660|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
143312938|NCT03728582|516692661|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
143312939|NCT02732847|516692662|FG000|Overall Study|some filled early|42|||
143312940|NCT02732847|516692663|FG001|Overall Study|some filled early|42|||
143312941|NCT01018264|516692664|FG000|Overall Study|Withdrawal by Subject|1|||
143312942|NCT01018264|516692665|FG001|Overall Study|Withdrawal by Subject|0|||
143312943|NCT01018264|516692664|FG000|Overall Study|Lost to Follow-up|0|||
143312944|NCT01018264|516692665|FG001|Overall Study|Lost to Follow-up|1|||
143312945|NCT04439240|516692667|FG000|Overall Study|Ineligible|2|||
143312946|NCT04439240|516692667|FG000|Overall Study|Never started treatment|2|||
143312947|NCT04439240|516692667|FG000|Overall Study|Adverse Event|12|||
143312948|NCT04439240|516692667|FG000|Overall Study|Death|2|||
143312949|NCT04439240|516692667|FG000|Overall Study|Disease progression|25|||
143312950|NCT04439240|516692667|FG000|Overall Study|Other diseases|2|||
143312951|NCT04439240|516692667|FG000|Overall Study|Withdrawal by Subject|3|||
143312952|NCT04439240|516692667|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
143312953|NCT04439240|516692667|FG000|Overall Study|Symptomatic decline|1|||
143312954|NCT04439240|516692667|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
143312955|NCT04439240|516692667|FG000|Overall Study|Clinical progression|1|||
143312956|NCT04542070|516692668|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
143312957|NCT04542070|516692669|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
143312958|NCT04542070|516692670|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
143312959|NCT04542070|516692671|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
143312960|NCT04542070|516692668|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
143312961|NCT04542070|516692669|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
143312962|NCT04542070|516692670|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
143312963|NCT04542070|516692671|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
143312964|NCT04542070|516692668|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
143312965|NCT04542070|516692669|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
143312966|NCT04542070|516692670|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
143312967|NCT04542070|516692671|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
143312968|NCT04542070|516692668|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
143312969|NCT04542070|516692669|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
143312970|NCT04542070|516692670|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
143312971|NCT04542070|516692671|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
143312972|NCT04542070|516692668|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
143312973|NCT04542070|516692669|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
143312974|NCT04542070|516692670|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
143312975|NCT04542070|516692671|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
143312976|NCT04542070|516692668|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
143376034|NCT01040689|516921628|FG000|Overall Study|Withdrawal by Subject|2|||
143376035|NCT01040689|516921629|FG001|Overall Study|Withdrawal by Subject|1|||
143312977|NCT04542070|516692669|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
143312978|NCT04542070|516692670|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
143312979|NCT04542070|516692671|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
143312980|NCT04542070|516692668|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
143312981|NCT04542070|516692669|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
143312982|NCT04542070|516692670|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
143312983|NCT04542070|516692671|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
143312984|NCT04542070|516692668|FG000|Maintenance + Extension Period|Adverse Event|10|||
143312985|NCT04542070|516692669|FG001|Maintenance + Extension Period|Adverse Event|2|||
143312986|NCT04542070|516692670|FG002|Maintenance + Extension Period|Adverse Event|0|||
143312987|NCT04542070|516692671|FG003|Maintenance + Extension Period|Adverse Event|0|||
143312988|NCT04542070|516692668|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
143312989|NCT04542070|516692669|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
143312990|NCT04542070|516692670|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
143312991|NCT04542070|516692671|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
143312992|NCT04542070|516692668|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
143312993|NCT04542070|516692669|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
143312994|NCT04542070|516692670|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
143312995|NCT04542070|516692671|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
143312996|NCT04542070|516692668|FG000|Maintenance + Extension Period|Physician Decision|1|||
143312997|NCT04542070|516692669|FG001|Maintenance + Extension Period|Physician Decision|1|||
143312998|NCT04542070|516692670|FG002|Maintenance + Extension Period|Physician Decision|0|||
143312999|NCT04542070|516692671|FG003|Maintenance + Extension Period|Physician Decision|0|||
143313000|NCT04542070|516692668|FG000|Maintenance + Extension Period|Protocol Violation|2|||
143313001|NCT04542070|516692669|FG001|Maintenance + Extension Period|Protocol Violation|5|||
143313002|NCT04542070|516692670|FG002|Maintenance + Extension Period|Protocol Violation|0|||
143313003|NCT04542070|516692671|FG003|Maintenance + Extension Period|Protocol Violation|0|||
143313004|NCT04542070|516692668|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
143313005|NCT04542070|516692669|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
143313006|NCT04542070|516692670|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
143313007|NCT04542070|516692671|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
143313008|NCT04542070|516692668|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
143313009|NCT04542070|516692669|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
143313010|NCT04542070|516692670|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
143313011|NCT04542070|516692671|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
143313012|NCT04542070|516692668|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
143313013|NCT04542070|516692669|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
143313014|NCT04542070|516692670|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
143313015|NCT04542070|516692671|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
143313016|NCT04542070|516692668|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
143313017|NCT04542070|516692669|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
143313018|NCT04542070|516692670|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
143313019|NCT04542070|516692671|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
143313020|NCT04542070|516692668|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
143313021|NCT04542070|516692669|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
143313022|NCT04542070|516692670|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
143313023|NCT04542070|516692671|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
143313024|NCT04542070|516692668|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
143313025|NCT04542070|516692669|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
143313026|NCT04542070|516692670|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
143313027|NCT04542070|516692671|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
143313028|NCT04542070|516692668|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
143313029|NCT04542070|516692669|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
143313030|NCT04542070|516692670|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
143313031|NCT04542070|516692671|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
143313032|NCT01696032|516692675|FG000|Overall Study|Withdrawal by Subject|0|||
143313033|NCT01696032|516692676|FG001|Overall Study|Withdrawal by Subject|0|||
143313034|NCT01696032|516692677|FG002|Overall Study|Withdrawal by Subject|1|||
143313035|NCT01696032|516692678|FG003|Overall Study|Withdrawal by Subject|2|||
143313036|NCT01696032|516692675|FG000|Overall Study|Death|14|||
143313037|NCT01696032|516692676|FG001|Overall Study|Death|4|||
143313038|NCT01696032|516692677|FG002|Overall Study|Death|43|||
143313039|NCT01696032|516692678|FG003|Overall Study|Death|18|||
143313040|NCT01696032|516692675|FG000|Overall Study|Lost to Follow-up|0|||
143313041|NCT01696032|516692676|FG001|Overall Study|Lost to Follow-up|1|||
143313042|NCT01696032|516692677|FG002|Overall Study|Lost to Follow-up|0|||
143313043|NCT01696032|516692678|FG003|Overall Study|Lost to Follow-up|0|||
143313044|NCT01696032|516692675|FG000|Overall Study|Database lock|0|||
143313045|NCT01696032|516692676|FG001|Overall Study|Database lock|1|||
143313046|NCT01696032|516692677|FG002|Overall Study|Database lock|7|||
143313047|NCT01696032|516692678|FG003|Overall Study|Database lock|2|||
143313048|NCT03025828|516692679|FG000|Overall Study|Lost to Follow-up|1|||
143313049|NCT03306264|516692682|FG000|Overall Study|Death|33|||
143313050|NCT03306264|516692683|FG001|Overall Study|Death|25|||
143313051|NCT03306264|516692684|FG002|Overall Study|Death|34|||
143313052|NCT03306264|516692685|FG003|Overall Study|Death|34|||
143313053|NCT03306264|516692682|FG000|Overall Study|Complete Consent Withdrawal|4|||
143313054|NCT03306264|516692683|FG001|Overall Study|Complete Consent Withdrawal|4|||
143313055|NCT03306264|516692684|FG002|Overall Study|Complete Consent Withdrawal|1|||
143313056|NCT03306264|516692685|FG003|Overall Study|Complete Consent Withdrawal|8|||
143313057|NCT03306264|516692682|FG000|Overall Study|Lost to Follow-up|1|||
143313058|NCT03306264|516692683|FG001|Overall Study|Lost to Follow-up|0|||
143313059|NCT03306264|516692684|FG002|Overall Study|Lost to Follow-up|1|||
143313060|NCT03306264|516692685|FG003|Overall Study|Lost to Follow-up|0|||
143313061|NCT03306264|516692682|FG000|Overall Study|Rollover to ASTX727-06|10|||
143313062|NCT03306264|516692683|FG001|Overall Study|Rollover to ASTX727-06|18|||
143313063|NCT03306264|516692684|FG002|Overall Study|Rollover to ASTX727-06|4|||
143313064|NCT03306264|516692685|FG003|Overall Study|Rollover to ASTX727-06|2|||
143313065|NCT03306264|516692682|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
143313066|NCT03306264|516692683|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
143313067|NCT03306264|516692684|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
143313068|NCT03306264|516692685|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
143313069|NCT03120013|516692688|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
143313070|NCT03120013|516692689|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
143313071|NCT01462357|516692691|FG000|Overall Study|Death|0|||
143313072|NCT01462357|516692692|FG001|Overall Study|Death|0|||
143313073|NCT01462357|516692693|FG002|Overall Study|Death|1|||
143313074|NCT01462357|516692691|FG000|Overall Study|Withdrawal by Subject|3|||
143313075|NCT01462357|516692692|FG001|Overall Study|Withdrawal by Subject|11|||
143313076|NCT01462357|516692693|FG002|Overall Study|Withdrawal by Subject|3|||
143313077|NCT01462357|516692691|FG000|Overall Study|Migrated/moved from study area|2|||
143313078|NCT01462357|516692692|FG001|Overall Study|Migrated/moved from study area|3|||
143313079|NCT01462357|516692693|FG002|Overall Study|Migrated/moved from study area|1|||
143313080|NCT01462357|516692691|FG000|Overall Study|Lost to Follow-up|3|||
143313081|NCT01462357|516692692|FG001|Overall Study|Lost to Follow-up|5|||
143313082|NCT01462357|516692693|FG002|Overall Study|Lost to Follow-up|7|||
143313083|NCT01247090|516692694|FG000|Overall Study|Physician Decision|1|||
143313084|NCT01247090|516692695|FG001|Overall Study|Physician Decision|0|||
143313085|NCT01247090|516692696|FG002|Overall Study|Physician Decision|0|||
143313086|NCT01247090|516692694|FG000|Overall Study|Withdrawal by Subject|0|||
143313087|NCT01247090|516692695|FG001|Overall Study|Withdrawal by Subject|1|||
143313088|NCT01247090|516692696|FG002|Overall Study|Withdrawal by Subject|0|||
143313089|NCT01282216|516692699|FG000|Overall Study|Graft failure|0|||
143313090|NCT01282216|516692700|FG001|Overall Study|Graft failure|0|||
143313091|NCT01282216|516692701|FG002|Overall Study|Graft failure|3|||
143313092|NCT01282216|516692702|FG003|Overall Study|Graft failure|2|||
143313093|NCT01282216|516692699|FG000|Overall Study|Physician Decision|0|||
143313094|NCT01282216|516692700|FG001|Overall Study|Physician Decision|0|||
143313095|NCT01282216|516692701|FG002|Overall Study|Physician Decision|11|||
143313096|NCT01282216|516692702|FG003|Overall Study|Physician Decision|0|||
143313097|NCT01282216|516692699|FG000|Overall Study|Relapse|0|||
143313098|NCT01282216|516692700|FG001|Overall Study|Relapse|0|||
143313099|NCT01282216|516692701|FG002|Overall Study|Relapse|17|||
143313100|NCT01282216|516692702|FG003|Overall Study|Relapse|6|||
143313101|NCT01282216|516692699|FG000|Overall Study|Death|0|||
143313102|NCT01282216|516692700|FG001|Overall Study|Death|0|||
143313103|NCT01282216|516692701|FG002|Overall Study|Death|2|||
143313104|NCT01282216|516692702|FG003|Overall Study|Death|0|||
143313105|NCT02908529|516692705|FG000|Overall Study|Lost to Follow-up|0|||
143313106|NCT02908529|516692706|FG001|Overall Study|Lost to Follow-up|2|||
143313107|NCT01660412|516692712|FG000|Overall Study|Protocol Violation|0|||
143313108|NCT01660412|516692713|FG001|Overall Study|Protocol Violation|3|||
143313109|NCT03013491|516692714|FG000|Main Study|Death|2|||
143313110|NCT03013491|516692715|FG001|Main Study|Death|2|||
143313111|NCT03013491|516692716|FG002|Main Study|Death|5|||
143313112|NCT03013491|516692717|FG003|Main Study|Death|3|||
143313113|NCT03013491|516692718|FG004|Main Study|Death|9|||
143313114|NCT03013491|516692719|FG005|Main Study|Death|12|||
143313115|NCT03013491|516692720|FG006|Main Study|Death|3|||
143313116|NCT03013491|516692721|FG007|Main Study|Death|5|||
143313117|NCT03013491|516692722|FG008|Main Study|Death|1|||
143313118|NCT03013491|516692723|FG009|Main Study|Death|2|||
143313119|NCT03013491|516692724|FG010|Main Study|Death|4|||
143313120|NCT03013491|516692725|FG011|Main Study|Death|1|||
143313121|NCT03013491|516692726|FG012|Main Study|Death|1|||
143313122|NCT03013491|516692727|FG013|Main Study|Death|4|||
143313123|NCT03013491|516692728|FG014|Main Study|Death|0|||
143313124|NCT03013491|516692729|FG015|Main Study|Death|3|||
143313125|NCT03013491|516692730|FG016|Main Study|Death|5|||
143313126|NCT03013491|516692731|FG017|Main Study|Death|1|||
143313127|NCT03013491|516692732|FG018|Main Study|Death|47|||
143313128|NCT03013491|516692714|FG000|Main Study|Lost to Follow-up|0|||
143313129|NCT03013491|516692715|FG001|Main Study|Lost to Follow-up|0|||
143313130|NCT03013491|516692716|FG002|Main Study|Lost to Follow-up|1|||
143313131|NCT03013491|516692717|FG003|Main Study|Lost to Follow-up|0|||
143313132|NCT03013491|516692718|FG004|Main Study|Lost to Follow-up|1|||
143313133|NCT03013491|516692719|FG005|Main Study|Lost to Follow-up|0|||
143313134|NCT03013491|516692720|FG006|Main Study|Lost to Follow-up|0|||
143313135|NCT03013491|516692721|FG007|Main Study|Lost to Follow-up|0|||
143313136|NCT03013491|516692722|FG008|Main Study|Lost to Follow-up|0|||
143313137|NCT03013491|516692723|FG009|Main Study|Lost to Follow-up|0|||
143313138|NCT03013491|516692724|FG010|Main Study|Lost to Follow-up|0|||
143313139|NCT03013491|516692725|FG011|Main Study|Lost to Follow-up|0|||
143313140|NCT03013491|516692726|FG012|Main Study|Lost to Follow-up|0|||
143313141|NCT03013491|516692727|FG013|Main Study|Lost to Follow-up|0|||
143313142|NCT03013491|516692728|FG014|Main Study|Lost to Follow-up|0|||
143313143|NCT03013491|516692729|FG015|Main Study|Lost to Follow-up|0|||
143313144|NCT03013491|516692730|FG016|Main Study|Lost to Follow-up|0|||
143313145|NCT03013491|516692731|FG017|Main Study|Lost to Follow-up|0|||
143313146|NCT03013491|516692732|FG018|Main Study|Lost to Follow-up|3|||
143313147|NCT03013491|516692714|FG000|Main Study|Termination of the study by Sponsor|0|||
143313148|NCT03013491|516692715|FG001|Main Study|Termination of the study by Sponsor|0|||
143313149|NCT03013491|516692716|FG002|Main Study|Termination of the study by Sponsor|2|||
143313150|NCT03013491|516692717|FG003|Main Study|Termination of the study by Sponsor|0|||
143313151|NCT03013491|516692718|FG004|Main Study|Termination of the study by Sponsor|1|||
143313152|NCT03013491|516692719|FG005|Main Study|Termination of the study by Sponsor|2|||
143313153|NCT03013491|516692720|FG006|Main Study|Termination of the study by Sponsor|0|||
143313154|NCT03013491|516692721|FG007|Main Study|Termination of the study by Sponsor|0|||
143313155|NCT03013491|516692722|FG008|Main Study|Termination of the study by Sponsor|1|||
143313156|NCT03013491|516692723|FG009|Main Study|Termination of the study by Sponsor|1|||
143313157|NCT03013491|516692724|FG010|Main Study|Termination of the study by Sponsor|1|||
143313158|NCT03013491|516692725|FG011|Main Study|Termination of the study by Sponsor|2|||
143313159|NCT03013491|516692726|FG012|Main Study|Termination of the study by Sponsor|0|||
143313160|NCT03013491|516692727|FG013|Main Study|Termination of the study by Sponsor|0|||
143313161|NCT03013491|516692728|FG014|Main Study|Termination of the study by Sponsor|0|||
143313162|NCT03013491|516692729|FG015|Main Study|Termination of the study by Sponsor|0|||
143313163|NCT03013491|516692730|FG016|Main Study|Termination of the study by Sponsor|0|||
143313164|NCT03013491|516692731|FG017|Main Study|Termination of the study by Sponsor|1|||
143313165|NCT03013491|516692732|FG018|Main Study|Termination of the study by Sponsor|13|||
143313166|NCT03013491|516692714|FG000|Main Study|Withdrawal by Subject|0|||
143313167|NCT03013491|516692715|FG001|Main Study|Withdrawal by Subject|0|||
143313168|NCT03013491|516692716|FG002|Main Study|Withdrawal by Subject|0|||
143313169|NCT03013491|516692717|FG003|Main Study|Withdrawal by Subject|4|||
143313170|NCT03013491|516692718|FG004|Main Study|Withdrawal by Subject|2|||
143313171|NCT03013491|516692719|FG005|Main Study|Withdrawal by Subject|1|||
143313172|NCT03013491|516692720|FG006|Main Study|Withdrawal by Subject|0|||
143313173|NCT03013491|516692721|FG007|Main Study|Withdrawal by Subject|0|||
143313174|NCT03013491|516692722|FG008|Main Study|Withdrawal by Subject|0|||
143313175|NCT03013491|516692723|FG009|Main Study|Withdrawal by Subject|0|||
143313176|NCT03013491|516692724|FG010|Main Study|Withdrawal by Subject|1|||
143313177|NCT03013491|516692725|FG011|Main Study|Withdrawal by Subject|2|||
143313178|NCT03013491|516692726|FG012|Main Study|Withdrawal by Subject|0|||
143313179|NCT03013491|516692727|FG013|Main Study|Withdrawal by Subject|2|||
143313180|NCT03013491|516692728|FG014|Main Study|Withdrawal by Subject|0|||
143313181|NCT03013491|516692729|FG015|Main Study|Withdrawal by Subject|0|||
143313182|NCT03013491|516692730|FG016|Main Study|Withdrawal by Subject|0|||
143313183|NCT03013491|516692731|FG017|Main Study|Withdrawal by Subject|0|||
143313184|NCT03013491|516692732|FG018|Main Study|Withdrawal by Subject|18|||
143313185|NCT03013491|516692714|FG000|Main Study|Disease progression|0|||
143313186|NCT03013491|516692715|FG001|Main Study|Disease progression|0|||
143313187|NCT03013491|516692716|FG002|Main Study|Disease progression|0|||
143313188|NCT03013491|516692717|FG003|Main Study|Disease progression|1|||
143313189|NCT03013491|516692718|FG004|Main Study|Disease progression|0|||
143313190|NCT03013491|516692719|FG005|Main Study|Disease progression|0|||
143313191|NCT03013491|516692720|FG006|Main Study|Disease progression|0|||
143313192|NCT03013491|516692721|FG007|Main Study|Disease progression|0|||
143313193|NCT03013491|516692722|FG008|Main Study|Disease progression|1|||
143313194|NCT03013491|516692723|FG009|Main Study|Disease progression|0|||
143313195|NCT03013491|516692724|FG010|Main Study|Disease progression|1|||
143313196|NCT03013491|516692725|FG011|Main Study|Disease progression|0|||
143313197|NCT03013491|516692726|FG012|Main Study|Disease progression|0|||
143313198|NCT03013491|516692727|FG013|Main Study|Disease progression|0|||
143313199|NCT03013491|516692728|FG014|Main Study|Disease progression|0|||
143313200|NCT03013491|516692729|FG015|Main Study|Disease progression|0|||
143313201|NCT03013491|516692730|FG016|Main Study|Disease progression|0|||
143313202|NCT03013491|516692731|FG017|Main Study|Disease progression|0|||
143313203|NCT03013491|516692732|FG018|Main Study|Disease progression|4|||
143313204|NCT03013491|516692714|FG000|Main Study|Symptomatic deterioration|0|||
143313205|NCT03013491|516692715|FG001|Main Study|Symptomatic deterioration|0|||
143313206|NCT03013491|516692716|FG002|Main Study|Symptomatic deterioration|0|||
143313207|NCT03013491|516692717|FG003|Main Study|Symptomatic deterioration|0|||
143313208|NCT03013491|516692718|FG004|Main Study|Symptomatic deterioration|0|||
143313209|NCT03013491|516692719|FG005|Main Study|Symptomatic deterioration|1|||
143313210|NCT03013491|516692720|FG006|Main Study|Symptomatic deterioration|0|||
143313211|NCT03013491|516692721|FG007|Main Study|Symptomatic deterioration|0|||
143313212|NCT03013491|516692722|FG008|Main Study|Symptomatic deterioration|0|||
143313213|NCT03013491|516692723|FG009|Main Study|Symptomatic deterioration|0|||
143313214|NCT03013491|516692724|FG010|Main Study|Symptomatic deterioration|0|||
143313215|NCT03013491|516692725|FG011|Main Study|Symptomatic deterioration|0|||
143313216|NCT03013491|516692726|FG012|Main Study|Symptomatic deterioration|0|||
143313217|NCT03013491|516692727|FG013|Main Study|Symptomatic deterioration|0|||
143313218|NCT03013491|516692728|FG014|Main Study|Symptomatic deterioration|0|||
143313219|NCT03013491|516692729|FG015|Main Study|Symptomatic deterioration|0|||
143313220|NCT03013491|516692730|FG016|Main Study|Symptomatic deterioration|0|||
143313221|NCT03013491|516692731|FG017|Main Study|Symptomatic deterioration|0|||
143313222|NCT03013491|516692732|FG018|Main Study|Symptomatic deterioration|0|||
143313223|NCT03013491|516692714|FG000|Main Study|Protocol version 8.0 approval|0|||
143376036|NCT01040689|516921630|FG002|Overall Study|Withdrawal by Subject|1|||
143376037|NCT01040689|516921631|FG003|Overall Study|Withdrawal by Subject|0|||
143376038|NCT01040689|516921628|FG000|Overall Study|Other reasons not listed above|0|||
143376039|NCT01040689|516921629|FG001|Overall Study|Other reasons not listed above|1|||
143376040|NCT01040689|516921630|FG002|Overall Study|Other reasons not listed above|0|||
143376041|NCT01040689|516921631|FG003|Overall Study|Other reasons not listed above|0|||
143313224|NCT03013491|516692715|FG001|Main Study|Protocol version 8.0 approval|0|||
143313225|NCT03013491|516692716|FG002|Main Study|Protocol version 8.0 approval|0|||
143313226|NCT03013491|516692717|FG003|Main Study|Protocol version 8.0 approval|0|||
143313227|NCT03013491|516692718|FG004|Main Study|Protocol version 8.0 approval|0|||
143313228|NCT03013491|516692719|FG005|Main Study|Protocol version 8.0 approval|0|||
143313229|NCT03013491|516692720|FG006|Main Study|Protocol version 8.0 approval|0|||
143313230|NCT03013491|516692721|FG007|Main Study|Protocol version 8.0 approval|0|||
143313231|NCT03013491|516692722|FG008|Main Study|Protocol version 8.0 approval|0|||
143313232|NCT03013491|516692723|FG009|Main Study|Protocol version 8.0 approval|0|||
143313233|NCT03013491|516692724|FG010|Main Study|Protocol version 8.0 approval|1|||
143313234|NCT03013491|516692725|FG011|Main Study|Protocol version 8.0 approval|0|||
143313235|NCT03013491|516692726|FG012|Main Study|Protocol version 8.0 approval|0|||
143313236|NCT03013491|516692727|FG013|Main Study|Protocol version 8.0 approval|0|||
143313237|NCT03013491|516692728|FG014|Main Study|Protocol version 8.0 approval|0|||
143313238|NCT03013491|516692729|FG015|Main Study|Protocol version 8.0 approval|0|||
143313239|NCT03013491|516692730|FG016|Main Study|Protocol version 8.0 approval|0|||
143313240|NCT03013491|516692731|FG017|Main Study|Protocol version 8.0 approval|0|||
143313241|NCT03013491|516692732|FG018|Main Study|Protocol version 8.0 approval|0|||
143313242|NCT03013491|516692714|FG000|Main Study|Partial withdrawal with survival follow-up only|0|||
143313243|NCT03013491|516692715|FG001|Main Study|Partial withdrawal with survival follow-up only|0|||
143313244|NCT03013491|516692716|FG002|Main Study|Partial withdrawal with survival follow-up only|0|||
143313245|NCT03013491|516692717|FG003|Main Study|Partial withdrawal with survival follow-up only|0|||
143313246|NCT03013491|516692718|FG004|Main Study|Partial withdrawal with survival follow-up only|0|||
143313247|NCT03013491|516692719|FG005|Main Study|Partial withdrawal with survival follow-up only|0|||
143313248|NCT03013491|516692720|FG006|Main Study|Partial withdrawal with survival follow-up only|0|||
143313249|NCT03013491|516692721|FG007|Main Study|Partial withdrawal with survival follow-up only|0|||
143313250|NCT03013491|516692722|FG008|Main Study|Partial withdrawal with survival follow-up only|0|||
143376042|NCT02755805|516921632|FG000|Overall Study|Lost to Follow-up|1|||
143376043|NCT02755805|516921633|FG001|Overall Study|Lost to Follow-up|2|||
143313251|NCT03013491|516692723|FG009|Main Study|Partial withdrawal with survival follow-up only|0|||
143313252|NCT03013491|516692724|FG010|Main Study|Partial withdrawal with survival follow-up only|0|||
143376044|NCT02755805|516921632|FG000|Overall Study|Refused assessments|1|||
143376045|NCT02755805|516921633|FG001|Overall Study|Refused assessments|0|||
143376046|NCT02755805|516921632|FG000|Overall Study|Withdrawal by Subject|0|||
143376047|NCT02755805|516921633|FG001|Overall Study|Withdrawal by Subject|2|||
143376048|NCT03593213|516921635|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
143376049|NCT03593213|516921636|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
143376050|NCT03593213|516921637|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
143376051|NCT03593213|516921638|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
143376052|NCT03593213|516921635|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
143313253|NCT03013491|516692725|FG011|Main Study|Partial withdrawal with survival follow-up only|1|||
143313254|NCT03013491|516692726|FG012|Main Study|Partial withdrawal with survival follow-up only|0|||
143313255|NCT03013491|516692727|FG013|Main Study|Partial withdrawal with survival follow-up only|0|||
143313256|NCT03013491|516692728|FG014|Main Study|Partial withdrawal with survival follow-up only|0|||
143313257|NCT03013491|516692729|FG015|Main Study|Partial withdrawal with survival follow-up only|0|||
143313258|NCT03013491|516692730|FG016|Main Study|Partial withdrawal with survival follow-up only|0|||
143313259|NCT03013491|516692731|FG017|Main Study|Partial withdrawal with survival follow-up only|0|||
143313260|NCT03013491|516692732|FG018|Main Study|Partial withdrawal with survival follow-up only|0|||
143313261|NCT03013491|516692714|FG000|Main Study|Start of new anticancer therapy|0|||
143313262|NCT03013491|516692715|FG001|Main Study|Start of new anticancer therapy|0|||
143313263|NCT03013491|516692716|FG002|Main Study|Start of new anticancer therapy|0|||
143313264|NCT03013491|516692717|FG003|Main Study|Start of new anticancer therapy|0|||
143313265|NCT03013491|516692718|FG004|Main Study|Start of new anticancer therapy|0|||
143313266|NCT03013491|516692719|FG005|Main Study|Start of new anticancer therapy|0|||
143313267|NCT03013491|516692720|FG006|Main Study|Start of new anticancer therapy|0|||
143313268|NCT03013491|516692721|FG007|Main Study|Start of new anticancer therapy|0|||
143313269|NCT03013491|516692722|FG008|Main Study|Start of new anticancer therapy|0|||
143313270|NCT03013491|516692723|FG009|Main Study|Start of new anticancer therapy|0|||
143313271|NCT03013491|516692724|FG010|Main Study|Start of new anticancer therapy|0|||
143313272|NCT03013491|516692725|FG011|Main Study|Start of new anticancer therapy|0|||
143313273|NCT03013491|516692726|FG012|Main Study|Start of new anticancer therapy|0|||
143313274|NCT03013491|516692727|FG013|Main Study|Start of new anticancer therapy|0|||
143313275|NCT03013491|516692728|FG014|Main Study|Start of new anticancer therapy|0|||
143313276|NCT03013491|516692729|FG015|Main Study|Start of new anticancer therapy|0|||
143313277|NCT03013491|516692730|FG016|Main Study|Start of new anticancer therapy|0|||
143313278|NCT03013491|516692731|FG017|Main Study|Start of new anticancer therapy|0|||
143313279|NCT03013491|516692732|FG018|Main Study|Start of new anticancer therapy|2|||
143313280|NCT03013491|516692714|FG000|Long-term Extension|Disease progression|0|||
143313281|NCT03013491|516692715|FG001|Long-term Extension|Disease progression|0|||
143313282|NCT03013491|516692716|FG002|Long-term Extension|Disease progression|0|||
143313283|NCT03013491|516692717|FG003|Long-term Extension|Disease progression|1|||
143313284|NCT03013491|516692718|FG004|Long-term Extension|Disease progression|0|||
143313285|NCT03013491|516692719|FG005|Long-term Extension|Disease progression|0|||
143313286|NCT03013491|516692720|FG006|Long-term Extension|Disease progression|0|||
143313287|NCT03013491|516692721|FG007|Long-term Extension|Disease progression|0|||
143313288|NCT03013491|516692722|FG008|Long-term Extension|Disease progression|0|||
143313289|NCT03013491|516692723|FG009|Long-term Extension|Disease progression|0|||
143313290|NCT03013491|516692724|FG010|Long-term Extension|Disease progression|0|||
143313291|NCT03013491|516692725|FG011|Long-term Extension|Disease progression|0|||
143313292|NCT03013491|516692726|FG012|Long-term Extension|Disease progression|0|||
143313293|NCT03013491|516692727|FG013|Long-term Extension|Disease progression|0|||
143313294|NCT03013491|516692728|FG014|Long-term Extension|Disease progression|0|||
143313295|NCT03013491|516692729|FG015|Long-term Extension|Disease progression|0|||
143313296|NCT03013491|516692730|FG016|Long-term Extension|Disease progression|0|||
143313297|NCT03013491|516692731|FG017|Long-term Extension|Disease progression|0|||
143313298|NCT03013491|516692732|FG018|Long-term Extension|Disease progression|1|||
143313299|NCT03013491|516692714|FG000|Long-term Extension|Withdrawal by Subject|0|||
143313300|NCT03013491|516692715|FG001|Long-term Extension|Withdrawal by Subject|0|||
143313301|NCT03013491|516692716|FG002|Long-term Extension|Withdrawal by Subject|0|||
143313302|NCT03013491|516692717|FG003|Long-term Extension|Withdrawal by Subject|0|||
143313303|NCT03013491|516692718|FG004|Long-term Extension|Withdrawal by Subject|0|||
143313304|NCT03013491|516692719|FG005|Long-term Extension|Withdrawal by Subject|0|||
143313305|NCT03013491|516692720|FG006|Long-term Extension|Withdrawal by Subject|0|||
143313306|NCT03013491|516692721|FG007|Long-term Extension|Withdrawal by Subject|1|||
143313307|NCT03013491|516692722|FG008|Long-term Extension|Withdrawal by Subject|0|||
143313308|NCT03013491|516692723|FG009|Long-term Extension|Withdrawal by Subject|0|||
143313309|NCT03013491|516692724|FG010|Long-term Extension|Withdrawal by Subject|0|||
143313310|NCT03013491|516692725|FG011|Long-term Extension|Withdrawal by Subject|0|||
143313311|NCT03013491|516692726|FG012|Long-term Extension|Withdrawal by Subject|0|||
143313312|NCT03013491|516692727|FG013|Long-term Extension|Withdrawal by Subject|0|||
143313313|NCT03013491|516692728|FG014|Long-term Extension|Withdrawal by Subject|0|||
143313314|NCT03013491|516692729|FG015|Long-term Extension|Withdrawal by Subject|0|||
143313315|NCT03013491|516692730|FG016|Long-term Extension|Withdrawal by Subject|0|||
143313316|NCT03013491|516692731|FG017|Long-term Extension|Withdrawal by Subject|0|||
143313317|NCT03013491|516692732|FG018|Long-term Extension|Withdrawal by Subject|0|||
143313318|NCT03013491|516692714|FG000|Long-term Extension|Adverse Event|0|||
143313319|NCT03013491|516692715|FG001|Long-term Extension|Adverse Event|0|||
143313320|NCT03013491|516692716|FG002|Long-term Extension|Adverse Event|0|||
143313321|NCT03013491|516692717|FG003|Long-term Extension|Adverse Event|0|||
143313322|NCT03013491|516692718|FG004|Long-term Extension|Adverse Event|0|||
143313323|NCT03013491|516692719|FG005|Long-term Extension|Adverse Event|0|||
143313324|NCT03013491|516692720|FG006|Long-term Extension|Adverse Event|0|||
143313325|NCT03013491|516692721|FG007|Long-term Extension|Adverse Event|0|||
143313326|NCT03013491|516692722|FG008|Long-term Extension|Adverse Event|0|||
143313327|NCT03013491|516692723|FG009|Long-term Extension|Adverse Event|0|||
143313328|NCT03013491|516692724|FG010|Long-term Extension|Adverse Event|0|||
143313329|NCT03013491|516692725|FG011|Long-term Extension|Adverse Event|0|||
143313330|NCT03013491|516692726|FG012|Long-term Extension|Adverse Event|0|||
143313331|NCT03013491|516692727|FG013|Long-term Extension|Adverse Event|0|||
143313332|NCT03013491|516692728|FG014|Long-term Extension|Adverse Event|0|||
143313333|NCT03013491|516692729|FG015|Long-term Extension|Adverse Event|0|||
143313334|NCT03013491|516692730|FG016|Long-term Extension|Adverse Event|0|||
143313335|NCT03013491|516692731|FG017|Long-term Extension|Adverse Event|0|||
143313336|NCT03013491|516692732|FG018|Long-term Extension|Adverse Event|1|||
143313337|NCT03013491|516692714|FG000|Long-term Extension|Death|0|||
143313338|NCT03013491|516692715|FG001|Long-term Extension|Death|0|||
143313339|NCT03013491|516692716|FG002|Long-term Extension|Death|0|||
143313340|NCT03013491|516692717|FG003|Long-term Extension|Death|0|||
143313341|NCT03013491|516692718|FG004|Long-term Extension|Death|0|||
143313342|NCT03013491|516692719|FG005|Long-term Extension|Death|0|||
143313343|NCT03013491|516692720|FG006|Long-term Extension|Death|0|||
143313344|NCT03013491|516692721|FG007|Long-term Extension|Death|0|||
143313345|NCT03013491|516692722|FG008|Long-term Extension|Death|0|||
143313346|NCT03013491|516692723|FG009|Long-term Extension|Death|0|||
143313347|NCT03013491|516692724|FG010|Long-term Extension|Death|0|||
143313348|NCT03013491|516692725|FG011|Long-term Extension|Death|0|||
143313349|NCT03013491|516692726|FG012|Long-term Extension|Death|0|||
143313350|NCT03013491|516692727|FG013|Long-term Extension|Death|0|||
143313351|NCT03013491|516692728|FG014|Long-term Extension|Death|0|||
143313352|NCT03013491|516692729|FG015|Long-term Extension|Death|0|||
143313353|NCT03013491|516692730|FG016|Long-term Extension|Death|0|||
143313354|NCT03013491|516692731|FG017|Long-term Extension|Death|0|||
143313355|NCT03013491|516692732|FG018|Long-term Extension|Death|1|||
143313356|NCT04579679|516692735|FG000|Overall Study|New Antitumor Therapy|6|||
143313357|NCT04579679|516692736|FG001|Overall Study|New Antitumor Therapy|4|||
143313358|NCT04579679|516692737|FG002|Overall Study|New Antitumor Therapy|7|||
143313359|NCT04579679|516692738|FG003|Overall Study|New Antitumor Therapy|0|||
143313360|NCT04579679|516692735|FG000|Overall Study|Withdrawal of Consent|1|||
143313361|NCT04579679|516692736|FG001|Overall Study|Withdrawal of Consent|1|||
143313362|NCT04579679|516692737|FG002|Overall Study|Withdrawal of Consent|2|||
143313363|NCT04579679|516692738|FG003|Overall Study|Withdrawal of Consent|4|||
143313364|NCT04579679|516692735|FG000|Overall Study|Death|2|||
143313365|NCT04579679|516692736|FG001|Overall Study|Death|2|||
143313366|NCT04579679|516692737|FG002|Overall Study|Death|2|||
143313367|NCT04579679|516692738|FG003|Overall Study|Death|0|||
143313368|NCT04579679|516692735|FG000|Overall Study|Adverse Event|0|||
143313369|NCT04579679|516692736|FG001|Overall Study|Adverse Event|4|||
143313370|NCT04579679|516692737|FG002|Overall Study|Adverse Event|0|||
143313371|NCT04579679|516692738|FG003|Overall Study|Adverse Event|0|||
143313372|NCT04579679|516692735|FG000|Overall Study|Disease Progression|9|||
143313373|NCT04579679|516692736|FG001|Overall Study|Disease Progression|13|||
143313374|NCT04579679|516692737|FG002|Overall Study|Disease Progression|7|||
143313375|NCT04579679|516692738|FG003|Overall Study|Disease Progression|0|||
143313376|NCT04579679|516692735|FG000|Overall Study|Physician Decision|0|||
143313377|NCT04579679|516692736|FG001|Overall Study|Physician Decision|0|||
143313378|NCT04579679|516692737|FG002|Overall Study|Physician Decision|1|||
143313379|NCT04579679|516692738|FG003|Overall Study|Physician Decision|0|||
143313380|NCT04579679|516692735|FG000|Overall Study|Study Terminated by Sponsor|2|||
143313381|NCT04579679|516692736|FG001|Overall Study|Study Terminated by Sponsor|7|||
143313382|NCT04579679|516692737|FG002|Overall Study|Study Terminated by Sponsor|1|||
143313383|NCT04579679|516692738|FG003|Overall Study|Study Terminated by Sponsor|0|||
143313384|NCT01038778|516692741|FG000|Overall Study|Withdrawal by Subject|0|||
143313385|NCT01038778|516692742|FG001|Overall Study|Withdrawal by Subject|2|||
143313386|NCT01038778|516692743|FG002|Overall Study|Withdrawal by Subject|3|||
143313387|NCT04524403|516694354|FG000|Overall Study|Withdrawal by Subject|10|||
143313388|NCT04524403|516694355|FG001|Overall Study|Withdrawal by Subject|3|||
143313389|NCT04524403|516694356|FG002|Overall Study|Withdrawal by Subject|8|||
143313390|NCT04524403|516694354|FG000|Overall Study|Lost to Follow-up|3|||
143313391|NCT04524403|516694355|FG001|Overall Study|Lost to Follow-up|4|||
143313392|NCT04524403|516694356|FG002|Overall Study|Lost to Follow-up|3|||
143313393|NCT04524403|516694354|FG000|Overall Study|Adverse Event|3|||
143313394|NCT04524403|516694355|FG001|Overall Study|Adverse Event|1|||
143313395|NCT04524403|516694356|FG002|Overall Study|Adverse Event|4|||
143313396|NCT04524403|516694354|FG000|Overall Study|Non-compliant with study drug|1|||
143313397|NCT04524403|516694355|FG001|Overall Study|Non-compliant with study drug|2|||
143313398|NCT04524403|516694356|FG002|Overall Study|Non-compliant with study drug|3|||
143313399|NCT04524403|516694354|FG000|Overall Study|Moved|0|||
143313400|NCT04524403|516694355|FG001|Overall Study|Moved|1|||
143313401|NCT04524403|516694356|FG002|Overall Study|Moved|0|||
143313402|NCT02383758|516694357|FG000|Overall Study|Withdrawal by Subject|0|||
143313403|NCT02383758|516694358|FG001|Overall Study|Withdrawal by Subject|2|||
143313404|NCT01513317|516694363|FG000|Overall Study|Withdrawal by Subject|15|||
143313405|NCT01513317|516694364|FG001|Overall Study|Withdrawal by Subject|4|||
143313406|NCT01513317|516694363|FG000|Overall Study|Death|1|||
143376053|NCT03593213|516921636|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
143376054|NCT03593213|516921637|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
143376055|NCT03593213|516921638|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
143376056|NCT03593213|516921635|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
143376057|NCT03593213|516921636|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
143376058|NCT03593213|516921637|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
143376059|NCT03593213|516921638|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
143376060|NCT03593213|516921635|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
143376061|NCT03593213|516921636|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
143376062|NCT03593213|516921637|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
143376063|NCT03593213|516921638|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
143376064|NCT03593213|516921635|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
143376065|NCT03593213|516921636|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
143376066|NCT03593213|516921637|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
143376067|NCT03593213|516921638|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
143376068|NCT03593213|516921635|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
143376069|NCT03593213|516921636|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
143376070|NCT03593213|516921637|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
143376071|NCT03593213|516921638|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
143376072|NCT03593213|516921635|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
143376073|NCT03593213|516921636|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
143376074|NCT03593213|516921637|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
143376075|NCT03593213|516921638|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
143376076|NCT03593213|516921635|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
143376077|NCT03593213|516921636|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
143376078|NCT03593213|516921637|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
143376079|NCT03593213|516921638|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
143376080|NCT03593213|516921635|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
143376081|NCT03593213|516921636|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
143376082|NCT03593213|516921637|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
143376083|NCT03593213|516921638|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
143376084|NCT03593213|516921635|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
143376085|NCT03593213|516921636|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
143376086|NCT03593213|516921637|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
143376087|NCT03593213|516921638|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
143376088|NCT03593213|516921635|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
143376089|NCT03593213|516921636|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
143376090|NCT03593213|516921637|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
143376091|NCT03593213|516921638|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
143376092|NCT03593213|516921635|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
143376093|NCT03593213|516921636|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
143376094|NCT03593213|516921637|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
143376095|NCT03593213|516921638|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
143376096|NCT03593213|516921635|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
143376097|NCT03593213|516921636|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
143376098|NCT03593213|516921637|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
143376099|NCT03593213|516921638|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
143376100|NCT03593213|516921635|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
143376101|NCT03593213|516921636|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
143376102|NCT03593213|516921637|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
143376103|NCT03593213|516921638|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
143376104|NCT03593213|516921635|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
143376105|NCT03593213|516921636|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
143376106|NCT03593213|516921637|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
143376107|NCT03593213|516921638|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
143376108|NCT03593213|516921635|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
143376109|NCT03593213|516921636|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
143376110|NCT03593213|516921637|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
143376111|NCT03593213|516921638|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
143376112|NCT03593213|516921635|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
143376113|NCT03593213|516921636|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
143376114|NCT03593213|516921637|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
143376115|NCT03593213|516921638|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
143376116|NCT03593213|516921635|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
143376117|NCT03593213|516921636|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
143376118|NCT03593213|516921637|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
143376119|NCT03593213|516921638|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
143376120|NCT03593213|516921635|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
143376121|NCT03593213|516921636|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
143376122|NCT03593213|516921637|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
143376123|NCT03593213|516921638|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
143376124|NCT03691428|516921641|FG000|Overall Study|Withdrawal by Subject|6|||
143376125|NCT03691428|516921642|FG001|Overall Study|Withdrawal by Subject|8|||
143376126|NCT01460290|516921643|FG000|Overall Study|Adverse Event|3|||
143376127|NCT01460290|516921643|FG000|Overall Study|Elevated liver function|1|||
143376128|NCT02527148|516921644|FG000|Overall Study|Did not receive study intervention|1|||
143376129|NCT02527148|516921645|FG001|Overall Study|Did not receive study intervention|0|||
143376130|NCT00494780|516921646|FG000|Overall Study|Adverse Event|1|||
143376131|NCT00494780|516921647|FG001|Overall Study|Adverse Event|0|||
143376132|NCT00494780|516921646|FG000|Overall Study|Withdrew before Dosed|0|||
143376133|NCT00494780|516921647|FG001|Overall Study|Withdrew before Dosed|1|||
143376134|NCT00494780|516921646|FG000|Overall Study|Progression of Study Disease|7|||
143376135|NCT00494780|516921647|FG001|Overall Study|Progression of Study Disease|8|||
143376136|NCT00494780|516921646|FG000|Overall Study|New Treatment|2|||
143376137|NCT00494780|516921647|FG001|Overall Study|New Treatment|2|||
143376138|NCT00494780|516921646|FG000|Overall Study|Non-compliance|1|||
143376139|NCT00494780|516921647|FG001|Overall Study|Non-compliance|0|||
143376140|NCT00494780|516921646|FG000|Overall Study|Residual Tumour Mass|0|||
143376141|NCT00494780|516921647|FG001|Overall Study|Residual Tumour Mass|1|||
143376142|NCT00494780|516921646|FG000|Overall Study|Insurance Issues|0|||
143376143|NCT00494780|516921647|FG001|Overall Study|Insurance Issues|1|||
143376144|NCT01190007|516921648|FG000|Overall Study|Withdrawal by Subject|4|||
143376145|NCT01190007|516921648|FG000|Overall Study|Adverse Event|8|||
143376146|NCT01190007|516921648|FG000|Overall Study|Difficulty of visit for complications|1|||
143376147|NCT01190007|516921648|FG000|Overall Study|Participant was arrested|1|||
143313407|NCT01513317|516694364|FG001|Overall Study|Death|1|||
143313408|NCT01513317|516694363|FG000|Overall Study|Study terminated by sponsor|18|||
143313409|NCT01513317|516694364|FG001|Overall Study|Study terminated by sponsor|18|||
143313410|NCT01513317|516694363|FG000|Overall Study|Other|0|||
143313411|NCT01513317|516694364|FG001|Overall Study|Other|1|||
143313412|NCT01610700|516694365|FG000|Overall Study|Adverse Event|3|||
143313413|NCT01610700|516694366|FG001|Overall Study|Adverse Event|1|||
143313414|NCT01610700|516694365|FG000|Overall Study|Withdrawal by Subject|0|||
143313415|NCT01610700|516694366|FG001|Overall Study|Withdrawal by Subject|1|||
143313416|NCT01610700|516694365|FG000|Overall Study|subject took one dose of street cannabis|0|||
143313417|NCT01610700|516694366|FG001|Overall Study|subject took one dose of street cannabis|1|||
143313418|NCT02564198|516694367|FG000|Overall Study|Withdrawal by Subject|2|||
143313419|NCT02564198|516694368|FG001|Overall Study|Withdrawal by Subject|4|||
143313420|NCT02564198|516694369|FG002|Overall Study|Withdrawal by Subject|0|||
143313421|NCT02564198|516694367|FG000|Overall Study|Adverse Event|0|||
143313422|NCT02564198|516694368|FG001|Overall Study|Adverse Event|1|||
143313423|NCT02564198|516694369|FG002|Overall Study|Adverse Event|0|||
143313424|NCT00120042|516694370|FG000|Overall Study|all completed protocl|0|||
143313425|NCT00120042|516694371|FG001|Overall Study|all completed protocl|0|||
143313426|NCT00120042|516694372|FG002|Overall Study|all completed protocl|0|||
143313427|NCT03852316|516694373|FG000|Overall Study|Protocol Violation|1|||
143313428|NCT03852316|516694373|FG000|Overall Study|Withdrawal by Subject|2|||
143313429|NCT03852316|516694373|FG000|Overall Study|Enrolled but Device not Utilized|1|||
143313430|NCT00529386|516694374|FG000|Overall Study|Lost to Follow-up|1|||
143313431|NCT00844545|516694375|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
143313432|NCT00844545|516694375|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
143313433|NCT00844545|516694375|FG000|Extension Treatment Period|Adverse Event|2|||
143313434|NCT00844545|516694375|FG000|Post Treatment Period|Withdrawal by Subject|1|||
143313435|NCT02039427|516694376|FG000|Overall Study|Duration of surgery > 3h|1|||
143313436|NCT02039427|516694377|FG001|Overall Study|Duration of surgery > 3h|1|||
143313437|NCT02039427|516694378|FG002|Overall Study|Duration of surgery > 3h|0|||
143313438|NCT02039427|516694379|FG003|Overall Study|Duration of surgery > 3h|0|||
143313439|NCT02039427|516694376|FG000|Overall Study|Withdrawal on concent|0|||
143313440|NCT02039427|516694377|FG001|Overall Study|Withdrawal on concent|0|||
143313441|NCT02039427|516694378|FG002|Overall Study|Withdrawal on concent|0|||
143313442|NCT02039427|516694379|FG003|Overall Study|Withdrawal on concent|1|||
143313443|NCT02039427|516694376|FG000|Overall Study|Cancellation of surgery|0|||
143376148|NCT00189202|516921659|FG000|Overall Study|Physician Decision|5|||
143376149|NCT00638963|516921662|FG000|Overall Study|Withdrawal by Subject|1|||
143376150|NCT00638963|516921663|FG001|Overall Study|Withdrawal by Subject|0|||
143376151|NCT02448446|516921667|FG000|Overall Study|Withdrawal by Subject|1|||
143376152|NCT02448446|516921668|FG001|Overall Study|Withdrawal by Subject|0|||
143376153|NCT01254188|516921669|FG000|Overall Study|Disease Progression|6|||
143376154|NCT01254188|516921669|FG000|Overall Study|Protocol Violation|6|||
143376155|NCT01254188|516921669|FG000|Overall Study|Pregnancy|2|||
143376156|NCT01254188|516921669|FG000|Overall Study|Death|4|||
143376157|NCT01254188|516921669|FG000|Overall Study|Lost to Follow-up|5|||
143376158|NCT01254188|516921669|FG000|Overall Study|Withdrawal by Subject|7|||
143376159|NCT01254188|516921669|FG000|Overall Study|Adverse Event|43|||
143376160|NCT01254188|516921669|FG000|Overall Study|per investigator discretion|20|||
143313444|NCT02039427|516694377|FG001|Overall Study|Cancellation of surgery|0|||
143313445|NCT02039427|516694378|FG002|Overall Study|Cancellation of surgery|1|||
143313446|NCT02039427|516694379|FG003|Overall Study|Cancellation of surgery|0|||
143313447|NCT02039427|516694376|FG000|Overall Study|Loss of follow - up|1|||
143313448|NCT02039427|516694377|FG001|Overall Study|Loss of follow - up|0|||
143313449|NCT02039427|516694378|FG002|Overall Study|Loss of follow - up|2|||
143313450|NCT02039427|516694379|FG003|Overall Study|Loss of follow - up|4|||
143313451|NCT02039427|516694376|FG000|Overall Study|Steroid Use|1|||
143313452|NCT02039427|516694377|FG001|Overall Study|Steroid Use|0|||
143313453|NCT02039427|516694378|FG002|Overall Study|Steroid Use|0|||
143313454|NCT02039427|516694379|FG003|Overall Study|Steroid Use|0|||
143313455|NCT00226941|516694385|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
143313456|NCT00226941|516694386|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
143313457|NCT00226941|516694387|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
143313458|NCT00226941|516694388|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
143313459|NCT00226941|516694385|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
143313460|NCT00226941|516694386|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
143313461|NCT00226941|516694387|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
143313462|NCT00226941|516694388|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
143313463|NCT03732638|516694389|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
143313464|NCT03732638|516694390|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
143313465|NCT03732638|516694389|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
143313466|NCT03732638|516694390|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
143313467|NCT03732638|516694389|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
143313468|NCT03732638|516694390|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
143313469|NCT03732638|516694389|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
143313470|NCT03732638|516694390|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
143313471|NCT03732638|516694389|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
143313472|NCT03732638|516694390|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
143313473|NCT03732638|516694389|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
143313474|NCT03732638|516694390|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
143313475|NCT03732638|516694389|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
143313476|NCT03732638|516694390|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
143313477|NCT03732638|516694389|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
143313478|NCT03732638|516694390|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
143376161|NCT02755116|516921676|FG000|Overall Study|surgery converted to open, pt admitted|3|||
143376162|NCT02755116|516921677|FG001|Overall Study|surgery converted to open, pt admitted|1|||
143313479|NCT03732638|516694389|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
143313480|NCT03732638|516694390|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
143313481|NCT03732638|516694389|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
143313482|NCT03732638|516694390|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
143313483|NCT03732638|516694389|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
143313484|NCT03732638|516694390|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
143376163|NCT02423291|516921678|FG000|Overall Study|Lack of Efficacy|14|||
143376164|NCT02423291|516921678|FG000|Overall Study|Adverse Event|1|||
143376165|NCT04740164|516921686|FG000|Overall Study|Lack of Efficacy|4|||
143376166|NCT04740164|516921687|FG001|Overall Study|Lack of Efficacy|0|||
143376167|NCT04740164|516921686|FG000|Overall Study|Physician Decision|3|||
143376168|NCT04740164|516921687|FG001|Overall Study|Physician Decision|3|||
143376169|NCT05323734|516921688|FG000|Overall Study|Adverse Event|5|||
143376170|NCT05323734|516921689|FG001|Overall Study|Adverse Event|2|||
143376171|NCT05323734|516921688|FG000|Overall Study|Physician Decision|1|||
143376172|NCT05323734|516921689|FG001|Overall Study|Physician Decision|0|||
143376173|NCT05323734|516921688|FG000|Overall Study|Lack of Efficacy|1|||
143376174|NCT05323734|516921689|FG001|Overall Study|Lack of Efficacy|2|||
143376175|NCT05323734|516921688|FG000|Overall Study|Withdrawal by Subject|2|||
143376176|NCT05323734|516921689|FG001|Overall Study|Withdrawal by Subject|0|||
143376177|NCT05323734|516921688|FG000|Overall Study|Participant Withdrawn Due|0|||
143376178|NCT05323734|516921689|FG001|Overall Study|Participant Withdrawn Due|1|||
143376179|NCT05061693|516921690|FG000|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
143376180|NCT05061693|516921691|FG001|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
143376181|NCT05061693|516921692|FG002|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
143376182|NCT05061693|516921693|FG003|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
143376183|NCT05061693|516921694|FG004|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
143376184|NCT05061693|516921695|FG005|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
143313485|NCT03732638|516694389|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
143313486|NCT03732638|516694390|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
143313487|NCT03732638|516694389|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
143313488|NCT03732638|516694390|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
143313489|NCT03732638|516694389|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
143313490|NCT03732638|516694390|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
143313491|NCT03732638|516694389|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
143313492|NCT03732638|516694390|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
143313493|NCT03732638|516694389|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
143313494|NCT03732638|516694390|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
143313495|NCT03732638|516694389|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
143313496|NCT03732638|516694390|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
143313497|NCT03732638|516694389|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
143313498|NCT03732638|516694390|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
143313499|NCT03732638|516694389|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
143313500|NCT03732638|516694390|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
143313501|NCT03732638|516694389|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
143313502|NCT03732638|516694390|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
143313503|NCT03732638|516694389|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
143376185|NCT05061693|516921696|FG006|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
143376186|NCT05061693|516921697|FG007|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
143376187|NCT05061693|516921698|FG008|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
143376188|NCT05061693|516921699|FG009|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
143313504|NCT03732638|516694390|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
143313505|NCT03732638|516694389|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
143376189|NCT05061693|516921700|FG010|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
143376190|NCT05061693|516921701|FG011|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
143376191|NCT05061693|516921690|FG000|16-week Placebo-controlled (PC) Period|Death|0|||
143376192|NCT05061693|516921691|FG001|16-week Placebo-controlled (PC) Period|Death|1|||
143376193|NCT05061693|516921692|FG002|16-week Placebo-controlled (PC) Period|Death|0|||
143376194|NCT05061693|516921693|FG003|16-week Placebo-controlled (PC) Period|Death|0|||
143376195|NCT05061693|516921694|FG004|16-week Placebo-controlled (PC) Period|Death|0|||
143376196|NCT05061693|516921695|FG005|16-week Placebo-controlled (PC) Period|Death|0|||
143376197|NCT05061693|516921696|FG006|16-week Placebo-controlled (PC) Period|Death|0|||
143376198|NCT05061693|516921697|FG007|16-week Placebo-controlled (PC) Period|Death|0|||
143376199|NCT05061693|516921698|FG008|16-week Placebo-controlled (PC) Period|Death|0|||
143376200|NCT05061693|516921699|FG009|16-week Placebo-controlled (PC) Period|Death|0|||
143376201|NCT05061693|516921700|FG010|16-week Placebo-controlled (PC) Period|Death|0|||
143376202|NCT05061693|516921701|FG011|16-week Placebo-controlled (PC) Period|Death|0|||
143376203|NCT05061693|516921690|FG000|16-week Placebo-controlled (PC) Period|Lack of Efficacy|1|||
143376204|NCT05061693|516921691|FG001|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
143376205|NCT05061693|516921692|FG002|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
143376206|NCT05061693|516921693|FG003|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
143376207|NCT05061693|516921694|FG004|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
143376208|NCT05061693|516921695|FG005|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
143376209|NCT05061693|516921696|FG006|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
143376210|NCT05061693|516921697|FG007|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
143376211|NCT05061693|516921698|FG008|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
143376212|NCT05061693|516921699|FG009|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
143376213|NCT05061693|516921700|FG010|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
143376214|NCT05061693|516921701|FG011|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
143376215|NCT05061693|516921690|FG000|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
143376216|NCT05061693|516921691|FG001|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
143376217|NCT05061693|516921692|FG002|16-week Placebo-controlled (PC) Period|Lost to Follow-up|1|||
143376218|NCT05061693|516921693|FG003|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
143376219|NCT05061693|516921694|FG004|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
143376220|NCT05061693|516921695|FG005|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
143376221|NCT05061693|516921696|FG006|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
143376222|NCT05061693|516921697|FG007|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
143376223|NCT05061693|516921698|FG008|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
143376224|NCT05061693|516921699|FG009|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
143376225|NCT05061693|516921700|FG010|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
143376226|NCT05061693|516921701|FG011|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
143376227|NCT05061693|516921690|FG000|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
143376228|NCT05061693|516921691|FG001|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
143376229|NCT05061693|516921692|FG002|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
143376230|NCT05061693|516921693|FG003|16-week Placebo-controlled (PC) Period|Protocol Violation|2|||
143376231|NCT05061693|516921694|FG004|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
143376232|NCT05061693|516921695|FG005|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
143376233|NCT05061693|516921696|FG006|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
143376234|NCT05061693|516921697|FG007|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
143376235|NCT05061693|516921698|FG008|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
143376236|NCT05061693|516921699|FG009|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
143376237|NCT05061693|516921700|FG010|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
143376238|NCT05061693|516921701|FG011|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
143376239|NCT05061693|516921690|FG000|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
143376240|NCT05061693|516921691|FG001|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|4|||
143376241|NCT05061693|516921692|FG002|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
143376242|NCT05061693|516921693|FG003|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
143376243|NCT05061693|516921694|FG004|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
143376244|NCT05061693|516921695|FG005|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
143376245|NCT05061693|516921696|FG006|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
143376246|NCT05061693|516921697|FG007|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
143376247|NCT05061693|516921698|FG008|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
143376248|NCT05061693|516921699|FG009|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
143376249|NCT05061693|516921700|FG010|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
143376250|NCT05061693|516921701|FG011|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
143313506|NCT03732638|516694390|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
143313507|NCT03732638|516694389|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
143313508|NCT03732638|516694390|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
143313509|NCT03732638|516694389|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
143376251|NCT05061693|516921690|FG000|24-week Extension Period|Adverse Event|0|||
143376252|NCT05061693|516921691|FG001|24-week Extension Period|Adverse Event|0|||
143376253|NCT05061693|516921692|FG002|24-week Extension Period|Adverse Event|0|||
143376254|NCT05061693|516921693|FG003|24-week Extension Period|Adverse Event|0|||
143376255|NCT05061693|516921694|FG004|24-week Extension Period|Adverse Event|0|||
143376256|NCT05061693|516921695|FG005|24-week Extension Period|Adverse Event|0|||
143376257|NCT05061693|516921696|FG006|24-week Extension Period|Adverse Event|0|||
143376258|NCT05061693|516921697|FG007|24-week Extension Period|Adverse Event|2|||
143376259|NCT05061693|516921698|FG008|24-week Extension Period|Adverse Event|2|||
143376260|NCT05061693|516921699|FG009|24-week Extension Period|Adverse Event|0|||
143376261|NCT05061693|516921700|FG010|24-week Extension Period|Adverse Event|1|||
143376262|NCT05061693|516921701|FG011|24-week Extension Period|Adverse Event|3|||
143376263|NCT05061693|516921690|FG000|24-week Extension Period|Lack of Efficacy|0|||
143376264|NCT05061693|516921691|FG001|24-week Extension Period|Lack of Efficacy|0|||
143376265|NCT05061693|516921692|FG002|24-week Extension Period|Lack of Efficacy|0|||
143376266|NCT05061693|516921693|FG003|24-week Extension Period|Lack of Efficacy|0|||
143376267|NCT05061693|516921694|FG004|24-week Extension Period|Lack of Efficacy|0|||
143376268|NCT05061693|516921695|FG005|24-week Extension Period|Lack of Efficacy|0|||
143376269|NCT05061693|516921696|FG006|24-week Extension Period|Lack of Efficacy|0|||
143376270|NCT05061693|516921697|FG007|24-week Extension Period|Lack of Efficacy|0|||
143376271|NCT05061693|516921698|FG008|24-week Extension Period|Lack of Efficacy|0|||
143376272|NCT05061693|516921699|FG009|24-week Extension Period|Lack of Efficacy|0|||
143376273|NCT05061693|516921700|FG010|24-week Extension Period|Lack of Efficacy|2|||
143376274|NCT05061693|516921701|FG011|24-week Extension Period|Lack of Efficacy|0|||
143376275|NCT05061693|516921690|FG000|24-week Extension Period|Lost to Follow-up|0|||
143376276|NCT05061693|516921691|FG001|24-week Extension Period|Lost to Follow-up|0|||
143376277|NCT05061693|516921692|FG002|24-week Extension Period|Lost to Follow-up|0|||
143376278|NCT05061693|516921693|FG003|24-week Extension Period|Lost to Follow-up|0|||
143376279|NCT05061693|516921694|FG004|24-week Extension Period|Lost to Follow-up|0|||
143313510|NCT03732638|516694390|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
143313511|NCT04354831|516694391|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
143313512|NCT04354831|516694392|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
143313513|NCT02738775|516694393|FG000|Overall Study|Withdrawal by Subject|0|||
143313514|NCT02738775|516694394|FG001|Overall Study|Withdrawal by Subject|1|||
143313515|NCT02738775|516694395|FG002|Overall Study|Withdrawal by Subject|0|||
143313516|NCT02738775|516694396|FG003|Overall Study|Withdrawal by Subject|0|||
143313517|NCT02738775|516694397|FG004|Overall Study|Withdrawal by Subject|0|||
143313518|NCT02738775|516694398|FG005|Overall Study|Withdrawal by Subject|0|||
143313519|NCT02738775|516694393|FG000|Overall Study|Adverse Event|0|||
143313520|NCT02738775|516694394|FG001|Overall Study|Adverse Event|0|||
143313521|NCT02738775|516694395|FG002|Overall Study|Adverse Event|0|||
143313522|NCT02738775|516694396|FG003|Overall Study|Adverse Event|1|||
143313523|NCT02738775|516694397|FG004|Overall Study|Adverse Event|0|||
143313524|NCT02738775|516694398|FG005|Overall Study|Adverse Event|0|||
143313525|NCT02738775|516694393|FG000|Overall Study|Pregnancy|0|||
143313526|NCT02738775|516694394|FG001|Overall Study|Pregnancy|1|||
143313527|NCT02738775|516694395|FG002|Overall Study|Pregnancy|0|||
143313528|NCT02738775|516694396|FG003|Overall Study|Pregnancy|0|||
143313529|NCT02738775|516694397|FG004|Overall Study|Pregnancy|0|||
143313530|NCT02738775|516694398|FG005|Overall Study|Pregnancy|0|||
143313531|NCT02738775|516694393|FG000|Overall Study|Missing|0|||
143313532|NCT02738775|516694394|FG001|Overall Study|Missing|0|||
143313533|NCT02738775|516694395|FG002|Overall Study|Missing|0|||
143313534|NCT02738775|516694396|FG003|Overall Study|Missing|0|||
143313535|NCT02738775|516694397|FG004|Overall Study|Missing|0|||
143313536|NCT02738775|516694398|FG005|Overall Study|Missing|1|||
143313537|NCT03217136|516694401|FG000|Overall Study|Lost to Follow-up|2|||
143313538|NCT03217136|516694402|FG001|Overall Study|Lost to Follow-up|1|||
143313539|NCT03217136|516694401|FG000|Overall Study|Site Randomized Participant in Error|0|||
143313540|NCT03217136|516694402|FG001|Overall Study|Site Randomized Participant in Error|1|||
143313541|NCT03217136|516694401|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
143313542|NCT03217136|516694402|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
143313543|NCT03217136|516694401|FG000|Overall Study|Dispensing Error|1|||
143313544|NCT03217136|516694402|FG001|Overall Study|Dispensing Error|0|||
143313545|NCT03217136|516694401|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
143376280|NCT05061693|516921695|FG005|24-week Extension Period|Lost to Follow-up|0|||
143376281|NCT05061693|516921696|FG006|24-week Extension Period|Lost to Follow-up|1|||
143376282|NCT05061693|516921697|FG007|24-week Extension Period|Lost to Follow-up|0|||
143313546|NCT03217136|516694402|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
143313547|NCT06640829|516694405|FG000|Overall Study|Withdrawal by Subject|1|||
143313548|NCT06640829|516694405|FG000|Overall Study|Lost to Follow-up|1|||
143313549|NCT01350128|516694408|FG000|Overall Study|Withdrawal by Subject|3|||
143313550|NCT01350128|516694408|FG000|Overall Study|Protocol discontinuation criteria|8|||
143313551|NCT01350128|516694408|FG000|Overall Study|Physician Decision|1|||
143313552|NCT01350128|516694408|FG000|Overall Study|Lost to Follow-up|2|||
143313553|NCT01252290|516694409|FG000|Overall Study|Withdrawal by Subject|1|||
143313554|NCT02075437|516694410|FG000|Overall Study|Withdrawal by Subject|5|||
143313555|NCT02075437|516694410|FG000|Overall Study|Lost to Follow-up|1|||
143313556|NCT00673452|516694411|FG000|Acute Double-Blind Phase|Adverse Event|41|||
143313557|NCT00673452|516694412|FG001|Acute Double-Blind Phase|Adverse Event|24|||
143313558|NCT00673452|516694411|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
143313559|NCT00673452|516694412|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
143313560|NCT00673452|516694411|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
143313561|NCT00673452|516694412|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
143313562|NCT00673452|516694411|FG000|Acute Double-Blind Phase|Physician Decision|0|||
143313563|NCT00673452|516694412|FG001|Acute Double-Blind Phase|Physician Decision|6|||
143313564|NCT00673452|516694411|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
143313565|NCT00673452|516694412|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
143313566|NCT00673452|516694411|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
143313567|NCT00673452|516694412|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
143313568|NCT00673452|516694411|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
143313569|NCT00673452|516694412|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
143313570|NCT00673452|516694411|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
143313571|NCT00673452|516694412|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
143313572|NCT00673452|516694411|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
143313573|NCT00673452|516694412|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
143313574|NCT00673452|516694411|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
143313575|NCT00673452|516694412|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
143313576|NCT00673452|516694411|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
143313577|NCT00673452|516694412|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
143313578|NCT00673452|516694411|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
143313579|NCT00673452|516694412|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
143313580|NCT00673452|516694411|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
143313581|NCT00673452|516694412|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
143313582|NCT00673452|516694411|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
143313583|NCT00673452|516694412|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
143313584|NCT00673452|516694411|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
143313585|NCT00673452|516694412|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
143376283|NCT05061693|516921698|FG008|24-week Extension Period|Lost to Follow-up|1|||
143376284|NCT05061693|516921699|FG009|24-week Extension Period|Lost to Follow-up|1|||
143376285|NCT05061693|516921700|FG010|24-week Extension Period|Lost to Follow-up|0|||
143376286|NCT05061693|516921701|FG011|24-week Extension Period|Lost to Follow-up|0|||
143376287|NCT05061693|516921690|FG000|24-week Extension Period|Withdrawal by Subject|0|||
143376288|NCT05061693|516921691|FG001|24-week Extension Period|Withdrawal by Subject|0|||
143376289|NCT05061693|516921692|FG002|24-week Extension Period|Withdrawal by Subject|0|||
143376290|NCT05061693|516921693|FG003|24-week Extension Period|Withdrawal by Subject|0|||
143376291|NCT05061693|516921694|FG004|24-week Extension Period|Withdrawal by Subject|0|||
143376292|NCT05061693|516921695|FG005|24-week Extension Period|Withdrawal by Subject|0|||
143376293|NCT05061693|516921696|FG006|24-week Extension Period|Withdrawal by Subject|0|||
143376294|NCT05061693|516921697|FG007|24-week Extension Period|Withdrawal by Subject|0|||
143376295|NCT05061693|516921698|FG008|24-week Extension Period|Withdrawal by Subject|1|||
143376296|NCT05061693|516921699|FG009|24-week Extension Period|Withdrawal by Subject|2|||
143376297|NCT05061693|516921700|FG010|24-week Extension Period|Withdrawal by Subject|2|||
143376298|NCT05061693|516921701|FG011|24-week Extension Period|Withdrawal by Subject|1|||
143376299|NCT05061693|516921690|FG000|24-week Extension Period|Sponsor Decision|0|||
143313586|NCT03049813|516694417|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
143313587|NCT03049813|516694418|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
143376300|NCT05061693|516921691|FG001|24-week Extension Period|Sponsor Decision|0|||
143313588|NCT03049813|516694419|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
143313589|NCT03049813|516694420|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
143313590|NCT03049813|516694417|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
143313591|NCT03049813|516694418|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
143313592|NCT03049813|516694419|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
143376301|NCT05061693|516921692|FG002|24-week Extension Period|Sponsor Decision|0|||
143376302|NCT05061693|516921693|FG003|24-week Extension Period|Sponsor Decision|0|||
143376303|NCT05061693|516921694|FG004|24-week Extension Period|Sponsor Decision|0|||
143313593|NCT03049813|516694420|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
143313594|NCT03049813|516694417|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
143313595|NCT03049813|516694418|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
143313596|NCT03049813|516694419|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
143313597|NCT03049813|516694420|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
143313598|NCT03049813|516694417|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
143313599|NCT03049813|516694418|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
143313600|NCT03049813|516694419|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
143313601|NCT03049813|516694420|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
143313602|NCT01813019|516694421|FG000|Overall Study|Adverse Event|0|||
143313603|NCT01813019|516694422|FG001|Overall Study|Adverse Event|3|||
143313604|NCT01813019|516694421|FG000|Overall Study|Withdrawal by Subject|3|||
143313605|NCT01813019|516694422|FG001|Overall Study|Withdrawal by Subject|2|||
143313606|NCT01813019|516694421|FG000|Overall Study|administrative problems|2|||
143313607|NCT01813019|516694422|FG001|Overall Study|administrative problems|0|||
143313608|NCT01813019|516694421|FG000|Overall Study|Protocol Deviation|2|||
143313609|NCT01813019|516694422|FG001|Overall Study|Protocol Deviation|1|||
143313610|NCT01193556|516694425|FG000|Overall Study|Study termination|26|||
143313611|NCT01193556|516694426|FG001|Overall Study|Study termination|25|||
143313612|NCT02203591|516694430|FG000|Overall Study|Did not meet treatment day baseline|147|||
143313613|NCT02203591|516694431|FG001|Overall Study|Did not meet treatment day baseline|141|||
143313614|NCT02203591|516694432|FG002|Overall Study|Did not meet treatment day baseline|150|||
143313615|NCT02203591|516694433|FG003|Overall Study|Did not meet treatment day baseline|45|||
143313616|NCT02203591|516694434|FG004|Overall Study|Did not meet treatment day baseline|33|||
143313617|NCT02203591|516694435|FG005|Overall Study|Did not meet treatment day baseline|35|||
143313618|NCT02203591|516694436|FG006|Overall Study|Did not meet treatment day baseline|29|||
143313619|NCT02203591|516694437|FG007|Overall Study|Did not meet treatment day baseline|12|||
143313620|NCT02203591|516694430|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
143313621|NCT02203591|516694431|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
143313622|NCT02203591|516694432|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
143313623|NCT02203591|516694433|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
143313624|NCT02203591|516694434|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
143313625|NCT02203591|516694435|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
143313626|NCT02203591|516694436|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
143313627|NCT02203591|516694437|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
143313628|NCT00094653|516694441|FG000|Overall Study|Death|306|||
143313629|NCT00094653|516694442|FG001|Overall Study|Death|100|||
143313630|NCT00094653|516694443|FG002|Overall Study|Death|119|||
143313631|NCT00094653|516694441|FG000|Overall Study|Subject Withdrew Consent|10|||
143313632|NCT00094653|516694442|FG001|Overall Study|Subject Withdrew Consent|2|||
143313633|NCT00094653|516694443|FG002|Overall Study|Subject Withdrew Consent|3|||
143313634|NCT00094653|516694441|FG000|Overall Study|Other|2|||
143313635|NCT00094653|516694442|FG001|Overall Study|Other|2|||
143313636|NCT00094653|516694443|FG002|Overall Study|Other|2|||
143313637|NCT00094653|516694441|FG000|Overall Study|Lost to Follow-up|3|||
143313638|NCT00094653|516694442|FG001|Overall Study|Lost to Follow-up|2|||
143313639|NCT00094653|516694443|FG002|Overall Study|Lost to Follow-up|1|||
143313640|NCT00094653|516694441|FG000|Overall Study|Protocol Violation|0|||
143313641|NCT00094653|516694442|FG001|Overall Study|Protocol Violation|0|||
143313642|NCT00094653|516694443|FG002|Overall Study|Protocol Violation|1|||
143313643|NCT01565291|516694445|FG000|Overall Study|Withdrawal by Subject|1|||
143313644|NCT01565291|516694446|FG001|Overall Study|Withdrawal by Subject|0|||
143313645|NCT02143843|516694447|FG000|Overall Study|Adverse Event|8|||
143313646|NCT02143843|516694447|FG000|Overall Study|Lack of Efficacy|2|||
143313647|NCT02143843|516694447|FG000|Overall Study|Withdrawal by Subject|2|||
143313648|NCT02702401|516694449|FG000|Overall Study|Death|242|||
143313649|NCT02702401|516694450|FG001|Overall Study|Death|125|||
143313650|NCT02702401|516694449|FG000|Overall Study|Withdrawal by Subject|15|||
143313651|NCT02702401|516694450|FG001|Overall Study|Withdrawal by Subject|5|||
143313652|NCT02702401|516694449|FG000|Overall Study|Sponsor Decision|19|||
143313653|NCT02702401|516694450|FG001|Overall Study|Sponsor Decision|3|||
143313654|NCT02702401|516694449|FG000|Overall Study|Physician Decision|1|||
143313655|NCT02702401|516694450|FG001|Overall Study|Physician Decision|2|||
143313656|NCT02702401|516694449|FG000|Overall Study|Lost to Follow-up|1|||
143313657|NCT02702401|516694450|FG001|Overall Study|Lost to Follow-up|0|||
143313658|NCT04292730|516694455|FG000|Overall Study|Lost to Follow-up|8|||
143313659|NCT04292730|516694456|FG001|Overall Study|Lost to Follow-up|12|||
143313660|NCT04292730|516694457|FG002|Overall Study|Lost to Follow-up|12|||
143313661|NCT04292730|516694458|FG003|Overall Study|Lost to Follow-up|48|||
143313662|NCT04292730|516694455|FG000|Overall Study|Death|2|||
143313663|NCT04292730|516694456|FG001|Overall Study|Death|2|||
143313664|NCT04292730|516694457|FG002|Overall Study|Death|4|||
143313665|NCT04292730|516694458|FG003|Overall Study|Death|12|||
143313666|NCT04292730|516694455|FG000|Overall Study|Withdrew Consent|2|||
143313667|NCT04292730|516694456|FG001|Overall Study|Withdrew Consent|2|||
143313668|NCT04292730|516694457|FG002|Overall Study|Withdrew Consent|5|||
143313669|NCT04292730|516694458|FG003|Overall Study|Withdrew Consent|6|||
143313670|NCT04292730|516694455|FG000|Overall Study|Non-Compliance with Study Drug|0|||
143313671|NCT04292730|516694456|FG001|Overall Study|Non-Compliance with Study Drug|1|||
143313672|NCT04292730|516694457|FG002|Overall Study|Non-Compliance with Study Drug|0|||
143313673|NCT04292730|516694458|FG003|Overall Study|Non-Compliance with Study Drug|0|||
143313674|NCT04292730|516694455|FG000|Overall Study|Protocol Violation|0|||
143313675|NCT04292730|516694456|FG001|Overall Study|Protocol Violation|0|||
143313676|NCT04292730|516694457|FG002|Overall Study|Protocol Violation|1|||
143313677|NCT04292730|516694458|FG003|Overall Study|Protocol Violation|0|||
143313678|NCT04292730|516694455|FG000|Overall Study|Randomized but not Treated|8|||
143313679|NCT04292730|516694456|FG001|Overall Study|Randomized but not Treated|4|||
143313680|NCT04292730|516694457|FG002|Overall Study|Randomized but not Treated|0|||
143313681|NCT04292730|516694458|FG003|Overall Study|Randomized but not Treated|14|||
143313682|NCT01527292|516694459|FG000|Overall Study|Physician Decision|0|||
143313683|NCT01527292|516694460|FG001|Overall Study|Physician Decision|3|||
143313684|NCT00806546|516694470|FG000|Overall Study|Enrolled, not treated|35|||
143313685|NCT00806546|516694470|FG000|Overall Study|Lost to Follow-up|32|||
143313686|NCT00806546|516694470|FG000|Overall Study|Adverse Event|74|||
143313687|NCT00806546|516694470|FG000|Overall Study|Withdrawal by Subject|75|||
143313688|NCT00806546|516694470|FG000|Overall Study|Protocol Violation|49|||
143313689|NCT00806546|516694470|FG000|Overall Study|Various|42|||
143313690|NCT02457325|516694478|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
143313691|NCT02457325|516694479|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
143313692|NCT03385239|516694480|FG000|Overall Study|Voluntary Withdrawal|2|||
143313693|NCT03385239|516694481|FG001|Overall Study|Voluntary Withdrawal|3|||
143313694|NCT03385239|516694482|FG002|Overall Study|Voluntary Withdrawal|2|||
143313695|NCT03385239|516694483|FG003|Overall Study|Voluntary Withdrawal|3|||
143313696|NCT03385239|516694484|FG004|Overall Study|Voluntary Withdrawal|0|||
143313697|NCT03385239|516694480|FG000|Overall Study|Adverse Event|0|||
143313698|NCT03385239|516694481|FG001|Overall Study|Adverse Event|0|||
143313699|NCT03385239|516694482|FG002|Overall Study|Adverse Event|1|||
143313700|NCT03385239|516694483|FG003|Overall Study|Adverse Event|0|||
143313701|NCT03385239|516694484|FG004|Overall Study|Adverse Event|0|||
143313702|NCT03385239|516694480|FG000|Overall Study|Other|0|||
143313703|NCT03385239|516694481|FG001|Overall Study|Other|0|||
143313704|NCT03385239|516694482|FG002|Overall Study|Other|0|||
143313705|NCT03385239|516694483|FG003|Overall Study|Other|1|||
143313706|NCT03385239|516694484|FG004|Overall Study|Other|0|||
143313707|NCT01574703|516694485|FG000|Overall Study|Adverse Event|0|||
143313708|NCT01574703|516694486|FG001|Overall Study|Adverse Event|2|||
143313709|NCT01574703|516694487|FG002|Overall Study|Adverse Event|1|||
143313710|NCT01574703|516694488|FG003|Overall Study|Adverse Event|1|||
143313711|NCT01574703|516694485|FG000|Overall Study|Protocol Violation|0|||
143313712|NCT01574703|516694486|FG001|Overall Study|Protocol Violation|0|||
143313713|NCT01574703|516694487|FG002|Overall Study|Protocol Violation|0|||
143313714|NCT01574703|516694488|FG003|Overall Study|Protocol Violation|1|||
143313715|NCT01574703|516694485|FG000|Overall Study|Unspecified Reason|27|||
143313716|NCT01574703|516694486|FG001|Overall Study|Unspecified Reason|15|||
143313717|NCT01574703|516694487|FG002|Overall Study|Unspecified Reason|20|||
143313718|NCT01574703|516694488|FG003|Overall Study|Unspecified Reason|16|||
143313719|NCT01574703|516694485|FG000|Overall Study|Withdrawal by Subject|53|||
143313720|NCT01574703|516694486|FG001|Overall Study|Withdrawal by Subject|52|||
143313721|NCT01574703|516694487|FG002|Overall Study|Withdrawal by Subject|36|||
143313722|NCT01574703|516694488|FG003|Overall Study|Withdrawal by Subject|61|||
143313723|NCT01574703|516694485|FG000|Overall Study|Met Withdrawal Criteria|0|||
143313724|NCT01574703|516694486|FG001|Overall Study|Met Withdrawal Criteria|1|||
143313725|NCT01574703|516694487|FG002|Overall Study|Met Withdrawal Criteria|1|||
143313726|NCT01574703|516694488|FG003|Overall Study|Met Withdrawal Criteria|0|||
143313727|NCT01574703|516694485|FG000|Overall Study|Lost to Follow-up|43|||
143313728|NCT01574703|516694486|FG001|Overall Study|Lost to Follow-up|41|||
143313729|NCT01574703|516694487|FG002|Overall Study|Lost to Follow-up|46|||
143313730|NCT01574703|516694488|FG003|Overall Study|Lost to Follow-up|35|||
143313731|NCT01574703|516694485|FG000|Overall Study|Death|2|||
143313732|NCT01574703|516694486|FG001|Overall Study|Death|1|||
143313733|NCT01574703|516694487|FG002|Overall Study|Death|1|||
143313734|NCT01574703|516694488|FG003|Overall Study|Death|0|||
143313735|NCT02751983|516694489|FG000|Treatment|Stopped ACT, but Remained in study|2|||
143313736|NCT02751983|516694490|FG001|Treatment|Stopped ACT, but Remained in study|0|||
143313737|NCT02751983|516694489|FG000|Treatment|Discharged prior to beginning ACT|2|||
143313738|NCT02751983|516694490|FG001|Treatment|Discharged prior to beginning ACT|0|||
143313739|NCT02751983|516694489|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
143313740|NCT02751983|516694490|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
143313741|NCT02751983|516694489|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
143313742|NCT02751983|516694490|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
143313743|NCT02751983|516694489|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
143313744|NCT02751983|516694490|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
143313745|NCT03139916|516694491|FG000|Overall Study|Withdrawal by Subject|2|||
143313746|NCT03139916|516694491|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
143313747|NCT00813358|516694492|FG000|Overall Study|Death|32|||
143313748|NCT00813358|516694492|FG000|Overall Study|Lost to Follow-up|12|||
143313749|NCT00813358|516694492|FG000|Overall Study|other endpoints|5|||
143313750|NCT00813358|516694492|FG000|Overall Study|Withdrawal by Subject|20|||
143313751|NCT01451424|516694494|FG000|Overall Study|Withdrawal by Subject|1|||
143313752|NCT01451424|516694495|FG001|Overall Study|Withdrawal by Subject|1|||
143313753|NCT01451424|516694496|FG002|Overall Study|Withdrawal by Subject|0|||
143313754|NCT01451424|516694497|FG003|Overall Study|Withdrawal by Subject|2|||
143313755|NCT01451424|516694494|FG000|Overall Study|Lost to Follow-up|0|||
143313756|NCT01451424|516694495|FG001|Overall Study|Lost to Follow-up|1|||
143313757|NCT01451424|516694496|FG002|Overall Study|Lost to Follow-up|0|||
143313758|NCT01451424|516694497|FG003|Overall Study|Lost to Follow-up|1|||
143313759|NCT01451424|516694494|FG000|Overall Study|Physician Decision|0|||
143313760|NCT01451424|516694495|FG001|Overall Study|Physician Decision|0|||
143313761|NCT01451424|516694496|FG002|Overall Study|Physician Decision|1|||
143313762|NCT01451424|516694497|FG003|Overall Study|Physician Decision|1|||
143313763|NCT01451424|516694494|FG000|Overall Study|Adverse Event|0|||
143313764|NCT01451424|516694495|FG001|Overall Study|Adverse Event|0|||
143313765|NCT01451424|516694496|FG002|Overall Study|Adverse Event|0|||
143313766|NCT01451424|516694497|FG003|Overall Study|Adverse Event|1|||
143313767|NCT02553421|516694498|FG000|Overall Study|Lost to Follow-up|21|||
143313768|NCT02553421|516694499|FG001|Overall Study|Lost to Follow-up|1|||
143313769|NCT02553421|516694498|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
143313770|NCT02553421|516694499|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
143313771|NCT02553421|516694498|FG000|Overall Study|Improper Device Placement|3|||
143313772|NCT02553421|516694499|FG001|Overall Study|Improper Device Placement|0|||
143313773|NCT03665038|516694501|FG000|Overall Study|Lost to Follow-up|0|||
143313774|NCT03665038|516694502|FG001|Overall Study|Lost to Follow-up|0|||
143313775|NCT03665038|516694503|FG002|Overall Study|Lost to Follow-up|1|||
143313776|NCT03890367|516694509|FG000|Overall Study|Withdrawal by parent/guardian|1|||
143313777|NCT03890367|516694510|FG001|Overall Study|Withdrawal by parent/guardian|3|||
143313778|NCT03890367|516694511|FG002|Overall Study|Withdrawal by parent/guardian|0|||
143313779|NCT03890367|516694509|FG000|Overall Study|Protocol deviation|2|||
143313780|NCT03890367|516694510|FG001|Overall Study|Protocol deviation|2|||
143313781|NCT03890367|516694511|FG002|Overall Study|Protocol deviation|1|||
143313782|NCT03890367|516694509|FG000|Overall Study|Lost to Follow-up|1|||
143313783|NCT03890367|516694510|FG001|Overall Study|Lost to Follow-up|1|||
143313784|NCT03890367|516694511|FG002|Overall Study|Lost to Follow-up|0|||
143313785|NCT02649972|516696120|FG000|Overall Study|Not treated|1|||
143313786|NCT03228680|516696121|FG000|Overall Study|Adverse Event|13|||
143313787|NCT03228680|516696122|FG001|Overall Study|Adverse Event|18|||
143313788|NCT03228680|516696121|FG000|Overall Study|Randomization failure|0|||
143313789|NCT03228680|516696122|FG001|Overall Study|Randomization failure|1|||
143313790|NCT03228680|516696121|FG000|Overall Study|Withdrawal by Subject|1|||
143313791|NCT03228680|516696122|FG001|Overall Study|Withdrawal by Subject|0|||
143313792|NCT03228680|516696121|FG000|Overall Study|Other|9|||
143313793|NCT03228680|516696122|FG001|Overall Study|Other|16|||
143313794|NCT02167035|516696123|FG000|Overall Study|Adverse Event|2|||
143313795|NCT02167035|516696124|FG001|Overall Study|Adverse Event|2|||
143313796|NCT02167035|516696123|FG000|Overall Study|Lost to Follow-up|3|||
143313797|NCT02167035|516696124|FG001|Overall Study|Lost to Follow-up|3|||
143313798|NCT02167035|516696123|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
143376304|NCT05061693|516921695|FG005|24-week Extension Period|Sponsor Decision|0|||
143376305|NCT05061693|516921696|FG006|24-week Extension Period|Sponsor Decision|0|||
143376306|NCT05061693|516921697|FG007|24-week Extension Period|Sponsor Decision|1|||
143376307|NCT05061693|516921698|FG008|24-week Extension Period|Sponsor Decision|0|||
143313799|NCT02167035|516696124|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
143313800|NCT02148003|516696125|FG000|Overall Study|Failed inclusion criteria|1|||
143313801|NCT02148003|516696126|FG001|Overall Study|Failed inclusion criteria|0|||
143313802|NCT02148003|516696125|FG000|Overall Study|Met exclusion criteria|0|||
143313803|NCT02148003|516696126|FG001|Overall Study|Met exclusion criteria|1|||
143313804|NCT02148003|516696125|FG000|Overall Study|Withdrawal by Subject|0|||
143313805|NCT02148003|516696126|FG001|Overall Study|Withdrawal by Subject|1|||
143313806|NCT02489981|516696127|FG000|Overall Study|Adverse Event|21|||
143313807|NCT02489981|516696127|FG000|Overall Study|Insufficient effectiveness|16|||
143313808|NCT02489981|516696127|FG000|Overall Study|Improved|31|||
143313809|NCT02489981|516696127|FG000|Overall Study|Lost to Follow-up|31|||
143313810|NCT02489981|516696127|FG000|Overall Study|Other than listed|28|||
143313811|NCT00796861|516696128|FG000|Overall Study|Withdrawal by Subject|2|||
143313812|NCT00796861|516696128|FG000|Overall Study|Death|2|||
143313813|NCT04532112|516696131|FG000|Overall Study|Adverse Event|3|||
143313814|NCT04532112|516696132|FG001|Overall Study|Adverse Event|0|||
143313815|NCT03586869|516696133|FG000|Overall Study|Progressive Disease|3|||
143313816|NCT02992899|516696134|FG000|Overall Study|Withdrawal by Subject|1|||
143376308|NCT05061693|516921699|FG009|24-week Extension Period|Sponsor Decision|0|||
143313817|NCT02992899|516696135|FG001|Overall Study|Withdrawal by Subject|0|||
143313818|NCT02992899|516696134|FG000|Overall Study|Lost to Follow-up|1|||
143313819|NCT02992899|516696135|FG001|Overall Study|Lost to Follow-up|3|||
143313820|NCT01034397|516696136|FG000|Overall Study|Lack of compliance|0|||
143313821|NCT01034397|516696137|FG001|Overall Study|Lack of compliance|1|||
143313822|NCT01034397|516696136|FG000|Overall Study|Lack of Efficacy|3|||
143313823|NCT01034397|516696137|FG001|Overall Study|Lack of Efficacy|0|||
143313824|NCT01034397|516696136|FG000|Overall Study|Adverse Event|4|||
143313825|NCT01034397|516696137|FG001|Overall Study|Adverse Event|0|||
143313826|NCT01034397|516696136|FG000|Overall Study|Other|0|||
143313827|NCT01034397|516696137|FG001|Overall Study|Other|1|||
143313828|NCT01785524|516696138|FG000|Overall Study|Withdrawal by Subject|2|||
143313829|NCT01785524|516696139|FG001|Overall Study|Withdrawal by Subject|2|||
143313830|NCT01060384|516696140|FG000|Overall Study|Withdrawal by Subject|0|||
143313831|NCT01060384|516696141|FG001|Overall Study|Withdrawal by Subject|1|||
143313832|NCT01060384|516696142|FG002|Overall Study|Withdrawal by Subject|0|||
143313833|NCT01060384|516696143|FG003|Overall Study|Withdrawal by Subject|0|||
143313834|NCT01060384|516696144|FG004|Overall Study|Withdrawal by Subject|0|||
143313835|NCT01060384|516696140|FG000|Overall Study|Death|0|||
143313836|NCT01060384|516696141|FG001|Overall Study|Death|0|||
143313837|NCT01060384|516696142|FG002|Overall Study|Death|0|||
143313838|NCT01060384|516696143|FG003|Overall Study|Death|0|||
143313839|NCT01060384|516696144|FG004|Overall Study|Death|1|||
143313840|NCT01060384|516696140|FG000|Overall Study|Intercurrent illness|0|||
143313841|NCT01060384|516696141|FG001|Overall Study|Intercurrent illness|0|||
143313842|NCT01060384|516696142|FG002|Overall Study|Intercurrent illness|0|||
143313843|NCT01060384|516696143|FG003|Overall Study|Intercurrent illness|0|||
143313844|NCT01060384|516696144|FG004|Overall Study|Intercurrent illness|1|||
143313845|NCT00812929|516696147|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
143313846|NCT00812929|516696148|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
143313847|NCT00812929|516696149|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
143313848|NCT00812929|516696150|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
143313849|NCT00812929|516696151|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
143313850|NCT00812929|516696152|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
143313851|NCT00812929|516696153|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
143313852|NCT00812929|516696154|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
143313853|NCT00812929|516696155|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
143313854|NCT00812929|516696156|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
143313855|NCT00812929|516696147|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
143313856|NCT00812929|516696148|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
143313857|NCT00812929|516696149|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
143313858|NCT00812929|516696150|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
143313859|NCT00812929|516696151|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
143313860|NCT00812929|516696152|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
143313861|NCT00812929|516696153|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
143313862|NCT00812929|516696154|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
143313863|NCT00812929|516696155|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
143313864|NCT00812929|516696156|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
143313865|NCT00812929|516696147|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
143313866|NCT00812929|516696148|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
143313867|NCT00812929|516696149|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
143313868|NCT00812929|516696150|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
143313869|NCT00812929|516696151|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
143313870|NCT00812929|516696152|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
143313871|NCT00812929|516696153|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
143313872|NCT00812929|516696154|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
143313873|NCT00812929|516696155|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
143313874|NCT00812929|516696156|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
143313875|NCT00678691|516696161|FG000|Overall Study|Adverse Event|6|||
143313876|NCT00678691|516696162|FG001|Overall Study|Adverse Event|4|||
143313877|NCT03192150|516696169|FG000|Overall Study|Adverse Event|14|||
143313878|NCT03192150|516696170|FG001|Overall Study|Adverse Event|12|||
143313879|NCT03192150|516696169|FG000|Overall Study|Lack of Efficacy|23|||
143313880|NCT03192150|516696170|FG001|Overall Study|Lack of Efficacy|30|||
143313881|NCT03192150|516696169|FG000|Overall Study|Lost to Follow-up|1|||
143313882|NCT03192150|516696170|FG001|Overall Study|Lost to Follow-up|1|||
143313883|NCT03192150|516696169|FG000|Overall Study|Withdrawal by Subject|4|||
143313884|NCT03192150|516696170|FG001|Overall Study|Withdrawal by Subject|2|||
143313885|NCT03192150|516696169|FG000|Overall Study|Protocol Violation|5|||
143313886|NCT03192150|516696170|FG001|Overall Study|Protocol Violation|2|||
143313887|NCT03192150|516696169|FG000|Overall Study|Surgery Canceled|6|||
143313888|NCT03192150|516696170|FG001|Overall Study|Surgery Canceled|2|||
143313889|NCT03192150|516696169|FG000|Overall Study|Other-Various Administrative Reasons|2|||
143313890|NCT03192150|516696170|FG001|Overall Study|Other-Various Administrative Reasons|5|||
143313891|NCT02579616|516696171|FG000|Overall Study|Participants did not receive treatment|3|||
143313892|NCT02939404|516696172|FG000|Chamber at 24°C, ad Libitum Diet|Adverse Event|2|||
143313893|NCT02939404|516696173|FG001|Chamber at 24°C, ad Libitum Diet|Adverse Event|1|||
143313894|NCT02939404|516696172|FG000|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|3|||
143313895|NCT02939404|516696173|FG001|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|2|||
143313896|NCT00261716|516696195|FG000|Overall Study|Withdrawal by Subject|6|||
143313897|NCT00261716|516696196|FG001|Overall Study|Withdrawal by Subject|8|||
143313898|NCT00261716|516696195|FG000|Overall Study|Lost to Follow-up|0|||
143313899|NCT00261716|516696196|FG001|Overall Study|Lost to Follow-up|2|||
143313900|NCT02047110|516696199|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
143313901|NCT02047110|516696200|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
143313902|NCT02047110|516696201|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
143313903|NCT02047110|516696202|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
143313904|NCT02047110|516696199|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
143313905|NCT02047110|516696200|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
143313906|NCT02047110|516696201|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
143313907|NCT02047110|516696202|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
143313908|NCT02047110|516696199|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
143313909|NCT02047110|516696200|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
143313910|NCT02047110|516696201|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
143313911|NCT02047110|516696202|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
143313912|NCT02047110|516696199|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
143313913|NCT02047110|516696200|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
143313914|NCT02047110|516696201|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
143313915|NCT02047110|516696202|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
143313916|NCT02047110|516696199|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
143313917|NCT02047110|516696200|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
143313918|NCT02047110|516696201|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
143313919|NCT02047110|516696202|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
143313920|NCT02047110|516696199|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
143313921|NCT02047110|516696200|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
143313922|NCT02047110|516696201|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
143313923|NCT02047110|516696202|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
143313924|NCT02047110|516696199|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
143313925|NCT02047110|516696200|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
143313926|NCT02047110|516696201|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
143313927|NCT02047110|516696202|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
143313928|NCT02047110|516696199|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
143313929|NCT02047110|516696200|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
143313930|NCT02047110|516696201|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
143313931|NCT02047110|516696202|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
143313932|NCT02047110|516696199|FG000|Escape Treatment Period|Adverse Event|1|||
143313933|NCT02047110|516696200|FG001|Escape Treatment Period|Adverse Event|2|||
143313934|NCT02047110|516696201|FG002|Escape Treatment Period|Adverse Event|2|||
143313935|NCT02047110|516696202|FG003|Escape Treatment Period|Adverse Event|0|||
143313936|NCT02047110|516696199|FG000|Escape Treatment Period|Other than specified|1|||
143313937|NCT02047110|516696200|FG001|Escape Treatment Period|Other than specified|2|||
143313938|NCT02047110|516696201|FG002|Escape Treatment Period|Other than specified|0|||
143313939|NCT02047110|516696202|FG003|Escape Treatment Period|Other than specified|1|||
143313940|NCT02047110|516696199|FG000|OLE Treatment Period|Other than specified|0|||
143313941|NCT02047110|516696200|FG001|OLE Treatment Period|Other than specified|0|||
143313942|NCT02047110|516696201|FG002|OLE Treatment Period|Other than specified|1|||
143313943|NCT02047110|516696202|FG003|OLE Treatment Period|Other than specified|0|||
143313944|NCT01632800|516696205|FG000|Overall Study|Subject did not fit in apparatus|1|||
143313945|NCT01000051|516696206|FG000|Overall Study|Withdrawal by Subject|1|||
143313946|NCT01000051|516696207|FG001|Overall Study|Withdrawal by Subject|1|||
143313947|NCT01000051|516696206|FG000|Overall Study|Disease Progression|1|||
143313948|NCT01000051|516696207|FG001|Overall Study|Disease Progression|0|||
143313949|NCT01000051|516696206|FG000|Overall Study|Serious noncompliance|1|||
143313950|NCT01000051|516696207|FG001|Overall Study|Serious noncompliance|0|||
143313951|NCT02247349|516696208|FG000|Overall Study|Disease Progression|7|||
143313952|NCT02247349|516696209|FG001|Overall Study|Disease Progression|4|||
143313953|NCT02247349|516696210|FG002|Overall Study|Disease Progression|26|||
143313954|NCT02247349|516696211|FG003|Overall Study|Disease Progression|31|||
143313955|NCT02247349|516696212|FG004|Overall Study|Disease Progression|16|||
143313956|NCT02247349|516696213|FG005|Overall Study|Disease Progression|6|||
143313957|NCT02247349|516696208|FG000|Overall Study|Study drug toxicity|0|||
143313958|NCT02247349|516696209|FG001|Overall Study|Study drug toxicity|1|||
143376309|NCT05061693|516921700|FG010|24-week Extension Period|Sponsor Decision|0|||
143376310|NCT05061693|516921701|FG011|24-week Extension Period|Sponsor Decision|0|||
143313959|NCT02247349|516696210|FG002|Overall Study|Study drug toxicity|1|||
143313960|NCT02247349|516696211|FG003|Overall Study|Study drug toxicity|1|||
143313961|NCT02247349|516696212|FG004|Overall Study|Study drug toxicity|2|||
143313962|NCT02247349|516696213|FG005|Overall Study|Study drug toxicity|2|||
143313963|NCT02247349|516696208|FG000|Overall Study|Death|0|||
143313964|NCT02247349|516696209|FG001|Overall Study|Death|0|||
143313965|NCT02247349|516696210|FG002|Overall Study|Death|0|||
143313966|NCT02247349|516696211|FG003|Overall Study|Death|1|||
143313967|NCT02247349|516696212|FG004|Overall Study|Death|0|||
143313968|NCT02247349|516696213|FG005|Overall Study|Death|0|||
143313969|NCT02247349|516696208|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
143313970|NCT02247349|516696209|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
143313971|NCT02247349|516696210|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
143313972|NCT02247349|516696211|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
143313973|NCT02247349|516696212|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
143313974|NCT02247349|516696213|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
143313975|NCT02247349|516696208|FG000|Overall Study|Participant request to discontinue study treatment|0|||
143313976|NCT02247349|516696209|FG001|Overall Study|Participant request to discontinue study treatment|0|||
143313977|NCT02247349|516696210|FG002|Overall Study|Participant request to discontinue study treatment|1|||
143313978|NCT02247349|516696211|FG003|Overall Study|Participant request to discontinue study treatment|2|||
143313979|NCT02247349|516696212|FG004|Overall Study|Participant request to discontinue study treatment|1|||
143313980|NCT02247349|516696213|FG005|Overall Study|Participant request to discontinue study treatment|0|||
143313981|NCT02247349|516696208|FG000|Overall Study|Withdrawal by Subject|0|||
143313982|NCT02247349|516696209|FG001|Overall Study|Withdrawal by Subject|1|||
143313983|NCT02247349|516696210|FG002|Overall Study|Withdrawal by Subject|0|||
143313984|NCT02247349|516696211|FG003|Overall Study|Withdrawal by Subject|0|||
143313985|NCT02247349|516696212|FG004|Overall Study|Withdrawal by Subject|0|||
143313986|NCT02247349|516696213|FG005|Overall Study|Withdrawal by Subject|0|||
143313987|NCT02247349|516696208|FG000|Overall Study|Administrative reason by sponsor|0|||
143313988|NCT02247349|516696209|FG001|Overall Study|Administrative reason by sponsor|0|||
143313989|NCT02247349|516696210|FG002|Overall Study|Administrative reason by sponsor|0|||
143313990|NCT02247349|516696211|FG003|Overall Study|Administrative reason by sponsor|0|||
143313991|NCT02247349|516696212|FG004|Overall Study|Administrative reason by sponsor|1|||
143313992|NCT02247349|516696213|FG005|Overall Study|Administrative reason by sponsor|0|||
143313993|NCT02247349|516696208|FG000|Overall Study|Other reasons|0|||
143313994|NCT02247349|516696209|FG001|Overall Study|Other reasons|0|||
143313995|NCT02247349|516696210|FG002|Overall Study|Other reasons|1|||
143313996|NCT02247349|516696211|FG003|Overall Study|Other reasons|0|||
143313997|NCT02247349|516696212|FG004|Overall Study|Other reasons|0|||
143313998|NCT02247349|516696213|FG005|Overall Study|Other reasons|0|||
143313999|NCT04936685|516696216|FG000|Overall Study|Protocol Violation|1|||
143314000|NCT04936685|516696217|FG001|Overall Study|Protocol Violation|0|||
143314001|NCT02075320|516696221|FG000|Overall Study|Withdrawal by Subject|2|||
143314002|NCT02985736|516696222|FG000|Overall Study|Lost to Follow-up|3|||
143314003|NCT00382733|516696223|FG000|Overall Study|Withdrawal by Subject|0|||
143314004|NCT00382733|516696224|FG001|Overall Study|Withdrawal by Subject|1|||
143314005|NCT00382733|516696225|FG002|Overall Study|Withdrawal by Subject|0|||
143314006|NCT00382733|516696226|FG003|Overall Study|Withdrawal by Subject|0|||
143314007|NCT00382733|516696227|FG004|Overall Study|Withdrawal by Subject|0|||
143314008|NCT00550836|516696228|FG000|Overall Study|Withdrawal by Subject|3|||
143314009|NCT00550836|516696229|FG001|Overall Study|Withdrawal by Subject|9|||
143314010|NCT01458171|516696232|FG000|Overall Study|Adverse Event|1|||
143314011|NCT00578565|516696233|FG000|Overall Study|Adverse Event|3|||
143314012|NCT00515827|516696234|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
143314013|NCT00515827|516696235|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
143314014|NCT00515827|516696234|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
143314015|NCT00515827|516696235|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
143314016|NCT00480779|516696241|FG000|Overall Study|Other|2|||
143314017|NCT00480779|516696242|FG001|Overall Study|Other|0|||
143314018|NCT00480779|516696241|FG000|Overall Study|Job and Health-related|0|||
143314019|NCT00480779|516696242|FG001|Overall Study|Job and Health-related|3|||
143314020|NCT00854581|516696245|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
143314021|NCT00854581|516696245|FG000|Induction (Up to Day 21)|Death|1|||
143314022|NCT00854581|516696245|FG000|Induction (Up to Day 21)|Physician Decision|1|||
143314023|NCT00854581|516696245|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
143314024|NCT00378703|516696248|FG000|Overall Study|Disease progression|59|||
143314025|NCT00378703|516696249|FG001|Overall Study|Disease progression|43|||
143314026|NCT00378703|516696250|FG002|Overall Study|Disease progression|48|||
143314027|NCT00378703|516696251|FG003|Overall Study|Disease progression|49|||
143314028|NCT00378703|516696248|FG000|Overall Study|Adverse Event|11|||
143314029|NCT00378703|516696249|FG001|Overall Study|Adverse Event|17|||
143314030|NCT00378703|516696250|FG002|Overall Study|Adverse Event|20|||
143314031|NCT00378703|516696251|FG003|Overall Study|Adverse Event|18|||
143314032|NCT00378703|516696248|FG000|Overall Study|Death|2|||
143314033|NCT00378703|516696249|FG001|Overall Study|Death|2|||
143376311|NCT05061693|516921690|FG000|24-week Extension Period|Site Closure|0|||
143376312|NCT05061693|516921691|FG001|24-week Extension Period|Site Closure|0|||
143376313|NCT05061693|516921692|FG002|24-week Extension Period|Site Closure|0|||
143376314|NCT05061693|516921693|FG003|24-week Extension Period|Site Closure|0|||
143314034|NCT00378703|516696250|FG002|Overall Study|Death|4|||
143314035|NCT00378703|516696251|FG003|Overall Study|Death|3|||
143314036|NCT00378703|516696248|FG000|Overall Study|Withdrawal by Subject|4|||
143314037|NCT00378703|516696249|FG001|Overall Study|Withdrawal by Subject|8|||
143314038|NCT00378703|516696250|FG002|Overall Study|Withdrawal by Subject|5|||
143314039|NCT00378703|516696251|FG003|Overall Study|Withdrawal by Subject|7|||
143314040|NCT00378703|516696248|FG000|Overall Study|Physician Decision|1|||
143314041|NCT00378703|516696249|FG001|Overall Study|Physician Decision|4|||
143314042|NCT00378703|516696250|FG002|Overall Study|Physician Decision|1|||
143314043|NCT00378703|516696251|FG003|Overall Study|Physician Decision|0|||
143314044|NCT00378703|516696248|FG000|Overall Study|Alternative therapy|4|||
143314045|NCT00378703|516696249|FG001|Overall Study|Alternative therapy|2|||
143314046|NCT00378703|516696250|FG002|Overall Study|Alternative therapy|0|||
143314047|NCT00378703|516696251|FG003|Overall Study|Alternative therapy|0|||
143314048|NCT00378703|516696248|FG000|Overall Study|Other complicated disease|0|||
143314049|NCT00378703|516696249|FG001|Overall Study|Other complicated disease|2|||
143314050|NCT00378703|516696250|FG002|Overall Study|Other complicated disease|2|||
143314051|NCT00378703|516696251|FG003|Overall Study|Other complicated disease|0|||
143314052|NCT00378703|516696248|FG000|Overall Study|Symptomatic deterioration|0|||
143314053|NCT00378703|516696249|FG001|Overall Study|Symptomatic deterioration|1|||
143314054|NCT00378703|516696250|FG002|Overall Study|Symptomatic deterioration|0|||
143314055|NCT00378703|516696251|FG003|Overall Study|Symptomatic deterioration|2|||
143314056|NCT00378703|516696248|FG000|Overall Study|Surgery|1|||
143314057|NCT00378703|516696249|FG001|Overall Study|Surgery|0|||
143314058|NCT00378703|516696250|FG002|Overall Study|Surgery|0|||
143314059|NCT00378703|516696251|FG003|Overall Study|Surgery|1|||
143314060|NCT00378703|516696248|FG000|Overall Study|Joint decision of physician and patient|1|||
143314061|NCT00378703|516696249|FG001|Overall Study|Joint decision of physician and patient|0|||
143314062|NCT00378703|516696250|FG002|Overall Study|Joint decision of physician and patient|0|||
143314063|NCT00378703|516696251|FG003|Overall Study|Joint decision of physician and patient|0|||
143314064|NCT00378703|516696248|FG000|Overall Study|Adverse events and progressive disease|0|||
143314065|NCT00378703|516696249|FG001|Overall Study|Adverse events and progressive disease|0|||
143314066|NCT00378703|516696250|FG002|Overall Study|Adverse events and progressive disease|0|||
143314067|NCT00378703|516696251|FG003|Overall Study|Adverse events and progressive disease|1|||
143314068|NCT00378703|516696248|FG000|Overall Study|Relocation|0|||
143314069|NCT00378703|516696249|FG001|Overall Study|Relocation|0|||
143314070|NCT00378703|516696250|FG002|Overall Study|Relocation|1|||
143314071|NCT00378703|516696251|FG003|Overall Study|Relocation|0|||
143314072|NCT00378703|516696248|FG000|Overall Study|Ineligible|4|||
143314073|NCT00378703|516696249|FG001|Overall Study|Ineligible|7|||
143314074|NCT00378703|516696250|FG002|Overall Study|Ineligible|7|||
143314075|NCT00378703|516696251|FG003|Overall Study|Ineligible|7|||
143314076|NCT00378703|516696248|FG000|Overall Study|Never started treatment|1|||
143314077|NCT00378703|516696249|FG001|Overall Study|Never started treatment|4|||
143314078|NCT00378703|516696250|FG002|Overall Study|Never started treatment|0|||
143314079|NCT00378703|516696251|FG003|Overall Study|Never started treatment|0|||
143314080|NCT00378703|516696248|FG000|Overall Study|Other|1|||
143314081|NCT00378703|516696249|FG001|Overall Study|Other|1|||
143314082|NCT00378703|516696250|FG002|Overall Study|Other|2|||
143376315|NCT05061693|516921694|FG004|24-week Extension Period|Site Closure|0|||
143314083|NCT00378703|516696251|FG003|Overall Study|Other|3|||
143314084|NCT01466192|516696265|FG000|Overall Study|Physician Decision|1|||
143314085|NCT01466192|516696265|FG000|Overall Study|Withdrawal by Subject|3|||
143314086|NCT00700011|516696266|FG000|Overall Study|Death|0|||
143314087|NCT00700011|516696267|FG001|Overall Study|Death|1|||
143314088|NCT00678561|516696268|FG000|Overall Study|Adverse Event|0|||
143314089|NCT00678561|516696269|FG001|Overall Study|Adverse Event|1|||
143376316|NCT05061693|516921695|FG005|24-week Extension Period|Site Closure|0|||
143314090|NCT00678561|516696270|FG002|Overall Study|Adverse Event|1|||
143314091|NCT00678561|516696271|FG003|Overall Study|Adverse Event|0|||
143314092|NCT00678561|516696272|FG004|Overall Study|Adverse Event|1|||
143314093|NCT00678561|516696273|FG005|Overall Study|Adverse Event|0|||
143314094|NCT00678561|516696274|FG006|Overall Study|Adverse Event|0|||
143314095|NCT00678561|516696275|FG007|Overall Study|Adverse Event|0|||
143314096|NCT00678561|516696268|FG000|Overall Study|Protocol Violation|0|||
143314097|NCT00678561|516696269|FG001|Overall Study|Protocol Violation|0|||
143314098|NCT00678561|516696270|FG002|Overall Study|Protocol Violation|0|||
143314099|NCT00678561|516696271|FG003|Overall Study|Protocol Violation|0|||
143314100|NCT00678561|516696272|FG004|Overall Study|Protocol Violation|1|||
143314101|NCT00678561|516696273|FG005|Overall Study|Protocol Violation|1|||
143314102|NCT00678561|516696274|FG006|Overall Study|Protocol Violation|0|||
143314103|NCT00678561|516696275|FG007|Overall Study|Protocol Violation|0|||
143376317|NCT05061693|516921696|FG006|24-week Extension Period|Site Closure|0|||
143376318|NCT05061693|516921697|FG007|24-week Extension Period|Site Closure|0|||
143376319|NCT05061693|516921698|FG008|24-week Extension Period|Site Closure|1|||
143376320|NCT05061693|516921699|FG009|24-week Extension Period|Site Closure|0|||
143376321|NCT05061693|516921700|FG010|24-week Extension Period|Site Closure|0|||
143376322|NCT05061693|516921701|FG011|24-week Extension Period|Site Closure|1|||
143376323|NCT03823911|516921702|FG000|Overall Study|Lost to Follow-up|1|||
143376324|NCT03823911|516921703|FG001|Overall Study|Lost to Follow-up|5|||
143376325|NCT03823911|516921704|FG002|Overall Study|Lost to Follow-up|2|||
143376326|NCT03823911|516921702|FG000|Overall Study|Did not meet eligibility criteria|13|||
143376327|NCT03823911|516921703|FG001|Overall Study|Did not meet eligibility criteria|7|||
143376328|NCT03823911|516921704|FG002|Overall Study|Did not meet eligibility criteria|4|||
143376329|NCT03823911|516921702|FG000|Overall Study|Death|0|||
143376330|NCT03823911|516921703|FG001|Overall Study|Death|1|||
143376331|NCT03823911|516921704|FG002|Overall Study|Death|0|||
143376332|NCT01152190|516921705|FG000|Overall Study|Adverse Event|2|||
143376333|NCT01152190|516921706|FG001|Overall Study|Adverse Event|4|||
143376334|NCT01152190|516921705|FG000|Overall Study|Death|1|||
143376335|NCT01152190|516921706|FG001|Overall Study|Death|0|||
143376336|NCT01152190|516921705|FG000|Overall Study|Protocol Violation|1|||
143376337|NCT01152190|516921706|FG001|Overall Study|Protocol Violation|1|||
143376338|NCT01152190|516921705|FG000|Overall Study|Withdrawal by Subject|1|||
143376339|NCT01152190|516921706|FG001|Overall Study|Withdrawal by Subject|3|||
143376340|NCT00094575|516921721|FG000|Overall Study|Death|146|||
143376341|NCT00094575|516921722|FG001|Overall Study|Death|146|||
143376342|NCT00732381|516921730|FG000|Overall Study|Adverse Event|1|||
143376343|NCT00732381|516921731|FG001|Overall Study|Adverse Event|0|||
143376344|NCT00732381|516921730|FG000|Overall Study|Treatment Failure|1|||
143376345|NCT00732381|516921731|FG001|Overall Study|Treatment Failure|1|||
143376346|NCT01420549|516921732|FG000|Overall Study|Adverse Event|1|||
143376347|NCT01420549|516921733|FG001|Overall Study|Adverse Event|1|||
143376348|NCT01420549|516921732|FG000|Overall Study|Lost to Follow-up|2|||
143376349|NCT01420549|516921733|FG001|Overall Study|Lost to Follow-up|2|||
143376350|NCT01420549|516921732|FG000|Overall Study|Protocol Violation|0|||
143376351|NCT01420549|516921733|FG001|Overall Study|Protocol Violation|1|||
143376352|NCT01420549|516921732|FG000|Overall Study|Non-adherence to medication|4|||
143376353|NCT01420549|516921733|FG001|Overall Study|Non-adherence to medication|1|||
143376354|NCT01170026|516922918|FG000|Overall Study|Lost to Follow-up|4|||
143376355|NCT01170026|516922919|FG001|Overall Study|Lost to Follow-up|2|||
143376356|NCT03785782|516922929|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
143376357|NCT03785782|516922930|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
143376358|NCT03785782|516922929|FG000|Overall Study|Withdrawal by Subject|1|||
143376359|NCT03785782|516922930|FG001|Overall Study|Withdrawal by Subject|1|||
143376360|NCT03785782|516922929|FG000|Overall Study|insufficient image quality.|3|||
143376361|NCT03785782|516922930|FG001|Overall Study|insufficient image quality.|0|||
143376362|NCT03889925|516922931|FG000|Overall Study|Lost to Follow-up|11|||
143376363|NCT03889925|516922932|FG001|Overall Study|Lost to Follow-up|10|||
143376364|NCT00304031|516922933|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
143376365|NCT00304031|516922934|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
143376366|NCT00304031|516922935|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
143376367|NCT00304031|516922933|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
143376368|NCT00304031|516922934|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
143376369|NCT00304031|516922935|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
143376370|NCT00304031|516922933|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
143376371|NCT00304031|516922934|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
143376372|NCT00304031|516922935|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
143376373|NCT00304031|516922933|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
143376374|NCT00304031|516922934|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
143376375|NCT00304031|516922935|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
143376376|NCT00304031|516922933|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
143376377|NCT00304031|516922934|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
143376378|NCT00304031|516922935|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
143376379|NCT00304031|516922933|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
143376380|NCT00304031|516922934|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
143376381|NCT00304031|516922935|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
143376382|NCT00304031|516922933|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
143376383|NCT00304031|516922934|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
143376384|NCT00304031|516922935|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
143376385|NCT00304031|516922933|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
143376386|NCT00304031|516922934|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
143376387|NCT00304031|516922935|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
143314104|NCT00678561|516696268|FG000|Overall Study|Withdrawal by Subject|0|||
143314105|NCT00678561|516696269|FG001|Overall Study|Withdrawal by Subject|0|||
143314106|NCT00678561|516696270|FG002|Overall Study|Withdrawal by Subject|0|||
143314107|NCT00678561|516696271|FG003|Overall Study|Withdrawal by Subject|0|||
143314108|NCT00678561|516696272|FG004|Overall Study|Withdrawal by Subject|0|||
143314109|NCT00678561|516696273|FG005|Overall Study|Withdrawal by Subject|0|||
143314110|NCT00678561|516696274|FG006|Overall Study|Withdrawal by Subject|0|||
143314111|NCT00678561|516696275|FG007|Overall Study|Withdrawal by Subject|1|||
143314112|NCT00004031|516696276|FG000|Overall Study|Adverse Event|5|||
143314113|NCT00004031|516696277|FG001|Overall Study|Adverse Event|0|||
143314114|NCT00004031|516696276|FG000|Overall Study|Refusal unrelated to adverse events|2|||
143314115|NCT00004031|516696277|FG001|Overall Study|Refusal unrelated to adverse events|11|||
143314116|NCT00004031|516696276|FG000|Overall Study|Progression/relapse|9|||
143314117|NCT00004031|516696277|FG001|Overall Study|Progression/relapse|4|||
143314118|NCT00004031|516696276|FG000|Overall Study|Death|3|||
143314119|NCT00004031|516696277|FG001|Overall Study|Death|1|||
143314120|NCT00004031|516696276|FG000|Overall Study|Other- not protocol specified|3|||
143314121|NCT00004031|516696277|FG001|Overall Study|Other- not protocol specified|3|||
143314122|NCT00004031|516696276|FG000|Overall Study|Reason under review|3|||
143314123|NCT00004031|516696277|FG001|Overall Study|Reason under review|2|||
143314124|NCT03551210|516696278|FG000|Overall Study|Adverse Event|5|||
143314125|NCT03551210|516696279|FG001|Overall Study|Adverse Event|6|||
143314126|NCT03551210|516696278|FG000|Overall Study|Withdrawal by Subject|1|||
143314127|NCT03551210|516696279|FG001|Overall Study|Withdrawal by Subject|7|||
143314128|NCT03551210|516696278|FG000|Overall Study|Needed in other antibiotic treatment|2|||
143314129|NCT03551210|516696279|FG001|Overall Study|Needed in other antibiotic treatment|5|||
143314130|NCT03551210|516696278|FG000|Overall Study|Lost to Follow-up|1|||
143314131|NCT03551210|516696279|FG001|Overall Study|Lost to Follow-up|1|||
143314132|NCT03551210|516696278|FG000|Overall Study|Absence of visit 4 and 5|1|||
143314133|NCT03551210|516696279|FG001|Overall Study|Absence of visit 4 and 5|0|||
143314134|NCT03551210|516696278|FG000|Overall Study|No drug for dispensing|0|||
143314135|NCT03551210|516696279|FG001|Overall Study|No drug for dispensing|1|||
143314136|NCT03265119|516696280|FG000|Overall Study|Adverse Event|2|||
143314137|NCT03265119|516696281|FG001|Overall Study|Adverse Event|1|||
143314138|NCT03265119|516696280|FG000|Overall Study|Lack of Efficacy|3|||
143314139|NCT03265119|516696281|FG001|Overall Study|Lack of Efficacy|0|||
143314140|NCT03265119|516696280|FG000|Overall Study|Protocol Violation|1|||
143314141|NCT03265119|516696281|FG001|Overall Study|Protocol Violation|2|||
143314142|NCT03265119|516696280|FG000|Overall Study|Withdrawal by Subject|2|||
143314143|NCT03265119|516696281|FG001|Overall Study|Withdrawal by Subject|4|||
143314144|NCT03265119|516696280|FG000|Overall Study|Lost to Follow-up|1|||
143314145|NCT03265119|516696281|FG001|Overall Study|Lost to Follow-up|0|||
143314146|NCT03265119|516696280|FG000|Overall Study|Lack of Compliance|1|||
143314147|NCT03265119|516696281|FG001|Overall Study|Lack of Compliance|0|||
143314148|NCT03085927|516698458|FG000|Overall Study|Withdrawal by Subject|1|||
143314149|NCT03085927|516698459|FG001|Overall Study|Withdrawal by Subject|4|||
143314150|NCT03085927|516698458|FG000|Overall Study|Lost to Follow-up|3|||
143314151|NCT03085927|516698459|FG001|Overall Study|Lost to Follow-up|1|||
143314152|NCT03085927|516698458|FG000|Overall Study|Death|1|||
143314153|NCT03085927|516698459|FG001|Overall Study|Death|0|||
143314154|NCT03085927|516698458|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
143314155|NCT03085927|516698459|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
143314156|NCT03085927|516698458|FG000|Overall Study|Dyad Became Ineligible|0|||
143314157|NCT03085927|516698459|FG001|Overall Study|Dyad Became Ineligible|1|||
143314158|NCT00600821|516698463|FG000|Overall Study|Death|45|||
143314159|NCT00600821|516698464|FG001|Overall Study|Death|46|||
143314160|NCT00600821|516698463|FG000|Overall Study|Lost to Follow-up|2|||
143314161|NCT00600821|516698464|FG001|Overall Study|Lost to Follow-up|2|||
143314162|NCT00600821|516698463|FG000|Overall Study|Withdrawal by Subject|1|||
143314163|NCT00600821|516698464|FG001|Overall Study|Withdrawal by Subject|1|||
143314164|NCT00600821|516698463|FG000|Overall Study|Terminated by sponsor|8|||
143314165|NCT00600821|516698464|FG001|Overall Study|Terminated by sponsor|6|||
143314166|NCT00600821|516698463|FG000|Overall Study|Objective progression or relapse|0|||
143314167|NCT00600821|516698464|FG001|Overall Study|Objective progression or relapse|1|||
143314168|NCT00600821|516698463|FG000|Overall Study|Randomized but not treated|0|||
143314169|NCT00600821|516698464|FG001|Overall Study|Randomized but not treated|1|||
143314170|NCT00600821|516698463|FG000|Overall Study|Other|2|||
143314171|NCT00600821|516698464|FG001|Overall Study|Other|3|||
143314172|NCT02602288|516698465|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
143314173|NCT02602288|516698466|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
143314174|NCT02602288|516698465|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
143314175|NCT02602288|516698466|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
143314176|NCT02602288|516698465|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
143314177|NCT02602288|516698466|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
143314178|NCT02602288|516698465|FG000|12 Month Follow-up|Lost to Follow-up|0|||
143314179|NCT02602288|516698466|FG001|12 Month Follow-up|Lost to Follow-up|4|||
143314180|NCT02602288|516698465|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
143314181|NCT02602288|516698466|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
143314182|NCT02066298|516698470|FG000|Overall Study|Lost to Follow-up|3|||
143314183|NCT02066298|516698471|FG001|Overall Study|Lost to Follow-up|2|||
143314184|NCT02066298|516698472|FG002|Overall Study|Lost to Follow-up|3|||
143314185|NCT02066298|516698473|FG003|Overall Study|Lost to Follow-up|2|||
143314186|NCT02066298|516698474|FG004|Overall Study|Lost to Follow-up|3|||
143314187|NCT02066298|516698475|FG005|Overall Study|Lost to Follow-up|4|||
143314188|NCT02066298|516698470|FG000|Overall Study|Withdrawal by Subject|6|||
143314189|NCT02066298|516698471|FG001|Overall Study|Withdrawal by Subject|6|||
143314190|NCT02066298|516698472|FG002|Overall Study|Withdrawal by Subject|6|||
143314191|NCT02066298|516698473|FG003|Overall Study|Withdrawal by Subject|4|||
143314192|NCT02066298|516698474|FG004|Overall Study|Withdrawal by Subject|5|||
143314193|NCT02066298|516698475|FG005|Overall Study|Withdrawal by Subject|8|||
143314194|NCT02066298|516698470|FG000|Overall Study|Physician Decision|0|||
143314195|NCT02066298|516698471|FG001|Overall Study|Physician Decision|0|||
143314196|NCT02066298|516698472|FG002|Overall Study|Physician Decision|1|||
143314197|NCT02066298|516698473|FG003|Overall Study|Physician Decision|0|||
143314198|NCT02066298|516698474|FG004|Overall Study|Physician Decision|1|||
143314199|NCT02066298|516698475|FG005|Overall Study|Physician Decision|0|||
143314200|NCT04260191|516698476|FG000|Overall Study|Decision by Sponsor|0|||
143314201|NCT04260191|516698477|FG001|Overall Study|Decision by Sponsor|1|||
143314202|NCT04260191|516698478|FG002|Overall Study|Decision by Sponsor|0|||
143314203|NCT04260191|516698476|FG000|Overall Study|Withdrawal by Subject|1|||
143314204|NCT04260191|516698477|FG001|Overall Study|Withdrawal by Subject|0|||
143314205|NCT04260191|516698478|FG002|Overall Study|Withdrawal by Subject|3|||
143314206|NCT04260191|516698476|FG000|Overall Study|Death|4|||
143314207|NCT04260191|516698477|FG001|Overall Study|Death|3|||
143314208|NCT04260191|516698478|FG002|Overall Study|Death|2|||
143314209|NCT00630877|516698479|FG000|Overall Study|Adverse Event|11|||
143314210|NCT00630877|516698480|FG001|Overall Study|Adverse Event|8|||
143314211|NCT00630877|516698481|FG002|Overall Study|Adverse Event|7|||
143314212|NCT00630877|516698479|FG000|Overall Study|Withdrawal by Subject|3|||
143314213|NCT00630877|516698480|FG001|Overall Study|Withdrawal by Subject|4|||
143314214|NCT00630877|516698481|FG002|Overall Study|Withdrawal by Subject|0|||
143314215|NCT00630877|516698479|FG000|Overall Study|Lost to Follow-up|2|||
143314216|NCT00630877|516698480|FG001|Overall Study|Lost to Follow-up|0|||
143314217|NCT00630877|516698481|FG002|Overall Study|Lost to Follow-up|0|||
143314218|NCT00630877|516698479|FG000|Overall Study|Noncompliance|2|||
143314219|NCT00630877|516698480|FG001|Overall Study|Noncompliance|3|||
143314220|NCT00630877|516698481|FG002|Overall Study|Noncompliance|1|||
143314221|NCT00630877|516698479|FG000|Overall Study|Protocol violation|1|||
143314222|NCT00630877|516698480|FG001|Overall Study|Protocol violation|0|||
143314223|NCT00630877|516698481|FG002|Overall Study|Protocol violation|1|||
143314224|NCT00630877|516698479|FG000|Overall Study|Personal reasons|0|||
143314225|NCT00630877|516698480|FG001|Overall Study|Personal reasons|0|||
143314226|NCT00630877|516698481|FG002|Overall Study|Personal reasons|1|||
143314227|NCT01643473|516698482|FG000|Overall Study|Lost to Follow-up|1|||
143314228|NCT01643473|516698483|FG001|Overall Study|Lost to Follow-up|0|||
143314229|NCT01519518|516698485|FG000|Overall Study|Consent not available|7|||
143314230|NCT01519518|516698486|FG001|Overall Study|Consent not available|10|||
143314231|NCT02033889|516698487|FG000|Overall Study|Adverse Event|3|||
143314232|NCT02033889|516698488|FG001|Overall Study|Adverse Event|1|||
143314233|NCT02033889|516698489|FG002|Overall Study|Adverse Event|3|||
143314234|NCT02033889|516698487|FG000|Overall Study|Death|3|||
143314235|NCT02033889|516698488|FG001|Overall Study|Death|1|||
143314236|NCT02033889|516698489|FG002|Overall Study|Death|2|||
143314237|NCT02033889|516698487|FG000|Overall Study|Excluded Medication|1|||
143314238|NCT02033889|516698488|FG001|Overall Study|Excluded Medication|1|||
143314239|NCT02033889|516698489|FG002|Overall Study|Excluded Medication|0|||
143314240|NCT02033889|516698487|FG000|Overall Study|Lost to Follow-up|8|||
143314241|NCT02033889|516698488|FG001|Overall Study|Lost to Follow-up|5|||
143314242|NCT02033889|516698489|FG002|Overall Study|Lost to Follow-up|6|||
143314243|NCT02033889|516698487|FG000|Overall Study|Non-Compliance With Study Drug|1|||
143314244|NCT02033889|516698488|FG001|Overall Study|Non-Compliance With Study Drug|0|||
143314245|NCT02033889|516698489|FG002|Overall Study|Non-Compliance With Study Drug|0|||
143314246|NCT02033889|516698487|FG000|Overall Study|Physician Decision|0|||
143314247|NCT02033889|516698488|FG001|Overall Study|Physician Decision|1|||
143314248|NCT02033889|516698489|FG002|Overall Study|Physician Decision|1|||
143314249|NCT02033889|516698487|FG000|Overall Study|Participant moved|0|||
143314250|NCT02033889|516698488|FG001|Overall Study|Participant moved|1|||
143314251|NCT02033889|516698489|FG002|Overall Study|Participant moved|0|||
143314252|NCT02033889|516698487|FG000|Overall Study|Withdrawal by Subject|18|||
143314253|NCT02033889|516698488|FG001|Overall Study|Withdrawal by Subject|10|||
143314254|NCT02033889|516698489|FG002|Overall Study|Withdrawal by Subject|13|||
143314255|NCT02343458|516698493|FG000|Overall Study|Adverse Event|15|||
143314256|NCT02343458|516698494|FG001|Overall Study|Adverse Event|14|||
143314257|NCT02343458|516698495|FG002|Overall Study|Adverse Event|15|||
143314258|NCT02343458|516698496|FG003|Overall Study|Adverse Event|3|||
143376388|NCT00304031|516922933|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
143376389|NCT00304031|516922934|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
143376390|NCT00304031|516922935|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
143376391|NCT02396316|516922938|FG000|Overall Study|Physician Decision|1|||
143376392|NCT02396316|516922939|FG001|Overall Study|Physician Decision|0|||
143376393|NCT02396316|516922938|FG000|Overall Study|Progressive disease|6|||
143376394|NCT02396316|516922939|FG001|Overall Study|Progressive disease|3|||
143376395|NCT02396316|516922938|FG000|Overall Study|Protocol Violation|0|||
143376396|NCT02396316|516922939|FG001|Overall Study|Protocol Violation|1|||
143376397|NCT02396316|516922938|FG000|Overall Study|Treatment unblinded|0|||
143376398|NCT02396316|516922939|FG001|Overall Study|Treatment unblinded|1|||
143376399|NCT00566735|516922940|FG000|Overall Study|Withdrawal by Subject|0|||
143314259|NCT02343458|516698493|FG000|Overall Study|Lack of Efficacy|3|||
143314260|NCT02343458|516698494|FG001|Overall Study|Lack of Efficacy|8|||
143314261|NCT02343458|516698495|FG002|Overall Study|Lack of Efficacy|4|||
143314262|NCT02343458|516698496|FG003|Overall Study|Lack of Efficacy|8|||
143314263|NCT02343458|516698493|FG000|Overall Study|Withdrawal by Subject|18|||
143314264|NCT02343458|516698494|FG001|Overall Study|Withdrawal by Subject|17|||
143376400|NCT00566735|516922941|FG001|Overall Study|Withdrawal by Subject|1|||
143376401|NCT00566735|516922940|FG000|Overall Study|Refused neuropsychological testing|2|||
143376402|NCT00566735|516922941|FG001|Overall Study|Refused neuropsychological testing|5|||
143376403|NCT00566735|516922940|FG000|Overall Study|Switched into a manic episode|0|||
143376404|NCT00566735|516922941|FG001|Overall Study|Switched into a manic episode|1|||
143376405|NCT01460446|516922953|FG000|Overall Study|Non-compliance|2|||
143376406|NCT01460446|516922954|FG001|Overall Study|Non-compliance|9|||
143376407|NCT01460446|516922953|FG000|Overall Study|Consent Withdrawn|0|||
143376408|NCT01460446|516922954|FG001|Overall Study|Consent Withdrawn|4|||
143376409|NCT01460446|516922953|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
143376410|NCT01460446|516922954|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
143376411|NCT01460446|516922953|FG000|Overall Study|Surgery/Illness|1|||
143376412|NCT01460446|516922954|FG001|Overall Study|Surgery/Illness|1|||
143376413|NCT01460446|516922953|FG000|Overall Study|Pregnancy|1|||
143376414|NCT01460446|516922954|FG001|Overall Study|Pregnancy|0|||
143314265|NCT02343458|516698495|FG002|Overall Study|Withdrawal by Subject|23|||
143314266|NCT02343458|516698496|FG003|Overall Study|Withdrawal by Subject|14|||
143314267|NCT02343458|516698493|FG000|Overall Study|Physician Decision|1|||
143314268|NCT02343458|516698494|FG001|Overall Study|Physician Decision|4|||
143314269|NCT02343458|516698495|FG002|Overall Study|Physician Decision|2|||
143314270|NCT02343458|516698496|FG003|Overall Study|Physician Decision|2|||
143314271|NCT02343458|516698493|FG000|Overall Study|Lost to Follow-up|5|||
143314272|NCT02343458|516698494|FG001|Overall Study|Lost to Follow-up|5|||
143314273|NCT02343458|516698495|FG002|Overall Study|Lost to Follow-up|3|||
143314274|NCT02343458|516698496|FG003|Overall Study|Lost to Follow-up|1|||
143314275|NCT02343458|516698493|FG000|Overall Study|Protocol Violation|2|||
143314276|NCT02343458|516698494|FG001|Overall Study|Protocol Violation|5|||
143314277|NCT02343458|516698495|FG002|Overall Study|Protocol Violation|2|||
143314278|NCT02343458|516698496|FG003|Overall Study|Protocol Violation|2|||
143314279|NCT02343458|516698493|FG000|Overall Study|Protocol Specified Criteria|17|||
143314280|NCT02343458|516698494|FG001|Overall Study|Protocol Specified Criteria|13|||
143314281|NCT02343458|516698495|FG002|Overall Study|Protocol Specified Criteria|14|||
143314282|NCT02343458|516698496|FG003|Overall Study|Protocol Specified Criteria|8|||
143314283|NCT01312909|516698497|FG000|Overall Study|Randomized but not treated|1|||
143314284|NCT01312909|516698498|FG001|Overall Study|Randomized but not treated|3|||
143314285|NCT01312909|516698499|FG002|Overall Study|Randomized but not treated|1|||
143314286|NCT01312909|516698497|FG000|Overall Study|Adverse Event|1|||
143376415|NCT01460446|516922953|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
143376416|NCT01460446|516922954|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
143376417|NCT00714714|516922957|FG000|Overall Study|Adverse Event|1|||
143376418|NCT03644849|516922958|FG000|Overall Study|Lost to Follow-up|1|||
143376419|NCT03644849|516922959|FG001|Overall Study|Lost to Follow-up|3|||
143376420|NCT02593149|516922961|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
143376421|NCT02593149|516922962|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
143376422|NCT02593149|516922961|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
143376423|NCT02593149|516922962|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
143376424|NCT00979992|516922963|FG000|Overall Study|Ineligible - inadequate pathology|1|||
143376425|NCT00979992|516922963|FG000|Overall Study|Ineligible - wrong cell type|2|||
143376426|NCT00979992|516922963|FG000|Overall Study|Refused - Never Treated|2|||
143376427|NCT00346151|516922964|FG000|Overall Study|Withdrawal by Subject|3|||
143314287|NCT01312909|516698498|FG001|Overall Study|Adverse Event|0|||
143314288|NCT01312909|516698499|FG002|Overall Study|Adverse Event|3|||
143314289|NCT01312909|516698497|FG000|Overall Study|Protocol Violation|2|||
143314290|NCT01312909|516698498|FG001|Overall Study|Protocol Violation|0|||
143314291|NCT01312909|516698499|FG002|Overall Study|Protocol Violation|2|||
143314292|NCT01312909|516698497|FG000|Overall Study|Other|9|||
143314293|NCT01312909|516698498|FG001|Overall Study|Other|6|||
143314294|NCT01312909|516698499|FG002|Overall Study|Other|11|||
143314295|NCT01312909|516698497|FG000|Overall Study|Withdrawal by Subject|8|||
143314296|NCT01312909|516698498|FG001|Overall Study|Withdrawal by Subject|10|||
143314297|NCT01312909|516698499|FG002|Overall Study|Withdrawal by Subject|7|||
143314298|NCT01312909|516698497|FG000|Overall Study|Lost to Follow-up|21|||
143314299|NCT01312909|516698498|FG001|Overall Study|Lost to Follow-up|17|||
143314300|NCT01312909|516698499|FG002|Overall Study|Lost to Follow-up|20|||
143314301|NCT01312909|516698497|FG000|Overall Study|Insufficient clinical response|0|||
143314302|NCT01312909|516698498|FG001|Overall Study|Insufficient clinical response|0|||
143314303|NCT01312909|516698499|FG002|Overall Study|Insufficient clinical response|1|||
143314304|NCT01312909|516698497|FG000|Overall Study|Entrance criteria not met|0|||
143314305|NCT01312909|516698498|FG001|Overall Study|Entrance criteria not met|0|||
143314306|NCT01312909|516698499|FG002|Overall Study|Entrance criteria not met|2|||
143314307|NCT01913041|516698500|FG000|Overall Study|Protocol Violation|35|||
143314308|NCT01913041|516698500|FG000|Overall Study|Withdrawal by Subject|3|||
143314309|NCT01913041|516698500|FG000|Overall Study|Physician Decision|1|||
143314310|NCT01639001|516698509|FG000|Overall Study|Refused further follow-up|9|||
143314311|NCT01639001|516698510|FG001|Overall Study|Refused further follow-up|12|||
143314312|NCT01639001|516698509|FG000|Overall Study|Lost to Follow-up|3|||
143314313|NCT01639001|516698510|FG001|Overall Study|Lost to Follow-up|0|||
143314314|NCT01639001|516698509|FG000|Overall Study|Death|62|||
143314315|NCT01639001|516698510|FG001|Overall Study|Death|61|||
143314316|NCT01639001|516698509|FG000|Overall Study|Randomized but not treated|0|||
143314317|NCT01639001|516698510|FG001|Overall Study|Randomized but not treated|2|||
143314318|NCT01639001|516698509|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
143314319|NCT01639001|516698510|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
143314320|NCT02660359|516698511|FG000|Overall Study|Protocol Deviation|0|||
143314321|NCT02660359|516698512|FG001|Overall Study|Protocol Deviation|0|||
143314322|NCT02660359|516698513|FG002|Overall Study|Protocol Deviation|1|||
143314323|NCT02660359|516698511|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
143314324|NCT02660359|516698512|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
143314325|NCT02660359|516698513|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
143314326|NCT02660359|516698511|FG000|Overall Study|Lack of Efficacy|1|||
143314327|NCT02660359|516698512|FG001|Overall Study|Lack of Efficacy|1|||
143314328|NCT02660359|516698513|FG002|Overall Study|Lack of Efficacy|1|||
143314329|NCT02660359|516698511|FG000|Overall Study|Adverse Event|0|||
143314330|NCT02660359|516698512|FG001|Overall Study|Adverse Event|1|||
143314331|NCT02660359|516698513|FG002|Overall Study|Adverse Event|0|||
143314332|NCT02660359|516698511|FG000|Overall Study|Other|2|||
143314333|NCT02660359|516698512|FG001|Overall Study|Other|1|||
143314334|NCT02660359|516698513|FG002|Overall Study|Other|3|||
143314335|NCT02660359|516698511|FG000|Overall Study|Withdrawal by Subject|7|||
143314336|NCT02660359|516698512|FG001|Overall Study|Withdrawal by Subject|5|||
143314337|NCT02660359|516698513|FG002|Overall Study|Withdrawal by Subject|8|||
143314338|NCT02660359|516698511|FG000|Overall Study|Lost to Follow-up|3|||
143314339|NCT02660359|516698512|FG001|Overall Study|Lost to Follow-up|3|||
143314340|NCT02660359|516698513|FG002|Overall Study|Lost to Follow-up|0|||
143314341|NCT03394391|516698514|FG000|Overall Study|Lost to Follow-up|1|||
143314342|NCT03394391|516698515|FG001|Overall Study|Lost to Follow-up|2|||
143314343|NCT00424372|516698516|FG000|Overall Study|Death|1|||
143314344|NCT00424372|516698516|FG000|Overall Study|Adverse Event|18|||
143314345|NCT00424372|516698516|FG000|Overall Study|Lack of Efficacy|6|||
143314346|NCT00424372|516698516|FG000|Overall Study|Withdrawal by Subject|4|||
143314347|NCT00424372|516698516|FG000|Overall Study|Protocol Violation|1|||
143314348|NCT00424372|516698516|FG000|Overall Study|Health deterioration|1|||
143314349|NCT04622254|516698517|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
143314350|NCT04622254|516698518|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
143314351|NCT04622254|516698519|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
143314352|NCT04622254|516698520|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
143314353|NCT04622254|516698521|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
143314354|NCT04622254|516698522|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
143314355|NCT04622254|516698517|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
143314356|NCT04622254|516698518|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
143314357|NCT04622254|516698519|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
143314358|NCT04622254|516698520|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
143314359|NCT04622254|516698521|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
143314360|NCT04622254|516698522|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
143314361|NCT04622254|516698517|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
143314362|NCT04622254|516698518|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
143314363|NCT04622254|516698519|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
143314364|NCT04622254|516698520|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
143314365|NCT04622254|516698521|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
143314366|NCT04622254|516698522|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
143314367|NCT04622254|516698517|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
143314368|NCT04622254|516698518|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
143314369|NCT04622254|516698519|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
143376428|NCT02957136|516922965|FG000|Overall Study|Withdrawal by Subject|2|||
143376429|NCT02957136|516922966|FG001|Overall Study|Withdrawal by Subject|1|||
143376430|NCT00439569|516922969|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
143376431|NCT00439569|516922969|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
143376432|NCT00439569|516922969|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
143376433|NCT02200770|516922971|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
143376434|NCT02200770|516922972|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
143376435|NCT02200770|516922971|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
143376436|NCT02200770|516922972|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
143376437|NCT02200770|516922971|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
143376438|NCT02200770|516922972|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
143376439|NCT02200770|516922971|FG000|Randomized-controlled Period (RCP)|Other|1|||
143376440|NCT02200770|516922972|FG001|Randomized-controlled Period (RCP)|Other|2|||
143376441|NCT02200770|516922971|FG000|Open-label Period (OLP)|Adverse Event|1|||
143376442|NCT02200770|516922972|FG001|Open-label Period (OLP)|Adverse Event|2|||
143376443|NCT02200770|516922971|FG000|Open-label Period (OLP)|Death|1|||
143376444|NCT02200770|516922972|FG001|Open-label Period (OLP)|Death|2|||
143376445|NCT02200770|516922971|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
143376446|NCT02200770|516922972|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
143376447|NCT02200770|516922971|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
143376448|NCT02200770|516922972|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
143376449|NCT02200770|516922971|FG000|Open-label Period (OLP)|Other|6|||
143376450|NCT02200770|516922972|FG001|Open-label Period (OLP)|Other|15|||
143376451|NCT01510717|516922973|FG000|Overall Study|Adverse Event|1|||
143376452|NCT01510717|516922974|FG001|Overall Study|Adverse Event|2|||
143376453|NCT01510717|516922973|FG000|Overall Study|Death|1|||
143376454|NCT01510717|516922974|FG001|Overall Study|Death|0|||
143376455|NCT01510717|516922973|FG000|Overall Study|Lost to Follow-up|0|||
143376456|NCT01510717|516922974|FG001|Overall Study|Lost to Follow-up|1|||
143376457|NCT01510717|516922973|FG000|Overall Study|Withdrawal by Subject|0|||
143376458|NCT01510717|516922974|FG001|Overall Study|Withdrawal by Subject|2|||
143376459|NCT02555215|516922975|FG000|Overall Study|Other|1|||
143376460|NCT02555215|516922975|FG000|Overall Study|Investigator Decision|2|||
143376461|NCT00529789|516922976|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
143376462|NCT00529789|516922976|FG000|Study Period II/III|Adverse Event|3|||
143376463|NCT00529789|516922976|FG000|Study Period II/III|Lack of Efficacy|2|||
143376464|NCT00529789|516922976|FG000|Study Period II/III|Withdrawal by Subject|1|||
143376465|NCT00529789|516922976|FG000|Study Period II/III|Protocol Violation|3|||
143376466|NCT00529789|516922976|FG000|Study Period II/III|Physician Decision|3|||
143376467|NCT00529789|516922976|FG000|Study Period II/III|Lost to Follow-up|3|||
143376468|NCT00529789|516922976|FG000|Study Period IV|Parent/Caregiver Decision|1|||
143376469|NCT00529789|516922976|FG000|Study Period IV|Adverse Event|1|||
143376470|NCT00529789|516922976|FG000|Study Period IV|Lack of Efficacy|1|||
143376471|NCT00529789|516922976|FG000|Study Period IV|Lost to Follow-up|3|||
143376472|NCT01595061|516922977|FG000|Overall Study|Never Treated|3|||
143376473|NCT01595061|516922977|FG000|Overall Study|Inadequate Pathology|1|||
143376474|NCT03194958|516922978|FG000|Overall Study|Death|0|||
143376475|NCT03194958|516922979|FG001|Overall Study|Death|1|||
143376476|NCT03194958|516922980|FG002|Overall Study|Death|1|||
143376477|NCT03194958|516922981|FG003|Overall Study|Death|1|||
143376478|NCT03194958|516922978|FG000|Overall Study|Withdrawal by Subject|24|||
143376479|NCT03194958|516922979|FG001|Overall Study|Withdrawal by Subject|27|||
143376480|NCT03194958|516922980|FG002|Overall Study|Withdrawal by Subject|7|||
143376481|NCT03194958|516922981|FG003|Overall Study|Withdrawal by Subject|22|||
143376482|NCT03194958|516922978|FG000|Overall Study|Lost to Follow-up|168|||
143376483|NCT03194958|516922979|FG001|Overall Study|Lost to Follow-up|196|||
143376484|NCT03194958|516922980|FG002|Overall Study|Lost to Follow-up|174|||
143376485|NCT03194958|516922981|FG003|Overall Study|Lost to Follow-up|186|||
143376486|NCT01968226|516922983|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
143376487|NCT00959946|516922987|FG000|Overall Study|Adverse Event|0|||
143376488|NCT00959946|516922988|FG001|Overall Study|Adverse Event|0|||
143376489|NCT00959946|516922989|FG002|Overall Study|Adverse Event|2|||
143376490|NCT00959946|516922990|FG003|Overall Study|Adverse Event|1|||
143376491|NCT00959946|516922991|FG004|Overall Study|Adverse Event|0|||
143376492|NCT00959946|516922992|FG005|Overall Study|Adverse Event|1|||
143376493|NCT00959946|516922993|FG006|Overall Study|Adverse Event|0|||
143376494|NCT00959946|516922994|FG007|Overall Study|Adverse Event|0|||
143376495|NCT00959946|516922987|FG000|Overall Study|Death|0|||
143376496|NCT00959946|516922988|FG001|Overall Study|Death|0|||
143376497|NCT00959946|516922989|FG002|Overall Study|Death|0|||
143376498|NCT00959946|516922990|FG003|Overall Study|Death|0|||
143376499|NCT00959946|516922991|FG004|Overall Study|Death|0|||
143376500|NCT00959946|516922992|FG005|Overall Study|Death|1|||
143376501|NCT00959946|516922993|FG006|Overall Study|Death|0|||
143376502|NCT00959946|516922994|FG007|Overall Study|Death|0|||
143314370|NCT04622254|516698520|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
143314371|NCT04622254|516698521|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
143314372|NCT04622254|516698522|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
143314373|NCT04622254|516698517|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
143314374|NCT04622254|516698518|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
143314375|NCT04622254|516698519|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
143314376|NCT04622254|516698520|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
143314377|NCT04622254|516698521|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
143314378|NCT04622254|516698522|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
143314379|NCT04622254|516698517|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
143314380|NCT04622254|516698518|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
143314381|NCT04622254|516698519|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
143314382|NCT04622254|516698520|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
143314383|NCT04622254|516698521|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
143314384|NCT04622254|516698522|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
143314385|NCT04622254|516698517|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
143314386|NCT04622254|516698518|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
143314387|NCT04622254|516698519|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
143314388|NCT04622254|516698520|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
143314389|NCT04622254|516698521|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
143314390|NCT04622254|516698522|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
143314391|NCT04622254|516698517|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
143314392|NCT04622254|516698518|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
143314393|NCT04622254|516698519|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
143314394|NCT04622254|516698520|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
143314395|NCT04622254|516698521|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
143314396|NCT04622254|516698522|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
143314397|NCT04622254|516698517|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
143314398|NCT04622254|516698518|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
143314399|NCT04622254|516698519|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
143314400|NCT04622254|516698520|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
143314401|NCT04622254|516698521|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
143314402|NCT04622254|516698522|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
143314403|NCT04622254|516698517|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
143314404|NCT04622254|516698518|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
143314405|NCT04622254|516698519|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
143314406|NCT04622254|516698520|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
143314407|NCT04622254|516698521|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
143314408|NCT04622254|516698522|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
143314409|NCT04622254|516698517|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
143314410|NCT04622254|516698518|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
143314411|NCT04622254|516698519|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
143314412|NCT04622254|516698520|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
143314413|NCT04622254|516698521|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
143314414|NCT04622254|516698522|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
143314415|NCT00098839|516698525|FG000|Overall Study|Adverse Event|5|||
143314416|NCT00098839|516698526|FG001|Overall Study|Adverse Event|2|||
143314417|NCT00098839|516698525|FG000|Overall Study|Death|1|||
143314418|NCT00098839|516698526|FG001|Overall Study|Death|2|||
143314419|NCT00098839|516698525|FG000|Overall Study|Physician Decision|4|||
143314420|NCT00098839|516698526|FG001|Overall Study|Physician Decision|14|||
143314421|NCT00098839|516698525|FG000|Overall Study|Withdrawal by Subject|1|||
143314422|NCT00098839|516698526|FG001|Overall Study|Withdrawal by Subject|0|||
143314423|NCT00098839|516698525|FG000|Overall Study|Refusal of further protocol therapy|3|||
143314424|NCT00098839|516698526|FG001|Overall Study|Refusal of further protocol therapy|1|||
143314425|NCT00098839|516698525|FG000|Overall Study|Relapse|6|||
143314426|NCT00098839|516698526|FG001|Overall Study|Relapse|3|||
143314427|NCT00098839|516698525|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
143314428|NCT00098839|516698526|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
143314429|NCT00098839|516698525|FG000|Overall Study|Ineligible|2|||
143314430|NCT00098839|516698526|FG001|Overall Study|Ineligible|0|||
143314431|NCT01430585|516698527|FG000|Overall Study|Death|1|||
143314432|NCT01430585|516698527|FG000|Overall Study|Objective Progression or Relapse|3|||
143314433|NCT01430585|516698527|FG000|Overall Study|Study Terminated by Sponsor|3|||
143314434|NCT01430585|516698527|FG000|Overall Study|Other|7|||
143314435|NCT01448850|516698528|FG000|Overall Study|Death|3|||
143314436|NCT01448850|516698529|FG001|Overall Study|Death|6|||
143314437|NCT01448850|516698528|FG000|Overall Study|Withdrawal by Subject|13|||
143314438|NCT01448850|516698529|FG001|Overall Study|Withdrawal by Subject|21|||
143314439|NCT01448850|516698528|FG000|Overall Study|Lost to Follow-up|3|||
143314440|NCT01448850|516698529|FG001|Overall Study|Lost to Follow-up|1|||
143314441|NCT01448850|516698528|FG000|Overall Study|Other|15|||
143376503|NCT00959946|516922987|FG000|Overall Study|Disease Progression|2|||
143376504|NCT00959946|516922988|FG001|Overall Study|Disease Progression|4|||
143376505|NCT00959946|516922989|FG002|Overall Study|Disease Progression|2|||
143376506|NCT00959946|516922990|FG003|Overall Study|Disease Progression|4|||
143376507|NCT00959946|516922991|FG004|Overall Study|Disease Progression|4|||
143376508|NCT00959946|516922992|FG005|Overall Study|Disease Progression|6|||
143376509|NCT00959946|516922993|FG006|Overall Study|Disease Progression|2|||
143376510|NCT00959946|516922994|FG007|Overall Study|Disease Progression|2|||
143376511|NCT00959946|516922987|FG000|Overall Study|Withdrawal by Subject|0|||
143376512|NCT00959946|516922988|FG001|Overall Study|Withdrawal by Subject|0|||
143376513|NCT00959946|516922989|FG002|Overall Study|Withdrawal by Subject|0|||
143376514|NCT00959946|516922990|FG003|Overall Study|Withdrawal by Subject|0|||
143376515|NCT00959946|516922991|FG004|Overall Study|Withdrawal by Subject|0|||
143376516|NCT00959946|516922992|FG005|Overall Study|Withdrawal by Subject|1|||
143376517|NCT00959946|516922993|FG006|Overall Study|Withdrawal by Subject|0|||
143376518|NCT00959946|516922994|FG007|Overall Study|Withdrawal by Subject|0|||
143376519|NCT00566527|516922995|FG000|Overall Study|Reason not provided|3|||
143376520|NCT00566527|516922996|FG001|Overall Study|Reason not provided|11|||
143376521|NCT00566527|516922997|FG002|Overall Study|Reason not provided|10|||
143376522|NCT00566527|516922995|FG000|Overall Study|Adverse Event|2|||
143376523|NCT00566527|516922996|FG001|Overall Study|Adverse Event|0|||
143376524|NCT00566527|516922997|FG002|Overall Study|Adverse Event|1|||
143376525|NCT00566527|516922995|FG000|Overall Study|Physician Decision|3|||
143376526|NCT00566527|516922996|FG001|Overall Study|Physician Decision|8|||
143376527|NCT00566527|516922997|FG002|Overall Study|Physician Decision|20|||
143376528|NCT00566527|516922995|FG000|Overall Study|Lost to Follow-up|3|||
143376529|NCT00566527|516922996|FG001|Overall Study|Lost to Follow-up|4|||
143376530|NCT00566527|516922997|FG002|Overall Study|Lost to Follow-up|4|||
143376531|NCT00566527|516922995|FG000|Overall Study|Withdrawal by Subject|6|||
143376532|NCT00566527|516922996|FG001|Overall Study|Withdrawal by Subject|43|||
143376533|NCT00566527|516922997|FG002|Overall Study|Withdrawal by Subject|43|||
143376534|NCT00457743|516922998|FG000|Overall Study|Adverse Event|0|||
143376535|NCT00457743|516922999|FG001|Overall Study|Adverse Event|4|||
143376536|NCT00457743|516923000|FG002|Overall Study|Adverse Event|0|||
143376537|NCT00457743|516922998|FG000|Overall Study|Lack of Efficacy|3|||
143376538|NCT00457743|516922999|FG001|Overall Study|Lack of Efficacy|23|||
143376539|NCT00457743|516923000|FG002|Overall Study|Lack of Efficacy|3|||
143376540|NCT00356265|516923001|FG000|Overall Study|Withdrawal by Subject|0|||
143376541|NCT00356265|516923002|FG001|Overall Study|Withdrawal by Subject|0|||
143376542|NCT00356265|516923003|FG002|Overall Study|Withdrawal by Subject|1|||
143376543|NCT01837966|516923007|FG000|Overall Study|Withdrawal by Subject|2|||
143376544|NCT01837966|516923008|FG001|Overall Study|Withdrawal by Subject|1|||
143376545|NCT01202955|516923009|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
143376546|NCT01202955|516923010|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
143376547|NCT00159783|516923016|FG000|Overall Study|Adverse Event|5|||
143376548|NCT00159783|516923017|FG001|Overall Study|Adverse Event|7|||
143376549|NCT00159783|516923018|FG002|Overall Study|Adverse Event|9|||
143376550|NCT00159783|516923016|FG000|Overall Study|Lack of Efficacy|1|||
143376551|NCT00159783|516923017|FG001|Overall Study|Lack of Efficacy|2|||
143376552|NCT00159783|516923018|FG002|Overall Study|Lack of Efficacy|3|||
143376553|NCT00159783|516923016|FG000|Overall Study|Withdrawal by Subject|7|||
143376554|NCT00159783|516923017|FG001|Overall Study|Withdrawal by Subject|11|||
143376555|NCT00159783|516923018|FG002|Overall Study|Withdrawal by Subject|12|||
143376556|NCT00159783|516923016|FG000|Overall Study|Lost to Follow-up|6|||
143376557|NCT00159783|516923017|FG001|Overall Study|Lost to Follow-up|5|||
143376558|NCT00159783|516923018|FG002|Overall Study|Lost to Follow-up|11|||
143376559|NCT00159783|516923016|FG000|Overall Study|Other|0|||
143376560|NCT00159783|516923017|FG001|Overall Study|Other|2|||
143376561|NCT00159783|516923018|FG002|Overall Study|Other|4|||
143376562|NCT02928224|516923019|FG000|Overall Study|Lost to Follow-up|1|||
143376563|NCT02928224|516923020|FG001|Overall Study|Lost to Follow-up|1|||
143376564|NCT02928224|516923021|FG002|Overall Study|Lost to Follow-up|3|||
143376565|NCT02928224|516923022|FG003|Overall Study|Lost to Follow-up|0|||
143376566|NCT02928224|516923019|FG000|Overall Study|Death|30|||
143376567|NCT02928224|516923020|FG001|Overall Study|Death|209|||
143376568|NCT02928224|516923021|FG002|Overall Study|Death|193|||
143376569|NCT02928224|516923022|FG003|Overall Study|Death|198|||
143376570|NCT02928224|516923019|FG000|Overall Study|Withdrawal by Subject|0|||
143376571|NCT02928224|516923020|FG001|Overall Study|Withdrawal by Subject|3|||
143376572|NCT02928224|516923021|FG002|Overall Study|Withdrawal by Subject|7|||
143376573|NCT02928224|516923022|FG003|Overall Study|Withdrawal by Subject|20|||
143376574|NCT02928224|516923019|FG000|Overall Study|Study participation terminated by sponsor|3|||
143376575|NCT02928224|516923020|FG001|Overall Study|Study participation terminated by sponsor|8|||
143376576|NCT02928224|516923021|FG002|Overall Study|Study participation terminated by sponsor|12|||
143376577|NCT02928224|516923022|FG003|Overall Study|Study participation terminated by sponsor|3|||
143376578|NCT02928224|516923019|FG000|Overall Study|Other|3|||
143376579|NCT02928224|516923020|FG001|Overall Study|Other|3|||
143376580|NCT02928224|516923021|FG002|Overall Study|Other|5|||
143376581|NCT02928224|516923022|FG003|Overall Study|Other|0|||
143376582|NCT02538107|516923023|FG000|Overall Study|Did not receive any Mircera dose|11|||
143376583|NCT02538107|516923023|FG000|Overall Study|Missing|5|||
143376584|NCT02538107|516923023|FG000|Overall Study|Necessity of dialysis|20|||
143376585|NCT02538107|516923023|FG000|Overall Study|Administration of other ESA|11|||
143376586|NCT02538107|516923023|FG000|Overall Study|No further treatment necessary|18|||
143376587|NCT02538107|516923023|FG000|Overall Study|Withdrawal by Subject|17|||
143376588|NCT02538107|516923023|FG000|Overall Study|Death|4|||
143376589|NCT02538107|516923023|FG000|Overall Study|Administrative reason|5|||
143376590|NCT02538107|516923023|FG000|Overall Study|Adverse Event|4|||
143376591|NCT02538107|516923023|FG000|Overall Study|Surgery|1|||
143376592|NCT02538107|516923023|FG000|Overall Study|Other|7|||
143376593|NCT02538107|516923023|FG000|Overall Study|Not recorded|7|||
143376594|NCT01278394|516923026|FG000|Overall Study|Lost to Follow-up|1|||
143376595|NCT01236560|516923027|FG000|Overall Study|Adverse Event|0|||
143376596|NCT01236560|516923028|FG001|Overall Study|Adverse Event|2|||
143376597|NCT01236560|516923029|FG002|Overall Study|Adverse Event|1|||
143376598|NCT01236560|516923030|FG003|Overall Study|Adverse Event|3|||
143376599|NCT01236560|516923031|FG004|Overall Study|Adverse Event|0|||
143376600|NCT01236560|516923032|FG005|Overall Study|Adverse Event|0|||
143376601|NCT01236560|516923027|FG000|Overall Study|Death|0|||
143376602|NCT01236560|516923028|FG001|Overall Study|Death|1|||
143376603|NCT01236560|516923029|FG002|Overall Study|Death|0|||
143376604|NCT01236560|516923030|FG003|Overall Study|Death|1|||
143376605|NCT01236560|516923031|FG004|Overall Study|Death|0|||
143376606|NCT01236560|516923032|FG005|Overall Study|Death|0|||
143376607|NCT01236560|516923027|FG000|Overall Study|Lost to Follow-up|0|||
143376608|NCT01236560|516923028|FG001|Overall Study|Lost to Follow-up|1|||
143376609|NCT01236560|516923029|FG002|Overall Study|Lost to Follow-up|1|||
143376610|NCT01236560|516923030|FG003|Overall Study|Lost to Follow-up|0|||
143376611|NCT01236560|516923031|FG004|Overall Study|Lost to Follow-up|0|||
143376612|NCT01236560|516923032|FG005|Overall Study|Lost to Follow-up|0|||
143376613|NCT01236560|516923027|FG000|Overall Study|Physician Decision|0|||
143376614|NCT01236560|516923028|FG001|Overall Study|Physician Decision|1|||
143376615|NCT01236560|516923029|FG002|Overall Study|Physician Decision|8|||
143376616|NCT01236560|516923030|FG003|Overall Study|Physician Decision|0|||
143376617|NCT01236560|516923031|FG004|Overall Study|Physician Decision|0|||
143376618|NCT01236560|516923032|FG005|Overall Study|Physician Decision|0|||
143376619|NCT01236560|516923027|FG000|Overall Study|Withdrawal by Subject|0|||
143376620|NCT01236560|516923028|FG001|Overall Study|Withdrawal by Subject|0|||
143376621|NCT01236560|516923029|FG002|Overall Study|Withdrawal by Subject|1|||
143376622|NCT01236560|516923030|FG003|Overall Study|Withdrawal by Subject|2|||
143376623|NCT01236560|516923031|FG004|Overall Study|Withdrawal by Subject|0|||
143376624|NCT01236560|516923032|FG005|Overall Study|Withdrawal by Subject|0|||
143376625|NCT01236560|516923027|FG000|Overall Study|Progressive disease|5|||
143376626|NCT01236560|516923028|FG001|Overall Study|Progressive disease|19|||
143376627|NCT01236560|516923029|FG002|Overall Study|Progressive disease|9|||
143376628|NCT01236560|516923030|FG003|Overall Study|Progressive disease|16|||
143376629|NCT01236560|516923031|FG004|Overall Study|Progressive disease|0|||
143376630|NCT01236560|516923032|FG005|Overall Study|Progressive disease|0|||
143376631|NCT02115139|516923033|FG000|Overall Study|Protocol Violation|1|||
143376632|NCT02115139|516923033|FG000|Overall Study|treatment discontinuation|6|||
143376633|NCT00468910|516923034|FG000|Overall Study|Lost to Follow-up|2|||
143376634|NCT00468910|516923035|FG001|Overall Study|Lost to Follow-up|1|||
143376635|NCT00468910|516923034|FG000|Overall Study|Withdrawal by Subject|2|||
143376636|NCT00468910|516923035|FG001|Overall Study|Withdrawal by Subject|1|||
143376637|NCT00468910|516923034|FG000|Overall Study|Medical Contraindication|0|||
143376638|NCT00468910|516923035|FG001|Overall Study|Medical Contraindication|1|||
143376639|NCT01576484|516923037|FG000|Overall Study|Adverse Event|1|||
143376640|NCT01576484|516923038|FG001|Overall Study|Adverse Event|1|||
143376641|NCT01576484|516923037|FG000|Overall Study|Protocol Violation|0|||
143376642|NCT01576484|516923038|FG001|Overall Study|Protocol Violation|2|||
143376643|NCT01576484|516923037|FG000|Overall Study|Sponsor Decision|2|||
143376644|NCT01576484|516923038|FG001|Overall Study|Sponsor Decision|8|||
143376645|NCT01576484|516923037|FG000|Overall Study|Withdrawal by Subject|0|||
143376646|NCT01576484|516923038|FG001|Overall Study|Withdrawal by Subject|3|||
143376647|NCT01576484|516923037|FG000|Overall Study|Other|2|||
143376648|NCT01576484|516923038|FG001|Overall Study|Other|5|||
143376649|NCT03603717|516923042|FG000|Overall Study|Lost to Follow-up|20|||
143376650|NCT03603717|516923043|FG001|Overall Study|Lost to Follow-up|20|||
143376651|NCT03603717|516923042|FG000|Overall Study|Withdrawal by Subject|16|||
143376652|NCT03603717|516923043|FG001|Overall Study|Withdrawal by Subject|10|||
143376653|NCT00457691|516923044|FG000|Overall Study|Adverse Event|4|||
143376654|NCT00457691|516923045|FG001|Overall Study|Adverse Event|1|||
143376655|NCT00457691|516923044|FG000|Overall Study|Death|163|||
143376656|NCT00457691|516923045|FG001|Overall Study|Death|148|||
143376657|NCT00457691|516923044|FG000|Overall Study|Protocol Violation|1|||
143376658|NCT00457691|516923045|FG001|Overall Study|Protocol Violation|3|||
143376659|NCT00457691|516923044|FG000|Overall Study|Lost to Follow-up|23|||
143376660|NCT00457691|516923045|FG001|Overall Study|Lost to Follow-up|14|||
143314442|NCT01448850|516698529|FG001|Overall Study|Other|12|||
143314443|NCT00482391|516698530|FG000|Overall Study|Withdrawal by Subject|1|||
143314444|NCT00482391|516698530|FG000|Overall Study|Adverse Event|1|||
143314445|NCT00482391|516698530|FG000|Overall Study|Death|1|||
143314446|NCT02664038|516698533|FG000|13 Week|Lost to Follow-up|7|||
143314447|NCT02664038|516698534|FG001|13 Week|Lost to Follow-up|14|||
143314448|NCT02664038|516698533|FG000|13 Week|Withdrawal by Subject|1|||
143314449|NCT02664038|516698534|FG001|13 Week|Withdrawal by Subject|0|||
143314450|NCT02664038|516698533|FG000|26 Week|Lost to Follow-up|5|||
143314451|NCT02664038|516698534|FG001|26 Week|Lost to Follow-up|4|||
143314452|NCT02606136|516698544|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
143314453|NCT02606136|516698544|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
143314454|NCT02606136|516698544|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
143314455|NCT02606136|516698544|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
143314456|NCT03296696|516698545|FG000|Overall Study|Started Other Antitumor Therapy|1|||
143314457|NCT03296696|516698546|FG001|Overall Study|Started Other Antitumor Therapy|2|||
143314458|NCT03296696|516698547|FG002|Overall Study|Started Other Antitumor Therapy|1|||
143314459|NCT03296696|516698548|FG003|Overall Study|Started Other Antitumor Therapy|2|||
143314460|NCT03296696|516698549|FG004|Overall Study|Started Other Antitumor Therapy|1|||
143314461|NCT03296696|516698550|FG005|Overall Study|Started Other Antitumor Therapy|1|||
143314462|NCT03296696|516698551|FG006|Overall Study|Started Other Antitumor Therapy|2|||
143314463|NCT03296696|516698552|FG007|Overall Study|Started Other Antitumor Therapy|3|||
143314464|NCT03296696|516698553|FG008|Overall Study|Started Other Antitumor Therapy|1|||
143314465|NCT03296696|516698554|FG009|Overall Study|Started Other Antitumor Therapy|0|||
143314466|NCT03296696|516698545|FG000|Overall Study|Death|0|||
143314467|NCT03296696|516698546|FG001|Overall Study|Death|1|||
143314468|NCT03296696|516698547|FG002|Overall Study|Death|1|||
143314469|NCT03296696|516698548|FG003|Overall Study|Death|2|||
143314470|NCT03296696|516698549|FG004|Overall Study|Death|2|||
143314471|NCT03296696|516698550|FG005|Overall Study|Death|3|||
143314472|NCT03296696|516698551|FG006|Overall Study|Death|1|||
143314473|NCT03296696|516698552|FG007|Overall Study|Death|2|||
143314474|NCT03296696|516698553|FG008|Overall Study|Death|0|||
143314475|NCT03296696|516698554|FG009|Overall Study|Death|0|||
143314476|NCT03296696|516698545|FG000|Overall Study|Withdrawal by Subject|0|||
143314477|NCT03296696|516698546|FG001|Overall Study|Withdrawal by Subject|0|||
143314478|NCT03296696|516698547|FG002|Overall Study|Withdrawal by Subject|1|||
143314479|NCT03296696|516698548|FG003|Overall Study|Withdrawal by Subject|0|||
143314480|NCT03296696|516698549|FG004|Overall Study|Withdrawal by Subject|1|||
143314481|NCT03296696|516698550|FG005|Overall Study|Withdrawal by Subject|0|||
143314482|NCT03296696|516698551|FG006|Overall Study|Withdrawal by Subject|0|||
143314483|NCT03296696|516698552|FG007|Overall Study|Withdrawal by Subject|0|||
143314484|NCT03296696|516698553|FG008|Overall Study|Withdrawal by Subject|0|||
143314485|NCT03296696|516698554|FG009|Overall Study|Withdrawal by Subject|1|||
143314486|NCT04694131|516698560|FG000|Overall Study|Withdrawal by Subject|7|||
143314487|NCT04694131|516698560|FG000|Overall Study|Screen Failure|1|||
143314488|NCT04694131|516698560|FG000|Overall Study|High stimulation threshold|3|||
143314489|NCT04456699|516698561|FG000|Overall Study|Death|48|||
143314490|NCT04456699|516698562|FG001|Overall Study|Death|50|||
143314491|NCT04456699|516698563|FG002|Overall Study|Death|52|||
143314492|NCT04456699|516698561|FG000|Overall Study|Physician Decision|0|||
143314493|NCT04456699|516698562|FG001|Overall Study|Physician Decision|0|||
143314494|NCT04456699|516698563|FG002|Overall Study|Physician Decision|2|||
143314495|NCT04456699|516698561|FG000|Overall Study|Sponsor Decision|55|||
143314496|NCT04456699|516698562|FG001|Overall Study|Sponsor Decision|61|||
143314497|NCT04456699|516698563|FG002|Overall Study|Sponsor Decision|50|||
143314498|NCT04456699|516698561|FG000|Overall Study|Withdrawal by Subject|8|||
143314499|NCT04456699|516698562|FG001|Overall Study|Withdrawal by Subject|4|||
143314500|NCT04456699|516698563|FG002|Overall Study|Withdrawal by Subject|5|||
143314501|NCT01859715|516698569|FG000|Overall Study|No 2nd VAS|16|||
143314502|NCT01859715|516698570|FG001|Overall Study|No 2nd VAS|8|||
143314503|NCT01859715|516698571|FG002|Overall Study|No 2nd VAS|23|||
143314504|NCT00086580|516698572|FG000|Treatment Period|Disease progression|9|||
143314505|NCT00086580|516698573|FG001|Treatment Period|Disease progression|8|||
143314506|NCT00086580|516698572|FG000|Treatment Period|Unable to comply with protocol|3|||
143314507|NCT00086580|516698573|FG001|Treatment Period|Unable to comply with protocol|1|||
143314508|NCT00086580|516698572|FG000|Treatment Period|Withdrawal by Subject|7|||
143314509|NCT00086580|516698573|FG001|Treatment Period|Withdrawal by Subject|8|||
143314510|NCT00086580|516698572|FG000|Treatment Period|Physician Decision|13|||
143314511|NCT00086580|516698573|FG001|Treatment Period|Physician Decision|7|||
143314512|NCT00086580|516698572|FG000|Treatment Period|AE - not treatment related|7|||
143314513|NCT00086580|516698573|FG001|Treatment Period|AE - not treatment related|7|||
143314514|NCT00086580|516698572|FG000|Treatment Period|Toxicity - treatment related|15|||
143314515|NCT00086580|516698573|FG001|Treatment Period|Toxicity - treatment related|15|||
143314516|NCT00086580|516698572|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
143314517|NCT00086580|516698573|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
143314518|NCT00086580|516698572|FG000|Treatment Period|Death|5|||
143314519|NCT00086580|516698573|FG001|Treatment Period|Death|7|||
143376661|NCT00457691|516923044|FG000|Overall Study|Study terminated by Sponsor|1|||
143376662|NCT00457691|516923045|FG001|Overall Study|Study terminated by Sponsor|1|||
143376663|NCT00457691|516923044|FG000|Overall Study|Subject refused (reason other than AE)|14|||
143376664|NCT00457691|516923045|FG001|Overall Study|Subject refused (reason other than AE)|19|||
143376665|NCT00457691|516923044|FG000|Overall Study|Disease progression, study terminated|180|||
143314520|NCT00086580|516698572|FG000|Treatment Period|Other|5|||
143314521|NCT00086580|516698573|FG001|Treatment Period|Other|3|||
143314522|NCT00086580|516698572|FG000|Follow-up Period|Disease progression|72|||
143314523|NCT00086580|516698573|FG001|Follow-up Period|Disease progression|99|||
143314524|NCT00086580|516698572|FG000|Follow-up Period|Unable to comply with protocol|5|||
143314525|NCT00086580|516698573|FG001|Follow-up Period|Unable to comply with protocol|0|||
143314526|NCT00086580|516698572|FG000|Follow-up Period|Withdrawal by Subject|6|||
143314527|NCT00086580|516698573|FG001|Follow-up Period|Withdrawal by Subject|6|||
143314528|NCT00086580|516698572|FG000|Follow-up Period|Physician Decision|0|||
143314529|NCT00086580|516698573|FG001|Follow-up Period|Physician Decision|1|||
143314530|NCT00086580|516698572|FG000|Follow-up Period|AE - not related|1|||
143314531|NCT00086580|516698573|FG001|Follow-up Period|AE - not related|0|||
143314532|NCT00086580|516698572|FG000|Follow-up Period|Death|13|||
143314533|NCT00086580|516698573|FG001|Follow-up Period|Death|7|||
143314534|NCT00086580|516698572|FG000|Follow-up Period|Other|7|||
143314535|NCT00086580|516698573|FG001|Follow-up Period|Other|6|||
143314536|NCT00086580|516698572|FG000|Observation Period|Unable to comply with protocol|1|||
143314537|NCT00086580|516698573|FG001|Observation Period|Unable to comply with protocol|1|||
143314538|NCT00086580|516698572|FG000|Observation Period|Withdrawal by Subject|4|||
143314539|NCT00086580|516698573|FG001|Observation Period|Withdrawal by Subject|2|||
143314540|NCT00086580|516698572|FG000|Observation Period|Death|33|||
143314541|NCT00086580|516698573|FG001|Observation Period|Death|55|||
143314542|NCT00086580|516698572|FG000|Observation Period|Other|8|||
143314543|NCT00086580|516698573|FG001|Observation Period|Other|7|||
143314544|NCT03235024|516698575|FG000|Overall Study|Adverse Event|2|||
143314545|NCT03235024|516698576|FG001|Overall Study|Adverse Event|2|||
143314546|NCT03235024|516698575|FG000|Overall Study|Death|1|||
143314547|NCT03235024|516698576|FG001|Overall Study|Death|0|||
143314548|NCT03235024|516698575|FG000|Overall Study|Lost to Follow-up|2|||
143314549|NCT03235024|516698576|FG001|Overall Study|Lost to Follow-up|5|||
143314550|NCT03235024|516698575|FG000|Overall Study|Protocol Violation|1|||
143314551|NCT03235024|516698576|FG001|Overall Study|Protocol Violation|0|||
143314552|NCT03235024|516698575|FG000|Overall Study|Withdrawal by Subject|0|||
143314553|NCT03235024|516698576|FG001|Overall Study|Withdrawal by Subject|3|||
143314554|NCT02357576|516698577|FG000|Treatment Period|Withdrawal by Subject|0|||
143314555|NCT02357576|516698578|FG001|Treatment Period|Withdrawal by Subject|1|||
143314556|NCT02357576|516698577|FG000|Treatment Period|Physician Decision|0|||
143314557|NCT02357576|516698578|FG001|Treatment Period|Physician Decision|1|||
143314558|NCT02357576|516698577|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
143314559|NCT02357576|516698578|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
143314560|NCT02357576|516698577|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
143314561|NCT02357576|516698578|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
143314562|NCT02357576|516698577|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
143314563|NCT02357576|516698578|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
143314564|NCT02357576|516698577|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
143314565|NCT02357576|516698578|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
143314566|NCT00699699|516698579|FG000|Overall Study|Adverse Event|36|||
143314567|NCT00699699|516698579|FG000|Overall Study|Individual different reasons|21|||
143314568|NCT00705575|516698580|FG000|Overall Study|Abnormal laboratory value(s)|0|||
143314569|NCT00705575|516698581|FG001|Overall Study|Abnormal laboratory value(s)|3|||
143314570|NCT00705575|516698580|FG000|Overall Study|Abnormal test procedure result(s)|2|||
143314571|NCT00705575|516698581|FG001|Overall Study|Abnormal test procedure result(s)|12|||
143314572|NCT00705575|516698580|FG000|Overall Study|Adverse Event|11|||
143376666|NCT00457691|516923045|FG001|Overall Study|Disease progression, study terminated|196|||
143376667|NCT03512756|516923046|FG000|Part 1|Death|23|||
143376668|NCT03512756|516923047|FG001|Part 1|Death|18|||
143376669|NCT03512756|516923048|FG002|Part 1|Death|0|||
143314573|NCT00705575|516698581|FG001|Overall Study|Adverse Event|15|||
143314574|NCT00705575|516698580|FG000|Overall Study|Lost to Follow-up|3|||
143314575|NCT00705575|516698581|FG001|Overall Study|Lost to Follow-up|4|||
143314576|NCT00705575|516698580|FG000|Overall Study|Protocol Violation|2|||
143314577|NCT00705575|516698581|FG001|Overall Study|Protocol Violation|2|||
143314578|NCT00705575|516698580|FG000|Overall Study|Withdrawal by Subject|5|||
143314579|NCT00705575|516698581|FG001|Overall Study|Withdrawal by Subject|10|||
143314580|NCT03773757|516698583|FG000|Overall Study|Withdrawal by Subject|2|||
143376670|NCT03512756|516923049|FG003|Part 1|Death|0|||
143376671|NCT03512756|516923046|FG000|Part 1|Lost to Follow-up|0|||
143376672|NCT03512756|516923047|FG001|Part 1|Lost to Follow-up|3|||
143376673|NCT03512756|516923048|FG002|Part 1|Lost to Follow-up|0|||
143376674|NCT03512756|516923049|FG003|Part 1|Lost to Follow-up|0|||
143376675|NCT03512756|516923046|FG000|Part 1|Physician Decision|0|||
143376676|NCT03512756|516923047|FG001|Part 1|Physician Decision|1|||
143314581|NCT03773757|516698584|FG001|Overall Study|Withdrawal by Subject|4|||
143314582|NCT02410811|516698585|FG000|Overall Study|Withdrawal by Subject|0|||
143314583|NCT02410811|516698586|FG001|Overall Study|Withdrawal by Subject|0|||
143314584|NCT02410811|516698587|FG002|Overall Study|Withdrawal by Subject|1|||
143314585|NCT02410811|516698588|FG003|Overall Study|Withdrawal by Subject|0|||
143314586|NCT00057746|516698589|FG000|Overall Study|Withdrawal by Subject|0|||
143314587|NCT00057746|516698590|FG001|Overall Study|Withdrawal by Subject|0|||
143314588|NCT00057746|516698591|FG002|Overall Study|Withdrawal by Subject|1|||
143314589|NCT01109316|516698592|FG000|Study Period 1|Adverse Event|0|||
143314590|NCT01109316|516698593|FG001|Study Period 1|Adverse Event|0|||
143314591|NCT01109316|516698594|FG002|Study Period 1|Adverse Event|1|||
143314592|NCT01109316|516698595|FG003|Study Period 1|Adverse Event|0|||
143314593|NCT01109316|516698596|FG004|Study Period 1|Adverse Event|0|||
143314594|NCT01109316|516698597|FG005|Study Period 1|Adverse Event|0|||
143314595|NCT01109316|516698592|FG000|Study Period 1|Lost to Follow-up|0|||
143314596|NCT01109316|516698593|FG001|Study Period 1|Lost to Follow-up|0|||
143314597|NCT01109316|516698594|FG002|Study Period 1|Lost to Follow-up|1|||
143314598|NCT01109316|516698595|FG003|Study Period 1|Lost to Follow-up|1|||
143314599|NCT01109316|516698596|FG004|Study Period 1|Lost to Follow-up|0|||
143314600|NCT01109316|516698597|FG005|Study Period 1|Lost to Follow-up|0|||
143314601|NCT01109316|516698592|FG000|Study Period 1|Withdrawal by Subject|0|||
143314602|NCT01109316|516698593|FG001|Study Period 1|Withdrawal by Subject|0|||
143314603|NCT01109316|516698594|FG002|Study Period 1|Withdrawal by Subject|1|||
143314604|NCT01109316|516698595|FG003|Study Period 1|Withdrawal by Subject|0|||
143314605|NCT01109316|516698596|FG004|Study Period 1|Withdrawal by Subject|2|||
143314606|NCT01109316|516698597|FG005|Study Period 1|Withdrawal by Subject|0|||
143314607|NCT01109316|516698592|FG000|Study Period 1|Sponsor Decision|0|||
143314608|NCT01109316|516698593|FG001|Study Period 1|Sponsor Decision|0|||
143314609|NCT01109316|516698594|FG002|Study Period 1|Sponsor Decision|0|||
143314610|NCT01109316|516698595|FG003|Study Period 1|Sponsor Decision|0|||
143314611|NCT01109316|516698596|FG004|Study Period 1|Sponsor Decision|0|||
143314612|NCT01109316|516698597|FG005|Study Period 1|Sponsor Decision|2|||
143314613|NCT01109316|516698592|FG000|Study Period 2|Entry Criteria Not Met|0|||
143314614|NCT01109316|516698593|FG001|Study Period 2|Entry Criteria Not Met|1|||
143314615|NCT01109316|516698594|FG002|Study Period 2|Entry Criteria Not Met|0|||
143376677|NCT03512756|516923048|FG002|Part 1|Physician Decision|0|||
143376678|NCT03512756|516923049|FG003|Part 1|Physician Decision|0|||
143376679|NCT03512756|516923046|FG000|Part 1|Withdrawal by Subject|2|||
143376680|NCT03512756|516923047|FG001|Part 1|Withdrawal by Subject|2|||
143376681|NCT03512756|516923048|FG002|Part 1|Withdrawal by Subject|0|||
143376682|NCT03512756|516923049|FG003|Part 1|Withdrawal by Subject|0|||
143376683|NCT03512756|516923046|FG000|Part 2|Death|0|||
143376684|NCT03512756|516923047|FG001|Part 2|Death|0|||
143376685|NCT03512756|516923048|FG002|Part 2|Death|32|||
143376686|NCT03512756|516923049|FG003|Part 2|Death|21|||
143376687|NCT03512756|516923046|FG000|Part 2|Lost to Follow-up|0|||
143376688|NCT03512756|516923047|FG001|Part 2|Lost to Follow-up|0|||
143376689|NCT03512756|516923048|FG002|Part 2|Lost to Follow-up|1|||
143376690|NCT03512756|516923049|FG003|Part 2|Lost to Follow-up|0|||
143376691|NCT03512756|516923046|FG000|Part 2|Physician Decision|0|||
143376692|NCT03512756|516923047|FG001|Part 2|Physician Decision|0|||
143376693|NCT03512756|516923048|FG002|Part 2|Physician Decision|2|||
143376694|NCT03512756|516923049|FG003|Part 2|Physician Decision|4|||
143376695|NCT03512756|516923046|FG000|Part 2|Study Terminated by Sponsor|0|||
143376696|NCT03512756|516923047|FG001|Part 2|Study Terminated by Sponsor|0|||
143376697|NCT03512756|516923048|FG002|Part 2|Study Terminated by Sponsor|2|||
143376698|NCT03512756|516923049|FG003|Part 2|Study Terminated by Sponsor|6|||
143376699|NCT03512756|516923046|FG000|Part 2|Protocol Violation|0|||
143376700|NCT03512756|516923047|FG001|Part 2|Protocol Violation|0|||
143376701|NCT03512756|516923048|FG002|Part 2|Protocol Violation|1|||
143376702|NCT03512756|516923049|FG003|Part 2|Protocol Violation|0|||
143376703|NCT03512756|516923046|FG000|Part 2|Withdrawal by Subject|0|||
143376704|NCT03512756|516923047|FG001|Part 2|Withdrawal by Subject|0|||
143376705|NCT03512756|516923048|FG002|Part 2|Withdrawal by Subject|3|||
143314616|NCT01109316|516698595|FG003|Study Period 2|Entry Criteria Not Met|0|||
143314617|NCT01109316|516698596|FG004|Study Period 2|Entry Criteria Not Met|0|||
143314618|NCT01109316|516698597|FG005|Study Period 2|Entry Criteria Not Met|0|||
143314619|NCT01109316|516698592|FG000|Study Period 2|Physician Decision|0|||
143314620|NCT01109316|516698593|FG001|Study Period 2|Physician Decision|0|||
143376706|NCT03512756|516923049|FG003|Part 2|Withdrawal by Subject|9|||
143376707|NCT05777785|516925159|FG000|Overall Study|Withdrawal by Subject|5|||
143314621|NCT01109316|516698594|FG002|Study Period 2|Physician Decision|0|||
143376708|NCT05777785|516925159|FG000|Overall Study|Lost to Follow-up|1|||
143376709|NCT05644444|516925164|FG000|Tolerance Phase|Adverse Event|0|||
143376710|NCT05644444|516925165|FG001|Tolerance Phase|Adverse Event|2|||
143376711|NCT05644444|516925164|FG000|Treatment Phase|Adverse Event|0|||
143376712|NCT05644444|516925165|FG001|Treatment Phase|Adverse Event|2|||
143376713|NCT04817670|516925166|FG000|Overall Study|Withdrawal by Subject|1|||
143376714|NCT04817670|516925167|FG001|Overall Study|Withdrawal by Subject|0|||
143376715|NCT04817670|516925168|FG002|Overall Study|Withdrawal by Subject|0|||
143376716|NCT04817670|516925169|FG003|Overall Study|Withdrawal by Subject|0|||
143376717|NCT04817670|516925170|FG004|Overall Study|Withdrawal by Subject|0|||
143376718|NCT04817670|516925166|FG000|Overall Study|Lost to Follow-up|0|||
143376719|NCT04817670|516925167|FG001|Overall Study|Lost to Follow-up|0|||
143376720|NCT04817670|516925168|FG002|Overall Study|Lost to Follow-up|1|||
143376721|NCT04817670|516925169|FG003|Overall Study|Lost to Follow-up|0|||
143376722|NCT04817670|516925170|FG004|Overall Study|Lost to Follow-up|0|||
143376723|NCT04250883|516925172|FG000|Overall Study|Lost to Follow-up|1|||
143376724|NCT04250883|516925173|FG001|Overall Study|Lost to Follow-up|0|||
143376725|NCT04588259|516925174|FG000|Run-in Period|Run-in failure|0|||
143376726|NCT04588259|516925175|FG001|Run-in Period|Run-in failure|23|||
143376727|NCT04588259|516925174|FG000|Run-in Period|Withdrawn before randomisation|0|||
143376728|NCT04588259|516925175|FG001|Run-in Period|Withdrawn before randomisation|8|||
143376729|NCT04588259|516925174|FG000|Treatment Period|Withdrawal by Subject|6|||
143376730|NCT04588259|516925175|FG001|Treatment Period|Withdrawal by Subject|6|||
143376731|NCT01188655|516925176|FG000|Overall Study|Lack of Efficacy|1|||
143376732|NCT01188655|516925176|FG000|Overall Study|Lost to Follow-up|1|||
143376733|NCT01188655|516925176|FG000|Overall Study|Other|11|||
143376734|NCT00925899|516925177|FG000|Part 1|Death|1|||
143376735|NCT00925899|516925178|FG001|Part 1|Death|2|||
143376736|NCT00925899|516925177|FG000|Part 1|Withdrawal by Subject|10|||
143376737|NCT00925899|516925178|FG001|Part 1|Withdrawal by Subject|9|||
143376738|NCT00683696|516925179|FG000|Overall Study|Withdrawn due to study closure|337|||
143376739|NCT00683696|516925180|FG001|Overall Study|Withdrawn due to study closure|338|||
143376740|NCT00683696|516925179|FG000|Overall Study|Withdrawn prior to study closure|13|||
143376741|NCT00683696|516925180|FG001|Overall Study|Withdrawn prior to study closure|28|||
143376742|NCT00683696|516925179|FG000|Overall Study|Lost to Follow-up|5|||
143376743|NCT00683696|516925180|FG001|Overall Study|Lost to Follow-up|6|||
143376744|NCT00683696|516925179|FG000|Overall Study|Vital status follow-up only|3|||
143376745|NCT00683696|516925180|FG001|Overall Study|Vital status follow-up only|3|||
143376746|NCT00683696|516925179|FG000|Overall Study|Death|46|||
143376747|NCT00683696|516925180|FG001|Overall Study|Death|30|||
143376748|NCT00089544|516925181|FG000|Overall Study|Ineligible|1|||
143376749|NCT00089544|516925182|FG001|Overall Study|Ineligible|0|||
143376750|NCT01823536|516925183|FG000|Overall Study|Lost to Follow-up|1|||
143376751|NCT01823536|516925184|FG001|Overall Study|Lost to Follow-up|0|||
143376752|NCT01823536|516925185|FG002|Overall Study|Lost to Follow-up|0|||
143376753|NCT01823536|516925186|FG003|Overall Study|Lost to Follow-up|1|||
143314622|NCT01109316|516698595|FG003|Study Period 2|Physician Decision|1|||
143314623|NCT01109316|516698596|FG004|Study Period 2|Physician Decision|0|||
143314624|NCT01109316|516698597|FG005|Study Period 2|Physician Decision|0|||
143314625|NCT01109316|516698592|FG000|Study Period 2|Protocol Violation|1|||
143314626|NCT01109316|516698593|FG001|Study Period 2|Protocol Violation|0|||
143314627|NCT01109316|516698594|FG002|Study Period 2|Protocol Violation|0|||
143314628|NCT01109316|516698595|FG003|Study Period 2|Protocol Violation|0|||
143314629|NCT01109316|516698596|FG004|Study Period 2|Protocol Violation|0|||
143314630|NCT01109316|516698597|FG005|Study Period 2|Protocol Violation|0|||
143314631|NCT01109316|516698592|FG000|Study Period 2|Withdrawal by Subject|0|||
143314632|NCT01109316|516698593|FG001|Study Period 2|Withdrawal by Subject|0|||
143314633|NCT01109316|516698594|FG002|Study Period 2|Withdrawal by Subject|1|||
143314634|NCT01109316|516698595|FG003|Study Period 2|Withdrawal by Subject|0|||
143314635|NCT01109316|516698596|FG004|Study Period 2|Withdrawal by Subject|0|||
143314636|NCT01109316|516698597|FG005|Study Period 2|Withdrawal by Subject|1|||
143314637|NCT01109316|516698592|FG000|Study Period 3|Lost to Follow-up|0|||
143314638|NCT01109316|516698593|FG001|Study Period 3|Lost to Follow-up|0|||
143314639|NCT01109316|516698594|FG002|Study Period 3|Lost to Follow-up|0|||
143314640|NCT01109316|516698595|FG003|Study Period 3|Lost to Follow-up|0|||
143314641|NCT01109316|516698596|FG004|Study Period 3|Lost to Follow-up|1|||
143314642|NCT01109316|516698597|FG005|Study Period 3|Lost to Follow-up|0|||
143376754|NCT01823536|516925187|FG004|Overall Study|Lost to Follow-up|1|||
143376755|NCT01823536|516925188|FG005|Overall Study|Lost to Follow-up|0|||
143376756|NCT01823536|516925183|FG000|Overall Study|Protocol Violation|0|||
143376757|NCT01823536|516925184|FG001|Overall Study|Protocol Violation|1|||
143376758|NCT01823536|516925185|FG002|Overall Study|Protocol Violation|0|||
143376759|NCT01823536|516925186|FG003|Overall Study|Protocol Violation|0|||
143376760|NCT01823536|516925187|FG004|Overall Study|Protocol Violation|0|||
143376761|NCT01823536|516925188|FG005|Overall Study|Protocol Violation|0|||
143314643|NCT01109316|516698592|FG000|Study Period 3|Withdrawal by Subject|1|||
143314644|NCT01109316|516698593|FG001|Study Period 3|Withdrawal by Subject|0|||
143376762|NCT01823536|516925183|FG000|Overall Study|Withdrawal by Subject|1|||
143376763|NCT01823536|516925184|FG001|Overall Study|Withdrawal by Subject|1|||
143376764|NCT01823536|516925185|FG002|Overall Study|Withdrawal by Subject|0|||
143314645|NCT01109316|516698594|FG002|Study Period 3|Withdrawal by Subject|0|||
143376765|NCT01823536|516925186|FG003|Overall Study|Withdrawal by Subject|0|||
143314646|NCT01109316|516698595|FG003|Study Period 3|Withdrawal by Subject|0|||
143314647|NCT01109316|516698596|FG004|Study Period 3|Withdrawal by Subject|1|||
143314648|NCT01109316|516698597|FG005|Study Period 3|Withdrawal by Subject|0|||
143314649|NCT03511560|516698605|FG000|Overall Study|Death|0|||
143314650|NCT03511560|516698606|FG001|Overall Study|Death|1|||
143314651|NCT03511560|516698605|FG000|Overall Study|Adverse Event|0|||
143314652|NCT03511560|516698606|FG001|Overall Study|Adverse Event|2|||
143314653|NCT03511560|516698605|FG000|Overall Study|Transplant cancelled|0|||
143314654|NCT03511560|516698606|FG001|Overall Study|Transplant cancelled|1|||
143314655|NCT03511560|516698605|FG000|Overall Study|Patient switched to another drug|1|||
143314656|NCT03511560|516698606|FG001|Overall Study|Patient switched to another drug|0|||
143314657|NCT00179413|516698611|FG000|Overall Study|Adverse Event|38|||
143314658|NCT00179413|516698612|FG001|Overall Study|Adverse Event|20|||
143314659|NCT00179413|516698611|FG000|Overall Study|Withdrawal by Subject|87|||
143314660|NCT00179413|516698612|FG001|Overall Study|Withdrawal by Subject|95|||
143314661|NCT00439140|516698613|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
143314662|NCT00439140|516698614|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
143314663|NCT00439140|516698615|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
143314664|NCT00439140|516698613|FG000|Treatment Cycle 1|Personal reasons|0|||
143314665|NCT00439140|516698614|FG001|Treatment Cycle 1|Personal reasons|2|||
143314666|NCT00439140|516698615|FG002|Treatment Cycle 1|Personal reasons|0|||
143314667|NCT00439140|516698613|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
143314668|NCT00439140|516698614|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
143314669|NCT00439140|516698615|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
143314670|NCT00439140|516698613|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
143314671|NCT00439140|516698614|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
143314672|NCT00439140|516698615|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
143314673|NCT00439140|516698613|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
143314674|NCT00439140|516698614|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
143314675|NCT00439140|516698615|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
143314676|NCT01192152|516698619|FG000|Period 1|left prematurely (while on treatment B)|0|||
143314677|NCT01192152|516698620|FG001|Period 1|left prematurely (while on treatment B)|1|||
143314678|NCT01192152|516698619|FG000|Period 3|family emergency|1|||
143314679|NCT01192152|516698620|FG001|Period 3|family emergency|0|||
143314680|NCT01559311|516698622|FG000|Overall Study|Protocol Violation|0|||
143314681|NCT01559311|516698623|FG001|Overall Study|Protocol Violation|0|||
143314682|NCT01559311|516698624|FG002|Overall Study|Protocol Violation|2|||
143314683|NCT01559311|516698622|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
143314684|NCT01559311|516698623|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
143314685|NCT01559311|516698624|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
143314686|NCT01559311|516698622|FG000|Overall Study|Withdrawal by Subject|2|||
143314687|NCT01559311|516698623|FG001|Overall Study|Withdrawal by Subject|1|||
143314688|NCT01559311|516698624|FG002|Overall Study|Withdrawal by Subject|0|||
143314689|NCT01559311|516698622|FG000|Overall Study|Death|0|||
143314690|NCT01559311|516698623|FG001|Overall Study|Death|2|||
143314691|NCT01559311|516698624|FG002|Overall Study|Death|3|||
143314692|NCT01559311|516698622|FG000|Overall Study|Lost to Follow-up|0|||
143314693|NCT01559311|516698623|FG001|Overall Study|Lost to Follow-up|3|||
143314694|NCT01559311|516698624|FG002|Overall Study|Lost to Follow-up|2|||
143314695|NCT01559311|516698622|FG000|Overall Study|Adverse Event|0|||
143314696|NCT01559311|516698623|FG001|Overall Study|Adverse Event|0|||
143314697|NCT01559311|516698624|FG002|Overall Study|Adverse Event|1|||
143314698|NCT05013905|516698625|FG000|Overall Study|Adverse Event|1|||
143314699|NCT05013905|516698625|FG000|Overall Study|Lack of Efficacy|1|||
143314700|NCT01849588|516698626|FG000|Overall Study|Lack of Efficacy|3|||
143314701|NCT01339390|516698629|FG000|Overall Study|Death|32|||
143314702|NCT01339390|516698630|FG001|Overall Study|Death|29|||
143314703|NCT01339390|516698629|FG000|Overall Study|Lost to Follow-up|125|||
143314704|NCT01339390|516698630|FG001|Overall Study|Lost to Follow-up|127|||
143314705|NCT01541930|516698635|FG000|Overall Study|Withdrawal by Subject|1|||
143314706|NCT01957475|516698636|FG000|Test Period 1|Withdrawal by Subject|1|||
143314707|NCT01957475|516698637|FG001|Test Period 1|Withdrawal by Subject|0|||
143314708|NCT01957475|516698636|FG000|Test Period 1|Other|1|||
143314709|NCT01957475|516698637|FG001|Test Period 1|Other|0|||
143314710|NCT01957475|516698636|FG000|Test Period 1|Lack of Efficacy|0|||
143314711|NCT01957475|516698637|FG001|Test Period 1|Lack of Efficacy|1|||
143314712|NCT01957475|516698636|FG000|Test Period 2|Adverse Event|1|||
143314713|NCT01957475|516698637|FG001|Test Period 2|Adverse Event|0|||
143314714|NCT01552772|516698638|FG000|Overall Study|Lost to Follow-up|2|||
143314715|NCT01552772|516698638|FG000|Overall Study|Adverse Event|1|||
143314716|NCT01552772|516698638|FG000|Overall Study|Protocol Deviation|1|||
143314717|NCT02920983|516698641|FG000|Dispense 1|Unacceptable Lens Fit|0|||
143314718|NCT02920983|516698642|FG001|Dispense 1|Unacceptable Lens Fit|0|||
143314719|NCT02920983|516698643|FG002|Dispense 1|Unacceptable Lens Fit|0|||
143314720|NCT02920983|516698644|FG003|Dispense 1|Unacceptable Lens Fit|0|||
143314721|NCT02920983|516698645|FG004|Dispense 1|Unacceptable Lens Fit|1|||
143314722|NCT02920983|516698646|FG005|Dispense 1|Unacceptable Lens Fit|0|||
143314723|NCT02920983|516698641|FG000|Dispense 2|Unscceptable lens fit|1|||
143314724|NCT02920983|516698642|FG001|Dispense 2|Unscceptable lens fit|0|||
143314725|NCT02920983|516698643|FG002|Dispense 2|Unscceptable lens fit|0|||
143314726|NCT02920983|516698644|FG003|Dispense 2|Unscceptable lens fit|0|||
143314727|NCT02920983|516698645|FG004|Dispense 2|Unscceptable lens fit|1|||
143314728|NCT02920983|516698646|FG005|Dispense 2|Unscceptable lens fit|0|||
143314729|NCT02920983|516698641|FG000|Dispense 3|Unacceptable Lens Fit|1|||
143314730|NCT02920983|516698642|FG001|Dispense 3|Unacceptable Lens Fit|1|||
143314731|NCT02920983|516698643|FG002|Dispense 3|Unacceptable Lens Fit|0|||
143314732|NCT02920983|516698644|FG003|Dispense 3|Unacceptable Lens Fit|0|||
143314733|NCT02920983|516698645|FG004|Dispense 3|Unacceptable Lens Fit|1|||
143314734|NCT02920983|516698646|FG005|Dispense 3|Unacceptable Lens Fit|0|||
143314735|NCT04497987|516698647|FG000|Overall Study|Adverse Event|1|||
143314736|NCT04497987|516698648|FG001|Overall Study|Adverse Event|0|||
143314737|NCT04497987|516698647|FG000|Overall Study|Death|21|||
143314738|NCT04497987|516698648|FG001|Overall Study|Death|13|||
143314739|NCT04497987|516698647|FG000|Overall Study|Lost to Follow-up|19|||
143314740|NCT04497987|516698648|FG001|Overall Study|Lost to Follow-up|17|||
143314741|NCT04497987|516698647|FG000|Overall Study|Other - as reported by the investigator|22|||
143314742|NCT04497987|516698648|FG001|Overall Study|Other - as reported by the investigator|16|||
143314743|NCT04497987|516698647|FG000|Overall Study|Physician Decision|1|||
143314744|NCT04497987|516698648|FG001|Overall Study|Physician Decision|0|||
143314745|NCT04497987|516698647|FG000|Overall Study|Withdrawal by Subject|35|||
143314746|NCT04497987|516698648|FG001|Overall Study|Withdrawal by Subject|21|||
143314747|NCT00646958|516700042|FG000|Overall Study|Lack of Efficacy|1|||
143314748|NCT00646958|516700043|FG001|Overall Study|Lack of Efficacy|0|||
143314749|NCT00646958|516700044|FG002|Overall Study|Lack of Efficacy|0|||
143314750|NCT00646958|516700042|FG000|Overall Study|Adverse Event|4|||
143314751|NCT00646958|516700043|FG001|Overall Study|Adverse Event|0|||
143314752|NCT00646958|516700044|FG002|Overall Study|Adverse Event|0|||
143314753|NCT00646958|516700042|FG000|Overall Study|Lost to Follow-up|1|||
143314754|NCT00646958|516700043|FG001|Overall Study|Lost to Follow-up|5|||
143314755|NCT00646958|516700044|FG002|Overall Study|Lost to Follow-up|7|||
143314756|NCT00646958|516700042|FG000|Overall Study|Protocol Violation|1|||
143314757|NCT00646958|516700043|FG001|Overall Study|Protocol Violation|1|||
143314758|NCT00646958|516700044|FG002|Overall Study|Protocol Violation|0|||
143314759|NCT00646958|516700042|FG000|Overall Study|Abnormal screening lab tests|1|||
143314760|NCT00646958|516700043|FG001|Overall Study|Abnormal screening lab tests|1|||
143314761|NCT00646958|516700044|FG002|Overall Study|Abnormal screening lab tests|0|||
143314762|NCT00646958|516700042|FG000|Overall Study|Withdrawal by Subject|1|||
143314763|NCT00646958|516700043|FG001|Overall Study|Withdrawal by Subject|2|||
143314764|NCT00646958|516700044|FG002|Overall Study|Withdrawal by Subject|0|||
143314765|NCT00646958|516700042|FG000|Overall Study|Did not receive study drug|2|||
143376766|NCT01823536|516925187|FG004|Overall Study|Withdrawal by Subject|0|||
143376767|NCT01823536|516925188|FG005|Overall Study|Withdrawal by Subject|0|||
143376768|NCT01823536|516925183|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
143376769|NCT01823536|516925184|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
143376770|NCT01823536|516925185|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
143376771|NCT01823536|516925186|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
143376772|NCT01823536|516925187|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
143376773|NCT01823536|516925188|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
143376774|NCT01823536|516925183|FG000|Overall Study|Met exclusion criterion No 6|0|||
143376775|NCT01823536|516925184|FG001|Overall Study|Met exclusion criterion No 6|0|||
143376776|NCT01823536|516925185|FG002|Overall Study|Met exclusion criterion No 6|0|||
143376777|NCT01823536|516925186|FG003|Overall Study|Met exclusion criterion No 6|1|||
143376778|NCT01823536|516925187|FG004|Overall Study|Met exclusion criterion No 6|0|||
143376779|NCT01823536|516925188|FG005|Overall Study|Met exclusion criterion No 6|0|||
143376780|NCT01823536|516925183|FG000|Overall Study|Subject moved out of the state|0|||
143376781|NCT01823536|516925184|FG001|Overall Study|Subject moved out of the state|0|||
143376782|NCT01823536|516925185|FG002|Overall Study|Subject moved out of the state|0|||
143376783|NCT01823536|516925186|FG003|Overall Study|Subject moved out of the state|0|||
143376784|NCT01823536|516925187|FG004|Overall Study|Subject moved out of the state|1|||
143376785|NCT01823536|516925188|FG005|Overall Study|Subject moved out of the state|0|||
143376786|NCT03648762|516925189|FG000|Overall Study|Lost to Follow-up|1|||
143376787|NCT03648762|516925190|FG001|Overall Study|Lost to Follow-up|2|||
143376788|NCT03648762|516925191|FG002|Overall Study|Lost to Follow-up|0|||
143376789|NCT03648762|516925189|FG000|Overall Study|Withdrawal by Subject|5|||
143314766|NCT00646958|516700043|FG001|Overall Study|Did not receive study drug|0|||
143314767|NCT00646958|516700044|FG002|Overall Study|Did not receive study drug|2|||
143314768|NCT00194012|516700045|FG000|Randomized Phase|Lack of Efficacy|8|||
143314769|NCT00194012|516700046|FG001|Randomized Phase|Lack of Efficacy|18|||
143314770|NCT00194012|516700045|FG000|Randomized Phase|Study nonadherence|2|||
143314771|NCT00194012|516700046|FG001|Randomized Phase|Study nonadherence|1|||
143314772|NCT00194012|516700045|FG000|Randomized Phase|Withdrawal by Subject|3|||
143314773|NCT00194012|516700046|FG001|Randomized Phase|Withdrawal by Subject|3|||
143314774|NCT00194012|516700045|FG000|Randomized Phase|Adverse Event|2|||
143314775|NCT00194012|516700046|FG001|Randomized Phase|Adverse Event|1|||
143314776|NCT00194012|516700045|FG000|Randomized Phase|Participant reported having a rash|1|||
143314777|NCT00194012|516700046|FG001|Randomized Phase|Participant reported having a rash|0|||
143314778|NCT00194012|516700045|FG000|Randomized Phase|Emesis and enuresis|0|||
143314779|NCT00194012|516700046|FG001|Randomized Phase|Emesis and enuresis|1|||
143314780|NCT00194012|516700045|FG000|Randomized Phase|Oral/nasal twitching|0|||
143314781|NCT00194012|516700046|FG001|Randomized Phase|Oral/nasal twitching|1|||
143314782|NCT00194012|516700045|FG000|Open Label Extension (OLE)|Weight Gain|1|||
143314783|NCT00194012|516700046|FG001|Open Label Extension (OLE)|Weight Gain|0|||
143314784|NCT00194012|516700045|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
143314785|NCT00194012|516700046|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
143314786|NCT00194012|516700045|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
143314787|NCT00194012|516700046|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
143314788|NCT00194012|516700045|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
143314789|NCT00194012|516700046|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
143314790|NCT02200042|516700053|FG000|Overall Study|Withdrawal by Subject|0|||
143314791|NCT02200042|516700054|FG001|Overall Study|Withdrawal by Subject|1|||
143314792|NCT01969838|516700055|FG000|Double-blind Phase|Adverse Event|10|||
143314793|NCT01969838|516700056|FG001|Double-blind Phase|Adverse Event|4|||
143314794|NCT01969838|516700057|FG002|Double-blind Phase|Adverse Event|0|||
143314795|NCT01969838|516700058|FG003|Double-blind Phase|Adverse Event|0|||
143314796|NCT01969838|516700055|FG000|Double-blind Phase|Death|5|||
143314797|NCT01969838|516700056|FG001|Double-blind Phase|Death|2|||
143314798|NCT01969838|516700057|FG002|Double-blind Phase|Death|0|||
143314799|NCT01969838|516700058|FG003|Double-blind Phase|Death|0|||
143314800|NCT01969838|516700055|FG000|Double-blind Phase|Physician Decision|5|||
143314801|NCT01969838|516700056|FG001|Double-blind Phase|Physician Decision|1|||
143314802|NCT01969838|516700057|FG002|Double-blind Phase|Physician Decision|0|||
143314803|NCT01969838|516700058|FG003|Double-blind Phase|Physician Decision|0|||
143314804|NCT01969838|516700055|FG000|Double-blind Phase|Subject Decision|4|||
143314805|NCT01969838|516700056|FG001|Double-blind Phase|Subject Decision|2|||
143314806|NCT01969838|516700057|FG002|Double-blind Phase|Subject Decision|0|||
143314807|NCT01969838|516700058|FG003|Double-blind Phase|Subject Decision|0|||
143314808|NCT01969838|516700055|FG000|Double-blind Phase|Disease Progression|2|||
143314809|NCT01969838|516700056|FG001|Double-blind Phase|Disease Progression|0|||
143314810|NCT01969838|516700057|FG002|Double-blind Phase|Disease Progression|0|||
143314811|NCT01969838|516700058|FG003|Double-blind Phase|Disease Progression|0|||
143314812|NCT01969838|516700055|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
143314813|NCT01969838|516700056|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
143314814|NCT01969838|516700057|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
143314815|NCT01969838|516700058|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
143314816|NCT01969838|516700055|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
143314817|NCT01969838|516700056|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
143314818|NCT01969838|516700057|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
143314819|NCT01969838|516700058|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
143314820|NCT01969838|516700055|FG000|Open-label Phase|Adverse Event|0|||
143314821|NCT01969838|516700056|FG001|Open-label Phase|Adverse Event|0|||
143314822|NCT01969838|516700057|FG002|Open-label Phase|Adverse Event|37|||
143314823|NCT01969838|516700058|FG003|Open-label Phase|Adverse Event|49|||
143314824|NCT01969838|516700055|FG000|Open-label Phase|Disease Progression|0|||
143314825|NCT01969838|516700056|FG001|Open-label Phase|Disease Progression|0|||
143314826|NCT01969838|516700057|FG002|Open-label Phase|Disease Progression|26|||
143314827|NCT01969838|516700058|FG003|Open-label Phase|Disease Progression|27|||
143314828|NCT01969838|516700055|FG000|Open-label Phase|Lack of Efficacy|0|||
143314829|NCT01969838|516700056|FG001|Open-label Phase|Lack of Efficacy|0|||
143314830|NCT01969838|516700057|FG002|Open-label Phase|Lack of Efficacy|17|||
143314831|NCT01969838|516700058|FG003|Open-label Phase|Lack of Efficacy|19|||
143314832|NCT01969838|516700055|FG000|Open-label Phase|Subject Decision|0|||
143314833|NCT01969838|516700056|FG001|Open-label Phase|Subject Decision|0|||
143314834|NCT01969838|516700057|FG002|Open-label Phase|Subject Decision|14|||
143314835|NCT01969838|516700058|FG003|Open-label Phase|Subject Decision|15|||
143314836|NCT01969838|516700055|FG000|Open-label Phase|Death|0|||
143314837|NCT01969838|516700056|FG001|Open-label Phase|Death|0|||
143314838|NCT01969838|516700057|FG002|Open-label Phase|Death|13|||
143314839|NCT01969838|516700058|FG003|Open-label Phase|Death|11|||
143314840|NCT01969838|516700055|FG000|Open-label Phase|Physician Decision|0|||
143314841|NCT01969838|516700056|FG001|Open-label Phase|Physician Decision|0|||
143314842|NCT01969838|516700057|FG002|Open-label Phase|Physician Decision|9|||
143314843|NCT01969838|516700058|FG003|Open-label Phase|Physician Decision|14|||
143314844|NCT01969838|516700055|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
143314845|NCT01969838|516700056|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
143314846|NCT01969838|516700057|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
143314847|NCT01969838|516700058|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
143314848|NCT00408993|516700059|FG000|Overall Study|Adverse Event|15|||
143314849|NCT00408993|516700060|FG001|Overall Study|Adverse Event|4|||
143314850|NCT00408993|516700059|FG000|Overall Study|Protocol Violation|1|||
143314851|NCT00408993|516700060|FG001|Overall Study|Protocol Violation|6|||
143314852|NCT00408993|516700059|FG000|Overall Study|Lack of Efficacy|1|||
143314853|NCT00408993|516700060|FG001|Overall Study|Lack of Efficacy|4|||
143314854|NCT00408993|516700059|FG000|Overall Study|Withdrawal by Subject|2|||
143314855|NCT00408993|516700060|FG001|Overall Study|Withdrawal by Subject|3|||
143314856|NCT03738865|516700061|FG000|Overall Study|Withdrawal by Subject|3|||
143314857|NCT03738865|516700062|FG001|Overall Study|Withdrawal by Subject|3|||
143314858|NCT03738865|516700061|FG000|Overall Study|Adverse Event|2|||
143314859|NCT03738865|516700062|FG001|Overall Study|Adverse Event|0|||
143314860|NCT03738865|516700061|FG000|Overall Study|Physician Decision|0|||
143314861|NCT03738865|516700062|FG001|Overall Study|Physician Decision|1|||
143314862|NCT00298896|516700063|FG000|Overall Study|Death|3|||
143314863|NCT00298896|516700063|FG000|Overall Study|Physician Decision|2|||
143314864|NCT00298896|516700063|FG000|Overall Study|Intercurrent Illness|1|||
143314865|NCT00298896|516700063|FG000|Overall Study|Disease Progression|41|||
143314866|NCT00298896|516700063|FG000|Overall Study|Withdrawal by Subject|2|||
143314867|NCT00298896|516700063|FG000|Overall Study|Assigned to treatment in error|1|||
143314868|NCT02880371|516700064|FG000|Phase 1b|Lost to Follow-up|1|||
143314869|NCT02880371|516700065|FG001|Phase 1b|Lost to Follow-up|0|||
143314870|NCT02880371|516700066|FG002|Phase 1b|Lost to Follow-up|0|||
143314871|NCT02880371|516700067|FG003|Phase 1b|Lost to Follow-up|0|||
143314872|NCT02880371|516700068|FG004|Phase 1b|Lost to Follow-up|0|||
143314873|NCT02880371|516700069|FG005|Phase 1b|Lost to Follow-up|0|||
143314874|NCT02880371|516700070|FG006|Phase 1b|Lost to Follow-up|0|||
143314875|NCT02880371|516700071|FG007|Phase 1b|Lost to Follow-up|0|||
143314876|NCT02880371|516700064|FG000|Phase 1b|Participants terminated by Sponsor|1|||
143314877|NCT02880371|516700065|FG001|Phase 1b|Participants terminated by Sponsor|0|||
143314878|NCT02880371|516700066|FG002|Phase 1b|Participants terminated by Sponsor|0|||
143314879|NCT02880371|516700067|FG003|Phase 1b|Participants terminated by Sponsor|0|||
143314880|NCT02880371|516700068|FG004|Phase 1b|Participants terminated by Sponsor|0|||
143314881|NCT02880371|516700069|FG005|Phase 1b|Participants terminated by Sponsor|0|||
143314882|NCT02880371|516700070|FG006|Phase 1b|Participants terminated by Sponsor|0|||
143314883|NCT02880371|516700071|FG007|Phase 1b|Participants terminated by Sponsor|0|||
143314884|NCT02880371|516700064|FG000|Phase 1b|Withdrawal by Subject|0|||
143314885|NCT02880371|516700065|FG001|Phase 1b|Withdrawal by Subject|0|||
143314886|NCT02880371|516700066|FG002|Phase 1b|Withdrawal by Subject|1|||
143314887|NCT02880371|516700067|FG003|Phase 1b|Withdrawal by Subject|0|||
143314888|NCT02880371|516700068|FG004|Phase 1b|Withdrawal by Subject|0|||
143314889|NCT02880371|516700069|FG005|Phase 1b|Withdrawal by Subject|0|||
143314890|NCT02880371|516700070|FG006|Phase 1b|Withdrawal by Subject|0|||
143314891|NCT02880371|516700071|FG007|Phase 1b|Withdrawal by Subject|0|||
143314892|NCT02880371|516700064|FG000|Phase 1b|Death|4|||
143314893|NCT02880371|516700065|FG001|Phase 1b|Death|6|||
143314894|NCT02880371|516700066|FG002|Phase 1b|Death|5|||
143314895|NCT02880371|516700067|FG003|Phase 1b|Death|1|||
143314896|NCT02880371|516700068|FG004|Phase 1b|Death|0|||
143314897|NCT02880371|516700069|FG005|Phase 1b|Death|0|||
143314898|NCT02880371|516700070|FG006|Phase 1b|Death|0|||
143314899|NCT02880371|516700071|FG007|Phase 1b|Death|0|||
143314900|NCT02880371|516700064|FG000|Phase 1b|Enrolled but not Treated|0|||
143314901|NCT02880371|516700065|FG001|Phase 1b|Enrolled but not Treated|1|||
143314902|NCT02880371|516700066|FG002|Phase 1b|Enrolled but not Treated|0|||
143314903|NCT02880371|516700067|FG003|Phase 1b|Enrolled but not Treated|0|||
143314904|NCT02880371|516700068|FG004|Phase 1b|Enrolled but not Treated|0|||
143314905|NCT02880371|516700069|FG005|Phase 1b|Enrolled but not Treated|0|||
143314906|NCT02880371|516700070|FG006|Phase 1b|Enrolled but not Treated|0|||
143314907|NCT02880371|516700071|FG007|Phase 1b|Enrolled but not Treated|0|||
143314908|NCT02880371|516700064|FG000|Phase 2|Enrolled but not Treated|0|||
143314909|NCT02880371|516700065|FG001|Phase 2|Enrolled but not Treated|0|||
143314910|NCT02880371|516700066|FG002|Phase 2|Enrolled but not Treated|0|||
143314911|NCT02880371|516700067|FG003|Phase 2|Enrolled but not Treated|0|||
143314912|NCT02880371|516700068|FG004|Phase 2|Enrolled but not Treated|0|||
143314913|NCT02880371|516700069|FG005|Phase 2|Enrolled but not Treated|1|||
143376790|NCT03648762|516925190|FG001|Overall Study|Withdrawal by Subject|2|||
143314914|NCT02880371|516700070|FG006|Phase 2|Enrolled but not Treated|1|||
143314915|NCT02880371|516700071|FG007|Phase 2|Enrolled but not Treated|0|||
143314916|NCT02880371|516700064|FG000|Phase 2|Other|0|||
143314917|NCT02880371|516700065|FG001|Phase 2|Other|0|||
143314918|NCT02880371|516700066|FG002|Phase 2|Other|0|||
143314919|NCT02880371|516700067|FG003|Phase 2|Other|0|||
143314920|NCT02880371|516700068|FG004|Phase 2|Other|0|||
143314921|NCT02880371|516700069|FG005|Phase 2|Other|1|||
143314922|NCT02880371|516700070|FG006|Phase 2|Other|2|||
143314923|NCT02880371|516700071|FG007|Phase 2|Other|1|||
143314924|NCT02880371|516700064|FG000|Phase 2|Participants terminated by Sponsor|0|||
143314925|NCT02880371|516700065|FG001|Phase 2|Participants terminated by Sponsor|0|||
143314926|NCT02880371|516700066|FG002|Phase 2|Participants terminated by Sponsor|0|||
143314927|NCT02880371|516700067|FG003|Phase 2|Participants terminated by Sponsor|0|||
143314928|NCT02880371|516700068|FG004|Phase 2|Participants terminated by Sponsor|1|||
143314929|NCT02880371|516700069|FG005|Phase 2|Participants terminated by Sponsor|6|||
143314930|NCT02880371|516700070|FG006|Phase 2|Participants terminated by Sponsor|1|||
143314931|NCT02880371|516700071|FG007|Phase 2|Participants terminated by Sponsor|5|||
143314932|NCT02880371|516700064|FG000|Phase 2|Death|0|||
143314933|NCT02880371|516700065|FG001|Phase 2|Death|0|||
143314934|NCT02880371|516700066|FG002|Phase 2|Death|0|||
143314935|NCT02880371|516700067|FG003|Phase 2|Death|0|||
143314936|NCT02880371|516700068|FG004|Phase 2|Death|1|||
143314937|NCT02880371|516700069|FG005|Phase 2|Death|10|||
143314938|NCT02880371|516700070|FG006|Phase 2|Death|20|||
143314939|NCT02880371|516700071|FG007|Phase 2|Death|5|||
143314940|NCT02880371|516700064|FG000|Phase 2|Lost to Follow-up|0|||
143314941|NCT02880371|516700065|FG001|Phase 2|Lost to Follow-up|0|||
143314942|NCT02880371|516700066|FG002|Phase 2|Lost to Follow-up|0|||
143314943|NCT02880371|516700067|FG003|Phase 2|Lost to Follow-up|0|||
143314944|NCT02880371|516700068|FG004|Phase 2|Lost to Follow-up|0|||
143314945|NCT02880371|516700069|FG005|Phase 2|Lost to Follow-up|0|||
143314946|NCT02880371|516700070|FG006|Phase 2|Lost to Follow-up|3|||
143314947|NCT02880371|516700071|FG007|Phase 2|Lost to Follow-up|0|||
143314948|NCT02880371|516700064|FG000|Phase 2|Withdrawal by Subject|0|||
143314949|NCT02880371|516700065|FG001|Phase 2|Withdrawal by Subject|0|||
143314950|NCT02880371|516700066|FG002|Phase 2|Withdrawal by Subject|0|||
143314951|NCT02880371|516700067|FG003|Phase 2|Withdrawal by Subject|0|||
143314952|NCT02880371|516700068|FG004|Phase 2|Withdrawal by Subject|0|||
143314953|NCT02880371|516700069|FG005|Phase 2|Withdrawal by Subject|1|||
143314954|NCT02880371|516700070|FG006|Phase 2|Withdrawal by Subject|1|||
143314955|NCT02880371|516700071|FG007|Phase 2|Withdrawal by Subject|0|||
143314956|NCT02880371|516700064|FG000|Phase 2|End of Study page not completed by error|0|||
143314957|NCT02880371|516700065|FG001|Phase 2|End of Study page not completed by error|0|||
143314958|NCT02880371|516700066|FG002|Phase 2|End of Study page not completed by error|0|||
143314959|NCT02880371|516700067|FG003|Phase 2|End of Study page not completed by error|0|||
143314960|NCT02880371|516700068|FG004|Phase 2|End of Study page not completed by error|0|||
143314961|NCT02880371|516700069|FG005|Phase 2|End of Study page not completed by error|1|||
143314962|NCT02880371|516700070|FG006|Phase 2|End of Study page not completed by error|0|||
143314963|NCT02880371|516700071|FG007|Phase 2|End of Study page not completed by error|0|||
143314964|NCT00451282|516700075|FG000|Overall Study|Lost to Follow-up|6|||
143314965|NCT00451282|516700076|FG001|Overall Study|Lost to Follow-up|5|||
143314966|NCT03348904|516700078|FG000|Overall Study|Administrative reason by the sponsor|0|||
143314967|NCT03348904|516700079|FG001|Overall Study|Administrative reason by the sponsor|1|||
143314968|NCT03348904|516700080|FG002|Overall Study|Administrative reason by the sponsor|0|||
143314969|NCT01743092|516700082|FG000|Overall Study|Lost to Follow-up|14|||
143314970|NCT01743092|516700083|FG001|Overall Study|Lost to Follow-up|15|||
143314971|NCT00087568|516700084|FG000|Overall Study|Adverse Event|4|||
143314972|NCT00087568|516700085|FG001|Overall Study|Adverse Event|0|||
143314973|NCT00087568|516700084|FG000|Overall Study|Withdrawal by Subject|1|||
143314974|NCT00087568|516700085|FG001|Overall Study|Withdrawal by Subject|1|||
143314975|NCT00087568|516700084|FG000|Overall Study|Lost to Follow-up|1|||
143314976|NCT00087568|516700085|FG001|Overall Study|Lost to Follow-up|0|||
143314977|NCT00087568|516700084|FG000|Overall Study|Lack of Efficacy|24|||
143314978|NCT00087568|516700085|FG001|Overall Study|Lack of Efficacy|1|||
143314979|NCT02370888|516700090|FG000|Overall Study|disease progression|2|||
143314980|NCT02370888|516700090|FG000|Overall Study|did not meet chimerism criteria|6|||
143314981|NCT01332305|516700091|FG000|Overall Study|Adverse Event|1|||
143314982|NCT01332305|516700092|FG001|Overall Study|Adverse Event|4|||
143314983|NCT01332305|516700093|FG002|Overall Study|Adverse Event|6|||
143314984|NCT01332305|516700094|FG003|Overall Study|Adverse Event|3|||
143314985|NCT01332305|516700095|FG004|Overall Study|Adverse Event|5|||
143314986|NCT01332305|516700091|FG000|Overall Study|Withdrawal by Subject|6|||
143314987|NCT01332305|516700092|FG001|Overall Study|Withdrawal by Subject|5|||
143314988|NCT01332305|516700093|FG002|Overall Study|Withdrawal by Subject|4|||
143314989|NCT01332305|516700094|FG003|Overall Study|Withdrawal by Subject|1|||
143314990|NCT01332305|516700095|FG004|Overall Study|Withdrawal by Subject|0|||
143314991|NCT01332305|516700091|FG000|Overall Study|Lost to Follow-up|0|||
143314992|NCT01332305|516700092|FG001|Overall Study|Lost to Follow-up|2|||
143314993|NCT01332305|516700093|FG002|Overall Study|Lost to Follow-up|3|||
143314994|NCT01332305|516700094|FG003|Overall Study|Lost to Follow-up|2|||
143314995|NCT01332305|516700095|FG004|Overall Study|Lost to Follow-up|3|||
143314996|NCT01332305|516700091|FG000|Overall Study|Protocol Violation|1|||
143314997|NCT01332305|516700092|FG001|Overall Study|Protocol Violation|2|||
143376791|NCT03648762|516925191|FG002|Overall Study|Withdrawal by Subject|1|||
143314998|NCT01332305|516700093|FG002|Overall Study|Protocol Violation|1|||
143314999|NCT01332305|516700094|FG003|Overall Study|Protocol Violation|0|||
143315000|NCT01332305|516700095|FG004|Overall Study|Protocol Violation|3|||
143315001|NCT01332305|516700091|FG000|Overall Study|Withdrawal by Sponsor|1|||
143315002|NCT01332305|516700092|FG001|Overall Study|Withdrawal by Sponsor|0|||
143315003|NCT01332305|516700093|FG002|Overall Study|Withdrawal by Sponsor|0|||
143315004|NCT01332305|516700094|FG003|Overall Study|Withdrawal by Sponsor|1|||
143315005|NCT01332305|516700095|FG004|Overall Study|Withdrawal by Sponsor|1|||
143315006|NCT01332305|516700091|FG000|Overall Study|Treatment Failure|1|||
143315007|NCT01332305|516700092|FG001|Overall Study|Treatment Failure|1|||
143315008|NCT01332305|516700093|FG002|Overall Study|Treatment Failure|0|||
143315009|NCT01332305|516700094|FG003|Overall Study|Treatment Failure|0|||
143315010|NCT01332305|516700095|FG004|Overall Study|Treatment Failure|0|||
143315011|NCT01332305|516700091|FG000|Overall Study|Physician Decision|0|||
143315012|NCT01332305|516700092|FG001|Overall Study|Physician Decision|0|||
143315013|NCT01332305|516700093|FG002|Overall Study|Physician Decision|0|||
143315014|NCT01332305|516700094|FG003|Overall Study|Physician Decision|1|||
143315015|NCT01332305|516700095|FG004|Overall Study|Physician Decision|0|||
143315016|NCT01263873|516700096|FG000|Overall Study|One provider unable to complete numbers|1|||
143315017|NCT01263873|516700097|FG001|Overall Study|One provider unable to complete numbers|1|||
143315018|NCT00779766|516700098|FG000|Month 24|Serious Adverse Event|2|||
143315019|NCT00779766|516700099|FG001|Month 24|Serious Adverse Event|3|||
143315020|NCT00779766|516700098|FG000|Month 24|Adverse Event|3|||
143315021|NCT00779766|516700099|FG001|Month 24|Adverse Event|3|||
143315022|NCT00779766|516700098|FG000|Month 24|Protocol Violation|3|||
143315023|NCT00779766|516700099|FG001|Month 24|Protocol Violation|1|||
143315024|NCT00779766|516700098|FG000|Month 24|Withdrawal by Subject|159|||
143315025|NCT00779766|516700099|FG001|Month 24|Withdrawal by Subject|127|||
143315026|NCT00779766|516700098|FG000|Month 24|Migrated/moved from study area|138|||
143315027|NCT00779766|516700099|FG001|Month 24|Migrated/moved from study area|162|||
143315028|NCT00779766|516700098|FG000|Month 24|Lost to Follow-up|9|||
143315029|NCT00779766|516700099|FG001|Month 24|Lost to Follow-up|9|||
143315030|NCT00779766|516700098|FG000|Month 24|Other|18|||
143315031|NCT00779766|516700099|FG001|Month 24|Other|27|||
143315032|NCT00779766|516700098|FG000|Month 48|Withdrawal by Subject|68|||
143315033|NCT00779766|516700099|FG001|Month 48|Withdrawal by Subject|63|||
143315034|NCT00779766|516700098|FG000|Month 48|Migrated/moved from study area|76|||
143315035|NCT00779766|516700099|FG001|Month 48|Migrated/moved from study area|75|||
143315036|NCT00779766|516700098|FG000|Month 48|Lost to Follow-up|29|||
143315037|NCT00779766|516700099|FG001|Month 48|Lost to Follow-up|30|||
143315038|NCT00779766|516700098|FG000|Month 48|Other|1|||
143315039|NCT00779766|516700099|FG001|Month 48|Other|0|||
143315040|NCT00779766|516700098|FG000|Month 72|Withdrawal by Subject|55|||
143315041|NCT00779766|516700099|FG001|Month 72|Withdrawal by Subject|71|||
143315042|NCT00779766|516700098|FG000|Month 72|Migrated/moved from study area|124|||
143315043|NCT00779766|516700099|FG001|Month 72|Migrated/moved from study area|109|||
143315044|NCT00779766|516700098|FG000|Month 72|Lost to Follow-up|6|||
143315045|NCT00779766|516700099|FG001|Month 72|Lost to Follow-up|8|||
143315046|NCT00779766|516700098|FG000|Month 72|Other|0|||
143315047|NCT00779766|516700099|FG001|Month 72|Other|1|||
143315048|NCT01959581|516700106|FG000|Overall Study|Lost to Follow-up|5|||
143315049|NCT03495908|516700107|FG000|Overall Study|Withdrawal by Subject|3|||
143315050|NCT03495908|516700108|FG001|Overall Study|Withdrawal by Subject|1|||
143315051|NCT03495908|516700107|FG000|Overall Study|Lost to Follow-up|1|||
143315052|NCT03495908|516700108|FG001|Overall Study|Lost to Follow-up|4|||
143315053|NCT03495908|516700107|FG000|Overall Study|Adverse Event|0|||
143315054|NCT03495908|516700108|FG001|Overall Study|Adverse Event|2|||
143315055|NCT03495908|516700107|FG000|Overall Study|Death|1|||
143315056|NCT03495908|516700108|FG001|Overall Study|Death|0|||
143315057|NCT03495908|516700107|FG000|Overall Study|Physician Decision|5|||
143315058|NCT03495908|516700108|FG001|Overall Study|Physician Decision|4|||
143315059|NCT03495908|516700107|FG000|Overall Study|No documented reason|0|||
143315060|NCT03495908|516700108|FG001|Overall Study|No documented reason|2|||
143315061|NCT03075644|516700115|FG000|Overall Study|Withdrawal by Subject|1|||
143315062|NCT03075644|516700116|FG001|Overall Study|Withdrawal by Subject|1|||
143315063|NCT02563028|516700121|FG000|Overall Study|Lack of equipment|1|||
143315064|NCT02563028|516700121|FG000|Overall Study|Unable to elicit VEP post induction|1|||
143315065|NCT03254134|516700122|FG000|Overall Study|Not eligible patients|599|||
143315066|NCT03254134|516700123|FG001|Overall Study|Not eligible patients|3630|||
143315067|NCT03181542|516700124|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
143315068|NCT03181542|516700125|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
143315069|NCT01009099|516700126|FG000|Overall Study|Lost to Follow-up|1|||
143315070|NCT01009099|516700127|FG001|Overall Study|Lost to Follow-up|0|||
143315071|NCT01009099|516700126|FG000|Overall Study|Physician Decision|3|||
143315072|NCT01009099|516700127|FG001|Overall Study|Physician Decision|2|||
143315073|NCT01009099|516700126|FG000|Overall Study|Withdrawal by Subject|1|||
143315074|NCT01009099|516700127|FG001|Overall Study|Withdrawal by Subject|1|||
143315075|NCT01009099|516700126|FG000|Overall Study|Death|0|||
143315076|NCT01009099|516700127|FG001|Overall Study|Death|1|||
143315077|NCT01856543|516700128|FG000|Overall Study|Treatment discontinued|6|||
143315078|NCT01856543|516700129|FG001|Overall Study|Treatment discontinued|3|||
143315079|NCT01856543|516700128|FG000|Overall Study|Withdrawn before start|7|||
143315080|NCT01856543|516700129|FG001|Overall Study|Withdrawn before start|3|||
143315081|NCT04545515|516700130|FG000|Overall Study|Adverse Event|1|||
143315082|NCT04545515|516700130|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
143315083|NCT04545515|516700130|FG000|Overall Study|Commercial drug is available for participant|7|||
143315084|NCT02501096|516700131|FG000|Overall Study|Lost to Follow-up|0|||
143315085|NCT02501096|516700132|FG001|Overall Study|Lost to Follow-up|0|||
143315086|NCT02501096|516700133|FG002|Overall Study|Lost to Follow-up|0|||
143315087|NCT02501096|516700134|FG003|Overall Study|Lost to Follow-up|0|||
143315088|NCT02501096|516700135|FG004|Overall Study|Lost to Follow-up|1|||
143315089|NCT02501096|516700136|FG005|Overall Study|Lost to Follow-up|1|||
143315090|NCT02501096|516700137|FG006|Overall Study|Lost to Follow-up|3|||
143315091|NCT02501096|516700138|FG007|Overall Study|Lost to Follow-up|0|||
143315092|NCT02501096|516700139|FG008|Overall Study|Lost to Follow-up|0|||
143315093|NCT02501096|516700131|FG000|Overall Study|Withdrawal by Subject|1|||
143315094|NCT02501096|516700132|FG001|Overall Study|Withdrawal by Subject|0|||
143315095|NCT02501096|516700133|FG002|Overall Study|Withdrawal by Subject|7|||
143315096|NCT02501096|516700134|FG003|Overall Study|Withdrawal by Subject|13|||
143315097|NCT02501096|516700135|FG004|Overall Study|Withdrawal by Subject|2|||
143315098|NCT02501096|516700136|FG005|Overall Study|Withdrawal by Subject|2|||
143315099|NCT02501096|516700137|FG006|Overall Study|Withdrawal by Subject|2|||
143315100|NCT02501096|516700138|FG007|Overall Study|Withdrawal by Subject|3|||
143315101|NCT02501096|516700139|FG008|Overall Study|Withdrawal by Subject|0|||
143315102|NCT02501096|516700131|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
143315103|NCT02501096|516700132|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
143315104|NCT02501096|516700133|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
143315105|NCT02501096|516700134|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
143315106|NCT02501096|516700135|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
143315107|NCT02501096|516700136|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
143315108|NCT02501096|516700137|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
143315109|NCT02501096|516700138|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
143315110|NCT02501096|516700139|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
143315111|NCT02501096|516700131|FG000|Overall Study|Death|1|||
143315112|NCT02501096|516700132|FG001|Overall Study|Death|1|||
143315113|NCT02501096|516700133|FG002|Overall Study|Death|88|||
143315114|NCT02501096|516700134|FG003|Overall Study|Death|74|||
143315115|NCT02501096|516700135|FG004|Overall Study|Death|15|||
143315116|NCT02501096|516700136|FG005|Overall Study|Death|16|||
143315117|NCT02501096|516700137|FG006|Overall Study|Death|15|||
143315118|NCT02501096|516700138|FG007|Overall Study|Death|16|||
143315119|NCT02501096|516700139|FG008|Overall Study|Death|1|||
143315120|NCT01848990|516700140|FG000|Overall Study|Adverse Event|6|||
143315121|NCT01848990|516700141|FG001|Overall Study|Adverse Event|2|||
143315122|NCT01848990|516700142|FG002|Overall Study|Adverse Event|0|||
143315123|NCT01848990|516700140|FG000|Overall Study|Lost to Follow-up|6|||
143315124|NCT01848990|516700141|FG001|Overall Study|Lost to Follow-up|2|||
143315125|NCT01848990|516700142|FG002|Overall Study|Lost to Follow-up|2|||
143315126|NCT01848990|516700140|FG000|Overall Study|Protocol Violation|1|||
143315127|NCT01848990|516700141|FG001|Overall Study|Protocol Violation|1|||
143315128|NCT01848990|516700142|FG002|Overall Study|Protocol Violation|0|||
143315129|NCT01848990|516700140|FG000|Overall Study|Withdrawal by Subject|29|||
143315130|NCT01848990|516700141|FG001|Overall Study|Withdrawal by Subject|10|||
143315131|NCT01848990|516700142|FG002|Overall Study|Withdrawal by Subject|11|||
143315132|NCT01848990|516700140|FG000|Overall Study|Physician Decision|1|||
143315133|NCT01848990|516700141|FG001|Overall Study|Physician Decision|1|||
143315134|NCT01848990|516700142|FG002|Overall Study|Physician Decision|0|||
143315135|NCT01848990|516700140|FG000|Overall Study|Non Compliance|1|||
143315136|NCT01848990|516700141|FG001|Overall Study|Non Compliance|0|||
143315137|NCT01848990|516700142|FG002|Overall Study|Non Compliance|0|||
143315138|NCT01848990|516700140|FG000|Overall Study|Death|1|||
143315139|NCT01848990|516700141|FG001|Overall Study|Death|0|||
143315140|NCT01848990|516700142|FG002|Overall Study|Death|1|||
143315141|NCT01848990|516700140|FG000|Overall Study|Other|1|||
143315142|NCT01848990|516700141|FG001|Overall Study|Other|4|||
143315143|NCT01848990|516700142|FG002|Overall Study|Other|2|||
143315144|NCT00096044|516700143|FG000|Overall Study|Withdrawal by Subject|9|||
143315145|NCT00096044|516700143|FG000|Overall Study|Adverse Event|21|||
143376792|NCT03345901|516925196|FG000|Overall Study|The study was terminated|18|||
143376793|NCT00722046|516925197|FG000|Overall Study|Adverse Event|0|||
143376794|NCT00722046|516925198|FG001|Overall Study|Adverse Event|1|||
143315146|NCT00096044|516700143|FG000|Overall Study|Disease Progression|4|||
143315147|NCT03149237|516700144|FG000|Overall Study|Withdrawal by Subject|4|||
143376795|NCT00722046|516925199|FG002|Overall Study|Adverse Event|2|||
143376796|NCT00722046|516925200|FG003|Overall Study|Adverse Event|1|||
143315148|NCT03149237|516700145|FG001|Overall Study|Withdrawal by Subject|5|||
143315149|NCT02442830|516700146|FG000|Overall Study|Technical Failure|0|||
143315150|NCT02442830|516700147|FG001|Overall Study|Technical Failure|1|||
143315151|NCT04587193|516700148|FG000|Overall Study|Screen failure after consent|3|||
143315152|NCT04587193|516700149|FG001|Overall Study|Screen failure after consent|0|||
143315153|NCT04587193|516700148|FG000|Overall Study|Device broke during study|3|||
143315154|NCT04587193|516700149|FG001|Overall Study|Device broke during study|2|||
143315155|NCT03851016|516700152|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
143315156|NCT03851016|516700153|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
143376797|NCT00722046|516925201|FG004|Overall Study|Adverse Event|2|||
143315157|NCT03878134|516700154|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
143315158|NCT00853658|516700155|FG000|Overall Study|Death|713|||
143315159|NCT00853658|516700156|FG001|Overall Study|Death|768|||
143315160|NCT00853658|516700157|FG002|Overall Study|Death|753|||
143315161|NCT00853658|516700155|FG000|Overall Study|Lost to Follow-up|11|||
143315162|NCT00853658|516700156|FG001|Overall Study|Lost to Follow-up|6|||
143315163|NCT00853658|516700157|FG002|Overall Study|Lost to Follow-up|11|||
143315164|NCT00853658|516700155|FG000|Overall Study|H.A. Request|26|||
143315165|NCT00853658|516700156|FG001|Overall Study|H.A. Request|23|||
143315166|NCT00853658|516700157|FG002|Overall Study|H.A. Request|19|||
143315167|NCT00853658|516700155|FG000|Overall Study|IRB request|0|||
143315168|NCT00853658|516700156|FG001|Overall Study|IRB request|0|||
143315169|NCT00853658|516700157|FG002|Overall Study|IRB request|2|||
143315170|NCT00853658|516700155|FG000|Overall Study|Vital Status known (alive) at study end|2|||
143315171|NCT00853658|516700156|FG001|Overall Study|Vital Status known (alive) at study end|3|||
143315172|NCT00853658|516700157|FG002|Overall Study|Vital Status known (alive) at study end|3|||
143315173|NCT00853658|516700155|FG000|Overall Study|Vital Status unknown at study end|1|||
143315174|NCT00853658|516700156|FG001|Overall Study|Vital Status unknown at study end|1|||
143315175|NCT00853658|516700157|FG002|Overall Study|Vital Status unknown at study end|0|||
143315176|NCT00853658|516700155|FG000|Overall Study|Vital Status at study end N/A|8|||
143315177|NCT00853658|516700156|FG001|Overall Study|Vital Status at study end N/A|10|||
143315178|NCT00853658|516700157|FG002|Overall Study|Vital Status at study end N/A|10|||
143315179|NCT00853658|516700155|FG000|Overall Study|Patient's request|21|||
143315180|NCT00853658|516700156|FG001|Overall Study|Patient's request|17|||
143315181|NCT00853658|516700157|FG002|Overall Study|Patient's request|11|||
143315182|NCT00853658|516700155|FG000|Overall Study|Missing study completion information|5|||
143315183|NCT00853658|516700156|FG001|Overall Study|Missing study completion information|4|||
143315184|NCT00853658|516700157|FG002|Overall Study|Missing study completion information|6|||
143315185|NCT00586469|516700159|FG000|Overall Study|Adverse Event|0|||
143315186|NCT00586469|516700160|FG001|Overall Study|Adverse Event|1|||
143315187|NCT01227512|516700163|FG000|Overall Study|Physician Decision|6|||
143315188|NCT01227512|516700164|FG001|Overall Study|Physician Decision|6|||
143315189|NCT01227512|516700163|FG000|Overall Study|Adverse Event|4|||
143315190|NCT01227512|516700164|FG001|Overall Study|Adverse Event|3|||
143315191|NCT01227512|516700163|FG000|Overall Study|Withdrawal by Subject|3|||
143315192|NCT01227512|516700164|FG001|Overall Study|Withdrawal by Subject|0|||
143315193|NCT01227512|516700163|FG000|Overall Study|Participant met withdrawal criteria|0|||
143315194|NCT01227512|516700164|FG001|Overall Study|Participant met withdrawal criteria|1|||
143315195|NCT04055116|516700171|FG000|First Intervention|Physician Decision|2|||
143315196|NCT04055116|516700172|FG001|First Intervention|Physician Decision|7|||
143315197|NCT02774681|516700173|FG000|Treatment on Study|Progressive Disease|7|||
143315198|NCT02774681|516700173|FG000|Follow-Up for 3 Years|Death|11|||
143315199|NCT02774681|516700173|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
143315200|NCT00512096|516700174|FG000|Overall Study|Adverse Event|2|||
143315201|NCT00512096|516700174|FG000|Overall Study|Withdrawal by Subject|2|||
143315202|NCT00512096|516700174|FG000|Overall Study|Lack of Efficacy|3|||
143315203|NCT02696096|516700178|FG000|Overall Study|ruled out at screening|1|||
143315204|NCT02696096|516700178|FG000|Overall Study|did not attend second fMRI|1|||
143315205|NCT02556710|516701606|FG000|Overall Study|Surgical treatment|3|||
143315206|NCT02556710|516701607|FG001|Overall Study|Surgical treatment|0|||
143315207|NCT02556710|516701606|FG000|Overall Study|Required proscribed pain medication|2|||
143315208|NCT02556710|516701607|FG001|Overall Study|Required proscribed pain medication|1|||
143315209|NCT02556710|516701606|FG000|Overall Study|Lack of Efficacy|1|||
143315210|NCT02556710|516701607|FG001|Overall Study|Lack of Efficacy|0|||
143315211|NCT02556710|516701606|FG000|Overall Study|Worsening osteoarthritis|1|||
143315212|NCT02556710|516701607|FG001|Overall Study|Worsening osteoarthritis|0|||
143315213|NCT02556710|516701606|FG000|Overall Study|Moved out of state|1|||
143315214|NCT02556710|516701607|FG001|Overall Study|Moved out of state|0|||
143315215|NCT02556710|516701606|FG000|Overall Study|Missing reason|3|||
143315216|NCT02556710|516701607|FG001|Overall Study|Missing reason|1|||
143315217|NCT02556710|516701606|FG000|Overall Study|Pain as lack of efficacy|0|||
143315218|NCT02556710|516701607|FG001|Overall Study|Pain as lack of efficacy|4|||
143315219|NCT01310413|516701612|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
143315220|NCT01310413|516701613|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
143315221|NCT01310413|516701614|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
143315222|NCT01310413|516701615|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
143315223|NCT01310413|516701616|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
143315224|NCT01310413|516701617|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
143315225|NCT01310413|516701618|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
143315226|NCT01310413|516701612|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
143315227|NCT01310413|516701613|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
143315228|NCT01310413|516701614|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
143315229|NCT01310413|516701615|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
143315230|NCT01310413|516701616|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
143315231|NCT01310413|516701617|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
143315232|NCT01310413|516701618|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
143315233|NCT01310413|516701612|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
143315234|NCT01310413|516701613|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
143315235|NCT01310413|516701614|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
143315236|NCT01310413|516701615|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
143315237|NCT01310413|516701616|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
143315238|NCT01310413|516701617|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
143315239|NCT01310413|516701618|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
143315240|NCT01310413|516701612|FG000|Day 0 to Day 385|Other|1|||
143315241|NCT01310413|516701613|FG001|Day 0 to Day 385|Other|0|||
143315242|NCT01310413|516701614|FG002|Day 0 to Day 385|Other|3|||
143315243|NCT01310413|516701615|FG003|Day 0 to Day 385|Other|0|||
143315244|NCT01310413|516701616|FG004|Day 0 to Day 385|Other|0|||
143315245|NCT01310413|516701617|FG005|Day 0 to Day 385|Other|0|||
143315246|NCT01310413|516701618|FG006|Day 0 to Day 385|Other|0|||
143315247|NCT01310413|516701612|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
143315248|NCT01310413|516701613|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
143315249|NCT01310413|516701614|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
143315250|NCT01310413|516701615|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
143315251|NCT01310413|516701616|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
143315252|NCT01310413|516701617|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
143315253|NCT01310413|516701618|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
143315254|NCT01310413|516701612|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
143315255|NCT01310413|516701613|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
143315256|NCT01310413|516701614|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
143315257|NCT01310413|516701615|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
143315258|NCT01310413|516701616|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
143315259|NCT01310413|516701617|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
143315260|NCT01310413|516701618|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
143315261|NCT02391948|516701619|FG000|6-month Assessment|Death|0|||
143315262|NCT02391948|516701620|FG001|6-month Assessment|Death|0|||
143315263|NCT02391948|516701621|FG002|6-month Assessment|Death|0|||
143315264|NCT02391948|516701622|FG003|6-month Assessment|Death|0|||
143315265|NCT02391948|516701623|FG004|6-month Assessment|Death|1|||
143315266|NCT02391948|516701619|FG000|6-month Assessment|Withdrawal by Subject|0|||
143315267|NCT02391948|516701620|FG001|6-month Assessment|Withdrawal by Subject|0|||
143315268|NCT02391948|516701621|FG002|6-month Assessment|Withdrawal by Subject|1|||
143315269|NCT02391948|516701622|FG003|6-month Assessment|Withdrawal by Subject|2|||
143315270|NCT02391948|516701623|FG004|6-month Assessment|Withdrawal by Subject|0|||
143315271|NCT02391948|516701619|FG000|6-month Assessment|Lost to Follow-up|4|||
143315272|NCT02391948|516701620|FG001|6-month Assessment|Lost to Follow-up|5|||
143315273|NCT02391948|516701621|FG002|6-month Assessment|Lost to Follow-up|2|||
143315274|NCT02391948|516701622|FG003|6-month Assessment|Lost to Follow-up|3|||
143315275|NCT02391948|516701623|FG004|6-month Assessment|Lost to Follow-up|1|||
143315276|NCT02391948|516701619|FG000|6-month Assessment|Medical issue/illness|1|||
143315277|NCT02391948|516701620|FG001|6-month Assessment|Medical issue/illness|1|||
143315278|NCT02391948|516701621|FG002|6-month Assessment|Medical issue/illness|0|||
143315279|NCT02391948|516701622|FG003|6-month Assessment|Medical issue/illness|0|||
143315280|NCT02391948|516701623|FG004|6-month Assessment|Medical issue/illness|0|||
143315281|NCT02391948|516701619|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
143315282|NCT02391948|516701620|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
143315283|NCT02391948|516701621|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
143315284|NCT02391948|516701622|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
143315285|NCT02391948|516701623|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
143315286|NCT02391948|516701619|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
143315287|NCT02391948|516701620|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
143315288|NCT02391948|516701621|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
143315289|NCT02391948|516701622|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
143315290|NCT02391948|516701623|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
143315291|NCT02391948|516701619|FG000|12-month Assessment|Death|0|||
143315292|NCT02391948|516701620|FG001|12-month Assessment|Death|0|||
143315293|NCT02391948|516701621|FG002|12-month Assessment|Death|0|||
143315294|NCT02391948|516701622|FG003|12-month Assessment|Death|1|||
143315295|NCT02391948|516701623|FG004|12-month Assessment|Death|0|||
143315296|NCT02391948|516701619|FG000|12-month Assessment|Withdrawal by Subject|1|||
143315297|NCT02391948|516701620|FG001|12-month Assessment|Withdrawal by Subject|0|||
143315298|NCT02391948|516701621|FG002|12-month Assessment|Withdrawal by Subject|0|||
143315299|NCT02391948|516701622|FG003|12-month Assessment|Withdrawal by Subject|1|||
143315300|NCT02391948|516701623|FG004|12-month Assessment|Withdrawal by Subject|0|||
143315301|NCT02391948|516701619|FG000|12-month Assessment|Lost to Follow-up|5|||
143315302|NCT02391948|516701620|FG001|12-month Assessment|Lost to Follow-up|4|||
143315303|NCT02391948|516701621|FG002|12-month Assessment|Lost to Follow-up|4|||
143315304|NCT02391948|516701622|FG003|12-month Assessment|Lost to Follow-up|4|||
143315305|NCT02391948|516701623|FG004|12-month Assessment|Lost to Follow-up|5|||
143315306|NCT02391948|516701619|FG000|12-month Assessment|Medical issue/illness|0|||
143315307|NCT02391948|516701620|FG001|12-month Assessment|Medical issue/illness|1|||
143315308|NCT02391948|516701621|FG002|12-month Assessment|Medical issue/illness|0|||
143315309|NCT02391948|516701622|FG003|12-month Assessment|Medical issue/illness|1|||
143315310|NCT02391948|516701623|FG004|12-month Assessment|Medical issue/illness|0|||
143315311|NCT02391948|516701619|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
143315312|NCT02391948|516701620|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
143315313|NCT02391948|516701621|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
143315314|NCT02391948|516701622|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
143315315|NCT02391948|516701623|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
143315316|NCT02391948|516701619|FG000|18-month Assessment|Death|0|||
143315317|NCT02391948|516701620|FG001|18-month Assessment|Death|0|||
143315318|NCT02391948|516701621|FG002|18-month Assessment|Death|0|||
143315319|NCT02391948|516701622|FG003|18-month Assessment|Death|1|||
143315320|NCT02391948|516701623|FG004|18-month Assessment|Death|1|||
143315321|NCT02391948|516701619|FG000|18-month Assessment|Withdrawal by Subject|1|||
143315322|NCT02391948|516701620|FG001|18-month Assessment|Withdrawal by Subject|0|||
143315323|NCT02391948|516701621|FG002|18-month Assessment|Withdrawal by Subject|0|||
143315324|NCT02391948|516701622|FG003|18-month Assessment|Withdrawal by Subject|1|||
143315325|NCT02391948|516701623|FG004|18-month Assessment|Withdrawal by Subject|0|||
143315326|NCT02391948|516701619|FG000|18-month Assessment|Lost to Follow-up|2|||
143315327|NCT02391948|516701620|FG001|18-month Assessment|Lost to Follow-up|6|||
143315328|NCT02391948|516701621|FG002|18-month Assessment|Lost to Follow-up|2|||
143315329|NCT02391948|516701622|FG003|18-month Assessment|Lost to Follow-up|2|||
143315330|NCT02391948|516701623|FG004|18-month Assessment|Lost to Follow-up|3|||
143315331|NCT02391948|516701619|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
143315332|NCT02391948|516701620|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
143315333|NCT02391948|516701621|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
143315334|NCT02391948|516701622|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
143315335|NCT02391948|516701623|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
143315336|NCT02391948|516701619|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
143315337|NCT02391948|516701620|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
143315338|NCT02391948|516701621|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
143315339|NCT02391948|516701622|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
143315340|NCT02391948|516701623|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
143315341|NCT02391948|516701619|FG000|24-month Assessment|Death|0|||
143315342|NCT02391948|516701620|FG001|24-month Assessment|Death|0|||
143315343|NCT02391948|516701621|FG002|24-month Assessment|Death|0|||
143315344|NCT02391948|516701622|FG003|24-month Assessment|Death|0|||
143315345|NCT02391948|516701623|FG004|24-month Assessment|Death|1|||
143315346|NCT02391948|516701619|FG000|24-month Assessment|Withdrawal by Subject|1|||
143315347|NCT02391948|516701620|FG001|24-month Assessment|Withdrawal by Subject|1|||
143315348|NCT02391948|516701621|FG002|24-month Assessment|Withdrawal by Subject|0|||
143315349|NCT02391948|516701622|FG003|24-month Assessment|Withdrawal by Subject|0|||
143315350|NCT02391948|516701623|FG004|24-month Assessment|Withdrawal by Subject|1|||
143315351|NCT02391948|516701619|FG000|24-month Assessment|Lost to Follow-up|5|||
143315352|NCT02391948|516701620|FG001|24-month Assessment|Lost to Follow-up|4|||
143315353|NCT02391948|516701621|FG002|24-month Assessment|Lost to Follow-up|0|||
143315354|NCT02391948|516701622|FG003|24-month Assessment|Lost to Follow-up|0|||
143315355|NCT02391948|516701623|FG004|24-month Assessment|Lost to Follow-up|0|||
143315356|NCT02391948|516701619|FG000|24-month Assessment|Medical issue/illness|0|||
143315357|NCT02391948|516701620|FG001|24-month Assessment|Medical issue/illness|0|||
143315358|NCT02391948|516701621|FG002|24-month Assessment|Medical issue/illness|1|||
143315359|NCT02391948|516701622|FG003|24-month Assessment|Medical issue/illness|0|||
143315360|NCT02391948|516701623|FG004|24-month Assessment|Medical issue/illness|0|||
143315361|NCT02391948|516701619|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
143315362|NCT02391948|516701620|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
143315363|NCT02391948|516701621|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
143315364|NCT02391948|516701622|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
143315365|NCT02391948|516701623|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
143315366|NCT02348489|516701626|FG000|Overall Study|Death|336|||
143315367|NCT02348489|516701627|FG001|Overall Study|Death|335|||
143315368|NCT02348489|516701626|FG000|Overall Study|Withdrawal by Subject|14|||
143315369|NCT02348489|516701627|FG001|Overall Study|Withdrawal by Subject|27|||
143315370|NCT02348489|516701626|FG000|Overall Study|Lost to Follow-up|3|||
143315371|NCT02348489|516701627|FG001|Overall Study|Lost to Follow-up|5|||
143315372|NCT02866682|516701628|FG000|Overall Study|Death|0|||
143315373|NCT02866682|516701629|FG001|Overall Study|Death|1|||
143315374|NCT02866682|516701628|FG000|Overall Study|Lost to Follow-up|0|||
143315375|NCT02866682|516701629|FG001|Overall Study|Lost to Follow-up|4|||
143315376|NCT02866682|516701628|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
143315377|NCT02866682|516701629|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
143315378|NCT02866682|516701628|FG000|Overall Study|Other|0|||
143315379|NCT02866682|516701629|FG001|Overall Study|Other|1|||
143315380|NCT00201006|516701630|FG000|Overall Study|Withdrawal by Subject|7|||
143315381|NCT00201006|516701631|FG001|Overall Study|Withdrawal by Subject|2|||
143315382|NCT00201006|516701632|FG002|Overall Study|Withdrawal by Subject|3|||
143315383|NCT00201006|516701630|FG000|Overall Study|Adverse Event|1|||
143315384|NCT00201006|516701631|FG001|Overall Study|Adverse Event|0|||
143315385|NCT00201006|516701632|FG002|Overall Study|Adverse Event|1|||
143315386|NCT00938431|516701636|FG000|Overall Study|Adverse Event|5|||
143315387|NCT00938431|516701637|FG001|Overall Study|Adverse Event|8|||
143315388|NCT00938431|516701638|FG002|Overall Study|Adverse Event|6|||
143315389|NCT00938431|516701636|FG000|Overall Study|Lack of Efficacy|0|||
143315390|NCT00938431|516701637|FG001|Overall Study|Lack of Efficacy|1|||
143315391|NCT00938431|516701638|FG002|Overall Study|Lack of Efficacy|0|||
143315392|NCT00938431|516701636|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
143315393|NCT00938431|516701637|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
143315394|NCT00938431|516701638|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
143315395|NCT00938431|516701636|FG000|Overall Study|Dosing compliance issue|0|||
143315396|NCT00938431|516701637|FG001|Overall Study|Dosing compliance issue|0|||
143315397|NCT00938431|516701638|FG002|Overall Study|Dosing compliance issue|1|||
143315398|NCT00938431|516701636|FG000|Overall Study|Reached maximum dose early|0|||
143315399|NCT00938431|516701637|FG001|Overall Study|Reached maximum dose early|0|||
143315400|NCT00938431|516701638|FG002|Overall Study|Reached maximum dose early|1|||
143315401|NCT02086591|516701639|FG000|Overall Study|Adverse Event|1|||
143315402|NCT02086591|516701639|FG000|Overall Study|Withdrawal by Subject|1|||
143315403|NCT02086591|516701639|FG000|Overall Study|protocol terminated|3|||
143315404|NCT00723801|516701641|FG000|Overall Study|Lost to Follow-up|1|||
143315405|NCT00723801|516701642|FG001|Overall Study|Lost to Follow-up|2|||
143315406|NCT00723801|516701641|FG000|Overall Study|Protocol Violation|2|||
143315407|NCT00723801|516701642|FG001|Overall Study|Protocol Violation|1|||
143315408|NCT01824303|516701645|FG000|Randomized Study|Withdrawal by Subject|1|||
143315409|NCT01824303|516701646|FG001|Randomized Study|Withdrawal by Subject|1|||
143315410|NCT01824303|516701645|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
143315411|NCT01824303|516701646|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
143315412|NCT04086472|516701647|FG000|Overall Study|Lost to Follow-up|1|||
143315413|NCT04086472|516701648|FG001|Overall Study|Lost to Follow-up|0|||
143315414|NCT04086472|516701649|FG002|Overall Study|Lost to Follow-up|0|||
143315415|NCT04086472|516701650|FG003|Overall Study|Lost to Follow-up|0|||
143315416|NCT04086472|516701651|FG004|Overall Study|Lost to Follow-up|1|||
143315417|NCT04086472|516701647|FG000|Overall Study|Physician Decision|0|||
143315418|NCT04086472|516701648|FG001|Overall Study|Physician Decision|1|||
143315419|NCT04086472|516701649|FG002|Overall Study|Physician Decision|1|||
143315420|NCT04086472|516701650|FG003|Overall Study|Physician Decision|0|||
143315421|NCT04086472|516701651|FG004|Overall Study|Physician Decision|0|||
143315422|NCT04086472|516701647|FG000|Overall Study|Withdrawal by Subject|1|||
143315423|NCT04086472|516701648|FG001|Overall Study|Withdrawal by Subject|1|||
143315424|NCT04086472|516701649|FG002|Overall Study|Withdrawal by Subject|1|||
143315425|NCT04086472|516701650|FG003|Overall Study|Withdrawal by Subject|0|||
143315426|NCT04086472|516701651|FG004|Overall Study|Withdrawal by Subject|0|||
143315427|NCT04086472|516701647|FG000|Overall Study|Various reasons|2|||
143315428|NCT04086472|516701648|FG001|Overall Study|Various reasons|0|||
143315429|NCT04086472|516701649|FG002|Overall Study|Various reasons|0|||
143315430|NCT04086472|516701650|FG003|Overall Study|Various reasons|3|||
143315431|NCT04086472|516701651|FG004|Overall Study|Various reasons|1|||
143315432|NCT04116229|516701657|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
143315433|NCT04116229|516701658|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
143315434|NCT04116229|516701657|FG000|Overall Study|Scheduling not possible.|0|||
143315435|NCT04116229|516701658|FG001|Overall Study|Scheduling not possible.|1|||
143315436|NCT02809976|516701661|FG000|Overall Study|Lost to Follow-up|1|||
143315437|NCT02809976|516701661|FG000|Overall Study|Withdrawal by Subject|1|||
143315438|NCT04574362|516701662|FG000|Overall Study|Other|0|||
143376798|NCT00722046|516925202|FG005|Overall Study|Adverse Event|1|||
143376799|NCT00722046|516925203|FG006|Overall Study|Adverse Event|0|||
143376800|NCT00722046|516925197|FG000|Overall Study|Death|0|||
143315439|NCT04574362|516701663|FG001|Overall Study|Other|5|||
143315440|NCT04574362|516701662|FG000|Overall Study|COVID-19|0|||
143315441|NCT04574362|516701663|FG001|Overall Study|COVID-19|1|||
143315442|NCT04574362|516701662|FG000|Overall Study|Adverse Event|1|||
143376801|NCT00722046|516925198|FG001|Overall Study|Death|1|||
143315443|NCT04574362|516701663|FG001|Overall Study|Adverse Event|1|||
143315444|NCT04574362|516701662|FG000|Overall Study|Withdrawal by Subject|2|||
143376802|NCT00722046|516925199|FG002|Overall Study|Death|0|||
143376803|NCT00722046|516925200|FG003|Overall Study|Death|0|||
143315445|NCT04574362|516701663|FG001|Overall Study|Withdrawal by Subject|4|||
143315446|NCT04574362|516701662|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
143315447|NCT04574362|516701663|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
143315448|NCT04574362|516701662|FG000|Overall Study|Participant refused to come to the hospital|1|||
143315449|NCT04574362|516701663|FG001|Overall Study|Participant refused to come to the hospital|0|||
143315450|NCT04574362|516701662|FG000|Overall Study|Participant refused the visit|1|||
143315451|NCT04574362|516701663|FG001|Overall Study|Participant refused the visit|0|||
143315452|NCT04574362|516701662|FG000|Overall Study|Participant quit early because of business trip|1|||
143315453|NCT04574362|516701663|FG001|Overall Study|Participant quit early because of business trip|0|||
143315454|NCT00211081|516701665|FG000|Overall Study|Withdrawal by Subject|2|||
143315455|NCT01600040|516701666|FG000|Overall Study|Withdrawal by Subject|1|||
143315456|NCT04027686|516701667|FG000|Overall Study|Lost to Follow-up|2|||
143315457|NCT04027686|516701668|FG001|Overall Study|Lost to Follow-up|0|||
143315458|NCT04027686|516701667|FG000|Overall Study|Withdrawal by Subject|0|||
143315459|NCT04027686|516701668|FG001|Overall Study|Withdrawal by Subject|1|||
143315460|NCT00047463|516701669|FG000|Overall Study|Withdrawal by Subject|0|||
143315461|NCT00047463|516701670|FG001|Overall Study|Withdrawal by Subject|3|||
143315462|NCT00113516|516701671|FG000|Part 1|Adverse Event|6|||
143315463|NCT00113516|516701672|FG001|Part 1|Adverse Event|0|||
143315464|NCT00113516|516701671|FG000|Part 1|Death|3|||
143315465|NCT00113516|516701672|FG001|Part 1|Death|0|||
143315466|NCT00113516|516701671|FG000|Part 1|Other|3|||
143315467|NCT00113516|516701672|FG001|Part 1|Other|0|||
143315468|NCT00113516|516701671|FG000|Part 1|Withdrawal by Subject|2|||
143315469|NCT00113516|516701672|FG001|Part 1|Withdrawal by Subject|0|||
143315470|NCT00113516|516701671|FG000|Part 1|Lack of Efficacy|2|||
143315471|NCT00113516|516701672|FG001|Part 1|Lack of Efficacy|0|||
143315472|NCT00113516|516701671|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
143315473|NCT00113516|516701672|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
143315474|NCT00113516|516701671|FG000|Part 1|Laboratory Abnormality|1|||
143315475|NCT00113516|516701672|FG001|Part 1|Laboratory Abnormality|0|||
143315476|NCT00113516|516701671|FG000|Part 1|Ongoing|1|||
143315477|NCT00113516|516701672|FG001|Part 1|Ongoing|0|||
143315478|NCT00113516|516701671|FG000|Part 1|Missing|65|||
143315479|NCT00113516|516701672|FG001|Part 1|Missing|0|||
143315480|NCT00113516|516701671|FG000|Part 2|Adverse Event|0|||
143315481|NCT00113516|516701672|FG001|Part 2|Adverse Event|16|||
143315482|NCT00113516|516701671|FG000|Part 2|Death|0|||
143315483|NCT00113516|516701672|FG001|Part 2|Death|5|||
143315484|NCT00113516|516701671|FG000|Part 2|Lack of Efficacy|0|||
143315485|NCT00113516|516701672|FG001|Part 2|Lack of Efficacy|37|||
143315486|NCT00113516|516701671|FG000|Part 2|Withdrawal by Subject|0|||
143315487|NCT00113516|516701672|FG001|Part 2|Withdrawal by Subject|3|||
143315488|NCT00113516|516701671|FG000|Part 2|Other|0|||
143315489|NCT00113516|516701672|FG001|Part 2|Other|3|||
143315490|NCT00113516|516701671|FG000|Part 2|Laboratory Abnormality|0|||
143315491|NCT00113516|516701672|FG001|Part 2|Laboratory Abnormality|1|||
143315492|NCT00113516|516701671|FG000|Part 2|Ongoing|0|||
143315493|NCT00113516|516701672|FG001|Part 2|Ongoing|1|||
143315494|NCT00642304|516701673|FG000|Overall Study|Adverse Event|1|||
143315495|NCT00642304|516701673|FG000|Overall Study|Death|1|||
143315496|NCT00642304|516701673|FG000|Overall Study|Blood transfusion|2|||
143315497|NCT00642304|516701673|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
143315498|NCT00642304|516701673|FG000|Overall Study|Transplantation|1|||
143315499|NCT01412424|516701679|FG000|Core Treatment Period|Treatment Failure|24|||
143315500|NCT01412424|516701679|FG000|Core Treatment Period|Adverse Event|21|||
143315501|NCT01412424|516701679|FG000|Core Treatment Period|Patient Request|5|||
143315502|NCT01412424|516701679|FG000|Core Treatment Period|Lost to Follow-up|2|||
143315503|NCT01412424|516701679|FG000|Core Treatment Period|Sponsor Request|1|||
143315504|NCT01412424|516701679|FG000|Extension Treatment Period|Adverse Event|2|||
143315505|NCT01412424|516701679|FG000|Extension Treatment Period|Treatment Failure|2|||
143315506|NCT01412424|516701679|FG000|Extension Treatment Period|Patient Request|2|||
143315507|NCT02170727|516701680|FG000|Overall Study|Lost to Follow-up|1|||
143315508|NCT02170727|516701681|FG001|Overall Study|Lost to Follow-up|0|||
143315509|NCT02170727|516701680|FG000|Overall Study|Withdrawal by Subject|2|||
143315510|NCT02170727|516701681|FG001|Overall Study|Withdrawal by Subject|0|||
143315511|NCT00414050|516701682|FG000|Overall Study|Adverse Event|1|||
143315512|NCT00414050|516701683|FG001|Overall Study|Adverse Event|1|||
143315513|NCT00414050|516701684|FG002|Overall Study|Adverse Event|1|||
143315514|NCT00414050|516701685|FG003|Overall Study|Adverse Event|1|||
143315515|NCT00414050|516701682|FG000|Overall Study|Lost to Follow-up|2|||
143315516|NCT00414050|516701683|FG001|Overall Study|Lost to Follow-up|2|||
143315517|NCT00414050|516701684|FG002|Overall Study|Lost to Follow-up|1|||
143315518|NCT00414050|516701685|FG003|Overall Study|Lost to Follow-up|1|||
143315519|NCT00414050|516701682|FG000|Overall Study|Withdrawal by Subject|5|||
143315520|NCT00414050|516701683|FG001|Overall Study|Withdrawal by Subject|3|||
143315521|NCT00414050|516701684|FG002|Overall Study|Withdrawal by Subject|2|||
143315522|NCT00414050|516701685|FG003|Overall Study|Withdrawal by Subject|4|||
143315523|NCT00414050|516701682|FG000|Overall Study|Subject discontinued for other reason|1|||
143315524|NCT00414050|516701683|FG001|Overall Study|Subject discontinued for other reason|2|||
143315525|NCT00414050|516701684|FG002|Overall Study|Subject discontinued for other reason|2|||
143315526|NCT00414050|516701685|FG003|Overall Study|Subject discontinued for other reason|1|||
143315527|NCT00414050|516701682|FG000|Overall Study|Subject Moved|0|||
143315528|NCT00414050|516701683|FG001|Overall Study|Subject Moved|0|||
143315529|NCT00414050|516701684|FG002|Overall Study|Subject Moved|0|||
143315530|NCT00414050|516701685|FG003|Overall Study|Subject Moved|1|||
143315531|NCT01706250|516701689|FG000|Overall Study|Lost to Follow-up|2|||
143315532|NCT03286140|516701690|FG000|Overall Study|Withdrawal by Subject|10|||
143315533|NCT03286140|516701691|FG001|Overall Study|Withdrawal by Subject|5|||
143315534|NCT03286140|516701690|FG000|Overall Study|Lost to Follow-up|5|||
143315535|NCT03286140|516701691|FG001|Overall Study|Lost to Follow-up|10|||
143315536|NCT03286140|516701690|FG000|Overall Study|Failure to comply|0|||
143315537|NCT03286140|516701691|FG001|Overall Study|Failure to comply|1|||
143376804|NCT00722046|516925201|FG004|Overall Study|Death|0|||
143376805|NCT00722046|516925202|FG005|Overall Study|Death|0|||
143376806|NCT00722046|516925203|FG006|Overall Study|Death|2|||
143376807|NCT00722046|516925197|FG000|Overall Study|Protocol Violation|1|||
143376808|NCT00722046|516925198|FG001|Overall Study|Protocol Violation|0|||
143376809|NCT00722046|516925199|FG002|Overall Study|Protocol Violation|0|||
143376810|NCT00722046|516925200|FG003|Overall Study|Protocol Violation|0|||
143376811|NCT00722046|516925201|FG004|Overall Study|Protocol Violation|0|||
143376812|NCT00722046|516925202|FG005|Overall Study|Protocol Violation|1|||
143376813|NCT00722046|516925203|FG006|Overall Study|Protocol Violation|0|||
143376814|NCT00722046|516925197|FG000|Overall Study|Withdrawal by Subject|3|||
143376815|NCT00722046|516925198|FG001|Overall Study|Withdrawal by Subject|3|||
143376816|NCT00722046|516925199|FG002|Overall Study|Withdrawal by Subject|4|||
143376817|NCT00722046|516925200|FG003|Overall Study|Withdrawal by Subject|4|||
143376818|NCT00722046|516925201|FG004|Overall Study|Withdrawal by Subject|4|||
143376819|NCT00722046|516925202|FG005|Overall Study|Withdrawal by Subject|7|||
143376820|NCT00722046|516925203|FG006|Overall Study|Withdrawal by Subject|3|||
143376821|NCT00722046|516925197|FG000|Overall Study|Randomized, but not treated|1|||
143376822|NCT00722046|516925198|FG001|Overall Study|Randomized, but not treated|1|||
143376823|NCT00722046|516925199|FG002|Overall Study|Randomized, but not treated|0|||
143376824|NCT00722046|516925200|FG003|Overall Study|Randomized, but not treated|2|||
143376825|NCT00722046|516925201|FG004|Overall Study|Randomized, but not treated|0|||
143376826|NCT00722046|516925202|FG005|Overall Study|Randomized, but not treated|0|||
143376827|NCT00722046|516925203|FG006|Overall Study|Randomized, but not treated|0|||
143376828|NCT00722046|516925197|FG000|Overall Study|Other|0|||
143376829|NCT00722046|516925198|FG001|Overall Study|Other|0|||
143376830|NCT00722046|516925199|FG002|Overall Study|Other|1|||
143376831|NCT00722046|516925200|FG003|Overall Study|Other|1|||
143376832|NCT00722046|516925201|FG004|Overall Study|Other|3|||
143376833|NCT00722046|516925202|FG005|Overall Study|Other|2|||
143376834|NCT00722046|516925203|FG006|Overall Study|Other|1|||
143376835|NCT00925587|516925204|FG000|Overall Study|Protocol Specified Criteria|6|||
143376836|NCT00925587|516925205|FG001|Overall Study|Protocol Specified Criteria|6|||
143376837|NCT00925587|516925204|FG000|Overall Study|Physician Decision|4|||
143376838|NCT00925587|516925205|FG001|Overall Study|Physician Decision|1|||
143376839|NCT00925587|516925204|FG000|Overall Study|Protocol Violation|6|||
143376840|NCT00925587|516925205|FG001|Overall Study|Protocol Violation|4|||
143376841|NCT00925587|516925204|FG000|Overall Study|Withdrawal by Subject|9|||
143376842|NCT00925587|516925205|FG001|Overall Study|Withdrawal by Subject|6|||
143376843|NCT00925587|516925204|FG000|Overall Study|Death|5|||
143376844|NCT00925587|516925205|FG001|Overall Study|Death|5|||
143376845|NCT00925587|516925204|FG000|Overall Study|Adverse Event|6|||
143376846|NCT00925587|516925205|FG001|Overall Study|Adverse Event|2|||
143376847|NCT00925587|516925204|FG000|Overall Study|Lost to Follow-up|0|||
143376848|NCT00925587|516925205|FG001|Overall Study|Lost to Follow-up|1|||
143376849|NCT01599104|516925209|FG000|Overall Study|Withdrawal by Subject|1|||
143376850|NCT01599104|516925210|FG001|Overall Study|Withdrawal by Subject|1|||
143376851|NCT01599104|516925211|FG002|Overall Study|Withdrawal by Subject|2|||
143376852|NCT01599104|516925209|FG000|Overall Study|Technical Problems|1|||
143376853|NCT01599104|516925210|FG001|Overall Study|Technical Problems|0|||
143376854|NCT01599104|516925211|FG002|Overall Study|Technical Problems|0|||
143376855|NCT01599104|516925209|FG000|Overall Study|Physician Decision|3|||
143376856|NCT01599104|516925210|FG001|Overall Study|Physician Decision|2|||
143376857|NCT01599104|516925211|FG002|Overall Study|Physician Decision|2|||
143376858|NCT01599104|516925209|FG000|Overall Study|Non-compliance with study treatment|0|||
143376859|NCT01599104|516925210|FG001|Overall Study|Non-compliance with study treatment|1|||
143315538|NCT02486406|516701692|FG000|Overall Study|Withdrew consent|1|||
143315539|NCT02486406|516701693|FG001|Overall Study|Withdrew consent|0|||
143315540|NCT02486406|516701694|FG002|Overall Study|Withdrew consent|0|||
143315541|NCT02486406|516701695|FG003|Overall Study|Withdrew consent|1|||
143376860|NCT01599104|516925211|FG002|Overall Study|Non-compliance with study treatment|0|||
143376861|NCT01599104|516925209|FG000|Overall Study|Lack of Efficacy|4|||
143376862|NCT01599104|516925210|FG001|Overall Study|Lack of Efficacy|4|||
143376863|NCT01599104|516925211|FG002|Overall Study|Lack of Efficacy|10|||
143376864|NCT01599104|516925209|FG000|Overall Study|Adverse Event|7|||
143376865|NCT01599104|516925210|FG001|Overall Study|Adverse Event|6|||
143376866|NCT01599104|516925211|FG002|Overall Study|Adverse Event|12|||
143376867|NCT02271854|516925216|FG000|Overall Study|Withdrawal by Subject|2|||
143376868|NCT02271854|516925216|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
143376869|NCT02271854|516925216|FG000|Overall Study|Lost to Follow-up|1|||
143376870|NCT01149369|516925219|FG000|Overall Study|Adverse Event|6|||
143376871|NCT01149369|516925220|FG001|Overall Study|Adverse Event|3|||
143376872|NCT01424397|516925221|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
143376873|NCT01424397|516925222|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
143376874|NCT01424397|516925223|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
143376875|NCT01424397|516925224|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
143376876|NCT01424397|516925225|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
143376877|NCT01424397|516925226|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
143376878|NCT01424397|516925227|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
143376879|NCT01424397|516925228|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
143376880|NCT01424397|516925229|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
143376881|NCT01424397|516925230|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
143376882|NCT01424397|516925231|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
143376883|NCT01424397|516925232|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
143376884|NCT01185561|516925233|FG000|Overall Study|Lost to Follow-up|0|||
143376885|NCT01185561|516925234|FG001|Overall Study|Lost to Follow-up|4|||
143376886|NCT01185561|516925233|FG000|Overall Study|Withdrawal by Subject|2|||
143376887|NCT01185561|516925234|FG001|Overall Study|Withdrawal by Subject|8|||
143376888|NCT01078116|516925235|FG000|Overall Study|Lost to Follow-up|17|||
143376889|NCT01078116|516925235|FG000|Overall Study|Adverse Event|5|||
143376890|NCT01078116|516925235|FG000|Overall Study|Withdrawal by Subject|8|||
143376891|NCT01078116|516925235|FG000|Overall Study|Lack of effectiveness|15|||
143376892|NCT01078116|516925235|FG000|Overall Study|Case report form not completed|3|||
143376893|NCT02616900|516925236|FG000|Overall Study|Lack of Efficacy|7|||
143376894|NCT02616900|516925236|FG000|Overall Study|Lost to Follow-up|2|||
143376895|NCT02616900|516925236|FG000|Overall Study|Protocol Violation|5|||
143376896|NCT02616900|516925236|FG000|Overall Study|Withdrawal by Subject|3|||
143376897|NCT02616900|516925236|FG000|Overall Study|Incomplete data|6|||
143376898|NCT02242487|516925237|FG000|Overall Study|Adverse Event|13|||
143376899|NCT02242487|516925238|FG001|Overall Study|Adverse Event|15|||
143376900|NCT02242487|516925237|FG000|Overall Study|Lack of Efficacy|4|||
143376901|NCT02242487|516925238|FG001|Overall Study|Lack of Efficacy|6|||
143376902|NCT02242487|516925237|FG000|Overall Study|Protocol Violation|2|||
143376903|NCT02242487|516925238|FG001|Overall Study|Protocol Violation|0|||
143376904|NCT02242487|516925237|FG000|Overall Study|Lost to Follow-up|2|||
143376905|NCT02242487|516925238|FG001|Overall Study|Lost to Follow-up|1|||
143376906|NCT02242487|516925237|FG000|Overall Study|Other - Miscellaneous|4|||
143376907|NCT02242487|516925238|FG001|Overall Study|Other - Miscellaneous|6|||
143376908|NCT02242487|516925237|FG000|Overall Study|Withdrawal by Subject|37|||
143376909|NCT02242487|516925238|FG001|Overall Study|Withdrawal by Subject|19|||
143376910|NCT00508924|516925241|FG000|Overall Study|Protocol Violation|0|||
143376911|NCT00508924|516925242|FG001|Overall Study|Protocol Violation|0|||
143376912|NCT00508924|516925243|FG002|Overall Study|Protocol Violation|1|||
143376913|NCT00508924|516925244|FG003|Overall Study|Protocol Violation|1|||
143376914|NCT04532528|516925245|FG000|Overall Study|Adverse Event|12|||
143376915|NCT04532528|516925246|FG001|Overall Study|Adverse Event|17|||
143376916|NCT04532528|516925245|FG000|Overall Study|Withdrawal of consent|16|||
143376917|NCT04532528|516925246|FG001|Overall Study|Withdrawal of consent|17|||
143376918|NCT04532528|516925245|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
143376919|NCT04532528|516925246|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
143376920|NCT04532528|516925245|FG000|Overall Study|Lost to Follow-up|69|||
143376921|NCT04532528|516925246|FG001|Overall Study|Lost to Follow-up|68|||
143376922|NCT04532528|516925245|FG000|Overall Study|Administrative problems|12|||
143376923|NCT04532528|516925246|FG001|Overall Study|Administrative problems|14|||
143376924|NCT04532528|516925245|FG000|Overall Study|Death|3|||
143376925|NCT04532528|516925246|FG001|Overall Study|Death|3|||
143376926|NCT04532528|516925245|FG000|Overall Study|Other|38|||
143376927|NCT04532528|516925246|FG001|Overall Study|Other|46|||
143376928|NCT01140048|516925252|FG000|Overall Study|Physician Decision|1|||
143376929|NCT01140048|516925252|FG000|Overall Study|Withdrawal by Subject|13|||
143376930|NCT01140048|516925252|FG000|Overall Study|Lost to Follow-up|31|||
143376931|NCT02888080|516925253|FG000|Overall Study|Subject / Guardian decision|1|||
143376932|NCT02888080|516925254|FG001|Overall Study|Subject / Guardian decision|3|||
143376933|NCT02888080|516925253|FG000|Overall Study|New Therapy for study indication|1|||
143376934|NCT02888080|516925254|FG001|Overall Study|New Therapy for study indication|0|||
143376935|NCT02888080|516925253|FG000|Overall Study|Lack of Efficacy|0|||
143376936|NCT02888080|516925254|FG001|Overall Study|Lack of Efficacy|1|||
143376937|NCT02888080|516925253|FG000|Overall Study|Adverse Event|0|||
143376938|NCT02888080|516925254|FG001|Overall Study|Adverse Event|1|||
143376939|NCT00980330|516925255|FG000|Overall Study|Adverse Event|0|||
143376940|NCT00980330|516925256|FG001|Overall Study|Adverse Event|0|||
143376941|NCT00980330|516925257|FG002|Overall Study|Adverse Event|0|||
143376942|NCT00980330|516925258|FG003|Overall Study|Adverse Event|1|||
143376943|NCT00980330|516925259|FG004|Overall Study|Adverse Event|0|||
143376944|NCT00980330|516925260|FG005|Overall Study|Adverse Event|0|||
143376945|NCT00980330|516925261|FG006|Overall Study|Adverse Event|0|||
143376946|NCT00980330|516925255|FG000|Overall Study|Lost to Follow-up|1|||
143376947|NCT00980330|516925256|FG001|Overall Study|Lost to Follow-up|1|||
143376948|NCT00980330|516925257|FG002|Overall Study|Lost to Follow-up|4|||
143376949|NCT00980330|516925258|FG003|Overall Study|Lost to Follow-up|2|||
143376950|NCT00980330|516925259|FG004|Overall Study|Lost to Follow-up|1|||
143376951|NCT00980330|516925260|FG005|Overall Study|Lost to Follow-up|1|||
143376952|NCT00980330|516925261|FG006|Overall Study|Lost to Follow-up|2|||
143376953|NCT00980330|516925255|FG000|Overall Study|Withdrawal by Subject|2|||
143376954|NCT00980330|516925256|FG001|Overall Study|Withdrawal by Subject|4|||
143315542|NCT02486406|516701692|FG000|Overall Study|Lost to Follow-up|1|||
143315543|NCT02486406|516701693|FG001|Overall Study|Lost to Follow-up|3|||
143315544|NCT02486406|516701694|FG002|Overall Study|Lost to Follow-up|1|||
143315545|NCT02486406|516701695|FG003|Overall Study|Lost to Follow-up|3|||
143315546|NCT02486406|516701692|FG000|Overall Study|Other, not specified|0|||
143315547|NCT02486406|516701693|FG001|Overall Study|Other, not specified|0|||
143315548|NCT02486406|516701694|FG002|Overall Study|Other, not specified|1|||
143315549|NCT02486406|516701695|FG003|Overall Study|Other, not specified|0|||
143315550|NCT01826825|516701696|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
143315551|NCT01826825|516701697|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
143315552|NCT01858194|516701698|FG000|Overall Study|Total Artificial Heart Implant|0|||
143315553|NCT01858194|516701699|FG001|Overall Study|Total Artificial Heart Implant|1|||
143315554|NCT01858194|516701698|FG000|Overall Study|Lost to Follow-up|0|||
143315555|NCT01858194|516701699|FG001|Overall Study|Lost to Follow-up|1|||
143315556|NCT03509948|516701703|FG000|Overall Study|Protocol Violation|0|||
143315557|NCT03509948|516701704|FG001|Overall Study|Protocol Violation|1|||
143315558|NCT03221257|516701705|FG000|Overall Study|Lost to Follow-up|0|||
143315559|NCT03221257|516701706|FG001|Overall Study|Lost to Follow-up|1|||
143315560|NCT03221257|516701705|FG000|Overall Study|Withdrawal by Subject|1|||
143315561|NCT03221257|516701706|FG001|Overall Study|Withdrawal by Subject|1|||
143315562|NCT05402995|516701707|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
143315563|NCT05402995|516701708|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
143315564|NCT05402995|516701709|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
143315565|NCT05402995|516701710|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
143315566|NCT01071512|516701711|FG000|Overall Study|Adverse Event|1|||
143315567|NCT01071512|516701711|FG000|Overall Study|Development of antibodies to drug|2|||
143315568|NCT01071512|516701711|FG000|Overall Study|positive anti-JC virus antibody test|2|||
143315569|NCT02188485|516701716|FG000|Overall Study|Withdrawal by Subject|2|||
143315570|NCT02188485|516701717|FG001|Overall Study|Withdrawal by Subject|1|||
143315571|NCT02188485|516701716|FG000|Overall Study|PI withdrew, lack of capacity|0|||
143315572|NCT02188485|516701717|FG001|Overall Study|PI withdrew, lack of capacity|2|||
143315573|NCT00799617|516701718|FG000|Main Testosterone Trial|Randomized in error|1|||
143315574|NCT00799617|516701719|FG001|Main Testosterone Trial|Randomized in error|1|||
143315575|NCT00799617|516701718|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
143315576|NCT00799617|516701719|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
143315577|NCT00799617|516701718|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
143315578|NCT00799617|516701719|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
143315579|NCT00799617|516701718|FG000|Sexual Funtion Trial|No Baseline Data|4|||
143315580|NCT00799617|516701719|FG001|Sexual Funtion Trial|No Baseline Data|7|||
143315581|NCT00799617|516701718|FG000|Physical Function Trial|Lost to Follow-up|6|||
143315582|NCT00799617|516701719|FG001|Physical Function Trial|Lost to Follow-up|11|||
143315583|NCT00799617|516701718|FG000|Vitality Trial|Lost to Follow-up|7|||
143315584|NCT00799617|516701719|FG001|Vitality Trial|Lost to Follow-up|22|||
143315585|NCT00799617|516701718|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
143315586|NCT00799617|516701719|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
143315587|NCT00799617|516701718|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
143315588|NCT00799617|516701719|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
143376955|NCT00980330|516925257|FG002|Overall Study|Withdrawal by Subject|4|||
143315589|NCT00799617|516701718|FG000|Bone Trial|Month 12 scan not available|6|||
143315590|NCT00799617|516701719|FG001|Bone Trial|Month 12 scan not available|16|||
143315591|NCT00799617|516701718|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
143315592|NCT00799617|516701719|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
143376956|NCT00980330|516925258|FG003|Overall Study|Withdrawal by Subject|1|||
143315593|NCT00799617|516701718|FG000|Anemia Trial|Withdrawal by Subject|3|||
143376957|NCT00980330|516925259|FG004|Overall Study|Withdrawal by Subject|3|||
143376958|NCT00980330|516925260|FG005|Overall Study|Withdrawal by Subject|2|||
143376959|NCT00980330|516925261|FG006|Overall Study|Withdrawal by Subject|5|||
143376960|NCT00980330|516925255|FG000|Overall Study|(not specified)|2|||
143376961|NCT00980330|516925256|FG001|Overall Study|(not specified)|0|||
143376962|NCT00980330|516925257|FG002|Overall Study|(not specified)|0|||
143376963|NCT00980330|516925258|FG003|Overall Study|(not specified)|1|||
143376964|NCT00980330|516925259|FG004|Overall Study|(not specified)|1|||
143376965|NCT00980330|516925260|FG005|Overall Study|(not specified)|1|||
143376966|NCT00980330|516925261|FG006|Overall Study|(not specified)|0|||
143376967|NCT00666276|516925264|FG000|Overall Study|Protocol Violation|34|||
143376968|NCT01039688|516925265|FG000|Overall Study|Adverse Event|38|||
143376969|NCT01039688|516925266|FG001|Overall Study|Adverse Event|39|||
143376970|NCT01039688|516925267|FG002|Overall Study|Adverse Event|24|||
143376971|NCT01039688|516925265|FG000|Overall Study|Lack of Efficacy|20|||
143376972|NCT01039688|516925266|FG001|Overall Study|Lack of Efficacy|11|||
143376973|NCT01039688|516925267|FG002|Overall Study|Lack of Efficacy|26|||
143376974|NCT01039688|516925265|FG000|Overall Study|Lost to Follow-up|11|||
143376975|NCT01039688|516925266|FG001|Overall Study|Lost to Follow-up|9|||
143376976|NCT01039688|516925267|FG002|Overall Study|Lost to Follow-up|5|||
143376977|NCT01039688|516925265|FG000|Overall Study|Other|13|||
143376978|NCT01039688|516925266|FG001|Overall Study|Other|25|||
143376979|NCT01039688|516925267|FG002|Overall Study|Other|12|||
143376980|NCT01039688|516925265|FG000|Overall Study|Withdrawal by Subject|23|||
143376981|NCT01039688|516925266|FG001|Overall Study|Withdrawal by Subject|27|||
143376982|NCT01039688|516925267|FG002|Overall Study|Withdrawal by Subject|13|||
143376983|NCT01039688|516925265|FG000|Overall Study|Death|2|||
143376984|NCT01039688|516925266|FG001|Overall Study|Death|0|||
143376985|NCT01039688|516925267|FG002|Overall Study|Death|0|||
143315594|NCT00799617|516701719|FG001|Anemia Trial|Withdrawal by Subject|3|||
143315595|NCT01712984|516701720|FG000|Overall Study|Adverse Event|0|||
143315596|NCT01712984|516701721|FG001|Overall Study|Adverse Event|0|||
143315597|NCT01712984|516701722|FG002|Overall Study|Adverse Event|1|||
143315598|NCT01712984|516701720|FG000|Overall Study|Protocol Violation|2|||
143315599|NCT01712984|516701721|FG001|Overall Study|Protocol Violation|0|||
143315600|NCT01712984|516701722|FG002|Overall Study|Protocol Violation|1|||
143315601|NCT01712984|516701720|FG000|Overall Study|Lost to Follow-up|8|||
143315602|NCT01712984|516701721|FG001|Overall Study|Lost to Follow-up|10|||
143315603|NCT01712984|516701722|FG002|Overall Study|Lost to Follow-up|1|||
143315604|NCT01712984|516701720|FG000|Overall Study|Withdrawal by Subject|6|||
143315605|NCT01712984|516701721|FG001|Overall Study|Withdrawal by Subject|6|||
143315606|NCT01712984|516701722|FG002|Overall Study|Withdrawal by Subject|7|||
143315607|NCT00437034|516701725|FG000|Overall Study|Adverse Event|1|||
143315608|NCT00437034|516701725|FG000|Overall Study|Disease progression during treatment|5|||
143315609|NCT01069289|516701728|FG000|Overall Study|Withdrawal by Subject|15|||
143315610|NCT01069289|516701729|FG001|Overall Study|Withdrawal by Subject|26|||
143315611|NCT01069289|516701728|FG000|Overall Study|Adverse Event|21|||
143315612|NCT01069289|516701729|FG001|Overall Study|Adverse Event|28|||
143315613|NCT01069289|516701728|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
143315614|NCT01069289|516701729|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
143315615|NCT01069289|516701728|FG000|Overall Study|Severe non-compliance to protocol|3|||
143315616|NCT01069289|516701729|FG001|Overall Study|Severe non-compliance to protocol|2|||
143315617|NCT01069289|516701728|FG000|Overall Study|Due to deteriorating health condition|1|||
143315618|NCT01069289|516701729|FG001|Overall Study|Due to deteriorating health condition|0|||
143315619|NCT00298038|516701730|FG000|Overall Study|Lost to Follow-up|0|||
143315620|NCT00298038|516701731|FG001|Overall Study|Lost to Follow-up|1|||
143315621|NCT00298038|516701730|FG000|Overall Study|Liver Transplant|0|||
143315622|NCT00298038|516701731|FG001|Overall Study|Liver Transplant|1|||
143315623|NCT00298038|516701730|FG000|Overall Study|Protocol Violation|1|||
143315624|NCT00298038|516701731|FG001|Overall Study|Protocol Violation|3|||
143315625|NCT00298038|516701730|FG000|Overall Study|Death|6|||
143315626|NCT00298038|516701731|FG001|Overall Study|Death|3|||
143315627|NCT00298038|516701730|FG000|Overall Study|Withdrawal by Subject|6|||
143376986|NCT02594735|516925268|FG000|Overall Study|Adverse Event|1|||
143376987|NCT03844269|516925272|FG000|Overall Study|Withdrawal pre-intervention|1|||
143376988|NCT03844269|516925272|FG000|Overall Study|Did not complete the intervention|2|||
143315628|NCT00298038|516701731|FG001|Overall Study|Withdrawal by Subject|9|||
143315629|NCT00298038|516701730|FG000|Overall Study|Adverse Event|8|||
143315630|NCT00298038|516701731|FG001|Overall Study|Adverse Event|7|||
143315631|NCT00298038|516701730|FG000|Overall Study|Breakthrough overt HE episode|28|||
143376989|NCT00665444|516925273|FG000|Overall Study|Physician Decision|1|||
143376990|NCT00665444|516925273|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
143376991|NCT00101010|516925277|FG000|Overall Study|Physician Decision|1|||
143376992|NCT03520413|516925278|FG000|Overall Study|Lost to Follow-up|1|||
143315632|NCT00298038|516701731|FG001|Overall Study|Breakthrough overt HE episode|69|||
143315633|NCT00298038|516701730|FG000|Overall Study|Noncompliance|1|||
143315634|NCT00298038|516701731|FG001|Overall Study|Noncompliance|0|||
143315635|NCT00298038|516701730|FG000|Overall Study|Cocaine Abuse|1|||
143376993|NCT03520413|516925279|FG001|Overall Study|Lost to Follow-up|1|||
143315636|NCT00298038|516701731|FG001|Overall Study|Cocaine Abuse|0|||
143315637|NCT00298038|516701730|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
143315638|NCT00298038|516701731|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
143315639|NCT02707640|516701732|FG000|Overall Study|Adverse Event|4|||
143315640|NCT02707640|516701733|FG001|Overall Study|Adverse Event|2|||
143315641|NCT02707640|516701732|FG000|Overall Study|Death|1|||
143315642|NCT02707640|516701733|FG001|Overall Study|Death|2|||
143315643|NCT02707640|516701732|FG000|Overall Study|Physician Decision|2|||
143315644|NCT02707640|516701733|FG001|Overall Study|Physician Decision|0|||
143315645|NCT02707640|516701732|FG000|Overall Study|Withdrawal by Subject|0|||
143315646|NCT02707640|516701733|FG001|Overall Study|Withdrawal by Subject|1|||
143315647|NCT02707640|516701732|FG000|Overall Study|Participant's Personal Decision|1|||
143315648|NCT02707640|516701733|FG001|Overall Study|Participant's Personal Decision|2|||
143315649|NCT02707640|516701732|FG000|Overall Study|Sponsor Discretion|1|||
143315650|NCT02707640|516701733|FG001|Overall Study|Sponsor Discretion|0|||
143376994|NCT03520413|516925278|FG000|Overall Study|Withdrawal by Subject|1|||
143376995|NCT03520413|516925279|FG001|Overall Study|Withdrawal by Subject|2|||
143376996|NCT03520413|516925278|FG000|Overall Study|Death|0|||
143376997|NCT03520413|516925279|FG001|Overall Study|Death|1|||
143376998|NCT03520413|516925278|FG000|Overall Study|Physician Decision|3|||
143376999|NCT03520413|516925279|FG001|Overall Study|Physician Decision|3|||
143377000|NCT03520413|516925278|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
143377001|NCT03520413|516925279|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
143377002|NCT04054635|516925284|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
143377003|NCT04054635|516925285|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
143377004|NCT04054635|516925286|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
143377005|NCT04054635|516925284|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
143377006|NCT04054635|516925285|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
143377007|NCT04054635|516925286|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
143377008|NCT03737240|516925287|FG000|Overall Study|Lost to Follow-up|16|||
143377009|NCT03737240|516925288|FG001|Overall Study|Lost to Follow-up|15|||
143377010|NCT00891930|516925289|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
143377011|NCT00891930|516925289|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
143377012|NCT00891930|516925289|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
143377013|NCT00891930|516925289|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
143377014|NCT00891930|516925289|FG000|Part 2 Panitumumab + AMG479|Death|30|||
143377015|NCT00535145|516925294|FG000|Phase I|Adverse Event|3|||
143377016|NCT00535145|516925294|FG000|Phase I|Lost to Follow-up|7|||
143377017|NCT00535145|516925294|FG000|Phase I|Withdrawal by Subject|6|||
143377018|NCT00535145|516925294|FG000|Phase I|(eligibility)|8|||
143377019|NCT00535145|516925294|FG000|Phase I|(protocol violation)|1|||
143377020|NCT00535145|516925294|FG000|Phase I|(PI decision)|1|||
143377021|NCT00535145|516925294|FG000|Phase I|(diagnosis)|3|||
143377022|NCT00535145|516925294|FG000|Phase II|Adverse Event|2|||
143377023|NCT00535145|516925294|FG000|Phase II|Lack of Efficacy|1|||
143377024|NCT00535145|516925294|FG000|Phase II|Lost to Follow-up|5|||
143377025|NCT00535145|516925294|FG000|Phase II|Withdrawal by Subject|5|||
143377026|NCT00535145|516925294|FG000|Phase II|Subject non-compliance|2|||
143377027|NCT00433199|516925298|FG000|Double-Blind Period|Adverse Event|0|||
143377028|NCT00433199|516925299|FG001|Double-Blind Period|Adverse Event|25|||
143377029|NCT00433199|516925298|FG000|Double-Blind Period|Lack of Efficacy|0|||
143377030|NCT00433199|516925299|FG001|Double-Blind Period|Lack of Efficacy|2|||
143377031|NCT00433199|516925298|FG000|Double-Blind Period|Lost to Follow-up|2|||
143377032|NCT00433199|516925299|FG001|Double-Blind Period|Lost to Follow-up|5|||
143377033|NCT00433199|516925298|FG000|Double-Blind Period|Withdrawal by Subject|8|||
143377034|NCT00433199|516925299|FG001|Double-Blind Period|Withdrawal by Subject|19|||
143377035|NCT00433199|516925298|FG000|Double-Blind Period|Protocol Violation|1|||
143377036|NCT00433199|516925299|FG001|Double-Blind Period|Protocol Violation|10|||
143377037|NCT00433199|516925298|FG000|Double-Blind Period|Administrative|1|||
143377038|NCT00433199|516925299|FG001|Double-Blind Period|Administrative|5|||
143377039|NCT00433199|516925298|FG000|Open-Label Period|Adverse Event|0|||
143377040|NCT00433199|516925299|FG001|Open-Label Period|Adverse Event|19|||
143377041|NCT00433199|516925298|FG000|Open-Label Period|Lack of Efficacy|0|||
143377042|NCT00433199|516925299|FG001|Open-Label Period|Lack of Efficacy|2|||
143377043|NCT00433199|516925298|FG000|Open-Label Period|Lost to Follow-up|0|||
143377044|NCT00433199|516925299|FG001|Open-Label Period|Lost to Follow-up|3|||
143377045|NCT00433199|516925298|FG000|Open-Label Period|Withdrawal by Subject|0|||
143377046|NCT00433199|516925299|FG001|Open-Label Period|Withdrawal by Subject|7|||
143377047|NCT00433199|516925298|FG000|Open-Label Period|Protocol Violation|0|||
143377048|NCT00433199|516925299|FG001|Open-Label Period|Protocol Violation|2|||
143377049|NCT00433199|516925298|FG000|Open-Label Period|Administrative|0|||
143377050|NCT00433199|516925299|FG001|Open-Label Period|Administrative|1|||
143377051|NCT04305405|516925300|FG000|Overall Study|Withdrawal by parent/guardian|0|||
143377052|NCT04305405|516925301|FG001|Overall Study|Withdrawal by parent/guardian|1|||
143377053|NCT00206375|516925302|FG000|Overall Study|Lost to Follow-up|1|||
143377054|NCT00206375|516925303|FG001|Overall Study|Lost to Follow-up|0|||
143377055|NCT00206375|516925304|FG002|Overall Study|Lost to Follow-up|0|||
143315651|NCT02293005|516703167|FG000|Overall Study|Adverse Event|2|||
143315652|NCT02293005|516703167|FG000|Overall Study|Death|4|||
143315653|NCT02293005|516703167|FG000|Overall Study|Lost to Follow-up|1|||
143315654|NCT02293005|516703167|FG000|Overall Study|Withdrawal by Subject|2|||
143315655|NCT02293005|516703167|FG000|Overall Study|Progression|17|||
143315656|NCT03328897|516703168|FG000|Randomized-treatment Epoch|Adverse Event|4|||
143315657|NCT03328897|516703169|FG001|Randomized-treatment Epoch|Adverse Event|1|||
143315658|NCT03328897|516703170|FG002|Randomized-treatment Epoch|Adverse Event|1|||
143315659|NCT03328897|516703168|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
143315660|NCT03328897|516703169|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
143315661|NCT03328897|516703170|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
143315662|NCT03328897|516703168|FG000|Randomized-treatment Epoch|Pregnancy|3|||
143315663|NCT03328897|516703169|FG001|Randomized-treatment Epoch|Pregnancy|0|||
143315664|NCT03328897|516703170|FG002|Randomized-treatment Epoch|Pregnancy|0|||
143315665|NCT03328897|516703168|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
143315666|NCT03328897|516703169|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
143315667|NCT03328897|516703170|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
143315668|NCT03328897|516703168|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
143315669|NCT03328897|516703169|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
143315670|NCT03328897|516703170|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
143315671|NCT03328897|516703168|FG000|Follow-up Epoch|Adverse Event|4|||
143315672|NCT03328897|516703169|FG001|Follow-up Epoch|Adverse Event|0|||
143315673|NCT03328897|516703170|FG002|Follow-up Epoch|Adverse Event|1|||
143315674|NCT03328897|516703168|FG000|Follow-up Epoch|Lack of Efficacy|1|||
143315675|NCT03328897|516703169|FG001|Follow-up Epoch|Lack of Efficacy|1|||
143315676|NCT03328897|516703170|FG002|Follow-up Epoch|Lack of Efficacy|1|||
143315677|NCT03328897|516703168|FG000|Follow-up Epoch|Lost to Follow-up|0|||
143315678|NCT03328897|516703169|FG001|Follow-up Epoch|Lost to Follow-up|1|||
143315679|NCT03328897|516703170|FG002|Follow-up Epoch|Lost to Follow-up|0|||
143315680|NCT03328897|516703168|FG000|Follow-up Epoch|Pregnancy|1|||
143315681|NCT03328897|516703169|FG001|Follow-up Epoch|Pregnancy|0|||
143315682|NCT03328897|516703170|FG002|Follow-up Epoch|Pregnancy|0|||
143315683|NCT03328897|516703168|FG000|Follow-up Epoch|Patient/guardian decision|2|||
143315684|NCT03328897|516703169|FG001|Follow-up Epoch|Patient/guardian decision|1|||
143315685|NCT03328897|516703170|FG002|Follow-up Epoch|Patient/guardian decision|0|||
143315686|NCT00608829|516703172|FG000|Overall Study|Death|6|||
143315687|NCT00608829|516703172|FG000|Overall Study|Withdrawal by Subject|4|||
143315688|NCT00608829|516703172|FG000|Overall Study|Subject refuses to follow up or return.|5|||
143315689|NCT02564471|516703173|FG000|Overall Study|Adverse Event|1|||
143315690|NCT02564471|516703174|FG001|Overall Study|Adverse Event|0|||
143315691|NCT02564471|516703175|FG002|Overall Study|Adverse Event|0|||
143315692|NCT02564471|516703176|FG003|Overall Study|Adverse Event|0|||
143315693|NCT02564471|516703173|FG000|Overall Study|Withdrawal by Subject|2|||
143315694|NCT02564471|516703174|FG001|Overall Study|Withdrawal by Subject|1|||
143315695|NCT02564471|516703175|FG002|Overall Study|Withdrawal by Subject|3|||
143315696|NCT02564471|516703176|FG003|Overall Study|Withdrawal by Subject|0|||
143315697|NCT02564471|516703173|FG000|Overall Study|Lost to Follow-up|0|||
143315698|NCT02564471|516703174|FG001|Overall Study|Lost to Follow-up|2|||
143315699|NCT02564471|516703175|FG002|Overall Study|Lost to Follow-up|0|||
143315700|NCT02564471|516703176|FG003|Overall Study|Lost to Follow-up|0|||
143315701|NCT00941733|516703177|FG000|Overall Study|Death|24|||
143315702|NCT00941733|516703178|FG001|Overall Study|Death|10|||
143315703|NCT00941733|516703177|FG000|Overall Study|Withdrawal by Subject|14|||
143315704|NCT00941733|516703178|FG001|Overall Study|Withdrawal by Subject|6|||
143315705|NCT00941733|516703177|FG000|Overall Study|Adverse Event|20|||
143315706|NCT00941733|516703178|FG001|Overall Study|Adverse Event|4|||
143315707|NCT00941733|516703177|FG000|Overall Study|Lost to Follow-up|1|||
143315708|NCT00941733|516703178|FG001|Overall Study|Lost to Follow-up|2|||
143315709|NCT00941733|516703177|FG000|Overall Study|Protocol Violation|15|||
143315710|NCT00941733|516703178|FG001|Overall Study|Protocol Violation|6|||
143315711|NCT01076400|516703180|FG000|Overall Study|Adverse Event|2|||
143315712|NCT01076400|516703181|FG001|Overall Study|Adverse Event|0|||
143315713|NCT01076400|516703182|FG002|Overall Study|Adverse Event|0|||
143315714|NCT01076400|516703180|FG000|Overall Study|Progressive Disease|5|||
143377056|NCT00206375|516925302|FG000|Overall Study|Withdrawal by Subject|2|||
143315715|NCT01076400|516703181|FG001|Overall Study|Progressive Disease|0|||
143315716|NCT01076400|516703182|FG002|Overall Study|Progressive Disease|0|||
143377057|NCT00206375|516925303|FG001|Overall Study|Withdrawal by Subject|1|||
143315717|NCT00612066|516703185|FG000|Overall Study|Adverse Event|1|||
143315718|NCT03019536|516703187|FG000|Overall Study|Withdrawal by Subject|1|||
143315719|NCT03019536|516703188|FG001|Overall Study|Withdrawal by Subject|1|||
143315720|NCT03019536|516703189|FG002|Overall Study|Withdrawal by Subject|0|||
143315721|NCT03019536|516703187|FG000|Overall Study|Adverse Event|0|||
143315722|NCT03019536|516703188|FG001|Overall Study|Adverse Event|0|||
143315723|NCT03019536|516703189|FG002|Overall Study|Adverse Event|2|||
143315724|NCT00182689|516703195|FG000|Overall Study|Adverse Event|8|||
143315725|NCT00182689|516703196|FG001|Overall Study|Adverse Event|11|||
143315726|NCT00182689|516703195|FG000|Overall Study|Withdrawal by Subject|2|||
143377058|NCT00206375|516925304|FG002|Overall Study|Withdrawal by Subject|3|||
143377059|NCT00206375|516925302|FG000|Overall Study|Study terminated due to lack of funds|0|||
143377060|NCT00206375|516925303|FG001|Overall Study|Study terminated due to lack of funds|1|||
143315727|NCT00182689|516703196|FG001|Overall Study|Withdrawal by Subject|2|||
143315728|NCT00182689|516703195|FG000|Overall Study|Progression|27|||
143315729|NCT00182689|516703196|FG001|Overall Study|Progression|29|||
143315730|NCT00182689|516703195|FG000|Overall Study|Death|1|||
143315731|NCT00182689|516703196|FG001|Overall Study|Death|0|||
143315732|NCT00182689|516703195|FG000|Overall Study|not protocol specified|0|||
143315733|NCT00182689|516703196|FG001|Overall Study|not protocol specified|3|||
143315734|NCT00182689|516703195|FG000|Overall Study|Ineligible|1|||
143315735|NCT00182689|516703196|FG001|Overall Study|Ineligible|4|||
143315736|NCT00182689|516703195|FG000|Overall Study|Never received treatment|1|||
143315737|NCT00182689|516703196|FG001|Overall Study|Never received treatment|0|||
143315738|NCT00659646|516703199|FG000|Overall Study|Protocol Violation|12|||
143315739|NCT00659646|516703200|FG001|Overall Study|Protocol Violation|8|||
143315740|NCT00659646|516703199|FG000|Overall Study|Adverse Event|1|||
143315741|NCT00659646|516703200|FG001|Overall Study|Adverse Event|0|||
143315742|NCT00659646|516703199|FG000|Overall Study|Lost to Follow-up|1|||
143315743|NCT00659646|516703200|FG001|Overall Study|Lost to Follow-up|0|||
143315744|NCT00659646|516703199|FG000|Overall Study|protocol noncompliance after randomized|1|||
143315745|NCT00659646|516703200|FG001|Overall Study|protocol noncompliance after randomized|0|||
143315746|NCT01750268|516703202|FG000|Overall Study|Lost to Follow-up|0|||
143315747|NCT01750268|516703203|FG001|Overall Study|Lost to Follow-up|2|||
143315748|NCT01750268|516703202|FG000|Overall Study|Physician Decision|0|||
143315749|NCT01750268|516703203|FG001|Overall Study|Physician Decision|3|||
143315750|NCT01750268|516703202|FG000|Overall Study|Withdrawal by Subject|2|||
143315751|NCT01750268|516703203|FG001|Overall Study|Withdrawal by Subject|0|||
143315752|NCT00966940|516703204|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
143315753|NCT00966940|516703205|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
143315754|NCT00966940|516703204|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
143315755|NCT00966940|516703205|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
143315756|NCT01529645|516703210|FG000|Overall Study|Lost to Follow-up|0|||
143315757|NCT01529645|516703211|FG001|Overall Study|Lost to Follow-up|1|||
143315758|NCT01529645|516703212|FG002|Overall Study|Lost to Follow-up|1|||
143315759|NCT01529645|516703213|FG003|Overall Study|Lost to Follow-up|1|||
143315760|NCT01529645|516703214|FG004|Overall Study|Lost to Follow-up|1|||
143315761|NCT01529645|516703215|FG005|Overall Study|Lost to Follow-up|0|||
143315762|NCT01529645|516703216|FG006|Overall Study|Lost to Follow-up|2|||
143315763|NCT01529645|516703217|FG007|Overall Study|Lost to Follow-up|0|||
143315764|NCT01529645|516703218|FG008|Overall Study|Lost to Follow-up|1|||
143315765|NCT01529645|516703219|FG009|Overall Study|Lost to Follow-up|0|||
143315766|NCT01529645|516703210|FG000|Overall Study|SAE - Premature contractions|0|||
143315767|NCT01529645|516703211|FG001|Overall Study|SAE - Premature contractions|0|||
143315768|NCT01529645|516703212|FG002|Overall Study|SAE - Premature contractions|1|||
143315769|NCT01529645|516703213|FG003|Overall Study|SAE - Premature contractions|0|||
143315770|NCT01529645|516703214|FG004|Overall Study|SAE - Premature contractions|0|||
143315771|NCT01529645|516703215|FG005|Overall Study|SAE - Premature contractions|0|||
143315772|NCT01529645|516703216|FG006|Overall Study|SAE - Premature contractions|0|||
143315773|NCT01529645|516703217|FG007|Overall Study|SAE - Premature contractions|0|||
143315774|NCT01529645|516703218|FG008|Overall Study|SAE - Premature contractions|0|||
143315775|NCT01529645|516703219|FG009|Overall Study|SAE - Premature contractions|0|||
143315776|NCT01529645|516703210|FG000|Overall Study|Withdrawal by Subject|2|||
143315777|NCT01529645|516703211|FG001|Overall Study|Withdrawal by Subject|0|||
143315778|NCT01529645|516703212|FG002|Overall Study|Withdrawal by Subject|0|||
143315779|NCT01529645|516703213|FG003|Overall Study|Withdrawal by Subject|1|||
143315780|NCT01529645|516703214|FG004|Overall Study|Withdrawal by Subject|1|||
143315781|NCT01529645|516703215|FG005|Overall Study|Withdrawal by Subject|1|||
143315782|NCT01529645|516703216|FG006|Overall Study|Withdrawal by Subject|0|||
143315783|NCT01529645|516703217|FG007|Overall Study|Withdrawal by Subject|0|||
143315784|NCT01529645|516703218|FG008|Overall Study|Withdrawal by Subject|0|||
143315785|NCT01529645|516703219|FG009|Overall Study|Withdrawal by Subject|0|||
143315786|NCT00274716|516703224|FG000|Phase A|Other non-reported reason|4|||
143315787|NCT00274716|516703225|FG001|Phase A|Other non-reported reason|2|||
143315788|NCT00274716|516703226|FG002|Phase A|Other non-reported reason|1|||
143315789|NCT00274716|516703227|FG003|Phase A|Other non-reported reason|2|||
143315790|NCT00274716|516703228|FG004|Phase A|Other non-reported reason|0|||
143315791|NCT00274716|516703229|FG005|Phase A|Other non-reported reason|1|||
143315792|NCT00274716|516703224|FG000|Phase A|Participant moved|0|||
143315793|NCT00274716|516703225|FG001|Phase A|Participant moved|0|||
143315794|NCT00274716|516703226|FG002|Phase A|Participant moved|1|||
143377061|NCT00206375|516925304|FG002|Overall Study|Study terminated due to lack of funds|1|||
143377062|NCT02674750|516925305|FG000|Overall Study|Death|4|||
143377063|NCT02674750|516925306|FG001|Overall Study|Death|5|||
143377064|NCT02674750|516925307|FG002|Overall Study|Death|8|||
143377065|NCT02674750|516925305|FG000|Overall Study|Lost to Follow-up|0|||
143377066|NCT02674750|516925306|FG001|Overall Study|Lost to Follow-up|8|||
143377067|NCT02674750|516925307|FG002|Overall Study|Lost to Follow-up|0|||
143377068|NCT02674750|516925305|FG000|Overall Study|Lack of Efficacy|1|||
143377069|NCT02674750|516925306|FG001|Overall Study|Lack of Efficacy|17|||
143377070|NCT02674750|516925307|FG002|Overall Study|Lack of Efficacy|3|||
143377071|NCT02674750|516925305|FG000|Overall Study|Withdrawal by Subject|0|||
143377072|NCT02674750|516925306|FG001|Overall Study|Withdrawal by Subject|7|||
143377073|NCT02674750|516925307|FG002|Overall Study|Withdrawal by Subject|1|||
143377074|NCT02674750|516925305|FG000|Overall Study|Other|0|||
143377075|NCT02674750|516925306|FG001|Overall Study|Other|8|||
143377076|NCT02674750|516925307|FG002|Overall Study|Other|0|||
143377077|NCT01787760|516925310|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
143377078|NCT01787760|516925311|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
143377079|NCT01787760|516925312|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
143377080|NCT01787760|516925310|FG000|Overall Study|Decompensated on left exotropia|0|||
143377081|NCT01787760|516925311|FG001|Overall Study|Decompensated on left exotropia|0|||
143377082|NCT01787760|516925312|FG002|Overall Study|Decompensated on left exotropia|1|||
143377083|NCT01787760|516925310|FG000|Overall Study|Dryness|0|||
143377084|NCT01787760|516925311|FG001|Overall Study|Dryness|1|||
143377085|NCT01787760|516925312|FG002|Overall Study|Dryness|0|||
143377086|NCT01787760|516925310|FG000|Overall Study|Relocation|1|||
143377087|NCT01787760|516925311|FG001|Overall Study|Relocation|1|||
143377088|NCT01787760|516925312|FG002|Overall Study|Relocation|0|||
143377089|NCT01787760|516925310|FG000|Overall Study|Lens discomfort|3|||
143377090|NCT01787760|516925311|FG001|Overall Study|Lens discomfort|0|||
143377091|NCT01787760|516925312|FG002|Overall Study|Lens discomfort|0|||
143377092|NCT01787760|516925310|FG000|Overall Study|Lens handling difficulty|1|||
143377093|NCT01787760|516925311|FG001|Overall Study|Lens handling difficulty|2|||
143377094|NCT01787760|516925312|FG002|Overall Study|Lens handling difficulty|0|||
143377095|NCT01787760|516925310|FG000|Overall Study|Protocol Violation|6|||
143377096|NCT01787760|516925311|FG001|Overall Study|Protocol Violation|0|||
143377097|NCT01787760|516925312|FG002|Overall Study|Protocol Violation|1|||
143377098|NCT01787760|516925310|FG000|Overall Study|Withdrawal by Subject|5|||
143377099|NCT01787760|516925311|FG001|Overall Study|Withdrawal by Subject|1|||
143377100|NCT01787760|516925312|FG002|Overall Study|Withdrawal by Subject|2|||
143377101|NCT01787760|516925310|FG000|Overall Study|Lost to Follow-up|1|||
143377102|NCT01787760|516925311|FG001|Overall Study|Lost to Follow-up|0|||
143377103|NCT01787760|516925312|FG002|Overall Study|Lost to Follow-up|1|||
143377104|NCT01787760|516925310|FG000|Overall Study|Stroke|1|||
143377105|NCT01787760|516925311|FG001|Overall Study|Stroke|0|||
143377106|NCT01787760|516925312|FG002|Overall Study|Stroke|0|||
143377107|NCT01787760|516925310|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
143377108|NCT01787760|516925311|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
143377109|NCT01787760|516925312|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
143377110|NCT01787760|516925310|FG000|Overall Study|Unsatisfactory physiological response|2|||
143377111|NCT01787760|516925311|FG001|Overall Study|Unsatisfactory physiological response|4|||
143377112|NCT01787760|516925312|FG002|Overall Study|Unsatisfactory physiological response|0|||
143377113|NCT01787760|516925310|FG000|Overall Study|Unsatisfactory visual response|1|||
143377114|NCT01787760|516925311|FG001|Overall Study|Unsatisfactory visual response|1|||
143377115|NCT01787760|516925312|FG002|Overall Study|Unsatisfactory visual response|0|||
143377116|NCT01787760|516925310|FG000|Overall Study|Near vision blur|1|||
143377117|NCT01787760|516925311|FG001|Overall Study|Near vision blur|0|||
143377118|NCT01787760|516925312|FG002|Overall Study|Near vision blur|0|||
143377119|NCT00632424|516925319|FG000|Overall Study|Disease Progression|17|||
143377120|NCT00632424|516925319|FG000|Overall Study|Study Drug Toxicity|1|||
143377121|NCT03073941|516926716|FG000|Overall Study|Received non-study device intraoperatively|0|||
143377122|NCT03073941|516926717|FG001|Overall Study|Received non-study device intraoperatively|2|||
143377123|NCT03073941|516926716|FG000|Overall Study|Death|1|||
143377124|NCT03073941|516926717|FG001|Overall Study|Death|0|||
143377125|NCT03073941|516926716|FG000|Overall Study|Withdrawal by Subject|1|||
143377126|NCT03073941|516926717|FG001|Overall Study|Withdrawal by Subject|3|||
143377127|NCT03073941|516926716|FG000|Overall Study|Lost to Follow-up|5|||
143377128|NCT03073941|516926717|FG001|Overall Study|Lost to Follow-up|4|||
143377129|NCT03073941|516926716|FG000|Overall Study|Adverse Event|4|||
143377130|NCT03073941|516926717|FG001|Overall Study|Adverse Event|2|||
143377131|NCT03073941|516926716|FG000|Overall Study|Met an exclusion criterion|0|||
143377132|NCT03073941|516926717|FG001|Overall Study|Met an exclusion criterion|1|||
143377133|NCT01391832|516926718|FG000|Overall Study|Withdrawal by Subject|21|||
143377134|NCT01391832|516926719|FG001|Overall Study|Withdrawal by Subject|22|||
143377135|NCT01391832|516926718|FG000|Overall Study|Lost to Follow-up|0|||
143377136|NCT01391832|516926719|FG001|Overall Study|Lost to Follow-up|1|||
143377137|NCT01318382|516926723|FG000|Overall Study|Physician Decision|2|||
143377138|NCT01318382|516926723|FG000|Overall Study|Device Malfunction|10|||
143377139|NCT01318382|516926723|FG000|Overall Study|Protocol Violation|1|||
143377140|NCT01308567|516926724|FG000|Overall Study|Lost to Follow-up|2|||
143377141|NCT01308567|516926725|FG001|Overall Study|Lost to Follow-up|4|||
143377142|NCT01308567|516926726|FG002|Overall Study|Lost to Follow-up|4|||
143377143|NCT02564744|516926729|FG000|Overall Study|Investigator decision|0|||
143377144|NCT02564744|516926730|FG001|Overall Study|Investigator decision|0|||
143377145|NCT02564744|516926731|FG002|Overall Study|Investigator decision|0|||
143377146|NCT02564744|516926732|FG003|Overall Study|Investigator decision|0|||
143377147|NCT02564744|516926733|FG004|Overall Study|Investigator decision|1|||
143377148|NCT02564744|516926729|FG000|Overall Study|Death|10|||
143377149|NCT02564744|516926730|FG001|Overall Study|Death|5|||
143377150|NCT02564744|516926731|FG002|Overall Study|Death|4|||
143377151|NCT02564744|516926732|FG003|Overall Study|Death|16|||
143377152|NCT02564744|516926733|FG004|Overall Study|Death|16|||
143377153|NCT02564744|516926729|FG000|Overall Study|End of study Page Missing|0|||
143377154|NCT02564744|516926730|FG001|Overall Study|End of study Page Missing|0|||
143377155|NCT02564744|516926731|FG002|Overall Study|End of study Page Missing|3|||
143377156|NCT02564744|516926732|FG003|Overall Study|End of study Page Missing|3|||
143377157|NCT02564744|516926733|FG004|Overall Study|End of study Page Missing|0|||
143377158|NCT02564744|516926729|FG000|Overall Study|Subject Withdrew Consent|1|||
143377159|NCT02564744|516926730|FG001|Overall Study|Subject Withdrew Consent|1|||
143377160|NCT02564744|516926731|FG002|Overall Study|Subject Withdrew Consent|1|||
143377161|NCT02564744|516926732|FG003|Overall Study|Subject Withdrew Consent|0|||
143377162|NCT02564744|516926733|FG004|Overall Study|Subject Withdrew Consent|2|||
143377163|NCT02564744|516926729|FG000|Overall Study|Lost to Follow-up|0|||
143377164|NCT02564744|516926730|FG001|Overall Study|Lost to Follow-up|1|||
143377165|NCT02564744|516926731|FG002|Overall Study|Lost to Follow-up|0|||
143377166|NCT02564744|516926732|FG003|Overall Study|Lost to Follow-up|0|||
143377167|NCT02564744|516926733|FG004|Overall Study|Lost to Follow-up|1|||
143377168|NCT02564744|516926729|FG000|Overall Study|Reason not specified|1|||
143377169|NCT02564744|516926730|FG001|Overall Study|Reason not specified|0|||
143377170|NCT02564744|516926731|FG002|Overall Study|Reason not specified|0|||
143377171|NCT02564744|516926732|FG003|Overall Study|Reason not specified|0|||
143377172|NCT02564744|516926733|FG004|Overall Study|Reason not specified|0|||
143377173|NCT01177670|516926742|FG000|Overall Study|Study Terminated|115|||
143377174|NCT01177670|516926742|FG000|Overall Study|Physician Decision|50|||
143377175|NCT01177670|516926742|FG000|Overall Study|Withdrawal by Subject|4|||
143377176|NCT01636687|516926746|FG000|Induction Period|Withdrawal by Subject|1|||
143377177|NCT01636687|516926747|FG001|Induction Period|Withdrawal by Subject|0|||
143377178|NCT01636687|516926748|FG002|Induction Period|Withdrawal by Subject|0|||
143377179|NCT01636687|516926749|FG003|Induction Period|Withdrawal by Subject|0|||
143377180|NCT01636687|516926750|FG004|Induction Period|Withdrawal by Subject|0|||
143377181|NCT01636687|516926746|FG000|Induction Period|Adverse Event|1|||
143377182|NCT01636687|516926747|FG001|Induction Period|Adverse Event|0|||
143377183|NCT01636687|516926748|FG002|Induction Period|Adverse Event|0|||
143377184|NCT01636687|516926749|FG003|Induction Period|Adverse Event|0|||
143377185|NCT01636687|516926750|FG004|Induction Period|Adverse Event|1|||
143377186|NCT01636687|516926746|FG000|Induction Period|Lack of Efficacy|0|||
143377187|NCT01636687|516926747|FG001|Induction Period|Lack of Efficacy|0|||
143377188|NCT01636687|516926748|FG002|Induction Period|Lack of Efficacy|0|||
143377189|NCT01636687|516926749|FG003|Induction Period|Lack of Efficacy|0|||
143377190|NCT01636687|516926750|FG004|Induction Period|Lack of Efficacy|1|||
143377191|NCT01636687|516926746|FG000|Induction Period|Physician Decision|1|||
143377192|NCT01636687|516926747|FG001|Induction Period|Physician Decision|0|||
143315795|NCT00274716|516703227|FG003|Phase A|Participant moved|0|||
143315796|NCT00274716|516703228|FG004|Phase A|Participant moved|0|||
143315797|NCT00274716|516703229|FG005|Phase A|Participant moved|1|||
143315798|NCT00274716|516703224|FG000|Phase A|Site Terminated|0|||
143315799|NCT00274716|516703225|FG001|Phase A|Site Terminated|0|||
143315800|NCT00274716|516703226|FG002|Phase A|Site Terminated|0|||
143315801|NCT00274716|516703227|FG003|Phase A|Site Terminated|1|||
143315802|NCT00274716|516703228|FG004|Phase A|Site Terminated|0|||
143315803|NCT00274716|516703229|FG005|Phase A|Site Terminated|0|||
143315804|NCT00274716|516703224|FG000|Phase A|Protocol Violation|1|||
143315805|NCT00274716|516703225|FG001|Phase A|Protocol Violation|0|||
143315806|NCT00274716|516703226|FG002|Phase A|Protocol Violation|0|||
143377193|NCT01636687|516926748|FG002|Induction Period|Physician Decision|0|||
143377194|NCT01636687|516926749|FG003|Induction Period|Physician Decision|0|||
143377195|NCT01636687|516926750|FG004|Induction Period|Physician Decision|0|||
143315807|NCT00274716|516703227|FG003|Phase A|Protocol Violation|1|||
143315808|NCT00274716|516703228|FG004|Phase A|Protocol Violation|0|||
143315809|NCT00274716|516703229|FG005|Phase A|Protocol Violation|0|||
143315810|NCT00274716|516703224|FG000|Phase A|Met criteria for discontinuation|1|||
143377196|NCT01636687|516926746|FG000|Maintenance Period|Withdrawal by Subject|2|||
143377197|NCT01636687|516926747|FG001|Maintenance Period|Withdrawal by Subject|0|||
143377198|NCT01636687|516926748|FG002|Maintenance Period|Withdrawal by Subject|2|||
143377199|NCT01636687|516926749|FG003|Maintenance Period|Withdrawal by Subject|0|||
143377200|NCT01636687|516926750|FG004|Maintenance Period|Withdrawal by Subject|0|||
143315811|NCT00274716|516703225|FG001|Phase A|Met criteria for discontinuation|1|||
143315812|NCT00274716|516703226|FG002|Phase A|Met criteria for discontinuation|0|||
143315813|NCT00274716|516703227|FG003|Phase A|Met criteria for discontinuation|0|||
143315814|NCT00274716|516703228|FG004|Phase A|Met criteria for discontinuation|0|||
143315815|NCT00274716|516703229|FG005|Phase A|Met criteria for discontinuation|0|||
143315816|NCT00274716|516703224|FG000|Phase A|Withdrawal by Subject|2|||
143315817|NCT00274716|516703225|FG001|Phase A|Withdrawal by Subject|2|||
143315818|NCT00274716|516703226|FG002|Phase A|Withdrawal by Subject|1|||
143315819|NCT00274716|516703227|FG003|Phase A|Withdrawal by Subject|3|||
143315820|NCT00274716|516703228|FG004|Phase A|Withdrawal by Subject|0|||
143315821|NCT00274716|516703229|FG005|Phase A|Withdrawal by Subject|1|||
143315822|NCT00274716|516703224|FG000|Phase A|Adverse Event|2|||
143315823|NCT00274716|516703225|FG001|Phase A|Adverse Event|3|||
143315824|NCT00274716|516703226|FG002|Phase A|Adverse Event|3|||
143315825|NCT00274716|516703227|FG003|Phase A|Adverse Event|0|||
143315826|NCT00274716|516703228|FG004|Phase A|Adverse Event|2|||
143315827|NCT00274716|516703229|FG005|Phase A|Adverse Event|0|||
143315828|NCT00274716|516703224|FG000|Phase A|Completed but did not enter Phase B|1|||
143315829|NCT00274716|516703225|FG001|Phase A|Completed but did not enter Phase B|2|||
143315830|NCT00274716|516703226|FG002|Phase A|Completed but did not enter Phase B|2|||
143315831|NCT00274716|516703227|FG003|Phase A|Completed but did not enter Phase B|2|||
143315832|NCT00274716|516703228|FG004|Phase A|Completed but did not enter Phase B|1|||
143315833|NCT00274716|516703229|FG005|Phase A|Completed but did not enter Phase B|1|||
143315834|NCT00274716|516703224|FG000|Phase B|Adverse Event|0|||
143315835|NCT00274716|516703225|FG001|Phase B|Adverse Event|0|||
143315836|NCT00274716|516703226|FG002|Phase B|Adverse Event|2|||
143315837|NCT00274716|516703227|FG003|Phase B|Adverse Event|0|||
143315838|NCT00274716|516703228|FG004|Phase B|Adverse Event|0|||
143315839|NCT00274716|516703229|FG005|Phase B|Adverse Event|1|||
143315840|NCT00274716|516703224|FG000|Phase B|Protocol Violation|0|||
143315841|NCT00274716|516703225|FG001|Phase B|Protocol Violation|2|||
143315842|NCT00274716|516703226|FG002|Phase B|Protocol Violation|0|||
143315843|NCT00274716|516703227|FG003|Phase B|Protocol Violation|0|||
143315844|NCT00274716|516703228|FG004|Phase B|Protocol Violation|0|||
143315845|NCT00274716|516703229|FG005|Phase B|Protocol Violation|0|||
143315846|NCT00274716|516703224|FG000|Phase B|Withdrawal by Subject|0|||
143315847|NCT00274716|516703225|FG001|Phase B|Withdrawal by Subject|1|||
143315848|NCT00274716|516703226|FG002|Phase B|Withdrawal by Subject|0|||
143315849|NCT00274716|516703227|FG003|Phase B|Withdrawal by Subject|0|||
143315850|NCT00274716|516703228|FG004|Phase B|Withdrawal by Subject|0|||
143315851|NCT00274716|516703229|FG005|Phase B|Withdrawal by Subject|0|||
143315852|NCT00274716|516703224|FG000|Phase B|Participant moved|1|||
143315853|NCT00274716|516703225|FG001|Phase B|Participant moved|0|||
143315854|NCT00274716|516703226|FG002|Phase B|Participant moved|0|||
143315855|NCT00274716|516703227|FG003|Phase B|Participant moved|0|||
143315856|NCT00274716|516703228|FG004|Phase B|Participant moved|0|||
143315857|NCT00274716|516703229|FG005|Phase B|Participant moved|0|||
143315858|NCT00274716|516703224|FG000|Phase B|Other non-reported reason|0|||
143315859|NCT00274716|516703225|FG001|Phase B|Other non-reported reason|0|||
143315860|NCT00274716|516703226|FG002|Phase B|Other non-reported reason|1|||
143315861|NCT00274716|516703227|FG003|Phase B|Other non-reported reason|1|||
143315862|NCT00274716|516703228|FG004|Phase B|Other non-reported reason|0|||
143315863|NCT00274716|516703229|FG005|Phase B|Other non-reported reason|0|||
143377201|NCT01636687|516926746|FG000|Maintenance Period|Adverse Event|1|||
143377202|NCT01636687|516926747|FG001|Maintenance Period|Adverse Event|0|||
143377203|NCT01636687|516926748|FG002|Maintenance Period|Adverse Event|0|||
143377204|NCT01636687|516926749|FG003|Maintenance Period|Adverse Event|0|||
143377205|NCT01636687|516926750|FG004|Maintenance Period|Adverse Event|0|||
143377206|NCT01636687|516926746|FG000|Maintenance Period|Lack of Efficacy|4|||
143377207|NCT01636687|516926747|FG001|Maintenance Period|Lack of Efficacy|1|||
143315864|NCT00274716|516703224|FG000|Phase B|Lost to Follow-up|0|||
143315865|NCT00274716|516703225|FG001|Phase B|Lost to Follow-up|1|||
143315866|NCT00274716|516703226|FG002|Phase B|Lost to Follow-up|0|||
143315867|NCT00274716|516703227|FG003|Phase B|Lost to Follow-up|0|||
143315868|NCT00274716|516703228|FG004|Phase B|Lost to Follow-up|0|||
143315869|NCT00274716|516703229|FG005|Phase B|Lost to Follow-up|0|||
143315870|NCT01774903|516703230|FG000|Overall Study|Adverse Event|7|||
143315871|NCT01774903|516703230|FG000|Overall Study|Withdrawal by Subject|2|||
143315872|NCT01774903|516703230|FG000|Overall Study|Lack of Efficacy|1|||
143315873|NCT01774903|516703230|FG000|Overall Study|Ineligible to continue the trial|1|||
143315874|NCT02212730|516703233|FG000|Overall Study|Tumor not of the required cell histology|1|||
143315875|NCT02212730|516703234|FG001|Overall Study|Tumor not of the required cell histology|0|||
143315876|NCT02212730|516703233|FG000|Overall Study|Withdrawal by Subject|1|||
143315877|NCT02212730|516703234|FG001|Overall Study|Withdrawal by Subject|0|||
143315878|NCT02212730|516703233|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
143315879|NCT02212730|516703234|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
143315880|NCT02944578|516703237|FG000|Overall Study|Physician Decision|1|||
143315881|NCT02944578|516703238|FG001|Overall Study|Physician Decision|0|||
143315882|NCT02691455|516703239|FG000|Overall Study|Withdrawal by Subject|1|||
143315883|NCT02691455|516703240|FG001|Overall Study|Withdrawal by Subject|2|||
143377208|NCT01636687|516926748|FG002|Maintenance Period|Lack of Efficacy|0|||
143377209|NCT01636687|516926749|FG003|Maintenance Period|Lack of Efficacy|0|||
143377210|NCT01636687|516926750|FG004|Maintenance Period|Lack of Efficacy|0|||
143377211|NCT01636687|516926746|FG000|Maintenance Period|Lost to Follow-up|1|||
143377212|NCT01636687|516926747|FG001|Maintenance Period|Lost to Follow-up|1|||
143377213|NCT01636687|516926748|FG002|Maintenance Period|Lost to Follow-up|0|||
143377214|NCT01636687|516926749|FG003|Maintenance Period|Lost to Follow-up|0|||
143377215|NCT01636687|516926750|FG004|Maintenance Period|Lost to Follow-up|1|||
143377216|NCT01636687|516926746|FG000|Maintenance Period|Physician Decision|0|||
143377217|NCT01636687|516926747|FG001|Maintenance Period|Physician Decision|0|||
143377218|NCT01636687|516926748|FG002|Maintenance Period|Physician Decision|0|||
143377219|NCT01636687|516926749|FG003|Maintenance Period|Physician Decision|0|||
143377220|NCT01636687|516926750|FG004|Maintenance Period|Physician Decision|1|||
143377221|NCT01636687|516926746|FG000|Extension Period|technical problems|0|||
143377222|NCT01636687|516926747|FG001|Extension Period|technical problems|1|||
143377223|NCT01636687|516926748|FG002|Extension Period|technical problems|2|||
143377224|NCT01636687|516926749|FG003|Extension Period|technical problems|1|||
143377225|NCT01636687|516926750|FG004|Extension Period|technical problems|0|||
143377226|NCT01636687|516926746|FG000|Extension Period|Adverse Event|4|||
143377227|NCT01636687|516926747|FG001|Extension Period|Adverse Event|3|||
143377228|NCT01636687|516926748|FG002|Extension Period|Adverse Event|2|||
143377229|NCT01636687|516926749|FG003|Extension Period|Adverse Event|1|||
143377230|NCT01636687|516926750|FG004|Extension Period|Adverse Event|0|||
143377231|NCT01636687|516926746|FG000|Extension Period|Lack of Efficacy|7|||
143377232|NCT01636687|516926747|FG001|Extension Period|Lack of Efficacy|0|||
143377233|NCT01636687|516926748|FG002|Extension Period|Lack of Efficacy|2|||
143377234|NCT01636687|516926749|FG003|Extension Period|Lack of Efficacy|1|||
143377235|NCT01636687|516926750|FG004|Extension Period|Lack of Efficacy|0|||
143377236|NCT01636687|516926746|FG000|Extension Period|Lost to Follow-up|1|||
143377237|NCT01636687|516926747|FG001|Extension Period|Lost to Follow-up|0|||
143377238|NCT01636687|516926748|FG002|Extension Period|Lost to Follow-up|1|||
143377239|NCT01636687|516926749|FG003|Extension Period|Lost to Follow-up|0|||
143377240|NCT01636687|516926750|FG004|Extension Period|Lost to Follow-up|0|||
143377241|NCT01636687|516926746|FG000|Extension Period|Physician Decision|1|||
143377242|NCT01636687|516926747|FG001|Extension Period|Physician Decision|0|||
143377243|NCT01636687|516926748|FG002|Extension Period|Physician Decision|0|||
143377244|NCT01636687|516926749|FG003|Extension Period|Physician Decision|1|||
143377245|NCT01636687|516926750|FG004|Extension Period|Physician Decision|0|||
143377246|NCT01636687|516926746|FG000|Extension Period|study terminated by sponsor|33|||
143377247|NCT01636687|516926747|FG001|Extension Period|study terminated by sponsor|50|||
143377248|NCT01636687|516926748|FG002|Extension Period|study terminated by sponsor|17|||
143377249|NCT01636687|516926749|FG003|Extension Period|study terminated by sponsor|23|||
143377250|NCT01636687|516926750|FG004|Extension Period|study terminated by sponsor|0|||
143377251|NCT01636687|516926746|FG000|Extension Period|Withdrawal by Subject|1|||
143377252|NCT01636687|516926747|FG001|Extension Period|Withdrawal by Subject|0|||
143377253|NCT01636687|516926748|FG002|Extension Period|Withdrawal by Subject|1|||
143377254|NCT01636687|516926749|FG003|Extension Period|Withdrawal by Subject|1|||
143377255|NCT01636687|516926750|FG004|Extension Period|Withdrawal by Subject|0|||
143377256|NCT01636687|516926746|FG000|Follow-up Period|Withdrawal by Subject|1|||
143377257|NCT01636687|516926747|FG001|Follow-up Period|Withdrawal by Subject|0|||
143377258|NCT01636687|516926748|FG002|Follow-up Period|Withdrawal by Subject|0|||
143377259|NCT01636687|516926749|FG003|Follow-up Period|Withdrawal by Subject|0|||
143377260|NCT01636687|516926750|FG004|Follow-up Period|Withdrawal by Subject|1|||
143377261|NCT02918279|516926753|FG000|Overall Study|Lost to Follow-up|3|||
143377262|NCT02918279|516926754|FG001|Overall Study|Lost to Follow-up|6|||
143377263|NCT02918279|516926753|FG000|Overall Study|Withdrawal by Subject|5|||
143377264|NCT02918279|516926754|FG001|Overall Study|Withdrawal by Subject|15|||
143377265|NCT02918279|516926753|FG000|Overall Study|Withdrawal by parent/guardian|2|||
143377266|NCT02918279|516926754|FG001|Overall Study|Withdrawal by parent/guardian|1|||
143377267|NCT02918279|516926753|FG000|Overall Study|Other|3|||
143377268|NCT02918279|516926754|FG001|Overall Study|Other|1|||
143377269|NCT00636207|516926759|FG000|Overall Study|Adverse Event|1|||
143377270|NCT00636207|516926760|FG001|Overall Study|Adverse Event|0|||
143377271|NCT00636207|516926761|FG002|Overall Study|Adverse Event|0|||
143377272|NCT00636207|516926762|FG003|Overall Study|Adverse Event|0|||
143377273|NCT00636207|516926763|FG004|Overall Study|Adverse Event|0|||
143377274|NCT00636207|516926764|FG005|Overall Study|Adverse Event|0|||
143377275|NCT00636207|516926765|FG006|Overall Study|Adverse Event|0|||
143377276|NCT00636207|516926759|FG000|Overall Study|Withdrawal by Subject|0|||
143377277|NCT00636207|516926760|FG001|Overall Study|Withdrawal by Subject|1|||
143377278|NCT00636207|516926761|FG002|Overall Study|Withdrawal by Subject|0|||
143377279|NCT00636207|516926762|FG003|Overall Study|Withdrawal by Subject|0|||
143377280|NCT00636207|516926763|FG004|Overall Study|Withdrawal by Subject|1|||
143377281|NCT00636207|516926764|FG005|Overall Study|Withdrawal by Subject|0|||
143377282|NCT00636207|516926765|FG006|Overall Study|Withdrawal by Subject|0|||
143377283|NCT01641198|516926766|FG000|After 12 Months of Function|Lost to Follow-up|3|||
143377284|NCT01641198|516926767|FG001|After 12 Months of Function|Lost to Follow-up|2|||
143377285|NCT01641198|516926768|FG002|After 12 Months of Function|Lost to Follow-up|2|||
143377286|NCT01641198|516926766|FG000|After 12 Months of Function|Protocol Violation|1|||
143377287|NCT01641198|516926767|FG001|After 12 Months of Function|Protocol Violation|0|||
143377288|NCT01641198|516926768|FG002|After 12 Months of Function|Protocol Violation|0|||
143377289|NCT01641198|516926766|FG000|After 12 Months of Function|Adverse Event|0|||
143377290|NCT01641198|516926767|FG001|After 12 Months of Function|Adverse Event|1|||
143377291|NCT01641198|516926768|FG002|After 12 Months of Function|Adverse Event|0|||
143377292|NCT01641198|516926766|FG000|After 24 Months of Function|Lost to Follow-up|4|||
143377293|NCT01641198|516926767|FG001|After 24 Months of Function|Lost to Follow-up|9|||
143377294|NCT01641198|516926768|FG002|After 24 Months of Function|Lost to Follow-up|6|||
143377295|NCT01641198|516926766|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
143377296|NCT01641198|516926767|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
143377297|NCT01641198|516926768|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
143377298|NCT01641198|516926766|FG000|At 15-20 Years of Function|Death|1|||
143377299|NCT01641198|516926767|FG001|At 15-20 Years of Function|Death|0|||
143377300|NCT01641198|516926768|FG002|At 15-20 Years of Function|Death|1|||
143377301|NCT02529995|516926770|FG000|Part A|Ongoing Study at Data Cut-off|14|||
143377302|NCT02529995|516926771|FG001|Part A|Ongoing Study at Data Cut-off|16|||
143377303|NCT02529995|516926770|FG000|Part A|Discontinued Study|1|||
143377304|NCT02529995|516926771|FG001|Part A|Discontinued Study|0|||
143377305|NCT02529995|516926770|FG000|Part B|Ongoing Study at Data Cut-off|0|||
143377306|NCT02529995|516926771|FG001|Part B|Ongoing Study at Data Cut-off|7|||
143377307|NCT02529995|516926770|FG000|Part B|Discontinued Study|6|||
143377308|NCT02529995|516926771|FG001|Part B|Discontinued Study|5|||
143377309|NCT00364013|516926776|FG000|Overall Study|Ineligibility determined|4|||
143377310|NCT00364013|516926777|FG001|Overall Study|Ineligibility determined|2|||
143377311|NCT00364013|516926776|FG000|Overall Study|Adverse Event|4|||
143377312|NCT00364013|516926777|FG001|Overall Study|Adverse Event|3|||
143377313|NCT00364013|516926776|FG000|Overall Study|Withdrawal by Subject|13|||
143377314|NCT00364013|516926777|FG001|Overall Study|Withdrawal by Subject|18|||
143377315|NCT00364013|516926776|FG000|Overall Study|Physician Decision|3|||
143377316|NCT00364013|516926777|FG001|Overall Study|Physician Decision|3|||
143377317|NCT00364013|516926776|FG000|Overall Study|Lost to Follow-up|10|||
143377318|NCT00364013|516926777|FG001|Overall Study|Lost to Follow-up|3|||
143377319|NCT00364013|516926776|FG000|Overall Study|Protocol-specified criteria|6|||
143377320|NCT00364013|516926777|FG001|Overall Study|Protocol-specified criteria|6|||
143377321|NCT00364013|516926776|FG000|Overall Study|Other|41|||
143377322|NCT00364013|516926777|FG001|Overall Study|Other|47|||
143377323|NCT00364013|516926776|FG000|Overall Study|Ongoing|20|||
143377324|NCT00364013|516926777|FG001|Overall Study|Ongoing|13|||
143377325|NCT02507752|516926778|FG000|Overall Study|Adverse Event|1|||
143377326|NCT02507752|516926778|FG000|Overall Study|Protocol Violation|6|||
143377327|NCT02507752|516926778|FG000|Overall Study|Lost to Follow-up|7|||
143377328|NCT02507752|516926778|FG000|Overall Study|Infusion reaction at first infusion|1|||
143377329|NCT02507752|516926778|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
143377330|NCT02507752|516926778|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
143377331|NCT01369498|516926783|FG000|Overall Study|Lack of Efficacy|9|||
143377332|NCT01369498|516926784|FG001|Overall Study|Lack of Efficacy|9|||
143377333|NCT01369498|516926785|FG002|Overall Study|Lack of Efficacy|1|||
143377334|NCT01369498|516926786|FG003|Overall Study|Lack of Efficacy|3|||
143377335|NCT01369498|516926783|FG000|Overall Study|Adverse Event|1|||
143377336|NCT01369498|516926784|FG001|Overall Study|Adverse Event|2|||
143377337|NCT01369498|516926785|FG002|Overall Study|Adverse Event|0|||
143377338|NCT01369498|516926786|FG003|Overall Study|Adverse Event|1|||
143377339|NCT01369498|516926783|FG000|Overall Study|Withdrawal of Consent|0|||
143377340|NCT01369498|516926784|FG001|Overall Study|Withdrawal of Consent|1|||
143377341|NCT01369498|516926785|FG002|Overall Study|Withdrawal of Consent|1|||
143377342|NCT01369498|516926786|FG003|Overall Study|Withdrawal of Consent|1|||
143377343|NCT01369498|516926783|FG000|Overall Study|Death|0|||
143377344|NCT01369498|516926784|FG001|Overall Study|Death|0|||
143377345|NCT01369498|516926785|FG002|Overall Study|Death|1|||
143377346|NCT01369498|516926786|FG003|Overall Study|Death|0|||
143377347|NCT01369498|516926783|FG000|Overall Study|Investigator's Discretion|1|||
143377348|NCT01369498|516926784|FG001|Overall Study|Investigator's Discretion|0|||
143377349|NCT01369498|516926785|FG002|Overall Study|Investigator's Discretion|1|||
143377350|NCT01369498|516926786|FG003|Overall Study|Investigator's Discretion|3|||
143377351|NCT01369498|516926783|FG000|Overall Study|Unknown Reason|1|||
143377352|NCT01369498|516926784|FG001|Overall Study|Unknown Reason|0|||
143377353|NCT01369498|516926785|FG002|Overall Study|Unknown Reason|11|||
143377354|NCT01369498|516926786|FG003|Overall Study|Unknown Reason|6|||
143377355|NCT01369498|516926783|FG000|Overall Study|Disease Progression|0|||
143377356|NCT01369498|516926784|FG001|Overall Study|Disease Progression|0|||
143377357|NCT01369498|516926785|FG002|Overall Study|Disease Progression|0|||
143377358|NCT01369498|516926786|FG003|Overall Study|Disease Progression|1|||
143377359|NCT01444417|516926793|FG000|Overall Study|Ineligibility Determined|0|||
143377360|NCT01444417|516926794|FG001|Overall Study|Ineligibility Determined|1|||
143377361|NCT01444417|516926793|FG000|Overall Study|Withdrawal by Subject|2|||
143377362|NCT01444417|516926794|FG001|Overall Study|Withdrawal by Subject|0|||
143377363|NCT01124734|516926796|FG000|Overall Study|Disease progression|13|||
143377364|NCT01124734|516926796|FG000|Overall Study|Adverse Event|1|||
143377365|NCT01124734|516926796|FG000|Overall Study|Withdrawal by Subject|1|||
143377366|NCT01124734|516926796|FG000|Overall Study|Elected for alternative treatment|2|||
143377367|NCT02214160|516926797|FG000|Overall Study|Withdrawal by Subject|1|||
143377368|NCT02214160|516926798|FG001|Overall Study|Withdrawal by Subject|0|||
143377369|NCT02214160|516926799|FG002|Overall Study|Withdrawal by Subject|6|||
143377370|NCT02214160|516926797|FG000|Overall Study|Death|2|||
143377371|NCT02214160|516926798|FG001|Overall Study|Death|2|||
143377372|NCT02214160|516926799|FG002|Overall Study|Death|1|||
143377373|NCT02214160|516926797|FG000|Overall Study|Subject Non-Compliance|0|||
143377374|NCT02214160|516926798|FG001|Overall Study|Subject Non-Compliance|3|||
143377375|NCT02214160|516926799|FG002|Overall Study|Subject Non-Compliance|1|||
143377376|NCT02214160|516926797|FG000|Overall Study|Adverse Event|0|||
143377377|NCT02214160|516926798|FG001|Overall Study|Adverse Event|1|||
143377378|NCT02214160|516926799|FG002|Overall Study|Adverse Event|1|||
143377379|NCT02214160|516926797|FG000|Overall Study|Sponsor Decision|0|||
143377380|NCT02214160|516926798|FG001|Overall Study|Sponsor Decision|2|||
143377381|NCT02214160|516926799|FG002|Overall Study|Sponsor Decision|0|||
143377382|NCT02214160|516926797|FG000|Overall Study|Protocol Violation|1|||
143377383|NCT02214160|516926798|FG001|Overall Study|Protocol Violation|0|||
143377384|NCT02214160|516926799|FG002|Overall Study|Protocol Violation|0|||
143377385|NCT02214160|516926797|FG000|Overall Study|Physician Decision|0|||
143377386|NCT02214160|516926798|FG001|Overall Study|Physician Decision|0|||
143377387|NCT02214160|516926799|FG002|Overall Study|Physician Decision|1|||
143377388|NCT02423798|516926800|FG000|Overall Study|Withdrawal by Subject|3|||
143377389|NCT01430611|516926806|FG000|Overall Study|Adverse Event|0|||
143377390|NCT01430611|516926807|FG001|Overall Study|Adverse Event|1|||
143377391|NCT01430611|516926806|FG000|Overall Study|Protocol Violation|1|||
143377392|NCT01430611|516926807|FG001|Overall Study|Protocol Violation|0|||
143377393|NCT01430611|516926806|FG000|Overall Study|Lost to Follow-up|1|||
143377394|NCT01430611|516926807|FG001|Overall Study|Lost to Follow-up|0|||
143377395|NCT01430611|516926806|FG000|Overall Study|Withdrawal by Subject|15|||
143377396|NCT01430611|516926807|FG001|Overall Study|Withdrawal by Subject|14|||
143377397|NCT02204982|516926808|FG000|Overall Study|Patient ineligible-medical monitor|1|||
143377398|NCT02204982|516926809|FG001|Overall Study|Patient ineligible-medical monitor|0|||
143377399|NCT02204982|516926808|FG000|Overall Study|Withdrawal by Subject|1|||
143377400|NCT02204982|516926809|FG001|Overall Study|Withdrawal by Subject|0|||
143377401|NCT02204982|516926808|FG000|Overall Study|Adverse Event|1|||
143377402|NCT02204982|516926809|FG001|Overall Study|Adverse Event|0|||
143377403|NCT02204982|516926808|FG000|Overall Study|Adverse Event and Investigator decision|1|||
143377404|NCT02204982|516926809|FG001|Overall Study|Adverse Event and Investigator decision|0|||
143377405|NCT02204982|516926808|FG000|Overall Study|Physician Decision|0|||
143377406|NCT02204982|516926809|FG001|Overall Study|Physician Decision|2|||
143377407|NCT02204982|516926808|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
143377408|NCT02204982|516926809|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
143377409|NCT02204982|516926808|FG000|Overall Study|Termination of Study bySponsor|0|||
143377410|NCT02204982|516926809|FG001|Overall Study|Termination of Study bySponsor|1|||
143377411|NCT01943916|516926810|FG000|Overall Study|Technically invalid images|10|||
143377412|NCT01943916|516926810|FG000|Overall Study|Enrollment Failure|23|||
143377413|NCT01943916|516926810|FG000|Overall Study|Pilot Phase exclusion|100|||
143377414|NCT01943916|516926810|FG000|Overall Study|Quality Assurance Reader Fail|130|||
143377415|NCT01943916|516926810|FG000|Overall Study|Technical Failure|39|||
143377416|NCT01943916|516926810|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
143377417|NCT01943916|516926810|FG000|Overall Study|No Truth Panel Review|38|||
143377418|NCT01943916|516926810|FG000|Overall Study|Protocol Deviation|1|||
143377419|NCT00958633|516926813|FG000|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
143377420|NCT00958633|516926814|FG001|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
143377421|NCT00958633|516926815|FG002|Open-Label (up to 16 Weeks)|Lost to Follow-up|14|||
143377422|NCT00958633|516926813|FG000|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
143377423|NCT00958633|516926814|FG001|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
143315884|NCT02691455|516703239|FG000|Overall Study|Lost to Follow-up|15|||
143315885|NCT02691455|516703240|FG001|Overall Study|Lost to Follow-up|15|||
143315886|NCT00577122|516703244|FG000|Overall Study|Adverse Event|0|||
143315887|NCT00577122|516703245|FG001|Overall Study|Adverse Event|2|||
143315888|NCT00577122|516703244|FG000|Overall Study|Progression, relapse during active trt|6|||
143315889|NCT00577122|516703245|FG001|Overall Study|Progression, relapse during active trt|8|||
143315890|NCT00577122|516703244|FG000|Overall Study|Prog, refract disease during active trt|8|||
143315891|NCT00577122|516703245|FG001|Overall Study|Prog, refract disease during active trt|5|||
143315892|NCT00577122|516703244|FG000|Overall Study|Alternative Therapy|0|||
143315893|NCT00577122|516703245|FG001|Overall Study|Alternative Therapy|1|||
143315894|NCT00440271|516703247|FG000|Overall Study|Protocol Violation|1|||
143315895|NCT00440271|516703248|FG001|Overall Study|Protocol Violation|1|||
143315896|NCT00440271|516703247|FG000|Overall Study|Adverse Event|0|||
143315897|NCT00440271|516703248|FG001|Overall Study|Adverse Event|1|||
143315898|NCT00440271|516703247|FG000|Overall Study|Lost to Follow-up|1|||
143315899|NCT00440271|516703248|FG001|Overall Study|Lost to Follow-up|0|||
143315900|NCT00440271|516703247|FG000|Overall Study|Withdrawal by Subject|0|||
143315901|NCT00440271|516703248|FG001|Overall Study|Withdrawal by Subject|2|||
143315902|NCT00440271|516703247|FG000|Overall Study|Lack of Efficacy|0|||
143315903|NCT00440271|516703248|FG001|Overall Study|Lack of Efficacy|1|||
143315904|NCT00440271|516703247|FG000|Overall Study|Due to closure of trial|8|||
143315905|NCT00440271|516703248|FG001|Overall Study|Due to closure of trial|10|||
143315906|NCT00440271|516703247|FG000|Overall Study|Other|2|||
143315907|NCT00440271|516703248|FG001|Overall Study|Other|0|||
143315908|NCT03755765|516703265|FG000|Overall Study|Withdrawal by Subject|2|||
143315909|NCT03755765|516703266|FG001|Overall Study|Withdrawal by Subject|4|||
143315910|NCT03755765|516703267|FG002|Overall Study|Withdrawal by Subject|4|||
143315911|NCT02104557|516703268|FG000|Overall Study|Adverse Event|24|||
143315912|NCT02104557|516703268|FG000|Overall Study|Lost to Follow-up|34|||
143315913|NCT02104557|516703268|FG000|Overall Study|Violated the usage and dosage|14|||
143315914|NCT02104557|516703268|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
143315915|NCT02104557|516703268|FG000|Overall Study|Administered Sayana prior to the contract|1|||
143315916|NCT02104557|516703268|FG000|Overall Study|Other|17|||
143315917|NCT02104557|516703268|FG000|Overall Study|Change to other contraception methods|5|||
143315918|NCT02104557|516703268|FG000|Overall Study|Discontinuation due to no pain|1|||
143315919|NCT02104557|516703268|FG000|Overall Study|Withdrawal consent|2|||
143315920|NCT02104557|516703268|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
143315921|NCT02104557|516703268|FG000|Overall Study|Discontinuation of contraception|9|||
143315922|NCT02178475|516703271|FG000|Overall Study|Withdrawal by Subject|7|||
143315923|NCT02178475|516703271|FG000|Overall Study|Lost to Follow-up|10|||
143315924|NCT02178475|516703271|FG000|Overall Study|Death|13|||
143315925|NCT02178475|516703271|FG000|Overall Study|Protocol-specified Criteria|99|||
143315926|NCT01274637|516703274|FG000|Overall Study|Withdrawal by Subject|0|||
143315927|NCT01274637|516703275|FG001|Overall Study|Withdrawal by Subject|1|||
143315928|NCT01274637|516703274|FG000|Overall Study|Lost to Follow-up|0|||
143315929|NCT01274637|516703275|FG001|Overall Study|Lost to Follow-up|1|||
143315930|NCT01490060|516703276|FG000|Cycle 1|Change of Treatment|0|||
143315931|NCT01490060|516703277|FG001|Cycle 1|Change of Treatment|1|||
143315932|NCT01490060|516703278|FG002|Cycle 1|Change of Treatment|1|||
143315933|NCT01490060|516703279|FG003|Cycle 1|Change of Treatment|1|||
143315934|NCT01490060|516703276|FG000|Cycle 1|Insurance Denied|0|||
143315935|NCT01490060|516703277|FG001|Cycle 1|Insurance Denied|0|||
143315936|NCT01490060|516703278|FG002|Cycle 1|Insurance Denied|2|||
143315937|NCT01490060|516703279|FG003|Cycle 1|Insurance Denied|0|||
143315938|NCT01490060|516703276|FG000|Cycle 1|Withdrawal by Subject|0|||
143315939|NCT01490060|516703277|FG001|Cycle 1|Withdrawal by Subject|0|||
143315940|NCT01490060|516703278|FG002|Cycle 1|Withdrawal by Subject|0|||
143315941|NCT01490060|516703279|FG003|Cycle 1|Withdrawal by Subject|1|||
143315942|NCT01490060|516703276|FG000|Cycle 1|Treatment at Another Facility|0|||
143315943|NCT01490060|516703277|FG001|Cycle 1|Treatment at Another Facility|0|||
143315944|NCT01490060|516703278|FG002|Cycle 1|Treatment at Another Facility|0|||
143315945|NCT01490060|516703279|FG003|Cycle 1|Treatment at Another Facility|1|||
143315946|NCT01490060|516703276|FG000|Cycle 2|Change of Treatment|1|||
143315947|NCT01490060|516703277|FG001|Cycle 2|Change of Treatment|1|||
143315948|NCT01490060|516703278|FG002|Cycle 2|Change of Treatment|0|||
143315949|NCT01490060|516703279|FG003|Cycle 2|Change of Treatment|0|||
143315950|NCT01490060|516703276|FG000|Cycle 2|Non-Compliance|0|||
143315951|NCT01490060|516703277|FG001|Cycle 2|Non-Compliance|0|||
143315952|NCT01490060|516703278|FG002|Cycle 2|Non-Compliance|1|||
143315953|NCT01490060|516703279|FG003|Cycle 2|Non-Compliance|0|||
143315954|NCT01490060|516703276|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
143315955|NCT01490060|516703277|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
143315956|NCT01490060|516703278|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
143315957|NCT01490060|516703279|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
143315958|NCT02863354|516703282|FG000|Year 1|Lost to Follow-up|1|||
143315959|NCT02863354|516703283|FG001|Year 1|Lost to Follow-up|1|||
143315960|NCT02863354|516703282|FG000|Year 1|Withdrawal by Subject|3|||
143315961|NCT02863354|516703283|FG001|Year 1|Withdrawal by Subject|0|||
143315962|NCT02863354|516703282|FG000|Year 1|Death|0|||
143315963|NCT02863354|516703283|FG001|Year 1|Death|1|||
143315964|NCT02863354|516703282|FG000|Year 2|Lost to Follow-up|2|||
143315965|NCT02863354|516703283|FG001|Year 2|Lost to Follow-up|2|||
143315966|NCT03698773|516703284|FG000|Overall Study|Lost to Follow-up|2|||
143315967|NCT03698773|516703285|FG001|Overall Study|Lost to Follow-up|1|||
143315968|NCT00724451|516703286|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
143315969|NCT00724451|516703286|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
143315970|NCT00724451|516703286|FG000|Overall Study|Not Eligible for Treatment|431|||
143315971|NCT00724451|516703286|FG000|Overall Study|Participant Refused Treatment|89|||
143315972|NCT00724451|516703286|FG000|Overall Study|Never Started Treatment|89|||
143315973|NCT00724451|516703286|FG000|Overall Study|Unknown; No Data Sources Available|9|||
143315974|NCT00724451|516703286|FG000|Overall Study|Physician Decision|116|||
143315975|NCT00724451|516703286|FG000|Overall Study|Withdrawal by Subject|45|||
143315976|NCT00724451|516703286|FG000|Overall Study|Investigator + Participant Decision|13|||
143315977|NCT01599650|516703287|FG000|Overall Study|Administrative issue|1|||
143315978|NCT01599650|516703288|FG001|Overall Study|Administrative issue|0|||
143315979|NCT01599650|516703289|FG002|Overall Study|Administrative issue|1|||
143315980|NCT01599650|516703287|FG000|Overall Study|Physician Decision|2|||
143315981|NCT01599650|516703288|FG001|Overall Study|Physician Decision|0|||
143315982|NCT01599650|516703289|FG002|Overall Study|Physician Decision|7|||
143315983|NCT01599650|516703287|FG000|Overall Study|Protocol Violation|0|||
143315984|NCT01599650|516703288|FG001|Overall Study|Protocol Violation|3|||
143315985|NCT01599650|516703289|FG002|Overall Study|Protocol Violation|0|||
143315986|NCT01599650|516703287|FG000|Overall Study|Death|2|||
143315987|NCT01599650|516703288|FG001|Overall Study|Death|1|||
143315988|NCT01599650|516703289|FG002|Overall Study|Death|2|||
143315989|NCT01599650|516703287|FG000|Overall Study|Lost to Follow-up|3|||
143315990|NCT01599650|516703288|FG001|Overall Study|Lost to Follow-up|3|||
143315991|NCT01599650|516703289|FG002|Overall Study|Lost to Follow-up|3|||
143315992|NCT01599650|516703287|FG000|Overall Study|Withdrawal by Subject|11|||
143315993|NCT01599650|516703288|FG001|Overall Study|Withdrawal by Subject|11|||
143315994|NCT01599650|516703289|FG002|Overall Study|Withdrawal by Subject|10|||
143315995|NCT01599650|516703287|FG000|Overall Study|Adverse Event|3|||
143315996|NCT01599650|516703288|FG001|Overall Study|Adverse Event|8|||
143315997|NCT01599650|516703289|FG002|Overall Study|Adverse Event|4|||
143315998|NCT00720876|516703290|FG000|Overall Study|found to be ineligible after starting tx|2|||
143315999|NCT03304379|516703292|FG000|Overall Study|Protocol Violation|8|||
143316000|NCT03304379|516703293|FG001|Overall Study|Protocol Violation|10|||
143316001|NCT03304379|516703294|FG002|Overall Study|Protocol Violation|5|||
143316002|NCT03304379|516703295|FG003|Overall Study|Protocol Violation|0|||
143316003|NCT03304379|516703296|FG004|Overall Study|Protocol Violation|2|||
143316004|NCT03304379|516703292|FG000|Overall Study|Adverse Event|4|||
143316005|NCT03304379|516703293|FG001|Overall Study|Adverse Event|20|||
143316006|NCT03304379|516703294|FG002|Overall Study|Adverse Event|17|||
143316007|NCT03304379|516703295|FG003|Overall Study|Adverse Event|1|||
143316008|NCT03304379|516703296|FG004|Overall Study|Adverse Event|0|||
143316009|NCT03304379|516703292|FG000|Overall Study|Lack of Efficacy|17|||
143316010|NCT03304379|516703293|FG001|Overall Study|Lack of Efficacy|16|||
143316011|NCT03304379|516703294|FG002|Overall Study|Lack of Efficacy|20|||
143316012|NCT03304379|516703295|FG003|Overall Study|Lack of Efficacy|0|||
143316013|NCT03304379|516703296|FG004|Overall Study|Lack of Efficacy|0|||
143316014|NCT03304379|516703292|FG000|Overall Study|Physician Decision|6|||
143316015|NCT03304379|516703293|FG001|Overall Study|Physician Decision|10|||
143316016|NCT03304379|516703294|FG002|Overall Study|Physician Decision|6|||
143316017|NCT03304379|516703295|FG003|Overall Study|Physician Decision|9|||
143316018|NCT03304379|516703296|FG004|Overall Study|Physician Decision|10|||
143316019|NCT03304379|516703292|FG000|Overall Study|Withdrawal by Subject|26|||
143316020|NCT03304379|516703293|FG001|Overall Study|Withdrawal by Subject|58|||
143316021|NCT03304379|516703294|FG002|Overall Study|Withdrawal by Subject|66|||
143316022|NCT03304379|516703295|FG003|Overall Study|Withdrawal by Subject|3|||
143316023|NCT03304379|516703296|FG004|Overall Study|Withdrawal by Subject|5|||
143316024|NCT03304379|516703292|FG000|Overall Study|Lost to Follow-up|8|||
143316025|NCT03304379|516703293|FG001|Overall Study|Lost to Follow-up|24|||
143316026|NCT03304379|516703294|FG002|Overall Study|Lost to Follow-up|35|||
143316027|NCT03304379|516703295|FG003|Overall Study|Lost to Follow-up|4|||
143316028|NCT03304379|516703296|FG004|Overall Study|Lost to Follow-up|0|||
143316029|NCT03304379|516703292|FG000|Overall Study|Death|1|||
143316030|NCT03304379|516703293|FG001|Overall Study|Death|2|||
143316031|NCT03304379|516703294|FG002|Overall Study|Death|0|||
143316032|NCT03304379|516703295|FG003|Overall Study|Death|0|||
143316033|NCT03304379|516703296|FG004|Overall Study|Death|0|||
143316034|NCT03304379|516703292|FG000|Overall Study|Other|0|||
143316035|NCT03304379|516703293|FG001|Overall Study|Other|1|||
143316036|NCT03304379|516703294|FG002|Overall Study|Other|0|||
143316037|NCT03304379|516703295|FG003|Overall Study|Other|0|||
143377424|NCT00958633|516926815|FG002|Open-Label (up to 16 Weeks)|Withdrawal by Subject|18|||
143377425|NCT00958633|516926813|FG000|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
143316038|NCT03304379|516703296|FG004|Overall Study|Other|0|||
143316039|NCT02802345|516703310|FG000|Overall Study|Not Treated|0|||
143316040|NCT02802345|516703311|FG001|Overall Study|Not Treated|1|||
143316041|NCT02802345|516703310|FG000|Overall Study|Adverse Event|28|||
143316042|NCT02802345|516703311|FG001|Overall Study|Adverse Event|20|||
143316043|NCT02802345|516703310|FG000|Overall Study|Withdrawal by Subject|3|||
143316044|NCT02802345|516703311|FG001|Overall Study|Withdrawal by Subject|3|||
143316045|NCT02802345|516703310|FG000|Overall Study|Protocol Violation|0|||
143316046|NCT02802345|516703311|FG001|Overall Study|Protocol Violation|1|||
143316047|NCT02802345|516703310|FG000|Overall Study|Other than listed|1|||
143316048|NCT02802345|516703311|FG001|Overall Study|Other than listed|5|||
143316049|NCT04632940|516703314|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
143316050|NCT04632940|516703315|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
143316051|NCT04632940|516703314|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
143316052|NCT04632940|516703315|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
143316053|NCT04632940|516703314|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
143316054|NCT04632940|516703315|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
143316055|NCT04632940|516703314|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
143316056|NCT04632940|516703315|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
143316057|NCT04632940|516703314|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
143316058|NCT04632940|516703315|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
143316059|NCT04632940|516703314|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
143316060|NCT04632940|516703315|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
143316061|NCT04632940|516703314|FG000|OLE Period (52 Weeks)|Other than specified|0|||
143316062|NCT04632940|516703315|FG001|OLE Period (52 Weeks)|Other than specified|1|||
143316063|NCT04632940|516703314|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
143316064|NCT04632940|516703315|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
143316065|NCT00684424|516703316|FG000|Overall Study|Adverse Event|1|||
143316066|NCT00684424|516703316|FG000|Overall Study|Lost to Follow-up|2|||
143316067|NCT00684424|516703316|FG000|Overall Study|Other|2|||
143316068|NCT02550652|516703325|FG000|Overall Study|Death|1|||
143316069|NCT02550652|516703326|FG001|Overall Study|Death|4|||
143316070|NCT02550652|516703325|FG000|Overall Study|Lack of Efficacy|1|||
143316071|NCT02550652|516703326|FG001|Overall Study|Lack of Efficacy|0|||
143316072|NCT02550652|516703325|FG000|Overall Study|Withdrawal by Subject|4|||
143316073|NCT02550652|516703326|FG001|Overall Study|Withdrawal by Subject|7|||
143316074|NCT02550652|516703325|FG000|Overall Study|Post Trial Access|1|||
143316075|NCT02550652|516703326|FG001|Overall Study|Post Trial Access|0|||
143316076|NCT02550652|516703325|FG000|Overall Study|Lost to Follow-up|1|||
143316077|NCT02550652|516703326|FG001|Overall Study|Lost to Follow-up|3|||
143316078|NCT02550652|516703325|FG000|Overall Study|Physician Decision|0|||
143316079|NCT02550652|516703326|FG001|Overall Study|Physician Decision|2|||
143316080|NCT02550652|516703325|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
143377426|NCT00958633|516926814|FG001|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
143377427|NCT00958633|516926815|FG002|Open-Label (up to 16 Weeks)|Worsening of symptoms|13|||
143377428|NCT00958633|516926813|FG000|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
143377429|NCT00958633|516926814|FG001|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
143377430|NCT00958633|516926815|FG002|Open-Label (up to 16 Weeks)|Lack of Efficacy|8|||
143377431|NCT00958633|516926813|FG000|Open-Label (up to 16 Weeks)|Non-adherence|0|||
143377432|NCT00958633|516926814|FG001|Open-Label (up to 16 Weeks)|Non-adherence|0|||
143377433|NCT00958633|516926815|FG002|Open-Label (up to 16 Weeks)|Non-adherence|2|||
143377434|NCT00958633|516926813|FG000|Open-Label (up to 16 Weeks)|Physician Decision|0|||
143377435|NCT00958633|516926814|FG001|Open-Label (up to 16 Weeks)|Physician Decision|0|||
143377436|NCT00958633|516926815|FG002|Open-Label (up to 16 Weeks)|Physician Decision|4|||
143377437|NCT00958633|516926813|FG000|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|1|||
143377438|NCT00958633|516926814|FG001|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
143316081|NCT02550652|516703326|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
143316082|NCT00205712|516703327|FG000|Overall Study|Lost to Follow-up|0|||
143316083|NCT00205712|516703328|FG001|Overall Study|Lost to Follow-up|1|||
143316084|NCT02517905|516703329|FG000|Overall Study|Lost to Follow-up|4|||
143316085|NCT02517905|516703330|FG001|Overall Study|Lost to Follow-up|0|||
143316086|NCT02517905|516703329|FG000|Overall Study|Withdrawal by Subject|4|||
143316087|NCT02517905|516703330|FG001|Overall Study|Withdrawal by Subject|0|||
143316088|NCT02517905|516703329|FG000|Overall Study|Screen failure|2|||
143316089|NCT02517905|516703330|FG001|Overall Study|Screen failure|2|||
143316090|NCT01755416|516703333|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
143316091|NCT01755416|516703334|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
143316092|NCT01976845|516703335|FG000|Overall Study|Physician Decision|8|||
143316093|NCT01976845|516703336|FG001|Overall Study|Physician Decision|8|||
143316094|NCT01976845|516703337|FG002|Overall Study|Physician Decision|3|||
143316095|NCT03655236|516703338|FG000|Subject Disposition in Part 1 Period|Adverse Event|25|||
143316096|NCT03655236|516703339|FG001|Subject Disposition in Part 1 Period|Adverse Event|55|||
143316097|NCT03655236|516703340|FG002|Subject Disposition in Part 1 Period|Adverse Event|12|||
143316098|NCT03655236|516703338|FG000|Subject Disposition in Part 1 Period|Death|1|||
143316099|NCT03655236|516703339|FG001|Subject Disposition in Part 1 Period|Death|0|||
143316100|NCT03655236|516703340|FG002|Subject Disposition in Part 1 Period|Death|0|||
143316101|NCT03655236|516703338|FG000|Subject Disposition in Part 1 Period|Physician Decision|0|||
143316102|NCT03655236|516703339|FG001|Subject Disposition in Part 1 Period|Physician Decision|3|||
143316103|NCT03655236|516703340|FG002|Subject Disposition in Part 1 Period|Physician Decision|2|||
143316104|NCT03655236|516703338|FG000|Subject Disposition in Part 1 Period|Lost to Follow-up|1|||
143316105|NCT03655236|516703339|FG001|Subject Disposition in Part 1 Period|Lost to Follow-up|3|||
143316106|NCT03655236|516703340|FG002|Subject Disposition in Part 1 Period|Lost to Follow-up|2|||
143316107|NCT03655236|516703338|FG000|Subject Disposition in Part 1 Period|Parkinson's disease progression|2|||
143316108|NCT03655236|516703339|FG001|Subject Disposition in Part 1 Period|Parkinson's disease progression|8|||
143316109|NCT03655236|516703340|FG002|Subject Disposition in Part 1 Period|Parkinson's disease progression|5|||
143316110|NCT03655236|516703338|FG000|Subject Disposition in Part 1 Period|Poor compliance|0|||
143316111|NCT03655236|516703339|FG001|Subject Disposition in Part 1 Period|Poor compliance|2|||
143316112|NCT03655236|516703340|FG002|Subject Disposition in Part 1 Period|Poor compliance|0|||
143316113|NCT03655236|516703338|FG000|Subject Disposition in Part 1 Period|Protocol Violation|1|||
143316114|NCT03655236|516703339|FG001|Subject Disposition in Part 1 Period|Protocol Violation|1|||
143316115|NCT03655236|516703340|FG002|Subject Disposition in Part 1 Period|Protocol Violation|0|||
143316116|NCT03655236|516703338|FG000|Subject Disposition in Part 1 Period|Requires prohibited medication|4|||
143377439|NCT00958633|516926815|FG002|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
143377440|NCT02261467|516926816|FG000|Overall Study|Enrolled in Error|1|||
143377441|NCT02261467|516926817|FG001|Overall Study|Enrolled in Error|0|||
143377442|NCT02261467|516926816|FG000|Overall Study|Protocol Violation|0|||
143377443|NCT02261467|516926817|FG001|Overall Study|Protocol Violation|1|||
143377444|NCT02261467|516926816|FG000|Overall Study|Personal Reasons|17|||
143377445|NCT02261467|516926817|FG001|Overall Study|Personal Reasons|22|||
143377446|NCT02261467|516926816|FG000|Overall Study|Lost to Follow-up|2|||
143377447|NCT02261467|516926817|FG001|Overall Study|Lost to Follow-up|13|||
143377448|NCT02261467|516926816|FG000|Overall Study|Adverse Event|1|||
143377449|NCT02261467|516926817|FG001|Overall Study|Adverse Event|1|||
143377450|NCT03144674|516926827|FG000|Overall Study|Participant Transferred to Rollover Study|1|||
143377451|NCT03144674|516926828|FG001|Overall Study|Participant Transferred to Rollover Study|1|||
143377452|NCT03144674|516926829|FG002|Overall Study|Participant Transferred to Rollover Study|5|||
143377453|NCT03144674|516926830|FG003|Overall Study|Participant Transferred to Rollover Study|6|||
143377454|NCT03144674|516926827|FG000|Overall Study|Death|3|||
143377455|NCT03144674|516926828|FG001|Overall Study|Death|2|||
143377456|NCT03144674|516926829|FG002|Overall Study|Death|6|||
143377457|NCT03144674|516926830|FG003|Overall Study|Death|24|||
143377458|NCT03144674|516926827|FG000|Overall Study|Lost to Follow-up|0|||
143377459|NCT03144674|516926828|FG001|Overall Study|Lost to Follow-up|1|||
143377460|NCT03144674|516926829|FG002|Overall Study|Lost to Follow-up|0|||
143377461|NCT03144674|516926830|FG003|Overall Study|Lost to Follow-up|4|||
143377462|NCT03144674|516926827|FG000|Overall Study|Withdrawal by Participant|0|||
143377463|NCT03144674|516926828|FG001|Overall Study|Withdrawal by Participant|0|||
143377464|NCT03144674|516926829|FG002|Overall Study|Withdrawal by Participant|2|||
143377465|NCT03144674|516926830|FG003|Overall Study|Withdrawal by Participant|6|||
143377466|NCT03144674|516926827|FG000|Overall Study|Discharged from the Trust|0|||
143377467|NCT03144674|516926828|FG001|Overall Study|Discharged from the Trust|0|||
143377468|NCT03144674|516926829|FG002|Overall Study|Discharged from the Trust|1|||
143377469|NCT03144674|516926830|FG003|Overall Study|Discharged from the Trust|0|||
143377470|NCT03144674|516926827|FG000|Overall Study|Exclusion Criteria Met|0|||
143316117|NCT03655236|516703339|FG001|Subject Disposition in Part 1 Period|Requires prohibited medication|5|||
143316118|NCT03655236|516703340|FG002|Subject Disposition in Part 1 Period|Requires prohibited medication|3|||
143316119|NCT03655236|516703338|FG000|Subject Disposition in Part 1 Period|Study terminated by Sponsor|12|||
143316120|NCT03655236|516703339|FG001|Subject Disposition in Part 1 Period|Study terminated by Sponsor|8|||
143316121|NCT03655236|516703340|FG002|Subject Disposition in Part 1 Period|Study terminated by Sponsor|13|||
143316122|NCT03655236|516703338|FG000|Subject Disposition in Part 1 Period|Withdrawal by Subject|0|||
143316123|NCT03655236|516703339|FG001|Subject Disposition in Part 1 Period|Withdrawal by Subject|5|||
143316124|NCT03655236|516703340|FG002|Subject Disposition in Part 1 Period|Withdrawal by Subject|3|||
143377471|NCT03144674|516926828|FG001|Overall Study|Exclusion Criteria Met|0|||
143377472|NCT03144674|516926829|FG002|Overall Study|Exclusion Criteria Met|1|||
143377473|NCT03144674|516926830|FG003|Overall Study|Exclusion Criteria Met|0|||
143377474|NCT03144674|516926827|FG000|Overall Study|Changed Physicians|0|||
143377475|NCT03144674|516926828|FG001|Overall Study|Changed Physicians|0|||
143377476|NCT03144674|516926829|FG002|Overall Study|Changed Physicians|0|||
143377477|NCT03144674|516926830|FG003|Overall Study|Changed Physicians|1|||
143377478|NCT03144674|516926827|FG000|Overall Study|Removed for Safety|0|||
143377479|NCT03144674|516926828|FG001|Overall Study|Removed for Safety|0|||
143377480|NCT03144674|516926829|FG002|Overall Study|Removed for Safety|0|||
143377481|NCT03144674|516926830|FG003|Overall Study|Removed for Safety|1|||
143377482|NCT03144674|516926827|FG000|Overall Study|Site Closed|0|||
143377483|NCT03144674|516926828|FG001|Overall Study|Site Closed|0|||
143377484|NCT03144674|516926829|FG002|Overall Study|Site Closed|0|||
143377485|NCT03144674|516926830|FG003|Overall Study|Site Closed|1|||
143377486|NCT03144674|516926827|FG000|Overall Study|Histological Criteria Not Met|0|||
143377487|NCT03144674|516926828|FG001|Overall Study|Histological Criteria Not Met|0|||
143377488|NCT03144674|516926829|FG002|Overall Study|Histological Criteria Not Met|0|||
143377489|NCT03144674|516926830|FG003|Overall Study|Histological Criteria Not Met|1|||
143377490|NCT03144674|516926827|FG000|Overall Study|Multifactorial Cognitive Decline|0|||
143377491|NCT03144674|516926828|FG001|Overall Study|Multifactorial Cognitive Decline|0|||
143377492|NCT03144674|516926829|FG002|Overall Study|Multifactorial Cognitive Decline|0|||
143377493|NCT03144674|516926830|FG003|Overall Study|Multifactorial Cognitive Decline|1|||
143377494|NCT03144674|516926827|FG000|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
143377495|NCT03144674|516926828|FG001|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
143377496|NCT03144674|516926829|FG002|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
143377497|NCT03144674|516926830|FG003|Overall Study|Progression of Chronic Lymphocytic Leukemia|1|||
143377498|NCT01395758|516926831|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
143377499|NCT01395758|516926832|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
143377500|NCT01395758|516926833|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
143377501|NCT00357097|516926836|FG000|Overall Study|Did not meet inclusion criteria|5|||
143377502|NCT00357097|516926837|FG001|Overall Study|Did not meet inclusion criteria|3|||
143377503|NCT00357097|516926836|FG000|Overall Study|Adverse Event|34|||
143377504|NCT00357097|516926837|FG001|Overall Study|Adverse Event|6|||
143377505|NCT00357097|516926836|FG000|Overall Study|Withdrawal by Subject|8|||
143377506|NCT00357097|516926837|FG001|Overall Study|Withdrawal by Subject|7|||
143377507|NCT00357097|516926836|FG000|Overall Study|Non-compliance|1|||
143377508|NCT00357097|516926837|FG001|Overall Study|Non-compliance|2|||
143377509|NCT00357097|516926836|FG000|Overall Study|Lack of Efficacy|2|||
143377510|NCT00357097|516926837|FG001|Overall Study|Lack of Efficacy|8|||
143377511|NCT00357097|516926836|FG000|Overall Study|Met Exclusion Criteria|3|||
143377512|NCT00357097|516926837|FG001|Overall Study|Met Exclusion Criteria|1|||
143377513|NCT00357097|516926836|FG000|Overall Study|Other|1|||
143377514|NCT00357097|516926837|FG001|Overall Study|Other|1|||
143377515|NCT00357097|516926836|FG000|Overall Study|Increase of RLS Symptoms|0|||
143377516|NCT00357097|516926837|FG001|Overall Study|Increase of RLS Symptoms|1|||
143377517|NCT00794118|516926838|FG000|Overall Study|Lost to Follow-up|16|||
143377518|NCT00794118|516926838|FG000|Overall Study|Withdrawal by Subject|9|||
143377519|NCT00794118|516926838|FG000|Overall Study|Changed hospital center|2|||
143377520|NCT01597258|516926839|FG000|Overall Study|No Drug Administration|1|||
143377521|NCT02531113|516926840|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
143377522|NCT02531113|516926840|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
143377523|NCT02531113|516926840|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
143377524|NCT02531113|516926840|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
143377525|NCT02531113|516926840|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
143377526|NCT02531113|516926840|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
143377527|NCT02531113|516926840|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
143377528|NCT02531113|516926840|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
143377529|NCT05135000|516926845|FG000|Overall Study|Adverse Event|2|||
143377530|NCT05135000|516926846|FG001|Overall Study|Adverse Event|0|||
143377531|NCT05135000|516926845|FG000|Overall Study|Lost to Follow-up|1|||
143377532|NCT05135000|516926846|FG001|Overall Study|Lost to Follow-up|0|||
143377533|NCT05135000|516926845|FG000|Overall Study|Study Terminated by Sponsor|6|||
143377534|NCT05135000|516926846|FG001|Overall Study|Study Terminated by Sponsor|3|||
143377535|NCT02763319|516928159|FG000|Overall Study|Adverse Event|12|||
143377536|NCT02763319|516928160|FG001|Overall Study|Adverse Event|3|||
143377537|NCT02763319|516928159|FG000|Overall Study|Death|123|||
143377538|NCT02763319|516928160|FG001|Overall Study|Death|123|||
143377539|NCT02763319|516928159|FG000|Overall Study|Lost to Follow-up|6|||
143377540|NCT02763319|516928160|FG001|Overall Study|Lost to Follow-up|7|||
143377541|NCT02763319|516928159|FG000|Overall Study|Noncompliance with Study Drug|2|||
143377542|NCT02763319|516928160|FG001|Overall Study|Noncompliance with Study Drug|0|||
143377543|NCT02763319|516928159|FG000|Overall Study|"Captured as Other in Database"|29|||
143377544|NCT02763319|516928160|FG001|Overall Study|"Captured as Other in Database"|34|||
143377545|NCT02763319|516928159|FG000|Overall Study|Physician Decision|1|||
143377546|NCT02763319|516928160|FG001|Overall Study|Physician Decision|7|||
143377547|NCT02763319|516928159|FG000|Overall Study|Progressive Disease|24|||
143377548|NCT02763319|516928160|FG001|Overall Study|Progressive Disease|27|||
143377549|NCT02763319|516928159|FG000|Overall Study|Completed the Maximum per Protocol Treatment Period|1|||
143377550|NCT02763319|516928160|FG001|Overall Study|Completed the Maximum per Protocol Treatment Period|0|||
143377551|NCT02763319|516928159|FG000|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|2|||
143377552|NCT02763319|516928160|FG001|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|1|||
143377553|NCT02763319|516928159|FG000|Overall Study|Withdrawal by Subject|26|||
143377554|NCT02763319|516928160|FG001|Overall Study|Withdrawal by Subject|25|||
143377555|NCT03936660|516928162|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
143377556|NCT03936660|516928163|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
143377557|NCT01875848|516928167|FG000|Overall Study|Withdrawal by Subject|2|||
143377558|NCT01875848|516928168|FG001|Overall Study|Withdrawal by Subject|0|||
143377559|NCT02407249|516928169|FG000|Overall Study|Did not complete 12-month follow-up|13|||
143377560|NCT02407249|516928169|FG000|Overall Study|Not treated|13|||
143377561|NCT00840177|516928170|FG000|Overall Study|Adverse Event|5|||
143377562|NCT00840177|516928171|FG001|Overall Study|Adverse Event|1|||
143377563|NCT00840177|516928172|FG002|Overall Study|Adverse Event|1|||
143377564|NCT00840177|516928170|FG000|Overall Study|Refusal unrelated to adverse events|1|||
143377565|NCT00840177|516928171|FG001|Overall Study|Refusal unrelated to adverse events|0|||
143377566|NCT00840177|516928172|FG002|Overall Study|Refusal unrelated to adverse events|1|||
143377567|NCT00840177|516928170|FG000|Overall Study|Progression/relapse|2|||
143377568|NCT00840177|516928171|FG001|Overall Study|Progression/relapse|0|||
143377569|NCT00840177|516928172|FG002|Overall Study|Progression/relapse|0|||
143377570|NCT00840177|516928170|FG000|Overall Study|Death|4|||
143377571|NCT00840177|516928171|FG001|Overall Study|Death|5|||
143377572|NCT00840177|516928172|FG002|Overall Study|Death|5|||
143377573|NCT00840177|516928170|FG000|Overall Study|not protocol specified|6|||
143377574|NCT00840177|516928171|FG001|Overall Study|not protocol specified|3|||
143377575|NCT00840177|516928172|FG002|Overall Study|not protocol specified|0|||
143377576|NCT00840177|516928170|FG000|Overall Study|Ineligible|0|||
143377577|NCT00840177|516928171|FG001|Overall Study|Ineligible|0|||
143377578|NCT00840177|516928172|FG002|Overall Study|Ineligible|3|||
143377579|NCT00840177|516928170|FG000|Overall Study|Did not start treatment|0|||
143377580|NCT00840177|516928171|FG001|Overall Study|Did not start treatment|0|||
143377581|NCT00840177|516928172|FG002|Overall Study|Did not start treatment|1|||
143377582|NCT00434304|516928174|FG000|Overall Study|Adverse Event|14|||
143377583|NCT00434304|516928174|FG000|Overall Study|Lack of Efficacy|2|||
143377584|NCT00434304|516928174|FG000|Overall Study|Withdrawal by Subject|4|||
143377585|NCT05262738|516928175|FG000|Overall Study|Withdrawal by Subject|1|||
143377586|NCT05262738|516928176|FG001|Overall Study|Withdrawal by Subject|0|||
143377587|NCT02374463|516928179|FG000|Overall Study|Withdrawal by Subject|3|||
143377588|NCT02374463|516928180|FG001|Overall Study|Withdrawal by Subject|3|||
143377589|NCT00077675|516928189|FG000|Overall Study|Adverse Event|1|||
143377590|NCT00077675|516928190|FG001|Overall Study|Adverse Event|2|||
143377591|NCT00077675|516928189|FG000|Overall Study|Lost to Follow-up|6|||
143377592|NCT00077675|516928190|FG001|Overall Study|Lost to Follow-up|3|||
143377593|NCT00077675|516928189|FG000|Overall Study|Withdrawal by Subject|1|||
143377594|NCT00077675|516928190|FG001|Overall Study|Withdrawal by Subject|0|||
143377595|NCT00077675|516928189|FG000|Overall Study|Other|0|||
143377596|NCT00077675|516928190|FG001|Overall Study|Other|1|||
143377597|NCT00077675|516928189|FG000|Overall Study|Never received study treatment|3|||
143377598|NCT00077675|516928190|FG001|Overall Study|Never received study treatment|3|||
143377599|NCT02601820|516928191|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
143377600|NCT02601820|516928191|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
143377601|NCT02601820|516928191|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
143377602|NCT02601820|516928191|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
143377603|NCT01599793|516928192|FG000|Overall Study|Adverse Event|2|||
143377604|NCT00391898|516928199|FG000|Overall Study|Adverse Event|3|||
143377605|NCT00391898|516928200|FG001|Overall Study|Adverse Event|0|||
143377606|NCT00391898|516928199|FG000|Overall Study|Other|8|||
143377607|NCT00391898|516928200|FG001|Overall Study|Other|10|||
143377608|NCT00244855|516928203|FG000|Overall Study|Withdrawal by Subject|0|||
143377609|NCT00244855|516928204|FG001|Overall Study|Withdrawal by Subject|1|||
143377610|NCT00869258|516928205|FG000|Overall Study|Physician Decision|1|||
143377611|NCT01236001|516928206|FG000|Overall Study|Adverse Event|5|||
143377612|NCT01236001|516928207|FG001|Overall Study|Adverse Event|14|||
143377613|NCT01236001|516928206|FG000|Overall Study|Lack of Efficacy|6|||
143377614|NCT01236001|516928207|FG001|Overall Study|Lack of Efficacy|6|||
143377615|NCT01236001|516928206|FG000|Overall Study|Lost to Follow-up|6|||
143377616|NCT01236001|516928207|FG001|Overall Study|Lost to Follow-up|1|||
143377617|NCT01236001|516928206|FG000|Overall Study|Incompliance|1|||
143377618|NCT01236001|516928207|FG001|Overall Study|Incompliance|0|||
143377619|NCT01236001|516928206|FG000|Overall Study|Planned Visit After End of Study|0|||
143316125|NCT03655236|516703338|FG000|Subject Disposition in Part 1 Period|Withdrawal of consent|11|||
143316126|NCT03655236|516703339|FG001|Subject Disposition in Part 1 Period|Withdrawal of consent|16|||
143316127|NCT03655236|516703340|FG002|Subject Disposition in Part 1 Period|Withdrawal of consent|6|||
143316128|NCT03655236|516703338|FG000|Subject Disposition in Part 1 Period|Other|0|||
143316129|NCT03655236|516703339|FG001|Subject Disposition in Part 1 Period|Other|2|||
143316130|NCT03655236|516703340|FG002|Subject Disposition in Part 1 Period|Other|2|||
143316131|NCT03655236|516703338|FG000|Subject Disposition in Part 2 Period|Adverse Event|2|||
143316132|NCT03655236|516703339|FG001|Subject Disposition in Part 2 Period|Adverse Event|5|||
143316133|NCT03655236|516703340|FG002|Subject Disposition in Part 2 Period|Adverse Event|12|||
143316134|NCT03655236|516703338|FG000|Subject Disposition in Part 2 Period|Lost to Follow-up|1|||
143316135|NCT03655236|516703339|FG001|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
143316136|NCT03655236|516703340|FG002|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
143316137|NCT03655236|516703338|FG000|Subject Disposition in Part 2 Period|Parkinson's disease progression|4|||
143316138|NCT03655236|516703339|FG001|Subject Disposition in Part 2 Period|Parkinson's disease progression|0|||
143316139|NCT03655236|516703340|FG002|Subject Disposition in Part 2 Period|Parkinson's disease progression|2|||
143316140|NCT03655236|516703338|FG000|Subject Disposition in Part 2 Period|Protocol Violation|1|||
143316141|NCT03655236|516703339|FG001|Subject Disposition in Part 2 Period|Protocol Violation|0|||
143316142|NCT03655236|516703340|FG002|Subject Disposition in Part 2 Period|Protocol Violation|4|||
143316143|NCT03655236|516703338|FG000|Subject Disposition in Part 2 Period|Requires prohibited medication|3|||
143316144|NCT03655236|516703339|FG001|Subject Disposition in Part 2 Period|Requires prohibited medication|1|||
143316145|NCT03655236|516703340|FG002|Subject Disposition in Part 2 Period|Requires prohibited medication|5|||
143316146|NCT03655236|516703338|FG000|Subject Disposition in Part 2 Period|Study terminated by Sponsor|18|||
143316147|NCT03655236|516703339|FG001|Subject Disposition in Part 2 Period|Study terminated by Sponsor|11|||
143316148|NCT03655236|516703340|FG002|Subject Disposition in Part 2 Period|Study terminated by Sponsor|13|||
143316149|NCT03655236|516703338|FG000|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
143316150|NCT03655236|516703339|FG001|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
143316151|NCT03655236|516703340|FG002|Subject Disposition in Part 2 Period|Withdrawal by Subject|2|||
143316152|NCT03655236|516703338|FG000|Subject Disposition in Part 2 Period|Withdrawal of consent|5|||
143316153|NCT03655236|516703339|FG001|Subject Disposition in Part 2 Period|Withdrawal of consent|1|||
143316154|NCT03655236|516703340|FG002|Subject Disposition in Part 2 Period|Withdrawal of consent|12|||
143316155|NCT03655236|516703338|FG000|Subject Disposition in Part 2 Period|Other|1|||
143316156|NCT03655236|516703339|FG001|Subject Disposition in Part 2 Period|Other|0|||
143316157|NCT03655236|516703340|FG002|Subject Disposition in Part 2 Period|Other|0|||
143316158|NCT00827372|516704955|FG000|Overall Study|Adverse Event|5|||
143316159|NCT00827372|516704955|FG000|Overall Study|Lack of Efficacy|3|||
143316160|NCT02139644|516704956|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
143316161|NCT02139644|516704957|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
143316162|NCT02139644|516704958|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
143316163|NCT02139644|516704959|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
143316164|NCT02139644|516704960|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
143316165|NCT02139644|516704961|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
143316166|NCT02139644|516704956|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
143316167|NCT02139644|516704957|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
143316168|NCT02139644|516704958|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
143316169|NCT02139644|516704959|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
143316170|NCT02139644|516704960|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
143316171|NCT02139644|516704961|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
143316172|NCT02139644|516704956|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
143316173|NCT02139644|516704957|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
143316174|NCT02139644|516704958|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
143316175|NCT02139644|516704959|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
143316176|NCT02139644|516704960|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
143316177|NCT02139644|516704961|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
143316178|NCT02139644|516704956|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
143316179|NCT02139644|516704957|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
143316180|NCT02139644|516704958|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
143316181|NCT02139644|516704959|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
143316182|NCT02139644|516704960|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
143316183|NCT02139644|516704961|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
143316184|NCT02139644|516704956|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
143316185|NCT02139644|516704957|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
143316186|NCT02139644|516704958|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
143316187|NCT02139644|516704959|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
143316188|NCT02139644|516704960|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
143316189|NCT02139644|516704961|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
143316190|NCT02139644|516704956|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
143316191|NCT02139644|516704957|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
143316192|NCT02139644|516704958|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
143316193|NCT02139644|516704959|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
143316194|NCT02139644|516704960|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
143316195|NCT02139644|516704961|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
143316196|NCT02139644|516704956|FG000|Run-In Period (Pre-assignment)|Other|6|||
143316197|NCT02139644|516704957|FG001|Run-In Period (Pre-assignment)|Other|0|||
143316198|NCT02139644|516704958|FG002|Run-In Period (Pre-assignment)|Other|0|||
143316199|NCT02139644|516704959|FG003|Run-In Period (Pre-assignment)|Other|0|||
143316200|NCT02139644|516704960|FG004|Run-In Period (Pre-assignment)|Other|0|||
143316201|NCT02139644|516704961|FG005|Run-In Period (Pre-assignment)|Other|0|||
143316202|NCT02139644|516704956|FG000|Treatment Period|Adverse Event|0|||
143316203|NCT02139644|516704957|FG001|Treatment Period|Adverse Event|0|||
143316204|NCT02139644|516704958|FG002|Treatment Period|Adverse Event|3|||
143316205|NCT02139644|516704959|FG003|Treatment Period|Adverse Event|2|||
143316206|NCT02139644|516704960|FG004|Treatment Period|Adverse Event|1|||
143316207|NCT02139644|516704961|FG005|Treatment Period|Adverse Event|6|||
143316208|NCT02139644|516704956|FG000|Treatment Period|Withdrawal by Subject|0|||
143316209|NCT02139644|516704957|FG001|Treatment Period|Withdrawal by Subject|0|||
143316210|NCT02139644|516704958|FG002|Treatment Period|Withdrawal by Subject|2|||
143316211|NCT02139644|516704959|FG003|Treatment Period|Withdrawal by Subject|2|||
143316212|NCT02139644|516704960|FG004|Treatment Period|Withdrawal by Subject|3|||
143316213|NCT02139644|516704961|FG005|Treatment Period|Withdrawal by Subject|2|||
143316214|NCT02139644|516704956|FG000|Treatment Period|Non-compliance|0|||
143316215|NCT02139644|516704957|FG001|Treatment Period|Non-compliance|0|||
143316216|NCT02139644|516704958|FG002|Treatment Period|Non-compliance|0|||
143316217|NCT02139644|516704959|FG003|Treatment Period|Non-compliance|1|||
143316218|NCT02139644|516704960|FG004|Treatment Period|Non-compliance|0|||
143316219|NCT02139644|516704961|FG005|Treatment Period|Non-compliance|0|||
143316220|NCT02139644|516704956|FG000|Treatment Period|Protocol Violation|0|||
143316221|NCT02139644|516704957|FG001|Treatment Period|Protocol Violation|0|||
143316222|NCT02139644|516704958|FG002|Treatment Period|Protocol Violation|0|||
143316223|NCT02139644|516704959|FG003|Treatment Period|Protocol Violation|1|||
143316224|NCT02139644|516704960|FG004|Treatment Period|Protocol Violation|1|||
143316225|NCT02139644|516704961|FG005|Treatment Period|Protocol Violation|1|||
143316226|NCT02139644|516704956|FG000|Treatment Period|Disease progression|0|||
143316227|NCT02139644|516704957|FG001|Treatment Period|Disease progression|0|||
143316228|NCT02139644|516704958|FG002|Treatment Period|Disease progression|0|||
143316229|NCT02139644|516704959|FG003|Treatment Period|Disease progression|1|||
143316230|NCT02139644|516704960|FG004|Treatment Period|Disease progression|1|||
143316231|NCT02139644|516704961|FG005|Treatment Period|Disease progression|2|||
143316232|NCT02139644|516704956|FG000|Treatment Period|Lost to Follow-up|0|||
143316233|NCT02139644|516704957|FG001|Treatment Period|Lost to Follow-up|0|||
143316234|NCT02139644|516704958|FG002|Treatment Period|Lost to Follow-up|1|||
143316235|NCT02139644|516704959|FG003|Treatment Period|Lost to Follow-up|1|||
143316236|NCT02139644|516704960|FG004|Treatment Period|Lost to Follow-up|1|||
143316237|NCT02139644|516704961|FG005|Treatment Period|Lost to Follow-up|1|||
143316238|NCT02139644|516704956|FG000|Treatment Period|Lack of Efficacy|0|||
143316239|NCT02139644|516704957|FG001|Treatment Period|Lack of Efficacy|0|||
143316240|NCT02139644|516704958|FG002|Treatment Period|Lack of Efficacy|1|||
143316241|NCT02139644|516704959|FG003|Treatment Period|Lack of Efficacy|0|||
143316242|NCT02139644|516704960|FG004|Treatment Period|Lack of Efficacy|1|||
143316243|NCT02139644|516704961|FG005|Treatment Period|Lack of Efficacy|4|||
143316244|NCT02139644|516704956|FG000|Treatment Period|Other|0|||
143316245|NCT02139644|516704957|FG001|Treatment Period|Other|3|||
143316246|NCT02139644|516704958|FG002|Treatment Period|Other|1|||
143316247|NCT02139644|516704959|FG003|Treatment Period|Other|1|||
143316248|NCT02139644|516704960|FG004|Treatment Period|Other|0|||
143316249|NCT02139644|516704961|FG005|Treatment Period|Other|1|||
143316250|NCT02766608|516704962|FG000|Overall Study|Adverse Event|27|||
143316251|NCT02766608|516704963|FG001|Overall Study|Adverse Event|22|||
143316252|NCT02766608|516704964|FG002|Overall Study|Adverse Event|17|||
143316253|NCT02766608|516704965|FG003|Overall Study|Adverse Event|13|||
143316254|NCT02766608|516704966|FG004|Overall Study|Adverse Event|12|||
143316255|NCT02766608|516704962|FG000|Overall Study|Withdrawal by Subject|21|||
143316256|NCT02766608|516704963|FG001|Overall Study|Withdrawal by Subject|20|||
143316257|NCT02766608|516704964|FG002|Overall Study|Withdrawal by Subject|24|||
143316258|NCT02766608|516704965|FG003|Overall Study|Withdrawal by Subject|13|||
143316259|NCT02766608|516704966|FG004|Overall Study|Withdrawal by Subject|10|||
143316260|NCT02766608|516704962|FG000|Overall Study|Lack of Efficacy|16|||
143316261|NCT02766608|516704963|FG001|Overall Study|Lack of Efficacy|15|||
143316262|NCT02766608|516704964|FG002|Overall Study|Lack of Efficacy|32|||
143316263|NCT02766608|516704965|FG003|Overall Study|Lack of Efficacy|8|||
143316264|NCT02766608|516704966|FG004|Overall Study|Lack of Efficacy|2|||
143316265|NCT02766608|516704962|FG000|Overall Study|Lost to Follow-up|6|||
143316266|NCT02766608|516704963|FG001|Overall Study|Lost to Follow-up|3|||
143316267|NCT02766608|516704964|FG002|Overall Study|Lost to Follow-up|5|||
143316268|NCT02766608|516704965|FG003|Overall Study|Lost to Follow-up|2|||
143316269|NCT02766608|516704966|FG004|Overall Study|Lost to Follow-up|2|||
143316270|NCT02766608|516704962|FG000|Overall Study|Physician Decision|3|||
143316271|NCT02766608|516704963|FG001|Overall Study|Physician Decision|2|||
143316272|NCT02766608|516704964|FG002|Overall Study|Physician Decision|3|||
143316273|NCT02766608|516704965|FG003|Overall Study|Physician Decision|1|||
143316274|NCT02766608|516704966|FG004|Overall Study|Physician Decision|2|||
143316275|NCT02766608|516704962|FG000|Overall Study|Protocol disc criteria|3|||
143316276|NCT02766608|516704963|FG001|Overall Study|Protocol disc criteria|3|||
143316277|NCT02766608|516704964|FG002|Overall Study|Protocol disc criteria|4|||
143316278|NCT02766608|516704965|FG003|Overall Study|Protocol disc criteria|0|||
143316279|NCT02766608|516704966|FG004|Overall Study|Protocol disc criteria|0|||
143316280|NCT02766608|516704962|FG000|Overall Study|Protocol Violation|0|||
143316281|NCT02766608|516704963|FG001|Overall Study|Protocol Violation|4|||
143316282|NCT02766608|516704964|FG002|Overall Study|Protocol Violation|4|||
143316283|NCT02766608|516704965|FG003|Overall Study|Protocol Violation|0|||
143316284|NCT02766608|516704966|FG004|Overall Study|Protocol Violation|1|||
143316285|NCT02766608|516704962|FG000|Overall Study|Administrative Reasons|3|||
143316286|NCT02766608|516704963|FG001|Overall Study|Administrative Reasons|1|||
143316287|NCT02766608|516704964|FG002|Overall Study|Administrative Reasons|1|||
143316288|NCT02766608|516704965|FG003|Overall Study|Administrative Reasons|0|||
143316289|NCT02766608|516704966|FG004|Overall Study|Administrative Reasons|0|||
143316290|NCT02080091|516704967|FG000|Overall Study|Study Terminated|22|||
143316291|NCT02080091|516704967|FG000|Overall Study|Death|1|||
143316292|NCT02080091|516704967|FG000|Overall Study|Withdrawal by Subject|1|||
143316293|NCT02080091|516704967|FG000|Overall Study|Other|1|||
143316294|NCT01265953|516704970|FG000|Overall Study|Non compliance|5|||
143316295|NCT01265953|516704971|FG001|Overall Study|Non compliance|3|||
143316296|NCT02648698|516704975|FG000|Overall Study|Protocol Violation|1|||
143316297|NCT02648698|516704976|FG001|Overall Study|Protocol Violation|5|||
143316298|NCT01640301|516704977|FG000|Overall Study|Death|0|||
143316299|NCT01640301|516704978|FG001|Overall Study|Death|8|||
143316300|NCT03143829|516704979|FG000|Overall Study|Withdrawal by Subject|2|||
143316301|NCT03143829|516704980|FG001|Overall Study|Withdrawal by Subject|5|||
143316302|NCT03143829|516704979|FG000|Overall Study|Lost to Follow-up|0|||
143316303|NCT03143829|516704980|FG001|Overall Study|Lost to Follow-up|2|||
143316304|NCT03143829|516704979|FG000|Overall Study|Death|1|||
143316305|NCT03143829|516704980|FG001|Overall Study|Death|1|||
143316306|NCT03143829|516704979|FG000|Overall Study|changed treatment, no longer eligible|2|||
143316307|NCT03143829|516704980|FG001|Overall Study|changed treatment, no longer eligible|2|||
143316308|NCT00672477|516704981|FG000|Overall Study|Adverse Event|10|||
143316309|NCT00672477|516704982|FG001|Overall Study|Adverse Event|7|||
143316310|NCT00672477|516704981|FG000|Overall Study|Death|7|||
143316311|NCT00672477|516704982|FG001|Overall Study|Death|11|||
143316312|NCT00672477|516704981|FG000|Overall Study|Physician Decision|2|||
143316313|NCT00672477|516704982|FG001|Overall Study|Physician Decision|0|||
143316314|NCT00672477|516704981|FG000|Overall Study|Protocol Violation|1|||
143316315|NCT00672477|516704982|FG001|Overall Study|Protocol Violation|1|||
143316316|NCT00672477|516704981|FG000|Overall Study|Withdrawal by Subject|5|||
143316317|NCT00672477|516704982|FG001|Overall Study|Withdrawal by Subject|3|||
143316318|NCT00672477|516704981|FG000|Overall Study|Lack of Efficacy|1|||
143316319|NCT00672477|516704982|FG001|Overall Study|Lack of Efficacy|1|||
143316320|NCT00672477|516704981|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
143316321|NCT00672477|516704982|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
143316322|NCT00924950|516704986|FG000|Overall Study|Lost to Follow-up|2|||
143316323|NCT04193202|516704987|FG000|Overall Study|Adverse Event|2|||
143316324|NCT04193202|516704988|FG001|Overall Study|Adverse Event|1|||
143377620|NCT01236001|516928207|FG001|Overall Study|Planned Visit After End of Study|1|||
143377621|NCT03451721|516928210|FG000|Overall Study|Death|1|||
143316325|NCT04193202|516704987|FG000|Overall Study|Death|0|||
143316326|NCT04193202|516704988|FG001|Overall Study|Death|1|||
143316327|NCT04193202|516704987|FG000|Overall Study|Physician Decision|1|||
143316328|NCT04193202|516704988|FG001|Overall Study|Physician Decision|1|||
143316329|NCT04193202|516704987|FG000|Overall Study|Protocol Violation|2|||
143316330|NCT04193202|516704988|FG001|Overall Study|Protocol Violation|2|||
143316331|NCT04193202|516704987|FG000|Overall Study|Withdrawal by Subject|11|||
143316332|NCT04193202|516704988|FG001|Overall Study|Withdrawal by Subject|5|||
143316333|NCT01602315|516704989|FG000|Overall Study|Protocol Violation|0|||
143377622|NCT00960141|516928211|FG000|Overall Study|Adverse Event|4|||
143377623|NCT00960141|516928212|FG001|Overall Study|Adverse Event|8|||
143377624|NCT00960141|516928213|FG002|Overall Study|Adverse Event|2|||
143377625|NCT00960141|516928211|FG000|Overall Study|Lack of Efficacy|3|||
143377626|NCT00960141|516928212|FG001|Overall Study|Lack of Efficacy|4|||
143377627|NCT00960141|516928213|FG002|Overall Study|Lack of Efficacy|2|||
143377628|NCT00960141|516928211|FG000|Overall Study|Lost to Follow-up|1|||
143377629|NCT00960141|516928212|FG001|Overall Study|Lost to Follow-up|0|||
143377630|NCT00960141|516928213|FG002|Overall Study|Lost to Follow-up|0|||
143377631|NCT00960141|516928211|FG000|Overall Study|Protocol Violation|1|||
143377632|NCT00960141|516928212|FG001|Overall Study|Protocol Violation|3|||
143377633|NCT00960141|516928213|FG002|Overall Study|Protocol Violation|2|||
143377634|NCT00960141|516928211|FG000|Overall Study|Withdrawal by Subject|1|||
143377635|NCT00960141|516928212|FG001|Overall Study|Withdrawal by Subject|2|||
143377636|NCT00960141|516928213|FG002|Overall Study|Withdrawal by Subject|1|||
143377637|NCT00939510|516928214|FG000|Overall Study|Withdrawal by Subject|1|||
143377638|NCT03903822|516928217|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
143377639|NCT03903822|516928218|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
143377640|NCT03903822|516928219|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
143377641|NCT03903822|516928220|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
143377642|NCT03903822|516928221|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
143377643|NCT03903822|516928222|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
143377644|NCT03903822|516928223|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
143377645|NCT03903822|516928224|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
143377646|NCT03903822|516928217|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
143377647|NCT03903822|516928218|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
143377648|NCT03903822|516928219|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
143377649|NCT03903822|516928220|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
143377650|NCT03903822|516928221|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
143377651|NCT03903822|516928222|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
143377652|NCT03903822|516928223|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
143377653|NCT03903822|516928224|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
143377654|NCT03903822|516928217|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
143377655|NCT03903822|516928218|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
143377656|NCT03903822|516928219|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
143377657|NCT03903822|516928220|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
143377658|NCT03903822|516928221|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
143377659|NCT03903822|516928222|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
143377660|NCT03903822|516928223|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
143377661|NCT03903822|516928224|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
143377662|NCT03903822|516928217|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
143377663|NCT03903822|516928218|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
143377664|NCT03903822|516928219|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
143377665|NCT03903822|516928220|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
143377666|NCT03903822|516928221|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
143377667|NCT03903822|516928222|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
143377668|NCT03903822|516928223|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
143377669|NCT03903822|516928224|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
143377670|NCT03903822|516928217|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
143377671|NCT03903822|516928218|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
143377672|NCT03903822|516928219|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
143377673|NCT03903822|516928220|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
143377674|NCT03903822|516928221|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
143377675|NCT03903822|516928222|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
143377676|NCT03903822|516928223|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
143377677|NCT03903822|516928224|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
143377678|NCT03903822|516928217|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
143377679|NCT03903822|516928218|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
143377680|NCT03903822|516928219|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
143377681|NCT03903822|516928220|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
143377682|NCT03903822|516928221|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
143377683|NCT03903822|516928222|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
143377684|NCT03903822|516928223|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
143377685|NCT03903822|516928224|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
143377686|NCT03903822|516928217|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
143377687|NCT03903822|516928218|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
143377688|NCT03903822|516928219|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
143377689|NCT03903822|516928220|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
143377690|NCT03903822|516928221|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
143377691|NCT03903822|516928222|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
143377692|NCT03903822|516928223|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
143377693|NCT03903822|516928224|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
143377694|NCT03903822|516928217|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
143377695|NCT03903822|516928218|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
143377696|NCT03903822|516928219|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
143377697|NCT03903822|516928220|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
143377698|NCT03903822|516928221|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
143377699|NCT03903822|516928222|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
143377700|NCT03903822|516928223|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
143377701|NCT03903822|516928224|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
143377702|NCT03903822|516928217|FG000|Treatment Phase (6 Weeks)|Other|2|||
143377703|NCT03903822|516928218|FG001|Treatment Phase (6 Weeks)|Other|1|||
143377704|NCT03903822|516928219|FG002|Treatment Phase (6 Weeks)|Other|0|||
143377705|NCT03903822|516928220|FG003|Treatment Phase (6 Weeks)|Other|0|||
143377706|NCT03903822|516928221|FG004|Treatment Phase (6 Weeks)|Other|1|||
143377707|NCT03903822|516928222|FG005|Treatment Phase (6 Weeks)|Other|1|||
143377708|NCT03903822|516928223|FG006|Treatment Phase (6 Weeks)|Other|0|||
143377709|NCT03903822|516928224|FG007|Treatment Phase (6 Weeks)|Other|0|||
143377710|NCT03903822|516928217|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
143377711|NCT03903822|516928218|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
143377712|NCT03903822|516928219|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
143377713|NCT03903822|516928220|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
143377714|NCT03903822|516928221|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
143377715|NCT03903822|516928222|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
143377716|NCT03903822|516928223|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
143377717|NCT03903822|516928224|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
143377718|NCT03903822|516928217|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
143377719|NCT03903822|516928218|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
143377720|NCT03903822|516928219|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
143316334|NCT01602315|516704990|FG001|Overall Study|Protocol Violation|0|||
143316335|NCT01602315|516704991|FG002|Overall Study|Protocol Violation|0|||
143316336|NCT01602315|516704992|FG003|Overall Study|Protocol Violation|0|||
143316337|NCT01602315|516704993|FG004|Overall Study|Protocol Violation|0|||
143316338|NCT01602315|516704994|FG005|Overall Study|Protocol Violation|1|||
143316339|NCT01602315|516704995|FG006|Overall Study|Protocol Violation|0|||
143316340|NCT01602315|516704989|FG000|Overall Study|Physician Decision|2|||
143316341|NCT01602315|516704990|FG001|Overall Study|Physician Decision|0|||
143316342|NCT01602315|516704991|FG002|Overall Study|Physician Decision|0|||
143316343|NCT01602315|516704992|FG003|Overall Study|Physician Decision|0|||
143316344|NCT01602315|516704993|FG004|Overall Study|Physician Decision|2|||
143316345|NCT01602315|516704994|FG005|Overall Study|Physician Decision|1|||
143316346|NCT01602315|516704995|FG006|Overall Study|Physician Decision|1|||
143316347|NCT01602315|516704989|FG000|Overall Study|Disease progression|6|||
143316348|NCT01602315|516704990|FG001|Overall Study|Disease progression|3|||
143316349|NCT01602315|516704991|FG002|Overall Study|Disease progression|10|||
143316350|NCT01602315|516704992|FG003|Overall Study|Disease progression|1|||
143316351|NCT01602315|516704993|FG004|Overall Study|Disease progression|41|||
143316352|NCT01602315|516704994|FG005|Overall Study|Disease progression|12|||
143316353|NCT01602315|516704995|FG006|Overall Study|Disease progression|15|||
143316354|NCT01602315|516704989|FG000|Overall Study|Death|1|||
143316355|NCT01602315|516704990|FG001|Overall Study|Death|1|||
143316356|NCT01602315|516704991|FG002|Overall Study|Death|1|||
143316357|NCT01602315|516704992|FG003|Overall Study|Death|1|||
143316358|NCT01602315|516704993|FG004|Overall Study|Death|7|||
143316359|NCT01602315|516704994|FG005|Overall Study|Death|2|||
143316360|NCT01602315|516704995|FG006|Overall Study|Death|2|||
143316361|NCT01602315|516704989|FG000|Overall Study|Withdrawal by Subject|2|||
143316362|NCT01602315|516704990|FG001|Overall Study|Withdrawal by Subject|0|||
143316363|NCT01602315|516704991|FG002|Overall Study|Withdrawal by Subject|2|||
143316364|NCT01602315|516704992|FG003|Overall Study|Withdrawal by Subject|0|||
143316365|NCT01602315|516704993|FG004|Overall Study|Withdrawal by Subject|6|||
143316366|NCT01602315|516704994|FG005|Overall Study|Withdrawal by Subject|0|||
143316367|NCT01602315|516704995|FG006|Overall Study|Withdrawal by Subject|1|||
143377721|NCT03903822|516928220|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
143377722|NCT03903822|516928221|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
143377723|NCT03903822|516928222|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
143377724|NCT03903822|516928223|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
143316368|NCT01602315|516704989|FG000|Overall Study|Adverse Event|5|||
143377725|NCT03903822|516928224|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
143377726|NCT03903822|516928217|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
143316369|NCT01602315|516704990|FG001|Overall Study|Adverse Event|1|||
143316370|NCT01602315|516704991|FG002|Overall Study|Adverse Event|5|||
143316371|NCT01602315|516704992|FG003|Overall Study|Adverse Event|4|||
143316372|NCT01602315|516704993|FG004|Overall Study|Adverse Event|15|||
143377727|NCT03903822|516928218|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
143377728|NCT03903822|516928219|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
143377729|NCT03903822|516928220|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
143377730|NCT03903822|516928221|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
143377731|NCT03903822|516928222|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
143377732|NCT03903822|516928223|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
143377733|NCT03903822|516928224|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
143377734|NCT03903822|516928217|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
143377735|NCT03903822|516928218|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
143377736|NCT03903822|516928219|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
143377737|NCT03903822|516928220|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
143377738|NCT03903822|516928221|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
143377739|NCT03903822|516928222|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
143377740|NCT03903822|516928223|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
143377741|NCT03903822|516928224|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
143377742|NCT03903822|516928217|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
143377743|NCT03903822|516928218|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
143377744|NCT03903822|516928219|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
143377745|NCT03903822|516928220|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
143377746|NCT03903822|516928221|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
143377747|NCT03903822|516928222|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
143377748|NCT03903822|516928223|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
143377749|NCT03903822|516928224|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
143377750|NCT03903822|516928217|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
143377751|NCT03903822|516928218|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
143377752|NCT03903822|516928219|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
143377753|NCT03903822|516928220|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
143377754|NCT03903822|516928221|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
143377755|NCT03903822|516928222|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
143377756|NCT03903822|516928223|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
143377757|NCT03903822|516928224|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
143377758|NCT03903822|516928217|FG000|Follow up Phase (4 Weeks)|Other|1|||
143377759|NCT03903822|516928218|FG001|Follow up Phase (4 Weeks)|Other|1|||
143377760|NCT03903822|516928219|FG002|Follow up Phase (4 Weeks)|Other|0|||
143377761|NCT03903822|516928220|FG003|Follow up Phase (4 Weeks)|Other|0|||
143377762|NCT03903822|516928221|FG004|Follow up Phase (4 Weeks)|Other|0|||
143377763|NCT03903822|516928222|FG005|Follow up Phase (4 Weeks)|Other|0|||
143377764|NCT03903822|516928223|FG006|Follow up Phase (4 Weeks)|Other|0|||
143377765|NCT03903822|516928224|FG007|Follow up Phase (4 Weeks)|Other|0|||
143377766|NCT03368664|516928234|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
143377767|NCT03368664|516928234|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
143377768|NCT03368664|516928234|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
143377769|NCT03368664|516928234|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
143377770|NCT00837616|516928235|FG000|Overall Study|Withdrawal by Subject|0|||
143377771|NCT00837616|516928236|FG001|Overall Study|Withdrawal by Subject|1|||
143377772|NCT03942042|516928242|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
143377773|NCT03942042|516928243|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
143377774|NCT03942042|516928242|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
143377775|NCT03942042|516928243|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
143377776|NCT01685606|516928248|FG000|Overall Study|Withdrawal by Subject|1|||
143377777|NCT00736853|516928249|FG000|Open-Label Period|Physician Decision|2|||
143377778|NCT00736853|516928250|FG001|Open-Label Period|Physician Decision|0|||
143377779|NCT00736853|516928251|FG002|Open-Label Period|Physician Decision|0|||
143377780|NCT00736853|516928249|FG000|Open-Label Period|Adverse Event|31|||
143316373|NCT01602315|516704994|FG005|Overall Study|Adverse Event|3|||
143316374|NCT01602315|516704995|FG006|Overall Study|Adverse Event|9|||
143316375|NCT01602315|516704989|FG000|Overall Study|Subject/guardian decision|0|||
143316376|NCT01602315|516704990|FG001|Overall Study|Subject/guardian decision|0|||
143316377|NCT01602315|516704991|FG002|Overall Study|Subject/guardian decision|0|||
143316378|NCT01602315|516704992|FG003|Overall Study|Subject/guardian decision|0|||
143316379|NCT01602315|516704993|FG004|Overall Study|Subject/guardian decision|0|||
143316380|NCT01602315|516704994|FG005|Overall Study|Subject/guardian decision|0|||
143316381|NCT01602315|516704995|FG006|Overall Study|Subject/guardian decision|1|||
143316382|NCT01602315|516704989|FG000|Overall Study|Cross-over patients to combo treatment|0|||
143316383|NCT01602315|516704990|FG001|Overall Study|Cross-over patients to combo treatment|0|||
143377781|NCT00736853|516928250|FG001|Open-Label Period|Adverse Event|0|||
143316384|NCT01602315|516704991|FG002|Overall Study|Cross-over patients to combo treatment|0|||
143316385|NCT01602315|516704992|FG003|Overall Study|Cross-over patients to combo treatment|0|||
143316386|NCT01602315|516704993|FG004|Overall Study|Cross-over patients to combo treatment|0|||
143316387|NCT01602315|516704994|FG005|Overall Study|Cross-over patients to combo treatment|16|||
143316388|NCT01602315|516704995|FG006|Overall Study|Cross-over patients to combo treatment|0|||
143316389|NCT01777997|516704996|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
143316390|NCT01777997|516704996|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
143316391|NCT01777997|516704996|FG000|Weeks 48 to 72/96 on ART|Death|1|||
143316392|NCT01777997|516704996|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
143316393|NCT01694706|516704997|FG000|Overall Study|Adverse Event|0|||
143316394|NCT01694706|516704998|FG001|Overall Study|Adverse Event|1|||
143316395|NCT01694706|516704999|FG002|Overall Study|Adverse Event|0|||
143316396|NCT01694706|516704997|FG000|Overall Study|other reason not defined above|1|||
143316397|NCT01694706|516704998|FG001|Overall Study|other reason not defined above|0|||
143316398|NCT01694706|516704999|FG002|Overall Study|other reason not defined above|0|||
143316399|NCT00975975|516705004|FG000|Overall Study|Death|6|||
143316400|NCT00961259|516705005|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
143316401|NCT00961259|516705006|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
143316402|NCT00961259|516705007|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
143316403|NCT01252251|516705008|FG000|Overall Study|Withdrawal by Subject|1|||
143316404|NCT01324024|516705009|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
143316405|NCT01324024|516705010|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
143316406|NCT01923181|516705011|FG000|Overall Study|Protocol Violation|2|||
143316407|NCT01923181|516705012|FG001|Overall Study|Protocol Violation|2|||
143316408|NCT01923181|516705013|FG002|Overall Study|Protocol Violation|0|||
143316409|NCT01923181|516705014|FG003|Overall Study|Protocol Violation|2|||
143316410|NCT01923181|516705015|FG004|Overall Study|Protocol Violation|2|||
143316411|NCT01923181|516705016|FG005|Overall Study|Protocol Violation|1|||
143316412|NCT01923181|516705017|FG006|Overall Study|Protocol Violation|1|||
143316413|NCT01923181|516705018|FG007|Overall Study|Protocol Violation|2|||
143316414|NCT01923181|516705019|FG008|Overall Study|Protocol Violation|1|||
143316415|NCT01923181|516705011|FG000|Overall Study|Withdrawal by Subject|0|||
143316416|NCT01923181|516705012|FG001|Overall Study|Withdrawal by Subject|1|||
143316417|NCT01923181|516705013|FG002|Overall Study|Withdrawal by Subject|0|||
143316418|NCT01923181|516705014|FG003|Overall Study|Withdrawal by Subject|1|||
143316419|NCT01923181|516705015|FG004|Overall Study|Withdrawal by Subject|4|||
143316420|NCT01923181|516705016|FG005|Overall Study|Withdrawal by Subject|2|||
143316421|NCT01923181|516705017|FG006|Overall Study|Withdrawal by Subject|4|||
143316422|NCT01923181|516705018|FG007|Overall Study|Withdrawal by Subject|3|||
143316423|NCT01923181|516705019|FG008|Overall Study|Withdrawal by Subject|1|||
143316424|NCT01923181|516705011|FG000|Overall Study|Other|1|||
143316425|NCT01923181|516705012|FG001|Overall Study|Other|0|||
143316426|NCT01923181|516705013|FG002|Overall Study|Other|0|||
143316427|NCT01923181|516705014|FG003|Overall Study|Other|1|||
143316428|NCT01923181|516705015|FG004|Overall Study|Other|0|||
143316429|NCT01923181|516705016|FG005|Overall Study|Other|0|||
143316430|NCT01923181|516705017|FG006|Overall Study|Other|0|||
143316431|NCT01923181|516705018|FG007|Overall Study|Other|0|||
143316432|NCT01923181|516705019|FG008|Overall Study|Other|0|||
143316433|NCT01923181|516705011|FG000|Overall Study|Lost to Follow-up|0|||
143316434|NCT01923181|516705012|FG001|Overall Study|Lost to Follow-up|3|||
143316435|NCT01923181|516705013|FG002|Overall Study|Lost to Follow-up|2|||
143316436|NCT01923181|516705014|FG003|Overall Study|Lost to Follow-up|1|||
143316437|NCT01923181|516705015|FG004|Overall Study|Lost to Follow-up|2|||
143316438|NCT01923181|516705016|FG005|Overall Study|Lost to Follow-up|1|||
143316439|NCT01923181|516705017|FG006|Overall Study|Lost to Follow-up|3|||
143316440|NCT01923181|516705018|FG007|Overall Study|Lost to Follow-up|3|||
143316441|NCT01923181|516705019|FG008|Overall Study|Lost to Follow-up|1|||
143316442|NCT02057757|516705020|FG000|Overall Study|Withdrawal by Subject|3|||
143316443|NCT02057757|516705021|FG001|Overall Study|Withdrawal by Subject|5|||
143316444|NCT02057757|516705020|FG000|Overall Study|Death|2|||
143316445|NCT02057757|516705021|FG001|Overall Study|Death|0|||
143316446|NCT02057757|516705020|FG000|Overall Study|Lost to Follow-up|8|||
143316447|NCT02057757|516705021|FG001|Overall Study|Lost to Follow-up|3|||
143316448|NCT02057757|516705020|FG000|Overall Study|Non-compliance|1|||
143316449|NCT02057757|516705021|FG001|Overall Study|Non-compliance|0|||
143316450|NCT00456092|516705022|FG000|Extension Phase|Grade 2 or Greater AE|2|||
143316451|NCT00456092|516705023|FG001|Extension Phase|Grade 2 or Greater AE|2|||
143316452|NCT00456092|516705024|FG002|Extension Phase|Grade 2 or Greater AE|0|||
143316453|NCT00456092|516705025|FG003|Extension Phase|Grade 2 or Greater AE|0|||
143316454|NCT00456092|516705026|FG004|Extension Phase|Grade 2 or Greater AE|2|||
143316455|NCT00456092|516705022|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
143316456|NCT00456092|516705023|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
143316457|NCT00456092|516705024|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
143316458|NCT00456092|516705025|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
143316459|NCT00456092|516705026|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
143316460|NCT00456092|516705022|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
143316461|NCT00456092|516705023|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
143316462|NCT00456092|516705024|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
143316463|NCT00456092|516705025|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
143316464|NCT00456092|516705026|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
143316465|NCT00456092|516705022|FG000|Extension Phase|Withdrew Consent|2|||
143316466|NCT00456092|516705023|FG001|Extension Phase|Withdrew Consent|0|||
143316467|NCT00456092|516705024|FG002|Extension Phase|Withdrew Consent|0|||
143316468|NCT00456092|516705025|FG003|Extension Phase|Withdrew Consent|0|||
143316469|NCT00456092|516705026|FG004|Extension Phase|Withdrew Consent|0|||
143316470|NCT00456092|516705022|FG000|Extension Phase|Lost to Follow-up|1|||
143316471|NCT00456092|516705023|FG001|Extension Phase|Lost to Follow-up|1|||
143316472|NCT00456092|516705024|FG002|Extension Phase|Lost to Follow-up|0|||
143316473|NCT00456092|516705025|FG003|Extension Phase|Lost to Follow-up|0|||
143316474|NCT00456092|516705026|FG004|Extension Phase|Lost to Follow-up|1|||
143316475|NCT00456092|516705022|FG000|Extension Phase|Other|2|||
143316476|NCT00456092|516705023|FG001|Extension Phase|Other|0|||
143316477|NCT00456092|516705024|FG002|Extension Phase|Other|0|||
143316478|NCT00456092|516705025|FG003|Extension Phase|Other|1|||
143316479|NCT00456092|516705026|FG004|Extension Phase|Other|1|||
143316480|NCT00456092|516705022|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
143316481|NCT00456092|516705023|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
143316482|NCT00456092|516705024|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
143316483|NCT00456092|516705025|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
143316484|NCT00456092|516705026|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
143316485|NCT00456092|516705022|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
143316486|NCT00456092|516705023|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
143316487|NCT00456092|516705024|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
143316488|NCT00456092|516705025|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
143316489|NCT00456092|516705026|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
143316490|NCT00456092|516705022|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
143316491|NCT00456092|516705023|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
143316492|NCT00456092|516705024|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
143316493|NCT00456092|516705025|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
143316494|NCT00456092|516705026|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
143316495|NCT00456092|516705022|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
143316496|NCT00456092|516705023|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
143316497|NCT00456092|516705024|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
143316498|NCT00456092|516705025|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
143316499|NCT00456092|516705026|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
143316500|NCT00456092|516705022|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
143316501|NCT00456092|516705023|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
143316502|NCT00456092|516705024|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
143316503|NCT00456092|516705025|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
143316504|NCT00456092|516705026|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
143316505|NCT00456092|516705022|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
143316506|NCT00456092|516705023|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
143316507|NCT00456092|516705024|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
143316508|NCT00456092|516705025|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
143316509|NCT00456092|516705026|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
143316510|NCT00456092|516705022|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
143316511|NCT00456092|516705023|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
143316512|NCT00456092|516705024|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
143316513|NCT00456092|516705025|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
143316514|NCT00456092|516705026|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
143316515|NCT00456092|516705022|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
143316516|NCT00456092|516705023|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
143316517|NCT00456092|516705024|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
143316518|NCT00456092|516705025|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
143316519|NCT00456092|516705026|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
143316520|NCT00456092|516705022|FG000|Treatment Phase (12 Weeks)|Other|1|||
143316521|NCT00456092|516705023|FG001|Treatment Phase (12 Weeks)|Other|0|||
143316522|NCT00456092|516705024|FG002|Treatment Phase (12 Weeks)|Other|1|||
143316523|NCT00456092|516705025|FG003|Treatment Phase (12 Weeks)|Other|0|||
143316524|NCT00456092|516705026|FG004|Treatment Phase (12 Weeks)|Other|0|||
143316525|NCT01565993|516705027|FG000|Overall Study|Physician Decision|0|||
143316526|NCT01565993|516705028|FG001|Overall Study|Physician Decision|3|||
143316527|NCT02252081|516705029|FG000|Overall Study|Withdrawal by Subject|2|||
143316528|NCT02252081|516705030|FG001|Overall Study|Withdrawal by Subject|1|||
143316529|NCT02252081|516705029|FG000|Overall Study|Adverse Event|4|||
143316530|NCT02252081|516705030|FG001|Overall Study|Adverse Event|1|||
143316531|NCT02252081|516705029|FG000|Overall Study|non compliance & others|0|||
143316532|NCT02252081|516705030|FG001|Overall Study|non compliance & others|2|||
143316533|NCT00048724|516705031|FG000|Overall Study|Adverse Event|53|||
143316534|NCT00048724|516705032|FG001|Overall Study|Adverse Event|12|||
143316535|NCT00048724|516705031|FG000|Overall Study|Withdrawal by Subject|34|||
143316536|NCT00048724|516705032|FG001|Overall Study|Withdrawal by Subject|54|||
143316537|NCT00048724|516705031|FG000|Overall Study|Lost to Follow-up|5|||
143316538|NCT00048724|516705032|FG001|Overall Study|Lost to Follow-up|5|||
143316539|NCT00048724|516705031|FG000|Overall Study|Protocol-defined Clinical Event|17|||
143316540|NCT00048724|516705032|FG001|Overall Study|Protocol-defined Clinical Event|32|||
143316541|NCT00048724|516705031|FG000|Overall Study|Noncompliance With Protocol|4|||
143316542|NCT00048724|516705032|FG001|Overall Study|Noncompliance With Protocol|12|||
143316543|NCT00048724|516705031|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
143316544|NCT00048724|516705032|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
143316545|NCT00048724|516705031|FG000|Overall Study|Administrative|1|||
143316546|NCT00048724|516705032|FG001|Overall Study|Administrative|1|||
143316547|NCT01158222|516705034|FG000|Overall Study|Not eligible for intermediate phase|17|||
143316548|NCT00111228|516705037|FG000|Overall Study|Withdrawal by Subject|5|||
143316549|NCT00111228|516705038|FG001|Overall Study|Withdrawal by Subject|1|||
143316550|NCT00111228|516705039|FG002|Overall Study|Withdrawal by Subject|0|||
143316551|NCT03095417|516705042|FG000|Overall Study|missed|1|||
143316552|NCT03095417|516705043|FG001|Overall Study|missed|2|||
143316553|NCT03095417|516705044|FG002|Overall Study|missed|0|||
143316554|NCT03095417|516705045|FG003|Overall Study|missed|1|||
143316555|NCT03095417|516705042|FG000|Overall Study|Lost to Follow-up|2|||
143316556|NCT03095417|516705043|FG001|Overall Study|Lost to Follow-up|2|||
143316557|NCT03095417|516705044|FG002|Overall Study|Lost to Follow-up|1|||
143316558|NCT03095417|516705045|FG003|Overall Study|Lost to Follow-up|0|||
143316559|NCT03095417|516705042|FG000|Overall Study|refusal|0|||
143316560|NCT03095417|516705043|FG001|Overall Study|refusal|1|||
143316561|NCT03095417|516705044|FG002|Overall Study|refusal|0|||
143316562|NCT03095417|516705045|FG003|Overall Study|refusal|1|||
143316563|NCT03095417|516705042|FG000|Overall Study|Withdrawal by Subject|8|||
143316564|NCT03095417|516705043|FG001|Overall Study|Withdrawal by Subject|2|||
143316565|NCT03095417|516705044|FG002|Overall Study|Withdrawal by Subject|5|||
143316566|NCT03095417|516705045|FG003|Overall Study|Withdrawal by Subject|4|||
143316567|NCT03095417|516705042|FG000|Overall Study|Physician Decision|1|||
143316568|NCT03095417|516705043|FG001|Overall Study|Physician Decision|2|||
143316569|NCT03095417|516705044|FG002|Overall Study|Physician Decision|2|||
143316570|NCT03095417|516705045|FG003|Overall Study|Physician Decision|2|||
143316571|NCT03095417|516705042|FG000|Overall Study|Death|1|||
143316572|NCT03095417|516705043|FG001|Overall Study|Death|2|||
143316573|NCT03095417|516705044|FG002|Overall Study|Death|1|||
143316574|NCT03095417|516705045|FG003|Overall Study|Death|3|||
143316575|NCT03795922|516705047|FG000|Overall Study|Adverse Event|2|||
143316576|NCT03795922|516705048|FG001|Overall Study|Adverse Event|1|||
143316577|NCT03795922|516705047|FG000|Overall Study|Withdrawal by Subject|5|||
143316578|NCT03795922|516705048|FG001|Overall Study|Withdrawal by Subject|13|||
143316579|NCT03795922|516705047|FG000|Overall Study|Lost to Follow-up|2|||
143316580|NCT03795922|516705048|FG001|Overall Study|Lost to Follow-up|3|||
143316581|NCT03795922|516705047|FG000|Overall Study|Pregnancy|0|||
143316582|NCT03795922|516705048|FG001|Overall Study|Pregnancy|1|||
143316583|NCT03795922|516705047|FG000|Overall Study|Physician Decision|1|||
143316584|NCT03795922|516705048|FG001|Overall Study|Physician Decision|2|||
143316585|NCT03795922|516705047|FG000|Overall Study|Protocol Violation|0|||
143316586|NCT03795922|516705048|FG001|Overall Study|Protocol Violation|1|||
143316587|NCT03795922|516705047|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
143316588|NCT03795922|516705048|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
143316589|NCT02520531|516705054|FG000|Overall Study|Revision of study device components|2|||
143316590|NCT02520531|516705055|FG001|Overall Study|Revision of study device components|2|||
143377782|NCT00736853|516928251|FG002|Open-Label Period|Adverse Event|0|||
143316591|NCT02520531|516705054|FG000|Overall Study|Death|1|||
143377783|NCT00736853|516928249|FG000|Open-Label Period|Withdrawal by Subject|16|||
143377784|NCT00736853|516928250|FG001|Open-Label Period|Withdrawal by Subject|0|||
143377785|NCT00736853|516928251|FG002|Open-Label Period|Withdrawal by Subject|0|||
143377786|NCT00736853|516928249|FG000|Open-Label Period|Started but not treated|42|||
143316592|NCT02520531|516705055|FG001|Overall Study|Death|2|||
143316593|NCT02520531|516705054|FG000|Overall Study|Lost to Follow-up|1|||
143316594|NCT02520531|516705055|FG001|Overall Study|Lost to Follow-up|1|||
143316595|NCT02520531|516705054|FG000|Overall Study|Meet exclusion criterion|0|||
143316596|NCT02520531|516705055|FG001|Overall Study|Meet exclusion criterion|1|||
143316597|NCT02520531|516705054|FG000|Overall Study|Withdrawal by Subject|1|||
143316598|NCT02520531|516705055|FG001|Overall Study|Withdrawal by Subject|0|||
143316599|NCT02520531|516705054|FG000|Overall Study|Not study device|1|||
143316600|NCT02520531|516705055|FG001|Overall Study|Not study device|0|||
143316601|NCT01752933|516705062|FG000|Treatment|Disease Progression|3|||
143316602|NCT01752933|516705063|FG001|Treatment|Disease Progression|29|||
143316603|NCT01752933|516705062|FG000|Treatment|Withdrawal by Subject|0|||
143316604|NCT01752933|516705063|FG001|Treatment|Withdrawal by Subject|5|||
143316605|NCT01752933|516705062|FG000|Treatment|Adverse Event|1|||
143316606|NCT01752933|516705063|FG001|Treatment|Adverse Event|4|||
143316607|NCT01752933|516705062|FG000|Treatment|Physician Decision|0|||
143316608|NCT01752933|516705063|FG001|Treatment|Physician Decision|3|||
143316609|NCT01752933|516705062|FG000|Treatment|Death|0|||
143316610|NCT01752933|516705063|FG001|Treatment|Death|2|||
143316611|NCT01752933|516705062|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
143316612|NCT01752933|516705063|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
143316613|NCT01752933|516705062|FG000|Treatment|Patient noncompliant|0|||
143316614|NCT01752933|516705063|FG001|Treatment|Patient noncompliant|1|||
143316615|NCT01752933|516705062|FG000|Treatment|Patient unable to travel to appointments|0|||
143316616|NCT01752933|516705063|FG001|Treatment|Patient unable to travel to appointments|1|||
143316617|NCT01752933|516705062|FG000|Overall Study and Follow-up|Death|4|||
143316618|NCT01752933|516705063|FG001|Overall Study and Follow-up|Death|34|||
143316619|NCT01752933|516705062|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
143316620|NCT01752933|516705063|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
143316621|NCT01752933|516705062|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
143316622|NCT01752933|516705063|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
143316623|NCT01752933|516705062|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
143316624|NCT01752933|516705063|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
143316625|NCT01649856|516705066|FG000|Overall Study|Withdrawal by Subject|14|||
143316626|NCT01649856|516705067|FG001|Overall Study|Withdrawal by Subject|14|||
143316627|NCT01649856|516705066|FG000|Overall Study|Protocol Violation|4|||
143316628|NCT01649856|516705067|FG001|Overall Study|Protocol Violation|4|||
143316629|NCT01649856|516705066|FG000|Overall Study|Treatment Failure|1|||
143316630|NCT01649856|516705067|FG001|Overall Study|Treatment Failure|1|||
143316631|NCT01649856|516705066|FG000|Overall Study|Death|69|||
143316632|NCT01649856|516705067|FG001|Overall Study|Death|34|||
143316633|NCT01649856|516705066|FG000|Overall Study|Stable or Progressed Disease|5|||
143316634|NCT01649856|516705067|FG001|Overall Study|Stable or Progressed Disease|3|||
143316635|NCT01649856|516705066|FG000|Overall Study|Lost to Follow-up|20|||
143316636|NCT01649856|516705067|FG001|Overall Study|Lost to Follow-up|16|||
143316637|NCT01649856|516705066|FG000|Overall Study|Lack of Compliance|6|||
143316638|NCT01649856|516705067|FG001|Overall Study|Lack of Compliance|1|||
143316639|NCT01649856|516705066|FG000|Overall Study|Other|20|||
143316640|NCT01649856|516705067|FG001|Overall Study|Other|5|||
143316641|NCT00622635|516705068|FG000|Treatment Period 1|Adverse Event|0|||
143316642|NCT00622635|516705069|FG001|Treatment Period 1|Adverse Event|0|||
143316643|NCT00622635|516705070|FG002|Treatment Period 1|Adverse Event|1|||
143316644|NCT00622635|516705071|FG003|Treatment Period 1|Adverse Event|0|||
143316645|NCT00622635|516705072|FG004|Treatment Period 1|Adverse Event|0|||
143316646|NCT00622635|516705073|FG005|Treatment Period 1|Adverse Event|0|||
143316647|NCT00622635|516705068|FG000|Treatment Period 1|Withdrawal by Subject|0|||
143316648|NCT00622635|516705069|FG001|Treatment Period 1|Withdrawal by Subject|1|||
143316649|NCT00622635|516705070|FG002|Treatment Period 1|Withdrawal by Subject|0|||
143316650|NCT00622635|516705071|FG003|Treatment Period 1|Withdrawal by Subject|0|||
143316651|NCT00622635|516705072|FG004|Treatment Period 1|Withdrawal by Subject|0|||
143316652|NCT00622635|516705073|FG005|Treatment Period 1|Withdrawal by Subject|0|||
143316653|NCT00622635|516705068|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
143316654|NCT00622635|516705069|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
143316655|NCT00622635|516705070|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
143316656|NCT00622635|516705071|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
143316657|NCT00622635|516705072|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
143316658|NCT00622635|516705073|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
143316659|NCT00622635|516705068|FG000|Treatment Period 2|Adverse Event|1|||
143316660|NCT00622635|516705069|FG001|Treatment Period 2|Adverse Event|0|||
143316661|NCT00622635|516705070|FG002|Treatment Period 2|Adverse Event|0|||
143316662|NCT00622635|516705071|FG003|Treatment Period 2|Adverse Event|0|||
143316663|NCT00622635|516705072|FG004|Treatment Period 2|Adverse Event|0|||
143316664|NCT00622635|516705073|FG005|Treatment Period 2|Adverse Event|0|||
143316665|NCT00622635|516705068|FG000|Treatment Period 3|Adverse Event|0|||
143316666|NCT00622635|516705069|FG001|Treatment Period 3|Adverse Event|0|||
143316667|NCT00622635|516705070|FG002|Treatment Period 3|Adverse Event|0|||
143316668|NCT00622635|516705071|FG003|Treatment Period 3|Adverse Event|2|||
143316669|NCT00622635|516705072|FG004|Treatment Period 3|Adverse Event|0|||
143316670|NCT00622635|516705073|FG005|Treatment Period 3|Adverse Event|0|||
143316671|NCT00622635|516705068|FG000|Treatment Period 3|Withdrawal by Subject|0|||
143316672|NCT00622635|516705069|FG001|Treatment Period 3|Withdrawal by Subject|0|||
143316673|NCT00622635|516705070|FG002|Treatment Period 3|Withdrawal by Subject|0|||
143316674|NCT00622635|516705071|FG003|Treatment Period 3|Withdrawal by Subject|1|||
143316675|NCT00622635|516705072|FG004|Treatment Period 3|Withdrawal by Subject|0|||
143316676|NCT00622635|516705073|FG005|Treatment Period 3|Withdrawal by Subject|0|||
143316677|NCT00835406|516705074|FG000|Period: First Intervention|Adverse Event|0|||
143316678|NCT00835406|516705075|FG001|Period: First Intervention|Adverse Event|1|||
143316679|NCT00835406|516705074|FG000|Period: First Intervention|Withdrawal by Subject|2|||
143316680|NCT00835406|516705075|FG001|Period: First Intervention|Withdrawal by Subject|0|||
143316681|NCT00835406|516705074|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
143377787|NCT00736853|516928250|FG001|Open-Label Period|Started but not treated|0|||
143316682|NCT00835406|516705075|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
143316683|NCT03027466|516705081|FG000|Overall Study|Opting out of the app|1869|||
143316684|NCT03027466|516705082|FG001|Overall Study|Opting out of the app|1819|||
143316685|NCT03027466|516705083|FG002|Overall Study|Opting out of the app|1743|||
143316686|NCT03027466|516705084|FG003|Overall Study|Opting out of the app|1821|||
143316687|NCT01079234|516705095|FG000|Main: Week 0 to 26|Adverse Event|5|||
143316688|NCT01079234|516705096|FG001|Main: Week 0 to 26|Adverse Event|4|||
143316689|NCT01079234|516705097|FG002|Main: Week 0 to 26|Adverse Event|1|||
143316690|NCT01079234|516705098|FG003|Main: Week 0 to 26|Adverse Event|0|||
143316691|NCT01079234|516705095|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
143316692|NCT01079234|516705096|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
143316693|NCT01079234|516705097|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
143316694|NCT01079234|516705098|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
143316695|NCT01079234|516705095|FG000|Main: Week 0 to 26|Protocol Violation|6|||
143316696|NCT01079234|516705096|FG001|Main: Week 0 to 26|Protocol Violation|2|||
143316697|NCT01079234|516705097|FG002|Main: Week 0 to 26|Protocol Violation|4|||
143316698|NCT01079234|516705098|FG003|Main: Week 0 to 26|Protocol Violation|0|||
143316699|NCT01079234|516705095|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
143316700|NCT01079234|516705096|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
143316701|NCT01079234|516705097|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
143316702|NCT01079234|516705098|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
143316703|NCT01079234|516705095|FG000|Main: Week 0 to 26|Unclassified|7|||
143316704|NCT01079234|516705096|FG001|Main: Week 0 to 26|Unclassified|13|||
143316705|NCT01079234|516705097|FG002|Main: Week 0 to 26|Unclassified|4|||
143316706|NCT01079234|516705098|FG003|Main: Week 0 to 26|Unclassified|0|||
143316707|NCT01079234|516705095|FG000|Extension: Week 27 to 52|Adverse Event|0|||
143316708|NCT01079234|516705096|FG001|Extension: Week 27 to 52|Adverse Event|0|||
143316709|NCT01079234|516705097|FG002|Extension: Week 27 to 52|Adverse Event|1|||
143316710|NCT01079234|516705098|FG003|Extension: Week 27 to 52|Adverse Event|0|||
143316711|NCT01079234|516705095|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
143316712|NCT01079234|516705096|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
143316713|NCT01079234|516705097|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
143316714|NCT01079234|516705098|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
143316715|NCT01079234|516705095|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
143316716|NCT01079234|516705096|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
143316717|NCT01079234|516705097|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
143316718|NCT01079234|516705098|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
143316719|NCT01079234|516705095|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
143316720|NCT01079234|516705096|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
143316721|NCT01079234|516705097|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
143316722|NCT01079234|516705098|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
143316723|NCT01079234|516705095|FG000|Extension: Week 27 to 52|Unclassified|0|||
143316724|NCT01079234|516705096|FG001|Extension: Week 27 to 52|Unclassified|0|||
143316725|NCT01079234|516705097|FG002|Extension: Week 27 to 52|Unclassified|4|||
143316726|NCT01079234|516705098|FG003|Extension: Week 27 to 52|Unclassified|7|||
143316727|NCT01334866|516705103|FG000|Overall Study|Withdrawal by Subject|10|||
143316728|NCT01334866|516705103|FG000|Overall Study|Lost to Follow-up|3|||
143316729|NCT01334866|516705103|FG000|Overall Study|Physician Decision|3|||
143316730|NCT01334866|516705103|FG000|Overall Study|medically necessary prior to procedure|2|||
143316731|NCT01334866|516705103|FG000|Overall Study|medically necessary post-procedure|1|||
143316732|NCT00958880|516705117|FG000|Overall Study|Lost to Follow-up|2|||
143316733|NCT00958880|516705118|FG001|Overall Study|Lost to Follow-up|2|||
143316734|NCT02047604|516705121|FG000|Overall Study|Withdrawal by Subject|0|||
143316735|NCT02047604|516705122|FG001|Overall Study|Withdrawal by Subject|0|||
143316736|NCT02047604|516705123|FG002|Overall Study|Withdrawal by Subject|0|||
143316737|NCT02047604|516705124|FG003|Overall Study|Withdrawal by Subject|0|||
143316738|NCT02047604|516705125|FG004|Overall Study|Withdrawal by Subject|1|||
143316739|NCT02047604|516705126|FG005|Overall Study|Withdrawal by Subject|1|||
143316740|NCT01818336|516707296|FG000|Overall Study|Declined retest visit|0|||
143316741|NCT01818336|516707297|FG001|Overall Study|Declined retest visit|11|||
143316742|NCT01818336|516707296|FG000|Overall Study|Lost to Follow-up|0|||
143316743|NCT01818336|516707297|FG001|Overall Study|Lost to Follow-up|1|||
143316744|NCT03042312|516707300|FG000|Overall Study|Administrative Reason|1|||
143316745|NCT03042312|516707301|FG001|Overall Study|Administrative Reason|1|||
143316746|NCT03042312|516707300|FG000|Overall Study|Adverse Event|0|||
143316747|NCT03042312|516707301|FG001|Overall Study|Adverse Event|1|||
143316748|NCT03042312|516707300|FG000|Overall Study|Lost to Follow-up|1|||
143316749|NCT03042312|516707301|FG001|Overall Study|Lost to Follow-up|3|||
143316750|NCT03042312|516707300|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
143316751|NCT03042312|516707301|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
143316752|NCT03042312|516707300|FG000|Overall Study|Withdrawal by Subject|4|||
143316753|NCT03042312|516707301|FG001|Overall Study|Withdrawal by Subject|5|||
143316754|NCT04258839|516707304|FG000|Overall Study|Adverse Event|2|||
143316755|NCT04258839|516707305|FG001|Overall Study|Adverse Event|4|||
143316756|NCT04258839|516707304|FG000|Overall Study|Lack of Efficacy|0|||
143316757|NCT04258839|516707305|FG001|Overall Study|Lack of Efficacy|2|||
143316758|NCT04258839|516707304|FG000|Overall Study|Lost to Follow-up|2|||
143316759|NCT04258839|516707305|FG001|Overall Study|Lost to Follow-up|0|||
143316760|NCT04258839|516707304|FG000|Overall Study|Withdrawal by Subject|1|||
143316761|NCT04258839|516707305|FG001|Overall Study|Withdrawal by Subject|2|||
143316762|NCT04258839|516707304|FG000|Overall Study|Withdrawal by Caregiver|5|||
143316763|NCT04258839|516707305|FG001|Overall Study|Withdrawal by Caregiver|6|||
143316764|NCT04258839|516707304|FG000|Overall Study|Reason not Specified|0|||
143316765|NCT04258839|516707305|FG001|Overall Study|Reason not Specified|1|||
143316766|NCT02932891|516707310|FG000|Overall Study|Lost to Follow-up|2|||
143316767|NCT02932891|516707310|FG000|Overall Study|HPA Suppress|2|||
143316768|NCT03603964|516707311|FG000|Overall Study|Death|9|||
143316769|NCT03603964|516707311|FG000|Overall Study|Withdrawal by participant|7|||
143316770|NCT03603964|516707311|FG000|Overall Study|Study terminated by Sponsor|19|||
143316771|NCT04317586|516707312|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
143316772|NCT04317586|516707312|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
143316773|NCT00563797|516707313|FG000|Overall Study|Lost to Follow-up|7|||
143316774|NCT00563797|516707314|FG001|Overall Study|Lost to Follow-up|2|||
143316775|NCT00807092|516707317|FG000|Overall Study|Adverse Event|0|||
143316776|NCT00807092|516707318|FG001|Overall Study|Adverse Event|1|||
143316777|NCT00807092|516707317|FG000|Overall Study|Protocol Violation|0|||
143316778|NCT00807092|516707318|FG001|Overall Study|Protocol Violation|2|||
143316779|NCT00807092|516707317|FG000|Overall Study|Withdrawal by Subject|1|||
143316780|NCT00807092|516707318|FG001|Overall Study|Withdrawal by Subject|0|||
143316781|NCT00807092|516707317|FG000|Overall Study|CGMS data collection failed|0|||
143316782|NCT00807092|516707318|FG001|Overall Study|CGMS data collection failed|1|||
143316783|NCT01794949|516707319|FG000|Overall Study|Lost to Follow-up|1|||
143316784|NCT01794949|516707320|FG001|Overall Study|Lost to Follow-up|0|||
143316785|NCT00530023|516707328|FG000|Overall Study|Withdrawal by Subject|0|||
143316786|NCT00530023|516707329|FG001|Overall Study|Withdrawal by Subject|1|||
143316787|NCT01931839|516707330|FG000|Overall Study|Death|0|||
143316788|NCT01931839|516707331|FG001|Overall Study|Death|1|||
143316789|NCT01931839|516707332|FG002|Overall Study|Death|2|||
143316790|NCT01931839|516707333|FG003|Overall Study|Death|0|||
143316791|NCT01931839|516707334|FG004|Overall Study|Death|0|||
143316792|NCT01931839|516707335|FG005|Overall Study|Death|0|||
143316793|NCT01931839|516707336|FG006|Overall Study|Death|0|||
143316794|NCT01931839|516707330|FG000|Overall Study|Physician Decision|1|||
143316795|NCT01931839|516707331|FG001|Overall Study|Physician Decision|0|||
143316796|NCT01931839|516707332|FG002|Overall Study|Physician Decision|1|||
143316797|NCT01931839|516707333|FG003|Overall Study|Physician Decision|0|||
143316798|NCT01931839|516707334|FG004|Overall Study|Physician Decision|0|||
143316799|NCT01931839|516707335|FG005|Overall Study|Physician Decision|0|||
143316800|NCT01931839|516707336|FG006|Overall Study|Physician Decision|1|||
143316801|NCT01931839|516707330|FG000|Overall Study|Withdrawal of consent|0|||
143316802|NCT01931839|516707331|FG001|Overall Study|Withdrawal of consent|0|||
143316803|NCT01931839|516707332|FG002|Overall Study|Withdrawal of consent|0|||
143316804|NCT01931839|516707333|FG003|Overall Study|Withdrawal of consent|0|||
143316805|NCT01931839|516707334|FG004|Overall Study|Withdrawal of consent|1|||
143316806|NCT01931839|516707335|FG005|Overall Study|Withdrawal of consent|0|||
143316807|NCT01931839|516707336|FG006|Overall Study|Withdrawal of consent|0|||
143316808|NCT01931839|516707330|FG000|Overall Study|Adverse Event|9|||
143316809|NCT01931839|516707331|FG001|Overall Study|Adverse Event|4|||
143316810|NCT01931839|516707332|FG002|Overall Study|Adverse Event|1|||
143316811|NCT01931839|516707333|FG003|Overall Study|Adverse Event|3|||
143316812|NCT01931839|516707334|FG004|Overall Study|Adverse Event|0|||
143316813|NCT01931839|516707335|FG005|Overall Study|Adverse Event|0|||
143316814|NCT01931839|516707336|FG006|Overall Study|Adverse Event|1|||
143316815|NCT01931839|516707330|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
143316816|NCT01931839|516707331|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
143316817|NCT01931839|516707332|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
143316818|NCT01931839|516707333|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
143316819|NCT01931839|516707334|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
143316820|NCT01931839|516707335|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
143316821|NCT01931839|516707336|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
143316822|NCT01931839|516707330|FG000|Overall Study|Other non-compliance|15|||
143316823|NCT01931839|516707331|FG001|Overall Study|Other non-compliance|9|||
143316824|NCT01931839|516707332|FG002|Overall Study|Other non-compliance|12|||
143316825|NCT01931839|516707333|FG003|Overall Study|Other non-compliance|3|||
143316826|NCT01931839|516707334|FG004|Overall Study|Other non-compliance|0|||
143316827|NCT01931839|516707335|FG005|Overall Study|Other non-compliance|3|||
143316828|NCT01931839|516707336|FG006|Overall Study|Other non-compliance|0|||
143316829|NCT01931839|516707330|FG000|Overall Study|Lost to Follow-up|1|||
143316830|NCT01931839|516707331|FG001|Overall Study|Lost to Follow-up|2|||
143377788|NCT00736853|516928251|FG002|Open-Label Period|Started but not treated|0|||
143316831|NCT01931839|516707332|FG002|Overall Study|Lost to Follow-up|4|||
143316832|NCT01931839|516707333|FG003|Overall Study|Lost to Follow-up|5|||
143316833|NCT01931839|516707334|FG004|Overall Study|Lost to Follow-up|0|||
143316834|NCT01931839|516707335|FG005|Overall Study|Lost to Follow-up|0|||
143316835|NCT01931839|516707336|FG006|Overall Study|Lost to Follow-up|0|||
143316836|NCT01931839|516707330|FG000|Overall Study|Other|4|||
143316837|NCT01931839|516707331|FG001|Overall Study|Other|2|||
143316838|NCT01931839|516707332|FG002|Overall Study|Other|6|||
143316839|NCT01931839|516707333|FG003|Overall Study|Other|0|||
143316840|NCT01931839|516707334|FG004|Overall Study|Other|0|||
143316841|NCT01931839|516707335|FG005|Overall Study|Other|0|||
143316842|NCT01931839|516707336|FG006|Overall Study|Other|0|||
143316843|NCT03224468|516707342|FG000|Overall Study|Did not obtain MM card|53|||
143316844|NCT03224468|516707343|FG001|Overall Study|Did not obtain MM card|0|||
143316845|NCT03224468|516707342|FG000|Overall Study|Lost to Follow-up|4|||
143316846|NCT03224468|516707343|FG001|Overall Study|Lost to Follow-up|11|||
143316847|NCT03224468|516707342|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
143316848|NCT03224468|516707343|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
143316849|NCT01978119|516707344|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
143316850|NCT01978119|516707345|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
143316851|NCT01978119|516707344|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
143316852|NCT01978119|516707345|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
143316853|NCT01978119|516707344|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
143316854|NCT01978119|516707345|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
143316855|NCT00812812|516707346|FG000|Overall Study|Adverse Event|2|||
143316856|NCT00812812|516707347|FG001|Overall Study|Adverse Event|1|||
143316857|NCT00812812|516707346|FG000|Overall Study|Lack of Efficacy|1|||
143316858|NCT00812812|516707347|FG001|Overall Study|Lack of Efficacy|0|||
143316859|NCT00812812|516707346|FG000|Overall Study|Lost to Follow-up|0|||
143316860|NCT00812812|516707347|FG001|Overall Study|Lost to Follow-up|1|||
143316861|NCT00812812|516707346|FG000|Overall Study|Withdrawal by Subject|0|||
143316862|NCT00812812|516707347|FG001|Overall Study|Withdrawal by Subject|2|||
143316863|NCT02571452|516707348|FG000|Overall Study Treatment|Protocol Violation|0|||
143316864|NCT02571452|516707349|FG001|Overall Study Treatment|Protocol Violation|1|||
143316865|NCT02571452|516707348|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
143316866|NCT02571452|516707349|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
143316867|NCT02571452|516707348|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
143316868|NCT02571452|516707349|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
143316869|NCT01877421|516707350|FG000|Phase 2|Lost to Follow-up|0|||
143316870|NCT01877421|516707351|FG001|Phase 2|Lost to Follow-up|0|||
143316871|NCT01877421|516707352|FG002|Phase 2|Lost to Follow-up|0|||
143316872|NCT01877421|516707353|FG003|Phase 2|Lost to Follow-up|0|||
143316873|NCT01877421|516707354|FG004|Phase 2|Lost to Follow-up|0|||
143316874|NCT01877421|516707355|FG005|Phase 2|Lost to Follow-up|0|||
143316875|NCT01877421|516707356|FG006|Phase 2|Lost to Follow-up|1|||
143316876|NCT01877421|516707357|FG007|Phase 2|Lost to Follow-up|0|||
143316877|NCT01877421|516707358|FG008|Phase 2|Lost to Follow-up|0|||
143316878|NCT01877421|516707359|FG009|Phase 2|Lost to Follow-up|0|||
143316879|NCT01877421|516707360|FG010|Phase 2|Lost to Follow-up|0|||
143316880|NCT01877421|516707361|FG011|Phase 2|Lost to Follow-up|0|||
143316881|NCT01877421|516707362|FG012|Phase 2|Lost to Follow-up|0|||
143316882|NCT01877421|516707363|FG013|Phase 2|Lost to Follow-up|0|||
143316883|NCT01877421|516707364|FG014|Phase 2|Lost to Follow-up|0|||
143316884|NCT01877421|516707365|FG015|Phase 2|Lost to Follow-up|0|||
143316885|NCT01877421|516707366|FG016|Phase 2|Lost to Follow-up|0|||
143316886|NCT01877421|516707367|FG017|Phase 2|Lost to Follow-up|0|||
143377789|NCT00736853|516928249|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
143377790|NCT00736853|516928250|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
143377791|NCT00736853|516928251|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
143316887|NCT01877421|516707350|FG000|Phase 2|Withdrawal by Subject|0|||
143316888|NCT01877421|516707351|FG001|Phase 2|Withdrawal by Subject|0|||
143316889|NCT01877421|516707352|FG002|Phase 2|Withdrawal by Subject|0|||
143316890|NCT01877421|516707353|FG003|Phase 2|Withdrawal by Subject|0|||
143377792|NCT00736853|516928249|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
143316891|NCT01877421|516707354|FG004|Phase 2|Withdrawal by Subject|0|||
143316892|NCT01877421|516707355|FG005|Phase 2|Withdrawal by Subject|0|||
143316893|NCT01877421|516707356|FG006|Phase 2|Withdrawal by Subject|0|||
143316894|NCT01877421|516707357|FG007|Phase 2|Withdrawal by Subject|0|||
143316895|NCT01877421|516707358|FG008|Phase 2|Withdrawal by Subject|1|||
143316896|NCT01877421|516707359|FG009|Phase 2|Withdrawal by Subject|0|||
143316897|NCT01877421|516707360|FG010|Phase 2|Withdrawal by Subject|1|||
143316898|NCT01877421|516707361|FG011|Phase 2|Withdrawal by Subject|0|||
143316899|NCT01877421|516707362|FG012|Phase 2|Withdrawal by Subject|1|||
143316900|NCT01877421|516707363|FG013|Phase 2|Withdrawal by Subject|0|||
143316901|NCT01877421|516707364|FG014|Phase 2|Withdrawal by Subject|0|||
143316902|NCT01877421|516707365|FG015|Phase 2|Withdrawal by Subject|1|||
143316903|NCT01877421|516707366|FG016|Phase 2|Withdrawal by Subject|0|||
143316904|NCT01877421|516707367|FG017|Phase 2|Withdrawal by Subject|0|||
143316905|NCT01877421|516707350|FG000|Phase 2|Protocol Violation|0|||
143316906|NCT01877421|516707351|FG001|Phase 2|Protocol Violation|0|||
143316907|NCT01877421|516707352|FG002|Phase 2|Protocol Violation|0|||
143316908|NCT01877421|516707353|FG003|Phase 2|Protocol Violation|0|||
143316909|NCT01877421|516707354|FG004|Phase 2|Protocol Violation|0|||
143316910|NCT01877421|516707355|FG005|Phase 2|Protocol Violation|0|||
143316911|NCT01877421|516707356|FG006|Phase 2|Protocol Violation|0|||
143316912|NCT01877421|516707357|FG007|Phase 2|Protocol Violation|0|||
143316913|NCT01877421|516707358|FG008|Phase 2|Protocol Violation|0|||
143316914|NCT01877421|516707359|FG009|Phase 2|Protocol Violation|0|||
143316915|NCT01877421|516707360|FG010|Phase 2|Protocol Violation|1|||
143316916|NCT01877421|516707361|FG011|Phase 2|Protocol Violation|0|||
143316917|NCT01877421|516707362|FG012|Phase 2|Protocol Violation|0|||
143316918|NCT01877421|516707363|FG013|Phase 2|Protocol Violation|0|||
143316919|NCT01877421|516707364|FG014|Phase 2|Protocol Violation|0|||
143316920|NCT01877421|516707365|FG015|Phase 2|Protocol Violation|0|||
143316921|NCT01877421|516707366|FG016|Phase 2|Protocol Violation|0|||
143316922|NCT01877421|516707367|FG017|Phase 2|Protocol Violation|0|||
143316923|NCT02464969|516707368|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
143316924|NCT02464969|516707369|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
143316925|NCT02464969|516707368|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
143316926|NCT02464969|516707369|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
143316927|NCT02464969|516707368|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
143316928|NCT02464969|516707369|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
143316929|NCT02464969|516707368|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
143316930|NCT02464969|516707369|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
143316931|NCT02464969|516707368|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
143316932|NCT02464969|516707369|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
143316933|NCT02464969|516707368|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
143316934|NCT02464969|516707369|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
143316935|NCT02464969|516707368|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
143316936|NCT02464969|516707369|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
143316937|NCT02464969|516707368|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
143316938|NCT02464969|516707369|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
143316939|NCT02464969|516707368|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
143316940|NCT02464969|516707369|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
143316941|NCT02464969|516707368|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
143316942|NCT02464969|516707369|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
143316943|NCT02464969|516707368|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
143316944|NCT02464969|516707369|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
143316945|NCT00908960|516707370|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
143316946|NCT00908960|516707371|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
143316947|NCT00908960|516707372|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
143316948|NCT02480621|516707383|FG000|Randomization|Withdrawal by Subject|1|||
143316949|NCT02480621|516707384|FG001|Randomization|Withdrawal by Subject|0|||
143316950|NCT02480621|516707383|FG000|Randomization|Surgeon did not give intervention|0|||
143316951|NCT02480621|516707384|FG001|Randomization|Surgeon did not give intervention|1|||
143316952|NCT02480621|516707383|FG000|Follow Up|Lost to Follow-up|4|||
143316953|NCT02480621|516707384|FG001|Follow Up|Lost to Follow-up|2|||
143316954|NCT00887341|516707395|FG000|Overall Study|Refused treatment|1|||
143316955|NCT00887341|516707396|FG001|Overall Study|Refused treatment|0|||
143316956|NCT00887341|516707395|FG000|Overall Study|Withdrawal by Subject|1|||
143316957|NCT00887341|516707396|FG001|Overall Study|Withdrawal by Subject|1|||
143316958|NCT00887341|516707395|FG000|Overall Study|Adverse Event|0|||
143316959|NCT00887341|516707396|FG001|Overall Study|Adverse Event|1|||
143316960|NCT00887341|516707395|FG000|Overall Study|Lost to Follow-up|0|||
143316961|NCT00887341|516707396|FG001|Overall Study|Lost to Follow-up|1|||
143316962|NCT01591681|516707399|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
143316963|NCT01591681|516707399|FG000|Overall Study|Failed to use system during run-in|1|||
143316964|NCT00179647|516707402|FG000|Overall Study|Adverse Event|294|||
143316965|NCT00179647|516707402|FG000|Overall Study|Lack of Efficacy|478|||
143316966|NCT00179647|516707402|FG000|Overall Study|Withdrawal by Subject|83|||
143316967|NCT00179647|516707402|FG000|Overall Study|Lost to Follow-up|4|||
143316968|NCT00179647|516707402|FG000|Overall Study|Death|94|||
143316969|NCT00179647|516707402|FG000|Overall Study|Other|960|||
143316970|NCT00281840|516707403|FG000|Overall Study|Adverse Event|12|||
143316971|NCT00281840|516707403|FG000|Overall Study|Physician Decision|6|||
143316972|NCT00281840|516707403|FG000|Overall Study|Withdrawal by Subject|3|||
143316973|NCT00281840|516707403|FG000|Overall Study|Disease Progression|2|||
143316974|NCT00281840|516707403|FG000|Overall Study|exceed maximum delay in treatment|1|||
143316975|NCT00281840|516707403|FG000|Overall Study|Complicating Disease|1|||
143316976|NCT02138214|516707404|FG000|Overall Study|Withdrawal by Subject|0|||
143316977|NCT02138214|516707405|FG001|Overall Study|Withdrawal by Subject|1|||
143316978|NCT02138214|516707406|FG002|Overall Study|Withdrawal by Subject|0|||
143316979|NCT02138214|516707404|FG000|Overall Study|Lost to Follow-up|0|||
143316980|NCT02138214|516707405|FG001|Overall Study|Lost to Follow-up|2|||
143316981|NCT02138214|516707406|FG002|Overall Study|Lost to Follow-up|4|||
143316982|NCT02138214|516707404|FG000|Overall Study|Screen Failure|0|||
143316983|NCT02138214|516707405|FG001|Overall Study|Screen Failure|1|||
143316984|NCT02138214|516707406|FG002|Overall Study|Screen Failure|0|||
143316985|NCT02185768|516707407|FG000|Overall Study|Patients were not treated|2|||
143316986|NCT02158039|516707413|FG000|Overall Study|Withdrawal by Subject|1|||
143316987|NCT02158039|516707413|FG000|Overall Study|Screen Failure|9|||
143316988|NCT03062891|516707420|FG000|Overall Study|Withdrawal by Subject|2|||
143316989|NCT03062891|516707421|FG001|Overall Study|Withdrawal by Subject|0|||
143316990|NCT03062891|516707420|FG000|Overall Study|Lost to Follow-up|50|||
143316991|NCT03062891|516707421|FG001|Overall Study|Lost to Follow-up|38|||
143316992|NCT02127307|516707422|FG000|Overall Study|Protocol Violation|36|||
143316993|NCT02127307|516707422|FG000|Overall Study|Lost to Follow-up|2|||
143316994|NCT02127307|516707422|FG000|Overall Study|Death|101|||
143316995|NCT02127307|516707422|FG000|Overall Study|Other than specified above|169|||
143316996|NCT04187196|516707433|FG000|Overall Study|Screen Failure|2|||
143316997|NCT04187196|516707434|FG001|Overall Study|Screen Failure|0|||
143316998|NCT01687166|516707435|FG000|Overall Study|Attempt subject|2|||
143316999|NCT01687166|516707436|FG001|Overall Study|Attempt subject|3|||
143317000|NCT01687166|516707437|FG002|Overall Study|Attempt subject|2|||
143317001|NCT01687166|516707438|FG003|Overall Study|Attempt subject|0|||
143317002|NCT01687166|516707435|FG000|Overall Study|Did not meet eligibility criteria|4|||
143317003|NCT01687166|516707436|FG001|Overall Study|Did not meet eligibility criteria|6|||
143317004|NCT01687166|516707437|FG002|Overall Study|Did not meet eligibility criteria|1|||
143317005|NCT01687166|516707438|FG003|Overall Study|Did not meet eligibility criteria|1|||
143317006|NCT01687166|516707435|FG000|Overall Study|Adverse Event|2|||
143317007|NCT01687166|516707436|FG001|Overall Study|Adverse Event|1|||
143317008|NCT01687166|516707437|FG002|Overall Study|Adverse Event|0|||
143317009|NCT01687166|516707438|FG003|Overall Study|Adverse Event|0|||
143317010|NCT01687166|516707435|FG000|Overall Study|Physician Decision|3|||
143317011|NCT01687166|516707436|FG001|Overall Study|Physician Decision|2|||
143317012|NCT01687166|516707437|FG002|Overall Study|Physician Decision|1|||
143317013|NCT01687166|516707438|FG003|Overall Study|Physician Decision|0|||
143317014|NCT01687166|516707435|FG000|Overall Study|Withdrawal by Subject|11|||
143317015|NCT01687166|516707436|FG001|Overall Study|Withdrawal by Subject|4|||
143317016|NCT01687166|516707437|FG002|Overall Study|Withdrawal by Subject|3|||
143317017|NCT01687166|516707438|FG003|Overall Study|Withdrawal by Subject|0|||
143317018|NCT01687166|516707435|FG000|Overall Study|Lost to Follow-up|2|||
143317019|NCT01687166|516707436|FG001|Overall Study|Lost to Follow-up|5|||
143317020|NCT01687166|516707437|FG002|Overall Study|Lost to Follow-up|1|||
143317021|NCT01687166|516707438|FG003|Overall Study|Lost to Follow-up|0|||
143317022|NCT01687166|516707435|FG000|Overall Study|Equipment/Device Availability|0|||
143317023|NCT01687166|516707436|FG001|Overall Study|Equipment/Device Availability|1|||
143317024|NCT01687166|516707437|FG002|Overall Study|Equipment/Device Availability|0|||
143317025|NCT01687166|516707438|FG003|Overall Study|Equipment/Device Availability|0|||
143317026|NCT01687166|516707435|FG000|Overall Study|Death|1|||
143317027|NCT01687166|516707436|FG001|Overall Study|Death|1|||
143317028|NCT01687166|516707437|FG002|Overall Study|Death|0|||
143317029|NCT01687166|516707438|FG003|Overall Study|Death|0|||
143317030|NCT01687166|516707435|FG000|Overall Study|Protocol Violation|1|||
143317031|NCT01687166|516707436|FG001|Overall Study|Protocol Violation|1|||
143317032|NCT01687166|516707437|FG002|Overall Study|Protocol Violation|1|||
143317033|NCT01687166|516707438|FG003|Overall Study|Protocol Violation|0|||
143317034|NCT01687166|516707435|FG000|Overall Study|Subject moved out of state|0|||
143317035|NCT01687166|516707436|FG001|Overall Study|Subject moved out of state|1|||
143317036|NCT01687166|516707437|FG002|Overall Study|Subject moved out of state|0|||
143317037|NCT01687166|516707438|FG003|Overall Study|Subject moved out of state|0|||
143317038|NCT01687166|516707435|FG000|Overall Study|Patient unable to be compliant|1|||
143317039|NCT01687166|516707436|FG001|Overall Study|Patient unable to be compliant|0|||
143317040|NCT01687166|516707437|FG002|Overall Study|Patient unable to be compliant|0|||
143317041|NCT01687166|516707438|FG003|Overall Study|Patient unable to be compliant|0|||
143317042|NCT01687166|516707435|FG000|Overall Study|Physician choice to use different device|1|||
143317043|NCT01687166|516707436|FG001|Overall Study|Physician choice to use different device|2|||
143317044|NCT01687166|516707437|FG002|Overall Study|Physician choice to use different device|4|||
143317045|NCT01687166|516707438|FG003|Overall Study|Physician choice to use different device|0|||
143317046|NCT01687166|516707435|FG000|Overall Study|Insurance|0|||
143317047|NCT01687166|516707436|FG001|Overall Study|Insurance|0|||
143317048|NCT01687166|516707437|FG002|Overall Study|Insurance|1|||
143317049|NCT01687166|516707438|FG003|Overall Study|Insurance|1|||
143317050|NCT02755831|516707439|FG000|Overall Study|Lost to Follow-up|3|||
143317051|NCT02755831|516707440|FG001|Overall Study|Lost to Follow-up|3|||
143317052|NCT02316717|516707441|FG000|Overall Study|Adverse Event|2|||
143317053|NCT02316717|516707442|FG001|Overall Study|Adverse Event|2|||
143317054|NCT02316717|516707443|FG002|Overall Study|Adverse Event|0|||
143317055|NCT02316717|516707441|FG000|Overall Study|Lost to Follow-up|1|||
143317056|NCT02316717|516707442|FG001|Overall Study|Lost to Follow-up|2|||
143317057|NCT02316717|516707443|FG002|Overall Study|Lost to Follow-up|1|||
143317058|NCT02316717|516707441|FG000|Overall Study|Non compliance|3|||
143317059|NCT02316717|516707442|FG001|Overall Study|Non compliance|1|||
143317060|NCT02316717|516707443|FG002|Overall Study|Non compliance|0|||
143317061|NCT02316717|516707441|FG000|Overall Study|Protocol Violation|2|||
143317062|NCT02316717|516707442|FG001|Overall Study|Protocol Violation|0|||
143317063|NCT02316717|516707443|FG002|Overall Study|Protocol Violation|0|||
143317064|NCT02316717|516707441|FG000|Overall Study|Withdrawal by Subject|2|||
143317065|NCT02316717|516707442|FG001|Overall Study|Withdrawal by Subject|1|||
143317066|NCT02316717|516707443|FG002|Overall Study|Withdrawal by Subject|1|||
143317067|NCT02316717|516707441|FG000|Overall Study|Death|0|||
143317068|NCT02316717|516707442|FG001|Overall Study|Death|0|||
143317069|NCT02316717|516707443|FG002|Overall Study|Death|1|||
143317070|NCT02316717|516707441|FG000|Overall Study|Physician Decision|0|||
143317071|NCT02316717|516707442|FG001|Overall Study|Physician Decision|1|||
143317072|NCT02316717|516707443|FG002|Overall Study|Physician Decision|0|||
143317073|NCT02316717|516707441|FG000|Overall Study|TBC|1|||
143317074|NCT02316717|516707442|FG001|Overall Study|TBC|0|||
143317075|NCT02316717|516707443|FG002|Overall Study|TBC|0|||
143317076|NCT02296112|516707444|FG000|Overall Study|Disease progression|7|||
143317077|NCT02296112|516707444|FG000|Overall Study|Toxicity|1|||
143317078|NCT02296112|516707444|FG000|Overall Study|Began an alternate therapy|1|||
143317079|NCT01516879|516707445|FG000|Overall Study|Withdrawal by Subject|9|||
143317080|NCT01516879|516707446|FG001|Overall Study|Withdrawal by Subject|11|||
143317081|NCT01516879|516707445|FG000|Overall Study|Death|0|||
143317082|NCT01516879|516707446|FG001|Overall Study|Death|2|||
143317083|NCT01516879|516707445|FG000|Overall Study|Lost to Follow-up|2|||
143317084|NCT01516879|516707446|FG001|Overall Study|Lost to Follow-up|11|||
143317085|NCT01516879|516707445|FG000|Overall Study|Other|5|||
143317086|NCT01516879|516707446|FG001|Overall Study|Other|10|||
143317087|NCT01720069|516707447|FG000|Overall Study|Could not use e-diary correctly|0|||
143317088|NCT01720069|516707448|FG001|Overall Study|Could not use e-diary correctly|1|||
143317089|NCT01720069|516707449|FG002|Overall Study|Could not use e-diary correctly|1|||
143317090|NCT01720069|516707447|FG000|Overall Study|Randomised without baseline values|0|||
143317091|NCT01720069|516707448|FG001|Overall Study|Randomised without baseline values|0|||
143317092|NCT01720069|516707449|FG002|Overall Study|Randomised without baseline values|1|||
143317093|NCT01720069|516707447|FG000|Overall Study|Adverse Event|0|||
143317094|NCT01720069|516707448|FG001|Overall Study|Adverse Event|0|||
143317095|NCT01720069|516707449|FG002|Overall Study|Adverse Event|1|||
143317096|NCT01720069|516707447|FG000|Overall Study|Lack of Efficacy|0|||
143317097|NCT01720069|516707448|FG001|Overall Study|Lack of Efficacy|4|||
143317098|NCT01720069|516707449|FG002|Overall Study|Lack of Efficacy|0|||
143317099|NCT01720069|516707447|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
143317100|NCT01720069|516707448|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
143317101|NCT01720069|516707449|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
143317102|NCT01720069|516707447|FG000|Overall Study|Withdrawal by Subject|0|||
143317103|NCT01720069|516707448|FG001|Overall Study|Withdrawal by Subject|2|||
143317104|NCT01720069|516707449|FG002|Overall Study|Withdrawal by Subject|1|||
143317105|NCT01720069|516707447|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
143317106|NCT01720069|516707448|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
143317107|NCT01720069|516707449|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
143317108|NCT01720069|516707447|FG000|Overall Study|Non-compliance on using e-diary|0|||
143317109|NCT01720069|516707448|FG001|Overall Study|Non-compliance on using e-diary|0|||
143317110|NCT01720069|516707449|FG002|Overall Study|Non-compliance on using e-diary|1|||
143317111|NCT01720069|516707447|FG000|Overall Study|Lost to Follow-up|0|||
143317112|NCT01720069|516707448|FG001|Overall Study|Lost to Follow-up|0|||
143317113|NCT01720069|516707449|FG002|Overall Study|Lost to Follow-up|1|||
143317114|NCT00508742|516707450|FG000|Period 1: Infant Series|Adverse Event|5|||
143317115|NCT00508742|516707451|FG001|Period 1: Infant Series|Adverse Event|4|||
143317116|NCT00508742|516707450|FG000|Period 1: Infant Series|Protocol Violation|1|||
143317117|NCT00508742|516707451|FG001|Period 1: Infant Series|Protocol Violation|0|||
143317118|NCT00508742|516707450|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
143317119|NCT00508742|516707451|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
143317120|NCT00508742|516707450|FG000|Period 1: Infant Series|Physician Decision|1|||
143317121|NCT00508742|516707451|FG001|Period 1: Infant Series|Physician Decision|0|||
143317122|NCT00508742|516707450|FG000|Period 1: Infant Series|Other|4|||
143317123|NCT00508742|516707451|FG001|Period 1: Infant Series|Other|1|||
143317124|NCT00508742|516707450|FG000|Period 2: After Infant Series|Adverse Event|2|||
143317125|NCT00508742|516707451|FG001|Period 2: After Infant Series|Adverse Event|6|||
143317126|NCT00508742|516707450|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
143317127|NCT00508742|516707451|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
143317128|NCT00508742|516707450|FG000|Period 2: After Infant Series|Protocol Violation|1|||
143317129|NCT00508742|516707451|FG001|Period 2: After Infant Series|Protocol Violation|0|||
143317130|NCT00508742|516707450|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
143317131|NCT00508742|516707451|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
143317132|NCT00508742|516707450|FG000|Period 2: After Infant Series|Failed to Return|1|||
143317133|NCT00508742|516707451|FG001|Period 2: After Infant Series|Failed to Return|0|||
143317134|NCT00508742|516707450|FG000|Period 2: After Infant Series|Other|2|||
143317135|NCT00508742|516707451|FG001|Period 2: After Infant Series|Other|1|||
143317136|NCT00508742|516707450|FG000|Period 3: Toddler Dose|Adverse Event|1|||
143317137|NCT00508742|516707451|FG001|Period 3: Toddler Dose|Adverse Event|0|||
143317138|NCT00508742|516707450|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
143317139|NCT00508742|516707451|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
143317140|NCT00508742|516707450|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
143317141|NCT00508742|516707451|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
143317142|NCT00508742|516707450|FG000|Period 3: Toddler Dose|Other|5|||
143317143|NCT00508742|516707451|FG001|Period 3: Toddler Dose|Other|4|||
143317144|NCT04568122|516707452|FG000|Overall Study|Lost to Follow-up|48|||
143317145|NCT04568122|516707453|FG001|Overall Study|Lost to Follow-up|44|||
143317146|NCT04568122|516707454|FG002|Overall Study|Lost to Follow-up|4|||
143317147|NCT04568122|516707455|FG003|Overall Study|Lost to Follow-up|0|||
143317148|NCT04568122|516707456|FG004|Overall Study|Lost to Follow-up|0|||
143317149|NCT02460224|516707464|FG000|Overall Study|Adverse Event|0|||
143317150|NCT02460224|516707465|FG001|Overall Study|Adverse Event|0|||
143317151|NCT02460224|516707466|FG002|Overall Study|Adverse Event|0|||
143317152|NCT02460224|516707467|FG003|Overall Study|Adverse Event|0|||
143317153|NCT02460224|516707468|FG004|Overall Study|Adverse Event|0|||
143317154|NCT02460224|516707469|FG005|Overall Study|Adverse Event|0|||
143317155|NCT02460224|516707470|FG006|Overall Study|Adverse Event|1|||
143317156|NCT02460224|516707471|FG007|Overall Study|Adverse Event|0|||
143317157|NCT02460224|516707472|FG008|Overall Study|Adverse Event|0|||
143317158|NCT02460224|516707473|FG009|Overall Study|Adverse Event|0|||
143317159|NCT02460224|516707474|FG010|Overall Study|Adverse Event|0|||
143317160|NCT02460224|516707475|FG011|Overall Study|Adverse Event|0|||
143317161|NCT02460224|516707476|FG012|Overall Study|Adverse Event|1|||
143317162|NCT02460224|516707477|FG013|Overall Study|Adverse Event|0|||
143317163|NCT02460224|516707478|FG014|Overall Study|Adverse Event|0|||
143317164|NCT02460224|516707479|FG015|Overall Study|Adverse Event|0|||
143377793|NCT00736853|516928250|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
143377794|NCT00736853|516928251|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
143377795|NCT00736853|516928249|FG000|Double-Blind Period|Lack of Efficacy|0|||
143317165|NCT02460224|516707480|FG016|Overall Study|Adverse Event|1|||
143317166|NCT02460224|516707481|FG017|Overall Study|Adverse Event|0|||
143317167|NCT02460224|516707482|FG018|Overall Study|Adverse Event|1|||
143317168|NCT02460224|516707483|FG019|Overall Study|Adverse Event|0|||
143317169|NCT02460224|516707484|FG020|Overall Study|Adverse Event|1|||
143317170|NCT02460224|516707485|FG021|Overall Study|Adverse Event|1|||
143317171|NCT02460224|516707486|FG022|Overall Study|Adverse Event|1|||
143317172|NCT02460224|516707487|FG023|Overall Study|Adverse Event|0|||
143317173|NCT02460224|516707488|FG024|Overall Study|Adverse Event|0|||
143317174|NCT02460224|516707489|FG025|Overall Study|Adverse Event|0|||
143317175|NCT02460224|516707490|FG026|Overall Study|Adverse Event|11|||
143317176|NCT02460224|516707491|FG027|Overall Study|Adverse Event|1|||
143317177|NCT02460224|516707492|FG028|Overall Study|Adverse Event|6|||
143317178|NCT02460224|516707464|FG000|Overall Study|Death|0|||
143317179|NCT02460224|516707465|FG001|Overall Study|Death|0|||
143317180|NCT02460224|516707466|FG002|Overall Study|Death|0|||
143317181|NCT02460224|516707467|FG003|Overall Study|Death|0|||
143317182|NCT02460224|516707468|FG004|Overall Study|Death|0|||
143317183|NCT02460224|516707469|FG005|Overall Study|Death|2|||
143317184|NCT02460224|516707470|FG006|Overall Study|Death|1|||
143317185|NCT02460224|516707471|FG007|Overall Study|Death|0|||
143317186|NCT02460224|516707472|FG008|Overall Study|Death|0|||
143317187|NCT02460224|516707473|FG009|Overall Study|Death|1|||
143317188|NCT02460224|516707474|FG010|Overall Study|Death|0|||
143317189|NCT02460224|516707475|FG011|Overall Study|Death|0|||
143317190|NCT02460224|516707476|FG012|Overall Study|Death|0|||
143317191|NCT02460224|516707477|FG013|Overall Study|Death|1|||
143317192|NCT02460224|516707478|FG014|Overall Study|Death|0|||
143317193|NCT02460224|516707479|FG015|Overall Study|Death|0|||
143317194|NCT02460224|516707480|FG016|Overall Study|Death|2|||
143317195|NCT02460224|516707481|FG017|Overall Study|Death|1|||
143317196|NCT02460224|516707482|FG018|Overall Study|Death|0|||
143317197|NCT02460224|516707483|FG019|Overall Study|Death|2|||
143317198|NCT02460224|516707484|FG020|Overall Study|Death|0|||
143317199|NCT02460224|516707485|FG021|Overall Study|Death|0|||
143317200|NCT02460224|516707486|FG022|Overall Study|Death|0|||
143317201|NCT02460224|516707487|FG023|Overall Study|Death|0|||
143317202|NCT02460224|516707488|FG024|Overall Study|Death|1|||
143317203|NCT02460224|516707489|FG025|Overall Study|Death|1|||
143317204|NCT02460224|516707490|FG026|Overall Study|Death|5|||
143317205|NCT02460224|516707491|FG027|Overall Study|Death|0|||
143317206|NCT02460224|516707492|FG028|Overall Study|Death|1|||
143317207|NCT02460224|516707464|FG000|Overall Study|Lost to Follow-up|0|||
143317208|NCT02460224|516707465|FG001|Overall Study|Lost to Follow-up|0|||
143317209|NCT02460224|516707466|FG002|Overall Study|Lost to Follow-up|0|||
143317210|NCT02460224|516707467|FG003|Overall Study|Lost to Follow-up|0|||
143317211|NCT02460224|516707468|FG004|Overall Study|Lost to Follow-up|0|||
143317212|NCT02460224|516707469|FG005|Overall Study|Lost to Follow-up|0|||
143317213|NCT02460224|516707470|FG006|Overall Study|Lost to Follow-up|0|||
143317214|NCT02460224|516707471|FG007|Overall Study|Lost to Follow-up|0|||
143317215|NCT02460224|516707472|FG008|Overall Study|Lost to Follow-up|0|||
143317216|NCT02460224|516707473|FG009|Overall Study|Lost to Follow-up|0|||
143317217|NCT02460224|516707474|FG010|Overall Study|Lost to Follow-up|0|||
143317218|NCT02460224|516707475|FG011|Overall Study|Lost to Follow-up|0|||
143317219|NCT02460224|516707476|FG012|Overall Study|Lost to Follow-up|0|||
143317220|NCT02460224|516707477|FG013|Overall Study|Lost to Follow-up|0|||
143317221|NCT02460224|516707478|FG014|Overall Study|Lost to Follow-up|0|||
143317222|NCT02460224|516707479|FG015|Overall Study|Lost to Follow-up|0|||
143317223|NCT02460224|516707480|FG016|Overall Study|Lost to Follow-up|0|||
143317224|NCT02460224|516707481|FG017|Overall Study|Lost to Follow-up|0|||
143317225|NCT02460224|516707482|FG018|Overall Study|Lost to Follow-up|0|||
143317226|NCT02460224|516707483|FG019|Overall Study|Lost to Follow-up|0|||
143317227|NCT02460224|516707484|FG020|Overall Study|Lost to Follow-up|0|||
143317228|NCT02460224|516707485|FG021|Overall Study|Lost to Follow-up|0|||
143317229|NCT02460224|516707486|FG022|Overall Study|Lost to Follow-up|1|||
143317230|NCT02460224|516707487|FG023|Overall Study|Lost to Follow-up|0|||
143317231|NCT02460224|516707488|FG024|Overall Study|Lost to Follow-up|0|||
143317232|NCT02460224|516707489|FG025|Overall Study|Lost to Follow-up|0|||
143317233|NCT02460224|516707490|FG026|Overall Study|Lost to Follow-up|0|||
143317234|NCT02460224|516707491|FG027|Overall Study|Lost to Follow-up|0|||
143317235|NCT02460224|516707492|FG028|Overall Study|Lost to Follow-up|0|||
143317236|NCT02460224|516707464|FG000|Overall Study|Physician Decision|0|||
143317237|NCT02460224|516707465|FG001|Overall Study|Physician Decision|1|||
143317238|NCT02460224|516707466|FG002|Overall Study|Physician Decision|0|||
143317239|NCT02460224|516707467|FG003|Overall Study|Physician Decision|0|||
143317240|NCT02460224|516707468|FG004|Overall Study|Physician Decision|1|||
143317241|NCT02460224|516707469|FG005|Overall Study|Physician Decision|0|||
143317242|NCT02460224|516707470|FG006|Overall Study|Physician Decision|0|||
143317243|NCT02460224|516707471|FG007|Overall Study|Physician Decision|1|||
143317244|NCT02460224|516707472|FG008|Overall Study|Physician Decision|0|||
143317245|NCT02460224|516707473|FG009|Overall Study|Physician Decision|0|||
143317246|NCT02460224|516707474|FG010|Overall Study|Physician Decision|0|||
143317247|NCT02460224|516707475|FG011|Overall Study|Physician Decision|1|||
143317248|NCT02460224|516707476|FG012|Overall Study|Physician Decision|0|||
143317249|NCT02460224|516707477|FG013|Overall Study|Physician Decision|1|||
143317250|NCT02460224|516707478|FG014|Overall Study|Physician Decision|0|||
143317251|NCT02460224|516707479|FG015|Overall Study|Physician Decision|0|||
143317252|NCT02460224|516707480|FG016|Overall Study|Physician Decision|2|||
143317253|NCT02460224|516707481|FG017|Overall Study|Physician Decision|1|||
143317254|NCT02460224|516707482|FG018|Overall Study|Physician Decision|1|||
143317255|NCT02460224|516707483|FG019|Overall Study|Physician Decision|2|||
143317256|NCT02460224|516707484|FG020|Overall Study|Physician Decision|1|||
143317257|NCT02460224|516707485|FG021|Overall Study|Physician Decision|1|||
143317258|NCT02460224|516707486|FG022|Overall Study|Physician Decision|0|||
143317259|NCT02460224|516707487|FG023|Overall Study|Physician Decision|0|||
143317260|NCT02460224|516707488|FG024|Overall Study|Physician Decision|1|||
143317261|NCT02460224|516707489|FG025|Overall Study|Physician Decision|0|||
143317262|NCT02460224|516707490|FG026|Overall Study|Physician Decision|14|||
143317263|NCT02460224|516707491|FG027|Overall Study|Physician Decision|1|||
143317264|NCT02460224|516707492|FG028|Overall Study|Physician Decision|6|||
143317265|NCT02460224|516707464|FG000|Overall Study|Progressive disease|15|||
143317266|NCT02460224|516707465|FG001|Overall Study|Progressive disease|11|||
143317267|NCT02460224|516707466|FG002|Overall Study|Progressive disease|5|||
143317268|NCT02460224|516707467|FG003|Overall Study|Progressive disease|6|||
143317269|NCT02460224|516707468|FG004|Overall Study|Progressive disease|3|||
143317270|NCT02460224|516707469|FG005|Overall Study|Progressive disease|26|||
143317271|NCT02460224|516707470|FG006|Overall Study|Progressive disease|28|||
143317272|NCT02460224|516707471|FG007|Overall Study|Progressive disease|4|||
143317273|NCT02460224|516707472|FG008|Overall Study|Progressive disease|5|||
143317274|NCT02460224|516707473|FG009|Overall Study|Progressive disease|9|||
143317275|NCT02460224|516707474|FG010|Overall Study|Progressive disease|5|||
143317276|NCT02460224|516707475|FG011|Overall Study|Progressive disease|4|||
143317277|NCT02460224|516707476|FG012|Overall Study|Progressive disease|5|||
143317278|NCT02460224|516707477|FG013|Overall Study|Progressive disease|4|||
143317279|NCT02460224|516707478|FG014|Overall Study|Progressive disease|5|||
143317280|NCT02460224|516707479|FG015|Overall Study|Progressive disease|5|||
143317281|NCT02460224|516707480|FG016|Overall Study|Progressive disease|15|||
143317282|NCT02460224|516707481|FG017|Overall Study|Progressive disease|3|||
143317283|NCT02460224|516707482|FG018|Overall Study|Progressive disease|8|||
143317284|NCT02460224|516707483|FG019|Overall Study|Progressive disease|3|||
143317285|NCT02460224|516707484|FG020|Overall Study|Progressive disease|4|||
143317286|NCT02460224|516707485|FG021|Overall Study|Progressive disease|9|||
143317287|NCT02460224|516707486|FG022|Overall Study|Progressive disease|4|||
143317288|NCT02460224|516707487|FG023|Overall Study|Progressive disease|11|||
143317289|NCT02460224|516707488|FG024|Overall Study|Progressive disease|4|||
143317290|NCT02460224|516707489|FG025|Overall Study|Progressive disease|5|||
143317291|NCT02460224|516707490|FG026|Overall Study|Progressive disease|85|||
143317292|NCT02460224|516707491|FG027|Overall Study|Progressive disease|17|||
143317293|NCT02460224|516707492|FG028|Overall Study|Progressive disease|77|||
143317294|NCT02460224|516707464|FG000|Overall Study|Subject/guardian decision|2|||
143317295|NCT02460224|516707465|FG001|Overall Study|Subject/guardian decision|0|||
143317296|NCT02460224|516707466|FG002|Overall Study|Subject/guardian decision|1|||
143317297|NCT02460224|516707467|FG003|Overall Study|Subject/guardian decision|0|||
143317298|NCT02460224|516707468|FG004|Overall Study|Subject/guardian decision|2|||
143317299|NCT02460224|516707469|FG005|Overall Study|Subject/guardian decision|2|||
143317300|NCT02460224|516707470|FG006|Overall Study|Subject/guardian decision|0|||
143317301|NCT02460224|516707471|FG007|Overall Study|Subject/guardian decision|0|||
143317302|NCT02460224|516707472|FG008|Overall Study|Subject/guardian decision|1|||
143317303|NCT02460224|516707473|FG009|Overall Study|Subject/guardian decision|1|||
143317304|NCT02460224|516707474|FG010|Overall Study|Subject/guardian decision|0|||
143317305|NCT02460224|516707475|FG011|Overall Study|Subject/guardian decision|1|||
143317306|NCT02460224|516707476|FG012|Overall Study|Subject/guardian decision|0|||
143317307|NCT02460224|516707477|FG013|Overall Study|Subject/guardian decision|0|||
143317308|NCT02460224|516707478|FG014|Overall Study|Subject/guardian decision|0|||
143317309|NCT02460224|516707479|FG015|Overall Study|Subject/guardian decision|1|||
143317310|NCT02460224|516707480|FG016|Overall Study|Subject/guardian decision|0|||
143317311|NCT02460224|516707481|FG017|Overall Study|Subject/guardian decision|1|||
143317312|NCT02460224|516707482|FG018|Overall Study|Subject/guardian decision|2|||
143317313|NCT02460224|516707483|FG019|Overall Study|Subject/guardian decision|0|||
143317314|NCT02460224|516707484|FG020|Overall Study|Subject/guardian decision|0|||
143317315|NCT02460224|516707485|FG021|Overall Study|Subject/guardian decision|1|||
143317316|NCT02460224|516707486|FG022|Overall Study|Subject/guardian decision|0|||
143317317|NCT02460224|516707487|FG023|Overall Study|Subject/guardian decision|0|||
143317318|NCT02460224|516707488|FG024|Overall Study|Subject/guardian decision|0|||
143317319|NCT02460224|516707489|FG025|Overall Study|Subject/guardian decision|0|||
143317320|NCT02460224|516707490|FG026|Overall Study|Subject/guardian decision|6|||
143317321|NCT02460224|516707491|FG027|Overall Study|Subject/guardian decision|2|||
143317322|NCT02460224|516707492|FG028|Overall Study|Subject/guardian decision|3|||
143317323|NCT03146650|516707493|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
143317324|NCT03146650|516707493|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
143317325|NCT03146650|516707493|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
143317326|NCT03146650|516707493|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
143317327|NCT03146650|516707493|FG000|2 Year Follow-up|Death|11|||
143317328|NCT03146650|516707493|FG000|2 Year Follow-up|Still in follow-up|7|||
143317329|NCT03146650|516707493|FG000|2 Year Follow-up|Lost to Follow-up|1|||
143317330|NCT00555438|516707498|FG000|10 Days Post-operative|Death|4|||
143317331|NCT00555438|516707498|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
143317332|NCT00459134|516707499|FG000|Overall Study|Physician Decision|1|||
143317333|NCT00459134|516707500|FG001|Overall Study|Physician Decision|1|||
143317334|NCT00459134|516707499|FG000|Overall Study|Withdrawal by Subject|8|||
143317335|NCT00459134|516707500|FG001|Overall Study|Withdrawal by Subject|7|||
143317336|NCT00459134|516707499|FG000|Overall Study|Lost to Follow-up|6|||
143317337|NCT00459134|516707500|FG001|Overall Study|Lost to Follow-up|7|||
143317338|NCT00459134|516707499|FG000|Overall Study|Surgery|1|||
143317339|NCT00459134|516707500|FG001|Overall Study|Surgery|2|||
143317340|NCT00459134|516707499|FG000|Overall Study|Toxicity|4|||
143317341|NCT00459134|516707500|FG001|Overall Study|Toxicity|5|||
143317342|NCT00459134|516707499|FG000|Overall Study|Progression|1|||
143317343|NCT00459134|516707500|FG001|Overall Study|Progression|0|||
143317344|NCT00459134|516707499|FG000|Overall Study|Multiple Reasons|2|||
143317345|NCT00459134|516707500|FG001|Overall Study|Multiple Reasons|3|||
143317346|NCT00829621|516707501|FG000|Overall Study|Death|1|||
143317347|NCT00829621|516707502|FG001|Overall Study|Death|0|||
143317348|NCT00829621|516707501|FG000|Overall Study|Lost to Follow-up|3|||
143317349|NCT00829621|516707502|FG001|Overall Study|Lost to Follow-up|4|||
143317350|NCT00441337|516707503|FG000|Overall Study|Disease Progression|6|||
143317351|NCT00441337|516707504|FG001|Overall Study|Disease Progression|6|||
143317352|NCT00441337|516707505|FG002|Overall Study|Disease Progression|4|||
143317353|NCT00441337|516707506|FG003|Overall Study|Disease Progression|18|||
143317354|NCT00441337|516707503|FG000|Overall Study|Lost to Follow-up|0|||
143317355|NCT00441337|516707504|FG001|Overall Study|Lost to Follow-up|0|||
143317356|NCT00441337|516707505|FG002|Overall Study|Lost to Follow-up|0|||
143317357|NCT00441337|516707506|FG003|Overall Study|Lost to Follow-up|1|||
143317358|NCT00441337|516707503|FG000|Overall Study|Sponsor Decision|0|||
143317359|NCT00441337|516707504|FG001|Overall Study|Sponsor Decision|0|||
143317360|NCT00441337|516707505|FG002|Overall Study|Sponsor Decision|1|||
143317361|NCT00441337|516707506|FG003|Overall Study|Sponsor Decision|2|||
143317362|NCT00441337|516707503|FG000|Overall Study|Did not meet inclusion criteria|0|||
143317363|NCT00441337|516707504|FG001|Overall Study|Did not meet inclusion criteria|0|||
143317364|NCT00441337|516707505|FG002|Overall Study|Did not meet inclusion criteria|1|||
143317365|NCT00441337|516707506|FG003|Overall Study|Did not meet inclusion criteria|0|||
143317366|NCT06748040|516707507|FG000|Overall Study|Death|3|||
143317367|NCT06748040|516707508|FG001|Overall Study|Death|4|||
143317368|NCT06748040|516707507|FG000|Overall Study|Lost to Follow-up|134|||
143317369|NCT06748040|516707508|FG001|Overall Study|Lost to Follow-up|132|||
143317370|NCT06748040|516707507|FG000|Overall Study|Withdrawal by Subject|3|||
143317371|NCT06748040|516707508|FG001|Overall Study|Withdrawal by Subject|5|||
143317372|NCT02805257|516709225|FG000|Overall Study|Lost to Follow-up|7|||
143317373|NCT02805257|516709226|FG001|Overall Study|Lost to Follow-up|6|||
143317374|NCT02805257|516709225|FG000|Overall Study|Death|0|||
143317375|NCT02805257|516709226|FG001|Overall Study|Death|1|||
143317376|NCT01043874|516709228|FG000|Overall Study|Adverse Event|3|||
143317377|NCT01043874|516709228|FG000|Overall Study|Withdrawal by Subject|1|||
143317378|NCT01043874|516709228|FG000|Overall Study|Lack of Efficacy|1|||
143317379|NCT01043874|516709228|FG000|Overall Study|Administrative Problems|1|||
143317380|NCT01627249|516709233|FG000|Overall Study|Death|3|||
143317381|NCT01627249|516709234|FG001|Overall Study|Death|5|||
143317382|NCT01627249|516709235|FG002|Overall Study|Death|3|||
143317383|NCT01627249|516709233|FG000|Overall Study|Withdrawal by Subject|12|||
143317384|NCT01627249|516709234|FG001|Overall Study|Withdrawal by Subject|6|||
143317385|NCT01627249|516709235|FG002|Overall Study|Withdrawal by Subject|9|||
143317386|NCT01627249|516709233|FG000|Overall Study|Missed Visit|1|||
143317387|NCT01627249|516709234|FG001|Overall Study|Missed Visit|1|||
143317388|NCT01627249|516709235|FG002|Overall Study|Missed Visit|0|||
143317389|NCT03266588|516709236|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
143317390|NCT03266588|516709237|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
143317391|NCT03266588|516709238|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
143317392|NCT03266588|516709236|FG000|Observational Period|Withdrawal by Subject|44|||
143317393|NCT03266588|516709237|FG001|Observational Period|Withdrawal by Subject|22|||
143317394|NCT03266588|516709238|FG002|Observational Period|Withdrawal by Subject|13|||
143317395|NCT03266588|516709236|FG000|Observational Period|Non-compliance|18|||
143317396|NCT03266588|516709237|FG001|Observational Period|Non-compliance|12|||
143317397|NCT03266588|516709238|FG002|Observational Period|Non-compliance|10|||
143317398|NCT03266588|516709236|FG000|Observational Period|Lost to Follow-up|8|||
143317399|NCT03266588|516709237|FG001|Observational Period|Lost to Follow-up|12|||
143317400|NCT03266588|516709238|FG002|Observational Period|Lost to Follow-up|4|||
143317401|NCT03266588|516709236|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
143317402|NCT03266588|516709237|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
143317403|NCT03266588|516709238|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
143317404|NCT03266588|516709236|FG000|Observational Period|Protocol Deviation|1|||
143317405|NCT03266588|516709237|FG001|Observational Period|Protocol Deviation|0|||
143317406|NCT03266588|516709238|FG002|Observational Period|Protocol Deviation|0|||
143317407|NCT03266588|516709236|FG000|Observational Period|Other Reasons|3|||
143317408|NCT03266588|516709237|FG001|Observational Period|Other Reasons|0|||
143317409|NCT03266588|516709238|FG002|Observational Period|Other Reasons|1|||
143317410|NCT03266588|516709236|FG000|Long-term Treatment Period|Adverse Event|33|||
143317411|NCT03266588|516709237|FG001|Long-term Treatment Period|Adverse Event|17|||
143317412|NCT03266588|516709238|FG002|Long-term Treatment Period|Adverse Event|8|||
143317413|NCT03266588|516709236|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
143317414|NCT03266588|516709237|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
143317415|NCT03266588|516709238|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
143317416|NCT03266588|516709236|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
143317417|NCT03266588|516709237|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
143317418|NCT03266588|516709238|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
143317419|NCT03266588|516709236|FG000|Long-term Treatment Period|Non-Compliance|126|||
143317420|NCT03266588|516709237|FG001|Long-term Treatment Period|Non-Compliance|57|||
143317421|NCT03266588|516709238|FG002|Long-term Treatment Period|Non-Compliance|7|||
143317422|NCT03266588|516709236|FG000|Long-term Treatment Period|Pregnancy|11|||
143317423|NCT03266588|516709237|FG001|Long-term Treatment Period|Pregnancy|5|||
143317424|NCT03266588|516709238|FG002|Long-term Treatment Period|Pregnancy|0|||
143317425|NCT03266588|516709236|FG000|Long-term Treatment Period|Protocol Deviation|17|||
143317426|NCT03266588|516709237|FG001|Long-term Treatment Period|Protocol Deviation|10|||
143317427|NCT03266588|516709238|FG002|Long-term Treatment Period|Protocol Deviation|4|||
143317428|NCT03266588|516709236|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
143317429|NCT03266588|516709237|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
143317430|NCT03266588|516709238|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
143317431|NCT03266588|516709236|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
143317432|NCT03266588|516709237|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
143317433|NCT03266588|516709238|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
143317434|NCT03266588|516709236|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
143317435|NCT03266588|516709237|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
143317436|NCT03266588|516709238|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
143317437|NCT03266588|516709236|FG000|Long-term Treatment Period|Other Reasons|5|||
143317438|NCT03266588|516709237|FG001|Long-term Treatment Period|Other Reasons|0|||
143317439|NCT03266588|516709238|FG002|Long-term Treatment Period|Other Reasons|0|||
143317440|NCT03266588|516709236|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
143317441|NCT03266588|516709237|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
143317442|NCT03266588|516709238|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
143317443|NCT01040871|516709239|FG000|Overall Study|Adverse Event|6|||
143317444|NCT01040871|516709240|FG001|Overall Study|Adverse Event|2|||
143317445|NCT01040871|516709239|FG000|Overall Study|Withdrawal by Subject|2|||
143317446|NCT01040871|516709240|FG001|Overall Study|Withdrawal by Subject|0|||
143317447|NCT01040871|516709239|FG000|Overall Study|Death|1|||
143317448|NCT01040871|516709240|FG001|Overall Study|Death|3|||
143317449|NCT01040871|516709239|FG000|Overall Study|Lack of Efficacy|1|||
143317450|NCT01040871|516709240|FG001|Overall Study|Lack of Efficacy|1|||
143317451|NCT01040871|516709239|FG000|Overall Study|drug supply issue|1|||
143317452|NCT01040871|516709240|FG001|Overall Study|drug supply issue|0|||
143317453|NCT01040871|516709239|FG000|Overall Study|Randomized and Not Treated|2|||
143317454|NCT01040871|516709240|FG001|Overall Study|Randomized and Not Treated|1|||
143317455|NCT02886572|516709241|FG000|Overall Study|Death|8|||
143317456|NCT00767000|516709245|FG000|54-week Study|Adverse Event|4|||
143317457|NCT00767000|516709246|FG001|54-week Study|Adverse Event|6|||
143317458|NCT00767000|516709247|FG002|54-week Study|Adverse Event|6|||
143317459|NCT00767000|516709248|FG003|54-week Study|Adverse Event|8|||
143317460|NCT00767000|516709249|FG004|54-week Study|Adverse Event|4|||
143317461|NCT00767000|516709245|FG000|54-week Study|Creaninine/creatinine clearance|2|||
143317462|NCT00767000|516709246|FG001|54-week Study|Creaninine/creatinine clearance|1|||
143317463|NCT00767000|516709247|FG002|54-week Study|Creaninine/creatinine clearance|2|||
143317464|NCT00767000|516709248|FG003|54-week Study|Creaninine/creatinine clearance|2|||
143317465|NCT00767000|516709249|FG004|54-week Study|Creaninine/creatinine clearance|4|||
143317466|NCT00767000|516709245|FG000|54-week Study|Hyperglycemia|0|||
143317467|NCT00767000|516709246|FG001|54-week Study|Hyperglycemia|0|||
143317468|NCT00767000|516709247|FG002|54-week Study|Hyperglycemia|1|||
143317469|NCT00767000|516709248|FG003|54-week Study|Hyperglycemia|0|||
143317470|NCT00767000|516709249|FG004|54-week Study|Hyperglycemia|1|||
143317471|NCT00767000|516709245|FG000|54-week Study|Hypoglycemia|0|||
143317472|NCT00767000|516709246|FG001|54-week Study|Hypoglycemia|1|||
143317473|NCT00767000|516709247|FG002|54-week Study|Hypoglycemia|0|||
143317474|NCT00767000|516709248|FG003|54-week Study|Hypoglycemia|0|||
143317475|NCT00767000|516709249|FG004|54-week Study|Hypoglycemia|0|||
143317476|NCT00767000|516709245|FG000|54-week Study|Interruption of study medication|0|||
143317477|NCT00767000|516709246|FG001|54-week Study|Interruption of study medication|0|||
143317478|NCT00767000|516709247|FG002|54-week Study|Interruption of study medication|1|||
143317479|NCT00767000|516709248|FG003|54-week Study|Interruption of study medication|0|||
143317480|NCT00767000|516709249|FG004|54-week Study|Interruption of study medication|0|||
143317481|NCT00767000|516709245|FG000|54-week Study|Lack of Efficacy|2|||
143317482|NCT00767000|516709246|FG001|54-week Study|Lack of Efficacy|0|||
143317483|NCT00767000|516709247|FG002|54-week Study|Lack of Efficacy|1|||
143317484|NCT00767000|516709248|FG003|54-week Study|Lack of Efficacy|0|||
143377796|NCT00736853|516928250|FG001|Double-Blind Period|Lack of Efficacy|19|||
143377797|NCT00736853|516928251|FG002|Double-Blind Period|Lack of Efficacy|42|||
143377798|NCT00736853|516928249|FG000|Double-Blind Period|Adverse Event|0|||
143377799|NCT00736853|516928250|FG001|Double-Blind Period|Adverse Event|3|||
143377800|NCT00736853|516928251|FG002|Double-Blind Period|Adverse Event|2|||
143377801|NCT00736853|516928249|FG000|Double-Blind Period|Withdrawal by Subject|0|||
143377802|NCT00736853|516928250|FG001|Double-Blind Period|Withdrawal by Subject|1|||
143377803|NCT00736853|516928251|FG002|Double-Blind Period|Withdrawal by Subject|4|||
143377804|NCT00736853|516928249|FG000|Double-Blind Period|Ineligible to participate the study|0|||
143377805|NCT00736853|516928250|FG001|Double-Blind Period|Ineligible to participate the study|1|||
143377806|NCT00736853|516928251|FG002|Double-Blind Period|Ineligible to participate the study|0|||
143377807|NCT01199705|516928252|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
143377808|NCT00933400|516928253|FG000|Overall Study|Withdrawal by Subject|21|||
143377809|NCT00933400|516928254|FG001|Overall Study|Withdrawal by Subject|1|||
143377810|NCT01415349|516928255|FG000|Treatment Period 1|Adverse Event|0|||
143377811|NCT01415349|516928256|FG001|Treatment Period 1|Adverse Event|1|||
143377812|NCT01415349|516928255|FG000|Treatment Period 1|Withdrawal by Subject|0|||
143377813|NCT01415349|516928256|FG001|Treatment Period 1|Withdrawal by Subject|1|||
143377814|NCT01041417|516928257|FG000|Overall Study|Adverse Event|5|||
143377815|NCT01041417|516928258|FG001|Overall Study|Adverse Event|2|||
143377816|NCT01041417|516928257|FG000|Overall Study|Lost to Follow-up|1|||
143377817|NCT01041417|516928258|FG001|Overall Study|Lost to Follow-up|1|||
143377818|NCT01041417|516928257|FG000|Overall Study|Death|1|||
143377819|NCT01041417|516928258|FG001|Overall Study|Death|0|||
143377820|NCT01764464|516928259|FG000|First Intervention|Withdrawal by Subject|1|||
143377821|NCT01764464|516928260|FG001|First Intervention|Withdrawal by Subject|0|||
143377822|NCT01764464|516928259|FG000|First Intervention|Lost to Follow-up|1|||
143377823|NCT01764464|516928260|FG001|First Intervention|Lost to Follow-up|0|||
143377824|NCT01764464|516928259|FG000|First Intervention|Adverse Event|0|||
143377825|NCT01764464|516928260|FG001|First Intervention|Adverse Event|2|||
143377826|NCT01764464|516928259|FG000|First Intervention|did not receive study drug|0|||
143377827|NCT01764464|516928260|FG001|First Intervention|did not receive study drug|1|||
143377828|NCT01764464|516928259|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
143377829|NCT01764464|516928260|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
143377830|NCT03473340|516928261|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
143377831|NCT03473340|516928262|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
143377832|NCT03473340|516928261|FG000|Overall Study|Withdrawal by Subject|1|||
143377833|NCT03473340|516928262|FG001|Overall Study|Withdrawal by Subject|0|||
143377834|NCT03473340|516928261|FG000|Overall Study|Lost to Follow-up|1|||
143377835|NCT03473340|516928262|FG001|Overall Study|Lost to Follow-up|2|||
143377836|NCT02079844|516928263|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
143377837|NCT02079844|516928264|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
143377838|NCT02079844|516928265|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
143377839|NCT02079844|516928263|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
143377840|NCT02079844|516928264|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
143377841|NCT02079844|516928265|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
143377842|NCT00203411|516928266|FG000|Follow-up|Progressive Disease|4|||
143377843|NCT04980755|516928267|FG000|Body Reprogramming Courses|Too unwell to attend|6|||
143377844|NCT04980755|516928267|FG000|Body Reprogramming Courses|Work commitment|2|||
143377845|NCT04980755|516928267|FG000|Body Reprogramming Courses|Unsure when the course started|1|||
143377846|NCT04980755|516928267|FG000|Body Reprogramming Courses|Could not be contacted to provide a reason|6|||
143377847|NCT01212991|516928268|FG000|Double-blind|Lost to Follow-up|8|||
143377848|NCT01212991|516928269|FG001|Double-blind|Lost to Follow-up|4|||
143377849|NCT01212991|516928270|FG002|Double-blind|Lost to Follow-up|0|||
143377850|NCT01212991|516928268|FG000|Double-blind|Death|699|||
143377851|NCT01212991|516928269|FG001|Double-blind|Death|550|||
143377852|NCT01212991|516928270|FG002|Double-blind|Death|0|||
143377853|NCT01212991|516928268|FG000|Double-blind|Withdrawal by Subject|16|||
143377854|NCT01212991|516928269|FG001|Double-blind|Withdrawal by Subject|19|||
143377855|NCT01212991|516928270|FG002|Double-blind|Withdrawal by Subject|0|||
143377856|NCT01212991|516928268|FG000|Double-blind|Other|7|||
143377857|NCT01212991|516928269|FG001|Double-blind|Other|0|||
143377858|NCT01212991|516928270|FG002|Double-blind|Other|0|||
143377859|NCT01212991|516928268|FG000|Double-blind|Sponsor decision|142|||
143377860|NCT01212991|516928269|FG001|Double-blind|Sponsor decision|38|||
143377861|NCT01212991|516928270|FG002|Double-blind|Sponsor decision|0|||
143377862|NCT01212991|516928268|FG000|Open-label|Death|0|||
143377863|NCT01212991|516928269|FG001|Open-label|Death|0|||
143377864|NCT01212991|516928270|FG002|Open-label|Death|166|||
143377865|NCT01212991|516928268|FG000|Open-label|Lost to Follow-up|0|||
143377866|NCT01212991|516928269|FG001|Open-label|Lost to Follow-up|0|||
143377867|NCT01212991|516928270|FG002|Open-label|Lost to Follow-up|5|||
143377868|NCT01212991|516928268|FG000|Open-label|Withdrawal by Subject|0|||
143377869|NCT01212991|516928269|FG001|Open-label|Withdrawal by Subject|0|||
143377870|NCT01212991|516928270|FG002|Open-label|Withdrawal by Subject|7|||
143377871|NCT01212991|516928268|FG000|Open-label|Sponsor decision|0|||
143377872|NCT01212991|516928269|FG001|Open-label|Sponsor decision|0|||
143377873|NCT01212991|516928270|FG002|Open-label|Sponsor decision|53|||
143317485|NCT00767000|516709249|FG004|54-week Study|Lack of Efficacy|5|||
143317486|NCT00767000|516709245|FG000|54-week Study|Lost to Follow-up|4|||
143317487|NCT00767000|516709246|FG001|54-week Study|Lost to Follow-up|0|||
143317488|NCT00767000|516709247|FG002|54-week Study|Lost to Follow-up|1|||
143317489|NCT00767000|516709248|FG003|54-week Study|Lost to Follow-up|4|||
143317490|NCT00767000|516709249|FG004|54-week Study|Lost to Follow-up|2|||
143317491|NCT00767000|516709245|FG000|54-week Study|Physician Decision|4|||
143317492|NCT00767000|516709246|FG001|54-week Study|Physician Decision|0|||
143317493|NCT00767000|516709247|FG002|54-week Study|Physician Decision|1|||
143317494|NCT00767000|516709248|FG003|54-week Study|Physician Decision|1|||
143317495|NCT00767000|516709249|FG004|54-week Study|Physician Decision|1|||
143317496|NCT00767000|516709245|FG000|54-week Study|Progressive disease|0|||
143317497|NCT00767000|516709246|FG001|54-week Study|Progressive disease|0|||
143317498|NCT00767000|516709247|FG002|54-week Study|Progressive disease|1|||
143317499|NCT00767000|516709248|FG003|54-week Study|Progressive disease|0|||
143317500|NCT00767000|516709249|FG004|54-week Study|Progressive disease|0|||
143317501|NCT00767000|516709245|FG000|54-week Study|Protocol Violation|0|||
143317502|NCT00767000|516709246|FG001|54-week Study|Protocol Violation|0|||
143317503|NCT00767000|516709247|FG002|54-week Study|Protocol Violation|1|||
143317504|NCT00767000|516709248|FG003|54-week Study|Protocol Violation|2|||
143317505|NCT00767000|516709249|FG004|54-week Study|Protocol Violation|0|||
143317506|NCT00767000|516709245|FG000|54-week Study|Withdrawal by Subject|2|||
143317507|NCT00767000|516709246|FG001|54-week Study|Withdrawal by Subject|3|||
143317508|NCT00767000|516709247|FG002|54-week Study|Withdrawal by Subject|5|||
143317509|NCT00767000|516709248|FG003|54-week Study|Withdrawal by Subject|11|||
143317510|NCT00767000|516709249|FG004|54-week Study|Withdrawal by Subject|13|||
143317511|NCT00767000|516709245|FG000|54-week Study|Study terminated by sponsor|90|||
143317512|NCT00767000|516709246|FG001|54-week Study|Study terminated by sponsor|102|||
143317513|NCT00767000|516709247|FG002|54-week Study|Study terminated by sponsor|89|||
143317514|NCT00767000|516709248|FG003|54-week Study|Study terminated by sponsor|196|||
143317515|NCT00767000|516709249|FG004|54-week Study|Study terminated by sponsor|194|||
143317516|NCT00767000|516709245|FG000|54-week Study|Reason not reported|0|||
143317517|NCT00767000|516709246|FG001|54-week Study|Reason not reported|0|||
143317518|NCT00767000|516709247|FG002|54-week Study|Reason not reported|0|||
143317519|NCT00767000|516709248|FG003|54-week Study|Reason not reported|1|||
143317520|NCT00767000|516709249|FG004|54-week Study|Reason not reported|0|||
143317521|NCT00767000|516709245|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
143317522|NCT00767000|516709246|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
143317523|NCT00767000|516709247|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
143317524|NCT00767000|516709248|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
143317525|NCT00767000|516709249|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
143317526|NCT01257204|516709252|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
143317527|NCT01257204|516709253|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
143317528|NCT01257204|516709254|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
143317529|NCT01257204|516709252|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
143317530|NCT01257204|516709253|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
143317531|NCT01257204|516709254|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
143317532|NCT01257204|516709252|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
143317533|NCT01257204|516709253|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
143317534|NCT01257204|516709254|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
143317535|NCT01257204|516709252|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
143317536|NCT01257204|516709253|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
143317537|NCT01257204|516709254|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
143317538|NCT01257204|516709252|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
143317539|NCT01257204|516709253|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
143317540|NCT01257204|516709254|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
143317541|NCT01257204|516709252|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
143317542|NCT01257204|516709253|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
143317543|NCT01257204|516709254|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
143317544|NCT01257204|516709252|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
143317545|NCT01257204|516709253|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
143317546|NCT01257204|516709254|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
143317547|NCT01257204|516709252|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
143317548|NCT01257204|516709253|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
143317549|NCT01257204|516709254|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
143317550|NCT01257204|516709252|FG000|Follow-up Period (up to Week 48)|Other|0|||
143317551|NCT01257204|516709253|FG001|Follow-up Period (up to Week 48)|Other|0|||
143317552|NCT01257204|516709254|FG002|Follow-up Period (up to Week 48)|Other|5|||
143317553|NCT03614793|516709256|FG000|Overall Study|Lost to Follow-up|1|||
143377874|NCT01212991|516928268|FG000|Open-label|Other|0|||
143377875|NCT01212991|516928269|FG001|Open-label|Other|0|||
143377876|NCT01212991|516928270|FG002|Open-label|Other|3|||
143377877|NCT01622868|516930343|FG000|Overall Study|Protocol Violation|7|||
143377878|NCT01622868|516930344|FG001|Overall Study|Protocol Violation|0|||
143377879|NCT00610649|516930345|FG000|Overall Study|Adverse Event|1|||
143377880|NCT00610649|516930346|FG001|Overall Study|Adverse Event|0|||
143377881|NCT00610649|516930347|FG002|Overall Study|Adverse Event|0|||
143377882|NCT00610649|516930348|FG003|Overall Study|Adverse Event|0|||
143377883|NCT00610649|516930349|FG004|Overall Study|Adverse Event|0|||
143377884|NCT00610649|516930350|FG005|Overall Study|Adverse Event|0|||
143377885|NCT00610649|516930351|FG006|Overall Study|Adverse Event|0|||
143377886|NCT00610649|516930352|FG007|Overall Study|Adverse Event|0|||
143377887|NCT00610649|516930353|FG008|Overall Study|Adverse Event|0|||
143377888|NCT00610649|516930354|FG009|Overall Study|Adverse Event|0|||
143377889|NCT00610649|516930355|FG010|Overall Study|Adverse Event|1|||
143377890|NCT00610649|516930345|FG000|Overall Study|Family Emergency|0|||
143377891|NCT00610649|516930346|FG001|Overall Study|Family Emergency|1|||
143377892|NCT00610649|516930347|FG002|Overall Study|Family Emergency|0|||
143377893|NCT00610649|516930348|FG003|Overall Study|Family Emergency|0|||
143377894|NCT00610649|516930349|FG004|Overall Study|Family Emergency|0|||
143377895|NCT00610649|516930350|FG005|Overall Study|Family Emergency|0|||
143377896|NCT00610649|516930351|FG006|Overall Study|Family Emergency|0|||
143377897|NCT00610649|516930352|FG007|Overall Study|Family Emergency|0|||
143377898|NCT00610649|516930353|FG008|Overall Study|Family Emergency|0|||
143377899|NCT00610649|516930354|FG009|Overall Study|Family Emergency|0|||
143377900|NCT00610649|516930355|FG010|Overall Study|Family Emergency|0|||
143377901|NCT00610649|516930345|FG000|Overall Study|Withdrawal by Subject|0|||
143377902|NCT00610649|516930346|FG001|Overall Study|Withdrawal by Subject|0|||
143377903|NCT00610649|516930347|FG002|Overall Study|Withdrawal by Subject|0|||
143377904|NCT00610649|516930348|FG003|Overall Study|Withdrawal by Subject|0|||
143377905|NCT00610649|516930349|FG004|Overall Study|Withdrawal by Subject|0|||
143377906|NCT00610649|516930350|FG005|Overall Study|Withdrawal by Subject|0|||
143377907|NCT00610649|516930351|FG006|Overall Study|Withdrawal by Subject|0|||
143377908|NCT00610649|516930352|FG007|Overall Study|Withdrawal by Subject|0|||
143377909|NCT00610649|516930353|FG008|Overall Study|Withdrawal by Subject|0|||
143377910|NCT00610649|516930354|FG009|Overall Study|Withdrawal by Subject|1|||
143377911|NCT00610649|516930355|FG010|Overall Study|Withdrawal by Subject|0|||
143377912|NCT04252586|516930356|FG000|Overall Study|Withdrawal by parent/guardian|3|||
143317554|NCT03614793|516709257|FG001|Overall Study|Lost to Follow-up|2|||
143317555|NCT03614793|516709256|FG000|Overall Study|Lack of Efficacy|0|||
143317556|NCT03614793|516709257|FG001|Overall Study|Lack of Efficacy|5|||
143317557|NCT03614793|516709256|FG000|Overall Study|Withdrawal by Subject|0|||
143317558|NCT03614793|516709257|FG001|Overall Study|Withdrawal by Subject|1|||
143317559|NCT03614793|516709256|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
143317560|NCT03614793|516709257|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
143317561|NCT02082522|516709258|FG000|Overall Study|Sponsor termination|5|||
143317562|NCT02082522|516709259|FG001|Overall Study|Sponsor termination|3|||
143317563|NCT02082522|516709258|FG000|Overall Study|Withdrawal by Subject|2|||
143317564|NCT02082522|516709259|FG001|Overall Study|Withdrawal by Subject|4|||
143317565|NCT02082522|516709258|FG000|Overall Study|Death|1|||
143317566|NCT02082522|516709259|FG001|Overall Study|Death|0|||
143317567|NCT02082522|516709258|FG000|Overall Study|Lost to Follow-up|1|||
143317568|NCT02082522|516709259|FG001|Overall Study|Lost to Follow-up|0|||
143317569|NCT02082522|516709258|FG000|Overall Study|Physician Decision|3|||
143317570|NCT02082522|516709259|FG001|Overall Study|Physician Decision|1|||
143317571|NCT02082522|516709258|FG000|Overall Study|Disease progression|2|||
143317572|NCT02082522|516709259|FG001|Overall Study|Disease progression|2|||
143317573|NCT02082522|516709258|FG000|Overall Study|Chemotherapy change|1|||
143317574|NCT02082522|516709259|FG001|Overall Study|Chemotherapy change|3|||
143317575|NCT01863446|516709260|FG000|Overall Study|Withdrawal by Subject|1|||
143317576|NCT01863446|516709261|FG001|Overall Study|Withdrawal by Subject|0|||
143317577|NCT01863446|516709262|FG002|Overall Study|Withdrawal by Subject|1|||
143377913|NCT04252586|516930356|FG000|Overall Study|Adverse Event|1|||
143377914|NCT04252586|516930356|FG000|Overall Study|Death|2|||
143377915|NCT04252586|516930356|FG000|Overall Study|Study terminated by sponsor|4|||
143317578|NCT01863446|516709263|FG003|Overall Study|Withdrawal by Subject|2|||
143317579|NCT01863446|516709260|FG000|Overall Study|Physician Decision|0|||
143317580|NCT01863446|516709261|FG001|Overall Study|Physician Decision|0|||
143317581|NCT01863446|516709262|FG002|Overall Study|Physician Decision|1|||
143317582|NCT01863446|516709263|FG003|Overall Study|Physician Decision|0|||
143377916|NCT04252586|516930356|FG000|Overall Study|Sponsor request|10|||
143377917|NCT04252586|516930356|FG000|Overall Study|Did not complete treatment period|1|||
143317583|NCT00633984|516709264|FG000|Overall Study|Lost to Follow-up|0|||
143317584|NCT00633984|516709265|FG001|Overall Study|Lost to Follow-up|6|||
143317585|NCT00633984|516709264|FG000|Overall Study|Withdrawal by Subject|8|||
143317586|NCT00633984|516709265|FG001|Overall Study|Withdrawal by Subject|7|||
143317587|NCT00633984|516709264|FG000|Overall Study|Hospitalized|1|||
143377918|NCT00414544|516930357|FG000|Overall Study|Lost to Follow-up|14|||
143377919|NCT00542789|516930360|FG000|Overall Study|Adverse Event|18|||
143377920|NCT00542789|516930361|FG001|Overall Study|Adverse Event|17|||
143377921|NCT00542789|516930360|FG000|Overall Study|Withdrawal by Subject|7|||
143377922|NCT00542789|516930361|FG001|Overall Study|Withdrawal by Subject|3|||
143377923|NCT00542789|516930360|FG000|Overall Study|Protocol Violation|8|||
143377924|NCT00542789|516930361|FG001|Overall Study|Protocol Violation|1|||
143377925|NCT00542789|516930360|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
143377926|NCT00542789|516930361|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
143377927|NCT01571596|516930363|FG000|Overall Study|Adverse Event|2|||
143377928|NCT01571596|516930364|FG001|Overall Study|Adverse Event|0|||
143377929|NCT01571596|516930365|FG002|Overall Study|Adverse Event|0|||
143377930|NCT01571596|516930363|FG000|Overall Study|Study Terminated by the Sponsor|0|||
143377931|NCT01571596|516930364|FG001|Overall Study|Study Terminated by the Sponsor|1|||
143377932|NCT01571596|516930365|FG002|Overall Study|Study Terminated by the Sponsor|1|||
143377933|NCT04512482|516930369|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
143377934|NCT04512482|516930370|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
143377935|NCT00585052|516930371|FG000|Overall Study|Withdrawal by Subject|1|||
143377936|NCT00774397|516930374|FG000|Overall Study|Adverse Event|1|||
143377937|NCT00774397|516930375|FG001|Overall Study|Adverse Event|3|||
143377938|NCT00774397|516930376|FG002|Overall Study|Adverse Event|16|||
143377939|NCT00774397|516930377|FG003|Overall Study|Adverse Event|8|||
143377940|NCT00774397|516930378|FG004|Overall Study|Adverse Event|8|||
143377941|NCT00774397|516930379|FG005|Overall Study|Adverse Event|3|||
143377942|NCT00774397|516930380|FG006|Overall Study|Adverse Event|16|||
143377943|NCT00774397|516930374|FG000|Overall Study|Lack of Efficacy|11|||
143377944|NCT00774397|516930375|FG001|Overall Study|Lack of Efficacy|4|||
143377945|NCT00774397|516930376|FG002|Overall Study|Lack of Efficacy|5|||
143377946|NCT00774397|516930377|FG003|Overall Study|Lack of Efficacy|3|||
143377947|NCT00774397|516930378|FG004|Overall Study|Lack of Efficacy|27|||
143377948|NCT00774397|516930379|FG005|Overall Study|Lack of Efficacy|15|||
143377949|NCT00774397|516930380|FG006|Overall Study|Lack of Efficacy|9|||
143377950|NCT00774397|516930374|FG000|Overall Study|Protocol Violation|0|||
143377951|NCT00774397|516930375|FG001|Overall Study|Protocol Violation|1|||
143377952|NCT00774397|516930376|FG002|Overall Study|Protocol Violation|3|||
143377953|NCT00774397|516930377|FG003|Overall Study|Protocol Violation|1|||
143377954|NCT00774397|516930378|FG004|Overall Study|Protocol Violation|2|||
143317588|NCT00633984|516709265|FG001|Overall Study|Hospitalized|0|||
143317589|NCT02496884|516709266|FG000|Overall Study|Counted twice as enrolled|2|||
143317590|NCT02496884|516709267|FG001|Overall Study|Counted twice as enrolled|0|||
143317591|NCT02496884|516709268|FG002|Overall Study|Counted twice as enrolled|0|||
143317592|NCT02496884|516709269|FG003|Overall Study|Counted twice as enrolled|0|||
143317593|NCT02496884|516709266|FG000|Overall Study|Withdrawal by Subject|0|||
143317594|NCT02496884|516709267|FG001|Overall Study|Withdrawal by Subject|3|||
143317595|NCT02496884|516709268|FG002|Overall Study|Withdrawal by Subject|0|||
143317596|NCT02496884|516709269|FG003|Overall Study|Withdrawal by Subject|0|||
143317597|NCT02956629|516709272|FG000|Overall Study|Adverse Event|0|||
143317598|NCT02956629|516709273|FG001|Overall Study|Adverse Event|0|||
143317599|NCT02956629|516709274|FG002|Overall Study|Adverse Event|1|||
143317600|NCT02956629|516709275|FG003|Overall Study|Adverse Event|0|||
143317601|NCT02956629|516709276|FG004|Overall Study|Adverse Event|0|||
143317602|NCT02956629|516709277|FG005|Overall Study|Adverse Event|0|||
143317603|NCT02956629|516709272|FG000|Overall Study|Lost to Follow-up|2|||
143317604|NCT02956629|516709273|FG001|Overall Study|Lost to Follow-up|5|||
143317605|NCT02956629|516709274|FG002|Overall Study|Lost to Follow-up|3|||
143377955|NCT00774397|516930379|FG005|Overall Study|Protocol Violation|1|||
143377956|NCT00774397|516930380|FG006|Overall Study|Protocol Violation|0|||
143377957|NCT00774397|516930374|FG000|Overall Study|Lost to Follow-up|0|||
143377958|NCT00774397|516930375|FG001|Overall Study|Lost to Follow-up|1|||
143377959|NCT00774397|516930376|FG002|Overall Study|Lost to Follow-up|1|||
143377960|NCT00774397|516930377|FG003|Overall Study|Lost to Follow-up|1|||
143377961|NCT00774397|516930378|FG004|Overall Study|Lost to Follow-up|0|||
143317606|NCT02956629|516709275|FG003|Overall Study|Lost to Follow-up|1|||
143317607|NCT02956629|516709276|FG004|Overall Study|Lost to Follow-up|0|||
143317608|NCT02956629|516709277|FG005|Overall Study|Lost to Follow-up|1|||
143317609|NCT02956629|516709272|FG000|Overall Study|Withdrawal by Subject|3|||
143317610|NCT02956629|516709273|FG001|Overall Study|Withdrawal by Subject|1|||
143377962|NCT00774397|516930379|FG005|Overall Study|Lost to Follow-up|1|||
143377963|NCT00774397|516930380|FG006|Overall Study|Lost to Follow-up|0|||
143377964|NCT00774397|516930374|FG000|Overall Study|Refused to continue trial medication|1|||
143377965|NCT00774397|516930375|FG001|Overall Study|Refused to continue trial medication|3|||
143377966|NCT00774397|516930376|FG002|Overall Study|Refused to continue trial medication|2|||
143377967|NCT00774397|516930377|FG003|Overall Study|Refused to continue trial medication|2|||
143317611|NCT02956629|516709274|FG002|Overall Study|Withdrawal by Subject|0|||
143317612|NCT02956629|516709275|FG003|Overall Study|Withdrawal by Subject|0|||
143317613|NCT02956629|516709276|FG004|Overall Study|Withdrawal by Subject|0|||
143317614|NCT02956629|516709277|FG005|Overall Study|Withdrawal by Subject|0|||
143317615|NCT00003498|516709278|FG000|Overall Study|Not evaluable.|4|||
143317616|NCT04067141|516709282|FG000|First Intervention|Withdrawal by Subject|0|||
143317617|NCT04067141|516709283|FG001|First Intervention|Withdrawal by Subject|1|||
143317618|NCT04067141|516709282|FG000|Second Intervention|Adverse Event|0|||
143317619|NCT04067141|516709283|FG001|Second Intervention|Adverse Event|2|||
143317620|NCT03295201|516709284|FG000|Overall Study|Lost to Follow-up|1|||
143317621|NCT03295201|516709285|FG001|Overall Study|Lost to Follow-up|1|||
143317622|NCT03295201|516709284|FG000|Overall Study|Hospital admission|0|||
143317623|NCT03295201|516709285|FG001|Overall Study|Hospital admission|1|||
143317624|NCT00572572|516709286|FG000|Overall Study|Withdrawal by Subject|3|||
143317625|NCT00572572|516709287|FG001|Overall Study|Withdrawal by Subject|6|||
143317626|NCT00889421|516709288|FG000|Overall Study|Lack of Efficacy|3|||
143317627|NCT01958918|516709289|FG000|Overall Study|Death|1|||
143317628|NCT01958918|516709290|FG001|Overall Study|Death|3|||
143317629|NCT01958918|516709289|FG000|Overall Study|Lost to Follow-up|4|||
143317630|NCT01958918|516709290|FG001|Overall Study|Lost to Follow-up|7|||
143317631|NCT01958918|516709289|FG000|Overall Study|Withdrawal by Subject|13|||
143317632|NCT01958918|516709290|FG001|Overall Study|Withdrawal by Subject|8|||
143317633|NCT01958918|516709289|FG000|Overall Study|Lack of Efficacy|13|||
143317634|NCT01958918|516709290|FG001|Overall Study|Lack of Efficacy|10|||
143317635|NCT01958918|516709289|FG000|Overall Study|Adverse Event|12|||
143317636|NCT01958918|516709290|FG001|Overall Study|Adverse Event|12|||
143317637|NCT01958918|516709289|FG000|Overall Study|administrative problems|0|||
143317638|NCT01958918|516709290|FG001|Overall Study|administrative problems|2|||
143317639|NCT02114892|516709294|FG000|Overall Study|Lost to Follow-up|1|||
143317640|NCT02114892|516709295|FG001|Overall Study|Lost to Follow-up|2|||
143317641|NCT00659269|516709299|FG000|Overall Study|Physician Decision|1|||
143317642|NCT00659269|516709300|FG001|Overall Study|Physician Decision|1|||
143317643|NCT00718042|516709302|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
143317644|NCT00718042|516709303|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
143317645|NCT00718042|516709304|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
143317646|NCT00718042|516709305|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
143317647|NCT00718042|516709306|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
143317648|NCT00718042|516709307|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
143317649|NCT00718042|516709302|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
143317650|NCT00718042|516709303|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
143317651|NCT00718042|516709304|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
143317652|NCT00718042|516709305|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
143317653|NCT00718042|516709306|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
143317654|NCT00718042|516709307|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
143317655|NCT00718042|516709302|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
143317656|NCT00718042|516709303|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
143317657|NCT00718042|516709304|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
143317658|NCT00718042|516709305|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
143317659|NCT00718042|516709306|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
143317660|NCT00718042|516709307|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
143317661|NCT00718042|516709302|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
143317662|NCT00718042|516709303|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
143317663|NCT00718042|516709304|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
143317664|NCT00718042|516709305|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
143317665|NCT00718042|516709306|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
143317666|NCT00718042|516709307|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
143317667|NCT00718042|516709302|FG000|Donor Follow-up|Lost to Follow-up|13|||
143317668|NCT00718042|516709303|FG001|Donor Follow-up|Lost to Follow-up|0|||
143317669|NCT00718042|516709304|FG002|Donor Follow-up|Lost to Follow-up|0|||
143317670|NCT00718042|516709305|FG003|Donor Follow-up|Lost to Follow-up|0|||
143317671|NCT00718042|516709306|FG004|Donor Follow-up|Lost to Follow-up|19|||
143317672|NCT00718042|516709307|FG005|Donor Follow-up|Lost to Follow-up|0|||
143317673|NCT04327934|516709308|FG000|Overall Study|Did not qualify|7|||
143317674|NCT04327934|516709309|FG001|Overall Study|Did not qualify|4|||
143317675|NCT04327934|516709308|FG000|Overall Study|Physician Decision|0|||
143317676|NCT04327934|516709309|FG001|Overall Study|Physician Decision|1|||
143317677|NCT02443298|516709310|FG000|Overall Study|Adverse Event|3|||
143317678|NCT02443298|516709311|FG001|Overall Study|Adverse Event|3|||
143317679|NCT02443298|516709310|FG000|Overall Study|Withdrawal by Subject|1|||
143317680|NCT02443298|516709311|FG001|Overall Study|Withdrawal by Subject|2|||
143317681|NCT02399085|516709314|FG000|Overall Study|Adverse Event|16|||
143317682|NCT02399085|516709314|FG000|Overall Study|Death|2|||
143317683|NCT02399085|516709314|FG000|Overall Study|Withdrawal by Subject|8|||
143317684|NCT02399085|516709314|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
143317685|NCT02399085|516709314|FG000|Overall Study|Physician Decision|5|||
143317686|NCT01158924|516709315|FG000|Overall Study|Withdrawal by Subject|1|||
143317687|NCT01158924|516709316|FG001|Overall Study|Withdrawal by Subject|2|||
143317688|NCT01158924|516709315|FG000|Overall Study|Lost to Follow-up|0|||
143317689|NCT01158924|516709316|FG001|Overall Study|Lost to Follow-up|1|||
143317690|NCT01416805|516709321|FG000|Overall Study|Lost to Follow-up|4|||
143317691|NCT01416805|516709322|FG001|Overall Study|Lost to Follow-up|4|||
143317692|NCT03056690|516709323|FG000|Overall Study|Adverse Event|3|||
143317693|NCT03056690|516709324|FG001|Overall Study|Adverse Event|2|||
143317694|NCT03056690|516709323|FG000|Overall Study|Lack of Efficacy|1|||
143317695|NCT03056690|516709324|FG001|Overall Study|Lack of Efficacy|2|||
143317696|NCT03056690|516709323|FG000|Overall Study|Lost to Follow-up|3|||
143317697|NCT03056690|516709324|FG001|Overall Study|Lost to Follow-up|2|||
143317698|NCT03056690|516709323|FG000|Overall Study|Protocol Violation|2|||
143317699|NCT03056690|516709324|FG001|Overall Study|Protocol Violation|2|||
143317700|NCT03056690|516709323|FG000|Overall Study|Withdrawal by Subject|3|||
143317701|NCT03056690|516709324|FG001|Overall Study|Withdrawal by Subject|6|||
143317702|NCT03056690|516709323|FG000|Overall Study|Non-compliance with Study Drug|1|||
143317703|NCT03056690|516709324|FG001|Overall Study|Non-compliance with Study Drug|0|||
143317704|NCT03056690|516709323|FG000|Overall Study|Miscellaneous|1|||
143317705|NCT03056690|516709324|FG001|Overall Study|Miscellaneous|2|||
143317706|NCT01723904|516709325|FG000|Overall Study|Noncompliant|3|||
143317707|NCT01723904|516709325|FG000|Overall Study|Adverse Event|5|||
143317708|NCT01723904|516709325|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
143317709|NCT00235989|516709332|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
143317710|NCT00235989|516709333|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
143317711|NCT00235989|516709334|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
143317712|NCT00235989|516709335|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
143317713|NCT00235989|516709336|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
143317714|NCT00235989|516709337|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
143317715|NCT00235989|516709332|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
143317716|NCT00235989|516709333|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
143317717|NCT00235989|516709334|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
143317718|NCT00235989|516709335|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
143317719|NCT00235989|516709336|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
143317720|NCT00235989|516709337|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
143317721|NCT00235989|516709332|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
143317722|NCT00235989|516709333|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
143317723|NCT00235989|516709334|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
143317724|NCT00235989|516709335|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
143317725|NCT00235989|516709336|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
143317726|NCT00235989|516709337|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
143317727|NCT00235989|516709332|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
143317728|NCT00235989|516709333|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
143317729|NCT00235989|516709334|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
143317730|NCT00235989|516709335|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
143317731|NCT00235989|516709336|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
143317732|NCT00235989|516709337|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
143317733|NCT00235989|516709332|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
143317734|NCT00235989|516709333|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
143317735|NCT00235989|516709334|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
143317736|NCT00235989|516709335|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
143317737|NCT00235989|516709336|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
143317738|NCT00235989|516709337|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
143317739|NCT01971346|516709340|FG000|Overall Study|Protocol Violation|3|||
143317740|NCT01971346|516709340|FG000|Overall Study|Lost to Follow-up|2|||
143317741|NCT01971346|516709340|FG000|Overall Study|Withdrawal by Subject|2|||
143317742|NCT01971346|516709340|FG000|Overall Study|Physician Decision|1|||
143317743|NCT00183872|516709341|FG000|Overall Study|Death|3|||
143317744|NCT00183872|516709341|FG000|Overall Study|Adverse Event|9|||
143317745|NCT00183872|516709341|FG000|Overall Study|Withdrawal by Subject|2|||
143317746|NCT00183872|516709341|FG000|Overall Study|Drug delayed more than 28 days|2|||
143317747|NCT02052466|516709342|FG000|Overall Study|Withdrawal by Subject|1|||
143317748|NCT02052466|516709342|FG000|Overall Study|Acromial fracture|1|||
143317749|NCT02797262|516709344|FG000|Overall Study|Withdrawal by Subject|5|||
143317750|NCT02797262|516709345|FG001|Overall Study|Withdrawal by Subject|1|||
143317751|NCT02797262|516709344|FG000|Overall Study|Lost to Follow-up|10|||
143317752|NCT02797262|516709345|FG001|Overall Study|Lost to Follow-up|7|||
143317753|NCT02797262|516709344|FG000|Overall Study|Death|1|||
143317754|NCT02797262|516709345|FG001|Overall Study|Death|2|||
143317755|NCT02797262|516709344|FG000|Overall Study|Adverse Event|1|||
143317756|NCT02797262|516709345|FG001|Overall Study|Adverse Event|0|||
143317757|NCT02797262|516709344|FG000|Overall Study|COVID-19|2|||
143317758|NCT02797262|516709345|FG001|Overall Study|COVID-19|1|||
143317759|NCT02797262|516709344|FG000|Overall Study|Out-of-country|1|||
143317760|NCT02797262|516709345|FG001|Overall Study|Out-of-country|0|||
143317761|NCT01600586|516709346|FG000|Overall Study|Physician Decision|3|||
143377968|NCT00774397|516930378|FG004|Overall Study|Refused to continue trial medication|6|||
143377969|NCT00774397|516930379|FG005|Overall Study|Refused to continue trial medication|2|||
143377970|NCT00774397|516930380|FG006|Overall Study|Refused to continue trial medication|3|||
143377971|NCT00774397|516930374|FG000|Overall Study|Not treated|0|||
143377972|NCT00774397|516930375|FG001|Overall Study|Not treated|0|||
143377973|NCT00774397|516930376|FG002|Overall Study|Not treated|0|||
143377974|NCT00774397|516930377|FG003|Overall Study|Not treated|0|||
143377975|NCT00774397|516930378|FG004|Overall Study|Not treated|1|||
143377976|NCT00774397|516930379|FG005|Overall Study|Not treated|0|||
143377977|NCT00774397|516930380|FG006|Overall Study|Not treated|1|||
143377978|NCT00774397|516930374|FG000|Overall Study|Other than those stated above|1|||
143377979|NCT00774397|516930375|FG001|Overall Study|Other than those stated above|1|||
143377980|NCT00774397|516930376|FG002|Overall Study|Other than those stated above|3|||
143377981|NCT00774397|516930377|FG003|Overall Study|Other than those stated above|2|||
143377982|NCT00774397|516930378|FG004|Overall Study|Other than those stated above|2|||
143377983|NCT00774397|516930379|FG005|Overall Study|Other than those stated above|0|||
143377984|NCT00774397|516930380|FG006|Overall Study|Other than those stated above|1|||
143377985|NCT00858117|516930384|FG000|Treatment on Study|Adverse Event|2|||
143377986|NCT00858117|516930384|FG000|Follow up for 5 Years|Death|4|||
143377987|NCT00858117|516930384|FG000|Follow up for 5 Years|No further data collected for study|9|||
143377988|NCT02499159|516930385|FG000|Randomization|Protocol Violation|1|||
143377989|NCT02499159|516930386|FG001|Randomization|Protocol Violation|1|||
143377990|NCT02499159|516930385|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
143377991|NCT02499159|516930386|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
143377992|NCT02499159|516930385|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
143377993|NCT02499159|516930386|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
143377994|NCT02499159|516930385|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
143377995|NCT02499159|516930386|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
143377996|NCT02499159|516930385|FG000|30-Day Follow-Up Phone Call|Other|1|||
143377997|NCT02499159|516930386|FG001|30-Day Follow-Up Phone Call|Other|0|||
143377998|NCT00277355|516930393|FG000|Overall Study|Withdrawal by Subject|3|||
143377999|NCT00277355|516930394|FG001|Overall Study|Withdrawal by Subject|3|||
143378000|NCT00277355|516930393|FG000|Overall Study|Lost to Follow-up|2|||
143378001|NCT00277355|516930394|FG001|Overall Study|Lost to Follow-up|2|||
143378002|NCT00277355|516930393|FG000|Overall Study|Adverse Event|5|||
143378003|NCT00277355|516930394|FG001|Overall Study|Adverse Event|0|||
143378004|NCT00277355|516930393|FG000|Overall Study|Death|3|||
143378005|NCT00277355|516930394|FG001|Overall Study|Death|0|||
143378006|NCT00277355|516930393|FG000|Overall Study|Physician Decision|1|||
143378007|NCT00277355|516930394|FG001|Overall Study|Physician Decision|0|||
143378008|NCT02765100|516930395|FG000|Overall Study|subject found ineligible after baseline|1|||
143378009|NCT02765100|516930396|FG001|Overall Study|subject found ineligible after baseline|1|||
143378010|NCT02765100|516930395|FG000|Overall Study|Lost to Follow-up|0|||
143378011|NCT02765100|516930396|FG001|Overall Study|Lost to Follow-up|1|||
143378012|NCT02675244|516930399|FG000|Overall Study|Death|9|||
143378013|NCT02675244|516930400|FG001|Overall Study|Death|6|||
143378014|NCT02675244|516930399|FG000|Overall Study|Withdrawal by Subject|3|||
143378015|NCT02675244|516930400|FG001|Overall Study|Withdrawal by Subject|6|||
143378016|NCT02675244|516930399|FG000|Overall Study|Lost to Follow-up|1|||
143378017|NCT02675244|516930400|FG001|Overall Study|Lost to Follow-up|1|||
143378018|NCT02675244|516930399|FG000|Overall Study|Ongoing at 2 Years|190|||
143378019|NCT02675244|516930400|FG001|Overall Study|Ongoing at 2 Years|185|||
143378020|NCT00309907|516930402|FG000|Overall Study|Death|4|||
143378021|NCT00309907|516930402|FG000|Overall Study|Physician Decision|1|||
143378022|NCT00309907|516930402|FG000|Overall Study|Ineligible|11|||
143378023|NCT00309907|516930402|FG000|Overall Study|Major infectious event|4|||
143378024|NCT01075217|516930403|FG000|Overall Study|Adverse Event|1|||
143378025|NCT01075217|516930404|FG001|Overall Study|Adverse Event|1|||
143378026|NCT01075217|516930403|FG000|Overall Study|Physician Decision|1|||
143378027|NCT01075217|516930404|FG001|Overall Study|Physician Decision|0|||
143378028|NCT00293293|516930407|FG000|Overall Study|Withdrawal by Subject|1|||
143378029|NCT00293293|516930408|FG001|Overall Study|Withdrawal by Subject|1|||
143378030|NCT00293293|516930407|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
143378031|NCT00293293|516930408|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
143378032|NCT00293293|516930407|FG000|Overall Study|Patient discontinued chemotherapy|0|||
143378033|NCT00293293|516930408|FG001|Overall Study|Patient discontinued chemotherapy|1|||
143378034|NCT02512965|516930411|FG000|Overall Study|Withdrawal by Subject|0|||
143378035|NCT02512965|516930412|FG001|Overall Study|Withdrawal by Subject|4|||
143378036|NCT01185782|516930413|FG000|Overall Study|Adverse Event|0|||
143378037|NCT01185782|516930414|FG001|Overall Study|Adverse Event|1|||
143378038|NCT01185782|516930413|FG000|Overall Study|Protocol Violation|1|||
143378039|NCT01185782|516930414|FG001|Overall Study|Protocol Violation|0|||
143378040|NCT01185782|516930413|FG000|Overall Study|Poor Response to Treatment|3|||
143378041|NCT01185782|516930414|FG001|Overall Study|Poor Response to Treatment|1|||
143378042|NCT01185782|516930413|FG000|Overall Study|Other|2|||
143378043|NCT01185782|516930414|FG001|Overall Study|Other|5|||
143378044|NCT01185782|516930413|FG000|Overall Study|Randomized but not treated|0|||
143317762|NCT01600586|516709347|FG001|Overall Study|Physician Decision|3|||
143317763|NCT00965848|516709355|FG000|Overall Study|Protocol Violation|3|||
143317764|NCT00965848|516709356|FG001|Overall Study|Protocol Violation|0|||
143317765|NCT00965848|516709357|FG002|Overall Study|Protocol Violation|1|||
143317766|NCT00965848|516709355|FG000|Overall Study|Death|11|||
143317767|NCT00965848|516709356|FG001|Overall Study|Death|1|||
143317768|NCT00965848|516709357|FG002|Overall Study|Death|5|||
143317769|NCT00965848|516709355|FG000|Overall Study|Lost to Follow-up|0|||
143317770|NCT00965848|516709356|FG001|Overall Study|Lost to Follow-up|0|||
143317771|NCT00965848|516709357|FG002|Overall Study|Lost to Follow-up|1|||
143317772|NCT00965848|516709355|FG000|Overall Study|Withdrawal by Subject|1|||
143317773|NCT00965848|516709356|FG001|Overall Study|Withdrawal by Subject|0|||
143317774|NCT00965848|516709357|FG002|Overall Study|Withdrawal by Subject|0|||
143317775|NCT00965848|516709355|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
143317776|NCT00965848|516709356|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
143317777|NCT00965848|516709357|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
143317778|NCT00965848|516709355|FG000|Overall Study|Not Clinically Evaluable|7|||
143317779|NCT00965848|516709356|FG001|Overall Study|Not Clinically Evaluable|1|||
143317780|NCT00965848|516709357|FG002|Overall Study|Not Clinically Evaluable|1|||
143317781|NCT00965848|516709355|FG000|Overall Study|Other|5|||
143317782|NCT00965848|516709356|FG001|Overall Study|Other|0|||
143317783|NCT00965848|516709357|FG002|Overall Study|Other|1|||
143317784|NCT00813761|516709358|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
143317785|NCT00813761|516709359|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
143317786|NCT00813761|516709360|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
143317787|NCT00813761|516709361|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
143317788|NCT00813761|516709358|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
143317789|NCT00813761|516709359|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
143317790|NCT00813761|516709360|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
143317791|NCT00813761|516709361|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
143317792|NCT00813761|516709358|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
143317793|NCT00813761|516709359|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
143317794|NCT00813761|516709360|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
143317795|NCT00813761|516709361|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
143317796|NCT00813761|516709358|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
143317797|NCT00813761|516709359|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
143317798|NCT00813761|516709360|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
143317799|NCT00813761|516709361|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
143317800|NCT00813761|516709358|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
143317801|NCT00813761|516709359|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
143317802|NCT00813761|516709360|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
143317803|NCT00813761|516709361|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
143317804|NCT00813761|516709358|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
143317805|NCT00813761|516709359|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
143317806|NCT00813761|516709360|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
143317807|NCT00813761|516709361|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
143317808|NCT00813761|516709358|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
143317809|NCT00813761|516709359|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
143317810|NCT00813761|516709360|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
143317811|NCT00813761|516709361|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
143317812|NCT00813761|516709358|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
143317813|NCT00813761|516709359|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
143317814|NCT00813761|516709360|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
143317815|NCT00813761|516709361|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
143317816|NCT00813761|516709358|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
143317817|NCT00813761|516709359|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
143317818|NCT00813761|516709360|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
143317819|NCT00813761|516709361|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
143317820|NCT00813761|516709358|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
143317821|NCT00813761|516709359|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
143317822|NCT00813761|516709360|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
143378045|NCT01185782|516930414|FG001|Overall Study|Randomized but not treated|4|||
143378046|NCT01061151|516930416|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
143378047|NCT01061151|516930417|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
143378048|NCT01061151|516930418|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
143378049|NCT01061151|516930419|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
143378050|NCT01061151|516930416|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
143378051|NCT01061151|516930417|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
143378052|NCT01061151|516930418|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
143378053|NCT01061151|516930419|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
143378054|NCT01061151|516930416|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
143378055|NCT01061151|516930417|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
143378056|NCT01061151|516930418|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
143378057|NCT01061151|516930419|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
143378058|NCT01061151|516930416|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
143378059|NCT01061151|516930417|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
143378060|NCT01061151|516930418|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
143378061|NCT01061151|516930419|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
143378062|NCT01061151|516930416|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
143378063|NCT01061151|516930417|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
143378064|NCT01061151|516930418|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
143378065|NCT01061151|516930419|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
143378066|NCT01061151|516930416|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
143378067|NCT01061151|516930417|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
143378068|NCT01061151|516930418|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
143378069|NCT01061151|516930419|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
143378070|NCT01061151|516930416|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
143378071|NCT01061151|516930417|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
143378072|NCT01061151|516930418|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
143378073|NCT01061151|516930419|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
143378074|NCT01061151|516930416|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
143378075|NCT01061151|516930417|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
143378076|NCT01061151|516930418|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
143378077|NCT01061151|516930419|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
143378078|NCT01061151|516930416|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
143378079|NCT01061151|516930417|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
143378080|NCT01061151|516930418|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
143378081|NCT01061151|516930419|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
143378082|NCT01061151|516930416|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
143317823|NCT00813761|516709361|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
143317824|NCT00813761|516709358|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
143317825|NCT00813761|516709359|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
143317826|NCT00813761|516709360|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
143317827|NCT00813761|516709361|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
143317828|NCT00813761|516709358|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
143317829|NCT00813761|516709359|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
143317830|NCT00813761|516709360|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
143317831|NCT00813761|516709361|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
143317832|NCT00691210|516709362|FG000|Overall Study|Progression of Disease|0|||
143317833|NCT00691210|516709363|FG001|Overall Study|Progression of Disease|0|||
143317834|NCT00691210|516709364|FG002|Overall Study|Progression of Disease|0|||
143317835|NCT00691210|516709365|FG003|Overall Study|Progression of Disease|2|||
143317836|NCT00691210|516709366|FG004|Overall Study|Progression of Disease|0|||
143317837|NCT00691210|516709367|FG005|Overall Study|Progression of Disease|0|||
143317838|NCT00691210|516709368|FG006|Overall Study|Progression of Disease|0|||
143317839|NCT00691210|516709369|FG007|Overall Study|Progression of Disease|0|||
143317840|NCT00691210|516709362|FG000|Overall Study|Lack of Efficacy|0|||
143317841|NCT00691210|516709363|FG001|Overall Study|Lack of Efficacy|0|||
143317842|NCT00691210|516709364|FG002|Overall Study|Lack of Efficacy|0|||
143317843|NCT00691210|516709365|FG003|Overall Study|Lack of Efficacy|1|||
143317844|NCT00691210|516709366|FG004|Overall Study|Lack of Efficacy|0|||
143378083|NCT01061151|516930417|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
143378084|NCT01061151|516930418|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
143378085|NCT01061151|516930419|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
143378086|NCT01061151|516930416|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
143317845|NCT00691210|516709367|FG005|Overall Study|Lack of Efficacy|1|||
143317846|NCT00691210|516709368|FG006|Overall Study|Lack of Efficacy|0|||
143317847|NCT00691210|516709369|FG007|Overall Study|Lack of Efficacy|0|||
143317848|NCT01208233|516709371|FG000|Overall Study|Adverse Event|0|||
143378087|NCT01061151|516930417|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
143378088|NCT01061151|516930418|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
143378089|NCT01061151|516930419|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
143378090|NCT01061151|516930416|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
143378091|NCT01061151|516930417|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
143378092|NCT01061151|516930418|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
143378093|NCT01061151|516930419|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
143378094|NCT01061151|516930416|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
143378095|NCT01061151|516930417|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
143378096|NCT01061151|516930418|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
143378097|NCT01061151|516930419|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
143378098|NCT01061151|516930416|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
143378099|NCT01061151|516930417|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
143378100|NCT01061151|516930418|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
143378101|NCT01061151|516930419|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
143378102|NCT01061151|516930416|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
143378103|NCT01061151|516930417|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
143378104|NCT01061151|516930418|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
143378105|NCT01061151|516930419|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
143378106|NCT01792830|516930420|FG000|Overall Study|Withdrawal by Subject|22|||
143378107|NCT01792830|516930421|FG001|Overall Study|Withdrawal by Subject|0|||
143378108|NCT01792830|516930422|FG002|Overall Study|Withdrawal by Subject|0|||
143378109|NCT01792830|516930423|FG003|Overall Study|Withdrawal by Subject|2|||
143378110|NCT01792830|516930424|FG004|Overall Study|Withdrawal by Subject|1|||
143378111|NCT01792830|516930425|FG005|Overall Study|Withdrawal by Subject|1|||
143378112|NCT01792830|516930426|FG006|Overall Study|Withdrawal by Subject|1|||
143378113|NCT01792830|516930427|FG007|Overall Study|Withdrawal by Subject|1|||
143378114|NCT01792830|516930428|FG008|Overall Study|Withdrawal by Subject|7|||
143378115|NCT01792830|516930429|FG009|Overall Study|Withdrawal by Subject|0|||
143378116|NCT01792830|516930430|FG010|Overall Study|Withdrawal by Subject|2|||
143378117|NCT01792830|516930420|FG000|Overall Study|Death|3|||
143378118|NCT01792830|516930421|FG001|Overall Study|Death|0|||
143378119|NCT01792830|516930422|FG002|Overall Study|Death|0|||
143378120|NCT01792830|516930423|FG003|Overall Study|Death|1|||
143378121|NCT01792830|516930424|FG004|Overall Study|Death|0|||
143378122|NCT01792830|516930425|FG005|Overall Study|Death|0|||
143378123|NCT01792830|516930426|FG006|Overall Study|Death|1|||
143378124|NCT01792830|516930427|FG007|Overall Study|Death|0|||
143378125|NCT01792830|516930428|FG008|Overall Study|Death|1|||
143378126|NCT01792830|516930429|FG009|Overall Study|Death|0|||
143378127|NCT01792830|516930430|FG010|Overall Study|Death|1|||
143378128|NCT01792830|516930420|FG000|Overall Study|Adverse Event|0|||
143378129|NCT01792830|516930421|FG001|Overall Study|Adverse Event|0|||
143378130|NCT01792830|516930422|FG002|Overall Study|Adverse Event|0|||
143378131|NCT01792830|516930423|FG003|Overall Study|Adverse Event|0|||
143378132|NCT01792830|516930424|FG004|Overall Study|Adverse Event|0|||
143378133|NCT01792830|516930425|FG005|Overall Study|Adverse Event|0|||
143378134|NCT01792830|516930426|FG006|Overall Study|Adverse Event|0|||
143317849|NCT01208233|516709372|FG001|Overall Study|Adverse Event|1|||
143317850|NCT01208233|516709373|FG002|Overall Study|Adverse Event|2|||
143317851|NCT01208233|516709374|FG003|Overall Study|Adverse Event|0|||
143317852|NCT01208233|516709375|FG004|Overall Study|Adverse Event|3|||
143317853|NCT01208233|516709376|FG005|Overall Study|Adverse Event|5|||
143317854|NCT01208233|516709371|FG000|Overall Study|Death|0|||
143317855|NCT01208233|516709372|FG001|Overall Study|Death|0|||
143317856|NCT01208233|516709373|FG002|Overall Study|Death|0|||
143317857|NCT01208233|516709374|FG003|Overall Study|Death|0|||
143317858|NCT01208233|516709375|FG004|Overall Study|Death|3|||
143317859|NCT01208233|516709376|FG005|Overall Study|Death|5|||
143317860|NCT01208233|516709371|FG000|Overall Study|Did not meet entrance criteria|2|||
143317861|NCT01208233|516709372|FG001|Overall Study|Did not meet entrance criteria|1|||
143317862|NCT01208233|516709373|FG002|Overall Study|Did not meet entrance criteria|1|||
143317863|NCT01208233|516709374|FG003|Overall Study|Did not meet entrance criteria|0|||
143317864|NCT01208233|516709375|FG004|Overall Study|Did not meet entrance criteria|1|||
143317865|NCT01208233|516709376|FG005|Overall Study|Did not meet entrance criteria|0|||
143317866|NCT01208233|516709371|FG000|Overall Study|Medication error without adverse event|0|||
143317867|NCT01208233|516709372|FG001|Overall Study|Medication error without adverse event|0|||
143378135|NCT01792830|516930427|FG007|Overall Study|Adverse Event|0|||
143378136|NCT01792830|516930428|FG008|Overall Study|Adverse Event|1|||
143378137|NCT01792830|516930429|FG009|Overall Study|Adverse Event|0|||
143378138|NCT01792830|516930430|FG010|Overall Study|Adverse Event|0|||
143317868|NCT01208233|516709373|FG002|Overall Study|Medication error without adverse event|0|||
143317869|NCT01208233|516709374|FG003|Overall Study|Medication error without adverse event|0|||
143317870|NCT01208233|516709375|FG004|Overall Study|Medication error without adverse event|0|||
143317871|NCT01208233|516709376|FG005|Overall Study|Medication error without adverse event|1|||
143317872|NCT01208233|516709371|FG000|Overall Study|Study terminated by sponsor|0|||
143317873|NCT01208233|516709372|FG001|Overall Study|Study terminated by sponsor|0|||
143317874|NCT01208233|516709373|FG002|Overall Study|Study terminated by sponsor|0|||
143317875|NCT01208233|516709374|FG003|Overall Study|Study terminated by sponsor|0|||
143317876|NCT01208233|516709375|FG004|Overall Study|Study terminated by sponsor|10|||
143317877|NCT01208233|516709376|FG005|Overall Study|Study terminated by sponsor|7|||
143317878|NCT01208233|516709371|FG000|Overall Study|Protocol Violation|0|||
143317879|NCT01208233|516709372|FG001|Overall Study|Protocol Violation|0|||
143317880|NCT01208233|516709373|FG002|Overall Study|Protocol Violation|0|||
143317881|NCT01208233|516709374|FG003|Overall Study|Protocol Violation|0|||
143317882|NCT01208233|516709375|FG004|Overall Study|Protocol Violation|3|||
143317883|NCT01208233|516709376|FG005|Overall Study|Protocol Violation|0|||
143317884|NCT01208233|516709371|FG000|Overall Study|Other|2|||
143317885|NCT01208233|516709372|FG001|Overall Study|Other|1|||
143317886|NCT01208233|516709373|FG002|Overall Study|Other|0|||
143317887|NCT01208233|516709374|FG003|Overall Study|Other|0|||
143317888|NCT01208233|516709375|FG004|Overall Study|Other|0|||
143317889|NCT01208233|516709376|FG005|Overall Study|Other|1|||
143317890|NCT01208233|516709371|FG000|Overall Study|Withdrawal by Subject|1|||
143317891|NCT01208233|516709372|FG001|Overall Study|Withdrawal by Subject|0|||
143317892|NCT01208233|516709373|FG002|Overall Study|Withdrawal by Subject|1|||
143317893|NCT01208233|516709374|FG003|Overall Study|Withdrawal by Subject|1|||
143317894|NCT01208233|516709375|FG004|Overall Study|Withdrawal by Subject|4|||
143317895|NCT01208233|516709376|FG005|Overall Study|Withdrawal by Subject|2|||
143317896|NCT00983814|516709377|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
143317897|NCT00983814|516709378|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
143317898|NCT00983814|516709379|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
143317899|NCT00983814|516709377|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
143317900|NCT00983814|516709378|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
143317901|NCT00983814|516709379|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
143317902|NCT00983814|516709377|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
143317903|NCT00983814|516709378|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
143317904|NCT00983814|516709379|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
143317905|NCT00983814|516709377|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
143317906|NCT00983814|516709378|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
143317907|NCT00983814|516709379|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
143317908|NCT00983814|516709377|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
143317909|NCT00983814|516709378|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
143317910|NCT00983814|516709379|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
143317911|NCT01181895|516709382|FG000|Overall Study|Adverse Event|3|||
143317912|NCT01181895|516709383|FG001|Overall Study|Adverse Event|1|||
143317913|NCT01181895|516709384|FG002|Overall Study|Adverse Event|1|||
143317914|NCT01181895|516709382|FG000|Overall Study|Lack of Efficacy|8|||
143317915|NCT01181895|516709383|FG001|Overall Study|Lack of Efficacy|9|||
143317916|NCT01181895|516709384|FG002|Overall Study|Lack of Efficacy|9|||
143317917|NCT01181895|516709382|FG000|Overall Study|Protocol Violation|2|||
143317918|NCT01181895|516709383|FG001|Overall Study|Protocol Violation|1|||
143317919|NCT01181895|516709384|FG002|Overall Study|Protocol Violation|0|||
143317920|NCT01181895|516709382|FG000|Overall Study|Lost to Follow-up|0|||
143317921|NCT01181895|516709383|FG001|Overall Study|Lost to Follow-up|1|||
143317922|NCT01181895|516709384|FG002|Overall Study|Lost to Follow-up|2|||
143317923|NCT01181895|516709382|FG000|Overall Study|Investigator Discretion|1|||
143317924|NCT01181895|516709383|FG001|Overall Study|Investigator Discretion|2|||
143317925|NCT01181895|516709384|FG002|Overall Study|Investigator Discretion|1|||
143317926|NCT01181895|516709382|FG000|Overall Study|Withdrawal by Subject|3|||
143317927|NCT01181895|516709383|FG001|Overall Study|Withdrawal by Subject|0|||
143317928|NCT01181895|516709384|FG002|Overall Study|Withdrawal by Subject|5|||
143317929|NCT05789875|516709387|FG000|Overall Study|Lost to Follow-up|6|||
143317930|NCT01994395|516709388|FG000|Overall Study|Withdrawal by Subject|1|||
143317931|NCT01994395|516709389|FG001|Overall Study|Withdrawal by Subject|2|||
143317932|NCT02447991|516709392|FG000|Overall Study|Withdrawn by subject - no data|0|||
143317933|NCT02447991|516709393|FG001|Overall Study|Withdrawn by subject - no data|2|||
143317934|NCT02447991|516709392|FG000|Overall Study|Withdrawn by Subject - with data|4|||
143317935|NCT02447991|516709393|FG001|Overall Study|Withdrawn by Subject - with data|4|||
143378139|NCT01943799|516930446|FG000|Overall Study|Lost to Follow-up|0|||
143378140|NCT01943799|516930447|FG001|Overall Study|Lost to Follow-up|1|||
143317936|NCT02447991|516709392|FG000|Overall Study|Lost to Follow-up - no data|3|||
143317937|NCT02447991|516709393|FG001|Overall Study|Lost to Follow-up - no data|6|||
143317938|NCT02447991|516709392|FG000|Overall Study|Lost to follow-up - with data|0|||
143317939|NCT02447991|516709393|FG001|Overall Study|Lost to follow-up - with data|3|||
143317940|NCT02447991|516709392|FG000|Overall Study|End of study - no treatment results|3|||
143317941|NCT02447991|516709393|FG001|Overall Study|End of study - no treatment results|6|||
143378141|NCT01943799|516930448|FG002|Overall Study|Lost to Follow-up|1|||
143378142|NCT01943799|516930449|FG003|Overall Study|Lost to Follow-up|0|||
143378143|NCT01943799|516930446|FG000|Overall Study|Protocol Violation|1|||
143378144|NCT01943799|516930447|FG001|Overall Study|Protocol Violation|0|||
143378145|NCT01943799|516930448|FG002|Overall Study|Protocol Violation|0|||
143378146|NCT01943799|516930449|FG003|Overall Study|Protocol Violation|0|||
143378147|NCT01943799|516930446|FG000|Overall Study|Withdrawal by Subject|4|||
143378148|NCT01943799|516930447|FG001|Overall Study|Withdrawal by Subject|2|||
143378149|NCT01943799|516930448|FG002|Overall Study|Withdrawal by Subject|1|||
143378150|NCT01943799|516930449|FG003|Overall Study|Withdrawal by Subject|0|||
143378151|NCT05274217|516930450|FG000|Overall Study|Study terminated.|11|||
143378152|NCT05274217|516930451|FG001|Overall Study|Study terminated.|0|||
143378153|NCT04594759|516930452|FG000|Overall Study|Lost to Follow-up|3|||
143378154|NCT03811574|516930455|FG000|Overall Study|Withdrawal by Subject|2|||
143378155|NCT03811574|516930456|FG001|Overall Study|Withdrawal by Subject|4|||
143378156|NCT03811574|516930457|FG002|Overall Study|Withdrawal by Subject|0|||
143378157|NCT01832480|516930458|FG000|Overall Study|Lost to Follow-up|33|||
143378158|NCT01832480|516930459|FG001|Overall Study|Lost to Follow-up|30|||
143378159|NCT01832480|516930458|FG000|Overall Study|Withdrawal by Subject|0|||
143378160|NCT01832480|516930459|FG001|Overall Study|Withdrawal by Subject|2|||
143378161|NCT01832480|516930458|FG000|Overall Study|post randomization ineligible|8|||
143378162|NCT01832480|516930459|FG001|Overall Study|post randomization ineligible|10|||
143378163|NCT01373346|516930463|FG000|Overall Study|Death|1|||
143378164|NCT01198028|516930464|FG000|Overall Study|Adverse Event|5|||
143378165|NCT01198028|516930464|FG000|Overall Study|Death|3|||
143378166|NCT01198028|516930464|FG000|Overall Study|Physician Decision|2|||
143378167|NCT02528188|516930465|FG000|Overall Study|Adverse Event|23|||
143378168|NCT02528188|516930466|FG001|Overall Study|Adverse Event|22|||
143378169|NCT02528188|516930467|FG002|Overall Study|Adverse Event|8|||
143378170|NCT02528188|516930465|FG000|Overall Study|Protocol Violation|4|||
143378171|NCT02528188|516930466|FG001|Overall Study|Protocol Violation|6|||
143378172|NCT02528188|516930467|FG002|Overall Study|Protocol Violation|4|||
143378173|NCT02528188|516930465|FG000|Overall Study|Lack of Efficacy|19|||
143378174|NCT02528188|516930466|FG001|Overall Study|Lack of Efficacy|21|||
143378175|NCT02528188|516930467|FG002|Overall Study|Lack of Efficacy|22|||
143378176|NCT02528188|516930465|FG000|Overall Study|Withdrawal by Subject|97|||
143378177|NCT02528188|516930466|FG001|Overall Study|Withdrawal by Subject|104|||
143378178|NCT02528188|516930467|FG002|Overall Study|Withdrawal by Subject|100|||
143378179|NCT02528188|516930465|FG000|Overall Study|Lost to Follow-up|25|||
143378180|NCT02528188|516930466|FG001|Overall Study|Lost to Follow-up|21|||
143378181|NCT02528188|516930467|FG002|Overall Study|Lost to Follow-up|31|||
143378182|NCT02528188|516930465|FG000|Overall Study|Death|4|||
143378183|NCT02528188|516930466|FG001|Overall Study|Death|4|||
143378184|NCT02528188|516930467|FG002|Overall Study|Death|0|||
143378185|NCT02528188|516930465|FG000|Overall Study|Other|89|||
143378186|NCT02528188|516930466|FG001|Overall Study|Other|91|||
143378187|NCT02528188|516930467|FG002|Overall Study|Other|74|||
143378188|NCT02528188|516930465|FG000|Overall Study|Randomized but not treated|6|||
143378189|NCT02528188|516930466|FG001|Overall Study|Randomized but not treated|7|||
143378190|NCT02528188|516930467|FG002|Overall Study|Randomized but not treated|12|||
143378191|NCT00529659|516930468|FG000|Overall Study|Adverse Event|8|||
143378192|NCT00529659|516930469|FG001|Overall Study|Adverse Event|7|||
143378193|NCT00529659|516930468|FG000|Overall Study|Lost to Follow-up|0|||
143378194|NCT00529659|516930469|FG001|Overall Study|Lost to Follow-up|2|||
143378195|NCT00529659|516930468|FG000|Overall Study|Physician Decision|0|||
143378196|NCT00529659|516930469|FG001|Overall Study|Physician Decision|2|||
143378197|NCT00529659|516930468|FG000|Overall Study|Protocol Violation|2|||
143378198|NCT00529659|516930469|FG001|Overall Study|Protocol Violation|6|||
143378199|NCT00529659|516930468|FG000|Overall Study|Withdrawal by Subject|1|||
143378200|NCT00529659|516930469|FG001|Overall Study|Withdrawal by Subject|6|||
143378201|NCT03887650|516930471|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
143378202|NCT03887650|516930472|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
143378203|NCT03887650|516930471|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
143378204|NCT03887650|516930472|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
143378205|NCT03887650|516930471|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
143378206|NCT03887650|516930472|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
143378207|NCT01170962|516930473|FG000|Treatment Period|Lack of Efficacy|96|||
143378208|NCT01170962|516930474|FG001|Treatment Period|Lack of Efficacy|91|||
143378209|NCT01170962|516930475|FG002|Treatment Period|Lack of Efficacy|7|||
143378210|NCT01170962|516930473|FG000|Treatment Period|Adverse Event|11|||
143378211|NCT01170962|516930474|FG001|Treatment Period|Adverse Event|12|||
143378212|NCT01170962|516930475|FG002|Treatment Period|Adverse Event|3|||
143378213|NCT01170962|516930473|FG000|Treatment Period|Withdrawal by Subject|2|||
143378214|NCT01170962|516930474|FG001|Treatment Period|Withdrawal by Subject|1|||
143378215|NCT01170962|516930475|FG002|Treatment Period|Withdrawal by Subject|0|||
143378216|NCT01170962|516930473|FG000|Treatment Period|Lost to Follow-up|1|||
143378217|NCT01170962|516930474|FG001|Treatment Period|Lost to Follow-up|1|||
143378218|NCT01170962|516930475|FG002|Treatment Period|Lost to Follow-up|1|||
143378219|NCT01170962|516930473|FG000|Treatment Period|Participant no longer meets criteria|0|||
143378220|NCT01170962|516930474|FG001|Treatment Period|Participant no longer meets criteria|1|||
143378221|NCT01170962|516930475|FG002|Treatment Period|Participant no longer meets criteria|0|||
143378222|NCT01170962|516930473|FG000|Treatment Period|Request to discontinue treatment|7|||
143378223|NCT01170962|516930474|FG001|Treatment Period|Request to discontinue treatment|3|||
143378224|NCT01170962|516930475|FG002|Treatment Period|Request to discontinue treatment|1|||
143378225|NCT01170962|516930473|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
143378226|NCT01170962|516930474|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
143378227|NCT01170962|516930475|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
143378228|NCT01170962|516930473|FG000|Follow up Period|Withdrawal by Subject|14|||
143378229|NCT01170962|516930474|FG001|Follow up Period|Withdrawal by Subject|10|||
143378230|NCT01170962|516930475|FG002|Follow up Period|Withdrawal by Subject|2|||
143378231|NCT01170962|516930473|FG000|Follow up Period|Lost to Follow-up|13|||
143378232|NCT01170962|516930474|FG001|Follow up Period|Lost to Follow-up|8|||
143378233|NCT01170962|516930475|FG002|Follow up Period|Lost to Follow-up|1|||
143378234|NCT01170962|516930473|FG000|Follow up Period|Death|2|||
143378235|NCT01170962|516930474|FG001|Follow up Period|Death|2|||
143378236|NCT01170962|516930475|FG002|Follow up Period|Death|0|||
143378237|NCT01170962|516930473|FG000|Follow up Period|Others|10|||
143378238|NCT01170962|516930474|FG001|Follow up Period|Others|7|||
143317942|NCT02447991|516709392|FG000|Overall Study|End of study - partial treatment results|0|||
143317943|NCT02447991|516709393|FG001|Overall Study|End of study - partial treatment results|9|||
143317944|NCT03333486|516709396|FG000|Overall Study|Withdrawal by Subject|1|||
143317945|NCT03333486|516709396|FG000|Overall Study|Lost to Follow-up|1|||
143317946|NCT03246529|516709397|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
143317947|NCT03246529|516709398|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
143317948|NCT03246529|516709399|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
143317949|NCT03246529|516709397|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
143317950|NCT03246529|516709398|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
143317951|NCT03246529|516709399|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
143317952|NCT03246529|516709397|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
143317953|NCT03246529|516709398|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
143317954|NCT03246529|516709399|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
143317955|NCT03246529|516709397|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
143317956|NCT03246529|516709398|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
143317957|NCT03246529|516709399|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
143317958|NCT03246529|516709397|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
143317959|NCT03246529|516709398|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
143317960|NCT03246529|516709399|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
143317961|NCT03246529|516709397|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
143317962|NCT03246529|516709398|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
143317963|NCT03246529|516709399|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
143317964|NCT03246529|516709397|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
143317965|NCT03246529|516709398|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
143317966|NCT03246529|516709399|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
143317967|NCT03246529|516709397|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
143317968|NCT03246529|516709398|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
143317969|NCT03246529|516709399|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
143317970|NCT03246529|516709397|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
143317971|NCT03246529|516709398|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
143317972|NCT03246529|516709399|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
143317973|NCT03136068|516711117|FG000|Overall Study|Lost to Follow-up|1|||
143317974|NCT03136068|516711118|FG001|Overall Study|Lost to Follow-up|1|||
143317975|NCT03136068|516711117|FG000|Overall Study|Protocol Violation|1|||
143317976|NCT03136068|516711118|FG001|Overall Study|Protocol Violation|0|||
143317977|NCT00317772|516711123|FG000|Overall Study|Adverse Event|0|||
143317978|NCT00317772|516711124|FG001|Overall Study|Adverse Event|0|||
143317979|NCT00317772|516711125|FG002|Overall Study|Adverse Event|0|||
143317980|NCT00317772|516711126|FG003|Overall Study|Adverse Event|2|||
143317981|NCT00317772|516711123|FG000|Overall Study|Disease Progression|2|||
143378239|NCT01170962|516930475|FG002|Follow up Period|Others|3|||
143378240|NCT00704184|516930481|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
143378241|NCT00704184|516930482|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
143378242|NCT00704184|516930483|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
143378243|NCT00704184|516930484|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
143378244|NCT00704184|516930485|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
143378245|NCT00704184|516930481|FG000|Open-Label Treatment|Adverse Event|0|||
143378246|NCT00704184|516930482|FG001|Open-Label Treatment|Adverse Event|0|||
143378247|NCT00704184|516930483|FG002|Open-Label Treatment|Adverse Event|2|||
143378248|NCT00704184|516930484|FG003|Open-Label Treatment|Adverse Event|0|||
143317982|NCT00317772|516711124|FG001|Overall Study|Disease Progression|2|||
143317983|NCT00317772|516711125|FG002|Overall Study|Disease Progression|1|||
143317984|NCT00317772|516711126|FG003|Overall Study|Disease Progression|7|||
143317985|NCT03087591|516711127|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
143317986|NCT03087591|516711127|FG000|Overall Study|Withdrawal by Subject|1|||
143317987|NCT01073618|516711130|FG000|Overall Study|Death|208|||
143317988|NCT01073618|516711130|FG000|Overall Study|Adverse Event|19|||
143317989|NCT01073618|516711130|FG000|Overall Study|Other|80|||
143317990|NCT02696850|516711131|FG000|Overall Study|Withdrawal by Subject|3|||
143317991|NCT02696850|516711132|FG001|Overall Study|Withdrawal by Subject|3|||
143317992|NCT02696850|516711131|FG000|Overall Study|Lost to Follow-up|8|||
143317993|NCT02696850|516711132|FG001|Overall Study|Lost to Follow-up|5|||
143317994|NCT00673049|516711135|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
143317995|NCT00673049|516711136|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
143317996|NCT00673049|516711137|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
143317997|NCT00673049|516711138|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
143317998|NCT00673049|516711135|FG000|Before Progression on Erlotinib|Death|235|||
143317999|NCT00673049|516711136|FG001|Before Progression on Erlotinib|Death|167|||
143318000|NCT00673049|516711137|FG002|Before Progression on Erlotinib|Death|1|||
143318001|NCT00673049|516711138|FG003|Before Progression on Erlotinib|Death|0|||
143318002|NCT00673049|516711135|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
143318003|NCT00673049|516711136|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
143318004|NCT00673049|516711137|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
143318005|NCT00673049|516711138|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
143318006|NCT00673049|516711135|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
143318007|NCT00673049|516711136|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
143318008|NCT00673049|516711137|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
143318009|NCT00673049|516711138|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
143318010|NCT00673049|516711135|FG000|Before Progression on Erlotinib|Other|1|||
143318011|NCT00673049|516711136|FG001|Before Progression on Erlotinib|Other|2|||
143318012|NCT00673049|516711137|FG002|Before Progression on Erlotinib|Other|0|||
143318013|NCT00673049|516711138|FG003|Before Progression on Erlotinib|Other|0|||
143318014|NCT00673049|516711135|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
143318015|NCT00673049|516711136|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
143318016|NCT00673049|516711137|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
143318017|NCT00673049|516711138|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
143318018|NCT00673049|516711135|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
143318019|NCT00673049|516711136|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
143318020|NCT00673049|516711137|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
143318021|NCT00673049|516711138|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
143318022|NCT00673049|516711135|FG000|After Progression on Erlotinib|Death|0|||
143318023|NCT00673049|516711136|FG001|After Progression on Erlotinib|Death|0|||
143318024|NCT00673049|516711137|FG002|After Progression on Erlotinib|Death|0|||
143318025|NCT00673049|516711138|FG003|After Progression on Erlotinib|Death|71|||
143318026|NCT00673049|516711135|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
143318027|NCT00673049|516711136|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
143318028|NCT00673049|516711137|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
143318029|NCT00673049|516711138|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
143318030|NCT00673049|516711135|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
143318031|NCT00673049|516711136|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
143318032|NCT00673049|516711137|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
143318033|NCT00673049|516711138|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
143318034|NCT00673049|516711135|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
143318035|NCT00673049|516711136|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
143318036|NCT00673049|516711137|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
143318037|NCT00673049|516711138|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
143318038|NCT02621606|516711139|FG000|Overall Study|Withdrawal by Subject|0|||
143318039|NCT02621606|516711140|FG001|Overall Study|Withdrawal by Subject|1|||
143318040|NCT02621606|516711141|FG002|Overall Study|Withdrawal by Subject|0|||
143318041|NCT02044510|516711142|FG000|Overall Study|Adverse Event|1|||
143318042|NCT02044510|516711143|FG001|Overall Study|Adverse Event|2|||
143318043|NCT01175824|516711144|FG000|Overall Study|Adverse Event|2|||
143318044|NCT01175824|516711145|FG001|Overall Study|Adverse Event|1|||
143318045|NCT01175824|516711144|FG000|Overall Study|Lack of Efficacy|2|||
143318046|NCT01175824|516711145|FG001|Overall Study|Lack of Efficacy|0|||
143318047|NCT01175824|516711144|FG000|Overall Study|Lost to Follow-up|0|||
143318048|NCT01175824|516711145|FG001|Overall Study|Lost to Follow-up|1|||
143318049|NCT01175824|516711144|FG000|Overall Study|Physician Decision|0|||
143318050|NCT01175824|516711145|FG001|Overall Study|Physician Decision|4|||
143318051|NCT01175824|516711144|FG000|Overall Study|Protocol Violation|2|||
143318052|NCT01175824|516711145|FG001|Overall Study|Protocol Violation|5|||
143318053|NCT01175824|516711144|FG000|Overall Study|Withdrawal by Subject|3|||
143318054|NCT01175824|516711145|FG001|Overall Study|Withdrawal by Subject|7|||
143318055|NCT01175824|516711144|FG000|Overall Study|Sponsor Decision|1|||
143318056|NCT01175824|516711145|FG001|Overall Study|Sponsor Decision|0|||
143318057|NCT01175824|516711144|FG000|Overall Study|Entry Criteria Not Met|6|||
143318058|NCT01175824|516711145|FG001|Overall Study|Entry Criteria Not Met|4|||
143318059|NCT03455855|516711146|FG000|Overall Study|Lost to Follow-up|4|||
143318060|NCT03455855|516711147|FG001|Overall Study|Lost to Follow-up|2|||
143318061|NCT02979535|516711148|FG000|Overall Study|Non compliance with the protocol|78|||
143318062|NCT02979535|516711149|FG001|Overall Study|Non compliance with the protocol|82|||
143318063|NCT02979535|516711148|FG000|Overall Study|Consent withdrawn by participant|11|||
143318064|NCT02979535|516711149|FG001|Overall Study|Consent withdrawn by participant|18|||
143318065|NCT02979535|516711148|FG000|Overall Study|Lost to Follow-up|6|||
143318066|NCT02979535|516711149|FG001|Overall Study|Lost to Follow-up|1|||
143318067|NCT04820673|516711153|FG000|Overall Study|Adverse Event|6|||
143318068|NCT04820673|516711153|FG000|Overall Study|Due to Lack of Effectiveness|1|||
143318069|NCT04820673|516711153|FG000|Overall Study|Pregnancy|1|||
143318070|NCT04820673|516711153|FG000|Overall Study|Voluntary Withdrawal|20|||
143318071|NCT04820673|516711153|FG000|Overall Study|Lost to Follow-up|10|||
143318072|NCT00587587|516711154|FG000|Overall Study|Lost to Follow-up|6|||
143318073|NCT00587587|516711155|FG001|Overall Study|Lost to Follow-up|1|||
143318074|NCT00982319|516711164|FG000|Overall Study|Surgery date change|1|||
143318075|NCT00982319|516711165|FG001|Overall Study|Surgery date change|0|||
143318076|NCT00982319|516711164|FG000|Overall Study|Preop values out of acceptable range|1|||
143318077|NCT00982319|516711165|FG001|Overall Study|Preop values out of acceptable range|1|||
143318078|NCT00982319|516711164|FG000|Overall Study|Pregnancy|0|||
143318079|NCT00982319|516711165|FG001|Overall Study|Pregnancy|1|||
143318080|NCT01933334|516711166|FG000|Overall Study|Adverse Event|5|||
143318081|NCT01933334|516711167|FG001|Overall Study|Adverse Event|1|||
143318082|NCT01933334|516711166|FG000|Overall Study|Withdrawal by Subject|0|||
143318083|NCT01933334|516711167|FG001|Overall Study|Withdrawal by Subject|1|||
143318084|NCT00097591|516711169|FG000|Overall Study|Withdrawal of consent|342|||
143318085|NCT00097591|516711170|FG001|Overall Study|Withdrawal of consent|323|||
143318086|NCT00097591|516711169|FG000|Overall Study|Less than 6 months on study drug|9|||
143318087|NCT00097591|516711170|FG001|Overall Study|Less than 6 months on study drug|7|||
143318088|NCT00097591|516711169|FG000|Overall Study|Unable to attend termination visit|53|||
143318089|NCT00097591|516711170|FG001|Overall Study|Unable to attend termination visit|51|||
143318090|NCT00097591|516711169|FG000|Overall Study|Lost to follow up|6|||
143318091|NCT00097591|516711170|FG001|Overall Study|Lost to follow up|10|||
143318092|NCT00097591|516711169|FG000|Overall Study|Other|0|||
143318093|NCT00097591|516711170|FG001|Overall Study|Other|3|||
143318094|NCT01168999|516711175|FG000|Overall Study|Lost to Follow-up|2|||
143318095|NCT01168999|516711176|FG001|Overall Study|Lost to Follow-up|1|||
143318096|NCT01168999|516711177|FG002|Overall Study|Lost to Follow-up|0|||
143318097|NCT01168999|516711178|FG003|Overall Study|Lost to Follow-up|0|||
143318098|NCT01276327|516711179|FG000|Overall Study|Adverse Event|1|||
143318099|NCT01276327|516711180|FG001|Overall Study|Adverse Event|3|||
143318100|NCT01276327|516711179|FG000|Overall Study|Withdrawal by Subject|1|||
143318101|NCT01276327|516711180|FG001|Overall Study|Withdrawal by Subject|0|||
143318102|NCT03003676|516711181|FG000|Overall Study|Lack of Efficacy|5|||
143318103|NCT03003676|516711182|FG001|Overall Study|Lack of Efficacy|7|||
143318104|NCT03003676|516711181|FG000|Overall Study|Withdrawal by Subject|0|||
143318105|NCT03003676|516711182|FG001|Overall Study|Withdrawal by Subject|1|||
143318106|NCT03003676|516711181|FG000|Overall Study|Hepatitis B infection|1|||
143318107|NCT03003676|516711182|FG001|Overall Study|Hepatitis B infection|0|||
143318108|NCT03766646|516711185|FG000|Overall Study|Withdrawal by Subject|1|||
143318109|NCT03766646|516711186|FG001|Overall Study|Withdrawal by Subject|0|||
143318110|NCT03766646|516711185|FG000|Overall Study|Protocol Violation|0|||
143318111|NCT03766646|516711186|FG001|Overall Study|Protocol Violation|3|||
143318112|NCT00009737|516711189|FG000|Overall Study|Adverse Event|112|||
143318113|NCT00009737|516711190|FG001|Overall Study|Adverse Event|75|||
143318114|NCT00009737|516711189|FG000|Overall Study|Death|4|||
143318115|NCT00009737|516711190|FG001|Overall Study|Death|6|||
143318116|NCT00009737|516711189|FG000|Overall Study|Lack of Efficacy|17|||
143318117|NCT00009737|516711190|FG001|Overall Study|Lack of Efficacy|15|||
143318118|NCT00009737|516711189|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
143318119|NCT00009737|516711190|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
143318120|NCT00009737|516711189|FG000|Overall Study|Other Protocol Violation|1|||
143318121|NCT00009737|516711190|FG001|Overall Study|Other Protocol Violation|0|||
143318122|NCT00009737|516711189|FG000|Overall Study|Refused Treatment|15|||
143318123|NCT00009737|516711190|FG001|Overall Study|Refused Treatment|16|||
143318124|NCT00009737|516711189|FG000|Overall Study|Lost to Follow-up|1|||
143318125|NCT00009737|516711190|FG001|Overall Study|Lost to Follow-up|1|||
143318126|NCT00009737|516711189|FG000|Overall Study|Administrative/Other Reasons|7|||
143378249|NCT00704184|516930485|FG004|Open-Label Treatment|Adverse Event|1|||
143378250|NCT00704184|516930481|FG000|Open-Label Treatment|Lack of Efficacy|0|||
143378251|NCT00704184|516930482|FG001|Open-Label Treatment|Lack of Efficacy|2|||
143378252|NCT00704184|516930483|FG002|Open-Label Treatment|Lack of Efficacy|2|||
143378253|NCT00704184|516930484|FG003|Open-Label Treatment|Lack of Efficacy|2|||
143378254|NCT00704184|516930485|FG004|Open-Label Treatment|Lack of Efficacy|1|||
143378255|NCT00704184|516930481|FG000|Open-Label Treatment|Physician Decision|0|||
143378256|NCT00704184|516930482|FG001|Open-Label Treatment|Physician Decision|0|||
143378257|NCT00704184|516930483|FG002|Open-Label Treatment|Physician Decision|0|||
143378258|NCT00704184|516930484|FG003|Open-Label Treatment|Physician Decision|0|||
143378259|NCT00704184|516930485|FG004|Open-Label Treatment|Physician Decision|1|||
143378260|NCT00704184|516930481|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
143378261|NCT00704184|516930482|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
143378262|NCT00704184|516930483|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
143378263|NCT00704184|516930484|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
143378264|NCT00704184|516930485|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
143378265|NCT00716859|516930486|FG000|Overall Study|Adverse Event|4|||
143378266|NCT00716859|516930487|FG001|Overall Study|Adverse Event|1|||
143378267|NCT00716859|516930486|FG000|Overall Study|Lack of Efficacy|3|||
143378268|NCT00716859|516930487|FG001|Overall Study|Lack of Efficacy|0|||
143378269|NCT00716859|516930486|FG000|Overall Study|Withdrawal by Subject|1|||
143378270|NCT00716859|516930487|FG001|Overall Study|Withdrawal by Subject|3|||
143378271|NCT00716859|516930486|FG000|Overall Study|Not treated|1|||
143378272|NCT00716859|516930487|FG001|Overall Study|Not treated|1|||
143378273|NCT02918071|516930488|FG000|Overall Study|Withdrawal by Subject|2|||
143378274|NCT02918071|516930488|FG000|Overall Study|Lost to Follow-up|1|||
143378275|NCT01616459|516930490|FG000|Overall Study|Adverse Event|1|||
143378276|NCT01616459|516930491|FG001|Overall Study|Adverse Event|1|||
143378277|NCT01616459|516930492|FG002|Overall Study|Adverse Event|2|||
143378278|NCT01616459|516930493|FG003|Overall Study|Adverse Event|0|||
143378279|NCT01616459|516930490|FG000|Overall Study|Lost to Follow-up|1|||
143378280|NCT01616459|516930491|FG001|Overall Study|Lost to Follow-up|11|||
143378281|NCT01616459|516930492|FG002|Overall Study|Lost to Follow-up|3|||
143378282|NCT01616459|516930493|FG003|Overall Study|Lost to Follow-up|2|||
143378283|NCT01616459|516930490|FG000|Overall Study|Protocol Violation|0|||
143378284|NCT01616459|516930491|FG001|Overall Study|Protocol Violation|0|||
143378285|NCT01616459|516930492|FG002|Overall Study|Protocol Violation|0|||
143378286|NCT01616459|516930493|FG003|Overall Study|Protocol Violation|2|||
143378287|NCT01616459|516930490|FG000|Overall Study|Withdrawal by Subject|2|||
143378288|NCT01616459|516930491|FG001|Overall Study|Withdrawal by Subject|4|||
143378289|NCT01616459|516930492|FG002|Overall Study|Withdrawal by Subject|4|||
143378290|NCT01616459|516930493|FG003|Overall Study|Withdrawal by Subject|4|||
143378291|NCT01616459|516930490|FG000|Overall Study|Other reason|0|||
143378292|NCT01616459|516930491|FG001|Overall Study|Other reason|1|||
143378293|NCT01616459|516930492|FG002|Overall Study|Other reason|1|||
143378294|NCT01616459|516930493|FG003|Overall Study|Other reason|0|||
143378295|NCT03394885|516930494|FG000|Overall Study|Adverse Event|4|||
143378296|NCT03394885|516930494|FG000|Overall Study|Lack of Efficacy|1|||
143378297|NCT03394885|516930494|FG000|Overall Study|Physician Decision|1|||
143378298|NCT03394885|516930494|FG000|Overall Study|Withdrawal by Subject|8|||
143378299|NCT03394885|516930494|FG000|Overall Study|Alternative Therapy|1|||
143378300|NCT00801983|516930495|FG000|Period 1|Lost to Follow-up|2|||
143378301|NCT00801983|516930496|FG001|Period 1|Lost to Follow-up|0|||
143378302|NCT00801983|516930495|FG000|Period 1|Withdrawal by Subject|2|||
143378303|NCT00801983|516930496|FG001|Period 1|Withdrawal by Subject|8|||
143378304|NCT00801983|516930495|FG000|Period 2|Withdrawal by Subject|2|||
143378305|NCT00801983|516930496|FG001|Period 2|Withdrawal by Subject|1|||
143378306|NCT04425629|516932416|FG000|Overall Study|Adverse Event|0|||
143378307|NCT04425629|516932417|FG001|Overall Study|Adverse Event|0|||
143378308|NCT04425629|516932418|FG002|Overall Study|Adverse Event|0|||
143378309|NCT04425629|516932419|FG003|Overall Study|Adverse Event|0|||
143378310|NCT04425629|516932420|FG004|Overall Study|Adverse Event|1|||
143378311|NCT04425629|516932421|FG005|Overall Study|Adverse Event|0|||
143378312|NCT04425629|516932422|FG006|Overall Study|Adverse Event|0|||
143378313|NCT04425629|516932423|FG007|Overall Study|Adverse Event|0|||
143378314|NCT04425629|516932424|FG008|Overall Study|Adverse Event|0|||
143378315|NCT04425629|516932425|FG009|Overall Study|Adverse Event|3|||
143378316|NCT04425629|516932426|FG010|Overall Study|Adverse Event|2|||
143378317|NCT04425629|516932427|FG011|Overall Study|Adverse Event|1|||
143378318|NCT04425629|516932428|FG012|Overall Study|Adverse Event|1|||
143378319|NCT04425629|516932429|FG013|Overall Study|Adverse Event|0|||
143378320|NCT04425629|516932430|FG014|Overall Study|Adverse Event|0|||
143378321|NCT04425629|516932431|FG015|Overall Study|Adverse Event|0|||
143378322|NCT04425629|516932432|FG016|Overall Study|Adverse Event|0|||
143378323|NCT04425629|516932433|FG017|Overall Study|Adverse Event|0|||
143378324|NCT04425629|516932434|FG018|Overall Study|Adverse Event|0|||
143378325|NCT04425629|516932416|FG000|Overall Study|Lost to Follow-up|1|||
143318127|NCT00009737|516711190|FG001|Overall Study|Administrative/Other Reasons|1|||
143318128|NCT01172938|516711192|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
143318129|NCT01172938|516711193|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
143318130|NCT01172938|516711194|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
143318131|NCT01172938|516711195|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
143318132|NCT01172938|516711196|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
143318133|NCT01172938|516711197|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
143318134|NCT01172938|516711198|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
143318135|NCT01172938|516711199|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
143318136|NCT01172938|516711200|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
143318137|NCT01172938|516711192|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
143318138|NCT01172938|516711193|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
143318139|NCT01172938|516711194|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
143318140|NCT01172938|516711195|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
143318141|NCT01172938|516711196|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
143318142|NCT01172938|516711197|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
143318143|NCT01172938|516711198|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
143318144|NCT01172938|516711199|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
143318145|NCT01172938|516711200|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
143318146|NCT01172938|516711192|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
143318147|NCT01172938|516711193|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
143318148|NCT01172938|516711194|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
143318149|NCT01172938|516711195|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
143318150|NCT01172938|516711196|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
143318151|NCT01172938|516711197|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
143318152|NCT01172938|516711198|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
143318153|NCT01172938|516711199|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
143318154|NCT01172938|516711200|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
143318155|NCT01172938|516711192|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
143318156|NCT01172938|516711193|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
143318157|NCT01172938|516711194|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
143318158|NCT01172938|516711195|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
143318159|NCT01172938|516711196|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
143318160|NCT01172938|516711197|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
143318161|NCT01172938|516711198|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
143318162|NCT01172938|516711199|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
143318163|NCT01172938|516711200|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
143318164|NCT01172938|516711192|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
143318165|NCT01172938|516711193|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
143318166|NCT01172938|516711194|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
143318167|NCT01172938|516711195|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
143318168|NCT01172938|516711196|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
143318169|NCT01172938|516711197|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
143318170|NCT01172938|516711198|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
143318171|NCT01172938|516711199|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
143318172|NCT01172938|516711200|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
143318173|NCT01172938|516711192|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
143318174|NCT01172938|516711193|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
143318175|NCT01172938|516711194|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
143318176|NCT01172938|516711195|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
143318177|NCT01172938|516711196|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
143318178|NCT01172938|516711197|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
143318179|NCT01172938|516711198|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
143318180|NCT01172938|516711199|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
143318181|NCT01172938|516711200|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
143318182|NCT01172938|516711192|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
143318183|NCT01172938|516711193|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
143318184|NCT01172938|516711194|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
143318185|NCT01172938|516711195|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
143318186|NCT01172938|516711196|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
143318187|NCT01172938|516711197|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
143318188|NCT01172938|516711198|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
143318189|NCT01172938|516711199|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
143318190|NCT01172938|516711200|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
143318191|NCT01172938|516711192|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
143318192|NCT01172938|516711193|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
143318193|NCT01172938|516711194|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
143318194|NCT01172938|516711195|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
143318195|NCT01172938|516711196|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
143318196|NCT01172938|516711197|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
143318197|NCT01172938|516711198|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
143318198|NCT01172938|516711199|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
143318199|NCT01172938|516711200|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
143318200|NCT01172938|516711192|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
143318201|NCT01172938|516711193|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
143318202|NCT01172938|516711194|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
143318203|NCT01172938|516711195|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
143318204|NCT01172938|516711196|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
143318205|NCT01172938|516711197|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
143318206|NCT01172938|516711198|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
143318207|NCT01172938|516711199|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
143318208|NCT01172938|516711200|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
143318209|NCT01172938|516711192|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
143318210|NCT01172938|516711193|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
143318211|NCT01172938|516711194|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
143318212|NCT01172938|516711195|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
143318213|NCT01172938|516711196|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
143318214|NCT01172938|516711197|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
143318215|NCT01172938|516711198|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
143318216|NCT01172938|516711199|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
143318217|NCT01172938|516711200|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
143318218|NCT01172938|516711192|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
143318219|NCT01172938|516711193|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
143318220|NCT01172938|516711194|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
143318221|NCT01172938|516711195|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
143318222|NCT01172938|516711196|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
143318223|NCT01172938|516711197|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
143318224|NCT01172938|516711198|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
143318225|NCT01172938|516711199|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
143318226|NCT01172938|516711200|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
143318227|NCT01172938|516711192|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
143318228|NCT01172938|516711193|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
143318229|NCT01172938|516711194|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
143318230|NCT01172938|516711195|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
143318231|NCT01172938|516711196|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
143318232|NCT01172938|516711197|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
143318233|NCT01172938|516711198|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
143318234|NCT01172938|516711199|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
143318235|NCT01172938|516711200|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
143318236|NCT01172938|516711192|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
143318237|NCT01172938|516711193|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
143318238|NCT01172938|516711194|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
143318239|NCT01172938|516711195|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
143318240|NCT01172938|516711196|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
143318241|NCT01172938|516711197|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
143318242|NCT01172938|516711198|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
143318243|NCT01172938|516711199|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
143318244|NCT01172938|516711200|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
143318245|NCT01172938|516711192|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
143318246|NCT01172938|516711193|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
143318247|NCT01172938|516711194|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
143318248|NCT01172938|516711195|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
143318249|NCT01172938|516711196|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
143318250|NCT01172938|516711197|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
143318251|NCT01172938|516711198|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
143318252|NCT01172938|516711199|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
143318253|NCT01172938|516711200|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
143318254|NCT01172938|516711192|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
143378326|NCT04425629|516932417|FG001|Overall Study|Lost to Follow-up|3|||
143378327|NCT04425629|516932418|FG002|Overall Study|Lost to Follow-up|1|||
143378328|NCT04425629|516932419|FG003|Overall Study|Lost to Follow-up|7|||
143378329|NCT04425629|516932420|FG004|Overall Study|Lost to Follow-up|1|||
143378330|NCT04425629|516932421|FG005|Overall Study|Lost to Follow-up|2|||
143378331|NCT04425629|516932422|FG006|Overall Study|Lost to Follow-up|1|||
143378332|NCT04425629|516932423|FG007|Overall Study|Lost to Follow-up|0|||
143378333|NCT04425629|516932424|FG008|Overall Study|Lost to Follow-up|1|||
143378334|NCT04425629|516932425|FG009|Overall Study|Lost to Follow-up|64|||
143378335|NCT04425629|516932426|FG010|Overall Study|Lost to Follow-up|70|||
143378336|NCT04425629|516932427|FG011|Overall Study|Lost to Follow-up|98|||
143378337|NCT04425629|516932428|FG012|Overall Study|Lost to Follow-up|30|||
143378338|NCT04425629|516932429|FG013|Overall Study|Lost to Follow-up|0|||
143378339|NCT04425629|516932430|FG014|Overall Study|Lost to Follow-up|5|||
143378340|NCT04425629|516932431|FG015|Overall Study|Lost to Follow-up|4|||
143378341|NCT04425629|516932432|FG016|Overall Study|Lost to Follow-up|0|||
143378342|NCT04425629|516932433|FG017|Overall Study|Lost to Follow-up|3|||
143378343|NCT04425629|516932434|FG018|Overall Study|Lost to Follow-up|1|||
143378344|NCT04425629|516932416|FG000|Overall Study|Subject Decision|0|||
143378345|NCT04425629|516932417|FG001|Overall Study|Subject Decision|2|||
143378346|NCT04425629|516932418|FG002|Overall Study|Subject Decision|1|||
143378347|NCT04425629|516932419|FG003|Overall Study|Subject Decision|3|||
143378348|NCT04425629|516932420|FG004|Overall Study|Subject Decision|6|||
143378349|NCT04425629|516932421|FG005|Overall Study|Subject Decision|6|||
143378350|NCT04425629|516932422|FG006|Overall Study|Subject Decision|3|||
143378351|NCT04425629|516932423|FG007|Overall Study|Subject Decision|3|||
143318255|NCT01172938|516711193|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
143318256|NCT01172938|516711194|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
143318257|NCT01172938|516711195|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
143318258|NCT01172938|516711196|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
143318259|NCT01172938|516711197|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
143318260|NCT01172938|516711198|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
143318261|NCT01172938|516711199|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
143318262|NCT01172938|516711200|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
143318263|NCT01172938|516711192|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
143318264|NCT01172938|516711193|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
143318265|NCT01172938|516711194|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
143318266|NCT01172938|516711195|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
143318267|NCT01172938|516711196|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
143318268|NCT01172938|516711197|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
143378352|NCT04425629|516932424|FG008|Overall Study|Subject Decision|1|||
143378353|NCT04425629|516932425|FG009|Overall Study|Subject Decision|70|||
143378354|NCT04425629|516932426|FG010|Overall Study|Subject Decision|95|||
143378355|NCT04425629|516932427|FG011|Overall Study|Subject Decision|124|||
143378356|NCT04425629|516932428|FG012|Overall Study|Subject Decision|25|||
143378357|NCT04425629|516932429|FG013|Overall Study|Subject Decision|0|||
143378358|NCT04425629|516932430|FG014|Overall Study|Subject Decision|1|||
143378359|NCT04425629|516932431|FG015|Overall Study|Subject Decision|4|||
143378360|NCT04425629|516932432|FG016|Overall Study|Subject Decision|1|||
143378361|NCT04425629|516932433|FG017|Overall Study|Subject Decision|0|||
143378362|NCT04425629|516932434|FG018|Overall Study|Subject Decision|2|||
143378363|NCT04425629|516932416|FG000|Overall Study|Death|0|||
143378364|NCT04425629|516932417|FG001|Overall Study|Death|0|||
143378365|NCT04425629|516932418|FG002|Overall Study|Death|0|||
143378366|NCT04425629|516932419|FG003|Overall Study|Death|0|||
143378367|NCT04425629|516932420|FG004|Overall Study|Death|0|||
143378368|NCT04425629|516932421|FG005|Overall Study|Death|0|||
143378369|NCT04425629|516932422|FG006|Overall Study|Death|0|||
143378370|NCT04425629|516932423|FG007|Overall Study|Death|0|||
143378371|NCT04425629|516932424|FG008|Overall Study|Death|0|||
143378372|NCT04425629|516932425|FG009|Overall Study|Death|11|||
143378373|NCT04425629|516932426|FG010|Overall Study|Death|2|||
143378374|NCT04425629|516932427|FG011|Overall Study|Death|4|||
143378375|NCT04425629|516932428|FG012|Overall Study|Death|0|||
143378376|NCT04425629|516932429|FG013|Overall Study|Death|0|||
143378377|NCT04425629|516932430|FG014|Overall Study|Death|0|||
143378378|NCT04425629|516932431|FG015|Overall Study|Death|0|||
143378379|NCT04425629|516932432|FG016|Overall Study|Death|0|||
143378380|NCT04425629|516932433|FG017|Overall Study|Death|0|||
143378381|NCT04425629|516932434|FG018|Overall Study|Death|0|||
143378382|NCT04425629|516932416|FG000|Overall Study|Sponsor Request|0|||
143378383|NCT04425629|516932417|FG001|Overall Study|Sponsor Request|0|||
143378384|NCT04425629|516932418|FG002|Overall Study|Sponsor Request|0|||
143378385|NCT04425629|516932419|FG003|Overall Study|Sponsor Request|2|||
143378386|NCT04425629|516932420|FG004|Overall Study|Sponsor Request|2|||
143378387|NCT04425629|516932421|FG005|Overall Study|Sponsor Request|2|||
143378388|NCT04425629|516932422|FG006|Overall Study|Sponsor Request|1|||
143318269|NCT01172938|516711198|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
143318270|NCT01172938|516711199|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
143318271|NCT01172938|516711200|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
143318272|NCT01172938|516711192|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
143318273|NCT01172938|516711193|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
143318274|NCT01172938|516711194|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
143318275|NCT01172938|516711195|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
143318276|NCT01172938|516711196|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
143318277|NCT01172938|516711197|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
143318278|NCT01172938|516711198|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
143318279|NCT01172938|516711199|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
143318280|NCT01172938|516711200|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
143318281|NCT01172938|516711192|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
143318282|NCT01172938|516711193|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
143318283|NCT01172938|516711194|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
143318284|NCT01172938|516711195|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
143318285|NCT01172938|516711196|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
143318286|NCT01172938|516711197|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
143318287|NCT01172938|516711198|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
143318288|NCT01172938|516711199|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
143318289|NCT01172938|516711200|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
143318290|NCT01172938|516711192|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
143318291|NCT01172938|516711193|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
143318292|NCT01172938|516711194|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
143318293|NCT01172938|516711195|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
143318294|NCT01172938|516711196|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
143318295|NCT01172938|516711197|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
143318296|NCT01172938|516711198|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
143318297|NCT01172938|516711199|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
143318298|NCT01172938|516711200|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
143318299|NCT01172938|516711192|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
143318300|NCT01172938|516711193|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
143318301|NCT01172938|516711194|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
143318302|NCT01172938|516711195|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
143318303|NCT01172938|516711196|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
143318304|NCT01172938|516711197|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
143318305|NCT01172938|516711198|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
143318306|NCT01172938|516711199|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
143318307|NCT01172938|516711200|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
143318308|NCT01172938|516711192|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
143318309|NCT01172938|516711193|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
143318310|NCT01172938|516711194|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
143318311|NCT01172938|516711195|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
143318312|NCT01172938|516711196|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
143318313|NCT01172938|516711197|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
143318314|NCT01172938|516711198|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
143318315|NCT01172938|516711199|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
143318316|NCT01172938|516711200|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
143318317|NCT01172938|516711192|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
143318318|NCT01172938|516711193|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
143318319|NCT01172938|516711194|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
143318320|NCT01172938|516711195|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
143318321|NCT01172938|516711196|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
143318322|NCT01172938|516711197|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
143318323|NCT01172938|516711198|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
143318324|NCT01172938|516711199|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
143318325|NCT01172938|516711200|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
143318326|NCT01172938|516711192|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
143318327|NCT01172938|516711193|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
143318328|NCT01172938|516711194|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
143318329|NCT01172938|516711195|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
143318330|NCT01172938|516711196|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
143318331|NCT01172938|516711197|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
143318332|NCT01172938|516711198|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
143318333|NCT01172938|516711199|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
143318334|NCT01172938|516711200|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
143318335|NCT01172938|516711192|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
143318336|NCT01172938|516711193|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
143318337|NCT01172938|516711194|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
143318338|NCT01172938|516711195|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
143318339|NCT01172938|516711196|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
143318340|NCT01172938|516711197|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
143318341|NCT01172938|516711198|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
143318342|NCT01172938|516711199|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
143318343|NCT01172938|516711200|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
143318344|NCT01172938|516711192|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
143318345|NCT01172938|516711193|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
143318346|NCT01172938|516711194|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
143318347|NCT01172938|516711195|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
143318348|NCT01172938|516711196|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
143318349|NCT01172938|516711197|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
143318350|NCT01172938|516711198|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
143318351|NCT01172938|516711199|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
143318352|NCT01172938|516711200|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
143318353|NCT01172938|516711192|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
143318354|NCT01172938|516711193|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
143318355|NCT01172938|516711194|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
143318356|NCT01172938|516711195|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
143318357|NCT01172938|516711196|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
143318358|NCT01172938|516711197|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
143318359|NCT01172938|516711198|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
143318360|NCT01172938|516711199|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
143318361|NCT01172938|516711200|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
143318362|NCT01172938|516711192|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
143318363|NCT01172938|516711193|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
143318364|NCT01172938|516711194|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
143318365|NCT01172938|516711195|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
143318366|NCT01172938|516711196|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
143318367|NCT01172938|516711197|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
143318368|NCT01172938|516711198|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
143318369|NCT01172938|516711199|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
143318370|NCT01172938|516711200|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
143318371|NCT01172938|516711192|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
143318372|NCT01172938|516711193|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
143318373|NCT01172938|516711194|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
143318374|NCT01172938|516711195|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
143318375|NCT01172938|516711196|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
143318376|NCT01172938|516711197|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
143318377|NCT01172938|516711198|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
143318378|NCT01172938|516711199|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
143318379|NCT01172938|516711200|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
143318380|NCT01172938|516711192|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
143318381|NCT01172938|516711193|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
143318382|NCT01172938|516711194|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
143318383|NCT01172938|516711195|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
143318384|NCT01172938|516711196|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
143318385|NCT01172938|516711197|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
143318386|NCT01172938|516711198|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
143318387|NCT01172938|516711199|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
143318388|NCT01172938|516711200|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
143318389|NCT01172938|516711192|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
143318390|NCT01172938|516711193|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
143318391|NCT01172938|516711194|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
143318392|NCT01172938|516711195|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
143318393|NCT01172938|516711196|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
143318394|NCT01172938|516711197|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
143318395|NCT01172938|516711198|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
143318396|NCT01172938|516711199|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
143318397|NCT01172938|516711200|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
143318398|NCT01172938|516711192|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
143378389|NCT04425629|516932423|FG007|Overall Study|Sponsor Request|0|||
143378390|NCT04425629|516932424|FG008|Overall Study|Sponsor Request|0|||
143378391|NCT04425629|516932425|FG009|Overall Study|Sponsor Request|9|||
143378392|NCT04425629|516932426|FG010|Overall Study|Sponsor Request|9|||
143378393|NCT04425629|516932427|FG011|Overall Study|Sponsor Request|10|||
143378394|NCT04425629|516932428|FG012|Overall Study|Sponsor Request|8|||
143378395|NCT04425629|516932429|FG013|Overall Study|Sponsor Request|0|||
143378396|NCT04425629|516932430|FG014|Overall Study|Sponsor Request|0|||
143378397|NCT04425629|516932431|FG015|Overall Study|Sponsor Request|1|||
143378398|NCT04425629|516932432|FG016|Overall Study|Sponsor Request|0|||
143378399|NCT04425629|516932433|FG017|Overall Study|Sponsor Request|0|||
143378400|NCT04425629|516932434|FG018|Overall Study|Sponsor Request|0|||
143378401|NCT04425629|516932416|FG000|Overall Study|Physician Decision|0|||
143378402|NCT04425629|516932417|FG001|Overall Study|Physician Decision|0|||
143378403|NCT04425629|516932418|FG002|Overall Study|Physician Decision|0|||
143378404|NCT04425629|516932419|FG003|Overall Study|Physician Decision|0|||
143378405|NCT04425629|516932420|FG004|Overall Study|Physician Decision|0|||
143378406|NCT04425629|516932421|FG005|Overall Study|Physician Decision|0|||
143378407|NCT04425629|516932422|FG006|Overall Study|Physician Decision|0|||
143378408|NCT04425629|516932423|FG007|Overall Study|Physician Decision|0|||
143378409|NCT04425629|516932424|FG008|Overall Study|Physician Decision|0|||
143378410|NCT04425629|516932425|FG009|Overall Study|Physician Decision|4|||
143378411|NCT04425629|516932426|FG010|Overall Study|Physician Decision|3|||
143378412|NCT04425629|516932427|FG011|Overall Study|Physician Decision|5|||
143378413|NCT04425629|516932428|FG012|Overall Study|Physician Decision|1|||
143378414|NCT04425629|516932429|FG013|Overall Study|Physician Decision|0|||
143378415|NCT04425629|516932430|FG014|Overall Study|Physician Decision|0|||
143378416|NCT04425629|516932431|FG015|Overall Study|Physician Decision|1|||
143378417|NCT04425629|516932432|FG016|Overall Study|Physician Decision|0|||
143378418|NCT04425629|516932433|FG017|Overall Study|Physician Decision|0|||
143378419|NCT04425629|516932434|FG018|Overall Study|Physician Decision|0|||
143378420|NCT04425629|516932416|FG000|Overall Study|Lack of Efficacy|0|||
143378421|NCT04425629|516932417|FG001|Overall Study|Lack of Efficacy|0|||
143378422|NCT04425629|516932418|FG002|Overall Study|Lack of Efficacy|0|||
143378423|NCT04425629|516932419|FG003|Overall Study|Lack of Efficacy|0|||
143378424|NCT04425629|516932420|FG004|Overall Study|Lack of Efficacy|0|||
143378425|NCT04425629|516932421|FG005|Overall Study|Lack of Efficacy|0|||
143378426|NCT04425629|516932422|FG006|Overall Study|Lack of Efficacy|0|||
143378427|NCT04425629|516932423|FG007|Overall Study|Lack of Efficacy|0|||
143378428|NCT04425629|516932424|FG008|Overall Study|Lack of Efficacy|0|||
143378429|NCT04425629|516932425|FG009|Overall Study|Lack of Efficacy|0|||
143378430|NCT04425629|516932426|FG010|Overall Study|Lack of Efficacy|1|||
143378431|NCT04425629|516932427|FG011|Overall Study|Lack of Efficacy|0|||
143378432|NCT04425629|516932428|FG012|Overall Study|Lack of Efficacy|0|||
143378433|NCT04425629|516932429|FG013|Overall Study|Lack of Efficacy|0|||
143378434|NCT04425629|516932430|FG014|Overall Study|Lack of Efficacy|0|||
143378435|NCT04425629|516932431|FG015|Overall Study|Lack of Efficacy|0|||
143378436|NCT04425629|516932432|FG016|Overall Study|Lack of Efficacy|0|||
143378437|NCT04425629|516932433|FG017|Overall Study|Lack of Efficacy|0|||
143378438|NCT04425629|516932434|FG018|Overall Study|Lack of Efficacy|0|||
143378439|NCT02767765|516932437|FG000|Overall Study|Adverse Event|4|||
143378440|NCT02767765|516932437|FG000|Overall Study|Death|1|||
143378441|NCT02767765|516932437|FG000|Overall Study|Insufficient response|1|||
143378442|NCT02767765|516932437|FG000|Overall Study|Lost to Follow-up|2|||
143378443|NCT02767765|516932437|FG000|Overall Study|Investigator decision|1|||
143378444|NCT02767765|516932437|FG000|Overall Study|Non-Compliance|1|||
143378445|NCT02767765|516932437|FG000|Overall Study|Withdrawal by Subject|1|||
143378446|NCT01951170|516932438|FG000|Overall Study|Investigator decision|1|||
143378447|NCT00446459|516932441|FG000|8 Months|Protocol Violation|12|||
143378448|NCT00446459|516932441|FG000|12 Months|Protocol Violation|4|||
143378449|NCT00446459|516932441|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
143378450|NCT04425863|516932442|FG000|Overall Study|Death|0|||
143378451|NCT04425863|516932443|FG001|Overall Study|Death|0|||
143378452|NCT04425863|516932444|FG002|Overall Study|Death|1|||
143378453|NCT02652442|516932445|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
143378454|NCT00835770|516932446|FG000|Overall Study|MS Relapse|17|||
143378455|NCT00835770|516932447|FG001|Overall Study|MS Relapse|23|||
143378456|NCT00835770|516932446|FG000|Overall Study|MS Progression|14|||
143378457|NCT00835770|516932447|FG001|Overall Study|MS Progression|9|||
143378458|NCT00835770|516932446|FG000|Overall Study|Adverse Event|113|||
143378459|NCT00835770|516932447|FG001|Overall Study|Adverse Event|124|||
143378460|NCT00835770|516932446|FG000|Overall Study|Lost to Follow-up|22|||
143378461|NCT00835770|516932447|FG001|Overall Study|Lost to Follow-up|19|||
143378462|NCT00835770|516932446|FG000|Overall Study|Consent Withdrawn|144|||
143378463|NCT00835770|516932447|FG001|Overall Study|Consent Withdrawn|156|||
143378464|NCT00835770|516932446|FG000|Overall Study|Investigator Decision|42|||
143378465|NCT00835770|516932447|FG001|Overall Study|Investigator Decision|42|||
143378466|NCT00835770|516932446|FG000|Overall Study|Participant Non-Compliance|11|||
143378467|NCT00835770|516932447|FG001|Overall Study|Participant Non-Compliance|9|||
143378468|NCT00835770|516932446|FG000|Overall Study|Death|4|||
143378469|NCT00835770|516932447|FG001|Overall Study|Death|6|||
143378470|NCT00835770|516932446|FG000|Overall Study|Other|115|||
143378471|NCT00835770|516932447|FG001|Overall Study|Other|104|||
143378472|NCT00835770|516932446|FG000|Overall Study|Other|2|||
143378473|NCT00835770|516932447|FG001|Overall Study|Other|1|||
143378474|NCT03740009|516932448|FG000|Overall Study|Physician Decision|9|||
143378475|NCT03740009|516932448|FG000|Overall Study|Lost to Follow-up|1|||
143378476|NCT02988817|516932449|FG000|Overall Study|Withdrawal by Subject|1|||
143378477|NCT02988817|516932450|FG001|Overall Study|Withdrawal by Subject|0|||
143318399|NCT01172938|516711193|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
143318400|NCT01172938|516711194|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
143318401|NCT01172938|516711195|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
143318402|NCT01172938|516711196|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
143318403|NCT01172938|516711197|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
143318404|NCT01172938|516711198|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
143318405|NCT01172938|516711199|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
143318406|NCT01172938|516711200|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
143318407|NCT01172938|516711192|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
143318408|NCT01172938|516711193|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
143318409|NCT01172938|516711194|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
143318410|NCT01172938|516711195|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
143378478|NCT02988817|516932451|FG002|Overall Study|Withdrawal by Subject|0|||
143378479|NCT02988817|516932452|FG003|Overall Study|Withdrawal by Subject|1|||
143378480|NCT02988817|516932453|FG004|Overall Study|Withdrawal by Subject|3|||
143378481|NCT02988817|516932454|FG005|Overall Study|Withdrawal by Subject|1|||
143378482|NCT02988817|516932455|FG006|Overall Study|Withdrawal by Subject|2|||
143378483|NCT02988817|516932456|FG007|Overall Study|Withdrawal by Subject|1|||
143378484|NCT02988817|516932457|FG008|Overall Study|Withdrawal by Subject|1|||
143378485|NCT02988817|516932458|FG009|Overall Study|Withdrawal by Subject|1|||
143378486|NCT02988817|516932459|FG010|Overall Study|Withdrawal by Subject|1|||
143318411|NCT01172938|516711196|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
143318412|NCT01172938|516711197|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
143318413|NCT01172938|516711198|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
143318414|NCT01172938|516711199|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
143318415|NCT01172938|516711200|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
143318416|NCT01172938|516711192|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
143318417|NCT01172938|516711193|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
143318418|NCT01172938|516711194|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
143318419|NCT01172938|516711195|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
143318420|NCT01172938|516711196|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
143318421|NCT01172938|516711197|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
143318422|NCT01172938|516711198|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
143318423|NCT01172938|516711199|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
143318424|NCT01172938|516711200|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
143318425|NCT01172938|516711192|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
143318426|NCT01172938|516711193|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
143318427|NCT01172938|516711194|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
143318428|NCT01172938|516711195|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
143318429|NCT01172938|516711196|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
143318430|NCT01172938|516711197|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
143318431|NCT01172938|516711198|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
143318432|NCT01172938|516711199|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
143318433|NCT01172938|516711200|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
143378487|NCT02988817|516932460|FG011|Overall Study|Withdrawal by Subject|12|||
143378488|NCT02988817|516932461|FG012|Overall Study|Withdrawal by Subject|6|||
143378489|NCT02988817|516932462|FG013|Overall Study|Withdrawal by Subject|6|||
143378490|NCT02988817|516932463|FG014|Overall Study|Withdrawal by Subject|4|||
143378491|NCT02988817|516932464|FG015|Overall Study|Withdrawal by Subject|5|||
143378492|NCT02988817|516932465|FG016|Overall Study|Withdrawal by Subject|4|||
143378493|NCT02988817|516932466|FG017|Overall Study|Withdrawal by Subject|11|||
143378494|NCT02988817|516932467|FG018|Overall Study|Withdrawal by Subject|4|||
143378495|NCT02988817|516932468|FG019|Overall Study|Withdrawal by Subject|2|||
143378496|NCT02988817|516932449|FG000|Overall Study|Death|0|||
143378497|NCT02988817|516932450|FG001|Overall Study|Death|1|||
143378498|NCT02988817|516932451|FG002|Overall Study|Death|3|||
143378499|NCT02988817|516932452|FG003|Overall Study|Death|1|||
143378500|NCT02988817|516932453|FG004|Overall Study|Death|6|||
143378501|NCT02988817|516932454|FG005|Overall Study|Death|10|||
143378502|NCT02988817|516932455|FG006|Overall Study|Death|1|||
143378503|NCT02988817|516932456|FG007|Overall Study|Death|2|||
143378504|NCT02988817|516932457|FG008|Overall Study|Death|1|||
143378505|NCT02988817|516932458|FG009|Overall Study|Death|5|||
143378506|NCT02988817|516932459|FG010|Overall Study|Death|1|||
143378507|NCT02988817|516932460|FG011|Overall Study|Death|8|||
143378508|NCT02988817|516932461|FG012|Overall Study|Death|9|||
143378509|NCT02988817|516932462|FG013|Overall Study|Death|17|||
143378510|NCT02988817|516932463|FG014|Overall Study|Death|18|||
143378511|NCT02988817|516932464|FG015|Overall Study|Death|30|||
143378512|NCT02988817|516932465|FG016|Overall Study|Death|17|||
143378513|NCT02988817|516932466|FG017|Overall Study|Death|38|||
143378514|NCT02988817|516932467|FG018|Overall Study|Death|14|||
143378515|NCT02988817|516932468|FG019|Overall Study|Death|16|||
143378516|NCT02988817|516932449|FG000|Overall Study|Other|0|||
143378517|NCT02988817|516932450|FG001|Overall Study|Other|0|||
143378518|NCT02988817|516932451|FG002|Overall Study|Other|0|||
143378519|NCT02988817|516932452|FG003|Overall Study|Other|1|||
143378520|NCT02988817|516932453|FG004|Overall Study|Other|1|||
143378521|NCT02988817|516932454|FG005|Overall Study|Other|0|||
143378522|NCT02988817|516932455|FG006|Overall Study|Other|0|||
143378523|NCT02988817|516932456|FG007|Overall Study|Other|0|||
143378524|NCT02988817|516932457|FG008|Overall Study|Other|0|||
143378525|NCT02988817|516932458|FG009|Overall Study|Other|0|||
143378526|NCT02988817|516932459|FG010|Overall Study|Other|0|||
143378527|NCT02988817|516932460|FG011|Overall Study|Other|0|||
143378528|NCT02988817|516932461|FG012|Overall Study|Other|0|||
143378529|NCT02988817|516932462|FG013|Overall Study|Other|0|||
143378530|NCT02988817|516932463|FG014|Overall Study|Other|0|||
143378531|NCT02988817|516932464|FG015|Overall Study|Other|1|||
143378532|NCT02988817|516932465|FG016|Overall Study|Other|0|||
143378533|NCT02988817|516932466|FG017|Overall Study|Other|0|||
143378534|NCT02988817|516932467|FG018|Overall Study|Other|0|||
143378535|NCT02988817|516932468|FG019|Overall Study|Other|0|||
143378536|NCT02988817|516932449|FG000|Overall Study|Lost to Follow-up|0|||
143378537|NCT02988817|516932450|FG001|Overall Study|Lost to Follow-up|0|||
143378538|NCT02988817|516932451|FG002|Overall Study|Lost to Follow-up|0|||
143378539|NCT02988817|516932452|FG003|Overall Study|Lost to Follow-up|0|||
143378540|NCT02988817|516932453|FG004|Overall Study|Lost to Follow-up|0|||
143378541|NCT02988817|516932454|FG005|Overall Study|Lost to Follow-up|0|||
143378542|NCT02988817|516932455|FG006|Overall Study|Lost to Follow-up|0|||
143378543|NCT02988817|516932456|FG007|Overall Study|Lost to Follow-up|0|||
143378544|NCT02988817|516932457|FG008|Overall Study|Lost to Follow-up|1|||
143378545|NCT02988817|516932458|FG009|Overall Study|Lost to Follow-up|0|||
143378546|NCT02988817|516932459|FG010|Overall Study|Lost to Follow-up|1|||
143378547|NCT02988817|516932460|FG011|Overall Study|Lost to Follow-up|1|||
143378548|NCT02988817|516932461|FG012|Overall Study|Lost to Follow-up|0|||
143378549|NCT02988817|516932462|FG013|Overall Study|Lost to Follow-up|0|||
143378550|NCT02988817|516932463|FG014|Overall Study|Lost to Follow-up|1|||
143378551|NCT02988817|516932464|FG015|Overall Study|Lost to Follow-up|1|||
143378552|NCT02988817|516932465|FG016|Overall Study|Lost to Follow-up|2|||
143378553|NCT02988817|516932466|FG017|Overall Study|Lost to Follow-up|3|||
143378554|NCT02988817|516932467|FG018|Overall Study|Lost to Follow-up|0|||
143378555|NCT02988817|516932468|FG019|Overall Study|Lost to Follow-up|0|||
143378556|NCT02988817|516932449|FG000|Overall Study|Sponsor decision|0|||
143378557|NCT02988817|516932450|FG001|Overall Study|Sponsor decision|0|||
143378558|NCT02988817|516932451|FG002|Overall Study|Sponsor decision|0|||
143378559|NCT02988817|516932452|FG003|Overall Study|Sponsor decision|0|||
143378560|NCT02988817|516932453|FG004|Overall Study|Sponsor decision|0|||
143378561|NCT02988817|516932454|FG005|Overall Study|Sponsor decision|0|||
143378562|NCT02988817|516932455|FG006|Overall Study|Sponsor decision|0|||
143378563|NCT02988817|516932456|FG007|Overall Study|Sponsor decision|0|||
143378564|NCT02988817|516932457|FG008|Overall Study|Sponsor decision|0|||
143378565|NCT02988817|516932458|FG009|Overall Study|Sponsor decision|0|||
143378566|NCT02988817|516932459|FG010|Overall Study|Sponsor decision|0|||
143378567|NCT02988817|516932460|FG011|Overall Study|Sponsor decision|1|||
143378568|NCT02988817|516932461|FG012|Overall Study|Sponsor decision|1|||
143378569|NCT02988817|516932462|FG013|Overall Study|Sponsor decision|2|||
143378570|NCT02988817|516932463|FG014|Overall Study|Sponsor decision|2|||
143378571|NCT02988817|516932464|FG015|Overall Study|Sponsor decision|6|||
143378572|NCT02988817|516932465|FG016|Overall Study|Sponsor decision|2|||
143378573|NCT02988817|516932466|FG017|Overall Study|Sponsor decision|3|||
143378574|NCT02988817|516932467|FG018|Overall Study|Sponsor decision|2|||
143378575|NCT02988817|516932468|FG019|Overall Study|Sponsor decision|7|||
143378576|NCT02988817|516932449|FG000|Overall Study|Physician Decision|0|||
143378577|NCT02988817|516932450|FG001|Overall Study|Physician Decision|0|||
143378578|NCT02988817|516932451|FG002|Overall Study|Physician Decision|0|||
143378579|NCT02988817|516932452|FG003|Overall Study|Physician Decision|0|||
143378580|NCT02988817|516932453|FG004|Overall Study|Physician Decision|0|||
143378581|NCT02988817|516932454|FG005|Overall Study|Physician Decision|0|||
143378582|NCT02988817|516932455|FG006|Overall Study|Physician Decision|0|||
143378583|NCT02988817|516932456|FG007|Overall Study|Physician Decision|0|||
143378584|NCT02988817|516932457|FG008|Overall Study|Physician Decision|0|||
143378585|NCT02988817|516932458|FG009|Overall Study|Physician Decision|0|||
143378586|NCT02988817|516932459|FG010|Overall Study|Physician Decision|0|||
143378587|NCT02988817|516932460|FG011|Overall Study|Physician Decision|0|||
143378588|NCT02988817|516932461|FG012|Overall Study|Physician Decision|0|||
143378589|NCT02988817|516932462|FG013|Overall Study|Physician Decision|0|||
143378590|NCT02988817|516932463|FG014|Overall Study|Physician Decision|0|||
143378591|NCT02988817|516932464|FG015|Overall Study|Physician Decision|1|||
143378592|NCT02988817|516932465|FG016|Overall Study|Physician Decision|0|||
143378593|NCT02988817|516932466|FG017|Overall Study|Physician Decision|0|||
143378594|NCT02988817|516932467|FG018|Overall Study|Physician Decision|1|||
143378595|NCT02988817|516932468|FG019|Overall Study|Physician Decision|1|||
143378596|NCT05082935|516932475|FG000|Overall Study|Lost to Follow-up|549|||
143378597|NCT05082935|516932476|FG001|Overall Study|Lost to Follow-up|631|||
143378598|NCT05082935|516932475|FG000|Overall Study|Withdrawal by Subject|27|||
143378599|NCT05082935|516932476|FG001|Overall Study|Withdrawal by Subject|58|||
143378600|NCT04530747|516932481|FG000|Overall Study|Withdrawal by Subject|1|||
143378601|NCT04530747|516932482|FG001|Overall Study|Withdrawal by Subject|0|||
143378602|NCT03292913|516932483|FG000|Overall Study|Death|9|||
143378603|NCT03292913|516932484|FG001|Overall Study|Death|3|||
143378604|NCT03292913|516932483|FG000|Overall Study|Lost to Follow-up|49|||
143378605|NCT03292913|516932484|FG001|Overall Study|Lost to Follow-up|49|||
143378606|NCT03292913|516932483|FG000|Overall Study|Withdrawal by Subject|2|||
143378607|NCT03292913|516932484|FG001|Overall Study|Withdrawal by Subject|0|||
143378608|NCT03292913|516932483|FG000|Overall Study|Clinic closed due to COVID|22|||
143378609|NCT03292913|516932484|FG001|Overall Study|Clinic closed due to COVID|36|||
143378610|NCT02379819|516932485|FG000|Overall Study|Withdrawal by Subject|10|||
143378611|NCT02379819|516932485|FG000|Overall Study|Death|2|||
143378612|NCT02379819|516932485|FG000|Overall Study|Lack of Efficacy|1|||
143378613|NCT02379819|516932485|FG000|Overall Study|Lost to Follow-up|1|||
143378614|NCT03950622|516932486|FG000|Overall Study|Withdrawal by Subject|1|||
143378615|NCT03950622|516932487|FG001|Overall Study|Withdrawal by Subject|0|||
143378616|NCT03950622|516932486|FG000|Overall Study|Protocol Deviation|0|||
143378617|NCT03950622|516932487|FG001|Overall Study|Protocol Deviation|1|||
143378618|NCT03950622|516932486|FG000|Overall Study|Physician Decision|1|||
143378619|NCT03950622|516932487|FG001|Overall Study|Physician Decision|0|||
143378620|NCT03950622|516932486|FG000|Overall Study|Lost to Follow-up|5|||
143378621|NCT03950622|516932487|FG001|Overall Study|Lost to Follow-up|5|||
143378622|NCT03950622|516932486|FG000|Overall Study|Death|1|||
143378623|NCT03950622|516932487|FG001|Overall Study|Death|1|||
143378624|NCT01839331|516932488|FG000|Overall Study|Early Termination|3|||
143378625|NCT01839331|516932489|FG001|Overall Study|Early Termination|0|||
143378626|NCT01839331|516932490|FG002|Overall Study|Early Termination|1|||
143378627|NCT01839331|516932491|FG003|Overall Study|Early Termination|2|||
143378628|NCT01839331|516932488|FG000|Overall Study|Protocol Violation|1|||
143378629|NCT01839331|516932489|FG001|Overall Study|Protocol Violation|6|||
143378630|NCT01839331|516932490|FG002|Overall Study|Protocol Violation|4|||
143378631|NCT01839331|516932491|FG003|Overall Study|Protocol Violation|3|||
143378632|NCT03752151|516932492|FG000|Overall Study|Withdrawal by Subject|1|||
143378633|NCT03752151|516932492|FG000|Overall Study|Protocol Violation|1|||
143378634|NCT04056624|516932493|FG000|Overall Study|Withdrawal by Subject|0|||
143378635|NCT04056624|516932494|FG001|Overall Study|Withdrawal by Subject|0|||
143378636|NCT04056624|516932495|FG002|Overall Study|Withdrawal by Subject|1|||
143378637|NCT04056624|516932493|FG000|Overall Study|Protocol Violation|1|||
143378638|NCT04056624|516932494|FG001|Overall Study|Protocol Violation|2|||
143378639|NCT04056624|516932495|FG002|Overall Study|Protocol Violation|0|||
143378640|NCT03531840|516932501|FG000|Overall Study|Death on study|3|||
143378641|NCT03531840|516932502|FG001|Overall Study|Death on study|2|||
143378642|NCT03531840|516932503|FG002|Overall Study|Death on study|1|||
143378643|NCT03531840|516932504|FG003|Overall Study|Death on study|2|||
143378644|NCT03531840|516932501|FG000|Overall Study|Death during follow up|2|||
143378645|NCT03531840|516932502|FG001|Overall Study|Death during follow up|3|||
143378646|NCT03531840|516932503|FG002|Overall Study|Death during follow up|4|||
143378647|NCT03531840|516932504|FG003|Overall Study|Death during follow up|1|||
143378648|NCT02092116|516932505|FG000|Overall Study|Withdrawal by Subject|0|||
143378649|NCT02092116|516932506|FG001|Overall Study|Withdrawal by Subject|3|||
143378650|NCT02092116|516932505|FG000|Overall Study|Adverse Event|0|||
143378651|NCT02092116|516932506|FG001|Overall Study|Adverse Event|1|||
143378652|NCT02267824|516932508|FG000|Overall Study|Pregnancy|1|||
143378653|NCT02267824|516932509|FG001|Overall Study|Pregnancy|1|||
143378654|NCT02267824|516932508|FG000|Overall Study|Lost to Follow-up|4|||
143378655|NCT02267824|516932509|FG001|Overall Study|Lost to Follow-up|0|||
143378656|NCT02267824|516932508|FG000|Overall Study|Protocol Violation|3|||
143378657|NCT02267824|516932509|FG001|Overall Study|Protocol Violation|0|||
143378658|NCT02267824|516932508|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
143378659|NCT02267824|516932509|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
143378660|NCT03074331|516932510|FG000|Overall Study|Enrolled but Not Treated|1|||
143378661|NCT03074331|516932510|FG000|Overall Study|Lost to Follow-up|5|||
143378662|NCT03074331|516932510|FG000|Overall Study|Withdrew Consent|1|||
143378663|NCT00350792|516932512|FG000|Overall Study|Adverse Event|11|||
143378664|NCT00350792|516932512|FG000|Overall Study|Death from Study Disease|1|||
143378665|NCT00350792|516932512|FG000|Overall Study|Death from Study Drug Toxicity|1|||
143378666|NCT00350792|516932512|FG000|Overall Study|Death Not Study Drug Related|2|||
143378667|NCT00350792|516932512|FG000|Overall Study|Protocol Violation|1|||
143378668|NCT00350792|516932512|FG000|Overall Study|Withdrawal by Subject|4|||
143378669|NCT00350792|516932512|FG000|Overall Study|Physician Decision|2|||
143378670|NCT00350792|516932512|FG000|Overall Study|Lack of Efficacy|11|||
143378671|NCT01546753|516932513|FG000|Overall Study|anxiety|1|||
143378672|NCT01546753|516932514|FG001|Overall Study|anxiety|1|||
143378673|NCT01546753|516932513|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
143378674|NCT01546753|516932514|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
143378675|NCT00546754|516932515|FG000|Overall Study|Serious Adverse Event|1|||
143378676|NCT00546754|516932516|FG001|Overall Study|Serious Adverse Event|1|||
143318434|NCT01172938|516711192|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
143318435|NCT01172938|516711193|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
143318436|NCT01172938|516711194|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
143318437|NCT01172938|516711195|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
143318438|NCT01172938|516711196|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
143318439|NCT01172938|516711197|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
143318440|NCT01172938|516711198|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
143318441|NCT01172938|516711199|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
143318442|NCT01172938|516711200|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
143318443|NCT01172938|516711192|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
143318444|NCT01172938|516711193|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
143318445|NCT01172938|516711194|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
143318446|NCT01172938|516711195|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
143318447|NCT01172938|516711196|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
143318448|NCT01172938|516711197|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
143318449|NCT01172938|516711198|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
143318450|NCT01172938|516711199|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
143318451|NCT01172938|516711200|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
143318452|NCT01172938|516711192|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
143318453|NCT01172938|516711193|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
143318454|NCT01172938|516711194|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
143318455|NCT01172938|516711195|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
143318456|NCT01172938|516711196|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
143318457|NCT01172938|516711197|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
143318458|NCT01172938|516711198|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
143318459|NCT01172938|516711199|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
143318460|NCT01172938|516711200|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
143318461|NCT01172938|516711192|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
143318462|NCT01172938|516711193|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
143318463|NCT01172938|516711194|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
143318464|NCT01172938|516711195|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
143318465|NCT01172938|516711196|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
143318466|NCT01172938|516711197|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
143318467|NCT01172938|516711198|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
143318468|NCT01172938|516711199|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
143318469|NCT01172938|516711200|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
143318470|NCT01172938|516711192|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
143318471|NCT01172938|516711193|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
143318472|NCT01172938|516711194|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
143318473|NCT01172938|516711195|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
143318474|NCT01172938|516711196|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
143318475|NCT01172938|516711197|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
143318476|NCT01172938|516711198|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
143318477|NCT01172938|516711199|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
143318478|NCT01172938|516711200|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
143318479|NCT05282004|516711205|FG000|Overall Study|Adverse Event|2|||
143318480|NCT04808609|516711206|FG000|Overall Study|Lost to Follow-up|0|||
143318481|NCT04808609|516711207|FG001|Overall Study|Lost to Follow-up|2|||
143378677|NCT00546754|516932515|FG000|Overall Study|Adverse Event|11|||
143378678|NCT00546754|516932516|FG001|Overall Study|Adverse Event|16|||
143378679|NCT00546754|516932515|FG000|Overall Study|Lack of Efficacy|1|||
143378680|NCT00546754|516932516|FG001|Overall Study|Lack of Efficacy|1|||
143378681|NCT00546754|516932515|FG000|Overall Study|Lost to Follow-up|9|||
143378682|NCT00546754|516932516|FG001|Overall Study|Lost to Follow-up|15|||
143378683|NCT00546754|516932515|FG000|Overall Study|Protocol Violation|3|||
143378684|NCT00546754|516932516|FG001|Overall Study|Protocol Violation|0|||
143378685|NCT00546754|516932515|FG000|Overall Study|Withdrawal by Subject|6|||
143318482|NCT04808609|516711206|FG000|Overall Study|Administrative Withdrawal|0|||
143318483|NCT04808609|516711207|FG001|Overall Study|Administrative Withdrawal|1|||
143318484|NCT01993719|516711208|FG000|First Drug Administration|Not treated|1|||
143318485|NCT01993719|516711209|FG001|First Drug Administration|Not treated|0|||
143318486|NCT01993719|516711210|FG002|First Drug Administration|Not treated|0|||
143318487|NCT01993719|516711211|FG003|First Drug Administration|Not treated|0|||
143318488|NCT01993719|516711212|FG004|First Drug Administration|Not treated|0|||
143318489|NCT04713748|516711217|FG000|Overall Study|Not enough kits allocated|35|||
143318490|NCT02461589|516711218|FG000|Overall Study|Withdrawal by Subject|5|||
143318491|NCT02461589|516711219|FG001|Overall Study|Withdrawal by Subject|1|||
143318492|NCT02461589|516711220|FG002|Overall Study|Withdrawal by Subject|3|||
143318493|NCT02461589|516711221|FG003|Overall Study|Withdrawal by Subject|2|||
143318494|NCT02461589|516711222|FG004|Overall Study|Withdrawal by Subject|1|||
143318495|NCT02461589|516711223|FG005|Overall Study|Withdrawal by Subject|2|||
143318496|NCT02461589|516711224|FG006|Overall Study|Withdrawal by Subject|1|||
143318497|NCT02461589|516711225|FG007|Overall Study|Withdrawal by Subject|3|||
143318498|NCT02461589|516711226|FG008|Overall Study|Withdrawal by Subject|3|||
143318499|NCT02461589|516711227|FG009|Overall Study|Withdrawal by Subject|1|||
143318500|NCT02461589|516711218|FG000|Overall Study|Lost to Follow-up|0|||
143318501|NCT02461589|516711219|FG001|Overall Study|Lost to Follow-up|0|||
143318502|NCT02461589|516711220|FG002|Overall Study|Lost to Follow-up|2|||
143318503|NCT02461589|516711221|FG003|Overall Study|Lost to Follow-up|3|||
143318504|NCT02461589|516711222|FG004|Overall Study|Lost to Follow-up|1|||
143318505|NCT02461589|516711223|FG005|Overall Study|Lost to Follow-up|1|||
143318506|NCT02461589|516711224|FG006|Overall Study|Lost to Follow-up|3|||
143318507|NCT02461589|516711225|FG007|Overall Study|Lost to Follow-up|1|||
143318508|NCT02461589|516711226|FG008|Overall Study|Lost to Follow-up|3|||
143318509|NCT02461589|516711227|FG009|Overall Study|Lost to Follow-up|1|||
143318510|NCT02461589|516711218|FG000|Overall Study|Death|0|||
143318511|NCT02461589|516711219|FG001|Overall Study|Death|0|||
143318512|NCT02461589|516711220|FG002|Overall Study|Death|0|||
143318513|NCT02461589|516711221|FG003|Overall Study|Death|0|||
143318514|NCT02461589|516711222|FG004|Overall Study|Death|0|||
143318515|NCT02461589|516711223|FG005|Overall Study|Death|0|||
143318516|NCT02461589|516711224|FG006|Overall Study|Death|0|||
143318517|NCT02461589|516711225|FG007|Overall Study|Death|1|||
143318518|NCT02461589|516711226|FG008|Overall Study|Death|0|||
143318519|NCT02461589|516711227|FG009|Overall Study|Death|0|||
143318520|NCT02461589|516711218|FG000|Overall Study|Unclassified|0|||
143318521|NCT02461589|516711219|FG001|Overall Study|Unclassified|0|||
143318522|NCT02461589|516711220|FG002|Overall Study|Unclassified|0|||
143318523|NCT02461589|516711221|FG003|Overall Study|Unclassified|0|||
143318524|NCT02461589|516711222|FG004|Overall Study|Unclassified|0|||
143318525|NCT02461589|516711223|FG005|Overall Study|Unclassified|0|||
143318526|NCT02461589|516711224|FG006|Overall Study|Unclassified|1|||
143318527|NCT02461589|516711225|FG007|Overall Study|Unclassified|0|||
143318528|NCT02461589|516711226|FG008|Overall Study|Unclassified|0|||
143318529|NCT02461589|516711227|FG009|Overall Study|Unclassified|2|||
143318530|NCT02461589|516711218|FG000|Overall Study|Missing follow-up information|1|||
143318531|NCT02461589|516711219|FG001|Overall Study|Missing follow-up information|1|||
143318532|NCT02461589|516711220|FG002|Overall Study|Missing follow-up information|0|||
143318533|NCT02461589|516711221|FG003|Overall Study|Missing follow-up information|0|||
143318534|NCT02461589|516711222|FG004|Overall Study|Missing follow-up information|0|||
143318535|NCT02461589|516711223|FG005|Overall Study|Missing follow-up information|0|||
143318536|NCT02461589|516711224|FG006|Overall Study|Missing follow-up information|1|||
143318537|NCT02461589|516711225|FG007|Overall Study|Missing follow-up information|0|||
143318538|NCT02461589|516711226|FG008|Overall Study|Missing follow-up information|0|||
143318539|NCT02461589|516711227|FG009|Overall Study|Missing follow-up information|0|||
143318540|NCT02461589|516711218|FG000|Overall Study|Withdrawal from trial before exposure|0|||
143318541|NCT02461589|516711219|FG001|Overall Study|Withdrawal from trial before exposure|0|||
143318542|NCT02461589|516711220|FG002|Overall Study|Withdrawal from trial before exposure|0|||
143318543|NCT02461589|516711221|FG003|Overall Study|Withdrawal from trial before exposure|0|||
143318544|NCT02461589|516711222|FG004|Overall Study|Withdrawal from trial before exposure|0|||
143318545|NCT02461589|516711223|FG005|Overall Study|Withdrawal from trial before exposure|0|||
143318546|NCT02461589|516711224|FG006|Overall Study|Withdrawal from trial before exposure|0|||
143318547|NCT02461589|516711225|FG007|Overall Study|Withdrawal from trial before exposure|0|||
143378686|NCT00546754|516932516|FG001|Overall Study|Withdrawal by Subject|7|||
143378687|NCT00546754|516932515|FG000|Overall Study|Dyspnea|1|||
143378688|NCT00546754|516932516|FG001|Overall Study|Dyspnea|0|||
143318548|NCT02461589|516711226|FG008|Overall Study|Withdrawal from trial before exposure|0|||
143318549|NCT02461589|516711227|FG009|Overall Study|Withdrawal from trial before exposure|1|||
143318550|NCT01038921|516711228|FG000|Overall Study|Withdrawal by Subject|1|||
143318551|NCT01038921|516711229|FG001|Overall Study|Withdrawal by Subject|0|||
143318552|NCT01038921|516711228|FG000|Overall Study|Physician Decision|1|||
143318553|NCT01038921|516711229|FG001|Overall Study|Physician Decision|0|||
143318554|NCT01831089|516711230|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
143378689|NCT00546754|516932515|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
143378690|NCT00546754|516932516|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
143378691|NCT00546754|516932515|FG000|Overall Study|Hip Replacement|1|||
143378692|NCT00546754|516932516|FG001|Overall Study|Hip Replacement|0|||
143378693|NCT00546754|516932515|FG000|Overall Study|Suicide|1|||
143378694|NCT00546754|516932516|FG001|Overall Study|Suicide|0|||
143378695|NCT00546754|516932515|FG000|Overall Study|Missing Cooperation|1|||
143378696|NCT00546754|516932516|FG001|Overall Study|Missing Cooperation|0|||
143378697|NCT00546754|516932515|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
143378698|NCT00546754|516932516|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
143378699|NCT00546754|516932515|FG000|Overall Study|Patient's Decision|0|||
143378700|NCT00546754|516932516|FG001|Overall Study|Patient's Decision|1|||
143378701|NCT00546754|516932515|FG000|Overall Study|Missing|14|||
143378702|NCT00546754|516932516|FG001|Overall Study|Missing|7|||
143378703|NCT00311363|516932521|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
143378704|NCT00311363|516932522|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
143378705|NCT00311363|516932523|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
143378706|NCT00311363|516932521|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
143378707|NCT00311363|516932522|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
143378708|NCT00311363|516932523|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
143378709|NCT00311363|516932521|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
143378710|NCT00311363|516932522|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
143378711|NCT00311363|516932523|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
143378712|NCT00311363|516932521|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
143378713|NCT00311363|516932522|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
143378714|NCT00311363|516932523|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
143378715|NCT00311363|516932521|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
143378716|NCT00311363|516932522|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
143378717|NCT00311363|516932523|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
143378718|NCT00311363|516932521|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
143378719|NCT00311363|516932522|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
143378720|NCT00311363|516932523|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
143378721|NCT00311363|516932521|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
143378722|NCT00311363|516932522|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
143378723|NCT00311363|516932523|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
143378724|NCT00311363|516932521|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
143378725|NCT00311363|516932522|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
143378726|NCT00311363|516932523|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
143378727|NCT00311363|516932521|FG000|24-Week Single-Blind Treatment Period|Death|1|||
143378728|NCT00311363|516932522|FG001|24-Week Single-Blind Treatment Period|Death|0|||
143378729|NCT00311363|516932523|FG002|24-Week Single-Blind Treatment Period|Death|0|||
143378730|NCT00311363|516932521|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
143378731|NCT00311363|516932522|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
143378732|NCT00311363|516932523|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
143378733|NCT00311363|516932521|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
143378734|NCT00311363|516932522|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
143378735|NCT00311363|516932523|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
143378736|NCT00311363|516932521|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
143378737|NCT00311363|516932522|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
143378738|NCT00311363|516932523|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
143378739|NCT00311363|516932521|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
143378740|NCT00311363|516932522|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
143378741|NCT00311363|516932523|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
143378742|NCT00311363|516932521|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
143378743|NCT00311363|516932522|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
143378744|NCT00311363|516932523|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
143378745|NCT00311363|516932521|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
143378746|NCT00311363|516932522|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
143378747|NCT00311363|516932523|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
143378748|NCT00396084|516932524|FG000|Overall Study|Adverse Event|0|||
143378749|NCT00396084|516932525|FG001|Overall Study|Adverse Event|0|||
143378750|NCT00396084|516932526|FG002|Overall Study|Adverse Event|0|||
143378751|NCT00396084|516932527|FG003|Overall Study|Adverse Event|0|||
143378752|NCT00396084|516932528|FG004|Overall Study|Adverse Event|1|||
143378753|NCT00396084|516932529|FG005|Overall Study|Adverse Event|2|||
143378754|NCT00396084|516932524|FG000|Overall Study|Withdrawal by Subject|0|||
143378755|NCT00396084|516932525|FG001|Overall Study|Withdrawal by Subject|0|||
143378756|NCT00396084|516932526|FG002|Overall Study|Withdrawal by Subject|0|||
143378757|NCT00396084|516932527|FG003|Overall Study|Withdrawal by Subject|1|||
143318555|NCT01831089|516711231|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
143318556|NCT01831089|516711232|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
143318557|NCT01831089|516711233|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
143318558|NCT01831089|516711234|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
143318559|NCT01831089|516711235|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
143318560|NCT01831089|516711230|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
143318561|NCT01831089|516711231|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
143318562|NCT01831089|516711232|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
143318563|NCT01831089|516711233|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
143318564|NCT01831089|516711234|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
143318565|NCT01831089|516711235|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
143318566|NCT01831089|516711230|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
143318567|NCT01831089|516711231|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
143318568|NCT01831089|516711232|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
143318569|NCT01831089|516711233|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
143318570|NCT01831089|516711234|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
143318571|NCT01831089|516711235|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
143318572|NCT01831089|516711230|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
143318573|NCT01831089|516711231|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
143318574|NCT01831089|516711232|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
143318575|NCT01831089|516711233|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
143318576|NCT01831089|516711234|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
143318577|NCT01831089|516711235|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
143318578|NCT01831089|516711230|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
143318579|NCT01831089|516711231|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
143318580|NCT01831089|516711232|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
143318581|NCT01831089|516711233|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
143318582|NCT01831089|516711234|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
143318583|NCT01831089|516711235|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
143318584|NCT01831089|516711230|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
143318585|NCT01831089|516711231|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
143318586|NCT01831089|516711232|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
143318587|NCT01831089|516711233|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
143318588|NCT01831089|516711234|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
143318589|NCT01831089|516711235|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
143318590|NCT01831089|516711230|FG000|Cohort III: Dose Level 3|Global end of study|0|||
143318591|NCT01831089|516711231|FG001|Cohort III: Dose Level 3|Global end of study|0|||
143318592|NCT01831089|516711232|FG002|Cohort III: Dose Level 3|Global end of study|1|||
143318593|NCT01831089|516711233|FG003|Cohort III: Dose Level 3|Global end of study|0|||
143318594|NCT01831089|516711234|FG004|Cohort III: Dose Level 3|Global end of study|0|||
143318595|NCT01831089|516711235|FG005|Cohort III: Dose Level 3|Global end of study|0|||
143318596|NCT01831089|516711230|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
143318597|NCT01831089|516711231|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
143318598|NCT01831089|516711232|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
143318599|NCT01831089|516711233|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
143318600|NCT01831089|516711234|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
143318601|NCT01831089|516711235|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
143318602|NCT01831089|516711230|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
143318603|NCT01831089|516711231|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
143318604|NCT01831089|516711232|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
143318605|NCT01831089|516711233|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
143318606|NCT01831089|516711234|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
143318607|NCT01831089|516711235|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
143318608|NCT01831089|516711230|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
143318609|NCT01831089|516711231|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
143318610|NCT01831089|516711232|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
143318611|NCT01831089|516711233|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
143318612|NCT01831089|516711234|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
143318613|NCT01831089|516711235|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
143318614|NCT01831089|516711230|FG000|Cohort V: Dose Level 5|Death|0|||
143318615|NCT01831089|516711231|FG001|Cohort V: Dose Level 5|Death|0|||
143318616|NCT01831089|516711232|FG002|Cohort V: Dose Level 5|Death|0|||
143318617|NCT01831089|516711233|FG003|Cohort V: Dose Level 5|Death|0|||
143318618|NCT01831089|516711234|FG004|Cohort V: Dose Level 5|Death|1|||
143318619|NCT01831089|516711235|FG005|Cohort V: Dose Level 5|Death|0|||
143318620|NCT01831089|516711230|FG000|Cohort V: Dose Level 5|Global end of study|0|||
143318621|NCT01831089|516711231|FG001|Cohort V: Dose Level 5|Global end of study|0|||
143318622|NCT01831089|516711232|FG002|Cohort V: Dose Level 5|Global end of study|0|||
143378758|NCT00396084|516932528|FG004|Overall Study|Withdrawal by Subject|0|||
143378759|NCT00396084|516932529|FG005|Overall Study|Withdrawal by Subject|0|||
143378760|NCT01697969|516932532|FG000|Overall Study|Did not meet inc/exc criteria|3|||
143378761|NCT05609032|516932536|FG000|Overall Study|Lost to Follow-up|3|||
143378762|NCT05609032|516932537|FG001|Overall Study|Lost to Follow-up|1|||
143378763|NCT05609032|516932536|FG000|Overall Study|Withdrawal by Subject|1|||
143378764|NCT05609032|516932537|FG001|Overall Study|Withdrawal by Subject|0|||
143378765|NCT03764475|516932538|FG000|Overall Study|Adverse Event|11|||
143378766|NCT03764475|516932539|FG001|Overall Study|Adverse Event|2|||
143378767|NCT03764475|516932538|FG000|Overall Study|Lost to Follow-up|24|||
143378768|NCT03764475|516932539|FG001|Overall Study|Lost to Follow-up|10|||
143378769|NCT03764475|516932538|FG000|Overall Study|Withdrawal by Subject|26|||
143378770|NCT03764475|516932539|FG001|Overall Study|Withdrawal by Subject|10|||
143378771|NCT03764475|516932538|FG000|Overall Study|Lack of Efficacy|3|||
143378772|NCT03764475|516932539|FG001|Overall Study|Lack of Efficacy|0|||
143378773|NCT03764475|516932538|FG000|Overall Study|COVID-19 Disruption|2|||
143378774|NCT03764475|516932539|FG001|Overall Study|COVID-19 Disruption|0|||
143378775|NCT05510245|516932543|FG000|Overall Study|Withdrawal by Subject|1|||
143378776|NCT05510245|516932544|FG001|Overall Study|Withdrawal by Subject|0|||
143378777|NCT05510245|516932545|FG002|Overall Study|Withdrawal by Subject|0|||
143378778|NCT00970359|516932551|FG000|Overall Study|Not Treated|4|||
143378779|NCT01565148|516932552|FG000|Overall Study|Withdrawal by Subject|1|||
143378780|NCT01565148|516932553|FG001|Overall Study|Withdrawal by Subject|1|||
143378781|NCT01565148|516932554|FG002|Overall Study|Withdrawal by Subject|1|||
143378782|NCT01565148|516932555|FG003|Overall Study|Withdrawal by Subject|2|||
143378783|NCT01565148|516932552|FG000|Overall Study|Lost to Follow-up|4|||
143378784|NCT01565148|516932553|FG001|Overall Study|Lost to Follow-up|4|||
143378785|NCT01565148|516932554|FG002|Overall Study|Lost to Follow-up|0|||
143378786|NCT01565148|516932555|FG003|Overall Study|Lost to Follow-up|3|||
143378787|NCT01565148|516932552|FG000|Overall Study|Rescue Therapy|8|||
143378788|NCT01565148|516932553|FG001|Overall Study|Rescue Therapy|5|||
143378789|NCT01565148|516932554|FG002|Overall Study|Rescue Therapy|5|||
143378790|NCT01565148|516932555|FG003|Overall Study|Rescue Therapy|8|||
143378791|NCT01565148|516932552|FG000|Overall Study|Death|0|||
143378792|NCT01565148|516932553|FG001|Overall Study|Death|0|||
143378793|NCT01565148|516932554|FG002|Overall Study|Death|1|||
143378794|NCT01565148|516932555|FG003|Overall Study|Death|0|||
143378795|NCT01565148|516932552|FG000|Overall Study|Physician Decision|2|||
143378796|NCT01565148|516932553|FG001|Overall Study|Physician Decision|5|||
143378797|NCT01565148|516932554|FG002|Overall Study|Physician Decision|0|||
143378798|NCT01565148|516932555|FG003|Overall Study|Physician Decision|0|||
143378799|NCT01759771|516932556|FG000|Overall Study|Withdrawal by Subject|1|||
143378800|NCT01759771|516932557|FG001|Overall Study|Withdrawal by Subject|1|||
143378801|NCT05368831|516932558|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
143378802|NCT01692730|516932559|FG000|Overall Study|Lost to Follow-up|225|||
143378803|NCT01692730|516932560|FG001|Overall Study|Lost to Follow-up|227|||
143378804|NCT01849055|516932561|FG000|Overall Study|Withdrawal by Subject|0|||
143378805|NCT01849055|516932562|FG001|Overall Study|Withdrawal by Subject|0|||
143378806|NCT01849055|516932563|FG002|Overall Study|Withdrawal by Subject|1|||
143378807|NCT01849055|516932564|FG003|Overall Study|Withdrawal by Subject|0|||
143378808|NCT01849055|516932565|FG004|Overall Study|Withdrawal by Subject|0|||
143378809|NCT01849055|516932566|FG005|Overall Study|Withdrawal by Subject|0|||
143378810|NCT00223795|516932567|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
143378811|NCT00223795|516932568|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
143378812|NCT00223795|516932567|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
143378813|NCT00223795|516932568|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
143378814|NCT02299375|516932573|FG000|Overall Study|Adverse Event, serious fatal|1|||
143378815|NCT02299375|516932574|FG001|Overall Study|Adverse Event, serious fatal|3|||
143378816|NCT02299375|516932573|FG000|Overall Study|Adverse Event, non-fatal|8|||
143378817|NCT02299375|516932574|FG001|Overall Study|Adverse Event, non-fatal|9|||
143378818|NCT02299375|516932573|FG000|Overall Study|Lack of Efficacy|1|||
143378819|NCT02299375|516932574|FG001|Overall Study|Lack of Efficacy|3|||
143378820|NCT02299375|516932573|FG000|Overall Study|Protocol Violation|1|||
143378821|NCT02299375|516932574|FG001|Overall Study|Protocol Violation|3|||
143378822|NCT02299375|516932573|FG000|Overall Study|Other: Met stopping criteria|1|||
143378823|NCT02299375|516932574|FG001|Overall Study|Other: Met stopping criteria|0|||
143378824|NCT02299375|516932573|FG000|Overall Study|Other: Study closed/terminated|66|||
143378825|NCT02299375|516932574|FG001|Overall Study|Other: Study closed/terminated|55|||
143378826|NCT02299375|516932573|FG000|Overall Study|Lost to Follow-up|0|||
143378827|NCT02299375|516932574|FG001|Overall Study|Lost to Follow-up|2|||
143378828|NCT02299375|516932573|FG000|Overall Study|Physician Decision|1|||
143318623|NCT01831089|516711233|FG003|Cohort V: Dose Level 5|Global end of study|0|||
143318624|NCT01831089|516711234|FG004|Cohort V: Dose Level 5|Global end of study|2|||
143318625|NCT01831089|516711235|FG005|Cohort V: Dose Level 5|Global end of study|0|||
143318626|NCT01831089|516711230|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
143318627|NCT01831089|516711231|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
143318628|NCT01831089|516711232|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
143318629|NCT01831089|516711233|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
143318630|NCT01831089|516711234|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
143318631|NCT01831089|516711235|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
143318632|NCT01831089|516711230|FG000|Cohort B: Arm B|Progressive disease|0|||
143318633|NCT01831089|516711231|FG001|Cohort B: Arm B|Progressive disease|0|||
143318634|NCT01831089|516711232|FG002|Cohort B: Arm B|Progressive disease|0|||
143318635|NCT01831089|516711233|FG003|Cohort B: Arm B|Progressive disease|0|||
143318636|NCT01831089|516711234|FG004|Cohort B: Arm B|Progressive disease|0|||
143318637|NCT01831089|516711235|FG005|Cohort B: Arm B|Progressive disease|8|||
143318638|NCT01831089|516711230|FG000|Cohort B: Arm B|Physician Decision|0|||
143318639|NCT01831089|516711231|FG001|Cohort B: Arm B|Physician Decision|0|||
143318640|NCT01831089|516711232|FG002|Cohort B: Arm B|Physician Decision|0|||
143318641|NCT01831089|516711233|FG003|Cohort B: Arm B|Physician Decision|0|||
143318642|NCT01831089|516711234|FG004|Cohort B: Arm B|Physician Decision|0|||
143318643|NCT01831089|516711235|FG005|Cohort B: Arm B|Physician Decision|2|||
143318644|NCT01831089|516711230|FG000|Cohort B: Arm B|Never treated|0|||
143318645|NCT01831089|516711231|FG001|Cohort B: Arm B|Never treated|0|||
143318646|NCT01831089|516711232|FG002|Cohort B: Arm B|Never treated|0|||
143318647|NCT01831089|516711233|FG003|Cohort B: Arm B|Never treated|0|||
143318648|NCT01831089|516711234|FG004|Cohort B: Arm B|Never treated|0|||
143318649|NCT01831089|516711235|FG005|Cohort B: Arm B|Never treated|2|||
143318650|NCT01831089|516711230|FG000|Cohort B: Arm B|Adverse Event|0|||
143318651|NCT01831089|516711231|FG001|Cohort B: Arm B|Adverse Event|0|||
143318652|NCT01831089|516711232|FG002|Cohort B: Arm B|Adverse Event|0|||
143318653|NCT01831089|516711233|FG003|Cohort B: Arm B|Adverse Event|0|||
143318654|NCT01831089|516711234|FG004|Cohort B: Arm B|Adverse Event|0|||
143318655|NCT01831089|516711235|FG005|Cohort B: Arm B|Adverse Event|1|||
143318656|NCT01831089|516711230|FG000|Cohort B: Arm B|Global end of study|0|||
143318657|NCT01831089|516711231|FG001|Cohort B: Arm B|Global end of study|0|||
143318658|NCT01831089|516711232|FG002|Cohort B: Arm B|Global end of study|0|||
143318659|NCT01831089|516711233|FG003|Cohort B: Arm B|Global end of study|0|||
143318660|NCT01831089|516711234|FG004|Cohort B: Arm B|Global end of study|0|||
143318661|NCT01831089|516711235|FG005|Cohort B: Arm B|Global end of study|1|||
143318662|NCT01047683|516711236|FG000|Overall Study|Adverse Event|3|||
143318663|NCT01047683|516711237|FG001|Overall Study|Adverse Event|1|||
143318664|NCT01047683|516711238|FG002|Overall Study|Adverse Event|0|||
143318665|NCT01047683|516711236|FG000|Overall Study|Withdrew Consent|1|||
143318666|NCT01047683|516711237|FG001|Overall Study|Withdrew Consent|4|||
143318667|NCT01047683|516711238|FG002|Overall Study|Withdrew Consent|2|||
143318668|NCT01047683|516711236|FG000|Overall Study|Lost to Follow-up|0|||
143318669|NCT01047683|516711237|FG001|Overall Study|Lost to Follow-up|1|||
143318670|NCT01047683|516711238|FG002|Overall Study|Lost to Follow-up|0|||
143318671|NCT01047683|516711236|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
143318672|NCT01047683|516711237|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
143318673|NCT01047683|516711238|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
143318674|NCT00833924|516711240|FG000|Overall Study|Death|21|||
143318675|NCT00833924|516711240|FG000|Overall Study|Conversion|2|||
143318676|NCT00833924|516711240|FG000|Overall Study|Lost to Follow-up|2|||
143318677|NCT00833924|516711240|FG000|Overall Study|Withdrawal by Subject|13|||
143318678|NCT00833924|516711240|FG000|Overall Study|In study follow-up|71|||
143318679|NCT01485861|516711241|FG000|Phase Ib|Death|1|||
143318680|NCT01485861|516711242|FG001|Phase Ib|Death|0|||
143318681|NCT01485861|516711243|FG002|Phase Ib|Death|0|||
143318682|NCT01485861|516711244|FG003|Phase Ib|Death|0|||
143318683|NCT01485861|516711245|FG004|Phase Ib|Death|0|||
143318684|NCT01485861|516711246|FG005|Phase Ib|Death|0|||
143318685|NCT01485861|516711241|FG000|Phase Ib|Physician Decision|1|||
143318686|NCT01485861|516711242|FG001|Phase Ib|Physician Decision|1|||
143318687|NCT01485861|516711243|FG002|Phase Ib|Physician Decision|0|||
143318688|NCT01485861|516711244|FG003|Phase Ib|Physician Decision|0|||
143318689|NCT01485861|516711245|FG004|Phase Ib|Physician Decision|0|||
143318690|NCT01485861|516711246|FG005|Phase Ib|Physician Decision|0|||
143318691|NCT01485861|516711241|FG000|Phase Ib|Adverse Event|0|||
143318692|NCT01485861|516711242|FG001|Phase Ib|Adverse Event|4|||
143318693|NCT01485861|516711243|FG002|Phase Ib|Adverse Event|0|||
143318694|NCT01485861|516711244|FG003|Phase Ib|Adverse Event|0|||
143318695|NCT01485861|516711245|FG004|Phase Ib|Adverse Event|0|||
143318696|NCT01485861|516711246|FG005|Phase Ib|Adverse Event|0|||
143318697|NCT01485861|516711241|FG000|Phase Ib|Progression of disease|5|||
143318698|NCT01485861|516711242|FG001|Phase Ib|Progression of disease|0|||
143318699|NCT01485861|516711243|FG002|Phase Ib|Progression of disease|0|||
143318700|NCT01485861|516711244|FG003|Phase Ib|Progression of disease|0|||
143318701|NCT01485861|516711245|FG004|Phase Ib|Progression of disease|0|||
143318702|NCT01485861|516711246|FG005|Phase Ib|Progression of disease|0|||
143318703|NCT01485861|516711241|FG000|Phase Ib|Other|3|||
143318704|NCT01485861|516711242|FG001|Phase Ib|Other|0|||
143318705|NCT01485861|516711243|FG002|Phase Ib|Other|0|||
143318706|NCT01485861|516711244|FG003|Phase Ib|Other|0|||
143318707|NCT01485861|516711245|FG004|Phase Ib|Other|0|||
143318708|NCT01485861|516711246|FG005|Phase Ib|Other|0|||
143318709|NCT01485861|516711241|FG000|Phase Ib|Withdrawal by Subject|4|||
143318710|NCT01485861|516711242|FG001|Phase Ib|Withdrawal by Subject|1|||
143318711|NCT01485861|516711243|FG002|Phase Ib|Withdrawal by Subject|0|||
143318712|NCT01485861|516711244|FG003|Phase Ib|Withdrawal by Subject|0|||
143318713|NCT01485861|516711245|FG004|Phase Ib|Withdrawal by Subject|0|||
143318714|NCT01485861|516711246|FG005|Phase Ib|Withdrawal by Subject|0|||
143318715|NCT01485861|516711241|FG000|Phase II|Death|0|||
143318716|NCT01485861|516711242|FG001|Phase II|Death|0|||
143318717|NCT01485861|516711243|FG002|Phase II|Death|67|||
143318718|NCT01485861|516711244|FG003|Phase II|Death|71|||
143318719|NCT01485861|516711245|FG004|Phase II|Death|68|||
143318720|NCT01485861|516711246|FG005|Phase II|Death|0|||
143318721|NCT01485861|516711241|FG000|Phase II|Progression of Disease|0|||
143318722|NCT01485861|516711242|FG001|Phase II|Progression of Disease|0|||
143318723|NCT01485861|516711243|FG002|Phase II|Progression of Disease|1|||
143318724|NCT01485861|516711244|FG003|Phase II|Progression of Disease|0|||
143318725|NCT01485861|516711245|FG004|Phase II|Progression of Disease|0|||
143318726|NCT01485861|516711246|FG005|Phase II|Progression of Disease|0|||
143318727|NCT01485861|516711241|FG000|Phase II|Other|0|||
143318728|NCT01485861|516711242|FG001|Phase II|Other|0|||
143318729|NCT01485861|516711243|FG002|Phase II|Other|0|||
143318730|NCT01485861|516711244|FG003|Phase II|Other|1|||
143318731|NCT01485861|516711245|FG004|Phase II|Other|0|||
143318732|NCT01485861|516711246|FG005|Phase II|Other|0|||
143318733|NCT01485861|516711241|FG000|Phase II|Withdrawal by Subject|0|||
143318734|NCT01485861|516711242|FG001|Phase II|Withdrawal by Subject|0|||
143318735|NCT01485861|516711243|FG002|Phase II|Withdrawal by Subject|6|||
143318736|NCT01485861|516711244|FG003|Phase II|Withdrawal by Subject|3|||
143318737|NCT01485861|516711245|FG004|Phase II|Withdrawal by Subject|4|||
143318738|NCT01485861|516711246|FG005|Phase II|Withdrawal by Subject|0|||
143318739|NCT01485861|516711241|FG000|Phase II|Lost to Follow-up|0|||
143318740|NCT01485861|516711242|FG001|Phase II|Lost to Follow-up|0|||
143318741|NCT01485861|516711243|FG002|Phase II|Lost to Follow-up|2|||
143318742|NCT01485861|516711244|FG003|Phase II|Lost to Follow-up|3|||
143318743|NCT01485861|516711245|FG004|Phase II|Lost to Follow-up|5|||
143318744|NCT01485861|516711246|FG005|Phase II|Lost to Follow-up|0|||
143318745|NCT01485861|516711241|FG000|Phase II|Study Ended|0|||
143318746|NCT01485861|516711242|FG001|Phase II|Study Ended|0|||
143318747|NCT01485861|516711243|FG002|Phase II|Study Ended|7|||
143318748|NCT01485861|516711244|FG003|Phase II|Study Ended|8|||
143318749|NCT01485861|516711245|FG004|Phase II|Study Ended|6|||
143318750|NCT01485861|516711246|FG005|Phase II|Study Ended|0|||
143318751|NCT01485861|516711241|FG000|Safety Phase|Death|0|||
143318752|NCT01485861|516711242|FG001|Safety Phase|Death|0|||
143318753|NCT01485861|516711243|FG002|Safety Phase|Death|0|||
143318754|NCT01485861|516711244|FG003|Safety Phase|Death|0|||
143318755|NCT01485861|516711245|FG004|Safety Phase|Death|0|||
143318756|NCT01485861|516711246|FG005|Safety Phase|Death|2|||
143318757|NCT01485861|516711241|FG000|Safety Phase|Adverse Event|0|||
143318758|NCT01485861|516711242|FG001|Safety Phase|Adverse Event|0|||
143318759|NCT01485861|516711243|FG002|Safety Phase|Adverse Event|0|||
143318760|NCT01485861|516711244|FG003|Safety Phase|Adverse Event|0|||
143318761|NCT01485861|516711245|FG004|Safety Phase|Adverse Event|0|||
143318762|NCT01485861|516711246|FG005|Safety Phase|Adverse Event|1|||
143318763|NCT01485861|516711241|FG000|Safety Phase|Other|0|||
143318764|NCT01485861|516711242|FG001|Safety Phase|Other|0|||
143318765|NCT01485861|516711243|FG002|Safety Phase|Other|0|||
143318766|NCT01485861|516711244|FG003|Safety Phase|Other|0|||
143318767|NCT01485861|516711245|FG004|Safety Phase|Other|0|||
143318768|NCT01485861|516711246|FG005|Safety Phase|Other|5|||
143318769|NCT01485861|516711241|FG000|Safety Phase|Progression of Disease|0|||
143318770|NCT01485861|516711242|FG001|Safety Phase|Progression of Disease|0|||
143318771|NCT01485861|516711243|FG002|Safety Phase|Progression of Disease|0|||
143318772|NCT01485861|516711244|FG003|Safety Phase|Progression of Disease|0|||
143318773|NCT01485861|516711245|FG004|Safety Phase|Progression of Disease|0|||
143318774|NCT01485861|516711246|FG005|Safety Phase|Progression of Disease|9|||
143318775|NCT01485861|516711241|FG000|Safety Phase|Withdrawal by Subject|0|||
143318776|NCT01485861|516711242|FG001|Safety Phase|Withdrawal by Subject|0|||
143318777|NCT01485861|516711243|FG002|Safety Phase|Withdrawal by Subject|0|||
143318778|NCT01485861|516711244|FG003|Safety Phase|Withdrawal by Subject|0|||
143318779|NCT01485861|516711245|FG004|Safety Phase|Withdrawal by Subject|0|||
143318780|NCT01485861|516711246|FG005|Safety Phase|Withdrawal by Subject|6|||
143318781|NCT01485861|516711241|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
143318782|NCT01485861|516711242|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
143318783|NCT01485861|516711243|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
143378829|NCT02299375|516932574|FG001|Overall Study|Physician Decision|1|||
143318784|NCT01485861|516711244|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
143318785|NCT01485861|516711245|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
143318786|NCT01485861|516711246|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
143318787|NCT01260922|516711248|FG000|First Intervention|Withdrawal by Subject|0|||
143318788|NCT01260922|516711249|FG001|First Intervention|Withdrawal by Subject|1|||
143318789|NCT01260922|516711248|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
143318790|NCT01260922|516711249|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
143318791|NCT01260922|516711248|FG000|Second Intervention|Emesis|0|||
143318792|NCT01260922|516711249|FG001|Second Intervention|Emesis|2|||
143318793|NCT02822794|516711250|FG000|Overall Study|Withdrew Consent|1|||
143318794|NCT02822794|516711251|FG001|Overall Study|Withdrew Consent|0|||
143318795|NCT05101252|516711254|FG000|Overall Study|Unsatisfactory Test Article|1|||
143318796|NCT05101252|516711255|FG001|Overall Study|Unsatisfactory Test Article|0|||
143318797|NCT05101252|516711254|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
143318798|NCT05101252|516711255|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
143318799|NCT05101252|516711254|FG000|Overall Study|Withdrew Consent during study|0|||
143318800|NCT05101252|516711255|FG001|Overall Study|Withdrew Consent during study|1|||
143318801|NCT05101252|516711254|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
143318802|NCT05101252|516711255|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
143318803|NCT02266381|516711256|FG000|Overall Study|Physician Decision|3|||
143318804|NCT02266381|516711257|FG001|Overall Study|Physician Decision|5|||
143318805|NCT02266381|516711258|FG002|Overall Study|Physician Decision|4|||
143318806|NCT03732248|516711259|FG000|Overall Study|Withdrawal by Subject|1|||
143318807|NCT03732248|516711260|FG001|Overall Study|Withdrawal by Subject|0|||
143318808|NCT00733824|516711261|FG000|Phase I|Withdrawal by Subject|1|||
143318809|NCT00733824|516711262|FG001|Phase I|Withdrawal by Subject|0|||
143318810|NCT00733824|516711263|FG002|Phase I|Withdrawal by Subject|0|||
143318811|NCT00733824|516711264|FG003|Phase I|Withdrawal by Subject|0|||
143318812|NCT00733824|516711265|FG004|Phase I|Withdrawal by Subject|0|||
143318813|NCT01243944|516711266|FG000|Overall Study|Adverse Event|15|||
143318814|NCT01243944|516711267|FG001|Overall Study|Adverse Event|13|||
143318815|NCT01243944|516711266|FG000|Overall Study|Lost to Follow-up|2|||
143318816|NCT01243944|516711267|FG001|Overall Study|Lost to Follow-up|1|||
143318817|NCT01243944|516711266|FG000|Overall Study|Physician Decision|2|||
143318818|NCT01243944|516711267|FG001|Overall Study|Physician Decision|7|||
143318819|NCT01243944|516711266|FG000|Overall Study|Disease progression|12|||
143318820|NCT01243944|516711267|FG001|Overall Study|Disease progression|11|||
143318821|NCT01243944|516711266|FG000|Overall Study|Protocol deviation|1|||
143318822|NCT01243944|516711267|FG001|Overall Study|Protocol deviation|1|||
143318823|NCT01243944|516711266|FG000|Overall Study|Participant decision|10|||
143318824|NCT01243944|516711267|FG001|Overall Study|Participant decision|15|||
143318825|NCT01243944|516711266|FG000|Overall Study|Death|2|||
143318826|NCT01243944|516711267|FG001|Overall Study|Death|3|||
143318827|NCT01243944|516711266|FG000|Overall Study|Non-compliance with study treatment|1|||
143318828|NCT01243944|516711267|FG001|Overall Study|Non-compliance with study treatment|0|||
143318829|NCT01410110|516711276|FG000|Overall Study|Withdrawal by Subject|4|||
143318830|NCT01410110|516711277|FG001|Overall Study|Withdrawal by Subject|2|||
143318831|NCT02799082|516711280|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
143318832|NCT02799082|516711281|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
143318833|NCT02799082|516711280|FG000|Overall Study|Protocol Violation|0|||
143318834|NCT02799082|516711281|FG001|Overall Study|Protocol Violation|1|||
143318835|NCT04496258|516711282|FG000|Overall Study|Withdrawal by Subject|2|||
143318836|NCT04496258|516711283|FG001|Overall Study|Withdrawal by Subject|1|||
143318837|NCT00298831|516711287|FG000|Overall Study|Adverse Event|1|||
143318838|NCT00298831|516711287|FG000|Overall Study|Lost to Follow-up|3|||
143318839|NCT00298831|516711287|FG000|Overall Study|Withdrawal by Subject|1|||
143318840|NCT00298831|516711287|FG000|Overall Study|Participants did not receive treatment|27|||
143318841|NCT00595582|516711288|FG000|Overall Study|Pilot study that PI terminated|2|||
143318842|NCT00595582|516711288|FG000|Overall Study|Lost to Follow-up|1|||
143318843|NCT00595582|516711288|FG000|Overall Study|Adverse Event|2|||
143318844|NCT00595582|516711288|FG000|Overall Study|Physician Decision|5|||
143318845|NCT01978184|516711290|FG000|Overall Study|Progressive disease|5|||
143318846|NCT01978184|516711291|FG001|Overall Study|Progressive disease|5|||
143318847|NCT01978184|516711290|FG000|Overall Study|Other than PDA|2|||
143318848|NCT01978184|516711291|FG001|Overall Study|Other than PDA|2|||
143318849|NCT01978184|516711290|FG000|Overall Study|Physician Decision|0|||
143318850|NCT01978184|516711291|FG001|Overall Study|Physician Decision|3|||
143318851|NCT01978184|516711290|FG000|Overall Study|Noncompliance|1|||
143318852|NCT01978184|516711291|FG001|Overall Study|Noncompliance|2|||
143318853|NCT01978184|516711290|FG000|Overall Study|Death|1|||
143318854|NCT01978184|516711291|FG001|Overall Study|Death|0|||
143318855|NCT01978184|516711290|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
143318856|NCT01978184|516711291|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
143318857|NCT02460198|516711293|FG000|Overall Study|Adverse Event|1|||
143318858|NCT02460198|516711294|FG001|Overall Study|Adverse Event|3|||
143318859|NCT02460198|516711293|FG000|Overall Study|Death|36|||
143318860|NCT02460198|516711294|FG001|Overall Study|Death|28|||
143318861|NCT02460198|516711293|FG000|Overall Study|Lost to Follow-up|1|||
143318862|NCT02460198|516711294|FG001|Overall Study|Lost to Follow-up|1|||
143318863|NCT02460198|516711293|FG000|Overall Study|Transferred to Extension Study|15|||
143318864|NCT02460198|516711294|FG001|Overall Study|Transferred to Extension Study|15|||
143318865|NCT02460198|516711293|FG000|Overall Study|Withdrawal by Subject|2|||
143318866|NCT02460198|516711294|FG001|Overall Study|Withdrawal by Subject|4|||
143318867|NCT02460198|516711293|FG000|Overall Study|Site Terminated By Sponsor|0|||
143318868|NCT02460198|516711294|FG001|Overall Study|Site Terminated By Sponsor|1|||
143318869|NCT02460198|516711293|FG000|Overall Study|Did Not Continue on Extension Study|6|||
143318870|NCT02460198|516711294|FG001|Overall Study|Did Not Continue on Extension Study|11|||
143318871|NCT00931307|516711295|FG000|Overall Study|Lack of Efficacy|12|||
143318872|NCT00931307|516711295|FG000|Overall Study|Biomicroscopy|1|||
143318873|NCT00432380|516713139|FG000|Overall Study|Migrated/moved from study area|3|||
143318874|NCT00432380|516713140|FG001|Overall Study|Migrated/moved from study area|4|||
143318875|NCT00432380|516713141|FG002|Overall Study|Migrated/moved from study area|1|||
143318876|NCT00432380|516713139|FG000|Overall Study|Adverse Event|1|||
143318877|NCT00432380|516713140|FG001|Overall Study|Adverse Event|0|||
143318878|NCT00432380|516713141|FG002|Overall Study|Adverse Event|0|||
143318879|NCT01071395|516713142|FG000|Overall Study|Withdrawal by Subject|2|||
143318880|NCT01071395|516713143|FG001|Overall Study|Withdrawal by Subject|1|||
143318881|NCT01071395|516713142|FG000|Overall Study|Adverse Event|3|||
143318882|NCT01071395|516713143|FG001|Overall Study|Adverse Event|1|||
143318883|NCT01337089|516713146|FG000|Overall Study|Adverse Event|237|||
143318884|NCT01337089|516713146|FG000|Overall Study|Withdrawal by Subject|129|||
143318885|NCT01337089|516713146|FG000|Overall Study|Withdrawal by Investigator|33|||
143318886|NCT01337089|516713146|FG000|Overall Study|Met Withdrawal Criteria|3|||
143318887|NCT01337089|516713146|FG000|Overall Study|Lost to Follow-up|2|||
143318888|NCT04419493|516713147|FG000|Wash-out After Period 1|Adverse Event|1|||
143318889|NCT04419493|516713148|FG001|Wash-out After Period 1|Adverse Event|2|||
143318890|NCT04419493|516713149|FG002|Wash-out After Period 1|Adverse Event|1|||
143318891|NCT04419493|516713150|FG003|Wash-out After Period 1|Adverse Event|0|||
143318892|NCT00524134|516713151|FG000|Overall Study|Withdrawal by Subject|1|||
143318893|NCT00524134|516713151|FG000|Overall Study|Physician Decision|1|||
143318894|NCT01782131|516713152|FG000|Overall Study|Death|93|||
143318895|NCT01782131|516713153|FG001|Overall Study|Death|96|||
143318896|NCT01782131|516713152|FG000|Overall Study|Lost to Follow-up|1|||
143318897|NCT01782131|516713153|FG001|Overall Study|Lost to Follow-up|3|||
143318898|NCT01782131|516713152|FG000|Overall Study|Withdrawal by Subject|10|||
143318899|NCT01782131|516713153|FG001|Overall Study|Withdrawal by Subject|10|||
143318900|NCT01782131|516713152|FG000|Overall Study|Randomized but not treated|5|||
143318901|NCT01782131|516713153|FG001|Overall Study|Randomized but not treated|5|||
143318902|NCT01782131|516713152|FG000|Overall Study|Reason not provided|0|||
143318903|NCT01782131|516713153|FG001|Overall Study|Reason not provided|1|||
143318904|NCT00796718|516713154|FG000|Overall Study|Adverse Event|2|||
143318905|NCT00796718|516713154|FG000|Overall Study|Exclusion Criteria|1|||
143318906|NCT00796718|516713154|FG000|Overall Study|Lost to Follow-up|5|||
143318907|NCT00796718|516713154|FG000|Overall Study|Withdrawal by Informed Consent|1|||
143318908|NCT02627677|516713156|FG000|Overall Study|Adverse event (not progressive disease)|1|||
143318909|NCT02627677|516713157|FG001|Overall Study|Adverse event (not progressive disease)|4|||
143318910|NCT02627677|516713158|FG002|Overall Study|Adverse event (not progressive disease)|1|||
143318911|NCT02627677|516713156|FG000|Overall Study|Progressive disease|1|||
143318912|NCT02627677|516713157|FG001|Overall Study|Progressive disease|3|||
143318913|NCT02627677|516713158|FG002|Overall Study|Progressive disease|0|||
143318914|NCT02627677|516713156|FG000|Overall Study|Lack of Efficacy|1|||
143318915|NCT02627677|516713157|FG001|Overall Study|Lack of Efficacy|2|||
143318916|NCT02627677|516713158|FG002|Overall Study|Lack of Efficacy|0|||
143318917|NCT02627677|516713156|FG000|Overall Study|Lost to Follow-up|0|||
143318918|NCT02627677|516713157|FG001|Overall Study|Lost to Follow-up|0|||
143318919|NCT02627677|516713158|FG002|Overall Study|Lost to Follow-up|1|||
143318920|NCT02627677|516713156|FG000|Overall Study|Pregnancy|0|||
143318921|NCT02627677|516713157|FG001|Overall Study|Pregnancy|1|||
143318922|NCT02627677|516713158|FG002|Overall Study|Pregnancy|0|||
143318923|NCT02627677|516713156|FG000|Overall Study|Study Terminated by Sponsor|5|||
143318924|NCT02627677|516713157|FG001|Overall Study|Study Terminated by Sponsor|10|||
143318925|NCT02627677|516713158|FG002|Overall Study|Study Terminated by Sponsor|6|||
143318926|NCT02627677|516713156|FG000|Overall Study|Physician Decision|0|||
143378830|NCT02299375|516932573|FG000|Overall Study|Withdrawal by Subject|1|||
143378831|NCT02299375|516932574|FG001|Overall Study|Withdrawal by Subject|4|||
143318927|NCT02627677|516713157|FG001|Overall Study|Physician Decision|0|||
143318928|NCT02627677|516713158|FG002|Overall Study|Physician Decision|2|||
143318929|NCT02627677|516713156|FG000|Overall Study|Withdrawal by Subject|2|||
143318930|NCT02627677|516713157|FG001|Overall Study|Withdrawal by Subject|1|||
143318931|NCT02627677|516713158|FG002|Overall Study|Withdrawal by Subject|1|||
143318932|NCT02627677|516713156|FG000|Overall Study|Reason not Specified|0|||
143378832|NCT04411056|516934074|FG000|Overall Study|surgery cancelled|1|||
143378833|NCT04411056|516934075|FG001|Overall Study|surgery cancelled|0|||
143378834|NCT04411056|516934074|FG000|Overall Study|Equipment problem during intubation|0|||
143378835|NCT04411056|516934075|FG001|Overall Study|Equipment problem during intubation|1|||
143378836|NCT04623008|516934076|FG000|Baseline to T2|Withdrawal by Subject|4|||
143378837|NCT04623008|516934077|FG001|Baseline to T2|Withdrawal by Subject|2|||
143378838|NCT04623008|516934076|FG000|Baseline to T3|Withdrawal by Subject|4|||
143378839|NCT04623008|516934077|FG001|Baseline to T3|Withdrawal by Subject|2|||
143378840|NCT05985044|516934080|FG000|Overall Study|Death|6|||
143378841|NCT05985044|516934080|FG000|Overall Study|Lost to Follow-up|4|||
143378842|NCT05985044|516934080|FG000|Overall Study|Incapacitation|3|||
143378843|NCT05985044|516934080|FG000|Overall Study|Withdrawal by Subject|2|||
143378844|NCT03312907|516934083|FG000|Overall Study|Adverse Event|1|||
143378845|NCT03312907|516934084|FG001|Overall Study|Adverse Event|6|||
143378846|NCT03312907|516934085|FG002|Overall Study|Adverse Event|1|||
143378847|NCT03312907|516934083|FG000|Overall Study|Protocol Violation|2|||
143378848|NCT03312907|516934084|FG001|Overall Study|Protocol Violation|3|||
143378849|NCT03312907|516934085|FG002|Overall Study|Protocol Violation|4|||
143378850|NCT03312907|516934083|FG000|Overall Study|Lost to Follow-up|2|||
143378851|NCT03312907|516934084|FG001|Overall Study|Lost to Follow-up|3|||
143378852|NCT03312907|516934085|FG002|Overall Study|Lost to Follow-up|2|||
143378853|NCT03312907|516934083|FG000|Overall Study|Physician Decision|3|||
143378854|NCT03312907|516934084|FG001|Overall Study|Physician Decision|4|||
143378855|NCT03312907|516934085|FG002|Overall Study|Physician Decision|2|||
143378856|NCT03312907|516934083|FG000|Overall Study|Withdrawal by Subject|9|||
143378857|NCT03312907|516934084|FG001|Overall Study|Withdrawal by Subject|14|||
143378858|NCT03312907|516934085|FG002|Overall Study|Withdrawal by Subject|10|||
143378859|NCT03189524|516934090|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
143378860|NCT03189524|516934091|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
143378861|NCT03189524|516934092|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
143378862|NCT03189524|516934090|FG000|Overall Study|Death|2|||
143378863|NCT03189524|516934091|FG001|Overall Study|Death|2|||
143378864|NCT03189524|516934092|FG002|Overall Study|Death|1|||
143378865|NCT03189524|516934090|FG000|Overall Study|Lost to Follow-up|1|||
143378866|NCT03189524|516934091|FG001|Overall Study|Lost to Follow-up|0|||
143378867|NCT03189524|516934092|FG002|Overall Study|Lost to Follow-up|8|||
143378868|NCT03189524|516934090|FG000|Overall Study|Withdrawal by Subject|1|||
143378869|NCT03189524|516934091|FG001|Overall Study|Withdrawal by Subject|1|||
143378870|NCT03189524|516934092|FG002|Overall Study|Withdrawal by Subject|3|||
143378871|NCT03189524|516934090|FG000|Overall Study|Progressive Disease|0|||
143378872|NCT03189524|516934091|FG001|Overall Study|Progressive Disease|2|||
143378873|NCT03189524|516934092|FG002|Overall Study|Progressive Disease|0|||
143378874|NCT01780298|516934094|FG000|Overall Study|Physician Decision|1|||
143378875|NCT01780298|516934095|FG001|Overall Study|Physician Decision|5|||
143378876|NCT01780298|516934096|FG002|Overall Study|Physician Decision|1|||
143378877|NCT01780298|516934097|FG003|Overall Study|Physician Decision|1|||
143378878|NCT01780298|516934094|FG000|Overall Study|Subject not matched|1|||
143378879|NCT01780298|516934095|FG001|Overall Study|Subject not matched|0|||
143378880|NCT01780298|516934096|FG002|Overall Study|Subject not matched|1|||
143378881|NCT01780298|516934097|FG003|Overall Study|Subject not matched|0|||
143378882|NCT01780298|516934094|FG000|Overall Study|Adverse Event|0|||
143378883|NCT01780298|516934095|FG001|Overall Study|Adverse Event|0|||
143378884|NCT01780298|516934096|FG002|Overall Study|Adverse Event|2|||
143378885|NCT01780298|516934097|FG003|Overall Study|Adverse Event|0|||
143378886|NCT04907474|516934102|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
143378887|NCT04907474|516934103|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
143378888|NCT03873779|516934104|FG000|Overall Study|Withdrawal by Subject|1|||
143378889|NCT02581215|516934105|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
143378890|NCT02581215|516934106|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
143378891|NCT02581215|516934105|FG000|Overall Study|Eligibility Criteria Not Met|0|||
143378892|NCT02581215|516934106|FG001|Overall Study|Eligibility Criteria Not Met|1|||
143378893|NCT04279574|516934109|FG000|Overall Study|Death|1|||
143378894|NCT04279574|516934110|FG001|Overall Study|Death|0|||
143378895|NCT04279574|516934109|FG000|Overall Study|lost restoration, tooth fracture|1|||
143378896|NCT04279574|516934110|FG001|Overall Study|lost restoration, tooth fracture|0|||
143378897|NCT04279574|516934109|FG000|Overall Study|Lost to Follow-up|0|||
143378898|NCT04279574|516934110|FG001|Overall Study|Lost to Follow-up|1|||
143378899|NCT02566902|516934113|FG000|Overall Study|Protocol Violation|2|||
143378900|NCT02566902|516934114|FG001|Overall Study|Protocol Violation|1|||
143378901|NCT00232180|516934117|FG000|Double-blind (DB) Phase|Death|186|||
143378902|NCT00232180|516934118|FG001|Double-blind (DB) Phase|Death|222|||
143378903|NCT00232180|516934119|FG002|Double-blind (DB) Phase|Death|0|||
143378904|NCT00232180|516934117|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
143378905|NCT00232180|516934118|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
143318933|NCT02627677|516713157|FG001|Overall Study|Reason not Specified|0|||
143318934|NCT02627677|516713158|FG002|Overall Study|Reason not Specified|1|||
143318935|NCT02627677|516713156|FG000|Overall Study|Randomized but not Treated|1|||
143318936|NCT02627677|516713157|FG001|Overall Study|Randomized but not Treated|0|||
143318937|NCT02627677|516713158|FG002|Overall Study|Randomized but not Treated|0|||
143318938|NCT02039505|516713159|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
143318939|NCT02039505|516713160|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
143318940|NCT02039505|516713161|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
143318941|NCT02039505|516713162|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
143318942|NCT02039505|516713163|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
143318943|NCT02039505|516713164|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
143318944|NCT02039505|516713165|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
143318945|NCT02039505|516713159|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
143318946|NCT02039505|516713160|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
143318947|NCT02039505|516713161|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
143318948|NCT02039505|516713162|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
143318949|NCT02039505|516713163|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
143318950|NCT02039505|516713164|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
143318951|NCT02039505|516713165|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
143318952|NCT02039505|516713159|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
143318953|NCT02039505|516713160|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
143318954|NCT02039505|516713161|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
143318955|NCT02039505|516713162|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
143318956|NCT02039505|516713163|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
143318957|NCT02039505|516713164|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
143318958|NCT02039505|516713165|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
143318959|NCT02039505|516713159|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
143318960|NCT02039505|516713160|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
143318961|NCT02039505|516713161|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
143318962|NCT02039505|516713162|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
143318963|NCT02039505|516713163|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
143318964|NCT02039505|516713164|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
143318965|NCT02039505|516713165|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
143318966|NCT02039505|516713159|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
143318967|NCT02039505|516713160|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
143318968|NCT02039505|516713161|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
143318969|NCT02039505|516713162|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
143318970|NCT02039505|516713163|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
143318971|NCT02039505|516713164|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
143318972|NCT02039505|516713165|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
143318973|NCT02039505|516713159|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
143318974|NCT02039505|516713160|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
143318975|NCT02039505|516713161|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
143318976|NCT02039505|516713162|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
143318977|NCT02039505|516713163|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
143318978|NCT02039505|516713164|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
143318979|NCT02039505|516713165|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
143318980|NCT02039505|516713159|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
143318981|NCT02039505|516713160|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
143318982|NCT02039505|516713161|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
143318983|NCT02039505|516713162|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
143318984|NCT02039505|516713163|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
143318985|NCT02039505|516713164|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
143318986|NCT02039505|516713165|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
143318987|NCT02039505|516713159|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
143318988|NCT02039505|516713160|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
143318989|NCT02039505|516713161|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
143318990|NCT02039505|516713162|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
143318991|NCT02039505|516713163|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
143318992|NCT02039505|516713164|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
143318993|NCT02039505|516713165|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
143318994|NCT02039505|516713159|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
143318995|NCT02039505|516713160|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
143318996|NCT02039505|516713161|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
143318997|NCT02039505|516713162|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
143318998|NCT02039505|516713163|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
143318999|NCT02039505|516713164|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
143319000|NCT02039505|516713165|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
143319001|NCT02039505|516713159|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
143319002|NCT02039505|516713160|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
143319003|NCT02039505|516713161|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
143319004|NCT02039505|516713162|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
143319005|NCT02039505|516713163|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
143319006|NCT02039505|516713164|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
143319007|NCT02039505|516713165|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
143319008|NCT02039505|516713159|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
143319009|NCT02039505|516713160|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
143319010|NCT02039505|516713161|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
143319011|NCT02039505|516713162|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
143319012|NCT02039505|516713163|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
143319013|NCT02039505|516713164|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
143319014|NCT02039505|516713165|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
143319015|NCT01163682|516713167|FG000|Overall Study|Lost to Follow-up|6|||
143319016|NCT01163682|516713168|FG001|Overall Study|Lost to Follow-up|9|||
143319017|NCT01557946|516713169|FG000|Overall Study|Adverse Event|3|||
143319018|NCT01557946|516713170|FG001|Overall Study|Adverse Event|0|||
143319019|NCT02013765|516713171|FG000|Overall Study|Trial was terminated by sponsor|1|||
143319020|NCT01731171|516713179|FG000|Overall Study|Withdrawal by Subject|4|||
143319021|NCT01731171|516713180|FG001|Overall Study|Withdrawal by Subject|1|||
143319022|NCT01731171|516713179|FG000|Overall Study|Lost to Follow-up|3|||
143319023|NCT01731171|516713180|FG001|Overall Study|Lost to Follow-up|2|||
143319024|NCT01731171|516713179|FG000|Overall Study|Moved out of Area|0|||
143319025|NCT01731171|516713180|FG001|Overall Study|Moved out of Area|2|||
143319026|NCT01731171|516713179|FG000|Overall Study|Terminated for Lack of Adherence|0|||
143319027|NCT01731171|516713180|FG001|Overall Study|Terminated for Lack of Adherence|1|||
143319028|NCT01731171|516713179|FG000|Overall Study|Terminated for Safety Reasons|0|||
143319029|NCT01731171|516713180|FG001|Overall Study|Terminated for Safety Reasons|1|||
143319030|NCT03653429|516713185|FG000|Overall Study|Physician Decision|4|||
143319031|NCT03653429|516713186|FG001|Overall Study|Physician Decision|10|||
143319032|NCT00403546|516713187|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
143319033|NCT00403546|516713188|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
143319034|NCT00403546|516713189|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
143319035|NCT00403546|516713187|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
143319036|NCT00403546|516713188|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
143319037|NCT00403546|516713189|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
143319038|NCT00403546|516713187|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
143319039|NCT00403546|516713188|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
143319040|NCT00403546|516713189|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
143319041|NCT00403546|516713187|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
143319042|NCT00403546|516713188|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
143319043|NCT00403546|516713189|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
143319044|NCT00403546|516713187|FG000|Screening Phase|Screening Failure|22|||
143319045|NCT00403546|516713188|FG001|Screening Phase|Screening Failure|0|||
143319046|NCT00403546|516713189|FG002|Screening Phase|Screening Failure|0|||
143319047|NCT00403546|516713187|FG000|Screening Phase|Adverse Event|1|||
143319048|NCT00403546|516713188|FG001|Screening Phase|Adverse Event|0|||
143319049|NCT00403546|516713189|FG002|Screening Phase|Adverse Event|0|||
143319050|NCT00403546|516713187|FG000|Screening Phase|Terminated Prior to Randomization|5|||
143319051|NCT00403546|516713188|FG001|Screening Phase|Terminated Prior to Randomization|0|||
143319052|NCT00403546|516713189|FG002|Screening Phase|Terminated Prior to Randomization|0|||
143319053|NCT00403546|516713187|FG000|Randomized Trial|Early Terminations|0|||
143319054|NCT00403546|516713188|FG001|Randomized Trial|Early Terminations|17|||
143319055|NCT00403546|516713189|FG002|Randomized Trial|Early Terminations|16|||
143319056|NCT02604589|516713195|FG000|Overall Study|catheter dislodgement|0|||
143319057|NCT02604589|516713196|FG001|Overall Study|catheter dislodgement|0|||
143319058|NCT02604589|516713197|FG002|Overall Study|catheter dislodgement|1|||
143319059|NCT00793910|516713198|FG000|Overall Study|discarded study pills|0|||
143319060|NCT00793910|516713199|FG001|Overall Study|discarded study pills|1|||
143319061|NCT00793910|516713198|FG000|Overall Study|did not pick up medications|1|||
143319062|NCT00793910|516713199|FG001|Overall Study|did not pick up medications|1|||
143319063|NCT00793910|516713198|FG000|Overall Study|ineligible based on entry criteria|2|||
143319064|NCT00793910|516713199|FG001|Overall Study|ineligible based on entry criteria|3|||
143319065|NCT00793910|516713198|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
143378906|NCT00232180|516934119|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
143378907|NCT00232180|516934117|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
143378908|NCT00232180|516934118|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
143378909|NCT00232180|516934119|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
143378910|NCT00232180|516934117|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
143378911|NCT00232180|516934118|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
143378912|NCT00232180|516934119|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
143378913|NCT00232180|516934117|FG000|Double-blind (DB) Phase|Adverse Event|83|||
143378914|NCT00232180|516934118|FG001|Double-blind (DB) Phase|Adverse Event|100|||
143378915|NCT00232180|516934119|FG002|Double-blind (DB) Phase|Adverse Event|0|||
143378916|NCT00232180|516934117|FG000|Double-blind (DB) Phase|Other|70|||
143378917|NCT00232180|516934118|FG001|Double-blind (DB) Phase|Other|75|||
143378918|NCT00232180|516934119|FG002|Double-blind (DB) Phase|Other|0|||
143378919|NCT00232180|516934117|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
143378920|NCT00232180|516934118|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
143378921|NCT00232180|516934119|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
143378922|NCT00232180|516934117|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
143378923|NCT00232180|516934118|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
143378924|NCT00232180|516934119|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
143378925|NCT00232180|516934117|FG000|Open Label Phase|Death|0|||
143378926|NCT00232180|516934118|FG001|Open Label Phase|Death|0|||
143378927|NCT00232180|516934119|FG002|Open Label Phase|Death|48|||
143378928|NCT00232180|516934117|FG000|Open Label Phase|Lost to Follow-up|0|||
143378929|NCT00232180|516934118|FG001|Open Label Phase|Lost to Follow-up|0|||
143378930|NCT00232180|516934119|FG002|Open Label Phase|Lost to Follow-up|5|||
143378931|NCT00232180|516934117|FG000|Open Label Phase|Protocol Violation|0|||
143378932|NCT00232180|516934118|FG001|Open Label Phase|Protocol Violation|0|||
143378933|NCT00232180|516934119|FG002|Open Label Phase|Protocol Violation|3|||
143378934|NCT00232180|516934117|FG000|Open Label Phase|Study terminated by sponsor|0|||
143378935|NCT00232180|516934118|FG001|Open Label Phase|Study terminated by sponsor|0|||
143378936|NCT00232180|516934119|FG002|Open Label Phase|Study terminated by sponsor|3|||
143378937|NCT00232180|516934117|FG000|Open Label Phase|Withdrawal by Subject|0|||
143378938|NCT00232180|516934118|FG001|Open Label Phase|Withdrawal by Subject|0|||
143378939|NCT00232180|516934119|FG002|Open Label Phase|Withdrawal by Subject|37|||
143378940|NCT00232180|516934117|FG000|Open Label Phase|Other|0|||
143378941|NCT00232180|516934118|FG001|Open Label Phase|Other|0|||
143378942|NCT00232180|516934119|FG002|Open Label Phase|Other|16|||
143378943|NCT00232180|516934117|FG000|Open Label Phase|Adverse Event|0|||
143378944|NCT00232180|516934118|FG001|Open Label Phase|Adverse Event|0|||
143378945|NCT00232180|516934119|FG002|Open Label Phase|Adverse Event|25|||
143378946|NCT00232180|516934117|FG000|Open Label Phase|Laboratory abnormality|0|||
143378947|NCT00232180|516934118|FG001|Open Label Phase|Laboratory abnormality|0|||
143378948|NCT00232180|516934119|FG002|Open Label Phase|Laboratory abnormality|10|||
143378949|NCT00232180|516934117|FG000|Open Label Phase|Randomized but not treated|0|||
143378950|NCT00232180|516934118|FG001|Open Label Phase|Randomized but not treated|0|||
143378951|NCT00232180|516934119|FG002|Open Label Phase|Randomized but not treated|1|||
143378952|NCT04259450|516934121|FG000|Overall Study|Adverse event/ Toxicity|0|||
143378953|NCT04259450|516934122|FG001|Overall Study|Adverse event/ Toxicity|3|||
143378954|NCT04259450|516934123|FG002|Overall Study|Adverse event/ Toxicity|0|||
143378955|NCT04259450|516934124|FG003|Overall Study|Adverse event/ Toxicity|1|||
143378956|NCT04259450|516934125|FG004|Overall Study|Adverse event/ Toxicity|0|||
143378957|NCT04259450|516934126|FG005|Overall Study|Adverse event/ Toxicity|0|||
143378958|NCT04259450|516934127|FG006|Overall Study|Adverse event/ Toxicity|0|||
143378959|NCT04259450|516934128|FG007|Overall Study|Adverse event/ Toxicity|1|||
143378960|NCT04259450|516934129|FG008|Overall Study|Adverse event/ Toxicity|0|||
143378961|NCT04259450|516934130|FG009|Overall Study|Adverse event/ Toxicity|3|||
143378962|NCT04259450|516934121|FG000|Overall Study|Disease progression|2|||
143378963|NCT04259450|516934122|FG001|Overall Study|Disease progression|3|||
143378964|NCT04259450|516934123|FG002|Overall Study|Disease progression|4|||
143378965|NCT04259450|516934124|FG003|Overall Study|Disease progression|4|||
143378966|NCT04259450|516934125|FG004|Overall Study|Disease progression|6|||
143378967|NCT04259450|516934126|FG005|Overall Study|Disease progression|6|||
143378968|NCT04259450|516934127|FG006|Overall Study|Disease progression|6|||
143378969|NCT04259450|516934128|FG007|Overall Study|Disease progression|15|||
143378970|NCT04259450|516934129|FG008|Overall Study|Disease progression|6|||
143378971|NCT04259450|516934130|FG009|Overall Study|Disease progression|18|||
143378972|NCT04259450|516934121|FG000|Overall Study|Death|0|||
143378973|NCT04259450|516934122|FG001|Overall Study|Death|0|||
143378974|NCT04259450|516934123|FG002|Overall Study|Death|0|||
143378975|NCT04259450|516934124|FG003|Overall Study|Death|0|||
143378976|NCT04259450|516934125|FG004|Overall Study|Death|0|||
143378977|NCT04259450|516934126|FG005|Overall Study|Death|0|||
143378978|NCT04259450|516934127|FG006|Overall Study|Death|0|||
143378979|NCT04259450|516934128|FG007|Overall Study|Death|1|||
143378980|NCT04259450|516934129|FG008|Overall Study|Death|1|||
143378981|NCT04259450|516934130|FG009|Overall Study|Death|0|||
143378982|NCT04259450|516934121|FG000|Overall Study|Withdrawal by Subject|0|||
143378983|NCT04259450|516934122|FG001|Overall Study|Withdrawal by Subject|0|||
143378984|NCT04259450|516934123|FG002|Overall Study|Withdrawal by Subject|0|||
143378985|NCT04259450|516934124|FG003|Overall Study|Withdrawal by Subject|0|||
143378986|NCT04259450|516934125|FG004|Overall Study|Withdrawal by Subject|0|||
143378987|NCT04259450|516934126|FG005|Overall Study|Withdrawal by Subject|0|||
143378988|NCT04259450|516934127|FG006|Overall Study|Withdrawal by Subject|0|||
143378989|NCT04259450|516934128|FG007|Overall Study|Withdrawal by Subject|1|||
143378990|NCT04259450|516934129|FG008|Overall Study|Withdrawal by Subject|0|||
143378991|NCT04259450|516934130|FG009|Overall Study|Withdrawal by Subject|0|||
143378992|NCT04259450|516934121|FG000|Overall Study|Other than listed|0|||
143378993|NCT04259450|516934122|FG001|Overall Study|Other than listed|0|||
143378994|NCT04259450|516934123|FG002|Overall Study|Other than listed|0|||
143378995|NCT04259450|516934124|FG003|Overall Study|Other than listed|0|||
143378996|NCT04259450|516934125|FG004|Overall Study|Other than listed|0|||
143378997|NCT04259450|516934126|FG005|Overall Study|Other than listed|0|||
143378998|NCT04259450|516934127|FG006|Overall Study|Other than listed|0|||
143378999|NCT04259450|516934128|FG007|Overall Study|Other than listed|1|||
143379000|NCT04259450|516934129|FG008|Overall Study|Other than listed|1|||
143379001|NCT04259450|516934130|FG009|Overall Study|Other than listed|2|||
143379002|NCT03452189|516934131|FG000|First Intervention (3 Months)|Adverse Event|1|||
143379003|NCT03452189|516934132|FG001|First Intervention (3 Months)|Adverse Event|0|||
143379004|NCT03452189|516934131|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
143379005|NCT03452189|516934132|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
143379006|NCT02724592|516934139|FG000|Overall Study|Lost to Follow-up|4|||
143379007|NCT02724592|516934140|FG001|Overall Study|Lost to Follow-up|1|||
143379008|NCT02584829|516934141|FG000|Overall Study|Physician Decision|1|||
143379009|NCT02584829|516934142|FG001|Overall Study|Physician Decision|0|||
143379010|NCT02584829|516934141|FG000|Overall Study|Withdrawal by Subject|0|||
143379011|NCT02584829|516934142|FG001|Overall Study|Withdrawal by Subject|1|||
143379012|NCT02584829|516934141|FG000|Overall Study|Progressive Disease|0|||
143379013|NCT02584829|516934142|FG001|Overall Study|Progressive Disease|3|||
143379014|NCT04723394|516934152|FG000|Overall Study|Adverse Event|0|||
143379015|NCT04723394|516934153|FG001|Overall Study|Adverse Event|3|||
143379016|NCT04723394|516934152|FG000|Overall Study|Death|8|||
143379017|NCT04723394|516934153|FG001|Overall Study|Death|8|||
143379018|NCT04723394|516934152|FG000|Overall Study|Lost to Follow-up|20|||
143379019|NCT04723394|516934153|FG001|Overall Study|Lost to Follow-up|17|||
143379020|NCT04723394|516934152|FG000|Overall Study|Physician Decision|1|||
143379021|NCT04723394|516934153|FG001|Overall Study|Physician Decision|0|||
143379022|NCT04723394|516934152|FG000|Overall Study|Withdrawal by Subject|20|||
143379023|NCT04723394|516934153|FG001|Overall Study|Withdrawal by Subject|34|||
143379024|NCT04723394|516934152|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
143379025|NCT04723394|516934153|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
143379026|NCT00371787|516934154|FG000|Overall Study|Withdrawal by Subject|3|||
143379027|NCT00371787|516934155|FG001|Overall Study|Withdrawal by Subject|1|||
143379028|NCT02706717|516934165|FG000|Overall Study|Withdrawal by Subject|1|||
143379029|NCT02706717|516934166|FG001|Overall Study|Withdrawal by Subject|8|||
143379030|NCT02706717|516934165|FG000|Overall Study|Lost to Follow-up|0|||
143379031|NCT02706717|516934166|FG001|Overall Study|Lost to Follow-up|1|||
143379032|NCT02706717|516934165|FG000|Overall Study|Physician Decision|0|||
143379033|NCT02706717|516934166|FG001|Overall Study|Physician Decision|1|||
143379034|NCT02706717|516934165|FG000|Overall Study|Death|0|||
143379035|NCT02706717|516934166|FG001|Overall Study|Death|1|||
143379036|NCT00106080|516934170|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
143379037|NCT00106080|516934171|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
143379038|NCT01414738|516934173|FG000|Overall Study|Death|26|||
143379039|NCT01414738|516934173|FG000|Overall Study|Refused testing|5|||
143379040|NCT01414738|516934173|FG000|Overall Study|Lost to Follow-up|2|||
143379041|NCT01414738|516934173|FG000|Overall Study|Refused, disease progression|8|||
143379042|NCT01414738|516934173|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
143379043|NCT01266122|516934174|FG000|Overall Study|Lost to Follow-up|6|||
143379044|NCT01266122|516934175|FG001|Overall Study|Lost to Follow-up|6|||
143379045|NCT00529516|516934176|FG000|Overall Study|Adverse Event|2|||
143379046|NCT00529516|516934177|FG001|Overall Study|Adverse Event|1|||
143379047|NCT00529516|516934178|FG002|Overall Study|Adverse Event|0|||
143379048|NCT00529516|516934176|FG000|Overall Study|Withdrawal by Subject|1|||
143379049|NCT00529516|516934177|FG001|Overall Study|Withdrawal by Subject|1|||
143379050|NCT00529516|516934178|FG002|Overall Study|Withdrawal by Subject|0|||
143379051|NCT00529516|516934176|FG000|Overall Study|Lost to Follow-up|0|||
143379052|NCT00529516|516934177|FG001|Overall Study|Lost to Follow-up|0|||
143379053|NCT00529516|516934178|FG002|Overall Study|Lost to Follow-up|1|||
143379054|NCT00703820|516934181|FG000|Overall Study|Adverse Event|12|||
143379055|NCT00703820|516934182|FG001|Overall Study|Adverse Event|17|||
143379056|NCT00703820|516934181|FG000|Overall Study|Death|5|||
143379057|NCT00703820|516934182|FG001|Overall Study|Death|0|||
143379058|NCT00703820|516934181|FG000|Overall Study|Lack of Efficacy|11|||
143379059|NCT00703820|516934182|FG001|Overall Study|Lack of Efficacy|11|||
143379060|NCT00703820|516934181|FG000|Overall Study|Received non-protocol therapy|1|||
143379061|NCT00703820|516934182|FG001|Overall Study|Received non-protocol therapy|0|||
143379062|NCT00703820|516934181|FG000|Overall Study|Physician Decision|4|||
143379063|NCT00703820|516934182|FG001|Overall Study|Physician Decision|5|||
143379064|NCT00703820|516934181|FG000|Overall Study|Withdrawal by Subject|2|||
143379065|NCT00703820|516934182|FG001|Overall Study|Withdrawal by Subject|1|||
143379066|NCT01102231|516934183|FG000|Overall Study|Protocol Violation|3|||
143379067|NCT01102231|516934183|FG000|Overall Study|Lack of Efficacy|2|||
143379068|NCT01102231|516934183|FG000|Overall Study|Death|2|||
143379069|NCT01102231|516934183|FG000|Overall Study|Adverse Event|3|||
143379070|NCT01102231|516934183|FG000|Overall Study|Withdrawal by Subject|1|||
143379071|NCT01102231|516934183|FG000|Overall Study|Did not received the treatment|4|||
143379072|NCT01199575|516934184|FG000|Overall Study|Withdrawal by Subject|5|||
143379073|NCT01239316|516934185|FG000|Overall Study|Progression/Relapse|11|||
143379074|NCT01239316|516934185|FG000|Overall Study|Adverse Event|1|||
143379075|NCT03122886|516935323|FG000|Overall Study|Withdrawal by Subject|1|||
143379076|NCT03122886|516935324|FG001|Overall Study|Withdrawal by Subject|2|||
143379077|NCT03422276|516935329|FG000|Overall Study|Withdrawal by Subject|21|||
143379078|NCT03422276|516935330|FG001|Overall Study|Withdrawal by Subject|25|||
143379079|NCT03422276|516935331|FG002|Overall Study|Withdrawal by Subject|14|||
143379080|NCT03422276|516935332|FG003|Overall Study|Withdrawal by Subject|16|||
143379081|NCT03422276|516935329|FG000|Overall Study|Death|14|||
143379082|NCT03422276|516935330|FG001|Overall Study|Death|21|||
143379083|NCT03422276|516935331|FG002|Overall Study|Death|3|||
143379084|NCT03422276|516935332|FG003|Overall Study|Death|1|||
143379085|NCT03422276|516935329|FG000|Overall Study|Discontinued, ineligible|4|||
143379086|NCT03422276|516935330|FG001|Overall Study|Discontinued, ineligible|3|||
143379087|NCT03422276|516935331|FG002|Overall Study|Discontinued, ineligible|0|||
143379088|NCT03422276|516935332|FG003|Overall Study|Discontinued, ineligible|0|||
143379089|NCT03422276|516935329|FG000|Overall Study|Lost to Follow-up|15|||
143379090|NCT03422276|516935330|FG001|Overall Study|Lost to Follow-up|8|||
143379091|NCT03422276|516935331|FG002|Overall Study|Lost to Follow-up|13|||
143379092|NCT03422276|516935332|FG003|Overall Study|Lost to Follow-up|4|||
143379093|NCT03422276|516935329|FG000|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
143379094|NCT03422276|516935330|FG001|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
143379095|NCT03422276|516935331|FG002|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
143379096|NCT03422276|516935332|FG003|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
143379097|NCT03422276|516935329|FG000|Overall Study|Incarcerated prior to first follow-up|0|||
143379098|NCT03422276|516935330|FG001|Overall Study|Incarcerated prior to first follow-up|1|||
143379099|NCT03422276|516935331|FG002|Overall Study|Incarcerated prior to first follow-up|0|||
143379100|NCT03422276|516935332|FG003|Overall Study|Incarcerated prior to first follow-up|0|||
143379101|NCT03422276|516935329|FG000|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
143379102|NCT03422276|516935330|FG001|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
143379103|NCT03422276|516935331|FG002|Overall Study|Discontinued, no longer caregiver for patient participant|10|||
143379104|NCT03422276|516935332|FG003|Overall Study|Discontinued, no longer caregiver for patient participant|3|||
143379105|NCT03422276|516935329|FG000|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
143379106|NCT03422276|516935330|FG001|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
143319066|NCT00793910|516713199|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
143319067|NCT00793910|516713198|FG000|Overall Study|Withdrawal by Subject|0|||
143319068|NCT00793910|516713199|FG001|Overall Study|Withdrawal by Subject|1|||
143319069|NCT01700946|516713200|FG000|Overall Study|Lost to Follow-up|1|||
143319070|NCT01700946|516713201|FG001|Overall Study|Lost to Follow-up|0|||
143319071|NCT01700946|516713200|FG000|Overall Study|Physician Decision|7|||
143319072|NCT01700946|516713201|FG001|Overall Study|Physician Decision|12|||
143319073|NCT01700946|516713200|FG000|Overall Study|Withdrawal by Subject|0|||
143319074|NCT01700946|516713201|FG001|Overall Study|Withdrawal by Subject|2|||
143319075|NCT01700946|516713200|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
143319076|NCT01700946|516713201|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
143319077|NCT01700946|516713200|FG000|Overall Study|Relapse|2|||
143319078|NCT01700946|516713201|FG001|Overall Study|Relapse|1|||
143379107|NCT03422276|516935331|FG002|Overall Study|Discontinued, for caregiver, death of patient participant|8|||
143319079|NCT01700946|516713200|FG000|Overall Study|Unacceptable toxicity|1|||
143319080|NCT01700946|516713201|FG001|Overall Study|Unacceptable toxicity|0|||
143319081|NCT05061446|516713211|FG000|Overall Study|Adverse Event|2|||
143379108|NCT03422276|516935332|FG003|Overall Study|Discontinued, for caregiver, death of patient participant|17|||
143379109|NCT03422276|516935329|FG000|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
143319082|NCT05061446|516713212|FG001|Overall Study|Adverse Event|0|||
143319083|NCT05061446|516713213|FG002|Overall Study|Adverse Event|0|||
143319084|NCT05061446|516713211|FG000|Overall Study|Participant no longer available due to personal reason|0|||
143319085|NCT05061446|516713212|FG001|Overall Study|Participant no longer available due to personal reason|1|||
143319086|NCT05061446|516713213|FG002|Overall Study|Participant no longer available due to personal reason|0|||
143319087|NCT05857527|516713216|FG000|Overall Study|Withdrawal by Subject|0|||
143319088|NCT05857527|516713217|FG001|Overall Study|Withdrawal by Subject|1|||
143319089|NCT02543346|516713218|FG000|Second Priming Visit|Withdrawal by Subject|0|||
143319090|NCT02543346|516713219|FG001|Second Priming Visit|Withdrawal by Subject|2|||
143319091|NCT02543346|516713220|FG002|Second Priming Visit|Withdrawal by Subject|2|||
143319092|NCT02543346|516713221|FG003|Second Priming Visit|Withdrawal by Subject|2|||
143319093|NCT02543346|516713218|FG000|Second Priming Visit|Adverse Event|1|||
143319094|NCT02543346|516713219|FG001|Second Priming Visit|Adverse Event|0|||
143379110|NCT03422276|516935330|FG001|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
143379111|NCT03422276|516935331|FG002|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|1|||
143379112|NCT03422276|516935332|FG003|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
143379113|NCT02279095|516935338|FG000|Overall Study|Non-Compliance|1|||
143379114|NCT02279095|516935338|FG000|Overall Study|Withdrawal by Subject|8|||
143379115|NCT02279095|516935338|FG000|Overall Study|Adverse Event|2|||
143379116|NCT02279095|516935338|FG000|Overall Study|Other|7|||
143379117|NCT02279095|516935338|FG000|Overall Study|Lost to Follow-up|1|||
143379118|NCT05938413|516935339|FG000|Overall Study|Lost to Follow-up|1|||
143379119|NCT05938413|516935340|FG001|Overall Study|Lost to Follow-up|7|||
143379120|NCT05938413|516935339|FG000|Overall Study|Withdrawal by Subject|1|||
143379121|NCT05938413|516935340|FG001|Overall Study|Withdrawal by Subject|1|||
143379122|NCT04922021|516935341|FG000|Overall Study|Withdrawal by Subject|4|||
143379123|NCT04922021|516935342|FG001|Overall Study|Withdrawal by Subject|10|||
143379124|NCT04922021|516935341|FG000|Overall Study|Adverse Event|2|||
143379125|NCT04922021|516935342|FG001|Overall Study|Adverse Event|2|||
143379126|NCT04922021|516935341|FG000|Overall Study|Lack of Efficacy|0|||
143379127|NCT04922021|516935342|FG001|Overall Study|Lack of Efficacy|1|||
143379128|NCT04922021|516935341|FG000|Overall Study|Multiple reasons|1|||
143379129|NCT04922021|516935342|FG001|Overall Study|Multiple reasons|0|||
143379130|NCT03756571|516935349|FG000|Overall Study|Lost to Follow-up|1|||
143379131|NCT03756571|516935350|FG001|Overall Study|Lost to Follow-up|1|||
143379132|NCT00421889|516935351|FG000|Overall Study|Adverse Event|1|||
143379133|NCT00421889|516935352|FG001|Overall Study|Adverse Event|0|||
143379134|NCT00421889|516935353|FG002|Overall Study|Adverse Event|1|||
143379135|NCT00421889|516935354|FG003|Overall Study|Adverse Event|1|||
143379136|NCT00421889|516935355|FG004|Overall Study|Adverse Event|1|||
143379137|NCT00421889|516935356|FG005|Overall Study|Adverse Event|4|||
143379138|NCT00421889|516935357|FG006|Overall Study|Adverse Event|1|||
143379139|NCT00421889|516935358|FG007|Overall Study|Adverse Event|0|||
143379140|NCT00421889|516935359|FG008|Overall Study|Adverse Event|2|||
143379141|NCT00421889|516935351|FG000|Overall Study|Withdrawal by Subject|1|||
143379142|NCT00421889|516935352|FG001|Overall Study|Withdrawal by Subject|3|||
143379143|NCT00421889|516935353|FG002|Overall Study|Withdrawal by Subject|0|||
143379144|NCT00421889|516935354|FG003|Overall Study|Withdrawal by Subject|0|||
143379145|NCT00421889|516935355|FG004|Overall Study|Withdrawal by Subject|2|||
143379146|NCT00421889|516935356|FG005|Overall Study|Withdrawal by Subject|0|||
143379147|NCT00421889|516935357|FG006|Overall Study|Withdrawal by Subject|0|||
143379148|NCT00421889|516935358|FG007|Overall Study|Withdrawal by Subject|0|||
143379149|NCT00421889|516935359|FG008|Overall Study|Withdrawal by Subject|0|||
143379150|NCT00421889|516935351|FG000|Overall Study|Death|0|||
143379151|NCT00421889|516935352|FG001|Overall Study|Death|0|||
143379152|NCT00421889|516935353|FG002|Overall Study|Death|0|||
143379153|NCT00421889|516935354|FG003|Overall Study|Death|0|||
143379154|NCT00421889|516935355|FG004|Overall Study|Death|1|||
143379155|NCT00421889|516935356|FG005|Overall Study|Death|1|||
143379156|NCT00421889|516935357|FG006|Overall Study|Death|0|||
143319095|NCT02543346|516713220|FG002|Second Priming Visit|Adverse Event|0|||
143319096|NCT02543346|516713221|FG003|Second Priming Visit|Adverse Event|0|||
143319097|NCT01748994|516713222|FG000|Overall Study|Lost to Follow-up|8|||
143319098|NCT01748994|516713223|FG001|Overall Study|Lost to Follow-up|6|||
143319099|NCT02141516|516713224|FG000|Overall Study|Adverse Event|0|||
143379157|NCT00421889|516935358|FG007|Overall Study|Death|0|||
143319100|NCT02141516|516713225|FG001|Overall Study|Adverse Event|1|||
143379158|NCT00421889|516935359|FG008|Overall Study|Death|0|||
143379159|NCT00421889|516935351|FG000|Overall Study|Progressive disease|3|||
143379160|NCT00421889|516935352|FG001|Overall Study|Progressive disease|2|||
143379161|NCT00421889|516935353|FG002|Overall Study|Progressive disease|2|||
143379162|NCT00421889|516935354|FG003|Overall Study|Progressive disease|3|||
143379163|NCT00421889|516935355|FG004|Overall Study|Progressive disease|2|||
143379164|NCT00421889|516935356|FG005|Overall Study|Progressive disease|21|||
143379165|NCT00421889|516935357|FG006|Overall Study|Progressive disease|3|||
143379166|NCT00421889|516935358|FG007|Overall Study|Progressive disease|1|||
143379167|NCT00421889|516935359|FG008|Overall Study|Progressive disease|5|||
143379168|NCT00421889|516935351|FG000|Overall Study|Patient/Investigator request|0|||
143379169|NCT00421889|516935352|FG001|Overall Study|Patient/Investigator request|0|||
143379170|NCT00421889|516935353|FG002|Overall Study|Patient/Investigator request|0|||
143379171|NCT00421889|516935354|FG003|Overall Study|Patient/Investigator request|0|||
143379172|NCT00421889|516935355|FG004|Overall Study|Patient/Investigator request|0|||
143379173|NCT00421889|516935356|FG005|Overall Study|Patient/Investigator request|9|||
143379174|NCT00421889|516935357|FG006|Overall Study|Patient/Investigator request|0|||
143379175|NCT00421889|516935358|FG007|Overall Study|Patient/Investigator request|1|||
143379176|NCT00421889|516935359|FG008|Overall Study|Patient/Investigator request|3|||
143379177|NCT00421889|516935351|FG000|Overall Study|Lost to Follow-up|0|||
143379178|NCT00421889|516935352|FG001|Overall Study|Lost to Follow-up|0|||
143379179|NCT00421889|516935353|FG002|Overall Study|Lost to Follow-up|0|||
143379180|NCT00421889|516935354|FG003|Overall Study|Lost to Follow-up|0|||
143379181|NCT00421889|516935355|FG004|Overall Study|Lost to Follow-up|0|||
143379182|NCT00421889|516935356|FG005|Overall Study|Lost to Follow-up|0|||
143379183|NCT00421889|516935357|FG006|Overall Study|Lost to Follow-up|0|||
143379184|NCT00421889|516935358|FG007|Overall Study|Lost to Follow-up|0|||
143379185|NCT00421889|516935359|FG008|Overall Study|Lost to Follow-up|1|||
143379186|NCT00978042|516935360|FG000|Initial Treatment Period|Treated in Error|0|||
143379187|NCT00978042|516935361|FG001|Initial Treatment Period|Treated in Error|3|||
143379188|NCT00978042|516935360|FG000|Initial Treatment Period|Ineligibility|1|||
143379189|NCT00978042|516935361|FG001|Initial Treatment Period|Ineligibility|0|||
143379190|NCT00978042|516935360|FG000|Initial Treatment Period|Lost to Follow-up|21|||
143379191|NCT00978042|516935361|FG001|Initial Treatment Period|Lost to Follow-up|3|||
143379192|NCT00978042|516935360|FG000|Initial Treatment Period|Adverse Event|2|||
143379193|NCT00978042|516935361|FG001|Initial Treatment Period|Adverse Event|0|||
143379194|NCT00978042|516935360|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
143379195|NCT00978042|516935361|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
143379196|NCT00978042|516935360|FG000|Initial Treatment Period|Consent withdrawn|22|||
143379197|NCT00978042|516935361|FG001|Initial Treatment Period|Consent withdrawn|9|||
143379198|NCT00978042|516935360|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
143379199|NCT00978042|516935361|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
143379200|NCT03051165|516935364|FG000|Overall Study|Withdrawal by Subject|1|||
143379201|NCT03051165|516935364|FG000|Overall Study|Early termination of study|12|||
143379202|NCT00761605|516935367|FG000|Overall Study|Adverse Event|26|||
143379203|NCT00761605|516935367|FG000|Overall Study|Death|2|||
143379204|NCT00761605|516935367|FG000|Overall Study|Lack of Efficacy|26|||
143379205|NCT00761605|516935367|FG000|Overall Study|Lost to Follow-up|29|||
143379206|NCT00761605|516935367|FG000|Overall Study|Withdrawal by Subject|37|||
143379207|NCT00761605|516935367|FG000|Overall Study|Other|21|||
143379208|NCT01290341|516935369|FG000|Overall Study|Protocol Violation|7|||
143379209|NCT01290341|516935370|FG001|Overall Study|Protocol Violation|3|||
143379210|NCT01290341|516935369|FG000|Overall Study|Adverse Event|1|||
143379211|NCT01290341|516935370|FG001|Overall Study|Adverse Event|0|||
143379212|NCT01290341|516935369|FG000|Overall Study|Lost to Follow-up|21|||
143379213|NCT01290341|516935370|FG001|Overall Study|Lost to Follow-up|10|||
143379214|NCT01290341|516935369|FG000|Overall Study|Withdrawal by Subject|19|||
143379215|NCT01290341|516935370|FG001|Overall Study|Withdrawal by Subject|5|||
143379216|NCT01290341|516935369|FG000|Overall Study|Negative baseline culture and others|44|||
143379217|NCT01290341|516935370|FG001|Overall Study|Negative baseline culture and others|11|||
143379218|NCT03036813|516935371|FG000|Overall Study|Adverse Event|6|||
143379219|NCT03036813|516935372|FG001|Overall Study|Adverse Event|11|||
143379220|NCT03036813|516935373|FG002|Overall Study|Adverse Event|6|||
143319101|NCT02141516|516713226|FG002|Overall Study|Adverse Event|0|||
143319102|NCT02141516|516713224|FG000|Overall Study|Lost to Follow-up|0|||
143319103|NCT02141516|516713225|FG001|Overall Study|Lost to Follow-up|1|||
143319104|NCT02141516|516713226|FG002|Overall Study|Lost to Follow-up|0|||
143319105|NCT02141516|516713224|FG000|Overall Study|Other|0|||
143319106|NCT02141516|516713225|FG001|Overall Study|Other|3|||
143319107|NCT02141516|516713226|FG002|Overall Study|Other|0|||
143319108|NCT03251924|516713227|FG000|Overall Study|Disease Progression|6|||
143319109|NCT03251924|516713228|FG001|Overall Study|Disease Progression|6|||
143319110|NCT03251924|516713229|FG002|Overall Study|Disease Progression|7|||
143319111|NCT03251924|516713230|FG003|Overall Study|Disease Progression|8|||
143319112|NCT03251924|516713231|FG004|Overall Study|Disease Progression|8|||
143319113|NCT03251924|516713232|FG005|Overall Study|Disease Progression|7|||
143319114|NCT03251924|516713233|FG006|Overall Study|Disease Progression|6|||
143319115|NCT03251924|516713234|FG007|Overall Study|Disease Progression|10|||
143319116|NCT03251924|516713235|FG008|Overall Study|Disease Progression|6|||
143319117|NCT03251924|516713227|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
143319118|NCT03251924|516713228|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
143319119|NCT03251924|516713229|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
143319120|NCT03251924|516713230|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
143319121|NCT03251924|516713231|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
143319122|NCT03251924|516713232|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
143319123|NCT03251924|516713233|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
143319124|NCT03251924|516713234|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
143319125|NCT03251924|516713235|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
143319126|NCT03251924|516713227|FG000|Overall Study|Death|0|||
143319127|NCT03251924|516713228|FG001|Overall Study|Death|1|||
143319128|NCT03251924|516713229|FG002|Overall Study|Death|0|||
143319129|NCT03251924|516713230|FG003|Overall Study|Death|1|||
143319130|NCT03251924|516713231|FG004|Overall Study|Death|1|||
143319131|NCT03251924|516713232|FG005|Overall Study|Death|1|||
143319132|NCT03251924|516713233|FG006|Overall Study|Death|0|||
143319133|NCT03251924|516713234|FG007|Overall Study|Death|0|||
143319134|NCT03251924|516713235|FG008|Overall Study|Death|0|||
143319135|NCT03251924|516713227|FG000|Overall Study|Study Drug Toxicity|0|||
143319136|NCT03251924|516713228|FG001|Overall Study|Study Drug Toxicity|0|||
143319137|NCT03251924|516713229|FG002|Overall Study|Study Drug Toxicity|0|||
143319138|NCT03251924|516713230|FG003|Overall Study|Study Drug Toxicity|1|||
143319139|NCT03251924|516713231|FG004|Overall Study|Study Drug Toxicity|0|||
143319140|NCT03251924|516713232|FG005|Overall Study|Study Drug Toxicity|0|||
143319141|NCT03251924|516713233|FG006|Overall Study|Study Drug Toxicity|0|||
143319142|NCT03251924|516713234|FG007|Overall Study|Study Drug Toxicity|0|||
143319143|NCT03251924|516713235|FG008|Overall Study|Study Drug Toxicity|1|||
143319144|NCT03251924|516713227|FG000|Overall Study|Other Reasons|0|||
143319145|NCT03251924|516713228|FG001|Overall Study|Other Reasons|0|||
143319146|NCT03251924|516713229|FG002|Overall Study|Other Reasons|0|||
143319147|NCT03251924|516713230|FG003|Overall Study|Other Reasons|0|||
143319148|NCT03251924|516713231|FG004|Overall Study|Other Reasons|0|||
143319149|NCT03251924|516713232|FG005|Overall Study|Other Reasons|0|||
143319150|NCT03251924|516713233|FG006|Overall Study|Other Reasons|0|||
143319151|NCT03251924|516713234|FG007|Overall Study|Other Reasons|0|||
143319152|NCT03251924|516713235|FG008|Overall Study|Other Reasons|1|||
143319153|NCT03251924|516713227|FG000|Overall Study|Participant request to discontinue study treatment|0|||
143319154|NCT03251924|516713228|FG001|Overall Study|Participant request to discontinue study treatment|0|||
143319155|NCT03251924|516713229|FG002|Overall Study|Participant request to discontinue study treatment|0|||
143319156|NCT03251924|516713230|FG003|Overall Study|Participant request to discontinue study treatment|0|||
143319157|NCT03251924|516713231|FG004|Overall Study|Participant request to discontinue study treatment|0|||
143319158|NCT03251924|516713232|FG005|Overall Study|Participant request to discontinue study treatment|0|||
143319159|NCT03251924|516713233|FG006|Overall Study|Participant request to discontinue study treatment|0|||
143319160|NCT03251924|516713234|FG007|Overall Study|Participant request to discontinue study treatment|1|||
143319161|NCT03251924|516713235|FG008|Overall Study|Participant request to discontinue study treatment|0|||
143319162|NCT00153101|516713236|FG000|Overall Study|Lost to Follow-up|14|||
143319163|NCT00153101|516713237|FG001|Overall Study|Lost to Follow-up|14|||
143319164|NCT00153101|516713238|FG002|Overall Study|Lost to Follow-up|12|||
143319165|NCT00153101|516713239|FG003|Overall Study|Lost to Follow-up|5|||
143319166|NCT00153101|516713240|FG004|Overall Study|Lost to Follow-up|5|||
143319167|NCT00153101|516713236|FG000|Overall Study|Withdrawal by Subject|3|||
143319168|NCT00153101|516713237|FG001|Overall Study|Withdrawal by Subject|4|||
143319169|NCT00153101|516713238|FG002|Overall Study|Withdrawal by Subject|3|||
143319170|NCT00153101|516713239|FG003|Overall Study|Withdrawal by Subject|3|||
143379221|NCT03036813|516935371|FG000|Overall Study|Withdrawal by Subject|12|||
143319171|NCT00153101|516713240|FG004|Overall Study|Withdrawal by Subject|5|||
143319172|NCT02610140|516713241|FG000|Randomization and Treatment Period|Radiological progression|23|||
143319173|NCT02610140|516713242|FG001|Randomization and Treatment Period|Radiological progression|15|||
143319174|NCT02610140|516713241|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
143379222|NCT03036813|516935372|FG001|Overall Study|Withdrawal by Subject|6|||
143319175|NCT02610140|516713242|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
143319176|NCT02610140|516713241|FG000|Randomization and Treatment Period|Protocol Violation|1|||
143319177|NCT02610140|516713242|FG001|Randomization and Treatment Period|Protocol Violation|0|||
143319178|NCT02610140|516713241|FG000|Randomization and Treatment Period|Physician Decision|0|||
143319179|NCT02610140|516713242|FG001|Randomization and Treatment Period|Physician Decision|1|||
143319180|NCT02610140|516713241|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
143319181|NCT02610140|516713242|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
143319182|NCT02610140|516713241|FG000|Randomization and Treatment Period|Death|7|||
143319183|NCT02610140|516713242|FG001|Randomization and Treatment Period|Death|1|||
143319184|NCT02610140|516713241|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
143319185|NCT02610140|516713242|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
143319186|NCT02610140|516713241|FG000|Randomization and Treatment Period|Adverse Event|44|||
143319187|NCT02610140|516713242|FG001|Randomization and Treatment Period|Adverse Event|13|||
143319188|NCT02610140|516713241|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
143319189|NCT02610140|516713242|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
143319190|NCT02610140|516713241|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
143319191|NCT02610140|516713242|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
143319192|NCT02610140|516713241|FG000|Randomization and Treatment Period|Not treated|3|||
143319193|NCT02610140|516713242|FG001|Randomization and Treatment Period|Not treated|10|||
143319194|NCT02610140|516713241|FG000|Safety Follow-up|Other|0|||
143319195|NCT02610140|516713242|FG001|Safety Follow-up|Other|2|||
143319196|NCT02610140|516713241|FG000|Safety Follow-up|Lost to Follow-up|1|||
143319197|NCT02610140|516713242|FG001|Safety Follow-up|Lost to Follow-up|0|||
143319198|NCT02610140|516713241|FG000|Safety Follow-up|No follow-up|5|||
143319199|NCT02610140|516713242|FG001|Safety Follow-up|No follow-up|3|||
143319200|NCT02610140|516713241|FG000|Safety Follow-up|Death|12|||
143319201|NCT02610140|516713242|FG001|Safety Follow-up|Death|2|||
143319202|NCT02610140|516713241|FG000|Safety Follow-up|Deterioration of general conditions|15|||
143319203|NCT02610140|516713242|FG001|Safety Follow-up|Deterioration of general conditions|5|||
143319204|NCT02610140|516713241|FG000|Safety Follow-up|Withdrawal by Subject|12|||
143319205|NCT02610140|516713242|FG001|Safety Follow-up|Withdrawal by Subject|12|||
143319206|NCT02610140|516713241|FG000|Active Follow-up|Progressive disease - radiological|30|||
143319207|NCT02610140|516713242|FG001|Active Follow-up|Progressive disease - radiological|22|||
143319208|NCT02610140|516713241|FG000|Active Follow-up|Death|8|||
143319209|NCT02610140|516713242|FG001|Active Follow-up|Death|1|||
143319210|NCT02610140|516713241|FG000|Active Follow-up|Withdrawal by Subject|4|||
143319211|NCT02610140|516713242|FG001|Active Follow-up|Withdrawal by Subject|0|||
143319212|NCT02610140|516713241|FG000|Active Follow-up|Progressive disease - clinical|1|||
143319213|NCT02610140|516713242|FG001|Active Follow-up|Progressive disease - clinical|2|||
143319214|NCT02610140|516713241|FG000|Active Follow-up|Deterioration of general conditions|1|||
143319215|NCT02610140|516713242|FG001|Active Follow-up|Deterioration of general conditions|0|||
143319216|NCT02610140|516713241|FG000|Active Follow-up|Ongoing but not completed|4|||
143319217|NCT02610140|516713242|FG001|Active Follow-up|Ongoing but not completed|1|||
143319218|NCT02610140|516713241|FG000|Long-term Follow-up|Death|86|||
143319219|NCT02610140|516713242|FG001|Long-term Follow-up|Death|44|||
143319220|NCT02610140|516713241|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
143319221|NCT02610140|516713242|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
143319222|NCT02610140|516713241|FG000|Long-term Follow-up|Lost to Follow-up|1|||
143319223|NCT02610140|516713242|FG001|Long-term Follow-up|Lost to Follow-up|2|||
143319224|NCT02610140|516713241|FG000|Long-term Follow-up|Ongoing but not completed|30|||
143319225|NCT02610140|516713242|FG001|Long-term Follow-up|Ongoing but not completed|17|||
143319226|NCT03169153|516713243|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
143319227|NCT03169153|516713244|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
143319228|NCT03169153|516713243|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
143319229|NCT03169153|516713244|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
143319230|NCT03169153|516713243|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
143319231|NCT03169153|516713244|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
143319232|NCT03169153|516713243|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
143319233|NCT03169153|516713244|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
143319234|NCT02617589|516713245|FG000|Randomization|Request to Discontinue Study Treatment|1|||
143319235|NCT02617589|516713246|FG001|Randomization|Request to Discontinue Study Treatment|3|||
143319236|NCT02617589|516713245|FG000|Randomization|Participant Withdrew Consent|1|||
143319237|NCT02617589|516713246|FG001|Randomization|Participant Withdrew Consent|2|||
143319238|NCT02617589|516713245|FG000|Treatment|Other Reasons|3|||
143319239|NCT02617589|516713246|FG001|Treatment|Other Reasons|3|||
143319240|NCT02617589|516713245|FG000|Treatment|Poor/Non Compliance|1|||
143319241|NCT02617589|516713246|FG001|Treatment|Poor/Non Compliance|1|||
143319242|NCT02617589|516713245|FG000|Treatment|Maximum Clinical Benefit|0|||
143319243|NCT02617589|516713246|FG001|Treatment|Maximum Clinical Benefit|2|||
143319244|NCT02617589|516713245|FG000|Treatment|Participant Withdrew Consent|2|||
143379223|NCT03036813|516935373|FG002|Overall Study|Withdrawal by Subject|10|||
143379224|NCT03036813|516935371|FG000|Overall Study|Lost to Follow-up|1|||
143379225|NCT03036813|516935372|FG001|Overall Study|Lost to Follow-up|1|||
143379226|NCT03036813|516935373|FG002|Overall Study|Lost to Follow-up|0|||
143379227|NCT03036813|516935371|FG000|Overall Study|Physician Decision|2|||
143379228|NCT03036813|516935372|FG001|Overall Study|Physician Decision|1|||
143379229|NCT03036813|516935373|FG002|Overall Study|Physician Decision|1|||
143379230|NCT03036813|516935371|FG000|Overall Study|Non-Compliance|1|||
143379231|NCT03036813|516935372|FG001|Overall Study|Non-Compliance|5|||
143379232|NCT03036813|516935373|FG002|Overall Study|Non-Compliance|3|||
143379233|NCT03036813|516935371|FG000|Overall Study|Pregnancy|0|||
143379234|NCT03036813|516935372|FG001|Overall Study|Pregnancy|0|||
143379235|NCT03036813|516935373|FG002|Overall Study|Pregnancy|1|||
143379236|NCT03036813|516935371|FG000|Overall Study|Other|0|||
143379237|NCT03036813|516935372|FG001|Overall Study|Other|3|||
143379238|NCT03036813|516935373|FG002|Overall Study|Other|5|||
143379239|NCT00785512|516935380|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
143319245|NCT02617589|516713246|FG001|Treatment|Participant Withdrew Consent|6|||
143319246|NCT02617589|516713245|FG000|Treatment|Participant Request to Discontinue|12|||
143319247|NCT02617589|516713246|FG001|Treatment|Participant Request to Discontinue|21|||
143319248|NCT02617589|516713245|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
143319249|NCT02617589|516713246|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
143319250|NCT02617589|516713245|FG000|Treatment|Death|1|||
143319251|NCT02617589|516713246|FG001|Treatment|Death|1|||
143319252|NCT02617589|516713245|FG000|Treatment|Study Drug Toxicity|27|||
143319253|NCT02617589|516713246|FG001|Treatment|Study Drug Toxicity|20|||
143319254|NCT02617589|516713245|FG000|Treatment|Disease Progression|216|||
143319255|NCT02617589|516713246|FG001|Treatment|Disease Progression|136|||
143319256|NCT00861341|516713247|FG000|Overall Study|Withdrawal by Subject|2|||
143319257|NCT01975389|516713248|FG000|Overall Study|Adverse Event|10|||
143319258|NCT01975389|516713249|FG001|Overall Study|Adverse Event|6|||
143319259|NCT01975389|516713248|FG000|Overall Study|Death|61|||
143319260|NCT01975389|516713249|FG001|Overall Study|Death|54|||
143319261|NCT01975389|516713248|FG000|Overall Study|Lost to Follow-up|81|||
143319262|NCT01975389|516713249|FG001|Overall Study|Lost to Follow-up|86|||
143319263|NCT01975389|516713248|FG000|Overall Study|Withdrawal by Subject|90|||
143319264|NCT01975389|516713249|FG001|Overall Study|Withdrawal by Subject|76|||
143319265|NCT01975389|516713248|FG000|Overall Study|Other|6|||
143319266|NCT01975389|516713249|FG001|Overall Study|Other|9|||
143319267|NCT01975389|516713248|FG000|Overall Study|Randomized, not treated|4|||
143319268|NCT01975389|516713249|FG001|Overall Study|Randomized, not treated|5|||
143319269|NCT01312961|516713250|FG000|Overall Study|Adverse Event|3|||
143319270|NCT01312961|516713251|FG001|Overall Study|Adverse Event|3|||
143319271|NCT01312961|516713250|FG000|Overall Study|Lack of Efficacy|11|||
143319272|NCT01312961|516713251|FG001|Overall Study|Lack of Efficacy|1|||
143319273|NCT01312961|516713250|FG000|Overall Study|Poor compliance to protocol|1|||
143319274|NCT01312961|516713251|FG001|Overall Study|Poor compliance to protocol|0|||
143319275|NCT01312961|516713250|FG000|Overall Study|Other than specified above|2|||
143319276|NCT01312961|516713251|FG001|Overall Study|Other than specified above|3|||
143319277|NCT00983580|516713257|FG000|Overall Study|Cancel Prior to treatment|1|||
143319278|NCT00983580|516713258|FG001|Overall Study|Cancel Prior to treatment|3|||
143319279|NCT00983580|516713257|FG000|Overall Study|Protocol Violation|1|||
143319280|NCT00983580|516713258|FG001|Overall Study|Protocol Violation|1|||
143319281|NCT00983580|516713257|FG000|Overall Study|Ineligible|3|||
143319282|NCT00983580|516713258|FG001|Overall Study|Ineligible|0|||
143319283|NCT04382612|516713259|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
143319284|NCT01328002|516713260|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
143319285|NCT01328002|516713261|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
143319286|NCT01328002|516713260|FG000|Open-Label Period|Adverse Event|8|||
143319287|NCT01328002|516713261|FG001|Open-Label Period|Adverse Event|0|||
143319288|NCT01328002|516713260|FG000|Open-Label Period|Lack of Efficacy|3|||
143319289|NCT01328002|516713261|FG001|Open-Label Period|Lack of Efficacy|0|||
143319290|NCT01328002|516713260|FG000|Open-Label Period|Protocol Violation|2|||
143319291|NCT01328002|516713261|FG001|Open-Label Period|Protocol Violation|0|||
143319292|NCT01328002|516713260|FG000|Open-Label Period|Withdrawal by Subject|9|||
143319293|NCT01328002|516713261|FG001|Open-Label Period|Withdrawal by Subject|0|||
143319294|NCT01328002|516713260|FG000|Open-Label Period|Lost to Follow-up|6|||
143319295|NCT01328002|516713261|FG001|Open-Label Period|Lost to Follow-up|0|||
143319296|NCT01328002|516713260|FG000|Open-Label Period|Other Reason|2|||
143379240|NCT00785512|516935381|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
143379241|NCT00785512|516935380|FG000|Overall Study|Adverse Event|0|||
143379242|NCT00785512|516935381|FG001|Overall Study|Adverse Event|0|||
143379243|NCT00785512|516935380|FG000|Overall Study|Lack of Efficacy|0|||
143319297|NCT01328002|516713261|FG001|Open-Label Period|Other Reason|0|||
143319298|NCT01328002|516713260|FG000|Double-Blind Period|Adverse Event|1|||
143319299|NCT01328002|516713261|FG001|Double-Blind Period|Adverse Event|0|||
143319300|NCT01328002|516713260|FG000|Double-Blind Period|Lack of Efficacy|1|||
143379244|NCT00785512|516935381|FG001|Overall Study|Lack of Efficacy|2|||
143379245|NCT00785512|516935380|FG000|Overall Study|Withdrawal by Subject|0|||
143379246|NCT00785512|516935381|FG001|Overall Study|Withdrawal by Subject|1|||
143379247|NCT00785512|516935380|FG000|Overall Study|Lost to Follow-up|3|||
143379248|NCT00785512|516935381|FG001|Overall Study|Lost to Follow-up|0|||
143379249|NCT00785512|516935380|FG000|Overall Study|Precedure Refused|0|||
143379250|NCT00785512|516935381|FG001|Overall Study|Precedure Refused|0|||
143379251|NCT00785512|516935380|FG000|Overall Study|IVRS Programing Error|0|||
143379252|NCT00785512|516935381|FG001|Overall Study|IVRS Programing Error|0|||
143379253|NCT00785512|516935380|FG000|Overall Study|Physician Decision|0|||
143379254|NCT00785512|516935381|FG001|Overall Study|Physician Decision|0|||
143379255|NCT00785512|516935380|FG000|Overall Study|Lack of compliance|0|||
143379256|NCT00785512|516935381|FG001|Overall Study|Lack of compliance|1|||
143379257|NCT00529100|516935386|FG000|Overall Study|Adverse Event|0|||
143379258|NCT00529100|516935387|FG001|Overall Study|Adverse Event|5|||
143379259|NCT00529100|516935386|FG000|Overall Study|Protocol Violation|0|||
143379260|NCT00529100|516935387|FG001|Overall Study|Protocol Violation|1|||
143379261|NCT00529100|516935386|FG000|Overall Study|Progressive Disease|0|||
143379262|NCT00529100|516935387|FG001|Overall Study|Progressive Disease|1|||
143379263|NCT00529100|516935386|FG000|Overall Study|Withdrawal by Subject|0|||
143379264|NCT00529100|516935387|FG001|Overall Study|Withdrawal by Subject|1|||
143379265|NCT00529100|516935386|FG000|Overall Study|Participant Ineligibility|0|||
143379266|NCT00529100|516935387|FG001|Overall Study|Participant Ineligibility|1|||
143379267|NCT00603954|516935397|FG000|Overall Study|Protocol Violation|1|||
143379268|NCT00603954|516935398|FG001|Overall Study|Protocol Violation|2|||
143379269|NCT02708108|516935399|FG000|Overall Study|Death|1|||
143379270|NCT02708108|516935400|FG001|Overall Study|Death|2|||
143379271|NCT02708108|516935399|FG000|Overall Study|Regimen change|1|||
143379272|NCT02708108|516935400|FG001|Overall Study|Regimen change|0|||
143379273|NCT02708108|516935399|FG000|Overall Study|No MRD and no imaging available|0|||
143379274|NCT02708108|516935400|FG001|Overall Study|No MRD and no imaging available|1|||
143379275|NCT04556981|516935403|FG000|Overall Study|Death|0|||
143379276|NCT04556981|516935404|FG001|Overall Study|Death|1|||
143379277|NCT04556981|516935403|FG000|Overall Study|Lost to Follow-up|2|||
143379278|NCT04556981|516935404|FG001|Overall Study|Lost to Follow-up|11|||
143379279|NCT04556981|516935403|FG000|Overall Study|Moved from the study area|1|||
143379280|NCT04556981|516935404|FG001|Overall Study|Moved from the study area|4|||
143379281|NCT04556981|516935403|FG000|Overall Study|Withdrawal by Subject|2|||
143379282|NCT04556981|516935404|FG001|Overall Study|Withdrawal by Subject|2|||
143379283|NCT04556981|516935403|FG000|Overall Study|Other|2|||
143379284|NCT04556981|516935404|FG001|Overall Study|Other|1|||
143379285|NCT02477605|516935408|FG000|Overall Study|Discontinued prior to treatment|1|||
143379286|NCT02477605|516935409|FG001|Overall Study|Discontinued prior to treatment|0|||
143379287|NCT02477605|516935408|FG000|Overall Study|Lost to Follow-up|0|||
143379288|NCT02477605|516935409|FG001|Overall Study|Lost to Follow-up|2|||
143379289|NCT02477605|516935408|FG000|Overall Study|Withdrawal by Subject|0|||
143379290|NCT02477605|516935409|FG001|Overall Study|Withdrawal by Subject|1|||
143379291|NCT02477605|516935408|FG000|Overall Study|Administered gas during surgery|0|||
143379292|NCT02477605|516935409|FG001|Overall Study|Administered gas during surgery|1|||
143379293|NCT02574455|516935411|FG000|Overall Study|Death|197|||
143379294|NCT02574455|516935412|FG001|Overall Study|Death|210|||
143379295|NCT02574455|516935411|FG000|Overall Study|Withdrawal of Consent|11|||
143379296|NCT02574455|516935412|FG001|Overall Study|Withdrawal of Consent|28|||
143379297|NCT02574455|516935411|FG000|Overall Study|Lost to Follow-up|4|||
143379298|NCT02574455|516935412|FG001|Overall Study|Lost to Follow-up|4|||
143379299|NCT02574455|516935411|FG000|Overall Study|Sponsor's Decision|55|||
143379300|NCT02574455|516935412|FG001|Overall Study|Sponsor's Decision|20|||
143379301|NCT01388361|516935413|FG000|Overall Study|Adverse Event|0|||
143379302|NCT01388361|516935414|FG001|Overall Study|Adverse Event|5|||
143379303|NCT01388361|516935415|FG002|Overall Study|Adverse Event|1|||
143379304|NCT01388361|516935413|FG000|Overall Study|Protocol Violation|0|||
143379305|NCT01388361|516935414|FG001|Overall Study|Protocol Violation|0|||
143379306|NCT01388361|516935415|FG002|Overall Study|Protocol Violation|2|||
143379307|NCT01388361|516935413|FG000|Overall Study|Withdrawal criteria|12|||
143379308|NCT01388361|516935414|FG001|Overall Study|Withdrawal criteria|7|||
143379309|NCT01388361|516935415|FG002|Overall Study|Withdrawal criteria|10|||
143379310|NCT01388361|516935413|FG000|Overall Study|Unclassified|0|||
143379311|NCT01388361|516935414|FG001|Overall Study|Unclassified|0|||
143379312|NCT01388361|516935415|FG002|Overall Study|Unclassified|1|||
143379313|NCT01061671|516935418|FG000|Overall Study|Withdrawal by Subject|16|||
143379314|NCT01061671|516935419|FG001|Overall Study|Withdrawal by Subject|20|||
143379315|NCT01061671|516935418|FG000|Overall Study|Lost to Follow-up|3|||
143379316|NCT01061671|516935419|FG001|Overall Study|Lost to Follow-up|5|||
143379317|NCT01061671|516935418|FG000|Overall Study|Death|28|||
143379318|NCT01061671|516935419|FG001|Overall Study|Death|30|||
143379319|NCT03565315|516935423|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
143379320|NCT03565315|516935424|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
143379321|NCT03565315|516935425|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
143319301|NCT01328002|516713261|FG001|Double-Blind Period|Lack of Efficacy|0|||
143319302|NCT03149328|516713262|FG000|Overall Study|Withdrawal by Subject|30|||
143319303|NCT03149328|516713263|FG001|Overall Study|Withdrawal by Subject|26|||
143319304|NCT03149328|516713262|FG000|Overall Study|Changed Dialysis Modality|18|||
143319305|NCT03149328|516713263|FG001|Overall Study|Changed Dialysis Modality|1|||
143319306|NCT03149328|516713262|FG000|Overall Study|Transplant|9|||
143319307|NCT03149328|516713263|FG001|Overall Study|Transplant|1|||
143319308|NCT03149328|516713262|FG000|Overall Study|Lost to Follow-up|25|||
143319309|NCT03149328|516713263|FG001|Overall Study|Lost to Follow-up|16|||
143319310|NCT03149328|516713262|FG000|Overall Study|Left Study Site|1|||
143319311|NCT03149328|516713263|FG001|Overall Study|Left Study Site|2|||
143319312|NCT03149328|516713262|FG000|Overall Study|Language Barrier|1|||
143319313|NCT03149328|516713263|FG001|Overall Study|Language Barrier|0|||
143319314|NCT01306617|516713267|FG000|Overall Study|Adverse Event|1|||
143319315|NCT01306617|516713268|FG001|Overall Study|Adverse Event|0|||
143319316|NCT01306617|516713269|FG002|Overall Study|Adverse Event|0|||
143319317|NCT01306617|516713267|FG000|Overall Study|Virologic Failure|0|||
143319318|NCT01306617|516713268|FG001|Overall Study|Virologic Failure|0|||
143319319|NCT01306617|516713269|FG002|Overall Study|Virologic Failure|5|||
143319320|NCT01306617|516713267|FG000|Overall Study|Non-compliance|0|||
143319321|NCT01306617|516713268|FG001|Overall Study|Non-compliance|1|||
143319322|NCT01306617|516713269|FG002|Overall Study|Non-compliance|0|||
143319323|NCT00766415|516713271|FG000|Overall Study|Withdrawal by Subject|0|||
143319324|NCT00766415|516713272|FG001|Overall Study|Withdrawal by Subject|1|||
143319325|NCT00061048|516713273|FG000|Overall Study|Adverse Event|2|||
143319326|NCT00061048|516713273|FG000|Overall Study|disease progression|20|||
143319327|NCT01114516|516713274|FG000|Overall Study|Lost to Follow-up|2|||
143319328|NCT01114516|516713275|FG001|Overall Study|Lost to Follow-up|1|||
143319329|NCT02758236|516713277|FG000|Overall Study|Investigator discretion|43|||
143319330|NCT00023452|516713278|FG000|Overall Study|Ineligible for Study|163|||
143319331|NCT00023452|516713279|FG001|Overall Study|Ineligible for Study|159|||
143319332|NCT00023452|516713278|FG000|Overall Study|Out of Window|129|||
143319333|NCT00023452|516713279|FG001|Overall Study|Out of Window|69|||
143319334|NCT00023452|516713278|FG000|Overall Study|Death|2|||
143319335|NCT00023452|516713279|FG001|Overall Study|Death|0|||
143319336|NCT00023452|516713278|FG000|Overall Study|Withdrawal by Subject|66|||
143319337|NCT00023452|516713279|FG001|Overall Study|Withdrawal by Subject|54|||
143319338|NCT00023452|516713278|FG000|Overall Study|Adverse Event|139|||
143319339|NCT00023452|516713279|FG001|Overall Study|Adverse Event|196|||
143319340|NCT00023452|516713278|FG000|Overall Study|Lost to Follow-up|293|||
143319341|NCT00023452|516713279|FG001|Overall Study|Lost to Follow-up|60|||
143319342|NCT00023452|516713278|FG000|Overall Study|Physician Decision|49|||
143319343|NCT00023452|516713279|FG001|Overall Study|Physician Decision|21|||
143319344|NCT00023452|516713278|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
143319345|NCT00023452|516713279|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
143319346|NCT00023452|516713278|FG000|Overall Study|Pregnant|53|||
143319347|NCT00023452|516713279|FG001|Overall Study|Pregnant|20|||
143319348|NCT00023452|516713278|FG000|Overall Study|Other|204|||
143319349|NCT00023452|516713279|FG001|Overall Study|Other|69|||
143319350|NCT01940705|516713284|FG000|Overall Study|Lost to Follow-up|1|||
143319351|NCT01940705|516713285|FG001|Overall Study|Lost to Follow-up|3|||
143319352|NCT01940705|516713286|FG002|Overall Study|Lost to Follow-up|2|||
143319353|NCT01940705|516713287|FG003|Overall Study|Lost to Follow-up|2|||
143319354|NCT01940705|516713284|FG000|Overall Study|Withdrawal by Subject|2|||
143319355|NCT01940705|516713285|FG001|Overall Study|Withdrawal by Subject|2|||
143319356|NCT01940705|516713286|FG002|Overall Study|Withdrawal by Subject|3|||
143319357|NCT01940705|516713287|FG003|Overall Study|Withdrawal by Subject|2|||
143319358|NCT01940705|516713284|FG000|Overall Study|Intervention not given|0|||
143319359|NCT01940705|516713285|FG001|Overall Study|Intervention not given|3|||
143319360|NCT01940705|516713286|FG002|Overall Study|Intervention not given|3|||
143319361|NCT01940705|516713287|FG003|Overall Study|Intervention not given|0|||
143379322|NCT03565315|516935426|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
143379323|NCT00440011|516935427|FG000|Overall Study|Adverse Event|2|||
143319362|NCT01940705|516713284|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
143319363|NCT01940705|516713285|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
143319364|NCT01940705|516713286|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
143319365|NCT01940705|516713287|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
143319366|NCT02770391|516713294|FG000|Overall Study|Lost to Follow-up|2|||
143319367|NCT02770391|516713294|FG000|Overall Study|Withdrawal by Subject|1|||
143319368|NCT02770391|516713294|FG000|Overall Study|Surgery delayed unevaluable|2|||
143319369|NCT02770391|516713294|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
143319370|NCT00898677|516713297|FG000|Overall Study|Adverse Event|0|||
143319371|NCT00898677|516713298|FG001|Overall Study|Adverse Event|0|||
143319372|NCT00898677|516713299|FG002|Overall Study|Adverse Event|1|||
143319373|NCT00898677|516713300|FG003|Overall Study|Adverse Event|0|||
143319374|NCT00898677|516713297|FG000|Overall Study|Lost to Follow-up|0|||
143319375|NCT00898677|516713298|FG001|Overall Study|Lost to Follow-up|0|||
143319376|NCT00898677|516713299|FG002|Overall Study|Lost to Follow-up|2|||
143379324|NCT00440011|516935428|FG001|Overall Study|Adverse Event|0|||
143379325|NCT00440011|516935427|FG000|Overall Study|Lost to Follow-up|0|||
143379326|NCT00440011|516935428|FG001|Overall Study|Lost to Follow-up|2|||
143379327|NCT00440011|516935427|FG000|Overall Study|Protocol Violation|1|||
143379328|NCT00440011|516935428|FG001|Overall Study|Protocol Violation|1|||
143379329|NCT00440011|516935427|FG000|Overall Study|Withdrawal by Subject|1|||
143379330|NCT00440011|516935428|FG001|Overall Study|Withdrawal by Subject|0|||
143379331|NCT01083316|516935432|FG000|Overall Study|Adverse Event|2|||
143379332|NCT01083316|516935432|FG000|Overall Study|Withdrawal by Subject|1|||
143379333|NCT00419341|516935433|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
143379334|NCT00419341|516935433|FG000|Wash in/Wash Out Period|Adverse Event|2|||
143379335|NCT00419341|516935433|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
143379336|NCT00419341|516935433|FG000|Efficacy Period|Withdrawal by Subject|6|||
143379337|NCT00419341|516935433|FG000|Efficacy Period|Protocol Violation|1|||
143379338|NCT00419341|516935433|FG000|Efficacy Period|Lost to Follow-up|1|||
143379339|NCT00419341|516935433|FG000|Efficacy Period|Non-compliance|1|||
143379340|NCT00419341|516935433|FG000|Efficacy Period|Termination of study site|1|||
143379341|NCT04200365|516935436|FG000|Overall Study|Adverse Event|2|||
143379342|NCT04200365|516935436|FG000|Overall Study|Progressive Disease|4|||
143379343|NCT04200365|516935436|FG000|Overall Study|Lack of Efficacy|1|||
143379344|NCT04200365|516935436|FG000|Overall Study|Study Closure|4|||
143379345|NCT01499199|516935439|FG000|Overall Study|Adverse Event|1|||
143379346|NCT01499199|516935439|FG000|Overall Study|Lack of Efficacy|1|||
143379347|NCT02139943|516935447|FG000|Overall Study|Adverse Event|0|||
143379348|NCT02139943|516935448|FG001|Overall Study|Adverse Event|1|||
143379349|NCT02139943|516935449|FG002|Overall Study|Adverse Event|2|||
143379350|NCT02139943|516935447|FG000|Overall Study|Lost to Follow-up|3|||
143379351|NCT02139943|516935448|FG001|Overall Study|Lost to Follow-up|2|||
143379352|NCT02139943|516935449|FG002|Overall Study|Lost to Follow-up|2|||
143379353|NCT02139943|516935447|FG000|Overall Study|Withdrawal by Subject|4|||
143379354|NCT02139943|516935448|FG001|Overall Study|Withdrawal by Subject|3|||
143379355|NCT02139943|516935449|FG002|Overall Study|Withdrawal by Subject|0|||
143379356|NCT02139943|516935447|FG000|Overall Study|Other|0|||
143379357|NCT02139943|516935448|FG001|Overall Study|Other|0|||
143379358|NCT02139943|516935449|FG002|Overall Study|Other|1|||
143379359|NCT02139943|516935447|FG000|Overall Study|Participant wishes to discontinue|2|||
143379360|NCT02139943|516935448|FG001|Overall Study|Participant wishes to discontinue|0|||
143379361|NCT02139943|516935449|FG002|Overall Study|Participant wishes to discontinue|0|||
143379362|NCT02139943|516935447|FG000|Overall Study|Participant in Poor Compliance|1|||
143379363|NCT02139943|516935448|FG001|Overall Study|Participant in Poor Compliance|0|||
143379364|NCT02139943|516935449|FG002|Overall Study|Participant in Poor Compliance|1|||
143379365|NCT02139943|516935447|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
143379366|NCT02139943|516935448|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
143379367|NCT02139943|516935449|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
143379368|NCT00411216|516935452|FG000|Overall Study|Ten participants were entered into the c|0|||
143379369|NCT00411216|516935453|FG001|Overall Study|Ten participants were entered into the c|2|||
143379370|NCT01251354|516935458|FG000|Overall Study|Adverse Event|1|||
143379371|NCT01251354|516935458|FG000|Overall Study|Investigator's Decision|1|||
143379372|NCT01251354|516935458|FG000|Overall Study|Disease Progression|4|||
143379373|NCT04688450|516936656|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
143379374|NCT04688450|516936656|FG000|Overall Study|Withdrawal by Subject|1|||
143379375|NCT03237481|516936657|FG000|Overall Study|Lost to Follow-up|1|||
143379376|NCT03237481|516936658|FG001|Overall Study|Lost to Follow-up|0|||
143379377|NCT03237481|516936659|FG002|Overall Study|Lost to Follow-up|0|||
143379378|NCT03237481|516936657|FG000|Overall Study|Protocol Violation|1|||
143379379|NCT03237481|516936658|FG001|Overall Study|Protocol Violation|0|||
143379380|NCT03237481|516936659|FG002|Overall Study|Protocol Violation|0|||
143379381|NCT03237481|516936657|FG000|Overall Study|Withdrawal by Subject|3|||
143379382|NCT03237481|516936658|FG001|Overall Study|Withdrawal by Subject|2|||
143379383|NCT03237481|516936659|FG002|Overall Study|Withdrawal by Subject|1|||
143379384|NCT02544074|516936660|FG000|Overall Study|Withdrawal by Subject|0|||
143379385|NCT02544074|516936661|FG001|Overall Study|Withdrawal by Subject|1|||
143379386|NCT02544074|516936662|FG002|Overall Study|Withdrawal by Subject|0|||
143379387|NCT02544074|516936663|FG003|Overall Study|Withdrawal by Subject|0|||
143379388|NCT02544074|516936664|FG004|Overall Study|Withdrawal by Subject|0|||
143379389|NCT02544074|516936665|FG005|Overall Study|Withdrawal by Subject|0|||
143379390|NCT02544074|516936666|FG006|Overall Study|Withdrawal by Subject|0|||
143379391|NCT02544074|516936667|FG007|Overall Study|Withdrawal by Subject|0|||
143379392|NCT02544074|516936668|FG008|Overall Study|Withdrawal by Subject|0|||
143379393|NCT02544074|516936669|FG009|Overall Study|Withdrawal by Subject|0|||
143379394|NCT02544074|516936670|FG010|Overall Study|Withdrawal by Subject|0|||
143379395|NCT02544074|516936671|FG011|Overall Study|Withdrawal by Subject|0|||
143379396|NCT02544074|516936672|FG012|Overall Study|Withdrawal by Subject|0|||
143379397|NCT02544074|516936673|FG013|Overall Study|Withdrawal by Subject|0|||
143379398|NCT02544074|516936674|FG014|Overall Study|Withdrawal by Subject|0|||
143319377|NCT00898677|516713300|FG003|Overall Study|Lost to Follow-up|0|||
143319378|NCT00898677|516713297|FG000|Overall Study|Protocol Violation|1|||
143319379|NCT00898677|516713298|FG001|Overall Study|Protocol Violation|1|||
143319380|NCT00898677|516713299|FG002|Overall Study|Protocol Violation|2|||
143319381|NCT00898677|516713300|FG003|Overall Study|Protocol Violation|0|||
143319382|NCT00898677|516713297|FG000|Overall Study|Withdrawal by Subject|0|||
143319383|NCT00898677|516713298|FG001|Overall Study|Withdrawal by Subject|0|||
143319384|NCT00898677|516713299|FG002|Overall Study|Withdrawal by Subject|0|||
143319385|NCT00898677|516713300|FG003|Overall Study|Withdrawal by Subject|1|||
143319386|NCT00898677|516713297|FG000|Overall Study|Not Treated: Adverse Event|0|||
143319387|NCT00898677|516713298|FG001|Overall Study|Not Treated: Adverse Event|2|||
143319388|NCT00898677|516713299|FG002|Overall Study|Not Treated: Adverse Event|1|||
143319389|NCT00898677|516713300|FG003|Overall Study|Not Treated: Adverse Event|0|||
143319390|NCT00898677|516713297|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
143319391|NCT00898677|516713298|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
143319392|NCT00898677|516713299|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
143319393|NCT00898677|516713300|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
143319394|NCT00898677|516713297|FG000|Overall Study|Not Treated: Pregnancy|0|||
143319395|NCT00898677|516713298|FG001|Overall Study|Not Treated: Pregnancy|0|||
143319396|NCT00898677|516713299|FG002|Overall Study|Not Treated: Pregnancy|1|||
143319397|NCT00898677|516713300|FG003|Overall Study|Not Treated: Pregnancy|0|||
143319398|NCT00898677|516713297|FG000|Overall Study|Not Treated: Protocol Violation|2|||
143319399|NCT00898677|516713298|FG001|Overall Study|Not Treated: Protocol Violation|0|||
143319400|NCT00898677|516713299|FG002|Overall Study|Not Treated: Protocol Violation|2|||
143319401|NCT00898677|516713300|FG003|Overall Study|Not Treated: Protocol Violation|0|||
143319402|NCT00898677|516713297|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
143319403|NCT00898677|516713298|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
143319404|NCT00898677|516713299|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
143319405|NCT00898677|516713300|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
143319406|NCT00898677|516713297|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
143319407|NCT00898677|516713298|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
143319408|NCT00898677|516713299|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
143319409|NCT00898677|516713300|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
143319410|NCT00898677|516713297|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
143319411|NCT00898677|516713298|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
143319412|NCT00898677|516713299|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
143319413|NCT00898677|516713300|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
143319414|NCT00898677|516713297|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
143319415|NCT00898677|516713298|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
143319416|NCT00898677|516713299|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
143319417|NCT00898677|516713300|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
143319418|NCT00898677|516713297|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
143319419|NCT00898677|516713298|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
143319420|NCT00898677|516713299|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
143319421|NCT00898677|516713300|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
143319422|NCT00898677|516713297|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
143319423|NCT00898677|516713298|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
143319424|NCT00898677|516713299|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
143319425|NCT00898677|516713300|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
143319426|NCT00898677|516713297|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
143319427|NCT00898677|516713298|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
143319428|NCT00898677|516713299|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
143319429|NCT00898677|516713300|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
143319430|NCT00836875|516713309|FG000|Overall Study|Death|3|||
143319431|NCT00836875|516713310|FG001|Overall Study|Death|2|||
143319432|NCT00836875|516713309|FG000|Overall Study|Withdrawal by Subject|0|||
143319433|NCT00836875|516713310|FG001|Overall Study|Withdrawal by Subject|1|||
143319434|NCT00774995|516713316|FG000|Overall Study|Protocol Violation|0|||
143319435|NCT00774995|516713317|FG001|Overall Study|Protocol Violation|0|||
143319436|NCT00774995|516713318|FG002|Overall Study|Protocol Violation|1|||
143319437|NCT00774995|516713319|FG003|Overall Study|Protocol Violation|0|||
143379399|NCT02544074|516936675|FG015|Overall Study|Withdrawal by Subject|0|||
143319438|NCT03422003|516715052|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
143319439|NCT03422003|516715053|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
143319440|NCT03422003|516715052|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
143319441|NCT03422003|516715053|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
143319442|NCT01404312|516715054|FG000|Overall Study|Death|21|||
143319443|NCT01404312|516715055|FG001|Overall Study|Death|27|||
143319444|NCT01404312|516715054|FG000|Overall Study|Withdrawal by Subject|15|||
143379400|NCT02544074|516936676|FG016|Overall Study|Withdrawal by Subject|0|||
143379401|NCT02544074|516936677|FG017|Overall Study|Withdrawal by Subject|0|||
143379402|NCT02544074|516936678|FG018|Overall Study|Withdrawal by Subject|0|||
143379403|NCT02544074|516936679|FG019|Overall Study|Withdrawal by Subject|0|||
143379404|NCT02544074|516936680|FG020|Overall Study|Withdrawal by Subject|0|||
143379405|NCT02544074|516936660|FG000|Overall Study|Tablet error|0|||
143379406|NCT02544074|516936661|FG001|Overall Study|Tablet error|0|||
143379407|NCT02544074|516936662|FG002|Overall Study|Tablet error|0|||
143379408|NCT02544074|516936663|FG003|Overall Study|Tablet error|0|||
143379409|NCT02544074|516936664|FG004|Overall Study|Tablet error|0|||
143379410|NCT02544074|516936665|FG005|Overall Study|Tablet error|1|||
143379411|NCT02544074|516936666|FG006|Overall Study|Tablet error|0|||
143379412|NCT02544074|516936667|FG007|Overall Study|Tablet error|0|||
143379413|NCT02544074|516936668|FG008|Overall Study|Tablet error|0|||
143379414|NCT02544074|516936669|FG009|Overall Study|Tablet error|1|||
143379415|NCT02544074|516936670|FG010|Overall Study|Tablet error|0|||
143379416|NCT02544074|516936671|FG011|Overall Study|Tablet error|0|||
143379417|NCT02544074|516936672|FG012|Overall Study|Tablet error|0|||
143379418|NCT02544074|516936673|FG013|Overall Study|Tablet error|0|||
143379419|NCT02544074|516936674|FG014|Overall Study|Tablet error|0|||
143379420|NCT02544074|516936675|FG015|Overall Study|Tablet error|0|||
143379421|NCT02544074|516936676|FG016|Overall Study|Tablet error|0|||
143379422|NCT02544074|516936677|FG017|Overall Study|Tablet error|0|||
143379423|NCT02544074|516936678|FG018|Overall Study|Tablet error|0|||
143379424|NCT02544074|516936679|FG019|Overall Study|Tablet error|0|||
143379425|NCT02544074|516936680|FG020|Overall Study|Tablet error|0|||
143379426|NCT05386238|516936681|FG000|Overall Study|Lost to Follow-up|3|||
143379427|NCT05386238|516936682|FG001|Overall Study|Lost to Follow-up|2|||
143379428|NCT05386238|516936681|FG000|Overall Study|Withdrawal by Subject|0|||
143379429|NCT05386238|516936682|FG001|Overall Study|Withdrawal by Subject|1|||
143379430|NCT02411084|516936684|FG000|Overall Study|Lack of Efficacy|6|||
143379431|NCT02411084|516936685|FG001|Overall Study|Lack of Efficacy|3|||
143379432|NCT02411084|516936684|FG000|Overall Study|Death|5|||
143379433|NCT02411084|516936685|FG001|Overall Study|Death|4|||
143379434|NCT02411084|516936684|FG000|Overall Study|Adverse Event|2|||
143379435|NCT02411084|516936685|FG001|Overall Study|Adverse Event|1|||
143379436|NCT02411084|516936684|FG000|Overall Study|Other reasons|0|||
143379437|NCT02411084|516936685|FG001|Overall Study|Other reasons|5|||
143379438|NCT03112174|516936688|FG000|Overall Study|Withdrawal by Subject|3|||
143379439|NCT03112174|516936689|FG001|Overall Study|Withdrawal by Subject|0|||
143379440|NCT03112174|516936690|FG002|Overall Study|Withdrawal by Subject|11|||
143379441|NCT03112174|516936691|FG003|Overall Study|Withdrawal by Subject|9|||
143379442|NCT03112174|516936692|FG004|Overall Study|Withdrawal by Subject|7|||
143379443|NCT03112174|516936688|FG000|Overall Study|Lost to Follow-up|1|||
143379444|NCT03112174|516936689|FG001|Overall Study|Lost to Follow-up|1|||
143379445|NCT03112174|516936690|FG002|Overall Study|Lost to Follow-up|2|||
143379446|NCT03112174|516936691|FG003|Overall Study|Lost to Follow-up|3|||
143379447|NCT03112174|516936692|FG004|Overall Study|Lost to Follow-up|2|||
143379448|NCT03112174|516936688|FG000|Overall Study|Death|8|||
143379449|NCT03112174|516936689|FG001|Overall Study|Death|3|||
143379450|NCT03112174|516936690|FG002|Overall Study|Death|67|||
143379451|NCT03112174|516936691|FG003|Overall Study|Death|73|||
143379452|NCT03112174|516936692|FG004|Overall Study|Death|18|||
143379453|NCT03112174|516936688|FG000|Overall Study|Other, Not Specified|1|||
143379454|NCT03112174|516936689|FG001|Overall Study|Other, Not Specified|0|||
143379455|NCT03112174|516936690|FG002|Overall Study|Other, Not Specified|1|||
143379456|NCT03112174|516936691|FG003|Overall Study|Other, Not Specified|2|||
143379457|NCT03112174|516936692|FG004|Overall Study|Other, Not Specified|0|||
143379458|NCT02748317|516936695|FG000|Overall Study|Withdrawal by Subject|14|||
143379459|NCT02748317|516936695|FG000|Overall Study|Lost to Follow-up|8|||
143379460|NCT02748317|516936695|FG000|Overall Study|Death|1|||
143379461|NCT00332241|516936696|FG000|Overall Study|Lack of Efficacy|6|||
143379462|NCT00332241|516936697|FG001|Overall Study|Lack of Efficacy|1|||
143379463|NCT00332241|516936696|FG000|Overall Study|Adverse Event|3|||
143379464|NCT00332241|516936697|FG001|Overall Study|Adverse Event|5|||
143379465|NCT00332241|516936696|FG000|Overall Study|Withdrawal by Subject|2|||
143379466|NCT00332241|516936697|FG001|Overall Study|Withdrawal by Subject|1|||
143379467|NCT00332241|516936696|FG000|Overall Study|Lost to Follow-up|4|||
143379468|NCT00332241|516936697|FG001|Overall Study|Lost to Follow-up|1|||
143379469|NCT01534494|516936698|FG000|Overall Study|Withdrawal by Subject|1|||
143379470|NCT00802464|516936699|FG000|Month 0 - Month 8|Adverse Event|0|||
143379471|NCT00802464|516936700|FG001|Month 0 - Month 8|Adverse Event|1|||
143379472|NCT00802464|516936701|FG002|Month 0 - Month 8|Adverse Event|1|||
143379473|NCT00802464|516936702|FG003|Month 0 - Month 8|Adverse Event|2|||
143379474|NCT00802464|516936699|FG000|Month 0 - Month 8|Protocol Violation|0|||
143379475|NCT00802464|516936700|FG001|Month 0 - Month 8|Protocol Violation|0|||
143379476|NCT00802464|516936701|FG002|Month 0 - Month 8|Protocol Violation|1|||
143319445|NCT01404312|516715055|FG001|Overall Study|Withdrawal by Subject|18|||
143319446|NCT01404312|516715054|FG000|Overall Study|Participant Unable to get to clinic|93|||
143319447|NCT01404312|516715055|FG001|Overall Study|Participant Unable to get to clinic|103|||
143319448|NCT01404312|516715054|FG000|Overall Study|Lost to Follow-up|115|||
143319449|NCT01404312|516715055|FG001|Overall Study|Lost to Follow-up|111|||
143319450|NCT01404312|516715054|FG000|Overall Study|Site closed|22|||
143319451|NCT01404312|516715055|FG001|Overall Study|Site closed|21|||
143319452|NCT01404312|516715054|FG000|Overall Study|Participant not willing to adhere to req|31|||
143319453|NCT01404312|516715055|FG001|Overall Study|Participant not willing to adhere to req|29|||
143319454|NCT01404312|516715054|FG000|Overall Study|Severe debilitation, unable to continue|1|||
143319455|NCT01404312|516715055|FG001|Overall Study|Severe debilitation, unable to continue|2|||
143319456|NCT03794089|516715058|FG000|Overall Study|Lost to Follow-up|4|||
143319457|NCT03794089|516715059|FG001|Overall Study|Lost to Follow-up|1|||
143319458|NCT03794089|516715058|FG000|Overall Study|Withdrawal by Subject|2|||
143319459|NCT03794089|516715059|FG001|Overall Study|Withdrawal by Subject|0|||
143319460|NCT03985423|516715060|FG000|Overall Study|Adverse Event|1|||
143319461|NCT03985423|516715060|FG000|Overall Study|Death|2|||
143319462|NCT03985423|516715060|FG000|Overall Study|Physician Decision|1|||
143319463|NCT03985423|516715060|FG000|Overall Study|Withdrawal by Subject|2|||
143319464|NCT03985423|516715060|FG000|Overall Study|Lack of insurance and citizenship|1|||
143319465|NCT01045447|516715071|FG000|Overall Study|Adverse Event|0|||
143319466|NCT01045447|516715072|FG001|Overall Study|Adverse Event|1|||
143319467|NCT01045447|516715071|FG000|Overall Study|Lack of Efficacy|3|||
143319468|NCT01045447|516715072|FG001|Overall Study|Lack of Efficacy|1|||
143319469|NCT01045447|516715071|FG000|Overall Study|Protocol Violation|6|||
143319470|NCT01045447|516715072|FG001|Overall Study|Protocol Violation|3|||
143319471|NCT01045447|516715071|FG000|Overall Study|Withdrawal Criteria|10|||
143319472|NCT01045447|516715072|FG001|Overall Study|Withdrawal Criteria|10|||
143319473|NCT01045447|516715071|FG000|Overall Study|Unclassified|17|||
143319474|NCT01045447|516715072|FG001|Overall Study|Unclassified|13|||
143319475|NCT00129987|516715073|FG000|1st Educational Session|Withdrawal by Subject|141|||
143319476|NCT00129987|516715074|FG001|1st Educational Session|Withdrawal by Subject|109|||
143319477|NCT00129987|516715073|FG000|1 Year|Withdrawal by Subject|32|||
143319478|NCT00129987|516715074|FG001|1 Year|Withdrawal by Subject|21|||
143319479|NCT00116805|516715075|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
143319480|NCT00116805|516715076|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
143319481|NCT00116805|516715075|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
143319482|NCT00116805|516715076|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
143319483|NCT00116805|516715075|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
143319484|NCT00116805|516715076|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
143319485|NCT00116805|516715075|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
143319486|NCT00116805|516715076|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
143319487|NCT00116805|516715075|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
143319488|NCT00116805|516715076|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
143319489|NCT00116805|516715075|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
143319490|NCT00116805|516715076|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
143319491|NCT00116805|516715075|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
143319492|NCT00116805|516715076|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
143319493|NCT00116805|516715075|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
143319494|NCT00116805|516715076|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
143319495|NCT00116805|516715075|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
143319496|NCT00116805|516715076|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
143319497|NCT00116805|516715075|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
143319498|NCT00116805|516715076|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
143319499|NCT00116805|516715075|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
143319500|NCT00116805|516715076|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
143319501|NCT00116805|516715075|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
143319502|NCT00116805|516715076|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
143319503|NCT00116805|516715075|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
143319504|NCT00116805|516715076|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
143319505|NCT00116805|516715075|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
143319506|NCT00116805|516715076|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
143319507|NCT00116805|516715075|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
143319508|NCT00116805|516715076|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
143319509|NCT00116805|516715075|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
143319510|NCT00116805|516715076|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
143319511|NCT00116805|516715075|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
143319512|NCT00116805|516715076|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
143319513|NCT00116805|516715075|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
143319514|NCT00116805|516715076|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
143319515|NCT00116805|516715075|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
143379477|NCT00802464|516936702|FG003|Month 0 - Month 8|Protocol Violation|0|||
143379478|NCT00802464|516936699|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
143379479|NCT00802464|516936700|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
143319516|NCT00116805|516715076|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
143319517|NCT00116805|516715075|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
143379480|NCT00802464|516936701|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
143379481|NCT00802464|516936702|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
143379482|NCT00802464|516936699|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
143379483|NCT00802464|516936700|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
143379484|NCT00802464|516936701|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
143379485|NCT00802464|516936702|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
143379486|NCT00802464|516936699|FG000|Month 0 - Month 8|Other|0|||
143379487|NCT00802464|516936700|FG001|Month 0 - Month 8|Other|0|||
143379488|NCT00802464|516936701|FG002|Month 0 - Month 8|Other|1|||
143379489|NCT00802464|516936702|FG003|Month 0 - Month 8|Other|0|||
143379490|NCT00802464|516936699|FG000|Month 8 - Month 14|Adverse Event|0|||
143379491|NCT00802464|516936700|FG001|Month 8 - Month 14|Adverse Event|1|||
143379492|NCT00802464|516936701|FG002|Month 8 - Month 14|Adverse Event|0|||
143379493|NCT00802464|516936702|FG003|Month 8 - Month 14|Adverse Event|0|||
143379494|NCT00802464|516936699|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
143379495|NCT00802464|516936700|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
143379496|NCT00802464|516936701|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
143379497|NCT00802464|516936702|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
143379498|NCT00802464|516936699|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
143379499|NCT00802464|516936700|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
143379500|NCT00802464|516936701|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
143379501|NCT00802464|516936702|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
143379502|NCT01939899|516936709|FG000|Lead-in Dose Finding Phase|Death|0|||
143379503|NCT01939899|516936710|FG001|Lead-in Dose Finding Phase|Death|3|||
143379504|NCT01939899|516936711|FG002|Lead-in Dose Finding Phase|Death|1|||
143379505|NCT01939899|516936712|FG003|Lead-in Dose Finding Phase|Death|0|||
143379506|NCT01939899|516936713|FG004|Lead-in Dose Finding Phase|Death|0|||
143379507|NCT01939899|516936709|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
143379508|NCT01939899|516936710|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
143379509|NCT01939899|516936711|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
143379510|NCT01939899|516936712|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
143379511|NCT01939899|516936713|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
143379512|NCT01939899|516936709|FG000|Lead-in Dose Finding Phase|Other|0|||
143319518|NCT00116805|516715076|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
143319519|NCT00116805|516715075|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
143319520|NCT00116805|516715076|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
143319521|NCT00116805|516715075|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
143319522|NCT00116805|516715076|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
143319523|NCT00116805|516715075|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
143319524|NCT00116805|516715076|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
143319525|NCT00116805|516715075|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
143319526|NCT00116805|516715076|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
143319527|NCT00116805|516715075|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
143319528|NCT00116805|516715076|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
143319529|NCT00116805|516715075|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
143319530|NCT00116805|516715076|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
143319531|NCT00116805|516715075|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
143319532|NCT00116805|516715076|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
143319533|NCT00116805|516715075|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
143379513|NCT01939899|516936710|FG001|Lead-in Dose Finding Phase|Other|0|||
143379514|NCT01939899|516936711|FG002|Lead-in Dose Finding Phase|Other|1|||
143379515|NCT01939899|516936712|FG003|Lead-in Dose Finding Phase|Other|0|||
143379516|NCT01939899|516936713|FG004|Lead-in Dose Finding Phase|Other|0|||
143379517|NCT01939899|516936709|FG000|Phase 2|Withdrawal by Subject|0|||
143379518|NCT01939899|516936710|FG001|Phase 2|Withdrawal by Subject|0|||
143379519|NCT01939899|516936711|FG002|Phase 2|Withdrawal by Subject|0|||
143379520|NCT01939899|516936712|FG003|Phase 2|Withdrawal by Subject|2|||
143379521|NCT01939899|516936713|FG004|Phase 2|Withdrawal by Subject|0|||
143379522|NCT01939899|516936709|FG000|Phase 2|Disease Progression|0|||
143379523|NCT01939899|516936710|FG001|Phase 2|Disease Progression|0|||
143379524|NCT01939899|516936711|FG002|Phase 2|Disease Progression|0|||
143379525|NCT01939899|516936712|FG003|Phase 2|Disease Progression|9|||
143379526|NCT01939899|516936713|FG004|Phase 2|Disease Progression|1|||
143379527|NCT01972724|516936716|FG000|Double-Blind|Rescue Criteria Met|1|||
143379528|NCT01972724|516936717|FG001|Double-Blind|Rescue Criteria Met|0|||
143379529|NCT01972724|516936718|FG002|Double-Blind|Rescue Criteria Met|0|||
143379530|NCT01972724|516936716|FG000|Double-Blind|Adverse Event|1|||
143379531|NCT01972724|516936717|FG001|Double-Blind|Adverse Event|0|||
143379532|NCT01972724|516936718|FG002|Double-Blind|Adverse Event|0|||
143379533|NCT01972724|516936716|FG000|Double-Blind|Withdrawal of Consent|2|||
143379534|NCT01972724|516936717|FG001|Double-Blind|Withdrawal of Consent|1|||
143379535|NCT01972724|516936718|FG002|Double-Blind|Withdrawal of Consent|0|||
143379536|NCT01972724|516936716|FG000|Double-Blind|Significant Protocol Deviation|5|||
143379537|NCT01972724|516936717|FG001|Double-Blind|Significant Protocol Deviation|8|||
143379538|NCT01972724|516936718|FG002|Double-Blind|Significant Protocol Deviation|0|||
143379539|NCT01972724|516936716|FG000|Open-Label|Withdrew Consent|0|||
143379540|NCT01972724|516936717|FG001|Open-Label|Withdrew Consent|0|||
143379541|NCT01972724|516936718|FG002|Open-Label|Withdrew Consent|3|||
143379542|NCT01972724|516936716|FG000|Open-Label|Significant Protocol Deviation|0|||
143379543|NCT01972724|516936717|FG001|Open-Label|Significant Protocol Deviation|0|||
143379544|NCT01972724|516936718|FG002|Open-Label|Significant Protocol Deviation|2|||
143379545|NCT02597920|516936720|FG000|Overall Study|Worsening of other pre-existing disease|0|||
143379546|NCT02597920|516936721|FG001|Overall Study|Worsening of other pre-existing disease|1|||
143379547|NCT02597920|516936722|FG002|Overall Study|Worsening of other pre-existing disease|0|||
143379548|NCT02597920|516936720|FG000|Overall Study|Other adverse event|20|||
143379549|NCT02597920|516936721|FG001|Overall Study|Other adverse event|30|||
143379550|NCT02597920|516936722|FG002|Overall Study|Other adverse event|0|||
143379551|NCT02597920|516936720|FG000|Overall Study|Lost to Follow-up|7|||
143379552|NCT02597920|516936721|FG001|Overall Study|Lost to Follow-up|9|||
143379553|NCT02597920|516936722|FG002|Overall Study|Lost to Follow-up|0|||
143379554|NCT02597920|516936720|FG000|Overall Study|Refuse to continue in the study|3|||
143379555|NCT02597920|516936721|FG001|Overall Study|Refuse to continue in the study|13|||
143379556|NCT02597920|516936722|FG002|Overall Study|Refuse to continue in the study|1|||
143379557|NCT02597920|516936720|FG000|Overall Study|Other than specified|10|||
143379558|NCT02597920|516936721|FG001|Overall Study|Other than specified|31|||
143379559|NCT02597920|516936722|FG002|Overall Study|Other than specified|5|||
143379560|NCT02597920|516936720|FG000|Overall Study|Other|1|||
143379561|NCT02597920|516936721|FG001|Overall Study|Other|0|||
143379562|NCT02597920|516936722|FG002|Overall Study|Other|0|||
143379563|NCT00642850|516936723|FG000|Overall Study|Death|7|||
143379564|NCT00642850|516936723|FG000|Overall Study|Adverse Event|2|||
143379565|NCT00642850|516936723|FG000|Overall Study|Lack of Efficacy|1|||
143379566|NCT00642850|516936723|FG000|Overall Study|Protocol Violation|2|||
143379567|NCT00642850|516936723|FG000|Overall Study|Kidney transplantation|8|||
143379568|NCT00642850|516936723|FG000|Overall Study|Blood transfusion|6|||
143379569|NCT00642850|516936723|FG000|Overall Study|Other reasons|7|||
143379570|NCT05489484|516936728|FG000|Overall Study|withdrawn|1|||
143379571|NCT00444600|516936731|FG000|Overall Study|Death|7|||
143379572|NCT00444600|516936732|FG001|Overall Study|Death|5|||
143379573|NCT00444600|516936733|FG002|Overall Study|Death|3|||
143379574|NCT00444600|516936734|FG003|Overall Study|Death|2|||
143379575|NCT00444600|516936731|FG000|Overall Study|Dropped|11|||
143379576|NCT00444600|516936732|FG001|Overall Study|Dropped|11|||
143379577|NCT00444600|516936733|FG002|Overall Study|Dropped|7|||
143379578|NCT00444600|516936734|FG003|Overall Study|Dropped|7|||
143379579|NCT00444600|516936731|FG000|Overall Study|Missed visit|1|||
143379580|NCT00444600|516936732|FG001|Overall Study|Missed visit|0|||
143379581|NCT00444600|516936733|FG002|Overall Study|Missed visit|0|||
143379582|NCT00444600|516936734|FG003|Overall Study|Missed visit|1|||
143379583|NCT00111813|516936735|FG000|Overall Study|Adverse Event|1|||
143379584|NCT00111813|516936736|FG001|Overall Study|Adverse Event|2|||
143379585|NCT00111813|516936737|FG002|Overall Study|Adverse Event|4|||
143379586|NCT00111813|516936738|FG003|Overall Study|Adverse Event|2|||
143379587|NCT00111813|516936739|FG004|Overall Study|Adverse Event|2|||
143379588|NCT00111813|516936740|FG005|Overall Study|Adverse Event|2|||
143379589|NCT00111813|516936735|FG000|Overall Study|Progressive disease|2|||
143379590|NCT00111813|516936736|FG001|Overall Study|Progressive disease|1|||
143379591|NCT00111813|516936737|FG002|Overall Study|Progressive disease|5|||
143379592|NCT00111813|516936738|FG003|Overall Study|Progressive disease|3|||
143379593|NCT00111813|516936739|FG004|Overall Study|Progressive disease|4|||
143379594|NCT00111813|516936740|FG005|Overall Study|Progressive disease|3|||
143379595|NCT00111813|516936735|FG000|Overall Study|Lack of Efficacy|0|||
143379596|NCT00111813|516936736|FG001|Overall Study|Lack of Efficacy|0|||
143379597|NCT00111813|516936737|FG002|Overall Study|Lack of Efficacy|0|||
143379598|NCT00111813|516936738|FG003|Overall Study|Lack of Efficacy|0|||
143379599|NCT00111813|516936739|FG004|Overall Study|Lack of Efficacy|0|||
143379600|NCT00111813|516936740|FG005|Overall Study|Lack of Efficacy|1|||
143379601|NCT00111813|516936735|FG000|Overall Study|Other|0|||
143319534|NCT00116805|516715076|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
143319535|NCT00116805|516715075|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
143319536|NCT00116805|516715076|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
143319537|NCT00116805|516715075|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
143319538|NCT00116805|516715076|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
143319539|NCT00116805|516715075|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
143319540|NCT00116805|516715076|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
143319541|NCT00116805|516715075|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
143319542|NCT00116805|516715076|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
143319543|NCT00116805|516715075|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
143319544|NCT00116805|516715076|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
143319545|NCT00116805|516715075|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
143319546|NCT00116805|516715076|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
143319547|NCT00116805|516715075|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
143319548|NCT00116805|516715076|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
143319549|NCT00116805|516715075|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
143319550|NCT00116805|516715076|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
143319551|NCT00116805|516715075|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
143319552|NCT00116805|516715076|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
143319553|NCT00116805|516715075|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
143319554|NCT00116805|516715076|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
143319555|NCT00116805|516715075|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
143319556|NCT00116805|516715076|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
143319557|NCT00116805|516715075|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
143319558|NCT00116805|516715076|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
143319559|NCT00116805|516715075|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
143319560|NCT00116805|516715076|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
143319561|NCT00116805|516715075|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
143319562|NCT00116805|516715076|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
143319563|NCT00116805|516715075|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
143319564|NCT00116805|516715076|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
143319565|NCT00116805|516715075|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
143319566|NCT00116805|516715076|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
143319567|NCT00116805|516715075|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
143319568|NCT00116805|516715076|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
143319569|NCT01760954|516715077|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
143319570|NCT01760954|516715078|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
143319571|NCT01760954|516715079|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
143319572|NCT01760954|516715080|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
143319573|NCT01760954|516715077|FG000|Treatment Period (6 Months)|Adverse Event|5|||
143319574|NCT01760954|516715078|FG001|Treatment Period (6 Months)|Adverse Event|3|||
143319575|NCT01760954|516715079|FG002|Treatment Period (6 Months)|Adverse Event|4|||
143319576|NCT01760954|516715080|FG003|Treatment Period (6 Months)|Adverse Event|10|||
143319577|NCT01760954|516715077|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
143319578|NCT01760954|516715078|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
143319579|NCT01760954|516715079|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
143319580|NCT01760954|516715080|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
143319581|NCT01760954|516715077|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
143319582|NCT01760954|516715078|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
143319583|NCT01760954|516715079|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
143319584|NCT01760954|516715080|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
143319585|NCT01760954|516715077|FG000|Treatment Period (6 Months)|Pregnancy|5|||
143319586|NCT01760954|516715078|FG001|Treatment Period (6 Months)|Pregnancy|0|||
143319587|NCT01760954|516715079|FG002|Treatment Period (6 Months)|Pregnancy|3|||
143319588|NCT01760954|516715080|FG003|Treatment Period (6 Months)|Pregnancy|2|||
143319589|NCT01760954|516715077|FG000|Treatment Period (6 Months)|Non-compliance|1|||
143319590|NCT01760954|516715078|FG001|Treatment Period (6 Months)|Non-compliance|4|||
143319591|NCT01760954|516715079|FG002|Treatment Period (6 Months)|Non-compliance|0|||
143319592|NCT01760954|516715080|FG003|Treatment Period (6 Months)|Non-compliance|3|||
143319593|NCT01760954|516715077|FG000|Treatment Period (6 Months)|Other|0|||
143319594|NCT01760954|516715078|FG001|Treatment Period (6 Months)|Other|3|||
143319595|NCT01760954|516715079|FG002|Treatment Period (6 Months)|Other|3|||
143319596|NCT01760954|516715080|FG003|Treatment Period (6 Months)|Other|1|||
143319597|NCT01760954|516715077|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
143319598|NCT01760954|516715078|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
143379602|NCT00111813|516936736|FG001|Overall Study|Other|0|||
143379603|NCT00111813|516936737|FG002|Overall Study|Other|1|||
143379604|NCT00111813|516936738|FG003|Overall Study|Other|0|||
143379605|NCT00111813|516936739|FG004|Overall Study|Other|0|||
143379606|NCT00111813|516936740|FG005|Overall Study|Other|0|||
143379607|NCT01985334|516936743|FG000|Overall Study|Administrative problems|1|||
143379608|NCT01985334|516936744|FG001|Overall Study|Administrative problems|1|||
143379609|NCT01985334|516936745|FG002|Overall Study|Administrative problems|0|||
143379610|NCT01985334|516936746|FG003|Overall Study|Administrative problems|2|||
143379611|NCT01985334|516936747|FG004|Overall Study|Administrative problems|0|||
143379612|NCT01985334|516936748|FG005|Overall Study|Administrative problems|1|||
143379613|NCT01985334|516936749|FG006|Overall Study|Administrative problems|1|||
143379614|NCT01985334|516936750|FG007|Overall Study|Administrative problems|3|||
143379615|NCT01985334|516936743|FG000|Overall Study|Death|1|||
143379616|NCT01985334|516936744|FG001|Overall Study|Death|0|||
143379617|NCT01985334|516936745|FG002|Overall Study|Death|0|||
143379618|NCT01985334|516936746|FG003|Overall Study|Death|3|||
143319599|NCT01760954|516715079|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
143319600|NCT01760954|516715080|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
143319601|NCT01760954|516715077|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
143319602|NCT01760954|516715078|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
143319603|NCT01760954|516715079|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
143319604|NCT01760954|516715080|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
143319605|NCT01760954|516715077|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
143319606|NCT01760954|516715078|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
143319607|NCT01760954|516715079|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
143319608|NCT01760954|516715080|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
143319609|NCT01760954|516715077|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
143319610|NCT01760954|516715078|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
143319611|NCT01760954|516715079|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
143319612|NCT01760954|516715080|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
143319613|NCT01760954|516715077|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
143319614|NCT01760954|516715078|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
143319615|NCT01760954|516715079|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
143319616|NCT01760954|516715080|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
143319617|NCT01760954|516715077|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
143319618|NCT01760954|516715078|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
143319619|NCT01760954|516715079|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
143319620|NCT01760954|516715080|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
143319621|NCT01760954|516715077|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
143319622|NCT01760954|516715078|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
143319623|NCT01760954|516715079|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
143319624|NCT01760954|516715080|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
143319625|NCT01760954|516715077|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
143319626|NCT01760954|516715078|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
143319627|NCT01760954|516715079|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
143319628|NCT01760954|516715080|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
143319629|NCT00353704|516715081|FG000|Overall Study|Protocol Violation|3|||
143319630|NCT00353704|516715082|FG001|Overall Study|Protocol Violation|1|||
143319631|NCT01343082|516715083|FG000|The run-in Period|Not meeting criteria|3|||
143319632|NCT01343082|516715084|FG001|The run-in Period|Not meeting criteria|4|||
143319633|NCT01343082|516715085|FG002|The run-in Period|Not meeting criteria|5|||
143319634|NCT01343082|516715083|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
143319635|NCT01343082|516715084|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
143319636|NCT01343082|516715085|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
143319637|NCT01343082|516715083|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
143319638|NCT01343082|516715084|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
143319639|NCT01343082|516715085|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
143319640|NCT01343082|516715083|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
143319641|NCT01343082|516715084|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
143319642|NCT01343082|516715085|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
143379619|NCT01985334|516936747|FG004|Overall Study|Death|0|||
143379620|NCT01985334|516936748|FG005|Overall Study|Death|0|||
143379621|NCT01985334|516936749|FG006|Overall Study|Death|1|||
143379622|NCT01985334|516936750|FG007|Overall Study|Death|2|||
143379623|NCT01985334|516936743|FG000|Overall Study|Worsening of disease|0|||
143379624|NCT01985334|516936744|FG001|Overall Study|Worsening of disease|0|||
143379625|NCT01985334|516936745|FG002|Overall Study|Worsening of disease|0|||
143319643|NCT01343082|516715083|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
143319644|NCT01343082|516715084|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
143319645|NCT01343082|516715085|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
143319646|NCT04265755|516715086|FG000|Overall Study|Withdrawal by Subject|39|||
143319647|NCT04265755|516715086|FG000|Overall Study|Decision by sponsor|2|||
143319648|NCT04265755|516715086|FG000|Overall Study|Lost to Follow-up|11|||
143319649|NCT04265755|516715086|FG000|Overall Study|Death|1|||
143319650|NCT01375049|516715087|FG000|Overall Study|Adverse Event|2|||
143319651|NCT01375049|516715087|FG000|Overall Study|Lost to Follow-up|1|||
143319652|NCT01375049|516715087|FG000|Overall Study|Withdrawal by Subject|2|||
143319653|NCT01375049|516715087|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
143319654|NCT01575561|516715088|FG000|Overall Study|Adverse Event|9|||
143319655|NCT01575561|516715088|FG000|Overall Study|Lack of Efficacy|8|||
143319656|NCT01575561|516715088|FG000|Overall Study|Lost to Follow-up|6|||
143319657|NCT01575561|516715088|FG000|Overall Study|Protocol Violation|4|||
143319658|NCT01575561|516715088|FG000|Overall Study|Withdrawal by Subject|11|||
143319659|NCT01575561|516715088|FG000|Overall Study|administration|1|||
143319660|NCT02554773|516715089|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
143319661|NCT02554773|516715090|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
143319662|NCT02554773|516715089|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
143319663|NCT02554773|516715090|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
143319664|NCT02554773|516715089|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
143319665|NCT02554773|516715090|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
143319666|NCT02554773|516715089|FG000|Original Dose Regimen (SAS 1)|Death|1|||
143319667|NCT02554773|516715090|FG001|Original Dose Regimen (SAS 1)|Death|0|||
143319668|NCT02554773|516715089|FG000|Original Dose Regimen (SAS 1)|Other|4|||
143319669|NCT02554773|516715090|FG001|Original Dose Regimen (SAS 1)|Other|0|||
143319670|NCT02554773|516715089|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
143319671|NCT02554773|516715090|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
143319672|NCT02554773|516715089|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
143319673|NCT02554773|516715090|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
143319674|NCT02554773|516715089|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
143319675|NCT02554773|516715090|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
143319676|NCT02554773|516715089|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
143319677|NCT02554773|516715090|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
143319678|NCT02840877|516715091|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
143319679|NCT02840877|516715091|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
143319680|NCT02840877|516715091|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
143319681|NCT02840877|516715091|FG000|Baseline to 12 Weeks|Death|1|||
143319682|NCT02840877|516715091|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
143319683|NCT02840877|516715091|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
143319684|NCT02840877|516715091|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
143319685|NCT02840877|516715091|FG000|12 Weeks to 6 Months|Treatment failure|1|||
143319686|NCT02840877|516715091|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
143319687|NCT02840877|516715091|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
143319688|NCT02840877|516715091|FG000|12 Weeks to 6 Months|Death|1|||
143319689|NCT02840877|516715091|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
143319690|NCT02840877|516715091|FG000|6 Months to 18 Months|Treatment failure|7|||
143319691|NCT02840877|516715091|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
143319692|NCT02840877|516715091|FG000|6 Months to 18 Months|Moved/transferred out|6|||
143319693|NCT02840877|516715091|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
143319694|NCT02840877|516715091|FG000|6 Months to 18 Months|Death|4|||
143319695|NCT02840877|516715091|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
143319696|NCT02840877|516715091|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
143319697|NCT02840877|516715091|FG000|6 Months to 18 Months|Still in study.|14|||
143319698|NCT02530619|516715101|FG000|Registered for Study|Withdrawal by Subject|2|||
143319699|NCT02530619|516715101|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
143319700|NCT02530619|516715101|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
143319701|NCT02530619|516715101|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
143319702|NCT02530619|516715101|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
143319703|NCT02530619|516715101|FG000|Follow-up Period (6 Months)|Death|4|||
143319704|NCT02530619|516715101|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
143319705|NCT02530619|516715101|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
143319706|NCT01854554|516715114|FG000|Overall Study|Denial of Insurance Coverage|12|||
143319707|NCT01854554|516715115|FG001|Overall Study|Denial of Insurance Coverage|0|||
143319708|NCT01854554|516715114|FG000|Overall Study|Decided to get treatment locally|1|||
143319709|NCT01854554|516715115|FG001|Overall Study|Decided to get treatment locally|5|||
143319710|NCT01854554|516715114|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
143319711|NCT01854554|516715115|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
143319712|NCT01854554|516715114|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
143319713|NCT01854554|516715115|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
143319714|NCT01854554|516715114|FG000|Overall Study|Progression|0|||
143319715|NCT01854554|516715115|FG001|Overall Study|Progression|1|||
143319716|NCT01854554|516715114|FG000|Overall Study|Lost to Follow-up|0|||
143319717|NCT01854554|516715115|FG001|Overall Study|Lost to Follow-up|1|||
143319718|NCT02819726|516715116|FG000|Part A (All Participants)|Lost to Follow-up|0|||
143319719|NCT02819726|516715117|FG001|Part A (All Participants)|Lost to Follow-up|1|||
143319720|NCT02819726|516715118|FG002|Part A (All Participants)|Lost to Follow-up|0|||
143319721|NCT02819726|516715119|FG003|Part A (All Participants)|Lost to Follow-up|0|||
143319722|NCT02819726|516715116|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
143319723|NCT02819726|516715117|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
143319724|NCT02819726|516715118|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
143319725|NCT02819726|516715119|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
143319726|NCT02819726|516715116|FG000|Part A (All Participants)|Protocol non-compliance|3|||
143319727|NCT02819726|516715117|FG001|Part A (All Participants)|Protocol non-compliance|4|||
143319728|NCT02819726|516715118|FG002|Part A (All Participants)|Protocol non-compliance|5|||
143319729|NCT02819726|516715119|FG003|Part A (All Participants)|Protocol non-compliance|0|||
143319730|NCT02819726|516715116|FG000|Part B (All Participants)|Lost to Follow-up|1|||
143319731|NCT02819726|516715117|FG001|Part B (All Participants)|Lost to Follow-up|1|||
143319732|NCT02819726|516715118|FG002|Part B (All Participants)|Lost to Follow-up|2|||
143319733|NCT02819726|516715119|FG003|Part B (All Participants)|Lost to Follow-up|2|||
143319734|NCT02819726|516715116|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
143319735|NCT02819726|516715117|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
143319736|NCT02819726|516715118|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
143319737|NCT02819726|516715119|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
143319738|NCT02819726|516715116|FG000|Part B (All Participants)|Protocol non-compliance|0|||
143319739|NCT02819726|516715117|FG001|Part B (All Participants)|Protocol non-compliance|0|||
143319740|NCT02819726|516715118|FG002|Part B (All Participants)|Protocol non-compliance|1|||
143319741|NCT02819726|516715119|FG003|Part B (All Participants)|Protocol non-compliance|0|||
143319742|NCT00359762|516715120|FG000|Period II|Adverse Event|17|||
143319743|NCT00359762|516715121|FG001|Period II|Adverse Event|0|||
143319744|NCT00359762|516715122|FG002|Period II|Adverse Event|0|||
143319745|NCT00359762|516715123|FG003|Period II|Adverse Event|0|||
143319746|NCT00359762|516715124|FG004|Period II|Adverse Event|49|||
143319747|NCT00359762|516715120|FG000|Period II|Protocol Violation|18|||
143319748|NCT00359762|516715121|FG001|Period II|Protocol Violation|0|||
143319749|NCT00359762|516715122|FG002|Period II|Protocol Violation|0|||
143319750|NCT00359762|516715123|FG003|Period II|Protocol Violation|0|||
143319751|NCT00359762|516715124|FG004|Period II|Protocol Violation|11|||
143319752|NCT00359762|516715120|FG000|Period II|Physician Decision|17|||
143319753|NCT00359762|516715121|FG001|Period II|Physician Decision|0|||
143319754|NCT00359762|516715122|FG002|Period II|Physician Decision|0|||
143319755|NCT00359762|516715123|FG003|Period II|Physician Decision|0|||
143319756|NCT00359762|516715124|FG004|Period II|Physician Decision|23|||
143319757|NCT00359762|516715120|FG000|Period II|Death|2|||
143319758|NCT00359762|516715121|FG001|Period II|Death|0|||
143319759|NCT00359762|516715122|FG002|Period II|Death|0|||
143319760|NCT00359762|516715123|FG003|Period II|Death|0|||
143319761|NCT00359762|516715124|FG004|Period II|Death|4|||
143319762|NCT00359762|516715120|FG000|Period II|Lack of Efficacy|11|||
143319763|NCT00359762|516715121|FG001|Period II|Lack of Efficacy|0|||
143319764|NCT00359762|516715122|FG002|Period II|Lack of Efficacy|0|||
143319765|NCT00359762|516715123|FG003|Period II|Lack of Efficacy|0|||
143319766|NCT00359762|516715124|FG004|Period II|Lack of Efficacy|8|||
143319767|NCT00359762|516715120|FG000|Period II|Lost to follow up|5|||
143319768|NCT00359762|516715121|FG001|Period II|Lost to follow up|0|||
143319769|NCT00359762|516715122|FG002|Period II|Lost to follow up|0|||
143319770|NCT00359762|516715123|FG003|Period II|Lost to follow up|0|||
143319771|NCT00359762|516715124|FG004|Period II|Lost to follow up|5|||
143319772|NCT00359762|516715120|FG000|Period II|Entry Criteria Not Met|8|||
143319773|NCT00359762|516715121|FG001|Period II|Entry Criteria Not Met|0|||
143319774|NCT00359762|516715122|FG002|Period II|Entry Criteria Not Met|0|||
143319775|NCT00359762|516715123|FG003|Period II|Entry Criteria Not Met|0|||
143319776|NCT00359762|516715124|FG004|Period II|Entry Criteria Not Met|4|||
143319777|NCT00359762|516715120|FG000|Period II|Subject Decision|50|||
143319778|NCT00359762|516715121|FG001|Period II|Subject Decision|0|||
143319779|NCT00359762|516715122|FG002|Period II|Subject Decision|0|||
143319780|NCT00359762|516715123|FG003|Period II|Subject Decision|0|||
143319781|NCT00359762|516715124|FG004|Period II|Subject Decision|70|||
143319782|NCT00359762|516715120|FG000|Period III|Protocol Violation|0|||
143319783|NCT00359762|516715121|FG001|Period III|Protocol Violation|5|||
143319784|NCT00359762|516715122|FG002|Period III|Protocol Violation|3|||
143319785|NCT00359762|516715123|FG003|Period III|Protocol Violation|8|||
143319786|NCT00359762|516715124|FG004|Period III|Protocol Violation|0|||
143379626|NCT01985334|516936746|FG003|Overall Study|Worsening of disease|1|||
143379627|NCT01985334|516936747|FG004|Overall Study|Worsening of disease|0|||
143379628|NCT01985334|516936748|FG005|Overall Study|Worsening of disease|3|||
143379629|NCT01985334|516936749|FG006|Overall Study|Worsening of disease|0|||
143379630|NCT01985334|516936750|FG007|Overall Study|Worsening of disease|1|||
143379631|NCT01985334|516936743|FG000|Overall Study|Other|2|||
143379632|NCT01985334|516936744|FG001|Overall Study|Other|9|||
143379633|NCT01985334|516936745|FG002|Overall Study|Other|7|||
143379634|NCT01985334|516936746|FG003|Overall Study|Other|17|||
143379635|NCT01985334|516936747|FG004|Overall Study|Other|4|||
143379636|NCT01985334|516936748|FG005|Overall Study|Other|8|||
143379637|NCT01985334|516936749|FG006|Overall Study|Other|4|||
143379638|NCT01985334|516936750|FG007|Overall Study|Other|7|||
143379639|NCT01985334|516936743|FG000|Overall Study|Protocol deviation|6|||
143379640|NCT01985334|516936744|FG001|Overall Study|Protocol deviation|31|||
143379641|NCT01985334|516936745|FG002|Overall Study|Protocol deviation|25|||
143379642|NCT01985334|516936746|FG003|Overall Study|Protocol deviation|84|||
143379643|NCT01985334|516936747|FG004|Overall Study|Protocol deviation|17|||
143379644|NCT01985334|516936748|FG005|Overall Study|Protocol deviation|47|||
143379645|NCT01985334|516936749|FG006|Overall Study|Protocol deviation|15|||
143379646|NCT01985334|516936750|FG007|Overall Study|Protocol deviation|42|||
143379647|NCT01985334|516936743|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
143379648|NCT01985334|516936744|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
143379649|NCT01985334|516936745|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
143379650|NCT01985334|516936746|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
143379651|NCT01985334|516936747|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
143379652|NCT01985334|516936748|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
143379653|NCT01985334|516936749|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
143379654|NCT01985334|516936750|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
143379655|NCT01985334|516936743|FG000|Overall Study|Subject withdrawal of consent|3|||
143379656|NCT01985334|516936744|FG001|Overall Study|Subject withdrawal of consent|6|||
143319787|NCT00359762|516715120|FG000|Period III|Adverse Event|0|||
143319788|NCT00359762|516715121|FG001|Period III|Adverse Event|3|||
143319789|NCT00359762|516715122|FG002|Period III|Adverse Event|4|||
143319790|NCT00359762|516715123|FG003|Period III|Adverse Event|10|||
143319791|NCT00359762|516715124|FG004|Period III|Adverse Event|0|||
143319792|NCT00359762|516715120|FG000|Period III|Physician Decision|0|||
143319793|NCT00359762|516715121|FG001|Period III|Physician Decision|5|||
143319794|NCT00359762|516715122|FG002|Period III|Physician Decision|9|||
143319795|NCT00359762|516715123|FG003|Period III|Physician Decision|15|||
143319796|NCT00359762|516715124|FG004|Period III|Physician Decision|0|||
143319797|NCT00359762|516715120|FG000|Period III|Lack of Efficacy|0|||
143319798|NCT00359762|516715121|FG001|Period III|Lack of Efficacy|7|||
143319799|NCT00359762|516715122|FG002|Period III|Lack of Efficacy|5|||
143319800|NCT00359762|516715123|FG003|Period III|Lack of Efficacy|9|||
143319801|NCT00359762|516715124|FG004|Period III|Lack of Efficacy|0|||
143319802|NCT00359762|516715120|FG000|Period III|Lost to follow up|0|||
143319803|NCT00359762|516715121|FG001|Period III|Lost to follow up|1|||
143319804|NCT00359762|516715122|FG002|Period III|Lost to follow up|1|||
143319805|NCT00359762|516715123|FG003|Period III|Lost to follow up|2|||
143319806|NCT00359762|516715124|FG004|Period III|Lost to follow up|0|||
143319807|NCT00359762|516715120|FG000|Period III|Entry Criteria Not Met|0|||
143319808|NCT00359762|516715121|FG001|Period III|Entry Criteria Not Met|1|||
143319809|NCT00359762|516715122|FG002|Period III|Entry Criteria Not Met|0|||
143319810|NCT00359762|516715123|FG003|Period III|Entry Criteria Not Met|1|||
143319811|NCT00359762|516715124|FG004|Period III|Entry Criteria Not Met|0|||
143379657|NCT01985334|516936745|FG002|Overall Study|Subject withdrawal of consent|2|||
143379658|NCT01985334|516936746|FG003|Overall Study|Subject withdrawal of consent|28|||
143379659|NCT01985334|516936747|FG004|Overall Study|Subject withdrawal of consent|4|||
143379660|NCT01985334|516936748|FG005|Overall Study|Subject withdrawal of consent|19|||
143379661|NCT01985334|516936749|FG006|Overall Study|Subject withdrawal of consent|0|||
143379662|NCT01985334|516936750|FG007|Overall Study|Subject withdrawal of consent|20|||
143379663|NCT01985334|516936743|FG000|Overall Study|Adverse Event|0|||
143379664|NCT01985334|516936744|FG001|Overall Study|Adverse Event|8|||
143379665|NCT01985334|516936745|FG002|Overall Study|Adverse Event|2|||
143379666|NCT01985334|516936746|FG003|Overall Study|Adverse Event|26|||
143379667|NCT01985334|516936747|FG004|Overall Study|Adverse Event|3|||
143379668|NCT01985334|516936748|FG005|Overall Study|Adverse Event|18|||
143319812|NCT00359762|516715120|FG000|Period III|Subject Decision|0|||
143319813|NCT00359762|516715121|FG001|Period III|Subject Decision|7|||
143319814|NCT00359762|516715122|FG002|Period III|Subject Decision|8|||
143379669|NCT01985334|516936749|FG006|Overall Study|Adverse Event|3|||
143379670|NCT01985334|516936750|FG007|Overall Study|Adverse Event|15|||
143379671|NCT01985334|516936743|FG000|Overall Study|Other|4|||
143379672|NCT01985334|516936744|FG001|Overall Study|Other|2|||
143319815|NCT00359762|516715123|FG003|Period III|Subject Decision|20|||
143319816|NCT00359762|516715124|FG004|Period III|Subject Decision|0|||
143319817|NCT02613481|516715128|FG000|Overall Study|Lost to Follow-up|7|||
143319818|NCT02613481|516715128|FG000|Overall Study|Withdrawal by Subject|2|||
143319819|NCT01033747|516715129|FG000|Overall Study|Adverse Event|9|||
143319820|NCT01033747|516715130|FG001|Overall Study|Adverse Event|4|||
143319821|NCT01033747|516715129|FG000|Overall Study|Abnormal Laboratory Value|1|||
143319822|NCT01033747|516715130|FG001|Overall Study|Abnormal Laboratory Value|0|||
143319823|NCT01033747|516715129|FG000|Overall Study|Abnormal test procedure|0|||
143319824|NCT01033747|516715130|FG001|Overall Study|Abnormal test procedure|1|||
143319825|NCT01033747|516715129|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
143319826|NCT01033747|516715130|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
143319827|NCT01033747|516715129|FG000|Overall Study|Protocol Violation|1|||
143319828|NCT01033747|516715130|FG001|Overall Study|Protocol Violation|0|||
143319829|NCT01033747|516715129|FG000|Overall Study|Withdrawal by Subject|9|||
143319830|NCT01033747|516715130|FG001|Overall Study|Withdrawal by Subject|6|||
143319831|NCT01033747|516715129|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
143319832|NCT01033747|516715130|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
143319833|NCT01033747|516715129|FG000|Overall Study|Stopped at end of Extension 1|2|||
143319834|NCT01033747|516715130|FG001|Overall Study|Stopped at end of Extension 1|0|||
143319835|NCT02647658|516715131|FG000|Overall Study|Consent refusal|15|||
143319836|NCT02647658|516715132|FG001|Overall Study|Consent refusal|24|||
143319837|NCT00803023|516715133|FG000|Overall Study|Adverse Event|5|||
143319838|NCT00803023|516715134|FG001|Overall Study|Adverse Event|4|||
143319839|NCT00803023|516715135|FG002|Overall Study|Adverse Event|8|||
143319840|NCT00803023|516715136|FG003|Overall Study|Adverse Event|6|||
143319841|NCT00803023|516715133|FG000|Overall Study|Withdrawal by Subject|0|||
143319842|NCT00803023|516715134|FG001|Overall Study|Withdrawal by Subject|2|||
143319843|NCT00803023|516715135|FG002|Overall Study|Withdrawal by Subject|0|||
143319844|NCT00803023|516715136|FG003|Overall Study|Withdrawal by Subject|0|||
143319845|NCT00803023|516715133|FG000|Overall Study|Lost to Follow-up|0|||
143319846|NCT00803023|516715134|FG001|Overall Study|Lost to Follow-up|1|||
143319847|NCT00803023|516715135|FG002|Overall Study|Lost to Follow-up|2|||
143319848|NCT00803023|516715136|FG003|Overall Study|Lost to Follow-up|1|||
143319849|NCT00803023|516715133|FG000|Overall Study|Lack of Efficacy|0|||
143319850|NCT00803023|516715134|FG001|Overall Study|Lack of Efficacy|1|||
143319851|NCT00803023|516715135|FG002|Overall Study|Lack of Efficacy|1|||
143319852|NCT00803023|516715136|FG003|Overall Study|Lack of Efficacy|1|||
143319853|NCT01542528|516715137|FG000|Overall Study|Lost to Follow-up|2|||
143319854|NCT01542528|516715138|FG001|Overall Study|Lost to Follow-up|1|||
143319855|NCT01542528|516715137|FG000|Overall Study|Physician Decision|1|||
143319856|NCT01542528|516715138|FG001|Overall Study|Physician Decision|0|||
143319857|NCT01542528|516715137|FG000|Overall Study|Withdrawal by Subject|9|||
143319858|NCT01542528|516715138|FG001|Overall Study|Withdrawal by Subject|6|||
143319859|NCT04382326|516715145|FG000|Overall Study|Adverse Event, not serious|1|||
143319860|NCT04382326|516715146|FG001|Overall Study|Adverse Event, not serious|2|||
143319861|NCT04382326|516715145|FG000|Overall Study|Other|1|||
143319862|NCT04382326|516715146|FG001|Overall Study|Other|0|||
143319863|NCT04382326|516715145|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
143319864|NCT04382326|516715146|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
143319865|NCT04382326|516715145|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
143319866|NCT04382326|516715146|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
143319867|NCT04382326|516715145|FG000|Overall Study|Protocol Violation|29|||
143319868|NCT04382326|516715146|FG001|Overall Study|Protocol Violation|23|||
143319869|NCT04382326|516715145|FG000|Overall Study|Physician Decision|0|||
143319870|NCT04382326|516715146|FG001|Overall Study|Physician Decision|1|||
143319871|NCT04382326|516715145|FG000|Overall Study|Lost to Follow-up|48|||
143319872|NCT04382326|516715146|FG001|Overall Study|Lost to Follow-up|63|||
143379673|NCT01985334|516936745|FG002|Overall Study|Other|3|||
143379674|NCT01985334|516936746|FG003|Overall Study|Other|10|||
143379675|NCT01985334|516936747|FG004|Overall Study|Other|1|||
143319873|NCT04382326|516715145|FG000|Overall Study|Adverse Event, non-fatal|1|||
143319874|NCT04382326|516715146|FG001|Overall Study|Adverse Event, non-fatal|1|||
143319875|NCT00406029|516715149|FG000|Overall Study|Adverse Event|12|||
143319876|NCT00406029|516715150|FG001|Overall Study|Adverse Event|2|||
143319877|NCT00406029|516715151|FG002|Overall Study|Adverse Event|5|||
143319878|NCT00406029|516715152|FG003|Overall Study|Adverse Event|10|||
143319879|NCT00406029|516715153|FG004|Overall Study|Adverse Event|7|||
143379676|NCT01985334|516936748|FG005|Overall Study|Other|6|||
143379677|NCT01985334|516936749|FG006|Overall Study|Other|2|||
143319880|NCT00406029|516715149|FG000|Overall Study|Withdrawal by Subject|3|||
143319881|NCT00406029|516715150|FG001|Overall Study|Withdrawal by Subject|4|||
143319882|NCT00406029|516715151|FG002|Overall Study|Withdrawal by Subject|2|||
143319883|NCT00406029|516715152|FG003|Overall Study|Withdrawal by Subject|2|||
143319884|NCT00406029|516715153|FG004|Overall Study|Withdrawal by Subject|0|||
143379678|NCT01985334|516936750|FG007|Overall Study|Other|2|||
143379679|NCT01985334|516936743|FG000|Overall Study|Medication non-compliance|0|||
143319885|NCT00406029|516715149|FG000|Overall Study|Protocol Violation|1|||
143319886|NCT00406029|516715150|FG001|Overall Study|Protocol Violation|2|||
143319887|NCT00406029|516715151|FG002|Overall Study|Protocol Violation|0|||
143319888|NCT00406029|516715152|FG003|Overall Study|Protocol Violation|2|||
143319889|NCT00406029|516715153|FG004|Overall Study|Protocol Violation|0|||
143319890|NCT00406029|516715149|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
143319891|NCT00406029|516715150|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
143319892|NCT00406029|516715151|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
143319893|NCT00406029|516715152|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
143319894|NCT00406029|516715153|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
143319895|NCT00406029|516715149|FG000|Overall Study|Randomized in Error|0|||
143319896|NCT00406029|516715150|FG001|Overall Study|Randomized in Error|0|||
143319897|NCT00406029|516715151|FG002|Overall Study|Randomized in Error|2|||
143319898|NCT00406029|516715152|FG003|Overall Study|Randomized in Error|3|||
143319899|NCT00406029|516715153|FG004|Overall Study|Randomized in Error|1|||
143319900|NCT03299192|516715158|FG000|Overall Study|Fell before classes started|1|||
143319901|NCT03299192|516715159|FG001|Overall Study|Fell before classes started|0|||
143319902|NCT03299192|516715160|FG002|Overall Study|Fell before classes started|0|||
143319903|NCT03299192|516715158|FG000|Overall Study|Other|0|||
143319904|NCT03299192|516715159|FG001|Overall Study|Other|2|||
143319905|NCT03299192|516715160|FG002|Overall Study|Other|1|||
143319906|NCT01652716|516715165|FG000|Overall Study|Loss of glucose control|1|||
143319907|NCT01652716|516715166|FG001|Overall Study|Loss of glucose control|0|||
143319908|NCT01652716|516715165|FG000|Overall Study|Administrative|0|||
143319909|NCT01652716|516715166|FG001|Overall Study|Administrative|2|||
143319910|NCT01652716|516715165|FG000|Overall Study|Investigator decision|1|||
143319911|NCT01652716|516715166|FG001|Overall Study|Investigator decision|4|||
143319912|NCT01652716|516715165|FG000|Overall Study|Lost to Follow-up|12|||
143319913|NCT01652716|516715166|FG001|Overall Study|Lost to Follow-up|11|||
143319914|NCT01652716|516715165|FG000|Overall Study|Protocol Violation|2|||
143319915|NCT01652716|516715166|FG001|Overall Study|Protocol Violation|1|||
143319916|NCT01652716|516715165|FG000|Overall Study|Adverse Event|7|||
143319917|NCT01652716|516715166|FG001|Overall Study|Adverse Event|10|||
143319918|NCT01652716|516715165|FG000|Overall Study|Withdrawal by Subject|33|||
143319919|NCT01652716|516715166|FG001|Overall Study|Withdrawal by Subject|18|||
143319920|NCT01337297|516715169|FG000|Overall Study|They entered to single anodal tDCS|4|||
143319921|NCT01337297|516715170|FG001|Overall Study|They entered to single anodal tDCS|3|||
143319922|NCT01337297|516715169|FG000|Overall Study|Lost to Follow-up|1|||
143319923|NCT01337297|516715170|FG001|Overall Study|Lost to Follow-up|3|||
143319924|NCT02778204|516715171|FG000|Overall Study|Adverse Event|1|||
143319925|NCT02778204|516715172|FG001|Overall Study|Adverse Event|0|||
143319926|NCT02778204|516715173|FG002|Overall Study|Adverse Event|0|||
143319927|NCT02778204|516715174|FG003|Overall Study|Adverse Event|0|||
143319928|NCT02778204|516715171|FG000|Overall Study|Withdrawal by Subject|0|||
143319929|NCT02778204|516715172|FG001|Overall Study|Withdrawal by Subject|0|||
143319930|NCT02778204|516715173|FG002|Overall Study|Withdrawal by Subject|1|||
143319931|NCT02778204|516715174|FG003|Overall Study|Withdrawal by Subject|2|||
143319932|NCT02778204|516715171|FG000|Overall Study|Lost to Follow-up|1|||
143319933|NCT02778204|516715172|FG001|Overall Study|Lost to Follow-up|0|||
143319934|NCT02778204|516715173|FG002|Overall Study|Lost to Follow-up|2|||
143319935|NCT02778204|516715174|FG003|Overall Study|Lost to Follow-up|1|||
143319936|NCT02778204|516715171|FG000|Overall Study|Protocol Violation|0|||
143319937|NCT02778204|516715172|FG001|Overall Study|Protocol Violation|0|||
143319938|NCT02778204|516715173|FG002|Overall Study|Protocol Violation|1|||
143319939|NCT02778204|516715174|FG003|Overall Study|Protocol Violation|0|||
143319940|NCT02778204|516715171|FG000|Overall Study|Eligibility Violation|0|||
143319941|NCT02778204|516715172|FG001|Overall Study|Eligibility Violation|0|||
143319942|NCT02778204|516715173|FG002|Overall Study|Eligibility Violation|0|||
143319943|NCT02778204|516715174|FG003|Overall Study|Eligibility Violation|1|||
143319944|NCT04122443|516715175|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
143379680|NCT01985334|516936744|FG001|Overall Study|Medication non-compliance|4|||
143319945|NCT04122443|516715176|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
143319946|NCT04122443|516715177|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
143319947|NCT04122443|516715175|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
143319948|NCT04122443|516715176|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
143319949|NCT04122443|516715177|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
143319950|NCT01916304|516715178|FG000|Overall Study|Screening failure|17|||
143319951|NCT01898793|516715179|FG000|Overall Study|Death|2|||
143319952|NCT01898793|516715180|FG001|Overall Study|Death|1|||
143319953|NCT01898793|516715181|FG002|Overall Study|Death|4|||
143319954|NCT01898793|516715182|FG003|Overall Study|Death|0|||
143319955|NCT01898793|516715183|FG004|Overall Study|Death|0|||
143319956|NCT01898793|516715184|FG005|Overall Study|Death|0|||
143319957|NCT01898793|516715185|FG006|Overall Study|Death|0|||
143319958|NCT01578551|516715188|FG000|Overall Study|Adverse Event|1|||
143319959|NCT01578551|516715189|FG001|Overall Study|Adverse Event|0|||
143319960|NCT04028388|516715196|FG000|Overall Study|Evaluations missing|3|||
143319961|NCT04028388|516715197|FG001|Overall Study|Evaluations missing|6|||
143319962|NCT04028388|516715196|FG000|Overall Study|Not started|2|||
143319963|NCT04028388|516715197|FG001|Overall Study|Not started|0|||
143319964|NCT01312467|516715201|FG000|Overall Study|Adverse Event|4|||
143319965|NCT01312467|516715201|FG000|Overall Study|Lost to Follow-up|1|||
143319966|NCT01312467|516715201|FG000|Overall Study|Withdrawal by Subject|2|||
143319967|NCT01312467|516715201|FG000|Overall Study|Deported to country of origin|1|||
143319968|NCT01312467|516715201|FG000|Overall Study|Another medical condition|1|||
143319969|NCT01312467|516715201|FG000|Overall Study|Ineligible|4|||
143319970|NCT00129259|516715204|FG000|Overall Study|Lost to Follow-up|1|||
143319971|NCT00129259|516715205|FG001|Overall Study|Lost to Follow-up|1|||
143319972|NCT00129259|516715204|FG000|Overall Study|Withdrawal by Subject|2|||
143319973|NCT00129259|516715205|FG001|Overall Study|Withdrawal by Subject|1|||
143319974|NCT00129259|516715204|FG000|Overall Study|Only available minimal phone assessments|0|||
143319975|NCT00129259|516715205|FG001|Overall Study|Only available minimal phone assessments|1|||
143319976|NCT01632579|516715208|FG000|Washout Period|Adverse Event|1|||
143319977|NCT01632579|516715209|FG001|Washout Period|Adverse Event|0|||
143319978|NCT01632579|516715210|FG002|Washout Period|Adverse Event|0|||
143319979|NCT01632579|516715211|FG003|Washout Period|Adverse Event|0|||
143319980|NCT01632579|516715212|FG004|Washout Period|Adverse Event|0|||
143319981|NCT01632579|516715213|FG005|Washout Period|Adverse Event|0|||
143319982|NCT01632579|516715214|FG006|Washout Period|Adverse Event|0|||
143319983|NCT01632579|516715215|FG007|Washout Period|Adverse Event|0|||
143319984|NCT01632579|516715216|FG008|Washout Period|Adverse Event|0|||
143319985|NCT01632579|516715208|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
143319986|NCT01632579|516715209|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
143319987|NCT01632579|516715210|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
143319988|NCT01632579|516715211|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
143319989|NCT01632579|516715212|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
143319990|NCT01632579|516715213|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
143319991|NCT01632579|516715214|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
143319992|NCT01632579|516715215|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
143319993|NCT01632579|516715216|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
143319994|NCT00818441|516715217|FG000|Overall Study|Death|69|||
143319995|NCT00818441|516715218|FG001|Overall Study|Death|26|||
143319996|NCT00818441|516715217|FG000|Overall Study|Other|5|||
143319997|NCT00818441|516715218|FG001|Overall Study|Other|0|||
143319998|NCT00818441|516715217|FG000|Overall Study|Lost to Follow-up|2|||
143319999|NCT00818441|516715218|FG001|Overall Study|Lost to Follow-up|1|||
143320000|NCT00818441|516715217|FG000|Overall Study|Withdrawal by Subject|2|||
143320001|NCT00818441|516715218|FG001|Overall Study|Withdrawal by Subject|0|||
143320002|NCT00818441|516715217|FG000|Overall Study|Adverse Event|0|||
143320003|NCT00818441|516715218|FG001|Overall Study|Adverse Event|1|||
143320004|NCT00818441|516715217|FG000|Overall Study|Study terminated by sponsor|11|||
143320005|NCT00818441|516715218|FG001|Overall Study|Study terminated by sponsor|2|||
143320006|NCT02199691|516715219|FG000|Overall Study|Protocol Violation|3|||
143320007|NCT02199691|516715220|FG001|Overall Study|Protocol Violation|3|||
143320008|NCT02199691|516715221|FG002|Overall Study|Protocol Violation|6|||
143320009|NCT02199691|516715222|FG003|Overall Study|Protocol Violation|7|||
143320010|NCT02199691|516715219|FG000|Overall Study|Withdrawal by Subject|5|||
143320011|NCT02199691|516715220|FG001|Overall Study|Withdrawal by Subject|3|||
143320012|NCT02199691|516715221|FG002|Overall Study|Withdrawal by Subject|12|||
143320013|NCT02199691|516715222|FG003|Overall Study|Withdrawal by Subject|13|||
143379681|NCT01985334|516936745|FG002|Overall Study|Medication non-compliance|1|||
143320014|NCT02199691|516715219|FG000|Overall Study|Lost to Follow-up|2|||
143320015|NCT02199691|516715220|FG001|Overall Study|Lost to Follow-up|1|||
143320016|NCT02199691|516715221|FG002|Overall Study|Lost to Follow-up|9|||
143320017|NCT02199691|516715222|FG003|Overall Study|Lost to Follow-up|10|||
143320018|NCT01209624|516715228|FG000|Overall Study|Death|2|||
143320019|NCT01209624|516715228|FG000|Overall Study|Adverse Event|13|||
143320020|NCT01209624|516715228|FG000|Overall Study|Lack of Efficacy|17|||
143379682|NCT01985334|516936746|FG003|Overall Study|Medication non-compliance|6|||
143320021|NCT01209624|516715228|FG000|Overall Study|Lost to Follow-up|290|||
143320022|NCT01209624|516715228|FG000|Overall Study|Other|4|||
143320023|NCT03403634|516715233|FG000|Overall Study|Disease progression|3|||
143320024|NCT03403634|516715233|FG000|Overall Study|Did not meet eligibility criteria|4|||
143320025|NCT03964454|516715234|FG000|Overall Study|Lost to Follow-up|13|||
143320026|NCT03964454|516715235|FG001|Overall Study|Lost to Follow-up|7|||
143320027|NCT03964454|516715234|FG000|Overall Study|Withdrawal by Subject|4|||
143320028|NCT03964454|516715235|FG001|Overall Study|Withdrawal by Subject|11|||
143320029|NCT00071487|516717191|FG000|52-Week Double-Blind Period|Adverse Event|5|||
143320030|NCT00071487|516717192|FG001|52-Week Double-Blind Period|Adverse Event|8|||
143320031|NCT00071487|516717193|FG002|52-Week Double-Blind Period|Adverse Event|4|||
143320032|NCT00071487|516717194|FG003|52-Week Double-Blind Period|Adverse Event|8|||
143320033|NCT00071487|516717191|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
143320034|NCT00071487|516717192|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
143320035|NCT00071487|516717193|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
143320036|NCT00071487|516717194|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
143320037|NCT00071487|516717191|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
143320038|NCT00071487|516717192|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
143320039|NCT00071487|516717193|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
143320040|NCT00071487|516717194|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
143320041|NCT00071487|516717191|FG000|52-Week Double-Blind Period|Physician Decision|1|||
143320042|NCT00071487|516717192|FG001|52-Week Double-Blind Period|Physician Decision|0|||
143320043|NCT00071487|516717193|FG002|52-Week Double-Blind Period|Physician Decision|0|||
143320044|NCT00071487|516717194|FG003|52-Week Double-Blind Period|Physician Decision|0|||
143320045|NCT00071487|516717191|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
143320046|NCT00071487|516717192|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
143320047|NCT00071487|516717193|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
143320048|NCT00071487|516717194|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
143320049|NCT00071487|516717191|FG000|52-Week Double-Blind Period|Pregnancy|0|||
143320050|NCT00071487|516717192|FG001|52-Week Double-Blind Period|Pregnancy|1|||
143320051|NCT00071487|516717193|FG002|52-Week Double-Blind Period|Pregnancy|0|||
143320052|NCT00071487|516717194|FG003|52-Week Double-Blind Period|Pregnancy|0|||
143320053|NCT00071487|516717191|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
143320054|NCT00071487|516717192|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
143320055|NCT00071487|516717193|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
143320056|NCT00071487|516717194|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
143320057|NCT00071487|516717191|FG000|52-Week Double-Blind Period|Death|0|||
143320058|NCT00071487|516717192|FG001|52-Week Double-Blind Period|Death|1|||
143320059|NCT00071487|516717193|FG002|52-Week Double-Blind Period|Death|0|||
143320060|NCT00071487|516717194|FG003|52-Week Double-Blind Period|Death|0|||
143320061|NCT00071487|516717191|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
143320062|NCT00071487|516717192|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
143320063|NCT00071487|516717193|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
143320064|NCT00071487|516717194|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
143320065|NCT00071487|516717191|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
143320066|NCT00071487|516717192|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
143320067|NCT00071487|516717193|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
143320068|NCT00071487|516717194|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
143320069|NCT00071487|516717191|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
143320070|NCT00071487|516717192|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
143320071|NCT00071487|516717193|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
143320072|NCT00071487|516717194|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
143320073|NCT00071487|516717191|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
143320074|NCT00071487|516717192|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
143320075|NCT00071487|516717193|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
143320076|NCT00071487|516717194|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
143320077|NCT00071487|516717191|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
143320078|NCT00071487|516717192|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
143320079|NCT00071487|516717193|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
143320080|NCT00071487|516717194|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
143320081|NCT00071487|516717191|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
143320082|NCT00071487|516717192|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
143320083|NCT00071487|516717193|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
143320084|NCT00071487|516717194|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
143320085|NCT00071487|516717191|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
143320086|NCT00071487|516717192|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
143320087|NCT00071487|516717193|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
143320088|NCT00071487|516717194|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
143320089|NCT02318329|516717197|FG000|Overall Study|Progressive Disease|2|||
143320090|NCT02318329|516717198|FG001|Overall Study|Progressive Disease|3|||
143320091|NCT02318329|516717199|FG002|Overall Study|Progressive Disease|2|||
143379683|NCT01985334|516936747|FG004|Overall Study|Medication non-compliance|2|||
143379684|NCT01985334|516936748|FG005|Overall Study|Medication non-compliance|3|||
143379685|NCT01985334|516936749|FG006|Overall Study|Medication non-compliance|1|||
143379686|NCT01985334|516936750|FG007|Overall Study|Medication non-compliance|3|||
143379687|NCT01985334|516936743|FG000|Overall Study|Use of prohibited treatment|1|||
143379688|NCT01985334|516936744|FG001|Overall Study|Use of prohibited treatment|4|||
143379689|NCT01985334|516936745|FG002|Overall Study|Use of prohibited treatment|1|||
143379690|NCT01985334|516936746|FG003|Overall Study|Use of prohibited treatment|2|||
143379691|NCT01985334|516936747|FG004|Overall Study|Use of prohibited treatment|1|||
143379692|NCT01985334|516936748|FG005|Overall Study|Use of prohibited treatment|6|||
143379693|NCT01985334|516936749|FG006|Overall Study|Use of prohibited treatment|2|||
143379694|NCT01985334|516936750|FG007|Overall Study|Use of prohibited treatment|0|||
143379695|NCT01985334|516936743|FG000|Overall Study|Investigator decision|0|||
143379696|NCT01985334|516936744|FG001|Overall Study|Investigator decision|3|||
143379697|NCT01985334|516936745|FG002|Overall Study|Investigator decision|0|||
143379698|NCT01985334|516936746|FG003|Overall Study|Investigator decision|7|||
143379699|NCT01985334|516936747|FG004|Overall Study|Investigator decision|1|||
143379700|NCT01985334|516936748|FG005|Overall Study|Investigator decision|1|||
143379701|NCT01985334|516936749|FG006|Overall Study|Investigator decision|0|||
143379702|NCT01985334|516936750|FG007|Overall Study|Investigator decision|4|||
143379703|NCT01985334|516936743|FG000|Overall Study|Lost to Follow-up|0|||
143379704|NCT01985334|516936744|FG001|Overall Study|Lost to Follow-up|2|||
143379705|NCT01985334|516936745|FG002|Overall Study|Lost to Follow-up|0|||
143379706|NCT01985334|516936746|FG003|Overall Study|Lost to Follow-up|3|||
143379707|NCT01985334|516936747|FG004|Overall Study|Lost to Follow-up|1|||
143379708|NCT01985334|516936748|FG005|Overall Study|Lost to Follow-up|4|||
143379709|NCT01985334|516936749|FG006|Overall Study|Lost to Follow-up|0|||
143379710|NCT01985334|516936750|FG007|Overall Study|Lost to Follow-up|3|||
143379711|NCT00914589|516936751|FG000|Overall Study|Adverse Event|1|||
143379712|NCT00914589|516936752|FG001|Overall Study|Adverse Event|0|||
143379713|NCT00914589|516936753|FG002|Overall Study|Adverse Event|1|||
143379714|NCT00914589|516936751|FG000|Overall Study|Protocol Violation|8|||
143379715|NCT00914589|516936752|FG001|Overall Study|Protocol Violation|6|||
143379716|NCT00914589|516936753|FG002|Overall Study|Protocol Violation|3|||
143379717|NCT00914589|516936751|FG000|Overall Study|unclassified|16|||
143379718|NCT00914589|516936752|FG001|Overall Study|unclassified|9|||
143379719|NCT00914589|516936753|FG002|Overall Study|unclassified|7|||
143379720|NCT00914589|516936751|FG000|Overall Study|Death|0|||
143379721|NCT00914589|516936752|FG001|Overall Study|Death|1|||
143379722|NCT00914589|516936753|FG002|Overall Study|Death|1|||
143379723|NCT00520546|516936758|FG000|Overall Study|Withdrawal by Subject|1|||
143379724|NCT00520546|516936758|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
143379725|NCT03988023|516936762|FG000|Overall Study|Non-compliance|3|||
143379726|NCT03988023|516936763|FG001|Overall Study|Non-compliance|0|||
143379727|NCT03988023|516936762|FG000|Overall Study|Withdrawal by Subject|39|||
143379728|NCT03988023|516936763|FG001|Overall Study|Withdrawal by Subject|37|||
143379729|NCT03988023|516936762|FG000|Overall Study|Adverse Event|0|||
143379730|NCT03988023|516936763|FG001|Overall Study|Adverse Event|2|||
143379731|NCT03988023|516936762|FG000|Overall Study|Physician Decision|0|||
143379732|NCT03988023|516936763|FG001|Overall Study|Physician Decision|1|||
143379733|NCT03988023|516936762|FG000|Overall Study|Lost to Follow-up|5|||
143379734|NCT03988023|516936763|FG001|Overall Study|Lost to Follow-up|8|||
143379735|NCT03988023|516936762|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
143379736|NCT03988023|516936763|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
143379737|NCT03988023|516936762|FG000|Overall Study|Lack of Efficacy|3|||
143379738|NCT03988023|516936763|FG001|Overall Study|Lack of Efficacy|1|||
143379739|NCT03988023|516936762|FG000|Overall Study|COVID-19 pandemic|225|||
143379740|NCT03988023|516936763|FG001|Overall Study|COVID-19 pandemic|227|||
143379741|NCT03733119|516936765|FG000|Overall Study|Physician Decision|2|||
143379742|NCT03733119|516936766|FG001|Overall Study|Physician Decision|1|||
143379743|NCT03733119|516936765|FG000|Overall Study|ineligible to treat per protocol|0|||
143379744|NCT03733119|516936766|FG001|Overall Study|ineligible to treat per protocol|1|||
143379745|NCT03684044|516936767|FG000|Overall Study|Adverse Event|3|||
143379746|NCT03684044|516936768|FG001|Overall Study|Adverse Event|0|||
143379747|NCT03684044|516936767|FG000|Overall Study|Death|4|||
143379748|NCT03684044|516936768|FG001|Overall Study|Death|7|||
143379749|NCT03684044|516936767|FG000|Overall Study|Lost to Follow-up|3|||
143379750|NCT03684044|516936768|FG001|Overall Study|Lost to Follow-up|2|||
143379751|NCT03684044|516936767|FG000|Overall Study|Patient Not Available|0|||
143379752|NCT03684044|516936768|FG001|Overall Study|Patient Not Available|2|||
143379753|NCT03684044|516936767|FG000|Overall Study|Physician Decision|1|||
143379754|NCT03684044|516936768|FG001|Overall Study|Physician Decision|0|||
143379755|NCT03684044|516936767|FG000|Overall Study|Withdrawal by Subject|11|||
143379756|NCT03684044|516936768|FG001|Overall Study|Withdrawal by Subject|9|||
143379757|NCT03703336|516936769|FG000|Overall Study|Parent withdrew consent|29|||
143379758|NCT03703336|516936770|FG001|Overall Study|Parent withdrew consent|8|||
143379759|NCT03703336|516936769|FG000|Overall Study|Migration|3|||
143379760|NCT03703336|516936770|FG001|Overall Study|Migration|3|||
143320092|NCT02318329|516717200|FG003|Overall Study|Progressive Disease|3|||
143320093|NCT02318329|516717201|FG004|Overall Study|Progressive Disease|3|||
143320094|NCT02318329|516717202|FG005|Overall Study|Progressive Disease|3|||
143320095|NCT02318329|516717203|FG006|Overall Study|Progressive Disease|1|||
143320096|NCT02318329|516717204|FG007|Overall Study|Progressive Disease|1|||
143320097|NCT02318329|516717205|FG008|Overall Study|Progressive Disease|5|||
143320098|NCT02318329|516717206|FG009|Overall Study|Progressive Disease|39|||
143320099|NCT02318329|516717197|FG000|Overall Study|Death|0|||
143320100|NCT02318329|516717198|FG001|Overall Study|Death|0|||
143320101|NCT02318329|516717199|FG002|Overall Study|Death|0|||
143320102|NCT02318329|516717200|FG003|Overall Study|Death|0|||
143320103|NCT02318329|516717201|FG004|Overall Study|Death|0|||
143320104|NCT02318329|516717202|FG005|Overall Study|Death|0|||
143320105|NCT02318329|516717203|FG006|Overall Study|Death|0|||
143320106|NCT02318329|516717204|FG007|Overall Study|Death|0|||
143320107|NCT02318329|516717205|FG008|Overall Study|Death|0|||
143320108|NCT02318329|516717206|FG009|Overall Study|Death|5|||
143320109|NCT02318329|516717197|FG000|Overall Study|Lost to Follow-up|0|||
143320110|NCT02318329|516717198|FG001|Overall Study|Lost to Follow-up|0|||
143320111|NCT02318329|516717199|FG002|Overall Study|Lost to Follow-up|0|||
143320112|NCT02318329|516717200|FG003|Overall Study|Lost to Follow-up|0|||
143320113|NCT02318329|516717201|FG004|Overall Study|Lost to Follow-up|0|||
143320114|NCT02318329|516717202|FG005|Overall Study|Lost to Follow-up|0|||
143320115|NCT02318329|516717203|FG006|Overall Study|Lost to Follow-up|0|||
143320116|NCT02318329|516717204|FG007|Overall Study|Lost to Follow-up|0|||
143320117|NCT02318329|516717205|FG008|Overall Study|Lost to Follow-up|0|||
143320118|NCT02318329|516717206|FG009|Overall Study|Lost to Follow-up|1|||
143320119|NCT02318329|516717197|FG000|Overall Study|Withdrawal by Subject|0|||
143320120|NCT02318329|516717198|FG001|Overall Study|Withdrawal by Subject|0|||
143320121|NCT02318329|516717199|FG002|Overall Study|Withdrawal by Subject|0|||
143320122|NCT02318329|516717200|FG003|Overall Study|Withdrawal by Subject|0|||
143320123|NCT02318329|516717201|FG004|Overall Study|Withdrawal by Subject|0|||
143320124|NCT02318329|516717202|FG005|Overall Study|Withdrawal by Subject|0|||
143320125|NCT02318329|516717203|FG006|Overall Study|Withdrawal by Subject|0|||
143320126|NCT02318329|516717204|FG007|Overall Study|Withdrawal by Subject|0|||
143320127|NCT02318329|516717205|FG008|Overall Study|Withdrawal by Subject|0|||
143320128|NCT02318329|516717206|FG009|Overall Study|Withdrawal by Subject|6|||
143320129|NCT02318329|516717197|FG000|Overall Study|Other|1|||
143320130|NCT02318329|516717198|FG001|Overall Study|Other|1|||
143320131|NCT02318329|516717199|FG002|Overall Study|Other|1|||
143320132|NCT02318329|516717200|FG003|Overall Study|Other|0|||
143320133|NCT02318329|516717201|FG004|Overall Study|Other|0|||
143320134|NCT02318329|516717202|FG005|Overall Study|Other|0|||
143320135|NCT02318329|516717203|FG006|Overall Study|Other|0|||
143320136|NCT02318329|516717204|FG007|Overall Study|Other|0|||
143320137|NCT02318329|516717205|FG008|Overall Study|Other|1|||
143320138|NCT02318329|516717206|FG009|Overall Study|Other|1|||
143320139|NCT00581945|516717209|FG000|Overall Study|Adverse Event|4|||
143320140|NCT00581945|516717210|FG001|Overall Study|Adverse Event|4|||
143320141|NCT00581945|516717209|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
143320142|NCT00581945|516717210|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
143320143|NCT00581945|516717209|FG000|Overall Study|Withdrawal by Subject|2|||
143320144|NCT00581945|516717210|FG001|Overall Study|Withdrawal by Subject|6|||
143320145|NCT00581945|516717209|FG000|Overall Study|Death|1|||
143320146|NCT00581945|516717210|FG001|Overall Study|Death|0|||
143320147|NCT01075321|516717217|FG000|Overall Study|Withdrawal by Subject|0|||
143320148|NCT01075321|516717218|FG001|Overall Study|Withdrawal by Subject|0|||
143320149|NCT01075321|516717219|FG002|Overall Study|Withdrawal by Subject|1|||
143379761|NCT03703336|516936769|FG000|Overall Study|Protocol Violation|3|||
143379762|NCT03703336|516936770|FG001|Overall Study|Protocol Violation|1|||
143379763|NCT03703336|516936769|FG000|Overall Study|Physician Decision|2|||
143379764|NCT03703336|516936770|FG001|Overall Study|Physician Decision|0|||
143379765|NCT03703336|516936769|FG000|Overall Study|Adverse Event|0|||
143379766|NCT03703336|516936770|FG001|Overall Study|Adverse Event|2|||
143320150|NCT01075321|516717220|FG003|Overall Study|Withdrawal by Subject|1|||
143320151|NCT01075321|516717217|FG000|Overall Study|Protocol Violation|0|||
143320152|NCT01075321|516717218|FG001|Overall Study|Protocol Violation|0|||
143320153|NCT01075321|516717219|FG002|Overall Study|Protocol Violation|1|||
143320154|NCT01075321|516717220|FG003|Overall Study|Protocol Violation|0|||
143320155|NCT01075321|516717217|FG000|Overall Study|Treatment Incomplete due to progression|1|||
143320156|NCT01075321|516717218|FG001|Overall Study|Treatment Incomplete due to progression|0|||
143320157|NCT01075321|516717219|FG002|Overall Study|Treatment Incomplete due to progression|0|||
143320158|NCT01075321|516717220|FG003|Overall Study|Treatment Incomplete due to progression|0|||
143320159|NCT01075321|516717217|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
143320160|NCT01075321|516717218|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
143320161|NCT01075321|516717219|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
143379767|NCT03703336|516936769|FG000|Overall Study|Lost to Follow-up|1|||
143379768|NCT03703336|516936770|FG001|Overall Study|Lost to Follow-up|0|||
143320162|NCT01075321|516717220|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
143379769|NCT02568683|516936771|FG000|Overall Study|Death|0|||
143320163|NCT02032901|516717221|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
143320164|NCT02032901|516717222|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
143320165|NCT02032901|516717221|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
143320166|NCT02032901|516717222|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
143320167|NCT01722331|516717223|FG000|Part 1|Adverse Event|5|||
143320168|NCT01722331|516717224|FG001|Part 1|Adverse Event|0|||
143320169|NCT01722331|516717225|FG002|Part 1|Adverse Event|0|||
143320170|NCT01722331|516717226|FG003|Part 1|Adverse Event|0|||
143320171|NCT01722331|516717227|FG004|Part 1|Adverse Event|0|||
143320172|NCT01722331|516717228|FG005|Part 1|Adverse Event|0|||
143320173|NCT01722331|516717229|FG006|Part 1|Adverse Event|0|||
143320174|NCT01722331|516717223|FG000|Part 1|Lack of Efficacy|0|||
143320175|NCT01722331|516717224|FG001|Part 1|Lack of Efficacy|0|||
143320176|NCT01722331|516717225|FG002|Part 1|Lack of Efficacy|1|||
143320177|NCT01722331|516717226|FG003|Part 1|Lack of Efficacy|0|||
143320178|NCT01722331|516717227|FG004|Part 1|Lack of Efficacy|2|||
143320179|NCT01722331|516717228|FG005|Part 1|Lack of Efficacy|0|||
143320180|NCT01722331|516717229|FG006|Part 1|Lack of Efficacy|0|||
143320181|NCT01722331|516717223|FG000|Part 1|Lost to Follow-up|1|||
143320182|NCT01722331|516717224|FG001|Part 1|Lost to Follow-up|0|||
143320183|NCT01722331|516717225|FG002|Part 1|Lost to Follow-up|2|||
143320184|NCT01722331|516717226|FG003|Part 1|Lost to Follow-up|0|||
143320185|NCT01722331|516717227|FG004|Part 1|Lost to Follow-up|1|||
143320186|NCT01722331|516717228|FG005|Part 1|Lost to Follow-up|0|||
143320187|NCT01722331|516717229|FG006|Part 1|Lost to Follow-up|0|||
143320188|NCT01722331|516717223|FG000|Part 1|Physician Decision|0|||
143320189|NCT01722331|516717224|FG001|Part 1|Physician Decision|0|||
143320190|NCT01722331|516717225|FG002|Part 1|Physician Decision|3|||
143320191|NCT01722331|516717226|FG003|Part 1|Physician Decision|0|||
143320192|NCT01722331|516717227|FG004|Part 1|Physician Decision|1|||
143320193|NCT01722331|516717228|FG005|Part 1|Physician Decision|0|||
143320194|NCT01722331|516717229|FG006|Part 1|Physician Decision|0|||
143320195|NCT01722331|516717223|FG000|Part 1|Pregnancy|1|||
143320196|NCT01722331|516717224|FG001|Part 1|Pregnancy|0|||
143320197|NCT01722331|516717225|FG002|Part 1|Pregnancy|0|||
143320198|NCT01722331|516717226|FG003|Part 1|Pregnancy|0|||
143320199|NCT01722331|516717227|FG004|Part 1|Pregnancy|0|||
143320200|NCT01722331|516717228|FG005|Part 1|Pregnancy|0|||
143320201|NCT01722331|516717229|FG006|Part 1|Pregnancy|0|||
143320202|NCT01722331|516717223|FG000|Part 1|Progressive Disease|0|||
143320203|NCT01722331|516717224|FG001|Part 1|Progressive Disease|0|||
143320204|NCT01722331|516717225|FG002|Part 1|Progressive Disease|0|||
143320205|NCT01722331|516717226|FG003|Part 1|Progressive Disease|0|||
143320206|NCT01722331|516717227|FG004|Part 1|Progressive Disease|1|||
143320207|NCT01722331|516717228|FG005|Part 1|Progressive Disease|0|||
143320208|NCT01722331|516717229|FG006|Part 1|Progressive Disease|0|||
143320209|NCT01722331|516717223|FG000|Part 1|Protocol Violation|1|||
143320210|NCT01722331|516717224|FG001|Part 1|Protocol Violation|0|||
143320211|NCT01722331|516717225|FG002|Part 1|Protocol Violation|0|||
143320212|NCT01722331|516717226|FG003|Part 1|Protocol Violation|0|||
143320213|NCT01722331|516717227|FG004|Part 1|Protocol Violation|1|||
143320214|NCT01722331|516717228|FG005|Part 1|Protocol Violation|0|||
143320215|NCT01722331|516717229|FG006|Part 1|Protocol Violation|0|||
143320216|NCT01722331|516717223|FG000|Part 1|Withdrawal by Subject|2|||
143320217|NCT01722331|516717224|FG001|Part 1|Withdrawal by Subject|0|||
143320218|NCT01722331|516717225|FG002|Part 1|Withdrawal by Subject|3|||
143320219|NCT01722331|516717226|FG003|Part 1|Withdrawal by Subject|0|||
143320220|NCT01722331|516717227|FG004|Part 1|Withdrawal by Subject|3|||
143320221|NCT01722331|516717228|FG005|Part 1|Withdrawal by Subject|0|||
143320222|NCT01722331|516717229|FG006|Part 1|Withdrawal by Subject|0|||
143320223|NCT01722331|516717223|FG000|Part 2|Adverse Event|3|||
143320224|NCT01722331|516717224|FG001|Part 2|Adverse Event|0|||
143320225|NCT01722331|516717225|FG002|Part 2|Adverse Event|0|||
143379770|NCT02568683|516936772|FG001|Overall Study|Death|2|||
143379771|NCT02568683|516936771|FG000|Overall Study|Withdrew Consent|1|||
143379772|NCT02568683|516936772|FG001|Overall Study|Withdrew Consent|0|||
143379773|NCT02568683|516936771|FG000|Overall Study|Study Terminated By Sponsor|5|||
143379774|NCT02568683|516936772|FG001|Overall Study|Study Terminated By Sponsor|2|||
143379775|NCT03807778|516936788|FG000|Overall Study|Adverse Event|0|||
143379776|NCT03807778|516936789|FG001|Overall Study|Adverse Event|0|||
143379777|NCT03807778|516936790|FG002|Overall Study|Adverse Event|3|||
143379778|NCT03807778|516936791|FG003|Overall Study|Adverse Event|5|||
143379779|NCT03807778|516936788|FG000|Overall Study|Progressive Disease|4|||
143379780|NCT03807778|516936789|FG001|Overall Study|Progressive Disease|2|||
143379781|NCT03807778|516936790|FG002|Overall Study|Progressive Disease|8|||
143379782|NCT03807778|516936791|FG003|Overall Study|Progressive Disease|15|||
143379783|NCT03807778|516936788|FG000|Overall Study|Symptomatic Deterioration|0|||
143379784|NCT03807778|516936789|FG001|Overall Study|Symptomatic Deterioration|1|||
143379785|NCT03807778|516936790|FG002|Overall Study|Symptomatic Deterioration|0|||
143379786|NCT03807778|516936791|FG003|Overall Study|Symptomatic Deterioration|1|||
143379787|NCT03807778|516936788|FG000|Overall Study|Withdrawal by Subject|0|||
143379788|NCT03807778|516936789|FG001|Overall Study|Withdrawal by Subject|1|||
143379789|NCT03807778|516936790|FG002|Overall Study|Withdrawal by Subject|0|||
143379790|NCT03807778|516936791|FG003|Overall Study|Withdrawal by Subject|1|||
143379791|NCT03807778|516936788|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
143379792|NCT03807778|516936789|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
143379793|NCT03807778|516936790|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
143379794|NCT03807778|516936791|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
143379795|NCT03960463|516938092|FG000|Overall Study|Withdrawal by Subject|2|||
143379796|NCT03960463|516938093|FG001|Overall Study|Withdrawal by Subject|0|||
143379797|NCT05568615|516938094|FG000|Overall Study|Death|1|||
143379798|NCT05568615|516938094|FG000|Overall Study|Physician Decision|1|||
143379799|NCT05194917|516938095|FG000|Overall Study|Lost to Follow-up|7|||
143379800|NCT05194917|516938096|FG001|Overall Study|Lost to Follow-up|5|||
143379801|NCT05194917|516938097|FG002|Overall Study|Lost to Follow-up|6|||
143379802|NCT05194917|516938098|FG003|Overall Study|Lost to Follow-up|5|||
143379803|NCT03481777|516938108|FG000|Overall Study|Withdrawal by Subject|36|||
143379804|NCT03481777|516938109|FG001|Overall Study|Withdrawal by Subject|31|||
143379805|NCT03481777|516938108|FG000|Overall Study|Non stroke = non target population|277|||
143379806|NCT03481777|516938109|FG001|Overall Study|Non stroke = non target population|254|||
143379807|NCT04139668|516938114|FG000|Overall Study|Withdrawal by Subject|1|||
143379808|NCT04300647|516938116|FG000|Pre-Crossover|Death|19|||
143379809|NCT04300647|516938117|FG001|Pre-Crossover|Death|58|||
143379810|NCT04300647|516938118|FG002|Pre-Crossover|Death|0|||
143379811|NCT04300647|516938116|FG000|Pre-Crossover|Lost to Follow-up|0|||
143379812|NCT04300647|516938117|FG001|Pre-Crossover|Lost to Follow-up|3|||
143379813|NCT04300647|516938118|FG002|Pre-Crossover|Lost to Follow-up|0|||
143379814|NCT04300647|516938116|FG000|Pre-Crossover|Withdrawal by Subject|2|||
143379815|NCT04300647|516938117|FG001|Pre-Crossover|Withdrawal by Subject|4|||
143379816|NCT04300647|516938118|FG002|Pre-Crossover|Withdrawal by Subject|0|||
143379817|NCT04300647|516938116|FG000|Pre-Crossover|On-going in Study|24|||
143379818|NCT04300647|516938117|FG001|Pre-Crossover|On-going in Study|61|||
143379819|NCT04300647|516938118|FG002|Pre-Crossover|On-going in Study|0|||
143379820|NCT04300647|516938116|FG000|Post-Crossover|Death|0|||
143379821|NCT04300647|516938117|FG001|Post-Crossover|Death|0|||
143379822|NCT04300647|516938118|FG002|Post-Crossover|Death|3|||
143379823|NCT04300647|516938116|FG000|Post-Crossover|Lost to Follow-up|0|||
143379824|NCT04300647|516938117|FG001|Post-Crossover|Lost to Follow-up|0|||
143379825|NCT04300647|516938118|FG002|Post-Crossover|Lost to Follow-up|1|||
143379826|NCT04300647|516938116|FG000|Post-Crossover|Withdrawal by Subject|0|||
143379827|NCT04300647|516938117|FG001|Post-Crossover|Withdrawal by Subject|0|||
143379828|NCT04300647|516938118|FG002|Post-Crossover|Withdrawal by Subject|1|||
143379829|NCT04300647|516938116|FG000|Post-Crossover|On-going in Study|0|||
143379830|NCT04300647|516938117|FG001|Post-Crossover|On-going in Study|0|||
143379831|NCT04300647|516938118|FG002|Post-Crossover|On-going in Study|8|||
143379832|NCT05057897|516938126|FG000|Overall Study|Site closure|2|||
143379833|NCT05057897|516938127|FG001|Overall Study|Site closure|2|||
143379834|NCT05057897|516938126|FG000|Overall Study|Death|1|||
143379835|NCT05057897|516938127|FG001|Overall Study|Death|0|||
143379836|NCT04714320|516938132|FG000|Overall Study|Voluntary Withdrawal|4|||
143379837|NCT04714320|516938133|FG001|Overall Study|Voluntary Withdrawal|1|||
143379838|NCT04714320|516938134|FG002|Overall Study|Voluntary Withdrawal|2|||
143379839|NCT04714320|516938132|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
143379840|NCT04714320|516938133|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
143379841|NCT04714320|516938134|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
143379842|NCT04714320|516938132|FG000|Overall Study|Reason Not Specified|1|||
143320226|NCT01722331|516717226|FG003|Part 2|Adverse Event|0|||
143320227|NCT01722331|516717227|FG004|Part 2|Adverse Event|0|||
143320228|NCT01722331|516717228|FG005|Part 2|Adverse Event|1|||
143320229|NCT01722331|516717229|FG006|Part 2|Adverse Event|0|||
143320230|NCT01722331|516717223|FG000|Part 2|Lack of Efficacy|3|||
143320231|NCT01722331|516717224|FG001|Part 2|Lack of Efficacy|0|||
143320232|NCT01722331|516717225|FG002|Part 2|Lack of Efficacy|11|||
143320233|NCT01722331|516717226|FG003|Part 2|Lack of Efficacy|0|||
143320234|NCT01722331|516717227|FG004|Part 2|Lack of Efficacy|0|||
143320235|NCT01722331|516717228|FG005|Part 2|Lack of Efficacy|3|||
143320236|NCT01722331|516717229|FG006|Part 2|Lack of Efficacy|3|||
143320237|NCT01722331|516717223|FG000|Part 2|Lost to Follow-up|0|||
143320238|NCT01722331|516717224|FG001|Part 2|Lost to Follow-up|0|||
143320239|NCT01722331|516717225|FG002|Part 2|Lost to Follow-up|3|||
143320240|NCT01722331|516717226|FG003|Part 2|Lost to Follow-up|0|||
143320241|NCT01722331|516717227|FG004|Part 2|Lost to Follow-up|0|||
143320242|NCT01722331|516717228|FG005|Part 2|Lost to Follow-up|1|||
143320243|NCT01722331|516717229|FG006|Part 2|Lost to Follow-up|1|||
143320244|NCT01722331|516717223|FG000|Part 2|Non-Compliance with Study Drug|1|||
143320245|NCT01722331|516717224|FG001|Part 2|Non-Compliance with Study Drug|0|||
143320246|NCT01722331|516717225|FG002|Part 2|Non-Compliance with Study Drug|1|||
143320247|NCT01722331|516717226|FG003|Part 2|Non-Compliance with Study Drug|0|||
143320248|NCT01722331|516717227|FG004|Part 2|Non-Compliance with Study Drug|0|||
143320249|NCT01722331|516717228|FG005|Part 2|Non-Compliance with Study Drug|0|||
143320250|NCT01722331|516717229|FG006|Part 2|Non-Compliance with Study Drug|0|||
143320251|NCT01722331|516717223|FG000|Part 2|Physician Decision|0|||
143320252|NCT01722331|516717224|FG001|Part 2|Physician Decision|0|||
143320253|NCT01722331|516717225|FG002|Part 2|Physician Decision|2|||
143320254|NCT01722331|516717226|FG003|Part 2|Physician Decision|0|||
143320255|NCT01722331|516717227|FG004|Part 2|Physician Decision|0|||
143320256|NCT01722331|516717228|FG005|Part 2|Physician Decision|0|||
143320257|NCT01722331|516717229|FG006|Part 2|Physician Decision|0|||
143320258|NCT01722331|516717223|FG000|Part 2|Pregnancy|0|||
143320259|NCT01722331|516717224|FG001|Part 2|Pregnancy|0|||
143320260|NCT01722331|516717225|FG002|Part 2|Pregnancy|0|||
143320261|NCT01722331|516717226|FG003|Part 2|Pregnancy|0|||
143320262|NCT01722331|516717227|FG004|Part 2|Pregnancy|0|||
143320263|NCT01722331|516717228|FG005|Part 2|Pregnancy|1|||
143320264|NCT01722331|516717229|FG006|Part 2|Pregnancy|0|||
143320265|NCT01722331|516717223|FG000|Part 2|Progressive Disease|0|||
143320266|NCT01722331|516717224|FG001|Part 2|Progressive Disease|0|||
143320267|NCT01722331|516717225|FG002|Part 2|Progressive Disease|1|||
143320268|NCT01722331|516717226|FG003|Part 2|Progressive Disease|0|||
143320269|NCT01722331|516717227|FG004|Part 2|Progressive Disease|0|||
143320270|NCT01722331|516717228|FG005|Part 2|Progressive Disease|0|||
143320271|NCT01722331|516717229|FG006|Part 2|Progressive Disease|0|||
143320272|NCT01722331|516717223|FG000|Part 2|Protocol Violation|1|||
143320273|NCT01722331|516717224|FG001|Part 2|Protocol Violation|0|||
143320274|NCT01722331|516717225|FG002|Part 2|Protocol Violation|0|||
143320275|NCT01722331|516717226|FG003|Part 2|Protocol Violation|0|||
143320276|NCT01722331|516717227|FG004|Part 2|Protocol Violation|0|||
143320277|NCT01722331|516717228|FG005|Part 2|Protocol Violation|0|||
143320278|NCT01722331|516717229|FG006|Part 2|Protocol Violation|0|||
143320279|NCT01722331|516717223|FG000|Part 2|Withdrawal by Subject|5|||
143320280|NCT01722331|516717224|FG001|Part 2|Withdrawal by Subject|0|||
143320281|NCT01722331|516717225|FG002|Part 2|Withdrawal by Subject|3|||
143320282|NCT01722331|516717226|FG003|Part 2|Withdrawal by Subject|0|||
143320283|NCT01722331|516717227|FG004|Part 2|Withdrawal by Subject|0|||
143320284|NCT01722331|516717228|FG005|Part 2|Withdrawal by Subject|2|||
143320285|NCT01722331|516717229|FG006|Part 2|Withdrawal by Subject|2|||
143320286|NCT01722331|516717223|FG000|Part 2|Other Protocol Specified Criteria|6|||
143320287|NCT01722331|516717224|FG001|Part 2|Other Protocol Specified Criteria|0|||
143320288|NCT01722331|516717225|FG002|Part 2|Other Protocol Specified Criteria|10|||
143320289|NCT01722331|516717226|FG003|Part 2|Other Protocol Specified Criteria|0|||
143320290|NCT01722331|516717227|FG004|Part 2|Other Protocol Specified Criteria|0|||
143320291|NCT01722331|516717228|FG005|Part 2|Other Protocol Specified Criteria|2|||
143320292|NCT01722331|516717229|FG006|Part 2|Other Protocol Specified Criteria|1|||
143320293|NCT01722331|516717223|FG000|Part 3|Adverse Event|2|||
143320294|NCT01722331|516717224|FG001|Part 3|Adverse Event|2|||
143320295|NCT01722331|516717225|FG002|Part 3|Adverse Event|0|||
143320296|NCT01722331|516717226|FG003|Part 3|Adverse Event|1|||
143320297|NCT01722331|516717227|FG004|Part 3|Adverse Event|0|||
143320298|NCT01722331|516717228|FG005|Part 3|Adverse Event|0|||
143320299|NCT01722331|516717229|FG006|Part 3|Adverse Event|0|||
143320300|NCT01722331|516717223|FG000|Part 3|Death|1|||
143320301|NCT01722331|516717224|FG001|Part 3|Death|0|||
143320302|NCT01722331|516717225|FG002|Part 3|Death|0|||
143320303|NCT01722331|516717226|FG003|Part 3|Death|0|||
143320304|NCT01722331|516717227|FG004|Part 3|Death|0|||
143320305|NCT01722331|516717228|FG005|Part 3|Death|0|||
143320306|NCT01722331|516717229|FG006|Part 3|Death|0|||
143320307|NCT01722331|516717223|FG000|Part 3|Lack of Efficacy|1|||
143320308|NCT01722331|516717224|FG001|Part 3|Lack of Efficacy|0|||
143320309|NCT01722331|516717225|FG002|Part 3|Lack of Efficacy|0|||
143320310|NCT01722331|516717226|FG003|Part 3|Lack of Efficacy|0|||
143320311|NCT01722331|516717227|FG004|Part 3|Lack of Efficacy|0|||
143320312|NCT01722331|516717228|FG005|Part 3|Lack of Efficacy|0|||
143320313|NCT01722331|516717229|FG006|Part 3|Lack of Efficacy|0|||
143320314|NCT01722331|516717223|FG000|Part 3|Lost to Follow-up|3|||
143320315|NCT01722331|516717224|FG001|Part 3|Lost to Follow-up|4|||
143320316|NCT01722331|516717225|FG002|Part 3|Lost to Follow-up|0|||
143320317|NCT01722331|516717226|FG003|Part 3|Lost to Follow-up|0|||
143320318|NCT01722331|516717227|FG004|Part 3|Lost to Follow-up|0|||
143320319|NCT01722331|516717228|FG005|Part 3|Lost to Follow-up|1|||
143320320|NCT01722331|516717229|FG006|Part 3|Lost to Follow-up|0|||
143320321|NCT01722331|516717223|FG000|Part 3|Non-Compliance with Study Drug|0|||
143320322|NCT01722331|516717224|FG001|Part 3|Non-Compliance with Study Drug|1|||
143320323|NCT01722331|516717225|FG002|Part 3|Non-Compliance with Study Drug|0|||
143320324|NCT01722331|516717226|FG003|Part 3|Non-Compliance with Study Drug|0|||
143320325|NCT01722331|516717227|FG004|Part 3|Non-Compliance with Study Drug|0|||
143320326|NCT01722331|516717228|FG005|Part 3|Non-Compliance with Study Drug|0|||
143320327|NCT01722331|516717229|FG006|Part 3|Non-Compliance with Study Drug|0|||
143320328|NCT01722331|516717223|FG000|Part 3|Physician Decision|1|||
143320329|NCT01722331|516717224|FG001|Part 3|Physician Decision|1|||
143320330|NCT01722331|516717225|FG002|Part 3|Physician Decision|0|||
143320331|NCT01722331|516717226|FG003|Part 3|Physician Decision|0|||
143320332|NCT01722331|516717227|FG004|Part 3|Physician Decision|0|||
143320333|NCT01722331|516717228|FG005|Part 3|Physician Decision|0|||
143320334|NCT01722331|516717229|FG006|Part 3|Physician Decision|1|||
143320335|NCT01722331|516717223|FG000|Part 3|Protocol Violation|2|||
143320336|NCT01722331|516717224|FG001|Part 3|Protocol Violation|1|||
143320337|NCT01722331|516717225|FG002|Part 3|Protocol Violation|0|||
143320338|NCT01722331|516717226|FG003|Part 3|Protocol Violation|0|||
143320339|NCT01722331|516717227|FG004|Part 3|Protocol Violation|0|||
143320340|NCT01722331|516717228|FG005|Part 3|Protocol Violation|0|||
143320341|NCT01722331|516717229|FG006|Part 3|Protocol Violation|0|||
143320342|NCT01722331|516717223|FG000|Part 3|Withdrawal by Subject|4|||
143320343|NCT01722331|516717224|FG001|Part 3|Withdrawal by Subject|7|||
143320344|NCT01722331|516717225|FG002|Part 3|Withdrawal by Subject|0|||
143320345|NCT01722331|516717226|FG003|Part 3|Withdrawal by Subject|0|||
143320346|NCT01722331|516717227|FG004|Part 3|Withdrawal by Subject|0|||
143320347|NCT01722331|516717228|FG005|Part 3|Withdrawal by Subject|2|||
143320348|NCT01722331|516717229|FG006|Part 3|Withdrawal by Subject|1|||
143320349|NCT01722331|516717223|FG000|Part 3|Other Protocol Specified Criteria|1|||
143320350|NCT01722331|516717224|FG001|Part 3|Other Protocol Specified Criteria|1|||
143320351|NCT01722331|516717225|FG002|Part 3|Other Protocol Specified Criteria|0|||
143320352|NCT01722331|516717226|FG003|Part 3|Other Protocol Specified Criteria|0|||
143320353|NCT01722331|516717227|FG004|Part 3|Other Protocol Specified Criteria|0|||
143320354|NCT01722331|516717228|FG005|Part 3|Other Protocol Specified Criteria|0|||
143320355|NCT01722331|516717229|FG006|Part 3|Other Protocol Specified Criteria|0|||
143320356|NCT01154166|516717232|FG000|Overall Study|Adverse Event|14|||
143320357|NCT01154166|516717233|FG001|Overall Study|Adverse Event|9|||
143320358|NCT01154166|516717232|FG000|Overall Study|Lost to Follow-up|1|||
143320359|NCT01154166|516717233|FG001|Overall Study|Lost to Follow-up|1|||
143320360|NCT01154166|516717232|FG000|Overall Study|Protocol Violation|4|||
143320361|NCT01154166|516717233|FG001|Overall Study|Protocol Violation|1|||
143320362|NCT01154166|516717232|FG000|Overall Study|Withdrawal by Subject|10|||
143320363|NCT01154166|516717233|FG001|Overall Study|Withdrawal by Subject|1|||
143320364|NCT01154166|516717232|FG000|Overall Study|Lack of Efficacy|3|||
143320365|NCT01154166|516717233|FG001|Overall Study|Lack of Efficacy|0|||
143320366|NCT01154166|516717232|FG000|Overall Study|Disease Progression|1|||
143320367|NCT01154166|516717233|FG001|Overall Study|Disease Progression|0|||
143320368|NCT01154166|516717232|FG000|Overall Study|Poor Compliance|1|||
143320369|NCT01154166|516717233|FG001|Overall Study|Poor Compliance|0|||
143320370|NCT01762761|516717234|FG000|Overall Study|Adverse Event|15|||
143320371|NCT01762761|516717235|FG001|Overall Study|Adverse Event|17|||
143320372|NCT01762761|516717234|FG000|Overall Study|Lack of Efficacy|9|||
143320373|NCT01762761|516717235|FG001|Overall Study|Lack of Efficacy|25|||
143320374|NCT01762761|516717234|FG000|Overall Study|Protocol Violation|1|||
143320375|NCT01762761|516717235|FG001|Overall Study|Protocol Violation|1|||
143320376|NCT01762761|516717234|FG000|Overall Study|Study closed/terminated|0|||
143320377|NCT01762761|516717235|FG001|Overall Study|Study closed/terminated|2|||
143320378|NCT01762761|516717234|FG000|Overall Study|Lost to Follow-up|3|||
143320379|NCT01762761|516717235|FG001|Overall Study|Lost to Follow-up|6|||
143320380|NCT01762761|516717234|FG000|Overall Study|Physician Decision|4|||
143320381|NCT01762761|516717235|FG001|Overall Study|Physician Decision|6|||
143320382|NCT01762761|516717234|FG000|Overall Study|Withdrawal by Subject|7|||
143320383|NCT01762761|516717235|FG001|Overall Study|Withdrawal by Subject|8|||
143320384|NCT01709227|516717241|FG000|Overall Study|Physician Decision|1|||
143320385|NCT01709227|516717242|FG001|Overall Study|Physician Decision|0|||
143320386|NCT01709227|516717241|FG000|Overall Study|Pleural Peritoneal communication|0|||
143320387|NCT01709227|516717242|FG001|Overall Study|Pleural Peritoneal communication|9|||
143320388|NCT00389324|516717246|FG000|Run-In Phase|Adverse Event|1|||
143320389|NCT00389324|516717246|FG000|Run-In Phase|Lost to Follow-up|1|||
143320390|NCT00389324|516717246|FG000|Run-In Phase|Withdrawal by Subject|1|||
143320391|NCT00389324|516717246|FG000|Subcutaneous Phase|Adverse Event|2|||
143320392|NCT00389324|516717246|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
143320393|NCT00389324|516717246|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
143320394|NCT00389324|516717246|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
143320395|NCT01925183|516717249|FG000|Overall Study|Adverse Event|1|||
143320396|NCT01925183|516717250|FG001|Overall Study|Adverse Event|0|||
143320397|NCT02159482|516717253|FG000|Overall Study|Withdrawal by Subject|2|||
143320398|NCT02159482|516717253|FG000|Overall Study|Physician Decision|3|||
143320399|NCT04479618|516717254|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
143320400|NCT04479618|516717255|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
143320401|NCT04479618|516717256|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
143320402|NCT04479618|516717254|FG000|Overall Study|Lack of Efficacy|1|||
143320403|NCT04479618|516717255|FG001|Overall Study|Lack of Efficacy|0|||
143320404|NCT04479618|516717256|FG002|Overall Study|Lack of Efficacy|0|||
143320405|NCT04479618|516717254|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
143320406|NCT04479618|516717255|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
143320407|NCT04479618|516717256|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
143320408|NCT04479618|516717254|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
143320409|NCT04479618|516717255|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
143320410|NCT04479618|516717256|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
143320411|NCT04479618|516717254|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
143320412|NCT04479618|516717255|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
143320413|NCT04479618|516717256|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
143320414|NCT04479618|516717254|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
143320415|NCT04479618|516717255|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
143320416|NCT04479618|516717256|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
143320417|NCT04443218|516717263|FG000|Overall Study|Exited study for other reasons|9|||
143320418|NCT04443218|516717263|FG000|Overall Study|Withdrawal by Subject|1|||
143320419|NCT04443218|516717263|FG000|Overall Study|Lost to Follow-up|4|||
143320420|NCT04443218|516717263|FG000|Overall Study|Death|19|||
143320421|NCT04096560|516717264|FG000|Overall Study|Reason not Specified|1|||
143320422|NCT04096560|516717265|FG001|Overall Study|Reason not Specified|0|||
143320423|NCT04096560|516717266|FG002|Overall Study|Reason not Specified|0|||
143320424|NCT04096560|516717267|FG003|Overall Study|Reason not Specified|0|||
143320425|NCT04096560|516717268|FG004|Overall Study|Reason not Specified|1|||
143320426|NCT04096560|516717269|FG005|Overall Study|Reason not Specified|1|||
143320427|NCT04096560|516717270|FG006|Overall Study|Reason not Specified|1|||
143320428|NCT04096560|516717271|FG007|Overall Study|Reason not Specified|0|||
143320429|NCT04096560|516717264|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
143320430|NCT04096560|516717265|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
143320431|NCT04096560|516717266|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
143320432|NCT04096560|516717267|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
143320433|NCT04096560|516717268|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
143320434|NCT04096560|516717269|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
143320435|NCT04096560|516717270|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
143320436|NCT04096560|516717271|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
143320437|NCT04096560|516717264|FG000|Overall Study|Study Terminated by Sponsor|0|||
143320438|NCT04096560|516717265|FG001|Overall Study|Study Terminated by Sponsor|0|||
143320439|NCT04096560|516717266|FG002|Overall Study|Study Terminated by Sponsor|0|||
143320440|NCT04096560|516717267|FG003|Overall Study|Study Terminated by Sponsor|5|||
143320441|NCT04096560|516717268|FG004|Overall Study|Study Terminated by Sponsor|6|||
143320442|NCT04096560|516717269|FG005|Overall Study|Study Terminated by Sponsor|4|||
143320443|NCT04096560|516717270|FG006|Overall Study|Study Terminated by Sponsor|6|||
143320444|NCT04096560|516717271|FG007|Overall Study|Study Terminated by Sponsor|1|||
143320445|NCT04096560|516717264|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
143320446|NCT04096560|516717265|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
143320447|NCT04096560|516717266|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
143320448|NCT04096560|516717267|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
143320449|NCT04096560|516717268|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
143379843|NCT04714320|516938133|FG001|Overall Study|Reason Not Specified|3|||
143379844|NCT04714320|516938134|FG002|Overall Study|Reason Not Specified|3|||
143320450|NCT04096560|516717269|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
143320451|NCT04096560|516717270|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
143320452|NCT04096560|516717271|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
143320453|NCT00534352|516717274|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
143320454|NCT00534352|516717274|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
143320455|NCT00534352|516717274|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
143320456|NCT00534352|516717274|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
143320457|NCT00534352|516717274|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
143320458|NCT00534352|516717274|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
143320459|NCT04079933|516717287|FG000|Overall Study|Withdrawal by Subject|3|||
143320460|NCT04079933|516717288|FG001|Overall Study|Withdrawal by Subject|4|||
143320461|NCT04079933|516717287|FG000|Overall Study|Lost to Follow-up|0|||
143320462|NCT04079933|516717288|FG001|Overall Study|Lost to Follow-up|1|||
143320463|NCT04788147|516717289|FG000|Overall Study|Screen Failure|3|||
143320464|NCT04788147|516717290|FG001|Overall Study|Screen Failure|10|||
143320465|NCT04788147|516717289|FG000|Overall Study|Incomplete RMRS image session|2|||
143320466|NCT04788147|516717290|FG001|Overall Study|Incomplete RMRS image session|0|||
143320467|NCT02401672|516717293|FG000|Overall Study|Withdrawal by Subject|1|||
143320468|NCT02401672|516717294|FG001|Overall Study|Withdrawal by Subject|3|||
143320469|NCT04796610|516717295|FG000|Overall Study|Withdrawal by Subject|1|||
143320470|NCT04796610|516717296|FG001|Overall Study|Withdrawal by Subject|0|||
143320471|NCT04796610|516717297|FG002|Overall Study|Withdrawal by Subject|0|||
143320472|NCT04796610|516717298|FG003|Overall Study|Withdrawal by Subject|0|||
143320473|NCT04796610|516717295|FG000|Overall Study|Lost to Follow-up|2|||
143320474|NCT04796610|516717296|FG001|Overall Study|Lost to Follow-up|0|||
143320475|NCT04796610|516717297|FG002|Overall Study|Lost to Follow-up|1|||
143320476|NCT04796610|516717298|FG003|Overall Study|Lost to Follow-up|1|||
143320477|NCT01459796|516717299|FG000|Overall Study|Non compliance with protocol|2|||
143320478|NCT01459796|516717300|FG001|Overall Study|Non compliance with protocol|4|||
143320479|NCT01459796|516717299|FG000|Overall Study|Adverse Event|5|||
143320480|NCT01459796|516717300|FG001|Overall Study|Adverse Event|5|||
143320481|NCT01459796|516717299|FG000|Overall Study|Withdrawal by Subject|6|||
143320482|NCT01459796|516717300|FG001|Overall Study|Withdrawal by Subject|3|||
143320483|NCT01459796|516717299|FG000|Overall Study|Lost to Follow-up|5|||
143320484|NCT01459796|516717300|FG001|Overall Study|Lost to Follow-up|4|||
143320485|NCT01459796|516717299|FG000|Overall Study|Reason unspecified|1|||
143320486|NCT01459796|516717300|FG001|Overall Study|Reason unspecified|2|||
143320487|NCT01459796|516717299|FG000|Overall Study|Decision by the sponsor|75|||
143320488|NCT01459796|516717300|FG001|Overall Study|Decision by the sponsor|108|||
143320489|NCT00701051|516717301|FG000|Screening|Failed Screening|40|||
143320490|NCT00701051|516717302|FG001|Screening|Failed Screening|0|||
143320491|NCT00701051|516717303|FG002|Screening|Failed Screening|0|||
143320492|NCT00701051|516717301|FG000|Screening|Time conflicts|19|||
143320493|NCT00701051|516717302|FG001|Screening|Time conflicts|0|||
143320494|NCT00701051|516717303|FG002|Screening|Time conflicts|0|||
143320495|NCT00701051|516717301|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
143320496|NCT00701051|516717302|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
143320497|NCT00701051|516717303|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
143320498|NCT02059148|516717304|FG000|Treatment 1|Protocol Violation|0|||
143320499|NCT02059148|516717305|FG001|Treatment 1|Protocol Violation|0|||
143320500|NCT02059148|516717306|FG002|Treatment 1|Protocol Violation|0|||
143320501|NCT02059148|516717307|FG003|Treatment 1|Protocol Violation|0|||
143320502|NCT02059148|516717308|FG004|Treatment 1|Protocol Violation|0|||
143320503|NCT02059148|516717309|FG005|Treatment 1|Protocol Violation|1|||
143320504|NCT03634579|516717313|FG000|Overall Study|study termination|9|||
143320505|NCT01525082|516717314|FG000|Overall Study|Death|1|||
143320506|NCT03321981|516717315|FG000|Overall Study|Progressive Disease (PD)|15|||
143320507|NCT03321981|516717316|FG001|Overall Study|Progressive Disease (PD)|30|||
143320508|NCT03321981|516717317|FG002|Overall Study|Progressive Disease (PD)|47|||
143320509|NCT03321981|516717315|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
143320510|NCT03321981|516717316|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
143320511|NCT03321981|516717317|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
143320512|NCT03321981|516717315|FG000|Overall Study|Adverse Event|0|||
143320513|NCT03321981|516717316|FG001|Overall Study|Adverse Event|0|||
143320514|NCT03321981|516717317|FG002|Overall Study|Adverse Event|2|||
143320515|NCT03321981|516717315|FG000|Overall Study|symptomatic deterioration|0|||
143320516|NCT03321981|516717316|FG001|Overall Study|symptomatic deterioration|1|||
143320517|NCT03321981|516717317|FG002|Overall Study|symptomatic deterioration|1|||
143320518|NCT03321981|516717315|FG000|Overall Study|Lack of compliance|0|||
143320519|NCT03321981|516717316|FG001|Overall Study|Lack of compliance|1|||
143320520|NCT03321981|516717317|FG002|Overall Study|Lack of compliance|0|||
143320521|NCT03321981|516717315|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
143379845|NCT01353313|516938135|FG000|Overall Study|Lost to Follow-up|22|||
143320522|NCT03321981|516717316|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
143320523|NCT03321981|516717317|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
143320524|NCT03321981|516717315|FG000|Overall Study|Death|0|||
143320525|NCT03321981|516717316|FG001|Overall Study|Death|1|||
143320526|NCT03321981|516717317|FG002|Overall Study|Death|0|||
143320527|NCT03321981|516717315|FG000|Overall Study|Subject withdrawal of investigational product|0|||
143320528|NCT03321981|516717316|FG001|Overall Study|Subject withdrawal of investigational product|1|||
143320529|NCT03321981|516717317|FG002|Overall Study|Subject withdrawal of investigational product|0|||
143320530|NCT03321981|516717315|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
143320531|NCT03321981|516717316|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
143320532|NCT03321981|516717317|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
143320533|NCT03321981|516717315|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
143320534|NCT03321981|516717316|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
143320535|NCT03321981|516717317|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
143320536|NCT04111497|516717320|FG000|Overall Study|relapse of primary disease|1|||
143320537|NCT04111497|516717320|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
143320538|NCT03880578|516717321|FG000|Overall Study|Withdrawal by Subject|0|||
143320539|NCT03880578|516717322|FG001|Overall Study|Withdrawal by Subject|3|||
143320540|NCT03880578|516717323|FG002|Overall Study|Withdrawal by Subject|1|||
143320541|NCT03880578|516717321|FG000|Overall Study|Death|0|||
143320542|NCT03880578|516717322|FG001|Overall Study|Death|1|||
143320543|NCT03880578|516717323|FG002|Overall Study|Death|0|||
143320544|NCT01440946|516717324|FG000|Overall Study|Lost to Follow-up|1|||
143320545|NCT01440946|516717325|FG001|Overall Study|Lost to Follow-up|1|||
143320546|NCT01440946|516717324|FG000|Overall Study|Physician Decision|1|||
143320547|NCT01440946|516717325|FG001|Overall Study|Physician Decision|0|||
143320548|NCT01603875|516717329|FG000|Overall Study|Preexisting rabies antibody|3|||
143320549|NCT01603875|516717330|FG001|Overall Study|Preexisting rabies antibody|4|||
143320550|NCT01603875|516717331|FG002|Overall Study|Preexisting rabies antibody|3|||
143320551|NCT01603875|516717329|FG000|Overall Study|Lost to Follow-up|4|||
143320552|NCT01603875|516717330|FG001|Overall Study|Lost to Follow-up|3|||
143320553|NCT01603875|516717331|FG002|Overall Study|Lost to Follow-up|6|||
143320554|NCT01603875|516717329|FG000|Overall Study|Protocol Violation|0|||
143320555|NCT01603875|516717330|FG001|Overall Study|Protocol Violation|1|||
143320556|NCT01603875|516717331|FG002|Overall Study|Protocol Violation|0|||
143320557|NCT01072201|516717332|FG000|Overall Study|Lost to Follow-up|0|||
143320558|NCT01072201|516717333|FG001|Overall Study|Lost to Follow-up|1|||
143320559|NCT04666441|516717334|FG000|Overall Study|Lost to Follow-up|1|||
143320560|NCT04666441|516717335|FG001|Overall Study|Lost to Follow-up|4|||
143320561|NCT04666441|516717336|FG002|Overall Study|Lost to Follow-up|1|||
143320562|NCT04666441|516717337|FG003|Overall Study|Lost to Follow-up|3|||
143320563|NCT04666441|516717338|FG004|Overall Study|Lost to Follow-up|0|||
143320564|NCT04666441|516717339|FG005|Overall Study|Lost to Follow-up|2|||
143320565|NCT04666441|516717340|FG006|Overall Study|Lost to Follow-up|2|||
143320566|NCT04666441|516717341|FG007|Overall Study|Lost to Follow-up|2|||
143320567|NCT04666441|516717334|FG000|Overall Study|Subject Decision|1|||
143320568|NCT04666441|516717335|FG001|Overall Study|Subject Decision|1|||
143320569|NCT04666441|516717336|FG002|Overall Study|Subject Decision|3|||
143320570|NCT04666441|516717337|FG003|Overall Study|Subject Decision|1|||
143320571|NCT04666441|516717338|FG004|Overall Study|Subject Decision|0|||
143320572|NCT04666441|516717339|FG005|Overall Study|Subject Decision|1|||
143320573|NCT04666441|516717340|FG006|Overall Study|Subject Decision|3|||
143320574|NCT04666441|516717341|FG007|Overall Study|Subject Decision|2|||
143320575|NCT01431508|516717343|FG000|Overall Study|Lack of Efficacy|1|||
143320576|NCT01431508|516717343|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
143320577|NCT01609556|516717347|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
143320578|NCT01609556|516717348|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
143320579|NCT01609556|516717349|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
143320580|NCT01609556|516717350|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
143320581|NCT01609556|516717351|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
143320582|NCT01609556|516717352|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
143320583|NCT01609556|516717353|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
143320584|NCT01609556|516717354|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
143320585|NCT01609556|516717355|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
143320586|NCT01609556|516717356|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
143320587|NCT01609556|516717357|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
143320588|NCT01609556|516717358|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
143320589|NCT01609556|516717359|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
143320590|NCT01609556|516717360|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
143320591|NCT01609556|516717361|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
143320592|NCT01609556|516717362|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
143320593|NCT01609556|516717347|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
143320594|NCT01609556|516717348|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
143320595|NCT01609556|516717349|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
143320596|NCT01609556|516717350|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
143320597|NCT01609556|516717351|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
143320598|NCT01609556|516717352|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
143320599|NCT01609556|516717353|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
143320600|NCT01609556|516717354|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
143320601|NCT01609556|516717355|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
143320602|NCT01609556|516717356|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
143320603|NCT01609556|516717357|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
143320604|NCT01609556|516717358|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
143320605|NCT01609556|516717359|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
143320606|NCT01609556|516717360|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
143320607|NCT01609556|516717361|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
143320608|NCT01609556|516717362|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
143320609|NCT01609556|516717347|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
143320610|NCT01609556|516717348|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
143320611|NCT01609556|516717349|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
143320612|NCT01609556|516717350|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
143320613|NCT01609556|516717351|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
143320614|NCT01609556|516717352|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
143320615|NCT01609556|516717353|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
143320616|NCT01609556|516717354|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
143320617|NCT01609556|516717355|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
143320618|NCT01609556|516717356|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
143320619|NCT01609556|516717357|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
143320620|NCT01609556|516717358|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
143320621|NCT01609556|516717359|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
143320622|NCT01609556|516717360|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
143320623|NCT01609556|516717361|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
143320624|NCT01609556|516717362|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
143320625|NCT01609556|516717347|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
143320626|NCT01609556|516717348|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
143320627|NCT01609556|516717349|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
143320628|NCT01609556|516717350|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
143320629|NCT01609556|516717351|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
143320630|NCT01609556|516717352|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
143320631|NCT01609556|516717353|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
143320632|NCT01609556|516717354|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
143320633|NCT01609556|516717355|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
143320634|NCT01609556|516717356|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
143320635|NCT01609556|516717357|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
143320636|NCT01609556|516717358|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
143379846|NCT01353313|516938136|FG001|Overall Study|Lost to Follow-up|23|||
143379847|NCT01353313|516938135|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
143379848|NCT01353313|516938136|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
143379849|NCT04755660|516938137|FG000|Overall Study|Lost to Follow-up|1|||
143379850|NCT04755660|516938138|FG001|Overall Study|Lost to Follow-up|1|||
143379851|NCT04755660|516938139|FG002|Overall Study|Lost to Follow-up|0|||
143379852|NCT04755660|516938137|FG000|Overall Study|Withdrawal by Subject|0|||
143379853|NCT04755660|516938138|FG001|Overall Study|Withdrawal by Subject|1|||
143379854|NCT04755660|516938139|FG002|Overall Study|Withdrawal by Subject|1|||
143379855|NCT04755660|516938137|FG000|Overall Study|Physician Decision|0|||
143320637|NCT01609556|516717359|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
143320638|NCT01609556|516717360|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
143320639|NCT01609556|516717361|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
143320640|NCT01609556|516717362|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
143320641|NCT01609556|516717347|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
143320642|NCT01609556|516717348|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
143320643|NCT01609556|516717349|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
143320644|NCT01609556|516717350|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
143320645|NCT01609556|516717351|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
143320646|NCT01609556|516717352|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
143320647|NCT01609556|516717353|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
143320648|NCT01609556|516717354|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
143320649|NCT01609556|516717355|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
143320650|NCT01609556|516717356|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
143320651|NCT01609556|516717357|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
143320652|NCT01609556|516717358|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
143320653|NCT01609556|516717359|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
143320654|NCT01609556|516717360|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
143320655|NCT01609556|516717361|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
143320656|NCT01609556|516717362|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
143320657|NCT01609556|516717347|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
143320658|NCT01609556|516717348|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
143320659|NCT01609556|516717349|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
143320660|NCT01609556|516717350|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
143320661|NCT01609556|516717351|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
143320662|NCT01609556|516717352|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
143320663|NCT01609556|516717353|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
143320664|NCT01609556|516717354|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
143320665|NCT01609556|516717355|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
143320666|NCT01609556|516717356|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
143320667|NCT01609556|516717357|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
143320668|NCT01609556|516717358|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
143320669|NCT01609556|516717359|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
143320670|NCT01609556|516717360|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
143320671|NCT01609556|516717361|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
143320672|NCT01609556|516717362|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
143320673|NCT01609556|516717347|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
143320674|NCT01609556|516717348|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
143320675|NCT01609556|516717349|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
143320676|NCT01609556|516717350|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
143320677|NCT01609556|516717351|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
143320678|NCT01609556|516717352|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
143320679|NCT01609556|516717353|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
143320680|NCT01609556|516717354|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
143320681|NCT01609556|516717355|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
143320682|NCT01609556|516717356|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
143320683|NCT01609556|516717357|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
143320684|NCT01609556|516717358|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
143320685|NCT01609556|516717359|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
143320686|NCT01609556|516717360|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
143320687|NCT01609556|516717361|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
143320688|NCT01609556|516717362|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
143320689|NCT01609556|516717347|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
143320690|NCT01609556|516717348|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
143320691|NCT01609556|516717349|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
143320692|NCT01609556|516717350|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
143320693|NCT01609556|516717351|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
143320694|NCT01609556|516717352|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
143320695|NCT01609556|516717353|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
143320696|NCT01609556|516717354|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
143320697|NCT01609556|516717355|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
143320698|NCT01609556|516717356|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
143320699|NCT01609556|516717357|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
143320700|NCT01609556|516717358|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
143379856|NCT04755660|516938138|FG001|Overall Study|Physician Decision|0|||
143379857|NCT04755660|516938139|FG002|Overall Study|Physician Decision|1|||
143379858|NCT02824029|516938141|FG000|Overall Study|Didn't receive treatment|2|||
143379859|NCT02824029|516938141|FG000|Overall Study|Patient decision to discontinue treatment|3|||
143379860|NCT02824029|516938141|FG000|Overall Study|Non-compliant|5|||
143379861|NCT02824029|516938141|FG000|Overall Study|Progression of disease|15|||
143379862|NCT02824029|516938141|FG000|Overall Study|Inadequate response to therapy|2|||
143379863|NCT02824029|516938141|FG000|Overall Study|Possible progression per treating physician|1|||
143379864|NCT04524390|516938142|FG000|Double Blind|Consent Withdrawal by subject|2|||
143379865|NCT04524390|516938143|FG001|Double Blind|Consent Withdrawal by subject|1|||
143379866|NCT04524390|516938144|FG002|Double Blind|Consent Withdrawal by subject|0|||
143379867|NCT04524390|516938142|FG000|Double Blind|Adverse Event|5|||
143379868|NCT04524390|516938143|FG001|Double Blind|Adverse Event|3|||
143379869|NCT04524390|516938144|FG002|Double Blind|Adverse Event|0|||
143379870|NCT04524390|516938142|FG000|Double Blind|Liver Transplant|5|||
143379871|NCT04524390|516938143|FG001|Double Blind|Liver Transplant|6|||
143379872|NCT04524390|516938144|FG002|Double Blind|Liver Transplant|0|||
143379873|NCT04524390|516938142|FG000|Double Blind|Disease Progression|0|||
143379874|NCT04524390|516938143|FG001|Double Blind|Disease Progression|1|||
143379875|NCT04524390|516938144|FG002|Double Blind|Disease Progression|0|||
143379876|NCT04524390|516938142|FG000|Open-Label|Drug interruption criteria|0|||
143379877|NCT04524390|516938143|FG001|Open-Label|Drug interruption criteria|0|||
143379878|NCT04524390|516938144|FG002|Open-Label|Drug interruption criteria|1|||
143379879|NCT04524390|516938142|FG000|Open-Label|Liver Transplant|0|||
143379880|NCT04524390|516938143|FG001|Open-Label|Liver Transplant|0|||
143379881|NCT04524390|516938144|FG002|Open-Label|Liver Transplant|1|||
143379882|NCT04524390|516938142|FG000|Open-Label|Disease Progression|0|||
143379883|NCT04524390|516938143|FG001|Open-Label|Disease Progression|0|||
143379884|NCT04524390|516938144|FG002|Open-Label|Disease Progression|1|||
143320701|NCT01609556|516717359|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
143320702|NCT01609556|516717360|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
143320703|NCT01609556|516717361|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
143320704|NCT01609556|516717362|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
143320705|NCT01609556|516717347|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
143320706|NCT01609556|516717348|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
143320707|NCT01609556|516717349|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
143320708|NCT01609556|516717350|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
143320709|NCT01609556|516717351|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
143320710|NCT01609556|516717352|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
143320711|NCT01609556|516717353|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
143320712|NCT01609556|516717354|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
143320713|NCT01609556|516717355|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
143320714|NCT01609556|516717356|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
143320715|NCT01609556|516717357|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
143320716|NCT01609556|516717358|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
143320717|NCT01609556|516717359|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
143320718|NCT01609556|516717360|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
143320719|NCT01609556|516717361|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
143320720|NCT01609556|516717362|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
143320721|NCT01609556|516717347|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
143320722|NCT01609556|516717348|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
143379885|NCT04524390|516938142|FG000|Open-Label|Adverse Event|0|||
143379886|NCT04524390|516938143|FG001|Open-Label|Adverse Event|0|||
143379887|NCT04524390|516938144|FG002|Open-Label|Adverse Event|3|||
143379888|NCT04524390|516938142|FG000|Open-Label|Study Termination by sponsor|0|||
143379889|NCT04524390|516938143|FG001|Open-Label|Study Termination by sponsor|0|||
143379890|NCT04524390|516938144|FG002|Open-Label|Study Termination by sponsor|45|||
143379891|NCT03088813|516938147|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
143379892|NCT03088813|516938148|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
143379893|NCT03088813|516938149|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
143379894|NCT03088813|516938150|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
143320723|NCT01609556|516717349|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
143320724|NCT01609556|516717350|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
143320725|NCT01609556|516717351|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
143320726|NCT01609556|516717352|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
143320727|NCT01609556|516717353|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
143320728|NCT01609556|516717354|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
143320729|NCT01609556|516717355|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
143320730|NCT01609556|516717356|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
143320731|NCT01609556|516717357|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
143320732|NCT01609556|516717358|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
143320733|NCT01609556|516717359|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
143320734|NCT01609556|516717360|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
143320735|NCT01609556|516717361|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
143320736|NCT01609556|516717362|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
143320737|NCT01609556|516717347|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
143320738|NCT01609556|516717348|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
143320739|NCT01609556|516717349|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
143320740|NCT01609556|516717350|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
143320741|NCT01609556|516717351|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
143320742|NCT01609556|516717352|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
143320743|NCT01609556|516717353|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
143320744|NCT01609556|516717354|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
143320745|NCT01609556|516717355|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
143320746|NCT01609556|516717356|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
143320747|NCT01609556|516717357|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
143320748|NCT01609556|516717358|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
143320749|NCT01609556|516717359|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
143320750|NCT01609556|516717360|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
143320751|NCT01609556|516717361|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
143320752|NCT01609556|516717362|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
143320753|NCT01609556|516717347|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
143320754|NCT01609556|516717348|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
143320755|NCT01609556|516717349|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
143320756|NCT01609556|516717350|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
143320757|NCT01609556|516717351|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
143320758|NCT01609556|516717352|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
143320759|NCT01609556|516717353|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
143320760|NCT01609556|516717354|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
143320761|NCT01609556|516717355|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
143320762|NCT01609556|516717356|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
143320763|NCT01609556|516717357|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
143320764|NCT01609556|516717358|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
143320765|NCT01609556|516717359|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
143320766|NCT01609556|516717360|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
143320767|NCT01609556|516717361|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
143320768|NCT01609556|516717362|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
143320769|NCT01609556|516717347|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
143320770|NCT01609556|516717348|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
143320771|NCT01609556|516717349|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
143320772|NCT01609556|516717350|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
143320773|NCT01609556|516717351|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
143320774|NCT01609556|516717352|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
143320775|NCT01609556|516717353|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
143320776|NCT01609556|516717354|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
143320777|NCT01609556|516717355|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
143320778|NCT01609556|516717356|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
143320779|NCT01609556|516717357|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
143320780|NCT01609556|516717358|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
143320781|NCT01609556|516717359|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
143320782|NCT01609556|516717360|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
143320783|NCT01609556|516717361|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
143320784|NCT01609556|516717362|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
143320785|NCT01609556|516717347|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
143320786|NCT01609556|516717348|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
143320787|NCT01609556|516717349|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
143320788|NCT01609556|516717350|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
143320789|NCT01609556|516717351|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
143320790|NCT01609556|516717352|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
143320791|NCT01609556|516717353|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
143320792|NCT01609556|516717354|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
143320793|NCT01609556|516717355|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
143320794|NCT01609556|516717356|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
143320795|NCT01609556|516717357|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
143320796|NCT01609556|516717358|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
143320797|NCT01609556|516717359|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
143320798|NCT01609556|516717360|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
143320799|NCT01609556|516717361|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
143320800|NCT01609556|516717362|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
143320801|NCT01609556|516717347|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
143320802|NCT01609556|516717348|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
143320803|NCT01609556|516717349|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
143320804|NCT01609556|516717350|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
143320805|NCT01609556|516717351|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
143320806|NCT01609556|516717352|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
143320807|NCT01609556|516717353|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
143320808|NCT01609556|516717354|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
143320809|NCT01609556|516717355|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
143320810|NCT01609556|516717356|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
143320811|NCT01609556|516717357|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
143320812|NCT01609556|516717358|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
143320813|NCT01609556|516717359|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
143320814|NCT01609556|516717360|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
143320815|NCT01609556|516717361|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
143320816|NCT01609556|516717362|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
143320817|NCT03779841|516717363|FG000|Randomized Population|Did Not Receive Treatment|3|||
143320818|NCT03779841|516717364|FG001|Randomized Population|Did Not Receive Treatment|1|||
143320819|NCT03779841|516717365|FG002|Randomized Population|Did Not Receive Treatment|0|||
143320820|NCT03779841|516717363|FG000|Treated (Safety) Population|Adverse Event|1|||
143320821|NCT03779841|516717364|FG001|Treated (Safety) Population|Adverse Event|1|||
143320822|NCT03779841|516717365|FG002|Treated (Safety) Population|Adverse Event|0|||
143320823|NCT03779841|516717363|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
143320824|NCT03779841|516717364|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
143320825|NCT03779841|516717365|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
143320826|NCT03779841|516717363|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
143320827|NCT03779841|516717364|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
143320828|NCT03779841|516717365|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
143320829|NCT03779841|516717363|FG000|Treated (Safety) Population|Death|1|||
143320830|NCT03779841|516717364|FG001|Treated (Safety) Population|Death|0|||
143320831|NCT03779841|516717365|FG002|Treated (Safety) Population|Death|2|||
143320832|NCT02788175|516717366|FG000|Overall Study|Protocol Violation|3|||
143320833|NCT02788175|516717366|FG000|Overall Study|Withdrawal by Subject|4|||
143320834|NCT02788175|516717366|FG000|Overall Study|Ineligible prior to study agent|6|||
143320835|NCT00162136|516717367|FG000|Overall Study|Adverse Event|1|||
143320836|NCT00162136|516717367|FG000|Overall Study|Death|1|||
143320837|NCT00162136|516717367|FG000|Overall Study|Disease Progression/Relapse|23|||
143320838|NCT00162136|516717367|FG000|Overall Study|Investigator Request|5|||
143320839|NCT00162136|516717367|FG000|Overall Study|Study Drug Toxicity|4|||
143320840|NCT00162136|516717367|FG000|Overall Study|Withdrawal by Subject|1|||
143320841|NCT03930745|516717368|FG000|Overall Study|Lost to Follow-up|10|||
143320842|NCT03930745|516717369|FG001|Overall Study|Lost to Follow-up|5|||
143320843|NCT03930745|516717368|FG000|Overall Study|Withdrawal by Subject|1|||
143320844|NCT03930745|516717369|FG001|Overall Study|Withdrawal by Subject|2|||
143320845|NCT03930745|516717368|FG000|Overall Study|Protocol Violation|2|||
143320846|NCT03930745|516717369|FG001|Overall Study|Protocol Violation|2|||
143320847|NCT03930745|516717368|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
143320848|NCT03930745|516717369|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
143320849|NCT03930745|516717368|FG000|Overall Study|Adverse Event|0|||
143320850|NCT03930745|516717369|FG001|Overall Study|Adverse Event|1|||
143320851|NCT03930745|516717368|FG000|Overall Study|Pregnancy|0|||
143320852|NCT03930745|516717369|FG001|Overall Study|Pregnancy|1|||
143320853|NCT03285477|516717372|FG000|Treatment and Response Assessment Period|Death|1|||
143320854|NCT03285477|516717373|FG001|Treatment and Response Assessment Period|Death|0|||
143320855|NCT03285477|516717372|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
143320856|NCT03285477|516717373|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
143320857|NCT03285477|516717372|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
143320858|NCT03285477|516717373|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
143320859|NCT03285477|516717372|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
143320860|NCT03285477|516717373|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
143320861|NCT03285477|516717372|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
143320862|NCT03285477|516717373|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
143320863|NCT01159938|516719036|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
143320864|NCT01159938|516719037|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
143320865|NCT01159938|516719038|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
143320866|NCT01159938|516719039|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
143320867|NCT01159938|516719040|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
143320868|NCT00982020|516719041|FG000|Overall Study|Adverse Event|19|||
143320869|NCT00982020|516719042|FG001|Overall Study|Adverse Event|15|||
143320870|NCT00982020|516719041|FG000|Overall Study|Withdrawal by Subject|11|||
143320871|NCT00982020|516719042|FG001|Overall Study|Withdrawal by Subject|14|||
143320872|NCT00982020|516719041|FG000|Overall Study|Lost to Follow-up|5|||
143320873|NCT00982020|516719042|FG001|Overall Study|Lost to Follow-up|11|||
143320874|NCT00982020|516719041|FG000|Overall Study|Lack of Efficacy|10|||
143320875|NCT00982020|516719042|FG001|Overall Study|Lack of Efficacy|4|||
143320876|NCT00982020|516719041|FG000|Overall Study|Parent/Caregiver Decision|5|||
143320877|NCT00982020|516719042|FG001|Overall Study|Parent/Caregiver Decision|5|||
143320878|NCT00982020|516719041|FG000|Overall Study|Treatment Non-compliance|3|||
143320879|NCT00982020|516719042|FG001|Overall Study|Treatment Non-compliance|6|||
143320880|NCT00982020|516719041|FG000|Overall Study|Physician Decision|2|||
143320881|NCT00982020|516719042|FG001|Overall Study|Physician Decision|5|||
143320882|NCT00982020|516719041|FG000|Overall Study|Entry Criteria Not Met|2|||
143320883|NCT00982020|516719042|FG001|Overall Study|Entry Criteria Not Met|1|||
143320884|NCT00982020|516719041|FG000|Overall Study|Protocol Violation|0|||
143320885|NCT00982020|516719042|FG001|Overall Study|Protocol Violation|2|||
143320886|NCT00982020|516719041|FG000|Overall Study|Clinical Relapse|0|||
143320887|NCT00982020|516719042|FG001|Overall Study|Clinical Relapse|1|||
143320888|NCT00466193|516719043|FG000|Overall Study|Adverse Event|0|||
143320889|NCT00466193|516719044|FG001|Overall Study|Adverse Event|1|||
143320890|NCT00466193|516719043|FG000|Overall Study|Lost to Follow-up|2|||
143320891|NCT00466193|516719044|FG001|Overall Study|Lost to Follow-up|4|||
143320892|NCT00466193|516719043|FG000|Overall Study|Physician Decision|1|||
143320893|NCT00466193|516719044|FG001|Overall Study|Physician Decision|0|||
143320894|NCT00466193|516719043|FG000|Overall Study|Protocol Violation|1|||
143320895|NCT00466193|516719044|FG001|Overall Study|Protocol Violation|1|||
143320896|NCT00466193|516719043|FG000|Overall Study|Withdrawal by Subject|7|||
143320897|NCT00466193|516719044|FG001|Overall Study|Withdrawal by Subject|2|||
143320898|NCT00466193|516719043|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
143320899|NCT00466193|516719044|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
143320900|NCT02525133|516719050|FG000|Overall Study|Adverse Event|0|||
143320901|NCT02525133|516719051|FG001|Overall Study|Adverse Event|1|||
143320902|NCT02525133|516719050|FG000|Overall Study|Death|0|||
143320903|NCT02525133|516719051|FG001|Overall Study|Death|1|||
143320904|NCT02525133|516719050|FG000|Overall Study|did not meet randomization criteria|1|||
143320905|NCT02525133|516719051|FG001|Overall Study|did not meet randomization criteria|0|||
143320906|NCT02525133|516719050|FG000|Overall Study|Lost to Follow-up|5|||
143320907|NCT02525133|516719051|FG001|Overall Study|Lost to Follow-up|1|||
143320908|NCT02525133|516719050|FG000|Overall Study|randomized not enrolled|3|||
143320909|NCT02525133|516719051|FG001|Overall Study|randomized not enrolled|0|||
143320910|NCT02525133|516719050|FG000|Overall Study|Withdrawal by Subject|1|||
143320911|NCT02525133|516719051|FG001|Overall Study|Withdrawal by Subject|0|||
143320912|NCT00562159|516719052|FG000|Overall Study|Adverse Event|11|||
143320913|NCT00562159|516719053|FG001|Overall Study|Adverse Event|8|||
143320914|NCT00562159|516719052|FG000|Overall Study|Lost to Follow-up|5|||
143320915|NCT00562159|516719053|FG001|Overall Study|Lost to Follow-up|4|||
143320916|NCT00562159|516719052|FG000|Overall Study|Withdrawal by Subject|9|||
143320917|NCT00562159|516719053|FG001|Overall Study|Withdrawal by Subject|8|||
143320918|NCT00562159|516719052|FG000|Overall Study|Protocol Violation|12|||
143320919|NCT00562159|516719053|FG001|Overall Study|Protocol Violation|12|||
143320920|NCT00562159|516719052|FG000|Overall Study|Did not meet protocol eligibility|1|||
143320921|NCT00562159|516719053|FG001|Overall Study|Did not meet protocol eligibility|1|||
143320922|NCT01181921|516719055|FG000|Overall Study|Lost to Follow-up|1|||
143320923|NCT01992536|516719057|FG000|Overall Study|Administrative Reason|0|||
143320924|NCT01992536|516719058|FG001|Overall Study|Administrative Reason|0|||
143320925|NCT01992536|516719059|FG002|Overall Study|Administrative Reason|0|||
143320926|NCT01992536|516719060|FG003|Overall Study|Administrative Reason|0|||
143320927|NCT01992536|516719061|FG004|Overall Study|Administrative Reason|0|||
143320928|NCT01992536|516719062|FG005|Overall Study|Administrative Reason|0|||
143320929|NCT01992536|516719063|FG006|Overall Study|Administrative Reason|7|||
143320930|NCT01992536|516719064|FG007|Overall Study|Administrative Reason|0|||
143320931|NCT01992536|516719065|FG008|Overall Study|Administrative Reason|0|||
143320932|NCT01992536|516719066|FG009|Overall Study|Administrative Reason|0|||
143320933|NCT01992536|516719057|FG000|Overall Study|Lost to Follow-up|4|||
143379895|NCT03088813|516938147|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
143379896|NCT03088813|516938148|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
143379897|NCT03088813|516938149|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
143379898|NCT03088813|516938150|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
143379899|NCT03088813|516938147|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
143320934|NCT01992536|516719058|FG001|Overall Study|Lost to Follow-up|2|||
143320935|NCT01992536|516719059|FG002|Overall Study|Lost to Follow-up|1|||
143320936|NCT01992536|516719060|FG003|Overall Study|Lost to Follow-up|0|||
143379900|NCT03088813|516938148|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
143379901|NCT03088813|516938149|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
143379902|NCT03088813|516938150|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
143379903|NCT03088813|516938147|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
143379904|NCT03088813|516938148|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
143379905|NCT03088813|516938149|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
143379906|NCT03088813|516938150|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
143379907|NCT03088813|516938147|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
143379908|NCT03088813|516938148|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
143379909|NCT03088813|516938149|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
143379910|NCT03088813|516938150|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
143379911|NCT03088813|516938147|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
143379912|NCT03088813|516938148|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
143379913|NCT03088813|516938149|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
143379914|NCT03088813|516938150|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
143379915|NCT03088813|516938147|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
143379916|NCT03088813|516938148|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
143379917|NCT03088813|516938149|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
143379918|NCT03088813|516938150|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
143379919|NCT03613740|516938151|FG000|Overall Study|Lost to Follow-up|1|||
143379920|NCT03613740|516938152|FG001|Overall Study|Lost to Follow-up|1|||
143379921|NCT03575052|516938153|FG000|Overall Study|Adverse Event|6|||
143379922|NCT03575052|516938154|FG001|Overall Study|Adverse Event|10|||
143379923|NCT03575052|516938153|FG000|Overall Study|Not further specified|5|||
143379924|NCT03575052|516938154|FG001|Overall Study|Not further specified|7|||
143379925|NCT03575052|516938153|FG000|Overall Study|Withdrawal by Subject|5|||
143379926|NCT03575052|516938154|FG001|Overall Study|Withdrawal by Subject|6|||
143379927|NCT03575052|516938153|FG000|Overall Study|Lost to Follow-up|3|||
143379928|NCT03575052|516938154|FG001|Overall Study|Lost to Follow-up|0|||
143379929|NCT03575052|516938153|FG000|Overall Study|Death|2|||
143379930|NCT03575052|516938154|FG001|Overall Study|Death|1|||
143379931|NCT03575052|516938153|FG000|Overall Study|Lack of Efficacy|2|||
143379932|NCT03575052|516938154|FG001|Overall Study|Lack of Efficacy|1|||
143379933|NCT03575052|516938153|FG000|Overall Study|Study drug noncompliance|1|||
143379934|NCT03575052|516938154|FG001|Overall Study|Study drug noncompliance|2|||
143379935|NCT03575052|516938153|FG000|Overall Study|Protocol Violation|0|||
143379936|NCT03575052|516938154|FG001|Overall Study|Protocol Violation|2|||
143379937|NCT03575052|516938153|FG000|Overall Study|Physician Decision|1|||
143379938|NCT03575052|516938154|FG001|Overall Study|Physician Decision|0|||
143379939|NCT04188379|516938155|FG000|Overall Study|Withdrawal by Subject|10|||
143379940|NCT04188379|516938156|FG001|Overall Study|Withdrawal by Subject|3|||
143379941|NCT04188379|516938155|FG000|Overall Study|Physician Decision|0|||
143379942|NCT04188379|516938156|FG001|Overall Study|Physician Decision|1|||
143379943|NCT04188379|516938155|FG000|Overall Study|Adverse Event|3|||
143379944|NCT04188379|516938156|FG001|Overall Study|Adverse Event|1|||
143379945|NCT04188379|516938155|FG000|Overall Study|Pregnancy|1|||
143320937|NCT01992536|516719061|FG004|Overall Study|Lost to Follow-up|0|||
143320938|NCT01992536|516719062|FG005|Overall Study|Lost to Follow-up|1|||
143320939|NCT01992536|516719063|FG006|Overall Study|Lost to Follow-up|0|||
143320940|NCT01992536|516719064|FG007|Overall Study|Lost to Follow-up|0|||
143320941|NCT01992536|516719065|FG008|Overall Study|Lost to Follow-up|1|||
143320942|NCT01992536|516719066|FG009|Overall Study|Lost to Follow-up|1|||
143320943|NCT01992536|516719057|FG000|Overall Study|Withdrawal by Subject|0|||
143379946|NCT04188379|516938156|FG001|Overall Study|Pregnancy|0|||
143320944|NCT01992536|516719058|FG001|Overall Study|Withdrawal by Subject|1|||
143320945|NCT01992536|516719059|FG002|Overall Study|Withdrawal by Subject|0|||
143320946|NCT01992536|516719060|FG003|Overall Study|Withdrawal by Subject|2|||
143320947|NCT01992536|516719061|FG004|Overall Study|Withdrawal by Subject|0|||
143379947|NCT04188379|516938155|FG000|Overall Study|Lack of Efficacy|8|||
143379948|NCT04188379|516938156|FG001|Overall Study|Lack of Efficacy|5|||
143379949|NCT04188379|516938155|FG000|Overall Study|Other|0|||
143379950|NCT04188379|516938156|FG001|Overall Study|Other|3|||
143379951|NCT01693120|516938157|FG000|Enrollment|Lost to Follow-up|1|||
143379952|NCT01693120|516938157|FG000|Enrollment|Withdrawal by Subject|10|||
143379953|NCT01693120|516938157|FG000|Enrollment|Protocol Violation|46|||
143379954|NCT01693120|516938157|FG000|Enrollment|Physician Decision|3|||
143320948|NCT01992536|516719062|FG005|Overall Study|Withdrawal by Subject|0|||
143320949|NCT01992536|516719063|FG006|Overall Study|Withdrawal by Subject|0|||
143320950|NCT01992536|516719064|FG007|Overall Study|Withdrawal by Subject|0|||
143320951|NCT01992536|516719065|FG008|Overall Study|Withdrawal by Subject|0|||
143320952|NCT01992536|516719066|FG009|Overall Study|Withdrawal by Subject|0|||
143320953|NCT03669081|516719067|FG000|Overall Study|Data could not be validated|1|||
143320954|NCT03669081|516719068|FG001|Overall Study|Data could not be validated|1|||
143320955|NCT02519504|516719069|FG000|Overall Study|Protocol Violation|6|||
143320956|NCT02519504|516719070|FG001|Overall Study|Protocol Violation|5|||
143320957|NCT02519504|516719069|FG000|Overall Study|Ineligible for direct testing|12|||
143320958|NCT02519504|516719070|FG001|Overall Study|Ineligible for direct testing|12|||
143320959|NCT02519504|516719069|FG000|Overall Study|Did not participate in direct testing|95|||
143320960|NCT02519504|516719070|FG001|Overall Study|Did not participate in direct testing|86|||
143320961|NCT02317575|516719071|FG000|Period 1|Difficulty with venous cannulation|0|||
143320962|NCT02317575|516719072|FG001|Period 1|Difficulty with venous cannulation|1|||
143320963|NCT02317575|516719073|FG002|Period 1|Difficulty with venous cannulation|0|||
143320964|NCT02317575|516719074|FG003|Period 1|Difficulty with venous cannulation|0|||
143320965|NCT02317575|516719075|FG004|Period 1|Difficulty with venous cannulation|0|||
143320966|NCT02317575|516719071|FG000|Period 1|Withdrawal by Subject|1|||
143320967|NCT02317575|516719072|FG001|Period 1|Withdrawal by Subject|0|||
143320968|NCT02317575|516719073|FG002|Period 1|Withdrawal by Subject|0|||
143320969|NCT02317575|516719074|FG003|Period 1|Withdrawal by Subject|0|||
143320970|NCT02317575|516719075|FG004|Period 1|Withdrawal by Subject|0|||
143320971|NCT03551938|516719078|FG000|3-Month Follow Up|Lost to Follow-up|39|||
143320972|NCT03551938|516719079|FG001|3-Month Follow Up|Lost to Follow-up|38|||
143320973|NCT03551938|516719078|FG000|6-Month Follow Up|Lost to Follow-up|46|||
143320974|NCT03551938|516719079|FG001|6-Month Follow Up|Lost to Follow-up|42|||
143320975|NCT03551938|516719078|FG000|9-Month Follow Up|Lost to Follow-up|44|||
143320976|NCT03551938|516719079|FG001|9-Month Follow Up|Lost to Follow-up|43|||
143320977|NCT01430130|516719082|FG000|Overall Study|Lost to Follow-up|1|||
143320978|NCT01430130|516719082|FG000|Overall Study|Infection on Control Side of Incision|1|||
143320979|NCT03525834|516719083|FG000|Overall Study|Progressive disease|1|||
143320980|NCT02828111|516719085|FG000|Overall Study|Withdrawal by Subject|0|||
143320981|NCT02828111|516719086|FG001|Overall Study|Withdrawal by Subject|0|||
143320982|NCT02828111|516719087|FG002|Overall Study|Withdrawal by Subject|2|||
143320983|NCT02828111|516719088|FG003|Overall Study|Withdrawal by Subject|0|||
143320984|NCT02828111|516719089|FG004|Overall Study|Withdrawal by Subject|0|||
143320985|NCT02828111|516719085|FG000|Overall Study|Lost to Follow-up|0|||
143320986|NCT02828111|516719086|FG001|Overall Study|Lost to Follow-up|0|||
143320987|NCT02828111|516719087|FG002|Overall Study|Lost to Follow-up|0|||
143320988|NCT02828111|516719088|FG003|Overall Study|Lost to Follow-up|1|||
143320989|NCT02828111|516719089|FG004|Overall Study|Lost to Follow-up|1|||
143320990|NCT01751568|516719104|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
143320991|NCT01751568|516719105|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
143320992|NCT01751568|516719106|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
143320993|NCT02660944|516719107|FG000|Overall Study|Adverse Event|3|||
143320994|NCT02660944|516719108|FG001|Overall Study|Adverse Event|4|||
143320995|NCT02660944|516719107|FG000|Overall Study|Physician Decision|3|||
143320996|NCT02660944|516719108|FG001|Overall Study|Physician Decision|1|||
143320997|NCT02660944|516719107|FG000|Overall Study|Withdrawal by Subject|5|||
143320998|NCT02660944|516719108|FG001|Overall Study|Withdrawal by Subject|3|||
143320999|NCT02660944|516719107|FG000|Overall Study|Lost to Follow-up|4|||
143321000|NCT02660944|516719108|FG001|Overall Study|Lost to Follow-up|1|||
143321001|NCT02660944|516719107|FG000|Overall Study|Subject schedule|0|||
143321002|NCT02660944|516719108|FG001|Overall Study|Subject schedule|1|||
143321003|NCT02660944|516719107|FG000|Overall Study|Exclusion criteria met|2|||
143321004|NCT02660944|516719108|FG001|Overall Study|Exclusion criteria met|0|||
143321005|NCT02843568|516719109|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
143321006|NCT02843568|516719110|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
143321007|NCT02843568|516719109|FG000|Overall Study|Death|3|||
143321008|NCT02843568|516719110|FG001|Overall Study|Death|3|||
143321009|NCT02843568|516719109|FG000|Overall Study|Withdrawal by Subject|1|||
143321010|NCT02843568|516719110|FG001|Overall Study|Withdrawal by Subject|1|||
143321011|NCT02843568|516719109|FG000|Overall Study|Lost to Follow-up|2|||
143321012|NCT02843568|516719110|FG001|Overall Study|Lost to Follow-up|0|||
143321013|NCT03586999|516719111|FG000|Overall Study|Lack of Efficacy|2|||
143321014|NCT01229436|516719112|FG000|Overall Study|Withdrawal by Subject|2|||
143321015|NCT01229436|516719112|FG000|Overall Study|Lost to Follow-up|3|||
143321016|NCT03231371|516719113|FG000|Overall Study|Withdrawal by Subject|1|||
143321017|NCT03231371|516719113|FG000|Overall Study|chose or were ineligible to have MRI|12|||
143321018|NCT03321019|516719122|FG000|Overall Study|Withdrawal by Subject|0|||
143321019|NCT03321019|516719123|FG001|Overall Study|Withdrawal by Subject|6|||
143321020|NCT03321019|516719122|FG000|Overall Study|Lost to Follow-up|0|||
143321021|NCT03321019|516719123|FG001|Overall Study|Lost to Follow-up|22|||
143321022|NCT04934670|516719124|FG000|Overall Study|Death|4|||
143321023|NCT04934670|516719125|FG001|Overall Study|Death|0|||
143321024|NCT04934670|516719124|FG000|Overall Study|Lost to Follow-up|1|||
143321025|NCT04934670|516719125|FG001|Overall Study|Lost to Follow-up|4|||
143321026|NCT03067441|516719128|FG000|Overall Study|Withdrawal by Subject|16|||
143321027|NCT03067441|516719129|FG001|Overall Study|Withdrawal by Subject|34|||
143321028|NCT03067441|516719128|FG000|Overall Study|Lost to Follow-up|7|||
143321029|NCT03067441|516719129|FG001|Overall Study|Lost to Follow-up|5|||
143321030|NCT03067441|516719128|FG000|Overall Study|Adverse Event|7|||
143321031|NCT03067441|516719129|FG001|Overall Study|Adverse Event|14|||
143321032|NCT03067441|516719128|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
143321033|NCT03067441|516719129|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
143321034|NCT03067441|516719128|FG000|Overall Study|Physician Decision|1|||
143321035|NCT03067441|516719129|FG001|Overall Study|Physician Decision|3|||
143321036|NCT03067441|516719128|FG000|Overall Study|Other|1|||
143321037|NCT03067441|516719129|FG001|Overall Study|Other|1|||
143321038|NCT03105362|516719134|FG000|Overall Study|Withdrawal by Subject|1|||
143321039|NCT03105362|516719134|FG000|Overall Study|Lost to Follow-up|1|||
143321040|NCT01198600|516719139|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
143321041|NCT01198600|516719140|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
143321042|NCT01198600|516719141|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
143321043|NCT01198600|516719142|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
143321044|NCT01198600|516719139|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
143321045|NCT01198600|516719140|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
143321046|NCT01198600|516719141|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
143321047|NCT01198600|516719142|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
143321048|NCT01198600|516719139|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
143321049|NCT01198600|516719140|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
143321050|NCT01198600|516719141|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
143321051|NCT01198600|516719142|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
143321052|NCT01198600|516719139|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
143321053|NCT01198600|516719140|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
143321054|NCT01198600|516719141|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
143321055|NCT01198600|516719142|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
143321056|NCT01198600|516719139|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
143321057|NCT01198600|516719140|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
143321058|NCT01198600|516719141|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
143321059|NCT01198600|516719142|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
143321060|NCT01198600|516719139|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
143321061|NCT01198600|516719140|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
143321062|NCT01198600|516719141|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
143321063|NCT01198600|516719142|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
143321064|NCT01198600|516719139|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
143321065|NCT01198600|516719140|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
143321066|NCT01198600|516719141|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
143321067|NCT01198600|516719142|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
143321068|NCT04177108|516719144|FG000|Overall Study|Withdrawal by Subject|4|||
143321069|NCT04177108|516719145|FG001|Overall Study|Withdrawal by Subject|8|||
143321070|NCT04177108|516719146|FG002|Overall Study|Withdrawal by Subject|9|||
143321071|NCT04177108|516719147|FG003|Overall Study|Withdrawal by Subject|11|||
143321072|NCT04177108|516719148|FG004|Overall Study|Withdrawal by Subject|13|||
143321073|NCT04177108|516719144|FG000|Overall Study|Physician Decision|23|||
143321074|NCT04177108|516719145|FG001|Overall Study|Physician Decision|15|||
143321075|NCT04177108|516719146|FG002|Overall Study|Physician Decision|18|||
143321076|NCT04177108|516719147|FG003|Overall Study|Physician Decision|29|||
143321077|NCT04177108|516719148|FG004|Overall Study|Physician Decision|23|||
143321078|NCT04177108|516719144|FG000|Overall Study|Reason Not Specified|0|||
143321079|NCT04177108|516719145|FG001|Overall Study|Reason Not Specified|1|||
143321080|NCT04177108|516719146|FG002|Overall Study|Reason Not Specified|0|||
143321081|NCT04177108|516719147|FG003|Overall Study|Reason Not Specified|0|||
143321082|NCT04177108|516719148|FG004|Overall Study|Reason Not Specified|2|||
143321083|NCT04177108|516719144|FG000|Overall Study|Lost to Follow-up|0|||
143321084|NCT04177108|516719145|FG001|Overall Study|Lost to Follow-up|0|||
143321085|NCT04177108|516719146|FG002|Overall Study|Lost to Follow-up|1|||
143321086|NCT04177108|516719147|FG003|Overall Study|Lost to Follow-up|1|||
143321087|NCT04177108|516719148|FG004|Overall Study|Lost to Follow-up|1|||
143321088|NCT04177108|516719144|FG000|Overall Study|Death|16|||
143321089|NCT04177108|516719145|FG001|Overall Study|Death|19|||
143321090|NCT04177108|516719146|FG002|Overall Study|Death|13|||
143321091|NCT04177108|516719147|FG003|Overall Study|Death|17|||
143321092|NCT04177108|516719148|FG004|Overall Study|Death|18|||
143321093|NCT02041429|516719151|FG000|Overall Study|Progressive Disease|2|||
143321094|NCT02041429|516719152|FG001|Overall Study|Progressive Disease|2|||
143321095|NCT02041429|516719153|FG002|Overall Study|Progressive Disease|3|||
143321096|NCT02041429|516719154|FG003|Overall Study|Progressive Disease|2|||
143321097|NCT02041429|516719151|FG000|Overall Study|Toxicity|0|||
143321098|NCT02041429|516719152|FG001|Overall Study|Toxicity|1|||
143321099|NCT02041429|516719153|FG002|Overall Study|Toxicity|4|||
143321100|NCT02041429|516719154|FG003|Overall Study|Toxicity|2|||
143321101|NCT02041429|516719151|FG000|Overall Study|Withdrawal by Subject|0|||
143321102|NCT02041429|516719152|FG001|Overall Study|Withdrawal by Subject|1|||
143321103|NCT02041429|516719153|FG002|Overall Study|Withdrawal by Subject|0|||
143321104|NCT02041429|516719154|FG003|Overall Study|Withdrawal by Subject|0|||
143321105|NCT02041429|516719151|FG000|Overall Study|On Maintenance Therapy|1|||
143321106|NCT02041429|516719152|FG001|Overall Study|On Maintenance Therapy|0|||
143321107|NCT02041429|516719153|FG002|Overall Study|On Maintenance Therapy|0|||
143321108|NCT02041429|516719154|FG003|Overall Study|On Maintenance Therapy|2|||
143321109|NCT00784043|516719155|FG000|Overall Study|Withdrawal by Subject|8|||
143321110|NCT00784043|516719156|FG001|Overall Study|Withdrawal by Subject|5|||
143321111|NCT00784043|516719155|FG000|Overall Study|Protocol Terminated|23|||
143321112|NCT00784043|516719156|FG001|Overall Study|Protocol Terminated|1|||
143321113|NCT01143259|516719157|FG000|Overall Study|Withdrawal by Subject|3|||
143321114|NCT01143259|516719158|FG001|Overall Study|Withdrawal by Subject|2|||
143321115|NCT01143259|516719157|FG000|Overall Study|Protocol Violation|13|||
143321116|NCT01143259|516719158|FG001|Overall Study|Protocol Violation|9|||
143321117|NCT01143259|516719157|FG000|Overall Study|Screen Failure|7|||
143321118|NCT01143259|516719158|FG001|Overall Study|Screen Failure|9|||
143321119|NCT00099983|516719159|FG000|Overall Study|Lost to Follow-up|2|||
143321120|NCT00099983|516719160|FG001|Overall Study|Lost to Follow-up|3|||
143321121|NCT00099983|516719159|FG000|Overall Study|Missing Source Documents|14|||
143321122|NCT00099983|516719160|FG001|Overall Study|Missing Source Documents|15|||
143321123|NCT00099983|516719159|FG000|Overall Study|Withdrawal by Subject|3|||
143321124|NCT00099983|516719160|FG001|Overall Study|Withdrawal by Subject|2|||
143321125|NCT00099983|516719159|FG000|Overall Study|Adverse Event|1|||
143321126|NCT00099983|516719160|FG001|Overall Study|Adverse Event|1|||
143321127|NCT00099983|516719159|FG000|Overall Study|Lack of Efficacy|0|||
143321128|NCT00099983|516719160|FG001|Overall Study|Lack of Efficacy|1|||
143321129|NCT00099983|516719159|FG000|Overall Study|Unable to return for appointments|1|||
143321130|NCT00099983|516719160|FG001|Overall Study|Unable to return for appointments|1|||
143321131|NCT00099983|516719159|FG000|Overall Study|Moved|1|||
143321132|NCT00099983|516719160|FG001|Overall Study|Moved|0|||
143321133|NCT00099983|516719159|FG000|Overall Study|Other psychiatric problem|1|||
143321134|NCT00099983|516719160|FG001|Overall Study|Other psychiatric problem|0|||
143321135|NCT00099983|516719159|FG000|Overall Study|Incarcerated|0|||
143321136|NCT00099983|516719160|FG001|Overall Study|Incarcerated|1|||
143321137|NCT00099983|516719159|FG000|Overall Study|Intolerant of burden of visits|0|||
143321138|NCT00099983|516719160|FG001|Overall Study|Intolerant of burden of visits|1|||
143321139|NCT00099983|516719159|FG000|Overall Study|Other issue|1|||
143321140|NCT00099983|516719160|FG001|Overall Study|Other issue|0|||
143321141|NCT03835533|516719165|FG000|Overall Study|Death|5|||
143321142|NCT03835533|516719166|FG001|Overall Study|Death|10|||
143321143|NCT03835533|516719167|FG002|Overall Study|Death|9|||
143321144|NCT03835533|516719165|FG000|Overall Study|Withdrawal by Subject|2|||
143321145|NCT03835533|516719166|FG001|Overall Study|Withdrawal by Subject|2|||
143321146|NCT03835533|516719167|FG002|Overall Study|Withdrawal by Subject|2|||
143321147|NCT03835533|516719165|FG000|Overall Study|Lost to Follow-up|1|||
143321148|NCT03835533|516719166|FG001|Overall Study|Lost to Follow-up|0|||
143321149|NCT03835533|516719167|FG002|Overall Study|Lost to Follow-up|0|||
143321150|NCT02207829|516719168|FG000|Overall Study|Adverse Event|10|||
143321151|NCT02207829|516719169|FG001|Overall Study|Adverse Event|9|||
143321152|NCT02207829|516719168|FG000|Overall Study|Lack of Efficacy|7|||
143321153|NCT02207829|516719169|FG001|Overall Study|Lack of Efficacy|5|||
143321154|NCT02207829|516719168|FG000|Overall Study|Lost to Follow-up|2|||
143321155|NCT02207829|516719169|FG001|Overall Study|Lost to Follow-up|2|||
143321156|NCT02207829|516719168|FG000|Overall Study|Protocol deviation|5|||
143321157|NCT02207829|516719169|FG001|Overall Study|Protocol deviation|4|||
143321158|NCT02207829|516719168|FG000|Overall Study|Withdrew consent|18|||
143321159|NCT02207829|516719169|FG001|Overall Study|Withdrew consent|14|||
143321160|NCT01418209|516719170|FG000|Overall Study|Withdrawal by Subject|1|||
143321161|NCT01418209|516719171|FG001|Overall Study|Withdrawal by Subject|0|||
143321162|NCT01418209|516719172|FG002|Overall Study|Withdrawal by Subject|1|||
143321163|NCT01418209|516719170|FG000|Overall Study|Did not provide hot flash diary data|1|||
143321164|NCT01418209|516719171|FG001|Overall Study|Did not provide hot flash diary data|3|||
143321165|NCT01418209|516719172|FG002|Overall Study|Did not provide hot flash diary data|3|||
143321166|NCT00101101|516719173|FG000|Overall Study|never received vaccine|20|||
143321167|NCT00360334|516719174|FG000|Overall Study|Adverse Event|7|||
143321168|NCT00360334|516719175|FG001|Overall Study|Adverse Event|4|||
143321169|NCT00360334|516719174|FG000|Overall Study|Protocol Violation|1|||
143321170|NCT00360334|516719175|FG001|Overall Study|Protocol Violation|1|||
143321171|NCT00360334|516719174|FG000|Overall Study|Physician Decision|2|||
143321172|NCT00360334|516719175|FG001|Overall Study|Physician Decision|3|||
143321173|NCT00360334|516719174|FG000|Overall Study|Lack of Efficacy|0|||
143321174|NCT00360334|516719175|FG001|Overall Study|Lack of Efficacy|1|||
143321175|NCT00360334|516719174|FG000|Overall Study|Entry criterion not met|1|||
143321176|NCT00360334|516719175|FG001|Overall Study|Entry criterion not met|2|||
143321177|NCT00360334|516719174|FG000|Overall Study|Subject decision|8|||
143321178|NCT00360334|516719175|FG001|Overall Study|Subject decision|2|||
143321179|NCT05204134|516719177|FG000|Overall Study|Withdrawal by Subject|3|||
143321180|NCT05204134|516719177|FG000|Overall Study|Physician Decision|1|||
143321181|NCT02752048|516719180|FG000|Overall Study|Withdrawal by Subject|0|||
143321182|NCT02752048|516719181|FG001|Overall Study|Withdrawal by Subject|0|||
143321183|NCT02752048|516719182|FG002|Overall Study|Withdrawal by Subject|3|||
143321184|NCT00132769|516719183|FG000|Overall Study|Withdrawal by Subject|1|||
143321185|NCT00132769|516719184|FG001|Overall Study|Withdrawal by Subject|3|||
143321186|NCT00132769|516719183|FG000|Overall Study|Lack of Efficacy|7|||
143321187|NCT00132769|516719184|FG001|Overall Study|Lack of Efficacy|6|||
143321188|NCT00132769|516719183|FG000|Overall Study|Adverse Event|2|||
143321189|NCT00132769|516719184|FG001|Overall Study|Adverse Event|1|||
143321190|NCT00132769|516719183|FG000|Overall Study|Protocol Violation|1|||
143321191|NCT00132769|516719184|FG001|Overall Study|Protocol Violation|1|||
143321192|NCT04452344|516719185|FG000|Overall Study|Withdrawal by Subject|3|||
143321193|NCT04452344|516719186|FG001|Overall Study|Withdrawal by Subject|6|||
143321194|NCT04452344|516719185|FG000|Overall Study|Adverse Event|1|||
143321195|NCT04452344|516719186|FG001|Overall Study|Adverse Event|2|||
143321196|NCT04452344|516719185|FG000|Overall Study|Lost to Follow-up|2|||
143321197|NCT04452344|516719186|FG001|Overall Study|Lost to Follow-up|2|||
143321198|NCT04452344|516719185|FG000|Overall Study|No Post-Op Visit|6|||
143321199|NCT04452344|516719186|FG001|Overall Study|No Post-Op Visit|7|||
143321200|NCT04095858|516719188|FG000|Overall Study|Death|1|||
143321201|NCT04095858|516719189|FG001|Overall Study|Death|0|||
143321202|NCT04095858|516719188|FG000|Overall Study|Study terminated by Sponsor|2|||
143321203|NCT04095858|516719189|FG001|Overall Study|Study terminated by Sponsor|4|||
143321204|NCT01344460|516719190|FG000|Overall Study|Withdrawal by Subject|1|||
143321205|NCT01344460|516719190|FG000|Overall Study|Lost to Follow-up|2|||
143321206|NCT03483623|516719192|FG000|Overall Study|43 complete sets achieved|1|||
143321207|NCT00852397|516719195|FG000|Overall Study|Adverse Event|4|||
143321208|NCT00852397|516719196|FG001|Overall Study|Adverse Event|6|||
143321209|NCT00852397|516719197|FG002|Overall Study|Adverse Event|4|||
143321210|NCT00852397|516719195|FG000|Overall Study|Death|0|||
143321211|NCT00852397|516719196|FG001|Overall Study|Death|0|||
143321212|NCT00852397|516719197|FG002|Overall Study|Death|1|||
143321213|NCT00852397|516719195|FG000|Overall Study|Withdrawal by Subject|4|||
143321214|NCT00852397|516719196|FG001|Overall Study|Withdrawal by Subject|1|||
143321215|NCT00852397|516719197|FG002|Overall Study|Withdrawal by Subject|2|||
143321216|NCT00852397|516719195|FG000|Overall Study|Study terminated by sponsor|2|||
143321217|NCT00852397|516719196|FG001|Overall Study|Study terminated by sponsor|1|||
143321218|NCT00852397|516719197|FG002|Overall Study|Study terminated by sponsor|6|||
143321219|NCT00852397|516719195|FG000|Overall Study|Difficulty in study site visit|1|||
143321220|NCT00852397|516719196|FG001|Overall Study|Difficulty in study site visit|0|||
143321221|NCT00852397|516719197|FG002|Overall Study|Difficulty in study site visit|0|||
143321222|NCT00852397|516719195|FG000|Overall Study|Protocol Violation|0|||
143321223|NCT00852397|516719196|FG001|Overall Study|Protocol Violation|0|||
143321224|NCT00852397|516719197|FG002|Overall Study|Protocol Violation|1|||
143321225|NCT01968434|516719201|FG000|Overall Study|Lost to Follow-up|3|||
143321226|NCT01968434|516719202|FG001|Overall Study|Lost to Follow-up|6|||
143321227|NCT00428610|516719205|FG000|Overall Study|Death Due to Adverse Event|3|||
143321228|NCT00428610|516719206|FG001|Overall Study|Death Due to Adverse Event|0|||
143321229|NCT00428610|516719207|FG002|Overall Study|Death Due to Adverse Event|5|||
143321230|NCT00428610|516719205|FG000|Overall Study|Death Due to Progressive Disease|0|||
143321231|NCT00428610|516719206|FG001|Overall Study|Death Due to Progressive Disease|0|||
143321232|NCT00428610|516719207|FG002|Overall Study|Death Due to Progressive Disease|2|||
143321233|NCT00428610|516719205|FG000|Overall Study|Adverse Event|2|||
143321234|NCT00428610|516719206|FG001|Overall Study|Adverse Event|3|||
143321235|NCT00428610|516719207|FG002|Overall Study|Adverse Event|2|||
143321236|NCT00428610|516719205|FG000|Overall Study|Investigator Decision|2|||
143321237|NCT00428610|516719206|FG001|Overall Study|Investigator Decision|1|||
143321238|NCT00428610|516719207|FG002|Overall Study|Investigator Decision|1|||
143321239|NCT00428610|516719205|FG000|Overall Study|Progressive Disease|42|||
143321240|NCT00428610|516719206|FG001|Overall Study|Progressive Disease|14|||
143321241|NCT00428610|516719207|FG002|Overall Study|Progressive Disease|22|||
143321242|NCT00428610|516719205|FG000|Overall Study|Withdrawal by Subject|4|||
143321243|NCT00428610|516719206|FG001|Overall Study|Withdrawal by Subject|0|||
143321244|NCT00428610|516719207|FG002|Overall Study|Withdrawal by Subject|0|||
143321245|NCT01539291|516721471|FG000|Study GS-US-312-0116|Adverse Event|9|||
143321246|NCT01539291|516721472|FG001|Study GS-US-312-0116|Adverse Event|0|||
143321247|NCT01539291|516721473|FG002|Study GS-US-312-0116|Adverse Event|0|||
143321248|NCT01539291|516721474|FG003|Study GS-US-312-0116|Adverse Event|0|||
143321249|NCT01539291|516721471|FG000|Study GS-US-312-0116|Physician Decision|1|||
143321250|NCT01539291|516721472|FG001|Study GS-US-312-0116|Physician Decision|0|||
143321251|NCT01539291|516721473|FG002|Study GS-US-312-0116|Physician Decision|0|||
143321252|NCT01539291|516721474|FG003|Study GS-US-312-0116|Physician Decision|0|||
143321253|NCT01539291|516721471|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
143321254|NCT01539291|516721472|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
143321255|NCT01539291|516721473|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
143321256|NCT01539291|516721474|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
143321257|NCT01539291|516721471|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
143321258|NCT01539291|516721472|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
143321259|NCT01539291|516721473|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
143321260|NCT01539291|516721474|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
143321261|NCT01539291|516721471|FG000|Study GS-US-312-0116|Other|1|||
143321262|NCT01539291|516721472|FG001|Study GS-US-312-0116|Other|0|||
143321263|NCT01539291|516721473|FG002|Study GS-US-312-0116|Other|0|||
143321264|NCT01539291|516721474|FG003|Study GS-US-312-0116|Other|0|||
143321265|NCT01539291|516721471|FG000|Study GS-US-312-0117|Adverse Event|22|||
143321266|NCT01539291|516721472|FG001|Study GS-US-312-0117|Adverse Event|1|||
143321267|NCT01539291|516721473|FG002|Study GS-US-312-0117|Adverse Event|9|||
143321268|NCT01539291|516721474|FG003|Study GS-US-312-0117|Adverse Event|12|||
143321269|NCT01539291|516721471|FG000|Study GS-US-312-0117|Physician Decision|9|||
143321270|NCT01539291|516721472|FG001|Study GS-US-312-0117|Physician Decision|0|||
143321271|NCT01539291|516721473|FG002|Study GS-US-312-0117|Physician Decision|6|||
143321272|NCT01539291|516721474|FG003|Study GS-US-312-0117|Physician Decision|4|||
143321273|NCT01539291|516721471|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
143321274|NCT01539291|516721472|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
143321275|NCT01539291|516721473|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
143321276|NCT01539291|516721474|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
143321277|NCT01539291|516721471|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
143321278|NCT01539291|516721472|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
143321279|NCT01539291|516721473|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
143321280|NCT01539291|516721474|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
143321281|NCT01539291|516721471|FG000|Study GS-US-312-0117|Other|2|||
143321282|NCT01539291|516721472|FG001|Study GS-US-312-0117|Other|1|||
143321283|NCT01539291|516721473|FG002|Study GS-US-312-0117|Other|1|||
143321284|NCT01539291|516721474|FG003|Study GS-US-312-0117|Other|1|||
143321285|NCT04450264|516721475|FG000|Overall Study|Incomplete survey|13|||
143321286|NCT04450264|516721476|FG001|Overall Study|Incomplete survey|19|||
143321287|NCT03320070|516721477|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
143321288|NCT03320070|516721478|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
143321289|NCT03320070|516721477|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
143379955|NCT01693120|516938157|FG000|Enrollment|Adverse Event|1|||
143379956|NCT01693120|516938157|FG000|Enrollment|Study closed|8|||
143379957|NCT01693120|516938157|FG000|Enrollment|Other|1|||
143379958|NCT01693120|516938157|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
143321290|NCT03320070|516721478|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
143321291|NCT03320070|516721477|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
143321292|NCT03320070|516721478|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
143321293|NCT03320070|516721477|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
143321294|NCT03320070|516721478|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
143321295|NCT03320070|516721477|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
143321296|NCT03320070|516721478|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
143379959|NCT01693120|516938157|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
143379960|NCT01693120|516938157|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
143321297|NCT03320070|516721477|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
143321298|NCT03320070|516721478|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
143321299|NCT00003457|516721484|FG000|Overall Study|Not evaluable|9|||
143321300|NCT02246998|516721485|FG000|Overall Study|Adverse Event|0|||
143321301|NCT02246998|516721486|FG001|Overall Study|Adverse Event|1|||
143321302|NCT02246998|516721487|FG002|Overall Study|Adverse Event|1|||
143321303|NCT02246998|516721488|FG003|Overall Study|Adverse Event|0|||
143321304|NCT02246998|516721485|FG000|Overall Study|Lost to Follow-up|1|||
143321305|NCT02246998|516721486|FG001|Overall Study|Lost to Follow-up|0|||
143321306|NCT02246998|516721487|FG002|Overall Study|Lost to Follow-up|0|||
143321307|NCT02246998|516721488|FG003|Overall Study|Lost to Follow-up|1|||
143321308|NCT02246998|516721485|FG000|Overall Study|Randomized but Never Dosed|1|||
143321309|NCT02246998|516721486|FG001|Overall Study|Randomized but Never Dosed|2|||
143321310|NCT02246998|516721487|FG002|Overall Study|Randomized but Never Dosed|2|||
143321311|NCT02246998|516721488|FG003|Overall Study|Randomized but Never Dosed|1|||
143321312|NCT02473614|516721496|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
143321313|NCT02473614|516721497|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
143321314|NCT01075074|516721498|FG000|Overall Study|Surgeon changed to open incisional case|1|||
143321315|NCT01075074|516721499|FG001|Overall Study|Surgeon changed to open incisional case|2|||
143321316|NCT01075074|516721500|FG002|Overall Study|Surgeon changed to open incisional case|2|||
143321317|NCT02416791|516721501|FG000|6 Months|Lost to Follow-up|0|||
143321318|NCT02416791|516721502|FG001|6 Months|Lost to Follow-up|0|||
143321319|NCT02416791|516721503|FG002|6 Months|Lost to Follow-up|1|||
143321320|NCT01054729|516721504|FG000|Overall Study|Randomized but Not Treated|0|||
143321321|NCT01054729|516721505|FG001|Overall Study|Randomized but Not Treated|1|||
143321322|NCT01054729|516721506|FG002|Overall Study|Randomized but Not Treated|0|||
143321323|NCT01054729|516721507|FG003|Overall Study|Randomized but Not Treated|0|||
143321324|NCT01054729|516721504|FG000|Overall Study|Adverse Event|1|||
143321325|NCT01054729|516721505|FG001|Overall Study|Adverse Event|1|||
143321326|NCT01054729|516721506|FG002|Overall Study|Adverse Event|2|||
143321327|NCT01054729|516721507|FG003|Overall Study|Adverse Event|1|||
143321328|NCT01054729|516721504|FG000|Overall Study|Withdrawal by Subject|1|||
143321329|NCT01054729|516721505|FG001|Overall Study|Withdrawal by Subject|0|||
143321330|NCT01054729|516721506|FG002|Overall Study|Withdrawal by Subject|1|||
143321331|NCT01054729|516721507|FG003|Overall Study|Withdrawal by Subject|0|||
143321332|NCT01054729|516721504|FG000|Overall Study|Lost to Follow-up|0|||
143321333|NCT01054729|516721505|FG001|Overall Study|Lost to Follow-up|1|||
143321334|NCT01054729|516721506|FG002|Overall Study|Lost to Follow-up|0|||
143321335|NCT01054729|516721507|FG003|Overall Study|Lost to Follow-up|0|||
143321336|NCT01054729|516721504|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
143321337|NCT01054729|516721505|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
143321338|NCT01054729|516721506|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
143321339|NCT01054729|516721507|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
143321340|NCT01054729|516721504|FG000|Overall Study|Non-responder|1|||
143321341|NCT01054729|516721505|FG001|Overall Study|Non-responder|0|||
143321342|NCT01054729|516721506|FG002|Overall Study|Non-responder|1|||
143321343|NCT01054729|516721507|FG003|Overall Study|Non-responder|1|||
143321344|NCT01054729|516721504|FG000|Overall Study|PEG/RBV Non-responder|1|||
143321345|NCT01054729|516721505|FG001|Overall Study|PEG/RBV Non-responder|0|||
143321346|NCT01054729|516721506|FG002|Overall Study|PEG/RBV Non-responder|1|||
143321347|NCT01054729|516721507|FG003|Overall Study|PEG/RBV Non-responder|0|||
143321348|NCT01054729|516721504|FG000|Overall Study|Personal/Obligations|0|||
143321349|NCT01054729|516721505|FG001|Overall Study|Personal/Obligations|1|||
143321350|NCT01054729|516721506|FG002|Overall Study|Personal/Obligations|0|||
143321351|NCT01054729|516721507|FG003|Overall Study|Personal/Obligations|0|||
143321352|NCT01054729|516721504|FG000|Overall Study|Subject moved|0|||
143321353|NCT01054729|516721505|FG001|Overall Study|Subject moved|0|||
143321354|NCT01054729|516721506|FG002|Overall Study|Subject moved|1|||
143321355|NCT01054729|516721507|FG003|Overall Study|Subject moved|0|||
143321356|NCT01054729|516721504|FG000|Overall Study|Lack of Efficacy|0|||
143321357|NCT01054729|516721505|FG001|Overall Study|Lack of Efficacy|0|||
143321358|NCT01054729|516721506|FG002|Overall Study|Lack of Efficacy|0|||
143321359|NCT01054729|516721507|FG003|Overall Study|Lack of Efficacy|1|||
143321360|NCT02352493|516721515|FG000|Overall Study|Pregnancy|0|||
143321361|NCT02352493|516721516|FG001|Overall Study|Pregnancy|0|||
143321362|NCT02352493|516721517|FG002|Overall Study|Pregnancy|0|||
143321363|NCT02352493|516721518|FG003|Overall Study|Pregnancy|0|||
143321364|NCT02352493|516721519|FG004|Overall Study|Pregnancy|0|||
143321365|NCT02352493|516721520|FG005|Overall Study|Pregnancy|0|||
143321366|NCT02352493|516721521|FG006|Overall Study|Pregnancy|1|||
143321367|NCT02352493|516721522|FG007|Overall Study|Pregnancy|0|||
143321368|NCT02352493|516721523|FG008|Overall Study|Pregnancy|1|||
143321369|NCT02352493|516721524|FG009|Overall Study|Pregnancy|0|||
143321370|NCT02352493|516721525|FG010|Overall Study|Pregnancy|0|||
143321371|NCT02352493|516721526|FG011|Overall Study|Pregnancy|0|||
143321372|NCT02352493|516721527|FG012|Overall Study|Pregnancy|0|||
143321373|NCT02352493|516721528|FG013|Overall Study|Pregnancy|0|||
143321374|NCT02352493|516721529|FG014|Overall Study|Pregnancy|0|||
143321375|NCT02352493|516721530|FG015|Overall Study|Pregnancy|0|||
143321376|NCT02352493|516721531|FG016|Overall Study|Pregnancy|0|||
143321377|NCT02352493|516721532|FG017|Overall Study|Pregnancy|0|||
143321378|NCT02352493|516721515|FG000|Overall Study|Withdrawal by Subject|0|||
143321379|NCT02352493|516721516|FG001|Overall Study|Withdrawal by Subject|0|||
143321380|NCT02352493|516721517|FG002|Overall Study|Withdrawal by Subject|0|||
143321381|NCT02352493|516721518|FG003|Overall Study|Withdrawal by Subject|0|||
143321382|NCT02352493|516721519|FG004|Overall Study|Withdrawal by Subject|0|||
143321383|NCT02352493|516721520|FG005|Overall Study|Withdrawal by Subject|0|||
143321384|NCT02352493|516721521|FG006|Overall Study|Withdrawal by Subject|0|||
143321385|NCT02352493|516721522|FG007|Overall Study|Withdrawal by Subject|0|||
143321386|NCT02352493|516721523|FG008|Overall Study|Withdrawal by Subject|1|||
143321387|NCT02352493|516721524|FG009|Overall Study|Withdrawal by Subject|0|||
143321388|NCT02352493|516721525|FG010|Overall Study|Withdrawal by Subject|0|||
143321389|NCT02352493|516721526|FG011|Overall Study|Withdrawal by Subject|0|||
143321390|NCT02352493|516721527|FG012|Overall Study|Withdrawal by Subject|0|||
143321391|NCT02352493|516721528|FG013|Overall Study|Withdrawal by Subject|0|||
143321392|NCT02352493|516721529|FG014|Overall Study|Withdrawal by Subject|1|||
143321393|NCT02352493|516721530|FG015|Overall Study|Withdrawal by Subject|0|||
143321394|NCT02352493|516721531|FG016|Overall Study|Withdrawal by Subject|0|||
143321395|NCT02352493|516721532|FG017|Overall Study|Withdrawal by Subject|0|||
143321396|NCT02352493|516721515|FG000|Overall Study|Lost to Follow-up|0|||
143321397|NCT02352493|516721516|FG001|Overall Study|Lost to Follow-up|0|||
143321398|NCT02352493|516721517|FG002|Overall Study|Lost to Follow-up|0|||
143321399|NCT02352493|516721518|FG003|Overall Study|Lost to Follow-up|0|||
143321400|NCT02352493|516721519|FG004|Overall Study|Lost to Follow-up|0|||
143321401|NCT02352493|516721520|FG005|Overall Study|Lost to Follow-up|0|||
143321402|NCT02352493|516721521|FG006|Overall Study|Lost to Follow-up|0|||
143321403|NCT02352493|516721522|FG007|Overall Study|Lost to Follow-up|0|||
143321404|NCT02352493|516721523|FG008|Overall Study|Lost to Follow-up|0|||
143321405|NCT02352493|516721524|FG009|Overall Study|Lost to Follow-up|1|||
143321406|NCT02352493|516721525|FG010|Overall Study|Lost to Follow-up|0|||
143321407|NCT02352493|516721526|FG011|Overall Study|Lost to Follow-up|0|||
143321408|NCT02352493|516721527|FG012|Overall Study|Lost to Follow-up|1|||
143321409|NCT02352493|516721528|FG013|Overall Study|Lost to Follow-up|2|||
143321410|NCT02352493|516721529|FG014|Overall Study|Lost to Follow-up|0|||
143321411|NCT02352493|516721530|FG015|Overall Study|Lost to Follow-up|0|||
143321412|NCT02352493|516721531|FG016|Overall Study|Lost to Follow-up|0|||
143321413|NCT02352493|516721532|FG017|Overall Study|Lost to Follow-up|0|||
143321414|NCT02546544|516721533|FG000|Overall Study|Disease Progression|14|||
143321415|NCT02546544|516721533|FG000|Overall Study|Adverse Event|1|||
143321416|NCT02546544|516721533|FG000|Overall Study|Withdrawal by Subject|1|||
143321417|NCT01921348|516721534|FG000|Overall Study|Withdrawal by Subject|1|||
143321418|NCT01921348|516721535|FG001|Overall Study|Withdrawal by Subject|0|||
143321419|NCT01921348|516721534|FG000|Overall Study|Lost to Follow-up|0|||
143321420|NCT01921348|516721535|FG001|Overall Study|Lost to Follow-up|2|||
143321421|NCT01465334|516721536|FG000|Overall Study|Disease Progression|1|||
143321422|NCT01465334|516721537|FG001|Overall Study|Disease Progression|0|||
143321423|NCT01465334|516721536|FG000|Overall Study|Adverse Event|1|||
143321424|NCT01465334|516721537|FG001|Overall Study|Adverse Event|0|||
143321425|NCT01465334|516721536|FG000|Overall Study|Richter's transformation|0|||
143321426|NCT01465334|516721537|FG001|Overall Study|Richter's transformation|3|||
143321427|NCT01465334|516721536|FG000|Overall Study|Refractory Disease|0|||
143321428|NCT01465334|516721537|FG001|Overall Study|Refractory Disease|3|||
143321429|NCT01114646|516721541|FG000|Overall Study|Withdrawal by Subject|3|||
143321430|NCT01114646|516721542|FG001|Overall Study|Withdrawal by Subject|2|||
143321431|NCT01046110|516721543|FG000|Overall Study|Adverse Event|9|||
143321432|NCT01046110|516721544|FG001|Overall Study|Adverse Event|2|||
143321433|NCT01046110|516721543|FG000|Overall Study|Lack of Efficacy|0|||
143321434|NCT01046110|516721544|FG001|Overall Study|Lack of Efficacy|1|||
143321435|NCT01046110|516721543|FG000|Overall Study|Protocol Violation|7|||
143321436|NCT01046110|516721544|FG001|Overall Study|Protocol Violation|12|||
143379961|NCT01693120|516938157|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
143321437|NCT01046110|516721543|FG000|Overall Study|Withdrawal Criteria|3|||
143321438|NCT01046110|516721544|FG001|Overall Study|Withdrawal Criteria|5|||
143321439|NCT01046110|516721543|FG000|Overall Study|Unclassified|36|||
143321440|NCT01046110|516721544|FG001|Overall Study|Unclassified|35|||
143321441|NCT01233817|516721545|FG000|Overall Study|Lost to Follow-up|1|||
143321442|NCT01233817|516721545|FG000|Overall Study|Withdrawal by Subject|2|||
143321443|NCT01202773|516721546|FG000|Overall Study|Adverse Event|4|||
143321444|NCT01202773|516721547|FG001|Overall Study|Adverse Event|5|||
143321445|NCT01202773|516721548|FG002|Overall Study|Adverse Event|5|||
143321446|NCT01202773|516721546|FG000|Overall Study|Lack of Efficacy|5|||
143321447|NCT01202773|516721547|FG001|Overall Study|Lack of Efficacy|4|||
143321448|NCT01202773|516721548|FG002|Overall Study|Lack of Efficacy|9|||
143321449|NCT01202773|516721546|FG000|Overall Study|Entry Criteria Not Met|2|||
143321450|NCT01202773|516721547|FG001|Overall Study|Entry Criteria Not Met|0|||
143321451|NCT01202773|516721548|FG002|Overall Study|Entry Criteria Not Met|1|||
143321452|NCT01202773|516721546|FG000|Overall Study|Lost to Follow-up|1|||
143321453|NCT01202773|516721547|FG001|Overall Study|Lost to Follow-up|2|||
143321454|NCT01202773|516721548|FG002|Overall Study|Lost to Follow-up|2|||
143321455|NCT01202773|516721546|FG000|Overall Study|Withdrawal by Subject|13|||
143321456|NCT01202773|516721547|FG001|Overall Study|Withdrawal by Subject|6|||
143321457|NCT01202773|516721548|FG002|Overall Study|Withdrawal by Subject|5|||
143321458|NCT01202773|516721546|FG000|Overall Study|Physician Decision|2|||
143321459|NCT01202773|516721547|FG001|Overall Study|Physician Decision|0|||
143321460|NCT01202773|516721548|FG002|Overall Study|Physician Decision|0|||
143321461|NCT01202773|516721546|FG000|Overall Study|Protocol Violation|11|||
143321462|NCT01202773|516721547|FG001|Overall Study|Protocol Violation|6|||
143321463|NCT01202773|516721548|FG002|Overall Study|Protocol Violation|10|||
143321464|NCT01202773|516721546|FG000|Overall Study|Sponsor Decision|19|||
143321465|NCT01202773|516721547|FG001|Overall Study|Sponsor Decision|20|||
143321466|NCT01202773|516721548|FG002|Overall Study|Sponsor Decision|23|||
143321467|NCT00575588|516721549|FG000|Overall Study|Adverse Event|11|||
143321468|NCT00575588|516721550|FG001|Overall Study|Adverse Event|13|||
143321469|NCT00575588|516721549|FG000|Overall Study|Withdrawal by Subject|27|||
143321470|NCT00575588|516721550|FG001|Overall Study|Withdrawal by Subject|31|||
143321471|NCT00575588|516721549|FG000|Overall Study|Lost to Follow-up|1|||
143321472|NCT00575588|516721550|FG001|Overall Study|Lost to Follow-up|3|||
143321473|NCT00575588|516721549|FG000|Overall Study|Death|4|||
143321474|NCT00575588|516721550|FG001|Overall Study|Death|2|||
143321475|NCT00575588|516721549|FG000|Overall Study|Incorrect enrollment|8|||
143321476|NCT00575588|516721550|FG001|Overall Study|Incorrect enrollment|4|||
143321477|NCT00575588|516721549|FG000|Overall Study|Study specific discontinuation criteria|203|||
143321478|NCT00575588|516721550|FG001|Overall Study|Study specific discontinuation criteria|218|||
143321479|NCT00575588|516721549|FG000|Overall Study|Severe non-compliance to protocol|5|||
143321480|NCT00575588|516721550|FG001|Overall Study|Severe non-compliance to protocol|7|||
143321481|NCT00575588|516721549|FG000|Overall Study|Safety reasons|2|||
143321482|NCT00575588|516721550|FG001|Overall Study|Safety reasons|1|||
143321483|NCT00575588|516721549|FG000|Overall Study|Elevated triglyceride|1|||
143321484|NCT00575588|516721550|FG001|Overall Study|Elevated triglyceride|0|||
143321485|NCT00575588|516721549|FG000|Overall Study|Patient moved|1|||
143321486|NCT00575588|516721550|FG001|Overall Study|Patient moved|3|||
143321487|NCT00575588|516721549|FG000|Overall Study|Impossible to determine HbA1c|0|||
143321488|NCT00575588|516721550|FG001|Overall Study|Impossible to determine HbA1c|1|||
143321489|NCT01343407|516721551|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
143321490|NCT01343407|516721552|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
143321491|NCT01343407|516721553|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
143321492|NCT01343407|516721554|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
143321493|NCT01343407|516721555|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
143321494|NCT01343407|516721556|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
143321495|NCT01343407|516721551|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
143321496|NCT01343407|516721552|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
143321497|NCT01343407|516721553|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
143321498|NCT01343407|516721554|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
143321499|NCT01343407|516721555|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
143321500|NCT01343407|516721556|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
143321501|NCT00797667|516721564|FG000|Overall Study|Lack of Efficacy|0|||
143321502|NCT00797667|516721565|FG001|Overall Study|Lack of Efficacy|1|||
143321503|NCT00797667|516721566|FG002|Overall Study|Lack of Efficacy|0|||
143321504|NCT00797667|516721564|FG000|Overall Study|Lost to Follow-up|8|||
143321505|NCT00797667|516721565|FG001|Overall Study|Lost to Follow-up|12|||
143321506|NCT00797667|516721566|FG002|Overall Study|Lost to Follow-up|2|||
143321507|NCT00797667|516721564|FG000|Overall Study|Physician Decision|3|||
143321508|NCT00797667|516721565|FG001|Overall Study|Physician Decision|1|||
143321509|NCT00797667|516721566|FG002|Overall Study|Physician Decision|0|||
143321510|NCT00797667|516721564|FG000|Overall Study|Pregnancy|2|||
143321511|NCT00797667|516721565|FG001|Overall Study|Pregnancy|0|||
143321512|NCT00797667|516721566|FG002|Overall Study|Pregnancy|0|||
143321513|NCT00797667|516721564|FG000|Overall Study|Protocol Violation|2|||
143321514|NCT00797667|516721565|FG001|Overall Study|Protocol Violation|7|||
143321515|NCT00797667|516721566|FG002|Overall Study|Protocol Violation|0|||
143321516|NCT00797667|516721564|FG000|Overall Study|Study Terminated by Sponsor|217|||
143321517|NCT00797667|516721565|FG001|Overall Study|Study Terminated by Sponsor|216|||
143321518|NCT00797667|516721566|FG002|Overall Study|Study Terminated by Sponsor|115|||
143321519|NCT00797667|516721564|FG000|Overall Study|Withdrawal by Subject|9|||
143321520|NCT00797667|516721565|FG001|Overall Study|Withdrawal by Subject|14|||
143321521|NCT00797667|516721566|FG002|Overall Study|Withdrawal by Subject|2|||
143321522|NCT00797667|516721564|FG000|Overall Study|Adverse Event|19|||
143379962|NCT01693120|516938157|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
143379963|NCT03624972|516938166|FG000|Overall Study|Lost to Follow-up|2|||
143379964|NCT03624972|516938167|FG001|Overall Study|Lost to Follow-up|0|||
143379965|NCT03624972|516938168|FG002|Overall Study|Lost to Follow-up|0|||
143379966|NCT03624972|516938166|FG000|Overall Study|Withdrawal by Subject|0|||
143379967|NCT03624972|516938167|FG001|Overall Study|Withdrawal by Subject|2|||
143379968|NCT03624972|516938168|FG002|Overall Study|Withdrawal by Subject|0|||
143379969|NCT00431834|516938169|FG000|Overall Study|Withdrawal by Subject|7|||
143321523|NCT00797667|516721565|FG001|Overall Study|Adverse Event|8|||
143321524|NCT00797667|516721566|FG002|Overall Study|Adverse Event|8|||
143321525|NCT01986829|516721571|FG000|Overall Study|Death|1|||
143321526|NCT02504866|516721572|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
143321527|NCT02504866|516721573|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
143321528|NCT02504866|516721574|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
143321529|NCT00781326|516721577|FG000|Phase I|Adverse Event|1|||
143321530|NCT00781326|516721577|FG000|Phase I|Withdrawal by Subject|1|||
143321531|NCT00781326|516721577|FG000|Phase I|Physician Decision|2|||
143321532|NCT00096941|516721578|FG000|Overall Study|disease progression|3|||
143321533|NCT01775137|516721579|FG000|Overall Study|Death|1|||
143321534|NCT01775137|516721579|FG000|Overall Study|Protocol deviation|2|||
143321535|NCT01775137|516721579|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
143321536|NCT01775137|516721579|FG000|Overall Study|Adverse Event|1|||
143321537|NCT01775137|516721579|FG000|Overall Study|Withdrawal by participants|5|||
143321538|NCT02673697|516721582|FG000|Overall Study|Adverse Event|2|||
143321539|NCT02673697|516721583|FG001|Overall Study|Adverse Event|0|||
143321540|NCT02673697|516721582|FG000|Overall Study|Death|32|||
143321541|NCT02673697|516721583|FG001|Overall Study|Death|24|||
143321542|NCT02673697|516721582|FG000|Overall Study|Lost to Follow-up|5|||
143321543|NCT02673697|516721583|FG001|Overall Study|Lost to Follow-up|2|||
143321544|NCT02673697|516721582|FG000|Overall Study|Physician Decision|2|||
143321545|NCT02673697|516721583|FG001|Overall Study|Physician Decision|1|||
143321546|NCT02673697|516721582|FG000|Overall Study|Withdrawal by Subject|10|||
143321547|NCT02673697|516721583|FG001|Overall Study|Withdrawal by Subject|7|||
143321548|NCT02673697|516721582|FG000|Overall Study|Change subj medical status|1|||
143321549|NCT02673697|516721583|FG001|Overall Study|Change subj medical status|2|||
143321550|NCT02673697|516721582|FG000|Overall Study|Explant|10|||
143321551|NCT02673697|516721583|FG001|Overall Study|Explant|5|||
143321552|NCT02673697|516721582|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
143321553|NCT02673697|516721583|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
143321554|NCT00437489|516721584|FG000|Overall Study|Study terminated by sponsor|23|||
143321555|NCT00437489|516721585|FG001|Overall Study|Study terminated by sponsor|21|||
143321556|NCT00437489|516721584|FG000|Overall Study|Lost to Follow-up|0|||
143321557|NCT00437489|516721585|FG001|Overall Study|Lost to Follow-up|1|||
143321558|NCT01592708|516721586|FG000|Overall Study|Protocol Violation|3|||
143321559|NCT01592708|516721587|FG001|Overall Study|Protocol Violation|0|||
143321560|NCT02328326|516721594|FG000|Overall Study|Withdrawal by Subject|10|||
143321561|NCT02328326|516721595|FG001|Overall Study|Withdrawal by Subject|3|||
143321562|NCT02328326|516721594|FG000|Overall Study|Death|2|||
143321563|NCT02328326|516721595|FG001|Overall Study|Death|1|||
143321564|NCT02328326|516721594|FG000|Overall Study|Lost to Follow-up|10|||
143321565|NCT02328326|516721595|FG001|Overall Study|Lost to Follow-up|4|||
143321566|NCT02056301|516721596|FG000|Overall Study|Protocol Violation|1|||
143321567|NCT02056301|516721597|FG001|Overall Study|Protocol Violation|2|||
143321568|NCT02056301|516721596|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
143321569|NCT02056301|516721597|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
143321570|NCT02056301|516721596|FG000|Overall Study|Withdrawal by Subject|0|||
143379970|NCT00431834|516938169|FG000|Overall Study|Death|3|||
143379971|NCT00431834|516938169|FG000|Overall Study|Missed Endpoint Visit|2|||
143379972|NCT00431834|516938169|FG000|Overall Study|Lost to Follow-up|1|||
143379973|NCT02647905|516938170|FG000|Overall Study|Lost to Follow-up|1|||
143321571|NCT02056301|516721597|FG001|Overall Study|Withdrawal by Subject|1|||
143321572|NCT02056301|516721596|FG000|Overall Study|Issues with epidural|0|||
143321573|NCT02056301|516721597|FG001|Overall Study|Issues with epidural|3|||
143321574|NCT01767116|516721601|FG000|Overall Study|Lost to Follow-up|2|||
143321575|NCT01767116|516721602|FG001|Overall Study|Lost to Follow-up|2|||
143321576|NCT02209324|516721603|FG000|Overall Study|Adverse Event|2|||
143321577|NCT02209324|516721603|FG000|Overall Study|Lack of Efficacy|1|||
143321578|NCT02209324|516721603|FG000|Overall Study|Lost to Follow-up|1|||
143321579|NCT02209324|516721603|FG000|Overall Study|Physician Decision|3|||
143321580|NCT02209324|516721603|FG000|Overall Study|Protocol Violation|14|||
143321581|NCT02209324|516721603|FG000|Overall Study|Withdrawal by Subject|8|||
143321582|NCT02209324|516721603|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
143321583|NCT02209324|516721603|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
143321584|NCT02209324|516721603|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
143321585|NCT03433456|516721604|FG000|Overall Study|Death|1|||
143321586|NCT03433456|516721605|FG001|Overall Study|Death|1|||
143321587|NCT03433456|516721604|FG000|Overall Study|Lost to Follow-up|14|||
143321588|NCT03433456|516721605|FG001|Overall Study|Lost to Follow-up|11|||
143379974|NCT02647905|516938170|FG000|Overall Study|Withdrawal by Subject|2|||
143379975|NCT05132478|516938171|FG000|Overall Study|did not complete survey after consent|1|||
143379976|NCT05132478|516938172|FG001|Overall Study|did not complete survey after consent|1|||
143379977|NCT05132478|516938171|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
143379978|NCT05132478|516938172|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
143379979|NCT00595413|516938173|FG000|Overall Study|Adverse Event|0|||
143379980|NCT00595413|516938174|FG001|Overall Study|Adverse Event|2|||
143379981|NCT00595413|516938175|FG002|Overall Study|Adverse Event|1|||
143379982|NCT00595413|516938176|FG003|Overall Study|Adverse Event|1|||
143379983|NCT00595413|516938173|FG000|Overall Study|Lost to Follow-up|2|||
143379984|NCT00595413|516938174|FG001|Overall Study|Lost to Follow-up|2|||
143379985|NCT00595413|516938175|FG002|Overall Study|Lost to Follow-up|1|||
143379986|NCT00595413|516938176|FG003|Overall Study|Lost to Follow-up|3|||
143379987|NCT00595413|516938173|FG000|Overall Study|Death|0|||
143379988|NCT00595413|516938174|FG001|Overall Study|Death|0|||
143379989|NCT00595413|516938175|FG002|Overall Study|Death|1|||
143379990|NCT00595413|516938176|FG003|Overall Study|Death|0|||
143379991|NCT00595413|516938173|FG000|Overall Study|Other|5|||
143379992|NCT00595413|516938174|FG001|Overall Study|Other|1|||
143379993|NCT00595413|516938175|FG002|Overall Study|Other|5|||
143379994|NCT00595413|516938176|FG003|Overall Study|Other|0|||
143379995|NCT00807937|516938177|FG000|Overall Study|Adverse Event|12|||
143379996|NCT00807937|516938178|FG001|Overall Study|Adverse Event|12|||
143379997|NCT00807937|516938179|FG002|Overall Study|Adverse Event|5|||
143379998|NCT00807937|516938180|FG003|Overall Study|Adverse Event|4|||
143379999|NCT00807937|516938177|FG000|Overall Study|Protocol Violation|4|||
143380000|NCT00807937|516938178|FG001|Overall Study|Protocol Violation|5|||
143380001|NCT00807937|516938179|FG002|Overall Study|Protocol Violation|3|||
143380002|NCT00807937|516938180|FG003|Overall Study|Protocol Violation|3|||
143380003|NCT00807937|516938177|FG000|Overall Study|Withdrawal by Subject|5|||
143380004|NCT00807937|516938178|FG001|Overall Study|Withdrawal by Subject|4|||
143380005|NCT00807937|516938179|FG002|Overall Study|Withdrawal by Subject|1|||
143380006|NCT00807937|516938180|FG003|Overall Study|Withdrawal by Subject|4|||
143380007|NCT00807937|516938177|FG000|Overall Study|Lost to Follow-up|4|||
143380008|NCT00807937|516938178|FG001|Overall Study|Lost to Follow-up|0|||
143380009|NCT00807937|516938179|FG002|Overall Study|Lost to Follow-up|2|||
143380010|NCT00807937|516938180|FG003|Overall Study|Lost to Follow-up|1|||
143380011|NCT00807937|516938177|FG000|Overall Study|Lack of Efficacy|0|||
143380012|NCT00807937|516938178|FG001|Overall Study|Lack of Efficacy|0|||
143380013|NCT00807937|516938179|FG002|Overall Study|Lack of Efficacy|1|||
143380014|NCT00807937|516938180|FG003|Overall Study|Lack of Efficacy|2|||
143380015|NCT00807937|516938177|FG000|Overall Study|Intake of prohibited medicine|0|||
143380016|NCT00807937|516938178|FG001|Overall Study|Intake of prohibited medicine|0|||
143380017|NCT00807937|516938179|FG002|Overall Study|Intake of prohibited medicine|2|||
143380018|NCT00807937|516938180|FG003|Overall Study|Intake of prohibited medicine|0|||
143380019|NCT00807937|516938177|FG000|Overall Study|All other reasons (not provided)|2|||
143380020|NCT00807937|516938178|FG001|Overall Study|All other reasons (not provided)|4|||
143380021|NCT00807937|516938179|FG002|Overall Study|All other reasons (not provided)|0|||
143380022|NCT00807937|516938180|FG003|Overall Study|All other reasons (not provided)|1|||
143380023|NCT04629950|516938183|FG000|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
143380024|NCT04629950|516938184|FG001|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
143380025|NCT04629950|516938185|FG002|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
143380026|NCT04629950|516938186|FG003|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
143380027|NCT04629950|516938183|FG000|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
143380028|NCT04629950|516938184|FG001|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|2|||
143380029|NCT04629950|516938185|FG002|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
143380030|NCT04629950|516938186|FG003|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
143380031|NCT04629950|516938183|FG000|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
143380032|NCT04629950|516938184|FG001|Double-Blind Placebo Controlled Trial|Adverse Event|2|||
143380033|NCT04629950|516938185|FG002|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
143380034|NCT04629950|516938186|FG003|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
143380035|NCT04629950|516938183|FG000|Extension Study|Withdrawal by Subject|0|||
143380036|NCT04629950|516938184|FG001|Extension Study|Withdrawal by Subject|0|||
143380037|NCT04629950|516938185|FG002|Extension Study|Withdrawal by Subject|1|||
143380038|NCT04629950|516938186|FG003|Extension Study|Withdrawal by Subject|0|||
143380039|NCT04629950|516938183|FG000|Extension Study|Adverse Event|0|||
143380040|NCT04629950|516938184|FG001|Extension Study|Adverse Event|0|||
143380041|NCT04629950|516938185|FG002|Extension Study|Adverse Event|0|||
143380042|NCT04629950|516938186|FG003|Extension Study|Adverse Event|1|||
143380043|NCT03233633|516938187|FG000|Overall Study|Adverse Event|2|||
143380044|NCT03233633|516938187|FG000|Overall Study|Less Than 3 Days of Data|6|||
143380045|NCT02088853|516938188|FG000|Overall Study|Pregnancy|1|||
143380046|NCT02088853|516938189|FG001|Overall Study|Pregnancy|0|||
143380047|NCT05782231|516938190|FG000|Overall Study|Withdrawal by Subject|1|||
143380048|NCT01198145|516938191|FG000|Overall Study|Withdrawal by Subject|1|||
143380049|NCT01198145|516938192|FG001|Overall Study|Withdrawal by Subject|1|||
143380050|NCT03830866|516938193|FG000|Overall Study|Death|90|||
143380051|NCT03830866|516938194|FG001|Overall Study|Death|111|||
143380052|NCT03830866|516938193|FG000|Overall Study|Lost to Follow-up|7|||
143380053|NCT03830866|516938194|FG001|Overall Study|Lost to Follow-up|7|||
143380054|NCT03830866|516938193|FG000|Overall Study|Withdrawal by Subject|19|||
143380055|NCT03830866|516938194|FG001|Overall Study|Withdrawal by Subject|16|||
143380056|NCT03830866|516938193|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
143380057|NCT03830866|516938194|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
143380058|NCT03830866|516938193|FG000|Overall Study|Other|1|||
143380059|NCT03830866|516938194|FG001|Overall Study|Other|1|||
143380060|NCT00510887|516938196|FG000|Overall Study|Lost to Follow-up|1|||
143380061|NCT01561989|516938197|FG000|Overall Study|accural target not met.|5|||
143380062|NCT01561989|516938198|FG001|Overall Study|accural target not met.|6|||
143380063|NCT01736215|516938199|FG000|Overall Study|Early termination of erythropoietin use|1|||
143380064|NCT01736215|516938199|FG000|Overall Study|Adverse Event|4|||
143380065|NCT01736215|516938199|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
143380066|NCT01736215|516938199|FG000|Overall Study|Insufficient data to perform analysis|8|||
143380067|NCT03447249|516938200|FG000|Overall Study|Adverse Event|1|||
143380068|NCT03447249|516938201|FG001|Overall Study|Adverse Event|0|||
143380069|NCT03447249|516938200|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
143380070|NCT03447249|516938201|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
143380071|NCT03447249|516938200|FG000|Overall Study|Other|3|||
143380072|NCT03447249|516938201|FG001|Overall Study|Other|0|||
143380073|NCT01248936|516938202|FG000|Overall Study|Sponsor Decision|259|||
143380074|NCT01248936|516938202|FG000|Overall Study|Progression of Disease|50|||
143380075|NCT01248936|516938202|FG000|Overall Study|Death|26|||
143380076|NCT01248936|516938202|FG000|Overall Study|Withdrawal of Consent|20|||
143380077|NCT01248936|516938202|FG000|Overall Study|Adverse Event|8|||
143380078|NCT01248936|516938202|FG000|Overall Study|Lost to Follow-up|7|||
143380079|NCT01248936|516938202|FG000|Overall Study|Refused Treatment|1|||
143380080|NCT01248936|516938202|FG000|Overall Study|Other reason|3|||
143380081|NCT00390299|516938203|FG000|Overall Study|Cancellation|1|||
143380082|NCT00390299|516938204|FG001|Overall Study|Cancellation|0|||
143380083|NCT00390299|516938205|FG002|Overall Study|Cancellation|0|||
143380084|NCT00390299|516938206|FG003|Overall Study|Cancellation|0|||
143380085|NCT00390299|516938207|FG004|Overall Study|Cancellation|0|||
143380086|NCT01207492|516938213|FG000|Overall Study|Still on study|1|||
143380087|NCT01207492|516938213|FG000|Overall Study|Withdrawal by Subject|9|||
143380088|NCT01207492|516938213|FG000|Overall Study|Physician Decision|1|||
143380089|NCT01207492|516938213|FG000|Overall Study|Progressive disease|3|||
143380090|NCT01207492|516938213|FG000|Overall Study|Toxicity|1|||
143380091|NCT02769858|516938214|FG000|Overall Study|Withdrawal by Subject|2|||
143380092|NCT05094141|516938220|FG000|Overall Study|Death|0|||
143380093|NCT05094141|516938221|FG001|Overall Study|Death|0|||
143380094|NCT05094141|516938222|FG002|Overall Study|Death|1|||
143380095|NCT05094141|516938220|FG000|Overall Study|Withdrawal by Subject|0|||
143380096|NCT05094141|516938221|FG001|Overall Study|Withdrawal by Subject|0|||
143380097|NCT05094141|516938222|FG002|Overall Study|Withdrawal by Subject|1|||
143380098|NCT05094141|516938220|FG000|Overall Study|Subject did not want to wear the VR Helmet|0|||
143380099|NCT05094141|516938221|FG001|Overall Study|Subject did not want to wear the VR Helmet|0|||
143380100|NCT05094141|516938222|FG002|Overall Study|Subject did not want to wear the VR Helmet|2|||
143380101|NCT05094141|516938220|FG000|Overall Study|Did not participate in randomization|0|||
143380102|NCT05094141|516938221|FG001|Overall Study|Did not participate in randomization|0|||
143380103|NCT05094141|516938222|FG002|Overall Study|Did not participate in randomization|33|||
143380104|NCT05505045|516940593|FG000|Overall Study|Withdrawal by Subject|2|||
143380105|NCT05505045|516940594|FG001|Overall Study|Withdrawal by Subject|1|||
143380106|NCT04278586|516940597|FG000|Overall Study|Withdrawal by Subject|13|||
143380107|NCT04278586|516940598|FG001|Overall Study|Withdrawal by Subject|6|||
143380108|NCT04278586|516940597|FG000|Overall Study|Lost to Follow-up|37|||
143380109|NCT04278586|516940598|FG001|Overall Study|Lost to Follow-up|24|||
143380110|NCT02791230|516940599|FG000|Overall Study|Adverse Event|10|||
143380111|NCT02791230|516940600|FG001|Overall Study|Adverse Event|9|||
143380112|NCT02791230|516940601|FG002|Overall Study|Adverse Event|66|||
143380113|NCT02791230|516940599|FG000|Overall Study|Death|38|||
143380114|NCT02791230|516940600|FG001|Overall Study|Death|25|||
143380115|NCT02791230|516940601|FG002|Overall Study|Death|184|||
143380116|NCT02791230|516940599|FG000|Overall Study|Lack of Efficacy|1|||
143380117|NCT02791230|516940600|FG001|Overall Study|Lack of Efficacy|0|||
143380118|NCT02791230|516940601|FG002|Overall Study|Lack of Efficacy|3|||
143380119|NCT02791230|516940599|FG000|Overall Study|Lost to Follow-up|0|||
143380120|NCT02791230|516940600|FG001|Overall Study|Lost to Follow-up|0|||
143380121|NCT02791230|516940601|FG002|Overall Study|Lost to Follow-up|10|||
143380122|NCT02791230|516940599|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
143380123|NCT02791230|516940600|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
143321589|NCT03433456|516721604|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
143321590|NCT03433456|516721605|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
143321591|NCT01785602|516721609|FG000|Overall Study|Withdrawal by Subject|2|||
143321592|NCT01785602|516721610|FG001|Overall Study|Withdrawal by Subject|0|||
143321593|NCT01785602|516721609|FG000|Overall Study|Lost to Follow-up|1|||
143321594|NCT01785602|516721610|FG001|Overall Study|Lost to Follow-up|1|||
143321595|NCT01785602|516721609|FG000|Overall Study|Adverse Event|3|||
143321596|NCT01785602|516721610|FG001|Overall Study|Adverse Event|5|||
143321597|NCT01785602|516721609|FG000|Overall Study|Administrative problems|7|||
143321598|NCT01785602|516721610|FG001|Overall Study|Administrative problems|3|||
143321599|NCT01427712|516721611|FG000|Overall Study|Transfer to a different hospital|2|||
143321600|NCT01427712|516721611|FG000|Overall Study|Lost to Follow-up|1|||
143321601|NCT01427712|516721611|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
143321602|NCT01427712|516721611|FG000|Overall Study|Failure to visit|1|||
143321603|NCT00439777|516721612|FG000|Treatment Period|Death|29|||
143321604|NCT00439777|516721613|FG001|Treatment Period|Death|21|||
143321605|NCT00439777|516721612|FG000|Treatment Period|Study terminated by sponsor|125|||
143321606|NCT00439777|516721613|FG001|Treatment Period|Study terminated by sponsor|132|||
143321607|NCT00439777|516721612|FG000|Treatment Period|Site closed by investigator|0|||
143321608|NCT00439777|516721613|FG001|Treatment Period|Site closed by investigator|1|||
143321609|NCT00439777|516721612|FG000|Treatment Period|Did not take study treatment|7|||
143321610|NCT00439777|516721613|FG001|Treatment Period|Did not take study treatment|8|||
143321611|NCT00439777|516721612|FG000|Treatment Period|Adverse Event|111|||
143321612|NCT00439777|516721613|FG001|Treatment Period|Adverse Event|92|||
143321613|NCT00439777|516721612|FG000|Treatment Period|Protocol Violation|23|||
143321614|NCT00439777|516721613|FG001|Treatment Period|Protocol Violation|30|||
143321615|NCT00439777|516721612|FG000|Treatment Period|Withdrawal by Subject|66|||
143321616|NCT00439777|516721613|FG001|Treatment Period|Withdrawal by Subject|118|||
143321617|NCT00439777|516721612|FG000|Treatment Period|Lack of Efficacy|1|||
143321618|NCT00439777|516721613|FG001|Treatment Period|Lack of Efficacy|4|||
143321619|NCT00439777|516721612|FG000|Treatment Period|Lost to Follow-up|8|||
143321620|NCT00439777|516721613|FG001|Treatment Period|Lost to Follow-up|10|||
143321621|NCT00439777|516721612|FG000|Treatment Period|Protocol driven decision point|1|||
143321622|NCT00439777|516721613|FG001|Treatment Period|Protocol driven decision point|3|||
143321623|NCT00439777|516721612|FG000|Treatment Period|Physician Decision|7|||
143321624|NCT00439777|516721613|FG001|Treatment Period|Physician Decision|18|||
143321625|NCT00439777|516721612|FG000|Treatment Period|Clinical endpoint reached|26|||
143321626|NCT00439777|516721613|FG001|Treatment Period|Clinical endpoint reached|13|||
143321627|NCT00439777|516721612|FG000|Treatment Period|Technical problems|3|||
143321628|NCT00439777|516721613|FG001|Treatment Period|Technical problems|1|||
143321629|NCT00439777|516721612|FG000|Treatment Period|Participant convenience|12|||
143321630|NCT00439777|516721613|FG001|Treatment Period|Participant convenience|8|||
143321631|NCT00439777|516721612|FG000|Observational Period|Protocol Violation|0|||
143321632|NCT00439777|516721613|FG001|Observational Period|Protocol Violation|2|||
143321633|NCT00439777|516721612|FG000|Observational Period|Withdrawal by Subject|9|||
143321634|NCT00439777|516721613|FG001|Observational Period|Withdrawal by Subject|5|||
143321635|NCT00439777|516721612|FG000|Observational Period|Lost to Follow-up|1|||
143321636|NCT00439777|516721613|FG001|Observational Period|Lost to Follow-up|11|||
143321637|NCT00439777|516721612|FG000|Observational Period|Death|27|||
143321638|NCT00439777|516721613|FG001|Observational Period|Death|20|||
143321639|NCT00439777|516721612|FG000|Observational Period|Study terminated by sponsor|3|||
143321640|NCT00439777|516721613|FG001|Observational Period|Study terminated by sponsor|1|||
143321641|NCT00439777|516721612|FG000|Observational Period|Protocol driven decision point|0|||
143321642|NCT00439777|516721613|FG001|Observational Period|Protocol driven decision point|1|||
143321643|NCT00439777|516721612|FG000|Observational Period|Lack of Efficacy|1|||
143321644|NCT00439777|516721613|FG001|Observational Period|Lack of Efficacy|0|||
143321645|NCT00439777|516721612|FG000|Observational Period|Technical problems|0|||
143321646|NCT00439777|516721613|FG001|Observational Period|Technical problems|1|||
143321647|NCT00661492|516721614|FG000|Overall Study|Adverse Event|16|||
143321648|NCT00661492|516721615|FG001|Overall Study|Adverse Event|13|||
143321649|NCT00661492|516721614|FG000|Overall Study|Disease Progression|44|||
143321650|NCT00661492|516721615|FG001|Overall Study|Disease Progression|14|||
143321651|NCT00661492|516721614|FG000|Overall Study|Patient Request|6|||
143321652|NCT00661492|516721615|FG001|Overall Study|Patient Request|1|||
143321653|NCT00661492|516721614|FG000|Overall Study|Investigator Request|1|||
143321654|NCT00661492|516721615|FG001|Overall Study|Investigator Request|0|||
143321655|NCT00661492|516721614|FG000|Overall Study|Lost to Follow-up|0|||
143321656|NCT00661492|516721615|FG001|Overall Study|Lost to Follow-up|1|||
143321657|NCT00661492|516721614|FG000|Overall Study|Other|1|||
143321658|NCT00661492|516721615|FG001|Overall Study|Other|0|||
143321659|NCT03855189|516721616|FG000|Overall Study|Adverse Event|5|||
143321660|NCT03855189|516721617|FG001|Overall Study|Adverse Event|2|||
143321661|NCT03855189|516721618|FG002|Overall Study|Adverse Event|4|||
143321662|NCT03855189|516721616|FG000|Overall Study|Treatment Failure|1|||
143321663|NCT03855189|516721617|FG001|Overall Study|Treatment Failure|1|||
143321664|NCT03855189|516721618|FG002|Overall Study|Treatment Failure|2|||
143321665|NCT03855189|516721616|FG000|Overall Study|Noncompliance with Protocol|0|||
143321666|NCT03855189|516721617|FG001|Overall Study|Noncompliance with Protocol|1|||
143321667|NCT03855189|516721618|FG002|Overall Study|Noncompliance with Protocol|0|||
143321668|NCT03855189|516721616|FG000|Overall Study|Did Not Return|4|||
143321669|NCT03855189|516721617|FG001|Overall Study|Did Not Return|3|||
143321670|NCT03855189|516721618|FG002|Overall Study|Did Not Return|0|||
143321671|NCT02641080|516721619|FG000|Overall Study|Physician Decision|2|||
143321672|NCT02641080|516721620|FG001|Overall Study|Physician Decision|0|||
143321673|NCT02641080|516721619|FG000|Overall Study|Withdrawal by Subject|0|||
143321674|NCT02641080|516721620|FG001|Overall Study|Withdrawal by Subject|1|||
143321675|NCT02641080|516721619|FG000|Overall Study|Rehab Center denied use of pumps|0|||
143321676|NCT02641080|516721620|FG001|Overall Study|Rehab Center denied use of pumps|3|||
143321677|NCT02641080|516721619|FG000|Overall Study|Lost to Follow-up|0|||
143321678|NCT02641080|516721620|FG001|Overall Study|Lost to Follow-up|3|||
143321679|NCT04307186|516721621|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
143321680|NCT04307186|516721621|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
143321681|NCT04307186|516721621|FG000|Washout 3-14 Days|Progressive disease|1|||
143321682|NCT04307186|516721621|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
143321683|NCT04307186|516721621|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
143321684|NCT00586105|516721623|FG000|Overall Study|Adverse Event|4|||
143321685|NCT00586105|516721623|FG000|Overall Study|Death|2|||
143321686|NCT00586105|516721623|FG000|Overall Study|Protocol Violation|1|||
143321687|NCT00586105|516721623|FG000|Overall Study|Withdrawal by Subject|3|||
143321688|NCT00586105|516721623|FG000|Overall Study|Disease progression|19|||
143321689|NCT00586105|516721623|FG000|Overall Study|Switched to commercial drug|9|||
143321690|NCT00586105|516721623|FG000|Overall Study|Reason not reported|1|||
143321691|NCT03791398|516721626|FG000|Overall Study|Progression of Disease Under Study|2|||
143321692|NCT03791398|516721627|FG001|Overall Study|Progression of Disease Under Study|0|||
143321693|NCT03791398|516721628|FG002|Overall Study|Progression of Disease Under Study|0|||
143321694|NCT00766376|516721629|FG000|Overall Study|Withdrawal by Subject|27|||
143321695|NCT01800903|516721630|FG000|Second Test Period|unable to catheterise|1|||
143321696|NCT01800903|516721631|FG001|Second Test Period|unable to catheterise|0|||
143321697|NCT01800903|516721632|FG002|Second Test Period|unable to catheterise|0|||
143321698|NCT01800903|516721633|FG003|Second Test Period|unable to catheterise|0|||
143321699|NCT01800903|516721634|FG004|Second Test Period|unable to catheterise|0|||
143321700|NCT01800903|516721635|FG005|Second Test Period|unable to catheterise|0|||
143321701|NCT00080223|516721638|FG000|Overall Study|Adverse Event|23|||
143321702|NCT00080223|516721638|FG000|Overall Study|Death|21|||
143321703|NCT00080223|516721638|FG000|Overall Study|Withdrawal by Subject|13|||
143321704|NCT00080223|516721638|FG000|Overall Study|Lung Transplantation|9|||
143321705|NCT00080223|516721638|FG000|Overall Study|Non-compliance With Study Treatment|7|||
143321706|NCT00080223|516721638|FG000|Overall Study|Participant unwilling to continue|2|||
143321707|NCT00080223|516721638|FG000|Overall Study|Physician Decision|1|||
143321708|NCT03099382|516721645|FG000|Overall Study|Protocol Violation|2|||
143321709|NCT03099382|516721646|FG001|Overall Study|Protocol Violation|3|||
143321710|NCT01802411|516721647|FG000|Overall Study|Death|2|||
143321711|NCT01802411|516721648|FG001|Overall Study|Death|1|||
143321712|NCT01802411|516721647|FG000|Overall Study|Adverse Event|2|||
143321713|NCT01802411|516721648|FG001|Overall Study|Adverse Event|7|||
143321714|NCT01802411|516721647|FG000|Overall Study|Lack of Efficacy|8|||
143321715|NCT01802411|516721648|FG001|Overall Study|Lack of Efficacy|10|||
143380124|NCT02791230|516940601|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
143380125|NCT02791230|516940599|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
143380126|NCT02791230|516940600|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
143321716|NCT01802411|516721647|FG000|Overall Study|Withdrawal by Subject|0|||
143321717|NCT01802411|516721648|FG001|Overall Study|Withdrawal by Subject|2|||
143321718|NCT01802411|516721647|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
143321719|NCT01802411|516721648|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
143321720|NCT01802411|516721647|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
143321721|NCT01802411|516721648|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
143321722|NCT01802411|516721647|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
143321723|NCT01802411|516721648|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
143321724|NCT00560833|516721661|FG000|Overall Study|Adverse Event|16|||
143321725|NCT00560833|516721662|FG001|Overall Study|Adverse Event|10|||
143321726|NCT00560833|516721663|FG002|Overall Study|Adverse Event|25|||
143321727|NCT00560833|516721664|FG003|Overall Study|Adverse Event|23|||
143321728|NCT00560833|516721665|FG004|Overall Study|Adverse Event|35|||
143321729|NCT00560833|516721661|FG000|Overall Study|Lost to Follow-up|0|||
143321730|NCT00560833|516721662|FG001|Overall Study|Lost to Follow-up|0|||
143321731|NCT00560833|516721663|FG002|Overall Study|Lost to Follow-up|1|||
143321732|NCT00560833|516721664|FG003|Overall Study|Lost to Follow-up|0|||
143321733|NCT00560833|516721665|FG004|Overall Study|Lost to Follow-up|0|||
143321734|NCT00560833|516721661|FG000|Overall Study|Lack of Efficacy|22|||
143321735|NCT00560833|516721662|FG001|Overall Study|Lack of Efficacy|9|||
143321736|NCT00560833|516721663|FG002|Overall Study|Lack of Efficacy|6|||
143321737|NCT00560833|516721664|FG003|Overall Study|Lack of Efficacy|4|||
143321738|NCT00560833|516721665|FG004|Overall Study|Lack of Efficacy|4|||
143321739|NCT00560833|516721661|FG000|Overall Study|Participant uncooperative|5|||
143321740|NCT00560833|516721662|FG001|Overall Study|Participant uncooperative|5|||
143321741|NCT00560833|516721663|FG002|Overall Study|Participant uncooperative|4|||
143321742|NCT00560833|516721664|FG003|Overall Study|Participant uncooperative|4|||
143321743|NCT00560833|516721665|FG004|Overall Study|Participant uncooperative|2|||
143321744|NCT00560833|516721661|FG000|Overall Study|Other|1|||
143321745|NCT00560833|516721662|FG001|Overall Study|Other|1|||
143321746|NCT00560833|516721663|FG002|Overall Study|Other|3|||
143321747|NCT00560833|516721664|FG003|Overall Study|Other|0|||
143321748|NCT00560833|516721665|FG004|Overall Study|Other|0|||
143321749|NCT00560833|516721661|FG000|Overall Study|Never received drug|0|||
143321750|NCT00560833|516721662|FG001|Overall Study|Never received drug|1|||
143321751|NCT00560833|516721663|FG002|Overall Study|Never received drug|0|||
143321752|NCT00560833|516721664|FG003|Overall Study|Never received drug|0|||
143321753|NCT00560833|516721665|FG004|Overall Study|Never received drug|1|||
143321754|NCT01059617|516721666|FG000|Overall Study|Other|7|||
143321755|NCT01059617|516721667|FG001|Overall Study|Other|1|||
143321756|NCT01059617|516721668|FG002|Overall Study|Other|8|||
143321757|NCT01059617|516721669|FG003|Overall Study|Other|6|||
143321758|NCT00612313|516721671|FG000|Overall Study|Withdrawal by Subject|6|||
143321759|NCT00612313|516721672|FG001|Overall Study|Withdrawal by Subject|9|||
143321760|NCT00612313|516721671|FG000|Overall Study|Lost to Follow-up|11|||
143321761|NCT00612313|516721672|FG001|Overall Study|Lost to Follow-up|4|||
143321762|NCT03864614|516721676|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
143321763|NCT03864614|516721677|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
143321764|NCT03864614|516721678|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
143321765|NCT03864614|516721679|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
143321766|NCT03864614|516721676|FG000|Overall Study|Withdrawal by Subject|72|||
143321767|NCT03864614|516721677|FG001|Overall Study|Withdrawal by Subject|100|||
143321768|NCT03864614|516721678|FG002|Overall Study|Withdrawal by Subject|1|||
143321769|NCT03864614|516721679|FG003|Overall Study|Withdrawal by Subject|21|||
143321770|NCT03864614|516721676|FG000|Overall Study|Lost to Follow-up|45|||
143321771|NCT03864614|516721677|FG001|Overall Study|Lost to Follow-up|54|||
143321772|NCT03864614|516721678|FG002|Overall Study|Lost to Follow-up|0|||
143321773|NCT03864614|516721679|FG003|Overall Study|Lost to Follow-up|9|||
143321774|NCT03864614|516721676|FG000|Overall Study|Adverse Event|42|||
143321775|NCT03864614|516721677|FG001|Overall Study|Adverse Event|30|||
143321776|NCT03864614|516721678|FG002|Overall Study|Adverse Event|1|||
143321777|NCT03864614|516721679|FG003|Overall Study|Adverse Event|9|||
143321778|NCT03864614|516721676|FG000|Overall Study|Protocol Deviation|6|||
143321779|NCT03864614|516721677|FG001|Overall Study|Protocol Deviation|26|||
143321780|NCT03864614|516721678|FG002|Overall Study|Protocol Deviation|0|||
143321781|NCT03864614|516721679|FG003|Overall Study|Protocol Deviation|1|||
143321782|NCT03864614|516721676|FG000|Overall Study|Physician Decision|7|||
143321783|NCT03864614|516721677|FG001|Overall Study|Physician Decision|10|||
143321784|NCT03864614|516721678|FG002|Overall Study|Physician Decision|1|||
143321785|NCT03864614|516721679|FG003|Overall Study|Physician Decision|5|||
143321786|NCT03864614|516721676|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
143321787|NCT03864614|516721677|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
143321788|NCT03864614|516721678|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
143321789|NCT03864614|516721679|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
143321790|NCT03864614|516721676|FG000|Overall Study|Sponsor Decision|1|||
143321791|NCT03864614|516721677|FG001|Overall Study|Sponsor Decision|2|||
143321792|NCT03864614|516721678|FG002|Overall Study|Sponsor Decision|0|||
143321793|NCT03864614|516721679|FG003|Overall Study|Sponsor Decision|0|||
143321794|NCT03864614|516721676|FG000|Overall Study|Pregnancy|0|||
143321795|NCT03864614|516721677|FG001|Overall Study|Pregnancy|1|||
143321796|NCT03864614|516721678|FG002|Overall Study|Pregnancy|0|||
143321797|NCT03864614|516721679|FG003|Overall Study|Pregnancy|0|||
143321798|NCT03864614|516721676|FG000|Overall Study|Other|7|||
143321799|NCT03864614|516721677|FG001|Overall Study|Other|9|||
143321800|NCT03864614|516721678|FG002|Overall Study|Other|1|||
143321801|NCT03864614|516721679|FG003|Overall Study|Other|4|||
143321802|NCT03864614|516721676|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
143321803|NCT03864614|516721677|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
143321804|NCT03864614|516721678|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
143321805|NCT03864614|516721679|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
143321806|NCT02239510|516723626|FG000|Overall Study|Lost to Follow-up|2|||
143321807|NCT02239510|516723627|FG001|Overall Study|Lost to Follow-up|1|||
143321808|NCT00464542|516723632|FG000|Pre-treatment|Withdrawal by Subject|2|||
143321809|NCT03859323|516723633|FG000|Overall Study|Lost to Follow-up|0|||
143321810|NCT03859323|516723634|FG001|Overall Study|Lost to Follow-up|0|||
143321811|NCT03859323|516723635|FG002|Overall Study|Lost to Follow-up|0|||
143321812|NCT03859323|516723636|FG003|Overall Study|Lost to Follow-up|0|||
143321813|NCT03859323|516723637|FG004|Overall Study|Lost to Follow-up|0|||
143321814|NCT03859323|516723638|FG005|Overall Study|Lost to Follow-up|0|||
143321815|NCT03859323|516723639|FG006|Overall Study|Lost to Follow-up|1|||
143321816|NCT03859323|516723640|FG007|Overall Study|Lost to Follow-up|0|||
143321817|NCT03859323|516723641|FG008|Overall Study|Lost to Follow-up|0|||
143321818|NCT03859323|516723642|FG009|Overall Study|Lost to Follow-up|0|||
143321819|NCT03859323|516723643|FG010|Overall Study|Lost to Follow-up|0|||
143321820|NCT03859323|516723644|FG011|Overall Study|Lost to Follow-up|0|||
143321821|NCT03859323|516723645|FG012|Overall Study|Lost to Follow-up|0|||
143321822|NCT03859323|516723633|FG000|Overall Study|Withdrawal by Subject|0|||
143321823|NCT03859323|516723634|FG001|Overall Study|Withdrawal by Subject|0|||
143321824|NCT03859323|516723635|FG002|Overall Study|Withdrawal by Subject|1|||
143321825|NCT03859323|516723636|FG003|Overall Study|Withdrawal by Subject|0|||
143321826|NCT03859323|516723637|FG004|Overall Study|Withdrawal by Subject|0|||
143321827|NCT03859323|516723638|FG005|Overall Study|Withdrawal by Subject|1|||
143321828|NCT03859323|516723639|FG006|Overall Study|Withdrawal by Subject|0|||
143321829|NCT03859323|516723640|FG007|Overall Study|Withdrawal by Subject|0|||
143321830|NCT03859323|516723641|FG008|Overall Study|Withdrawal by Subject|0|||
143321831|NCT03859323|516723642|FG009|Overall Study|Withdrawal by Subject|1|||
143321832|NCT03859323|516723643|FG010|Overall Study|Withdrawal by Subject|1|||
143321833|NCT03859323|516723644|FG011|Overall Study|Withdrawal by Subject|2|||
143321834|NCT03859323|516723645|FG012|Overall Study|Withdrawal by Subject|1|||
143321835|NCT03859323|516723633|FG000|Overall Study|Pregnancy|0|||
143321836|NCT03859323|516723634|FG001|Overall Study|Pregnancy|0|||
143321837|NCT03859323|516723635|FG002|Overall Study|Pregnancy|0|||
143321838|NCT03859323|516723636|FG003|Overall Study|Pregnancy|0|||
143321839|NCT03859323|516723637|FG004|Overall Study|Pregnancy|0|||
143321840|NCT03859323|516723638|FG005|Overall Study|Pregnancy|0|||
143321841|NCT03859323|516723639|FG006|Overall Study|Pregnancy|0|||
143321842|NCT03859323|516723640|FG007|Overall Study|Pregnancy|0|||
143321843|NCT03859323|516723641|FG008|Overall Study|Pregnancy|0|||
143321844|NCT03859323|516723642|FG009|Overall Study|Pregnancy|1|||
143321845|NCT03859323|516723643|FG010|Overall Study|Pregnancy|0|||
143321846|NCT03859323|516723644|FG011|Overall Study|Pregnancy|0|||
143321847|NCT03859323|516723645|FG012|Overall Study|Pregnancy|0|||
143321848|NCT00262834|516723648|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
143321849|NCT00262834|516723649|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
143321850|NCT00844194|516723653|FG000|Overall Study|Adverse Event|17|||
143321851|NCT00844194|516723654|FG001|Overall Study|Adverse Event|5|||
143321852|NCT00844194|516723653|FG000|Overall Study|Protocol Violation|1|||
143321853|NCT00844194|516723654|FG001|Overall Study|Protocol Violation|1|||
143321854|NCT00844194|516723653|FG000|Overall Study|Lost to Follow-up|1|||
143321855|NCT00844194|516723654|FG001|Overall Study|Lost to Follow-up|1|||
143321856|NCT00844194|516723653|FG000|Overall Study|Withdrawal by Subject|2|||
143321857|NCT00844194|516723654|FG001|Overall Study|Withdrawal by Subject|1|||
143321858|NCT00844194|516723653|FG000|Overall Study|Lack of Efficacy|3|||
143321859|NCT00844194|516723654|FG001|Overall Study|Lack of Efficacy|0|||
143321860|NCT00844194|516723653|FG000|Overall Study|Other reason (not specified)|1|||
143321861|NCT00844194|516723654|FG001|Overall Study|Other reason (not specified)|0|||
143321862|NCT00765245|516723655|FG000|Overall Study|disease progression|3|||
143321863|NCT00765245|516723656|FG001|Overall Study|disease progression|2|||
143321864|NCT00765245|516723655|FG000|Overall Study|Withdrawal by Subject|3|||
143321865|NCT00765245|516723656|FG001|Overall Study|Withdrawal by Subject|0|||
143321866|NCT00765245|516723655|FG000|Overall Study|Adverse Event|5|||
143321867|NCT00765245|516723656|FG001|Overall Study|Adverse Event|0|||
143321868|NCT00765245|516723655|FG000|Overall Study|Physician Decision|1|||
143321869|NCT00765245|516723656|FG001|Overall Study|Physician Decision|0|||
143321870|NCT00765245|516723655|FG000|Overall Study|Death|1|||
143321871|NCT00765245|516723656|FG001|Overall Study|Death|0|||
143321872|NCT02162810|516723658|FG000|Overall Study|Protocol Violation|1|||
143321873|NCT02162810|516723659|FG001|Overall Study|Protocol Violation|0|||
143321874|NCT02162810|516723658|FG000|Overall Study|patients did not report compliance|4|||
143321875|NCT02162810|516723659|FG001|Overall Study|patients did not report compliance|1|||
143321876|NCT02223390|516723664|FG000|Overall Study|Lost to Follow-up|9|||
143380127|NCT02791230|516940601|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
143380128|NCT02791230|516940599|FG000|Overall Study|Study sites terminated by sponsor|1|||
143380129|NCT02791230|516940600|FG001|Overall Study|Study sites terminated by sponsor|0|||
143380130|NCT02791230|516940601|FG002|Overall Study|Study sites terminated by sponsor|5|||
143380131|NCT02791230|516940599|FG000|Overall Study|Other|9|||
143321877|NCT02223390|516723665|FG001|Overall Study|Lost to Follow-up|4|||
143321878|NCT02548962|516723667|FG000|Overall Study|Withdrawal by Subject|1|||
143321879|NCT02548962|516723668|FG001|Overall Study|Withdrawal by Subject|0|||
143321880|NCT04831736|516723669|FG000|Overall Study|Withdrawal by Subject|0|||
143321881|NCT04831736|516723670|FG001|Overall Study|Withdrawal by Subject|1|||
143321882|NCT00795600|516723671|FG000|Overall Study|Adverse Event|1|||
143321883|NCT00795600|516723672|FG001|Overall Study|Adverse Event|1|||
143380132|NCT02791230|516940600|FG001|Overall Study|Other|1|||
143380133|NCT02791230|516940601|FG002|Overall Study|Other|28|||
143380134|NCT02791230|516940599|FG000|Overall Study|Protocol Violation|0|||
143380135|NCT02791230|516940600|FG001|Overall Study|Protocol Violation|0|||
143380136|NCT02791230|516940601|FG002|Overall Study|Protocol Violation|4|||
143380137|NCT02791230|516940599|FG000|Overall Study|Withdrawal by Subject|24|||
143380138|NCT02791230|516940600|FG001|Overall Study|Withdrawal by Subject|13|||
143380139|NCT02791230|516940601|FG002|Overall Study|Withdrawal by Subject|172|||
143380140|NCT02791230|516940599|FG000|Overall Study|Enrolled but not treated|0|||
143380141|NCT02791230|516940600|FG001|Overall Study|Enrolled but not treated|0|||
143380142|NCT02791230|516940601|FG002|Overall Study|Enrolled but not treated|5|||
143380143|NCT04941287|516940605|FG000|Overall Study|Rapid decline before starting treatment|3|||
143380144|NCT04941287|516940606|FG001|Overall Study|Rapid decline before starting treatment|1|||
143380145|NCT02980276|516940607|FG000|Overall Study|Withdrawal by Subject|4|||
143380146|NCT02980276|516940608|FG001|Overall Study|Withdrawal by Subject|4|||
143380147|NCT02980276|516940607|FG000|Overall Study|Physician Decision|0|||
143380148|NCT02980276|516940608|FG001|Overall Study|Physician Decision|1|||
143380149|NCT02980276|516940607|FG000|Overall Study|Lost to Follow-up|18|||
143380150|NCT02980276|516940608|FG001|Overall Study|Lost to Follow-up|18|||
143380151|NCT02980276|516940607|FG000|Overall Study|Death|1|||
143380152|NCT02980276|516940608|FG001|Overall Study|Death|0|||
143380153|NCT02980276|516940607|FG000|Overall Study|Miscellaneous other|10|||
143380154|NCT02980276|516940608|FG001|Overall Study|Miscellaneous other|4|||
143380155|NCT01998984|516940609|FG000|Overall Study|Adverse Event|0|||
143380156|NCT01998984|516940610|FG001|Overall Study|Adverse Event|0|||
143380157|NCT01998984|516940611|FG002|Overall Study|Adverse Event|0|||
143380158|NCT01998984|516940612|FG003|Overall Study|Adverse Event|1|||
143380159|NCT01998984|516940609|FG000|Overall Study|Lost to Follow-up|0|||
143380160|NCT01998984|516940610|FG001|Overall Study|Lost to Follow-up|1|||
143380161|NCT01998984|516940611|FG002|Overall Study|Lost to Follow-up|0|||
143380162|NCT01998984|516940612|FG003|Overall Study|Lost to Follow-up|1|||
143380163|NCT01998984|516940609|FG000|Overall Study|Withdrawal by Subject|0|||
143380164|NCT01998984|516940610|FG001|Overall Study|Withdrawal by Subject|0|||
143380165|NCT01998984|516940611|FG002|Overall Study|Withdrawal by Subject|1|||
143380166|NCT01998984|516940612|FG003|Overall Study|Withdrawal by Subject|0|||
143380167|NCT01998984|516940609|FG000|Overall Study|Other|0|||
143380168|NCT01998984|516940610|FG001|Overall Study|Other|0|||
143380169|NCT01998984|516940611|FG002|Overall Study|Other|0|||
143380170|NCT01998984|516940612|FG003|Overall Study|Other|1|||
143380171|NCT03025789|516940614|FG000|Overall Study|Lack of Efficacy|6|||
143380172|NCT03025789|516940615|FG001|Overall Study|Lack of Efficacy|1|||
143380173|NCT03025789|516940614|FG000|Overall Study|Death|1|||
143380174|NCT03025789|516940615|FG001|Overall Study|Death|0|||
143321884|NCT00795600|516723671|FG000|Overall Study|Protocol Violation|1|||
143321885|NCT00795600|516723672|FG001|Overall Study|Protocol Violation|2|||
143321886|NCT00795600|516723671|FG000|Overall Study|Withdrawal by Subject|1|||
143321887|NCT00795600|516723672|FG001|Overall Study|Withdrawal by Subject|0|||
143321888|NCT00795600|516723671|FG000|Overall Study|Unclassified|1|||
143321889|NCT00795600|516723672|FG001|Overall Study|Unclassified|1|||
143321890|NCT03936244|516723676|FG000|Overall Study|Lost to Follow-up|5|||
143321891|NCT03936244|516723677|FG001|Overall Study|Lost to Follow-up|1|||
143321892|NCT03936244|516723676|FG000|Overall Study|Physician Decision|7|||
143321893|NCT03936244|516723677|FG001|Overall Study|Physician Decision|3|||
143321894|NCT01248884|516723682|FG000|Overall Study|Withdrawal by Subject|1|||
143321895|NCT01248884|516723683|FG001|Overall Study|Withdrawal by Subject|3|||
143321896|NCT01248884|516723684|FG002|Overall Study|Withdrawal by Subject|1|||
143321897|NCT01248884|516723682|FG000|Overall Study|Adverse Event|1|||
143321898|NCT01248884|516723683|FG001|Overall Study|Adverse Event|0|||
143321899|NCT01248884|516723684|FG002|Overall Study|Adverse Event|0|||
143321900|NCT02511431|516723685|FG000|Treatment|Lost to Follow-up|0|||
143321901|NCT02511431|516723686|FG001|Treatment|Lost to Follow-up|0|||
143321902|NCT02511431|516723687|FG002|Treatment|Lost to Follow-up|1|||
143321903|NCT02511431|516723688|FG003|Treatment|Lost to Follow-up|0|||
143321904|NCT02511431|516723689|FG004|Treatment|Lost to Follow-up|0|||
143380175|NCT03025789|516940614|FG000|Overall Study|Withdrawal by Subject|0|||
143380176|NCT03025789|516940615|FG001|Overall Study|Withdrawal by Subject|2|||
143380177|NCT02723955|516940616|FG000|Escalation Phase|Death|1|||
143380178|NCT02723955|516940617|FG001|Escalation Phase|Death|1|||
143380179|NCT02723955|516940618|FG002|Escalation Phase|Death|2|||
143321905|NCT02511431|516723690|FG005|Treatment|Lost to Follow-up|1|||
143321906|NCT00614939|516723693|FG000|Overall Study|Withdrawal by Subject|10|||
143321907|NCT00614939|516723694|FG001|Overall Study|Withdrawal by Subject|17|||
143321908|NCT00614939|516723693|FG000|Overall Study|Study specific discontinuation criteris|13|||
143321909|NCT00614939|516723694|FG001|Overall Study|Study specific discontinuation criteris|16|||
143380180|NCT02723955|516940619|FG003|Escalation Phase|Death|7|||
143380181|NCT02723955|516940620|FG004|Escalation Phase|Death|18|||
143380182|NCT02723955|516940621|FG005|Escalation Phase|Death|17|||
143380183|NCT02723955|516940622|FG006|Escalation Phase|Death|11|||
143380184|NCT02723955|516940623|FG007|Escalation Phase|Death|21|||
143380185|NCT02723955|516940624|FG008|Escalation Phase|Death|3|||
143380186|NCT02723955|516940625|FG009|Escalation Phase|Death|0|||
143321910|NCT00614939|516723693|FG000|Overall Study|Adverse Event|2|||
143321911|NCT00614939|516723694|FG001|Overall Study|Adverse Event|5|||
143321912|NCT00614939|516723693|FG000|Overall Study|Incorrect enrollment|1|||
143321913|NCT00614939|516723694|FG001|Overall Study|Incorrect enrollment|2|||
143321914|NCT00614939|516723693|FG000|Overall Study|Death|4|||
143321915|NCT00614939|516723694|FG001|Overall Study|Death|3|||
143321916|NCT00614939|516723693|FG000|Overall Study|Poor/non-compliance|4|||
143321917|NCT00614939|516723694|FG001|Overall Study|Poor/non-compliance|0|||
143321918|NCT00614939|516723693|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
143321919|NCT00614939|516723694|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
143321920|NCT00840970|516723695|FG000|Overall Study|Adverse Event|0|||
143321921|NCT00840970|516723696|FG001|Overall Study|Adverse Event|0|||
143321922|NCT00840970|516723697|FG002|Overall Study|Adverse Event|1|||
143321923|NCT00504829|516723698|FG000|Overall Study|Protocol Violation|6|||
143321924|NCT00504829|516723699|FG001|Overall Study|Protocol Violation|4|||
143321925|NCT00504829|516723700|FG002|Overall Study|Protocol Violation|10|||
143321926|NCT03465540|516723701|FG000|Overall Study|Withdrawal by Subject|0|||
143321927|NCT03465540|516723702|FG001|Overall Study|Withdrawal by Subject|0|||
143321928|NCT03465540|516723703|FG002|Overall Study|Withdrawal by Subject|1|||
143321929|NCT03465540|516723704|FG003|Overall Study|Withdrawal by Subject|1|||
143321930|NCT03465540|516723705|FG004|Overall Study|Withdrawal by Subject|1|||
143321931|NCT03465540|516723706|FG005|Overall Study|Withdrawal by Subject|0|||
143321932|NCT03465540|516723701|FG000|Overall Study|Lost to Follow-up|0|||
143321933|NCT03465540|516723702|FG001|Overall Study|Lost to Follow-up|1|||
143321934|NCT03465540|516723703|FG002|Overall Study|Lost to Follow-up|0|||
143321935|NCT03465540|516723704|FG003|Overall Study|Lost to Follow-up|0|||
143321936|NCT03465540|516723705|FG004|Overall Study|Lost to Follow-up|1|||
143321937|NCT03465540|516723706|FG005|Overall Study|Lost to Follow-up|0|||
143321938|NCT03465540|516723701|FG000|Overall Study|Death|1|||
143321939|NCT03465540|516723702|FG001|Overall Study|Death|1|||
143321940|NCT03465540|516723703|FG002|Overall Study|Death|0|||
143321941|NCT03465540|516723704|FG003|Overall Study|Death|2|||
143321942|NCT03465540|516723705|FG004|Overall Study|Death|0|||
143321943|NCT03465540|516723706|FG005|Overall Study|Death|2|||
143321944|NCT03465540|516723701|FG000|Overall Study|Protocol specified criteria|0|||
143321945|NCT03465540|516723702|FG001|Overall Study|Protocol specified criteria|2|||
143321946|NCT03465540|516723703|FG002|Overall Study|Protocol specified criteria|2|||
143321947|NCT03465540|516723704|FG003|Overall Study|Protocol specified criteria|0|||
143321948|NCT03465540|516723705|FG004|Overall Study|Protocol specified criteria|2|||
143321949|NCT03465540|516723706|FG005|Overall Study|Protocol specified criteria|0|||
143321950|NCT01854827|516723707|FG000|Overall Study|Death|1|||
143321951|NCT00736996|516723708|FG000|Overall Study|Lost to Follow-up|1|||
143321952|NCT00736996|516723709|FG001|Overall Study|Lost to Follow-up|9|||
143321953|NCT00736996|516723710|FG002|Overall Study|Lost to Follow-up|2|||
143321954|NCT00462384|516723711|FG000|Overall Study|Adverse Event|2|||
143321955|NCT00462384|516723711|FG000|Overall Study|Death|2|||
143321956|NCT00462384|516723711|FG000|Overall Study|Withdrawal by Subject|1|||
143321957|NCT00462384|516723711|FG000|Overall Study|Other|4|||
143321958|NCT02667912|516723712|FG000|Overall Study|Death|3|||
143321959|NCT02667912|516723713|FG001|Overall Study|Death|1|||
143321960|NCT02667912|516723712|FG000|Overall Study|Withdrawal by Subject|1|||
143321961|NCT02667912|516723713|FG001|Overall Study|Withdrawal by Subject|2|||
143321962|NCT02667912|516723712|FG000|Overall Study|Withdrawal by Subject|1|||
143321963|NCT02667912|516723713|FG001|Overall Study|Withdrawal by Subject|0|||
143321964|NCT02079805|516723714|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
143321965|NCT02079805|516723715|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
143321966|NCT02079805|516723714|FG000|Overall Study|Voluntary Withdrawal|0|||
143321967|NCT02079805|516723715|FG001|Overall Study|Voluntary Withdrawal|1|||
143321968|NCT00383435|516723716|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
143321969|NCT00383435|516723717|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
143321970|NCT00383435|516723718|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
143321971|NCT00383435|516723719|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
143321972|NCT00383435|516723720|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
143321973|NCT00383435|516723716|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
143321974|NCT00383435|516723717|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
143321975|NCT00383435|516723718|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
143321976|NCT00383435|516723719|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
143321977|NCT00383435|516723720|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
143321978|NCT00383435|516723716|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
143321979|NCT00383435|516723717|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
143321980|NCT00383435|516723718|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
143321981|NCT00383435|516723719|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
143321982|NCT00383435|516723720|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
143321983|NCT00383435|516723716|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
143321984|NCT00383435|516723717|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
143380187|NCT02723955|516940626|FG010|Escalation Phase|Death|0|||
143380188|NCT02723955|516940627|FG011|Escalation Phase|Death|0|||
143321985|NCT00383435|516723718|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
143321986|NCT00383435|516723719|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
143321987|NCT00383435|516723720|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
143321988|NCT00383435|516723716|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
143321989|NCT00383435|516723717|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
143321990|NCT00383435|516723718|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
143321991|NCT00383435|516723719|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
143321992|NCT00383435|516723720|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
143321993|NCT00383435|516723716|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
143321994|NCT00383435|516723717|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
143321995|NCT00383435|516723718|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
143321996|NCT00383435|516723719|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
143321997|NCT00383435|516723720|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
143321998|NCT00383435|516723716|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
143321999|NCT00383435|516723717|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
143322000|NCT00383435|516723718|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
143322001|NCT00383435|516723719|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
143322002|NCT00383435|516723720|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
143322003|NCT00383435|516723716|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
143322004|NCT00383435|516723717|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
143322005|NCT00383435|516723718|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
143322006|NCT00383435|516723719|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
143322007|NCT00383435|516723720|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
143322008|NCT00383435|516723716|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
143322009|NCT00383435|516723717|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
143322010|NCT00383435|516723718|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
143322011|NCT00383435|516723719|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
143322012|NCT00383435|516723720|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
143322013|NCT00383435|516723716|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
143322014|NCT00383435|516723717|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
143322015|NCT00383435|516723718|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
143322016|NCT00383435|516723719|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
143322017|NCT00383435|516723720|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
143322018|NCT00383435|516723716|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
143322019|NCT00383435|516723717|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
143322020|NCT00383435|516723718|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
143322021|NCT00383435|516723719|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
143322022|NCT00383435|516723720|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
143322023|NCT00383435|516723716|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
143322024|NCT00383435|516723717|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
143322025|NCT00383435|516723718|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
143322026|NCT00383435|516723719|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
143322027|NCT00383435|516723720|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
143322028|NCT00383435|516723716|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
143322029|NCT00383435|516723717|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
143322030|NCT00383435|516723718|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
143322031|NCT00383435|516723719|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
143322032|NCT00383435|516723720|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
143322033|NCT00383435|516723716|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
143322034|NCT00383435|516723717|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
143322035|NCT00383435|516723718|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
143380189|NCT02723955|516940628|FG012|Escalation Phase|Death|2|||
143380190|NCT02723955|516940629|FG013|Escalation Phase|Death|4|||
143380191|NCT02723955|516940630|FG014|Escalation Phase|Death|5|||
143380192|NCT02723955|516940631|FG015|Escalation Phase|Death|6|||
143380193|NCT02723955|516940632|FG016|Escalation Phase|Death|6|||
143380194|NCT02723955|516940633|FG017|Escalation Phase|Death|7|||
143380195|NCT02723955|516940634|FG018|Escalation Phase|Death|1|||
143380196|NCT02723955|516940635|FG019|Escalation Phase|Death|3|||
143380197|NCT02723955|516940636|FG020|Escalation Phase|Death|13|||
143380198|NCT02723955|516940637|FG021|Escalation Phase|Death|3|||
143380199|NCT02723955|516940638|FG022|Escalation Phase|Death|2|||
143380200|NCT02723955|516940639|FG023|Escalation Phase|Death|4|||
143380201|NCT02723955|516940640|FG024|Escalation Phase|Death|31|||
143322036|NCT00383435|516723719|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
143322037|NCT00383435|516723720|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
143322038|NCT00383435|516723716|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
143322039|NCT00383435|516723717|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
143322040|NCT00383435|516723718|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
143322041|NCT00383435|516723719|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
143322042|NCT00383435|516723720|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
143322043|NCT00383435|516723716|FG000|26-Week Treatment Safety Extension|Administrative|1|||
143322044|NCT00383435|516723717|FG001|26-Week Treatment Safety Extension|Administrative|1|||
143322045|NCT00383435|516723718|FG002|26-Week Treatment Safety Extension|Administrative|0|||
143322046|NCT00383435|516723719|FG003|26-Week Treatment Safety Extension|Administrative|1|||
143322047|NCT00383435|516723720|FG004|26-Week Treatment Safety Extension|Administrative|0|||
143322048|NCT02682264|516723721|FG000|Overall Study|Withdrawal by Subject|56|||
143322049|NCT02682264|516723722|FG001|Overall Study|Withdrawal by Subject|45|||
143322050|NCT02682264|516723721|FG000|Overall Study|Lost to Follow-up|49|||
143322051|NCT02682264|516723722|FG001|Overall Study|Lost to Follow-up|41|||
143322052|NCT02682264|516723721|FG000|Overall Study|Lack of Efficacy|14|||
143322053|NCT02682264|516723722|FG001|Overall Study|Lack of Efficacy|16|||
143322054|NCT02682264|516723721|FG000|Overall Study|Withdrawal by Parent|6|||
143322055|NCT02682264|516723722|FG001|Overall Study|Withdrawal by Parent|7|||
143322056|NCT02682264|516723721|FG000|Overall Study|Adverse Event|9|||
143322057|NCT02682264|516723722|FG001|Overall Study|Adverse Event|0|||
143322058|NCT02682264|516723721|FG000|Overall Study|Noncompliance with study drug|1|||
143322059|NCT02682264|516723722|FG001|Overall Study|Noncompliance with study drug|4|||
143322060|NCT02682264|516723721|FG000|Overall Study|Pregnancy|1|||
143322061|NCT02682264|516723722|FG001|Overall Study|Pregnancy|2|||
143322062|NCT02682264|516723721|FG000|Overall Study|Recovery|1|||
143322063|NCT02682264|516723722|FG001|Overall Study|Recovery|2|||
143322064|NCT02682264|516723721|FG000|Overall Study|Progressive Disease|1|||
143322065|NCT02682264|516723722|FG001|Overall Study|Progressive Disease|0|||
143322066|NCT02682264|516723721|FG000|Overall Study|Technical Problems|0|||
143322067|NCT02682264|516723722|FG001|Overall Study|Technical Problems|1|||
143322068|NCT02682264|516723721|FG000|Overall Study|Moved abroad and unable to continue|0|||
143322069|NCT02682264|516723722|FG001|Overall Study|Moved abroad and unable to continue|3|||
143322070|NCT02682264|516723721|FG000|Overall Study|Stopped test article application|0|||
143322071|NCT02682264|516723722|FG001|Overall Study|Stopped test article application|1|||
143322072|NCT03447769|516723724|FG000|Overall Study|Progressive disease|138|||
143322073|NCT03447769|516723725|FG001|Overall Study|Progressive disease|148|||
143322074|NCT03447769|516723724|FG000|Overall Study|Study terminated by Sponsor|60|||
143322075|NCT03447769|516723725|FG001|Overall Study|Study terminated by Sponsor|44|||
143322076|NCT03447769|516723724|FG000|Overall Study|Adverse Event|34|||
143322077|NCT03447769|516723725|FG001|Overall Study|Adverse Event|31|||
143322078|NCT03447769|516723724|FG000|Overall Study|Patient decision|27|||
143322079|NCT03447769|516723725|FG001|Overall Study|Patient decision|27|||
143322080|NCT03447769|516723724|FG000|Overall Study|Protocol deviation|4|||
143322081|NCT03447769|516723725|FG001|Overall Study|Protocol deviation|6|||
143322082|NCT03447769|516723724|FG000|Overall Study|Death|2|||
143322083|NCT03447769|516723725|FG001|Overall Study|Death|7|||
143322084|NCT03447769|516723724|FG000|Overall Study|Technical problems|1|||
143322085|NCT03447769|516723725|FG001|Overall Study|Technical problems|0|||
143322086|NCT03447769|516723724|FG000|Overall Study|Lost to Follow-up|0|||
143322087|NCT03447769|516723725|FG001|Overall Study|Lost to Follow-up|1|||
143322088|NCT03447769|516723724|FG000|Overall Study|Physician Decision|13|||
143322089|NCT03447769|516723725|FG001|Overall Study|Physician Decision|5|||
143322090|NCT01255358|516723727|FG000|Overall Study|Adverse Event|2|||
143322091|NCT01255358|516723727|FG000|Overall Study|Protocol Violation|2|||
143322092|NCT03950739|516723728|FG000|Treatment Phase|Adverse Event|2|||
143322093|NCT03950739|516723728|FG000|Optional Extension Phase|Death|1|||
143322094|NCT03950739|516723728|FG000|Optional Extension Phase|Progressive Disease|5|||
143322095|NCT03950739|516723728|FG000|Optional Extension Phase|Adverse Event|7|||
143322096|NCT03950739|516723728|FG000|Optional Extension Phase|Lost to Follow-up|2|||
143322097|NCT03950739|516723728|FG000|Optional Extension Phase|Site Closure|2|||
143322098|NCT03950739|516723728|FG000|Optional Extension Phase|Pregnancy|1|||
143322099|NCT03625570|516723730|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
143322100|NCT03625570|516723731|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
143322101|NCT03625570|516723730|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
143322102|NCT03625570|516723731|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
143322103|NCT03625570|516723730|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
143322104|NCT03625570|516723731|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
143380202|NCT02723955|516940641|FG025|Escalation Phase|Death|7|||
143380203|NCT02723955|516940642|FG026|Escalation Phase|Death|13|||
143380204|NCT02723955|516940643|FG027|Escalation Phase|Death|0|||
143380205|NCT02723955|516940644|FG028|Escalation Phase|Death|1|||
143380206|NCT02723955|516940645|FG029|Escalation Phase|Death|0|||
143380207|NCT02723955|516940646|FG030|Escalation Phase|Death|0|||
143380208|NCT02723955|516940647|FG031|Escalation Phase|Death|0|||
143380209|NCT02723955|516940648|FG032|Escalation Phase|Death|0|||
143380210|NCT02723955|516940649|FG033|Escalation Phase|Death|0|||
143380211|NCT02723955|516940650|FG034|Escalation Phase|Death|0|||
143380212|NCT02723955|516940651|FG035|Escalation Phase|Death|0|||
143380213|NCT02723955|516940652|FG036|Escalation Phase|Death|0|||
143380214|NCT02723955|516940653|FG037|Escalation Phase|Death|0|||
143380215|NCT02723955|516940654|FG038|Escalation Phase|Death|0|||
143380216|NCT02723955|516940655|FG039|Escalation Phase|Death|0|||
143380217|NCT02723955|516940656|FG040|Escalation Phase|Death|0|||
143380218|NCT02723955|516940657|FG041|Escalation Phase|Death|0|||
143380219|NCT02723955|516940658|FG042|Escalation Phase|Death|0|||
143380220|NCT02723955|516940616|FG000|Escalation Phase|Lost to Follow-up|0|||
143380221|NCT02723955|516940617|FG001|Escalation Phase|Lost to Follow-up|0|||
143380222|NCT02723955|516940618|FG002|Escalation Phase|Lost to Follow-up|0|||
143380223|NCT02723955|516940619|FG003|Escalation Phase|Lost to Follow-up|0|||
143380224|NCT02723955|516940620|FG004|Escalation Phase|Lost to Follow-up|0|||
143380225|NCT02723955|516940621|FG005|Escalation Phase|Lost to Follow-up|2|||
143380226|NCT02723955|516940622|FG006|Escalation Phase|Lost to Follow-up|1|||
143380227|NCT02723955|516940623|FG007|Escalation Phase|Lost to Follow-up|1|||
143380228|NCT02723955|516940624|FG008|Escalation Phase|Lost to Follow-up|1|||
143380229|NCT02723955|516940625|FG009|Escalation Phase|Lost to Follow-up|0|||
143380230|NCT02723955|516940626|FG010|Escalation Phase|Lost to Follow-up|0|||
143380231|NCT02723955|516940627|FG011|Escalation Phase|Lost to Follow-up|0|||
143380232|NCT02723955|516940628|FG012|Escalation Phase|Lost to Follow-up|1|||
143380233|NCT02723955|516940629|FG013|Escalation Phase|Lost to Follow-up|0|||
143380234|NCT02723955|516940630|FG014|Escalation Phase|Lost to Follow-up|0|||
143380235|NCT02723955|516940631|FG015|Escalation Phase|Lost to Follow-up|0|||
143380236|NCT02723955|516940632|FG016|Escalation Phase|Lost to Follow-up|1|||
143380237|NCT02723955|516940633|FG017|Escalation Phase|Lost to Follow-up|2|||
143380238|NCT02723955|516940634|FG018|Escalation Phase|Lost to Follow-up|0|||
143380239|NCT02723955|516940635|FG019|Escalation Phase|Lost to Follow-up|1|||
143380240|NCT02723955|516940636|FG020|Escalation Phase|Lost to Follow-up|2|||
143380241|NCT02723955|516940637|FG021|Escalation Phase|Lost to Follow-up|1|||
143380242|NCT02723955|516940638|FG022|Escalation Phase|Lost to Follow-up|0|||
143380243|NCT02723955|516940639|FG023|Escalation Phase|Lost to Follow-up|0|||
143380244|NCT02723955|516940640|FG024|Escalation Phase|Lost to Follow-up|1|||
143380245|NCT02723955|516940641|FG025|Escalation Phase|Lost to Follow-up|1|||
143380246|NCT02723955|516940642|FG026|Escalation Phase|Lost to Follow-up|3|||
143380247|NCT02723955|516940643|FG027|Escalation Phase|Lost to Follow-up|0|||
143380248|NCT02723955|516940644|FG028|Escalation Phase|Lost to Follow-up|1|||
143380249|NCT02723955|516940645|FG029|Escalation Phase|Lost to Follow-up|0|||
143380250|NCT02723955|516940646|FG030|Escalation Phase|Lost to Follow-up|0|||
143380251|NCT02723955|516940647|FG031|Escalation Phase|Lost to Follow-up|0|||
143380252|NCT02723955|516940648|FG032|Escalation Phase|Lost to Follow-up|0|||
143380253|NCT02723955|516940649|FG033|Escalation Phase|Lost to Follow-up|0|||
143380254|NCT02723955|516940650|FG034|Escalation Phase|Lost to Follow-up|0|||
143380255|NCT02723955|516940651|FG035|Escalation Phase|Lost to Follow-up|0|||
143380256|NCT02723955|516940652|FG036|Escalation Phase|Lost to Follow-up|0|||
143380257|NCT02723955|516940653|FG037|Escalation Phase|Lost to Follow-up|0|||
143380258|NCT02723955|516940654|FG038|Escalation Phase|Lost to Follow-up|0|||
143322105|NCT00022516|516723732|FG000|Overall Study|Adverse Event|0|||
143322106|NCT00022516|516723733|FG001|Overall Study|Adverse Event|59|||
143322107|NCT00022516|516723732|FG000|Overall Study|Lack of Efficacy|0|||
143322108|NCT00022516|516723733|FG001|Overall Study|Lack of Efficacy|27|||
143322109|NCT00022516|516723732|FG000|Overall Study|Physician Decision|0|||
143322110|NCT00022516|516723733|FG001|Overall Study|Physician Decision|1|||
143322111|NCT00022516|516723732|FG000|Overall Study|Protocol Violation|1|||
143322112|NCT00022516|516723733|FG001|Overall Study|Protocol Violation|3|||
143322113|NCT00022516|516723732|FG000|Overall Study|Withdrawal by Subject|2|||
143322114|NCT00022516|516723733|FG001|Overall Study|Withdrawal by Subject|113|||
143380259|NCT02723955|516940655|FG039|Escalation Phase|Lost to Follow-up|0|||
143380260|NCT02723955|516940656|FG040|Escalation Phase|Lost to Follow-up|0|||
143380261|NCT02723955|516940657|FG041|Escalation Phase|Lost to Follow-up|0|||
143380262|NCT02723955|516940658|FG042|Escalation Phase|Lost to Follow-up|0|||
143380263|NCT02723955|516940616|FG000|Escalation Phase|Physician Decision|0|||
143380264|NCT02723955|516940617|FG001|Escalation Phase|Physician Decision|0|||
143380265|NCT02723955|516940618|FG002|Escalation Phase|Physician Decision|0|||
143380266|NCT02723955|516940619|FG003|Escalation Phase|Physician Decision|0|||
143380267|NCT02723955|516940620|FG004|Escalation Phase|Physician Decision|0|||
143380268|NCT02723955|516940621|FG005|Escalation Phase|Physician Decision|2|||
143380269|NCT02723955|516940622|FG006|Escalation Phase|Physician Decision|0|||
143380270|NCT02723955|516940623|FG007|Escalation Phase|Physician Decision|0|||
143380271|NCT02723955|516940624|FG008|Escalation Phase|Physician Decision|0|||
143380272|NCT02723955|516940625|FG009|Escalation Phase|Physician Decision|0|||
143380273|NCT02723955|516940626|FG010|Escalation Phase|Physician Decision|0|||
143380274|NCT02723955|516940627|FG011|Escalation Phase|Physician Decision|0|||
143380275|NCT02723955|516940628|FG012|Escalation Phase|Physician Decision|0|||
143380276|NCT02723955|516940629|FG013|Escalation Phase|Physician Decision|0|||
143380277|NCT02723955|516940630|FG014|Escalation Phase|Physician Decision|0|||
143380278|NCT02723955|516940631|FG015|Escalation Phase|Physician Decision|0|||
143380279|NCT02723955|516940632|FG016|Escalation Phase|Physician Decision|0|||
143380280|NCT02723955|516940633|FG017|Escalation Phase|Physician Decision|0|||
143380281|NCT02723955|516940634|FG018|Escalation Phase|Physician Decision|0|||
143380282|NCT02723955|516940635|FG019|Escalation Phase|Physician Decision|0|||
143380283|NCT02723955|516940636|FG020|Escalation Phase|Physician Decision|0|||
143380284|NCT02723955|516940637|FG021|Escalation Phase|Physician Decision|0|||
143380285|NCT02723955|516940638|FG022|Escalation Phase|Physician Decision|0|||
143380286|NCT02723955|516940639|FG023|Escalation Phase|Physician Decision|0|||
143380287|NCT02723955|516940640|FG024|Escalation Phase|Physician Decision|0|||
143380288|NCT02723955|516940641|FG025|Escalation Phase|Physician Decision|0|||
143380289|NCT02723955|516940642|FG026|Escalation Phase|Physician Decision|2|||
143380290|NCT02723955|516940643|FG027|Escalation Phase|Physician Decision|0|||
143380291|NCT02723955|516940644|FG028|Escalation Phase|Physician Decision|0|||
143380292|NCT02723955|516940645|FG029|Escalation Phase|Physician Decision|0|||
143380293|NCT02723955|516940646|FG030|Escalation Phase|Physician Decision|0|||
143380294|NCT02723955|516940647|FG031|Escalation Phase|Physician Decision|0|||
143380295|NCT02723955|516940648|FG032|Escalation Phase|Physician Decision|0|||
143380296|NCT02723955|516940649|FG033|Escalation Phase|Physician Decision|0|||
143380297|NCT02723955|516940650|FG034|Escalation Phase|Physician Decision|0|||
143380298|NCT02723955|516940651|FG035|Escalation Phase|Physician Decision|0|||
143380299|NCT02723955|516940652|FG036|Escalation Phase|Physician Decision|0|||
143380300|NCT02723955|516940653|FG037|Escalation Phase|Physician Decision|0|||
143380301|NCT02723955|516940654|FG038|Escalation Phase|Physician Decision|0|||
143380302|NCT02723955|516940655|FG039|Escalation Phase|Physician Decision|0|||
143380303|NCT02723955|516940656|FG040|Escalation Phase|Physician Decision|0|||
143380304|NCT02723955|516940657|FG041|Escalation Phase|Physician Decision|0|||
143380305|NCT02723955|516940658|FG042|Escalation Phase|Physician Decision|0|||
143380306|NCT02723955|516940616|FG000|Escalation Phase|Withdrawal by Subject|0|||
143380307|NCT02723955|516940617|FG001|Escalation Phase|Withdrawal by Subject|0|||
143380308|NCT02723955|516940618|FG002|Escalation Phase|Withdrawal by Subject|0|||
143380309|NCT02723955|516940619|FG003|Escalation Phase|Withdrawal by Subject|0|||
143380310|NCT02723955|516940620|FG004|Escalation Phase|Withdrawal by Subject|1|||
143380311|NCT02723955|516940621|FG005|Escalation Phase|Withdrawal by Subject|1|||
143380312|NCT02723955|516940622|FG006|Escalation Phase|Withdrawal by Subject|1|||
143380313|NCT02723955|516940623|FG007|Escalation Phase|Withdrawal by Subject|1|||
143380314|NCT02723955|516940624|FG008|Escalation Phase|Withdrawal by Subject|0|||
143380315|NCT02723955|516940625|FG009|Escalation Phase|Withdrawal by Subject|0|||
143380316|NCT02723955|516940626|FG010|Escalation Phase|Withdrawal by Subject|0|||
143380317|NCT02723955|516940627|FG011|Escalation Phase|Withdrawal by Subject|0|||
143380318|NCT02723955|516940628|FG012|Escalation Phase|Withdrawal by Subject|1|||
143380319|NCT02723955|516940629|FG013|Escalation Phase|Withdrawal by Subject|0|||
143380320|NCT02723955|516940630|FG014|Escalation Phase|Withdrawal by Subject|0|||
143380321|NCT02723955|516940631|FG015|Escalation Phase|Withdrawal by Subject|0|||
143380322|NCT02723955|516940632|FG016|Escalation Phase|Withdrawal by Subject|1|||
143380323|NCT02723955|516940633|FG017|Escalation Phase|Withdrawal by Subject|0|||
143380324|NCT02723955|516940634|FG018|Escalation Phase|Withdrawal by Subject|0|||
143380325|NCT02723955|516940635|FG019|Escalation Phase|Withdrawal by Subject|0|||
143380326|NCT02723955|516940636|FG020|Escalation Phase|Withdrawal by Subject|0|||
143380327|NCT02723955|516940637|FG021|Escalation Phase|Withdrawal by Subject|0|||
143380328|NCT02723955|516940638|FG022|Escalation Phase|Withdrawal by Subject|0|||
143380329|NCT02723955|516940639|FG023|Escalation Phase|Withdrawal by Subject|2|||
143380330|NCT02723955|516940640|FG024|Escalation Phase|Withdrawal by Subject|0|||
143380331|NCT02723955|516940641|FG025|Escalation Phase|Withdrawal by Subject|1|||
143380332|NCT02723955|516940642|FG026|Escalation Phase|Withdrawal by Subject|0|||
143380333|NCT02723955|516940643|FG027|Escalation Phase|Withdrawal by Subject|0|||
143380334|NCT02723955|516940644|FG028|Escalation Phase|Withdrawal by Subject|1|||
143380335|NCT02723955|516940645|FG029|Escalation Phase|Withdrawal by Subject|0|||
143380336|NCT02723955|516940646|FG030|Escalation Phase|Withdrawal by Subject|0|||
143380337|NCT02723955|516940647|FG031|Escalation Phase|Withdrawal by Subject|0|||
143380338|NCT02723955|516940648|FG032|Escalation Phase|Withdrawal by Subject|0|||
143380339|NCT02723955|516940649|FG033|Escalation Phase|Withdrawal by Subject|0|||
143380340|NCT02723955|516940650|FG034|Escalation Phase|Withdrawal by Subject|0|||
143380341|NCT02723955|516940651|FG035|Escalation Phase|Withdrawal by Subject|0|||
143380342|NCT02723955|516940652|FG036|Escalation Phase|Withdrawal by Subject|0|||
143322115|NCT00022516|516723732|FG000|Overall Study|Incomplete documentation|0|||
143322116|NCT00022516|516723733|FG001|Overall Study|Incomplete documentation|27|||
143322117|NCT03783923|516723735|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
143322118|NCT03783923|516723736|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
143322119|NCT03783923|516723735|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
143322120|NCT03783923|516723736|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
143322121|NCT03783923|516723735|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
143322122|NCT03783923|516723736|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
143322123|NCT03783923|516723735|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
143322124|NCT03783923|516723736|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
143322125|NCT03783923|516723735|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
143322126|NCT03783923|516723736|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
143322127|NCT01024387|516723738|FG000|Overall Study|Radiographic Progression|29|||
143322128|NCT01024387|516723738|FG000|Overall Study|Symptomatic Progression|10|||
143322129|NCT01024387|516723738|FG000|Overall Study|Physician Decision|5|||
143322130|NCT01024387|516723738|FG000|Overall Study|Withdrawal by Subject|5|||
143322131|NCT01024387|516723738|FG000|Overall Study|Death|2|||
143322132|NCT01024387|516723738|FG000|Overall Study|Prolonged Treatment Delay|1|||
143322133|NCT01024387|516723738|FG000|Overall Study|Adverse Event|3|||
143322134|NCT01024387|516723738|FG000|Overall Study|Other|5|||
143322135|NCT00803634|516723739|FG000|Overall Study|Withdrew Consent|1|||
143322136|NCT00803634|516723740|FG001|Overall Study|Withdrew Consent|0|||
143322137|NCT00803634|516723739|FG000|Overall Study|Lost to Follow-up|2|||
143322138|NCT00803634|516723740|FG001|Overall Study|Lost to Follow-up|3|||
143322139|NCT00803634|516723739|FG000|Overall Study|Death|3|||
143322140|NCT00803634|516723740|FG001|Overall Study|Death|2|||
143322141|NCT03864900|516723743|FG000|Overall Study|Withdrawal by Subject|1|||
143322142|NCT03864900|516723744|FG001|Overall Study|Withdrawal by Subject|1|||
143322143|NCT03864900|516723743|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
143322144|NCT03864900|516723744|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
143322145|NCT03238001|516723745|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
143322146|NCT03238001|516723745|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
143322147|NCT03238001|516723745|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
143322148|NCT03238001|516723745|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
143322149|NCT03238001|516723745|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
143322150|NCT03238001|516723745|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
143322151|NCT03238001|516723745|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
143322152|NCT03238001|516723745|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
143322153|NCT01866709|516723749|FG000|Overall Study|Adverse Event|1|||
143322154|NCT01866709|516723750|FG001|Overall Study|Adverse Event|0|||
143322155|NCT03191903|516723753|FG000|Overall Study|Withdrawal by Subject|6|||
143322156|NCT03191903|516723754|FG001|Overall Study|Withdrawal by Subject|5|||
143322157|NCT03191903|516723755|FG002|Overall Study|Withdrawal by Subject|4|||
143322158|NCT03191903|516723753|FG000|Overall Study|Adverse Event|1|||
143322159|NCT03191903|516723754|FG001|Overall Study|Adverse Event|0|||
143322160|NCT03191903|516723755|FG002|Overall Study|Adverse Event|0|||
143322161|NCT00503685|516723759|FG000|Overall Study|Adverse Event|0|||
143322162|NCT00503685|516723760|FG001|Overall Study|Adverse Event|0|||
143322163|NCT00503685|516723761|FG002|Overall Study|Adverse Event|2|||
143322164|NCT00503685|516723759|FG000|Overall Study|Withdrawal by Subject|0|||
143322165|NCT00503685|516723760|FG001|Overall Study|Withdrawal by Subject|1|||
143322166|NCT00503685|516723761|FG002|Overall Study|Withdrawal by Subject|0|||
143322167|NCT00503685|516723759|FG000|Overall Study|Protocol Violation|0|||
143322168|NCT00503685|516723760|FG001|Overall Study|Protocol Violation|1|||
143322169|NCT00503685|516723761|FG002|Overall Study|Protocol Violation|0|||
143322170|NCT00503685|516723759|FG000|Overall Study|Eligibility Criteria Not Met|0|||
143322171|NCT00503685|516723760|FG001|Overall Study|Eligibility Criteria Not Met|1|||
143322172|NCT00503685|516723761|FG002|Overall Study|Eligibility Criteria Not Met|0|||
143322173|NCT01110239|516723766|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
143322174|NCT01110239|516723767|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
143322175|NCT01110239|516723768|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
143322176|NCT01110239|516723769|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
143322177|NCT01110239|516723766|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
143322178|NCT01110239|516723767|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
143322179|NCT01110239|516723768|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
143322180|NCT01110239|516723769|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
143322181|NCT04369469|516723774|FG000|Overall Study|Lost to Follow-up|2|||
143322182|NCT04369469|516723775|FG001|Overall Study|Lost to Follow-up|4|||
143322183|NCT04369469|516723774|FG000|Overall Study|Physician Decision|2|||
143322184|NCT04369469|516723775|FG001|Overall Study|Physician Decision|1|||
143322185|NCT04369469|516723774|FG000|Overall Study|Withdrawal by Subject|2|||
143322186|NCT04369469|516723775|FG001|Overall Study|Withdrawal by Subject|3|||
143322187|NCT04369469|516723774|FG000|Overall Study|Adverse Event|1|||
143322188|NCT04369469|516723775|FG001|Overall Study|Adverse Event|0|||
143322189|NCT04369469|516723774|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
143322190|NCT04369469|516723775|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
143322191|NCT04369469|516723774|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
143322192|NCT04369469|516723775|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
143322193|NCT04369469|516723774|FG000|Overall Study|Unable to Provide Consent|0|||
143322194|NCT04369469|516723775|FG001|Overall Study|Unable to Provide Consent|1|||
143322195|NCT03135522|516723776|FG000|Overall Study|Adverse Event|1|||
143322196|NCT03135522|516723777|FG001|Overall Study|Adverse Event|0|||
143322197|NCT00499369|516723778|FG000|Overall Study|Adverse Event|2|||
143322198|NCT00499369|516723779|FG001|Overall Study|Adverse Event|2|||
143322199|NCT00499369|516723780|FG002|Overall Study|Adverse Event|3|||
143322200|NCT00499369|516723781|FG003|Overall Study|Adverse Event|1|||
143322201|NCT00499369|516723782|FG004|Overall Study|Adverse Event|2|||
143322202|NCT00499369|516723778|FG000|Overall Study|Withdrawal by Subject|0|||
143322203|NCT00499369|516723779|FG001|Overall Study|Withdrawal by Subject|1|||
143322204|NCT00499369|516723780|FG002|Overall Study|Withdrawal by Subject|1|||
143322205|NCT00499369|516723781|FG003|Overall Study|Withdrawal by Subject|0|||
143322206|NCT00499369|516723782|FG004|Overall Study|Withdrawal by Subject|0|||
143322207|NCT00499369|516723778|FG000|Overall Study|Progression|10|||
143322208|NCT00499369|516723779|FG001|Overall Study|Progression|12|||
143322209|NCT00499369|516723780|FG002|Overall Study|Progression|9|||
143322210|NCT00499369|516723781|FG003|Overall Study|Progression|6|||
143322211|NCT00499369|516723782|FG004|Overall Study|Progression|10|||
143322212|NCT00499369|516723778|FG000|Overall Study|Death|0|||
143322213|NCT00499369|516723779|FG001|Overall Study|Death|1|||
143322214|NCT00499369|516723780|FG002|Overall Study|Death|0|||
143322215|NCT00499369|516723781|FG003|Overall Study|Death|0|||
143322216|NCT00499369|516723782|FG004|Overall Study|Death|0|||
143322217|NCT00499369|516723778|FG000|Overall Study|Not protocol specified|2|||
143322218|NCT00499369|516723779|FG001|Overall Study|Not protocol specified|0|||
143322219|NCT00499369|516723780|FG002|Overall Study|Not protocol specified|3|||
143322220|NCT00499369|516723781|FG003|Overall Study|Not protocol specified|1|||
143322221|NCT00499369|516723782|FG004|Overall Study|Not protocol specified|0|||
143322222|NCT00499369|516723778|FG000|Overall Study|Ineligible|2|||
143322223|NCT00499369|516723779|FG001|Overall Study|Ineligible|2|||
143322224|NCT00499369|516723780|FG002|Overall Study|Ineligible|1|||
143322225|NCT00499369|516723781|FG003|Overall Study|Ineligible|1|||
143322226|NCT00499369|516723782|FG004|Overall Study|Ineligible|0|||
143322227|NCT01898195|516723783|FG000|Smoking Abstinence|Did not have good measurements|35|||
143322228|NCT01898195|516723784|FG001|Smoking Abstinence|Did not have good measurements|38|||
143322229|NCT01898195|516723785|FG002|Smoking Abstinence|Did not have good measurements|36|||
143322230|NCT01337245|516723786|FG000|Overall Study|Lost to Follow-up|1|||
143322231|NCT03283670|516723787|FG000|Placebo Gas|Withdrawal by Subject|2|||
143322232|NCT03283670|516723787|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
143322233|NCT03283670|516723787|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
143322234|NCT00136955|516725486|FG000|Overall Study|Adverse Event|8|||
143322235|NCT00136955|516725486|FG000|Overall Study|Lost to Follow-up|1|||
143322236|NCT00136955|516725486|FG000|Overall Study|Withdrawal by Subject|2|||
143322237|NCT00136955|516725486|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
143322238|NCT00074282|516725487|FG000|Step 1|Adverse Event|32|||
143322239|NCT00074282|516725488|FG001|Step 1|Adverse Event|0|||
143322240|NCT00074282|516725489|FG002|Step 1|Adverse Event|0|||
143322241|NCT00074282|516725487|FG000|Step 1|Death|6|||
143322242|NCT00074282|516725488|FG001|Step 1|Death|0|||
143322243|NCT00074282|516725489|FG002|Step 1|Death|0|||
143322244|NCT00074282|516725487|FG000|Step 1|Withdrawal by Subject|7|||
143322245|NCT00074282|516725488|FG001|Step 1|Withdrawal by Subject|0|||
143322246|NCT00074282|516725489|FG002|Step 1|Withdrawal by Subject|0|||
143322247|NCT00074282|516725487|FG000|Step 1|Disease progression|2|||
143322248|NCT00074282|516725488|FG001|Step 1|Disease progression|0|||
143322249|NCT00074282|516725489|FG002|Step 1|Disease progression|0|||
143322250|NCT00074282|516725487|FG000|Step 1|Alternative therapy|2|||
143322251|NCT00074282|516725488|FG001|Step 1|Alternative therapy|0|||
143322252|NCT00074282|516725489|FG002|Step 1|Alternative therapy|0|||
143322253|NCT00074282|516725487|FG000|Step 1|Other complicating disease|2|||
143322254|NCT00074282|516725488|FG001|Step 1|Other complicating disease|0|||
143322255|NCT00074282|516725489|FG002|Step 1|Other complicating disease|0|||
143322256|NCT00074282|516725487|FG000|Step 1|Physician Decision|1|||
143322257|NCT00074282|516725488|FG001|Step 1|Physician Decision|0|||
143322258|NCT00074282|516725489|FG002|Step 1|Physician Decision|0|||
143322259|NCT00074282|516725487|FG000|Step 1|Ineligible|4|||
143322260|NCT00074282|516725488|FG001|Step 1|Ineligible|0|||
143322261|NCT00074282|516725489|FG002|Step 1|Ineligible|0|||
143322262|NCT00074282|516725487|FG000|Step 1|Never started treatment|2|||
143322263|NCT00074282|516725488|FG001|Step 1|Never started treatment|0|||
143322264|NCT00074282|516725489|FG002|Step 1|Never started treatment|0|||
143322265|NCT00074282|516725487|FG000|Step 2|Adverse Event|0|||
143322266|NCT00074282|516725488|FG001|Step 2|Adverse Event|2|||
143322267|NCT00074282|516725489|FG002|Step 2|Adverse Event|12|||
143322268|NCT00074282|516725487|FG000|Step 2|Disease progression|0|||
143322269|NCT00074282|516725488|FG001|Step 2|Disease progression|0|||
143322270|NCT00074282|516725489|FG002|Step 2|Disease progression|5|||
143322271|NCT00074282|516725487|FG000|Step 2|Death|0|||
143322272|NCT00074282|516725488|FG001|Step 2|Death|0|||
143322273|NCT00074282|516725489|FG002|Step 2|Death|3|||
143322274|NCT00074282|516725487|FG000|Step 2|Withdrawal by Subject|0|||
143322275|NCT00074282|516725488|FG001|Step 2|Withdrawal by Subject|0|||
143322276|NCT00074282|516725489|FG002|Step 2|Withdrawal by Subject|2|||
143322277|NCT00074282|516725487|FG000|Step 2|Physician Decision|0|||
143322278|NCT00074282|516725488|FG001|Step 2|Physician Decision|0|||
143322279|NCT00074282|516725489|FG002|Step 2|Physician Decision|1|||
143322280|NCT00074282|516725487|FG000|Step 2|Ineligible|0|||
143322281|NCT00074282|516725488|FG001|Step 2|Ineligible|0|||
143322282|NCT00074282|516725489|FG002|Step 2|Ineligible|1|||
143322283|NCT01682460|516725491|FG000|Overall Study|Withdrawal by Subject|2|||
143322284|NCT01682460|516725491|FG000|Overall Study|Did not meet inclusion criteria|2|||
143322285|NCT02055352|516725495|FG000|Overall Study|Adverse Event|0|||
143322286|NCT02055352|516725496|FG001|Overall Study|Adverse Event|1|||
143322287|NCT02055352|516725495|FG000|Overall Study|Non-eligible|0|||
143322288|NCT02055352|516725496|FG001|Overall Study|Non-eligible|1|||
143322289|NCT02055352|516725495|FG000|Overall Study|Poor compliance|1|||
143322290|NCT02055352|516725496|FG001|Overall Study|Poor compliance|1|||
143322291|NCT02055352|516725495|FG000|Overall Study|Death|1|||
143322292|NCT02055352|516725496|FG001|Overall Study|Death|2|||
143322293|NCT02055352|516725495|FG000|Overall Study|Patient decision|1|||
143322294|NCT02055352|516725496|FG001|Overall Study|Patient decision|1|||
143322295|NCT02055352|516725495|FG000|Overall Study|Use of prohibited treatment|0|||
143322296|NCT02055352|516725496|FG001|Overall Study|Use of prohibited treatment|3|||
143322297|NCT02055352|516725495|FG000|Overall Study|AE, study drug would be detrimental|1|||
143322298|NCT02055352|516725496|FG001|Overall Study|AE, study drug would be detrimental|3|||
143322299|NCT02055352|516725495|FG000|Overall Study|Withdrawal of informed consent|1|||
143322300|NCT02055352|516725496|FG001|Overall Study|Withdrawal of informed consent|0|||
143322301|NCT02055352|516725495|FG000|Overall Study|Reason unknown|1|||
143322302|NCT02055352|516725496|FG001|Overall Study|Reason unknown|5|||
143322303|NCT05349617|516725499|FG000|Overall Study|Death|1|||
143322304|NCT05349617|516725500|FG001|Overall Study|Death|1|||
143322305|NCT05349617|516725499|FG000|Overall Study|Lost to Follow-up|3|||
143322306|NCT05349617|516725500|FG001|Overall Study|Lost to Follow-up|8|||
143322307|NCT05349617|516725499|FG000|Overall Study|Withdrawal by Subject|2|||
143322308|NCT05349617|516725500|FG001|Overall Study|Withdrawal by Subject|10|||
143322309|NCT03811912|516725503|FG000|Overall Study|Withdrew Consent|4|||
143322310|NCT03811912|516725504|FG001|Overall Study|Withdrew Consent|2|||
143322311|NCT04401579|516725505|FG000|Overall Study|Death|23|||
143322312|NCT04401579|516725506|FG001|Overall Study|Death|36|||
143322313|NCT04401579|516725505|FG000|Overall Study|Lost to Follow-up|40|||
143322314|NCT04401579|516725506|FG001|Overall Study|Lost to Follow-up|41|||
143322315|NCT04401579|516725505|FG000|Overall Study|Withdrawal by Subject|8|||
143322316|NCT04401579|516725506|FG001|Overall Study|Withdrawal by Subject|16|||
143322317|NCT04401579|516725505|FG000|Overall Study|Physician Decision|1|||
143322318|NCT04401579|516725506|FG001|Overall Study|Physician Decision|2|||
143322319|NCT04401579|516725505|FG000|Overall Study|Became ineligible after enrollment|1|||
143322320|NCT04401579|516725506|FG001|Overall Study|Became ineligible after enrollment|1|||
143322321|NCT04401579|516725505|FG000|Overall Study|Enrolled but treatment not administered|7|||
143322322|NCT04401579|516725506|FG001|Overall Study|Enrolled but treatment not administered|9|||
143322323|NCT04401579|516725505|FG000|Overall Study|Adverse Event|2|||
143380343|NCT02723955|516940653|FG037|Escalation Phase|Withdrawal by Subject|0|||
143380344|NCT02723955|516940654|FG038|Escalation Phase|Withdrawal by Subject|0|||
143322324|NCT04401579|516725506|FG001|Overall Study|Adverse Event|1|||
143322325|NCT04401579|516725505|FG000|Overall Study|Scheduling error|1|||
143322326|NCT04401579|516725506|FG001|Overall Study|Scheduling error|2|||
143322327|NCT04401579|516725505|FG000|Overall Study|Transferred to another hospital|1|||
143322328|NCT04401579|516725506|FG001|Overall Study|Transferred to another hospital|2|||
143322329|NCT00489970|516725507|FG000|Persistence Year 9|Lost to Follow-up|2|||
143322330|NCT00489970|516725508|FG001|Persistence Year 9|Lost to Follow-up|2|||
143322331|NCT00489970|516725509|FG002|Persistence Year 9|Lost to Follow-up|3|||
143322332|NCT00489970|516725507|FG000|Persistence Year 9|Other|1|||
143322333|NCT00489970|516725508|FG001|Persistence Year 9|Other|0|||
143322334|NCT00489970|516725509|FG002|Persistence Year 9|Other|2|||
143322335|NCT01438411|516725510|FG000|Overall Study|Adverse Event|8|||
143322336|NCT01438411|516725510|FG000|Overall Study|Lost to Follow-up|1|||
143322337|NCT01438411|516725510|FG000|Overall Study|Lack of Efficacy|1|||
143322338|NCT01438411|516725510|FG000|Overall Study|Withdrawal by Subject|3|||
143322339|NCT01863680|516725511|FG000|Overall Study|Adverse Event|17|||
143322340|NCT01863680|516725511|FG000|Overall Study|Risk of OHSS|17|||
143322341|NCT01863680|516725511|FG000|Overall Study|Spontaneous pregnancy|2|||
143322342|NCT01863680|516725511|FG000|Overall Study|Withdrawal by Subject|1|||
143322343|NCT01863680|516725511|FG000|Overall Study|Did not undergo IVF/ET|14|||
143322344|NCT01863680|516725511|FG000|Overall Study|Other|6|||
143322345|NCT00618514|516725512|FG000|Overall Study|Lost to Follow-up|11|||
143322346|NCT00618514|516725513|FG001|Overall Study|Lost to Follow-up|12|||
143322347|NCT00618514|516725514|FG002|Overall Study|Lost to Follow-up|4|||
143322348|NCT00566228|516725519|FG000|Overall Study|Withdrawal by Subject|1|||
143322349|NCT00566228|516725520|FG001|Overall Study|Withdrawal by Subject|0|||
143322350|NCT00566228|516725519|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
143322351|NCT00566228|516725520|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
143322352|NCT00566228|516725519|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
143322353|NCT00566228|516725520|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
143322354|NCT00566228|516725519|FG000|Overall Study|progressed before infusion could occur|0|||
143322355|NCT00566228|516725520|FG001|Overall Study|progressed before infusion could occur|1|||
143322356|NCT02707055|516725523|FG000|Phase 1|Withdrawal by Subject|1|||
143322357|NCT02707055|516725524|FG001|Phase 1|Withdrawal by Subject|2|||
143322358|NCT02707055|516725523|FG000|Phase 1|Physician Decision|0|||
143322359|NCT02707055|516725524|FG001|Phase 1|Physician Decision|1|||
143322360|NCT02707055|516725523|FG000|Phase 2|Adverse Event|1|||
143322361|NCT02707055|516725524|FG001|Phase 2|Adverse Event|2|||
143322362|NCT00902304|516725525|FG000|Overall Study|Adverse Event|4|||
143322363|NCT00902304|516725526|FG001|Overall Study|Adverse Event|10|||
143322364|NCT00902304|516725527|FG002|Overall Study|Adverse Event|25|||
143322365|NCT00902304|516725525|FG000|Overall Study|Investigator discretion|3|||
143322366|NCT00902304|516725526|FG001|Overall Study|Investigator discretion|5|||
143322367|NCT00902304|516725527|FG002|Overall Study|Investigator discretion|13|||
143322368|NCT00902304|516725525|FG000|Overall Study|Lost to Follow-up|7|||
143322369|NCT00902304|516725526|FG001|Overall Study|Lost to Follow-up|7|||
143322370|NCT00902304|516725527|FG002|Overall Study|Lost to Follow-up|7|||
143322371|NCT00902304|516725525|FG000|Overall Study|Protocol Violation|9|||
143322372|NCT00902304|516725526|FG001|Overall Study|Protocol Violation|18|||
143322373|NCT00902304|516725527|FG002|Overall Study|Protocol Violation|20|||
143322374|NCT00902304|516725525|FG000|Overall Study|Withdrawal by Subject|32|||
143322375|NCT00902304|516725526|FG001|Overall Study|Withdrawal by Subject|22|||
143322376|NCT00902304|516725527|FG002|Overall Study|Withdrawal by Subject|43|||
143322377|NCT00902304|516725525|FG000|Overall Study|includes pregnancy|3|||
143322378|NCT00902304|516725526|FG001|Overall Study|includes pregnancy|9|||
143322379|NCT00902304|516725527|FG002|Overall Study|includes pregnancy|2|||
143322380|NCT05706506|516725528|FG000|Overall Study|Adverse Event|1|||
143322381|NCT05706506|516725528|FG000|Overall Study|Withdrawal by Subject|4|||
143322382|NCT05706506|516725528|FG000|Overall Study|Lost to Follow-up|2|||
143322383|NCT05706506|516725528|FG000|Overall Study|Inadvertent Enrolment|12|||
143322384|NCT05706506|516725528|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
143322385|NCT05706506|516725528|FG000|Overall Study|Participant Moved Out of State|1|||
143322386|NCT04837482|516725529|FG000|Period 2|Withdrawal by Subject|0|||
143322387|NCT04837482|516725530|FG001|Period 2|Withdrawal by Subject|1|||
143322388|NCT02646423|516725534|FG000|Overall Study|Adverse Event|5|||
143322389|NCT02646423|516725535|FG001|Overall Study|Adverse Event|7|||
143322390|NCT02646423|516725534|FG000|Overall Study|Ineligible|2|||
143322391|NCT02646423|516725535|FG001|Overall Study|Ineligible|1|||
143322392|NCT00086346|516725536|FG000|Randomization|Did not receive test article|4|||
143322393|NCT00086346|516725537|FG001|Randomization|Did not receive test article|4|||
143322394|NCT00086346|516725536|FG000|Patients Dosed With Test Article|Adverse Event|94|||
143322395|NCT00086346|516725537|FG001|Patients Dosed With Test Article|Adverse Event|11|||
143322396|NCT00086346|516725536|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
143322397|NCT00086346|516725537|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
143322398|NCT00086346|516725536|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
143322399|NCT00086346|516725537|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
143322400|NCT00086346|516725536|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
143322401|NCT00086346|516725537|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
143322402|NCT00086346|516725536|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
143322403|NCT00086346|516725537|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
143322404|NCT00086346|516725536|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
143322405|NCT00086346|516725537|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
143322406|NCT03727750|516725538|FG000|Overall Study|Death|45|||
143322407|NCT03727750|516725538|FG000|Overall Study|Withdrawal by Subject|2|||
143322408|NCT03727750|516725538|FG000|Overall Study|Lost to Follow-up|1|||
143322409|NCT03727750|516725538|FG000|Overall Study|Other|1|||
143322410|NCT01303627|516725539|FG000|Overall Study|the failure while performing URS|0|||
143322411|NCT01303627|516725540|FG001|Overall Study|the failure while performing URS|1|||
143322412|NCT00321919|516725543|FG000|Overall Study|Adverse Event|17|||
143322413|NCT00321919|516725544|FG001|Overall Study|Adverse Event|10|||
143322414|NCT00321919|516725543|FG000|Overall Study|Death|21|||
143322415|NCT00321919|516725544|FG001|Overall Study|Death|17|||
143322416|NCT00321919|516725543|FG000|Overall Study|Insufficient Therapeutic Response|1|||
143322417|NCT00321919|516725544|FG001|Overall Study|Insufficient Therapeutic Response|0|||
143322418|NCT00321919|516725543|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
143322419|NCT00321919|516725544|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
143322420|NCT00321919|516725543|FG000|Overall Study|Refused Treatment|23|||
143322421|NCT00321919|516725544|FG001|Overall Study|Refused Treatment|14|||
143322422|NCT00321919|516725543|FG000|Overall Study|Other Protocol Violation|2|||
143322423|NCT00321919|516725544|FG001|Overall Study|Other Protocol Violation|3|||
143322424|NCT00321919|516725543|FG000|Overall Study|Failure to Return|3|||
143322425|NCT00321919|516725544|FG001|Overall Study|Failure to Return|1|||
143322426|NCT00321919|516725543|FG000|Overall Study|Other withdrawal reason|7|||
143322427|NCT00321919|516725544|FG001|Overall Study|Other withdrawal reason|6|||
143322428|NCT01227889|516725545|FG000|Randomized Phase (RP)|Adverse Event|13|||
143322429|NCT01227889|516725546|FG001|Randomized Phase (RP)|Adverse Event|0|||
143322430|NCT01227889|516725545|FG000|Randomized Phase (RP)|Physician Decision|13|||
143322431|NCT01227889|516725546|FG001|Randomized Phase (RP)|Physician Decision|5|||
143322432|NCT01227889|516725545|FG000|Randomized Phase (RP)|Progressive Disease|135|||
143322433|NCT01227889|516725546|FG001|Randomized Phase (RP)|Progressive Disease|52|||
143322434|NCT01227889|516725545|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
143322435|NCT01227889|516725546|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
143322436|NCT01227889|516725545|FG000|Randomized Phase (RP)|Missing|1|||
143322437|NCT01227889|516725546|FG001|Randomized Phase (RP)|Missing|3|||
143322438|NCT01227889|516725545|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
143322439|NCT01227889|516725546|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
143322440|NCT01227889|516725545|FG000|Crossover Phase|Adverse Event|0|||
143322441|NCT01227889|516725546|FG001|Crossover Phase|Adverse Event|1|||
143322442|NCT01227889|516725545|FG000|Crossover Phase|Physician Decision|0|||
143322443|NCT01227889|516725546|FG001|Crossover Phase|Physician Decision|3|||
143322444|NCT01227889|516725545|FG000|Crossover Phase|Progressive Disease|0|||
143322445|NCT01227889|516725546|FG001|Crossover Phase|Progressive Disease|31|||
143322446|NCT01227889|516725545|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
143322447|NCT01227889|516725546|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
143322448|NCT01227889|516725545|FG000|Crossover Phase|Withdrawal by Subject|0|||
143322449|NCT01227889|516725546|FG001|Crossover Phase|Withdrawal by Subject|1|||
143322450|NCT04121962|516725549|FG000|Overall Study|Lost to Follow-up|42|||
143322451|NCT04121962|516725550|FG001|Overall Study|Lost to Follow-up|39|||
143322452|NCT01175382|516725551|FG000|Overall Study|Lost to Follow-up|4|||
143322453|NCT01175382|516725552|FG001|Overall Study|Lost to Follow-up|3|||
143322454|NCT01175382|516725553|FG002|Overall Study|Lost to Follow-up|1|||
143322455|NCT01175382|516725551|FG000|Overall Study|Physician Decision|0|||
143322456|NCT01175382|516725552|FG001|Overall Study|Physician Decision|1|||
143322457|NCT01175382|516725553|FG002|Overall Study|Physician Decision|0|||
143322458|NCT01175382|516725551|FG000|Overall Study|Withdrawal by Subject|0|||
143322459|NCT01175382|516725552|FG001|Overall Study|Withdrawal by Subject|0|||
143322460|NCT01175382|516725553|FG002|Overall Study|Withdrawal by Subject|1|||
143322461|NCT01175382|516725551|FG000|Overall Study|No longer having problem|1|||
143322462|NCT01175382|516725552|FG001|Overall Study|No longer having problem|0|||
143322463|NCT01175382|516725553|FG002|Overall Study|No longer having problem|1|||
143322464|NCT01175382|516725551|FG000|Overall Study|Unable/unwilling to attend visits|3|||
143322465|NCT01175382|516725552|FG001|Overall Study|Unable/unwilling to attend visits|1|||
143322466|NCT01175382|516725553|FG002|Overall Study|Unable/unwilling to attend visits|2|||
143322467|NCT01175382|516725551|FG000|Overall Study|Unwilling to follow protocol|0|||
143322468|NCT01175382|516725552|FG001|Overall Study|Unwilling to follow protocol|1|||
143322469|NCT01175382|516725553|FG002|Overall Study|Unwilling to follow protocol|0|||
143322470|NCT01175382|516725551|FG000|Overall Study|Unable to tolerate study meds|0|||
143322471|NCT01175382|516725552|FG001|Overall Study|Unable to tolerate study meds|1|||
143322472|NCT01175382|516725553|FG002|Overall Study|Unable to tolerate study meds|1|||
143322473|NCT00774787|516725554|FG000|Overall Study|Lost to Follow-up|1|||
143322474|NCT02019719|516725555|FG000|Overall Study|Adverse Event|1|||
143322475|NCT02019719|516725556|FG001|Overall Study|Adverse Event|0|||
143322476|NCT02019719|516725557|FG002|Overall Study|Adverse Event|0|||
143322477|NCT02019719|516725558|FG003|Overall Study|Adverse Event|1|||
143322478|NCT02019719|516725559|FG004|Overall Study|Adverse Event|1|||
143322479|NCT02019719|516725555|FG000|Overall Study|Protocol Violation|1|||
143322480|NCT02019719|516725556|FG001|Overall Study|Protocol Violation|1|||
143322481|NCT02019719|516725557|FG002|Overall Study|Protocol Violation|0|||
143322482|NCT02019719|516725558|FG003|Overall Study|Protocol Violation|0|||
143322483|NCT02019719|516725559|FG004|Overall Study|Protocol Violation|0|||
143322484|NCT02019719|516725555|FG000|Overall Study|Protocol defined stopping criteria|2|||
143322485|NCT02019719|516725556|FG001|Overall Study|Protocol defined stopping criteria|0|||
143322486|NCT02019719|516725557|FG002|Overall Study|Protocol defined stopping criteria|0|||
143322487|NCT02019719|516725558|FG003|Overall Study|Protocol defined stopping criteria|1|||
143322488|NCT02019719|516725559|FG004|Overall Study|Protocol defined stopping criteria|1|||
143322489|NCT02019719|516725555|FG000|Overall Study|Physician Decision|2|||
143322490|NCT02019719|516725556|FG001|Overall Study|Physician Decision|0|||
143322491|NCT02019719|516725557|FG002|Overall Study|Physician Decision|0|||
143322492|NCT02019719|516725558|FG003|Overall Study|Physician Decision|0|||
143322493|NCT02019719|516725559|FG004|Overall Study|Physician Decision|0|||
143322494|NCT02731131|516725563|FG000|Overall Study|Psychiatric Disorder|0|||
143322495|NCT02731131|516725564|FG001|Overall Study|Psychiatric Disorder|1|||
143322496|NCT02731131|516725563|FG000|Overall Study|Refused Therapy|0|||
143322497|NCT02731131|516725564|FG001|Overall Study|Refused Therapy|1|||
143322498|NCT01055639|516725569|FG000|Overall Study|Adverse Event|0|||
143322499|NCT01055639|516725570|FG001|Overall Study|Adverse Event|1|||
143322500|NCT01055639|516725569|FG000|Overall Study|Lack of Efficacy|0|||
143322501|NCT01055639|516725570|FG001|Overall Study|Lack of Efficacy|1|||
143322502|NCT01055639|516725569|FG000|Overall Study|Lost to Follow-up|8|||
143322503|NCT01055639|516725570|FG001|Overall Study|Lost to Follow-up|11|||
143322504|NCT01055639|516725569|FG000|Overall Study|Protocol Violation|5|||
143322505|NCT01055639|516725570|FG001|Overall Study|Protocol Violation|5|||
143322506|NCT01055639|516725569|FG000|Overall Study|Withdrawal by Subject|8|||
143322507|NCT01055639|516725570|FG001|Overall Study|Withdrawal by Subject|11|||
143322508|NCT01197950|516725574|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
143322509|NCT01197950|516725575|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
143322510|NCT01197950|516725576|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
143322511|NCT01659021|516725577|FG000|Main Study|Adverse Event|2|||
143322512|NCT01659021|516725578|FG001|Main Study|Adverse Event|3|||
143322513|NCT01659021|516725577|FG000|Main Study|Lost to Follow-up|1|||
143322514|NCT01659021|516725578|FG001|Main Study|Lost to Follow-up|0|||
143322515|NCT01659021|516725577|FG000|Main Study|Unknown Reasons|2|||
143322516|NCT01659021|516725578|FG001|Main Study|Unknown Reasons|1|||
143322517|NCT01659021|516725577|FG000|Main Study|Physician Decision|34|||
143322518|NCT01659021|516725578|FG001|Main Study|Physician Decision|16|||
143322519|NCT01659021|516725577|FG000|Main Study|Withdrawal by Subject|19|||
143322520|NCT01659021|516725578|FG001|Main Study|Withdrawal by Subject|16|||
143322521|NCT01659021|516725577|FG000|Main Study|Study Terminated by Sponsor|16|||
143322522|NCT01659021|516725578|FG001|Main Study|Study Terminated by Sponsor|1|||
143322523|NCT01659021|516725577|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
143322524|NCT01659021|516725578|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
143322525|NCT01659021|516725577|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
143322526|NCT01659021|516725578|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
143322527|NCT00345579|516725581|FG000|Overall Study|Adverse Event|9|||
143322528|NCT00345579|516725582|FG001|Overall Study|Adverse Event|6|||
143322529|NCT00345579|516725581|FG000|Overall Study|Protocol Violation|14|||
143322530|NCT00345579|516725582|FG001|Overall Study|Protocol Violation|5|||
143322531|NCT00345579|516725581|FG000|Overall Study|Withdrawal by Subject|50|||
143322532|NCT00345579|516725582|FG001|Overall Study|Withdrawal by Subject|17|||
143322533|NCT00345579|516725581|FG000|Overall Study|Lost to Follow-up|82|||
143322534|NCT00345579|516725582|FG001|Overall Study|Lost to Follow-up|36|||
143322535|NCT00345579|516725581|FG000|Overall Study|Other|9|||
143322536|NCT00345579|516725582|FG001|Overall Study|Other|1|||
143322537|NCT01732835|516725583|FG000|6-month Primary Endpoint|Did not receive device|19|||
143322538|NCT01732835|516725583|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
143322539|NCT01732835|516725583|FG000|6-month Primary Endpoint|Adverse Event|3|||
143322540|NCT01732835|516725583|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
143322541|NCT01732835|516725583|FG000|2-year Extended Follow-up|Adverse Event|3|||
143322542|NCT01732835|516725583|FG000|2-year Extended Follow-up|Death|1|||
143322543|NCT03893448|516725588|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
143322544|NCT03893448|516725589|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
143322545|NCT03893448|516725588|FG000|Overall Study|Physician Decision|8|||
143322546|NCT03893448|516725589|FG001|Overall Study|Physician Decision|14|||
143322547|NCT03893448|516725588|FG000|Overall Study|Lost to Follow-up|34|||
143322548|NCT03893448|516725589|FG001|Overall Study|Lost to Follow-up|27|||
143322549|NCT03893448|516725588|FG000|Overall Study|Death|1|||
143322550|NCT03893448|516725589|FG001|Overall Study|Death|0|||
143322551|NCT00817089|516725594|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
143322552|NCT00817089|516725595|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
143322553|NCT00817089|516725596|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
143322554|NCT00817089|516725597|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
143322555|NCT00817089|516725594|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
143322556|NCT00817089|516725595|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
143322557|NCT00817089|516725596|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
143322558|NCT00817089|516725597|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
143322559|NCT00856583|516725601|FG000|Overall Study|Lack of Efficacy|389|||
143322560|NCT00856583|516725602|FG001|Overall Study|Lack of Efficacy|377|||
143322561|NCT00856583|516725601|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
143322562|NCT00856583|516725602|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
143322563|NCT00856583|516725601|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
143322564|NCT00856583|516725602|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
143322565|NCT00856583|516725601|FG000|Overall Study|Non-compliance|305|||
143322566|NCT00856583|516725602|FG001|Overall Study|Non-compliance|262|||
143322567|NCT00856583|516725601|FG000|Overall Study|Withdrawal by Subject|1092|||
143322568|NCT00856583|516725602|FG001|Overall Study|Withdrawal by Subject|919|||
143322569|NCT00856583|516725601|FG000|Overall Study|Physician Decision|59|||
143322570|NCT00856583|516725602|FG001|Overall Study|Physician Decision|82|||
143322571|NCT00856583|516725601|FG000|Overall Study|Pregnancy|14|||
143322572|NCT00856583|516725602|FG001|Overall Study|Pregnancy|5|||
143322573|NCT00856583|516725601|FG000|Overall Study|Other|92|||
143322574|NCT00856583|516725602|FG001|Overall Study|Other|104|||
143322575|NCT00856583|516725601|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
143322576|NCT00856583|516725602|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
143322577|NCT01944046|516725603|FG000|Randomized to DB|Adverse Event|5|||
143322578|NCT01944046|516725604|FG001|Randomized to DB|Adverse Event|2|||
143322579|NCT01944046|516725603|FG000|Randomized to DB|Clinical Worsening|3|||
143322580|NCT01944046|516725604|FG001|Randomized to DB|Clinical Worsening|2|||
143322581|NCT01944046|516725603|FG000|Randomized to DB|Lost to Follow-up|3|||
143322582|NCT01944046|516725604|FG001|Randomized to DB|Lost to Follow-up|3|||
143322583|NCT01944046|516725603|FG000|Randomized to DB|Withdrawal by Subject|2|||
143322584|NCT01944046|516725604|FG001|Randomized to DB|Withdrawal by Subject|4|||
143322585|NCT01944046|516725603|FG000|Randomized to DB|Physician Decision|1|||
143322586|NCT01944046|516725604|FG001|Randomized to DB|Physician Decision|2|||
143322587|NCT01944046|516725603|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
143322588|NCT01944046|516725604|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
143322589|NCT01944046|516725603|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
143322590|NCT01944046|516725604|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
143322591|NCT01944046|516725603|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
143322592|NCT01944046|516725604|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
143322593|NCT01944046|516725603|FG000|Open Label Eligible and Consented|Adverse Event|6|||
143322594|NCT01944046|516725604|FG001|Open Label Eligible and Consented|Adverse Event|1|||
143322595|NCT01944046|516725603|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
143322596|NCT01944046|516725604|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
143322597|NCT01944046|516725603|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
143322598|NCT01944046|516725604|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
143322599|NCT05799495|516725613|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
143322600|NCT05799495|516725614|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
143322601|NCT05799495|516725615|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
143322602|NCT05799495|516725616|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
143322603|NCT05799495|516725613|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
143322604|NCT05799495|516725614|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
143322605|NCT05799495|516725615|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
143322606|NCT05799495|516725616|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
143322607|NCT05799495|516725613|FG000|Treatment (Up to 5 Days)|Other|0|||
143322608|NCT05799495|516725614|FG001|Treatment (Up to 5 Days)|Other|1|||
143322609|NCT05799495|516725615|FG002|Treatment (Up to 5 Days)|Other|0|||
143322610|NCT05799495|516725616|FG003|Treatment (Up to 5 Days)|Other|0|||
143322611|NCT05799495|516725613|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
143322612|NCT05799495|516725614|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
143322613|NCT05799495|516725615|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
143322614|NCT05799495|516725616|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
143322615|NCT05799495|516725613|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
143322616|NCT05799495|516725614|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
143322617|NCT05799495|516725615|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
143322618|NCT05799495|516725616|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
143322619|NCT05799495|516725613|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
143322620|NCT05799495|516725614|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
143322621|NCT05799495|516725615|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
143322622|NCT05799495|516725616|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
143322623|NCT03694548|516725617|FG000|Part A Survey|Protocol Violation|3|||
143322624|NCT03694548|516725618|FG001|Part A Survey|Protocol Violation|3|||
143322625|NCT03694548|516725619|FG002|Part A Survey|Protocol Violation|0|||
143322626|NCT03694548|516725617|FG000|Part B Yoga Program|Protocol Violation|0|||
143322627|NCT03694548|516725618|FG001|Part B Yoga Program|Protocol Violation|0|||
143322628|NCT03694548|516725619|FG002|Part B Yoga Program|Protocol Violation|3|||
143322629|NCT03694548|516725617|FG000|Part B Yoga Program|Did not attend intervention|0|||
143322630|NCT03694548|516725618|FG001|Part B Yoga Program|Did not attend intervention|0|||
143322631|NCT03694548|516725619|FG002|Part B Yoga Program|Did not attend intervention|8|||
143322632|NCT00305058|516725620|FG000|Overall Study|Participant too young|1|||
143322633|NCT00305058|516725621|FG001|Overall Study|Participant too young|0|||
143322634|NCT00305058|516725620|FG000|Overall Study|Missing data collection instrument|3|||
143322635|NCT00305058|516725621|FG001|Overall Study|Missing data collection instrument|2|||
143322636|NCT00305058|516725620|FG000|Overall Study|Missing outcome data|3|||
143322637|NCT00305058|516725621|FG001|Overall Study|Missing outcome data|2|||
143322638|NCT01669343|516725626|FG000|Part A: All Patients|Withdrawal by Subject|7|||
143322639|NCT01669343|516725626|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
143322640|NCT01669343|516725626|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
143322641|NCT01669343|516725626|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
143322642|NCT01669343|516725626|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
143322643|NCT04433767|516725627|FG000|Overall Study|Adverse Event|1|||
143322644|NCT02371369|516725632|FG000|Part 1|Physician Decision|0|||
143322645|NCT02371369|516725633|FG001|Part 1|Physician Decision|3|||
143322646|NCT02371369|516725632|FG000|Part 1|Adverse Event|8|||
143322647|NCT02371369|516725633|FG001|Part 1|Adverse Event|0|||
143322648|NCT02371369|516725632|FG000|Part 1|Withdrawal by Subject|1|||
143322649|NCT02371369|516725633|FG001|Part 1|Withdrawal by Subject|6|||
143322650|NCT02371369|516725632|FG000|Part 1|Disease progression|0|||
143322651|NCT02371369|516725633|FG001|Part 1|Disease progression|1|||
143322652|NCT02371369|516725632|FG000|Part 1|Protocol Violation|0|||
143322653|NCT02371369|516725633|FG001|Part 1|Protocol Violation|1|||
143322654|NCT02371369|516725632|FG000|Part 2|Adverse Event|6|||
143322655|NCT02371369|516725633|FG001|Part 2|Adverse Event|5|||
143322656|NCT02371369|516725632|FG000|Part 2|Withdrawal by Subject|16|||
143322657|NCT02371369|516725633|FG001|Part 2|Withdrawal by Subject|6|||
143322658|NCT02371369|516725632|FG000|Part 2|Investigator decision|1|||
143322659|NCT02371369|516725633|FG001|Part 2|Investigator decision|2|||
143322660|NCT02371369|516725632|FG000|Part 2|Death|0|||
143322661|NCT02371369|516725633|FG001|Part 2|Death|1|||
143322662|NCT02371369|516725632|FG000|Part 2|Disease progression|1|||
143322663|NCT02371369|516725633|FG001|Part 2|Disease progression|0|||
143322664|NCT02371369|516725632|FG000|Part 2|Subject Noncompliance|1|||
143322665|NCT02371369|516725633|FG001|Part 2|Subject Noncompliance|0|||
143322666|NCT02371369|516725632|FG000|Part 2|Lost to Follow-up|1|||
143322667|NCT02371369|516725633|FG001|Part 2|Lost to Follow-up|1|||
143322668|NCT02371369|516725632|FG000|Part 2|Subject transitioned to commercial supply|6|||
143322669|NCT02371369|516725633|FG001|Part 2|Subject transitioned to commercial supply|4|||
143322670|NCT02371369|516725632|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
143322671|NCT02371369|516725633|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
143322672|NCT02371369|516725632|FG000|Part 2|Surgical resection of tumor|1|||
143322673|NCT02371369|516725633|FG001|Part 2|Surgical resection of tumor|1|||
143322674|NCT02371369|516725632|FG000|Part 2|Other|0|||
143322675|NCT02371369|516725633|FG001|Part 2|Other|1|||
143322676|NCT03165045|516725637|FG000|Visit 1|No registration after visit 1|9|||
143322677|NCT03165045|516725637|FG000|Visit 1|No treatment documented|10|||
143322678|NCT03165045|516725637|FG000|Visit 1|No visit 1|10|||
143322679|NCT03165045|516725637|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
143322680|NCT03165045|516725637|FG000|Visit 2|No available total CCQ score at all|29|||
143322681|NCT03165045|516725637|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
143322682|NCT00499889|516725641|FG000|Overall Study|Infection prior to treatment|1|||
143322683|NCT01660906|516725642|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
143322684|NCT03478891|516725644|FG000|Overall Study|Enrolled, but product never administered|0|||
143322685|NCT03478891|516725645|FG001|Overall Study|Enrolled, but product never administered|0|||
143322686|NCT03478891|516725646|FG002|Overall Study|Enrolled, but product never administered|1|||
143322687|NCT03478891|516725644|FG000|Overall Study|Moved from area|0|||
143322688|NCT03478891|516725645|FG001|Overall Study|Moved from area|0|||
143322689|NCT03478891|516725646|FG002|Overall Study|Moved from area|1|||
143322690|NCT03478891|516725644|FG000|Overall Study|Lost to Follow-up|1|||
143322691|NCT03478891|516725645|FG001|Overall Study|Lost to Follow-up|0|||
143322692|NCT03478891|516725646|FG002|Overall Study|Lost to Follow-up|1|||
143322693|NCT03823651|516725649|FG000|Overall Study|Death|5|||
143322694|NCT03823651|516725650|FG001|Overall Study|Death|0|||
143322695|NCT03823651|516725649|FG000|Overall Study|Physician Decision|1|||
143322696|NCT03823651|516725650|FG001|Overall Study|Physician Decision|0|||
143322697|NCT03823651|516725649|FG000|Overall Study|Caregiver to patient who died|0|||
143322698|NCT03823651|516725650|FG001|Overall Study|Caregiver to patient who died|5|||
143322699|NCT03823651|516725649|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
143322700|NCT03823651|516725650|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
143322701|NCT01850004|516725651|FG000|Overall Study|Poor/Non-compliance|1|||
143322702|NCT01850004|516725651|FG000|Overall Study|Participant Withdrew Consent|9|||
143322703|NCT01850004|516725651|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
143322704|NCT01850004|516725651|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
143322705|NCT01850004|516725651|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
143322706|NCT01850004|516725651|FG000|Overall Study|Other Reasons|2|||
143322707|NCT01850004|516725651|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
143322708|NCT01850004|516725651|FG000|Overall Study|Maximum Clinical Benefit|4|||
143322709|NCT05350449|516725652|FG000|Overall Study|Withdrawal by Subject|4|||
143322710|NCT05350449|516725653|FG001|Overall Study|Withdrawal by Subject|8|||
143322711|NCT00970502|516727955|FG000|Overall Study|Withdrawal by Subject|1|||
143322712|NCT02041195|516727956|FG000|Overall Study|Adverse Event|1|||
143322713|NCT02041195|516727957|FG001|Overall Study|Adverse Event|2|||
143322714|NCT02041195|516727958|FG002|Overall Study|Adverse Event|0|||
143322715|NCT02041195|516727959|FG003|Overall Study|Adverse Event|0|||
143322716|NCT02041195|516727960|FG004|Overall Study|Adverse Event|0|||
143322717|NCT02041195|516727961|FG005|Overall Study|Adverse Event|0|||
143322718|NCT02041195|516727962|FG006|Overall Study|Adverse Event|3|||
143322719|NCT02041195|516727963|FG007|Overall Study|Adverse Event|0|||
143322720|NCT02041195|516727956|FG000|Overall Study|Withdrawal by Subject|1|||
143322721|NCT02041195|516727957|FG001|Overall Study|Withdrawal by Subject|0|||
143322722|NCT02041195|516727958|FG002|Overall Study|Withdrawal by Subject|0|||
143322723|NCT02041195|516727959|FG003|Overall Study|Withdrawal by Subject|0|||
143322724|NCT02041195|516727960|FG004|Overall Study|Withdrawal by Subject|0|||
143322725|NCT02041195|516727961|FG005|Overall Study|Withdrawal by Subject|0|||
143322726|NCT02041195|516727962|FG006|Overall Study|Withdrawal by Subject|4|||
143322727|NCT02041195|516727963|FG007|Overall Study|Withdrawal by Subject|3|||
143322728|NCT02041195|516727956|FG000|Overall Study|Unable to comply with study visits|0|||
143322729|NCT02041195|516727957|FG001|Overall Study|Unable to comply with study visits|1|||
143322730|NCT02041195|516727958|FG002|Overall Study|Unable to comply with study visits|0|||
143322731|NCT02041195|516727959|FG003|Overall Study|Unable to comply with study visits|0|||
143322732|NCT02041195|516727960|FG004|Overall Study|Unable to comply with study visits|1|||
143322733|NCT02041195|516727961|FG005|Overall Study|Unable to comply with study visits|0|||
143322734|NCT02041195|516727962|FG006|Overall Study|Unable to comply with study visits|0|||
143322735|NCT02041195|516727963|FG007|Overall Study|Unable to comply with study visits|0|||
143322736|NCT03564496|516727964|FG000|Overall Study|Withdrawal by Subject|1|||
143322737|NCT03564496|516727965|FG001|Overall Study|Withdrawal by Subject|1|||
143322738|NCT03564496|516727966|FG002|Overall Study|Withdrawal by Subject|0|||
143322739|NCT03564496|516727964|FG000|Overall Study|Screen failure|0|||
143322740|NCT03564496|516727965|FG001|Overall Study|Screen failure|3|||
143322741|NCT03564496|516727966|FG002|Overall Study|Screen failure|0|||
143322742|NCT03832010|516727971|FG000|Overall Study|Withdrawal by Subject|2|||
143322743|NCT03832010|516727972|FG001|Overall Study|Withdrawal by Subject|1|||
143322744|NCT03832010|516727973|FG002|Overall Study|Withdrawal by Subject|0|||
143322745|NCT03832010|516727971|FG000|Overall Study|Lost to Follow-up|2|||
143322746|NCT03832010|516727972|FG001|Overall Study|Lost to Follow-up|1|||
143322747|NCT03832010|516727973|FG002|Overall Study|Lost to Follow-up|1|||
143322748|NCT00987467|516727974|FG000|Overall Study|Lost to Follow-up|2|||
143322749|NCT00512135|516727975|FG000|Overall Study|Not Treated|5|||
143322750|NCT00512135|516727975|FG000|Overall Study|Lack of Efficacy|2|||
143322751|NCT00512135|516727975|FG000|Overall Study|Adverse Event|6|||
143322752|NCT00512135|516727975|FG000|Overall Study|Withdrawal by Subject|22|||
143322753|NCT00512135|516727975|FG000|Overall Study|Lost to Follow-up|27|||
143322754|NCT00512135|516727975|FG000|Overall Study|Other|22|||
143322755|NCT00377819|516727976|FG000|Overall Study|Adverse Event|2|||
143322756|NCT00377819|516727977|FG001|Overall Study|Adverse Event|3|||
143322757|NCT00377819|516727976|FG000|Overall Study|Withdrawal by Subject|10|||
143322758|NCT00377819|516727977|FG001|Overall Study|Withdrawal by Subject|4|||
143322759|NCT00377819|516727976|FG000|Overall Study|Death|0|||
143322760|NCT00377819|516727977|FG001|Overall Study|Death|1|||
143322761|NCT00377819|516727976|FG000|Overall Study|Lost to Follow-up|0|||
143322762|NCT00377819|516727977|FG001|Overall Study|Lost to Follow-up|1|||
143322763|NCT00377819|516727976|FG000|Overall Study|Protocol Violation|1|||
143322764|NCT00377819|516727977|FG001|Overall Study|Protocol Violation|1|||
143322765|NCT04495374|516727978|FG000|Overall Study|Protocol Violation|2|||
143322766|NCT04495374|516727979|FG001|Overall Study|Protocol Violation|1|||
143322767|NCT02807948|516727980|FG000|Overall Study|Physician Decision|1|||
143322768|NCT02807948|516727981|FG001|Overall Study|Physician Decision|0|||
143322769|NCT01054820|516727985|FG000|Overall Study|Withdrawal by Subject|2|||
143322770|NCT02624804|516727986|FG000|Overall Study|Screen Failure|5|||
143322771|NCT00996996|516727990|FG000|Overall Study|Progressive Disease|10|||
143322772|NCT00996996|516727990|FG000|Overall Study|Non-compliance|8|||
143322773|NCT00996996|516727990|FG000|Overall Study|Lost to Follow-up|9|||
143322774|NCT00996996|516727990|FG000|Overall Study|Death|5|||
143322775|NCT00996996|516727990|FG000|Overall Study|Did Not Receive Study Medications|1|||
143322776|NCT00760929|516727991|FG000|Overall Study|Adverse Event|2|||
143322777|NCT00760929|516727992|FG001|Overall Study|Adverse Event|0|||
143322778|NCT00760929|516727993|FG002|Overall Study|Adverse Event|6|||
143322779|NCT00760929|516727994|FG003|Overall Study|Adverse Event|10|||
143322780|NCT00760929|516727991|FG000|Overall Study|Lack of Efficacy|0|||
143322781|NCT00760929|516727992|FG001|Overall Study|Lack of Efficacy|2|||
143322782|NCT00760929|516727993|FG002|Overall Study|Lack of Efficacy|1|||
143322783|NCT00760929|516727994|FG003|Overall Study|Lack of Efficacy|0|||
143322784|NCT00760929|516727991|FG000|Overall Study|Withdrawal by Subject|1|||
143322785|NCT00760929|516727992|FG001|Overall Study|Withdrawal by Subject|0|||
143322786|NCT00760929|516727993|FG002|Overall Study|Withdrawal by Subject|9|||
143322787|NCT00760929|516727994|FG003|Overall Study|Withdrawal by Subject|1|||
143322788|NCT00760929|516727991|FG000|Overall Study|Lost to Follow-up|0|||
143322789|NCT00760929|516727992|FG001|Overall Study|Lost to Follow-up|0|||
143322790|NCT00760929|516727993|FG002|Overall Study|Lost to Follow-up|1|||
143322791|NCT00760929|516727994|FG003|Overall Study|Lost to Follow-up|0|||
143322792|NCT00760929|516727991|FG000|Overall Study|Progression of Disease|21|||
143322793|NCT00760929|516727992|FG001|Overall Study|Progression of Disease|26|||
143322794|NCT00760929|516727993|FG002|Overall Study|Progression of Disease|38|||
143322795|NCT00760929|516727994|FG003|Overall Study|Progression of Disease|42|||
143322796|NCT00760929|516727991|FG000|Overall Study|Other|2|||
143322797|NCT00760929|516727992|FG001|Overall Study|Other|0|||
143322798|NCT00760929|516727993|FG002|Overall Study|Other|2|||
143322799|NCT00760929|516727994|FG003|Overall Study|Other|1|||
143322800|NCT00760929|516727991|FG000|Overall Study|Death|0|||
143322801|NCT00760929|516727992|FG001|Overall Study|Death|0|||
143322802|NCT00760929|516727993|FG002|Overall Study|Death|1|||
143322803|NCT00760929|516727994|FG003|Overall Study|Death|0|||
143322804|NCT00760929|516727991|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
143322805|NCT00760929|516727992|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
143322806|NCT00760929|516727993|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
143322807|NCT00760929|516727994|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
143322808|NCT02099838|516727995|FG000|Overall Study|Death|1|||
143322809|NCT02099838|516727996|FG001|Overall Study|Death|0|||
143322810|NCT02099838|516727995|FG000|Overall Study|Lost to Follow-up|3|||
143322811|NCT02099838|516727996|FG001|Overall Study|Lost to Follow-up|1|||
143322812|NCT02099838|516727995|FG000|Overall Study|Withdrawal by Subject|0|||
143322813|NCT02099838|516727996|FG001|Overall Study|Withdrawal by Subject|1|||
143322814|NCT04535037|516727997|FG000|Overall Study|Protocol Violation|1|||
143322815|NCT04535037|516727998|FG001|Overall Study|Protocol Violation|0|||
143322816|NCT04535037|516727997|FG000|Overall Study|Withdrawal by Subject|8|||
143322817|NCT04535037|516727998|FG001|Overall Study|Withdrawal by Subject|9|||
143322818|NCT04535037|516727997|FG000|Overall Study|Migrated / moved from the study area|1|||
143322819|NCT04535037|516727998|FG001|Overall Study|Migrated / moved from the study area|4|||
143322820|NCT04535037|516727997|FG000|Overall Study|Other|2|||
143322821|NCT04535037|516727998|FG001|Overall Study|Other|5|||
143322822|NCT01148810|516727999|FG000|Overall Study|Adverse Event|0|||
143322823|NCT01148810|516728000|FG001|Overall Study|Adverse Event|2|||
143322824|NCT01148810|516727999|FG000|Overall Study|Lack of Efficacy|0|||
143322825|NCT01148810|516728000|FG001|Overall Study|Lack of Efficacy|1|||
143322826|NCT01148810|516727999|FG000|Overall Study|Withdrawal by Subject|0|||
143322827|NCT01148810|516728000|FG001|Overall Study|Withdrawal by Subject|2|||
143322828|NCT01148810|516727999|FG000|Overall Study|Protocol Violation|1|||
143322829|NCT01148810|516728000|FG001|Overall Study|Protocol Violation|0|||
143322830|NCT02348216|516728006|FG000|Overall Study|Death|5|||
143322831|NCT02348216|516728007|FG001|Overall Study|Death|53|||
143322832|NCT02348216|516728008|FG002|Overall Study|Death|11|||
143322833|NCT02348216|516728009|FG003|Overall Study|Death|20|||
143322834|NCT02348216|516728010|FG004|Overall Study|Death|16|||
143322835|NCT02348216|516728011|FG005|Overall Study|Death|32|||
143322836|NCT02348216|516728012|FG006|Overall Study|Death|17|||
143322837|NCT02348216|516728006|FG000|Overall Study|Full consent withdrawal|0|||
143322838|NCT02348216|516728007|FG001|Overall Study|Full consent withdrawal|0|||
143322839|NCT02348216|516728008|FG002|Overall Study|Full consent withdrawal|0|||
143322840|NCT02348216|516728009|FG003|Overall Study|Full consent withdrawal|1|||
143322841|NCT02348216|516728010|FG004|Overall Study|Full consent withdrawal|3|||
143322842|NCT02348216|516728011|FG005|Overall Study|Full consent withdrawal|0|||
143322843|NCT02348216|516728012|FG006|Overall Study|Full consent withdrawal|3|||
143322844|NCT02348216|516728006|FG000|Overall Study|Lost to Follow-up|0|||
143322845|NCT02348216|516728007|FG001|Overall Study|Lost to Follow-up|5|||
143322846|NCT02348216|516728008|FG002|Overall Study|Lost to Follow-up|2|||
143322847|NCT02348216|516728009|FG003|Overall Study|Lost to Follow-up|0|||
143322848|NCT02348216|516728010|FG004|Overall Study|Lost to Follow-up|1|||
143322849|NCT02348216|516728011|FG005|Overall Study|Lost to Follow-up|1|||
143322850|NCT02348216|516728012|FG006|Overall Study|Lost to Follow-up|1|||
143322851|NCT02348216|516728006|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
143322852|NCT02348216|516728007|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
143322853|NCT02348216|516728008|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
143322854|NCT02348216|516728009|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
143322855|NCT02348216|516728010|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
143322856|NCT02348216|516728011|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
143322857|NCT02348216|516728012|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
143322858|NCT02348216|516728006|FG000|Overall Study|Reason not specified|2|||
143322859|NCT02348216|516728007|FG001|Overall Study|Reason not specified|19|||
143322860|NCT02348216|516728008|FG002|Overall Study|Reason not specified|11|||
143322861|NCT02348216|516728009|FG003|Overall Study|Reason not specified|17|||
143322862|NCT02348216|516728010|FG004|Overall Study|Reason not specified|21|||
143322863|NCT02348216|516728011|FG005|Overall Study|Reason not specified|17|||
143322864|NCT02348216|516728012|FG006|Overall Study|Reason not specified|19|||
143322865|NCT02417246|516728014|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
143322866|NCT02417246|516728015|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
143322867|NCT02417246|516728014|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
143322868|NCT02417246|516728015|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
143322869|NCT02417246|516728014|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
143322870|NCT02417246|516728015|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
143322871|NCT02417246|516728014|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
143322872|NCT02417246|516728015|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
143322873|NCT04408469|516728018|FG000|Overall Study|Lost to Follow-up|6|||
143322874|NCT04408469|516728019|FG001|Overall Study|Lost to Follow-up|9|||
143322875|NCT04408469|516728018|FG000|Overall Study|Withdrawal by Subject|6|||
143322876|NCT04408469|516728019|FG001|Overall Study|Withdrawal by Subject|1|||
143322877|NCT04408469|516728018|FG000|Overall Study|Dismissal due to ineligibility|0|||
143322878|NCT04408469|516728019|FG001|Overall Study|Dismissal due to ineligibility|1|||
143322879|NCT04321460|516728020|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
143322880|NCT04321460|516728021|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
143322881|NCT01308749|516728022|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
143322882|NCT01308749|516728023|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
143322883|NCT01308749|516728022|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
143322884|NCT01308749|516728023|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
143322885|NCT01308749|516728022|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
143322886|NCT01308749|516728023|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
143322887|NCT02553330|516728028|FG000|Overall Study|Study Terminated by Sponsor|2|||
143322888|NCT02553330|516728029|FG001|Overall Study|Study Terminated by Sponsor|13|||
143322889|NCT02553330|516728030|FG002|Overall Study|Study Terminated by Sponsor|12|||
143322890|NCT02553330|516728028|FG000|Overall Study|Withdrawal by Subject|3|||
143322891|NCT02553330|516728029|FG001|Overall Study|Withdrawal by Subject|19|||
143322892|NCT02553330|516728030|FG002|Overall Study|Withdrawal by Subject|21|||
143322893|NCT02553330|516728028|FG000|Overall Study|Other|0|||
143322894|NCT02553330|516728029|FG001|Overall Study|Other|1|||
143322895|NCT02553330|516728030|FG002|Overall Study|Other|0|||
143322896|NCT02553330|516728028|FG000|Overall Study|Non compliance to study treatment|0|||
143322897|NCT02553330|516728029|FG001|Overall Study|Non compliance to study treatment|1|||
143322898|NCT02553330|516728030|FG002|Overall Study|Non compliance to study treatment|0|||
143322899|NCT02553330|516728028|FG000|Overall Study|Adverse Event|0|||
143322900|NCT02553330|516728029|FG001|Overall Study|Adverse Event|1|||
143322901|NCT02553330|516728030|FG002|Overall Study|Adverse Event|0|||
143322902|NCT02553330|516728028|FG000|Overall Study|Lost to Follow-up|0|||
143322903|NCT02553330|516728029|FG001|Overall Study|Lost to Follow-up|4|||
143322904|NCT02553330|516728030|FG002|Overall Study|Lost to Follow-up|4|||
143322905|NCT01666002|516728031|FG000|Overall Study|Lost to Follow-up|5|||
143322906|NCT01666002|516728032|FG001|Overall Study|Lost to Follow-up|0|||
143322907|NCT04827212|516728043|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
143322908|NCT04827212|516728044|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
143322909|NCT04827212|516728043|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
143322910|NCT04827212|516728044|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
143322911|NCT00599326|516728053|FG000|Overall Study|Lost to Follow-up|1|||
143322912|NCT00599326|516728053|FG000|Overall Study|Noncompliant|1|||
143322913|NCT00784810|516728054|FG000|Overall Study|Adverse Event|32|||
143322914|NCT00784810|516728055|FG001|Overall Study|Adverse Event|20|||
143322915|NCT00784810|516728054|FG000|Overall Study|Lack of Efficacy|14|||
143322916|NCT00784810|516728055|FG001|Overall Study|Lack of Efficacy|11|||
143322917|NCT00784810|516728054|FG000|Overall Study|Withdrawal by Subject|11|||
143322918|NCT00784810|516728055|FG001|Overall Study|Withdrawal by Subject|9|||
143322919|NCT00784810|516728054|FG000|Overall Study|Administrative|5|||
143322920|NCT00784810|516728055|FG001|Overall Study|Administrative|8|||
143322921|NCT00784810|516728054|FG000|Overall Study|Lost to Follow-up|1|||
143322922|NCT00784810|516728055|FG001|Overall Study|Lost to Follow-up|1|||
143322923|NCT04137380|516728056|FG000|Overall Study|Physician Decision|0|||
143322924|NCT04137380|516728057|FG001|Overall Study|Physician Decision|0|||
143322925|NCT04137380|516728058|FG002|Overall Study|Physician Decision|0|||
143322926|NCT04137380|516728059|FG003|Overall Study|Physician Decision|1|||
143322927|NCT04137380|516728060|FG004|Overall Study|Physician Decision|0|||
143322928|NCT04137380|516728061|FG005|Overall Study|Physician Decision|0|||
143322929|NCT04137380|516728062|FG006|Overall Study|Physician Decision|0|||
143322930|NCT02265705|516728068|FG000|Treatment Period Week 0-24|Adverse Event|3|||
143322931|NCT02265705|516728069|FG001|Treatment Period Week 0-24|Adverse Event|2|||
143322932|NCT02265705|516728070|FG002|Treatment Period Week 0-24|Adverse Event|0|||
143322933|NCT02265705|516728071|FG003|Treatment Period Week 0-24|Adverse Event|0|||
143322934|NCT02265705|516728072|FG004|Treatment Period Week 0-24|Adverse Event|0|||
143322935|NCT02265705|516728073|FG005|Treatment Period Week 0-24|Adverse Event|0|||
143322936|NCT02265705|516728074|FG006|Treatment Period Week 0-24|Adverse Event|0|||
143322937|NCT02265705|516728068|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
143322938|NCT02265705|516728069|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
143322939|NCT02265705|516728070|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
143322940|NCT02265705|516728071|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
143322941|NCT02265705|516728072|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
143322942|NCT02265705|516728073|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
143322943|NCT02265705|516728074|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
143322944|NCT02265705|516728068|FG000|Treatment Period Week 0-24|Physician Decision|1|||
143322945|NCT02265705|516728069|FG001|Treatment Period Week 0-24|Physician Decision|0|||
143322946|NCT02265705|516728070|FG002|Treatment Period Week 0-24|Physician Decision|0|||
143322947|NCT02265705|516728071|FG003|Treatment Period Week 0-24|Physician Decision|0|||
143322948|NCT02265705|516728072|FG004|Treatment Period Week 0-24|Physician Decision|0|||
143322949|NCT02265705|516728073|FG005|Treatment Period Week 0-24|Physician Decision|0|||
143322950|NCT02265705|516728074|FG006|Treatment Period Week 0-24|Physician Decision|0|||
143322951|NCT02265705|516728068|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
143322952|NCT02265705|516728069|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
143322953|NCT02265705|516728070|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
143322954|NCT02265705|516728071|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
143322955|NCT02265705|516728072|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
143322956|NCT02265705|516728073|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
143322957|NCT02265705|516728074|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
143322958|NCT02265705|516728068|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
143322959|NCT02265705|516728069|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
143322960|NCT02265705|516728070|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
143322961|NCT02265705|516728071|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
143322962|NCT02265705|516728072|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
143322963|NCT02265705|516728073|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
143322964|NCT02265705|516728074|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
143322965|NCT02265705|516728068|FG000|Rescue Period|Withdrawal by Subject|0|||
143322966|NCT02265705|516728069|FG001|Rescue Period|Withdrawal by Subject|0|||
143322967|NCT02265705|516728070|FG002|Rescue Period|Withdrawal by Subject|1|||
143322968|NCT02265705|516728071|FG003|Rescue Period|Withdrawal by Subject|0|||
143322969|NCT02265705|516728072|FG004|Rescue Period|Withdrawal by Subject|0|||
143322970|NCT02265705|516728073|FG005|Rescue Period|Withdrawal by Subject|0|||
143322971|NCT02265705|516728074|FG006|Rescue Period|Withdrawal by Subject|0|||
143322972|NCT02265705|516728068|FG000|Rescue Period|Death|0|||
143322973|NCT02265705|516728069|FG001|Rescue Period|Death|0|||
143322974|NCT02265705|516728070|FG002|Rescue Period|Death|1|||
143322975|NCT02265705|516728071|FG003|Rescue Period|Death|0|||
143322976|NCT02265705|516728072|FG004|Rescue Period|Death|0|||
143322977|NCT02265705|516728073|FG005|Rescue Period|Death|0|||
143322978|NCT02265705|516728074|FG006|Rescue Period|Death|0|||
143322979|NCT02265705|516728068|FG000|Rescue Period|Lack of Efficacy|0|||
143322980|NCT02265705|516728069|FG001|Rescue Period|Lack of Efficacy|0|||
143322981|NCT02265705|516728070|FG002|Rescue Period|Lack of Efficacy|1|||
143322982|NCT02265705|516728071|FG003|Rescue Period|Lack of Efficacy|0|||
143322983|NCT02265705|516728072|FG004|Rescue Period|Lack of Efficacy|0|||
143322984|NCT02265705|516728073|FG005|Rescue Period|Lack of Efficacy|0|||
143322985|NCT02265705|516728074|FG006|Rescue Period|Lack of Efficacy|0|||
143322986|NCT02265705|516728068|FG000|Open Label Period|Adverse Event|0|||
143322987|NCT02265705|516728069|FG001|Open Label Period|Adverse Event|0|||
143322988|NCT02265705|516728070|FG002|Open Label Period|Adverse Event|0|||
143322989|NCT02265705|516728071|FG003|Open Label Period|Adverse Event|2|||
143322990|NCT02265705|516728072|FG004|Open Label Period|Adverse Event|2|||
143322991|NCT02265705|516728073|FG005|Open Label Period|Adverse Event|0|||
143322992|NCT02265705|516728074|FG006|Open Label Period|Adverse Event|0|||
143322993|NCT02265705|516728068|FG000|Open Label Period|Physician Decision|0|||
143322994|NCT02265705|516728069|FG001|Open Label Period|Physician Decision|0|||
143322995|NCT02265705|516728070|FG002|Open Label Period|Physician Decision|0|||
143322996|NCT02265705|516728071|FG003|Open Label Period|Physician Decision|0|||
143322997|NCT02265705|516728072|FG004|Open Label Period|Physician Decision|1|||
143322998|NCT02265705|516728073|FG005|Open Label Period|Physician Decision|0|||
143322999|NCT02265705|516728074|FG006|Open Label Period|Physician Decision|0|||
143323000|NCT02265705|516728068|FG000|Open Label Period|Withdrawal by Subject|0|||
143323001|NCT02265705|516728069|FG001|Open Label Period|Withdrawal by Subject|0|||
143323002|NCT02265705|516728070|FG002|Open Label Period|Withdrawal by Subject|0|||
143323003|NCT02265705|516728071|FG003|Open Label Period|Withdrawal by Subject|0|||
143323004|NCT02265705|516728072|FG004|Open Label Period|Withdrawal by Subject|2|||
143323005|NCT02265705|516728073|FG005|Open Label Period|Withdrawal by Subject|0|||
143323006|NCT02265705|516728074|FG006|Open Label Period|Withdrawal by Subject|0|||
143323007|NCT02265705|516728068|FG000|Follow-up Period|Sponsor Decision|0|||
143323008|NCT02265705|516728069|FG001|Follow-up Period|Sponsor Decision|0|||
143323009|NCT02265705|516728070|FG002|Follow-up Period|Sponsor Decision|0|||
143323010|NCT02265705|516728071|FG003|Follow-up Period|Sponsor Decision|0|||
143323011|NCT02265705|516728072|FG004|Follow-up Period|Sponsor Decision|0|||
143323012|NCT02265705|516728073|FG005|Follow-up Period|Sponsor Decision|1|||
143323013|NCT02265705|516728074|FG006|Follow-up Period|Sponsor Decision|6|||
143323014|NCT02265705|516728068|FG000|Follow-up Period|Adverse Event|0|||
143323015|NCT02265705|516728069|FG001|Follow-up Period|Adverse Event|0|||
143323016|NCT02265705|516728070|FG002|Follow-up Period|Adverse Event|0|||
143323017|NCT02265705|516728071|FG003|Follow-up Period|Adverse Event|0|||
143380345|NCT02723955|516940655|FG039|Escalation Phase|Withdrawal by Subject|0|||
143380346|NCT02723955|516940656|FG040|Escalation Phase|Withdrawal by Subject|0|||
143380347|NCT02723955|516940657|FG041|Escalation Phase|Withdrawal by Subject|0|||
143380348|NCT02723955|516940658|FG042|Escalation Phase|Withdrawal by Subject|0|||
143380349|NCT02723955|516940616|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
143380350|NCT02723955|516940617|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
143380351|NCT02723955|516940618|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
143380352|NCT02723955|516940619|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
143380353|NCT02723955|516940620|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
143380354|NCT02723955|516940621|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
143380355|NCT02723955|516940622|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
143380356|NCT02723955|516940623|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
143380357|NCT02723955|516940624|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
143380358|NCT02723955|516940625|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
143380359|NCT02723955|516940626|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
143380360|NCT02723955|516940627|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
143380361|NCT02723955|516940628|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
143380362|NCT02723955|516940629|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
143380363|NCT02723955|516940630|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
143380364|NCT02723955|516940631|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
143380365|NCT02723955|516940632|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
143380366|NCT02723955|516940633|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
143380367|NCT02723955|516940634|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
143380368|NCT02723955|516940635|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
143380369|NCT02723955|516940636|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
143380370|NCT02723955|516940637|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
143380371|NCT02723955|516940638|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
143380372|NCT02723955|516940639|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
143380373|NCT02723955|516940640|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
143380374|NCT02723955|516940641|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
143380375|NCT02723955|516940642|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
143380376|NCT02723955|516940643|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
143380377|NCT02723955|516940644|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
143454247|NCT01712659|517208171|FG003|Dose Escalation|Physician Decision|0|||
143454248|NCT01712659|517208172|FG004|Dose Escalation|Physician Decision|0|||
143454249|NCT01712659|517208168|FG000|Dose Escalation|Unable to take study drug|0|||
143454250|NCT01712659|517208169|FG001|Dose Escalation|Unable to take study drug|1|||
143454251|NCT01712659|517208170|FG002|Dose Escalation|Unable to take study drug|0|||
143454252|NCT01712659|517208171|FG003|Dose Escalation|Unable to take study drug|0|||
143454253|NCT01712659|517208172|FG004|Dose Escalation|Unable to take study drug|0|||
143454254|NCT01712659|517208168|FG000|Dose Expansion|Early disease progression|1|||
143454255|NCT01712659|517208169|FG001|Dose Expansion|Early disease progression|0|||
143454256|NCT01712659|517208170|FG002|Dose Expansion|Early disease progression|0|||
143454257|NCT01712659|517208171|FG003|Dose Expansion|Early disease progression|0|||
143454258|NCT01712659|517208172|FG004|Dose Expansion|Early disease progression|0|||
143380378|NCT02723955|516940645|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
143380379|NCT02723955|516940646|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
143380380|NCT02723955|516940647|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
143380381|NCT02723955|516940648|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
143380382|NCT02723955|516940649|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
143380383|NCT02723955|516940650|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
143380384|NCT02723955|516940651|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
143380385|NCT02723955|516940652|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
143380386|NCT02723955|516940653|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
143380387|NCT02723955|516940654|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
143380388|NCT02723955|516940655|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
143380389|NCT02723955|516940656|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
143380390|NCT02723955|516940657|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
143380391|NCT02723955|516940658|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
143380392|NCT02723955|516940616|FG000|Escalation Phase|Site Closed|0|||
143380393|NCT02723955|516940617|FG001|Escalation Phase|Site Closed|0|||
143380394|NCT02723955|516940618|FG002|Escalation Phase|Site Closed|0|||
143380395|NCT02723955|516940619|FG003|Escalation Phase|Site Closed|0|||
143380396|NCT02723955|516940620|FG004|Escalation Phase|Site Closed|0|||
143380397|NCT02723955|516940621|FG005|Escalation Phase|Site Closed|0|||
143380398|NCT02723955|516940622|FG006|Escalation Phase|Site Closed|0|||
143380399|NCT02723955|516940623|FG007|Escalation Phase|Site Closed|0|||
143380400|NCT02723955|516940624|FG008|Escalation Phase|Site Closed|0|||
143380401|NCT02723955|516940625|FG009|Escalation Phase|Site Closed|0|||
143380402|NCT02723955|516940626|FG010|Escalation Phase|Site Closed|0|||
143380403|NCT02723955|516940627|FG011|Escalation Phase|Site Closed|0|||
143380404|NCT02723955|516940628|FG012|Escalation Phase|Site Closed|0|||
143323018|NCT02265705|516728072|FG004|Follow-up Period|Adverse Event|0|||
143323019|NCT02265705|516728073|FG005|Follow-up Period|Adverse Event|0|||
143323020|NCT02265705|516728074|FG006|Follow-up Period|Adverse Event|3|||
143323021|NCT02265705|516728068|FG000|Follow-up Period|Physician Decision|0|||
143323022|NCT02265705|516728069|FG001|Follow-up Period|Physician Decision|0|||
143323023|NCT02265705|516728070|FG002|Follow-up Period|Physician Decision|0|||
143323024|NCT02265705|516728071|FG003|Follow-up Period|Physician Decision|0|||
143323025|NCT02265705|516728072|FG004|Follow-up Period|Physician Decision|0|||
143323026|NCT02265705|516728073|FG005|Follow-up Period|Physician Decision|0|||
143323027|NCT02265705|516728074|FG006|Follow-up Period|Physician Decision|1|||
143323028|NCT02265705|516728068|FG000|Follow-up Period|Withdrawal by Subject|0|||
143323029|NCT02265705|516728069|FG001|Follow-up Period|Withdrawal by Subject|0|||
143323030|NCT02265705|516728070|FG002|Follow-up Period|Withdrawal by Subject|0|||
143323031|NCT02265705|516728071|FG003|Follow-up Period|Withdrawal by Subject|0|||
143323032|NCT02265705|516728072|FG004|Follow-up Period|Withdrawal by Subject|0|||
143323033|NCT02265705|516728073|FG005|Follow-up Period|Withdrawal by Subject|0|||
143323034|NCT02265705|516728074|FG006|Follow-up Period|Withdrawal by Subject|1|||
143323035|NCT00779246|516728075|FG000|Overall Study|Missing sufficient data for analysis|33|||
143323036|NCT00779246|516728076|FG001|Overall Study|Missing sufficient data for analysis|53|||
143323037|NCT00148343|516728077|FG000|Overall Study|Withdrawal by Subject|12|||
143323038|NCT00148343|516728078|FG001|Overall Study|Withdrawal by Subject|7|||
143323039|NCT00148343|516728077|FG000|Overall Study|Physician Decision|3|||
143323040|NCT00148343|516728078|FG001|Overall Study|Physician Decision|4|||
143323041|NCT03579459|516728079|FG000|Overall Study|Adverse Event|7|||
143323042|NCT03579459|516728080|FG001|Overall Study|Adverse Event|6|||
143323043|NCT03579459|516728081|FG002|Overall Study|Adverse Event|2|||
143323044|NCT03579459|516728082|FG003|Overall Study|Adverse Event|6|||
143323045|NCT03579459|516728079|FG000|Overall Study|Death|1|||
143323046|NCT03579459|516728080|FG001|Overall Study|Death|0|||
143323047|NCT03579459|516728081|FG002|Overall Study|Death|1|||
143323048|NCT03579459|516728082|FG003|Overall Study|Death|2|||
143323049|NCT03579459|516728079|FG000|Overall Study|Lost to Follow-up|6|||
143323050|NCT03579459|516728080|FG001|Overall Study|Lost to Follow-up|2|||
143323051|NCT03579459|516728081|FG002|Overall Study|Lost to Follow-up|4|||
143323052|NCT03579459|516728082|FG003|Overall Study|Lost to Follow-up|1|||
143323053|NCT03579459|516728079|FG000|Overall Study|Physician Decision|0|||
143323054|NCT03579459|516728080|FG001|Overall Study|Physician Decision|1|||
143380405|NCT02723955|516940629|FG013|Escalation Phase|Site Closed|0|||
143380406|NCT02723955|516940630|FG014|Escalation Phase|Site Closed|0|||
143323055|NCT03579459|516728081|FG002|Overall Study|Physician Decision|0|||
143323056|NCT03579459|516728082|FG003|Overall Study|Physician Decision|1|||
143323057|NCT03579459|516728079|FG000|Overall Study|Protocol Violation|1|||
143323058|NCT03579459|516728080|FG001|Overall Study|Protocol Violation|2|||
143323059|NCT03579459|516728081|FG002|Overall Study|Protocol Violation|3|||
143323060|NCT03579459|516728082|FG003|Overall Study|Protocol Violation|5|||
143323061|NCT03579459|516728079|FG000|Overall Study|Withdrawal by Subject|12|||
143323062|NCT03579459|516728080|FG001|Overall Study|Withdrawal by Subject|8|||
143323063|NCT03579459|516728081|FG002|Overall Study|Withdrawal by Subject|11|||
143323064|NCT03579459|516728082|FG003|Overall Study|Withdrawal by Subject|8|||
143323065|NCT03579459|516728079|FG000|Overall Study|Medication error without associated adverse event|2|||
143323066|NCT03579459|516728080|FG001|Overall Study|Medication error without associated adverse event|1|||
143323067|NCT03579459|516728081|FG002|Overall Study|Medication error without associated adverse event|1|||
143323068|NCT03579459|516728082|FG003|Overall Study|Medication error without associated adverse event|0|||
143323069|NCT03579459|516728079|FG000|Overall Study|Other|0|||
143323070|NCT03579459|516728080|FG001|Overall Study|Other|1|||
143323071|NCT03579459|516728081|FG002|Overall Study|Other|1|||
143323072|NCT03579459|516728082|FG003|Overall Study|Other|0|||
143323073|NCT03579459|516728079|FG000|Overall Study|Randomized not vaccinated|0|||
143323074|NCT03579459|516728080|FG001|Overall Study|Randomized not vaccinated|2|||
143323075|NCT03579459|516728081|FG002|Overall Study|Randomized not vaccinated|0|||
143323076|NCT03579459|516728082|FG003|Overall Study|Randomized not vaccinated|1|||
143323077|NCT02844946|516728084|FG000|Overall Study|Lost to Follow-up|7|||
143323078|NCT02844946|516728085|FG001|Overall Study|Lost to Follow-up|0|||
143323079|NCT02806986|516728086|FG000|Treatment Stage 1|Adverse Event|1|||
143323080|NCT02806986|516728086|FG000|Treatment Stage 2|Adverse Event|3|||
143323081|NCT02806986|516728086|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
143323082|NCT00346034|516728087|FG000|Overall Study|Adverse Event|34|||
143323083|NCT00346034|516728087|FG000|Overall Study|Lack of Efficacy|8|||
143323084|NCT00346034|516728087|FG000|Overall Study|Withdrawal by Subject|13|||
143323085|NCT00346034|516728087|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
143323086|NCT00346034|516728087|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
143323087|NCT04000165|516728088|FG000|Overall Study|Physician Decision|1|||
143323088|NCT04000165|516728088|FG000|Overall Study|Withdrawal by Subject|1|||
143323089|NCT00941603|516728089|FG000|Overall Study|Adverse Event|10|||
143323090|NCT00941603|516728090|FG001|Overall Study|Adverse Event|15|||
143323091|NCT00941603|516728091|FG002|Overall Study|Adverse Event|5|||
143323092|NCT00941603|516728092|FG003|Overall Study|Adverse Event|1|||
143323093|NCT00941603|516728093|FG004|Overall Study|Adverse Event|4|||
143323094|NCT00941603|516728094|FG005|Overall Study|Adverse Event|0|||
143323095|NCT00941603|516728089|FG000|Overall Study|Lost to Follow-up|0|||
143323096|NCT00941603|516728090|FG001|Overall Study|Lost to Follow-up|0|||
143323097|NCT00941603|516728091|FG002|Overall Study|Lost to Follow-up|0|||
143323098|NCT00941603|516728092|FG003|Overall Study|Lost to Follow-up|1|||
143323099|NCT00941603|516728093|FG004|Overall Study|Lost to Follow-up|0|||
143323100|NCT00941603|516728094|FG005|Overall Study|Lost to Follow-up|2|||
143323101|NCT00941603|516728089|FG000|Overall Study|Withdrawal by Subject|0|||
143323102|NCT00941603|516728090|FG001|Overall Study|Withdrawal by Subject|0|||
143323103|NCT00941603|516728091|FG002|Overall Study|Withdrawal by Subject|0|||
143323104|NCT00941603|516728092|FG003|Overall Study|Withdrawal by Subject|2|||
143323105|NCT00941603|516728093|FG004|Overall Study|Withdrawal by Subject|0|||
143323106|NCT00941603|516728094|FG005|Overall Study|Withdrawal by Subject|1|||
143323107|NCT00941603|516728089|FG000|Overall Study|Protocol Violation|0|||
143323108|NCT00941603|516728090|FG001|Overall Study|Protocol Violation|1|||
143323109|NCT00941603|516728091|FG002|Overall Study|Protocol Violation|0|||
143323110|NCT00941603|516728092|FG003|Overall Study|Protocol Violation|0|||
143323111|NCT00941603|516728093|FG004|Overall Study|Protocol Violation|0|||
143323112|NCT00941603|516728094|FG005|Overall Study|Protocol Violation|0|||
143323113|NCT00941603|516728089|FG000|Overall Study|Did not meet protocol eligibility|1|||
143323114|NCT00941603|516728090|FG001|Overall Study|Did not meet protocol eligibility|0|||
143323115|NCT00941603|516728091|FG002|Overall Study|Did not meet protocol eligibility|0|||
143323116|NCT00941603|516728092|FG003|Overall Study|Did not meet protocol eligibility|0|||
143323117|NCT00941603|516728093|FG004|Overall Study|Did not meet protocol eligibility|0|||
143323118|NCT00941603|516728094|FG005|Overall Study|Did not meet protocol eligibility|0|||
143323119|NCT00407537|516728095|FG000|Overall Study|Death|5|||
143323120|NCT00407537|516728096|FG001|Overall Study|Death|2|||
143323121|NCT00407537|516728095|FG000|Overall Study|Adverse Event|36|||
143323122|NCT00407537|516728096|FG001|Overall Study|Adverse Event|0|||
143323123|NCT00407537|516728095|FG000|Overall Study|Lost to Follow-up|12|||
143323124|NCT00407537|516728096|FG001|Overall Study|Lost to Follow-up|19|||
143323125|NCT00407537|516728095|FG000|Overall Study|Other|6|||
143323126|NCT00407537|516728096|FG001|Overall Study|Other|7|||
143323127|NCT00407537|516728095|FG000|Overall Study|Withdrawal by Subject|34|||
143323128|NCT00407537|516728096|FG001|Overall Study|Withdrawal by Subject|16|||
143323129|NCT01753193|516728097|FG000|Overall Study|Withdrawal by Subject|23|||
143323130|NCT01753193|516728097|FG000|Overall Study|Lost to Follow-up|6|||
143323131|NCT01753193|516728097|FG000|Overall Study|Death|1|||
143323132|NCT01753193|516728097|FG000|Overall Study|Other|16|||
143323133|NCT00583557|516728098|FG000|Overall Study|Withdrawal by Subject|18|||
143323134|NCT00583557|516728098|FG000|Overall Study|Adverse Event|9|||
143323135|NCT00583557|516728098|FG000|Overall Study|Lack of Efficacy|31|||
143323136|NCT00583557|516728098|FG000|Overall Study|Lack of Compliance|5|||
143323137|NCT00583557|516728098|FG000|Overall Study|Other|5|||
143323138|NCT00583557|516728098|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
143380407|NCT02723955|516940631|FG015|Escalation Phase|Site Closed|1|||
143380408|NCT02723955|516940632|FG016|Escalation Phase|Site Closed|0|||
143380409|NCT02723955|516940633|FG017|Escalation Phase|Site Closed|2|||
143380410|NCT02723955|516940634|FG018|Escalation Phase|Site Closed|0|||
143380411|NCT02723955|516940635|FG019|Escalation Phase|Site Closed|0|||
143380412|NCT02723955|516940636|FG020|Escalation Phase|Site Closed|1|||
143380413|NCT02723955|516940637|FG021|Escalation Phase|Site Closed|0|||
143380414|NCT02723955|516940638|FG022|Escalation Phase|Site Closed|0|||
143380415|NCT02723955|516940639|FG023|Escalation Phase|Site Closed|0|||
143380416|NCT02723955|516940640|FG024|Escalation Phase|Site Closed|3|||
143380417|NCT02723955|516940641|FG025|Escalation Phase|Site Closed|1|||
143380418|NCT02723955|516940642|FG026|Escalation Phase|Site Closed|3|||
143380419|NCT02723955|516940643|FG027|Escalation Phase|Site Closed|1|||
143380420|NCT02723955|516940644|FG028|Escalation Phase|Site Closed|1|||
143380421|NCT02723955|516940645|FG029|Escalation Phase|Site Closed|0|||
143380422|NCT02723955|516940646|FG030|Escalation Phase|Site Closed|0|||
143380423|NCT02723955|516940647|FG031|Escalation Phase|Site Closed|0|||
143380424|NCT02723955|516940648|FG032|Escalation Phase|Site Closed|0|||
143380425|NCT02723955|516940649|FG033|Escalation Phase|Site Closed|0|||
143380426|NCT02723955|516940650|FG034|Escalation Phase|Site Closed|0|||
143380427|NCT02723955|516940651|FG035|Escalation Phase|Site Closed|0|||
143380428|NCT02723955|516940652|FG036|Escalation Phase|Site Closed|0|||
143380429|NCT02723955|516940653|FG037|Escalation Phase|Site Closed|0|||
143380430|NCT02723955|516940654|FG038|Escalation Phase|Site Closed|0|||
143380431|NCT02723955|516940655|FG039|Escalation Phase|Site Closed|0|||
143380432|NCT02723955|516940656|FG040|Escalation Phase|Site Closed|0|||
143380433|NCT02723955|516940657|FG041|Escalation Phase|Site Closed|0|||
143380434|NCT02723955|516940658|FG042|Escalation Phase|Site Closed|0|||
143380435|NCT02723955|516940616|FG000|Expansion Phase|Death|0|||
143380436|NCT02723955|516940617|FG001|Expansion Phase|Death|0|||
143380437|NCT02723955|516940618|FG002|Expansion Phase|Death|0|||
143380438|NCT02723955|516940619|FG003|Expansion Phase|Death|0|||
143380439|NCT02723955|516940620|FG004|Expansion Phase|Death|0|||
143380440|NCT02723955|516940621|FG005|Expansion Phase|Death|0|||
143380441|NCT02723955|516940622|FG006|Expansion Phase|Death|0|||
143380442|NCT02723955|516940623|FG007|Expansion Phase|Death|0|||
143380443|NCT02723955|516940624|FG008|Expansion Phase|Death|0|||
143380444|NCT02723955|516940625|FG009|Expansion Phase|Death|25|||
143380445|NCT02723955|516940626|FG010|Expansion Phase|Death|69|||
143380446|NCT02723955|516940627|FG011|Expansion Phase|Death|48|||
143380447|NCT02723955|516940628|FG012|Expansion Phase|Death|0|||
143380448|NCT02723955|516940629|FG013|Expansion Phase|Death|0|||
143380449|NCT02723955|516940630|FG014|Expansion Phase|Death|0|||
143380450|NCT02723955|516940631|FG015|Expansion Phase|Death|0|||
143380451|NCT02723955|516940632|FG016|Expansion Phase|Death|0|||
143380452|NCT02723955|516940633|FG017|Expansion Phase|Death|0|||
143380453|NCT02723955|516940634|FG018|Expansion Phase|Death|0|||
143380454|NCT02723955|516940635|FG019|Expansion Phase|Death|0|||
143380455|NCT02723955|516940636|FG020|Expansion Phase|Death|0|||
143380456|NCT02723955|516940637|FG021|Expansion Phase|Death|0|||
143380457|NCT02723955|516940638|FG022|Expansion Phase|Death|0|||
143380458|NCT02723955|516940639|FG023|Expansion Phase|Death|0|||
143380459|NCT02723955|516940640|FG024|Expansion Phase|Death|0|||
143380460|NCT02723955|516940641|FG025|Expansion Phase|Death|0|||
143380461|NCT02723955|516940642|FG026|Expansion Phase|Death|0|||
143380462|NCT02723955|516940643|FG027|Expansion Phase|Death|0|||
143380463|NCT02723955|516940644|FG028|Expansion Phase|Death|0|||
143380464|NCT02723955|516940645|FG029|Expansion Phase|Death|12|||
143380465|NCT02723955|516940646|FG030|Expansion Phase|Death|202|||
143380466|NCT02723955|516940647|FG031|Expansion Phase|Death|31|||
143380467|NCT02723955|516940648|FG032|Expansion Phase|Death|17|||
143380468|NCT02723955|516940649|FG033|Expansion Phase|Death|2|||
143380469|NCT02723955|516940650|FG034|Expansion Phase|Death|3|||
143380470|NCT02723955|516940651|FG035|Expansion Phase|Death|3|||
143380471|NCT02723955|516940652|FG036|Expansion Phase|Death|1|||
143380472|NCT02723955|516940653|FG037|Expansion Phase|Death|0|||
143380473|NCT02723955|516940654|FG038|Expansion Phase|Death|0|||
143380474|NCT02723955|516940655|FG039|Expansion Phase|Death|0|||
143380475|NCT02723955|516940656|FG040|Expansion Phase|Death|0|||
143380476|NCT02723955|516940657|FG041|Expansion Phase|Death|0|||
143380477|NCT02723955|516940658|FG042|Expansion Phase|Death|0|||
143380478|NCT02723955|516940616|FG000|Expansion Phase|Lost to Follow-up|0|||
143380479|NCT02723955|516940617|FG001|Expansion Phase|Lost to Follow-up|0|||
143380480|NCT02723955|516940618|FG002|Expansion Phase|Lost to Follow-up|0|||
143380481|NCT02723955|516940619|FG003|Expansion Phase|Lost to Follow-up|0|||
143380482|NCT02723955|516940620|FG004|Expansion Phase|Lost to Follow-up|0|||
143380483|NCT02723955|516940621|FG005|Expansion Phase|Lost to Follow-up|0|||
143380484|NCT02723955|516940622|FG006|Expansion Phase|Lost to Follow-up|0|||
143380485|NCT02723955|516940623|FG007|Expansion Phase|Lost to Follow-up|0|||
143323139|NCT01131312|516728099|FG000|Overall Study|Lost to Follow-up|425|||
143323140|NCT01131312|516728100|FG001|Overall Study|Lost to Follow-up|229|||
143323141|NCT01131312|516728101|FG002|Overall Study|Lost to Follow-up|351|||
143323142|NCT02347761|516728102|FG000|All Collected|Death|1|||
143323143|NCT02347761|516728103|FG001|All Collected|Death|0|||
143323144|NCT02347761|516728104|FG002|All Collected|Death|0|||
143323145|NCT02347761|516728102|FG000|All Collected|Lost to Follow-up|3|||
143323146|NCT02347761|516728103|FG001|All Collected|Lost to Follow-up|2|||
143323147|NCT02347761|516728104|FG002|All Collected|Lost to Follow-up|3|||
143323148|NCT02347761|516728102|FG000|All Collected|Withdrawal by Subject|11|||
143323149|NCT02347761|516728103|FG001|All Collected|Withdrawal by Subject|11|||
143323150|NCT02347761|516728104|FG002|All Collected|Withdrawal by Subject|22|||
143323151|NCT02347761|516728102|FG000|All Collected|invetigator disretion|2|||
143323152|NCT02347761|516728103|FG001|All Collected|invetigator disretion|0|||
143323153|NCT02347761|516728104|FG002|All Collected|invetigator disretion|0|||
143323154|NCT02347761|516728102|FG000|All Collected|instillation site pain|0|||
143323155|NCT02347761|516728103|FG001|All Collected|instillation site pain|0|||
143323156|NCT02347761|516728104|FG002|All Collected|instillation site pain|1|||
143323157|NCT02347761|516728102|FG000|All Collected|exacerbation of COPD|0|||
143323158|NCT02347761|516728103|FG001|All Collected|exacerbation of COPD|0|||
143323159|NCT02347761|516728104|FG002|All Collected|exacerbation of COPD|1|||
143323160|NCT02347761|516728102|FG000|All Collected|moved/travel|0|||
143323161|NCT02347761|516728103|FG001|All Collected|moved/travel|1|||
143323162|NCT02347761|516728104|FG002|All Collected|moved/travel|0|||
143323163|NCT02347761|516728102|FG000|On Study Treatment|Lack of Efficacy|2|||
143323164|NCT02347761|516728103|FG001|On Study Treatment|Lack of Efficacy|3|||
143323165|NCT02347761|516728104|FG002|On Study Treatment|Lack of Efficacy|4|||
143323166|NCT02347761|516728102|FG000|On Study Treatment|non-compliance with study medication|0|||
143323167|NCT02347761|516728103|FG001|On Study Treatment|non-compliance with study medication|0|||
143323168|NCT02347761|516728104|FG002|On Study Treatment|non-compliance with study medication|2|||
143323169|NCT02347761|516728102|FG000|On Study Treatment|Withdrawal by Subject|7|||
143323170|NCT02347761|516728103|FG001|On Study Treatment|Withdrawal by Subject|3|||
143323171|NCT02347761|516728104|FG002|On Study Treatment|Withdrawal by Subject|5|||
143323172|NCT02347761|516728102|FG000|On Study Treatment|move/travel|2|||
143323173|NCT02347761|516728103|FG001|On Study Treatment|move/travel|6|||
143323174|NCT02347761|516728104|FG002|On Study Treatment|move/travel|5|||
143323175|NCT02347761|516728102|FG000|On Study Treatment|dissastisfaction with device|2|||
143323176|NCT02347761|516728103|FG001|On Study Treatment|dissastisfaction with device|1|||
143323177|NCT02347761|516728104|FG002|On Study Treatment|dissastisfaction with device|4|||
143323178|NCT02347761|516728102|FG000|On Study Treatment|Lost to Follow-up|2|||
143323179|NCT02347761|516728103|FG001|On Study Treatment|Lost to Follow-up|1|||
143323180|NCT02347761|516728104|FG002|On Study Treatment|Lost to Follow-up|1|||
143323181|NCT02347761|516728102|FG000|On Study Treatment|investigator discretion|2|||
143323182|NCT02347761|516728103|FG001|On Study Treatment|investigator discretion|0|||
143323183|NCT02347761|516728104|FG002|On Study Treatment|investigator discretion|0|||
143323184|NCT02347761|516728102|FG000|On Study Treatment|durg not working|0|||
143323185|NCT02347761|516728103|FG001|On Study Treatment|durg not working|1|||
143323186|NCT02347761|516728104|FG002|On Study Treatment|durg not working|1|||
143323187|NCT02347761|516728102|FG000|On Study Treatment|Adverse Event|10|||
143323188|NCT02347761|516728103|FG001|On Study Treatment|Adverse Event|8|||
143323189|NCT02347761|516728104|FG002|On Study Treatment|Adverse Event|20|||
143323190|NCT03879798|516728105|FG000|Overall Study|Adverse Event|0|||
143323191|NCT03879798|516728106|FG001|Overall Study|Adverse Event|0|||
143323192|NCT03879798|516728107|FG002|Overall Study|Adverse Event|0|||
143323193|NCT03879798|516728108|FG003|Overall Study|Adverse Event|0|||
143323194|NCT03879798|516728109|FG004|Overall Study|Adverse Event|0|||
143323195|NCT03879798|516728110|FG005|Overall Study|Adverse Event|1|||
143323196|NCT03879798|516728105|FG000|Overall Study|Lack of Efficacy|0|||
143323197|NCT03879798|516728106|FG001|Overall Study|Lack of Efficacy|0|||
143380486|NCT02723955|516940624|FG008|Expansion Phase|Lost to Follow-up|0|||
143380487|NCT02723955|516940625|FG009|Expansion Phase|Lost to Follow-up|0|||
143380488|NCT02723955|516940626|FG010|Expansion Phase|Lost to Follow-up|4|||
143323198|NCT03879798|516728107|FG002|Overall Study|Lack of Efficacy|0|||
143323199|NCT03879798|516728108|FG003|Overall Study|Lack of Efficacy|0|||
143323200|NCT03879798|516728109|FG004|Overall Study|Lack of Efficacy|0|||
143323201|NCT03879798|516728110|FG005|Overall Study|Lack of Efficacy|1|||
143323202|NCT03879798|516728105|FG000|Overall Study|Withdrawal by Subject|0|||
143323203|NCT03879798|516728106|FG001|Overall Study|Withdrawal by Subject|0|||
143323204|NCT03879798|516728107|FG002|Overall Study|Withdrawal by Subject|0|||
143323205|NCT03879798|516728108|FG003|Overall Study|Withdrawal by Subject|0|||
143323206|NCT03879798|516728109|FG004|Overall Study|Withdrawal by Subject|0|||
143323207|NCT03879798|516728110|FG005|Overall Study|Withdrawal by Subject|1|||
143323208|NCT03264989|516728111|FG000|Overall Study|Lost to Follow-up|1|||
143323209|NCT03264989|516728112|FG001|Overall Study|Lost to Follow-up|0|||
143323210|NCT03264989|516728111|FG000|Overall Study|New Therapy for study Indication|1|||
143323211|NCT03264989|516728112|FG001|Overall Study|New Therapy for study Indication|0|||
143380489|NCT02723955|516940627|FG011|Expansion Phase|Lost to Follow-up|1|||
143323212|NCT03264989|516728111|FG000|Overall Study|Protocol Violation|0|||
143323213|NCT03264989|516728112|FG001|Overall Study|Protocol Violation|1|||
143323214|NCT03264989|516728111|FG000|Overall Study|Patient decision|13|||
143323215|NCT03264989|516728112|FG001|Overall Study|Patient decision|0|||
143323216|NCT03264989|516728111|FG000|Overall Study|Physician Decision|6|||
143323217|NCT03264989|516728112|FG001|Overall Study|Physician Decision|4|||
143323218|NCT03264989|516728111|FG000|Overall Study|Adverse Event|2|||
143323219|NCT03264989|516728112|FG001|Overall Study|Adverse Event|1|||
143323220|NCT03264989|516728111|FG000|Overall Study|Death|1|||
143323221|NCT03264989|516728112|FG001|Overall Study|Death|1|||
143323222|NCT03264989|516728111|FG000|Overall Study|Pregnancy|2|||
143323223|NCT03264989|516728112|FG001|Overall Study|Pregnancy|0|||
143323224|NCT03264989|516728111|FG000|Overall Study|End of Study|19|||
143323225|NCT03264989|516728112|FG001|Overall Study|End of Study|5|||
143323226|NCT01343056|516728115|FG000|Overall Study|Lost to Follow-up|7|||
143323227|NCT01343056|516728116|FG001|Overall Study|Lost to Follow-up|5|||
143323228|NCT01343056|516728117|FG002|Overall Study|Lost to Follow-up|3|||
143323229|NCT01343056|516728118|FG003|Overall Study|Lost to Follow-up|9|||
143323230|NCT00413413|516728122|FG000|Single-Blind|Adverse Event|0|||
143323231|NCT00413413|516728123|FG001|Single-Blind|Adverse Event|9|||
143323232|NCT00413413|516728124|FG002|Single-Blind|Adverse Event|0|||
143323233|NCT00413413|516728122|FG000|Single-Blind|Lack of Efficacy|0|||
143323234|NCT00413413|516728123|FG001|Single-Blind|Lack of Efficacy|5|||
143323235|NCT00413413|516728124|FG002|Single-Blind|Lack of Efficacy|0|||
143323236|NCT00413413|516728122|FG000|Single-Blind|Subject no longer requires study drug|0|||
143323237|NCT00413413|516728123|FG001|Single-Blind|Subject no longer requires study drug|151|||
143323238|NCT00413413|516728124|FG002|Single-Blind|Subject no longer requires study drug|0|||
143323239|NCT00413413|516728122|FG000|Single-Blind|Protocol Violation|0|||
143323240|NCT00413413|516728123|FG001|Single-Blind|Protocol Violation|16|||
143323241|NCT00413413|516728124|FG002|Single-Blind|Protocol Violation|0|||
143323242|NCT00413413|516728122|FG000|Single-Blind|Withdrawal by Subject|0|||
143323243|NCT00413413|516728123|FG001|Single-Blind|Withdrawal by Subject|27|||
143323244|NCT00413413|516728124|FG002|Single-Blind|Withdrawal by Subject|0|||
143323245|NCT00413413|516728122|FG000|Single-Blind|Lost to Follow-up|0|||
143323246|NCT00413413|516728123|FG001|Single-Blind|Lost to Follow-up|8|||
143323247|NCT00413413|516728124|FG002|Single-Blind|Lost to Follow-up|0|||
143323248|NCT00413413|516728122|FG000|Double-Blind|Adverse Event|6|||
143323249|NCT00413413|516728123|FG001|Double-Blind|Adverse Event|0|||
143323250|NCT00413413|516728124|FG002|Double-Blind|Adverse Event|5|||
143323251|NCT00413413|516728122|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
143323252|NCT00413413|516728123|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
143323253|NCT00413413|516728124|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
143323254|NCT00413413|516728122|FG000|Double-Blind|Protocol deviation|1|||
143323255|NCT00413413|516728123|FG001|Double-Blind|Protocol deviation|2|||
143323256|NCT00413413|516728124|FG002|Double-Blind|Protocol deviation|1|||
143323257|NCT00413413|516728122|FG000|Double-Blind|Subject withdrew consent|4|||
143323258|NCT00413413|516728123|FG001|Double-Blind|Subject withdrew consent|6|||
143323259|NCT00413413|516728124|FG002|Double-Blind|Subject withdrew consent|9|||
143323260|NCT00413413|516728122|FG000|Double-Blind|Lost to Follow-up|3|||
143323261|NCT00413413|516728123|FG001|Double-Blind|Lost to Follow-up|4|||
143323262|NCT00413413|516728124|FG002|Double-Blind|Lost to Follow-up|2|||
143323263|NCT01040130|516728125|FG000|Overall Study|Adverse Event|1|||
143323264|NCT01040130|516728126|FG001|Overall Study|Adverse Event|1|||
143323265|NCT01040130|516728127|FG002|Overall Study|Adverse Event|0|||
143323266|NCT01040130|516728128|FG003|Overall Study|Adverse Event|5|||
143323267|NCT01040130|516728129|FG004|Overall Study|Adverse Event|0|||
143323268|NCT01040130|516728130|FG005|Overall Study|Adverse Event|3|||
143323269|NCT01040130|516728125|FG000|Overall Study|Protocol Violation|0|||
143323270|NCT01040130|516728126|FG001|Overall Study|Protocol Violation|0|||
143323271|NCT01040130|516728127|FG002|Overall Study|Protocol Violation|2|||
143323272|NCT01040130|516728128|FG003|Overall Study|Protocol Violation|0|||
143323273|NCT01040130|516728129|FG004|Overall Study|Protocol Violation|0|||
143323274|NCT01040130|516728130|FG005|Overall Study|Protocol Violation|0|||
143323275|NCT01040130|516728125|FG000|Overall Study|Withdrawal by Subject|0|||
143323276|NCT01040130|516728126|FG001|Overall Study|Withdrawal by Subject|2|||
143323277|NCT01040130|516728127|FG002|Overall Study|Withdrawal by Subject|0|||
143323278|NCT01040130|516728128|FG003|Overall Study|Withdrawal by Subject|0|||
143323279|NCT01040130|516728129|FG004|Overall Study|Withdrawal by Subject|0|||
143323280|NCT01040130|516728130|FG005|Overall Study|Withdrawal by Subject|1|||
143323281|NCT01040130|516728125|FG000|Overall Study|Other reasons not listed above|2|||
143323282|NCT01040130|516728126|FG001|Overall Study|Other reasons not listed above|0|||
143323283|NCT01040130|516728127|FG002|Overall Study|Other reasons not listed above|0|||
143323284|NCT01040130|516728128|FG003|Overall Study|Other reasons not listed above|0|||
143323285|NCT01040130|516728129|FG004|Overall Study|Other reasons not listed above|0|||
143323286|NCT01040130|516728130|FG005|Overall Study|Other reasons not listed above|0|||
143323287|NCT03029208|516728131|FG000|Overall Study|Withdrawal by Subject|2|||
143323288|NCT03029208|516728132|FG001|Overall Study|Withdrawal by Subject|3|||
143323289|NCT03029208|516728131|FG000|Overall Study|Lost to Follow-up|0|||
143323290|NCT03029208|516728132|FG001|Overall Study|Lost to Follow-up|1|||
143323291|NCT03207750|516728135|FG000|Overall Study|Adverse Event|3|||
143323292|NCT03207750|516728136|FG001|Overall Study|Adverse Event|2|||
143323293|NCT03207750|516728135|FG000|Overall Study|Lost to Follow-up|21|||
143323294|NCT03207750|516728136|FG001|Overall Study|Lost to Follow-up|29|||
143323295|NCT03207750|516728135|FG000|Overall Study|Protocol Violation|0|||
143323296|NCT03207750|516728136|FG001|Overall Study|Protocol Violation|1|||
143323297|NCT03207750|516728135|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
143323298|NCT03207750|516728136|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
143323299|NCT03207750|516728135|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
143323300|NCT03207750|516728136|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
143323301|NCT03207750|516728135|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
143323302|NCT03207750|516728136|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
143323303|NCT03207750|516728135|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
143323304|NCT03207750|516728136|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
143323305|NCT03207750|516728135|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
143323306|NCT03207750|516728136|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
143323307|NCT02493361|516728137|FG000|Overall Study|Withdrawal by Subject|3|||
143323308|NCT02334748|516728138|FG000|Overall Study|Adverse Event|1|||
143323309|NCT02334748|516728138|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
143323310|NCT02334748|516728138|FG000|Overall Study|Patient no longer required study drug|2|||
143323311|NCT02334748|516728138|FG000|Overall Study|Lack of Efficacy|4|||
143323312|NCT01046643|516728139|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
143323313|NCT01046643|516728140|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
143323314|NCT01046643|516728141|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
143323315|NCT01046643|516728142|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
143323316|NCT01985126|516728151|FG000|Overall Study|Death|15|||
143323317|NCT01985126|516728152|FG001|Overall Study|Death|69|||
143323318|NCT01985126|516728151|FG000|Overall Study|Lost to Follow-up|0|||
143323319|NCT01985126|516728152|FG001|Overall Study|Lost to Follow-up|8|||
143323320|NCT01985126|516728151|FG000|Overall Study|Study Terminated By Sponsor|1|||
143323321|NCT01985126|516728152|FG001|Overall Study|Study Terminated By Sponsor|22|||
143323322|NCT01985126|516728151|FG000|Overall Study|Withdrawal by Subject|2|||
143323323|NCT01985126|516728152|FG001|Overall Study|Withdrawal by Subject|7|||
143323324|NCT04102501|516728153|FG000|Overall Study|Withdrawal by Subject|7|||
143323325|NCT04102501|516728154|FG001|Overall Study|Withdrawal by Subject|9|||
143323326|NCT04102501|516728153|FG000|Overall Study|Adverse Event|1|||
143323327|NCT04102501|516728154|FG001|Overall Study|Adverse Event|3|||
143323328|NCT02338362|516728155|FG000|Overall Study|Withdrawal by Subject|1|||
143323329|NCT02338362|516728156|FG001|Overall Study|Withdrawal by Subject|1|||
143323330|NCT04798586|516728157|FG000|Overall Study|Death|2|||
143323331|NCT00345397|516728162|FG000|Overall Study|Death|1|||
143323332|NCT01870843|516728163|FG000|Overall Study|Adverse Event|10|||
143323333|NCT01870843|516728163|FG000|Overall Study|Lost to Follow-up|24|||
143323334|NCT01870843|516728163|FG000|Overall Study|Death|1|||
143323335|NCT01870843|516728163|FG000|Overall Study|Withdrawal by Subject|18|||
143323336|NCT03325712|516728164|FG000|Overall Study|Protocol Violation|0|||
143323337|NCT03325712|516728165|FG001|Overall Study|Protocol Violation|0|||
143323338|NCT03325712|516728166|FG002|Overall Study|Protocol Violation|0|||
143323339|NCT03325712|516728167|FG003|Overall Study|Protocol Violation|0|||
143323340|NCT03325712|516728168|FG004|Overall Study|Protocol Violation|1|||
143323341|NCT03325712|516728169|FG005|Overall Study|Protocol Violation|0|||
143323342|NCT03325712|516728170|FG006|Overall Study|Protocol Violation|0|||
143323343|NCT03325712|516728171|FG007|Overall Study|Protocol Violation|0|||
143323344|NCT03325712|516728164|FG000|Overall Study|Adverse Event|0|||
143323345|NCT03325712|516728165|FG001|Overall Study|Adverse Event|0|||
143323346|NCT03325712|516728166|FG002|Overall Study|Adverse Event|0|||
143323347|NCT03325712|516728167|FG003|Overall Study|Adverse Event|0|||
143323348|NCT03325712|516728168|FG004|Overall Study|Adverse Event|1|||
143323349|NCT03325712|516728169|FG005|Overall Study|Adverse Event|0|||
143323350|NCT03325712|516728170|FG006|Overall Study|Adverse Event|0|||
143323351|NCT03325712|516728171|FG007|Overall Study|Adverse Event|0|||
143323352|NCT04782323|516728172|FG000|Overall Study|Death|1|||
143323353|NCT04782323|516728173|FG001|Overall Study|Death|0|||
143323354|NCT04782323|516728174|FG002|Overall Study|Death|0|||
143323355|NCT04782323|516728175|FG003|Overall Study|Death|0|||
143323356|NCT04782323|516728176|FG004|Overall Study|Death|1|||
143323357|NCT04782323|516728177|FG005|Overall Study|Death|1|||
143323358|NCT04782323|516728178|FG006|Overall Study|Death|1|||
143323359|NCT04782323|516728179|FG007|Overall Study|Death|0|||
143323360|NCT04782323|516728172|FG000|Overall Study|Withdrawal by Subject|0|||
143323361|NCT04782323|516728173|FG001|Overall Study|Withdrawal by Subject|0|||
143323362|NCT04782323|516728174|FG002|Overall Study|Withdrawal by Subject|1|||
143323363|NCT04782323|516728175|FG003|Overall Study|Withdrawal by Subject|0|||
143323364|NCT04782323|516728176|FG004|Overall Study|Withdrawal by Subject|0|||
143323365|NCT04782323|516728177|FG005|Overall Study|Withdrawal by Subject|1|||
143323366|NCT04782323|516728178|FG006|Overall Study|Withdrawal by Subject|0|||
143323367|NCT04782323|516728179|FG007|Overall Study|Withdrawal by Subject|1|||
143323368|NCT04782323|516728172|FG000|Overall Study|Lost to Follow-up|0|||
143323369|NCT04782323|516728173|FG001|Overall Study|Lost to Follow-up|1|||
143323370|NCT04782323|516728174|FG002|Overall Study|Lost to Follow-up|1|||
143323371|NCT04782323|516728175|FG003|Overall Study|Lost to Follow-up|0|||
143323372|NCT04782323|516728176|FG004|Overall Study|Lost to Follow-up|0|||
143323373|NCT04782323|516728177|FG005|Overall Study|Lost to Follow-up|1|||
143323374|NCT04782323|516728178|FG006|Overall Study|Lost to Follow-up|1|||
143323375|NCT04782323|516728179|FG007|Overall Study|Lost to Follow-up|2|||
143323376|NCT04782323|516728172|FG000|Overall Study|randomization in error|1|||
143323377|NCT04782323|516728173|FG001|Overall Study|randomization in error|0|||
143323378|NCT04782323|516728174|FG002|Overall Study|randomization in error|0|||
143323379|NCT04782323|516728175|FG003|Overall Study|randomization in error|0|||
143323380|NCT04782323|516728176|FG004|Overall Study|randomization in error|0|||
143323381|NCT04782323|516728177|FG005|Overall Study|randomization in error|0|||
143323382|NCT04782323|516728178|FG006|Overall Study|randomization in error|0|||
143323383|NCT04782323|516728179|FG007|Overall Study|randomization in error|0|||
143323384|NCT00927927|516728182|FG000|Overall Study|Withdrawal by Subject|0|||
143323385|NCT00927927|516728183|FG001|Overall Study|Withdrawal by Subject|0|||
143323386|NCT00927927|516728184|FG002|Overall Study|Withdrawal by Subject|0|||
143323387|NCT00927927|516728185|FG003|Overall Study|Withdrawal by Subject|0|||
143323388|NCT00927927|516728186|FG004|Overall Study|Withdrawal by Subject|0|||
143323389|NCT00927927|516728187|FG005|Overall Study|Withdrawal by Subject|0|||
143323390|NCT00927927|516728188|FG006|Overall Study|Withdrawal by Subject|0|||
143323391|NCT00927927|516728189|FG007|Overall Study|Withdrawal by Subject|2|||
143323392|NCT00927927|516728190|FG008|Overall Study|Withdrawal by Subject|0|||
143323393|NCT00927927|516728191|FG009|Overall Study|Withdrawal by Subject|0|||
143323394|NCT00927927|516728192|FG010|Overall Study|Withdrawal by Subject|0|||
143323395|NCT00927927|516728193|FG011|Overall Study|Withdrawal by Subject|2|||
143323396|NCT00927927|516728194|FG012|Overall Study|Withdrawal by Subject|0|||
143323397|NCT00927927|516728195|FG013|Overall Study|Withdrawal by Subject|0|||
143323398|NCT00927927|516728196|FG014|Overall Study|Withdrawal by Subject|0|||
143323399|NCT00993447|516729569|FG000|Overall Study|Withdrawal by Subject|23|||
143323400|NCT00993447|516729570|FG001|Overall Study|Withdrawal by Subject|8|||
143323401|NCT00993447|516729569|FG000|Overall Study|Protocol Violation|12|||
143323402|NCT00993447|516729570|FG001|Overall Study|Protocol Violation|8|||
143323403|NCT00993447|516729569|FG000|Overall Study|Lost to Follow-up|1|||
143323404|NCT00993447|516729570|FG001|Overall Study|Lost to Follow-up|3|||
143323405|NCT00993447|516729569|FG000|Overall Study|Adverse Event|1|||
143323406|NCT00993447|516729570|FG001|Overall Study|Adverse Event|0|||
143323407|NCT02053350|516729571|FG000|Overall Study|Withdrawal by Subject|1|||
143323408|NCT02053350|516729571|FG000|Overall Study|Adverse Event|4|||
143323409|NCT01747772|516729572|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
143323410|NCT02244944|516729573|FG000|Overall Study|Withdrawal by Subject|1|||
143323411|NCT02244944|516729573|FG000|Overall Study|Study Terminated|1|||
143323412|NCT02280044|516729578|FG000|Overall Study|Planned alternate|0|||
143323413|NCT02280044|516729579|FG001|Overall Study|Planned alternate|2|||
143323414|NCT02367911|516729580|FG000|Overall Study|Withdrawal by Subject|3|||
143323415|NCT02367911|516729581|FG001|Overall Study|Withdrawal by Subject|2|||
143323416|NCT02367911|516729580|FG000|Overall Study|Lost to Follow-up|2|||
143323417|NCT02367911|516729581|FG001|Overall Study|Lost to Follow-up|2|||
143323418|NCT02105116|516729582|FG000|Overall Study|not eligible for step 2 of trial|5|||
143323419|NCT02105116|516729582|FG000|Overall Study|Death|1|||
143323420|NCT02492100|516729583|FG000|Overall Study|Death|1|||
143323421|NCT02590354|516729584|FG000|Phase 1|Active hepatitis B or C infection|1|||
143380490|NCT02723955|516940628|FG012|Expansion Phase|Lost to Follow-up|0|||
143380491|NCT02723955|516940629|FG013|Expansion Phase|Lost to Follow-up|0|||
143323422|NCT02590354|516729584|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
143323423|NCT02590354|516729584|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
143323424|NCT02590354|516729584|FG000|Phase 1|Subject does not want to participate|20|||
143323425|NCT02590354|516729584|FG000|Phase 1|Lost to Follow-up|1|||
143323426|NCT02590354|516729584|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
143323427|NCT01175668|516729585|FG000|Overall Study|Withdrawal by Subject|2|||
143323428|NCT01175668|516729586|FG001|Overall Study|Withdrawal by Subject|0|||
143323429|NCT00096135|516729587|FG000|Overall Study|Physician Decision|20|||
143323430|NCT00096135|516729588|FG001|Overall Study|Physician Decision|4|||
143323431|NCT00096135|516729587|FG000|Overall Study|Refusal of further protocol therapy|4|||
143323432|NCT00096135|516729588|FG001|Overall Study|Refusal of further protocol therapy|1|||
143323433|NCT00096135|516729587|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
143323434|NCT00096135|516729588|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
143323435|NCT00096135|516729587|FG000|Overall Study|Other, specify|15|||
143323436|NCT00096135|516729588|FG001|Overall Study|Other, specify|3|||
143380492|NCT02723955|516940630|FG014|Expansion Phase|Lost to Follow-up|0|||
143323437|NCT00096135|516729587|FG000|Overall Study|Ineligible|2|||
143323438|NCT00096135|516729588|FG001|Overall Study|Ineligible|0|||
143323439|NCT01568047|516729589|FG000|Overall Study|Ineligibility|1|||
143323440|NCT01568047|516729590|FG001|Overall Study|Ineligibility|0|||
143323441|NCT01568047|516729591|FG002|Overall Study|Ineligibility|0|||
143323442|NCT01568047|516729592|FG003|Overall Study|Ineligibility|0|||
143323443|NCT01568047|516729589|FG000|Overall Study|Withdrawal by Subject|0|||
143323444|NCT01568047|516729590|FG001|Overall Study|Withdrawal by Subject|1|||
143323445|NCT01568047|516729591|FG002|Overall Study|Withdrawal by Subject|0|||
143323446|NCT01568047|516729592|FG003|Overall Study|Withdrawal by Subject|0|||
143323447|NCT01568047|516729589|FG000|Overall Study|Adverse Event|0|||
143323448|NCT01568047|516729590|FG001|Overall Study|Adverse Event|0|||
143323449|NCT01568047|516729591|FG002|Overall Study|Adverse Event|1|||
143323450|NCT01568047|516729592|FG003|Overall Study|Adverse Event|1|||
143323451|NCT00874029|516729593|FG000|Overall Study|Withdrawal by Subject|10|||
143323452|NCT00874029|516729593|FG000|Overall Study|Pregnancy|4|||
143323453|NCT00874029|516729593|FG000|Overall Study|Physician Decision|1|||
143323454|NCT00874029|516729593|FG000|Overall Study|Adverse Event|1|||
143323455|NCT00874029|516729593|FG000|Overall Study|Lost to Follow-up|5|||
143323456|NCT02937545|516729600|FG000|Overall Study|Withdrawal by Subject|1|||
143323457|NCT02937545|516729601|FG001|Overall Study|Withdrawal by Subject|2|||
143323458|NCT02937545|516729602|FG002|Overall Study|Withdrawal by Subject|6|||
143323459|NCT02937545|516729603|FG003|Overall Study|Withdrawal by Subject|7|||
143323460|NCT02937545|516729600|FG000|Overall Study|Lost to Follow-up|1|||
143323461|NCT02937545|516729601|FG001|Overall Study|Lost to Follow-up|0|||
143323462|NCT02937545|516729602|FG002|Overall Study|Lost to Follow-up|0|||
143323463|NCT02937545|516729603|FG003|Overall Study|Lost to Follow-up|0|||
143323464|NCT02007577|516729604|FG000|Overall Study|Adverse Event|1|||
143323465|NCT02007577|516729605|FG001|Overall Study|Adverse Event|0|||
143323466|NCT02007577|516729604|FG000|Overall Study|Withdrawal by Subject|0|||
143323467|NCT02007577|516729605|FG001|Overall Study|Withdrawal by Subject|1|||
143323468|NCT06281548|516729612|FG000|Overall Study|Lost to Follow-up|3|||
143323469|NCT01618838|516729613|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
143323470|NCT00288587|516729614|FG000|Overall Study|Death|4|||
143323471|NCT00288587|516729615|FG001|Overall Study|Death|4|||
143323472|NCT00288587|516729614|FG000|Overall Study|Transplant|0|||
143323473|NCT00288587|516729615|FG001|Overall Study|Transplant|3|||
143323474|NCT00288587|516729614|FG000|Overall Study|Adverse Event|0|||
143323475|NCT00288587|516729615|FG001|Overall Study|Adverse Event|1|||
143323476|NCT00288587|516729614|FG000|Overall Study|Physician Decision|0|||
143323477|NCT00288587|516729615|FG001|Overall Study|Physician Decision|2|||
143323478|NCT00288587|516729614|FG000|Overall Study|Severe Aortic Stenosis|1|||
143323479|NCT00288587|516729615|FG001|Overall Study|Severe Aortic Stenosis|0|||
143323480|NCT01434602|516729616|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
143323481|NCT01434602|516729617|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
143323482|NCT01434602|516729618|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
143323483|NCT01434602|516729619|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
143323484|NCT01434602|516729620|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
143323485|NCT01434602|516729616|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
143323486|NCT01434602|516729617|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
143323487|NCT01434602|516729618|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
143323488|NCT01434602|516729619|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
143323489|NCT01434602|516729620|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
143323490|NCT01434602|516729616|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
143323491|NCT01434602|516729617|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
143323492|NCT01434602|516729618|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
143323493|NCT01434602|516729619|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
143323494|NCT01434602|516729620|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
143323495|NCT01434602|516729616|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
143323496|NCT01434602|516729617|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
143323497|NCT01434602|516729618|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
143323498|NCT01434602|516729619|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
143323499|NCT01434602|516729620|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
143323500|NCT01434602|516729616|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
143323501|NCT01434602|516729617|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
143323502|NCT01434602|516729618|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
143323503|NCT01434602|516729619|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
143380493|NCT02723955|516940631|FG015|Expansion Phase|Lost to Follow-up|0|||
143380494|NCT02723955|516940632|FG016|Expansion Phase|Lost to Follow-up|0|||
143380495|NCT02723955|516940633|FG017|Expansion Phase|Lost to Follow-up|0|||
143380496|NCT02723955|516940634|FG018|Expansion Phase|Lost to Follow-up|0|||
143380497|NCT02723955|516940635|FG019|Expansion Phase|Lost to Follow-up|0|||
143380498|NCT02723955|516940636|FG020|Expansion Phase|Lost to Follow-up|0|||
143380499|NCT02723955|516940637|FG021|Expansion Phase|Lost to Follow-up|0|||
143380500|NCT02723955|516940638|FG022|Expansion Phase|Lost to Follow-up|0|||
143380501|NCT02723955|516940639|FG023|Expansion Phase|Lost to Follow-up|0|||
143380502|NCT02723955|516940640|FG024|Expansion Phase|Lost to Follow-up|0|||
143380503|NCT02723955|516940641|FG025|Expansion Phase|Lost to Follow-up|0|||
143380504|NCT02723955|516940642|FG026|Expansion Phase|Lost to Follow-up|0|||
143380505|NCT02723955|516940643|FG027|Expansion Phase|Lost to Follow-up|0|||
143380506|NCT02723955|516940644|FG028|Expansion Phase|Lost to Follow-up|0|||
143380507|NCT02723955|516940645|FG029|Expansion Phase|Lost to Follow-up|1|||
143380508|NCT02723955|516940646|FG030|Expansion Phase|Lost to Follow-up|19|||
143380509|NCT02723955|516940647|FG031|Expansion Phase|Lost to Follow-up|2|||
143380510|NCT02723955|516940648|FG032|Expansion Phase|Lost to Follow-up|1|||
143380511|NCT02723955|516940649|FG033|Expansion Phase|Lost to Follow-up|0|||
143380512|NCT02723955|516940650|FG034|Expansion Phase|Lost to Follow-up|0|||
143380513|NCT02723955|516940651|FG035|Expansion Phase|Lost to Follow-up|0|||
143380514|NCT02723955|516940652|FG036|Expansion Phase|Lost to Follow-up|0|||
143380515|NCT02723955|516940653|FG037|Expansion Phase|Lost to Follow-up|0|||
143380516|NCT02723955|516940654|FG038|Expansion Phase|Lost to Follow-up|0|||
143380517|NCT02723955|516940655|FG039|Expansion Phase|Lost to Follow-up|0|||
143380518|NCT02723955|516940656|FG040|Expansion Phase|Lost to Follow-up|0|||
143380519|NCT02723955|516940657|FG041|Expansion Phase|Lost to Follow-up|0|||
143380520|NCT02723955|516940658|FG042|Expansion Phase|Lost to Follow-up|0|||
143380521|NCT02723955|516940616|FG000|Expansion Phase|Physician Decision|0|||
143380522|NCT02723955|516940617|FG001|Expansion Phase|Physician Decision|0|||
143380523|NCT02723955|516940618|FG002|Expansion Phase|Physician Decision|0|||
143380524|NCT02723955|516940619|FG003|Expansion Phase|Physician Decision|0|||
143380525|NCT02723955|516940620|FG004|Expansion Phase|Physician Decision|0|||
143380526|NCT02723955|516940621|FG005|Expansion Phase|Physician Decision|0|||
143380527|NCT02723955|516940622|FG006|Expansion Phase|Physician Decision|0|||
143380528|NCT02723955|516940623|FG007|Expansion Phase|Physician Decision|0|||
143380529|NCT02723955|516940624|FG008|Expansion Phase|Physician Decision|0|||
143380530|NCT02723955|516940625|FG009|Expansion Phase|Physician Decision|0|||
143380531|NCT02723955|516940626|FG010|Expansion Phase|Physician Decision|0|||
143380532|NCT02723955|516940627|FG011|Expansion Phase|Physician Decision|0|||
143380533|NCT02723955|516940628|FG012|Expansion Phase|Physician Decision|0|||
143380534|NCT02723955|516940629|FG013|Expansion Phase|Physician Decision|0|||
143380535|NCT02723955|516940630|FG014|Expansion Phase|Physician Decision|0|||
143380536|NCT02723955|516940631|FG015|Expansion Phase|Physician Decision|0|||
143380537|NCT02723955|516940632|FG016|Expansion Phase|Physician Decision|0|||
143380538|NCT02723955|516940633|FG017|Expansion Phase|Physician Decision|0|||
143380539|NCT02723955|516940634|FG018|Expansion Phase|Physician Decision|0|||
143380540|NCT02723955|516940635|FG019|Expansion Phase|Physician Decision|0|||
143380541|NCT02723955|516940636|FG020|Expansion Phase|Physician Decision|0|||
143380542|NCT02723955|516940637|FG021|Expansion Phase|Physician Decision|0|||
143380543|NCT02723955|516940638|FG022|Expansion Phase|Physician Decision|0|||
143380544|NCT02723955|516940639|FG023|Expansion Phase|Physician Decision|0|||
143380545|NCT02723955|516940640|FG024|Expansion Phase|Physician Decision|0|||
143380546|NCT02723955|516940641|FG025|Expansion Phase|Physician Decision|0|||
143380547|NCT02723955|516940642|FG026|Expansion Phase|Physician Decision|0|||
143380548|NCT02723955|516940643|FG027|Expansion Phase|Physician Decision|0|||
143380549|NCT02723955|516940644|FG028|Expansion Phase|Physician Decision|0|||
143380550|NCT02723955|516940645|FG029|Expansion Phase|Physician Decision|0|||
143380551|NCT02723955|516940646|FG030|Expansion Phase|Physician Decision|1|||
143380552|NCT02723955|516940647|FG031|Expansion Phase|Physician Decision|1|||
143380553|NCT02723955|516940648|FG032|Expansion Phase|Physician Decision|0|||
143380554|NCT02723955|516940649|FG033|Expansion Phase|Physician Decision|0|||
143380555|NCT02723955|516940650|FG034|Expansion Phase|Physician Decision|0|||
143380556|NCT02723955|516940651|FG035|Expansion Phase|Physician Decision|0|||
143380557|NCT02723955|516940652|FG036|Expansion Phase|Physician Decision|0|||
143380558|NCT02723955|516940653|FG037|Expansion Phase|Physician Decision|0|||
143380559|NCT02723955|516940654|FG038|Expansion Phase|Physician Decision|0|||
143380560|NCT02723955|516940655|FG039|Expansion Phase|Physician Decision|0|||
143380561|NCT02723955|516940656|FG040|Expansion Phase|Physician Decision|0|||
143323504|NCT01434602|516729620|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
143323505|NCT01434602|516729616|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
143323506|NCT01434602|516729617|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
143323507|NCT01434602|516729618|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
143323508|NCT01434602|516729619|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
143323509|NCT01434602|516729620|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
143323510|NCT01434602|516729616|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
143323511|NCT01434602|516729617|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
143323512|NCT01434602|516729618|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
143323513|NCT01434602|516729619|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
143323514|NCT01434602|516729620|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
143323515|NCT01434602|516729616|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
143323516|NCT01434602|516729617|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
143323517|NCT01434602|516729618|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
143323518|NCT01434602|516729619|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
143323519|NCT01434602|516729620|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
143323520|NCT01434602|516729616|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
143323521|NCT01434602|516729617|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
143323522|NCT01434602|516729618|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
143323523|NCT01434602|516729619|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
143323524|NCT01434602|516729620|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
143323525|NCT01434602|516729616|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
143323526|NCT01434602|516729617|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
143323527|NCT01434602|516729618|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
143323528|NCT01434602|516729619|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
143323529|NCT01434602|516729620|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
143323530|NCT01764945|516729625|FG000|Overall Study|Adverse Event|0|||
143323531|NCT01764945|516729626|FG001|Overall Study|Adverse Event|1|||
143323532|NCT01764945|516729627|FG002|Overall Study|Adverse Event|0|||
143323533|NCT01764945|516729628|FG003|Overall Study|Adverse Event|0|||
143323534|NCT01764945|516729629|FG004|Overall Study|Adverse Event|0|||
143323535|NCT01764945|516729630|FG005|Overall Study|Adverse Event|0|||
143323536|NCT01764945|516729631|FG006|Overall Study|Adverse Event|1|||
143323537|NCT01764945|516729632|FG007|Overall Study|Adverse Event|0|||
143323538|NCT05077267|516729634|FG000|Treatment Period|Lost to Follow-up|0|||
143323539|NCT05077267|516729635|FG001|Treatment Period|Lost to Follow-up|1|||
143323540|NCT05077267|516729636|FG002|Treatment Period|Lost to Follow-up|0|||
143323541|NCT05077267|516729634|FG000|Treatment Period|Withdrawal by Subject|0|||
143323542|NCT05077267|516729635|FG001|Treatment Period|Withdrawal by Subject|1|||
143323543|NCT05077267|516729636|FG002|Treatment Period|Withdrawal by Subject|0|||
143323544|NCT05077267|516729634|FG000|Follow-up Period|Lost to Follow-up|0|||
143323545|NCT05077267|516729635|FG001|Follow-up Period|Lost to Follow-up|5|||
143323546|NCT05077267|516729636|FG002|Follow-up Period|Lost to Follow-up|7|||
143323547|NCT05077267|516729634|FG000|Follow-up Period|Withdrawal by Subject|0|||
143323548|NCT05077267|516729635|FG001|Follow-up Period|Withdrawal by Subject|2|||
143323549|NCT05077267|516729636|FG002|Follow-up Period|Withdrawal by Subject|5|||
143323550|NCT05077267|516729634|FG000|Follow-up Period|Study terminated by sponsor|0|||
143323551|NCT05077267|516729635|FG001|Follow-up Period|Study terminated by sponsor|27|||
143323552|NCT05077267|516729636|FG002|Follow-up Period|Study terminated by sponsor|23|||
143323553|NCT05077267|516729634|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
143323554|NCT05077267|516729635|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
143323555|NCT05077267|516729636|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
143323556|NCT05077267|516729634|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
143323557|NCT05077267|516729635|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
143323558|NCT05077267|516729636|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
143323559|NCT01587651|516729637|FG000|Overall Study|Adverse Event|0|||
143323560|NCT01587651|516729638|FG001|Overall Study|Adverse Event|1|||
143323561|NCT01587651|516729639|FG002|Overall Study|Adverse Event|0|||
143323562|NCT01587651|516729637|FG000|Overall Study|Protocol Violation|0|||
143323563|NCT01587651|516729638|FG001|Overall Study|Protocol Violation|1|||
143323564|NCT01587651|516729639|FG002|Overall Study|Protocol Violation|1|||
143323565|NCT01587651|516729637|FG000|Overall Study|Withdrawal by Subject|0|||
143323566|NCT01587651|516729638|FG001|Overall Study|Withdrawal by Subject|1|||
143323567|NCT01587651|516729639|FG002|Overall Study|Withdrawal by Subject|0|||
143323568|NCT01136291|516729640|FG000|Overall Study|Lost to Follow-up|1|||
143323569|NCT01136291|516729641|FG001|Overall Study|Lost to Follow-up|1|||
143323570|NCT00759109|516729649|FG000|Overall Study|Adverse Event|17|||
143323571|NCT00759109|516729650|FG001|Overall Study|Adverse Event|12|||
143323572|NCT00759109|516729649|FG000|Overall Study|Inability to comply|1|||
143323573|NCT00759109|516729650|FG001|Overall Study|Inability to comply|1|||
143380562|NCT02723955|516940657|FG041|Expansion Phase|Physician Decision|0|||
143380563|NCT02723955|516940658|FG042|Expansion Phase|Physician Decision|0|||
143380564|NCT02723955|516940616|FG000|Expansion Phase|Withdrawal by Subject|0|||
143380565|NCT02723955|516940617|FG001|Expansion Phase|Withdrawal by Subject|0|||
143380566|NCT02723955|516940618|FG002|Expansion Phase|Withdrawal by Subject|0|||
143380567|NCT02723955|516940619|FG003|Expansion Phase|Withdrawal by Subject|0|||
143380568|NCT02723955|516940620|FG004|Expansion Phase|Withdrawal by Subject|0|||
143380569|NCT02723955|516940621|FG005|Expansion Phase|Withdrawal by Subject|0|||
143380570|NCT02723955|516940622|FG006|Expansion Phase|Withdrawal by Subject|0|||
143380571|NCT02723955|516940623|FG007|Expansion Phase|Withdrawal by Subject|0|||
143380572|NCT02723955|516940624|FG008|Expansion Phase|Withdrawal by Subject|0|||
143380573|NCT02723955|516940625|FG009|Expansion Phase|Withdrawal by Subject|2|||
143380574|NCT02723955|516940626|FG010|Expansion Phase|Withdrawal by Subject|1|||
143380575|NCT02723955|516940627|FG011|Expansion Phase|Withdrawal by Subject|0|||
143380576|NCT02723955|516940628|FG012|Expansion Phase|Withdrawal by Subject|0|||
143380577|NCT02723955|516940629|FG013|Expansion Phase|Withdrawal by Subject|0|||
143380578|NCT02723955|516940630|FG014|Expansion Phase|Withdrawal by Subject|0|||
143380579|NCT02723955|516940631|FG015|Expansion Phase|Withdrawal by Subject|0|||
143380580|NCT02723955|516940632|FG016|Expansion Phase|Withdrawal by Subject|0|||
143380581|NCT02723955|516940633|FG017|Expansion Phase|Withdrawal by Subject|0|||
143380582|NCT02723955|516940634|FG018|Expansion Phase|Withdrawal by Subject|0|||
143380583|NCT02723955|516940635|FG019|Expansion Phase|Withdrawal by Subject|0|||
143380584|NCT02723955|516940636|FG020|Expansion Phase|Withdrawal by Subject|0|||
143380585|NCT02723955|516940637|FG021|Expansion Phase|Withdrawal by Subject|0|||
143380586|NCT02723955|516940638|FG022|Expansion Phase|Withdrawal by Subject|0|||
143380587|NCT02723955|516940639|FG023|Expansion Phase|Withdrawal by Subject|0|||
143380588|NCT02723955|516940640|FG024|Expansion Phase|Withdrawal by Subject|0|||
143380589|NCT02723955|516940641|FG025|Expansion Phase|Withdrawal by Subject|0|||
143380590|NCT02723955|516940642|FG026|Expansion Phase|Withdrawal by Subject|0|||
143380591|NCT02723955|516940643|FG027|Expansion Phase|Withdrawal by Subject|0|||
143380592|NCT02723955|516940644|FG028|Expansion Phase|Withdrawal by Subject|0|||
143380593|NCT02723955|516940645|FG029|Expansion Phase|Withdrawal by Subject|0|||
143380594|NCT02723955|516940646|FG030|Expansion Phase|Withdrawal by Subject|8|||
143380595|NCT02723955|516940647|FG031|Expansion Phase|Withdrawal by Subject|4|||
143380596|NCT02723955|516940648|FG032|Expansion Phase|Withdrawal by Subject|0|||
143380597|NCT02723955|516940649|FG033|Expansion Phase|Withdrawal by Subject|0|||
143380598|NCT02723955|516940650|FG034|Expansion Phase|Withdrawal by Subject|0|||
143380599|NCT02723955|516940651|FG035|Expansion Phase|Withdrawal by Subject|1|||
143380600|NCT02723955|516940652|FG036|Expansion Phase|Withdrawal by Subject|0|||
143380601|NCT02723955|516940653|FG037|Expansion Phase|Withdrawal by Subject|0|||
143380602|NCT02723955|516940654|FG038|Expansion Phase|Withdrawal by Subject|0|||
143380603|NCT02723955|516940655|FG039|Expansion Phase|Withdrawal by Subject|0|||
143380604|NCT02723955|516940656|FG040|Expansion Phase|Withdrawal by Subject|0|||
143380605|NCT02723955|516940657|FG041|Expansion Phase|Withdrawal by Subject|0|||
143380606|NCT02723955|516940658|FG042|Expansion Phase|Withdrawal by Subject|0|||
143380607|NCT02723955|516940616|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143380608|NCT02723955|516940617|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143380609|NCT02723955|516940618|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143380610|NCT02723955|516940619|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143380611|NCT02723955|516940620|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143380612|NCT02723955|516940621|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143380613|NCT02723955|516940622|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143323574|NCT00759109|516729649|FG000|Overall Study|Withdrawal by Subject|9|||
143323575|NCT00759109|516729650|FG001|Overall Study|Withdrawal by Subject|5|||
143323576|NCT00759109|516729649|FG000|Overall Study|Death|4|||
143323577|NCT00759109|516729650|FG001|Overall Study|Death|3|||
143323578|NCT00759109|516729649|FG000|Overall Study|Lost to Follow-up|4|||
143323579|NCT00759109|516729650|FG001|Overall Study|Lost to Follow-up|6|||
143323580|NCT00759109|516729649|FG000|Overall Study|Started new therapy|2|||
143323581|NCT00759109|516729650|FG001|Overall Study|Started new therapy|6|||
143323582|NCT00759109|516729649|FG000|Overall Study|HCV RNA negative|1|||
143323583|NCT00759109|516729650|FG001|Overall Study|HCV RNA negative|0|||
143380614|NCT02723955|516940623|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143380615|NCT02723955|516940624|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143380616|NCT02723955|516940625|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
143323584|NCT00759109|516729649|FG000|Overall Study|Participant moved to a different city|0|||
143380617|NCT02723955|516940626|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
143380618|NCT02723955|516940627|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
143380619|NCT02723955|516940628|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143380620|NCT02723955|516940629|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143323585|NCT00759109|516729650|FG001|Overall Study|Participant moved to a different city|1|||
143323586|NCT00759109|516729649|FG000|Overall Study|Participant had a liver transplant|0|||
143323587|NCT00759109|516729650|FG001|Overall Study|Participant had a liver transplant|1|||
143323588|NCT00759109|516729649|FG000|Overall Study|Lost during study|1|||
143323589|NCT00759109|516729650|FG001|Overall Study|Lost during study|0|||
143323590|NCT02308033|516729651|FG000|Overall Study|Normal Gram stain at Baseline|13|||
143323591|NCT02308033|516729652|FG001|Overall Study|Normal Gram stain at Baseline|10|||
143323592|NCT02308033|516729651|FG000|Overall Study|Positive for STD at Baseline|7|||
143323593|NCT02308033|516729652|FG001|Overall Study|Positive for STD at Baseline|4|||
143323594|NCT02308033|516729651|FG000|Overall Study|Lost to Follow-up|6|||
143323595|NCT02308033|516729652|FG001|Overall Study|Lost to Follow-up|5|||
143323596|NCT01827904|516729653|FG000|Main Study|Withdrawal by Subject|1|||
143323597|NCT01827904|516729654|FG001|Main Study|Withdrawal by Subject|0|||
143323598|NCT01827904|516729655|FG002|Main Study|Withdrawal by Subject|0|||
143323599|NCT01827904|516729653|FG000|Main Study|Adverse Event|1|||
143323600|NCT01827904|516729654|FG001|Main Study|Adverse Event|0|||
143323601|NCT01827904|516729655|FG002|Main Study|Adverse Event|0|||
143323602|NCT01827904|516729653|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
143323603|NCT01827904|516729654|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
143323604|NCT01827904|516729655|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
143323605|NCT01827904|516729653|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
143323606|NCT01827904|516729654|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
143323607|NCT01827904|516729655|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
143323608|NCT01827904|516729653|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
143323609|NCT01827904|516729654|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
143323610|NCT01827904|516729655|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
143323611|NCT01827904|516729653|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
143323612|NCT01827904|516729654|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
143323613|NCT01827904|516729655|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
143323614|NCT01827904|516729653|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
143323615|NCT01827904|516729654|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
143323616|NCT01827904|516729655|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
143323617|NCT01827904|516729653|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
143323618|NCT01827904|516729654|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
143323619|NCT01827904|516729655|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
143323620|NCT01827904|516729653|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
143323621|NCT01827904|516729654|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
143323622|NCT01827904|516729655|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
143323623|NCT01827904|516729653|FG000|Long-term Annual Follow-up|Physician Decision|1|||
143323624|NCT01827904|516729654|FG001|Long-term Annual Follow-up|Physician Decision|0|||
143323625|NCT01827904|516729655|FG002|Long-term Annual Follow-up|Physician Decision|0|||
143323626|NCT01827904|516729653|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
143323627|NCT01827904|516729654|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
143323628|NCT01827904|516729655|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
143323629|NCT01827904|516729653|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
143323630|NCT01827904|516729654|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
143323631|NCT01827904|516729655|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
143323632|NCT00142909|516729656|FG000|Randomization|Various Reasons|7|||
143323633|NCT00142909|516729657|FG001|Randomization|Various Reasons|10|||
143323634|NCT00142909|516729656|FG000|Medications Begin|Protocol Violation|2|||
143323635|NCT00142909|516729657|FG001|Medications Begin|Protocol Violation|0|||
143323636|NCT00142909|516729656|FG000|Medications Begin|Withdrawal by Subject|5|||
143323637|NCT00142909|516729657|FG001|Medications Begin|Withdrawal by Subject|3|||
143323638|NCT00142909|516729656|FG000|Medications Begin|Withdrawal by Subject|2|||
143323639|NCT00142909|516729657|FG001|Medications Begin|Withdrawal by Subject|0|||
143323640|NCT02265237|516729659|FG000|As Treated (Overall Study)|Adverse Event|1|||
143323641|NCT02265237|516729660|FG001|As Treated (Overall Study)|Adverse Event|1|||
143323642|NCT02265237|516729661|FG002|As Treated (Overall Study)|Adverse Event|0|||
143323643|NCT02265237|516729662|FG003|As Treated (Overall Study)|Adverse Event|0|||
143323644|NCT02265237|516729659|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
143323645|NCT02265237|516729660|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
143323646|NCT02265237|516729661|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
143323647|NCT02265237|516729662|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
143323648|NCT02265237|516729659|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
143323649|NCT02265237|516729660|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
143323650|NCT02265237|516729661|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
143323651|NCT02265237|516729662|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
143323652|NCT02265237|516729659|FG000|As Treated (Overall Study)|Other|2|||
143380621|NCT02723955|516940630|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143380622|NCT02723955|516940631|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143380623|NCT02723955|516940632|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143380624|NCT02723955|516940633|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143380625|NCT02723955|516940634|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143380626|NCT02723955|516940635|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143380627|NCT02723955|516940636|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143380628|NCT02723955|516940637|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143380629|NCT02723955|516940638|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143380630|NCT02723955|516940639|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143380631|NCT02723955|516940640|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143380632|NCT02723955|516940641|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143380633|NCT02723955|516940642|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143380634|NCT02723955|516940643|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143380635|NCT02723955|516940644|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143380636|NCT02723955|516940645|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143380637|NCT02723955|516940646|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
143380638|NCT02723955|516940647|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143380639|NCT02723955|516940648|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143380640|NCT02723955|516940649|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143323653|NCT02265237|516729660|FG001|As Treated (Overall Study)|Other|0|||
143323654|NCT02265237|516729661|FG002|As Treated (Overall Study)|Other|3|||
143323655|NCT02265237|516729662|FG003|As Treated (Overall Study)|Other|1|||
143323656|NCT01178853|516729664|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
143323657|NCT01178853|516729665|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
143323658|NCT01178853|516729664|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
143323659|NCT01178853|516729665|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
143323660|NCT01178853|516729664|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
143323661|NCT01178853|516729665|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
143323662|NCT01178853|516729664|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
143323663|NCT01178853|516729665|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
143323664|NCT01178853|516729664|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
143323665|NCT01178853|516729665|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
143323666|NCT03550313|516729666|FG000|Overall Study|Adverse Event|0|||
143323667|NCT03550313|516729667|FG001|Overall Study|Adverse Event|1|||
143323668|NCT03550313|516729668|FG002|Overall Study|Adverse Event|0|||
143323669|NCT03550313|516729666|FG000|Overall Study|Lost to Follow-up|5|||
143323670|NCT03550313|516729667|FG001|Overall Study|Lost to Follow-up|7|||
143323671|NCT03550313|516729668|FG002|Overall Study|Lost to Follow-up|12|||
143323672|NCT03550313|516729666|FG000|Overall Study|Study terminated by sponsor|44|||
143323673|NCT03550313|516729667|FG001|Overall Study|Study terminated by sponsor|37|||
143323674|NCT03550313|516729668|FG002|Overall Study|Study terminated by sponsor|48|||
143323675|NCT03550313|516729666|FG000|Overall Study|No longer met eligibility criteria|3|||
143323676|NCT03550313|516729667|FG001|Overall Study|No longer met eligibility criteria|5|||
143323677|NCT03550313|516729668|FG002|Overall Study|No longer met eligibility criteria|6|||
143323678|NCT03550313|516729666|FG000|Overall Study|Withdrawal by parent/guardian|20|||
143323679|NCT03550313|516729667|FG001|Overall Study|Withdrawal by parent/guardian|18|||
143323680|NCT03550313|516729668|FG002|Overall Study|Withdrawal by parent/guardian|26|||
143323681|NCT03550313|516729666|FG000|Overall Study|Other|4|||
143323682|NCT03550313|516729667|FG001|Overall Study|Other|2|||
143323683|NCT03550313|516729668|FG002|Overall Study|Other|2|||
143323684|NCT03550313|516729666|FG000|Overall Study|Randomized but not vaccinated|3|||
143323685|NCT03550313|516729667|FG001|Overall Study|Randomized but not vaccinated|23|||
143323686|NCT03550313|516729668|FG002|Overall Study|Randomized but not vaccinated|2|||
143323687|NCT03550313|516729666|FG000|Overall Study|Sites terminated due to quality issues|18|||
143323688|NCT03550313|516729667|FG001|Overall Study|Sites terminated due to quality issues|17|||
143323689|NCT03550313|516729668|FG002|Overall Study|Sites terminated due to quality issues|18|||
143323690|NCT00839072|516729669|FG000|First Intervention Period|Withdrawal by Subject|1|||
143323691|NCT00839072|516729670|FG001|First Intervention Period|Withdrawal by Subject|0|||
143323692|NCT00839072|516729669|FG000|First Intervention Period|Adverse Event|1|||
143323693|NCT00839072|516729670|FG001|First Intervention Period|Adverse Event|1|||
143323694|NCT00839072|516729669|FG000|Second Intervention Period|Withdrawal by Subject|1|||
143323695|NCT00839072|516729670|FG001|Second Intervention Period|Withdrawal by Subject|0|||
143323696|NCT01297062|516729672|FG000|Overall Study|Adverse Event|2|||
143323697|NCT01297062|516729673|FG001|Overall Study|Adverse Event|0|||
143323698|NCT01297062|516729674|FG002|Overall Study|Adverse Event|1|||
143323699|NCT01297062|516729675|FG003|Overall Study|Adverse Event|0|||
143323700|NCT01297062|516729676|FG004|Overall Study|Adverse Event|0|||
143323701|NCT01297062|516729677|FG005|Overall Study|Adverse Event|0|||
143323702|NCT01297062|516729678|FG006|Overall Study|Adverse Event|0|||
143323703|NCT01297062|516729672|FG000|Overall Study|Physician Decision|1|||
143323704|NCT01297062|516729673|FG001|Overall Study|Physician Decision|0|||
143323705|NCT01297062|516729674|FG002|Overall Study|Physician Decision|1|||
143323706|NCT01297062|516729675|FG003|Overall Study|Physician Decision|0|||
143323707|NCT01297062|516729676|FG004|Overall Study|Physician Decision|0|||
143323708|NCT01297062|516729677|FG005|Overall Study|Physician Decision|0|||
143323709|NCT01297062|516729678|FG006|Overall Study|Physician Decision|6|||
143323710|NCT01297062|516729672|FG000|Overall Study|Protocol Violation|0|||
143323711|NCT01297062|516729673|FG001|Overall Study|Protocol Violation|0|||
143323712|NCT01297062|516729674|FG002|Overall Study|Protocol Violation|0|||
143323713|NCT01297062|516729675|FG003|Overall Study|Protocol Violation|0|||
143323714|NCT01297062|516729676|FG004|Overall Study|Protocol Violation|1|||
143323715|NCT01297062|516729677|FG005|Overall Study|Protocol Violation|0|||
143323716|NCT01297062|516729678|FG006|Overall Study|Protocol Violation|0|||
143323717|NCT01297062|516729672|FG000|Overall Study|Subject Decision|1|||
143323718|NCT01297062|516729673|FG001|Overall Study|Subject Decision|1|||
143323719|NCT01297062|516729674|FG002|Overall Study|Subject Decision|0|||
143323720|NCT01297062|516729675|FG003|Overall Study|Subject Decision|1|||
143323721|NCT01297062|516729676|FG004|Overall Study|Subject Decision|1|||
143323722|NCT01297062|516729677|FG005|Overall Study|Subject Decision|1|||
143323723|NCT01297062|516729678|FG006|Overall Study|Subject Decision|2|||
143323724|NCT02720484|516729685|FG000|Treatment on Study|Adverse Event|1|||
143323725|NCT02720484|516729685|FG000|Treatment on Study|Withdrawal by Subject|1|||
143323726|NCT02720484|516729685|FG000|Treatment on Study|Progressive Disease|4|||
143323727|NCT02720484|516729685|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
143323728|NCT02720484|516729685|FG000|Follow Up for 2 Years|Death|3|||
143323729|NCT02720484|516729685|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
143323730|NCT05070897|516729688|FG000|Overall Study|Protocol Violation|123|||
143323731|NCT05070897|516729689|FG001|Overall Study|Protocol Violation|68|||
143323732|NCT01617629|516729690|FG000|Overall Study|Death|2|||
143323733|NCT01617629|516729690|FG000|Overall Study|Investigator's Clinical Judgement|1|||
143323734|NCT01617629|516729690|FG000|Overall Study|Reason Not Specified|1|||
143323735|NCT01617629|516729690|FG000|Overall Study|Participant Withdrew Consent|2|||
143323736|NCT01663636|516729691|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
143323737|NCT01663636|516729692|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
143323738|NCT02838017|516729694|FG000|Overall Study|Lost to Follow-up|14|||
143323739|NCT02838017|516729695|FG001|Overall Study|Lost to Follow-up|11|||
143323740|NCT01692197|516729696|FG000|Overall Study|Failed Screening|3|||
143323741|NCT02120924|516729697|FG000|Overall Study|Lack of Efficacy|1|||
143323742|NCT02120924|516729698|FG001|Overall Study|Lack of Efficacy|2|||
143323743|NCT02120924|516729699|FG002|Overall Study|Lack of Efficacy|3|||
143323744|NCT02120924|516729697|FG000|Overall Study|Adverse Event|0|||
143323745|NCT02120924|516729698|FG001|Overall Study|Adverse Event|1|||
143323746|NCT02120924|516729699|FG002|Overall Study|Adverse Event|3|||
143323747|NCT02120924|516729697|FG000|Overall Study|Withdrawal by Subject|16|||
143323748|NCT02120924|516729698|FG001|Overall Study|Withdrawal by Subject|20|||
143323749|NCT02120924|516729699|FG002|Overall Study|Withdrawal by Subject|8|||
143323750|NCT02120924|516729697|FG000|Overall Study|Lost to Follow-up|14|||
143323751|NCT02120924|516729698|FG001|Overall Study|Lost to Follow-up|14|||
143323752|NCT02120924|516729699|FG002|Overall Study|Lost to Follow-up|11|||
143323753|NCT02120924|516729697|FG000|Overall Study|Pregnancy|2|||
143323754|NCT02120924|516729698|FG001|Overall Study|Pregnancy|0|||
143323755|NCT02120924|516729699|FG002|Overall Study|Pregnancy|0|||
143323756|NCT02120924|516729697|FG000|Overall Study|Protocol Violation|3|||
143323757|NCT02120924|516729698|FG001|Overall Study|Protocol Violation|7|||
143323758|NCT02120924|516729699|FG002|Overall Study|Protocol Violation|2|||
143323759|NCT02120924|516729697|FG000|Overall Study|Physician Decision|0|||
143323760|NCT02120924|516729698|FG001|Overall Study|Physician Decision|1|||
143323761|NCT02120924|516729699|FG002|Overall Study|Physician Decision|1|||
143323762|NCT02120924|516729697|FG000|Overall Study|Death|1|||
143323763|NCT02120924|516729698|FG001|Overall Study|Death|0|||
143323764|NCT02120924|516729699|FG002|Overall Study|Death|0|||
143323765|NCT02120924|516729697|FG000|Overall Study|Compliance with IP|5|||
143323766|NCT02120924|516729698|FG001|Overall Study|Compliance with IP|1|||
143323767|NCT02120924|516729699|FG002|Overall Study|Compliance with IP|1|||
143323768|NCT01884350|516729700|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
143323769|NCT01884350|516729701|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
143323770|NCT01884350|516729702|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
143323771|NCT01884350|516729700|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
143323772|NCT01884350|516729701|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
143323773|NCT01884350|516729702|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
143323774|NCT01884350|516729700|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
143323775|NCT01884350|516729701|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
143323776|NCT01884350|516729702|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
143323777|NCT01884350|516729700|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
143323778|NCT01884350|516729701|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
143323779|NCT01884350|516729702|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
143323780|NCT01884350|516729700|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
143323781|NCT01884350|516729701|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
143323782|NCT01884350|516729702|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
143323783|NCT01884350|516729700|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
143323784|NCT01884350|516729701|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
143323785|NCT01884350|516729702|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
143323786|NCT01884350|516729700|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
143323787|NCT01884350|516729701|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
143323788|NCT01884350|516729702|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
143323789|NCT01884350|516729700|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
143323790|NCT01884350|516729701|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
143323791|NCT01884350|516729702|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
143323792|NCT01884350|516729700|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
143323793|NCT01884350|516729701|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
143323794|NCT01884350|516729702|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
143323795|NCT01884350|516729700|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
143323796|NCT01884350|516729701|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
143323797|NCT01884350|516729702|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
143323798|NCT01884350|516729700|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
143323799|NCT01884350|516729701|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
143323800|NCT01884350|516729702|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
143323801|NCT01884350|516729700|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
143323802|NCT01884350|516729701|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
143323803|NCT01884350|516729702|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
143323804|NCT01884350|516729700|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
143323805|NCT01884350|516729701|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
143323806|NCT01884350|516729702|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
143323807|NCT01884350|516729700|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
143323808|NCT01884350|516729701|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
143323809|NCT01884350|516729702|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
143323810|NCT01884350|516729700|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
143323811|NCT01884350|516729701|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
143380641|NCT02723955|516940650|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143380642|NCT02723955|516940651|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143380643|NCT02723955|516940652|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143380644|NCT02723955|516940653|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143380645|NCT02723955|516940654|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143380646|NCT02723955|516940655|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143380647|NCT02723955|516940656|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143380648|NCT02723955|516940657|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143380649|NCT02723955|516940658|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
143380650|NCT02723955|516940616|FG000|Expansion Phase|Site Closed|0|||
143380651|NCT02723955|516940617|FG001|Expansion Phase|Site Closed|0|||
143380652|NCT02723955|516940618|FG002|Expansion Phase|Site Closed|0|||
143380653|NCT02723955|516940619|FG003|Expansion Phase|Site Closed|0|||
143380654|NCT02723955|516940620|FG004|Expansion Phase|Site Closed|0|||
143380655|NCT02723955|516940621|FG005|Expansion Phase|Site Closed|0|||
143380656|NCT02723955|516940622|FG006|Expansion Phase|Site Closed|0|||
143380657|NCT02723955|516940623|FG007|Expansion Phase|Site Closed|0|||
143380658|NCT02723955|516940624|FG008|Expansion Phase|Site Closed|0|||
143380659|NCT02723955|516940625|FG009|Expansion Phase|Site Closed|1|||
143380660|NCT02723955|516940626|FG010|Expansion Phase|Site Closed|2|||
143380661|NCT02723955|516940627|FG011|Expansion Phase|Site Closed|6|||
143380662|NCT02723955|516940628|FG012|Expansion Phase|Site Closed|0|||
143380663|NCT02723955|516940629|FG013|Expansion Phase|Site Closed|0|||
143323812|NCT01884350|516729702|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
143323813|NCT01884350|516729700|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
143323814|NCT01884350|516729701|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
143323815|NCT01884350|516729702|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
143323816|NCT01884350|516729700|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
143323817|NCT01884350|516729701|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
143323818|NCT01884350|516729702|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
143323819|NCT01884350|516729700|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
143323820|NCT01884350|516729701|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
143323821|NCT01884350|516729702|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
143323822|NCT01884350|516729700|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
143323823|NCT01884350|516729701|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
143323824|NCT01884350|516729702|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
143323825|NCT01884350|516729700|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
143323826|NCT01884350|516729701|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
143323827|NCT01884350|516729702|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
143323828|NCT01884350|516729700|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
143323829|NCT01884350|516729701|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
143323830|NCT01884350|516729702|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
143323831|NCT01884350|516729700|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
143323832|NCT01884350|516729701|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
143323833|NCT01884350|516729702|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
143323834|NCT03588572|516729709|FG000|Visitation 1|Lack of Efficacy|1|||
143323835|NCT03588572|516729710|FG001|Visitation 1|Lack of Efficacy|1|||
143323836|NCT03588572|516729709|FG000|Visitation 2|Lost to Follow-up|1|||
143323837|NCT03588572|516729710|FG001|Visitation 2|Lost to Follow-up|1|||
143323838|NCT03588572|516729709|FG000|Visitation 2|Lack of Efficacy|0|||
143323839|NCT03588572|516729710|FG001|Visitation 2|Lack of Efficacy|1|||
143323840|NCT03588572|516729709|FG000|Visitation 2|Withdrawal by Subject|1|||
143323841|NCT03588572|516729710|FG001|Visitation 2|Withdrawal by Subject|0|||
143323842|NCT03588572|516729709|FG000|Visitation 3|Lost to Follow-up|1|||
143323843|NCT03588572|516729710|FG001|Visitation 3|Lost to Follow-up|1|||
143323844|NCT03588572|516729709|FG000|Visitation 3|Physician Decision|1|||
143323845|NCT03588572|516729710|FG001|Visitation 3|Physician Decision|1|||
143323846|NCT03588572|516729709|FG000|Visitation 3|Withdrawal by Subject|1|||
143323847|NCT03588572|516729710|FG001|Visitation 3|Withdrawal by Subject|0|||
143323848|NCT01165281|516729711|FG000|Overall Study|Adverse Event|12|||
143323849|NCT01165281|516729712|FG001|Overall Study|Adverse Event|14|||
143323850|NCT01165281|516729711|FG000|Overall Study|Death|3|||
143323851|NCT01165281|516729712|FG001|Overall Study|Death|4|||
143323852|NCT01165281|516729711|FG000|Overall Study|Lack of Efficacy|4|||
143323853|NCT01165281|516729712|FG001|Overall Study|Lack of Efficacy|1|||
143323854|NCT01165281|516729711|FG000|Overall Study|Lost to Follow-up|0|||
143323855|NCT01165281|516729712|FG001|Overall Study|Lost to Follow-up|1|||
143323856|NCT01165281|516729711|FG000|Overall Study|Physician Decision|8|||
143323857|NCT01165281|516729712|FG001|Overall Study|Physician Decision|1|||
143323858|NCT01165281|516729711|FG000|Overall Study|Protocol Violation|6|||
143323859|NCT01165281|516729712|FG001|Overall Study|Protocol Violation|5|||
143323860|NCT01165281|516729711|FG000|Overall Study|Withdrawal by Subject|8|||
143323861|NCT01165281|516729712|FG001|Overall Study|Withdrawal by Subject|7|||
143323862|NCT01165281|516729711|FG000|Overall Study|Noncompliance with Study Drug|1|||
143323863|NCT01165281|516729712|FG001|Overall Study|Noncompliance with Study Drug|4|||
143323864|NCT01165281|516729711|FG000|Overall Study|Progressive Disease|10|||
143323865|NCT01165281|516729712|FG001|Overall Study|Progressive Disease|14|||
143323866|NCT01165281|516729711|FG000|Overall Study|Other|6|||
143323867|NCT01165281|516729712|FG001|Overall Study|Other|0|||
143323868|NCT02863991|516729713|FG000|Overall Study|Death|0|||
143323869|NCT02863991|516729714|FG001|Overall Study|Death|3|||
143323870|NCT02863991|516729713|FG000|Overall Study|Lack of Efficacy|0|||
143323871|NCT02863991|516729714|FG001|Overall Study|Lack of Efficacy|1|||
143323872|NCT02863991|516729713|FG000|Overall Study|Study Terminated|2|||
143323873|NCT02863991|516729714|FG001|Overall Study|Study Terminated|8|||
143323874|NCT00364858|516729719|FG000|Overall Study|Adverse Event|1|||
143323875|NCT00364858|516729720|FG001|Overall Study|Adverse Event|5|||
143323876|NCT00364858|516729719|FG000|Overall Study|Withdrawal by Subject|1|||
143323877|NCT00364858|516729720|FG001|Overall Study|Withdrawal by Subject|1|||
143323878|NCT00364858|516729719|FG000|Overall Study|Pregnancy|1|||
143323879|NCT00364858|516729720|FG001|Overall Study|Pregnancy|1|||
143323880|NCT00364858|516729719|FG000|Overall Study|Clinical failure|2|||
143323881|NCT00364858|516729720|FG001|Overall Study|Clinical failure|13|||
143323882|NCT00364858|516729719|FG000|Overall Study|Discontinuation at baseline|1|||
143323883|NCT00364858|516729720|FG001|Overall Study|Discontinuation at baseline|0|||
143323884|NCT00364858|516729719|FG000|Overall Study|Non-compliant|1|||
143380664|NCT02723955|516940630|FG014|Expansion Phase|Site Closed|0|||
143380665|NCT02723955|516940631|FG015|Expansion Phase|Site Closed|0|||
143380666|NCT02723955|516940632|FG016|Expansion Phase|Site Closed|0|||
143380667|NCT02723955|516940633|FG017|Expansion Phase|Site Closed|0|||
143380668|NCT02723955|516940634|FG018|Expansion Phase|Site Closed|0|||
143380669|NCT02723955|516940635|FG019|Expansion Phase|Site Closed|0|||
143380670|NCT02723955|516940636|FG020|Expansion Phase|Site Closed|0|||
143380671|NCT02723955|516940637|FG021|Expansion Phase|Site Closed|0|||
143380672|NCT02723955|516940638|FG022|Expansion Phase|Site Closed|0|||
143380673|NCT02723955|516940639|FG023|Expansion Phase|Site Closed|0|||
143380674|NCT02723955|516940640|FG024|Expansion Phase|Site Closed|0|||
143380675|NCT02723955|516940641|FG025|Expansion Phase|Site Closed|0|||
143380676|NCT02723955|516940642|FG026|Expansion Phase|Site Closed|0|||
143380677|NCT02723955|516940643|FG027|Expansion Phase|Site Closed|0|||
143380678|NCT02723955|516940644|FG028|Expansion Phase|Site Closed|0|||
143380679|NCT02723955|516940645|FG029|Expansion Phase|Site Closed|0|||
143380680|NCT02723955|516940646|FG030|Expansion Phase|Site Closed|8|||
143380681|NCT02723955|516940647|FG031|Expansion Phase|Site Closed|4|||
143380682|NCT02723955|516940648|FG032|Expansion Phase|Site Closed|2|||
143380683|NCT02723955|516940649|FG033|Expansion Phase|Site Closed|2|||
143380684|NCT02723955|516940650|FG034|Expansion Phase|Site Closed|0|||
143380685|NCT02723955|516940651|FG035|Expansion Phase|Site Closed|0|||
143380686|NCT02723955|516940652|FG036|Expansion Phase|Site Closed|0|||
143380687|NCT02723955|516940653|FG037|Expansion Phase|Site Closed|0|||
143380688|NCT02723955|516940654|FG038|Expansion Phase|Site Closed|0|||
143380689|NCT02723955|516940655|FG039|Expansion Phase|Site Closed|0|||
143380690|NCT02723955|516940656|FG040|Expansion Phase|Site Closed|0|||
143380691|NCT02723955|516940657|FG041|Expansion Phase|Site Closed|0|||
143380692|NCT02723955|516940658|FG042|Expansion Phase|Site Closed|0|||
143380693|NCT02723955|516940616|FG000|Crossover/ Re-treatment Phase|Death|0|||
143380694|NCT02723955|516940617|FG001|Crossover/ Re-treatment Phase|Death|0|||
143380695|NCT02723955|516940618|FG002|Crossover/ Re-treatment Phase|Death|0|||
143380696|NCT02723955|516940619|FG003|Crossover/ Re-treatment Phase|Death|0|||
143380697|NCT02723955|516940620|FG004|Crossover/ Re-treatment Phase|Death|0|||
143380698|NCT02723955|516940621|FG005|Crossover/ Re-treatment Phase|Death|0|||
143380699|NCT02723955|516940622|FG006|Crossover/ Re-treatment Phase|Death|0|||
143380700|NCT02723955|516940623|FG007|Crossover/ Re-treatment Phase|Death|0|||
143380701|NCT02723955|516940624|FG008|Crossover/ Re-treatment Phase|Death|0|||
143380702|NCT02723955|516940625|FG009|Crossover/ Re-treatment Phase|Death|0|||
143380703|NCT02723955|516940626|FG010|Crossover/ Re-treatment Phase|Death|0|||
143380704|NCT02723955|516940627|FG011|Crossover/ Re-treatment Phase|Death|0|||
143380705|NCT02723955|516940628|FG012|Crossover/ Re-treatment Phase|Death|0|||
143380706|NCT02723955|516940629|FG013|Crossover/ Re-treatment Phase|Death|0|||
143380707|NCT02723955|516940630|FG014|Crossover/ Re-treatment Phase|Death|0|||
143380708|NCT02723955|516940631|FG015|Crossover/ Re-treatment Phase|Death|0|||
143380709|NCT02723955|516940632|FG016|Crossover/ Re-treatment Phase|Death|0|||
143380710|NCT02723955|516940633|FG017|Crossover/ Re-treatment Phase|Death|0|||
143380711|NCT02723955|516940634|FG018|Crossover/ Re-treatment Phase|Death|0|||
143380712|NCT02723955|516940635|FG019|Crossover/ Re-treatment Phase|Death|0|||
143380713|NCT02723955|516940636|FG020|Crossover/ Re-treatment Phase|Death|0|||
143380714|NCT02723955|516940637|FG021|Crossover/ Re-treatment Phase|Death|0|||
143380715|NCT02723955|516940638|FG022|Crossover/ Re-treatment Phase|Death|0|||
143380716|NCT02723955|516940639|FG023|Crossover/ Re-treatment Phase|Death|0|||
143380717|NCT02723955|516940640|FG024|Crossover/ Re-treatment Phase|Death|0|||
143380718|NCT02723955|516940641|FG025|Crossover/ Re-treatment Phase|Death|0|||
143380719|NCT02723955|516940642|FG026|Crossover/ Re-treatment Phase|Death|0|||
143380720|NCT02723955|516940643|FG027|Crossover/ Re-treatment Phase|Death|0|||
143380721|NCT02723955|516940644|FG028|Crossover/ Re-treatment Phase|Death|0|||
143380722|NCT02723955|516940645|FG029|Crossover/ Re-treatment Phase|Death|0|||
143380723|NCT02723955|516940646|FG030|Crossover/ Re-treatment Phase|Death|0|||
143380724|NCT02723955|516940647|FG031|Crossover/ Re-treatment Phase|Death|0|||
143380725|NCT02723955|516940648|FG032|Crossover/ Re-treatment Phase|Death|0|||
143380726|NCT02723955|516940649|FG033|Crossover/ Re-treatment Phase|Death|0|||
143380727|NCT02723955|516940650|FG034|Crossover/ Re-treatment Phase|Death|0|||
143380728|NCT02723955|516940651|FG035|Crossover/ Re-treatment Phase|Death|0|||
143380729|NCT02723955|516940652|FG036|Crossover/ Re-treatment Phase|Death|0|||
143380730|NCT02723955|516940653|FG037|Crossover/ Re-treatment Phase|Death|1|||
143380731|NCT02723955|516940654|FG038|Crossover/ Re-treatment Phase|Death|14|||
143380732|NCT02723955|516940655|FG039|Crossover/ Re-treatment Phase|Death|32|||
143380733|NCT02723955|516940656|FG040|Crossover/ Re-treatment Phase|Death|2|||
143380734|NCT02723955|516940657|FG041|Crossover/ Re-treatment Phase|Death|1|||
143380735|NCT02723955|516940658|FG042|Crossover/ Re-treatment Phase|Death|0|||
143380736|NCT02723955|516940616|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143380737|NCT02723955|516940617|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143380738|NCT02723955|516940618|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143380739|NCT02723955|516940619|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143380740|NCT02723955|516940620|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143323885|NCT00364858|516729720|FG001|Overall Study|Non-compliant|0|||
143323886|NCT00364858|516729719|FG000|Overall Study|Return to Q2 regimen|0|||
143323887|NCT00364858|516729720|FG001|Overall Study|Return to Q2 regimen|1|||
143323888|NCT00364858|516729719|FG000|Overall Study|Clinical baseline issue|0|||
143323889|NCT00364858|516729720|FG001|Overall Study|Clinical baseline issue|1|||
143323890|NCT01307501|516729721|FG000|Overall Study|Treatment Failure|1|||
143323891|NCT01307501|516729721|FG000|Overall Study|Death|20|||
143323892|NCT01307501|516729721|FG000|Overall Study|Lost to Follow-up|1|||
143323893|NCT01307501|516729721|FG000|Overall Study|Starting Hospice|1|||
143323894|NCT00363766|516729722|FG000|Overall Study|Progressive Disease|15|||
143323895|NCT00363766|516729723|FG001|Overall Study|Progressive Disease|9|||
143323896|NCT00363766|516729722|FG000|Overall Study|Adverse Event|10|||
143323897|NCT00363766|516729723|FG001|Overall Study|Adverse Event|2|||
143323898|NCT00363766|516729722|FG000|Overall Study|Disease Related Death|1|||
143323899|NCT00363766|516729723|FG001|Overall Study|Disease Related Death|3|||
143323900|NCT00363766|516729722|FG000|Overall Study|Not Disease Related Death|3|||
143323901|NCT00363766|516729723|FG001|Overall Study|Not Disease Related Death|4|||
143323902|NCT00363766|516729722|FG000|Overall Study|Withdrawal by Subject|2|||
143323903|NCT00363766|516729723|FG001|Overall Study|Withdrawal by Subject|0|||
143323904|NCT00363766|516729722|FG000|Overall Study|Physician Decision|1|||
143323905|NCT00363766|516729723|FG001|Overall Study|Physician Decision|2|||
143323906|NCT00558285|516729724|FG000|Overall Study|Adverse Event|1|||
143323907|NCT00558285|516729725|FG001|Overall Study|Adverse Event|1|||
143323908|NCT00558285|516729726|FG002|Overall Study|Adverse Event|4|||
143323909|NCT00558285|516729727|FG003|Overall Study|Adverse Event|1|||
143323910|NCT00558285|516729728|FG004|Overall Study|Adverse Event|2|||
143323911|NCT00558285|516729724|FG000|Overall Study|Abnormal test procedure result(s)|1|||
143323912|NCT00558285|516729725|FG001|Overall Study|Abnormal test procedure result(s)|0|||
143323913|NCT00558285|516729726|FG002|Overall Study|Abnormal test procedure result(s)|0|||
143323914|NCT00558285|516729727|FG003|Overall Study|Abnormal test procedure result(s)|0|||
143323915|NCT00558285|516729728|FG004|Overall Study|Abnormal test procedure result(s)|0|||
143323916|NCT00558285|516729724|FG000|Overall Study|Subject withdrew consent|2|||
143323917|NCT00558285|516729725|FG001|Overall Study|Subject withdrew consent|0|||
143323918|NCT00558285|516729726|FG002|Overall Study|Subject withdrew consent|1|||
143323919|NCT00558285|516729727|FG003|Overall Study|Subject withdrew consent|1|||
143323920|NCT00558285|516729728|FG004|Overall Study|Subject withdrew consent|1|||
143323921|NCT00558285|516729724|FG000|Overall Study|Lost to Follow-up|1|||
143323922|NCT00558285|516729725|FG001|Overall Study|Lost to Follow-up|1|||
143323923|NCT00558285|516729726|FG002|Overall Study|Lost to Follow-up|0|||
143323924|NCT00558285|516729727|FG003|Overall Study|Lost to Follow-up|0|||
143323925|NCT00558285|516729728|FG004|Overall Study|Lost to Follow-up|0|||
143323926|NCT00558285|516729724|FG000|Overall Study|Administrative problems|0|||
143323927|NCT00558285|516729725|FG001|Overall Study|Administrative problems|0|||
143323928|NCT00558285|516729726|FG002|Overall Study|Administrative problems|0|||
143323929|NCT00558285|516729727|FG003|Overall Study|Administrative problems|1|||
143323930|NCT00558285|516729728|FG004|Overall Study|Administrative problems|1|||
143323931|NCT00558285|516729724|FG000|Overall Study|Protocol deviation|1|||
143323932|NCT00558285|516729725|FG001|Overall Study|Protocol deviation|1|||
143323933|NCT00558285|516729726|FG002|Overall Study|Protocol deviation|0|||
143323934|NCT00558285|516729727|FG003|Overall Study|Protocol deviation|1|||
143323935|NCT00558285|516729728|FG004|Overall Study|Protocol deviation|0|||
143323936|NCT02345512|516729735|FG000|Overall Study|Adverse Event|1|||
143323937|NCT02345512|516729735|FG000|Overall Study|Withdrawal by Subject|1|||
143323938|NCT03712917|516729738|FG000|Overall Study|Pregnancy|0|||
143323939|NCT03712917|516729739|FG001|Overall Study|Pregnancy|0|||
143323940|NCT03712917|516729740|FG002|Overall Study|Pregnancy|1|||
143323941|NCT03712917|516729738|FG000|Overall Study|Adverse Event|0|||
143323942|NCT03712917|516729739|FG001|Overall Study|Adverse Event|4|||
143323943|NCT03712917|516729740|FG002|Overall Study|Adverse Event|3|||
143323944|NCT03712917|516729738|FG000|Overall Study|Lost to Follow-up|9|||
143323945|NCT03712917|516729739|FG001|Overall Study|Lost to Follow-up|4|||
143323946|NCT03712917|516729740|FG002|Overall Study|Lost to Follow-up|5|||
143323947|NCT04295564|516731653|FG000|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|1|||
143323948|NCT04295564|516731654|FG001|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|0|||
143323949|NCT01773226|516731656|FG000|Overall Study|Withdrawal by Subject|1|||
143323950|NCT00724282|516731663|FG000|Overall Study|Withdrawal by Subject|3|||
143323951|NCT00724282|516731663|FG000|Overall Study|Physician Decision|1|||
143323952|NCT00674986|516731664|FG000|Overall Study|Adverse Event|2|||
143323953|NCT00674986|516731665|FG001|Overall Study|Adverse Event|1|||
143323954|NCT00674986|516731664|FG000|Overall Study|Subject withdrew consent|12|||
143323955|NCT00674986|516731665|FG001|Overall Study|Subject withdrew consent|19|||
143323956|NCT00674986|516731664|FG000|Overall Study|Lost to Follow-up|25|||
143323957|NCT00674986|516731665|FG001|Overall Study|Lost to Follow-up|53|||
143323958|NCT00674986|516731664|FG000|Overall Study|Other reasons|4|||
143323959|NCT00674986|516731665|FG001|Overall Study|Other reasons|8|||
143323960|NCT01880424|516731667|FG000|Overall Study|Adverse Event|7|||
143323961|NCT01880424|516731668|FG001|Overall Study|Adverse Event|6|||
143323962|NCT01880424|516731667|FG000|Overall Study|Lack of Efficacy|1|||
143323963|NCT01880424|516731668|FG001|Overall Study|Lack of Efficacy|4|||
143323964|NCT01880424|516731667|FG000|Overall Study|Lost to Follow-up|3|||
143323965|NCT01880424|516731668|FG001|Overall Study|Lost to Follow-up|2|||
143323966|NCT01880424|516731667|FG000|Overall Study|Protocol Violation|11|||
143323967|NCT01880424|516731668|FG001|Overall Study|Protocol Violation|13|||
143323968|NCT01880424|516731667|FG000|Overall Study|Withdrawal by Subject|10|||
143323969|NCT01880424|516731668|FG001|Overall Study|Withdrawal by Subject|30|||
143323970|NCT01880424|516731667|FG000|Overall Study|Other|1|||
143323971|NCT01880424|516731668|FG001|Overall Study|Other|0|||
143323972|NCT03521635|516731669|FG000|Overall Study|Adverse Event|1|||
143323973|NCT03521635|516731670|FG001|Overall Study|Adverse Event|1|||
143323974|NCT03521635|516731669|FG000|Overall Study|Refused to complete study visit|1|||
143323975|NCT03521635|516731670|FG001|Overall Study|Refused to complete study visit|0|||
143323976|NCT03521635|516731669|FG000|Overall Study|Refused to continue trial medication|2|||
143323977|NCT03521635|516731670|FG001|Overall Study|Refused to continue trial medication|2|||
143323978|NCT03521635|516731669|FG000|Overall Study|Lost to Follow-up|0|||
143323979|NCT03521635|516731670|FG001|Overall Study|Lost to Follow-up|1|||
143323980|NCT03521635|516731669|FG000|Overall Study|Meet exclusion criteria|0|||
143323981|NCT03521635|516731670|FG001|Overall Study|Meet exclusion criteria|1|||
143323982|NCT03521635|516731669|FG000|Overall Study|Patient not taken study medicine|0|||
143323983|NCT03521635|516731670|FG001|Overall Study|Patient not taken study medicine|1|||
143323984|NCT05732454|516731671|FG000|Part 1: DB Period|Withdrawal by Subject|1|||
143323985|NCT05732454|516731672|FG001|Part 1: DB Period|Withdrawal by Subject|2|||
143323986|NCT05732454|516731671|FG000|Part 1: DB Period|Adverse Event|1|||
143323987|NCT05732454|516731672|FG001|Part 1: DB Period|Adverse Event|0|||
143323988|NCT05732454|516731671|FG000|Part 1: DB Period|Lost to Follow-up|1|||
143323989|NCT05732454|516731672|FG001|Part 1: DB Period|Lost to Follow-up|0|||
143323990|NCT05732454|516731671|FG000|Part 1: DB Period|Protocol Violation|0|||
143323991|NCT05732454|516731672|FG001|Part 1: DB Period|Protocol Violation|1|||
143323992|NCT05732454|516731671|FG000|Part 1: OLE Period|Study Terminated by Sponsor|25|||
143323993|NCT05732454|516731672|FG001|Part 1: OLE Period|Study Terminated by Sponsor|19|||
143323994|NCT05732454|516731671|FG000|Part 1: OLE Period|Withdrawal by Subject|2|||
143323995|NCT05732454|516731672|FG001|Part 1: OLE Period|Withdrawal by Subject|3|||
143323996|NCT05732454|516731671|FG000|Part 1: OLE Period|Adverse Event|0|||
143323997|NCT05732454|516731672|FG001|Part 1: OLE Period|Adverse Event|1|||
143323998|NCT05732454|516731671|FG000|Part 1: OLE Period|Lack of Efficacy|0|||
143323999|NCT05732454|516731672|FG001|Part 1: OLE Period|Lack of Efficacy|1|||
143324000|NCT01153633|516731673|FG000|Overall Study|Protocol Violation|1|||
143324001|NCT01153633|516731674|FG001|Overall Study|Protocol Violation|1|||
143324002|NCT01153633|516731673|FG000|Overall Study|Therapeutic failure|3|||
143324003|NCT01153633|516731674|FG001|Overall Study|Therapeutic failure|3|||
143324004|NCT01003899|516731679|FG000|Overall Study|Other Adverse Event|8|||
143324005|NCT01003899|516731679|FG000|Overall Study|Not entered|4|||
143324006|NCT01003899|516731679|FG000|Overall Study|Not treated|1|||
143324007|NCT01003899|516731679|FG000|Overall Study|Progressive disease|34|||
143324008|NCT00352365|516731680|FG000|Induction Therapy|Adverse Event|7|||
143324009|NCT00352365|516731680|FG000|Induction Therapy|Progression/Relapse|8|||
143324010|NCT00352365|516731680|FG000|Induction Therapy|Death|7|||
143324011|NCT00352365|516731680|FG000|Induction Therapy|Not protocol specified|1|||
143324012|NCT00352365|516731680|FG000|Induction Therapy|Not eligible|3|||
143324013|NCT00352365|516731680|FG000|Induction Therapy|Death before starting protocol therapy|1|||
143324014|NCT00352365|516731680|FG000|Maintenance Therapy|Progression/Relapse|3|||
143324015|NCT00352365|516731680|FG000|Maintenance Therapy|Death|2|||
143324016|NCT00352365|516731680|FG000|Maintenance Therapy|Not protocol specified|3|||
143324017|NCT00352365|516731680|FG000|Maintenance Therapy|Not eligible|4|||
143324018|NCT01262651|516731681|FG000|Overall Study|Adverse Event|40|||
143324019|NCT01262651|516731682|FG001|Overall Study|Adverse Event|35|||
143324020|NCT01262651|516731681|FG000|Overall Study|Withdrawal by Subject|15|||
143324021|NCT01262651|516731682|FG001|Overall Study|Withdrawal by Subject|11|||
143324022|NCT01262651|516731681|FG000|Overall Study|Withdrawal by Investigator|2|||
143324023|NCT01262651|516731682|FG001|Overall Study|Withdrawal by Investigator|2|||
143324024|NCT01262651|516731681|FG000|Overall Study|Met Withdrawal Criteria|1|||
143324025|NCT01262651|516731682|FG001|Overall Study|Met Withdrawal Criteria|0|||
143324026|NCT04969783|516731683|FG000|Overall Study|Lost to Follow-up|2|||
143324027|NCT04969783|516731684|FG001|Overall Study|Lost to Follow-up|0|||
143324028|NCT04969783|516731683|FG000|Overall Study|Withdrawal by Subject|4|||
143324029|NCT04969783|516731684|FG001|Overall Study|Withdrawal by Subject|0|||
143324030|NCT04969783|516731683|FG000|Overall Study|Physician Decision|6|||
143324031|NCT04969783|516731684|FG001|Overall Study|Physician Decision|0|||
143324032|NCT03422250|516731685|FG000|Intervention|Adverse Event|0|||
143324033|NCT03422250|516731686|FG001|Intervention|Adverse Event|1|||
143324034|NCT03422250|516731687|FG002|Intervention|Adverse Event|0|||
143324035|NCT03422250|516731688|FG003|Intervention|Adverse Event|1|||
143324036|NCT03422250|516731685|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
143454259|NCT01712659|517208168|FG000|Dose Expansion|Physician Decision|1|||
143324037|NCT03422250|516731686|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
143324038|NCT03422250|516731687|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
143324039|NCT03422250|516731688|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
143324040|NCT03422250|516731685|FG000|Follow-up|Withdrawal by Subject|0|||
143324041|NCT03422250|516731686|FG001|Follow-up|Withdrawal by Subject|0|||
143324042|NCT03422250|516731687|FG002|Follow-up|Withdrawal by Subject|0|||
143324043|NCT03422250|516731688|FG003|Follow-up|Withdrawal by Subject|1|||
143324044|NCT03422250|516731685|FG000|Follow-up|Adverse Event|0|||
143324045|NCT03422250|516731686|FG001|Follow-up|Adverse Event|0|||
143324046|NCT03422250|516731687|FG002|Follow-up|Adverse Event|0|||
143324047|NCT03422250|516731688|FG003|Follow-up|Adverse Event|1|||
143324048|NCT02896855|516731698|FG000|Overall Study|Death|50|||
143324049|NCT02896855|516731699|FG001|Overall Study|Death|40|||
143324050|NCT02896855|516731698|FG000|Overall Study|Lost to Follow-up|15|||
143324051|NCT02896855|516731699|FG001|Overall Study|Lost to Follow-up|9|||
143324052|NCT02896855|516731698|FG000|Overall Study|Withdrawal by Subject|7|||
143324053|NCT02896855|516731699|FG001|Overall Study|Withdrawal by Subject|4|||
143324054|NCT01205685|516731700|FG000|Overall Study|Disease Progression|10|||
143324055|NCT01205685|516731700|FG000|Overall Study|Withdrawal by Subject|1|||
143324056|NCT02169674|516731701|FG000|Overall Study|Withdrawal by Subject|2|||
143324057|NCT02169674|516731702|FG001|Overall Study|Withdrawal by Subject|1|||
143324058|NCT02169674|516731701|FG000|Overall Study|Seroprotected|30|||
143324059|NCT02169674|516731702|FG001|Overall Study|Seroprotected|76|||
143324060|NCT02169674|516731701|FG000|Overall Study|Lost to Follow-up|0|||
143324061|NCT02169674|516731702|FG001|Overall Study|Lost to Follow-up|1|||
143324062|NCT03058679|516731705|FG000|Baseline to Week 6|Lost to Follow-up|3|||
143324063|NCT03058679|516731706|FG001|Baseline to Week 6|Lost to Follow-up|2|||
143324064|NCT03058679|516731705|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
143324065|NCT03058679|516731706|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
143324066|NCT03058679|516731705|FG000|Baseline to Week 6|Adverse Event|6|||
143324067|NCT03058679|516731706|FG001|Baseline to Week 6|Adverse Event|6|||
143324068|NCT03058679|516731705|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
143324069|NCT03058679|516731706|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
143324070|NCT03058679|516731705|FG000|Baseline to Week 6|Difficulty following the diet|0|||
143324071|NCT03058679|516731706|FG001|Baseline to Week 6|Difficulty following the diet|2|||
143324072|NCT03058679|516731705|FG000|Baseline to Week 6|Physician Decision|1|||
143324073|NCT03058679|516731706|FG001|Baseline to Week 6|Physician Decision|0|||
143324074|NCT03058679|516731705|FG000|Week 6 to Week 12|Change in medication|5|||
143324075|NCT03058679|516731706|FG001|Week 6 to Week 12|Change in medication|7|||
143324076|NCT03058679|516731705|FG000|Week 6 to Week 12|Adverse Event|4|||
143324077|NCT03058679|516731706|FG001|Week 6 to Week 12|Adverse Event|3|||
143324078|NCT03058679|516731705|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
143324079|NCT03058679|516731706|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
143324080|NCT03058679|516731705|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
143324081|NCT03058679|516731706|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
143324082|NCT00563784|516731707|FG000|Overall Study|Withdrawal by Subject|2|||
143324083|NCT00563784|516731707|FG000|Overall Study|Screen Failures|20|||
143324084|NCT02528214|516731714|FG000|Overall Study|Protocol Violation|0|||
143324085|NCT02528214|516731715|FG001|Overall Study|Protocol Violation|1|||
143324086|NCT02528214|516731714|FG000|Overall Study|Adverse Event|0|||
143324087|NCT02528214|516731715|FG001|Overall Study|Adverse Event|1|||
143324088|NCT02528214|516731714|FG000|Overall Study|Other than specified above|0|||
143324089|NCT02528214|516731715|FG001|Overall Study|Other than specified above|1|||
143324090|NCT01380327|516731716|FG000|Overall Study|Lost to Follow-up|0|||
143324091|NCT01380327|516731717|FG001|Overall Study|Lost to Follow-up|1|||
143324092|NCT01380327|516731718|FG002|Overall Study|Lost to Follow-up|1|||
143324093|NCT01380327|516731716|FG000|Overall Study|Protocol Violation|3|||
143324094|NCT01380327|516731717|FG001|Overall Study|Protocol Violation|2|||
143324095|NCT01380327|516731718|FG002|Overall Study|Protocol Violation|3|||
143324096|NCT01380327|516731716|FG000|Overall Study|Withdrawal by Subject|0|||
143324097|NCT01380327|516731717|FG001|Overall Study|Withdrawal by Subject|0|||
143324098|NCT01380327|516731718|FG002|Overall Study|Withdrawal by Subject|1|||
143324099|NCT01380327|516731716|FG000|Overall Study|Housing situation precluded ability to k|0|||
143324100|NCT01380327|516731717|FG001|Overall Study|Housing situation precluded ability to k|0|||
143324101|NCT01380327|516731718|FG002|Overall Study|Housing situation precluded ability to k|1|||
143324102|NCT01380327|516731716|FG000|Overall Study|Questionable onset of epilepsy|0|||
143324103|NCT01380327|516731717|FG001|Overall Study|Questionable onset of epilepsy|0|||
143324104|NCT01380327|516731718|FG002|Overall Study|Questionable onset of epilepsy|1|||
143324105|NCT02504294|516731721|FG000|Overall Study|Adverse Event|15|||
143324106|NCT02504294|516731722|FG001|Overall Study|Adverse Event|12|||
143324107|NCT02504294|516731721|FG000|Overall Study|Withdrawal by Subject|7|||
143324108|NCT02504294|516731722|FG001|Overall Study|Withdrawal by Subject|1|||
143324109|NCT02504294|516731721|FG000|Overall Study|Protocol Violation|27|||
143324110|NCT02504294|516731722|FG001|Overall Study|Protocol Violation|26|||
143324111|NCT02504294|516731721|FG000|Overall Study|Physician Decision|1|||
143324112|NCT02504294|516731722|FG001|Overall Study|Physician Decision|2|||
143380741|NCT02723955|516940621|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143380742|NCT02723955|516940622|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143380743|NCT02723955|516940623|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143380744|NCT02723955|516940624|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143380745|NCT02723955|516940625|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143380746|NCT02723955|516940626|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143380747|NCT02723955|516940627|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143380748|NCT02723955|516940628|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143380749|NCT02723955|516940629|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143380750|NCT02723955|516940630|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143380751|NCT02723955|516940631|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143380752|NCT02723955|516940632|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143380753|NCT02723955|516940633|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143324113|NCT02504294|516731721|FG000|Overall Study|Lost to Follow-up|6|||
143324114|NCT02504294|516731722|FG001|Overall Study|Lost to Follow-up|7|||
143324115|NCT00968669|516731723|FG000|Overall Study|Lost to Follow-up|5|||
143324116|NCT00968669|516731724|FG001|Overall Study|Lost to Follow-up|2|||
143324117|NCT00968669|516731725|FG002|Overall Study|Lost to Follow-up|1|||
143324118|NCT00968669|516731726|FG003|Overall Study|Lost to Follow-up|4|||
143324119|NCT00968669|516731723|FG000|Overall Study|Withdrawal by Subject|9|||
143324120|NCT00968669|516731724|FG001|Overall Study|Withdrawal by Subject|7|||
143324121|NCT00968669|516731725|FG002|Overall Study|Withdrawal by Subject|5|||
143324122|NCT00968669|516731726|FG003|Overall Study|Withdrawal by Subject|3|||
143324123|NCT00968669|516731723|FG000|Overall Study|Pregnancy|0|||
143324124|NCT00968669|516731724|FG001|Overall Study|Pregnancy|0|||
143324125|NCT00968669|516731725|FG002|Overall Study|Pregnancy|2|||
143324126|NCT00968669|516731726|FG003|Overall Study|Pregnancy|0|||
143324127|NCT00968669|516731723|FG000|Overall Study|AE|1|||
143324128|NCT00968669|516731724|FG001|Overall Study|AE|0|||
143324129|NCT00968669|516731725|FG002|Overall Study|AE|0|||
143324130|NCT00968669|516731726|FG003|Overall Study|AE|0|||
143324131|NCT00968669|516731723|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
143324132|NCT00968669|516731724|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
143324133|NCT00968669|516731725|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
143324134|NCT00968669|516731726|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
143324135|NCT00968669|516731723|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
143324136|NCT00968669|516731724|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
143324137|NCT00968669|516731725|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
143324138|NCT00968669|516731726|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
143324139|NCT00968669|516731723|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
143324140|NCT00968669|516731724|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
143324141|NCT00968669|516731725|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
143324142|NCT00968669|516731726|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
143324143|NCT00968669|516731723|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
143324144|NCT00968669|516731724|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
143324145|NCT00968669|516731725|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
143324146|NCT00968669|516731726|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
143324147|NCT00968669|516731723|FG000|Overall Study|EARLY WITHDRAWAL|0|||
143324148|NCT00968669|516731724|FG001|Overall Study|EARLY WITHDRAWAL|1|||
143324149|NCT00968669|516731725|FG002|Overall Study|EARLY WITHDRAWAL|0|||
143324150|NCT00968669|516731726|FG003|Overall Study|EARLY WITHDRAWAL|0|||
143324151|NCT00968669|516731723|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
143324152|NCT00968669|516731724|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
143324153|NCT00968669|516731725|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
143324154|NCT00968669|516731726|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
143380754|NCT02723955|516940634|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143324155|NCT00968669|516731723|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
143324156|NCT00968669|516731724|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
143324157|NCT00968669|516731725|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
143380755|NCT02723955|516940635|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143380756|NCT02723955|516940636|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143380757|NCT02723955|516940637|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143380758|NCT02723955|516940638|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143380759|NCT02723955|516940639|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143380760|NCT02723955|516940640|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143324158|NCT00968669|516731726|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
143324159|NCT00968669|516731723|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
143324160|NCT00968669|516731724|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
143324161|NCT00968669|516731725|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
143324162|NCT00968669|516731726|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
143324163|NCT00968669|516731723|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
143380761|NCT02723955|516940641|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143380762|NCT02723955|516940642|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143380763|NCT02723955|516940643|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143380764|NCT02723955|516940644|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143380765|NCT02723955|516940645|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143380766|NCT02723955|516940646|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143380767|NCT02723955|516940647|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143380768|NCT02723955|516940648|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143380769|NCT02723955|516940649|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143380770|NCT02723955|516940650|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143380771|NCT02723955|516940651|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143380772|NCT02723955|516940652|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143380773|NCT02723955|516940653|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143380774|NCT02723955|516940654|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143380775|NCT02723955|516940655|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
143380776|NCT02723955|516940656|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143380777|NCT02723955|516940657|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143380778|NCT02723955|516940658|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
143380779|NCT02723955|516940616|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
143380780|NCT02723955|516940617|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
143380781|NCT02723955|516940618|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
143380782|NCT02723955|516940619|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
143380783|NCT02723955|516940620|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
143380784|NCT02723955|516940621|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
143380785|NCT02723955|516940622|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
143380786|NCT02723955|516940623|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
143380787|NCT02723955|516940624|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
143380788|NCT02723955|516940625|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
143380789|NCT02723955|516940626|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
143380790|NCT02723955|516940627|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
143380791|NCT02723955|516940628|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
143380792|NCT02723955|516940629|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
143380793|NCT02723955|516940630|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
143380794|NCT02723955|516940631|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
143380795|NCT02723955|516940632|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
143380796|NCT02723955|516940633|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
143380797|NCT02723955|516940634|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
143380798|NCT02723955|516940635|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
143380799|NCT02723955|516940636|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
143380800|NCT02723955|516940637|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
143380801|NCT02723955|516940638|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
143380802|NCT02723955|516940639|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
143380803|NCT02723955|516940640|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
143324164|NCT00968669|516731724|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
143324165|NCT00968669|516731725|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
143324166|NCT00968669|516731726|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
143324167|NCT00968669|516731723|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
143324168|NCT00968669|516731724|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
143324169|NCT00968669|516731725|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
143324170|NCT00968669|516731726|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
143324171|NCT00968669|516731723|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
143324172|NCT00968669|516731724|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
143324173|NCT00968669|516731725|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
143324174|NCT00968669|516731726|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
143324175|NCT00968669|516731723|FG000|Overall Study|SPONSOR DECISION|0|||
143324176|NCT00968669|516731724|FG001|Overall Study|SPONSOR DECISION|1|||
143380804|NCT02723955|516940641|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
143380805|NCT02723955|516940642|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
143380806|NCT02723955|516940643|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
143380807|NCT02723955|516940644|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
143324177|NCT00968669|516731725|FG002|Overall Study|SPONSOR DECISION|0|||
143324178|NCT00968669|516731726|FG003|Overall Study|SPONSOR DECISION|0|||
143324179|NCT00968669|516731723|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
143380808|NCT02723955|516940645|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
143380809|NCT02723955|516940646|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
143380810|NCT02723955|516940647|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
143380811|NCT02723955|516940648|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
143380812|NCT02723955|516940649|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
143380813|NCT02723955|516940650|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
143324180|NCT00968669|516731724|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
143324181|NCT00968669|516731725|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
143324182|NCT00968669|516731726|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
143324183|NCT00968669|516731723|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
143324184|NCT00968669|516731724|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
143324185|NCT00968669|516731725|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
143324186|NCT00968669|516731726|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
143324187|NCT00968669|516731723|FG000|Overall Study|SUBJECT INCARCERATED|0|||
143324188|NCT00968669|516731724|FG001|Overall Study|SUBJECT INCARCERATED|1|||
143324189|NCT00968669|516731725|FG002|Overall Study|SUBJECT INCARCERATED|0|||
143324190|NCT00968669|516731726|FG003|Overall Study|SUBJECT INCARCERATED|0|||
143324191|NCT00968669|516731723|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
143324192|NCT00968669|516731724|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
143324193|NCT00968669|516731725|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
143324194|NCT00968669|516731726|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
143324195|NCT00968669|516731723|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
143324196|NCT00968669|516731724|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
143324197|NCT00968669|516731725|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
143324198|NCT00968669|516731726|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
143324199|NCT01953926|516731727|FG000|Overall Study|Withdrawal by Subject|23|||
143324200|NCT01953926|516731728|FG001|Overall Study|Withdrawal by Subject|3|||
143324201|NCT01953926|516731729|FG002|Overall Study|Withdrawal by Subject|3|||
143324202|NCT01953926|516731730|FG003|Overall Study|Withdrawal by Subject|5|||
143324203|NCT01953926|516731731|FG004|Overall Study|Withdrawal by Subject|6|||
143324204|NCT01953926|516731732|FG005|Overall Study|Withdrawal by Subject|0|||
143324205|NCT01953926|516731733|FG006|Overall Study|Withdrawal by Subject|1|||
143324206|NCT01953926|516731727|FG000|Overall Study|Physician Decision|1|||
143324207|NCT01953926|516731728|FG001|Overall Study|Physician Decision|0|||
143324208|NCT01953926|516731729|FG002|Overall Study|Physician Decision|0|||
143324209|NCT01953926|516731730|FG003|Overall Study|Physician Decision|0|||
143324210|NCT01953926|516731731|FG004|Overall Study|Physician Decision|2|||
143324211|NCT01953926|516731732|FG005|Overall Study|Physician Decision|0|||
143324212|NCT01953926|516731733|FG006|Overall Study|Physician Decision|0|||
143324213|NCT01953926|516731727|FG000|Overall Study|Lost to Follow-up|18|||
143324214|NCT01953926|516731728|FG001|Overall Study|Lost to Follow-up|3|||
143324215|NCT01953926|516731729|FG002|Overall Study|Lost to Follow-up|0|||
143324216|NCT01953926|516731730|FG003|Overall Study|Lost to Follow-up|5|||
143324217|NCT01953926|516731731|FG004|Overall Study|Lost to Follow-up|3|||
143324218|NCT01953926|516731732|FG005|Overall Study|Lost to Follow-up|0|||
143324219|NCT01953926|516731733|FG006|Overall Study|Lost to Follow-up|0|||
143324220|NCT01953926|516731727|FG000|Overall Study|Protocol Violation|1|||
143324221|NCT01953926|516731728|FG001|Overall Study|Protocol Violation|0|||
143324222|NCT01953926|516731729|FG002|Overall Study|Protocol Violation|0|||
143324223|NCT01953926|516731730|FG003|Overall Study|Protocol Violation|0|||
143324224|NCT01953926|516731731|FG004|Overall Study|Protocol Violation|0|||
143324225|NCT01953926|516731732|FG005|Overall Study|Protocol Violation|0|||
143324226|NCT01953926|516731733|FG006|Overall Study|Protocol Violation|0|||
143324227|NCT01953926|516731727|FG000|Overall Study|Other, Disease progression|2|||
143324228|NCT01953926|516731728|FG001|Overall Study|Other, Disease progression|1|||
143324229|NCT01953926|516731729|FG002|Overall Study|Other, Disease progression|0|||
143324230|NCT01953926|516731730|FG003|Overall Study|Other, Disease progression|0|||
143324231|NCT01953926|516731731|FG004|Overall Study|Other, Disease progression|1|||
143324232|NCT01953926|516731732|FG005|Overall Study|Other, Disease progression|0|||
143324233|NCT01953926|516731733|FG006|Overall Study|Other, Disease progression|0|||
143324234|NCT01953926|516731727|FG000|Overall Study|Discontinuation of study by sponsor|41|||
143324235|NCT01953926|516731728|FG001|Overall Study|Discontinuation of study by sponsor|7|||
143324236|NCT01953926|516731729|FG002|Overall Study|Discontinuation of study by sponsor|5|||
143324237|NCT01953926|516731730|FG003|Overall Study|Discontinuation of study by sponsor|12|||
143324238|NCT01953926|516731731|FG004|Overall Study|Discontinuation of study by sponsor|46|||
143324239|NCT01953926|516731732|FG005|Overall Study|Discontinuation of study by sponsor|5|||
143324240|NCT01953926|516731733|FG006|Overall Study|Discontinuation of study by sponsor|6|||
143324241|NCT01953926|516731727|FG000|Overall Study|Not Treated|1|||
143324242|NCT01953926|516731728|FG001|Overall Study|Not Treated|0|||
143324243|NCT01953926|516731729|FG002|Overall Study|Not Treated|1|||
143380814|NCT02723955|516940651|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
143324244|NCT01953926|516731730|FG003|Overall Study|Not Treated|0|||
143324245|NCT01953926|516731731|FG004|Overall Study|Not Treated|0|||
143324246|NCT01953926|516731732|FG005|Overall Study|Not Treated|0|||
143324247|NCT01953926|516731733|FG006|Overall Study|Not Treated|0|||
143324248|NCT01949480|516731736|FG000|Overall Study|Physician Decision|5|||
143324249|NCT01949480|516731737|FG001|Overall Study|Physician Decision|8|||
143324250|NCT00144339|516731738|FG000|Overall Study|Adverse Event|746|||
143324251|NCT00144339|516731739|FG001|Overall Study|Adverse Event|627|||
143324252|NCT00144339|516731738|FG000|Overall Study|Protocol Violation|75|||
143324253|NCT00144339|516731739|FG001|Overall Study|Protocol Violation|48|||
143324254|NCT00144339|516731738|FG000|Overall Study|Withdrawal by Subject|403|||
143324255|NCT00144339|516731739|FG001|Overall Study|Withdrawal by Subject|300|||
143324256|NCT00144339|516731738|FG000|Overall Study|Lost to Follow-up|76|||
143324257|NCT00144339|516731739|FG001|Overall Study|Lost to Follow-up|64|||
143324258|NCT00144339|516731738|FG000|Overall Study|Other|58|||
143324259|NCT00144339|516731739|FG001|Overall Study|Other|60|||
143324260|NCT00968617|516731740|FG000|Overall Study|Study terminated by sponsor|6|||
143324261|NCT03538626|516731745|FG000|Overall Study|Withdrawal by Subject|0|||
143324262|NCT03538626|516731746|FG001|Overall Study|Withdrawal by Subject|1|||
143324263|NCT03538626|516731747|FG002|Overall Study|Withdrawal by Subject|0|||
143324264|NCT03538626|516731748|FG003|Overall Study|Withdrawal by Subject|0|||
143324265|NCT03538626|516731749|FG004|Overall Study|Withdrawal by Subject|0|||
143324266|NCT03538626|516731750|FG005|Overall Study|Withdrawal by Subject|0|||
143324267|NCT03538626|516731751|FG006|Overall Study|Withdrawal by Subject|0|||
143324268|NCT03538626|516731752|FG007|Overall Study|Withdrawal by Subject|0|||
143324269|NCT03538626|516731745|FG000|Overall Study|Lost to Follow-up|0|||
143324270|NCT03538626|516731746|FG001|Overall Study|Lost to Follow-up|0|||
143324271|NCT03538626|516731747|FG002|Overall Study|Lost to Follow-up|0|||
143324272|NCT03538626|516731748|FG003|Overall Study|Lost to Follow-up|0|||
143324273|NCT03538626|516731749|FG004|Overall Study|Lost to Follow-up|0|||
143324274|NCT03538626|516731750|FG005|Overall Study|Lost to Follow-up|0|||
143324275|NCT03538626|516731751|FG006|Overall Study|Lost to Follow-up|1|||
143324276|NCT03538626|516731752|FG007|Overall Study|Lost to Follow-up|0|||
143324277|NCT02911948|516731754|FG000|Overall Study|Protocol Violation|0|||
143324278|NCT02911948|516731755|FG001|Overall Study|Protocol Violation|1|||
143324279|NCT02911948|516731754|FG000|Overall Study|Withdrawal by Subject|0|||
143324280|NCT02911948|516731755|FG001|Overall Study|Withdrawal by Subject|2|||
143324281|NCT02911948|516731754|FG000|Overall Study|Lack of Efficacy|0|||
143324282|NCT02911948|516731755|FG001|Overall Study|Lack of Efficacy|1|||
143324283|NCT02911948|516731754|FG000|Overall Study|Unclassified|0|||
143324284|NCT02911948|516731755|FG001|Overall Study|Unclassified|3|||
143324285|NCT01660763|516731771|FG000|Overall Study|Lack of Efficacy|45|||
143324286|NCT01660763|516731772|FG001|Overall Study|Lack of Efficacy|50|||
143324287|NCT01660763|516731771|FG000|Overall Study|Adverse Event|22|||
143324288|NCT01660763|516731772|FG001|Overall Study|Adverse Event|7|||
143324289|NCT01660763|516731771|FG000|Overall Study|Protocol Violation|1|||
143324290|NCT01660763|516731772|FG001|Overall Study|Protocol Violation|0|||
143324291|NCT01660763|516731771|FG000|Overall Study|Withdrawal by Subject|4|||
143324292|NCT01660763|516731772|FG001|Overall Study|Withdrawal by Subject|0|||
143324293|NCT01660763|516731771|FG000|Overall Study|Patient ready for early discharge|28|||
143380815|NCT02723955|516940652|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
143380816|NCT02723955|516940653|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
143380817|NCT02723955|516940654|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
143380818|NCT02723955|516940655|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
143380819|NCT02723955|516940656|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
143380820|NCT02723955|516940657|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
143380821|NCT02723955|516940658|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
143380822|NCT02723955|516940616|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
143380823|NCT02723955|516940617|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
143380824|NCT02723955|516940618|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
143380825|NCT02723955|516940619|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
143380826|NCT02723955|516940620|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
143380827|NCT02723955|516940621|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
143380828|NCT02723955|516940622|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
143380829|NCT02723955|516940623|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
143380830|NCT02723955|516940624|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
143380831|NCT02723955|516940625|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
143380832|NCT02723955|516940626|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
143380833|NCT02723955|516940627|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
143380834|NCT02723955|516940628|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
143380835|NCT02723955|516940629|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
143380836|NCT02723955|516940630|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
143380837|NCT02723955|516940631|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
143324294|NCT01660763|516731772|FG001|Overall Study|Patient ready for early discharge|4|||
143324295|NCT01910519|516731773|FG000|Overall Study|Withdrawal by Subject|2|||
143324296|NCT01910519|516731774|FG001|Overall Study|Withdrawal by Subject|0|||
143324297|NCT01910519|516731773|FG000|Overall Study|Adverse Event|2|||
143324298|NCT01910519|516731774|FG001|Overall Study|Adverse Event|0|||
143324299|NCT04266028|516731775|FG000|Overall Study|Adverse Event|0|||
143380838|NCT02723955|516940632|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
143324300|NCT04266028|516731776|FG001|Overall Study|Adverse Event|0|||
143324301|NCT04266028|516731777|FG002|Overall Study|Adverse Event|1|||
143324302|NCT04266028|516731778|FG003|Overall Study|Adverse Event|0|||
143324303|NCT04266028|516731779|FG004|Overall Study|Adverse Event|1|||
143324304|NCT04266028|516731780|FG005|Overall Study|Adverse Event|0|||
143324305|NCT04266028|516731781|FG006|Overall Study|Adverse Event|2|||
143324306|NCT04266028|516731782|FG007|Overall Study|Adverse Event|0|||
143324307|NCT04266028|516731775|FG000|Overall Study|temporary halt of the study|0|||
143324308|NCT04266028|516731776|FG001|Overall Study|temporary halt of the study|0|||
143380839|NCT02723955|516940633|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
143380840|NCT02723955|516940634|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
143380841|NCT02723955|516940635|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
143380842|NCT02723955|516940636|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
143380843|NCT02723955|516940637|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
143380844|NCT02723955|516940638|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
143380845|NCT02723955|516940639|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
143380846|NCT02723955|516940640|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
143380847|NCT02723955|516940641|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
143380848|NCT02723955|516940642|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
143380849|NCT02723955|516940643|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
143380850|NCT02723955|516940644|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
143380851|NCT02723955|516940645|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
143380852|NCT02723955|516940646|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
143380853|NCT02723955|516940647|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
143380854|NCT02723955|516940648|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
143380855|NCT02723955|516940649|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
143380856|NCT02723955|516940650|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
143380857|NCT02723955|516940651|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
143380858|NCT02723955|516940652|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
143380859|NCT02723955|516940653|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
143380860|NCT02723955|516940654|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
143380861|NCT02723955|516940655|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
143380862|NCT02723955|516940656|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
143380863|NCT02723955|516940657|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
143380864|NCT02723955|516940658|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
143380865|NCT04999085|516940661|FG000|Overall Study|Death|1|||
143380866|NCT05056246|516940662|FG000|Overall Study|Adverse Event|0|||
143380867|NCT05056246|516940663|FG001|Overall Study|Adverse Event|0|||
143380868|NCT05056246|516940664|FG002|Overall Study|Adverse Event|0|||
143380869|NCT05056246|516940665|FG003|Overall Study|Adverse Event|0|||
143380870|NCT05056246|516940666|FG004|Overall Study|Adverse Event|1|||
143380871|NCT05056246|516940662|FG000|Overall Study|Lost to Follow-up|0|||
143380872|NCT05056246|516940663|FG001|Overall Study|Lost to Follow-up|0|||
143380873|NCT05056246|516940664|FG002|Overall Study|Lost to Follow-up|0|||
143380874|NCT05056246|516940665|FG003|Overall Study|Lost to Follow-up|2|||
143380875|NCT05056246|516940666|FG004|Overall Study|Lost to Follow-up|0|||
143380876|NCT05056246|516940662|FG000|Overall Study|Withdrawal by Subject|0|||
143380877|NCT05056246|516940663|FG001|Overall Study|Withdrawal by Subject|1|||
143380878|NCT05056246|516940664|FG002|Overall Study|Withdrawal by Subject|0|||
143380879|NCT05056246|516940665|FG003|Overall Study|Withdrawal by Subject|0|||
143380880|NCT05056246|516940666|FG004|Overall Study|Withdrawal by Subject|0|||
143380881|NCT03346538|516940667|FG000|Overall Study|Physician Decision|0|||
143380882|NCT03346538|516940668|FG001|Overall Study|Physician Decision|1|||
143380883|NCT03346538|516940669|FG002|Overall Study|Physician Decision|0|||
143380884|NCT03346538|516940667|FG000|Overall Study|Withdrawal by Subject|3|||
143380885|NCT03346538|516940668|FG001|Overall Study|Withdrawal by Subject|2|||
143380886|NCT03346538|516940669|FG002|Overall Study|Withdrawal by Subject|0|||
143380887|NCT03346538|516940667|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
143380888|NCT03346538|516940668|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
143380889|NCT03346538|516940669|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
143380890|NCT05672667|516940670|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
143380891|NCT01903811|516940678|FG000|Overall Study|No measurable disease|1|||
143380892|NCT01903811|516940679|FG001|Overall Study|No measurable disease|1|||
143380893|NCT01903811|516940678|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
143380894|NCT01903811|516940679|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
143380895|NCT01903811|516940678|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
143380896|NCT01903811|516940679|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
143380897|NCT01903811|516940678|FG000|Overall Study|Withdrawal by Subject|0|||
143380898|NCT01903811|516940679|FG001|Overall Study|Withdrawal by Subject|1|||
143380899|NCT04540913|516940680|FG000|Overall Study|Withdrawal by Subject|14|||
143380900|NCT04540913|516940681|FG001|Overall Study|Withdrawal by Subject|3|||
143380901|NCT05137236|516940686|FG000|Part A|Other than Specified|1|||
143380902|NCT05137236|516940687|FG001|Part A|Other than Specified|0|||
143380903|NCT05137236|516940688|FG002|Part A|Other than Specified|0|||
143380904|NCT05137236|516940689|FG003|Part A|Other than Specified|0|||
143380905|NCT05137236|516940690|FG004|Part A|Other than Specified|0|||
143380906|NCT05137236|516940691|FG005|Part A|Other than Specified|0|||
143380907|NCT05137236|516940692|FG006|Part A|Other than Specified|0|||
143380908|NCT05137236|516940693|FG007|Part A|Other than Specified|0|||
143380909|NCT05137236|516940686|FG000|Part A|Withdrawal by Subject|0|||
143380910|NCT05137236|516940687|FG001|Part A|Withdrawal by Subject|4|||
143380911|NCT05137236|516940688|FG002|Part A|Withdrawal by Subject|1|||
143380912|NCT05137236|516940689|FG003|Part A|Withdrawal by Subject|1|||
143380913|NCT05137236|516940690|FG004|Part A|Withdrawal by Subject|3|||
143380914|NCT05137236|516940691|FG005|Part A|Withdrawal by Subject|2|||
143380915|NCT05137236|516940692|FG006|Part A|Withdrawal by Subject|0|||
143380916|NCT05137236|516940693|FG007|Part A|Withdrawal by Subject|0|||
143380917|NCT05137236|516940686|FG000|Part A|Lost to Follow-up|5|||
143380918|NCT05137236|516940687|FG001|Part A|Lost to Follow-up|7|||
143380919|NCT05137236|516940688|FG002|Part A|Lost to Follow-up|1|||
143380920|NCT05137236|516940689|FG003|Part A|Lost to Follow-up|3|||
143380921|NCT05137236|516940690|FG004|Part A|Lost to Follow-up|3|||
143380922|NCT05137236|516940691|FG005|Part A|Lost to Follow-up|8|||
143380923|NCT05137236|516940692|FG006|Part A|Lost to Follow-up|0|||
143380924|NCT05137236|516940693|FG007|Part A|Lost to Follow-up|0|||
143380925|NCT05137236|516940686|FG000|Part B|Withdrawal by Subject|0|||
143380926|NCT05137236|516940687|FG001|Part B|Withdrawal by Subject|0|||
143380927|NCT05137236|516940688|FG002|Part B|Withdrawal by Subject|0|||
143380928|NCT05137236|516940689|FG003|Part B|Withdrawal by Subject|0|||
143380929|NCT05137236|516940690|FG004|Part B|Withdrawal by Subject|0|||
143380930|NCT05137236|516940691|FG005|Part B|Withdrawal by Subject|0|||
143380931|NCT05137236|516940692|FG006|Part B|Withdrawal by Subject|0|||
143380932|NCT05137236|516940693|FG007|Part B|Withdrawal by Subject|2|||
143380933|NCT05137236|516940686|FG000|Part B|Lost to Follow-up|0|||
143380934|NCT05137236|516940687|FG001|Part B|Lost to Follow-up|0|||
143380935|NCT05137236|516940688|FG002|Part B|Lost to Follow-up|0|||
143380936|NCT05137236|516940689|FG003|Part B|Lost to Follow-up|0|||
143380937|NCT05137236|516940690|FG004|Part B|Lost to Follow-up|0|||
143380938|NCT05137236|516940691|FG005|Part B|Lost to Follow-up|0|||
143380939|NCT05137236|516940692|FG006|Part B|Lost to Follow-up|5|||
143380940|NCT05137236|516940693|FG007|Part B|Lost to Follow-up|5|||
143380941|NCT05137236|516940686|FG000|Part B|Death|0|||
143324309|NCT04266028|516731777|FG002|Overall Study|temporary halt of the study|0|||
143324310|NCT04266028|516731778|FG003|Overall Study|temporary halt of the study|0|||
143324311|NCT04266028|516731779|FG004|Overall Study|temporary halt of the study|0|||
143324312|NCT04266028|516731780|FG005|Overall Study|temporary halt of the study|0|||
143324313|NCT04266028|516731781|FG006|Overall Study|temporary halt of the study|2|||
143324314|NCT04266028|516731782|FG007|Overall Study|temporary halt of the study|1|||
143324315|NCT04266028|516731775|FG000|Overall Study|Onset of birch pollen season|0|||
143324316|NCT04266028|516731776|FG001|Overall Study|Onset of birch pollen season|0|||
143324317|NCT04266028|516731777|FG002|Overall Study|Onset of birch pollen season|0|||
143324318|NCT04266028|516731778|FG003|Overall Study|Onset of birch pollen season|0|||
143324319|NCT04266028|516731779|FG004|Overall Study|Onset of birch pollen season|1|||
143380942|NCT05137236|516940687|FG001|Part B|Death|0|||
143380943|NCT05137236|516940688|FG002|Part B|Death|0|||
143380944|NCT05137236|516940689|FG003|Part B|Death|0|||
143380945|NCT05137236|516940690|FG004|Part B|Death|0|||
143380946|NCT05137236|516940691|FG005|Part B|Death|0|||
143380947|NCT05137236|516940692|FG006|Part B|Death|0|||
143380948|NCT05137236|516940693|FG007|Part B|Death|2|||
143380949|NCT01471691|516940695|FG000|Overall Study|Lack of Efficacy|0|||
143380950|NCT01471691|516940696|FG001|Overall Study|Lack of Efficacy|1|||
143380951|NCT01808339|516940697|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
143380952|NCT01808339|516940698|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
143380953|NCT01808339|516940699|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
143380954|NCT01808339|516940700|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
143380955|NCT01808339|516940701|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
143380956|NCT01808339|516940702|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
143380957|NCT01808339|516940697|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
143380958|NCT01808339|516940698|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
143380959|NCT01808339|516940699|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
143380960|NCT01808339|516940700|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
143324320|NCT04266028|516731780|FG005|Overall Study|Onset of birch pollen season|0|||
143324321|NCT04266028|516731781|FG006|Overall Study|Onset of birch pollen season|0|||
143324322|NCT04266028|516731782|FG007|Overall Study|Onset of birch pollen season|0|||
143324323|NCT01458574|516731783|FG000|Overall Study|Adverse Event|5|||
143380961|NCT01808339|516940701|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
143380962|NCT01808339|516940702|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
143380963|NCT01808339|516940697|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
143380964|NCT01808339|516940698|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
143380965|NCT01808339|516940699|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
143324324|NCT01458574|516731784|FG001|Overall Study|Adverse Event|9|||
143380966|NCT01808339|516940700|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
143324325|NCT01458574|516731785|FG002|Overall Study|Adverse Event|7|||
143324326|NCT01458574|516731783|FG000|Overall Study|Lack of Efficacy|70|||
143324327|NCT01458574|516731784|FG001|Overall Study|Lack of Efficacy|53|||
143324328|NCT01458574|516731785|FG002|Overall Study|Lack of Efficacy|132|||
143380967|NCT01808339|516940701|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
143380968|NCT01808339|516940702|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
143380969|NCT02622568|516940703|FG000|Overall Study|Lost to Follow-up|5|||
143380970|NCT02622568|516940704|FG001|Overall Study|Lost to Follow-up|5|||
143380971|NCT01854385|516940711|FG000|Pre-Treatment|Withdrawal by Subject|4|||
143380972|NCT01854385|516940711|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
143324329|NCT01458574|516731783|FG000|Overall Study|Lost to Follow-up|3|||
143380973|NCT01854385|516940711|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
143380974|NCT01854385|516940711|FG000|Pre-Treatment|Unable to come for study visits|1|||
143380975|NCT01854385|516940711|FG000|Treatment|Lost to Follow-up|1|||
143324330|NCT01458574|516731784|FG001|Overall Study|Lost to Follow-up|2|||
143324331|NCT01458574|516731785|FG002|Overall Study|Lost to Follow-up|1|||
143324332|NCT01458574|516731783|FG000|Overall Study|Pregnancy|1|||
143324333|NCT01458574|516731784|FG001|Overall Study|Pregnancy|1|||
143324334|NCT01458574|516731785|FG002|Overall Study|Pregnancy|0|||
143324335|NCT01458574|516731783|FG000|Overall Study|Protocol Violation|0|||
143324336|NCT01458574|516731784|FG001|Overall Study|Protocol Violation|1|||
143324337|NCT01458574|516731785|FG002|Overall Study|Protocol Violation|0|||
143324338|NCT01458574|516731783|FG000|Overall Study|Withdrawal by Subject|6|||
143324339|NCT01458574|516731784|FG001|Overall Study|Withdrawal by Subject|3|||
143324340|NCT01458574|516731785|FG002|Overall Study|Withdrawal by Subject|5|||
143324341|NCT01458574|516731783|FG000|Overall Study|Other|2|||
143324342|NCT01458574|516731784|FG001|Overall Study|Other|1|||
143324343|NCT01458574|516731785|FG002|Overall Study|Other|0|||
143324344|NCT01458574|516731783|FG000|Overall Study|Randomized but not treated|0|||
143324345|NCT01458574|516731784|FG001|Overall Study|Randomized but not treated|1|||
143324346|NCT01458574|516731785|FG002|Overall Study|Randomized but not treated|0|||
143324347|NCT02125786|516731786|FG000|Overall Study|Still in Follow-up|3|||
143324348|NCT02125786|516731786|FG000|Overall Study|Screen Failure|2|||
143324349|NCT02125786|516731786|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
143324350|NCT02125786|516731786|FG000|Overall Study|Progressive Disease|44|||
143324351|NCT02125786|516731786|FG000|Overall Study|Death|8|||
143324352|NCT04964089|516731789|FG000|Overall Study|Adverse Event|8|||
143324353|NCT04964089|516731790|FG001|Overall Study|Adverse Event|6|||
143324354|NCT04964089|516731789|FG000|Overall Study|Non-compliance with study schedule|1|||
143324355|NCT04964089|516731790|FG001|Overall Study|Non-compliance with study schedule|0|||
143324356|NCT04964089|516731789|FG000|Overall Study|Withdrawal by Subject|6|||
143324357|NCT04964089|516731790|FG001|Overall Study|Withdrawal by Subject|5|||
143324358|NCT04964089|516731789|FG000|Overall Study|Lost to Follow-up|1|||
143324359|NCT04964089|516731790|FG001|Overall Study|Lost to Follow-up|1|||
143324360|NCT04964089|516731789|FG000|Overall Study|Progressive disease|4|||
143324361|NCT04964089|516731790|FG001|Overall Study|Progressive disease|0|||
143324362|NCT04964089|516731789|FG000|Overall Study|Physician Decision|1|||
143324363|NCT04964089|516731790|FG001|Overall Study|Physician Decision|0|||
143324364|NCT04964089|516731789|FG000|Overall Study|Participant did not want to continue study treatment|1|||
143324365|NCT04964089|516731790|FG001|Overall Study|Participant did not want to continue study treatment|0|||
143324366|NCT04964089|516731789|FG000|Overall Study|Participant moved to different state|1|||
143324367|NCT04964089|516731790|FG001|Overall Study|Participant moved to different state|0|||
143324368|NCT04964089|516731789|FG000|Overall Study|Participant decided to discontinue|0|||
143324369|NCT04964089|516731790|FG001|Overall Study|Participant decided to discontinue|1|||
143324370|NCT01682837|516731791|FG000|Baseline|Withdrawal by Subject|5|||
143324371|NCT01664078|516731794|FG000|Overall Study|Death|9|||
143324372|NCT01664078|516731794|FG000|Overall Study|Withdrawal by Subject|4|||
143324373|NCT01664078|516731794|FG000|Overall Study|Lost to Follow-up|2|||
143324374|NCT01664078|516731794|FG000|Overall Study|missed 5 year visit|1|||
143324375|NCT01664078|516731794|FG000|Overall Study|Other|53|||
143324376|NCT03832946|516731797|FG000|Overall Study|Adverse Event|3|||
143324377|NCT03832946|516731798|FG001|Overall Study|Adverse Event|1|||
143380976|NCT05119855|516940712|FG000|Overall Study|Randomized by Mistake Without Study Treatment|0|||
143380977|NCT05119855|516940713|FG001|Overall Study|Randomized by Mistake Without Study Treatment|1|||
143380978|NCT05119855|516940712|FG000|Overall Study|Withdrawal By Parent/Guardian|10|||
143324378|NCT03832946|516731797|FG000|Overall Study|Lost to Follow-up|1|||
143324379|NCT03832946|516731798|FG001|Overall Study|Lost to Follow-up|0|||
143324380|NCT03832946|516731797|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
143324381|NCT03832946|516731798|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
143454260|NCT01712659|517208169|FG001|Dose Expansion|Physician Decision|0|||
143324382|NCT03832946|516731797|FG000|Overall Study|Lack of Efficacy|1|||
143324383|NCT03832946|516731798|FG001|Overall Study|Lack of Efficacy|0|||
143324384|NCT03832946|516731797|FG000|Overall Study|Withdrawal by Subject|12|||
143324385|NCT03832946|516731798|FG001|Overall Study|Withdrawal by Subject|9|||
143380979|NCT05119855|516940713|FG001|Overall Study|Withdrawal By Parent/Guardian|10|||
143380980|NCT05119855|516940712|FG000|Overall Study|Lost to Follow-up|6|||
143380981|NCT05119855|516940713|FG001|Overall Study|Lost to Follow-up|8|||
143380982|NCT02932579|516940714|FG000|Overall Study|Withdrawal by Subject|4|||
143380983|NCT02932579|516940715|FG001|Overall Study|Withdrawal by Subject|1|||
143380984|NCT02549170|516940722|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
143380985|NCT02549170|516940723|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
143380986|NCT02549170|516940724|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
143380987|NCT02549170|516940725|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
143380988|NCT02549170|516940726|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
143380989|NCT02549170|516940722|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
143380990|NCT02549170|516940723|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
143380991|NCT02549170|516940724|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
143380992|NCT02549170|516940725|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
143380993|NCT02549170|516940726|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
143380994|NCT02549170|516940722|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
143380995|NCT02549170|516940723|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
143380996|NCT02549170|516940724|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
143380997|NCT02549170|516940725|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
143380998|NCT02549170|516940726|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
143380999|NCT00409838|516940730|FG000|Short-term Period|Adverse Event|0|||
143381000|NCT00409838|516940731|FG001|Short-term Period|Adverse Event|1|||
143381001|NCT00409838|516940730|FG000|Short-term Period|Lost to Follow-up|0|||
143381002|NCT00409838|516940731|FG001|Short-term Period|Lost to Follow-up|1|||
143381003|NCT00409838|516940730|FG000|Short-term Period|Withdrawal by Subject|2|||
143381004|NCT00409838|516940731|FG001|Short-term Period|Withdrawal by Subject|3|||
143381005|NCT00409838|516940730|FG000|Short-term Period|Never Treated|1|||
143381006|NCT00409838|516940731|FG001|Short-term Period|Never Treated|0|||
143381007|NCT00409838|516940730|FG000|Long-term Extension Period|Adverse Event|10|||
143381008|NCT00409838|516940731|FG001|Long-term Extension Period|Adverse Event|0|||
143381009|NCT00409838|516940730|FG000|Long-term Extension Period|Death|1|||
143381010|NCT00409838|516940731|FG001|Long-term Extension Period|Death|0|||
143381011|NCT00409838|516940730|FG000|Long-term Extension Period|Lack of Efficacy|2|||
143381012|NCT00409838|516940731|FG001|Long-term Extension Period|Lack of Efficacy|0|||
143381013|NCT00409838|516940730|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
143381014|NCT00409838|516940731|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
143381015|NCT00409838|516940730|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
143381016|NCT00409838|516940731|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
143381017|NCT00409838|516940730|FG000|Long-term Extension Period|Pregnancy|1|||
143381018|NCT00409838|516940731|FG001|Long-term Extension Period|Pregnancy|0|||
143381019|NCT04788641|516940732|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
143381020|NCT04788641|516940733|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
143381021|NCT04788641|516940734|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
143381022|NCT04788641|516940735|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
143381023|NCT04788641|516940732|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
143381024|NCT04788641|516940733|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
143381025|NCT04788641|516940734|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
143381026|NCT04788641|516940735|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
143381027|NCT04788641|516940732|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
143381028|NCT04788641|516940733|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
143381029|NCT04788641|516940734|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
143381030|NCT04788641|516940735|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
143381031|NCT01250769|516940736|FG000|Overall Study|Withdrawal by Subject|0|||
143381032|NCT01250769|516940737|FG001|Overall Study|Withdrawal by Subject|1|||
143381033|NCT01250769|516940738|FG002|Overall Study|Withdrawal by Subject|1|||
143381034|NCT01250769|516940739|FG003|Overall Study|Withdrawal by Subject|0|||
143381035|NCT01250769|516940736|FG000|Overall Study|Adverse Event|0|||
143381036|NCT01250769|516940737|FG001|Overall Study|Adverse Event|0|||
143381037|NCT01250769|516940738|FG002|Overall Study|Adverse Event|1|||
143381038|NCT01250769|516940739|FG003|Overall Study|Adverse Event|0|||
143381039|NCT03283371|516940740|FG000|Placebo-controlled|Adverse Event|1|||
143381040|NCT03283371|516940741|FG001|Placebo-controlled|Adverse Event|1|||
143381041|NCT03283371|516940742|FG002|Placebo-controlled|Adverse Event|0|||
143381042|NCT03283371|516940743|FG003|Placebo-controlled|Adverse Event|0|||
143381043|NCT03283371|516940740|FG000|Placebo-controlled|Lack of Efficacy|1|||
143381044|NCT03283371|516940741|FG001|Placebo-controlled|Lack of Efficacy|0|||
143381045|NCT03283371|516940742|FG002|Placebo-controlled|Lack of Efficacy|0|||
143381046|NCT03283371|516940743|FG003|Placebo-controlled|Lack of Efficacy|0|||
143324386|NCT02715765|516731799|FG000|Overall Study|Study Termination|3|||
143324387|NCT02715765|516731800|FG001|Overall Study|Study Termination|0|||
143324388|NCT02715765|516731801|FG002|Overall Study|Study Termination|0|||
143324389|NCT02663817|516731802|FG000|Overall Study|Screen failure|2|||
143324390|NCT01308580|516731804|FG000|Overall Study|Lost to Follow-up|12|||
143324391|NCT01308580|516731805|FG001|Overall Study|Lost to Follow-up|7|||
143324392|NCT04827576|516733925|FG000|Overall Study|Death|5|||
143324393|NCT04827576|516733926|FG001|Overall Study|Death|17|||
143324394|NCT04827576|516733927|FG002|Overall Study|Death|17|||
143324395|NCT04827576|516733928|FG003|Overall Study|Death|32|||
143324396|NCT04827576|516733925|FG000|Overall Study|Study Terminated by Sponsor|2|||
143324397|NCT04827576|516733926|FG001|Overall Study|Study Terminated by Sponsor|9|||
143324398|NCT04827576|516733927|FG002|Overall Study|Study Terminated by Sponsor|7|||
143324399|NCT04827576|516733928|FG003|Overall Study|Study Terminated by Sponsor|5|||
143324400|NCT04827576|516733925|FG000|Overall Study|Investigator's Discretion|1|||
143324401|NCT04827576|516733926|FG001|Overall Study|Investigator's Discretion|0|||
143324402|NCT04827576|516733927|FG002|Overall Study|Investigator's Discretion|2|||
143324403|NCT04827576|516733928|FG003|Overall Study|Investigator's Discretion|5|||
143324404|NCT04827576|516733925|FG000|Overall Study|Withdrew Consent|0|||
143324405|NCT04827576|516733926|FG001|Overall Study|Withdrew Consent|3|||
143324406|NCT04827576|516733927|FG002|Overall Study|Withdrew Consent|0|||
143324407|NCT04827576|516733928|FG003|Overall Study|Withdrew Consent|0|||
143324408|NCT04827576|516733925|FG000|Overall Study|Lost to Follow-up|1|||
143324409|NCT04827576|516733926|FG001|Overall Study|Lost to Follow-up|0|||
143324410|NCT04827576|516733927|FG002|Overall Study|Lost to Follow-up|0|||
143324411|NCT04827576|516733928|FG003|Overall Study|Lost to Follow-up|0|||
143324412|NCT01261611|516733929|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
143324413|NCT01261611|516733930|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
143324414|NCT01261611|516733931|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
143324415|NCT01261611|516733929|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
143324416|NCT01261611|516733930|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
143324417|NCT01261611|516733931|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
143324418|NCT01261611|516733929|FG000|Treatment Cycle 1|Adverse Event|0|||
143324419|NCT01261611|516733930|FG001|Treatment Cycle 1|Adverse Event|1|||
143324420|NCT01261611|516733931|FG002|Treatment Cycle 1|Adverse Event|0|||
143324421|NCT01261611|516733929|FG000|Treatment Cycle 1|Protocol Violation|0|||
143324422|NCT01261611|516733930|FG001|Treatment Cycle 1|Protocol Violation|0|||
143324423|NCT01261611|516733931|FG002|Treatment Cycle 1|Protocol Violation|2|||
143324424|NCT01261611|516733929|FG000|Treatment Cycle 2|Completed study|4|||
143324425|NCT01261611|516733930|FG001|Treatment Cycle 2|Completed study|0|||
143324426|NCT01261611|516733931|FG002|Treatment Cycle 2|Completed study|0|||
143324427|NCT01261611|516733929|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
143324428|NCT01261611|516733930|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
143324429|NCT01261611|516733931|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
143324430|NCT01261611|516733929|FG000|Treatment Cycle 2|Adverse Event|1|||
143324431|NCT01261611|516733930|FG001|Treatment Cycle 2|Adverse Event|0|||
143324432|NCT01261611|516733931|FG002|Treatment Cycle 2|Adverse Event|0|||
143324433|NCT01261611|516733929|FG000|Treatment Cycle 2|Protocol Violation|2|||
143324434|NCT01261611|516733930|FG001|Treatment Cycle 2|Protocol Violation|0|||
143324435|NCT01261611|516733931|FG002|Treatment Cycle 2|Protocol Violation|0|||
143324436|NCT01261611|516733929|FG000|Treatment Cycle 2|Not otherwise specified|2|||
143324437|NCT01261611|516733930|FG001|Treatment Cycle 2|Not otherwise specified|0|||
143324438|NCT01261611|516733931|FG002|Treatment Cycle 2|Not otherwise specified|0|||
143324439|NCT01261611|516733929|FG000|Treatment Cycle 3|Completed study|24|||
143324440|NCT01261611|516733930|FG001|Treatment Cycle 3|Completed study|0|||
143324441|NCT01261611|516733931|FG002|Treatment Cycle 3|Completed study|0|||
143324442|NCT01261611|516733929|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
143324443|NCT01261611|516733930|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
143324444|NCT01261611|516733931|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
143324445|NCT01261611|516733929|FG000|Treatment Cycle 3|Adverse Event|1|||
143324446|NCT01261611|516733930|FG001|Treatment Cycle 3|Adverse Event|0|||
143324447|NCT01261611|516733931|FG002|Treatment Cycle 3|Adverse Event|0|||
143324448|NCT01261611|516733929|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
143324449|NCT01261611|516733930|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
143324450|NCT01261611|516733931|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
143324451|NCT01261611|516733929|FG000|Treatment Cycle 4|Completed study|87|||
143324452|NCT01261611|516733930|FG001|Treatment Cycle 4|Completed study|0|||
143324453|NCT01261611|516733931|FG002|Treatment Cycle 4|Completed study|0|||
143324454|NCT01261611|516733929|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
143324455|NCT01261611|516733930|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
143324456|NCT01261611|516733931|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
143324457|NCT01261611|516733929|FG000|Treatment Cycle 4|Adverse Event|1|||
143324458|NCT01261611|516733930|FG001|Treatment Cycle 4|Adverse Event|0|||
143324459|NCT01261611|516733931|FG002|Treatment Cycle 4|Adverse Event|0|||
143324460|NCT01261611|516733929|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
143324461|NCT01261611|516733930|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
143324462|NCT01261611|516733931|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
143324463|NCT01261611|516733929|FG000|Treatment Cycle 4|Not otherwise specified|3|||
143324464|NCT01261611|516733930|FG001|Treatment Cycle 4|Not otherwise specified|0|||
143324465|NCT01261611|516733931|FG002|Treatment Cycle 4|Not otherwise specified|0|||
143324466|NCT01261611|516733929|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
143324467|NCT01261611|516733930|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
143324468|NCT01261611|516733931|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
143324469|NCT01261611|516733929|FG000|Treatment Cycle 5|Adverse Event|1|||
143324470|NCT01261611|516733930|FG001|Treatment Cycle 5|Adverse Event|0|||
143324471|NCT01261611|516733931|FG002|Treatment Cycle 5|Adverse Event|0|||
143324472|NCT01261611|516733929|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
143324473|NCT01261611|516733930|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
143324474|NCT01261611|516733931|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
143324475|NCT01159691|516733935|FG000|Overall Study|Lost to Follow-up|2|||
143324476|NCT01159691|516733935|FG000|Overall Study|Unknown reasons|1|||
143324477|NCT01159691|516733935|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
143324478|NCT01159691|516733935|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
143324479|NCT01159691|516733935|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
143324480|NCT01159691|516733935|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
143324481|NCT01159691|516733935|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
143324482|NCT01159691|516733935|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
143324483|NCT01928719|516733936|FG000|Overall Study|Lost to Follow-up|26|||
143324484|NCT01928719|516733937|FG001|Overall Study|Lost to Follow-up|11|||
143324485|NCT01928719|516733936|FG000|Overall Study|Withdrawal by Subject|22|||
143324486|NCT01928719|516733937|FG001|Overall Study|Withdrawal by Subject|7|||
143324487|NCT01928719|516733936|FG000|Overall Study|Protocol Violation|3|||
143324488|NCT01928719|516733937|FG001|Overall Study|Protocol Violation|1|||
143324489|NCT01928719|516733936|FG000|Overall Study|Adverse Event|1|||
143324490|NCT01928719|516733937|FG001|Overall Study|Adverse Event|0|||
143324491|NCT00263666|516733938|FG000|Overall Study|Adverse Event|6|||
143324492|NCT00263666|516733939|FG001|Overall Study|Adverse Event|8|||
143324493|NCT00263666|516733938|FG000|Overall Study|Lost to Follow-up|1|||
143324494|NCT00263666|516733939|FG001|Overall Study|Lost to Follow-up|2|||
143324495|NCT00263666|516733938|FG000|Overall Study|Withdrawal by Subject|0|||
143324496|NCT00263666|516733939|FG001|Overall Study|Withdrawal by Subject|1|||
143324497|NCT01490632|516733940|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
143324498|NCT01490632|516733941|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
143324499|NCT01490632|516733942|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
143324500|NCT01490632|516733943|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
143324501|NCT01490632|516733944|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
143324502|NCT01490632|516733945|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
143324503|NCT01490632|516733946|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
143324504|NCT01490632|516733947|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
143324505|NCT01490632|516733948|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
143324506|NCT01490632|516733949|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
143324507|NCT01490632|516733950|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
143324508|NCT01490632|516733951|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
143324509|NCT01490632|516733952|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
143324510|NCT01490632|516733953|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
143324511|NCT01490632|516733954|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
143324512|NCT01490632|516733955|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
143324513|NCT01490632|516733956|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
143324514|NCT01490632|516733957|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
143324515|NCT01490632|516733958|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
143324516|NCT01490632|516733959|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
143324517|NCT01490632|516733940|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
143324518|NCT01490632|516733941|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
143324519|NCT01490632|516733942|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
143324520|NCT01490632|516733943|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
143324521|NCT01490632|516733944|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
143324522|NCT01490632|516733945|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
143324523|NCT01490632|516733946|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
143324524|NCT01490632|516733947|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
143324525|NCT01490632|516733948|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
143324526|NCT01490632|516733949|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
143324527|NCT01490632|516733950|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
143324528|NCT01490632|516733951|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
143324529|NCT01490632|516733952|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
143381047|NCT03283371|516940740|FG000|Placebo-controlled|Withdrawal by Subject|1|||
143324530|NCT01490632|516733953|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
143324531|NCT01490632|516733954|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
143381048|NCT03283371|516940741|FG001|Placebo-controlled|Withdrawal by Subject|1|||
143324532|NCT01490632|516733955|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
143324533|NCT01490632|516733956|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
143324534|NCT01490632|516733957|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
143324535|NCT01490632|516733958|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
143324536|NCT01490632|516733959|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
143324537|NCT01490632|516733940|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
143324538|NCT01490632|516733941|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
143324539|NCT01490632|516733942|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
143324540|NCT01490632|516733943|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
143324541|NCT01490632|516733944|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
143324542|NCT01490632|516733945|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
143324543|NCT01490632|516733946|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
143324544|NCT01490632|516733947|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
143324545|NCT01490632|516733948|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
143324546|NCT01490632|516733949|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
143324547|NCT01490632|516733950|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
143324548|NCT01490632|516733951|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
143324549|NCT01490632|516733952|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
143324550|NCT01490632|516733953|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
143324551|NCT01490632|516733954|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
143324552|NCT01490632|516733955|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
143324553|NCT01490632|516733956|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
143324554|NCT01490632|516733957|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
143324555|NCT01490632|516733958|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
143324556|NCT01490632|516733959|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
143324557|NCT01490632|516733940|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
143324558|NCT01490632|516733941|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
143324559|NCT01490632|516733942|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
143324560|NCT01490632|516733943|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
143324561|NCT01490632|516733944|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
143324562|NCT01490632|516733945|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
143324563|NCT01490632|516733946|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
143324564|NCT01490632|516733947|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
143324565|NCT01490632|516733948|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
143324566|NCT01490632|516733949|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
143324567|NCT01490632|516733950|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
143324568|NCT01490632|516733951|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
143324569|NCT01490632|516733952|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
143324570|NCT01490632|516733953|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
143324571|NCT01490632|516733954|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
143324572|NCT01490632|516733955|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
143324573|NCT01490632|516733956|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
143324574|NCT01490632|516733957|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
143324575|NCT01490632|516733958|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
143324576|NCT01490632|516733959|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
143324577|NCT01490632|516733940|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
143324578|NCT01490632|516733941|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
143324579|NCT01490632|516733942|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
143324580|NCT01490632|516733943|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
143324581|NCT01490632|516733944|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
143324582|NCT01490632|516733945|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
143324583|NCT01490632|516733946|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
143324584|NCT01490632|516733947|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
143324585|NCT01490632|516733948|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
143324586|NCT01490632|516733949|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
143324587|NCT01490632|516733950|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
143324588|NCT01490632|516733951|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
143324589|NCT01490632|516733952|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
143324590|NCT01490632|516733953|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
143324591|NCT01490632|516733954|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
143324592|NCT01490632|516733955|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
143324593|NCT01490632|516733956|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
143324594|NCT01490632|516733957|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
143324595|NCT01490632|516733958|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
143324596|NCT01490632|516733959|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
143324597|NCT01490632|516733940|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
143324598|NCT01490632|516733941|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
143324599|NCT01490632|516733942|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
143324600|NCT01490632|516733943|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
143324601|NCT01490632|516733944|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
143324602|NCT01490632|516733945|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
143324603|NCT01490632|516733946|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
143324604|NCT01490632|516733947|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
143324605|NCT01490632|516733948|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
143324606|NCT01490632|516733949|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
143324607|NCT01490632|516733950|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
143324608|NCT01490632|516733951|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
143324609|NCT01490632|516733952|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
143324610|NCT01490632|516733953|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
143324611|NCT01490632|516733954|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
143324612|NCT01490632|516733955|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
143324613|NCT01490632|516733956|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
143324614|NCT01490632|516733957|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
143324615|NCT01490632|516733958|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
143324616|NCT01490632|516733959|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
143324617|NCT01490632|516733940|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
143324618|NCT01490632|516733941|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
143324619|NCT01490632|516733942|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
143324620|NCT01490632|516733943|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
143324621|NCT01490632|516733944|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
143324622|NCT01490632|516733945|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
143324623|NCT01490632|516733946|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
143324624|NCT01490632|516733947|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
143324625|NCT01490632|516733948|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
143324626|NCT01490632|516733949|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
143324627|NCT01490632|516733950|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
143324628|NCT01490632|516733951|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
143324629|NCT01490632|516733952|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
143324630|NCT01490632|516733953|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
143324631|NCT01490632|516733954|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
143324632|NCT01490632|516733955|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
143324633|NCT01490632|516733956|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
143324634|NCT01490632|516733957|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
143324635|NCT01490632|516733958|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
143324636|NCT01490632|516733959|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
143324637|NCT01490632|516733940|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
143324638|NCT01490632|516733941|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
143324639|NCT01490632|516733942|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
143324640|NCT01490632|516733943|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
143324641|NCT01490632|516733944|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
143324642|NCT01490632|516733945|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
143324643|NCT01490632|516733946|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
143324644|NCT01490632|516733947|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
143324645|NCT01490632|516733948|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
143324646|NCT01490632|516733949|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
143324647|NCT01490632|516733950|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
143324648|NCT01490632|516733951|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
143324649|NCT01490632|516733952|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
143324650|NCT01490632|516733953|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
143324651|NCT01490632|516733954|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
143324652|NCT01490632|516733955|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
143324653|NCT01490632|516733956|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
143324654|NCT01490632|516733957|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
143324655|NCT01490632|516733958|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
143324656|NCT01490632|516733959|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
143324657|NCT01490632|516733940|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
143381049|NCT03283371|516940742|FG002|Placebo-controlled|Withdrawal by Subject|0|||
143324658|NCT01490632|516733941|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
143381050|NCT03283371|516940743|FG003|Placebo-controlled|Withdrawal by Subject|0|||
143381051|NCT03283371|516940740|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
143324659|NCT01490632|516733942|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
143324660|NCT01490632|516733943|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
143324661|NCT01490632|516733944|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
143324662|NCT01490632|516733945|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
143324663|NCT01490632|516733946|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
143324664|NCT01490632|516733947|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
143324665|NCT01490632|516733948|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
143324666|NCT01490632|516733949|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
143324667|NCT01490632|516733950|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
143324668|NCT01490632|516733951|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
143324669|NCT01490632|516733952|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
143324670|NCT01490632|516733953|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
143324671|NCT01490632|516733954|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
143324672|NCT01490632|516733955|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
143324673|NCT01490632|516733956|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
143324674|NCT01490632|516733957|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
143324675|NCT01490632|516733958|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
143324676|NCT01490632|516733959|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
143324677|NCT01490632|516733940|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
143324678|NCT01490632|516733941|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
143324679|NCT01490632|516733942|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
143324680|NCT01490632|516733943|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
143324681|NCT01490632|516733944|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
143324682|NCT01490632|516733945|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
143324683|NCT01490632|516733946|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
143324684|NCT01490632|516733947|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
143324685|NCT01490632|516733948|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
143324686|NCT01490632|516733949|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
143324687|NCT01490632|516733950|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
143324688|NCT01490632|516733951|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
143324689|NCT01490632|516733952|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
143324690|NCT01490632|516733953|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
143324691|NCT01490632|516733954|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
143324692|NCT01490632|516733955|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
143324693|NCT01490632|516733956|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
143324694|NCT01490632|516733957|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
143324695|NCT01490632|516733958|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
143324696|NCT01490632|516733959|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
143324697|NCT01490632|516733940|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
143324698|NCT01490632|516733941|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
143324699|NCT01490632|516733942|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
143324700|NCT01490632|516733943|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
143324701|NCT01490632|516733944|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
143324702|NCT01490632|516733945|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
143324703|NCT01490632|516733946|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
143324704|NCT01490632|516733947|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
143324705|NCT01490632|516733948|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
143324706|NCT01490632|516733949|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
143324707|NCT01490632|516733950|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
143324708|NCT01490632|516733951|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
143324709|NCT01490632|516733952|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
143324710|NCT01490632|516733953|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
143324711|NCT01490632|516733954|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
143324712|NCT01490632|516733955|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
143324713|NCT01490632|516733956|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
143324714|NCT01490632|516733957|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
143324715|NCT01490632|516733958|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
143324716|NCT01490632|516733959|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
143324717|NCT01490632|516733940|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
143324718|NCT01490632|516733941|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
143324719|NCT01490632|516733942|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
143324720|NCT01490632|516733943|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
143324721|NCT01490632|516733944|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
143324722|NCT01490632|516733945|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
143454261|NCT01712659|517208170|FG002|Dose Expansion|Physician Decision|0|||
143324723|NCT01490632|516733946|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
143324724|NCT01490632|516733947|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
143324725|NCT01490632|516733948|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
143324726|NCT01490632|516733949|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
143324727|NCT01490632|516733950|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
143324728|NCT01490632|516733951|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
143324729|NCT01490632|516733952|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
143324730|NCT01490632|516733953|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
143324731|NCT01490632|516733954|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
143324732|NCT01490632|516733955|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
143324733|NCT01490632|516733956|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
143324734|NCT01490632|516733957|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
143324735|NCT01490632|516733958|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
143324736|NCT01490632|516733959|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
143324737|NCT01490632|516733940|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
143324738|NCT01490632|516733941|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
143324739|NCT01490632|516733942|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
143324740|NCT01490632|516733943|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
143324741|NCT01490632|516733944|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
143324742|NCT01490632|516733945|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
143324743|NCT01490632|516733946|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
143324744|NCT01490632|516733947|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
143324745|NCT01490632|516733948|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
143324746|NCT01490632|516733949|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
143324747|NCT01490632|516733950|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
143324748|NCT01490632|516733951|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
143324749|NCT01490632|516733952|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
143324750|NCT01490632|516733953|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
143324751|NCT01490632|516733954|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
143324752|NCT01490632|516733955|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
143324753|NCT01490632|516733956|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
143324754|NCT01490632|516733957|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
143324755|NCT01490632|516733958|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
143324756|NCT01490632|516733959|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
143324757|NCT01490632|516733940|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
143324758|NCT01490632|516733941|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
143324759|NCT01490632|516733942|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
143324760|NCT01490632|516733943|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
143324761|NCT01490632|516733944|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
143324762|NCT01490632|516733945|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
143324763|NCT01490632|516733946|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
143324764|NCT01490632|516733947|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
143324765|NCT01490632|516733948|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
143324766|NCT01490632|516733949|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
143324767|NCT01490632|516733950|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
143324768|NCT01490632|516733951|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
143324769|NCT01490632|516733952|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
143324770|NCT01490632|516733953|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
143324771|NCT01490632|516733954|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
143324772|NCT01490632|516733955|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
143324773|NCT01490632|516733956|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
143324774|NCT01490632|516733957|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
143324775|NCT01490632|516733958|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
143324776|NCT01490632|516733959|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
143324777|NCT01490632|516733940|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
143381052|NCT03283371|516940741|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
143324778|NCT01490632|516733941|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
143324779|NCT01490632|516733942|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
143324780|NCT01490632|516733943|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
143324781|NCT01490632|516733944|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
143324782|NCT01490632|516733945|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
143324783|NCT01490632|516733946|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
143324784|NCT01490632|516733947|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
143324785|NCT01490632|516733948|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
143324786|NCT01490632|516733949|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
143324787|NCT01490632|516733950|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
143324788|NCT01490632|516733951|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
143324789|NCT01490632|516733952|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
143324790|NCT01490632|516733953|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
143324791|NCT01490632|516733954|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
143324792|NCT01490632|516733955|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
143324793|NCT01490632|516733956|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
143324794|NCT01490632|516733957|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
143324795|NCT01490632|516733958|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
143324796|NCT01490632|516733959|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
143324797|NCT01490632|516733940|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
143324798|NCT01490632|516733941|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
143324799|NCT01490632|516733942|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
143324800|NCT01490632|516733943|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
143324801|NCT01490632|516733944|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
143324802|NCT01490632|516733945|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
143324803|NCT01490632|516733946|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
143324804|NCT01490632|516733947|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
143324805|NCT01490632|516733948|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
143324806|NCT01490632|516733949|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
143324807|NCT01490632|516733950|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
143324808|NCT01490632|516733951|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
143324809|NCT01490632|516733952|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
143324810|NCT01490632|516733953|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
143324811|NCT01490632|516733954|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
143324812|NCT01490632|516733955|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
143324813|NCT01490632|516733956|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
143324814|NCT01490632|516733957|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
143324815|NCT01490632|516733958|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
143324816|NCT01490632|516733959|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
143324817|NCT01490632|516733940|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
143324818|NCT01490632|516733941|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
143324819|NCT01490632|516733942|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
143324820|NCT01490632|516733943|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
143324821|NCT01490632|516733944|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
143324822|NCT01490632|516733945|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
143324823|NCT01490632|516733946|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
143324824|NCT01490632|516733947|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
143324825|NCT01490632|516733948|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
143324826|NCT01490632|516733949|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
143324827|NCT01490632|516733950|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
143324828|NCT01490632|516733951|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
143324829|NCT01490632|516733952|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
143324830|NCT01490632|516733953|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
143324831|NCT01490632|516733954|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
143324832|NCT01490632|516733955|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
143324833|NCT01490632|516733956|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
143324834|NCT01490632|516733957|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
143324835|NCT01490632|516733958|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
143324836|NCT01490632|516733959|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
143324837|NCT01490632|516733940|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
143324838|NCT01490632|516733941|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
143324839|NCT01490632|516733942|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
143324840|NCT01490632|516733943|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
143324841|NCT01490632|516733944|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
143381053|NCT03283371|516940742|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
143381054|NCT03283371|516940743|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
143324842|NCT01490632|516733945|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
143324843|NCT01490632|516733946|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
143324844|NCT01490632|516733947|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
143324845|NCT01490632|516733948|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
143324846|NCT01490632|516733949|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
143324847|NCT01490632|516733950|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
143324848|NCT01490632|516733951|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
143324849|NCT01490632|516733952|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
143324850|NCT01490632|516733953|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
143324851|NCT01490632|516733954|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
143324852|NCT01490632|516733955|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
143324853|NCT01490632|516733956|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
143324854|NCT01490632|516733957|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
143324855|NCT01490632|516733958|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
143324856|NCT01490632|516733959|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
143324857|NCT01490632|516733940|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
143324858|NCT01490632|516733941|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
143324859|NCT01490632|516733942|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
143324860|NCT01490632|516733943|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
143324861|NCT01490632|516733944|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
143324862|NCT01490632|516733945|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
143324863|NCT01490632|516733946|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
143324864|NCT01490632|516733947|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
143324865|NCT01490632|516733948|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
143324866|NCT01490632|516733949|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
143324867|NCT01490632|516733950|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
143324868|NCT01490632|516733951|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
143324869|NCT01490632|516733952|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
143324870|NCT01490632|516733953|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
143324871|NCT01490632|516733954|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
143324872|NCT01490632|516733955|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
143324873|NCT01490632|516733956|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
143324874|NCT01490632|516733957|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
143324875|NCT01490632|516733958|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
143324876|NCT01490632|516733959|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
143324877|NCT01490632|516733940|FG000|Part D: Re-Treatment Period|Death|0|||
143324878|NCT01490632|516733941|FG001|Part D: Re-Treatment Period|Death|0|||
143324879|NCT01490632|516733942|FG002|Part D: Re-Treatment Period|Death|0|||
143324880|NCT01490632|516733943|FG003|Part D: Re-Treatment Period|Death|0|||
143324881|NCT01490632|516733944|FG004|Part D: Re-Treatment Period|Death|0|||
143324882|NCT01490632|516733945|FG005|Part D: Re-Treatment Period|Death|0|||
143324883|NCT01490632|516733946|FG006|Part D: Re-Treatment Period|Death|0|||
143324884|NCT01490632|516733947|FG007|Part D: Re-Treatment Period|Death|0|||
143324885|NCT01490632|516733948|FG008|Part D: Re-Treatment Period|Death|0|||
143324886|NCT01490632|516733949|FG009|Part D: Re-Treatment Period|Death|0|||
143324887|NCT01490632|516733950|FG010|Part D: Re-Treatment Period|Death|0|||
143324888|NCT01490632|516733951|FG011|Part D: Re-Treatment Period|Death|0|||
143324889|NCT01490632|516733952|FG012|Part D: Re-Treatment Period|Death|0|||
143324890|NCT01490632|516733953|FG013|Part D: Re-Treatment Period|Death|0|||
143324891|NCT01490632|516733954|FG014|Part D: Re-Treatment Period|Death|0|||
143324892|NCT01490632|516733955|FG015|Part D: Re-Treatment Period|Death|0|||
143324893|NCT01490632|516733956|FG016|Part D: Re-Treatment Period|Death|0|||
143324894|NCT01490632|516733957|FG017|Part D: Re-Treatment Period|Death|0|||
143324895|NCT01490632|516733958|FG018|Part D: Re-Treatment Period|Death|1|||
143324896|NCT01490632|516733959|FG019|Part D: Re-Treatment Period|Death|0|||
143324897|NCT01490632|516733940|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
143324898|NCT01490632|516733941|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
143324899|NCT01490632|516733942|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
143324900|NCT01490632|516733943|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
143324901|NCT01490632|516733944|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
143324902|NCT01490632|516733945|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
143324903|NCT01490632|516733946|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
143324904|NCT01490632|516733947|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
143324905|NCT01490632|516733948|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
143324906|NCT01490632|516733949|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
143324907|NCT01490632|516733950|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
143324908|NCT01490632|516733951|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
143324909|NCT01490632|516733952|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
143324910|NCT01490632|516733953|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
143324911|NCT01490632|516733954|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
143324912|NCT01490632|516733955|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
143324913|NCT01490632|516733956|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
143324914|NCT01490632|516733957|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
143324915|NCT01490632|516733958|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
143324916|NCT01490632|516733959|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
143324917|NCT01490632|516733940|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
143324918|NCT01490632|516733941|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
143324919|NCT01490632|516733942|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
143324920|NCT01490632|516733943|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
143324921|NCT01490632|516733944|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
143324922|NCT01490632|516733945|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
143324923|NCT01490632|516733946|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
143324924|NCT01490632|516733947|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
143324925|NCT01490632|516733948|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
143324926|NCT01490632|516733949|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
143324927|NCT01490632|516733950|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
143324928|NCT01490632|516733951|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
143324929|NCT01490632|516733952|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
143324930|NCT01490632|516733953|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
143324931|NCT01490632|516733954|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
143324932|NCT01490632|516733955|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
143324933|NCT01490632|516733956|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
143324934|NCT01490632|516733957|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
143324935|NCT01490632|516733958|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
143324936|NCT01490632|516733959|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
143324937|NCT01490632|516733940|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
143324938|NCT01490632|516733941|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
143324939|NCT01490632|516733942|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
143324940|NCT01490632|516733943|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
143324941|NCT01490632|516733944|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
143324942|NCT01490632|516733945|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
143324943|NCT01490632|516733946|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
143324944|NCT01490632|516733947|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
143324945|NCT01490632|516733948|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
143324946|NCT01490632|516733949|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
143324947|NCT01490632|516733950|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
143324948|NCT01490632|516733951|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
143324949|NCT01490632|516733952|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
143324950|NCT01490632|516733953|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
143324951|NCT01490632|516733954|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
143324952|NCT01490632|516733955|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
143324953|NCT01490632|516733956|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
143324954|NCT01490632|516733957|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
143324955|NCT01490632|516733958|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
143324956|NCT01490632|516733959|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
143324957|NCT01490632|516733940|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
143324958|NCT01490632|516733941|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
143324959|NCT01490632|516733942|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
143324960|NCT01490632|516733943|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
143324961|NCT01490632|516733944|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
143324962|NCT01490632|516733945|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
143324963|NCT01490632|516733946|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
143324964|NCT01490632|516733947|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
143324965|NCT01490632|516733948|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
143324966|NCT01490632|516733949|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
143324967|NCT01490632|516733950|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
143324968|NCT01490632|516733951|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
143324969|NCT01490632|516733952|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
143324970|NCT01490632|516733953|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
143324971|NCT01490632|516733954|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
143324972|NCT01490632|516733955|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
143324973|NCT01490632|516733956|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
143324974|NCT01490632|516733957|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
143324975|NCT01490632|516733958|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
143324976|NCT01490632|516733959|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
143324977|NCT01490632|516733940|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
143324978|NCT01490632|516733941|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
143324979|NCT01490632|516733942|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
143324980|NCT01490632|516733943|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
143324981|NCT01490632|516733944|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
143324982|NCT01490632|516733945|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
143324983|NCT01490632|516733946|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
143324984|NCT01490632|516733947|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
143324985|NCT01490632|516733948|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
143324986|NCT01490632|516733949|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
143324987|NCT01490632|516733950|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
143324988|NCT01490632|516733951|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
143324989|NCT01490632|516733952|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
143324990|NCT01490632|516733953|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
143324991|NCT01490632|516733954|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
143324992|NCT01490632|516733955|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
143324993|NCT01490632|516733956|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
143324994|NCT01490632|516733957|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
143324995|NCT01490632|516733958|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
143324996|NCT01490632|516733959|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
143324997|NCT00467870|516733962|FG000|Overall Study|Adverse Event|13|||
143324998|NCT00467870|516733963|FG001|Overall Study|Adverse Event|9|||
143324999|NCT00467870|516733964|FG002|Overall Study|Adverse Event|1|||
143325000|NCT00467870|516733965|FG003|Overall Study|Adverse Event|15|||
143325001|NCT00467870|516733966|FG004|Overall Study|Adverse Event|15|||
143325002|NCT00467870|516733967|FG005|Overall Study|Adverse Event|1|||
143325003|NCT00467870|516733962|FG000|Overall Study|Protocol Violation|2|||
143325004|NCT00467870|516733963|FG001|Overall Study|Protocol Violation|1|||
143325005|NCT00467870|516733964|FG002|Overall Study|Protocol Violation|1|||
143325006|NCT00467870|516733965|FG003|Overall Study|Protocol Violation|2|||
143325007|NCT00467870|516733966|FG004|Overall Study|Protocol Violation|0|||
143325008|NCT00467870|516733967|FG005|Overall Study|Protocol Violation|0|||
143325009|NCT00467870|516733962|FG000|Overall Study|Withdrawal by Subject|14|||
143325010|NCT00467870|516733963|FG001|Overall Study|Withdrawal by Subject|21|||
143325011|NCT00467870|516733964|FG002|Overall Study|Withdrawal by Subject|0|||
143325012|NCT00467870|516733965|FG003|Overall Study|Withdrawal by Subject|9|||
143325013|NCT00467870|516733966|FG004|Overall Study|Withdrawal by Subject|10|||
143325014|NCT00467870|516733967|FG005|Overall Study|Withdrawal by Subject|1|||
143325015|NCT00467870|516733962|FG000|Overall Study|Lost to Follow-up|5|||
143325016|NCT00467870|516733963|FG001|Overall Study|Lost to Follow-up|3|||
143325017|NCT00467870|516733964|FG002|Overall Study|Lost to Follow-up|1|||
143325018|NCT00467870|516733965|FG003|Overall Study|Lost to Follow-up|1|||
143325019|NCT00467870|516733966|FG004|Overall Study|Lost to Follow-up|3|||
143325020|NCT00467870|516733967|FG005|Overall Study|Lost to Follow-up|0|||
143325021|NCT00467870|516733962|FG000|Overall Study|Subject Non-compliance|3|||
143325022|NCT00467870|516733963|FG001|Overall Study|Subject Non-compliance|4|||
143325023|NCT00467870|516733964|FG002|Overall Study|Subject Non-compliance|0|||
143325024|NCT00467870|516733965|FG003|Overall Study|Subject Non-compliance|1|||
143325025|NCT00467870|516733966|FG004|Overall Study|Subject Non-compliance|5|||
143325026|NCT00467870|516733967|FG005|Overall Study|Subject Non-compliance|0|||
143325027|NCT00467870|516733962|FG000|Overall Study|Other/Unknown|8|||
143325028|NCT00467870|516733963|FG001|Overall Study|Other/Unknown|5|||
143325029|NCT00467870|516733964|FG002|Overall Study|Other/Unknown|1|||
143325030|NCT00467870|516733965|FG003|Overall Study|Other/Unknown|5|||
143325031|NCT00467870|516733966|FG004|Overall Study|Other/Unknown|4|||
143325032|NCT00467870|516733967|FG005|Overall Study|Other/Unknown|0|||
143325033|NCT01917526|516733968|FG000|Overall Study|Protocol Violation|1|||
143325034|NCT01917526|516733969|FG001|Overall Study|Protocol Violation|1|||
143325035|NCT02261363|516733970|FG000|Overall Study|Lost to Follow-up|21|||
143325036|NCT01517802|516733971|FG000|Overall Study|Death|1|||
143325037|NCT03268811|516733976|FG000|Overall Study|Adverse Event|0|||
143325038|NCT03268811|516733977|FG001|Overall Study|Adverse Event|1|||
143325039|NCT02031276|516733978|FG000|Period 1 Double-blind IV|Adverse Event|6|||
143325040|NCT02031276|516733979|FG001|Period 1 Double-blind IV|Adverse Event|5|||
143325041|NCT02031276|516733980|FG002|Period 1 Double-blind IV|Adverse Event|1|||
143325042|NCT02031276|516733978|FG000|Period 1 Double-blind IV|Other|0|||
143325043|NCT02031276|516733979|FG001|Period 1 Double-blind IV|Other|1|||
143325044|NCT02031276|516733980|FG002|Period 1 Double-blind IV|Other|0|||
143325045|NCT02031276|516733978|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
143325046|NCT02031276|516733979|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
143325047|NCT02031276|516733980|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
143325048|NCT02031276|516733978|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
143325049|NCT02031276|516733979|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
143325050|NCT02031276|516733980|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
143325051|NCT02031276|516733978|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
143325052|NCT02031276|516733979|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
143325053|NCT02031276|516733980|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
143325054|NCT02031276|516733978|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
143325055|NCT02031276|516733979|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
143325056|NCT02031276|516733980|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
143325057|NCT02031276|516733978|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
143325058|NCT02031276|516733979|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
143325059|NCT02031276|516733980|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
143325060|NCT02031276|516733978|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
143325061|NCT02031276|516733979|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
143325062|NCT02031276|516733980|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
143325063|NCT02031276|516733978|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
143325064|NCT02031276|516733979|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
143325065|NCT02031276|516733980|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
143325066|NCT04726709|516733987|FG000|Overall Study|Withdrawal by Subject|2|||
143325067|NCT04726709|516733988|FG001|Overall Study|Withdrawal by Subject|2|||
143325068|NCT03073603|516733990|FG000|Overall Study|Noncompliance|3|||
143325069|NCT03073603|516733991|FG001|Overall Study|Noncompliance|1|||
143325070|NCT03073603|516733990|FG000|Overall Study|Adverse Event|5|||
143325071|NCT03073603|516733991|FG001|Overall Study|Adverse Event|3|||
143325072|NCT03073603|516733990|FG000|Overall Study|Physician Decision|1|||
143325073|NCT03073603|516733991|FG001|Overall Study|Physician Decision|2|||
143325074|NCT03073603|516733990|FG000|Overall Study|Required treatment not allowed by protocol|1|||
143325075|NCT03073603|516733991|FG001|Overall Study|Required treatment not allowed by protocol|0|||
143325076|NCT03073603|516733990|FG000|Overall Study|Financial or insurance-related|8|||
143325077|NCT03073603|516733991|FG001|Overall Study|Financial or insurance-related|0|||
143325078|NCT03073603|516733990|FG000|Overall Study|Withdrawal by Subject|0|||
143325079|NCT03073603|516733991|FG001|Overall Study|Withdrawal by Subject|1|||
143325080|NCT03073603|516733990|FG000|Overall Study|Discontinued DMT|4|||
143325081|NCT03073603|516733991|FG001|Overall Study|Discontinued DMT|0|||
143325082|NCT03073603|516733990|FG000|Overall Study|Restarted DMT|0|||
143325083|NCT03073603|516733991|FG001|Overall Study|Restarted DMT|1|||
143325084|NCT04757649|516733992|FG000|Overall Study|Withdrawal by Subject|1|||
143325085|NCT04757649|516733992|FG000|Overall Study|Adverse Event|1|||
143325086|NCT01286779|516733993|FG000|Overall Study|Withdrawal by Subject|9|||
143325087|NCT01286779|516733993|FG000|Overall Study|Protocol Violation|5|||
143325088|NCT01286779|516733993|FG000|Overall Study|Physician Decision|2|||
143325089|NCT01286779|516733993|FG000|Overall Study|Participant had scheduled surgery|1|||
143325090|NCT01286779|516733993|FG000|Overall Study|Participant moved to another country|1|||
143325091|NCT01286779|516733993|FG000|Overall Study|Discontinued by sponsor|1|||
143325092|NCT00574080|516733998|FG000|Overall Study|Death|10|||
143325093|NCT00574080|516733999|FG001|Overall Study|Death|10|||
143325094|NCT02862106|516734000|FG000|Overall Study|Adverse Event|4|||
143325095|NCT02862106|516734001|FG001|Overall Study|Adverse Event|0|||
143325096|NCT02862106|516734000|FG000|Overall Study|Protocol Violation|16|||
143325097|NCT02862106|516734001|FG001|Overall Study|Protocol Violation|1|||
143325098|NCT02862106|516734000|FG000|Overall Study|Lost to Follow-up|15|||
143325099|NCT02862106|516734001|FG001|Overall Study|Lost to Follow-up|5|||
143325100|NCT02862106|516734000|FG000|Overall Study|Withdrawal by Subject|2|||
143325101|NCT02862106|516734001|FG001|Overall Study|Withdrawal by Subject|0|||
143325102|NCT02862106|516734000|FG000|Overall Study|Subjects moved to other city|1|||
143325103|NCT02862106|516734001|FG001|Overall Study|Subjects moved to other city|0|||
143325104|NCT03434119|516734002|FG000|Overall Study|Randomized but not treated|1|||
143325105|NCT03434119|516734003|FG001|Overall Study|Randomized but not treated|0|||
143325106|NCT03434119|516734002|FG000|Overall Study|Adverse Event|1|||
143325107|NCT03434119|516734003|FG001|Overall Study|Adverse Event|0|||
143325108|NCT03434119|516734002|FG000|Overall Study|Poor Compliance to Protocol|0|||
143325109|NCT03434119|516734003|FG001|Overall Study|Poor Compliance to Protocol|1|||
143325110|NCT03434119|516734002|FG000|Overall Study|Study Terminated by Sponsor|91|||
143325111|NCT03434119|516734003|FG001|Overall Study|Study Terminated by Sponsor|102|||
143325112|NCT03434119|516734002|FG000|Overall Study|Withdrawal by Subject|7|||
143325113|NCT03434119|516734003|FG001|Overall Study|Withdrawal by Subject|5|||
143381055|NCT03283371|516940740|FG000|Open-label Phase|Adverse Event|0|||
143381056|NCT03283371|516940741|FG001|Open-label Phase|Adverse Event|0|||
143325114|NCT03434119|516734002|FG000|Overall Study|Other than specified|7|||
143325115|NCT03434119|516734003|FG001|Overall Study|Other than specified|5|||
143325116|NCT04360824|516734004|FG000|Overall Study|Withdrawal by Subject|2|||
143325117|NCT04360824|516734005|FG001|Overall Study|Withdrawal by Subject|1|||
143325118|NCT04360824|516734004|FG000|Overall Study|Did not receive assigned treatment|1|||
143325119|NCT04360824|516734005|FG001|Overall Study|Did not receive assigned treatment|3|||
143325120|NCT00304070|516734006|FG000|Overall Study|Death|0|||
143325121|NCT00304070|516734007|FG001|Overall Study|Death|0|||
143325122|NCT00304070|516734008|FG002|Overall Study|Death|3|||
143325123|NCT00304070|516734006|FG000|Overall Study|Lost to Follow-up|0|||
143381057|NCT03283371|516940742|FG002|Open-label Phase|Adverse Event|2|||
143325124|NCT00304070|516734007|FG001|Overall Study|Lost to Follow-up|0|||
143325125|NCT00304070|516734008|FG002|Overall Study|Lost to Follow-up|1|||
143325126|NCT00304070|516734006|FG000|Overall Study|Physician Decision|0|||
143381058|NCT03283371|516940743|FG003|Open-label Phase|Adverse Event|0|||
143325127|NCT00304070|516734007|FG001|Overall Study|Physician Decision|0|||
143325128|NCT00304070|516734008|FG002|Overall Study|Physician Decision|3|||
143325129|NCT00304070|516734006|FG000|Overall Study|Withdrawal by Subject|0|||
143325130|NCT00304070|516734007|FG001|Overall Study|Withdrawal by Subject|0|||
143325131|NCT00304070|516734008|FG002|Overall Study|Withdrawal by Subject|1|||
143325132|NCT00304070|516734006|FG000|Overall Study|Progressive Disease|3|||
143325133|NCT00304070|516734007|FG001|Overall Study|Progressive Disease|7|||
143325134|NCT00304070|516734008|FG002|Overall Study|Progressive Disease|4|||
143325135|NCT00320216|516734009|FG000|Overall Study|Adverse Event|0|||
143325136|NCT00320216|516734010|FG001|Overall Study|Adverse Event|6|||
143325137|NCT00320216|516734011|FG002|Overall Study|Adverse Event|0|||
143325138|NCT00320216|516734012|FG003|Overall Study|Adverse Event|2|||
143325139|NCT00320216|516734013|FG004|Overall Study|Adverse Event|2|||
143325140|NCT00320216|516734009|FG000|Overall Study|Lack of Efficacy|6|||
143325141|NCT00320216|516734010|FG001|Overall Study|Lack of Efficacy|2|||
143325142|NCT00320216|516734011|FG002|Overall Study|Lack of Efficacy|1|||
143325143|NCT00320216|516734012|FG003|Overall Study|Lack of Efficacy|0|||
143325144|NCT00320216|516734013|FG004|Overall Study|Lack of Efficacy|1|||
143325145|NCT00320216|516734009|FG000|Overall Study|Lost to Follow-up|3|||
143325146|NCT00320216|516734010|FG001|Overall Study|Lost to Follow-up|0|||
143325147|NCT00320216|516734011|FG002|Overall Study|Lost to Follow-up|0|||
143325148|NCT00320216|516734012|FG003|Overall Study|Lost to Follow-up|0|||
143325149|NCT00320216|516734013|FG004|Overall Study|Lost to Follow-up|0|||
143325150|NCT00320216|516734009|FG000|Overall Study|Other|7|||
143325151|NCT00320216|516734010|FG001|Overall Study|Other|2|||
143325152|NCT00320216|516734011|FG002|Overall Study|Other|5|||
143325153|NCT00320216|516734012|FG003|Overall Study|Other|1|||
143325154|NCT00320216|516734013|FG004|Overall Study|Other|3|||
143325155|NCT00377676|516734014|FG000|Overall Study|Adverse Event|498|||
143325156|NCT00377676|516734015|FG001|Overall Study|Adverse Event|107|||
143325157|NCT00377676|516734014|FG000|Overall Study|Protocol Violation|33|||
143325158|NCT00377676|516734015|FG001|Overall Study|Protocol Violation|27|||
143325159|NCT00377676|516734014|FG000|Overall Study|Death|5|||
143325160|NCT00377676|516734015|FG001|Overall Study|Death|2|||
143325161|NCT00377676|516734014|FG000|Overall Study|Withdrawal by Subject|187|||
143325162|NCT00377676|516734015|FG001|Overall Study|Withdrawal by Subject|72|||
143325163|NCT00377676|516734014|FG000|Overall Study|Lost to Follow-up|120|||
143325164|NCT00377676|516734015|FG001|Overall Study|Lost to Follow-up|56|||
143325165|NCT00377676|516734014|FG000|Overall Study|Other|118|||
143325166|NCT00377676|516734015|FG001|Overall Study|Other|58|||
143325167|NCT06027216|516734026|FG000|Overall Study|Did not qualify|8|||
143325168|NCT05348681|516734027|FG000|Overall Study|Study terminated by Sponsor|8|||
143325169|NCT05348681|516734028|FG001|Overall Study|Study terminated by Sponsor|3|||
143325170|NCT05348681|516734027|FG000|Overall Study|Withdrawal by Subject|1|||
143325171|NCT05348681|516734028|FG001|Overall Study|Withdrawal by Subject|1|||
143325172|NCT05348681|516734027|FG000|Overall Study|Lost to Follow-up|1|||
143325173|NCT05348681|516734028|FG001|Overall Study|Lost to Follow-up|1|||
143325174|NCT05348681|516734027|FG000|Overall Study|Adverse Event|1|||
143325175|NCT05348681|516734028|FG001|Overall Study|Adverse Event|0|||
143325176|NCT05348681|516734027|FG000|Overall Study|Other|2|||
143325177|NCT05348681|516734028|FG001|Overall Study|Other|1|||
143325178|NCT03646513|516734032|FG000|Overall Study|Premature study termination|4|||
143325179|NCT00782340|516734033|FG000|Open Label Titration|Adverse Event|12|||
143325180|NCT00782340|516734034|FG001|Open Label Titration|Adverse Event|0|||
143325181|NCT00782340|516734035|FG002|Open Label Titration|Adverse Event|0|||
143325182|NCT00782340|516734033|FG000|Open Label Titration|Treatment failure|50|||
143325183|NCT00782340|516734034|FG001|Open Label Titration|Treatment failure|0|||
143325184|NCT00782340|516734035|FG002|Open Label Titration|Treatment failure|0|||
143325185|NCT00782340|516734033|FG000|Open Label Titration|Protocol Violation|5|||
143325186|NCT00782340|516734034|FG001|Open Label Titration|Protocol Violation|0|||
143325187|NCT00782340|516734035|FG002|Open Label Titration|Protocol Violation|0|||
143325188|NCT00782340|516734033|FG000|Open Label Titration|Withdrawal by Subject|5|||
143325189|NCT00782340|516734034|FG001|Open Label Titration|Withdrawal by Subject|0|||
143325190|NCT00782340|516734035|FG002|Open Label Titration|Withdrawal by Subject|0|||
143325191|NCT00782340|516734033|FG000|Open Label Titration|Enrollment capped|16|||
143381059|NCT03283371|516940740|FG000|Open-label Phase|Withdrawal by Subject|0|||
143381060|NCT03283371|516940741|FG001|Open-label Phase|Withdrawal by Subject|0|||
143325192|NCT00782340|516734034|FG001|Open Label Titration|Enrollment capped|0|||
143325193|NCT00782340|516734035|FG002|Open Label Titration|Enrollment capped|0|||
143325194|NCT00782340|516734033|FG000|Open Label Titration|Did not meet responder criteria|2|||
143325195|NCT00782340|516734034|FG001|Open Label Titration|Did not meet responder criteria|0|||
143381061|NCT03283371|516940742|FG002|Open-label Phase|Withdrawal by Subject|1|||
143325196|NCT00782340|516734035|FG002|Open Label Titration|Did not meet responder criteria|0|||
143325197|NCT00782340|516734033|FG000|Open Label Titration|Lost to Follow-up|5|||
143325198|NCT00782340|516734034|FG001|Open Label Titration|Lost to Follow-up|0|||
143325199|NCT00782340|516734035|FG002|Open Label Titration|Lost to Follow-up|0|||
143325200|NCT00782340|516734033|FG000|Open Label Titration|Randomized in error|6|||
143325201|NCT00782340|516734034|FG001|Open Label Titration|Randomized in error|0|||
143325202|NCT00782340|516734035|FG002|Open Label Titration|Randomized in error|0|||
143325203|NCT00553267|516734039|FG000|Overall Study|Adverse Event|8|||
143325204|NCT00553267|516734040|FG001|Overall Study|Adverse Event|10|||
143325205|NCT00553267|516734041|FG002|Overall Study|Adverse Event|5|||
143325206|NCT00553267|516734039|FG000|Overall Study|Non compliant with protocol|3|||
143325207|NCT00553267|516734040|FG001|Overall Study|Non compliant with protocol|3|||
143325208|NCT00553267|516734041|FG002|Overall Study|Non compliant with protocol|2|||
143325209|NCT00553267|516734039|FG000|Overall Study|Lost to Follow-up|0|||
143325210|NCT00553267|516734040|FG001|Overall Study|Lost to Follow-up|0|||
143325211|NCT00553267|516734041|FG002|Overall Study|Lost to Follow-up|1|||
143325212|NCT00553267|516734039|FG000|Overall Study|Consent withdrawn|2|||
143325213|NCT00553267|516734040|FG001|Overall Study|Consent withdrawn|3|||
143325214|NCT00553267|516734041|FG002|Overall Study|Consent withdrawn|1|||
143325215|NCT00553267|516734039|FG000|Overall Study|Specified category|1|||
143325216|NCT00553267|516734040|FG001|Overall Study|Specified category|2|||
143325217|NCT00553267|516734041|FG002|Overall Study|Specified category|1|||
143325218|NCT00709722|516734042|FG000|Overall Study|Adverse Event|1|||
143325219|NCT03359096|516734043|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
143325220|NCT03359096|516734044|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
143325221|NCT03359096|516734043|FG000|First Intervention (4 Weeks)|Death|1|||
143325222|NCT03359096|516734044|FG001|First Intervention (4 Weeks)|Death|0|||
143325223|NCT03359096|516734043|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
143325224|NCT03359096|516734044|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
143325225|NCT01306162|516734045|FG000|Period 1|Adverse Event|0|||
143325226|NCT01306162|516734046|FG001|Period 1|Adverse Event|0|||
143325227|NCT01306162|516734047|FG002|Period 1|Adverse Event|0|||
143325228|NCT01306162|516734048|FG003|Period 1|Adverse Event|1|||
143325229|NCT01306162|516734045|FG000|Washout 1|Non-compliance to protocol|0|||
143325230|NCT01306162|516734046|FG001|Washout 1|Non-compliance to protocol|1|||
143325231|NCT01306162|516734047|FG002|Washout 1|Non-compliance to protocol|0|||
143325232|NCT01306162|516734048|FG003|Washout 1|Non-compliance to protocol|0|||
143325233|NCT02252211|516734055|FG000|Overall Study|Adverse Event|0|||
143325234|NCT02252211|516734056|FG001|Overall Study|Adverse Event|1|||
143325235|NCT02252211|516734057|FG002|Overall Study|Adverse Event|0|||
143325236|NCT02252211|516734055|FG000|Overall Study|Progressive disease|3|||
143325237|NCT02252211|516734056|FG001|Overall Study|Progressive disease|2|||
143325238|NCT02252211|516734057|FG002|Overall Study|Progressive disease|0|||
143325239|NCT02252211|516734055|FG000|Overall Study|Withdrawal by Subject|1|||
143325240|NCT02252211|516734056|FG001|Overall Study|Withdrawal by Subject|0|||
143325241|NCT02252211|516734057|FG002|Overall Study|Withdrawal by Subject|0|||
143325242|NCT02252211|516734055|FG000|Overall Study|Serious Adverse Event During Screening|1|||
143325243|NCT02252211|516734056|FG001|Overall Study|Serious Adverse Event During Screening|0|||
143325244|NCT02252211|516734057|FG002|Overall Study|Serious Adverse Event During Screening|1|||
143325245|NCT02952924|516734063|FG000|Overall Study|Protocol Violation|0|||
143325246|NCT02952924|516734064|FG001|Overall Study|Protocol Violation|0|||
143325247|NCT02952924|516734065|FG002|Overall Study|Protocol Violation|0|||
143325248|NCT02952924|516734066|FG003|Overall Study|Protocol Violation|0|||
143325249|NCT02952924|516734067|FG004|Overall Study|Protocol Violation|0|||
143325250|NCT02952924|516734068|FG005|Overall Study|Protocol Violation|0|||
143325251|NCT02952924|516734069|FG006|Overall Study|Protocol Violation|0|||
143325252|NCT02952924|516734070|FG007|Overall Study|Protocol Violation|0|||
143325253|NCT02952924|516734071|FG008|Overall Study|Protocol Violation|0|||
143325254|NCT02952924|516734072|FG009|Overall Study|Protocol Violation|0|||
143325255|NCT02952924|516734073|FG010|Overall Study|Protocol Violation|0|||
143325256|NCT02952924|516734074|FG011|Overall Study|Protocol Violation|0|||
143325257|NCT02952924|516734075|FG012|Overall Study|Protocol Violation|0|||
143325258|NCT02952924|516734076|FG013|Overall Study|Protocol Violation|0|||
143325259|NCT02952924|516734077|FG014|Overall Study|Protocol Violation|0|||
143325260|NCT02952924|516734078|FG015|Overall Study|Protocol Violation|0|||
143325261|NCT02952924|516734079|FG016|Overall Study|Protocol Violation|0|||
143325262|NCT02952924|516734080|FG017|Overall Study|Protocol Violation|0|||
143325263|NCT02952924|516734081|FG018|Overall Study|Protocol Violation|0|||
143381062|NCT03283371|516940743|FG003|Open-label Phase|Withdrawal by Subject|0|||
143325264|NCT02952924|516734082|FG019|Overall Study|Protocol Violation|1|||
143325265|NCT02952924|516734083|FG020|Overall Study|Protocol Violation|0|||
143325266|NCT02952924|516734084|FG021|Overall Study|Protocol Violation|0|||
143325267|NCT02952924|516734063|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
143325268|NCT02952924|516734064|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
143325269|NCT02952924|516734065|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
143325270|NCT02952924|516734066|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
143325271|NCT02952924|516734067|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
143325272|NCT02952924|516734068|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
143325273|NCT02952924|516734069|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
143325274|NCT02952924|516734070|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
143381063|NCT03283371|516940740|FG000|Open-label Phase|Other|0|||
143381064|NCT03283371|516940741|FG001|Open-label Phase|Other|0|||
143325275|NCT02952924|516734071|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
143325276|NCT02952924|516734072|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
143325277|NCT02952924|516734073|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
143325278|NCT02952924|516734074|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
143325279|NCT02952924|516734075|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
143325280|NCT02952924|516734076|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
143325281|NCT02952924|516734077|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
143325282|NCT02952924|516734078|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
143325283|NCT02952924|516734079|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
143325284|NCT02952924|516734080|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
143325285|NCT02952924|516734081|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
143325286|NCT02952924|516734082|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
143325287|NCT02952924|516734083|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
143325288|NCT02952924|516734084|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
143325289|NCT02952924|516734063|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
143325290|NCT02952924|516734064|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
143325291|NCT02952924|516734065|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
143325292|NCT02952924|516734066|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
143325293|NCT02952924|516734067|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
143325294|NCT02952924|516734068|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
143325295|NCT02952924|516734069|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
143325296|NCT02952924|516734070|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
143325297|NCT02952924|516734071|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
143325298|NCT02952924|516734072|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
143325299|NCT02952924|516734073|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
143325300|NCT02952924|516734074|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
143325301|NCT02952924|516734075|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
143325302|NCT02952924|516734076|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
143325303|NCT02952924|516734077|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
143325304|NCT02952924|516734078|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
143325305|NCT02952924|516734079|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
143325306|NCT02952924|516734080|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
143325307|NCT02952924|516734081|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
143325308|NCT02952924|516734082|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
143325309|NCT02952924|516734083|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
143325310|NCT02952924|516734084|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
143325311|NCT02952924|516734063|FG000|Overall Study|Noncompliance with study drug|0|||
143325312|NCT02952924|516734064|FG001|Overall Study|Noncompliance with study drug|0|||
143325313|NCT02952924|516734065|FG002|Overall Study|Noncompliance with study drug|0|||
143325314|NCT02952924|516734066|FG003|Overall Study|Noncompliance with study drug|0|||
143325315|NCT02952924|516734067|FG004|Overall Study|Noncompliance with study drug|0|||
143325316|NCT02952924|516734068|FG005|Overall Study|Noncompliance with study drug|0|||
143325317|NCT02952924|516734069|FG006|Overall Study|Noncompliance with study drug|0|||
143325318|NCT02952924|516734070|FG007|Overall Study|Noncompliance with study drug|0|||
143325319|NCT02952924|516734071|FG008|Overall Study|Noncompliance with study drug|0|||
143325320|NCT02952924|516734072|FG009|Overall Study|Noncompliance with study drug|0|||
143325321|NCT02952924|516734073|FG010|Overall Study|Noncompliance with study drug|0|||
143325322|NCT02952924|516734074|FG011|Overall Study|Noncompliance with study drug|0|||
143325323|NCT02952924|516734075|FG012|Overall Study|Noncompliance with study drug|0|||
143325324|NCT02952924|516734076|FG013|Overall Study|Noncompliance with study drug|0|||
143325325|NCT02952924|516734077|FG014|Overall Study|Noncompliance with study drug|0|||
143325326|NCT02952924|516734078|FG015|Overall Study|Noncompliance with study drug|0|||
143325327|NCT02952924|516734079|FG016|Overall Study|Noncompliance with study drug|0|||
143325328|NCT02952924|516734080|FG017|Overall Study|Noncompliance with study drug|0|||
143325329|NCT02952924|516734081|FG018|Overall Study|Noncompliance with study drug|0|||
143325330|NCT02952924|516734082|FG019|Overall Study|Noncompliance with study drug|0|||
143325331|NCT02952924|516734083|FG020|Overall Study|Noncompliance with study drug|0|||
143325332|NCT02952924|516734084|FG021|Overall Study|Noncompliance with study drug|1|||
143325333|NCT01934218|516734086|FG000|Double-blind Phase|Adverse Event|8|||
143325334|NCT01934218|516734087|FG001|Double-blind Phase|Adverse Event|8|||
143325335|NCT01934218|516734086|FG000|Double-blind Phase|Lack of Efficacy|6|||
143325336|NCT01934218|516734087|FG001|Double-blind Phase|Lack of Efficacy|7|||
143325337|NCT01934218|516734086|FG000|Double-blind Phase|Lost to Follow-up|7|||
143325338|NCT01934218|516734087|FG001|Double-blind Phase|Lost to Follow-up|14|||
143325339|NCT01934218|516734086|FG000|Double-blind Phase|Physician Decision|1|||
143325340|NCT01934218|516734087|FG001|Double-blind Phase|Physician Decision|2|||
143325341|NCT01934218|516734086|FG000|Double-blind Phase|Protocol Violation|4|||
143325342|NCT01934218|516734087|FG001|Double-blind Phase|Protocol Violation|0|||
143325343|NCT01934218|516734086|FG000|Double-blind Phase|Withdrawal by Subject|16|||
143325344|NCT01934218|516734087|FG001|Double-blind Phase|Withdrawal by Subject|13|||
143325345|NCT01934218|516734086|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
143325346|NCT01934218|516734087|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
143325347|NCT01934218|516734086|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
143325348|NCT01934218|516734087|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
143325349|NCT01934218|516734086|FG000|Open-Label Phase|Adverse Event|2|||
143325350|NCT01934218|516734087|FG001|Open-Label Phase|Adverse Event|4|||
143325351|NCT01934218|516734086|FG000|Open-Label Phase|Lack of Efficacy|1|||
143325352|NCT01934218|516734087|FG001|Open-Label Phase|Lack of Efficacy|4|||
143325353|NCT01934218|516734086|FG000|Open-Label Phase|Lost to Follow-up|4|||
143325354|NCT01934218|516734087|FG001|Open-Label Phase|Lost to Follow-up|2|||
143325355|NCT01934218|516734086|FG000|Open-Label Phase|Physician Decision|1|||
143325356|NCT01934218|516734087|FG001|Open-Label Phase|Physician Decision|0|||
143325357|NCT01934218|516734086|FG000|Open-Label Phase|Protocol Violation|1|||
143325358|NCT01934218|516734087|FG001|Open-Label Phase|Protocol Violation|0|||
143325359|NCT01934218|516734086|FG000|Open-Label Phase|Withdrawal by Subject|13|||
143325360|NCT01934218|516734087|FG001|Open-Label Phase|Withdrawal by Subject|11|||
143325361|NCT01934218|516734086|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
143325362|NCT01934218|516734087|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
143325363|NCT01934218|516734086|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
143325364|NCT01934218|516734087|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
143325365|NCT02232893|516734093|FG000|Overall Study|Withdrawal by Subject|4|||
143325366|NCT02232893|516734094|FG001|Overall Study|Withdrawal by Subject|1|||
143325367|NCT02232893|516734093|FG000|Overall Study|Adverse Event|0|||
143325368|NCT02232893|516734094|FG001|Overall Study|Adverse Event|1|||
143325369|NCT02232893|516734093|FG000|Overall Study|Sponsor request early termination|0|||
143325370|NCT02232893|516734094|FG001|Overall Study|Sponsor request early termination|1|||
143325371|NCT02232893|516734093|FG000|Overall Study|Developed exclusion criteria|0|||
143325372|NCT02232893|516734094|FG001|Overall Study|Developed exclusion criteria|1|||
143325373|NCT02232893|516734093|FG000|Overall Study|Other|0|||
143325374|NCT02232893|516734094|FG001|Overall Study|Other|3|||
143325375|NCT03867734|516734097|FG000|Overall Study|Lost to Follow-up|2|||
143325376|NCT03965052|516734098|FG000|Overall Study|Protocol Violation|1|||
143325377|NCT03965052|516734099|FG001|Overall Study|Protocol Violation|0|||
143325378|NCT00380068|516734105|FG000|Overall Study|Adverse Event|40|||
143325379|NCT00380068|516734105|FG000|Overall Study|Withdrawal by Subject|10|||
143325380|NCT00380068|516734105|FG000|Overall Study|Not compliant|6|||
143325381|NCT00380068|516734105|FG000|Overall Study|Lost to Follow-up|1|||
143325382|NCT00380068|516734105|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
143325383|NCT00380068|516734105|FG000|Overall Study|Lung transplant|3|||
143325384|NCT00380068|516734105|FG000|Overall Study|Physician Decision|2|||
143325385|NCT00380068|516734105|FG000|Overall Study|Partipant moved away|1|||
143325386|NCT00380068|516734105|FG000|Overall Study|Lack of Efficacy|5|||
143325387|NCT03351049|516734106|FG000|Overall Study|Withdrawal|26|||
143325388|NCT03351049|516734107|FG001|Overall Study|Withdrawal|22|||
143325389|NCT02730819|516734117|FG000|Overall Study|Lost to Follow-up|9|||
143325390|NCT02121847|516734118|FG000|Overall Study|Administrative Reasons|1|||
143325391|NCT02121847|516734118|FG000|Overall Study|Adverse Event|2|||
143325392|NCT01410448|516734124|FG000|Overall Study|No conversion to everolimus|0|||
143325393|NCT01410448|516734125|FG001|Overall Study|No conversion to everolimus|24|||
143325394|NCT01410448|516734124|FG000|Overall Study|Graft loss|4|||
143325395|NCT01410448|516734125|FG001|Overall Study|Graft loss|1|||
143325396|NCT01410448|516734124|FG000|Overall Study|Administrative issues|2|||
143325397|NCT01410448|516734125|FG001|Overall Study|Administrative issues|1|||
143325398|NCT01410448|516734124|FG000|Overall Study|Lost to Follow-up|1|||
143325399|NCT01410448|516734125|FG001|Overall Study|Lost to Follow-up|0|||
143325400|NCT01410448|516734124|FG000|Overall Study|Withdrawal by Subject|3|||
143325401|NCT01410448|516734125|FG001|Overall Study|Withdrawal by Subject|2|||
143325402|NCT01410448|516734124|FG000|Overall Study|Protocol Violation|0|||
143325403|NCT01410448|516734125|FG001|Overall Study|Protocol Violation|4|||
143325404|NCT01410448|516734124|FG000|Overall Study|Death|2|||
143325405|NCT01410448|516734125|FG001|Overall Study|Death|3|||
143325406|NCT00932893|516734128|FG000|Overall Study|Death|115|||
143325407|NCT00932893|516734129|FG001|Overall Study|Death|24|||
143325408|NCT00932893|516734128|FG000|Overall Study|Lost to Follow-up|8|||
143325409|NCT00932893|516734129|FG001|Overall Study|Lost to Follow-up|0|||
143325410|NCT00932893|516734128|FG000|Overall Study|Withdrawal by Subject|5|||
143325411|NCT00932893|516734129|FG001|Overall Study|Withdrawal by Subject|2|||
143325412|NCT00932893|516734128|FG000|Overall Study|Other|5|||
143325413|NCT00932893|516734129|FG001|Overall Study|Other|144|||
143325414|NCT04537923|516736417|FG000|Overall Study|Adverse Event|2|||
143325415|NCT04537923|516736418|FG001|Overall Study|Adverse Event|1|||
143325416|NCT04537923|516736419|FG002|Overall Study|Adverse Event|2|||
143325417|NCT04537923|516736420|FG003|Overall Study|Adverse Event|4|||
143325418|NCT04537923|516736417|FG000|Overall Study|Death|3|||
143325419|NCT04537923|516736418|FG001|Overall Study|Death|3|||
143325420|NCT04537923|516736419|FG002|Overall Study|Death|1|||
143325421|NCT04537923|516736420|FG003|Overall Study|Death|11|||
143325422|NCT04537923|516736417|FG000|Overall Study|Lost to Follow-up|1|||
143325423|NCT04537923|516736418|FG001|Overall Study|Lost to Follow-up|2|||
143325424|NCT04537923|516736419|FG002|Overall Study|Lost to Follow-up|1|||
143325425|NCT04537923|516736420|FG003|Overall Study|Lost to Follow-up|6|||
143325426|NCT04537923|516736417|FG000|Overall Study|Physician Decision|1|||
143325427|NCT04537923|516736418|FG001|Overall Study|Physician Decision|0|||
143325428|NCT04537923|516736419|FG002|Overall Study|Physician Decision|2|||
143325429|NCT04537923|516736420|FG003|Overall Study|Physician Decision|5|||
143325430|NCT04537923|516736417|FG000|Overall Study|Pregnancy|1|||
143325431|NCT04537923|516736418|FG001|Overall Study|Pregnancy|0|||
143325432|NCT04537923|516736419|FG002|Overall Study|Pregnancy|0|||
143325433|NCT04537923|516736420|FG003|Overall Study|Pregnancy|0|||
143325434|NCT04537923|516736417|FG000|Overall Study|Withdrawal by Subject|4|||
143325435|NCT04537923|516736418|FG001|Overall Study|Withdrawal by Subject|4|||
143325436|NCT04537923|516736419|FG002|Overall Study|Withdrawal by Subject|4|||
143325437|NCT04537923|516736420|FG003|Overall Study|Withdrawal by Subject|58|||
143325438|NCT04537923|516736417|FG000|Overall Study|Missed study visits|2|||
143325439|NCT04537923|516736418|FG001|Overall Study|Missed study visits|0|||
143325440|NCT04537923|516736419|FG002|Overall Study|Missed study visits|0|||
143325441|NCT04537923|516736420|FG003|Overall Study|Missed study visits|3|||
143325442|NCT04537923|516736417|FG000|Overall Study|Sponsor's decision|0|||
143325443|NCT04537923|516736418|FG001|Overall Study|Sponsor's decision|0|||
143325444|NCT04537923|516736419|FG002|Overall Study|Sponsor's decision|1|||
143325445|NCT04537923|516736420|FG003|Overall Study|Sponsor's decision|1|||
143325446|NCT04537923|516736417|FG000|Overall Study|Safety reasons|1|||
143325447|NCT04537923|516736418|FG001|Overall Study|Safety reasons|0|||
143325448|NCT04537923|516736419|FG002|Overall Study|Safety reasons|0|||
143325449|NCT04537923|516736420|FG003|Overall Study|Safety reasons|0|||
143325450|NCT02527798|516736421|FG000|Overall Study|Physician Decision|1|||
143325451|NCT02527798|516736422|FG001|Overall Study|Physician Decision|0|||
143325452|NCT02527798|516736423|FG002|Overall Study|Physician Decision|1|||
143325453|NCT02527798|516736424|FG003|Overall Study|Physician Decision|1|||
143325454|NCT02527798|516736425|FG004|Overall Study|Physician Decision|0|||
143325455|NCT02527798|516736426|FG005|Overall Study|Physician Decision|0|||
143325456|NCT02527798|516736421|FG000|Overall Study|Death|0|||
143325457|NCT02527798|516736422|FG001|Overall Study|Death|0|||
143325458|NCT02527798|516736423|FG002|Overall Study|Death|1|||
143325459|NCT02527798|516736424|FG003|Overall Study|Death|0|||
143325460|NCT02527798|516736425|FG004|Overall Study|Death|0|||
143325461|NCT02527798|516736426|FG005|Overall Study|Death|0|||
143325462|NCT02527798|516736421|FG000|Overall Study|Withdrawal by Subject|0|||
143325463|NCT02527798|516736422|FG001|Overall Study|Withdrawal by Subject|1|||
143325464|NCT02527798|516736423|FG002|Overall Study|Withdrawal by Subject|2|||
143325465|NCT02527798|516736424|FG003|Overall Study|Withdrawal by Subject|0|||
143325466|NCT02527798|516736425|FG004|Overall Study|Withdrawal by Subject|0|||
143325467|NCT02527798|516736426|FG005|Overall Study|Withdrawal by Subject|0|||
143325468|NCT02527798|516736421|FG000|Overall Study|Reason undisclosed|1|||
143325469|NCT02527798|516736422|FG001|Overall Study|Reason undisclosed|0|||
143325470|NCT02527798|516736423|FG002|Overall Study|Reason undisclosed|1|||
143325471|NCT02527798|516736424|FG003|Overall Study|Reason undisclosed|0|||
143325472|NCT02527798|516736425|FG004|Overall Study|Reason undisclosed|0|||
143325473|NCT02527798|516736426|FG005|Overall Study|Reason undisclosed|0|||
143325474|NCT02527798|516736421|FG000|Overall Study|Did not receive intervention|1|||
143325475|NCT02527798|516736422|FG001|Overall Study|Did not receive intervention|1|||
143325476|NCT02527798|516736423|FG002|Overall Study|Did not receive intervention|0|||
143325477|NCT02527798|516736424|FG003|Overall Study|Did not receive intervention|0|||
143325478|NCT02527798|516736425|FG004|Overall Study|Did not receive intervention|0|||
143325479|NCT02527798|516736426|FG005|Overall Study|Did not receive intervention|0|||
143325480|NCT04745169|516736427|FG000|Overall Study|Kidney transplantation|1|||
143325481|NCT04745169|516736427|FG000|Overall Study|Participant health problems|3|||
143325482|NCT04745169|516736427|FG000|Overall Study|Physician Decision|2|||
143325483|NCT01808690|516736428|FG000|Overall Study|Withdrawal by Subject|1|||
143325484|NCT01808690|516736429|FG001|Overall Study|Withdrawal by Subject|2|||
143325485|NCT03586648|516736432|FG000|Period 1|Withdrawal by Subject|0|||
143325486|NCT03586648|516736433|FG001|Period 1|Withdrawal by Subject|1|||
143325487|NCT03586648|516736432|FG000|Period 1|Lost to Follow-up|1|||
143325488|NCT03586648|516736433|FG001|Period 1|Lost to Follow-up|1|||
143325489|NCT03586648|516736432|FG000|Period 1|Adverse Event|1|||
143325490|NCT03586648|516736433|FG001|Period 1|Adverse Event|0|||
143325491|NCT03586648|516736432|FG000|Period 1|Study related symptoms or complaints|2|||
143325492|NCT03586648|516736433|FG001|Period 1|Study related symptoms or complaints|1|||
143325493|NCT03586648|516736432|FG000|Period 1|Physician Decision|0|||
143325494|NCT03586648|516736433|FG001|Period 1|Physician Decision|1|||
143325495|NCT03586648|516736432|FG000|Period 2|Adverse Event|1|||
143325496|NCT03586648|516736433|FG001|Period 2|Adverse Event|0|||
143325497|NCT02395120|516736434|FG000|Overall Study|Missed follow-up dental exam|57|||
143325498|NCT02395120|516736435|FG001|Overall Study|Missed follow-up dental exam|62|||
143325499|NCT02395120|516736436|FG002|Overall Study|Missed follow-up dental exam|6|||
143325500|NCT02395120|516736437|FG003|Overall Study|Missed follow-up dental exam|6|||
143325501|NCT02395120|516736438|FG004|Overall Study|Missed follow-up dental exam|51|||
143325502|NCT00377234|516736439|FG000|Overall Study|Adverse Event|14|||
143325503|NCT00377234|516736440|FG001|Overall Study|Adverse Event|17|||
143325504|NCT00377234|516736439|FG000|Overall Study|Withdrawal by Subject|11|||
143325505|NCT00377234|516736440|FG001|Overall Study|Withdrawal by Subject|9|||
143325506|NCT00377234|516736439|FG000|Overall Study|Lost to Follow-up|4|||
143325507|NCT00377234|516736440|FG001|Overall Study|Lost to Follow-up|2|||
143325508|NCT00377234|516736439|FG000|Overall Study|Administrative|2|||
143325509|NCT00377234|516736440|FG001|Overall Study|Administrative|1|||
143325510|NCT00377234|516736439|FG000|Overall Study|Not assigned|3|||
143325511|NCT00377234|516736440|FG001|Overall Study|Not assigned|2|||
143325512|NCT00896168|516736443|FG000|Overall Study|Adverse Event|4|||
143325513|NCT00896168|516736444|FG001|Overall Study|Adverse Event|7|||
143325514|NCT00896168|516736443|FG000|Overall Study|Treatment failure|8|||
143325515|NCT00896168|516736444|FG001|Overall Study|Treatment failure|10|||
143325516|NCT00896168|516736443|FG000|Overall Study|Lost to Follow-up|1|||
143325517|NCT00896168|516736444|FG001|Overall Study|Lost to Follow-up|1|||
143325518|NCT00896168|516736443|FG000|Overall Study|Other|1|||
143325519|NCT00896168|516736444|FG001|Overall Study|Other|1|||
143325520|NCT00384085|516736446|FG000|Overall Study|Adverse Event|5|||
143325521|NCT00384085|516736447|FG001|Overall Study|Adverse Event|5|||
143325522|NCT00384085|516736448|FG002|Overall Study|Adverse Event|4|||
143325523|NCT00384085|516736446|FG000|Overall Study|Lack of Efficacy|0|||
143325524|NCT00384085|516736447|FG001|Overall Study|Lack of Efficacy|3|||
143325525|NCT00384085|516736448|FG002|Overall Study|Lack of Efficacy|2|||
143325526|NCT00384085|516736446|FG000|Overall Study|No longer Requires Study Treatment|1|||
143325527|NCT00384085|516736447|FG001|Overall Study|No longer Requires Study Treatment|0|||
143325528|NCT00384085|516736448|FG002|Overall Study|No longer Requires Study Treatment|1|||
143325529|NCT00384085|516736446|FG000|Overall Study|Protocol Violation|2|||
143325530|NCT00384085|516736447|FG001|Overall Study|Protocol Violation|2|||
143325531|NCT00384085|516736448|FG002|Overall Study|Protocol Violation|2|||
143325532|NCT00384085|516736446|FG000|Overall Study|Lost to Follow-up|9|||
143325533|NCT00384085|516736447|FG001|Overall Study|Lost to Follow-up|9|||
143325534|NCT00384085|516736448|FG002|Overall Study|Lost to Follow-up|10|||
143325535|NCT00384085|516736446|FG000|Overall Study|Progressive Disease|0|||
143325536|NCT00384085|516736447|FG001|Overall Study|Progressive Disease|1|||
143325537|NCT00384085|516736448|FG002|Overall Study|Progressive Disease|0|||
143325538|NCT00384085|516736446|FG000|Overall Study|Withdrawal by Subject|14|||
143325539|NCT00384085|516736447|FG001|Overall Study|Withdrawal by Subject|19|||
143325540|NCT00384085|516736448|FG002|Overall Study|Withdrawal by Subject|29|||
143325541|NCT00384085|516736446|FG000|Overall Study|Patient non-compliant|4|||
143325542|NCT00384085|516736447|FG001|Overall Study|Patient non-compliant|4|||
143325543|NCT00384085|516736448|FG002|Overall Study|Patient non-compliant|5|||
143325544|NCT00384085|516736446|FG000|Overall Study|Physician Decision|1|||
143325545|NCT00384085|516736447|FG001|Overall Study|Physician Decision|0|||
143325546|NCT00384085|516736448|FG002|Overall Study|Physician Decision|0|||
143381065|NCT03283371|516940742|FG002|Open-label Phase|Other|1|||
143325547|NCT00384085|516736446|FG000|Overall Study|Loss of site personnel|1|||
143325548|NCT00384085|516736447|FG001|Overall Study|Loss of site personnel|0|||
143325549|NCT00384085|516736448|FG002|Overall Study|Loss of site personnel|1|||
143325550|NCT00384085|516736446|FG000|Overall Study|Sponsor decision|1|||
143325551|NCT00384085|516736447|FG001|Overall Study|Sponsor decision|2|||
143325552|NCT00384085|516736448|FG002|Overall Study|Sponsor decision|1|||
143325553|NCT00384085|516736446|FG000|Overall Study|Patient moved|1|||
143325554|NCT00384085|516736447|FG001|Overall Study|Patient moved|0|||
143325555|NCT00384085|516736448|FG002|Overall Study|Patient moved|1|||
143325556|NCT00384085|516736446|FG000|Overall Study|Patient required surgery|0|||
143325557|NCT00384085|516736447|FG001|Overall Study|Patient required surgery|1|||
143325558|NCT00384085|516736448|FG002|Overall Study|Patient required surgery|0|||
143325559|NCT03725982|516736449|FG000|First Intervention|Withdrawal by Subject|0|||
143325560|NCT03725982|516736450|FG001|First Intervention|Withdrawal by Subject|1|||
143325561|NCT03725982|516736449|FG000|First Intervention|Physician Decision|1|||
143325562|NCT03725982|516736450|FG001|First Intervention|Physician Decision|1|||
143325563|NCT01944631|516736452|FG000|Overall Study|Adverse Event|1|||
143325564|NCT01944631|516736453|FG001|Overall Study|Adverse Event|0|||
143325565|NCT01944631|516736452|FG000|Overall Study|Lost to Follow-up|3|||
143325566|NCT01944631|516736453|FG001|Overall Study|Lost to Follow-up|1|||
143325567|NCT01944631|516736452|FG000|Overall Study|Withdrawal by Subject|0|||
143325568|NCT01944631|516736453|FG001|Overall Study|Withdrawal by Subject|1|||
143325569|NCT00838110|516736454|FG000|Overall Study|Death|0|||
143325570|NCT00838110|516736455|FG001|Overall Study|Death|0|||
143325571|NCT00838110|516736456|FG002|Overall Study|Death|1|||
143325572|NCT00838110|516736457|FG003|Overall Study|Death|2|||
143325573|NCT00838110|516736454|FG000|Overall Study|Adverse Event|11|||
143325574|NCT00838110|516736455|FG001|Overall Study|Adverse Event|10|||
143325575|NCT00838110|516736456|FG002|Overall Study|Adverse Event|8|||
143325576|NCT00838110|516736457|FG003|Overall Study|Adverse Event|7|||
143325577|NCT00838110|516736454|FG000|Overall Study|Withdrawal by Subject|5|||
143325578|NCT00838110|516736455|FG001|Overall Study|Withdrawal by Subject|6|||
143325579|NCT00838110|516736456|FG002|Overall Study|Withdrawal by Subject|3|||
143325580|NCT00838110|516736457|FG003|Overall Study|Withdrawal by Subject|4|||
143325581|NCT00838110|516736454|FG000|Overall Study|Other|3|||
143325582|NCT00838110|516736455|FG001|Overall Study|Other|3|||
143325583|NCT00838110|516736456|FG002|Overall Study|Other|3|||
143325584|NCT00838110|516736457|FG003|Overall Study|Other|2|||
143325585|NCT00838110|516736454|FG000|Overall Study|Protocol Violation|0|||
143325586|NCT00838110|516736455|FG001|Overall Study|Protocol Violation|2|||
143325587|NCT00838110|516736456|FG002|Overall Study|Protocol Violation|1|||
143325588|NCT00838110|516736457|FG003|Overall Study|Protocol Violation|1|||
143325589|NCT00838110|516736454|FG000|Overall Study|Lost to Follow-up|3|||
143325590|NCT00838110|516736455|FG001|Overall Study|Lost to Follow-up|0|||
143325591|NCT00838110|516736456|FG002|Overall Study|Lost to Follow-up|0|||
143325592|NCT00838110|516736457|FG003|Overall Study|Lost to Follow-up|0|||
143325593|NCT00838110|516736454|FG000|Overall Study|Did not meet eligibility criteria|0|||
143325594|NCT00838110|516736455|FG001|Overall Study|Did not meet eligibility criteria|0|||
143325595|NCT00838110|516736456|FG002|Overall Study|Did not meet eligibility criteria|1|||
143325596|NCT00838110|516736457|FG003|Overall Study|Did not meet eligibility criteria|2|||
143325597|NCT00838110|516736454|FG000|Overall Study|Randomized but not treated|0|||
143325598|NCT00838110|516736455|FG001|Overall Study|Randomized but not treated|1|||
143325599|NCT00838110|516736456|FG002|Overall Study|Randomized but not treated|0|||
143325600|NCT00838110|516736457|FG003|Overall Study|Randomized but not treated|0|||
143325601|NCT02811861|516736458|FG000|Overall Study|Radiological Disease Progression|123|||
143325602|NCT02811861|516736459|FG001|Overall Study|Radiological Disease Progression|97|||
143325603|NCT02811861|516736460|FG002|Overall Study|Radiological Disease Progression|174|||
143325604|NCT02811861|516736458|FG000|Overall Study|Clinical Disease Progression|20|||
143325605|NCT02811861|516736459|FG001|Overall Study|Clinical Disease Progression|19|||
143325606|NCT02811861|516736460|FG002|Overall Study|Clinical Disease Progression|22|||
143325607|NCT02811861|516736458|FG000|Overall Study|Adverse Event|63|||
143325608|NCT02811861|516736459|FG001|Overall Study|Adverse Event|60|||
143325609|NCT02811861|516736460|FG002|Overall Study|Adverse Event|41|||
143325610|NCT02811861|516736458|FG000|Overall Study|Lost to Follow-up|0|||
143325611|NCT02811861|516736459|FG001|Overall Study|Lost to Follow-up|0|||
143325612|NCT02811861|516736460|FG002|Overall Study|Lost to Follow-up|1|||
143325613|NCT02811861|516736458|FG000|Overall Study|Subject Choice|29|||
143325614|NCT02811861|516736459|FG001|Overall Study|Subject Choice|17|||
143325615|NCT02811861|516736460|FG002|Overall Study|Subject Choice|23|||
143325616|NCT02811861|516736458|FG000|Overall Study|Withdrawal by Subject|4|||
143325617|NCT02811861|516736459|FG001|Overall Study|Withdrawal by Subject|4|||
143325618|NCT02811861|516736460|FG002|Overall Study|Withdrawal by Subject|9|||
143325619|NCT02811861|516736458|FG000|Overall Study|Other|4|||
143325620|NCT02811861|516736459|FG001|Overall Study|Other|13|||
143325621|NCT02811861|516736460|FG002|Overall Study|Other|3|||
143325622|NCT02811861|516736458|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
143325623|NCT02811861|516736459|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
143325624|NCT02811861|516736460|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
143325625|NCT02811861|516736458|FG000|Overall Study|Randomized but not treated|2|||
143325626|NCT02811861|516736459|FG001|Overall Study|Randomized but not treated|3|||
143325627|NCT02811861|516736460|FG002|Overall Study|Randomized but not treated|17|||
143325628|NCT04743908|516736461|FG000|Overall Study|Death|1|||
143325629|NCT04743908|516736462|FG001|Overall Study|Death|0|||
143325630|NCT04743908|516736461|FG000|Overall Study|Lost to Follow-up|181|||
143325631|NCT04743908|516736462|FG001|Overall Study|Lost to Follow-up|180|||
143325632|NCT04743908|516736461|FG000|Overall Study|Withdrawal by Subject|1|||
143325633|NCT04743908|516736462|FG001|Overall Study|Withdrawal by Subject|2|||
143325634|NCT03822533|516736463|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
143325635|NCT03822533|516736464|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
143325636|NCT03822533|516736463|FG000|3 Month Follow-up|Lost to Follow-up|2|||
143325637|NCT03822533|516736464|FG001|3 Month Follow-up|Lost to Follow-up|2|||
143325638|NCT03822533|516736463|FG000|6 Month Follow-up|Lost to Follow-up|3|||
143325639|NCT03822533|516736464|FG001|6 Month Follow-up|Lost to Follow-up|0|||
143325640|NCT03822533|516736463|FG000|12 Month Follow-up|Lost to Follow-up|2|||
143325641|NCT03822533|516736464|FG001|12 Month Follow-up|Lost to Follow-up|3|||
143325642|NCT03822533|516736463|FG000|12 Month Follow-up|Pregnancy|0|||
143325643|NCT03822533|516736464|FG001|12 Month Follow-up|Pregnancy|1|||
143325644|NCT03822533|516736463|FG000|12 Month Follow-up|Surgery|2|||
143325645|NCT03822533|516736464|FG001|12 Month Follow-up|Surgery|0|||
143325646|NCT03822533|516736463|FG000|12 Month Follow-up|Wrong address|1|||
143325647|NCT03822533|516736464|FG001|12 Month Follow-up|Wrong address|0|||
143325648|NCT03822533|516736463|FG000|12 Month Follow-up|No symptoms|1|||
143325649|NCT03822533|516736464|FG001|12 Month Follow-up|No symptoms|0|||
143325650|NCT03822533|516736463|FG000|12 Month Follow-up|Changed primary care center|0|||
143325651|NCT03822533|516736464|FG001|12 Month Follow-up|Changed primary care center|1|||
143325652|NCT02489500|516736468|FG000|Overall Study|Death|1|||
143325653|NCT02489500|516736469|FG001|Overall Study|Death|1|||
143325654|NCT00328510|516736470|FG000|Overall Study|Gag disorder, could not use frame|4|||
143325655|NCT00328510|516736471|FG001|Overall Study|Gag disorder, could not use frame|0|||
143325656|NCT00328510|516736470|FG000|Overall Study|Dentition problems, could not use frame|1|||
143325657|NCT00328510|516736471|FG001|Overall Study|Dentition problems, could not use frame|0|||
143325658|NCT00328510|516736470|FG000|Overall Study|Withdrawal by Subject|4|||
143325659|NCT00328510|516736471|FG001|Overall Study|Withdrawal by Subject|2|||
143325660|NCT00328510|516736470|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
143325661|NCT00328510|516736471|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
143325662|NCT00328510|516736470|FG000|Overall Study|Treatment changed to a single fraction|1|||
143325663|NCT00328510|516736471|FG001|Overall Study|Treatment changed to a single fraction|1|||
143325664|NCT01990950|516736473|FG000|Overall Study|Death|3|||
143325665|NCT01990950|516736473|FG000|Overall Study|Lost to Follow-up|2|||
143325666|NCT01990950|516736473|FG000|Overall Study|Withdrawal by Subject|6|||
143325667|NCT02349295|516736474|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
143325668|NCT02349295|516736475|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
143325669|NCT02349295|516736476|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
143325670|NCT02349295|516736477|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
143325671|NCT02349295|516736478|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
143325672|NCT02349295|516736479|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
143325673|NCT02349295|516736480|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
143325674|NCT02349295|516736481|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
143325675|NCT02349295|516736482|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
143325676|NCT02349295|516736483|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
143325677|NCT02349295|516736484|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
143325678|NCT02349295|516736485|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
143325679|NCT02349295|516736486|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
143325680|NCT02349295|516736487|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
143325681|NCT02349295|516736474|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
143325682|NCT02349295|516736475|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
143325683|NCT02349295|516736476|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
143325684|NCT02349295|516736477|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
143325685|NCT02349295|516736478|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
143325686|NCT02349295|516736479|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
143325687|NCT02349295|516736480|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
143325688|NCT02349295|516736481|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
143325689|NCT02349295|516736482|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
143325690|NCT02349295|516736483|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
143325691|NCT02349295|516736484|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
143325692|NCT02349295|516736485|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
143325693|NCT02349295|516736486|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
143325694|NCT02349295|516736487|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
143325695|NCT02349295|516736474|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
143325696|NCT02349295|516736475|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
143325697|NCT02349295|516736476|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
143325698|NCT02349295|516736477|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
143325699|NCT02349295|516736478|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
143325700|NCT02349295|516736479|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
143325701|NCT02349295|516736480|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
143325702|NCT02349295|516736481|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
143325703|NCT02349295|516736482|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
143325704|NCT02349295|516736483|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
143325705|NCT02349295|516736484|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
143325706|NCT02349295|516736485|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
143325707|NCT02349295|516736486|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
143325708|NCT02349295|516736487|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
143325709|NCT02349295|516736474|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
143325710|NCT02349295|516736475|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
143325711|NCT02349295|516736476|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
143325712|NCT02349295|516736477|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
143325713|NCT02349295|516736478|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
143325714|NCT02349295|516736479|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
143325715|NCT02349295|516736480|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
143325716|NCT02349295|516736481|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
143325717|NCT02349295|516736482|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
143325718|NCT02349295|516736483|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
143325719|NCT02349295|516736484|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
143325720|NCT02349295|516736485|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
143325721|NCT02349295|516736486|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
143325722|NCT02349295|516736487|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
143325723|NCT02349295|516736474|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
143325724|NCT02349295|516736475|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
143325725|NCT02349295|516736476|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
143325726|NCT02349295|516736477|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
143325727|NCT02349295|516736478|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
143325728|NCT02349295|516736479|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
143325729|NCT02349295|516736480|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
143325730|NCT02349295|516736481|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
143325731|NCT02349295|516736482|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
143325732|NCT02349295|516736483|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
143325733|NCT02349295|516736484|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
143325734|NCT02349295|516736485|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
143325735|NCT02349295|516736486|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
143325736|NCT02349295|516736487|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
143325737|NCT02349295|516736474|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
143325738|NCT02349295|516736475|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
143325739|NCT02349295|516736476|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
143325740|NCT02349295|516736477|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
143325741|NCT02349295|516736478|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
143325742|NCT02349295|516736479|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
143325743|NCT02349295|516736480|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
143325744|NCT02349295|516736481|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
143325745|NCT02349295|516736482|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
143325746|NCT02349295|516736483|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
143325747|NCT02349295|516736484|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
143325748|NCT02349295|516736485|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
143325749|NCT02349295|516736486|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
143325750|NCT02349295|516736487|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
143325751|NCT02349295|516736474|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
143325752|NCT02349295|516736475|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
143325753|NCT02349295|516736476|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
143325754|NCT02349295|516736477|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
143325755|NCT02349295|516736478|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
143325756|NCT02349295|516736479|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
143325757|NCT02349295|516736480|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
143325758|NCT02349295|516736481|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
143325759|NCT02349295|516736482|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
143325760|NCT02349295|516736483|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
143325761|NCT02349295|516736484|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
143325762|NCT02349295|516736485|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
143325763|NCT02349295|516736486|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
143325764|NCT02349295|516736487|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
143325765|NCT02349295|516736474|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
143325766|NCT02349295|516736475|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
143325767|NCT02349295|516736476|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
143325768|NCT02349295|516736477|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
143325769|NCT02349295|516736478|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
143325770|NCT02349295|516736479|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
143325771|NCT02349295|516736480|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
143325772|NCT02349295|516736481|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
143325773|NCT02349295|516736482|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
143325774|NCT02349295|516736483|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
143381066|NCT03283371|516940743|FG003|Open-label Phase|Other|1|||
143381067|NCT00243503|516940744|FG000|Overall Study|Adverse Event|11|||
143325775|NCT02349295|516736484|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
143325776|NCT02349295|516736485|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
143325777|NCT02349295|516736486|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
143325778|NCT02349295|516736487|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
143325779|NCT02349295|516736474|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
143325780|NCT02349295|516736475|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
143325781|NCT02349295|516736476|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
143325782|NCT02349295|516736477|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
143325783|NCT02349295|516736478|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
143325784|NCT02349295|516736479|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
143325785|NCT02349295|516736480|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
143325786|NCT02349295|516736481|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
143325787|NCT02349295|516736482|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
143325788|NCT02349295|516736483|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
143325789|NCT02349295|516736484|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
143325790|NCT02349295|516736485|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
143325791|NCT02349295|516736486|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
143325792|NCT02349295|516736487|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
143325793|NCT02349295|516736474|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
143325794|NCT02349295|516736475|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
143325795|NCT02349295|516736476|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
143325796|NCT02349295|516736477|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
143325797|NCT02349295|516736478|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
143325798|NCT02349295|516736479|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
143325799|NCT02349295|516736480|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
143325800|NCT02349295|516736481|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
143325801|NCT02349295|516736482|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
143325802|NCT02349295|516736483|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
143325803|NCT02349295|516736484|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
143325804|NCT02349295|516736485|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
143325805|NCT02349295|516736486|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
143325806|NCT02349295|516736487|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
143325807|NCT02349295|516736474|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
143325808|NCT02349295|516736475|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
143325809|NCT02349295|516736476|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
143325810|NCT02349295|516736477|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
143325811|NCT02349295|516736478|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
143325812|NCT02349295|516736479|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
143325813|NCT02349295|516736480|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
143325814|NCT02349295|516736481|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
143325815|NCT02349295|516736482|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
143325816|NCT02349295|516736483|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
143325817|NCT02349295|516736484|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
143325818|NCT02349295|516736485|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
143325819|NCT02349295|516736486|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
143325820|NCT02349295|516736487|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
143325821|NCT02349295|516736474|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
143325822|NCT02349295|516736475|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
143325823|NCT02349295|516736476|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
143325824|NCT02349295|516736477|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
143325825|NCT02349295|516736478|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
143325826|NCT02349295|516736479|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
143325827|NCT02349295|516736480|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
143325828|NCT02349295|516736481|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
143325829|NCT02349295|516736482|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
143325830|NCT02349295|516736483|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
143325831|NCT02349295|516736484|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
143325832|NCT02349295|516736485|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
143325833|NCT02349295|516736486|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
143325834|NCT02349295|516736487|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
143325835|NCT02349295|516736474|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
143325836|NCT02349295|516736475|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
143325837|NCT02349295|516736476|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
143325838|NCT02349295|516736477|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
143325839|NCT02349295|516736478|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
143325840|NCT02349295|516736479|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
143325841|NCT02349295|516736480|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
143325842|NCT02349295|516736481|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
143325843|NCT02349295|516736482|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
143325844|NCT02349295|516736483|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
143325845|NCT02349295|516736484|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
143325846|NCT02349295|516736485|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
143325847|NCT02349295|516736486|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
143325848|NCT02349295|516736487|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
143325849|NCT02349295|516736474|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
143325850|NCT02349295|516736475|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
143325851|NCT02349295|516736476|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
143325852|NCT02349295|516736477|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
143325853|NCT02349295|516736478|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
143325854|NCT02349295|516736479|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
143325855|NCT02349295|516736480|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
143325856|NCT02349295|516736481|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
143325857|NCT02349295|516736482|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
143325858|NCT02349295|516736483|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
143325859|NCT02349295|516736484|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
143325860|NCT02349295|516736485|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
143325861|NCT02349295|516736486|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
143325862|NCT02349295|516736487|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
143325863|NCT02349295|516736474|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
143325864|NCT02349295|516736475|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
143325865|NCT02349295|516736476|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
143325866|NCT02349295|516736477|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
143325867|NCT02349295|516736478|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
143325868|NCT02349295|516736479|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
143325869|NCT02349295|516736480|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
143325870|NCT02349295|516736481|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
143325871|NCT02349295|516736482|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
143325872|NCT02349295|516736483|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
143325873|NCT02349295|516736484|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
143325874|NCT02349295|516736485|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
143325875|NCT02349295|516736486|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
143325876|NCT02349295|516736487|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
143325877|NCT02349295|516736474|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
143325878|NCT02349295|516736475|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
143325879|NCT02349295|516736476|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
143325880|NCT02349295|516736477|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
143325881|NCT02349295|516736478|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
143325882|NCT02349295|516736479|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
143325883|NCT02349295|516736480|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
143325884|NCT02349295|516736481|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
143325885|NCT02349295|516736482|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
143325886|NCT02349295|516736483|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
143325887|NCT02349295|516736484|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
143325888|NCT02349295|516736485|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
143325889|NCT02349295|516736486|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
143325890|NCT02349295|516736487|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
143325891|NCT02349295|516736474|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
143325892|NCT02349295|516736475|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
143325893|NCT02349295|516736476|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
143325894|NCT02349295|516736477|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
143381068|NCT00243503|516940744|FG000|Overall Study|Withdrawal by Subject|1|||
143381069|NCT00243503|516940744|FG000|Overall Study|Lack of Efficacy|44|||
143381070|NCT00243503|516940744|FG000|Overall Study|Death|1|||
143325895|NCT02349295|516736478|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
143325896|NCT02349295|516736479|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
143325897|NCT02349295|516736480|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
143325898|NCT02349295|516736481|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
143325899|NCT02349295|516736482|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
143325900|NCT02349295|516736483|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
143325901|NCT02349295|516736484|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
143325902|NCT02349295|516736485|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
143325903|NCT02349295|516736486|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
143325904|NCT02349295|516736487|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
143325905|NCT02349295|516736474|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
143325906|NCT02349295|516736475|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
143325907|NCT02349295|516736476|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
143325908|NCT02349295|516736477|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
143325909|NCT02349295|516736478|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
143325910|NCT02349295|516736479|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
143325911|NCT02349295|516736480|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
143325912|NCT02349295|516736481|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
143325913|NCT02349295|516736482|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
143325914|NCT02349295|516736483|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
143325915|NCT02349295|516736484|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
143325916|NCT02349295|516736485|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
143325917|NCT02349295|516736486|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
143325918|NCT02349295|516736487|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
143325919|NCT02863926|516736488|FG000|Overall Study|Physician Decision|1|||
143325920|NCT02863926|516736489|FG001|Overall Study|Physician Decision|0|||
143325921|NCT02863926|516736488|FG000|Overall Study|Lost to Follow-up|1|||
143325922|NCT02863926|516736489|FG001|Overall Study|Lost to Follow-up|1|||
143325923|NCT02014116|516736493|FG000|Overall Study|Progressive Disease|3|||
143325924|NCT02014116|516736494|FG001|Overall Study|Progressive Disease|4|||
143325925|NCT02014116|516736495|FG002|Overall Study|Progressive Disease|2|||
143325926|NCT02014116|516736496|FG003|Overall Study|Progressive Disease|6|||
143325927|NCT02014116|516736497|FG004|Overall Study|Progressive Disease|1|||
143325928|NCT02014116|516736498|FG005|Overall Study|Progressive Disease|13|||
143325929|NCT02014116|516736499|FG006|Overall Study|Progressive Disease|1|||
143325930|NCT02014116|516736500|FG007|Overall Study|Progressive Disease|3|||
143325931|NCT02014116|516736501|FG008|Overall Study|Progressive Disease|7|||
143325932|NCT02014116|516736493|FG000|Overall Study|Adverse Event|0|||
143325933|NCT02014116|516736494|FG001|Overall Study|Adverse Event|0|||
143325934|NCT02014116|516736495|FG002|Overall Study|Adverse Event|0|||
143325935|NCT02014116|516736496|FG003|Overall Study|Adverse Event|0|||
143325936|NCT02014116|516736497|FG004|Overall Study|Adverse Event|1|||
143325937|NCT02014116|516736498|FG005|Overall Study|Adverse Event|0|||
143325938|NCT02014116|516736499|FG006|Overall Study|Adverse Event|0|||
143325939|NCT02014116|516736500|FG007|Overall Study|Adverse Event|1|||
143325940|NCT02014116|516736501|FG008|Overall Study|Adverse Event|0|||
143325941|NCT02014116|516736493|FG000|Overall Study|Lost to Follow-up|0|||
143325942|NCT02014116|516736494|FG001|Overall Study|Lost to Follow-up|0|||
143325943|NCT02014116|516736495|FG002|Overall Study|Lost to Follow-up|0|||
143325944|NCT02014116|516736496|FG003|Overall Study|Lost to Follow-up|0|||
143325945|NCT02014116|516736497|FG004|Overall Study|Lost to Follow-up|0|||
143325946|NCT02014116|516736498|FG005|Overall Study|Lost to Follow-up|1|||
143325947|NCT02014116|516736499|FG006|Overall Study|Lost to Follow-up|0|||
143325948|NCT02014116|516736500|FG007|Overall Study|Lost to Follow-up|0|||
143325949|NCT02014116|516736501|FG008|Overall Study|Lost to Follow-up|1|||
143325950|NCT02014116|516736493|FG000|Overall Study|Death|0|||
143325951|NCT02014116|516736494|FG001|Overall Study|Death|0|||
143325952|NCT02014116|516736495|FG002|Overall Study|Death|0|||
143325953|NCT02014116|516736496|FG003|Overall Study|Death|0|||
143325954|NCT02014116|516736497|FG004|Overall Study|Death|0|||
143325955|NCT02014116|516736498|FG005|Overall Study|Death|0|||
143325956|NCT02014116|516736499|FG006|Overall Study|Death|0|||
143325957|NCT02014116|516736500|FG007|Overall Study|Death|1|||
143325958|NCT02014116|516736501|FG008|Overall Study|Death|1|||
143325959|NCT02014116|516736493|FG000|Overall Study|Withdrawal by Subject|0|||
143325960|NCT02014116|516736494|FG001|Overall Study|Withdrawal by Subject|0|||
143325961|NCT02014116|516736495|FG002|Overall Study|Withdrawal by Subject|1|||
143325962|NCT02014116|516736496|FG003|Overall Study|Withdrawal by Subject|1|||
143325963|NCT02014116|516736497|FG004|Overall Study|Withdrawal by Subject|0|||
143325964|NCT02014116|516736498|FG005|Overall Study|Withdrawal by Subject|1|||
143325965|NCT02014116|516736499|FG006|Overall Study|Withdrawal by Subject|0|||
143325966|NCT02014116|516736500|FG007|Overall Study|Withdrawal by Subject|0|||
143325967|NCT02014116|516736501|FG008|Overall Study|Withdrawal by Subject|0|||
143325968|NCT02014116|516736493|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
143325969|NCT02014116|516736494|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
143325970|NCT02014116|516736495|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
143325971|NCT02014116|516736496|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
143325972|NCT02014116|516736497|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
143325973|NCT02014116|516736498|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
143325974|NCT02014116|516736499|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
143325975|NCT02014116|516736500|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
143325976|NCT02014116|516736501|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
143325977|NCT02014116|516736493|FG000|Overall Study|Physician Decision|0|||
143325978|NCT02014116|516736494|FG001|Overall Study|Physician Decision|0|||
143325979|NCT02014116|516736495|FG002|Overall Study|Physician Decision|0|||
143325980|NCT02014116|516736496|FG003|Overall Study|Physician Decision|0|||
143325981|NCT02014116|516736497|FG004|Overall Study|Physician Decision|0|||
143325982|NCT02014116|516736498|FG005|Overall Study|Physician Decision|0|||
143325983|NCT02014116|516736499|FG006|Overall Study|Physician Decision|0|||
143325984|NCT02014116|516736500|FG007|Overall Study|Physician Decision|0|||
143325985|NCT02014116|516736501|FG008|Overall Study|Physician Decision|1|||
143325986|NCT00093145|516736506|FG000|Overall Study|Unacceptable Toxicity Only|2|||
143325987|NCT00093145|516736506|FG000|Overall Study|Physician Decision|5|||
143325988|NCT00093145|516736506|FG000|Overall Study|Withdrawal by Subject|9|||
143325989|NCT00093145|516736506|FG000|Overall Study|Other|1|||
143325990|NCT01310036|516736507|FG000|Overall Study|Administrative/other|10|||
143325991|NCT01310036|516736507|FG000|Overall Study|Withdrew Consent|11|||
143325992|NCT01310036|516736507|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
143325993|NCT01310036|516736507|FG000|Overall Study|Progression of Disease|164|||
143325994|NCT01310036|516736507|FG000|Overall Study|Death|1|||
143325995|NCT01310036|516736507|FG000|Overall Study|Adverse event or intercurrent illness|12|||
143325996|NCT02365467|516736513|FG000|Overall Study|Death|3|||
143325997|NCT02043782|516736514|FG000|Period 1|Adverse Event|0|||
143325998|NCT02043782|516736515|FG001|Period 1|Adverse Event|0|||
143325999|NCT02043782|516736516|FG002|Period 1|Adverse Event|1|||
143326000|NCT02043782|516736517|FG003|Period 1|Adverse Event|0|||
143326001|NCT02043782|516736518|FG004|Period 1|Adverse Event|0|||
143326002|NCT02043782|516736519|FG005|Period 1|Adverse Event|0|||
143326003|NCT04667117|516736520|FG000|Investigational Period|Lost to Follow-up|0|||
143326004|NCT04667117|516736521|FG001|Investigational Period|Lost to Follow-up|0|||
143326005|NCT04667117|516736522|FG002|Investigational Period|Lost to Follow-up|1|||
143326006|NCT04667117|516736520|FG000|Investigational Period|Protocol Deviation|0|||
143326007|NCT04667117|516736521|FG001|Investigational Period|Protocol Deviation|1|||
143326008|NCT04667117|516736522|FG002|Investigational Period|Protocol Deviation|0|||
143326009|NCT04667117|516736520|FG000|Extension Period|Lost to Follow-up|1|||
143326010|NCT04667117|516736521|FG001|Extension Period|Lost to Follow-up|0|||
143326011|NCT04667117|516736522|FG002|Extension Period|Lost to Follow-up|0|||
143326012|NCT00833989|516736526|FG000|Overall Study|Physician Decision|0|||
143326013|NCT00833989|516736527|FG001|Overall Study|Physician Decision|0|||
143326014|NCT00833989|516736528|FG002|Overall Study|Physician Decision|0|||
143326015|NCT00833989|516736529|FG003|Overall Study|Physician Decision|1|||
143326016|NCT00833989|516736526|FG000|Overall Study|Withdrawal by Subject|3|||
143326017|NCT00833989|516736527|FG001|Overall Study|Withdrawal by Subject|0|||
143326018|NCT00833989|516736528|FG002|Overall Study|Withdrawal by Subject|1|||
143326019|NCT00833989|516736529|FG003|Overall Study|Withdrawal by Subject|1|||
143326020|NCT01109992|516736530|FG000|Overall Study|Withdrawal by Subject|0|||
143326021|NCT01109992|516736531|FG001|Overall Study|Withdrawal by Subject|1|||
143326022|NCT01109992|516736530|FG000|Overall Study|Movement during rest scan.|0|||
143326023|NCT01109992|516736531|FG001|Overall Study|Movement during rest scan.|1|||
143326024|NCT00690755|516736532|FG000|Overall Study|Physician Decision|2|||
143326025|NCT00690755|516736533|FG001|Overall Study|Physician Decision|0|||
143326026|NCT00690755|516736534|FG002|Overall Study|Physician Decision|46|||
143326027|NCT00690755|516736535|FG003|Overall Study|Physician Decision|5|||
143326028|NCT00690755|516736536|FG004|Overall Study|Physician Decision|0|||
143326029|NCT00690755|516736537|FG005|Overall Study|Physician Decision|4|||
143326030|NCT00690755|516736538|FG006|Overall Study|Physician Decision|0|||
143326031|NCT02310750|516736539|FG000|HP Period 1|Lost to Follow-up|0|||
143326032|NCT02310750|516736540|FG001|HP Period 1|Lost to Follow-up|0|||
143326033|NCT02310750|516736541|FG002|HP Period 1|Lost to Follow-up|0|||
143326034|NCT02310750|516736542|FG003|HP Period 1|Lost to Follow-up|0|||
143326035|NCT02310750|516736543|FG004|HP Period 1|Lost to Follow-up|0|||
143326036|NCT02310750|516736544|FG005|HP Period 1|Lost to Follow-up|0|||
143326037|NCT02310750|516736545|FG006|HP Period 1|Lost to Follow-up|1|||
143326038|NCT02310750|516736546|FG007|HP Period 1|Lost to Follow-up|0|||
143326039|NCT02310750|516736547|FG008|HP Period 1|Lost to Follow-up|0|||
143326040|NCT02310750|516736548|FG009|HP Period 1|Lost to Follow-up|0|||
143326041|NCT02310750|516736549|FG010|HP Period 1|Lost to Follow-up|0|||
143326042|NCT02310750|516736550|FG011|HP Period 1|Lost to Follow-up|0|||
143326043|NCT02310750|516736551|FG012|HP Period 1|Lost to Follow-up|0|||
143326044|NCT02310750|516736552|FG013|HP Period 1|Lost to Follow-up|0|||
143326045|NCT02310750|516736553|FG014|HP Period 1|Lost to Follow-up|0|||
143326046|NCT02310750|516736554|FG015|HP Period 1|Lost to Follow-up|0|||
143326047|NCT02310750|516736539|FG000|HP Period 1|Withdrawal by Subject|1|||
143326048|NCT02310750|516736540|FG001|HP Period 1|Withdrawal by Subject|0|||
143326049|NCT02310750|516736541|FG002|HP Period 1|Withdrawal by Subject|0|||
143326050|NCT02310750|516736542|FG003|HP Period 1|Withdrawal by Subject|1|||
143326051|NCT02310750|516736543|FG004|HP Period 1|Withdrawal by Subject|0|||
143326052|NCT02310750|516736544|FG005|HP Period 1|Withdrawal by Subject|0|||
143326053|NCT02310750|516736545|FG006|HP Period 1|Withdrawal by Subject|0|||
143326054|NCT02310750|516736546|FG007|HP Period 1|Withdrawal by Subject|0|||
143326055|NCT02310750|516736547|FG008|HP Period 1|Withdrawal by Subject|0|||
143326056|NCT02310750|516736548|FG009|HP Period 1|Withdrawal by Subject|0|||
143326057|NCT02310750|516736549|FG010|HP Period 1|Withdrawal by Subject|0|||
143326058|NCT02310750|516736550|FG011|HP Period 1|Withdrawal by Subject|0|||
143326059|NCT02310750|516736551|FG012|HP Period 1|Withdrawal by Subject|0|||
143326060|NCT02310750|516736552|FG013|HP Period 1|Withdrawal by Subject|0|||
143326061|NCT02310750|516736553|FG014|HP Period 1|Withdrawal by Subject|0|||
143326062|NCT02310750|516736554|FG015|HP Period 1|Withdrawal by Subject|0|||
143326063|NCT02310750|516736539|FG000|HP Washout 1|Lost to Follow-up|0|||
143326064|NCT02310750|516736540|FG001|HP Washout 1|Lost to Follow-up|0|||
143326065|NCT02310750|516736541|FG002|HP Washout 1|Lost to Follow-up|1|||
143326066|NCT02310750|516736542|FG003|HP Washout 1|Lost to Follow-up|1|||
143326067|NCT02310750|516736543|FG004|HP Washout 1|Lost to Follow-up|2|||
143326068|NCT02310750|516736544|FG005|HP Washout 1|Lost to Follow-up|2|||
143326069|NCT02310750|516736545|FG006|HP Washout 1|Lost to Follow-up|3|||
143326070|NCT02310750|516736546|FG007|HP Washout 1|Lost to Follow-up|0|||
143326071|NCT02310750|516736547|FG008|HP Washout 1|Lost to Follow-up|0|||
143326072|NCT02310750|516736548|FG009|HP Washout 1|Lost to Follow-up|0|||
143326073|NCT02310750|516736549|FG010|HP Washout 1|Lost to Follow-up|0|||
143326074|NCT02310750|516736550|FG011|HP Washout 1|Lost to Follow-up|0|||
143326075|NCT02310750|516736551|FG012|HP Washout 1|Lost to Follow-up|0|||
143326076|NCT02310750|516736552|FG013|HP Washout 1|Lost to Follow-up|0|||
143326077|NCT02310750|516736553|FG014|HP Washout 1|Lost to Follow-up|0|||
143326078|NCT02310750|516736554|FG015|HP Washout 1|Lost to Follow-up|0|||
143326079|NCT02310750|516736539|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
143326080|NCT02310750|516736540|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
143326081|NCT02310750|516736541|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
143326082|NCT02310750|516736542|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
143326083|NCT02310750|516736543|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
143326084|NCT02310750|516736544|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
143326085|NCT02310750|516736545|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
143326086|NCT02310750|516736546|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
143326087|NCT02310750|516736547|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
143326088|NCT02310750|516736548|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
143326089|NCT02310750|516736549|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
143326090|NCT02310750|516736550|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
143326091|NCT02310750|516736551|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
143326092|NCT02310750|516736552|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
143326093|NCT02310750|516736553|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
143326094|NCT02310750|516736554|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
143326095|NCT02310750|516736539|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
143326096|NCT02310750|516736540|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
143326097|NCT02310750|516736541|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
143326098|NCT02310750|516736542|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
143326099|NCT02310750|516736543|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
143326100|NCT02310750|516736544|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
143326101|NCT02310750|516736545|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
143326102|NCT02310750|516736546|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
143326103|NCT02310750|516736547|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
143326104|NCT02310750|516736548|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
143326105|NCT02310750|516736549|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
143326106|NCT02310750|516736550|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
143326107|NCT02310750|516736551|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
143381071|NCT00243503|516940744|FG000|Overall Study|Other|1|||
143381072|NCT00093015|516940745|FG000|Overall Study|Withdrawal by Subject|194|||
143381073|NCT00093015|516940746|FG001|Overall Study|Withdrawal by Subject|171|||
143326108|NCT02310750|516736552|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
143326109|NCT02310750|516736553|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
143381074|NCT00093015|516940745|FG000|Overall Study|Lost to Follow-up|96|||
143381075|NCT00093015|516940746|FG001|Overall Study|Lost to Follow-up|108|||
143326110|NCT02310750|516736554|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
143326111|NCT02310750|516736539|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
143381076|NCT00093015|516940745|FG000|Overall Study|Death|375|||
143326112|NCT02310750|516736540|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
143326113|NCT02310750|516736541|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
143326114|NCT02310750|516736542|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
143326115|NCT02310750|516736543|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
143326116|NCT02310750|516736544|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
143326117|NCT02310750|516736545|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
143326118|NCT02310750|516736546|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
143326119|NCT02310750|516736547|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
143326120|NCT02310750|516736548|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
143326121|NCT02310750|516736549|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
143326122|NCT02310750|516736550|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
143326123|NCT02310750|516736551|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
143326124|NCT02310750|516736552|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
143326125|NCT02310750|516736553|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
143326126|NCT02310750|516736554|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
143326127|NCT02310750|516736539|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
143326128|NCT02310750|516736540|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
143326129|NCT02310750|516736541|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
143326130|NCT02310750|516736542|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
143326131|NCT02310750|516736543|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
143326132|NCT02310750|516736544|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
143326133|NCT02310750|516736545|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
143326134|NCT02310750|516736546|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
143326135|NCT02310750|516736547|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
143326136|NCT02310750|516736548|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
143326137|NCT02310750|516736549|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
143326138|NCT02310750|516736550|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
143326139|NCT02310750|516736551|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
143326140|NCT02310750|516736552|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
143326141|NCT02310750|516736553|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
143326142|NCT02310750|516736554|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
143326143|NCT02310750|516736539|FG000|HP Washout 2|Lost to Follow-up|0|||
143326144|NCT02310750|516736540|FG001|HP Washout 2|Lost to Follow-up|0|||
143326145|NCT02310750|516736541|FG002|HP Washout 2|Lost to Follow-up|0|||
143326146|NCT02310750|516736542|FG003|HP Washout 2|Lost to Follow-up|0|||
143326147|NCT02310750|516736543|FG004|HP Washout 2|Lost to Follow-up|1|||
143326148|NCT02310750|516736544|FG005|HP Washout 2|Lost to Follow-up|0|||
143326149|NCT02310750|516736545|FG006|HP Washout 2|Lost to Follow-up|7|||
143326150|NCT02310750|516736546|FG007|HP Washout 2|Lost to Follow-up|0|||
143326151|NCT02310750|516736547|FG008|HP Washout 2|Lost to Follow-up|0|||
143326152|NCT02310750|516736548|FG009|HP Washout 2|Lost to Follow-up|0|||
143326153|NCT02310750|516736549|FG010|HP Washout 2|Lost to Follow-up|0|||
143326154|NCT02310750|516736550|FG011|HP Washout 2|Lost to Follow-up|0|||
143326155|NCT02310750|516736551|FG012|HP Washout 2|Lost to Follow-up|0|||
143326156|NCT02310750|516736552|FG013|HP Washout 2|Lost to Follow-up|0|||
143326157|NCT02310750|516736553|FG014|HP Washout 2|Lost to Follow-up|0|||
143326158|NCT02310750|516736554|FG015|HP Washout 2|Lost to Follow-up|0|||
143326159|NCT03585244|516736555|FG000|Overall Study|Withdrawal by Subject|15|||
143326160|NCT02105948|516736556|FG000|Overall Study|Adverse Event|10|||
143326161|NCT02105948|516736557|FG001|Overall Study|Adverse Event|7|||
143326162|NCT02105948|516736558|FG002|Overall Study|Adverse Event|11|||
143326163|NCT02105948|516736559|FG003|Overall Study|Adverse Event|11|||
143326164|NCT02105948|516736556|FG000|Overall Study|Lack of Efficacy|0|||
143326165|NCT02105948|516736557|FG001|Overall Study|Lack of Efficacy|1|||
143326166|NCT02105948|516736558|FG002|Overall Study|Lack of Efficacy|3|||
143326167|NCT02105948|516736559|FG003|Overall Study|Lack of Efficacy|2|||
143326168|NCT02105948|516736556|FG000|Overall Study|Lost to Follow-up|0|||
143326169|NCT02105948|516736557|FG001|Overall Study|Lost to Follow-up|0|||
143326170|NCT02105948|516736558|FG002|Overall Study|Lost to Follow-up|2|||
143326171|NCT02105948|516736559|FG003|Overall Study|Lost to Follow-up|1|||
143326172|NCT02105948|516736556|FG000|Overall Study|Physician Decision|2|||
143326173|NCT02105948|516736557|FG001|Overall Study|Physician Decision|2|||
143326174|NCT02105948|516736558|FG002|Overall Study|Physician Decision|2|||
143326175|NCT02105948|516736559|FG003|Overall Study|Physician Decision|2|||
143326176|NCT02105948|516736556|FG000|Overall Study|Withdrawal by Subject|15|||
143326177|NCT02105948|516736557|FG001|Overall Study|Withdrawal by Subject|10|||
143326178|NCT02105948|516736558|FG002|Overall Study|Withdrawal by Subject|10|||
143326179|NCT02105948|516736559|FG003|Overall Study|Withdrawal by Subject|11|||
143326180|NCT01220557|516736561|FG000|Overall Study|Lost to Follow-up|5|||
143326181|NCT01220557|516736562|FG001|Overall Study|Lost to Follow-up|3|||
143326182|NCT01220557|516736561|FG000|Overall Study|attended less than 6 lessons|1|||
143326183|NCT01220557|516736562|FG001|Overall Study|attended less than 6 lessons|2|||
143326184|NCT01090453|516736565|FG000|Overall Study|Withdrawal by Subject|1|||
143326185|NCT01090453|516736566|FG001|Overall Study|Withdrawal by Subject|2|||
143326186|NCT01090453|516736565|FG000|Overall Study|Lost to Follow-up|7|||
143326187|NCT01090453|516736566|FG001|Overall Study|Lost to Follow-up|7|||
143326188|NCT01090453|516736565|FG000|Overall Study|Non serious AEs|1|||
143326189|NCT01090453|516736566|FG001|Overall Study|Non serious AEs|0|||
143326190|NCT01090453|516736565|FG000|Overall Study|Protocol Violation|2|||
143326191|NCT01090453|516736566|FG001|Overall Study|Protocol Violation|0|||
143326192|NCT01090453|516736565|FG000|Overall Study|Other|2|||
143326193|NCT01090453|516736566|FG001|Overall Study|Other|4|||
143326194|NCT01090453|516736565|FG000|Overall Study|Eligibility Criteria|0|||
143326195|NCT01090453|516736566|FG001|Overall Study|Eligibility Criteria|1|||
143326196|NCT04072159|516736567|FG000|Overall Study|Lost to Follow-up|6|||
143326197|NCT04072159|516736568|FG001|Overall Study|Lost to Follow-up|6|||
143326198|NCT04072159|516736567|FG000|Overall Study|Withdrawal by Subject|2|||
143326199|NCT04072159|516736568|FG001|Overall Study|Withdrawal by Subject|0|||
143326200|NCT00522275|516736569|FG000|Overall Study|Adverse Event|35|||
143326201|NCT00522275|516736569|FG000|Overall Study|Lack of Efficacy|80|||
143326202|NCT00522275|516736569|FG000|Overall Study|Subject withdrew consent|16|||
143326203|NCT00522275|516736569|FG000|Overall Study|Protocol deviation|1|||
143326204|NCT00522275|516736569|FG000|Overall Study|Unsatisfactory compliance|11|||
143326205|NCT00522275|516736569|FG000|Overall Study|Lost to Follow-up|8|||
143326206|NCT00522275|516736569|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
143326207|NCT00522275|516736569|FG000|Overall Study|Other: Subject is pregnant|2|||
143326208|NCT00522275|516736569|FG000|Overall Study|Other: Subject relocated|2|||
143326209|NCT00522275|516736569|FG000|Overall Study|Other: Subject arrested|1|||
143326210|NCT00522275|516736569|FG000|Overall Study|Other: Site / clinic closed|4|||
143326211|NCT00522275|516736569|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
143326212|NCT00522275|516736569|FG000|Overall Study|Other: Sponsor request|2|||
143326213|NCT00522275|516736569|FG000|Overall Study|Other: Subject ran out of medication|1|||
143326214|NCT00522275|516736569|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
143326215|NCT04323436|516736571|FG000|Overall Study|Adverse Event|7|||
143326216|NCT04323436|516736572|FG001|Overall Study|Adverse Event|0|||
143326217|NCT04323436|516736573|FG002|Overall Study|Adverse Event|0|||
143326218|NCT04323436|516736571|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
143326219|NCT04323436|516736572|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
143326220|NCT04323436|516736573|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
143326221|NCT04323436|516736571|FG000|Overall Study|Death|1|||
143326222|NCT04323436|516736572|FG001|Overall Study|Death|0|||
143326223|NCT04323436|516736573|FG002|Overall Study|Death|0|||
143326224|NCT04323436|516736571|FG000|Overall Study|Physician Decision|2|||
143326225|NCT04323436|516736572|FG001|Overall Study|Physician Decision|0|||
143326226|NCT04323436|516736573|FG002|Overall Study|Physician Decision|0|||
143326227|NCT04323436|516736571|FG000|Overall Study|Progressive disease|10|||
143326228|NCT04323436|516736572|FG001|Overall Study|Progressive disease|0|||
143326229|NCT04323436|516736573|FG002|Overall Study|Progressive disease|0|||
143326230|NCT04323436|516736571|FG000|Overall Study|Subject decision|3|||
143326231|NCT04323436|516736572|FG001|Overall Study|Subject decision|0|||
143326232|NCT04323436|516736573|FG002|Overall Study|Subject decision|0|||
143326233|NCT01196975|516736574|FG000|Overall Study|Adverse Event|2|||
143326234|NCT01196975|516736575|FG001|Overall Study|Adverse Event|2|||
143326235|NCT01196975|516736576|FG002|Overall Study|Adverse Event|0|||
143326236|NCT01196975|516736577|FG003|Overall Study|Adverse Event|0|||
143326237|NCT01196975|516736578|FG004|Overall Study|Adverse Event|2|||
143326238|NCT01196975|516736574|FG000|Overall Study|Withdrawal by Subject|2|||
143326239|NCT01196975|516736575|FG001|Overall Study|Withdrawal by Subject|1|||
143326240|NCT01196975|516736576|FG002|Overall Study|Withdrawal by Subject|0|||
143326241|NCT01196975|516736577|FG003|Overall Study|Withdrawal by Subject|1|||
143326242|NCT01196975|516736578|FG004|Overall Study|Withdrawal by Subject|0|||
143326243|NCT01196975|516736574|FG000|Overall Study|Lost to Follow-up|11|||
143326244|NCT01196975|516736575|FG001|Overall Study|Lost to Follow-up|6|||
143326245|NCT01196975|516736576|FG002|Overall Study|Lost to Follow-up|5|||
143326246|NCT01196975|516736577|FG003|Overall Study|Lost to Follow-up|5|||
143326247|NCT01196975|516736578|FG004|Overall Study|Lost to Follow-up|11|||
143326248|NCT01365494|516736579|FG000|Overall Study|Adverse Event|1|||
143326249|NCT01365494|516736580|FG001|Overall Study|Adverse Event|0|||
143326250|NCT01365494|516736579|FG000|Overall Study|Withdrawal by Subject|0|||
143326251|NCT01365494|516736580|FG001|Overall Study|Withdrawal by Subject|1|||
143326252|NCT01365494|516736579|FG000|Overall Study|Lost to Follow-up|1|||
143326253|NCT01365494|516736580|FG001|Overall Study|Lost to Follow-up|2|||
143326254|NCT03021187|516736581|FG000|Overall Study|Death|0|||
143326255|NCT03021187|516736582|FG001|Overall Study|Death|0|||
143326256|NCT03021187|516736583|FG002|Overall Study|Death|3|||
143326257|NCT03021187|516736584|FG003|Overall Study|Death|0|||
143326258|NCT03021187|516736581|FG000|Overall Study|Withdrawal by Subject|0|||
143326259|NCT03021187|516736582|FG001|Overall Study|Withdrawal by Subject|6|||
143326260|NCT03021187|516736583|FG002|Overall Study|Withdrawal by Subject|2|||
143326261|NCT03021187|516736584|FG003|Overall Study|Withdrawal by Subject|5|||
143326262|NCT03021187|516736581|FG000|Overall Study|Lost to Follow-up|10|||
143326263|NCT03021187|516736582|FG001|Overall Study|Lost to Follow-up|3|||
143326264|NCT03021187|516736583|FG002|Overall Study|Lost to Follow-up|1|||
143326265|NCT03021187|516736584|FG003|Overall Study|Lost to Follow-up|4|||
143326266|NCT03832192|516736587|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
143326267|NCT03832192|516736588|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
143326268|NCT02663128|516736589|FG000|Period 2|Physician Decision|0|||
143326269|NCT02663128|516736590|FG001|Period 2|Physician Decision|0|||
143326270|NCT02663128|516736591|FG002|Period 2|Physician Decision|0|||
143326271|NCT02663128|516736592|FG003|Period 2|Physician Decision|0|||
143326272|NCT02663128|516736593|FG004|Period 2|Physician Decision|1|||
143326273|NCT02663128|516736594|FG005|Period 2|Physician Decision|0|||
143326274|NCT03394924|516736597|FG000|Overall Study|Adverse Event|0|||
143326275|NCT03394924|516736598|FG001|Overall Study|Adverse Event|5|||
143326276|NCT03394924|516736599|FG002|Overall Study|Adverse Event|0|||
143326277|NCT03394924|516736597|FG000|Overall Study|Withdrawal by Subject|2|||
143326278|NCT03394924|516736598|FG001|Overall Study|Withdrawal by Subject|0|||
143326279|NCT03394924|516736599|FG002|Overall Study|Withdrawal by Subject|0|||
143326280|NCT03394924|516736597|FG000|Overall Study|Lost to Follow-up|0|||
143326281|NCT03394924|516736598|FG001|Overall Study|Lost to Follow-up|1|||
143326282|NCT03394924|516736599|FG002|Overall Study|Lost to Follow-up|0|||
143326283|NCT03394924|516736597|FG000|Overall Study|Did not meet all inclusion criteria|1|||
143326284|NCT03394924|516736598|FG001|Overall Study|Did not meet all inclusion criteria|0|||
143326285|NCT03394924|516736599|FG002|Overall Study|Did not meet all inclusion criteria|0|||
143326286|NCT02276482|516736602|FG000|Overall Study|Adverse Event|1|||
143326287|NCT02276482|516736603|FG001|Overall Study|Adverse Event|0|||
143326288|NCT02276482|516736602|FG000|Overall Study|Withdrawal by Subject|1|||
143326289|NCT02276482|516736603|FG001|Overall Study|Withdrawal by Subject|0|||
143326290|NCT02276482|516736602|FG000|Overall Study|Gram-negative infection|1|||
143326291|NCT02276482|516736603|FG001|Overall Study|Gram-negative infection|0|||
143326292|NCT02276482|516736602|FG000|Overall Study|Reason not specified|0|||
143326293|NCT02276482|516736603|FG001|Overall Study|Reason not specified|1|||
143326294|NCT03277313|516736606|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
143326295|NCT03277313|516736607|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
143326296|NCT03277313|516736606|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
143326297|NCT03277313|516736607|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
143326298|NCT03277313|516736606|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
143326299|NCT03277313|516736607|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
143326300|NCT03277313|516736606|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
143326301|NCT03277313|516736607|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
143326302|NCT03277313|516736606|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
143326303|NCT03277313|516736607|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
143326304|NCT02005471|516736608|FG000|Main Study|Adverse Event|0|||
143326305|NCT02005471|516736609|FG001|Main Study|Adverse Event|1|||
143326306|NCT02005471|516736610|FG002|Main Study|Adverse Event|0|||
143326307|NCT02005471|516736611|FG003|Main Study|Adverse Event|0|||
143326308|NCT02005471|516736608|FG000|Main Study|Death|83|||
143326309|NCT02005471|516736609|FG001|Main Study|Death|52|||
143326310|NCT02005471|516736610|FG002|Main Study|Death|0|||
143326311|NCT02005471|516736611|FG003|Main Study|Death|0|||
143326312|NCT02005471|516736608|FG000|Main Study|Lost to Follow-up|4|||
143326313|NCT02005471|516736609|FG001|Main Study|Lost to Follow-up|5|||
143326314|NCT02005471|516736610|FG002|Main Study|Lost to Follow-up|0|||
143326315|NCT02005471|516736611|FG003|Main Study|Lost to Follow-up|0|||
143326316|NCT02005471|516736608|FG000|Main Study|Physician Decision|3|||
143326317|NCT02005471|516736609|FG001|Main Study|Physician Decision|1|||
143326318|NCT02005471|516736610|FG002|Main Study|Physician Decision|0|||
143326319|NCT02005471|516736611|FG003|Main Study|Physician Decision|0|||
143326320|NCT02005471|516736608|FG000|Main Study|Withdrawal by Subject|26|||
143326321|NCT02005471|516736609|FG001|Main Study|Withdrawal by Subject|11|||
143381077|NCT00093015|516940746|FG001|Overall Study|Death|385|||
143326322|NCT02005471|516736610|FG002|Main Study|Withdrawal by Subject|0|||
143326323|NCT02005471|516736611|FG003|Main Study|Withdrawal by Subject|0|||
143326324|NCT02005471|516736608|FG000|Main Study|Reason not Specified|0|||
143326325|NCT02005471|516736609|FG001|Main Study|Reason not Specified|6|||
143326326|NCT02005471|516736610|FG002|Main Study|Reason not Specified|0|||
143326327|NCT02005471|516736611|FG003|Main Study|Reason not Specified|0|||
143326328|NCT02005471|516736608|FG000|Main Study|Randomized but not Dosed|8|||
143326329|NCT02005471|516736609|FG001|Main Study|Randomized but not Dosed|0|||
143326330|NCT02005471|516736610|FG002|Main Study|Randomized but not Dosed|0|||
143326331|NCT02005471|516736611|FG003|Main Study|Randomized but not Dosed|0|||
143326332|NCT02005471|516736608|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
143326333|NCT02005471|516736609|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
143326334|NCT02005471|516736610|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
143326335|NCT02005471|516736611|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
143326336|NCT02005471|516736608|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
143326337|NCT02005471|516736609|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
143326338|NCT02005471|516736610|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
143326339|NCT02005471|516736611|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
143326340|NCT02005471|516736608|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
143326341|NCT02005471|516736609|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
143326342|NCT02005471|516736610|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
143326343|NCT02005471|516736611|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
143326344|NCT00627705|516736613|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
143326345|NCT00627705|516736614|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
143326346|NCT00627705|516736613|FG000|Overall Study|Adverse Event|1|||
143326347|NCT00627705|516736614|FG001|Overall Study|Adverse Event|0|||
143326348|NCT00627705|516736613|FG000|Overall Study|Withdrawal by Subject|0|||
143326349|NCT00627705|516736614|FG001|Overall Study|Withdrawal by Subject|2|||
143326350|NCT00627705|516736613|FG000|Overall Study|Lost to Follow-up|0|||
143326351|NCT00627705|516736614|FG001|Overall Study|Lost to Follow-up|1|||
143326352|NCT01438541|516736615|FG000|Overall Study|Physician Decision|1|||
143326353|NCT01438541|516736615|FG000|Overall Study|Withdrawal by Subject|1|||
143326354|NCT01438541|516736615|FG000|Overall Study|discharge from the hospital|5|||
143326355|NCT02091167|516736616|FG000|Overall Study|Lost to Follow-up|0|||
143326356|NCT02091167|516736617|FG001|Overall Study|Lost to Follow-up|2|||
143326357|NCT03662750|516736618|FG000|Overall Study|Withdrawal by Subject|1|||
143326358|NCT04546581|516738592|FG000|Overall Study|Adverse Event|9|||
143326359|NCT04546581|516738593|FG001|Overall Study|Adverse Event|3|||
143326360|NCT04546581|516738592|FG000|Overall Study|Physician Decision|0|||
143326361|NCT04546581|516738593|FG001|Overall Study|Physician Decision|1|||
143326362|NCT04546581|516738592|FG000|Overall Study|Protocol Violation|1|||
143326363|NCT04546581|516738593|FG001|Overall Study|Protocol Violation|2|||
143326364|NCT04546581|516738592|FG000|Overall Study|Withdrawal by Subject|3|||
143326365|NCT04546581|516738593|FG001|Overall Study|Withdrawal by Subject|7|||
143326366|NCT02526693|516738594|FG000|Overall Study|Physician Decision|3|||
143326367|NCT02526693|516738595|FG001|Overall Study|Physician Decision|1|||
143326368|NCT01275625|516738596|FG000|Overall Study|Death|1|||
143326369|NCT01275625|516738596|FG000|Overall Study|Lack of Efficacy|2|||
143326370|NCT01275625|516738596|FG000|Overall Study|Lost to Follow-up|1|||
143326371|NCT01275625|516738596|FG000|Overall Study|Withdrawal by Subject|3|||
143326372|NCT01275625|516738596|FG000|Overall Study|Protocol Violation|1|||
143326373|NCT01275625|516738596|FG000|Overall Study|Adverse Event|4|||
143326374|NCT01275625|516738596|FG000|Overall Study|Other|1|||
143326375|NCT01349569|516738598|FG000|Overall Study|Lack of Efficacy|4|||
143326376|NCT03581305|516738599|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
143326377|NCT03581305|516738600|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
143326378|NCT03581305|516738599|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
143326379|NCT03581305|516738600|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
143326380|NCT03581305|516738599|FG000|Serotonergic Study|Withdrawal by Subject|5|||
143326381|NCT03581305|516738600|FG001|Serotonergic Study|Withdrawal by Subject|1|||
143326382|NCT01798927|516738601|FG000|Overall Study|Withdrawal by Subject|1|||
143326383|NCT00626522|516738602|FG000|Overall Study|Protocol Violation|0|||
143326384|NCT00626522|516738603|FG001|Overall Study|Protocol Violation|0|||
143326385|NCT00626522|516738604|FG002|Overall Study|Protocol Violation|0|||
143326386|NCT00626522|516738605|FG003|Overall Study|Protocol Violation|0|||
143326387|NCT00626522|516738606|FG004|Overall Study|Protocol Violation|1|||
143326388|NCT00626522|516738607|FG005|Overall Study|Protocol Violation|0|||
143326389|NCT00626522|516738602|FG000|Overall Study|Adverse Event|2|||
143326390|NCT00626522|516738603|FG001|Overall Study|Adverse Event|1|||
143326391|NCT00626522|516738604|FG002|Overall Study|Adverse Event|2|||
143326392|NCT00626522|516738605|FG003|Overall Study|Adverse Event|0|||
143326393|NCT00626522|516738606|FG004|Overall Study|Adverse Event|1|||
143326394|NCT00626522|516738607|FG005|Overall Study|Adverse Event|1|||
143326395|NCT00626522|516738602|FG000|Overall Study|Withdrawal by Subject|2|||
143326396|NCT00626522|516738603|FG001|Overall Study|Withdrawal by Subject|5|||
143326397|NCT00626522|516738604|FG002|Overall Study|Withdrawal by Subject|5|||
143326398|NCT00626522|516738605|FG003|Overall Study|Withdrawal by Subject|0|||
143326399|NCT00626522|516738606|FG004|Overall Study|Withdrawal by Subject|4|||
143326400|NCT00626522|516738607|FG005|Overall Study|Withdrawal by Subject|1|||
143326401|NCT00626522|516738602|FG000|Overall Study|COPD exacerbation|0|||
143326402|NCT00626522|516738603|FG001|Overall Study|COPD exacerbation|0|||
143326403|NCT00626522|516738604|FG002|Overall Study|COPD exacerbation|0|||
143326404|NCT00626522|516738605|FG003|Overall Study|COPD exacerbation|1|||
143326405|NCT00626522|516738606|FG004|Overall Study|COPD exacerbation|1|||
143326406|NCT00626522|516738607|FG005|Overall Study|COPD exacerbation|0|||
143326407|NCT00626522|516738602|FG000|Overall Study|Lost to Follow-up|0|||
143326408|NCT00626522|516738603|FG001|Overall Study|Lost to Follow-up|1|||
143326409|NCT00626522|516738604|FG002|Overall Study|Lost to Follow-up|0|||
143326410|NCT00626522|516738605|FG003|Overall Study|Lost to Follow-up|0|||
143326411|NCT00626522|516738606|FG004|Overall Study|Lost to Follow-up|0|||
143326412|NCT00626522|516738607|FG005|Overall Study|Lost to Follow-up|0|||
143326413|NCT00626522|516738602|FG000|Overall Study|Inconsistent reason reported|1|||
143326414|NCT00626522|516738603|FG001|Overall Study|Inconsistent reason reported|0|||
143326415|NCT00626522|516738604|FG002|Overall Study|Inconsistent reason reported|0|||
143326416|NCT00626522|516738605|FG003|Overall Study|Inconsistent reason reported|0|||
143326417|NCT00626522|516738606|FG004|Overall Study|Inconsistent reason reported|0|||
143326418|NCT00626522|516738607|FG005|Overall Study|Inconsistent reason reported|0|||
143326419|NCT00626522|516738602|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
143326420|NCT00626522|516738603|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
143326421|NCT00626522|516738604|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
143326422|NCT00626522|516738605|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
143326423|NCT00626522|516738606|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
143326424|NCT00626522|516738607|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
143326425|NCT03240588|516738618|FG000|Overall Study|Death|3|||
143326426|NCT03240588|516738619|FG001|Overall Study|Death|0|||
143326427|NCT03240588|516738620|FG002|Overall Study|Death|0|||
143326428|NCT03240588|516738618|FG000|Overall Study|Adverse Event|5|||
143326429|NCT03240588|516738619|FG001|Overall Study|Adverse Event|4|||
143326430|NCT03240588|516738620|FG002|Overall Study|Adverse Event|0|||
143326431|NCT03240588|516738618|FG000|Overall Study|Lost to Follow-up|9|||
143326432|NCT03240588|516738619|FG001|Overall Study|Lost to Follow-up|4|||
143326433|NCT03240588|516738620|FG002|Overall Study|Lost to Follow-up|0|||
143326434|NCT03240588|516738618|FG000|Overall Study|Physician Decision|3|||
143326435|NCT03240588|516738619|FG001|Overall Study|Physician Decision|2|||
143326436|NCT03240588|516738620|FG002|Overall Study|Physician Decision|0|||
143326437|NCT03240588|516738618|FG000|Overall Study|Did not meet eligibility criteria|0|||
143326438|NCT03240588|516738619|FG001|Overall Study|Did not meet eligibility criteria|6|||
143326439|NCT03240588|516738620|FG002|Overall Study|Did not meet eligibility criteria|0|||
143326440|NCT03240588|516738618|FG000|Overall Study|No longer meets protocol criteria|12|||
143326441|NCT03240588|516738619|FG001|Overall Study|No longer meets protocol criteria|7|||
143326442|NCT03240588|516738620|FG002|Overall Study|No longer meets protocol criteria|0|||
143326443|NCT03240588|516738618|FG000|Overall Study|Withdrawal by Subject|60|||
143326444|NCT03240588|516738619|FG001|Overall Study|Withdrawal by Subject|52|||
143326445|NCT03240588|516738620|FG002|Overall Study|Withdrawal by Subject|7|||
143326446|NCT03240588|516738618|FG000|Overall Study|Other, additional details not available.|0|||
143326447|NCT03240588|516738619|FG001|Overall Study|Other, additional details not available.|12|||
143326448|NCT03240588|516738620|FG002|Overall Study|Other, additional details not available.|1|||
143326449|NCT03240588|516738618|FG000|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|14|||
143326450|NCT03240588|516738619|FG001|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|3|||
143326451|NCT03240588|516738620|FG002|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|0|||
143326452|NCT03240588|516738618|FG000|Overall Study|Closure of study|55|||
143326453|NCT03240588|516738619|FG001|Overall Study|Closure of study|3|||
143326454|NCT03240588|516738620|FG002|Overall Study|Closure of study|0|||
143326455|NCT03240588|516738618|FG000|Overall Study|Subject non-compliance|23|||
143326456|NCT03240588|516738619|FG001|Overall Study|Subject non-compliance|2|||
143326457|NCT03240588|516738620|FG002|Overall Study|Subject non-compliance|1|||
143326458|NCT03240588|516738618|FG000|Overall Study|Device Deficiency|1|||
143326459|NCT03240588|516738619|FG001|Overall Study|Device Deficiency|0|||
143326460|NCT03240588|516738620|FG002|Overall Study|Device Deficiency|0|||
143326461|NCT03240588|516738618|FG000|Overall Study|End of study information not provided to determine reason for withdrawal.|0|||
143326462|NCT03240588|516738619|FG001|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
143326463|NCT03240588|516738620|FG002|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
143326464|NCT02091726|516738622|FG000|Overall Study|Lost to Follow-up|6|||
143326465|NCT01914926|516738629|FG000|Overall Study|Adverse Event|1|||
143326466|NCT01914926|516738630|FG001|Overall Study|Adverse Event|0|||
143454262|NCT01712659|517208171|FG003|Dose Expansion|Physician Decision|0|||
143326467|NCT01914926|516738629|FG000|Overall Study|uncooperative, agitated and removed|0|||
143326468|NCT01914926|516738630|FG001|Overall Study|uncooperative, agitated and removed|1|||
143326469|NCT00823719|516738631|FG000|Overall Study|Adverse Event|1|||
143454263|NCT01712659|517208172|FG004|Dose Expansion|Physician Decision|0|||
143454264|NCT00844532|517208180|FG000|Overall Study|Death|16|||
143454265|NCT00844532|517208180|FG000|Overall Study|Withdrawal by Subject|16|||
143454266|NCT00844532|517208180|FG000|Overall Study|Lost to Follow-up|7|||
143454267|NCT00948766|517208181|FG000|Core Study|Adverse Event|73|||
143454268|NCT00948766|517208182|FG001|Core Study|Adverse Event|51|||
143454269|NCT00948766|517208181|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
143454270|NCT00948766|517208182|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
143454271|NCT00948766|517208181|FG000|Core Study|Patient Withdrew Consent|27|||
143454272|NCT00948766|517208182|FG001|Core Study|Patient Withdrew Consent|46|||
143326470|NCT00823719|516738632|FG001|Overall Study|Adverse Event|2|||
143326471|NCT00823719|516738631|FG000|Overall Study|Physician Decision|1|||
143326472|NCT00823719|516738632|FG001|Overall Study|Physician Decision|4|||
143326473|NCT00823719|516738631|FG000|Overall Study|Withdrawal by Subject|0|||
143326474|NCT00823719|516738632|FG001|Overall Study|Withdrawal by Subject|1|||
143326475|NCT00823719|516738631|FG000|Overall Study|Disease Progression|4|||
143326476|NCT00823719|516738632|FG001|Overall Study|Disease Progression|4|||
143326477|NCT04955639|516738633|FG000|Overall Study|Withdrawal by Subject|2|||
143326478|NCT04955639|516738634|FG001|Overall Study|Withdrawal by Subject|2|||
143326479|NCT04955639|516738633|FG000|Overall Study|Week 26 survey not completed|2|||
143326480|NCT04955639|516738634|FG001|Overall Study|Week 26 survey not completed|2|||
143326481|NCT01369342|516738635|FG000|Overall Study|Withdrawal by Subject|7|||
143326482|NCT01369342|516738636|FG001|Overall Study|Withdrawal by Subject|7|||
143326483|NCT01369342|516738637|FG002|Overall Study|Withdrawal by Subject|2|||
143326484|NCT01369342|516738635|FG000|Overall Study|Lost to Follow-up|5|||
143326485|NCT01369342|516738636|FG001|Overall Study|Lost to Follow-up|2|||
143326486|NCT01369342|516738637|FG002|Overall Study|Lost to Follow-up|1|||
143326487|NCT01369342|516738635|FG000|Overall Study|Not Treated|1|||
143326488|NCT01369342|516738636|FG001|Overall Study|Not Treated|0|||
143326489|NCT01369342|516738637|FG002|Overall Study|Not Treated|0|||
143326490|NCT03204279|516738641|FG000|Overall Study|Withdrawal by Subject|0|||
143326491|NCT03204279|516738642|FG001|Overall Study|Withdrawal by Subject|1|||
143326492|NCT04969250|516738647|FG000|Overall Study|Protocol Violation|0|||
143326493|NCT04969250|516738648|FG001|Overall Study|Protocol Violation|2|||
143326494|NCT04969250|516738649|FG002|Overall Study|Protocol Violation|3|||
143326495|NCT04969250|516738650|FG003|Overall Study|Protocol Violation|8|||
143326496|NCT04969250|516738647|FG000|Overall Study|Withdrawal by Subject|0|||
143326497|NCT04969250|516738648|FG001|Overall Study|Withdrawal by Subject|1|||
143326498|NCT04969250|516738649|FG002|Overall Study|Withdrawal by Subject|0|||
143326499|NCT04969250|516738650|FG003|Overall Study|Withdrawal by Subject|0|||
143326500|NCT02119416|516738651|FG000|Overall Study|Protocol Violation|1|||
143326501|NCT02119416|516738652|FG001|Overall Study|Protocol Violation|1|||
143326502|NCT02119416|516738653|FG002|Overall Study|Protocol Violation|1|||
143326503|NCT02119416|516738651|FG000|Overall Study|wrong pubertal stage|1|||
143326504|NCT02119416|516738652|FG001|Overall Study|wrong pubertal stage|0|||
143326505|NCT02119416|516738653|FG002|Overall Study|wrong pubertal stage|1|||
143326506|NCT02278328|516738654|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
143326507|NCT02278328|516738655|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
143326508|NCT02278328|516738656|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
143326509|NCT02278328|516738654|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
143326510|NCT02278328|516738655|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
143326511|NCT02278328|516738656|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
143326512|NCT02278328|516738654|FG000|Neuropsych Screening|incomplete consent|0|||
143326513|NCT02278328|516738655|FG001|Neuropsych Screening|incomplete consent|0|||
143326514|NCT02278328|516738656|FG002|Neuropsych Screening|incomplete consent|2|||
143326515|NCT00130533|516738657|FG000|Overall Study|Withdrawal by Subject|33|||
143326516|NCT00130533|516738658|FG001|Overall Study|Withdrawal by Subject|6|||
143326517|NCT00130533|516738657|FG000|Overall Study|Adverse Event|34|||
143326518|NCT00130533|516738658|FG001|Overall Study|Adverse Event|1|||
143326519|NCT00130533|516738657|FG000|Overall Study|Disease relapse|9|||
143326520|NCT00130533|516738658|FG001|Overall Study|Disease relapse|13|||
143326521|NCT00130533|516738657|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
143326522|NCT00130533|516738658|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
143326523|NCT00130533|516738657|FG000|Overall Study|Death|4|||
143326524|NCT00130533|516738658|FG001|Overall Study|Death|2|||
143326525|NCT00130533|516738657|FG000|Overall Study|Protocol Violation|5|||
143326526|NCT00130533|516738658|FG001|Overall Study|Protocol Violation|1|||
143326527|NCT00130533|516738657|FG000|Overall Study|Lost to Follow-up|1|||
143326528|NCT00130533|516738658|FG001|Overall Study|Lost to Follow-up|1|||
143326529|NCT00130533|516738657|FG000|Overall Study|Sponsor´s decision|2|||
143381078|NCT03076515|516940749|FG000|Overall Study|DMC decision based on interim analysis|25|||
143326530|NCT00130533|516738658|FG001|Overall Study|Sponsor´s decision|0|||
143326531|NCT00130533|516738657|FG000|Overall Study|Second Primary Malignancy|0|||
143326532|NCT00130533|516738658|FG001|Overall Study|Second Primary Malignancy|1|||
143326533|NCT00130533|516738657|FG000|Overall Study|Other|12|||
143326534|NCT00130533|516738658|FG001|Overall Study|Other|5|||
143326535|NCT02384759|516738665|FG000|Overall Study|Patients not treated|3|||
143326536|NCT02384759|516738666|FG001|Overall Study|Patients not treated|2|||
143326537|NCT01605617|516738667|FG000|First Intervention|Adverse Event|0|||
143326538|NCT01605617|516738668|FG001|First Intervention|Adverse Event|1|||
143326539|NCT01605617|516738667|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
143326540|NCT01605617|516738668|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
143326541|NCT03043664|516738669|FG000|Overall Study|Lost to Follow-up|1|||
143326542|NCT03593655|516738670|FG000|First Product Use Period|Withdrawal by Subject|1|||
143326543|NCT03593655|516738671|FG001|First Product Use Period|Withdrawal by Subject|1|||
143326544|NCT03593655|516738670|FG000|First Product Use Period|Lost to Follow-up|1|||
143326545|NCT03593655|516738671|FG001|First Product Use Period|Lost to Follow-up|3|||
143326546|NCT03593655|516738670|FG000|Second Product Use Period|Withdrawal by Subject|1|||
143326547|NCT03593655|516738671|FG001|Second Product Use Period|Withdrawal by Subject|1|||
143326548|NCT03593655|516738670|FG000|Second Product Use Period|Lost to Follow-up|1|||
143326549|NCT03593655|516738671|FG001|Second Product Use Period|Lost to Follow-up|0|||
143326550|NCT03593655|516738670|FG000|Third Product Use Period|Lost to Follow-up|1|||
143326551|NCT03593655|516738671|FG001|Third Product Use Period|Lost to Follow-up|2|||
143326552|NCT03593655|516738670|FG000|Third Product Use Period|Physician Decision|0|||
143326553|NCT03593655|516738671|FG001|Third Product Use Period|Physician Decision|1|||
143326554|NCT03593655|516738670|FG000|Third Product Use Period|Withdrawal by Subject|0|||
143326555|NCT03593655|516738671|FG001|Third Product Use Period|Withdrawal by Subject|1|||
143326556|NCT03732209|516738672|FG000|Overall Study|Lost to Follow-up|4|||
143326557|NCT03732209|516738673|FG001|Overall Study|Lost to Follow-up|4|||
143326558|NCT03732209|516738672|FG000|Overall Study|Withdrawal by Subject|8|||
143326559|NCT03732209|516738673|FG001|Overall Study|Withdrawal by Subject|9|||
143326560|NCT05046795|516738674|FG000|Overall Study|Adverse Event|13|||
143326561|NCT05046795|516738675|FG001|Overall Study|Adverse Event|15|||
143326562|NCT05046795|516738674|FG000|Overall Study|Withdrawal by Subject|4|||
143326563|NCT05046795|516738675|FG001|Overall Study|Withdrawal by Subject|7|||
143326564|NCT05046795|516738674|FG000|Overall Study|Physician Decision|1|||
143326565|NCT05046795|516738675|FG001|Overall Study|Physician Decision|2|||
143326566|NCT05046795|516738674|FG000|Overall Study|Protocol Violation|1|||
143326567|NCT05046795|516738675|FG001|Overall Study|Protocol Violation|2|||
143326568|NCT05046795|516738674|FG000|Overall Study|Death|1|||
143326569|NCT05046795|516738675|FG001|Overall Study|Death|0|||
143326570|NCT05046795|516738674|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
143326571|NCT05046795|516738675|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
143326572|NCT02864082|516738676|FG000|Overall Study|Adverse Event|1|||
143326573|NCT02864082|516738677|FG001|Overall Study|Adverse Event|1|||
143326574|NCT02864082|516738676|FG000|Overall Study|Lost to Follow-up|0|||
143326575|NCT02864082|516738677|FG001|Overall Study|Lost to Follow-up|1|||
143326576|NCT02864082|516738676|FG000|Overall Study|Withdrawal by Subject|2|||
143326577|NCT02864082|516738677|FG001|Overall Study|Withdrawal by Subject|2|||
143326578|NCT01127178|516738678|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
143326579|NCT01127178|516738679|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
143326580|NCT01127178|516738678|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
143326581|NCT01127178|516738679|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
143326582|NCT01127178|516738678|FG000|Dose Escalation: Treatment Phase|Other|2|||
143326583|NCT01127178|516738679|FG001|Dose Escalation: Treatment Phase|Other|0|||
143326584|NCT01127178|516738678|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
143326585|NCT01127178|516738679|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
143326586|NCT01127178|516738678|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
143326587|NCT01127178|516738679|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
143326588|NCT01127178|516738678|FG000|Dose Escalation: Extension Phase|Other|1|||
143326589|NCT01127178|516738679|FG001|Dose Escalation: Extension Phase|Other|0|||
143326590|NCT04139317|516738680|FG000|Overall Study|Adverse Event|10|||
143326591|NCT04139317|516738681|FG001|Overall Study|Adverse Event|2|||
143326592|NCT04139317|516738680|FG000|Overall Study|Death|6|||
143326593|NCT04139317|516738681|FG001|Overall Study|Death|4|||
143326594|NCT04139317|516738680|FG000|Overall Study|Lost to Follow-up|1|||
143326595|NCT04139317|516738681|FG001|Overall Study|Lost to Follow-up|0|||
143326596|NCT04139317|516738680|FG000|Overall Study|Physician Decision|3|||
143326597|NCT04139317|516738681|FG001|Overall Study|Physician Decision|1|||
143326598|NCT04139317|516738680|FG000|Overall Study|Progressive Disease|19|||
143381079|NCT03076515|516940750|FG001|Overall Study|DMC decision based on interim analysis|29|||
143326599|NCT04139317|516738681|FG001|Overall Study|Progressive Disease|9|||
143326600|NCT04139317|516738680|FG000|Overall Study|Subject Decision|2|||
143326601|NCT04139317|516738681|FG001|Overall Study|Subject Decision|2|||
143326602|NCT04389840|516738684|FG000|Overall Study|Adverse Event|0|||
143326603|NCT04389840|516738685|FG001|Overall Study|Adverse Event|0|||
143326604|NCT04389840|516738686|FG002|Overall Study|Adverse Event|0|||
143326605|NCT04389840|516738687|FG003|Overall Study|Adverse Event|1|||
143326606|NCT04389840|516738688|FG004|Overall Study|Adverse Event|0|||
143326607|NCT04389840|516738689|FG005|Overall Study|Adverse Event|0|||
143326608|NCT04389840|516738684|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
143326609|NCT04389840|516738685|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
143326610|NCT04389840|516738686|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
143326611|NCT04389840|516738687|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
143326612|NCT04389840|516738688|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
143326613|NCT04389840|516738689|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
143326614|NCT04389840|516738684|FG000|Overall Study|Death|0|||
143326615|NCT04389840|516738685|FG001|Overall Study|Death|1|||
143326616|NCT04389840|516738686|FG002|Overall Study|Death|0|||
143326617|NCT04389840|516738687|FG003|Overall Study|Death|0|||
143326618|NCT04389840|516738688|FG004|Overall Study|Death|0|||
143326619|NCT04389840|516738689|FG005|Overall Study|Death|0|||
143326620|NCT00214136|516738692|FG000|Overall Study|Death|5|||
143326621|NCT04287920|516738693|FG000|Overall Study|Lost to Follow-up|1|||
143326622|NCT04287920|516738694|FG001|Overall Study|Lost to Follow-up|1|||
143326623|NCT04287920|516738693|FG000|Overall Study|Withdrawal by Subject|0|||
143326624|NCT04287920|516738694|FG001|Overall Study|Withdrawal by Subject|3|||
143326625|NCT01226745|516738697|FG000|Overall Study|Did not complete schedule of assessments|8|||
143326626|NCT01226745|516738698|FG001|Overall Study|Did not complete schedule of assessments|3|||
143326627|NCT01226745|516738699|FG002|Overall Study|Did not complete schedule of assessments|6|||
143326628|NCT01226745|516738700|FG003|Overall Study|Did not complete schedule of assessments|0|||
143326629|NCT01226745|516738701|FG004|Overall Study|Did not complete schedule of assessments|0|||
143326630|NCT01226745|516738702|FG005|Overall Study|Did not complete schedule of assessments|1|||
143326631|NCT01226745|516738697|FG000|Overall Study|Lost to Follow-up|2|||
143326632|NCT01226745|516738698|FG001|Overall Study|Lost to Follow-up|6|||
143326633|NCT01226745|516738699|FG002|Overall Study|Lost to Follow-up|6|||
143326634|NCT01226745|516738700|FG003|Overall Study|Lost to Follow-up|1|||
143326635|NCT01226745|516738701|FG004|Overall Study|Lost to Follow-up|1|||
143326636|NCT01226745|516738702|FG005|Overall Study|Lost to Follow-up|2|||
143326637|NCT01226745|516738697|FG000|Overall Study|Death|1|||
143326638|NCT01226745|516738698|FG001|Overall Study|Death|0|||
143326639|NCT01226745|516738699|FG002|Overall Study|Death|0|||
143326640|NCT01226745|516738700|FG003|Overall Study|Death|0|||
143326641|NCT01226745|516738701|FG004|Overall Study|Death|0|||
143326642|NCT01226745|516738702|FG005|Overall Study|Death|1|||
143326643|NCT01226745|516738697|FG000|Overall Study|Other|6|||
143326644|NCT01226745|516738698|FG001|Overall Study|Other|7|||
143326645|NCT01226745|516738699|FG002|Overall Study|Other|8|||
143326646|NCT01226745|516738700|FG003|Overall Study|Other|4|||
143326647|NCT01226745|516738701|FG004|Overall Study|Other|3|||
143326648|NCT01226745|516738702|FG005|Overall Study|Other|1|||
143326649|NCT01435577|516738703|FG000|Overall Study|Adverse Event|10|||
143326650|NCT01435577|516738704|FG001|Overall Study|Adverse Event|0|||
143326651|NCT01435577|516738703|FG000|Overall Study|Lack of Efficacy|7|||
143326652|NCT01435577|516738704|FG001|Overall Study|Lack of Efficacy|51|||
143326653|NCT01435577|516738703|FG000|Overall Study|Alternative treatment started|0|||
143326654|NCT01435577|516738704|FG001|Overall Study|Alternative treatment started|1|||
143326655|NCT03738150|516738706|FG000|Base Study|Withdrawal by Subject|1|||
143326656|NCT03738150|516738706|FG000|Extension Study|Withdrawal by Subject|1|||
143326657|NCT00809757|516738711|FG000|Overall Study|Adverse Event|2|||
143326658|NCT00809757|516738712|FG001|Overall Study|Adverse Event|3|||
143326659|NCT00809757|516738713|FG002|Overall Study|Adverse Event|3|||
143326660|NCT00809757|516738711|FG000|Overall Study|Lost to Follow-up|0|||
143326661|NCT00809757|516738712|FG001|Overall Study|Lost to Follow-up|0|||
143326662|NCT00809757|516738713|FG002|Overall Study|Lost to Follow-up|1|||
143326663|NCT00809757|516738711|FG000|Overall Study|Protocol Violation|1|||
143326664|NCT00809757|516738712|FG001|Overall Study|Protocol Violation|1|||
143326665|NCT00809757|516738713|FG002|Overall Study|Protocol Violation|1|||
143326666|NCT00809757|516738711|FG000|Overall Study|Withdrawal by Subject|2|||
143326667|NCT00809757|516738712|FG001|Overall Study|Withdrawal by Subject|1|||
143326668|NCT00809757|516738713|FG002|Overall Study|Withdrawal by Subject|3|||
143326669|NCT00809757|516738711|FG000|Overall Study|Subject Uncooperative|1|||
143326670|NCT00809757|516738712|FG001|Overall Study|Subject Uncooperative|0|||
143326671|NCT00809757|516738713|FG002|Overall Study|Subject Uncooperative|2|||
143326672|NCT00809757|516738711|FG000|Overall Study|Noncompliance with Medication|0|||
143326673|NCT00809757|516738712|FG001|Overall Study|Noncompliance with Medication|0|||
143381080|NCT02101281|516940751|FG000|Overall Study|Adverse Event|0|||
143326674|NCT00809757|516738713|FG002|Overall Study|Noncompliance with Medication|1|||
143326675|NCT00253864|516738714|FG000|Overall Study|Lost to Follow-up|5|||
143326676|NCT00253864|516738715|FG001|Overall Study|Lost to Follow-up|8|||
143326677|NCT00659334|516738716|FG000|Overall Study|Screen Failure|8|||
143326678|NCT00659334|516738717|FG001|Overall Study|Screen Failure|5|||
143326679|NCT00659334|516738718|FG002|Overall Study|Screen Failure|0|||
143326680|NCT00659334|516738719|FG003|Overall Study|Screen Failure|0|||
143326681|NCT00659334|516738720|FG004|Overall Study|Screen Failure|0|||
143326682|NCT00659334|516738721|FG005|Overall Study|Screen Failure|0|||
143326683|NCT00659334|516738722|FG006|Overall Study|Screen Failure|1|||
143326684|NCT02535065|516738726|FG000|Overall Study|Death|13|||
143326685|NCT02535065|516738726|FG000|Overall Study|Lost to Follow-up|1|||
143326686|NCT02535065|516738726|FG000|Overall Study|Withdrawal by Subject|6|||
143326687|NCT01781572|516738730|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
143326688|NCT01781572|516738731|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
143326689|NCT01781572|516738732|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
143326690|NCT01781572|516738730|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
143326691|NCT01781572|516738731|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
143326692|NCT01781572|516738732|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
143326693|NCT01781572|516738730|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
143326694|NCT01781572|516738731|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
143326695|NCT01781572|516738732|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
143326696|NCT01781572|516738730|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
143326697|NCT01781572|516738731|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
143326698|NCT01781572|516738732|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
143326699|NCT01781572|516738730|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
143326700|NCT01781572|516738731|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
143326701|NCT01781572|516738732|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
143326702|NCT01781572|516738730|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
143326703|NCT01781572|516738731|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
143326704|NCT01781572|516738732|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
143326705|NCT01781572|516738730|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
143326706|NCT01781572|516738731|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
143326707|NCT01781572|516738732|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
143326708|NCT01781572|516738730|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
143326709|NCT01781572|516738731|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
143326710|NCT01781572|516738732|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
143326711|NCT01781572|516738730|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
143326712|NCT01781572|516738731|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
143326713|NCT01781572|516738732|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
143326714|NCT01781572|516738730|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
143326715|NCT01781572|516738731|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
143326716|NCT01781572|516738732|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
143326717|NCT01781572|516738730|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
143326718|NCT01781572|516738731|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
143326719|NCT01781572|516738732|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
143326720|NCT01781572|516738730|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
143326721|NCT01781572|516738731|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
143326722|NCT01781572|516738732|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
143326723|NCT01781572|516738730|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
143326724|NCT01781572|516738731|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
143326725|NCT01781572|516738732|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
143326726|NCT01781572|516738730|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
143326727|NCT01781572|516738731|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
143326728|NCT01781572|516738732|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
143326729|NCT01781572|516738730|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
143326730|NCT01781572|516738731|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
143326731|NCT01781572|516738732|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
143326732|NCT01781572|516738730|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
143326733|NCT01781572|516738731|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
143381081|NCT02101281|516940752|FG001|Overall Study|Adverse Event|1|||
143326734|NCT01781572|516738732|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
143326735|NCT01781572|516738730|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
143326736|NCT01781572|516738731|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
143326737|NCT01781572|516738732|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
143326738|NCT01781572|516738730|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
143326739|NCT01781572|516738731|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
143381082|NCT00174382|516940753|FG000|Overall Study|Death|2|||
143381083|NCT00174382|516940753|FG000|Overall Study|Adverse Event|19|||
143381084|NCT00174382|516940753|FG000|Overall Study|Withdrawal by Subject|6|||
143381085|NCT00174382|516940753|FG000|Overall Study|Protocol Violation|3|||
143381086|NCT00174382|516940753|FG000|Overall Study|Arrived early for last visit in error|1|||
143326740|NCT01781572|516738732|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
143326741|NCT01218438|516738733|FG000|Epoch 1|Physician Decision|2|||
143326742|NCT01218438|516738733|FG000|Epoch 1|Adverse Event|1|||
143326743|NCT01218438|516738733|FG000|Epoch 3|Withdrawal by Subject|3|||
143381087|NCT00174382|516940753|FG000|Overall Study|Subject felt pill not effective enough|1|||
143326744|NCT01218438|516738733|FG000|Epoch 3|Adverse Event|1|||
143326745|NCT01218438|516738733|FG000|Epoch 4|Physician Decision|1|||
143381088|NCT00174382|516940753|FG000|Overall Study|Lost to Follow-up|1|||
143381089|NCT05052996|516940757|FG000|Overall Study|Still on study|0|||
143381090|NCT05052996|516940758|FG001|Overall Study|Still on study|0|||
143381091|NCT05052996|516940759|FG002|Overall Study|Still on study|47|||
143381092|NCT05052996|516940760|FG003|Overall Study|Still on study|44|||
143381093|NCT05052996|516940757|FG000|Overall Study|Cohort terminated by sponsor|21|||
143381094|NCT05052996|516940758|FG001|Overall Study|Cohort terminated by sponsor|12|||
143381095|NCT05052996|516940759|FG002|Overall Study|Cohort terminated by sponsor|0|||
143381096|NCT05052996|516940760|FG003|Overall Study|Cohort terminated by sponsor|0|||
143381097|NCT05052996|516940757|FG000|Overall Study|Withdrew consent|1|||
143381098|NCT05052996|516940758|FG001|Overall Study|Withdrew consent|0|||
143381099|NCT05052996|516940759|FG002|Overall Study|Withdrew consent|1|||
143381100|NCT05052996|516940760|FG003|Overall Study|Withdrew consent|2|||
143381101|NCT05052996|516940757|FG000|Overall Study|Lost to Follow-up|1|||
143381102|NCT05052996|516940758|FG001|Overall Study|Lost to Follow-up|0|||
143381103|NCT05052996|516940759|FG002|Overall Study|Lost to Follow-up|0|||
143381104|NCT05052996|516940760|FG003|Overall Study|Lost to Follow-up|2|||
143381105|NCT05052996|516940757|FG000|Overall Study|Adverse Event|0|||
143381106|NCT05052996|516940758|FG001|Overall Study|Adverse Event|0|||
143381107|NCT05052996|516940759|FG002|Overall Study|Adverse Event|2|||
143381108|NCT05052996|516940760|FG003|Overall Study|Adverse Event|0|||
143326746|NCT01218438|516738733|FG000|Epoch 4|Withdrawal by Subject|2|||
143326747|NCT00045110|516738734|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
143326748|NCT00045110|516738735|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
143326749|NCT00045110|516738736|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
143326750|NCT00045110|516738734|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
143326751|NCT00045110|516738735|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
143326752|NCT00045110|516738736|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
143326753|NCT00045110|516738734|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
143326754|NCT00045110|516738735|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
143326755|NCT00045110|516738736|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
143326756|NCT03096782|516738741|FG000|Overall Study|Death|1|||
143326757|NCT03096782|516738741|FG000|Overall Study|Participant Relapsed|1|||
143326758|NCT03156023|516738742|FG000|Overall Study|Withdrawal by Subject|1|||
143326759|NCT03156023|516738743|FG001|Overall Study|Withdrawal by Subject|0|||
143326760|NCT03156023|516738744|FG002|Overall Study|Withdrawal by Subject|2|||
143326761|NCT03156023|516738745|FG003|Overall Study|Withdrawal by Subject|1|||
143326762|NCT03156023|516738746|FG004|Overall Study|Withdrawal by Subject|1|||
143326763|NCT03156023|516738742|FG000|Overall Study|Lost to Follow-up|0|||
143326764|NCT03156023|516738743|FG001|Overall Study|Lost to Follow-up|0|||
143326765|NCT03156023|516738744|FG002|Overall Study|Lost to Follow-up|0|||
143326766|NCT03156023|516738745|FG003|Overall Study|Lost to Follow-up|0|||
143326767|NCT03156023|516738746|FG004|Overall Study|Lost to Follow-up|1|||
143326768|NCT01625897|516739948|FG000|Overall Study|Adverse Event|27|||
143326769|NCT01625897|516739949|FG001|Overall Study|Adverse Event|10|||
143326770|NCT01625897|516739948|FG000|Overall Study|Physician Decision|0|||
143326771|NCT01625897|516739949|FG001|Overall Study|Physician Decision|1|||
143326772|NCT01625897|516739948|FG000|Overall Study|Withdrawal by Subject|25|||
143326773|NCT01625897|516739949|FG001|Overall Study|Withdrawal by Subject|3|||
143326774|NCT00156065|516739950|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
143326775|NCT00156065|516739951|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
143326776|NCT00156065|516739952|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
143326777|NCT00156065|516739950|FG000|Overall Study|Adverse Event|8|||
143326778|NCT00156065|516739951|FG001|Overall Study|Adverse Event|11|||
143326779|NCT00156065|516739952|FG002|Overall Study|Adverse Event|4|||
143326780|NCT00156065|516739950|FG000|Overall Study|Lack of Efficacy|2|||
143326781|NCT00156065|516739951|FG001|Overall Study|Lack of Efficacy|9|||
143326782|NCT00156065|516739952|FG002|Overall Study|Lack of Efficacy|3|||
143326783|NCT00156065|516739950|FG000|Overall Study|Withdrawal by Subject|13|||
143326784|NCT00156065|516739951|FG001|Overall Study|Withdrawal by Subject|26|||
143326785|NCT00156065|516739952|FG002|Overall Study|Withdrawal by Subject|16|||
143326786|NCT00156065|516739950|FG000|Overall Study|Lost to Follow-up|5|||
143326787|NCT00156065|516739951|FG001|Overall Study|Lost to Follow-up|7|||
143326788|NCT00156065|516739952|FG002|Overall Study|Lost to Follow-up|1|||
143326789|NCT00156065|516739950|FG000|Overall Study|Other|2|||
143326790|NCT00156065|516739951|FG001|Overall Study|Other|9|||
143326791|NCT00156065|516739952|FG002|Overall Study|Other|3|||
143326792|NCT01432366|516739953|FG000|Overall Study|Non-Responder|7|||
143326793|NCT01432366|516739953|FG000|Overall Study|Adverse Event|8|||
143381109|NCT05052996|516940757|FG000|Overall Study|Randomized but never treated|0|||
143381110|NCT05052996|516940758|FG001|Overall Study|Randomized but never treated|0|||
143381111|NCT05052996|516940759|FG002|Overall Study|Randomized but never treated|1|||
143326794|NCT01432366|516739953|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
143326795|NCT01432366|516739953|FG000|Overall Study|Pregnancy|1|||
143381112|NCT05052996|516940760|FG003|Overall Study|Randomized but never treated|1|||
143326796|NCT01432366|516739953|FG000|Overall Study|Lost to Follow-up|13|||
143326797|NCT01432366|516739953|FG000|Overall Study|Lack of Efficacy|1|||
143326798|NCT01432366|516739953|FG000|Overall Study|Site Closed|20|||
143326799|NCT01432366|516739953|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
143326800|NCT01432366|516739953|FG000|Overall Study|Other|14|||
143326801|NCT01585103|516739954|FG000|Overall Study|Unable to swallow Cytosponge|6|||
143326802|NCT01412944|516739955|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
143326803|NCT01412944|516739956|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
143326804|NCT01412944|516739957|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
143326805|NCT01412944|516739958|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
143326806|NCT01412944|516739959|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
143326807|NCT01412944|516739960|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
143326808|NCT01412944|516739955|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
143326809|NCT01412944|516739956|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
143326810|NCT01412944|516739957|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
143326811|NCT01412944|516739958|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
143326812|NCT01412944|516739959|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
143326813|NCT01412944|516739960|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
143326814|NCT01412944|516739955|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
143326815|NCT01412944|516739956|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
143326816|NCT01412944|516739957|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
143326817|NCT01412944|516739958|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
143326818|NCT01412944|516739959|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
143326819|NCT01412944|516739960|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
143326820|NCT01412944|516739955|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
143326821|NCT01412944|516739956|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
143326822|NCT01412944|516739957|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
143326823|NCT01412944|516739958|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
143326824|NCT01412944|516739959|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
143326825|NCT01412944|516739960|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
143326826|NCT01412944|516739955|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
143326827|NCT01412944|516739956|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
143326828|NCT01412944|516739957|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
143326829|NCT01412944|516739958|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
143326830|NCT01412944|516739959|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
143326831|NCT01412944|516739960|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
143326832|NCT01412944|516739955|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
143326833|NCT01412944|516739956|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
143326834|NCT01412944|516739957|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
143326835|NCT01412944|516739958|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
143326836|NCT01412944|516739959|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
143326837|NCT01412944|516739960|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
143326838|NCT01412944|516739955|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
143326839|NCT01412944|516739956|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
143326840|NCT01412944|516739957|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
143326841|NCT01412944|516739958|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
143326842|NCT01412944|516739959|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
143326843|NCT01412944|516739960|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
143326844|NCT01412944|516739955|FG000|Entire: IV + Maintenance|Adverse Event|0|||
143326845|NCT01412944|516739956|FG001|Entire: IV + Maintenance|Adverse Event|0|||
143326846|NCT01412944|516739957|FG002|Entire: IV + Maintenance|Adverse Event|0|||
143326847|NCT01412944|516739958|FG003|Entire: IV + Maintenance|Adverse Event|0|||
143326848|NCT01412944|516739959|FG004|Entire: IV + Maintenance|Adverse Event|1|||
143326849|NCT01412944|516739960|FG005|Entire: IV + Maintenance|Adverse Event|0|||
143326850|NCT01412944|516739955|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
143326851|NCT01412944|516739956|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
143326852|NCT01412944|516739957|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
143326853|NCT01412944|516739958|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
143326854|NCT01412944|516739959|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
143326855|NCT01412944|516739960|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
143326856|NCT01412944|516739955|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
143326857|NCT01412944|516739956|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
143326858|NCT01412944|516739957|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
143326859|NCT01412944|516739958|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
143326860|NCT01412944|516739959|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
143326861|NCT01412944|516739960|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
143326862|NCT01412944|516739955|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
143326863|NCT01412944|516739956|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
143381113|NCT05052996|516940757|FG000|Overall Study|Protocol Violation|1|||
143381114|NCT05052996|516940758|FG001|Overall Study|Protocol Violation|0|||
143381115|NCT05052996|516940759|FG002|Overall Study|Protocol Violation|0|||
143381116|NCT05052996|516940760|FG003|Overall Study|Protocol Violation|0|||
143381117|NCT03951805|516940761|FG000|Overall Study|Adverse Event|1|||
143381118|NCT03951805|516940762|FG001|Overall Study|Adverse Event|0|||
143381119|NCT03951805|516940763|FG002|Overall Study|Adverse Event|0|||
143381120|NCT03951805|516940764|FG003|Overall Study|Adverse Event|0|||
143381121|NCT03485950|516940765|FG000|Overall Study|Adverse Event|1|||
143381122|NCT03485950|516940766|FG001|Overall Study|Adverse Event|0|||
143381123|NCT03485950|516940765|FG000|Overall Study|Death|3|||
143381124|NCT03485950|516940766|FG001|Overall Study|Death|2|||
143381125|NCT03485950|516940765|FG000|Overall Study|Withdrawal by Subject|3|||
143381126|NCT03485950|516940766|FG001|Overall Study|Withdrawal by Subject|0|||
143381127|NCT00988858|516940767|FG000|Overall Study|Adverse Event|7|||
143381128|NCT00988858|516940767|FG000|Overall Study|Death|1|||
143381129|NCT00988858|516940767|FG000|Overall Study|Physician Decision|1|||
143381130|NCT00988858|516940767|FG000|Overall Study|Sponsor Decision|1|||
143381131|NCT00580866|516940768|FG000|Overall Study|Lost to Follow-up|2|||
143381132|NCT00580866|516940769|FG001|Overall Study|Lost to Follow-up|2|||
143381133|NCT00609336|516940770|FG000|Overall Study|Protocol Violation|3|||
143381134|NCT00609336|516940770|FG000|Overall Study|Death|1|||
143381135|NCT00609336|516940770|FG000|Overall Study|LA or Met at Surgery|9|||
143381136|NCT02238483|516940771|FG000|Overall Study|Withdrawal by Subject|2|||
143381137|NCT02238483|516940772|FG001|Overall Study|Withdrawal by Subject|7|||
143381138|NCT02238483|516940771|FG000|Overall Study|Lost to Follow-up|1|||
143381139|NCT02238483|516940772|FG001|Overall Study|Lost to Follow-up|1|||
143381140|NCT02238483|516940771|FG000|Overall Study|Protocol Violation|1|||
143381141|NCT02238483|516940772|FG001|Overall Study|Protocol Violation|2|||
143381142|NCT02238483|516940771|FG000|Overall Study|Death|1|||
143381143|NCT02238483|516940772|FG001|Overall Study|Death|0|||
143381144|NCT02238483|516940771|FG000|Overall Study|Adverse Event|7|||
143381145|NCT02238483|516940772|FG001|Overall Study|Adverse Event|3|||
143381146|NCT02238483|516940771|FG000|Overall Study|Withdrawn due to physician decision|1|||
143381147|NCT02238483|516940772|FG001|Overall Study|Withdrawn due to physician decision|0|||
143381148|NCT02238483|516940771|FG000|Overall Study|Completion status not recorded|1|||
143381149|NCT02238483|516940772|FG001|Overall Study|Completion status not recorded|1|||
143381150|NCT02238483|516940771|FG000|Overall Study|Illness in family member|1|||
143381151|NCT02238483|516940772|FG001|Overall Study|Illness in family member|0|||
143381152|NCT02692417|516940781|FG000|Overall Study|Withdrawal by Subject|5|||
143381153|NCT02692417|516940782|FG001|Overall Study|Withdrawal by Subject|1|||
143381154|NCT02692417|516940781|FG000|Overall Study|Adverse Event|1|||
143381155|NCT02692417|516940782|FG001|Overall Study|Adverse Event|0|||
143381156|NCT01803555|516940783|FG000|Overall Study|Adverse Event|3|||
143381157|NCT01803555|516940784|FG001|Overall Study|Adverse Event|2|||
143381158|NCT01803555|516940783|FG000|Overall Study|Withdrawal by Subject|3|||
143381159|NCT01803555|516940784|FG001|Overall Study|Withdrawal by Subject|3|||
143381160|NCT01803555|516940783|FG000|Overall Study|Non-compliance|1|||
143381161|NCT01803555|516940784|FG001|Overall Study|Non-compliance|1|||
143381162|NCT01803555|516940783|FG000|Overall Study|Protocol Violation|3|||
143381163|NCT01803555|516940784|FG001|Overall Study|Protocol Violation|5|||
143381164|NCT01803555|516940783|FG000|Overall Study|Lost to Follow-up|0|||
143381165|NCT01803555|516940784|FG001|Overall Study|Lost to Follow-up|2|||
143381166|NCT01803555|516940783|FG000|Overall Study|Other than specified|3|||
143381167|NCT01803555|516940784|FG001|Overall Study|Other than specified|5|||
143381168|NCT01551355|516940785|FG000|Overall Study|Lost to Follow-up|51|||
143381169|NCT01551355|516940786|FG001|Overall Study|Lost to Follow-up|49|||
143381170|NCT01551355|516940787|FG002|Overall Study|Lost to Follow-up|34|||
143381171|NCT01551355|516940788|FG003|Overall Study|Lost to Follow-up|24|||
143381172|NCT01551355|516940789|FG004|Overall Study|Lost to Follow-up|9|||
143381173|NCT01551355|516940790|FG005|Overall Study|Lost to Follow-up|6|||
143381174|NCT01925339|516940791|FG000|Overall Study|Adverse Event|2|||
143381175|NCT01925339|516940792|FG001|Overall Study|Adverse Event|0|||
143381176|NCT00823472|516940793|FG000|Overall Study|Physician Decision|24|||
143381177|NCT00823472|516940794|FG001|Overall Study|Physician Decision|28|||
143326864|NCT01412944|516739957|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
143326865|NCT01412944|516739958|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
143326866|NCT01412944|516739959|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
143326867|NCT01412944|516739960|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
143326868|NCT01412944|516739955|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
143326869|NCT01412944|516739956|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
143326870|NCT01412944|516739957|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
143326871|NCT01412944|516739958|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
143326872|NCT01412944|516739959|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
143326873|NCT01412944|516739960|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
143326874|NCT01412944|516739955|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
143326875|NCT01412944|516739956|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
143326876|NCT01412944|516739957|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
143326877|NCT01412944|516739958|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
143326878|NCT01412944|516739959|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
143326879|NCT01412944|516739960|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
143326880|NCT01412944|516739955|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
143326881|NCT01412944|516739956|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
143326882|NCT01412944|516739957|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
143326883|NCT01412944|516739958|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
143326884|NCT01412944|516739959|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
143326885|NCT01412944|516739960|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
143326886|NCT01412944|516739955|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
143326887|NCT01412944|516739956|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
143326888|NCT01412944|516739957|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
143326889|NCT01412944|516739958|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
143326890|NCT01412944|516739959|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
143326891|NCT01412944|516739960|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
143326892|NCT01412944|516739955|FG000|Entire: IV + Maintenance|Adverse Event|0|||
143326893|NCT01412944|516739956|FG001|Entire: IV + Maintenance|Adverse Event|1|||
143326894|NCT01412944|516739957|FG002|Entire: IV + Maintenance|Adverse Event|0|||
143326895|NCT01412944|516739958|FG003|Entire: IV + Maintenance|Adverse Event|0|||
143326896|NCT01412944|516739959|FG004|Entire: IV + Maintenance|Adverse Event|0|||
143326897|NCT01412944|516739960|FG005|Entire: IV + Maintenance|Adverse Event|0|||
143326898|NCT02301143|516739962|FG000|Induction Period|Enrolled But Not Treated|1|||
143326899|NCT02301143|516739963|FG001|Induction Period|Enrolled But Not Treated|0|||
143326900|NCT02301143|516739962|FG000|Induction Period|Death|1|||
143326901|NCT02301143|516739963|FG001|Induction Period|Death|0|||
143326902|NCT02301143|516739962|FG000|Induction Period|Adverse Event|22|||
143326903|NCT02301143|516739963|FG001|Induction Period|Adverse Event|0|||
143326904|NCT02301143|516739962|FG000|Induction Period|Progressive Disease|8|||
143326905|NCT02301143|516739963|FG001|Induction Period|Progressive Disease|0|||
143326906|NCT02301143|516739962|FG000|Induction Period|Withdrawal by Subject|3|||
143326907|NCT02301143|516739963|FG001|Induction Period|Withdrawal by Subject|0|||
143326908|NCT02301143|516739962|FG000|Induction Period|Noncompliance with Study Drug|1|||
143326909|NCT02301143|516739963|FG001|Induction Period|Noncompliance with Study Drug|0|||
143326910|NCT02301143|516739962|FG000|Induction Period|Physician Decision|4|||
143326911|NCT02301143|516739963|FG001|Induction Period|Physician Decision|0|||
143326912|NCT02301143|516739962|FG000|Induction Period|Symptomatic Deterioration|2|||
143326913|NCT02301143|516739963|FG001|Induction Period|Symptomatic Deterioration|0|||
143326914|NCT02301143|516739962|FG000|Induction Period|Protocol Violation|2|||
143326915|NCT02301143|516739963|FG001|Induction Period|Protocol Violation|0|||
143326916|NCT02301143|516739962|FG000|Induction Period|Other|1|||
143326917|NCT02301143|516739963|FG001|Induction Period|Other|0|||
143326918|NCT02301143|516739962|FG000|Investigator's Choice|Adverse Event|0|||
143326919|NCT02301143|516739963|FG001|Investigator's Choice|Adverse Event|3|||
143326920|NCT02301143|516739962|FG000|Investigator's Choice|Progressive Disease|0|||
143326921|NCT02301143|516739963|FG001|Investigator's Choice|Progressive Disease|3|||
143326922|NCT02301143|516739962|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
143326923|NCT02301143|516739963|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
143326924|NCT02301143|516739962|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
143326925|NCT02301143|516739963|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
143326926|NCT02301143|516739962|FG000|Investigator's Choice|Other|0|||
143326927|NCT02301143|516739963|FG001|Investigator's Choice|Other|1|||
143326928|NCT02301143|516739962|FG000|Investigator's Choice|Unresectable Surgery|0|||
143326929|NCT02301143|516739963|FG001|Investigator's Choice|Unresectable Surgery|1|||
143326930|NCT03214367|516739964|FG000|Lead-in Period|Withdrawal by Subject|50|||
143326931|NCT03214367|516739965|FG001|Lead-in Period|Withdrawal by Subject|0|||
143326932|NCT03214367|516739966|FG002|Lead-in Period|Withdrawal by Subject|0|||
143326933|NCT03214367|516739967|FG003|Lead-in Period|Withdrawal by Subject|0|||
143326934|NCT03214367|516739968|FG004|Lead-in Period|Withdrawal by Subject|2|||
143326935|NCT03214367|516739969|FG005|Lead-in Period|Withdrawal by Subject|0|||
143326936|NCT03214367|516739970|FG006|Lead-in Period|Withdrawal by Subject|0|||
143381178|NCT03783026|516942101|FG000|Treatment Phase|Adverse Event|15|||
143326937|NCT03214367|516739971|FG007|Lead-in Period|Withdrawal by Subject|0|||
143326938|NCT03214367|516739964|FG000|Lead-in Period|Adverse Event|3|||
143326939|NCT03214367|516739965|FG001|Lead-in Period|Adverse Event|0|||
143326940|NCT03214367|516739966|FG002|Lead-in Period|Adverse Event|0|||
143326941|NCT03214367|516739967|FG003|Lead-in Period|Adverse Event|0|||
143326942|NCT03214367|516739968|FG004|Lead-in Period|Adverse Event|0|||
143326943|NCT03214367|516739969|FG005|Lead-in Period|Adverse Event|0|||
143326944|NCT03214367|516739970|FG006|Lead-in Period|Adverse Event|0|||
143326945|NCT03214367|516739971|FG007|Lead-in Period|Adverse Event|0|||
143326946|NCT03214367|516739964|FG000|Lead-in Period|Lost to Follow-up|12|||
143326947|NCT03214367|516739965|FG001|Lead-in Period|Lost to Follow-up|0|||
143326948|NCT03214367|516739966|FG002|Lead-in Period|Lost to Follow-up|0|||
143326949|NCT03214367|516739967|FG003|Lead-in Period|Lost to Follow-up|0|||
143326950|NCT03214367|516739968|FG004|Lead-in Period|Lost to Follow-up|0|||
143326951|NCT03214367|516739969|FG005|Lead-in Period|Lost to Follow-up|0|||
143326952|NCT03214367|516739970|FG006|Lead-in Period|Lost to Follow-up|0|||
143326953|NCT03214367|516739971|FG007|Lead-in Period|Lost to Follow-up|0|||
143326954|NCT03214367|516739964|FG000|Lead-in Period|Sponsor Decision|11|||
143326955|NCT03214367|516739965|FG001|Lead-in Period|Sponsor Decision|0|||
143326956|NCT03214367|516739966|FG002|Lead-in Period|Sponsor Decision|0|||
143326957|NCT03214367|516739967|FG003|Lead-in Period|Sponsor Decision|0|||
143326958|NCT03214367|516739968|FG004|Lead-in Period|Sponsor Decision|0|||
143326959|NCT03214367|516739969|FG005|Lead-in Period|Sponsor Decision|0|||
143326960|NCT03214367|516739970|FG006|Lead-in Period|Sponsor Decision|0|||
143326961|NCT03214367|516739971|FG007|Lead-in Period|Sponsor Decision|0|||
143326962|NCT03214367|516739964|FG000|Lead-in Period|Physician Decision|12|||
143326963|NCT03214367|516739965|FG001|Lead-in Period|Physician Decision|0|||
143326964|NCT03214367|516739966|FG002|Lead-in Period|Physician Decision|0|||
143326965|NCT03214367|516739967|FG003|Lead-in Period|Physician Decision|0|||
143326966|NCT03214367|516739968|FG004|Lead-in Period|Physician Decision|0|||
143326967|NCT03214367|516739969|FG005|Lead-in Period|Physician Decision|0|||
143326968|NCT03214367|516739970|FG006|Lead-in Period|Physician Decision|0|||
143326969|NCT03214367|516739971|FG007|Lead-in Period|Physician Decision|0|||
143326970|NCT03214367|516739964|FG000|Lead-in Period|Protocol Violation|5|||
143326971|NCT03214367|516739965|FG001|Lead-in Period|Protocol Violation|0|||
143326972|NCT03214367|516739966|FG002|Lead-in Period|Protocol Violation|0|||
143326973|NCT03214367|516739967|FG003|Lead-in Period|Protocol Violation|0|||
143326974|NCT03214367|516739968|FG004|Lead-in Period|Protocol Violation|0|||
143326975|NCT03214367|516739969|FG005|Lead-in Period|Protocol Violation|0|||
143326976|NCT03214367|516739970|FG006|Lead-in Period|Protocol Violation|0|||
143326977|NCT03214367|516739971|FG007|Lead-in Period|Protocol Violation|0|||
143326978|NCT03214367|516739964|FG000|Lead-in Period|Treatment Interruption|1|||
143326979|NCT03214367|516739965|FG001|Lead-in Period|Treatment Interruption|0|||
143326980|NCT03214367|516739966|FG002|Lead-in Period|Treatment Interruption|0|||
143326981|NCT03214367|516739967|FG003|Lead-in Period|Treatment Interruption|0|||
143326982|NCT03214367|516739968|FG004|Lead-in Period|Treatment Interruption|0|||
143326983|NCT03214367|516739969|FG005|Lead-in Period|Treatment Interruption|0|||
143326984|NCT03214367|516739970|FG006|Lead-in Period|Treatment Interruption|0|||
143326985|NCT03214367|516739971|FG007|Lead-in Period|Treatment Interruption|0|||
143326986|NCT03214367|516739964|FG000|Treatment Period|Adverse Event|0|||
143326987|NCT03214367|516739965|FG001|Treatment Period|Adverse Event|1|||
143326988|NCT03214367|516739966|FG002|Treatment Period|Adverse Event|4|||
143326989|NCT03214367|516739967|FG003|Treatment Period|Adverse Event|2|||
143326990|NCT03214367|516739968|FG004|Treatment Period|Adverse Event|0|||
143326991|NCT03214367|516739969|FG005|Treatment Period|Adverse Event|0|||
143326992|NCT03214367|516739970|FG006|Treatment Period|Adverse Event|0|||
143326993|NCT03214367|516739971|FG007|Treatment Period|Adverse Event|0|||
143326994|NCT03214367|516739964|FG000|Treatment Period|Death|0|||
143326995|NCT03214367|516739965|FG001|Treatment Period|Death|1|||
143326996|NCT03214367|516739966|FG002|Treatment Period|Death|1|||
143326997|NCT03214367|516739967|FG003|Treatment Period|Death|1|||
143326998|NCT03214367|516739968|FG004|Treatment Period|Death|0|||
143326999|NCT03214367|516739969|FG005|Treatment Period|Death|0|||
143327000|NCT03214367|516739970|FG006|Treatment Period|Death|0|||
143327001|NCT03214367|516739971|FG007|Treatment Period|Death|0|||
143327002|NCT03214367|516739964|FG000|Treatment Period|Lost to Follow-up|0|||
143327003|NCT03214367|516739965|FG001|Treatment Period|Lost to Follow-up|5|||
143327004|NCT03214367|516739966|FG002|Treatment Period|Lost to Follow-up|3|||
143327005|NCT03214367|516739967|FG003|Treatment Period|Lost to Follow-up|2|||
143327006|NCT03214367|516739968|FG004|Treatment Period|Lost to Follow-up|0|||
143327007|NCT03214367|516739969|FG005|Treatment Period|Lost to Follow-up|2|||
143327008|NCT03214367|516739970|FG006|Treatment Period|Lost to Follow-up|1|||
143327009|NCT03214367|516739971|FG007|Treatment Period|Lost to Follow-up|0|||
143327010|NCT03214367|516739964|FG000|Treatment Period|Sponsor Decision|0|||
143327011|NCT03214367|516739965|FG001|Treatment Period|Sponsor Decision|3|||
143327012|NCT03214367|516739966|FG002|Treatment Period|Sponsor Decision|0|||
143327013|NCT03214367|516739967|FG003|Treatment Period|Sponsor Decision|0|||
143327014|NCT03214367|516739968|FG004|Treatment Period|Sponsor Decision|0|||
143327015|NCT03214367|516739969|FG005|Treatment Period|Sponsor Decision|0|||
143381179|NCT03783026|516942101|FG000|Treatment Phase|Lack of Efficacy|11|||
143381180|NCT03783026|516942101|FG000|Treatment Phase|Withdrawal by Subject|6|||
143381181|NCT03783026|516942101|FG000|Treatment Phase|Lost to Follow-up|2|||
143381182|NCT03783026|516942101|FG000|Treatment Phase|Protocol Deviation|8|||
143381183|NCT03783026|516942101|FG000|Treatment Phase|Did Not Receive Treatment|1|||
143381184|NCT03783026|516942101|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
143327016|NCT03214367|516739970|FG006|Treatment Period|Sponsor Decision|0|||
143327017|NCT03214367|516739971|FG007|Treatment Period|Sponsor Decision|0|||
143327018|NCT03214367|516739964|FG000|Treatment Period|Physician Decision|0|||
143327019|NCT03214367|516739965|FG001|Treatment Period|Physician Decision|1|||
143327020|NCT03214367|516739966|FG002|Treatment Period|Physician Decision|2|||
143327021|NCT03214367|516739967|FG003|Treatment Period|Physician Decision|0|||
143327022|NCT03214367|516739968|FG004|Treatment Period|Physician Decision|0|||
143327023|NCT03214367|516739969|FG005|Treatment Period|Physician Decision|0|||
143327024|NCT03214367|516739970|FG006|Treatment Period|Physician Decision|0|||
143327025|NCT03214367|516739971|FG007|Treatment Period|Physician Decision|0|||
143327026|NCT03214367|516739964|FG000|Treatment Period|Protocol Violation|0|||
143327027|NCT03214367|516739965|FG001|Treatment Period|Protocol Violation|3|||
143327028|NCT03214367|516739966|FG002|Treatment Period|Protocol Violation|0|||
143327029|NCT03214367|516739967|FG003|Treatment Period|Protocol Violation|0|||
143327030|NCT03214367|516739968|FG004|Treatment Period|Protocol Violation|0|||
143327031|NCT03214367|516739969|FG005|Treatment Period|Protocol Violation|0|||
143327032|NCT03214367|516739970|FG006|Treatment Period|Protocol Violation|0|||
143327033|NCT03214367|516739971|FG007|Treatment Period|Protocol Violation|0|||
143327034|NCT03214367|516739964|FG000|Treatment Period|Withdrawal by Subject|0|||
143327035|NCT03214367|516739965|FG001|Treatment Period|Withdrawal by Subject|20|||
143327036|NCT03214367|516739966|FG002|Treatment Period|Withdrawal by Subject|23|||
143327037|NCT03214367|516739967|FG003|Treatment Period|Withdrawal by Subject|14|||
143327038|NCT03214367|516739968|FG004|Treatment Period|Withdrawal by Subject|0|||
143327039|NCT03214367|516739969|FG005|Treatment Period|Withdrawal by Subject|1|||
143327040|NCT03214367|516739970|FG006|Treatment Period|Withdrawal by Subject|1|||
143327041|NCT03214367|516739971|FG007|Treatment Period|Withdrawal by Subject|1|||
143327042|NCT04717596|516739972|FG000|Overall Study|Withdrawal by Subject|4|||
143327043|NCT03555396|516739973|FG000|Overall Study|Death|3|||
143327044|NCT03555396|516739974|FG001|Overall Study|Death|1|||
143327045|NCT03555396|516739973|FG000|Overall Study|Lost to Follow-up|0|||
143327046|NCT03555396|516739974|FG001|Overall Study|Lost to Follow-up|2|||
143327047|NCT02536508|516739975|FG000|Overall Study|Withdrawal by Subject|18|||
143327048|NCT02536508|516739976|FG001|Overall Study|Withdrawal by Subject|13|||
143327049|NCT02536508|516739977|FG002|Overall Study|Withdrawal by Subject|7|||
143327050|NCT02536508|516739975|FG000|Overall Study|Adverse Event|14|||
143327051|NCT02536508|516739976|FG001|Overall Study|Adverse Event|13|||
143327052|NCT02536508|516739977|FG002|Overall Study|Adverse Event|6|||
143327053|NCT02536508|516739975|FG000|Overall Study|Lost to Follow-up|12|||
143327054|NCT02536508|516739976|FG001|Overall Study|Lost to Follow-up|4|||
143327055|NCT02536508|516739977|FG002|Overall Study|Lost to Follow-up|0|||
143327056|NCT02536508|516739975|FG000|Overall Study|Lack of Efficacy|3|||
143327057|NCT02536508|516739976|FG001|Overall Study|Lack of Efficacy|5|||
143327058|NCT02536508|516739977|FG002|Overall Study|Lack of Efficacy|4|||
143327059|NCT02536508|516739975|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
143327060|NCT02536508|516739976|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
143327061|NCT02536508|516739977|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
143327062|NCT02536508|516739975|FG000|Overall Study|Physician Decision|0|||
143327063|NCT02536508|516739976|FG001|Overall Study|Physician Decision|4|||
143327064|NCT02536508|516739977|FG002|Overall Study|Physician Decision|2|||
143327065|NCT02536508|516739975|FG000|Overall Study|Major Protocol Deviation|2|||
143327066|NCT02536508|516739976|FG001|Overall Study|Major Protocol Deviation|2|||
143327067|NCT02536508|516739977|FG002|Overall Study|Major Protocol Deviation|2|||
143327068|NCT02536508|516739975|FG000|Overall Study|Administrative Reasons|0|||
143327069|NCT02536508|516739976|FG001|Overall Study|Administrative Reasons|1|||
143381185|NCT04814186|516942102|FG000|Treatment Phase|Adverse Event|1|||
143381186|NCT04814186|516942102|FG000|Treatment Phase|Death|6|||
143381187|NCT04814186|516942102|FG000|Treatment Phase|Withdrawal by Subject|2|||
143381188|NCT04814186|516942102|FG000|Treatment Phase|Other|1|||
143381189|NCT04814186|516942102|FG000|Follow-Up Phase|Adverse Event|1|||
143327070|NCT02536508|516739977|FG002|Overall Study|Administrative Reasons|0|||
143327071|NCT00434057|516739979|FG000|Overall Study|Withdrawal by Subject|1|||
143327072|NCT02473952|516739980|FG000|Overall Study|Adverse Event|2|||
143327073|NCT02473952|516739981|FG001|Overall Study|Adverse Event|2|||
143327074|NCT02473952|516739980|FG000|Overall Study|Withdrawal by Subject|0|||
143327075|NCT02473952|516739981|FG001|Overall Study|Withdrawal by Subject|6|||
143327076|NCT00455195|516739984|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
143327077|NCT00455195|516739985|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
143327078|NCT00455195|516739984|FG000|Double-blind Study AGLU02704|Death|1|||
143327079|NCT00455195|516739985|FG001|Double-blind Study AGLU02704|Death|0|||
143381190|NCT04814186|516942102|FG000|Follow-Up Phase|Death|6|||
143381191|NCT04814186|516942102|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
143327080|NCT00455195|516739984|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
143327081|NCT00455195|516739985|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
143327082|NCT00455195|516739984|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
143327083|NCT00455195|516739985|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
143327084|NCT02148250|516739988|FG000|Screening|Withdrawal by Subject|5|||
143327085|NCT02148250|516739989|FG001|Screening|Withdrawal by Subject|0|||
143327086|NCT00922428|516739992|FG000|Overall Study|retrospective/extremely implausible data|2|||
143327087|NCT00922428|516739992|FG000|Overall Study|no medication use or questionable use|13|||
143327088|NCT03701555|516739993|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
143327089|NCT03701555|516739994|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
143327090|NCT03701555|516739995|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
143327091|NCT03701555|516739996|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
143327092|NCT03701555|516739997|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
143327093|NCT03701555|516739998|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
143327094|NCT03701555|516739999|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
143327095|NCT03701555|516740000|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
143327096|NCT03701555|516740001|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
143327097|NCT03701555|516740002|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
143327098|NCT03701555|516740003|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
143327099|NCT03701555|516740004|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
143327100|NCT03701555|516740005|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
143327101|NCT03701555|516740006|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
143327102|NCT03701555|516740007|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
143327103|NCT03701555|516740008|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
143327104|NCT03701555|516740009|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
143327105|NCT03701555|516740010|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
143327106|NCT03701555|516740011|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
143327107|NCT03701555|516740012|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
143327108|NCT03701555|516740013|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
143327109|NCT03701555|516740014|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
143327110|NCT03701555|516740015|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
143327111|NCT03701555|516740016|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
143327112|NCT03701555|516740017|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
143381192|NCT04814186|516942102|FG000|Follow-Up Phase|Other|1|||
143381193|NCT04043455|516942111|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
143381194|NCT04043455|516942112|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
143381195|NCT04043455|516942113|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
143381196|NCT04043455|516942114|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
143381197|NCT04043455|516942115|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
143381198|NCT04043455|516942116|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
143381199|NCT04043455|516942111|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
143381200|NCT04043455|516942112|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
143381201|NCT04043455|516942113|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
143381202|NCT04043455|516942114|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
143381203|NCT04043455|516942115|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
143381204|NCT04043455|516942116|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
143381205|NCT04043455|516942111|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
143381206|NCT04043455|516942112|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
143381207|NCT04043455|516942113|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
143381208|NCT04043455|516942114|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
143381209|NCT04043455|516942115|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
143381210|NCT04043455|516942116|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
143381211|NCT04043455|516942111|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
143381212|NCT04043455|516942112|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
143381213|NCT04043455|516942113|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
143327113|NCT03701555|516740018|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
143327114|NCT03701555|516740019|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
143327115|NCT03701555|516740020|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
143327116|NCT03701555|516740021|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
143327117|NCT03701555|516740022|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
143327118|NCT03701555|516740023|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
143327119|NCT03701555|516740024|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
143327120|NCT03701555|516740025|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
143327121|NCT03701555|516740026|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
143327122|NCT03701555|516740027|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
143327123|NCT03701555|516740028|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
143327124|NCT03701555|516739993|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
143327125|NCT03701555|516739994|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
143327126|NCT03701555|516739995|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
143327127|NCT03701555|516739996|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
143327128|NCT03701555|516739997|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
143327129|NCT03701555|516739998|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
143327130|NCT03701555|516739999|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
143327131|NCT03701555|516740000|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
143327132|NCT03701555|516740001|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
143327133|NCT03701555|516740002|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
143327134|NCT03701555|516740003|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
143327135|NCT03701555|516740004|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
143327136|NCT03701555|516740005|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
143327137|NCT03701555|516740006|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
143327138|NCT03701555|516740007|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
143327139|NCT03701555|516740008|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
143327140|NCT03701555|516740009|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
143327141|NCT03701555|516740010|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
143327142|NCT03701555|516740011|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
143327143|NCT03701555|516740012|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
143327144|NCT03701555|516740013|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
143327145|NCT03701555|516740014|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
143327146|NCT03701555|516740015|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
143327147|NCT03701555|516740016|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
143327148|NCT03701555|516740017|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
143327149|NCT03701555|516740018|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
143327150|NCT03701555|516740019|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
143327151|NCT03701555|516740020|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
143327152|NCT03701555|516740021|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
143327153|NCT03701555|516740022|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
143327154|NCT03701555|516740023|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
143327155|NCT03701555|516740024|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
143327156|NCT03701555|516740025|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
143327157|NCT03701555|516740026|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
143327158|NCT03701555|516740027|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
143327159|NCT03701555|516740028|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
143327160|NCT03701555|516739993|FG000|Part 2 (Day 1)|Other|0|||
143327161|NCT03701555|516739994|FG001|Part 2 (Day 1)|Other|0|||
143327162|NCT03701555|516739995|FG002|Part 2 (Day 1)|Other|0|||
143327163|NCT03701555|516739996|FG003|Part 2 (Day 1)|Other|0|||
143327164|NCT03701555|516739997|FG004|Part 2 (Day 1)|Other|0|||
143327165|NCT03701555|516739998|FG005|Part 2 (Day 1)|Other|0|||
143327166|NCT03701555|516739999|FG006|Part 2 (Day 1)|Other|0|||
143327167|NCT03701555|516740000|FG007|Part 2 (Day 1)|Other|0|||
143327168|NCT03701555|516740001|FG008|Part 2 (Day 1)|Other|0|||
143327169|NCT03701555|516740002|FG009|Part 2 (Day 1)|Other|0|||
143327170|NCT03701555|516740003|FG010|Part 2 (Day 1)|Other|3|||
143327171|NCT03701555|516740004|FG011|Part 2 (Day 1)|Other|1|||
143327172|NCT03701555|516740005|FG012|Part 2 (Day 1)|Other|0|||
143327173|NCT03701555|516740006|FG013|Part 2 (Day 1)|Other|1|||
143327174|NCT03701555|516740007|FG014|Part 2 (Day 1)|Other|0|||
143327175|NCT03701555|516740008|FG015|Part 2 (Day 1)|Other|2|||
143327176|NCT03701555|516740009|FG016|Part 2 (Day 1)|Other|2|||
143327177|NCT03701555|516740010|FG017|Part 2 (Day 1)|Other|0|||
143327178|NCT03701555|516740011|FG018|Part 2 (Day 1)|Other|0|||
143327179|NCT03701555|516740012|FG019|Part 2 (Day 1)|Other|0|||
143327180|NCT03701555|516740013|FG020|Part 2 (Day 1)|Other|0|||
143327181|NCT03701555|516740014|FG021|Part 2 (Day 1)|Other|0|||
143327182|NCT03701555|516740015|FG022|Part 2 (Day 1)|Other|0|||
143327183|NCT03701555|516740016|FG023|Part 2 (Day 1)|Other|0|||
143327184|NCT03701555|516740017|FG024|Part 2 (Day 1)|Other|0|||
143327185|NCT03701555|516740018|FG025|Part 2 (Day 1)|Other|0|||
143327186|NCT03701555|516740019|FG026|Part 2 (Day 1)|Other|0|||
143327187|NCT03701555|516740020|FG027|Part 2 (Day 1)|Other|0|||
143327188|NCT03701555|516740021|FG028|Part 2 (Day 1)|Other|0|||
143327189|NCT03701555|516740022|FG029|Part 2 (Day 1)|Other|0|||
143327190|NCT03701555|516740023|FG030|Part 2 (Day 1)|Other|0|||
143327191|NCT03701555|516740024|FG031|Part 2 (Day 1)|Other|0|||
143327192|NCT03701555|516740025|FG032|Part 2 (Day 1)|Other|0|||
143327193|NCT03701555|516740026|FG033|Part 2 (Day 1)|Other|0|||
143381214|NCT04043455|516942114|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
143381215|NCT04043455|516942115|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
143381216|NCT04043455|516942116|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
143327194|NCT03701555|516740027|FG034|Part 2 (Day 1)|Other|0|||
143327195|NCT03701555|516740028|FG035|Part 2 (Day 1)|Other|0|||
143327196|NCT03701555|516739993|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
143327197|NCT03701555|516739994|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
143327198|NCT03701555|516739995|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
143327199|NCT03701555|516739996|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
143327200|NCT03701555|516739997|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
143327201|NCT03701555|516739998|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
143327202|NCT03701555|516739999|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
143327203|NCT03701555|516740000|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
143327204|NCT03701555|516740001|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
143327205|NCT03701555|516740002|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
143327206|NCT03701555|516740003|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
143327207|NCT03701555|516740004|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
143327208|NCT03701555|516740005|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
143327209|NCT03701555|516740006|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
143327210|NCT03701555|516740007|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
143327211|NCT03701555|516740008|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
143327212|NCT03701555|516740009|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
143327213|NCT03701555|516740010|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
143327214|NCT03701555|516740011|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
143327215|NCT03701555|516740012|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
143327216|NCT03701555|516740013|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
143327217|NCT03701555|516740014|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
143327218|NCT03701555|516740015|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
143327219|NCT03701555|516740016|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
143327220|NCT03701555|516740017|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
143327221|NCT03701555|516740018|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
143327222|NCT03701555|516740019|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
143327223|NCT03701555|516740020|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
143327224|NCT03701555|516740021|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
143327225|NCT03701555|516740022|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
143327226|NCT03701555|516740023|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
143327227|NCT03701555|516740024|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
143327228|NCT03701555|516740025|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
143327229|NCT03701555|516740026|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
143327230|NCT03701555|516740027|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
143327231|NCT03701555|516740028|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
143327232|NCT03701555|516739993|FG000|Part 3 (Day 1)|Subject Decision|0|||
143327233|NCT03701555|516739994|FG001|Part 3 (Day 1)|Subject Decision|0|||
143327234|NCT03701555|516739995|FG002|Part 3 (Day 1)|Subject Decision|0|||
143327235|NCT03701555|516739996|FG003|Part 3 (Day 1)|Subject Decision|0|||
143327236|NCT03701555|516739997|FG004|Part 3 (Day 1)|Subject Decision|0|||
143327237|NCT03701555|516739998|FG005|Part 3 (Day 1)|Subject Decision|0|||
143327238|NCT03701555|516739999|FG006|Part 3 (Day 1)|Subject Decision|0|||
143327239|NCT03701555|516740000|FG007|Part 3 (Day 1)|Subject Decision|0|||
143327240|NCT03701555|516740001|FG008|Part 3 (Day 1)|Subject Decision|0|||
143327241|NCT03701555|516740002|FG009|Part 3 (Day 1)|Subject Decision|0|||
143327242|NCT03701555|516740003|FG010|Part 3 (Day 1)|Subject Decision|0|||
143327243|NCT03701555|516740004|FG011|Part 3 (Day 1)|Subject Decision|0|||
143327244|NCT03701555|516740005|FG012|Part 3 (Day 1)|Subject Decision|0|||
143327245|NCT03701555|516740006|FG013|Part 3 (Day 1)|Subject Decision|0|||
143327246|NCT03701555|516740007|FG014|Part 3 (Day 1)|Subject Decision|0|||
143327247|NCT03701555|516740008|FG015|Part 3 (Day 1)|Subject Decision|0|||
143327248|NCT03701555|516740009|FG016|Part 3 (Day 1)|Subject Decision|0|||
143327249|NCT03701555|516740010|FG017|Part 3 (Day 1)|Subject Decision|0|||
143327250|NCT03701555|516740011|FG018|Part 3 (Day 1)|Subject Decision|0|||
143327251|NCT03701555|516740012|FG019|Part 3 (Day 1)|Subject Decision|0|||
143327252|NCT03701555|516740013|FG020|Part 3 (Day 1)|Subject Decision|0|||
143381217|NCT04043455|516942111|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
143381218|NCT04043455|516942112|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
143327253|NCT03701555|516740014|FG021|Part 3 (Day 1)|Subject Decision|0|||
143327254|NCT03701555|516740015|FG022|Part 3 (Day 1)|Subject Decision|0|||
143327255|NCT03701555|516740016|FG023|Part 3 (Day 1)|Subject Decision|0|||
143327256|NCT03701555|516740017|FG024|Part 3 (Day 1)|Subject Decision|0|||
143454273|NCT00948766|517208181|FG000|Core Study|Lost to Follow-up|3|||
143327257|NCT03701555|516740018|FG025|Part 3 (Day 1)|Subject Decision|0|||
143327258|NCT03701555|516740019|FG026|Part 3 (Day 1)|Subject Decision|1|||
143327259|NCT03701555|516740020|FG027|Part 3 (Day 1)|Subject Decision|0|||
143327260|NCT03701555|516740021|FG028|Part 3 (Day 1)|Subject Decision|0|||
143327261|NCT03701555|516740022|FG029|Part 3 (Day 1)|Subject Decision|0|||
143327262|NCT03701555|516740023|FG030|Part 3 (Day 1)|Subject Decision|0|||
143327263|NCT03701555|516740024|FG031|Part 3 (Day 1)|Subject Decision|2|||
143327264|NCT03701555|516740025|FG032|Part 3 (Day 1)|Subject Decision|1|||
143381219|NCT04043455|516942113|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
143381220|NCT04043455|516942114|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
143381221|NCT04043455|516942115|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
143381222|NCT04043455|516942116|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
143381223|NCT04043455|516942111|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
143381224|NCT04043455|516942112|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
143381225|NCT04043455|516942113|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
143381226|NCT04043455|516942114|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
143381227|NCT04043455|516942115|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
143381228|NCT04043455|516942116|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
143381229|NCT04043455|516942111|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
143381230|NCT04043455|516942112|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
143381231|NCT04043455|516942113|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
143381232|NCT04043455|516942114|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
143381233|NCT04043455|516942115|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
143381234|NCT04043455|516942116|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
143381235|NCT04043455|516942111|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
143381236|NCT04043455|516942112|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
143381237|NCT04043455|516942113|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
143381238|NCT04043455|516942114|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
143381239|NCT04043455|516942115|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
143381240|NCT04043455|516942116|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
143381241|NCT04043455|516942111|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
143381242|NCT04043455|516942112|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
143381243|NCT04043455|516942113|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
143381244|NCT04043455|516942114|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
143381245|NCT04043455|516942115|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
143381246|NCT04043455|516942116|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
143381247|NCT04043455|516942111|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
143381248|NCT04043455|516942112|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
143381249|NCT04043455|516942113|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
143381250|NCT04043455|516942114|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
143381251|NCT04043455|516942115|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
143381252|NCT04043455|516942116|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
143381253|NCT04043455|516942111|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
143381254|NCT04043455|516942112|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
143381255|NCT04043455|516942113|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
143381256|NCT04043455|516942114|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
143381257|NCT04043455|516942115|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
143381258|NCT04043455|516942116|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
143381259|NCT01600014|516942119|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
143381260|NCT01600014|516942120|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
143381261|NCT01600014|516942119|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
143381262|NCT01600014|516942120|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
143381263|NCT01600014|516942119|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
143327265|NCT03701555|516740026|FG033|Part 3 (Day 1)|Subject Decision|1|||
143327266|NCT03701555|516740027|FG034|Part 3 (Day 1)|Subject Decision|0|||
143327267|NCT03701555|516740028|FG035|Part 3 (Day 1)|Subject Decision|0|||
143327268|NCT03701555|516739993|FG000|Part 3 (Day 1)|Other|0|||
143327269|NCT03701555|516739994|FG001|Part 3 (Day 1)|Other|0|||
143327270|NCT03701555|516739995|FG002|Part 3 (Day 1)|Other|0|||
143327271|NCT03701555|516739996|FG003|Part 3 (Day 1)|Other|0|||
143327272|NCT03701555|516739997|FG004|Part 3 (Day 1)|Other|0|||
143327273|NCT03701555|516739998|FG005|Part 3 (Day 1)|Other|0|||
143327274|NCT03701555|516739999|FG006|Part 3 (Day 1)|Other|0|||
143327275|NCT03701555|516740000|FG007|Part 3 (Day 1)|Other|0|||
143327276|NCT03701555|516740001|FG008|Part 3 (Day 1)|Other|0|||
143327277|NCT03701555|516740002|FG009|Part 3 (Day 1)|Other|0|||
143327278|NCT03701555|516740003|FG010|Part 3 (Day 1)|Other|0|||
143327279|NCT03701555|516740004|FG011|Part 3 (Day 1)|Other|0|||
143327280|NCT03701555|516740005|FG012|Part 3 (Day 1)|Other|0|||
143327281|NCT03701555|516740006|FG013|Part 3 (Day 1)|Other|0|||
143327282|NCT03701555|516740007|FG014|Part 3 (Day 1)|Other|0|||
143327283|NCT03701555|516740008|FG015|Part 3 (Day 1)|Other|0|||
143327284|NCT03701555|516740009|FG016|Part 3 (Day 1)|Other|0|||
143327285|NCT03701555|516740010|FG017|Part 3 (Day 1)|Other|0|||
143327286|NCT03701555|516740011|FG018|Part 3 (Day 1)|Other|0|||
143327287|NCT03701555|516740012|FG019|Part 3 (Day 1)|Other|0|||
143327288|NCT03701555|516740013|FG020|Part 3 (Day 1)|Other|0|||
143327289|NCT03701555|516740014|FG021|Part 3 (Day 1)|Other|0|||
143327290|NCT03701555|516740015|FG022|Part 3 (Day 1)|Other|0|||
143327291|NCT03701555|516740016|FG023|Part 3 (Day 1)|Other|0|||
143327292|NCT03701555|516740017|FG024|Part 3 (Day 1)|Other|1|||
143327293|NCT03701555|516740018|FG025|Part 3 (Day 1)|Other|1|||
143327294|NCT03701555|516740019|FG026|Part 3 (Day 1)|Other|0|||
143327295|NCT03701555|516740020|FG027|Part 3 (Day 1)|Other|0|||
143327296|NCT03701555|516740021|FG028|Part 3 (Day 1)|Other|0|||
143327297|NCT03701555|516740022|FG029|Part 3 (Day 1)|Other|1|||
143327298|NCT03701555|516740023|FG030|Part 3 (Day 1)|Other|1|||
143327299|NCT03701555|516740024|FG031|Part 3 (Day 1)|Other|0|||
143327300|NCT03701555|516740025|FG032|Part 3 (Day 1)|Other|1|||
143327301|NCT03701555|516740026|FG033|Part 3 (Day 1)|Other|1|||
143327302|NCT03701555|516740027|FG034|Part 3 (Day 1)|Other|0|||
143327303|NCT03701555|516740028|FG035|Part 3 (Day 1)|Other|0|||
143327304|NCT02508311|516740031|FG000|Overall Study|Withdrawal by Subject|1|||
143327305|NCT02508311|516740032|FG001|Overall Study|Withdrawal by Subject|0|||
143327306|NCT00448539|516740033|FG000|Overall Study|Medication non-compliance|4|||
143327307|NCT00448539|516740034|FG001|Overall Study|Medication non-compliance|1|||
143327308|NCT00448539|516740033|FG000|Overall Study|Protocol Violation|1|||
143327309|NCT00448539|516740034|FG001|Overall Study|Protocol Violation|0|||
143327310|NCT00448539|516740033|FG000|Overall Study|Request of the investigator or sponsor|67|||
143327311|NCT00448539|516740034|FG001|Overall Study|Request of the investigator or sponsor|54|||
143327312|NCT00448539|516740033|FG000|Overall Study|Withdrawal by Subject|20|||
143327313|NCT00448539|516740034|FG001|Overall Study|Withdrawal by Subject|24|||
143327314|NCT00448539|516740033|FG000|Overall Study|Diary non-compliance|1|||
143327315|NCT00448539|516740034|FG001|Overall Study|Diary non-compliance|0|||
143327316|NCT00448539|516740033|FG000|Overall Study|Adverse Event|9|||
143327317|NCT00448539|516740034|FG001|Overall Study|Adverse Event|26|||
143327318|NCT00448539|516740033|FG000|Overall Study|Lack of Efficacy|27|||
143327319|NCT00448539|516740034|FG001|Overall Study|Lack of Efficacy|40|||
143327320|NCT00448539|516740033|FG000|Overall Study|Miscellaneous|2|||
143327321|NCT00448539|516740034|FG001|Overall Study|Miscellaneous|1|||
143327322|NCT00448539|516740033|FG000|Overall Study|Change of meds|2|||
143327323|NCT00448539|516740034|FG001|Overall Study|Change of meds|3|||
143327324|NCT00448539|516740033|FG000|Overall Study|Lost to Follow-up|1|||
143327325|NCT00448539|516740034|FG001|Overall Study|Lost to Follow-up|3|||
143327326|NCT00695903|516740035|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
143327327|NCT00695903|516740036|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
143327328|NCT00695903|516740035|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
143327329|NCT00695903|516740036|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
143327330|NCT00695903|516740035|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
143327331|NCT00695903|516740036|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
143327332|NCT00695903|516740035|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
143327333|NCT00695903|516740036|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
143327334|NCT00695903|516740035|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
143327335|NCT00695903|516740036|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
143327336|NCT00695903|516740035|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
143327337|NCT00695903|516740036|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
143327338|NCT00695903|516740035|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
143327339|NCT00695903|516740036|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
143327340|NCT00695903|516740035|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
143327341|NCT00695903|516740036|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
143327342|NCT00695903|516740035|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
143327343|NCT00695903|516740036|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
143327344|NCT01059565|516740039|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
143327345|NCT01059565|516740040|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
143327346|NCT01059565|516740039|FG000|24-Week Randomized Phase|Adverse Event|5|||
143327347|NCT01059565|516740040|FG001|24-Week Randomized Phase|Adverse Event|0|||
143327348|NCT01059565|516740039|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
143327349|NCT01059565|516740040|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
143327350|NCT01059565|516740039|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
143327351|NCT01059565|516740040|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
143327352|NCT01059565|516740039|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
143327353|NCT01059565|516740040|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
143327354|NCT01059565|516740039|FG000|24-Week Open-Label Phase|Adverse Event|2|||
143327355|NCT01059565|516740040|FG001|24-Week Open-Label Phase|Adverse Event|0|||
143327356|NCT01059565|516740039|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
143327357|NCT01059565|516740040|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
143327358|NCT01059565|516740039|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
143327359|NCT01059565|516740040|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
143327360|NCT01059565|516740039|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
143327361|NCT01059565|516740040|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
143327362|NCT01059565|516740039|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
143327363|NCT01059565|516740040|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
143327364|NCT01059565|516740039|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
143327365|NCT01059565|516740040|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
143327366|NCT03927950|516740041|FG000|Overall Study|Adverse Event|9|||
143327367|NCT00121238|516740042|FG000|Overall Study|disease progression before intervention|1|||
143327368|NCT00121238|516740042|FG000|Overall Study|Protocol Violation|2|||
143327369|NCT03579563|516740044|FG000|Overall Study|Lost to Follow-up|0|||
143327370|NCT03579563|516740045|FG001|Overall Study|Lost to Follow-up|0|||
143327371|NCT03579563|516740046|FG002|Overall Study|Lost to Follow-up|0|||
143327372|NCT03579563|516740047|FG003|Overall Study|Lost to Follow-up|0|||
143327373|NCT03579563|516740048|FG004|Overall Study|Lost to Follow-up|1|||
143327374|NCT03579563|516740049|FG005|Overall Study|Lost to Follow-up|0|||
143327375|NCT03579563|516740044|FG000|Overall Study|Lack of Efficacy|1|||
143327376|NCT03579563|516740045|FG001|Overall Study|Lack of Efficacy|1|||
143327377|NCT03579563|516740046|FG002|Overall Study|Lack of Efficacy|4|||
143327378|NCT03579563|516740047|FG003|Overall Study|Lack of Efficacy|1|||
143327379|NCT03579563|516740048|FG004|Overall Study|Lack of Efficacy|2|||
143327380|NCT03579563|516740049|FG005|Overall Study|Lack of Efficacy|3|||
143327381|NCT03579563|516740044|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
143327382|NCT03579563|516740045|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
143327383|NCT03579563|516740046|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
143327384|NCT03579563|516740047|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
143327385|NCT03579563|516740048|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
143327386|NCT03579563|516740049|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
143327387|NCT03579563|516740044|FG000|Overall Study|Time/distance concern|0|||
143327388|NCT03579563|516740045|FG001|Overall Study|Time/distance concern|0|||
143327389|NCT03579563|516740046|FG002|Overall Study|Time/distance concern|1|||
143327390|NCT03579563|516740047|FG003|Overall Study|Time/distance concern|0|||
143327391|NCT03579563|516740048|FG004|Overall Study|Time/distance concern|0|||
143327392|NCT03579563|516740049|FG005|Overall Study|Time/distance concern|1|||
143327393|NCT03579563|516740044|FG000|Overall Study|COVID shutdown|2|||
143327394|NCT03579563|516740045|FG001|Overall Study|COVID shutdown|3|||
143327395|NCT03579563|516740046|FG002|Overall Study|COVID shutdown|4|||
143327396|NCT03579563|516740047|FG003|Overall Study|COVID shutdown|3|||
143327397|NCT03579563|516740048|FG004|Overall Study|COVID shutdown|1|||
143327398|NCT03579563|516740049|FG005|Overall Study|COVID shutdown|2|||
143327399|NCT03579563|516740044|FG000|Overall Study|Protocol administration error|1|||
143327400|NCT03579563|516740045|FG001|Overall Study|Protocol administration error|0|||
143327401|NCT03579563|516740046|FG002|Overall Study|Protocol administration error|1|||
143327402|NCT03579563|516740047|FG003|Overall Study|Protocol administration error|0|||
143327403|NCT03579563|516740048|FG004|Overall Study|Protocol administration error|1|||
143327404|NCT03579563|516740049|FG005|Overall Study|Protocol administration error|5|||
143327405|NCT03621696|516740050|FG000|Overall Study|Not eligible|0|||
143327406|NCT03621696|516740051|FG001|Overall Study|Not eligible|0|||
143327407|NCT03621696|516740052|FG002|Overall Study|Not eligible|0|||
143327408|NCT03621696|516740053|FG003|Overall Study|Not eligible|5|||
143327409|NCT03621696|516740050|FG000|Overall Study|Withdrawal by Subject|1|||
143327410|NCT03621696|516740051|FG001|Overall Study|Withdrawal by Subject|1|||
143327411|NCT03621696|516740052|FG002|Overall Study|Withdrawal by Subject|1|||
143327412|NCT03621696|516740053|FG003|Overall Study|Withdrawal by Subject|0|||
143327413|NCT03621696|516740050|FG000|Overall Study|Physician Decision|0|||
143327414|NCT03621696|516740051|FG001|Overall Study|Physician Decision|0|||
143327415|NCT03621696|516740052|FG002|Overall Study|Physician Decision|1|||
143327416|NCT03621696|516740053|FG003|Overall Study|Physician Decision|0|||
143327417|NCT01715805|516740054|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
143327418|NCT01715805|516740055|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
143327419|NCT01715805|516740056|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
143327420|NCT01715805|516740057|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
143327421|NCT01715805|516740054|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
143327422|NCT01715805|516740055|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
143327423|NCT01715805|516740056|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
143327424|NCT01715805|516740057|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
143327425|NCT01715805|516740054|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
143327426|NCT01715805|516740055|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
143327427|NCT01715805|516740056|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
143381264|NCT01600014|516942120|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
143381265|NCT01600014|516942119|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
143327428|NCT01715805|516740057|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
143327429|NCT01715805|516740054|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
143381266|NCT01600014|516942120|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
143381267|NCT01600014|516942119|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
143381268|NCT01600014|516942120|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
143381269|NCT01600014|516942119|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
143381270|NCT01600014|516942120|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
143381271|NCT01600014|516942119|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
143381272|NCT01600014|516942120|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
143381273|NCT01600014|516942119|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
143381274|NCT01600014|516942120|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
143381275|NCT01600014|516942119|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
143381276|NCT01600014|516942120|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
143381277|NCT01600014|516942119|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
143381278|NCT01600014|516942120|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
143381279|NCT01600014|516942119|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
143381280|NCT01600014|516942120|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
143381281|NCT01600014|516942119|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
143381282|NCT01600014|516942120|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
143381283|NCT01600014|516942119|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
143381284|NCT01600014|516942120|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
143381285|NCT01600014|516942119|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
143381286|NCT01600014|516942120|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
143381287|NCT01600014|516942119|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
143381288|NCT01600014|516942120|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
143381289|NCT01600014|516942119|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
143327430|NCT01715805|516740055|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
143327431|NCT01715805|516740056|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
143327432|NCT01715805|516740057|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
143327433|NCT01715805|516740054|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
143327434|NCT01715805|516740055|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
143327435|NCT01715805|516740056|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
143327436|NCT01715805|516740057|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
143327437|NCT01715805|516740054|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
143327438|NCT01715805|516740055|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
143327439|NCT01715805|516740056|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
143327440|NCT01715805|516740057|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
143327441|NCT01715805|516740054|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
143327442|NCT01715805|516740055|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
143327443|NCT01715805|516740056|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
143327444|NCT01715805|516740057|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
143327445|NCT01715805|516740054|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
143327446|NCT01715805|516740055|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
143327447|NCT01715805|516740056|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
143327448|NCT01715805|516740057|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
143327449|NCT01715805|516740054|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
143327450|NCT01715805|516740055|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
143327451|NCT01715805|516740056|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
143327452|NCT01715805|516740057|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
143327453|NCT01715805|516740054|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
143327454|NCT01715805|516740055|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
143327455|NCT01715805|516740056|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
143327456|NCT01715805|516740057|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
143327457|NCT01715805|516740054|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
143327458|NCT01715805|516740055|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
143327459|NCT01715805|516740056|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
143327460|NCT01715805|516740057|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
143327461|NCT01715805|516740054|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
143327462|NCT01715805|516740055|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
143327463|NCT01715805|516740056|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
143327464|NCT01715805|516740057|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
143327465|NCT01715805|516740054|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
143381290|NCT01600014|516942120|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
143381291|NCT01600014|516942119|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
143381292|NCT01600014|516942120|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
143381293|NCT02879448|516942121|FG000|Overall Study|Death|251|||
143381294|NCT02879448|516942122|FG001|Overall Study|Death|263|||
143381295|NCT02879448|516942121|FG000|Overall Study|Lost to Follow-up|23|||
143381296|NCT02879448|516942122|FG001|Overall Study|Lost to Follow-up|28|||
143381297|NCT02879448|516942121|FG000|Overall Study|Withdrawal by Subject|42|||
143381298|NCT02879448|516942122|FG001|Overall Study|Withdrawal by Subject|79|||
143381299|NCT02879448|516942121|FG000|Overall Study|Other Reasons|8|||
143381300|NCT02879448|516942122|FG001|Overall Study|Other Reasons|12|||
143381301|NCT02300298|516942123|FG000|Disposition for Nintedanib|Progressive disease|10|||
143381302|NCT02300298|516942124|FG001|Disposition for Nintedanib|Progressive disease|0|||
143381303|NCT02300298|516942123|FG000|Disposition for Docetaxel|Progressive disease|0|||
143381304|NCT02300298|516942124|FG001|Disposition for Docetaxel|Progressive disease|6|||
143381305|NCT02300298|516942123|FG000|Disposition for Docetaxel|other adverse event|0|||
143381306|NCT02300298|516942124|FG001|Disposition for Docetaxel|other adverse event|4|||
143381307|NCT03285763|516942125|FG000|Overall Study|Death|470|||
143381308|NCT03285763|516942125|FG000|Overall Study|Lost to Follow-up|18|||
143381309|NCT03285763|516942125|FG000|Overall Study|Physician Decision|2|||
143381310|NCT03285763|516942125|FG000|Overall Study|Study Terminated By Sponsor|79|||
143381311|NCT03285763|516942125|FG000|Overall Study|Withdrawal by Subject|33|||
143381312|NCT03990649|516942126|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
143381313|NCT03990649|516942127|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
143381314|NCT03990649|516942128|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
143381315|NCT03990649|516942126|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
143381316|NCT03990649|516942127|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
143381317|NCT03990649|516942128|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
143381318|NCT03990649|516942126|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
143381319|NCT03990649|516942127|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
143381320|NCT03990649|516942128|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
143381321|NCT03990649|516942126|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
143381322|NCT03990649|516942127|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
143381323|NCT03990649|516942128|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
143381324|NCT03990649|516942126|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
143381325|NCT03990649|516942127|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
143381326|NCT03990649|516942128|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
143381327|NCT03990649|516942126|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
143381328|NCT03990649|516942127|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
143381329|NCT03990649|516942128|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
143381330|NCT03990649|516942126|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
143381331|NCT03990649|516942127|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
143381332|NCT03990649|516942128|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
143381333|NCT05773313|516942129|FG000|Overall Study|Lost to Follow-up|3|||
143381334|NCT03050814|516942130|FG000|Overall Study|Screen failures|0|||
143381335|NCT03050814|516942131|FG001|Overall Study|Screen failures|0|||
143381336|NCT03050814|516942132|FG002|Overall Study|Screen failures|4|||
143381337|NCT01443845|516942136|FG000|Overall Study|Protocol Violation|43|||
143381338|NCT01443845|516942137|FG001|Overall Study|Protocol Violation|45|||
143381339|NCT01443845|516942136|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
143381340|NCT01443845|516942137|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
143381341|NCT01443845|516942136|FG000|Overall Study|Deterioration in pulmonary function|1|||
143381342|NCT01443845|516942137|FG001|Overall Study|Deterioration in pulmonary function|4|||
143381343|NCT01443845|516942136|FG000|Overall Study|Lack of Efficacy|10|||
143381344|NCT01443845|516942137|FG001|Overall Study|Lack of Efficacy|5|||
143381345|NCT01443845|516942136|FG000|Overall Study|Adverse Event|64|||
143381346|NCT01443845|516942137|FG001|Overall Study|Adverse Event|138|||
143381347|NCT01443845|516942136|FG000|Overall Study|Withdrawal by Subject|63|||
143381348|NCT01443845|516942137|FG001|Overall Study|Withdrawal by Subject|67|||
143381349|NCT01443845|516942136|FG000|Overall Study|Military Conflict - Site Terminated|20|||
143381350|NCT01443845|516942137|FG001|Overall Study|Military Conflict - Site Terminated|21|||
143381351|NCT01443845|516942136|FG000|Overall Study|Lost to Follow-up|9|||
143381352|NCT01443845|516942137|FG001|Overall Study|Lost to Follow-up|13|||
143381353|NCT00402246|516942138|FG000|Overall Study|Death|62|||
143381354|NCT00402246|516942139|FG001|Overall Study|Death|58|||
143381355|NCT00402246|516942138|FG000|Overall Study|Lost to Follow-up|20|||
143381356|NCT00402246|516942139|FG001|Overall Study|Lost to Follow-up|28|||
143381357|NCT00402246|516942138|FG000|Overall Study|Withdrawal by Subject|72|||
143381358|NCT00402246|516942139|FG001|Overall Study|Withdrawal by Subject|87|||
143381359|NCT00402246|516942138|FG000|Overall Study|Physician Decision|24|||
143381360|NCT00402246|516942139|FG001|Overall Study|Physician Decision|26|||
143381361|NCT00402246|516942138|FG000|Overall Study|Protocol Violation|25|||
143381362|NCT00402246|516942139|FG001|Overall Study|Protocol Violation|24|||
143381363|NCT00402246|516942138|FG000|Overall Study|Missed Final Visit|1|||
143327466|NCT01715805|516740055|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
143327467|NCT01715805|516740056|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
143327468|NCT01715805|516740057|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
143327469|NCT01715805|516740054|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
143327470|NCT01715805|516740055|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
143381364|NCT00402246|516942139|FG001|Overall Study|Missed Final Visit|2|||
143381365|NCT00402246|516942138|FG000|Overall Study|Insurance Issues|2|||
143327471|NCT01715805|516740056|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
143327472|NCT01715805|516740057|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
143327473|NCT02372396|516740064|FG000|Overall Study|Lost to Follow-up|7|||
143327474|NCT02372396|516740065|FG001|Overall Study|Lost to Follow-up|9|||
143327475|NCT01272934|516740066|FG000|Overall Study|Adverse Event|0|||
143327476|NCT01272934|516740067|FG001|Overall Study|Adverse Event|1|||
143327477|NCT01272934|516740066|FG000|Overall Study|Abnormal Laboratory Value|0|||
143327478|NCT01272934|516740067|FG001|Overall Study|Abnormal Laboratory Value|1|||
143327479|NCT04313634|516740068|FG000|Overall Study|Adverse Event|2|||
143327480|NCT04313634|516740069|FG001|Overall Study|Adverse Event|2|||
143327481|NCT04313634|516740070|FG002|Overall Study|Adverse Event|0|||
143327482|NCT04313634|516740068|FG000|Overall Study|Withdrawal by Subject|1|||
143327483|NCT04313634|516740069|FG001|Overall Study|Withdrawal by Subject|0|||
143381366|NCT00402246|516942139|FG001|Overall Study|Insurance Issues|1|||
143381367|NCT00402246|516942138|FG000|Overall Study|Heart Transplant|0|||
143381368|NCT00402246|516942139|FG001|Overall Study|Heart Transplant|1|||
143381369|NCT00402246|516942138|FG000|Overall Study|Patient's device explanted|6|||
143381370|NCT00402246|516942139|FG001|Overall Study|Patient's device explanted|2|||
143381371|NCT00402246|516942138|FG000|Overall Study|Center Closure|5|||
143381372|NCT00402246|516942139|FG001|Overall Study|Center Closure|3|||
143381373|NCT00402246|516942138|FG000|Overall Study|Deterioriating Condition|3|||
143381374|NCT00402246|516942139|FG001|Overall Study|Deterioriating Condition|2|||
143381375|NCT00818246|516942146|FG000|Overall Study|Impossible to match pictures|5|||
143381376|NCT00296036|516942147|FG000|Overall Study|Withdrawal by Subject|1|||
143381377|NCT00296036|516942148|FG001|Overall Study|Withdrawal by Subject|0|||
143381378|NCT00296036|516942149|FG002|Overall Study|Withdrawal by Subject|2|||
143381379|NCT00296036|516942150|FG003|Overall Study|Withdrawal by Subject|1|||
143381380|NCT00296036|516942151|FG004|Overall Study|Withdrawal by Subject|2|||
143381381|NCT00296036|516942152|FG005|Overall Study|Withdrawal by Subject|1|||
143381382|NCT00296036|516942147|FG000|Overall Study|Protocol Violation|0|||
143327484|NCT04313634|516740070|FG002|Overall Study|Withdrawal by Subject|1|||
143327485|NCT04313634|516740068|FG000|Overall Study|Protocol Violation|0|||
143327486|NCT04313634|516740069|FG001|Overall Study|Protocol Violation|0|||
143327487|NCT04313634|516740070|FG002|Overall Study|Protocol Violation|1|||
143327488|NCT03273946|516740085|FG000|Overall Study|Withdrawal by Subject|5|||
143327489|NCT03273946|516740085|FG000|Overall Study|Unwillingness of the guardian|1|||
143327490|NCT03273946|516740085|FG000|Overall Study|Participant refused to use the drug|2|||
143327491|NCT03273946|516740085|FG000|Overall Study|Participant relative refused to use drug|1|||
143327492|NCT00718718|516740086|FG000|Prior to Week 12|Adverse Event|0|||
143327493|NCT00718718|516740087|FG001|Prior to Week 12|Adverse Event|0|||
143327494|NCT00718718|516740088|FG002|Prior to Week 12|Adverse Event|0|||
143327495|NCT00718718|516740089|FG003|Prior to Week 12|Adverse Event|0|||
143327496|NCT00718718|516740090|FG004|Prior to Week 12|Adverse Event|0|||
143327497|NCT00718718|516740091|FG005|Prior to Week 12|Adverse Event|0|||
143327498|NCT00718718|516740092|FG006|Prior to Week 12|Adverse Event|0|||
143327499|NCT00718718|516740093|FG007|Prior to Week 12|Adverse Event|1|||
143327500|NCT00718718|516740094|FG008|Prior to Week 12|Adverse Event|1|||
143327501|NCT00718718|516740095|FG009|Prior to Week 12|Adverse Event|0|||
143327502|NCT00718718|516740086|FG000|Prior to Week 12|Withdrawal by Subject|0|||
143327503|NCT00718718|516740087|FG001|Prior to Week 12|Withdrawal by Subject|0|||
143327504|NCT00718718|516740088|FG002|Prior to Week 12|Withdrawal by Subject|0|||
143327505|NCT00718718|516740089|FG003|Prior to Week 12|Withdrawal by Subject|0|||
143381383|NCT00296036|516942148|FG001|Overall Study|Protocol Violation|0|||
143381384|NCT00296036|516942149|FG002|Overall Study|Protocol Violation|0|||
143381385|NCT00296036|516942150|FG003|Overall Study|Protocol Violation|0|||
143381386|NCT00296036|516942151|FG004|Overall Study|Protocol Violation|0|||
143381387|NCT00296036|516942152|FG005|Overall Study|Protocol Violation|3|||
143381388|NCT03403413|516942153|FG000|Overall Study|Lack of Efficacy|2|||
143381389|NCT03655262|516942154|FG000|Overall Study|Withdrawal by Subject|0|||
143381390|NCT03655262|516942155|FG001|Overall Study|Withdrawal by Subject|0|||
143381391|NCT03655262|516942156|FG002|Overall Study|Withdrawal by Subject|1|||
143381392|NCT00567489|516942158|FG000|Overall Study|Adverse Event|6|||
143381393|NCT00567489|516942159|FG001|Overall Study|Adverse Event|14|||
143381394|NCT00567489|516942158|FG000|Overall Study|Physician Decision|0|||
143381395|NCT00567489|516942159|FG001|Overall Study|Physician Decision|4|||
143381396|NCT00567489|516942158|FG000|Overall Study|Withdrawal by Subject|0|||
143381397|NCT00567489|516942159|FG001|Overall Study|Withdrawal by Subject|2|||
143327506|NCT00718718|516740090|FG004|Prior to Week 12|Withdrawal by Subject|3|||
143327507|NCT00718718|516740091|FG005|Prior to Week 12|Withdrawal by Subject|0|||
143327508|NCT00718718|516740092|FG006|Prior to Week 12|Withdrawal by Subject|1|||
143327509|NCT00718718|516740093|FG007|Prior to Week 12|Withdrawal by Subject|1|||
143327510|NCT00718718|516740094|FG008|Prior to Week 12|Withdrawal by Subject|1|||
143327511|NCT00718718|516740095|FG009|Prior to Week 12|Withdrawal by Subject|0|||
143327512|NCT00718718|516740086|FG000|Prior to Week 12|Other|1|||
143327513|NCT00718718|516740087|FG001|Prior to Week 12|Other|0|||
143327514|NCT00718718|516740088|FG002|Prior to Week 12|Other|1|||
143327515|NCT00718718|516740089|FG003|Prior to Week 12|Other|0|||
143327516|NCT00718718|516740090|FG004|Prior to Week 12|Other|0|||
143327517|NCT00718718|516740091|FG005|Prior to Week 12|Other|0|||
143327518|NCT00718718|516740092|FG006|Prior to Week 12|Other|0|||
143327519|NCT00718718|516740093|FG007|Prior to Week 12|Other|0|||
143327520|NCT00718718|516740094|FG008|Prior to Week 12|Other|0|||
143327521|NCT00718718|516740095|FG009|Prior to Week 12|Other|0|||
143327522|NCT00718718|516740086|FG000|Week 12 to End of Study|Adverse Event|0|||
143327523|NCT00718718|516740087|FG001|Week 12 to End of Study|Adverse Event|0|||
143327524|NCT00718718|516740088|FG002|Week 12 to End of Study|Adverse Event|0|||
143327525|NCT00718718|516740089|FG003|Week 12 to End of Study|Adverse Event|0|||
143327526|NCT00718718|516740090|FG004|Week 12 to End of Study|Adverse Event|0|||
143327527|NCT00718718|516740091|FG005|Week 12 to End of Study|Adverse Event|0|||
143327528|NCT00718718|516740092|FG006|Week 12 to End of Study|Adverse Event|0|||
143327529|NCT00718718|516740093|FG007|Week 12 to End of Study|Adverse Event|1|||
143327530|NCT00718718|516740094|FG008|Week 12 to End of Study|Adverse Event|0|||
143327531|NCT00718718|516740095|FG009|Week 12 to End of Study|Adverse Event|0|||
143327532|NCT00718718|516740086|FG000|Week 12 to End of Study|Death|0|||
143327533|NCT00718718|516740087|FG001|Week 12 to End of Study|Death|0|||
143327534|NCT00718718|516740088|FG002|Week 12 to End of Study|Death|0|||
143327535|NCT00718718|516740089|FG003|Week 12 to End of Study|Death|0|||
143327536|NCT00718718|516740090|FG004|Week 12 to End of Study|Death|0|||
143327537|NCT00718718|516740091|FG005|Week 12 to End of Study|Death|1|||
143327538|NCT00718718|516740092|FG006|Week 12 to End of Study|Death|0|||
143327539|NCT00718718|516740093|FG007|Week 12 to End of Study|Death|0|||
143327540|NCT00718718|516740094|FG008|Week 12 to End of Study|Death|0|||
143327541|NCT00718718|516740095|FG009|Week 12 to End of Study|Death|0|||
143327542|NCT00718718|516740086|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
143327543|NCT00718718|516740087|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
143327544|NCT00718718|516740088|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
143327545|NCT00718718|516740089|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
143327546|NCT00718718|516740090|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
143327547|NCT00718718|516740091|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
143327548|NCT00718718|516740092|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
143327549|NCT00718718|516740093|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
143327550|NCT00718718|516740094|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
143327551|NCT00718718|516740095|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
143327552|NCT00718718|516740086|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
143327553|NCT00718718|516740087|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
143327554|NCT00718718|516740088|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
143327555|NCT00718718|516740089|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
143327556|NCT00718718|516740090|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
143327557|NCT00718718|516740091|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
143327558|NCT00718718|516740092|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
143327559|NCT00718718|516740093|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
143327560|NCT00718718|516740094|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
143327561|NCT00718718|516740095|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
143327562|NCT00718718|516740086|FG000|Week 12 to End of Study|Other|0|||
143327563|NCT00718718|516740087|FG001|Week 12 to End of Study|Other|1|||
143381398|NCT00567489|516942158|FG000|Overall Study|Renal Transplantation|0|||
143381399|NCT00567489|516942159|FG001|Overall Study|Renal Transplantation|3|||
143381400|NCT00567489|516942158|FG000|Overall Study|Other|1|||
143327564|NCT00718718|516740088|FG002|Week 12 to End of Study|Other|0|||
143327565|NCT00718718|516740089|FG003|Week 12 to End of Study|Other|1|||
143327566|NCT00718718|516740090|FG004|Week 12 to End of Study|Other|0|||
143327567|NCT00718718|516740091|FG005|Week 12 to End of Study|Other|0|||
143327568|NCT00718718|516740092|FG006|Week 12 to End of Study|Other|1|||
143327569|NCT00718718|516740093|FG007|Week 12 to End of Study|Other|0|||
143327570|NCT00718718|516740094|FG008|Week 12 to End of Study|Other|0|||
143327571|NCT00718718|516740095|FG009|Week 12 to End of Study|Other|0|||
143327572|NCT01358526|516740108|FG000|Open-label Titration Period|Adverse Event|95|||
143327573|NCT01358526|516740109|FG001|Open-label Titration Period|Adverse Event|0|||
143327574|NCT01358526|516740110|FG002|Open-label Titration Period|Adverse Event|0|||
143327575|NCT01358526|516740108|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
143381401|NCT00567489|516942159|FG001|Overall Study|Other|0|||
143381402|NCT00068601|516942161|FG000|Overall Study|Ineligible|11|||
143381403|NCT00068601|516942162|FG001|Overall Study|Ineligible|13|||
143381404|NCT00068601|516942161|FG000|Overall Study|Not evaluable: withdrew consent|5|||
143381405|NCT00068601|516942162|FG001|Overall Study|Not evaluable: withdrew consent|4|||
143381406|NCT00068601|516942161|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
143381407|NCT00068601|516942162|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
143381408|NCT00068601|516942161|FG000|Overall Study|Death|11|||
143381409|NCT00068601|516942162|FG001|Overall Study|Death|3|||
143381410|NCT00068601|516942161|FG000|Overall Study|Lost to Follow-up|3|||
143381411|NCT00068601|516942162|FG001|Overall Study|Lost to Follow-up|2|||
143381412|NCT00068601|516942161|FG000|Overall Study|Missing primary outcome data|30|||
143381413|NCT00068601|516942162|FG001|Overall Study|Missing primary outcome data|34|||
143381414|NCT01070069|516942165|FG000|Overall Study|Death|1|||
143381415|NCT01070069|516942166|FG001|Overall Study|Death|0|||
143381416|NCT01070069|516942167|FG002|Overall Study|Death|2|||
143381417|NCT01070069|516942168|FG003|Overall Study|Death|0|||
143381418|NCT01070069|516942169|FG004|Overall Study|Death|1|||
143381419|NCT01070069|516942165|FG000|Overall Study|Withdrawal by Subject|1|||
143381420|NCT01070069|516942166|FG001|Overall Study|Withdrawal by Subject|1|||
143381421|NCT01070069|516942167|FG002|Overall Study|Withdrawal by Subject|4|||
143381422|NCT01070069|516942168|FG003|Overall Study|Withdrawal by Subject|0|||
143381423|NCT01070069|516942169|FG004|Overall Study|Withdrawal by Subject|0|||
143381424|NCT01070069|516942165|FG000|Overall Study|Lost to Follow-up|4|||
143381425|NCT01070069|516942166|FG001|Overall Study|Lost to Follow-up|1|||
143381426|NCT01070069|516942167|FG002|Overall Study|Lost to Follow-up|0|||
143381427|NCT01070069|516942168|FG003|Overall Study|Lost to Follow-up|0|||
143381428|NCT01070069|516942169|FG004|Overall Study|Lost to Follow-up|3|||
143381429|NCT02372253|516942182|FG000|Overall Study|Non Compliance|2|||
143381430|NCT02372253|516942183|FG001|Overall Study|Non Compliance|0|||
143381431|NCT03750968|516942184|FG000|Overall Study|Adverse Event|2|||
143381432|NCT03750968|516942185|FG001|Overall Study|Adverse Event|0|||
143381433|NCT03750968|516942184|FG000|Overall Study|Lost to Follow-up|1|||
143381434|NCT03750968|516942185|FG001|Overall Study|Lost to Follow-up|3|||
143381435|NCT02409667|516942186|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
143381436|NCT02409667|516942187|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
143381437|NCT02409667|516942188|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
143381438|NCT02409667|516942189|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
143381439|NCT02409667|516942190|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
143381440|NCT02409667|516942186|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
143381441|NCT02409667|516942187|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
143381442|NCT02409667|516942188|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
143381443|NCT02409667|516942189|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
143381444|NCT02409667|516942190|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
143381445|NCT02409667|516942186|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
143381446|NCT02409667|516942187|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
143381447|NCT02409667|516942188|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
143381448|NCT02409667|516942189|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
143381449|NCT02409667|516942190|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
143381450|NCT02409667|516942186|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
143381451|NCT02409667|516942187|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
143381452|NCT02409667|516942188|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
143381453|NCT02409667|516942189|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
143381454|NCT02409667|516942190|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
143381455|NCT02409667|516942186|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
143381456|NCT02409667|516942187|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
143381457|NCT02409667|516942188|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
143381458|NCT02409667|516942189|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
143381459|NCT02409667|516942190|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
143381460|NCT02409667|516942186|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
143381461|NCT02409667|516942187|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
143381462|NCT02409667|516942188|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
143381463|NCT02409667|516942189|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
143381464|NCT02409667|516942190|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
143381465|NCT02409667|516942186|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
143381466|NCT02409667|516942187|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
143381467|NCT02409667|516942188|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
143381468|NCT02409667|516942189|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
143381469|NCT02409667|516942190|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
143381470|NCT02409667|516942186|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
143327576|NCT01358526|516740109|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
143327577|NCT01358526|516740110|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
143327578|NCT01358526|516740108|FG000|Open-label Titration Period|Lost to Follow-up|25|||
143327579|NCT01358526|516740109|FG001|Open-label Titration Period|Lost to Follow-up|0|||
143327580|NCT01358526|516740110|FG002|Open-label Titration Period|Lost to Follow-up|0|||
143327581|NCT01358526|516740108|FG000|Open-label Titration Period|Lack of Efficacy|107|||
143327582|NCT01358526|516740109|FG001|Open-label Titration Period|Lack of Efficacy|0|||
143327583|NCT01358526|516740110|FG002|Open-label Titration Period|Lack of Efficacy|0|||
143327584|NCT01358526|516740108|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
143327585|NCT01358526|516740109|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
143327586|NCT01358526|516740110|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
143327587|NCT01358526|516740108|FG000|Open-label Titration Period|Administrative|8|||
143327588|NCT01358526|516740109|FG001|Open-label Titration Period|Administrative|0|||
143327589|NCT01358526|516740110|FG002|Open-label Titration Period|Administrative|0|||
143327590|NCT01358526|516740108|FG000|Open-label Titration Period|Did not qualify|178|||
143327591|NCT01358526|516740109|FG001|Open-label Titration Period|Did not qualify|0|||
143327592|NCT01358526|516740110|FG002|Open-label Titration Period|Did not qualify|0|||
143327593|NCT01358526|516740108|FG000|Double-blind Phase|Adverse Event|0|||
143327594|NCT01358526|516740109|FG001|Double-blind Phase|Adverse Event|24|||
143327595|NCT01358526|516740110|FG002|Double-blind Phase|Adverse Event|23|||
143327596|NCT01358526|516740108|FG000|Double-blind Phase|Withdrawal by Subject|0|||
143327597|NCT01358526|516740109|FG001|Double-blind Phase|Withdrawal by Subject|10|||
143327598|NCT01358526|516740110|FG002|Double-blind Phase|Withdrawal by Subject|8|||
143327599|NCT01358526|516740108|FG000|Double-blind Phase|Lost to Follow-up|0|||
143327600|NCT01358526|516740109|FG001|Double-blind Phase|Lost to Follow-up|4|||
143327601|NCT01358526|516740110|FG002|Double-blind Phase|Lost to Follow-up|1|||
143327602|NCT01358526|516740108|FG000|Double-blind Phase|Lack of Efficacy|0|||
143327603|NCT01358526|516740109|FG001|Double-blind Phase|Lack of Efficacy|31|||
143327604|NCT01358526|516740110|FG002|Double-blind Phase|Lack of Efficacy|73|||
143327605|NCT01358526|516740108|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
143327606|NCT01358526|516740109|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
143327607|NCT01358526|516740110|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
143327608|NCT01358526|516740108|FG000|Double-blind Phase|Administrative|0|||
143327609|NCT01358526|516740109|FG001|Double-blind Phase|Administrative|6|||
143327610|NCT01358526|516740110|FG002|Double-blind Phase|Administrative|10|||
143327611|NCT04558346|516740111|FG000|Overall Study|Withdrawal by Subject|2|||
143327612|NCT04558346|516740112|FG001|Overall Study|Withdrawal by Subject|0|||
143327613|NCT04558346|516740111|FG000|Overall Study|Lost to Follow-up|0|||
143327614|NCT04558346|516740112|FG001|Overall Study|Lost to Follow-up|1|||
143327615|NCT04558346|516740111|FG000|Overall Study|Adverse Event|0|||
143327616|NCT04558346|516740112|FG001|Overall Study|Adverse Event|1|||
143327617|NCT01462344|516740113|FG000|Overall Study|Withdrawal by Subject|245|||
143327618|NCT01462344|516740114|FG001|Overall Study|Withdrawal by Subject|226|||
143327619|NCT01462344|516740113|FG000|Overall Study|Adverse Event|24|||
143327620|NCT01462344|516740114|FG001|Overall Study|Adverse Event|23|||
143327621|NCT01462344|516740113|FG000|Overall Study|Asthma Exacerbation|34|||
143327622|NCT01462344|516740114|FG001|Overall Study|Asthma Exacerbation|35|||
143327623|NCT01462344|516740113|FG000|Overall Study|Lack of Efficacy|5|||
143327624|NCT01462344|516740114|FG001|Overall Study|Lack of Efficacy|6|||
143327625|NCT01462344|516740113|FG000|Overall Study|Protocol Violation|68|||
143327626|NCT01462344|516740114|FG001|Overall Study|Protocol Violation|53|||
143327627|NCT01462344|516740113|FG000|Overall Study|Lost to Follow-up|7|||
143327628|NCT01462344|516740114|FG001|Overall Study|Lost to Follow-up|7|||
143327629|NCT01962974|516740117|FG000|Overall Study|Study termination|7|||
143327630|NCT03086447|516740118|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
143327631|NCT03086447|516740119|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
143327632|NCT03086447|516740118|FG000|Overall Study|Lost Lens|2|||
143327633|NCT03086447|516740119|FG001|Overall Study|Lost Lens|5|||
143327634|NCT03086447|516740118|FG000|Overall Study|Product quality complaint|0|||
143327635|NCT03086447|516740119|FG001|Overall Study|Product quality complaint|1|||
143327636|NCT03086447|516740118|FG000|Overall Study|Lens Damage|1|||
143327637|NCT03086447|516740119|FG001|Overall Study|Lens Damage|6|||
143327638|NCT03086447|516740118|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
143327639|NCT03086447|516740119|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
143327640|NCT03086447|516740118|FG000|Overall Study|Test Article No Longer Available|1|||
143327641|NCT03086447|516740119|FG001|Overall Study|Test Article No Longer Available|0|||
143327642|NCT03086447|516740118|FG000|Overall Study|Protocol Violation|2|||
143327643|NCT03086447|516740119|FG001|Overall Study|Protocol Violation|4|||
143327644|NCT03086447|516740118|FG000|Overall Study|Lost to Follow-up|0|||
143327645|NCT03086447|516740119|FG001|Overall Study|Lost to Follow-up|1|||
143327646|NCT03086447|516740118|FG000|Overall Study|Adverse Event|3|||
143327647|NCT03086447|516740119|FG001|Overall Study|Adverse Event|0|||
143327648|NCT03086447|516740118|FG000|Overall Study|Lens Discomfort|2|||
143327649|NCT03086447|516740119|FG001|Overall Study|Lens Discomfort|1|||
143327650|NCT01174342|516740121|FG000|Overall Study|Conversion to cesarean section|4|||
143327651|NCT00360529|516740122|FG000|Overall Study|Adverse Event|10|||
143327652|NCT00360529|516740123|FG001|Overall Study|Adverse Event|23|||
143327653|NCT00360529|516740124|FG002|Overall Study|Adverse Event|33|||
143327654|NCT00360529|516740122|FG000|Overall Study|Protocol Violation|3|||
143327655|NCT00360529|516740123|FG001|Overall Study|Protocol Violation|3|||
143327656|NCT00360529|516740124|FG002|Overall Study|Protocol Violation|11|||
143327657|NCT00360529|516740122|FG000|Overall Study|Lost to Follow-up|14|||
143327658|NCT00360529|516740123|FG001|Overall Study|Lost to Follow-up|10|||
143327659|NCT00360529|516740124|FG002|Overall Study|Lost to Follow-up|13|||
143327660|NCT00360529|516740122|FG000|Overall Study|Withdrawal by Subject|22|||
143327661|NCT00360529|516740123|FG001|Overall Study|Withdrawal by Subject|14|||
143327662|NCT00360529|516740124|FG002|Overall Study|Withdrawal by Subject|18|||
143327663|NCT00360529|516740122|FG000|Overall Study|Lack of Efficacy|8|||
143327664|NCT00360529|516740123|FG001|Overall Study|Lack of Efficacy|6|||
143327665|NCT00360529|516740124|FG002|Overall Study|Lack of Efficacy|5|||
143327666|NCT00360529|516740122|FG000|Overall Study|Reason discontinued not explained above|4|||
143327667|NCT00360529|516740123|FG001|Overall Study|Reason discontinued not explained above|9|||
143327668|NCT00360529|516740124|FG002|Overall Study|Reason discontinued not explained above|11|||
143327669|NCT00110617|516740125|FG000|Overall Study|Adverse Event|2|||
143327670|NCT00110617|516740126|FG001|Overall Study|Adverse Event|4|||
143327671|NCT00110617|516740125|FG000|Overall Study|Abnormal Laboratory Value|4|||
143327672|NCT00110617|516740126|FG001|Overall Study|Abnormal Laboratory Value|2|||
143327673|NCT00110617|516740125|FG000|Overall Study|Lack of Efficacy|1|||
143327674|NCT00110617|516740126|FG001|Overall Study|Lack of Efficacy|0|||
143327675|NCT00110617|516740125|FG000|Overall Study|Patient no longer requires study drug|1|||
143327676|NCT00110617|516740126|FG001|Overall Study|Patient no longer requires study drug|0|||
143327677|NCT00110617|516740125|FG000|Overall Study|Protocol Violation|5|||
143327678|NCT00110617|516740126|FG001|Overall Study|Protocol Violation|0|||
143327679|NCT00110617|516740125|FG000|Overall Study|Withdrawal by Subject|10|||
143327680|NCT00110617|516740126|FG001|Overall Study|Withdrawal by Subject|4|||
143327681|NCT00110617|516740125|FG000|Overall Study|Lost to Follow-up|9|||
143327682|NCT00110617|516740126|FG001|Overall Study|Lost to Follow-up|1|||
143327683|NCT00110617|516740125|FG000|Overall Study|Administrative problems|6|||
143327684|NCT00110617|516740126|FG001|Overall Study|Administrative problems|5|||
143327685|NCT00110617|516740125|FG000|Overall Study|Death|1|||
143327686|NCT00110617|516740126|FG001|Overall Study|Death|1|||
143327687|NCT00110617|516740125|FG000|Overall Study|Did not receive study drug|0|||
143327688|NCT00110617|516740126|FG001|Overall Study|Did not receive study drug|12|||
143327689|NCT03069482|516742598|FG000|Overall Study|Lost to Follow-up|0|||
143327690|NCT03069482|516742599|FG001|Overall Study|Lost to Follow-up|1|||
143327691|NCT03069482|516742598|FG000|Overall Study|Physician Decision|1|||
143327692|NCT03069482|516742599|FG001|Overall Study|Physician Decision|0|||
143327693|NCT00791765|516742600|FG000|Weeks 1 to 12|Adverse Event|0|||
143327694|NCT00791765|516742601|FG001|Weeks 1 to 12|Adverse Event|1|||
143327695|NCT00791765|516742600|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
143327696|NCT00791765|516742601|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
143327697|NCT00791765|516742600|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
143327698|NCT00791765|516742601|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
143327699|NCT00791765|516742600|FG000|Weeks 1 to 12|Physician Decision|1|||
143327700|NCT00791765|516742601|FG001|Weeks 1 to 12|Physician Decision|0|||
143327701|NCT00791765|516742600|FG000|Weeks 1 to 12|Disease progression|3|||
143327702|NCT00791765|516742601|FG001|Weeks 1 to 12|Disease progression|0|||
143327703|NCT00791765|516742600|FG000|Weeks 1 to 12|Ineligibility determined|0|||
143327704|NCT00791765|516742601|FG001|Weeks 1 to 12|Ineligibility determined|3|||
143327705|NCT00791765|516742600|FG000|Weeks 13 to 24|Protocol deviation|2|||
143327706|NCT00791765|516742601|FG001|Weeks 13 to 24|Protocol deviation|0|||
143327707|NCT00791765|516742600|FG000|Weeks 13 to 24|Adverse Event|0|||
143327708|NCT00791765|516742601|FG001|Weeks 13 to 24|Adverse Event|3|||
143327709|NCT00791765|516742600|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
143327710|NCT00791765|516742601|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
143327711|NCT00791765|516742600|FG000|Weeks 13 to 24|Disease progression|0|||
143327712|NCT00791765|516742601|FG001|Weeks 13 to 24|Disease progression|1|||
143327713|NCT00791765|516742600|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
143327714|NCT00791765|516742601|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
143327715|NCT00791765|516742600|FG000|Weeks 13 to 24|Other|0|||
143327716|NCT00791765|516742601|FG001|Weeks 13 to 24|Other|1|||
143327717|NCT02891187|516742602|FG000|Overall Study|Lost to Follow-up|1|||
143327718|NCT02891187|516742603|FG001|Overall Study|Lost to Follow-up|2|||
143327719|NCT03147248|516742610|FG000|Overall Study|Adverse Event|0|||
143327720|NCT03147248|516742611|FG001|Overall Study|Adverse Event|2|||
143381471|NCT02409667|516942187|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
143327721|NCT03147248|516742612|FG002|Overall Study|Adverse Event|2|||
143454274|NCT00948766|517208182|FG001|Core Study|Lost to Follow-up|2|||
143327722|NCT03147248|516742613|FG003|Overall Study|Adverse Event|2|||
143327723|NCT03147248|516742614|FG004|Overall Study|Adverse Event|6|||
143327724|NCT03147248|516742615|FG005|Overall Study|Adverse Event|11|||
143327725|NCT03147248|516742610|FG000|Overall Study|Disease progression|1|||
143327726|NCT03147248|516742611|FG001|Overall Study|Disease progression|0|||
143327727|NCT03147248|516742612|FG002|Overall Study|Disease progression|0|||
143327728|NCT03147248|516742613|FG003|Overall Study|Disease progression|0|||
143327729|NCT03147248|516742614|FG004|Overall Study|Disease progression|0|||
143327730|NCT03147248|516742615|FG005|Overall Study|Disease progression|2|||
143327731|NCT03147248|516742610|FG000|Overall Study|Withdrawal by Subject|0|||
143327732|NCT03147248|516742611|FG001|Overall Study|Withdrawal by Subject|0|||
143327733|NCT03147248|516742612|FG002|Overall Study|Withdrawal by Subject|0|||
143327734|NCT03147248|516742613|FG003|Overall Study|Withdrawal by Subject|0|||
143327735|NCT03147248|516742614|FG004|Overall Study|Withdrawal by Subject|12|||
143327736|NCT03147248|516742615|FG005|Overall Study|Withdrawal by Subject|9|||
143327737|NCT03147248|516742610|FG000|Overall Study|Protocol Violation|0|||
143327738|NCT03147248|516742611|FG001|Overall Study|Protocol Violation|0|||
143327739|NCT03147248|516742612|FG002|Overall Study|Protocol Violation|0|||
143327740|NCT03147248|516742613|FG003|Overall Study|Protocol Violation|0|||
143327741|NCT03147248|516742614|FG004|Overall Study|Protocol Violation|2|||
143327742|NCT03147248|516742615|FG005|Overall Study|Protocol Violation|0|||
143327743|NCT03147248|516742610|FG000|Overall Study|Lost to Follow-up|0|||
143327744|NCT03147248|516742611|FG001|Overall Study|Lost to Follow-up|0|||
143327745|NCT03147248|516742612|FG002|Overall Study|Lost to Follow-up|0|||
143327746|NCT03147248|516742613|FG003|Overall Study|Lost to Follow-up|0|||
143327747|NCT03147248|516742614|FG004|Overall Study|Lost to Follow-up|2|||
143327748|NCT03147248|516742615|FG005|Overall Study|Lost to Follow-up|0|||
143327749|NCT03147248|516742610|FG000|Overall Study|Pregnancy|0|||
143327750|NCT03147248|516742611|FG001|Overall Study|Pregnancy|0|||
143327751|NCT03147248|516742612|FG002|Overall Study|Pregnancy|0|||
143327752|NCT03147248|516742613|FG003|Overall Study|Pregnancy|0|||
143327753|NCT03147248|516742614|FG004|Overall Study|Pregnancy|1|||
143327754|NCT03147248|516742615|FG005|Overall Study|Pregnancy|0|||
143327755|NCT03147248|516742610|FG000|Overall Study|Death|0|||
143327756|NCT03147248|516742611|FG001|Overall Study|Death|0|||
143327757|NCT03147248|516742612|FG002|Overall Study|Death|0|||
143327758|NCT03147248|516742613|FG003|Overall Study|Death|0|||
143327759|NCT03147248|516742614|FG004|Overall Study|Death|0|||
143327760|NCT03147248|516742615|FG005|Overall Study|Death|4|||
143327761|NCT03147248|516742610|FG000|Overall Study|Physician Decision|0|||
143327762|NCT03147248|516742611|FG001|Overall Study|Physician Decision|0|||
143327763|NCT03147248|516742612|FG002|Overall Study|Physician Decision|0|||
143327764|NCT03147248|516742613|FG003|Overall Study|Physician Decision|0|||
143327765|NCT03147248|516742614|FG004|Overall Study|Physician Decision|2|||
143327766|NCT03147248|516742615|FG005|Overall Study|Physician Decision|4|||
143327767|NCT03147248|516742610|FG000|Overall Study|Prolonged Dosing Interval|0|||
143327768|NCT03147248|516742611|FG001|Overall Study|Prolonged Dosing Interval|0|||
143327769|NCT03147248|516742612|FG002|Overall Study|Prolonged Dosing Interval|0|||
143327770|NCT03147248|516742613|FG003|Overall Study|Prolonged Dosing Interval|0|||
143327771|NCT03147248|516742614|FG004|Overall Study|Prolonged Dosing Interval|1|||
143327772|NCT03147248|516742615|FG005|Overall Study|Prolonged Dosing Interval|1|||
143327773|NCT03750552|516742616|FG000|Overall Study|Adverse Event|5|||
143327774|NCT03750552|516742617|FG001|Overall Study|Adverse Event|1|||
143327775|NCT03750552|516742616|FG000|Overall Study|Withdrawal by Subject|1|||
143327776|NCT03750552|516742617|FG001|Overall Study|Withdrawal by Subject|1|||
143327777|NCT03750552|516742616|FG000|Overall Study|Other|2|||
143327778|NCT03750552|516742617|FG001|Overall Study|Other|0|||
143327779|NCT02062632|516742618|FG000|Overall Study|No treatment data|1|||
143327780|NCT00773968|516742620|FG000|Overall Study|Adverse Event|2|||
143327781|NCT00773968|516742620|FG000|Overall Study|Death|1|||
143327782|NCT00773968|516742620|FG000|Overall Study|Failure to Return|2|||
143327783|NCT00773968|516742620|FG000|Overall Study|Lack of Efficacy|3|||
143327784|NCT00773968|516742620|FG000|Overall Study|Protocol Violation|1|||
143327785|NCT00773968|516742620|FG000|Overall Study|Withdrawal by Subject|11|||
143327786|NCT00773968|516742620|FG000|Overall Study|Screen Failure|17|||
143327787|NCT00773968|516742620|FG000|Overall Study|Other|8|||
143381472|NCT02409667|516942188|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
143381473|NCT02409667|516942189|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
143327788|NCT04579757|516742626|FG000|Overall Study|Adverse Event|0|||
143327789|NCT04579757|516742627|FG001|Overall Study|Adverse Event|0|||
143327790|NCT04579757|516742628|FG002|Overall Study|Adverse Event|0|||
143327791|NCT04579757|516742629|FG003|Overall Study|Adverse Event|2|||
143327792|NCT04579757|516742630|FG004|Overall Study|Adverse Event|1|||
143327793|NCT04579757|516742631|FG005|Overall Study|Adverse Event|1|||
143327794|NCT04579757|516742632|FG006|Overall Study|Adverse Event|0|||
143327795|NCT04579757|516742633|FG007|Overall Study|Adverse Event|0|||
143327796|NCT04579757|516742634|FG008|Overall Study|Adverse Event|0|||
143327797|NCT04579757|516742626|FG000|Overall Study|Death|4|||
143327798|NCT04579757|516742627|FG001|Overall Study|Death|1|||
143327799|NCT04579757|516742628|FG002|Overall Study|Death|14|||
143327800|NCT04579757|516742629|FG003|Overall Study|Death|3|||
143327801|NCT04579757|516742630|FG004|Overall Study|Death|2|||
143327802|NCT04579757|516742631|FG005|Overall Study|Death|7|||
143327803|NCT04579757|516742632|FG006|Overall Study|Death|0|||
143327804|NCT04579757|516742633|FG007|Overall Study|Death|1|||
143327805|NCT04579757|516742634|FG008|Overall Study|Death|3|||
143327806|NCT04579757|516742626|FG000|Overall Study|Physician Decision|0|||
143327807|NCT04579757|516742627|FG001|Overall Study|Physician Decision|0|||
143327808|NCT04579757|516742628|FG002|Overall Study|Physician Decision|0|||
143327809|NCT04579757|516742629|FG003|Overall Study|Physician Decision|2|||
143327810|NCT04579757|516742630|FG004|Overall Study|Physician Decision|1|||
143327811|NCT04579757|516742631|FG005|Overall Study|Physician Decision|1|||
143327812|NCT04579757|516742632|FG006|Overall Study|Physician Decision|1|||
143327813|NCT04579757|516742633|FG007|Overall Study|Physician Decision|0|||
143327814|NCT04579757|516742634|FG008|Overall Study|Physician Decision|0|||
143327815|NCT04579757|516742626|FG000|Overall Study|Study Terminated By Sponsor|0|||
143327816|NCT04579757|516742627|FG001|Overall Study|Study Terminated By Sponsor|0|||
143327817|NCT04579757|516742628|FG002|Overall Study|Study Terminated By Sponsor|0|||
143327818|NCT04579757|516742629|FG003|Overall Study|Study Terminated By Sponsor|0|||
143327819|NCT04579757|516742630|FG004|Overall Study|Study Terminated By Sponsor|2|||
143327820|NCT04579757|516742631|FG005|Overall Study|Study Terminated By Sponsor|0|||
143327821|NCT04579757|516742632|FG006|Overall Study|Study Terminated By Sponsor|0|||
143327822|NCT04579757|516742633|FG007|Overall Study|Study Terminated By Sponsor|2|||
143327823|NCT04579757|516742634|FG008|Overall Study|Study Terminated By Sponsor|0|||
143327824|NCT04579757|516742626|FG000|Overall Study|Withdrawal by Subject|1|||
143327825|NCT04579757|516742627|FG001|Overall Study|Withdrawal by Subject|1|||
143327826|NCT04579757|516742628|FG002|Overall Study|Withdrawal by Subject|0|||
143327827|NCT04579757|516742629|FG003|Overall Study|Withdrawal by Subject|0|||
143327828|NCT04579757|516742630|FG004|Overall Study|Withdrawal by Subject|2|||
143327829|NCT04579757|516742631|FG005|Overall Study|Withdrawal by Subject|1|||
143327830|NCT04579757|516742632|FG006|Overall Study|Withdrawal by Subject|0|||
143327831|NCT04579757|516742633|FG007|Overall Study|Withdrawal by Subject|3|||
143327832|NCT04579757|516742634|FG008|Overall Study|Withdrawal by Subject|0|||
143327833|NCT04579757|516742626|FG000|Overall Study|Radiological or Clinical PD|1|||
143327834|NCT04579757|516742627|FG001|Overall Study|Radiological or Clinical PD|4|||
143327835|NCT04579757|516742628|FG002|Overall Study|Radiological or Clinical PD|1|||
143327836|NCT04579757|516742629|FG003|Overall Study|Radiological or Clinical PD|3|||
143327837|NCT04579757|516742630|FG004|Overall Study|Radiological or Clinical PD|9|||
143327838|NCT04579757|516742631|FG005|Overall Study|Radiological or Clinical PD|4|||
143327839|NCT04579757|516742632|FG006|Overall Study|Radiological or Clinical PD|2|||
143327840|NCT04579757|516742633|FG007|Overall Study|Radiological or Clinical PD|2|||
143327841|NCT04579757|516742634|FG008|Overall Study|Radiological or Clinical PD|0|||
143327842|NCT04579757|516742626|FG000|Overall Study|Start of New Therapy|0|||
143327843|NCT04579757|516742627|FG001|Overall Study|Start of New Therapy|0|||
143327844|NCT04579757|516742628|FG002|Overall Study|Start of New Therapy|0|||
143327845|NCT04579757|516742629|FG003|Overall Study|Start of New Therapy|0|||
143327846|NCT04579757|516742630|FG004|Overall Study|Start of New Therapy|2|||
143327847|NCT04579757|516742631|FG005|Overall Study|Start of New Therapy|1|||
143327848|NCT04579757|516742632|FG006|Overall Study|Start of New Therapy|0|||
143327849|NCT04579757|516742633|FG007|Overall Study|Start of New Therapy|0|||
143327850|NCT04579757|516742634|FG008|Overall Study|Start of New Therapy|0|||
143327851|NCT02008890|516742637|FG000|Period 1|Withdrawal by Subject|7|||
143327852|NCT02008890|516742638|FG001|Period 1|Withdrawal by Subject|7|||
143327853|NCT02008890|516742639|FG002|Period 1|Withdrawal by Subject|5|||
143327854|NCT02008890|516742640|FG003|Period 1|Withdrawal by Subject|0|||
143327855|NCT02008890|516742641|FG004|Period 1|Withdrawal by Subject|0|||
143327856|NCT02008890|516742637|FG000|Period 1|Pregnancy|1|||
143327857|NCT02008890|516742638|FG001|Period 1|Pregnancy|0|||
143327858|NCT02008890|516742639|FG002|Period 1|Pregnancy|0|||
143327859|NCT02008890|516742640|FG003|Period 1|Pregnancy|0|||
143327860|NCT02008890|516742641|FG004|Period 1|Pregnancy|0|||
143327861|NCT02008890|516742637|FG000|Period 1|Physician Decision|1|||
143327862|NCT02008890|516742638|FG001|Period 1|Physician Decision|0|||
143327863|NCT02008890|516742639|FG002|Period 1|Physician Decision|1|||
143327864|NCT02008890|516742640|FG003|Period 1|Physician Decision|0|||
143327865|NCT02008890|516742641|FG004|Period 1|Physician Decision|0|||
143327866|NCT02008890|516742637|FG000|Period 1|Adverse Event|6|||
143327867|NCT02008890|516742638|FG001|Period 1|Adverse Event|8|||
143327868|NCT02008890|516742639|FG002|Period 1|Adverse Event|6|||
143327869|NCT02008890|516742640|FG003|Period 1|Adverse Event|0|||
143327870|NCT02008890|516742641|FG004|Period 1|Adverse Event|0|||
143327871|NCT02008890|516742637|FG000|Period 2|Adverse Event|12|||
143327872|NCT02008890|516742638|FG001|Period 2|Adverse Event|7|||
143327873|NCT02008890|516742639|FG002|Period 2|Adverse Event|0|||
143327874|NCT02008890|516742640|FG003|Period 2|Adverse Event|5|||
143327875|NCT02008890|516742641|FG004|Period 2|Adverse Event|5|||
143327876|NCT02008890|516742637|FG000|Period 2|Withdrawal by Subject|11|||
143327877|NCT02008890|516742638|FG001|Period 2|Withdrawal by Subject|8|||
143327878|NCT02008890|516742639|FG002|Period 2|Withdrawal by Subject|0|||
143381474|NCT02409667|516942190|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
143381475|NCT02409667|516942186|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
143327879|NCT02008890|516742640|FG003|Period 2|Withdrawal by Subject|7|||
143327880|NCT02008890|516742641|FG004|Period 2|Withdrawal by Subject|2|||
143327881|NCT02008890|516742637|FG000|Period 2|Physician Decision|4|||
143327882|NCT02008890|516742638|FG001|Period 2|Physician Decision|0|||
143327883|NCT02008890|516742639|FG002|Period 2|Physician Decision|0|||
143327884|NCT02008890|516742640|FG003|Period 2|Physician Decision|2|||
143327885|NCT02008890|516742641|FG004|Period 2|Physician Decision|1|||
143327886|NCT02008890|516742637|FG000|Period 2|Lost to Follow-up|0|||
143327887|NCT02008890|516742638|FG001|Period 2|Lost to Follow-up|0|||
143327888|NCT02008890|516742639|FG002|Period 2|Lost to Follow-up|1|||
143327889|NCT02008890|516742640|FG003|Period 2|Lost to Follow-up|0|||
143327890|NCT02008890|516742641|FG004|Period 2|Lost to Follow-up|0|||
143327891|NCT02008890|516742637|FG000|Extension Period|Withdrawal by Subject|3|||
143327892|NCT02008890|516742638|FG001|Extension Period|Withdrawal by Subject|2|||
143327893|NCT02008890|516742639|FG002|Extension Period|Withdrawal by Subject|0|||
143327894|NCT02008890|516742640|FG003|Extension Period|Withdrawal by Subject|4|||
143327895|NCT02008890|516742641|FG004|Extension Period|Withdrawal by Subject|2|||
143327896|NCT02008890|516742637|FG000|Extension Period|Lost to Follow-up|1|||
143327897|NCT02008890|516742638|FG001|Extension Period|Lost to Follow-up|0|||
143327898|NCT02008890|516742639|FG002|Extension Period|Lost to Follow-up|0|||
143327899|NCT02008890|516742640|FG003|Extension Period|Lost to Follow-up|0|||
143327900|NCT02008890|516742641|FG004|Extension Period|Lost to Follow-up|0|||
143327901|NCT02008890|516742637|FG000|Extension Period|Adverse Event|1|||
143327902|NCT02008890|516742638|FG001|Extension Period|Adverse Event|3|||
143327903|NCT02008890|516742639|FG002|Extension Period|Adverse Event|0|||
143327904|NCT02008890|516742640|FG003|Extension Period|Adverse Event|0|||
143327905|NCT02008890|516742641|FG004|Extension Period|Adverse Event|2|||
143327906|NCT02332720|516742642|FG000|Part A and Part B|Lost to Follow-up|1|||
143327907|NCT02332720|516742643|FG001|Part A and Part B|Lost to Follow-up|0|||
143327908|NCT02332720|516742644|FG002|Part A and Part B|Lost to Follow-up|0|||
143327909|NCT02332720|516742645|FG003|Part A and Part B|Lost to Follow-up|0|||
143327910|NCT02332720|516742646|FG004|Part A and Part B|Lost to Follow-up|0|||
143327911|NCT02332720|516742647|FG005|Part A and Part B|Lost to Follow-up|2|||
143327912|NCT02332720|516742648|FG006|Part A and Part B|Lost to Follow-up|1|||
143327913|NCT02332720|516742649|FG007|Part A and Part B|Lost to Follow-up|1|||
143327914|NCT02332720|516742650|FG008|Part A and Part B|Lost to Follow-up|0|||
143327915|NCT02332720|516742651|FG009|Part A and Part B|Lost to Follow-up|0|||
143327916|NCT02332720|516742652|FG010|Part A and Part B|Lost to Follow-up|0|||
143327917|NCT02332720|516742653|FG011|Part A and Part B|Lost to Follow-up|0|||
143327918|NCT02332720|516742654|FG012|Part A and Part B|Lost to Follow-up|0|||
143327919|NCT02332720|516742655|FG013|Part A and Part B|Lost to Follow-up|0|||
143327920|NCT02332720|516742656|FG014|Part A and Part B|Lost to Follow-up|0|||
143327921|NCT02332720|516742657|FG015|Part A and Part B|Lost to Follow-up|1|||
143327922|NCT02332720|516742658|FG016|Part A and Part B|Lost to Follow-up|0|||
143327923|NCT02332720|516742659|FG017|Part A and Part B|Lost to Follow-up|0|||
143327924|NCT02332720|516742660|FG018|Part A and Part B|Lost to Follow-up|0|||
143327925|NCT02332720|516742661|FG019|Part A and Part B|Lost to Follow-up|0|||
143327926|NCT02332720|516742662|FG020|Part A and Part B|Lost to Follow-up|0|||
143327927|NCT02332720|516742663|FG021|Part A and Part B|Lost to Follow-up|0|||
143327928|NCT02332720|516742664|FG022|Part A and Part B|Lost to Follow-up|0|||
143327929|NCT02332720|516742642|FG000|Part A and Part B|Adverse Event|0|||
143327930|NCT02332720|516742643|FG001|Part A and Part B|Adverse Event|0|||
143327931|NCT02332720|516742644|FG002|Part A and Part B|Adverse Event|0|||
143327932|NCT02332720|516742645|FG003|Part A and Part B|Adverse Event|0|||
143327933|NCT02332720|516742646|FG004|Part A and Part B|Adverse Event|0|||
143327934|NCT02332720|516742647|FG005|Part A and Part B|Adverse Event|0|||
143327935|NCT02332720|516742648|FG006|Part A and Part B|Adverse Event|0|||
143327936|NCT02332720|516742649|FG007|Part A and Part B|Adverse Event|0|||
143327937|NCT02332720|516742650|FG008|Part A and Part B|Adverse Event|0|||
143327938|NCT02332720|516742651|FG009|Part A and Part B|Adverse Event|0|||
143327939|NCT02332720|516742652|FG010|Part A and Part B|Adverse Event|0|||
143327940|NCT02332720|516742653|FG011|Part A and Part B|Adverse Event|0|||
143327941|NCT02332720|516742654|FG012|Part A and Part B|Adverse Event|0|||
143327942|NCT02332720|516742655|FG013|Part A and Part B|Adverse Event|0|||
143327943|NCT02332720|516742656|FG014|Part A and Part B|Adverse Event|0|||
143327944|NCT02332720|516742657|FG015|Part A and Part B|Adverse Event|0|||
143327945|NCT02332720|516742658|FG016|Part A and Part B|Adverse Event|0|||
143327946|NCT02332720|516742659|FG017|Part A and Part B|Adverse Event|1|||
143327947|NCT02332720|516742660|FG018|Part A and Part B|Adverse Event|0|||
143327948|NCT02332720|516742661|FG019|Part A and Part B|Adverse Event|0|||
143327949|NCT02332720|516742662|FG020|Part A and Part B|Adverse Event|0|||
143327950|NCT02332720|516742663|FG021|Part A and Part B|Adverse Event|0|||
143327951|NCT02332720|516742664|FG022|Part A and Part B|Adverse Event|0|||
143327952|NCT02332720|516742642|FG000|Part A and Part B|Physician Decision|0|||
143327953|NCT02332720|516742643|FG001|Part A and Part B|Physician Decision|0|||
143327954|NCT02332720|516742644|FG002|Part A and Part B|Physician Decision|0|||
143327955|NCT02332720|516742645|FG003|Part A and Part B|Physician Decision|0|||
143327956|NCT02332720|516742646|FG004|Part A and Part B|Physician Decision|0|||
143327957|NCT02332720|516742647|FG005|Part A and Part B|Physician Decision|0|||
143327958|NCT02332720|516742648|FG006|Part A and Part B|Physician Decision|0|||
143327959|NCT02332720|516742649|FG007|Part A and Part B|Physician Decision|0|||
143327960|NCT02332720|516742650|FG008|Part A and Part B|Physician Decision|0|||
143327961|NCT02332720|516742651|FG009|Part A and Part B|Physician Decision|0|||
143381476|NCT02409667|516942187|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
143381477|NCT02409667|516942188|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
143381478|NCT02409667|516942189|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
143381479|NCT02409667|516942190|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
143381480|NCT02409667|516942186|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
143381481|NCT02409667|516942187|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
143381482|NCT02409667|516942188|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
143381483|NCT02409667|516942189|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
143381484|NCT02409667|516942190|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
143381485|NCT02409667|516942186|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
143381486|NCT02409667|516942187|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
143381487|NCT02409667|516942188|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
143381488|NCT02409667|516942189|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
143381489|NCT02409667|516942190|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
143381490|NCT02409667|516942186|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
143381491|NCT02409667|516942187|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
143381492|NCT02409667|516942188|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
143381493|NCT02409667|516942189|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
143381494|NCT02409667|516942190|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
143381495|NCT02409667|516942186|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
143381496|NCT02409667|516942187|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
143381497|NCT02409667|516942188|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
143381498|NCT02409667|516942189|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
143381499|NCT02409667|516942190|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
143381500|NCT02409667|516942186|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
143381501|NCT02409667|516942187|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
143381502|NCT02409667|516942188|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
143381503|NCT02409667|516942189|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
143381504|NCT02409667|516942190|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
143381505|NCT02409667|516942186|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
143381506|NCT02409667|516942187|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
143381507|NCT02409667|516942188|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
143381508|NCT02409667|516942189|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
143381509|NCT02409667|516942190|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
143381510|NCT02409667|516942186|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
143381511|NCT02409667|516942187|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
143381512|NCT02409667|516942188|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
143381513|NCT02409667|516942189|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
143381514|NCT02409667|516942190|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
143381515|NCT04766034|516942191|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
143381516|NCT04766034|516942192|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
143381517|NCT04766034|516942193|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
143381518|NCT04766034|516942194|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
143381519|NCT04766034|516942195|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
143381520|NCT04766034|516942191|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
143381521|NCT04766034|516942192|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
143381522|NCT04766034|516942193|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
143381523|NCT04766034|516942194|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
143381524|NCT04766034|516942195|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
143381525|NCT04766034|516942191|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
143381526|NCT04766034|516942192|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
143381527|NCT04766034|516942193|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
143381528|NCT04766034|516942194|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
143381529|NCT04766034|516942195|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
143381530|NCT04766034|516942191|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
143381531|NCT04766034|516942192|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
143381532|NCT04766034|516942193|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
143381533|NCT04766034|516942194|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
143381534|NCT04766034|516942195|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
143381535|NCT01205048|516942203|FG000|Overall Study|Withdrawal by Subject|14|||
143381536|NCT01205048|516942203|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
143381537|NCT01205048|516942203|FG000|Overall Study|Lost to Follow-up|4|||
143381538|NCT01205048|516942203|FG000|Overall Study|Other|2|||
143381539|NCT01255670|516942204|FG000|Overall Study|Adverse Event|10|||
143381540|NCT01255670|516942205|FG001|Overall Study|Adverse Event|10|||
143381541|NCT01255670|516942204|FG000|Overall Study|Lost to Follow-up|16|||
143381542|NCT01255670|516942205|FG001|Overall Study|Lost to Follow-up|10|||
143381543|NCT03892564|516942206|FG000|Overall Study|Withdrawal by Subject|2|||
143381544|NCT03664960|516942207|FG000|Overall Study|Adverse Event|0|||
143381545|NCT03664960|516942208|FG001|Overall Study|Adverse Event|3|||
143381546|NCT03664960|516942207|FG000|Overall Study|Lost to Follow-up|3|||
143381547|NCT03664960|516942208|FG001|Overall Study|Lost to Follow-up|2|||
143381548|NCT03664960|516942207|FG000|Overall Study|Physician Decision|1|||
143381549|NCT03664960|516942208|FG001|Overall Study|Physician Decision|0|||
143381550|NCT03664960|516942207|FG000|Overall Study|Withdrawal by Subject|3|||
143381551|NCT03664960|516942208|FG001|Overall Study|Withdrawal by Subject|14|||
143381552|NCT03664960|516942207|FG000|Overall Study|Sponsor Decision|1|||
143381553|NCT03664960|516942208|FG001|Overall Study|Sponsor Decision|1|||
143381554|NCT03664960|516942207|FG000|Overall Study|Other|1|||
143381555|NCT03664960|516942208|FG001|Overall Study|Other|2|||
143381556|NCT04019444|516942209|FG000|Overall Study|Withdrawal by Subject|0|||
143381557|NCT04019444|516942210|FG001|Overall Study|Withdrawal by Subject|1|||
143381558|NCT04019444|516942211|FG002|Overall Study|Withdrawal by Subject|0|||
143381559|NCT04019444|516942212|FG003|Overall Study|Withdrawal by Subject|1|||
143381560|NCT04019444|516942209|FG000|Overall Study|Solicited Event|0|||
143381561|NCT04019444|516942210|FG001|Overall Study|Solicited Event|0|||
143381562|NCT04019444|516942211|FG002|Overall Study|Solicited Event|2|||
143381563|NCT04019444|516942212|FG003|Overall Study|Solicited Event|0|||
143381564|NCT01609218|516942215|FG000|Period 1|Adverse Event|3|||
143381565|NCT01609218|516942216|FG001|Period 1|Adverse Event|5|||
143381566|NCT01609218|516942215|FG000|Period 1|Sponsor Decision|0|||
143381567|NCT01609218|516942216|FG001|Period 1|Sponsor Decision|1|||
143381568|NCT01609218|516942215|FG000|Period 2|Adverse Event|1|||
143381569|NCT01609218|516942216|FG001|Period 2|Adverse Event|0|||
143381570|NCT00774852|516942226|FG000|Overall Study|Adverse Event|9|||
143381571|NCT00774852|516942227|FG001|Overall Study|Adverse Event|6|||
143381572|NCT00774852|516942226|FG000|Overall Study|Death|2|||
143381573|NCT00774852|516942227|FG001|Overall Study|Death|1|||
143381574|NCT00774852|516942226|FG000|Overall Study|Lack of Efficacy|3|||
143381575|NCT00774852|516942227|FG001|Overall Study|Lack of Efficacy|7|||
143381576|NCT00774852|516942226|FG000|Overall Study|Lost to Follow-up|9|||
143381577|NCT00774852|516942227|FG001|Overall Study|Lost to Follow-up|5|||
143381578|NCT00774852|516942226|FG000|Overall Study|Physician Decision|2|||
143381579|NCT00774852|516942227|FG001|Overall Study|Physician Decision|6|||
143381580|NCT00774852|516942226|FG000|Overall Study|Pregnancy|1|||
143381581|NCT00774852|516942227|FG001|Overall Study|Pregnancy|2|||
143381582|NCT00774852|516942226|FG000|Overall Study|Withdrawal by Subject|2|||
143381583|NCT00774852|516942227|FG001|Overall Study|Withdrawal by Subject|2|||
143381584|NCT00774852|516942226|FG000|Overall Study|Non-responder|15|||
143381585|NCT00774852|516942227|FG001|Overall Study|Non-responder|11|||
143381586|NCT00774852|516942226|FG000|Overall Study|Subject non-compliance|0|||
143381587|NCT00774852|516942227|FG001|Overall Study|Subject non-compliance|1|||
143381588|NCT00774852|516942226|FG000|Overall Study|Protocol Violation|1|||
143381589|NCT00774852|516942227|FG001|Overall Study|Protocol Violation|0|||
143381590|NCT00774852|516942226|FG000|Overall Study|Subject received prohibited medication|1|||
143381591|NCT00774852|516942227|FG001|Overall Study|Subject received prohibited medication|0|||
143381592|NCT03997916|516942231|FG000|Overall Study|Protocol Violation|35|||
143381593|NCT02807779|516942234|FG000|Overall Study|Lost to Follow-up|1|||
143381594|NCT02807779|516942235|FG001|Overall Study|Lost to Follow-up|0|||
143381595|NCT02807779|516942236|FG002|Overall Study|Lost to Follow-up|0|||
143381596|NCT02807779|516942234|FG000|Overall Study|Physician Decision|2|||
143381597|NCT02807779|516942235|FG001|Overall Study|Physician Decision|0|||
143381598|NCT02807779|516942236|FG002|Overall Study|Physician Decision|1|||
143381599|NCT02807779|516942234|FG000|Overall Study|Death|1|||
143381600|NCT02807779|516942235|FG001|Overall Study|Death|1|||
143381601|NCT02807779|516942236|FG002|Overall Study|Death|0|||
143381602|NCT01853748|516944441|FG000|Allocation|Withdrawal by Subject|1|||
143381603|NCT01853748|516944442|FG001|Allocation|Withdrawal by Subject|13|||
143381604|NCT01853748|516944441|FG000|Allocation|not sufficient to receive intervention|0|||
143381605|NCT01853748|516944442|FG001|Allocation|not sufficient to receive intervention|1|||
143381606|NCT01853748|516944441|FG000|Follow-Up|Withdrawal by Subject|7|||
143381607|NCT01853748|516944442|FG001|Follow-Up|Withdrawal by Subject|6|||
143381608|NCT01853748|516944441|FG000|Follow-Up|Adverse Event|67|||
143381609|NCT01853748|516944442|FG001|Follow-Up|Adverse Event|7|||
143381610|NCT01853748|516944441|FG000|Follow-Up|not available for data collection|16|||
143381611|NCT01853748|516944442|FG001|Follow-Up|not available for data collection|4|||
143327962|NCT02332720|516742652|FG010|Part A and Part B|Physician Decision|0|||
143327963|NCT02332720|516742653|FG011|Part A and Part B|Physician Decision|0|||
143327964|NCT02332720|516742654|FG012|Part A and Part B|Physician Decision|0|||
143327965|NCT02332720|516742655|FG013|Part A and Part B|Physician Decision|0|||
143327966|NCT02332720|516742656|FG014|Part A and Part B|Physician Decision|0|||
143327967|NCT02332720|516742657|FG015|Part A and Part B|Physician Decision|0|||
143327968|NCT02332720|516742658|FG016|Part A and Part B|Physician Decision|0|||
143327969|NCT02332720|516742659|FG017|Part A and Part B|Physician Decision|0|||
143327970|NCT02332720|516742660|FG018|Part A and Part B|Physician Decision|1|||
143327971|NCT02332720|516742661|FG019|Part A and Part B|Physician Decision|0|||
143327972|NCT02332720|516742662|FG020|Part A and Part B|Physician Decision|0|||
143327973|NCT02332720|516742663|FG021|Part A and Part B|Physician Decision|0|||
143327974|NCT02332720|516742664|FG022|Part A and Part B|Physician Decision|0|||
143327975|NCT02332720|516742642|FG000|Part A and Part B|Withdrawal by Subject|0|||
143327976|NCT02332720|516742643|FG001|Part A and Part B|Withdrawal by Subject|0|||
143327977|NCT02332720|516742644|FG002|Part A and Part B|Withdrawal by Subject|0|||
143327978|NCT02332720|516742645|FG003|Part A and Part B|Withdrawal by Subject|0|||
143327979|NCT02332720|516742646|FG004|Part A and Part B|Withdrawal by Subject|0|||
143327980|NCT02332720|516742647|FG005|Part A and Part B|Withdrawal by Subject|1|||
143327981|NCT02332720|516742648|FG006|Part A and Part B|Withdrawal by Subject|0|||
143327982|NCT02332720|516742649|FG007|Part A and Part B|Withdrawal by Subject|0|||
143327983|NCT02332720|516742650|FG008|Part A and Part B|Withdrawal by Subject|0|||
143327984|NCT02332720|516742651|FG009|Part A and Part B|Withdrawal by Subject|0|||
143327985|NCT02332720|516742652|FG010|Part A and Part B|Withdrawal by Subject|0|||
143327986|NCT02332720|516742653|FG011|Part A and Part B|Withdrawal by Subject|0|||
143327987|NCT02332720|516742654|FG012|Part A and Part B|Withdrawal by Subject|0|||
143327988|NCT02332720|516742655|FG013|Part A and Part B|Withdrawal by Subject|0|||
143327989|NCT02332720|516742656|FG014|Part A and Part B|Withdrawal by Subject|0|||
143327990|NCT02332720|516742657|FG015|Part A and Part B|Withdrawal by Subject|0|||
143327991|NCT02332720|516742658|FG016|Part A and Part B|Withdrawal by Subject|0|||
143327992|NCT02332720|516742659|FG017|Part A and Part B|Withdrawal by Subject|0|||
143327993|NCT02332720|516742660|FG018|Part A and Part B|Withdrawal by Subject|0|||
143327994|NCT02332720|516742661|FG019|Part A and Part B|Withdrawal by Subject|1|||
143327995|NCT02332720|516742662|FG020|Part A and Part B|Withdrawal by Subject|0|||
143327996|NCT02332720|516742663|FG021|Part A and Part B|Withdrawal by Subject|0|||
143327997|NCT02332720|516742664|FG022|Part A and Part B|Withdrawal by Subject|0|||
143327998|NCT02207816|516742665|FG000|Overall Study|Serious Adverse Event|0|||
143327999|NCT02207816|516742666|FG001|Overall Study|Serious Adverse Event|5|||
143328000|NCT02207816|516742667|FG002|Overall Study|Serious Adverse Event|2|||
143328001|NCT02207816|516742665|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
143328002|NCT02207816|516742666|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
143328003|NCT02207816|516742667|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
143328004|NCT02207816|516742665|FG000|Overall Study|Withdrawal by Subject|4|||
143328005|NCT02207816|516742666|FG001|Overall Study|Withdrawal by Subject|9|||
143328006|NCT02207816|516742667|FG002|Overall Study|Withdrawal by Subject|7|||
143328007|NCT02207816|516742665|FG000|Overall Study|Migrated/Moved From Study Area|41|||
143328008|NCT02207816|516742666|FG001|Overall Study|Migrated/Moved From Study Area|60|||
143328009|NCT02207816|516742667|FG002|Overall Study|Migrated/Moved From Study Area|51|||
143328010|NCT02207816|516742665|FG000|Overall Study|Lost to Follow-up|3|||
143328011|NCT02207816|516742666|FG001|Overall Study|Lost to Follow-up|9|||
143328012|NCT02207816|516742667|FG002|Overall Study|Lost to Follow-up|1|||
143328013|NCT02207816|516742665|FG000|Overall Study|Other|1|||
143328014|NCT02207816|516742666|FG001|Overall Study|Other|2|||
143328015|NCT02207816|516742667|FG002|Overall Study|Other|4|||
143328016|NCT06111742|516742668|FG000|Overall Study|Did not receive intervention|1|||
143328017|NCT06111742|516742669|FG001|Overall Study|Did not receive intervention|0|||
143328018|NCT06111742|516742670|FG002|Overall Study|Did not receive intervention|0|||
143328019|NCT06111742|516742668|FG000|Overall Study|Withdrawal by Subject|2|||
143328020|NCT06111742|516742669|FG001|Overall Study|Withdrawal by Subject|0|||
143328021|NCT06111742|516742670|FG002|Overall Study|Withdrawal by Subject|0|||
143328022|NCT03489304|516742671|FG000|Overall Study|Lost to Follow-up|4|||
143328023|NCT02239679|516742672|FG000|Overall Study|Lost to Follow-up|1|||
143328024|NCT02239679|516742673|FG001|Overall Study|Lost to Follow-up|0|||
143328025|NCT02239679|516742674|FG002|Overall Study|Lost to Follow-up|0|||
143328026|NCT02239679|516742672|FG000|Overall Study|Withdrawal by Subject|2|||
143328027|NCT02239679|516742673|FG001|Overall Study|Withdrawal by Subject|3|||
143328028|NCT02239679|516742674|FG002|Overall Study|Withdrawal by Subject|1|||
143328029|NCT02605954|516742675|FG000|Overall Study|Adverse Event|5|||
143328030|NCT02605954|516742676|FG001|Overall Study|Adverse Event|1|||
143328031|NCT02605954|516742675|FG000|Overall Study|Investigator's Discretion|1|||
143328032|NCT02605954|516742676|FG001|Overall Study|Investigator's Discretion|0|||
143328033|NCT02605954|516742675|FG000|Overall Study|Non-Compliance with Study Drug|1|||
143328034|NCT02605954|516742676|FG001|Overall Study|Non-Compliance with Study Drug|0|||
143328035|NCT02605954|516742675|FG000|Overall Study|Withdrew Consent|2|||
143328036|NCT02605954|516742676|FG001|Overall Study|Withdrew Consent|2|||
143328037|NCT02605954|516742675|FG000|Overall Study|Lost to Follow-up|3|||
143328038|NCT02605954|516742676|FG001|Overall Study|Lost to Follow-up|0|||
143328039|NCT02605954|516742675|FG000|Overall Study|Randomized but not treated|0|||
143328040|NCT02605954|516742676|FG001|Overall Study|Randomized but not treated|1|||
143328041|NCT02370602|516742677|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
143328042|NCT02370602|516742678|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
143328043|NCT02370602|516742679|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
143328044|NCT02370602|516742680|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
143328045|NCT02370602|516742681|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
143328046|NCT02370602|516742682|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
143328047|NCT02103439|516742684|FG000|Overall Study|Adverse Event|0|||
143328048|NCT02103439|516742685|FG001|Overall Study|Adverse Event|2|||
143328049|NCT02103439|516742684|FG000|Overall Study|Withdrawal by Subject|3|||
143328050|NCT02103439|516742685|FG001|Overall Study|Withdrawal by Subject|1|||
143328051|NCT03349710|516742686|FG000|Treatment Period|Death|0|||
143328052|NCT03349710|516742687|FG001|Treatment Period|Death|0|||
143328053|NCT03349710|516742688|FG002|Treatment Period|Death|1|||
143328054|NCT03349710|516742689|FG003|Treatment Period|Death|0|||
143328055|NCT03349710|516742686|FG000|Treatment Period|Disease Progression|0|||
143328056|NCT03349710|516742687|FG001|Treatment Period|Disease Progression|2|||
143328057|NCT03349710|516742688|FG002|Treatment Period|Disease Progression|0|||
143328058|NCT03349710|516742689|FG003|Treatment Period|Disease Progression|1|||
143328059|NCT03349710|516742686|FG000|Treatment Period|Study Drug Toxicity|1|||
143328060|NCT03349710|516742687|FG001|Treatment Period|Study Drug Toxicity|0|||
143328061|NCT03349710|516742688|FG002|Treatment Period|Study Drug Toxicity|1|||
143328062|NCT03349710|516742689|FG003|Treatment Period|Study Drug Toxicity|1|||
143328063|NCT03349710|516742686|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
143328064|NCT03349710|516742687|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
143328065|NCT03349710|516742688|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
143328066|NCT03349710|516742689|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
143328067|NCT03349710|516742686|FG000|Treatment Period|admin reason by sponsor|0|||
143328068|NCT03349710|516742687|FG001|Treatment Period|admin reason by sponsor|7|||
143328069|NCT03349710|516742688|FG002|Treatment Period|admin reason by sponsor|0|||
143328070|NCT03349710|516742689|FG003|Treatment Period|admin reason by sponsor|19|||
143328071|NCT03349710|516742686|FG000|Treatment Period|Other Reason|2|||
143328072|NCT03349710|516742687|FG001|Treatment Period|Other Reason|0|||
143328073|NCT03349710|516742688|FG002|Treatment Period|Other Reason|2|||
143328074|NCT03349710|516742689|FG003|Treatment Period|Other Reason|1|||
143328075|NCT03349710|516742686|FG000|Treatment Period|completed|6|||
143328076|NCT03349710|516742687|FG001|Treatment Period|completed|0|||
143328077|NCT03349710|516742688|FG002|Treatment Period|completed|18|||
143328078|NCT03349710|516742689|FG003|Treatment Period|completed|1|||
143328079|NCT03349710|516742686|FG000|Treatment Period|participant request to discontinue|0|||
143328080|NCT03349710|516742687|FG001|Treatment Period|participant request to discontinue|0|||
143328081|NCT03349710|516742688|FG002|Treatment Period|participant request to discontinue|4|||
143328082|NCT03349710|516742689|FG003|Treatment Period|participant request to discontinue|0|||
143328083|NCT03349710|516742686|FG000|Treatment Period|participant withdrew consent|1|||
143328084|NCT03349710|516742687|FG001|Treatment Period|participant withdrew consent|0|||
143328085|NCT03349710|516742688|FG002|Treatment Period|participant withdrew consent|0|||
143328086|NCT03349710|516742689|FG003|Treatment Period|participant withdrew consent|0|||
143328087|NCT02696317|516742690|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
143328088|NCT02696317|516742691|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
143328089|NCT02696317|516742690|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
143328090|NCT02696317|516742691|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
143328091|NCT01343368|516742692|FG000|Overall Study|Death|1|||
143328092|NCT01343368|516742693|FG001|Overall Study|Death|0|||
143328093|NCT01343368|516742692|FG000|Overall Study|Lost to Follow-up|1|||
143328094|NCT01343368|516742693|FG001|Overall Study|Lost to Follow-up|0|||
143328095|NCT00237744|516742694|FG000|Overall Study|Withdrawal by Subject|3|||
143328096|NCT00237744|516742695|FG001|Overall Study|Withdrawal by Subject|1|||
143328097|NCT00237744|516742696|FG002|Overall Study|Withdrawal by Subject|0|||
143328098|NCT04447404|516742697|FG000|Overall Study|Death|2|||
143328099|NCT04447404|516742698|FG001|Overall Study|Death|0|||
143328100|NCT00321854|516742699|FG000|Overall Study|Adverse Event|41|||
143328101|NCT00321854|516742700|FG001|Overall Study|Adverse Event|43|||
143328102|NCT00321854|516742699|FG000|Overall Study|Lack of Efficacy|9|||
143328103|NCT00321854|516742700|FG001|Overall Study|Lack of Efficacy|14|||
143328104|NCT00321854|516742699|FG000|Overall Study|Protocol Violation|6|||
143328105|NCT00321854|516742700|FG001|Overall Study|Protocol Violation|5|||
143328106|NCT00321854|516742699|FG000|Overall Study|Lost to Follow-up|0|||
143328107|NCT00321854|516742700|FG001|Overall Study|Lost to Follow-up|2|||
143328108|NCT00321854|516742699|FG000|Overall Study|Withdrawal by Subject|6|||
143328109|NCT00321854|516742700|FG001|Overall Study|Withdrawal by Subject|17|||
143328110|NCT00321854|516742699|FG000|Overall Study|Other|1|||
143328111|NCT00321854|516742700|FG001|Overall Study|Other|1|||
143328112|NCT01064739|516742701|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
143328113|NCT00454051|516742704|FG000|Overall Study|Adverse Event|1|||
143328114|NCT00454051|516742705|FG001|Overall Study|Adverse Event|2|||
143328115|NCT00454051|516742704|FG000|Overall Study|Withdrawal by Subject|1|||
143328116|NCT00454051|516742705|FG001|Overall Study|Withdrawal by Subject|0|||
143328117|NCT00454051|516742704|FG000|Overall Study|Protocol Violation|1|||
143328118|NCT00454051|516742705|FG001|Overall Study|Protocol Violation|1|||
143328119|NCT04258020|516742706|FG000|Overall Study|Withdrawal by Subject|1|||
143328120|NCT04258020|516742707|FG001|Overall Study|Withdrawal by Subject|0|||
143328121|NCT02097472|516742708|FG000|Received Vaccination 2|Adverse Event|0|||
143328122|NCT02097472|516742709|FG001|Received Vaccination 2|Adverse Event|0|||
143328123|NCT02097472|516742710|FG002|Received Vaccination 2|Adverse Event|0|||
143328124|NCT02097472|516742711|FG003|Received Vaccination 2|Adverse Event|0|||
143328125|NCT02097472|516742712|FG004|Received Vaccination 2|Adverse Event|0|||
143328126|NCT02097472|516742713|FG005|Received Vaccination 2|Adverse Event|0|||
143328127|NCT02097472|516742714|FG006|Received Vaccination 2|Adverse Event|1|||
143328128|NCT02097472|516742715|FG007|Received Vaccination 2|Adverse Event|0|||
143328129|NCT03966157|516742716|FG000|Overall Study|Physician Decision|1|||
143328130|NCT03966157|516742717|FG001|Overall Study|Physician Decision|0|||
143328131|NCT03305016|516742718|FG000|Overall Study|Withdrawal by Subject|2|||
143328132|NCT03834779|516742719|FG000|Overall Study|Death|1|||
143328133|NCT03834779|516742720|FG001|Overall Study|Death|2|||
143328134|NCT03834779|516742719|FG000|Overall Study|Lost to Follow-up|6|||
143328135|NCT03834779|516742720|FG001|Overall Study|Lost to Follow-up|4|||
143328136|NCT01540851|516742725|FG000|Overall Study|Lost to Follow-up|14|||
143328137|NCT01540851|516742726|FG001|Overall Study|Lost to Follow-up|15|||
143328138|NCT01540851|516742725|FG000|Overall Study|Withdrawal by Subject|7|||
143328139|NCT01540851|516742726|FG001|Overall Study|Withdrawal by Subject|3|||
143328140|NCT00325468|516742727|FG000|Overall Study|Adverse Event|1|||
143328141|NCT00325468|516742728|FG001|Overall Study|Adverse Event|1|||
143328142|NCT00325468|516742729|FG002|Overall Study|Adverse Event|0|||
143328143|NCT00325468|516742730|FG003|Overall Study|Adverse Event|5|||
143328144|NCT00325468|516742731|FG004|Overall Study|Adverse Event|1|||
143328145|NCT00325468|516742727|FG000|Overall Study|Death|2|||
143328146|NCT00325468|516742728|FG001|Overall Study|Death|0|||
143328147|NCT00325468|516742729|FG002|Overall Study|Death|2|||
143328148|NCT00325468|516742730|FG003|Overall Study|Death|4|||
143328149|NCT00325468|516742731|FG004|Overall Study|Death|0|||
143328150|NCT00325468|516742727|FG000|Overall Study|Lost to Follow-up|0|||
143328151|NCT00325468|516742728|FG001|Overall Study|Lost to Follow-up|0|||
143328152|NCT00325468|516742729|FG002|Overall Study|Lost to Follow-up|1|||
143328153|NCT00325468|516742730|FG003|Overall Study|Lost to Follow-up|2|||
143328154|NCT00325468|516742731|FG004|Overall Study|Lost to Follow-up|2|||
143328155|NCT00325468|516742727|FG000|Overall Study|Physician Decision|1|||
143328156|NCT00325468|516742728|FG001|Overall Study|Physician Decision|1|||
143328157|NCT00325468|516742729|FG002|Overall Study|Physician Decision|0|||
143328158|NCT00325468|516742730|FG003|Overall Study|Physician Decision|1|||
143328159|NCT00325468|516742731|FG004|Overall Study|Physician Decision|0|||
143328160|NCT00325468|516742727|FG000|Overall Study|Withdrawal by Subject|3|||
143328161|NCT00325468|516742728|FG001|Overall Study|Withdrawal by Subject|1|||
143328162|NCT00325468|516742729|FG002|Overall Study|Withdrawal by Subject|0|||
143328163|NCT00325468|516742730|FG003|Overall Study|Withdrawal by Subject|14|||
143328164|NCT00325468|516742731|FG004|Overall Study|Withdrawal by Subject|4|||
143328165|NCT00325468|516742727|FG000|Overall Study|site closure etc|4|||
143328166|NCT00325468|516742728|FG001|Overall Study|site closure etc|2|||
143328167|NCT00325468|516742729|FG002|Overall Study|site closure etc|1|||
143328168|NCT00325468|516742730|FG003|Overall Study|site closure etc|8|||
143328169|NCT00325468|516742731|FG004|Overall Study|site closure etc|1|||
143328170|NCT04349553|516742732|FG000|Overall Study|Withdrawal by Subject|1|||
143328171|NCT04349553|516742733|FG001|Overall Study|Withdrawal by Subject|0|||
143328172|NCT04349553|516742734|FG002|Overall Study|Withdrawal by Subject|1|||
143328173|NCT04349553|516742735|FG003|Overall Study|Withdrawal by Subject|0|||
143328174|NCT02219932|516742736|FG000|Overall Study|Other|5|||
143328175|NCT02219932|516742737|FG001|Overall Study|Other|11|||
143328176|NCT02219932|516742736|FG000|Overall Study|Death|1|||
143328177|NCT02219932|516742737|FG001|Overall Study|Death|1|||
143328178|NCT02219932|516742736|FG000|Overall Study|Investigator Decision|0|||
143328179|NCT02219932|516742737|FG001|Overall Study|Investigator Decision|1|||
143328180|NCT02219932|516742736|FG000|Overall Study|Consent Withdrawn|11|||
143381612|NCT02576509|516944443|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
143328181|NCT02219932|516742737|FG001|Overall Study|Consent Withdrawn|7|||
143328182|NCT02219932|516742736|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
143328183|NCT02219932|516742737|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
143328184|NCT02219932|516742736|FG000|Overall Study|Protocol Violation|10|||
143328185|NCT02219932|516742737|FG001|Overall Study|Protocol Violation|6|||
143328186|NCT02219932|516742736|FG000|Overall Study|Pregnancy|1|||
143328187|NCT02219932|516742737|FG001|Overall Study|Pregnancy|0|||
143328188|NCT02219932|516742736|FG000|Overall Study|Lost to Follow-up|4|||
143328189|NCT02219932|516742737|FG001|Overall Study|Lost to Follow-up|2|||
143328190|NCT02219932|516742736|FG000|Overall Study|Adverse Event|23|||
143381613|NCT02576509|516944444|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
143381614|NCT02576509|516944443|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
143381615|NCT02576509|516944444|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
143381616|NCT02576509|516944443|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
143328191|NCT02219932|516742737|FG001|Overall Study|Adverse Event|21|||
143328192|NCT01618864|516742738|FG000|Overall Study|Withdrawal by Subject|2|||
143328193|NCT01618864|516742738|FG000|Overall Study|Lost to Follow-up|2|||
143328194|NCT05177770|516742739|FG000|Overall Study|Death|4|||
143328195|NCT05177770|516742739|FG000|Overall Study|Withdrawal by Subject|1|||
143328196|NCT05177770|516742739|FG000|Overall Study|Adverse Event prior to dosing|1|||
143328197|NCT02199028|516742747|FG000|Week 1|Adverse Event|1|||
143328198|NCT02199028|516742748|FG001|Week 1|Adverse Event|0|||
143328199|NCT02199028|516742747|FG000|Week 3|Adverse Event|1|||
143328200|NCT02199028|516742748|FG001|Week 3|Adverse Event|0|||
143328201|NCT01881126|516742749|FG000|Overall Study|Non-compliance|1|||
143328202|NCT01881126|516742750|FG001|Overall Study|Non-compliance|1|||
143328203|NCT01881126|516742749|FG000|Overall Study|Adverse Event|0|||
143328204|NCT01881126|516742750|FG001|Overall Study|Adverse Event|1|||
143328205|NCT00695669|516742753|FG000|Overall Study|Adverse Event|0|||
143328206|NCT00695669|516742754|FG001|Overall Study|Adverse Event|0|||
143328207|NCT00695669|516742755|FG002|Overall Study|Adverse Event|2|||
143328208|NCT00695669|516742756|FG003|Overall Study|Adverse Event|0|||
143328209|NCT00695669|516742753|FG000|Overall Study|Lost to Follow-up|4|||
143328210|NCT00695669|516742754|FG001|Overall Study|Lost to Follow-up|4|||
143328211|NCT00695669|516742755|FG002|Overall Study|Lost to Follow-up|1|||
143328212|NCT00695669|516742756|FG003|Overall Study|Lost to Follow-up|4|||
143328213|NCT05045625|516742757|FG000|Overall Study|Lost to Follow-up|3|||
143328214|NCT00047879|516742758|FG000|Overall Study|Progressive disease|4|||
143328215|NCT00047879|516742759|FG001|Overall Study|Progressive disease|3|||
143328216|NCT01003249|516742765|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
143328217|NCT01003249|516742766|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
143328218|NCT01003249|516742765|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
143328219|NCT01003249|516742766|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
143328220|NCT01003249|516742765|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
143328221|NCT01003249|516742766|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
143328222|NCT01003249|516742765|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
143328223|NCT01003249|516742766|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
143328224|NCT03387852|516742770|FG000|Overall Study|Adverse event (AE)|3|||
143328225|NCT03387852|516742771|FG001|Overall Study|Adverse event (AE)|0|||
143328226|NCT03387852|516742772|FG002|Overall Study|Adverse event (AE)|2|||
143328227|NCT03387852|516742773|FG003|Overall Study|Adverse event (AE)|0|||
143328228|NCT03387852|516742770|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
143328229|NCT03387852|516742771|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
143328230|NCT03387852|516742772|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
143328231|NCT03387852|516742773|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
143328232|NCT03387852|516742770|FG000|Overall Study|Withdrawal by participant|1|||
143328233|NCT03387852|516742771|FG001|Overall Study|Withdrawal by participant|1|||
143328234|NCT03387852|516742772|FG002|Overall Study|Withdrawal by participant|3|||
143328235|NCT03387852|516742773|FG003|Overall Study|Withdrawal by participant|2|||
143328236|NCT03387852|516742770|FG000|Overall Study|Other- Unspecified|1|||
143328237|NCT03387852|516742771|FG001|Overall Study|Other- Unspecified|1|||
143328238|NCT03387852|516742772|FG002|Overall Study|Other- Unspecified|2|||
143328239|NCT03387852|516742773|FG003|Overall Study|Other- Unspecified|1|||
143328240|NCT03387852|516742770|FG000|Overall Study|Poor compliance to protocol|0|||
143328241|NCT03387852|516742771|FG001|Overall Study|Poor compliance to protocol|0|||
143328242|NCT03387852|516742772|FG002|Overall Study|Poor compliance to protocol|0|||
143328243|NCT03387852|516742773|FG003|Overall Study|Poor compliance to protocol|1|||
143328244|NCT03387852|516742770|FG000|Overall Study|Randomized and not treated|0|||
143328245|NCT03387852|516742771|FG001|Overall Study|Randomized and not treated|0|||
143328246|NCT03387852|516742772|FG002|Overall Study|Randomized and not treated|0|||
143328247|NCT03387852|516742773|FG003|Overall Study|Randomized and not treated|1|||
143328248|NCT01218646|516742776|FG000|Overall Study|Adverse Event|0|||
143328249|NCT01218646|516742777|FG001|Overall Study|Adverse Event|0|||
143328250|NCT01218646|516742778|FG002|Overall Study|Adverse Event|1|||
143328251|NCT01218646|516742779|FG003|Overall Study|Adverse Event|0|||
143328252|NCT01218646|516742776|FG000|Overall Study|Lost to Follow-up|1|||
143328253|NCT01218646|516742777|FG001|Overall Study|Lost to Follow-up|0|||
143328254|NCT01218646|516742778|FG002|Overall Study|Lost to Follow-up|0|||
143328255|NCT01218646|516742779|FG003|Overall Study|Lost to Follow-up|0|||
143381617|NCT02576509|516944444|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
143328256|NCT01218646|516742776|FG000|Overall Study|Protocol Violation|0|||
143328257|NCT01218646|516742777|FG001|Overall Study|Protocol Violation|0|||
143328258|NCT01218646|516742778|FG002|Overall Study|Protocol Violation|1|||
143328259|NCT01218646|516742779|FG003|Overall Study|Protocol Violation|1|||
143328260|NCT00722761|516742780|FG000|Overall Study|Lost to Follow-up|1|||
143328261|NCT00722761|516742781|FG001|Overall Study|Lost to Follow-up|4|||
143328262|NCT00722761|516742780|FG000|Overall Study|Withdrawal by Subject|5|||
143381618|NCT02576509|516944443|FG000|Treatment Period|Disease progression|263|||
143381619|NCT02576509|516944444|FG001|Treatment Period|Disease progression|244|||
143381620|NCT02576509|516944443|FG000|Treatment Period|Study drug toxicity|37|||
143381621|NCT02576509|516944444|FG001|Treatment Period|Study drug toxicity|41|||
143381622|NCT02576509|516944443|FG000|Treatment Period|Death|1|||
143381623|NCT02576509|516944444|FG001|Treatment Period|Death|1|||
143381624|NCT02576509|516944443|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
143381625|NCT02576509|516944444|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
143381626|NCT02576509|516944443|FG000|Treatment Period|Participant request to stop treatment|8|||
143381627|NCT02576509|516944444|FG001|Treatment Period|Participant request to stop treatment|18|||
143381628|NCT02576509|516944443|FG000|Treatment Period|Participant withdrew consent|3|||
143381629|NCT02576509|516944444|FG001|Treatment Period|Participant withdrew consent|7|||
143381630|NCT02576509|516944443|FG000|Treatment Period|Lost to Follow-up|0|||
143381631|NCT02576509|516944444|FG001|Treatment Period|Lost to Follow-up|1|||
143381632|NCT02576509|516944443|FG000|Treatment Period|Maximum clinical benefit|1|||
143381633|NCT02576509|516944444|FG001|Treatment Period|Maximum clinical benefit|0|||
143381634|NCT02576509|516944443|FG000|Treatment Period|Poor/non-compliance|1|||
143381635|NCT02576509|516944444|FG001|Treatment Period|Poor/non-compliance|1|||
143381636|NCT02576509|516944443|FG000|Treatment Period|Participant no longer meets criteria|1|||
143381637|NCT02576509|516944444|FG001|Treatment Period|Participant no longer meets criteria|0|||
143381638|NCT02576509|516944443|FG000|Treatment Period|Other reason|12|||
143381639|NCT02576509|516944444|FG001|Treatment Period|Other reason|8|||
143381640|NCT02576509|516944443|FG000|Treatment Period|NOT REPORTED|1|||
143381641|NCT02576509|516944444|FG001|Treatment Period|NOT REPORTED|0|||
143381642|NCT02576509|516944443|FG000|Treatment Period|Administrative reason by sponsor|0|||
143381643|NCT02576509|516944444|FG001|Treatment Period|Administrative reason by sponsor|1|||
143381644|NCT01643070|516944447|FG000|Overall Study|Withdrawal by Subject|3|||
143381645|NCT01643070|516944448|FG001|Overall Study|Withdrawal by Subject|1|||
143381646|NCT01643070|516944447|FG000|Overall Study|Death|1|||
143381647|NCT01643070|516944448|FG001|Overall Study|Death|0|||
143381648|NCT01643070|516944447|FG000|Overall Study|Pregressive disease|0|||
143381649|NCT01643070|516944448|FG001|Overall Study|Pregressive disease|2|||
143381650|NCT03398148|516944449|FG000|Substudy 1 Period 1|Adverse Event|5|||
143328263|NCT00722761|516742781|FG001|Overall Study|Withdrawal by Subject|2|||
143328264|NCT02075593|516742782|FG000|Overall Study|Withdrawal by Subject|1|||
143328265|NCT04414696|516742785|FG000|3-month Follow up|Withdrawal by Subject|1|||
143328266|NCT04414696|516742786|FG001|3-month Follow up|Withdrawal by Subject|0|||
143328267|NCT04414696|516742785|FG000|3-month Follow up|Lost to Follow-up|22|||
143328268|NCT04414696|516742786|FG001|3-month Follow up|Lost to Follow-up|23|||
143328269|NCT04414696|516742785|FG000|6-month Follow up|Withdrawal by Subject|1|||
143328270|NCT04414696|516742786|FG001|6-month Follow up|Withdrawal by Subject|2|||
143328271|NCT04414696|516742785|FG000|6-month Follow up|Lost to Follow-up|5|||
143328272|NCT04414696|516742786|FG001|6-month Follow up|Lost to Follow-up|2|||
143328273|NCT05819749|516742787|FG000|Overall Study|Lost to Follow-up|1|||
143328274|NCT00726752|516742788|FG000|Overall Study|Lack of Efficacy|6|||
143328275|NCT00924287|516744798|FG000|Overall Study|Death|1|||
143328276|NCT00907153|516744806|FG000|Overall Study|Lost to Follow-up|1|||
143328277|NCT00907153|516744807|FG001|Overall Study|Lost to Follow-up|1|||
143328278|NCT00907153|516744806|FG000|Overall Study|Withdrawal by Subject|1|||
143328279|NCT00907153|516744807|FG001|Overall Study|Withdrawal by Subject|3|||
143328280|NCT01983293|516744810|FG000|Overall Study|Withdrawal by Subject|29|||
143328281|NCT01983293|516744811|FG001|Overall Study|Withdrawal by Subject|15|||
143328282|NCT01983293|516744810|FG000|Overall Study|Missing 12-month visit|3|||
143328283|NCT01983293|516744811|FG001|Overall Study|Missing 12-month visit|3|||
143328284|NCT01983293|516744810|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
143328285|NCT01983293|516744811|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
143328286|NCT02522494|516744818|FG000|Overall Study|Lost to Follow-up|6|||
143328287|NCT02522494|516744819|FG001|Overall Study|Lost to Follow-up|2|||
143328288|NCT02522494|516744818|FG000|Overall Study|Withdrawal by Subject|1|||
143328289|NCT02522494|516744819|FG001|Overall Study|Withdrawal by Subject|0|||
143381651|NCT03398148|516944450|FG001|Substudy 1 Period 1|Adverse Event|2|||
143381652|NCT03398148|516944451|FG002|Substudy 1 Period 1|Adverse Event|2|||
143381653|NCT03398148|516944452|FG003|Substudy 1 Period 1|Adverse Event|0|||
143328290|NCT02522494|516744818|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
143328291|NCT02522494|516744819|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
143328292|NCT02522494|516744818|FG000|Overall Study|Participant did not watch the video|1|||
143381654|NCT03398148|516944453|FG004|Substudy 1 Period 1|Adverse Event|8|||
143381655|NCT03398148|516944454|FG005|Substudy 1 Period 1|Adverse Event|0|||
143381656|NCT03398148|516944455|FG006|Substudy 1 Period 1|Adverse Event|0|||
143381657|NCT03398148|516944456|FG007|Substudy 1 Period 1|Adverse Event|0|||
143381658|NCT03398148|516944457|FG008|Substudy 1 Period 1|Adverse Event|0|||
143328293|NCT02522494|516744819|FG001|Overall Study|Participant did not watch the video|0|||
143328294|NCT02522494|516744818|FG000|Overall Study|Death|0|||
143381659|NCT03398148|516944458|FG009|Substudy 1 Period 1|Adverse Event|0|||
143381660|NCT03398148|516944459|FG010|Substudy 1 Period 1|Adverse Event|0|||
143381661|NCT03398148|516944460|FG011|Substudy 1 Period 1|Adverse Event|0|||
143381662|NCT03398148|516944461|FG012|Substudy 1 Period 1|Adverse Event|0|||
143381663|NCT03398148|516944462|FG013|Substudy 1 Period 1|Adverse Event|0|||
143328295|NCT02522494|516744819|FG001|Overall Study|Death|1|||
143328296|NCT02388724|516744824|FG000|Overall Study|Reason not Specified|0|||
143328297|NCT02388724|516744825|FG001|Overall Study|Reason not Specified|1|||
143328298|NCT02388724|516744824|FG000|Overall Study|Major Protocol Deviation|3|||
143328299|NCT02388724|516744825|FG001|Overall Study|Major Protocol Deviation|3|||
143328300|NCT02388724|516744824|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
143328301|NCT02388724|516744825|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
143328302|NCT02388724|516744824|FG000|Overall Study|Voluntary Withdrawal|6|||
143328303|NCT02388724|516744825|FG001|Overall Study|Voluntary Withdrawal|5|||
143328304|NCT02388724|516744824|FG000|Overall Study|Randomized but not Treated|0|||
143328305|NCT02388724|516744825|FG001|Overall Study|Randomized but not Treated|2|||
143328306|NCT03461003|516744826|FG000|Overall Study|Lost to Follow-up|2|||
143328307|NCT03461003|516744827|FG001|Overall Study|Lost to Follow-up|2|||
143328308|NCT03461003|516744826|FG000|Overall Study|Withdrawal by Subject|3|||
143328309|NCT03461003|516744827|FG001|Overall Study|Withdrawal by Subject|1|||
143328310|NCT02047045|516744833|FG000|Baseline|Withdrawal by Subject|3|||
143328311|NCT02047045|516744834|FG001|Baseline|Withdrawal by Subject|2|||
143328312|NCT02047045|516744833|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
143328313|NCT02047045|516744834|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
143328314|NCT02047045|516744833|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
143328315|NCT02047045|516744834|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
143328316|NCT02047045|516744833|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
143328317|NCT02047045|516744834|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
143328318|NCT02047045|516744833|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
143328319|NCT02047045|516744834|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
143328320|NCT02047045|516744833|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
143328321|NCT02047045|516744834|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
143328322|NCT02047045|516744833|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
143328323|NCT02047045|516744834|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
143328324|NCT02047045|516744833|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
143328325|NCT02047045|516744834|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
143328326|NCT02047045|516744833|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
143328327|NCT02047045|516744834|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
143328328|NCT03508843|516744835|FG000|Overall Study|Withdrawal by Subject|1|||
143328329|NCT03508843|516744835|FG000|Overall Study|technical difficulties|2|||
143328330|NCT04066114|516744836|FG000|Overall Study|Adverse Event|1|||
143328331|NCT04066114|516744837|FG001|Overall Study|Adverse Event|0|||
143328332|NCT04066114|516744838|FG002|Overall Study|Adverse Event|0|||
143328333|NCT04066114|516744836|FG000|Overall Study|Withdrawal by Subject|1|||
143328334|NCT04066114|516744837|FG001|Overall Study|Withdrawal by Subject|0|||
143328335|NCT04066114|516744838|FG002|Overall Study|Withdrawal by Subject|0|||
143328336|NCT04066114|516744836|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
143328337|NCT04066114|516744837|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
143328338|NCT04066114|516744838|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
143328339|NCT02460991|516744840|FG000|Overall Study|Withdrawal by Subject|0|||
143328340|NCT02460991|516744841|FG001|Overall Study|Withdrawal by Subject|2|||
143328341|NCT00856856|516744842|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
143328342|NCT00856856|516744842|FG000|4-year Clinical Follow-up|Missed visit|1|||
143328343|NCT02117570|516744845|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
143328344|NCT02117570|516744846|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
143328345|NCT02117570|516744847|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
143328346|NCT02117570|516744845|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
143328347|NCT02117570|516744846|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
143328348|NCT02117570|516744847|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
143328349|NCT02117570|516744845|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
143328350|NCT02117570|516744846|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
143328351|NCT02117570|516744847|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
143328352|NCT02117570|516744845|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
143328353|NCT02117570|516744846|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
143328354|NCT02117570|516744847|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
143328355|NCT02117570|516744845|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
143328356|NCT02117570|516744846|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
143328357|NCT02117570|516744847|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
143328358|NCT02117570|516744845|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
143328359|NCT02117570|516744846|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
143328360|NCT02117570|516744847|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
143381664|NCT03398148|516944463|FG014|Substudy 1 Period 1|Adverse Event|0|||
143381665|NCT03398148|516944449|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
143328361|NCT02117570|516744845|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
143328362|NCT02117570|516744846|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
143328363|NCT02117570|516744847|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
143328364|NCT01296568|516744867|FG000|Continued Access Phase|Lost to Follow-up|1|||
143328365|NCT01296568|516744867|FG000|Continued Access Phase|Withdrawal by Subject|1|||
143328366|NCT01296568|516744867|FG000|Continued Access Phase|Disease Progression|1|||
143328367|NCT04723576|516744870|FG000|Overall Study|Withdrawal by Subject|2133|||
143328368|NCT04723576|516744871|FG001|Overall Study|Withdrawal by Subject|3234|||
143328369|NCT00413153|516744872|FG000|Overall Study|Withdrawal by Subject|1|||
143328370|NCT00413153|516744873|FG001|Overall Study|Withdrawal by Subject|1|||
143328371|NCT00413153|516744872|FG000|Overall Study|Adverse Event|1|||
143328372|NCT00413153|516744873|FG001|Overall Study|Adverse Event|0|||
143328373|NCT04004611|516744874|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
143328374|NCT04004611|516744875|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
143328375|NCT04004611|516744876|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
143328376|NCT04004611|516744877|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
143328377|NCT04004611|516744878|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
143328378|NCT04004611|516744879|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
143328379|NCT04004611|516744880|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
143328380|NCT04004611|516744881|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
143328381|NCT04004611|516744882|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
143328382|NCT04004611|516744874|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
143328383|NCT04004611|516744875|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
143328384|NCT04004611|516744876|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
143328385|NCT04004611|516744877|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
143328386|NCT04004611|516744878|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
143328387|NCT04004611|516744879|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
143328388|NCT04004611|516744880|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
143328389|NCT04004611|516744881|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
143328390|NCT04004611|516744882|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
143328391|NCT04004611|516744874|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
143328392|NCT04004611|516744875|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
143328393|NCT04004611|516744876|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
143328394|NCT04004611|516744877|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
143328395|NCT04004611|516744878|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
143328396|NCT04004611|516744879|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
143328397|NCT04004611|516744880|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
143328398|NCT04004611|516744881|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
143328399|NCT04004611|516744882|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
143328400|NCT04004611|516744874|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
143328401|NCT04004611|516744875|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
143328402|NCT04004611|516744876|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
143328403|NCT04004611|516744877|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
143328404|NCT04004611|516744878|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
143328405|NCT04004611|516744879|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
143328406|NCT04004611|516744880|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
143328407|NCT04004611|516744881|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
143328408|NCT04004611|516744882|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
143328409|NCT04004611|516744874|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
143328410|NCT04004611|516744875|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
143328411|NCT04004611|516744876|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
143328412|NCT04004611|516744877|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
143328413|NCT04004611|516744878|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
143328414|NCT04004611|516744879|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
143328415|NCT04004611|516744880|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
143328416|NCT04004611|516744881|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
143328417|NCT04004611|516744882|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
143328418|NCT04004611|516744874|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
143328419|NCT04004611|516744875|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
143328420|NCT04004611|516744876|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
143328421|NCT04004611|516744877|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
143328422|NCT04004611|516744878|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
143328423|NCT04004611|516744879|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
143328424|NCT04004611|516744880|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
143328425|NCT04004611|516744881|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
143381666|NCT03398148|516944450|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
143381667|NCT03398148|516944451|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
143381668|NCT03398148|516944452|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
143381669|NCT03398148|516944453|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
143381670|NCT03398148|516944454|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
143381671|NCT03398148|516944455|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
143381672|NCT03398148|516944456|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
143381673|NCT03398148|516944457|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
143381674|NCT03398148|516944458|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
143381675|NCT03398148|516944459|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
143381676|NCT03398148|516944460|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
143381677|NCT03398148|516944461|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
143381678|NCT03398148|516944462|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
143381679|NCT03398148|516944463|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
143381680|NCT03398148|516944449|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
143381681|NCT03398148|516944450|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
143381682|NCT03398148|516944451|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
143381683|NCT03398148|516944452|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
143381684|NCT03398148|516944453|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
143381685|NCT03398148|516944454|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
143381686|NCT03398148|516944455|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
143381687|NCT03398148|516944456|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
143381688|NCT03398148|516944457|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
143381689|NCT03398148|516944458|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
143381690|NCT03398148|516944459|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
143381691|NCT03398148|516944460|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
143381692|NCT03398148|516944461|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
143381693|NCT03398148|516944462|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
143381694|NCT03398148|516944463|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
143381695|NCT03398148|516944449|FG000|Substudy 1 Period 1|Other|0|||
143381696|NCT03398148|516944450|FG001|Substudy 1 Period 1|Other|1|||
143381697|NCT03398148|516944451|FG002|Substudy 1 Period 1|Other|0|||
143381698|NCT03398148|516944452|FG003|Substudy 1 Period 1|Other|0|||
143381699|NCT03398148|516944453|FG004|Substudy 1 Period 1|Other|3|||
143381700|NCT03398148|516944454|FG005|Substudy 1 Period 1|Other|0|||
143381701|NCT03398148|516944455|FG006|Substudy 1 Period 1|Other|0|||
143381702|NCT03398148|516944456|FG007|Substudy 1 Period 1|Other|0|||
143381703|NCT03398148|516944457|FG008|Substudy 1 Period 1|Other|0|||
143381704|NCT03398148|516944458|FG009|Substudy 1 Period 1|Other|0|||
143381705|NCT03398148|516944459|FG010|Substudy 1 Period 1|Other|0|||
143381706|NCT03398148|516944460|FG011|Substudy 1 Period 1|Other|0|||
143381707|NCT03398148|516944461|FG012|Substudy 1 Period 1|Other|0|||
143381708|NCT03398148|516944462|FG013|Substudy 1 Period 1|Other|0|||
143381709|NCT03398148|516944463|FG014|Substudy 1 Period 1|Other|0|||
143381710|NCT03398148|516944449|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
143381711|NCT03398148|516944450|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
143381712|NCT03398148|516944451|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
143328426|NCT04004611|516744882|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
143328427|NCT03263429|516744883|FG000|Overall Study|Withdrawal by Subject|0|||
143328428|NCT03263429|516744884|FG001|Overall Study|Withdrawal by Subject|1|||
143328429|NCT03263429|516744885|FG002|Overall Study|Withdrawal by Subject|0|||
143328430|NCT03263429|516744883|FG000|Overall Study|Follow-Up Period Completed|0|||
143328431|NCT03263429|516744884|FG001|Overall Study|Follow-Up Period Completed|2|||
143328432|NCT03263429|516744885|FG002|Overall Study|Follow-Up Period Completed|0|||
143328433|NCT03263429|516744883|FG000|Overall Study|Death|3|||
143328434|NCT03263429|516744884|FG001|Overall Study|Death|5|||
143328435|NCT03263429|516744885|FG002|Overall Study|Death|16|||
143328436|NCT03263429|516744883|FG000|Overall Study|Participant unable to return|0|||
143328437|NCT03263429|516744884|FG001|Overall Study|Participant unable to return|0|||
143328438|NCT03263429|516744885|FG002|Overall Study|Participant unable to return|1|||
143328439|NCT03263429|516744883|FG000|Overall Study|Study Closed|0|||
143381713|NCT03398148|516944452|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
143381714|NCT03398148|516944453|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
143381715|NCT03398148|516944454|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
143381716|NCT03398148|516944455|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
143381717|NCT03398148|516944456|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
143381718|NCT03398148|516944457|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
143381719|NCT03398148|516944458|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
143381720|NCT03398148|516944459|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
143381721|NCT03398148|516944460|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
143381722|NCT03398148|516944461|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
143381723|NCT03398148|516944462|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
143381724|NCT03398148|516944463|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
143381725|NCT03398148|516944449|FG000|Substudy 1 Period 2|Adverse Event|0|||
143381726|NCT03398148|516944450|FG001|Substudy 1 Period 2|Adverse Event|0|||
143328440|NCT03263429|516744884|FG001|Overall Study|Study Closed|0|||
143381727|NCT03398148|516944451|FG002|Substudy 1 Period 2|Adverse Event|0|||
143381728|NCT03398148|516944452|FG003|Substudy 1 Period 2|Adverse Event|0|||
143381729|NCT03398148|516944453|FG004|Substudy 1 Period 2|Adverse Event|0|||
143381730|NCT03398148|516944454|FG005|Substudy 1 Period 2|Adverse Event|2|||
143381731|NCT03398148|516944455|FG006|Substudy 1 Period 2|Adverse Event|4|||
143381732|NCT03398148|516944456|FG007|Substudy 1 Period 2|Adverse Event|0|||
143381733|NCT03398148|516944457|FG008|Substudy 1 Period 2|Adverse Event|0|||
143381734|NCT03398148|516944458|FG009|Substudy 1 Period 2|Adverse Event|0|||
143381735|NCT03398148|516944459|FG010|Substudy 1 Period 2|Adverse Event|0|||
143381736|NCT03398148|516944460|FG011|Substudy 1 Period 2|Adverse Event|0|||
143381737|NCT03398148|516944461|FG012|Substudy 1 Period 2|Adverse Event|0|||
143381738|NCT03398148|516944462|FG013|Substudy 1 Period 2|Adverse Event|0|||
143381739|NCT03398148|516944463|FG014|Substudy 1 Period 2|Adverse Event|0|||
143381740|NCT03398148|516944449|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
143381741|NCT03398148|516944450|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
143381742|NCT03398148|516944451|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
143381743|NCT03398148|516944452|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
143381744|NCT03398148|516944453|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
143381745|NCT03398148|516944454|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
143381746|NCT03398148|516944455|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
143381747|NCT03398148|516944456|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
143381748|NCT03398148|516944457|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
143381749|NCT03398148|516944458|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
143381750|NCT03398148|516944459|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
143381751|NCT03398148|516944460|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
143381752|NCT03398148|516944461|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
143381753|NCT03398148|516944462|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
143381754|NCT03398148|516944463|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
143381755|NCT03398148|516944449|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
143381756|NCT03398148|516944450|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
143381757|NCT03398148|516944451|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
143328441|NCT03263429|516744885|FG002|Overall Study|Study Closed|1|||
143328442|NCT01519206|516744886|FG000|Overall Study|Lost to Follow-up|3|||
143328443|NCT01519206|516744886|FG000|Overall Study|Missed Visit|2|||
143328444|NCT03526250|516744892|FG000|Overall Study|Adverse Event|4|||
143328445|NCT03526250|516744892|FG000|Overall Study|Progressive Disease|16|||
143328446|NCT03526250|516744892|FG000|Overall Study|No Treatment|3|||
143328447|NCT04420221|516744893|FG000|Overall Study|Withdrawal by Subject|0|||
143328448|NCT04420221|516744894|FG001|Overall Study|Withdrawal by Subject|0|||
143328449|NCT04420221|516744895|FG002|Overall Study|Withdrawal by Subject|0|||
143328450|NCT04420221|516744896|FG003|Overall Study|Withdrawal by Subject|0|||
143328451|NCT04420221|516744897|FG004|Overall Study|Withdrawal by Subject|0|||
143328452|NCT04420221|516744898|FG005|Overall Study|Withdrawal by Subject|20|||
143328453|NCT04420221|516744899|FG006|Overall Study|Withdrawal by Subject|5|||
143328454|NCT04420221|516744893|FG000|Overall Study|Other|0|||
143328455|NCT04420221|516744894|FG001|Overall Study|Other|0|||
143328456|NCT04420221|516744895|FG002|Overall Study|Other|0|||
143328457|NCT04420221|516744896|FG003|Overall Study|Other|0|||
143328458|NCT04420221|516744897|FG004|Overall Study|Other|0|||
143328459|NCT04420221|516744898|FG005|Overall Study|Other|1|||
143328460|NCT04420221|516744899|FG006|Overall Study|Other|1|||
143328461|NCT04420221|516744893|FG000|Overall Study|Lost to Follow-up|0|||
143328462|NCT04420221|516744894|FG001|Overall Study|Lost to Follow-up|0|||
143328463|NCT04420221|516744895|FG002|Overall Study|Lost to Follow-up|0|||
143328464|NCT04420221|516744896|FG003|Overall Study|Lost to Follow-up|0|||
143381758|NCT03398148|516944452|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
143381759|NCT03398148|516944453|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
143381760|NCT03398148|516944454|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
143381761|NCT03398148|516944455|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
143381762|NCT03398148|516944456|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
143381763|NCT03398148|516944457|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
143381764|NCT03398148|516944458|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
143381765|NCT03398148|516944459|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
143381766|NCT03398148|516944460|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
143381767|NCT03398148|516944461|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
143381768|NCT03398148|516944462|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
143381769|NCT03398148|516944463|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
143381770|NCT03398148|516944449|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
143381771|NCT03398148|516944450|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
143381772|NCT03398148|516944451|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
143381773|NCT03398148|516944452|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
143328465|NCT04420221|516744897|FG004|Overall Study|Lost to Follow-up|0|||
143328466|NCT04420221|516744898|FG005|Overall Study|Lost to Follow-up|3|||
143328467|NCT04420221|516744899|FG006|Overall Study|Lost to Follow-up|2|||
143328468|NCT04420221|516744893|FG000|Overall Study|Migrated / Moved from the Study Area|0|||
143328469|NCT04420221|516744894|FG001|Overall Study|Migrated / Moved from the Study Area|0|||
143328470|NCT04420221|516744895|FG002|Overall Study|Migrated / Moved from the Study Area|0|||
143328471|NCT04420221|516744896|FG003|Overall Study|Migrated / Moved from the Study Area|0|||
143328472|NCT04420221|516744897|FG004|Overall Study|Migrated / Moved from the Study Area|0|||
143328473|NCT04420221|516744898|FG005|Overall Study|Migrated / Moved from the Study Area|1|||
143328474|NCT04420221|516744899|FG006|Overall Study|Migrated / Moved from the Study Area|2|||
143328475|NCT02647359|516744900|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
143328476|NCT02647359|516744901|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
143328477|NCT02647359|516744900|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
143328478|NCT02647359|516744901|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
143328479|NCT02647359|516744900|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
143328480|NCT02647359|516744901|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
143328481|NCT02647359|516744900|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
143328482|NCT02647359|516744901|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
143328483|NCT02647359|516744900|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
143328484|NCT02647359|516744901|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
143328485|NCT02647359|516744900|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
143328486|NCT02647359|516744901|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
143328487|NCT04642638|516744902|FG000|Overall Study|Withdrawal by Subject|23|||
143328488|NCT04642638|516744903|FG001|Overall Study|Withdrawal by Subject|29|||
143328489|NCT04642638|516744904|FG002|Overall Study|Withdrawal by Subject|9|||
143328490|NCT04642638|516744905|FG003|Overall Study|Withdrawal by Subject|7|||
143328491|NCT04642638|516744906|FG004|Overall Study|Withdrawal by Subject|61|||
143328492|NCT04642638|516744907|FG005|Overall Study|Withdrawal by Subject|27|||
143328493|NCT04642638|516744902|FG000|Overall Study|Lost to Follow-up|17|||
143328494|NCT04642638|516744903|FG001|Overall Study|Lost to Follow-up|18|||
143328495|NCT04642638|516744904|FG002|Overall Study|Lost to Follow-up|5|||
143328496|NCT04642638|516744905|FG003|Overall Study|Lost to Follow-up|5|||
143328497|NCT04642638|516744906|FG004|Overall Study|Lost to Follow-up|6|||
143328498|NCT04642638|516744907|FG005|Overall Study|Lost to Follow-up|3|||
143328499|NCT04642638|516744902|FG000|Overall Study|Adverse Event|0|||
143328500|NCT04642638|516744903|FG001|Overall Study|Adverse Event|0|||
143328501|NCT04642638|516744904|FG002|Overall Study|Adverse Event|1|||
143328502|NCT04642638|516744905|FG003|Overall Study|Adverse Event|0|||
143328503|NCT04642638|516744906|FG004|Overall Study|Adverse Event|10|||
143328504|NCT04642638|516744907|FG005|Overall Study|Adverse Event|3|||
143328505|NCT04642638|516744902|FG000|Overall Study|Reason Not Specified|1|||
143328506|NCT04642638|516744903|FG001|Overall Study|Reason Not Specified|4|||
143328507|NCT04642638|516744904|FG002|Overall Study|Reason Not Specified|0|||
143328508|NCT04642638|516744905|FG003|Overall Study|Reason Not Specified|0|||
143328509|NCT04642638|516744906|FG004|Overall Study|Reason Not Specified|38|||
143328510|NCT04642638|516744907|FG005|Overall Study|Reason Not Specified|16|||
143328511|NCT04642638|516744902|FG000|Overall Study|Physician Decision|0|||
143328512|NCT04642638|516744903|FG001|Overall Study|Physician Decision|0|||
143328513|NCT04642638|516744904|FG002|Overall Study|Physician Decision|0|||
143328514|NCT04642638|516744905|FG003|Overall Study|Physician Decision|0|||
143328515|NCT04642638|516744906|FG004|Overall Study|Physician Decision|2|||
143328516|NCT04642638|516744907|FG005|Overall Study|Physician Decision|1|||
143328517|NCT04642638|516744902|FG000|Overall Study|Protocol Deviation|0|||
143328518|NCT04642638|516744903|FG001|Overall Study|Protocol Deviation|0|||
143328519|NCT04642638|516744904|FG002|Overall Study|Protocol Deviation|0|||
143328520|NCT04642638|516744905|FG003|Overall Study|Protocol Deviation|0|||
143328521|NCT04642638|516744906|FG004|Overall Study|Protocol Deviation|1|||
143328522|NCT04642638|516744907|FG005|Overall Study|Protocol Deviation|3|||
143328523|NCT04642638|516744902|FG000|Overall Study|Study Terminated|0|||
143328524|NCT04642638|516744903|FG001|Overall Study|Study Terminated|0|||
143328525|NCT04642638|516744904|FG002|Overall Study|Study Terminated|0|||
143328526|NCT04642638|516744905|FG003|Overall Study|Study Terminated|0|||
143328527|NCT04642638|516744906|FG004|Overall Study|Study Terminated|484|||
143328528|NCT04642638|516744907|FG005|Overall Study|Study Terminated|250|||
143328529|NCT04642638|516744902|FG000|Overall Study|Pregnancy|0|||
143328530|NCT04642638|516744903|FG001|Overall Study|Pregnancy|0|||
143328531|NCT04642638|516744904|FG002|Overall Study|Pregnancy|0|||
143328532|NCT04642638|516744905|FG003|Overall Study|Pregnancy|0|||
143328533|NCT04642638|516744906|FG004|Overall Study|Pregnancy|1|||
143328534|NCT04642638|516744907|FG005|Overall Study|Pregnancy|0|||
143328535|NCT00511004|516744908|FG000|Overall Study|Lost to Follow-up|0|||
143328536|NCT00511004|516744909|FG001|Overall Study|Lost to Follow-up|0|||
143328537|NCT00511004|516744910|FG002|Overall Study|Lost to Follow-up|4|||
143328538|NCT00990652|516744911|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
143328539|NCT00990652|516744911|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
143328540|NCT01672801|516744918|FG000|Overall Study|Screen Failure|0|||
143328541|NCT01672801|516744919|FG001|Overall Study|Screen Failure|1|||
143328542|NCT02384954|516744929|FG000|Phase 1|Progressive Disease|2|||
143328543|NCT02384954|516744930|FG001|Phase 1|Progressive Disease|0|||
143328544|NCT02384954|516744931|FG002|Phase 1|Progressive Disease|1|||
143328545|NCT02384954|516744932|FG003|Phase 1|Progressive Disease|1|||
143381774|NCT03398148|516944453|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
143381775|NCT03398148|516944454|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
143381776|NCT03398148|516944455|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
143381777|NCT03398148|516944456|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
143381778|NCT03398148|516944457|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
143381779|NCT03398148|516944458|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
143381780|NCT03398148|516944459|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
143381781|NCT03398148|516944460|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
143381782|NCT03398148|516944461|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
143381783|NCT03398148|516944462|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
143381784|NCT03398148|516944463|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
143381785|NCT03398148|516944449|FG000|Substudy 1 Period 2|Other|0|||
143381786|NCT03398148|516944450|FG001|Substudy 1 Period 2|Other|0|||
143381787|NCT03398148|516944451|FG002|Substudy 1 Period 2|Other|0|||
143381788|NCT03398148|516944452|FG003|Substudy 1 Period 2|Other|0|||
143381789|NCT03398148|516944453|FG004|Substudy 1 Period 2|Other|0|||
143381790|NCT03398148|516944454|FG005|Substudy 1 Period 2|Other|0|||
143381791|NCT03398148|516944455|FG006|Substudy 1 Period 2|Other|1|||
143381792|NCT03398148|516944456|FG007|Substudy 1 Period 2|Other|0|||
143381793|NCT03398148|516944457|FG008|Substudy 1 Period 2|Other|0|||
143381794|NCT03398148|516944458|FG009|Substudy 1 Period 2|Other|0|||
143381795|NCT03398148|516944459|FG010|Substudy 1 Period 2|Other|0|||
143381796|NCT03398148|516944460|FG011|Substudy 1 Period 2|Other|0|||
143381797|NCT03398148|516944461|FG012|Substudy 1 Period 2|Other|0|||
143381798|NCT03398148|516944462|FG013|Substudy 1 Period 2|Other|0|||
143381799|NCT03398148|516944463|FG014|Substudy 1 Period 2|Other|0|||
143381800|NCT03398148|516944449|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
143381801|NCT03398148|516944450|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
143381802|NCT03398148|516944451|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
143381803|NCT03398148|516944452|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
143381804|NCT03398148|516944453|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
143381805|NCT03398148|516944454|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
143381806|NCT03398148|516944455|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
143381807|NCT03398148|516944456|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
143381808|NCT03398148|516944457|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
143381809|NCT03398148|516944458|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
143381810|NCT03398148|516944459|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
143381811|NCT03398148|516944460|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
143381812|NCT03398148|516944461|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
143381813|NCT03398148|516944462|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
143381814|NCT03398148|516944463|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
143381815|NCT03398148|516944449|FG000|Substudy 2 Period 1|Adverse Event|0|||
143381816|NCT03398148|516944450|FG001|Substudy 2 Period 1|Adverse Event|0|||
143381817|NCT03398148|516944451|FG002|Substudy 2 Period 1|Adverse Event|0|||
143381818|NCT03398148|516944452|FG003|Substudy 2 Period 1|Adverse Event|0|||
143381819|NCT03398148|516944453|FG004|Substudy 2 Period 1|Adverse Event|0|||
143381820|NCT03398148|516944454|FG005|Substudy 2 Period 1|Adverse Event|0|||
143381821|NCT03398148|516944455|FG006|Substudy 2 Period 1|Adverse Event|0|||
143381822|NCT03398148|516944456|FG007|Substudy 2 Period 1|Adverse Event|0|||
143381823|NCT03398148|516944457|FG008|Substudy 2 Period 1|Adverse Event|0|||
143381824|NCT03398148|516944458|FG009|Substudy 2 Period 1|Adverse Event|12|||
143381825|NCT03398148|516944459|FG010|Substudy 2 Period 1|Adverse Event|2|||
143381826|NCT03398148|516944460|FG011|Substudy 2 Period 1|Adverse Event|0|||
143381827|NCT03398148|516944461|FG012|Substudy 2 Period 1|Adverse Event|0|||
143381828|NCT03398148|516944462|FG013|Substudy 2 Period 1|Adverse Event|0|||
143381829|NCT03398148|516944463|FG014|Substudy 2 Period 1|Adverse Event|0|||
143381830|NCT03398148|516944449|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
143381831|NCT03398148|516944450|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
143381832|NCT03398148|516944451|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
143381833|NCT03398148|516944452|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
143381834|NCT03398148|516944453|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
143381835|NCT03398148|516944454|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
143381836|NCT03398148|516944455|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
143381837|NCT03398148|516944456|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
143381838|NCT03398148|516944457|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
143381839|NCT03398148|516944458|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
143381840|NCT03398148|516944459|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
143381841|NCT03398148|516944460|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
143381842|NCT03398148|516944461|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
143381843|NCT03398148|516944462|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
143381844|NCT03398148|516944463|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
143381845|NCT03398148|516944449|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
143381846|NCT03398148|516944450|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
143381847|NCT03398148|516944451|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
143381848|NCT03398148|516944452|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
143381849|NCT03398148|516944453|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
143381850|NCT03398148|516944454|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
143381851|NCT03398148|516944455|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
143381852|NCT03398148|516944456|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
143381853|NCT03398148|516944457|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
143381854|NCT03398148|516944458|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
143381855|NCT03398148|516944459|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
143381856|NCT03398148|516944460|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
143381857|NCT03398148|516944461|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
143381858|NCT03398148|516944462|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
143381859|NCT03398148|516944463|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
143381860|NCT03398148|516944449|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
143381861|NCT03398148|516944450|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
143381862|NCT03398148|516944451|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
143381863|NCT03398148|516944452|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
143381864|NCT03398148|516944453|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
143381865|NCT03398148|516944454|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
143381866|NCT03398148|516944455|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
143381867|NCT03398148|516944456|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
143381868|NCT03398148|516944457|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
143381869|NCT03398148|516944458|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
143381870|NCT03398148|516944459|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
143381871|NCT03398148|516944460|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
143381872|NCT03398148|516944461|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
143381873|NCT03398148|516944462|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
143381874|NCT03398148|516944463|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
143381875|NCT03398148|516944449|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
143381876|NCT03398148|516944450|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
143381877|NCT03398148|516944451|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
143381878|NCT03398148|516944452|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
143381879|NCT03398148|516944453|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
143381880|NCT03398148|516944454|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
143381881|NCT03398148|516944455|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
143381882|NCT03398148|516944456|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
143381883|NCT03398148|516944457|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
143381884|NCT03398148|516944458|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
143381885|NCT03398148|516944459|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
143381886|NCT03398148|516944460|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
143381887|NCT03398148|516944461|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
143381888|NCT03398148|516944462|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
143381889|NCT03398148|516944463|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
143381890|NCT03398148|516944449|FG000|Substudy 2 Period 1|Other|0|||
143328546|NCT02384954|516744933|FG004|Phase 1|Progressive Disease|0|||
143328547|NCT02384954|516744934|FG005|Phase 1|Progressive Disease|0|||
143328548|NCT02384954|516744935|FG006|Phase 1|Progressive Disease|0|||
143328549|NCT02384954|516744936|FG007|Phase 1|Progressive Disease|0|||
143328550|NCT02384954|516744937|FG008|Phase 1|Progressive Disease|0|||
143328551|NCT02384954|516744929|FG000|Phase 1|Adverse Event|0|||
143328552|NCT02384954|516744930|FG001|Phase 1|Adverse Event|0|||
143328553|NCT02384954|516744931|FG002|Phase 1|Adverse Event|1|||
143328554|NCT02384954|516744932|FG003|Phase 1|Adverse Event|0|||
143328555|NCT02384954|516744933|FG004|Phase 1|Adverse Event|0|||
143328556|NCT02384954|516744934|FG005|Phase 1|Adverse Event|0|||
143328557|NCT02384954|516744935|FG006|Phase 1|Adverse Event|0|||
143328558|NCT02384954|516744936|FG007|Phase 1|Adverse Event|0|||
143328559|NCT02384954|516744937|FG008|Phase 1|Adverse Event|0|||
143328560|NCT02384954|516744929|FG000|Phase 2|Progressive Disease|0|||
143328561|NCT02384954|516744930|FG001|Phase 2|Progressive Disease|0|||
143328562|NCT02384954|516744931|FG002|Phase 2|Progressive Disease|0|||
143328563|NCT02384954|516744932|FG003|Phase 2|Progressive Disease|0|||
143328564|NCT02384954|516744933|FG004|Phase 2|Progressive Disease|0|||
143328565|NCT02384954|516744934|FG005|Phase 2|Progressive Disease|0|||
143328566|NCT02384954|516744935|FG006|Phase 2|Progressive Disease|0|||
143328567|NCT02384954|516744936|FG007|Phase 2|Progressive Disease|1|||
143328568|NCT02384954|516744937|FG008|Phase 2|Progressive Disease|2|||
143328569|NCT02384954|516744929|FG000|Phase 2|Adverse Event|0|||
143381891|NCT03398148|516944450|FG001|Substudy 2 Period 1|Other|0|||
143381892|NCT03398148|516944451|FG002|Substudy 2 Period 1|Other|0|||
143381893|NCT03398148|516944452|FG003|Substudy 2 Period 1|Other|0|||
143328570|NCT02384954|516744930|FG001|Phase 2|Adverse Event|0|||
143328571|NCT02384954|516744931|FG002|Phase 2|Adverse Event|0|||
143328572|NCT02384954|516744932|FG003|Phase 2|Adverse Event|0|||
143381894|NCT03398148|516944453|FG004|Substudy 2 Period 1|Other|0|||
143381895|NCT03398148|516944454|FG005|Substudy 2 Period 1|Other|0|||
143328573|NCT02384954|516744933|FG004|Phase 2|Adverse Event|0|||
143328574|NCT02384954|516744934|FG005|Phase 2|Adverse Event|0|||
143328575|NCT02384954|516744935|FG006|Phase 2|Adverse Event|0|||
143328576|NCT02384954|516744936|FG007|Phase 2|Adverse Event|1|||
143328577|NCT02384954|516744937|FG008|Phase 2|Adverse Event|1|||
143328578|NCT02384954|516744929|FG000|Phase 2|Failure to meet continuation criteria|0|||
143328579|NCT02384954|516744930|FG001|Phase 2|Failure to meet continuation criteria|0|||
143328580|NCT02384954|516744931|FG002|Phase 2|Failure to meet continuation criteria|0|||
143328581|NCT02384954|516744932|FG003|Phase 2|Failure to meet continuation criteria|0|||
143328582|NCT02384954|516744933|FG004|Phase 2|Failure to meet continuation criteria|0|||
143328583|NCT02384954|516744934|FG005|Phase 2|Failure to meet continuation criteria|0|||
143328584|NCT02384954|516744935|FG006|Phase 2|Failure to meet continuation criteria|0|||
143328585|NCT02384954|516744936|FG007|Phase 2|Failure to meet continuation criteria|1|||
143328586|NCT02384954|516744937|FG008|Phase 2|Failure to meet continuation criteria|0|||
143328587|NCT03449030|516744949|FG000|Overall Study|Withdrawal by Subject|0|||
143328588|NCT03449030|516744950|FG001|Overall Study|Withdrawal by Subject|0|||
143328589|NCT03449030|516744951|FG002|Overall Study|Withdrawal by Subject|0|||
143328590|NCT03449030|516744952|FG003|Overall Study|Withdrawal by Subject|1|||
143328591|NCT03449030|516744953|FG004|Overall Study|Withdrawal by Subject|1|||
143328592|NCT03449030|516744954|FG005|Overall Study|Withdrawal by Subject|1|||
143328593|NCT03449030|516744955|FG006|Overall Study|Withdrawal by Subject|1|||
143328594|NCT03449030|516744956|FG007|Overall Study|Withdrawal by Subject|2|||
143328595|NCT03449030|516744957|FG008|Overall Study|Withdrawal by Subject|0|||
143328596|NCT03449030|516744958|FG009|Overall Study|Withdrawal by Subject|0|||
143328597|NCT03449030|516744949|FG000|Overall Study|Symptomatic Deterioration|0|||
143328598|NCT03449030|516744950|FG001|Overall Study|Symptomatic Deterioration|1|||
143328599|NCT03449030|516744951|FG002|Overall Study|Symptomatic Deterioration|0|||
143328600|NCT03449030|516744952|FG003|Overall Study|Symptomatic Deterioration|0|||
143328601|NCT03449030|516744953|FG004|Overall Study|Symptomatic Deterioration|0|||
143328602|NCT03449030|516744954|FG005|Overall Study|Symptomatic Deterioration|1|||
143328603|NCT03449030|516744955|FG006|Overall Study|Symptomatic Deterioration|1|||
143328604|NCT03449030|516744956|FG007|Overall Study|Symptomatic Deterioration|0|||
143328605|NCT03449030|516744957|FG008|Overall Study|Symptomatic Deterioration|2|||
143328606|NCT03449030|516744958|FG009|Overall Study|Symptomatic Deterioration|0|||
143328607|NCT03449030|516744949|FG000|Overall Study|Progressive Disease|1|||
143328608|NCT03449030|516744950|FG001|Overall Study|Progressive Disease|0|||
143328609|NCT03449030|516744951|FG002|Overall Study|Progressive Disease|1|||
143328610|NCT03449030|516744952|FG003|Overall Study|Progressive Disease|4|||
143328611|NCT03449030|516744953|FG004|Overall Study|Progressive Disease|5|||
143328612|NCT03449030|516744954|FG005|Overall Study|Progressive Disease|3|||
143328613|NCT03449030|516744955|FG006|Overall Study|Progressive Disease|0|||
143328614|NCT03449030|516744956|FG007|Overall Study|Progressive Disease|1|||
143328615|NCT03449030|516744957|FG008|Overall Study|Progressive Disease|1|||
143328616|NCT03449030|516744958|FG009|Overall Study|Progressive Disease|1|||
143328617|NCT03449030|516744949|FG000|Overall Study|Adverse Event|0|||
143328618|NCT03449030|516744950|FG001|Overall Study|Adverse Event|0|||
143328619|NCT03449030|516744951|FG002|Overall Study|Adverse Event|0|||
143328620|NCT03449030|516744952|FG003|Overall Study|Adverse Event|0|||
143328621|NCT03449030|516744953|FG004|Overall Study|Adverse Event|0|||
143328622|NCT03449030|516744954|FG005|Overall Study|Adverse Event|2|||
143328623|NCT03449030|516744955|FG006|Overall Study|Adverse Event|0|||
143328624|NCT03449030|516744956|FG007|Overall Study|Adverse Event|0|||
143328625|NCT03449030|516744957|FG008|Overall Study|Adverse Event|0|||
143328626|NCT03449030|516744958|FG009|Overall Study|Adverse Event|0|||
143328627|NCT03449030|516744949|FG000|Overall Study|Death|0|||
143328628|NCT03449030|516744950|FG001|Overall Study|Death|0|||
143328629|NCT03449030|516744951|FG002|Overall Study|Death|0|||
143328630|NCT03449030|516744952|FG003|Overall Study|Death|0|||
143328631|NCT03449030|516744953|FG004|Overall Study|Death|1|||
143328632|NCT03449030|516744954|FG005|Overall Study|Death|0|||
143328633|NCT03449030|516744955|FG006|Overall Study|Death|0|||
143328634|NCT03449030|516744956|FG007|Overall Study|Death|0|||
143328635|NCT03449030|516744957|FG008|Overall Study|Death|0|||
143328636|NCT03449030|516744958|FG009|Overall Study|Death|0|||
143328637|NCT03595904|516744960|FG000|Overall Study|Protocol Violation|3|||
143328638|NCT03595904|516744961|FG001|Overall Study|Protocol Violation|1|||
143328639|NCT03595904|516744960|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
143328640|NCT03595904|516744961|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
143328641|NCT03595904|516744960|FG000|Overall Study|Insurance complications|1|||
143328642|NCT03595904|516744961|FG001|Overall Study|Insurance complications|0|||
143328643|NCT03595904|516744960|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
143328644|NCT03595904|516744961|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
143328645|NCT00700401|516744969|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
143328646|NCT00700401|516744969|FG000|Overall Study|Adverse Event|5|||
143328647|NCT00700401|516744969|FG000|Overall Study|Refused Treatment|2|||
143328648|NCT00700401|516744969|FG000|Overall Study|Lost to Follow-up|1|||
143328649|NCT00700401|516744969|FG000|Overall Study|Treatment never started|1|||
143328650|NCT00700401|516744969|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
143328651|NCT00700401|516744969|FG000|Overall Study|Withdrawal by Subject|2|||
143328652|NCT00295750|516744970|FG000|Overall Study|Adverse Event|19|||
143328653|NCT00295750|516744971|FG001|Overall Study|Adverse Event|15|||
143328654|NCT00295750|516744972|FG002|Overall Study|Adverse Event|12|||
143328655|NCT00295750|516744970|FG000|Overall Study|Lack of Efficacy|1|||
143328656|NCT00295750|516744971|FG001|Overall Study|Lack of Efficacy|1|||
143328657|NCT00295750|516744972|FG002|Overall Study|Lack of Efficacy|0|||
143328658|NCT00295750|516744970|FG000|Overall Study|Lost to Follow-up|1|||
143328659|NCT00295750|516744971|FG001|Overall Study|Lost to Follow-up|4|||
143328660|NCT00295750|516744972|FG002|Overall Study|Lost to Follow-up|1|||
143328661|NCT00295750|516744970|FG000|Overall Study|Taking prohibited therapy|2|||
143328662|NCT00295750|516744971|FG001|Overall Study|Taking prohibited therapy|3|||
143328663|NCT00295750|516744972|FG002|Overall Study|Taking prohibited therapy|2|||
143328664|NCT00295750|516744970|FG000|Overall Study|Administrative errors|2|||
143328665|NCT00295750|516744971|FG001|Overall Study|Administrative errors|4|||
143328666|NCT00295750|516744972|FG002|Overall Study|Administrative errors|5|||
143328667|NCT00295750|516744970|FG000|Overall Study|Trial drug errors|1|||
143328668|NCT00295750|516744971|FG001|Overall Study|Trial drug errors|1|||
143328669|NCT00295750|516744972|FG002|Overall Study|Trial drug errors|0|||
143328670|NCT00295750|516744970|FG000|Overall Study|Disease progression|2|||
143328671|NCT00295750|516744971|FG001|Overall Study|Disease progression|1|||
143328672|NCT00295750|516744972|FG002|Overall Study|Disease progression|0|||
143328673|NCT00295750|516744970|FG000|Overall Study|Personal reasons|0|||
143328674|NCT00295750|516744971|FG001|Overall Study|Personal reasons|1|||
143328675|NCT00295750|516744972|FG002|Overall Study|Personal reasons|0|||
143328676|NCT00295750|516744970|FG000|Overall Study|Randomized but never received trial drug|4|||
143328677|NCT00295750|516744971|FG001|Overall Study|Randomized but never received trial drug|3|||
143328678|NCT00295750|516744972|FG002|Overall Study|Randomized but never received trial drug|3|||
143328679|NCT00295750|516744970|FG000|Overall Study|Withdrawal by Subject|9|||
143328680|NCT00295750|516744971|FG001|Overall Study|Withdrawal by Subject|4|||
143328681|NCT00295750|516744972|FG002|Overall Study|Withdrawal by Subject|7|||
143328682|NCT00295750|516744970|FG000|Overall Study|Protocol Violation|2|||
143328683|NCT00295750|516744971|FG001|Overall Study|Protocol Violation|4|||
143328684|NCT00295750|516744972|FG002|Overall Study|Protocol Violation|2|||
143328685|NCT01650259|516744973|FG000|Overall Study|Improvement|105|||
143328686|NCT01650259|516744974|FG001|Overall Study|Improvement|0|||
143328687|NCT01650259|516744973|FG000|Overall Study|Adverse Event|127|||
143328688|NCT01650259|516744974|FG001|Overall Study|Adverse Event|0|||
143328689|NCT01650259|516744973|FG000|Overall Study|Lack of Efficacy|143|||
143328690|NCT01650259|516744974|FG001|Overall Study|Lack of Efficacy|0|||
143328691|NCT01650259|516744973|FG000|Overall Study|Lost to Follow-up|435|||
143328692|NCT01650259|516744974|FG001|Overall Study|Lost to Follow-up|0|||
143328693|NCT01650259|516744973|FG000|Overall Study|Patients had no visit after entry|70|||
143328694|NCT01650259|516744974|FG001|Overall Study|Patients had no visit after entry|0|||
143328695|NCT01650259|516744973|FG000|Overall Study|CRF not collected|98|||
143328696|NCT01650259|516744974|FG001|Overall Study|CRF not collected|82|||
143328697|NCT01650259|516744973|FG000|Overall Study|Not treated|1|||
143328698|NCT01650259|516744974|FG001|Overall Study|Not treated|7|||
143328699|NCT01650259|516744973|FG000|Overall Study|Other than listed|64|||
143328700|NCT01650259|516744974|FG001|Overall Study|Other than listed|146|||
143328701|NCT00355082|516744980|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
143328702|NCT00355082|516744981|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
143328703|NCT00355082|516744982|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
143328704|NCT00355082|516744980|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
143328705|NCT00355082|516744981|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
143328706|NCT00355082|516744982|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
143328707|NCT00355082|516744980|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
143328708|NCT00355082|516744981|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
143328709|NCT00355082|516744982|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
143328710|NCT00355082|516744980|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
143328711|NCT00355082|516744981|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
143328712|NCT00355082|516744982|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
143381896|NCT03398148|516944455|FG006|Substudy 2 Period 1|Other|0|||
143381897|NCT03398148|516944456|FG007|Substudy 2 Period 1|Other|0|||
143381898|NCT03398148|516944457|FG008|Substudy 2 Period 1|Other|0|||
143381899|NCT03398148|516944458|FG009|Substudy 2 Period 1|Other|4|||
143381900|NCT03398148|516944459|FG010|Substudy 2 Period 1|Other|4|||
143381901|NCT03398148|516944460|FG011|Substudy 2 Period 1|Other|0|||
143381902|NCT03398148|516944461|FG012|Substudy 2 Period 1|Other|0|||
143381903|NCT03398148|516944462|FG013|Substudy 2 Period 1|Other|0|||
143381904|NCT03398148|516944463|FG014|Substudy 2 Period 1|Other|0|||
143381905|NCT03398148|516944449|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
143381906|NCT03398148|516944450|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
143381907|NCT03398148|516944451|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
143381908|NCT03398148|516944452|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
143381909|NCT03398148|516944453|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
143328713|NCT00355082|516744980|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
143328714|NCT00355082|516744981|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
143328715|NCT00355082|516744982|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
143328716|NCT00355082|516744980|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
143328717|NCT00355082|516744981|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
143328718|NCT00355082|516744982|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
143328719|NCT00355082|516744980|FG000|Continuation Phase|Adverse Event|2|||
143328720|NCT00355082|516744981|FG001|Continuation Phase|Adverse Event|0|||
143328721|NCT00355082|516744982|FG002|Continuation Phase|Adverse Event|1|||
143328722|NCT00355082|516744980|FG000|Continuation Phase|Lost to Follow-up|2|||
143328723|NCT00355082|516744981|FG001|Continuation Phase|Lost to Follow-up|0|||
143328724|NCT00355082|516744982|FG002|Continuation Phase|Lost to Follow-up|1|||
143328725|NCT00355082|516744980|FG000|Continuation Phase|Protocol Violation|1|||
143328726|NCT00355082|516744981|FG001|Continuation Phase|Protocol Violation|0|||
143328727|NCT00355082|516744982|FG002|Continuation Phase|Protocol Violation|1|||
143328728|NCT00355082|516744980|FG000|Continuation Phase|Withdrawal by Subject|4|||
143328729|NCT00355082|516744981|FG001|Continuation Phase|Withdrawal by Subject|0|||
143328730|NCT00355082|516744982|FG002|Continuation Phase|Withdrawal by Subject|0|||
143328731|NCT00355082|516744980|FG000|Continuation Phase|Lack of Efficacy|5|||
143328732|NCT00355082|516744981|FG001|Continuation Phase|Lack of Efficacy|0|||
143328733|NCT00355082|516744982|FG002|Continuation Phase|Lack of Efficacy|0|||
143328734|NCT00355082|516744980|FG000|Continuation Phase|Site Closed by Sponsor|8|||
143328735|NCT00355082|516744981|FG001|Continuation Phase|Site Closed by Sponsor|0|||
143328736|NCT00355082|516744982|FG002|Continuation Phase|Site Closed by Sponsor|0|||
143328737|NCT00355082|516744980|FG000|Continuation Phase|Scheduling Error|1|||
143328738|NCT00355082|516744981|FG001|Continuation Phase|Scheduling Error|0|||
143328739|NCT00355082|516744982|FG002|Continuation Phase|Scheduling Error|0|||
143328740|NCT00355082|516744980|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
143328741|NCT00355082|516744981|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
143328742|NCT00355082|516744982|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
143328743|NCT00724971|516744988|FG000|Overall Study|Adverse Event|5|||
143328744|NCT00724971|516744988|FG000|Overall Study|Withdrawal by Subject|1|||
143328745|NCT02132611|516744990|FG000|Overall Study|Death|2|||
143328746|NCT02194621|516744991|FG000|Overall Study|6 withdrew prior to randomization|2|||
143328747|NCT02194621|516744992|FG001|Overall Study|6 withdrew prior to randomization|2|||
143328748|NCT02194621|516744993|FG002|Overall Study|6 withdrew prior to randomization|2|||
143328749|NCT02194621|516744991|FG000|Overall Study|Withdrawal by Subject|4|||
143328750|NCT02194621|516744992|FG001|Overall Study|Withdrawal by Subject|4|||
143328751|NCT02194621|516744993|FG002|Overall Study|Withdrawal by Subject|7|||
143328752|NCT02493127|516745001|FG000|Overall Study|Lost to Follow-up|1|||
143328753|NCT02493127|516745002|FG001|Overall Study|Lost to Follow-up|1|||
143328754|NCT02763384|516745003|FG000|Overall Study|Physician Decision|1|||
143328755|NCT02763384|516745003|FG000|Overall Study|Rapid decline - went on hospice|1|||
143328756|NCT02096900|516745004|FG000|Overall Study|Did not receive medication|3|||
143328757|NCT02096900|516745005|FG001|Overall Study|Did not receive medication|1|||
143328758|NCT02096900|516745004|FG000|Overall Study|Surgery cancelled- medication received|1|||
143328759|NCT02096900|516745005|FG001|Overall Study|Surgery cancelled- medication received|1|||
143328760|NCT04177758|516745006|FG000|Overall Study|Lost to Follow-up|19|||
143328761|NCT04177758|516745007|FG001|Overall Study|Lost to Follow-up|11|||
143328762|NCT02298192|516745008|FG000|Overall Study|Unclassified|3|||
143328763|NCT02298192|516745009|FG001|Overall Study|Unclassified|2|||
143328764|NCT02298192|516745008|FG000|Overall Study|Withdrawal criteria|2|||
143328765|NCT02298192|516745009|FG001|Overall Study|Withdrawal criteria|0|||
143328766|NCT02298192|516745008|FG000|Overall Study|Withdrawal by Subject|6|||
143328767|NCT02298192|516745009|FG001|Overall Study|Withdrawal by Subject|1|||
143328768|NCT02298192|516745008|FG000|Overall Study|Lost to Follow-up|2|||
143328769|NCT02298192|516745009|FG001|Overall Study|Lost to Follow-up|1|||
143328770|NCT02298192|516745008|FG000|Overall Study|Adverse Event|6|||
143328771|NCT02298192|516745009|FG001|Overall Study|Adverse Event|2|||
143328772|NCT06167031|516745012|FG000|Overall Study|Lost to Follow-up|5|||
143328773|NCT06167031|516745013|FG001|Overall Study|Lost to Follow-up|1|||
143328774|NCT01877408|516747404|FG000|Overall Study|Lost to Follow-up|0|||
143328775|NCT01877408|516747405|FG001|Overall Study|Lost to Follow-up|2|||
143328776|NCT02621931|516747406|FG000|Overall Study|Death|0|||
143328777|NCT02621931|516747407|FG001|Overall Study|Death|1|||
143328778|NCT02621931|516747408|FG002|Overall Study|Death|0|||
143328779|NCT02621931|516747406|FG000|Overall Study|Adverse Event|8|||
143328780|NCT02621931|516747407|FG001|Overall Study|Adverse Event|5|||
143328781|NCT02621931|516747408|FG002|Overall Study|Adverse Event|7|||
143328782|NCT02621931|516747406|FG000|Overall Study|Withdrawal by Subject|12|||
143328783|NCT02621931|516747407|FG001|Overall Study|Withdrawal by Subject|10|||
143328784|NCT02621931|516747408|FG002|Overall Study|Withdrawal by Subject|11|||
143328785|NCT02621931|516747406|FG000|Overall Study|Protocol Violation|2|||
143328786|NCT02621931|516747407|FG001|Overall Study|Protocol Violation|2|||
143328787|NCT02621931|516747408|FG002|Overall Study|Protocol Violation|2|||
143381910|NCT03398148|516944454|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
143381911|NCT03398148|516944455|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
143381912|NCT03398148|516944456|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
143381913|NCT03398148|516944457|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
143381914|NCT03398148|516944458|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
143381915|NCT03398148|516944459|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
143381916|NCT03398148|516944460|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
143381917|NCT03398148|516944461|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
143381918|NCT03398148|516944462|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
143381919|NCT03398148|516944463|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
143381920|NCT03398148|516944449|FG000|Substudy 2 Period 2|Adverse Event|0|||
143381921|NCT03398148|516944450|FG001|Substudy 2 Period 2|Adverse Event|0|||
143381922|NCT03398148|516944451|FG002|Substudy 2 Period 2|Adverse Event|0|||
143381923|NCT03398148|516944452|FG003|Substudy 2 Period 2|Adverse Event|0|||
143381924|NCT03398148|516944453|FG004|Substudy 2 Period 2|Adverse Event|0|||
143381925|NCT03398148|516944454|FG005|Substudy 2 Period 2|Adverse Event|0|||
143381926|NCT03398148|516944455|FG006|Substudy 2 Period 2|Adverse Event|0|||
143381927|NCT03398148|516944456|FG007|Substudy 2 Period 2|Adverse Event|0|||
143381928|NCT03398148|516944457|FG008|Substudy 2 Period 2|Adverse Event|0|||
143381929|NCT03398148|516944458|FG009|Substudy 2 Period 2|Adverse Event|0|||
143381930|NCT03398148|516944459|FG010|Substudy 2 Period 2|Adverse Event|0|||
143381931|NCT03398148|516944460|FG011|Substudy 2 Period 2|Adverse Event|0|||
143328788|NCT02621931|516747406|FG000|Overall Study|Pregnancy|2|||
143381932|NCT03398148|516944461|FG012|Substudy 2 Period 2|Adverse Event|0|||
143381933|NCT03398148|516944462|FG013|Substudy 2 Period 2|Adverse Event|1|||
143328789|NCT02621931|516747407|FG001|Overall Study|Pregnancy|0|||
143328790|NCT02621931|516747408|FG002|Overall Study|Pregnancy|0|||
143328791|NCT02621931|516747406|FG000|Overall Study|Noncompliance to study procedures|0|||
143328792|NCT02621931|516747407|FG001|Overall Study|Noncompliance to study procedures|1|||
143328793|NCT02621931|516747408|FG002|Overall Study|Noncompliance to study procedures|2|||
143328794|NCT02621931|516747406|FG000|Overall Study|Lost to Follow-up|8|||
143328795|NCT02621931|516747407|FG001|Overall Study|Lost to Follow-up|7|||
143328796|NCT02621931|516747408|FG002|Overall Study|Lost to Follow-up|10|||
143328797|NCT02621931|516747406|FG000|Overall Study|Lack of Efficacy|0|||
143328798|NCT02621931|516747407|FG001|Overall Study|Lack of Efficacy|0|||
143328799|NCT02621931|516747408|FG002|Overall Study|Lack of Efficacy|1|||
143328800|NCT02621931|516747406|FG000|Overall Study|Other|1|||
143328801|NCT02621931|516747407|FG001|Overall Study|Other|1|||
143328802|NCT02621931|516747408|FG002|Overall Study|Other|3|||
143328803|NCT00920426|516747409|FG000|ITZ111451|Adverse Event|1|||
143328804|NCT00920426|516747410|FG001|ITZ111451|Adverse Event|0|||
143328805|NCT00920426|516747411|FG002|ITZ111451|Adverse Event|0|||
143328806|NCT00920426|516747412|FG003|ITZ111451|Adverse Event|0|||
143328807|NCT01292603|516747413|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
143328808|NCT01292603|516747414|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
143328809|NCT01292603|516747415|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
143328810|NCT01292603|516747416|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
143328811|NCT01292603|516747417|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
143328812|NCT01292603|516747418|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
143328813|NCT01292603|516747413|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
143328814|NCT01292603|516747414|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
143328815|NCT01292603|516747415|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
143328816|NCT01292603|516747416|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
143328817|NCT01292603|516747417|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
143328818|NCT01292603|516747418|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
143328819|NCT01292603|516747413|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
143328820|NCT01292603|516747414|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
143328821|NCT01292603|516747415|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
143328822|NCT01292603|516747416|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
143328823|NCT01292603|516747417|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
143328824|NCT01292603|516747418|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
143328825|NCT01292603|516747413|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
143328826|NCT01292603|516747414|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
143328827|NCT01292603|516747415|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
143328828|NCT01292603|516747416|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
143328829|NCT01292603|516747417|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
143328830|NCT01292603|516747418|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
143328831|NCT01292603|516747413|FG000|Part 1: Regular Follow-Up Period|Death|3|||
143328832|NCT01292603|516747414|FG001|Part 1: Regular Follow-Up Period|Death|1|||
143381934|NCT03398148|516944463|FG014|Substudy 2 Period 2|Adverse Event|3|||
143381935|NCT03398148|516944449|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
143328833|NCT01292603|516747415|FG002|Part 1: Regular Follow-Up Period|Death|3|||
143381936|NCT03398148|516944450|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
143381937|NCT03398148|516944451|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
143381938|NCT03398148|516944452|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
143328834|NCT01292603|516747416|FG003|Part 1: Regular Follow-Up Period|Death|1|||
143328835|NCT01292603|516747417|FG004|Part 1: Regular Follow-Up Period|Death|0|||
143328836|NCT01292603|516747418|FG005|Part 1: Regular Follow-Up Period|Death|0|||
143328837|NCT01292603|516747413|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
143328838|NCT01292603|516747414|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
143328839|NCT01292603|516747415|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
143328840|NCT01292603|516747416|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
143328841|NCT01292603|516747417|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
143328842|NCT01292603|516747418|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
143328843|NCT01292603|516747413|FG000|Part 2: Dose Confirmation Period|Death|0|||
143328844|NCT01292603|516747414|FG001|Part 2: Dose Confirmation Period|Death|0|||
143328845|NCT01292603|516747415|FG002|Part 2: Dose Confirmation Period|Death|0|||
143328846|NCT01292603|516747416|FG003|Part 2: Dose Confirmation Period|Death|0|||
143328847|NCT01292603|516747417|FG004|Part 2: Dose Confirmation Period|Death|1|||
143328848|NCT01292603|516747418|FG005|Part 2: Dose Confirmation Period|Death|0|||
143328849|NCT01292603|516747413|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
143328850|NCT01292603|516747414|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
143328851|NCT01292603|516747415|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
143328852|NCT01292603|516747416|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
143328853|NCT01292603|516747417|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
143328854|NCT01292603|516747418|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
143328855|NCT01292603|516747413|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
143328856|NCT01292603|516747414|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
143328857|NCT01292603|516747415|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
143328858|NCT01292603|516747416|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
143328859|NCT01292603|516747417|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
143328860|NCT01292603|516747418|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
143328861|NCT01292603|516747413|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
143328862|NCT01292603|516747414|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
143328863|NCT01292603|516747415|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
143328864|NCT01292603|516747416|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
143328865|NCT01292603|516747417|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
143328866|NCT01292603|516747418|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
143328867|NCT01292603|516747413|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
143328868|NCT01292603|516747414|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
143328869|NCT01292603|516747415|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
143328870|NCT01292603|516747416|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
143328871|NCT01292603|516747417|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
143328872|NCT01292603|516747418|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
143328873|NCT01292603|516747413|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
143328874|NCT01292603|516747414|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
143328875|NCT01292603|516747415|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
143328876|NCT01292603|516747416|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
143328877|NCT01292603|516747417|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
143328878|NCT01292603|516747418|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
143328879|NCT01292603|516747413|FG000|Part 2: Regular Follow-Up|Death|0|||
143328880|NCT01292603|516747414|FG001|Part 2: Regular Follow-Up|Death|0|||
143328881|NCT01292603|516747415|FG002|Part 2: Regular Follow-Up|Death|0|||
143328882|NCT01292603|516747416|FG003|Part 2: Regular Follow-Up|Death|0|||
143328883|NCT01292603|516747417|FG004|Part 2: Regular Follow-Up|Death|6|||
143328884|NCT01292603|516747418|FG005|Part 2: Regular Follow-Up|Death|3|||
143328885|NCT01292603|516747413|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
143328886|NCT01292603|516747414|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
143328887|NCT01292603|516747415|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
143328888|NCT01292603|516747416|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
143328889|NCT01292603|516747417|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
143328890|NCT01292603|516747418|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
143328891|NCT01292603|516747413|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
143328892|NCT01292603|516747414|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
143328893|NCT01292603|516747415|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
143381939|NCT03398148|516944453|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
143328894|NCT01292603|516747416|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
143328895|NCT01292603|516747417|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
143328896|NCT01292603|516747418|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
143328897|NCT01292603|516747413|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
143328898|NCT01292603|516747414|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
143328899|NCT01292603|516747415|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
143328900|NCT01292603|516747416|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
143381940|NCT03398148|516944454|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
143381941|NCT03398148|516944455|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
143328901|NCT01292603|516747417|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
143328902|NCT01292603|516747418|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
143328903|NCT01292603|516747413|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
143328904|NCT01292603|516747414|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
143328905|NCT01292603|516747415|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
143328906|NCT01292603|516747416|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
143328907|NCT01292603|516747417|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
143328908|NCT01292603|516747418|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
143328909|NCT01292603|516747413|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
143328910|NCT01292603|516747414|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
143328911|NCT01292603|516747415|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
143328912|NCT01292603|516747416|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
143328913|NCT01292603|516747417|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
143328914|NCT01292603|516747418|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
143328915|NCT01292603|516747413|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
143328916|NCT01292603|516747414|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
143328917|NCT01292603|516747415|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
143328918|NCT01292603|516747416|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
143328919|NCT01292603|516747417|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
143328920|NCT01292603|516747418|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
143328921|NCT01292603|516747413|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
143328922|NCT01292603|516747414|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
143328923|NCT01292603|516747415|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
143328924|NCT01292603|516747416|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
143328925|NCT01292603|516747417|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
143328926|NCT01292603|516747418|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
143328927|NCT01292603|516747413|FG000|Overall Survival Status|Death|3|||
143328928|NCT01292603|516747414|FG001|Overall Survival Status|Death|1|||
143328929|NCT01292603|516747415|FG002|Overall Survival Status|Death|3|||
143328930|NCT01292603|516747416|FG003|Overall Survival Status|Death|1|||
143328931|NCT01292603|516747417|FG004|Overall Survival Status|Death|16|||
143328932|NCT01292603|516747418|FG005|Overall Survival Status|Death|10|||
143328933|NCT03870763|516747421|FG000|Overall Study|Study terminated by sponsor|0|||
143328934|NCT03870763|516747422|FG001|Overall Study|Study terminated by sponsor|2|||
143328935|NCT03870763|516747423|FG002|Overall Study|Study terminated by sponsor|0|||
143328936|NCT03870763|516747421|FG000|Overall Study|Withdrawal by Subject|0|||
143328937|NCT03870763|516747422|FG001|Overall Study|Withdrawal by Subject|1|||
143328938|NCT03870763|516747423|FG002|Overall Study|Withdrawal by Subject|0|||
143328939|NCT03870763|516747421|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
143328940|NCT03870763|516747422|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
143328941|NCT03870763|516747423|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
143328942|NCT01912612|516747427|FG000|Overall Study|Adverse Event|4|||
143328943|NCT01912612|516747428|FG001|Overall Study|Adverse Event|0|||
143328944|NCT01912612|516747429|FG002|Overall Study|Adverse Event|0|||
143328945|NCT01912612|516747427|FG000|Overall Study|Withdrew consent|1|||
143328946|NCT01912612|516747428|FG001|Overall Study|Withdrew consent|0|||
143328947|NCT01912612|516747429|FG002|Overall Study|Withdrew consent|0|||
143328948|NCT01912612|516747427|FG000|Overall Study|Study design change|0|||
143328949|NCT01912612|516747428|FG001|Overall Study|Study design change|0|||
143328950|NCT01912612|516747429|FG002|Overall Study|Study design change|3|||
143328951|NCT01588184|516747430|FG000|Overall Study|Death|1|||
143328952|NCT01588184|516747431|FG001|Overall Study|Death|0|||
143328953|NCT01588184|516747432|FG002|Overall Study|Death|0|||
143328954|NCT01588184|516747433|FG003|Overall Study|Death|1|||
143328955|NCT01588184|516747434|FG004|Overall Study|Death|1|||
143328956|NCT01588184|516747435|FG005|Overall Study|Death|1|||
143328957|NCT01588184|516747430|FG000|Overall Study|Withdrawal by Subject|2|||
143328958|NCT01588184|516747431|FG001|Overall Study|Withdrawal by Subject|4|||
143328959|NCT01588184|516747432|FG002|Overall Study|Withdrawal by Subject|0|||
143328960|NCT01588184|516747433|FG003|Overall Study|Withdrawal by Subject|1|||
143328961|NCT01588184|516747434|FG004|Overall Study|Withdrawal by Subject|0|||
143328962|NCT01588184|516747435|FG005|Overall Study|Withdrawal by Subject|0|||
143328963|NCT01588184|516747430|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
143328964|NCT01588184|516747431|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
143328965|NCT01588184|516747432|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
143328966|NCT01588184|516747433|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
143328967|NCT01588184|516747434|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
143328968|NCT01588184|516747435|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
143328969|NCT01588184|516747430|FG000|Overall Study|multiple reasons|0|||
143328970|NCT01588184|516747431|FG001|Overall Study|multiple reasons|3|||
143328971|NCT01588184|516747432|FG002|Overall Study|multiple reasons|0|||
143328972|NCT01588184|516747433|FG003|Overall Study|multiple reasons|1|||
143328973|NCT01588184|516747434|FG004|Overall Study|multiple reasons|0|||
143328974|NCT01588184|516747435|FG005|Overall Study|multiple reasons|0|||
143328975|NCT05912400|516747437|FG000|Overall Study|Lost to Follow-up|1|||
143381942|NCT03398148|516944456|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
143381943|NCT03398148|516944457|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
143381944|NCT03398148|516944458|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
143381945|NCT03398148|516944459|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
143381946|NCT03398148|516944460|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
143381947|NCT03398148|516944461|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
143381948|NCT03398148|516944462|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
143381949|NCT03398148|516944463|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
143381950|NCT03398148|516944449|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
143381951|NCT03398148|516944450|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
143381952|NCT03398148|516944451|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
143381953|NCT03398148|516944452|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
143381954|NCT03398148|516944453|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
143381955|NCT03398148|516944454|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
143381956|NCT03398148|516944455|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
143381957|NCT03398148|516944456|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
143381958|NCT03398148|516944457|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
143381959|NCT03398148|516944458|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
143381960|NCT03398148|516944459|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
143381961|NCT03398148|516944460|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
143381962|NCT03398148|516944461|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
143381963|NCT03398148|516944462|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
143381964|NCT03398148|516944463|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
143381965|NCT03398148|516944449|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
143381966|NCT03398148|516944450|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
143381967|NCT03398148|516944451|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
143381968|NCT03398148|516944452|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
143381969|NCT03398148|516944453|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
143381970|NCT03398148|516944454|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
143381971|NCT03398148|516944455|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
143381972|NCT03398148|516944456|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
143381973|NCT03398148|516944457|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
143381974|NCT03398148|516944458|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
143381975|NCT03398148|516944459|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
143381976|NCT03398148|516944460|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
143381977|NCT03398148|516944461|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
143381978|NCT03398148|516944462|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
143381979|NCT03398148|516944463|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
143381980|NCT03398148|516944449|FG000|Substudy 2 Period 2|Other|0|||
143381981|NCT03398148|516944450|FG001|Substudy 2 Period 2|Other|0|||
143381982|NCT03398148|516944451|FG002|Substudy 2 Period 2|Other|0|||
143381983|NCT03398148|516944452|FG003|Substudy 2 Period 2|Other|0|||
143381984|NCT03398148|516944453|FG004|Substudy 2 Period 2|Other|0|||
143381985|NCT03398148|516944454|FG005|Substudy 2 Period 2|Other|0|||
143381986|NCT03398148|516944455|FG006|Substudy 2 Period 2|Other|0|||
143381987|NCT03398148|516944456|FG007|Substudy 2 Period 2|Other|0|||
143381988|NCT03398148|516944457|FG008|Substudy 2 Period 2|Other|0|||
143381989|NCT03398148|516944458|FG009|Substudy 2 Period 2|Other|0|||
143381990|NCT03398148|516944459|FG010|Substudy 2 Period 2|Other|0|||
143381991|NCT03398148|516944460|FG011|Substudy 2 Period 2|Other|0|||
143381992|NCT03398148|516944461|FG012|Substudy 2 Period 2|Other|0|||
143381993|NCT03398148|516944462|FG013|Substudy 2 Period 2|Other|1|||
143381994|NCT03398148|516944463|FG014|Substudy 2 Period 2|Other|1|||
143381995|NCT03398148|516944449|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
143381996|NCT03398148|516944450|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
143381997|NCT03398148|516944451|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
143381998|NCT03398148|516944452|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
143381999|NCT03398148|516944453|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
143382000|NCT03398148|516944454|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
143382001|NCT03398148|516944455|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
143328976|NCT05912400|516747438|FG001|Overall Study|Lost to Follow-up|0|||
143328977|NCT05912400|516747437|FG000|Overall Study|Physician Decision|6|||
143328978|NCT05912400|516747438|FG001|Overall Study|Physician Decision|0|||
143328979|NCT05912400|516747437|FG000|Overall Study|Withdrawal by Subject|1|||
143328980|NCT05912400|516747438|FG001|Overall Study|Withdrawal by Subject|0|||
143328981|NCT01259713|516747439|FG000|Overall Study|Adverse Event|54|||
143328982|NCT01259713|516747440|FG001|Overall Study|Adverse Event|23|||
143328983|NCT01259713|516747439|FG000|Overall Study|Death Not Related to IFI|8|||
143328984|NCT01259713|516747440|FG001|Overall Study|Death Not Related to IFI|1|||
143328985|NCT01259713|516747439|FG000|Overall Study|Investigators Discretion|14|||
143328986|NCT01259713|516747440|FG001|Overall Study|Investigators Discretion|6|||
143328987|NCT01259713|516747439|FG000|Overall Study|Lack of Efficacy|2|||
143382002|NCT03398148|516944456|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
143382003|NCT03398148|516944457|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
143382004|NCT03398148|516944458|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
143382005|NCT03398148|516944459|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
143382006|NCT03398148|516944460|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
143382007|NCT03398148|516944461|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
143382008|NCT03398148|516944462|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
143382009|NCT03398148|516944463|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
143382010|NCT04201834|516944470|FG000|Overall Study|Screen fail|1|||
143382011|NCT03358875|516944471|FG000|Overall Study|Death|409|||
143382012|NCT03358875|516944472|FG001|Overall Study|Death|223|||
143382013|NCT03358875|516944471|FG000|Overall Study|Study Closed by Sponsor|66|||
143382014|NCT03358875|516944472|FG001|Overall Study|Study Closed by Sponsor|29|||
143382015|NCT03358875|516944471|FG000|Overall Study|Withdrawal by Subject|13|||
143382016|NCT03358875|516944472|FG001|Overall Study|Withdrawal by Subject|16|||
143328988|NCT01259713|516747440|FG001|Overall Study|Lack of Efficacy|0|||
143328989|NCT01259713|516747439|FG000|Overall Study|Protocol Violation|5|||
143328990|NCT01259713|516747440|FG001|Overall Study|Protocol Violation|4|||
143328991|NCT01259713|516747439|FG000|Overall Study|Subject Withdrew Consent|12|||
143328992|NCT01259713|516747440|FG001|Overall Study|Subject Withdrew Consent|7|||
143328993|NCT01217073|516747441|FG000|Base Period|Adverse Event|1|||
143328994|NCT01217073|516747442|FG001|Base Period|Adverse Event|0|||
143328995|NCT01217073|516747443|FG002|Base Period|Adverse Event|1|||
143328996|NCT01217073|516747444|FG003|Base Period|Adverse Event|0|||
143328997|NCT01217073|516747445|FG004|Base Period|Adverse Event|4|||
143328998|NCT01217073|516747446|FG005|Base Period|Adverse Event|1|||
143328999|NCT01217073|516747447|FG006|Base Period|Adverse Event|0|||
143329000|NCT01217073|516747448|FG007|Base Period|Adverse Event|0|||
143329001|NCT01217073|516747441|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
143329002|NCT01217073|516747442|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
143329003|NCT01217073|516747443|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
143329004|NCT01217073|516747444|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
143329005|NCT01217073|516747445|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
143329006|NCT01217073|516747446|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
143329007|NCT01217073|516747447|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
143329008|NCT01217073|516747448|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
143329009|NCT01217073|516747441|FG000|Base Period|Excluded medication|0|||
143329010|NCT01217073|516747442|FG001|Base Period|Excluded medication|0|||
143329011|NCT01217073|516747443|FG002|Base Period|Excluded medication|0|||
143329012|NCT01217073|516747444|FG003|Base Period|Excluded medication|0|||
143329013|NCT01217073|516747445|FG004|Base Period|Excluded medication|1|||
143329014|NCT01217073|516747446|FG005|Base Period|Excluded medication|0|||
143329015|NCT01217073|516747447|FG006|Base Period|Excluded medication|0|||
143329016|NCT01217073|516747448|FG007|Base Period|Excluded medication|0|||
143329017|NCT01217073|516747441|FG000|Base Period|Lack of Efficacy|0|||
143329018|NCT01217073|516747442|FG001|Base Period|Lack of Efficacy|0|||
143329019|NCT01217073|516747443|FG002|Base Period|Lack of Efficacy|0|||
143329020|NCT01217073|516747444|FG003|Base Period|Lack of Efficacy|0|||
143329021|NCT01217073|516747445|FG004|Base Period|Lack of Efficacy|0|||
143329022|NCT01217073|516747446|FG005|Base Period|Lack of Efficacy|1|||
143329023|NCT01217073|516747447|FG006|Base Period|Lack of Efficacy|0|||
143329024|NCT01217073|516747448|FG007|Base Period|Lack of Efficacy|0|||
143329025|NCT01217073|516747441|FG000|Base Period|Lost to Follow-up|0|||
143329026|NCT01217073|516747442|FG001|Base Period|Lost to Follow-up|0|||
143329027|NCT01217073|516747443|FG002|Base Period|Lost to Follow-up|1|||
143329028|NCT01217073|516747444|FG003|Base Period|Lost to Follow-up|1|||
143329029|NCT01217073|516747445|FG004|Base Period|Lost to Follow-up|3|||
143329030|NCT01217073|516747446|FG005|Base Period|Lost to Follow-up|0|||
143329031|NCT01217073|516747447|FG006|Base Period|Lost to Follow-up|0|||
143329032|NCT01217073|516747448|FG007|Base Period|Lost to Follow-up|0|||
143329033|NCT01217073|516747441|FG000|Base Period|Physician Decision|0|||
143329034|NCT01217073|516747442|FG001|Base Period|Physician Decision|0|||
143382017|NCT03358875|516944471|FG000|Overall Study|Lost to Follow-up|13|||
143382018|NCT03358875|516944472|FG001|Overall Study|Lost to Follow-up|2|||
143382019|NCT03358875|516944471|FG000|Overall Study|Miscellaneous|33|||
143382020|NCT03358875|516944472|FG001|Overall Study|Miscellaneous|0|||
143382021|NCT03358875|516944471|FG000|Overall Study|Remained on Study|1|||
143329035|NCT01217073|516747443|FG002|Base Period|Physician Decision|0|||
143329036|NCT01217073|516747444|FG003|Base Period|Physician Decision|0|||
143329037|NCT01217073|516747445|FG004|Base Period|Physician Decision|1|||
143329038|NCT01217073|516747446|FG005|Base Period|Physician Decision|0|||
143329039|NCT01217073|516747447|FG006|Base Period|Physician Decision|0|||
143329040|NCT01217073|516747448|FG007|Base Period|Physician Decision|0|||
143329041|NCT01217073|516747441|FG000|Base Period|Protocol Violation|1|||
143329042|NCT01217073|516747442|FG001|Base Period|Protocol Violation|0|||
143329043|NCT01217073|516747443|FG002|Base Period|Protocol Violation|0|||
143329044|NCT01217073|516747444|FG003|Base Period|Protocol Violation|0|||
143329045|NCT01217073|516747445|FG004|Base Period|Protocol Violation|1|||
143329046|NCT01217073|516747446|FG005|Base Period|Protocol Violation|2|||
143329047|NCT01217073|516747447|FG006|Base Period|Protocol Violation|0|||
143329048|NCT01217073|516747448|FG007|Base Period|Protocol Violation|0|||
143329049|NCT01217073|516747441|FG000|Base Period|Withdrawal by Subject|4|||
143329050|NCT01217073|516747442|FG001|Base Period|Withdrawal by Subject|5|||
143329051|NCT01217073|516747443|FG002|Base Period|Withdrawal by Subject|5|||
143329052|NCT01217073|516747444|FG003|Base Period|Withdrawal by Subject|1|||
143329053|NCT01217073|516747445|FG004|Base Period|Withdrawal by Subject|5|||
143329054|NCT01217073|516747446|FG005|Base Period|Withdrawal by Subject|5|||
143329055|NCT01217073|516747447|FG006|Base Period|Withdrawal by Subject|0|||
143329056|NCT01217073|516747448|FG007|Base Period|Withdrawal by Subject|0|||
143329057|NCT01217073|516747441|FG000|Extension Period|Adverse Event|0|||
143329058|NCT01217073|516747442|FG001|Extension Period|Adverse Event|0|||
143329059|NCT01217073|516747443|FG002|Extension Period|Adverse Event|0|||
143329060|NCT01217073|516747444|FG003|Extension Period|Adverse Event|0|||
143329061|NCT01217073|516747445|FG004|Extension Period|Adverse Event|0|||
143329062|NCT01217073|516747446|FG005|Extension Period|Adverse Event|0|||
143329063|NCT01217073|516747447|FG006|Extension Period|Adverse Event|19|||
143329064|NCT01217073|516747448|FG007|Extension Period|Adverse Event|5|||
143329065|NCT01217073|516747441|FG000|Extension Period|ALT/AST|0|||
143329066|NCT01217073|516747442|FG001|Extension Period|ALT/AST|0|||
143329067|NCT01217073|516747443|FG002|Extension Period|ALT/AST|0|||
143329068|NCT01217073|516747444|FG003|Extension Period|ALT/AST|0|||
143329069|NCT01217073|516747445|FG004|Extension Period|ALT/AST|0|||
143329070|NCT01217073|516747446|FG005|Extension Period|ALT/AST|0|||
143329071|NCT01217073|516747447|FG006|Extension Period|ALT/AST|2|||
143329072|NCT01217073|516747448|FG007|Extension Period|ALT/AST|0|||
143329073|NCT01217073|516747441|FG000|Extension Period|Contraindication to study medication|0|||
143329074|NCT01217073|516747442|FG001|Extension Period|Contraindication to study medication|0|||
143329075|NCT01217073|516747443|FG002|Extension Period|Contraindication to study medication|0|||
143329076|NCT01217073|516747444|FG003|Extension Period|Contraindication to study medication|0|||
143329077|NCT01217073|516747445|FG004|Extension Period|Contraindication to study medication|0|||
143329078|NCT01217073|516747446|FG005|Extension Period|Contraindication to study medication|0|||
143329079|NCT01217073|516747447|FG006|Extension Period|Contraindication to study medication|1|||
143329080|NCT01217073|516747448|FG007|Extension Period|Contraindication to study medication|0|||
143329081|NCT01217073|516747441|FG000|Extension Period|Creatinine/eGFR|0|||
143329082|NCT01217073|516747442|FG001|Extension Period|Creatinine/eGFR|0|||
143329083|NCT01217073|516747443|FG002|Extension Period|Creatinine/eGFR|0|||
143329084|NCT01217073|516747444|FG003|Extension Period|Creatinine/eGFR|0|||
143329085|NCT01217073|516747445|FG004|Extension Period|Creatinine/eGFR|0|||
143329086|NCT01217073|516747446|FG005|Extension Period|Creatinine/eGFR|0|||
143329087|NCT01217073|516747447|FG006|Extension Period|Creatinine/eGFR|11|||
143329088|NCT01217073|516747448|FG007|Extension Period|Creatinine/eGFR|1|||
143329089|NCT01217073|516747441|FG000|Extension Period|Death|0|||
143329090|NCT01217073|516747442|FG001|Extension Period|Death|0|||
143329091|NCT01217073|516747443|FG002|Extension Period|Death|0|||
143329092|NCT01217073|516747444|FG003|Extension Period|Death|0|||
143329093|NCT01217073|516747445|FG004|Extension Period|Death|0|||
143329094|NCT01217073|516747446|FG005|Extension Period|Death|0|||
143329095|NCT01217073|516747447|FG006|Extension Period|Death|1|||
143329096|NCT01217073|516747448|FG007|Extension Period|Death|0|||
143329097|NCT01217073|516747441|FG000|Extension Period|Excluded medication|0|||
143329098|NCT01217073|516747442|FG001|Extension Period|Excluded medication|0|||
143329099|NCT01217073|516747443|FG002|Extension Period|Excluded medication|0|||
143329100|NCT01217073|516747444|FG003|Extension Period|Excluded medication|0|||
143329101|NCT01217073|516747445|FG004|Extension Period|Excluded medication|0|||
143329102|NCT01217073|516747446|FG005|Extension Period|Excluded medication|0|||
143329103|NCT01217073|516747447|FG006|Extension Period|Excluded medication|2|||
143329104|NCT01217073|516747448|FG007|Extension Period|Excluded medication|0|||
143329105|NCT01217073|516747441|FG000|Extension Period|Lack of Efficacy|0|||
143329106|NCT01217073|516747442|FG001|Extension Period|Lack of Efficacy|0|||
143329107|NCT01217073|516747443|FG002|Extension Period|Lack of Efficacy|0|||
143329108|NCT01217073|516747444|FG003|Extension Period|Lack of Efficacy|0|||
143329109|NCT01217073|516747445|FG004|Extension Period|Lack of Efficacy|0|||
143329110|NCT01217073|516747446|FG005|Extension Period|Lack of Efficacy|0|||
143329111|NCT01217073|516747447|FG006|Extension Period|Lack of Efficacy|3|||
143382022|NCT03358875|516944472|FG001|Overall Study|Remained on Study|0|||
143382023|NCT04440176|516944473|FG000|Overall Study|Withdrawal by Subject|5|||
143382024|NCT04440176|516944474|FG001|Overall Study|Withdrawal by Subject|3|||
143382025|NCT04440176|516944473|FG000|Overall Study|Withdrawal by parent/guardian|4|||
143382026|NCT04440176|516944474|FG001|Overall Study|Withdrawal by parent/guardian|5|||
143382027|NCT04440176|516944473|FG000|Overall Study|Adverse Event|2|||
143382028|NCT04440176|516944474|FG001|Overall Study|Adverse Event|6|||
143382029|NCT04440176|516944473|FG000|Overall Study|Lost to Follow-up|22|||
143382030|NCT04440176|516944474|FG001|Overall Study|Lost to Follow-up|23|||
143382031|NCT04440176|516944473|FG000|Overall Study|Medication error without associated adverse event|0|||
143382032|NCT04440176|516944474|FG001|Overall Study|Medication error without associated adverse event|1|||
143382033|NCT04440176|516944473|FG000|Overall Study|No longer met eligibility criteria|7|||
143382034|NCT04440176|516944474|FG001|Overall Study|No longer met eligibility criteria|1|||
143382035|NCT04440176|516944473|FG000|Overall Study|Other|1|||
143382036|NCT04440176|516944474|FG001|Overall Study|Other|2|||
143382037|NCT04440176|516944473|FG000|Overall Study|Protocol deviation|6|||
143382038|NCT04440176|516944474|FG001|Overall Study|Protocol deviation|8|||
143382039|NCT04440176|516944473|FG000|Overall Study|Randomized but not vaccinated|6|||
143382040|NCT04440176|516944474|FG001|Overall Study|Randomized but not vaccinated|3|||
143382041|NCT01631214|516944475|FG000|Overall Study|Withdrawal by Subject|276|||
143382042|NCT01631214|516944476|FG001|Overall Study|Withdrawal by Subject|290|||
143382043|NCT01631214|516944475|FG000|Overall Study|Death|113|||
143382044|NCT01631214|516944476|FG001|Overall Study|Death|106|||
143382045|NCT01631214|516944475|FG000|Overall Study|Lost to Follow-up|54|||
143382046|NCT01631214|516944476|FG001|Overall Study|Lost to Follow-up|40|||
143382047|NCT01631214|516944475|FG000|Overall Study|Adverse Event|45|||
143382048|NCT01631214|516944476|FG001|Overall Study|Adverse Event|45|||
143382049|NCT01631214|516944475|FG000|Overall Study|Other|22|||
143382050|NCT01631214|516944476|FG001|Overall Study|Other|19|||
143382051|NCT01631214|516944475|FG000|Overall Study|Noncompliance|16|||
143382052|NCT01631214|516944476|FG001|Overall Study|Noncompliance|15|||
143382053|NCT01631214|516944475|FG000|Overall Study|Requirement for Alternative Therapy|8|||
143382054|NCT01631214|516944476|FG001|Overall Study|Requirement for Alternative Therapy|3|||
143382055|NCT01631214|516944475|FG000|Overall Study|Protocol Deviation|4|||
143382056|NCT01631214|516944476|FG001|Overall Study|Protocol Deviation|3|||
143382057|NCT01631214|516944475|FG000|Overall Study|Ineligibility determined|5|||
143382058|NCT01631214|516944476|FG001|Overall Study|Ineligibility determined|2|||
143382059|NCT01631214|516944475|FG000|Overall Study|Administrative Decision|1|||
143382060|NCT01631214|516944476|FG001|Overall Study|Administrative Decision|0|||
143382061|NCT04847999|516944477|FG000|Overall Study|Lost to Follow-up|0|||
143382062|NCT04847999|516944478|FG001|Overall Study|Lost to Follow-up|1|||
143382063|NCT05288283|516944488|FG000|Overall Study|Study Terminated Early|1|||
143382064|NCT05288283|516944489|FG001|Overall Study|Study Terminated Early|1|||
143382065|NCT04153565|516944490|FG000|Overall Study|Death|13|||
143382066|NCT04300231|516944491|FG000|Overall Study|Protocol Violation|4|||
143382067|NCT04300231|516944492|FG001|Overall Study|Protocol Violation|3|||
143382068|NCT04300231|516944493|FG002|Overall Study|Protocol Violation|0|||
143382069|NCT04300231|516944494|FG003|Overall Study|Protocol Violation|2|||
143382070|NCT02991807|516944495|FG000|Overall Study|Withdrawal by Subject|2|||
143382071|NCT02991807|516944496|FG001|Overall Study|Withdrawal by Subject|1|||
143382072|NCT02991807|516944495|FG000|Overall Study|Physician Decision|0|||
143382073|NCT02991807|516944496|FG001|Overall Study|Physician Decision|1|||
143382074|NCT02991807|516944495|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
143382075|NCT02991807|516944496|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
143382076|NCT01121991|516944501|FG000|Overall Study|Lack of Ovarian Response|2|||
143382077|NCT01121991|516944501|FG000|Overall Study|No Oocytes Retrieved|3|||
143382078|NCT01121991|516944501|FG000|Overall Study|No Fertilization|1|||
143382079|NCT02121002|516944502|FG000|Overall Study|Physician Decision|2|||
143382080|NCT02121002|516944503|FG001|Overall Study|Physician Decision|0|||
143382081|NCT02121002|516944504|FG002|Overall Study|Physician Decision|0|||
143382082|NCT02121002|516944502|FG000|Overall Study|Withdrawal by Subject|3|||
143382083|NCT02121002|516944503|FG001|Overall Study|Withdrawal by Subject|1|||
143382084|NCT02121002|516944504|FG002|Overall Study|Withdrawal by Subject|4|||
143382085|NCT02121002|516944502|FG000|Overall Study|Protocol Violation|1|||
143382086|NCT02121002|516944503|FG001|Overall Study|Protocol Violation|2|||
143382087|NCT02121002|516944504|FG002|Overall Study|Protocol Violation|4|||
143382088|NCT02121002|516944502|FG000|Overall Study|Concomitant therapy|0|||
143382089|NCT02121002|516944503|FG001|Overall Study|Concomitant therapy|1|||
143382090|NCT02121002|516944504|FG002|Overall Study|Concomitant therapy|1|||
143382091|NCT02121002|516944502|FG000|Overall Study|Others|1|||
143382092|NCT02121002|516944503|FG001|Overall Study|Others|0|||
143382093|NCT02121002|516944504|FG002|Overall Study|Others|1|||
143382094|NCT01007396|516944505|FG000|Overall Study|Lost to Follow-up|47|||
143382095|NCT04110054|516944507|FG000|Overall Study|COVID-19 reason other than AE|0|||
143382096|NCT04110054|516944508|FG001|Overall Study|COVID-19 reason other than AE|0|||
143382097|NCT04110054|516944509|FG002|Overall Study|COVID-19 reason other than AE|2|||
143382098|NCT04110054|516944510|FG003|Overall Study|COVID-19 reason other than AE|0|||
143382099|NCT04110054|516944507|FG000|Overall Study|Withdrawal by Subject|0|||
143382100|NCT04110054|516944508|FG001|Overall Study|Withdrawal by Subject|3|||
143382101|NCT04110054|516944509|FG002|Overall Study|Withdrawal by Subject|2|||
143382102|NCT04110054|516944510|FG003|Overall Study|Withdrawal by Subject|0|||
143382103|NCT04110054|516944507|FG000|Overall Study|Adverse Event|1|||
143382104|NCT04110054|516944508|FG001|Overall Study|Adverse Event|1|||
143382105|NCT04110054|516944509|FG002|Overall Study|Adverse Event|4|||
143382106|NCT04110054|516944510|FG003|Overall Study|Adverse Event|3|||
143382107|NCT04452318|516944516|FG000|Overall Study|Physician Decision|1|||
143382108|NCT04452318|516944517|FG001|Overall Study|Physician Decision|2|||
143382109|NCT04452318|516944518|FG002|Overall Study|Physician Decision|0|||
143382110|NCT04452318|516944519|FG003|Overall Study|Physician Decision|2|||
143382111|NCT04452318|516944520|FG004|Overall Study|Physician Decision|0|||
143382112|NCT04452318|516944521|FG005|Overall Study|Physician Decision|2|||
143382113|NCT04452318|516944522|FG006|Overall Study|Physician Decision|5|||
143382114|NCT04452318|516944516|FG000|Overall Study|Death|2|||
143382115|NCT04452318|516944517|FG001|Overall Study|Death|3|||
143382116|NCT04452318|516944518|FG002|Overall Study|Death|0|||
143382117|NCT04452318|516944519|FG003|Overall Study|Death|0|||
143382118|NCT04452318|516944520|FG004|Overall Study|Death|0|||
143382119|NCT04452318|516944521|FG005|Overall Study|Death|0|||
143382120|NCT04452318|516944522|FG006|Overall Study|Death|0|||
143382121|NCT04452318|516944516|FG000|Overall Study|Lost to Follow-up|38|||
143382122|NCT04452318|516944517|FG001|Overall Study|Lost to Follow-up|28|||
143382123|NCT04452318|516944518|FG002|Overall Study|Lost to Follow-up|0|||
143382124|NCT04452318|516944519|FG003|Overall Study|Lost to Follow-up|3|||
143382125|NCT04452318|516944520|FG004|Overall Study|Lost to Follow-up|3|||
143382126|NCT04452318|516944521|FG005|Overall Study|Lost to Follow-up|2|||
143382127|NCT04452318|516944522|FG006|Overall Study|Lost to Follow-up|1|||
143382128|NCT04452318|516944516|FG000|Overall Study|Withdrawal by Subject|46|||
143382129|NCT04452318|516944517|FG001|Overall Study|Withdrawal by Subject|40|||
143382130|NCT04452318|516944518|FG002|Overall Study|Withdrawal by Subject|0|||
143382131|NCT04452318|516944519|FG003|Overall Study|Withdrawal by Subject|18|||
143382132|NCT04452318|516944520|FG004|Overall Study|Withdrawal by Subject|6|||
143382133|NCT04452318|516944521|FG005|Overall Study|Withdrawal by Subject|8|||
143382134|NCT04452318|516944522|FG006|Overall Study|Withdrawal by Subject|6|||
143382135|NCT02554786|516944525|FG000|Overall Study|Subject/guardian decision|29|||
143382136|NCT02554786|516944526|FG001|Overall Study|Subject/guardian decision|17|||
143382137|NCT02554786|516944527|FG002|Overall Study|Subject/guardian decision|18|||
143382138|NCT02554786|516944528|FG003|Overall Study|Subject/guardian decision|30|||
143382139|NCT02554786|516944529|FG004|Overall Study|Subject/guardian decision|20|||
143382140|NCT02554786|516944525|FG000|Overall Study|Lost to Follow-up|4|||
143382141|NCT02554786|516944526|FG001|Overall Study|Lost to Follow-up|3|||
143382142|NCT02554786|516944527|FG002|Overall Study|Lost to Follow-up|4|||
143382143|NCT02554786|516944528|FG003|Overall Study|Lost to Follow-up|2|||
143382144|NCT02554786|516944529|FG004|Overall Study|Lost to Follow-up|2|||
143382145|NCT02554786|516944525|FG000|Overall Study|Protocol deviation|1|||
143382146|NCT02554786|516944526|FG001|Overall Study|Protocol deviation|3|||
143382147|NCT02554786|516944527|FG002|Overall Study|Protocol deviation|3|||
143382148|NCT02554786|516944528|FG003|Overall Study|Protocol deviation|4|||
143382149|NCT02554786|516944529|FG004|Overall Study|Protocol deviation|2|||
143382150|NCT02554786|516944525|FG000|Overall Study|Technical problems|1|||
143382151|NCT02554786|516944526|FG001|Overall Study|Technical problems|1|||
143382152|NCT02554786|516944527|FG002|Overall Study|Technical problems|0|||
143382153|NCT02554786|516944528|FG003|Overall Study|Technical problems|2|||
143382154|NCT02554786|516944529|FG004|Overall Study|Technical problems|1|||
143382155|NCT02554786|516944525|FG000|Overall Study|Adverse Event|0|||
143382156|NCT02554786|516944526|FG001|Overall Study|Adverse Event|0|||
143382157|NCT02554786|516944527|FG002|Overall Study|Adverse Event|0|||
143382158|NCT02554786|516944528|FG003|Overall Study|Adverse Event|0|||
143382159|NCT02554786|516944529|FG004|Overall Study|Adverse Event|2|||
143382160|NCT02554786|516944525|FG000|Overall Study|Death|0|||
143382161|NCT02554786|516944526|FG001|Overall Study|Death|0|||
143382162|NCT02554786|516944527|FG002|Overall Study|Death|0|||
143382163|NCT02554786|516944528|FG003|Overall Study|Death|1|||
143382164|NCT02554786|516944529|FG004|Overall Study|Death|0|||
143329112|NCT01217073|516747448|FG007|Extension Period|Lack of Efficacy|0|||
143329113|NCT01217073|516747441|FG000|Extension Period|Lost to Follow-up|0|||
143329114|NCT01217073|516747442|FG001|Extension Period|Lost to Follow-up|0|||
143329115|NCT01217073|516747443|FG002|Extension Period|Lost to Follow-up|0|||
143329116|NCT01217073|516747444|FG003|Extension Period|Lost to Follow-up|0|||
143329117|NCT01217073|516747445|FG004|Extension Period|Lost to Follow-up|0|||
143329118|NCT01217073|516747446|FG005|Extension Period|Lost to Follow-up|0|||
143329119|NCT01217073|516747447|FG006|Extension Period|Lost to Follow-up|9|||
143329120|NCT01217073|516747448|FG007|Extension Period|Lost to Follow-up|1|||
143329121|NCT01217073|516747441|FG000|Extension Period|Non-compliance with study drug|0|||
143329122|NCT01217073|516747442|FG001|Extension Period|Non-compliance with study drug|0|||
143329123|NCT01217073|516747443|FG002|Extension Period|Non-compliance with study drug|0|||
143329124|NCT01217073|516747444|FG003|Extension Period|Non-compliance with study drug|0|||
143329125|NCT01217073|516747445|FG004|Extension Period|Non-compliance with study drug|0|||
143329126|NCT01217073|516747446|FG005|Extension Period|Non-compliance with study drug|0|||
143329127|NCT01217073|516747447|FG006|Extension Period|Non-compliance with study drug|0|||
143329128|NCT01217073|516747448|FG007|Extension Period|Non-compliance with study drug|1|||
143329129|NCT01217073|516747441|FG000|Extension Period|Physician Decision|0|||
143329130|NCT01217073|516747442|FG001|Extension Period|Physician Decision|0|||
143329131|NCT01217073|516747443|FG002|Extension Period|Physician Decision|0|||
143329132|NCT01217073|516747444|FG003|Extension Period|Physician Decision|0|||
143329133|NCT01217073|516747445|FG004|Extension Period|Physician Decision|0|||
143329134|NCT01217073|516747446|FG005|Extension Period|Physician Decision|0|||
143329135|NCT01217073|516747447|FG006|Extension Period|Physician Decision|4|||
143329136|NCT01217073|516747448|FG007|Extension Period|Physician Decision|1|||
143329137|NCT01217073|516747441|FG000|Extension Period|Protocol Violation|0|||
143329138|NCT01217073|516747442|FG001|Extension Period|Protocol Violation|0|||
143329139|NCT01217073|516747443|FG002|Extension Period|Protocol Violation|0|||
143329140|NCT01217073|516747444|FG003|Extension Period|Protocol Violation|0|||
143329141|NCT01217073|516747445|FG004|Extension Period|Protocol Violation|0|||
143329142|NCT01217073|516747446|FG005|Extension Period|Protocol Violation|0|||
143329143|NCT01217073|516747447|FG006|Extension Period|Protocol Violation|2|||
143329144|NCT01217073|516747448|FG007|Extension Period|Protocol Violation|1|||
143329145|NCT01217073|516747441|FG000|Extension Period|Site discontinued study participation|0|||
143329146|NCT01217073|516747442|FG001|Extension Period|Site discontinued study participation|0|||
143329147|NCT01217073|516747443|FG002|Extension Period|Site discontinued study participation|0|||
143329148|NCT01217073|516747444|FG003|Extension Period|Site discontinued study participation|0|||
143329149|NCT01217073|516747445|FG004|Extension Period|Site discontinued study participation|0|||
143329150|NCT01217073|516747446|FG005|Extension Period|Site discontinued study participation|0|||
143329151|NCT01217073|516747447|FG006|Extension Period|Site discontinued study participation|7|||
143329152|NCT01217073|516747448|FG007|Extension Period|Site discontinued study participation|2|||
143329153|NCT01217073|516747441|FG000|Extension Period|Withdrawal by Subject|0|||
143329154|NCT01217073|516747442|FG001|Extension Period|Withdrawal by Subject|0|||
143329155|NCT01217073|516747443|FG002|Extension Period|Withdrawal by Subject|0|||
143329156|NCT01217073|516747444|FG003|Extension Period|Withdrawal by Subject|0|||
143329157|NCT01217073|516747445|FG004|Extension Period|Withdrawal by Subject|0|||
143329158|NCT01217073|516747446|FG005|Extension Period|Withdrawal by Subject|0|||
143329159|NCT01217073|516747447|FG006|Extension Period|Withdrawal by Subject|30|||
143329160|NCT01217073|516747448|FG007|Extension Period|Withdrawal by Subject|8|||
143329161|NCT00620750|516747449|FG000|Overall Study|Lost to Follow-up|25|||
143329162|NCT04477187|516747450|FG000|Overall Study|Lost to Follow-up|2|||
143329163|NCT00765843|516747451|FG000|Overall Study|Lost to Follow-up|1|||
143329164|NCT00765843|516747452|FG001|Overall Study|Lost to Follow-up|3|||
143329165|NCT00765843|516747453|FG002|Overall Study|Lost to Follow-up|2|||
143329166|NCT00765843|516747451|FG000|Overall Study|did not return to receive intervention|0|||
143329167|NCT00765843|516747452|FG001|Overall Study|did not return to receive intervention|1|||
143329168|NCT00765843|516747453|FG002|Overall Study|did not return to receive intervention|0|||
143329169|NCT00765843|516747451|FG000|Overall Study|Adverse Event|0|||
143329170|NCT00765843|516747452|FG001|Overall Study|Adverse Event|0|||
143329171|NCT00765843|516747453|FG002|Overall Study|Adverse Event|1|||
143329172|NCT04862143|516747454|FG000|Overall Study|Adverse Event|1|||
143329173|NCT04862143|516747454|FG000|Overall Study|Study terminated by sponsor|1|||
143329174|NCT01571362|516747455|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
143329175|NCT01571362|516747456|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
143329176|NCT01571362|516747457|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
143329177|NCT01571362|516747455|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
143329178|NCT01571362|516747456|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
143329179|NCT01571362|516747457|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
143329180|NCT01571362|516747455|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
143329181|NCT01571362|516747456|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
143329182|NCT01571362|516747457|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
143329183|NCT01571362|516747455|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
143329184|NCT01571362|516747456|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
143329185|NCT01571362|516747457|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
143329186|NCT01571362|516747455|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
143329187|NCT01571362|516747456|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
143329188|NCT01571362|516747457|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
143329189|NCT01571362|516747455|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
143329190|NCT01571362|516747456|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
143329191|NCT01571362|516747457|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
143329192|NCT01571362|516747455|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
143329193|NCT01571362|516747456|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
143329194|NCT01571362|516747457|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
143329195|NCT01571362|516747455|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
143329196|NCT01571362|516747456|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
143329197|NCT01571362|516747457|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
143329198|NCT01571362|516747455|FG000|Double-Blind Treatment Period|Adverse Event|0|||
143329199|NCT01571362|516747456|FG001|Double-Blind Treatment Period|Adverse Event|9|||
143329200|NCT01571362|516747457|FG002|Double-Blind Treatment Period|Adverse Event|14|||
143329201|NCT01571362|516747455|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
143329202|NCT01571362|516747456|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
143329203|NCT01571362|516747457|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
143329204|NCT01571362|516747455|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
143329205|NCT01571362|516747456|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
143329206|NCT01571362|516747457|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
143329207|NCT01571362|516747455|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
143329208|NCT01571362|516747456|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
143329209|NCT01571362|516747457|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
143329210|NCT03117738|516747458|FG000|Overall Study|Withdrawal by Subject|3|||
143329211|NCT03117738|516747459|FG001|Overall Study|Withdrawal by Subject|1|||
143329212|NCT03117738|516747458|FG000|Overall Study|Lost to Follow-up|1|||
143329213|NCT03117738|516747459|FG001|Overall Study|Lost to Follow-up|4|||
143329214|NCT01669629|516747460|FG000|Period 1|protocol deviation|1|||
143329215|NCT01669629|516747461|FG001|Period 1|protocol deviation|2|||
143329216|NCT01221597|516747462|FG000|Overall Study|Adverse Event|4|||
143329217|NCT01221597|516747463|FG001|Overall Study|Adverse Event|1|||
143329218|NCT01221597|516747462|FG000|Overall Study|Withdrawal by Subject|20|||
143329219|NCT01221597|516747463|FG001|Overall Study|Withdrawal by Subject|6|||
143329220|NCT01221597|516747462|FG000|Overall Study|Lost to Follow-up|6|||
143329221|NCT01221597|516747463|FG001|Overall Study|Lost to Follow-up|5|||
143329222|NCT01221597|516747462|FG000|Overall Study|Protocol Violation|1|||
143329223|NCT01221597|516747463|FG001|Overall Study|Protocol Violation|0|||
143329224|NCT01221597|516747462|FG000|Overall Study|Other|3|||
143329225|NCT01221597|516747463|FG001|Overall Study|Other|4|||
143329226|NCT01221597|516747462|FG000|Overall Study|Death|2|||
143329227|NCT01221597|516747463|FG001|Overall Study|Death|0|||
143329228|NCT04420689|516747465|FG000|Overall Study|COVID-19 related hospitalization|0|||
143329229|NCT04420689|516747466|FG001|Overall Study|COVID-19 related hospitalization|0|||
143329230|NCT04420689|516747467|FG002|Overall Study|COVID-19 related hospitalization|0|||
143329231|NCT04420689|516747468|FG003|Overall Study|COVID-19 related hospitalization|0|||
143329232|NCT04420689|516747469|FG004|Overall Study|COVID-19 related hospitalization|1|||
143329233|NCT04420689|516747470|FG005|Overall Study|COVID-19 related hospitalization|0|||
143329234|NCT04420689|516747471|FG006|Overall Study|COVID-19 related hospitalization|0|||
143329235|NCT04420689|516747465|FG000|Overall Study|Physician Decision|0|||
143329236|NCT04420689|516747466|FG001|Overall Study|Physician Decision|0|||
143329237|NCT04420689|516747467|FG002|Overall Study|Physician Decision|0|||
143329238|NCT04420689|516747468|FG003|Overall Study|Physician Decision|0|||
143329239|NCT04420689|516747469|FG004|Overall Study|Physician Decision|0|||
143329240|NCT04420689|516747470|FG005|Overall Study|Physician Decision|1|||
143329241|NCT04420689|516747471|FG006|Overall Study|Physician Decision|0|||
143329242|NCT01292928|516747481|FG000|Overall Study|Death|8|||
143329243|NCT01292928|516747481|FG000|Overall Study|Withdrawal by Subject|8|||
143329244|NCT01292928|516747481|FG000|Overall Study|Lost to Follow-up|6|||
143329245|NCT01292928|516747481|FG000|Overall Study|Physician Decision|2|||
143329246|NCT00515502|516747482|FG000|Treatment Period 1|Adverse Event|0|||
143329247|NCT00515502|516747483|FG001|Treatment Period 1|Adverse Event|0|||
143329248|NCT00515502|516747484|FG002|Treatment Period 1|Adverse Event|0|||
143329249|NCT00515502|516747485|FG003|Treatment Period 1|Adverse Event|0|||
143329250|NCT00515502|516747486|FG004|Treatment Period 1|Adverse Event|0|||
143329251|NCT00515502|516747487|FG005|Treatment Period 1|Adverse Event|0|||
143329252|NCT00515502|516747488|FG006|Treatment Period 1|Adverse Event|1|||
143329253|NCT00515502|516747489|FG007|Treatment Period 1|Adverse Event|0|||
143329254|NCT00515502|516747490|FG008|Treatment Period 1|Adverse Event|1|||
143329255|NCT00515502|516747491|FG009|Treatment Period 1|Adverse Event|0|||
143329256|NCT00515502|516747492|FG010|Treatment Period 1|Adverse Event|0|||
143329257|NCT00515502|516747493|FG011|Treatment Period 1|Adverse Event|1|||
143329258|NCT00515502|516747482|FG000|Treatment Period 2|Adverse Event|0|||
143329259|NCT00515502|516747483|FG001|Treatment Period 2|Adverse Event|1|||
143329260|NCT00515502|516747484|FG002|Treatment Period 2|Adverse Event|0|||
143329261|NCT00515502|516747485|FG003|Treatment Period 2|Adverse Event|0|||
143329262|NCT00515502|516747486|FG004|Treatment Period 2|Adverse Event|0|||
143329263|NCT00515502|516747487|FG005|Treatment Period 2|Adverse Event|0|||
143329264|NCT00515502|516747488|FG006|Treatment Period 2|Adverse Event|0|||
143329265|NCT00515502|516747489|FG007|Treatment Period 2|Adverse Event|0|||
143329266|NCT00515502|516747490|FG008|Treatment Period 2|Adverse Event|0|||
143329267|NCT00515502|516747491|FG009|Treatment Period 2|Adverse Event|0|||
143329268|NCT00515502|516747492|FG010|Treatment Period 2|Adverse Event|0|||
143329269|NCT00515502|516747493|FG011|Treatment Period 2|Adverse Event|0|||
143329270|NCT02732938|516747497|FG000|Overall Study|Death|0|||
143329271|NCT02732938|516747498|FG001|Overall Study|Death|11|||
143329272|NCT02732938|516747499|FG002|Overall Study|Death|0|||
143329273|NCT02732938|516747497|FG000|Overall Study|Randomized but did not receive treatment|0|||
143329274|NCT02732938|516747498|FG001|Overall Study|Randomized but did not receive treatment|1|||
143329275|NCT02732938|516747499|FG002|Overall Study|Randomized but did not receive treatment|0|||
143329276|NCT02732938|516747497|FG000|Overall Study|Refused further follow-up|1|||
143329277|NCT02732938|516747498|FG001|Overall Study|Refused further follow-up|0|||
143329278|NCT02732938|516747499|FG002|Overall Study|Refused further follow-up|0|||
143329279|NCT02732938|516747497|FG000|Overall Study|Study terminated by sponsor|3|||
143329280|NCT02732938|516747498|FG001|Overall Study|Study terminated by sponsor|6|||
143329281|NCT02732938|516747499|FG002|Overall Study|Study terminated by sponsor|0|||
143329282|NCT04530448|516747500|FG000|Overall Study|Physician Decision|3|||
143329283|NCT04530448|516747501|FG001|Overall Study|Physician Decision|0|||
143329284|NCT01613248|516747502|FG000|Overall Study|Adverse Event|0|||
143329285|NCT01613248|516747503|FG001|Overall Study|Adverse Event|0|||
143329286|NCT01613248|516747504|FG002|Overall Study|Adverse Event|0|||
143329287|NCT01613248|516747505|FG003|Overall Study|Adverse Event|1|||
143329288|NCT01613248|516747506|FG004|Overall Study|Adverse Event|0|||
143329289|NCT01613248|516747507|FG005|Overall Study|Adverse Event|0|||
143329290|NCT01613248|516747502|FG000|Overall Study|Withdrawal by Subject|3|||
143329291|NCT01613248|516747503|FG001|Overall Study|Withdrawal by Subject|2|||
143329292|NCT01613248|516747504|FG002|Overall Study|Withdrawal by Subject|2|||
143329293|NCT01613248|516747505|FG003|Overall Study|Withdrawal by Subject|5|||
143329294|NCT01613248|516747506|FG004|Overall Study|Withdrawal by Subject|0|||
143329295|NCT01613248|516747507|FG005|Overall Study|Withdrawal by Subject|1|||
143329296|NCT01613248|516747502|FG000|Overall Study|Lost to Follow-up|5|||
143329297|NCT01613248|516747503|FG001|Overall Study|Lost to Follow-up|7|||
143329298|NCT01613248|516747504|FG002|Overall Study|Lost to Follow-up|4|||
143329299|NCT01613248|516747505|FG003|Overall Study|Lost to Follow-up|8|||
143329300|NCT01613248|516747506|FG004|Overall Study|Lost to Follow-up|4|||
143329301|NCT01613248|516747507|FG005|Overall Study|Lost to Follow-up|2|||
143329302|NCT01613248|516747502|FG000|Overall Study|Study Terminated by Sponsor|4|||
143329303|NCT01613248|516747503|FG001|Overall Study|Study Terminated by Sponsor|6|||
143329304|NCT01613248|516747504|FG002|Overall Study|Study Terminated by Sponsor|8|||
143329305|NCT01613248|516747505|FG003|Overall Study|Study Terminated by Sponsor|8|||
143329306|NCT01613248|516747506|FG004|Overall Study|Study Terminated by Sponsor|9|||
143329307|NCT01613248|516747507|FG005|Overall Study|Study Terminated by Sponsor|11|||
143329308|NCT01613248|516747502|FG000|Overall Study|Physician Decision|8|||
143329309|NCT01613248|516747503|FG001|Overall Study|Physician Decision|8|||
143329310|NCT01613248|516747504|FG002|Overall Study|Physician Decision|9|||
143329311|NCT01613248|516747505|FG003|Overall Study|Physician Decision|4|||
143329312|NCT01613248|516747506|FG004|Overall Study|Physician Decision|7|||
143329313|NCT01613248|516747507|FG005|Overall Study|Physician Decision|6|||
143329314|NCT01613248|516747502|FG000|Overall Study|Lack of Qualifying Event|9|||
143329315|NCT01613248|516747503|FG001|Overall Study|Lack of Qualifying Event|11|||
143329316|NCT01613248|516747504|FG002|Overall Study|Lack of Qualifying Event|10|||
143329317|NCT01613248|516747505|FG003|Overall Study|Lack of Qualifying Event|11|||
143329318|NCT01613248|516747506|FG004|Overall Study|Lack of Qualifying Event|15|||
143329319|NCT01613248|516747507|FG005|Overall Study|Lack of Qualifying Event|18|||
143329320|NCT01613248|516747502|FG000|Overall Study|Pregnancy|0|||
143329321|NCT01613248|516747503|FG001|Overall Study|Pregnancy|0|||
143329322|NCT01613248|516747504|FG002|Overall Study|Pregnancy|0|||
143329323|NCT01613248|516747505|FG003|Overall Study|Pregnancy|1|||
143329324|NCT01613248|516747506|FG004|Overall Study|Pregnancy|0|||
143329325|NCT01613248|516747507|FG005|Overall Study|Pregnancy|0|||
143382165|NCT02554786|516944525|FG000|Overall Study|Non-compliance with study treatment|0|||
143329326|NCT01491854|516747509|FG000|Overall Study|mainly due to premature termination|93|||
143329327|NCT01491854|516747509|FG000|Overall Study|Death|1|||
143329328|NCT01491854|516747509|FG000|Overall Study|Withdrawal by Subject|3|||
143382166|NCT02554786|516944526|FG001|Overall Study|Non-compliance with study treatment|1|||
143382167|NCT02554786|516944527|FG002|Overall Study|Non-compliance with study treatment|1|||
143382168|NCT02554786|516944528|FG003|Overall Study|Non-compliance with study treatment|0|||
143382169|NCT02554786|516944529|FG004|Overall Study|Non-compliance with study treatment|1|||
143382170|NCT02554786|516944525|FG000|Overall Study|Physician Decision|0|||
143382171|NCT02554786|516944526|FG001|Overall Study|Physician Decision|1|||
143382172|NCT02554786|516944527|FG002|Overall Study|Physician Decision|4|||
143382173|NCT02554786|516944528|FG003|Overall Study|Physician Decision|1|||
143382174|NCT02554786|516944529|FG004|Overall Study|Physician Decision|1|||
143382175|NCT02554786|516944525|FG000|Overall Study|Pregnancy|0|||
143382176|NCT02554786|516944526|FG001|Overall Study|Pregnancy|0|||
143382177|NCT02554786|516944527|FG002|Overall Study|Pregnancy|0|||
143382178|NCT02554786|516944528|FG003|Overall Study|Pregnancy|1|||
143382179|NCT02554786|516944529|FG004|Overall Study|Pregnancy|1|||
143382180|NCT00604669|516944530|FG000|Overall Study|lack of information in chart|7|||
143382181|NCT01695954|516944531|FG000|Overall Study|Withdrawal by Subject|4|||
143329329|NCT01491854|516747509|FG000|Overall Study|Lost to Follow-up|33|||
143329330|NCT01026974|516747521|FG000|Overall Study|Withdrawal by Subject|0|||
143329331|NCT01026974|516747522|FG001|Overall Study|Withdrawal by Subject|1|||
143329332|NCT01026974|516747523|FG002|Overall Study|Withdrawal by Subject|7|||
143329333|NCT01026974|516747524|FG003|Overall Study|Withdrawal by Subject|2|||
143329334|NCT01026974|516747521|FG000|Overall Study|Lost to Follow-up|1|||
143329335|NCT01026974|516747522|FG001|Overall Study|Lost to Follow-up|1|||
143329336|NCT01026974|516747523|FG002|Overall Study|Lost to Follow-up|4|||
143329337|NCT01026974|516747524|FG003|Overall Study|Lost to Follow-up|0|||
143329338|NCT01026974|516747521|FG000|Overall Study|Adverse Event|0|||
143329339|NCT01026974|516747522|FG001|Overall Study|Adverse Event|0|||
143329340|NCT01026974|516747523|FG002|Overall Study|Adverse Event|0|||
143329341|NCT01026974|516747524|FG003|Overall Study|Adverse Event|1|||
143329342|NCT01026974|516747521|FG000|Overall Study|Inappropriate enrollment|0|||
143329343|NCT01026974|516747522|FG001|Overall Study|Inappropriate enrollment|0|||
143329344|NCT01026974|516747523|FG002|Overall Study|Inappropriate enrollment|1|||
143329345|NCT01026974|516747524|FG003|Overall Study|Inappropriate enrollment|0|||
143329346|NCT03280121|516747526|FG000|Overall Study|Physician Decision|1|||
143329347|NCT03280121|516747526|FG000|Overall Study|Lost to Follow-up|1|||
143329348|NCT03280121|516747526|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
143329349|NCT03638141|516747536|FG000|Overall Study|1 subject was removed from the study due to non compliance and was never treated.|1|||
143329350|NCT03759873|516747537|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
143329351|NCT03759873|516747538|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
143329352|NCT03759873|516747539|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
143329353|NCT03759873|516747540|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
143329354|NCT03759873|516747537|FG000|Overall Study|Moved outside eligible area|0|||
143329355|NCT03759873|516747538|FG001|Overall Study|Moved outside eligible area|2|||
143329356|NCT03759873|516747539|FG002|Overall Study|Moved outside eligible area|0|||
143329357|NCT03759873|516747540|FG003|Overall Study|Moved outside eligible area|0|||
143329358|NCT03759873|516747537|FG000|Overall Study|Withdrawal by Subject|0|||
143329359|NCT03759873|516747538|FG001|Overall Study|Withdrawal by Subject|0|||
143329360|NCT03759873|516747539|FG002|Overall Study|Withdrawal by Subject|1|||
143329361|NCT03759873|516747540|FG003|Overall Study|Withdrawal by Subject|0|||
143329362|NCT01362140|516747543|FG000|Overall Study|Noncompliance|1|||
143329363|NCT01362140|516747544|FG001|Overall Study|Noncompliance|0|||
143329364|NCT01362140|516747543|FG000|Overall Study|Adverse Event|2|||
143329365|NCT01362140|516747544|FG001|Overall Study|Adverse Event|2|||
143382182|NCT01695954|516944532|FG001|Overall Study|Withdrawal by Subject|0|||
143382183|NCT01695954|516944531|FG000|Overall Study|Adverse Event|0|||
143382184|NCT01695954|516944532|FG001|Overall Study|Adverse Event|2|||
143382185|NCT04328727|516944534|FG000|Overall Study|Guardian Decision|1|||
143329366|NCT01362140|516747543|FG000|Overall Study|Withdrawal by Subject|3|||
143329367|NCT01362140|516747544|FG001|Overall Study|Withdrawal by Subject|3|||
143329368|NCT01362140|516747543|FG000|Overall Study|Administrative Decision|0|||
143329369|NCT01362140|516747544|FG001|Overall Study|Administrative Decision|1|||
143329370|NCT01362140|516747543|FG000|Overall Study|Death|2|||
143329371|NCT01362140|516747544|FG001|Overall Study|Death|1|||
143329372|NCT01362140|516747543|FG000|Overall Study|Other|1|||
143329373|NCT01362140|516747544|FG001|Overall Study|Other|1|||
143329374|NCT01362140|516747543|FG000|Overall Study|Protocol-specified Criteria|1|||
143382186|NCT04328727|516944534|FG000|Overall Study|Participant decision|4|||
143382187|NCT04328727|516944534|FG000|Overall Study|Death|3|||
143382188|NCT04149002|516944535|FG000|Overall Study|Lost to Follow-up|1|||
143382189|NCT04149002|516944536|FG001|Overall Study|Lost to Follow-up|0|||
143382190|NCT04149002|516944535|FG000|Overall Study|Withdrawal by Subject|1|||
143382191|NCT04149002|516944536|FG001|Overall Study|Withdrawal by Subject|0|||
143382192|NCT04583423|516944537|FG000|Overall Study|Lost to Follow-up|0|||
143382193|NCT04583423|516944538|FG001|Overall Study|Lost to Follow-up|1|||
143382194|NCT04583423|516944539|FG002|Overall Study|Lost to Follow-up|0|||
143382195|NCT04583423|516944540|FG003|Overall Study|Lost to Follow-up|2|||
143382196|NCT04583423|516944537|FG000|Overall Study|Study Terminated by Sponsor|32|||
143382197|NCT04583423|516944538|FG001|Overall Study|Study Terminated by Sponsor|35|||
143382198|NCT04583423|516944539|FG002|Overall Study|Study Terminated by Sponsor|36|||
143382199|NCT04583423|516944540|FG003|Overall Study|Study Terminated by Sponsor|33|||
143382200|NCT04583423|516944537|FG000|Overall Study|Withdrawal by Subject|3|||
143382201|NCT04583423|516944538|FG001|Overall Study|Withdrawal by Subject|1|||
143382202|NCT04583423|516944539|FG002|Overall Study|Withdrawal by Subject|2|||
143382203|NCT04583423|516944540|FG003|Overall Study|Withdrawal by Subject|1|||
143382204|NCT04704284|516944541|FG000|Overall Study|Withdrawal by Subject|1|||
143382205|NCT03930420|516944546|FG000|Overall Study|Withdrawal by Subject|7|||
143382206|NCT03930420|516944547|FG001|Overall Study|Withdrawal by Subject|9|||
143382207|NCT02321514|516944548|FG000|Overall Study|Death|15|||
143382208|NCT02321514|516944548|FG000|Overall Study|Missed Visit|7|||
143382209|NCT02321514|516944548|FG000|Overall Study|Study Exit|3|||
143382210|NCT04732338|516944551|FG000|Overall Study|Lost to Follow-up|3|||
143382211|NCT04732338|516944552|FG001|Overall Study|Lost to Follow-up|3|||
143382212|NCT00393484|516944553|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
143382213|NCT00393484|516944554|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
143382214|NCT00393484|516944553|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
143382215|NCT00393484|516944554|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
143382216|NCT00393484|516944553|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
143382217|NCT00393484|516944554|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
143382218|NCT00393484|516944553|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
143382219|NCT00393484|516944554|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
143382220|NCT00393484|516944553|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
143382221|NCT00393484|516944554|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
143382222|NCT00393484|516944553|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
143382223|NCT00393484|516944554|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
143382224|NCT00393484|516944553|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
143382225|NCT00393484|516944554|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
143382226|NCT00393484|516944553|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
143382227|NCT00393484|516944554|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
143382228|NCT00393484|516944553|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
143382229|NCT00393484|516944554|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
143382230|NCT00393484|516944553|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
143382231|NCT00393484|516944554|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
143382232|NCT03201562|516944555|FG000|Overall Study|Physician Decision|0|||
143382233|NCT03201562|516944556|FG001|Overall Study|Physician Decision|0|||
143382234|NCT03201562|516944557|FG002|Overall Study|Physician Decision|1|||
143382235|NCT03201562|516944555|FG000|Overall Study|Adverse Event|0|||
143329375|NCT01362140|516747544|FG001|Overall Study|Protocol-specified Criteria|2|||
143329376|NCT01362140|516747543|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
143329377|NCT01362140|516747544|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
143329378|NCT06476366|516747545|FG000|Overall Study|Lost to Follow-up|1|||
143329379|NCT06476366|516747546|FG001|Overall Study|Lost to Follow-up|3|||
143329380|NCT06476366|516747545|FG000|Overall Study|Adverse Event|1|||
143329381|NCT06476366|516747546|FG001|Overall Study|Adverse Event|0|||
143329382|NCT01910129|516747547|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
143329383|NCT01910129|516747548|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
143329384|NCT01910129|516747549|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
143329385|NCT01910129|516747547|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
143382236|NCT03201562|516944556|FG001|Overall Study|Adverse Event|0|||
143329386|NCT01910129|516747548|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
143329387|NCT01910129|516747549|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
143329388|NCT00965523|516747550|FG000|Study 221|Progressive Disease|4|||
143382237|NCT03201562|516944557|FG002|Overall Study|Adverse Event|1|||
143382238|NCT03201562|516944555|FG000|Overall Study|Lost to Follow-up|0|||
143382239|NCT03201562|516944556|FG001|Overall Study|Lost to Follow-up|1|||
143382240|NCT03201562|516944557|FG002|Overall Study|Lost to Follow-up|2|||
143382241|NCT00001277|516944558|FG000|Overall Study|Adverse Event|0|||
143329389|NCT00965523|516747550|FG000|Study 221|Physician Decision|3|||
143329390|NCT00965523|516747550|FG000|Study 224|Progressive Disease|5|||
143329391|NCT00965523|516747550|FG000|Study 224|Physician Decision|1|||
143329392|NCT02415400|516747551|FG000|Overall Study|Adverse Event|0|||
143382242|NCT00001277|516944559|FG001|Overall Study|Adverse Event|0|||
143382243|NCT00001277|516944560|FG002|Overall Study|Adverse Event|1|||
143382244|NCT00001277|516944558|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
143382245|NCT00001277|516944559|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
143382246|NCT00001277|516944560|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
143382247|NCT00065260|516944561|FG000|Overall Study|Death|0|||
143382248|NCT00065260|516944562|FG001|Overall Study|Death|1|||
143382249|NCT00088413|516944572|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
143382250|NCT00088413|516944573|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
143382251|NCT00088413|516944574|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
143382252|NCT00088413|516944575|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
143382253|NCT00088413|516944572|FG000|Overall Study|Adverse Events/Side Effects|0|||
143382254|NCT00088413|516944573|FG001|Overall Study|Adverse Events/Side Effects|1|||
143382255|NCT00088413|516944574|FG002|Overall Study|Adverse Events/Side Effects|1|||
143382256|NCT00088413|516944575|FG003|Overall Study|Adverse Events/Side Effects|0|||
143382257|NCT00088413|516944572|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
143382258|NCT00088413|516944573|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
143382259|NCT00088413|516944574|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
143382260|NCT00088413|516944575|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
143382261|NCT00088413|516944572|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
143382262|NCT00088413|516944573|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
143382263|NCT00088413|516944574|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
143382264|NCT00088413|516944575|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
143382265|NCT00088413|516944572|FG000|Overall Study|Death|0|||
143382266|NCT00088413|516944573|FG001|Overall Study|Death|1|||
143382267|NCT00088413|516944574|FG002|Overall Study|Death|0|||
143382268|NCT00088413|516944575|FG003|Overall Study|Death|0|||
143382269|NCT00088413|516944572|FG000|Overall Study|Progressive disease|9|||
143382270|NCT00088413|516944573|FG001|Overall Study|Progressive disease|11|||
143382271|NCT00088413|516944574|FG002|Overall Study|Progressive disease|8|||
143382272|NCT00088413|516944575|FG003|Overall Study|Progressive disease|14|||
143382273|NCT00088413|516944572|FG000|Overall Study|Other|0|||
143382274|NCT00088413|516944573|FG001|Overall Study|Other|1|||
143382275|NCT00088413|516944574|FG002|Overall Study|Other|0|||
143382276|NCT00088413|516944575|FG003|Overall Study|Other|0|||
143382277|NCT00088413|516944572|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
143382278|NCT00088413|516944573|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
143382279|NCT00088413|516944574|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
143382280|NCT00088413|516944575|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
143382281|NCT02539225|516944576|FG000|Part A|Adverse Event|13|||
143382282|NCT02539225|516944577|FG001|Part A|Adverse Event|4|||
143382283|NCT02539225|516944576|FG000|Part A|Withdrawal by Subject|2|||
143382284|NCT02539225|516944577|FG001|Part A|Withdrawal by Subject|4|||
143382285|NCT02539225|516944576|FG000|Part A|Physician Decision|4|||
143382286|NCT02539225|516944577|FG001|Part A|Physician Decision|7|||
143382287|NCT02539225|516944576|FG000|Part A|Did Not Receive study Drug|1|||
143382288|NCT02539225|516944577|FG001|Part A|Did Not Receive study Drug|1|||
143382289|NCT02539225|516944576|FG000|Pre Treatment for Part B|Progressive disease|1|||
143382290|NCT02539225|516944577|FG001|Pre Treatment for Part B|Progressive disease|1|||
143382291|NCT02539225|516944576|FG000|Pre Treatment for Part B|Adverse Event|1|||
143382292|NCT02539225|516944577|FG001|Pre Treatment for Part B|Adverse Event|1|||
143382293|NCT02539225|516944576|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
143382294|NCT02539225|516944577|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
143382295|NCT02539225|516944576|FG000|Pre Treatment for Part B|Physician Decision|2|||
143382296|NCT02539225|516944577|FG001|Pre Treatment for Part B|Physician Decision|0|||
143382297|NCT02539225|516944576|FG000|Part B|Adverse Event|4|||
143382298|NCT02539225|516944577|FG001|Part B|Adverse Event|4|||
143382299|NCT02539225|516944576|FG000|Part B|Withdrawal by Subject|0|||
143382300|NCT02539225|516944577|FG001|Part B|Withdrawal by Subject|3|||
143382301|NCT02539225|516944576|FG000|Part B|Physician Decision|0|||
143382302|NCT02539225|516944577|FG001|Part B|Physician Decision|9|||
143382303|NCT01044303|516944580|FG000|Overall Study|Lost to Follow-up|2|||
143382304|NCT03101371|516944587|FG000|Overall Study|Physician Decision|0|||
143382305|NCT03101371|516944588|FG001|Overall Study|Physician Decision|1|||
143382306|NCT03101371|516944587|FG000|Overall Study|Lost to Follow-up|1|||
143382307|NCT03101371|516944588|FG001|Overall Study|Lost to Follow-up|4|||
143382308|NCT03101371|516944587|FG000|Overall Study|Did not meet eligibility criteria|2|||
143382309|NCT03101371|516944588|FG001|Overall Study|Did not meet eligibility criteria|1|||
143382310|NCT01094184|516944591|FG000|Overall Study|Death|35|||
143382311|NCT01094184|516944592|FG001|Overall Study|Death|11|||
143382312|NCT02318134|516944593|FG000|Overall Study|Withdrawal by Subject|2|||
143382313|NCT02318134|516944594|FG001|Overall Study|Withdrawal by Subject|1|||
143382314|NCT00031694|516944599|FG000|Overall Study|Adverse Event|12|||
143382315|NCT00031694|516944599|FG000|Overall Study|Death|2|||
143382316|NCT00031694|516944599|FG000|Overall Study|Withdrawal by Subject|5|||
143382317|NCT01976312|516944600|FG000|Overall Study|Pregnancy|0|||
143382318|NCT01976312|516944601|FG001|Overall Study|Pregnancy|1|||
143382319|NCT01976312|516944600|FG000|Overall Study|Lost to Follow-up|2|||
143382320|NCT01976312|516944601|FG001|Overall Study|Lost to Follow-up|0|||
143382321|NCT01976312|516944600|FG000|Overall Study|Withdrawal by Subject|7|||
143382322|NCT01976312|516944601|FG001|Overall Study|Withdrawal by Subject|2|||
143382323|NCT01976312|516944600|FG000|Overall Study|Adverse Event|6|||
143382324|NCT01976312|516944601|FG001|Overall Study|Adverse Event|6|||
143382325|NCT01976312|516944600|FG000|Overall Study|Protocol Violation|2|||
143382326|NCT01976312|516944601|FG001|Overall Study|Protocol Violation|0|||
143382327|NCT01538719|516944602|FG000|Overall Study|Lost to Follow-up|2|||
143382328|NCT01538719|516944603|FG001|Overall Study|Lost to Follow-up|0|||
143382329|NCT04992390|516944604|FG000|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
143382330|NCT04992390|516944605|FG001|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
143382331|NCT04992390|516944606|FG002|Run-In/Screening Week|Recorded fewer than three intrusive memories|7|||
143382332|NCT04992390|516944604|FG000|Run-In/Screening Week|Lost to Follow-up|0|||
143382333|NCT04992390|516944605|FG001|Run-In/Screening Week|Lost to Follow-up|0|||
143382334|NCT04992390|516944606|FG002|Run-In/Screening Week|Lost to Follow-up|6|||
143382335|NCT04992390|516944604|FG000|Run-In/Screening Week|Withdrawal by Subject|0|||
143382336|NCT04992390|516944605|FG001|Run-In/Screening Week|Withdrawal by Subject|0|||
143382337|NCT04992390|516944606|FG002|Run-In/Screening Week|Withdrawal by Subject|1|||
143382338|NCT04992390|516944604|FG000|Baseline Questionnaires|Lost to Follow-up|0|||
143382339|NCT04992390|516944605|FG001|Baseline Questionnaires|Lost to Follow-up|0|||
143382340|NCT04992390|516944606|FG002|Baseline Questionnaires|Lost to Follow-up|1|||
143382341|NCT04992390|516944604|FG000|Baseline Questionnaires|Withdrawal by Subject|0|||
143382342|NCT04992390|516944605|FG001|Baseline Questionnaires|Withdrawal by Subject|0|||
143382343|NCT04992390|516944606|FG002|Baseline Questionnaires|Withdrawal by Subject|1|||
143382344|NCT04992390|516944604|FG000|Week 4 Primary Outcome|Lost to Follow-up|3|||
143382345|NCT04992390|516944605|FG001|Week 4 Primary Outcome|Lost to Follow-up|2|||
143382346|NCT04992390|516944606|FG002|Week 4 Primary Outcome|Lost to Follow-up|0|||
143329393|NCT02415400|516747552|FG001|Overall Study|Adverse Event|1|||
143329394|NCT02415400|516747553|FG002|Overall Study|Adverse Event|1|||
143329395|NCT02415400|516747554|FG003|Overall Study|Adverse Event|2|||
143329396|NCT02415400|516747551|FG000|Overall Study|Participant request to stop therapy|4|||
143329397|NCT02415400|516747552|FG001|Overall Study|Participant request to stop therapy|3|||
143329398|NCT02415400|516747553|FG002|Overall Study|Participant request to stop therapy|8|||
143329399|NCT02415400|516747554|FG003|Overall Study|Participant request to stop therapy|6|||
143329400|NCT02415400|516747551|FG000|Overall Study|Participant withdrew consent|14|||
143329401|NCT02415400|516747552|FG001|Overall Study|Participant withdrew consent|12|||
143329402|NCT02415400|516747553|FG002|Overall Study|Participant withdrew consent|30|||
143382347|NCT04992390|516944604|FG000|Week 4 Primary Outcome|Withdrawal by Subject|0|||
143382348|NCT04992390|516944605|FG001|Week 4 Primary Outcome|Withdrawal by Subject|2|||
143329403|NCT02415400|516747554|FG003|Overall Study|Participant withdrew consent|21|||
143382349|NCT04992390|516944606|FG002|Week 4 Primary Outcome|Withdrawal by Subject|0|||
143382350|NCT04992390|516944604|FG000|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|1|||
143382351|NCT04992390|516944605|FG001|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
143382352|NCT04992390|516944606|FG002|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
143382353|NCT04992390|516944604|FG000|Week 4 Secondary Outcomes|Lost to Follow-up|3|||
143329404|NCT02415400|516747551|FG000|Overall Study|Death|39|||
143382354|NCT04992390|516944605|FG001|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
143382355|NCT04992390|516944606|FG002|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
143382356|NCT04992390|516944604|FG000|Week 4 Secondary Outcomes|Withdrawal by Subject|1|||
143382357|NCT04992390|516944605|FG001|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
143329405|NCT02415400|516747552|FG001|Overall Study|Death|41|||
143329406|NCT02415400|516747553|FG002|Overall Study|Death|35|||
143329407|NCT02415400|516747554|FG003|Overall Study|Death|42|||
143329408|NCT02415400|516747551|FG000|Overall Study|Lost to Follow-up|3|||
143329409|NCT02415400|516747552|FG001|Overall Study|Lost to Follow-up|3|||
143329410|NCT02415400|516747553|FG002|Overall Study|Lost to Follow-up|2|||
143329411|NCT02415400|516747554|FG003|Overall Study|Lost to Follow-up|5|||
143329412|NCT02415400|516747551|FG000|Overall Study|Poor/Non-Compliance|0|||
143329413|NCT02415400|516747552|FG001|Overall Study|Poor/Non-Compliance|1|||
143329414|NCT02415400|516747553|FG002|Overall Study|Poor/Non-Compliance|3|||
143329415|NCT02415400|516747554|FG003|Overall Study|Poor/Non-Compliance|4|||
143329416|NCT02415400|516747551|FG000|Overall Study|Participant no longer meets criteria|2|||
143329417|NCT02415400|516747552|FG001|Overall Study|Participant no longer meets criteria|0|||
143329418|NCT02415400|516747553|FG002|Overall Study|Participant no longer meets criteria|0|||
143329419|NCT02415400|516747554|FG003|Overall Study|Participant no longer meets criteria|1|||
143329420|NCT02415400|516747551|FG000|Overall Study|Participant doesn't answer phone|1|||
143329421|NCT02415400|516747552|FG001|Overall Study|Participant doesn't answer phone|0|||
143329422|NCT02415400|516747553|FG002|Overall Study|Participant doesn't answer phone|0|||
143329423|NCT02415400|516747554|FG003|Overall Study|Participant doesn't answer phone|0|||
143329424|NCT02415400|516747551|FG000|Overall Study|Participant wanted home visits|1|||
143329425|NCT02415400|516747552|FG001|Overall Study|Participant wanted home visits|0|||
143329426|NCT02415400|516747553|FG002|Overall Study|Participant wanted home visits|0|||
143329427|NCT02415400|516747554|FG003|Overall Study|Participant wanted home visits|0|||
143329428|NCT02415400|516747551|FG000|Overall Study|Randomized in error|2|||
143329429|NCT02415400|516747552|FG001|Overall Study|Randomized in error|0|||
143329430|NCT02415400|516747553|FG002|Overall Study|Randomized in error|0|||
143329431|NCT02415400|516747554|FG003|Overall Study|Randomized in error|0|||
143329432|NCT02415400|516747551|FG000|Overall Study|No study drug on site|0|||
143329433|NCT02415400|516747552|FG001|Overall Study|No study drug on site|1|||
143329434|NCT02415400|516747553|FG002|Overall Study|No study drug on site|0|||
143329435|NCT02415400|516747554|FG003|Overall Study|No study drug on site|0|||
143329436|NCT02415400|516747551|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
143329437|NCT02415400|516747552|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
143329438|NCT02415400|516747553|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
143329439|NCT02415400|516747554|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
143329440|NCT02415400|516747551|FG000|Overall Study|Coagulation values cannot be set|0|||
143329441|NCT02415400|516747552|FG001|Overall Study|Coagulation values cannot be set|0|||
143329442|NCT02415400|516747553|FG002|Overall Study|Coagulation values cannot be set|1|||
143329443|NCT02415400|516747554|FG003|Overall Study|Coagulation values cannot be set|0|||
143329444|NCT02415400|516747551|FG000|Overall Study|State regulations prevent participation|0|||
143329445|NCT02415400|516747552|FG001|Overall Study|State regulations prevent participation|0|||
143329446|NCT02415400|516747553|FG002|Overall Study|State regulations prevent participation|1|||
143329447|NCT02415400|516747554|FG003|Overall Study|State regulations prevent participation|0|||
143329448|NCT02415400|516747551|FG000|Overall Study|Poor treatment monitoring|0|||
143329449|NCT02415400|516747552|FG001|Overall Study|Poor treatment monitoring|0|||
143329450|NCT02415400|516747553|FG002|Overall Study|Poor treatment monitoring|1|||
143329451|NCT02415400|516747554|FG003|Overall Study|Poor treatment monitoring|0|||
143329452|NCT02415400|516747551|FG000|Overall Study|Participant in jail|0|||
143329453|NCT02415400|516747552|FG001|Overall Study|Participant in jail|0|||
143329454|NCT02415400|516747553|FG002|Overall Study|Participant in jail|1|||
143329455|NCT02415400|516747554|FG003|Overall Study|Participant in jail|0|||
143329456|NCT02415400|516747551|FG000|Overall Study|Investigator decision|0|||
143329457|NCT02415400|516747552|FG001|Overall Study|Investigator decision|0|||
143329458|NCT02415400|516747553|FG002|Overall Study|Investigator decision|1|||
143329459|NCT02415400|516747554|FG003|Overall Study|Investigator decision|1|||
143329460|NCT02415400|516747551|FG000|Overall Study|Site closure; participant won't transfer|0|||
143329461|NCT02415400|516747552|FG001|Overall Study|Site closure; participant won't transfer|0|||
143329462|NCT02415400|516747553|FG002|Overall Study|Site closure; participant won't transfer|0|||
143329463|NCT02415400|516747554|FG003|Overall Study|Site closure; participant won't transfer|1|||
143329464|NCT01581281|516747557|FG000|Overall Study|Early Study Closure|15|||
143329465|NCT01581281|516747558|FG001|Overall Study|Early Study Closure|6|||
143329466|NCT01581281|516747559|FG002|Overall Study|Early Study Closure|12|||
143329467|NCT02081846|516747560|FG000|Overall Study|Withdrawal by Subject|1|||
143329468|NCT02081846|516747561|FG001|Overall Study|Withdrawal by Subject|0|||
143329469|NCT02081846|516747560|FG000|Overall Study|invalid consent|1|||
143329470|NCT02081846|516747561|FG001|Overall Study|invalid consent|0|||
143329471|NCT02576067|516747566|FG000|Overall Study|Death|0|||
143329472|NCT02576067|516747567|FG001|Overall Study|Death|1|||
143329473|NCT02576067|516747566|FG000|Overall Study|Lack of Efficacy|1|||
143329474|NCT02576067|516747567|FG001|Overall Study|Lack of Efficacy|0|||
143329475|NCT02576067|516747566|FG000|Overall Study|Lost to Follow-up|11|||
143329476|NCT02576067|516747567|FG001|Overall Study|Lost to Follow-up|0|||
143329477|NCT02576067|516747566|FG000|Overall Study|Withdrawal by Subject|11|||
143382358|NCT04992390|516944606|FG002|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
143329478|NCT02576067|516747567|FG001|Overall Study|Withdrawal by Subject|2|||
143382359|NCT04992390|516944604|FG000|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|5|||
143382360|NCT04992390|516944605|FG001|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|1|||
143382361|NCT04992390|516944606|FG002|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|0|||
143382362|NCT04992390|516944604|FG000|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
143382363|NCT04992390|516944605|FG001|Delayed Arm Receive Intervention|Withdrawal by Subject|1|||
143382364|NCT04992390|516944606|FG002|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
143382365|NCT04992390|516944604|FG000|Week 8 Replication After Crossover|Lost to Follow-up|0|||
143382366|NCT04992390|516944605|FG001|Week 8 Replication After Crossover|Lost to Follow-up|4|||
143382367|NCT04992390|516944606|FG002|Week 8 Replication After Crossover|Lost to Follow-up|0|||
143382368|NCT04992390|516944604|FG000|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
143382369|NCT04992390|516944605|FG001|Week 8 Replication After Crossover|Withdrawal by Subject|2|||
143382370|NCT04992390|516944606|FG002|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
143382371|NCT04992390|516944604|FG000|Week 8 - Other Secondary Outcomes|Lost to Follow-up|2|||
143382372|NCT04992390|516944605|FG001|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
143382373|NCT04992390|516944606|FG002|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
143382374|NCT04992390|516944604|FG000|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
143382375|NCT04992390|516944605|FG001|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|3|||
143382376|NCT04992390|516944606|FG002|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
143382377|NCT04939246|516944607|FG000|After Treatment|Death|4|||
143382378|NCT04939246|516944607|FG000|After Treatment|Lost to Follow-up|1|||
143382379|NCT04939246|516944607|FG000|After Treatment|Discharged to hospice|2|||
143382380|NCT01216176|516946419|FG000|Overall Study|Adverse Event|0|||
143382381|NCT01216176|516946420|FG001|Overall Study|Adverse Event|8|||
143382382|NCT01216176|516946421|FG002|Overall Study|Adverse Event|0|||
143382383|NCT01216176|516946419|FG000|Overall Study|Physician Decision|0|||
143382384|NCT01216176|516946420|FG001|Overall Study|Physician Decision|0|||
143382385|NCT01216176|516946421|FG002|Overall Study|Physician Decision|1|||
143382386|NCT00212355|516946422|FG000|Overall Study|Adverse Event|1|||
143382387|NCT00212355|516946422|FG000|Overall Study|Withdrawal by Subject|1|||
143382388|NCT00212355|516946422|FG000|Overall Study|A change of address|1|||
143382389|NCT04104321|516946428|FG000|Overall Study|didn't take the study drug|3|||
143382390|NCT03012841|516946429|FG000|Overall Study|Protocol Violation|0|||
143382391|NCT03012841|516946430|FG001|Overall Study|Protocol Violation|10|||
143382392|NCT03012841|516946429|FG000|Overall Study|Lost to Follow-up|6|||
143382393|NCT03012841|516946430|FG001|Overall Study|Lost to Follow-up|1|||
143382394|NCT03012841|516946429|FG000|Overall Study|Withdrawal by Subject|6|||
143382395|NCT03012841|516946430|FG001|Overall Study|Withdrawal by Subject|0|||
143382396|NCT03012841|516946429|FG000|Overall Study|Unable to complete 12 month visit|6|||
143382397|NCT03012841|516946430|FG001|Overall Study|Unable to complete 12 month visit|0|||
143382398|NCT03012841|516946429|FG000|Overall Study|Subject relocation|1|||
143382399|NCT03012841|516946430|FG001|Overall Study|Subject relocation|0|||
143382400|NCT03012841|516946429|FG000|Overall Study|Seasonal winter travel|1|||
143382401|NCT03012841|516946430|FG001|Overall Study|Seasonal winter travel|0|||
143382402|NCT03012841|516946429|FG000|Overall Study|Physician Decision|0|||
143382403|NCT03012841|516946430|FG001|Overall Study|Physician Decision|2|||
143382404|NCT03012841|516946429|FG000|Overall Study|No ablation performed|0|||
143382405|NCT03012841|516946430|FG001|Overall Study|No ablation performed|2|||
143382406|NCT03012841|516946429|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
143382407|NCT03012841|516946430|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
143382408|NCT03012841|516946429|FG000|Overall Study|Insurance change|0|||
143382409|NCT03012841|516946430|FG001|Overall Study|Insurance change|1|||
143382410|NCT05644002|516946431|FG000|Overall Study|Lost to Follow-up|1|||
143382411|NCT05644002|516946432|FG001|Overall Study|Lost to Follow-up|2|||
143382412|NCT05644002|516946431|FG000|Overall Study|Withdrawal by Subject|0|||
143382413|NCT05644002|516946432|FG001|Overall Study|Withdrawal by Subject|1|||
143382414|NCT04842500|516946433|FG000|Overall Study|Withdrawal by Subject|4|||
143382415|NCT04842500|516946434|FG001|Overall Study|Withdrawal by Subject|1|||
143382416|NCT04842500|516946435|FG002|Overall Study|Withdrawal by Subject|2|||
143382417|NCT04842500|516946436|FG003|Overall Study|Withdrawal by Subject|3|||
143382418|NCT04842500|516946433|FG000|Overall Study|Protocol Violation|1|||
143382419|NCT04842500|516946434|FG001|Overall Study|Protocol Violation|0|||
143382420|NCT04842500|516946435|FG002|Overall Study|Protocol Violation|0|||
143382421|NCT04842500|516946436|FG003|Overall Study|Protocol Violation|1|||
143382422|NCT04038957|516946442|FG000|Overall Study|Withdrawal by Subject|1|||
143382423|NCT04038957|516946442|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
143382424|NCT04065048|516946443|FG000|Overall Study|Withdrawal by Subject|1|||
143382425|NCT04065048|516946444|FG001|Overall Study|Withdrawal by Subject|2|||
143382426|NCT04065048|516946445|FG002|Overall Study|Withdrawal by Subject|1|||
143382427|NCT04065048|516946446|FG003|Overall Study|Withdrawal by Subject|1|||
143382428|NCT04065048|516946443|FG000|Overall Study|Adverse Event|1|||
143382429|NCT04065048|516946444|FG001|Overall Study|Adverse Event|0|||
143382430|NCT04065048|516946445|FG002|Overall Study|Adverse Event|1|||
143382431|NCT04065048|516946446|FG003|Overall Study|Adverse Event|0|||
143382432|NCT03397108|516946447|FG000|Overall Study|Lost to Follow-up|15|||
143382433|NCT03397108|516946448|FG001|Overall Study|Lost to Follow-up|0|||
143382434|NCT03397108|516946447|FG000|Overall Study|Insufficient milk production|3|||
143382435|NCT03397108|516946448|FG001|Overall Study|Insufficient milk production|2|||
143382436|NCT03397108|516946447|FG000|Overall Study|Withdrawal by Subject|2|||
143382437|NCT03397108|516946448|FG001|Overall Study|Withdrawal by Subject|0|||
143382438|NCT03554265|516946449|FG000|Overall Study|Withdrawal by Subject|2|||
143382439|NCT03554265|516946450|FG001|Overall Study|Withdrawal by Subject|2|||
143382440|NCT03554265|516946451|FG002|Overall Study|Withdrawal by Subject|3|||
143382441|NCT03554265|516946449|FG000|Overall Study|Physician Decision|0|||
143382442|NCT03554265|516946450|FG001|Overall Study|Physician Decision|0|||
143382443|NCT03554265|516946451|FG002|Overall Study|Physician Decision|1|||
143382444|NCT02652260|516946452|FG000|Base Study|Pregnancy|0|||
143382445|NCT02652260|516946453|FG001|Base Study|Pregnancy|1|||
143382446|NCT02652260|516946452|FG000|Base Study|Withdrawal by Subject|0|||
143382447|NCT02652260|516946453|FG001|Base Study|Withdrawal by Subject|1|||
143382448|NCT02652260|516946452|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
143382449|NCT02652260|516946453|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
143382450|NCT02652260|516946452|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
143382451|NCT02652260|516946453|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
143382452|NCT02652260|516946452|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
143382453|NCT02652260|516946453|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
143382454|NCT02652260|516946452|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
143382455|NCT02652260|516946453|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
143382456|NCT02652260|516946452|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
143382457|NCT02652260|516946453|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
143382458|NCT02652260|516946452|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
143382459|NCT02652260|516946453|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
143382460|NCT02652260|516946452|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
143382461|NCT02652260|516946453|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
143382462|NCT02652260|516946452|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
143382463|NCT02652260|516946453|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
143382464|NCT02652260|516946452|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
143382465|NCT02652260|516946453|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
143382466|NCT02652260|516946452|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
143382467|NCT02652260|516946453|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
143382468|NCT02652260|516946452|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
143382469|NCT02652260|516946453|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
143382470|NCT02652260|516946452|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
143382471|NCT02652260|516946453|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
143382472|NCT05096819|516946458|FG000|Overall Study|Withdrawal by Subject|3|||
143382473|NCT05096819|516946459|FG001|Overall Study|Withdrawal by Subject|0|||
143382474|NCT03324984|516946460|FG000|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|1|||
143382475|NCT03324984|516946461|FG001|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|4|||
143382476|NCT02152137|516946463|FG000|Overall Study|Withdrawal by Subject|1|||
143382477|NCT02152137|516946463|FG000|Overall Study|Originally assigned to Arm B|3|||
143382478|NCT04878354|516946464|FG000|Overall Study|Adverse Event|4|||
143382479|NCT04878354|516946465|FG001|Overall Study|Adverse Event|13|||
143382480|NCT04878354|516946464|FG000|Overall Study|Withdrawal by Subject|14|||
143382481|NCT04878354|516946465|FG001|Overall Study|Withdrawal by Subject|12|||
143382482|NCT04878354|516946464|FG000|Overall Study|Lost to Follow-up|4|||
143382483|NCT04878354|516946465|FG001|Overall Study|Lost to Follow-up|1|||
143382484|NCT04878354|516946464|FG000|Overall Study|Lack of Efficacy|1|||
143382485|NCT04878354|516946465|FG001|Overall Study|Lack of Efficacy|0|||
143382486|NCT04878354|516946464|FG000|Overall Study|Protocol Violation|0|||
143382487|NCT04878354|516946465|FG001|Overall Study|Protocol Violation|1|||
143382488|NCT04878354|516946464|FG000|Overall Study|"Reason stated as other in CRF"|2|||
143382489|NCT04878354|516946465|FG001|Overall Study|"Reason stated as other in CRF"|3|||
143382490|NCT06194214|516946481|FG000|Overall Study|Adverse Event|1|||
143382491|NCT04468776|516946482|FG000|Overall Study|Lost to Follow-up|4|||
143382492|NCT04468776|516946483|FG001|Overall Study|Lost to Follow-up|3|||
143382493|NCT04468776|516946484|FG002|Overall Study|Lost to Follow-up|4|||
143382494|NCT04468776|516946482|FG000|Overall Study|Withdrawal by Subject|1|||
143382495|NCT04468776|516946483|FG001|Overall Study|Withdrawal by Subject|10|||
143382496|NCT04468776|516946484|FG002|Overall Study|Withdrawal by Subject|4|||
143382497|NCT04468776|516946482|FG000|Overall Study|Physician Decision|0|||
143382498|NCT04468776|516946483|FG001|Overall Study|Physician Decision|1|||
143382499|NCT04468776|516946484|FG002|Overall Study|Physician Decision|1|||
143382500|NCT05687903|516946485|FG000|Overall Study|Protocol Deviation|1|||
143382501|NCT05687903|516946486|FG001|Overall Study|Protocol Deviation|1|||
143382502|NCT05687903|516946487|FG002|Overall Study|Protocol Deviation|0|||
143382503|NCT05687903|516946488|FG003|Overall Study|Protocol Deviation|1|||
143382504|NCT05687903|516946489|FG004|Overall Study|Protocol Deviation|0|||
143382505|NCT05613205|516946490|FG000|Overall Study|Lost to Follow-up|0|||
143382506|NCT05613205|516946491|FG001|Overall Study|Lost to Follow-up|0|||
143382507|NCT05613205|516946492|FG002|Overall Study|Lost to Follow-up|1|||
143382508|NCT05613205|516946493|FG003|Overall Study|Lost to Follow-up|1|||
143382509|NCT05613205|516946494|FG004|Overall Study|Lost to Follow-up|0|||
143382510|NCT05613205|516946490|FG000|Overall Study|Withdrawal by Subject|0|||
143382511|NCT05613205|516946491|FG001|Overall Study|Withdrawal by Subject|0|||
143382512|NCT05613205|516946492|FG002|Overall Study|Withdrawal by Subject|1|||
143382513|NCT05613205|516946493|FG003|Overall Study|Withdrawal by Subject|1|||
143382514|NCT05613205|516946494|FG004|Overall Study|Withdrawal by Subject|0|||
143382515|NCT04869982|516946504|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
143382516|NCT04869982|516946505|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
143382517|NCT04869982|516946504|FG000|Overall Study|Migrated / moved from the study area|1|||
143382518|NCT04869982|516946505|FG001|Overall Study|Migrated / moved from the study area|1|||
143382519|NCT04869982|516946504|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
143382520|NCT04869982|516946505|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
143382521|NCT04869982|516946504|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
143382522|NCT04869982|516946505|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
143382523|NCT04869982|516946504|FG000|Overall Study|Solicited adverse event|2|||
143382524|NCT04869982|516946505|FG001|Overall Study|Solicited adverse event|1|||
143382525|NCT04608045|516946506|FG000|Overall Study|Physician Decision|1|||
143382526|NCT03857620|516946507|FG000|Overall Study|Death|4|||
143382527|NCT03857620|516946508|FG001|Overall Study|Death|5|||
143382528|NCT03857620|516946509|FG002|Overall Study|Death|7|||
143382529|NCT03857620|516946507|FG000|Overall Study|Lost to Follow-up|2|||
143382530|NCT03857620|516946508|FG001|Overall Study|Lost to Follow-up|5|||
143382531|NCT03857620|516946509|FG002|Overall Study|Lost to Follow-up|3|||
143382532|NCT03857620|516946507|FG000|Overall Study|Disease progression or relapse after study registration|1|||
143382533|NCT03857620|516946508|FG001|Overall Study|Disease progression or relapse after study registration|5|||
143382534|NCT03857620|516946509|FG002|Overall Study|Disease progression or relapse after study registration|1|||
143382535|NCT03857620|516946507|FG000|Overall Study|Ineligible|5|||
143382536|NCT03857620|516946508|FG001|Overall Study|Ineligible|0|||
143382537|NCT03857620|516946509|FG002|Overall Study|Ineligible|2|||
143382538|NCT03857620|516946507|FG000|Overall Study|No malignancy|1|||
143382539|NCT03857620|516946508|FG001|Overall Study|No malignancy|0|||
143382540|NCT03857620|516946509|FG002|Overall Study|No malignancy|1|||
143382541|NCT03857620|516946507|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
143382542|NCT03857620|516946508|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
143382543|NCT03857620|516946509|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
143382544|NCT03857620|516946507|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
143382545|NCT03857620|516946508|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
143382546|NCT03857620|516946509|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
143382547|NCT03857620|516946507|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
143382548|NCT03857620|516946508|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
143382549|NCT03857620|516946509|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
143382550|NCT03857620|516946507|FG000|Overall Study|Surgery not performed, patient decision|0|||
143382551|NCT03857620|516946508|FG001|Overall Study|Surgery not performed, patient decision|3|||
143382552|NCT03857620|516946509|FG002|Overall Study|Surgery not performed, patient decision|1|||
143382553|NCT03857620|516946507|FG000|Overall Study|Surgery not performed, other reason|3|||
143382554|NCT03857620|516946508|FG001|Overall Study|Surgery not performed, other reason|1|||
143382555|NCT03857620|516946509|FG002|Overall Study|Surgery not performed, other reason|4|||
143382556|NCT03857620|516946507|FG000|Overall Study|Worsening performance status after surgery performed|0|||
143382557|NCT03857620|516946508|FG001|Overall Study|Worsening performance status after surgery performed|1|||
143382558|NCT03857620|516946509|FG002|Overall Study|Worsening performance status after surgery performed|1|||
143382559|NCT03271151|516946510|FG000|Overall Study|Lost to Follow-up|1|||
143382560|NCT03271151|516946511|FG001|Overall Study|Lost to Follow-up|3|||
143382561|NCT03271151|516946510|FG000|Overall Study|Withdrawal by Subject|1|||
143382562|NCT03271151|516946511|FG001|Overall Study|Withdrawal by Subject|0|||
143329479|NCT02576067|516747566|FG000|Overall Study|study closure of main CIRT trial)|0|||
143329480|NCT02576067|516747567|FG001|Overall Study|study closure of main CIRT trial)|8|||
143329481|NCT02576067|516747566|FG000|Overall Study|not randomized, failed run-in|7|||
143329482|NCT02576067|516747567|FG001|Overall Study|not randomized, failed run-in|0|||
143329483|NCT02576067|516747566|FG000|Overall Study|screen failure/ re-enrolled|0|||
143329484|NCT02576067|516747567|FG001|Overall Study|screen failure/ re-enrolled|25|||
143329485|NCT02576067|516747566|FG000|Overall Study|Physician Decision|4|||
143329486|NCT02576067|516747567|FG001|Overall Study|Physician Decision|0|||
143329487|NCT03346759|516747568|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
143329488|NCT03346759|516747569|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
143329489|NCT03346759|516747568|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
143329490|NCT03346759|516747569|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
143329491|NCT03346759|516747568|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
143329492|NCT03346759|516747569|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
143329493|NCT02625623|516747573|FG000|Overall Study|Participants randomized but not treated|9|||
143329494|NCT02625623|516747574|FG001|Overall Study|Participants randomized but not treated|1|||
143329495|NCT03826667|516747578|FG000|Overall Study|Protocol deviation|21|||
143329496|NCT00808808|516747579|FG000|Overall Study|Vaccinated; survey not completed|131|||
143329497|NCT00808808|516747580|FG001|Overall Study|Vaccinated; survey not completed|169|||
143329498|NCT00808808|516747581|FG002|Overall Study|Vaccinated; survey not completed|302|||
143329499|NCT00808808|516747579|FG000|Overall Study|Employee was not vaccinated.|2686|||
143329500|NCT00808808|516747580|FG001|Overall Study|Employee was not vaccinated.|2268|||
143329501|NCT00808808|516747581|FG002|Overall Study|Employee was not vaccinated.|2255|||
143329502|NCT04764396|516747582|FG000|Overall Study|Physician Decision|1|||
143329503|NCT04764396|516747583|FG001|Overall Study|Physician Decision|0|||
143329504|NCT02653482|516747585|FG000|Overall Study|Death|1|||
143329505|NCT02653482|516747586|FG001|Overall Study|Death|1|||
143329506|NCT02693665|516747589|FG000|Overall Study|Death|3|||
143329507|NCT02693665|516747590|FG001|Overall Study|Death|2|||
143329508|NCT02693665|516747589|FG000|Overall Study|Lost to Follow-up|7|||
143329509|NCT02693665|516747590|FG001|Overall Study|Lost to Follow-up|3|||
143329510|NCT02693665|516747589|FG000|Overall Study|Protocol Violation|1|||
143329511|NCT02693665|516747590|FG001|Overall Study|Protocol Violation|0|||
143329512|NCT02693665|516747589|FG000|Overall Study|Withdrawal by Subject|2|||
143329513|NCT02693665|516747590|FG001|Overall Study|Withdrawal by Subject|0|||
143329514|NCT02693665|516747589|FG000|Overall Study|patient wanted to leave it behind|1|||
143329515|NCT02693665|516747590|FG001|Overall Study|patient wanted to leave it behind|0|||
143329516|NCT02693665|516747589|FG000|Overall Study|anxiety|1|||
143329517|NCT02693665|516747590|FG001|Overall Study|anxiety|0|||
143329518|NCT02693665|516747589|FG000|Overall Study|family issues|1|||
143329519|NCT02693665|516747590|FG001|Overall Study|family issues|0|||
143329520|NCT02693665|516747589|FG000|Overall Study|no reason given|1|||
143329521|NCT02693665|516747590|FG001|Overall Study|no reason given|0|||
143329522|NCT01559844|516749762|FG000|Overall Study|Consent Withdrawn|7|||
143329523|NCT01559844|516749762|FG000|Overall Study|Death|5|||
143329524|NCT01559844|516749762|FG000|Overall Study|Efficacy Failure|10|||
143329525|NCT01559844|516749762|FG000|Overall Study|No Longer A Transplant Candidate|3|||
143329526|NCT02564523|516749765|FG000|Overall Study|Withdrawal by Subject|3|||
143329527|NCT02564523|516749766|FG001|Overall Study|Withdrawal by Subject|0|||
143329528|NCT02564523|516749767|FG002|Overall Study|Withdrawal by Subject|1|||
143329529|NCT02564523|516749768|FG003|Overall Study|Withdrawal by Subject|0|||
143329530|NCT02564523|516749769|FG004|Overall Study|Withdrawal by Subject|1|||
143329531|NCT02564523|516749770|FG005|Overall Study|Withdrawal by Subject|0|||
143329532|NCT02564523|516749771|FG006|Overall Study|Withdrawal by Subject|1|||
143329533|NCT02564523|516749772|FG007|Overall Study|Withdrawal by Subject|0|||
143329534|NCT02564523|516749773|FG008|Overall Study|Withdrawal by Subject|0|||
143329535|NCT02564523|516749774|FG009|Overall Study|Withdrawal by Subject|0|||
143329536|NCT02564523|516749775|FG010|Overall Study|Withdrawal by Subject|1|||
143329537|NCT02564523|516749776|FG011|Overall Study|Withdrawal by Subject|0|||
143329538|NCT02564523|516749777|FG012|Overall Study|Withdrawal by Subject|1|||
143329539|NCT02564523|516749778|FG013|Overall Study|Withdrawal by Subject|0|||
143329540|NCT02564523|516749779|FG014|Overall Study|Withdrawal by Subject|0|||
143329541|NCT02564523|516749780|FG015|Overall Study|Withdrawal by Subject|0|||
143329542|NCT02564523|516749781|FG016|Overall Study|Withdrawal by Subject|0|||
143329543|NCT02564523|516749782|FG017|Overall Study|Withdrawal by Subject|0|||
143329544|NCT02564523|516749765|FG000|Overall Study|Adverse Event|0|||
143329545|NCT02564523|516749766|FG001|Overall Study|Adverse Event|0|||
143329546|NCT02564523|516749767|FG002|Overall Study|Adverse Event|0|||
143329547|NCT02564523|516749768|FG003|Overall Study|Adverse Event|0|||
143329548|NCT02564523|516749769|FG004|Overall Study|Adverse Event|0|||
143329549|NCT02564523|516749770|FG005|Overall Study|Adverse Event|0|||
143329550|NCT02564523|516749771|FG006|Overall Study|Adverse Event|0|||
143329551|NCT02564523|516749772|FG007|Overall Study|Adverse Event|0|||
143329552|NCT02564523|516749773|FG008|Overall Study|Adverse Event|0|||
143329553|NCT02564523|516749774|FG009|Overall Study|Adverse Event|0|||
143329554|NCT02564523|516749775|FG010|Overall Study|Adverse Event|0|||
143382563|NCT03103321|516946512|FG000|Overall Study|Protocol Violation|1|||
143382564|NCT03103321|516946513|FG001|Overall Study|Protocol Violation|1|||
143382565|NCT03103321|516946514|FG002|Overall Study|Protocol Violation|1|||
143329555|NCT02564523|516749776|FG011|Overall Study|Adverse Event|0|||
143329556|NCT02564523|516749777|FG012|Overall Study|Adverse Event|0|||
143329557|NCT02564523|516749778|FG013|Overall Study|Adverse Event|0|||
143329558|NCT02564523|516749779|FG014|Overall Study|Adverse Event|0|||
143329559|NCT02564523|516749780|FG015|Overall Study|Adverse Event|0|||
143329560|NCT02564523|516749781|FG016|Overall Study|Adverse Event|0|||
143329561|NCT02564523|516749782|FG017|Overall Study|Adverse Event|1|||
143329562|NCT02564523|516749765|FG000|Overall Study|Death|0|||
143329563|NCT02564523|516749766|FG001|Overall Study|Death|0|||
143329564|NCT02564523|516749767|FG002|Overall Study|Death|0|||
143329565|NCT02564523|516749768|FG003|Overall Study|Death|0|||
143329566|NCT02564523|516749769|FG004|Overall Study|Death|0|||
143329567|NCT02564523|516749770|FG005|Overall Study|Death|0|||
143329568|NCT02564523|516749771|FG006|Overall Study|Death|1|||
143329569|NCT02564523|516749772|FG007|Overall Study|Death|0|||
143329570|NCT02564523|516749773|FG008|Overall Study|Death|0|||
143329571|NCT02564523|516749774|FG009|Overall Study|Death|0|||
143329572|NCT02564523|516749775|FG010|Overall Study|Death|1|||
143329573|NCT02564523|516749776|FG011|Overall Study|Death|0|||
143329574|NCT02564523|516749777|FG012|Overall Study|Death|0|||
143329575|NCT02564523|516749778|FG013|Overall Study|Death|0|||
143329576|NCT02564523|516749779|FG014|Overall Study|Death|0|||
143329577|NCT02564523|516749780|FG015|Overall Study|Death|0|||
143329578|NCT02564523|516749781|FG016|Overall Study|Death|0|||
143329579|NCT02564523|516749782|FG017|Overall Study|Death|0|||
143329580|NCT02564523|516749765|FG000|Overall Study|Lost to Follow-up|2|||
143329581|NCT02564523|516749766|FG001|Overall Study|Lost to Follow-up|1|||
143329582|NCT02564523|516749767|FG002|Overall Study|Lost to Follow-up|4|||
143329583|NCT02564523|516749768|FG003|Overall Study|Lost to Follow-up|0|||
143329584|NCT02564523|516749769|FG004|Overall Study|Lost to Follow-up|1|||
143329585|NCT02564523|516749770|FG005|Overall Study|Lost to Follow-up|0|||
143329586|NCT02564523|516749771|FG006|Overall Study|Lost to Follow-up|1|||
143329587|NCT02564523|516749772|FG007|Overall Study|Lost to Follow-up|0|||
143329588|NCT02564523|516749773|FG008|Overall Study|Lost to Follow-up|0|||
143329589|NCT02564523|516749774|FG009|Overall Study|Lost to Follow-up|0|||
143329590|NCT02564523|516749775|FG010|Overall Study|Lost to Follow-up|0|||
143329591|NCT02564523|516749776|FG011|Overall Study|Lost to Follow-up|1|||
143329592|NCT02564523|516749777|FG012|Overall Study|Lost to Follow-up|1|||
143329593|NCT02564523|516749778|FG013|Overall Study|Lost to Follow-up|0|||
143329594|NCT02564523|516749779|FG014|Overall Study|Lost to Follow-up|0|||
143329595|NCT02564523|516749780|FG015|Overall Study|Lost to Follow-up|0|||
143329596|NCT02564523|516749781|FG016|Overall Study|Lost to Follow-up|0|||
143329597|NCT02564523|516749782|FG017|Overall Study|Lost to Follow-up|0|||
143329598|NCT02564523|516749765|FG000|Overall Study|Physician Decision|0|||
143329599|NCT02564523|516749766|FG001|Overall Study|Physician Decision|0|||
143329600|NCT02564523|516749767|FG002|Overall Study|Physician Decision|0|||
143329601|NCT02564523|516749768|FG003|Overall Study|Physician Decision|0|||
143329602|NCT02564523|516749769|FG004|Overall Study|Physician Decision|1|||
143329603|NCT02564523|516749770|FG005|Overall Study|Physician Decision|0|||
143329604|NCT02564523|516749771|FG006|Overall Study|Physician Decision|0|||
143329605|NCT02564523|516749772|FG007|Overall Study|Physician Decision|0|||
143329606|NCT02564523|516749773|FG008|Overall Study|Physician Decision|0|||
143329607|NCT02564523|516749774|FG009|Overall Study|Physician Decision|0|||
143329608|NCT02564523|516749775|FG010|Overall Study|Physician Decision|1|||
143329609|NCT02564523|516749776|FG011|Overall Study|Physician Decision|0|||
143329610|NCT02564523|516749777|FG012|Overall Study|Physician Decision|0|||
143329611|NCT02564523|516749778|FG013|Overall Study|Physician Decision|0|||
143329612|NCT02564523|516749779|FG014|Overall Study|Physician Decision|0|||
143329613|NCT02564523|516749780|FG015|Overall Study|Physician Decision|0|||
143329614|NCT02564523|516749781|FG016|Overall Study|Physician Decision|0|||
143329615|NCT02564523|516749782|FG017|Overall Study|Physician Decision|0|||
143329616|NCT02564523|516749765|FG000|Overall Study|Protocol Violation|2|||
143329617|NCT02564523|516749766|FG001|Overall Study|Protocol Violation|2|||
143329618|NCT02564523|516749767|FG002|Overall Study|Protocol Violation|5|||
143329619|NCT02564523|516749768|FG003|Overall Study|Protocol Violation|0|||
143329620|NCT02564523|516749769|FG004|Overall Study|Protocol Violation|1|||
143329621|NCT02564523|516749770|FG005|Overall Study|Protocol Violation|0|||
143382566|NCT03103321|516946515|FG003|Overall Study|Protocol Violation|0|||
143382567|NCT04118452|516946516|FG000|Overall Study|Lost to Follow-up|5|||
143382568|NCT04118452|516946517|FG001|Overall Study|Lost to Follow-up|5|||
143329622|NCT02564523|516749771|FG006|Overall Study|Protocol Violation|0|||
143329623|NCT02564523|516749772|FG007|Overall Study|Protocol Violation|0|||
143329624|NCT02564523|516749773|FG008|Overall Study|Protocol Violation|0|||
143329625|NCT02564523|516749774|FG009|Overall Study|Protocol Violation|0|||
143329626|NCT02564523|516749775|FG010|Overall Study|Protocol Violation|0|||
143329627|NCT02564523|516749776|FG011|Overall Study|Protocol Violation|0|||
143329628|NCT02564523|516749777|FG012|Overall Study|Protocol Violation|0|||
143329629|NCT02564523|516749778|FG013|Overall Study|Protocol Violation|0|||
143329630|NCT02564523|516749779|FG014|Overall Study|Protocol Violation|0|||
143329631|NCT02564523|516749780|FG015|Overall Study|Protocol Violation|0|||
143382569|NCT04118452|516946516|FG000|Overall Study|Withdrawal by Subject|17|||
143382570|NCT04118452|516946517|FG001|Overall Study|Withdrawal by Subject|17|||
143382571|NCT05952076|516946518|FG000|Overall Study|Death|1|||
143382572|NCT05952076|516946519|FG001|Overall Study|Death|1|||
143329632|NCT02564523|516749781|FG016|Overall Study|Protocol Violation|0|||
143329633|NCT02564523|516749782|FG017|Overall Study|Protocol Violation|0|||
143329634|NCT02564523|516749765|FG000|Overall Study|Other|3|||
143329635|NCT02564523|516749766|FG001|Overall Study|Other|0|||
143329636|NCT02564523|516749767|FG002|Overall Study|Other|0|||
143329637|NCT02564523|516749768|FG003|Overall Study|Other|1|||
143329638|NCT02564523|516749769|FG004|Overall Study|Other|0|||
143329639|NCT02564523|516749770|FG005|Overall Study|Other|0|||
143329640|NCT02564523|516749771|FG006|Overall Study|Other|0|||
143329641|NCT02564523|516749772|FG007|Overall Study|Other|0|||
143329642|NCT02564523|516749773|FG008|Overall Study|Other|0|||
143329643|NCT02564523|516749774|FG009|Overall Study|Other|0|||
143329644|NCT02564523|516749775|FG010|Overall Study|Other|0|||
143329645|NCT02564523|516749776|FG011|Overall Study|Other|0|||
143329646|NCT02564523|516749777|FG012|Overall Study|Other|0|||
143329647|NCT02564523|516749778|FG013|Overall Study|Other|0|||
143329648|NCT02564523|516749779|FG014|Overall Study|Other|0|||
143329649|NCT02564523|516749780|FG015|Overall Study|Other|0|||
143329650|NCT02564523|516749781|FG016|Overall Study|Other|0|||
143329651|NCT02564523|516749782|FG017|Overall Study|Other|0|||
143329652|NCT01816594|516749785|FG000|Overall Study|Local Progress|0|||
143329653|NCT01816594|516749786|FG001|Overall Study|Local Progress|2|||
143329654|NCT01816594|516749785|FG000|Overall Study|Adverse Event|9|||
143329655|NCT01816594|516749786|FG001|Overall Study|Adverse Event|0|||
143329656|NCT01816594|516749785|FG000|Overall Study|Withdrawal by Subject|1|||
143329657|NCT01816594|516749786|FG001|Overall Study|Withdrawal by Subject|0|||
143329658|NCT01816594|516749785|FG000|Overall Study|Physician Decision|1|||
143329659|NCT01816594|516749786|FG001|Overall Study|Physician Decision|0|||
143329660|NCT03905655|516749787|FG000|Overall Study|Adverse Event|1|||
143329661|NCT03905655|516749788|FG001|Overall Study|Adverse Event|0|||
143329662|NCT03905655|516749789|FG002|Overall Study|Adverse Event|1|||
143329663|NCT03905655|516749790|FG003|Overall Study|Adverse Event|1|||
143329664|NCT02566031|516749791|FG000|Overall Study|Patient/guardian decision|14|||
143329665|NCT02566031|516749792|FG001|Overall Study|Patient/guardian decision|7|||
143329666|NCT02566031|516749791|FG000|Overall Study|Protocol deviation|2|||
143329667|NCT02566031|516749792|FG001|Overall Study|Protocol deviation|3|||
143329668|NCT02566031|516749791|FG000|Overall Study|Adverse Event|3|||
143329669|NCT02566031|516749792|FG001|Overall Study|Adverse Event|1|||
143329670|NCT02566031|516749791|FG000|Overall Study|Lost to Follow-up|1|||
143329671|NCT02566031|516749792|FG001|Overall Study|Lost to Follow-up|1|||
143329672|NCT03031938|516749793|FG000|Overall Study|Death|1|||
143329673|NCT03031938|516749794|FG001|Overall Study|Death|0|||
143329674|NCT02479412|516749797|FG000|Overall Study|Adverse Event|0|||
143329675|NCT02479412|516749798|FG001|Overall Study|Adverse Event|0|||
143329676|NCT02479412|516749799|FG002|Overall Study|Adverse Event|1|||
143329677|NCT02479412|516749800|FG003|Overall Study|Adverse Event|0|||
143329678|NCT02479412|516749801|FG004|Overall Study|Adverse Event|0|||
143329679|NCT02479412|516749802|FG005|Overall Study|Adverse Event|0|||
143329680|NCT02479412|516749803|FG006|Overall Study|Adverse Event|0|||
143329681|NCT02479412|516749804|FG007|Overall Study|Adverse Event|0|||
143329682|NCT02479412|516749805|FG008|Overall Study|Adverse Event|0|||
143329683|NCT02479412|516749797|FG000|Overall Study|Study-specific withdrawal criteria|0|||
143329684|NCT02479412|516749798|FG001|Overall Study|Study-specific withdrawal criteria|0|||
143329685|NCT02479412|516749799|FG002|Overall Study|Study-specific withdrawal criteria|1|||
143329686|NCT02479412|516749800|FG003|Overall Study|Study-specific withdrawal criteria|1|||
143329687|NCT02479412|516749801|FG004|Overall Study|Study-specific withdrawal criteria|0|||
143382573|NCT05952076|516946518|FG000|Overall Study|Lost to Follow-up|0|||
143329688|NCT02479412|516749802|FG005|Overall Study|Study-specific withdrawal criteria|0|||
143329689|NCT02479412|516749803|FG006|Overall Study|Study-specific withdrawal criteria|0|||
143329690|NCT02479412|516749804|FG007|Overall Study|Study-specific withdrawal criteria|1|||
143329691|NCT02479412|516749805|FG008|Overall Study|Study-specific withdrawal criteria|1|||
143329692|NCT02479412|516749797|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
143329693|NCT02479412|516749798|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
143329694|NCT02479412|516749799|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
143329695|NCT02479412|516749800|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
143329696|NCT02479412|516749801|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
143329697|NCT02479412|516749802|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
143329698|NCT02479412|516749803|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
143382574|NCT05952076|516946519|FG001|Overall Study|Lost to Follow-up|1|||
143382575|NCT01704079|516946520|FG000|Overall Study|Withdrawal by Subject|5|||
143329699|NCT02479412|516749804|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
143329700|NCT02479412|516749805|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
143329701|NCT03647501|516749806|FG000|Overall Study|Lost to Follow-up|1|||
143329702|NCT03647501|516749807|FG001|Overall Study|Lost to Follow-up|1|||
143329703|NCT03647501|516749806|FG000|Overall Study|Withdrawal by Subject|0|||
143329704|NCT03647501|516749807|FG001|Overall Study|Withdrawal by Subject|1|||
143329705|NCT03695172|516749808|FG000|Overall Study|Withdrawal by Subject|1|||
143329706|NCT03695172|516749809|FG001|Overall Study|Withdrawal by Subject|1|||
143329707|NCT03695172|516749810|FG002|Overall Study|Withdrawal by Subject|0|||
143329708|NCT02734212|516749811|FG000|Overall Study|Lost to Follow-up|5|||
143329709|NCT02734212|516749812|FG001|Overall Study|Lost to Follow-up|10|||
143329710|NCT04053764|516749813|FG000|Overall Study|Withdrawal by Subject|6|||
143329711|NCT04053764|516749814|FG001|Overall Study|Withdrawal by Subject|2|||
143329712|NCT04053764|516749813|FG000|Overall Study|Physician Decision|2|||
143329713|NCT04053764|516749814|FG001|Overall Study|Physician Decision|1|||
143329714|NCT04053764|516749813|FG000|Overall Study|Adverse Event|1|||
143329715|NCT04053764|516749814|FG001|Overall Study|Adverse Event|0|||
143329716|NCT04053764|516749813|FG000|Overall Study|Pregnancy|1|||
143329717|NCT04053764|516749814|FG001|Overall Study|Pregnancy|0|||
143329718|NCT04732286|516749815|FG000|Overall Study|Progressive Disease|2|||
143329719|NCT04732286|516749815|FG000|Overall Study|Physician Decision|1|||
143329720|NCT04732286|516749815|FG000|Overall Study|Study Terminated by Sponsor|31|||
143329721|NCT04732286|516749815|FG000|Overall Study|Withdrawal by Subject|10|||
143329722|NCT04732286|516749815|FG000|Overall Study|Non-compliance With Study Drug|1|||
143329723|NCT04732286|516749815|FG000|Overall Study|Lost to Follow-up|4|||
143329724|NCT04732286|516749815|FG000|Overall Study|Death|51|||
143329725|NCT02195986|516749818|FG000|Overall Study|Adverse Event|3|||
143329726|NCT02195986|516749819|FG001|Overall Study|Adverse Event|0|||
143329727|NCT02195986|516749820|FG002|Overall Study|Adverse Event|0|||
143329728|NCT02195986|516749818|FG000|Overall Study|Withdrawal by Subject|0|||
143329729|NCT02195986|516749819|FG001|Overall Study|Withdrawal by Subject|3|||
143329730|NCT02195986|516749820|FG002|Overall Study|Withdrawal by Subject|0|||
143329731|NCT02195986|516749818|FG000|Overall Study|Family Emergency|0|||
143329732|NCT02195986|516749819|FG001|Overall Study|Family Emergency|0|||
143329733|NCT02195986|516749820|FG002|Overall Study|Family Emergency|1|||
143329734|NCT02195986|516749818|FG000|Overall Study|Protocol Violation|0|||
143329735|NCT02195986|516749819|FG001|Overall Study|Protocol Violation|1|||
143329736|NCT02195986|516749820|FG002|Overall Study|Protocol Violation|1|||
143329737|NCT02195986|516749818|FG000|Overall Study|Non-compliance|0|||
143329738|NCT02195986|516749819|FG001|Overall Study|Non-compliance|1|||
143329739|NCT02195986|516749820|FG002|Overall Study|Non-compliance|0|||
143329740|NCT00319098|516749821|FG000|Overall Study|Serious adverse event|3|||
143329741|NCT00319098|516749822|FG001|Overall Study|Serious adverse event|0|||
143329742|NCT00319098|516749821|FG000|Overall Study|Adverse Event|20|||
143329743|NCT00319098|516749822|FG001|Overall Study|Adverse Event|1|||
143329744|NCT00319098|516749821|FG000|Overall Study|Withdrawal by Subject|37|||
143329745|NCT00319098|516749822|FG001|Overall Study|Withdrawal by Subject|8|||
143329746|NCT00319098|516749821|FG000|Overall Study|Migrated/moved from study area|2|||
143382576|NCT01704079|516946521|FG001|Overall Study|Withdrawal by Subject|7|||
143329747|NCT00319098|516749822|FG001|Overall Study|Migrated/moved from study area|1|||
143329748|NCT00319098|516749821|FG000|Overall Study|Lost to Follow-up|37|||
143382577|NCT01704079|516946520|FG000|Overall Study|Lost to Follow-up|2|||
143329749|NCT00319098|516749822|FG001|Overall Study|Lost to Follow-up|13|||
143329750|NCT00319098|516749821|FG000|Overall Study|Others|33|||
143329751|NCT00319098|516749822|FG001|Overall Study|Others|8|||
143329752|NCT00319098|516749821|FG000|Overall Study|Protocol Violation|3|||
143329753|NCT00319098|516749822|FG001|Overall Study|Protocol Violation|1|||
143329754|NCT02270450|516749825|FG000|Overall Study|Refusal unrelated to adverse event|3|||
143329755|NCT02270450|516749826|FG001|Overall Study|Refusal unrelated to adverse event|1|||
143382578|NCT01704079|516946521|FG001|Overall Study|Lost to Follow-up|5|||
143382579|NCT01704079|516946520|FG000|Overall Study|Adverse Event|4|||
143382580|NCT01704079|516946521|FG001|Overall Study|Adverse Event|7|||
143382581|NCT01704079|516946520|FG000|Overall Study|Protocol Violation|1|||
143382582|NCT01704079|516946521|FG001|Overall Study|Protocol Violation|0|||
143382583|NCT01704079|516946520|FG000|Overall Study|Subject noncompliance|2|||
143382584|NCT01704079|516946521|FG001|Overall Study|Subject noncompliance|3|||
143382585|NCT01704079|516946520|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
143382586|NCT01704079|516946521|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
143382587|NCT01000480|516946533|FG000|Induction Phase|Adverse Event|2|||
143382588|NCT01000480|516946533|FG000|Induction Phase|Lost to Follow-up|1|||
143382589|NCT01000480|516946533|FG000|Induction Phase|Physician Decision|1|||
143382590|NCT01000480|516946533|FG000|Induction Phase|Entry Criteria Not Met|3|||
143382591|NCT01000480|516946533|FG000|Concurrent Therapy Phase|Adverse Event|4|||
143382592|NCT01000480|516946533|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
143382593|NCT01000480|516946533|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
143382594|NCT01000480|516946533|FG000|Concurrent Therapy Phase|Physician Decision|1|||
143382595|NCT02374307|516946535|FG000|3-months Follow-up|Lost to Follow-up|1|||
143382596|NCT02374307|516946536|FG001|3-months Follow-up|Lost to Follow-up|2|||
143382597|NCT02374307|516946535|FG000|3-months Follow-up|Withdrawal by Subject|1|||
143382598|NCT02374307|516946536|FG001|3-months Follow-up|Withdrawal by Subject|4|||
143382599|NCT02374307|516946535|FG000|3-months Follow-up|Death|1|||
143382600|NCT02374307|516946536|FG001|3-months Follow-up|Death|2|||
143382601|NCT02374307|516946535|FG000|3-months Follow-up|Missed first follow-up|5|||
143382602|NCT02374307|516946536|FG001|3-months Follow-up|Missed first follow-up|1|||
143382603|NCT02374307|516946535|FG000|6-months Follow-up|Lost to Follow-up|1|||
143382604|NCT02374307|516946536|FG001|6-months Follow-up|Lost to Follow-up|2|||
143382605|NCT02374307|516946535|FG000|6-months Follow-up|Death|2|||
143382606|NCT02374307|516946536|FG001|6-months Follow-up|Death|1|||
143382607|NCT02374307|516946535|FG000|6-months Follow-up|Withdrawal by Subject|0|||
143382608|NCT02374307|516946536|FG001|6-months Follow-up|Withdrawal by Subject|3|||
143382609|NCT03330795|516946543|FG000|Overall Study|Death|3|||
143382610|NCT03330795|516946543|FG000|Overall Study|No longer eligible to receive transplants or study interventions due to medical contraindication|1|||
143382611|NCT00539734|516946545|FG000|Overall Study|Protocol Violation|1|||
143382612|NCT02538341|516946548|FG000|Overall Study|Lost to Follow-up|51|||
143382613|NCT02538341|516946549|FG001|Overall Study|Lost to Follow-up|46|||
143382614|NCT02538341|516946548|FG000|Overall Study|Withdrawal by Subject|3|||
143382615|NCT02538341|516946549|FG001|Overall Study|Withdrawal by Subject|1|||
143382616|NCT02538341|516946548|FG000|Overall Study|Death|2|||
143382617|NCT02538341|516946549|FG001|Overall Study|Death|0|||
143382618|NCT00331136|516946550|FG000|Overall Study|Adverse Event|3|||
143382619|NCT00331136|516946551|FG001|Overall Study|Adverse Event|5|||
143382620|NCT00331136|516946552|FG002|Overall Study|Adverse Event|0|||
143382621|NCT00331136|516946553|FG003|Overall Study|Adverse Event|1|||
143382622|NCT00331136|516946550|FG000|Overall Study|Withdrawal by Subject|0|||
143382623|NCT00331136|516946551|FG001|Overall Study|Withdrawal by Subject|1|||
143382624|NCT00331136|516946552|FG002|Overall Study|Withdrawal by Subject|0|||
143382625|NCT00331136|516946553|FG003|Overall Study|Withdrawal by Subject|0|||
143382626|NCT00331136|516946550|FG000|Overall Study|Lost to Follow-up|0|||
143382627|NCT00331136|516946551|FG001|Overall Study|Lost to Follow-up|1|||
143382628|NCT00331136|516946552|FG002|Overall Study|Lost to Follow-up|0|||
143382629|NCT00331136|516946553|FG003|Overall Study|Lost to Follow-up|0|||
143382630|NCT00331136|516946550|FG000|Overall Study|Protocol Violation|1|||
143382631|NCT00331136|516946551|FG001|Overall Study|Protocol Violation|0|||
143382632|NCT00331136|516946552|FG002|Overall Study|Protocol Violation|0|||
143382633|NCT00331136|516946553|FG003|Overall Study|Protocol Violation|0|||
143382634|NCT00331136|516946550|FG000|Overall Study|Not treated|1|||
143382635|NCT00331136|516946551|FG001|Overall Study|Not treated|0|||
143382636|NCT00331136|516946552|FG002|Overall Study|Not treated|0|||
143382637|NCT00331136|516946553|FG003|Overall Study|Not treated|0|||
143382638|NCT04484935|516946558|FG000|Overall Study|Other|0|||
143382639|NCT04484935|516946559|FG001|Overall Study|Other|1|||
143382640|NCT04484935|516946558|FG000|Overall Study|Withdrawal by parent/guardian|0|||
143382641|NCT04484935|516946559|FG001|Overall Study|Withdrawal by parent/guardian|1|||
143382642|NCT04484935|516946558|FG000|Overall Study|Lost to Follow-up|1|||
143382643|NCT04484935|516946559|FG001|Overall Study|Lost to Follow-up|0|||
143382644|NCT04484935|516946558|FG000|Overall Study|Death|2|||
143382645|NCT04484935|516946559|FG001|Overall Study|Death|1|||
143382646|NCT02178098|516946562|FG000|Overall Study|Withdrawal by Subject|0|||
143382647|NCT02178098|516946563|FG001|Overall Study|Withdrawal by Subject|6|||
143382648|NCT02178098|516946562|FG000|Overall Study|Adverse Event|1|||
143382649|NCT02178098|516946563|FG001|Overall Study|Adverse Event|2|||
143382650|NCT02178098|516946562|FG000|Overall Study|Protocol Violation|1|||
143382651|NCT02178098|516946563|FG001|Overall Study|Protocol Violation|1|||
143382652|NCT02178098|516946562|FG000|Overall Study|Lost to Follow-up|0|||
143382653|NCT02178098|516946563|FG001|Overall Study|Lost to Follow-up|1|||
143382654|NCT02178098|516946562|FG000|Overall Study|Sponsor Request|1|||
143382655|NCT02178098|516946563|FG001|Overall Study|Sponsor Request|0|||
143382656|NCT02178098|516946562|FG000|Overall Study|Other|2|||
143382657|NCT02178098|516946563|FG001|Overall Study|Other|2|||
143382658|NCT01109524|516946571|FG000|Overall Study|Disease Progression|29|||
143382659|NCT01109524|516946571|FG000|Overall Study|Study Drug toxicity|6|||
143382660|NCT01109524|516946571|FG000|Overall Study|Adverse Event|4|||
143382661|NCT01109524|516946571|FG000|Overall Study|Withdrawal by Subject|2|||
143382662|NCT01109524|516946571|FG000|Overall Study|Maximum clinical benefit|3|||
143382663|NCT01109524|516946571|FG000|Overall Study|Death|2|||
143382664|NCT01109524|516946571|FG000|Overall Study|No longer meets criteria|2|||
143382665|NCT01109524|516946571|FG000|Overall Study|Participant requested to end treatment|4|||
143382666|NCT01109524|516946571|FG000|Overall Study|Other|5|||
143382667|NCT02556138|516946575|FG000|Overall Study|Withdrawal by Subject|1|||
143382668|NCT04428112|516946576|FG000|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|4|||
143382669|NCT04428112|516946577|FG001|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|5|||
143382670|NCT04428112|516946576|FG000|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|68|||
143382671|NCT04428112|516946577|FG001|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|29|||
143382672|NCT04428112|516946576|FG000|Overall Study|Withdrawal by Subject|9|||
143382673|NCT04428112|516946577|FG001|Overall Study|Withdrawal by Subject|4|||
143382674|NCT04428112|516946576|FG000|Overall Study|Lost to Follow-up|27|||
143382675|NCT04428112|516946577|FG001|Overall Study|Lost to Follow-up|7|||
143382676|NCT05028582|516946579|FG000|Overall Study|Lost to Follow-up|11|||
143382677|NCT05028582|516946580|FG001|Overall Study|Lost to Follow-up|9|||
143382678|NCT05028582|516946579|FG000|Overall Study|Withdrawal by Subject|9|||
143382679|NCT05028582|516946580|FG001|Overall Study|Withdrawal by Subject|10|||
143382680|NCT05028582|516946579|FG000|Overall Study|Adverse Event|5|||
143382681|NCT05028582|516946580|FG001|Overall Study|Adverse Event|2|||
143382682|NCT05028582|516946579|FG000|Overall Study|Miscellaneous|3|||
143382683|NCT05028582|516946580|FG001|Overall Study|Miscellaneous|2|||
143382684|NCT05028582|516946579|FG000|Overall Study|Lack of Efficacy|3|||
143382685|NCT05028582|516946580|FG001|Overall Study|Lack of Efficacy|1|||
143382686|NCT05028582|516946579|FG000|Overall Study|Physician Decision|0|||
143382687|NCT05028582|516946580|FG001|Overall Study|Physician Decision|1|||
143382688|NCT04310735|516948304|FG000|Overall Study|Withdrawal by Subject|1|||
143382689|NCT04310735|516948305|FG001|Overall Study|Withdrawal by Subject|3|||
143382690|NCT04310735|516948306|FG002|Overall Study|Withdrawal by Subject|8|||
143382691|NCT04310735|516948304|FG000|Overall Study|Equipment malfunction|0|||
143382692|NCT04310735|516948305|FG001|Overall Study|Equipment malfunction|1|||
143382693|NCT04310735|516948306|FG002|Overall Study|Equipment malfunction|0|||
143382694|NCT03683069|516948307|FG000|Overall Study|see limitations|12|||
143382695|NCT03683069|516948308|FG001|Overall Study|see limitations|13|||
143382696|NCT05696080|516948309|FG000|Overall Study|Lost to Follow-up|2|||
143382697|NCT05696080|516948310|FG001|Overall Study|Lost to Follow-up|1|||
143382698|NCT05696080|516948309|FG000|Overall Study|Physician Decision|1|||
143382699|NCT05696080|516948310|FG001|Overall Study|Physician Decision|0|||
143382700|NCT05696080|516948309|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
143382701|NCT05696080|516948310|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
143382702|NCT05696080|516948309|FG000|Overall Study|Withdrawal by Subject|12|||
143382703|NCT05696080|516948310|FG001|Overall Study|Withdrawal by Subject|0|||
143382704|NCT03954184|516948311|FG000|Overall Study|Lost to Follow-up|500|||
143382705|NCT03954184|516948312|FG001|Overall Study|Lost to Follow-up|0|||
143382706|NCT03398200|516948313|FG000|Overall Study|Withdrawal by Subject|0|||
143382707|NCT03398200|516948314|FG001|Overall Study|Withdrawal by Subject|1|||
143382708|NCT05104697|516948317|FG000|Overall Study|Withdrawal by Subject|0|||
143382709|NCT05104697|516948318|FG001|Overall Study|Withdrawal by Subject|1|||
143382710|NCT03845465|516948319|FG000|Baseline Through Intervention|Withdrawal by Subject|4|||
143382711|NCT03845465|516948320|FG001|Baseline Through Intervention|Withdrawal by Subject|0|||
143382712|NCT03845465|516948319|FG000|6-month Data Collection|Withdrawal by Subject|0|||
143382713|NCT03845465|516948320|FG001|6-month Data Collection|Withdrawal by Subject|2|||
143382714|NCT03845465|516948319|FG000|12-month Data Collection|Withdrawal by Subject|0|||
143382715|NCT03845465|516948320|FG001|12-month Data Collection|Withdrawal by Subject|2|||
143382716|NCT05656911|516948323|FG000|Treatment Phase|Physician Decision|2|||
143382717|NCT05656911|516948324|FG001|Treatment Phase|Physician Decision|0|||
143382718|NCT05656911|516948323|FG000|Treatment Phase|Lack of Efficacy|6|||
143382719|NCT05656911|516948324|FG001|Treatment Phase|Lack of Efficacy|3|||
143382720|NCT05656911|516948323|FG000|Treatment Phase|Subject Decision|4|||
143382721|NCT05656911|516948324|FG001|Treatment Phase|Subject Decision|2|||
143382722|NCT05656911|516948323|FG000|Treatment Phase|Other Reasons|1|||
143382723|NCT05656911|516948324|FG001|Treatment Phase|Other Reasons|0|||
143382724|NCT05656911|516948323|FG000|Treatment Phase|Adverse Event|3|||
143382725|NCT05656911|516948324|FG001|Treatment Phase|Adverse Event|1|||
143382726|NCT05656911|516948323|FG000|Follow-up Phase|Subject Decision|0|||
143382727|NCT05656911|516948324|FG001|Follow-up Phase|Subject Decision|1|||
143382728|NCT05656911|516948323|FG000|Follow-up Phase|Missing|1|||
143382729|NCT05656911|516948324|FG001|Follow-up Phase|Missing|0|||
143382730|NCT03547908|516948325|FG000|Blinded Phase|Lost to Follow-up|3|||
143382731|NCT03547908|516948326|FG001|Blinded Phase|Lost to Follow-up|3|||
143382732|NCT03547908|516948327|FG002|Blinded Phase|Lost to Follow-up|0|||
143382733|NCT03547908|516948328|FG003|Blinded Phase|Lost to Follow-up|0|||
143382734|NCT03547908|516948325|FG000|Blinded Phase|Withdrew Consent|2|||
143382735|NCT03547908|516948326|FG001|Blinded Phase|Withdrew Consent|3|||
143382736|NCT03547908|516948327|FG002|Blinded Phase|Withdrew Consent|0|||
143382737|NCT03547908|516948328|FG003|Blinded Phase|Withdrew Consent|0|||
143382738|NCT03547908|516948325|FG000|Blinded Phase|Investigator's Discretion|2|||
143382739|NCT03547908|516948326|FG001|Blinded Phase|Investigator's Discretion|1|||
143382740|NCT03547908|516948327|FG002|Blinded Phase|Investigator's Discretion|0|||
143382741|NCT03547908|516948328|FG003|Blinded Phase|Investigator's Discretion|0|||
143382742|NCT03547908|516948325|FG000|Blinded Phase|Death|2|||
143382743|NCT03547908|516948326|FG001|Blinded Phase|Death|0|||
143382744|NCT03547908|516948327|FG002|Blinded Phase|Death|0|||
143382745|NCT03547908|516948328|FG003|Blinded Phase|Death|0|||
143382746|NCT03547908|516948325|FG000|Blinded Phase|Non-compliance With Study Drug|0|||
143382747|NCT03547908|516948326|FG001|Blinded Phase|Non-compliance With Study Drug|2|||
143382748|NCT03547908|516948327|FG002|Blinded Phase|Non-compliance With Study Drug|0|||
143382749|NCT03547908|516948328|FG003|Blinded Phase|Non-compliance With Study Drug|0|||
143382750|NCT03547908|516948325|FG000|Blinded Phase|Adverse Event|1|||
143382751|NCT03547908|516948326|FG001|Blinded Phase|Adverse Event|0|||
143382752|NCT03547908|516948327|FG002|Blinded Phase|Adverse Event|0|||
143382753|NCT03547908|516948328|FG003|Blinded Phase|Adverse Event|0|||
143382754|NCT03547908|516948325|FG000|Blinded Phase|Randomized But Never Treated|1|||
143382755|NCT03547908|516948326|FG001|Blinded Phase|Randomized But Never Treated|0|||
143382756|NCT03547908|516948327|FG002|Blinded Phase|Randomized But Never Treated|0|||
143382757|NCT03547908|516948328|FG003|Blinded Phase|Randomized But Never Treated|0|||
143382758|NCT03547908|516948325|FG000|Open-label Extension Phase|Lost to Follow-up|0|||
143382759|NCT03547908|516948326|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
143382760|NCT03547908|516948327|FG002|Open-label Extension Phase|Lost to Follow-up|3|||
143382761|NCT03547908|516948328|FG003|Open-label Extension Phase|Lost to Follow-up|1|||
143382762|NCT03547908|516948325|FG000|Open-label Extension Phase|Death|0|||
143382763|NCT03547908|516948326|FG001|Open-label Extension Phase|Death|0|||
143382764|NCT03547908|516948327|FG002|Open-label Extension Phase|Death|1|||
143382765|NCT03547908|516948328|FG003|Open-label Extension Phase|Death|0|||
143382766|NCT04607044|516948335|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
143382767|NCT04607044|516948335|FG000|Overall Study|Adverse Event|1|||
143382768|NCT04607044|516948335|FG000|Overall Study|Did not receive study device|3|||
143382769|NCT04607044|516948335|FG000|Overall Study|Death|1|||
143382770|NCT05403801|516948336|FG000|Overall Study|Withdrawal by Subject|2|||
143382771|NCT05075408|516948337|FG000|Overall Study|Withdrawal by Subject|5|||
143382772|NCT05075408|516948338|FG001|Overall Study|Withdrawal by Subject|3|||
143382773|NCT05075408|516948339|FG002|Overall Study|Withdrawal by Subject|4|||
143382774|NCT05075408|516948337|FG000|Overall Study|Adverse Event|5|||
143382775|NCT05075408|516948338|FG001|Overall Study|Adverse Event|7|||
143382776|NCT05075408|516948339|FG002|Overall Study|Adverse Event|8|||
143382777|NCT05075408|516948337|FG000|Overall Study|Protocol Violation|0|||
143382778|NCT05075408|516948338|FG001|Overall Study|Protocol Violation|1|||
143382779|NCT05075408|516948339|FG002|Overall Study|Protocol Violation|0|||
143382780|NCT05075408|516948337|FG000|Overall Study|Lost to Follow-up|2|||
143382781|NCT05075408|516948338|FG001|Overall Study|Lost to Follow-up|1|||
143382782|NCT05075408|516948339|FG002|Overall Study|Lost to Follow-up|1|||
143382783|NCT05075408|516948337|FG000|Overall Study|Physician Decision|1|||
143382784|NCT05075408|516948338|FG001|Overall Study|Physician Decision|0|||
143382785|NCT05075408|516948339|FG002|Overall Study|Physician Decision|0|||
143382786|NCT05075408|516948337|FG000|Overall Study|Other-unspecified|3|||
143382787|NCT05075408|516948338|FG001|Overall Study|Other-unspecified|2|||
143382788|NCT05075408|516948339|FG002|Overall Study|Other-unspecified|0|||
143382789|NCT03651895|516948340|FG000|First Drug Assignment|Adverse Event|4|||
143382790|NCT03651895|516948341|FG001|First Drug Assignment|Adverse Event|5|||
143382791|NCT03651895|516948340|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
143382792|NCT03651895|516948341|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
143382793|NCT05419505|516948343|FG000|Overall Study|Adverse Event|0|||
143382794|NCT05419505|516948344|FG001|Overall Study|Adverse Event|0|||
143382795|NCT05419505|516948345|FG002|Overall Study|Adverse Event|0|||
143382796|NCT05419505|516948346|FG003|Overall Study|Adverse Event|1|||
143382797|NCT05419505|516948347|FG004|Overall Study|Adverse Event|0|||
143382798|NCT05419505|516948348|FG005|Overall Study|Adverse Event|0|||
143382799|NCT05419505|516948349|FG006|Overall Study|Adverse Event|0|||
143382800|NCT05419505|516948350|FG007|Overall Study|Adverse Event|0|||
143382801|NCT05419505|516948343|FG000|Overall Study|Withdrawal by Subject|1|||
143382802|NCT05419505|516948344|FG001|Overall Study|Withdrawal by Subject|2|||
143382803|NCT05419505|516948345|FG002|Overall Study|Withdrawal by Subject|0|||
143382804|NCT05419505|516948346|FG003|Overall Study|Withdrawal by Subject|0|||
143382805|NCT05419505|516948347|FG004|Overall Study|Withdrawal by Subject|0|||
143382806|NCT05419505|516948348|FG005|Overall Study|Withdrawal by Subject|0|||
143382807|NCT05419505|516948349|FG006|Overall Study|Withdrawal by Subject|1|||
143382808|NCT05419505|516948350|FG007|Overall Study|Withdrawal by Subject|0|||
143382809|NCT05419505|516948343|FG000|Overall Study|Lost to Follow-up|2|||
143382810|NCT05419505|516948344|FG001|Overall Study|Lost to Follow-up|1|||
143382811|NCT05419505|516948345|FG002|Overall Study|Lost to Follow-up|0|||
143382812|NCT05419505|516948346|FG003|Overall Study|Lost to Follow-up|0|||
143382813|NCT05419505|516948347|FG004|Overall Study|Lost to Follow-up|1|||
143382814|NCT05419505|516948348|FG005|Overall Study|Lost to Follow-up|2|||
143382815|NCT05419505|516948349|FG006|Overall Study|Lost to Follow-up|0|||
143382816|NCT05419505|516948350|FG007|Overall Study|Lost to Follow-up|1|||
143382817|NCT02780388|516948353|FG000|Overall Study|Lost to Follow-up|0|||
143382818|NCT02780388|516948354|FG001|Overall Study|Lost to Follow-up|1|||
143382819|NCT02780388|516948355|FG002|Overall Study|Lost to Follow-up|0|||
143382820|NCT02780388|516948356|FG003|Overall Study|Lost to Follow-up|0|||
143382821|NCT02780388|516948357|FG004|Overall Study|Lost to Follow-up|0|||
143382822|NCT02780388|516948353|FG000|Overall Study|Withdrawal by Subject|1|||
143382823|NCT02780388|516948354|FG001|Overall Study|Withdrawal by Subject|1|||
143382824|NCT02780388|516948355|FG002|Overall Study|Withdrawal by Subject|0|||
143382825|NCT02780388|516948356|FG003|Overall Study|Withdrawal by Subject|0|||
143382826|NCT02780388|516948357|FG004|Overall Study|Withdrawal by Subject|0|||
143382827|NCT04527146|516948358|FG000|Overall Study|Withdrawal by Subject|12|||
143382828|NCT04527146|516948359|FG001|Overall Study|Withdrawal by Subject|15|||
143382829|NCT04527146|516948360|FG002|Overall Study|Withdrawal by Subject|7|||
143382830|NCT04527146|516948361|FG003|Overall Study|Withdrawal by Subject|16|||
143382831|NCT04527146|516948358|FG000|Overall Study|Lost to Follow-up|13|||
143382832|NCT04527146|516948359|FG001|Overall Study|Lost to Follow-up|9|||
143382833|NCT04527146|516948360|FG002|Overall Study|Lost to Follow-up|16|||
143382834|NCT04527146|516948361|FG003|Overall Study|Lost to Follow-up|13|||
143382835|NCT04527146|516948358|FG000|Overall Study|Death|0|||
143382836|NCT04527146|516948359|FG001|Overall Study|Death|1|||
143382837|NCT04527146|516948360|FG002|Overall Study|Death|1|||
143382838|NCT04527146|516948361|FG003|Overall Study|Death|0|||
143382839|NCT04527146|516948358|FG000|Overall Study|Adverse Event|0|||
143382840|NCT04527146|516948359|FG001|Overall Study|Adverse Event|0|||
143382841|NCT04527146|516948360|FG002|Overall Study|Adverse Event|1|||
143382842|NCT04527146|516948361|FG003|Overall Study|Adverse Event|0|||
143382843|NCT04527146|516948358|FG000|Overall Study|Ineligible after randomization|2|||
143382844|NCT04527146|516948359|FG001|Overall Study|Ineligible after randomization|0|||
143382845|NCT04527146|516948360|FG002|Overall Study|Ineligible after randomization|2|||
143382846|NCT04527146|516948361|FG003|Overall Study|Ineligible after randomization|2|||
143382847|NCT04527146|516948358|FG000|Overall Study|Moved to a different group|6|||
143382848|NCT04527146|516948359|FG001|Overall Study|Moved to a different group|3|||
143382849|NCT04527146|516948360|FG002|Overall Study|Moved to a different group|0|||
143382850|NCT04527146|516948361|FG003|Overall Study|Moved to a different group|2|||
143382851|NCT05107401|516948362|FG000|Overall Study|Lost to Follow-up|13|||
143382852|NCT05107401|516948363|FG001|Overall Study|Lost to Follow-up|12|||
143382853|NCT04247542|516948366|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
143382854|NCT04247542|516948367|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
143382855|NCT04247542|516948368|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
143382856|NCT04247542|516948366|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
143382857|NCT04247542|516948367|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
143382858|NCT04247542|516948368|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
143382859|NCT02201108|516948369|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
143382860|NCT02201108|516948370|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
143382861|NCT02201108|516948371|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
143382862|NCT02201108|516948369|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
143382863|NCT02201108|516948370|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
143382864|NCT02201108|516948371|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
143382865|NCT02201108|516948369|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
143382866|NCT02201108|516948370|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
143382867|NCT02201108|516948371|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
143382868|NCT02201108|516948369|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
143329756|NCT02270450|516749827|FG002|Overall Study|Refusal unrelated to adverse event|5|||
143329757|NCT02270450|516749828|FG003|Overall Study|Refusal unrelated to adverse event|14|||
143329758|NCT02270450|516749825|FG000|Overall Study|Progression/relapse|1|||
143329759|NCT02270450|516749826|FG001|Overall Study|Progression/relapse|2|||
143329760|NCT02270450|516749827|FG002|Overall Study|Progression/relapse|4|||
143329761|NCT02270450|516749828|FG003|Overall Study|Progression/relapse|9|||
143329762|NCT02270450|516749825|FG000|Overall Study|Death|19|||
143329763|NCT02270450|516749826|FG001|Overall Study|Death|19|||
143329764|NCT02270450|516749827|FG002|Overall Study|Death|31|||
143329765|NCT02270450|516749828|FG003|Overall Study|Death|59|||
143329766|NCT02363738|516749829|FG000|Overall Study|Adverse Event|5|||
143329767|NCT02363738|516749830|FG001|Overall Study|Adverse Event|2|||
143329768|NCT02363738|516749829|FG000|Overall Study|Lack of Efficacy|1|||
143329769|NCT02363738|516749830|FG001|Overall Study|Lack of Efficacy|2|||
143329770|NCT02363738|516749829|FG000|Overall Study|Lost to Follow-up|2|||
143329771|NCT02363738|516749830|FG001|Overall Study|Lost to Follow-up|1|||
143329772|NCT02187991|516749835|FG000|Overall Study|Adverse Event|13|||
143329773|NCT02187991|516749836|FG001|Overall Study|Adverse Event|14|||
143329774|NCT02187991|516749837|FG002|Overall Study|Adverse Event|3|||
143329775|NCT02187991|516749838|FG003|Overall Study|Adverse Event|2|||
143329776|NCT02187991|516749835|FG000|Overall Study|Withdrawal by Subject|9|||
143329777|NCT02187991|516749836|FG001|Overall Study|Withdrawal by Subject|6|||
143329778|NCT02187991|516749837|FG002|Overall Study|Withdrawal by Subject|3|||
143329779|NCT02187991|516749838|FG003|Overall Study|Withdrawal by Subject|2|||
143329780|NCT02187991|516749835|FG000|Overall Study|Physician Decision|4|||
143329781|NCT02187991|516749836|FG001|Overall Study|Physician Decision|4|||
143329782|NCT02187991|516749837|FG002|Overall Study|Physician Decision|0|||
143329783|NCT02187991|516749838|FG003|Overall Study|Physician Decision|2|||
143329784|NCT02187991|516749835|FG000|Overall Study|Other, unrelated complication|7|||
143329785|NCT02187991|516749836|FG001|Overall Study|Other, unrelated complication|1|||
143329786|NCT02187991|516749837|FG002|Overall Study|Other, unrelated complication|1|||
143329787|NCT02187991|516749838|FG003|Overall Study|Other, unrelated complication|2|||
143329788|NCT02187991|516749835|FG000|Overall Study|Death|1|||
143329789|NCT02187991|516749836|FG001|Overall Study|Death|3|||
143329790|NCT02187991|516749837|FG002|Overall Study|Death|0|||
143329791|NCT02187991|516749838|FG003|Overall Study|Death|0|||
143329792|NCT01392560|516749839|FG000|Overall Study|Adverse Event|2|||
143329793|NCT01392560|516749839|FG000|Overall Study|not entered|8|||
143329794|NCT01392560|516749839|FG000|Overall Study|discontinued during placebo run-in|2|||
143329795|NCT01939028|516749840|FG000|Overall Study|Withdrawal by Subject|5|||
143329796|NCT01939028|516749840|FG000|Overall Study|Physician Decision|7|||
143329797|NCT00092131|516749846|FG000|Treatment Period I|Adverse Event|1|||
143329798|NCT00092131|516749847|FG001|Treatment Period I|Adverse Event|0|||
143329799|NCT00092131|516749846|FG000|Treatment Period II|Adverse Event|0|||
143329800|NCT00092131|516749847|FG001|Treatment Period II|Adverse Event|1|||
143329801|NCT02372409|516749850|FG000|Overall Study|Lost to Follow-up|1|||
143329802|NCT02372409|516749851|FG001|Overall Study|Lost to Follow-up|0|||
143329803|NCT02372409|516749850|FG000|Overall Study|Disease progression|1|||
143329804|NCT02372409|516749851|FG001|Overall Study|Disease progression|1|||
143329805|NCT01808313|516749852|FG000|Overall Study|Adverse Event|5|||
143329806|NCT01808313|516749852|FG000|Overall Study|Protocol Violation|2|||
143329807|NCT01808313|516749852|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
143329808|NCT01808313|516749852|FG000|Overall Study|Lost to Follow-up|1|||
143329809|NCT01808313|516749852|FG000|Overall Study|Physician Decision|1|||
143329810|NCT03674177|516749857|FG000|Overall Study|Lost to Follow-up|2|||
143329811|NCT03674177|516749858|FG001|Overall Study|Lost to Follow-up|1|||
143329812|NCT03674177|516749859|FG002|Overall Study|Lost to Follow-up|0|||
143329813|NCT03674177|516749860|FG003|Overall Study|Lost to Follow-up|2|||
143329814|NCT03943095|516749861|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
143329815|NCT03943095|516749862|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
143329816|NCT03943095|516749861|FG000|Overall Study|Withdrawal by Subject|1|||
143329817|NCT03943095|516749862|FG001|Overall Study|Withdrawal by Subject|0|||
143329818|NCT00714168|516749863|FG000|Overall Study|Pregnancy|5|||
143329819|NCT00714168|516749864|FG001|Overall Study|Pregnancy|4|||
143329820|NCT00714168|516749863|FG000|Overall Study|Lost to Follow-up|32|||
143329821|NCT00714168|516749864|FG001|Overall Study|Lost to Follow-up|50|||
143329822|NCT00714168|516749863|FG000|Overall Study|Relocation|4|||
143382869|NCT02201108|516948370|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
143382870|NCT02201108|516948371|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
143382871|NCT02201108|516948369|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
143382872|NCT02201108|516948370|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
143382873|NCT02201108|516948371|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
143382874|NCT02201108|516948369|FG000|Open Label Period (up to Week 192)|Other reason|4|||
143382875|NCT02201108|516948370|FG001|Open Label Period (up to Week 192)|Other reason|7|||
143382876|NCT02201108|516948371|FG002|Open Label Period (up to Week 192)|Other reason|0|||
143382877|NCT02201108|516948369|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
143382878|NCT02201108|516948370|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
143382879|NCT02201108|516948371|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
143382880|NCT02201108|516948369|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
143382881|NCT02201108|516948370|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
143382882|NCT02201108|516948371|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
143382883|NCT02201108|516948369|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
143382884|NCT02201108|516948370|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
143382885|NCT02201108|516948371|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
143382886|NCT03215030|516948372|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
143382887|NCT03215030|516948373|FG001|Part 1: Dose Escalation|Lost to Follow-up|1|||
143329823|NCT00714168|516749864|FG001|Overall Study|Relocation|3|||
143329824|NCT00714168|516749863|FG000|Overall Study|Non-study medical condition|3|||
143329825|NCT00714168|516749864|FG001|Overall Study|Non-study medical condition|2|||
143329826|NCT04988308|516749866|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
143329827|NCT04988308|516749867|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
143329828|NCT04988308|516749868|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
143329829|NCT04988308|516749869|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
143329830|NCT04988308|516749870|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
143329831|NCT04988308|516749871|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
143329832|NCT04988308|516749866|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
143329833|NCT04988308|516749867|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
143329834|NCT04988308|516749868|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
143329835|NCT04988308|516749869|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
143329836|NCT04988308|516749870|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
143329837|NCT04988308|516749871|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
143329838|NCT04988308|516749866|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
143329839|NCT04988308|516749867|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
143329840|NCT04988308|516749868|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
143329841|NCT04988308|516749869|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
143329842|NCT04988308|516749870|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
143329843|NCT04988308|516749871|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
143329844|NCT04988308|516749866|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
143329845|NCT04988308|516749867|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
143329846|NCT04988308|516749868|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
143329847|NCT04988308|516749869|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
143329848|NCT04988308|516749870|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
143329849|NCT04988308|516749871|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
143329850|NCT04988308|516749866|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
143329851|NCT04988308|516749867|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
143329852|NCT04988308|516749868|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
143329853|NCT04988308|516749869|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
143329854|NCT04988308|516749870|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
143329855|NCT04988308|516749871|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
143329856|NCT04988308|516749866|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
143382888|NCT03215030|516948374|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
143382889|NCT03215030|516948375|FG003|Part 1: Dose Escalation|Lost to Follow-up|1|||
143329857|NCT04988308|516749867|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
143329858|NCT04988308|516749868|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
143329859|NCT04988308|516749869|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
143329860|NCT04988308|516749870|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
143329861|NCT04988308|516749871|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
143329862|NCT04988308|516749866|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
143329863|NCT04988308|516749867|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
143329864|NCT04988308|516749868|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
143329865|NCT04988308|516749869|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
143329866|NCT04988308|516749870|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
143329867|NCT04988308|516749871|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
143382890|NCT03215030|516948376|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
143382891|NCT03215030|516948377|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
143382892|NCT03215030|516948378|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
143382893|NCT03215030|516948379|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
143382894|NCT03215030|516948380|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
143382895|NCT03215030|516948381|FG009|Part 1: Dose Escalation|Lost to Follow-up|0|||
143382896|NCT03215030|516948382|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
143382897|NCT03215030|516948383|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
143382898|NCT03215030|516948372|FG000|Part 1: Dose Escalation|Withdrawal by Subject|2|||
143382899|NCT03215030|516948373|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
143382900|NCT03215030|516948374|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
143382901|NCT03215030|516948375|FG003|Part 1: Dose Escalation|Withdrawal by Subject|2|||
143382902|NCT03215030|516948376|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
143382903|NCT03215030|516948377|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
143382904|NCT03215030|516948378|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
143382905|NCT03215030|516948379|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
143382906|NCT03215030|516948380|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
143382907|NCT03215030|516948381|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
143382908|NCT03215030|516948382|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
143382909|NCT03215030|516948383|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
143382910|NCT03215030|516948372|FG000|Part 1: Dose Escalation|Death|15|||
143382911|NCT03215030|516948373|FG001|Part 1: Dose Escalation|Death|6|||
143382912|NCT03215030|516948374|FG002|Part 1: Dose Escalation|Death|6|||
143382913|NCT03215030|516948375|FG003|Part 1: Dose Escalation|Death|8|||
143382914|NCT03215030|516948376|FG004|Part 1: Dose Escalation|Death|0|||
143382915|NCT03215030|516948377|FG005|Part 1: Dose Escalation|Death|0|||
143382916|NCT03215030|516948378|FG006|Part 1: Dose Escalation|Death|0|||
143382917|NCT03215030|516948379|FG007|Part 1: Dose Escalation|Death|0|||
143382918|NCT03215030|516948380|FG008|Part 1: Dose Escalation|Death|0|||
143382919|NCT03215030|516948381|FG009|Part 1: Dose Escalation|Death|0|||
143382920|NCT03215030|516948382|FG010|Part 1: Dose Escalation|Death|0|||
143382921|NCT03215030|516948383|FG011|Part 1: Dose Escalation|Death|0|||
143382922|NCT03215030|516948372|FG000|Part 1: Dose Escalation|Reason Not Specified|0|||
143382923|NCT03215030|516948373|FG001|Part 1: Dose Escalation|Reason Not Specified|0|||
143382924|NCT03215030|516948374|FG002|Part 1: Dose Escalation|Reason Not Specified|0|||
143382925|NCT03215030|516948375|FG003|Part 1: Dose Escalation|Reason Not Specified|3|||
143382926|NCT03215030|516948376|FG004|Part 1: Dose Escalation|Reason Not Specified|0|||
143382927|NCT03215030|516948377|FG005|Part 1: Dose Escalation|Reason Not Specified|0|||
143382928|NCT03215030|516948378|FG006|Part 1: Dose Escalation|Reason Not Specified|0|||
143382929|NCT03215030|516948379|FG007|Part 1: Dose Escalation|Reason Not Specified|0|||
143382930|NCT03215030|516948380|FG008|Part 1: Dose Escalation|Reason Not Specified|0|||
143382931|NCT03215030|516948381|FG009|Part 1: Dose Escalation|Reason Not Specified|0|||
143382932|NCT03215030|516948382|FG010|Part 1: Dose Escalation|Reason Not Specified|0|||
143382933|NCT03215030|516948383|FG011|Part 1: Dose Escalation|Reason Not Specified|0|||
143382934|NCT03215030|516948372|FG000|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
143382935|NCT03215030|516948373|FG001|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
143382936|NCT03215030|516948374|FG002|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
143382937|NCT03215030|516948375|FG003|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
143382938|NCT03215030|516948376|FG004|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
143382939|NCT03215030|516948377|FG005|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
143382940|NCT03215030|516948378|FG006|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
143382941|NCT03215030|516948379|FG007|Part 2: Dose Expansion|Study Terminated by Sponsor|1|||
143382942|NCT03215030|516948380|FG008|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
143382943|NCT03215030|516948381|FG009|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
143382944|NCT03215030|516948382|FG010|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
143382945|NCT03215030|516948383|FG011|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
143382946|NCT03215030|516948372|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
143382947|NCT03215030|516948373|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
143382948|NCT03215030|516948374|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
143382949|NCT03215030|516948375|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
143382950|NCT03215030|516948376|FG004|Part 2: Dose Expansion|Withdrawal by Subject|1|||
143382951|NCT03215030|516948377|FG005|Part 2: Dose Expansion|Withdrawal by Subject|1|||
143382952|NCT03215030|516948378|FG006|Part 2: Dose Expansion|Withdrawal by Subject|5|||
143329868|NCT04988308|516749866|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
143329869|NCT04988308|516749867|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
143329870|NCT04988308|516749868|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
143329871|NCT04988308|516749869|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
143329872|NCT04988308|516749870|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
143329873|NCT04988308|516749871|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
143329874|NCT04988308|516749866|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
143329875|NCT04988308|516749867|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
143329876|NCT04988308|516749868|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
143329877|NCT04988308|516749869|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
143329878|NCT04988308|516749870|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
143329879|NCT04988308|516749871|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
143329880|NCT03034577|516749876|FG000|Overall Study|Withdrawal by Subject|6|||
143329881|NCT03034577|516749877|FG001|Overall Study|Withdrawal by Subject|9|||
143329882|NCT03034577|516749876|FG000|Overall Study|Lost to Follow-up|25|||
143329883|NCT03034577|516749877|FG001|Overall Study|Lost to Follow-up|26|||
143329884|NCT02352948|516749883|FG000|Overall Study|Death|47|||
143329885|NCT02352948|516749884|FG001|Overall Study|Death|48|||
143329886|NCT02352948|516749885|FG002|Overall Study|Death|114|||
143329887|NCT02352948|516749886|FG003|Overall Study|Death|74|||
143329888|NCT02352948|516749887|FG004|Overall Study|Death|77|||
143329889|NCT02352948|516749888|FG005|Overall Study|Death|44|||
143329890|NCT02352948|516749883|FG000|Overall Study|Lost to Follow-up|1|||
143329891|NCT02352948|516749884|FG001|Overall Study|Lost to Follow-up|0|||
143329892|NCT02352948|516749885|FG002|Overall Study|Lost to Follow-up|2|||
143329893|NCT02352948|516749886|FG003|Overall Study|Lost to Follow-up|1|||
143329894|NCT02352948|516749887|FG004|Overall Study|Lost to Follow-up|2|||
143329895|NCT02352948|516749888|FG005|Overall Study|Lost to Follow-up|1|||
143329896|NCT02352948|516749883|FG000|Overall Study|Withdrawal by Subject|1|||
143329897|NCT02352948|516749884|FG001|Overall Study|Withdrawal by Subject|10|||
143329898|NCT02352948|516749885|FG002|Overall Study|Withdrawal by Subject|11|||
143329899|NCT02352948|516749886|FG003|Overall Study|Withdrawal by Subject|23|||
143329900|NCT02352948|516749887|FG004|Overall Study|Withdrawal by Subject|9|||
143329901|NCT02352948|516749888|FG005|Overall Study|Withdrawal by Subject|4|||
143329902|NCT02352948|516749883|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
143329903|NCT02352948|516749884|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
143329904|NCT02352948|516749885|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
143329905|NCT02352948|516749886|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
143329906|NCT02352948|516749887|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
143329907|NCT02352948|516749888|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
143329908|NCT02352948|516749883|FG000|Overall Study|Other|0|||
143329909|NCT02352948|516749884|FG001|Overall Study|Other|0|||
143329910|NCT02352948|516749885|FG002|Overall Study|Other|2|||
143329911|NCT02352948|516749886|FG003|Overall Study|Other|0|||
143329912|NCT02352948|516749887|FG004|Overall Study|Other|0|||
143329913|NCT02352948|516749888|FG005|Overall Study|Other|0|||
143329914|NCT00679939|516749890|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
143329915|NCT00679939|516749891|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
143329916|NCT00679939|516749890|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
143329917|NCT00679939|516749891|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
143329918|NCT00679939|516749890|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
143329919|NCT00679939|516749891|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
143329920|NCT00679939|516749890|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
143329921|NCT00679939|516749891|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
143329922|NCT00679939|516749890|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
143329923|NCT00679939|516749891|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
143329924|NCT00679939|516749890|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
143329925|NCT00679939|516749891|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
143329926|NCT00679939|516749890|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
143329927|NCT00679939|516749891|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
143329928|NCT00679939|516749890|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
143329929|NCT00679939|516749891|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
143329930|NCT00679939|516749890|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
143329931|NCT00679939|516749891|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
143329932|NCT00679939|516749890|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
143329933|NCT00679939|516749891|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
143329934|NCT00983073|516749895|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
143329935|NCT00983073|516749895|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
143329936|NCT00983073|516749895|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
143329937|NCT00983073|516749895|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
143329938|NCT00983073|516749895|FG000|Titration and Optimal Dose Period|Other reason|4|||
143382953|NCT03215030|516948379|FG007|Part 2: Dose Expansion|Withdrawal by Subject|2|||
143382954|NCT03215030|516948380|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
143382955|NCT03215030|516948381|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
143382956|NCT03215030|516948382|FG010|Part 2: Dose Expansion|Withdrawal by Subject|0|||
143382957|NCT03215030|516948383|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
143382958|NCT03215030|516948372|FG000|Part 2: Dose Expansion|Death|0|||
143382959|NCT03215030|516948373|FG001|Part 2: Dose Expansion|Death|0|||
143382960|NCT03215030|516948374|FG002|Part 2: Dose Expansion|Death|0|||
143382961|NCT03215030|516948375|FG003|Part 2: Dose Expansion|Death|0|||
143382962|NCT03215030|516948376|FG004|Part 2: Dose Expansion|Death|3|||
143382963|NCT03215030|516948377|FG005|Part 2: Dose Expansion|Death|1|||
143382964|NCT03215030|516948378|FG006|Part 2: Dose Expansion|Death|5|||
143382965|NCT03215030|516948379|FG007|Part 2: Dose Expansion|Death|4|||
143382966|NCT03215030|516948380|FG008|Part 2: Dose Expansion|Death|0|||
143382967|NCT03215030|516948381|FG009|Part 2: Dose Expansion|Death|0|||
143382968|NCT03215030|516948382|FG010|Part 2: Dose Expansion|Death|0|||
143382969|NCT03215030|516948383|FG011|Part 2: Dose Expansion|Death|0|||
143382970|NCT03215030|516948372|FG000|Part 2: Dose Expansion|Reason Not Specified|0|||
143382971|NCT03215030|516948373|FG001|Part 2: Dose Expansion|Reason Not Specified|0|||
143382972|NCT03215030|516948374|FG002|Part 2: Dose Expansion|Reason Not Specified|0|||
143382973|NCT03215030|516948375|FG003|Part 2: Dose Expansion|Reason Not Specified|0|||
143382974|NCT03215030|516948376|FG004|Part 2: Dose Expansion|Reason Not Specified|0|||
143382975|NCT03215030|516948377|FG005|Part 2: Dose Expansion|Reason Not Specified|0|||
143382976|NCT03215030|516948378|FG006|Part 2: Dose Expansion|Reason Not Specified|4|||
143382977|NCT03215030|516948379|FG007|Part 2: Dose Expansion|Reason Not Specified|2|||
143382978|NCT03215030|516948380|FG008|Part 2: Dose Expansion|Reason Not Specified|0|||
143329939|NCT00983073|516749895|FG000|Maintenance Period|Adverse Event|5|||
143329940|NCT00983073|516749895|FG000|Maintenance Period|Withdrawal by Subject|2|||
143329941|NCT00983073|516749895|FG000|Maintenance Period|Lack of Efficacy|2|||
143329942|NCT00983073|516749895|FG000|Maintenance Period|Other Reason|7|||
143329943|NCT01453595|516749896|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
143329944|NCT01453595|516749897|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
143329945|NCT01453595|516749898|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
143329946|NCT03230916|516749901|FG000|Overall Study|Withdrawal by Subject|0|||
143329947|NCT03230916|516749902|FG001|Overall Study|Withdrawal by Subject|0|||
143329948|NCT03230916|516749903|FG002|Overall Study|Withdrawal by Subject|0|||
143329949|NCT03230916|516749904|FG003|Overall Study|Withdrawal by Subject|0|||
143329950|NCT03230916|516749905|FG004|Overall Study|Withdrawal by Subject|0|||
143329951|NCT03230916|516749906|FG005|Overall Study|Withdrawal by Subject|1|||
143329952|NCT03230916|516749907|FG006|Overall Study|Withdrawal by Subject|0|||
143329953|NCT03230916|516749908|FG007|Overall Study|Withdrawal by Subject|0|||
143329954|NCT03230916|516749909|FG008|Overall Study|Withdrawal by Subject|0|||
143329955|NCT03230916|516749910|FG009|Overall Study|Withdrawal by Subject|0|||
143329956|NCT03230916|516749911|FG010|Overall Study|Withdrawal by Subject|0|||
143329957|NCT01128413|516749912|FG000|Overall Study|Withdrawal by Subject|1|||
143329958|NCT01128413|516749913|FG001|Overall Study|Withdrawal by Subject|0|||
143329959|NCT01128413|516749912|FG000|Overall Study|NICOM Monitor Problems|2|||
143329960|NCT01128413|516749913|FG001|Overall Study|NICOM Monitor Problems|1|||
143329961|NCT01128413|516749912|FG000|Overall Study|Pt made DNR|1|||
143329962|NCT01128413|516749913|FG001|Overall Study|Pt made DNR|0|||
143329963|NCT01864564|516749915|FG000|Overall Study|Lost to Follow-up|17|||
143329964|NCT01864564|516749916|FG001|Overall Study|Lost to Follow-up|23|||
143329965|NCT01864564|516749915|FG000|Overall Study|Withdrawal by Subject|20|||
143329966|NCT01864564|516749916|FG001|Overall Study|Withdrawal by Subject|11|||
143329967|NCT01864564|516749915|FG000|Overall Study|Protocol Violation|0|||
143329968|NCT01864564|516749916|FG001|Overall Study|Protocol Violation|27|||
143329969|NCT01864564|516749915|FG000|Overall Study|not reported|0|||
143382979|NCT03215030|516948381|FG009|Part 2: Dose Expansion|Reason Not Specified|0|||
143329970|NCT01864564|516749916|FG001|Overall Study|not reported|34|||
143329971|NCT02269670|516749917|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
143329972|NCT04370054|516749918|FG000|Treatment Phase|Lost to Follow-up|1|||
143329973|NCT04370054|516749918|FG000|Treatment Phase|Withdrawal by Subject|1|||
143382980|NCT03215030|516948382|FG010|Part 2: Dose Expansion|Reason Not Specified|0|||
143382981|NCT03215030|516948383|FG011|Part 2: Dose Expansion|Reason Not Specified|0|||
143382982|NCT03215030|516948372|FG000|Part 3: Dose Extension|Lost to Follow-up|0|||
143329974|NCT04370054|516749918|FG000|Follow-Up Phase|Ongoing|75|||
143382983|NCT03215030|516948373|FG001|Part 3: Dose Extension|Lost to Follow-up|0|||
143382984|NCT03215030|516948374|FG002|Part 3: Dose Extension|Lost to Follow-up|0|||
143382985|NCT03215030|516948375|FG003|Part 3: Dose Extension|Lost to Follow-up|0|||
143382986|NCT03215030|516948376|FG004|Part 3: Dose Extension|Lost to Follow-up|0|||
143382987|NCT03215030|516948377|FG005|Part 3: Dose Extension|Lost to Follow-up|0|||
143382988|NCT03215030|516948378|FG006|Part 3: Dose Extension|Lost to Follow-up|0|||
143382989|NCT03215030|516948379|FG007|Part 3: Dose Extension|Lost to Follow-up|0|||
143382990|NCT03215030|516948380|FG008|Part 3: Dose Extension|Lost to Follow-up|0|||
143382991|NCT03215030|516948381|FG009|Part 3: Dose Extension|Lost to Follow-up|2|||
143382992|NCT03215030|516948382|FG010|Part 3: Dose Extension|Lost to Follow-up|0|||
143382993|NCT03215030|516948383|FG011|Part 3: Dose Extension|Lost to Follow-up|0|||
143382994|NCT03215030|516948372|FG000|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
143382995|NCT03215030|516948373|FG001|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
143382996|NCT03215030|516948374|FG002|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
143382997|NCT03215030|516948375|FG003|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
143382998|NCT03215030|516948376|FG004|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
143382999|NCT03215030|516948377|FG005|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
143383000|NCT03215030|516948378|FG006|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
143383001|NCT03215030|516948379|FG007|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
143383002|NCT03215030|516948380|FG008|Part 3: Dose Extension|Study Terminated by Sponsor|38|||
143383003|NCT03215030|516948381|FG009|Part 3: Dose Extension|Study Terminated by Sponsor|39|||
143383004|NCT03215030|516948382|FG010|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
143383005|NCT03215030|516948383|FG011|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
143383006|NCT03215030|516948372|FG000|Part 3: Dose Extension|Withdrawal by Subject|0|||
143383007|NCT03215030|516948373|FG001|Part 3: Dose Extension|Withdrawal by Subject|0|||
143383008|NCT03215030|516948374|FG002|Part 3: Dose Extension|Withdrawal by Subject|0|||
143383009|NCT03215030|516948375|FG003|Part 3: Dose Extension|Withdrawal by Subject|0|||
143383010|NCT03215030|516948376|FG004|Part 3: Dose Extension|Withdrawal by Subject|0|||
143383011|NCT03215030|516948377|FG005|Part 3: Dose Extension|Withdrawal by Subject|0|||
143383012|NCT03215030|516948378|FG006|Part 3: Dose Extension|Withdrawal by Subject|0|||
143383013|NCT03215030|516948379|FG007|Part 3: Dose Extension|Withdrawal by Subject|0|||
143383014|NCT03215030|516948380|FG008|Part 3: Dose Extension|Withdrawal by Subject|6|||
143383015|NCT03215030|516948381|FG009|Part 3: Dose Extension|Withdrawal by Subject|7|||
143329975|NCT04657211|516749919|FG000|Overall Study|Withdrawal by Subject|21|||
143329976|NCT04657211|516749919|FG000|Overall Study|Lost to Follow-up|113|||
143329977|NCT04657211|516749919|FG000|Overall Study|Death|47|||
143329978|NCT04657211|516749919|FG000|Overall Study|Transfer to another institution|21|||
143329979|NCT04657211|516749919|FG000|Overall Study|Other|29|||
143329980|NCT05557942|516749921|FG000|Overall Study|Death|0|||
143329981|NCT05557942|516749922|FG001|Overall Study|Death|0|||
143329982|NCT05557942|516749923|FG002|Overall Study|Death|0|||
143329983|NCT05557942|516749924|FG003|Overall Study|Death|2|||
143329984|NCT05557942|516749925|FG004|Overall Study|Death|1|||
143329985|NCT05557942|516749926|FG005|Overall Study|Death|1|||
143329986|NCT05557942|516749921|FG000|Overall Study|Physician Decision|1|||
143329987|NCT05557942|516749922|FG001|Overall Study|Physician Decision|1|||
143329988|NCT05557942|516749923|FG002|Overall Study|Physician Decision|2|||
143329989|NCT05557942|516749924|FG003|Overall Study|Physician Decision|3|||
143329990|NCT05557942|516749925|FG004|Overall Study|Physician Decision|0|||
143329991|NCT05557942|516749926|FG005|Overall Study|Physician Decision|2|||
143329992|NCT05557942|516749921|FG000|Overall Study|Study terminated by sponsor|17|||
143329993|NCT05557942|516749922|FG001|Overall Study|Study terminated by sponsor|17|||
143329994|NCT05557942|516749923|FG002|Overall Study|Study terminated by sponsor|14|||
143329995|NCT05557942|516749924|FG003|Overall Study|Study terminated by sponsor|40|||
143329996|NCT05557942|516749925|FG004|Overall Study|Study terminated by sponsor|45|||
143329997|NCT05557942|516749926|FG005|Overall Study|Study terminated by sponsor|37|||
143383016|NCT03215030|516948382|FG010|Part 3: Dose Extension|Withdrawal by Subject|0|||
143383017|NCT03215030|516948383|FG011|Part 3: Dose Extension|Withdrawal by Subject|0|||
143383018|NCT03215030|516948372|FG000|Part 3: Dose Extension|Death|0|||
143383019|NCT03215030|516948373|FG001|Part 3: Dose Extension|Death|0|||
143383020|NCT03215030|516948374|FG002|Part 3: Dose Extension|Death|0|||
143383021|NCT03215030|516948375|FG003|Part 3: Dose Extension|Death|0|||
143383022|NCT03215030|516948376|FG004|Part 3: Dose Extension|Death|0|||
143383023|NCT03215030|516948377|FG005|Part 3: Dose Extension|Death|0|||
143383024|NCT03215030|516948378|FG006|Part 3: Dose Extension|Death|0|||
143383025|NCT03215030|516948379|FG007|Part 3: Dose Extension|Death|0|||
143383026|NCT03215030|516948380|FG008|Part 3: Dose Extension|Death|19|||
143329998|NCT05557942|516749921|FG000|Overall Study|Protocol Violation|0|||
143329999|NCT05557942|516749922|FG001|Overall Study|Protocol Violation|0|||
143383027|NCT03215030|516948381|FG009|Part 3: Dose Extension|Death|20|||
143383028|NCT03215030|516948382|FG010|Part 3: Dose Extension|Death|0|||
143383029|NCT03215030|516948383|FG011|Part 3: Dose Extension|Death|0|||
143330000|NCT05557942|516749923|FG002|Overall Study|Protocol Violation|0|||
143330001|NCT05557942|516749924|FG003|Overall Study|Protocol Violation|0|||
143330002|NCT05557942|516749925|FG004|Overall Study|Protocol Violation|0|||
143330003|NCT05557942|516749926|FG005|Overall Study|Protocol Violation|1|||
143330004|NCT05557942|516749921|FG000|Overall Study|Withdrawal by Subject|0|||
143383030|NCT03215030|516948372|FG000|Part 3: Dose Extension|Reason Not Specified|0|||
143383031|NCT03215030|516948373|FG001|Part 3: Dose Extension|Reason Not Specified|0|||
143383032|NCT03215030|516948374|FG002|Part 3: Dose Extension|Reason Not Specified|0|||
143383033|NCT03215030|516948375|FG003|Part 3: Dose Extension|Reason Not Specified|0|||
143383034|NCT03215030|516948376|FG004|Part 3: Dose Extension|Reason Not Specified|0|||
143383035|NCT03215030|516948377|FG005|Part 3: Dose Extension|Reason Not Specified|0|||
143383036|NCT03215030|516948378|FG006|Part 3: Dose Extension|Reason Not Specified|0|||
143383037|NCT03215030|516948379|FG007|Part 3: Dose Extension|Reason Not Specified|0|||
143383038|NCT03215030|516948380|FG008|Part 3: Dose Extension|Reason Not Specified|3|||
143383039|NCT03215030|516948381|FG009|Part 3: Dose Extension|Reason Not Specified|0|||
143383040|NCT03215030|516948382|FG010|Part 3: Dose Extension|Reason Not Specified|0|||
143383041|NCT03215030|516948383|FG011|Part 3: Dose Extension|Reason Not Specified|0|||
143383042|NCT03215030|516948372|FG000|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
143383043|NCT03215030|516948373|FG001|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
143383044|NCT03215030|516948374|FG002|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
143383045|NCT03215030|516948375|FG003|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
143383046|NCT03215030|516948376|FG004|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
143383047|NCT03215030|516948377|FG005|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
143383048|NCT03215030|516948378|FG006|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
143383049|NCT03215030|516948379|FG007|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
143383050|NCT03215030|516948380|FG008|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
143383051|NCT03215030|516948381|FG009|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
143383052|NCT03215030|516948382|FG010|Japan Safety Lead-In|Study Terminated by Sponsor|3|||
143383053|NCT03215030|516948383|FG011|Japan Safety Lead-In|Study Terminated by Sponsor|2|||
143383054|NCT03438188|516948384|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
143383055|NCT03438188|516948385|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
143383056|NCT03438188|516948386|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
143383057|NCT03438188|516948384|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
143383058|NCT03438188|516948385|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
143383059|NCT03438188|516948386|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
143383060|NCT03438188|516948384|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
143383061|NCT03438188|516948385|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
143383062|NCT03438188|516948386|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
143383063|NCT03438188|516948384|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
143383064|NCT03438188|516948385|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
143383065|NCT03438188|516948386|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
143383066|NCT03438188|516948384|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
143383067|NCT03438188|516948385|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
143383068|NCT03438188|516948386|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
143383069|NCT06629454|516948392|FG000|Overall Study|Withdraw by Clinician Decision|1|||
143383070|NCT05136404|516948393|FG000|Period 1|Adverse Event|0|||
143383071|NCT05136404|516948394|FG001|Period 1|Adverse Event|1|||
143383072|NCT05136404|516948395|FG002|Period 1|Adverse Event|1|||
143383073|NCT05136404|516948393|FG000|Period 2|Inappropriate Behavior|0|||
143383074|NCT05136404|516948394|FG001|Period 2|Inappropriate Behavior|0|||
143330005|NCT05557942|516749922|FG001|Overall Study|Withdrawal by Subject|0|||
143330006|NCT05557942|516749923|FG002|Overall Study|Withdrawal by Subject|0|||
143330007|NCT05557942|516749924|FG003|Overall Study|Withdrawal by Subject|0|||
143330008|NCT05557942|516749925|FG004|Overall Study|Withdrawal by Subject|2|||
143330009|NCT05557942|516749926|FG005|Overall Study|Withdrawal by Subject|0|||
143330010|NCT00710424|516749929|FG000|Overall Study|Adverse Event|30|||
143330011|NCT00710424|516749930|FG001|Overall Study|Adverse Event|12|||
143330012|NCT00710424|516749929|FG000|Overall Study|Lack of Efficacy|4|||
143330013|NCT00710424|516749930|FG001|Overall Study|Lack of Efficacy|5|||
143330014|NCT00710424|516749929|FG000|Overall Study|Withdrawal by Subject|5|||
143330015|NCT00710424|516749930|FG001|Overall Study|Withdrawal by Subject|3|||
143330016|NCT00710424|516749929|FG000|Overall Study|Lost to Follow-up|0|||
143330017|NCT00710424|516749930|FG001|Overall Study|Lost to Follow-up|1|||
143330018|NCT00710424|516749929|FG000|Overall Study|Refused medication, no side effects|1|||
143330019|NCT00710424|516749930|FG001|Overall Study|Refused medication, no side effects|0|||
143330020|NCT00710424|516749929|FG000|Overall Study|Non-compliance with stable analgesia|1|||
143330021|NCT00710424|516749930|FG001|Overall Study|Non-compliance with stable analgesia|0|||
143330022|NCT00710424|516749929|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
143330023|NCT00710424|516749930|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
143330024|NCT00710424|516749929|FG000|Overall Study|Subject thought medication changed|1|||
143330025|NCT00710424|516749930|FG001|Overall Study|Subject thought medication changed|0|||
143330026|NCT00710424|516749929|FG000|Overall Study|Ceased treatment due to travel|1|||
143383075|NCT05136404|516948395|FG002|Period 2|Inappropriate Behavior|1|||
143383076|NCT05136404|516948393|FG000|Period 3|Adverse Event|0|||
143383077|NCT05136404|516948394|FG001|Period 3|Adverse Event|0|||
143330027|NCT00710424|516749930|FG001|Overall Study|Ceased treatment due to travel|0|||
143330028|NCT00710424|516749929|FG000|Overall Study|Subject preferred paracetamol|0|||
143330029|NCT00710424|516749930|FG001|Overall Study|Subject preferred paracetamol|1|||
143330030|NCT00710424|516749929|FG000|Overall Study|Felt good so stopped treatment|0|||
143330031|NCT00710424|516749930|FG001|Overall Study|Felt good so stopped treatment|1|||
143330032|NCT01962493|516749931|FG000|Overall Study|Adverse Event|1|||
143330033|NCT01962493|516749932|FG001|Overall Study|Adverse Event|2|||
143330034|NCT01962493|516749931|FG000|Overall Study|Protocol Violation|0|||
143330035|NCT01962493|516749932|FG001|Overall Study|Protocol Violation|1|||
143330036|NCT01962493|516749931|FG000|Overall Study|Withdrawal by Subject|4|||
143330037|NCT01962493|516749932|FG001|Overall Study|Withdrawal by Subject|2|||
143330038|NCT03776136|516749933|FG000|Overall Study|Death|85|||
143330039|NCT03776136|516749933|FG000|Overall Study|Withdrawal by Subject|3|||
143330040|NCT03776136|516749933|FG000|Overall Study|Sponsor Decision|15|||
143330041|NCT06273774|516749934|FG000|Overall Study|Participant was out of state.|0|||
143330042|NCT06273774|516749935|FG001|Overall Study|Participant was out of state.|0|||
143330043|NCT06273774|516749936|FG002|Overall Study|Participant was out of state.|0|||
143330044|NCT06273774|516749937|FG003|Overall Study|Participant was out of state.|0|||
143330045|NCT06273774|516749938|FG004|Overall Study|Participant was out of state.|0|||
143330046|NCT06273774|516749939|FG005|Overall Study|Participant was out of state.|1|||
143330047|NCT06273774|516749934|FG000|Overall Study|Lost to Follow-up|0|||
143330048|NCT06273774|516749935|FG001|Overall Study|Lost to Follow-up|0|||
143330049|NCT06273774|516749936|FG002|Overall Study|Lost to Follow-up|0|||
143330050|NCT06273774|516749937|FG003|Overall Study|Lost to Follow-up|0|||
143330051|NCT06273774|516749938|FG004|Overall Study|Lost to Follow-up|1|||
143330052|NCT06273774|516749939|FG005|Overall Study|Lost to Follow-up|0|||
143330053|NCT02010060|516749940|FG000|Overall Study|Lost to Follow-up|1|||
143330054|NCT02010060|516749941|FG001|Overall Study|Lost to Follow-up|2|||
143330055|NCT02010060|516749942|FG002|Overall Study|Lost to Follow-up|2|||
143330056|NCT02010060|516749940|FG000|Overall Study|Injury|0|||
143330057|NCT02010060|516749941|FG001|Overall Study|Injury|1|||
143330058|NCT02010060|516749942|FG002|Overall Study|Injury|0|||
143330059|NCT00660010|516749945|FG000|Overall Study|Withdrawal by Subject|2|||
143330060|NCT00660010|516749945|FG000|Overall Study|Lost to Follow-up|3|||
143330061|NCT00660010|516749945|FG000|Overall Study|Adverse Event|1|||
143330062|NCT00660010|516749945|FG000|Overall Study|Noncompliance with visit schedule|3|||
143330063|NCT00844857|516752255|FG000|Overall Study|Adverse Event|24|||
143330064|NCT00844857|516752256|FG001|Overall Study|Adverse Event|5|||
143330065|NCT00844857|516752255|FG000|Overall Study|Sponsor Decision|1|||
143330066|NCT00844857|516752256|FG001|Overall Study|Sponsor Decision|1|||
143330067|NCT00844857|516752255|FG000|Overall Study|Physician Decision|2|||
143330068|NCT00844857|516752256|FG001|Overall Study|Physician Decision|0|||
143330069|NCT00844857|516752255|FG000|Overall Study|Parent/Caregiver Decision|6|||
143330070|NCT00844857|516752256|FG001|Overall Study|Parent/Caregiver Decision|2|||
143330071|NCT00844857|516752255|FG000|Overall Study|Withdrawal by Subject|8|||
143330072|NCT00844857|516752256|FG001|Overall Study|Withdrawal by Subject|7|||
143330073|NCT00844857|516752255|FG000|Overall Study|Protocol Violation|6|||
143330074|NCT00844857|516752256|FG001|Overall Study|Protocol Violation|0|||
143330075|NCT00844857|516752255|FG000|Overall Study|Lack of Efficacy|5|||
143330076|NCT00844857|516752256|FG001|Overall Study|Lack of Efficacy|5|||
143330077|NCT00844857|516752255|FG000|Overall Study|Clinical Relapse|0|||
143330078|NCT00844857|516752256|FG001|Overall Study|Clinical Relapse|1|||
143330079|NCT00844857|516752255|FG000|Overall Study|Entry Criteria Not Met|0|||
143330080|NCT00844857|516752256|FG001|Overall Study|Entry Criteria Not Met|1|||
143330081|NCT00844857|516752255|FG000|Overall Study|Lost to Follow-up|2|||
143330082|NCT00844857|516752256|FG001|Overall Study|Lost to Follow-up|3|||
143330083|NCT00844857|516752255|FG000|Overall Study|Did Not Take Study Drug|3|||
143330084|NCT00844857|516752256|FG001|Overall Study|Did Not Take Study Drug|1|||
143330085|NCT00844857|516752255|FG000|Overall Study|Good Clinical Practice Violations|21|||
143330086|NCT00844857|516752256|FG001|Overall Study|Good Clinical Practice Violations|11|||
143330087|NCT00570674|516752257|FG000|Overall Study|Withdrawal by Subject|0|||
143330088|NCT00570674|516752258|FG001|Overall Study|Withdrawal by Subject|0|||
143330089|NCT00570674|516752259|FG002|Overall Study|Withdrawal by Subject|1|||
143330090|NCT00570674|516752260|FG003|Overall Study|Withdrawal by Subject|0|||
143330091|NCT00570674|516752261|FG004|Overall Study|Withdrawal by Subject|0|||
143330092|NCT00570674|516752262|FG005|Overall Study|Withdrawal by Subject|0|||
143330093|NCT00570674|516752263|FG006|Overall Study|Withdrawal by Subject|0|||
143330094|NCT02985866|516752269|FG000|Overall Study|Poor CGM data|1|||
143330095|NCT02985866|516752270|FG001|Overall Study|Poor CGM data|1|||
143330096|NCT02120027|516752273|FG000|Overall Study|Adverse Event|4|||
143330097|NCT02120027|516752274|FG001|Overall Study|Adverse Event|5|||
143330098|NCT02120027|516752273|FG000|Overall Study|Lack of Efficacy|3|||
143330099|NCT02120027|516752274|FG001|Overall Study|Lack of Efficacy|5|||
143330100|NCT02120027|516752273|FG000|Overall Study|Lost to Follow-up|5|||
143330101|NCT02120027|516752274|FG001|Overall Study|Lost to Follow-up|13|||
143330102|NCT02120027|516752273|FG000|Overall Study|Other|4|||
143330103|NCT02120027|516752274|FG001|Overall Study|Other|0|||
143330104|NCT02120027|516752273|FG000|Overall Study|Physician Decision|4|||
143330105|NCT02120027|516752274|FG001|Overall Study|Physician Decision|3|||
143330106|NCT02120027|516752273|FG000|Overall Study|Protocol Violation|18|||
143330107|NCT02120027|516752274|FG001|Overall Study|Protocol Violation|21|||
143330108|NCT02120027|516752273|FG000|Overall Study|Study terminated by Sponsor|45|||
143330109|NCT02120027|516752274|FG001|Overall Study|Study terminated by Sponsor|47|||
143330110|NCT02120027|516752273|FG000|Overall Study|Withdrawal by Subject|33|||
143330111|NCT02120027|516752274|FG001|Overall Study|Withdrawal by Subject|25|||
143330112|NCT03393000|516752277|FG000|Overall Study|Death|11|||
143330113|NCT03393000|516752277|FG000|Overall Study|Withdrawal by Subject|2|||
143330114|NCT03393000|516752277|FG000|Overall Study|Physician Decision|1|||
143330115|NCT01773070|516752278|FG000|Overall Study|Withdrawal by Subject|24|||
143330116|NCT01773070|516752278|FG000|Overall Study|Lost to Follow-up|39|||
143330117|NCT01773070|516752278|FG000|Overall Study|Other|15|||
143330118|NCT01773070|516752278|FG000|Overall Study|Death (unrelated to study procedures)|3|||
143330119|NCT01471054|516752279|FG000|Overall Study|Study terminated prematurely|4|||
143330120|NCT01471054|516752280|FG001|Overall Study|Study terminated prematurely|0|||
143330121|NCT01843192|516752281|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
143330122|NCT01843192|516752282|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
143330123|NCT01843192|516752283|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
143330124|NCT02181803|516752284|FG000|Overall Study|Withdrawal by Subject|0|||
143330125|NCT02181803|516752285|FG001|Overall Study|Withdrawal by Subject|2|||
143330126|NCT02181803|516752286|FG002|Overall Study|Withdrawal by Subject|0|||
143383078|NCT05136404|516948395|FG002|Period 3|Adverse Event|1|||
143330127|NCT02181803|516752287|FG003|Overall Study|Withdrawal by Subject|0|||
143330128|NCT02181803|516752288|FG004|Overall Study|Withdrawal by Subject|0|||
143330129|NCT02181803|516752289|FG005|Overall Study|Withdrawal by Subject|0|||
143330130|NCT02181803|516752290|FG006|Overall Study|Withdrawal by Subject|0|||
143330131|NCT02181803|516752291|FG007|Overall Study|Withdrawal by Subject|0|||
143330132|NCT02181803|516752292|FG008|Overall Study|Withdrawal by Subject|0|||
143330133|NCT02181803|516752284|FG000|Overall Study|Physician Decision|0|||
143330134|NCT02181803|516752285|FG001|Overall Study|Physician Decision|0|||
143330135|NCT02181803|516752286|FG002|Overall Study|Physician Decision|0|||
143330136|NCT02181803|516752287|FG003|Overall Study|Physician Decision|1|||
143330137|NCT02181803|516752288|FG004|Overall Study|Physician Decision|0|||
143330138|NCT02181803|516752289|FG005|Overall Study|Physician Decision|0|||
143330139|NCT02181803|516752290|FG006|Overall Study|Physician Decision|0|||
143330140|NCT02181803|516752291|FG007|Overall Study|Physician Decision|1|||
143330141|NCT02181803|516752292|FG008|Overall Study|Physician Decision|0|||
143330142|NCT02181803|516752284|FG000|Overall Study|Adverse Event|0|||
143330143|NCT02181803|516752285|FG001|Overall Study|Adverse Event|2|||
143330144|NCT02181803|516752286|FG002|Overall Study|Adverse Event|0|||
143330145|NCT02181803|516752287|FG003|Overall Study|Adverse Event|1|||
143330146|NCT02181803|516752288|FG004|Overall Study|Adverse Event|0|||
143330147|NCT02181803|516752289|FG005|Overall Study|Adverse Event|0|||
143330148|NCT02181803|516752290|FG006|Overall Study|Adverse Event|1|||
143330149|NCT02181803|516752291|FG007|Overall Study|Adverse Event|0|||
143330150|NCT02181803|516752292|FG008|Overall Study|Adverse Event|0|||
143330151|NCT00951041|516752293|FG000|Overall Study|Withdrawal by Subject|1|||
143330152|NCT00951041|516752294|FG001|Overall Study|Withdrawal by Subject|1|||
143330153|NCT00951041|516752293|FG000|Overall Study|Lost to Follow-up|1|||
143330154|NCT00951041|516752294|FG001|Overall Study|Lost to Follow-up|0|||
143330155|NCT00951041|516752293|FG000|Overall Study|Other|3|||
143330156|NCT00951041|516752294|FG001|Overall Study|Other|0|||
143330157|NCT02277106|516752295|FG000|Stage 2|Adverse Event|0|||
143330158|NCT02277106|516752296|FG001|Stage 2|Adverse Event|0|||
143330159|NCT02277106|516752297|FG002|Stage 2|Adverse Event|1|||
143330160|NCT03667053|516752299|FG000|Overall Study|Withdrawal by Subject|1|||
143330161|NCT03667053|516752300|FG001|Overall Study|Withdrawal by Subject|0|||
143330162|NCT03667053|516752301|FG002|Overall Study|Withdrawal by Subject|0|||
143330163|NCT01324271|516752302|FG000|Overall Study|Lost to Follow-up|3|||
143330164|NCT01324271|516752303|FG001|Overall Study|Lost to Follow-up|0|||
143330165|NCT01324271|516752302|FG000|Overall Study|Physician Decision|1|||
143330166|NCT01324271|516752303|FG001|Overall Study|Physician Decision|0|||
143330167|NCT03996473|516752304|FG000|Treatment Assignment|Withdrawal by Subject|1|||
143330168|NCT03996473|516752304|FG000|Treatment Assignment|Progressive disease|6|||
143330169|NCT03996473|516752304|FG000|Treatment Assignment|Study drug never administered|1|||
143330170|NCT03996473|516752304|FG000|Active Follow-up|Death|1|||
143330171|NCT03996473|516752304|FG000|Long-term Follow-up|Death|5|||
143330172|NCT06116591|516752305|FG000|Overall Study|No longer met eligibility criteria|0|||
143330173|NCT06116591|516752306|FG001|Overall Study|No longer met eligibility criteria|1|||
143330174|NCT06116591|516752305|FG000|Overall Study|Other: Change in life situation|0|||
143330175|NCT06116591|516752306|FG001|Overall Study|Other: Change in life situation|1|||
143330176|NCT05585307|516752307|FG000|Overall Study|Lost to Follow-up|0|||
143330177|NCT05585307|516752308|FG001|Overall Study|Lost to Follow-up|0|||
143330178|NCT05585307|516752309|FG002|Overall Study|Lost to Follow-up|0|||
143330179|NCT05585307|516752310|FG003|Overall Study|Lost to Follow-up|0|||
143330180|NCT05585307|516752311|FG004|Overall Study|Lost to Follow-up|0|||
143330181|NCT05585307|516752312|FG005|Overall Study|Lost to Follow-up|0|||
143330182|NCT05585307|516752313|FG006|Overall Study|Lost to Follow-up|1|||
143330183|NCT05585307|516752314|FG007|Overall Study|Lost to Follow-up|0|||
143330184|NCT01869491|516752315|FG000|Overall Study|Adverse Event|3|||
143330185|NCT01869491|516752316|FG001|Overall Study|Adverse Event|5|||
143330186|NCT01869491|516752315|FG000|Overall Study|Lack of Efficacy|0|||
143330187|NCT01869491|516752316|FG001|Overall Study|Lack of Efficacy|3|||
143330188|NCT01869491|516752315|FG000|Overall Study|Withdrawal by Subject|6|||
143330189|NCT01869491|516752316|FG001|Overall Study|Withdrawal by Subject|7|||
143330190|NCT01869491|516752315|FG000|Overall Study|Lost to Follow-up|11|||
143330191|NCT01869491|516752316|FG001|Overall Study|Lost to Follow-up|9|||
143330192|NCT01869491|516752315|FG000|Overall Study|No further need of investigational product|1|||
143330193|NCT01869491|516752316|FG001|Overall Study|No further need of investigational product|0|||
143330194|NCT04818346|516752317|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
143330195|NCT04818346|516752318|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
143330196|NCT04818346|516752319|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
143330197|NCT04818346|516752320|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
143330198|NCT04818346|516752317|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
143330199|NCT04818346|516752318|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
143330200|NCT04818346|516752319|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
143330201|NCT04818346|516752320|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
143330202|NCT04818346|516752317|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
143330203|NCT04818346|516752318|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
143330204|NCT04818346|516752319|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
143330205|NCT04818346|516752320|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
143330206|NCT04818346|516752317|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
143330207|NCT04818346|516752318|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
143330208|NCT04818346|516752319|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
143330209|NCT04818346|516752320|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
143330210|NCT04818346|516752317|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
143330211|NCT04818346|516752318|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
143330212|NCT04818346|516752319|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
143330213|NCT04818346|516752320|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
143330214|NCT04818346|516752317|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
143330215|NCT04818346|516752318|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
143330216|NCT04818346|516752319|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
143330217|NCT04818346|516752320|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
143330218|NCT04818346|516752317|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
143330219|NCT04818346|516752318|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
143330220|NCT04818346|516752319|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
143330221|NCT04818346|516752320|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
143330222|NCT04818346|516752317|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
143330223|NCT04818346|516752318|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
143330224|NCT04818346|516752319|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
143330225|NCT04818346|516752320|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
143330226|NCT04818346|516752317|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
143330227|NCT04818346|516752318|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
143330228|NCT04818346|516752319|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
143330229|NCT04818346|516752320|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
143330230|NCT04818346|516752317|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
143330231|NCT04818346|516752318|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
143330232|NCT04818346|516752319|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
143330233|NCT04818346|516752320|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
143330234|NCT04818346|516752317|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
143330235|NCT04818346|516752318|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
143330236|NCT04818346|516752319|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
143330237|NCT04818346|516752320|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
143330238|NCT04818346|516752317|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
143330239|NCT04818346|516752318|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
143330240|NCT04818346|516752319|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
143330241|NCT04818346|516752320|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
143330242|NCT04818346|516752317|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
143330243|NCT04818346|516752318|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
143330244|NCT04818346|516752319|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
143330245|NCT04818346|516752320|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
143330246|NCT04818346|516752317|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
143330247|NCT04818346|516752318|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
143330248|NCT04818346|516752319|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
143330249|NCT04818346|516752320|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
143330250|NCT04818346|516752317|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
143330251|NCT04818346|516752318|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
143330252|NCT04818346|516752319|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
143330253|NCT04818346|516752320|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
143330254|NCT00492284|516752321|FG000|Overall Study|Adverse Event|0|||
143330255|NCT00492284|516752322|FG001|Overall Study|Adverse Event|1|||
143330256|NCT00492284|516752323|FG002|Overall Study|Adverse Event|1|||
143330257|NCT00492284|516752324|FG003|Overall Study|Adverse Event|2|||
143330258|NCT00492284|516752321|FG000|Overall Study|Lost to Follow-up|0|||
143330259|NCT00492284|516752322|FG001|Overall Study|Lost to Follow-up|0|||
143330260|NCT00492284|516752323|FG002|Overall Study|Lost to Follow-up|3|||
143330261|NCT00492284|516752324|FG003|Overall Study|Lost to Follow-up|1|||
143330262|NCT00492284|516752321|FG000|Overall Study|Death|0|||
143330263|NCT00492284|516752322|FG001|Overall Study|Death|3|||
143330264|NCT00492284|516752323|FG002|Overall Study|Death|2|||
143330265|NCT00492284|516752324|FG003|Overall Study|Death|5|||
143330266|NCT00492284|516752321|FG000|Overall Study|Withdrawal by Subject|1|||
143330267|NCT00492284|516752322|FG001|Overall Study|Withdrawal by Subject|0|||
143330268|NCT00492284|516752323|FG002|Overall Study|Withdrawal by Subject|0|||
143330269|NCT00492284|516752324|FG003|Overall Study|Withdrawal by Subject|2|||
143330270|NCT04313881|516752327|FG000|Overall Study|Death|138|||
143330271|NCT04313881|516752328|FG001|Overall Study|Death|126|||
143330272|NCT04313881|516752327|FG000|Overall Study|Study terminated by sponsor|108|||
143330273|NCT04313881|516752328|FG001|Overall Study|Study terminated by sponsor|129|||
143330274|NCT04313881|516752327|FG000|Overall Study|Consent withdrawn|19|||
143330275|NCT04313881|516752328|FG001|Overall Study|Consent withdrawn|15|||
143330276|NCT04313881|516752327|FG000|Overall Study|Reason not Specified|3|||
143330277|NCT04313881|516752328|FG001|Overall Study|Reason not Specified|1|||
143330278|NCT00727272|516752329|FG000|Washout Period A|Adverse Event|0|||
143330279|NCT00727272|516752330|FG001|Washout Period A|Adverse Event|0|||
143330280|NCT00727272|516752331|FG002|Washout Period A|Adverse Event|1|||
143330281|NCT00727272|516752329|FG000|Washout Period B|Withdrawal by Subject|0|||
143330282|NCT00727272|516752330|FG001|Washout Period B|Withdrawal by Subject|0|||
143330283|NCT00727272|516752331|FG002|Washout Period B|Withdrawal by Subject|1|||
143330284|NCT00651664|516752332|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
143330285|NCT00651664|516752333|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
143330286|NCT00651664|516752334|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
143330287|NCT00651664|516752335|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
143330288|NCT00651664|516752336|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
143330289|NCT00651664|516752337|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
143330290|NCT00651664|516752338|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
143330291|NCT00651664|516752339|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
143330292|NCT00651664|516752340|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
143330293|NCT00651664|516752341|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
143330294|NCT00651664|516752332|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
143330295|NCT00651664|516752333|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
143330296|NCT00651664|516752334|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
143330297|NCT00651664|516752335|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
143330298|NCT00651664|516752336|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
143330299|NCT00651664|516752337|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
143330300|NCT00651664|516752338|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
143330301|NCT00651664|516752339|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
143330302|NCT00651664|516752340|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
143330303|NCT00651664|516752341|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
143330304|NCT00651664|516752332|FG000|Overall Study|Progressive Disease|3|||
143330305|NCT00651664|516752333|FG001|Overall Study|Progressive Disease|3|||
143330306|NCT00651664|516752334|FG002|Overall Study|Progressive Disease|3|||
143330307|NCT00651664|516752335|FG003|Overall Study|Progressive Disease|12|||
143330308|NCT00651664|516752336|FG004|Overall Study|Progressive Disease|4|||
143330309|NCT00651664|516752337|FG005|Overall Study|Progressive Disease|1|||
143330310|NCT00651664|516752338|FG006|Overall Study|Progressive Disease|3|||
143330311|NCT00651664|516752339|FG007|Overall Study|Progressive Disease|6|||
143330312|NCT00651664|516752340|FG008|Overall Study|Progressive Disease|5|||
143330313|NCT00651664|516752341|FG009|Overall Study|Progressive Disease|5|||
143330314|NCT00651664|516752332|FG000|Overall Study|Patient Declined Further Treatment|0|||
143330315|NCT00651664|516752333|FG001|Overall Study|Patient Declined Further Treatment|0|||
143330316|NCT00651664|516752334|FG002|Overall Study|Patient Declined Further Treatment|0|||
143330317|NCT00651664|516752335|FG003|Overall Study|Patient Declined Further Treatment|1|||
143330318|NCT00651664|516752336|FG004|Overall Study|Patient Declined Further Treatment|1|||
143330319|NCT00651664|516752337|FG005|Overall Study|Patient Declined Further Treatment|1|||
143330320|NCT00651664|516752338|FG006|Overall Study|Patient Declined Further Treatment|0|||
143330321|NCT00651664|516752339|FG007|Overall Study|Patient Declined Further Treatment|0|||
143330322|NCT00651664|516752340|FG008|Overall Study|Patient Declined Further Treatment|0|||
143330323|NCT00651664|516752341|FG009|Overall Study|Patient Declined Further Treatment|1|||
143330324|NCT00651664|516752332|FG000|Overall Study|Symptomatic Deterioration|0|||
143330325|NCT00651664|516752333|FG001|Overall Study|Symptomatic Deterioration|0|||
143330326|NCT00651664|516752334|FG002|Overall Study|Symptomatic Deterioration|0|||
143330327|NCT00651664|516752335|FG003|Overall Study|Symptomatic Deterioration|1|||
143330328|NCT00651664|516752336|FG004|Overall Study|Symptomatic Deterioration|0|||
143330329|NCT00651664|516752337|FG005|Overall Study|Symptomatic Deterioration|0|||
143330330|NCT00651664|516752338|FG006|Overall Study|Symptomatic Deterioration|1|||
143330331|NCT00651664|516752339|FG007|Overall Study|Symptomatic Deterioration|0|||
143330332|NCT00651664|516752340|FG008|Overall Study|Symptomatic Deterioration|1|||
143330333|NCT00651664|516752341|FG009|Overall Study|Symptomatic Deterioration|0|||
143330334|NCT00651664|516752332|FG000|Overall Study|Reason not Specified|0|||
143330335|NCT00651664|516752333|FG001|Overall Study|Reason not Specified|0|||
143330336|NCT00651664|516752334|FG002|Overall Study|Reason not Specified|0|||
143330337|NCT00651664|516752335|FG003|Overall Study|Reason not Specified|0|||
143330338|NCT00651664|516752336|FG004|Overall Study|Reason not Specified|0|||
143330339|NCT00651664|516752337|FG005|Overall Study|Reason not Specified|0|||
143330340|NCT00651664|516752338|FG006|Overall Study|Reason not Specified|1|||
143330341|NCT00651664|516752339|FG007|Overall Study|Reason not Specified|0|||
143330342|NCT00651664|516752340|FG008|Overall Study|Reason not Specified|0|||
143330343|NCT00651664|516752341|FG009|Overall Study|Reason not Specified|0|||
143330344|NCT00688636|516752342|FG000|Overall Study|Adverse Event|2|||
143330345|NCT00688636|516752343|FG001|Overall Study|Adverse Event|1|||
143330346|NCT01572727|516752344|FG000|Overall Study|Adverse Event|43|||
143330347|NCT01572727|516752345|FG001|Overall Study|Adverse Event|15|||
143330348|NCT01572727|516752344|FG000|Overall Study|Lost to Follow-up|1|||
143330349|NCT01572727|516752345|FG001|Overall Study|Lost to Follow-up|1|||
143330350|NCT01572727|516752344|FG000|Overall Study|Physician Decision|23|||
143330351|NCT01572727|516752345|FG001|Overall Study|Physician Decision|9|||
143330352|NCT01572727|516752344|FG000|Overall Study|Progressive disease|59|||
143330353|NCT01572727|516752345|FG001|Overall Study|Progressive disease|82|||
143330354|NCT01572727|516752344|FG000|Overall Study|Protocol Violation|0|||
143330355|NCT01572727|516752345|FG001|Overall Study|Protocol Violation|1|||
143330356|NCT01572727|516752344|FG000|Overall Study|Study terminated by sponsor|61|||
143330357|NCT01572727|516752345|FG001|Overall Study|Study terminated by sponsor|83|||
143330358|NCT01572727|516752344|FG000|Overall Study|Parent/guardian decision|14|||
143330359|NCT01572727|516752345|FG001|Overall Study|Parent/guardian decision|9|||
143330360|NCT01572727|516752344|FG000|Overall Study|Death|2|||
143330361|NCT01572727|516752345|FG001|Overall Study|Death|2|||
143330362|NCT01572727|516752344|FG000|Overall Study|Untreated|4|||
143330363|NCT01572727|516752345|FG001|Overall Study|Untreated|7|||
143330364|NCT01474681|516752346|FG000|Overall Study|Death|0|||
143330365|NCT01474681|516752347|FG001|Overall Study|Death|3|||
143330366|NCT01474681|516752348|FG002|Overall Study|Death|2|||
143330367|NCT01474681|516752349|FG003|Overall Study|Death|6|||
143330368|NCT02834780|516752352|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
143330369|NCT02834780|516752353|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
143330370|NCT02834780|516752354|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
143330371|NCT02834780|516752355|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
143330372|NCT02834780|516752356|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
143330373|NCT02834780|516752357|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
143330374|NCT02834780|516752358|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
143330375|NCT02834780|516752359|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
143330376|NCT02834780|516752360|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
143330377|NCT02834780|516752361|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
143330378|NCT02834780|516752362|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
143330379|NCT02834780|516752363|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
143330380|NCT02834780|516752364|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
143330381|NCT02834780|516752352|FG000|Overall Study|Withdrawal by Subject|0|||
143330382|NCT02834780|516752353|FG001|Overall Study|Withdrawal by Subject|0|||
143330383|NCT02834780|516752354|FG002|Overall Study|Withdrawal by Subject|1|||
143330384|NCT02834780|516752355|FG003|Overall Study|Withdrawal by Subject|0|||
143330385|NCT02834780|516752356|FG004|Overall Study|Withdrawal by Subject|0|||
143330386|NCT02834780|516752357|FG005|Overall Study|Withdrawal by Subject|0|||
143330387|NCT02834780|516752358|FG006|Overall Study|Withdrawal by Subject|0|||
143330388|NCT02834780|516752359|FG007|Overall Study|Withdrawal by Subject|0|||
143330389|NCT02834780|516752360|FG008|Overall Study|Withdrawal by Subject|0|||
143330390|NCT02834780|516752361|FG009|Overall Study|Withdrawal by Subject|0|||
143330391|NCT02834780|516752362|FG010|Overall Study|Withdrawal by Subject|1|||
143330392|NCT02834780|516752363|FG011|Overall Study|Withdrawal by Subject|0|||
143330393|NCT02834780|516752364|FG012|Overall Study|Withdrawal by Subject|0|||
143330394|NCT02834780|516752352|FG000|Overall Study|Adverse Event|0|||
143330395|NCT02834780|516752353|FG001|Overall Study|Adverse Event|0|||
143330396|NCT02834780|516752354|FG002|Overall Study|Adverse Event|0|||
143330397|NCT02834780|516752355|FG003|Overall Study|Adverse Event|0|||
143330398|NCT02834780|516752356|FG004|Overall Study|Adverse Event|1|||
143330399|NCT02834780|516752357|FG005|Overall Study|Adverse Event|0|||
143330400|NCT02834780|516752358|FG006|Overall Study|Adverse Event|1|||
143330401|NCT02834780|516752359|FG007|Overall Study|Adverse Event|1|||
143330402|NCT02834780|516752360|FG008|Overall Study|Adverse Event|0|||
143330403|NCT02834780|516752361|FG009|Overall Study|Adverse Event|2|||
143330404|NCT02834780|516752362|FG010|Overall Study|Adverse Event|0|||
143330405|NCT02834780|516752363|FG011|Overall Study|Adverse Event|3|||
143330406|NCT02834780|516752364|FG012|Overall Study|Adverse Event|2|||
143330407|NCT02834780|516752352|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
143330408|NCT02834780|516752353|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
143330409|NCT02834780|516752354|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
143330410|NCT02834780|516752355|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
143330411|NCT02834780|516752356|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
143330412|NCT02834780|516752357|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
143330413|NCT02834780|516752358|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
143330414|NCT02834780|516752359|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
143330415|NCT02834780|516752360|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
143330416|NCT02834780|516752361|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
143383079|NCT03584516|516948396|FG000|Part 1|Death|2|||
143383080|NCT03584516|516948397|FG001|Part 1|Death|3|||
143383081|NCT03584516|516948398|FG002|Part 1|Death|0|||
143383082|NCT03584516|516948399|FG003|Part 1|Death|0|||
143383083|NCT03584516|516948400|FG004|Part 1|Death|0|||
143383084|NCT03584516|516948401|FG005|Part 1|Death|0|||
143330417|NCT02834780|516752362|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
143330418|NCT02834780|516752363|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
143330419|NCT02834780|516752364|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
143330420|NCT02834780|516752352|FG000|Overall Study|Other|1|||
143330421|NCT02834780|516752353|FG001|Overall Study|Other|0|||
143330422|NCT02834780|516752354|FG002|Overall Study|Other|1|||
143330423|NCT02834780|516752355|FG003|Overall Study|Other|2|||
143330424|NCT02834780|516752356|FG004|Overall Study|Other|0|||
143330425|NCT02834780|516752357|FG005|Overall Study|Other|0|||
143330426|NCT02834780|516752358|FG006|Overall Study|Other|0|||
143330427|NCT02834780|516752359|FG007|Overall Study|Other|0|||
143330428|NCT02834780|516752360|FG008|Overall Study|Other|0|||
143330429|NCT02834780|516752361|FG009|Overall Study|Other|0|||
143330430|NCT02834780|516752362|FG010|Overall Study|Other|0|||
143330431|NCT02834780|516752363|FG011|Overall Study|Other|0|||
143330432|NCT02834780|516752364|FG012|Overall Study|Other|1|||
143330433|NCT03150056|516752365|FG000|Overall Study|Withdrawal by Subject|0|||
143330434|NCT03150056|516752366|FG001|Overall Study|Withdrawal by Subject|0|||
143330435|NCT03150056|516752367|FG002|Overall Study|Withdrawal by Subject|0|||
143330436|NCT03150056|516752368|FG003|Overall Study|Withdrawal by Subject|0|||
143330437|NCT03150056|516752369|FG004|Overall Study|Withdrawal by Subject|0|||
143330438|NCT03150056|516752370|FG005|Overall Study|Withdrawal by Subject|2|||
143330439|NCT03150056|516752365|FG000|Overall Study|Study terminated by Sponsor|1|||
143330440|NCT03150056|516752366|FG001|Overall Study|Study terminated by Sponsor|3|||
143330441|NCT03150056|516752367|FG002|Overall Study|Study terminated by Sponsor|1|||
143330442|NCT03150056|516752368|FG003|Overall Study|Study terminated by Sponsor|1|||
143330443|NCT03150056|516752369|FG004|Overall Study|Study terminated by Sponsor|5|||
143330444|NCT03150056|516752370|FG005|Overall Study|Study terminated by Sponsor|6|||
143330445|NCT03150056|516752365|FG000|Overall Study|Death|9|||
143330446|NCT03150056|516752366|FG001|Overall Study|Death|2|||
143330447|NCT03150056|516752367|FG002|Overall Study|Death|2|||
143330448|NCT03150056|516752368|FG003|Overall Study|Death|7|||
143330449|NCT03150056|516752369|FG004|Overall Study|Death|8|||
143330450|NCT03150056|516752370|FG005|Overall Study|Death|10|||
143330451|NCT02251990|516752372|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
143330452|NCT02251990|516752373|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
143330453|NCT02251990|516752372|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
143330454|NCT02251990|516752373|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
143330455|NCT02251990|516752372|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
143330456|NCT02251990|516752373|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
143330457|NCT02251990|516752372|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
143330458|NCT02251990|516752373|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
143330459|NCT02251990|516752372|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
143330460|NCT02251990|516752373|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
143330461|NCT02251990|516752372|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
143330462|NCT02251990|516752373|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
143330463|NCT00535730|516752374|FG000|Overall Study|Adverse Event|1|||
143330464|NCT00535730|516752375|FG001|Overall Study|Adverse Event|1|||
143330465|NCT00535730|516752374|FG000|Overall Study|Lost to Follow-up|0|||
143330466|NCT00535730|516752375|FG001|Overall Study|Lost to Follow-up|1|||
143330467|NCT00535730|516752374|FG000|Overall Study|Physician Decision|0|||
143330468|NCT00535730|516752375|FG001|Overall Study|Physician Decision|1|||
143330469|NCT00535730|516752374|FG000|Overall Study|Protocol Violation|1|||
143330470|NCT00535730|516752375|FG001|Overall Study|Protocol Violation|0|||
143330471|NCT00535730|516752374|FG000|Overall Study|Withdrawal by Subject|0|||
143330472|NCT00535730|516752375|FG001|Overall Study|Withdrawal by Subject|4|||
143383085|NCT03584516|516948396|FG000|Part 1|Withdrawal by Subject|2|||
143383086|NCT03584516|516948397|FG001|Part 1|Withdrawal by Subject|0|||
143383087|NCT03584516|516948398|FG002|Part 1|Withdrawal by Subject|0|||
143383088|NCT03584516|516948399|FG003|Part 1|Withdrawal by Subject|0|||
143383089|NCT03584516|516948400|FG004|Part 1|Withdrawal by Subject|0|||
143383090|NCT03584516|516948401|FG005|Part 1|Withdrawal by Subject|0|||
143383091|NCT03584516|516948396|FG000|Part 1|Lost to Follow-up|1|||
143330473|NCT04330638|516752376|FG000|Overall Study|Adverse Event|9|||
143330474|NCT04330638|516752377|FG001|Overall Study|Adverse Event|10|||
143383092|NCT03584516|516948397|FG001|Part 1|Lost to Follow-up|0|||
143383093|NCT03584516|516948398|FG002|Part 1|Lost to Follow-up|0|||
143383094|NCT03584516|516948399|FG003|Part 1|Lost to Follow-up|0|||
143330475|NCT04330638|516752378|FG002|Overall Study|Adverse Event|15|||
143330476|NCT04330638|516752379|FG003|Overall Study|Adverse Event|6|||
143330477|NCT04330638|516752380|FG004|Overall Study|Adverse Event|10|||
143330478|NCT04330638|516752381|FG005|Overall Study|Adverse Event|5|||
143330479|NCT04330638|516752376|FG000|Overall Study|Other|2|||
143383095|NCT03584516|516948400|FG004|Part 1|Lost to Follow-up|0|||
143330480|NCT04330638|516752377|FG001|Overall Study|Other|2|||
143330481|NCT04330638|516752378|FG002|Overall Study|Other|5|||
143330482|NCT04330638|516752379|FG003|Overall Study|Other|1|||
143330483|NCT04330638|516752380|FG004|Overall Study|Other|3|||
143330484|NCT04330638|516752381|FG005|Overall Study|Other|2|||
143330485|NCT04330638|516752376|FG000|Overall Study|Withdrawal by Subject|4|||
143330486|NCT04330638|516752377|FG001|Overall Study|Withdrawal by Subject|0|||
143330487|NCT04330638|516752378|FG002|Overall Study|Withdrawal by Subject|0|||
143330488|NCT04330638|516752379|FG003|Overall Study|Withdrawal by Subject|0|||
143330489|NCT04330638|516752380|FG004|Overall Study|Withdrawal by Subject|0|||
143330490|NCT04330638|516752381|FG005|Overall Study|Withdrawal by Subject|0|||
143330491|NCT04330638|516752376|FG000|Overall Study|Lost to Follow-up|3|||
143330492|NCT04330638|516752377|FG001|Overall Study|Lost to Follow-up|2|||
143330493|NCT04330638|516752378|FG002|Overall Study|Lost to Follow-up|3|||
143330494|NCT04330638|516752379|FG003|Overall Study|Lost to Follow-up|2|||
143330495|NCT04330638|516752380|FG004|Overall Study|Lost to Follow-up|3|||
143330496|NCT04330638|516752381|FG005|Overall Study|Lost to Follow-up|0|||
143330497|NCT02293538|516752382|FG000|Overall Study|Adverse Event|0|||
143330498|NCT02293538|516752383|FG001|Overall Study|Adverse Event|1|||
143330499|NCT02293538|516752382|FG000|Overall Study|Lost to Follow-up|1|||
143330500|NCT02293538|516752383|FG001|Overall Study|Lost to Follow-up|0|||
143330501|NCT02293538|516752382|FG000|Overall Study|Withdrawal by Subject|0|||
143330502|NCT02293538|516752383|FG001|Overall Study|Withdrawal by Subject|1|||
143330503|NCT00322348|516752385|FG000|Overall Study|Adverse Event|0|||
143330504|NCT00322348|516752386|FG001|Overall Study|Adverse Event|1|||
143330505|NCT00322348|516752385|FG000|Overall Study|Withdrawal by Subject|1|||
143330506|NCT00322348|516752386|FG001|Overall Study|Withdrawal by Subject|4|||
143330507|NCT00322348|516752385|FG000|Overall Study|Lost to Follow-up|1|||
143330508|NCT00322348|516752386|FG001|Overall Study|Lost to Follow-up|0|||
143330509|NCT00322348|516752385|FG000|Overall Study|Death|0|||
143330510|NCT00322348|516752386|FG001|Overall Study|Death|2|||
143330511|NCT00322348|516752385|FG000|Overall Study|Disease Progression|30|||
143330512|NCT00322348|516752386|FG001|Overall Study|Disease Progression|25|||
143330513|NCT00322348|516752385|FG000|Overall Study|Reasons not specified|5|||
143330514|NCT00322348|516752386|FG001|Overall Study|Reasons not specified|1|||
143330515|NCT00936858|516752387|FG000|Overall Study|Death|3|||
143330516|NCT00936858|516752387|FG000|Overall Study|Progression|29|||
143330517|NCT00936858|516752387|FG000|Overall Study|Withdrawal by Subject|5|||
143330518|NCT00936858|516752387|FG000|Overall Study|Adverse Event|1|||
143330519|NCT00936858|516752387|FG000|Overall Study|Physician Decision|7|||
143330520|NCT00936858|516752387|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
143330521|NCT00936858|516752387|FG000|Overall Study|Lost to Follow-up|1|||
143330522|NCT00989287|516752399|FG000|Overall Study|Adverse Event|1|||
143330523|NCT00989287|516752400|FG001|Overall Study|Adverse Event|0|||
143330524|NCT00989287|516752399|FG000|Overall Study|Lost to Follow-up|0|||
143330525|NCT00989287|516752400|FG001|Overall Study|Lost to Follow-up|1|||
143330526|NCT02341417|516752401|FG000|Overall Study|Withdrawal by Subject|0|||
143330527|NCT02341417|516752402|FG001|Overall Study|Withdrawal by Subject|2|||
143330528|NCT02341417|516752403|FG002|Overall Study|Withdrawal by Subject|0|||
143330529|NCT02341417|516752401|FG000|Overall Study|Decision by sponsor|2|||
143330530|NCT02341417|516752402|FG001|Overall Study|Decision by sponsor|0|||
143330531|NCT02341417|516752403|FG002|Overall Study|Decision by sponsor|0|||
143330532|NCT02341417|516752401|FG000|Overall Study|Death|0|||
143330533|NCT02341417|516752402|FG001|Overall Study|Death|0|||
143330534|NCT02341417|516752403|FG002|Overall Study|Death|1|||
143330535|NCT01857531|516752417|FG000|Overall Study|Withdrawal by Subject|4|||
143330536|NCT03570619|516752418|FG000|Overall Study|Adverse Event|2|||
143330537|NCT03570619|516752419|FG001|Overall Study|Adverse Event|0|||
143330538|NCT03570619|516752420|FG002|Overall Study|Adverse Event|1|||
143330539|NCT03570619|516752418|FG000|Overall Study|new diagnosis of new malignancy|1|||
143330540|NCT03570619|516752419|FG001|Overall Study|new diagnosis of new malignancy|0|||
143330541|NCT03570619|516752420|FG002|Overall Study|new diagnosis of new malignancy|0|||
143330542|NCT03570619|516752418|FG000|Overall Study|Physician Decision|1|||
143330543|NCT03570619|516752419|FG001|Overall Study|Physician Decision|1|||
143330544|NCT03570619|516752420|FG002|Overall Study|Physician Decision|0|||
143330545|NCT03570619|516752418|FG000|Overall Study|Withdrawal by Subject|0|||
143330546|NCT03570619|516752419|FG001|Overall Study|Withdrawal by Subject|2|||
143330547|NCT03570619|516752420|FG002|Overall Study|Withdrawal by Subject|0|||
143330548|NCT04773587|516752421|FG000|Overall Study|Lost to Follow-up|11|||
143330549|NCT04773587|516752422|FG001|Overall Study|Lost to Follow-up|3|||
143330550|NCT04773587|516752421|FG000|Overall Study|Adverse Event|6|||
143330551|NCT04773587|516752422|FG001|Overall Study|Adverse Event|3|||
143330552|NCT04773587|516752421|FG000|Overall Study|Lack of Efficacy|5|||
143330553|NCT04773587|516752422|FG001|Overall Study|Lack of Efficacy|2|||
143330554|NCT04773587|516752421|FG000|Overall Study|Withdrawal by Subject|4|||
143330555|NCT04773587|516752422|FG001|Overall Study|Withdrawal by Subject|5|||
143330556|NCT04773587|516752421|FG000|Overall Study|Noncompliance|1|||
143330557|NCT04773587|516752422|FG001|Overall Study|Noncompliance|0|||
143330558|NCT04773587|516752421|FG000|Overall Study|Protocol Violation|1|||
143330559|NCT04773587|516752422|FG001|Overall Study|Protocol Violation|0|||
143330560|NCT04773587|516752421|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
143330561|NCT04773587|516752422|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
143330562|NCT04656847|516752423|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
143330563|NCT03301051|516752424|FG000|Overall Study|Adverse Event|0|||
143330564|NCT03301051|516752425|FG001|Overall Study|Adverse Event|4|||
143330565|NCT03301051|516752424|FG000|Overall Study|Withdrawal by Subject|59|||
143330566|NCT03301051|516752425|FG001|Overall Study|Withdrawal by Subject|65|||
143330567|NCT03301051|516752424|FG000|Overall Study|Lost to Follow-up|263|||
143330568|NCT03301051|516752425|FG001|Overall Study|Lost to Follow-up|282|||
143330569|NCT03301051|516752424|FG000|Overall Study|Protocol Violation|1|||
143330570|NCT03301051|516752425|FG001|Overall Study|Protocol Violation|3|||
143330571|NCT03301051|516752424|FG000|Overall Study|Physician Decision|1|||
143330572|NCT03301051|516752425|FG001|Overall Study|Physician Decision|3|||
143330573|NCT03301051|516752424|FG000|Overall Study|Death|1|||
143330574|NCT03301051|516752425|FG001|Overall Study|Death|1|||
143330575|NCT03301051|516752424|FG000|Overall Study|Miscellaneous|8|||
143330576|NCT03301051|516752425|FG001|Overall Study|Miscellaneous|4|||
143330577|NCT03301051|516752424|FG000|Overall Study|Randomized, not vaccinated|13|||
143330578|NCT03301051|516752425|FG001|Overall Study|Randomized, not vaccinated|10|||
143330579|NCT00622167|516752426|FG000|Overall Study|Did not meet angiographic criteria|20|||
143330580|NCT03336619|516752427|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
143330581|NCT03336619|516752428|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
143330582|NCT03336619|516752427|FG000|Overall Study|Withdrawal by Subject|17|||
143330583|NCT03336619|516752428|FG001|Overall Study|Withdrawal by Subject|16|||
143330584|NCT03336619|516752427|FG000|Overall Study|Adverse Event|2|||
143330585|NCT03336619|516752428|FG001|Overall Study|Adverse Event|5|||
143330586|NCT03336619|516752427|FG000|Overall Study|Physician Decision|3|||
143330587|NCT03336619|516752428|FG001|Overall Study|Physician Decision|0|||
143330588|NCT02820623|516752429|FG000|Overall Study|Withdrawal by Subject|1|||
143330589|NCT02820623|516752430|FG001|Overall Study|Withdrawal by Subject|3|||
143330590|NCT02820623|516752431|FG002|Overall Study|Withdrawal by Subject|3|||
143330591|NCT02820623|516752429|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
143330592|NCT02820623|516752430|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
143330593|NCT02820623|516752431|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
143330594|NCT02820623|516752429|FG000|Overall Study|Therapist unable to enroll clients|1|||
143330595|NCT02820623|516752430|FG001|Overall Study|Therapist unable to enroll clients|1|||
143330596|NCT02820623|516752431|FG002|Overall Study|Therapist unable to enroll clients|3|||
143330597|NCT02820623|516752429|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
143330598|NCT02820623|516752430|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
143330599|NCT02820623|516752431|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
143330600|NCT04598152|516752443|FG000|Overall Study|Lost to Follow-up|0|||
143330601|NCT04598152|516752444|FG001|Overall Study|Lost to Follow-up|1|||
143330602|NCT03077724|516752447|FG000|Overall Study|Lost to Follow-up|5|||
143330603|NCT03077724|516752448|FG001|Overall Study|Lost to Follow-up|1|||
143330604|NCT03077724|516752447|FG000|Overall Study|Withdrawal by Subject|3|||
143330605|NCT03077724|516752448|FG001|Overall Study|Withdrawal by Subject|1|||
143330606|NCT00234065|516752449|FG000|Overall Study|Adverse Event|268|||
143330607|NCT00234065|516752450|FG001|Overall Study|Adverse Event|166|||
143330608|NCT00234065|516752449|FG000|Overall Study|Withdrawal by Subject|73|||
143330609|NCT00234065|516752450|FG001|Overall Study|Withdrawal by Subject|56|||
143330610|NCT00234065|516752449|FG000|Overall Study|Physician Decision|23|||
143330611|NCT00234065|516752450|FG001|Overall Study|Physician Decision|22|||
143330612|NCT00234065|516752449|FG000|Overall Study|Not Classified|111|||
143330613|NCT00234065|516752450|FG001|Overall Study|Not Classified|112|||
143330614|NCT02313428|516752451|FG000|Overall Study|Lost to Follow-up|1|||
143330615|NCT02313428|516752452|FG001|Overall Study|Lost to Follow-up|1|||
143330616|NCT05374421|516752453|FG000|Overall Study|Withdrawal by Subject|3|||
143330617|NCT05374421|516752454|FG001|Overall Study|Withdrawal by Subject|4|||
143330618|NCT02979639|516754265|FG000|Overall Study|Withdrawal based on medical judgement|1|||
143330619|NCT02979639|516754265|FG000|Overall Study|Lost to Follow-up|8|||
143330620|NCT02979639|516754265|FG000|Overall Study|Withdrawal by Subject|3|||
143330621|NCT02979639|516754265|FG000|Overall Study|Adverse Event|2|||
143330622|NCT00955357|516754267|FG000|Titration Phase|Adverse Event|9|||
143330623|NCT00955357|516754268|FG001|Titration Phase|Adverse Event|46|||
143330624|NCT00955357|516754267|FG000|Titration Phase|Lack of Efficacy|0|||
143330625|NCT00955357|516754268|FG001|Titration Phase|Lack of Efficacy|2|||
143330626|NCT00955357|516754267|FG000|Titration Phase|Protocol Violation|3|||
143330627|NCT00955357|516754268|FG001|Titration Phase|Protocol Violation|7|||
143330628|NCT00955357|516754267|FG000|Titration Phase|Lost to Follow-up|1|||
143383096|NCT03584516|516948401|FG005|Part 1|Lost to Follow-up|0|||
143383097|NCT03584516|516948396|FG000|Part 1|Study Terminated by Sponsor|0|||
143383098|NCT03584516|516948397|FG001|Part 1|Study Terminated by Sponsor|2|||
143383099|NCT03584516|516948398|FG002|Part 1|Study Terminated by Sponsor|0|||
143383100|NCT03584516|516948399|FG003|Part 1|Study Terminated by Sponsor|0|||
143383101|NCT03584516|516948400|FG004|Part 1|Study Terminated by Sponsor|0|||
143383102|NCT03584516|516948401|FG005|Part 1|Study Terminated by Sponsor|0|||
143383103|NCT03584516|516948396|FG000|Part 1 Expansion|Death|0|||
143383104|NCT03584516|516948397|FG001|Part 1 Expansion|Death|0|||
143383105|NCT03584516|516948398|FG002|Part 1 Expansion|Death|9|||
143383106|NCT03584516|516948399|FG003|Part 1 Expansion|Death|8|||
143383107|NCT03584516|516948400|FG004|Part 1 Expansion|Death|4|||
143383108|NCT03584516|516948401|FG005|Part 1 Expansion|Death|5|||
143383109|NCT03584516|516948396|FG000|Part 1 Expansion|Lost to Follow-up|0|||
143383110|NCT03584516|516948397|FG001|Part 1 Expansion|Lost to Follow-up|0|||
143383111|NCT03584516|516948398|FG002|Part 1 Expansion|Lost to Follow-up|0|||
143383112|NCT03584516|516948399|FG003|Part 1 Expansion|Lost to Follow-up|1|||
143383113|NCT03584516|516948400|FG004|Part 1 Expansion|Lost to Follow-up|0|||
143383114|NCT03584516|516948401|FG005|Part 1 Expansion|Lost to Follow-up|0|||
143383115|NCT03584516|516948396|FG000|Part 1 Expansion|Physician Decision|0|||
143383116|NCT03584516|516948397|FG001|Part 1 Expansion|Physician Decision|0|||
143383117|NCT03584516|516948398|FG002|Part 1 Expansion|Physician Decision|4|||
143383118|NCT03584516|516948399|FG003|Part 1 Expansion|Physician Decision|3|||
143383119|NCT03584516|516948400|FG004|Part 1 Expansion|Physician Decision|2|||
143383120|NCT03584516|516948401|FG005|Part 1 Expansion|Physician Decision|3|||
143383121|NCT03584516|516948396|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
143383122|NCT03584516|516948397|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
143383123|NCT03584516|516948398|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
143383124|NCT03584516|516948399|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
143383125|NCT03584516|516948400|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
143383126|NCT03584516|516948401|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
143383127|NCT03584516|516948396|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
143383128|NCT03584516|516948397|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
143383129|NCT03584516|516948398|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
143383130|NCT03584516|516948399|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
143383131|NCT03584516|516948400|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
143383132|NCT03584516|516948401|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
143383133|NCT03584516|516948396|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
143383134|NCT03584516|516948397|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
143383135|NCT03584516|516948398|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
143383136|NCT03584516|516948399|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
143383137|NCT03584516|516948400|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
143383138|NCT03584516|516948401|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
143383139|NCT03584516|516948396|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
143383140|NCT03584516|516948397|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
143383141|NCT03584516|516948398|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
143383142|NCT03584516|516948399|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
143383143|NCT03584516|516948400|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
143383144|NCT03584516|516948401|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
143383145|NCT05986565|516948402|FG000|Overall Study|Lost to Follow-up|8|||
143383146|NCT05986565|516948403|FG001|Overall Study|Lost to Follow-up|3|||
143383147|NCT05986565|516948402|FG000|Overall Study|Withdrawal by Subject|0|||
143383148|NCT05986565|516948403|FG001|Overall Study|Withdrawal by Subject|1|||
143383149|NCT00670046|516948406|FG000|Overall Study|Lost to Follow-up|1|||
143383150|NCT00670046|516948407|FG001|Overall Study|Lost to Follow-up|1|||
143383151|NCT00670046|516948406|FG000|Overall Study|Withdrawal by Subject|0|||
143383152|NCT00670046|516948407|FG001|Overall Study|Withdrawal by Subject|1|||
143383153|NCT00505934|516948415|FG000|Overall Study|Adverse Event|1|||
143383154|NCT00505934|516948415|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
143383155|NCT00505934|516948415|FG000|Overall Study|Other: IV dose needed to be changed|1|||
143383156|NCT02015520|516948420|FG000|Overall Study|Lack of Efficacy|1|||
143383157|NCT02015520|516948421|FG001|Overall Study|Lack of Efficacy|0|||
143383158|NCT02015520|516948422|FG002|Overall Study|Lack of Efficacy|3|||
143383159|NCT02015520|516948423|FG003|Overall Study|Lack of Efficacy|2|||
143383160|NCT02015520|516948420|FG000|Overall Study|Adverse Event|0|||
143383161|NCT02015520|516948421|FG001|Overall Study|Adverse Event|0|||
143383162|NCT02015520|516948422|FG002|Overall Study|Adverse Event|0|||
143383163|NCT02015520|516948423|FG003|Overall Study|Adverse Event|1|||
143383164|NCT02015520|516948420|FG000|Overall Study|Withdrawal by Subject|2|||
143383165|NCT02015520|516948421|FG001|Overall Study|Withdrawal by Subject|2|||
143383166|NCT02015520|516948422|FG002|Overall Study|Withdrawal by Subject|1|||
143383167|NCT02015520|516948423|FG003|Overall Study|Withdrawal by Subject|0|||
143383168|NCT02015520|516948420|FG000|Overall Study|Death|1|||
143383169|NCT02015520|516948421|FG001|Overall Study|Death|0|||
143383170|NCT02015520|516948422|FG002|Overall Study|Death|0|||
143330629|NCT00955357|516754268|FG001|Titration Phase|Lost to Follow-up|3|||
143330630|NCT00955357|516754267|FG000|Titration Phase|Withdrawal by Subject|3|||
143330631|NCT00955357|516754268|FG001|Titration Phase|Withdrawal by Subject|5|||
143330632|NCT00955357|516754267|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
143330633|NCT00955357|516754268|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
143383171|NCT02015520|516948423|FG003|Overall Study|Death|0|||
143383172|NCT02015520|516948420|FG000|Overall Study|Lost to Follow-up|0|||
143383173|NCT02015520|516948421|FG001|Overall Study|Lost to Follow-up|0|||
143383174|NCT02015520|516948422|FG002|Overall Study|Lost to Follow-up|1|||
143383175|NCT02015520|516948423|FG003|Overall Study|Lost to Follow-up|0|||
143383176|NCT02015520|516948420|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
143383177|NCT02015520|516948421|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
143383178|NCT02015520|516948422|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
143383179|NCT02015520|516948423|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
143383180|NCT02015520|516948420|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
143383181|NCT02015520|516948421|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
143383182|NCT02015520|516948422|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
143383183|NCT02015520|516948423|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
143383184|NCT01610297|516948424|FG000|Overall Study|Lost to Follow-up|1|||
143383185|NCT02590432|516948428|FG000|Open-label Treatment Period|Adverse Event|97|||
143383186|NCT02590432|516948429|FG001|Open-label Treatment Period|Adverse Event|79|||
143383187|NCT02590432|516948430|FG002|Open-label Treatment Period|Adverse Event|0|||
143383188|NCT02590432|516948431|FG003|Open-label Treatment Period|Adverse Event|0|||
143383189|NCT02590432|516948432|FG004|Open-label Treatment Period|Adverse Event|0|||
143383190|NCT02590432|516948433|FG005|Open-label Treatment Period|Adverse Event|0|||
143383191|NCT02590432|516948434|FG006|Open-label Treatment Period|Adverse Event|0|||
143383192|NCT02590432|516948435|FG007|Open-label Treatment Period|Adverse Event|0|||
143383193|NCT02590432|516948436|FG008|Open-label Treatment Period|Adverse Event|0|||
143383194|NCT02590432|516948428|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
143383195|NCT02590432|516948429|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
143383196|NCT02590432|516948430|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
143383197|NCT02590432|516948431|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
143383198|NCT02590432|516948432|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
143383199|NCT02590432|516948433|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
143383200|NCT02590432|516948434|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
143383201|NCT02590432|516948435|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
143383202|NCT02590432|516948436|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
143383203|NCT02590432|516948428|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
143383204|NCT02590432|516948429|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
143383205|NCT02590432|516948430|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
143383206|NCT02590432|516948431|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
143383207|NCT02590432|516948432|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
143383208|NCT02590432|516948433|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
143383209|NCT02590432|516948434|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
143383210|NCT02590432|516948435|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
143383211|NCT02590432|516948436|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
143383212|NCT02590432|516948428|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
143383213|NCT02590432|516948429|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
143383214|NCT02590432|516948430|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
143383215|NCT02590432|516948431|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
143383216|NCT02590432|516948432|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
143383217|NCT02590432|516948433|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
143383218|NCT02590432|516948434|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
143383219|NCT02590432|516948435|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
143383220|NCT02590432|516948436|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
143383221|NCT02590432|516948428|FG000|Open-label Treatment Period|Protocol Violation|10|||
143383222|NCT02590432|516948429|FG001|Open-label Treatment Period|Protocol Violation|4|||
143383223|NCT02590432|516948430|FG002|Open-label Treatment Period|Protocol Violation|0|||
143383224|NCT02590432|516948431|FG003|Open-label Treatment Period|Protocol Violation|0|||
143383225|NCT02590432|516948432|FG004|Open-label Treatment Period|Protocol Violation|0|||
143383226|NCT02590432|516948433|FG005|Open-label Treatment Period|Protocol Violation|0|||
143383227|NCT02590432|516948434|FG006|Open-label Treatment Period|Protocol Violation|0|||
143383228|NCT02590432|516948435|FG007|Open-label Treatment Period|Protocol Violation|0|||
143383229|NCT02590432|516948436|FG008|Open-label Treatment Period|Protocol Violation|0|||
143383230|NCT02590432|516948428|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
143383231|NCT02590432|516948429|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
143383232|NCT02590432|516948430|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
143383233|NCT02590432|516948431|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
143383234|NCT02590432|516948432|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
143383235|NCT02590432|516948433|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
143383236|NCT02590432|516948434|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
143383237|NCT02590432|516948435|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
143383238|NCT02590432|516948436|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
143383239|NCT02590432|516948428|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
143330634|NCT00955357|516754267|FG000|Titration Phase|Study medication not tolerated|0|||
143330635|NCT00955357|516754268|FG001|Titration Phase|Study medication not tolerated|1|||
143330636|NCT00955357|516754267|FG000|Titration Phase|Non compliance to study procedures|0|||
143330637|NCT00955357|516754268|FG001|Titration Phase|Non compliance to study procedures|1|||
143330638|NCT00955357|516754267|FG000|Maintenance Phase|Adverse Event|3|||
143330639|NCT00955357|516754268|FG001|Maintenance Phase|Adverse Event|23|||
143330640|NCT00955357|516754267|FG000|Maintenance Phase|Lack of Efficacy|0|||
143330641|NCT00955357|516754268|FG001|Maintenance Phase|Lack of Efficacy|4|||
143330642|NCT00955357|516754267|FG000|Maintenance Phase|Protocol Violation|2|||
143330643|NCT00955357|516754268|FG001|Maintenance Phase|Protocol Violation|6|||
143330644|NCT00955357|516754267|FG000|Maintenance Phase|Lost to Follow-up|2|||
143330645|NCT00955357|516754268|FG001|Maintenance Phase|Lost to Follow-up|7|||
143330646|NCT00955357|516754267|FG000|Maintenance Phase|Withdrawal by Subject|4|||
143330647|NCT00955357|516754268|FG001|Maintenance Phase|Withdrawal by Subject|4|||
143330648|NCT00955357|516754267|FG000|Maintenance Phase|Patient moving out of area|0|||
143330649|NCT00955357|516754268|FG001|Maintenance Phase|Patient moving out of area|1|||
143330650|NCT00955357|516754267|FG000|Maintenance Phase|Non compliance to study procedures|1|||
143330651|NCT00955357|516754268|FG001|Maintenance Phase|Non compliance to study procedures|0|||
143330652|NCT01258608|516754269|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
143330653|NCT01258608|516754270|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
143330654|NCT01258608|516754269|FG000|Overall Study|Clinical progression|1|||
143330655|NCT01258608|516754270|FG001|Overall Study|Clinical progression|0|||
143330656|NCT01258608|516754269|FG000|Overall Study|Sponsor decision|0|||
143330657|NCT01258608|516754270|FG001|Overall Study|Sponsor decision|1|||
143330658|NCT01258608|516754269|FG000|Overall Study|Physician Decision|6|||
143330659|NCT01258608|516754270|FG001|Overall Study|Physician Decision|1|||
143330660|NCT01258608|516754269|FG000|Overall Study|Lost to Follow-up|0|||
143330661|NCT01258608|516754270|FG001|Overall Study|Lost to Follow-up|1|||
143330662|NCT01258608|516754269|FG000|Overall Study|Lack of compliance|1|||
143330663|NCT01258608|516754270|FG001|Overall Study|Lack of compliance|0|||
143330664|NCT01258608|516754269|FG000|Overall Study|Lack of Efficacy|0|||
143330665|NCT01258608|516754270|FG001|Overall Study|Lack of Efficacy|1|||
143330666|NCT01258608|516754269|FG000|Overall Study|Adverse Event|6|||
143330667|NCT01258608|516754270|FG001|Overall Study|Adverse Event|10|||
143330668|NCT01258608|516754269|FG000|Overall Study|Withdrawal by Subject|6|||
143330669|NCT01258608|516754270|FG001|Overall Study|Withdrawal by Subject|5|||
143330670|NCT02943408|516754280|FG000|Overall Study|Lost to Follow-up|7|||
143330671|NCT02943408|516754281|FG001|Overall Study|Lost to Follow-up|1|||
143330672|NCT02943408|516754280|FG000|Overall Study|Withdrawal by Subject|0|||
143330673|NCT02943408|516754281|FG001|Overall Study|Withdrawal by Subject|1|||
143330674|NCT01949311|516754284|FG000|Overall Study|Lost to Follow-up|73|||
143330675|NCT01949311|516754284|FG000|Overall Study|Terminated by Sponsor|708|||
143330676|NCT01949311|516754284|FG000|Overall Study|Withdrawal by Subject|375|||
143330677|NCT01949311|516754284|FG000|Overall Study|Lack of Efficacy|50|||
143330678|NCT01949311|516754284|FG000|Overall Study|Protocol Deviation|34|||
143330679|NCT01949311|516754284|FG000|Overall Study|Pregnancy|20|||
143330680|NCT01949311|516754284|FG000|Overall Study|Physician Decision|9|||
143330681|NCT01949311|516754284|FG000|Overall Study|Other|4|||
143330682|NCT01949311|516754284|FG000|Overall Study|Adverse Event|107|||
143330683|NCT02314624|516754285|FG000|Overall Study|No participating patient|16|||
143330684|NCT02314624|516754286|FG001|Overall Study|No participating patient|13|||
143330685|NCT02314624|516754285|FG000|Overall Study|Participant withdrew|7|||
143330686|NCT02314624|516754286|FG001|Overall Study|Participant withdrew|2|||
143330687|NCT02314624|516754285|FG000|Overall Study|Lost to Follow-up|2|||
143330688|NCT02314624|516754286|FG001|Overall Study|Lost to Follow-up|5|||
143330689|NCT02314624|516754285|FG000|Overall Study|Dropped/Excluded by PI|6|||
143330690|NCT02314624|516754286|FG001|Overall Study|Dropped/Excluded by PI|6|||
143330691|NCT00713648|516754287|FG000|Overall Study|Adverse Event|1|||
143383240|NCT02590432|516948429|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
143383241|NCT02590432|516948430|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
143383242|NCT02590432|516948431|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
143383243|NCT02590432|516948432|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
143383244|NCT02590432|516948433|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
143383245|NCT02590432|516948434|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
143383246|NCT02590432|516948435|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
143383247|NCT02590432|516948436|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
143383248|NCT02590432|516948428|FG000|Double-blind Treatment Period|Adverse Event|0|||
143383249|NCT02590432|516948429|FG001|Double-blind Treatment Period|Adverse Event|0|||
143383250|NCT02590432|516948430|FG002|Double-blind Treatment Period|Adverse Event|14|||
143383251|NCT02590432|516948431|FG003|Double-blind Treatment Period|Adverse Event|12|||
143383252|NCT02590432|516948432|FG004|Double-blind Treatment Period|Adverse Event|6|||
143383253|NCT02590432|516948433|FG005|Double-blind Treatment Period|Adverse Event|22|||
143383254|NCT02590432|516948434|FG006|Double-blind Treatment Period|Adverse Event|20|||
143383255|NCT02590432|516948435|FG007|Double-blind Treatment Period|Adverse Event|0|||
143383256|NCT02590432|516948436|FG008|Double-blind Treatment Period|Adverse Event|0|||
143383257|NCT02590432|516948428|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
143383258|NCT02590432|516948429|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
143383259|NCT02590432|516948430|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
143383260|NCT02590432|516948431|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
143383261|NCT02590432|516948432|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
143383262|NCT02590432|516948433|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
143383263|NCT02590432|516948434|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
143383264|NCT02590432|516948435|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
143383265|NCT02590432|516948436|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
143383266|NCT02590432|516948428|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
143383267|NCT02590432|516948429|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
143383268|NCT02590432|516948430|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
143383269|NCT02590432|516948431|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
143383270|NCT02590432|516948432|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
143383271|NCT02590432|516948433|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
143383272|NCT02590432|516948434|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
143383273|NCT02590432|516948435|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
143383274|NCT02590432|516948436|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
143383275|NCT02590432|516948428|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
143383276|NCT02590432|516948429|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
143383277|NCT02590432|516948430|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
143383278|NCT02590432|516948431|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
143383279|NCT02590432|516948432|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
143383280|NCT02590432|516948433|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
143383281|NCT02590432|516948434|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
143383282|NCT02590432|516948435|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
143383283|NCT02590432|516948436|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
143383284|NCT02590432|516948428|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
143383285|NCT02590432|516948429|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
143383286|NCT02590432|516948430|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
143383287|NCT02590432|516948431|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
143383288|NCT02590432|516948432|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
143383289|NCT02590432|516948433|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
143383290|NCT02590432|516948434|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
143383291|NCT02590432|516948435|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
143383292|NCT02590432|516948436|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
143383293|NCT02590432|516948428|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
143383294|NCT02590432|516948429|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
143383295|NCT02590432|516948430|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
143383296|NCT02590432|516948431|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
143383297|NCT02590432|516948432|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
143383298|NCT02590432|516948433|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
143383299|NCT02590432|516948434|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
143383300|NCT02590432|516948435|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
143383301|NCT02590432|516948436|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
143330692|NCT00713648|516754287|FG000|Overall Study|Unclassified|2|||
143330693|NCT00713648|516754287|FG000|Overall Study|According to Protocol|2|||
143330694|NCT00713648|516754287|FG000|Overall Study|Development of antibodies|3|||
143383302|NCT02590432|516948428|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
143383303|NCT02590432|516948429|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
143383304|NCT02590432|516948430|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
143383305|NCT02590432|516948431|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
143383306|NCT02590432|516948432|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
143383307|NCT02590432|516948433|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
143383308|NCT02590432|516948434|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
143383309|NCT02590432|516948435|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
143383310|NCT02590432|516948436|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
143383311|NCT02590432|516948428|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
143383312|NCT02590432|516948429|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
143383313|NCT02590432|516948430|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
143383314|NCT02590432|516948431|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
143383315|NCT02590432|516948432|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
143383316|NCT02590432|516948433|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
143383317|NCT02590432|516948434|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
143383318|NCT02590432|516948435|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
143383319|NCT02590432|516948436|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
143383320|NCT02590432|516948428|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
143383321|NCT02590432|516948429|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
143383322|NCT02590432|516948430|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
143383323|NCT02590432|516948431|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
143383324|NCT02590432|516948432|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
143383325|NCT02590432|516948433|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
143383326|NCT02590432|516948434|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
143383327|NCT02590432|516948435|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
143383328|NCT02590432|516948436|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
143383329|NCT02590432|516948428|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
143383330|NCT02590432|516948429|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
143383331|NCT02590432|516948430|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
143383332|NCT02590432|516948431|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
143383333|NCT02590432|516948432|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
143383334|NCT02590432|516948433|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
143383335|NCT02590432|516948434|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
143383336|NCT02590432|516948435|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
143383337|NCT02590432|516948436|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
143383338|NCT02590432|516948428|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
143383339|NCT02590432|516948429|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
143383340|NCT02590432|516948430|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
143383341|NCT02590432|516948431|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
143383342|NCT02590432|516948432|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
143383343|NCT02590432|516948433|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
143383344|NCT02590432|516948434|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
143383345|NCT02590432|516948435|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
143383346|NCT02590432|516948436|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
143383347|NCT02590432|516948428|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
143383348|NCT02590432|516948429|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
143383349|NCT02590432|516948430|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
143383350|NCT02590432|516948431|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
143383351|NCT02590432|516948432|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
143383352|NCT02590432|516948433|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
143383353|NCT02590432|516948434|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
143383354|NCT02590432|516948435|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
143383355|NCT02590432|516948436|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
143383356|NCT02006758|516948437|FG000|Overall Study|Protocol Violation|1|||
143383357|NCT02006758|516948437|FG000|Overall Study|Death|1|||
143383358|NCT02006758|516948437|FG000|Overall Study|Lost to Follow-up|4|||
143383359|NCT02006758|516948437|FG000|Overall Study|Withdrawal by Subject|4|||
143383360|NCT02006758|516948437|FG000|Overall Study|Procedurally excluded|1|||
143383361|NCT02006758|516948437|FG000|Overall Study|Other|2|||
143383362|NCT01619410|516948438|FG000|Overall Study|Lost to Follow-up|7|||
143383363|NCT01619410|516948439|FG001|Overall Study|Lost to Follow-up|4|||
143383364|NCT01771731|516948447|FG000|Overall Study|Physician Decision|1|||
143383365|NCT01771731|516948448|FG001|Overall Study|Physician Decision|0|||
143383366|NCT01771731|516948447|FG000|Overall Study|Protocol Violation|0|||
143383367|NCT01771731|516948448|FG001|Overall Study|Protocol Violation|1|||
143383368|NCT01771731|516948447|FG000|Overall Study|Adverse event: Pain Crisis|1|||
143383369|NCT01771731|516948448|FG001|Overall Study|Adverse event: Pain Crisis|1|||
143383370|NCT00976495|516948449|FG000|Overall Study|Withdrawal by Subject|0|||
143383371|NCT00976495|516948450|FG001|Overall Study|Withdrawal by Subject|1|||
143383372|NCT00976495|516948451|FG002|Overall Study|Withdrawal by Subject|0|||
143383373|NCT02272816|516948452|FG000|Overall Study|Adverse Event|1|||
143383374|NCT04048382|516948456|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
143383375|NCT04048382|516948457|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
143383376|NCT04048382|516948456|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
143383377|NCT04048382|516948457|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
143383378|NCT04048382|516948456|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
143383379|NCT04048382|516948457|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
143383380|NCT02269475|516948459|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
143383381|NCT02269475|516948460|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
143383382|NCT02269475|516948459|FG000|Overall Study|Withdrawal by Subject|0|||
143383383|NCT02269475|516948460|FG001|Overall Study|Withdrawal by Subject|1|||
143383384|NCT01037985|516948461|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
143383385|NCT01037985|516948462|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
143383386|NCT01037985|516948461|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
143383387|NCT01037985|516948462|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
143383388|NCT01037985|516948461|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
143383389|NCT01037985|516948462|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
143383390|NCT01037985|516948461|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
143383391|NCT01037985|516948462|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
143383392|NCT03481816|516948463|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
143383393|NCT03481816|516948464|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
143383394|NCT03481816|516948463|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
143383395|NCT03481816|516948464|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
143383396|NCT03481816|516948463|FG000|Dose Expansion|Withdrawal by Subject|0|||
143383397|NCT03481816|516948464|FG001|Dose Expansion|Withdrawal by Subject|2|||
143383398|NCT03481816|516948463|FG000|Dose Expansion|Physician Decision|0|||
143383399|NCT03481816|516948464|FG001|Dose Expansion|Physician Decision|5|||
143383400|NCT06024174|516948465|FG000|Overall Study|Other Reasons|1|||
143383401|NCT06024174|516948465|FG000|Overall Study|Study terminated by Sponsor|4|||
143383402|NCT04994509|516948466|FG000|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1909|||
143383403|NCT04994509|516948467|FG001|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1910|||
143383404|NCT04994509|516948468|FG002|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|937|||
143383405|NCT04994509|516948466|FG000|Overall Study|Withdrew Consent|73|||
143383406|NCT04994509|516948467|FG001|Overall Study|Withdrew Consent|72|||
143383407|NCT04994509|516948468|FG002|Overall Study|Withdrew Consent|46|||
143383408|NCT04994509|516948466|FG000|Overall Study|Lost to Follow-up|39|||
143383409|NCT04994509|516948467|FG001|Overall Study|Lost to Follow-up|36|||
143383410|NCT04994509|516948468|FG002|Overall Study|Lost to Follow-up|26|||
143383411|NCT04994509|516948466|FG000|Overall Study|HIV-1 Infection|4|||
143383412|NCT04994509|516948467|FG001|Overall Study|HIV-1 Infection|20|||
143383413|NCT04994509|516948468|FG002|Overall Study|HIV-1 Infection|12|||
143383414|NCT04994509|516948466|FG000|Overall Study|Investigator's Discretion|9|||
143383415|NCT04994509|516948467|FG001|Overall Study|Investigator's Discretion|8|||
143383416|NCT04994509|516948468|FG002|Overall Study|Investigator's Discretion|11|||
143383417|NCT04994509|516948466|FG000|Overall Study|Randomized but Never Treated|10|||
143383418|NCT04994509|516948467|FG001|Overall Study|Randomized but Never Treated|10|||
143383419|NCT04994509|516948468|FG002|Overall Study|Randomized but Never Treated|3|||
143383420|NCT04994509|516948466|FG000|Overall Study|Pregnancy|5|||
143383421|NCT04994509|516948467|FG001|Overall Study|Pregnancy|5|||
143383422|NCT04994509|516948468|FG002|Overall Study|Pregnancy|0|||
143383423|NCT04994509|516948466|FG000|Overall Study|Death|0|||
143383424|NCT04994509|516948467|FG001|Overall Study|Death|5|||
143383425|NCT04994509|516948468|FG002|Overall Study|Death|0|||
143383426|NCT04994509|516948466|FG000|Overall Study|Adverse Event|2|||
143383427|NCT04994509|516948467|FG001|Overall Study|Adverse Event|1|||
143383428|NCT04994509|516948468|FG002|Overall Study|Adverse Event|0|||
143383429|NCT04994509|516948466|FG000|Overall Study|Non-compliance With Study Drug|1|||
143383430|NCT04994509|516948467|FG001|Overall Study|Non-compliance With Study Drug|1|||
143383431|NCT04994509|516948468|FG002|Overall Study|Non-compliance With Study Drug|1|||
143383432|NCT04994509|516948466|FG000|Overall Study|Withdrew Assent|3|||
143383433|NCT04994509|516948467|FG001|Overall Study|Withdrew Assent|0|||
143383434|NCT04994509|516948468|FG002|Overall Study|Withdrew Assent|0|||
143383435|NCT04994509|516948466|FG000|Overall Study|Protocol Violation|1|||
143383436|NCT04994509|516948467|FG001|Overall Study|Protocol Violation|0|||
143383437|NCT04994509|516948468|FG002|Overall Study|Protocol Violation|0|||
143383438|NCT04402294|516948470|FG000|Washout (at Least 7 Days)|Withdrawal by Subject|1|||
143383439|NCT04402294|516948471|FG001|Washout (at Least 7 Days)|Withdrawal by Subject|0|||
143383440|NCT04402294|516948470|FG000|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|0|||
143383441|NCT04402294|516948471|FG001|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|1|||
143383442|NCT04459416|516950172|FG000|Overall Study|Lost to Follow-up|2|||
143383443|NCT04459416|516950173|FG001|Overall Study|Lost to Follow-up|0|||
143383444|NCT04459416|516950172|FG000|Overall Study|Withdrawal by Subject|8|||
143383445|NCT04459416|516950173|FG001|Overall Study|Withdrawal by Subject|10|||
143383446|NCT04459416|516950172|FG000|Overall Study|Disease progression|0|||
143383447|NCT04459416|516950173|FG001|Overall Study|Disease progression|3|||
143383448|NCT05134337|516950174|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
143383449|NCT05134337|516950175|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
143383450|NCT03725722|516950176|FG000|Overall Study|Lack of Efficacy|2|||
143383451|NCT03725722|516950177|FG001|Overall Study|Lack of Efficacy|1|||
143383452|NCT03725722|516950178|FG002|Overall Study|Lack of Efficacy|2|||
143383453|NCT03725722|516950179|FG003|Overall Study|Lack of Efficacy|0|||
143383454|NCT03725722|516950180|FG004|Overall Study|Lack of Efficacy|2|||
143383455|NCT03725722|516950176|FG000|Overall Study|Adverse Event|2|||
143383456|NCT03725722|516950177|FG001|Overall Study|Adverse Event|2|||
143383457|NCT03725722|516950178|FG002|Overall Study|Adverse Event|1|||
143383458|NCT03725722|516950179|FG003|Overall Study|Adverse Event|0|||
143383459|NCT03725722|516950180|FG004|Overall Study|Adverse Event|6|||
143383460|NCT03725722|516950176|FG000|Overall Study|Withdrawal by Subject|4|||
143383461|NCT03725722|516950177|FG001|Overall Study|Withdrawal by Subject|1|||
143383462|NCT03725722|516950178|FG002|Overall Study|Withdrawal by Subject|0|||
143383463|NCT03725722|516950179|FG003|Overall Study|Withdrawal by Subject|4|||
143383464|NCT03725722|516950180|FG004|Overall Study|Withdrawal by Subject|4|||
143383465|NCT03725722|516950176|FG000|Overall Study|Lost to Follow-up|3|||
143383466|NCT03725722|516950177|FG001|Overall Study|Lost to Follow-up|1|||
143383467|NCT03725722|516950178|FG002|Overall Study|Lost to Follow-up|2|||
143383468|NCT03725722|516950179|FG003|Overall Study|Lost to Follow-up|2|||
143383469|NCT03725722|516950180|FG004|Overall Study|Lost to Follow-up|1|||
143383470|NCT03725722|516950176|FG000|Overall Study|Personal reasons|0|||
143383471|NCT03725722|516950177|FG001|Overall Study|Personal reasons|0|||
143383472|NCT03725722|516950178|FG002|Overall Study|Personal reasons|1|||
143383473|NCT03725722|516950179|FG003|Overall Study|Personal reasons|0|||
143383474|NCT03725722|516950180|FG004|Overall Study|Personal reasons|1|||
143383475|NCT03725722|516950176|FG000|Overall Study|COVID-19 situation|0|||
143383476|NCT03725722|516950177|FG001|Overall Study|COVID-19 situation|1|||
143383477|NCT03725722|516950178|FG002|Overall Study|COVID-19 situation|0|||
143383478|NCT03725722|516950179|FG003|Overall Study|COVID-19 situation|0|||
143330695|NCT00082173|516754288|FG000|Overall Study|Withdrawal by Subject|3|||
143330696|NCT00082173|516754289|FG001|Overall Study|Withdrawal by Subject|5|||
143330697|NCT00082173|516754288|FG000|Overall Study|Lost to Follow-up|1|||
143330698|NCT00082173|516754289|FG001|Overall Study|Lost to Follow-up|0|||
143330699|NCT00082173|516754288|FG000|Overall Study|Adverse Event|1|||
143330700|NCT00082173|516754289|FG001|Overall Study|Adverse Event|0|||
143330701|NCT00082173|516754288|FG000|Overall Study|Culture negative or resistant at baselin|5|||
143330702|NCT00082173|516754289|FG001|Overall Study|Culture negative or resistant at baselin|6|||
143330703|NCT00746590|516754290|FG000|Overall Study|Death|1|||
143330704|NCT00464815|516754293|FG000|Overall Study|Withdrawal by Subject|6|||
143330705|NCT00464815|516754294|FG001|Overall Study|Withdrawal by Subject|3|||
143330706|NCT00254982|516754297|FG000|Overall Study|Other|2|||
143330707|NCT00254982|516754298|FG001|Overall Study|Other|1|||
143330708|NCT00254982|516754297|FG000|Overall Study|Lack of Efficacy|5|||
143330709|NCT00254982|516754298|FG001|Overall Study|Lack of Efficacy|3|||
143330710|NCT00254982|516754297|FG000|Overall Study|Lost to Follow-up|5|||
143330711|NCT00254982|516754298|FG001|Overall Study|Lost to Follow-up|3|||
143330712|NCT00254982|516754297|FG000|Overall Study|Adverse Event|18|||
143330713|NCT00254982|516754298|FG001|Overall Study|Adverse Event|16|||
143330714|NCT00254982|516754297|FG000|Overall Study|Withdrawal by Subject|1|||
143330715|NCT00254982|516754298|FG001|Overall Study|Withdrawal by Subject|1|||
143330716|NCT00254982|516754297|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
143330717|NCT00254982|516754298|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
143330718|NCT00254982|516754297|FG000|Overall Study|Protocol deviation|1|||
143383479|NCT03725722|516950180|FG004|Overall Study|COVID-19 situation|0|||
143383480|NCT03481660|516950184|FG000|Overall Study|Adverse Event|5|||
143383481|NCT03481660|516950185|FG001|Overall Study|Adverse Event|4|||
143383482|NCT03481660|516950184|FG000|Overall Study|Death|13|||
143383483|NCT03481660|516950185|FG001|Overall Study|Death|9|||
143330719|NCT00254982|516754298|FG001|Overall Study|Protocol deviation|1|||
143383484|NCT03481660|516950184|FG000|Overall Study|Lost to Follow-up|2|||
143330720|NCT00254982|516754297|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
143383485|NCT03481660|516950185|FG001|Overall Study|Lost to Follow-up|2|||
143383486|NCT03481660|516950184|FG000|Overall Study|Physician Decision|2|||
143383487|NCT03481660|516950185|FG001|Overall Study|Physician Decision|3|||
143383488|NCT03481660|516950184|FG000|Overall Study|Withdrawal by Subject|14|||
143330721|NCT00254982|516754298|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
143330722|NCT00254982|516754297|FG000|Overall Study|Malignancy|0|||
143330723|NCT00254982|516754298|FG001|Overall Study|Malignancy|2|||
143330724|NCT00254982|516754297|FG000|Overall Study|Opportunistic infection|1|||
143330725|NCT00254982|516754298|FG001|Overall Study|Opportunistic infection|0|||
143330726|NCT00254982|516754297|FG000|Overall Study|Abnormal liver function tests|2|||
143330727|NCT00254982|516754298|FG001|Overall Study|Abnormal liver function tests|1|||
143330728|NCT04402866|516754307|FG000|Overall Study|Discontinued Prior to Treatment|0|||
143330729|NCT04402866|516754308|FG001|Overall Study|Discontinued Prior to Treatment|0|||
143330730|NCT04402866|516754309|FG002|Overall Study|Discontinued Prior to Treatment|0|||
143330731|NCT04402866|516754310|FG003|Overall Study|Discontinued Prior to Treatment|0|||
143330732|NCT04402866|516754311|FG004|Overall Study|Discontinued Prior to Treatment|2|||
143330733|NCT04402866|516754312|FG005|Overall Study|Discontinued Prior to Treatment|3|||
143330734|NCT04402866|516754307|FG000|Overall Study|Adverse Event|2|||
143330735|NCT04402866|516754308|FG001|Overall Study|Adverse Event|1|||
143330736|NCT04402866|516754309|FG002|Overall Study|Adverse Event|0|||
143330737|NCT04402866|516754310|FG003|Overall Study|Adverse Event|0|||
143330738|NCT04402866|516754311|FG004|Overall Study|Adverse Event|13|||
143330739|NCT04402866|516754312|FG005|Overall Study|Adverse Event|8|||
143330740|NCT04402866|516754307|FG000|Overall Study|Miscellaneous|0|||
143330741|NCT04402866|516754308|FG001|Overall Study|Miscellaneous|0|||
143330742|NCT04402866|516754309|FG002|Overall Study|Miscellaneous|1|||
143330743|NCT04402866|516754310|FG003|Overall Study|Miscellaneous|0|||
143330744|NCT04402866|516754311|FG004|Overall Study|Miscellaneous|0|||
143330745|NCT04402866|516754312|FG005|Overall Study|Miscellaneous|0|||
143330746|NCT04402866|516754307|FG000|Overall Study|Lost to Follow-up|0|||
143330747|NCT04402866|516754308|FG001|Overall Study|Lost to Follow-up|0|||
143330748|NCT04402866|516754309|FG002|Overall Study|Lost to Follow-up|0|||
143330749|NCT04402866|516754310|FG003|Overall Study|Lost to Follow-up|0|||
143330750|NCT04402866|516754311|FG004|Overall Study|Lost to Follow-up|0|||
143330751|NCT04402866|516754312|FG005|Overall Study|Lost to Follow-up|1|||
143330752|NCT04402866|516754307|FG000|Overall Study|Withdrawal by Subject|0|||
143330753|NCT04402866|516754308|FG001|Overall Study|Withdrawal by Subject|0|||
143330754|NCT04402866|516754309|FG002|Overall Study|Withdrawal by Subject|0|||
143330755|NCT04402866|516754310|FG003|Overall Study|Withdrawal by Subject|0|||
143330756|NCT04402866|516754311|FG004|Overall Study|Withdrawal by Subject|0|||
143330757|NCT04402866|516754312|FG005|Overall Study|Withdrawal by Subject|2|||
143330758|NCT00487162|516754313|FG000|Overall Study|Adverse Event|0|||
143330759|NCT00487162|516754314|FG001|Overall Study|Adverse Event|1|||
143330760|NCT00487162|516754313|FG000|Overall Study|Physician Decision|0|||
143330761|NCT00487162|516754314|FG001|Overall Study|Physician Decision|1|||
143330762|NCT00487162|516754313|FG000|Overall Study|Withdrawal by Subject|2|||
143330763|NCT00487162|516754314|FG001|Overall Study|Withdrawal by Subject|3|||
143330764|NCT00815295|516754315|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
143330765|NCT00815295|516754316|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
143330766|NCT00815295|516754317|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
143330767|NCT01433354|516754322|FG000|Overall Study|Adverse Event|6|||
143330768|NCT01433354|516754322|FG000|Overall Study|Lost to Follow-up|1|||
143330769|NCT01433354|516754322|FG000|Overall Study|Administrative problems|90|||
143330770|NCT01433354|516754322|FG000|Overall Study|Protocol Violation|2|||
143330771|NCT01433354|516754322|FG000|Overall Study|Lack of Efficacy|17|||
143330772|NCT01433354|516754322|FG000|Overall Study|Subject Withdrew Consent|3|||
143330773|NCT02015676|516754331|FG000|Overall Study|Adverse Event|2|||
143330774|NCT02015676|516754332|FG001|Overall Study|Adverse Event|18|||
143330775|NCT02015676|516754333|FG002|Overall Study|Adverse Event|0|||
143330776|NCT02015676|516754331|FG000|Overall Study|Lack of Efficacy|2|||
143330777|NCT02015676|516754332|FG001|Overall Study|Lack of Efficacy|4|||
143330778|NCT02015676|516754333|FG002|Overall Study|Lack of Efficacy|0|||
143330779|NCT02015676|516754331|FG000|Overall Study|Protocol Violation|1|||
143330780|NCT02015676|516754332|FG001|Overall Study|Protocol Violation|0|||
143330781|NCT02015676|516754333|FG002|Overall Study|Protocol Violation|0|||
143330782|NCT02015676|516754331|FG000|Overall Study|Withdrawal by Subject|1|||
143330783|NCT02015676|516754332|FG001|Overall Study|Withdrawal by Subject|7|||
143330784|NCT02015676|516754333|FG002|Overall Study|Withdrawal by Subject|1|||
143330785|NCT02015676|516754331|FG000|Overall Study|Administrative reasons|0|||
143330786|NCT02015676|516754332|FG001|Overall Study|Administrative reasons|3|||
143330787|NCT02015676|516754333|FG002|Overall Study|Administrative reasons|1|||
143330788|NCT02015676|516754331|FG000|Overall Study|Death|0|||
143330789|NCT02015676|516754332|FG001|Overall Study|Death|1|||
143330790|NCT02015676|516754333|FG002|Overall Study|Death|0|||
143330791|NCT02015676|516754331|FG000|Overall Study|Disease progression|3|||
143330792|NCT02015676|516754332|FG001|Overall Study|Disease progression|1|||
143330793|NCT02015676|516754333|FG002|Overall Study|Disease progression|1|||
143330794|NCT03321396|516754339|FG000|Overall Study|Physician Decision|1|||
143330795|NCT01654549|516754340|FG000|Overall Study|H.pylori eradication not successful|0|||
143330796|NCT01654549|516754341|FG001|Overall Study|H.pylori eradication not successful|1|||
143330797|NCT02633137|516754352|FG000|Overall Study|Adverse Event|1|||
143330798|NCT02633137|516754352|FG000|Overall Study|Lack of Efficacy|2|||
143383489|NCT03481660|516950185|FG001|Overall Study|Withdrawal by Subject|7|||
143383490|NCT00186992|516950186|FG000|Overall Study|Withdrawal by Subject|5|||
143383491|NCT00186992|516950186|FG000|Overall Study|Physician's discretion|13|||
143383492|NCT00186992|516950186|FG000|Overall Study|PI Discretion|4|||
143383493|NCT00186992|516950186|FG000|Overall Study|Ineligible|2|||
143383494|NCT00186992|516950186|FG000|Overall Study|Lost to Follow-up|2|||
143383495|NCT00186992|516950186|FG000|Overall Study|Still on Study|9|||
143383496|NCT05307783|516950189|FG000|Overall Study|Death|7|||
143383497|NCT05307783|516950189|FG000|Overall Study|Lost to Follow-up|4|||
143383498|NCT02473250|516950193|FG000|Overall Study|Lost to Follow-up|10|||
143383499|NCT02473250|516950193|FG000|Overall Study|Physician Decision|5|||
143383500|NCT02473250|516950193|FG000|Overall Study|Did not tolerate medication washout|3|||
143383501|NCT02473250|516950193|FG000|Overall Study|Antidepressant effect of divalproex|2|||
143383502|NCT03433339|516950194|FG000|Overall Study|Lost to Follow-up|2|||
143383503|NCT03433339|516950195|FG001|Overall Study|Lost to Follow-up|0|||
143383504|NCT03433339|516950194|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
143383505|NCT03433339|516950195|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
143383506|NCT03433339|516950194|FG000|Overall Study|Withdrawal by Subject|0|||
143383507|NCT03433339|516950195|FG001|Overall Study|Withdrawal by Subject|2|||
143383508|NCT02461628|516950200|FG000|Overall Study|Refused to complete survey|4|||
143383509|NCT02461628|516950201|FG001|Overall Study|Refused to complete survey|7|||
143383510|NCT04759833|516950202|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
143383511|NCT04759833|516950203|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
143383512|NCT04759833|516950204|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
143383513|NCT04759833|516950205|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
143383514|NCT04759833|516950206|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
143383515|NCT04759833|516950202|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
143383516|NCT04759833|516950203|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
143383517|NCT04759833|516950204|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
143383518|NCT04759833|516950205|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
143383519|NCT04759833|516950206|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
143383520|NCT04759833|516950202|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
143383521|NCT04759833|516950203|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
143383522|NCT04759833|516950204|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
143383523|NCT04759833|516950205|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
143383524|NCT04759833|516950206|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
143383525|NCT04759833|516950202|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
143383526|NCT04759833|516950203|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
143383527|NCT04759833|516950204|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
143383528|NCT04759833|516950205|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
143383529|NCT04759833|516950206|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
143383530|NCT04759833|516950202|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
143383531|NCT04759833|516950203|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
143383532|NCT04759833|516950204|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
143383533|NCT04759833|516950205|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
143383534|NCT04759833|516950206|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
143383535|NCT04759833|516950202|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
143383536|NCT04759833|516950203|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
143330799|NCT02633137|516754352|FG000|Overall Study|Withdrawal by Subject|1|||
143330800|NCT04307004|516754353|FG000|Randomization 1|Withdrawal by Subject|25|||
143330801|NCT04307004|516754354|FG001|Randomization 1|Withdrawal by Subject|26|||
143330802|NCT04307004|516754355|FG002|Randomization 1|Withdrawal by Subject|0|||
143330803|NCT04307004|516754356|FG003|Randomization 1|Withdrawal by Subject|0|||
143330804|NCT04307004|516754353|FG000|Randomization 2|Withdrawal by Subject|0|||
143330805|NCT04307004|516754354|FG001|Randomization 2|Withdrawal by Subject|0|||
143330806|NCT04307004|516754355|FG002|Randomization 2|Withdrawal by Subject|28|||
143330807|NCT04307004|516754356|FG003|Randomization 2|Withdrawal by Subject|23|||
143330808|NCT05545072|516754359|FG000|Overall Study|Lost to Follow-up|1|||
143330809|NCT05545072|516754360|FG001|Overall Study|Lost to Follow-up|0|||
143330810|NCT05545072|516754359|FG000|Overall Study|Study ended prematurely due to funding|2|||
143330811|NCT05545072|516754360|FG001|Overall Study|Study ended prematurely due to funding|2|||
143330812|NCT05130970|516754361|FG000|Overall Study|Adverse Event|1|||
143330813|NCT05130970|516754362|FG001|Overall Study|Adverse Event|1|||
143330814|NCT05130970|516754361|FG000|Overall Study|Death|0|||
143330815|NCT05130970|516754362|FG001|Overall Study|Death|1|||
143330816|NCT05130970|516754361|FG000|Overall Study|Lost to Follow-up|0|||
143330817|NCT05130970|516754362|FG001|Overall Study|Lost to Follow-up|1|||
143330818|NCT05130970|516754361|FG000|Overall Study|Physician Decision|0|||
143330819|NCT05130970|516754362|FG001|Overall Study|Physician Decision|1|||
143330820|NCT05130970|516754361|FG000|Overall Study|Withdrawal by Subject|1|||
143330821|NCT05130970|516754362|FG001|Overall Study|Withdrawal by Subject|1|||
143330822|NCT01972841|516754363|FG000|Overall Study|Randomized but Never Received Treatment|2|||
143330823|NCT01972841|516754364|FG001|Overall Study|Randomized but Never Received Treatment|5|||
143330824|NCT01972841|516754365|FG002|Overall Study|Randomized but Never Received Treatment|4|||
143330825|NCT01972841|516754366|FG003|Overall Study|Randomized but Never Received Treatment|2|||
143330826|NCT01972841|516754367|FG004|Overall Study|Randomized but Never Received Treatment|6|||
143330827|NCT01972841|516754368|FG005|Overall Study|Randomized but Never Received Treatment|13|||
143330828|NCT01972841|516754363|FG000|Overall Study|Adverse Event|13|||
143330829|NCT01972841|516754364|FG001|Overall Study|Adverse Event|8|||
143330830|NCT01972841|516754365|FG002|Overall Study|Adverse Event|12|||
143330831|NCT01972841|516754366|FG003|Overall Study|Adverse Event|9|||
143330832|NCT01972841|516754367|FG004|Overall Study|Adverse Event|21|||
143330833|NCT01972841|516754368|FG005|Overall Study|Adverse Event|26|||
143330834|NCT01972841|516754363|FG000|Overall Study|Lack of Efficacy|1|||
143330835|NCT01972841|516754364|FG001|Overall Study|Lack of Efficacy|0|||
143330836|NCT01972841|516754365|FG002|Overall Study|Lack of Efficacy|0|||
143330837|NCT01972841|516754366|FG003|Overall Study|Lack of Efficacy|2|||
143330838|NCT01972841|516754367|FG004|Overall Study|Lack of Efficacy|4|||
143330839|NCT01972841|516754368|FG005|Overall Study|Lack of Efficacy|1|||
143330840|NCT01972841|516754363|FG000|Overall Study|Lost to Follow-up|4|||
143330841|NCT01972841|516754364|FG001|Overall Study|Lost to Follow-up|2|||
143330842|NCT01972841|516754365|FG002|Overall Study|Lost to Follow-up|4|||
143330843|NCT01972841|516754366|FG003|Overall Study|Lost to Follow-up|2|||
143330844|NCT01972841|516754367|FG004|Overall Study|Lost to Follow-up|9|||
143330845|NCT01972841|516754368|FG005|Overall Study|Lost to Follow-up|3|||
143330846|NCT01972841|516754363|FG000|Overall Study|Protocol Violation|2|||
143330847|NCT01972841|516754364|FG001|Overall Study|Protocol Violation|2|||
143330848|NCT01972841|516754365|FG002|Overall Study|Protocol Violation|3|||
143330849|NCT01972841|516754366|FG003|Overall Study|Protocol Violation|5|||
143330850|NCT01972841|516754367|FG004|Overall Study|Protocol Violation|9|||
143330851|NCT01972841|516754368|FG005|Overall Study|Protocol Violation|4|||
143330852|NCT01972841|516754363|FG000|Overall Study|Withdrawal by participants|21|||
143330853|NCT01972841|516754364|FG001|Overall Study|Withdrawal by participants|27|||
143330854|NCT01972841|516754365|FG002|Overall Study|Withdrawal by participants|23|||
143330855|NCT01972841|516754366|FG003|Overall Study|Withdrawal by participants|16|||
143330856|NCT01972841|516754367|FG004|Overall Study|Withdrawal by participants|33|||
143330857|NCT01972841|516754368|FG005|Overall Study|Withdrawal by participants|34|||
143330858|NCT01972841|516754363|FG000|Overall Study|Miscellaneous|0|||
143330859|NCT01972841|516754364|FG001|Overall Study|Miscellaneous|0|||
143330860|NCT01972841|516754365|FG002|Overall Study|Miscellaneous|4|||
143330861|NCT01972841|516754366|FG003|Overall Study|Miscellaneous|1|||
143330862|NCT01972841|516754367|FG004|Overall Study|Miscellaneous|0|||
143383537|NCT04759833|516950204|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
143383538|NCT04759833|516950205|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
143330863|NCT01972841|516754368|FG005|Overall Study|Miscellaneous|4|||
143330864|NCT01972841|516754363|FG000|Overall Study|Did not have end of treatment page|0|||
143330865|NCT01972841|516754364|FG001|Overall Study|Did not have end of treatment page|0|||
143454275|NCT00948766|517208181|FG000|Core Study|Administrative Problems|2|||
143330866|NCT01972841|516754365|FG002|Overall Study|Did not have end of treatment page|0|||
143330867|NCT01972841|516754366|FG003|Overall Study|Did not have end of treatment page|0|||
143330868|NCT01972841|516754367|FG004|Overall Study|Did not have end of treatment page|1|||
143330869|NCT01972841|516754368|FG005|Overall Study|Did not have end of treatment page|0|||
143330870|NCT04969198|516754371|FG000|Overall Study|Withdrawal by Subject|20|||
143330871|NCT04969198|516754371|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
143330872|NCT04969198|516754371|FG000|Overall Study|Lost to Follow-up|20|||
143330873|NCT04009291|516754372|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
143330874|NCT04009291|516754373|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
143330875|NCT04009291|516754374|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
143330876|NCT04009291|516754375|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
143330877|NCT04009291|516754376|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
143330878|NCT04009291|516754372|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
143330879|NCT04009291|516754373|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
143330880|NCT04009291|516754374|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
143330881|NCT04009291|516754375|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
143330882|NCT04009291|516754376|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
143330883|NCT01270347|516754377|FG000|Core Phase|Adverse Event|1|||
143330884|NCT01270347|516754378|FG001|Core Phase|Adverse Event|6|||
143330885|NCT01270347|516754377|FG000|Core Phase|Withdrawal by Subject|1|||
143330886|NCT01270347|516754378|FG001|Core Phase|Withdrawal by Subject|2|||
143330887|NCT01270347|516754377|FG000|Core Phase|Lost to Follow-up|0|||
143330888|NCT01270347|516754378|FG001|Core Phase|Lost to Follow-up|1|||
143330889|NCT01270347|516754377|FG000|Core Phase|Miscellaneous|8|||
143330890|NCT01270347|516754378|FG001|Core Phase|Miscellaneous|14|||
143330891|NCT01270347|516754377|FG000|Extension Phase|Adverse Event|1|||
143330892|NCT01270347|516754378|FG001|Extension Phase|Adverse Event|3|||
143330893|NCT01270347|516754377|FG000|Extension Phase|Withdrawal by Subject|3|||
143330894|NCT01270347|516754378|FG001|Extension Phase|Withdrawal by Subject|4|||
143330895|NCT01270347|516754377|FG000|Extension Phase|Miscellaneous|2|||
143330896|NCT01270347|516754378|FG001|Extension Phase|Miscellaneous|2|||
143330897|NCT01556438|516754381|FG000|Overall Study|Adverse Event|4|||
143330898|NCT01556438|516754382|FG001|Overall Study|Adverse Event|2|||
143330899|NCT01556438|516754381|FG000|Overall Study|Sponsor Decision|0|||
143330900|NCT01556438|516754382|FG001|Overall Study|Sponsor Decision|2|||
143330901|NCT01556438|516754381|FG000|Overall Study|Progressive Disease|0|||
143330902|NCT01556438|516754382|FG001|Overall Study|Progressive Disease|6|||
143330903|NCT01556438|516754381|FG000|Overall Study|Death|0|||
143330904|NCT01556438|516754382|FG001|Overall Study|Death|1|||
143330905|NCT03282227|516754383|FG000|Overall Study|Exposure Goals Achieved|60|||
143330906|NCT03282227|516754383|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
143330907|NCT03282227|516754383|FG000|Overall Study|Adverse Event|15|||
143330908|NCT03282227|516754383|FG000|Overall Study|Lost to Follow-up|21|||
143330909|NCT03282227|516754383|FG000|Overall Study|Withdrawal by Subject|20|||
143330910|NCT03282227|516754383|FG000|Overall Study|Lack of Efficacy|12|||
143330911|NCT03282227|516754383|FG000|Overall Study|Sponsor decision|3|||
143330912|NCT03282227|516754383|FG000|Overall Study|Physician Decision|2|||
143330913|NCT03282227|516754383|FG000|Overall Study|Pregnancy|2|||
143330914|NCT03282227|516754383|FG000|Overall Study|Other|1|||
143330915|NCT02491671|516754384|FG000|Overall Study|Adverse Event|6|||
143330916|NCT02491671|516754385|FG001|Overall Study|Adverse Event|8|||
143330917|NCT02491671|516754384|FG000|Overall Study|Death|0|||
143330918|NCT02491671|516754385|FG001|Overall Study|Death|2|||
143330919|NCT02491671|516754384|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
143330920|NCT02491671|516754385|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
143330921|NCT03265600|516754386|FG000|Overall Study|Lost to Follow-up|17|||
143330922|NCT03265600|516754387|FG001|Overall Study|Lost to Follow-up|5|||
143330923|NCT03265600|516754386|FG000|Overall Study|Withdrawal by Subject|4|||
143330924|NCT03265600|516754387|FG001|Overall Study|Withdrawal by Subject|2|||
143330925|NCT03265600|516754386|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
143330926|NCT03265600|516754387|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
143330927|NCT01954017|516754388|FG000|Overall Study|Adverse Event|0|||
143330928|NCT01954017|516754389|FG001|Overall Study|Adverse Event|0|||
143330929|NCT01954017|516754390|FG002|Overall Study|Adverse Event|1|||
143330930|NCT01954017|516754388|FG000|Overall Study|Death|2|||
143330931|NCT01954017|516754389|FG001|Overall Study|Death|1|||
143330932|NCT01954017|516754390|FG002|Overall Study|Death|1|||
143330933|NCT01954017|516754388|FG000|Overall Study|Withdrawal by Subject|0|||
143330934|NCT01954017|516754389|FG001|Overall Study|Withdrawal by Subject|1|||
143330935|NCT01954017|516754390|FG002|Overall Study|Withdrawal by Subject|0|||
143330936|NCT01954017|516754388|FG000|Overall Study|Protocol Violation|0|||
143330937|NCT01954017|516754389|FG001|Overall Study|Protocol Violation|3|||
143330938|NCT01954017|516754390|FG002|Overall Study|Protocol Violation|2|||
143330939|NCT01954017|516754388|FG000|Overall Study|Necrotizing enterocolitis|1|||
143330940|NCT01954017|516754389|FG001|Overall Study|Necrotizing enterocolitis|0|||
143330941|NCT01954017|516754390|FG002|Overall Study|Necrotizing enterocolitis|1|||
143330942|NCT01954017|516754388|FG000|Overall Study|Enteral intake stopped >7 days|0|||
143330943|NCT01954017|516754389|FG001|Overall Study|Enteral intake stopped >7 days|1|||
143330944|NCT01954017|516754390|FG002|Overall Study|Enteral intake stopped >7 days|1|||
143330945|NCT01954017|516754388|FG000|Overall Study|All other reasons|2|||
143330946|NCT01954017|516754389|FG001|Overall Study|All other reasons|2|||
143330947|NCT01954017|516754390|FG002|Overall Study|All other reasons|7|||
143330948|NCT00435370|516754391|FG000|Overall Study|Adverse Event|8|||
143330949|NCT00435370|516754392|FG001|Overall Study|Adverse Event|8|||
143330950|NCT00435370|516754391|FG000|Overall Study|Withdrawal by Subject|10|||
143330951|NCT00435370|516754392|FG001|Overall Study|Withdrawal by Subject|10|||
143330952|NCT00435370|516754391|FG000|Overall Study|Antipsychotic medication changed|4|||
143330953|NCT00435370|516754392|FG001|Overall Study|Antipsychotic medication changed|2|||
143330954|NCT01965834|516754394|FG000|Overall Study|Lack of Efficacy|4|||
143330955|NCT00744653|516754401|FG000|Overall Study|antineoplastic treatment|11|||
143330956|NCT00744653|516754401|FG000|Overall Study|Death|1|||
143330957|NCT00744653|516754401|FG000|Overall Study|Lost to Follow-up|1|||
143330958|NCT00744653|516754401|FG000|Overall Study|Physician Decision|3|||
143330959|NCT01986881|516756332|FG000|Overall Study|Death|228|||
143330960|NCT01986881|516756333|FG001|Overall Study|Death|233|||
143330961|NCT01986881|516756334|FG002|Overall Study|Death|247|||
143330962|NCT01986881|516756332|FG000|Overall Study|Lost to Follow-up|51|||
143330963|NCT01986881|516756333|FG001|Overall Study|Lost to Follow-up|44|||
143330964|NCT01986881|516756334|FG002|Overall Study|Lost to Follow-up|55|||
143330965|NCT01986881|516756332|FG000|Overall Study|Physician Decision|7|||
143330966|NCT01986881|516756333|FG001|Overall Study|Physician Decision|4|||
143330967|NCT01986881|516756334|FG002|Overall Study|Physician Decision|6|||
143330968|NCT01986881|516756332|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
143330969|NCT01986881|516756333|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
143330970|NCT01986881|516756334|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
143330971|NCT01986881|516756332|FG000|Overall Study|Withdrawal by Subject|41|||
143330972|NCT01986881|516756333|FG001|Overall Study|Withdrawal by Subject|60|||
143330973|NCT01986881|516756334|FG002|Overall Study|Withdrawal by Subject|45|||
143330974|NCT01986881|516756332|FG000|Overall Study|Subject Moved|0|||
143330975|NCT01986881|516756333|FG001|Overall Study|Subject Moved|1|||
143330976|NCT01986881|516756334|FG002|Overall Study|Subject Moved|0|||
143330977|NCT01986881|516756332|FG000|Overall Study|Other|1|||
143330978|NCT01986881|516756333|FG001|Overall Study|Other|2|||
143330979|NCT01986881|516756334|FG002|Overall Study|Other|2|||
143330980|NCT02057874|516756336|FG000|Overall Study|participant did not return for scan|1|||
143330981|NCT01738984|516756339|FG000|Overall Study|Pregnancy|4|||
143330982|NCT01738984|516756340|FG001|Overall Study|Pregnancy|0|||
143330983|NCT01738984|516756339|FG000|Overall Study|Withdrawal by Subject|1|||
143330984|NCT01738984|516756340|FG001|Overall Study|Withdrawal by Subject|0|||
143330985|NCT01738984|516756339|FG000|Overall Study|Lost to Follow-up|59|||
143330986|NCT01738984|516756340|FG001|Overall Study|Lost to Follow-up|39|||
143330987|NCT04205630|516756345|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
143330988|NCT04205630|516756345|FG000|Overall Study|Disease clinical progression|7|||
143330989|NCT04205630|516756345|FG000|Overall Study|Withdrawal by Subject|2|||
143330990|NCT04205630|516756345|FG000|Overall Study|Adverse Event|17|||
143330991|NCT04205630|516756345|FG000|Overall Study|Other|1|||
143330992|NCT01621126|516756349|FG000|Overall Study|Physician Decision|6|||
143330993|NCT00886340|516756350|FG000|Overall Study|Withdrawal by Subject|0|||
143330994|NCT00886340|516756351|FG001|Overall Study|Withdrawal by Subject|7|||
143330995|NCT02338154|516756352|FG000|Overall Study|Death|46|||
143330996|NCT02338154|516756352|FG000|Overall Study|Valve Implant Failure|17|||
143330997|NCT02338154|516756352|FG000|Overall Study|Valve Explant|11|||
143330998|NCT02338154|516756352|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
143330999|NCT02338154|516756352|FG000|Overall Study|Lost to Follow-up|8|||
143331000|NCT02338154|516756352|FG000|Overall Study|Other Reason|3|||
143331001|NCT02338154|516756352|FG000|Overall Study|Patients Without Exit Form|47|||
143331002|NCT02338154|516756352|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
143331003|NCT04279314|516756353|FG000|Overall Study|Adverse Event|55|||
143331004|NCT04279314|516756353|FG000|Overall Study|Withdrawal by Subject|5|||
143331005|NCT04279314|516756353|FG000|Overall Study|Lack of Efficacy|5|||
143331006|NCT04279314|516756353|FG000|Overall Study|Protocol Violation|3|||
143331007|NCT04279314|516756353|FG000|Overall Study|Other (not COVID-19 related)|2|||
143331008|NCT02481310|516756354|FG000|Follow up|Still in follow up|0|||
143383539|NCT04759833|516950206|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
143383540|NCT04759833|516950202|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
143383541|NCT04759833|516950203|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
143383542|NCT04759833|516950204|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
143383543|NCT04759833|516950205|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
143383544|NCT04759833|516950206|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
143383545|NCT04759833|516950202|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
143383546|NCT04759833|516950203|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
143383547|NCT04759833|516950204|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
143383548|NCT04759833|516950205|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
143383549|NCT04759833|516950206|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
143383550|NCT04759833|516950202|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
143331009|NCT02481310|516756355|FG001|Follow up|Still in follow up|3|||
143331010|NCT02481310|516756356|FG002|Follow up|Still in follow up|0|||
143331011|NCT02925455|516756362|FG000|Overall Study|Withdrawal by Subject|2|||
143331012|NCT02925455|516756363|FG001|Overall Study|Withdrawal by Subject|0|||
143331013|NCT00686166|516756364|FG000|Overall Study|Adverse Event|7|||
143331014|NCT00686166|516756364|FG000|Overall Study|Withdrawal by Subject|1|||
143331015|NCT00686166|516756364|FG000|Overall Study|Progression/Relapse|1|||
143331016|NCT00686166|516756364|FG000|Overall Study|Death|1|||
143331017|NCT00686166|516756364|FG000|Overall Study|Not Protocol Specified|1|||
143331018|NCT00686166|516756364|FG000|Overall Study|Ineligible|5|||
143331019|NCT00686166|516756364|FG000|Overall Study|Did not begin protocol therapy|4|||
143331020|NCT01514448|516756365|FG000|Overall Study|Death|7|||
143331021|NCT01514448|516756366|FG001|Overall Study|Death|8|||
143331022|NCT01514448|516756365|FG000|Overall Study|Withdrawal by Subject|2|||
143331023|NCT01514448|516756366|FG001|Overall Study|Withdrawal by Subject|0|||
143331024|NCT01514448|516756365|FG000|Overall Study|Lost to Follow-up|2|||
143331025|NCT01514448|516756366|FG001|Overall Study|Lost to Follow-up|0|||
143331026|NCT01514448|516756365|FG000|Overall Study|New Cancer Therapy|1|||
143331027|NCT01514448|516756366|FG001|Overall Study|New Cancer Therapy|0|||
143331028|NCT03912259|516756367|FG000|Overall Study|Adverse Event (AE)|2|||
143331029|NCT03912259|516756368|FG001|Overall Study|Adverse Event (AE)|4|||
143331030|NCT03912259|516756367|FG000|Overall Study|Lack of Efficacy|4|||
143331031|NCT03912259|516756368|FG001|Overall Study|Lack of Efficacy|1|||
143331032|NCT03912259|516756367|FG000|Overall Study|Withdrawal by Subject|11|||
143331033|NCT03912259|516756368|FG001|Overall Study|Withdrawal by Subject|1|||
143331034|NCT00360308|516756369|FG000|Overall Study|Adverse Event|15|||
143331035|NCT00360308|516756370|FG001|Overall Study|Adverse Event|14|||
143331036|NCT00360308|516756371|FG002|Overall Study|Adverse Event|25|||
143331037|NCT00360308|516756369|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
143331038|NCT00360308|516756370|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
143331039|NCT00360308|516756371|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
143331040|NCT00360308|516756369|FG000|Overall Study|Protocol Violation|2|||
143331041|NCT00360308|516756370|FG001|Overall Study|Protocol Violation|1|||
143331042|NCT00360308|516756371|FG002|Overall Study|Protocol Violation|2|||
143331043|NCT00360308|516756369|FG000|Overall Study|Withdrawal by Subject|11|||
143331044|NCT00360308|516756370|FG001|Overall Study|Withdrawal by Subject|7|||
143331045|NCT00360308|516756371|FG002|Overall Study|Withdrawal by Subject|14|||
143331046|NCT00360308|516756369|FG000|Overall Study|Lack of Efficacy|3|||
143331047|NCT00360308|516756370|FG001|Overall Study|Lack of Efficacy|0|||
143331048|NCT00360308|516756371|FG002|Overall Study|Lack of Efficacy|2|||
143331049|NCT00360308|516756369|FG000|Overall Study|Other|2|||
143331050|NCT00360308|516756370|FG001|Overall Study|Other|1|||
143331051|NCT00360308|516756371|FG002|Overall Study|Other|1|||
143331052|NCT00360308|516756369|FG000|Overall Study|Study termination by sponsor|43|||
143331053|NCT00360308|516756370|FG001|Overall Study|Study termination by sponsor|55|||
143331054|NCT00360308|516756371|FG002|Overall Study|Study termination by sponsor|44|||
143331055|NCT04786444|516756372|FG000|Overall Study|Withdrawal by Subject|4|||
143331056|NCT04786444|516756373|FG001|Overall Study|Withdrawal by Subject|7|||
143331057|NCT04786444|516756374|FG002|Overall Study|Withdrawal by Subject|2|||
143331058|NCT04786444|516756372|FG000|Overall Study|Lost to Follow-up|11|||
143331059|NCT04786444|516756373|FG001|Overall Study|Lost to Follow-up|9|||
143331060|NCT04786444|516756374|FG002|Overall Study|Lost to Follow-up|10|||
143331061|NCT04786444|516756372|FG000|Overall Study|Subject would like to become pregnant|0|||
143331062|NCT04786444|516756373|FG001|Overall Study|Subject would like to become pregnant|1|||
143331063|NCT04786444|516756374|FG002|Overall Study|Subject would like to become pregnant|0|||
143331064|NCT03166618|516756375|FG000|Overall Study|Study was Terminated|0|||
143331065|NCT03166618|516756376|FG001|Overall Study|Study was Terminated|1|||
143331066|NCT01925950|516756377|FG000|Part 2|Withdrawal by Subject|1|||
143331067|NCT01925950|516756378|FG001|Part 2|Withdrawal by Subject|0|||
143331068|NCT03137303|516756380|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
143331069|NCT03137303|516756381|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
143383551|NCT04759833|516950203|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
143383552|NCT04759833|516950204|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
143383553|NCT04759833|516950205|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
143383554|NCT04759833|516950206|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
143383555|NCT04759833|516950202|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
143383556|NCT04759833|516950203|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
143383557|NCT04759833|516950204|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
143383558|NCT04759833|516950205|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
143383559|NCT04759833|516950206|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
143383560|NCT04759833|516950202|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
143383561|NCT04759833|516950203|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
143383562|NCT04759833|516950204|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
143383563|NCT04759833|516950205|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
143383564|NCT04759833|516950206|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
143383565|NCT04759833|516950202|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
143383566|NCT04759833|516950203|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
143383567|NCT04759833|516950204|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
143383568|NCT04759833|516950205|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
143383569|NCT04759833|516950206|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
143383570|NCT04759833|516950202|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
143383571|NCT04759833|516950203|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
143383572|NCT04759833|516950204|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
143383573|NCT04759833|516950205|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
143383574|NCT04759833|516950206|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
143383575|NCT03446157|516950207|FG000|Overall Study|Death|11|||
143383576|NCT03446157|516950208|FG001|Overall Study|Death|9|||
143383577|NCT03446157|516950207|FG000|Overall Study|Lost to Follow-up|0|||
143383578|NCT03446157|516950208|FG001|Overall Study|Lost to Follow-up|1|||
143383579|NCT03446157|516950207|FG000|Overall Study|Withdrawal by Subject|2|||
143383580|NCT03446157|516950208|FG001|Overall Study|Withdrawal by Subject|1|||
143383581|NCT02386553|516950209|FG000|Overall Study|Reason Not Specified|1|||
143383582|NCT02386553|516950210|FG001|Overall Study|Reason Not Specified|1|||
143383583|NCT02386553|516950209|FG000|Overall Study|Withdrawal by parent/Guardian|1|||
143383584|NCT02386553|516950210|FG001|Overall Study|Withdrawal by parent/Guardian|0|||
143383585|NCT00998881|516950214|FG000|Overall Study|Adverse Event|2|||
143383586|NCT00998881|516950215|FG001|Overall Study|Adverse Event|2|||
143383587|NCT00998881|516950214|FG000|Overall Study|Lack of Efficacy|1|||
143383588|NCT00998881|516950215|FG001|Overall Study|Lack of Efficacy|0|||
143383589|NCT00998881|516950214|FG000|Overall Study|Physician Decision|3|||
143383590|NCT00998881|516950215|FG001|Overall Study|Physician Decision|0|||
143383591|NCT00998881|516950214|FG000|Overall Study|Withdrawal by Subject|1|||
143383592|NCT00998881|516950215|FG001|Overall Study|Withdrawal by Subject|0|||
143383593|NCT00998881|516950214|FG000|Overall Study|Personal matter|1|||
143383594|NCT00998881|516950215|FG001|Overall Study|Personal matter|0|||
143383595|NCT02740231|516950216|FG000|Overall Study|Withdrawal by Subject|1|||
143383596|NCT02740231|516950217|FG001|Overall Study|Withdrawal by Subject|1|||
143383597|NCT02740231|516950218|FG002|Overall Study|Withdrawal by Subject|1|||
143383598|NCT02740231|516950219|FG003|Overall Study|Withdrawal by Subject|0|||
143383599|NCT02740231|516950216|FG000|Overall Study|Lack of Efficacy|0|||
143383600|NCT02740231|516950217|FG001|Overall Study|Lack of Efficacy|1|||
143383601|NCT02740231|516950218|FG002|Overall Study|Lack of Efficacy|0|||
143383602|NCT02740231|516950219|FG003|Overall Study|Lack of Efficacy|4|||
143383603|NCT02740231|516950216|FG000|Overall Study|Lost to Follow-up|1|||
143383604|NCT02740231|516950217|FG001|Overall Study|Lost to Follow-up|3|||
143383605|NCT02740231|516950218|FG002|Overall Study|Lost to Follow-up|0|||
143383606|NCT02740231|516950219|FG003|Overall Study|Lost to Follow-up|3|||
143383607|NCT02740231|516950216|FG000|Overall Study|Adverse Event|0|||
143383608|NCT02740231|516950217|FG001|Overall Study|Adverse Event|1|||
143383609|NCT02740231|516950218|FG002|Overall Study|Adverse Event|0|||
143383610|NCT02740231|516950219|FG003|Overall Study|Adverse Event|1|||
143383611|NCT02462759|516950220|FG000|Part 1: Double Blind|Death|1|||
143383612|NCT02462759|516950221|FG001|Part 1: Double Blind|Death|0|||
143383613|NCT02462759|516950222|FG002|Part 1: Double Blind|Death|0|||
143383614|NCT04600752|516950223|FG000|Overall Study|Physician Decision|0|||
143383615|NCT04600752|516950224|FG001|Overall Study|Physician Decision|0|||
143383616|NCT04600752|516950225|FG002|Overall Study|Physician Decision|1|||
143383617|NCT04600752|516950223|FG000|Overall Study|Adverse Event|0|||
143383618|NCT04600752|516950224|FG001|Overall Study|Adverse Event|1|||
143383619|NCT04600752|516950225|FG002|Overall Study|Adverse Event|0|||
143383620|NCT04600752|516950223|FG000|Overall Study|Withdrawal by Subject|2|||
143383621|NCT04600752|516950224|FG001|Overall Study|Withdrawal by Subject|1|||
143383622|NCT04600752|516950225|FG002|Overall Study|Withdrawal by Subject|0|||
143383623|NCT04600752|516950223|FG000|Overall Study|Lack of Efficacy|1|||
143383624|NCT04600752|516950224|FG001|Overall Study|Lack of Efficacy|0|||
143383625|NCT04600752|516950225|FG002|Overall Study|Lack of Efficacy|0|||
143383626|NCT00632203|516950226|FG000|Overall Study|Did not start study treatment|1|||
143383627|NCT00632203|516950227|FG001|Overall Study|Did not start study treatment|0|||
143383628|NCT00999167|516950228|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
143383629|NCT00999167|516950229|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
143383630|NCT00999167|516950230|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
143383631|NCT00999167|516950228|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
143383632|NCT00999167|516950229|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
143383633|NCT00999167|516950230|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
143383634|NCT00999167|516950228|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
143383635|NCT00999167|516950229|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
143383636|NCT00999167|516950230|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
143383637|NCT00999167|516950228|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
143383638|NCT00999167|516950229|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
143383639|NCT00999167|516950230|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
143383640|NCT00999167|516950228|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
143383641|NCT00999167|516950229|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
143383642|NCT00999167|516950230|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
143383643|NCT00999167|516950228|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
143383644|NCT00999167|516950229|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
143383645|NCT00999167|516950230|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
143383646|NCT00999167|516950228|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
143383647|NCT00999167|516950229|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
143383648|NCT00999167|516950230|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
143383649|NCT00999167|516950228|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
143383650|NCT00999167|516950229|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
143383651|NCT00999167|516950230|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
143383652|NCT01340066|516950238|FG000|Placebo Run in Period|Screen Failures|27|||
143383653|NCT01340066|516950239|FG001|Placebo Run in Period|Screen Failures|0|||
143383654|NCT01340066|516950240|FG002|Placebo Run in Period|Screen Failures|0|||
143383655|NCT01340066|516950238|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
143383656|NCT01340066|516950239|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
143383657|NCT01340066|516950240|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
143383658|NCT01340066|516950238|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
143383659|NCT01340066|516950239|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
143383660|NCT01340066|516950240|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
143383661|NCT01340066|516950238|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
143383662|NCT01340066|516950239|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
143383663|NCT01340066|516950240|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
143383664|NCT03771352|516950243|FG000|Overall Study|Screen failure|2|||
143383665|NCT03771352|516950243|FG000|Overall Study|Withdrawal by Subject|2|||
143383666|NCT03338816|516950249|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
143383667|NCT03338816|516950250|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
143383668|NCT03338816|516950251|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
143383669|NCT03338816|516950252|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
143383670|NCT03338816|516950249|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
143331070|NCT03137303|516756380|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
143331071|NCT03137303|516756381|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
143331072|NCT03137303|516756380|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
143331073|NCT03137303|516756381|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
143331074|NCT03137303|516756380|FG000|T3: 9-month Follow-up|Death|1|||
143331075|NCT03137303|516756381|FG001|T3: 9-month Follow-up|Death|0|||
143331076|NCT03137303|516756380|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
143331077|NCT03137303|516756381|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
143331078|NCT03137303|516756380|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
143331079|NCT03137303|516756381|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
143331080|NCT03137303|516756380|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
143331081|NCT03137303|516756381|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
143331082|NCT03561090|516756382|FG000|Overall Study|Adverse Event|11|||
143331083|NCT03561090|516756383|FG001|Overall Study|Adverse Event|7|||
143331084|NCT03561090|516756382|FG000|Overall Study|Non-Compliance With Study Drug|2|||
143331085|NCT03561090|516756383|FG001|Overall Study|Non-Compliance With Study Drug|0|||
143331086|NCT03561090|516756382|FG000|Overall Study|Protocol Violation|2|||
143383671|NCT03338816|516950250|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
143383672|NCT03338816|516950251|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
143383673|NCT03338816|516950252|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
143383674|NCT03338816|516950249|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
143383675|NCT03338816|516950250|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
143383676|NCT03338816|516950251|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
143383677|NCT03338816|516950252|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
143383678|NCT03338816|516950249|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
143383679|NCT03338816|516950250|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
143383680|NCT03338816|516950251|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
143383681|NCT03338816|516950252|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
143383682|NCT03338816|516950249|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
143383683|NCT03338816|516950250|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
143383684|NCT03338816|516950251|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
143383685|NCT03338816|516950252|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
143331087|NCT03561090|516756383|FG001|Overall Study|Protocol Violation|2|||
143331088|NCT03561090|516756382|FG000|Overall Study|Withdrawal by Subject|7|||
143331089|NCT03561090|516756383|FG001|Overall Study|Withdrawal by Subject|7|||
143331090|NCT03561090|516756382|FG000|Overall Study|Lost to Follow-up|7|||
143331091|NCT03561090|516756383|FG001|Overall Study|Lost to Follow-up|2|||
143331092|NCT03561090|516756382|FG000|Overall Study|Study Terminated by Sponsor|10|||
143331093|NCT03561090|516756383|FG001|Overall Study|Study Terminated by Sponsor|15|||
143331094|NCT03561090|516756382|FG000|Overall Study|Randomized by Mistake|1|||
143331095|NCT03561090|516756383|FG001|Overall Study|Randomized by Mistake|1|||
143331096|NCT03561090|516756382|FG000|Overall Study|Other Not Specified|0|||
143331097|NCT03561090|516756383|FG001|Overall Study|Other Not Specified|2|||
143331098|NCT04162769|516756390|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
143331099|NCT04162769|516756391|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
143331100|NCT04162769|516756392|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
143331101|NCT04162769|516756393|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
143331102|NCT04162769|516756390|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
143331103|NCT04162769|516756391|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
143331104|NCT04162769|516756392|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
143331105|NCT04162769|516756393|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
143331106|NCT04162769|516756390|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
143331107|NCT04162769|516756391|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
143331108|NCT04162769|516756392|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
143331109|NCT04162769|516756393|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
143331110|NCT04162769|516756390|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
143331111|NCT04162769|516756391|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
143331112|NCT04162769|516756392|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
143331113|NCT04162769|516756393|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
143331114|NCT04162769|516756390|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
143331115|NCT04162769|516756391|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
143331116|NCT04162769|516756392|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
143331117|NCT04162769|516756393|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
143331118|NCT04162769|516756390|FG000|Double-blind Treatment (12-Week)|Other|0|||
143331119|NCT04162769|516756391|FG001|Double-blind Treatment (12-Week)|Other|1|||
143331120|NCT04162769|516756392|FG002|Double-blind Treatment (12-Week)|Other|1|||
143331121|NCT04162769|516756393|FG003|Double-blind Treatment (12-Week)|Other|0|||
143331122|NCT04162769|516756390|FG000|OLE Period (52-Week)|Adverse Event|0|||
143331123|NCT04162769|516756391|FG001|OLE Period (52-Week)|Adverse Event|0|||
143331124|NCT04162769|516756392|FG002|OLE Period (52-Week)|Adverse Event|0|||
143331125|NCT04162769|516756393|FG003|OLE Period (52-Week)|Adverse Event|5|||
143331126|NCT04162769|516756390|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
143331127|NCT04162769|516756391|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
143331128|NCT04162769|516756392|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
143331129|NCT04162769|516756393|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
143331130|NCT04162769|516756390|FG000|OLE Period (52-Week)|Physician Decision|0|||
143331131|NCT04162769|516756391|FG001|OLE Period (52-Week)|Physician Decision|0|||
143331132|NCT04162769|516756392|FG002|OLE Period (52-Week)|Physician Decision|0|||
143383686|NCT03338816|516950249|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
143383687|NCT03338816|516950250|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
143331133|NCT04162769|516756393|FG003|OLE Period (52-Week)|Physician Decision|1|||
143331134|NCT04162769|516756390|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
143331135|NCT04162769|516756391|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
143331136|NCT04162769|516756392|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
143331137|NCT04162769|516756393|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
143331138|NCT04162769|516756390|FG000|OLE Period (52-Week)|Protocol deviation|0|||
143331139|NCT04162769|516756391|FG001|OLE Period (52-Week)|Protocol deviation|0|||
143331140|NCT04162769|516756392|FG002|OLE Period (52-Week)|Protocol deviation|0|||
143331141|NCT04162769|516756393|FG003|OLE Period (52-Week)|Protocol deviation|2|||
143331142|NCT00725452|516756397|FG000|Overall Study|Adverse Event|3|||
143331143|NCT00725452|516756397|FG000|Overall Study|Lack of Efficacy|2|||
143331144|NCT00725452|516756397|FG000|Overall Study|Reason not specified|1|||
143331145|NCT00725452|516756397|FG000|Overall Study|Physician Decision|1|||
143331146|NCT00725452|516756397|FG000|Overall Study|Withdrawal by Subject|3|||
143331147|NCT00725452|516756397|FG000|Overall Study|Lost to Follow-up|1|||
143331148|NCT02163733|516756398|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
143331149|NCT02163733|516756399|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
143331150|NCT02163733|516756400|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
143331151|NCT02163733|516756398|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
143331152|NCT02163733|516756399|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
143331153|NCT02163733|516756400|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
143331154|NCT02723864|516756401|FG000|Overall Study|Refused further treatment|1|||
143331155|NCT02723864|516756402|FG001|Overall Study|Refused further treatment|0|||
143331156|NCT02723864|516756403|FG002|Overall Study|Refused further treatment|0|||
143331157|NCT02723864|516756404|FG003|Overall Study|Refused further treatment|0|||
143331158|NCT02723864|516756405|FG004|Overall Study|Refused further treatment|1|||
143331159|NCT02723864|516756406|FG005|Overall Study|Refused further treatment|2|||
143331160|NCT02723864|516756407|FG006|Overall Study|Refused further treatment|0|||
143331161|NCT02723864|516756401|FG000|Overall Study|Exceed treatment hold time|0|||
143331162|NCT02723864|516756402|FG001|Overall Study|Exceed treatment hold time|1|||
143331163|NCT02723864|516756403|FG002|Overall Study|Exceed treatment hold time|0|||
143331164|NCT02723864|516756404|FG003|Overall Study|Exceed treatment hold time|0|||
143331165|NCT02723864|516756405|FG004|Overall Study|Exceed treatment hold time|0|||
143331166|NCT02723864|516756406|FG005|Overall Study|Exceed treatment hold time|0|||
143331167|NCT02723864|516756407|FG006|Overall Study|Exceed treatment hold time|0|||
143331168|NCT02723864|516756401|FG000|Overall Study|Clinical progression|0|||
143331169|NCT02723864|516756402|FG001|Overall Study|Clinical progression|0|||
143331170|NCT02723864|516756403|FG002|Overall Study|Clinical progression|1|||
143331171|NCT02723864|516756404|FG003|Overall Study|Clinical progression|0|||
143331172|NCT02723864|516756405|FG004|Overall Study|Clinical progression|0|||
143331173|NCT02723864|516756406|FG005|Overall Study|Clinical progression|3|||
143331174|NCT02723864|516756407|FG006|Overall Study|Clinical progression|1|||
143331175|NCT02723864|516756401|FG000|Overall Study|Physician Decision|0|||
143331176|NCT02723864|516756402|FG001|Overall Study|Physician Decision|0|||
143331177|NCT02723864|516756403|FG002|Overall Study|Physician Decision|0|||
143331178|NCT02723864|516756404|FG003|Overall Study|Physician Decision|0|||
143331179|NCT02723864|516756405|FG004|Overall Study|Physician Decision|0|||
143331180|NCT02723864|516756406|FG005|Overall Study|Physician Decision|0|||
143331181|NCT02723864|516756407|FG006|Overall Study|Physician Decision|1|||
143331182|NCT02723864|516756401|FG000|Overall Study|Changes in patient condition|0|||
143331183|NCT02723864|516756402|FG001|Overall Study|Changes in patient condition|0|||
143331184|NCT02723864|516756403|FG002|Overall Study|Changes in patient condition|0|||
143331185|NCT02723864|516756404|FG003|Overall Study|Changes in patient condition|0|||
143331186|NCT02723864|516756405|FG004|Overall Study|Changes in patient condition|0|||
143331187|NCT02723864|516756406|FG005|Overall Study|Changes in patient condition|1|||
143331188|NCT02723864|516756407|FG006|Overall Study|Changes in patient condition|0|||
143331189|NCT02723864|516756401|FG000|Overall Study|Patient choice|0|||
143331190|NCT02723864|516756402|FG001|Overall Study|Patient choice|0|||
143331191|NCT02723864|516756403|FG002|Overall Study|Patient choice|0|||
143331192|NCT02723864|516756404|FG003|Overall Study|Patient choice|0|||
143331193|NCT02723864|516756405|FG004|Overall Study|Patient choice|0|||
143331194|NCT02723864|516756406|FG005|Overall Study|Patient choice|1|||
143331195|NCT02723864|516756407|FG006|Overall Study|Patient choice|0|||
143331196|NCT02723864|516756401|FG000|Overall Study|Adverse Event|0|||
143331197|NCT02723864|516756402|FG001|Overall Study|Adverse Event|0|||
143331198|NCT02723864|516756403|FG002|Overall Study|Adverse Event|0|||
143331199|NCT02723864|516756404|FG003|Overall Study|Adverse Event|0|||
143331200|NCT02723864|516756405|FG004|Overall Study|Adverse Event|0|||
143331201|NCT02723864|516756406|FG005|Overall Study|Adverse Event|1|||
143331202|NCT02723864|516756407|FG006|Overall Study|Adverse Event|0|||
143331203|NCT02723864|516756401|FG000|Overall Study|Started new treatment|0|||
143331204|NCT02723864|516756402|FG001|Overall Study|Started new treatment|0|||
143331205|NCT02723864|516756403|FG002|Overall Study|Started new treatment|0|||
143331206|NCT02723864|516756404|FG003|Overall Study|Started new treatment|0|||
143331207|NCT02723864|516756405|FG004|Overall Study|Started new treatment|0|||
143331208|NCT02723864|516756406|FG005|Overall Study|Started new treatment|1|||
143331209|NCT02723864|516756407|FG006|Overall Study|Started new treatment|0|||
143331210|NCT02723864|516756401|FG000|Overall Study|Switched to alternative treatment|0|||
143331211|NCT02723864|516756402|FG001|Overall Study|Switched to alternative treatment|0|||
143331212|NCT02723864|516756403|FG002|Overall Study|Switched to alternative treatment|0|||
143331213|NCT02723864|516756404|FG003|Overall Study|Switched to alternative treatment|0|||
143331214|NCT02723864|516756405|FG004|Overall Study|Switched to alternative treatment|0|||
143331215|NCT02723864|516756406|FG005|Overall Study|Switched to alternative treatment|1|||
143331216|NCT02723864|516756407|FG006|Overall Study|Switched to alternative treatment|0|||
143331217|NCT02723864|516756401|FG000|Overall Study|Late determination of ineligibility|0|||
143331218|NCT02723864|516756402|FG001|Overall Study|Late determination of ineligibility|0|||
143331219|NCT02723864|516756403|FG002|Overall Study|Late determination of ineligibility|0|||
143331220|NCT02723864|516756404|FG003|Overall Study|Late determination of ineligibility|0|||
143331221|NCT02723864|516756405|FG004|Overall Study|Late determination of ineligibility|0|||
143331222|NCT02723864|516756406|FG005|Overall Study|Late determination of ineligibility|1|||
143331223|NCT02723864|516756407|FG006|Overall Study|Late determination of ineligibility|0|||
143331224|NCT01733732|516756412|FG000|Overall Study|Adverse Event|1|||
143331225|NCT01733732|516756413|FG001|Overall Study|Adverse Event|0|||
143331226|NCT01733732|516756412|FG000|Overall Study|Did not attend all study visits|1|||
143331227|NCT01733732|516756413|FG001|Overall Study|Did not attend all study visits|0|||
143331228|NCT03643952|516756414|FG000|Overall Study|Lack of Efficacy|1|||
143331229|NCT02807558|516756419|FG000|Overall Study|Consent withdrawn by participant|4|||
143331230|NCT02807558|516756420|FG001|Overall Study|Consent withdrawn by participant|0|||
143331231|NCT02807558|516756421|FG002|Overall Study|Consent withdrawn by participant|4|||
143331232|NCT02807558|516756422|FG003|Overall Study|Consent withdrawn by participant|2|||
143331233|NCT02807558|516756423|FG004|Overall Study|Consent withdrawn by participant|1|||
143331234|NCT02807558|516756424|FG005|Overall Study|Consent withdrawn by participant|0|||
143331235|NCT02807558|516756419|FG000|Overall Study|Non-compliance with Study Drug|0|||
143331236|NCT02807558|516756420|FG001|Overall Study|Non-compliance with Study Drug|0|||
143331237|NCT02807558|516756421|FG002|Overall Study|Non-compliance with Study Drug|1|||
143331238|NCT02807558|516756422|FG003|Overall Study|Non-compliance with Study Drug|0|||
143331239|NCT02807558|516756423|FG004|Overall Study|Non-compliance with Study Drug|0|||
143331240|NCT02807558|516756424|FG005|Overall Study|Non-compliance with Study Drug|0|||
143331241|NCT02807558|516756419|FG000|Overall Study|Adverse Event|0|||
143331242|NCT02807558|516756420|FG001|Overall Study|Adverse Event|0|||
143331243|NCT02807558|516756421|FG002|Overall Study|Adverse Event|9|||
143331244|NCT02807558|516756422|FG003|Overall Study|Adverse Event|0|||
143331245|NCT02807558|516756423|FG004|Overall Study|Adverse Event|0|||
143331246|NCT02807558|516756424|FG005|Overall Study|Adverse Event|0|||
143331247|NCT02807558|516756419|FG000|Overall Study|Death|23|||
143331248|NCT02807558|516756420|FG001|Overall Study|Death|2|||
143331249|NCT02807558|516756421|FG002|Overall Study|Death|3|||
143331250|NCT02807558|516756422|FG003|Overall Study|Death|43|||
143331251|NCT02807558|516756423|FG004|Overall Study|Death|24|||
143331252|NCT02807558|516756424|FG005|Overall Study|Death|15|||
143331253|NCT02807558|516756419|FG000|Overall Study|Progressive Disease|0|||
143331254|NCT02807558|516756420|FG001|Overall Study|Progressive Disease|0|||
143331255|NCT02807558|516756421|FG002|Overall Study|Progressive Disease|1|||
143331256|NCT02807558|516756422|FG003|Overall Study|Progressive Disease|0|||
143331257|NCT02807558|516756423|FG004|Overall Study|Progressive Disease|0|||
143331258|NCT02807558|516756424|FG005|Overall Study|Progressive Disease|0|||
143331259|NCT02807558|516756419|FG000|Overall Study|Other than specified|1|||
143331260|NCT02807558|516756420|FG001|Overall Study|Other than specified|0|||
143331261|NCT02807558|516756421|FG002|Overall Study|Other than specified|2|||
143331262|NCT02807558|516756422|FG003|Overall Study|Other than specified|0|||
143331263|NCT02807558|516756423|FG004|Overall Study|Other than specified|1|||
143331264|NCT02807558|516756424|FG005|Overall Study|Other than specified|1|||
143331265|NCT02807558|516756419|FG000|Overall Study|Lack of Efficacy|0|||
143331266|NCT02807558|516756420|FG001|Overall Study|Lack of Efficacy|0|||
143331267|NCT02807558|516756421|FG002|Overall Study|Lack of Efficacy|9|||
143331268|NCT02807558|516756422|FG003|Overall Study|Lack of Efficacy|0|||
143331269|NCT02807558|516756423|FG004|Overall Study|Lack of Efficacy|0|||
143331270|NCT02807558|516756424|FG005|Overall Study|Lack of Efficacy|0|||
143331271|NCT03644186|516756425|FG000|Overall Study|Withdrawal by Subject|1|||
143331272|NCT03644186|516756426|FG001|Overall Study|Withdrawal by Subject|1|||
143331273|NCT02701985|516756429|FG000|Overall Study|Withdrawal by Subject|1|||
143331274|NCT02701985|516756430|FG001|Overall Study|Withdrawal by Subject|1|||
143331275|NCT02701985|516756429|FG000|Overall Study|Lost to Follow-up|1|||
143331276|NCT02701985|516756430|FG001|Overall Study|Lost to Follow-up|0|||
143331277|NCT02701985|516756429|FG000|Overall Study|Death|1|||
143331278|NCT02701985|516756430|FG001|Overall Study|Death|0|||
143383688|NCT03338816|516950251|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
143331279|NCT02701985|516756429|FG000|Overall Study|Adverse Event|0|||
143331280|NCT02701985|516756430|FG001|Overall Study|Adverse Event|5|||
143331281|NCT04391023|516756431|FG000|Overall Study|Withdrawal by Subject|2|||
143331282|NCT04391023|516756432|FG001|Overall Study|Withdrawal by Subject|2|||
143331283|NCT02085408|516756436|FG000|Step 1: Induction|Disease Progression|19|||
143331284|NCT02085408|516756437|FG001|Step 1: Induction|Disease Progression|19|||
143331285|NCT02085408|516756436|FG000|Step 1: Induction|Adverse Event|18|||
143331286|NCT02085408|516756437|FG001|Step 1: Induction|Adverse Event|17|||
143331287|NCT02085408|516756436|FG000|Step 1: Induction|Death|33|||
143331288|NCT02085408|516756437|FG001|Step 1: Induction|Death|30|||
143331289|NCT02085408|516756436|FG000|Step 1: Induction|Withdrawal by Subject|16|||
143331290|NCT02085408|516756437|FG001|Step 1: Induction|Withdrawal by Subject|8|||
143331291|NCT02085408|516756436|FG000|Step 1: Induction|Alternative Therapy|15|||
143331292|NCT02085408|516756437|FG001|Step 1: Induction|Alternative Therapy|19|||
143331293|NCT02085408|516756436|FG000|Step 1: Induction|Complicating Disease|2|||
143331294|NCT02085408|516756437|FG001|Step 1: Induction|Complicating Disease|3|||
143331295|NCT02085408|516756436|FG000|Step 1: Induction|Other|27|||
143331296|NCT02085408|516756437|FG001|Step 1: Induction|Other|39|||
143331297|NCT02085408|516756436|FG000|Step 1: Induction|Never started treatment|6|||
143331298|NCT02085408|516756437|FG001|Step 1: Induction|Never started treatment|4|||
143331299|NCT02085408|516756436|FG000|Step 2: Consolidation|Disease Progression|5|||
143331300|NCT02085408|516756437|FG001|Step 2: Consolidation|Disease Progression|20|||
143331301|NCT02085408|516756436|FG000|Step 2: Consolidation|Adverse Event|9|||
143331302|NCT02085408|516756437|FG001|Step 2: Consolidation|Adverse Event|8|||
143331303|NCT02085408|516756436|FG000|Step 2: Consolidation|Death|4|||
143331304|NCT02085408|516756437|FG001|Step 2: Consolidation|Death|3|||
143331305|NCT02085408|516756436|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
143331306|NCT02085408|516756437|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
143331307|NCT02085408|516756436|FG000|Step 2: Consolidation|Alternative Therapy|9|||
143331308|NCT02085408|516756437|FG001|Step 2: Consolidation|Alternative Therapy|3|||
143331309|NCT02085408|516756436|FG000|Step 2: Consolidation|Complicating Disease|0|||
143331310|NCT02085408|516756437|FG001|Step 2: Consolidation|Complicating Disease|2|||
143331311|NCT02085408|516756436|FG000|Step 2: Consolidation|Other|6|||
143331312|NCT02085408|516756437|FG001|Step 2: Consolidation|Other|6|||
143331313|NCT02085408|516756436|FG000|Step 2: Consolidation|Never started treatment|4|||
143331314|NCT02085408|516756437|FG001|Step 2: Consolidation|Never started treatment|3|||
143331315|NCT02085408|516756436|FG000|Step 3: Maintenance|Disease Progression|13|||
143331316|NCT02085408|516756437|FG001|Step 3: Maintenance|Disease Progression|11|||
143331317|NCT02085408|516756436|FG000|Step 3: Maintenance|Adverse Event|2|||
143331318|NCT02085408|516756437|FG001|Step 3: Maintenance|Adverse Event|4|||
143331319|NCT02085408|516756436|FG000|Step 3: Maintenance|Death|1|||
143331320|NCT02085408|516756437|FG001|Step 3: Maintenance|Death|2|||
143331321|NCT02085408|516756436|FG000|Step 3: Maintenance|Alternative Therapy|1|||
143331322|NCT02085408|516756437|FG001|Step 3: Maintenance|Alternative Therapy|1|||
143331323|NCT02085408|516756436|FG000|Step 3: Maintenance|Complicating Disease|0|||
143331324|NCT02085408|516756437|FG001|Step 3: Maintenance|Complicating Disease|1|||
143331325|NCT02085408|516756436|FG000|Step 3: Maintenance|Other|3|||
143331326|NCT02085408|516756437|FG001|Step 3: Maintenance|Other|2|||
143331327|NCT02085408|516756436|FG000|Step 3: Maintenance|Never started treatment|5|||
143331328|NCT02085408|516756437|FG001|Step 3: Maintenance|Never started treatment|1|||
143331329|NCT02189798|516756438|FG000|Extended Use Phase|Withdrawal by Subject|0|||
143331330|NCT02189798|516756439|FG001|Extended Use Phase|Withdrawal by Subject|4|||
143331331|NCT02189798|516756438|FG000|Extended Use Phase|Physician Decision|1|||
143331332|NCT02189798|516756439|FG001|Extended Use Phase|Physician Decision|0|||
143331333|NCT02189798|516756438|FG000|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|11|||
143331334|NCT02189798|516756439|FG001|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|1|||
143331335|NCT02189798|516756438|FG000|Extended Use Phase|Explanted prior to 24 month visit|1|||
143331336|NCT02189798|516756439|FG001|Extended Use Phase|Explanted prior to 24 month visit|0|||
143331337|NCT02189798|516756438|FG000|Extended Use Phase|Travel Issues|2|||
143331338|NCT02189798|516756439|FG001|Extended Use Phase|Travel Issues|1|||
143331339|NCT02189798|516756438|FG000|Extended Use Phase|No longer perceiving a benefit from acoustic component|0|||
143331340|NCT02189798|516756439|FG001|Extended Use Phase|No longer perceiving a benefit from acoustic component|3|||
143331341|NCT05553808|516756442|FG000|Overall Study|Death|25|||
143331342|NCT05553808|516756443|FG001|Overall Study|Death|62|||
143331343|NCT05553808|516756442|FG000|Overall Study|Site Closed|6|||
143331344|NCT05553808|516756443|FG001|Overall Study|Site Closed|6|||
143331345|NCT05553808|516756442|FG000|Overall Study|Lost to Follow-up|1|||
143331346|NCT05553808|516756443|FG001|Overall Study|Lost to Follow-up|0|||
143331347|NCT05553808|516756442|FG000|Overall Study|Withdrawal by Subject|3|||
143331348|NCT05553808|516756443|FG001|Overall Study|Withdrawal by Subject|2|||
143331349|NCT02273141|516756444|FG000|Overall Study|Adverse Event|0|||
143331350|NCT02273141|516756445|FG001|Overall Study|Adverse Event|1|||
143331351|NCT02273141|516756444|FG000|Overall Study|Lost to Follow-up|1|||
143331352|NCT02273141|516756445|FG001|Overall Study|Lost to Follow-up|3|||
143331353|NCT02273141|516756444|FG000|Overall Study|Withdrawal by Subject|10|||
143331354|NCT02273141|516756445|FG001|Overall Study|Withdrawal by Subject|15|||
143331355|NCT02273141|516756444|FG000|Overall Study|Various|6|||
143331356|NCT02273141|516756445|FG001|Overall Study|Various|6|||
143331357|NCT00529399|516756446|FG000|Overall Study|Lost to Follow-up|1|||
143331358|NCT00529399|516756447|FG001|Overall Study|Lost to Follow-up|0|||
143331359|NCT00529399|516756448|FG002|Overall Study|Lost to Follow-up|1|||
143331360|NCT00529399|516756446|FG000|Overall Study|Withdrawal by Subject|1|||
143331361|NCT00529399|516756447|FG001|Overall Study|Withdrawal by Subject|0|||
143331362|NCT00529399|516756448|FG002|Overall Study|Withdrawal by Subject|1|||
143331363|NCT00529399|516756446|FG000|Overall Study|Non-compliant|0|||
143331364|NCT00529399|516756447|FG001|Overall Study|Non-compliant|1|||
143331365|NCT00529399|516756448|FG002|Overall Study|Non-compliant|0|||
143331366|NCT02576678|516756459|FG000|Overall Study|Adverse Event|0|||
143331367|NCT02576678|516756460|FG001|Overall Study|Adverse Event|0|||
143331368|NCT02576678|516756461|FG002|Overall Study|Adverse Event|2|||
143331369|NCT02576678|516756459|FG000|Overall Study|Withdrawal by Subject|3|||
143331370|NCT02576678|516756460|FG001|Overall Study|Withdrawal by Subject|1|||
143331371|NCT02576678|516756461|FG002|Overall Study|Withdrawal by Subject|2|||
143331372|NCT02576678|516756459|FG000|Overall Study|Lost to Follow-up|0|||
143331373|NCT02576678|516756460|FG001|Overall Study|Lost to Follow-up|0|||
143331374|NCT02576678|516756461|FG002|Overall Study|Lost to Follow-up|1|||
143331375|NCT02576678|516756459|FG000|Overall Study|Miscellaneous|2|||
143331376|NCT02576678|516756460|FG001|Overall Study|Miscellaneous|0|||
143331377|NCT02576678|516756461|FG002|Overall Study|Miscellaneous|0|||
143331378|NCT00584727|516756462|FG000|First Intervention|Discontinuation|0|||
143331379|NCT00584727|516756463|FG001|First Intervention|Discontinuation|0|||
143331380|NCT00584727|516756464|FG002|First Intervention|Discontinuation|1|||
143331381|NCT00584727|516756465|FG003|First Intervention|Discontinuation|0|||
143331382|NCT00584727|516756466|FG004|First Intervention|Discontinuation|0|||
143331383|NCT00584727|516756467|FG005|First Intervention|Discontinuation|0|||
143331384|NCT00584727|516756462|FG000|Third Intervention|Protocol Violation|0|||
143331385|NCT00584727|516756463|FG001|Third Intervention|Protocol Violation|0|||
143331386|NCT00584727|516756464|FG002|Third Intervention|Protocol Violation|1|||
143331387|NCT00584727|516756465|FG003|Third Intervention|Protocol Violation|0|||
143331388|NCT00584727|516756466|FG004|Third Intervention|Protocol Violation|4|||
143331389|NCT00584727|516756467|FG005|Third Intervention|Protocol Violation|2|||
143331390|NCT00729833|516756470|FG000|Overall Study|Death|5|||
143331391|NCT00729833|516756471|FG001|Overall Study|Death|1|||
143331392|NCT00729833|516756472|FG002|Overall Study|Death|3|||
143331393|NCT00729833|516756473|FG003|Overall Study|Death|5|||
143331394|NCT00729833|516756470|FG000|Overall Study|Study Terminated by Sponsor|0|||
143331395|NCT00729833|516756471|FG001|Overall Study|Study Terminated by Sponsor|0|||
143331396|NCT00729833|516756472|FG002|Overall Study|Study Terminated by Sponsor|1|||
143331397|NCT00729833|516756473|FG003|Overall Study|Study Terminated by Sponsor|0|||
143331398|NCT00729833|516756470|FG000|Overall Study|Lost to Follow-up|1|||
143331399|NCT00729833|516756471|FG001|Overall Study|Lost to Follow-up|0|||
143331400|NCT00729833|516756472|FG002|Overall Study|Lost to Follow-up|0|||
143331401|NCT00729833|516756473|FG003|Overall Study|Lost to Follow-up|0|||
143331402|NCT00729833|516756470|FG000|Overall Study|Withdrawal by Subject|3|||
143331403|NCT00729833|516756471|FG001|Overall Study|Withdrawal by Subject|1|||
143331404|NCT00729833|516756472|FG002|Overall Study|Withdrawal by Subject|3|||
143331405|NCT00729833|516756473|FG003|Overall Study|Withdrawal by Subject|0|||
143331406|NCT00729833|516756470|FG000|Overall Study|Unspecified Reasons|11|||
143331407|NCT00729833|516756471|FG001|Overall Study|Unspecified Reasons|5|||
143331408|NCT00729833|516756472|FG002|Overall Study|Unspecified Reasons|5|||
143331409|NCT00729833|516756473|FG003|Overall Study|Unspecified Reasons|1|||
143331410|NCT03152552|516756474|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
143331411|NCT03152552|516756475|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
143331412|NCT03152552|516756476|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
143331413|NCT03152552|516756477|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
143331414|NCT03152552|516756478|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
143331415|NCT03152552|516756474|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
143331416|NCT03152552|516756475|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
143331417|NCT03152552|516756476|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
143331418|NCT03152552|516756477|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
143331419|NCT03152552|516756478|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
143331420|NCT03152552|516756474|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
143331421|NCT03152552|516756475|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
143331422|NCT03152552|516756476|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
143331423|NCT03152552|516756477|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
143331424|NCT03152552|516756478|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
143331425|NCT03152552|516756474|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
143331426|NCT03152552|516756475|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
143331427|NCT03152552|516756476|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
143331428|NCT03152552|516756477|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
143331429|NCT03152552|516756478|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
143331430|NCT03152552|516756474|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
143331431|NCT03152552|516756475|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
143331432|NCT03152552|516756476|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
143331433|NCT03152552|516756477|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
143331434|NCT03152552|516756478|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
143331435|NCT03152552|516756474|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
143331436|NCT03152552|516756475|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
143331437|NCT03152552|516756476|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
143331438|NCT03152552|516756477|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
143331439|NCT03152552|516756478|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
143331440|NCT03152552|516756474|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
143331441|NCT03152552|516756475|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
143331442|NCT03152552|516756476|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
143331443|NCT03152552|516756477|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
143331444|NCT03152552|516756478|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
143331445|NCT01300546|516756481|FG000|Overall Study|Withdrawal by Subject|1|||
143331446|NCT01300546|516756482|FG001|Overall Study|Withdrawal by Subject|0|||
143331447|NCT01300546|516756481|FG000|Overall Study|Lost to Follow-up|0|||
143331448|NCT01300546|516756482|FG001|Overall Study|Lost to Follow-up|2|||
143331449|NCT01300546|516756481|FG000|Overall Study|Lack of Efficacy|0|||
143331450|NCT01300546|516756482|FG001|Overall Study|Lack of Efficacy|3|||
143331451|NCT01300546|516756481|FG000|Overall Study|Adverse Event|0|||
143331452|NCT01300546|516756482|FG001|Overall Study|Adverse Event|1|||
143331453|NCT00127608|516756487|FG000|Overall Study|VZV DNA negative|1|||
143331454|NCT05245864|516756488|FG000|Overall Study|Withdrawal by Subject|1|||
143331455|NCT05245864|516756489|FG001|Overall Study|Withdrawal by Subject|1|||
143331456|NCT01329029|516756492|FG000|Overall Study|Withdrawal by Subject|117|||
143331457|NCT01329029|516756493|FG001|Overall Study|Withdrawal by Subject|87|||
143331458|NCT01329029|516756492|FG000|Overall Study|Adverse Event|82|||
143331459|NCT01329029|516756493|FG001|Overall Study|Adverse Event|29|||
143331460|NCT01329029|516756492|FG000|Overall Study|Death|16|||
143331461|NCT01329029|516756493|FG001|Overall Study|Death|19|||
143331462|NCT01329029|516756492|FG000|Overall Study|Other|14|||
143331463|NCT01329029|516756493|FG001|Overall Study|Other|20|||
143331464|NCT01329029|516756492|FG000|Overall Study|COPD Exacerbation|11|||
143331465|NCT01329029|516756493|FG001|Overall Study|COPD Exacerbation|18|||
143331466|NCT01329029|516756492|FG000|Overall Study|Physician Decision|16|||
143331467|NCT01329029|516756493|FG001|Overall Study|Physician Decision|13|||
143331468|NCT01329029|516756492|FG000|Overall Study|Lost to Follow-up|8|||
143331469|NCT01329029|516756493|FG001|Overall Study|Lost to Follow-up|5|||
143331470|NCT01329029|516756492|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
143331471|NCT01329029|516756493|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
143331472|NCT00680407|516756499|FG000|Overall Study|Lost to Follow-up|3|||
143331473|NCT00680407|516756500|FG001|Overall Study|Lost to Follow-up|3|||
143331474|NCT00680407|516756501|FG002|Overall Study|Lost to Follow-up|1|||
143331475|NCT00680407|516756499|FG000|Overall Study|Withdrawal by Subject|5|||
143331476|NCT00680407|516756500|FG001|Overall Study|Withdrawal by Subject|2|||
143331477|NCT00680407|516756501|FG002|Overall Study|Withdrawal by Subject|2|||
143331478|NCT00506493|516756502|FG000|Overall Study|Death|6|||
143331479|NCT00506493|516756502|FG000|Overall Study|Withdrawal by Subject|5|||
143331480|NCT03576768|516758001|FG000|Overall Study|Lost to Follow-up|3|||
143331481|NCT03576768|516758002|FG001|Overall Study|Lost to Follow-up|3|||
143331482|NCT03576768|516758003|FG002|Overall Study|Lost to Follow-up|0|||
143331483|NCT03576768|516758004|FG003|Overall Study|Lost to Follow-up|0|||
143331484|NCT00590902|516758005|FG000|Overall Study|Death|1|||
143331485|NCT00785291|516758006|FG000|Overall Study|Never began treatment|8|||
143331486|NCT00785291|516758007|FG001|Overall Study|Never began treatment|4|||
143331487|NCT00785291|516758008|FG002|Overall Study|Never began treatment|4|||
143331488|NCT00785291|516758006|FG000|Overall Study|Adverse Event|39|||
143331489|NCT00785291|516758007|FG001|Overall Study|Adverse Event|70|||
143331490|NCT00785291|516758008|FG002|Overall Study|Adverse Event|56|||
143331491|NCT00785291|516758006|FG000|Overall Study|Death|7|||
143331492|NCT00785291|516758007|FG001|Overall Study|Death|4|||
143331493|NCT00785291|516758008|FG002|Overall Study|Death|3|||
143331494|NCT00785291|516758006|FG000|Overall Study|Withdrawal by Subject|35|||
143331495|NCT00785291|516758007|FG001|Overall Study|Withdrawal by Subject|36|||
143331496|NCT00785291|516758008|FG002|Overall Study|Withdrawal by Subject|17|||
143331497|NCT00785291|516758006|FG000|Overall Study|Alternative Therapy|12|||
143331498|NCT00785291|516758007|FG001|Overall Study|Alternative Therapy|6|||
143331499|NCT00785291|516758008|FG002|Overall Study|Alternative Therapy|7|||
143383689|NCT03338816|516950252|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
143383690|NCT03338816|516950249|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
143331500|NCT00785291|516758006|FG000|Overall Study|Complicating illness|6|||
143331501|NCT00785291|516758007|FG001|Overall Study|Complicating illness|4|||
143331502|NCT00785291|516758008|FG002|Overall Study|Complicating illness|4|||
143331503|NCT00785291|516758006|FG000|Overall Study|Other Medical Reasons|29|||
143331504|NCT00785291|516758007|FG001|Overall Study|Other Medical Reasons|25|||
143331505|NCT00785291|516758008|FG002|Overall Study|Other Medical Reasons|15|||
143331506|NCT02119260|516758009|FG000|Overall Study|Adverse Event|1|||
143331507|NCT02119260|516758010|FG001|Overall Study|Adverse Event|0|||
143331508|NCT02119260|516758011|FG002|Overall Study|Adverse Event|0|||
143331509|NCT02119260|516758012|FG003|Overall Study|Adverse Event|0|||
143331510|NCT02119260|516758013|FG004|Overall Study|Adverse Event|0|||
143331511|NCT02119260|516758014|FG005|Overall Study|Adverse Event|0|||
143331512|NCT02119260|516758015|FG006|Overall Study|Adverse Event|0|||
143331513|NCT02119260|516758009|FG000|Overall Study|Withdrew consent|0|||
143331514|NCT02119260|516758010|FG001|Overall Study|Withdrew consent|1|||
143331515|NCT02119260|516758011|FG002|Overall Study|Withdrew consent|1|||
143331516|NCT02119260|516758012|FG003|Overall Study|Withdrew consent|0|||
143331517|NCT02119260|516758013|FG004|Overall Study|Withdrew consent|0|||
143331518|NCT02119260|516758014|FG005|Overall Study|Withdrew consent|0|||
143331519|NCT02119260|516758015|FG006|Overall Study|Withdrew consent|0|||
143331520|NCT00440531|516758019|FG000|Overall Study|Adverse Event|1|||
143331521|NCT00440531|516758020|FG001|Overall Study|Adverse Event|0|||
143331522|NCT00440531|516758021|FG002|Overall Study|Adverse Event|2|||
143331523|NCT00440531|516758019|FG000|Overall Study|Withdrawal by Subject|2|||
143331524|NCT00440531|516758020|FG001|Overall Study|Withdrawal by Subject|0|||
143331525|NCT00440531|516758021|FG002|Overall Study|Withdrawal by Subject|0|||
143331526|NCT00440531|516758019|FG000|Overall Study|Protocol Violation|1|||
143331527|NCT00440531|516758020|FG001|Overall Study|Protocol Violation|2|||
143331528|NCT00440531|516758021|FG002|Overall Study|Protocol Violation|0|||
143331529|NCT00440531|516758019|FG000|Overall Study|Lost to Follow-up|4|||
143331530|NCT00440531|516758020|FG001|Overall Study|Lost to Follow-up|3|||
143331531|NCT00440531|516758021|FG002|Overall Study|Lost to Follow-up|5|||
143331532|NCT00440531|516758019|FG000|Overall Study|see pre-assignment details|2|||
143331533|NCT00440531|516758020|FG001|Overall Study|see pre-assignment details|0|||
143331534|NCT00440531|516758021|FG002|Overall Study|see pre-assignment details|0|||
143331535|NCT00447057|516758022|FG000|Overall Study|Adverse Event|4|||
143331536|NCT00447057|516758023|FG001|Overall Study|Adverse Event|10|||
143331537|NCT00447057|516758024|FG002|Overall Study|Adverse Event|0|||
143331538|NCT00447057|516758025|FG003|Overall Study|Adverse Event|3|||
143331539|NCT00447057|516758022|FG000|Overall Study|Death due to study disease|6|||
143331540|NCT00447057|516758023|FG001|Overall Study|Death due to study disease|4|||
143331541|NCT00447057|516758024|FG002|Overall Study|Death due to study disease|1|||
143331542|NCT00447057|516758025|FG003|Overall Study|Death due to study disease|1|||
143331543|NCT00447057|516758022|FG000|Overall Study|Lost to Follow-up|0|||
143331544|NCT00447057|516758023|FG001|Overall Study|Lost to Follow-up|1|||
143331545|NCT00447057|516758024|FG002|Overall Study|Lost to Follow-up|0|||
143331546|NCT00447057|516758025|FG003|Overall Study|Lost to Follow-up|0|||
143331547|NCT00447057|516758022|FG000|Overall Study|Entry criteria not met|1|||
143331548|NCT00447057|516758023|FG001|Overall Study|Entry criteria not met|1|||
143331549|NCT00447057|516758024|FG002|Overall Study|Entry criteria not met|0|||
143331550|NCT00447057|516758025|FG003|Overall Study|Entry criteria not met|0|||
143331551|NCT00447057|516758022|FG000|Overall Study|Protocol Violation|0|||
143331552|NCT00447057|516758023|FG001|Overall Study|Protocol Violation|1|||
143331553|NCT00447057|516758024|FG002|Overall Study|Protocol Violation|0|||
143331554|NCT00447057|516758025|FG003|Overall Study|Protocol Violation|0|||
143331555|NCT00447057|516758022|FG000|Overall Study|Withdrawal by Subject|4|||
143331556|NCT00447057|516758023|FG001|Overall Study|Withdrawal by Subject|5|||
143331557|NCT00447057|516758024|FG002|Overall Study|Withdrawal by Subject|1|||
143331558|NCT00447057|516758025|FG003|Overall Study|Withdrawal by Subject|1|||
143331559|NCT00447057|516758022|FG000|Overall Study|Physician Decision|9|||
143331560|NCT00447057|516758023|FG001|Overall Study|Physician Decision|6|||
143331561|NCT00447057|516758024|FG002|Overall Study|Physician Decision|3|||
143331562|NCT00447057|516758025|FG003|Overall Study|Physician Decision|1|||
143331563|NCT00447057|516758022|FG000|Overall Study|Sponsor decision|1|||
143331564|NCT00447057|516758023|FG001|Overall Study|Sponsor decision|1|||
143331565|NCT00447057|516758024|FG002|Overall Study|Sponsor decision|0|||
143331566|NCT00447057|516758025|FG003|Overall Study|Sponsor decision|0|||
143331567|NCT00447057|516758022|FG000|Overall Study|Progressive disease|58|||
143331568|NCT00447057|516758023|FG001|Overall Study|Progressive disease|43|||
143331569|NCT00447057|516758024|FG002|Overall Study|Progressive disease|13|||
143331570|NCT00447057|516758025|FG003|Overall Study|Progressive disease|18|||
143331571|NCT00447057|516758022|FG000|Overall Study|Death due to adverse event|0|||
143331572|NCT00447057|516758023|FG001|Overall Study|Death due to adverse event|0|||
143331573|NCT00447057|516758024|FG002|Overall Study|Death due to adverse event|1|||
143331574|NCT00447057|516758025|FG003|Overall Study|Death due to adverse event|2|||
143331575|NCT00447057|516758022|FG000|Overall Study|Death, study drug related|0|||
143331576|NCT00447057|516758023|FG001|Overall Study|Death, study drug related|1|||
143331577|NCT00447057|516758024|FG002|Overall Study|Death, study drug related|0|||
143331578|NCT00447057|516758025|FG003|Overall Study|Death, study drug related|0|||
143383691|NCT03338816|516950250|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
143383692|NCT03338816|516950251|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
143383693|NCT03338816|516950252|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
143383694|NCT04238247|516950253|FG000|Phase 1: Baseline Intervention|Withdrawal by Subject|3|||
143383695|NCT04238247|516950254|FG001|Phase 1: Baseline Intervention|Withdrawal by Subject|19|||
143383696|NCT04238247|516950255|FG002|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
143383697|NCT04238247|516950256|FG003|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
143383698|NCT04238247|516950253|FG000|Phase 1: Baseline Intervention|Lost to Follow-up|11|||
143383699|NCT04238247|516950254|FG001|Phase 1: Baseline Intervention|Lost to Follow-up|49|||
143383700|NCT04238247|516950255|FG002|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
143383701|NCT04238247|516950256|FG003|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
143383702|NCT04238247|516950253|FG000|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
143383703|NCT04238247|516950254|FG001|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|1|||
143383704|NCT04238247|516950255|FG002|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
143383705|NCT04238247|516950256|FG003|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|2|||
143383706|NCT04238247|516950253|FG000|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|7|||
143383707|NCT04238247|516950254|FG001|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|11|||
143383708|NCT04238247|516950255|FG002|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|8|||
143383709|NCT04238247|516950256|FG003|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|4|||
143383710|NCT03833167|516950261|FG000|Overall Study|Withdrawal by Subject|4|||
143383711|NCT03833167|516950262|FG001|Overall Study|Withdrawal by Subject|6|||
143383712|NCT03833167|516950261|FG000|Overall Study|Ongoing|186|||
143383713|NCT03833167|516950262|FG001|Overall Study|Ongoing|194|||
143383714|NCT03833167|516950261|FG000|Overall Study|Lost to Follow-up|1|||
143383715|NCT03833167|516950262|FG001|Overall Study|Lost to Follow-up|1|||
143383716|NCT03833167|516950261|FG000|Overall Study|Physician Decision|0|||
143383717|NCT03833167|516950262|FG001|Overall Study|Physician Decision|2|||
143383718|NCT03833167|516950261|FG000|Overall Study|Death|34|||
143383719|NCT03833167|516950262|FG001|Overall Study|Death|22|||
143383720|NCT01948661|516950263|FG000|Overall Study|Withdrawal by Subject|2|||
143383721|NCT01948661|516950264|FG001|Overall Study|Withdrawal by Subject|4|||
143383722|NCT06061081|516950265|FG000|Overall Study|Withdrawal by Subject|1|||
143383723|NCT06061081|516950266|FG001|Overall Study|Withdrawal by Subject|0|||
143383724|NCT06061081|516950267|FG002|Overall Study|Withdrawal by Subject|0|||
143383725|NCT06061081|516950268|FG003|Overall Study|Withdrawal by Subject|0|||
143383726|NCT06061081|516950269|FG004|Overall Study|Withdrawal by Subject|0|||
143383727|NCT02252172|516950270|FG000|Overall Study|Lost to Follow-up|9|||
143383728|NCT02252172|516950271|FG001|Overall Study|Lost to Follow-up|6|||
143383729|NCT02252172|516950270|FG000|Overall Study|Death|218|||
143383730|NCT02252172|516950271|FG001|Overall Study|Death|175|||
143383731|NCT02252172|516950270|FG000|Overall Study|Withdrawal by Subject|20|||
143383732|NCT02252172|516950271|FG001|Overall Study|Withdrawal by Subject|15|||
143383733|NCT02252172|516950270|FG000|Overall Study|Physician Decision|0|||
143383734|NCT02252172|516950271|FG001|Overall Study|Physician Decision|1|||
143383735|NCT02252172|516950270|FG000|Overall Study|End of data collection|122|||
143383736|NCT02252172|516950271|FG001|Overall Study|End of data collection|170|||
143383737|NCT02252172|516950270|FG000|Overall Study|Site closure|0|||
143383738|NCT02252172|516950271|FG001|Overall Study|Site closure|1|||
143383739|NCT05575076|516950272|FG000|Overall Study|Adverse Event|24|||
143383740|NCT05575076|516950272|FG000|Overall Study|Death|7|||
143383741|NCT05575076|516950272|FG000|Overall Study|Lost to Follow-up|16|||
143383742|NCT05575076|516950272|FG000|Overall Study|Non-Compliance|3|||
143383743|NCT05575076|516950272|FG000|Overall Study|Physician Decision|6|||
143383744|NCT05575076|516950272|FG000|Overall Study|Sponsor Requests to be Withdrawn|7|||
143383745|NCT05575076|516950272|FG000|Overall Study|Withdrawal by Subject|71|||
143383746|NCT05575076|516950272|FG000|Overall Study|Study Terminated by Sponsor|630|||
143383747|NCT05575076|516950272|FG000|Overall Study|Other|17|||
143383748|NCT03380390|516950273|FG000|Overall Study|Adverse Event|3|||
143383749|NCT02886286|516950274|FG000|Overall Study|pump motor stall|0|||
143383750|NCT02886286|516950275|FG001|Overall Study|pump motor stall|1|||
143383751|NCT01127373|516950276|FG000|Overall Study|Not Treated|3|||
143383752|NCT01127373|516950276|FG000|Overall Study|Lost to Follow-up|7|||
143383753|NCT01127373|516950276|FG000|Overall Study|Withdrawal by Subject|1|||
143383754|NCT01127373|516950276|FG000|Overall Study|Disease progression|1|||
143383755|NCT00522951|516950281|FG000|Period 1|body motion|0|||
143383756|NCT00522951|516950282|FG001|Period 1|body motion|1|||
143383757|NCT00522951|516950281|FG000|Washout Period|Adverse Event|0|||
143383758|NCT00522951|516950282|FG001|Washout Period|Adverse Event|1|||
143383759|NCT00522951|516950281|FG000|Washout Period|Death|0|||
143383760|NCT00522951|516950282|FG001|Washout Period|Death|1|||
143383761|NCT00522951|516950281|FG000|Period 2|Withdrawal by Subject|1|||
143383762|NCT00522951|516950282|FG001|Period 2|Withdrawal by Subject|0|||
143383763|NCT00522951|516950281|FG000|Period 2|residual contrast medium|1|||
143383764|NCT00522951|516950282|FG001|Period 2|residual contrast medium|1|||
143383765|NCT01426412|516950285|FG000|Overall Study|Withdrawal by Subject|1|||
143383766|NCT01426412|516950286|FG001|Overall Study|Withdrawal by Subject|0|||
143383767|NCT01426412|516950287|FG002|Overall Study|Withdrawal by Subject|0|||
143383768|NCT01426412|516950288|FG003|Overall Study|Withdrawal by Subject|0|||
143383769|NCT01426412|516950289|FG004|Overall Study|Withdrawal by Subject|1|||
143383770|NCT01426412|516950290|FG005|Overall Study|Withdrawal by Subject|0|||
143383771|NCT01426412|516950291|FG006|Overall Study|Withdrawal by Subject|0|||
143383772|NCT01426412|516950292|FG007|Overall Study|Withdrawal by Subject|3|||
143383773|NCT01426412|516950293|FG008|Overall Study|Withdrawal by Subject|1|||
143383774|NCT02376790|516950294|FG000|Overall Study|Withdrawal by Subject|43|||
143383775|NCT02376790|516950295|FG001|Overall Study|Withdrawal by Subject|36|||
143383776|NCT02376790|516950296|FG002|Overall Study|Withdrawal by Subject|37|||
143331579|NCT01549613|516758033|FG000|Overall Study|Lost to Follow-up|11|||
143331580|NCT01549613|516758034|FG001|Overall Study|Lost to Follow-up|11|||
143383777|NCT02376790|516950294|FG000|Overall Study|Decision by Sponsor|2|||
143383778|NCT02376790|516950295|FG001|Overall Study|Decision by Sponsor|1|||
143383779|NCT02376790|516950296|FG002|Overall Study|Decision by Sponsor|4|||
143383780|NCT02376790|516950294|FG000|Overall Study|Lost to Follow-up|15|||
143383781|NCT02376790|516950295|FG001|Overall Study|Lost to Follow-up|10|||
143383782|NCT02376790|516950296|FG002|Overall Study|Lost to Follow-up|12|||
143383783|NCT03014453|516950297|FG000|Overall Study|Lost to Follow-up|12|||
143383784|NCT03014453|516950297|FG000|Overall Study|Discontinued GER|3|||
143383785|NCT03014453|516950297|FG000|Overall Study|Excluded|19|||
143331581|NCT02216123|516758035|FG000|Overall Study|Lost to Follow-up|4|||
143331582|NCT02216123|516758036|FG001|Overall Study|Lost to Follow-up|2|||
143331583|NCT02216123|516758035|FG000|Overall Study|Withdrawal by Subject|2|||
143331584|NCT02216123|516758036|FG001|Overall Study|Withdrawal by Subject|0|||
143331585|NCT02131272|516758037|FG000|Overall Study|Withdrawal by parent|0|||
143331586|NCT02131272|516758038|FG001|Overall Study|Withdrawal by parent|1|||
143331587|NCT02131272|516758037|FG000|Overall Study|Withdrawal by Subject|0|||
143331588|NCT02131272|516758038|FG001|Overall Study|Withdrawal by Subject|1|||
143331589|NCT02131272|516758037|FG000|Overall Study|Withdrawal Criteria|1|||
143331590|NCT02131272|516758038|FG001|Overall Study|Withdrawal Criteria|0|||
143331591|NCT00381940|516758039|FG000|Overall Study|Lack of Efficacy|3|||
143331592|NCT00381940|516758039|FG000|Overall Study|Protocol Violation|1|||
143331593|NCT00381940|516758039|FG000|Overall Study|Ineligible|1|||
143331594|NCT03162224|516758040|FG000|Overall Study|Death|4|||
143331595|NCT03162224|516758041|FG001|Overall Study|Death|5|||
143331596|NCT03162224|516758042|FG002|Overall Study|Death|8|||
143331597|NCT03162224|516758040|FG000|Overall Study|Withdrawal by Subject|1|||
143331598|NCT03162224|516758041|FG001|Overall Study|Withdrawal by Subject|0|||
143331599|NCT03162224|516758042|FG002|Overall Study|Withdrawal by Subject|1|||
143331600|NCT03162224|516758040|FG000|Overall Study|Lost to Follow-up|0|||
143331601|NCT03162224|516758041|FG001|Overall Study|Lost to Follow-up|1|||
143331602|NCT03162224|516758042|FG002|Overall Study|Lost to Follow-up|0|||
143331603|NCT03162224|516758040|FG000|Overall Study|Other|6|||
143331604|NCT03162224|516758041|FG001|Overall Study|Other|2|||
143331605|NCT03162224|516758042|FG002|Overall Study|Other|1|||
143331606|NCT05159622|516758043|FG000|Overall Study|Lost to Follow-up|4|||
143331607|NCT05159622|516758044|FG001|Overall Study|Lost to Follow-up|5|||
143331608|NCT02633800|516758045|FG000|Overall Study|Death|3|||
143331609|NCT02633800|516758046|FG001|Overall Study|Death|3|||
143331610|NCT02633800|516758045|FG000|Overall Study|Reason not provided|1|||
143331611|NCT02633800|516758046|FG001|Overall Study|Reason not provided|0|||
143331612|NCT02633800|516758045|FG000|Overall Study|Radiologic(al) progression|23|||
143331613|NCT02633800|516758046|FG001|Overall Study|Radiologic(al) progression|23|||
143331614|NCT02633800|516758045|FG000|Overall Study|Clinical progression|3|||
143331615|NCT02633800|516758046|FG001|Overall Study|Clinical progression|6|||
143331616|NCT02633800|516758045|FG000|Overall Study|Study terminated by sponsor|6|||
143331617|NCT02633800|516758046|FG001|Overall Study|Study terminated by sponsor|5|||
143331618|NCT02633800|516758045|FG000|Overall Study|Adverse event, non-fatal|7|||
143331619|NCT02633800|516758046|FG001|Overall Study|Adverse event, non-fatal|2|||
143383786|NCT03014453|516950297|FG000|Overall Study|Refused to take part in|37|||
143383787|NCT02141074|516950302|FG000|Pre-prophylaxis|Adverse Event|3|||
143383788|NCT02141074|516950303|FG001|Pre-prophylaxis|Adverse Event|0|||
143383789|NCT02141074|516950302|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
143383790|NCT02141074|516950303|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
143383791|NCT02141074|516950302|FG000|Prophylaxis|Adverse Event|0|||
143383792|NCT02141074|516950303|FG001|Prophylaxis|Adverse Event|4|||
143383793|NCT02141074|516950302|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
143383794|NCT02141074|516950303|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
143383795|NCT02141074|516950302|FG000|Prophylaxis|Withdrawal by Subject|0|||
143383796|NCT02141074|516950303|FG001|Prophylaxis|Withdrawal by Subject|1|||
143383797|NCT03101930|516950306|FG000|Overall Study|Withdrawal by Subject|2|||
143383798|NCT03101930|516950307|FG001|Overall Study|Withdrawal by Subject|1|||
143383799|NCT03101930|516950308|FG002|Overall Study|Withdrawal by Subject|2|||
143383800|NCT00262301|516950309|FG000|Double-blind Phase|Lost to Follow-up|1|||
143331620|NCT02633800|516758045|FG000|Overall Study|Withdrawal by Subject|0|||
143383801|NCT00262301|516950310|FG001|Double-blind Phase|Lost to Follow-up|0|||
143383802|NCT00262301|516950311|FG002|Double-blind Phase|Lost to Follow-up|0|||
143383803|NCT00262301|516950309|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
143383804|NCT00262301|516950310|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
143383805|NCT00262301|516950311|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
143383806|NCT01017146|516950312|FG000|Overall Study|Adverse Event|11|||
143383807|NCT01017146|516950313|FG001|Overall Study|Adverse Event|1|||
143383808|NCT01017146|516950312|FG000|Overall Study|Lost to Follow-up|14|||
143383809|NCT01017146|516950313|FG001|Overall Study|Lost to Follow-up|14|||
143383810|NCT01017146|516950312|FG000|Overall Study|Noncompliance with Study Product|1|||
143383811|NCT01017146|516950313|FG001|Overall Study|Noncompliance with Study Product|1|||
143383812|NCT01017146|516950312|FG000|Overall Study|Withdrawal by Subject|32|||
143383813|NCT01017146|516950313|FG001|Overall Study|Withdrawal by Subject|16|||
143383814|NCT01017146|516950312|FG000|Overall Study|Relocation|0|||
143383815|NCT01017146|516950313|FG001|Overall Study|Relocation|4|||
143383816|NCT01017146|516950312|FG000|Overall Study|Pregnancy|2|||
143331621|NCT02633800|516758046|FG001|Overall Study|Withdrawal by Subject|3|||
143331622|NCT02633800|516758045|FG000|Overall Study|Patient Request|1|||
143331623|NCT02633800|516758046|FG001|Overall Study|Patient Request|1|||
143331624|NCT01358968|516758050|FG000|Period 2|Adverse Event|0|||
143331625|NCT01358968|516758051|FG001|Period 2|Adverse Event|1|||
143331626|NCT01358968|516758052|FG002|Period 2|Adverse Event|0|||
143331627|NCT01358968|516758053|FG003|Period 2|Adverse Event|0|||
143331628|NCT01358968|516758050|FG000|Continued Access Phase|Progression of Disease|0|||
143331629|NCT01358968|516758051|FG001|Continued Access Phase|Progression of Disease|0|||
143331630|NCT01358968|516758052|FG002|Continued Access Phase|Progression of Disease|8|||
143331631|NCT01358968|516758053|FG003|Continued Access Phase|Progression of Disease|4|||
143331632|NCT01358968|516758050|FG000|Continued Access Phase|Protocol Violation|0|||
143331633|NCT01358968|516758051|FG001|Continued Access Phase|Protocol Violation|0|||
143331634|NCT01358968|516758052|FG002|Continued Access Phase|Protocol Violation|0|||
143331635|NCT01358968|516758053|FG003|Continued Access Phase|Protocol Violation|2|||
143331636|NCT01358968|516758050|FG000|Continued Access Phase|Withdrawal by Subject|0|||
143331637|NCT01358968|516758051|FG001|Continued Access Phase|Withdrawal by Subject|0|||
143331638|NCT01358968|516758052|FG002|Continued Access Phase|Withdrawal by Subject|3|||
143331639|NCT01358968|516758053|FG003|Continued Access Phase|Withdrawal by Subject|0|||
143331640|NCT01358968|516758050|FG000|Continued Access Phase|Death|0|||
143331641|NCT01358968|516758051|FG001|Continued Access Phase|Death|0|||
143331642|NCT01358968|516758052|FG002|Continued Access Phase|Death|1|||
143331643|NCT01358968|516758053|FG003|Continued Access Phase|Death|1|||
143331644|NCT04052204|516758058|FG000|Overall Study|Death|1|||
143331645|NCT04052204|516758059|FG001|Overall Study|Death|0|||
143331646|NCT04052204|516758060|FG002|Overall Study|Death|0|||
143331647|NCT04052204|516758058|FG000|Overall Study|Progressive disease|1|||
143331648|NCT04052204|516758059|FG001|Overall Study|Progressive disease|0|||
143331649|NCT04052204|516758060|FG002|Overall Study|Progressive disease|0|||
143331650|NCT04052204|516758058|FG000|Overall Study|Other|1|||
143331651|NCT04052204|516758059|FG001|Overall Study|Other|0|||
143331652|NCT04052204|516758060|FG002|Overall Study|Other|0|||
143331653|NCT04794803|516758065|FG000|Overall Study|Death|1|||
143331654|NCT04794803|516758066|FG001|Overall Study|Death|3|||
143331655|NCT04794803|516758065|FG000|Overall Study|Lost to Follow-up|2|||
143331656|NCT04794803|516758066|FG001|Overall Study|Lost to Follow-up|2|||
143331657|NCT04794803|516758065|FG000|Overall Study|Withdrawal by Subject|1|||
143331658|NCT04794803|516758066|FG001|Overall Study|Withdrawal by Subject|0|||
143331659|NCT04794803|516758065|FG000|Overall Study|Physician Decision|1|||
143331660|NCT04794803|516758066|FG001|Overall Study|Physician Decision|1|||
143331661|NCT04794803|516758065|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
143331662|NCT04794803|516758066|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
143331663|NCT04794803|516758065|FG000|Overall Study|Refused to continue the treatment|1|||
143383817|NCT01017146|516950313|FG001|Overall Study|Pregnancy|1|||
143383818|NCT01017146|516950312|FG000|Overall Study|Protocol Violation|2|||
143383819|NCT01017146|516950313|FG001|Overall Study|Protocol Violation|0|||
143383820|NCT01017146|516950312|FG000|Overall Study|Took Excluded Medication|2|||
143383821|NCT01017146|516950313|FG001|Overall Study|Took Excluded Medication|0|||
143383822|NCT01017146|516950312|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
143383823|NCT01017146|516950313|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
143383824|NCT01017146|516950312|FG000|Overall Study|Change in Work Situation|1|||
143383825|NCT01017146|516950313|FG001|Overall Study|Change in Work Situation|0|||
143383826|NCT01747486|516950317|FG000|Stage 1|Physician Decision|3|||
143383827|NCT01747486|516950318|FG001|Stage 1|Physician Decision|0|||
143383828|NCT01747486|516950317|FG000|Stage 1|Withdrawal by Subject|4|||
143383829|NCT01747486|516950318|FG001|Stage 1|Withdrawal by Subject|3|||
143383830|NCT01747486|516950317|FG000|Stage 1|Disease progression|4|||
143331664|NCT04794803|516758066|FG001|Overall Study|Refused to continue the treatment|0|||
143331665|NCT04794803|516758065|FG000|Overall Study|Patient admitted to ICU|0|||
143331666|NCT04794803|516758066|FG001|Overall Study|Patient admitted to ICU|1|||
143331667|NCT00476476|516758067|FG000|Overall Study|Adverse Event|2|||
143331668|NCT00476476|516758068|FG001|Overall Study|Adverse Event|7|||
143331669|NCT00476476|516758067|FG000|Overall Study|Progressive Disease|0|||
143331670|NCT00476476|516758068|FG001|Overall Study|Progressive Disease|17|||
143331671|NCT00971048|516758069|FG000|Overall Study|Protocol Violation|1|||
143331672|NCT00971048|516758070|FG001|Overall Study|Protocol Violation|2|||
143331673|NCT00971048|516758071|FG002|Overall Study|Protocol Violation|0|||
143331674|NCT00971048|516758072|FG003|Overall Study|Protocol Violation|1|||
143331675|NCT00971048|516758069|FG000|Overall Study|Adverse Event|0|||
143331676|NCT00971048|516758070|FG001|Overall Study|Adverse Event|0|||
143331677|NCT00971048|516758071|FG002|Overall Study|Adverse Event|1|||
143331678|NCT00971048|516758072|FG003|Overall Study|Adverse Event|0|||
143331679|NCT00971048|516758069|FG000|Overall Study|Physician Decision|0|||
143331680|NCT00971048|516758070|FG001|Overall Study|Physician Decision|0|||
143331681|NCT00971048|516758071|FG002|Overall Study|Physician Decision|0|||
143331682|NCT00971048|516758072|FG003|Overall Study|Physician Decision|1|||
143331683|NCT04124926|516758076|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
143331684|NCT04124926|516758077|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
143331685|NCT04124926|516758078|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
143331686|NCT04124926|516758079|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
143331687|NCT04124926|516758080|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
143331688|NCT04124926|516758076|FG000|Healing Phase|Protocol Violation|0|||
143331689|NCT04124926|516758077|FG001|Healing Phase|Protocol Violation|1|||
143331690|NCT04124926|516758078|FG002|Healing Phase|Protocol Violation|0|||
143331691|NCT04124926|516758079|FG003|Healing Phase|Protocol Violation|0|||
143331692|NCT04124926|516758080|FG004|Healing Phase|Protocol Violation|0|||
143331693|NCT04124926|516758076|FG000|Healing Phase|Lost to Follow-up|5|||
143331694|NCT04124926|516758077|FG001|Healing Phase|Lost to Follow-up|4|||
143331695|NCT04124926|516758078|FG002|Healing Phase|Lost to Follow-up|0|||
143331696|NCT04124926|516758079|FG003|Healing Phase|Lost to Follow-up|0|||
143331697|NCT04124926|516758080|FG004|Healing Phase|Lost to Follow-up|0|||
143331698|NCT04124926|516758076|FG000|Healing Phase|Voluntary Withdrawal|10|||
143331699|NCT04124926|516758077|FG001|Healing Phase|Voluntary Withdrawal|7|||
143331700|NCT04124926|516758078|FG002|Healing Phase|Voluntary Withdrawal|0|||
143331701|NCT04124926|516758079|FG003|Healing Phase|Voluntary Withdrawal|0|||
143331702|NCT04124926|516758080|FG004|Healing Phase|Voluntary Withdrawal|0|||
143331703|NCT04124926|516758076|FG000|Healing Phase|Withdrawal of Consent|5|||
143331704|NCT04124926|516758077|FG001|Healing Phase|Withdrawal of Consent|3|||
143331705|NCT04124926|516758078|FG002|Healing Phase|Withdrawal of Consent|0|||
143331706|NCT04124926|516758079|FG003|Healing Phase|Withdrawal of Consent|0|||
143331707|NCT04124926|516758080|FG004|Healing Phase|Withdrawal of Consent|0|||
143331708|NCT04124926|516758076|FG000|Healing Phase|Miscellaneous|8|||
143331709|NCT04124926|516758077|FG001|Healing Phase|Miscellaneous|7|||
143331710|NCT04124926|516758078|FG002|Healing Phase|Miscellaneous|0|||
143331711|NCT04124926|516758079|FG003|Healing Phase|Miscellaneous|0|||
143331712|NCT04124926|516758080|FG004|Healing Phase|Miscellaneous|0|||
143331713|NCT04124926|516758076|FG000|Healing Phase|Randomized but not Treated|0|||
143331714|NCT04124926|516758077|FG001|Healing Phase|Randomized but not Treated|3|||
143331715|NCT04124926|516758078|FG002|Healing Phase|Randomized but not Treated|0|||
143331716|NCT04124926|516758079|FG003|Healing Phase|Randomized but not Treated|0|||
143331717|NCT04124926|516758080|FG004|Healing Phase|Randomized but not Treated|0|||
143331718|NCT04124926|516758076|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
143331719|NCT04124926|516758077|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
143331720|NCT04124926|516758078|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
143331721|NCT04124926|516758079|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
143331722|NCT04124926|516758080|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
143331723|NCT04124926|516758076|FG000|Maintenance Phase|Protocol Violation|0|||
143331724|NCT04124926|516758077|FG001|Maintenance Phase|Protocol Violation|0|||
143331725|NCT04124926|516758078|FG002|Maintenance Phase|Protocol Violation|3|||
143331726|NCT04124926|516758079|FG003|Maintenance Phase|Protocol Violation|0|||
143331727|NCT04124926|516758080|FG004|Maintenance Phase|Protocol Violation|0|||
143331728|NCT04124926|516758076|FG000|Maintenance Phase|Lost to Follow-up|0|||
143331729|NCT04124926|516758077|FG001|Maintenance Phase|Lost to Follow-up|0|||
143331730|NCT04124926|516758078|FG002|Maintenance Phase|Lost to Follow-up|7|||
143331731|NCT04124926|516758079|FG003|Maintenance Phase|Lost to Follow-up|8|||
143331732|NCT04124926|516758080|FG004|Maintenance Phase|Lost to Follow-up|9|||
143331733|NCT04124926|516758076|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
143331734|NCT04124926|516758077|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
143331735|NCT04124926|516758078|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
143331736|NCT04124926|516758079|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
143331737|NCT04124926|516758080|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
143331738|NCT04124926|516758076|FG000|Maintenance Phase|Pregnancy|0|||
143331739|NCT04124926|516758077|FG001|Maintenance Phase|Pregnancy|0|||
143331740|NCT04124926|516758078|FG002|Maintenance Phase|Pregnancy|0|||
143331741|NCT04124926|516758079|FG003|Maintenance Phase|Pregnancy|1|||
143331742|NCT04124926|516758080|FG004|Maintenance Phase|Pregnancy|0|||
143331743|NCT04124926|516758076|FG000|Maintenance Phase|Lack of Efficacy|0|||
143331744|NCT04124926|516758077|FG001|Maintenance Phase|Lack of Efficacy|0|||
143331745|NCT04124926|516758078|FG002|Maintenance Phase|Lack of Efficacy|0|||
143331746|NCT04124926|516758079|FG003|Maintenance Phase|Lack of Efficacy|0|||
143331747|NCT04124926|516758080|FG004|Maintenance Phase|Lack of Efficacy|1|||
143331748|NCT04124926|516758076|FG000|Maintenance Phase|Withdrawal of Consent|0|||
143331749|NCT04124926|516758077|FG001|Maintenance Phase|Withdrawal of Consent|0|||
143331750|NCT04124926|516758078|FG002|Maintenance Phase|Withdrawal of Consent|5|||
143331751|NCT04124926|516758079|FG003|Maintenance Phase|Withdrawal of Consent|5|||
143331752|NCT04124926|516758080|FG004|Maintenance Phase|Withdrawal of Consent|5|||
143331753|NCT04124926|516758076|FG000|Maintenance Phase|Miscellaneous|0|||
143331754|NCT04124926|516758077|FG001|Maintenance Phase|Miscellaneous|0|||
143331755|NCT04124926|516758078|FG002|Maintenance Phase|Miscellaneous|1|||
143331756|NCT04124926|516758079|FG003|Maintenance Phase|Miscellaneous|2|||
143331757|NCT04124926|516758080|FG004|Maintenance Phase|Miscellaneous|4|||
143331758|NCT04124926|516758076|FG000|Maintenance Phase|Randomized but not Treated|0|||
143331759|NCT04124926|516758077|FG001|Maintenance Phase|Randomized but not Treated|0|||
143331760|NCT04124926|516758078|FG002|Maintenance Phase|Randomized but not Treated|2|||
143331761|NCT04124926|516758079|FG003|Maintenance Phase|Randomized but not Treated|2|||
143331762|NCT04124926|516758080|FG004|Maintenance Phase|Randomized but not Treated|0|||
143331763|NCT00937924|516758090|FG000|Overall Study|Lost to Follow-up|44|||
143331764|NCT00937924|516758091|FG001|Overall Study|Lost to Follow-up|44|||
143331765|NCT00937924|516758092|FG002|Overall Study|Lost to Follow-up|41|||
143331766|NCT02013622|516758093|FG000|Overall Study|Lost to Follow-up|10|||
143331767|NCT02013622|516758093|FG000|Overall Study|Adverse Event|3|||
143331768|NCT02013622|516758093|FG000|Overall Study|Met Withdrawal Criteria|3|||
143331769|NCT02013622|516758093|FG000|Overall Study|Withdrawal by Subject|6|||
143331770|NCT02013622|516758093|FG000|Overall Study|Protocol Deviation|1|||
143331771|NCT02013622|516758093|FG000|Overall Study|Lack of Efficacy|1|||
143331772|NCT03152526|516758098|FG000|Overall Study|Withdrawal by Subject|0|||
143331773|NCT03152526|516758099|FG001|Overall Study|Withdrawal by Subject|1|||
143331774|NCT02395042|516758100|FG000|Treatment 1 Period|Adverse Event|1|||
143331775|NCT02395042|516758101|FG001|Treatment 1 Period|Adverse Event|3|||
143331776|NCT02395042|516758102|FG002|Treatment 1 Period|Adverse Event|1|||
143331777|NCT02395042|516758100|FG000|Treatment 1 Period|Lack of Efficacy|1|||
143331778|NCT02395042|516758101|FG001|Treatment 1 Period|Lack of Efficacy|1|||
143331779|NCT02395042|516758102|FG002|Treatment 1 Period|Lack of Efficacy|0|||
143331780|NCT02395042|516758100|FG000|Treatment 1 Period|Lost to Follow-up|1|||
143331781|NCT02395042|516758101|FG001|Treatment 1 Period|Lost to Follow-up|0|||
143331782|NCT02395042|516758102|FG002|Treatment 1 Period|Lost to Follow-up|0|||
143331783|NCT02395042|516758100|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
143331784|NCT02395042|516758101|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
143331785|NCT02395042|516758102|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
143331786|NCT02395042|516758100|FG000|Treatment 2 Period|Lack of Efficacy|1|||
143331787|NCT02395042|516758101|FG001|Treatment 2 Period|Lack of Efficacy|1|||
143331788|NCT02395042|516758102|FG002|Treatment 2 Period|Lack of Efficacy|0|||
143331789|NCT03206203|516758105|FG000|Treatment|Death|38|||
143331790|NCT03206203|516758106|FG001|Treatment|Death|26|||
143331791|NCT03206203|516758107|FG002|Treatment|Death|0|||
143331792|NCT03206203|516758105|FG000|Treatment|Withdrawal by Subject|1|||
143331793|NCT03206203|516758106|FG001|Treatment|Withdrawal by Subject|0|||
143331794|NCT03206203|516758107|FG002|Treatment|Withdrawal by Subject|0|||
143331795|NCT03206203|516758105|FG000|Treatment|Lost to Follow-up|4|||
143331796|NCT03206203|516758106|FG001|Treatment|Lost to Follow-up|0|||
143331797|NCT03206203|516758107|FG002|Treatment|Lost to Follow-up|0|||
143331798|NCT03206203|516758105|FG000|Treatment|N/A in Follow-Up|8|||
143331799|NCT03206203|516758106|FG001|Treatment|N/A in Follow-Up|1|||
143331800|NCT03206203|516758107|FG002|Treatment|N/A in Follow-Up|0|||
143383831|NCT01747486|516950318|FG001|Stage 1|Disease progression|9|||
143383832|NCT01747486|516950317|FG000|Stage 1|Death|1|||
143383833|NCT01747486|516950318|FG001|Stage 1|Death|1|||
143383834|NCT01747486|516950317|FG000|Stage 2|Physician Decision|2|||
143383835|NCT01747486|516950318|FG001|Stage 2|Physician Decision|0|||
143383836|NCT01747486|516950317|FG000|Stage 2|Withdrawal by Subject|1|||
143383837|NCT01747486|516950318|FG001|Stage 2|Withdrawal by Subject|0|||
143383838|NCT01747486|516950317|FG000|Stage 2|New Cancer Therapy|3|||
143383839|NCT01747486|516950318|FG001|Stage 2|New Cancer Therapy|0|||
143383840|NCT01747486|516950317|FG000|Stage 2|Disease Progression|3|||
143383841|NCT01747486|516950318|FG001|Stage 2|Disease Progression|0|||
143383842|NCT01084707|516950319|FG000|Overall Study|Withdrawal by Subject|6|||
143383843|NCT00087139|516950320|FG000|Overall Study|Adverse Event|18|||
143383844|NCT00087139|516950321|FG001|Overall Study|Adverse Event|17|||
143383845|NCT00087139|516950322|FG002|Overall Study|Adverse Event|13|||
143383846|NCT00087139|516950320|FG000|Overall Study|Death|2|||
143383847|NCT00087139|516950321|FG001|Overall Study|Death|1|||
143383848|NCT00087139|516950322|FG002|Overall Study|Death|0|||
143383849|NCT00087139|516950320|FG000|Overall Study|Withdrawal by Subject|3|||
143383850|NCT00087139|516950321|FG001|Overall Study|Withdrawal by Subject|2|||
143383851|NCT00087139|516950322|FG002|Overall Study|Withdrawal by Subject|2|||
143383852|NCT00087139|516950320|FG000|Overall Study|Physician Decision|1|||
143383853|NCT00087139|516950321|FG001|Overall Study|Physician Decision|1|||
143383854|NCT00087139|516950322|FG002|Overall Study|Physician Decision|1|||
143383855|NCT00087139|516950320|FG000|Overall Study|Disease progression|9|||
143383856|NCT00087139|516950321|FG001|Overall Study|Disease progression|19|||
143383857|NCT00087139|516950322|FG002|Overall Study|Disease progression|12|||
143383858|NCT00087139|516950320|FG000|Overall Study|Ineligible|4|||
143383859|NCT00087139|516950321|FG001|Overall Study|Ineligible|7|||
143383860|NCT00087139|516950322|FG002|Overall Study|Ineligible|4|||
143383861|NCT00087139|516950320|FG000|Overall Study|Symptomatic deterioration|1|||
143383862|NCT00087139|516950321|FG001|Overall Study|Symptomatic deterioration|1|||
143383863|NCT00087139|516950322|FG002|Overall Study|Symptomatic deterioration|3|||
143383864|NCT00087139|516950320|FG000|Overall Study|Use of coumadin|1|||
143383865|NCT00087139|516950321|FG001|Overall Study|Use of coumadin|0|||
143383866|NCT00087139|516950322|FG002|Overall Study|Use of coumadin|0|||
143383867|NCT00087139|516950320|FG000|Overall Study|Response achieved|0|||
143383868|NCT00087139|516950321|FG001|Overall Study|Response achieved|1|||
143383869|NCT00087139|516950322|FG002|Overall Study|Response achieved|0|||
143383870|NCT00087139|516950320|FG000|Overall Study|Extradural disease|0|||
143383871|NCT00087139|516950321|FG001|Overall Study|Extradural disease|0|||
143383872|NCT00087139|516950322|FG002|Overall Study|Extradural disease|1|||
143383873|NCT05171777|516950323|FG000|Treatment Crossover Period|Adverse Event|9|||
143383874|NCT05171777|516950324|FG001|Treatment Crossover Period|Adverse Event|6|||
143383875|NCT05171777|516950325|FG002|Treatment Crossover Period|Adverse Event|0|||
143383876|NCT05171777|516950326|FG003|Treatment Crossover Period|Adverse Event|0|||
143383877|NCT05171777|516950323|FG000|Treatment Crossover Period|Death|5|||
143383878|NCT05171777|516950324|FG001|Treatment Crossover Period|Death|5|||
143383879|NCT05171777|516950325|FG002|Treatment Crossover Period|Death|0|||
143383880|NCT05171777|516950326|FG003|Treatment Crossover Period|Death|0|||
143383881|NCT05171777|516950323|FG000|Treatment Crossover Period|Disease Relapse|0|||
143383882|NCT05171777|516950324|FG001|Treatment Crossover Period|Disease Relapse|1|||
143383883|NCT05171777|516950325|FG002|Treatment Crossover Period|Disease Relapse|0|||
143383884|NCT05171777|516950326|FG003|Treatment Crossover Period|Disease Relapse|0|||
143383885|NCT05171777|516950323|FG000|Treatment Crossover Period|Reason not Specified|2|||
143383886|NCT05171777|516950324|FG001|Treatment Crossover Period|Reason not Specified|1|||
143383887|NCT05171777|516950325|FG002|Treatment Crossover Period|Reason not Specified|0|||
143383888|NCT05171777|516950326|FG003|Treatment Crossover Period|Reason not Specified|0|||
143383889|NCT05171777|516950323|FG000|Treatment Crossover Period|Physician Decision|0|||
143383890|NCT05171777|516950324|FG001|Treatment Crossover Period|Physician Decision|1|||
143383891|NCT05171777|516950325|FG002|Treatment Crossover Period|Physician Decision|0|||
143383892|NCT05171777|516950326|FG003|Treatment Crossover Period|Physician Decision|0|||
143383893|NCT05171777|516950323|FG000|Treatment Crossover Period|Progressive Disease|13|||
143383894|NCT05171777|516950324|FG001|Treatment Crossover Period|Progressive Disease|9|||
143383895|NCT05171777|516950325|FG002|Treatment Crossover Period|Progressive Disease|0|||
143383896|NCT05171777|516950326|FG003|Treatment Crossover Period|Progressive Disease|0|||
143383897|NCT05171777|516950323|FG000|Treatment Crossover Period|Protocol Violation|0|||
143383898|NCT05171777|516950324|FG001|Treatment Crossover Period|Protocol Violation|2|||
143383899|NCT05171777|516950325|FG002|Treatment Crossover Period|Protocol Violation|0|||
143383900|NCT05171777|516950326|FG003|Treatment Crossover Period|Protocol Violation|0|||
143383901|NCT05171777|516950323|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
143383902|NCT05171777|516950324|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
143383903|NCT05171777|516950325|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
143383904|NCT05171777|516950326|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
143383905|NCT05171777|516950323|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
143331801|NCT03206203|516758105|FG000|Treatment|Disease progression|0|||
143331802|NCT03206203|516758106|FG001|Treatment|Disease progression|1|||
143331803|NCT03206203|516758107|FG002|Treatment|Disease progression|0|||
143331804|NCT03206203|516758105|FG000|Treatment|Refused follow-up|0|||
143331805|NCT03206203|516758106|FG001|Treatment|Refused follow-up|1|||
143331806|NCT03206203|516758107|FG002|Treatment|Refused follow-up|0|||
143331807|NCT03206203|516758105|FG000|Treatment|Cross over to Arm 1|0|||
143331808|NCT03206203|516758106|FG001|Treatment|Cross over to Arm 1|19|||
143331809|NCT03206203|516758107|FG002|Treatment|Cross over to Arm 1|0|||
143331810|NCT03206203|516758105|FG000|Optional Cross-Over|Death|0|||
143331811|NCT03206203|516758106|FG001|Optional Cross-Over|Death|0|||
143331812|NCT03206203|516758107|FG002|Optional Cross-Over|Death|14|||
143383906|NCT05171777|516950324|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
143331813|NCT03206203|516758105|FG000|Optional Cross-Over|Refused follow-up|0|||
143331814|NCT03206203|516758106|FG001|Optional Cross-Over|Refused follow-up|0|||
143331815|NCT03206203|516758107|FG002|Optional Cross-Over|Refused follow-up|2|||
143331816|NCT03998618|516758108|FG000|Overall Study|Death|7|||
143383907|NCT05171777|516950325|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
143383908|NCT05171777|516950326|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
143383909|NCT05171777|516950323|FG000|Treatment Crossover Period|Ongoing in the Crossover Period|3|||
143383910|NCT05171777|516950324|FG001|Treatment Crossover Period|Ongoing in the Crossover Period|6|||
143383911|NCT05171777|516950325|FG002|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
143383912|NCT05171777|516950326|FG003|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
143383913|NCT05171777|516950323|FG000|Treatment Continuation Period|Death|0|||
143383914|NCT05171777|516950324|FG001|Treatment Continuation Period|Death|0|||
143383915|NCT05171777|516950325|FG002|Treatment Continuation Period|Death|1|||
143383916|NCT05171777|516950326|FG003|Treatment Continuation Period|Death|6|||
143383917|NCT05171777|516950323|FG000|Treatment Continuation Period|Ongoing in Continuation Period|0|||
143383918|NCT05171777|516950324|FG001|Treatment Continuation Period|Ongoing in Continuation Period|0|||
143383919|NCT05171777|516950325|FG002|Treatment Continuation Period|Ongoing in Continuation Period|21|||
143383920|NCT05171777|516950326|FG003|Treatment Continuation Period|Ongoing in Continuation Period|79|||
143383921|NCT02412748|516950327|FG000|Overall Study|Lost to Follow-up|38|||
143383922|NCT02412748|516950328|FG001|Overall Study|Lost to Follow-up|39|||
143383923|NCT01959698|516950329|FG000|Overall Study|Adverse Event|0|||
143383924|NCT01959698|516950330|FG001|Overall Study|Adverse Event|0|||
143383925|NCT01959698|516950331|FG002|Overall Study|Adverse Event|0|||
143383926|NCT01959698|516950332|FG003|Overall Study|Adverse Event|0|||
143383927|NCT01959698|516950333|FG004|Overall Study|Adverse Event|0|||
143383928|NCT01959698|516950334|FG005|Overall Study|Adverse Event|0|||
143383929|NCT01959698|516950335|FG006|Overall Study|Adverse Event|1|||
143383930|NCT01959698|516950329|FG000|Overall Study|Physician Decision|1|||
143383931|NCT01959698|516950330|FG001|Overall Study|Physician Decision|0|||
143383932|NCT01959698|516950331|FG002|Overall Study|Physician Decision|1|||
143383933|NCT01959698|516950332|FG003|Overall Study|Physician Decision|2|||
143383934|NCT01959698|516950333|FG004|Overall Study|Physician Decision|0|||
143383935|NCT01959698|516950334|FG005|Overall Study|Physician Decision|3|||
143383936|NCT01959698|516950335|FG006|Overall Study|Physician Decision|3|||
143383937|NCT04579380|516952687|FG000|Overall Study|Death|9|||
143383938|NCT04579380|516952688|FG001|Overall Study|Death|22|||
143383939|NCT04579380|516952689|FG002|Overall Study|Death|22|||
143383940|NCT04579380|516952690|FG003|Overall Study|Death|17|||
143383941|NCT04579380|516952691|FG004|Overall Study|Death|6|||
143383942|NCT04579380|516952692|FG005|Overall Study|Death|21|||
143383943|NCT04579380|516952693|FG006|Overall Study|Death|10|||
143383944|NCT04579380|516952694|FG007|Overall Study|Death|11|||
143383945|NCT04579380|516952695|FG008|Overall Study|Death|25|||
143383946|NCT04579380|516952687|FG000|Overall Study|Withdrawal by Subject|0|||
143383947|NCT04579380|516952688|FG001|Overall Study|Withdrawal by Subject|3|||
143383948|NCT04579380|516952689|FG002|Overall Study|Withdrawal by Subject|4|||
143383949|NCT04579380|516952690|FG003|Overall Study|Withdrawal by Subject|0|||
143383950|NCT04579380|516952691|FG004|Overall Study|Withdrawal by Subject|1|||
143383951|NCT04579380|516952692|FG005|Overall Study|Withdrawal by Subject|2|||
143383952|NCT04579380|516952693|FG006|Overall Study|Withdrawal by Subject|0|||
143383953|NCT04579380|516952694|FG007|Overall Study|Withdrawal by Subject|1|||
143383954|NCT04579380|516952695|FG008|Overall Study|Withdrawal by Subject|2|||
143383955|NCT04579380|516952687|FG000|Overall Study|Ongoing|2|||
143383956|NCT04579380|516952688|FG001|Overall Study|Ongoing|6|||
143383957|NCT04579380|516952689|FG002|Overall Study|Ongoing|4|||
143383958|NCT04579380|516952690|FG003|Overall Study|Ongoing|8|||
143383959|NCT04579380|516952691|FG004|Overall Study|Ongoing|5|||
143383960|NCT04579380|516952692|FG005|Overall Study|Ongoing|8|||
143383961|NCT04579380|516952693|FG006|Overall Study|Ongoing|3|||
143383962|NCT04579380|516952694|FG007|Overall Study|Ongoing|19|||
143383963|NCT04579380|516952695|FG008|Overall Study|Ongoing|6|||
143383964|NCT01259401|516952696|FG000|4-month Follow-up|Death|0|||
143383965|NCT01259401|516952697|FG001|4-month Follow-up|Death|1|||
143383966|NCT01259401|516952696|FG000|4-month Follow-up|Lost to Follow-up|0|||
143383967|NCT01259401|516952697|FG001|4-month Follow-up|Lost to Follow-up|1|||
143383968|NCT05478525|516952698|FG000|Overall Study|Withdrawal by Subject|0|||
143383969|NCT05478525|516952699|FG001|Overall Study|Withdrawal by Subject|1|||
143383970|NCT05478525|516952700|FG002|Overall Study|Withdrawal by Subject|2|||
143383971|NCT05478525|516952701|FG003|Overall Study|Withdrawal by Subject|0|||
143383972|NCT05478525|516952698|FG000|Overall Study|COVID-19 Infection|2|||
143383973|NCT05478525|516952699|FG001|Overall Study|COVID-19 Infection|0|||
143383974|NCT05478525|516952700|FG002|Overall Study|COVID-19 Infection|1|||
143383975|NCT05478525|516952701|FG003|Overall Study|COVID-19 Infection|1|||
143383976|NCT01649271|516952702|FG000|Overall Study|Progressive disease|4|||
143383977|NCT01649271|516952703|FG001|Overall Study|Progressive disease|5|||
143383978|NCT01649271|516952702|FG000|Overall Study|Other Adverse Event|0|||
143383979|NCT01649271|516952703|FG001|Overall Study|Other Adverse Event|2|||
143383980|NCT01649271|516952702|FG000|Overall Study|Withdrawal by Subject|1|||
143383981|NCT01649271|516952703|FG001|Overall Study|Withdrawal by Subject|0|||
143383982|NCT01649271|516952702|FG000|Overall Study|Other than stated above|1|||
143383983|NCT01649271|516952703|FG001|Overall Study|Other than stated above|0|||
143383984|NCT05756075|516952704|FG000|Overall Study|Withdrawal by Subject|16|||
143383985|NCT05756075|516952705|FG001|Overall Study|Withdrawal by Subject|9|||
143383986|NCT01991977|516952706|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
143383987|NCT01991977|516952706|FG000|Overall Study|Withdrew after start of treatment|5|||
143383988|NCT03821844|516952707|FG000|Overall Study|Death|37|||
143383989|NCT03821844|516952708|FG001|Overall Study|Death|31|||
143383990|NCT03821844|516952707|FG000|Overall Study|Discharged|10|||
143383991|NCT03821844|516952708|FG001|Overall Study|Discharged|14|||
143383992|NCT03821844|516952707|FG000|Overall Study|Not present in facility at followup|2|||
143383993|NCT03821844|516952708|FG001|Overall Study|Not present in facility at followup|3|||
143383994|NCT02605837|516952710|FG000|Overall Study|Adverse Event|3|||
143383995|NCT02605837|516952711|FG001|Overall Study|Adverse Event|1|||
143383996|NCT02605837|516952710|FG000|Overall Study|Non-Compliance with Study Drug|0|||
143383997|NCT02605837|516952711|FG001|Overall Study|Non-Compliance with Study Drug|1|||
143383998|NCT02605837|516952710|FG000|Overall Study|Withdrawal by Subject|8|||
143383999|NCT02605837|516952711|FG001|Overall Study|Withdrawal by Subject|8|||
143384000|NCT02605837|516952710|FG000|Overall Study|Physician Decision|0|||
143384001|NCT02605837|516952711|FG001|Overall Study|Physician Decision|1|||
143384002|NCT05307978|516952712|FG000|Overall Study|Lost to Follow-up|0|||
143384003|NCT05307978|516952713|FG001|Overall Study|Lost to Follow-up|1|||
143384004|NCT05307978|516952714|FG002|Overall Study|Lost to Follow-up|0|||
143384005|NCT05307978|516952715|FG003|Overall Study|Lost to Follow-up|4|||
143384006|NCT05307978|516952716|FG004|Overall Study|Lost to Follow-up|0|||
143384007|NCT05307978|516952717|FG005|Overall Study|Lost to Follow-up|0|||
143384008|NCT05307978|516952718|FG006|Overall Study|Lost to Follow-up|1|||
143384009|NCT03416023|516952719|FG000|Overall Study|Exclusion criteria failure|1|||
143384010|NCT03416023|516952719|FG000|Overall Study|Withdrawal by Subject|6|||
143384011|NCT03416023|516952719|FG000|Overall Study|Explanted|7|||
143384012|NCT03416023|516952719|FG000|Overall Study|Physician Decision|1|||
143384013|NCT03416023|516952719|FG000|Overall Study|Lost to Follow-up|1|||
143384014|NCT03416023|516952719|FG000|Overall Study|Death|1|||
143384015|NCT02837510|516952720|FG000|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
143384016|NCT02837510|516952721|FG001|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
143384017|NCT02837510|516952720|FG000|Washout (2 Weeks)|Adverse Event|0|||
143384018|NCT02837510|516952721|FG001|Washout (2 Weeks)|Adverse Event|1|||
143384019|NCT02837510|516952720|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
143384020|NCT02837510|516952721|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
143384021|NCT02837510|516952720|FG000|2nd Pretreatment fMRI Session|Adverse Event|1|||
143384022|NCT02837510|516952721|FG001|2nd Pretreatment fMRI Session|Adverse Event|0|||
143384023|NCT02837510|516952720|FG000|2nd Pretreatment fMRI Session|Lost to Follow-up|0|||
143384024|NCT02837510|516952721|FG001|2nd Pretreatment fMRI Session|Lost to Follow-up|1|||
143384025|NCT02837510|516952720|FG000|Quit Attempt (6 Months)|Adverse Event|2|||
143384026|NCT02837510|516952721|FG001|Quit Attempt (6 Months)|Adverse Event|2|||
143384027|NCT04337372|516952723|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
143384028|NCT04337372|516952724|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
143384029|NCT04337372|516952725|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
143384030|NCT04337372|516952726|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
143384031|NCT04337372|516952723|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
143384032|NCT04337372|516952724|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
143384033|NCT04337372|516952725|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
143384034|NCT04337372|516952726|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
143384035|NCT04337372|516952723|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
143384036|NCT04337372|516952724|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
143384037|NCT04337372|516952725|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
143384038|NCT04337372|516952726|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
143384039|NCT04337372|516952723|FG000|Day 2: EEG Measures|Protocol Violation|6|||
143384040|NCT04337372|516952724|FG001|Day 2: EEG Measures|Protocol Violation|6|||
143384041|NCT04337372|516952725|FG002|Day 2: EEG Measures|Protocol Violation|5|||
143384042|NCT04337372|516952726|FG003|Day 2: EEG Measures|Protocol Violation|17|||
143384043|NCT04883645|516952727|FG000|Overall Study|Death|1|||
143384044|NCT03460236|516952731|FG000|Overall Study|failed radiographic screening|16|||
143384045|NCT03460236|516952731|FG000|Overall Study|Withdrawal by Subject|11|||
143384046|NCT02819843|516952735|FG000|Overall Study|Disease progression before RT|0|||
143384047|NCT02819843|516952736|FG001|Overall Study|Disease progression before RT|1|||
143384048|NCT04732494|516952737|FG000|Overall Study|Death|39|||
143384049|NCT04732494|516952738|FG001|Overall Study|Death|36|||
143384050|NCT04732494|516952737|FG000|Overall Study|Study Closed by Sponsor|20|||
143384051|NCT04732494|516952738|FG001|Overall Study|Study Closed by Sponsor|15|||
143384052|NCT04732494|516952737|FG000|Overall Study|Withdrawal by Subject|2|||
143384053|NCT04732494|516952738|FG001|Overall Study|Withdrawal by Subject|7|||
143384054|NCT04732494|516952737|FG000|Overall Study|Lost to Follow-up|1|||
143384055|NCT04732494|516952738|FG001|Overall Study|Lost to Follow-up|5|||
143384056|NCT03055858|516952739|FG000|Overall Study|Death|9|||
143384057|NCT03055858|516952739|FG000|Overall Study|Withdrawal by Subject|11|||
143384058|NCT03055858|516952739|FG000|Overall Study|Lost to Follow-up|6|||
143384059|NCT03055858|516952739|FG000|Overall Study|Missed Follow-Up Visits|18|||
143384060|NCT04586920|516952740|FG000|Overall Study|Lost to Follow-up|0|||
143384061|NCT04586920|516952741|FG001|Overall Study|Lost to Follow-up|0|||
143384062|NCT04586920|516952742|FG002|Overall Study|Lost to Follow-up|0|||
143384063|NCT04586920|516952743|FG003|Overall Study|Lost to Follow-up|0|||
143384064|NCT04586920|516952744|FG004|Overall Study|Lost to Follow-up|0|||
143384065|NCT04586920|516952745|FG005|Overall Study|Lost to Follow-up|0|||
143384066|NCT04586920|516952746|FG006|Overall Study|Lost to Follow-up|1|||
143384067|NCT04586920|516952747|FG007|Overall Study|Lost to Follow-up|1|||
143384068|NCT04586920|516952748|FG008|Overall Study|Lost to Follow-up|0|||
143384069|NCT04586920|516952749|FG009|Overall Study|Lost to Follow-up|1|||
143384070|NCT04586920|516952750|FG010|Overall Study|Lost to Follow-up|0|||
143384071|NCT04586920|516952751|FG011|Overall Study|Lost to Follow-up|0|||
143384072|NCT04586920|516952752|FG012|Overall Study|Lost to Follow-up|0|||
143384073|NCT04586920|516952753|FG013|Overall Study|Lost to Follow-up|1|||
143384074|NCT04586920|516952754|FG014|Overall Study|Lost to Follow-up|0|||
143384075|NCT04586920|516952755|FG015|Overall Study|Lost to Follow-up|0|||
143384076|NCT04586920|516952756|FG016|Overall Study|Lost to Follow-up|0|||
143384077|NCT04586920|516952757|FG017|Overall Study|Lost to Follow-up|0|||
143384078|NCT04586920|516952740|FG000|Overall Study|Withdrawal by Subject|0|||
143384079|NCT04586920|516952741|FG001|Overall Study|Withdrawal by Subject|0|||
143384080|NCT04586920|516952742|FG002|Overall Study|Withdrawal by Subject|0|||
143384081|NCT04586920|516952743|FG003|Overall Study|Withdrawal by Subject|0|||
143384082|NCT04586920|516952744|FG004|Overall Study|Withdrawal by Subject|0|||
143331817|NCT03998618|516758109|FG001|Overall Study|Death|11|||
143331818|NCT03998618|516758108|FG000|Overall Study|hospice enrollment|3|||
143331819|NCT03998618|516758109|FG001|Overall Study|hospice enrollment|3|||
143331820|NCT03998618|516758108|FG000|Overall Study|Not feeling well/health problems|3|||
143331821|NCT03998618|516758109|FG001|Overall Study|Not feeling well/health problems|5|||
143331822|NCT03998618|516758108|FG000|Overall Study|Lost to Follow-up|6|||
143331823|NCT03998618|516758109|FG001|Overall Study|Lost to Follow-up|6|||
143331824|NCT03998618|516758108|FG000|Overall Study|Withdrawal by Subject|0|||
143331825|NCT03998618|516758109|FG001|Overall Study|Withdrawal by Subject|4|||
143331826|NCT01483924|516758110|FG000|Overall Study|Withdrawal by Subject|2|||
143331827|NCT01483924|516758111|FG001|Overall Study|Withdrawal by Subject|0|||
143331828|NCT01483924|516758112|FG002|Overall Study|Withdrawal by Subject|0|||
143331829|NCT01483924|516758113|FG003|Overall Study|Withdrawal by Subject|1|||
143331830|NCT01483924|516758114|FG004|Overall Study|Withdrawal by Subject|1|||
143331831|NCT01483924|516758110|FG000|Overall Study|Adverse Event|0|||
143331832|NCT01483924|516758111|FG001|Overall Study|Adverse Event|0|||
143331833|NCT01483924|516758112|FG002|Overall Study|Adverse Event|1|||
143331834|NCT01483924|516758113|FG003|Overall Study|Adverse Event|1|||
143331835|NCT01483924|516758114|FG004|Overall Study|Adverse Event|0|||
143331836|NCT01483924|516758110|FG000|Overall Study|Non-compliance|0|||
143331837|NCT01483924|516758111|FG001|Overall Study|Non-compliance|0|||
143331838|NCT01483924|516758112|FG002|Overall Study|Non-compliance|0|||
143331839|NCT01483924|516758113|FG003|Overall Study|Non-compliance|1|||
143331840|NCT01483924|516758114|FG004|Overall Study|Non-compliance|1|||
143331841|NCT01483924|516758110|FG000|Overall Study|Sponsor concern over ECG result|0|||
143331842|NCT01483924|516758111|FG001|Overall Study|Sponsor concern over ECG result|0|||
143331843|NCT01483924|516758112|FG002|Overall Study|Sponsor concern over ECG result|0|||
143331844|NCT01483924|516758113|FG003|Overall Study|Sponsor concern over ECG result|1|||
143331845|NCT01483924|516758114|FG004|Overall Study|Sponsor concern over ECG result|0|||
143331846|NCT00003298|516758115|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
143331847|NCT00003298|516758115|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
143331848|NCT00003298|516758115|FG000|Surgery|Unresectable at surgery|3|||
143331849|NCT00003298|516758115|FG000|Surgery|Progression before surgery|2|||
143331850|NCT00003298|516758115|FG000|Surgery|Unevaluable and off study|2|||
143331851|NCT00003298|516758115|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
143331852|NCT00003298|516758115|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
143331853|NCT00003298|516758115|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
143331854|NCT00003298|516758115|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
143331855|NCT00003298|516758115|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
143331856|NCT00003298|516758115|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
143331857|NCT00003298|516758115|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
143331858|NCT00003298|516758115|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
143331859|NCT00003298|516758115|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
143331860|NCT00003298|516758115|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
143331861|NCT00335322|516758117|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
143331862|NCT00335322|516758118|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
143331863|NCT00335322|516758119|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
143331864|NCT02308748|516758122|FG000|Period 1|Withdrawal by Subject|0|||
143331865|NCT02308748|516758123|FG001|Period 1|Withdrawal by Subject|0|||
143331866|NCT02308748|516758124|FG002|Period 1|Withdrawal by Subject|1|||
143331867|NCT02308748|516758125|FG003|Period 1|Withdrawal by Subject|0|||
143331868|NCT02308748|516758126|FG004|Period 1|Withdrawal by Subject|0|||
143331869|NCT02308748|516758127|FG005|Period 1|Withdrawal by Subject|0|||
143331870|NCT02308748|516758128|FG006|Period 1|Withdrawal by Subject|0|||
143331871|NCT02308748|516758129|FG007|Period 1|Withdrawal by Subject|0|||
143331872|NCT02308748|516758130|FG008|Period 1|Withdrawal by Subject|0|||
143331873|NCT02308748|516758131|FG009|Period 1|Withdrawal by Subject|0|||
143331874|NCT02308748|516758122|FG000|Period 2|Adverse Event|0|||
143331875|NCT02308748|516758123|FG001|Period 2|Adverse Event|0|||
143331876|NCT02308748|516758124|FG002|Period 2|Adverse Event|0|||
143331877|NCT02308748|516758125|FG003|Period 2|Adverse Event|0|||
143331878|NCT02308748|516758126|FG004|Period 2|Adverse Event|0|||
143331879|NCT02308748|516758127|FG005|Period 2|Adverse Event|0|||
143331880|NCT02308748|516758128|FG006|Period 2|Adverse Event|0|||
143331881|NCT02308748|516758129|FG007|Period 2|Adverse Event|1|||
143331882|NCT02308748|516758130|FG008|Period 2|Adverse Event|0|||
143331883|NCT02308748|516758131|FG009|Period 2|Adverse Event|0|||
143331884|NCT02308748|516758122|FG000|Period 3|Protocol Violation|0|||
143331885|NCT02308748|516758123|FG001|Period 3|Protocol Violation|0|||
143331886|NCT02308748|516758124|FG002|Period 3|Protocol Violation|0|||
143331887|NCT02308748|516758125|FG003|Period 3|Protocol Violation|0|||
143331888|NCT02308748|516758126|FG004|Period 3|Protocol Violation|0|||
143331889|NCT02308748|516758127|FG005|Period 3|Protocol Violation|0|||
143331890|NCT02308748|516758128|FG006|Period 3|Protocol Violation|0|||
143331891|NCT02308748|516758129|FG007|Period 3|Protocol Violation|0|||
143331892|NCT02308748|516758130|FG008|Period 3|Protocol Violation|0|||
143331893|NCT02308748|516758131|FG009|Period 3|Protocol Violation|1|||
143384083|NCT04586920|516952745|FG005|Overall Study|Withdrawal by Subject|0|||
143384084|NCT04586920|516952746|FG006|Overall Study|Withdrawal by Subject|0|||
143384085|NCT04586920|516952747|FG007|Overall Study|Withdrawal by Subject|1|||
143384086|NCT04586920|516952748|FG008|Overall Study|Withdrawal by Subject|0|||
143384087|NCT04586920|516952749|FG009|Overall Study|Withdrawal by Subject|1|||
143384088|NCT04586920|516952750|FG010|Overall Study|Withdrawal by Subject|0|||
143384089|NCT04586920|516952751|FG011|Overall Study|Withdrawal by Subject|1|||
143384090|NCT04586920|516952752|FG012|Overall Study|Withdrawal by Subject|0|||
143384091|NCT04586920|516952753|FG013|Overall Study|Withdrawal by Subject|0|||
143384092|NCT04586920|516952754|FG014|Overall Study|Withdrawal by Subject|0|||
143384093|NCT04586920|516952755|FG015|Overall Study|Withdrawal by Subject|0|||
143331894|NCT02308748|516758122|FG000|Period 5|Adverse Event|1|||
143331895|NCT02308748|516758123|FG001|Period 5|Adverse Event|0|||
143331896|NCT02308748|516758124|FG002|Period 5|Adverse Event|0|||
143331897|NCT02308748|516758125|FG003|Period 5|Adverse Event|0|||
143331898|NCT02308748|516758126|FG004|Period 5|Adverse Event|0|||
143331899|NCT02308748|516758127|FG005|Period 5|Adverse Event|0|||
143331900|NCT02308748|516758128|FG006|Period 5|Adverse Event|0|||
143331901|NCT02308748|516758129|FG007|Period 5|Adverse Event|0|||
143331902|NCT02308748|516758130|FG008|Period 5|Adverse Event|1|||
143384094|NCT04586920|516952756|FG016|Overall Study|Withdrawal by Subject|0|||
143384095|NCT04586920|516952757|FG017|Overall Study|Withdrawal by Subject|0|||
143384096|NCT02728557|516952758|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
143384097|NCT02728557|516952759|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
143384098|NCT02728557|516952758|FG000|Overall Study|Dissatisfaction with research tasks|0|||
143384099|NCT02728557|516952759|FG001|Overall Study|Dissatisfaction with research tasks|1|||
143384100|NCT02728557|516952758|FG000|Overall Study|Scheduling or change in availability|1|||
143384101|NCT02728557|516952759|FG001|Overall Study|Scheduling or change in availability|1|||
143384102|NCT01718743|516952760|FG000|Overall Study|Physician Decision|7|||
143384103|NCT01718743|516952760|FG000|Overall Study|Withdrawal by Subject|14|||
143384104|NCT01718743|516952760|FG000|Overall Study|Progressive Disease|22|||
143384105|NCT01718743|516952760|FG000|Overall Study|Toxicity|1|||
143384106|NCT01718743|516952760|FG000|Overall Study|Malignancy|1|||
143384107|NCT03416010|516952761|FG000|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|11|||
143384108|NCT03416010|516952762|FG001|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|32|||
143384109|NCT03416010|516952761|FG000|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|27|||
143384110|NCT03416010|516952762|FG001|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|38|||
143384111|NCT03416010|516952761|FG000|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|11|||
143384112|NCT03416010|516952762|FG001|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|12|||
143384113|NCT03416010|516952761|FG000|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|1|||
143384114|NCT03416010|516952762|FG001|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|0|||
143384115|NCT03416010|516952761|FG000|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|1|||
143384116|NCT03416010|516952762|FG001|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|3|||
143384117|NCT03416010|516952761|FG000|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|1|||
143384118|NCT03416010|516952762|FG001|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|3|||
143384119|NCT03416010|516952761|FG000|Timepoint 3 (6 Months Postpartum)|Missing Data|2|||
143384120|NCT03416010|516952762|FG001|Timepoint 3 (6 Months Postpartum)|Missing Data|3|||
143384121|NCT03948763|516952766|FG000|Overall Study|Sponsor's decision|0|||
143384122|NCT03948763|516952767|FG001|Overall Study|Sponsor's decision|2|||
143384123|NCT03948763|516952768|FG002|Overall Study|Sponsor's decision|6|||
143384124|NCT03948763|516952769|FG003|Overall Study|Sponsor's decision|4|||
143384125|NCT03948763|516952770|FG004|Overall Study|Sponsor's decision|0|||
143384126|NCT03948763|516952766|FG000|Overall Study|Physician Decision|0|||
143384127|NCT03948763|516952767|FG001|Overall Study|Physician Decision|0|||
143331903|NCT02308748|516758131|FG009|Period 5|Adverse Event|0|||
143331904|NCT01994954|516758136|FG000|Overall Study|Death|1|||
143384128|NCT03948763|516952768|FG002|Overall Study|Physician Decision|1|||
143384129|NCT03948763|516952769|FG003|Overall Study|Physician Decision|0|||
143384130|NCT03948763|516952770|FG004|Overall Study|Physician Decision|0|||
143384131|NCT03948763|516952766|FG000|Overall Study|Lost to Follow-up|0|||
143384132|NCT03948763|516952767|FG001|Overall Study|Lost to Follow-up|0|||
143384133|NCT03948763|516952768|FG002|Overall Study|Lost to Follow-up|0|||
143384134|NCT03948763|516952769|FG003|Overall Study|Lost to Follow-up|0|||
143384135|NCT03948763|516952770|FG004|Overall Study|Lost to Follow-up|1|||
143384136|NCT03948763|516952766|FG000|Overall Study|Death|2|||
143331905|NCT01994954|516758137|FG001|Overall Study|Death|0|||
143331906|NCT01994954|516758136|FG000|Overall Study|Withdrawal by Subject|9|||
143331907|NCT01994954|516758137|FG001|Overall Study|Withdrawal by Subject|14|||
143331908|NCT01994954|516758136|FG000|Overall Study|Physician Decision|2|||
143331909|NCT01994954|516758137|FG001|Overall Study|Physician Decision|2|||
143331910|NCT01994954|516758136|FG000|Overall Study|Lost to Follow-up|8|||
143331911|NCT01994954|516758137|FG001|Overall Study|Lost to Follow-up|10|||
143331912|NCT01994954|516758136|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
143331913|NCT01994954|516758137|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
143331914|NCT01454583|516758140|FG000|1st Year|Lost to Follow-up|1057|||
143331915|NCT01454583|516758141|FG001|1st Year|Lost to Follow-up|318|||
143331916|NCT01454583|516758142|FG002|1st Year|Lost to Follow-up|180|||
143331917|NCT01454583|516758140|FG000|2nd Year|Lost to Follow-up|3965|||
143331918|NCT01454583|516758141|FG001|2nd Year|Lost to Follow-up|1049|||
143331919|NCT01454583|516758142|FG002|2nd Year|Lost to Follow-up|737|||
143331920|NCT01454583|516758140|FG000|3rd Year|Lost to Follow-up|1959|||
143331921|NCT01454583|516758141|FG001|3rd Year|Lost to Follow-up|512|||
143331922|NCT01454583|516758142|FG002|3rd Year|Lost to Follow-up|297|||
143331923|NCT01967732|516758143|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
143331924|NCT01967732|516758144|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
143331925|NCT01967732|516758145|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
143331926|NCT01967732|516758146|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
143331927|NCT01967732|516758143|FG000|First Intervention (Day 1)|Poor venous access|0|||
143331928|NCT01967732|516758144|FG001|First Intervention (Day 1)|Poor venous access|1|||
143331929|NCT01967732|516758145|FG002|First Intervention (Day 1)|Poor venous access|0|||
143331930|NCT01967732|516758146|FG003|First Intervention (Day 1)|Poor venous access|0|||
143331931|NCT00113568|516758153|FG000|Overall Study|Adverse Event|97|||
143331932|NCT00113568|516758153|FG000|Overall Study|Death|1|||
143384137|NCT03948763|516952767|FG001|Overall Study|Death|12|||
143331933|NCT00113568|516758153|FG000|Overall Study|Lack of Efficacy|30|||
143331934|NCT00113568|516758153|FG000|Overall Study|Lost to Follow-up|156|||
143384138|NCT03948763|516952768|FG002|Overall Study|Death|13|||
143384139|NCT03948763|516952769|FG003|Overall Study|Death|10|||
143384140|NCT03948763|516952770|FG004|Overall Study|Death|11|||
143331935|NCT00113568|516758153|FG000|Overall Study|Protocol Violation|32|||
143331936|NCT00113568|516758153|FG000|Overall Study|Withdrawal by Subject|117|||
143331937|NCT00113568|516758153|FG000|Overall Study|Other|112|||
143331938|NCT01022762|516758156|FG000|Overall Study|Adverse Event|3|||
143331939|NCT01022762|516758157|FG001|Overall Study|Adverse Event|1|||
143331940|NCT01022762|516758156|FG000|Overall Study|Lack of Efficacy|0|||
143331941|NCT01022762|516758157|FG001|Overall Study|Lack of Efficacy|1|||
143331942|NCT01022762|516758156|FG000|Overall Study|Protocol Violation|7|||
143331943|NCT01022762|516758157|FG001|Overall Study|Protocol Violation|6|||
143331944|NCT01022762|516758156|FG000|Overall Study|Unclassified|12|||
143331945|NCT01022762|516758157|FG001|Overall Study|Unclassified|20|||
143331946|NCT04084314|516758158|FG000|Overall Study|Subject/guardian decision|91|||
143331947|NCT04084314|516758158|FG000|Overall Study|Adverse Event|24|||
143331948|NCT04084314|516758158|FG000|Overall Study|Lost to Follow-up|19|||
143331949|NCT04084314|516758158|FG000|Overall Study|New therapy for study indication|9|||
143331950|NCT04084314|516758158|FG000|Overall Study|Pregnancy|9|||
143331951|NCT04084314|516758158|FG000|Overall Study|Withdrawal of informed consent|8|||
143331952|NCT04084314|516758158|FG000|Overall Study|Physician Decision|4|||
143331953|NCT04084314|516758158|FG000|Overall Study|Protocol Deviation|3|||
143331954|NCT01565707|516758159|FG000|Overall Study|Adverse Event|1|||
143331955|NCT01565707|516758160|FG001|Overall Study|Adverse Event|6|||
143331956|NCT01565707|516758161|FG002|Overall Study|Adverse Event|2|||
143331957|NCT01565707|516758162|FG003|Overall Study|Adverse Event|1|||
143331958|NCT01565707|516758159|FG000|Overall Study|Lost to Follow-up|1|||
143331959|NCT01565707|516758160|FG001|Overall Study|Lost to Follow-up|0|||
143331960|NCT01565707|516758161|FG002|Overall Study|Lost to Follow-up|0|||
143331961|NCT01565707|516758162|FG003|Overall Study|Lost to Follow-up|0|||
143331962|NCT01565707|516758159|FG000|Overall Study|Protocol Violation|1|||
143331963|NCT01565707|516758160|FG001|Overall Study|Protocol Violation|0|||
143331964|NCT01565707|516758161|FG002|Overall Study|Protocol Violation|0|||
143331965|NCT01565707|516758162|FG003|Overall Study|Protocol Violation|1|||
143331966|NCT01565707|516758159|FG000|Overall Study|Withdrawal by Subject|3|||
143331967|NCT01565707|516758160|FG001|Overall Study|Withdrawal by Subject|1|||
143331968|NCT01565707|516758161|FG002|Overall Study|Withdrawal by Subject|1|||
143331969|NCT01565707|516758162|FG003|Overall Study|Withdrawal by Subject|1|||
143331970|NCT01565707|516758159|FG000|Overall Study|Randomized but not evaluable|2|||
143331971|NCT01565707|516758160|FG001|Overall Study|Randomized but not evaluable|0|||
143331972|NCT01565707|516758161|FG002|Overall Study|Randomized but not evaluable|0|||
143331973|NCT01565707|516758162|FG003|Overall Study|Randomized but not evaluable|0|||
143331974|NCT01565707|516758159|FG000|Overall Study|Miscellaneous|1|||
143331975|NCT01565707|516758160|FG001|Overall Study|Miscellaneous|1|||
143331976|NCT01565707|516758161|FG002|Overall Study|Miscellaneous|0|||
143331977|NCT01565707|516758162|FG003|Overall Study|Miscellaneous|2|||
143331978|NCT03754803|516758163|FG000|Overall Study|Withdrawal by Subject|2|||
143331979|NCT00003508|516760020|FG000|Overall Study|Not evaluable|5|||
143331980|NCT02822222|516760027|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
143331981|NCT02822222|516760028|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
143331982|NCT00677833|516760029|FG000|Overall Study|Withdrawal by Subject|4|||
143331983|NCT00677833|516760030|FG001|Overall Study|Withdrawal by Subject|0|||
143331984|NCT00677833|516760031|FG002|Overall Study|Withdrawal by Subject|1|||
143331985|NCT00677833|516760032|FG003|Overall Study|Withdrawal by Subject|3|||
143331986|NCT00677833|516760029|FG000|Overall Study|Lost to Follow-up|0|||
143384141|NCT03948763|516952766|FG000|Overall Study|Withdrawal by Subject|1|||
143331987|NCT00677833|516760030|FG001|Overall Study|Lost to Follow-up|0|||
143331988|NCT00677833|516760031|FG002|Overall Study|Lost to Follow-up|1|||
143331989|NCT00677833|516760032|FG003|Overall Study|Lost to Follow-up|0|||
143331990|NCT02184611|516760033|FG000|Overall Study|Lack of Efficacy|11|||
143331991|NCT02184611|516760034|FG001|Overall Study|Lack of Efficacy|15|||
143331992|NCT02184611|516760033|FG000|Overall Study|Withdrawal by Subject|5|||
143331993|NCT02184611|516760034|FG001|Overall Study|Withdrawal by Subject|6|||
143331994|NCT02184611|516760033|FG000|Overall Study|Adverse Event|4|||
143331995|NCT02184611|516760034|FG001|Overall Study|Adverse Event|5|||
143331996|NCT02184611|516760033|FG000|Overall Study|Protocol Violation|1|||
143331997|NCT02184611|516760034|FG001|Overall Study|Protocol Violation|1|||
143331998|NCT02184611|516760033|FG000|Overall Study|Protocol defined stopping criteria|0|||
143331999|NCT02184611|516760034|FG001|Overall Study|Protocol defined stopping criteria|1|||
143332000|NCT00160680|516760035|FG000|Overall Study|Adverse Event|0|||
143332001|NCT00160680|516760036|FG001|Overall Study|Adverse Event|1|||
143332002|NCT00160680|516760035|FG000|Overall Study|Lack of Efficacy|2|||
143332003|NCT00160680|516760036|FG001|Overall Study|Lack of Efficacy|1|||
143332004|NCT00160680|516760035|FG000|Overall Study|Lost to Follow-up|3|||
143332005|NCT00160680|516760036|FG001|Overall Study|Lost to Follow-up|2|||
143332006|NCT00160680|516760035|FG000|Overall Study|Withdrawal by Subject|4|||
143332007|NCT00160680|516760036|FG001|Overall Study|Withdrawal by Subject|9|||
143332008|NCT04493216|516760037|FG000|Overall Study|Study terminated by sponsor|30|||
143332009|NCT04493216|516760038|FG001|Overall Study|Study terminated by sponsor|33|||
143332010|NCT04493216|516760039|FG002|Overall Study|Study terminated by sponsor|28|||
143332011|NCT04493216|516760040|FG003|Overall Study|Study terminated by sponsor|27|||
143332012|NCT04493216|516760037|FG000|Overall Study|Withdrawal by Subject|2|||
143332013|NCT04493216|516760038|FG001|Overall Study|Withdrawal by Subject|1|||
143332014|NCT04493216|516760039|FG002|Overall Study|Withdrawal by Subject|1|||
143332015|NCT04493216|516760040|FG003|Overall Study|Withdrawal by Subject|2|||
143332016|NCT04493216|516760037|FG000|Overall Study|Protocol Violation|1|||
143332017|NCT04493216|516760038|FG001|Overall Study|Protocol Violation|2|||
143332018|NCT04493216|516760039|FG002|Overall Study|Protocol Violation|0|||
143332019|NCT04493216|516760040|FG003|Overall Study|Protocol Violation|2|||
143332020|NCT04493216|516760037|FG000|Overall Study|Physician Decision|0|||
143332021|NCT04493216|516760038|FG001|Overall Study|Physician Decision|0|||
143332022|NCT04493216|516760039|FG002|Overall Study|Physician Decision|1|||
143332023|NCT04493216|516760040|FG003|Overall Study|Physician Decision|0|||
143332024|NCT04493216|516760037|FG000|Overall Study|Lost to Follow-up|2|||
143332025|NCT04493216|516760038|FG001|Overall Study|Lost to Follow-up|1|||
143332026|NCT04493216|516760039|FG002|Overall Study|Lost to Follow-up|0|||
143332027|NCT04493216|516760040|FG003|Overall Study|Lost to Follow-up|1|||
143332028|NCT04493216|516760037|FG000|Overall Study|Adverse Event|1|||
143332029|NCT04493216|516760038|FG001|Overall Study|Adverse Event|4|||
143332030|NCT04493216|516760039|FG002|Overall Study|Adverse Event|5|||
143332031|NCT04493216|516760040|FG003|Overall Study|Adverse Event|2|||
143332032|NCT04493216|516760037|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
143332033|NCT04493216|516760038|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
143332034|NCT04493216|516760039|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
143332035|NCT04493216|516760040|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
143332036|NCT00985725|516760048|FG000|Overall Study|Adverse Event|4|||
143332037|NCT00985725|516760049|FG001|Overall Study|Adverse Event|1|||
143332038|NCT00985725|516760048|FG000|Overall Study|Protocol Violation|1|||
143332039|NCT00985725|516760049|FG001|Overall Study|Protocol Violation|3|||
143332040|NCT00985725|516760048|FG000|Overall Study|Withdrawal by Subject|4|||
143332041|NCT00985725|516760049|FG001|Overall Study|Withdrawal by Subject|4|||
143332042|NCT00985725|516760048|FG000|Overall Study|Lost to Follow-up|1|||
143332043|NCT00985725|516760049|FG001|Overall Study|Lost to Follow-up|1|||
143332044|NCT00985725|516760048|FG000|Overall Study|Lack of Efficacy|0|||
143332045|NCT00985725|516760049|FG001|Overall Study|Lack of Efficacy|1|||
143332046|NCT00985725|516760048|FG000|Overall Study|Non-compliance|1|||
143332047|NCT00985725|516760049|FG001|Overall Study|Non-compliance|2|||
143332048|NCT00985725|516760048|FG000|Overall Study|Out-of-window visits|0|||
143332049|NCT00985725|516760049|FG001|Overall Study|Out-of-window visits|1|||
143384142|NCT03948763|516952767|FG001|Overall Study|Withdrawal by Subject|1|||
143384143|NCT03948763|516952768|FG002|Overall Study|Withdrawal by Subject|0|||
143384144|NCT03948763|516952769|FG003|Overall Study|Withdrawal by Subject|2|||
143384145|NCT03948763|516952770|FG004|Overall Study|Withdrawal by Subject|4|||
143384146|NCT06023082|516952772|FG000|Overall Study|Withdrawal by Subject|2|||
143332050|NCT03151005|516760050|FG000|Overall Study|Lost to Follow-up|5|||
143332051|NCT03151005|516760051|FG001|Overall Study|Lost to Follow-up|5|||
143332052|NCT03945188|516760054|FG000|Overall Study|Protocol Violation|1|||
143332053|NCT03945188|516760055|FG001|Overall Study|Protocol Violation|0|||
143332054|NCT03945188|516760054|FG000|Overall Study|Disease worsening|79|||
143332055|NCT03945188|516760055|FG001|Overall Study|Disease worsening|73|||
143332056|NCT03945188|516760054|FG000|Overall Study|Physician Decision|2|||
143332057|NCT03945188|516760055|FG001|Overall Study|Physician Decision|2|||
143332058|NCT03945188|516760054|FG000|Overall Study|Lack of Efficacy|7|||
143332059|NCT03945188|516760055|FG001|Overall Study|Lack of Efficacy|4|||
143332060|NCT03945188|516760054|FG000|Overall Study|Pregnancy|2|||
143332061|NCT03945188|516760055|FG001|Overall Study|Pregnancy|0|||
143332062|NCT03945188|516760054|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
143332063|NCT03945188|516760055|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
143332064|NCT03945188|516760054|FG000|Overall Study|Adverse Event|10|||
143332065|NCT03945188|516760055|FG001|Overall Study|Adverse Event|5|||
143332066|NCT03945188|516760054|FG000|Overall Study|Other|2|||
143332067|NCT03945188|516760055|FG001|Overall Study|Other|2|||
143332068|NCT03945188|516760054|FG000|Overall Study|Lost to Follow-up|1|||
143332069|NCT03945188|516760055|FG001|Overall Study|Lost to Follow-up|2|||
143332070|NCT01618162|516760081|FG000|Overall Study|Protocol Violation|13|||
143332071|NCT01618162|516760082|FG001|Overall Study|Protocol Violation|10|||
143332072|NCT01618162|516760081|FG000|Overall Study|Adverse Event|9|||
143332073|NCT01618162|516760082|FG001|Overall Study|Adverse Event|2|||
143332074|NCT01618162|516760081|FG000|Overall Study|Withdrawal Criteria|2|||
143332075|NCT01618162|516760082|FG001|Overall Study|Withdrawal Criteria|10|||
143332076|NCT01618162|516760081|FG000|Overall Study|Unclassified|14|||
143332077|NCT01618162|516760082|FG001|Overall Study|Unclassified|13|||
143332078|NCT00423176|516760085|FG000|Overall Study|Adverse Event|4|||
143332079|NCT00423176|516760086|FG001|Overall Study|Adverse Event|6|||
143332080|NCT00423176|516760085|FG000|Overall Study|Treatment Failure|1|||
143332081|NCT00423176|516760086|FG001|Overall Study|Treatment Failure|6|||
143332082|NCT00423176|516760085|FG000|Overall Study|Lost to Follow-up|4|||
143332083|NCT00423176|516760086|FG001|Overall Study|Lost to Follow-up|7|||
143332084|NCT00423176|516760085|FG000|Overall Study|Withdrawal by Subject|4|||
143332085|NCT00423176|516760086|FG001|Overall Study|Withdrawal by Subject|3|||
143332086|NCT00423176|516760085|FG000|Overall Study|Protocol Violation|1|||
143332087|NCT00423176|516760086|FG001|Overall Study|Protocol Violation|3|||
143332088|NCT00423176|516760085|FG000|Overall Study|Did not meet protocol eligibility|2|||
143332089|NCT00423176|516760086|FG001|Overall Study|Did not meet protocol eligibility|4|||
143332090|NCT01640808|516760088|FG000|Overall Study|Unable to continue dynamic CT|14|||
143332091|NCT01640808|516760089|FG001|Overall Study|Unable to continue dynamic CT|4|||
143332092|NCT01640808|516760088|FG000|Overall Study|Withdrawal by Subject|12|||
143332093|NCT01640808|516760089|FG001|Overall Study|Withdrawal by Subject|4|||
143332094|NCT01640808|516760088|FG000|Overall Study|Lost to Follow-up|4|||
143332095|NCT01640808|516760089|FG001|Overall Study|Lost to Follow-up|0|||
143332096|NCT01640808|516760088|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
143332097|NCT01640808|516760089|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
143332098|NCT01640808|516760088|FG000|Overall Study|Administration of anticancer drugs|2|||
143332099|NCT01640808|516760089|FG001|Overall Study|Administration of anticancer drugs|1|||
143332100|NCT01640808|516760088|FG000|Overall Study|Physician Decision|19|||
143332101|NCT01640808|516760089|FG001|Overall Study|Physician Decision|5|||
143332102|NCT01640808|516760088|FG000|Overall Study|Randomized but not treated|4|||
143332103|NCT01640808|516760089|FG001|Overall Study|Randomized but not treated|2|||
143332104|NCT02477111|516760090|FG000|Overall Study|Death|28|||
143332105|NCT02477111|516760090|FG000|Overall Study|Withdrawal by Subject|19|||
143332106|NCT02477111|516760090|FG000|Overall Study|Lost to Follow-up|4|||
143332107|NCT02192502|516760092|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
143332108|NCT02192502|516760093|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
143332109|NCT02192502|516760092|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
143332110|NCT02192502|516760093|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
143332111|NCT02192502|516760092|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
143332112|NCT02192502|516760093|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
143332113|NCT01381692|516760094|FG000|Overall Study|Adverse Event|1|||
143332114|NCT01381692|516760095|FG001|Overall Study|Adverse Event|0|||
143332115|NCT01381692|516760096|FG002|Overall Study|Adverse Event|0|||
143332116|NCT01381692|516760097|FG003|Overall Study|Adverse Event|0|||
143332117|NCT01381692|516760098|FG004|Overall Study|Adverse Event|0|||
143332118|NCT01381692|516760099|FG005|Overall Study|Adverse Event|0|||
143332119|NCT01506193|516760102|FG000|Overall Study|Protocol Violation|1|||
143332120|NCT01506193|516760103|FG001|Overall Study|Protocol Violation|0|||
143332121|NCT01506193|516760104|FG002|Overall Study|Protocol Violation|1|||
143332122|NCT01506193|516760102|FG000|Overall Study|Migrated/moved from study area|0|||
143332123|NCT01506193|516760103|FG001|Overall Study|Migrated/moved from study area|0|||
143332124|NCT01506193|516760104|FG002|Overall Study|Migrated/moved from study area|1|||
143332125|NCT01506193|516760102|FG000|Overall Study|Adverse event, non-fatal|0|||
143384147|NCT06023082|516952772|FG000|Overall Study|Lost to Follow-up|15|||
143384148|NCT06023082|516952772|FG000|Overall Study|Side effects|5|||
143332126|NCT01506193|516760103|FG001|Overall Study|Adverse event, non-fatal|0|||
143332127|NCT01506193|516760104|FG002|Overall Study|Adverse event, non-fatal|1|||
143332128|NCT01506193|516760102|FG000|Overall Study|Withdrawal by Subject|5|||
143332129|NCT01506193|516760103|FG001|Overall Study|Withdrawal by Subject|1|||
143332130|NCT01506193|516760104|FG002|Overall Study|Withdrawal by Subject|8|||
143332131|NCT01506193|516760102|FG000|Overall Study|Lost to Follow-up|8|||
143332132|NCT01506193|516760103|FG001|Overall Study|Lost to Follow-up|3|||
143332133|NCT01506193|516760104|FG002|Overall Study|Lost to Follow-up|3|||
143332134|NCT01388816|516760109|FG000|Overall Study|Adverse Event|0|||
143332135|NCT01388816|516760110|FG001|Overall Study|Adverse Event|2|||
143332136|NCT01388816|516760111|FG002|Overall Study|Adverse Event|0|||
143332137|NCT01388816|516760112|FG003|Overall Study|Adverse Event|0|||
143332138|NCT01388816|516760109|FG000|Overall Study|Lost to Follow-up|0|||
143332139|NCT01388816|516760110|FG001|Overall Study|Lost to Follow-up|1|||
143332140|NCT01388816|516760111|FG002|Overall Study|Lost to Follow-up|0|||
143332141|NCT01388816|516760112|FG003|Overall Study|Lost to Follow-up|0|||
143332142|NCT01388816|516760109|FG000|Overall Study|Withdrawal by Subject|2|||
143332143|NCT01388816|516760110|FG001|Overall Study|Withdrawal by Subject|1|||
143332144|NCT01388816|516760111|FG002|Overall Study|Withdrawal by Subject|1|||
143332145|NCT01388816|516760112|FG003|Overall Study|Withdrawal by Subject|0|||
143332146|NCT01388816|516760109|FG000|Overall Study|Protocol Violation|0|||
143332147|NCT01388816|516760110|FG001|Overall Study|Protocol Violation|0|||
143332148|NCT01388816|516760111|FG002|Overall Study|Protocol Violation|2|||
143332149|NCT01388816|516760112|FG003|Overall Study|Protocol Violation|0|||
143332150|NCT00743366|516760113|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
143332151|NCT00743366|516760114|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
143332152|NCT01328574|516760115|FG000|Overall Study|Refused further treatment|1|||
143332153|NCT02472964|516760122|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
143332154|NCT02472964|516760123|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
143332155|NCT02472964|516760122|FG000|Part 1 (up to Week 24)|disease progression|58|||
143332156|NCT02472964|516760123|FG001|Part 1 (up to Week 24)|disease progression|47|||
143332157|NCT02472964|516760122|FG000|Part 1 (up to Week 24)|Death|3|||
143332158|NCT02472964|516760123|FG001|Part 1 (up to Week 24)|Death|6|||
143384149|NCT05846646|516952773|FG000|Overall Study|Physician Decision|1|||
143384150|NCT05846646|516952774|FG001|Overall Study|Physician Decision|0|||
143384151|NCT05846646|516952775|FG002|Overall Study|Physician Decision|0|||
143332159|NCT02472964|516760122|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
143384152|NCT05846646|516952773|FG000|Overall Study|Lack of Efficacy|1|||
143332160|NCT02472964|516760123|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
143332161|NCT02472964|516760122|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
143332162|NCT02472964|516760123|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
143332163|NCT02472964|516760122|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
143384153|NCT05846646|516952774|FG001|Overall Study|Lack of Efficacy|1|||
143384154|NCT05846646|516952775|FG002|Overall Study|Lack of Efficacy|0|||
143332164|NCT02472964|516760123|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
143332165|NCT02472964|516760122|FG000|Part 1 (up to Week 24)|Other|2|||
143332166|NCT02472964|516760123|FG001|Part 1 (up to Week 24)|Other|1|||
143332167|NCT02472964|516760122|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
143332168|NCT02472964|516760123|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
143332169|NCT02472964|516760122|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
143332170|NCT02472964|516760123|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
143332171|NCT02472964|516760122|FG000|Part 2 (Week 24-week 48)|Death|0|||
143332172|NCT02472964|516760123|FG001|Part 2 (Week 24-week 48)|Death|1|||
143332173|NCT02472964|516760122|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
143332174|NCT02472964|516760123|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
143332175|NCT02472964|516760122|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
143332176|NCT02472964|516760123|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
143332177|NCT02472964|516760122|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
143332178|NCT02472964|516760123|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
143332179|NCT02472964|516760122|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
143332180|NCT02472964|516760123|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
143332181|NCT01988779|516760137|FG000|Overall Study|Withdrawal by Subject|2|||
143332182|NCT01988779|516760138|FG001|Overall Study|Withdrawal by Subject|2|||
143332183|NCT01988779|516760137|FG000|Overall Study|Protocol Violation|1|||
143332184|NCT01988779|516760138|FG001|Overall Study|Protocol Violation|0|||
143332185|NCT00377403|516760139|FG000|Overall Study|Unable to contact for telephone intervie|4|||
143332186|NCT00377403|516760140|FG001|Overall Study|Unable to contact for telephone intervie|7|||
143332187|NCT01041638|516760141|FG000|Overall Study|Adverse Event|4|||
143332188|NCT01041638|516760141|FG000|Overall Study|Death|1|||
143332189|NCT01041638|516760141|FG000|Overall Study|Lack of Efficacy|7|||
143332190|NCT01041638|516760141|FG000|Overall Study|Physician Decision|4|||
143332191|NCT01041638|516760141|FG000|Overall Study|Withdrawal by Subject|11|||
143332192|NCT00417079|516760143|FG000|Overall Study|Disease progression|267|||
143332193|NCT00417079|516760144|FG001|Overall Study|Disease progression|180|||
143332194|NCT00417079|516760143|FG000|Overall Study|Adverse Event|32|||
143332195|NCT00417079|516760144|FG001|Overall Study|Adverse Event|67|||
143332196|NCT00417079|516760143|FG000|Overall Study|Non-compliance to protocol|0|||
143332197|NCT00417079|516760144|FG001|Overall Study|Non-compliance to protocol|1|||
143332198|NCT00417079|516760143|FG000|Overall Study|Lost to Follow-up|2|||
143332199|NCT00417079|516760144|FG001|Overall Study|Lost to Follow-up|0|||
143332200|NCT00417079|516760143|FG000|Overall Study|Withdrawal by Subject|17|||
143332201|NCT00417079|516760144|FG001|Overall Study|Withdrawal by Subject|8|||
143332202|NCT00417079|516760143|FG000|Overall Study|Not treated|6|||
143332203|NCT00417079|516760144|FG001|Overall Study|Not treated|7|||
143332204|NCT00417079|516760143|FG000|Overall Study|Screened failure|2|||
143332205|NCT00417079|516760144|FG001|Overall Study|Screened failure|1|||
143332206|NCT00417079|516760143|FG000|Overall Study|Investigator's decision|1|||
143332207|NCT00417079|516760144|FG001|Overall Study|Investigator's decision|4|||
143332208|NCT00417079|516760143|FG000|Overall Study|Non-confirmed Disease progression|1|||
143332209|NCT00417079|516760144|FG001|Overall Study|Non-confirmed Disease progression|1|||
143332210|NCT00417079|516760143|FG000|Overall Study|Clinical deterioration|1|||
143332211|NCT00417079|516760144|FG001|Overall Study|Clinical deterioration|0|||
143332212|NCT00417079|516760143|FG000|Overall Study|Screening error|2|||
143332213|NCT00417079|516760144|FG001|Overall Study|Screening error|1|||
143332214|NCT00417079|516760143|FG000|Overall Study|Withdrawal by subject's family|0|||
143332215|NCT00417079|516760144|FG001|Overall Study|Withdrawal by subject's family|1|||
143332216|NCT00417079|516760143|FG000|Overall Study|Patient unable to come to the clinic|0|||
143332217|NCT00417079|516760144|FG001|Overall Study|Patient unable to come to the clinic|1|||
143332218|NCT00417079|516760143|FG000|Overall Study|abnormal liver function tests|0|||
143332219|NCT00417079|516760144|FG001|Overall Study|abnormal liver function tests|1|||
143332220|NCT01687257|516760147|FG000|Overall Study|Efficacy Failure|6|||
143332221|NCT01687257|516760148|FG001|Overall Study|Efficacy Failure|0|||
143332222|NCT01687257|516760149|FG002|Overall Study|Efficacy Failure|5|||
143332223|NCT01687257|516760147|FG000|Overall Study|Subject Withdrew Consent|1|||
143384155|NCT05846646|516952773|FG000|Overall Study|Early Study Termination|1|||
143384156|NCT05846646|516952774|FG001|Overall Study|Early Study Termination|2|||
143384157|NCT05846646|516952775|FG002|Overall Study|Early Study Termination|0|||
143384158|NCT04791709|516952776|FG000|Overall Study|Withdrawal by Subject|3|||
143384159|NCT00792636|516952777|FG000|Overall Study|Protocol Violation|17|||
143384160|NCT00792636|516952778|FG001|Overall Study|Protocol Violation|23|||
143384161|NCT00792636|516952779|FG002|Overall Study|Protocol Violation|20|||
143384162|NCT00792636|516952777|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
143384163|NCT00792636|516952778|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
143384164|NCT00792636|516952779|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
143384165|NCT00792636|516952777|FG000|Overall Study|Lost to Follow-up|13|||
143384166|NCT00792636|516952778|FG001|Overall Study|Lost to Follow-up|19|||
143384167|NCT00792636|516952779|FG002|Overall Study|Lost to Follow-up|14|||
143384168|NCT00792636|516952777|FG000|Overall Study|Withdrew Consent|10|||
143384169|NCT00792636|516952778|FG001|Overall Study|Withdrew Consent|13|||
143384170|NCT00792636|516952779|FG002|Overall Study|Withdrew Consent|9|||
143384171|NCT00792636|516952777|FG000|Overall Study|Lack of Efficacy|3|||
143384172|NCT00792636|516952778|FG001|Overall Study|Lack of Efficacy|4|||
143384173|NCT00792636|516952779|FG002|Overall Study|Lack of Efficacy|13|||
143384174|NCT00792636|516952777|FG000|Overall Study|Adverse Event|4|||
143384175|NCT00792636|516952778|FG001|Overall Study|Adverse Event|2|||
143384176|NCT00792636|516952779|FG002|Overall Study|Adverse Event|3|||
143384177|NCT00792636|516952777|FG000|Overall Study|Investigator Discretion|2|||
143384178|NCT00792636|516952778|FG001|Overall Study|Investigator Discretion|0|||
143384179|NCT00792636|516952779|FG002|Overall Study|Investigator Discretion|2|||
143384180|NCT01046136|516952780|FG000|Overall Study|Withdrawal by Subject|0|||
143384181|NCT01046136|516952781|FG001|Overall Study|Withdrawal by Subject|4|||
143384182|NCT01046136|516952780|FG000|Overall Study|Physician Decision|1|||
143384183|NCT01046136|516952781|FG001|Overall Study|Physician Decision|1|||
143384184|NCT01046136|516952780|FG000|Overall Study|Lost to Follow-up|3|||
143384185|NCT01046136|516952781|FG001|Overall Study|Lost to Follow-up|3|||
143384186|NCT04579250|516952782|FG000|Overall Study|Withdrawal by Subject|1|||
143384187|NCT04579250|516952783|FG001|Overall Study|Withdrawal by Subject|1|||
143384188|NCT04579250|516952784|FG002|Overall Study|Withdrawal by Subject|0|||
143384189|NCT04579250|516952782|FG000|Overall Study|Lost to Follow-up|1|||
143384190|NCT04579250|516952783|FG001|Overall Study|Lost to Follow-up|1|||
143384191|NCT04579250|516952784|FG002|Overall Study|Lost to Follow-up|0|||
143384192|NCT04579250|516952782|FG000|Overall Study|Moved from area|0|||
143384193|NCT04579250|516952783|FG001|Overall Study|Moved from area|1|||
143384194|NCT04579250|516952784|FG002|Overall Study|Moved from area|2|||
143384195|NCT02058108|516952785|FG000|Overall Study|Abnormal Laboratory Values|0|||
143384196|NCT02058108|516952786|FG001|Overall Study|Abnormal Laboratory Values|1|||
143384197|NCT02058108|516952785|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
143384198|NCT02058108|516952786|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
143384199|NCT02058108|516952785|FG000|Overall Study|No longer requires study drug|0|||
143384200|NCT02058108|516952786|FG001|Overall Study|No longer requires study drug|1|||
143384201|NCT02058108|516952785|FG000|Overall Study|Withdrawal by Subject|1|||
143384202|NCT02058108|516952786|FG001|Overall Study|Withdrawal by Subject|0|||
143384203|NCT02058108|516952785|FG000|Overall Study|Administrative problems|3|||
143384204|NCT02058108|516952786|FG001|Overall Study|Administrative problems|3|||
143384205|NCT02058108|516952785|FG000|Overall Study|Protocol Violation|0|||
143384206|NCT02058108|516952786|FG001|Overall Study|Protocol Violation|1|||
143384207|NCT00727909|516952790|FG000|Overall Study|Withdrawal by Subject|5|||
143384208|NCT00727909|516952791|FG001|Overall Study|Withdrawal by Subject|11|||
143384209|NCT00727909|516952792|FG002|Overall Study|Withdrawal by Subject|8|||
143384210|NCT00727909|516952793|FG003|Overall Study|Withdrawal by Subject|5|||
143384211|NCT00727909|516952790|FG000|Overall Study|Death|0|||
143384212|NCT00727909|516952791|FG001|Overall Study|Death|0|||
143384213|NCT00727909|516952792|FG002|Overall Study|Death|1|||
143384214|NCT00727909|516952793|FG003|Overall Study|Death|0|||
143384215|NCT01696773|516952794|FG000|Days 15-27, Washout|Adverse Event|1|||
143384216|NCT01696773|516952795|FG001|Days 15-27, Washout|Adverse Event|0|||
143384217|NCT05623345|516952796|FG000|Overall Study|Withdrawal by Subject|14|||
143384218|NCT05623345|516952797|FG001|Overall Study|Withdrawal by Subject|0|||
143384219|NCT05623345|516952798|FG002|Overall Study|Withdrawal by Subject|9|||
143384220|NCT05623345|516952799|FG003|Overall Study|Withdrawal by Subject|20|||
143384221|NCT05623345|516952796|FG000|Overall Study|Lost to Follow-up|3|||
143384222|NCT05623345|516952797|FG001|Overall Study|Lost to Follow-up|0|||
143384223|NCT05623345|516952798|FG002|Overall Study|Lost to Follow-up|7|||
143384224|NCT05623345|516952799|FG003|Overall Study|Lost to Follow-up|2|||
143384225|NCT05623345|516952796|FG000|Overall Study|Termination of Study By Sponsor|37|||
143384226|NCT05623345|516952797|FG001|Overall Study|Termination of Study By Sponsor|4|||
143384227|NCT05623345|516952798|FG002|Overall Study|Termination of Study By Sponsor|40|||
143384228|NCT05623345|516952799|FG003|Overall Study|Termination of Study By Sponsor|38|||
143384229|NCT00411151|516952800|FG000|Overall Study|Death|38|||
143332224|NCT01687257|516760148|FG001|Overall Study|Subject Withdrew Consent|1|||
143332225|NCT01687257|516760149|FG002|Overall Study|Subject Withdrew Consent|1|||
143332226|NCT01687257|516760147|FG000|Overall Study|Adverse Event|1|||
143332227|NCT01687257|516760148|FG001|Overall Study|Adverse Event|0|||
143332228|NCT01687257|516760149|FG002|Overall Study|Adverse Event|0|||
143332229|NCT01687257|516760147|FG000|Overall Study|Investigator's Discretion|0|||
143332230|NCT01687257|516760148|FG001|Overall Study|Investigator's Discretion|3|||
143332231|NCT01687257|516760149|FG002|Overall Study|Investigator's Discretion|0|||
143332232|NCT04403698|516760150|FG000|Overall Study|Adverse Event|1|||
143332233|NCT04403698|516760151|FG001|Overall Study|Adverse Event|1|||
143332234|NCT04403698|516760150|FG000|Overall Study|Lost to Follow-up|1|||
143332235|NCT04403698|516760151|FG001|Overall Study|Lost to Follow-up|0|||
143332236|NCT04403698|516760150|FG000|Overall Study|Protocol Violation|0|||
143332237|NCT04403698|516760151|FG001|Overall Study|Protocol Violation|1|||
143332238|NCT01922076|516760152|FG000|Overall Study|Adverse Event|0|||
143332239|NCT01922076|516760153|FG001|Overall Study|Adverse Event|0|||
143332240|NCT01922076|516760154|FG002|Overall Study|Adverse Event|0|||
143332241|NCT01922076|516760155|FG003|Overall Study|Adverse Event|0|||
143332242|NCT01922076|516760156|FG004|Overall Study|Adverse Event|1|||
143332243|NCT01922076|516760157|FG005|Overall Study|Adverse Event|0|||
143332244|NCT01922076|516760158|FG006|Overall Study|Adverse Event|0|||
143332245|NCT01922076|516760152|FG000|Overall Study|Physician Decision|0|||
143332246|NCT01922076|516760153|FG001|Overall Study|Physician Decision|0|||
143332247|NCT01922076|516760154|FG002|Overall Study|Physician Decision|1|||
143332248|NCT01922076|516760155|FG003|Overall Study|Physician Decision|0|||
143332249|NCT01922076|516760156|FG004|Overall Study|Physician Decision|0|||
143332250|NCT01922076|516760157|FG005|Overall Study|Physician Decision|0|||
143332251|NCT01922076|516760158|FG006|Overall Study|Physician Decision|0|||
143332252|NCT01922076|516760152|FG000|Overall Study|Withdrawal by Subject|0|||
143332253|NCT01922076|516760153|FG001|Overall Study|Withdrawal by Subject|0|||
143332254|NCT01922076|516760154|FG002|Overall Study|Withdrawal by Subject|0|||
143332255|NCT01922076|516760155|FG003|Overall Study|Withdrawal by Subject|1|||
143332256|NCT01922076|516760156|FG004|Overall Study|Withdrawal by Subject|0|||
143332257|NCT01922076|516760157|FG005|Overall Study|Withdrawal by Subject|1|||
143332258|NCT01922076|516760158|FG006|Overall Study|Withdrawal by Subject|1|||
143332259|NCT04899349|516760159|FG000|Overall Study|Study terminated by Sponsor|2|||
143332260|NCT04899349|516760160|FG001|Overall Study|Study terminated by Sponsor|0|||
143332261|NCT01018394|516760161|FG000|Overall Study|Withdrawal by Subject|5|||
143332262|NCT01018394|516760162|FG001|Overall Study|Withdrawal by Subject|5|||
143332263|NCT01018394|516760161|FG000|Overall Study|Lost to Follow-up|4|||
143332264|NCT01018394|516760162|FG001|Overall Study|Lost to Follow-up|3|||
143332265|NCT00683644|516760163|FG000|Overall Study|Withdrawal by Subject|4|||
143332266|NCT00683644|516760164|FG001|Overall Study|Withdrawal by Subject|2|||
143332267|NCT00683644|516760163|FG000|Overall Study|Lost to Follow-up|1|||
143332268|NCT00683644|516760164|FG001|Overall Study|Lost to Follow-up|4|||
143332269|NCT00683644|516760163|FG000|Overall Study|Adverse Event|1|||
143332270|NCT00683644|516760164|FG001|Overall Study|Adverse Event|2|||
143332271|NCT00683644|516760163|FG000|Overall Study|Low copper, other health problems,|7|||
143332272|NCT00683644|516760164|FG001|Overall Study|Low copper, other health problems,|6|||
143332273|NCT03085485|516760165|FG000|Overall Study|Death|1|||
143332274|NCT03085485|516760166|FG001|Overall Study|Death|0|||
143332275|NCT03085485|516760165|FG000|Overall Study|Lost to Follow-up|1|||
143332276|NCT03085485|516760166|FG001|Overall Study|Lost to Follow-up|0|||
143332277|NCT01302119|516760167|FG000|Overall Study|Withdrawal by Subject|30|||
143332278|NCT01302119|516760168|FG001|Overall Study|Withdrawal by Subject|20|||
143332279|NCT01302119|516760167|FG000|Overall Study|Lost to Follow-up|10|||
143332280|NCT01302119|516760168|FG001|Overall Study|Lost to Follow-up|4|||
143332281|NCT01302119|516760167|FG000|Overall Study|Adverse Event|2|||
143332282|NCT01302119|516760168|FG001|Overall Study|Adverse Event|1|||
143332283|NCT01302119|516760167|FG000|Overall Study|Non-compliance|4|||
143332284|NCT01302119|516760168|FG001|Overall Study|Non-compliance|2|||
143332285|NCT01302119|516760167|FG000|Overall Study|Non-specific|4|||
143332286|NCT01302119|516760168|FG001|Overall Study|Non-specific|1|||
143332287|NCT01775904|516760172|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
143332288|NCT01775904|516760172|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
143332289|NCT04891419|516760173|FG000|Overall Study|Withdrawal by Subject|4|||
143332290|NCT04891419|516760174|FG001|Overall Study|Withdrawal by Subject|0|||
143332291|NCT04891419|516760173|FG000|Overall Study|Lost to Follow-up|1|||
143332292|NCT04891419|516760174|FG001|Overall Study|Lost to Follow-up|3|||
143332293|NCT00802074|516760178|FG000|Overall Study|Adverse Event|1|||
143332294|NCT00802074|516760179|FG001|Overall Study|Adverse Event|1|||
143332295|NCT00802074|516760180|FG002|Overall Study|Adverse Event|1|||
143332296|NCT00802074|516760181|FG003|Overall Study|Adverse Event|0|||
143332297|NCT00802074|516760182|FG004|Overall Study|Adverse Event|0|||
143332298|NCT00802074|516760183|FG005|Overall Study|Adverse Event|0|||
143332299|NCT00802074|516760178|FG000|Overall Study|Withdrawal by Subject|1|||
143332300|NCT00802074|516760179|FG001|Overall Study|Withdrawal by Subject|0|||
143332301|NCT00802074|516760180|FG002|Overall Study|Withdrawal by Subject|0|||
143332302|NCT00802074|516760181|FG003|Overall Study|Withdrawal by Subject|0|||
143332303|NCT00802074|516760182|FG004|Overall Study|Withdrawal by Subject|0|||
143332304|NCT00802074|516760183|FG005|Overall Study|Withdrawal by Subject|0|||
143332305|NCT00833638|516760184|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
143332306|NCT00833638|516760185|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
143332307|NCT00833638|516760186|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
143332308|NCT00833638|516760184|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
143332309|NCT00833638|516760185|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
143332310|NCT00833638|516760186|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
143332311|NCT00833638|516760184|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
143332312|NCT00833638|516760185|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
143332313|NCT00833638|516760186|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
143332314|NCT00833638|516760184|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
143332315|NCT00833638|516760185|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
143332316|NCT00833638|516760186|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
143332317|NCT00833638|516760184|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
143332318|NCT00833638|516760185|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
143332319|NCT00833638|516760186|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
143332320|NCT00833638|516760184|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
143332321|NCT00833638|516760185|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
143332322|NCT00833638|516760186|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
143332323|NCT00833638|516760184|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
143332324|NCT00833638|516760185|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
143332325|NCT00833638|516760186|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
143332326|NCT00833638|516760184|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
143332327|NCT00833638|516760185|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
143332328|NCT00833638|516760186|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
143332329|NCT00833638|516760184|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
143332330|NCT00833638|516760185|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
143332331|NCT00833638|516760186|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
143332332|NCT01178086|516760187|FG000|Overall Study|Participant refusal|7|||
143332333|NCT01178086|516760187|FG000|Overall Study|Physician Decision|44|||
143332334|NCT01178086|516760187|FG000|Overall Study|Switch to other CLL therapy|113|||
143332335|NCT01178086|516760187|FG000|Overall Study|Death|59|||
143332336|NCT01178086|516760187|FG000|Overall Study|Other unspecified|89|||
143332337|NCT01178086|516760187|FG000|Overall Study|Excluded from EAS|20|||
143332338|NCT01261338|516760190|FG000|Overall Study|Withdrawal by Subject|3|||
143332339|NCT01261338|516760191|FG001|Overall Study|Withdrawal by Subject|2|||
143332340|NCT00126438|516760192|FG000|Overall Study|Withdrawal due to adverse event|1|||
143332341|NCT00126438|516760193|FG001|Overall Study|Withdrawal due to adverse event|0|||
143332342|NCT00126438|516760192|FG000|Overall Study|Lost to Follow-up|22|||
143332343|NCT00126438|516760193|FG001|Overall Study|Lost to Follow-up|0|||
143332344|NCT00126438|516760192|FG000|Overall Study|Protocol Violation|8|||
143332345|NCT00126438|516760193|FG001|Overall Study|Protocol Violation|8|||
143332346|NCT00126438|516760192|FG000|Overall Study|Withdrawal by Subject|3|||
143332347|NCT00126438|516760193|FG001|Overall Study|Withdrawal by Subject|2|||
143332348|NCT02899728|516760194|FG000|Overall Study|Withdrawal by Subject|1|||
143332349|NCT02899728|516760195|FG001|Overall Study|Withdrawal by Subject|1|||
143332350|NCT05540522|516760197|FG000|Overall Study|Adverse Event|1|||
143332351|NCT05540522|516760198|FG001|Overall Study|Adverse Event|0|||
143332352|NCT05540522|516760199|FG002|Overall Study|Adverse Event|2|||
143332353|NCT05540522|516760200|FG003|Overall Study|Adverse Event|5|||
143332354|NCT05540522|516760197|FG000|Overall Study|Lost to Follow-up|487|||
143332355|NCT05540522|516760198|FG001|Overall Study|Lost to Follow-up|427|||
143332356|NCT05540522|516760199|FG002|Overall Study|Lost to Follow-up|146|||
143332357|NCT05540522|516760200|FG003|Overall Study|Lost to Follow-up|166|||
143332358|NCT05540522|516760197|FG000|Overall Study|Physician Decision|11|||
143332359|NCT05540522|516760198|FG001|Overall Study|Physician Decision|19|||
143332360|NCT05540522|516760199|FG002|Overall Study|Physician Decision|8|||
143332361|NCT05540522|516760200|FG003|Overall Study|Physician Decision|13|||
143332362|NCT05540522|516760197|FG000|Overall Study|Pregnancy|1|||
143332363|NCT05540522|516760198|FG001|Overall Study|Pregnancy|0|||
143332364|NCT05540522|516760199|FG002|Overall Study|Pregnancy|0|||
143332365|NCT05540522|516760200|FG003|Overall Study|Pregnancy|0|||
143332366|NCT05540522|516760197|FG000|Overall Study|Protocol Violation|3|||
143332367|NCT05540522|516760198|FG001|Overall Study|Protocol Violation|1|||
143332368|NCT05540522|516760199|FG002|Overall Study|Protocol Violation|9|||
143332369|NCT05540522|516760200|FG003|Overall Study|Protocol Violation|7|||
143332370|NCT05540522|516760197|FG000|Overall Study|Withdrawal by Subject|168|||
143332371|NCT05540522|516760198|FG001|Overall Study|Withdrawal by Subject|134|||
143332372|NCT05540522|516760199|FG002|Overall Study|Withdrawal by Subject|331|||
143332373|NCT05540522|516760200|FG003|Overall Study|Withdrawal by Subject|322|||
143332374|NCT05540522|516760197|FG000|Overall Study|Death|7|||
143332375|NCT05540522|516760198|FG001|Overall Study|Death|9|||
143332376|NCT05540522|516760199|FG002|Overall Study|Death|49|||
143332377|NCT05540522|516760200|FG003|Overall Study|Death|46|||
143332378|NCT05540522|516760197|FG000|Overall Study|Not vaccinated|34|||
143332379|NCT05540522|516760198|FG001|Overall Study|Not vaccinated|53|||
143332380|NCT05540522|516760199|FG002|Overall Study|Not vaccinated|57|||
143332381|NCT05540522|516760200|FG003|Overall Study|Not vaccinated|50|||
143332382|NCT05540522|516760197|FG000|Overall Study|No longer meets eligibility criteria|0|||
143332383|NCT05540522|516760198|FG001|Overall Study|No longer meets eligibility criteria|0|||
143332384|NCT05540522|516760199|FG002|Overall Study|No longer meets eligibility criteria|3|||
143332385|NCT05540522|516760200|FG003|Overall Study|No longer meets eligibility criteria|2|||
143332386|NCT05540522|516760197|FG000|Overall Study|Other (Unspecified)|8|||
143332387|NCT05540522|516760198|FG001|Overall Study|Other (Unspecified)|10|||
143332388|NCT05540522|516760199|FG002|Overall Study|Other (Unspecified)|4|||
143332389|NCT05540522|516760200|FG003|Overall Study|Other (Unspecified)|2|||
143332390|NCT04348604|516760201|FG000|Week 8|Withdrawal by Subject|1|||
143332391|NCT04348604|516760202|FG001|Week 8|Withdrawal by Subject|1|||
143332392|NCT04348604|516760201|FG000|Week 8|Lost to Follow-up|1|||
143332393|NCT04348604|516760202|FG001|Week 8|Lost to Follow-up|2|||
143332394|NCT04348604|516760201|FG000|Week 8|Suspended|0|||
143332395|NCT04348604|516760202|FG001|Week 8|Suspended|1|||
143332396|NCT04348604|516760201|FG000|Week 12|Lost to Follow-up|1|||
143332397|NCT04348604|516760202|FG001|Week 12|Lost to Follow-up|2|||
143332398|NCT04348604|516760201|FG000|Week 12|Withdrawal by Subject|1|||
143332399|NCT04348604|516760202|FG001|Week 12|Withdrawal by Subject|0|||
143332400|NCT04348604|516760201|FG000|Week 24|Lost to Follow-up|2|||
143332401|NCT04348604|516760202|FG001|Week 24|Lost to Follow-up|1|||
143332402|NCT02097108|516760203|FG000|Overall Study|Adverse Event|1|||
143332403|NCT02097108|516760203|FG000|Overall Study|patient was abroad for 6 months|1|||
143332404|NCT04918784|516762175|FG000|Overall Study|Amputation - no longer eligible|1|||
143332405|NCT04918784|516762176|FG001|Overall Study|Amputation - no longer eligible|2|||
143332406|NCT04918784|516762175|FG000|Overall Study|Death|1|||
143332407|NCT04918784|516762176|FG001|Overall Study|Death|0|||
143332408|NCT04918784|516762175|FG000|Overall Study|patient non-compliance|3|||
143332409|NCT04918784|516762176|FG001|Overall Study|patient non-compliance|1|||
143332410|NCT04918784|516762175|FG000|Overall Study|Adverse Event|1|||
143332411|NCT04918784|516762176|FG001|Overall Study|Adverse Event|0|||
143332412|NCT01712009|516762177|FG000|Overall Study|Withdrawal by Subject|24|||
143332413|NCT01712009|516762178|FG001|Overall Study|Withdrawal by Subject|15|||
143332414|NCT01712009|516762179|FG002|Overall Study|Withdrawal by Subject|8|||
143332415|NCT01712009|516762177|FG000|Overall Study|Lost to Follow-up|2|||
143332416|NCT01712009|516762178|FG001|Overall Study|Lost to Follow-up|0|||
143332417|NCT01712009|516762179|FG002|Overall Study|Lost to Follow-up|1|||
143332418|NCT01712009|516762177|FG000|Overall Study|Decision by Sponsor|12|||
143332419|NCT01712009|516762178|FG001|Overall Study|Decision by Sponsor|14|||
143332420|NCT01712009|516762179|FG002|Overall Study|Decision by Sponsor|12|||
143332421|NCT02160314|516762180|FG000|Overall Study|Adverse Event|0|||
143332422|NCT02160314|516762181|FG001|Overall Study|Adverse Event|6|||
143332423|NCT02160314|516762180|FG000|Overall Study|Protocol Violation|0|||
143332424|NCT02160314|516762181|FG001|Overall Study|Protocol Violation|4|||
143332425|NCT02160314|516762180|FG000|Overall Study|Withdrawal by Subject|1|||
143332426|NCT02160314|516762181|FG001|Overall Study|Withdrawal by Subject|2|||
143332427|NCT02160314|516762180|FG000|Overall Study|Lost to Follow-up|0|||
143332428|NCT02160314|516762181|FG001|Overall Study|Lost to Follow-up|1|||
143332429|NCT00593567|516762185|FG000|Overall Study|Adverse Event|2|||
143332430|NCT00593567|516762186|FG001|Overall Study|Adverse Event|0|||
143332431|NCT00593567|516762185|FG000|Overall Study|Physician Decision|2|||
143332432|NCT00593567|516762186|FG001|Overall Study|Physician Decision|0|||
143384230|NCT00411151|516952800|FG000|Overall Study|Withdrawal by Subject|2|||
143384231|NCT00411151|516952800|FG000|Overall Study|Lost to Follow-up|2|||
143384232|NCT00411151|516952800|FG000|Overall Study|Protocol Violation|1|||
143384233|NCT00411151|516952800|FG000|Overall Study|Trial prematurely closed|4|||
143384234|NCT04431726|516952806|FG000|Overall Study|Ongoing in the Study|55|||
143384235|NCT03732820|516952807|FG000|Overall Study|Death|168|||
143384236|NCT03732820|516952808|FG001|Overall Study|Death|203|||
143384237|NCT03732820|516952807|FG000|Overall Study|Other|2|||
143384238|NCT03732820|516952808|FG001|Overall Study|Other|2|||
143384239|NCT03732820|516952807|FG000|Overall Study|Failure to meet randomisation criteria|1|||
143384240|NCT03732820|516952808|FG001|Overall Study|Failure to meet randomisation criteria|1|||
143384241|NCT03732820|516952807|FG000|Overall Study|Patient decision|14|||
143384242|NCT03732820|516952808|FG001|Overall Study|Patient decision|10|||
143384243|NCT03732820|516952807|FG000|Overall Study|Screen failure|0|||
143384244|NCT03732820|516952808|FG001|Overall Study|Screen failure|1|||
143384245|NCT03732820|516952807|FG000|Overall Study|Patients ongoing study at data cut off|210|||
143384246|NCT03732820|516952808|FG001|Overall Study|Patients ongoing study at data cut off|178|||
143332433|NCT00593567|516762185|FG000|Overall Study|Protocol Violation|13|||
143332434|NCT00593567|516762186|FG001|Overall Study|Protocol Violation|7|||
143332435|NCT00593567|516762185|FG000|Overall Study|Lack of Efficacy|2|||
143332436|NCT00593567|516762186|FG001|Overall Study|Lack of Efficacy|1|||
143384247|NCT03732820|516952807|FG000|Overall Study|Lost to Follow-up|4|||
143384248|NCT03732820|516952808|FG001|Overall Study|Lost to Follow-up|2|||
143384249|NCT05198310|516952809|FG000|Overall Study|Lost to Follow-up|0|||
143384250|NCT05198310|516952810|FG001|Overall Study|Lost to Follow-up|1|||
143384251|NCT05198310|516952811|FG002|Overall Study|Lost to Follow-up|0|||
143384252|NCT05198310|516952812|FG003|Overall Study|Lost to Follow-up|0|||
143384253|NCT05198310|516952813|FG004|Overall Study|Lost to Follow-up|0|||
143384254|NCT05198310|516952814|FG005|Overall Study|Lost to Follow-up|0|||
143384255|NCT05198310|516952815|FG006|Overall Study|Lost to Follow-up|0|||
143384256|NCT05198310|516952816|FG007|Overall Study|Lost to Follow-up|0|||
143384257|NCT05198310|516952809|FG000|Overall Study|Withdrawal by Subject|0|||
143384258|NCT05198310|516952810|FG001|Overall Study|Withdrawal by Subject|0|||
143384259|NCT05198310|516952811|FG002|Overall Study|Withdrawal by Subject|0|||
143384260|NCT05198310|516952812|FG003|Overall Study|Withdrawal by Subject|2|||
143384261|NCT05198310|516952813|FG004|Overall Study|Withdrawal by Subject|0|||
143384262|NCT05198310|516952814|FG005|Overall Study|Withdrawal by Subject|2|||
143384263|NCT05198310|516952815|FG006|Overall Study|Withdrawal by Subject|1|||
143384264|NCT05198310|516952816|FG007|Overall Study|Withdrawal by Subject|3|||
143384265|NCT04287985|516952819|FG000|Overall Study|Adverse Event|1|||
143384266|NCT04287985|516952820|FG001|Overall Study|Adverse Event|0|||
143384267|NCT04287985|516952821|FG002|Overall Study|Adverse Event|0|||
143384268|NCT04287985|516952822|FG003|Overall Study|Adverse Event|0|||
143384269|NCT04287985|516952819|FG000|Overall Study|Protocol Violation|0|||
143384270|NCT04287985|516952820|FG001|Overall Study|Protocol Violation|1|||
143384271|NCT04287985|516952821|FG002|Overall Study|Protocol Violation|0|||
143384272|NCT04287985|516952822|FG003|Overall Study|Protocol Violation|0|||
143384273|NCT04287985|516952819|FG000|Overall Study|Physician Decision|0|||
143384274|NCT04287985|516952820|FG001|Overall Study|Physician Decision|0|||
143384275|NCT04287985|516952821|FG002|Overall Study|Physician Decision|0|||
143384276|NCT04287985|516952822|FG003|Overall Study|Physician Decision|1|||
143384277|NCT04287985|516952819|FG000|Overall Study|Withdrawal by Subject|2|||
143384278|NCT04287985|516952820|FG001|Overall Study|Withdrawal by Subject|1|||
143384279|NCT04287985|516952821|FG002|Overall Study|Withdrawal by Subject|1|||
143384280|NCT04287985|516952822|FG003|Overall Study|Withdrawal by Subject|2|||
143384281|NCT02789020|516952823|FG000|Overall Study|Withdrawal by Subject|6|||
143384282|NCT02789020|516952824|FG001|Overall Study|Withdrawal by Subject|5|||
143384283|NCT00843882|516952837|FG000|Step 1|Lack of Efficacy|14|||
143384284|NCT00843882|516952838|FG001|Step 1|Lack of Efficacy|10|||
143384285|NCT00843882|516952839|FG002|Step 1|Lack of Efficacy|21|||
143384286|NCT00843882|516952837|FG000|Step 1|Adverse Event|8|||
143384287|NCT00843882|516952838|FG001|Step 1|Adverse Event|17|||
143384288|NCT00843882|516952839|FG002|Step 1|Adverse Event|20|||
143384289|NCT00843882|516952837|FG000|Step 1|Death|1|||
143384290|NCT00843882|516952838|FG001|Step 1|Death|2|||
143384291|NCT00843882|516952839|FG002|Step 1|Death|4|||
143384292|NCT00843882|516952837|FG000|Step 1|Withdrawal by Subject|6|||
143384293|NCT00843882|516952838|FG001|Step 1|Withdrawal by Subject|12|||
143384294|NCT00843882|516952839|FG002|Step 1|Withdrawal by Subject|9|||
143384295|NCT00843882|516952837|FG000|Step 1|Physician Decision|0|||
143384296|NCT00843882|516952838|FG001|Step 1|Physician Decision|5|||
143384297|NCT00843882|516952839|FG002|Step 1|Physician Decision|1|||
143384298|NCT00843882|516952837|FG000|Step 1|Patient and physician's decision|0|||
143384299|NCT00843882|516952838|FG001|Step 1|Patient and physician's decision|0|||
143384300|NCT00843882|516952839|FG002|Step 1|Patient and physician's decision|1|||
143384301|NCT00843882|516952837|FG000|Step 1|Other complicating disease|1|||
143384302|NCT00843882|516952838|FG001|Step 1|Other complicating disease|3|||
143384303|NCT00843882|516952839|FG002|Step 1|Other complicating disease|4|||
143384304|NCT00843882|516952837|FG000|Step 1|Alternative therapy|0|||
143384305|NCT00843882|516952838|FG001|Step 1|Alternative therapy|1|||
143384306|NCT00843882|516952839|FG002|Step 1|Alternative therapy|1|||
143384307|NCT00843882|516952837|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
143384308|NCT00843882|516952838|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
143384309|NCT00843882|516952839|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
143384310|NCT00843882|516952837|FG000|Step 1|Off treatment reason unknown|0|||
143384311|NCT00843882|516952838|FG001|Step 1|Off treatment reason unknown|1|||
143384312|NCT00843882|516952839|FG002|Step 1|Off treatment reason unknown|4|||
143384313|NCT00843882|516952837|FG000|Step 1|Never started treatment|2|||
143384314|NCT00843882|516952838|FG001|Step 1|Never started treatment|0|||
143384315|NCT00843882|516952839|FG002|Step 1|Never started treatment|0|||
143384316|NCT00843882|516952837|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
143384317|NCT00843882|516952838|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
143384318|NCT00843882|516952839|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
143384319|NCT00843882|516952837|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
143384320|NCT00843882|516952838|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
143384321|NCT00843882|516952839|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
143384322|NCT00843882|516952837|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
143332437|NCT00593567|516762185|FG000|Overall Study|Withdrawal by Subject|1|||
143332438|NCT00593567|516762186|FG001|Overall Study|Withdrawal by Subject|2|||
143332439|NCT03224182|516762194|FG000|Overall Study|Study Drug Not Instilled|6|||
143332440|NCT03224182|516762195|FG001|Overall Study|Study Drug Not Instilled|1|||
143332441|NCT03224182|516762194|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
143332442|NCT03224182|516762195|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
143332443|NCT03224182|516762194|FG000|Overall Study|Withdrew of Consent|4|||
143332444|NCT03224182|516762195|FG001|Overall Study|Withdrew of Consent|2|||
143332445|NCT03224182|516762194|FG000|Overall Study|Investigator Decision|3|||
143332446|NCT03224182|516762195|FG001|Overall Study|Investigator Decision|1|||
143332447|NCT03224182|516762194|FG000|Overall Study|Sponsor Decision|26|||
143332448|NCT03224182|516762195|FG001|Overall Study|Sponsor Decision|12|||
143332449|NCT03224182|516762194|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
143332450|NCT03224182|516762195|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
143332451|NCT03224182|516762194|FG000|Overall Study|Lost to Follow-up|1|||
143332452|NCT03224182|516762195|FG001|Overall Study|Lost to Follow-up|0|||
143332453|NCT03224182|516762194|FG000|Overall Study|Participant Had Recurrence|11|||
143332454|NCT03224182|516762195|FG001|Overall Study|Participant Had Recurrence|5|||
143332455|NCT03224182|516762194|FG000|Overall Study|Death|0|||
143332456|NCT03224182|516762195|FG001|Overall Study|Death|1|||
143332457|NCT03224182|516762194|FG000|Overall Study|Reason not Specified|3|||
143332458|NCT03224182|516762195|FG001|Overall Study|Reason not Specified|3|||
143332459|NCT03224182|516762194|FG000|Overall Study|Other|1|||
143332460|NCT03224182|516762195|FG001|Overall Study|Other|0|||
143332461|NCT00643916|516762196|FG000|Overall Study|Protocol Violation|0|||
143332462|NCT00643916|516762197|FG001|Overall Study|Protocol Violation|1|||
143332463|NCT00643916|516762198|FG002|Overall Study|Protocol Violation|1|||
143332464|NCT00643916|516762199|FG003|Overall Study|Protocol Violation|1|||
143332465|NCT00643916|516762200|FG004|Overall Study|Protocol Violation|0|||
143332466|NCT00643916|516762201|FG005|Overall Study|Protocol Violation|0|||
143332467|NCT00643916|516762196|FG000|Overall Study|Lost to Follow-up|0|||
143332468|NCT00643916|516762197|FG001|Overall Study|Lost to Follow-up|1|||
143332469|NCT00643916|516762198|FG002|Overall Study|Lost to Follow-up|0|||
143332470|NCT00643916|516762199|FG003|Overall Study|Lost to Follow-up|0|||
143332471|NCT00643916|516762200|FG004|Overall Study|Lost to Follow-up|0|||
143332472|NCT00643916|516762201|FG005|Overall Study|Lost to Follow-up|0|||
143332473|NCT00643916|516762196|FG000|Overall Study|Withdrawal by Subject|2|||
143332474|NCT00643916|516762197|FG001|Overall Study|Withdrawal by Subject|2|||
143332475|NCT00643916|516762198|FG002|Overall Study|Withdrawal by Subject|2|||
143332476|NCT00643916|516762199|FG003|Overall Study|Withdrawal by Subject|1|||
143332477|NCT00643916|516762200|FG004|Overall Study|Withdrawal by Subject|0|||
143332478|NCT00643916|516762201|FG005|Overall Study|Withdrawal by Subject|1|||
143332479|NCT00643916|516762196|FG000|Overall Study|Not Vaccinated|2|||
143332480|NCT00643916|516762197|FG001|Overall Study|Not Vaccinated|2|||
143332481|NCT00643916|516762198|FG002|Overall Study|Not Vaccinated|3|||
143332482|NCT00643916|516762199|FG003|Overall Study|Not Vaccinated|0|||
143332483|NCT00643916|516762200|FG004|Overall Study|Not Vaccinated|2|||
143332484|NCT00643916|516762201|FG005|Overall Study|Not Vaccinated|0|||
143332485|NCT02606279|516762205|FG000|Overall Study|Lost to Follow-up|0|||
143332486|NCT02606279|516762206|FG001|Overall Study|Lost to Follow-up|1|||
143332487|NCT02583425|516762207|FG000|Screening|Did not meet entry criteria|12|||
143332488|NCT02583425|516762207|FG000|Baseline|Did not meet continued criteria|5|||
143332489|NCT02583425|516762207|FG000|Treatment Period|Adverse Event|1|||
143332490|NCT01597050|516762211|FG000|Overall Study|Withdrawal by Subject|1|||
143332491|NCT01597050|516762212|FG001|Overall Study|Withdrawal by Subject|0|||
143332492|NCT01627327|516762213|FG000|Overall Study|Adverse Event|6|||
143332493|NCT01627327|516762214|FG001|Overall Study|Adverse Event|12|||
143332494|NCT01627327|516762213|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
143332495|NCT01627327|516762214|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
143332496|NCT01627327|516762213|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
143332497|NCT01627327|516762214|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
143332498|NCT01627327|516762213|FG000|Overall Study|Protocol Violation|4|||
143332499|NCT01627327|516762214|FG001|Overall Study|Protocol Violation|10|||
143332500|NCT01627327|516762213|FG000|Overall Study|Lost to Follow-up|1|||
143332501|NCT01627327|516762214|FG001|Overall Study|Lost to Follow-up|3|||
143332502|NCT01627327|516762213|FG000|Overall Study|Physician Decision|1|||
143332503|NCT01627327|516762214|FG001|Overall Study|Physician Decision|0|||
143332504|NCT01627327|516762213|FG000|Overall Study|Withdrawal by Subject|3|||
143332505|NCT01627327|516762214|FG001|Overall Study|Withdrawal by Subject|3|||
143332506|NCT04528069|516762217|FG000|Overall Study|Adverse Event|1|||
143332507|NCT04528069|516762217|FG000|Overall Study|Lost to Follow-up|1|||
143332508|NCT04528069|516762217|FG000|Overall Study|Patient Unable to Come|1|||
143332509|NCT04528069|516762217|FG000|Overall Study|Patient Unable to Attend|1|||
143332510|NCT01814371|516762220|FG000|Overall Study|Lost to Follow-up|30|||
143332511|NCT01814371|516762221|FG001|Overall Study|Lost to Follow-up|27|||
143332512|NCT02794285|516762222|FG000|Overall Study|Adverse Event|11|||
143332513|NCT02794285|516762223|FG001|Overall Study|Adverse Event|4|||
143384323|NCT00843882|516952838|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
143384324|NCT00843882|516952839|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
143384325|NCT00843882|516952837|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
143384326|NCT00843882|516952838|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
143384327|NCT00843882|516952839|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
143384328|NCT00843882|516952837|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
143384329|NCT00843882|516952838|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
143384330|NCT00843882|516952839|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
143384331|NCT00843882|516952837|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
143384332|NCT00843882|516952838|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
143384333|NCT00843882|516952839|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
143384334|NCT00843882|516952837|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
143384335|NCT00843882|516952838|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
143384336|NCT00843882|516952839|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
143384337|NCT05450458|516952843|FG000|Overall Study|Lost to Follow-up|4|||
143384338|NCT00901901|516952844|FG000|Treatment Period|Adverse Event|120|||
143384339|NCT00901901|516952845|FG001|Treatment Period|Adverse Event|128|||
143384340|NCT00901901|516952844|FG000|Treatment Period|Withdrawal by Subject|26|||
143384341|NCT00901901|516952845|FG001|Treatment Period|Withdrawal by Subject|24|||
143384342|NCT00901901|516952844|FG000|Treatment Period|Physician Decision|2|||
143384343|NCT00901901|516952845|FG001|Treatment Period|Physician Decision|2|||
143384344|NCT00901901|516952844|FG000|Treatment Period|Lost to Follow-up|3|||
143384345|NCT00901901|516952845|FG001|Treatment Period|Lost to Follow-up|5|||
143384346|NCT00901901|516952844|FG000|Treatment Period|Noncompliance with study medication|4|||
143384347|NCT00901901|516952845|FG001|Treatment Period|Noncompliance with study medication|1|||
143384348|NCT00901901|516952844|FG000|Treatment Period|Missing|1|||
143384349|NCT00901901|516952845|FG001|Treatment Period|Missing|0|||
143384350|NCT00901901|516952844|FG000|Treatment Period|Never treated|0|||
143384351|NCT00901901|516952845|FG001|Treatment Period|Never treated|3|||
143384352|NCT00901901|516952844|FG000|Treatment Period|Protocol driven decision point|0|||
143384353|NCT00901901|516952845|FG001|Treatment Period|Protocol driven decision point|2|||
143384354|NCT00901901|516952844|FG000|Treatment Period|Study terminated by sponsor|2|||
143384355|NCT00901901|516952845|FG001|Treatment Period|Study terminated by sponsor|0|||
143384356|NCT00901901|516952844|FG000|Treatment Period|Protocol Violation|5|||
143384357|NCT00901901|516952845|FG001|Treatment Period|Protocol Violation|9|||
143384358|NCT00901901|516952844|FG000|Treatment Period|Switch to commercial drug|1|||
143384359|NCT00901901|516952845|FG001|Treatment Period|Switch to commercial drug|1|||
143384360|NCT00901901|516952844|FG000|Treatment Period|Transfer to treatment continuation study|5|||
143384361|NCT00901901|516952845|FG001|Treatment Period|Transfer to treatment continuation study|2|||
143384362|NCT00901901|516952844|FG000|Follow-up Period|Death|181|||
143384363|NCT00901901|516952845|FG001|Follow-up Period|Death|208|||
143384364|NCT00901901|516952844|FG000|Follow-up Period|Protocol driven decision point|47|||
143384365|NCT00901901|516952845|FG001|Follow-up Period|Protocol driven decision point|36|||
143384366|NCT00901901|516952844|FG000|Follow-up Period|Withdrawal by Subject|6|||
143384367|NCT00901901|516952845|FG001|Follow-up Period|Withdrawal by Subject|9|||
143384368|NCT00901901|516952844|FG000|Follow-up Period|Lost to Follow-up|12|||
143384369|NCT00901901|516952845|FG001|Follow-up Period|Lost to Follow-up|8|||
143384370|NCT00901901|516952844|FG000|Follow-up Period|Missing|94|||
143384371|NCT00901901|516952845|FG001|Follow-up Period|Missing|80|||
143384372|NCT00632749|516952848|FG000|Overall Study|Progressive disease|3|||
143384373|NCT00632749|516952849|FG001|Overall Study|Progressive disease|2|||
143384374|NCT00632749|516952850|FG002|Overall Study|Progressive disease|2|||
143384375|NCT00632749|516952851|FG003|Overall Study|Progressive disease|2|||
143384376|NCT00632749|516952852|FG004|Overall Study|Progressive disease|4|||
143384377|NCT00632749|516952853|FG005|Overall Study|Progressive disease|4|||
143384378|NCT00632749|516952854|FG006|Overall Study|Progressive disease|3|||
143384379|NCT00632749|516952855|FG007|Overall Study|Progressive disease|2|||
143384380|NCT00632749|516952856|FG008|Overall Study|Progressive disease|3|||
143384381|NCT00632749|516952857|FG009|Overall Study|Progressive disease|2|||
143384382|NCT00632749|516952858|FG010|Overall Study|Progressive disease|4|||
143384383|NCT00632749|516952859|FG011|Overall Study|Progressive disease|3|||
143384384|NCT00632749|516952860|FG012|Overall Study|Progressive disease|2|||
143384385|NCT00632749|516952861|FG013|Overall Study|Progressive disease|4|||
143384386|NCT00632749|516952848|FG000|Overall Study|Other Adverse event|1|||
143384387|NCT00632749|516952849|FG001|Overall Study|Other Adverse event|1|||
143384388|NCT00632749|516952850|FG002|Overall Study|Other Adverse event|1|||
143384389|NCT00632749|516952851|FG003|Overall Study|Other Adverse event|1|||
143384390|NCT00632749|516952852|FG004|Overall Study|Other Adverse event|2|||
143384391|NCT00632749|516952853|FG005|Overall Study|Other Adverse event|4|||
143384392|NCT00632749|516952854|FG006|Overall Study|Other Adverse event|1|||
143332514|NCT02794285|516762224|FG002|Overall Study|Adverse Event|5|||
143332515|NCT02794285|516762225|FG003|Overall Study|Adverse Event|8|||
143332516|NCT02794285|516762222|FG000|Overall Study|Condition Under Investigation Improved|1|||
143332517|NCT02794285|516762223|FG001|Overall Study|Condition Under Investigation Improved|0|||
143332518|NCT02794285|516762224|FG002|Overall Study|Condition Under Investigation Improved|0|||
143332519|NCT02794285|516762225|FG003|Overall Study|Condition Under Investigation Improved|0|||
143332520|NCT02794285|516762222|FG000|Overall Study|Condition Under Investigation Worsened|0|||
143332521|NCT02794285|516762223|FG001|Overall Study|Condition Under Investigation Worsened|2|||
143332522|NCT02794285|516762224|FG002|Overall Study|Condition Under Investigation Worsened|1|||
143332523|NCT02794285|516762225|FG003|Overall Study|Condition Under Investigation Worsened|0|||
143332524|NCT02794285|516762222|FG000|Overall Study|Death|2|||
143332525|NCT02794285|516762223|FG001|Overall Study|Death|1|||
143332526|NCT02794285|516762224|FG002|Overall Study|Death|2|||
143332527|NCT02794285|516762225|FG003|Overall Study|Death|0|||
143332528|NCT02794285|516762222|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
143332529|NCT02794285|516762223|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
143332530|NCT02794285|516762224|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
143332531|NCT02794285|516762225|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
143332532|NCT02794285|516762222|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
143332533|NCT02794285|516762223|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
143332534|NCT02794285|516762224|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
143332535|NCT02794285|516762225|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
143332536|NCT02794285|516762222|FG000|Overall Study|Lack of Efficacy|10|||
143332537|NCT02794285|516762223|FG001|Overall Study|Lack of Efficacy|6|||
143332538|NCT02794285|516762224|FG002|Overall Study|Lack of Efficacy|3|||
143332539|NCT02794285|516762225|FG003|Overall Study|Lack of Efficacy|3|||
143332540|NCT02794285|516762222|FG000|Overall Study|Lost to Follow-up|5|||
143332541|NCT02794285|516762223|FG001|Overall Study|Lost to Follow-up|6|||
143332542|NCT02794285|516762224|FG002|Overall Study|Lost to Follow-up|3|||
143332543|NCT02794285|516762225|FG003|Overall Study|Lost to Follow-up|1|||
143332544|NCT02794285|516762222|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
143332545|NCT02794285|516762223|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
143332546|NCT02794285|516762224|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
143332547|NCT02794285|516762225|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
143332548|NCT02794285|516762222|FG000|Overall Study|Withdrawal by Subject|38|||
143332549|NCT02794285|516762223|FG001|Overall Study|Withdrawal by Subject|29|||
143332550|NCT02794285|516762224|FG002|Overall Study|Withdrawal by Subject|20|||
143332551|NCT02794285|516762225|FG003|Overall Study|Withdrawal by Subject|12|||
143332552|NCT02794285|516762222|FG000|Overall Study|Missing|1|||
143332553|NCT02794285|516762223|FG001|Overall Study|Missing|0|||
143332554|NCT02794285|516762224|FG002|Overall Study|Missing|0|||
143332555|NCT02794285|516762225|FG003|Overall Study|Missing|0|||
143332556|NCT02794285|516762222|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
143332557|NCT02794285|516762223|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
143332558|NCT02794285|516762224|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
143332559|NCT02794285|516762225|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
143332560|NCT02794285|516762222|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
143332561|NCT02794285|516762223|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
143332562|NCT02794285|516762224|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
143332563|NCT02794285|516762225|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
143332564|NCT03252587|516762226|FG000|Overall Study|Adverse Event|3|||
143332565|NCT03252587|516762227|FG001|Overall Study|Adverse Event|8|||
143332566|NCT03252587|516762228|FG002|Overall Study|Adverse Event|6|||
143332567|NCT03252587|516762229|FG003|Overall Study|Adverse Event|12|||
143332568|NCT03252587|516762226|FG000|Overall Study|Lack of Efficacy|7|||
143332569|NCT03252587|516762227|FG001|Overall Study|Lack of Efficacy|2|||
143332570|NCT03252587|516762228|FG002|Overall Study|Lack of Efficacy|2|||
143332571|NCT03252587|516762229|FG003|Overall Study|Lack of Efficacy|4|||
143332572|NCT03252587|516762226|FG000|Overall Study|Lost to Follow-up|2|||
143332573|NCT03252587|516762227|FG001|Overall Study|Lost to Follow-up|0|||
143332574|NCT03252587|516762228|FG002|Overall Study|Lost to Follow-up|0|||
143332575|NCT03252587|516762229|FG003|Overall Study|Lost to Follow-up|2|||
143332576|NCT03252587|516762226|FG000|Overall Study|Pregnancy|2|||
143332577|NCT03252587|516762227|FG001|Overall Study|Pregnancy|1|||
143332578|NCT03252587|516762228|FG002|Overall Study|Pregnancy|0|||
143332579|NCT03252587|516762229|FG003|Overall Study|Pregnancy|1|||
143332580|NCT03252587|516762226|FG000|Overall Study|Withdrawal by Subject|8|||
143332581|NCT03252587|516762227|FG001|Overall Study|Withdrawal by Subject|4|||
143332582|NCT03252587|516762228|FG002|Overall Study|Withdrawal by Subject|4|||
143332583|NCT03252587|516762229|FG003|Overall Study|Withdrawal by Subject|4|||
143332584|NCT03252587|516762226|FG000|Overall Study|Other Reasons|2|||
143332585|NCT03252587|516762227|FG001|Overall Study|Other Reasons|5|||
143332586|NCT03252587|516762228|FG002|Overall Study|Other Reasons|5|||
143332587|NCT03252587|516762229|FG003|Overall Study|Other Reasons|4|||
143332588|NCT00868439|516762236|FG000|Overall Study|Adverse Event|4|||
143332589|NCT00868439|516762237|FG001|Overall Study|Adverse Event|3|||
143332590|NCT00868439|516762236|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
143332591|NCT00868439|516762237|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
143332592|NCT00868439|516762236|FG000|Overall Study|Death|0|||
143332593|NCT00868439|516762237|FG001|Overall Study|Death|1|||
143332594|NCT00868439|516762236|FG000|Overall Study|Protocol Violation|1|||
143332595|NCT00868439|516762237|FG001|Overall Study|Protocol Violation|1|||
143332596|NCT00868439|516762236|FG000|Overall Study|Physician Decision|1|||
143332597|NCT00868439|516762237|FG001|Overall Study|Physician Decision|0|||
143332598|NCT00868439|516762236|FG000|Overall Study|Withdrawal by Subject|0|||
143332599|NCT00868439|516762237|FG001|Overall Study|Withdrawal by Subject|1|||
143332600|NCT00224874|516762240|FG000|Overall Study|Withdrawal by Subject|0|||
143332601|NCT00224874|516762241|FG001|Overall Study|Withdrawal by Subject|0|||
143332602|NCT00224874|516762242|FG002|Overall Study|Withdrawal by Subject|1|||
143332603|NCT00224874|516762243|FG003|Overall Study|Withdrawal by Subject|0|||
143332604|NCT00911534|516762244|FG000|Overall Study|Adverse Event|4|||
143332605|NCT00911534|516762245|FG001|Overall Study|Adverse Event|4|||
143332606|NCT00911534|516762244|FG000|Overall Study|Lost to Follow-up|2|||
143332607|NCT00911534|516762245|FG001|Overall Study|Lost to Follow-up|4|||
143332608|NCT00911534|516762244|FG000|Overall Study|Withdrawal by Subject|2|||
143332609|NCT00911534|516762245|FG001|Overall Study|Withdrawal by Subject|1|||
143332610|NCT00911534|516762244|FG000|Overall Study|Lack of Efficacy|4|||
143332611|NCT00911534|516762245|FG001|Overall Study|Lack of Efficacy|1|||
143332612|NCT00911534|516762244|FG000|Overall Study|Withdrawal of consent|1|||
143332613|NCT00911534|516762245|FG001|Overall Study|Withdrawal of consent|4|||
143332614|NCT00911534|516762244|FG000|Overall Study|Other|2|||
143332615|NCT00911534|516762245|FG001|Overall Study|Other|2|||
143332616|NCT05072080|516762246|FG000|Overall Study|Death|0|||
143332617|NCT05072080|516762247|FG001|Overall Study|Death|0|||
143332618|NCT05072080|516762248|FG002|Overall Study|Death|1|||
143332619|NCT05072080|516762249|FG003|Overall Study|Death|0|||
143332620|NCT05072080|516762246|FG000|Overall Study|Lost to Follow-up|65|||
143332621|NCT05072080|516762247|FG001|Overall Study|Lost to Follow-up|70|||
143332622|NCT05072080|516762248|FG002|Overall Study|Lost to Follow-up|58|||
143332623|NCT05072080|516762249|FG003|Overall Study|Lost to Follow-up|23|||
143332624|NCT05072080|516762246|FG000|Overall Study|Physician Decision|2|||
143332625|NCT05072080|516762247|FG001|Overall Study|Physician Decision|1|||
143332626|NCT05072080|516762248|FG002|Overall Study|Physician Decision|1|||
143332627|NCT05072080|516762249|FG003|Overall Study|Physician Decision|0|||
143332628|NCT05072080|516762246|FG000|Overall Study|Withdrawal by Subject|45|||
143332629|NCT05072080|516762247|FG001|Overall Study|Withdrawal by Subject|30|||
143332630|NCT05072080|516762248|FG002|Overall Study|Withdrawal by Subject|27|||
143332631|NCT05072080|516762249|FG003|Overall Study|Withdrawal by Subject|7|||
143332632|NCT05072080|516762246|FG000|Overall Study|Sponsor Decision|0|||
143332633|NCT05072080|516762247|FG001|Overall Study|Sponsor Decision|1|||
143332634|NCT05072080|516762248|FG002|Overall Study|Sponsor Decision|0|||
143332635|NCT05072080|516762249|FG003|Overall Study|Sponsor Decision|0|||
143332636|NCT05072080|516762246|FG000|Overall Study|Subject moved|1|||
143332637|NCT05072080|516762247|FG001|Overall Study|Subject moved|3|||
143332638|NCT05072080|516762248|FG002|Overall Study|Subject moved|5|||
143332639|NCT05072080|516762249|FG003|Overall Study|Subject moved|2|||
143332640|NCT05072080|516762246|FG000|Overall Study|Withdrawal by parent|0|||
143332641|NCT05072080|516762247|FG001|Overall Study|Withdrawal by parent|0|||
143332642|NCT05072080|516762248|FG002|Overall Study|Withdrawal by parent|1|||
143332643|NCT05072080|516762249|FG003|Overall Study|Withdrawal by parent|0|||
143332644|NCT05072080|516762246|FG000|Overall Study|Subject was deployed|0|||
143332645|NCT05072080|516762247|FG001|Overall Study|Subject was deployed|1|||
143332646|NCT05072080|516762248|FG002|Overall Study|Subject was deployed|0|||
143332647|NCT05072080|516762249|FG003|Overall Study|Subject was deployed|0|||
143332648|NCT05072080|516762246|FG000|Overall Study|Subject left site without receiving dose|0|||
143332649|NCT05072080|516762247|FG001|Overall Study|Subject left site without receiving dose|1|||
143332650|NCT05072080|516762248|FG002|Overall Study|Subject left site without receiving dose|0|||
143332651|NCT05072080|516762249|FG003|Overall Study|Subject left site without receiving dose|0|||
143332652|NCT05072080|516762246|FG000|Overall Study|Subject incarcerated|0|||
143332653|NCT05072080|516762247|FG001|Overall Study|Subject incarcerated|1|||
143332654|NCT05072080|516762248|FG002|Overall Study|Subject incarcerated|0|||
143332655|NCT05072080|516762249|FG003|Overall Study|Subject incarcerated|1|||
143332656|NCT05072080|516762246|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
143332657|NCT05072080|516762247|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
143332658|NCT05072080|516762248|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
143332659|NCT05072080|516762249|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
143332660|NCT05072080|516762246|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
143332661|NCT05072080|516762247|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
143332662|NCT05072080|516762248|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
143332663|NCT05072080|516762249|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
143332664|NCT03896035|516762251|FG000|Overall Study|Lost to Follow-up|2|||
143332665|NCT03896035|516762252|FG001|Overall Study|Lost to Follow-up|6|||
143332666|NCT03896035|516762251|FG000|Overall Study|Withdrawal by Subject|0|||
143332667|NCT03896035|516762252|FG001|Overall Study|Withdrawal by Subject|1|||
143332668|NCT03896035|516762251|FG000|Overall Study|Health/family health issues during COVID|0|||
143332669|NCT03896035|516762252|FG001|Overall Study|Health/family health issues during COVID|4|||
143332670|NCT01152580|516762256|FG000|Overall Study|Withdrawal by Subject|0|||
143332671|NCT01152580|516762257|FG001|Overall Study|Withdrawal by Subject|1|||
143332672|NCT00449176|516762259|FG000|Overall Study|Withdrawal by Subject|39|||
143332673|NCT00449176|516762260|FG001|Overall Study|Withdrawal by Subject|43|||
143332674|NCT00449176|516762261|FG002|Overall Study|Withdrawal by Subject|59|||
143332675|NCT00449176|516762259|FG000|Overall Study|Lost to Follow-up|13|||
143332676|NCT00449176|516762260|FG001|Overall Study|Lost to Follow-up|8|||
143384393|NCT00632749|516952855|FG007|Overall Study|Other Adverse event|2|||
143384394|NCT00632749|516952856|FG008|Overall Study|Other Adverse event|2|||
143384395|NCT00632749|516952857|FG009|Overall Study|Other Adverse event|0|||
143384396|NCT00632749|516952858|FG010|Overall Study|Other Adverse event|1|||
143384397|NCT00632749|516952859|FG011|Overall Study|Other Adverse event|0|||
143384398|NCT00632749|516952860|FG012|Overall Study|Other Adverse event|1|||
143384399|NCT00632749|516952861|FG013|Overall Study|Other Adverse event|0|||
143384400|NCT00632749|516952848|FG000|Overall Study|Refuse to continue medication|0|||
143384401|NCT00632749|516952849|FG001|Overall Study|Refuse to continue medication|0|||
143384402|NCT00632749|516952850|FG002|Overall Study|Refuse to continue medication|0|||
143332677|NCT00449176|516762261|FG002|Overall Study|Lost to Follow-up|12|||
143332678|NCT00449176|516762259|FG000|Overall Study|Adverse Event|51|||
143332679|NCT00449176|516762260|FG001|Overall Study|Adverse Event|107|||
143332680|NCT00449176|516762261|FG002|Overall Study|Adverse Event|15|||
143332681|NCT00449176|516762259|FG000|Overall Study|Lack of Efficacy|13|||
143332682|NCT00449176|516762260|FG001|Overall Study|Lack of Efficacy|7|||
143332683|NCT00449176|516762261|FG002|Overall Study|Lack of Efficacy|50|||
143332684|NCT00449176|516762259|FG000|Overall Study|Study drug non-compliant|14|||
143332685|NCT00449176|516762260|FG001|Overall Study|Study drug non-compliant|11|||
143332686|NCT00449176|516762261|FG002|Overall Study|Study drug non-compliant|11|||
143332687|NCT00449176|516762259|FG000|Overall Study|all other|22|||
143332688|NCT00449176|516762260|FG001|Overall Study|all other|19|||
143332689|NCT00449176|516762261|FG002|Overall Study|all other|20|||
143332690|NCT00675766|516762262|FG000|Overall Study|Lost to Follow-up|6|||
143332691|NCT00675766|516762263|FG001|Overall Study|Lost to Follow-up|5|||
143332692|NCT00675766|516762264|FG002|Overall Study|Lost to Follow-up|21|||
143332693|NCT00675766|516762265|FG003|Overall Study|Lost to Follow-up|26|||
143332694|NCT01749982|516762266|FG000|Overall Study|Physician Decision|0|||
143332695|NCT01749982|516762267|FG001|Overall Study|Physician Decision|0|||
143332696|NCT01749982|516762268|FG002|Overall Study|Physician Decision|0|||
143332697|NCT01749982|516762269|FG003|Overall Study|Physician Decision|1|||
143332698|NCT01749982|516762266|FG000|Overall Study|Lost to Follow-up|0|||
143332699|NCT01749982|516762267|FG001|Overall Study|Lost to Follow-up|0|||
143332700|NCT01749982|516762268|FG002|Overall Study|Lost to Follow-up|0|||
143332701|NCT01749982|516762269|FG003|Overall Study|Lost to Follow-up|1|||
143332702|NCT01749982|516762266|FG000|Overall Study|Withdrawal by Subject|0|||
143332703|NCT01749982|516762267|FG001|Overall Study|Withdrawal by Subject|0|||
143332704|NCT01749982|516762268|FG002|Overall Study|Withdrawal by Subject|0|||
143332705|NCT01749982|516762269|FG003|Overall Study|Withdrawal by Subject|1|||
143332706|NCT00736645|516762270|FG000|Overall Study|Adverse Event|0|||
143332707|NCT00736645|516762271|FG001|Overall Study|Adverse Event|2|||
143332708|NCT00736645|516762272|FG002|Overall Study|Adverse Event|0|||
143332709|NCT00736645|516762273|FG003|Overall Study|Adverse Event|0|||
143384403|NCT00632749|516952851|FG003|Overall Study|Refuse to continue medication|1|||
143384404|NCT00632749|516952852|FG004|Overall Study|Refuse to continue medication|0|||
143384405|NCT00632749|516952853|FG005|Overall Study|Refuse to continue medication|0|||
143384406|NCT00632749|516952854|FG006|Overall Study|Refuse to continue medication|0|||
143384407|NCT00632749|516952855|FG007|Overall Study|Refuse to continue medication|0|||
143384408|NCT00632749|516952856|FG008|Overall Study|Refuse to continue medication|0|||
143384409|NCT00632749|516952857|FG009|Overall Study|Refuse to continue medication|1|||
143384410|NCT00632749|516952858|FG010|Overall Study|Refuse to continue medication|0|||
143332710|NCT03792126|516762276|FG000|Overall Study|Adverse Event|1|||
143332711|NCT03792126|516762277|FG001|Overall Study|Adverse Event|2|||
143384411|NCT00632749|516952859|FG011|Overall Study|Refuse to continue medication|0|||
143384412|NCT00632749|516952860|FG012|Overall Study|Refuse to continue medication|0|||
143332712|NCT03792126|516762276|FG000|Overall Study|Death|0|||
143332713|NCT03792126|516762277|FG001|Overall Study|Death|1|||
143332714|NCT03792126|516762276|FG000|Overall Study|Lost to Follow-up|1|||
143332715|NCT03792126|516762277|FG001|Overall Study|Lost to Follow-up|0|||
143332716|NCT03792126|516762276|FG000|Overall Study|Withdrawal by Subject|0|||
143332717|NCT03792126|516762277|FG001|Overall Study|Withdrawal by Subject|1|||
143332718|NCT03792126|516762276|FG000|Overall Study|COVID-19 Restrictions|1|||
143332719|NCT03792126|516762277|FG001|Overall Study|COVID-19 Restrictions|3|||
143332720|NCT03792126|516762276|FG000|Overall Study|Symptoms resolved|0|||
143332721|NCT03792126|516762277|FG001|Overall Study|Symptoms resolved|3|||
143332722|NCT00441090|516762279|FG000|Overall Study|Adverse Event|0|||
143332723|NCT00441090|516762280|FG001|Overall Study|Adverse Event|1|||
143332724|NCT00441090|516762281|FG002|Overall Study|Adverse Event|1|||
143332725|NCT00441090|516762282|FG003|Overall Study|Adverse Event|0|||
143332726|NCT00441090|516762283|FG004|Overall Study|Adverse Event|0|||
143332727|NCT00441090|516762279|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
143332728|NCT00441090|516762280|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
143332729|NCT00441090|516762281|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
143332730|NCT00441090|516762282|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
143332731|NCT00441090|516762283|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
143332732|NCT00441090|516762279|FG000|Overall Study|Withdrawal by Subject|1|||
143332733|NCT00441090|516762280|FG001|Overall Study|Withdrawal by Subject|0|||
143332734|NCT00441090|516762281|FG002|Overall Study|Withdrawal by Subject|1|||
143332735|NCT00441090|516762282|FG003|Overall Study|Withdrawal by Subject|0|||
143332736|NCT00441090|516762283|FG004|Overall Study|Withdrawal by Subject|0|||
143332737|NCT00441090|516762279|FG000|Overall Study|Lack of Efficacy|1|||
143332738|NCT00441090|516762280|FG001|Overall Study|Lack of Efficacy|0|||
143332739|NCT00441090|516762281|FG002|Overall Study|Lack of Efficacy|0|||
143332740|NCT00441090|516762282|FG003|Overall Study|Lack of Efficacy|0|||
143332741|NCT00441090|516762283|FG004|Overall Study|Lack of Efficacy|0|||
143332742|NCT00518115|516762284|FG000|Overall Study|Adverse Event|6|||
143332743|NCT00518115|516762285|FG001|Overall Study|Adverse Event|1|||
143332744|NCT00518115|516762286|FG002|Overall Study|Adverse Event|5|||
143332745|NCT00518115|516762287|FG003|Overall Study|Adverse Event|6|||
143332746|NCT00518115|516762288|FG004|Overall Study|Adverse Event|5|||
143332747|NCT00518115|516762289|FG005|Overall Study|Adverse Event|5|||
143332748|NCT00518115|516762290|FG006|Overall Study|Adverse Event|5|||
143332749|NCT00518115|516762291|FG007|Overall Study|Adverse Event|10|||
143332750|NCT00518115|516762292|FG008|Overall Study|Adverse Event|2|||
143332751|NCT00518115|516762293|FG009|Overall Study|Adverse Event|9|||
143332752|NCT00518115|516762284|FG000|Overall Study|Lost to Follow-up|0|||
143332753|NCT00518115|516762285|FG001|Overall Study|Lost to Follow-up|0|||
143332754|NCT00518115|516762286|FG002|Overall Study|Lost to Follow-up|2|||
143332755|NCT00518115|516762287|FG003|Overall Study|Lost to Follow-up|3|||
143332756|NCT00518115|516762288|FG004|Overall Study|Lost to Follow-up|1|||
143332757|NCT00518115|516762289|FG005|Overall Study|Lost to Follow-up|3|||
143332758|NCT00518115|516762290|FG006|Overall Study|Lost to Follow-up|0|||
143332759|NCT00518115|516762291|FG007|Overall Study|Lost to Follow-up|1|||
143332760|NCT00518115|516762292|FG008|Overall Study|Lost to Follow-up|1|||
143332761|NCT00518115|516762293|FG009|Overall Study|Lost to Follow-up|1|||
143332762|NCT00518115|516762284|FG000|Overall Study|Protocol Violation|1|||
143332763|NCT00518115|516762285|FG001|Overall Study|Protocol Violation|3|||
143332764|NCT00518115|516762286|FG002|Overall Study|Protocol Violation|1|||
143332765|NCT00518115|516762287|FG003|Overall Study|Protocol Violation|0|||
143332766|NCT00518115|516762288|FG004|Overall Study|Protocol Violation|0|||
143332767|NCT00518115|516762289|FG005|Overall Study|Protocol Violation|0|||
143332768|NCT00518115|516762290|FG006|Overall Study|Protocol Violation|0|||
143332769|NCT00518115|516762291|FG007|Overall Study|Protocol Violation|0|||
143332770|NCT00518115|516762292|FG008|Overall Study|Protocol Violation|0|||
143332771|NCT00518115|516762293|FG009|Overall Study|Protocol Violation|0|||
143332772|NCT00518115|516762284|FG000|Overall Study|Withdrawal by Subject|1|||
143332773|NCT00518115|516762285|FG001|Overall Study|Withdrawal by Subject|1|||
143332774|NCT00518115|516762286|FG002|Overall Study|Withdrawal by Subject|5|||
143332775|NCT00518115|516762287|FG003|Overall Study|Withdrawal by Subject|0|||
143332776|NCT00518115|516762288|FG004|Overall Study|Withdrawal by Subject|2|||
143332777|NCT00518115|516762289|FG005|Overall Study|Withdrawal by Subject|1|||
143332778|NCT00518115|516762290|FG006|Overall Study|Withdrawal by Subject|0|||
143332779|NCT00518115|516762291|FG007|Overall Study|Withdrawal by Subject|2|||
143332780|NCT00518115|516762292|FG008|Overall Study|Withdrawal by Subject|1|||
143332781|NCT00518115|516762293|FG009|Overall Study|Withdrawal by Subject|3|||
143332782|NCT00518115|516762284|FG000|Overall Study|Lack of Efficacy|1|||
143332783|NCT00518115|516762285|FG001|Overall Study|Lack of Efficacy|0|||
143332784|NCT00518115|516762286|FG002|Overall Study|Lack of Efficacy|1|||
143332785|NCT00518115|516762287|FG003|Overall Study|Lack of Efficacy|1|||
143332786|NCT00518115|516762288|FG004|Overall Study|Lack of Efficacy|0|||
143332787|NCT00518115|516762289|FG005|Overall Study|Lack of Efficacy|0|||
143332788|NCT00518115|516762290|FG006|Overall Study|Lack of Efficacy|0|||
143332789|NCT00518115|516762291|FG007|Overall Study|Lack of Efficacy|1|||
143332790|NCT00518115|516762292|FG008|Overall Study|Lack of Efficacy|0|||
143332791|NCT00518115|516762293|FG009|Overall Study|Lack of Efficacy|0|||
143332792|NCT00518115|516762284|FG000|Overall Study|Non-Compliance|1|||
143332793|NCT00518115|516762285|FG001|Overall Study|Non-Compliance|0|||
143332794|NCT00518115|516762286|FG002|Overall Study|Non-Compliance|1|||
143332795|NCT00518115|516762287|FG003|Overall Study|Non-Compliance|0|||
143332796|NCT00518115|516762288|FG004|Overall Study|Non-Compliance|1|||
143332797|NCT00518115|516762289|FG005|Overall Study|Non-Compliance|1|||
143332798|NCT00518115|516762290|FG006|Overall Study|Non-Compliance|1|||
143332799|NCT00518115|516762291|FG007|Overall Study|Non-Compliance|1|||
143332800|NCT00518115|516762292|FG008|Overall Study|Non-Compliance|0|||
143332801|NCT00518115|516762293|FG009|Overall Study|Non-Compliance|1|||
143332802|NCT00518115|516762284|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
143332803|NCT00518115|516762285|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
143332804|NCT00518115|516762286|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
143332805|NCT00518115|516762287|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
143332806|NCT00518115|516762288|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
143332807|NCT00518115|516762289|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
143332808|NCT00518115|516762290|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
143332809|NCT00518115|516762291|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
143332810|NCT00518115|516762292|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
143332811|NCT00518115|516762293|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
143332812|NCT00518115|516762284|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
143332813|NCT00518115|516762285|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
143332814|NCT00518115|516762286|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
143332815|NCT00518115|516762287|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
143332816|NCT00518115|516762288|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
143332817|NCT00518115|516762289|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
143332818|NCT00518115|516762290|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
143332819|NCT00518115|516762291|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
143332820|NCT00518115|516762292|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
143332821|NCT00518115|516762293|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
143332822|NCT00518115|516762284|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
143332823|NCT00518115|516762285|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
143332824|NCT00518115|516762286|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
143332825|NCT00518115|516762287|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
143332826|NCT00518115|516762288|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
143332827|NCT00518115|516762289|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
143332828|NCT00518115|516762290|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
143332829|NCT00518115|516762291|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
143332830|NCT00518115|516762292|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
143332831|NCT00518115|516762293|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
143332832|NCT00518115|516762284|FG000|Overall Study|Wrong Monotherapy Administered|0|||
143332833|NCT00518115|516762285|FG001|Overall Study|Wrong Monotherapy Administered|0|||
143332834|NCT00518115|516762286|FG002|Overall Study|Wrong Monotherapy Administered|1|||
143332835|NCT00518115|516762287|FG003|Overall Study|Wrong Monotherapy Administered|0|||
143332836|NCT00518115|516762288|FG004|Overall Study|Wrong Monotherapy Administered|0|||
143332837|NCT00518115|516762289|FG005|Overall Study|Wrong Monotherapy Administered|0|||
143332838|NCT00518115|516762290|FG006|Overall Study|Wrong Monotherapy Administered|1|||
143332839|NCT00518115|516762291|FG007|Overall Study|Wrong Monotherapy Administered|0|||
143332840|NCT00518115|516762292|FG008|Overall Study|Wrong Monotherapy Administered|0|||
143332841|NCT00518115|516762293|FG009|Overall Study|Wrong Monotherapy Administered|0|||
143332842|NCT00518115|516762284|FG000|Overall Study|Violation of Exclusion Criteria|0|||
143332843|NCT00518115|516762285|FG001|Overall Study|Violation of Exclusion Criteria|0|||
143332844|NCT00518115|516762286|FG002|Overall Study|Violation of Exclusion Criteria|0|||
143332845|NCT00518115|516762287|FG003|Overall Study|Violation of Exclusion Criteria|1|||
143332846|NCT00518115|516762288|FG004|Overall Study|Violation of Exclusion Criteria|0|||
143332847|NCT00518115|516762289|FG005|Overall Study|Violation of Exclusion Criteria|0|||
143332848|NCT00518115|516762290|FG006|Overall Study|Violation of Exclusion Criteria|1|||
143332849|NCT00518115|516762291|FG007|Overall Study|Violation of Exclusion Criteria|0|||
143332850|NCT00518115|516762292|FG008|Overall Study|Violation of Exclusion Criteria|0|||
143332851|NCT00518115|516762293|FG009|Overall Study|Violation of Exclusion Criteria|0|||
143332852|NCT00518115|516762284|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
143332853|NCT00518115|516762285|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
143332854|NCT00518115|516762286|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
143332855|NCT00518115|516762287|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
143332856|NCT00518115|516762288|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
143332857|NCT00518115|516762289|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
143332858|NCT00518115|516762290|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
143332859|NCT00518115|516762291|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
143332860|NCT00518115|516762292|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
143332861|NCT00518115|516762293|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
143332862|NCT00518115|516762284|FG000|Overall Study|Withdrew Consent|0|||
143332863|NCT00518115|516762285|FG001|Overall Study|Withdrew Consent|0|||
143332864|NCT00518115|516762286|FG002|Overall Study|Withdrew Consent|0|||
143332865|NCT00518115|516762287|FG003|Overall Study|Withdrew Consent|0|||
143384413|NCT00632749|516952861|FG013|Overall Study|Refuse to continue medication|0|||
143384414|NCT00632749|516952848|FG000|Overall Study|Reason other than those specified above|0|||
143384415|NCT00632749|516952849|FG001|Overall Study|Reason other than those specified above|2|||
143384416|NCT00632749|516952850|FG002|Overall Study|Reason other than those specified above|0|||
143384417|NCT00632749|516952851|FG003|Overall Study|Reason other than those specified above|0|||
143384418|NCT00632749|516952852|FG004|Overall Study|Reason other than those specified above|1|||
143384419|NCT00632749|516952853|FG005|Overall Study|Reason other than those specified above|0|||
143384420|NCT00632749|516952854|FG006|Overall Study|Reason other than those specified above|1|||
143384421|NCT00632749|516952855|FG007|Overall Study|Reason other than those specified above|0|||
143384422|NCT00632749|516952856|FG008|Overall Study|Reason other than those specified above|0|||
143384423|NCT00632749|516952857|FG009|Overall Study|Reason other than those specified above|0|||
143384424|NCT00632749|516952858|FG010|Overall Study|Reason other than those specified above|2|||
143384425|NCT00632749|516952859|FG011|Overall Study|Reason other than those specified above|1|||
143384426|NCT00632749|516952860|FG012|Overall Study|Reason other than those specified above|0|||
143384427|NCT00632749|516952861|FG013|Overall Study|Reason other than those specified above|2|||
143332866|NCT00518115|516762288|FG004|Overall Study|Withdrew Consent|0|||
143332867|NCT00518115|516762289|FG005|Overall Study|Withdrew Consent|1|||
143332868|NCT00518115|516762290|FG006|Overall Study|Withdrew Consent|0|||
143332869|NCT00518115|516762291|FG007|Overall Study|Withdrew Consent|0|||
143332870|NCT00518115|516762292|FG008|Overall Study|Withdrew Consent|0|||
143332871|NCT00518115|516762293|FG009|Overall Study|Withdrew Consent|0|||
143332872|NCT00518115|516762284|FG000|Overall Study|Moved Out of State|0|||
143332873|NCT00518115|516762285|FG001|Overall Study|Moved Out of State|0|||
143332874|NCT00518115|516762286|FG002|Overall Study|Moved Out of State|0|||
143332875|NCT00518115|516762287|FG003|Overall Study|Moved Out of State|0|||
143332876|NCT00518115|516762288|FG004|Overall Study|Moved Out of State|0|||
143332877|NCT00518115|516762289|FG005|Overall Study|Moved Out of State|0|||
143332878|NCT00518115|516762290|FG006|Overall Study|Moved Out of State|0|||
143332879|NCT00518115|516762291|FG007|Overall Study|Moved Out of State|0|||
143332880|NCT00518115|516762292|FG008|Overall Study|Moved Out of State|0|||
143332881|NCT00518115|516762293|FG009|Overall Study|Moved Out of State|1|||
143332882|NCT00827918|516762294|FG000|Overall Study|Adverse Event|4|||
143332883|NCT00827918|516762295|FG001|Overall Study|Adverse Event|0|||
143332884|NCT00827918|516762296|FG002|Overall Study|Adverse Event|0|||
143332885|NCT00827918|516762294|FG000|Overall Study|Lack of Efficacy|16|||
143332886|NCT00827918|516762295|FG001|Overall Study|Lack of Efficacy|4|||
143332887|NCT00827918|516762296|FG002|Overall Study|Lack of Efficacy|15|||
143332888|NCT00827918|516762294|FG000|Overall Study|Physician Decision|1|||
143332889|NCT00827918|516762295|FG001|Overall Study|Physician Decision|0|||
143332890|NCT00827918|516762296|FG002|Overall Study|Physician Decision|0|||
143332891|NCT00827918|516762294|FG000|Overall Study|Pregnancy|0|||
143332892|NCT00827918|516762295|FG001|Overall Study|Pregnancy|1|||
143332893|NCT00827918|516762296|FG002|Overall Study|Pregnancy|0|||
143332894|NCT00827918|516762294|FG000|Overall Study|Progressive Disease|1|||
143332895|NCT00827918|516762295|FG001|Overall Study|Progressive Disease|1|||
143332896|NCT00827918|516762296|FG002|Overall Study|Progressive Disease|0|||
143332897|NCT00827918|516762294|FG000|Overall Study|Protocol Violation|0|||
143332898|NCT00827918|516762295|FG001|Overall Study|Protocol Violation|1|||
143332899|NCT00827918|516762296|FG002|Overall Study|Protocol Violation|0|||
143332900|NCT00827918|516762294|FG000|Overall Study|Withdrawal by Subject|6|||
143332901|NCT00827918|516762295|FG001|Overall Study|Withdrawal by Subject|2|||
143332902|NCT00827918|516762296|FG002|Overall Study|Withdrawal by Subject|6|||
143332903|NCT00843167|516762299|FG000|Treatment Period|Adverse Event|1|||
143332904|NCT00843167|516762300|FG001|Treatment Period|Adverse Event|5|||
143332905|NCT00843167|516762299|FG000|Treatment Period|Withdrawal by Subject|2|||
143332906|NCT00843167|516762300|FG001|Treatment Period|Withdrawal by Subject|3|||
143332907|NCT03743038|516762301|FG000|Overall Study|Physician Decision|1|||
143332908|NCT05207813|516762303|FG000|Overall Study|Lost to Follow-up|2|||
143332909|NCT00617344|516762304|FG000|Overall Study|Serious adverse event|1|||
143332910|NCT00617344|516762305|FG001|Overall Study|Serious adverse event|0|||
143332911|NCT00617344|516762306|FG002|Overall Study|Serious adverse event|0|||
143332912|NCT00617344|516762304|FG000|Overall Study|Other Adverse Event|1|||
143332913|NCT00617344|516762305|FG001|Overall Study|Other Adverse Event|1|||
143332914|NCT00617344|516762306|FG002|Overall Study|Other Adverse Event|0|||
143332915|NCT00617344|516762304|FG000|Overall Study|Protocol Violation|10|||
143332916|NCT00617344|516762305|FG001|Overall Study|Protocol Violation|8|||
143384428|NCT03210714|516952862|FG000|Overall Study|Adverse Event|6|||
143332917|NCT00617344|516762306|FG002|Overall Study|Protocol Violation|5|||
143332918|NCT00617344|516762304|FG000|Overall Study|Lost to Follow-up|5|||
143332919|NCT00617344|516762305|FG001|Overall Study|Lost to Follow-up|4|||
143332920|NCT00617344|516762306|FG002|Overall Study|Lost to Follow-up|1|||
143332921|NCT00617344|516762304|FG000|Overall Study|Withdrawal by Subject|8|||
143332922|NCT00617344|516762305|FG001|Overall Study|Withdrawal by Subject|9|||
143332923|NCT00617344|516762306|FG002|Overall Study|Withdrawal by Subject|2|||
143332924|NCT00490646|516762308|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
143332925|NCT00490646|516762309|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
143332926|NCT00490646|516762308|FG000|Overall Study|Never Treated (had an adverse event)|1|||
143332927|NCT00490646|516762309|FG001|Overall Study|Never Treated (had an adverse event)|0|||
143332928|NCT00490646|516762308|FG000|Overall Study|Never Treated (withdrew consent)|0|||
143332929|NCT00490646|516762309|FG001|Overall Study|Never Treated (withdrew consent)|1|||
143332930|NCT02137369|516762310|FG000|Overall Study|Withdrawal by Subject|3|||
143332931|NCT02137369|516762311|FG001|Overall Study|Withdrawal by Subject|2|||
143332932|NCT02137369|516762310|FG000|Overall Study|Adverse Event|2|||
143332933|NCT02137369|516762311|FG001|Overall Study|Adverse Event|0|||
143332934|NCT02137369|516762310|FG000|Overall Study|Lost to Follow-up|1|||
143332935|NCT02137369|516762311|FG001|Overall Study|Lost to Follow-up|0|||
143332936|NCT02137369|516762310|FG000|Overall Study|Moved away|2|||
143332937|NCT02137369|516762311|FG001|Overall Study|Moved away|0|||
143332938|NCT05608629|516762312|FG000|Overall Study|Lost to Follow-up|2|||
143332939|NCT01669122|516762315|FG000|Period I|Lost to Follow-up|1|||
143332940|NCT01669122|516762315|FG000|Washout Period II|Protocol Violation|2|||
143332941|NCT03762473|516762316|FG000|Overall Study|Death|1|||
143332942|NCT03762473|516762317|FG001|Overall Study|Death|0|||
143332943|NCT02962908|516762318|FG000|Overall Study|Lost to Follow-up|0|||
143332944|NCT02962908|516762319|FG001|Overall Study|Lost to Follow-up|3|||
143332945|NCT02962908|516762320|FG002|Overall Study|Lost to Follow-up|0|||
143332946|NCT02962908|516762321|FG003|Overall Study|Lost to Follow-up|1|||
143332947|NCT02962908|516762318|FG000|Overall Study|Withdrawal by Subject|0|||
143332948|NCT02962908|516762319|FG001|Overall Study|Withdrawal by Subject|3|||
143332949|NCT02962908|516762320|FG002|Overall Study|Withdrawal by Subject|0|||
143332950|NCT02962908|516762321|FG003|Overall Study|Withdrawal by Subject|2|||
143332951|NCT02962908|516762318|FG000|Overall Study|Protocol Violation|0|||
143332952|NCT02962908|516762319|FG001|Overall Study|Protocol Violation|1|||
143332953|NCT02962908|516762320|FG002|Overall Study|Protocol Violation|0|||
143332954|NCT02962908|516762321|FG003|Overall Study|Protocol Violation|0|||
143332955|NCT02962908|516762318|FG000|Overall Study|Physician Decision|0|||
143332956|NCT02962908|516762319|FG001|Overall Study|Physician Decision|1|||
143332957|NCT02962908|516762320|FG002|Overall Study|Physician Decision|0|||
143332958|NCT02962908|516762321|FG003|Overall Study|Physician Decision|0|||
143332959|NCT00829387|516762322|FG000|Overall Study|Withdrawal by Subject|2|||
143332960|NCT00829387|516762323|FG001|Overall Study|Withdrawal by Subject|3|||
143332961|NCT00829387|516762322|FG000|Overall Study|Disqualified by PI|1|||
143332962|NCT00829387|516762323|FG001|Overall Study|Disqualified by PI|0|||
143332963|NCT03543254|516762324|FG000|Overall Study|Lost to Follow-up|1|||
143332964|NCT02077166|516762325|FG000|Overall Study|Death|6|||
143332965|NCT02077166|516762326|FG001|Overall Study|Death|7|||
143332966|NCT02077166|516762327|FG002|Overall Study|Death|5|||
143332967|NCT02077166|516762328|FG003|Overall Study|Death|6|||
143332968|NCT02077166|516762329|FG004|Overall Study|Death|4|||
143332969|NCT02077166|516762330|FG005|Overall Study|Death|32|||
143332970|NCT02077166|516762331|FG006|Overall Study|Death|22|||
143332971|NCT02077166|516762325|FG000|Overall Study|Study Closure by Sponsor|3|||
143332972|NCT02077166|516762326|FG001|Overall Study|Study Closure by Sponsor|0|||
143332973|NCT02077166|516762327|FG002|Overall Study|Study Closure by Sponsor|2|||
143332974|NCT02077166|516762328|FG003|Overall Study|Study Closure by Sponsor|2|||
143332975|NCT02077166|516762329|FG004|Overall Study|Study Closure by Sponsor|2|||
143332976|NCT02077166|516762330|FG005|Overall Study|Study Closure by Sponsor|12|||
143332977|NCT02077166|516762331|FG006|Overall Study|Study Closure by Sponsor|4|||
143332978|NCT02077166|516762325|FG000|Overall Study|Lost to Follow-up|0|||
143332979|NCT02077166|516762326|FG001|Overall Study|Lost to Follow-up|0|||
143332980|NCT02077166|516762327|FG002|Overall Study|Lost to Follow-up|0|||
143332981|NCT02077166|516762328|FG003|Overall Study|Lost to Follow-up|0|||
143332982|NCT02077166|516762329|FG004|Overall Study|Lost to Follow-up|0|||
143332983|NCT02077166|516762330|FG005|Overall Study|Lost to Follow-up|1|||
143332984|NCT02077166|516762331|FG006|Overall Study|Lost to Follow-up|0|||
143332985|NCT02077166|516762325|FG000|Overall Study|Withdrawal by Subject|3|||
143332986|NCT02077166|516762326|FG001|Overall Study|Withdrawal by Subject|0|||
143332987|NCT02077166|516762327|FG002|Overall Study|Withdrawal by Subject|1|||
143332988|NCT02077166|516762328|FG003|Overall Study|Withdrawal by Subject|1|||
143332989|NCT02077166|516762329|FG004|Overall Study|Withdrawal by Subject|1|||
143332990|NCT02077166|516762330|FG005|Overall Study|Withdrawal by Subject|3|||
143332991|NCT02077166|516762331|FG006|Overall Study|Withdrawal by Subject|0|||
143384429|NCT03210714|516952862|FG000|Overall Study|Physician Decision|1|||
143332992|NCT02077166|516762325|FG000|Overall Study|Other, Not Specified|0|||
143332993|NCT02077166|516762326|FG001|Overall Study|Other, Not Specified|0|||
143332994|NCT02077166|516762327|FG002|Overall Study|Other, Not Specified|1|||
143332995|NCT02077166|516762328|FG003|Overall Study|Other, Not Specified|0|||
143332996|NCT02077166|516762329|FG004|Overall Study|Other, Not Specified|1|||
143332997|NCT02077166|516762330|FG005|Overall Study|Other, Not Specified|7|||
143332998|NCT02077166|516762331|FG006|Overall Study|Other, Not Specified|8|||
143332999|NCT03519854|516762332|FG000|Overall Study|Technical Error|0|||
143333000|NCT03519854|516762333|FG001|Overall Study|Technical Error|0|||
143333001|NCT03519854|516762334|FG002|Overall Study|Technical Error|1|||
143333002|NCT03519854|516762335|FG003|Overall Study|Technical Error|0|||
143333003|NCT03519854|516762336|FG004|Overall Study|Technical Error|0|||
143333004|NCT03519854|516762337|FG005|Overall Study|Technical Error|0|||
143333005|NCT03519854|516762338|FG006|Overall Study|Technical Error|0|||
143333006|NCT03519854|516762339|FG007|Overall Study|Technical Error|0|||
143333007|NCT03519854|516762340|FG008|Overall Study|Technical Error|0|||
143333008|NCT03519854|516762341|FG009|Overall Study|Technical Error|0|||
143333009|NCT03519854|516762342|FG010|Overall Study|Technical Error|0|||
143333010|NCT03519854|516762343|FG011|Overall Study|Technical Error|0|||
143333011|NCT03519854|516762344|FG012|Overall Study|Technical Error|0|||
143333012|NCT03519854|516762345|FG013|Overall Study|Technical Error|0|||
143333013|NCT03519854|516762346|FG014|Overall Study|Technical Error|0|||
143333014|NCT03519854|516762347|FG015|Overall Study|Technical Error|0|||
143333015|NCT03519854|516762348|FG016|Overall Study|Technical Error|0|||
143333016|NCT03519854|516762349|FG017|Overall Study|Technical Error|0|||
143333017|NCT00941330|516762350|FG000|Overall Study|Other|1|||
143333018|NCT00941330|516762351|FG001|Overall Study|Other|0|||
143333019|NCT00941330|516762350|FG000|Overall Study|Physician Decision|0|||
143333020|NCT00941330|516762351|FG001|Overall Study|Physician Decision|2|||
143333021|NCT02747238|516762352|FG000|Overall Study|Lack of Efficacy|0|||
143333022|NCT02747238|516762353|FG001|Overall Study|Lack of Efficacy|1|||
143333023|NCT02747238|516762352|FG000|Overall Study|Data lost|3|||
143333024|NCT02747238|516762353|FG001|Overall Study|Data lost|5|||
143333025|NCT05132699|516762357|FG000|Overall Study|Withdrawal by Subject|3|||
143333026|NCT05132699|516762358|FG001|Overall Study|Withdrawal by Subject|0|||
143333027|NCT02626780|516762362|FG000|Overall Study|Withdrawal by Subject|3|||
143333028|NCT04304833|516762363|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
143333029|NCT04304833|516762364|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
143333030|NCT01951625|516762365|FG000|Treatment Period|Protocol Violation|2|||
143333031|NCT01951625|516762366|FG001|Treatment Period|Protocol Violation|0|||
143333032|NCT01951625|516762367|FG002|Treatment Period|Protocol Violation|1|||
143333033|NCT01951625|516762368|FG003|Treatment Period|Protocol Violation|3|||
143333034|NCT01951625|516762369|FG004|Treatment Period|Protocol Violation|2|||
143333035|NCT01951625|516762365|FG000|Treatment Period|Physician Decision|0|||
143333036|NCT01951625|516762366|FG001|Treatment Period|Physician Decision|0|||
143333037|NCT01951625|516762367|FG002|Treatment Period|Physician Decision|0|||
143333038|NCT01951625|516762368|FG003|Treatment Period|Physician Decision|0|||
143333039|NCT01951625|516762369|FG004|Treatment Period|Physician Decision|1|||
143333040|NCT01951625|516762365|FG000|Treatment Period|Protocol driven decision point|0|||
143333041|NCT01951625|516762366|FG001|Treatment Period|Protocol driven decision point|5|||
143333042|NCT01951625|516762367|FG002|Treatment Period|Protocol driven decision point|0|||
143333043|NCT01951625|516762368|FG003|Treatment Period|Protocol driven decision point|2|||
143333044|NCT01951625|516762369|FG004|Treatment Period|Protocol driven decision point|1|||
143333045|NCT01951625|516762365|FG000|Treatment Period|Non compliance with study drug|1|||
143333046|NCT01951625|516762366|FG001|Treatment Period|Non compliance with study drug|2|||
143333047|NCT01951625|516762367|FG002|Treatment Period|Non compliance with study drug|2|||
143333048|NCT01951625|516762368|FG003|Treatment Period|Non compliance with study drug|0|||
143333049|NCT01951625|516762369|FG004|Treatment Period|Non compliance with study drug|0|||
143333050|NCT01951625|516762365|FG000|Treatment Period|Death|3|||
143333051|NCT01951625|516762366|FG001|Treatment Period|Death|2|||
143384430|NCT03210714|516952862|FG000|Overall Study|Progressive disease|11|||
143384431|NCT03210714|516952862|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
143384432|NCT00879333|516952863|FG000|Overall Study|Adverse Event|94|||
143333052|NCT01951625|516762367|FG002|Treatment Period|Death|2|||
143333053|NCT01951625|516762368|FG003|Treatment Period|Death|1|||
143333054|NCT01951625|516762369|FG004|Treatment Period|Death|2|||
143333055|NCT01951625|516762365|FG000|Treatment Period|Adverse Event|7|||
143333056|NCT01951625|516762366|FG001|Treatment Period|Adverse Event|10|||
143333057|NCT01951625|516762367|FG002|Treatment Period|Adverse Event|9|||
143384433|NCT00879333|516952864|FG001|Overall Study|Adverse Event|34|||
143333058|NCT01951625|516762368|FG003|Treatment Period|Adverse Event|8|||
143333059|NCT01951625|516762369|FG004|Treatment Period|Adverse Event|8|||
143333060|NCT01951625|516762365|FG000|Treatment Period|Withdrawal by Subject|5|||
143333061|NCT01951625|516762366|FG001|Treatment Period|Withdrawal by Subject|2|||
143333062|NCT01951625|516762367|FG002|Treatment Period|Withdrawal by Subject|1|||
143333063|NCT01951625|516762368|FG003|Treatment Period|Withdrawal by Subject|7|||
143333064|NCT01951625|516762369|FG004|Treatment Period|Withdrawal by Subject|3|||
143333065|NCT01951625|516762365|FG000|Treatment Period|Lost to Follow-up|1|||
143333066|NCT01951625|516762366|FG001|Treatment Period|Lost to Follow-up|0|||
143333067|NCT01951625|516762367|FG002|Treatment Period|Lost to Follow-up|0|||
143333068|NCT01951625|516762368|FG003|Treatment Period|Lost to Follow-up|1|||
143333069|NCT01951625|516762369|FG004|Treatment Period|Lost to Follow-up|0|||
143333070|NCT01951625|516762365|FG000|Follow Up Period|Non-compliance with study drug|1|||
143333071|NCT01951625|516762366|FG001|Follow Up Period|Non-compliance with study drug|0|||
143333072|NCT01951625|516762367|FG002|Follow Up Period|Non-compliance with study drug|0|||
143333073|NCT01951625|516762368|FG003|Follow Up Period|Non-compliance with study drug|0|||
143333074|NCT01951625|516762369|FG004|Follow Up Period|Non-compliance with study drug|0|||
143333075|NCT01951625|516762365|FG000|Follow Up Period|Death|1|||
143333076|NCT01951625|516762366|FG001|Follow Up Period|Death|3|||
143333077|NCT01951625|516762367|FG002|Follow Up Period|Death|2|||
143333078|NCT01951625|516762368|FG003|Follow Up Period|Death|2|||
143333079|NCT01951625|516762369|FG004|Follow Up Period|Death|1|||
143333080|NCT01951625|516762365|FG000|Follow Up Period|Logistical difficulties|1|||
143333081|NCT01951625|516762366|FG001|Follow Up Period|Logistical difficulties|2|||
143333082|NCT01951625|516762367|FG002|Follow Up Period|Logistical difficulties|0|||
143333083|NCT01951625|516762368|FG003|Follow Up Period|Logistical difficulties|0|||
143333084|NCT01951625|516762369|FG004|Follow Up Period|Logistical difficulties|0|||
143333085|NCT01951625|516762365|FG000|Follow Up Period|Adverse Event|0|||
143333086|NCT01951625|516762366|FG001|Follow Up Period|Adverse Event|3|||
143333087|NCT01951625|516762367|FG002|Follow Up Period|Adverse Event|2|||
143333088|NCT01951625|516762368|FG003|Follow Up Period|Adverse Event|3|||
143333089|NCT01951625|516762369|FG004|Follow Up Period|Adverse Event|5|||
143333090|NCT01951625|516762365|FG000|Follow Up Period|Withdrawal by Subject|4|||
143333091|NCT01951625|516762366|FG001|Follow Up Period|Withdrawal by Subject|1|||
143333092|NCT01951625|516762367|FG002|Follow Up Period|Withdrawal by Subject|0|||
143333093|NCT01951625|516762368|FG003|Follow Up Period|Withdrawal by Subject|5|||
143333094|NCT01951625|516762369|FG004|Follow Up Period|Withdrawal by Subject|3|||
143333095|NCT01951625|516762365|FG000|Follow Up Period|Lost to Follow-up|1|||
143333096|NCT01951625|516762366|FG001|Follow Up Period|Lost to Follow-up|0|||
143333097|NCT01951625|516762367|FG002|Follow Up Period|Lost to Follow-up|0|||
143333098|NCT01951625|516762368|FG003|Follow Up Period|Lost to Follow-up|1|||
143333099|NCT01951625|516762369|FG004|Follow Up Period|Lost to Follow-up|1|||
143333100|NCT00613951|516762372|FG000|Overall Study|Adverse Event|1|||
143333101|NCT00613951|516762373|FG001|Overall Study|Adverse Event|0|||
143333102|NCT00613951|516762374|FG002|Overall Study|Adverse Event|1|||
143333103|NCT00613951|516762372|FG000|Overall Study|Lack of Efficacy|0|||
143333104|NCT00613951|516762373|FG001|Overall Study|Lack of Efficacy|1|||
143333105|NCT00613951|516762374|FG002|Overall Study|Lack of Efficacy|1|||
143333106|NCT00613951|516762372|FG000|Overall Study|Protocol Violation|1|||
143333107|NCT00613951|516762373|FG001|Overall Study|Protocol Violation|1|||
143333108|NCT00613951|516762374|FG002|Overall Study|Protocol Violation|1|||
143333109|NCT00613951|516762372|FG000|Overall Study|Unclassified|5|||
143333110|NCT00613951|516762373|FG001|Overall Study|Unclassified|3|||
143333111|NCT00613951|516762374|FG002|Overall Study|Unclassified|2|||
143333112|NCT04050865|516764389|FG000|Overall Study|Adverse Event|1|||
143333113|NCT04050865|516764390|FG001|Overall Study|Adverse Event|0|||
143333114|NCT04050865|516764389|FG000|Overall Study|no insert|1|||
143333115|NCT04050865|516764390|FG001|Overall Study|no insert|0|||
143333116|NCT04050865|516764389|FG000|Overall Study|Only 1 insert|2|||
143333117|NCT04050865|516764390|FG001|Overall Study|Only 1 insert|3|||
143333118|NCT04050865|516764389|FG000|Overall Study|Physician Decision|0|||
143333119|NCT04050865|516764390|FG001|Overall Study|Physician Decision|1|||
143333120|NCT04050865|516764389|FG000|Overall Study|Withdrawal by Subject|0|||
143333121|NCT04050865|516764390|FG001|Overall Study|Withdrawal by Subject|1|||
143333122|NCT00857207|516764391|FG000|Overall Study|Withdrawal by Subject|13|||
143333123|NCT00857207|516764392|FG001|Overall Study|Withdrawal by Subject|0|||
143333124|NCT00857207|516764391|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
143333125|NCT00857207|516764392|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
143333126|NCT00857207|516764391|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
143333127|NCT00857207|516764392|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
143333128|NCT00499031|516764393|FG000|Overall Study|Improper pre-protocol treatment|1|||
143333129|NCT00499031|516764393|FG000|Overall Study|Required test not done|1|||
143333130|NCT00499031|516764393|FG000|Overall Study|Never treated|1|||
143333131|NCT03409666|516764396|FG000|Overall Study|Physician Decision|0|||
143333132|NCT03409666|516764397|FG001|Overall Study|Physician Decision|1|||
143333133|NCT03409666|516764396|FG000|Overall Study|Protocol Violation|0|||
143333134|NCT03409666|516764397|FG001|Overall Study|Protocol Violation|3|||
143333135|NCT02690974|516764404|FG000|Overall Study|Adverse Event|16|||
143333136|NCT02690974|516764404|FG000|Overall Study|Death|9|||
143333137|NCT02690974|516764404|FG000|Overall Study|Subject/guardian decision|4|||
143333138|NCT02690974|516764404|FG000|Overall Study|Lost to Follow-up|3|||
143333139|NCT02690974|516764404|FG000|Overall Study|Withdrawal of Informed Consent|3|||
143333140|NCT02690974|516764404|FG000|Overall Study|Physician Decision|2|||
143333141|NCT02690974|516764404|FG000|Overall Study|Non-compliance with study treatment|1|||
143333142|NCT02690974|516764404|FG000|Overall Study|Protocol-defined stopping criteria|1|||
143333143|NCT02690974|516764404|FG000|Overall Study|Protocol Deviation|1|||
143333144|NCT04605978|516764411|FG000|Overall Study|Adverse Event|2|||
143333145|NCT04605978|516764412|FG001|Overall Study|Adverse Event|1|||
143333146|NCT04605978|516764411|FG000|Overall Study|Withdrawal nonmedical reason|1|||
143333147|NCT04605978|516764412|FG001|Overall Study|Withdrawal nonmedical reason|1|||
143333148|NCT03104699|516764413|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
143333149|NCT03104699|516764414|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
143333150|NCT03104699|516764415|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
143333151|NCT03104699|516764416|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|8|||
143333152|NCT03104699|516764417|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
143333153|NCT03104699|516764418|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
143333154|NCT03104699|516764413|FG000|Phase 1: Dose Escalation|Physician Decision|0|||
143333155|NCT03104699|516764414|FG001|Phase 1: Dose Escalation|Physician Decision|0|||
143333156|NCT03104699|516764415|FG002|Phase 1: Dose Escalation|Physician Decision|2|||
143333157|NCT03104699|516764416|FG003|Phase 1: Dose Escalation|Physician Decision|1|||
143333158|NCT03104699|516764417|FG004|Phase 1: Dose Escalation|Physician Decision|0|||
143333159|NCT03104699|516764418|FG005|Phase 1: Dose Escalation|Physician Decision|0|||
143333160|NCT03104699|516764413|FG000|Phase 1: Dose Escalation|Death|6|||
143333161|NCT03104699|516764414|FG001|Phase 1: Dose Escalation|Death|3|||
143333162|NCT03104699|516764415|FG002|Phase 1: Dose Escalation|Death|0|||
143333163|NCT03104699|516764416|FG003|Phase 1: Dose Escalation|Death|1|||
143333164|NCT03104699|516764417|FG004|Phase 1: Dose Escalation|Death|1|||
143333165|NCT03104699|516764418|FG005|Phase 1: Dose Escalation|Death|0|||
143333166|NCT03104699|516764413|FG000|Phase 1: Dose Escalation|Completed Follow Up|2|||
143333167|NCT03104699|516764414|FG001|Phase 1: Dose Escalation|Completed Follow Up|2|||
143333168|NCT03104699|516764415|FG002|Phase 1: Dose Escalation|Completed Follow Up|1|||
143333169|NCT03104699|516764416|FG003|Phase 1: Dose Escalation|Completed Follow Up|0|||
143333170|NCT03104699|516764417|FG004|Phase 1: Dose Escalation|Completed Follow Up|2|||
143333171|NCT03104699|516764418|FG005|Phase 1: Dose Escalation|Completed Follow Up|0|||
143333172|NCT03104699|516764413|FG000|Phase 1: Dose Escalation|Lost to Follow-up|0|||
143333173|NCT03104699|516764414|FG001|Phase 1: Dose Escalation|Lost to Follow-up|1|||
143333174|NCT03104699|516764415|FG002|Phase 1: Dose Escalation|Lost to Follow-up|1|||
143333175|NCT03104699|516764416|FG003|Phase 1: Dose Escalation|Lost to Follow-up|0|||
143333176|NCT03104699|516764417|FG004|Phase 1: Dose Escalation|Lost to Follow-up|0|||
143333177|NCT03104699|516764418|FG005|Phase 1: Dose Escalation|Lost to Follow-up|0|||
143333178|NCT03104699|516764413|FG000|Phase 1: Dose Escalation|Progressive Disease|0|||
143333179|NCT03104699|516764414|FG001|Phase 1: Dose Escalation|Progressive Disease|0|||
143333180|NCT03104699|516764415|FG002|Phase 1: Dose Escalation|Progressive Disease|0|||
143333181|NCT03104699|516764416|FG003|Phase 1: Dose Escalation|Progressive Disease|0|||
143333182|NCT03104699|516764417|FG004|Phase 1: Dose Escalation|Progressive Disease|1|||
143333183|NCT03104699|516764418|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
143333184|NCT03104699|516764413|FG000|Phase 1: Dose Escalation|Disease Progression|0|||
143333185|NCT03104699|516764414|FG001|Phase 1: Dose Escalation|Disease Progression|2|||
143333186|NCT03104699|516764415|FG002|Phase 1: Dose Escalation|Disease Progression|0|||
143333187|NCT03104699|516764416|FG003|Phase 1: Dose Escalation|Disease Progression|0|||
143333188|NCT03104699|516764417|FG004|Phase 1: Dose Escalation|Disease Progression|0|||
143333189|NCT03104699|516764418|FG005|Phase 1: Dose Escalation|Disease Progression|0|||
143333190|NCT03104699|516764413|FG000|Phase 1: Dose Escalation|Protocol Violation|0|||
143333191|NCT03104699|516764414|FG001|Phase 1: Dose Escalation|Protocol Violation|0|||
143333192|NCT03104699|516764415|FG002|Phase 1: Dose Escalation|Protocol Violation|0|||
143333193|NCT03104699|516764416|FG003|Phase 1: Dose Escalation|Protocol Violation|0|||
143333194|NCT03104699|516764417|FG004|Phase 1: Dose Escalation|Protocol Violation|2|||
143333195|NCT03104699|516764418|FG005|Phase 1: Dose Escalation|Protocol Violation|0|||
143333196|NCT03104699|516764413|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
143333197|NCT03104699|516764414|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
143333198|NCT03104699|516764415|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
143333199|NCT03104699|516764416|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
143333200|NCT03104699|516764417|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
143333201|NCT03104699|516764418|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|6|||
143333202|NCT03104699|516764413|FG000|Phase 2: Dose Expansion|Death|0|||
143333203|NCT03104699|516764414|FG001|Phase 2: Dose Expansion|Death|0|||
143333204|NCT03104699|516764415|FG002|Phase 2: Dose Expansion|Death|0|||
143333205|NCT03104699|516764416|FG003|Phase 2: Dose Expansion|Death|0|||
143333206|NCT03104699|516764417|FG004|Phase 2: Dose Expansion|Death|0|||
143333207|NCT03104699|516764418|FG005|Phase 2: Dose Expansion|Death|107|||
143333208|NCT03104699|516764413|FG000|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
143333209|NCT03104699|516764414|FG001|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
143333210|NCT03104699|516764415|FG002|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
143333211|NCT03104699|516764416|FG003|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
143333212|NCT03104699|516764417|FG004|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
143333213|NCT03104699|516764418|FG005|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|1|||
143333214|NCT03104699|516764413|FG000|Phase 2: Dose Expansion|Administrative Study Closure|0|||
143333215|NCT03104699|516764414|FG001|Phase 2: Dose Expansion|Administrative Study Closure|0|||
143333216|NCT03104699|516764415|FG002|Phase 2: Dose Expansion|Administrative Study Closure|0|||
143333217|NCT03104699|516764416|FG003|Phase 2: Dose Expansion|Administrative Study Closure|0|||
143333218|NCT03104699|516764417|FG004|Phase 2: Dose Expansion|Administrative Study Closure|0|||
143333219|NCT03104699|516764418|FG005|Phase 2: Dose Expansion|Administrative Study Closure|13|||
143333220|NCT03104699|516764413|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
143333221|NCT03104699|516764414|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
143333222|NCT03104699|516764415|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
143333223|NCT03104699|516764416|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
143333224|NCT03104699|516764417|FG004|Phase 2: Dose Expansion|Lost to Follow-up|0|||
143333225|NCT03104699|516764418|FG005|Phase 2: Dose Expansion|Lost to Follow-up|5|||
143333226|NCT03104699|516764413|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
143333227|NCT03104699|516764414|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
143333228|NCT03104699|516764415|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
143333229|NCT03104699|516764416|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
143333230|NCT03104699|516764417|FG004|Phase 2: Dose Expansion|Progressive Disease|0|||
143333231|NCT03104699|516764418|FG005|Phase 2: Dose Expansion|Progressive Disease|1|||
143333232|NCT01690130|516764419|FG000|Overall Study|Subject have cancelled visit.|1|||
143333233|NCT01690130|516764420|FG001|Overall Study|Subject have cancelled visit.|0|||
143333234|NCT01644734|516764421|FG000|Overall Study|Adverse Event|4|||
143333235|NCT01644734|516764421|FG000|Overall Study|Lost to Follow-up|17|||
143333236|NCT01644734|516764421|FG000|Overall Study|Reasons other than stated above|7|||
143333237|NCT01644734|516764421|FG000|Overall Study|Missing documentation|238|||
143333238|NCT02462876|516764422|FG000|Overall Study|Death|3|||
143333239|NCT02462876|516764422|FG000|Overall Study|Lost to Follow-up|7|||
143333240|NCT02462876|516764422|FG000|Overall Study|Surgical Bypass|9|||
143333241|NCT02462876|516764422|FG000|Overall Study|Amputation Above the Metatarsals|1|||
143333242|NCT02462876|516764422|FG000|Overall Study|36 months follow-up visit missed|1|||
143333243|NCT02462876|516764422|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
143333244|NCT02462876|516764422|FG000|Overall Study|Patient did not come back to the vascular department|1|||
143333245|NCT02462876|516764422|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
143333246|NCT02462876|516764422|FG000|Overall Study|Patient refused to come back|1|||
143333247|NCT02462876|516764422|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
143333248|NCT02462876|516764422|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
143333249|NCT01786512|516764425|FG000|Overall Study|Lost to Follow-up|0|||
143333250|NCT01786512|516764426|FG001|Overall Study|Lost to Follow-up|0|||
143333251|NCT01786512|516764427|FG002|Overall Study|Lost to Follow-up|0|||
143333252|NCT01786512|516764428|FG003|Overall Study|Lost to Follow-up|0|||
143333253|NCT01786512|516764429|FG004|Overall Study|Lost to Follow-up|0|||
143333254|NCT01786512|516764430|FG005|Overall Study|Lost to Follow-up|0|||
143333255|NCT01786512|516764431|FG006|Overall Study|Lost to Follow-up|0|||
143333256|NCT01786512|516764432|FG007|Overall Study|Lost to Follow-up|0|||
143333257|NCT01786512|516764433|FG008|Overall Study|Lost to Follow-up|0|||
143384434|NCT00879333|516952863|FG000|Overall Study|Abnormal Laboratory Value|1|||
143333258|NCT01786512|516764434|FG009|Overall Study|Lost to Follow-up|1|||
143333259|NCT01786512|516764435|FG010|Overall Study|Lost to Follow-up|0|||
143333260|NCT01786512|516764425|FG000|Overall Study|Decision by sponsor|0|||
143333261|NCT01786512|516764426|FG001|Overall Study|Decision by sponsor|0|||
143333262|NCT01786512|516764427|FG002|Overall Study|Decision by sponsor|0|||
143333263|NCT01786512|516764428|FG003|Overall Study|Decision by sponsor|0|||
143333264|NCT01786512|516764429|FG004|Overall Study|Decision by sponsor|0|||
143333265|NCT01786512|516764430|FG005|Overall Study|Decision by sponsor|0|||
143333266|NCT01786512|516764431|FG006|Overall Study|Decision by sponsor|0|||
143333267|NCT01786512|516764432|FG007|Overall Study|Decision by sponsor|0|||
143333268|NCT01786512|516764433|FG008|Overall Study|Decision by sponsor|0|||
143333269|NCT01786512|516764434|FG009|Overall Study|Decision by sponsor|0|||
143333270|NCT01786512|516764435|FG010|Overall Study|Decision by sponsor|2|||
143333271|NCT01786512|516764425|FG000|Overall Study|Withdrawal by Subject|0|||
143333272|NCT01786512|516764426|FG001|Overall Study|Withdrawal by Subject|1|||
143333273|NCT01786512|516764427|FG002|Overall Study|Withdrawal by Subject|0|||
143333274|NCT01786512|516764428|FG003|Overall Study|Withdrawal by Subject|0|||
143333275|NCT01786512|516764429|FG004|Overall Study|Withdrawal by Subject|0|||
143333276|NCT01786512|516764430|FG005|Overall Study|Withdrawal by Subject|0|||
143333277|NCT01786512|516764431|FG006|Overall Study|Withdrawal by Subject|1|||
143333278|NCT01786512|516764432|FG007|Overall Study|Withdrawal by Subject|0|||
143333279|NCT01786512|516764433|FG008|Overall Study|Withdrawal by Subject|0|||
143333280|NCT01786512|516764434|FG009|Overall Study|Withdrawal by Subject|3|||
143333281|NCT01786512|516764435|FG010|Overall Study|Withdrawal by Subject|7|||
143333282|NCT01786512|516764425|FG000|Overall Study|Death|0|||
143333283|NCT01786512|516764426|FG001|Overall Study|Death|0|||
143333284|NCT01786512|516764427|FG002|Overall Study|Death|0|||
143333285|NCT01786512|516764428|FG003|Overall Study|Death|0|||
143333286|NCT01786512|516764429|FG004|Overall Study|Death|0|||
143333287|NCT01786512|516764430|FG005|Overall Study|Death|0|||
143333288|NCT01786512|516764431|FG006|Overall Study|Death|0|||
143333289|NCT01786512|516764432|FG007|Overall Study|Death|0|||
143333290|NCT01786512|516764433|FG008|Overall Study|Death|4|||
143333291|NCT01786512|516764434|FG009|Overall Study|Death|1|||
143333292|NCT01786512|516764435|FG010|Overall Study|Death|3|||
143333293|NCT03318523|516764436|FG000|PC Period: Up to Year 1|Adverse Event|1|||
143333294|NCT03318523|516764437|FG001|PC Period: Up to Year 1|Adverse Event|0|||
143333295|NCT03318523|516764438|FG002|PC Period: Up to Year 1|Adverse Event|2|||
143333296|NCT03318523|516764439|FG003|PC Period: Up to Year 1|Adverse Event|0|||
143333297|NCT03318523|516764440|FG004|PC Period: Up to Year 1|Adverse Event|0|||
143333298|NCT03318523|516764441|FG005|PC Period: Up to Year 1|Adverse Event|0|||
143333299|NCT03318523|516764442|FG006|PC Period: Up to Year 1|Adverse Event|0|||
143333300|NCT03318523|516764443|FG007|PC Period: Up to Year 1|Adverse Event|0|||
143333301|NCT03318523|516764444|FG008|PC Period: Up to Year 1|Adverse Event|0|||
143333302|NCT03318523|516764445|FG009|PC Period: Up to Year 1|Adverse Event|0|||
143333303|NCT03318523|516764436|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
143333304|NCT03318523|516764437|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
143333305|NCT03318523|516764438|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
143333306|NCT03318523|516764439|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
143333307|NCT03318523|516764440|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
143333308|NCT03318523|516764441|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
143333309|NCT03318523|516764442|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
143333310|NCT03318523|516764443|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
143333311|NCT03318523|516764444|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
143333312|NCT03318523|516764445|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
143333313|NCT03318523|516764436|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
143333314|NCT03318523|516764437|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
143333315|NCT03318523|516764438|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
143384435|NCT00879333|516952864|FG001|Overall Study|Abnormal Laboratory Value|0|||
143384436|NCT00879333|516952863|FG000|Overall Study|Withdrawal by Subject|20|||
143384437|NCT00879333|516952864|FG001|Overall Study|Withdrawal by Subject|7|||
143384438|NCT00879333|516952863|FG000|Overall Study|Lost to Follow-up|2|||
143384439|NCT00879333|516952864|FG001|Overall Study|Lost to Follow-up|1|||
143384440|NCT00879333|516952863|FG000|Overall Study|Administrative Problems|2|||
143384441|NCT00879333|516952864|FG001|Overall Study|Administrative Problems|0|||
143384442|NCT00879333|516952863|FG000|Overall Study|Death|16|||
143333316|NCT03318523|516764439|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
143333317|NCT03318523|516764440|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
143333318|NCT03318523|516764441|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
143333319|NCT03318523|516764442|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
143333320|NCT03318523|516764443|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
143333321|NCT03318523|516764444|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
143333322|NCT03318523|516764445|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
143333323|NCT03318523|516764436|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
143333324|NCT03318523|516764437|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
143333325|NCT03318523|516764438|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
143333326|NCT03318523|516764439|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
143333327|NCT03318523|516764440|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
143333328|NCT03318523|516764441|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
143333329|NCT03318523|516764442|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
143333330|NCT03318523|516764443|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
143333331|NCT03318523|516764444|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
143333332|NCT03318523|516764445|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
143333333|NCT03318523|516764436|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
143333334|NCT03318523|516764437|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
143333335|NCT03318523|516764438|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
143333336|NCT03318523|516764439|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
143333337|NCT03318523|516764440|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
143333338|NCT03318523|516764441|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
143333339|NCT03318523|516764442|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
143333340|NCT03318523|516764443|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
143333341|NCT03318523|516764444|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
143333342|NCT03318523|516764445|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
143333343|NCT03318523|516764436|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
143333344|NCT03318523|516764437|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
143333345|NCT03318523|516764438|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
143333346|NCT03318523|516764439|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
143333347|NCT03318523|516764440|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
143333348|NCT03318523|516764441|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
143333349|NCT03318523|516764442|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
143333350|NCT03318523|516764443|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
143333351|NCT03318523|516764444|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
143333352|NCT03318523|516764445|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
143333353|NCT03318523|516764436|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
143333354|NCT03318523|516764437|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
143333355|NCT03318523|516764438|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
143333356|NCT03318523|516764439|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
143333357|NCT03318523|516764440|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
143333358|NCT03318523|516764441|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
143333359|NCT03318523|516764442|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
143333360|NCT03318523|516764443|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
143333361|NCT03318523|516764444|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
143333362|NCT03318523|516764445|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
143333363|NCT03318523|516764436|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
143333364|NCT03318523|516764437|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
143333365|NCT03318523|516764438|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
143333366|NCT03318523|516764439|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
143384443|NCT00879333|516952864|FG001|Overall Study|Death|5|||
143384444|NCT00879333|516952863|FG000|Overall Study|Disease Progression|292|||
143384445|NCT00879333|516952864|FG001|Overall Study|Disease Progression|169|||
143384446|NCT00879333|516952863|FG000|Overall Study|Protocol Violation|1|||
143384447|NCT00879333|516952864|FG001|Overall Study|Protocol Violation|1|||
143384448|NCT02671435|516952871|FG000|Overall Study|Death|1|||
143384449|NCT02671435|516952872|FG001|Overall Study|Death|3|||
143384450|NCT02671435|516952873|FG002|Overall Study|Death|0|||
143384451|NCT02671435|516952874|FG003|Overall Study|Death|16|||
143384452|NCT02671435|516952875|FG004|Overall Study|Death|14|||
143384453|NCT02671435|516952876|FG005|Overall Study|Death|29|||
143384454|NCT02671435|516952877|FG006|Overall Study|Death|34|||
143384455|NCT02671435|516952878|FG007|Overall Study|Death|28|||
143384456|NCT02671435|516952879|FG008|Overall Study|Death|19|||
143384457|NCT02671435|516952880|FG009|Overall Study|Death|10|||
143384458|NCT02671435|516952881|FG010|Overall Study|Death|8|||
143384459|NCT02671435|516952882|FG011|Overall Study|Death|29|||
143384460|NCT02671435|516952883|FG012|Overall Study|Death|29|||
143384461|NCT02671435|516952884|FG013|Overall Study|Death|29|||
143384462|NCT02671435|516952885|FG014|Overall Study|Death|27|||
143384463|NCT02671435|516952871|FG000|Overall Study|Lost to Follow-up|0|||
143384464|NCT02671435|516952872|FG001|Overall Study|Lost to Follow-up|0|||
143384465|NCT02671435|516952873|FG002|Overall Study|Lost to Follow-up|1|||
143384466|NCT02671435|516952874|FG003|Overall Study|Lost to Follow-up|0|||
143384467|NCT02671435|516952875|FG004|Overall Study|Lost to Follow-up|1|||
143384468|NCT02671435|516952876|FG005|Overall Study|Lost to Follow-up|1|||
143384469|NCT02671435|516952877|FG006|Overall Study|Lost to Follow-up|2|||
143384470|NCT02671435|516952878|FG007|Overall Study|Lost to Follow-up|2|||
143384471|NCT02671435|516952879|FG008|Overall Study|Lost to Follow-up|0|||
143384472|NCT02671435|516952880|FG009|Overall Study|Lost to Follow-up|2|||
143384473|NCT02671435|516952881|FG010|Overall Study|Lost to Follow-up|0|||
143384474|NCT02671435|516952882|FG011|Overall Study|Lost to Follow-up|3|||
143384475|NCT02671435|516952883|FG012|Overall Study|Lost to Follow-up|3|||
143384476|NCT02671435|516952884|FG013|Overall Study|Lost to Follow-up|2|||
143384477|NCT02671435|516952885|FG014|Overall Study|Lost to Follow-up|0|||
143384478|NCT02671435|516952871|FG000|Overall Study|Withdrawal by Subject|2|||
143384479|NCT02671435|516952872|FG001|Overall Study|Withdrawal by Subject|0|||
143384480|NCT02671435|516952873|FG002|Overall Study|Withdrawal by Subject|2|||
143384481|NCT02671435|516952874|FG003|Overall Study|Withdrawal by Subject|2|||
143384482|NCT02671435|516952875|FG004|Overall Study|Withdrawal by Subject|2|||
143384483|NCT02671435|516952876|FG005|Overall Study|Withdrawal by Subject|7|||
143384484|NCT02671435|516952877|FG006|Overall Study|Withdrawal by Subject|2|||
143384485|NCT02671435|516952878|FG007|Overall Study|Withdrawal by Subject|7|||
143384486|NCT02671435|516952879|FG008|Overall Study|Withdrawal by Subject|1|||
143384487|NCT02671435|516952880|FG009|Overall Study|Withdrawal by Subject|1|||
143384488|NCT02671435|516952881|FG010|Overall Study|Withdrawal by Subject|2|||
143384489|NCT02671435|516952882|FG011|Overall Study|Withdrawal by Subject|4|||
143384490|NCT02671435|516952883|FG012|Overall Study|Withdrawal by Subject|4|||
143384491|NCT02671435|516952884|FG013|Overall Study|Withdrawal by Subject|4|||
143384492|NCT02671435|516952885|FG014|Overall Study|Withdrawal by Subject|2|||
143384493|NCT02671435|516952871|FG000|Overall Study|Un-specified|0|||
143384494|NCT02671435|516952872|FG001|Overall Study|Un-specified|0|||
143384495|NCT02671435|516952873|FG002|Overall Study|Un-specified|0|||
143384496|NCT02671435|516952874|FG003|Overall Study|Un-specified|0|||
143384497|NCT02671435|516952875|FG004|Overall Study|Un-specified|1|||
143384498|NCT02671435|516952876|FG005|Overall Study|Un-specified|3|||
143384499|NCT02671435|516952877|FG006|Overall Study|Un-specified|2|||
143384500|NCT02671435|516952878|FG007|Overall Study|Un-specified|3|||
143384501|NCT02671435|516952879|FG008|Overall Study|Un-specified|0|||
143384502|NCT02671435|516952880|FG009|Overall Study|Un-specified|5|||
143384503|NCT02671435|516952881|FG010|Overall Study|Un-specified|8|||
143384504|NCT02671435|516952882|FG011|Overall Study|Un-specified|4|||
143384505|NCT02671435|516952883|FG012|Overall Study|Un-specified|5|||
143384506|NCT02671435|516952884|FG013|Overall Study|Un-specified|9|||
143384507|NCT02671435|516952885|FG014|Overall Study|Un-specified|8|||
143384508|NCT01136876|516952886|FG000|Overall Study|Lost to Follow-up|0|||
143384509|NCT01136876|516952887|FG001|Overall Study|Lost to Follow-up|1|||
143384510|NCT01136876|516952886|FG000|Overall Study|Physician Decision|3|||
143384511|NCT01136876|516952887|FG001|Overall Study|Physician Decision|5|||
143384512|NCT01136876|516952886|FG000|Overall Study|Missing NGAL measurement|2|||
143384513|NCT01136876|516952887|FG001|Overall Study|Missing NGAL measurement|5|||
143384514|NCT00976937|516952888|FG000|Overall Study|Adverse Event|4|||
143384515|NCT00976937|516952889|FG001|Overall Study|Adverse Event|5|||
143384516|NCT00976937|516952888|FG000|Overall Study|Lost to Follow-up|2|||
143384517|NCT00976937|516952889|FG001|Overall Study|Lost to Follow-up|1|||
143384518|NCT00976937|516952888|FG000|Overall Study|Withdrawal by Subject|5|||
143384519|NCT00976937|516952889|FG001|Overall Study|Withdrawal by Subject|3|||
143384520|NCT00976937|516952888|FG000|Overall Study|Poor compliance to protocol|3|||
143384521|NCT00976937|516952889|FG001|Overall Study|Poor compliance to protocol|0|||
143384522|NCT00976937|516952888|FG000|Overall Study|Personal and Familial Reason|2|||
143384523|NCT00976937|516952889|FG001|Overall Study|Personal and Familial Reason|2|||
143384524|NCT03069313|516952890|FG000|Overall Study|Adverse Event|5|||
143384525|NCT02730871|516952892|FG000|Overall Study|Adverse Event|6|||
143384526|NCT02730871|516952893|FG001|Overall Study|Adverse Event|0|||
143384527|NCT05368558|516952896|FG000|Double Blind Period (DBP)|Withdrawal by Subject|1|||
143384528|NCT05368558|516952897|FG001|Double Blind Period (DBP)|Withdrawal by Subject|1|||
143384529|NCT05368558|516952898|FG002|Double Blind Period (DBP)|Withdrawal by Subject|2|||
143384530|NCT05368558|516952899|FG003|Double Blind Period (DBP)|Withdrawal by Subject|0|||
143384531|NCT05368558|516952900|FG004|Double Blind Period (DBP)|Withdrawal by Subject|0|||
143384532|NCT05368558|516952901|FG005|Double Blind Period (DBP)|Withdrawal by Subject|0|||
143384533|NCT05368558|516952902|FG006|Double Blind Period (DBP)|Withdrawal by Subject|0|||
143384534|NCT05368558|516952903|FG007|Double Blind Period (DBP)|Withdrawal by Subject|0|||
143384535|NCT05368558|516952904|FG008|Double Blind Period (DBP)|Withdrawal by Subject|0|||
143384536|NCT05368558|516952905|FG009|Double Blind Period (DBP)|Withdrawal by Subject|0|||
143384537|NCT05368558|516952906|FG010|Double Blind Period (DBP)|Withdrawal by Subject|0|||
143333367|NCT03318523|516764440|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
143333368|NCT03318523|516764441|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
143333369|NCT03318523|516764442|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
143333370|NCT03318523|516764443|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
143333371|NCT03318523|516764444|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
143333372|NCT03318523|516764445|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
143333373|NCT03581981|516764448|FG000|Overall Study|Withdrawal by Subject|12|||
143333374|NCT03581981|516764449|FG001|Overall Study|Withdrawal by Subject|13|||
143333375|NCT03581981|516764448|FG000|Overall Study|Physician Decision|1|||
143333376|NCT03581981|516764449|FG001|Overall Study|Physician Decision|2|||
143333377|NCT03581981|516764448|FG000|Overall Study|Lost to Follow-up|0|||
143333378|NCT03581981|516764449|FG001|Overall Study|Lost to Follow-up|4|||
143333379|NCT03232983|516764452|FG000|Period 1|Physician Decision|0|||
143333380|NCT03232983|516764453|FG001|Period 1|Physician Decision|0|||
143333381|NCT03232983|516764454|FG002|Period 1|Physician Decision|1|||
143333382|NCT03232983|516764455|FG003|Period 1|Physician Decision|0|||
143333383|NCT03232983|516764452|FG000|Washout Period 2|Physician Decision|0|||
143333384|NCT03232983|516764453|FG001|Washout Period 2|Physician Decision|0|||
143333385|NCT03232983|516764454|FG002|Washout Period 2|Physician Decision|1|||
143333386|NCT03232983|516764455|FG003|Washout Period 2|Physician Decision|0|||
143333387|NCT03232983|516764452|FG000|Washout Period 2|Withdrawal by Subject|0|||
143333388|NCT03232983|516764453|FG001|Washout Period 2|Withdrawal by Subject|0|||
143333389|NCT03232983|516764454|FG002|Washout Period 2|Withdrawal by Subject|0|||
143384538|NCT05368558|516952907|FG011|Double Blind Period (DBP)|Withdrawal by Subject|0|||
143384539|NCT05368558|516952896|FG000|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
143384540|NCT05368558|516952897|FG001|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
143384541|NCT05368558|516952898|FG002|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
143333390|NCT03232983|516764455|FG003|Washout Period 2|Withdrawal by Subject|1|||
143333391|NCT03232983|516764452|FG000|Period 4|Withdrawal by Subject|1|||
143333392|NCT03232983|516764453|FG001|Period 4|Withdrawal by Subject|0|||
143333393|NCT03232983|516764454|FG002|Period 4|Withdrawal by Subject|0|||
143384542|NCT05368558|516952899|FG003|Blinded Extension Period (BEP)|Withdrawal by Subject|1|||
143384543|NCT05368558|516952900|FG004|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
143384544|NCT05368558|516952901|FG005|Blinded Extension Period (BEP)|Withdrawal by Subject|2|||
143384545|NCT05368558|516952902|FG006|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
143384546|NCT05368558|516952903|FG007|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
143333394|NCT03232983|516764455|FG003|Period 4|Withdrawal by Subject|0|||
143333395|NCT01615328|516764456|FG000|Overall Study|Lost to Follow-up|3|||
143384547|NCT05368558|516952904|FG008|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
143384548|NCT05368558|516952905|FG009|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
143384549|NCT05368558|516952906|FG010|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
143384550|NCT05368558|516952907|FG011|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
143384551|NCT05368558|516952896|FG000|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
143384552|NCT05368558|516952897|FG001|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
143384553|NCT05368558|516952898|FG002|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
143384554|NCT05368558|516952899|FG003|Blinded Extension Period (BEP)|Study terminated by sponsor|1|||
143384555|NCT05368558|516952900|FG004|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
143384556|NCT05368558|516952901|FG005|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
143384557|NCT05368558|516952902|FG006|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
143384558|NCT05368558|516952903|FG007|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
143384559|NCT05368558|516952904|FG008|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
143384560|NCT05368558|516952905|FG009|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
143384561|NCT05368558|516952906|FG010|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
143384562|NCT05368558|516952907|FG011|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
143333396|NCT01615328|516764457|FG001|Overall Study|Lost to Follow-up|5|||
143333397|NCT00863655|516764458|FG000|Overall Study|Protocol Violation|4|||
143333398|NCT00863655|516764459|FG001|Overall Study|Protocol Violation|0|||
143333399|NCT00863655|516764458|FG000|Overall Study|Adverse Event|52|||
143333400|NCT00863655|516764459|FG001|Overall Study|Adverse Event|8|||
143333401|NCT00863655|516764458|FG000|Overall Study|Withdrawal by Subject|47|||
143333402|NCT00863655|516764459|FG001|Overall Study|Withdrawal by Subject|7|||
143333403|NCT00863655|516764458|FG000|Overall Study|Administrative problems|1|||
143333404|NCT00863655|516764459|FG001|Overall Study|Administrative problems|0|||
143333405|NCT00863655|516764458|FG000|Overall Study|Death|7|||
143333406|NCT00863655|516764459|FG001|Overall Study|Death|1|||
143333407|NCT00863655|516764458|FG000|Overall Study|New cancer therapy|5|||
143333408|NCT00863655|516764459|FG001|Overall Study|New cancer therapy|1|||
143333409|NCT00863655|516764458|FG000|Overall Study|Disease progression|364|||
143333410|NCT00863655|516764459|FG001|Overall Study|Disease progression|221|||
143333411|NCT00863655|516764458|FG000|Overall Study|Treatment completed as per protocol|5|||
143333412|NCT00863655|516764459|FG001|Overall Study|Treatment completed as per protocol|1|||
143333413|NCT02157779|516764462|FG000|Overall Study|Logistical|9|||
143333414|NCT02157779|516764463|FG001|Overall Study|Logistical|3|||
143333415|NCT02157779|516764462|FG000|Overall Study|Stopped attending, reason unknown|11|||
143333416|NCT02157779|516764463|FG001|Overall Study|Stopped attending, reason unknown|7|||
143333417|NCT02157779|516764462|FG000|Overall Study|No response to outreach after Baseline|1|||
143333418|NCT02157779|516764463|FG001|Overall Study|No response to outreach after Baseline|1|||
143333419|NCT02157779|516764462|FG000|Overall Study|Moved|1|||
143333420|NCT02157779|516764463|FG001|Overall Study|Moved|0|||
143333421|NCT02157779|516764462|FG000|Overall Study|Medical|1|||
143333422|NCT02157779|516764463|FG001|Overall Study|Medical|0|||
143333423|NCT02157779|516764462|FG000|Overall Study|Legal issue|1|||
143333424|NCT02157779|516764463|FG001|Overall Study|Legal issue|0|||
143333425|NCT02548455|516764464|FG000|Overall Study|Withdrawal by Subject|27|||
143333426|NCT02548455|516764464|FG000|Overall Study|Death|26|||
143333427|NCT02548455|516764464|FG000|Overall Study|Lost to Follow-up|14|||
143333428|NCT02548455|516764464|FG000|Overall Study|Visit not completed|173|||
143333429|NCT00002558|516764468|FG000|Overall Study|Withdrawal by Subject|0|||
143333430|NCT00002558|516764469|FG001|Overall Study|Withdrawal by Subject|1|||
143333431|NCT01260350|516764470|FG000|Overall Study|Lack of Efficacy|0|||
143333432|NCT01260350|516764471|FG001|Overall Study|Lack of Efficacy|0|||
143333433|NCT01260350|516764472|FG002|Overall Study|Lack of Efficacy|0|||
143333434|NCT01260350|516764473|FG003|Overall Study|Lack of Efficacy|0|||
143333435|NCT01260350|516764474|FG004|Overall Study|Lack of Efficacy|0|||
143333436|NCT01260350|516764475|FG005|Overall Study|Lack of Efficacy|0|||
143333437|NCT01260350|516764476|FG006|Overall Study|Lack of Efficacy|0|||
143384563|NCT05368558|516952896|FG000|Blinded Extension Period (BEP)|other|0|||
143384564|NCT05368558|516952897|FG001|Blinded Extension Period (BEP)|other|0|||
143384565|NCT05368558|516952898|FG002|Blinded Extension Period (BEP)|other|0|||
143384566|NCT05368558|516952899|FG003|Blinded Extension Period (BEP)|other|0|||
143384567|NCT05368558|516952900|FG004|Blinded Extension Period (BEP)|other|0|||
143384568|NCT05368558|516952901|FG005|Blinded Extension Period (BEP)|other|1|||
143384569|NCT05368558|516952902|FG006|Blinded Extension Period (BEP)|other|0|||
143384570|NCT05368558|516952903|FG007|Blinded Extension Period (BEP)|other|0|||
143333438|NCT01260350|516764477|FG007|Overall Study|Lack of Efficacy|0|||
143333439|NCT01260350|516764478|FG008|Overall Study|Lack of Efficacy|0|||
143333440|NCT01260350|516764479|FG009|Overall Study|Lack of Efficacy|0|||
143333441|NCT01260350|516764480|FG010|Overall Study|Lack of Efficacy|0|||
143333442|NCT01260350|516764481|FG011|Overall Study|Lack of Efficacy|0|||
143333443|NCT01260350|516764482|FG012|Overall Study|Lack of Efficacy|0|||
143333444|NCT01260350|516764483|FG013|Overall Study|Lack of Efficacy|0|||
143333445|NCT01260350|516764484|FG014|Overall Study|Lack of Efficacy|0|||
143333446|NCT01260350|516764485|FG015|Overall Study|Lack of Efficacy|0|||
143333447|NCT01260350|516764486|FG016|Overall Study|Lack of Efficacy|0|||
143333448|NCT01260350|516764487|FG017|Overall Study|Lack of Efficacy|1|||
143333449|NCT01260350|516764488|FG018|Overall Study|Lack of Efficacy|0|||
143333450|NCT01260350|516764489|FG019|Overall Study|Lack of Efficacy|0|||
143333451|NCT01260350|516764490|FG020|Overall Study|Lack of Efficacy|3|||
143333452|NCT01260350|516764491|FG021|Overall Study|Lack of Efficacy|0|||
143333453|NCT01260350|516764470|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
143333454|NCT01260350|516764471|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
143333455|NCT01260350|516764472|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
143333456|NCT01260350|516764473|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
143333457|NCT01260350|516764474|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
143333458|NCT01260350|516764475|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
143333459|NCT01260350|516764476|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
143333460|NCT01260350|516764477|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
143333461|NCT01260350|516764478|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
143333462|NCT01260350|516764479|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
143333463|NCT01260350|516764480|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
143333464|NCT01260350|516764481|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
143333465|NCT01260350|516764482|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
143333466|NCT01260350|516764483|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
143333467|NCT01260350|516764484|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
143333468|NCT01260350|516764485|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
143333469|NCT01260350|516764486|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
143333470|NCT01260350|516764487|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
143333471|NCT01260350|516764488|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
143333472|NCT01260350|516764489|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
143333473|NCT01260350|516764490|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
143333474|NCT01260350|516764491|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
143333475|NCT02261493|516764492|FG000|Overall Study|Noncompliance|0|||
143333476|NCT02261493|516764493|FG001|Overall Study|Noncompliance|0|||
143333477|NCT02261493|516764494|FG002|Overall Study|Noncompliance|2|||
143333478|NCT02261493|516764492|FG000|Overall Study|Physician Decision|0|||
143333479|NCT02261493|516764493|FG001|Overall Study|Physician Decision|1|||
143333480|NCT02261493|516764494|FG002|Overall Study|Physician Decision|0|||
143333481|NCT02261493|516764492|FG000|Overall Study|Undisclosed alcohol abuse|0|||
143333482|NCT02261493|516764493|FG001|Overall Study|Undisclosed alcohol abuse|1|||
143333483|NCT02261493|516764494|FG002|Overall Study|Undisclosed alcohol abuse|0|||
143333484|NCT02261493|516764492|FG000|Overall Study|Protocol Violation|1|||
143333485|NCT02261493|516764493|FG001|Overall Study|Protocol Violation|0|||
143333486|NCT02261493|516764494|FG002|Overall Study|Protocol Violation|0|||
143333487|NCT02261493|516764492|FG000|Overall Study|Personal Reasons|14|||
143333488|NCT02261493|516764493|FG001|Overall Study|Personal Reasons|14|||
143333489|NCT02261493|516764494|FG002|Overall Study|Personal Reasons|16|||
143333490|NCT02261493|516764492|FG000|Overall Study|Lost to Follow-up|14|||
143333491|NCT02261493|516764493|FG001|Overall Study|Lost to Follow-up|27|||
143333492|NCT02261493|516764494|FG002|Overall Study|Lost to Follow-up|8|||
143333493|NCT02261493|516764492|FG000|Overall Study|Pregnancy|1|||
143333494|NCT02261493|516764493|FG001|Overall Study|Pregnancy|2|||
143333495|NCT02261493|516764494|FG002|Overall Study|Pregnancy|0|||
143333496|NCT02261493|516764492|FG000|Overall Study|Lack of Efficacy|0|||
143333497|NCT02261493|516764493|FG001|Overall Study|Lack of Efficacy|1|||
143333498|NCT02261493|516764494|FG002|Overall Study|Lack of Efficacy|0|||
143333499|NCT02261493|516764492|FG000|Overall Study|Adverse Event|0|||
143333500|NCT02261493|516764493|FG001|Overall Study|Adverse Event|1|||
143333501|NCT02261493|516764494|FG002|Overall Study|Adverse Event|0|||
143333502|NCT00483184|516764495|FG000|Overall Study|Withdrawal by Subject|2|||
143333503|NCT00483184|516764496|FG001|Overall Study|Withdrawal by Subject|2|||
143333504|NCT00483184|516764497|FG002|Overall Study|Withdrawal by Subject|0|||
143333505|NCT00483184|516764495|FG000|Overall Study|Lost to Follow-up|1|||
143333506|NCT00483184|516764496|FG001|Overall Study|Lost to Follow-up|0|||
143333507|NCT00483184|516764497|FG002|Overall Study|Lost to Follow-up|0|||
143333508|NCT00483184|516764495|FG000|Overall Study|Adverse Event|1|||
143333509|NCT00483184|516764496|FG001|Overall Study|Adverse Event|2|||
143333510|NCT00483184|516764497|FG002|Overall Study|Adverse Event|2|||
143333511|NCT00483184|516764495|FG000|Overall Study|Protocol Violation|1|||
143333512|NCT00483184|516764496|FG001|Overall Study|Protocol Violation|0|||
143333513|NCT00483184|516764497|FG002|Overall Study|Protocol Violation|1|||
143333514|NCT02065336|516764501|FG000|Extension Phase|Study Terminated by Sponsor|0|||
143333515|NCT02065336|516764502|FG001|Extension Phase|Study Terminated by Sponsor|0|||
143333516|NCT02065336|516764503|FG002|Extension Phase|Study Terminated by Sponsor|0|||
143333517|NCT02065336|516764504|FG003|Extension Phase|Study Terminated by Sponsor|0|||
143333518|NCT02065336|516764505|FG004|Extension Phase|Study Terminated by Sponsor|0|||
143333519|NCT02065336|516764506|FG005|Extension Phase|Study Terminated by Sponsor|0|||
143384571|NCT05368558|516952904|FG008|Blinded Extension Period (BEP)|other|0|||
143384572|NCT05368558|516952905|FG009|Blinded Extension Period (BEP)|other|0|||
143384573|NCT05368558|516952906|FG010|Blinded Extension Period (BEP)|other|0|||
143384574|NCT05368558|516952907|FG011|Blinded Extension Period (BEP)|other|0|||
143384575|NCT04623775|516952908|FG000|Randomization|No Longer Meets Study Criteria|2|||
143384576|NCT04623775|516952909|FG001|Randomization|No Longer Meets Study Criteria|1|||
143333520|NCT02065336|516764507|FG006|Extension Phase|Study Terminated by Sponsor|0|||
143333521|NCT02065336|516764508|FG007|Extension Phase|Study Terminated by Sponsor|0|||
143333522|NCT02065336|516764509|FG008|Extension Phase|Study Terminated by Sponsor|2|||
143333523|NCT02065336|516764510|FG009|Extension Phase|Study Terminated by Sponsor|8|||
143333524|NCT00530855|516764511|FG000|Overall Study|Lack of Efficacy|20|||
143333525|NCT00530855|516764511|FG000|Overall Study|Withdrawal by Subject|30|||
143333526|NCT00530855|516764511|FG000|Overall Study|Fatal Serious AE|3|||
143333527|NCT00530855|516764511|FG000|Overall Study|Non Fatal Serious AE|7|||
143333528|NCT00530855|516764511|FG000|Overall Study|Non Fatal Non Serious AE|12|||
143333529|NCT00530855|516764511|FG000|Overall Study|Protocol Violation|3|||
143333530|NCT00530855|516764511|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
143333531|NCT00530855|516764511|FG000|Overall Study|Lost to Follow-up|9|||
143333532|NCT00530855|516764511|FG000|Overall Study|Other reason for premature termination|17|||
143333533|NCT01292876|516764512|FG000|Overall Study|Physician Decision|4|||
143333534|NCT01137474|516764516|FG000|Overall Study|Adverse Event|3|||
143333535|NCT01137474|516764517|FG001|Overall Study|Adverse Event|5|||
143333536|NCT01137474|516764518|FG002|Overall Study|Adverse Event|1|||
143333537|NCT01137474|516764519|FG003|Overall Study|Adverse Event|3|||
143333538|NCT01137474|516764516|FG000|Overall Study|Withdrawal by Subject|7|||
143333539|NCT01137474|516764517|FG001|Overall Study|Withdrawal by Subject|2|||
143333540|NCT01137474|516764518|FG002|Overall Study|Withdrawal by Subject|6|||
143333541|NCT01137474|516764519|FG003|Overall Study|Withdrawal by Subject|9|||
143333542|NCT01137474|516764516|FG000|Overall Study|No longer met study criteria|6|||
143333543|NCT01137474|516764517|FG001|Overall Study|No longer met study criteria|1|||
143333544|NCT01137474|516764518|FG002|Overall Study|No longer met study criteria|0|||
143333545|NCT01137474|516764519|FG003|Overall Study|No longer met study criteria|5|||
143333546|NCT01137474|516764516|FG000|Overall Study|Lost to Follow-up|5|||
143333547|NCT01137474|516764517|FG001|Overall Study|Lost to Follow-up|1|||
143333548|NCT01137474|516764518|FG002|Overall Study|Lost to Follow-up|0|||
143333549|NCT01137474|516764519|FG003|Overall Study|Lost to Follow-up|2|||
143333550|NCT01137474|516764516|FG000|Overall Study|Lack of Efficacy|0|||
143333551|NCT01137474|516764517|FG001|Overall Study|Lack of Efficacy|0|||
143333552|NCT01137474|516764518|FG002|Overall Study|Lack of Efficacy|0|||
143333553|NCT01137474|516764519|FG003|Overall Study|Lack of Efficacy|2|||
143333554|NCT01137474|516764516|FG000|Overall Study|Other|3|||
143333555|NCT01137474|516764517|FG001|Overall Study|Other|1|||
143333556|NCT01137474|516764518|FG002|Overall Study|Other|0|||
143333557|NCT01137474|516764519|FG003|Overall Study|Other|0|||
143333558|NCT01137474|516764516|FG000|Overall Study|Pregnancy|0|||
143333559|NCT01137474|516764517|FG001|Overall Study|Pregnancy|1|||
143333560|NCT01137474|516764518|FG002|Overall Study|Pregnancy|0|||
143333561|NCT01137474|516764519|FG003|Overall Study|Pregnancy|0|||
143333562|NCT01137474|516764516|FG000|Overall Study|Administrative reason by sponsor|0|||
143333563|NCT01137474|516764517|FG001|Overall Study|Administrative reason by sponsor|1|||
143333564|NCT01137474|516764518|FG002|Overall Study|Administrative reason by sponsor|0|||
143333565|NCT01137474|516764519|FG003|Overall Study|Administrative reason by sponsor|0|||
143333566|NCT02525874|516764520|FG000|Overall Study|Other|1|||
143333567|NCT02525874|516764520|FG000|Overall Study|Investigator Decision|1|||
143333568|NCT02525874|516764520|FG000|Overall Study|Consent withdrawn|22|||
143333569|NCT02525874|516764520|FG000|Overall Study|Non-compliance with study drug|3|||
143333570|NCT02525874|516764520|FG000|Overall Study|Adverse Event|17|||
143333571|NCT02525874|516764520|FG000|Overall Study|Lost to Follow-up|7|||
143333572|NCT02525874|516764520|FG000|Overall Study|Disease progression, defined by protocol|2|||
143333573|NCT02525874|516764520|FG000|Overall Study|Disease relapse|4|||
143333574|NCT02525874|516764520|FG000|Overall Study|Alternative Treatment for MS|2|||
143333575|NCT02525874|516764520|FG000|Overall Study|New lesions in Brain|1|||
143333576|NCT01692782|516764521|FG000|Overall Study|Adverse Event|12|||
143333577|NCT01692782|516764522|FG001|Overall Study|Adverse Event|32|||
143384577|NCT04623775|516952910|FG002|Randomization|No Longer Meets Study Criteria|0|||
143333578|NCT01692782|516764523|FG002|Overall Study|Adverse Event|2|||
143333579|NCT01692782|516764521|FG000|Overall Study|Lack of Efficacy|1|||
143333580|NCT01692782|516764522|FG001|Overall Study|Lack of Efficacy|2|||
143333581|NCT01692782|516764523|FG002|Overall Study|Lack of Efficacy|0|||
143333582|NCT01692782|516764521|FG000|Overall Study|Lost to Follow-up|2|||
143333583|NCT01692782|516764522|FG001|Overall Study|Lost to Follow-up|7|||
143333584|NCT01692782|516764523|FG002|Overall Study|Lost to Follow-up|1|||
143333585|NCT01692782|516764521|FG000|Overall Study|Pregnancy|1|||
143333586|NCT01692782|516764522|FG001|Overall Study|Pregnancy|0|||
143333587|NCT01692782|516764523|FG002|Overall Study|Pregnancy|0|||
143333588|NCT01692782|516764521|FG000|Overall Study|Protocol Violation|1|||
143333589|NCT01692782|516764522|FG001|Overall Study|Protocol Violation|0|||
143333590|NCT01692782|516764523|FG002|Overall Study|Protocol Violation|2|||
143333591|NCT01692782|516764521|FG000|Overall Study|Non-complance with study drug|0|||
143333592|NCT01692782|516764522|FG001|Overall Study|Non-complance with study drug|4|||
143333593|NCT01692782|516764523|FG002|Overall Study|Non-complance with study drug|1|||
143333594|NCT01692782|516764521|FG000|Overall Study|Non-compliant with study visits|0|||
143333595|NCT01692782|516764522|FG001|Overall Study|Non-compliant with study visits|0|||
143333596|NCT01692782|516764523|FG002|Overall Study|Non-compliant with study visits|1|||
143333597|NCT01692782|516764521|FG000|Overall Study|SAE not related to study drug|0|||
143333598|NCT01692782|516764522|FG001|Overall Study|SAE not related to study drug|1|||
143333599|NCT01692782|516764523|FG002|Overall Study|SAE not related to study drug|0|||
143333600|NCT01692782|516764521|FG000|Overall Study|Withdrawal by Subject|3|||
143333601|NCT01692782|516764522|FG001|Overall Study|Withdrawal by Subject|10|||
143333602|NCT01692782|516764523|FG002|Overall Study|Withdrawal by Subject|3|||
143333603|NCT04867369|516764524|FG000|Overall Study|Withdrawal by Subject|1|||
143333604|NCT04867369|516764525|FG001|Overall Study|Withdrawal by Subject|0|||
143333605|NCT05554237|516764526|FG000|Part 2 (7 Days)|Adverse Event|0|||
143333606|NCT05554237|516764527|FG001|Part 2 (7 Days)|Adverse Event|0|||
143333607|NCT05554237|516764528|FG002|Part 2 (7 Days)|Adverse Event|0|||
143333608|NCT05554237|516764529|FG003|Part 2 (7 Days)|Adverse Event|0|||
143333609|NCT05554237|516764530|FG004|Part 2 (7 Days)|Adverse Event|2|||
143333610|NCT05554237|516764531|FG005|Part 2 (7 Days)|Adverse Event|0|||
143333611|NCT05554237|516764532|FG006|Part 2 (7 Days)|Adverse Event|0|||
143333612|NCT05554237|516764533|FG007|Part 2 (7 Days)|Adverse Event|0|||
143333613|NCT05554237|516764534|FG008|Part 2 (7 Days)|Adverse Event|0|||
143333614|NCT05554237|516764535|FG009|Part 2 (7 Days)|Adverse Event|1|||
143333615|NCT05554237|516764536|FG010|Part 2 (7 Days)|Adverse Event|0|||
143333616|NCT05554237|516764537|FG011|Part 2 (7 Days)|Adverse Event|0|||
143333617|NCT05554237|516764538|FG012|Part 2 (7 Days)|Adverse Event|1|||
143333618|NCT05554237|516764539|FG013|Part 2 (7 Days)|Adverse Event|0|||
143333619|NCT02677116|516764540|FG000|Overall Study|Adverse Event|0|||
143333620|NCT02677116|516764541|FG001|Overall Study|Adverse Event|1|||
143333621|NCT02677116|516764542|FG002|Overall Study|Adverse Event|0|||
143333622|NCT02677116|516764543|FG003|Overall Study|Adverse Event|0|||
143333623|NCT02677116|516764544|FG004|Overall Study|Adverse Event|0|||
143333624|NCT02677116|516764545|FG005|Overall Study|Adverse Event|1|||
143333625|NCT02677116|516764546|FG006|Overall Study|Adverse Event|1|||
143333626|NCT02677116|516764547|FG007|Overall Study|Adverse Event|0|||
143333627|NCT02677116|516764548|FG008|Overall Study|Adverse Event|0|||
143333628|NCT02677116|516764540|FG000|Overall Study|Physician Decision|0|||
143333629|NCT02677116|516764541|FG001|Overall Study|Physician Decision|2|||
143333630|NCT02677116|516764542|FG002|Overall Study|Physician Decision|3|||
143333631|NCT02677116|516764543|FG003|Overall Study|Physician Decision|2|||
143333632|NCT02677116|516764544|FG004|Overall Study|Physician Decision|1|||
143333633|NCT02677116|516764545|FG005|Overall Study|Physician Decision|3|||
143333634|NCT02677116|516764546|FG006|Overall Study|Physician Decision|1|||
143333635|NCT02677116|516764547|FG007|Overall Study|Physician Decision|1|||
143333636|NCT02677116|516764548|FG008|Overall Study|Physician Decision|2|||
143333637|NCT02677116|516764540|FG000|Overall Study|Withdrawal by parent or guardian|2|||
143333638|NCT02677116|516764541|FG001|Overall Study|Withdrawal by parent or guardian|1|||
143333639|NCT02677116|516764542|FG002|Overall Study|Withdrawal by parent or guardian|0|||
143333640|NCT02677116|516764543|FG003|Overall Study|Withdrawal by parent or guardian|1|||
143333641|NCT02677116|516764544|FG004|Overall Study|Withdrawal by parent or guardian|0|||
143333642|NCT02677116|516764545|FG005|Overall Study|Withdrawal by parent or guardian|0|||
143333643|NCT02677116|516764546|FG006|Overall Study|Withdrawal by parent or guardian|2|||
143333644|NCT02677116|516764547|FG007|Overall Study|Withdrawal by parent or guardian|1|||
143333645|NCT02677116|516764548|FG008|Overall Study|Withdrawal by parent or guardian|0|||
143333646|NCT02677116|516764540|FG000|Overall Study|Withdrawal by Subject|1|||
143333647|NCT02677116|516764541|FG001|Overall Study|Withdrawal by Subject|0|||
143333648|NCT02677116|516764542|FG002|Overall Study|Withdrawal by Subject|0|||
143333649|NCT02677116|516764543|FG003|Overall Study|Withdrawal by Subject|0|||
143333650|NCT02677116|516764544|FG004|Overall Study|Withdrawal by Subject|0|||
143333651|NCT02677116|516764545|FG005|Overall Study|Withdrawal by Subject|0|||
143333652|NCT02677116|516764546|FG006|Overall Study|Withdrawal by Subject|0|||
143333653|NCT02677116|516764547|FG007|Overall Study|Withdrawal by Subject|0|||
143333654|NCT02677116|516764548|FG008|Overall Study|Withdrawal by Subject|0|||
143333655|NCT01569438|516764549|FG000|Overall Study|Lack of Efficacy|1|||
143333656|NCT01569438|516764550|FG001|Overall Study|Lack of Efficacy|2|||
143333657|NCT01569438|516764549|FG000|Overall Study|Withdrawal by Subject|0|||
143333658|NCT01569438|516764550|FG001|Overall Study|Withdrawal by Subject|3|||
143333659|NCT01569438|516764549|FG000|Overall Study|Adverse Event|2|||
143333660|NCT01569438|516764550|FG001|Overall Study|Adverse Event|15|||
143333661|NCT01569438|516764549|FG000|Overall Study|Protocol Violation|2|||
143333662|NCT01569438|516764550|FG001|Overall Study|Protocol Violation|0|||
143333663|NCT01569438|516764549|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
143333664|NCT01569438|516764550|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
143384578|NCT04623775|516952911|FG003|Randomization|No Longer Meets Study Criteria|0|||
143333665|NCT01569438|516764549|FG000|Overall Study|Sponsor/Physician decision|1|||
143333666|NCT01569438|516764550|FG001|Overall Study|Sponsor/Physician decision|1|||
143333667|NCT01569438|516764549|FG000|Overall Study|Unable to adhere to study schedule|0|||
143333668|NCT01569438|516764550|FG001|Overall Study|Unable to adhere to study schedule|1|||
143333669|NCT01207102|516764551|FG000|Overall Study|Withdrawal by Subject|5|||
143333670|NCT01207102|516764551|FG000|Overall Study|Adverse Event|2|||
143333671|NCT01207102|516764551|FG000|Overall Study|progression|2|||
143384579|NCT04623775|516952908|FG000|Randomization|Withdrew Consent|0|||
143384580|NCT04623775|516952909|FG001|Randomization|Withdrew Consent|0|||
143384581|NCT04623775|516952910|FG002|Randomization|Withdrew Consent|0|||
143384582|NCT04623775|516952911|FG003|Randomization|Withdrew Consent|1|||
143333672|NCT01207102|516764551|FG000|Overall Study|Withdrawal by Treating Physician|1|||
143333673|NCT01693068|516764552|FG000|Randomization Period|On-study|2|||
143333674|NCT01693068|516764553|FG001|Randomization Period|On-study|5|||
143333675|NCT01693068|516764554|FG002|Randomization Period|On-study|0|||
143333676|NCT01693068|516764552|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
143333677|NCT01693068|516764553|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
143333678|NCT01693068|516764554|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
143333679|NCT00295022|516764555|FG000|Overall Study|Adverse Event|1|||
143333680|NCT00295022|516764556|FG001|Overall Study|Adverse Event|1|||
143333681|NCT00295022|516764557|FG002|Overall Study|Adverse Event|2|||
143333682|NCT00295022|516764555|FG000|Overall Study|Lost to Follow-up|0|||
143333683|NCT00295022|516764556|FG001|Overall Study|Lost to Follow-up|0|||
143333684|NCT00295022|516764557|FG002|Overall Study|Lost to Follow-up|1|||
143333685|NCT00295022|516764555|FG000|Overall Study|Withdrawal by Subject|0|||
143333686|NCT00295022|516764556|FG001|Overall Study|Withdrawal by Subject|0|||
143333687|NCT00295022|516764557|FG002|Overall Study|Withdrawal by Subject|2|||
143333688|NCT01239030|516764558|FG000|Double Blind|Adverse Event|0|||
143333689|NCT01239030|516764559|FG001|Double Blind|Adverse Event|1|||
143333690|NCT01239030|516764560|FG002|Double Blind|Adverse Event|0|||
143333691|NCT01239030|516764561|FG003|Double Blind|Adverse Event|2|||
143333692|NCT01239030|516764562|FG004|Double Blind|Adverse Event|0|||
143333693|NCT01239030|516764558|FG000|Double Blind|Withdrawal by Subject|0|||
143333694|NCT01239030|516764559|FG001|Double Blind|Withdrawal by Subject|1|||
143333695|NCT01239030|516764560|FG002|Double Blind|Withdrawal by Subject|1|||
143333696|NCT01239030|516764561|FG003|Double Blind|Withdrawal by Subject|0|||
143333697|NCT01239030|516764562|FG004|Double Blind|Withdrawal by Subject|1|||
143333698|NCT01239030|516764558|FG000|Double Blind|Lost to Follow-up|1|||
143333699|NCT01239030|516764559|FG001|Double Blind|Lost to Follow-up|1|||
143333700|NCT01239030|516764560|FG002|Double Blind|Lost to Follow-up|0|||
143333701|NCT01239030|516764561|FG003|Double Blind|Lost to Follow-up|0|||
143333702|NCT01239030|516764562|FG004|Double Blind|Lost to Follow-up|0|||
143333703|NCT01239030|516764558|FG000|Double Blind|Physician Decision|0|||
143333704|NCT01239030|516764559|FG001|Double Blind|Physician Decision|1|||
143333705|NCT01239030|516764560|FG002|Double Blind|Physician Decision|0|||
143333706|NCT01239030|516764561|FG003|Double Blind|Physician Decision|0|||
143333707|NCT01239030|516764562|FG004|Double Blind|Physician Decision|0|||
143333708|NCT01239030|516764558|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
143333709|NCT01239030|516764559|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
143333710|NCT01239030|516764560|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
143333711|NCT01239030|516764561|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
143333712|NCT01239030|516764562|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
143333713|NCT01239030|516764558|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
143384583|NCT04623775|516952908|FG000|Randomization|Other Reasons|0|||
143384584|NCT04623775|516952909|FG001|Randomization|Other Reasons|0|||
143384585|NCT04623775|516952910|FG002|Randomization|Other Reasons|0|||
143384586|NCT04623775|516952911|FG003|Randomization|Other Reasons|1|||
143384587|NCT04623775|516952908|FG000|Treatment Period|participant withdrew consent|4|||
143384588|NCT04623775|516952909|FG001|Treatment Period|participant withdrew consent|0|||
143333714|NCT01239030|516764559|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
143333715|NCT01239030|516764560|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
143333716|NCT01239030|516764561|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
143333717|NCT01239030|516764562|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
143333718|NCT01239030|516764558|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
143384589|NCT04623775|516952910|FG002|Treatment Period|participant withdrew consent|1|||
143384590|NCT04623775|516952911|FG003|Treatment Period|participant withdrew consent|2|||
143384591|NCT04623775|516952908|FG000|Treatment Period|Death|3|||
143333719|NCT01239030|516764559|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
143333720|NCT01239030|516764560|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
143333721|NCT01239030|516764561|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
143333722|NCT01239030|516764562|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
143333723|NCT01239030|516764558|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
143333724|NCT01239030|516764559|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
143384592|NCT04623775|516952909|FG001|Treatment Period|Death|1|||
143384593|NCT04623775|516952910|FG002|Treatment Period|Death|4|||
143333725|NCT01239030|516764560|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
143333726|NCT01239030|516764561|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
143333727|NCT01239030|516764562|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
143333728|NCT03240692|516764573|FG000|Overall Study|Physician Decision|1|||
143333729|NCT03240692|516764573|FG000|Overall Study|Withdrawal by Subject|1|||
143333730|NCT02300220|516764574|FG000|Overall Study|Lost to Follow-up|1|||
143333731|NCT02300220|516764575|FG001|Overall Study|Lost to Follow-up|2|||
143333732|NCT02300220|516764574|FG000|Overall Study|Death|1|||
143333733|NCT02300220|516764575|FG001|Overall Study|Death|1|||
143333734|NCT02300220|516764574|FG000|Overall Study|Adverse Event|1|||
143333735|NCT02300220|516764575|FG001|Overall Study|Adverse Event|1|||
143333736|NCT02300220|516764574|FG000|Overall Study|Protocol Violation|1|||
143333737|NCT02300220|516764575|FG001|Overall Study|Protocol Violation|0|||
143333738|NCT02300220|516764574|FG000|Overall Study|Withdrawal by Subject|0|||
143333739|NCT02300220|516764575|FG001|Overall Study|Withdrawal by Subject|2|||
143333740|NCT02300220|516764574|FG000|Overall Study|Did not tolerate IMP|0|||
143333741|NCT02300220|516764575|FG001|Overall Study|Did not tolerate IMP|1|||
143333742|NCT04322682|516764576|FG000|Overall Study|Withdrawal by Subject|33|||
143333743|NCT04322682|516764577|FG001|Overall Study|Withdrawal by Subject|47|||
143333744|NCT04322682|516764576|FG000|Overall Study|Death|5|||
143333745|NCT04322682|516764577|FG001|Overall Study|Death|9|||
143333746|NCT04322682|516764576|FG000|Overall Study|Lost to Follow-up|4|||
143333747|NCT04322682|516764577|FG001|Overall Study|Lost to Follow-up|8|||
143384594|NCT04623775|516952911|FG003|Treatment Period|Death|2|||
143384595|NCT04623775|516952908|FG000|Treatment Period|Lost to Follow-up|0|||
143384596|NCT04623775|516952909|FG001|Treatment Period|Lost to Follow-up|2|||
143384597|NCT04623775|516952910|FG002|Treatment Period|Lost to Follow-up|0|||
143333748|NCT04322682|516764576|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
143333749|NCT04322682|516764577|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
143384598|NCT04623775|516952911|FG003|Treatment Period|Lost to Follow-up|0|||
143384599|NCT04623775|516952908|FG000|Treatment Period|poor/non compliance|0|||
143384600|NCT04623775|516952909|FG001|Treatment Period|poor/non compliance|0|||
143384601|NCT04623775|516952910|FG002|Treatment Period|poor/non compliance|1|||
143384602|NCT04623775|516952911|FG003|Treatment Period|poor/non compliance|0|||
143384603|NCT04623775|516952908|FG000|Treatment Period|participant no longer meets study criteria|0|||
143384604|NCT04623775|516952909|FG001|Treatment Period|participant no longer meets study criteria|1|||
143384605|NCT04623775|516952910|FG002|Treatment Period|participant no longer meets study criteria|0|||
143384606|NCT04623775|516952911|FG003|Treatment Period|participant no longer meets study criteria|0|||
143384607|NCT04623775|516952908|FG000|Treatment Period|administrative reasons by sponsor|3|||
143384608|NCT04623775|516952909|FG001|Treatment Period|administrative reasons by sponsor|2|||
143384609|NCT04623775|516952910|FG002|Treatment Period|administrative reasons by sponsor|0|||
143384610|NCT04623775|516952911|FG003|Treatment Period|administrative reasons by sponsor|0|||
143384611|NCT04623775|516952908|FG000|Treatment Period|other reasons|2|||
143384612|NCT04623775|516952909|FG001|Treatment Period|other reasons|0|||
143384613|NCT04623775|516952910|FG002|Treatment Period|other reasons|1|||
143384614|NCT04623775|516952911|FG003|Treatment Period|other reasons|1|||
143384615|NCT04623775|516952908|FG000|Treatment Period|disease progression|40|||
143384616|NCT04623775|516952909|FG001|Treatment Period|disease progression|35|||
143384617|NCT04623775|516952910|FG002|Treatment Period|disease progression|63|||
143384618|NCT04623775|516952911|FG003|Treatment Period|disease progression|63|||
143333750|NCT04123067|516764578|FG000|Overall Study|Lost to Follow-up|0|||
143333751|NCT04123067|516764579|FG001|Overall Study|Lost to Follow-up|1|||
143333752|NCT02238379|516764580|FG000|Overall Study|Lost to Follow-up|1|||
143333753|NCT02238379|516764581|FG001|Overall Study|Lost to Follow-up|0|||
143333754|NCT01441102|516764582|FG000|Overall Study|Adverse Event|1|||
143333755|NCT01441102|516764582|FG000|Overall Study|Withdrawal by Subject|2|||
143333756|NCT00605280|516764583|FG000|Year 1|Protocol Violation|0|||
143333757|NCT00605280|516764584|FG001|Year 1|Protocol Violation|0|||
143333758|NCT00605280|516764585|FG002|Year 1|Protocol Violation|0|||
143333759|NCT00605280|516764586|FG003|Year 1|Protocol Violation|1|||
143333760|NCT00605280|516764583|FG000|Year 1|Adverse Event|3|||
143333761|NCT00605280|516764584|FG001|Year 1|Adverse Event|1|||
143333762|NCT00605280|516764585|FG002|Year 1|Adverse Event|1|||
143333763|NCT00605280|516764586|FG003|Year 1|Adverse Event|5|||
143333764|NCT00605280|516764583|FG000|Year 1|Physician Decision|7|||
143333765|NCT00605280|516764584|FG001|Year 1|Physician Decision|4|||
143333766|NCT00605280|516764585|FG002|Year 1|Physician Decision|0|||
143333767|NCT00605280|516764586|FG003|Year 1|Physician Decision|6|||
143333768|NCT00605280|516764583|FG000|Year 1|Withdrawal by Subject|2|||
143333769|NCT00605280|516764584|FG001|Year 1|Withdrawal by Subject|4|||
143333770|NCT00605280|516764585|FG002|Year 1|Withdrawal by Subject|0|||
143333771|NCT00605280|516764586|FG003|Year 1|Withdrawal by Subject|4|||
143333772|NCT00605280|516764583|FG000|Year 1|Other|2|||
143333773|NCT00605280|516764584|FG001|Year 1|Other|1|||
143333774|NCT00605280|516764585|FG002|Year 1|Other|0|||
143333775|NCT00605280|516764586|FG003|Year 1|Other|1|||
143333776|NCT00605280|516764583|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
143333777|NCT00605280|516764584|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
143333778|NCT00605280|516764585|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
143333779|NCT00605280|516764586|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
143333780|NCT00605280|516764583|FG000|Year 2|Adverse Event|4|||
143333781|NCT00605280|516764584|FG001|Year 2|Adverse Event|0|||
143333782|NCT00605280|516764585|FG002|Year 2|Adverse Event|2|||
143333783|NCT00605280|516764586|FG003|Year 2|Adverse Event|4|||
143333784|NCT00605280|516764583|FG000|Year 2|Physician Decision|11|||
143333785|NCT00605280|516764584|FG001|Year 2|Physician Decision|6|||
143333786|NCT00605280|516764585|FG002|Year 2|Physician Decision|4|||
143333787|NCT00605280|516764586|FG003|Year 2|Physician Decision|11|||
143333788|NCT00605280|516764583|FG000|Year 2|Withdrawal by Subject|4|||
143384619|NCT04623775|516952908|FG000|Treatment Period|study drug toxicity|12|||
143384620|NCT04623775|516952909|FG001|Treatment Period|study drug toxicity|15|||
143384621|NCT04623775|516952910|FG002|Treatment Period|study drug toxicity|13|||
143384622|NCT04623775|516952911|FG003|Treatment Period|study drug toxicity|12|||
143384623|NCT04623775|516952908|FG000|Treatment Period|AE unrelated to study drug|4|||
143333789|NCT00605280|516764584|FG001|Year 2|Withdrawal by Subject|0|||
143333790|NCT00605280|516764585|FG002|Year 2|Withdrawal by Subject|0|||
143333791|NCT00605280|516764586|FG003|Year 2|Withdrawal by Subject|4|||
143333792|NCT00605280|516764583|FG000|Year 2|Other|1|||
143333793|NCT00605280|516764584|FG001|Year 2|Other|0|||
143333794|NCT00605280|516764585|FG002|Year 2|Other|0|||
143333795|NCT00605280|516764586|FG003|Year 2|Other|1|||
143333796|NCT00605280|516764583|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
143333797|NCT00605280|516764584|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
143333798|NCT00605280|516764585|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
143333799|NCT00605280|516764586|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
143333800|NCT00605280|516764583|FG000|Year 3 Extension|Adverse Event|2|||
143333801|NCT00605280|516764584|FG001|Year 3 Extension|Adverse Event|0|||
143333802|NCT00605280|516764585|FG002|Year 3 Extension|Adverse Event|0|||
143333803|NCT00605280|516764586|FG003|Year 3 Extension|Adverse Event|2|||
143333804|NCT00605280|516764583|FG000|Year 3 Extension|Physician Decision|0|||
143333805|NCT00605280|516764584|FG001|Year 3 Extension|Physician Decision|0|||
143333806|NCT00605280|516764585|FG002|Year 3 Extension|Physician Decision|0|||
143333807|NCT00605280|516764586|FG003|Year 3 Extension|Physician Decision|2|||
143333808|NCT00605280|516764583|FG000|Year 3 Extension|Withdrawal by Subject|2|||
143333809|NCT00605280|516764584|FG001|Year 3 Extension|Withdrawal by Subject|0|||
143333810|NCT00605280|516764585|FG002|Year 3 Extension|Withdrawal by Subject|0|||
143333811|NCT00605280|516764586|FG003|Year 3 Extension|Withdrawal by Subject|5|||
143333812|NCT00605280|516764583|FG000|Year 3 Extension|Other|2|||
143333813|NCT00605280|516764584|FG001|Year 3 Extension|Other|0|||
143333814|NCT00605280|516764585|FG002|Year 3 Extension|Other|0|||
143333815|NCT00605280|516764586|FG003|Year 3 Extension|Other|0|||
143333816|NCT00605280|516764583|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
143333817|NCT00605280|516764584|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
143333818|NCT00605280|516764585|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
143333819|NCT00605280|516764586|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
143333820|NCT03969719|516764589|FG000|Overall Study|Other reasons not specified|1|||
143333821|NCT03969719|516764590|FG001|Overall Study|Other reasons not specified|1|||
143333822|NCT03969719|516764591|FG002|Overall Study|Other reasons not specified|3|||
143333823|NCT03969719|516764589|FG000|Overall Study|Withdrawal by Subject|2|||
143333824|NCT03969719|516764590|FG001|Overall Study|Withdrawal by Subject|3|||
143333825|NCT03969719|516764591|FG002|Overall Study|Withdrawal by Subject|2|||
143333826|NCT03969719|516764589|FG000|Overall Study|Protocol Violation|1|||
143333827|NCT03969719|516764590|FG001|Overall Study|Protocol Violation|2|||
143333828|NCT03969719|516764591|FG002|Overall Study|Protocol Violation|0|||
143333829|NCT03969719|516764589|FG000|Overall Study|Adverse Event|0|||
143333830|NCT03969719|516764590|FG001|Overall Study|Adverse Event|2|||
143333831|NCT03969719|516764591|FG002|Overall Study|Adverse Event|0|||
143333832|NCT03969719|516764589|FG000|Overall Study|Lost to Follow-up|0|||
143333833|NCT03969719|516764590|FG001|Overall Study|Lost to Follow-up|1|||
143333834|NCT03969719|516764591|FG002|Overall Study|Lost to Follow-up|0|||
143333835|NCT00951275|516764595|FG000|Overall Study|Administrative Reason|1|||
143333836|NCT00951275|516764595|FG000|Overall Study|Adverse Event|7|||
143333837|NCT00951275|516764595|FG000|Overall Study|Withdrawal by Subject|4|||
143333838|NCT00951275|516764595|FG000|Overall Study|Protocol Violation|1|||
143333839|NCT00655980|516764596|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
143333840|NCT00655980|516764597|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
143333841|NCT00655980|516764598|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
143333842|NCT02858895|516764600|FG000|Overall Study|Disease progression|31|||
143333843|NCT02858895|516764600|FG000|Overall Study|Death|2|||
143333844|NCT02858895|516764600|FG000|Overall Study|Adverse Event|1|||
143333845|NCT02858895|516764600|FG000|Overall Study|Withdrawal by Subject|3|||
143333846|NCT02858895|516764600|FG000|Overall Study|hospice,|1|||
143333847|NCT02858895|516764600|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
143333848|NCT01266642|516764603|FG000|Overall Study|Protocol Violation|0|||
143333849|NCT01266642|516764604|FG001|Overall Study|Protocol Violation|1|||
143333850|NCT01266850|516766304|FG000|Overall Study|Lost to Follow-up|19|||
143333851|NCT01266850|516766305|FG001|Overall Study|Lost to Follow-up|19|||
143333852|NCT01266850|516766306|FG002|Overall Study|Lost to Follow-up|13|||
143333853|NCT01266850|516766307|FG003|Overall Study|Lost to Follow-up|13|||
143333854|NCT01266850|516766308|FG004|Overall Study|Lost to Follow-up|12|||
143333855|NCT01266850|516766304|FG000|Overall Study|Withdrawal by Subject|8|||
143333856|NCT01266850|516766305|FG001|Overall Study|Withdrawal by Subject|9|||
143333857|NCT01266850|516766306|FG002|Overall Study|Withdrawal by Subject|6|||
143333858|NCT01266850|516766307|FG003|Overall Study|Withdrawal by Subject|9|||
143333859|NCT01266850|516766308|FG004|Overall Study|Withdrawal by Subject|12|||
143333860|NCT01266850|516766304|FG000|Overall Study|Physician Decision|3|||
143333861|NCT01266850|516766305|FG001|Overall Study|Physician Decision|6|||
143333862|NCT01266850|516766306|FG002|Overall Study|Physician Decision|4|||
143333863|NCT01266850|516766307|FG003|Overall Study|Physician Decision|4|||
143333864|NCT01266850|516766308|FG004|Overall Study|Physician Decision|3|||
143333865|NCT01266850|516766304|FG000|Overall Study|Protocol Violation|0|||
143333866|NCT01266850|516766305|FG001|Overall Study|Protocol Violation|1|||
143333867|NCT01266850|516766306|FG002|Overall Study|Protocol Violation|0|||
143333868|NCT01266850|516766307|FG003|Overall Study|Protocol Violation|1|||
143333869|NCT01266850|516766308|FG004|Overall Study|Protocol Violation|2|||
143333870|NCT01266850|516766304|FG000|Overall Study|Adverse Event|0|||
143333871|NCT01266850|516766305|FG001|Overall Study|Adverse Event|0|||
143333872|NCT01266850|516766306|FG002|Overall Study|Adverse Event|0|||
143333873|NCT01266850|516766307|FG003|Overall Study|Adverse Event|0|||
143333874|NCT01266850|516766308|FG004|Overall Study|Adverse Event|1|||
143333875|NCT01266850|516766304|FG000|Overall Study|Site Closure|0|||
143333876|NCT01266850|516766305|FG001|Overall Study|Site Closure|1|||
143333877|NCT01266850|516766306|FG002|Overall Study|Site Closure|1|||
143333878|NCT01266850|516766307|FG003|Overall Study|Site Closure|1|||
143333879|NCT01266850|516766308|FG004|Overall Study|Site Closure|0|||
143333880|NCT02030015|516766309|FG000|Overall Study|Withdrawal by Subject|3|||
143333881|NCT02030015|516766309|FG000|Overall Study|Death|13|||
143333882|NCT00833560|516766310|FG000|Overall Study|Toxicity|13|||
143333883|NCT00833560|516766310|FG000|Overall Study|Adverse Event|11|||
143333884|NCT00833560|516766310|FG000|Overall Study|Protocol Violation|6|||
143333885|NCT00833560|516766310|FG000|Overall Study|Lack of Efficacy|4|||
143333886|NCT00833560|516766310|FG000|Overall Study|Death|2|||
143333887|NCT00833560|516766310|FG000|Overall Study|Pregression of other disease|1|||
143333888|NCT00833560|516766310|FG000|Overall Study|Other|5|||
143333889|NCT00428090|516766317|FG000|Overall Study|Adverse Event|10|||
143333890|NCT00428090|516766318|FG001|Overall Study|Adverse Event|8|||
143333891|NCT00428090|516766319|FG002|Overall Study|Adverse Event|10|||
143333892|NCT00428090|516766320|FG003|Overall Study|Adverse Event|11|||
143333893|NCT00428090|516766317|FG000|Overall Study|Lost to Follow-up|3|||
143333894|NCT00428090|516766318|FG001|Overall Study|Lost to Follow-up|6|||
143333895|NCT00428090|516766319|FG002|Overall Study|Lost to Follow-up|1|||
143333896|NCT00428090|516766320|FG003|Overall Study|Lost to Follow-up|4|||
143333897|NCT00428090|516766317|FG000|Overall Study|Protocol Violation|3|||
143333898|NCT00428090|516766318|FG001|Overall Study|Protocol Violation|1|||
143333899|NCT00428090|516766319|FG002|Overall Study|Protocol Violation|3|||
143333900|NCT00428090|516766320|FG003|Overall Study|Protocol Violation|3|||
143333901|NCT00428090|516766317|FG000|Overall Study|Withdrawal by Subject|10|||
143333902|NCT00428090|516766318|FG001|Overall Study|Withdrawal by Subject|12|||
143333903|NCT00428090|516766319|FG002|Overall Study|Withdrawal by Subject|15|||
143333904|NCT00428090|516766320|FG003|Overall Study|Withdrawal by Subject|5|||
143333905|NCT00428090|516766317|FG000|Overall Study|Sponsor terminated study|0|||
143333906|NCT00428090|516766318|FG001|Overall Study|Sponsor terminated study|1|||
143333907|NCT00428090|516766319|FG002|Overall Study|Sponsor terminated study|0|||
143333908|NCT00428090|516766320|FG003|Overall Study|Sponsor terminated study|0|||
143333909|NCT00428090|516766317|FG000|Overall Study|Non-compliance|4|||
143333910|NCT00428090|516766318|FG001|Overall Study|Non-compliance|0|||
143333911|NCT00428090|516766319|FG002|Overall Study|Non-compliance|1|||
143333912|NCT00428090|516766320|FG003|Overall Study|Non-compliance|3|||
143333913|NCT00428090|516766317|FG000|Overall Study|Par. did not returned to visit|1|||
143333914|NCT00428090|516766318|FG001|Overall Study|Par. did not returned to visit|0|||
143333915|NCT00428090|516766319|FG002|Overall Study|Par. did not returned to visit|0|||
143333916|NCT00428090|516766320|FG003|Overall Study|Par. did not returned to visit|1|||
143333917|NCT00428090|516766317|FG000|Overall Study|Follow-Up visit not possible|1|||
143333918|NCT00428090|516766318|FG001|Overall Study|Follow-Up visit not possible|0|||
143333919|NCT00428090|516766319|FG002|Overall Study|Follow-Up visit not possible|0|||
143333920|NCT00428090|516766320|FG003|Overall Study|Follow-Up visit not possible|0|||
143333921|NCT00428090|516766317|FG000|Overall Study|Prohibited medication used for SAE|1|||
143333922|NCT00428090|516766318|FG001|Overall Study|Prohibited medication used for SAE|0|||
143333923|NCT00428090|516766319|FG002|Overall Study|Prohibited medication used for SAE|0|||
143333924|NCT00428090|516766320|FG003|Overall Study|Prohibited medication used for SAE|0|||
143333925|NCT00428090|516766317|FG000|Overall Study|Death of par.|1|||
143333926|NCT00428090|516766318|FG001|Overall Study|Death of par.|0|||
143333927|NCT00428090|516766319|FG002|Overall Study|Death of par.|1|||
143333928|NCT00428090|516766320|FG003|Overall Study|Death of par.|0|||
143333929|NCT00428090|516766317|FG000|Overall Study|Visit 7 exceed the visit window|0|||
143333930|NCT00428090|516766318|FG001|Overall Study|Visit 7 exceed the visit window|1|||
143333931|NCT00428090|516766319|FG002|Overall Study|Visit 7 exceed the visit window|0|||
143333932|NCT00428090|516766320|FG003|Overall Study|Visit 7 exceed the visit window|0|||
143333933|NCT00428090|516766317|FG000|Overall Study|Medical monitor terminated par.|0|||
143333934|NCT00428090|516766318|FG001|Overall Study|Medical monitor terminated par.|1|||
143333935|NCT00428090|516766319|FG002|Overall Study|Medical monitor terminated par.|0|||
143333936|NCT00428090|516766320|FG003|Overall Study|Medical monitor terminated par.|0|||
143333937|NCT00428090|516766317|FG000|Overall Study|Mental status of par. was|0|||
143384624|NCT04623775|516952909|FG001|Treatment Period|AE unrelated to study drug|9|||
143384625|NCT04623775|516952910|FG002|Treatment Period|AE unrelated to study drug|12|||
143333938|NCT00428090|516766318|FG001|Overall Study|Mental status of par. was|1|||
143333939|NCT00428090|516766319|FG002|Overall Study|Mental status of par. was|0|||
143333940|NCT00428090|516766320|FG003|Overall Study|Mental status of par. was|0|||
143333941|NCT00428090|516766317|FG000|Overall Study|Worsening of AD|0|||
143333942|NCT00428090|516766318|FG001|Overall Study|Worsening of AD|0|||
143333943|NCT00428090|516766319|FG002|Overall Study|Worsening of AD|1|||
143333944|NCT00428090|516766320|FG003|Overall Study|Worsening of AD|0|||
143333945|NCT00428090|516766317|FG000|Overall Study|Excluded for concerning QTc value|0|||
143333946|NCT00428090|516766318|FG001|Overall Study|Excluded for concerning QTc value|0|||
143333947|NCT00428090|516766319|FG002|Overall Study|Excluded for concerning QTc value|1|||
143333948|NCT00428090|516766320|FG003|Overall Study|Excluded for concerning QTc value|0|||
143333949|NCT00428090|516766317|FG000|Overall Study|Insufficient AD documentation|0|||
143333950|NCT00428090|516766318|FG001|Overall Study|Insufficient AD documentation|0|||
143333951|NCT00428090|516766319|FG002|Overall Study|Insufficient AD documentation|1|||
143333952|NCT00428090|516766320|FG003|Overall Study|Insufficient AD documentation|0|||
143333953|NCT00428090|516766317|FG000|Overall Study|High MMSE scores|0|||
143333954|NCT00428090|516766318|FG001|Overall Study|High MMSE scores|0|||
143333955|NCT00428090|516766319|FG002|Overall Study|High MMSE scores|1|||
143333956|NCT00428090|516766320|FG003|Overall Study|High MMSE scores|0|||
143333957|NCT00428090|516766317|FG000|Overall Study|Deterioration of cognitive status|0|||
143333958|NCT00428090|516766318|FG001|Overall Study|Deterioration of cognitive status|0|||
143333959|NCT00428090|516766319|FG002|Overall Study|Deterioration of cognitive status|1|||
143333960|NCT00428090|516766320|FG003|Overall Study|Deterioration of cognitive status|0|||
143333961|NCT00428090|516766317|FG000|Overall Study|Serious adverse event|0|||
143333962|NCT00428090|516766318|FG001|Overall Study|Serious adverse event|0|||
143333963|NCT00428090|516766319|FG002|Overall Study|Serious adverse event|1|||
143333964|NCT00428090|516766320|FG003|Overall Study|Serious adverse event|0|||
143333965|NCT00428090|516766317|FG000|Overall Study|Excluded for heart insufficiency|0|||
143333966|NCT00428090|516766318|FG001|Overall Study|Excluded for heart insufficiency|0|||
143333967|NCT00428090|516766319|FG002|Overall Study|Excluded for heart insufficiency|1|||
143333968|NCT00428090|516766320|FG003|Overall Study|Excluded for heart insufficiency|0|||
143333969|NCT00428090|516766317|FG000|Overall Study|Raised Creatinine Value|0|||
143333970|NCT00428090|516766318|FG001|Overall Study|Raised Creatinine Value|0|||
143333971|NCT00428090|516766319|FG002|Overall Study|Raised Creatinine Value|0|||
143333972|NCT00428090|516766320|FG003|Overall Study|Raised Creatinine Value|1|||
143333973|NCT00512148|516766324|FG000|Primay Study Period|Withdrawal by Subject|1|||
143333974|NCT01666951|516766325|FG000|Overall Study|Not dosed|1|||
143333975|NCT01666951|516766326|FG001|Overall Study|Not dosed|1|||
143333976|NCT02623322|516766330|FG000|Overall Study|Lost to Follow-up|2|||
143333977|NCT02623322|516766331|FG001|Overall Study|Lost to Follow-up|1|||
143333978|NCT02623322|516766332|FG002|Overall Study|Lost to Follow-up|0|||
143333979|NCT03284788|516766336|FG000|Overall Study|Withdrawal by Subject|2|||
143333980|NCT03563716|516766337|FG000|Overall Study|Death|20|||
143333981|NCT03563716|516766338|FG001|Overall Study|Death|14|||
143333982|NCT03563716|516766337|FG000|Overall Study|Withdrawal by Subject|3|||
143333983|NCT03563716|516766338|FG001|Overall Study|Withdrawal by Subject|3|||
143333984|NCT03563716|516766337|FG000|Overall Study|Still on Study|45|||
143333985|NCT03563716|516766338|FG001|Overall Study|Still on Study|50|||
143333986|NCT02450331|516766342|FG000|Overall Study|Death|162|||
143333987|NCT02450331|516766343|FG001|Overall Study|Death|171|||
143333988|NCT02450331|516766342|FG000|Overall Study|Lost to Follow-up|14|||
143333989|NCT02450331|516766343|FG001|Overall Study|Lost to Follow-up|12|||
143333990|NCT02450331|516766342|FG000|Overall Study|Withdrawal by Subject|55|||
143333991|NCT02450331|516766343|FG001|Overall Study|Withdrawal by Subject|44|||
143333992|NCT02450331|516766342|FG000|Overall Study|Non-specified other|1|||
143333993|NCT02450331|516766343|FG001|Overall Study|Non-specified other|1|||
143333994|NCT00420199|516766348|FG000|Overall Study|Participant no longer met study criteria|1|||
143333995|NCT00420199|516766349|FG001|Overall Study|Participant no longer met study criteria|0|||
143333996|NCT00558428|516766356|FG000|Overall Study|Adverse Event|6|||
143333997|NCT00558428|516766357|FG001|Overall Study|Adverse Event|22|||
143333998|NCT00558428|516766358|FG002|Overall Study|Adverse Event|3|||
143333999|NCT00558428|516766359|FG003|Overall Study|Adverse Event|4|||
143334000|NCT00558428|516766356|FG000|Overall Study|Lost to Follow-up|0|||
143334001|NCT00558428|516766357|FG001|Overall Study|Lost to Follow-up|1|||
143334002|NCT00558428|516766358|FG002|Overall Study|Lost to Follow-up|0|||
143334003|NCT00558428|516766359|FG003|Overall Study|Lost to Follow-up|0|||
143334004|NCT00558428|516766356|FG000|Overall Study|Lack of Efficacy|0|||
143334005|NCT00558428|516766357|FG001|Overall Study|Lack of Efficacy|0|||
143334006|NCT00558428|516766358|FG002|Overall Study|Lack of Efficacy|1|||
143334007|NCT00558428|516766359|FG003|Overall Study|Lack of Efficacy|2|||
143334008|NCT00558428|516766356|FG000|Overall Study|Non compliant with protocol|1|||
143334009|NCT00558428|516766357|FG001|Overall Study|Non compliant with protocol|0|||
143334010|NCT00558428|516766358|FG002|Overall Study|Non compliant with protocol|0|||
143334011|NCT00558428|516766359|FG003|Overall Study|Non compliant with protocol|3|||
143334012|NCT00558428|516766356|FG000|Overall Study|Consent withdrawn|2|||
143334013|NCT00558428|516766357|FG001|Overall Study|Consent withdrawn|1|||
143334014|NCT00558428|516766358|FG002|Overall Study|Consent withdrawn|0|||
143334015|NCT00558428|516766359|FG003|Overall Study|Consent withdrawn|1|||
143334016|NCT00558428|516766356|FG000|Overall Study|Other|3|||
143334017|NCT00558428|516766357|FG001|Overall Study|Other|0|||
143334018|NCT00558428|516766358|FG002|Overall Study|Other|0|||
143334019|NCT00558428|516766359|FG003|Overall Study|Other|1|||
143334020|NCT00626028|516766360|FG000|Overall Study|Adverse Event|1|||
143334021|NCT00626028|516766361|FG001|Overall Study|Adverse Event|1|||
143334022|NCT00626028|516766360|FG000|Overall Study|Device Failure|0|||
143334023|NCT00626028|516766361|FG001|Overall Study|Device Failure|1|||
143334024|NCT00626028|516766360|FG000|Overall Study|Physician Decision|2|||
143334025|NCT00626028|516766361|FG001|Overall Study|Physician Decision|1|||
143334026|NCT00626028|516766360|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
143334027|NCT00626028|516766361|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
143334028|NCT05224050|516766362|FG000|Overall Study|Withdrawal by Subject|9|||
143334029|NCT05224050|516766362|FG000|Overall Study|Lost to Follow-up|3|||
143334030|NCT02436330|516766363|FG000|Cohort 1|Lost to Follow-up|5|||
143334031|NCT02436330|516766364|FG001|Cohort 1|Lost to Follow-up|2|||
143334032|NCT02436330|516766363|FG000|Cohort 1|Withdrawal by Subject|0|||
143334033|NCT02436330|516766364|FG001|Cohort 1|Withdrawal by Subject|1|||
143334034|NCT02436330|516766363|FG000|Cohort 2|Lost to Follow-up|2|||
143334035|NCT02436330|516766364|FG001|Cohort 2|Lost to Follow-up|0|||
143334036|NCT02436330|516766363|FG000|Cohort 2|Withdrawal by Subject|2|||
143334037|NCT02436330|516766364|FG001|Cohort 2|Withdrawal by Subject|3|||
143334038|NCT02436330|516766363|FG000|Cohort 3|Lost to Follow-up|1|||
143334039|NCT02436330|516766364|FG001|Cohort 3|Lost to Follow-up|0|||
143334040|NCT02436330|516766363|FG000|Cohort 3|Withdrawal by Subject|4|||
143334041|NCT02436330|516766364|FG001|Cohort 3|Withdrawal by Subject|0|||
143334042|NCT02436330|516766363|FG000|Cohort 4|Lost to Follow-up|1|||
143334043|NCT02436330|516766364|FG001|Cohort 4|Lost to Follow-up|0|||
143334044|NCT02436330|516766363|FG000|Cohort 4|Withdrawal by Subject|1|||
143334045|NCT02436330|516766364|FG001|Cohort 4|Withdrawal by Subject|0|||
143334046|NCT02436330|516766363|FG000|Cohort 5|Lost to Follow-up|3|||
143334047|NCT02436330|516766364|FG001|Cohort 5|Lost to Follow-up|2|||
143334048|NCT02436330|516766363|FG000|Cohort 5|Withdrawal by Subject|3|||
143334049|NCT02436330|516766364|FG001|Cohort 5|Withdrawal by Subject|2|||
143334050|NCT02436330|516766363|FG000|Cohort 6|Lost to Follow-up|2|||
143334051|NCT02436330|516766364|FG001|Cohort 6|Lost to Follow-up|0|||
143334052|NCT02436330|516766363|FG000|Cohort 6|Withdrawal by Subject|1|||
143334053|NCT02436330|516766364|FG001|Cohort 6|Withdrawal by Subject|1|||
143334054|NCT04575467|516766369|FG000|Overall Study|Adverse Event|0|||
143334055|NCT04575467|516766370|FG001|Overall Study|Adverse Event|1|||
143334056|NCT04575467|516766371|FG002|Overall Study|Adverse Event|0|||
143334057|NCT04575467|516766372|FG003|Overall Study|Adverse Event|0|||
143334058|NCT03182868|516766375|FG000|Overall Study|Protocol Violation|3|||
143334059|NCT03182868|516766376|FG001|Overall Study|Protocol Violation|0|||
143334060|NCT03182868|516766377|FG002|Overall Study|Protocol Violation|4|||
143334061|NCT03182868|516766378|FG003|Overall Study|Protocol Violation|1|||
143334062|NCT03182868|516766379|FG004|Overall Study|Protocol Violation|8|||
143334063|NCT03342638|516766380|FG000|Overall Study|Withdrawal by Subject|1|||
143334064|NCT03342638|516766381|FG001|Overall Study|Withdrawal by Subject|0|||
143334065|NCT03342638|516766380|FG000|Overall Study|Physician Decision|0|||
143334066|NCT03342638|516766381|FG001|Overall Study|Physician Decision|1|||
143334067|NCT01292239|516766386|FG000|Overall Study|Other|1|||
143334068|NCT01292239|516766387|FG001|Overall Study|Other|1|||
143334069|NCT01292239|516766386|FG000|Overall Study|Withdrawal by Subject|3|||
143384626|NCT04623775|516952911|FG003|Treatment Period|AE unrelated to study drug|9|||
143334070|NCT01292239|516766387|FG001|Overall Study|Withdrawal by Subject|6|||
143334071|NCT00262821|516766388|FG000|Overall Study|Ineligible - wrong stage|0|||
143334072|NCT00262821|516766389|FG001|Overall Study|Ineligible - wrong stage|3|||
143334073|NCT00262821|516766388|FG000|Overall Study|Ineligible - wrong cell type|2|||
143334074|NCT00262821|516766389|FG001|Overall Study|Ineligible - wrong cell type|2|||
143334075|NCT00262821|516766388|FG000|Overall Study|Ineligible - wrong primary|0|||
143334076|NCT00262821|516766389|FG001|Overall Study|Ineligible - wrong primary|1|||
143334077|NCT00262821|516766388|FG000|Overall Study|Ineligible - inadequate pathology|1|||
143334078|NCT00262821|516766389|FG001|Overall Study|Ineligible - inadequate pathology|3|||
143334079|NCT00262821|516766388|FG000|Overall Study|Ineligible - elevated creatinine|0|||
143334080|NCT00262821|516766389|FG001|Overall Study|Ineligible - elevated creatinine|2|||
143334081|NCT00262821|516766388|FG000|Overall Study|Ineligible - required test not done|1|||
143334082|NCT00262821|516766389|FG001|Overall Study|Ineligible - required test not done|4|||
143334083|NCT00262821|516766388|FG000|Overall Study|Inevaluable - inadequate data|0|||
143334084|NCT00262821|516766389|FG001|Overall Study|Inevaluable - inadequate data|4|||
143334085|NCT03213158|516766392|FG000|Overall Study|Withdrawal by Subject|1|||
143334086|NCT03213158|516766392|FG000|Overall Study|Physician Decision|2|||
143334087|NCT00587964|516766398|FG000|Overall Study|Withdrawal by Subject|1|||
143334088|NCT00587964|516766398|FG000|Overall Study|Lost to Follow-up|1|||
143334089|NCT00587964|516766398|FG000|Overall Study|Patient found to be ineligible|1|||
143334090|NCT00587964|516766398|FG000|Overall Study|Patient did not receive intervention|5|||
143334091|NCT00587964|516766398|FG000|Overall Study|Progression of Disease|4|||
143334092|NCT00540124|516766399|FG000|Overall Study|Adverse Event|0|||
143334093|NCT00540124|516766400|FG001|Overall Study|Adverse Event|2|||
143334094|NCT00540124|516766401|FG002|Overall Study|Adverse Event|1|||
143334095|NCT00540124|516766399|FG000|Overall Study|Entry Criteria Not Met|2|||
143334096|NCT00540124|516766400|FG001|Overall Study|Entry Criteria Not Met|0|||
143334097|NCT00540124|516766401|FG002|Overall Study|Entry Criteria Not Met|0|||
143334098|NCT00540124|516766399|FG000|Overall Study|Lack of Efficacy|1|||
143334099|NCT00540124|516766400|FG001|Overall Study|Lack of Efficacy|0|||
143334100|NCT00540124|516766401|FG002|Overall Study|Lack of Efficacy|0|||
143334101|NCT00540124|516766399|FG000|Overall Study|Withdrawal by Subject|1|||
143334102|NCT00540124|516766400|FG001|Overall Study|Withdrawal by Subject|1|||
143334103|NCT00540124|516766401|FG002|Overall Study|Withdrawal by Subject|0|||
143334104|NCT03649230|516766404|FG000|Overall Study|Adverse Event|12|||
143334105|NCT03649230|516766404|FG000|Overall Study|Death|8|||
143334106|NCT03649230|516766404|FG000|Overall Study|Withdrawal by Subject|6|||
143334107|NCT03649230|516766404|FG000|Overall Study|Physician Decision|5|||
143334108|NCT03649230|516766404|FG000|Overall Study|Disease progression|5|||
143334109|NCT03649230|516766404|FG000|Overall Study|Switched to non-HEC|5|||
143334110|NCT03649230|516766404|FG000|Overall Study|Chemotherapy discontinued|4|||
143334111|NCT03649230|516766404|FG000|Overall Study|Received only 3 HEC cycles|4|||
143334112|NCT03649230|516766404|FG000|Overall Study|Screen Failure|3|||
143334113|NCT03649230|516766404|FG000|Overall Study|Patient stopped treatment|2|||
143334114|NCT03649230|516766404|FG000|Overall Study|Protocol Violation|1|||
143334115|NCT03649230|516766404|FG000|Overall Study|Non-compliance|1|||
143334116|NCT03649230|516766404|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
143334117|NCT00734630|516766411|FG000|Overall Study|Lack of Efficacy|4|||
143334118|NCT00734630|516766412|FG001|Overall Study|Lack of Efficacy|4|||
143334119|NCT00734630|516766411|FG000|Overall Study|Withdrawal by Subject|7|||
143334120|NCT00734630|516766412|FG001|Overall Study|Withdrawal by Subject|9|||
143334121|NCT00734630|516766411|FG000|Overall Study|Lost to Follow-up|13|||
143334122|NCT00734630|516766412|FG001|Overall Study|Lost to Follow-up|7|||
143334123|NCT00734630|516766411|FG000|Overall Study|Protocol Violation|0|||
143334124|NCT00734630|516766412|FG001|Overall Study|Protocol Violation|3|||
143334125|NCT00734630|516766411|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
143334126|NCT00734630|516766412|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
143334127|NCT00734630|516766411|FG000|Overall Study|Adverse Event|3|||
143334128|NCT00734630|516766412|FG001|Overall Study|Adverse Event|6|||
143334129|NCT00734630|516766411|FG000|Overall Study|Randomized in Error|0|||
143334130|NCT00734630|516766412|FG001|Overall Study|Randomized in Error|1|||
143334131|NCT00734630|516766411|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
143334132|NCT00734630|516766412|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
143334133|NCT00734630|516766411|FG000|Overall Study|Poor Compliance|1|||
143334134|NCT00734630|516766412|FG001|Overall Study|Poor Compliance|1|||
143334135|NCT00977665|516766413|FG000|Overall Study|Withdrawal by Subject|1|||
143334136|NCT00977665|516766414|FG001|Overall Study|Withdrawal by Subject|3|||
143334137|NCT00977665|516766413|FG000|Overall Study|Physician Decision|2|||
143334138|NCT00977665|516766414|FG001|Overall Study|Physician Decision|1|||
143384627|NCT04623775|516952908|FG000|Treatment Period|participant request to discontinue treatment|0|||
143334139|NCT00977665|516766413|FG000|Overall Study|Sponsor requested withdrawal|0|||
143334140|NCT00977665|516766414|FG001|Overall Study|Sponsor requested withdrawal|1|||
143334141|NCT00977665|516766413|FG000|Overall Study|Lost to Follow-up|1|||
143334142|NCT00977665|516766414|FG001|Overall Study|Lost to Follow-up|0|||
143334143|NCT00977665|516766413|FG000|Overall Study|Death|3|||
143334144|NCT00977665|516766414|FG001|Overall Study|Death|2|||
143334145|NCT00977665|516766413|FG000|Overall Study|Adverse Event|14|||
143334146|NCT00977665|516766414|FG001|Overall Study|Adverse Event|7|||
143334147|NCT00977665|516766413|FG000|Overall Study|Treatment failure|0|||
143334148|NCT00977665|516766414|FG001|Overall Study|Treatment failure|1|||
143334149|NCT01330433|516766415|FG000|Overall Study|Death|1|||
143334150|NCT01330433|516766416|FG001|Overall Study|Death|3|||
143334151|NCT01330433|516766415|FG000|Overall Study|Lost to Follow-up|1|||
143334152|NCT01330433|516766416|FG001|Overall Study|Lost to Follow-up|0|||
143334153|NCT04302350|516766417|FG000|Overall Study|Physician Decision|1|||
143334154|NCT04302350|516766418|FG001|Overall Study|Physician Decision|1|||
143334155|NCT04302350|516766419|FG002|Overall Study|Physician Decision|2|||
143334156|NCT04302350|516766417|FG000|Overall Study|Lack of Efficacy|1|||
143334157|NCT04302350|516766418|FG001|Overall Study|Lack of Efficacy|1|||
143334158|NCT04302350|516766419|FG002|Overall Study|Lack of Efficacy|4|||
143334159|NCT04302350|516766417|FG000|Overall Study|Adverse Event|0|||
143334160|NCT04302350|516766418|FG001|Overall Study|Adverse Event|1|||
143334161|NCT04302350|516766419|FG002|Overall Study|Adverse Event|2|||
143334162|NCT01371851|516766422|FG000|Overall Study|Lost to Follow-up|5|||
143334163|NCT01371851|516766423|FG001|Overall Study|Lost to Follow-up|8|||
143334164|NCT01371851|516766422|FG000|Overall Study|was arrested and put in jail|0|||
143334165|NCT01371851|516766423|FG001|Overall Study|was arrested and put in jail|1|||
143334166|NCT01371851|516766422|FG000|Overall Study|non study related adverse event|1|||
143334167|NCT01371851|516766423|FG001|Overall Study|non study related adverse event|0|||
143334168|NCT01371851|516766422|FG000|Overall Study|Blood Pressure outside study parameters|2|||
143334169|NCT01371851|516766423|FG001|Overall Study|Blood Pressure outside study parameters|0|||
143334170|NCT00374322|516766424|FG000|Overall Study|Lost to Follow-up|92|||
143334171|NCT00374322|516766425|FG001|Overall Study|Lost to Follow-up|90|||
143334172|NCT00374322|516766424|FG000|Overall Study|Protocol Violation|8|||
143334173|NCT00374322|516766425|FG001|Overall Study|Protocol Violation|3|||
143334174|NCT00374322|516766424|FG000|Overall Study|Withdrawal by Subject|235|||
143334175|NCT00374322|516766425|FG001|Overall Study|Withdrawal by Subject|167|||
143334176|NCT00374322|516766424|FG000|Overall Study|Sponsor Terminated Study|866|||
143334177|NCT00374322|516766425|FG001|Overall Study|Sponsor Terminated Study|990|||
143334178|NCT00374322|516766424|FG000|Overall Study|Physician Decision|36|||
143334179|NCT00374322|516766425|FG001|Overall Study|Physician Decision|32|||
143334180|NCT00374322|516766424|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
143384628|NCT04623775|516952909|FG001|Treatment Period|participant request to discontinue treatment|2|||
143384629|NCT04623775|516952910|FG002|Treatment Period|participant request to discontinue treatment|2|||
143384630|NCT04623775|516952911|FG003|Treatment Period|participant request to discontinue treatment|0|||
143384631|NCT01303445|516952913|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
143384632|NCT01303445|516952914|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
143384633|NCT01303445|516952913|FG000|Second Intervention (7 Days)|Adverse Event|0|||
143384634|NCT01303445|516952914|FG001|Second Intervention (7 Days)|Adverse Event|2|||
143384635|NCT01303445|516952913|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
143384636|NCT01303445|516952914|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
143384637|NCT01303445|516952913|FG000|Washout (14 Days)|Protocol Violation|1|||
143384638|NCT01303445|516952914|FG001|Washout (14 Days)|Protocol Violation|0|||
143384639|NCT01303445|516952913|FG000|Washout (14 Days)|Lost to Follow-up|0|||
143384640|NCT01303445|516952914|FG001|Washout (14 Days)|Lost to Follow-up|2|||
143384641|NCT01303445|516952913|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
143384642|NCT01303445|516952914|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
143334181|NCT00374322|516766425|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
143334182|NCT00374322|516766424|FG000|Overall Study|Sponsor Decision|2|||
143334183|NCT00374322|516766425|FG001|Overall Study|Sponsor Decision|3|||
143334184|NCT00374322|516766424|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
143384643|NCT01303445|516952913|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
143384644|NCT01303445|516952914|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
143384645|NCT03690206|516952915|FG000|Overall Study|Withdrawal by Subject|2|||
143384646|NCT03690206|516952916|FG001|Overall Study|Withdrawal by Subject|0|||
143334185|NCT00374322|516766425|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
143334186|NCT00374322|516766424|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
143334187|NCT00374322|516766425|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
143334188|NCT00374322|516766424|FG000|Overall Study|Severe Toxicity|1|||
143334189|NCT00374322|516766425|FG001|Overall Study|Severe Toxicity|0|||
143334190|NCT00374322|516766424|FG000|Overall Study|Site Closed|2|||
143334191|NCT00374322|516766425|FG001|Overall Study|Site Closed|2|||
143334192|NCT00374322|516766424|FG000|Overall Study|Participant Changed Physician|1|||
143334193|NCT00374322|516766425|FG001|Overall Study|Participant Changed Physician|0|||
143334194|NCT00374322|516766424|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
143384647|NCT03690206|516952917|FG002|Overall Study|Withdrawal by Subject|0|||
143384648|NCT03690206|516952915|FG000|Overall Study|ICF withdrawal|2|||
143384649|NCT03690206|516952916|FG001|Overall Study|ICF withdrawal|0|||
143384650|NCT03690206|516952917|FG002|Overall Study|ICF withdrawal|0|||
143384651|NCT03913195|516954933|FG000|Overall Study|Adverse Event|0|||
143384652|NCT03913195|516954934|FG001|Overall Study|Adverse Event|0|||
143384653|NCT03913195|516954935|FG002|Overall Study|Adverse Event|1|||
143384654|NCT03913195|516954936|FG003|Overall Study|Adverse Event|1|||
143384655|NCT03913195|516954937|FG004|Overall Study|Adverse Event|0|||
143384656|NCT03913195|516954933|FG000|Overall Study|Withdrawal by Subject|0|||
143384657|NCT03913195|516954934|FG001|Overall Study|Withdrawal by Subject|0|||
143384658|NCT03913195|516954935|FG002|Overall Study|Withdrawal by Subject|1|||
143384659|NCT03913195|516954936|FG003|Overall Study|Withdrawal by Subject|0|||
143384660|NCT03913195|516954937|FG004|Overall Study|Withdrawal by Subject|1|||
143384661|NCT03913195|516954933|FG000|Overall Study|non adherence to study|0|||
143384662|NCT03913195|516954934|FG001|Overall Study|non adherence to study|0|||
143384663|NCT03913195|516954935|FG002|Overall Study|non adherence to study|1|||
143384664|NCT03913195|516954936|FG003|Overall Study|non adherence to study|0|||
143384665|NCT03913195|516954937|FG004|Overall Study|non adherence to study|0|||
143384666|NCT03899961|516954938|FG000|Overall Study|-delivery prior to|2|||
143384667|NCT03899961|516954939|FG001|Overall Study|-delivery prior to|7|||
143384668|NCT03899961|516954938|FG000|Overall Study|req general anesth|1|||
143384669|NCT03899961|516954939|FG001|Overall Study|req general anesth|2|||
143384670|NCT03899961|516954938|FG000|Overall Study|capacity|5|||
143384671|NCT03899961|516954939|FG001|Overall Study|capacity|6|||
143384672|NCT03899961|516954938|FG000|Overall Study|Withdrawal by Subject|1|||
143384673|NCT03899961|516954939|FG001|Overall Study|Withdrawal by Subject|1|||
143384674|NCT00979576|516954953|FG000|Combination Treatment Phase|Progressive disease|3|||
143384675|NCT00979576|516954954|FG001|Combination Treatment Phase|Progressive disease|1|||
143384676|NCT00979576|516954955|FG002|Combination Treatment Phase|Progressive disease|5|||
143384677|NCT00979576|516954953|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
143384678|NCT00979576|516954954|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
143384679|NCT00979576|516954955|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
143384680|NCT00979576|516954953|FG000|Combination Treatment Phase|Adverse Event|0|||
143384681|NCT00979576|516954954|FG001|Combination Treatment Phase|Adverse Event|2|||
143384682|NCT00979576|516954955|FG002|Combination Treatment Phase|Adverse Event|2|||
143384683|NCT00979576|516954953|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
143384684|NCT00979576|516954954|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
143384685|NCT00979576|516954955|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
143384686|NCT04855760|516954958|FG000|Overall Study|Adverse Event|21|||
143384687|NCT04855760|516954958|FG000|Overall Study|Withdrawal by Subject|116|||
143384688|NCT04855760|516954958|FG000|Overall Study|Lack of Efficacy|21|||
143384689|NCT04855760|516954958|FG000|Overall Study|Lost to Follow-up|49|||
143384690|NCT04855760|516954958|FG000|Overall Study|Protocol Violation|2|||
143384691|NCT04855760|516954958|FG000|Overall Study|Physician Decision|5|||
143384692|NCT04855760|516954958|FG000|Overall Study|Pregnancy|1|||
143384693|NCT04855760|516954958|FG000|Overall Study|Non-Compliance with Study Drug|11|||
143384694|NCT04855760|516954958|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
143384695|NCT04855760|516954958|FG000|Overall Study|Study Completed by Sponsor|202|||
143384696|NCT04855760|516954958|FG000|Overall Study|Other|13|||
143384697|NCT04840199|516954959|FG000|Overall Study|Study Terminated by Sponsor|8|||
143384698|NCT04840199|516954960|FG001|Overall Study|Study Terminated by Sponsor|9|||
143384699|NCT04840199|516954959|FG000|Overall Study|Lost to Follow-up|0|||
143334195|NCT00374322|516766425|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
143334196|NCT00374322|516766424|FG000|Overall Study|Noncompliance with Study Requirements|0|||
143334197|NCT00374322|516766425|FG001|Overall Study|Noncompliance with Study Requirements|1|||
143334198|NCT00374322|516766424|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
143334199|NCT00374322|516766425|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
143334200|NCT00374322|516766424|FG000|Overall Study|Did Not Receive Study Medication|8|||
143334201|NCT00374322|516766425|FG001|Overall Study|Did Not Receive Study Medication|6|||
143334202|NCT02012491|516766426|FG000|Overall Study|Lost to Follow-up|1|||
143334203|NCT02012491|516766427|FG001|Overall Study|Lost to Follow-up|0|||
143334204|NCT02012491|516766426|FG000|Overall Study|Protocol Violation|0|||
143334205|NCT02012491|516766427|FG001|Overall Study|Protocol Violation|1|||
143334206|NCT02012491|516766426|FG000|Overall Study|Withdrawal by Subject|1|||
143334207|NCT02012491|516766427|FG001|Overall Study|Withdrawal by Subject|0|||
143334208|NCT00450411|516766428|FG000|Overall Study|Protocol Violation|6|||
143334209|NCT00450411|516766428|FG000|Overall Study|No protocol treatment|2|||
143384700|NCT04840199|516954960|FG001|Overall Study|Lost to Follow-up|2|||
143384701|NCT04840199|516954959|FG000|Overall Study|Withdrawal by Subject|2|||
143384702|NCT04840199|516954960|FG001|Overall Study|Withdrawal by Subject|0|||
143384703|NCT04840199|516954959|FG000|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
143384704|NCT04840199|516954960|FG001|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
143384705|NCT03424811|516954967|FG000|Overall Study|Lost to Follow-up|9|||
143384706|NCT03424811|516954968|FG001|Overall Study|Lost to Follow-up|0|||
143384707|NCT04112316|516954970|FG000|First Period (8 Weeks)|Protocol Violation|1|||
143384708|NCT04112316|516954971|FG001|First Period (8 Weeks)|Protocol Violation|0|||
143384709|NCT04112316|516954970|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
143334210|NCT01400503|516766439|FG000|Overall Study|Withdrawal by Subject|1|||
143334211|NCT01400503|516766439|FG000|Overall Study|Study Terminated by Sponsor|58|||
143334212|NCT01400503|516766439|FG000|Overall Study|Other|1|||
143334213|NCT02130193|516766440|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
143334214|NCT02130193|516766441|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
143334215|NCT02130193|516766442|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
143334216|NCT02130193|516766440|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
143334217|NCT02130193|516766441|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
143334218|NCT02130193|516766442|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
143334219|NCT02130193|516766440|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
143334220|NCT02130193|516766441|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
143334221|NCT02130193|516766442|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
143334222|NCT02130193|516766440|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
143334223|NCT02130193|516766441|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
143334224|NCT02130193|516766442|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
143334225|NCT01297959|516766443|FG000|Overall Study|Adverse Event|0|||
143334226|NCT01297959|516766444|FG001|Overall Study|Adverse Event|1|||
143334227|NCT01297959|516766443|FG000|Overall Study|Protocol Violation|2|||
143334228|NCT01297959|516766444|FG001|Overall Study|Protocol Violation|1|||
143334229|NCT01297959|516766443|FG000|Overall Study|Withdrawal by Subject|5|||
143334230|NCT01297959|516766444|FG001|Overall Study|Withdrawal by Subject|4|||
143334231|NCT01297959|516766443|FG000|Overall Study|Physician Decision|0|||
143334232|NCT01297959|516766444|FG001|Overall Study|Physician Decision|1|||
143334233|NCT01297959|516766443|FG000|Overall Study|Unrelated medical illness / complication|0|||
143334234|NCT01297959|516766444|FG001|Overall Study|Unrelated medical illness / complication|2|||
143334235|NCT01297959|516766443|FG000|Overall Study|Other|13|||
143334236|NCT01297959|516766444|FG001|Overall Study|Other|7|||
143334237|NCT01212770|516766445|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
143334238|NCT01212770|516766446|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
143334239|NCT01212770|516766447|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
143334240|NCT01212770|516766448|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
143334241|NCT01212770|516766449|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
143334242|NCT01212770|516766450|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
143334243|NCT01212770|516766451|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
143334244|NCT01212770|516766452|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
143334245|NCT01212770|516766453|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
143334246|NCT01212770|516766445|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
143334247|NCT01212770|516766446|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
143334248|NCT01212770|516766447|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
143334249|NCT01212770|516766448|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
143334250|NCT01212770|516766449|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
143334251|NCT01212770|516766450|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
143334252|NCT01212770|516766451|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
143334253|NCT01212770|516766452|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
143334254|NCT01212770|516766453|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
143334255|NCT01212770|516766445|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
143334256|NCT01212770|516766446|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
143334257|NCT01212770|516766447|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
143334258|NCT01212770|516766448|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
143334259|NCT01212770|516766449|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
143334260|NCT01212770|516766450|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
143334261|NCT01212770|516766451|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
143334262|NCT01212770|516766452|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
143334263|NCT01212770|516766453|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
143334264|NCT01212770|516766445|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
143334265|NCT01212770|516766446|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
143334266|NCT01212770|516766447|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
143334267|NCT01212770|516766448|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
143334268|NCT01212770|516766449|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
143334269|NCT01212770|516766450|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
143384710|NCT04112316|516954971|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
143384711|NCT00567398|516954972|FG000|Overall Study|Adverse Event|6|||
143334270|NCT01212770|516766451|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
143334271|NCT01212770|516766452|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
143334272|NCT01212770|516766453|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
143334273|NCT01212770|516766445|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
143334274|NCT01212770|516766446|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
143334275|NCT01212770|516766447|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
143334276|NCT01212770|516766448|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
143334277|NCT01212770|516766449|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
143334278|NCT01212770|516766450|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
143334279|NCT01212770|516766451|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
143334280|NCT01212770|516766452|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
143334281|NCT01212770|516766453|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
143334282|NCT01212770|516766445|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
143334283|NCT01212770|516766446|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
143334284|NCT01212770|516766447|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
143334285|NCT01212770|516766448|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
143334286|NCT01212770|516766449|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
143334287|NCT01212770|516766450|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
143334288|NCT01212770|516766451|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
143334289|NCT01212770|516766452|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
143334290|NCT01212770|516766453|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
143334291|NCT01212770|516766445|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
143334292|NCT01212770|516766446|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
143334293|NCT01212770|516766447|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
143334294|NCT01212770|516766448|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
143334295|NCT01212770|516766449|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
143334296|NCT01212770|516766450|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
143334297|NCT01212770|516766451|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
143334298|NCT01212770|516766452|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
143334299|NCT01212770|516766453|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
143334300|NCT01212770|516766445|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
143334301|NCT01212770|516766446|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
143334302|NCT01212770|516766447|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
143334303|NCT01212770|516766448|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
143334304|NCT01212770|516766449|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
143334305|NCT01212770|516766450|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
143334306|NCT01212770|516766451|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
143334307|NCT01212770|516766452|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
143334308|NCT01212770|516766453|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
143334309|NCT01212770|516766445|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
143334310|NCT01212770|516766446|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
143334311|NCT01212770|516766447|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
143334312|NCT01212770|516766448|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
143334313|NCT01212770|516766449|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
143334314|NCT01212770|516766450|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
143334315|NCT01212770|516766451|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
143334316|NCT01212770|516766452|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
143334317|NCT01212770|516766453|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
143334318|NCT01212770|516766445|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
143334319|NCT01212770|516766446|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
143334320|NCT01212770|516766447|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
143334321|NCT01212770|516766448|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
143334322|NCT01212770|516766449|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
143334323|NCT01212770|516766450|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
143334324|NCT01212770|516766451|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
143334325|NCT01212770|516766452|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
143334326|NCT01212770|516766453|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
143334327|NCT01212770|516766445|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
143334328|NCT01212770|516766446|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
143334329|NCT01212770|516766447|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
143334330|NCT01212770|516766448|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
143334331|NCT01212770|516766449|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
143334332|NCT01212770|516766450|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
143334333|NCT01212770|516766451|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
143334334|NCT01212770|516766452|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
143334335|NCT01212770|516766453|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
143334336|NCT01212770|516766445|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
143334337|NCT01212770|516766446|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
143334338|NCT01212770|516766447|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
143334339|NCT01212770|516766448|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
143334340|NCT01212770|516766449|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
143334341|NCT01212770|516766450|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
143334342|NCT01212770|516766451|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
143334343|NCT01212770|516766452|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
143334344|NCT01212770|516766453|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
143334345|NCT01212770|516766445|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
143334346|NCT01212770|516766446|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
143334347|NCT01212770|516766447|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
143334348|NCT01212770|516766448|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
143334349|NCT01212770|516766449|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
143334350|NCT01212770|516766450|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
143334351|NCT01212770|516766451|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
143334352|NCT01212770|516766452|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
143334353|NCT01212770|516766453|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
143334354|NCT01212770|516766445|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
143334355|NCT01212770|516766446|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
143334356|NCT01212770|516766447|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
143334357|NCT01212770|516766448|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
143334358|NCT01212770|516766449|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
143334359|NCT01212770|516766450|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
143334360|NCT01212770|516766451|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
143334361|NCT01212770|516766452|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
143334362|NCT01212770|516766453|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
143334363|NCT01212770|516766445|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
143334364|NCT01212770|516766446|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
143334365|NCT01212770|516766447|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
143334366|NCT01212770|516766448|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
143334367|NCT01212770|516766449|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
143334368|NCT01212770|516766450|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
143334369|NCT01212770|516766451|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
143334370|NCT01212770|516766452|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
143334371|NCT01212770|516766453|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
143334372|NCT01212770|516766445|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
143334373|NCT01212770|516766446|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
143334374|NCT01212770|516766447|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
143334375|NCT01212770|516766448|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
143334376|NCT01212770|516766449|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
143334377|NCT01212770|516766450|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
143334378|NCT01212770|516766451|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
143334379|NCT01212770|516766452|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
143334380|NCT01212770|516766453|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
143334381|NCT01212770|516766445|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
143334382|NCT01212770|516766446|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
143334383|NCT01212770|516766447|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
143334384|NCT01212770|516766448|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
143334385|NCT01212770|516766449|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
143334386|NCT01212770|516766450|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
143334387|NCT01212770|516766451|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
143334388|NCT01212770|516766452|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
143334389|NCT01212770|516766453|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
143334390|NCT01212770|516766445|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
143334391|NCT01212770|516766446|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
143334392|NCT01212770|516766447|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
143334393|NCT01212770|516766448|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
143334394|NCT01212770|516766449|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
143334395|NCT01212770|516766450|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
143334396|NCT01212770|516766451|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
143334397|NCT01212770|516766452|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
143334398|NCT01212770|516766453|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
143334399|NCT01212770|516766445|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
143334400|NCT01212770|516766446|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
143334401|NCT01212770|516766447|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
143384712|NCT00567398|516954973|FG001|Overall Study|Adverse Event|14|||
143334402|NCT01212770|516766448|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
143334403|NCT01212770|516766449|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
143334404|NCT01212770|516766450|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
143334405|NCT01212770|516766451|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
143334406|NCT01212770|516766452|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
143334407|NCT01212770|516766453|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
143334408|NCT01212770|516766445|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
143334409|NCT01212770|516766446|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
143334410|NCT01212770|516766447|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
143334411|NCT01212770|516766448|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
143334412|NCT01212770|516766449|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
143334413|NCT01212770|516766450|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
143334414|NCT01212770|516766451|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
143334415|NCT01212770|516766452|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
143334416|NCT01212770|516766453|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
143334417|NCT01212770|516766445|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
143334418|NCT01212770|516766446|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
143334419|NCT01212770|516766447|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
143334420|NCT01212770|516766448|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
143334421|NCT01212770|516766449|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
143334422|NCT01212770|516766450|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
143334423|NCT01212770|516766451|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
143334424|NCT01212770|516766452|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
143334425|NCT01212770|516766453|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
143334426|NCT01212770|516766445|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
143334427|NCT01212770|516766446|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
143334428|NCT01212770|516766447|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
143334429|NCT01212770|516766448|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
143334430|NCT01212770|516766449|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
143334431|NCT01212770|516766450|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
143334432|NCT01212770|516766451|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
143334433|NCT01212770|516766452|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
143334434|NCT01212770|516766453|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
143334435|NCT01212770|516766445|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
143334436|NCT01212770|516766446|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
143334437|NCT01212770|516766447|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
143334438|NCT01212770|516766448|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
143334439|NCT01212770|516766449|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
143334440|NCT01212770|516766450|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
143334441|NCT01212770|516766451|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
143334442|NCT01212770|516766452|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
143334443|NCT01212770|516766453|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
143334444|NCT01212770|516766445|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
143334445|NCT01212770|516766446|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
143334446|NCT01212770|516766447|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
143334447|NCT01212770|516766448|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
143334448|NCT01212770|516766449|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
143334449|NCT01212770|516766450|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
143334450|NCT01212770|516766451|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
143334451|NCT01212770|516766452|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
143334452|NCT01212770|516766453|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
143334453|NCT01212770|516766445|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
143334454|NCT01212770|516766446|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
143334455|NCT01212770|516766447|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
143334456|NCT01212770|516766448|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
143334457|NCT01212770|516766449|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
143334458|NCT01212770|516766450|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
143334459|NCT01212770|516766451|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
143334460|NCT01212770|516766452|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
143334461|NCT01212770|516766453|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
143334462|NCT01212770|516766445|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
143334463|NCT01212770|516766446|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
143334464|NCT01212770|516766447|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
143334465|NCT01212770|516766448|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
143334466|NCT01212770|516766449|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
143334467|NCT01212770|516766450|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
143334468|NCT01212770|516766451|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
143334469|NCT01212770|516766452|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
143334470|NCT01212770|516766453|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
143334471|NCT01212770|516766445|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
143334472|NCT01212770|516766446|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
143334473|NCT01212770|516766447|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
143334474|NCT01212770|516766448|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
143334475|NCT01212770|516766449|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
143334476|NCT01212770|516766450|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
143334477|NCT01212770|516766451|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
143334478|NCT01212770|516766452|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
143334479|NCT01212770|516766453|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
143334480|NCT01212770|516766445|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
143334481|NCT01212770|516766446|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
143334482|NCT01212770|516766447|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
143334483|NCT01212770|516766448|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
143334484|NCT01212770|516766449|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
143334485|NCT01212770|516766450|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
143334486|NCT01212770|516766451|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
143334487|NCT01212770|516766452|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
143334488|NCT01212770|516766453|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
143334489|NCT01212770|516766445|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
143334490|NCT01212770|516766446|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
143334491|NCT01212770|516766447|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
143334492|NCT01212770|516766448|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
143334493|NCT01212770|516766449|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
143334494|NCT01212770|516766450|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
143334495|NCT01212770|516766451|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
143334496|NCT01212770|516766452|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
143334497|NCT01212770|516766453|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
143334498|NCT01212770|516766445|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
143334499|NCT01212770|516766446|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
143334500|NCT01212770|516766447|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
143334501|NCT01212770|516766448|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
143334502|NCT01212770|516766449|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
143334503|NCT01212770|516766450|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
143334504|NCT01212770|516766451|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
143334505|NCT01212770|516766452|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
143334506|NCT01212770|516766453|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
143334507|NCT01212770|516766445|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
143334508|NCT01212770|516766446|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
143334509|NCT01212770|516766447|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
143334510|NCT01212770|516766448|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
143334511|NCT01212770|516766449|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
143334512|NCT01212770|516766450|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
143334513|NCT01212770|516766451|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
143334514|NCT01212770|516766452|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
143334515|NCT01212770|516766453|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
143334516|NCT01212770|516766445|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
143334517|NCT01212770|516766446|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
143334518|NCT01212770|516766447|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
143334519|NCT01212770|516766448|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
143334520|NCT01212770|516766449|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
143334521|NCT01212770|516766450|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
143334522|NCT01212770|516766451|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
143334523|NCT01212770|516766452|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
143334524|NCT01212770|516766453|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
143334525|NCT01212770|516766445|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
143334526|NCT01212770|516766446|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
143334527|NCT01212770|516766447|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
143334528|NCT01212770|516766448|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
143334529|NCT01212770|516766449|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
143334530|NCT01212770|516766450|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
143334531|NCT01212770|516766451|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
143334532|NCT01212770|516766452|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
143334533|NCT01212770|516766453|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
143334534|NCT01212770|516766445|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
143334535|NCT01212770|516766446|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
143334536|NCT01212770|516766447|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
143334537|NCT01212770|516766448|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
143334538|NCT01212770|516766449|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
143334539|NCT01212770|516766450|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
143334540|NCT01212770|516766451|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
143334541|NCT01212770|516766452|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
143334542|NCT01212770|516766453|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
143334543|NCT01212770|516766445|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
143334544|NCT01212770|516766446|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
143334545|NCT01212770|516766447|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
143334546|NCT01212770|516766448|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
143334547|NCT01212770|516766449|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
143334548|NCT01212770|516766450|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
143334549|NCT01212770|516766451|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
143334550|NCT01212770|516766452|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
143334551|NCT01212770|516766453|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
143334552|NCT01212770|516766445|FG000|Long-term Safety Phase (Year 5)|Death|0|||
143334553|NCT01212770|516766446|FG001|Long-term Safety Phase (Year 5)|Death|0|||
143334554|NCT01212770|516766447|FG002|Long-term Safety Phase (Year 5)|Death|0|||
143334555|NCT01212770|516766448|FG003|Long-term Safety Phase (Year 5)|Death|0|||
143334556|NCT01212770|516766449|FG004|Long-term Safety Phase (Year 5)|Death|0|||
143334557|NCT01212770|516766450|FG005|Long-term Safety Phase (Year 5)|Death|0|||
143334558|NCT01212770|516766451|FG006|Long-term Safety Phase (Year 5)|Death|0|||
143334559|NCT01212770|516766452|FG007|Long-term Safety Phase (Year 5)|Death|1|||
143334560|NCT01212770|516766453|FG008|Long-term Safety Phase (Year 5)|Death|0|||
143334561|NCT00344461|516766456|FG000|Overall Study|Adverse Event|6|||
143334562|NCT00344461|516766456|FG000|Overall Study|Death|1|||
143334563|NCT00344461|516766456|FG000|Overall Study|Lack of Efficacy|2|||
143334564|NCT00344461|516766456|FG000|Overall Study|Lost to Follow-up|2|||
143334565|NCT00344461|516766456|FG000|Overall Study|Physician Decision|2|||
143334566|NCT00344461|516766456|FG000|Overall Study|Protocol Violation|6|||
143334567|NCT00344461|516766456|FG000|Overall Study|Withdrawal by Subject|2|||
143334568|NCT01667432|516766457|FG000|Overall Study|Premature Study Termination|26|||
143334569|NCT01667432|516766457|FG000|Overall Study|Failure to Return|10|||
143334570|NCT01667432|516766457|FG000|Overall Study|Moved to Another Center|3|||
143334571|NCT01667432|516766457|FG000|Overall Study|Lost to Follow-up|3|||
143334572|NCT01667432|516766457|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
143334573|NCT01667432|516766457|FG000|Overall Study|Insufficient Therapeutic Response|4|||
143334574|NCT01667432|516766457|FG000|Overall Study|Adverse Event|1|||
143334575|NCT01667432|516766457|FG000|Overall Study|Protocol Deviation|2|||
143334576|NCT01667432|516766457|FG000|Overall Study|Principal Investigator Decision|1|||
143334577|NCT01667432|516766457|FG000|Overall Study|Reason Not Specified|2|||
143334578|NCT01667432|516766457|FG000|Overall Study|Missing Information|4|||
143334579|NCT05338333|516766458|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
143334580|NCT05338333|516766459|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
143334581|NCT01475136|516766460|FG000|Overall Study|Sponsor Decision|0|||
143334582|NCT01475136|516766461|FG001|Overall Study|Sponsor Decision|1|||
143334583|NCT01475136|516766462|FG002|Overall Study|Sponsor Decision|0|||
143334584|NCT01475136|516766463|FG003|Overall Study|Sponsor Decision|0|||
143334585|NCT01475136|516766460|FG000|Overall Study|Entry Criteria Not Met|0|||
143334586|NCT01475136|516766461|FG001|Overall Study|Entry Criteria Not Met|2|||
143334587|NCT01475136|516766462|FG002|Overall Study|Entry Criteria Not Met|3|||
143334588|NCT01475136|516766463|FG003|Overall Study|Entry Criteria Not Met|1|||
143334589|NCT01475136|516766460|FG000|Overall Study|Withdrawal by Subject|0|||
143334590|NCT01475136|516766461|FG001|Overall Study|Withdrawal by Subject|0|||
143334591|NCT01475136|516766462|FG002|Overall Study|Withdrawal by Subject|0|||
143334592|NCT01475136|516766463|FG003|Overall Study|Withdrawal by Subject|2|||
143334593|NCT01475136|516766460|FG000|Overall Study|Adverse Event|1|||
143334594|NCT01475136|516766461|FG001|Overall Study|Adverse Event|0|||
143334595|NCT01475136|516766462|FG002|Overall Study|Adverse Event|0|||
143334596|NCT01475136|516766463|FG003|Overall Study|Adverse Event|1|||
143334597|NCT01475136|516766460|FG000|Overall Study|Death|0|||
143334598|NCT01475136|516766461|FG001|Overall Study|Death|0|||
143334599|NCT01475136|516766462|FG002|Overall Study|Death|0|||
143334600|NCT01475136|516766463|FG003|Overall Study|Death|1|||
143334601|NCT01323530|516768557|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
143334602|NCT01323530|516768558|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
143334603|NCT01323530|516768559|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
143334604|NCT01323530|516768560|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
143334605|NCT01323530|516768561|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
143334606|NCT01323530|516768562|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
143334607|NCT01323530|516768563|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
143334608|NCT01323530|516768557|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
143334609|NCT01323530|516768558|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
143334610|NCT01323530|516768559|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
143334611|NCT01323530|516768560|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
143334612|NCT01323530|516768561|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
143334613|NCT01323530|516768562|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
143334614|NCT01323530|516768563|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
143334615|NCT01323530|516768557|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
143334616|NCT01323530|516768558|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
143334617|NCT01323530|516768559|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
143334618|NCT01323530|516768560|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
143334619|NCT01323530|516768561|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
143334620|NCT01323530|516768562|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
143334621|NCT01323530|516768563|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
143334622|NCT01323530|516768557|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
143334623|NCT01323530|516768558|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
143334624|NCT01323530|516768559|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
143334625|NCT01323530|516768560|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
143334626|NCT01323530|516768561|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
143334627|NCT01323530|516768562|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
143334628|NCT01323530|516768563|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
143334629|NCT01323530|516768557|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
143334630|NCT01323530|516768558|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
143334631|NCT01323530|516768559|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
143334632|NCT01323530|516768560|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
143334633|NCT01323530|516768561|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
143334634|NCT01323530|516768562|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
143334635|NCT01323530|516768563|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
143334636|NCT01323530|516768557|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
143334637|NCT01323530|516768558|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
143334638|NCT01323530|516768559|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
143334639|NCT01323530|516768560|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
143334640|NCT01323530|516768561|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
143334641|NCT01323530|516768562|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
143334642|NCT01323530|516768563|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
143334643|NCT01323530|516768557|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
143334644|NCT01323530|516768558|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
143334645|NCT01323530|516768559|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
143334646|NCT01323530|516768560|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
143334647|NCT01323530|516768561|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
143334648|NCT01323530|516768562|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
143334649|NCT01323530|516768563|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
143334650|NCT01323530|516768557|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
143334651|NCT01323530|516768558|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
143334652|NCT01323530|516768559|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
143334653|NCT01323530|516768560|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
143334654|NCT01323530|516768561|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
143334655|NCT01323530|516768562|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
143334656|NCT01323530|516768563|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
143334657|NCT03014674|516768564|FG000|Overall Study|Withdrawal by Subject|1|||
143334658|NCT03014674|516768565|FG001|Overall Study|Withdrawal by Subject|0|||
143334659|NCT03014674|516768566|FG002|Overall Study|Withdrawal by Subject|0|||
143334660|NCT01332227|516768567|FG000|Overall Study|Adverse Event|4|||
143334661|NCT01332227|516768568|FG001|Overall Study|Adverse Event|1|||
143334662|NCT01332227|516768567|FG000|Overall Study|Withdrawal by Subject|5|||
143334663|NCT01332227|516768568|FG001|Overall Study|Withdrawal by Subject|1|||
143334664|NCT01332227|516768567|FG000|Overall Study|Lost to Follow-up|2|||
143334665|NCT01332227|516768568|FG001|Overall Study|Lost to Follow-up|0|||
143334666|NCT01332227|516768567|FG000|Overall Study|Lack of Efficacy|3|||
143334667|NCT01332227|516768568|FG001|Overall Study|Lack of Efficacy|1|||
143334668|NCT01332227|516768567|FG000|Overall Study|Poor compliance/noncompliance|1|||
143334669|NCT01332227|516768568|FG001|Overall Study|Poor compliance/noncompliance|1|||
143334670|NCT01332227|516768567|FG000|Overall Study|Patient moved from area|1|||
143334671|NCT01332227|516768568|FG001|Overall Study|Patient moved from area|0|||
143334672|NCT01332227|516768567|FG000|Overall Study|Patient began prohibited medication|0|||
143334673|NCT01332227|516768568|FG001|Overall Study|Patient began prohibited medication|1|||
143334674|NCT00514943|516768569|FG000|Stage 1|Progressive disease|4|||
143334675|NCT00514943|516768570|FG001|Stage 1|Progressive disease|8|||
143334676|NCT00514943|516768569|FG000|Stage 1|Other Adverse Event|16|||
143334677|NCT00514943|516768570|FG001|Stage 1|Other Adverse Event|6|||
143334678|NCT00514943|516768569|FG000|Stage 1|Not treated|1|||
143334679|NCT00514943|516768570|FG001|Stage 1|Not treated|2|||
143384713|NCT00567398|516954972|FG000|Overall Study|Physician Decision|0|||
143384714|NCT00567398|516954973|FG001|Overall Study|Physician Decision|4|||
143384715|NCT00567398|516954972|FG000|Overall Study|Withdrawal by Subject|0|||
143334680|NCT00514943|516768569|FG000|Stage 1|Patient refused to continue study meds|8|||
143334681|NCT00514943|516768570|FG001|Stage 1|Patient refused to continue study meds|3|||
143334682|NCT00514943|516768569|FG000|Stage 1|Other than stated above|1|||
143334683|NCT00514943|516768570|FG001|Stage 1|Other than stated above|7|||
143334684|NCT00514943|516768569|FG000|Stage 2|Progressive disease|27|||
143334685|NCT00514943|516768570|FG001|Stage 2|Progressive disease|24|||
143334686|NCT00514943|516768569|FG000|Stage 2|Other Adverse Event|3|||
143334687|NCT00514943|516768570|FG001|Stage 2|Other Adverse Event|10|||
143334688|NCT00514943|516768569|FG000|Stage 2|Patient refused to continue study meds|2|||
143334689|NCT00514943|516768570|FG001|Stage 2|Patient refused to continue study meds|0|||
143334690|NCT00514943|516768569|FG000|Stage 2|Other than stated above|0|||
143334691|NCT00514943|516768570|FG001|Stage 2|Other than stated above|2|||
143334692|NCT03751631|516768576|FG000|Overall Study|Withdrawal by Subject|0|||
143334693|NCT03751631|516768577|FG001|Overall Study|Withdrawal by Subject|0|||
143334694|NCT03751631|516768578|FG002|Overall Study|Withdrawal by Subject|1|||
143334695|NCT03751631|516768579|FG003|Overall Study|Withdrawal by Subject|1|||
143334696|NCT03751631|516768580|FG004|Overall Study|Withdrawal by Subject|0|||
143334697|NCT03751631|516768581|FG005|Overall Study|Withdrawal by Subject|0|||
143334698|NCT03813238|516768582|FG000|Overall Study|Adverse Event|0|||
143334699|NCT03813238|516768583|FG001|Overall Study|Adverse Event|6|||
143334700|NCT03813238|516768582|FG000|Overall Study|Withdrawal by parent/guardian|0|||
143334701|NCT03813238|516768583|FG001|Overall Study|Withdrawal by parent/guardian|2|||
143334702|NCT03813238|516768582|FG000|Overall Study|Lost to Follow-up|0|||
143334703|NCT03813238|516768583|FG001|Overall Study|Lost to Follow-up|1|||
143334704|NCT03813238|516768582|FG000|Overall Study|Other than specified|1|||
143334705|NCT03813238|516768583|FG001|Overall Study|Other than specified|2|||
143334706|NCT00605293|516768584|FG000|Overall Study|Death|2|||
143334707|NCT00605293|516768585|FG001|Overall Study|Death|1|||
143334708|NCT00605293|516768584|FG000|Overall Study|Insufficient Therapeutic Response|2|||
143334709|NCT00605293|516768585|FG001|Overall Study|Insufficient Therapeutic Response|0|||
143334710|NCT00605293|516768584|FG000|Overall Study|Adverse Event|1|||
143334711|NCT00605293|516768585|FG001|Overall Study|Adverse Event|0|||
143334712|NCT00605293|516768584|FG000|Overall Study|Holidays Dialysis Out|1|||
143334713|NCT00605293|516768585|FG001|Overall Study|Holidays Dialysis Out|0|||
143334714|NCT00605293|516768584|FG000|Overall Study|Blood Transfusion|7|||
143334715|NCT00605293|516768585|FG001|Overall Study|Blood Transfusion|1|||
143334716|NCT00605293|516768584|FG000|Overall Study|Renal Transplantation|3|||
143334717|NCT00605293|516768585|FG001|Overall Study|Renal Transplantation|1|||
143334718|NCT00605293|516768584|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
143334719|NCT00605293|516768585|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
143334720|NCT00605293|516768584|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
143334721|NCT00605293|516768585|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
143334722|NCT00605293|516768584|FG000|Overall Study|Principal Investigator Decision|0|||
143334723|NCT00605293|516768585|FG001|Overall Study|Principal Investigator Decision|1|||
143334724|NCT02565914|516768586|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
143334725|NCT02565914|516768586|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
143334726|NCT02565914|516768586|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
143334727|NCT02565914|516768586|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
143334728|NCT02565914|516768586|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
143334729|NCT02565914|516768586|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
143334730|NCT02565914|516768586|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
143334731|NCT02565914|516768586|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
143334732|NCT02565914|516768586|FG000|Part A (Up to 96 Weeks)|Other|18|||
143334733|NCT02565914|516768586|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
143334734|NCT02565914|516768586|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
143334735|NCT02565914|516768586|FG000|Part B (Up to 96 Weeks)|Other|1|||
143334736|NCT02565914|516768586|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
143334737|NCT02565914|516768586|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
143334738|NCT02565914|516768586|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
143334739|NCT02565914|516768586|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
143334740|NCT02565914|516768586|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
143334741|NCT02565914|516768586|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
143334742|NCT02565914|516768586|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
143334743|NCT02565914|516768586|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
143334744|NCT02565914|516768586|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
143334745|NCT02565914|516768586|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
143334746|NCT02565914|516768586|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
143334747|NCT02565914|516768586|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
143334748|NCT02080871|516768590|FG000|Overall Study|Death|1|||
143334749|NCT02080871|516768590|FG000|Overall Study|Lost to Follow-up|1|||
143334750|NCT00234052|516768591|FG000|Treatment|Withdrawal by Subject|3|||
143334751|NCT00234052|516768591|FG000|Treatment|Adverse Event|5|||
143334752|NCT00234052|516768591|FG000|Treatment|Death|2|||
143334753|NCT00234052|516768591|FG000|Treatment|Progressive Disease|11|||
143334754|NCT00234052|516768591|FG000|Follow-up for 5 Years|Death|41|||
143334755|NCT00234052|516768591|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
143334756|NCT00234052|516768591|FG000|Follow-up for 5 Years|Other|7|||
143334757|NCT01410474|516768592|FG000|Overall Study|Withdrawal by Subject|0|||
143334758|NCT01410474|516768593|FG001|Overall Study|Withdrawal by Subject|1|||
143334759|NCT02428296|516768594|FG000|Overall Study|Adverse Event|7|||
143334760|NCT02428296|516768594|FG000|Overall Study|Withdrawal by Subject|2|||
143334761|NCT00828984|516768595|FG000|Overall Study|Adverse Event|2|||
143334762|NCT00828984|516768596|FG001|Overall Study|Adverse Event|3|||
143334763|NCT00828984|516768597|FG002|Overall Study|Adverse Event|0|||
143334764|NCT00828984|516768595|FG000|Overall Study|Lost to Follow-up|5|||
143334765|NCT00828984|516768596|FG001|Overall Study|Lost to Follow-up|3|||
143334766|NCT00828984|516768597|FG002|Overall Study|Lost to Follow-up|1|||
143334767|NCT00828984|516768595|FG000|Overall Study|Withdrawal by Subject|4|||
143334768|NCT00828984|516768596|FG001|Overall Study|Withdrawal by Subject|4|||
143334769|NCT00828984|516768597|FG002|Overall Study|Withdrawal by Subject|4|||
143334770|NCT00828984|516768595|FG000|Overall Study|Ineligable|1|||
143334771|NCT00828984|516768596|FG001|Overall Study|Ineligable|2|||
143334772|NCT00828984|516768597|FG002|Overall Study|Ineligable|0|||
143334773|NCT00828984|516768595|FG000|Overall Study|Medical Contraindication|0|||
143334774|NCT00828984|516768596|FG001|Overall Study|Medical Contraindication|1|||
143334775|NCT00828984|516768597|FG002|Overall Study|Medical Contraindication|0|||
143334776|NCT00828984|516768595|FG000|Overall Study|Noncompliant|1|||
143334777|NCT00828984|516768596|FG001|Overall Study|Noncompliant|2|||
143334778|NCT00828984|516768597|FG002|Overall Study|Noncompliant|3|||
143334779|NCT00828984|516768595|FG000|Overall Study|ConMed|1|||
143334780|NCT00828984|516768596|FG001|Overall Study|ConMed|1|||
143334781|NCT00828984|516768597|FG002|Overall Study|ConMed|1|||
143334782|NCT00831779|516768601|FG000|Overall Study|Lost to Follow-up|1|||
143334783|NCT00831779|516768602|FG001|Overall Study|Lost to Follow-up|0|||
143334784|NCT00831779|516768601|FG000|Overall Study|No longer met criteria|0|||
143334785|NCT00831779|516768602|FG001|Overall Study|No longer met criteria|1|||
143334786|NCT00338884|516768603|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
143334787|NCT00338884|516768603|FG000|Overall Study|Adverse Event|14|||
143334788|NCT00338884|516768603|FG000|Overall Study|Death|8|||
143334789|NCT00338884|516768603|FG000|Overall Study|Other|4|||
143334790|NCT00338884|516768603|FG000|Overall Study|Global Deterioration of Health Status|3|||
143334791|NCT00338884|516768603|FG000|Overall Study|Withdrawal by Subject|3|||
143334792|NCT00338884|516768603|FG000|Overall Study|Lost to Follow-up|1|||
143334793|NCT00338884|516768603|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
143334794|NCT02355002|516768605|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
143334795|NCT02355002|516768606|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
143334796|NCT02355002|516768605|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
143334797|NCT02355002|516768606|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
143334798|NCT02355002|516768605|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
143334799|NCT02355002|516768606|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
143334800|NCT02355002|516768605|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
143334801|NCT02355002|516768606|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
143334802|NCT02355002|516768605|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
143334803|NCT02355002|516768606|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
143334804|NCT02355002|516768605|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
143334805|NCT02355002|516768606|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
143334806|NCT02355002|516768605|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
143334807|NCT02355002|516768606|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
143334808|NCT05711641|516768609|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
143334809|NCT05711641|516768610|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
143334810|NCT05711641|516768609|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
143334811|NCT05711641|516768610|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
143334812|NCT02363946|516768612|FG000|Overall Study|Lost to Follow-up|0|||
143334813|NCT02363946|516768613|FG001|Overall Study|Lost to Follow-up|0|||
143334814|NCT02363946|516768614|FG002|Overall Study|Lost to Follow-up|0|||
143334815|NCT02363946|516768615|FG003|Overall Study|Lost to Follow-up|0|||
143334816|NCT02363946|516768616|FG004|Overall Study|Lost to Follow-up|0|||
143334817|NCT02363946|516768617|FG005|Overall Study|Lost to Follow-up|0|||
143334818|NCT02363946|516768618|FG006|Overall Study|Lost to Follow-up|0|||
143334819|NCT02363946|516768619|FG007|Overall Study|Lost to Follow-up|1|||
143334820|NCT02363946|516768620|FG008|Overall Study|Lost to Follow-up|0|||
143334821|NCT02363946|516768621|FG009|Overall Study|Lost to Follow-up|0|||
143334822|NCT02363946|516768622|FG010|Overall Study|Lost to Follow-up|0|||
143334823|NCT02363946|516768623|FG011|Overall Study|Lost to Follow-up|0|||
143334824|NCT02363946|516768624|FG012|Overall Study|Lost to Follow-up|0|||
143334825|NCT02275065|516768626|FG000|Overall Study|Randomized but not treated|1|||
143334826|NCT02275065|516768627|FG001|Overall Study|Randomized but not treated|0|||
143334827|NCT02275065|516768628|FG002|Overall Study|Randomized but not treated|1|||
143334828|NCT02275065|516768629|FG003|Overall Study|Randomized but not treated|1|||
143334829|NCT02275065|516768630|FG004|Overall Study|Randomized but not treated|0|||
143334830|NCT01995461|516768631|FG000|Overall Study|Death|1|||
143334831|NCT01995461|516768631|FG000|Overall Study|Lost to Follow-up|2|||
143334832|NCT01995461|516768631|FG000|Overall Study|Withdrawal by Subject|2|||
143334833|NCT01777854|516768634|FG000|Overall Study|Physician Decision|3|||
143334834|NCT01777854|516768635|FG001|Overall Study|Physician Decision|3|||
143334835|NCT03311373|516768638|FG000|Overall Study|Adverse Event|1|||
143334836|NCT03311373|516768638|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
143334837|NCT03311373|516768638|FG000|Overall Study|Lost to Follow-up|1|||
143334838|NCT03311373|516768638|FG000|Overall Study|Physician Decision|1|||
143334839|NCT03311373|516768638|FG000|Overall Study|Withdrawal by Subject|3|||
143334840|NCT02291614|516768643|FG000|Overall Study|Lost to Follow-up|0|||
143334841|NCT02291614|516768644|FG001|Overall Study|Lost to Follow-up|0|||
143334842|NCT02291614|516768645|FG002|Overall Study|Lost to Follow-up|0|||
143334843|NCT02291614|516768646|FG003|Overall Study|Lost to Follow-up|0|||
143334844|NCT02291614|516768647|FG004|Overall Study|Lost to Follow-up|0|||
143334845|NCT02291614|516768648|FG005|Overall Study|Lost to Follow-up|0|||
143334846|NCT02291614|516768649|FG006|Overall Study|Lost to Follow-up|0|||
143334847|NCT02291614|516768650|FG007|Overall Study|Lost to Follow-up|1|||
143334848|NCT02291614|516768651|FG008|Overall Study|Lost to Follow-up|0|||
143334849|NCT02291614|516768652|FG009|Overall Study|Lost to Follow-up|0|||
143334850|NCT02291614|516768653|FG010|Overall Study|Lost to Follow-up|0|||
143334851|NCT02291614|516768643|FG000|Overall Study|Withdrawal by Subject|0|||
143334852|NCT02291614|516768644|FG001|Overall Study|Withdrawal by Subject|1|||
143334853|NCT02291614|516768645|FG002|Overall Study|Withdrawal by Subject|0|||
143334854|NCT02291614|516768646|FG003|Overall Study|Withdrawal by Subject|0|||
143334855|NCT02291614|516768647|FG004|Overall Study|Withdrawal by Subject|0|||
143334856|NCT02291614|516768648|FG005|Overall Study|Withdrawal by Subject|0|||
143334857|NCT02291614|516768649|FG006|Overall Study|Withdrawal by Subject|0|||
143334858|NCT02291614|516768650|FG007|Overall Study|Withdrawal by Subject|0|||
143334859|NCT02291614|516768651|FG008|Overall Study|Withdrawal by Subject|0|||
143334860|NCT02291614|516768652|FG009|Overall Study|Withdrawal by Subject|2|||
143334861|NCT02291614|516768653|FG010|Overall Study|Withdrawal by Subject|2|||
143334862|NCT02291614|516768643|FG000|Overall Study|Decision by sponsor|0|||
143334863|NCT02291614|516768644|FG001|Overall Study|Decision by sponsor|0|||
143334864|NCT02291614|516768645|FG002|Overall Study|Decision by sponsor|0|||
143334865|NCT02291614|516768646|FG003|Overall Study|Decision by sponsor|1|||
143334866|NCT02291614|516768647|FG004|Overall Study|Decision by sponsor|0|||
143334867|NCT02291614|516768648|FG005|Overall Study|Decision by sponsor|0|||
143334868|NCT02291614|516768649|FG006|Overall Study|Decision by sponsor|0|||
143334869|NCT02291614|516768650|FG007|Overall Study|Decision by sponsor|0|||
143334870|NCT02291614|516768651|FG008|Overall Study|Decision by sponsor|0|||
143334871|NCT02291614|516768652|FG009|Overall Study|Decision by sponsor|0|||
143334872|NCT02291614|516768653|FG010|Overall Study|Decision by sponsor|0|||
143334873|NCT02291614|516768643|FG000|Overall Study|Death|0|||
143334874|NCT02291614|516768644|FG001|Overall Study|Death|0|||
143334875|NCT02291614|516768645|FG002|Overall Study|Death|1|||
143334876|NCT02291614|516768646|FG003|Overall Study|Death|0|||
143334877|NCT02291614|516768647|FG004|Overall Study|Death|1|||
143334878|NCT02291614|516768648|FG005|Overall Study|Death|1|||
143334879|NCT02291614|516768649|FG006|Overall Study|Death|1|||
143334880|NCT02291614|516768650|FG007|Overall Study|Death|0|||
143334881|NCT02291614|516768651|FG008|Overall Study|Death|0|||
143334882|NCT02291614|516768652|FG009|Overall Study|Death|0|||
143334883|NCT02291614|516768653|FG010|Overall Study|Death|0|||
143334884|NCT00127101|516768654|FG000|Base Protocol|Adverse Event|0|||
143334885|NCT00127101|516768655|FG001|Base Protocol|Adverse Event|2|||
143334886|NCT00127101|516768656|FG002|Base Protocol|Adverse Event|1|||
143334887|NCT00127101|516768657|FG003|Base Protocol|Adverse Event|0|||
143334888|NCT00127101|516768658|FG004|Base Protocol|Adverse Event|0|||
143334889|NCT00127101|516768659|FG005|Base Protocol|Adverse Event|0|||
143334890|NCT00127101|516768654|FG000|Base Protocol|Lack of Efficacy|1|||
143334891|NCT00127101|516768655|FG001|Base Protocol|Lack of Efficacy|0|||
143334892|NCT00127101|516768656|FG002|Base Protocol|Lack of Efficacy|0|||
143334893|NCT00127101|516768657|FG003|Base Protocol|Lack of Efficacy|0|||
143334894|NCT00127101|516768658|FG004|Base Protocol|Lack of Efficacy|2|||
143334895|NCT00127101|516768659|FG005|Base Protocol|Lack of Efficacy|0|||
143334896|NCT00127101|516768654|FG000|Base Protocol|Withdrawal by Subject|1|||
143334897|NCT00127101|516768655|FG001|Base Protocol|Withdrawal by Subject|2|||
143334898|NCT00127101|516768656|FG002|Base Protocol|Withdrawal by Subject|1|||
143334899|NCT00127101|516768657|FG003|Base Protocol|Withdrawal by Subject|0|||
143334900|NCT00127101|516768658|FG004|Base Protocol|Withdrawal by Subject|0|||
143334901|NCT00127101|516768659|FG005|Base Protocol|Withdrawal by Subject|1|||
143334902|NCT00127101|516768654|FG000|Continuation Phase|Adverse Event|0|||
143334903|NCT00127101|516768655|FG001|Continuation Phase|Adverse Event|0|||
143334904|NCT00127101|516768656|FG002|Continuation Phase|Adverse Event|0|||
143334905|NCT00127101|516768657|FG003|Continuation Phase|Adverse Event|0|||
143334906|NCT00127101|516768658|FG004|Continuation Phase|Adverse Event|1|||
143334907|NCT00127101|516768659|FG005|Continuation Phase|Adverse Event|1|||
143334908|NCT00127101|516768654|FG000|Continuation Phase|Lack of Efficacy|0|||
143334909|NCT00127101|516768655|FG001|Continuation Phase|Lack of Efficacy|0|||
143334910|NCT00127101|516768656|FG002|Continuation Phase|Lack of Efficacy|0|||
143334911|NCT00127101|516768657|FG003|Continuation Phase|Lack of Efficacy|0|||
143334912|NCT00127101|516768658|FG004|Continuation Phase|Lack of Efficacy|0|||
143334913|NCT00127101|516768659|FG005|Continuation Phase|Lack of Efficacy|1|||
143334914|NCT00127101|516768654|FG000|Continuation Phase|Withdrawal by Subject|0|||
143334915|NCT00127101|516768655|FG001|Continuation Phase|Withdrawal by Subject|0|||
143334916|NCT00127101|516768656|FG002|Continuation Phase|Withdrawal by Subject|1|||
143334917|NCT00127101|516768657|FG003|Continuation Phase|Withdrawal by Subject|0|||
143334918|NCT00127101|516768658|FG004|Continuation Phase|Withdrawal by Subject|2|||
143334919|NCT00127101|516768659|FG005|Continuation Phase|Withdrawal by Subject|1|||
143334920|NCT01830127|516768660|FG000|Overall Study|Adverse Event|1|||
143334921|NCT01830127|516768661|FG001|Overall Study|Adverse Event|6|||
143334922|NCT01830127|516768660|FG000|Overall Study|Lack of Efficacy|3|||
143334923|NCT01830127|516768661|FG001|Overall Study|Lack of Efficacy|0|||
143334924|NCT01830127|516768660|FG000|Overall Study|Withdrawal by Subject|1|||
143334925|NCT01830127|516768661|FG001|Overall Study|Withdrawal by Subject|1|||
143334926|NCT01830127|516768660|FG000|Overall Study|Other reason not defined above|0|||
143334927|NCT01830127|516768661|FG001|Overall Study|Other reason not defined above|2|||
143334928|NCT01662310|516768662|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
143334929|NCT01662310|516768663|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
143334930|NCT01662310|516768664|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
143334931|NCT01662310|516768665|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
143334932|NCT01662310|516768666|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
143334933|NCT01662310|516768662|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
143334934|NCT01662310|516768663|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
143334935|NCT01662310|516768664|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
143334936|NCT01662310|516768665|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
143334937|NCT01662310|516768666|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
143334938|NCT01662310|516768662|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
143334939|NCT01662310|516768663|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
143334940|NCT01662310|516768664|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
143334941|NCT01662310|516768665|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
143334942|NCT01662310|516768666|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
143334943|NCT01662310|516768662|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
143334944|NCT01662310|516768663|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
143334945|NCT01662310|516768664|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
143334946|NCT01662310|516768665|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
143334947|NCT01662310|516768666|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
143334948|NCT01662310|516768662|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
143334949|NCT01662310|516768663|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
143334950|NCT01662310|516768664|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
143334951|NCT01662310|516768665|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
143334952|NCT01662310|516768666|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
143334953|NCT01662310|516768662|FG000|Run-In or Stabilization Phase|Other|1|||
143334954|NCT01662310|516768663|FG001|Run-In or Stabilization Phase|Other|0|||
143334955|NCT01662310|516768664|FG002|Run-In or Stabilization Phase|Other|0|||
143334956|NCT01662310|516768665|FG003|Run-In or Stabilization Phase|Other|0|||
143334957|NCT01662310|516768666|FG004|Run-In or Stabilization Phase|Other|0|||
143334958|NCT01662310|516768662|FG000|Double-Blind Phase|Adverse Event|0|||
143334959|NCT01662310|516768663|FG001|Double-Blind Phase|Adverse Event|0|||
143334960|NCT01662310|516768664|FG002|Double-Blind Phase|Adverse Event|1|||
143334961|NCT01662310|516768665|FG003|Double-Blind Phase|Adverse Event|0|||
143334962|NCT01662310|516768666|FG004|Double-Blind Phase|Adverse Event|0|||
143334963|NCT01662310|516768662|FG000|Double-Blind Phase|Lost to Follow-up|0|||
143334964|NCT01662310|516768663|FG001|Double-Blind Phase|Lost to Follow-up|3|||
143334965|NCT01662310|516768664|FG002|Double-Blind Phase|Lost to Follow-up|0|||
143334966|NCT01662310|516768665|FG003|Double-Blind Phase|Lost to Follow-up|0|||
143334967|NCT01662310|516768666|FG004|Double-Blind Phase|Lost to Follow-up|0|||
143334968|NCT01662310|516768662|FG000|Double-Blind Phase|Pregnancy|0|||
143334969|NCT01662310|516768663|FG001|Double-Blind Phase|Pregnancy|2|||
143334970|NCT01662310|516768664|FG002|Double-Blind Phase|Pregnancy|0|||
143334971|NCT01662310|516768665|FG003|Double-Blind Phase|Pregnancy|0|||
143334972|NCT01662310|516768666|FG004|Double-Blind Phase|Pregnancy|0|||
143334973|NCT01662310|516768662|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
143334974|NCT01662310|516768663|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
143334975|NCT01662310|516768664|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
143334976|NCT01662310|516768665|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
143334977|NCT01662310|516768666|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
143334978|NCT01662310|516768662|FG000|Double-Blind Phase|Other|0|||
143334979|NCT01662310|516768663|FG001|Double-Blind Phase|Other|0|||
143334980|NCT01662310|516768664|FG002|Double-Blind Phase|Other|1|||
143384716|NCT00567398|516954973|FG001|Overall Study|Withdrawal by Subject|2|||
143384717|NCT00567398|516954972|FG000|Overall Study|Renal Transplantation|0|||
143384718|NCT00567398|516954973|FG001|Overall Study|Renal Transplantation|3|||
143384719|NCT00567398|516954972|FG000|Overall Study|Other|1|||
143384720|NCT00567398|516954973|FG001|Overall Study|Other|0|||
143384721|NCT03517553|516954974|FG000|Overall Study|Withdrawal by Subject|2|||
143384722|NCT05215847|516954975|FG000|Overall Study|Lost to Follow-up|1|||
143384723|NCT04143061|516954976|FG000|Overall Study|Protocol Deviation|0|||
143384724|NCT04143061|516954977|FG001|Overall Study|Protocol Deviation|0|||
143384725|NCT04143061|516954978|FG002|Overall Study|Protocol Deviation|0|||
143384726|NCT04143061|516954979|FG003|Overall Study|Protocol Deviation|0|||
143384727|NCT04143061|516954980|FG004|Overall Study|Protocol Deviation|0|||
143384728|NCT04143061|516954981|FG005|Overall Study|Protocol Deviation|0|||
143384729|NCT04143061|516954982|FG006|Overall Study|Protocol Deviation|5|||
143384730|NCT04143061|516954983|FG007|Overall Study|Protocol Deviation|5|||
143384731|NCT04143061|516954976|FG000|Overall Study|Withdrawal by Subject|2|||
143384732|NCT04143061|516954977|FG001|Overall Study|Withdrawal by Subject|0|||
143384733|NCT04143061|516954978|FG002|Overall Study|Withdrawal by Subject|0|||
143384734|NCT04143061|516954979|FG003|Overall Study|Withdrawal by Subject|0|||
143384735|NCT04143061|516954980|FG004|Overall Study|Withdrawal by Subject|0|||
143384736|NCT04143061|516954981|FG005|Overall Study|Withdrawal by Subject|1|||
143384737|NCT04143061|516954982|FG006|Overall Study|Withdrawal by Subject|0|||
143384738|NCT04143061|516954983|FG007|Overall Study|Withdrawal by Subject|0|||
143384739|NCT04143061|516954976|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
143384740|NCT04143061|516954977|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
143384741|NCT04143061|516954978|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
143384742|NCT04143061|516954979|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
143334981|NCT01662310|516768665|FG003|Double-Blind Phase|Other|0|||
143334982|NCT01662310|516768666|FG004|Double-Blind Phase|Other|0|||
143334983|NCT01662310|516768662|FG000|Double-Blind Phase|Randomized but not treated|0|||
143334984|NCT01662310|516768663|FG001|Double-Blind Phase|Randomized but not treated|1|||
143334985|NCT01662310|516768664|FG002|Double-Blind Phase|Randomized but not treated|0|||
143334986|NCT01662310|516768665|FG003|Double-Blind Phase|Randomized but not treated|0|||
143334987|NCT01662310|516768666|FG004|Double-Blind Phase|Randomized but not treated|0|||
143334988|NCT01662310|516768662|FG000|Open-Label Extension Phase|Adverse Event|0|||
143334989|NCT01662310|516768663|FG001|Open-Label Extension Phase|Adverse Event|0|||
143334990|NCT01662310|516768664|FG002|Open-Label Extension Phase|Adverse Event|0|||
143334991|NCT01662310|516768665|FG003|Open-Label Extension Phase|Adverse Event|3|||
143334992|NCT01662310|516768666|FG004|Open-Label Extension Phase|Adverse Event|0|||
143334993|NCT01662310|516768662|FG000|Open-Label Extension Phase|Death|0|||
143334994|NCT01662310|516768663|FG001|Open-Label Extension Phase|Death|0|||
143334995|NCT01662310|516768664|FG002|Open-Label Extension Phase|Death|0|||
143334996|NCT01662310|516768665|FG003|Open-Label Extension Phase|Death|1|||
143334997|NCT01662310|516768666|FG004|Open-Label Extension Phase|Death|0|||
143334998|NCT01662310|516768662|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
143334999|NCT01662310|516768663|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
143335000|NCT01662310|516768664|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
143335001|NCT01662310|516768665|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
143335002|NCT01662310|516768666|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
143335003|NCT01662310|516768662|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
143335004|NCT01662310|516768663|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
143335005|NCT01662310|516768664|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
143335006|NCT01662310|516768665|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
143335007|NCT01662310|516768666|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
143335008|NCT01662310|516768662|FG000|Open-Label Extension Phase|Pregnancy|0|||
143335009|NCT01662310|516768663|FG001|Open-Label Extension Phase|Pregnancy|0|||
143335010|NCT01662310|516768664|FG002|Open-Label Extension Phase|Pregnancy|0|||
143335011|NCT01662310|516768665|FG003|Open-Label Extension Phase|Pregnancy|1|||
143335012|NCT01662310|516768666|FG004|Open-Label Extension Phase|Pregnancy|0|||
143335013|NCT01662310|516768662|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
143335014|NCT01662310|516768663|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
143335015|NCT01662310|516768664|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
143335016|NCT01662310|516768665|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
143335017|NCT01662310|516768666|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
143335018|NCT02432105|516768670|FG000|Overall Study|Lost to Follow-up|1|||
143335019|NCT02432105|516768671|FG001|Overall Study|Lost to Follow-up|1|||
143335020|NCT02432105|516768672|FG002|Overall Study|Lost to Follow-up|0|||
143335021|NCT02432105|516768670|FG000|Overall Study|Withdrawal by Subject|1|||
143335022|NCT02432105|516768671|FG001|Overall Study|Withdrawal by Subject|0|||
143335023|NCT02432105|516768672|FG002|Overall Study|Withdrawal by Subject|1|||
143335024|NCT02432105|516768670|FG000|Overall Study|Culture positive for yeast|0|||
143335025|NCT02432105|516768671|FG001|Overall Study|Culture positive for yeast|1|||
143335026|NCT02432105|516768672|FG002|Overall Study|Culture positive for yeast|0|||
143335027|NCT02432105|516768670|FG000|Overall Study|Randomized in error|0|||
143335028|NCT02432105|516768671|FG001|Overall Study|Randomized in error|0|||
143335029|NCT02432105|516768672|FG002|Overall Study|Randomized in error|2|||
143335030|NCT01302847|516768674|FG000|Overall Study|Death|0|||
143335031|NCT01302847|516768675|FG001|Overall Study|Death|1|||
143335032|NCT01302847|516768676|FG002|Overall Study|Death|0|||
143335033|NCT01302847|516768677|FG003|Overall Study|Death|0|||
143335034|NCT01302847|516768678|FG004|Overall Study|Death|0|||
143335035|NCT01302847|516768679|FG005|Overall Study|Death|1|||
143335036|NCT01302847|516768680|FG006|Overall Study|Death|1|||
143335037|NCT01302847|516768681|FG007|Overall Study|Death|0|||
143335038|NCT01302847|516768674|FG000|Overall Study|Pregnancy|2|||
143335039|NCT01302847|516768675|FG001|Overall Study|Pregnancy|0|||
143335040|NCT01302847|516768676|FG002|Overall Study|Pregnancy|0|||
143335041|NCT01302847|516768677|FG003|Overall Study|Pregnancy|0|||
143335042|NCT01302847|516768678|FG004|Overall Study|Pregnancy|0|||
143335043|NCT01302847|516768679|FG005|Overall Study|Pregnancy|0|||
143335044|NCT01302847|516768680|FG006|Overall Study|Pregnancy|0|||
143335045|NCT01302847|516768681|FG007|Overall Study|Pregnancy|0|||
143335046|NCT01302847|516768674|FG000|Overall Study|Virologic failure|0|||
143335047|NCT01302847|516768675|FG001|Overall Study|Virologic failure|2|||
143335048|NCT01302847|516768676|FG002|Overall Study|Virologic failure|0|||
143335049|NCT01302847|516768677|FG003|Overall Study|Virologic failure|2|||
143335050|NCT01302847|516768678|FG004|Overall Study|Virologic failure|1|||
143335051|NCT01302847|516768679|FG005|Overall Study|Virologic failure|3|||
143335052|NCT01302847|516768680|FG006|Overall Study|Virologic failure|1|||
143335053|NCT01302847|516768681|FG007|Overall Study|Virologic failure|2|||
143335054|NCT01302847|516768674|FG000|Overall Study|Severe debilitation, unable to continue|0|||
143335055|NCT01302847|516768675|FG001|Overall Study|Severe debilitation, unable to continue|0|||
143335056|NCT01302847|516768676|FG002|Overall Study|Severe debilitation, unable to continue|0|||
143384743|NCT04143061|516954980|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
143384744|NCT04143061|516954981|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
143384745|NCT04143061|516954982|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
143384746|NCT04143061|516954983|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
143384747|NCT03602014|516954992|FG000|Overall Study|Lost to Follow-up|2|||
143384748|NCT03602014|516954993|FG001|Overall Study|Lost to Follow-up|0|||
143384749|NCT03602014|516954994|FG002|Overall Study|Lost to Follow-up|0|||
143384750|NCT01898494|516954998|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
143384751|NCT01898494|516954999|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
143384752|NCT01898494|516955000|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
143384753|NCT01898494|516955001|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
143384754|NCT01898494|516955002|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
143384755|NCT01898494|516954998|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
143384756|NCT01898494|516954999|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
143384757|NCT01898494|516955000|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
143384758|NCT01898494|516955001|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
143384759|NCT01898494|516955002|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
143384760|NCT01898494|516954998|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
143384761|NCT01898494|516954999|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
143384762|NCT01898494|516955000|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
143384763|NCT01898494|516955001|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
143384764|NCT01898494|516955002|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
143384765|NCT01898494|516954998|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
143384766|NCT01898494|516954999|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
143384767|NCT01898494|516955000|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
143384768|NCT01898494|516955001|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
143384769|NCT01898494|516955002|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
143384770|NCT01898494|516954998|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
143384771|NCT01898494|516954999|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
143384772|NCT01898494|516955000|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
143384773|NCT01898494|516955001|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
143384774|NCT01898494|516955002|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
143384775|NCT01898494|516954998|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
143384776|NCT01898494|516954999|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
143384777|NCT01898494|516955000|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
143384778|NCT01898494|516955001|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
143384779|NCT01898494|516955002|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
143384780|NCT01898494|516954998|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
143384781|NCT01898494|516954999|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
143384782|NCT01898494|516955000|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
143384783|NCT01898494|516955001|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
143384784|NCT01898494|516955002|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
143384785|NCT01898494|516954998|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
143384786|NCT01898494|516954999|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
143384787|NCT01898494|516955000|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
143384788|NCT01898494|516955001|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
143384789|NCT01898494|516955002|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
143384790|NCT01898494|516954998|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
143384791|NCT01898494|516954999|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
143384792|NCT01898494|516955000|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
143384793|NCT01898494|516955001|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
143384794|NCT01898494|516955002|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
143384795|NCT01898494|516954998|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
143384796|NCT01898494|516954999|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
143384797|NCT01898494|516955000|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
143384798|NCT01898494|516955001|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
143384799|NCT01898494|516955002|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
143384800|NCT01898494|516954998|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
143384801|NCT01898494|516954999|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
143384802|NCT01898494|516955000|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
143384803|NCT01898494|516955001|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
143384804|NCT01898494|516955002|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
143384805|NCT01898494|516954998|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
143384806|NCT01898494|516954999|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
143384807|NCT01898494|516955000|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
143384808|NCT01898494|516955001|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
143384809|NCT01898494|516955002|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
143384810|NCT01898494|516954998|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
143335057|NCT01302847|516768677|FG003|Overall Study|Severe debilitation, unable to continue|0|||
143335058|NCT01302847|516768678|FG004|Overall Study|Severe debilitation, unable to continue|0|||
143335059|NCT01302847|516768679|FG005|Overall Study|Severe debilitation, unable to continue|1|||
143335060|NCT01302847|516768680|FG006|Overall Study|Severe debilitation, unable to continue|1|||
143335061|NCT01302847|516768681|FG007|Overall Study|Severe debilitation, unable to continue|0|||
143335062|NCT01302847|516768674|FG000|Overall Study|Not able to get to clinic|1|||
143335063|NCT01302847|516768675|FG001|Overall Study|Not able to get to clinic|1|||
143335064|NCT01302847|516768676|FG002|Overall Study|Not able to get to clinic|0|||
143335065|NCT01302847|516768677|FG003|Overall Study|Not able to get to clinic|0|||
143335066|NCT01302847|516768678|FG004|Overall Study|Not able to get to clinic|0|||
143335067|NCT01302847|516768679|FG005|Overall Study|Not able to get to clinic|0|||
143335068|NCT01302847|516768680|FG006|Overall Study|Not able to get to clinic|0|||
143335069|NCT01302847|516768681|FG007|Overall Study|Not able to get to clinic|0|||
143335070|NCT01302847|516768674|FG000|Overall Study|Site closing|2|||
143335071|NCT01302847|516768675|FG001|Overall Study|Site closing|2|||
143335072|NCT01302847|516768676|FG002|Overall Study|Site closing|0|||
143335073|NCT01302847|516768677|FG003|Overall Study|Site closing|0|||
143335074|NCT01302847|516768678|FG004|Overall Study|Site closing|0|||
143335075|NCT01302847|516768679|FG005|Overall Study|Site closing|0|||
143335076|NCT01302847|516768680|FG006|Overall Study|Site closing|0|||
143335077|NCT01302847|516768681|FG007|Overall Study|Site closing|0|||
143335078|NCT01302847|516768674|FG000|Overall Study|Withdrawal by Subject|1|||
143335079|NCT01302847|516768675|FG001|Overall Study|Withdrawal by Subject|0|||
143335080|NCT01302847|516768676|FG002|Overall Study|Withdrawal by Subject|0|||
143335081|NCT01302847|516768677|FG003|Overall Study|Withdrawal by Subject|0|||
143335082|NCT01302847|516768678|FG004|Overall Study|Withdrawal by Subject|1|||
143335083|NCT01302847|516768679|FG005|Overall Study|Withdrawal by Subject|0|||
143335084|NCT01302847|516768680|FG006|Overall Study|Withdrawal by Subject|0|||
143335085|NCT01302847|516768681|FG007|Overall Study|Withdrawal by Subject|1|||
143335086|NCT01302847|516768674|FG000|Overall Study|Not willing to adhere to requirements|5|||
143335087|NCT01302847|516768675|FG001|Overall Study|Not willing to adhere to requirements|0|||
143335088|NCT01302847|516768676|FG002|Overall Study|Not willing to adhere to requirements|1|||
143335089|NCT01302847|516768677|FG003|Overall Study|Not willing to adhere to requirements|0|||
143335090|NCT01302847|516768678|FG004|Overall Study|Not willing to adhere to requirements|0|||
143335091|NCT01302847|516768679|FG005|Overall Study|Not willing to adhere to requirements|0|||
143335092|NCT01302847|516768680|FG006|Overall Study|Not willing to adhere to requirements|0|||
143335093|NCT01302847|516768681|FG007|Overall Study|Not willing to adhere to requirements|2|||
143335094|NCT01302847|516768674|FG000|Overall Study|Site unable to contact participant|2|||
143335095|NCT01302847|516768675|FG001|Overall Study|Site unable to contact participant|1|||
143335096|NCT01302847|516768676|FG002|Overall Study|Site unable to contact participant|0|||
143335097|NCT01302847|516768677|FG003|Overall Study|Site unable to contact participant|0|||
143335098|NCT01302847|516768678|FG004|Overall Study|Site unable to contact participant|0|||
143335099|NCT01302847|516768679|FG005|Overall Study|Site unable to contact participant|0|||
143335100|NCT01302847|516768680|FG006|Overall Study|Site unable to contact participant|2|||
143335101|NCT01302847|516768681|FG007|Overall Study|Site unable to contact participant|0|||
143335102|NCT00707031|516768695|FG000|Overall Study|Adverse Event|45|||
143335103|NCT00707031|516768696|FG001|Overall Study|Adverse Event|45|||
143335104|NCT00707031|516768695|FG000|Overall Study|Lack of Efficacy|19|||
143335105|NCT00707031|516768696|FG001|Overall Study|Lack of Efficacy|6|||
143335106|NCT00707031|516768695|FG000|Overall Study|Lost to Follow-up|2|||
143335107|NCT00707031|516768696|FG001|Overall Study|Lost to Follow-up|1|||
143335108|NCT00707031|516768695|FG000|Overall Study|Protocol Violation|1|||
143335109|NCT00707031|516768696|FG001|Overall Study|Protocol Violation|0|||
143335110|NCT00707031|516768695|FG000|Overall Study|Withdrawal by Subject|7|||
143335111|NCT00707031|516768696|FG001|Overall Study|Withdrawal by Subject|8|||
143335112|NCT00707031|516768695|FG000|Overall Study|Poor Compliance to Protocol|7|||
143335113|NCT00707031|516768696|FG001|Overall Study|Poor Compliance to Protocol|13|||
143335114|NCT00707031|516768695|FG000|Overall Study|Familial or Personal Reasons|12|||
143335115|NCT00707031|516768696|FG001|Overall Study|Familial or Personal Reasons|15|||
143335116|NCT00707031|516768695|FG000|Overall Study|Serious Noncompliance|2|||
143335117|NCT00707031|516768696|FG001|Overall Study|Serious Noncompliance|3|||
143335118|NCT00707031|516768695|FG000|Overall Study|Sponsor Decision|9|||
143384811|NCT01898494|516954999|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
143335119|NCT00707031|516768696|FG001|Overall Study|Sponsor Decision|8|||
143335120|NCT00818753|516768702|FG000|Overall Study|Protocol Violation|1|||
143335121|NCT00818753|516768703|FG001|Overall Study|Protocol Violation|0|||
143335122|NCT00818753|516768704|FG002|Overall Study|Protocol Violation|0|||
143335123|NCT00818753|516768702|FG000|Overall Study|Other reason (not specified)|0|||
143335124|NCT00818753|516768703|FG001|Overall Study|Other reason (not specified)|0|||
143335125|NCT00818753|516768704|FG002|Overall Study|Other reason (not specified)|1|||
143335126|NCT00818753|516768702|FG000|Overall Study|Randomised and not treated|2|||
143335127|NCT00818753|516768703|FG001|Overall Study|Randomised and not treated|0|||
143335128|NCT00818753|516768704|FG002|Overall Study|Randomised and not treated|0|||
143335129|NCT01389973|516768705|FG000|Overall Study|Lost to Follow-up|1|||
143335130|NCT01389973|516768705|FG000|Overall Study|Trial Stopped by Sponsor|9|||
143335131|NCT01389973|516768705|FG000|Overall Study|Other|10|||
143335132|NCT00725296|516768706|FG000|Overall Study|Adverse Event|11|||
143335133|NCT00725296|516768706|FG000|Overall Study|Lack of Efficacy|7|||
143335134|NCT00725296|516768706|FG000|Overall Study|Withdrawal by Subject|3|||
143335135|NCT00725296|516768706|FG000|Overall Study|Non-Compliance|2|||
143335136|NCT00725296|516768706|FG000|Overall Study|Lost to Follow-up|1|||
143335137|NCT00725296|516768706|FG000|Overall Study|Other|38|||
143335138|NCT03360942|516768707|FG000|Overall Study|Device explanted|2|||
143335139|NCT03360942|516768707|FG000|Overall Study|Study closure|1|||
143335140|NCT03360942|516768707|FG000|Overall Study|Withdrawal by Subject|2|||
143335141|NCT02459574|516768713|FG000|Overall Study|Withdrawal by Subject|6|||
143335142|NCT02459574|516768714|FG001|Overall Study|Withdrawal by Subject|6|||
143335143|NCT02459574|516768715|FG002|Overall Study|Withdrawal by Subject|2|||
143335144|NCT02459574|516768713|FG000|Overall Study|Lost to Follow-up|1|||
143335145|NCT02459574|516768714|FG001|Overall Study|Lost to Follow-up|1|||
143335146|NCT02459574|516768715|FG002|Overall Study|Lost to Follow-up|0|||
143335147|NCT02459574|516768713|FG000|Overall Study|Death|0|||
143335148|NCT02459574|516768714|FG001|Overall Study|Death|1|||
143335149|NCT02459574|516768715|FG002|Overall Study|Death|0|||
143335150|NCT00251745|516768717|FG000|Overall Study|Adverse Event|7|||
143335151|NCT00251745|516768718|FG001|Overall Study|Adverse Event|9|||
143335152|NCT00251745|516768719|FG002|Overall Study|Adverse Event|11|||
143335153|NCT00251745|516768717|FG000|Overall Study|Lost to Follow-up|4|||
143335154|NCT00251745|516768718|FG001|Overall Study|Lost to Follow-up|2|||
143335155|NCT00251745|516768719|FG002|Overall Study|Lost to Follow-up|5|||
143335156|NCT00251745|516768717|FG000|Overall Study|Withdrawal by Subject|13|||
143335157|NCT00251745|516768718|FG001|Overall Study|Withdrawal by Subject|7|||
143335158|NCT00251745|516768719|FG002|Overall Study|Withdrawal by Subject|3|||
143335159|NCT00251745|516768717|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
143335160|NCT00251745|516768718|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
143335161|NCT00251745|516768719|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
143335162|NCT00251745|516768717|FG000|Overall Study|Lack of Efficacy|3|||
143335163|NCT00251745|516768718|FG001|Overall Study|Lack of Efficacy|0|||
143335164|NCT00251745|516768719|FG002|Overall Study|Lack of Efficacy|0|||
143335165|NCT00251745|516768717|FG000|Overall Study|Noncompliant|0|||
143335166|NCT00251745|516768718|FG001|Overall Study|Noncompliant|2|||
143335167|NCT00251745|516768719|FG002|Overall Study|Noncompliant|2|||
143335168|NCT00251745|516768717|FG000|Overall Study|Pregnancy|0|||
143335169|NCT00251745|516768718|FG001|Overall Study|Pregnancy|1|||
143335170|NCT00251745|516768719|FG002|Overall Study|Pregnancy|0|||
143335171|NCT00251745|516768717|FG000|Overall Study|Per Subject Request|0|||
143335172|NCT00251745|516768718|FG001|Overall Study|Per Subject Request|0|||
143335173|NCT00251745|516768719|FG002|Overall Study|Per Subject Request|1|||
143335174|NCT00251745|516768717|FG000|Overall Study|Per Investigator Request|1|||
143335175|NCT00251745|516768718|FG001|Overall Study|Per Investigator Request|0|||
143335176|NCT00251745|516768719|FG002|Overall Study|Per Investigator Request|0|||
143335177|NCT04508699|516768724|FG000|Overall Study|Lack of Efficacy|2|||
143335178|NCT04508699|516768725|FG001|Overall Study|Lack of Efficacy|15|||
143335179|NCT04508699|516768724|FG000|Overall Study|Withdrawal by Subject|0|||
143335180|NCT04508699|516768725|FG001|Overall Study|Withdrawal by Subject|2|||
143335181|NCT04866017|516768726|FG000|Overall Study|Study Terminated by Sponsor|13|||
143335182|NCT04866017|516768727|FG001|Overall Study|Study Terminated by Sponsor|14|||
143335183|NCT04866017|516768728|FG002|Overall Study|Study Terminated by Sponsor|13|||
143335184|NCT04866017|516768726|FG000|Overall Study|Death|8|||
143335185|NCT04866017|516768727|FG001|Overall Study|Death|4|||
143335186|NCT04866017|516768728|FG002|Overall Study|Death|8|||
143335187|NCT04866017|516768726|FG000|Overall Study|Withdrawal by Subject|1|||
143335188|NCT04866017|516768727|FG001|Overall Study|Withdrawal by Subject|0|||
143335189|NCT04866017|516768728|FG002|Overall Study|Withdrawal by Subject|1|||
143335190|NCT04866017|516768726|FG000|Overall Study|Physician Decision|0|||
143335191|NCT04866017|516768727|FG001|Overall Study|Physician Decision|1|||
143335192|NCT04866017|516768728|FG002|Overall Study|Physician Decision|0|||
143335193|NCT03355326|516768729|FG000|Overall Study|Protocol Violation|3|||
143335194|NCT03355326|516768730|FG001|Overall Study|Protocol Violation|3|||
143335195|NCT01194570|516770223|FG000|Overall Study|Adverse Event|22|||
143335196|NCT01194570|516770224|FG001|Overall Study|Adverse Event|40|||
143335197|NCT01194570|516770223|FG000|Overall Study|Death|6|||
143335198|NCT01194570|516770224|FG001|Overall Study|Death|20|||
143335199|NCT01194570|516770223|FG000|Overall Study|Lack of Efficacy|32|||
143335200|NCT01194570|516770224|FG001|Overall Study|Lack of Efficacy|33|||
143335201|NCT01194570|516770223|FG000|Overall Study|Lost to Follow-up|4|||
143335202|NCT01194570|516770224|FG001|Overall Study|Lost to Follow-up|15|||
143335203|NCT01194570|516770223|FG000|Overall Study|Non-Compliance|2|||
143335204|NCT01194570|516770224|FG001|Overall Study|Non-Compliance|2|||
143335205|NCT01194570|516770223|FG000|Overall Study|Non-Compliance With Study Drug|2|||
143335206|NCT01194570|516770224|FG001|Overall Study|Non-Compliance With Study Drug|2|||
143335207|NCT01194570|516770223|FG000|Overall Study|Other|18|||
143335208|NCT01194570|516770224|FG001|Overall Study|Other|47|||
143335209|NCT01194570|516770223|FG000|Overall Study|Physician Decision|10|||
143335210|NCT01194570|516770224|FG001|Overall Study|Physician Decision|25|||
143335211|NCT01194570|516770223|FG000|Overall Study|Protocol Violation|1|||
143335212|NCT01194570|516770224|FG001|Overall Study|Protocol Violation|2|||
143335213|NCT01194570|516770223|FG000|Overall Study|Study Terminated By Sponsor|0|||
143335214|NCT01194570|516770224|FG001|Overall Study|Study Terminated By Sponsor|1|||
143335215|NCT01194570|516770223|FG000|Overall Study|Withdrawal by Subject|57|||
143335216|NCT01194570|516770224|FG001|Overall Study|Withdrawal by Subject|82|||
143335217|NCT01194570|516770223|FG000|Overall Study|Pregnancy|1|||
143335218|NCT01194570|516770224|FG001|Overall Study|Pregnancy|1|||
143335219|NCT01377480|516770225|FG000|Overall Study|Protocol Violation|0|||
143335220|NCT01377480|516770226|FG001|Overall Study|Protocol Violation|0|||
143335221|NCT01377480|516770227|FG002|Overall Study|Protocol Violation|0|||
143335222|NCT01377480|516770228|FG003|Overall Study|Protocol Violation|4|||
143335223|NCT01377480|516770225|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
143335224|NCT01377480|516770226|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
143335225|NCT01377480|516770227|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
143335226|NCT01377480|516770228|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
143335227|NCT01377480|516770225|FG000|Overall Study|Withdrawal by Subject|0|||
143335228|NCT01377480|516770226|FG001|Overall Study|Withdrawal by Subject|0|||
143335229|NCT01377480|516770227|FG002|Overall Study|Withdrawal by Subject|1|||
143335230|NCT01377480|516770228|FG003|Overall Study|Withdrawal by Subject|0|||
143335231|NCT01377480|516770225|FG000|Overall Study|Serious adverse event|0|||
143335232|NCT01377480|516770226|FG001|Overall Study|Serious adverse event|0|||
143335233|NCT01377480|516770227|FG002|Overall Study|Serious adverse event|1|||
143335234|NCT01377480|516770228|FG003|Overall Study|Serious adverse event|1|||
143335235|NCT01377480|516770225|FG000|Overall Study|Other|0|||
143335236|NCT01377480|516770226|FG001|Overall Study|Other|0|||
143335237|NCT01377480|516770227|FG002|Overall Study|Other|7|||
143335238|NCT01377480|516770228|FG003|Overall Study|Other|6|||
143335239|NCT01735201|516770233|FG000|Overall Study|Adverse Event|1|||
143335240|NCT01735201|516770234|FG001|Overall Study|Adverse Event|1|||
143335241|NCT01735201|516770235|FG002|Overall Study|Adverse Event|0|||
143335242|NCT01735201|516770236|FG003|Overall Study|Adverse Event|1|||
143335243|NCT01735201|516770237|FG004|Overall Study|Adverse Event|1|||
143335244|NCT01735201|516770238|FG005|Overall Study|Adverse Event|3|||
143335245|NCT01735201|516770239|FG006|Overall Study|Adverse Event|2|||
143335246|NCT01735201|516770240|FG007|Overall Study|Adverse Event|1|||
143335247|NCT01735201|516770233|FG000|Overall Study|Personal Reasons|1|||
143335248|NCT01735201|516770234|FG001|Overall Study|Personal Reasons|0|||
143335249|NCT01735201|516770235|FG002|Overall Study|Personal Reasons|0|||
143335250|NCT01735201|516770236|FG003|Overall Study|Personal Reasons|0|||
143335251|NCT01735201|516770237|FG004|Overall Study|Personal Reasons|0|||
143335252|NCT01735201|516770238|FG005|Overall Study|Personal Reasons|0|||
143335253|NCT01735201|516770239|FG006|Overall Study|Personal Reasons|0|||
143335254|NCT01735201|516770240|FG007|Overall Study|Personal Reasons|0|||
143335255|NCT01735201|516770233|FG000|Overall Study|Protocol Violation|1|||
143335256|NCT01735201|516770234|FG001|Overall Study|Protocol Violation|0|||
143335257|NCT01735201|516770235|FG002|Overall Study|Protocol Violation|0|||
143335258|NCT01735201|516770236|FG003|Overall Study|Protocol Violation|0|||
143335259|NCT01735201|516770237|FG004|Overall Study|Protocol Violation|0|||
143335260|NCT01735201|516770238|FG005|Overall Study|Protocol Violation|0|||
143335261|NCT01735201|516770239|FG006|Overall Study|Protocol Violation|0|||
143335262|NCT01735201|516770240|FG007|Overall Study|Protocol Violation|0|||
143335263|NCT01735201|516770233|FG000|Overall Study|Other Miscellaneous Reasons|0|||
143335264|NCT01735201|516770234|FG001|Overall Study|Other Miscellaneous Reasons|0|||
143335265|NCT01735201|516770235|FG002|Overall Study|Other Miscellaneous Reasons|0|||
143335266|NCT01735201|516770236|FG003|Overall Study|Other Miscellaneous Reasons|1|||
143335267|NCT01735201|516770237|FG004|Overall Study|Other Miscellaneous Reasons|0|||
143335268|NCT01735201|516770238|FG005|Overall Study|Other Miscellaneous Reasons|2|||
143335269|NCT01735201|516770239|FG006|Overall Study|Other Miscellaneous Reasons|1|||
143335270|NCT01735201|516770240|FG007|Overall Study|Other Miscellaneous Reasons|1|||
143335271|NCT00289887|516770243|FG000|Overall Study|Adverse Event|3|||
143335272|NCT00289887|516770244|FG001|Overall Study|Adverse Event|3|||
143335273|NCT00289887|516770243|FG000|Overall Study|Lack of Efficacy|3|||
143335274|NCT00289887|516770244|FG001|Overall Study|Lack of Efficacy|11|||
143335275|NCT00289887|516770243|FG000|Overall Study|Lost to Follow-up|3|||
143335276|NCT00289887|516770244|FG001|Overall Study|Lost to Follow-up|3|||
143335277|NCT00289887|516770243|FG000|Overall Study|Protocol Violation|3|||
143335278|NCT00289887|516770244|FG001|Overall Study|Protocol Violation|1|||
143335279|NCT00289887|516770243|FG000|Overall Study|Withdrawal by Subject|3|||
143335280|NCT00289887|516770244|FG001|Overall Study|Withdrawal by Subject|8|||
143335281|NCT00289887|516770243|FG000|Overall Study|Other|7|||
143335282|NCT00289887|516770244|FG001|Overall Study|Other|3|||
143335283|NCT04128293|516770246|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
143335284|NCT04128293|516770247|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
143384812|NCT01898494|516955000|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
143384813|NCT01898494|516955001|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
143384814|NCT01898494|516955002|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
143384815|NCT01898494|516954998|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
143384816|NCT01898494|516954999|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
143384817|NCT01898494|516955000|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
143384818|NCT01898494|516955001|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
143384819|NCT01898494|516955002|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
143384820|NCT03289039|516955003|FG000|Overall Study|Withdrawal by Subject|0|||
143384821|NCT03289039|516955004|FG001|Overall Study|Withdrawal by Subject|1|||
143384822|NCT03289039|516955003|FG000|Overall Study|Became ineligible prior to treatment start|0|||
143384823|NCT03289039|516955004|FG001|Overall Study|Became ineligible prior to treatment start|1|||
143384824|NCT03289039|516955003|FG000|Overall Study|progressed before treatment start|1|||
143384825|NCT03289039|516955004|FG001|Overall Study|progressed before treatment start|0|||
143384826|NCT02553642|516955011|FG000|Overall Study|Withdrawal by Subject|0|||
143384827|NCT02553642|516955012|FG001|Overall Study|Withdrawal by Subject|3|||
143384828|NCT02553642|516955011|FG000|Overall Study|Physician Decision|0|||
143384829|NCT02553642|516955012|FG001|Overall Study|Physician Decision|1|||
143384830|NCT02553642|516955011|FG000|Overall Study|Additional cancer dx|0|||
143384831|NCT02553642|516955012|FG001|Overall Study|Additional cancer dx|1|||
143384832|NCT02553642|516955011|FG000|Overall Study|Never started treatment|0|||
143384833|NCT02553642|516955012|FG001|Overall Study|Never started treatment|1|||
143384834|NCT04711135|516955013|FG000|Overall Study|Physician Decision|0|||
143384835|NCT04711135|516955014|FG001|Overall Study|Physician Decision|1|||
143384836|NCT04711135|516955013|FG000|Overall Study|Ongoing treatment|0|||
143384837|NCT04711135|516955014|FG001|Overall Study|Ongoing treatment|1|||
143384838|NCT04281485|516955015|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
143384839|NCT04281485|516955016|FG001|Overall Study|No Longer Met Eligibility Criteria|2|||
143384840|NCT04281485|516955015|FG000|Overall Study|Ongoing (Safety data collection)|10|||
143384841|NCT04281485|516955016|FG001|Overall Study|Ongoing (Safety data collection)|5|||
143384842|NCT01095796|516955017|FG000|Overall Study|Randomized but Not Treated|5|||
143384843|NCT01095796|516955018|FG001|Overall Study|Randomized but Not Treated|2|||
143384844|NCT01095796|516955017|FG000|Overall Study|Adverse Event|9|||
143384845|NCT01095796|516955018|FG001|Overall Study|Adverse Event|19|||
143384846|NCT01095796|516955017|FG000|Overall Study|Death|3|||
143384847|NCT01095796|516955018|FG001|Overall Study|Death|2|||
143384848|NCT01095796|516955017|FG000|Overall Study|Pregnancy|2|||
143384849|NCT01095796|516955018|FG001|Overall Study|Pregnancy|0|||
143384850|NCT01095796|516955017|FG000|Overall Study|Lack of Efficacy|5|||
143384851|NCT01095796|516955018|FG001|Overall Study|Lack of Efficacy|3|||
143384852|NCT01095796|516955017|FG000|Overall Study|Investigator's Discretion|7|||
143384853|NCT01095796|516955018|FG001|Overall Study|Investigator's Discretion|2|||
143384854|NCT01095796|516955017|FG000|Overall Study|Withdrew Consent|16|||
143384855|NCT01095796|516955018|FG001|Overall Study|Withdrew Consent|22|||
143384856|NCT01095796|516955017|FG000|Overall Study|Lost to Follow-up|27|||
143384857|NCT01095796|516955018|FG001|Overall Study|Lost to Follow-up|29|||
143384858|NCT01095796|516955017|FG000|Overall Study|Participant Noncompliance|5|||
143384859|NCT01095796|516955018|FG001|Overall Study|Participant Noncompliance|10|||
143384860|NCT01095796|516955017|FG000|Overall Study|Protocol Violation|1|||
143384861|NCT01095796|516955018|FG001|Overall Study|Protocol Violation|0|||
143384862|NCT01095796|516955017|FG000|Overall Study|Participant Transferred to Another Study|215|||
143384863|NCT01095796|516955018|FG001|Overall Study|Participant Transferred to Another Study|200|||
143384864|NCT02638337|516955023|FG000|Overall Study|Adverse Event|6|||
143384865|NCT02638337|516955024|FG001|Overall Study|Adverse Event|10|||
143384866|NCT02638337|516955023|FG000|Overall Study|Protocol Violation|3|||
143384867|NCT02638337|516955024|FG001|Overall Study|Protocol Violation|0|||
143384868|NCT02638337|516955023|FG000|Overall Study|Withdrawal by Subject|13|||
143384869|NCT02638337|516955024|FG001|Overall Study|Withdrawal by Subject|16|||
143384870|NCT02638337|516955023|FG000|Overall Study|Lost to Follow-up|7|||
143384871|NCT02638337|516955024|FG001|Overall Study|Lost to Follow-up|7|||
143384872|NCT02638337|516955023|FG000|Overall Study|Other - Miscellaneous|4|||
143384873|NCT02638337|516955024|FG001|Overall Study|Other - Miscellaneous|3|||
143384874|NCT04950127|516955025|FG000|Part A (Day 1 to Week 24)|Adverse Event|4|||
143384875|NCT04950127|516955026|FG001|Part A (Day 1 to Week 24)|Adverse Event|2|||
143384876|NCT04950127|516955027|FG002|Part A (Day 1 to Week 24)|Adverse Event|0|||
143384877|NCT04950127|516955028|FG003|Part A (Day 1 to Week 24)|Adverse Event|0|||
143384878|NCT04950127|516955029|FG004|Part A (Day 1 to Week 24)|Adverse Event|0|||
143384879|NCT04950127|516955030|FG005|Part A (Day 1 to Week 24)|Adverse Event|0|||
143384880|NCT04950127|516955025|FG000|Part A (Day 1 to Week 24)|Physician Decision|3|||
143384881|NCT04950127|516955026|FG001|Part A (Day 1 to Week 24)|Physician Decision|2|||
143384882|NCT04950127|516955027|FG002|Part A (Day 1 to Week 24)|Physician Decision|0|||
143384883|NCT04950127|516955028|FG003|Part A (Day 1 to Week 24)|Physician Decision|0|||
143384884|NCT04950127|516955029|FG004|Part A (Day 1 to Week 24)|Physician Decision|0|||
143384885|NCT04950127|516955030|FG005|Part A (Day 1 to Week 24)|Physician Decision|0|||
143384886|NCT04950127|516955025|FG000|Part A (Day 1 to Week 24)|Withdrawal by Subject|9|||
143384887|NCT04950127|516955026|FG001|Part A (Day 1 to Week 24)|Withdrawal by Subject|7|||
143384888|NCT04950127|516955027|FG002|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
143384889|NCT04950127|516955028|FG003|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
143384890|NCT04950127|516955029|FG004|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
143384891|NCT04950127|516955030|FG005|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
143384892|NCT04950127|516955025|FG000|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
143384893|NCT04950127|516955026|FG001|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
143384894|NCT04950127|516955027|FG002|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
143384895|NCT04950127|516955028|FG003|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
143384896|NCT04950127|516955029|FG004|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
143384897|NCT04950127|516955030|FG005|Part B (Week 24 to Week 32)|Withdrawal by Subject|4|||
143384898|NCT04950127|516955025|FG000|Part B (Week 24 to Week 32)|Physician Decision|0|||
143384899|NCT04950127|516955026|FG001|Part B (Week 24 to Week 32)|Physician Decision|0|||
143384900|NCT04950127|516955027|FG002|Part B (Week 24 to Week 32)|Physician Decision|0|||
143384901|NCT04950127|516955028|FG003|Part B (Week 24 to Week 32)|Physician Decision|0|||
143384902|NCT04950127|516955029|FG004|Part B (Week 24 to Week 32)|Physician Decision|0|||
143384903|NCT04950127|516955030|FG005|Part B (Week 24 to Week 32)|Physician Decision|1|||
143384904|NCT04315181|516955031|FG000|Overall Study|Non-responsive to drug conditions.|1|||
143384905|NCT03271489|516955032|FG000|Double-Blind (DB) Period|Adverse Event|4|||
143384906|NCT03271489|516955033|FG001|Double-Blind (DB) Period|Adverse Event|1|||
143384907|NCT03271489|516955032|FG000|Double-Blind (DB) Period|Withdrawal by Subject|13|||
143384908|NCT03271489|516955033|FG001|Double-Blind (DB) Period|Withdrawal by Subject|10|||
143384909|NCT03271489|516955032|FG000|Double-Blind (DB) Period|Lost to Follow-up|9|||
143384910|NCT03271489|516955033|FG001|Double-Blind (DB) Period|Lost to Follow-up|9|||
143384911|NCT03271489|516955032|FG000|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
143384912|NCT03271489|516955033|FG001|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|2|||
143384913|NCT03271489|516955032|FG000|Double-Blind (DB) Period|Non-compliance with study procedures|0|||
143335285|NCT04128293|516770248|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
143335286|NCT04128293|516770249|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
143335287|NCT02035332|516770250|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
143335288|NCT03382782|516770256|FG000|Cohort 1|Withdrawal by Subject|11|||
143335289|NCT03382782|516770257|FG001|Cohort 1|Withdrawal by Subject|5|||
143335290|NCT03382782|516770258|FG002|Cohort 1|Withdrawal by Subject|0|||
143335291|NCT03382782|516770256|FG000|Cohort 2|Withdrawal by Subject|1|||
143335292|NCT03382782|516770257|FG001|Cohort 2|Withdrawal by Subject|1|||
143335293|NCT03382782|516770258|FG002|Cohort 2|Withdrawal by Subject|0|||
143335294|NCT03382782|516770256|FG000|Cohort 3|Withdrawal by Subject|1|||
143335295|NCT03382782|516770257|FG001|Cohort 3|Withdrawal by Subject|2|||
143335296|NCT03382782|516770258|FG002|Cohort 3|Withdrawal by Subject|0|||
143335297|NCT01791725|516770259|FG000|Overall Study|Withdrawal by Subject|0|||
143335298|NCT01791725|516770260|FG001|Overall Study|Withdrawal by Subject|1|||
143335299|NCT01791725|516770261|FG002|Overall Study|Withdrawal by Subject|0|||
143335300|NCT03255824|516770262|FG000|Overall Study|Under-sedation|2|||
143335301|NCT03255824|516770263|FG001|Overall Study|Under-sedation|1|||
143335302|NCT02001194|516770265|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
143335303|NCT02001194|516770266|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
143335304|NCT02001194|516770267|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
143335305|NCT02001194|516770268|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
143335306|NCT02001194|516770265|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
143335307|NCT02001194|516770266|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
143335308|NCT02001194|516770267|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
143335309|NCT02001194|516770268|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
143335310|NCT00522301|516770270|FG000|Overall Study|Withdrawal by Subject|1|||
143335311|NCT00522301|516770270|FG000|Overall Study|Adverse Event|5|||
143335312|NCT00337272|516770271|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
143335313|NCT00337272|516770272|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
143335314|NCT00337272|516770271|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
143335315|NCT00337272|516770272|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
143335316|NCT00337272|516770271|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
143335317|NCT00337272|516770272|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
143335318|NCT00337272|516770271|FG000|Treatment Period|Non-compliance|1|||
143335319|NCT00337272|516770272|FG001|Treatment Period|Non-compliance|1|||
143335320|NCT00337272|516770271|FG000|Treatment Period|Withdrawal by Subject|0|||
143335321|NCT00337272|516770272|FG001|Treatment Period|Withdrawal by Subject|1|||
143335322|NCT00337272|516770271|FG000|Withdrawal Period|Non-compliance|0|||
143335323|NCT00337272|516770272|FG001|Withdrawal Period|Non-compliance|1|||
143335324|NCT02366910|516770276|FG000|Overall Study|Withdrawal by Subject|2|||
143335325|NCT02366910|516770276|FG000|Overall Study|Screen Failure|3|||
143335326|NCT02219048|516770283|FG000|Overall Study|Adverse Event|2|||
143335327|NCT02219048|516770284|FG001|Overall Study|Adverse Event|5|||
143335328|NCT02219048|516770283|FG000|Overall Study|No longer meets eligibility criteria|1|||
143335329|NCT02219048|516770284|FG001|Overall Study|No longer meets eligibility criteria|0|||
143335330|NCT02219048|516770283|FG000|Overall Study|Study terminated by sponsor|16|||
143335331|NCT02219048|516770284|FG001|Overall Study|Study terminated by sponsor|15|||
143335332|NCT02219048|516770283|FG000|Overall Study|Withdrawal by Subject|2|||
143335333|NCT02219048|516770284|FG001|Overall Study|Withdrawal by Subject|0|||
143335334|NCT02219048|516770283|FG000|Overall Study|Other|0|||
143335335|NCT02219048|516770284|FG001|Overall Study|Other|1|||
143335336|NCT02054806|516770285|FG000|Overall Study|Sponsor Decision|31|||
143335337|NCT02054806|516770285|FG000|Overall Study|Withdrawal by Subject|43|||
143335338|NCT02054806|516770285|FG000|Overall Study|Protocol Violation|2|||
143335339|NCT02054806|516770285|FG000|Overall Study|Lost to Follow-up|10|||
143335340|NCT02054806|516770285|FG000|Overall Study|Death|391|||
143335341|NCT00952367|516770286|FG000|Overall Study|Withdrawal by Subject|2|||
143335342|NCT00952367|516770286|FG000|Overall Study|Noncoordination|1|||
143335343|NCT00952367|516770286|FG000|Overall Study|Protocol Violation|3|||
143335344|NCT02230956|516770287|FG000|Overall Study|Adverse Event|1|||
143335345|NCT02230956|516770288|FG001|Overall Study|Adverse Event|1|||
143335346|NCT02230956|516770289|FG002|Overall Study|Adverse Event|0|||
143335347|NCT02230956|516770287|FG000|Overall Study|Lack of Efficacy|1|||
143335348|NCT02230956|516770288|FG001|Overall Study|Lack of Efficacy|1|||
143335349|NCT02230956|516770289|FG002|Overall Study|Lack of Efficacy|1|||
143335350|NCT02230956|516770287|FG000|Overall Study|Lost to Follow-up|1|||
143335351|NCT02230956|516770288|FG001|Overall Study|Lost to Follow-up|1|||
143335352|NCT02230956|516770289|FG002|Overall Study|Lost to Follow-up|2|||
143335353|NCT02230956|516770287|FG000|Overall Study|Personal Reasons|2|||
143335354|NCT02230956|516770288|FG001|Overall Study|Personal Reasons|1|||
143335355|NCT02230956|516770289|FG002|Overall Study|Personal Reasons|1|||
143335356|NCT02230956|516770287|FG000|Overall Study|Protocol Violation|0|||
143335357|NCT02230956|516770288|FG001|Overall Study|Protocol Violation|1|||
143335358|NCT02230956|516770289|FG002|Overall Study|Protocol Violation|1|||
143335359|NCT02230956|516770287|FG000|Overall Study|Other Miscellaneous Reason|0|||
143335360|NCT02230956|516770288|FG001|Overall Study|Other Miscellaneous Reason|1|||
143335361|NCT02230956|516770289|FG002|Overall Study|Other Miscellaneous Reason|2|||
143335362|NCT04535947|516770292|FG000|Overall Study|Adverse Event|1|||
143335363|NCT04535947|516770293|FG001|Overall Study|Adverse Event|4|||
143335364|NCT04535947|516770292|FG000|Overall Study|Other reasons not specified|2|||
143335365|NCT04535947|516770293|FG001|Overall Study|Other reasons not specified|0|||
143335366|NCT04535947|516770292|FG000|Overall Study|Withdrawal by Subject|1|||
143335367|NCT04535947|516770293|FG001|Overall Study|Withdrawal by Subject|1|||
143335368|NCT01970982|516770295|FG000|Overall Study|Withdrawal by Subject|0|||
143335369|NCT01970982|516770296|FG001|Overall Study|Withdrawal by Subject|0|||
143335370|NCT01970982|516770297|FG002|Overall Study|Withdrawal by Subject|2|||
143335371|NCT00708916|516770300|FG000|Overall Study|Subject Noncompliance|2|||
143335372|NCT00708916|516770300|FG000|Overall Study|Adverse Event|2|||
143335373|NCT03492281|516770302|FG000|Overall Study|Withdrawal by Subject|21|||
143335374|NCT03492281|516770303|FG001|Overall Study|Withdrawal by Subject|14|||
143335375|NCT03492281|516770304|FG002|Overall Study|Withdrawal by Subject|13|||
143335376|NCT03492281|516770302|FG000|Overall Study|Lost to Follow-up|14|||
143335377|NCT03492281|516770303|FG001|Overall Study|Lost to Follow-up|15|||
143335378|NCT03492281|516770304|FG002|Overall Study|Lost to Follow-up|10|||
143335379|NCT03492281|516770302|FG000|Overall Study|Adverse Event|6|||
143335380|NCT03492281|516770303|FG001|Overall Study|Adverse Event|8|||
143335381|NCT03492281|516770304|FG002|Overall Study|Adverse Event|13|||
143335382|NCT03492281|516770302|FG000|Overall Study|Lack of Efficacy|3|||
143335383|NCT03492281|516770303|FG001|Overall Study|Lack of Efficacy|0|||
143335384|NCT03492281|516770304|FG002|Overall Study|Lack of Efficacy|1|||
143335385|NCT03492281|516770302|FG000|Overall Study|Physician Decision|1|||
143335386|NCT03492281|516770303|FG001|Overall Study|Physician Decision|0|||
143335387|NCT03492281|516770304|FG002|Overall Study|Physician Decision|3|||
143335388|NCT03492281|516770302|FG000|Overall Study|Protocol Violation|0|||
143335389|NCT03492281|516770303|FG001|Overall Study|Protocol Violation|2|||
143335390|NCT03492281|516770304|FG002|Overall Study|Protocol Violation|1|||
143335391|NCT03492281|516770302|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
143335392|NCT03492281|516770303|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
143335393|NCT03492281|516770304|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
143335394|NCT03492281|516770302|FG000|Overall Study|Death|0|||
143335395|NCT03492281|516770303|FG001|Overall Study|Death|0|||
143335396|NCT03492281|516770304|FG002|Overall Study|Death|1|||
143335397|NCT03492281|516770302|FG000|Overall Study|Captured as Other in Database|8|||
143335398|NCT03492281|516770303|FG001|Overall Study|Captured as Other in Database|6|||
143335399|NCT03492281|516770304|FG002|Overall Study|Captured as Other in Database|3|||
143335400|NCT00951483|516770305|FG000|Overall Study|Physician Decision|4|||
143335401|NCT00951483|516770306|FG001|Overall Study|Physician Decision|0|||
143335402|NCT00951483|516770305|FG000|Overall Study|Withdrawal by Subject|15|||
143335403|NCT00951483|516770306|FG001|Overall Study|Withdrawal by Subject|0|||
143335404|NCT03565887|516770307|FG000|Overall Study|Adverse Event|1|||
143335405|NCT03565887|516770308|FG001|Overall Study|Adverse Event|0|||
143335406|NCT03565887|516770307|FG000|Overall Study|Withdrawal by Subject|0|||
143335407|NCT03565887|516770308|FG001|Overall Study|Withdrawal by Subject|2|||
143335408|NCT03178266|516770309|FG000|Overall Study|Death|0|||
143335409|NCT03178266|516770310|FG001|Overall Study|Death|1|||
143335410|NCT03178266|516770309|FG000|Overall Study|Disont. Early|0|||
143335411|NCT03178266|516770310|FG001|Overall Study|Disont. Early|1|||
143335412|NCT03178266|516770309|FG000|Overall Study|Withdrawal by Subject|0|||
143335413|NCT03178266|516770310|FG001|Overall Study|Withdrawal by Subject|2|||
143335414|NCT03923933|516770319|FG000|Overall Study|Lost to Follow-up|1|||
143335415|NCT03923933|516770320|FG001|Overall Study|Lost to Follow-up|0|||
143335416|NCT03923933|516770319|FG000|Overall Study|Withdrawal by Subject|0|||
143335417|NCT03923933|516770320|FG001|Overall Study|Withdrawal by Subject|1|||
143335418|NCT00419263|516770321|FG000|Overall Study|Lost to Follow-up|2|||
143335419|NCT00419263|516770322|FG001|Overall Study|Lost to Follow-up|1|||
143335420|NCT00419263|516770323|FG002|Overall Study|Lost to Follow-up|1|||
143335421|NCT00419263|516770321|FG000|Overall Study|Randomized in Error, Not Treated|1|||
143335422|NCT00419263|516770322|FG001|Overall Study|Randomized in Error, Not Treated|1|||
143335423|NCT00419263|516770323|FG002|Overall Study|Randomized in Error, Not Treated|0|||
143335424|NCT00419263|516770321|FG000|Overall Study|Adverse Event|0|||
143335425|NCT00419263|516770322|FG001|Overall Study|Adverse Event|0|||
143335426|NCT00419263|516770323|FG002|Overall Study|Adverse Event|1|||
143335427|NCT00419263|516770321|FG000|Overall Study|Withdrawal by Subject|0|||
143335428|NCT00419263|516770322|FG001|Overall Study|Withdrawal by Subject|0|||
143335429|NCT00419263|516770323|FG002|Overall Study|Withdrawal by Subject|1|||
143335430|NCT02342886|516770324|FG000|Overall Study|Treatment non-compliance|1|||
143335431|NCT02342886|516770325|FG001|Overall Study|Treatment non-compliance|0|||
143335432|NCT02342886|516770326|FG002|Overall Study|Treatment non-compliance|0|||
143335433|NCT02342886|516770327|FG003|Overall Study|Treatment non-compliance|1|||
143335434|NCT02342886|516770328|FG004|Overall Study|Treatment non-compliance|0|||
143335435|NCT02342886|516770324|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
143335436|NCT02342886|516770325|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
143335437|NCT02342886|516770326|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
143335438|NCT02342886|516770327|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
143335439|NCT02342886|516770328|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
143335440|NCT02342886|516770324|FG000|Overall Study|Adverse event/specific toxicity|4|||
143335441|NCT02342886|516770325|FG001|Overall Study|Adverse event/specific toxicity|3|||
143335442|NCT02342886|516770326|FG002|Overall Study|Adverse event/specific toxicity|11|||
143335443|NCT02342886|516770327|FG003|Overall Study|Adverse event/specific toxicity|2|||
143335444|NCT02342886|516770328|FG004|Overall Study|Adverse event/specific toxicity|1|||
143335445|NCT02342886|516770324|FG000|Overall Study|Lost to Follow-up|1|||
143335446|NCT02342886|516770325|FG001|Overall Study|Lost to Follow-up|0|||
143335447|NCT02342886|516770326|FG002|Overall Study|Lost to Follow-up|0|||
143335448|NCT02342886|516770327|FG003|Overall Study|Lost to Follow-up|0|||
143335449|NCT02342886|516770328|FG004|Overall Study|Lost to Follow-up|0|||
143335450|NCT02342886|516770324|FG000|Overall Study|Death|1|||
143335451|NCT02342886|516770325|FG001|Overall Study|Death|2|||
143335452|NCT02342886|516770326|FG002|Overall Study|Death|1|||
143335453|NCT02342886|516770327|FG003|Overall Study|Death|0|||
143335454|NCT02342886|516770328|FG004|Overall Study|Death|1|||
143335455|NCT02342886|516770324|FG000|Overall Study|Withdrawal by Subject|0|||
143335456|NCT02342886|516770325|FG001|Overall Study|Withdrawal by Subject|1|||
143335457|NCT02342886|516770326|FG002|Overall Study|Withdrawal by Subject|0|||
143335458|NCT02342886|516770327|FG003|Overall Study|Withdrawal by Subject|1|||
143335459|NCT02342886|516770328|FG004|Overall Study|Withdrawal by Subject|0|||
143335460|NCT02342886|516770324|FG000|Overall Study|Investigator/sponsor decision|0|||
143335461|NCT02342886|516770325|FG001|Overall Study|Investigator/sponsor decision|2|||
143335462|NCT02342886|516770326|FG002|Overall Study|Investigator/sponsor decision|0|||
143335463|NCT02342886|516770327|FG003|Overall Study|Investigator/sponsor decision|3|||
143335464|NCT02342886|516770328|FG004|Overall Study|Investigator/sponsor decision|1|||
143335465|NCT02342886|516770324|FG000|Overall Study|Pregnancy|0|||
143335466|NCT02342886|516770325|FG001|Overall Study|Pregnancy|0|||
143335467|NCT02342886|516770326|FG002|Overall Study|Pregnancy|2|||
143335468|NCT02342886|516770327|FG003|Overall Study|Pregnancy|0|||
143335469|NCT02342886|516770328|FG004|Overall Study|Pregnancy|0|||
143335470|NCT02342886|516770324|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
143335471|NCT02342886|516770325|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
143335472|NCT02342886|516770326|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
143335473|NCT02342886|516770327|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
143335474|NCT02342886|516770328|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
143335475|NCT02342886|516770324|FG000|Overall Study|Protocol Violation|0|||
143335476|NCT02342886|516770325|FG001|Overall Study|Protocol Violation|0|||
143335477|NCT02342886|516770326|FG002|Overall Study|Protocol Violation|0|||
143335478|NCT02342886|516770327|FG003|Overall Study|Protocol Violation|2|||
143335479|NCT02342886|516770328|FG004|Overall Study|Protocol Violation|0|||
143335480|NCT01328080|516770329|FG000|Overall Study|Lost to Follow-up|5|||
143335481|NCT00862134|516770330|FG000|Overall Study|Death|1|||
143335482|NCT00862134|516770331|FG001|Overall Study|Death|0|||
143335483|NCT00862134|516770330|FG000|Overall Study|Physician Decision|0|||
143335484|NCT00862134|516770331|FG001|Overall Study|Physician Decision|1|||
143335485|NCT00862134|516770330|FG000|Overall Study|Withdrawal by Subject|1|||
143335486|NCT00862134|516770331|FG001|Overall Study|Withdrawal by Subject|2|||
143335487|NCT00862134|516770330|FG000|Overall Study|Sponsor terminated study|5|||
143335488|NCT00862134|516770331|FG001|Overall Study|Sponsor terminated study|7|||
143335489|NCT00862134|516770330|FG000|Overall Study|Adverse Event|2|||
143335490|NCT00862134|516770331|FG001|Overall Study|Adverse Event|2|||
143335491|NCT00862134|516770330|FG000|Overall Study|Withdrew prior to dosing|2|||
143335492|NCT00862134|516770331|FG001|Overall Study|Withdrew prior to dosing|0|||
143335493|NCT02191267|516770332|FG000|Overall Study|Withdrawal by Subject|1|||
143335494|NCT02191267|516770333|FG001|Overall Study|Withdrawal by Subject|0|||
143335495|NCT02191267|516770334|FG002|Overall Study|Withdrawal by Subject|0|||
143335496|NCT00765674|516770335|FG000|Overall Study|Adverse Event|7|||
143335497|NCT00765674|516770336|FG001|Overall Study|Adverse Event|2|||
143335498|NCT00765674|516770337|FG002|Overall Study|Adverse Event|8|||
143335499|NCT00765674|516770338|FG003|Overall Study|Adverse Event|11|||
143335500|NCT00765674|516770335|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
143335501|NCT00765674|516770336|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
143335502|NCT00765674|516770337|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
143335503|NCT00765674|516770338|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
143335504|NCT00765674|516770335|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
143335505|NCT00765674|516770336|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
143335506|NCT00765674|516770337|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
143335507|NCT00765674|516770338|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
143335508|NCT00765674|516770335|FG000|Overall Study|Lack of Efficacy|2|||
143335509|NCT00765674|516770336|FG001|Overall Study|Lack of Efficacy|3|||
143335510|NCT00765674|516770337|FG002|Overall Study|Lack of Efficacy|1|||
143335511|NCT00765674|516770338|FG003|Overall Study|Lack of Efficacy|2|||
143335512|NCT00765674|516770335|FG000|Overall Study|Protocol Violation|2|||
143335513|NCT00765674|516770336|FG001|Overall Study|Protocol Violation|0|||
143335514|NCT00765674|516770337|FG002|Overall Study|Protocol Violation|1|||
143335515|NCT00765674|516770338|FG003|Overall Study|Protocol Violation|0|||
143335516|NCT00765674|516770335|FG000|Overall Study|Withdrawal by Subject|5|||
143335517|NCT00765674|516770336|FG001|Overall Study|Withdrawal by Subject|7|||
143335518|NCT00765674|516770337|FG002|Overall Study|Withdrawal by Subject|3|||
143335519|NCT00765674|516770338|FG003|Overall Study|Withdrawal by Subject|8|||
143335520|NCT00765674|516770335|FG000|Overall Study|Lost to Follow-up|4|||
143335521|NCT00765674|516770336|FG001|Overall Study|Lost to Follow-up|6|||
143335522|NCT00765674|516770337|FG002|Overall Study|Lost to Follow-up|2|||
143335523|NCT00765674|516770338|FG003|Overall Study|Lost to Follow-up|1|||
143335524|NCT00765674|516770335|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
143335525|NCT00765674|516770336|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
143335526|NCT00765674|516770337|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
143335527|NCT00765674|516770338|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
143335528|NCT03015402|516770339|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
143335529|NCT03015402|516770340|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
143335530|NCT03015402|516770339|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
143335531|NCT03015402|516770340|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
143335532|NCT01813474|516770341|FG000|Overall Study|Withdrawal by Subject|0|||
143335533|NCT01813474|516770342|FG001|Overall Study|Withdrawal by Subject|0|||
143335534|NCT01813474|516770343|FG002|Overall Study|Withdrawal by Subject|1|||
143335535|NCT01813474|516770341|FG000|Overall Study|Adverse Event|1|||
143335536|NCT01813474|516770342|FG001|Overall Study|Adverse Event|1|||
143335537|NCT01813474|516770343|FG002|Overall Study|Adverse Event|0|||
143335538|NCT01813474|516770341|FG000|Overall Study|Lack of Efficacy|2|||
143335539|NCT01813474|516770342|FG001|Overall Study|Lack of Efficacy|6|||
143335540|NCT01813474|516770343|FG002|Overall Study|Lack of Efficacy|9|||
143335541|NCT01813474|516770341|FG000|Overall Study|Death|0|||
143335542|NCT01813474|516770342|FG001|Overall Study|Death|0|||
143335543|NCT01813474|516770343|FG002|Overall Study|Death|1|||
143335544|NCT00316082|516770349|FG000|Overall Study|Lack of Efficacy|2|||
143335545|NCT00316082|516770350|FG001|Overall Study|Lack of Efficacy|3|||
143335546|NCT00316082|516770351|FG002|Overall Study|Lack of Efficacy|3|||
143335547|NCT00316082|516770352|FG003|Overall Study|Lack of Efficacy|4|||
143335548|NCT00316082|516770353|FG004|Overall Study|Lack of Efficacy|6|||
143335549|NCT00316082|516770349|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
143335550|NCT00316082|516770350|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
143335551|NCT00316082|516770351|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
143335552|NCT00316082|516770352|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
143335553|NCT00316082|516770353|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
143335554|NCT00316082|516770349|FG000|Overall Study|Lost to Follow-up|7|||
143335555|NCT00316082|516770350|FG001|Overall Study|Lost to Follow-up|6|||
143335556|NCT00316082|516770351|FG002|Overall Study|Lost to Follow-up|7|||
143335557|NCT00316082|516770352|FG003|Overall Study|Lost to Follow-up|8|||
143335558|NCT00316082|516770353|FG004|Overall Study|Lost to Follow-up|6|||
143335559|NCT00316082|516770349|FG000|Overall Study|Poor/noncompliance|6|||
143335560|NCT00316082|516770350|FG001|Overall Study|Poor/noncompliance|1|||
143335561|NCT00316082|516770351|FG002|Overall Study|Poor/noncompliance|4|||
143335562|NCT00316082|516770352|FG003|Overall Study|Poor/noncompliance|1|||
143335563|NCT00316082|516770353|FG004|Overall Study|Poor/noncompliance|4|||
143335564|NCT00316082|516770349|FG000|Overall Study|Adverse Event|4|||
143335565|NCT00316082|516770350|FG001|Overall Study|Adverse Event|2|||
143335566|NCT00316082|516770351|FG002|Overall Study|Adverse Event|5|||
143335567|NCT00316082|516770352|FG003|Overall Study|Adverse Event|1|||
143335568|NCT00316082|516770353|FG004|Overall Study|Adverse Event|3|||
143335569|NCT00316082|516770349|FG000|Overall Study|Subject no longer meets study criteria|3|||
143335570|NCT00316082|516770350|FG001|Overall Study|Subject no longer meets study criteria|1|||
143335571|NCT00316082|516770351|FG002|Overall Study|Subject no longer meets study criteria|2|||
143335572|NCT00316082|516770352|FG003|Overall Study|Subject no longer meets study criteria|2|||
143335573|NCT00316082|516770353|FG004|Overall Study|Subject no longer meets study criteria|1|||
143335574|NCT00316082|516770349|FG000|Overall Study|Physician Decision|1|||
143335575|NCT00316082|516770350|FG001|Overall Study|Physician Decision|1|||
143335576|NCT00316082|516770351|FG002|Overall Study|Physician Decision|2|||
143335577|NCT00316082|516770352|FG003|Overall Study|Physician Decision|1|||
143335578|NCT00316082|516770353|FG004|Overall Study|Physician Decision|1|||
143335579|NCT00316082|516770349|FG000|Overall Study|Death|0|||
143335580|NCT00316082|516770350|FG001|Overall Study|Death|0|||
143335581|NCT00316082|516770351|FG002|Overall Study|Death|1|||
143335582|NCT00316082|516770352|FG003|Overall Study|Death|0|||
143335583|NCT00316082|516770353|FG004|Overall Study|Death|0|||
143335584|NCT00316082|516770349|FG000|Overall Study|Administrative reason by sponsor|0|||
143335585|NCT00316082|516770350|FG001|Overall Study|Administrative reason by sponsor|0|||
143335586|NCT00316082|516770351|FG002|Overall Study|Administrative reason by sponsor|1|||
143335587|NCT00316082|516770352|FG003|Overall Study|Administrative reason by sponsor|0|||
143335588|NCT00316082|516770353|FG004|Overall Study|Administrative reason by sponsor|0|||
143335589|NCT00528775|516770354|FG000|Overall Study|Other not specified|1|||
143335590|NCT00541450|516770361|FG000|Phase A|Adverse Event|3|||
143335591|NCT00541450|516770362|FG001|Phase A|Adverse Event|0|||
143335592|NCT00541450|516770361|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
143335593|NCT00541450|516770362|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
143335594|NCT00541450|516770361|FG000|Phase A|Hyperglycemia|0|||
143335595|NCT00541450|516770362|FG001|Phase A|Hyperglycemia|1|||
143335596|NCT00541450|516770361|FG000|Phase A|Lost to Follow-up|6|||
143335597|NCT00541450|516770362|FG001|Phase A|Lost to Follow-up|4|||
143335598|NCT00541450|516770361|FG000|Phase A|Physician Decision|2|||
143335599|NCT00541450|516770362|FG001|Phase A|Physician Decision|0|||
143335600|NCT00541450|516770361|FG000|Phase A|Protocol Violation|2|||
143335601|NCT00541450|516770362|FG001|Phase A|Protocol Violation|3|||
143335602|NCT00541450|516770361|FG000|Phase A|Withdrawal by Subject|7|||
143335603|NCT00541450|516770362|FG001|Phase A|Withdrawal by Subject|7|||
143335604|NCT00541450|516770361|FG000|Phase B|Adverse Event|6|||
143335605|NCT00541450|516770362|FG001|Phase B|Adverse Event|6|||
143335606|NCT00541450|516770361|FG000|Phase B|Hyperglycemia|10|||
143335607|NCT00541450|516770362|FG001|Phase B|Hyperglycemia|9|||
143335608|NCT00541450|516770361|FG000|Phase B|Lost to Follow-up|6|||
143335609|NCT00541450|516770362|FG001|Phase B|Lost to Follow-up|4|||
143335610|NCT00541450|516770361|FG000|Phase B|Physician Decision|4|||
143335611|NCT00541450|516770362|FG001|Phase B|Physician Decision|2|||
143335612|NCT00541450|516770361|FG000|Phase B|Pregnancy|0|||
143335613|NCT00541450|516770362|FG001|Phase B|Pregnancy|1|||
143335614|NCT00541450|516770361|FG000|Phase B|Protocol Violation|3|||
143335615|NCT00541450|516770362|FG001|Phase B|Protocol Violation|3|||
143335616|NCT00541450|516770361|FG000|Phase B|Withdrawal by Subject|8|||
143335617|NCT00541450|516770362|FG001|Phase B|Withdrawal by Subject|6|||
143335618|NCT02048072|516770363|FG000|Overall Study|Adverse Event|3|||
143335619|NCT02048072|516770363|FG000|Overall Study|Lost to Follow-up|1|||
143335620|NCT01112579|516770364|FG000|Overall Study|Missed Visit|1|||
143335621|NCT01112579|516770365|FG001|Overall Study|Missed Visit|1|||
143335622|NCT01112579|516770364|FG000|Overall Study|Death|0|||
143335623|NCT01112579|516770365|FG001|Overall Study|Death|2|||
143335624|NCT03645759|516770366|FG000|Overall Study|Lost to Follow-up|3|||
143335625|NCT03645759|516770367|FG001|Overall Study|Lost to Follow-up|2|||
143335626|NCT01648270|516770368|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
143335627|NCT00902694|516770369|FG000|Overall Study|Death|1|||
143335628|NCT00902694|516770370|FG001|Overall Study|Death|3|||
143335629|NCT00902694|516770369|FG000|Overall Study|Lost to Follow-up|1|||
143335630|NCT00902694|516770370|FG001|Overall Study|Lost to Follow-up|0|||
143335631|NCT00902694|516770369|FG000|Overall Study|Censored per protocol|3|||
143335632|NCT00902694|516770370|FG001|Overall Study|Censored per protocol|1|||
143335633|NCT00902694|516770369|FG000|Overall Study|Pregnancy|1|||
143335634|NCT00902694|516770370|FG001|Overall Study|Pregnancy|1|||
143335635|NCT00902694|516770369|FG000|Overall Study|Incarceration|1|||
143335636|NCT00902694|516770370|FG001|Overall Study|Incarceration|0|||
143335637|NCT04969263|516770371|FG000|Overall Study|Death|1|||
143335638|NCT04969263|516770371|FG000|Overall Study|Lost to Follow-up|2|||
143335639|NCT04969263|516770371|FG000|Overall Study|Withdrawal by Subject|5|||
143335640|NCT04969263|516770371|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
143335641|NCT02693743|516770372|FG000|Overall Study|Physician Decision|1|||
143335642|NCT02693743|516770373|FG001|Overall Study|Physician Decision|0|||
143335643|NCT03456700|516770374|FG000|Overall Study|Withdrawal by Subject|1|||
143335644|NCT04154787|516770375|FG000|Overall Study|Adverse Event|0|||
143335645|NCT04154787|516770376|FG001|Overall Study|Adverse Event|1|||
143335646|NCT04154787|516770377|FG002|Overall Study|Adverse Event|0|||
143335647|NCT04154787|516770375|FG000|Overall Study|Patient Requires Other Treatment|0|||
143335648|NCT04154787|516770376|FG001|Overall Study|Patient Requires Other Treatment|1|||
143335649|NCT04154787|516770377|FG002|Overall Study|Patient Requires Other Treatment|0|||
143335650|NCT04154787|516770375|FG000|Overall Study|Study Terminated By Sponsor|0|||
143335651|NCT04154787|516770376|FG001|Overall Study|Study Terminated By Sponsor|6|||
143335652|NCT04154787|516770377|FG002|Overall Study|Study Terminated By Sponsor|1|||
143335653|NCT04154787|516770375|FG000|Overall Study|Subject Decision|0|||
143335654|NCT04154787|516770376|FG001|Overall Study|Subject Decision|1|||
143335655|NCT04154787|516770377|FG002|Overall Study|Subject Decision|0|||
143335656|NCT04154787|516770375|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
143335657|NCT04154787|516770376|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
143335658|NCT04154787|516770377|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
143335659|NCT03053050|516770378|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
143335660|NCT03053050|516770379|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
143335661|NCT03053050|516770380|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
143335662|NCT03053050|516770381|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
143335663|NCT03053050|516770378|FG000|Randomized Phase|Withdrew Consent|16|||
143335664|NCT03053050|516770379|FG001|Randomized Phase|Withdrew Consent|8|||
143335665|NCT03053050|516770380|FG002|Randomized Phase|Withdrew Consent|9|||
143335666|NCT03053050|516770381|FG003|Randomized Phase|Withdrew Consent|0|||
143335667|NCT03053050|516770378|FG000|Randomized Phase|Investigator's Discretion|6|||
143335668|NCT03053050|516770379|FG001|Randomized Phase|Investigator's Discretion|6|||
143335669|NCT03053050|516770380|FG002|Randomized Phase|Investigator's Discretion|3|||
143335670|NCT03053050|516770381|FG003|Randomized Phase|Investigator's Discretion|0|||
143335671|NCT03053050|516770378|FG000|Randomized Phase|Lost to Follow-up|5|||
143335672|NCT03053050|516770379|FG001|Randomized Phase|Lost to Follow-up|1|||
143335673|NCT03053050|516770380|FG002|Randomized Phase|Lost to Follow-up|1|||
143335674|NCT03053050|516770381|FG003|Randomized Phase|Lost to Follow-up|0|||
143335675|NCT03053050|516770378|FG000|Randomized Phase|Adverse Event|0|||
143335676|NCT03053050|516770379|FG001|Randomized Phase|Adverse Event|1|||
143335677|NCT03053050|516770380|FG002|Randomized Phase|Adverse Event|0|||
143335678|NCT03053050|516770381|FG003|Randomized Phase|Adverse Event|0|||
143335679|NCT03053050|516770378|FG000|Randomized Phase|Randomized but Never Treated|2|||
143335680|NCT03053050|516770379|FG001|Randomized Phase|Randomized but Never Treated|2|||
143335681|NCT03053050|516770380|FG002|Randomized Phase|Randomized but Never Treated|2|||
143335682|NCT03053050|516770381|FG003|Randomized Phase|Randomized but Never Treated|0|||
143335683|NCT03053050|516770378|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
143335684|NCT03053050|516770379|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
143335685|NCT03053050|516770380|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
143335686|NCT03053050|516770381|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
143335687|NCT03053050|516770378|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
143335688|NCT03053050|516770379|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
143335689|NCT03053050|516770380|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
143335690|NCT03053050|516770381|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
143335691|NCT03053050|516770378|FG000|Open-label Phase|Withdrew Consent|0|||
143335692|NCT03053050|516770379|FG001|Open-label Phase|Withdrew Consent|0|||
143335693|NCT03053050|516770380|FG002|Open-label Phase|Withdrew Consent|0|||
143335694|NCT03053050|516770381|FG003|Open-label Phase|Withdrew Consent|6|||
143335695|NCT03053050|516770378|FG000|Open-label Phase|Investigator's Discretion|0|||
143335696|NCT03053050|516770379|FG001|Open-label Phase|Investigator's Discretion|0|||
143335697|NCT03053050|516770380|FG002|Open-label Phase|Investigator's Discretion|0|||
143335698|NCT03053050|516770381|FG003|Open-label Phase|Investigator's Discretion|4|||
143335699|NCT03703466|516770382|FG000|Overall Study|Death|2|||
143335700|NCT03703466|516770383|FG001|Overall Study|Death|1|||
143335701|NCT03703466|516770384|FG002|Overall Study|Death|0|||
143335702|NCT03703466|516770382|FG000|Overall Study|Withdrawal by Subject|0|||
143335703|NCT03703466|516770383|FG001|Overall Study|Withdrawal by Subject|3|||
143335704|NCT03703466|516770384|FG002|Overall Study|Withdrawal by Subject|0|||
143335705|NCT03703466|516770382|FG000|Overall Study|Completed < 3 Cycles|2|||
143335706|NCT03703466|516770383|FG001|Overall Study|Completed < 3 Cycles|2|||
143335707|NCT03703466|516770384|FG002|Overall Study|Completed < 3 Cycles|2|||
143335708|NCT01111123|516772180|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
143335709|NCT01111123|516772181|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
143335710|NCT01111123|516772180|FG000|Maintenance Phase|Lost to Follow-up|0|||
143335711|NCT01111123|516772181|FG001|Maintenance Phase|Lost to Follow-up|2|||
143335712|NCT01553318|516772185|FG000|Overall Study|Protocol Violation|3|||
143335713|NCT01553318|516772186|FG001|Overall Study|Protocol Violation|2|||
143335714|NCT01203930|516772192|FG000|Overall Study|Disease Progression|0|||
143335715|NCT01203930|516772193|FG001|Overall Study|Disease Progression|4|||
143335716|NCT01203930|516772192|FG000|Overall Study|Death|3|||
143335717|NCT01203930|516772193|FG001|Overall Study|Death|1|||
143384914|NCT03271489|516955033|FG001|Double-Blind (DB) Period|Non-compliance with study procedures|1|||
143384915|NCT03271489|516955032|FG000|Double-Blind (DB) Period|Other|6|||
143384916|NCT03271489|516955033|FG001|Double-Blind (DB) Period|Other|1|||
143384917|NCT03271489|516955032|FG000|Double-Blind (DB) Period|Missing|1|||
143384918|NCT03271489|516955033|FG001|Double-Blind (DB) Period|Missing|0|||
143384919|NCT03271489|516955032|FG000|Open-Label (OL) Period|Adverse Event|2|||
143384920|NCT03271489|516955033|FG001|Open-Label (OL) Period|Adverse Event|0|||
143384921|NCT03271489|516955032|FG000|Open-Label (OL) Period|Withdrawal by Subject|14|||
143384922|NCT03271489|516955033|FG001|Open-Label (OL) Period|Withdrawal by Subject|8|||
143384923|NCT03271489|516955032|FG000|Open-Label (OL) Period|Lost to Follow-up|10|||
143384924|NCT03271489|516955033|FG001|Open-Label (OL) Period|Lost to Follow-up|5|||
143384925|NCT03271489|516955032|FG000|Open-Label (OL) Period|Non-compliance with study procedures|4|||
143384926|NCT03271489|516955033|FG001|Open-Label (OL) Period|Non-compliance with study procedures|1|||
143384927|NCT03271489|516955032|FG000|Open-Label (OL) Period|No Specified|2|||
143384928|NCT03271489|516955033|FG001|Open-Label (OL) Period|No Specified|2|||
143384929|NCT03271489|516955032|FG000|Open-Label (OL) Period|Missing|2|||
143384930|NCT03271489|516955033|FG001|Open-Label (OL) Period|Missing|0|||
143384931|NCT03271489|516955032|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|16|||
143384932|NCT03271489|516955033|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|6|||
143384933|NCT03271489|516955032|FG000|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|40|||
143384934|NCT03271489|516955033|FG001|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|26|||
143384935|NCT03271489|516955032|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|35|||
143384936|NCT03271489|516955033|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|24|||
143384937|NCT03271489|516955032|FG000|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|5|||
143384938|NCT03271489|516955033|FG001|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
143384939|NCT03271489|516955032|FG000|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|9|||
143384940|NCT03271489|516955033|FG001|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|2|||
143384941|NCT03271489|516955032|FG000|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|1|||
143384942|NCT03271489|516955033|FG001|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|0|||
143384943|NCT03271489|516955032|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|21|||
143384944|NCT03271489|516955033|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|10|||
143384945|NCT03271489|516955032|FG000|Post-Treatment Follow-Up (PTFU) Period|Missing|3|||
143384946|NCT03271489|516955033|FG001|Post-Treatment Follow-Up (PTFU) Period|Missing|2|||
143384947|NCT02860130|516955034|FG000|Overall Study|Adverse Event|2|||
143384948|NCT02860130|516955035|FG001|Overall Study|Adverse Event|3|||
143384949|NCT02860130|516955034|FG000|Overall Study|Protocol Violation|1|||
143384950|NCT02860130|516955035|FG001|Overall Study|Protocol Violation|1|||
143384951|NCT02860130|516955034|FG000|Overall Study|Withdrawal by Subject|0|||
143384952|NCT02860130|516955035|FG001|Overall Study|Withdrawal by Subject|2|||
143384953|NCT02860130|516955034|FG000|Overall Study|Physician Decision|2|||
143384954|NCT02860130|516955035|FG001|Overall Study|Physician Decision|2|||
143384955|NCT02860130|516955034|FG000|Overall Study|Other|2|||
143384956|NCT02860130|516955035|FG001|Overall Study|Other|1|||
143384957|NCT01467427|516955036|FG000|Overall Study|Withdrawal by Subject|1|||
143384958|NCT01467427|516955037|FG001|Overall Study|Withdrawal by Subject|0|||
143384959|NCT01467427|516955036|FG000|Overall Study|Not continuing in extension phase|0|||
143384960|NCT01467427|516955037|FG001|Overall Study|Not continuing in extension phase|2|||
143384961|NCT01467427|516955036|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
143384962|NCT01467427|516955037|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
143384963|NCT01467427|516955036|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
143384964|NCT01467427|516955037|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
143384965|NCT01467427|516955036|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
143384966|NCT01467427|516955037|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
143384967|NCT01467427|516955036|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
143384968|NCT01467427|516955037|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
143384969|NCT04838613|516955040|FG000|Overall Study|Withdrawal by Subject|3|||
143384970|NCT04838613|516955041|FG001|Overall Study|Withdrawal by Subject|6|||
143384971|NCT04838613|516955040|FG000|Overall Study|Protocol Deviation|3|||
143384972|NCT04838613|516955041|FG001|Overall Study|Protocol Deviation|2|||
143384973|NCT04838613|516955040|FG000|Overall Study|Technical Problems|0|||
143384974|NCT04838613|516955041|FG001|Overall Study|Technical Problems|5|||
143384975|NCT04838613|516955040|FG000|Overall Study|Physician Decision|2|||
143384976|NCT04838613|516955041|FG001|Overall Study|Physician Decision|0|||
143384977|NCT04970654|516955042|FG000|Overall Study|Withdrawal by parents/guardian|1|||
143384978|NCT04970654|516955043|FG001|Overall Study|Withdrawal by parents/guardian|2|||
143384979|NCT04970654|516955042|FG000|Overall Study|Unclassified|2|||
143384980|NCT04970654|516955043|FG001|Overall Study|Unclassified|1|||
143384981|NCT04970654|516955042|FG000|Overall Study|Lost to Follow-up|1|||
143384982|NCT04970654|516955043|FG001|Overall Study|Lost to Follow-up|0|||
142941518|NCT00064701|515324681|FG001|One Year Post-transplant|Rejection|1|||
143335718|NCT01203930|516772192|FG000|Overall Study|Withdrew Consent|1|||
143335719|NCT01203930|516772193|FG001|Overall Study|Withdrew Consent|10|||
143335720|NCT01203930|516772192|FG000|Overall Study|Investigator Request|0|||
143335721|NCT01203930|516772193|FG001|Overall Study|Investigator Request|8|||
143335722|NCT01203930|516772192|FG000|Overall Study|Study Terminated by Sponsor|0|||
143335723|NCT01203930|516772193|FG001|Overall Study|Study Terminated by Sponsor|12|||
143335724|NCT01203930|516772192|FG000|Overall Study|Poor tolerance of study drug|0|||
143335725|NCT01203930|516772193|FG001|Overall Study|Poor tolerance of study drug|1|||
143335726|NCT01203930|516772192|FG000|Overall Study|Adverse Event|17|||
143335727|NCT01203930|516772193|FG001|Overall Study|Adverse Event|5|||
143335728|NCT02178059|516772194|FG000|Washout|Physician Decision|1|||
143335729|NCT02178059|516772195|FG001|Washout|Physician Decision|0|||
143335730|NCT02586025|516772196|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
143335731|NCT02586025|516772197|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
143335732|NCT02586025|516772196|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
143335733|NCT02586025|516772197|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
143335734|NCT02586025|516772196|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
143335735|NCT02586025|516772197|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
143335736|NCT02586025|516772196|FG000|Neoadjuvant Treatment|Death|1|||
143335737|NCT02586025|516772197|FG001|Neoadjuvant Treatment|Death|0|||
143335738|NCT02586025|516772196|FG000|Neoadjuvant Treatment|Adverse Event|1|||
143335739|NCT02586025|516772197|FG001|Neoadjuvant Treatment|Adverse Event|0|||
143335740|NCT02586025|516772196|FG000|Neoadjuvant Treatment|Physician Decision|2|||
143335741|NCT02586025|516772197|FG001|Neoadjuvant Treatment|Physician Decision|1|||
143335742|NCT02586025|516772196|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
143335743|NCT02586025|516772197|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
143335744|NCT02586025|516772196|FG000|Adjuvant Treatment|Recurrent Disease|4|||
143335745|NCT02586025|516772197|FG001|Adjuvant Treatment|Recurrent Disease|5|||
143335746|NCT02586025|516772196|FG000|Adjuvant Treatment|Physician Decision|0|||
143335747|NCT02586025|516772197|FG001|Adjuvant Treatment|Physician Decision|1|||
143335748|NCT02586025|516772196|FG000|Adjuvant Treatment|Pregnancy|1|||
143335749|NCT02586025|516772197|FG001|Adjuvant Treatment|Pregnancy|0|||
143335750|NCT02586025|516772196|FG000|Treatment-Free Follow-Up|Death|11|||
143335751|NCT02586025|516772197|FG001|Treatment-Free Follow-Up|Death|11|||
143335752|NCT02586025|516772196|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
143335753|NCT02586025|516772197|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
143335754|NCT02586025|516772196|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
143335755|NCT02586025|516772197|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
143335756|NCT02586025|516772196|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
143335757|NCT02586025|516772197|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
143335758|NCT02586025|516772196|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
143335759|NCT02586025|516772197|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
143335760|NCT00175825|516772198|FG000|Overall Study|Adverse Event|3|||
143335761|NCT00175825|516772199|FG001|Overall Study|Adverse Event|2|||
143335762|NCT00175825|516772200|FG002|Overall Study|Adverse Event|1|||
143335763|NCT00175825|516772201|FG003|Overall Study|Adverse Event|1|||
143335764|NCT00175825|516772198|FG000|Overall Study|Lost to Follow-up|1|||
143335765|NCT00175825|516772199|FG001|Overall Study|Lost to Follow-up|2|||
143335766|NCT00175825|516772200|FG002|Overall Study|Lost to Follow-up|0|||
143335767|NCT00175825|516772201|FG003|Overall Study|Lost to Follow-up|0|||
143335768|NCT00175825|516772198|FG000|Overall Study|Withdrawal by Subject|1|||
143335769|NCT00175825|516772199|FG001|Overall Study|Withdrawal by Subject|0|||
143335770|NCT00175825|516772200|FG002|Overall Study|Withdrawal by Subject|0|||
143335771|NCT00175825|516772201|FG003|Overall Study|Withdrawal by Subject|0|||
143335772|NCT00999466|516772204|FG000|Main Part|Withdrawal by Subject|0|||
143335773|NCT00999466|516772205|FG001|Main Part|Withdrawal by Subject|0|||
143335774|NCT00999466|516772206|FG002|Main Part|Withdrawal by Subject|2|||
143335775|NCT00999466|516772204|FG000|Main Part|Adverse Event|0|||
143335776|NCT00999466|516772205|FG001|Main Part|Adverse Event|4|||
143335777|NCT00999466|516772206|FG002|Main Part|Adverse Event|2|||
143335778|NCT03432364|516772207|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
143335779|NCT03040713|516772208|FG000|Overall Study|Positive amyloid scan|3|||
143335780|NCT02570126|516772211|FG000|Overall Study|Lost to Follow-up|2|||
143335781|NCT02570126|516772212|FG001|Overall Study|Lost to Follow-up|0|||
143335782|NCT02570126|516772211|FG000|Overall Study|Unable To Arrange Visit 3|1|||
143335783|NCT02570126|516772212|FG001|Overall Study|Unable To Arrange Visit 3|0|||
143335784|NCT02570126|516772211|FG000|Overall Study|Violation Of Procedures GSK|0|||
143335785|NCT02570126|516772212|FG001|Overall Study|Violation Of Procedures GSK|1|||
143335786|NCT02570126|516772211|FG000|Overall Study|Protocol Violation|0|||
143335787|NCT02570126|516772212|FG001|Overall Study|Protocol Violation|1|||
143335788|NCT02570126|516772211|FG000|Overall Study|Withdrawal by Subject|3|||
143335789|NCT02570126|516772212|FG001|Overall Study|Withdrawal by Subject|7|||
143335790|NCT01754467|516772213|FG000|Overall Study|Lost to Follow-up|1|||
143335791|NCT01970462|516772214|FG000|Overall Study|Lost to Follow-up|0|||
143335792|NCT01970462|516772215|FG001|Overall Study|Lost to Follow-up|2|||
143335793|NCT00917579|516772216|FG000|Washout >= 2 Weeks|Adverse Event|1|||
143335794|NCT00917579|516772217|FG001|Washout >= 2 Weeks|Adverse Event|0|||
143335795|NCT00917579|516772216|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
143335796|NCT00917579|516772217|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
143335797|NCT00754338|516772218|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
143335798|NCT00754338|516772219|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
143335799|NCT00754338|516772220|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
143335800|NCT00754338|516772221|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
143335801|NCT00754338|516772218|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
143335802|NCT00754338|516772219|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
143335803|NCT00754338|516772220|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
143335804|NCT00754338|516772221|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
143335805|NCT04020341|516772224|FG000|Overall Study|Adverse Event|8|||
143335806|NCT04020341|516772225|FG001|Overall Study|Adverse Event|6|||
143335807|NCT04020341|516772224|FG000|Overall Study|Lost to Follow-up|8|||
143335808|NCT04020341|516772225|FG001|Overall Study|Lost to Follow-up|2|||
143335809|NCT04020341|516772224|FG000|Overall Study|Withdrawal by Subject|16|||
143335810|NCT04020341|516772225|FG001|Overall Study|Withdrawal by Subject|16|||
143335811|NCT04020341|516772224|FG000|Overall Study|Participant not able to swallow the tablet|1|||
143335812|NCT04020341|516772225|FG001|Overall Study|Participant not able to swallow the tablet|0|||
143335813|NCT04020341|516772224|FG000|Overall Study|Physician Decision|0|||
143335814|NCT04020341|516772225|FG001|Overall Study|Physician Decision|2|||
143335815|NCT04020341|516772224|FG000|Overall Study|Protocol Deviation|0|||
143335816|NCT04020341|516772225|FG001|Overall Study|Protocol Deviation|2|||
143335817|NCT05763628|516772226|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
143335818|NCT05763628|516772227|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
143335819|NCT05763628|516772226|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
143335820|NCT05763628|516772227|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
143335821|NCT05763628|516772226|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
143335822|NCT05763628|516772227|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
143335823|NCT04683926|516772235|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
143335824|NCT04683926|516772236|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
143335825|NCT04683926|516772237|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
143335826|NCT04683926|516772238|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
143335827|NCT04385368|516772240|FG000|Overall Study|Death|5|||
143335828|NCT04385368|516772241|FG001|Overall Study|Death|5|||
143335829|NCT04385368|516772240|FG000|Overall Study|Physician Decision|3|||
143335830|NCT04385368|516772241|FG001|Overall Study|Physician Decision|0|||
143335831|NCT04385368|516772240|FG000|Overall Study|Withdrawal by Subject|4|||
143335832|NCT04385368|516772241|FG001|Overall Study|Withdrawal by Subject|3|||
143335833|NCT02123108|516772244|FG000|Overall Study|Death|2|||
143335834|NCT02123108|516772245|FG001|Overall Study|Death|3|||
143335835|NCT00677235|516772246|FG000|Overall Study|Withdrawal by Subject|1|||
143335836|NCT00677235|516772247|FG001|Overall Study|Withdrawal by Subject|1|||
143335837|NCT00677235|516772246|FG000|Overall Study|Lost to Follow-up|2|||
143335838|NCT00677235|516772247|FG001|Overall Study|Lost to Follow-up|1|||
143335839|NCT00677235|516772246|FG000|Overall Study|Death|37|||
143384983|NCT02137850|516955044|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
143384984|NCT02137850|516955045|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
143384985|NCT02137850|516955046|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
143384986|NCT02137850|516955044|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
143384987|NCT02137850|516955045|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
143384988|NCT02137850|516955046|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
143384989|NCT02137850|516955044|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
143384990|NCT02137850|516955045|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
143384991|NCT02137850|516955046|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
143335840|NCT00677235|516772247|FG001|Overall Study|Death|36|||
143384992|NCT02137850|516955044|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
143384993|NCT02137850|516955045|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
143384994|NCT02137850|516955046|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
143384995|NCT02137850|516955044|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
143335841|NCT00677235|516772246|FG000|Overall Study|Adverse Experience|1|||
143384996|NCT02137850|516955045|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
143335842|NCT00677235|516772247|FG001|Overall Study|Adverse Experience|0|||
143335843|NCT01113502|516772250|FG000|Overall Study|Withdrawal by Subject|1|||
143335844|NCT01113502|516772251|FG001|Overall Study|Withdrawal by Subject|0|||
143335845|NCT01113502|516772252|FG002|Overall Study|Withdrawal by Subject|1|||
143335846|NCT01113502|516772253|FG003|Overall Study|Withdrawal by Subject|1|||
143335847|NCT01113502|516772254|FG004|Overall Study|Withdrawal by Subject|0|||
143335848|NCT01113502|516772250|FG000|Overall Study|Adverse Event|0|||
143335849|NCT01113502|516772251|FG001|Overall Study|Adverse Event|0|||
143335850|NCT01113502|516772252|FG002|Overall Study|Adverse Event|3|||
143335851|NCT01113502|516772253|FG003|Overall Study|Adverse Event|2|||
143335852|NCT01113502|516772254|FG004|Overall Study|Adverse Event|0|||
143335853|NCT01362439|516772267|FG000|Overall Study|Adverse Event|1|||
143335854|NCT01362439|516772267|FG000|Overall Study|Lack of Efficacy|3|||
143335855|NCT01362439|516772267|FG000|Overall Study|Lost to Follow-up|2|||
143335856|NCT01362439|516772267|FG000|Overall Study|Study medication non-compliant|1|||
143335857|NCT01362439|516772267|FG000|Overall Study|Participant who withdrew consent|8|||
143335858|NCT01984684|516772270|FG000|Overall Study|Lost to Follow-up|25|||
143335859|NCT01984684|516772271|FG001|Overall Study|Lost to Follow-up|24|||
143335860|NCT01984684|516772270|FG000|Overall Study|Adverse Event|8|||
143335861|NCT01984684|516772271|FG001|Overall Study|Adverse Event|12|||
143335862|NCT01984684|516772270|FG000|Overall Study|Withdrawal by Subject|9|||
143335863|NCT01984684|516772271|FG001|Overall Study|Withdrawal by Subject|9|||
143335864|NCT01984684|516772270|FG000|Overall Study|Lack of Efficacy|3|||
143335865|NCT01984684|516772271|FG001|Overall Study|Lack of Efficacy|6|||
143335866|NCT01984684|516772270|FG000|Overall Study|Physician Decision|4|||
143335867|NCT01984684|516772271|FG001|Overall Study|Physician Decision|2|||
143335868|NCT01984684|516772270|FG000|Overall Study|Protocol Violation|4|||
143335869|NCT01984684|516772271|FG001|Overall Study|Protocol Violation|2|||
143335870|NCT01984684|516772270|FG000|Overall Study|Death|0|||
143335871|NCT01984684|516772271|FG001|Overall Study|Death|1|||
143335872|NCT01984684|516772270|FG000|Overall Study|Noncompliance with study drug|2|||
143335873|NCT01984684|516772271|FG001|Overall Study|Noncompliance with study drug|1|||
143335874|NCT01984684|516772270|FG000|Overall Study|Subject incarcerated|1|||
143335875|NCT01984684|516772271|FG001|Overall Study|Subject incarcerated|0|||
143335876|NCT01984684|516772270|FG000|Overall Study|Study drug not available at site|1|||
143335877|NCT01984684|516772271|FG001|Overall Study|Study drug not available at site|1|||
143335878|NCT01984684|516772270|FG000|Overall Study|Subject had inadequate IV access|0|||
143335879|NCT01984684|516772271|FG001|Overall Study|Subject had inadequate IV access|1|||
143335880|NCT03205371|516772276|FG000|Overall Study|Withdrawal by Subject|4|||
143335881|NCT03205371|516772277|FG001|Overall Study|Withdrawal by Subject|1|||
143335882|NCT03205371|516772278|FG002|Overall Study|Withdrawal by Subject|0|||
143335883|NCT03205371|516772279|FG003|Overall Study|Withdrawal by Subject|0|||
143335884|NCT03205371|516772280|FG004|Overall Study|Withdrawal by Subject|0|||
143335885|NCT03205371|516772281|FG005|Overall Study|Withdrawal by Subject|0|||
143335886|NCT03205371|516772282|FG006|Overall Study|Withdrawal by Subject|4|||
143335887|NCT03205371|516772283|FG007|Overall Study|Withdrawal by Subject|0|||
143335888|NCT03205371|516772284|FG008|Overall Study|Withdrawal by Subject|2|||
143335889|NCT03205371|516772285|FG009|Overall Study|Withdrawal by Subject|0|||
143335890|NCT03205371|516772286|FG010|Overall Study|Withdrawal by Subject|0|||
143335891|NCT03205371|516772287|FG011|Overall Study|Withdrawal by Subject|1|||
143335892|NCT03205371|516772276|FG000|Overall Study|Lost to Follow-up|0|||
143335893|NCT03205371|516772277|FG001|Overall Study|Lost to Follow-up|0|||
143335894|NCT03205371|516772278|FG002|Overall Study|Lost to Follow-up|0|||
143335895|NCT03205371|516772279|FG003|Overall Study|Lost to Follow-up|0|||
143335896|NCT03205371|516772280|FG004|Overall Study|Lost to Follow-up|0|||
143335897|NCT03205371|516772281|FG005|Overall Study|Lost to Follow-up|0|||
143335898|NCT03205371|516772282|FG006|Overall Study|Lost to Follow-up|5|||
143335899|NCT03205371|516772283|FG007|Overall Study|Lost to Follow-up|2|||
143335900|NCT03205371|516772284|FG008|Overall Study|Lost to Follow-up|3|||
143335901|NCT03205371|516772285|FG009|Overall Study|Lost to Follow-up|0|||
143335902|NCT03205371|516772286|FG010|Overall Study|Lost to Follow-up|0|||
143335903|NCT03205371|516772287|FG011|Overall Study|Lost to Follow-up|0|||
143335904|NCT03205371|516772276|FG000|Overall Study|Protocol Violation|0|||
143335905|NCT03205371|516772277|FG001|Overall Study|Protocol Violation|0|||
143335906|NCT03205371|516772278|FG002|Overall Study|Protocol Violation|0|||
143335907|NCT03205371|516772279|FG003|Overall Study|Protocol Violation|0|||
143335908|NCT03205371|516772280|FG004|Overall Study|Protocol Violation|0|||
143335909|NCT03205371|516772281|FG005|Overall Study|Protocol Violation|0|||
143335910|NCT03205371|516772282|FG006|Overall Study|Protocol Violation|1|||
143335911|NCT03205371|516772283|FG007|Overall Study|Protocol Violation|0|||
143335912|NCT03205371|516772284|FG008|Overall Study|Protocol Violation|0|||
143335913|NCT03205371|516772285|FG009|Overall Study|Protocol Violation|0|||
143335914|NCT03205371|516772286|FG010|Overall Study|Protocol Violation|0|||
143335915|NCT03205371|516772287|FG011|Overall Study|Protocol Violation|0|||
143335916|NCT03205371|516772276|FG000|Overall Study|Adverse Event|0|||
143335917|NCT03205371|516772277|FG001|Overall Study|Adverse Event|0|||
143335918|NCT03205371|516772278|FG002|Overall Study|Adverse Event|0|||
143335919|NCT03205371|516772279|FG003|Overall Study|Adverse Event|0|||
143335920|NCT03205371|516772280|FG004|Overall Study|Adverse Event|0|||
143335921|NCT03205371|516772281|FG005|Overall Study|Adverse Event|0|||
143335922|NCT03205371|516772282|FG006|Overall Study|Adverse Event|0|||
143335923|NCT03205371|516772283|FG007|Overall Study|Adverse Event|1|||
143335924|NCT03205371|516772284|FG008|Overall Study|Adverse Event|0|||
143335925|NCT03205371|516772285|FG009|Overall Study|Adverse Event|0|||
143335926|NCT03205371|516772286|FG010|Overall Study|Adverse Event|0|||
143335927|NCT03205371|516772287|FG011|Overall Study|Adverse Event|0|||
143335928|NCT03575325|516772288|FG000|Overall Study|Death|1|||
143335929|NCT04575051|516772289|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
143335930|NCT04575051|516772290|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
143335931|NCT04575051|516772291|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
143335932|NCT04575051|516772292|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
143335933|NCT04575051|516772293|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
143335934|NCT04575051|516772289|FG000|Time Period 1|Missing follow up|1|||
143335935|NCT04575051|516772290|FG001|Time Period 1|Missing follow up|3|||
143335936|NCT04575051|516772291|FG002|Time Period 1|Missing follow up|1|||
143335937|NCT04575051|516772292|FG003|Time Period 1|Missing follow up|3|||
143335938|NCT04575051|516772293|FG004|Time Period 1|Missing follow up|2|||
143335939|NCT04575051|516772289|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
143335940|NCT04575051|516772290|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
143335941|NCT04575051|516772291|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
143335942|NCT04575051|516772292|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
143335943|NCT04575051|516772293|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
143335944|NCT04575051|516772289|FG000|Time Period 2|Missing follow up|1|||
143335945|NCT04575051|516772290|FG001|Time Period 2|Missing follow up|8|||
143335946|NCT04575051|516772291|FG002|Time Period 2|Missing follow up|7|||
143335947|NCT04575051|516772292|FG003|Time Period 2|Missing follow up|0|||
143335948|NCT04575051|516772293|FG004|Time Period 2|Missing follow up|1|||
143335949|NCT04575051|516772289|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
143335950|NCT04575051|516772290|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
143335951|NCT04575051|516772291|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
143335952|NCT04575051|516772292|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
143335953|NCT04575051|516772293|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
143335954|NCT04575051|516772289|FG000|Time Period 3|Missing follow up|8|||
143335955|NCT04575051|516772290|FG001|Time Period 3|Missing follow up|6|||
143335956|NCT04575051|516772291|FG002|Time Period 3|Missing follow up|4|||
143335957|NCT04575051|516772292|FG003|Time Period 3|Missing follow up|3|||
143335958|NCT04575051|516772293|FG004|Time Period 3|Missing follow up|0|||
143335959|NCT04575051|516772289|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
143335960|NCT04575051|516772290|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
143335961|NCT04575051|516772291|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
143335962|NCT04575051|516772292|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
143335963|NCT04575051|516772293|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
143335964|NCT04575051|516772289|FG000|Time Period 4|Missing follow up|17|||
143335965|NCT04575051|516772290|FG001|Time Period 4|Missing follow up|3|||
143335966|NCT04575051|516772291|FG002|Time Period 4|Missing follow up|4|||
143335967|NCT04575051|516772292|FG003|Time Period 4|Missing follow up|2|||
143335968|NCT04575051|516772293|FG004|Time Period 4|Missing follow up|1|||
143335969|NCT04575051|516772289|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
143335970|NCT04575051|516772290|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
143335971|NCT04575051|516772291|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
143335972|NCT04575051|516772292|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
143335973|NCT04575051|516772293|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
143335974|NCT04575051|516772289|FG000|Time Period 5|Missing follow up|11|||
143335975|NCT04575051|516772290|FG001|Time Period 5|Missing follow up|8|||
143335976|NCT04575051|516772291|FG002|Time Period 5|Missing follow up|12|||
143335977|NCT04575051|516772292|FG003|Time Period 5|Missing follow up|3|||
143335978|NCT04575051|516772293|FG004|Time Period 5|Missing follow up|11|||
143335979|NCT03624504|516772294|FG000|Overall Study|Unsuccessful Implant|1|||
143335980|NCT02862457|516772295|FG000|Overall Study|Death|1|||
143335981|NCT02862457|516772296|FG001|Overall Study|Death|3|||
143335982|NCT02862457|516772297|FG002|Overall Study|Death|2|||
143335983|NCT02862457|516772298|FG003|Overall Study|Death|3|||
143335984|NCT02862457|516772299|FG004|Overall Study|Death|0|||
143335985|NCT02862457|516772300|FG005|Overall Study|Death|2|||
143335986|NCT02862457|516772301|FG006|Overall Study|Death|1|||
143335987|NCT02862457|516772295|FG000|Overall Study|Lost to Follow-up|1|||
143335988|NCT02862457|516772296|FG001|Overall Study|Lost to Follow-up|0|||
143335989|NCT02862457|516772297|FG002|Overall Study|Lost to Follow-up|0|||
143335990|NCT02862457|516772298|FG003|Overall Study|Lost to Follow-up|1|||
143335991|NCT02862457|516772299|FG004|Overall Study|Lost to Follow-up|0|||
143335992|NCT02862457|516772300|FG005|Overall Study|Lost to Follow-up|0|||
143335993|NCT02862457|516772301|FG006|Overall Study|Lost to Follow-up|0|||
143335994|NCT02862457|516772295|FG000|Overall Study|Withdrawal by Subject|0|||
143335995|NCT02862457|516772296|FG001|Overall Study|Withdrawal by Subject|0|||
143335996|NCT02862457|516772297|FG002|Overall Study|Withdrawal by Subject|1|||
143335997|NCT02862457|516772298|FG003|Overall Study|Withdrawal by Subject|0|||
143335998|NCT02862457|516772299|FG004|Overall Study|Withdrawal by Subject|0|||
143335999|NCT02862457|516772300|FG005|Overall Study|Withdrawal by Subject|1|||
143336000|NCT02862457|516772301|FG006|Overall Study|Withdrawal by Subject|0|||
143336001|NCT03364751|516772304|FG000|Overall Study|Withdrawal by Subject|1|||
143336002|NCT03364751|516772305|FG001|Overall Study|Withdrawal by Subject|0|||
143336003|NCT03364751|516772306|FG002|Overall Study|Withdrawal by Subject|0|||
143336004|NCT03364751|516772307|FG003|Overall Study|Withdrawal by Subject|0|||
143336005|NCT03364751|516772304|FG000|Overall Study|Lost to Follow-up|0|||
143336006|NCT03364751|516772305|FG001|Overall Study|Lost to Follow-up|1|||
143336007|NCT03364751|516772306|FG002|Overall Study|Lost to Follow-up|0|||
143336008|NCT03364751|516772307|FG003|Overall Study|Lost to Follow-up|0|||
143336009|NCT03583554|516772308|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
143336010|NCT03583554|516772309|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
143336011|NCT03583554|516772310|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
143336012|NCT02124265|516772314|FG000|Overall Study|Adverse Event|1|||
143336013|NCT00538590|516772317|FG000|Overall Study|Death|1|||
143336014|NCT00538590|516772318|FG001|Overall Study|Death|0|||
143336015|NCT00567190|516772319|FG000|Overall Study|Death|235|||
143336016|NCT00567190|516772320|FG001|Overall Study|Death|280|||
143336017|NCT00567190|516772319|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
143336018|NCT00567190|516772320|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
143336019|NCT00058123|516772321|FG000|Overall Study|Wrong histology|9|||
143336020|NCT00058123|516772321|FG000|Overall Study|Received >3 prior treatments|1|||
143336021|NCT00636610|516772322|FG000|Overall Study|Adverse Event|4|||
143336022|NCT00636610|516772323|FG001|Overall Study|Adverse Event|4|||
143336023|NCT00636610|516772322|FG000|Overall Study|Death|6|||
143336024|NCT00636610|516772323|FG001|Overall Study|Death|3|||
143336025|NCT00636610|516772322|FG000|Overall Study|Physician decision to withdraw patient|15|||
143336026|NCT00636610|516772323|FG001|Overall Study|Physician decision to withdraw patient|9|||
143336027|NCT00636610|516772322|FG000|Overall Study|Subject decision to withdraw|15|||
143336028|NCT00636610|516772323|FG001|Overall Study|Subject decision to withdraw|11|||
143336029|NCT00636610|516772322|FG000|Overall Study|Disease progression - radiographic|41|||
143336030|NCT00636610|516772323|FG001|Overall Study|Disease progression - radiographic|51|||
143336031|NCT00636610|516772322|FG000|Overall Study|Disease progression - clinical|8|||
143336032|NCT00636610|516772323|FG001|Overall Study|Disease progression - clinical|3|||
143336033|NCT00636610|516772322|FG000|Overall Study|Reason for discontinuation not available|3|||
143336034|NCT00636610|516772323|FG001|Overall Study|Reason for discontinuation not available|2|||
143336035|NCT00553696|516772328|FG000|Overall Study|Adverse Event|2|||
143336036|NCT00553696|516772329|FG001|Overall Study|Adverse Event|4|||
143336037|NCT00553696|516772330|FG002|Overall Study|Adverse Event|0|||
143336038|NCT00553696|516772331|FG003|Overall Study|Adverse Event|1|||
143336039|NCT00553696|516772328|FG000|Overall Study|Global deterioration of health status|0|||
143336040|NCT00553696|516772329|FG001|Overall Study|Global deterioration of health status|2|||
143336041|NCT00553696|516772330|FG002|Overall Study|Global deterioration of health status|0|||
143336042|NCT00553696|516772331|FG003|Overall Study|Global deterioration of health status|0|||
143336043|NCT00553696|516772328|FG000|Overall Study|Objective progression or relapse|2|||
143336044|NCT00553696|516772329|FG001|Overall Study|Objective progression or relapse|9|||
143336045|NCT00553696|516772330|FG002|Overall Study|Objective progression or relapse|6|||
143336046|NCT00553696|516772331|FG003|Overall Study|Objective progression or relapse|0|||
143336047|NCT00553696|516772328|FG000|Overall Study|Withdrawal by Subject|0|||
143336048|NCT00553696|516772329|FG001|Overall Study|Withdrawal by Subject|1|||
143336049|NCT00553696|516772330|FG002|Overall Study|Withdrawal by Subject|0|||
143336050|NCT00553696|516772331|FG003|Overall Study|Withdrawal by Subject|0|||
143336051|NCT00686881|516772332|FG000|Overall Study|Withdrawal by Subject|11|||
143336052|NCT00686881|516772333|FG001|Overall Study|Withdrawal by Subject|18|||
143336053|NCT00686881|516772332|FG000|Overall Study|Lost to Follow-up|0|||
143336054|NCT00686881|516772333|FG001|Overall Study|Lost to Follow-up|1|||
143336055|NCT00686881|516772332|FG000|Overall Study|Treatment-related adverse event|10|||
143336056|NCT00686881|516772333|FG001|Overall Study|Treatment-related adverse event|9|||
143336057|NCT00686881|516772332|FG000|Overall Study|Met discontinuation criteria|5|||
143336058|NCT00686881|516772333|FG001|Overall Study|Met discontinuation criteria|0|||
143336059|NCT00686881|516772332|FG000|Overall Study|Onset of malignant tumor|11|||
143336060|NCT00686881|516772333|FG001|Overall Study|Onset of malignant tumor|11|||
143336061|NCT00686881|516772332|FG000|Overall Study|Lack of Efficacy|4|||
143336062|NCT00686881|516772333|FG001|Overall Study|Lack of Efficacy|3|||
143336063|NCT00686881|516772332|FG000|Overall Study|Physician Decision|1|||
143336064|NCT00686881|516772333|FG001|Overall Study|Physician Decision|0|||
143336065|NCT00686881|516772332|FG000|Overall Study|Circumstances of site|1|||
143336066|NCT00686881|516772333|FG001|Overall Study|Circumstances of site|1|||
143336067|NCT00686881|516772332|FG000|Overall Study|Did not meet protocol eligibility|1|||
143336068|NCT00686881|516772333|FG001|Overall Study|Did not meet protocol eligibility|0|||
143336069|NCT00686881|516772332|FG000|Overall Study|Irregular visits|1|||
143336070|NCT00686881|516772333|FG001|Overall Study|Irregular visits|0|||
143336071|NCT00686881|516772332|FG000|Overall Study|Study discontinuation|35|||
143336072|NCT00686881|516772333|FG001|Overall Study|Study discontinuation|32|||
143336073|NCT00686881|516772332|FG000|Overall Study|Never received study drug|2|||
143336074|NCT00686881|516772333|FG001|Overall Study|Never received study drug|6|||
143336075|NCT02085252|516772336|FG000|Overall Study|Withdrawal of Consent|1|||
143336076|NCT02085252|516772337|FG001|Overall Study|Withdrawal of Consent|0|||
143336077|NCT02085252|516772336|FG000|Overall Study|Adverse Event|0|||
143336078|NCT02085252|516772337|FG001|Overall Study|Adverse Event|1|||
143336079|NCT02085252|516772336|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
143336080|NCT02085252|516772337|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
143336081|NCT02085252|516772336|FG000|Overall Study|Reason Not Specified|0|||
143336082|NCT02085252|516772337|FG001|Overall Study|Reason Not Specified|1|||
143336083|NCT02085252|516772336|FG000|Overall Study|Reason Unknown|0|||
143384997|NCT02137850|516955046|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
143384998|NCT02137850|516955044|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
143384999|NCT02137850|516955045|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
143385000|NCT02137850|516955046|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
143385001|NCT02137850|516955044|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
143385002|NCT02137850|516955045|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
143385003|NCT02137850|516955046|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
143385004|NCT02137850|516955044|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
143385005|NCT02137850|516955045|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
143385006|NCT02137850|516955046|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
143385007|NCT02137850|516955044|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
143385008|NCT02137850|516955045|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
143385009|NCT02137850|516955046|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
143385010|NCT02137850|516955044|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
143385011|NCT02137850|516955045|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
143385012|NCT02137850|516955046|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
143385013|NCT02137850|516955044|FG000|Main Phase: Prophylaxis|Other|0|||
143385014|NCT02137850|516955045|FG001|Main Phase: Prophylaxis|Other|1|||
143385015|NCT02137850|516955046|FG002|Main Phase: Prophylaxis|Other|0|||
143385016|NCT02137850|516955044|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
143385017|NCT02137850|516955045|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
143385018|NCT02137850|516955046|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
143385019|NCT02137850|516955044|FG000|Main Phase: Prophylaxis|Early site closure|0|||
143385020|NCT02137850|516955045|FG001|Main Phase: Prophylaxis|Early site closure|2|||
143385021|NCT02137850|516955046|FG002|Main Phase: Prophylaxis|Early site closure|0|||
143385022|NCT02137850|516955044|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
143385023|NCT02137850|516955045|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
143385024|NCT02137850|516955046|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
143385025|NCT02137850|516955044|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
143385026|NCT02137850|516955045|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
143385027|NCT02137850|516955046|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
143385028|NCT02137850|516955044|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
143385029|NCT02137850|516955045|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
143385030|NCT02137850|516955046|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
143336084|NCT02085252|516772337|FG001|Overall Study|Reason Unknown|1|||
143336085|NCT00671931|516772338|FG000|Overall Study|Physician Decision|1|||
143336086|NCT00671931|516772339|FG001|Overall Study|Physician Decision|0|||
143336087|NCT00671931|516772340|FG002|Overall Study|Physician Decision|0|||
143336088|NCT00671931|516772341|FG003|Overall Study|Physician Decision|2|||
143336089|NCT00671931|516772342|FG004|Overall Study|Physician Decision|1|||
143336090|NCT02925676|516772343|FG000|Overall Study|Withdrawal by Subject|1|||
143336091|NCT02151266|516772347|FG000|Overall Study|Lost to Follow-up|1|||
143336092|NCT02151266|516772348|FG001|Overall Study|Lost to Follow-up|4|||
143336093|NCT02151266|516772349|FG002|Overall Study|Lost to Follow-up|1|||
143336094|NCT02151266|516772347|FG000|Overall Study|Did NOT receive intervention|3|||
143336095|NCT02151266|516772348|FG001|Overall Study|Did NOT receive intervention|6|||
143336096|NCT02151266|516772349|FG002|Overall Study|Did NOT receive intervention|2|||
143336097|NCT02151266|516772347|FG000|Overall Study|Not able to exercise|4|||
143336098|NCT02151266|516772348|FG001|Overall Study|Not able to exercise|5|||
143336099|NCT02151266|516772349|FG002|Overall Study|Not able to exercise|4|||
143336100|NCT00981084|516772351|FG000|Post Intervention (Data Analysis)|poor effort|1|||
143336101|NCT00981084|516772352|FG001|Post Intervention (Data Analysis)|poor effort|1|||
143336102|NCT00981084|516772351|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
143385031|NCT02137850|516955044|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
143385032|NCT02137850|516955045|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
143385033|NCT02137850|516955046|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
143385034|NCT02137850|516955044|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
143385035|NCT02137850|516955045|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
143385036|NCT02137850|516955046|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
143385037|NCT02137850|516955044|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
143385038|NCT02137850|516955045|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
143336103|NCT00981084|516772352|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
143336104|NCT02291679|516772353|FG000|Overall Study|Adverse Event|2|||
143336105|NCT02291679|516772354|FG001|Overall Study|Adverse Event|12|||
143336106|NCT02291679|516772355|FG002|Overall Study|Adverse Event|19|||
143336107|NCT02291679|516772353|FG000|Overall Study|Protocol Violation|5|||
143336108|NCT02291679|516772354|FG001|Overall Study|Protocol Violation|1|||
143336109|NCT02291679|516772355|FG002|Overall Study|Protocol Violation|7|||
143336110|NCT02291679|516772353|FG000|Overall Study|Withdrew Consent|18|||
143336111|NCT02291679|516772354|FG001|Overall Study|Withdrew Consent|10|||
143336112|NCT02291679|516772355|FG002|Overall Study|Withdrew Consent|15|||
143336113|NCT02291679|516772353|FG000|Overall Study|Lost to Follow-up|12|||
143336114|NCT02291679|516772354|FG001|Overall Study|Lost to Follow-up|10|||
143336115|NCT02291679|516772355|FG002|Overall Study|Lost to Follow-up|9|||
143336116|NCT02291679|516772353|FG000|Overall Study|Insufficient Therapeutic Response|5|||
143336117|NCT02291679|516772354|FG001|Overall Study|Insufficient Therapeutic Response|5|||
143336118|NCT02291679|516772355|FG002|Overall Study|Insufficient Therapeutic Response|7|||
143336119|NCT02291679|516772353|FG000|Overall Study|Other|2|||
143336120|NCT02291679|516772354|FG001|Overall Study|Other|4|||
143336121|NCT02291679|516772355|FG002|Overall Study|Other|2|||
143336122|NCT02276222|516772356|FG000|Overall Study|Adverse Event|62|||
143336123|NCT02276222|516772357|FG001|Overall Study|Adverse Event|11|||
143336124|NCT02276222|516772356|FG000|Overall Study|Death|3|||
143336125|NCT02276222|516772357|FG001|Overall Study|Death|4|||
143336126|NCT02276222|516772356|FG000|Overall Study|Lack of Efficacy|13|||
143336127|NCT02276222|516772357|FG001|Overall Study|Lack of Efficacy|3|||
143336128|NCT02276222|516772356|FG000|Overall Study|Protocol Violation|3|||
143336129|NCT02276222|516772357|FG001|Overall Study|Protocol Violation|2|||
143336130|NCT02276222|516772356|FG000|Overall Study|Withdrawal by Subject|79|||
143336131|NCT02276222|516772357|FG001|Overall Study|Withdrawal by Subject|33|||
143336132|NCT02276222|516772356|FG000|Overall Study|non compliance with study medication|6|||
143336133|NCT02276222|516772357|FG001|Overall Study|non compliance with study medication|2|||
143336134|NCT02276222|516772356|FG000|Overall Study|sponsor decision|0|||
143336135|NCT02276222|516772357|FG001|Overall Study|sponsor decision|3|||
143336136|NCT02276222|516772356|FG000|Overall Study|Lost to Follow-up|15|||
143336137|NCT02276222|516772357|FG001|Overall Study|Lost to Follow-up|5|||
143336138|NCT02276222|516772356|FG000|Overall Study|Physician Decision|2|||
143336139|NCT02276222|516772357|FG001|Overall Study|Physician Decision|1|||
143336140|NCT02276222|516772356|FG000|Overall Study|sheduling conflict|1|||
143336141|NCT02276222|516772357|FG001|Overall Study|sheduling conflict|0|||
143336142|NCT02276222|516772356|FG000|Overall Study|subject withdrew after randomization|1|||
143336143|NCT02276222|516772357|FG001|Overall Study|subject withdrew after randomization|0|||
143336144|NCT00437645|516774199|FG000|Overall Study|Adverse Event|15|||
143336145|NCT00437645|516774200|FG001|Overall Study|Adverse Event|84|||
143336146|NCT00437645|516774199|FG000|Overall Study|Withdrawal by Subject|10|||
143336147|NCT00437645|516774200|FG001|Overall Study|Withdrawal by Subject|22|||
143336148|NCT00437645|516774199|FG000|Overall Study|Protocol Violation|3|||
143336149|NCT00437645|516774200|FG001|Overall Study|Protocol Violation|3|||
143336150|NCT00437645|516774199|FG000|Overall Study|Lost to Follow-up|2|||
143336151|NCT00437645|516774200|FG001|Overall Study|Lost to Follow-up|3|||
143336152|NCT00437645|516774199|FG000|Overall Study|Administrative problems|2|||
143336153|NCT00437645|516774200|FG001|Overall Study|Administrative problems|1|||
143336154|NCT00437645|516774199|FG000|Overall Study|Lack of Efficacy|2|||
143336155|NCT00437645|516774200|FG001|Overall Study|Lack of Efficacy|1|||
143336156|NCT00437645|516774199|FG000|Overall Study|Condition no longer requires study drug|1|||
143336157|NCT00437645|516774200|FG001|Overall Study|Condition no longer requires study drug|1|||
143336158|NCT03966053|516774201|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
143336159|NCT03548207|516774205|FG000|Overall Study|Death|10|||
143336160|NCT03548207|516774206|FG001|Overall Study|Death|23|||
143336161|NCT03548207|516774207|FG002|Overall Study|Death|3|||
143336162|NCT03548207|516774205|FG000|Overall Study|Lost to Follow-up|0|||
143336163|NCT03548207|516774206|FG001|Overall Study|Lost to Follow-up|2|||
143336164|NCT03548207|516774207|FG002|Overall Study|Lost to Follow-up|0|||
143336165|NCT03548207|516774205|FG000|Overall Study|Withdrawal by Subject|0|||
143336166|NCT03548207|516774206|FG001|Overall Study|Withdrawal by Subject|3|||
143336167|NCT03548207|516774207|FG002|Overall Study|Withdrawal by Subject|0|||
143336168|NCT03548207|516774205|FG000|Overall Study|Sponsor decision|19|||
143336169|NCT03548207|516774206|FG001|Overall Study|Sponsor decision|40|||
143336170|NCT03548207|516774207|FG002|Overall Study|Sponsor decision|6|||
143336171|NCT03548207|516774205|FG000|Overall Study|Randomized but not treated|6|||
143336172|NCT03548207|516774206|FG001|Overall Study|Randomized but not treated|10|||
143336173|NCT03548207|516774207|FG002|Overall Study|Randomized but not treated|4|||
143336174|NCT01699022|516774211|FG000|Overall Study|Early discontinuation from the study|3|||
143336175|NCT02066402|516774212|FG000|Overall Study|Adverse Event|1|||
143336176|NCT02066402|516774213|FG001|Overall Study|Adverse Event|2|||
143336177|NCT02066402|516774212|FG000|Overall Study|Lost to Follow-up|11|||
143336178|NCT02066402|516774213|FG001|Overall Study|Lost to Follow-up|8|||
143336179|NCT02066402|516774212|FG000|Overall Study|Withdrawal by Subject|14|||
143336180|NCT02066402|516774213|FG001|Overall Study|Withdrawal by Subject|11|||
143336181|NCT02066402|516774212|FG000|Overall Study|Progressive disease-clinical progression|0|||
143336182|NCT02066402|516774213|FG001|Overall Study|Progressive disease-clinical progression|1|||
143336183|NCT02066402|516774212|FG000|Overall Study|Protocol driven decision point|0|||
143336184|NCT02066402|516774213|FG001|Overall Study|Protocol driven decision point|1|||
143336185|NCT00152464|516774214|FG000|Overall Study|Adverse Event|3|||
143336186|NCT00152464|516774215|FG001|Overall Study|Adverse Event|6|||
143336187|NCT00152464|516774214|FG000|Overall Study|Lost to Follow-up|8|||
143336188|NCT00152464|516774215|FG001|Overall Study|Lost to Follow-up|4|||
143336189|NCT00152464|516774214|FG000|Overall Study|Protocol Violation|3|||
143336190|NCT00152464|516774215|FG001|Overall Study|Protocol Violation|1|||
143336191|NCT00152464|516774214|FG000|Overall Study|Withdrawal by Subject|21|||
143336192|NCT00152464|516774215|FG001|Overall Study|Withdrawal by Subject|22|||
143336193|NCT00152464|516774214|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
143336194|NCT00152464|516774215|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
143336195|NCT00152464|516774214|FG000|Overall Study|Eczema deterioration|0|||
143336196|NCT00152464|516774215|FG001|Overall Study|Eczema deterioration|1|||
143336197|NCT00152464|516774214|FG000|Overall Study|Parent decision|1|||
143336198|NCT00152464|516774215|FG001|Overall Study|Parent decision|1|||
143336199|NCT00152464|516774214|FG000|Overall Study|Investigator decision|1|||
143336200|NCT00152464|516774215|FG001|Overall Study|Investigator decision|0|||
143336201|NCT00152464|516774214|FG000|Overall Study|Lack of Efficacy|1|||
143336202|NCT00152464|516774215|FG001|Overall Study|Lack of Efficacy|0|||
143336203|NCT00152464|516774214|FG000|Overall Study|Eczema poorly controlled|1|||
143336204|NCT00152464|516774215|FG001|Overall Study|Eczema poorly controlled|0|||
143336205|NCT00152464|516774214|FG000|Overall Study|Patient relocated|1|||
143336206|NCT00152464|516774215|FG001|Overall Study|Patient relocated|0|||
143336207|NCT04465357|516774217|FG000|Overall Study|Adverse Event|2|||
143336208|NCT04465357|516774217|FG000|Overall Study|Lack of Efficacy|1|||
143336209|NCT04465357|516774217|FG000|Overall Study|Lost to Follow-up|2|||
143336210|NCT04465357|516774217|FG000|Overall Study|Withdrawal by Subject|6|||
143336211|NCT04465357|516774217|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
143336212|NCT00716092|516774219|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
143336213|NCT00716092|516774220|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
143336214|NCT00716092|516774221|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
143336215|NCT01132326|516774222|FG000|Overall Study|Lack of Efficacy|25|||
143336216|NCT01132326|516774222|FG000|Overall Study|Adverse Event|37|||
143336217|NCT01132326|516774222|FG000|Overall Study|Protocol Violation|1|||
143336218|NCT01132326|516774222|FG000|Overall Study|Lost to Follow-up|16|||
143336219|NCT01132326|516774222|FG000|Overall Study|Withdrawal by Subject|40|||
143336220|NCT01132326|516774222|FG000|Overall Study|Physician Decision|10|||
143336221|NCT01132326|516774222|FG000|Overall Study|Study Termination|80|||
143336222|NCT01132326|516774222|FG000|Overall Study|Declining Health|1|||
143336223|NCT01132326|516774222|FG000|Overall Study|Pregnancy|1|||
143336224|NCT01132326|516774222|FG000|Overall Study|Caregiver Withdrew Consent|1|||
143336225|NCT01132326|516774222|FG000|Overall Study|Death|5|||
143336226|NCT01132326|516774222|FG000|Overall Study|Subject Unable to Come To Visits|1|||
143336227|NCT01040260|516774223|FG000|Overall Study|Withdrawal by Subject|12|||
143336228|NCT01040260|516774224|FG001|Overall Study|Withdrawal by Subject|6|||
143336229|NCT01040260|516774223|FG000|Overall Study|Lost to Follow-up|3|||
143336230|NCT01040260|516774224|FG001|Overall Study|Lost to Follow-up|5|||
143336231|NCT00781391|516774226|FG000|Overall Study|never received study drug|24|||
143336232|NCT00781391|516774227|FG001|Overall Study|never received study drug|23|||
143336233|NCT00781391|516774228|FG002|Overall Study|never received study drug|32|||
143336234|NCT00781391|516774226|FG000|Overall Study|Protocol Violation|19|||
143336235|NCT00781391|516774227|FG001|Overall Study|Protocol Violation|17|||
143336236|NCT00781391|516774228|FG002|Overall Study|Protocol Violation|20|||
143336237|NCT00781391|516774226|FG000|Overall Study|Death|789|||
143336238|NCT00781391|516774227|FG001|Overall Study|Death|730|||
143336239|NCT00781391|516774228|FG002|Overall Study|Death|706|||
143336240|NCT00781391|516774226|FG000|Overall Study|Withdrawal by Subject|47|||
143336241|NCT00781391|516774227|FG001|Overall Study|Withdrawal by Subject|37|||
143336242|NCT00781391|516774228|FG002|Overall Study|Withdrawal by Subject|25|||
143336243|NCT00781391|516774226|FG000|Overall Study|Lost to Follow-up|0|||
143336244|NCT00781391|516774227|FG001|Overall Study|Lost to Follow-up|0|||
143336245|NCT00781391|516774228|FG002|Overall Study|Lost to Follow-up|1|||
143336246|NCT03802123|516774229|FG000|Overall Study|Withdrawal by Subject|3|||
143336247|NCT03802123|516774229|FG000|Overall Study|Physician Decision|1|||
143336248|NCT03802123|516774229|FG000|Overall Study|Subject moved to hospice care|1|||
143336249|NCT03802123|516774229|FG000|Overall Study|technician error|1|||
143336250|NCT03802123|516774229|FG000|Overall Study|Death|3|||
143336251|NCT03172702|516774231|FG000|Overall Study|Adverse Event|9|||
143336252|NCT03172702|516774231|FG000|Overall Study|Death|2|||
143336253|NCT03172702|516774231|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
143336254|NCT03172702|516774231|FG000|Overall Study|Withdrawal by Subject|5|||
143336255|NCT03172702|516774231|FG000|Overall Study|Other|2|||
143336256|NCT01077544|516774232|FG000|Overall Study|New Cancer Therapy|3|||
143336257|NCT01077544|516774233|FG001|Overall Study|New Cancer Therapy|3|||
143336258|NCT01077544|516774232|FG000|Overall Study|Adverse Event|0|||
143336259|NCT01077544|516774233|FG001|Overall Study|Adverse Event|1|||
143336260|NCT01077544|516774232|FG000|Overall Study|Disease Progression|0|||
143336261|NCT01077544|516774233|FG001|Overall Study|Disease Progression|1|||
143336262|NCT03923959|516774234|FG000|Overall Study|Death|16|||
143336263|NCT03923959|516774235|FG001|Overall Study|Death|12|||
143336264|NCT03923959|516774234|FG000|Overall Study|Lost to Follow-up|56|||
143336265|NCT03923959|516774235|FG001|Overall Study|Lost to Follow-up|56|||
143336266|NCT03923959|516774234|FG000|Overall Study|Withdrawal by Subject|1|||
143336267|NCT03923959|516774235|FG001|Overall Study|Withdrawal by Subject|1|||
143336268|NCT03923959|516774234|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
143336269|NCT03923959|516774235|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
143336270|NCT02954354|516774237|FG000|Overall Study|Adverse Event|2|||
143336271|NCT02954354|516774238|FG001|Overall Study|Adverse Event|2|||
143336272|NCT02954354|516774239|FG002|Overall Study|Adverse Event|4|||
143336273|NCT02954354|516774237|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
143336274|NCT02954354|516774238|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
143336275|NCT02954354|516774239|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
143336276|NCT02954354|516774237|FG000|Overall Study|Lack of Efficacy|0|||
143336277|NCT02954354|516774238|FG001|Overall Study|Lack of Efficacy|2|||
143336278|NCT02954354|516774239|FG002|Overall Study|Lack of Efficacy|0|||
143336279|NCT02954354|516774237|FG000|Overall Study|Withdrawal by Subject|17|||
143336280|NCT02954354|516774238|FG001|Overall Study|Withdrawal by Subject|9|||
143336281|NCT02954354|516774239|FG002|Overall Study|Withdrawal by Subject|11|||
143336282|NCT02954354|516774237|FG000|Overall Study|Lost to Follow-up|12|||
143336283|NCT02954354|516774238|FG001|Overall Study|Lost to Follow-up|5|||
143336284|NCT02954354|516774239|FG002|Overall Study|Lost to Follow-up|0|||
143336285|NCT02954354|516774237|FG000|Overall Study|Miscellaneous|2|||
143336286|NCT02954354|516774238|FG001|Overall Study|Miscellaneous|2|||
143336287|NCT02954354|516774239|FG002|Overall Study|Miscellaneous|1|||
143336288|NCT04642898|516774244|FG000|Overall Study|Withdrawal by Subject|2|||
143336289|NCT04642898|516774245|FG001|Overall Study|Withdrawal by Subject|4|||
143336290|NCT04642898|516774246|FG002|Overall Study|Withdrawal by Subject|4|||
143336291|NCT04642898|516774247|FG003|Overall Study|Withdrawal by Subject|6|||
143336292|NCT04642898|516774248|FG004|Overall Study|Withdrawal by Subject|2|||
143336293|NCT04642898|516774249|FG005|Overall Study|Withdrawal by Subject|6|||
143336294|NCT04642898|516774244|FG000|Overall Study|Lost to Follow-up|0|||
143336295|NCT04642898|516774245|FG001|Overall Study|Lost to Follow-up|0|||
143336296|NCT04642898|516774246|FG002|Overall Study|Lost to Follow-up|0|||
143336297|NCT04642898|516774247|FG003|Overall Study|Lost to Follow-up|2|||
143336298|NCT04642898|516774248|FG004|Overall Study|Lost to Follow-up|0|||
143336299|NCT04642898|516774249|FG005|Overall Study|Lost to Follow-up|1|||
143336300|NCT04642898|516774244|FG000|Overall Study|Therapist left trial before patient completed treatment|1|||
143336301|NCT04642898|516774245|FG001|Overall Study|Therapist left trial before patient completed treatment|0|||
143336302|NCT04642898|516774246|FG002|Overall Study|Therapist left trial before patient completed treatment|0|||
143336303|NCT04642898|516774247|FG003|Overall Study|Therapist left trial before patient completed treatment|0|||
143336304|NCT04642898|516774248|FG004|Overall Study|Therapist left trial before patient completed treatment|0|||
143336305|NCT04642898|516774249|FG005|Overall Study|Therapist left trial before patient completed treatment|1|||
143336306|NCT04642898|516774244|FG000|Overall Study|Ineligible due to conflict of interest with therapist|0|||
143336307|NCT04642898|516774245|FG001|Overall Study|Ineligible due to conflict of interest with therapist|0|||
143336308|NCT04642898|516774246|FG002|Overall Study|Ineligible due to conflict of interest with therapist|0|||
143336309|NCT04642898|516774247|FG003|Overall Study|Ineligible due to conflict of interest with therapist|0|||
143336310|NCT04642898|516774248|FG004|Overall Study|Ineligible due to conflict of interest with therapist|1|||
143336311|NCT04642898|516774249|FG005|Overall Study|Ineligible due to conflict of interest with therapist|0|||
143336312|NCT03574597|516774250|FG000|Overall Study|Withdrawal by Subject|67|||
143336313|NCT03574597|516774251|FG001|Overall Study|Withdrawal by Subject|96|||
143336314|NCT03574597|516774250|FG000|Overall Study|Lost to Follow-up|192|||
143336315|NCT03574597|516774251|FG001|Overall Study|Lost to Follow-up|188|||
143336316|NCT04495179|516774252|FG000|Overall Study|Lost to Follow-up|0|||
143336317|NCT04495179|516774253|FG001|Overall Study|Lost to Follow-up|1|||
143336318|NCT04495179|516774252|FG000|Overall Study|Withdrawal by Subject|2|||
143336319|NCT04495179|516774253|FG001|Overall Study|Withdrawal by Subject|4|||
143336320|NCT04495179|516774252|FG000|Overall Study|Study terminated by sponsor|0|||
143336321|NCT04495179|516774253|FG001|Overall Study|Study terminated by sponsor|18|||
143336322|NCT04495179|516774252|FG000|Overall Study|Death|0|||
143385039|NCT02137850|516955046|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
143336323|NCT04495179|516774253|FG001|Overall Study|Death|4|||
143336324|NCT04495179|516774252|FG000|Overall Study|Adverse Event|0|||
143336325|NCT04495179|516774253|FG001|Overall Study|Adverse Event|1|||
143336326|NCT00162370|516774254|FG000|Efficacy Population|Lost to Follow-up|51|||
143385040|NCT02137850|516955044|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
143385041|NCT02137850|516955045|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
143385042|NCT02137850|516955046|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
143385043|NCT02137850|516955044|FG000|Extension Phase: Prophylaxis|Other|0|||
143385044|NCT02137850|516955045|FG001|Extension Phase: Prophylaxis|Other|1|||
143385045|NCT02137850|516955046|FG002|Extension Phase: Prophylaxis|Other|0|||
143385046|NCT02137850|516955044|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
143385047|NCT02137850|516955045|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
143385048|NCT02137850|516955046|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
143385049|NCT05494788|516955047|FG000|Initial Treatment Period|Adverse Event|2|||
143385050|NCT05494788|516955047|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
143385051|NCT05494788|516955047|FG000|Extension Period|Adverse Event|1|||
143385052|NCT05494788|516955047|FG000|Extension Period|Withdrawal by Subject|1|||
143385053|NCT05480943|516955048|FG000|Evaluation for Thiamine Deficiency|Lost to Follow-up|31|||
143385054|NCT05480943|516955048|FG000|Evaluation for Thiamine Deficiency|Protocol Violation|12|||
143385055|NCT05480943|516955048|FG000|Evaluation for Thiamine Deficiency|Withdrawal by Subject|1|||
143385056|NCT05480943|516955048|FG000|Suspected Thiamine Deficiency|Lost to Follow-up|64|||
143385057|NCT00136435|516955049|FG000|Overall Study|Ineligible|8|||
143385058|NCT00136435|516955049|FG000|Overall Study|Induction Death|1|||
143385059|NCT00136435|516955049|FG000|Overall Study|Induction Failure|10|||
143385060|NCT00136435|516955049|FG000|Overall Study|Withdrew prior to initiating imatinib/Ph+|3|||
143385061|NCT00136435|516955049|FG000|Overall Study|Withdrawal by Subject|3|||
143385062|NCT00136435|516955049|FG000|Overall Study|Adverse Event|19|||
143385063|NCT00136435|516955049|FG000|Overall Study|Relapse|4|||
143385064|NCT00136435|516955049|FG000|Overall Study|Transplant in first Complete Remission (CR)|16|||
143385065|NCT02794480|516955050|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
143385066|NCT02794480|516955051|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
143385067|NCT02794480|516955052|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
143385068|NCT02794480|516955053|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
143385069|NCT02794480|516955050|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
143385070|NCT02794480|516955051|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
143385071|NCT02794480|516955052|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
143385072|NCT02794480|516955053|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
143385073|NCT02794480|516955050|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
143385074|NCT02794480|516955051|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
143385075|NCT02794480|516955052|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
143385076|NCT02794480|516955053|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
143336327|NCT00569582|516774268|FG000|Overall Study|Withdrawal by Subject|5|||
143336328|NCT00569582|516774268|FG000|Overall Study|Death|2|||
143336329|NCT00569582|516774268|FG000|Overall Study|Adverse Event|7|||
143336330|NCT00569582|516774268|FG000|Overall Study|Subject was too ill to travel.|1|||
143336331|NCT00569582|516774268|FG000|Overall Study|Subject was non-compliant.|1|||
143336332|NCT04040751|516774269|FG000|Overall Study|Withdrawal by Subject|2|||
143336333|NCT04040751|516774270|FG001|Overall Study|Withdrawal by Subject|0|||
143336334|NCT04040751|516774271|FG002|Overall Study|Withdrawal by Subject|2|||
143336335|NCT04040751|516774272|FG003|Overall Study|Withdrawal by Subject|0|||
143336336|NCT02355743|516774273|FG000|Overall Study|Withdrawal by Subject|1|||
143336337|NCT02355743|516774273|FG000|Overall Study|Lost to Follow-up|1|||
143336338|NCT04212091|516774279|FG000|Overall Study|Lost to Follow-up|0|||
143336339|NCT04212091|516774280|FG001|Overall Study|Lost to Follow-up|0|||
143336340|NCT04212091|516774281|FG002|Overall Study|Lost to Follow-up|0|||
143336341|NCT04212091|516774282|FG003|Overall Study|Lost to Follow-up|0|||
143336342|NCT04212091|516774283|FG004|Overall Study|Lost to Follow-up|1|||
143336343|NCT04212091|516774284|FG005|Overall Study|Lost to Follow-up|1|||
143336344|NCT04212091|516774279|FG000|Overall Study|Participant unable to adhere to visit|0|||
143336345|NCT04212091|516774280|FG001|Overall Study|Participant unable to adhere to visit|0|||
143336346|NCT04212091|516774281|FG002|Overall Study|Participant unable to adhere to visit|0|||
143336347|NCT04212091|516774282|FG003|Overall Study|Participant unable to adhere to visit|0|||
143336348|NCT04212091|516774283|FG004|Overall Study|Participant unable to adhere to visit|1|||
143336349|NCT04212091|516774284|FG005|Overall Study|Participant unable to adhere to visit|0|||
143336350|NCT02612311|516774285|FG000|Overall Study|Adverse Event|16|||
143336351|NCT02612311|516774286|FG001|Overall Study|Adverse Event|12|||
143336352|NCT02612311|516774287|FG002|Overall Study|Adverse Event|7|||
143336353|NCT02612311|516774288|FG003|Overall Study|Adverse Event|13|||
143336354|NCT02612311|516774285|FG000|Overall Study|Death|29|||
143336355|NCT02612311|516774286|FG001|Overall Study|Death|10|||
143336356|NCT02612311|516774287|FG002|Overall Study|Death|11|||
143336357|NCT02612311|516774288|FG003|Overall Study|Death|11|||
143336358|NCT02612311|516774285|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
143336359|NCT02612311|516774286|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
143336360|NCT02612311|516774287|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
143336361|NCT02612311|516774288|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
143336362|NCT02612311|516774285|FG000|Overall Study|Investigator's Decision|11|||
143336363|NCT02612311|516774286|FG001|Overall Study|Investigator's Decision|15|||
143336364|NCT02612311|516774287|FG002|Overall Study|Investigator's Decision|6|||
143336365|NCT02612311|516774288|FG003|Overall Study|Investigator's Decision|6|||
143336366|NCT02612311|516774285|FG000|Overall Study|Lack of Efficacy|0|||
143336367|NCT02612311|516774286|FG001|Overall Study|Lack of Efficacy|0|||
143385077|NCT02794480|516955050|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
143385078|NCT02794480|516955051|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
143336368|NCT02612311|516774287|FG002|Overall Study|Lack of Efficacy|1|||
143336369|NCT02612311|516774288|FG003|Overall Study|Lack of Efficacy|1|||
143336370|NCT02612311|516774285|FG000|Overall Study|Lost to Follow-up|2|||
143336371|NCT02612311|516774286|FG001|Overall Study|Lost to Follow-up|2|||
143336372|NCT02612311|516774287|FG002|Overall Study|Lost to Follow-up|1|||
143336373|NCT02612311|516774288|FG003|Overall Study|Lost to Follow-up|2|||
143336374|NCT02612311|516774285|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
143336375|NCT02612311|516774286|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
143336376|NCT02612311|516774287|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
143336377|NCT02612311|516774288|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
143336378|NCT02612311|516774285|FG000|Overall Study|Site Terminated by Sponsor|29|||
143336379|NCT02612311|516774286|FG001|Overall Study|Site Terminated by Sponsor|12|||
143336380|NCT02612311|516774287|FG002|Overall Study|Site Terminated by Sponsor|13|||
143336381|NCT02612311|516774288|FG003|Overall Study|Site Terminated by Sponsor|5|||
143336382|NCT02612311|516774285|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
143336383|NCT02612311|516774286|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
143336384|NCT02612311|516774287|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
143336385|NCT02612311|516774288|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
143336386|NCT02612311|516774285|FG000|Overall Study|Reason Not Specified|3|||
143336387|NCT02612311|516774286|FG001|Overall Study|Reason Not Specified|7|||
143336388|NCT02612311|516774287|FG002|Overall Study|Reason Not Specified|4|||
143336389|NCT02612311|516774288|FG003|Overall Study|Reason Not Specified|5|||
143336390|NCT02612311|516774285|FG000|Overall Study|Unknown/Missing|10|||
143336391|NCT02612311|516774286|FG001|Overall Study|Unknown/Missing|13|||
143336392|NCT02612311|516774287|FG002|Overall Study|Unknown/Missing|4|||
143336393|NCT02612311|516774288|FG003|Overall Study|Unknown/Missing|0|||
143336394|NCT02612311|516774285|FG000|Overall Study|Non-Compliance with Study|1|||
143336395|NCT02612311|516774286|FG001|Overall Study|Non-Compliance with Study|0|||
143336396|NCT02612311|516774287|FG002|Overall Study|Non-Compliance with Study|0|||
143336397|NCT02612311|516774288|FG003|Overall Study|Non-Compliance with Study|0|||
143336398|NCT02975973|516774289|FG000|Overall Study|Adverse Event|1|||
143336399|NCT02975973|516774290|FG001|Overall Study|Adverse Event|1|||
143336400|NCT02975973|516774291|FG002|Overall Study|Adverse Event|1|||
143336401|NCT02975973|516774292|FG003|Overall Study|Adverse Event|0|||
143336402|NCT03804710|516774294|FG000|Overall Study|Adverse Event|0|||
143336403|NCT03804710|516774295|FG001|Overall Study|Adverse Event|3|||
143336404|NCT03804710|516774294|FG000|Overall Study|Withdrawal by Subject|2|||
143336405|NCT03804710|516774295|FG001|Overall Study|Withdrawal by Subject|1|||
143336406|NCT03804710|516774294|FG000|Overall Study|Other|0|||
143336407|NCT03804710|516774295|FG001|Overall Study|Other|1|||
143336408|NCT04542018|516774296|FG000|Overall Study|Withdrawal by Subject|0|||
143336409|NCT04542018|516774297|FG001|Overall Study|Withdrawal by Subject|0|||
143336410|NCT04542018|516774298|FG002|Overall Study|Withdrawal by Subject|4|||
143336411|NCT04542018|516774296|FG000|Overall Study|Protocol Violation|0|||
143336412|NCT04542018|516774297|FG001|Overall Study|Protocol Violation|0|||
143336413|NCT04542018|516774298|FG002|Overall Study|Protocol Violation|2|||
143336414|NCT00689221|516774302|FG000|Overall Study|Ongoing at cut-off date|39|||
143336415|NCT00689221|516774303|FG001|Overall Study|Ongoing at cut-off date|36|||
143336416|NCT01812655|516774304|FG000|Overall Study|Protocol Violation|1|||
143336417|NCT01812655|516774305|FG001|Overall Study|Protocol Violation|1|||
143336418|NCT01812655|516774306|FG002|Overall Study|Protocol Violation|0|||
143336419|NCT01596582|516774308|FG000|Overall Study|Deemed ineligible after study visit|3|||
143336420|NCT01596582|516774309|FG001|Overall Study|Deemed ineligible after study visit|6|||
143336421|NCT01596582|516774308|FG000|Overall Study|Missing all outcome data|1|||
143336422|NCT01596582|516774309|FG001|Overall Study|Missing all outcome data|1|||
143336423|NCT01428076|516774310|FG000|Overall Study|Adverse Event|0|||
143336424|NCT01428076|516774311|FG001|Overall Study|Adverse Event|1|||
143336425|NCT04435665|516774312|FG000|Overall Study|Lost to Follow-up|0|||
143336426|NCT04435665|516774313|FG001|Overall Study|Lost to Follow-up|0|||
143385079|NCT02794480|516955052|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
143385080|NCT02794480|516955053|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
143385081|NCT02794480|516955050|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
143385082|NCT02794480|516955051|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
143385083|NCT02794480|516955052|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
143385084|NCT02794480|516955053|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
143385085|NCT04154384|516955055|FG000|Overall Study|Lost to Follow-up|24|||
143385086|NCT04154384|516955056|FG001|Overall Study|Lost to Follow-up|33|||
143385087|NCT04154384|516955057|FG002|Overall Study|Lost to Follow-up|0|||
143385088|NCT04154384|516955055|FG000|Overall Study|Withdrawal by Subject|7|||
143385089|NCT04154384|516955056|FG001|Overall Study|Withdrawal by Subject|18|||
143385090|NCT04154384|516955057|FG002|Overall Study|Withdrawal by Subject|0|||
143385091|NCT04154384|516955055|FG000|Overall Study|Missing outcome data|1|||
143385092|NCT04154384|516955056|FG001|Overall Study|Missing outcome data|0|||
143385093|NCT04154384|516955057|FG002|Overall Study|Missing outcome data|0|||
143385094|NCT05321069|516955058|FG000|Overall Study|Adverse Event|52|||
143385095|NCT05321069|516955059|FG001|Overall Study|Adverse Event|52|||
143385096|NCT05321069|516955060|FG002|Overall Study|Adverse Event|64|||
143385097|NCT05321069|516955058|FG000|Overall Study|Protocol Violation|1|||
143385098|NCT05321069|516955059|FG001|Overall Study|Protocol Violation|1|||
143385099|NCT05321069|516955060|FG002|Overall Study|Protocol Violation|0|||
143385100|NCT05321069|516955058|FG000|Overall Study|Withdrawal by Subject|23|||
143385101|NCT05321069|516955059|FG001|Overall Study|Withdrawal by Subject|18|||
143385102|NCT05321069|516955060|FG002|Overall Study|Withdrawal by Subject|12|||
143385103|NCT05321069|516955058|FG000|Overall Study|Lost to Follow-up|1|||
143385104|NCT05321069|516955059|FG001|Overall Study|Lost to Follow-up|0|||
143385105|NCT05321069|516955060|FG002|Overall Study|Lost to Follow-up|1|||
143385106|NCT05321069|516955058|FG000|Overall Study|No reason stated by the participants|23|||
143385107|NCT05321069|516955059|FG001|Overall Study|No reason stated by the participants|22|||
143385108|NCT05321069|516955060|FG002|Overall Study|No reason stated by the participants|16|||
143385109|NCT05321069|516955058|FG000|Overall Study|Lack of Efficacy|1|||
143385110|NCT05321069|516955059|FG001|Overall Study|Lack of Efficacy|1|||
143385111|NCT05321069|516955060|FG002|Overall Study|Lack of Efficacy|0|||
143385112|NCT04128319|516955063|FG000|Overall Study|Death|3|||
143385113|NCT04218266|516955066|FG000|Overall Study|Death|1|||
143385114|NCT04218266|516955067|FG001|Overall Study|Death|2|||
143385115|NCT04218266|516955068|FG002|Overall Study|Death|3|||
143385116|NCT04218266|516955066|FG000|Overall Study|Adverse Event|13|||
143385117|NCT04218266|516955067|FG001|Overall Study|Adverse Event|14|||
143385118|NCT04218266|516955068|FG002|Overall Study|Adverse Event|11|||
143385119|NCT04218266|516955066|FG000|Overall Study|Other|7|||
143385120|NCT04218266|516955067|FG001|Overall Study|Other|5|||
143385121|NCT04218266|516955068|FG002|Overall Study|Other|14|||
143385122|NCT04218266|516955066|FG000|Overall Study|Physician Decision|1|||
143385123|NCT04218266|516955067|FG001|Overall Study|Physician Decision|3|||
143385124|NCT04218266|516955068|FG002|Overall Study|Physician Decision|2|||
143385125|NCT04218266|516955066|FG000|Overall Study|Non-compliance with study drug|0|||
143385126|NCT04218266|516955067|FG001|Overall Study|Non-compliance with study drug|0|||
143385127|NCT04218266|516955068|FG002|Overall Study|Non-compliance with study drug|1|||
143385128|NCT04218266|516955066|FG000|Overall Study|Withdrawal by Subject|1|||
143385129|NCT04218266|516955067|FG001|Overall Study|Withdrawal by Subject|3|||
143385130|NCT04218266|516955068|FG002|Overall Study|Withdrawal by Subject|1|||
143385131|NCT04218266|516955066|FG000|Overall Study|Study drug never administered|2|||
143385132|NCT04218266|516955067|FG001|Overall Study|Study drug never administered|0|||
143385133|NCT04218266|516955068|FG002|Overall Study|Study drug never administered|0|||
143385134|NCT03432858|516955070|FG000|Overall Study|Protocol Violation|2|||
143385135|NCT03432858|516955071|FG001|Overall Study|Protocol Violation|1|||
143385136|NCT03432858|516955072|FG002|Overall Study|Protocol Violation|9|||
143336427|NCT04435665|516774314|FG002|Overall Study|Lost to Follow-up|0|||
143336428|NCT04435665|516774315|FG003|Overall Study|Lost to Follow-up|1|||
143336429|NCT00765388|516774316|FG000|Period 1|Lack of Efficacy|1|||
143336430|NCT00765388|516774317|FG001|Period 1|Lack of Efficacy|2|||
143336431|NCT00765388|516774316|FG000|Period 1|Lost to Follow-up|0|||
143336432|NCT00765388|516774317|FG001|Period 1|Lost to Follow-up|1|||
143336433|NCT00765388|516774316|FG000|Period 1|Herpes Zoster|0|||
143336434|NCT00765388|516774317|FG001|Period 1|Herpes Zoster|1|||
143336435|NCT00765388|516774316|FG000|Period 1|Hip operation|0|||
143336436|NCT00765388|516774317|FG001|Period 1|Hip operation|1|||
143336437|NCT02216773|516774318|FG000|Overall Study|Disease progression|4|||
143336438|NCT02216773|516774319|FG001|Overall Study|Disease progression|2|||
143336439|NCT02216773|516774318|FG000|Overall Study|Insufficient FLRV|4|||
143336440|NCT02216773|516774319|FG001|Overall Study|Insufficient FLRV|0|||
143336441|NCT02216773|516774318|FG000|Overall Study|Abandoned|4|||
143336442|NCT02216773|516774319|FG001|Overall Study|Abandoned|3|||
143336443|NCT04510675|516774322|FG000|Overall Study|Withdrawal by Subject|5|||
143336444|NCT00810264|516774323|FG000|Overall Study|Lost to Follow-up|191|||
143336445|NCT00810264|516774323|FG000|Overall Study|Withdrawal by subject or physician|721|||
143336446|NCT00810264|516774323|FG000|Overall Study|Death|641|||
143336447|NCT01563536|516774324|FG000|Overall Study|Withdrawal by Subject|0|||
143336448|NCT01563536|516774325|FG001|Overall Study|Withdrawal by Subject|2|||
143336449|NCT01563536|516774324|FG000|Overall Study|Lost to Follow-up|1|||
143336450|NCT01563536|516774325|FG001|Overall Study|Lost to Follow-up|0|||
143336451|NCT00313820|516774346|FG000|Assigned to Treatment|Other|1|||
143336452|NCT00313820|516774347|FG001|Assigned to Treatment|Other|0|||
143336453|NCT00313820|516774346|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
143336454|NCT00313820|516774347|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
143336455|NCT00313820|516774346|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
143336456|NCT00313820|516774347|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
143336457|NCT00313820|516774346|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
143336458|NCT00313820|516774347|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
143336459|NCT00313820|516774346|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
143336460|NCT00313820|516774347|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
143336461|NCT00313820|516774346|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
143336462|NCT00313820|516774347|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
143336463|NCT03260868|516774349|FG000|Overall Study|Poor Compliance to Protocol|0|||
143336464|NCT03260868|516774350|FG001|Overall Study|Poor Compliance to Protocol|2|||
143336465|NCT03260868|516774349|FG000|Overall Study|Study Terminated By Sponsor|2|||
143336466|NCT03260868|516774350|FG001|Overall Study|Study Terminated By Sponsor|1|||
143336467|NCT03260868|516774349|FG000|Overall Study|Other than specified above|1|||
143336468|NCT03260868|516774350|FG001|Overall Study|Other than specified above|0|||
143336469|NCT01169675|516774353|FG000|Overall Study|Progressive disease|13|||
143336470|NCT01169675|516774354|FG001|Overall Study|Progressive disease|2|||
143336471|NCT01169675|516774355|FG002|Overall Study|Progressive disease|5|||
143336472|NCT01169675|516774356|FG003|Overall Study|Progressive disease|15|||
143336473|NCT01169675|516774357|FG004|Overall Study|Progressive disease|1|||
143336474|NCT01169675|516774353|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
143336475|NCT01169675|516774354|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
143336476|NCT01169675|516774355|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
143336477|NCT01169675|516774356|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
143336478|NCT01169675|516774357|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
143336479|NCT01169675|516774353|FG000|Overall Study|Adverse Event|5|||
143336480|NCT01169675|516774354|FG001|Overall Study|Adverse Event|1|||
143336481|NCT01169675|516774355|FG002|Overall Study|Adverse Event|2|||
143336482|NCT01169675|516774356|FG003|Overall Study|Adverse Event|0|||
143336483|NCT01169675|516774357|FG004|Overall Study|Adverse Event|0|||
143336484|NCT01169675|516774353|FG000|Overall Study|Withdrawal by Subject|1|||
143336485|NCT01169675|516774354|FG001|Overall Study|Withdrawal by Subject|0|||
143336486|NCT01169675|516774355|FG002|Overall Study|Withdrawal by Subject|0|||
143336487|NCT01169675|516774356|FG003|Overall Study|Withdrawal by Subject|1|||
143336488|NCT01169675|516774357|FG004|Overall Study|Withdrawal by Subject|2|||
143336489|NCT01169675|516774353|FG000|Overall Study|Other Reason Not Defined Above|0|||
143336490|NCT01169675|516774354|FG001|Overall Study|Other Reason Not Defined Above|0|||
143336491|NCT01169675|516774355|FG002|Overall Study|Other Reason Not Defined Above|0|||
143336492|NCT01169675|516774356|FG003|Overall Study|Other Reason Not Defined Above|1|||
143336493|NCT01169675|516774357|FG004|Overall Study|Other Reason Not Defined Above|1|||
143336494|NCT02355028|516774358|FG000|Overall Study|Adverse Event|2|||
143336495|NCT02355028|516774359|FG001|Overall Study|Adverse Event|0|||
143336496|NCT02355028|516774358|FG000|Overall Study|Withdrawal by Subject|1|||
143336497|NCT02355028|516774359|FG001|Overall Study|Withdrawal by Subject|1|||
143336498|NCT02355028|516774358|FG000|Overall Study|Deemed ineligible after randomization|8|||
143336499|NCT02355028|516774359|FG001|Overall Study|Deemed ineligible after randomization|4|||
143336500|NCT01024608|516774361|FG000|Overall Study|Adverse Event|1|||
143336501|NCT01024608|516774362|FG001|Overall Study|Adverse Event|0|||
143336502|NCT01024608|516774361|FG000|Overall Study|Withdrawal by Subject|1|||
143336503|NCT01024608|516774362|FG001|Overall Study|Withdrawal by Subject|0|||
143336504|NCT01024608|516774361|FG000|Overall Study|Lost to Follow-up|0|||
143336505|NCT01024608|516774362|FG001|Overall Study|Lost to Follow-up|1|||
143336506|NCT01024608|516774361|FG000|Overall Study|Protocol Violation|0|||
143336507|NCT01024608|516774362|FG001|Overall Study|Protocol Violation|3|||
143336508|NCT01024608|516774361|FG000|Overall Study|Never received study treatment|2|||
143336509|NCT01024608|516774362|FG001|Overall Study|Never received study treatment|0|||
143336510|NCT02412137|516774369|FG000|Overall Study|Withdrawal by Subject|2|||
143336511|NCT02412137|516774370|FG001|Overall Study|Withdrawal by Subject|0|||
143336512|NCT02412137|516774369|FG000|Overall Study|Lost to Follow-up|21|||
143336513|NCT02412137|516774370|FG001|Overall Study|Lost to Follow-up|14|||
143336514|NCT02412137|516774369|FG000|Overall Study|Physician Decision|28|||
143336515|NCT02412137|516774370|FG001|Overall Study|Physician Decision|9|||
143336516|NCT02543658|516776190|FG000|Overall Study|Lack of Efficacy|0|||
143336517|NCT02543658|516776191|FG001|Overall Study|Lack of Efficacy|4|||
143336518|NCT04586569|516776192|FG000|Overall Study|Withdrawal by Subject|0|||
143336519|NCT04586569|516776193|FG001|Overall Study|Withdrawal by Subject|2|||
143336520|NCT04586569|516776192|FG000|Overall Study|No longer eligible|2|||
143336521|NCT04586569|516776193|FG001|Overall Study|No longer eligible|3|||
143336522|NCT04586569|516776192|FG000|Overall Study|Physician Decision|1|||
143336523|NCT04586569|516776193|FG001|Overall Study|Physician Decision|0|||
143336524|NCT04098406|516776194|FG000|Overall Study|Adverse Event|2|||
143336525|NCT04098406|516776195|FG001|Overall Study|Adverse Event|1|||
143336526|NCT04098406|516776194|FG000|Overall Study|Withdrawal by Subject|1|||
143336527|NCT04098406|516776195|FG001|Overall Study|Withdrawal by Subject|0|||
143336528|NCT03597568|516776196|FG000|Overall Study|Withdrawal by Subject|1|||
143336529|NCT03597568|516776197|FG001|Overall Study|Withdrawal by Subject|1|||
143385137|NCT03432858|516955070|FG000|Overall Study|Withdrawal by Subject|0|||
143336530|NCT03597568|516776196|FG000|Overall Study|Unable to analyze vascular data|1|||
143336531|NCT03597568|516776197|FG001|Overall Study|Unable to analyze vascular data|1|||
143336532|NCT00415610|516776198|FG000|Overall Study|Death|3|||
143336533|NCT00415610|516776199|FG001|Overall Study|Death|2|||
143336534|NCT00415610|516776200|FG002|Overall Study|Death|5|||
143336535|NCT01357616|516776201|FG000|Overall Study|Adverse Event|1|||
143336536|NCT01357616|516776202|FG001|Overall Study|Adverse Event|1|||
143336537|NCT01357616|516776201|FG000|Overall Study|Lost to Follow-up|4|||
143336538|NCT01357616|516776202|FG001|Overall Study|Lost to Follow-up|3|||
143336539|NCT01357616|516776201|FG000|Overall Study|Protocol Violation|0|||
143336540|NCT01357616|516776202|FG001|Overall Study|Protocol Violation|2|||
143336541|NCT01357616|516776201|FG000|Overall Study|Inadequate Control of IOP|1|||
143336542|NCT01357616|516776202|FG001|Overall Study|Inadequate Control of IOP|2|||
143336543|NCT01357616|516776201|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
143336544|NCT01357616|516776202|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
143336545|NCT01357616|516776201|FG000|Overall Study|Withdrawal by Subject|1|||
143336546|NCT01357616|516776202|FG001|Overall Study|Withdrawal by Subject|0|||
143336547|NCT03320018|516776207|FG000|Treatment Period|Withdrawal by Subject|1|||
143336548|NCT03320018|516776208|FG001|Treatment Period|Withdrawal by Subject|0|||
143336549|NCT03320018|516776207|FG000|Day 90 Follow up|Death|0|||
143336550|NCT03320018|516776208|FG001|Day 90 Follow up|Death|1|||
143336551|NCT02691182|516776209|FG000|Overall Study|Withdrawal by Subject|4|||
143336552|NCT02691182|516776210|FG001|Overall Study|Withdrawal by Subject|7|||
143336553|NCT02691182|516776211|FG002|Overall Study|Withdrawal by Subject|6|||
143336554|NCT02691182|516776212|FG003|Overall Study|Withdrawal by Subject|8|||
143336555|NCT02691182|516776209|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
143336556|NCT02691182|516776210|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
143336557|NCT02691182|516776211|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
143336558|NCT02691182|516776212|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
143336559|NCT02691182|516776209|FG000|Overall Study|Lost to Follow-up|8|||
143336560|NCT02691182|516776210|FG001|Overall Study|Lost to Follow-up|33|||
143336561|NCT02691182|516776211|FG002|Overall Study|Lost to Follow-up|19|||
143336562|NCT02691182|516776212|FG003|Overall Study|Lost to Follow-up|22|||
143336563|NCT02691182|516776209|FG000|Overall Study|Adverse Event|3|||
143336564|NCT02691182|516776210|FG001|Overall Study|Adverse Event|10|||
143336565|NCT02691182|516776211|FG002|Overall Study|Adverse Event|10|||
143336566|NCT02691182|516776212|FG003|Overall Study|Adverse Event|11|||
143336567|NCT02691182|516776209|FG000|Overall Study|Physician Decision|3|||
143336568|NCT02691182|516776210|FG001|Overall Study|Physician Decision|7|||
143336569|NCT02691182|516776211|FG002|Overall Study|Physician Decision|14|||
143336570|NCT02691182|516776212|FG003|Overall Study|Physician Decision|8|||
143336571|NCT02691182|516776209|FG000|Overall Study|Lack of Efficacy|0|||
143336572|NCT02691182|516776210|FG001|Overall Study|Lack of Efficacy|0|||
143336573|NCT02691182|516776211|FG002|Overall Study|Lack of Efficacy|0|||
143336574|NCT02691182|516776212|FG003|Overall Study|Lack of Efficacy|4|||
143336575|NCT02691182|516776209|FG000|Overall Study|Protocol Violation|2|||
143336576|NCT02691182|516776210|FG001|Overall Study|Protocol Violation|6|||
143336577|NCT02691182|516776211|FG002|Overall Study|Protocol Violation|6|||
143336578|NCT02691182|516776212|FG003|Overall Study|Protocol Violation|8|||
143336579|NCT02691182|516776209|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
143336580|NCT02691182|516776210|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
143336581|NCT02691182|516776211|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
143336582|NCT02691182|516776212|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
143336583|NCT02691182|516776209|FG000|Overall Study|Missing|0|||
143336584|NCT02691182|516776210|FG001|Overall Study|Missing|5|||
143336585|NCT02691182|516776211|FG002|Overall Study|Missing|1|||
143336586|NCT02691182|516776212|FG003|Overall Study|Missing|5|||
143336587|NCT05453110|516776217|FG000|Overall Study|Received intervention but did not complete primary outcome measure|5|||
143336588|NCT05453110|516776218|FG001|Overall Study|Received intervention but did not complete primary outcome measure|5|||
143336589|NCT05453110|516776219|FG002|Overall Study|Received intervention but did not complete primary outcome measure|6|||
143336590|NCT05906368|516776220|FG000|Overall Study|Withdrawal by Subject|1|||
143336591|NCT05906368|516776221|FG001|Overall Study|Withdrawal by Subject|1|||
143336592|NCT05906368|516776220|FG000|Overall Study|Ineligibility criteria identified|2|||
143336593|NCT05906368|516776221|FG001|Overall Study|Ineligibility criteria identified|0|||
143336594|NCT04493931|516776222|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
143336595|NCT04493931|516776223|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
143336596|NCT04493931|516776224|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
143336597|NCT04493931|516776225|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
143336598|NCT04493931|516776226|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
143336599|NCT04493931|516776227|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
143336600|NCT04493931|516776228|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
143336601|NCT04493931|516776222|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
143336602|NCT04493931|516776223|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
143336603|NCT04493931|516776224|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
143336604|NCT04493931|516776225|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
143336605|NCT04493931|516776226|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
143336606|NCT04493931|516776227|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
143336607|NCT04493931|516776228|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
143336608|NCT04493931|516776222|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
143336609|NCT04493931|516776223|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
143336610|NCT04493931|516776224|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
143336611|NCT04493931|516776225|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
143336612|NCT04493931|516776226|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
143336613|NCT04493931|516776227|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
143336614|NCT04493931|516776228|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
143336615|NCT04493931|516776222|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
143336616|NCT04493931|516776223|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
143336617|NCT04493931|516776224|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
143336618|NCT04493931|516776225|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
143336619|NCT04493931|516776226|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
143336620|NCT04493931|516776227|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
143336621|NCT04493931|516776228|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
143336622|NCT03338894|516776229|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
143336623|NCT00266825|516776236|FG000|Completed Follow-Up|Lost to Follow-up|14|||
143336624|NCT00266825|516776237|FG001|Completed Follow-Up|Lost to Follow-up|19|||
143336625|NCT00266825|516776236|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
143336626|NCT00266825|516776237|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
143336627|NCT00430248|516776238|FG000|Overall Study|Adverse Event|49|||
143336628|NCT00430248|516776239|FG001|Overall Study|Adverse Event|61|||
143336629|NCT00430248|516776240|FG002|Overall Study|Adverse Event|64|||
143336630|NCT00430248|516776238|FG000|Overall Study|Protocol Violation|10|||
143336631|NCT00430248|516776239|FG001|Overall Study|Protocol Violation|2|||
143336632|NCT00430248|516776240|FG002|Overall Study|Protocol Violation|4|||
143336633|NCT00430248|516776238|FG000|Overall Study|Personal Reasons|12|||
143336634|NCT00430248|516776239|FG001|Overall Study|Personal Reasons|24|||
143336635|NCT00430248|516776240|FG002|Overall Study|Personal Reasons|9|||
143336636|NCT00430248|516776238|FG000|Overall Study|Lost to Follow-up|28|||
143336637|NCT00430248|516776239|FG001|Overall Study|Lost to Follow-up|33|||
143336638|NCT00430248|516776240|FG002|Overall Study|Lost to Follow-up|28|||
143336639|NCT00430248|516776238|FG000|Overall Study|Therapeutic Failure|1|||
143336640|NCT00430248|516776239|FG001|Overall Study|Therapeutic Failure|1|||
143336641|NCT00430248|516776240|FG002|Overall Study|Therapeutic Failure|1|||
143336642|NCT00430248|516776238|FG000|Overall Study|Withdrawal by Subject|14|||
143336643|NCT00430248|516776239|FG001|Overall Study|Withdrawal by Subject|20|||
143336644|NCT00430248|516776240|FG002|Overall Study|Withdrawal by Subject|16|||
143336645|NCT00430248|516776238|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
143336646|NCT00430248|516776239|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
143336647|NCT00430248|516776240|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
143336648|NCT00430248|516776238|FG000|Overall Study|Gout Flare|3|||
143336649|NCT00430248|516776239|FG001|Overall Study|Gout Flare|7|||
143336650|NCT00430248|516776240|FG002|Overall Study|Gout Flare|2|||
143336651|NCT00430248|516776238|FG000|Overall Study|Reason Not Specified|8|||
143336652|NCT00430248|516776239|FG001|Overall Study|Reason Not Specified|8|||
143336653|NCT00430248|516776240|FG002|Overall Study|Reason Not Specified|11|||
143336654|NCT02799784|516776243|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
143336655|NCT02799784|516776244|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
143336656|NCT02799784|516776243|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
143336657|NCT02799784|516776244|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
143336658|NCT02799784|516776243|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
143336659|NCT02799784|516776244|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
143336660|NCT02799784|516776243|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
143385138|NCT03432858|516955071|FG001|Overall Study|Withdrawal by Subject|1|||
143385139|NCT03432858|516955072|FG002|Overall Study|Withdrawal by Subject|1|||
143385140|NCT03432858|516955070|FG000|Overall Study|Procedure canceled/rescheduled|0|||
143385141|NCT03432858|516955071|FG001|Overall Study|Procedure canceled/rescheduled|9|||
143385142|NCT03432858|516955072|FG002|Overall Study|Procedure canceled/rescheduled|6|||
143385143|NCT03432858|516955070|FG000|Overall Study|Required postop mobilization with splinting|0|||
143385144|NCT03432858|516955071|FG001|Overall Study|Required postop mobilization with splinting|0|||
143385145|NCT03432858|516955072|FG002|Overall Study|Required postop mobilization with splinting|1|||
143385146|NCT01011946|516955073|FG000|Overall Study|Transferred to another hospital|2|||
143385147|NCT01011946|516955073|FG000|Overall Study|No pathological lab value|1|||
143385148|NCT01424670|516955074|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
143385149|NCT01424670|516955075|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
143385150|NCT01424670|516955074|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
143385151|NCT01424670|516955075|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
143385152|NCT01424670|516955074|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
143385153|NCT01424670|516955075|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
143385154|NCT01424670|516955074|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
143385155|NCT01424670|516955075|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
143385156|NCT01424670|516955074|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
143385157|NCT01424670|516955075|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
143385158|NCT01424670|516955074|FG000|Continuation Period|Adverse Event|13|||
143385159|NCT01424670|516955075|FG001|Continuation Period|Adverse Event|5|||
143385160|NCT01424670|516955074|FG000|Continuation Period|Lost to Follow-up|2|||
143385161|NCT01424670|516955075|FG001|Continuation Period|Lost to Follow-up|0|||
143385162|NCT01424670|516955074|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
143385163|NCT01424670|516955075|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
143385164|NCT01424670|516955074|FG000|Continuation Period|Physician Decision|5|||
143385165|NCT01424670|516955075|FG001|Continuation Period|Physician Decision|4|||
143385166|NCT01424670|516955074|FG000|Continuation Period|Withdrawal by Subject|13|||
143385167|NCT01424670|516955075|FG001|Continuation Period|Withdrawal by Subject|4|||
143385168|NCT00761189|516955076|FG000|Overall Study|Adverse Event|42|||
143385169|NCT00761189|516955076|FG000|Overall Study|Lack of Efficacy|45|||
143385170|NCT00761189|516955076|FG000|Overall Study|Lost to Follow-up|36|||
143385171|NCT00761189|516955076|FG000|Overall Study|Withdrawal by Subject|49|||
143385172|NCT00761189|516955076|FG000|Overall Study|Other|13|||
143385173|NCT01494922|516955077|FG000|Overall Study|Adverse Event|1|||
143385174|NCT03988842|516955078|FG000|Overall Study|Death|1|||
143385175|NCT01227265|516955082|FG000|Overall Study|Did Not Receive Treatment|1|||
143385176|NCT01227265|516955083|FG001|Overall Study|Did Not Receive Treatment|2|||
143385177|NCT01227265|516955084|FG002|Overall Study|Did Not Receive Treatment|0|||
143385178|NCT01227265|516955082|FG000|Overall Study|Administrative|1|||
143385179|NCT01227265|516955083|FG001|Overall Study|Administrative|0|||
143385180|NCT01227265|516955084|FG002|Overall Study|Administrative|2|||
143385181|NCT01227265|516955082|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
143385182|NCT01227265|516955083|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
143385183|NCT01227265|516955084|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
143385184|NCT01227265|516955082|FG000|Overall Study|Protocol Violation|2|||
143385185|NCT01227265|516955083|FG001|Overall Study|Protocol Violation|1|||
143385186|NCT01227265|516955084|FG002|Overall Study|Protocol Violation|0|||
143385187|NCT01227265|516955082|FG000|Overall Study|Withdrawal by Subject|7|||
143385188|NCT01227265|516955083|FG001|Overall Study|Withdrawal by Subject|7|||
143385189|NCT01227265|516955084|FG002|Overall Study|Withdrawal by Subject|3|||
143385190|NCT01227265|516955082|FG000|Overall Study|Lost to Follow-up|2|||
143336661|NCT02799784|516776244|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
143336662|NCT02799784|516776243|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
143336663|NCT02799784|516776244|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
143336664|NCT02799784|516776243|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
143336665|NCT02799784|516776244|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
143336666|NCT01127646|516776245|FG000|Overall Study|Entry Criteria Not Met|1|||
143336667|NCT01127646|516776246|FG001|Overall Study|Entry Criteria Not Met|0|||
143336668|NCT01127646|516776245|FG000|Overall Study|Protocol Violation|0|||
143336669|NCT01127646|516776246|FG001|Overall Study|Protocol Violation|1|||
143336670|NCT04721925|516776250|FG000|2-Month Assessment|Lost to Follow-up|5|||
143336671|NCT04721925|516776251|FG001|2-Month Assessment|Lost to Follow-up|3|||
143336672|NCT04721925|516776250|FG000|4-Month Assessment|Lost to Follow-up|3|||
143336673|NCT04721925|516776251|FG001|4-Month Assessment|Lost to Follow-up|6|||
143336674|NCT04570436|516776255|FG000|Overall Study|Adverse Event|0|||
143336675|NCT04570436|516776256|FG001|Overall Study|Adverse Event|0|||
143336676|NCT04570436|516776257|FG002|Overall Study|Adverse Event|1|||
143336677|NCT04570436|516776258|FG003|Overall Study|Adverse Event|0|||
143385191|NCT01227265|516955083|FG001|Overall Study|Lost to Follow-up|0|||
143385192|NCT01227265|516955084|FG002|Overall Study|Lost to Follow-up|3|||
143385193|NCT01227265|516955082|FG000|Overall Study|Adverse Event|6|||
143385194|NCT01227265|516955083|FG001|Overall Study|Adverse Event|10|||
143385195|NCT01227265|516955084|FG002|Overall Study|Adverse Event|5|||
143385196|NCT03939312|516955085|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
143385197|NCT03939312|516955085|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
143385198|NCT03939312|516955085|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
143385199|NCT03939312|516955085|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
143385200|NCT03939312|516955085|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
143385201|NCT03939312|516955085|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
143385202|NCT03939312|516955085|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
143385203|NCT03939312|516955085|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
143385204|NCT03939312|516955085|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
143385205|NCT03939312|516955085|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
143385206|NCT03939312|516955085|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
143385207|NCT03939312|516955085|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
143385208|NCT02119650|516955086|FG000|Overall Study|Adverse Event|3|||
143385209|NCT02119650|516955087|FG001|Overall Study|Adverse Event|4|||
143385210|NCT02119650|516955086|FG000|Overall Study|Subject decision|2|||
143385211|NCT02119650|516955087|FG001|Overall Study|Subject decision|3|||
143385212|NCT02119650|516955086|FG000|Overall Study|Disease progression|11|||
143385213|NCT02119650|516955087|FG001|Overall Study|Disease progression|14|||
143385214|NCT02119650|516955086|FG000|Overall Study|Death|5|||
143385215|NCT02119650|516955087|FG001|Overall Study|Death|1|||
143385216|NCT02119650|516955086|FG000|Overall Study|Noncompliance with study treatment|1|||
143385217|NCT02119650|516955087|FG001|Overall Study|Noncompliance with study treatment|1|||
143385218|NCT02119650|516955086|FG000|Overall Study|Study terminated by the sponsor|1|||
143385219|NCT02119650|516955087|FG001|Overall Study|Study terminated by the sponsor|0|||
143385220|NCT02119650|516955086|FG000|Overall Study|Physician Decision|0|||
143385221|NCT02119650|516955087|FG001|Overall Study|Physician Decision|2|||
143385222|NCT02119650|516955086|FG000|Overall Study|Multiple reasons for termination|2|||
143385223|NCT02119650|516955087|FG001|Overall Study|Multiple reasons for termination|1|||
143385224|NCT03582722|516955091|FG000|Overall Study|Lost to Follow-up|1|||
143385225|NCT03582722|516955092|FG001|Overall Study|Lost to Follow-up|4|||
143385226|NCT03582722|516955091|FG000|Overall Study|Withdrawal by Subject|3|||
143385227|NCT03582722|516955092|FG001|Overall Study|Withdrawal by Subject|3|||
143385228|NCT03744312|516956502|FG000|Overall Study|Withdrawal by Subject|0|||
143385229|NCT03744312|516956503|FG001|Overall Study|Withdrawal by Subject|1|||
143385230|NCT03744312|516956502|FG000|Overall Study|Screen fail|0|||
143385231|NCT03744312|516956503|FG001|Overall Study|Screen fail|1|||
143385232|NCT04059354|516956504|FG000|Overall Study|COVID-19 pandemic|3|||
143385233|NCT02525692|516956506|FG000|Overall Study|Withdrawal by Subject|1|||
143385234|NCT02525692|516956507|FG001|Overall Study|Withdrawal by Subject|1|||
143385235|NCT02525692|516956508|FG002|Overall Study|Withdrawal by Subject|0|||
143385236|NCT02525692|516956509|FG003|Overall Study|Withdrawal by Subject|5|||
143385237|NCT02525692|516956510|FG004|Overall Study|Withdrawal by Subject|0|||
143385238|NCT02525692|516956511|FG005|Overall Study|Withdrawal by Subject|1|||
143385239|NCT02525692|516956506|FG000|Overall Study|Death|16|||
143385240|NCT02525692|516956507|FG001|Overall Study|Death|18|||
143385241|NCT02525692|516956508|FG002|Overall Study|Death|7|||
143385242|NCT02525692|516956509|FG003|Overall Study|Death|20|||
143385243|NCT02525692|516956510|FG004|Overall Study|Death|3|||
143385244|NCT02525692|516956511|FG005|Overall Study|Death|6|||
143385245|NCT02525692|516956506|FG000|Overall Study|Lost to Follow-up|0|||
143385246|NCT02525692|516956507|FG001|Overall Study|Lost to Follow-up|0|||
143385247|NCT02525692|516956508|FG002|Overall Study|Lost to Follow-up|1|||
143385248|NCT02525692|516956509|FG003|Overall Study|Lost to Follow-up|5|||
143385249|NCT02525692|516956510|FG004|Overall Study|Lost to Follow-up|0|||
143385250|NCT02525692|516956511|FG005|Overall Study|Lost to Follow-up|0|||
143385251|NCT05510232|516956512|FG000|Overall Study|Withdrawal by Subject|2|||
143385252|NCT05510232|516956513|FG001|Overall Study|Withdrawal by Subject|7|||
143385253|NCT05510232|516956514|FG002|Overall Study|Withdrawal by Subject|6|||
143385254|NCT04093362|516956517|FG000|Overall Study|Study Termination|1|||
143385255|NCT04093362|516956518|FG001|Overall Study|Study Termination|1|||
143385256|NCT04093362|516956517|FG000|Overall Study|Withdrawal of Consent|1|||
143385257|NCT04093362|516956518|FG001|Overall Study|Withdrawal of Consent|0|||
143385258|NCT04093362|516956517|FG000|Overall Study|Death|1|||
143385259|NCT04093362|516956518|FG001|Overall Study|Death|3|||
143385260|NCT04093362|516956517|FG000|Overall Study|Reason not Specified|1|||
143336678|NCT04570436|516776259|FG004|Overall Study|Adverse Event|0|||
143336679|NCT04570436|516776260|FG005|Overall Study|Adverse Event|0|||
143336680|NCT04570436|516776261|FG006|Overall Study|Adverse Event|0|||
143336681|NCT04570436|516776262|FG007|Overall Study|Adverse Event|0|||
143336682|NCT04570436|516776263|FG008|Overall Study|Adverse Event|0|||
143336683|NCT04570436|516776264|FG009|Overall Study|Adverse Event|0|||
143336684|NCT04570436|516776255|FG000|Overall Study|Physician Decision|1|||
143336685|NCT04570436|516776256|FG001|Overall Study|Physician Decision|0|||
143336686|NCT04570436|516776257|FG002|Overall Study|Physician Decision|0|||
143336687|NCT04570436|516776258|FG003|Overall Study|Physician Decision|0|||
143336688|NCT04570436|516776259|FG004|Overall Study|Physician Decision|0|||
143336689|NCT04570436|516776260|FG005|Overall Study|Physician Decision|0|||
143336690|NCT04570436|516776261|FG006|Overall Study|Physician Decision|0|||
143336691|NCT04570436|516776262|FG007|Overall Study|Physician Decision|0|||
143336692|NCT04570436|516776263|FG008|Overall Study|Physician Decision|0|||
143336693|NCT04570436|516776264|FG009|Overall Study|Physician Decision|0|||
143336694|NCT03002610|516776265|FG000|Overall Study|Withdrawal by Subject|6|||
143336695|NCT03002610|516776266|FG001|Overall Study|Withdrawal by Subject|25|||
143336696|NCT03002610|516776267|FG002|Overall Study|Withdrawal by Subject|13|||
143336697|NCT04860518|516776268|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
143336698|NCT04860518|516776269|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
143336699|NCT00594854|516776270|FG000|Overall Study|Study terminated|7|||
143336700|NCT00594854|516776271|FG001|Overall Study|Study terminated|10|||
143336701|NCT02835339|516776272|FG000|Overall Study|Did not receive allocated intervention|13|||
143336702|NCT02835339|516776273|FG001|Overall Study|Did not receive allocated intervention|16|||
143336703|NCT04918147|516776282|FG000|Overall Study|Disease flare as defined in protocol|0|||
143336704|NCT04918147|516776283|FG001|Overall Study|Disease flare as defined in protocol|2|||
143336705|NCT06134180|516776286|FG000|Overall Study|Lost to Follow-up|4|||
143336706|NCT02618967|516776287|FG000|Overall Study|Lost to Follow-up|0|||
143336707|NCT02618967|516776288|FG001|Overall Study|Lost to Follow-up|0|||
143336708|NCT02618967|516776289|FG002|Overall Study|Lost to Follow-up|1|||
143336709|NCT02618967|516776290|FG003|Overall Study|Lost to Follow-up|0|||
143336710|NCT02618967|516776291|FG004|Overall Study|Lost to Follow-up|2|||
143336711|NCT02618967|516776292|FG005|Overall Study|Lost to Follow-up|0|||
143336712|NCT02618967|516776293|FG006|Overall Study|Lost to Follow-up|0|||
143336713|NCT02618967|516776294|FG007|Overall Study|Lost to Follow-up|0|||
143336714|NCT02618967|516776287|FG000|Overall Study|Withdrawal by Subject|1|||
143336715|NCT02618967|516776288|FG001|Overall Study|Withdrawal by Subject|0|||
143336716|NCT02618967|516776289|FG002|Overall Study|Withdrawal by Subject|0|||
143336717|NCT02618967|516776290|FG003|Overall Study|Withdrawal by Subject|0|||
143336718|NCT02618967|516776291|FG004|Overall Study|Withdrawal by Subject|0|||
143336719|NCT02618967|516776292|FG005|Overall Study|Withdrawal by Subject|0|||
143336720|NCT02618967|516776293|FG006|Overall Study|Withdrawal by Subject|0|||
143336721|NCT02618967|516776294|FG007|Overall Study|Withdrawal by Subject|0|||
143336722|NCT01368965|516776295|FG000|Overall Study|Lost to Follow-up|12|||
143336723|NCT04085328|516776296|FG000|Overall Study|Witihdrew Consent|16|||
143336724|NCT04085328|516776297|FG001|Overall Study|Witihdrew Consent|16|||
143336725|NCT04085328|516776296|FG000|Overall Study|Adverse Event|8|||
143336726|NCT04085328|516776297|FG001|Overall Study|Adverse Event|7|||
143336727|NCT04085328|516776296|FG000|Overall Study|Lost to Follow-up|7|||
143336728|NCT04085328|516776297|FG001|Overall Study|Lost to Follow-up|2|||
143336729|NCT04085328|516776296|FG000|Overall Study|Physician Decision|0|||
143336730|NCT04085328|516776297|FG001|Overall Study|Physician Decision|1|||
143336731|NCT04085328|516776296|FG000|Overall Study|Pregnancy|0|||
143336732|NCT04085328|516776297|FG001|Overall Study|Pregnancy|1|||
143336733|NCT04085328|516776296|FG000|Overall Study|Reasons Related to COVID-19|5|||
143336734|NCT04085328|516776297|FG001|Overall Study|Reasons Related to COVID-19|8|||
143336735|NCT04085328|516776296|FG000|Overall Study|Did not meet inclusion criteria|1|||
143336736|NCT04085328|516776297|FG001|Overall Study|Did not meet inclusion criteria|1|||
143336737|NCT04085328|516776296|FG000|Overall Study|Early termination|1|||
143336738|NCT04085328|516776297|FG001|Overall Study|Early termination|0|||
143336739|NCT01298999|516776298|FG000|Overall Study|Physician Decision|0|||
143336740|NCT01298999|516776299|FG001|Overall Study|Physician Decision|1|||
143336741|NCT01298999|516776298|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
143336742|NCT01298999|516776299|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
143336743|NCT02816138|516776302|FG000|Overall Study|Adverse Event|1|||
143336744|NCT04839965|516776303|FG000|Overall Study|Death|6|||
143336745|NCT04839965|516776304|FG001|Overall Study|Death|6|||
143336746|NCT04839965|516776303|FG000|Overall Study|Lost to Follow-up|1|||
143336747|NCT04839965|516776304|FG001|Overall Study|Lost to Follow-up|0|||
143336748|NCT04102579|516776305|FG000|Overall Study|Withdrawal by Subject|3|||
143336749|NCT04102579|516776306|FG001|Overall Study|Withdrawal by Subject|4|||
143336750|NCT04102579|516776305|FG000|Overall Study|Lost to Follow-up|0|||
143336751|NCT04102579|516776306|FG001|Overall Study|Lost to Follow-up|1|||
143336752|NCT04102579|516776305|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
143336753|NCT04102579|516776306|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
143336754|NCT04102579|516776305|FG000|Overall Study|Other than Specified|1|||
143336755|NCT04102579|516776306|FG001|Overall Study|Other than Specified|0|||
143336756|NCT04102579|516776305|FG000|Overall Study|Not Dosed with Study Drug|0|||
143336757|NCT04102579|516776306|FG001|Overall Study|Not Dosed with Study Drug|1|||
143336758|NCT02170025|516776307|FG000|Overall Study|Adverse Event|2|||
143336759|NCT02170025|516776308|FG001|Overall Study|Adverse Event|0|||
143336760|NCT00572195|516776309|FG000|Overall Study|Withdrawal by Subject|50|||
143336761|NCT00572195|516776309|FG000|Overall Study|Death|9|||
143336762|NCT00572195|516776309|FG000|Overall Study|Adverse Event|4|||
143336763|NCT00572195|516776309|FG000|Overall Study|Lost to Follow-up|5|||
143336764|NCT01525602|516776310|FG000|Overall Study|Adverse Event|1|||
143336765|NCT01525602|516776311|FG001|Overall Study|Adverse Event|0|||
143336766|NCT01525602|516776312|FG002|Overall Study|Adverse Event|1|||
143336767|NCT01525602|516776313|FG003|Overall Study|Adverse Event|1|||
143336768|NCT01525602|516776314|FG004|Overall Study|Adverse Event|3|||
143336769|NCT01525602|516776315|FG005|Overall Study|Adverse Event|3|||
143336770|NCT01525602|516776316|FG006|Overall Study|Adverse Event|0|||
143336771|NCT01525602|516776317|FG007|Overall Study|Adverse Event|1|||
143336772|NCT01525602|516776310|FG000|Overall Study|Disease progression|6|||
143336773|NCT01525602|516776311|FG001|Overall Study|Disease progression|3|||
143336774|NCT01525602|516776312|FG002|Overall Study|Disease progression|2|||
143336775|NCT01525602|516776313|FG003|Overall Study|Disease progression|5|||
143336776|NCT01525602|516776314|FG004|Overall Study|Disease progression|22|||
143336777|NCT01525602|516776315|FG005|Overall Study|Disease progression|2|||
143336778|NCT01525602|516776316|FG006|Overall Study|Disease progression|3|||
143336779|NCT01525602|516776317|FG007|Overall Study|Disease progression|3|||
143336780|NCT01525602|516776310|FG000|Overall Study|Clinical progression|2|||
143336781|NCT01525602|516776311|FG001|Overall Study|Clinical progression|0|||
143336782|NCT01525602|516776312|FG002|Overall Study|Clinical progression|0|||
143336783|NCT01525602|516776313|FG003|Overall Study|Clinical progression|0|||
143336784|NCT01525602|516776314|FG004|Overall Study|Clinical progression|0|||
143336785|NCT01525602|516776315|FG005|Overall Study|Clinical progression|0|||
143336786|NCT01525602|516776316|FG006|Overall Study|Clinical progression|1|||
143336787|NCT01525602|516776317|FG007|Overall Study|Clinical progression|1|||
143336788|NCT01525602|516776310|FG000|Overall Study|Non-compliance|0|||
143336789|NCT01525602|516776311|FG001|Overall Study|Non-compliance|0|||
143336790|NCT01525602|516776312|FG002|Overall Study|Non-compliance|0|||
143336791|NCT01525602|516776313|FG003|Overall Study|Non-compliance|0|||
143336792|NCT01525602|516776314|FG004|Overall Study|Non-compliance|1|||
143336793|NCT01525602|516776315|FG005|Overall Study|Non-compliance|0|||
143336794|NCT01525602|516776316|FG006|Overall Study|Non-compliance|0|||
143336795|NCT01525602|516776317|FG007|Overall Study|Non-compliance|0|||
143336796|NCT01525602|516776310|FG000|Overall Study|Withdrawal by Subject|0|||
143336797|NCT01525602|516776311|FG001|Overall Study|Withdrawal by Subject|0|||
143336798|NCT01525602|516776312|FG002|Overall Study|Withdrawal by Subject|0|||
143336799|NCT01525602|516776313|FG003|Overall Study|Withdrawal by Subject|0|||
143336800|NCT01525602|516776314|FG004|Overall Study|Withdrawal by Subject|3|||
143336801|NCT01525602|516776315|FG005|Overall Study|Withdrawal by Subject|1|||
143336802|NCT01525602|516776316|FG006|Overall Study|Withdrawal by Subject|0|||
143336803|NCT01525602|516776317|FG007|Overall Study|Withdrawal by Subject|1|||
143336804|NCT01525602|516776310|FG000|Overall Study|Physician Decision|0|||
143336805|NCT01525602|516776311|FG001|Overall Study|Physician Decision|0|||
143336806|NCT01525602|516776312|FG002|Overall Study|Physician Decision|0|||
143336807|NCT01525602|516776313|FG003|Overall Study|Physician Decision|0|||
143336808|NCT01525602|516776314|FG004|Overall Study|Physician Decision|3|||
143336809|NCT01525602|516776315|FG005|Overall Study|Physician Decision|0|||
143336810|NCT01525602|516776316|FG006|Overall Study|Physician Decision|1|||
143336811|NCT01525602|516776317|FG007|Overall Study|Physician Decision|0|||
143336812|NCT01525602|516776310|FG000|Overall Study|Death|0|||
143336813|NCT01525602|516776311|FG001|Overall Study|Death|0|||
143336814|NCT01525602|516776312|FG002|Overall Study|Death|0|||
143336815|NCT01525602|516776313|FG003|Overall Study|Death|0|||
143336816|NCT01525602|516776314|FG004|Overall Study|Death|1|||
143336817|NCT01525602|516776315|FG005|Overall Study|Death|1|||
143336818|NCT01525602|516776316|FG006|Overall Study|Death|0|||
143336819|NCT01525602|516776317|FG007|Overall Study|Death|0|||
143336820|NCT01525602|516776310|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
143385261|NCT04093362|516956518|FG001|Overall Study|Reason not Specified|2|||
143385262|NCT03055377|516956528|FG000|Treatment Phase|Lost to Follow-up|28|||
143385263|NCT03055377|516956529|FG001|Treatment Phase|Lost to Follow-up|24|||
143385264|NCT03055377|516956528|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
143385265|NCT03055377|516956529|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
143385266|NCT04905407|516956530|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
143385267|NCT04905407|516956531|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
143385268|NCT04905407|516956532|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
143385269|NCT04905407|516956533|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
143385270|NCT04905407|516956530|FG000|Part 1 and Part 2|Death|7|||
143385271|NCT04905407|516956531|FG001|Part 1 and Part 2|Death|7|||
143385272|NCT04905407|516956532|FG002|Part 1 and Part 2|Death|7|||
143385273|NCT04905407|516956533|FG003|Part 1 and Part 2|Death|0|||
143385274|NCT04905407|516956530|FG000|Part 1 and Part 2|Other than specified|0|||
143385275|NCT04905407|516956531|FG001|Part 1 and Part 2|Other than specified|0|||
143385276|NCT04905407|516956532|FG002|Part 1 and Part 2|Other than specified|1|||
143385277|NCT04905407|516956533|FG003|Part 1 and Part 2|Other than specified|0|||
143385278|NCT04905407|516956530|FG000|Part 3|Death|0|||
143385279|NCT04905407|516956531|FG001|Part 3|Death|0|||
143385280|NCT04905407|516956532|FG002|Part 3|Death|0|||
143385281|NCT04905407|516956533|FG003|Part 3|Death|2|||
143385282|NCT04868110|516956540|FG000|Overall Study|Withdrawal by Subject|3|||
143385283|NCT04868110|516956541|FG001|Overall Study|Withdrawal by Subject|4|||
143385284|NCT03263026|516956542|FG000|Overall Study|Withdrawal by Subject|1|||
143385285|NCT03263026|516956543|FG001|Overall Study|Withdrawal by Subject|0|||
143385286|NCT03263026|516956542|FG000|Overall Study|Death|1|||
143385287|NCT03263026|516956543|FG001|Overall Study|Death|0|||
143385288|NCT03263026|516956542|FG000|Overall Study|Other/ Various|41|||
143385289|NCT03263026|516956543|FG001|Overall Study|Other/ Various|29|||
143385290|NCT01938547|516956544|FG000|Overall Study|Physician Decision|1|||
143385291|NCT04823611|516956549|FG000|Overall Study|Adverse Event|2|||
143385292|NCT04823611|516956550|FG001|Overall Study|Adverse Event|0|||
143385293|NCT04823611|516956551|FG002|Overall Study|Adverse Event|1|||
143385294|NCT04823611|516956552|FG003|Overall Study|Adverse Event|0|||
143385295|NCT04823611|516956553|FG004|Overall Study|Adverse Event|0|||
143385296|NCT04823611|516956554|FG005|Overall Study|Adverse Event|0|||
143385297|NCT04823611|516956555|FG006|Overall Study|Adverse Event|0|||
143385298|NCT03739996|516956559|FG000|Step 1 (Oral CAB + 2 NRTIs)|Determined to be ineligible|1|||
143385299|NCT03739996|516956559|FG000|Step 2 (CAB LA + VRC07-523LS)|Death|1|||
143385300|NCT03739996|516956559|FG000|Step 2 (CAB LA + VRC07-523LS)|Adverse Event|1|||
143385301|NCT03739996|516956559|FG000|Step 2 (CAB LA + VRC07-523LS)|Withdrawal by Subject|1|||
143385302|NCT03739996|516956559|FG000|Step 2 (CAB LA + VRC07-523LS)|Virologic failure, as defined by the protocol|5|||
143385303|NCT03739996|516956559|FG000|Step 2 (CAB LA + VRC07-523LS)|Participant refusal to remain on long-acting treatment|3|||
143385304|NCT03739996|516956559|FG000|Step 3 (SOC ART)|Death|1|||
143385305|NCT03739996|516956559|FG000|Step 3 (SOC ART)|Participant moved|1|||
143385306|NCT04716634|516956560|FG000|Overall Study|Death|24|||
143385307|NCT04716634|516956561|FG001|Overall Study|Death|24|||
143385308|NCT04716634|516956562|FG002|Overall Study|Death|8|||
143385309|NCT04716634|516956560|FG000|Overall Study|Closed by Sponsor|4|||
143385310|NCT04716634|516956561|FG001|Overall Study|Closed by Sponsor|4|||
143385311|NCT04716634|516956562|FG002|Overall Study|Closed by Sponsor|5|||
143385312|NCT04716634|516956560|FG000|Overall Study|Lost to Follow-up|1|||
143385313|NCT04716634|516956561|FG001|Overall Study|Lost to Follow-up|0|||
143385314|NCT04716634|516956562|FG002|Overall Study|Lost to Follow-up|1|||
143385315|NCT04716634|516956560|FG000|Overall Study|Withdrawal by Subject|0|||
143385316|NCT04716634|516956561|FG001|Overall Study|Withdrawal by Subject|0|||
143385317|NCT04716634|516956562|FG002|Overall Study|Withdrawal by Subject|1|||
143385318|NCT05444192|516956566|FG000|Overall Study|Lost to Follow-up|1|||
143385319|NCT05444192|516956567|FG001|Overall Study|Lost to Follow-up|0|||
143385320|NCT05415410|516956569|FG000|Overall Study|Death|3|||
143385321|NCT05415410|516956570|FG001|Overall Study|Death|6|||
143385322|NCT05415410|516956571|FG002|Overall Study|Death|1|||
143385323|NCT05415410|516956569|FG000|Overall Study|Trial Terminated by Sponsor|1|||
143385324|NCT05415410|516956570|FG001|Overall Study|Trial Terminated by Sponsor|5|||
143385325|NCT05415410|516956571|FG002|Overall Study|Trial Terminated by Sponsor|0|||
143385326|NCT05415410|516956569|FG000|Overall Study|Adverse Event|2|||
143385327|NCT05415410|516956570|FG001|Overall Study|Adverse Event|1|||
143385328|NCT05415410|516956571|FG002|Overall Study|Adverse Event|0|||
143385329|NCT05415410|516956569|FG000|Overall Study|Physician Decision due to Non-Compliance|1|||
143385330|NCT05415410|516956570|FG001|Overall Study|Physician Decision due to Non-Compliance|0|||
143385331|NCT05415410|516956571|FG002|Overall Study|Physician Decision due to Non-Compliance|0|||
143385332|NCT05415410|516956569|FG000|Overall Study|Withdrawal by Subject|1|||
143385333|NCT05415410|516956570|FG001|Overall Study|Withdrawal by Subject|0|||
143385334|NCT05415410|516956571|FG002|Overall Study|Withdrawal by Subject|0|||
143385335|NCT05415410|516956569|FG000|Overall Study|Pregnancy|5|||
143385336|NCT05415410|516956570|FG001|Overall Study|Pregnancy|2|||
143385337|NCT05415410|516956571|FG002|Overall Study|Pregnancy|0|||
143385338|NCT04424927|516956572|FG000|Single-blind Period (4 Weeks)|Not treated|1|||
143385339|NCT04424927|516956573|FG001|Single-blind Period (4 Weeks)|Not treated|0|||
143385340|NCT04424927|516956574|FG002|Single-blind Period (4 Weeks)|Not treated|0|||
143385341|NCT04424927|516956575|FG003|Single-blind Period (4 Weeks)|Not treated|0|||
143385342|NCT04424927|516956576|FG004|Single-blind Period (4 Weeks)|Not treated|0|||
143385343|NCT04424927|516956572|FG000|Single-blind Period (4 Weeks)|Run-in failure|27|||
143385344|NCT04424927|516956573|FG001|Single-blind Period (4 Weeks)|Run-in failure|0|||
143385345|NCT04424927|516956574|FG002|Single-blind Period (4 Weeks)|Run-in failure|0|||
143385346|NCT04424927|516956575|FG003|Single-blind Period (4 Weeks)|Run-in failure|0|||
143385347|NCT04424927|516956576|FG004|Single-blind Period (4 Weeks)|Run-in failure|0|||
143385348|NCT04424927|516956572|FG000|Single-blind Period (4 Weeks)|Withdrawal by Subject|7|||
143385349|NCT04424927|516956573|FG001|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
143385350|NCT04424927|516956574|FG002|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
143385351|NCT04424927|516956575|FG003|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
143385352|NCT04424927|516956576|FG004|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
143385353|NCT04424927|516956572|FG000|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|1|||
143385354|NCT04424927|516956573|FG001|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
143385355|NCT04424927|516956574|FG002|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
143385356|NCT04424927|516956575|FG003|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
143385357|NCT04424927|516956576|FG004|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
143385358|NCT04424927|516956572|FG000|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
143385359|NCT04424927|516956573|FG001|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
143385360|NCT04424927|516956574|FG002|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
143385361|NCT04424927|516956575|FG003|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
143385362|NCT04424927|516956576|FG004|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
143385363|NCT04424927|516956572|FG000|Double-blind Period (24 Weeks)|Withdrawal by Subject|0|||
143385364|NCT04424927|516956573|FG001|Double-blind Period (24 Weeks)|Withdrawal by Subject|3|||
143385365|NCT04424927|516956574|FG002|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
143385366|NCT04424927|516956575|FG003|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
143385367|NCT04424927|516956576|FG004|Double-blind Period (24 Weeks)|Withdrawal by Subject|6|||
143385368|NCT04424927|516956572|FG000|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
143385369|NCT04424927|516956573|FG001|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
143385370|NCT04424927|516956574|FG002|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
143385371|NCT04424927|516956575|FG003|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
143385372|NCT04424927|516956576|FG004|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
143385373|NCT04424927|516956572|FG000|Double-blind Period (24 Weeks)|Other|0|||
143385374|NCT04424927|516956573|FG001|Double-blind Period (24 Weeks)|Other|1|||
143385375|NCT04424927|516956574|FG002|Double-blind Period (24 Weeks)|Other|3|||
143385376|NCT04424927|516956575|FG003|Double-blind Period (24 Weeks)|Other|1|||
143385377|NCT04424927|516956576|FG004|Double-blind Period (24 Weeks)|Other|0|||
143385378|NCT02724956|516956580|FG000|Overall Study|Physician Decision|1|||
143385379|NCT02724956|516956581|FG001|Overall Study|Physician Decision|0|||
143385380|NCT02724956|516956580|FG000|Overall Study|Lack of Efficacy|0|||
143385381|NCT02724956|516956581|FG001|Overall Study|Lack of Efficacy|1|||
143385382|NCT02724956|516956580|FG000|Overall Study|Withdrawal by Subject|0|||
143385383|NCT02724956|516956581|FG001|Overall Study|Withdrawal by Subject|1|||
143385384|NCT01532388|516956582|FG000|3-month Follow-up|Lost to Follow-up|68|||
143385385|NCT01532388|516956583|FG001|3-month Follow-up|Lost to Follow-up|68|||
143385386|NCT01532388|516956582|FG000|6-month Follow-up|Lost to Follow-up|74|||
143385387|NCT01532388|516956583|FG001|6-month Follow-up|Lost to Follow-up|66|||
143385388|NCT01532388|516956582|FG000|12-month Follow-up|Lost to Follow-up|69|||
143385389|NCT01532388|516956583|FG001|12-month Follow-up|Lost to Follow-up|67|||
143385390|NCT01376700|516956584|FG000|Overall Study|Sponsor terminated study early|8|||
143385391|NCT01376700|516956584|FG000|Overall Study|Low or high titer inhibitor|8|||
143385392|NCT05384730|516956593|FG000|Overall Study|Adverse Event|1|||
143385393|NCT05384730|516956594|FG001|Overall Study|Adverse Event|0|||
143385394|NCT05384730|516956593|FG000|Overall Study|Lack of social support|2|||
143385395|NCT05384730|516956594|FG001|Overall Study|Lack of social support|0|||
143385396|NCT05384730|516956593|FG000|Overall Study|Hospital readmission|2|||
143385397|NCT05384730|516956594|FG001|Overall Study|Hospital readmission|0|||
143385398|NCT05384730|516956593|FG000|Overall Study|Disease progression|5|||
143385399|NCT05384730|516956594|FG001|Overall Study|Disease progression|0|||
143385400|NCT05384730|516956593|FG000|Overall Study|Overwhelmed with College commitments|0|||
143385401|NCT05384730|516956594|FG001|Overall Study|Overwhelmed with College commitments|2|||
143385402|NCT01711632|516956595|FG000|Overall Study|Adverse Event|4|||
143385403|NCT01711632|516956595|FG000|Overall Study|Death|3|||
143385404|NCT01711632|516956595|FG000|Overall Study|Lost to Follow-up|3|||
143385405|NCT01711632|516956595|FG000|Overall Study|Withdrawal by Subject|4|||
143385406|NCT01711632|516956595|FG000|Overall Study|Progressive disease|2|||
143385407|NCT01711632|516956595|FG000|Overall Study|No follow up required in re-treatment|3|||
143385408|NCT01711632|516956595|FG000|Overall Study|No follow up required in re-treatment|3|||
143385409|NCT03517969|516956596|FG000|Overall Study|Never started protocol treatment|3|||
143385410|NCT03517969|516956597|FG001|Overall Study|Never started protocol treatment|5|||
143385411|NCT03517969|516956596|FG000|Overall Study|Disease progression|11|||
143385412|NCT03517969|516956597|FG001|Overall Study|Disease progression|16|||
143385413|NCT03517969|516956596|FG000|Overall Study|PSA progression|8|||
143385414|NCT03517969|516956597|FG001|Overall Study|PSA progression|1|||
143385415|NCT03517969|516956596|FG000|Overall Study|Clinical progression|4|||
143385416|NCT03517969|516956597|FG001|Overall Study|Clinical progression|2|||
143385417|NCT03517969|516956596|FG000|Overall Study|Adverse Event|5|||
143385418|NCT03517969|516956597|FG001|Overall Study|Adverse Event|4|||
143385419|NCT03517969|516956596|FG000|Overall Study|Intercurrent illness|1|||
143385420|NCT03517969|516956597|FG001|Overall Study|Intercurrent illness|2|||
143385421|NCT03517969|516956596|FG000|Overall Study|Death|1|||
143385422|NCT03517969|516956597|FG001|Overall Study|Death|1|||
143385423|NCT03517969|516956596|FG000|Overall Study|Withdrawal by Subject|1|||
143385424|NCT03517969|516956597|FG001|Overall Study|Withdrawal by Subject|2|||
143385425|NCT03517969|516956596|FG000|Overall Study|Physician Decision|1|||
143385426|NCT03517969|516956597|FG001|Overall Study|Physician Decision|1|||
143385427|NCT03517969|516956596|FG000|Overall Study|No clinical benefit|1|||
143385428|NCT03517969|516956597|FG001|Overall Study|No clinical benefit|0|||
143385429|NCT03517969|516956596|FG000|Overall Study|Delayed treatment for dental treatment|1|||
143385430|NCT03517969|516956597|FG001|Overall Study|Delayed treatment for dental treatment|0|||
143385431|NCT03517969|516956596|FG000|Overall Study|Difficult to maintain appointment|0|||
143385432|NCT03517969|516956597|FG001|Overall Study|Difficult to maintain appointment|1|||
143385433|NCT03517969|516956596|FG000|Overall Study|Protocol Violation|0|||
143385434|NCT03517969|516956597|FG001|Overall Study|Protocol Violation|1|||
143385435|NCT04820686|516956601|FG000|Overall Study|Withdrawal by Subject|5|||
143385436|NCT04820686|516956602|FG001|Overall Study|Withdrawal by Subject|2|||
143385437|NCT04820686|516956603|FG002|Overall Study|Withdrawal by Subject|3|||
143385438|NCT04820686|516956601|FG000|Overall Study|Study Termination|25|||
143385439|NCT04820686|516956602|FG001|Overall Study|Study Termination|13|||
143385440|NCT04820686|516956603|FG002|Overall Study|Study Termination|14|||
143385441|NCT04820686|516956601|FG000|Overall Study|Adverse Event|0|||
143385442|NCT04820686|516956602|FG001|Overall Study|Adverse Event|1|||
143385443|NCT04820686|516956603|FG002|Overall Study|Adverse Event|0|||
143385444|NCT01872078|516956604|FG000|Overall Study|Adverse Event|0|||
143385445|NCT01872078|516956605|FG001|Overall Study|Adverse Event|0|||
143385446|NCT01872078|516956606|FG002|Overall Study|Adverse Event|1|||
143385447|NCT01872078|516956607|FG003|Overall Study|Adverse Event|0|||
143385448|NCT01872078|516956604|FG000|Overall Study|Dose administration non-compliance|0|||
143385449|NCT01872078|516956605|FG001|Overall Study|Dose administration non-compliance|0|||
143385450|NCT01872078|516956606|FG002|Overall Study|Dose administration non-compliance|0|||
143385451|NCT01872078|516956607|FG003|Overall Study|Dose administration non-compliance|1|||
143385452|NCT01872078|516956604|FG000|Overall Study|Protocol Violation|0|||
143385453|NCT01872078|516956605|FG001|Overall Study|Protocol Violation|0|||
143385454|NCT01872078|516956606|FG002|Overall Study|Protocol Violation|1|||
143385455|NCT01872078|516956607|FG003|Overall Study|Protocol Violation|0|||
143385456|NCT01872078|516956604|FG000|Overall Study|Withdrawal by Subject|0|||
143385457|NCT01872078|516956605|FG001|Overall Study|Withdrawal by Subject|0|||
143385458|NCT01872078|516956606|FG002|Overall Study|Withdrawal by Subject|1|||
143385459|NCT01872078|516956607|FG003|Overall Study|Withdrawal by Subject|0|||
143385460|NCT01872078|516956604|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
143385461|NCT01872078|516956605|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
143385462|NCT01872078|516956606|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
143385463|NCT01872078|516956607|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
143385464|NCT04377308|516956610|FG000|Overall Study|Withdrawal by Subject|0|||
143385465|NCT04377308|516956611|FG001|Overall Study|Withdrawal by Subject|1|||
143385466|NCT02759016|516956612|FG000|Overall Study|Not treated with BI 836826|1|||
143385467|NCT02759016|516956613|FG001|Overall Study|Not treated with BI 836826|0|||
143385468|NCT02759016|516956612|FG000|Overall Study|Progressive disease|1|||
143385469|NCT02759016|516956613|FG001|Overall Study|Progressive disease|0|||
143385470|NCT02759016|516956612|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
143385471|NCT02759016|516956613|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
143385472|NCT02759016|516956612|FG000|Overall Study|Other not defined above|2|||
143385473|NCT02759016|516956613|FG001|Overall Study|Other not defined above|1|||
143385474|NCT02891915|516956616|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
143385475|NCT02891915|516956617|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
143385476|NCT02891915|516956616|FG000|Overall Study|Withdrawal by Subject|3|||
143385477|NCT02891915|516956617|FG001|Overall Study|Withdrawal by Subject|3|||
143385478|NCT02891915|516956616|FG000|Overall Study|Became Ineligible After Enrollment|2|||
143385479|NCT02891915|516956617|FG001|Overall Study|Became Ineligible After Enrollment|1|||
143385480|NCT02891915|516956616|FG000|Overall Study|Lost to Follow-up|1|||
143385481|NCT02891915|516956617|FG001|Overall Study|Lost to Follow-up|4|||
143385482|NCT02891915|516956616|FG000|Overall Study|Physician Decision|1|||
143385483|NCT02891915|516956617|FG001|Overall Study|Physician Decision|0|||
143385484|NCT00709098|516956618|FG000|Double-blind Period|Withdrawal of consent|3|||
143385485|NCT00709098|516956619|FG001|Double-blind Period|Withdrawal of consent|3|||
143385486|NCT00709098|516956620|FG002|Double-blind Period|Withdrawal of consent|0|||
143385487|NCT00709098|516956618|FG000|Double-blind Period|Administrative reason|1|||
143385488|NCT00709098|516956619|FG001|Double-blind Period|Administrative reason|3|||
143385489|NCT00709098|516956620|FG002|Double-blind Period|Administrative reason|0|||
143385490|NCT00709098|516956618|FG000|Double-blind Period|Death|1|||
143385491|NCT00709098|516956619|FG001|Double-blind Period|Death|1|||
143385492|NCT00709098|516956620|FG002|Double-blind Period|Death|0|||
143385493|NCT00709098|516956618|FG000|Double-blind Period|Lost to Follow-up|1|||
143385494|NCT00709098|516956619|FG001|Double-blind Period|Lost to Follow-up|1|||
143385495|NCT00709098|516956620|FG002|Double-blind Period|Lost to Follow-up|0|||
143385496|NCT00709098|516956618|FG000|Open-label Period|Withdrawal of consent|0|||
143385497|NCT00709098|516956619|FG001|Open-label Period|Withdrawal of consent|0|||
143385498|NCT00709098|516956620|FG002|Open-label Period|Withdrawal of consent|7|||
143385499|NCT00709098|516956618|FG000|Open-label Period|Administrative reason|0|||
143385500|NCT00709098|516956619|FG001|Open-label Period|Administrative reason|0|||
143385501|NCT00709098|516956620|FG002|Open-label Period|Administrative reason|5|||
143385502|NCT00709098|516956618|FG000|Open-label Period|Death|0|||
143385503|NCT00709098|516956619|FG001|Open-label Period|Death|0|||
143385504|NCT00709098|516956620|FG002|Open-label Period|Death|1|||
143385505|NCT00709098|516956618|FG000|Open-label Period|Lost to Follow-up|0|||
143385506|NCT00709098|516956619|FG001|Open-label Period|Lost to Follow-up|0|||
143385507|NCT00709098|516956620|FG002|Open-label Period|Lost to Follow-up|1|||
143385508|NCT01721291|516956622|FG000|Overall Study|Withdrawal by Subject|1|||
143385509|NCT01721291|516956623|FG001|Overall Study|Withdrawal by Subject|0|||
143385510|NCT01721291|516956622|FG000|Overall Study|did not like the treatment|1|||
143385511|NCT01721291|516956623|FG001|Overall Study|did not like the treatment|0|||
143385512|NCT03978637|516956626|FG000|Overall Study|Death|0|||
143385513|NCT03978637|516956627|FG001|Overall Study|Death|2|||
143385514|NCT03978637|516956628|FG002|Overall Study|Death|2|||
143385515|NCT03978637|516956629|FG003|Overall Study|Death|0|||
143385516|NCT03978637|516956626|FG000|Overall Study|Withdrawal by Subject|0|||
143385517|NCT03978637|516956627|FG001|Overall Study|Withdrawal by Subject|0|||
143385518|NCT03978637|516956628|FG002|Overall Study|Withdrawal by Subject|1|||
143385519|NCT03978637|516956629|FG003|Overall Study|Withdrawal by Subject|0|||
143385520|NCT03978637|516956626|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
143385521|NCT03978637|516956627|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
143385522|NCT03978637|516956628|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
143385523|NCT03978637|516956629|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
143385524|NCT04923347|516957881|FG000|Overall Study|Withdrawal by Subject|14|||
143385525|NCT04924062|516957882|FG000|Overall Study|Death|49|||
143385526|NCT04924062|516957883|FG001|Overall Study|Death|63|||
143385527|NCT04924062|516957882|FG000|Overall Study|Participant On-going|26|||
143385528|NCT04924062|516957883|FG001|Overall Study|Participant On-going|20|||
143385529|NCT02396199|516957884|FG000|Overall Study|Lost to Follow-up|1|||
143385530|NCT02396199|516957884|FG000|Overall Study|Death|4|||
143385531|NCT04533022|516957885|FG000|Overall Study|Withdrawal by Subject|15|||
143385532|NCT04533022|516957885|FG000|Overall Study|Adverse Event|6|||
143385533|NCT04533022|516957885|FG000|Overall Study|Death|1|||
143385534|NCT04533022|516957885|FG000|Overall Study|FVC decline and FVCpp<60%|2|||
143385535|NCT04533022|516957885|FG000|Overall Study|FVC decline, FVCpp<60% and worsening of respiratory symptoms|1|||
143385536|NCT02163447|516957886|FG000|Overall Study|Withdrawal by Subject|2|||
143385537|NCT02163447|516957887|FG001|Overall Study|Withdrawal by Subject|0|||
143385538|NCT02163447|516957888|FG002|Overall Study|Withdrawal by Subject|1|||
143385539|NCT02163447|516957886|FG000|Overall Study|Lost to Follow-up|1|||
143385540|NCT02163447|516957887|FG001|Overall Study|Lost to Follow-up|3|||
143385541|NCT02163447|516957888|FG002|Overall Study|Lost to Follow-up|0|||
143385542|NCT02163447|516957886|FG000|Overall Study|Moved out of study area|2|||
143385543|NCT02163447|516957887|FG001|Overall Study|Moved out of study area|3|||
143385544|NCT02163447|516957888|FG002|Overall Study|Moved out of study area|2|||
143385545|NCT02163447|516957886|FG000|Overall Study|Became HIV infected at time of delivery|1|||
143385546|NCT02163447|516957887|FG001|Overall Study|Became HIV infected at time of delivery|0|||
143385547|NCT02163447|516957888|FG002|Overall Study|Became HIV infected at time of delivery|0|||
143385548|NCT03897686|516957889|FG000|Overall Study|Protocol Violation|1|||
143385549|NCT03897686|516957890|FG001|Overall Study|Protocol Violation|1|||
143385550|NCT03897686|516957889|FG000|Overall Study|Withdrawal by Subject|1|||
143385551|NCT03897686|516957890|FG001|Overall Study|Withdrawal by Subject|1|||
143385552|NCT05415436|516957891|FG000|Overall Study|Surgeon cancelled procedure|1|||
143385553|NCT05415436|516957892|FG001|Overall Study|Surgeon cancelled procedure|0|||
143385554|NCT05415436|516957891|FG000|Overall Study|Death|1|||
143385555|NCT05415436|516957892|FG001|Overall Study|Death|0|||
143385556|NCT03157167|516957902|FG000|Overall Study|Withdrawal by Subject|1|||
143385557|NCT03157167|516957903|FG001|Overall Study|Withdrawal by Subject|0|||
143336821|NCT01525602|516776311|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
143336822|NCT01525602|516776312|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
143336823|NCT01525602|516776313|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
143336824|NCT01525602|516776314|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
143336825|NCT01525602|516776315|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
143336826|NCT01525602|516776316|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
143336827|NCT01525602|516776317|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
143336828|NCT02532179|516778096|FG000|Overall Study|Lost to Follow-up|1|||
143336829|NCT02532179|516778096|FG000|Overall Study|Pregnancy|1|||
143336830|NCT02532179|516778096|FG000|Overall Study|Subject received depot steroid injection|1|||
143336831|NCT01337674|516778102|FG000|Treatment Period 1|Adverse Event|0|||
143336832|NCT01337674|516778103|FG001|Treatment Period 1|Adverse Event|1|||
143336833|NCT01337674|516778104|FG002|Treatment Period 1|Adverse Event|0|||
143336834|NCT01337674|516778105|FG003|Treatment Period 1|Adverse Event|0|||
143336835|NCT01337674|516778102|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
143336836|NCT01337674|516778103|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
143336837|NCT01337674|516778104|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
143336838|NCT01337674|516778105|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
143336839|NCT01337674|516778102|FG000|Treatment Period 2|Withdrawal by Subject|0|||
143336840|NCT01337674|516778103|FG001|Treatment Period 2|Withdrawal by Subject|0|||
143336841|NCT01337674|516778104|FG002|Treatment Period 2|Withdrawal by Subject|1|||
143336842|NCT01337674|516778105|FG003|Treatment Period 2|Withdrawal by Subject|0|||
143336843|NCT02127372|516778106|FG000|Overall Study|Withdrawal by Subject|1|||
143336844|NCT02127372|516778107|FG001|Overall Study|Withdrawal by Subject|0|||
143336845|NCT03837509|516778108|FG000|Phase 1|Death|5|||
143336846|NCT03837509|516778109|FG001|Phase 1|Death|2|||
143336847|NCT03837509|516778110|FG002|Phase 1|Death|0|||
143336848|NCT03837509|516778111|FG003|Phase 1|Death|0|||
143336849|NCT03837509|516778112|FG004|Phase 1|Death|0|||
143336850|NCT03837509|516778108|FG000|Phase 2|Death|0|||
143336851|NCT03837509|516778109|FG001|Phase 2|Death|0|||
143336852|NCT03837509|516778110|FG002|Phase 2|Death|0|||
143336853|NCT03837509|516778111|FG003|Phase 2|Death|1|||
143336854|NCT03837509|516778112|FG004|Phase 2|Death|1|||
143336855|NCT02173548|516778113|FG000|Overall Study|Lost to Follow-up|0|||
143336856|NCT02173548|516778114|FG001|Overall Study|Lost to Follow-up|2|||
143336857|NCT02173548|516778113|FG000|Overall Study|Withdrawal by Subject|1|||
143336858|NCT02173548|516778114|FG001|Overall Study|Withdrawal by Subject|0|||
143336859|NCT01756352|516778117|FG000|Overall Study|moved away and lost to followup|1|||
143336860|NCT03822117|516778118|FG000|Overall Study|Death|18|||
143336861|NCT03822117|516778119|FG001|Overall Study|Death|17|||
143336862|NCT03822117|516778120|FG002|Overall Study|Death|12|||
143336863|NCT03822117|516778121|FG003|Overall Study|Death|4|||
143336864|NCT03822117|516778118|FG000|Overall Study|Lost to Follow-up|1|||
143336865|NCT03822117|516778119|FG001|Overall Study|Lost to Follow-up|2|||
143336866|NCT03822117|516778120|FG002|Overall Study|Lost to Follow-up|3|||
143336867|NCT03822117|516778121|FG003|Overall Study|Lost to Follow-up|0|||
143336868|NCT03822117|516778118|FG000|Overall Study|Study Terminated by Sponsor|25|||
143336869|NCT03822117|516778119|FG001|Overall Study|Study Terminated by Sponsor|11|||
143336870|NCT03822117|516778120|FG002|Overall Study|Study Terminated by Sponsor|6|||
143336871|NCT03822117|516778121|FG003|Overall Study|Study Terminated by Sponsor|0|||
143336872|NCT03822117|516778118|FG000|Overall Study|Withdrawal by Subject|4|||
143336873|NCT03822117|516778119|FG001|Overall Study|Withdrawal by Subject|0|||
143336874|NCT03822117|516778120|FG002|Overall Study|Withdrawal by Subject|3|||
143336875|NCT03822117|516778121|FG003|Overall Study|Withdrawal by Subject|0|||
143336876|NCT03822117|516778118|FG000|Overall Study|Disease Progression|1|||
143336877|NCT03822117|516778119|FG001|Overall Study|Disease Progression|2|||
143336878|NCT03822117|516778120|FG002|Overall Study|Disease Progression|1|||
143336879|NCT03822117|516778121|FG003|Overall Study|Disease Progression|0|||
143336880|NCT03822117|516778118|FG000|Overall Study|Never Returned to Hospital|0|||
143336881|NCT03822117|516778119|FG001|Overall Study|Never Returned to Hospital|0|||
143336882|NCT03822117|516778120|FG002|Overall Study|Never Returned to Hospital|1|||
143336883|NCT03822117|516778121|FG003|Overall Study|Never Returned to Hospital|0|||
143336884|NCT03466086|516778130|FG000|Period 1|Sponsor decision due to study timeline|1|||
143336885|NCT03466086|516778131|FG001|Period 1|Sponsor decision due to study timeline|0|||
143336886|NCT03466086|516778130|FG000|Period 1|Withdrawal by Subject|1|||
143336887|NCT03466086|516778131|FG001|Period 1|Withdrawal by Subject|0|||
143336888|NCT01256411|516778135|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
143336889|NCT01256411|516778136|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
143336890|NCT01256411|516778137|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
143336891|NCT01256411|516778138|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
143385558|NCT03157167|516957904|FG002|Overall Study|Withdrawal by Subject|0|||
143385559|NCT02597946|516957905|FG000|Overall Study|Withdrawal by Subject|1|||
143385560|NCT02597946|516957905|FG000|Overall Study|Progressive disease|16|||
143385561|NCT02597946|516957905|FG000|Overall Study|Other than above|1|||
143385562|NCT05038566|516957911|FG000|Overall Study|Technical Difficulties with the Device|0|||
143385563|NCT05038566|516957912|FG001|Overall Study|Technical Difficulties with the Device|1|||
143385564|NCT01673984|516957921|FG000|Overall Study|Adverse Event|1|||
143385565|NCT01673984|516957922|FG001|Overall Study|Adverse Event|0|||
143385566|NCT01673984|516957921|FG000|Overall Study|Study termination|9|||
143385567|NCT01673984|516957922|FG001|Overall Study|Study termination|6|||
143385568|NCT00150813|516957923|FG000|Overall Study|Adverse Event|1|||
143385569|NCT00150813|516957923|FG000|Overall Study|Lack of Efficacy|1|||
143385570|NCT00150813|516957923|FG000|Overall Study|Lost to Follow-up|5|||
143385571|NCT00150813|516957923|FG000|Overall Study|Withdrawal by Subject|5|||
143385572|NCT00150813|516957923|FG000|Overall Study|Remission|3|||
143385573|NCT00150813|516957923|FG000|Overall Study|Planned pregancy|1|||
143385574|NCT00150813|516957923|FG000|Overall Study|Switch to commercially available LEV|2|||
143385575|NCT03052608|516957924|FG000|Treatment Phase|Adverse Event|10|||
143385576|NCT03052608|516957925|FG001|Treatment Phase|Adverse Event|12|||
143385577|NCT03052608|516957924|FG000|Treatment Phase|Death|6|||
143385578|NCT03052608|516957925|FG001|Treatment Phase|Death|4|||
143385579|NCT03052608|516957924|FG000|Treatment Phase|Withdrawal by Subject|4|||
143385580|NCT03052608|516957925|FG001|Treatment Phase|Withdrawal by Subject|12|||
143385581|NCT03052608|516957924|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
143385582|NCT03052608|516957925|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
143385583|NCT03052608|516957924|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
143385584|NCT03052608|516957925|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
143385585|NCT03052608|516957924|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
143385586|NCT03052608|516957925|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
143385587|NCT03052608|516957924|FG000|Treatment Phase|Ongoing|103|||
143385588|NCT03052608|516957925|FG001|Treatment Phase|Ongoing|31|||
143385589|NCT03052608|516957924|FG000|Long-Term Follow-up Phase|Death|23|||
143385590|NCT03052608|516957925|FG001|Long-Term Follow-up Phase|Death|28|||
143385591|NCT03052608|516957924|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
143385592|NCT03052608|516957925|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
143385593|NCT03052608|516957924|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
143385594|NCT03052608|516957925|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
143385595|NCT03052608|516957924|FG000|Long-Term Follow-up Phase|Ongoing|122|||
143385596|NCT03052608|516957925|FG001|Long-Term Follow-up Phase|Ongoing|99|||
143385597|NCT01820260|516957927|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
143385598|NCT01820260|516957928|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
143385599|NCT01820260|516957929|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
143385600|NCT01820260|516957930|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
143385601|NCT01820260|516957931|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
143385602|NCT01820260|516957932|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
143385603|NCT01820260|516957933|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
143385604|NCT01820260|516957934|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
143385605|NCT01820260|516957935|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
143385606|NCT01820260|516957936|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
143385607|NCT01820260|516957937|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
143385608|NCT01820260|516957938|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
143385609|NCT01820260|516957939|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
143385610|NCT01820260|516957940|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
143385611|NCT01820260|516957927|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
143385612|NCT01820260|516957928|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
143385613|NCT01820260|516957929|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
143385614|NCT01820260|516957930|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
143385615|NCT01820260|516957931|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
143385616|NCT01820260|516957932|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
143385617|NCT01820260|516957933|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
143385618|NCT01820260|516957934|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
143385619|NCT01820260|516957935|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
143385620|NCT01820260|516957936|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
143385621|NCT01820260|516957937|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
143385622|NCT01820260|516957938|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
143385623|NCT01820260|516957939|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
143385624|NCT01820260|516957940|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
143385625|NCT00894543|516957948|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
143385626|NCT00894543|516957949|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
143385627|NCT00894543|516957948|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
143385628|NCT00894543|516957949|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
143385629|NCT02919449|516957955|FG000|Overall Study|Withdrawal by Subject|1|||
143385630|NCT02919449|516957955|FG000|Overall Study|Investigator decision|1|||
143385631|NCT03578536|516957956|FG000|Overall Study|Lost to Follow-up|1|||
143385632|NCT04436107|516957958|FG000|Overall Study|Sponsor Ended Study|2|||
143385633|NCT04436107|516957959|FG001|Overall Study|Sponsor Ended Study|4|||
143385634|NCT04436107|516957960|FG002|Overall Study|Sponsor Ended Study|8|||
143385635|NCT04436107|516957961|FG003|Overall Study|Sponsor Ended Study|20|||
143385636|NCT04436107|516957958|FG000|Overall Study|Death|3|||
143385637|NCT04436107|516957959|FG001|Overall Study|Death|5|||
143385638|NCT04436107|516957960|FG002|Overall Study|Death|3|||
143385639|NCT04436107|516957961|FG003|Overall Study|Death|18|||
143385640|NCT04436107|516957958|FG000|Overall Study|Withdrawal by Subject|1|||
143385641|NCT04436107|516957959|FG001|Overall Study|Withdrawal by Subject|1|||
143385642|NCT04436107|516957960|FG002|Overall Study|Withdrawal by Subject|0|||
143385643|NCT04436107|516957961|FG003|Overall Study|Withdrawal by Subject|1|||
143385644|NCT00448669|516957962|FG000|Overall Study|Lost to Follow-up|52|||
143385645|NCT00448669|516957963|FG001|Overall Study|Lost to Follow-up|63|||
143385646|NCT00448669|516957962|FG000|Overall Study|Withdrawal by Subject|90|||
143385647|NCT00448669|516957963|FG001|Overall Study|Withdrawal by Subject|74|||
143385648|NCT00448669|516957962|FG000|Overall Study|Relocated|49|||
143385649|NCT00448669|516957963|FG001|Overall Study|Relocated|36|||
143385650|NCT00448669|516957962|FG000|Overall Study|Were withdrawn by investigator|10|||
143385651|NCT00448669|516957963|FG001|Overall Study|Were withdrawn by investigator|6|||
143385652|NCT00448669|516957962|FG000|Overall Study|Death|2|||
143385653|NCT00448669|516957963|FG001|Overall Study|Death|4|||
143385654|NCT00448669|516957962|FG000|Overall Study|Had other reasons|5|||
143385655|NCT00448669|516957963|FG001|Overall Study|Had other reasons|6|||
143385656|NCT00448669|516957962|FG000|Overall Study|HIV-infected at enrollment|1|||
143385657|NCT00448669|516957963|FG001|Overall Study|HIV-infected at enrollment|2|||
143385658|NCT00448669|516957962|FG000|Overall Study|Never started drug|9|||
143385659|NCT00448669|516957963|FG001|Overall Study|Never started drug|7|||
143385660|NCT04116736|516957964|FG000|Overall Study|Withdrew consent during study|3|||
143385661|NCT04116736|516957965|FG001|Overall Study|Withdrew consent during study|1|||
143385662|NCT04116736|516957964|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
143385663|NCT04116736|516957965|FG001|Overall Study|Subject no longer meets eligibility criteria|4|||
143385664|NCT04116736|516957964|FG000|Overall Study|Subject withdrawn due to non-compliance to protocol|11|||
143385665|NCT04116736|516957965|FG001|Overall Study|Subject withdrawn due to non-compliance to protocol|7|||
143385666|NCT04116736|516957964|FG000|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|1|||
143385667|NCT04116736|516957965|FG001|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|0|||
143385668|NCT04116736|516957964|FG000|Overall Study|Subject was enrolled in error|2|||
143385669|NCT04116736|516957965|FG001|Overall Study|Subject was enrolled in error|0|||
143385670|NCT04116736|516957964|FG000|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|1|||
143385671|NCT04116736|516957965|FG001|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|0|||
143385672|NCT04116736|516957964|FG000|Overall Study|Subject did not like the lenses graduation change|1|||
143385673|NCT04116736|516957965|FG001|Overall Study|Subject did not like the lenses graduation change|0|||
143385674|NCT04116736|516957964|FG000|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|1|||
143385675|NCT04116736|516957965|FG001|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|0|||
143385676|NCT00274469|516957966|FG000|Overall Study|Death|63|||
143385677|NCT00274469|516957967|FG001|Overall Study|Death|74|||
143385678|NCT00274469|516957966|FG000|Overall Study|Did not consent to OS follow-up|16|||
143385679|NCT00274469|516957967|FG001|Overall Study|Did not consent to OS follow-up|19|||
143385680|NCT05512962|516957968|FG000|Overall Study|Withdrawal by Subject|1|||
143385681|NCT05512962|516957969|FG001|Overall Study|Withdrawal by Subject|0|||
143385682|NCT04854096|516957971|FG000|Overall Study|Adverse Event|1|||
143385683|NCT04854096|516957972|FG001|Overall Study|Adverse Event|0|||
143385684|NCT04854096|516957971|FG000|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
143385685|NCT04854096|516957972|FG001|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
143385686|NCT04854096|516957971|FG000|Overall Study|Withdrawal by Subject|1|||
143385687|NCT04854096|516957972|FG001|Overall Study|Withdrawal by Subject|0|||
143385688|NCT04854096|516957971|FG000|Overall Study|Other reasons|1|||
143385689|NCT04854096|516957972|FG001|Overall Study|Other reasons|0|||
143385690|NCT04999592|516957973|FG000|Overall Study|Withdrawal by Subject|1|||
143385691|NCT04999592|516957974|FG001|Overall Study|Withdrawal by Subject|0|||
143385692|NCT04095104|516957976|FG000|Overall Study|Withdrawal by Subject|0|||
143385693|NCT04095104|516957977|FG001|Overall Study|Withdrawal by Subject|1|||
143385694|NCT05048186|516957980|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
143385695|NCT05048186|516957981|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
143385696|NCT05048186|516957980|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
143385697|NCT05048186|516957981|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
143385698|NCT01091168|516957984|FG000|Overall Study|Progressive disease|250|||
143385699|NCT01091168|516957985|FG001|Overall Study|Progressive disease|234|||
143385700|NCT01091168|516957984|FG000|Overall Study|Adverse Event|21|||
143385701|NCT01091168|516957985|FG001|Overall Study|Adverse Event|24|||
143385702|NCT01091168|516957984|FG000|Overall Study|Lost to Follow-up|0|||
143385703|NCT01091168|516957985|FG001|Overall Study|Lost to Follow-up|1|||
143385704|NCT01091168|516957984|FG000|Overall Study|Physician, patient's decision, other|27|||
143385705|NCT01091168|516957985|FG001|Overall Study|Physician, patient's decision, other|37|||
143385706|NCT02112916|516957986|FG000|Overall Study|Adverse Event|6|||
143385707|NCT02112916|516957987|FG001|Overall Study|Adverse Event|9|||
143385708|NCT02112916|516957988|FG002|Overall Study|Adverse Event|3|||
143385709|NCT02112916|516957989|FG003|Overall Study|Adverse Event|2|||
143385710|NCT02112916|516957986|FG000|Overall Study|Death|9|||
143385711|NCT02112916|516957987|FG001|Overall Study|Death|9|||
143385712|NCT02112916|516957988|FG002|Overall Study|Death|3|||
143385713|NCT02112916|516957989|FG003|Overall Study|Death|4|||
143385714|NCT02112916|516957986|FG000|Overall Study|Lost to Follow-up|1|||
143385715|NCT02112916|516957987|FG001|Overall Study|Lost to Follow-up|0|||
143385716|NCT02112916|516957988|FG002|Overall Study|Lost to Follow-up|0|||
143385717|NCT02112916|516957989|FG003|Overall Study|Lost to Follow-up|0|||
143385718|NCT02112916|516957986|FG000|Overall Study|Physician Decision|94|||
143385719|NCT02112916|516957987|FG001|Overall Study|Physician Decision|72|||
143385720|NCT02112916|516957988|FG002|Overall Study|Physician Decision|24|||
143385721|NCT02112916|516957989|FG003|Overall Study|Physician Decision|15|||
143385722|NCT02112916|516957986|FG000|Overall Study|Withdrawal by Subject|5|||
143385723|NCT02112916|516957987|FG001|Overall Study|Withdrawal by Subject|3|||
143385724|NCT02112916|516957988|FG002|Overall Study|Withdrawal by Subject|1|||
143385725|NCT02112916|516957989|FG003|Overall Study|Withdrawal by Subject|1|||
143385726|NCT02112916|516957986|FG000|Overall Study|Ineligible|4|||
143385727|NCT02112916|516957987|FG001|Overall Study|Ineligible|8|||
143385728|NCT02112916|516957988|FG002|Overall Study|Ineligible|3|||
143385729|NCT02112916|516957989|FG003|Overall Study|Ineligible|8|||
143385730|NCT02112916|516957986|FG000|Overall Study|Inevaluable|6|||
143385731|NCT02112916|516957987|FG001|Overall Study|Inevaluable|4|||
143385732|NCT02112916|516957988|FG002|Overall Study|Inevaluable|5|||
143385733|NCT02112916|516957989|FG003|Overall Study|Inevaluable|5|||
143385734|NCT02112916|516957986|FG000|Overall Study|Refusal of further protocol therapy|19|||
143385735|NCT02112916|516957987|FG001|Overall Study|Refusal of further protocol therapy|16|||
143385736|NCT02112916|516957988|FG002|Overall Study|Refusal of further protocol therapy|1|||
143385737|NCT02112916|516957989|FG003|Overall Study|Refusal of further protocol therapy|7|||
143385738|NCT02112916|516957986|FG000|Overall Study|Development of SMN|1|||
143385739|NCT02112916|516957987|FG001|Overall Study|Development of SMN|0|||
143385740|NCT02112916|516957988|FG002|Overall Study|Development of SMN|0|||
143385741|NCT02112916|516957989|FG003|Overall Study|Development of SMN|1|||
143385742|NCT02112916|516957986|FG000|Overall Study|Relapse/Progression|10|||
143385743|NCT02112916|516957987|FG001|Overall Study|Relapse/Progression|18|||
143385744|NCT02112916|516957988|FG002|Overall Study|Relapse/Progression|15|||
143385745|NCT02112916|516957989|FG003|Overall Study|Relapse/Progression|2|||
143385746|NCT02112916|516957986|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
143385747|NCT02112916|516957987|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
143385748|NCT02112916|516957988|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
143385749|NCT02112916|516957989|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
143385750|NCT02112916|516957986|FG000|Overall Study|Still on Therapy|44|||
143385751|NCT02112916|516957987|FG001|Overall Study|Still on Therapy|47|||
143385752|NCT02112916|516957988|FG002|Overall Study|Still on Therapy|3|||
143385753|NCT02112916|516957989|FG003|Overall Study|Still on Therapy|2|||
143385754|NCT02112916|516957986|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
143385755|NCT02112916|516957987|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
143385756|NCT02112916|516957988|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
143385757|NCT02112916|516957989|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
143385758|NCT02112916|516957986|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
143385759|NCT02112916|516957987|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
143385760|NCT02112916|516957988|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
143385761|NCT02112916|516957989|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
143385762|NCT05239039|516957990|FG000|Overall Study|Withdrawal by Subject|0|||
143385763|NCT05239039|516957991|FG001|Overall Study|Withdrawal by Subject|1|||
143385764|NCT04266912|516957993|FG000|Overall Study|Withdrawal by Subject|1|||
143385765|NCT04266912|516957994|FG001|Overall Study|Withdrawal by Subject|0|||
143385766|NCT04266912|516957995|FG002|Overall Study|Withdrawal by Subject|0|||
143385767|NCT04266912|516957996|FG003|Overall Study|Withdrawal by Subject|0|||
143385768|NCT04266912|516957993|FG000|Overall Study|Progression|6|||
143385769|NCT04266912|516957994|FG001|Overall Study|Progression|6|||
143385770|NCT04266912|516957995|FG002|Overall Study|Progression|0|||
143385771|NCT04266912|516957996|FG003|Overall Study|Progression|10|||
143385772|NCT03152786|516959233|FG000|Overall Study|Withdrawal by Subject|2|||
143385773|NCT03152786|516959234|FG001|Overall Study|Withdrawal by Subject|1|||
143385774|NCT02349412|516959237|FG000|Overall Study|Withdrawal by Subject|7|||
143385775|NCT02349412|516959238|FG001|Overall Study|Withdrawal by Subject|7|||
143385776|NCT06066541|516959239|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
143385777|NCT06066541|516959240|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
143385778|NCT06066541|516959241|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
143385779|NCT06066541|516959242|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
143385780|NCT06066541|516959243|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
143385781|NCT06066541|516959244|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
143385782|NCT06066541|516959245|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
143385783|NCT06066541|516959239|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
143385784|NCT06066541|516959240|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
143385785|NCT06066541|516959241|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
143385786|NCT06066541|516959242|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
143385787|NCT06066541|516959243|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
143385788|NCT06066541|516959244|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
143385789|NCT06066541|516959245|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
143385790|NCT03819686|516959248|FG000|Overall Study|Lost to Follow-up|2|||
143385791|NCT03819686|516959249|FG001|Overall Study|Lost to Follow-up|3|||
143385792|NCT04521478|516959253|FG000|Overall Study|Protocol Violation|2|||
143385793|NCT04521478|516959254|FG001|Overall Study|Protocol Violation|0|||
143385794|NCT04521478|516959255|FG002|Overall Study|Protocol Violation|1|||
143385795|NCT04521478|516959256|FG003|Overall Study|Protocol Violation|0|||
143385796|NCT04521478|516959257|FG004|Overall Study|Protocol Violation|0|||
143385797|NCT04521478|516959258|FG005|Overall Study|Protocol Violation|0|||
143385798|NCT04521478|516959253|FG000|Overall Study|Technical Problems|0|||
143385799|NCT04521478|516959254|FG001|Overall Study|Technical Problems|0|||
143385800|NCT04521478|516959255|FG002|Overall Study|Technical Problems|0|||
143385801|NCT04521478|516959256|FG003|Overall Study|Technical Problems|1|||
143385802|NCT04521478|516959257|FG004|Overall Study|Technical Problems|0|||
143385803|NCT04521478|516959258|FG005|Overall Study|Technical Problems|0|||
143385804|NCT04521478|516959253|FG000|Overall Study|Burden of Study Procedures|1|||
143385805|NCT04521478|516959254|FG001|Overall Study|Burden of Study Procedures|0|||
143385806|NCT04521478|516959255|FG002|Overall Study|Burden of Study Procedures|0|||
143385807|NCT04521478|516959256|FG003|Overall Study|Burden of Study Procedures|1|||
143385808|NCT04521478|516959257|FG004|Overall Study|Burden of Study Procedures|0|||
143385809|NCT04521478|516959258|FG005|Overall Study|Burden of Study Procedures|1|||
143385810|NCT04521478|516959253|FG000|Overall Study|Lack of Efficacy|0|||
143385811|NCT04521478|516959254|FG001|Overall Study|Lack of Efficacy|0|||
143385812|NCT04521478|516959255|FG002|Overall Study|Lack of Efficacy|0|||
143385813|NCT04521478|516959256|FG003|Overall Study|Lack of Efficacy|0|||
143385814|NCT04521478|516959257|FG004|Overall Study|Lack of Efficacy|1|||
143385815|NCT04521478|516959258|FG005|Overall Study|Lack of Efficacy|1|||
143385816|NCT04521478|516959253|FG000|Overall Study|Adverse Event|7|||
143385817|NCT04521478|516959254|FG001|Overall Study|Adverse Event|0|||
143385818|NCT04521478|516959255|FG002|Overall Study|Adverse Event|2|||
143385819|NCT04521478|516959256|FG003|Overall Study|Adverse Event|1|||
143385820|NCT04521478|516959257|FG004|Overall Study|Adverse Event|2|||
143385821|NCT04521478|516959258|FG005|Overall Study|Adverse Event|7|||
143385822|NCT04521478|516959253|FG000|Overall Study|No Reason Available|0|||
143385823|NCT04521478|516959254|FG001|Overall Study|No Reason Available|2|||
143385824|NCT04521478|516959255|FG002|Overall Study|No Reason Available|0|||
143385825|NCT04521478|516959256|FG003|Overall Study|No Reason Available|0|||
143385826|NCT04521478|516959257|FG004|Overall Study|No Reason Available|1|||
143385827|NCT04521478|516959258|FG005|Overall Study|No Reason Available|0|||
143385828|NCT04521478|516959253|FG000|Overall Study|Other than listed|3|||
143385829|NCT04521478|516959254|FG001|Overall Study|Other than listed|3|||
143385830|NCT04521478|516959255|FG002|Overall Study|Other than listed|3|||
143385831|NCT04521478|516959256|FG003|Overall Study|Other than listed|2|||
143385832|NCT04521478|516959257|FG004|Overall Study|Other than listed|3|||
143385833|NCT04521478|516959258|FG005|Overall Study|Other than listed|3|||
143385834|NCT04521478|516959253|FG000|Overall Study|Not treated|0|||
143385835|NCT04521478|516959254|FG001|Overall Study|Not treated|0|||
143385836|NCT04521478|516959255|FG002|Overall Study|Not treated|0|||
143385837|NCT04521478|516959256|FG003|Overall Study|Not treated|0|||
143385838|NCT04521478|516959257|FG004|Overall Study|Not treated|0|||
143385839|NCT04521478|516959258|FG005|Overall Study|Not treated|1|||
143385840|NCT05058391|516959259|FG000|Overall Study|Adverse Event|1|||
143385841|NCT03775109|516959262|FG000|Overall Study|Adverse Event|1|||
143385842|NCT03775109|516959263|FG001|Overall Study|Adverse Event|0|||
143385843|NCT03775109|516959262|FG000|Overall Study|COVID-19 outbreak|2|||
143385844|NCT03775109|516959263|FG001|Overall Study|COVID-19 outbreak|0|||
143385845|NCT03775109|516959262|FG000|Overall Study|Lost to Follow-up|0|||
143385846|NCT03775109|516959263|FG001|Overall Study|Lost to Follow-up|2|||
143385847|NCT03775109|516959262|FG000|Overall Study|Withdrawal by Subject|1|||
143385848|NCT03775109|516959263|FG001|Overall Study|Withdrawal by Subject|1|||
143385849|NCT03775109|516959262|FG000|Overall Study|Death|0|||
143385850|NCT03775109|516959263|FG001|Overall Study|Death|1|||
143385851|NCT03775109|516959262|FG000|Overall Study|Lack of Efficacy|1|||
143385852|NCT03775109|516959263|FG001|Overall Study|Lack of Efficacy|0|||
143385853|NCT05320432|516959269|FG000|Overall Study|Withdrawal by Subject|0|||
143385854|NCT05320432|516959270|FG001|Overall Study|Withdrawal by Subject|2|||
143385855|NCT04538417|516959273|FG000|Overall Study|Withdrawal by Subject|2|||
143385856|NCT00676715|516959275|FG000|Treatment Period (TP)|Adverse Event|0|||
143385857|NCT00676715|516959276|FG001|Treatment Period (TP)|Adverse Event|3|||
143385858|NCT00676715|516959277|FG002|Treatment Period (TP)|Adverse Event|2|||
143385859|NCT00676715|516959278|FG003|Treatment Period (TP)|Adverse Event|2|||
143385860|NCT00676715|516959275|FG000|Treatment Period (TP)|Death|0|||
143385861|NCT00676715|516959276|FG001|Treatment Period (TP)|Death|0|||
143385862|NCT00676715|516959277|FG002|Treatment Period (TP)|Death|1|||
143385863|NCT00676715|516959278|FG003|Treatment Period (TP)|Death|0|||
143385864|NCT00676715|516959275|FG000|Treatment Period (TP)|Failure to return|1|||
143385865|NCT00676715|516959276|FG001|Treatment Period (TP)|Failure to return|0|||
143385866|NCT00676715|516959277|FG002|Treatment Period (TP)|Failure to return|0|||
143385867|NCT00676715|516959278|FG003|Treatment Period (TP)|Failure to return|0|||
143385868|NCT00676715|516959275|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
143385869|NCT00676715|516959276|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
143385870|NCT00676715|516959277|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
143385871|NCT00676715|516959278|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
143385872|NCT00676715|516959275|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
143385873|NCT00676715|516959276|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
143385874|NCT00676715|516959277|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
143385875|NCT00676715|516959278|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
143385876|NCT00676715|516959275|FG000|Treatment Period (TP)|Withdrew consent|3|||
143385877|NCT00676715|516959276|FG001|Treatment Period (TP)|Withdrew consent|3|||
143385878|NCT00676715|516959277|FG002|Treatment Period (TP)|Withdrew consent|3|||
143385879|NCT00676715|516959278|FG003|Treatment Period (TP)|Withdrew consent|3|||
143385880|NCT00676715|516959275|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
143385881|NCT00676715|516959276|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
143385882|NCT00676715|516959277|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
143385883|NCT00676715|516959278|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
143385884|NCT00676715|516959275|FG000|Treatment Period (TP)|Administrative|0|||
143385885|NCT00676715|516959276|FG001|Treatment Period (TP)|Administrative|0|||
143385886|NCT00676715|516959277|FG002|Treatment Period (TP)|Administrative|0|||
143385887|NCT00676715|516959278|FG003|Treatment Period (TP)|Administrative|1|||
143385888|NCT00676715|516959275|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
143385889|NCT00676715|516959276|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
143385890|NCT00676715|516959277|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
143385891|NCT00676715|516959278|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
143385892|NCT00676715|516959275|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
143385893|NCT00676715|516959276|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
143385894|NCT00676715|516959277|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
143385895|NCT00676715|516959278|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
143385896|NCT00676715|516959275|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
143385897|NCT00676715|516959276|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
143385898|NCT00676715|516959277|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
143385899|NCT00676715|516959278|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
143385900|NCT00676715|516959275|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
143385901|NCT00676715|516959276|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
143385902|NCT00676715|516959277|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
143385903|NCT00676715|516959278|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
143385904|NCT00676715|516959275|FG000|Treatment-free Period (TFP)|Death|1|||
143385905|NCT00676715|516959276|FG001|Treatment-free Period (TFP)|Death|1|||
143385906|NCT00676715|516959277|FG002|Treatment-free Period (TFP)|Death|1|||
143385907|NCT00676715|516959278|FG003|Treatment-free Period (TFP)|Death|0|||
143385908|NCT00676715|516959275|FG000|Open Label Extension (OLE)|Reason not provided|3|||
143385909|NCT00676715|516959276|FG001|Open Label Extension (OLE)|Reason not provided|4|||
143385910|NCT00676715|516959277|FG002|Open Label Extension (OLE)|Reason not provided|1|||
143385911|NCT00676715|516959278|FG003|Open Label Extension (OLE)|Reason not provided|4|||
143385912|NCT00676715|516959275|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
143385913|NCT00676715|516959276|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
143385914|NCT00676715|516959277|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
143385915|NCT00676715|516959278|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
143385916|NCT00676715|516959275|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
143385917|NCT00676715|516959276|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
143385918|NCT00676715|516959277|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
143385919|NCT00676715|516959278|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
143385920|NCT00676715|516959275|FG000|Open Label Extension (OLE)|Adverse Event|0|||
143385921|NCT00676715|516959276|FG001|Open Label Extension (OLE)|Adverse Event|3|||
143385922|NCT00676715|516959277|FG002|Open Label Extension (OLE)|Adverse Event|1|||
143385923|NCT00676715|516959278|FG003|Open Label Extension (OLE)|Adverse Event|0|||
143385924|NCT00676715|516959275|FG000|Open Label Extension (OLE)|Death|2|||
143385925|NCT00676715|516959276|FG001|Open Label Extension (OLE)|Death|0|||
143385926|NCT00676715|516959277|FG002|Open Label Extension (OLE)|Death|2|||
143385927|NCT00676715|516959278|FG003|Open Label Extension (OLE)|Death|2|||
143385928|NCT05249439|516959279|FG000|Overall Study|Withdrawal by Subject|2|||
143385929|NCT05249439|516959280|FG001|Overall Study|Withdrawal by Subject|5|||
143385930|NCT05249439|516959279|FG000|Overall Study|Physician Decision|3|||
143385931|NCT05249439|516959280|FG001|Overall Study|Physician Decision|1|||
143385932|NCT02249949|516959281|FG000|Overall Study|Cancelled prior to treatment|2|||
143385933|NCT02365766|516959301|FG000|Overall Study|Withdrawal by Subject|0|||
143385934|NCT02365766|516959302|FG001|Overall Study|Withdrawal by Subject|0|||
143385935|NCT02365766|516959303|FG002|Overall Study|Withdrawal by Subject|1|||
143385936|NCT02365766|516959301|FG000|Overall Study|Eligibility Criteria Not Met|0|||
143385937|NCT02365766|516959302|FG001|Overall Study|Eligibility Criteria Not Met|0|||
143385938|NCT02365766|516959303|FG002|Overall Study|Eligibility Criteria Not Met|1|||
143385939|NCT00650104|516959306|FG000|Overall Study|Adverse Event|17|||
143385940|NCT00650104|516959306|FG000|Overall Study|Death|2|||
143385941|NCT00650104|516959306|FG000|Overall Study|Withdrawal by Subject|11|||
143385942|NCT00650104|516959306|FG000|Overall Study|Physician Decision|7|||
143385943|NCT00650104|516959306|FG000|Overall Study|Lost to Follow-up|1|||
143385944|NCT00650104|516959306|FG000|Overall Study|Non-compliance|2|||
143385945|NCT00650104|516959306|FG000|Overall Study|Sponsor Terminated Dosing|1|||
143385946|NCT04048681|516959307|FG000|Overall Study|family emergency|0|||
143385947|NCT04048681|516959308|FG001|Overall Study|family emergency|0|||
143385948|NCT04048681|516959309|FG002|Overall Study|family emergency|0|||
143385949|NCT04048681|516959310|FG003|Overall Study|family emergency|1|||
143385950|NCT04048681|516959311|FG004|Overall Study|family emergency|0|||
143385951|NCT03385629|516959312|FG000|Follow-up Well Child Visit 2|Lost to Follow-up|214|||
143385952|NCT03385629|516959313|FG001|Follow-up Well Child Visit 2|Lost to Follow-up|160|||
143385953|NCT03385629|516959312|FG000|Follow-up Well Child Visit 2|Withdrawal by Subject|6|||
143385954|NCT03385629|516959313|FG001|Follow-up Well Child Visit 2|Withdrawal by Subject|3|||
143385955|NCT03385629|516959312|FG000|Follow-up Well Child Visit 3|Lost to Follow-up|266|||
143385956|NCT03385629|516959313|FG001|Follow-up Well Child Visit 3|Lost to Follow-up|186|||
143385957|NCT04649359|516959316|FG000|Overall Study|Withdrawal by Subject|7|||
143385958|NCT04649359|516959317|FG001|Overall Study|Withdrawal by Subject|7|||
143385959|NCT04649359|516959316|FG000|Overall Study|Death|41|||
143385960|NCT04649359|516959317|FG001|Overall Study|Death|26|||
143385961|NCT04649359|516959316|FG000|Overall Study|Ongoing in the study|75|||
143385962|NCT04649359|516959317|FG001|Overall Study|Ongoing in the study|31|||
143385963|NCT04450342|516959330|FG000|Overall Study|Adverse Event|1|||
143385964|NCT04450342|516959331|FG001|Overall Study|Adverse Event|1|||
143385965|NCT04450342|516959332|FG002|Overall Study|Adverse Event|0|||
143385966|NCT04450342|516959330|FG000|Overall Study|Device not used|1|||
143385967|NCT04450342|516959331|FG001|Overall Study|Device not used|0|||
143385968|NCT04450342|516959332|FG002|Overall Study|Device not used|0|||
143385969|NCT04450342|516959330|FG000|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|1|||
143385970|NCT04450342|516959331|FG001|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
143385971|NCT04450342|516959332|FG002|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
143385972|NCT04450342|516959330|FG000|Overall Study|Physician Decision|1|||
143385973|NCT04450342|516959331|FG001|Overall Study|Physician Decision|0|||
143385974|NCT04450342|516959332|FG002|Overall Study|Physician Decision|1|||
143385975|NCT04450342|516959330|FG000|Overall Study|Protocol Deviation|0|||
143385976|NCT04450342|516959331|FG001|Overall Study|Protocol Deviation|1|||
143385977|NCT04450342|516959332|FG002|Overall Study|Protocol Deviation|0|||
143385978|NCT04450342|516959330|FG000|Overall Study|Reoperation|1|||
143385979|NCT04450342|516959331|FG001|Overall Study|Reoperation|1|||
143385980|NCT04450342|516959332|FG002|Overall Study|Reoperation|0|||
143385981|NCT04450342|516959330|FG000|Overall Study|Screen Failures|0|||
143385982|NCT04450342|516959331|FG001|Overall Study|Screen Failures|0|||
143385983|NCT04450342|516959332|FG002|Overall Study|Screen Failures|2|||
143385984|NCT04450342|516959330|FG000|Overall Study|Site Terminated by Sponsor|1|||
143385985|NCT04450342|516959331|FG001|Overall Study|Site Terminated by Sponsor|1|||
143385986|NCT04450342|516959332|FG002|Overall Study|Site Terminated by Sponsor|1|||
143385987|NCT04450342|516959330|FG000|Overall Study|Study Terminated by Sponsor|31|||
143385988|NCT04450342|516959331|FG001|Overall Study|Study Terminated by Sponsor|29|||
143385989|NCT04450342|516959332|FG002|Overall Study|Study Terminated by Sponsor|6|||
143385990|NCT04450342|516959330|FG000|Overall Study|Withdrawal by Subject|0|||
143385991|NCT04450342|516959331|FG001|Overall Study|Withdrawal by Subject|1|||
143385992|NCT04450342|516959332|FG002|Overall Study|Withdrawal by Subject|2|||
143385993|NCT05633407|516959333|FG000|Overall Study|Physician Decision|2|||
143385994|NCT05633407|516959334|FG001|Overall Study|Physician Decision|0|||
143385995|NCT05633407|516959333|FG000|Overall Study|Adverse Event|1|||
143385996|NCT05633407|516959334|FG001|Overall Study|Adverse Event|0|||
143385997|NCT05633407|516959333|FG000|Overall Study|Withdrawal by Subject|1|||
143385998|NCT05633407|516959334|FG001|Overall Study|Withdrawal by Subject|0|||
143385999|NCT05633407|516959333|FG000|Overall Study|Other|1|||
143386000|NCT05633407|516959334|FG001|Overall Study|Other|1|||
143386001|NCT02500758|516959335|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
143386002|NCT02500758|516959336|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
143386003|NCT02500758|516959335|FG000|Washout (1 Week)|Lost to Follow-up|2|||
143386004|NCT02500758|516959336|FG001|Washout (1 Week)|Lost to Follow-up|2|||
143386005|NCT02500758|516959335|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
143386006|NCT02500758|516959336|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
143386007|NCT02500758|516959335|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
143386008|NCT02500758|516959336|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
143386009|NCT02500758|516959335|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
143386010|NCT02500758|516959336|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
143386011|NCT02538900|516959339|FG000|Overall Study|Death|2|||
143386012|NCT02538900|516959340|FG001|Overall Study|Death|2|||
143386013|NCT02538900|516959341|FG002|Overall Study|Death|2|||
143386014|NCT02538900|516959339|FG000|Overall Study|Withdrawal by Subject|18|||
143386015|NCT02538900|516959340|FG001|Overall Study|Withdrawal by Subject|16|||
143386016|NCT02538900|516959341|FG002|Overall Study|Withdrawal by Subject|15|||
143386017|NCT02874534|516959342|FG000|Overall Study|Withdrawal by Subject|5|||
143386018|NCT02874534|516959343|FG001|Overall Study|Withdrawal by Subject|8|||
143386019|NCT02874534|516959342|FG000|Overall Study|Lost to Follow-up|2|||
143386020|NCT02874534|516959343|FG001|Overall Study|Lost to Follow-up|2|||
143386021|NCT02874534|516959342|FG000|Overall Study|Ongoing in study|1|||
143386022|NCT02874534|516959343|FG001|Overall Study|Ongoing in study|1|||
143386023|NCT02923180|516959344|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
143386024|NCT02923180|516959344|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
143386025|NCT01989455|516959349|FG000|Overall Study|Adverse Event|0|||
143386026|NCT01989455|516959350|FG001|Overall Study|Adverse Event|1|||
143386027|NCT01989455|516959351|FG002|Overall Study|Adverse Event|0|||
143386028|NCT01989455|516959352|FG003|Overall Study|Adverse Event|0|||
143386029|NCT01989455|516959353|FG004|Overall Study|Adverse Event|0|||
143386030|NCT01989455|516959349|FG000|Overall Study|Withdrawal by Subject|0|||
143386031|NCT01989455|516959350|FG001|Overall Study|Withdrawal by Subject|1|||
143386032|NCT01989455|516959351|FG002|Overall Study|Withdrawal by Subject|0|||
143386033|NCT01989455|516959352|FG003|Overall Study|Withdrawal by Subject|0|||
143386034|NCT01989455|516959353|FG004|Overall Study|Withdrawal by Subject|0|||
143386035|NCT01989455|516959349|FG000|Overall Study|Technical problems with infusion|0|||
143386036|NCT01989455|516959350|FG001|Overall Study|Technical problems with infusion|0|||
143386037|NCT01989455|516959351|FG002|Overall Study|Technical problems with infusion|1|||
143386038|NCT01989455|516959352|FG003|Overall Study|Technical problems with infusion|0|||
143386039|NCT01989455|516959353|FG004|Overall Study|Technical problems with infusion|1|||
143386040|NCT01101451|516959357|FG000|Overall Study|Eligible and never treated|0|||
143386041|NCT01101451|516959358|FG001|Overall Study|Eligible and never treated|5|||
143386042|NCT01101451|516959357|FG000|Overall Study|Ineligible and treated|12|||
143386043|NCT01101451|516959358|FG001|Overall Study|Ineligible and treated|8|||
143386044|NCT01101451|516959357|FG000|Overall Study|Ineligible and never treated|2|||
143386045|NCT01101451|516959358|FG001|Overall Study|Ineligible and never treated|2|||
143386046|NCT02814838|516959361|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
143386047|NCT02814838|516959362|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
143386048|NCT02814838|516959361|FG000|Overall Study|Consent withdrawal|1|||
143386049|NCT02814838|516959362|FG001|Overall Study|Consent withdrawal|1|||
143386050|NCT00593489|516959363|FG000|Allocation|did not attend workshop; allocation not|2|||
143386051|NCT00593489|516959364|FG001|Allocation|did not attend workshop; allocation not|1|||
143386052|NCT00073749|516959365|FG000|Overall Study|Disease Progression|2|||
143386053|NCT00073749|516959366|FG001|Overall Study|Disease Progression|0|||
143386054|NCT00073749|516959367|FG002|Overall Study|Disease Progression|3|||
143386055|NCT00073749|516959368|FG003|Overall Study|Disease Progression|2|||
143386056|NCT00073749|516959369|FG004|Overall Study|Disease Progression|3|||
143386057|NCT00073749|516959370|FG005|Overall Study|Disease Progression|1|||
143386058|NCT00073749|516959371|FG006|Overall Study|Disease Progression|3|||
143386059|NCT00073749|516959365|FG000|Overall Study|Death|0|||
143386060|NCT00073749|516959366|FG001|Overall Study|Death|1|||
143386061|NCT00073749|516959367|FG002|Overall Study|Death|1|||
143386062|NCT00073749|516959368|FG003|Overall Study|Death|0|||
143386063|NCT00073749|516959369|FG004|Overall Study|Death|0|||
143386064|NCT00073749|516959370|FG005|Overall Study|Death|0|||
143386065|NCT00073749|516959371|FG006|Overall Study|Death|29|||
143386066|NCT00073749|516959365|FG000|Overall Study|Adverse Event|0|||
143386067|NCT00073749|516959366|FG001|Overall Study|Adverse Event|3|||
143386068|NCT00073749|516959367|FG002|Overall Study|Adverse Event|6|||
143386069|NCT00073749|516959368|FG003|Overall Study|Adverse Event|4|||
143386070|NCT00073749|516959369|FG004|Overall Study|Adverse Event|2|||
143386071|NCT00073749|516959370|FG005|Overall Study|Adverse Event|1|||
143386072|NCT00073749|516959371|FG006|Overall Study|Adverse Event|0|||
143386073|NCT00073749|516959365|FG000|Overall Study|Physician Decision|0|||
143386074|NCT00073749|516959366|FG001|Overall Study|Physician Decision|0|||
143386075|NCT00073749|516959367|FG002|Overall Study|Physician Decision|1|||
143386076|NCT00073749|516959368|FG003|Overall Study|Physician Decision|0|||
143386077|NCT00073749|516959369|FG004|Overall Study|Physician Decision|0|||
143386078|NCT00073749|516959370|FG005|Overall Study|Physician Decision|2|||
143386079|NCT00073749|516959371|FG006|Overall Study|Physician Decision|0|||
143386080|NCT00073749|516959365|FG000|Overall Study|Withdrawal by Subject|0|||
143386081|NCT00073749|516959366|FG001|Overall Study|Withdrawal by Subject|1|||
143386082|NCT00073749|516959367|FG002|Overall Study|Withdrawal by Subject|0|||
143386083|NCT00073749|516959368|FG003|Overall Study|Withdrawal by Subject|0|||
143386084|NCT00073749|516959369|FG004|Overall Study|Withdrawal by Subject|1|||
143386085|NCT00073749|516959370|FG005|Overall Study|Withdrawal by Subject|0|||
143386086|NCT00073749|516959371|FG006|Overall Study|Withdrawal by Subject|2|||
143386087|NCT00073749|516959365|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
143386088|NCT00073749|516959366|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
143386089|NCT00073749|516959367|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
143386090|NCT00073749|516959368|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
143386091|NCT00073749|516959369|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
143386092|NCT00073749|516959370|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
143386093|NCT00073749|516959371|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
143386094|NCT00073749|516959365|FG000|Overall Study|Lost to Follow-up|0|||
143386095|NCT00073749|516959366|FG001|Overall Study|Lost to Follow-up|0|||
143386096|NCT00073749|516959367|FG002|Overall Study|Lost to Follow-up|0|||
143386097|NCT00073749|516959368|FG003|Overall Study|Lost to Follow-up|0|||
143386098|NCT00073749|516959369|FG004|Overall Study|Lost to Follow-up|0|||
143386099|NCT00073749|516959370|FG005|Overall Study|Lost to Follow-up|0|||
143386100|NCT00073749|516959371|FG006|Overall Study|Lost to Follow-up|2|||
143386101|NCT00073749|516959365|FG000|Overall Study|Other|0|||
143386102|NCT00073749|516959366|FG001|Overall Study|Other|0|||
143386103|NCT00073749|516959367|FG002|Overall Study|Other|0|||
143386104|NCT00073749|516959368|FG003|Overall Study|Other|0|||
143386105|NCT00073749|516959369|FG004|Overall Study|Other|0|||
143386106|NCT00073749|516959370|FG005|Overall Study|Other|2|||
143386107|NCT00073749|516959371|FG006|Overall Study|Other|0|||
143386108|NCT00951379|516959372|FG000|Overall Study|Adverse Event|4|||
143386109|NCT00951379|516959373|FG001|Overall Study|Adverse Event|1|||
143386110|NCT00951379|516959372|FG000|Overall Study|Withdrawal by Subject|1|||
143386111|NCT00951379|516959373|FG001|Overall Study|Withdrawal by Subject|0|||
143386112|NCT00951379|516959372|FG000|Overall Study|Noncompliance|1|||
143386113|NCT00951379|516959373|FG001|Overall Study|Noncompliance|0|||
143386114|NCT00951379|516959372|FG000|Overall Study|Disease Progression|0|||
143386115|NCT00951379|516959373|FG001|Overall Study|Disease Progression|1|||
143386116|NCT02742519|516959375|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
143386117|NCT02742519|516959376|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
143386118|NCT02742519|516959377|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
143386119|NCT02742519|516959375|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
143386120|NCT02742519|516959376|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
143386121|NCT02742519|516959377|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
143386122|NCT02742519|516959375|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
143386123|NCT02742519|516959376|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
143386124|NCT02742519|516959377|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
143386125|NCT03580369|516959378|FG000|Overall Study|No treatment due to mis-randomization|1|||
143386126|NCT03580369|516959379|FG001|Overall Study|No treatment due to mis-randomization|0|||
143386127|NCT03580369|516959380|FG002|Overall Study|No treatment due to mis-randomization|0|||
143386128|NCT03580369|516959381|FG003|Overall Study|No treatment due to mis-randomization|0|||
143386129|NCT03580369|516959382|FG004|Overall Study|No treatment due to mis-randomization|3|||
143386130|NCT03580369|516959383|FG005|Overall Study|No treatment due to mis-randomization|0|||
143386131|NCT03580369|516959384|FG006|Overall Study|No treatment due to mis-randomization|0|||
143386132|NCT03580369|516959385|FG007|Overall Study|No treatment due to mis-randomization|0|||
143386133|NCT03580369|516959378|FG000|Overall Study|Reason unknown|0|||
143386134|NCT03580369|516959379|FG001|Overall Study|Reason unknown|0|||
143386135|NCT03580369|516959380|FG002|Overall Study|Reason unknown|1|||
143386136|NCT03580369|516959381|FG003|Overall Study|Reason unknown|0|||
143386137|NCT03580369|516959382|FG004|Overall Study|Reason unknown|0|||
143386138|NCT03580369|516959383|FG005|Overall Study|Reason unknown|0|||
143386139|NCT03580369|516959384|FG006|Overall Study|Reason unknown|0|||
143386140|NCT03580369|516959385|FG007|Overall Study|Reason unknown|0|||
143386141|NCT03580369|516959378|FG000|Overall Study|Technical problems|0|||
143386142|NCT03580369|516959379|FG001|Overall Study|Technical problems|0|||
143386143|NCT03580369|516959380|FG002|Overall Study|Technical problems|0|||
143386144|NCT03580369|516959381|FG003|Overall Study|Technical problems|0|||
143386145|NCT03580369|516959382|FG004|Overall Study|Technical problems|1|||
143386146|NCT03580369|516959383|FG005|Overall Study|Technical problems|0|||
143386147|NCT03580369|516959384|FG006|Overall Study|Technical problems|2|||
143386148|NCT03580369|516959385|FG007|Overall Study|Technical problems|0|||
143386149|NCT03580369|516959378|FG000|Overall Study|Pregnancy|2|||
143386150|NCT03580369|516959379|FG001|Overall Study|Pregnancy|0|||
143386151|NCT03580369|516959380|FG002|Overall Study|Pregnancy|3|||
143386152|NCT03580369|516959381|FG003|Overall Study|Pregnancy|0|||
143386153|NCT03580369|516959382|FG004|Overall Study|Pregnancy|2|||
143386154|NCT03580369|516959383|FG005|Overall Study|Pregnancy|0|||
143386155|NCT03580369|516959384|FG006|Overall Study|Pregnancy|0|||
143386156|NCT03580369|516959385|FG007|Overall Study|Pregnancy|0|||
143386157|NCT03580369|516959378|FG000|Overall Study|Lost to Follow-up|2|||
143386158|NCT03580369|516959379|FG001|Overall Study|Lost to Follow-up|0|||
143386159|NCT03580369|516959380|FG002|Overall Study|Lost to Follow-up|2|||
143386160|NCT03580369|516959381|FG003|Overall Study|Lost to Follow-up|0|||
143386161|NCT03580369|516959382|FG004|Overall Study|Lost to Follow-up|3|||
143386162|NCT03580369|516959383|FG005|Overall Study|Lost to Follow-up|0|||
143386163|NCT03580369|516959384|FG006|Overall Study|Lost to Follow-up|1|||
143386164|NCT03580369|516959385|FG007|Overall Study|Lost to Follow-up|0|||
143386165|NCT03580369|516959378|FG000|Overall Study|Physician Decision|4|||
143386166|NCT03580369|516959379|FG001|Overall Study|Physician Decision|0|||
143386167|NCT03580369|516959380|FG002|Overall Study|Physician Decision|4|||
143386168|NCT03580369|516959381|FG003|Overall Study|Physician Decision|1|||
143386169|NCT03580369|516959382|FG004|Overall Study|Physician Decision|1|||
143386170|NCT03580369|516959383|FG005|Overall Study|Physician Decision|0|||
143386171|NCT03580369|516959384|FG006|Overall Study|Physician Decision|0|||
143386172|NCT03580369|516959385|FG007|Overall Study|Physician Decision|0|||
143386173|NCT03580369|516959378|FG000|Overall Study|Lack of Efficacy|3|||
143386174|NCT03580369|516959379|FG001|Overall Study|Lack of Efficacy|0|||
143386175|NCT03580369|516959380|FG002|Overall Study|Lack of Efficacy|7|||
143386176|NCT03580369|516959381|FG003|Overall Study|Lack of Efficacy|0|||
143386177|NCT03580369|516959382|FG004|Overall Study|Lack of Efficacy|2|||
143386178|NCT03580369|516959383|FG005|Overall Study|Lack of Efficacy|0|||
143386179|NCT03580369|516959384|FG006|Overall Study|Lack of Efficacy|3|||
143386180|NCT03580369|516959385|FG007|Overall Study|Lack of Efficacy|0|||
143386181|NCT03580369|516959378|FG000|Overall Study|Protocol Violation|6|||
143386182|NCT03580369|516959379|FG001|Overall Study|Protocol Violation|0|||
143386183|NCT03580369|516959380|FG002|Overall Study|Protocol Violation|6|||
143386184|NCT03580369|516959381|FG003|Overall Study|Protocol Violation|1|||
143386185|NCT03580369|516959382|FG004|Overall Study|Protocol Violation|8|||
143386186|NCT03580369|516959383|FG005|Overall Study|Protocol Violation|2|||
143386187|NCT03580369|516959384|FG006|Overall Study|Protocol Violation|1|||
143386188|NCT03580369|516959385|FG007|Overall Study|Protocol Violation|0|||
143386189|NCT03580369|516959378|FG000|Overall Study|Adverse Event|7|||
143386190|NCT03580369|516959379|FG001|Overall Study|Adverse Event|0|||
143386191|NCT03580369|516959380|FG002|Overall Study|Adverse Event|14|||
143386192|NCT03580369|516959381|FG003|Overall Study|Adverse Event|1|||
143386193|NCT03580369|516959382|FG004|Overall Study|Adverse Event|6|||
143386194|NCT03580369|516959383|FG005|Overall Study|Adverse Event|0|||
143386195|NCT03580369|516959384|FG006|Overall Study|Adverse Event|1|||
143386196|NCT03580369|516959385|FG007|Overall Study|Adverse Event|0|||
143386197|NCT03580369|516959378|FG000|Overall Study|Withdrawal by Subject|19|||
143386198|NCT03580369|516959379|FG001|Overall Study|Withdrawal by Subject|0|||
143386199|NCT03580369|516959380|FG002|Overall Study|Withdrawal by Subject|17|||
143386200|NCT03580369|516959381|FG003|Overall Study|Withdrawal by Subject|0|||
143386201|NCT03580369|516959382|FG004|Overall Study|Withdrawal by Subject|16|||
143386202|NCT03580369|516959383|FG005|Overall Study|Withdrawal by Subject|1|||
143386203|NCT03580369|516959384|FG006|Overall Study|Withdrawal by Subject|7|||
143386204|NCT03580369|516959385|FG007|Overall Study|Withdrawal by Subject|0|||
143386205|NCT03767517|516959391|FG000|Overall Study|Lost to Follow-up|16|||
143386206|NCT03767517|516959392|FG001|Overall Study|Lost to Follow-up|10|||
143386207|NCT03767517|516959391|FG000|Overall Study|Death|2|||
143386208|NCT03767517|516959392|FG001|Overall Study|Death|3|||
143386209|NCT05338086|516961069|FG000|Main Treatment Period (Day1 to Month 12)|Adverse Event|4|||
143386210|NCT05338086|516961070|FG001|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
143386211|NCT05338086|516961071|FG002|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
143386212|NCT05338086|516961072|FG003|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
143386213|NCT05338086|516961073|FG004|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
143386214|NCT05338086|516961069|FG000|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|1|||
143386215|NCT05338086|516961070|FG001|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|2|||
143386216|NCT05338086|516961071|FG002|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
143386217|NCT05338086|516961072|FG003|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
143386218|NCT05338086|516961073|FG004|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
143386219|NCT05338086|516961069|FG000|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
143386220|NCT05338086|516961070|FG001|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
143386221|NCT05338086|516961071|FG002|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
143386222|NCT05338086|516961072|FG003|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
143386223|NCT05338086|516961073|FG004|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
143386224|NCT05338086|516961069|FG000|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|1|||
143386225|NCT05338086|516961070|FG001|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
143386226|NCT05338086|516961071|FG002|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
143386227|NCT05338086|516961072|FG003|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
143386228|NCT05338086|516961073|FG004|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
143386229|NCT05338086|516961069|FG000|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
143386230|NCT05338086|516961070|FG001|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
143386231|NCT05338086|516961071|FG002|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
143386232|NCT05338086|516961072|FG003|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
143386233|NCT05338086|516961073|FG004|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
143386234|NCT05338086|516961069|FG000|Main Treatment Period (Day1 to Month 12)|other|23|||
143386235|NCT05338086|516961070|FG001|Main Treatment Period (Day1 to Month 12)|other|16|||
143386236|NCT05338086|516961071|FG002|Main Treatment Period (Day1 to Month 12)|other|0|||
143386237|NCT05338086|516961072|FG003|Main Treatment Period (Day1 to Month 12)|other|0|||
143386238|NCT05338086|516961073|FG004|Main Treatment Period (Day1 to Month 12)|other|0|||
143386239|NCT05338086|516961069|FG000|Transition Period (M12 to M18)|Death|0|||
143386240|NCT05338086|516961070|FG001|Transition Period (M12 to M18)|Death|0|||
143386241|NCT05338086|516961071|FG002|Transition Period (M12 to M18)|Death|1|||
143386242|NCT05338086|516961072|FG003|Transition Period (M12 to M18)|Death|0|||
143386243|NCT05338086|516961073|FG004|Transition Period (M12 to M18)|Death|0|||
143386244|NCT05338086|516961069|FG000|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
143386245|NCT05338086|516961070|FG001|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
143386246|NCT05338086|516961071|FG002|Transition Period (M12 to M18)|Withdrawal by Subject|4|||
143386247|NCT05338086|516961072|FG003|Transition Period (M12 to M18)|Withdrawal by Subject|3|||
143386248|NCT05338086|516961073|FG004|Transition Period (M12 to M18)|Withdrawal by Subject|2|||
143386249|NCT05338086|516961069|FG000|Transition Period (M12 to M18)|Burden of study procedures|0|||
143386250|NCT05338086|516961070|FG001|Transition Period (M12 to M18)|Burden of study procedures|0|||
143386251|NCT05338086|516961071|FG002|Transition Period (M12 to M18)|Burden of study procedures|1|||
143386252|NCT05338086|516961072|FG003|Transition Period (M12 to M18)|Burden of study procedures|0|||
143386253|NCT05338086|516961073|FG004|Transition Period (M12 to M18)|Burden of study procedures|0|||
143386254|NCT05338086|516961069|FG000|Transition Period (M12 to M18)|Subject left the country|0|||
143386255|NCT05338086|516961070|FG001|Transition Period (M12 to M18)|Subject left the country|0|||
143386256|NCT05338086|516961071|FG002|Transition Period (M12 to M18)|Subject left the country|0|||
143386257|NCT05338086|516961072|FG003|Transition Period (M12 to M18)|Subject left the country|0|||
143386258|NCT05338086|516961073|FG004|Transition Period (M12 to M18)|Subject left the country|1|||
143386259|NCT03940703|516961074|FG000|Overall Study|Still under treatment|31|||
143386260|NCT03940703|516961075|FG001|Overall Study|Still under treatment|0|||
143386261|NCT00753090|516961087|FG000|Overall Study|Withdrawal by Subject|10|||
143386262|NCT00753090|516961088|FG001|Overall Study|Withdrawal by Subject|10|||
143386263|NCT00753090|516961087|FG000|Overall Study|Death|17|||
143386264|NCT00753090|516961088|FG001|Overall Study|Death|6|||
143386265|NCT00753090|516961087|FG000|Overall Study|Study Prosthesis Removed|12|||
143386266|NCT00753090|516961088|FG001|Overall Study|Study Prosthesis Removed|3|||
143386267|NCT00753090|516961087|FG000|Overall Study|Lost to Follow-up|2|||
143386268|NCT00753090|516961088|FG001|Overall Study|Lost to Follow-up|2|||
143386269|NCT00753090|516961087|FG000|Overall Study|Other|127|||
143386270|NCT00753090|516961088|FG001|Overall Study|Other|75|||
143386271|NCT04052516|516961090|FG000|Overall Study|Withdrawal by Subject|4|||
143386272|NCT04052516|516961091|FG001|Overall Study|Withdrawal by Subject|5|||
143386273|NCT04052516|516961092|FG002|Overall Study|Withdrawal by Subject|6|||
143386274|NCT04052516|516961090|FG000|Overall Study|Adverse Event|3|||
143386275|NCT04052516|516961091|FG001|Overall Study|Adverse Event|2|||
143386276|NCT04052516|516961092|FG002|Overall Study|Adverse Event|8|||
143386277|NCT04052516|516961090|FG000|Overall Study|Lost to Follow-up|2|||
143386278|NCT04052516|516961091|FG001|Overall Study|Lost to Follow-up|5|||
143386279|NCT04052516|516961092|FG002|Overall Study|Lost to Follow-up|3|||
143386280|NCT04052516|516961090|FG000|Overall Study|Protocol Violation|1|||
143386281|NCT04052516|516961091|FG001|Overall Study|Protocol Violation|1|||
143386282|NCT04052516|516961092|FG002|Overall Study|Protocol Violation|0|||
143386283|NCT04052516|516961090|FG000|Overall Study|Death|1|||
143386284|NCT04052516|516961091|FG001|Overall Study|Death|0|||
143386285|NCT04052516|516961092|FG002|Overall Study|Death|0|||
143386286|NCT04052516|516961090|FG000|Overall Study|Physician Decision|0|||
143386287|NCT04052516|516961091|FG001|Overall Study|Physician Decision|1|||
143386288|NCT04052516|516961092|FG002|Overall Study|Physician Decision|0|||
143386289|NCT04052516|516961090|FG000|Overall Study|Pregnancy|1|||
143386290|NCT04052516|516961091|FG001|Overall Study|Pregnancy|0|||
143386291|NCT04052516|516961092|FG002|Overall Study|Pregnancy|0|||
143386292|NCT04052516|516961090|FG000|Overall Study|Requirement of prohibited concomitant medication|1|||
143386293|NCT04052516|516961091|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
143386294|NCT04052516|516961092|FG002|Overall Study|Requirement of prohibited concomitant medication|0|||
143386295|NCT04052516|516961090|FG000|Overall Study|Reason not recorded|0|||
143386296|NCT04052516|516961091|FG001|Overall Study|Reason not recorded|1|||
143386297|NCT04052516|516961092|FG002|Overall Study|Reason not recorded|0|||
143386298|NCT05113966|516961095|FG000|Overall Study|Death|21|||
143386299|NCT05113966|516961095|FG000|Overall Study|Study Terminated by Sponsor|9|||
143386300|NCT05386355|516961096|FG000|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
143386301|NCT05386355|516961097|FG001|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
143386302|NCT05386355|516961098|FG002|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
143386303|NCT05386355|516961099|FG003|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
143386304|NCT06143670|516961100|FG000|Overall Study|Lost to Follow-up|0|||
143386305|NCT06143670|516961101|FG001|Overall Study|Lost to Follow-up|1|||
143386306|NCT06143670|516961100|FG000|Overall Study|Withdrawal by Subject|3|||
143386307|NCT06143670|516961101|FG001|Overall Study|Withdrawal by Subject|0|||
143386308|NCT00739648|516961104|FG000|Overall Study|Adverse Event|3|||
143386309|NCT00739648|516961105|FG001|Overall Study|Adverse Event|15|||
143386310|NCT00739648|516961104|FG000|Overall Study|Withdrawal by Subject|13|||
143386311|NCT00739648|516961105|FG001|Overall Study|Withdrawal by Subject|25|||
143386312|NCT00739648|516961104|FG000|Overall Study|Lost to Follow-up|4|||
143386313|NCT00739648|516961105|FG001|Overall Study|Lost to Follow-up|7|||
143386314|NCT00739648|516961104|FG000|Overall Study|Death|2|||
143386315|NCT00739648|516961105|FG001|Overall Study|Death|0|||
143386316|NCT00739648|516961104|FG000|Overall Study|Do not know|4|||
143386317|NCT00739648|516961105|FG001|Overall Study|Do not know|6|||
143386318|NCT02840474|516961108|FG000|Overall Study|Lost to Follow-up|1|||
143386319|NCT02840474|516961109|FG001|Overall Study|Lost to Follow-up|0|||
143386320|NCT03192891|516961110|FG000|Overall Study|Lost to Follow-up|55|||
143386321|NCT04850807|516961111|FG000|Overall Study|Death|50|||
143386322|NCT04850807|516961112|FG001|Overall Study|Death|55|||
143386323|NCT04850807|516961111|FG000|Overall Study|Discharged|17|||
143386324|NCT04850807|516961112|FG001|Overall Study|Discharged|13|||
143386325|NCT04850807|516961111|FG000|Overall Study|Incomplete baseline data|3|||
143386326|NCT04850807|516961112|FG001|Overall Study|Incomplete baseline data|2|||
143386327|NCT05387447|516961113|FG000|Overall Study|Participants changed their minds about study participation.|3|||
143386328|NCT05387447|516961114|FG001|Overall Study|Participants changed their minds about study participation.|5|||
143386329|NCT03655132|516961117|FG000|Overall Study|Lost to Follow-up|2|||
143386330|NCT03655132|516961118|FG001|Overall Study|Lost to Follow-up|1|||
143386331|NCT03655132|516961117|FG000|Overall Study|Withdrawal by Subject|0|||
143386332|NCT03655132|516961118|FG001|Overall Study|Withdrawal by Subject|1|||
143386333|NCT03655132|516961117|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
143386334|NCT03655132|516961118|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
143386335|NCT02651324|516961120|FG000|Overall Study|drug not administered, due dispensing issue|1|||
143386336|NCT02651324|516961121|FG001|Overall Study|drug not administered, due dispensing issue|0|||
143386337|NCT05919082|516961124|FG000|Overall Study|Adverse Event|3|||
143386338|NCT05919082|516961125|FG001|Overall Study|Adverse Event|0|||
143386339|NCT05919082|516961124|FG000|Overall Study|Lost to Follow-up|0|||
143386340|NCT05919082|516961125|FG001|Overall Study|Lost to Follow-up|1|||
143386341|NCT05919082|516961124|FG000|Overall Study|Withdrawal by Subject|8|||
143386342|NCT05919082|516961125|FG001|Overall Study|Withdrawal by Subject|9|||
143386343|NCT05919082|516961124|FG000|Overall Study|Lack of Efficacy|0|||
143386344|NCT05919082|516961125|FG001|Overall Study|Lack of Efficacy|1|||
143386345|NCT05919082|516961124|FG000|Overall Study|Investigator Decision|1|||
143386346|NCT05919082|516961125|FG001|Overall Study|Investigator Decision|0|||
143386347|NCT02097420|516961129|FG000|Overall Study|Death|6|||
143386348|NCT02097420|516961129|FG000|Overall Study|Valve explanted|13|||
143386349|NCT02097420|516961129|FG000|Overall Study|Other Reason|1|||
143386350|NCT02728076|516961130|FG000|Overall Study|Physician Decision|4|||
143386351|NCT05458011|516961131|FG000|DB Period (12 Weeks)|Adverse Event|2|||
143386352|NCT05458011|516961132|FG001|DB Period (12 Weeks)|Adverse Event|1|||
143386353|NCT05458011|516961133|FG002|DB Period (12 Weeks)|Adverse Event|1|||
143386354|NCT05458011|516961131|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
143386355|NCT05458011|516961132|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
143386356|NCT05458011|516961133|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
143386357|NCT05458011|516961131|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
143386358|NCT05458011|516961132|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
143386359|NCT05458011|516961133|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
143386360|NCT05458011|516961131|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
143386361|NCT05458011|516961132|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
143386362|NCT05458011|516961133|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
143386363|NCT05458011|516961131|FG000|OL Period (12 Weeks)|Adverse Event|1|||
143386364|NCT05458011|516961132|FG001|OL Period (12 Weeks)|Adverse Event|2|||
143386365|NCT05458011|516961133|FG002|OL Period (12 Weeks)|Adverse Event|1|||
143386366|NCT05458011|516961131|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
143386367|NCT05458011|516961132|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
143386368|NCT05458011|516961133|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
143386369|NCT04820855|516961134|FG000|Overall Study|Lost to Follow-up|6|||
143386370|NCT04820855|516961135|FG001|Overall Study|Lost to Follow-up|9|||
143386371|NCT03526861|516961136|FG000|Initial Treatment Period|Not dosed|1|||
143386372|NCT03526861|516961137|FG001|Initial Treatment Period|Not dosed|1|||
143386373|NCT03526861|516961138|FG002|Initial Treatment Period|Not dosed|1|||
143386374|NCT03526861|516961139|FG003|Initial Treatment Period|Not dosed|0|||
143386375|NCT03526861|516961140|FG004|Initial Treatment Period|Not dosed|0|||
143386376|NCT03526861|516961141|FG005|Initial Treatment Period|Not dosed|0|||
143386377|NCT03526861|516961142|FG006|Initial Treatment Period|Not dosed|0|||
143386378|NCT03526861|516961143|FG007|Initial Treatment Period|Not dosed|0|||
143386379|NCT03526861|516961144|FG008|Initial Treatment Period|Not dosed|0|||
143386380|NCT03526861|516961136|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
143386381|NCT03526861|516961137|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
143386382|NCT03526861|516961138|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
143386383|NCT03526861|516961139|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
143386384|NCT03526861|516961140|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
143386385|NCT03526861|516961141|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
143386386|NCT03526861|516961142|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
143386387|NCT03526861|516961143|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
143386388|NCT03526861|516961144|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
143386389|NCT03526861|516961136|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
143386390|NCT03526861|516961137|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
143386391|NCT03526861|516961138|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
143386392|NCT03526861|516961139|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
143386393|NCT03526861|516961140|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
143386394|NCT03526861|516961141|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
143386395|NCT03526861|516961142|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
143386396|NCT03526861|516961143|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
143386397|NCT03526861|516961144|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
143386398|NCT03526861|516961136|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
143386399|NCT03526861|516961137|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
143386400|NCT03526861|516961138|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
143386401|NCT03526861|516961139|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
143386402|NCT03526861|516961140|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
143386403|NCT03526861|516961141|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
143386404|NCT03526861|516961142|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
143386405|NCT03526861|516961143|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
143386406|NCT03526861|516961144|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
143386407|NCT03526861|516961136|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
143386408|NCT03526861|516961137|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
143386409|NCT03526861|516961138|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
143386410|NCT03526861|516961139|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
143386411|NCT03526861|516961140|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
143386412|NCT03526861|516961141|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
143386413|NCT03526861|516961142|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
143386414|NCT03526861|516961143|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
143386415|NCT03526861|516961144|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
143386416|NCT03526861|516961136|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
143386417|NCT03526861|516961137|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
143386418|NCT03526861|516961138|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
143386419|NCT03526861|516961139|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
143386420|NCT03526861|516961140|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
143386421|NCT03526861|516961141|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
143386422|NCT03526861|516961142|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
143386423|NCT03526861|516961143|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
143386424|NCT03526861|516961144|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
143386425|NCT03526861|516961136|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
143386426|NCT03526861|516961137|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
143386427|NCT03526861|516961138|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
143386428|NCT03526861|516961139|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
143386429|NCT03526861|516961140|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
143386430|NCT03526861|516961141|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
143386431|NCT03526861|516961142|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
143386432|NCT03526861|516961143|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
143386433|NCT03526861|516961144|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
143386434|NCT03526861|516961136|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
143386435|NCT03526861|516961137|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
143386436|NCT03526861|516961138|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
143386437|NCT03526861|516961139|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
143386438|NCT03526861|516961140|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
143386439|NCT03526861|516961141|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
143386440|NCT03526861|516961142|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
143386441|NCT03526861|516961143|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
143386442|NCT03526861|516961144|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
143386443|NCT03526861|516961136|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
143386444|NCT03526861|516961137|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
143386445|NCT03526861|516961138|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
143386446|NCT03526861|516961139|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
143386447|NCT03526861|516961140|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
143386448|NCT03526861|516961141|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
143386449|NCT03526861|516961142|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
143386450|NCT03526861|516961143|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
143386451|NCT03526861|516961144|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
143386452|NCT04382898|516961145|FG000|Part 1: Dose Titration|Withdrawal by Subject|1|||
143386453|NCT04382898|516961146|FG001|Part 1: Dose Titration|Withdrawal by Subject|0|||
143386454|NCT04382898|516961147|FG002|Part 1: Dose Titration|Withdrawal by Subject|0|||
143386455|NCT04382898|516961148|FG003|Part 1: Dose Titration|Withdrawal by Subject|0|||
143386456|NCT04382898|516961149|FG004|Part 1: Dose Titration|Withdrawal by Subject|0|||
143386457|NCT04382898|516961145|FG000|Part 1: Dose Titration|Death|6|||
143386458|NCT04382898|516961146|FG001|Part 1: Dose Titration|Death|0|||
143386459|NCT04382898|516961147|FG002|Part 1: Dose Titration|Death|0|||
143386460|NCT04382898|516961148|FG003|Part 1: Dose Titration|Death|0|||
143386461|NCT04382898|516961149|FG004|Part 1: Dose Titration|Death|0|||
143386462|NCT04382898|516961145|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
143386463|NCT04382898|516961146|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
143386464|NCT04382898|516961147|FG002|Part 2: Dose Expansion|Withdrawal by Subject|1|||
143386465|NCT04382898|516961148|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
143386466|NCT04382898|516961149|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
143386467|NCT04382898|516961145|FG000|Part 2: Dose Expansion|Lost to Follow-up|0|||
143386468|NCT04382898|516961146|FG001|Part 2: Dose Expansion|Lost to Follow-up|0|||
143386469|NCT04382898|516961147|FG002|Part 2: Dose Expansion|Lost to Follow-up|1|||
143386470|NCT04382898|516961148|FG003|Part 2: Dose Expansion|Lost to Follow-up|0|||
143386471|NCT04382898|516961149|FG004|Part 2: Dose Expansion|Lost to Follow-up|0|||
143386472|NCT04382898|516961145|FG000|Part 2: Dose Expansion|Death|0|||
143386473|NCT04382898|516961146|FG001|Part 2: Dose Expansion|Death|17|||
143386474|NCT04382898|516961147|FG002|Part 2: Dose Expansion|Death|13|||
143386475|NCT04382898|516961148|FG003|Part 2: Dose Expansion|Death|1|||
143386476|NCT04382898|516961149|FG004|Part 2: Dose Expansion|Death|0|||
143386477|NCT04382898|516961145|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
143386478|NCT04382898|516961146|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
143386479|NCT04382898|516961147|FG002|Part 2: Dose Expansion|Progressive Disease|1|||
143386480|NCT04382898|516961148|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
143386481|NCT04382898|516961149|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
143386482|NCT04382898|516961145|FG000|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
143386483|NCT04382898|516961146|FG001|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
143386484|NCT04382898|516961147|FG002|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
143386485|NCT04382898|516961148|FG003|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
143386486|NCT04382898|516961149|FG004|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
143386487|NCT04382898|516961145|FG000|Part 2: Dose Expansion|Other|0|||
143386488|NCT04382898|516961146|FG001|Part 2: Dose Expansion|Other|0|||
143386489|NCT04382898|516961147|FG002|Part 2: Dose Expansion|Other|1|||
143386490|NCT04382898|516961148|FG003|Part 2: Dose Expansion|Other|0|||
143386491|NCT04382898|516961149|FG004|Part 2: Dose Expansion|Other|0|||
143386492|NCT05229120|516961150|FG000|Overall Study|Withdrawal by Subject|8|||
143386493|NCT00601900|516961154|FG000|Overall Study|Withdrawal by Subject|0|||
143386494|NCT00601900|516961155|FG001|Overall Study|Withdrawal by Subject|3|||
143386495|NCT01772472|516961156|FG000|Overall Study|Death|126|||
143386496|NCT01772472|516961157|FG001|Overall Study|Death|94|||
143386497|NCT01772472|516961156|FG000|Overall Study|Lost to Follow-up|51|||
143386498|NCT01772472|516961157|FG001|Overall Study|Lost to Follow-up|50|||
143386499|NCT01772472|516961156|FG000|Overall Study|Other|9|||
143386500|NCT01772472|516961157|FG001|Overall Study|Other|7|||
143386501|NCT01772472|516961156|FG000|Overall Study|Physician Decision|1|||
143386502|NCT01772472|516961157|FG001|Overall Study|Physician Decision|7|||
143386503|NCT01772472|516961156|FG000|Overall Study|Withdrawal by Subject|115|||
143386504|NCT01772472|516961157|FG001|Overall Study|Withdrawal by Subject|90|||
143386505|NCT01772472|516961156|FG000|Overall Study|Follow-up Terminated by Sponsor|441|||
143336892|NCT01256411|516778139|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
143336893|NCT01256411|516778140|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
143386506|NCT01772472|516961157|FG001|Overall Study|Follow-up Terminated by Sponsor|495|||
143386507|NCT02697136|516961158|FG000|Overall Study|Adverse Event|3|||
143386508|NCT02697136|516961159|FG001|Overall Study|Adverse Event|0|||
143386509|NCT04093752|516961161|FG000|Overall Study|Adverse Event|7|||
143386510|NCT04093752|516961162|FG001|Overall Study|Adverse Event|19|||
143386511|NCT04093752|516961163|FG002|Overall Study|Adverse Event|18|||
143386512|NCT04093752|516961164|FG003|Overall Study|Adverse Event|4|||
143386513|NCT04093752|516961161|FG000|Overall Study|Withdrawal by Subject|6|||
143386514|NCT04093752|516961162|FG001|Overall Study|Withdrawal by Subject|6|||
143386515|NCT04093752|516961163|FG002|Overall Study|Withdrawal by Subject|8|||
143386516|NCT04093752|516961164|FG003|Overall Study|Withdrawal by Subject|20|||
143386517|NCT04093752|516961161|FG000|Overall Study|Lost to Follow-up|2|||
143386518|NCT04093752|516961162|FG001|Overall Study|Lost to Follow-up|1|||
143386519|NCT04093752|516961163|FG002|Overall Study|Lost to Follow-up|1|||
143386520|NCT04093752|516961164|FG003|Overall Study|Lost to Follow-up|1|||
143336894|NCT01256411|516778135|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
143336895|NCT01256411|516778136|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
143336896|NCT01256411|516778137|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
143336897|NCT01256411|516778138|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
143336898|NCT01256411|516778139|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
143336899|NCT01256411|516778140|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
143336900|NCT01256411|516778135|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
143336901|NCT01256411|516778136|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
143336902|NCT01256411|516778137|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
143336903|NCT01256411|516778138|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
143336904|NCT01256411|516778139|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
143336905|NCT01256411|516778140|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
143336906|NCT01256411|516778135|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
143336907|NCT01256411|516778136|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
143336908|NCT01256411|516778137|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
143336909|NCT01256411|516778138|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
143336910|NCT01256411|516778139|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
143336911|NCT01256411|516778140|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
143336912|NCT01256411|516778135|FG000|Extension by Maximum Treatment|Adverse Event|4|||
143336913|NCT01256411|516778136|FG001|Extension by Maximum Treatment|Adverse Event|2|||
143336914|NCT01256411|516778137|FG002|Extension by Maximum Treatment|Adverse Event|1|||
143336915|NCT01256411|516778138|FG003|Extension by Maximum Treatment|Adverse Event|0|||
143336916|NCT01256411|516778139|FG004|Extension by Maximum Treatment|Adverse Event|0|||
143336917|NCT01256411|516778140|FG005|Extension by Maximum Treatment|Adverse Event|0|||
143336918|NCT01256411|516778135|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
143336919|NCT01256411|516778136|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
143336920|NCT01256411|516778137|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
143336921|NCT01256411|516778138|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
143336922|NCT01256411|516778139|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
143336923|NCT01256411|516778140|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
143336924|NCT01256411|516778135|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
143336925|NCT01256411|516778136|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
143336926|NCT01256411|516778137|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
143336927|NCT01256411|516778138|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
143336928|NCT01256411|516778139|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
143386521|NCT04093752|516961161|FG000|Overall Study|Death|0|||
143386522|NCT04093752|516961162|FG001|Overall Study|Death|0|||
143386523|NCT04093752|516961163|FG002|Overall Study|Death|1|||
143386524|NCT04093752|516961164|FG003|Overall Study|Death|2|||
143386525|NCT04093752|516961161|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
143386526|NCT04093752|516961162|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
143386527|NCT04093752|516961163|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
143386528|NCT04093752|516961164|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
143386529|NCT04093752|516961161|FG000|Overall Study|Covid 19|0|||
143386530|NCT04093752|516961162|FG001|Overall Study|Covid 19|0|||
143386531|NCT04093752|516961163|FG002|Overall Study|Covid 19|0|||
143386532|NCT04093752|516961164|FG003|Overall Study|Covid 19|1|||
143386533|NCT04093752|516961161|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
143386534|NCT04093752|516961162|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
143386535|NCT04093752|516961163|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
143386536|NCT04093752|516961164|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
143386537|NCT04093752|516961161|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
143386538|NCT04093752|516961162|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
142941519|NCT00064701|515324682|FG002|One Year Post-transplant|Rejection|16|||
143386539|NCT04093752|516961163|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
143386540|NCT04093752|516961164|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
143386541|NCT04093752|516961161|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
143386542|NCT04093752|516961162|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
143386543|NCT04093752|516961163|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
143386544|NCT04093752|516961164|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
143386545|NCT02140645|516961166|FG000|Overall Study|Not linked|5489|||
143386546|NCT02140645|516961167|FG001|Overall Study|Not linked|61654|||
143386547|NCT02140645|516961168|FG002|Overall Study|Not linked|4236|||
143386548|NCT02140645|516961169|FG003|Overall Study|Not linked|13833|||
143386549|NCT02140645|516961170|FG004|Overall Study|Not linked|3286|||
143386550|NCT02140645|516961171|FG005|Overall Study|Not linked|70896|||
143386551|NCT04757610|516961174|FG000|Overall Study|Adverse Event|13|||
143386552|NCT04757610|516961175|FG001|Overall Study|Adverse Event|10|||
143386553|NCT04757610|516961176|FG002|Overall Study|Adverse Event|5|||
143386554|NCT04757610|516961174|FG000|Overall Study|Death|5|||
143386555|NCT04757610|516961175|FG001|Overall Study|Death|13|||
143386556|NCT04757610|516961176|FG002|Overall Study|Death|8|||
143386557|NCT04757610|516961174|FG000|Overall Study|Lack of Efficacy|1|||
143386558|NCT04757610|516961175|FG001|Overall Study|Lack of Efficacy|2|||
143386559|NCT04757610|516961176|FG002|Overall Study|Lack of Efficacy|3|||
143386560|NCT04757610|516961174|FG000|Overall Study|Lost to Follow-up|7|||
143386561|NCT04757610|516961175|FG001|Overall Study|Lost to Follow-up|2|||
143386562|NCT04757610|516961176|FG002|Overall Study|Lost to Follow-up|7|||
143386563|NCT04757610|516961174|FG000|Overall Study|Physician Decision|4|||
143386564|NCT04757610|516961175|FG001|Overall Study|Physician Decision|1|||
143336929|NCT01256411|516778140|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
143336930|NCT01256411|516778135|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
143336931|NCT01256411|516778136|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
143336932|NCT01256411|516778137|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
143336933|NCT01256411|516778138|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
143336934|NCT01256411|516778139|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
143336935|NCT01256411|516778140|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
143336936|NCT01256411|516778135|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
143336937|NCT01256411|516778136|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
143336938|NCT01256411|516778137|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
143336939|NCT01256411|516778138|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
143336940|NCT01256411|516778139|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
143336941|NCT01256411|516778140|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
143336942|NCT01256411|516778135|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
143336943|NCT01256411|516778136|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
143336944|NCT01256411|516778137|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
143336945|NCT01256411|516778138|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
143336946|NCT01256411|516778139|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
143336947|NCT01256411|516778140|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
143336948|NCT00929162|516778141|FG000|Overall Study|Adverse Event|8|||
143336949|NCT00929162|516778142|FG001|Overall Study|Adverse Event|5|||
143336950|NCT00929162|516778141|FG000|Overall Study|Withdrawal by Subject|3|||
143336951|NCT00929162|516778142|FG001|Overall Study|Withdrawal by Subject|1|||
143336952|NCT00929162|516778141|FG000|Overall Study|Protocol Violation|32|||
143336953|NCT00929162|516778142|FG001|Overall Study|Protocol Violation|30|||
143336954|NCT00929162|516778141|FG000|Overall Study|Other termination reason|5|||
143336955|NCT00929162|516778142|FG001|Overall Study|Other termination reason|6|||
143336956|NCT01274182|516778143|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
143336957|NCT01274182|516778144|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
143336958|NCT01274182|516778145|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
143336959|NCT01274182|516778143|FG000|Overall Study|Adverse Event|4|||
143336960|NCT01274182|516778144|FG001|Overall Study|Adverse Event|5|||
143336961|NCT01274182|516778145|FG002|Overall Study|Adverse Event|3|||
143336962|NCT01274182|516778143|FG000|Overall Study|Withdrawal by Subject|5|||
143336963|NCT01274182|516778144|FG001|Overall Study|Withdrawal by Subject|5|||
143336964|NCT01274182|516778145|FG002|Overall Study|Withdrawal by Subject|3|||
143336965|NCT01274182|516778143|FG000|Overall Study|Lost to Follow-up|2|||
143336966|NCT01274182|516778144|FG001|Overall Study|Lost to Follow-up|3|||
143336967|NCT01274182|516778145|FG002|Overall Study|Lost to Follow-up|1|||
143336968|NCT01274182|516778143|FG000|Overall Study|Protocol Violation|3|||
143336969|NCT01274182|516778144|FG001|Overall Study|Protocol Violation|2|||
143336970|NCT01274182|516778145|FG002|Overall Study|Protocol Violation|0|||
143336971|NCT01274182|516778143|FG000|Overall Study|Death|1|||
143336972|NCT01274182|516778144|FG001|Overall Study|Death|0|||
143336973|NCT01274182|516778145|FG002|Overall Study|Death|1|||
143336974|NCT01822587|516778146|FG000|Overall Study|Lost to Follow-up|7|||
143336975|NCT01822587|516778147|FG001|Overall Study|Lost to Follow-up|9|||
143336976|NCT01822587|516778148|FG002|Overall Study|Lost to Follow-up|12|||
143386565|NCT04757610|516961176|FG002|Overall Study|Physician Decision|2|||
143386566|NCT04757610|516961174|FG000|Overall Study|Withdrawal by Subject|26|||
143386567|NCT04757610|516961175|FG001|Overall Study|Withdrawal by Subject|25|||
143386568|NCT04757610|516961176|FG002|Overall Study|Withdrawal by Subject|25|||
143386569|NCT04757610|516961174|FG000|Overall Study|Study Terminated by Sponsor|105|||
143386570|NCT04757610|516961175|FG001|Overall Study|Study Terminated by Sponsor|105|||
143386571|NCT04757610|516961176|FG002|Overall Study|Study Terminated by Sponsor|110|||
143386572|NCT04757610|516961174|FG000|Overall Study|Randomized in Error|1|||
143386573|NCT04757610|516961175|FG001|Overall Study|Randomized in Error|0|||
143386574|NCT04757610|516961176|FG002|Overall Study|Randomized in Error|0|||
143386575|NCT02965846|516961182|FG000|Overall Study|Lost to Follow-up|1|||
143386576|NCT02965846|516961183|FG001|Overall Study|Lost to Follow-up|0|||
143386577|NCT02965846|516961184|FG002|Overall Study|Lost to Follow-up|0|||
143386578|NCT02965846|516961182|FG000|Overall Study|Withdrawal by Subject|0|||
143386579|NCT02965846|516961183|FG001|Overall Study|Withdrawal by Subject|1|||
143386580|NCT02965846|516961184|FG002|Overall Study|Withdrawal by Subject|0|||
143386581|NCT02965846|516961182|FG000|Overall Study|Study Terminated By Sponsor|4|||
143386582|NCT02965846|516961183|FG001|Overall Study|Study Terminated By Sponsor|4|||
143386583|NCT02965846|516961184|FG002|Overall Study|Study Terminated By Sponsor|0|||
143386584|NCT02965846|516961182|FG000|Overall Study|Participants not randomized|0|||
143386585|NCT02965846|516961183|FG001|Overall Study|Participants not randomized|0|||
143386586|NCT02965846|516961184|FG002|Overall Study|Participants not randomized|33|||
143386587|NCT00611559|516961185|FG000|Overall Study|Lost to Follow-up|0|||
143386588|NCT00611559|516961186|FG001|Overall Study|Lost to Follow-up|1|||
143386589|NCT00611559|516961187|FG002|Overall Study|Lost to Follow-up|0|||
143386590|NCT00611559|516961185|FG000|Overall Study|Protocol Violation|1|||
143386591|NCT00611559|516961186|FG001|Overall Study|Protocol Violation|0|||
143386592|NCT00611559|516961187|FG002|Overall Study|Protocol Violation|1|||
143386593|NCT02910713|516961188|FG000|Overall Study|Protocol Violation|2|||
143386594|NCT02910713|516961188|FG000|Overall Study|Subject Choice|4|||
143386595|NCT02910713|516961188|FG000|Overall Study|Received One Application|10|||
143386596|NCT02910713|516961188|FG000|Overall Study|Received Neither Application|18|||
143386597|NCT02910713|516961188|FG000|Overall Study|Enrollment cap|7|||
143386598|NCT02910713|516961188|FG000|Overall Study|Investigator Discretion|1|||
143386599|NCT04442126|516961197|FG000|Overall Study|Withdrawal by Subject|0|||
143386600|NCT04442126|516961198|FG001|Overall Study|Withdrawal by Subject|0|||
143386601|NCT04442126|516961199|FG002|Overall Study|Withdrawal by Subject|0|||
143386602|NCT04442126|516961200|FG003|Overall Study|Withdrawal by Subject|2|||
143386603|NCT04442126|516961201|FG004|Overall Study|Withdrawal by Subject|1|||
143386604|NCT04442126|516961202|FG005|Overall Study|Withdrawal by Subject|0|||
143386605|NCT04442126|516961203|FG006|Overall Study|Withdrawal by Subject|1|||
143386606|NCT04442126|516961204|FG007|Overall Study|Withdrawal by Subject|1|||
143386607|NCT04442126|516961205|FG008|Overall Study|Withdrawal by Subject|3|||
143386608|NCT04442126|516961197|FG000|Overall Study|Death|1|||
143386609|NCT04442126|516961198|FG001|Overall Study|Death|0|||
143386610|NCT04442126|516961199|FG002|Overall Study|Death|0|||
143386611|NCT04442126|516961200|FG003|Overall Study|Death|1|||
143386612|NCT04442126|516961201|FG004|Overall Study|Death|2|||
143386613|NCT04442126|516961202|FG005|Overall Study|Death|2|||
143386614|NCT04442126|516961203|FG006|Overall Study|Death|4|||
143386615|NCT04442126|516961204|FG007|Overall Study|Death|1|||
143386616|NCT04442126|516961205|FG008|Overall Study|Death|5|||
143386617|NCT04442126|516961197|FG000|Overall Study|Study Terminated by Sponsor|0|||
143386618|NCT04442126|516961198|FG001|Overall Study|Study Terminated by Sponsor|0|||
143386619|NCT04442126|516961199|FG002|Overall Study|Study Terminated by Sponsor|0|||
143386620|NCT04442126|516961200|FG003|Overall Study|Study Terminated by Sponsor|0|||
143386621|NCT04442126|516961201|FG004|Overall Study|Study Terminated by Sponsor|0|||
143386622|NCT04442126|516961202|FG005|Overall Study|Study Terminated by Sponsor|1|||
143386623|NCT04442126|516961203|FG006|Overall Study|Study Terminated by Sponsor|4|||
143386624|NCT04442126|516961204|FG007|Overall Study|Study Terminated by Sponsor|2|||
143386625|NCT04442126|516961205|FG008|Overall Study|Study Terminated by Sponsor|10|||
143386626|NCT04442126|516961197|FG000|Overall Study|Lost to Follow-up|0|||
143386627|NCT04442126|516961198|FG001|Overall Study|Lost to Follow-up|0|||
143386628|NCT04442126|516961199|FG002|Overall Study|Lost to Follow-up|0|||
143386629|NCT04442126|516961200|FG003|Overall Study|Lost to Follow-up|0|||
143386630|NCT04442126|516961201|FG004|Overall Study|Lost to Follow-up|0|||
143386631|NCT04442126|516961202|FG005|Overall Study|Lost to Follow-up|0|||
143386632|NCT04442126|516961203|FG006|Overall Study|Lost to Follow-up|0|||
143386633|NCT04442126|516961204|FG007|Overall Study|Lost to Follow-up|1|||
143386634|NCT04442126|516961205|FG008|Overall Study|Lost to Follow-up|2|||
143386635|NCT04442126|516961197|FG000|Overall Study|Progressive Disease|0|||
143386636|NCT04442126|516961198|FG001|Overall Study|Progressive Disease|1|||
143386637|NCT04442126|516961199|FG002|Overall Study|Progressive Disease|3|||
143386638|NCT04442126|516961200|FG003|Overall Study|Progressive Disease|0|||
143386639|NCT04442126|516961201|FG004|Overall Study|Progressive Disease|3|||
143386640|NCT04442126|516961202|FG005|Overall Study|Progressive Disease|0|||
143386641|NCT04442126|516961203|FG006|Overall Study|Progressive Disease|0|||
143386642|NCT04442126|516961204|FG007|Overall Study|Progressive Disease|0|||
143386643|NCT04442126|516961205|FG008|Overall Study|Progressive Disease|0|||
143386644|NCT04442126|516961197|FG000|Overall Study|Other|0|||
143386645|NCT04442126|516961198|FG001|Overall Study|Other|0|||
143386646|NCT04442126|516961199|FG002|Overall Study|Other|0|||
143386647|NCT04442126|516961200|FG003|Overall Study|Other|0|||
143386648|NCT04442126|516961201|FG004|Overall Study|Other|0|||
143386649|NCT04442126|516961202|FG005|Overall Study|Other|0|||
143386650|NCT04442126|516961203|FG006|Overall Study|Other|0|||
143386651|NCT04442126|516961204|FG007|Overall Study|Other|0|||
143386652|NCT04442126|516961205|FG008|Overall Study|Other|1|||
143386653|NCT06450405|516961206|FG000|Overall Study|Study funding terminated.|0|||
143386654|NCT06450405|516961207|FG001|Overall Study|Study funding terminated.|2|||
143386655|NCT03833245|516962522|FG000|Overall Study|Death|0|||
143336977|NCT01822587|516778146|FG000|Overall Study|Physician Decision|9|||
143336978|NCT01822587|516778147|FG001|Overall Study|Physician Decision|6|||
143336979|NCT01822587|516778148|FG002|Overall Study|Physician Decision|6|||
143336980|NCT00117676|516778149|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
143336981|NCT00117676|516778150|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
143336982|NCT00117676|516778149|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
143336983|NCT00117676|516778150|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
143336984|NCT00117676|516778149|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
143336985|NCT00117676|516778150|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
143336986|NCT00117676|516778149|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
143336987|NCT00117676|516778150|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
143336988|NCT00117676|516778149|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
143336989|NCT00117676|516778150|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
143336990|NCT00117676|516778149|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
143336991|NCT00117676|516778150|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
143336992|NCT00117676|516778149|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
143336993|NCT00117676|516778150|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
143336994|NCT00117676|516778149|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
143336995|NCT00117676|516778150|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
143336996|NCT00117676|516778149|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
143336997|NCT00117676|516778150|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
143336998|NCT00117676|516778149|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
143336999|NCT00117676|516778150|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
143337000|NCT00117676|516778149|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
143337001|NCT00117676|516778150|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
143337002|NCT00117676|516778149|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
143337003|NCT00117676|516778150|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
143337004|NCT00117676|516778149|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
143337005|NCT00117676|516778150|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
143337006|NCT00117676|516778149|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
143337007|NCT00117676|516778150|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
143337008|NCT00117676|516778149|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
143337009|NCT00117676|516778150|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
143337010|NCT00117676|516778149|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
143337011|NCT00117676|516778150|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
143337012|NCT00117676|516778149|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
143337013|NCT00117676|516778150|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
143337014|NCT00117676|516778149|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
143337015|NCT00117676|516778150|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
143337016|NCT00117676|516778149|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
143337017|NCT00117676|516778150|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
143337018|NCT00117676|516778149|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
143337019|NCT00117676|516778150|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
143337020|NCT00117676|516778149|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
143337021|NCT00117676|516778150|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
143337022|NCT00117676|516778149|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
143337023|NCT00117676|516778150|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
143337024|NCT00117676|516778149|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
143337025|NCT00117676|516778150|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
143337026|NCT00117676|516778149|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
143337027|NCT00117676|516778150|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
143337028|NCT00117676|516778149|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
143337029|NCT00117676|516778150|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
143386656|NCT03833245|516962523|FG001|Overall Study|Death|1|||
143386657|NCT03347383|516962524|FG000|Overall Study|Death|39|||
143386658|NCT03347383|516962524|FG000|Overall Study|Withdrawal by Subject|3|||
143386659|NCT03347383|516962524|FG000|Overall Study|Lost to Follow-up|9|||
143386660|NCT04842643|516962525|FG000|Overall Study|Physician Decision|1|||
143386661|NCT04842643|516962525|FG000|Overall Study|Other|1|||
143386662|NCT03484702|516962526|FG000|Treatment Period|Death|3|||
143386663|NCT03484702|516962527|FG001|Treatment Period|Death|1|||
143386664|NCT03484702|516962528|FG002|Treatment Period|Death|0|||
143386665|NCT03484702|516962529|FG003|Treatment Period|Death|0|||
143386666|NCT03484702|516962530|FG004|Treatment Period|Death|0|||
143386667|NCT03484702|516962531|FG005|Treatment Period|Death|0|||
143386668|NCT03484702|516962526|FG000|Treatment Period|Adverse Event|1|||
143386669|NCT03484702|516962527|FG001|Treatment Period|Adverse Event|0|||
143386670|NCT03484702|516962528|FG002|Treatment Period|Adverse Event|0|||
143386671|NCT03484702|516962529|FG003|Treatment Period|Adverse Event|0|||
143386672|NCT03484702|516962530|FG004|Treatment Period|Adverse Event|0|||
143386673|NCT03484702|516962531|FG005|Treatment Period|Adverse Event|0|||
143386674|NCT03484702|516962526|FG000|Treatment Period|Participant Withdrew from Study|0|||
143386675|NCT03484702|516962527|FG001|Treatment Period|Participant Withdrew from Study|1|||
143386676|NCT03484702|516962528|FG002|Treatment Period|Participant Withdrew from Study|0|||
143386677|NCT03484702|516962529|FG003|Treatment Period|Participant Withdrew from Study|0|||
143386678|NCT03484702|516962530|FG004|Treatment Period|Participant Withdrew from Study|0|||
143386679|NCT03484702|516962531|FG005|Treatment Period|Participant Withdrew from Study|0|||
143386680|NCT03484702|516962526|FG000|Treatment Period|Physician Decision|0|||
143386681|NCT03484702|516962527|FG001|Treatment Period|Physician Decision|1|||
143386682|NCT03484702|516962528|FG002|Treatment Period|Physician Decision|0|||
143386683|NCT03484702|516962529|FG003|Treatment Period|Physician Decision|0|||
143386684|NCT03484702|516962530|FG004|Treatment Period|Physician Decision|0|||
143386685|NCT03484702|516962531|FG005|Treatment Period|Physician Decision|1|||
143386686|NCT01894061|516962535|FG000|Overall Study|Screen failure|1|||
143386687|NCT01894061|516962535|FG000|Overall Study|Withdrawal by Subject|1|||
143386688|NCT05110495|516962536|FG000|Overall Study|Lost to Follow-up|1|||
143386689|NCT05110495|516962536|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
143386690|NCT04173663|516962537|FG000|Overall Study|Withdrawal by Subject|1|||
143386691|NCT04173663|516962538|FG001|Overall Study|Withdrawal by Subject|6|||
143386692|NCT04173663|516962537|FG000|Overall Study|Lost to Follow-up|17|||
143386693|NCT04173663|516962538|FG001|Overall Study|Lost to Follow-up|24|||
143386694|NCT05141903|516962540|FG000|Overall Study|Withdrawal by Subject|0|||
143386695|NCT05141903|516962541|FG001|Overall Study|Withdrawal by Subject|1|||
143386696|NCT05141903|516962542|FG002|Overall Study|Withdrawal by Subject|1|||
143386697|NCT05141903|516962543|FG003|Overall Study|Withdrawal by Subject|0|||
143386698|NCT05141903|516962544|FG004|Overall Study|Withdrawal by Subject|0|||
143386699|NCT05141903|516962540|FG000|Overall Study|Other|1|||
143386700|NCT05141903|516962541|FG001|Overall Study|Other|1|||
143386701|NCT05141903|516962542|FG002|Overall Study|Other|0|||
143386702|NCT05141903|516962543|FG003|Overall Study|Other|0|||
143386703|NCT05141903|516962544|FG004|Overall Study|Other|0|||
143386704|NCT02630823|516962550|FG000|Overall Study|Withdrawal by Subject|1|||
143386705|NCT02630823|516962550|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
143386706|NCT03391466|516962553|FG000|Overall Study|Death|82|||
143386707|NCT03391466|516962554|FG001|Overall Study|Death|85|||
143386708|NCT03391466|516962553|FG000|Overall Study|Still on study|93|||
143386709|NCT03391466|516962554|FG001|Overall Study|Still on study|74|||
143386710|NCT03391466|516962553|FG000|Overall Study|Subject withdrawal of consent from further follow-up|0|||
143386711|NCT03391466|516962554|FG001|Overall Study|Subject withdrawal of consent from further follow-up|13|||
143386712|NCT03391466|516962553|FG000|Overall Study|Lost to Follow-up|5|||
143386713|NCT03391466|516962554|FG001|Overall Study|Lost to Follow-up|5|||
143386714|NCT03391466|516962553|FG000|Overall Study|Investigator decision|0|||
143386715|NCT03391466|516962554|FG001|Overall Study|Investigator decision|1|||
143386716|NCT03391466|516962553|FG000|Overall Study|Other|0|||
143386717|NCT03391466|516962554|FG001|Overall Study|Other|1|||
143386718|NCT05062265|516962562|FG000|Overall Study|Withdrawal by Subject|1|||
143386719|NCT05062265|516962563|FG001|Overall Study|Withdrawal by Subject|0|||
143386720|NCT05439603|516962564|FG000|Overall Study|met withdrawal criteria|2|||
143386721|NCT05461131|516962565|FG000|Overall Study|Lost to Follow-up|0|||
143386722|NCT05461131|516962566|FG001|Overall Study|Lost to Follow-up|2|||
143386723|NCT02682316|516962567|FG000|Overall Study|Benign Final Pathology|27|||
143386724|NCT02682316|516962568|FG001|Overall Study|Benign Final Pathology|26|||
143386725|NCT02682316|516962567|FG000|Overall Study|Reoperation before 30 days|7|||
143386726|NCT02682316|516962568|FG001|Overall Study|Reoperation before 30 days|6|||
143386727|NCT02682316|516962567|FG000|Overall Study|Ineligible|1|||
143386728|NCT02682316|516962568|FG001|Overall Study|Ineligible|0|||
143386729|NCT02682316|516962567|FG000|Overall Study|Death|1|||
143386730|NCT02682316|516962568|FG001|Overall Study|Death|0|||
143386731|NCT02682316|516962567|FG000|Overall Study|Lost to Follow-up|7|||
143386732|NCT02682316|516962568|FG001|Overall Study|Lost to Follow-up|3|||
143386733|NCT03101904|516962569|FG000|Wash Out (10 Days)|Adverse Event|1|||
143386734|NCT03101904|516962570|FG001|Wash Out (10 Days)|Adverse Event|0|||
143386735|NCT03101904|516962569|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
143386736|NCT03101904|516962570|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
143386737|NCT04703322|516962572|FG000|Overall Study|Ongoing|8|||
143386738|NCT04703322|516962572|FG000|Overall Study|Withdrawal by Subject|1|||
143386739|NCT04549168|516962576|FG000|Randomization Phase|Adverse Event|0|||
143386740|NCT04549168|516962577|FG001|Randomization Phase|Adverse Event|0|||
143386741|NCT04549168|516962578|FG002|Randomization Phase|Adverse Event|1|||
143386742|NCT04549168|516962576|FG000|Randomization Phase|Other|0|||
143386743|NCT04549168|516962577|FG001|Randomization Phase|Other|2|||
143386744|NCT04549168|516962578|FG002|Randomization Phase|Other|0|||
143386745|NCT04549168|516962576|FG000|Randomization Phase|Withdrawal by Subject|0|||
143386746|NCT04549168|516962577|FG001|Randomization Phase|Withdrawal by Subject|2|||
143386747|NCT04549168|516962578|FG002|Randomization Phase|Withdrawal by Subject|1|||
143386748|NCT05021640|516962588|FG000|Overall Study|Lost to Follow-up|0|||
143386749|NCT05021640|516962589|FG001|Overall Study|Lost to Follow-up|0|||
143386750|NCT05021640|516962590|FG002|Overall Study|Lost to Follow-up|0|||
143386751|NCT05021640|516962591|FG003|Overall Study|Lost to Follow-up|0|||
143386752|NCT05021640|516962592|FG004|Overall Study|Lost to Follow-up|1|||
143386753|NCT04737772|516962593|FG000|Phase 2 Study|Lost to Follow-up|15|||
143386754|NCT04737772|516962594|FG001|Phase 2 Study|Lost to Follow-up|15|||
143386755|NCT04737772|516962593|FG000|Phase 2 Study|Withdrawal by Subject|0|||
143386756|NCT04737772|516962594|FG001|Phase 2 Study|Withdrawal by Subject|1|||
143386757|NCT04737772|516962593|FG000|Phase 2 Study|Did not take any coaching calls|4|||
143386758|NCT04737772|516962594|FG001|Phase 2 Study|Did not take any coaching calls|0|||
143386759|NCT04737772|516962593|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
143386760|NCT04737772|516962594|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
143386761|NCT04737772|516962593|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
143386762|NCT04737772|516962594|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
143386763|NCT02549339|516962595|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
143386764|NCT02549339|516962596|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
143386765|NCT02549339|516962595|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
143386766|NCT02549339|516962596|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
143386767|NCT02549339|516962595|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
143386768|NCT02549339|516962596|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
143386769|NCT02549339|516962595|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
143386770|NCT02549339|516962596|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
143386771|NCT02549339|516962595|FG000|12-month Follow-up|Lack of Efficacy|0|||
143386772|NCT02549339|516962596|FG001|12-month Follow-up|Lack of Efficacy|2|||
143386773|NCT02549339|516962595|FG000|12-month Follow-up|Withdrawal by Subject|8|||
143386774|NCT02549339|516962596|FG001|12-month Follow-up|Withdrawal by Subject|3|||
143386775|NCT02549339|516962595|FG000|12-month Follow-up|Lost to Follow-up|1|||
143386776|NCT02549339|516962596|FG001|12-month Follow-up|Lost to Follow-up|3|||
143386777|NCT02549339|516962595|FG000|12-month Follow-up|Other|0|||
143386778|NCT02549339|516962596|FG001|12-month Follow-up|Other|3|||
143386779|NCT05054374|516962597|FG000|Overall Study|Withdrawal by Subject|1|||
143386780|NCT05054374|516962598|FG001|Overall Study|Withdrawal by Subject|0|||
143386781|NCT05054374|516962599|FG002|Overall Study|Withdrawal by Subject|0|||
143386782|NCT05054374|516962600|FG003|Overall Study|Withdrawal by Subject|0|||
143386783|NCT05054374|516962597|FG000|Overall Study|Progressive Disease|5|||
143386784|NCT05054374|516962598|FG001|Overall Study|Progressive Disease|0|||
143386785|NCT05054374|516962599|FG002|Overall Study|Progressive Disease|0|||
143386786|NCT05054374|516962600|FG003|Overall Study|Progressive Disease|0|||
143386787|NCT05691309|516962601|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
143386788|NCT05691309|516962601|FG000|Overall Study|vancomycin levels not evaluable|2|||
143386789|NCT01707030|516962602|FG000|Overall Study|Death|1|||
143386790|NCT01707030|516962603|FG001|Overall Study|Death|1|||
143386791|NCT01707030|516962602|FG000|Overall Study|Withdrawal by Subject|2|||
143386792|NCT01707030|516962603|FG001|Overall Study|Withdrawal by Subject|3|||
143386793|NCT01707030|516962602|FG000|Overall Study|Lost to Follow-up|8|||
143386794|NCT01707030|516962603|FG001|Overall Study|Lost to Follow-up|13|||
143386795|NCT04838262|516962605|FG000|Overall Study|Withdrawal by Subject|9|||
143386796|NCT04838262|516962606|FG001|Overall Study|Withdrawal by Subject|4|||
143386797|NCT04437433|516962609|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|7|||
143386798|NCT04437433|516962610|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|0|||
143386799|NCT04437433|516962609|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|1|||
143386800|NCT04437433|516962610|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|0|||
143386801|NCT04437433|516962609|FG000|Overall Study|Adverse Event|9|||
143386802|NCT04437433|516962610|FG001|Overall Study|Adverse Event|0|||
143386803|NCT04437433|516962609|FG000|Overall Study|Lack of Efficacy|4|||
143386804|NCT04437433|516962610|FG001|Overall Study|Lack of Efficacy|0|||
143386805|NCT04437433|516962609|FG000|Overall Study|Withdrawal by Subject|4|||
143386806|NCT04437433|516962610|FG001|Overall Study|Withdrawal by Subject|1|||
143386807|NCT04437433|516962609|FG000|Overall Study|Protocol Deviation|0|||
143386808|NCT04437433|516962610|FG001|Overall Study|Protocol Deviation|1|||
143386809|NCT04437433|516962609|FG000|Overall Study|Other, not specified|0|||
143386810|NCT04437433|516962610|FG001|Overall Study|Other, not specified|1|||
143386811|NCT04245501|516962613|FG000|Overall Study|Adverse Event|2|||
143386812|NCT04245501|516962614|FG001|Overall Study|Adverse Event|0|||
143386813|NCT04245501|516962613|FG000|Overall Study|ineligible participant unknowingly enrolled|0|||
143386814|NCT04245501|516962614|FG001|Overall Study|ineligible participant unknowingly enrolled|1|||
143386815|NCT03932682|516962615|FG000|Overall Study|Death|1|||
143386816|NCT03932682|516962616|FG001|Overall Study|Death|2|||
143386817|NCT03932682|516962615|FG000|Overall Study|Withdrawal by Subject|37|||
143386818|NCT03932682|516962616|FG001|Overall Study|Withdrawal by Subject|45|||
143386819|NCT03932682|516962615|FG000|Overall Study|Lost to Follow-up|19|||
143386820|NCT03932682|516962616|FG001|Overall Study|Lost to Follow-up|25|||
143386821|NCT03932682|516962615|FG000|Overall Study|Protocol Violation|0|||
143386822|NCT03932682|516962616|FG001|Overall Study|Protocol Violation|2|||
143386823|NCT03932682|516962615|FG000|Overall Study|Other|9|||
143386824|NCT03932682|516962616|FG001|Overall Study|Other|23|||
143386825|NCT04936035|516962617|FG000|Overall Study|Adverse Event|0|||
143386826|NCT04936035|516962618|FG001|Overall Study|Adverse Event|1|||
143386827|NCT04936035|516962619|FG002|Overall Study|Adverse Event|0|||
143386828|NCT04936035|516962620|FG003|Overall Study|Adverse Event|0|||
143386829|NCT04936035|516962621|FG004|Overall Study|Adverse Event|0|||
143386830|NCT04936035|516962617|FG000|Overall Study|Death|0|||
143386831|NCT04936035|516962618|FG001|Overall Study|Death|0|||
143386832|NCT04936035|516962619|FG002|Overall Study|Death|0|||
143386833|NCT04936035|516962620|FG003|Overall Study|Death|1|||
143386834|NCT04936035|516962621|FG004|Overall Study|Death|0|||
143386835|NCT04936035|516962617|FG000|Overall Study|Lost to Follow-up|0|||
143386836|NCT04936035|516962618|FG001|Overall Study|Lost to Follow-up|1|||
143386837|NCT04936035|516962619|FG002|Overall Study|Lost to Follow-up|1|||
143386838|NCT04936035|516962620|FG003|Overall Study|Lost to Follow-up|2|||
143386839|NCT04936035|516962621|FG004|Overall Study|Lost to Follow-up|1|||
143386840|NCT04936035|516962617|FG000|Overall Study|Physician Decision|0|||
143386841|NCT04936035|516962618|FG001|Overall Study|Physician Decision|1|||
143386842|NCT04936035|516962619|FG002|Overall Study|Physician Decision|0|||
143386843|NCT04936035|516962620|FG003|Overall Study|Physician Decision|0|||
143386844|NCT04936035|516962621|FG004|Overall Study|Physician Decision|0|||
143386845|NCT04936035|516962617|FG000|Overall Study|Protocol Deviation|0|||
143386846|NCT04936035|516962618|FG001|Overall Study|Protocol Deviation|0|||
143386847|NCT04936035|516962619|FG002|Overall Study|Protocol Deviation|1|||
143386848|NCT04936035|516962620|FG003|Overall Study|Protocol Deviation|0|||
143386849|NCT04936035|516962621|FG004|Overall Study|Protocol Deviation|0|||
143386850|NCT04936035|516962617|FG000|Overall Study|Subject Stopped Participation in the Study|5|||
143386851|NCT04936035|516962618|FG001|Overall Study|Subject Stopped Participation in the Study|5|||
143386852|NCT04936035|516962619|FG002|Overall Study|Subject Stopped Participation in the Study|1|||
143386853|NCT04936035|516962620|FG003|Overall Study|Subject Stopped Participation in the Study|2|||
143386854|NCT04936035|516962621|FG004|Overall Study|Subject Stopped Participation in the Study|3|||
143386855|NCT04936035|516962617|FG000|Overall Study|Reason Unknown|0|||
143386856|NCT04936035|516962618|FG001|Overall Study|Reason Unknown|0|||
143386857|NCT04936035|516962619|FG002|Overall Study|Reason Unknown|0|||
143386858|NCT04936035|516962620|FG003|Overall Study|Reason Unknown|0|||
143386859|NCT04936035|516962621|FG004|Overall Study|Reason Unknown|1|||
143386860|NCT04936035|516962617|FG000|Overall Study|Withdrawal by Subject|1|||
143386861|NCT04936035|516962618|FG001|Overall Study|Withdrawal by Subject|0|||
143386862|NCT04936035|516962619|FG002|Overall Study|Withdrawal by Subject|0|||
143386863|NCT04936035|516962620|FG003|Overall Study|Withdrawal by Subject|0|||
143386864|NCT04936035|516962621|FG004|Overall Study|Withdrawal by Subject|0|||
143386865|NCT04936035|516962617|FG000|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
143386866|NCT04936035|516962618|FG001|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
143386867|NCT04936035|516962619|FG002|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
143386868|NCT04936035|516962620|FG003|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|2|||
143386869|NCT04936035|516962621|FG004|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
143386870|NCT04936035|516962617|FG000|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
143386871|NCT04936035|516962618|FG001|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
143386872|NCT04936035|516962619|FG002|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
143386873|NCT04936035|516962620|FG003|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
143386874|NCT04936035|516962621|FG004|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|1|||
143386875|NCT04936035|516962617|FG000|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
143386876|NCT04936035|516962618|FG001|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
143386877|NCT04936035|516962619|FG002|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
143386878|NCT04936035|516962620|FG003|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
143386879|NCT04936035|516962621|FG004|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|1|||
143386880|NCT02323321|516962625|FG000|Overall Study|Re-Transplant|1|||
143386881|NCT02323321|516962625|FG000|Overall Study|Death|12|||
143386882|NCT00446225|516962626|FG000|Overall Study|Protocol Violation|1|||
143386883|NCT00446225|516962627|FG001|Overall Study|Protocol Violation|0|||
143386884|NCT00220740|516962628|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
143386885|NCT00220740|516962629|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
143386886|NCT00220740|516962628|FG000|Efficacy Period|Adverse Event|1|||
143386887|NCT00220740|516962629|FG001|Efficacy Period|Adverse Event|1|||
143386888|NCT00220740|516962628|FG000|Efficacy Period|Withdrawal by Subject|1|||
143386889|NCT00220740|516962629|FG001|Efficacy Period|Withdrawal by Subject|0|||
143386890|NCT00220740|516962628|FG000|Efficacy Period|Protocol Violation|1|||
143386891|NCT00220740|516962629|FG001|Efficacy Period|Protocol Violation|0|||
143386892|NCT00220740|516962628|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
143386893|NCT00220740|516962629|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
143386894|NCT03912831|516962636|FG000|Overall Study|Death|1|||
143386895|NCT03912831|516962637|FG001|Overall Study|Death|1|||
143386896|NCT03912831|516962638|FG002|Overall Study|Death|1|||
143386897|NCT03912831|516962639|FG003|Overall Study|Death|1|||
143386898|NCT03912831|516962640|FG004|Overall Study|Death|1|||
143386899|NCT03912831|516962641|FG005|Overall Study|Death|1|||
143386900|NCT03912831|516962636|FG000|Overall Study|Reason not Specified|0|||
143386901|NCT03912831|516962637|FG001|Overall Study|Reason not Specified|0|||
143386902|NCT03912831|516962638|FG002|Overall Study|Reason not Specified|0|||
143386903|NCT03912831|516962639|FG003|Overall Study|Reason not Specified|0|||
143386904|NCT03912831|516962640|FG004|Overall Study|Reason not Specified|1|||
143386905|NCT03912831|516962641|FG005|Overall Study|Reason not Specified|0|||
143386906|NCT03912831|516962636|FG000|Overall Study|Withdrawal by Participant|0|||
143386907|NCT03912831|516962637|FG001|Overall Study|Withdrawal by Participant|0|||
143386908|NCT03912831|516962638|FG002|Overall Study|Withdrawal by Participant|0|||
143386909|NCT03912831|516962639|FG003|Overall Study|Withdrawal by Participant|0|||
143386910|NCT03912831|516962640|FG004|Overall Study|Withdrawal by Participant|1|||
143386911|NCT03912831|516962641|FG005|Overall Study|Withdrawal by Participant|0|||
143386912|NCT03527160|516962642|FG000|Overall Study|No urine collected|13|||
143386913|NCT03527160|516962642|FG000|Overall Study|No clinical serum creatinine collected|6|||
143386914|NCT03527160|516962642|FG000|Overall Study|Did not meet inclusion|2|||
143386915|NCT04774237|516962645|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
143386916|NCT04774237|516962646|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
143386917|NCT04774237|516962647|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
143386918|NCT04774237|516962648|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
143386919|NCT04774237|516962649|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
143386920|NCT04774237|516962650|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
143386921|NCT03625882|516964082|FG000|Overall Study|Protocol Violation|3|||
143386922|NCT04178733|516964092|FG000|Overall Study|Investigator Decision|0|||
143386923|NCT04178733|516964093|FG001|Overall Study|Investigator Decision|0|||
143386924|NCT04178733|516964094|FG002|Overall Study|Investigator Decision|0|||
143386925|NCT04178733|516964095|FG003|Overall Study|Investigator Decision|1|||
143386926|NCT04178733|516964096|FG004|Overall Study|Investigator Decision|2|||
143386927|NCT01195831|516964103|FG000|Overall Study|Lost to Follow-up|2|||
143386928|NCT01195831|516964104|FG001|Overall Study|Lost to Follow-up|4|||
143386929|NCT01195831|516964103|FG000|Overall Study|Withdrawal by Subject|2|||
143386930|NCT01195831|516964104|FG001|Overall Study|Withdrawal by Subject|2|||
143386931|NCT01195831|516964103|FG000|Overall Study|Adverse Event|4|||
143386932|NCT01195831|516964104|FG001|Overall Study|Adverse Event|2|||
143386933|NCT01195831|516964103|FG000|Overall Study|Protocol Violation|0|||
143386934|NCT01195831|516964104|FG001|Overall Study|Protocol Violation|2|||
143386935|NCT04638998|516964105|FG000|Overall Study|Withdrawal by Subject|1|||
143386936|NCT04638998|516964106|FG001|Overall Study|Withdrawal by Subject|3|||
143386937|NCT01180634|516964109|FG000|Overall Study|Adverse Event|4|||
143386938|NCT01180634|516964110|FG001|Overall Study|Adverse Event|1|||
143386939|NCT01180634|516964109|FG000|Overall Study|Miscellaneous|2|||
143386940|NCT01180634|516964110|FG001|Overall Study|Miscellaneous|0|||
143386941|NCT01180634|516964109|FG000|Overall Study|Withdrawal by Subject|4|||
143386942|NCT01180634|516964110|FG001|Overall Study|Withdrawal by Subject|0|||
143386943|NCT04419168|516964111|FG000|Overall Study|Protocol Violation|1|||
143386944|NCT04419168|516964112|FG001|Overall Study|Protocol Violation|1|||
143386945|NCT04419168|516964111|FG000|Overall Study|Lost to Follow-up|7|||
143386946|NCT04419168|516964112|FG001|Overall Study|Lost to Follow-up|7|||
143386947|NCT04419168|516964111|FG000|Overall Study|Missed 6-month Visit|48|||
143386948|NCT04419168|516964112|FG001|Overall Study|Missed 6-month Visit|45|||
143386949|NCT03713086|516964113|FG000|Overall Study|Withdrawal by Subject|0|||
143386950|NCT03713086|516964114|FG001|Overall Study|Withdrawal by Subject|2|||
143386951|NCT03713086|516964115|FG002|Overall Study|Withdrawal by Subject|1|||
143386952|NCT03713086|516964116|FG003|Overall Study|Withdrawal by Subject|0|||
143386953|NCT03713086|516964113|FG000|Overall Study|Lost to Follow-up|0|||
143386954|NCT03713086|516964114|FG001|Overall Study|Lost to Follow-up|1|||
143386955|NCT03713086|516964115|FG002|Overall Study|Lost to Follow-up|0|||
143386956|NCT03713086|516964116|FG003|Overall Study|Lost to Follow-up|1|||
143386957|NCT05009251|516964117|FG000|Overall Study|Protocol Violation|100|||
143386958|NCT05009251|516964118|FG001|Overall Study|Protocol Violation|105|||
143386959|NCT05009251|516964119|FG002|Overall Study|Protocol Violation|119|||
143386960|NCT05009251|516964120|FG003|Overall Study|Protocol Violation|120|||
143386961|NCT05009251|516964121|FG004|Overall Study|Protocol Violation|119|||
143386962|NCT05009251|516964117|FG000|Overall Study|Death|25|||
143386963|NCT05009251|516964118|FG001|Overall Study|Death|22|||
143386964|NCT05009251|516964119|FG002|Overall Study|Death|24|||
143386965|NCT05009251|516964120|FG003|Overall Study|Death|19|||
143386966|NCT05009251|516964121|FG004|Overall Study|Death|15|||
143386967|NCT02662062|516964123|FG000|Overall Study|Withdrawal by Subject|1|||
143386968|NCT06311084|516964124|FG000|Overall Study|Lost to Follow-up|14|||
143386969|NCT05374837|516964125|FG000|Overall Study|Lost to Follow-up|17|||
143386970|NCT05374837|516964126|FG001|Overall Study|Lost to Follow-up|18|||
143386971|NCT04725240|516964127|FG000|Overall Study|Adverse Event|2|||
143386972|NCT05059262|516964134|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
143386973|NCT05059262|516964135|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
143386974|NCT05059262|516964134|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
143386975|NCT05059262|516964135|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
143386976|NCT05059262|516964134|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
143386977|NCT05059262|516964135|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
143386978|NCT05059262|516964134|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
143386979|NCT05059262|516964135|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
143386980|NCT05059262|516964134|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
143386981|NCT05059262|516964135|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
143386982|NCT05059262|516964134|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
143386983|NCT05059262|516964135|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
143386984|NCT05059262|516964134|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
143386985|NCT05059262|516964135|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
143386986|NCT05059262|516964134|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
143386987|NCT05059262|516964135|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
143386988|NCT05059262|516964134|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
143386989|NCT05059262|516964135|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
143386990|NCT03161379|516964143|FG000|Overall Study|Withdrawal by Subject|4|||
143386991|NCT03161379|516964143|FG000|Overall Study|disease progression during chemotherapy|5|||
143386992|NCT03161379|516964143|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
143386993|NCT03161379|516964143|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
143386994|NCT02312960|516964144|FG000|Overall Study|Death|24|||
143386995|NCT02312960|516964145|FG001|Overall Study|Death|32|||
143386996|NCT02312960|516964146|FG002|Overall Study|Death|25|||
143386997|NCT02312960|516964147|FG003|Overall Study|Death|11|||
143386998|NCT02312960|516964148|FG004|Overall Study|Death|5|||
143386999|NCT02312960|516964149|FG005|Overall Study|Death|5|||
143387000|NCT02312960|516964150|FG006|Overall Study|Death|8|||
143387001|NCT02312960|516964151|FG007|Overall Study|Death|5|||
143387002|NCT02312960|516964152|FG008|Overall Study|Death|7|||
143387003|NCT02312960|516964153|FG009|Overall Study|Death|3|||
143387004|NCT02312960|516964154|FG010|Overall Study|Death|3|||
143387005|NCT02312960|516964155|FG011|Overall Study|Death|1|||
143387006|NCT02312960|516964156|FG012|Overall Study|Death|25|||
143387007|NCT02312960|516964157|FG013|Overall Study|Death|19|||
143387008|NCT02312960|516964144|FG000|Overall Study|Missing|0|||
143387009|NCT02312960|516964145|FG001|Overall Study|Missing|0|||
143387010|NCT02312960|516964146|FG002|Overall Study|Missing|2|||
143387011|NCT02312960|516964147|FG003|Overall Study|Missing|0|||
143387012|NCT02312960|516964148|FG004|Overall Study|Missing|0|||
143387013|NCT02312960|516964149|FG005|Overall Study|Missing|0|||
143387014|NCT02312960|516964150|FG006|Overall Study|Missing|0|||
143387015|NCT02312960|516964151|FG007|Overall Study|Missing|0|||
143387016|NCT02312960|516964152|FG008|Overall Study|Missing|0|||
143387017|NCT02312960|516964153|FG009|Overall Study|Missing|0|||
143387018|NCT02312960|516964154|FG010|Overall Study|Missing|0|||
143387019|NCT02312960|516964155|FG011|Overall Study|Missing|0|||
143387020|NCT02312960|516964156|FG012|Overall Study|Missing|0|||
143387021|NCT02312960|516964157|FG013|Overall Study|Missing|0|||
143387022|NCT02312960|516964144|FG000|Overall Study|Lost to Follow-up|0|||
143387023|NCT02312960|516964145|FG001|Overall Study|Lost to Follow-up|0|||
143387024|NCT02312960|516964146|FG002|Overall Study|Lost to Follow-up|1|||
143387025|NCT02312960|516964147|FG003|Overall Study|Lost to Follow-up|0|||
143387026|NCT02312960|516964148|FG004|Overall Study|Lost to Follow-up|0|||
143387027|NCT02312960|516964149|FG005|Overall Study|Lost to Follow-up|0|||
143387028|NCT02312960|516964150|FG006|Overall Study|Lost to Follow-up|1|||
143387029|NCT02312960|516964151|FG007|Overall Study|Lost to Follow-up|1|||
143387030|NCT02312960|516964152|FG008|Overall Study|Lost to Follow-up|0|||
143387031|NCT02312960|516964153|FG009|Overall Study|Lost to Follow-up|1|||
143387032|NCT02312960|516964154|FG010|Overall Study|Lost to Follow-up|0|||
143387033|NCT02312960|516964155|FG011|Overall Study|Lost to Follow-up|0|||
143387034|NCT02312960|516964156|FG012|Overall Study|Lost to Follow-up|1|||
143387035|NCT02312960|516964157|FG013|Overall Study|Lost to Follow-up|0|||
143387036|NCT02312960|516964144|FG000|Overall Study|Withdrawal by Subject|1|||
143387037|NCT02312960|516964145|FG001|Overall Study|Withdrawal by Subject|2|||
143387038|NCT02312960|516964146|FG002|Overall Study|Withdrawal by Subject|0|||
143387039|NCT02312960|516964147|FG003|Overall Study|Withdrawal by Subject|0|||
143387040|NCT02312960|516964148|FG004|Overall Study|Withdrawal by Subject|1|||
143387041|NCT02312960|516964149|FG005|Overall Study|Withdrawal by Subject|0|||
143387042|NCT02312960|516964150|FG006|Overall Study|Withdrawal by Subject|1|||
143387043|NCT02312960|516964151|FG007|Overall Study|Withdrawal by Subject|2|||
143387044|NCT02312960|516964152|FG008|Overall Study|Withdrawal by Subject|2|||
143387045|NCT02312960|516964153|FG009|Overall Study|Withdrawal by Subject|3|||
143387046|NCT02312960|516964154|FG010|Overall Study|Withdrawal by Subject|0|||
143387047|NCT02312960|516964155|FG011|Overall Study|Withdrawal by Subject|0|||
143387048|NCT02312960|516964156|FG012|Overall Study|Withdrawal by Subject|2|||
143387049|NCT02312960|516964157|FG013|Overall Study|Withdrawal by Subject|0|||
143387050|NCT03958955|516964158|FG000|Overall Study|Adverse Event|1|||
143387051|NCT04089371|516964161|FG000|Overall Study|Withdrawal by Subject|0|||
143387052|NCT04089371|516964162|FG001|Overall Study|Withdrawal by Subject|1|||
143387053|NCT04089371|516964161|FG000|Overall Study|Study terminated early|0|||
143387054|NCT04089371|516964162|FG001|Overall Study|Study terminated early|9|||
143387055|NCT02900924|516964165|FG000|Overall Study|Death|52|||
143387056|NCT02900924|516964165|FG000|Overall Study|Lost to Follow-up|4|||
143387057|NCT02900924|516964165|FG000|Overall Study|Withdrawal by Subject|20|||
143387058|NCT02900924|516964165|FG000|Overall Study|Missed Visit|33|||
143387059|NCT05956002|516964166|FG000|Treatment Period 3|Adverse Event|0|||
143387060|NCT05956002|516964167|FG001|Treatment Period 3|Adverse Event|0|||
143387061|NCT05956002|516964168|FG002|Treatment Period 3|Adverse Event|1|||
143387062|NCT05956002|516964169|FG003|Treatment Period 3|Adverse Event|0|||
143387063|NCT02307565|516964170|FG000|Overall Study|Adverse Event|3|||
143387064|NCT02307565|516964171|FG001|Overall Study|Adverse Event|2|||
143387065|NCT02307565|516964170|FG000|Overall Study|Withdrawal by Subject|2|||
143387066|NCT02307565|516964171|FG001|Overall Study|Withdrawal by Subject|2|||
143387067|NCT00931710|516964174|FG000|Overall Study|Adverse Event|16|||
143387068|NCT00931710|516964175|FG001|Overall Study|Adverse Event|10|||
143387069|NCT00931710|516964174|FG000|Overall Study|Abnormal test procedure results|2|||
143387070|NCT00931710|516964175|FG001|Overall Study|Abnormal test procedure results|0|||
143387071|NCT00931710|516964174|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
143387072|NCT00931710|516964175|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
143387073|NCT00931710|516964174|FG000|Overall Study|Patient withdrew consent|4|||
143387074|NCT00931710|516964175|FG001|Overall Study|Patient withdrew consent|9|||
143387075|NCT00931710|516964174|FG000|Overall Study|Lost to Follow-up|6|||
143387076|NCT00931710|516964175|FG001|Overall Study|Lost to Follow-up|5|||
143387077|NCT00931710|516964174|FG000|Overall Study|Protocol deviation|1|||
143387078|NCT00931710|516964175|FG001|Overall Study|Protocol deviation|2|||
143387079|NCT04401800|516964176|FG000|Overall Study|Death|17|||
143387080|NCT04401800|516964176|FG000|Overall Study|Lost to Follow-up|5|||
143387081|NCT04401800|516964176|FG000|Overall Study|Withdrawal by Subject|4|||
143387082|NCT03338790|516964179|FG000|Overall Study|Disease Progression|65|||
143387083|NCT03338790|516964180|FG001|Overall Study|Disease Progression|43|||
143387084|NCT03338790|516964181|FG002|Overall Study|Disease Progression|50|||
143387085|NCT03338790|516964182|FG003|Overall Study|Disease Progression|37|||
143387086|NCT03338790|516964179|FG000|Overall Study|Study Drug Toxicity|9|||
143387087|NCT03338790|516964180|FG001|Overall Study|Study Drug Toxicity|8|||
143387088|NCT03338790|516964181|FG002|Overall Study|Study Drug Toxicity|15|||
143387089|NCT03338790|516964182|FG003|Overall Study|Study Drug Toxicity|0|||
143387090|NCT03338790|516964179|FG000|Overall Study|Death|1|||
143387091|NCT03338790|516964180|FG001|Overall Study|Death|1|||
143387092|NCT03338790|516964181|FG002|Overall Study|Death|1|||
143387093|NCT03338790|516964182|FG003|Overall Study|Death|0|||
143387094|NCT03338790|516964179|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
143387095|NCT03338790|516964180|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
143387096|NCT03338790|516964181|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
143387097|NCT03338790|516964182|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
143387098|NCT03338790|516964179|FG000|Overall Study|Participant request to discontinue study treatment|3|||
143387099|NCT03338790|516964180|FG001|Overall Study|Participant request to discontinue study treatment|3|||
143387100|NCT03338790|516964181|FG002|Overall Study|Participant request to discontinue study treatment|2|||
143387101|NCT03338790|516964182|FG003|Overall Study|Participant request to discontinue study treatment|1|||
143387102|NCT03338790|516964179|FG000|Overall Study|Poor/non-compliance|0|||
143387103|NCT03338790|516964180|FG001|Overall Study|Poor/non-compliance|1|||
143387104|NCT03338790|516964181|FG002|Overall Study|Poor/non-compliance|0|||
143387105|NCT03338790|516964182|FG003|Overall Study|Poor/non-compliance|0|||
143387106|NCT03338790|516964179|FG000|Overall Study|Participant withdrew consent|1|||
143387107|NCT03338790|516964180|FG001|Overall Study|Participant withdrew consent|0|||
143387108|NCT03338790|516964181|FG002|Overall Study|Participant withdrew consent|1|||
143387109|NCT03338790|516964182|FG003|Overall Study|Participant withdrew consent|1|||
143387110|NCT03338790|516964179|FG000|Overall Study|Other reasons|0|||
143387111|NCT03338790|516964180|FG001|Overall Study|Other reasons|5|||
143387112|NCT03338790|516964181|FG002|Overall Study|Other reasons|0|||
143387113|NCT03338790|516964182|FG003|Overall Study|Other reasons|2|||
143387114|NCT03338790|516964179|FG000|Overall Study|Not reported|0|||
143387115|NCT03338790|516964180|FG001|Overall Study|Not reported|0|||
143387116|NCT03338790|516964181|FG002|Overall Study|Not reported|1|||
143387117|NCT03338790|516964182|FG003|Overall Study|Not reported|0|||
143387118|NCT03338790|516964179|FG000|Overall Study|Completed treatment period|1|||
143387119|NCT03338790|516964180|FG001|Overall Study|Completed treatment period|2|||
143387120|NCT03338790|516964181|FG002|Overall Study|Completed treatment period|0|||
143387121|NCT03338790|516964182|FG003|Overall Study|Completed treatment period|0|||
143387122|NCT01494662|516964187|FG000|Overall Study|Withdrawal by Subject|0|||
143387123|NCT01494662|516964188|FG001|Overall Study|Withdrawal by Subject|0|||
143387124|NCT01494662|516964189|FG002|Overall Study|Withdrawal by Subject|1|||
143387125|NCT01494662|516964190|FG003|Overall Study|Withdrawal by Subject|0|||
143387126|NCT01494662|516964191|FG004|Overall Study|Withdrawal by Subject|0|||
143387127|NCT01494662|516964192|FG005|Overall Study|Withdrawal by Subject|0|||
143387128|NCT01494662|516964193|FG006|Overall Study|Withdrawal by Subject|0|||
143387129|NCT01494662|516964187|FG000|Overall Study|Physician Decision|0|||
143387130|NCT01494662|516964188|FG001|Overall Study|Physician Decision|0|||
143387131|NCT01494662|516964189|FG002|Overall Study|Physician Decision|1|||
143387132|NCT01494662|516964190|FG003|Overall Study|Physician Decision|0|||
143387133|NCT01494662|516964191|FG004|Overall Study|Physician Decision|0|||
143387134|NCT01494662|516964192|FG005|Overall Study|Physician Decision|0|||
143387135|NCT01494662|516964193|FG006|Overall Study|Physician Decision|0|||
143387136|NCT04072822|516964194|FG000|Treatment|Adverse Event|9|||
143387137|NCT04072822|516964195|FG001|Treatment|Adverse Event|5|||
143387138|NCT04072822|516964194|FG000|Treatment|Met Stopping Criteria|13|||
143387139|NCT04072822|516964195|FG001|Treatment|Met Stopping Criteria|24|||
143387140|NCT04072822|516964194|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
143387141|NCT04072822|516964195|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
143387142|NCT04072822|516964194|FG000|Treatment|Withdrawal by Subject|0|||
143387143|NCT04072822|516964195|FG001|Treatment|Withdrawal by Subject|2|||
143387144|NCT04072822|516964194|FG000|Treatment|Death|0|||
143387145|NCT04072822|516964195|FG001|Treatment|Death|2|||
143387146|NCT04072822|516964194|FG000|Treatment|Lost to Follow-up|11|||
143387147|NCT04072822|516964195|FG001|Treatment|Lost to Follow-up|3|||
143387148|NCT04072822|516964194|FG000|Treatment|Physician Decision|1|||
143387149|NCT04072822|516964195|FG001|Treatment|Physician Decision|0|||
143387150|NCT04072822|516964194|FG000|Treatment|Other|7|||
143387151|NCT04072822|516964195|FG001|Treatment|Other|9|||
143387152|NCT04072822|516964194|FG000|Follow-up|Withdrawal by Subject|1|||
143387153|NCT04072822|516964195|FG001|Follow-up|Withdrawal by Subject|0|||
143387154|NCT04072822|516964194|FG000|Follow-up|Lost to Follow-up|5|||
143387155|NCT04072822|516964195|FG001|Follow-up|Lost to Follow-up|4|||
143387156|NCT04391894|516964196|FG000|Overall Study|Adverse Event|1|||
143387157|NCT04391894|516964197|FG001|Overall Study|Adverse Event|1|||
143387158|NCT04391894|516964198|FG002|Overall Study|Adverse Event|1|||
143387159|NCT04391894|516964199|FG003|Overall Study|Adverse Event|1|||
143387160|NCT04391894|516964200|FG004|Overall Study|Adverse Event|1|||
143387161|NCT04391894|516964196|FG000|Overall Study|Lost to Follow-up|1|||
143387162|NCT04391894|516964197|FG001|Overall Study|Lost to Follow-up|0|||
143387163|NCT04391894|516964198|FG002|Overall Study|Lost to Follow-up|0|||
143387164|NCT04391894|516964199|FG003|Overall Study|Lost to Follow-up|0|||
143387165|NCT04391894|516964200|FG004|Overall Study|Lost to Follow-up|0|||
143387166|NCT04391894|516964196|FG000|Overall Study|Protocol Violation|0|||
143387167|NCT04391894|516964197|FG001|Overall Study|Protocol Violation|0|||
143387168|NCT04391894|516964198|FG002|Overall Study|Protocol Violation|0|||
143387169|NCT04391894|516964199|FG003|Overall Study|Protocol Violation|1|||
143387170|NCT04391894|516964200|FG004|Overall Study|Protocol Violation|0|||
143387171|NCT04391894|516964196|FG000|Overall Study|Withdrawal by Subject|2|||
143387172|NCT04391894|516964197|FG001|Overall Study|Withdrawal by Subject|0|||
143387173|NCT04391894|516964198|FG002|Overall Study|Withdrawal by Subject|3|||
143387174|NCT04391894|516964199|FG003|Overall Study|Withdrawal by Subject|0|||
143387175|NCT04391894|516964200|FG004|Overall Study|Withdrawal by Subject|1|||
143387176|NCT04391894|516964196|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
143387177|NCT04391894|516964197|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
143387178|NCT04391894|516964198|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
143387179|NCT04391894|516964199|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
143387180|NCT04391894|516964200|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
143387181|NCT01057433|516964208|FG000|Overall Study|Adverse Event|1|||
143387182|NCT05268302|516964209|FG000|Overall Study|Death|0|||
143387183|NCT05268302|516964210|FG001|Overall Study|Death|1|||
143387184|NCT03747484|516965459|FG000|Overall Study|Lack of Efficacy|0|||
143387185|NCT03747484|516965460|FG001|Overall Study|Lack of Efficacy|1|||
143387186|NCT03747484|516965461|FG002|Overall Study|Lack of Efficacy|1|||
143387187|NCT03747484|516965462|FG003|Overall Study|Lack of Efficacy|2|||
143387188|NCT03747484|516965463|FG004|Overall Study|Lack of Efficacy|2|||
143387189|NCT05691452|516965471|FG000|Overall Study|Withdrawal by Subject|1|||
143387190|NCT05691452|516965472|FG001|Overall Study|Withdrawal by Subject|1|||
143387191|NCT05691452|516965473|FG002|Overall Study|Withdrawal by Subject|0|||
143387192|NCT05691452|516965471|FG000|Overall Study|Physician Decision|1|||
143387193|NCT05691452|516965472|FG001|Overall Study|Physician Decision|0|||
143387194|NCT05691452|516965473|FG002|Overall Study|Physician Decision|0|||
143387195|NCT05691452|516965471|FG000|Overall Study|Lost to Follow-up|0|||
143387196|NCT05691452|516965472|FG001|Overall Study|Lost to Follow-up|0|||
143387197|NCT05691452|516965473|FG002|Overall Study|Lost to Follow-up|1|||
143387198|NCT05691452|516965471|FG000|Overall Study|Adverse Event|0|||
143387199|NCT05691452|516965472|FG001|Overall Study|Adverse Event|0|||
143337030|NCT00117676|516778149|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
143337031|NCT00117676|516778150|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
143337032|NCT00117676|516778149|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
143337033|NCT00117676|516778150|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
143337034|NCT00117676|516778149|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
143337035|NCT00117676|516778150|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
143337036|NCT00117676|516778149|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
143337037|NCT00117676|516778150|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
143337038|NCT00117676|516778149|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
143337039|NCT00117676|516778150|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
143337040|NCT00117676|516778149|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
143337041|NCT00117676|516778150|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
143337042|NCT00117676|516778149|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
143337043|NCT00117676|516778150|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
143337044|NCT00117676|516778149|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
143337045|NCT00117676|516778150|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
143337046|NCT00117676|516778149|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
143337047|NCT00117676|516778150|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
143337048|NCT00117676|516778149|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
143337049|NCT00117676|516778150|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
143337050|NCT00658567|516778151|FG000|Overall Study|Adverse Event|5|||
143337051|NCT00658567|516778152|FG001|Overall Study|Adverse Event|2|||
143337052|NCT00658567|516778153|FG002|Overall Study|Adverse Event|3|||
143337053|NCT00658567|516778151|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
143337054|NCT00658567|516778152|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
143337055|NCT00658567|516778153|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
143337056|NCT00658567|516778151|FG000|Overall Study|Physician Decision|0|||
143337057|NCT00658567|516778152|FG001|Overall Study|Physician Decision|1|||
143337058|NCT00658567|516778153|FG002|Overall Study|Physician Decision|0|||
143337059|NCT00658567|516778151|FG000|Overall Study|At Discretion of Sponsor|1|||
143337060|NCT00658567|516778152|FG001|Overall Study|At Discretion of Sponsor|1|||
143337061|NCT00658567|516778153|FG002|Overall Study|At Discretion of Sponsor|1|||
143337062|NCT01281644|516778154|FG000|Overall Study|Lost to Follow-up|3|||
143337063|NCT01281644|516778154|FG000|Overall Study|Withdrawal by Subject|2|||
143337064|NCT00691938|516778155|FG000|Overall Study|QTc prolongation|1|||
143337065|NCT00691938|516778156|FG001|Overall Study|QTc prolongation|0|||
143337066|NCT00691938|516778157|FG002|Overall Study|QTc prolongation|0|||
143337067|NCT00691938|516778158|FG003|Overall Study|QTc prolongation|0|||
143337068|NCT00691938|516778159|FG004|Overall Study|QTc prolongation|0|||
143337069|NCT00691938|516778160|FG005|Overall Study|QTc prolongation|0|||
143337070|NCT00691938|516778161|FG006|Overall Study|QTc prolongation|0|||
143337071|NCT04555096|516778166|FG000|Overall Study|Death|4|||
143337072|NCT04555096|516778167|FG001|Overall Study|Death|4|||
143337073|NCT04555096|516778166|FG000|Overall Study|Withdrawal by Subject|1|||
143337074|NCT04555096|516778167|FG001|Overall Study|Withdrawal by Subject|0|||
143337075|NCT04555096|516778166|FG000|Overall Study|Other|0|||
143337076|NCT04555096|516778167|FG001|Overall Study|Other|1|||
143337077|NCT03292146|516778174|FG000|Baseline to 12 months|Relocation|1|||
143337078|NCT03292146|516778175|FG001|Baseline to 12 months|Relocation|0|||
143337079|NCT03292146|516778174|FG000|Baseline to 12 months|Seeking higher level of care for eating disorder|1|||
143337080|NCT03292146|516778175|FG001|Baseline to 12 months|Seeking higher level of care for eating disorder|0|||
143337081|NCT03292146|516778174|FG000|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|0|||
143337082|NCT03292146|516778175|FG001|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|1|||
143337083|NCT03292146|516778174|FG000|12 months to 24 months|Planning pregnancy|2|||
143337084|NCT03292146|516778175|FG001|12 months to 24 months|Planning pregnancy|2|||
143337085|NCT03292146|516778174|FG000|12 months to 24 months|Personal reasons|1|||
143337086|NCT03292146|516778175|FG001|12 months to 24 months|Personal reasons|0|||
143337087|NCT03292146|516778174|FG000|12 months to 24 months|Lost to Follow-up|0|||
143337088|NCT03292146|516778175|FG001|12 months to 24 months|Lost to Follow-up|1|||
143337089|NCT03039023|516778176|FG000|Overall Study|Withdrawal by Subject|1|||
143337090|NCT03039023|516778177|FG001|Overall Study|Withdrawal by Subject|0|||
143337091|NCT03039023|516778178|FG002|Overall Study|Withdrawal by Subject|1|||
143337092|NCT03039023|516778179|FG003|Overall Study|Withdrawal by Subject|1|||
143337093|NCT03039023|516778180|FG004|Overall Study|Withdrawal by Subject|0|||
143337094|NCT03039023|516778176|FG000|Overall Study|Physician Decision|0|||
143337095|NCT03039023|516778177|FG001|Overall Study|Physician Decision|0|||
143337096|NCT03039023|516778178|FG002|Overall Study|Physician Decision|0|||
143337097|NCT03039023|516778179|FG003|Overall Study|Physician Decision|1|||
143337098|NCT03039023|516778180|FG004|Overall Study|Physician Decision|0|||
143387200|NCT05691452|516965473|FG002|Overall Study|Adverse Event|1|||
143387201|NCT04402489|516965477|FG000|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
143387202|NCT04402489|516965478|FG001|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|1|||
143387203|NCT04402489|516965479|FG002|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
143387204|NCT04402489|516965480|FG003|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
143387205|NCT04402489|516965481|FG004|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
143387206|NCT04402489|516965477|FG000|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|1|||
143387207|NCT04402489|516965478|FG001|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
143387208|NCT04402489|516965479|FG002|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
143387209|NCT04402489|516965480|FG003|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
143387210|NCT04402489|516965481|FG004|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
143387211|NCT04402489|516965477|FG000|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|3|||
143387212|NCT04402489|516965478|FG001|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
143387213|NCT04402489|516965479|FG002|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
143387214|NCT04402489|516965480|FG003|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
143387215|NCT04402489|516965481|FG004|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
143387216|NCT04402489|516965477|FG000|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
143387217|NCT04402489|516965478|FG001|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
143387218|NCT04402489|516965479|FG002|26 Weeks Double-Blind Extension (DBE)|Adverse Event|1|||
143387219|NCT04402489|516965480|FG003|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
143387220|NCT04402489|516965481|FG004|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
143387221|NCT04402489|516965477|FG000|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
143337099|NCT03701399|516778183|FG000|Overall Study|Adverse Event|3|||
143337100|NCT03701399|516778184|FG001|Overall Study|Adverse Event|5|||
143337101|NCT03701399|516778183|FG000|Overall Study|Withdrawal by Subject|6|||
143337102|NCT03701399|516778184|FG001|Overall Study|Withdrawal by Subject|3|||
143337103|NCT03701399|516778183|FG000|Overall Study|Investigators decision|1|||
143337104|NCT03701399|516778184|FG001|Overall Study|Investigators decision|2|||
143337105|NCT03701399|516778183|FG000|Overall Study|Lost to Follow-up|1|||
143337106|NCT03701399|516778184|FG001|Overall Study|Lost to Follow-up|2|||
143387222|NCT04402489|516965478|FG001|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
143387223|NCT04402489|516965479|FG002|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
143387224|NCT04402489|516965480|FG003|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|1|||
143387225|NCT04402489|516965481|FG004|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
143387226|NCT04402489|516965477|FG000|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
143387227|NCT04402489|516965478|FG001|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|1|||
143387228|NCT04402489|516965479|FG002|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|2|||
143387229|NCT04402489|516965480|FG003|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
143387230|NCT04402489|516965481|FG004|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
143387231|NCT05816551|516965489|FG000|Overall Study|Withdrawal by Subject|0|||
143387232|NCT05816551|516965490|FG001|Overall Study|Withdrawal by Subject|1|||
143387233|NCT05816551|516965489|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
143387234|NCT05816551|516965490|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
143387235|NCT03089398|516965493|FG000|Overall Study|Death|4|||
143387236|NCT03089398|516965494|FG001|Overall Study|Death|9|||
143387237|NCT03089398|516965493|FG000|Overall Study|Lost to Follow-up|21|||
143387238|NCT03089398|516965494|FG001|Overall Study|Lost to Follow-up|30|||
143387239|NCT03089398|516965493|FG000|Overall Study|Withdrawal by Subject|2|||
143387240|NCT03089398|516965494|FG001|Overall Study|Withdrawal by Subject|2|||
143387241|NCT02287311|516965502|FG000|Cohort 1: Dose Level 1|Death|2|||
143387242|NCT02287311|516965503|FG001|Cohort 1: Dose Level 1|Death|0|||
143387243|NCT02287311|516965504|FG002|Cohort 1: Dose Level 1|Death|0|||
143387244|NCT02287311|516965505|FG003|Cohort 1: Dose Level 1|Death|3|||
143387245|NCT02287311|516965506|FG004|Cohort 1: Dose Level 1|Death|0|||
143387246|NCT02287311|516965507|FG005|Cohort 1: Dose Level 1|Death|0|||
143387247|NCT02287311|516965508|FG006|Cohort 1: Dose Level 1|Death|1|||
143387248|NCT02287311|516965509|FG007|Cohort 1: Dose Level 1|Death|0|||
143387249|NCT02287311|516965510|FG008|Cohort 1: Dose Level 1|Death|0|||
143387250|NCT02287311|516965502|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
143387251|NCT02287311|516965503|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
143337107|NCT03701399|516778183|FG000|Overall Study|Death|1|||
143337108|NCT03701399|516778184|FG001|Overall Study|Death|1|||
143337109|NCT03701399|516778183|FG000|Overall Study|Randomized but not treated|1|||
143337110|NCT03701399|516778184|FG001|Overall Study|Randomized but not treated|0|||
143387252|NCT02287311|516965504|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
143387253|NCT02287311|516965505|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
143387254|NCT02287311|516965506|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
143337111|NCT04280562|516778185|FG000|Study|Adverse Event|2|||
143387255|NCT02287311|516965507|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
143387256|NCT02287311|516965508|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
143387257|NCT02287311|516965509|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
143387258|NCT02287311|516965510|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
143387259|NCT02287311|516965502|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
143387260|NCT02287311|516965503|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
143387261|NCT02287311|516965504|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
143387262|NCT02287311|516965505|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
143387263|NCT02287311|516965506|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
143387264|NCT02287311|516965507|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
143387265|NCT02287311|516965508|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
143387266|NCT02287311|516965509|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
143387267|NCT02287311|516965510|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
143387268|NCT02287311|516965502|FG000|Cohort 2: Dose Level 2|Death|0|||
143387269|NCT02287311|516965503|FG001|Cohort 2: Dose Level 2|Death|2|||
143387270|NCT02287311|516965504|FG002|Cohort 2: Dose Level 2|Death|0|||
143387271|NCT02287311|516965505|FG003|Cohort 2: Dose Level 2|Death|0|||
143387272|NCT02287311|516965506|FG004|Cohort 2: Dose Level 2|Death|2|||
143387273|NCT02287311|516965507|FG005|Cohort 2: Dose Level 2|Death|0|||
143387274|NCT02287311|516965508|FG006|Cohort 2: Dose Level 2|Death|0|||
143387275|NCT02287311|516965509|FG007|Cohort 2: Dose Level 2|Death|2|||
143387276|NCT02287311|516965510|FG008|Cohort 2: Dose Level 2|Death|0|||
143387277|NCT02287311|516965502|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
143387278|NCT02287311|516965503|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
143387279|NCT02287311|516965504|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
143387280|NCT02287311|516965505|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
143387281|NCT02287311|516965506|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
143387282|NCT02287311|516965507|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
143387283|NCT02287311|516965508|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
143387284|NCT02287311|516965509|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
143387285|NCT02287311|516965510|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
143387286|NCT02287311|516965502|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
143387287|NCT02287311|516965503|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
143387288|NCT02287311|516965504|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
143387289|NCT02287311|516965505|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
143387290|NCT02287311|516965506|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
143387291|NCT02287311|516965507|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
143387292|NCT02287311|516965508|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
143387293|NCT02287311|516965509|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
143387294|NCT02287311|516965510|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
143387295|NCT02287311|516965502|FG000|Cohort 3: Dose Level 3|Death|0|||
143387296|NCT02287311|516965503|FG001|Cohort 3: Dose Level 3|Death|0|||
143387297|NCT02287311|516965504|FG002|Cohort 3: Dose Level 3|Death|4|||
143387298|NCT02287311|516965505|FG003|Cohort 3: Dose Level 3|Death|0|||
143387299|NCT02287311|516965506|FG004|Cohort 3: Dose Level 3|Death|0|||
143387300|NCT02287311|516965507|FG005|Cohort 3: Dose Level 3|Death|4|||
143387301|NCT02287311|516965508|FG006|Cohort 3: Dose Level 3|Death|0|||
143387302|NCT02287311|516965509|FG007|Cohort 3: Dose Level 3|Death|0|||
143387303|NCT02287311|516965510|FG008|Cohort 3: Dose Level 3|Death|2|||
143387304|NCT02287311|516965502|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
143387305|NCT02287311|516965503|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
143387306|NCT02287311|516965504|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
143387307|NCT02287311|516965505|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
143387308|NCT02287311|516965506|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
143387309|NCT02287311|516965507|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
143387310|NCT02287311|516965508|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
143387311|NCT02287311|516965509|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
143387312|NCT02287311|516965510|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
143387313|NCT02287311|516965502|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
143387314|NCT02287311|516965503|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
143387315|NCT02287311|516965504|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
143387316|NCT02287311|516965505|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
143387317|NCT02287311|516965506|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
143387318|NCT02287311|516965507|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
143387319|NCT02287311|516965508|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
143387320|NCT02287311|516965509|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
143387321|NCT02287311|516965510|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
143387322|NCT03896516|516965511|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
143387323|NCT03896516|516965512|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
143387324|NCT03896516|516965511|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
143387325|NCT03896516|516965512|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
143387326|NCT03896516|516965511|FG000|Washout Period|Physician Decision|3|||
143387327|NCT03896516|516965512|FG001|Washout Period|Physician Decision|1|||
143387328|NCT03896516|516965511|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
143387329|NCT03896516|516965512|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
143387330|NCT03648840|516965517|FG000|First IV Infusion Session|Adverse Event|0|||
143387331|NCT03648840|516965518|FG001|First IV Infusion Session|Adverse Event|2|||
143387332|NCT03648840|516965517|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
143387333|NCT03648840|516965518|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
143387334|NCT03648840|516965517|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
143387335|NCT03648840|516965518|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
143387336|NCT03648840|516965517|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
143387337|NCT03648840|516965518|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
143387338|NCT05418296|516965522|FG000|Overall Study|Withdrawal by Subject|4|||
143387339|NCT05418296|516965523|FG001|Overall Study|Withdrawal by Subject|1|||
143387340|NCT05063994|516965524|FG000|Cortef Run-In|Withdrawal of Consent|1|||
143387341|NCT05063994|516965525|FG001|Cortef Run-In|Withdrawal of Consent|0|||
143387342|NCT05063994|516965526|FG002|Cortef Run-In|Withdrawal of Consent|0|||
143387343|NCT05063994|516965524|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
143387344|NCT05063994|516965525|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
143387345|NCT05063994|516965526|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
143387346|NCT05063994|516965524|FG000|Treatment|Physician Decision|0|||
143387347|NCT05063994|516965525|FG001|Treatment|Physician Decision|0|||
143387348|NCT05063994|516965526|FG002|Treatment|Physician Decision|1|||
143387349|NCT05063994|516965524|FG000|Treatment|Withdrawal by Subject|0|||
143387350|NCT05063994|516965525|FG001|Treatment|Withdrawal by Subject|0|||
143387351|NCT05063994|516965526|FG002|Treatment|Withdrawal by Subject|1|||
143387352|NCT05063994|516965524|FG000|Treatment|Withdrawal of Consent|0|||
143387353|NCT05063994|516965525|FG001|Treatment|Withdrawal of Consent|0|||
143387354|NCT05063994|516965526|FG002|Treatment|Withdrawal of Consent|1|||
143387355|NCT04630262|516965534|FG000|Overall Study|Intraoperative Screen Failure|5|||
143387356|NCT04630262|516965534|FG000|Overall Study|Study terminated prematurely|71|||
143387357|NCT04630262|516965534|FG000|Overall Study|Withdrawal by Subject|2|||
143387358|NCT04630262|516965534|FG000|Overall Study|Physician Decision|2|||
143387359|NCT03692676|516965536|FG000|Overall Study|exclude patients with prior use|4424|||
143387360|NCT03692676|516965537|FG001|Overall Study|exclude patients with prior use|24726|||
143387361|NCT03692676|516965538|FG002|Overall Study|exclude patients with prior use|0|||
143387362|NCT03692676|516965539|FG003|Overall Study|exclude patients with prior use|0|||
143387363|NCT03692676|516965536|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
143387364|NCT03692676|516965537|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
143387365|NCT03692676|516965538|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
143387366|NCT03692676|516965539|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
143387367|NCT03692676|516965536|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
143387368|NCT03692676|516965537|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
143387369|NCT03692676|516965538|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
143387370|NCT03692676|516965539|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
143387371|NCT03692676|516965536|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
143387372|NCT03692676|516965537|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
143387373|NCT03692676|516965538|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
143387374|NCT03692676|516965539|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
143387375|NCT03692676|516965536|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
143387376|NCT03692676|516965537|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
143387377|NCT03692676|516965538|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
143387378|NCT03692676|516965539|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
143387379|NCT03692676|516965536|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
143387380|NCT03692676|516965537|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
143387381|NCT03692676|516965538|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
143387382|NCT03692676|516965539|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
143387383|NCT03692676|516965536|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
143387384|NCT03692676|516965537|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
143387385|NCT03692676|516965538|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
143387386|NCT03692676|516965539|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
143387387|NCT03692676|516965536|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
143387388|NCT03692676|516965537|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
143387389|NCT03692676|516965538|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
143387390|NCT03692676|516965539|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
143387391|NCT03692676|516965536|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
143387392|NCT03692676|516965537|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
143387393|NCT03692676|516965538|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
143387394|NCT03692676|516965539|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
143387395|NCT03692676|516965536|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
143387396|NCT03692676|516965537|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
143387397|NCT03692676|516965538|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
143387398|NCT03692676|516965539|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
143387399|NCT03692676|516965536|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
143387400|NCT03692676|516965537|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
143387401|NCT03692676|516965538|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
143387402|NCT03692676|516965539|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
143387403|NCT03692676|516965536|FG000|Overall Study|Other|0|||
143387404|NCT03692676|516965537|FG001|Overall Study|Other|805|||
143387405|NCT03692676|516965538|FG002|Overall Study|Other|758|||
143387406|NCT03692676|516965539|FG003|Overall Study|Other|277|||
143387407|NCT03692676|516965536|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
143387408|NCT03692676|516965537|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
143387409|NCT03692676|516965538|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
143387410|NCT03692676|516965539|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
143387411|NCT03692611|516965540|FG000|Overall Study|Found to be ineligible postrandomization|3|||
143387412|NCT03692611|516965541|FG001|Overall Study|Found to be ineligible postrandomization|0|||
143387413|NCT03988634|516965547|FG000|Double-Blind|Adverse Event|4|||
143387414|NCT03988634|516965548|FG001|Double-Blind|Adverse Event|0|||
143387415|NCT03988634|516965549|FG002|Double-Blind|Adverse Event|0|||
143387416|NCT03988634|516965547|FG000|Double-Blind|Death|18|||
143387417|NCT03988634|516965548|FG001|Double-Blind|Death|26|||
143387418|NCT03988634|516965549|FG002|Double-Blind|Death|0|||
143387419|NCT03988634|516965547|FG000|Double-Blind|Lost to Follow-up|6|||
143387420|NCT03988634|516965548|FG001|Double-Blind|Lost to Follow-up|7|||
143387421|NCT03988634|516965549|FG002|Double-Blind|Lost to Follow-up|0|||
143387422|NCT03988634|516965547|FG000|Double-Blind|Physician Decision|9|||
143387423|NCT03988634|516965548|FG001|Double-Blind|Physician Decision|5|||
143387424|NCT03988634|516965549|FG002|Double-Blind|Physician Decision|0|||
143387425|NCT03988634|516965547|FG000|Double-Blind|Subject decision|24|||
143387426|NCT03988634|516965548|FG001|Double-Blind|Subject decision|13|||
143387427|NCT03988634|516965549|FG002|Double-Blind|Subject decision|0|||
143387428|NCT03988634|516965547|FG000|Open-Label|Adverse Event|0|||
143387429|NCT03988634|516965548|FG001|Open-Label|Adverse Event|0|||
143387430|NCT03988634|516965549|FG002|Open-Label|Adverse Event|7|||
143387431|NCT03988634|516965547|FG000|Open-Label|Physician Decision|0|||
143387432|NCT03988634|516965548|FG001|Open-Label|Physician Decision|0|||
143387433|NCT03988634|516965549|FG002|Open-Label|Physician Decision|1|||
143387434|NCT03988634|516965547|FG000|Open-Label|Technical problems|0|||
143387435|NCT03988634|516965548|FG001|Open-Label|Technical problems|0|||
143387436|NCT03988634|516965549|FG002|Open-Label|Technical problems|1|||
143387437|NCT05406921|516965550|FG000|Overall Study|Withdrawal by Subject|25|||
143387438|NCT05406921|516965551|FG001|Overall Study|Withdrawal by Subject|0|||
143387439|NCT05406921|516965552|FG002|Overall Study|Withdrawal by Subject|25|||
143387440|NCT05406921|516965550|FG000|Overall Study|Protocol Violation|0|||
143387441|NCT05406921|516965551|FG001|Overall Study|Protocol Violation|12|||
143387442|NCT05406921|516965552|FG002|Overall Study|Protocol Violation|0|||
143387443|NCT04831281|516965557|FG000|Overall Study|Adverse Event|1|||
143387444|NCT04831281|516965558|FG001|Overall Study|Adverse Event|0|||
143387445|NCT04831281|516965559|FG002|Overall Study|Adverse Event|3|||
143387446|NCT04831281|516965557|FG000|Overall Study|Withdrawal by Subject|0|||
143387447|NCT04831281|516965558|FG001|Overall Study|Withdrawal by Subject|1|||
143387448|NCT04831281|516965559|FG002|Overall Study|Withdrawal by Subject|2|||
143387449|NCT04831281|516965557|FG000|Overall Study|Undetermined|1|||
143387450|NCT04831281|516965558|FG001|Overall Study|Undetermined|1|||
143387451|NCT04831281|516965559|FG002|Overall Study|Undetermined|0|||
143387452|NCT00616967|516965560|FG000|Overall Study|Withdrawal by Subject|0|||
143387453|NCT00616967|516965561|FG001|Overall Study|Withdrawal by Subject|0|||
143387454|NCT00616967|516965562|FG002|Overall Study|Withdrawal by Subject|1|||
143387455|NCT02910583|516965563|FG000|Overall Study|Death|7|||
143387456|NCT02910583|516965564|FG001|Overall Study|Death|3|||
143387457|NCT02910583|516965563|FG000|Overall Study|Lost to Follow-up|1|||
143387458|NCT02910583|516965564|FG001|Overall Study|Lost to Follow-up|0|||
143387459|NCT02910583|516965563|FG000|Overall Study|Withdrawal by Subject|12|||
143387460|NCT02910583|516965564|FG001|Overall Study|Withdrawal by Subject|8|||
143337112|NCT04280562|516778186|FG001|Study|Adverse Event|0|||
143337113|NCT04280562|516778185|FG000|Study|Lost to Follow-up|3|||
143337114|NCT04280562|516778186|FG001|Study|Lost to Follow-up|3|||
143337115|NCT04559568|516778190|FG000|Overall Study|Physician Decision|0|||
143337116|NCT04559568|516778191|FG001|Overall Study|Physician Decision|0|||
143337117|NCT04559568|516778192|FG002|Overall Study|Physician Decision|0|||
143337118|NCT04559568|516778193|FG003|Overall Study|Physician Decision|0|||
143337119|NCT04559568|516778194|FG004|Overall Study|Physician Decision|0|||
143337120|NCT04559568|516778195|FG005|Overall Study|Physician Decision|0|||
143337121|NCT04559568|516778196|FG006|Overall Study|Physician Decision|0|||
143337122|NCT04559568|516778197|FG007|Overall Study|Physician Decision|0|||
143337123|NCT04559568|516778198|FG008|Overall Study|Physician Decision|0|||
143337124|NCT04559568|516778199|FG009|Overall Study|Physician Decision|1|||
143337125|NCT04559568|516778200|FG010|Overall Study|Physician Decision|0|||
143337126|NCT04559568|516778190|FG000|Overall Study|Withdrawal by Subject|0|||
143337127|NCT04559568|516778191|FG001|Overall Study|Withdrawal by Subject|0|||
143337128|NCT04559568|516778192|FG002|Overall Study|Withdrawal by Subject|0|||
143337129|NCT04559568|516778193|FG003|Overall Study|Withdrawal by Subject|0|||
143337130|NCT04559568|516778194|FG004|Overall Study|Withdrawal by Subject|0|||
143337131|NCT04559568|516778195|FG005|Overall Study|Withdrawal by Subject|0|||
143337132|NCT04559568|516778196|FG006|Overall Study|Withdrawal by Subject|0|||
143337133|NCT04559568|516778197|FG007|Overall Study|Withdrawal by Subject|0|||
143387461|NCT02910583|516965563|FG000|Overall Study|Other, Not Specified|6|||
143387462|NCT02910583|516965564|FG001|Overall Study|Other, Not Specified|3|||
143387463|NCT03393975|516965566|FG000|Urgent Treatment Period|Physician Decision|0|||
143387464|NCT03393975|516965567|FG001|Urgent Treatment Period|Physician Decision|0|||
143387465|NCT03393975|516965568|FG002|Urgent Treatment Period|Physician Decision|0|||
143387466|NCT03393975|516965569|FG003|Urgent Treatment Period|Physician Decision|1|||
143387467|NCT03393975|516965566|FG000|Prophylaxis Period 1|Reason not Specified|0|||
143387468|NCT03393975|516965567|FG001|Prophylaxis Period 1|Reason not Specified|1|||
143387469|NCT03393975|516965568|FG002|Prophylaxis Period 1|Reason not Specified|0|||
143387470|NCT03393975|516965569|FG003|Prophylaxis Period 1|Reason not Specified|0|||
143387471|NCT03393975|516965566|FG000|Prophylaxis Period 2|Reason not Specified|0|||
143387472|NCT03393975|516965567|FG001|Prophylaxis Period 2|Reason not Specified|1|||
143387473|NCT03393975|516965568|FG002|Prophylaxis Period 2|Reason not Specified|0|||
143387474|NCT03393975|516965569|FG003|Prophylaxis Period 2|Reason not Specified|0|||
143387475|NCT04060355|516965573|FG000|Overall Study|Lost to Follow-up|41|||
143387476|NCT02187003|516967045|FG000|Overall Study|Adverse Event|2|||
143387477|NCT02187003|516967046|FG001|Overall Study|Adverse Event|0|||
143387478|NCT02187003|516967045|FG000|Overall Study|Lost to Follow-up|14|||
143387479|NCT02187003|516967046|FG001|Overall Study|Lost to Follow-up|10|||
143387480|NCT02187003|516967045|FG000|Overall Study|Withdrawal by Subject|3|||
143387481|NCT02187003|516967046|FG001|Overall Study|Withdrawal by Subject|7|||
143387482|NCT02187003|516967045|FG000|Overall Study|Protocol Violation|2|||
143387483|NCT02187003|516967046|FG001|Overall Study|Protocol Violation|4|||
143387484|NCT02187003|516967045|FG000|Overall Study|Other|5|||
143387485|NCT02187003|516967046|FG001|Overall Study|Other|5|||
143387486|NCT02187003|516967045|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
143387487|NCT02187003|516967046|FG001|Overall Study|Withdrawal by Parent/Guardian|5|||
143387488|NCT04593472|516967047|FG000|Overall Study|Death|31|||
143387489|NCT04593472|516967048|FG001|Overall Study|Death|27|||
143387490|NCT04593472|516967047|FG000|Overall Study|Withdrawal by Subject|12|||
143387491|NCT04593472|516967048|FG001|Overall Study|Withdrawal by Subject|12|||
143387492|NCT04593472|516967047|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
143387493|NCT04593472|516967048|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
143387494|NCT04593472|516967047|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
143387495|NCT04593472|516967048|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
143387496|NCT04593472|516967047|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
143387497|NCT04593472|516967048|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
143387498|NCT04593472|516967047|FG000|Overall Study|Lost to Follow-up|0|||
143387499|NCT04593472|516967048|FG001|Overall Study|Lost to Follow-up|2|||
143387500|NCT04593472|516967047|FG000|Overall Study|Still collecting 24-month assessment|17|||
143387501|NCT04593472|516967048|FG001|Overall Study|Still collecting 24-month assessment|10|||
143387502|NCT04833777|516967053|FG000|Overall Study|Lost to Follow-up|1|||
143387503|NCT04833777|516967054|FG001|Overall Study|Lost to Follow-up|0|||
143387504|NCT05382936|516967057|FG000|Overall Study|Progressive Disease|3|||
143387505|NCT05382936|516967058|FG001|Overall Study|Progressive Disease|5|||
143387506|NCT05382936|516967059|FG002|Overall Study|Progressive Disease|2|||
143387507|NCT05382936|516967060|FG003|Overall Study|Progressive Disease|5|||
143387508|NCT05382936|516967057|FG000|Overall Study|Adverse Event|0|||
143387509|NCT05382936|516967058|FG001|Overall Study|Adverse Event|1|||
143387510|NCT05382936|516967059|FG002|Overall Study|Adverse Event|1|||
143387511|NCT05382936|516967060|FG003|Overall Study|Adverse Event|0|||
143387512|NCT05382936|516967057|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
143387513|NCT05382936|516967058|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
143387514|NCT05382936|516967059|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
143387515|NCT05382936|516967060|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
143387516|NCT05382936|516967057|FG000|Overall Study|Withdrawal by Subject|0|||
143387517|NCT05382936|516967058|FG001|Overall Study|Withdrawal by Subject|0|||
143387518|NCT05382936|516967059|FG002|Overall Study|Withdrawal by Subject|1|||
143387519|NCT05382936|516967060|FG003|Overall Study|Withdrawal by Subject|1|||
143387520|NCT04490915|516967061|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
143387521|NCT04490915|516967062|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
143387522|NCT04490915|516967061|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
143387523|NCT04490915|516967062|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
143387524|NCT04490915|516967061|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
143387525|NCT04490915|516967062|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
143387526|NCT04490915|516967061|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
143387527|NCT04490915|516967062|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
143387528|NCT04490915|516967061|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
143387529|NCT04490915|516967062|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
143387530|NCT04490915|516967061|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
143387531|NCT04490915|516967062|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
143387532|NCT04490915|516967061|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
143337134|NCT04559568|516778198|FG008|Overall Study|Withdrawal by Subject|0|||
143337135|NCT04559568|516778199|FG009|Overall Study|Withdrawal by Subject|0|||
143337136|NCT04559568|516778200|FG010|Overall Study|Withdrawal by Subject|1|||
143337137|NCT02712905|516778203|FG000|Monotherapy|Death|2|||
143337138|NCT02712905|516778204|FG001|Monotherapy|Death|5|||
143337139|NCT02712905|516778205|FG002|Monotherapy|Death|0|||
143337140|NCT02712905|516778206|FG003|Monotherapy|Death|3|||
143337141|NCT02712905|516778207|FG004|Monotherapy|Death|15|||
143337142|NCT02712905|516778208|FG005|Monotherapy|Death|1|||
143337143|NCT02712905|516778209|FG006|Monotherapy|Death|3|||
143337144|NCT02712905|516778210|FG007|Monotherapy|Death|3|||
143337145|NCT02712905|516778211|FG008|Monotherapy|Death|0|||
143337146|NCT02712905|516778212|FG009|Monotherapy|Death|27|||
143337147|NCT02712905|516778213|FG010|Monotherapy|Death|2|||
143337148|NCT02712905|516778214|FG011|Monotherapy|Death|5|||
143337149|NCT02712905|516778215|FG012|Monotherapy|Death|0|||
143337150|NCT02712905|516778216|FG013|Monotherapy|Death|0|||
143337151|NCT02712905|516778217|FG014|Monotherapy|Death|0|||
143337152|NCT02712905|516778218|FG015|Monotherapy|Death|0|||
143337153|NCT02712905|516778219|FG016|Monotherapy|Death|0|||
143337154|NCT02712905|516778220|FG017|Monotherapy|Death|0|||
143337155|NCT02712905|516778203|FG000|Monotherapy|Lost to Follow-up|0|||
143337156|NCT02712905|516778204|FG001|Monotherapy|Lost to Follow-up|1|||
143337157|NCT02712905|516778205|FG002|Monotherapy|Lost to Follow-up|0|||
143337158|NCT02712905|516778206|FG003|Monotherapy|Lost to Follow-up|1|||
143337159|NCT02712905|516778207|FG004|Monotherapy|Lost to Follow-up|0|||
143337160|NCT02712905|516778208|FG005|Monotherapy|Lost to Follow-up|0|||
143337161|NCT02712905|516778209|FG006|Monotherapy|Lost to Follow-up|0|||
143337162|NCT02712905|516778210|FG007|Monotherapy|Lost to Follow-up|0|||
143337163|NCT02712905|516778211|FG008|Monotherapy|Lost to Follow-up|0|||
143337164|NCT02712905|516778212|FG009|Monotherapy|Lost to Follow-up|2|||
143337165|NCT02712905|516778213|FG010|Monotherapy|Lost to Follow-up|0|||
143337166|NCT02712905|516778214|FG011|Monotherapy|Lost to Follow-up|0|||
143337167|NCT02712905|516778215|FG012|Monotherapy|Lost to Follow-up|0|||
143337168|NCT02712905|516778216|FG013|Monotherapy|Lost to Follow-up|0|||
143337169|NCT02712905|516778217|FG014|Monotherapy|Lost to Follow-up|0|||
143337170|NCT02712905|516778218|FG015|Monotherapy|Lost to Follow-up|0|||
143337171|NCT02712905|516778219|FG016|Monotherapy|Lost to Follow-up|0|||
143337172|NCT02712905|516778220|FG017|Monotherapy|Lost to Follow-up|0|||
143337173|NCT02712905|516778203|FG000|Monotherapy|Physician Decision|1|||
143337174|NCT02712905|516778204|FG001|Monotherapy|Physician Decision|0|||
143337175|NCT02712905|516778205|FG002|Monotherapy|Physician Decision|0|||
143337176|NCT02712905|516778206|FG003|Monotherapy|Physician Decision|1|||
143337177|NCT02712905|516778207|FG004|Monotherapy|Physician Decision|0|||
143337178|NCT02712905|516778208|FG005|Monotherapy|Physician Decision|0|||
143337179|NCT02712905|516778209|FG006|Monotherapy|Physician Decision|0|||
143337180|NCT02712905|516778210|FG007|Monotherapy|Physician Decision|0|||
143337181|NCT02712905|516778211|FG008|Monotherapy|Physician Decision|0|||
143337182|NCT02712905|516778212|FG009|Monotherapy|Physician Decision|1|||
143337183|NCT02712905|516778213|FG010|Monotherapy|Physician Decision|0|||
143337184|NCT02712905|516778214|FG011|Monotherapy|Physician Decision|0|||
143337185|NCT02712905|516778215|FG012|Monotherapy|Physician Decision|0|||
143337186|NCT02712905|516778216|FG013|Monotherapy|Physician Decision|0|||
143337187|NCT02712905|516778217|FG014|Monotherapy|Physician Decision|0|||
143337188|NCT02712905|516778218|FG015|Monotherapy|Physician Decision|0|||
143337189|NCT02712905|516778219|FG016|Monotherapy|Physician Decision|0|||
143337190|NCT02712905|516778220|FG017|Monotherapy|Physician Decision|0|||
143337191|NCT02712905|516778203|FG000|Monotherapy|Study Terminated by Sponsor|0|||
143337192|NCT02712905|516778204|FG001|Monotherapy|Study Terminated by Sponsor|0|||
143337193|NCT02712905|516778205|FG002|Monotherapy|Study Terminated by Sponsor|0|||
143337194|NCT02712905|516778206|FG003|Monotherapy|Study Terminated by Sponsor|0|||
143337195|NCT02712905|516778207|FG004|Monotherapy|Study Terminated by Sponsor|1|||
143337196|NCT02712905|516778208|FG005|Monotherapy|Study Terminated by Sponsor|0|||
143337197|NCT02712905|516778209|FG006|Monotherapy|Study Terminated by Sponsor|0|||
143337198|NCT02712905|516778210|FG007|Monotherapy|Study Terminated by Sponsor|0|||
143337199|NCT02712905|516778211|FG008|Monotherapy|Study Terminated by Sponsor|0|||
143337200|NCT02712905|516778212|FG009|Monotherapy|Study Terminated by Sponsor|2|||
143337201|NCT02712905|516778213|FG010|Monotherapy|Study Terminated by Sponsor|0|||
143337202|NCT02712905|516778214|FG011|Monotherapy|Study Terminated by Sponsor|0|||
143337203|NCT02712905|516778215|FG012|Monotherapy|Study Terminated by Sponsor|0|||
143337204|NCT02712905|516778216|FG013|Monotherapy|Study Terminated by Sponsor|0|||
143337205|NCT02712905|516778217|FG014|Monotherapy|Study Terminated by Sponsor|0|||
143337206|NCT02712905|516778218|FG015|Monotherapy|Study Terminated by Sponsor|0|||
143337207|NCT02712905|516778219|FG016|Monotherapy|Study Terminated by Sponsor|0|||
143337208|NCT02712905|516778220|FG017|Monotherapy|Study Terminated by Sponsor|0|||
143337209|NCT02712905|516778203|FG000|Monotherapy|Withdrawal by Subject|0|||
143337210|NCT02712905|516778204|FG001|Monotherapy|Withdrawal by Subject|0|||
143337211|NCT02712905|516778205|FG002|Monotherapy|Withdrawal by Subject|1|||
143337212|NCT02712905|516778206|FG003|Monotherapy|Withdrawal by Subject|0|||
143337213|NCT02712905|516778207|FG004|Monotherapy|Withdrawal by Subject|2|||
143387533|NCT04490915|516967062|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
143387534|NCT03016169|516967081|FG000|Overall Study|Lost to Follow-up|4|||
143387535|NCT03016169|516967081|FG000|Overall Study|Death|54|||
143387536|NCT03016169|516967081|FG000|Overall Study|Device Explant|11|||
143387537|NCT03016169|516967081|FG000|Overall Study|Withdrawal by Subject|19|||
143387538|NCT03016169|516967081|FG000|Overall Study|Other Reasons|1|||
143387539|NCT03779204|516967082|FG000|Overall Study|Lost to Follow-up|2|||
143387540|NCT03779204|516967083|FG001|Overall Study|Lost to Follow-up|0|||
143387541|NCT04421378|516967084|FG000|Overall Study|Adverse Event|2|||
143387542|NCT04421378|516967085|FG001|Overall Study|Adverse Event|7|||
143387543|NCT04421378|516967086|FG002|Overall Study|Adverse Event|0|||
143387544|NCT04421378|516967087|FG003|Overall Study|Adverse Event|1|||
143387545|NCT04421378|516967088|FG004|Overall Study|Adverse Event|0|||
143387546|NCT04421378|516967084|FG000|Overall Study|Physician Decision|1|||
143387547|NCT04421378|516967085|FG001|Overall Study|Physician Decision|2|||
143387548|NCT04421378|516967086|FG002|Overall Study|Physician Decision|0|||
143387549|NCT04421378|516967087|FG003|Overall Study|Physician Decision|0|||
143387550|NCT04421378|516967088|FG004|Overall Study|Physician Decision|0|||
143387551|NCT04421378|516967084|FG000|Overall Study|Progressive Disease|16|||
143387552|NCT04421378|516967085|FG001|Overall Study|Progressive Disease|4|||
143387553|NCT04421378|516967086|FG002|Overall Study|Progressive Disease|18|||
143387554|NCT04421378|516967087|FG003|Overall Study|Progressive Disease|11|||
143387555|NCT04421378|516967088|FG004|Overall Study|Progressive Disease|3|||
143387556|NCT04421378|516967084|FG000|Overall Study|Study Terminated by Sponsor|0|||
143387557|NCT04421378|516967085|FG001|Overall Study|Study Terminated by Sponsor|1|||
143387558|NCT04421378|516967086|FG002|Overall Study|Study Terminated by Sponsor|1|||
143387559|NCT04421378|516967087|FG003|Overall Study|Study Terminated by Sponsor|0|||
143387560|NCT04421378|516967088|FG004|Overall Study|Study Terminated by Sponsor|0|||
143387561|NCT04421378|516967084|FG000|Overall Study|Withdrawal by Subject|3|||
143387562|NCT04421378|516967085|FG001|Overall Study|Withdrawal by Subject|1|||
143387563|NCT04421378|516967086|FG002|Overall Study|Withdrawal by Subject|0|||
143387564|NCT04421378|516967087|FG003|Overall Study|Withdrawal by Subject|2|||
143387565|NCT04421378|516967088|FG004|Overall Study|Withdrawal by Subject|0|||
143387566|NCT04421378|516967084|FG000|Overall Study|Other|1|||
143387567|NCT04421378|516967085|FG001|Overall Study|Other|0|||
143387568|NCT04421378|516967086|FG002|Overall Study|Other|0|||
143387569|NCT04421378|516967087|FG003|Overall Study|Other|0|||
143387570|NCT04421378|516967088|FG004|Overall Study|Other|0|||
143387571|NCT04258709|516967089|FG000|Overall Study|Lost to Follow-up|10|||
143387572|NCT04258709|516967090|FG001|Overall Study|Lost to Follow-up|4|||
143387573|NCT04258709|516967089|FG000|Overall Study|Withdrawal by Subject|1|||
143387574|NCT04258709|516967090|FG001|Overall Study|Withdrawal by Subject|0|||
143387575|NCT04258709|516967089|FG000|Overall Study|Fetal demise|0|||
143387576|NCT04258709|516967090|FG001|Overall Study|Fetal demise|1|||
143387577|NCT04258709|516967089|FG000|Overall Study|Protocol Violation|1|||
143387578|NCT04258709|516967090|FG001|Overall Study|Protocol Violation|1|||
143387579|NCT04263311|516967091|FG000|Overall Study|Lost to Follow-up|1|||
143387580|NCT04263311|516967092|FG001|Overall Study|Lost to Follow-up|2|||
143387581|NCT04263311|516967093|FG002|Overall Study|Lost to Follow-up|0|||
143387582|NCT04263311|516967091|FG000|Overall Study|Health Issues|1|||
143387583|NCT04263311|516967092|FG001|Overall Study|Health Issues|0|||
143387584|NCT04263311|516967093|FG002|Overall Study|Health Issues|0|||
143387585|NCT04263311|516967091|FG000|Overall Study|Left the country|1|||
143387586|NCT04263311|516967092|FG001|Overall Study|Left the country|0|||
143387587|NCT04263311|516967093|FG002|Overall Study|Left the country|0|||
143387588|NCT04263311|516967091|FG000|Overall Study|Unable to maintain time commitment|1|||
143387589|NCT04263311|516967092|FG001|Overall Study|Unable to maintain time commitment|0|||
143387590|NCT04263311|516967093|FG002|Overall Study|Unable to maintain time commitment|0|||
143387591|NCT04263311|516967091|FG000|Overall Study|No longer interested|1|||
143387592|NCT04263311|516967092|FG001|Overall Study|No longer interested|0|||
143387593|NCT04263311|516967093|FG002|Overall Study|No longer interested|0|||
143387594|NCT04263311|516967091|FG000|Overall Study|Ineligible post consent|0|||
143387595|NCT04263311|516967092|FG001|Overall Study|Ineligible post consent|0|||
143387596|NCT04263311|516967093|FG002|Overall Study|Ineligible post consent|5|||
143387597|NCT04673929|516967094|FG000|Overall Study|Death|73|||
143387598|NCT04673929|516967094|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
143387599|NCT03315754|516967095|FG000|Overall Study|COVID-19 complications leading to death|1|||
143387600|NCT03315754|516967095|FG000|Overall Study|insurance coverage issue|1|||
143387601|NCT04024813|516967096|FG000|Overall Study|Study terminated by Sponsor|1|||
143387602|NCT05524233|516967099|FG000|Overall Study|Lost to Follow-up|2|||
143387603|NCT05524233|516967099|FG000|Overall Study|Adverse Event|2|||
143387604|NCT05524233|516967099|FG000|Overall Study|Withdrawal by Subject|1|||
143387605|NCT03453619|516967102|FG000|Core Study (Part A)|Physician Decision|0|||
143387606|NCT03453619|516967103|FG001|Core Study (Part A)|Physician Decision|0|||
143387607|NCT03453619|516967104|FG002|Core Study (Part A)|Physician Decision|2|||
143387608|NCT03453619|516967105|FG003|Core Study (Part A)|Physician Decision|0|||
143387609|NCT03453619|516967102|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
143387610|NCT03453619|516967103|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
143387611|NCT03453619|516967104|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
143387612|NCT03453619|516967105|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
143387613|NCT03453619|516967102|FG000|Core Study (Part A)|Other|0|||
143387614|NCT03453619|516967103|FG001|Core Study (Part A)|Other|1|||
143387615|NCT03453619|516967104|FG002|Core Study (Part A)|Other|0|||
143387616|NCT03453619|516967105|FG003|Core Study (Part A)|Other|0|||
143387617|NCT03453619|516967102|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
143387618|NCT03453619|516967103|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
143387619|NCT03453619|516967104|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
143387620|NCT03453619|516967105|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
143387621|NCT03453619|516967102|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
143387622|NCT03453619|516967103|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
143387623|NCT03453619|516967104|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
143387624|NCT03453619|516967105|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
143387625|NCT03453619|516967102|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
143387626|NCT03453619|516967103|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
143387627|NCT03453619|516967104|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
143387628|NCT03453619|516967105|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
143387629|NCT03453619|516967102|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
143387630|NCT03453619|516967103|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
143387631|NCT03453619|516967104|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
143387632|NCT03453619|516967105|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
143387633|NCT00170573|516967107|FG000|Overall Study|Violation of inclusion criteria|13|||
143387634|NCT04556656|516967109|FG000|Overall Study|Withdrawal by Subject|14|||
143387635|NCT04556656|516967110|FG001|Overall Study|Withdrawal by Subject|12|||
143387636|NCT04556656|516967109|FG000|Overall Study|Physician Decision|1|||
143387637|NCT04556656|516967110|FG001|Overall Study|Physician Decision|0|||
143387638|NCT04556656|516967109|FG000|Overall Study|Adverse Event|4|||
143387639|NCT04556656|516967110|FG001|Overall Study|Adverse Event|7|||
143387640|NCT04556656|516967109|FG000|Overall Study|Death|4|||
143387641|NCT04556656|516967110|FG001|Overall Study|Death|0|||
143387642|NCT04556656|516967109|FG000|Overall Study|Lost to Follow-up|3|||
143387643|NCT04556656|516967110|FG001|Overall Study|Lost to Follow-up|2|||
143387644|NCT04556656|516967109|FG000|Overall Study|Not further specified|2|||
143387645|NCT04556656|516967110|FG001|Overall Study|Not further specified|1|||
143387646|NCT05536440|516967111|FG000|Overall Study|Adverse Event|0|||
143387647|NCT05536440|516967112|FG001|Overall Study|Adverse Event|0|||
143387648|NCT05536440|516967113|FG002|Overall Study|Adverse Event|0|||
143387649|NCT05536440|516967114|FG003|Overall Study|Adverse Event|0|||
143387650|NCT05536440|516967115|FG004|Overall Study|Adverse Event|0|||
143387651|NCT05536440|516967116|FG005|Overall Study|Adverse Event|0|||
143387652|NCT05536440|516967117|FG006|Overall Study|Adverse Event|0|||
143387653|NCT05536440|516967118|FG007|Overall Study|Adverse Event|0|||
143387654|NCT05536440|516967119|FG008|Overall Study|Adverse Event|1|||
143387655|NCT01566695|516967120|FG000|Overall Study|Lack of Efficacy|1|||
143387656|NCT01566695|516967121|FG001|Overall Study|Lack of Efficacy|0|||
143387657|NCT01566695|516967120|FG000|Overall Study|Adverse Event|3|||
143387658|NCT01566695|516967121|FG001|Overall Study|Adverse Event|0|||
143387659|NCT01566695|516967120|FG000|Overall Study|Death|79|||
143387660|NCT01566695|516967121|FG001|Overall Study|Death|86|||
143387661|NCT01566695|516967120|FG000|Overall Study|Withdrawal by Subject|13|||
143387662|NCT01566695|516967121|FG001|Overall Study|Withdrawal by Subject|12|||
143387663|NCT01566695|516967120|FG000|Overall Study|Lost to Follow-up|0|||
143387664|NCT01566695|516967121|FG001|Overall Study|Lost to Follow-up|3|||
143387665|NCT01566695|516967120|FG000|Overall Study|Other reasons|11|||
143387666|NCT01566695|516967121|FG001|Overall Study|Other reasons|8|||
143387667|NCT05470400|516967122|FG000|Overall Study|Lost to Follow-up|0|||
143387668|NCT05470400|516967123|FG001|Overall Study|Lost to Follow-up|0|||
143387669|NCT05470400|516967124|FG002|Overall Study|Lost to Follow-up|0|||
143387670|NCT05470400|516967125|FG003|Overall Study|Lost to Follow-up|0|||
143387671|NCT05470400|516967126|FG004|Overall Study|Lost to Follow-up|0|||
143387672|NCT05470400|516967127|FG005|Overall Study|Lost to Follow-up|0|||
143387673|NCT05470400|516967128|FG006|Overall Study|Lost to Follow-up|0|||
143387674|NCT05470400|516967129|FG007|Overall Study|Lost to Follow-up|1|||
143387675|NCT05470400|516967122|FG000|Overall Study|Withdrawal by Subject|1|||
143387676|NCT05470400|516967123|FG001|Overall Study|Withdrawal by Subject|0|||
143387677|NCT05470400|516967124|FG002|Overall Study|Withdrawal by Subject|0|||
143387678|NCT05470400|516967125|FG003|Overall Study|Withdrawal by Subject|0|||
143387679|NCT05470400|516967126|FG004|Overall Study|Withdrawal by Subject|0|||
143387680|NCT05470400|516967127|FG005|Overall Study|Withdrawal by Subject|1|||
143387681|NCT05470400|516967128|FG006|Overall Study|Withdrawal by Subject|0|||
143387682|NCT05470400|516967129|FG007|Overall Study|Withdrawal by Subject|2|||
143387683|NCT03846505|516967140|FG000|Treatment Phase|Withdrawal by Subject|9|||
143387684|NCT03846505|516967141|FG001|Treatment Phase|Withdrawal by Subject|11|||
143387685|NCT03846505|516967140|FG000|Treatment Phase|Lost to Follow-up|6|||
143387686|NCT03846505|516967141|FG001|Treatment Phase|Lost to Follow-up|2|||
143387687|NCT03846505|516967140|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
143387688|NCT03846505|516967141|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
143387689|NCT03846505|516967140|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
143387690|NCT03846505|516967141|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
143387691|NCT05569252|516967142|FG000|Overall Study|Adverse event (central vision loss)|1|||
143387692|NCT05569252|516967143|FG001|Overall Study|Adverse event (central vision loss)|0|||
143387693|NCT05569252|516967144|FG002|Overall Study|Adverse event (central vision loss)|0|||
143387694|NCT05569252|516967145|FG003|Overall Study|Adverse event (central vision loss)|0|||
143387695|NCT03665597|516967146|FG000|Period 1|Adverse Event|1|||
143387696|NCT03665597|516967147|FG001|Period 1|Adverse Event|0|||
143387697|NCT03665597|516967148|FG002|Period 1|Adverse Event|0|||
143387698|NCT03665597|516967149|FG003|Period 1|Adverse Event|1|||
143387699|NCT03665597|516967150|FG004|Period 1|Adverse Event|0|||
143387700|NCT03665597|516967151|FG005|Period 1|Adverse Event|0|||
143387701|NCT03665597|516967152|FG006|Period 1|Adverse Event|0|||
143387702|NCT03665597|516967146|FG000|Period 1|Screen Failure|0|||
143387703|NCT03665597|516967147|FG001|Period 1|Screen Failure|0|||
143387704|NCT03665597|516967148|FG002|Period 1|Screen Failure|0|||
143387705|NCT03665597|516967149|FG003|Period 1|Screen Failure|1|||
143387706|NCT03665597|516967150|FG004|Period 1|Screen Failure|0|||
143387707|NCT03665597|516967151|FG005|Period 1|Screen Failure|0|||
143387708|NCT03665597|516967152|FG006|Period 1|Screen Failure|0|||
143387709|NCT03665597|516967146|FG000|Period 1|Death|0|||
143387710|NCT03665597|516967147|FG001|Period 1|Death|0|||
143387711|NCT03665597|516967148|FG002|Period 1|Death|0|||
143387712|NCT03665597|516967149|FG003|Period 1|Death|0|||
143387713|NCT03665597|516967150|FG004|Period 1|Death|0|||
143387714|NCT03665597|516967151|FG005|Period 1|Death|0|||
143387715|NCT03665597|516967152|FG006|Period 1|Death|45|||
143387716|NCT03665597|516967146|FG000|Period 1|Withdrawal by Subject|0|||
143387717|NCT03665597|516967147|FG001|Period 1|Withdrawal by Subject|0|||
143387718|NCT03665597|516967148|FG002|Period 1|Withdrawal by Subject|0|||
143387719|NCT03665597|516967149|FG003|Period 1|Withdrawal by Subject|0|||
143387720|NCT03665597|516967150|FG004|Period 1|Withdrawal by Subject|0|||
143387721|NCT03665597|516967151|FG005|Period 1|Withdrawal by Subject|0|||
143387722|NCT03665597|516967152|FG006|Period 1|Withdrawal by Subject|5|||
143387723|NCT03665597|516967146|FG000|Period 2|Adverse Event|0|||
143387724|NCT03665597|516967147|FG001|Period 2|Adverse Event|0|||
143387725|NCT03665597|516967148|FG002|Period 2|Adverse Event|0|||
143387726|NCT03665597|516967149|FG003|Period 2|Adverse Event|0|||
143387727|NCT03665597|516967150|FG004|Period 2|Adverse Event|0|||
143387728|NCT03665597|516967151|FG005|Period 2|Adverse Event|1|||
143387729|NCT03665597|516967152|FG006|Period 2|Adverse Event|0|||
143387730|NCT03665597|516967146|FG000|Period 3|Adverse Event|0|||
143387731|NCT03665597|516967147|FG001|Period 3|Adverse Event|1|||
143387732|NCT03665597|516967148|FG002|Period 3|Adverse Event|0|||
143387733|NCT03665597|516967149|FG003|Period 3|Adverse Event|0|||
143387734|NCT03665597|516967150|FG004|Period 3|Adverse Event|0|||
143387735|NCT03665597|516967151|FG005|Period 3|Adverse Event|0|||
143387736|NCT03665597|516967152|FG006|Period 3|Adverse Event|0|||
143387737|NCT03665597|516967146|FG000|Period 3|Death|0|||
143387738|NCT03665597|516967147|FG001|Period 3|Death|0|||
143387739|NCT03665597|516967148|FG002|Period 3|Death|0|||
143387740|NCT03665597|516967149|FG003|Period 3|Death|0|||
143387741|NCT03665597|516967150|FG004|Period 3|Death|1|||
143387742|NCT03665597|516967151|FG005|Period 3|Death|0|||
143387743|NCT03665597|516967152|FG006|Period 3|Death|0|||
143387744|NCT03665597|516967146|FG000|Period 4|Adverse Event|2|||
143387745|NCT03665597|516967147|FG001|Period 4|Adverse Event|2|||
143387746|NCT03665597|516967148|FG002|Period 4|Adverse Event|2|||
143387747|NCT03665597|516967149|FG003|Period 4|Adverse Event|2|||
143387748|NCT03665597|516967150|FG004|Period 4|Adverse Event|1|||
143387749|NCT03665597|516967151|FG005|Period 4|Adverse Event|0|||
143387750|NCT03665597|516967152|FG006|Period 4|Adverse Event|0|||
143387751|NCT03665597|516967146|FG000|Period 4|Death|0|||
143387752|NCT03665597|516967147|FG001|Period 4|Death|0|||
143387753|NCT03665597|516967148|FG002|Period 4|Death|2|||
143387754|NCT03665597|516967149|FG003|Period 4|Death|0|||
143387755|NCT03665597|516967150|FG004|Period 4|Death|0|||
143387756|NCT03665597|516967151|FG005|Period 4|Death|0|||
143387757|NCT03665597|516967152|FG006|Period 4|Death|0|||
143387758|NCT03665597|516967146|FG000|Period 4|Physician Decision|1|||
143387759|NCT03665597|516967147|FG001|Period 4|Physician Decision|2|||
143387760|NCT03665597|516967148|FG002|Period 4|Physician Decision|0|||
143387761|NCT03665597|516967149|FG003|Period 4|Physician Decision|0|||
143387762|NCT03665597|516967150|FG004|Period 4|Physician Decision|0|||
143387763|NCT03665597|516967151|FG005|Period 4|Physician Decision|0|||
143387764|NCT03665597|516967152|FG006|Period 4|Physician Decision|0|||
143387765|NCT05481320|516967156|FG000|Overall Study|Withdrawal by Subject|1|||
143387766|NCT05481320|516967157|FG001|Overall Study|Withdrawal by Subject|1|||
143387767|NCT05481320|516967156|FG000|Overall Study|Care recipent passed away|0|||
143387768|NCT05481320|516967157|FG001|Overall Study|Care recipent passed away|1|||
143387769|NCT05481320|516967156|FG000|Overall Study|Out-of-window assessment|0|||
143387770|NCT05481320|516967157|FG001|Overall Study|Out-of-window assessment|1|||
143387771|NCT05481320|516967156|FG000|Overall Study|No longer a primary caregiver|3|||
143387772|NCT05481320|516967157|FG001|Overall Study|No longer a primary caregiver|0|||
143387773|NCT05481320|516967156|FG000|Overall Study|Unable to contact|1|||
143387774|NCT05481320|516967157|FG001|Overall Study|Unable to contact|0|||
143387775|NCT05319860|516967161|FG000|Overall Study|Death|1|||
143387776|NCT05319860|516967162|FG001|Overall Study|Death|1|||
143387777|NCT05319860|516967161|FG000|Overall Study|Lost to Follow-up|3|||
143387778|NCT05319860|516967162|FG001|Overall Study|Lost to Follow-up|1|||
143387779|NCT05319860|516967161|FG000|Overall Study|Withdrawal by Subject|1|||
143387780|NCT05319860|516967162|FG001|Overall Study|Withdrawal by Subject|7|||
143387781|NCT04314895|516967163|FG000|Overall Study|Lost to Follow-up|1|||
143387782|NCT04314895|516967163|FG000|Overall Study|Death|10|||
143387783|NCT04314895|516967163|FG000|Overall Study|Physician Decision|2|||
143387784|NCT03361748|516967167|FG000|Overall Study|Death|77|||
143387785|NCT03361748|516967167|FG000|Overall Study|Lost to Follow-up|4|||
143387786|NCT03361748|516967167|FG000|Overall Study|Withdrawal by Subject|20|||
143387787|NCT02596126|516967169|FG000|Overall Study|Lost to Follow-up|12|||
143387788|NCT02596126|516967170|FG001|Overall Study|Lost to Follow-up|21|||
143387789|NCT02596126|516967169|FG000|Overall Study|Protocol Violation|7|||
143387790|NCT02596126|516967170|FG001|Overall Study|Protocol Violation|9|||
143387791|NCT05792423|516967179|FG000|Overall Study|Withdrawal by Subject|2|||
143387792|NCT02471638|516967180|FG000|Overall Study|Early Term Withdrawal|10|||
143387793|NCT04083235|516969131|FG000|Overall Study|Death|252|||
143387794|NCT04083235|516969132|FG001|Overall Study|Death|277|||
143387795|NCT04083235|516969131|FG000|Overall Study|Withdrawal by Subject|13|||
143387796|NCT04083235|516969132|FG001|Overall Study|Withdrawal by Subject|17|||
143387797|NCT04083235|516969131|FG000|Overall Study|Lost to Follow-up|1|||
143387798|NCT04083235|516969132|FG001|Overall Study|Lost to Follow-up|1|||
143387799|NCT04083235|516969131|FG000|Overall Study|Does not meet entry criteria|1|||
143387800|NCT04083235|516969132|FG001|Overall Study|Does not meet entry criteria|0|||
143387801|NCT04083235|516969131|FG000|Overall Study|Did not receive treatment|13|||
143387802|NCT04083235|516969132|FG001|Overall Study|Did not receive treatment|8|||
143387803|NCT04083235|516969131|FG000|Overall Study|Ongoing at the time of DCO|44|||
143387804|NCT04083235|516969132|FG001|Overall Study|Ongoing at the time of DCO|7|||
143387805|NCT02724878|516969134|FG000|Overall Study|Still on Active Therapy|15|||
143387806|NCT02724878|516969134|FG000|Overall Study|Disease Progression|31|||
143387807|NCT02724878|516969134|FG000|Overall Study|Toxicity|5|||
143387808|NCT02724878|516969134|FG000|Overall Study|Death|1|||
143387809|NCT02724878|516969134|FG000|Overall Study|Withdrawal by Subject|4|||
143387810|NCT02724878|516969134|FG000|Overall Study|Lost to Follow-up|2|||
143387811|NCT02724878|516969134|FG000|Overall Study|Protocol Violation|1|||
143387812|NCT02724878|516969134|FG000|Overall Study|Ineligible for Study Drug|5|||
143387813|NCT02724878|516969134|FG000|Overall Study|not started|1|||
143387814|NCT02927769|516969139|FG000|Induction Phase|Study drug toxicity|1|||
143387815|NCT02927769|516969140|FG001|Induction Phase|Study drug toxicity|1|||
143387816|NCT02927769|516969139|FG000|Induction Phase|Disease progression|0|||
143387817|NCT02927769|516969140|FG001|Induction Phase|Disease progression|1|||
143387818|NCT02927769|516969139|FG000|Intensification Phase|Study drug toxicity|1|||
143387819|NCT02927769|516969140|FG001|Intensification Phase|Study drug toxicity|0|||
143387820|NCT02807636|516969141|FG000|Overall Study|Lost to Follow-up|10|||
143387821|NCT02807636|516969142|FG001|Overall Study|Lost to Follow-up|13|||
143387822|NCT02807636|516969143|FG002|Overall Study|Lost to Follow-up|6|||
143387823|NCT02807636|516969141|FG000|Overall Study|Protocol Deviation|1|||
143387824|NCT02807636|516969142|FG001|Overall Study|Protocol Deviation|0|||
143387825|NCT02807636|516969143|FG002|Overall Study|Protocol Deviation|0|||
143387826|NCT02807636|516969141|FG000|Overall Study|Symptomatic Deterioration|0|||
143387827|NCT02807636|516969142|FG001|Overall Study|Symptomatic Deterioration|1|||
143387828|NCT02807636|516969143|FG002|Overall Study|Symptomatic Deterioration|0|||
143387829|NCT02807636|516969141|FG000|Overall Study|Withdrawal by Subject|39|||
143387830|NCT02807636|516969142|FG001|Overall Study|Withdrawal by Subject|28|||
143387831|NCT02807636|516969143|FG002|Overall Study|Withdrawal by Subject|24|||
143387832|NCT02807636|516969141|FG000|Overall Study|Death|303|||
143387833|NCT02807636|516969142|FG001|Overall Study|Death|332|||
143387834|NCT02807636|516969143|FG002|Overall Study|Death|272|||
143387835|NCT02807636|516969141|FG000|Overall Study|Study Terminated By Sponsor|47|||
143387836|NCT02807636|516969142|FG001|Overall Study|Study Terminated By Sponsor|76|||
143387837|NCT02807636|516969143|FG002|Overall Study|Study Terminated By Sponsor|60|||
143387838|NCT02807636|516969141|FG000|Overall Study|Physician Decision|0|||
143387839|NCT02807636|516969142|FG001|Overall Study|Physician Decision|1|||
143387840|NCT02807636|516969143|FG002|Overall Study|Physician Decision|0|||
143387841|NCT05082909|516969144|FG000|Overall Study|Protocol Violation|0|||
143387842|NCT05082909|516969145|FG001|Overall Study|Protocol Violation|0|||
143387843|NCT05082909|516969146|FG002|Overall Study|Protocol Violation|1|||
143387844|NCT05082909|516969147|FG003|Overall Study|Protocol Violation|0|||
143387845|NCT05082909|516969148|FG004|Overall Study|Protocol Violation|0|||
143387846|NCT05082909|516969149|FG005|Overall Study|Protocol Violation|0|||
143387847|NCT04088630|516969150|FG000|Overall Study|Lost to Follow-up|3|||
143387848|NCT04088630|516969151|FG001|Overall Study|Lost to Follow-up|2|||
143387849|NCT04088630|516969152|FG002|Overall Study|Lost to Follow-up|6|||
143387850|NCT04088630|516969150|FG000|Overall Study|Death|3|||
143387851|NCT04088630|516969151|FG001|Overall Study|Death|1|||
143387852|NCT04088630|516969152|FG002|Overall Study|Death|1|||
143387853|NCT04088630|516969150|FG000|Overall Study|Physician Decision|0|||
143387854|NCT04088630|516969151|FG001|Overall Study|Physician Decision|1|||
143387855|NCT04088630|516969152|FG002|Overall Study|Physician Decision|1|||
143387856|NCT03175029|516969153|FG000|Overall Study|Withdrawal by Subject|2|||
143387857|NCT03175029|516969154|FG001|Overall Study|Withdrawal by Subject|1|||
143387858|NCT03175029|516969153|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
143387859|NCT03175029|516969154|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
143387860|NCT02954341|516969157|FG000|Overall Study|Attempted Implant unsuccessful|5|||
143387861|NCT02954341|516969157|FG000|Overall Study|Death|90|||
143387862|NCT02954341|516969157|FG000|Overall Study|Withdrawal by Subject|4|||
143387863|NCT02954341|516969157|FG000|Overall Study|Physician Decision|13|||
143387864|NCT02954341|516969157|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
143387865|NCT02954341|516969157|FG000|Overall Study|Not implanted due to physician's decision|1|||
143387866|NCT02954341|516969157|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
143387867|NCT05227209|516969160|FG000|Overall Study|Adverse Event|11|||
143387868|NCT05227209|516969160|FG000|Overall Study|Lost to Follow-up|1|||
143387869|NCT05227209|516969160|FG000|Overall Study|Withdrawal by Subject|7|||
143387870|NCT05227209|516969160|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
143387871|NCT05633953|516969161|FG000|Overall Study|Adverse Event|7|||
143387872|NCT05633953|516969161|FG000|Overall Study|Death|30|||
143387873|NCT05633953|516969161|FG000|Overall Study|Lost to Follow-up|1|||
143387874|NCT05633953|516969161|FG000|Overall Study|Osilodrostat discontinued|4|||
143387875|NCT05633953|516969161|FG000|Overall Study|Physician Decision|1|||
143387876|NCT05633953|516969161|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
143387877|NCT05633953|516969161|FG000|Overall Study|Progressive disease|2|||
143387878|NCT02729311|516969162|FG000|Overall Study|Withdrawal by Subject|8|||
143387879|NCT02729311|516969163|FG001|Overall Study|Withdrawal by Subject|2|||
143387880|NCT02287610|516969164|FG000|Overall Study|Lost to Follow-up|3|||
143387881|NCT02287610|516969164|FG000|Overall Study|Withdrawal by Subject|8|||
143387882|NCT02287610|516969164|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
143387883|NCT01426425|516969166|FG000|Overall Study|Exited prior to EP study|22|||
143387884|NCT01426425|516969166|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
143387885|NCT01426425|516969166|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
143387886|NCT00512070|516969174|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
143387887|NCT00512070|516969175|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
143387888|NCT00512070|516969176|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
143337214|NCT02712905|516778208|FG005|Monotherapy|Withdrawal by Subject|0|||
143337215|NCT02712905|516778209|FG006|Monotherapy|Withdrawal by Subject|0|||
143337216|NCT02712905|516778210|FG007|Monotherapy|Withdrawal by Subject|0|||
143337217|NCT02712905|516778211|FG008|Monotherapy|Withdrawal by Subject|0|||
143337218|NCT02712905|516778212|FG009|Monotherapy|Withdrawal by Subject|4|||
143337219|NCT02712905|516778213|FG010|Monotherapy|Withdrawal by Subject|1|||
143337220|NCT02712905|516778214|FG011|Monotherapy|Withdrawal by Subject|2|||
143337221|NCT02712905|516778215|FG012|Monotherapy|Withdrawal by Subject|0|||
143337222|NCT02712905|516778216|FG013|Monotherapy|Withdrawal by Subject|0|||
143337223|NCT02712905|516778217|FG014|Monotherapy|Withdrawal by Subject|0|||
143337224|NCT02712905|516778218|FG015|Monotherapy|Withdrawal by Subject|0|||
143337225|NCT02712905|516778219|FG016|Monotherapy|Withdrawal by Subject|0|||
143337226|NCT02712905|516778220|FG017|Monotherapy|Withdrawal by Subject|0|||
143337227|NCT02712905|516778203|FG000|Monotherapy|Started New Cancer Drug|0|||
143337228|NCT02712905|516778204|FG001|Monotherapy|Started New Cancer Drug|0|||
143337229|NCT02712905|516778205|FG002|Monotherapy|Started New Cancer Drug|0|||
143337230|NCT02712905|516778206|FG003|Monotherapy|Started New Cancer Drug|0|||
143337231|NCT02712905|516778207|FG004|Monotherapy|Started New Cancer Drug|0|||
143337232|NCT02712905|516778208|FG005|Monotherapy|Started New Cancer Drug|1|||
143337233|NCT02712905|516778209|FG006|Monotherapy|Started New Cancer Drug|0|||
143337234|NCT02712905|516778210|FG007|Monotherapy|Started New Cancer Drug|0|||
143337235|NCT02712905|516778211|FG008|Monotherapy|Started New Cancer Drug|0|||
143337236|NCT02712905|516778212|FG009|Monotherapy|Started New Cancer Drug|0|||
143337237|NCT02712905|516778213|FG010|Monotherapy|Started New Cancer Drug|0|||
143337238|NCT02712905|516778214|FG011|Monotherapy|Started New Cancer Drug|0|||
143337239|NCT02712905|516778215|FG012|Monotherapy|Started New Cancer Drug|0|||
143337240|NCT02712905|516778216|FG013|Monotherapy|Started New Cancer Drug|0|||
143337241|NCT02712905|516778217|FG014|Monotherapy|Started New Cancer Drug|0|||
143337242|NCT02712905|516778218|FG015|Monotherapy|Started New Cancer Drug|0|||
143337243|NCT02712905|516778219|FG016|Monotherapy|Started New Cancer Drug|0|||
143337244|NCT02712905|516778220|FG017|Monotherapy|Started New Cancer Drug|0|||
143337245|NCT02712905|516778203|FG000|Monotherapy|Adverse Event|0|||
143337246|NCT02712905|516778204|FG001|Monotherapy|Adverse Event|0|||
143337247|NCT02712905|516778205|FG002|Monotherapy|Adverse Event|0|||
143337248|NCT02712905|516778206|FG003|Monotherapy|Adverse Event|0|||
143337249|NCT02712905|516778207|FG004|Monotherapy|Adverse Event|0|||
143337250|NCT02712905|516778208|FG005|Monotherapy|Adverse Event|0|||
143337251|NCT02712905|516778209|FG006|Monotherapy|Adverse Event|0|||
143337252|NCT02712905|516778210|FG007|Monotherapy|Adverse Event|0|||
143337253|NCT02712905|516778211|FG008|Monotherapy|Adverse Event|1|||
143337254|NCT02712905|516778212|FG009|Monotherapy|Adverse Event|0|||
143337255|NCT02712905|516778213|FG010|Monotherapy|Adverse Event|0|||
143337256|NCT02712905|516778214|FG011|Monotherapy|Adverse Event|0|||
143337257|NCT02712905|516778215|FG012|Monotherapy|Adverse Event|0|||
143337258|NCT02712905|516778216|FG013|Monotherapy|Adverse Event|0|||
143337259|NCT02712905|516778217|FG014|Monotherapy|Adverse Event|0|||
143337260|NCT02712905|516778218|FG015|Monotherapy|Adverse Event|0|||
143337261|NCT02712905|516778219|FG016|Monotherapy|Adverse Event|0|||
143337262|NCT02712905|516778220|FG017|Monotherapy|Adverse Event|0|||
143337263|NCT02712905|516778203|FG000|Combination Therapy|Death|0|||
143337264|NCT02712905|516778204|FG001|Combination Therapy|Death|0|||
143337265|NCT02712905|516778205|FG002|Combination Therapy|Death|0|||
143337266|NCT02712905|516778206|FG003|Combination Therapy|Death|0|||
143337267|NCT02712905|516778207|FG004|Combination Therapy|Death|0|||
143337268|NCT02712905|516778208|FG005|Combination Therapy|Death|0|||
143337269|NCT02712905|516778209|FG006|Combination Therapy|Death|0|||
143337270|NCT02712905|516778210|FG007|Combination Therapy|Death|0|||
143337271|NCT02712905|516778211|FG008|Combination Therapy|Death|0|||
143337272|NCT02712905|516778212|FG009|Combination Therapy|Death|0|||
143337273|NCT02712905|516778213|FG010|Combination Therapy|Death|0|||
143337274|NCT02712905|516778214|FG011|Combination Therapy|Death|0|||
143337275|NCT02712905|516778215|FG012|Combination Therapy|Death|5|||
143337276|NCT02712905|516778216|FG013|Combination Therapy|Death|6|||
143337277|NCT02712905|516778217|FG014|Combination Therapy|Death|1|||
143337278|NCT02712905|516778218|FG015|Combination Therapy|Death|3|||
143337279|NCT02712905|516778219|FG016|Combination Therapy|Death|1|||
143337280|NCT02712905|516778220|FG017|Combination Therapy|Death|3|||
143337281|NCT02712905|516778203|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
143337282|NCT02712905|516778204|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
143337283|NCT02712905|516778205|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
143337284|NCT02712905|516778206|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
143337285|NCT02712905|516778207|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
143337286|NCT02712905|516778208|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
143337287|NCT02712905|516778209|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
143337288|NCT02712905|516778210|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
143337289|NCT02712905|516778211|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
143337290|NCT02712905|516778212|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
143387889|NCT00512070|516969174|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
143387890|NCT00512070|516969175|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
143387891|NCT00512070|516969176|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
143387892|NCT05862870|516969177|FG000|Overall Study|Lost to Follow-up|3|||
143387893|NCT04321031|516969178|FG000|Overall Study|Adverse Event|0|||
143387894|NCT04321031|516969179|FG001|Overall Study|Adverse Event|2|||
143387895|NCT04321031|516969180|FG002|Overall Study|Adverse Event|2|||
143387896|NCT04321031|516969181|FG003|Overall Study|Adverse Event|2|||
143387897|NCT04321031|516969182|FG004|Overall Study|Adverse Event|2|||
143387898|NCT04321031|516969183|FG005|Overall Study|Adverse Event|2|||
143387899|NCT04321031|516969184|FG006|Overall Study|Adverse Event|0|||
143387900|NCT04321031|516969178|FG000|Overall Study|Lost to Follow-up|0|||
143387901|NCT04321031|516969179|FG001|Overall Study|Lost to Follow-up|0|||
143387902|NCT04321031|516969180|FG002|Overall Study|Lost to Follow-up|0|||
143387903|NCT04321031|516969181|FG003|Overall Study|Lost to Follow-up|1|||
143387904|NCT04321031|516969182|FG004|Overall Study|Lost to Follow-up|0|||
143387905|NCT04321031|516969183|FG005|Overall Study|Lost to Follow-up|2|||
143387906|NCT04321031|516969184|FG006|Overall Study|Lost to Follow-up|1|||
143387907|NCT04321031|516969178|FG000|Overall Study|Withdrawal by Subject|2|||
143387908|NCT04321031|516969179|FG001|Overall Study|Withdrawal by Subject|2|||
143387909|NCT04321031|516969180|FG002|Overall Study|Withdrawal by Subject|1|||
143387910|NCT04321031|516969181|FG003|Overall Study|Withdrawal by Subject|3|||
143387911|NCT04321031|516969182|FG004|Overall Study|Withdrawal by Subject|1|||
143387912|NCT04321031|516969183|FG005|Overall Study|Withdrawal by Subject|0|||
143387913|NCT04321031|516969184|FG006|Overall Study|Withdrawal by Subject|1|||
143387914|NCT04321031|516969178|FG000|Overall Study|Non-compliance with study drug|0|||
143387915|NCT04321031|516969179|FG001|Overall Study|Non-compliance with study drug|0|||
143387916|NCT04321031|516969180|FG002|Overall Study|Non-compliance with study drug|0|||
143387917|NCT04321031|516969181|FG003|Overall Study|Non-compliance with study drug|0|||
143387918|NCT04321031|516969182|FG004|Overall Study|Non-compliance with study drug|0|||
143387919|NCT04321031|516969183|FG005|Overall Study|Non-compliance with study drug|1|||
143387920|NCT04321031|516969184|FG006|Overall Study|Non-compliance with study drug|0|||
143387921|NCT04321031|516969178|FG000|Overall Study|Other|0|||
143387922|NCT04321031|516969179|FG001|Overall Study|Other|0|||
143387923|NCT04321031|516969180|FG002|Overall Study|Other|0|||
143387924|NCT04321031|516969181|FG003|Overall Study|Other|1|||
143387925|NCT04321031|516969182|FG004|Overall Study|Other|0|||
143387926|NCT04321031|516969183|FG005|Overall Study|Other|0|||
143387927|NCT04321031|516969184|FG006|Overall Study|Other|0|||
143387928|NCT03143153|516969187|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
143387929|NCT03143153|516969188|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
143387930|NCT03143153|516969189|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
143387931|NCT03143153|516969187|FG000|Pre-Treatment|Participant withdrew consent|0|||
143387932|NCT03143153|516969188|FG001|Pre-Treatment|Participant withdrew consent|1|||
143387933|NCT03143153|516969189|FG002|Pre-Treatment|Participant withdrew consent|12|||
143387934|NCT03143153|516969187|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
143387935|NCT03143153|516969188|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
143387936|NCT03143153|516969189|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
143387937|NCT03143153|516969187|FG000|Pre-Treatment|Other Reasons|1|||
143387938|NCT03143153|516969188|FG001|Pre-Treatment|Other Reasons|2|||
143387939|NCT03143153|516969189|FG002|Pre-Treatment|Other Reasons|1|||
143387940|NCT03143153|516969187|FG000|Pre-Treatment|Disease Progression|1|||
143387941|NCT03143153|516969188|FG001|Pre-Treatment|Disease Progression|1|||
143387942|NCT03143153|516969189|FG002|Pre-Treatment|Disease Progression|2|||
143387943|NCT03143153|516969187|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
143387944|NCT03143153|516969188|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
143387945|NCT03143153|516969189|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
143387946|NCT03143153|516969187|FG000|Treatment|Disease progression|174|||
143387947|NCT03143153|516969188|FG001|Treatment|Disease progression|184|||
143387948|NCT03143153|516969189|FG002|Treatment|Disease progression|193|||
143387949|NCT03143153|516969187|FG000|Treatment|Study drug toxicity|59|||
143387950|NCT03143153|516969188|FG001|Treatment|Study drug toxicity|33|||
143387951|NCT03143153|516969189|FG002|Treatment|Study drug toxicity|40|||
143387952|NCT03143153|516969187|FG000|Treatment|Death|5|||
143387953|NCT03143153|516969188|FG001|Treatment|Death|3|||
143387954|NCT03143153|516969189|FG002|Treatment|Death|4|||
143387955|NCT03143153|516969187|FG000|Treatment|Adverse event unrelated to study drug|19|||
143387956|NCT03143153|516969188|FG001|Treatment|Adverse event unrelated to study drug|28|||
143387957|NCT03143153|516969189|FG002|Treatment|Adverse event unrelated to study drug|12|||
143387958|NCT03143153|516969187|FG000|Treatment|Participant request to discontinue study treatment|13|||
143387959|NCT03143153|516969188|FG001|Treatment|Participant request to discontinue study treatment|15|||
143387960|NCT03143153|516969189|FG002|Treatment|Participant request to discontinue study treatment|20|||
143387961|NCT03143153|516969187|FG000|Treatment|Participant withdrew consent|3|||
143387962|NCT03143153|516969188|FG001|Treatment|Participant withdrew consent|4|||
143387963|NCT03143153|516969189|FG002|Treatment|Participant withdrew consent|12|||
143387964|NCT03143153|516969187|FG000|Treatment|Pregnancy|1|||
143387965|NCT03143153|516969188|FG001|Treatment|Pregnancy|0|||
143387966|NCT03143153|516969189|FG002|Treatment|Pregnancy|0|||
143387967|NCT03143153|516969187|FG000|Treatment|Maximum clinical benefit|1|||
143387968|NCT03143153|516969188|FG001|Treatment|Maximum clinical benefit|3|||
143387969|NCT03143153|516969189|FG002|Treatment|Maximum clinical benefit|4|||
143387970|NCT03143153|516969187|FG000|Treatment|Completed treatment as per Protocol|13|||
143387971|NCT03143153|516969188|FG001|Treatment|Completed treatment as per Protocol|8|||
143387972|NCT03143153|516969189|FG002|Treatment|Completed treatment as per Protocol|0|||
143387973|NCT03143153|516969187|FG000|Treatment|Other reasons|12|||
143387974|NCT03143153|516969188|FG001|Treatment|Other reasons|7|||
143387975|NCT03143153|516969189|FG002|Treatment|Other reasons|15|||
143387976|NCT03143153|516969187|FG000|Treatment|Not reported|1|||
143387977|NCT03143153|516969188|FG001|Treatment|Not reported|0|||
143387978|NCT03143153|516969189|FG002|Treatment|Not reported|0|||
143387979|NCT04237298|516969190|FG000|Overall Study|Lost to Follow-up|4|||
143387980|NCT04237298|516969191|FG001|Overall Study|Lost to Follow-up|5|||
143387981|NCT02530671|516969197|FG000|Overall Study|Lost to Follow-up|2|||
143387982|NCT02530671|516969198|FG001|Overall Study|Lost to Follow-up|0|||
143387983|NCT02530671|516969197|FG000|Overall Study|Withdrawal by Subject|1|||
143387984|NCT02530671|516969198|FG001|Overall Study|Withdrawal by Subject|0|||
143387985|NCT01415154|516969199|FG000|Overall Study|Lack of Efficacy|4|||
143387986|NCT01415154|516969200|FG001|Overall Study|Lack of Efficacy|5|||
143387987|NCT01415154|516969199|FG000|Overall Study|Withdrawal by Subject|7|||
143387988|NCT01415154|516969200|FG001|Overall Study|Withdrawal by Subject|8|||
143387989|NCT01415154|516969199|FG000|Overall Study|Lost to Follow-up|1|||
143387990|NCT01415154|516969200|FG001|Overall Study|Lost to Follow-up|4|||
143387991|NCT01415154|516969199|FG000|Overall Study|Protocol Violation|0|||
143387992|NCT01415154|516969200|FG001|Overall Study|Protocol Violation|1|||
143387993|NCT01415154|516969199|FG000|Overall Study|Satisfactory Response|0|||
143387994|NCT01415154|516969200|FG001|Overall Study|Satisfactory Response|1|||
143387995|NCT01415154|516969199|FG000|Overall Study|Adverse Event|1|||
143387996|NCT01415154|516969200|FG001|Overall Study|Adverse Event|1|||
143387997|NCT04541706|516969203|FG000|Overall Study|Withdrawal by Subject|3|||
143387998|NCT04541706|516969203|FG000|Overall Study|Progressive disease|33|||
143387999|NCT04541706|516969203|FG000|Overall Study|Physician Decision|1|||
143388000|NCT04541706|516969203|FG000|Overall Study|Lost to Follow-up|2|||
143388001|NCT04541706|516969203|FG000|Overall Study|Death|5|||
143388002|NCT04541706|516969203|FG000|Overall Study|Adverse Event|1|||
143388003|NCT04812535|516969204|FG000|Overall Study|Withdrawal by Subject|0|||
143388004|NCT04812535|516969205|FG001|Overall Study|Withdrawal by Subject|0|||
143388005|NCT04812535|516969206|FG002|Overall Study|Withdrawal by Subject|0|||
143388006|NCT04812535|516969207|FG003|Overall Study|Withdrawal by Subject|1|||
143388007|NCT04812535|516969204|FG000|Overall Study|Death|7|||
143388008|NCT04812535|516969205|FG001|Overall Study|Death|2|||
143388009|NCT04812535|516969206|FG002|Overall Study|Death|4|||
143388010|NCT04812535|516969207|FG003|Overall Study|Death|1|||
143388011|NCT04812535|516969204|FG000|Overall Study|Due to premature study termination by sponsor|2|||
143388012|NCT04812535|516969205|FG001|Overall Study|Due to premature study termination by sponsor|0|||
143388013|NCT04812535|516969206|FG002|Overall Study|Due to premature study termination by sponsor|1|||
143388014|NCT04812535|516969207|FG003|Overall Study|Due to premature study termination by sponsor|3|||
143388015|NCT03436745|516969208|FG000|Overall Study|Ineligible|0|||
143388016|NCT03436745|516969209|FG001|Overall Study|Ineligible|0|||
143388017|NCT03436745|516969210|FG002|Overall Study|Ineligible|1|||
143388018|NCT01809691|516969211|FG000|Overall Study|Currently on Treatment|192|||
143388019|NCT01809691|516969212|FG001|Overall Study|Currently on Treatment|100|||
143388020|NCT01809691|516969211|FG000|Overall Study|No Protocol Treatment|10|||
143388021|NCT01809691|516969212|FG001|Overall Study|No Protocol Treatment|11|||
143388022|NCT01809691|516969211|FG000|Overall Study|Adverse Event|80|||
143388023|NCT01809691|516969212|FG001|Overall Study|Adverse Event|21|||
143388024|NCT01809691|516969211|FG000|Overall Study|Disease Progression|226|||
143388025|NCT01809691|516969212|FG001|Overall Study|Disease Progression|372|||
143388026|NCT01809691|516969211|FG000|Overall Study|Death|26|||
143388027|NCT01809691|516969212|FG001|Overall Study|Death|13|||
143388028|NCT01809691|516969211|FG000|Overall Study|Participant Refusal|70|||
143388029|NCT01809691|516969212|FG001|Overall Study|Participant Refusal|72|||
143388030|NCT01809691|516969211|FG000|Overall Study|Other, Not Specified|34|||
143388031|NCT01809691|516969212|FG001|Overall Study|Other, Not Specified|52|||
143388032|NCT04588298|516969222|FG000|Overall Study|Adverse Event|0|||
143388033|NCT04588298|516969223|FG001|Overall Study|Adverse Event|0|||
143388034|NCT04588298|516969224|FG002|Overall Study|Adverse Event|1|||
143388035|NCT04588298|516969225|FG003|Overall Study|Adverse Event|0|||
143388036|NCT04588298|516969226|FG004|Overall Study|Adverse Event|2|||
143388037|NCT04588298|516969222|FG000|Overall Study|Withdrawal by Subject|1|||
143388038|NCT04588298|516969223|FG001|Overall Study|Withdrawal by Subject|0|||
143388039|NCT04588298|516969224|FG002|Overall Study|Withdrawal by Subject|0|||
143388040|NCT04588298|516969225|FG003|Overall Study|Withdrawal by Subject|1|||
143388041|NCT04588298|516969226|FG004|Overall Study|Withdrawal by Subject|0|||
143388042|NCT02281955|516969231|FG000|Overall Study|Death|1|||
143388043|NCT02783300|516969239|FG000|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
143388044|NCT02783300|516969240|FG001|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
143388045|NCT02783300|516969241|FG002|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
143388046|NCT02783300|516969242|FG003|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
143388047|NCT02783300|516969243|FG004|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
143388048|NCT02783300|516969244|FG005|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
143388049|NCT02783300|516969245|FG006|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|1|||
143388050|NCT02783300|516969246|FG007|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
143388051|NCT02783300|516969247|FG008|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
143388052|NCT02783300|516969248|FG009|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
143388053|NCT02783300|516969249|FG010|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
143388054|NCT02783300|516969250|FG011|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
143388055|NCT02783300|516969251|FG012|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
143388056|NCT02783300|516969252|FG013|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
143388057|NCT02783300|516969253|FG014|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
143388058|NCT02783300|516969254|FG015|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
143388059|NCT02783300|516969255|FG016|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
143388060|NCT02783300|516969256|FG017|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
143388061|NCT02783300|516969257|FG018|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
143388062|NCT02783300|516969258|FG019|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
143388063|NCT02783300|516969259|FG020|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
143388064|NCT02783300|516969260|FG021|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
143388065|NCT02783300|516969261|FG022|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
143388066|NCT02783300|516969262|FG023|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
143388067|NCT02783300|516969263|FG024|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
143388068|NCT02783300|516969264|FG025|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
143388069|NCT02783300|516969265|FG026|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
143388070|NCT02783300|516969239|FG000|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
143388071|NCT02783300|516969240|FG001|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
143388072|NCT02783300|516969241|FG002|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
143388073|NCT02783300|516969242|FG003|Part 1- Dose Escalation Phase|Lost to Follow-up|1|||
143388074|NCT02783300|516969243|FG004|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
143388075|NCT02783300|516969244|FG005|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
143388076|NCT02783300|516969245|FG006|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
143388077|NCT02783300|516969246|FG007|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
143388078|NCT02783300|516969247|FG008|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
143388079|NCT02783300|516969248|FG009|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
143388080|NCT02783300|516969249|FG010|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
143388081|NCT02783300|516969250|FG011|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
143388082|NCT02783300|516969251|FG012|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
143388083|NCT02783300|516969252|FG013|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
143388084|NCT02783300|516969253|FG014|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
143388085|NCT02783300|516969254|FG015|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
143388086|NCT02783300|516969255|FG016|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
143388087|NCT02783300|516969256|FG017|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
143388088|NCT02783300|516969257|FG018|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
143388089|NCT02783300|516969258|FG019|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
143388090|NCT02783300|516969259|FG020|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
143388091|NCT02783300|516969260|FG021|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
143388092|NCT02783300|516969261|FG022|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
143388093|NCT02783300|516969262|FG023|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
143388094|NCT02783300|516969263|FG024|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
143388095|NCT02783300|516969264|FG025|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
143388096|NCT02783300|516969265|FG026|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
143337291|NCT02712905|516778213|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
143337292|NCT02712905|516778214|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
143337293|NCT02712905|516778215|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
143337294|NCT02712905|516778216|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
143337295|NCT02712905|516778217|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
143337296|NCT02712905|516778218|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
143337297|NCT02712905|516778219|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
143337298|NCT02712905|516778220|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
143337299|NCT02712905|516778203|FG000|Combination Therapy|Withdrawal by Subject|0|||
143337300|NCT02712905|516778204|FG001|Combination Therapy|Withdrawal by Subject|0|||
143337301|NCT02712905|516778205|FG002|Combination Therapy|Withdrawal by Subject|0|||
143337302|NCT02712905|516778206|FG003|Combination Therapy|Withdrawal by Subject|0|||
143337303|NCT02712905|516778207|FG004|Combination Therapy|Withdrawal by Subject|0|||
143337304|NCT02712905|516778208|FG005|Combination Therapy|Withdrawal by Subject|0|||
143337305|NCT02712905|516778209|FG006|Combination Therapy|Withdrawal by Subject|0|||
143337306|NCT02712905|516778210|FG007|Combination Therapy|Withdrawal by Subject|0|||
143337307|NCT02712905|516778211|FG008|Combination Therapy|Withdrawal by Subject|0|||
143337308|NCT02712905|516778212|FG009|Combination Therapy|Withdrawal by Subject|0|||
143337309|NCT02712905|516778213|FG010|Combination Therapy|Withdrawal by Subject|0|||
143337310|NCT02712905|516778214|FG011|Combination Therapy|Withdrawal by Subject|0|||
143337311|NCT02712905|516778215|FG012|Combination Therapy|Withdrawal by Subject|0|||
143337312|NCT02712905|516778216|FG013|Combination Therapy|Withdrawal by Subject|0|||
143337313|NCT02712905|516778217|FG014|Combination Therapy|Withdrawal by Subject|0|||
143337314|NCT02712905|516778218|FG015|Combination Therapy|Withdrawal by Subject|1|||
143337315|NCT02712905|516778219|FG016|Combination Therapy|Withdrawal by Subject|0|||
143337316|NCT02712905|516778220|FG017|Combination Therapy|Withdrawal by Subject|2|||
143337317|NCT02712905|516778203|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
143337318|NCT02712905|516778204|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
143337319|NCT02712905|516778205|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
143337320|NCT02712905|516778206|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
143337321|NCT02712905|516778207|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
143337322|NCT02712905|516778208|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
143337323|NCT02712905|516778209|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
143337324|NCT02712905|516778210|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
143337325|NCT02712905|516778211|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
143337326|NCT02712905|516778212|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
143337327|NCT02712905|516778213|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
143337328|NCT02712905|516778214|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
143337329|NCT02712905|516778215|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
143337330|NCT02712905|516778216|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
143337331|NCT02712905|516778217|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
143337332|NCT02712905|516778218|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
143337333|NCT02712905|516778219|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
143337334|NCT02712905|516778220|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
143337335|NCT03721965|516778221|FG000|Overall Study|Death|1|||
143337336|NCT03721965|516778221|FG000|Overall Study|Study Terminated by Sponsor|1|||
143337337|NCT02454101|516778222|FG000|Overall Study|Adverse Event|2|||
143337338|NCT02454101|516778223|FG001|Overall Study|Adverse Event|3|||
143337339|NCT02454101|516778222|FG000|Overall Study|Lost to Follow-up|3|||
143337340|NCT02454101|516778223|FG001|Overall Study|Lost to Follow-up|4|||
143337341|NCT00045305|516778227|FG000|Overall Study|Lack of Efficacy|6|||
143337342|NCT00045305|516778227|FG000|Overall Study|Adverse Event|3|||
143337343|NCT00045305|516778227|FG000|Overall Study|Death|3|||
143337344|NCT00045305|516778227|FG000|Overall Study|site error|2|||
143388097|NCT02783300|516969239|FG000|Part 1- Dose Escalation Phase|Other reasons|0|||
143388098|NCT02783300|516969240|FG001|Part 1- Dose Escalation Phase|Other reasons|0|||
143388099|NCT02783300|516969241|FG002|Part 1- Dose Escalation Phase|Other reasons|0|||
143388100|NCT02783300|516969242|FG003|Part 1- Dose Escalation Phase|Other reasons|0|||
143388101|NCT02783300|516969243|FG004|Part 1- Dose Escalation Phase|Other reasons|0|||
143388102|NCT02783300|516969244|FG005|Part 1- Dose Escalation Phase|Other reasons|0|||
143388103|NCT02783300|516969245|FG006|Part 1- Dose Escalation Phase|Other reasons|0|||
143388104|NCT02783300|516969246|FG007|Part 1- Dose Escalation Phase|Other reasons|0|||
143388105|NCT02783300|516969247|FG008|Part 1- Dose Escalation Phase|Other reasons|0|||
143388106|NCT02783300|516969248|FG009|Part 1- Dose Escalation Phase|Other reasons|0|||
143388107|NCT02783300|516969249|FG010|Part 1- Dose Escalation Phase|Other reasons|0|||
143388108|NCT02783300|516969250|FG011|Part 1- Dose Escalation Phase|Other reasons|0|||
143388109|NCT02783300|516969251|FG012|Part 1- Dose Escalation Phase|Other reasons|2|||
143388110|NCT02783300|516969252|FG013|Part 1- Dose Escalation Phase|Other reasons|0|||
143388111|NCT02783300|516969253|FG014|Part 1- Dose Escalation Phase|Other reasons|0|||
143388112|NCT02783300|516969254|FG015|Part 1- Dose Escalation Phase|Other reasons|0|||
143388113|NCT02783300|516969255|FG016|Part 1- Dose Escalation Phase|Other reasons|0|||
143388114|NCT02783300|516969256|FG017|Part 1- Dose Escalation Phase|Other reasons|0|||
143388115|NCT02783300|516969257|FG018|Part 1- Dose Escalation Phase|Other reasons|0|||
143388116|NCT02783300|516969258|FG019|Part 1- Dose Escalation Phase|Other reasons|0|||
143388117|NCT02783300|516969259|FG020|Part 1- Dose Escalation Phase|Other reasons|0|||
143388118|NCT02783300|516969260|FG021|Part 1- Dose Escalation Phase|Other reasons|0|||
143388119|NCT02783300|516969261|FG022|Part 1- Dose Escalation Phase|Other reasons|0|||
143388120|NCT02783300|516969262|FG023|Part 1- Dose Escalation Phase|Other reasons|0|||
143388121|NCT02783300|516969263|FG024|Part 1- Dose Escalation Phase|Other reasons|0|||
143388122|NCT02783300|516969264|FG025|Part 1- Dose Escalation Phase|Other reasons|0|||
143388123|NCT02783300|516969265|FG026|Part 1- Dose Escalation Phase|Other reasons|0|||
143388124|NCT02783300|516969239|FG000|Part 1- Dose Escalation Phase|Investigator discretion|0|||
143388125|NCT02783300|516969240|FG001|Part 1- Dose Escalation Phase|Investigator discretion|0|||
143388126|NCT02783300|516969241|FG002|Part 1- Dose Escalation Phase|Investigator discretion|0|||
143388127|NCT02783300|516969242|FG003|Part 1- Dose Escalation Phase|Investigator discretion|0|||
143388128|NCT02783300|516969243|FG004|Part 1- Dose Escalation Phase|Investigator discretion|0|||
143388129|NCT02783300|516969244|FG005|Part 1- Dose Escalation Phase|Investigator discretion|0|||
143388130|NCT02783300|516969245|FG006|Part 1- Dose Escalation Phase|Investigator discretion|4|||
143388131|NCT02783300|516969246|FG007|Part 1- Dose Escalation Phase|Investigator discretion|0|||
143388132|NCT02783300|516969247|FG008|Part 1- Dose Escalation Phase|Investigator discretion|0|||
143388133|NCT02783300|516969248|FG009|Part 1- Dose Escalation Phase|Investigator discretion|0|||
143388134|NCT02783300|516969249|FG010|Part 1- Dose Escalation Phase|Investigator discretion|0|||
143388135|NCT02783300|516969250|FG011|Part 1- Dose Escalation Phase|Investigator discretion|0|||
143388136|NCT02783300|516969251|FG012|Part 1- Dose Escalation Phase|Investigator discretion|3|||
143388137|NCT02783300|516969252|FG013|Part 1- Dose Escalation Phase|Investigator discretion|0|||
143388138|NCT02783300|516969253|FG014|Part 1- Dose Escalation Phase|Investigator discretion|0|||
143388139|NCT02783300|516969254|FG015|Part 1- Dose Escalation Phase|Investigator discretion|0|||
143388140|NCT02783300|516969255|FG016|Part 1- Dose Escalation Phase|Investigator discretion|0|||
143388141|NCT02783300|516969256|FG017|Part 1- Dose Escalation Phase|Investigator discretion|0|||
143388142|NCT02783300|516969257|FG018|Part 1- Dose Escalation Phase|Investigator discretion|0|||
143388143|NCT02783300|516969258|FG019|Part 1- Dose Escalation Phase|Investigator discretion|0|||
143388144|NCT02783300|516969259|FG020|Part 1- Dose Escalation Phase|Investigator discretion|0|||
143388145|NCT02783300|516969260|FG021|Part 1- Dose Escalation Phase|Investigator discretion|0|||
143388146|NCT02783300|516969261|FG022|Part 1- Dose Escalation Phase|Investigator discretion|0|||
143388147|NCT02783300|516969262|FG023|Part 1- Dose Escalation Phase|Investigator discretion|0|||
143388148|NCT02783300|516969263|FG024|Part 1- Dose Escalation Phase|Investigator discretion|0|||
143388149|NCT02783300|516969264|FG025|Part 1- Dose Escalation Phase|Investigator discretion|0|||
143388150|NCT02783300|516969265|FG026|Part 1- Dose Escalation Phase|Investigator discretion|0|||
143388151|NCT02783300|516969239|FG000|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
143388152|NCT02783300|516969240|FG001|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
143388153|NCT02783300|516969241|FG002|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
143388154|NCT02783300|516969242|FG003|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
143388155|NCT02783300|516969243|FG004|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
143388156|NCT02783300|516969244|FG005|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
143388157|NCT02783300|516969245|FG006|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
143388158|NCT02783300|516969246|FG007|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
143388159|NCT02783300|516969247|FG008|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
143388160|NCT02783300|516969248|FG009|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
143388161|NCT02783300|516969249|FG010|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
143388162|NCT02783300|516969250|FG011|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
143388163|NCT02783300|516969251|FG012|Part 1- Dose Escalation Phase|Withdrawal by Subject|2|||
143388164|NCT02783300|516969252|FG013|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
143388165|NCT02783300|516969253|FG014|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
143388166|NCT02783300|516969254|FG015|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
143388167|NCT02783300|516969255|FG016|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
143388168|NCT02783300|516969256|FG017|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
143388169|NCT02783300|516969257|FG018|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
143388170|NCT02783300|516969258|FG019|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
143388171|NCT02783300|516969259|FG020|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
143388172|NCT02783300|516969260|FG021|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
143388173|NCT02783300|516969261|FG022|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
143388174|NCT02783300|516969262|FG023|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
143388175|NCT02783300|516969263|FG024|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
143388176|NCT02783300|516969264|FG025|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
143388177|NCT02783300|516969265|FG026|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
143388178|NCT02783300|516969239|FG000|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
143388179|NCT02783300|516969240|FG001|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
143388180|NCT02783300|516969241|FG002|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
143388181|NCT02783300|516969242|FG003|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
143388182|NCT02783300|516969243|FG004|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
143388183|NCT02783300|516969244|FG005|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
143388184|NCT02783300|516969245|FG006|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
143388185|NCT02783300|516969246|FG007|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
143388186|NCT02783300|516969247|FG008|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
143388187|NCT02783300|516969248|FG009|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
143388188|NCT02783300|516969249|FG010|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
143388189|NCT02783300|516969250|FG011|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
143388190|NCT02783300|516969251|FG012|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
143388191|NCT02783300|516969252|FG013|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
143388192|NCT02783300|516969253|FG014|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
143388193|NCT02783300|516969254|FG015|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
143388194|NCT02783300|516969255|FG016|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
143388195|NCT02783300|516969256|FG017|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
143388196|NCT02783300|516969257|FG018|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
143388197|NCT02783300|516969258|FG019|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
143388198|NCT02783300|516969259|FG020|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
143388199|NCT02783300|516969260|FG021|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
143388200|NCT02783300|516969261|FG022|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
143388201|NCT02783300|516969262|FG023|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
143388202|NCT02783300|516969263|FG024|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
143388203|NCT02783300|516969264|FG025|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
143388204|NCT02783300|516969265|FG026|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
143388205|NCT02783300|516969239|FG000|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
143388206|NCT02783300|516969240|FG001|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
143388207|NCT02783300|516969241|FG002|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
143388208|NCT02783300|516969242|FG003|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
143388209|NCT02783300|516969243|FG004|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
143388210|NCT02783300|516969244|FG005|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
143388211|NCT02783300|516969245|FG006|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
143388212|NCT02783300|516969246|FG007|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
143388213|NCT02783300|516969247|FG008|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
143388214|NCT02783300|516969248|FG009|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
143388215|NCT02783300|516969249|FG010|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
143388216|NCT02783300|516969250|FG011|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
143388217|NCT02783300|516969251|FG012|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
143388218|NCT02783300|516969252|FG013|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
143388219|NCT02783300|516969253|FG014|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
143388220|NCT02783300|516969254|FG015|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
143388221|NCT02783300|516969255|FG016|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
143337345|NCT01936857|516778228|FG000|Overall Study|Sent to prison or 06 center|11|||
143337346|NCT01936857|516778229|FG001|Overall Study|Sent to prison or 06 center|12|||
143388222|NCT02783300|516969256|FG017|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
143388223|NCT02783300|516969257|FG018|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
143388224|NCT02783300|516969258|FG019|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|2|||
143388225|NCT02783300|516969259|FG020|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
143388226|NCT02783300|516969260|FG021|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
143388227|NCT02783300|516969261|FG022|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
143388228|NCT02783300|516969262|FG023|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
143388229|NCT02783300|516969263|FG024|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
143388230|NCT02783300|516969264|FG025|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
143388231|NCT02783300|516969265|FG026|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
143388232|NCT02783300|516969239|FG000|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
143388233|NCT02783300|516969240|FG001|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
143388234|NCT02783300|516969241|FG002|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
143388235|NCT02783300|516969242|FG003|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
143388236|NCT02783300|516969243|FG004|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
143388237|NCT02783300|516969244|FG005|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
143388238|NCT02783300|516969245|FG006|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
143388239|NCT02783300|516969246|FG007|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
143388240|NCT02783300|516969247|FG008|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
143388241|NCT02783300|516969248|FG009|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
143388242|NCT02783300|516969249|FG010|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
143388243|NCT02783300|516969250|FG011|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
143388244|NCT02783300|516969251|FG012|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
143388245|NCT02783300|516969252|FG013|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
143388246|NCT02783300|516969253|FG014|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
143388247|NCT02783300|516969254|FG015|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
143388248|NCT02783300|516969255|FG016|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
143388249|NCT02783300|516969256|FG017|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
143388250|NCT02783300|516969257|FG018|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
143388251|NCT02783300|516969258|FG019|Part 2- Disease-specific Expansion Phase|Other reasons|3|||
143388252|NCT02783300|516969259|FG020|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
143388253|NCT02783300|516969260|FG021|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
143388254|NCT02783300|516969261|FG022|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
143388255|NCT02783300|516969262|FG023|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
143388256|NCT02783300|516969263|FG024|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
143388257|NCT02783300|516969264|FG025|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
143388258|NCT02783300|516969265|FG026|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
143388259|NCT02783300|516969239|FG000|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
143388260|NCT02783300|516969240|FG001|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
143388261|NCT02783300|516969241|FG002|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
143388262|NCT02783300|516969242|FG003|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
143388263|NCT02783300|516969243|FG004|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
143388264|NCT02783300|516969244|FG005|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
143337347|NCT01936857|516778228|FG000|Overall Study|Lost to Follow-up|10|||
143337348|NCT01936857|516778229|FG001|Overall Study|Lost to Follow-up|7|||
143337349|NCT01936857|516778228|FG000|Overall Study|Death|7|||
143337350|NCT01936857|516778229|FG001|Overall Study|Death|3|||
143337351|NCT01936857|516778228|FG000|Overall Study|Moved|2|||
143337352|NCT01936857|516778229|FG001|Overall Study|Moved|1|||
143337353|NCT01936857|516778228|FG000|Overall Study|Withdrawal by Subject|1|||
143337354|NCT01936857|516778229|FG001|Overall Study|Withdrawal by Subject|0|||
143337355|NCT01936857|516778228|FG000|Overall Study|Side effect of medication|1|||
143337356|NCT01936857|516778229|FG001|Overall Study|Side effect of medication|0|||
143337357|NCT01936857|516778228|FG000|Overall Study|Other|2|||
143337358|NCT01936857|516778229|FG001|Overall Study|Other|2|||
143337359|NCT02279043|516778230|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
143337360|NCT02279043|516778231|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
143337361|NCT02279043|516778232|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
143337362|NCT02279043|516778230|FG000|Overall Study|Lost to Follow-up|46|||
143337363|NCT02279043|516778231|FG001|Overall Study|Lost to Follow-up|88|||
143337364|NCT02279043|516778232|FG002|Overall Study|Lost to Follow-up|0|||
143337365|NCT00490282|516778233|FG000|Overall Study|Withdrawal by Subject|3|||
143337366|NCT04198805|516778237|FG000|Overall Study|Death|0|||
143337367|NCT04198805|516778238|FG001|Overall Study|Death|0|||
143337368|NCT04198805|516778239|FG002|Overall Study|Death|0|||
143337369|NCT04198805|516778240|FG003|Overall Study|Death|1|||
143337370|NCT04198805|516778237|FG000|Overall Study|Early Termination|8|||
143337371|NCT04198805|516778238|FG001|Overall Study|Early Termination|4|||
143337372|NCT04198805|516778239|FG002|Overall Study|Early Termination|6|||
143337373|NCT04198805|516778240|FG003|Overall Study|Early Termination|9|||
143337374|NCT01494584|516778243|FG000|Overall Study|Study Closed/Terminated|1|||
143337375|NCT01499082|516778244|FG000|Overall Study|Randomized but not Treated|0|||
143337376|NCT01499082|516778245|FG001|Overall Study|Randomized but not Treated|1|||
143337377|NCT01499082|516778244|FG000|Overall Study|Adverse Event|12|||
143337378|NCT01499082|516778245|FG001|Overall Study|Adverse Event|16|||
143337379|NCT01499082|516778244|FG000|Overall Study|Lack of Efficacy|1|||
143337380|NCT01499082|516778245|FG001|Overall Study|Lack of Efficacy|1|||
143337381|NCT01499082|516778244|FG000|Overall Study|Protocol Violation|6|||
143337382|NCT01499082|516778245|FG001|Overall Study|Protocol Violation|8|||
143337383|NCT01499082|516778244|FG000|Overall Study|Diverse Reasons|18|||
143337384|NCT01499082|516778245|FG001|Overall Study|Diverse Reasons|14|||
143337385|NCT01499082|516778244|FG000|Overall Study|Site Closure for Noncompliance|5|||
143337386|NCT01499082|516778245|FG001|Overall Study|Site Closure for Noncompliance|2|||
143337387|NCT01499082|516778244|FG000|Overall Study|Hypoglycemia|2|||
143337388|NCT01499082|516778245|FG001|Overall Study|Hypoglycemia|3|||
143337389|NCT01499082|516778244|FG000|Overall Study|Lost to Follow-up|1|||
143337390|NCT01499082|516778245|FG001|Overall Study|Lost to Follow-up|3|||
143337391|NCT03599349|516778246|FG000|Overall Study|Lost to Follow-up|1|||
143337392|NCT05380947|516778249|FG000|Washout Period 1|Not attend visit|1|||
143337393|NCT05380947|516778250|FG001|Washout Period 1|Not attend visit|0|||
143337394|NCT05380947|516778251|FG002|Washout Period 1|Not attend visit|0|||
143337395|NCT05380947|516778252|FG003|Washout Period 1|Not attend visit|0|||
143337396|NCT05380947|516778249|FG000|Washout Period 2|Adverse Event|1|||
143337397|NCT05380947|516778250|FG001|Washout Period 2|Adverse Event|0|||
143337398|NCT05380947|516778251|FG002|Washout Period 2|Adverse Event|0|||
143337399|NCT05380947|516778252|FG003|Washout Period 2|Adverse Event|0|||
143337400|NCT05380947|516778249|FG000|Washout Period 3|Adverse Event|0|||
143337401|NCT05380947|516778250|FG001|Washout Period 3|Adverse Event|1|||
143337402|NCT05380947|516778251|FG002|Washout Period 3|Adverse Event|0|||
143337403|NCT05380947|516778252|FG003|Washout Period 3|Adverse Event|0|||
143337404|NCT05380947|516778249|FG000|Washout Period 3|Not attend visit|0|||
143388265|NCT02783300|516969245|FG006|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
143388266|NCT02783300|516969246|FG007|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
143388267|NCT02783300|516969247|FG008|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
143388268|NCT02783300|516969248|FG009|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
143388269|NCT02783300|516969249|FG010|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
143388270|NCT02783300|516969250|FG011|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
143388271|NCT02783300|516969251|FG012|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
143388272|NCT02783300|516969252|FG013|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
143388273|NCT02783300|516969253|FG014|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
143337405|NCT05380947|516778250|FG001|Washout Period 3|Not attend visit|1|||
143337406|NCT05380947|516778251|FG002|Washout Period 3|Not attend visit|0|||
143337407|NCT05380947|516778252|FG003|Washout Period 3|Not attend visit|1|||
143337408|NCT06213701|516778253|FG000|Overall Study|Withdrawal by Subject|2|||
143337409|NCT06213701|516778254|FG001|Overall Study|Withdrawal by Subject|1|||
143337410|NCT06213701|516778255|FG002|Overall Study|Withdrawal by Subject|0|||
143337411|NCT01256567|516778257|FG000|Overall Study|Withdrawal by Subject|1|||
143337412|NCT00453986|516778267|FG000|Overall Study|Lost to Follow-up|6|||
143337413|NCT00453986|516778268|FG001|Overall Study|Lost to Follow-up|5|||
143337414|NCT00453986|516778269|FG002|Overall Study|Lost to Follow-up|6|||
143337415|NCT00453986|516778270|FG003|Overall Study|Lost to Follow-up|2|||
143337416|NCT00453986|516778271|FG004|Overall Study|Lost to Follow-up|0|||
143337417|NCT00522626|516778272|FG000|Overall Study|Lost to Follow-up|7|||
143337418|NCT00803452|516778273|FG000|Overall Study|Adverse Event|0|||
143337419|NCT00803452|516778274|FG001|Overall Study|Adverse Event|2|||
143337420|NCT00803452|516778273|FG000|Overall Study|Lost to Follow-up|0|||
143337421|NCT00803452|516778274|FG001|Overall Study|Lost to Follow-up|3|||
143337422|NCT05899686|516778275|FG000|Overall Study|Protocol Violation|1|||
143337423|NCT00608582|516778278|FG000|Overall Study|Lost to Follow-up|2|||
143337424|NCT00608582|516778279|FG001|Overall Study|Lost to Follow-up|0|||
143337425|NCT00608582|516778278|FG000|Overall Study|No Best Response in Phase 1 located|1|||
143337426|NCT00608582|516778279|FG001|Overall Study|No Best Response in Phase 1 located|1|||
143337427|NCT00608582|516778278|FG000|Overall Study|Illicit Drug Use|1|||
143337428|NCT00608582|516778279|FG001|Overall Study|Illicit Drug Use|0|||
143337429|NCT00608582|516778278|FG000|Overall Study|Early stage Design Change|0|||
143337430|NCT00608582|516778279|FG001|Overall Study|Early stage Design Change|3|||
143337431|NCT04922554|516778280|FG000|Overall Study|Adverse Event|4|||
143337432|NCT04922554|516778281|FG001|Overall Study|Adverse Event|0|||
143337433|NCT04922554|516778280|FG000|Overall Study|Withdrawal by Subject|1|||
143337434|NCT04922554|516778281|FG001|Overall Study|Withdrawal by Subject|0|||
143337435|NCT03076970|516779864|FG000|Washout Period 2|Adverse Event|0|||
143337436|NCT03076970|516779865|FG001|Washout Period 2|Adverse Event|0|||
143337437|NCT03076970|516779866|FG002|Washout Period 2|Adverse Event|0|||
143337438|NCT03076970|516779867|FG003|Washout Period 2|Adverse Event|0|||
143337439|NCT03076970|516779868|FG004|Washout Period 2|Adverse Event|1|||
143337440|NCT03076970|516779869|FG005|Washout Period 2|Adverse Event|0|||
143337441|NCT03076970|516779864|FG000|Period 3|Withdrawal by Subject|0|||
143337442|NCT03076970|516779865|FG001|Period 3|Withdrawal by Subject|0|||
143337443|NCT03076970|516779866|FG002|Period 3|Withdrawal by Subject|0|||
143337444|NCT03076970|516779867|FG003|Period 3|Withdrawal by Subject|0|||
143337445|NCT03076970|516779868|FG004|Period 3|Withdrawal by Subject|0|||
143337446|NCT03076970|516779869|FG005|Period 3|Withdrawal by Subject|1|||
143337447|NCT03076970|516779864|FG000|Period 3|Failure to meet I/E criteria|0|||
143337448|NCT03076970|516779865|FG001|Period 3|Failure to meet I/E criteria|0|||
143337449|NCT03076970|516779866|FG002|Period 3|Failure to meet I/E criteria|0|||
143337450|NCT03076970|516779867|FG003|Period 3|Failure to meet I/E criteria|0|||
143337451|NCT03076970|516779868|FG004|Period 3|Failure to meet I/E criteria|1|||
143337452|NCT03076970|516779869|FG005|Period 3|Failure to meet I/E criteria|0|||
143337453|NCT00789815|516779870|FG000|Overall Study|Protocol Violation|6|||
143337454|NCT00789815|516779871|FG001|Overall Study|Protocol Violation|1|||
143337455|NCT00789815|516779870|FG000|Overall Study|Intubation due to massive bleeding|1|||
143337456|NCT00789815|516779871|FG001|Overall Study|Intubation due to massive bleeding|0|||
143337457|NCT00119405|516779872|FG000|Overall Study|Withdrawal by Subject|1|||
143337458|NCT04958785|516779876|FG000|Overall Study|Study Terminated by Sponsor|4|||
143337459|NCT04958785|516779877|FG001|Overall Study|Study Terminated by Sponsor|10|||
143337460|NCT04958785|516779878|FG002|Overall Study|Study Terminated by Sponsor|7|||
143337461|NCT04958785|516779879|FG003|Overall Study|Study Terminated by Sponsor|6|||
143337462|NCT04958785|516779880|FG004|Overall Study|Study Terminated by Sponsor|34|||
143337463|NCT04958785|516779876|FG000|Overall Study|Death|2|||
143337464|NCT04958785|516779877|FG001|Overall Study|Death|3|||
143337465|NCT04958785|516779878|FG002|Overall Study|Death|4|||
143337466|NCT04958785|516779879|FG003|Overall Study|Death|5|||
143337467|NCT04958785|516779880|FG004|Overall Study|Death|5|||
143337468|NCT04958785|516779876|FG000|Overall Study|Withdrew consent|2|||
143337469|NCT04958785|516779877|FG001|Overall Study|Withdrew consent|0|||
143337470|NCT04958785|516779878|FG002|Overall Study|Withdrew consent|3|||
143337471|NCT04958785|516779879|FG003|Overall Study|Withdrew consent|1|||
143337472|NCT04958785|516779880|FG004|Overall Study|Withdrew consent|0|||
143337473|NCT04958785|516779876|FG000|Overall Study|Investigator's discretion|0|||
143337474|NCT04958785|516779877|FG001|Overall Study|Investigator's discretion|1|||
143337475|NCT04958785|516779878|FG002|Overall Study|Investigator's discretion|0|||
143337476|NCT04958785|516779879|FG003|Overall Study|Investigator's discretion|1|||
143337477|NCT04958785|516779880|FG004|Overall Study|Investigator's discretion|2|||
143337478|NCT04958785|516779876|FG000|Overall Study|Adverse Event|0|||
143337479|NCT04958785|516779877|FG001|Overall Study|Adverse Event|0|||
143337480|NCT04958785|516779878|FG002|Overall Study|Adverse Event|0|||
143337481|NCT04958785|516779879|FG003|Overall Study|Adverse Event|0|||
143337482|NCT04958785|516779880|FG004|Overall Study|Adverse Event|1|||
143337483|NCT04958785|516779876|FG000|Overall Study|Lost to Follow-up|0|||
143337484|NCT04958785|516779877|FG001|Overall Study|Lost to Follow-up|0|||
143337485|NCT04958785|516779878|FG002|Overall Study|Lost to Follow-up|0|||
143337486|NCT04958785|516779879|FG003|Overall Study|Lost to Follow-up|0|||
143337487|NCT04958785|516779880|FG004|Overall Study|Lost to Follow-up|1|||
143337488|NCT01224925|516779881|FG000|Overall Study|Lost to Follow-up|3|||
143337489|NCT01224925|516779882|FG001|Overall Study|Lost to Follow-up|2|||
143337490|NCT04244396|516779885|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
143337491|NCT04244396|516779885|FG000|Overall Study|Withdrawal by Subject|2|||
143337492|NCT04244396|516779885|FG000|Overall Study|Study termination|37|||
143337493|NCT05178121|516779886|FG000|Overall Study|Other|4|||
143337494|NCT05178121|516779886|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
143337495|NCT00949884|516779887|FG000|Overall Study|Adverse Event|14|||
143337496|NCT00949884|516779888|FG001|Overall Study|Adverse Event|3|||
143337497|NCT00949884|516779889|FG002|Overall Study|Adverse Event|12|||
143337498|NCT00949884|516779887|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
143337499|NCT00949884|516779888|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
143337500|NCT00949884|516779889|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
143337501|NCT00949884|516779887|FG000|Overall Study|Lost to Follow-up|7|||
143337502|NCT00949884|516779888|FG001|Overall Study|Lost to Follow-up|5|||
143337503|NCT00949884|516779889|FG002|Overall Study|Lost to Follow-up|5|||
143337504|NCT00949884|516779887|FG000|Overall Study|Physician Decision|5|||
143337505|NCT00949884|516779888|FG001|Overall Study|Physician Decision|0|||
143337506|NCT00949884|516779889|FG002|Overall Study|Physician Decision|6|||
143337507|NCT00949884|516779887|FG000|Overall Study|Treatment non-compliance|5|||
143337508|NCT00949884|516779888|FG001|Overall Study|Treatment non-compliance|0|||
143337509|NCT00949884|516779889|FG002|Overall Study|Treatment non-compliance|8|||
143337510|NCT00949884|516779887|FG000|Overall Study|Withdrawal by Subject|13|||
143337511|NCT00949884|516779888|FG001|Overall Study|Withdrawal by Subject|4|||
143337512|NCT00949884|516779889|FG002|Overall Study|Withdrawal by Subject|16|||
143337513|NCT00949884|516779887|FG000|Overall Study|Lack of Efficacy|4|||
143337514|NCT00949884|516779888|FG001|Overall Study|Lack of Efficacy|2|||
143337515|NCT00949884|516779889|FG002|Overall Study|Lack of Efficacy|7|||
143337516|NCT00949884|516779887|FG000|Overall Study|Study terminated by sponsor|0|||
143337517|NCT00949884|516779888|FG001|Overall Study|Study terminated by sponsor|0|||
143337518|NCT00949884|516779889|FG002|Overall Study|Study terminated by sponsor|1|||
143337519|NCT00245102|516779890|FG000|Overall Study|Not Treated|1|||
143337520|NCT00245102|516779891|FG001|Overall Study|Not Treated|0|||
143337521|NCT00245102|516779892|FG002|Overall Study|Not Treated|1|||
143337522|NCT00245102|516779893|FG003|Overall Study|Not Treated|0|||
143337523|NCT00245102|516779894|FG004|Overall Study|Not Treated|0|||
143337524|NCT00245102|516779895|FG005|Overall Study|Not Treated|0|||
143337525|NCT00245102|516779890|FG000|Overall Study|Protocol Violation|1|||
143337526|NCT00245102|516779891|FG001|Overall Study|Protocol Violation|0|||
143337527|NCT00245102|516779892|FG002|Overall Study|Protocol Violation|0|||
143337528|NCT00245102|516779893|FG003|Overall Study|Protocol Violation|0|||
143337529|NCT00245102|516779894|FG004|Overall Study|Protocol Violation|0|||
143337530|NCT00245102|516779895|FG005|Overall Study|Protocol Violation|0|||
143337531|NCT00245102|516779890|FG000|Overall Study|Death|0|||
143337532|NCT00245102|516779891|FG001|Overall Study|Death|0|||
143337533|NCT00245102|516779892|FG002|Overall Study|Death|0|||
143337534|NCT00245102|516779893|FG003|Overall Study|Death|1|||
143337535|NCT00245102|516779894|FG004|Overall Study|Death|0|||
143337536|NCT00245102|516779895|FG005|Overall Study|Death|0|||
143337537|NCT00245102|516779890|FG000|Overall Study|Adverse Event|4|||
143337538|NCT00245102|516779891|FG001|Overall Study|Adverse Event|2|||
143337539|NCT00245102|516779892|FG002|Overall Study|Adverse Event|5|||
143337540|NCT00245102|516779893|FG003|Overall Study|Adverse Event|1|||
143337541|NCT00245102|516779894|FG004|Overall Study|Adverse Event|0|||
143337542|NCT00245102|516779895|FG005|Overall Study|Adverse Event|2|||
143337543|NCT00245102|516779890|FG000|Overall Study|Decline in performance|0|||
143337544|NCT00245102|516779891|FG001|Overall Study|Decline in performance|2|||
143337545|NCT00245102|516779892|FG002|Overall Study|Decline in performance|0|||
143337546|NCT00245102|516779893|FG003|Overall Study|Decline in performance|1|||
143337547|NCT00245102|516779894|FG004|Overall Study|Decline in performance|0|||
143337548|NCT00245102|516779895|FG005|Overall Study|Decline in performance|2|||
143337549|NCT00245102|516779890|FG000|Overall Study|Participant needed surgery|0|||
143337550|NCT00245102|516779891|FG001|Overall Study|Participant needed surgery|0|||
143337551|NCT00245102|516779892|FG002|Overall Study|Participant needed surgery|1|||
143337552|NCT00245102|516779893|FG003|Overall Study|Participant needed surgery|0|||
143388274|NCT02783300|516969254|FG015|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
143388275|NCT02783300|516969255|FG016|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
143388276|NCT02783300|516969256|FG017|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
143388277|NCT02783300|516969257|FG018|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
143388278|NCT02783300|516969258|FG019|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
143388279|NCT02783300|516969259|FG020|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
143388280|NCT02783300|516969260|FG021|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
143388281|NCT02783300|516969261|FG022|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
143388282|NCT02783300|516969262|FG023|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
143388283|NCT02783300|516969263|FG024|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
143388284|NCT02783300|516969264|FG025|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
143388285|NCT02783300|516969265|FG026|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
143388286|NCT02783300|516969239|FG000|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
143388287|NCT02783300|516969240|FG001|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
143388288|NCT02783300|516969241|FG002|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
143388289|NCT02783300|516969242|FG003|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
143388290|NCT02783300|516969243|FG004|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
143388291|NCT02783300|516969244|FG005|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
143388292|NCT02783300|516969245|FG006|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
143388293|NCT02783300|516969246|FG007|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
143388294|NCT02783300|516969247|FG008|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
143388295|NCT02783300|516969248|FG009|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
143388296|NCT02783300|516969249|FG010|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
143388297|NCT02783300|516969250|FG011|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
143388298|NCT02783300|516969251|FG012|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
143388299|NCT02783300|516969252|FG013|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
143388300|NCT02783300|516969253|FG014|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|3|||
143388301|NCT02783300|516969254|FG015|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
143388302|NCT02783300|516969255|FG016|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
143388303|NCT02783300|516969256|FG017|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
143388304|NCT02783300|516969257|FG018|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|7|||
143388305|NCT02783300|516969258|FG019|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
143388306|NCT02783300|516969259|FG020|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
143388307|NCT02783300|516969260|FG021|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
143388308|NCT02783300|516969261|FG022|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
143388309|NCT02783300|516969262|FG023|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
143388310|NCT02783300|516969263|FG024|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
143337553|NCT00245102|516779894|FG004|Overall Study|Participant needed surgery|0|||
143337554|NCT00245102|516779895|FG005|Overall Study|Participant needed surgery|0|||
143337555|NCT00245102|516779890|FG000|Overall Study|Clinical progression|1|||
143388311|NCT02783300|516969264|FG025|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
143388312|NCT02783300|516969265|FG026|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
143388313|NCT02783300|516969239|FG000|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
143388314|NCT02783300|516969240|FG001|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
143388315|NCT02783300|516969241|FG002|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
143388316|NCT02783300|516969242|FG003|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
143388317|NCT02783300|516969243|FG004|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
143337556|NCT00245102|516779891|FG001|Overall Study|Clinical progression|0|||
143337557|NCT00245102|516779892|FG002|Overall Study|Clinical progression|0|||
143337558|NCT00245102|516779893|FG003|Overall Study|Clinical progression|0|||
143337559|NCT00245102|516779894|FG004|Overall Study|Clinical progression|0|||
143337560|NCT00245102|516779895|FG005|Overall Study|Clinical progression|0|||
143337561|NCT02293395|516779902|FG000|Overall Study|Lost to Follow-up|1|||
143337562|NCT02293395|516779903|FG001|Overall Study|Lost to Follow-up|0|||
143337563|NCT02293395|516779902|FG000|Overall Study|Withdrawal by Subject|8|||
143337564|NCT02293395|516779903|FG001|Overall Study|Withdrawal by Subject|7|||
143337565|NCT00224770|516779909|FG000|Overall Study|Lost to Follow-up|4|||
143337566|NCT00224770|516779910|FG001|Overall Study|Lost to Follow-up|2|||
143337567|NCT00224770|516779911|FG002|Overall Study|Lost to Follow-up|0|||
143337568|NCT01106430|516779912|FG000|Overall Study|Adverse Event|8|||
143337569|NCT01106430|516779913|FG001|Overall Study|Adverse Event|10|||
143337570|NCT01106430|516779912|FG000|Overall Study|Lack of Efficacy|2|||
143337571|NCT01106430|516779913|FG001|Overall Study|Lack of Efficacy|13|||
143337572|NCT01106430|516779912|FG000|Overall Study|Lost to Follow-up|5|||
143337573|NCT01106430|516779913|FG001|Overall Study|Lost to Follow-up|1|||
143337574|NCT01106430|516779912|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
143337575|NCT01106430|516779913|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
143337576|NCT01106430|516779912|FG000|Overall Study|Moved Out Of State|0|||
143337577|NCT01106430|516779913|FG001|Overall Study|Moved Out Of State|1|||
143337578|NCT01106430|516779912|FG000|Overall Study|Refused To Take Medication|0|||
143337579|NCT01106430|516779913|FG001|Overall Study|Refused To Take Medication|1|||
143337580|NCT01106430|516779912|FG000|Overall Study|Noncompliance|0|||
143337581|NCT01106430|516779913|FG001|Overall Study|Noncompliance|1|||
143337582|NCT01106430|516779912|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
143337583|NCT01106430|516779913|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
143337584|NCT01106430|516779912|FG000|Overall Study|Previous Use Of Marijuana|1|||
143337585|NCT01106430|516779913|FG001|Overall Study|Previous Use Of Marijuana|0|||
143337586|NCT01106430|516779912|FG000|Overall Study|Protocol Violation|7|||
143337587|NCT01106430|516779913|FG001|Overall Study|Protocol Violation|2|||
143337588|NCT01106430|516779912|FG000|Overall Study|Withdrawal by Subject|8|||
143337589|NCT01106430|516779913|FG001|Overall Study|Withdrawal by Subject|4|||
143337590|NCT00944658|516779916|FG000|Treatment 12 Weeks|Adverse Event|0|||
143337591|NCT00944658|516779917|FG001|Treatment 12 Weeks|Adverse Event|2|||
143337592|NCT00662857|516779918|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
143337593|NCT00662857|516779919|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
143337594|NCT00662857|516779918|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
143337595|NCT00662857|516779919|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
143337596|NCT00662857|516779918|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
143337597|NCT00662857|516779919|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
143337598|NCT00989092|516779920|FG000|Overall Study|Physician Decision|9|||
143337599|NCT00989092|516779921|FG001|Overall Study|Physician Decision|6|||
143337600|NCT00989092|516779920|FG000|Overall Study|Adverse Event|20|||
143337601|NCT00989092|516779921|FG001|Overall Study|Adverse Event|1|||
143388318|NCT02783300|516969244|FG005|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
143388319|NCT02783300|516969245|FG006|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
143388320|NCT02783300|516969246|FG007|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
143388321|NCT02783300|516969247|FG008|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
143388322|NCT02783300|516969248|FG009|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
143388323|NCT02783300|516969249|FG010|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
143388324|NCT02783300|516969250|FG011|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
143388325|NCT02783300|516969251|FG012|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
143388326|NCT02783300|516969252|FG013|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
143388327|NCT02783300|516969253|FG014|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
143388328|NCT02783300|516969254|FG015|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
143388329|NCT02783300|516969255|FG016|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
143388330|NCT02783300|516969256|FG017|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
143388331|NCT02783300|516969257|FG018|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
143388332|NCT02783300|516969258|FG019|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
143388333|NCT02783300|516969259|FG020|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
143388334|NCT02783300|516969260|FG021|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
143388335|NCT02783300|516969261|FG022|Part 2- Disease-specific Expansion Phase|Investigator discretion|2|||
143388336|NCT02783300|516969262|FG023|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
143388337|NCT02783300|516969263|FG024|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
143388338|NCT02783300|516969264|FG025|Part 2- Disease-specific Expansion Phase|Investigator discretion|4|||
143388339|NCT02783300|516969265|FG026|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
143388340|NCT02783300|516969239|FG000|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
143388341|NCT02783300|516969240|FG001|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
143388342|NCT02783300|516969241|FG002|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
143388343|NCT02783300|516969242|FG003|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
143388344|NCT02783300|516969243|FG004|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
143388345|NCT02783300|516969244|FG005|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
143388346|NCT02783300|516969245|FG006|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
143388347|NCT02783300|516969246|FG007|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
143388348|NCT02783300|516969247|FG008|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
143388349|NCT02783300|516969248|FG009|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
143388350|NCT02783300|516969249|FG010|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
143388351|NCT02783300|516969250|FG011|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
143388352|NCT02783300|516969251|FG012|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
143388353|NCT02783300|516969252|FG013|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
143388354|NCT02783300|516969253|FG014|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
143388355|NCT02783300|516969254|FG015|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
143388356|NCT02783300|516969255|FG016|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
143388357|NCT02783300|516969256|FG017|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
143388358|NCT02783300|516969257|FG018|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
143388359|NCT02783300|516969258|FG019|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
143388360|NCT02783300|516969259|FG020|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
143388361|NCT02783300|516969260|FG021|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
143388362|NCT02783300|516969261|FG022|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
143388363|NCT02783300|516969262|FG023|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
143388364|NCT02783300|516969263|FG024|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
143388365|NCT02783300|516969264|FG025|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
143388366|NCT02783300|516969265|FG026|Part 3- Dose Determination Phase|Withdrawal by Subject|1|||
143388367|NCT02783300|516969239|FG000|Part 3- Dose Determination Phase|Investigator discretion|0|||
143388368|NCT02783300|516969240|FG001|Part 3- Dose Determination Phase|Investigator discretion|0|||
143388369|NCT02783300|516969241|FG002|Part 3- Dose Determination Phase|Investigator discretion|0|||
143388370|NCT02783300|516969242|FG003|Part 3- Dose Determination Phase|Investigator discretion|0|||
143388371|NCT02783300|516969243|FG004|Part 3- Dose Determination Phase|Investigator discretion|0|||
143388372|NCT02783300|516969244|FG005|Part 3- Dose Determination Phase|Investigator discretion|0|||
143388373|NCT02783300|516969245|FG006|Part 3- Dose Determination Phase|Investigator discretion|0|||
143388374|NCT02783300|516969246|FG007|Part 3- Dose Determination Phase|Investigator discretion|0|||
143388375|NCT02783300|516969247|FG008|Part 3- Dose Determination Phase|Investigator discretion|0|||
143388376|NCT02783300|516969248|FG009|Part 3- Dose Determination Phase|Investigator discretion|0|||
143388377|NCT02783300|516969249|FG010|Part 3- Dose Determination Phase|Investigator discretion|0|||
143388378|NCT02783300|516969250|FG011|Part 3- Dose Determination Phase|Investigator discretion|0|||
143388379|NCT02783300|516969251|FG012|Part 3- Dose Determination Phase|Investigator discretion|0|||
143388380|NCT02783300|516969252|FG013|Part 3- Dose Determination Phase|Investigator discretion|0|||
143388381|NCT02783300|516969253|FG014|Part 3- Dose Determination Phase|Investigator discretion|0|||
143388382|NCT02783300|516969254|FG015|Part 3- Dose Determination Phase|Investigator discretion|0|||
143388383|NCT02783300|516969255|FG016|Part 3- Dose Determination Phase|Investigator discretion|0|||
143388384|NCT02783300|516969256|FG017|Part 3- Dose Determination Phase|Investigator discretion|0|||
143388385|NCT02783300|516969257|FG018|Part 3- Dose Determination Phase|Investigator discretion|0|||
143388386|NCT02783300|516969258|FG019|Part 3- Dose Determination Phase|Investigator discretion|0|||
143388387|NCT02783300|516969259|FG020|Part 3- Dose Determination Phase|Investigator discretion|0|||
143388388|NCT02783300|516969260|FG021|Part 3- Dose Determination Phase|Investigator discretion|0|||
143388389|NCT02783300|516969261|FG022|Part 3- Dose Determination Phase|Investigator discretion|0|||
143388390|NCT02783300|516969262|FG023|Part 3- Dose Determination Phase|Investigator discretion|0|||
143388391|NCT02783300|516969263|FG024|Part 3- Dose Determination Phase|Investigator discretion|0|||
143388392|NCT02783300|516969264|FG025|Part 3- Dose Determination Phase|Investigator discretion|0|||
143388393|NCT02783300|516969265|FG026|Part 3- Dose Determination Phase|Investigator discretion|3|||
143388394|NCT03535272|516969266|FG000|Overall Study|Lost to Follow-up|71|||
143388395|NCT03535272|516969267|FG001|Overall Study|Lost to Follow-up|73|||
143388396|NCT05592418|516969272|FG000|Overall Study|Adverse Event|1|||
143388397|NCT05592418|516969273|FG001|Overall Study|Adverse Event|0|||
143388398|NCT05592418|516969272|FG000|Overall Study|Lost to Follow-up|1|||
143388399|NCT05592418|516969273|FG001|Overall Study|Lost to Follow-up|3|||
143388400|NCT05592418|516969272|FG000|Overall Study|Withdrawal by Subject|2|||
143388401|NCT05592418|516969273|FG001|Overall Study|Withdrawal by Subject|7|||
143388402|NCT04831216|516969274|FG000|Overall Study|Lost to Follow-up|32|||
143388403|NCT02913872|516969277|FG000|Overall Study|Withdrawal by Subject|1|||
143388404|NCT03519581|516969280|FG000|Overall Study|Lost to Follow-up|3|||
143388405|NCT03519581|516969281|FG001|Overall Study|Lost to Follow-up|2|||
143388406|NCT03519581|516969280|FG000|Overall Study|Adverse Event|5|||
143388407|NCT03519581|516969281|FG001|Overall Study|Adverse Event|2|||
143388408|NCT03519581|516969280|FG000|Overall Study|Withdrawal by Subject|2|||
143388409|NCT03519581|516969281|FG001|Overall Study|Withdrawal by Subject|0|||
143388410|NCT03519581|516969280|FG000|Overall Study|Change to insurance|2|||
143388411|NCT03519581|516969281|FG001|Overall Study|Change to insurance|1|||
143388412|NCT03519581|516969280|FG000|Overall Study|Other|2|||
143388413|NCT03519581|516969281|FG001|Overall Study|Other|4|||
143388414|NCT03110315|516969282|FG000|Overall Study|Withdrawal by Subject|1|||
143388415|NCT03110315|516969283|FG001|Overall Study|Withdrawal by Subject|0|||
143388416|NCT05371652|516969285|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
143388417|NCT05371652|516969285|FG000|Overall Study|Withdrawal by Subject|12|||
143388418|NCT05371652|516969285|FG000|Overall Study|Adverse Event|1|||
143388419|NCT05371652|516969285|FG000|Overall Study|Other|11|||
143388420|NCT04410042|516969286|FG000|Overall Study|Not Eligible|1|||
143388421|NCT04410042|516969287|FG001|Overall Study|Not Eligible|1|||
143388422|NCT03978871|516969288|FG000|Overall Study|Lost to Follow-up|11|||
143388423|NCT03978871|516969289|FG001|Overall Study|Lost to Follow-up|12|||
143388424|NCT02811679|516969290|FG000|Overall Study|Adverse Event|1|||
143388425|NCT02811679|516969290|FG000|Overall Study|Lack of Efficacy|6|||
143388426|NCT02811679|516969290|FG000|Overall Study|Early study closure due to slow accrual|3|||
143388427|NCT03941860|516969291|FG000|Overall Study|Withdrawal by Subject|0|||
143388428|NCT03941860|516969292|FG001|Overall Study|Withdrawal by Subject|1|||
143388429|NCT01361711|516969293|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
143388430|NCT01361711|516969293|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
143388431|NCT01361711|516969293|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
143388432|NCT01361711|516969293|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
143388433|NCT01361711|516969293|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
143388434|NCT01361711|516969293|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
143388435|NCT01361711|516969293|FG000|Completed Week 18 of Treatment|Other|9|||
143388436|NCT01361711|516969293|FG000|10 Year Follow-up|Still in follow-up|22|||
143388437|NCT01361711|516969293|FG000|10 Year Follow-up|Death|7|||
143388438|NCT01361711|516969293|FG000|10 Year Follow-up|Developed new cancer|1|||
143388439|NCT01361711|516969293|FG000|10 Year Follow-up|Lost to Follow-up|2|||
143388440|NCT01361711|516969293|FG000|10 Year Follow-up|New treatment started|6|||
143388441|NCT01361711|516969293|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
143388442|NCT01361711|516969293|FG000|10 Year Follow-up|Progressive Disease|1|||
143388443|NCT03930342|516969294|FG000|Overall Study|Lost to Follow-up|70|||
143388444|NCT03930342|516969295|FG001|Overall Study|Lost to Follow-up|77|||
143388445|NCT01331005|516970874|FG000|Overall Study|Lost to Follow-up|2|||
143388446|NCT01331005|516970875|FG001|Overall Study|Lost to Follow-up|1|||
143388447|NCT01331005|516970874|FG000|Overall Study|Withdrawal by Subject|2|||
143388448|NCT01331005|516970875|FG001|Overall Study|Withdrawal by Subject|3|||
143388449|NCT01140880|516970878|FG000|Overall Study|Death|0|||
143388450|NCT01140880|516970879|FG001|Overall Study|Death|1|||
143388451|NCT01140880|516970878|FG000|Overall Study|Withdrawal by Subject|6|||
143388452|NCT01140880|516970879|FG001|Overall Study|Withdrawal by Subject|3|||
143388453|NCT01140880|516970878|FG000|Overall Study|Lost to Follow-up|8|||
143388454|NCT01140880|516970879|FG001|Overall Study|Lost to Follow-up|10|||
143388455|NCT01140880|516970878|FG000|Overall Study|Protocol Violation|0|||
143388456|NCT01140880|516970879|FG001|Overall Study|Protocol Violation|30|||
143388457|NCT03131648|516970881|FG000|Initial Treatment Period|Not dosed|2|||
143388458|NCT03131648|516970882|FG001|Initial Treatment Period|Not dosed|2|||
143388459|NCT03131648|516970883|FG002|Initial Treatment Period|Not dosed|0|||
143388460|NCT03131648|516970884|FG003|Initial Treatment Period|Not dosed|0|||
143388461|NCT03131648|516970885|FG004|Initial Treatment Period|Not dosed|0|||
143388462|NCT03131648|516970886|FG005|Initial Treatment Period|Not dosed|0|||
143388463|NCT03131648|516970887|FG006|Initial Treatment Period|Not dosed|0|||
143388464|NCT03131648|516970888|FG007|Initial Treatment Period|Not dosed|0|||
143388465|NCT03131648|516970881|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
143388466|NCT03131648|516970882|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
143388467|NCT03131648|516970883|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
143388468|NCT03131648|516970884|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
143388469|NCT03131648|516970885|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
143388470|NCT03131648|516970886|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
143388471|NCT03131648|516970887|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
143388472|NCT03131648|516970888|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
143388473|NCT03131648|516970881|FG000|Open-label Treatment|Discontinued IMP|0|||
143388474|NCT03131648|516970882|FG001|Open-label Treatment|Discontinued IMP|0|||
143388475|NCT03131648|516970883|FG002|Open-label Treatment|Discontinued IMP|0|||
143388476|NCT03131648|516970884|FG003|Open-label Treatment|Discontinued IMP|0|||
143388477|NCT03131648|516970885|FG004|Open-label Treatment|Discontinued IMP|0|||
143388478|NCT03131648|516970886|FG005|Open-label Treatment|Discontinued IMP|0|||
143388479|NCT03131648|516970887|FG006|Open-label Treatment|Discontinued IMP|112|||
143388480|NCT03131648|516970888|FG007|Open-label Treatment|Discontinued IMP|0|||
143388481|NCT03131648|516970881|FG000|Open-label Treatment|Completed Week 50|0|||
143388482|NCT03131648|516970882|FG001|Open-label Treatment|Completed Week 50|0|||
143337602|NCT00989092|516779920|FG000|Overall Study|Chemotherapy initiated|12|||
143388483|NCT03131648|516970883|FG002|Open-label Treatment|Completed Week 50|0|||
143388484|NCT03131648|516970884|FG003|Open-label Treatment|Completed Week 50|0|||
143388485|NCT03131648|516970885|FG004|Open-label Treatment|Completed Week 50|0|||
143388486|NCT03131648|516970886|FG005|Open-label Treatment|Completed Week 50|0|||
143388487|NCT03131648|516970887|FG006|Open-label Treatment|Completed Week 50|6|||
143388488|NCT03131648|516970888|FG007|Open-label Treatment|Completed Week 50|0|||
143388489|NCT03131648|516970881|FG000|Maintenance Treatment Period|Not dosed|0|||
143388490|NCT03131648|516970882|FG001|Maintenance Treatment Period|Not dosed|0|||
143388491|NCT03131648|516970883|FG002|Maintenance Treatment Period|Not dosed|3|||
143388492|NCT03131648|516970884|FG003|Maintenance Treatment Period|Not dosed|2|||
143388493|NCT03131648|516970885|FG004|Maintenance Treatment Period|Not dosed|1|||
143388494|NCT03131648|516970886|FG005|Maintenance Treatment Period|Not dosed|0|||
143388495|NCT03131648|516970887|FG006|Maintenance Treatment Period|Not dosed|0|||
143388496|NCT03131648|516970888|FG007|Maintenance Treatment Period|Not dosed|0|||
143388497|NCT03131648|516970881|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
143388498|NCT03131648|516970882|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
143388499|NCT03131648|516970883|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
143388500|NCT03131648|516970884|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
143388501|NCT03131648|516970885|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
143388502|NCT03131648|516970886|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
143388503|NCT03131648|516970887|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
143388504|NCT03131648|516970888|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
143388505|NCT03131648|516970881|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
143388506|NCT03131648|516970882|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
143388507|NCT03131648|516970883|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
143388508|NCT03131648|516970884|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
143388509|NCT03131648|516970885|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
143337603|NCT00989092|516779921|FG001|Overall Study|Chemotherapy initiated|4|||
143337604|NCT00989092|516779920|FG000|Overall Study|Withdrawal by Subject|17|||
143337605|NCT00989092|516779921|FG001|Overall Study|Withdrawal by Subject|9|||
143337606|NCT00989092|516779920|FG000|Overall Study|Death|14|||
143337607|NCT00989092|516779921|FG001|Overall Study|Death|2|||
143337608|NCT00989092|516779920|FG000|Overall Study|Ineligibility determined|3|||
143337609|NCT00989092|516779921|FG001|Overall Study|Ineligibility determined|3|||
143337610|NCT00989092|516779920|FG000|Overall Study|Lost to Follow-up|6|||
143337611|NCT00989092|516779921|FG001|Overall Study|Lost to Follow-up|2|||
143337612|NCT00989092|516779920|FG000|Overall Study|Other|3|||
143337613|NCT00989092|516779921|FG001|Overall Study|Other|1|||
143337614|NCT00989092|516779920|FG000|Overall Study|Protocol deviation|2|||
143337615|NCT00989092|516779921|FG001|Overall Study|Protocol deviation|0|||
143337616|NCT00989092|516779920|FG000|Overall Study|Erythropoietin therapy initiated|2|||
143337617|NCT00989092|516779921|FG001|Overall Study|Erythropoietin therapy initiated|0|||
143337618|NCT00989092|516779920|FG000|Overall Study|Did not receive study drug|2|||
143337619|NCT00989092|516779921|FG001|Overall Study|Did not receive study drug|0|||
143388510|NCT03131648|516970886|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
143337620|NCT03412812|516779922|FG000|Level 1|Death|3|||
143337621|NCT03412812|516779923|FG001|Level 1|Death|0|||
143388511|NCT03131648|516970887|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
143388512|NCT03131648|516970888|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
143337622|NCT03412812|516779922|FG000|Level 1|Adverse Event|0|||
143337623|NCT03412812|516779923|FG001|Level 1|Adverse Event|1|||
143337624|NCT03315143|516779928|FG000|Overall Study|Death|240|||
143337625|NCT03315143|516779929|FG001|Overall Study|Death|246|||
143337626|NCT03315143|516779928|FG000|Overall Study|Withdrawal by Subject|57|||
143337627|NCT03315143|516779929|FG001|Overall Study|Withdrawal by Subject|68|||
143337628|NCT03315143|516779928|FG000|Overall Study|Site Terminated by Sponsor|256|||
143337629|NCT03315143|516779929|FG001|Overall Study|Site Terminated by Sponsor|282|||
143337630|NCT03315143|516779928|FG000|Overall Study|Study Terminated by Sponsor|4723|||
143337631|NCT03315143|516779929|FG001|Overall Study|Study Terminated by Sponsor|4664|||
143337632|NCT03315143|516779928|FG000|Overall Study|Reason not Specified|16|||
143337633|NCT03315143|516779929|FG001|Overall Study|Reason not Specified|32|||
143337634|NCT02052310|516779930|FG000|Overall Study|Death|64|||
143337635|NCT02052310|516779931|FG001|Overall Study|Death|54|||
143337636|NCT02052310|516779930|FG000|Overall Study|Withdrawal by Subject|37|||
143337637|NCT02052310|516779931|FG001|Overall Study|Withdrawal by Subject|49|||
143337638|NCT02052310|516779930|FG000|Overall Study|Other than specified|32|||
143337639|NCT02052310|516779931|FG001|Overall Study|Other than specified|29|||
143337640|NCT02052310|516779930|FG000|Overall Study|Adverse Event|29|||
143337641|NCT02052310|516779931|FG001|Overall Study|Adverse Event|22|||
143337642|NCT02052310|516779930|FG000|Overall Study|Kidney Transplant|23|||
143337643|NCT02052310|516779931|FG001|Overall Study|Kidney Transplant|29|||
143337644|NCT02052310|516779930|FG000|Overall Study|Physician Decision|14|||
143337645|NCT02052310|516779931|FG001|Overall Study|Physician Decision|7|||
143337646|NCT02052310|516779930|FG000|Overall Study|Lack of Efficacy|6|||
143337647|NCT02052310|516779931|FG001|Overall Study|Lack of Efficacy|1|||
143337648|NCT02052310|516779930|FG000|Overall Study|Site Terminated by Sponsor|5|||
143337649|NCT02052310|516779931|FG001|Overall Study|Site Terminated by Sponsor|13|||
143337650|NCT02052310|516779930|FG000|Overall Study|Lost to Follow-up|4|||
143337651|NCT02052310|516779931|FG001|Overall Study|Lost to Follow-up|2|||
143337652|NCT02052310|516779930|FG000|Overall Study|Protocol Violation|1|||
143337653|NCT02052310|516779931|FG001|Overall Study|Protocol Violation|6|||
143337654|NCT02563002|516779932|FG000|Overall Study|Death|72|||
143337655|NCT02563002|516779933|FG001|Overall Study|Death|87|||
143337656|NCT02563002|516779932|FG000|Overall Study|Lost to Follow-up|5|||
143337657|NCT02563002|516779933|FG001|Overall Study|Lost to Follow-up|0|||
143337658|NCT02563002|516779932|FG000|Overall Study|Physician Decision|0|||
143337659|NCT02563002|516779933|FG001|Overall Study|Physician Decision|2|||
143337660|NCT02563002|516779932|FG000|Overall Study|Withdrawal by Subject|2|||
143337661|NCT02563002|516779933|FG001|Overall Study|Withdrawal by Subject|10|||
143337662|NCT02563002|516779932|FG000|Overall Study|Sponsor decision|74|||
143337663|NCT02563002|516779933|FG001|Overall Study|Sponsor decision|55|||
143337664|NCT04452877|516779940|FG000|Overall Study|Adverse Event|5|||
143337665|NCT04452877|516779940|FG000|Overall Study|Lost to Follow-up|1|||
143337666|NCT04452877|516779940|FG000|Overall Study|Physician Decision|4|||
143337667|NCT04452877|516779940|FG000|Overall Study|Progressive Disease|18|||
143337668|NCT04452877|516779940|FG000|Overall Study|Withdrawal by Subject|3|||
143337669|NCT01505387|516779941|FG000|Overall Study|Protocol Violation|1|||
143337670|NCT01505387|516779942|FG001|Overall Study|Protocol Violation|0|||
143337671|NCT01505387|516779941|FG000|Overall Study|Withdrawal by Subject|1|||
143337672|NCT01505387|516779942|FG001|Overall Study|Withdrawal by Subject|1|||
143337673|NCT01804816|516779943|FG000|No acupuncture (initial 5 weeks)|Withdrawal by Subject|3|||
143337674|NCT01804816|516779943|FG000|Acupuncture (second 5 weeks)|Physician Decision|1|||
143337675|NCT00952822|516779946|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
143337676|NCT00952822|516779947|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
143337677|NCT00952822|516779948|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
143337678|NCT00952822|516779949|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
143337679|NCT00952822|516779946|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
143337680|NCT00952822|516779947|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
143337681|NCT00952822|516779948|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
143337682|NCT00952822|516779949|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
143337683|NCT02684006|516779953|FG000|Overall Study|Other|18|||
143337684|NCT02684006|516779954|FG001|Overall Study|Other|6|||
143337685|NCT02684006|516779953|FG000|Overall Study|Protocol Violation|2|||
143337686|NCT02684006|516779954|FG001|Overall Study|Protocol Violation|1|||
143337687|NCT02684006|516779953|FG000|Overall Study|Non-compliance with study drug|1|||
143337688|NCT02684006|516779954|FG001|Overall Study|Non-compliance with study drug|1|||
143337689|NCT02684006|516779953|FG000|Overall Study|No longer met eligibility criteria|6|||
143337690|NCT02684006|516779954|FG001|Overall Study|No longer met eligibility criteria|2|||
143337691|NCT02684006|516779953|FG000|Overall Study|Lost to Follow-up|0|||
143337692|NCT02684006|516779954|FG001|Overall Study|Lost to Follow-up|1|||
143337693|NCT02684006|516779953|FG000|Overall Study|Death|25|||
143337694|NCT02684006|516779954|FG001|Overall Study|Death|22|||
143337695|NCT02684006|516779953|FG000|Overall Study|Global deterioration of health status|18|||
143337696|NCT02684006|516779954|FG001|Overall Study|Global deterioration of health status|20|||
143337697|NCT02684006|516779953|FG000|Overall Study|Physician Decision|15|||
143337698|NCT02684006|516779954|FG001|Overall Study|Physician Decision|8|||
143337699|NCT02684006|516779953|FG000|Overall Study|Adverse Event|86|||
143337700|NCT02684006|516779954|FG001|Overall Study|Adverse Event|65|||
143337701|NCT02684006|516779953|FG000|Overall Study|Withdrawal by Subject|29|||
143337702|NCT02684006|516779954|FG001|Overall Study|Withdrawal by Subject|43|||
143337703|NCT02684006|516779953|FG000|Overall Study|Progressive disease|236|||
143337704|NCT02684006|516779954|FG001|Overall Study|Progressive disease|266|||
143337705|NCT02684006|516779953|FG000|Overall Study|Participation terminated by sponsor|6|||
143337706|NCT02684006|516779954|FG001|Overall Study|Participation terminated by sponsor|9|||
143337707|NCT05103384|516779955|FG000|Overall Study|Too severely affected Off Meds/Off DBS to complete entire protocol|4|||
143337708|NCT05608499|516779956|FG000|Overall Study|Lack of Efficacy|1|||
143337709|NCT05608499|516779957|FG001|Overall Study|Lack of Efficacy|0|||
143337710|NCT05608499|516779956|FG000|Overall Study|Lost to Follow-up|0|||
143337711|NCT05608499|516779957|FG001|Overall Study|Lost to Follow-up|1|||
143337712|NCT00514735|516779958|FG000|Overall Study|Withdrawal by Subject|13|||
143337713|NCT00514735|516779959|FG001|Overall Study|Withdrawal by Subject|5|||
143337714|NCT00514735|516779958|FG000|Overall Study|Death|1|||
143337715|NCT00514735|516779959|FG001|Overall Study|Death|0|||
143337716|NCT00514735|516779958|FG000|Overall Study|Lost to Follow-up|0|||
143337717|NCT00514735|516779959|FG001|Overall Study|Lost to Follow-up|1|||
143337718|NCT04393441|516779965|FG000|Overall Study|Adverse Event|0|||
143337719|NCT04393441|516779966|FG001|Overall Study|Adverse Event|3|||
143337720|NCT04393441|516779965|FG000|Overall Study|Withdrawal by Subject|5|||
143337721|NCT04393441|516779966|FG001|Overall Study|Withdrawal by Subject|7|||
143337722|NCT04393441|516779965|FG000|Overall Study|Lost to Follow-up|0|||
143337723|NCT04393441|516779966|FG001|Overall Study|Lost to Follow-up|2|||
143337724|NCT04393441|516779965|FG000|Overall Study|Protocol Deviation|2|||
143337725|NCT04393441|516779966|FG001|Overall Study|Protocol Deviation|1|||
143337726|NCT04393441|516779965|FG000|Overall Study|Reason not Specified|1|||
143337727|NCT04393441|516779966|FG001|Overall Study|Reason not Specified|1|||
143337728|NCT04003610|516779967|FG000|Overall Study|Lost to Follow-up|0|||
143337729|NCT04003610|516779968|FG001|Overall Study|Lost to Follow-up|1|||
143337730|NCT04003610|516779969|FG002|Overall Study|Lost to Follow-up|0|||
143337731|NCT04003610|516779967|FG000|Overall Study|Death|0|||
143337732|NCT04003610|516779968|FG001|Overall Study|Death|0|||
143337733|NCT04003610|516779969|FG002|Overall Study|Death|3|||
143337734|NCT04003610|516779967|FG000|Overall Study|Study Terminated by Sponsor|0|||
143337735|NCT04003610|516779968|FG001|Overall Study|Study Terminated by Sponsor|0|||
143337736|NCT04003610|516779969|FG002|Overall Study|Study Terminated by Sponsor|3|||
143337737|NCT00771810|516779970|FG000|Overall Study|Adverse Event|3|||
143337738|NCT00771810|516779971|FG001|Overall Study|Adverse Event|0|||
143337739|NCT00771810|516779972|FG002|Overall Study|Adverse Event|2|||
143337740|NCT00771810|516779970|FG000|Overall Study|Lost to Follow-up|0|||
143337741|NCT00771810|516779971|FG001|Overall Study|Lost to Follow-up|0|||
143337742|NCT00771810|516779972|FG002|Overall Study|Lost to Follow-up|1|||
143337743|NCT00771810|516779970|FG000|Overall Study|Physician Decision|1|||
143337744|NCT00771810|516779971|FG001|Overall Study|Physician Decision|2|||
143337745|NCT00771810|516779972|FG002|Overall Study|Physician Decision|2|||
143337746|NCT00771810|516779970|FG000|Overall Study|Protocol Violation|0|||
143337747|NCT00771810|516779971|FG001|Overall Study|Protocol Violation|1|||
143337748|NCT00771810|516779972|FG002|Overall Study|Protocol Violation|1|||
143337749|NCT00771810|516779970|FG000|Overall Study|Withdrawal by Subject|1|||
143337750|NCT00771810|516779971|FG001|Overall Study|Withdrawal by Subject|2|||
143337751|NCT00771810|516779972|FG002|Overall Study|Withdrawal by Subject|0|||
143337752|NCT00771810|516779970|FG000|Overall Study|Other|0|||
143337753|NCT00771810|516779971|FG001|Overall Study|Other|0|||
143337754|NCT00771810|516779972|FG002|Overall Study|Other|1|||
143337755|NCT02660827|516779979|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
143337756|NCT02660827|516779979|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
143337757|NCT02660827|516779979|FG000|From Study to End of Continued Access|Adverse Event|3|||
143337758|NCT02660827|516779979|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
143337759|NCT02660827|516779979|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
143337760|NCT02660827|516779979|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
143337761|NCT02660827|516779979|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
143337762|NCT02660827|516779979|FG000|Period 2: Continued Access Period|Adverse Event|3|||
143388513|NCT03131648|516970881|FG000|Maintenance Treatment Period|Completed Week 50|0|||
143388514|NCT03131648|516970882|FG001|Maintenance Treatment Period|Completed Week 50|0|||
143388515|NCT03131648|516970883|FG002|Maintenance Treatment Period|Completed Week 50|0|||
143388516|NCT03131648|516970884|FG003|Maintenance Treatment Period|Completed Week 50|0|||
143388517|NCT03131648|516970885|FG004|Maintenance Treatment Period|Completed Week 50|1|||
143388518|NCT03131648|516970886|FG005|Maintenance Treatment Period|Completed Week 50|0|||
143388519|NCT03131648|516970887|FG006|Maintenance Treatment Period|Completed Week 50|0|||
143388520|NCT03131648|516970888|FG007|Maintenance Treatment Period|Completed Week 50|0|||
143388521|NCT03131648|516970881|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
143388522|NCT03131648|516970882|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
143388523|NCT03131648|516970883|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
143388524|NCT03131648|516970884|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
143388525|NCT03131648|516970885|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
143388526|NCT03131648|516970886|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
143388527|NCT03131648|516970887|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
143388528|NCT03131648|516970888|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
143388529|NCT04150718|516970896|FG000|Overall Study|Withdrawal by Subject|2|||
143388530|NCT04150718|516970897|FG001|Overall Study|Withdrawal by Subject|7|||
143388531|NCT04150718|516970898|FG002|Overall Study|Withdrawal by Subject|1|||
143388532|NCT04150718|516970896|FG000|Overall Study|Lost to Follow-up|1|||
143388533|NCT04150718|516970897|FG001|Overall Study|Lost to Follow-up|2|||
143388534|NCT04150718|516970898|FG002|Overall Study|Lost to Follow-up|0|||
143388535|NCT04150718|516970896|FG000|Overall Study|Ineligible|1|||
143388536|NCT04150718|516970897|FG001|Overall Study|Ineligible|0|||
143388537|NCT04150718|516970898|FG002|Overall Study|Ineligible|10|||
143388538|NCT02592330|516970899|FG000|Overall Study|Withdrawal by Subject|1|||
143388539|NCT02592330|516970900|FG001|Overall Study|Withdrawal by Subject|0|||
143388540|NCT02592330|516970899|FG000|Overall Study|Failed Biopsy|1|||
143388541|NCT02592330|516970900|FG001|Overall Study|Failed Biopsy|0|||
143388542|NCT03090152|516970901|FG000|Overall Study|Withdrawal by Subject|0|||
143388543|NCT03090152|516970902|FG001|Overall Study|Withdrawal by Subject|2|||
143388544|NCT03090152|516970903|FG002|Overall Study|Withdrawal by Subject|1|||
143388545|NCT03090152|516970901|FG000|Overall Study|Surgery Canceled|1|||
143388546|NCT03090152|516970902|FG001|Overall Study|Surgery Canceled|0|||
143388547|NCT03090152|516970903|FG002|Overall Study|Surgery Canceled|0|||
143388548|NCT03090152|516970901|FG000|Overall Study|Epidural catheter could not be placed|0|||
143388549|NCT03090152|516970902|FG001|Overall Study|Epidural catheter could not be placed|2|||
143388550|NCT03090152|516970903|FG002|Overall Study|Epidural catheter could not be placed|0|||
143388551|NCT05324124|516970907|FG000|Period 1|Withdrawal by Subject|1|||
143388552|NCT05324124|516970908|FG001|Period 1|Withdrawal by Subject|0|||
143388553|NCT05324124|516970907|FG000|Period 1|Physician Decision|0|||
143388554|NCT05324124|516970908|FG001|Period 1|Physician Decision|1|||
143388555|NCT04034251|516970909|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
143388556|NCT04034251|516970910|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
143388557|NCT04034251|516970911|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
143388558|NCT05034952|516970912|FG000|Overall Study|Adverse Event|1|||
143388559|NCT05034952|516970913|FG001|Overall Study|Adverse Event|0|||
143388560|NCT05034952|516970914|FG002|Overall Study|Adverse Event|0|||
143388561|NCT05034952|516970915|FG003|Overall Study|Adverse Event|0|||
143388562|NCT05034952|516970912|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
143388563|NCT05034952|516970913|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
143388564|NCT05034952|516970914|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
143388565|NCT05034952|516970915|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
143388566|NCT05034952|516970912|FG000|Overall Study|Lost to Follow-up|1|||
143388567|NCT05034952|516970913|FG001|Overall Study|Lost to Follow-up|4|||
143388568|NCT05034952|516970914|FG002|Overall Study|Lost to Follow-up|3|||
143388569|NCT05034952|516970915|FG003|Overall Study|Lost to Follow-up|3|||
143388570|NCT05034952|516970912|FG000|Overall Study|Other|0|||
143388571|NCT05034952|516970913|FG001|Overall Study|Other|0|||
143388572|NCT05034952|516970914|FG002|Overall Study|Other|0|||
143388573|NCT05034952|516970915|FG003|Overall Study|Other|1|||
143388574|NCT04950660|516970920|FG000|Overall Study|Protocol Violation|4|||
143388575|NCT04950660|516970921|FG001|Overall Study|Protocol Violation|2|||
143388576|NCT04950660|516970920|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
143388577|NCT04950660|516970921|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
143388578|NCT04950660|516970920|FG000|Overall Study|Withdrawal by Subject|0|||
143388579|NCT04950660|516970921|FG001|Overall Study|Withdrawal by Subject|1|||
143388580|NCT04950660|516970920|FG000|Overall Study|Hypotension|1|||
143388581|NCT04950660|516970921|FG001|Overall Study|Hypotension|0|||
143388582|NCT04783935|516970936|FG000|Overall Study|Withdrawal by Subject|6|||
143388583|NCT04783935|516970936|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
143388584|NCT04783935|516970936|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
143388585|NCT04783935|516970936|FG000|Overall Study|Lost to Follow-up|3|||
143388586|NCT04783935|516970936|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
143388587|NCT02437318|516970938|FG000|Overall Study|Progressive disease|207|||
143388588|NCT02437318|516970939|FG001|Overall Study|Progressive disease|240|||
143388589|NCT02437318|516970938|FG000|Overall Study|Subject/guardian decision|24|||
143388590|NCT02437318|516970939|FG001|Overall Study|Subject/guardian decision|11|||
143388591|NCT02437318|516970938|FG000|Overall Study|Physician Decision|29|||
143388592|NCT02437318|516970939|FG001|Overall Study|Physician Decision|22|||
143388593|NCT02437318|516970938|FG000|Overall Study|Adverse Event|14|||
143388594|NCT02437318|516970939|FG001|Overall Study|Adverse Event|4|||
143388595|NCT02437318|516970938|FG000|Overall Study|Death|4|||
143388596|NCT02437318|516970939|FG001|Overall Study|Death|4|||
143388597|NCT02437318|516970938|FG000|Overall Study|Protocol deviation|5|||
143388598|NCT02437318|516970939|FG001|Overall Study|Protocol deviation|7|||
143388599|NCT02437318|516970938|FG000|Overall Study|Sponsor decision|1|||
143388600|NCT02437318|516970939|FG001|Overall Study|Sponsor decision|0|||
143388601|NCT06074523|516970940|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
143388602|NCT06074523|516970940|FG000|Overall Study|Withdrawal by Subject|1|||
143388603|NCT03281291|516970941|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
143388604|NCT03281291|516970942|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
143388605|NCT03281291|516970943|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
143388606|NCT03281291|516970944|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
143388607|NCT03281291|516970945|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
143388608|NCT03281291|516970941|FG000|Overall Study|Protocol Deviation|2|||
143388609|NCT03281291|516970942|FG001|Overall Study|Protocol Deviation|0|||
143388610|NCT03281291|516970943|FG002|Overall Study|Protocol Deviation|1|||
143388611|NCT03281291|516970944|FG003|Overall Study|Protocol Deviation|2|||
143388612|NCT03281291|516970945|FG004|Overall Study|Protocol Deviation|1|||
143388613|NCT03281291|516970941|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
143388614|NCT03281291|516970942|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
143388615|NCT03281291|516970943|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
143388616|NCT03281291|516970944|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
143388617|NCT03281291|516970945|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
143388618|NCT03281291|516970941|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
143388619|NCT03281291|516970942|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
143388620|NCT03281291|516970943|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
143388621|NCT03281291|516970944|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
143388622|NCT03281291|516970945|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
143388623|NCT03281291|516970941|FG000|Overall Study|Lost to Follow-up|10|||
143388624|NCT03281291|516970942|FG001|Overall Study|Lost to Follow-up|10|||
143388625|NCT03281291|516970943|FG002|Overall Study|Lost to Follow-up|4|||
143388626|NCT03281291|516970944|FG003|Overall Study|Lost to Follow-up|6|||
143388627|NCT03281291|516970945|FG004|Overall Study|Lost to Follow-up|10|||
143388628|NCT03281291|516970941|FG000|Overall Study|Other|0|||
143388629|NCT03281291|516970942|FG001|Overall Study|Other|2|||
143388630|NCT03281291|516970943|FG002|Overall Study|Other|0|||
143388631|NCT03281291|516970944|FG003|Overall Study|Other|2|||
143388632|NCT03281291|516970945|FG004|Overall Study|Other|1|||
143388633|NCT00961571|516970946|FG000|Overall Study|Physician Decision|39|||
143388634|NCT05337748|516970948|FG000|Overall Study|Withdrawal by Subject|1|||
143388635|NCT05337748|516970949|FG001|Overall Study|Withdrawal by Subject|0|||
143388636|NCT05337748|516970948|FG000|Overall Study|Death|1|||
143388637|NCT05337748|516970949|FG001|Overall Study|Death|0|||
143388638|NCT02506959|516970950|FG000|Overall Study|Physician Decision|2|||
143388639|NCT02506959|516970951|FG001|Overall Study|Physician Decision|1|||
143388640|NCT02312557|516970957|FG000|Overall Study|Survival follow-up|4|||
143388641|NCT02736409|516970958|FG000|Overall Study|Withdrawal by Subject|4|||
143388642|NCT02736409|516970959|FG001|Overall Study|Withdrawal by Subject|2|||
143388643|NCT02736409|516970960|FG002|Overall Study|Withdrawal by Subject|17|||
143388644|NCT02736409|516970961|FG003|Overall Study|Withdrawal by Subject|3|||
143388645|NCT02736409|516970958|FG000|Overall Study|Non-Compliance with Study Drug|0|||
143388646|NCT02736409|516970959|FG001|Overall Study|Non-Compliance with Study Drug|0|||
143388647|NCT02736409|516970960|FG002|Overall Study|Non-Compliance with Study Drug|0|||
143388648|NCT02736409|516970961|FG003|Overall Study|Non-Compliance with Study Drug|1|||
143388649|NCT02736409|516970958|FG000|Overall Study|Adverse Event|0|||
143388650|NCT02736409|516970959|FG001|Overall Study|Adverse Event|1|||
143388651|NCT02736409|516970960|FG002|Overall Study|Adverse Event|5|||
143388652|NCT02736409|516970961|FG003|Overall Study|Adverse Event|4|||
143388653|NCT02736409|516970958|FG000|Overall Study|Other|0|||
143388654|NCT02736409|516970959|FG001|Overall Study|Other|0|||
143388655|NCT02736409|516970960|FG002|Overall Study|Other|1|||
143388656|NCT02736409|516970961|FG003|Overall Study|Other|1|||
143388657|NCT02736409|516970958|FG000|Overall Study|Pregnancy|0|||
143388658|NCT02736409|516970959|FG001|Overall Study|Pregnancy|0|||
143388659|NCT02736409|516970960|FG002|Overall Study|Pregnancy|1|||
143388660|NCT02736409|516970961|FG003|Overall Study|Pregnancy|0|||
143388661|NCT02736409|516970958|FG000|Overall Study|Lost to Follow-up|0|||
143388662|NCT02736409|516970959|FG001|Overall Study|Lost to Follow-up|0|||
143388663|NCT02736409|516970960|FG002|Overall Study|Lost to Follow-up|2|||
143388664|NCT02736409|516970961|FG003|Overall Study|Lost to Follow-up|1|||
143388665|NCT02736409|516970958|FG000|Overall Study|Physician Decision|0|||
143388666|NCT02736409|516970959|FG001|Overall Study|Physician Decision|0|||
143388667|NCT02736409|516970960|FG002|Overall Study|Physician Decision|0|||
143388668|NCT02736409|516970961|FG003|Overall Study|Physician Decision|2|||
143388669|NCT04390048|516970962|FG000|Overall Study|Withdrawal by Subject|1|||
143388670|NCT04390048|516970963|FG001|Overall Study|Withdrawal by Subject|3|||
143388671|NCT03126019|516970964|FG000|Overall Study|Death|5|||
143388672|NCT03126019|516970965|FG001|Overall Study|Death|27|||
143388673|NCT03126019|516970964|FG000|Overall Study|Lost to Follow-up|2|||
143388674|NCT03126019|516970965|FG001|Overall Study|Lost to Follow-up|4|||
143388675|NCT03126019|516970964|FG000|Overall Study|Withdrawal by Subject|1|||
143388676|NCT03126019|516970965|FG001|Overall Study|Withdrawal by Subject|9|||
143388677|NCT03126019|516970964|FG000|Overall Study|Physician Decision|1|||
143388678|NCT03126019|516970965|FG001|Overall Study|Physician Decision|0|||
143388679|NCT03126019|516970964|FG000|Overall Study|Transitioned to Rollover Study|0|||
143388680|NCT03126019|516970965|FG001|Overall Study|Transitioned to Rollover Study|11|||
143388681|NCT03126019|516970964|FG000|Overall Study|Did Not Return to Site for Care|0|||
143388682|NCT03126019|516970965|FG001|Overall Study|Did Not Return to Site for Care|1|||
143388683|NCT03126019|516970964|FG000|Overall Study|Site Closed|0|||
143388684|NCT03126019|516970965|FG001|Overall Study|Site Closed|1|||
143388685|NCT06283173|516971000|FG000|Overall Study|Did not show for first visit|10|||
143388686|NCT06283173|516971000|FG000|Overall Study|Lost to Follow-up|12|||
143388687|NCT06283173|516971000|FG000|Overall Study|Physician Decision|7|||
143388688|NCT05563246|516971010|FG000|Overall Study|Withdrawal by Subject|1|||
143388689|NCT05563246|516971011|FG001|Overall Study|Withdrawal by Subject|2|||
143388690|NCT05563246|516971012|FG002|Overall Study|Withdrawal by Subject|0|||
143388691|NCT05563246|516971013|FG003|Overall Study|Withdrawal by Subject|0|||
143388692|NCT05563246|516971010|FG000|Overall Study|Protocol Deviation|0|||
143388693|NCT05563246|516971011|FG001|Overall Study|Protocol Deviation|1|||
143388694|NCT05563246|516971012|FG002|Overall Study|Protocol Deviation|0|||
143388695|NCT05563246|516971013|FG003|Overall Study|Protocol Deviation|0|||
143388696|NCT05563246|516971010|FG000|Overall Study|Physician Decision|0|||
143388697|NCT05563246|516971011|FG001|Overall Study|Physician Decision|1|||
143388698|NCT05563246|516971012|FG002|Overall Study|Physician Decision|0|||
143388699|NCT05563246|516971013|FG003|Overall Study|Physician Decision|0|||
143388700|NCT05563246|516971010|FG000|Overall Study|Adverse Event|0|||
143388701|NCT05563246|516971011|FG001|Overall Study|Adverse Event|0|||
143388702|NCT05563246|516971012|FG002|Overall Study|Adverse Event|2|||
143388703|NCT05563246|516971013|FG003|Overall Study|Adverse Event|0|||
143388704|NCT05563246|516971010|FG000|Overall Study|Lost to Follow-up|0|||
143388705|NCT05563246|516971011|FG001|Overall Study|Lost to Follow-up|0|||
143388706|NCT05563246|516971012|FG002|Overall Study|Lost to Follow-up|1|||
143388707|NCT05563246|516971013|FG003|Overall Study|Lost to Follow-up|0|||
143388708|NCT03763708|516971017|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
143388709|NCT03763708|516971018|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
143388710|NCT03763708|516971019|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
143388711|NCT03763708|516971020|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
143388712|NCT03763708|516971021|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
143388713|NCT03763708|516971022|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
143388714|NCT03763708|516971023|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
143388715|NCT03763708|516971024|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
143388716|NCT03763708|516971025|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
143388717|NCT03763708|516971017|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
143388718|NCT03763708|516971018|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
143388719|NCT03763708|516971019|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
143388720|NCT03763708|516971020|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
143388721|NCT03763708|516971021|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
143388722|NCT03763708|516971022|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
143388723|NCT03763708|516971023|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
143388724|NCT03763708|516971024|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
143388725|NCT03763708|516971025|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
143388726|NCT03763708|516971017|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
143388727|NCT03763708|516971018|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
143388728|NCT03763708|516971019|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
143337763|NCT01422408|516779980|FG000|Overall Study|Adverse Event|1|||
143337764|NCT01422408|516779980|FG000|Overall Study|Withdrawal by Subject|3|||
143337765|NCT04672941|516779981|FG000|Overall Study|Investigator decision|1|||
143337766|NCT04672941|516779981|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
143337767|NCT04672941|516779981|FG000|Overall Study|COVID-19 related but no adverse event|1|||
143337768|NCT04672941|516779981|FG000|Overall Study|Adverse Event|2|||
143388729|NCT03763708|516971020|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
143388730|NCT03763708|516971021|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
143388731|NCT03763708|516971022|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
143337769|NCT04672941|516779981|FG000|Overall Study|Lost to Follow-up|2|||
143337770|NCT02953938|516779982|FG000|Overall Study|Adverse Event|0|||
143337771|NCT02953938|516779983|FG001|Overall Study|Adverse Event|1|||
143337772|NCT02953938|516779982|FG000|Overall Study|Withdrawal by Subject|1|||
143337773|NCT02953938|516779983|FG001|Overall Study|Withdrawal by Subject|1|||
143337774|NCT04274894|516779987|FG000|Overall Study|Adverse Event|7|||
143337775|NCT04274894|516779987|FG000|Overall Study|Withdrew consent|5|||
143337776|NCT04274894|516779987|FG000|Overall Study|Lost to Follow-up|9|||
143337777|NCT04274894|516779987|FG000|Overall Study|COVID-19 infection|1|||
143337778|NCT04274894|516779987|FG000|Overall Study|Other, not specified|20|||
143337779|NCT01939548|516779988|FG000|Overall Study|Non compliance|0|||
143337780|NCT01939548|516779989|FG001|Overall Study|Non compliance|2|||
143337781|NCT01939548|516779990|FG002|Overall Study|Non compliance|0|||
143337782|NCT01939548|516779988|FG000|Overall Study|Study Terminated by Sponsor|17|||
143337783|NCT01939548|516779989|FG001|Overall Study|Study Terminated by Sponsor|19|||
143337784|NCT01939548|516779990|FG002|Overall Study|Study Terminated by Sponsor|12|||
143337785|NCT01939548|516779988|FG000|Overall Study|Insufficient Clinical Response|1|||
143337786|NCT01939548|516779989|FG001|Overall Study|Insufficient Clinical Response|0|||
143337787|NCT01939548|516779990|FG002|Overall Study|Insufficient Clinical Response|0|||
143337788|NCT01939548|516779988|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
143337789|NCT01939548|516779989|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
143337790|NCT01939548|516779990|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
143337791|NCT01939548|516779988|FG000|Overall Study|Withdrawal by Subject|4|||
143337792|NCT01939548|516779989|FG001|Overall Study|Withdrawal by Subject|4|||
143337793|NCT01939548|516779990|FG002|Overall Study|Withdrawal by Subject|1|||
143337794|NCT01939548|516779988|FG000|Overall Study|Protocol Violation|7|||
143337795|NCT01939548|516779989|FG001|Overall Study|Protocol Violation|6|||
143337796|NCT01939548|516779990|FG002|Overall Study|Protocol Violation|5|||
143337797|NCT01939548|516779988|FG000|Overall Study|Lost to Follow-up|5|||
143337798|NCT01939548|516779989|FG001|Overall Study|Lost to Follow-up|5|||
143337799|NCT01939548|516779990|FG002|Overall Study|Lost to Follow-up|3|||
143337800|NCT01939548|516779988|FG000|Overall Study|Adverse Event|2|||
143337801|NCT01939548|516779989|FG001|Overall Study|Adverse Event|9|||
143337802|NCT01939548|516779990|FG002|Overall Study|Adverse Event|7|||
143337803|NCT01939548|516779988|FG000|Overall Study|Death|0|||
143337804|NCT01939548|516779989|FG001|Overall Study|Death|0|||
143337805|NCT01939548|516779990|FG002|Overall Study|Death|1|||
143337806|NCT01939548|516779988|FG000|Overall Study|Participant dropped|0|||
143337807|NCT01939548|516779989|FG001|Overall Study|Participant dropped|0|||
143337808|NCT01939548|516779990|FG002|Overall Study|Participant dropped|1|||
143337809|NCT01939548|516779988|FG000|Overall Study|Participant unwilling to continue|0|||
143337810|NCT01939548|516779989|FG001|Overall Study|Participant unwilling to continue|1|||
143337811|NCT01939548|516779990|FG002|Overall Study|Participant unwilling to continue|0|||
143337812|NCT01939548|516779988|FG000|Overall Study|Participant withdrew consent|0|||
143337813|NCT01939548|516779989|FG001|Overall Study|Participant withdrew consent|2|||
143337814|NCT01939548|516779990|FG002|Overall Study|Participant withdrew consent|0|||
143388732|NCT03763708|516971023|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
143388733|NCT03763708|516971024|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
143388734|NCT03763708|516971025|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
143388735|NCT03763708|516971017|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
143388736|NCT03763708|516971018|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
143388737|NCT03763708|516971019|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
143388738|NCT03763708|516971020|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
143388739|NCT03763708|516971021|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
143388740|NCT03763708|516971022|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
143388741|NCT03763708|516971023|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
143388742|NCT03763708|516971024|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
143388743|NCT03763708|516971025|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
143388744|NCT03763708|516971017|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
143388745|NCT03763708|516971018|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
143388746|NCT03763708|516971019|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
143388747|NCT03763708|516971020|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
143388748|NCT03763708|516971021|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
143388749|NCT03763708|516971022|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
143388750|NCT03763708|516971023|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
143388751|NCT03763708|516971024|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
143388752|NCT03763708|516971025|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
143388753|NCT03763708|516971017|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
143388754|NCT03763708|516971018|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
143388755|NCT03763708|516971019|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
143388756|NCT03763708|516971020|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
143388757|NCT03763708|516971021|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
143388758|NCT03763708|516971022|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
143388759|NCT03763708|516971023|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
143388760|NCT03763708|516971024|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
143388761|NCT03763708|516971025|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
143388762|NCT03763708|516971017|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
143388763|NCT03763708|516971018|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
143388764|NCT03763708|516971019|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
143388765|NCT03763708|516971020|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
143388766|NCT03763708|516971021|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
143388767|NCT03763708|516971022|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
143388768|NCT03763708|516971023|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
143388769|NCT03763708|516971024|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
143388770|NCT03763708|516971025|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
143388771|NCT03763708|516971017|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
143388772|NCT03763708|516971018|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
143388773|NCT03763708|516971019|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
143388774|NCT03763708|516971020|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
143388775|NCT03763708|516971021|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
143388776|NCT03763708|516971022|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
143388777|NCT03763708|516971023|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
143388778|NCT03763708|516971024|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
143388779|NCT03763708|516971025|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
143388780|NCT03763708|516971017|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
143388781|NCT03763708|516971018|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
143388782|NCT03763708|516971019|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
143388783|NCT03763708|516971020|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
143388784|NCT03763708|516971021|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
143388785|NCT03763708|516971022|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
143388786|NCT03763708|516971023|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
143388787|NCT03763708|516971024|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
143388788|NCT03763708|516971025|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
143388789|NCT01416831|516971026|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
143388790|NCT01416831|516971027|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
143388791|NCT04784559|516971030|FG000|Overall Study|Withdrawal by Subject|3|||
143388792|NCT04784559|516971031|FG001|Overall Study|Withdrawal by Subject|2|||
143388793|NCT04784559|516971032|FG002|Overall Study|Withdrawal by Subject|1|||
143388794|NCT04784559|516971030|FG000|Overall Study|Death|2|||
143388795|NCT04784559|516971031|FG001|Overall Study|Death|1|||
143388796|NCT04784559|516971032|FG002|Overall Study|Death|2|||
143388797|NCT04784559|516971030|FG000|Overall Study|Lost to Follow-up|0|||
143388798|NCT04784559|516971031|FG001|Overall Study|Lost to Follow-up|0|||
143388799|NCT04784559|516971032|FG002|Overall Study|Lost to Follow-up|2|||
143388800|NCT04784559|516971030|FG000|Overall Study|Participant worsened, PI decision|1|||
143388801|NCT04784559|516971031|FG001|Overall Study|Participant worsened, PI decision|0|||
143388802|NCT04784559|516971032|FG002|Overall Study|Participant worsened, PI decision|0|||
143388803|NCT04784559|516971030|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
143454276|NCT00948766|517208182|FG001|Core Study|Administrative Problems|2|||
143388804|NCT04784559|516971031|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
143388805|NCT04784559|516971032|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
143388806|NCT04784559|516971030|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
143388807|NCT04784559|516971031|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
143388808|NCT04784559|516971032|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
143388809|NCT04784559|516971030|FG000|Overall Study|Did not meet all inclusion criteria|0|||
143388810|NCT04784559|516971031|FG001|Overall Study|Did not meet all inclusion criteria|1|||
143388811|NCT04784559|516971032|FG002|Overall Study|Did not meet all inclusion criteria|0|||
143388812|NCT04784559|516971030|FG000|Overall Study|The participant was transferred to IRCU|0|||
143388813|NCT04784559|516971031|FG001|Overall Study|The participant was transferred to IRCU|1|||
143388814|NCT04784559|516971032|FG002|Overall Study|The participant was transferred to IRCU|0|||
143388815|NCT04784559|516971030|FG000|Overall Study|SAE|0|||
143388816|NCT04784559|516971031|FG001|Overall Study|SAE|1|||
143388817|NCT04784559|516971032|FG002|Overall Study|SAE|0|||
143388818|NCT04784559|516971030|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
143388819|NCT04784559|516971031|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
143388820|NCT04784559|516971032|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
143388821|NCT03138512|516971034|FG000|Randomization|Participants withdrew consent|0|||
143388822|NCT03138512|516971035|FG001|Randomization|Participants withdrew consent|1|||
143388823|NCT03138512|516971036|FG002|Randomization|Participants withdrew consent|1|||
143388824|NCT03138512|516971037|FG003|Randomization|Participants withdrew consent|0|||
143388825|NCT03138512|516971038|FG004|Randomization|Participants withdrew consent|0|||
143388826|NCT03138512|516971034|FG000|Randomization|Participant no longer meets study criteria|0|||
143388827|NCT03138512|516971035|FG001|Randomization|Participant no longer meets study criteria|3|||
143388828|NCT03138512|516971036|FG002|Randomization|Participant no longer meets study criteria|1|||
143388829|NCT03138512|516971037|FG003|Randomization|Participant no longer meets study criteria|1|||
143388830|NCT03138512|516971038|FG004|Randomization|Participant no longer meets study criteria|3|||
143388831|NCT03138512|516971034|FG000|Randomization|Other reasons|1|||
143388832|NCT03138512|516971035|FG001|Randomization|Other reasons|0|||
143388833|NCT03138512|516971036|FG002|Randomization|Other reasons|0|||
143388834|NCT03138512|516971037|FG003|Randomization|Other reasons|0|||
143388835|NCT03138512|516971038|FG004|Randomization|Other reasons|0|||
143388836|NCT03138512|516971034|FG000|Treatment Part A|Disease recurrence|10|||
143388837|NCT03138512|516971035|FG001|Treatment Part A|Disease recurrence|20|||
143388838|NCT03138512|516971036|FG002|Treatment Part A|Disease recurrence|0|||
143388839|NCT03138512|516971037|FG003|Treatment Part A|Disease recurrence|0|||
143337815|NCT01939548|516779988|FG000|Overall Study|Did not complete follow-up|0|||
143337816|NCT01939548|516779989|FG001|Overall Study|Did not complete follow-up|1|||
143337817|NCT01939548|516779990|FG002|Overall Study|Did not complete follow-up|0|||
143337818|NCT02453685|516779999|FG000|Overall Study|Adverse Event|0|||
143337819|NCT02453685|516780000|FG001|Overall Study|Adverse Event|1|||
143337820|NCT02453685|516779999|FG000|Overall Study|Protocol Violation|7|||
143337821|NCT02453685|516780000|FG001|Overall Study|Protocol Violation|4|||
143337822|NCT02453685|516779999|FG000|Overall Study|Lost to Follow-up|0|||
143337823|NCT02453685|516780000|FG001|Overall Study|Lost to Follow-up|1|||
143337824|NCT02453685|516779999|FG000|Overall Study|Withdrawal by Subject|8|||
143337825|NCT02453685|516780000|FG001|Overall Study|Withdrawal by Subject|4|||
143337826|NCT02453685|516779999|FG000|Overall Study|Unclassified|4|||
143337827|NCT02453685|516780000|FG001|Overall Study|Unclassified|2|||
143337828|NCT01659151|516780005|FG000|Overall Study|Inadequate TIL growth|1|||
143337829|NCT06223373|516780009|FG000|Overall Study|Lost to Follow-up|1|||
143337830|NCT06223373|516780010|FG001|Overall Study|Lost to Follow-up|2|||
143337831|NCT04981678|516780012|FG000|Overall Study|Lost to Follow-up|0|||
143337832|NCT04981678|516780013|FG001|Overall Study|Lost to Follow-up|1|||
143337833|NCT03421808|516780014|FG000|Overall Study|COVID related problems|2|||
143337834|NCT03421808|516780015|FG001|Overall Study|COVID related problems|0|||
143337835|NCT03421808|516780014|FG000|Overall Study|Withdrawal by Subject|1|||
143337836|NCT03421808|516780015|FG001|Overall Study|Withdrawal by Subject|0|||
143337837|NCT03421808|516780014|FG000|Overall Study|Protocol Violation|0|||
143337838|NCT03421808|516780015|FG001|Overall Study|Protocol Violation|1|||
143337839|NCT03764774|516780016|FG000|Overall Study|Withdrawal by Subject|0|||
143337840|NCT03764774|516780017|FG001|Overall Study|Withdrawal by Subject|0|||
143337841|NCT03764774|516780018|FG002|Overall Study|Withdrawal by Subject|0|||
143388840|NCT03138512|516971038|FG004|Treatment Part A|Disease recurrence|0|||
143388841|NCT03138512|516971034|FG000|Treatment Part A|Study Drug Toxicity|132|||
143388842|NCT03138512|516971035|FG001|Treatment Part A|Study Drug Toxicity|5|||
143388843|NCT03138512|516971036|FG002|Treatment Part A|Study Drug Toxicity|0|||
143388844|NCT03138512|516971037|FG003|Treatment Part A|Study Drug Toxicity|0|||
143388845|NCT03138512|516971038|FG004|Treatment Part A|Study Drug Toxicity|0|||
143388846|NCT03138512|516971034|FG000|Treatment Part A|Death|1|||
143388847|NCT03138512|516971035|FG001|Treatment Part A|Death|0|||
143388848|NCT03138512|516971036|FG002|Treatment Part A|Death|0|||
143388849|NCT03138512|516971037|FG003|Treatment Part A|Death|0|||
143388850|NCT03138512|516971038|FG004|Treatment Part A|Death|0|||
143388851|NCT03138512|516971034|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
143388852|NCT03138512|516971035|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
143388853|NCT03138512|516971036|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
143388854|NCT03138512|516971037|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
143388855|NCT03138512|516971038|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
143388856|NCT03138512|516971034|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
143388857|NCT03138512|516971035|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
143388858|NCT03138512|516971036|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
143388859|NCT03138512|516971037|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
143388860|NCT03138512|516971038|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
143388861|NCT03138512|516971034|FG000|Treatment Part A|Participant withdrew consent|2|||
143388862|NCT03138512|516971035|FG001|Treatment Part A|Participant withdrew consent|4|||
143388863|NCT03138512|516971036|FG002|Treatment Part A|Participant withdrew consent|0|||
143388864|NCT03138512|516971037|FG003|Treatment Part A|Participant withdrew consent|0|||
143388865|NCT03138512|516971038|FG004|Treatment Part A|Participant withdrew consent|0|||
143388866|NCT03138512|516971034|FG000|Treatment Part A|Lost to Follow-up|0|||
143388867|NCT03138512|516971035|FG001|Treatment Part A|Lost to Follow-up|1|||
143388868|NCT03138512|516971036|FG002|Treatment Part A|Lost to Follow-up|0|||
143388869|NCT03138512|516971037|FG003|Treatment Part A|Lost to Follow-up|0|||
143388870|NCT03138512|516971038|FG004|Treatment Part A|Lost to Follow-up|0|||
143388871|NCT03138512|516971034|FG000|Treatment Part A|Poor/non-compliance|1|||
143388872|NCT03138512|516971035|FG001|Treatment Part A|Poor/non-compliance|0|||
143388873|NCT03138512|516971036|FG002|Treatment Part A|Poor/non-compliance|0|||
143388874|NCT03138512|516971037|FG003|Treatment Part A|Poor/non-compliance|0|||
143388875|NCT03138512|516971038|FG004|Treatment Part A|Poor/non-compliance|0|||
143388876|NCT03138512|516971034|FG000|Treatment Part A|Pregnancy|0|||
143388877|NCT03138512|516971035|FG001|Treatment Part A|Pregnancy|1|||
143388878|NCT03138512|516971036|FG002|Treatment Part A|Pregnancy|0|||
143388879|NCT03138512|516971037|FG003|Treatment Part A|Pregnancy|0|||
143388880|NCT03138512|516971038|FG004|Treatment Part A|Pregnancy|0|||
143388881|NCT03138512|516971034|FG000|Treatment Part A|Other reasons|11|||
143388882|NCT03138512|516971035|FG001|Treatment Part A|Other reasons|8|||
143388883|NCT03138512|516971036|FG002|Treatment Part A|Other reasons|0|||
143388884|NCT03138512|516971037|FG003|Treatment Part A|Other reasons|0|||
143388885|NCT03138512|516971038|FG004|Treatment Part A|Other reasons|0|||
143388886|NCT03138512|516971034|FG000|Treatment Part B|Disease recurrence|0|||
143388887|NCT03138512|516971035|FG001|Treatment Part B|Disease recurrence|0|||
143388888|NCT03138512|516971036|FG002|Treatment Part B|Disease recurrence|6|||
143388889|NCT03138512|516971037|FG003|Treatment Part B|Disease recurrence|12|||
143388890|NCT03138512|516971038|FG004|Treatment Part B|Disease recurrence|10|||
143388891|NCT03138512|516971034|FG000|Treatment Part B|Study drug toxicity|0|||
143388892|NCT03138512|516971035|FG001|Treatment Part B|Study drug toxicity|0|||
143388893|NCT03138512|516971036|FG002|Treatment Part B|Study drug toxicity|63|||
143388894|NCT03138512|516971037|FG003|Treatment Part B|Study drug toxicity|3|||
143388895|NCT03138512|516971038|FG004|Treatment Part B|Study drug toxicity|45|||
143388896|NCT03138512|516971034|FG000|Treatment Part B|Death|0|||
143388897|NCT03138512|516971035|FG001|Treatment Part B|Death|0|||
143388898|NCT03138512|516971036|FG002|Treatment Part B|Death|1|||
143388899|NCT03138512|516971037|FG003|Treatment Part B|Death|0|||
143388900|NCT03138512|516971038|FG004|Treatment Part B|Death|0|||
143388901|NCT03138512|516971034|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
143388902|NCT03138512|516971035|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
143388903|NCT03138512|516971036|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
143388904|NCT03138512|516971037|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
143388905|NCT03138512|516971038|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
143388906|NCT03138512|516971034|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
143388907|NCT03138512|516971035|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
143388908|NCT03138512|516971036|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
143388909|NCT03138512|516971037|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
143388910|NCT03138512|516971038|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
143388911|NCT03138512|516971034|FG000|Treatment Part B|Participant withdrew consent|0|||
143388912|NCT03138512|516971035|FG001|Treatment Part B|Participant withdrew consent|0|||
143388913|NCT03138512|516971036|FG002|Treatment Part B|Participant withdrew consent|1|||
143388914|NCT03138512|516971037|FG003|Treatment Part B|Participant withdrew consent|1|||
143388915|NCT03138512|516971038|FG004|Treatment Part B|Participant withdrew consent|2|||
143388916|NCT03138512|516971034|FG000|Treatment Part B|Lost to Follow-up|0|||
143388917|NCT03138512|516971035|FG001|Treatment Part B|Lost to Follow-up|0|||
143388918|NCT03138512|516971036|FG002|Treatment Part B|Lost to Follow-up|0|||
143388919|NCT03138512|516971037|FG003|Treatment Part B|Lost to Follow-up|1|||
143388920|NCT03138512|516971038|FG004|Treatment Part B|Lost to Follow-up|0|||
143388921|NCT03138512|516971034|FG000|Treatment Part B|Poor/non-compliance|0|||
143388922|NCT03138512|516971035|FG001|Treatment Part B|Poor/non-compliance|0|||
143388923|NCT03138512|516971036|FG002|Treatment Part B|Poor/non-compliance|1|||
143388924|NCT03138512|516971037|FG003|Treatment Part B|Poor/non-compliance|1|||
143388925|NCT03138512|516971038|FG004|Treatment Part B|Poor/non-compliance|1|||
143388926|NCT03138512|516971034|FG000|Treatment Part B|Other reasons|0|||
143388927|NCT03138512|516971035|FG001|Treatment Part B|Other reasons|0|||
143388928|NCT03138512|516971036|FG002|Treatment Part B|Other reasons|3|||
143388929|NCT03138512|516971037|FG003|Treatment Part B|Other reasons|1|||
143388930|NCT03138512|516971038|FG004|Treatment Part B|Other reasons|5|||
143388931|NCT05323084|516971040|FG000|Period 2 - Washout|Lost to Follow-up|0|||
143388932|NCT05323084|516971041|FG001|Period 2 - Washout|Lost to Follow-up|1|||
143388933|NCT04382404|516971042|FG000|Overall Study|Adverse Event|1|||
143388934|NCT04382404|516971042|FG000|Overall Study|Lost to Follow-up|2|||
143388935|NCT03332017|516971047|FG000|Overall Study|Lost to Follow-up|1|||
143388936|NCT03332017|516971048|FG001|Overall Study|Lost to Follow-up|2|||
143388937|NCT03332017|516971047|FG000|Overall Study|Death|17|||
143388938|NCT03332017|516971048|FG001|Overall Study|Death|16|||
143388939|NCT03332017|516971047|FG000|Overall Study|Withdrawal by Subject|6|||
143388940|NCT03332017|516971048|FG001|Overall Study|Withdrawal by Subject|14|||
143388941|NCT03332017|516971047|FG000|Overall Study|Other|1|||
143388942|NCT03332017|516971048|FG001|Overall Study|Other|3|||
143388943|NCT03332017|516971047|FG000|Overall Study|Remained in Study (Ongoing)|47|||
143388944|NCT03332017|516971048|FG001|Overall Study|Remained in Study (Ongoing)|110|||
143388945|NCT04294225|516971053|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
143388946|NCT04294225|516971053|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
143388947|NCT04294225|516971053|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
143388948|NCT04294225|516971053|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
143388949|NCT04294225|516971053|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
143388950|NCT00920621|516972213|FG000|Overall Study|Lost to Follow-up|16|||
143388951|NCT00920621|516972214|FG001|Overall Study|Lost to Follow-up|17|||
143388952|NCT00920621|516972215|FG002|Overall Study|Lost to Follow-up|19|||
143388953|NCT00920621|516972216|FG003|Overall Study|Lost to Follow-up|21|||
143388954|NCT00920621|516972213|FG000|Overall Study|Fetal/neonatal deaths|16|||
143388955|NCT00920621|516972214|FG001|Overall Study|Fetal/neonatal deaths|14|||
143388956|NCT00920621|516972215|FG002|Overall Study|Fetal/neonatal deaths|16|||
143388957|NCT00920621|516972216|FG003|Overall Study|Fetal/neonatal deaths|14|||
143388958|NCT00920621|516972213|FG000|Overall Study|Blood sample not collected|22|||
143388959|NCT00920621|516972214|FG001|Overall Study|Blood sample not collected|14|||
143388960|NCT00920621|516972215|FG002|Overall Study|Blood sample not collected|0|||
143388961|NCT00920621|516972216|FG003|Overall Study|Blood sample not collected|0|||
143388962|NCT04956861|516972217|FG000|Overall Study|Withdrawal by Subject|4|||
143388963|NCT04956861|516972218|FG001|Overall Study|Withdrawal by Subject|4|||
143388964|NCT04956861|516972219|FG002|Overall Study|Withdrawal by Subject|2|||
143388965|NCT04956861|516972217|FG000|Overall Study|Physician Decision|4|||
143388966|NCT04956861|516972218|FG001|Overall Study|Physician Decision|5|||
143388967|NCT04956861|516972219|FG002|Overall Study|Physician Decision|1|||
143388968|NCT01580488|516972223|FG000|Overall Study|Withdrawal by Subject|1|||
143388969|NCT03336333|516972224|FG000|Overall Study|Remained on study at time of data cut-off|202|||
143388970|NCT03336333|516972225|FG001|Overall Study|Remained on study at time of data cut-off|219|||
143388971|NCT03336333|516972226|FG002|Overall Study|Remained on study at time of data cut-off|102|||
143388972|NCT03336333|516972224|FG000|Overall Study|Death|14|||
143388973|NCT03336333|516972225|FG001|Overall Study|Death|16|||
143388974|NCT03336333|516972226|FG002|Overall Study|Death|8|||
143388975|NCT03336333|516972224|FG000|Overall Study|Withdrawal by Subject|16|||
143337842|NCT03764774|516780019|FG003|Overall Study|Withdrawal by Subject|0|||
143337843|NCT03764774|516780020|FG004|Overall Study|Withdrawal by Subject|0|||
143337844|NCT03764774|516780021|FG005|Overall Study|Withdrawal by Subject|0|||
143337845|NCT03764774|516780022|FG006|Overall Study|Withdrawal by Subject|0|||
143337846|NCT03764774|516780023|FG007|Overall Study|Withdrawal by Subject|0|||
143337847|NCT03764774|516780024|FG008|Overall Study|Withdrawal by Subject|0|||
143337848|NCT03764774|516780025|FG009|Overall Study|Withdrawal by Subject|0|||
143337849|NCT03764774|516780026|FG010|Overall Study|Withdrawal by Subject|1|||
143337850|NCT03764774|516780027|FG011|Overall Study|Withdrawal by Subject|0|||
143337851|NCT03764774|516780028|FG012|Overall Study|Withdrawal by Subject|0|||
143337852|NCT03764774|516780029|FG013|Overall Study|Withdrawal by Subject|0|||
143337853|NCT03764774|516780016|FG000|Overall Study|Adverse Event|0|||
143337854|NCT03764774|516780017|FG001|Overall Study|Adverse Event|0|||
143337855|NCT03764774|516780018|FG002|Overall Study|Adverse Event|0|||
143337856|NCT03764774|516780019|FG003|Overall Study|Adverse Event|0|||
143337857|NCT03764774|516780020|FG004|Overall Study|Adverse Event|0|||
143337858|NCT03764774|516780021|FG005|Overall Study|Adverse Event|0|||
143337859|NCT03764774|516780022|FG006|Overall Study|Adverse Event|0|||
143337860|NCT03764774|516780023|FG007|Overall Study|Adverse Event|0|||
143337861|NCT03764774|516780024|FG008|Overall Study|Adverse Event|0|||
143337862|NCT03764774|516780025|FG009|Overall Study|Adverse Event|0|||
143337863|NCT03764774|516780026|FG010|Overall Study|Adverse Event|0|||
143337864|NCT03764774|516780027|FG011|Overall Study|Adverse Event|0|||
143337865|NCT03764774|516780028|FG012|Overall Study|Adverse Event|2|||
143337866|NCT03764774|516780029|FG013|Overall Study|Adverse Event|0|||
143337867|NCT03764774|516780016|FG000|Overall Study|Lost to Follow-up|0|||
143337868|NCT03764774|516780017|FG001|Overall Study|Lost to Follow-up|0|||
143337869|NCT03764774|516780018|FG002|Overall Study|Lost to Follow-up|0|||
143337870|NCT03764774|516780019|FG003|Overall Study|Lost to Follow-up|0|||
143337871|NCT03764774|516780020|FG004|Overall Study|Lost to Follow-up|0|||
143337872|NCT03764774|516780021|FG005|Overall Study|Lost to Follow-up|0|||
143337873|NCT03764774|516780022|FG006|Overall Study|Lost to Follow-up|0|||
143337874|NCT03764774|516780023|FG007|Overall Study|Lost to Follow-up|0|||
143337875|NCT03764774|516780024|FG008|Overall Study|Lost to Follow-up|0|||
143337876|NCT03764774|516780025|FG009|Overall Study|Lost to Follow-up|0|||
143337877|NCT03764774|516780026|FG010|Overall Study|Lost to Follow-up|0|||
143337878|NCT03764774|516780027|FG011|Overall Study|Lost to Follow-up|0|||
143337879|NCT03764774|516780028|FG012|Overall Study|Lost to Follow-up|0|||
143337880|NCT03764774|516780029|FG013|Overall Study|Lost to Follow-up|1|||
143337881|NCT03764774|516780016|FG000|Overall Study|Physician Decision|0|||
143337882|NCT03764774|516780017|FG001|Overall Study|Physician Decision|0|||
143337883|NCT03764774|516780018|FG002|Overall Study|Physician Decision|0|||
143337884|NCT03764774|516780019|FG003|Overall Study|Physician Decision|0|||
143337885|NCT03764774|516780020|FG004|Overall Study|Physician Decision|0|||
143337886|NCT03764774|516780021|FG005|Overall Study|Physician Decision|0|||
143337887|NCT03764774|516780022|FG006|Overall Study|Physician Decision|0|||
143337888|NCT03764774|516780023|FG007|Overall Study|Physician Decision|0|||
143337889|NCT03764774|516780024|FG008|Overall Study|Physician Decision|0|||
143337890|NCT03764774|516780025|FG009|Overall Study|Physician Decision|4|||
143337891|NCT03764774|516780026|FG010|Overall Study|Physician Decision|1|||
143337892|NCT03764774|516780027|FG011|Overall Study|Physician Decision|4|||
143337893|NCT03764774|516780028|FG012|Overall Study|Physician Decision|9|||
143337894|NCT03764774|516780029|FG013|Overall Study|Physician Decision|0|||
143337895|NCT03764774|516780016|FG000|Overall Study|Study Termination|0|||
143337896|NCT03764774|516780017|FG001|Overall Study|Study Termination|0|||
143337897|NCT03764774|516780018|FG002|Overall Study|Study Termination|0|||
143337898|NCT03764774|516780019|FG003|Overall Study|Study Termination|0|||
143388976|NCT03336333|516972225|FG001|Overall Study|Withdrawal by Subject|5|||
143388977|NCT03336333|516972226|FG002|Overall Study|Withdrawal by Subject|1|||
143337899|NCT03764774|516780020|FG004|Overall Study|Study Termination|0|||
143337900|NCT03764774|516780021|FG005|Overall Study|Study Termination|0|||
143337901|NCT03764774|516780022|FG006|Overall Study|Study Termination|0|||
143337902|NCT03764774|516780023|FG007|Overall Study|Study Termination|0|||
143337903|NCT03764774|516780024|FG008|Overall Study|Study Termination|0|||
143388978|NCT03336333|516972224|FG000|Overall Study|Physician Decision|5|||
143388979|NCT03336333|516972225|FG001|Overall Study|Physician Decision|1|||
143388980|NCT03336333|516972226|FG002|Overall Study|Physician Decision|0|||
143388981|NCT03336333|516972224|FG000|Overall Study|Lost to Follow-up|1|||
143388982|NCT03336333|516972225|FG001|Overall Study|Lost to Follow-up|0|||
143388983|NCT03336333|516972226|FG002|Overall Study|Lost to Follow-up|0|||
143388984|NCT02243709|516972229|FG000|Phase 1|Lost to Follow-up|0|||
143388985|NCT02243709|516972230|FG001|Phase 1|Lost to Follow-up|1|||
143388986|NCT02243709|516972229|FG000|Phase 1|Withdrawal by Subject|1|||
143388987|NCT02243709|516972230|FG001|Phase 1|Withdrawal by Subject|0|||
143388988|NCT02243709|516972229|FG000|Phase 1|Protocol Violation|0|||
143388989|NCT02243709|516972230|FG001|Phase 1|Protocol Violation|1|||
143388990|NCT02243709|516972229|FG000|Phase 1|Adverse Event|0|||
143388991|NCT02243709|516972230|FG001|Phase 1|Adverse Event|1|||
143388992|NCT04177823|516972232|FG000|Overall Study|Physician Decision|1|||
143388993|NCT04177823|516972232|FG000|Overall Study|Withdrawal by Subject|1|||
143388994|NCT04347161|516972233|FG000|Overall Study|Death|0|||
143388995|NCT04347161|516972234|FG001|Overall Study|Death|2|||
143388996|NCT04347161|516972233|FG000|Overall Study|Withdrawal by Subject|1|||
143388997|NCT04347161|516972234|FG001|Overall Study|Withdrawal by Subject|0|||
143388998|NCT04347161|516972233|FG000|Overall Study|Lost to Follow-up|0|||
143388999|NCT04347161|516972234|FG001|Overall Study|Lost to Follow-up|1|||
143389000|NCT04347161|516972233|FG000|Overall Study|No longer on study medication|1|||
143389001|NCT04347161|516972234|FG001|Overall Study|No longer on study medication|1|||
143389002|NCT04169373|516972235|FG000|Week 1 to Week 14|Adverse Event|1|||
143389003|NCT04169373|516972236|FG001|Week 1 to Week 14|Adverse Event|0|||
143389004|NCT04169373|516972237|FG002|Week 1 to Week 14|Adverse Event|1|||
143389005|NCT04169373|516972238|FG003|Week 1 to Week 14|Adverse Event|2|||
143389006|NCT04169373|516972235|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
143389007|NCT04169373|516972236|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
143389008|NCT04169373|516972237|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
143389009|NCT04169373|516972238|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
143389010|NCT04169373|516972235|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
143389011|NCT04169373|516972236|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
143389012|NCT04169373|516972237|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
143389013|NCT04169373|516972238|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
143389014|NCT04169373|516972235|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
143389015|NCT04169373|516972236|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
143389016|NCT04169373|516972237|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
143389017|NCT04169373|516972238|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
143389018|NCT04169373|516972235|FG000|Week 1 to Week 14|Other|1|||
143389019|NCT04169373|516972236|FG001|Week 1 to Week 14|Other|3|||
143389020|NCT04169373|516972237|FG002|Week 1 to Week 14|Other|3|||
143389021|NCT04169373|516972238|FG003|Week 1 to Week 14|Other|5|||
143389022|NCT04169373|516972235|FG000|Week 14 to Week 52|Adverse Event|1|||
143389023|NCT04169373|516972236|FG001|Week 14 to Week 52|Adverse Event|0|||
143389024|NCT04169373|516972237|FG002|Week 14 to Week 52|Adverse Event|0|||
143389025|NCT04169373|516972238|FG003|Week 14 to Week 52|Adverse Event|1|||
143389026|NCT04169373|516972235|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
143389027|NCT04169373|516972236|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
143389028|NCT04169373|516972237|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
143389029|NCT04169373|516972238|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
143389030|NCT04169373|516972235|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
143389031|NCT04169373|516972236|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
143389032|NCT04169373|516972237|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
143389033|NCT04169373|516972238|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
143389034|NCT04169373|516972235|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
143389035|NCT04169373|516972236|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
143389036|NCT04169373|516972237|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
143389037|NCT04169373|516972238|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
143389038|NCT04169373|516972235|FG000|Week 14 to Week 52|Other|4|||
143389039|NCT04169373|516972236|FG001|Week 14 to Week 52|Other|5|||
143389040|NCT04169373|516972237|FG002|Week 14 to Week 52|Other|4|||
143389041|NCT04169373|516972238|FG003|Week 14 to Week 52|Other|5|||
143389042|NCT04169373|516972235|FG000|Week 14 to Week 52|Ongoing|0|||
143389043|NCT04169373|516972236|FG001|Week 14 to Week 52|Ongoing|1|||
143389044|NCT04169373|516972237|FG002|Week 14 to Week 52|Ongoing|0|||
143389045|NCT04169373|516972238|FG003|Week 14 to Week 52|Ongoing|0|||
143389046|NCT04533347|516972239|FG000|Overall Study|Adverse Event|1|||
143389047|NCT04533347|516972240|FG001|Overall Study|Adverse Event|2|||
143389048|NCT04533347|516972239|FG000|Overall Study|Lost to Follow-up|2|||
143389049|NCT04533347|516972240|FG001|Overall Study|Lost to Follow-up|0|||
143389050|NCT04533347|516972239|FG000|Overall Study|Withdrawal by Subject|1|||
143389051|NCT04533347|516972240|FG001|Overall Study|Withdrawal by Subject|0|||
143389052|NCT03907397|516972241|FG000|Overall Study|Lost to Follow-up|0|||
143389053|NCT03907397|516972242|FG001|Overall Study|Lost to Follow-up|1|||
143389054|NCT03907397|516972241|FG000|Overall Study|Physician Decision|2|||
143389055|NCT03907397|516972242|FG001|Overall Study|Physician Decision|1|||
143389056|NCT03907397|516972241|FG000|Overall Study|Withdrawal by Subject|5|||
143337904|NCT03764774|516780025|FG009|Overall Study|Study Termination|1|||
143337905|NCT03764774|516780026|FG010|Overall Study|Study Termination|0|||
143337906|NCT03764774|516780027|FG011|Overall Study|Study Termination|0|||
143337907|NCT03764774|516780028|FG012|Overall Study|Study Termination|0|||
143337908|NCT03764774|516780029|FG013|Overall Study|Study Termination|2|||
143337909|NCT05809596|516780032|FG000|Overall Study|Death|16|||
143337910|NCT05809596|516780032|FG000|Overall Study|Withdrawal by Subject|4|||
143337911|NCT05809596|516780032|FG000|Overall Study|Physician Decision|1|||
143337912|NCT05809596|516780032|FG000|Overall Study|Missed Visit|2|||
143337913|NCT05809596|516780032|FG000|Overall Study|Other|3|||
143337914|NCT04233372|516781454|FG000|Overall Study|Lost to Follow-up|104|||
143337915|NCT04233372|516781454|FG000|Overall Study|Adverse Event|8|||
143337916|NCT04233372|516781454|FG000|Overall Study|Withdrawal by Subject|2|||
143337917|NCT01090310|516781455|FG000|Core Study|Adverse Event|2|||
143337918|NCT01090310|516781456|FG001|Core Study|Adverse Event|2|||
143337919|NCT01090310|516781457|FG002|Core Study|Adverse Event|1|||
143337920|NCT01090310|516781458|FG003|Core Study|Adverse Event|1|||
143337921|NCT01090310|516781455|FG000|Core Study|Subject withdrew consent|0|||
143337922|NCT01090310|516781456|FG001|Core Study|Subject withdrew consent|3|||
143337923|NCT01090310|516781457|FG002|Core Study|Subject withdrew consent|1|||
143337924|NCT01090310|516781458|FG003|Core Study|Subject withdrew consent|1|||
143337925|NCT01090310|516781455|FG000|Core Study|Abnormal test procedure result|0|||
143337926|NCT01090310|516781456|FG001|Core Study|Abnormal test procedure result|0|||
143337927|NCT01090310|516781457|FG002|Core Study|Abnormal test procedure result|1|||
143337928|NCT01090310|516781458|FG003|Core Study|Abnormal test procedure result|0|||
143337929|NCT01090310|516781455|FG000|Core Study|Administrative reasons|5|||
143337930|NCT01090310|516781456|FG001|Core Study|Administrative reasons|6|||
143337931|NCT01090310|516781457|FG002|Core Study|Administrative reasons|4|||
143337932|NCT01090310|516781458|FG003|Core Study|Administrative reasons|4|||
143337933|NCT01090310|516781455|FG000|Core Study|Protocol deviation|1|||
143337934|NCT01090310|516781456|FG001|Core Study|Protocol deviation|0|||
143337935|NCT01090310|516781457|FG002|Core Study|Protocol deviation|0|||
143337936|NCT01090310|516781458|FG003|Core Study|Protocol deviation|1|||
143337937|NCT01090310|516781455|FG000|Extension Study|Aministrative problems|13|||
143337938|NCT01090310|516781456|FG001|Extension Study|Aministrative problems|15|||
143337939|NCT01090310|516781457|FG002|Extension Study|Aministrative problems|14|||
143337940|NCT01090310|516781458|FG003|Extension Study|Aministrative problems|18|||
143337941|NCT01090310|516781455|FG000|Extension Study|Adverse Event|0|||
143337942|NCT01090310|516781456|FG001|Extension Study|Adverse Event|0|||
143337943|NCT01090310|516781457|FG002|Extension Study|Adverse Event|0|||
143337944|NCT01090310|516781458|FG003|Extension Study|Adverse Event|1|||
143337945|NCT01090310|516781455|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
143337946|NCT01090310|516781456|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
143337947|NCT01090310|516781457|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
143337948|NCT01090310|516781458|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
143337949|NCT01090310|516781455|FG000|Extension Study|Subject withdrew consent|0|||
143337950|NCT01090310|516781456|FG001|Extension Study|Subject withdrew consent|1|||
143337951|NCT01090310|516781457|FG002|Extension Study|Subject withdrew consent|0|||
143337952|NCT01090310|516781458|FG003|Extension Study|Subject withdrew consent|0|||
143337953|NCT00695786|516781459|FG000|Overall Study|Adverse Event|0|||
143337954|NCT00695786|516781460|FG001|Overall Study|Adverse Event|3|||
143337955|NCT00695786|516781461|FG002|Overall Study|Adverse Event|4|||
143389057|NCT03907397|516972242|FG001|Overall Study|Withdrawal by Subject|4|||
143389058|NCT03907397|516972241|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
143389059|NCT03907397|516972242|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
143389060|NCT03924986|516972244|FG000|Overall Study|Death|57|||
143389061|NCT03924986|516972245|FG001|Overall Study|Death|66|||
143389062|NCT03924986|516972244|FG000|Overall Study|Study Concluded by Sponsor|51|||
143389063|NCT03924986|516972245|FG001|Overall Study|Study Concluded by Sponsor|41|||
143389064|NCT03924986|516972244|FG000|Overall Study|Withdrawal by Subject|15|||
143389065|NCT03924986|516972245|FG001|Overall Study|Withdrawal by Subject|20|||
143389066|NCT03924986|516972244|FG000|Overall Study|Lost to Follow-up|7|||
143389067|NCT03924986|516972245|FG001|Overall Study|Lost to Follow-up|5|||
143389068|NCT03924986|516972244|FG000|Overall Study|Miscellaneous|1|||
143389069|NCT03924986|516972245|FG001|Overall Study|Miscellaneous|0|||
143389070|NCT03699709|516972251|FG000|Overall Study|Death|1|||
143389071|NCT03699709|516972252|FG001|Overall Study|Death|2|||
143389072|NCT03699709|516972251|FG000|Overall Study|Lost to Follow-up|10|||
143389073|NCT03699709|516972252|FG001|Overall Study|Lost to Follow-up|3|||
143389074|NCT03699709|516972251|FG000|Overall Study|Withdrawal by Subject|5|||
143389075|NCT03699709|516972252|FG001|Overall Study|Withdrawal by Subject|0|||
143389076|NCT03699709|516972251|FG000|Overall Study|incarcerated|1|||
143389077|NCT03699709|516972252|FG001|Overall Study|incarcerated|0|||
143389078|NCT03699709|516972251|FG000|Overall Study|scheduled, but no show|0|||
143389079|NCT03699709|516972252|FG001|Overall Study|scheduled, but no show|1|||
143389080|NCT02907099|516972253|FG000|Overall Study|Adverse Event|1|||
143389081|NCT02907099|516972253|FG000|Overall Study|Withdrawal by Subject|2|||
143389082|NCT02907099|516972253|FG000|Overall Study|Screen Fail|2|||
143389083|NCT04739956|516972257|FG000|Overall Study|Withdrawal by Subject|1|||
143389084|NCT04739956|516972258|FG001|Overall Study|Withdrawal by Subject|1|||
143389085|NCT03396926|516972262|FG000|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|0|||
143389086|NCT03396926|516972263|FG001|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|4|||
143389087|NCT04727554|516972265|FG000|Overall Study|Lost to Follow-up|0|||
143389088|NCT04727554|516972266|FG001|Overall Study|Lost to Follow-up|1|||
143389089|NCT04727554|516972265|FG000|Overall Study|Death|2|||
143389090|NCT04727554|516972266|FG001|Overall Study|Death|6|||
143389091|NCT04727554|516972265|FG000|Overall Study|Withdrawal by Subject|1|||
143389092|NCT04727554|516972266|FG001|Overall Study|Withdrawal by Subject|0|||
143389093|NCT01997840|516972269|FG000|Overall Study|Lost to Follow-up|0|||
143389094|NCT01997840|516972270|FG001|Overall Study|Lost to Follow-up|0|||
143389095|NCT01997840|516972271|FG002|Overall Study|Lost to Follow-up|1|||
143389096|NCT01997840|516972272|FG003|Overall Study|Lost to Follow-up|0|||
143389097|NCT01997840|516972269|FG000|Overall Study|Withdrawal by participant|0|||
143389098|NCT01997840|516972270|FG001|Overall Study|Withdrawal by participant|0|||
143389099|NCT01997840|516972271|FG002|Overall Study|Withdrawal by participant|8|||
143389100|NCT01997840|516972272|FG003|Overall Study|Withdrawal by participant|1|||
143389101|NCT01997840|516972269|FG000|Overall Study|Physician Decision|0|||
143389102|NCT01997840|516972270|FG001|Overall Study|Physician Decision|0|||
143389103|NCT01997840|516972271|FG002|Overall Study|Physician Decision|3|||
143389104|NCT01997840|516972272|FG003|Overall Study|Physician Decision|0|||
143389105|NCT01997840|516972269|FG000|Overall Study|Progressive disease|3|||
143389106|NCT01997840|516972270|FG001|Overall Study|Progressive disease|4|||
143389107|NCT01997840|516972271|FG002|Overall Study|Progressive disease|57|||
143389108|NCT01997840|516972272|FG003|Overall Study|Progressive disease|8|||
143389109|NCT01997840|516972269|FG000|Overall Study|Other reasons|0|||
143389110|NCT01997840|516972270|FG001|Overall Study|Other reasons|0|||
143389111|NCT01997840|516972271|FG002|Overall Study|Other reasons|1|||
143389112|NCT01997840|516972272|FG003|Overall Study|Other reasons|0|||
143389113|NCT01997840|516972269|FG000|Overall Study|Adverse Event|0|||
143389114|NCT01997840|516972270|FG001|Overall Study|Adverse Event|0|||
143389115|NCT01997840|516972271|FG002|Overall Study|Adverse Event|15|||
143389116|NCT01997840|516972272|FG003|Overall Study|Adverse Event|2|||
143389117|NCT05256706|516972274|FG000|Overall Study|Lost to Follow-up|9|||
143389118|NCT05256706|516972275|FG001|Overall Study|Lost to Follow-up|3|||
143389119|NCT05256706|516972274|FG000|Overall Study|Withdrawal by Subject|7|||
143389120|NCT05256706|516972275|FG001|Overall Study|Withdrawal by Subject|11|||
143389121|NCT05256706|516972274|FG000|Overall Study|Screen Failures|3|||
143389122|NCT05256706|516972275|FG001|Overall Study|Screen Failures|0|||
143389123|NCT03720795|516972280|FG000|Phase 1|Lost to Follow-up|4|||
143389124|NCT03720795|516972280|FG000|Phase 1|Withdrawal by Subject|6|||
143389125|NCT03720795|516972280|FG000|Phase 1|Protocol Violation|1|||
143389126|NCT03720795|516972280|FG000|Phase 1|Other|1|||
143389127|NCT03720795|516972280|FG000|Phase 2|Lost to Follow-up|5|||
143389128|NCT03720795|516972280|FG000|Phase 2|Withdrawal by Subject|10|||
143389129|NCT03720795|516972280|FG000|Phase 2|Protocol Violation|2|||
143389130|NCT03720795|516972280|FG000|3 Month Follow Up|Lost to Follow-up|2|||
143389131|NCT04322643|516972282|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
143389132|NCT03302494|516972285|FG000|Overall Study|Other|7|||
143389133|NCT03302494|516972286|FG001|Overall Study|Other|4|||
143389134|NCT03302494|516972287|FG002|Overall Study|Other|6|||
143389135|NCT03302494|516972285|FG000|Overall Study|Withdrawal by Subject|10|||
143389136|NCT03302494|516972286|FG001|Overall Study|Withdrawal by Subject|2|||
143389137|NCT03302494|516972287|FG002|Overall Study|Withdrawal by Subject|9|||
143389138|NCT03302494|516972285|FG000|Overall Study|Study Terminated by Sponsor|32|||
143389139|NCT03302494|516972286|FG001|Overall Study|Study Terminated by Sponsor|29|||
143389140|NCT03302494|516972287|FG002|Overall Study|Study Terminated by Sponsor|30|||
143389141|NCT03302494|516972285|FG000|Overall Study|Physician Decision|1|||
143389142|NCT03302494|516972286|FG001|Overall Study|Physician Decision|0|||
143389143|NCT03302494|516972287|FG002|Overall Study|Physician Decision|1|||
143389144|NCT03302494|516972285|FG000|Overall Study|Lost to Follow-up|1|||
143389145|NCT03302494|516972286|FG001|Overall Study|Lost to Follow-up|3|||
143389146|NCT03302494|516972287|FG002|Overall Study|Lost to Follow-up|3|||
143389147|NCT03302494|516972285|FG000|Overall Study|Death|13|||
143389148|NCT03302494|516972286|FG001|Overall Study|Death|11|||
143389149|NCT03302494|516972287|FG002|Overall Study|Death|4|||
143389150|NCT03302494|516972285|FG000|Overall Study|Adverse Event|1|||
143389151|NCT03302494|516972286|FG001|Overall Study|Adverse Event|2|||
143389152|NCT03302494|516972287|FG002|Overall Study|Adverse Event|0|||
143389153|NCT03302494|516972285|FG000|Overall Study|Randomized but not treated and discontinued during study hold|0|||
143389154|NCT03302494|516972286|FG001|Overall Study|Randomized but not treated and discontinued during study hold|2|||
143389155|NCT03302494|516972287|FG002|Overall Study|Randomized but not treated and discontinued during study hold|2|||
143389156|NCT05134233|516972288|FG000|Overall Study|Pregnancy|1|||
143389157|NCT05134233|516972288|FG000|Overall Study|MEP value too low|2|||
143389158|NCT05134233|516972288|FG000|Overall Study|Lost to Follow-up|1|||
143389159|NCT04763265|516972289|FG000|Overall Study|Adverse Event|1|||
143389160|NCT04763265|516972290|FG001|Overall Study|Adverse Event|0|||
143389161|NCT04763265|516972289|FG000|Overall Study|Lost to Follow-up|2|||
143389162|NCT04763265|516972290|FG001|Overall Study|Lost to Follow-up|4|||
143389163|NCT04763265|516972289|FG000|Overall Study|Withdrawal by Subject|0|||
143389164|NCT04763265|516972290|FG001|Overall Study|Withdrawal by Subject|1|||
143389165|NCT03652688|516972299|FG000|Baseline|Withdrawal by Subject|0|||
143389166|NCT03652688|516972300|FG001|Baseline|Withdrawal by Subject|3|||
143389167|NCT03652688|516972299|FG000|Follow-up|Lost to Follow-up|56|||
143389168|NCT03652688|516972300|FG001|Follow-up|Lost to Follow-up|54|||
143389169|NCT03468218|516972301|FG000|Overall Study|Adverse Event|5|||
143389170|NCT03468218|516972301|FG000|Overall Study|Progressive Disease|16|||
143389171|NCT03468218|516972301|FG000|Overall Study|Death|1|||
143389172|NCT03468218|516972301|FG000|Overall Study|Alternate therapy|1|||
143389173|NCT03468218|516972301|FG000|Overall Study|Withdrawal by Subject|2|||
143389174|NCT05089734|516972305|FG000|Overall Study|Still on study|122|||
143389175|NCT05089734|516972306|FG001|Overall Study|Still on study|101|||
143389176|NCT05089734|516972305|FG000|Overall Study|Death|161|||
143389177|NCT05089734|516972306|FG001|Overall Study|Death|179|||
143389178|NCT05089734|516972305|FG000|Overall Study|Withdrew consent|11|||
143389179|NCT05089734|516972306|FG001|Overall Study|Withdrew consent|24|||
143389180|NCT05089734|516972305|FG000|Overall Study|Lost to Follow-up|5|||
143389181|NCT05089734|516972306|FG001|Overall Study|Lost to Follow-up|0|||
143389182|NCT03396588|516972307|FG000|Overall Study|Physician Decision|2|||
143389183|NCT03396588|516972308|FG001|Overall Study|Physician Decision|3|||
143389184|NCT05179395|516972309|FG000|Overall Study|Lack of Efficacy|1|||
143389185|NCT00812461|516972310|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
143389186|NCT00812461|516972311|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
143389187|NCT00812461|516972310|FG000|All Treated Patients|Adverse Event|8|||
143389188|NCT00812461|516972311|FG001|All Treated Patients|Adverse Event|15|||
143389189|NCT00812461|516972310|FG000|All Treated Patients|Lack of Efficacy|13|||
143389190|NCT00812461|516972311|FG001|All Treated Patients|Lack of Efficacy|7|||
143389191|NCT00812461|516972310|FG000|All Treated Patients|Non-compliance|6|||
143389192|NCT00812461|516972311|FG001|All Treated Patients|Non-compliance|9|||
143389193|NCT00812461|516972310|FG000|All Treated Patients|Protocol Violation|36|||
143389194|NCT00812461|516972311|FG001|All Treated Patients|Protocol Violation|27|||
143389195|NCT00812461|516972310|FG000|All Treated Patients|Withdrawal by Subject|45|||
143389196|NCT00812461|516972311|FG001|All Treated Patients|Withdrawal by Subject|54|||
143389197|NCT00812461|516972310|FG000|All Treated Patients|Lost to Follow-up|11|||
143389198|NCT00812461|516972311|FG001|All Treated Patients|Lost to Follow-up|14|||
143389199|NCT00812461|516972310|FG000|All Treated Patients|Other Reason|13|||
143389200|NCT00812461|516972311|FG001|All Treated Patients|Other Reason|21|||
143389201|NCT05687916|516973880|FG000|Overall Study|Adverse Event|1|||
143389202|NCT05687916|516973881|FG001|Overall Study|Adverse Event|2|||
143389203|NCT05687916|516973882|FG002|Overall Study|Adverse Event|0|||
143389204|NCT05687916|516973880|FG000|Overall Study|Withdrawal by Subject|1|||
143389205|NCT05687916|516973881|FG001|Overall Study|Withdrawal by Subject|0|||
143389206|NCT05687916|516973882|FG002|Overall Study|Withdrawal by Subject|1|||
143389207|NCT05687916|516973880|FG000|Overall Study|Protocol Violation|0|||
143337956|NCT00695786|516781462|FG003|Overall Study|Adverse Event|2|||
143337957|NCT00695786|516781459|FG000|Overall Study|Lost to Follow-up|0|||
143337958|NCT00695786|516781460|FG001|Overall Study|Lost to Follow-up|5|||
143337959|NCT00695786|516781461|FG002|Overall Study|Lost to Follow-up|1|||
143337960|NCT00695786|516781462|FG003|Overall Study|Lost to Follow-up|1|||
143337961|NCT00695786|516781459|FG000|Overall Study|Withdrawal by Subject|0|||
143337962|NCT00695786|516781460|FG001|Overall Study|Withdrawal by Subject|4|||
143337963|NCT00695786|516781461|FG002|Overall Study|Withdrawal by Subject|3|||
143337964|NCT00695786|516781462|FG003|Overall Study|Withdrawal by Subject|1|||
143337965|NCT00695786|516781459|FG000|Overall Study|Deemed Ineligible|1|||
143337966|NCT00695786|516781460|FG001|Overall Study|Deemed Ineligible|0|||
143337967|NCT00695786|516781461|FG002|Overall Study|Deemed Ineligible|0|||
143337968|NCT00695786|516781462|FG003|Overall Study|Deemed Ineligible|0|||
143337969|NCT00695786|516781459|FG000|Overall Study|Lack of Efficacy|0|||
143337970|NCT00695786|516781460|FG001|Overall Study|Lack of Efficacy|0|||
143337971|NCT00695786|516781461|FG002|Overall Study|Lack of Efficacy|0|||
143337972|NCT00695786|516781462|FG003|Overall Study|Lack of Efficacy|4|||
143337973|NCT01364922|516781468|FG000|Open-label (OL) Period|Adverse Event|7|||
143337974|NCT01364922|516781469|FG001|Open-label (OL) Period|Adverse Event|0|||
143337975|NCT01364922|516781470|FG002|Open-label (OL) Period|Adverse Event|0|||
143337976|NCT01364922|516781468|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
143337977|NCT01364922|516781469|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
143337978|NCT01364922|516781470|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
143337979|NCT01364922|516781468|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
143337980|NCT01364922|516781469|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
143337981|NCT01364922|516781470|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
143337982|NCT01364922|516781468|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
143337983|NCT01364922|516781469|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
143337984|NCT01364922|516781470|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
143337985|NCT01364922|516781468|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
143337986|NCT01364922|516781469|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
143337987|NCT01364922|516781470|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
143337988|NCT01364922|516781468|FG000|Open-label (OL) Period|Other, Unspecified|1|||
143337989|NCT01364922|516781469|FG001|Open-label (OL) Period|Other, Unspecified|0|||
143337990|NCT01364922|516781470|FG002|Open-label (OL) Period|Other, Unspecified|0|||
143337991|NCT01364922|516781468|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
143337992|NCT01364922|516781469|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
143337993|NCT01364922|516781470|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
143337994|NCT01364922|516781468|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
143337995|NCT01364922|516781469|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
143337996|NCT01364922|516781470|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
143337997|NCT01364922|516781468|FG000|Double-Blind (DB) Period|Adverse Event|0|||
143337998|NCT01364922|516781469|FG001|Double-Blind (DB) Period|Adverse Event|0|||
143337999|NCT01364922|516781470|FG002|Double-Blind (DB) Period|Adverse Event|1|||
143338000|NCT01364922|516781468|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
143338001|NCT01364922|516781469|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
143338002|NCT01364922|516781470|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
143338003|NCT01787097|516781473|FG000|Overall Study|Withdrawal by Subject|1|||
143338004|NCT01787097|516781474|FG001|Overall Study|Withdrawal by Subject|0|||
143338005|NCT01787097|516781475|FG002|Overall Study|Withdrawal by Subject|0|||
143338006|NCT01787097|516781476|FG003|Overall Study|Withdrawal by Subject|0|||
143338007|NCT01953003|516781477|FG000|Overall Study|Not treated|0|||
143338008|NCT01953003|516781478|FG001|Overall Study|Not treated|1|||
143338009|NCT01953003|516781477|FG000|Overall Study|Progressive disease|35|||
143338010|NCT01953003|516781478|FG001|Overall Study|Progressive disease|45|||
143338011|NCT01953003|516781477|FG000|Overall Study|Related Adverse events|7|||
143338012|NCT01953003|516781478|FG001|Overall Study|Related Adverse events|2|||
143338013|NCT01953003|516781477|FG000|Overall Study|Non-related adverse events|0|||
143338014|NCT01953003|516781478|FG001|Overall Study|Non-related adverse events|2|||
143338015|NCT01953003|516781477|FG000|Overall Study|Protocol Violation|0|||
143338016|NCT01953003|516781478|FG001|Overall Study|Protocol Violation|1|||
143338017|NCT01953003|516781477|FG000|Overall Study|Withdrawal by Subject|14|||
143338018|NCT01953003|516781478|FG001|Overall Study|Withdrawal by Subject|4|||
143338019|NCT03391765|516781484|FG000|Overall Study|Adverse Event|2|||
143338020|NCT03391765|516781485|FG001|Overall Study|Adverse Event|0|||
143338021|NCT03391765|516781486|FG002|Overall Study|Adverse Event|0|||
143338022|NCT03391765|516781487|FG003|Overall Study|Adverse Event|2|||
143338023|NCT03391765|516781484|FG000|Overall Study|Withdrew consent|5|||
143338024|NCT03391765|516781485|FG001|Overall Study|Withdrew consent|7|||
143338025|NCT03391765|516781486|FG002|Overall Study|Withdrew consent|2|||
143338026|NCT03391765|516781487|FG003|Overall Study|Withdrew consent|5|||
143338027|NCT03391765|516781484|FG000|Overall Study|Other, not specified|44|||
143338028|NCT03391765|516781485|FG001|Overall Study|Other, not specified|38|||
143338029|NCT03391765|516781486|FG002|Overall Study|Other, not specified|21|||
143338030|NCT03391765|516781487|FG003|Overall Study|Other, not specified|16|||
143338031|NCT00838682|516781493|FG000|Overall Study|Lost to Follow-up|21|||
143389208|NCT05687916|516973881|FG001|Overall Study|Protocol Violation|2|||
143389209|NCT05687916|516973882|FG002|Overall Study|Protocol Violation|1|||
143389210|NCT05687916|516973880|FG000|Overall Study|Reason not Specified|1|||
143389211|NCT05687916|516973881|FG001|Overall Study|Reason not Specified|0|||
143389212|NCT05687916|516973882|FG002|Overall Study|Reason not Specified|0|||
143389213|NCT01261312|516973883|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
143389214|NCT01261312|516973884|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
143389215|NCT01261312|516973885|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
143389216|NCT01261312|516973886|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
143389217|NCT01261312|516973887|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
143389218|NCT01261312|516973888|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
143389219|NCT01261312|516973889|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
143389220|NCT01261312|516973890|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
143389221|NCT01261312|516973891|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
143389222|NCT01261312|516973892|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
143389223|NCT01261312|516973893|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
143389224|NCT01261312|516973894|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
143389225|NCT01261312|516973895|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
143389226|NCT01261312|516973883|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
143389227|NCT01261312|516973884|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
143389228|NCT01261312|516973885|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
143389229|NCT01261312|516973886|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
143389230|NCT01261312|516973887|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
143389231|NCT01261312|516973888|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
143389232|NCT01261312|516973889|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
143389233|NCT01261312|516973890|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
143389234|NCT01261312|516973891|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
143389235|NCT01261312|516973892|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
143389236|NCT01261312|516973893|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
143389237|NCT01261312|516973894|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
143389238|NCT01261312|516973895|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
143389239|NCT01261312|516973883|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
143389240|NCT01261312|516973884|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
143389241|NCT01261312|516973885|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
143389242|NCT01261312|516973886|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
143389243|NCT01261312|516973887|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
143389244|NCT01261312|516973888|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
143389245|NCT01261312|516973889|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
143389246|NCT01261312|516973890|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
143389247|NCT01261312|516973891|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
143389248|NCT01261312|516973892|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
143389249|NCT01261312|516973893|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
143389250|NCT01261312|516973894|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
143389251|NCT01261312|516973895|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
143389252|NCT01261312|516973883|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
143389253|NCT01261312|516973884|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
143389254|NCT01261312|516973885|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
143389255|NCT01261312|516973886|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
143389256|NCT01261312|516973887|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
143389257|NCT01261312|516973888|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
143389258|NCT01261312|516973889|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
143389259|NCT01261312|516973890|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
143389260|NCT01261312|516973891|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
143389261|NCT01261312|516973892|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
143389262|NCT01261312|516973893|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
143389263|NCT01261312|516973894|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
143389264|NCT01261312|516973895|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
143389265|NCT01261312|516973883|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
143389266|NCT01261312|516973884|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
143389267|NCT01261312|516973885|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
143389268|NCT01261312|516973886|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
143389269|NCT01261312|516973887|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
143389270|NCT01261312|516973888|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
143389271|NCT01261312|516973889|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
143389272|NCT01261312|516973890|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
143389273|NCT01261312|516973891|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
143389274|NCT01261312|516973892|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
143389275|NCT01261312|516973893|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
143389276|NCT01261312|516973894|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
143389277|NCT01261312|516973895|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
143389278|NCT01261312|516973883|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
143389279|NCT01261312|516973884|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
143389280|NCT01261312|516973885|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
143389281|NCT01261312|516973886|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
143389282|NCT01261312|516973887|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
143389283|NCT01261312|516973888|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
143389284|NCT01261312|516973889|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
143389285|NCT01261312|516973890|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
143389286|NCT01261312|516973891|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
143389287|NCT01261312|516973892|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
143389288|NCT01261312|516973893|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
143389289|NCT01261312|516973894|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
143389290|NCT01261312|516973895|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
143389291|NCT01261312|516973883|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
143389292|NCT01261312|516973884|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
143389293|NCT01261312|516973885|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
143389294|NCT01261312|516973886|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
143389295|NCT01261312|516973887|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
143389296|NCT01261312|516973888|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
143389297|NCT01261312|516973889|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
143389298|NCT01261312|516973890|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
143389299|NCT01261312|516973891|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
143389300|NCT01261312|516973892|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
143389301|NCT01261312|516973893|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
143389302|NCT01261312|516973894|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
143389303|NCT01261312|516973895|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
143389304|NCT01261312|516973883|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
143389305|NCT01261312|516973884|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
143389306|NCT01261312|516973885|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
143389307|NCT01261312|516973886|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
143389308|NCT01261312|516973887|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
143389309|NCT01261312|516973888|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
143389310|NCT01261312|516973889|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
143389311|NCT01261312|516973890|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
143389312|NCT01261312|516973891|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
143389313|NCT01261312|516973892|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
143389314|NCT01261312|516973893|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
143389315|NCT01261312|516973894|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
143389316|NCT01261312|516973895|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
143389317|NCT01261312|516973883|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
143389318|NCT01261312|516973884|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
143389319|NCT01261312|516973885|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
143389320|NCT01261312|516973886|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
143389321|NCT01261312|516973887|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
143389322|NCT01261312|516973888|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
143389323|NCT01261312|516973889|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
143389324|NCT01261312|516973890|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
143389325|NCT01261312|516973891|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
143389326|NCT01261312|516973892|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
143389327|NCT01261312|516973893|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
143389328|NCT01261312|516973894|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
143389329|NCT01261312|516973895|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
143389330|NCT01261312|516973883|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
143389331|NCT01261312|516973884|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
143389332|NCT01261312|516973885|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
143389333|NCT01261312|516973886|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
143389334|NCT01261312|516973887|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
143389335|NCT01261312|516973888|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
143389336|NCT01261312|516973889|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
143338032|NCT00838682|516781494|FG001|Overall Study|Lost to Follow-up|14|||
143338033|NCT00838682|516781493|FG000|Overall Study|detection of exclusion criteria|4|||
143338034|NCT00838682|516781494|FG001|Overall Study|detection of exclusion criteria|3|||
143338035|NCT00838682|516781493|FG000|Overall Study|Protocol Violation|0|||
143338036|NCT00838682|516781494|FG001|Overall Study|Protocol Violation|1|||
143338037|NCT00838682|516781493|FG000|Overall Study|Withdrawal by Subject|0|||
143338038|NCT00838682|516781494|FG001|Overall Study|Withdrawal by Subject|1|||
143338039|NCT02832622|516781500|FG000|Overall Study|MPP not programmed|1259|||
143338040|NCT02832622|516781500|FG000|Overall Study|Withdrawal by Subject|123|||
143338041|NCT02832622|516781500|FG000|Overall Study|Death|119|||
143338042|NCT02832622|516781500|FG000|Overall Study|Unsuccessful CRT implant|93|||
143338043|NCT02832622|516781500|FG000|Overall Study|Lost to Follow-up|45|||
143338044|NCT02832622|516781500|FG000|Overall Study|Patient non-compliance|42|||
143338045|NCT02832622|516781500|FG000|Overall Study|Withdrawal by other reasons|25|||
143338046|NCT02832622|516781500|FG000|Overall Study|System explant|24|||
143338047|NCT02832622|516781500|FG000|Overall Study|Physician Decision|6|||
143338048|NCT02472652|516781502|FG000|Overall Study|Lost to Follow-up|1|||
143338049|NCT00998400|516781507|FG000|Overall Study|Lack of interest/motivation|1|||
143338050|NCT00998400|516781508|FG001|Overall Study|Lack of interest/motivation|2|||
143338051|NCT00998400|516781507|FG000|Overall Study|Logistical problems|1|||
143338052|NCT00998400|516781508|FG001|Overall Study|Logistical problems|0|||
143338053|NCT03704584|516781509|FG000|Overall Study|Withdrawal by Subject|1|||
143338054|NCT03704584|516781510|FG001|Overall Study|Withdrawal by Subject|0|||
143338055|NCT03185832|516781511|FG000|Overall Study|Death|9|||
143338056|NCT03185832|516781512|FG001|Overall Study|Death|14|||
143338057|NCT03185832|516781513|FG002|Overall Study|Death|9|||
143338058|NCT03185832|516781514|FG003|Overall Study|Death|7|||
143338059|NCT03185832|516781511|FG000|Overall Study|Withdrawn - vital status available|0|||
143338060|NCT03185832|516781512|FG001|Overall Study|Withdrawn - vital status available|1|||
143338061|NCT03185832|516781513|FG002|Overall Study|Withdrawn - vital status available|1|||
143338062|NCT03185832|516781514|FG003|Overall Study|Withdrawn - vital status available|4|||
143338063|NCT01083641|516781516|FG000|Overall Study|Withdrawal by Subject|2|||
143338064|NCT03439189|516781517|FG000|Overall Study|Protocol Violation|19|||
143338065|NCT03439189|516781517|FG000|Overall Study|Lack of Efficacy|63|||
143338066|NCT01777321|516781518|FG000|Overall Study|Withdrawal by Subject|0|||
143338067|NCT01777321|516781519|FG001|Overall Study|Withdrawal by Subject|1|||
143338068|NCT05131165|516781522|FG000|Overall Study|Death|1|||
143338069|NCT05131165|516781523|FG001|Overall Study|Death|1|||
143338070|NCT05131165|516781524|FG002|Overall Study|Death|0|||
143338071|NCT05131165|516781522|FG000|Overall Study|Lost to Follow-up|2|||
143338072|NCT05131165|516781523|FG001|Overall Study|Lost to Follow-up|2|||
143338073|NCT05131165|516781524|FG002|Overall Study|Lost to Follow-up|5|||
143338074|NCT05131165|516781522|FG000|Overall Study|Transferred out of clinic|1|||
143338075|NCT05131165|516781523|FG001|Overall Study|Transferred out of clinic|0|||
143338076|NCT05131165|516781524|FG002|Overall Study|Transferred out of clinic|3|||
143338077|NCT05131165|516781522|FG000|Overall Study|Dropped out|1|||
143338078|NCT05131165|516781523|FG001|Overall Study|Dropped out|2|||
143338079|NCT05131165|516781524|FG002|Overall Study|Dropped out|0|||
143338080|NCT04539821|516781529|FG000|Overall Study|Withdrawal by Subject|2|||
143338081|NCT04539821|516781529|FG000|Overall Study|continued care with their physician|20|||
143338082|NCT04539821|516781529|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
143338083|NCT00595504|516781532|FG000|Overall Study|Withdrawal by Subject|1|||
143338084|NCT00595504|516781533|FG001|Overall Study|Withdrawal by Subject|3|||
143338085|NCT00595504|516781532|FG000|Overall Study|Physician Decision|1|||
143389337|NCT01261312|516973890|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
143389338|NCT01261312|516973891|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
143389339|NCT01261312|516973892|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
143389340|NCT01261312|516973893|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
143389341|NCT01261312|516973894|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
143389342|NCT01261312|516973895|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
143389343|NCT01261312|516973883|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
143389344|NCT01261312|516973884|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
143389345|NCT01261312|516973885|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
143389346|NCT01261312|516973886|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
143389347|NCT01261312|516973887|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
143389348|NCT01261312|516973888|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
143389349|NCT01261312|516973889|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
143389350|NCT01261312|516973890|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
143389351|NCT01261312|516973891|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
143389352|NCT01261312|516973892|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
143389353|NCT01261312|516973893|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
143389354|NCT01261312|516973894|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
143389355|NCT01261312|516973895|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
143389356|NCT01261312|516973883|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
143389357|NCT01261312|516973884|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
143389358|NCT01261312|516973885|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
143389359|NCT01261312|516973886|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
143389360|NCT01261312|516973887|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
143389361|NCT01261312|516973888|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
143389362|NCT01261312|516973889|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
143389363|NCT01261312|516973890|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
143389364|NCT01261312|516973891|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
143389365|NCT01261312|516973892|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
143389366|NCT01261312|516973893|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
143389367|NCT01261312|516973894|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
143389368|NCT01261312|516973895|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
143389369|NCT01261312|516973883|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
143389370|NCT01261312|516973884|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
143389371|NCT01261312|516973885|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
143389372|NCT01261312|516973886|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
143389373|NCT01261312|516973887|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
143389374|NCT01261312|516973888|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
143389375|NCT01261312|516973889|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
143389376|NCT01261312|516973890|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
143389377|NCT01261312|516973891|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
143389378|NCT01261312|516973892|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
143389379|NCT01261312|516973893|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
143389380|NCT01261312|516973894|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
143389381|NCT01261312|516973895|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
143389382|NCT01261312|516973883|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
143389383|NCT01261312|516973884|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
143389384|NCT01261312|516973885|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
143389385|NCT01261312|516973886|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
143389386|NCT01261312|516973887|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
143389387|NCT01261312|516973888|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
143389388|NCT01261312|516973889|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
143389389|NCT01261312|516973890|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
143389390|NCT01261312|516973891|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
143389391|NCT01261312|516973892|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
143389392|NCT01261312|516973893|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
143389393|NCT01261312|516973894|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
143389394|NCT01261312|516973895|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
143389395|NCT01261312|516973883|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
143389396|NCT01261312|516973884|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
143389397|NCT01261312|516973885|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
143389398|NCT01261312|516973886|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
143389399|NCT01261312|516973887|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
143389400|NCT01261312|516973888|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
143389401|NCT01261312|516973889|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
143389402|NCT01261312|516973890|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
143338086|NCT00595504|516781533|FG001|Overall Study|Physician Decision|0|||
143338087|NCT01050816|516781534|FG000|Overall Study|Lost to Follow-up|2|||
143338088|NCT01050816|516781534|FG000|Overall Study|patient's refusal|2|||
143338089|NCT03440372|516781535|FG000|Treatment|Adverse Event|16|||
143338090|NCT03440372|516781536|FG001|Treatment|Adverse Event|8|||
143338091|NCT03440372|516781535|FG000|Treatment|Lack of Efficacy|4|||
143338092|NCT03440372|516781536|FG001|Treatment|Lack of Efficacy|2|||
143338093|NCT03440372|516781535|FG000|Treatment|Withdrawal by Subject|12|||
143338094|NCT03440372|516781536|FG001|Treatment|Withdrawal by Subject|8|||
143338095|NCT03440372|516781535|FG000|Treatment|Lost to Follow-up|1|||
143338096|NCT03440372|516781536|FG001|Treatment|Lost to Follow-up|0|||
143338097|NCT03440372|516781535|FG000|Treatment|Pregnancy|1|||
143338098|NCT03440372|516781536|FG001|Treatment|Pregnancy|0|||
143338099|NCT03440372|516781535|FG000|Treatment|Study Terminated by Sponsor|2|||
143338100|NCT03440372|516781536|FG001|Treatment|Study Terminated by Sponsor|1|||
143338101|NCT03440372|516781535|FG000|Treatment|Other Reason|2|||
143338102|NCT03440372|516781536|FG001|Treatment|Other Reason|3|||
143338103|NCT00448448|516781537|FG000|Overall Study|Withdrawal by Subject|13|||
143338104|NCT00448448|516781538|FG001|Overall Study|Withdrawal by Subject|2|||
143338105|NCT00448448|516781537|FG000|Overall Study|On protocol when study ended|83|||
143338106|NCT00448448|516781538|FG001|Overall Study|On protocol when study ended|36|||
143338107|NCT00448448|516781537|FG000|Overall Study|Lost to Follow-up|2|||
143338108|NCT00448448|516781538|FG001|Overall Study|Lost to Follow-up|1|||
143338109|NCT00448448|516781537|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
143338110|NCT00448448|516781538|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
143338111|NCT00448448|516781537|FG000|Overall Study|Signed consent lost|0|||
143338112|NCT00448448|516781538|FG001|Overall Study|Signed consent lost|1|||
143338113|NCT03945292|516781539|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
143338114|NCT03945292|516781540|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
143338115|NCT03945292|516781541|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
143338116|NCT03945292|516781542|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
143338117|NCT03945292|516781543|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
143338118|NCT03945292|516781544|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
143338119|NCT03945292|516781545|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
143338120|NCT03945292|516781546|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
143338121|NCT03945292|516781539|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
143338122|NCT03945292|516781540|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
143338123|NCT03945292|516781541|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
143338124|NCT03945292|516781542|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
143338125|NCT03945292|516781543|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
143338126|NCT03945292|516781544|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
143338127|NCT03945292|516781545|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
143338128|NCT03945292|516781546|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
143338129|NCT03945292|516781539|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
143338130|NCT03945292|516781540|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
143338131|NCT03945292|516781541|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
143338132|NCT03945292|516781542|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
143338133|NCT03945292|516781543|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
143338134|NCT03945292|516781544|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
143338135|NCT03945292|516781545|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
143338136|NCT03945292|516781546|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
143338137|NCT02782169|516781547|FG000|Overall Study|Lost to Follow-up|1|||
143338138|NCT02782169|516781548|FG001|Overall Study|Lost to Follow-up|2|||
143338139|NCT04751942|516781550|FG000|Overall Study|Lost to Follow-up|9|||
143338140|NCT04751942|516781551|FG001|Overall Study|Lost to Follow-up|6|||
143338141|NCT00724152|516781553|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
143338142|NCT00724152|516781554|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
143338143|NCT00724152|516781555|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
143338144|NCT00724152|516781553|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
143338145|NCT00724152|516781554|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
143338146|NCT00724152|516781555|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
143338147|NCT03266770|516781556|FG000|Overall Study|Physician Decision|3|||
143338148|NCT03266770|516781556|FG000|Overall Study|Insufficient study supplies|1|||
143338149|NCT03266770|516781556|FG000|Overall Study|Adverse Event|1|||
143338150|NCT03848403|516781558|FG000|Period 2 (Day 8)|Adverse Event|1|||
143338151|NCT03848403|516781559|FG001|Period 2 (Day 8)|Adverse Event|2|||
143338152|NCT03848403|516781560|FG002|Period 2 (Day 8)|Adverse Event|2|||
143338153|NCT03848403|516781558|FG000|Period 2 (Day 8)|Physician Decision|0|||
143338154|NCT03848403|516781559|FG001|Period 2 (Day 8)|Physician Decision|1|||
143338155|NCT03848403|516781560|FG002|Period 2 (Day 8)|Physician Decision|0|||
143338156|NCT03848403|516781558|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
143338157|NCT03848403|516781559|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
143338158|NCT03848403|516781560|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
143338159|NCT00168038|516781561|FG000|Overall Study|Adverse Event|1|||
143338160|NCT00168038|516781561|FG000|Overall Study|Therapy failure|1|||
143338161|NCT02657031|516781564|FG000|Overall Study|Adverse Event|1|||
143338162|NCT02657031|516781565|FG001|Overall Study|Adverse Event|2|||
143338163|NCT02638948|516781568|FG000|Overall Study|Withdrawal by Subject|4|||
143338164|NCT02638948|516781569|FG001|Overall Study|Withdrawal by Subject|5|||
143338165|NCT02638948|516781570|FG002|Overall Study|Withdrawal by Subject|3|||
143338166|NCT02638948|516781571|FG003|Overall Study|Withdrawal by Subject|1|||
143338167|NCT02638948|516781568|FG000|Overall Study|Administrative Reason by Sponsor|0|||
143338168|NCT02638948|516781569|FG001|Overall Study|Administrative Reason by Sponsor|1|||
143338169|NCT02638948|516781570|FG002|Overall Study|Administrative Reason by Sponsor|0|||
143338170|NCT02638948|516781571|FG003|Overall Study|Administrative Reason by Sponsor|4|||
143338171|NCT02638948|516781568|FG000|Overall Study|Adverse Event|0|||
143338172|NCT02638948|516781569|FG001|Overall Study|Adverse Event|0|||
143338173|NCT02638948|516781570|FG002|Overall Study|Adverse Event|1|||
143338174|NCT02638948|516781571|FG003|Overall Study|Adverse Event|1|||
143338175|NCT02638948|516781568|FG000|Overall Study|Lack of Efficacy|1|||
143338176|NCT02638948|516781569|FG001|Overall Study|Lack of Efficacy|1|||
143338177|NCT02638948|516781570|FG002|Overall Study|Lack of Efficacy|0|||
143338178|NCT02638948|516781571|FG003|Overall Study|Lack of Efficacy|0|||
143338179|NCT02638948|516781568|FG000|Overall Study|Lost to Follow-up|0|||
143338180|NCT02638948|516781569|FG001|Overall Study|Lost to Follow-up|0|||
143338181|NCT02638948|516781570|FG002|Overall Study|Lost to Follow-up|1|||
143338182|NCT02638948|516781571|FG003|Overall Study|Lost to Follow-up|1|||
143338183|NCT02638948|516781568|FG000|Overall Study|Poor/Non-Compliance|0|||
143338184|NCT02638948|516781569|FG001|Overall Study|Poor/Non-Compliance|2|||
143338185|NCT02638948|516781570|FG002|Overall Study|Poor/Non-Compliance|1|||
143338186|NCT02638948|516781571|FG003|Overall Study|Poor/Non-Compliance|0|||
143338187|NCT02638948|516781568|FG000|Overall Study|Participant no longer met study criteria|0|||
143338188|NCT02638948|516781569|FG001|Overall Study|Participant no longer met study criteria|1|||
143338189|NCT02638948|516781570|FG002|Overall Study|Participant no longer met study criteria|0|||
143338190|NCT02638948|516781571|FG003|Overall Study|Participant no longer met study criteria|0|||
143338191|NCT02638948|516781568|FG000|Overall Study|Other than specified above|4|||
143338192|NCT02638948|516781569|FG001|Overall Study|Other than specified above|1|||
143338193|NCT02638948|516781570|FG002|Overall Study|Other than specified above|1|||
143338194|NCT02638948|516781571|FG003|Overall Study|Other than specified above|1|||
143338195|NCT05007392|516781574|FG000|Overall Study|Randomized but not treated|1|||
143338196|NCT05007392|516781575|FG001|Overall Study|Randomized but not treated|2|||
143338197|NCT05007392|516781574|FG000|Overall Study|Other|5|||
143338198|NCT05007392|516781575|FG001|Overall Study|Other|4|||
143338199|NCT05007392|516781574|FG000|Overall Study|Lost to Follow-up|1|||
143338200|NCT05007392|516781575|FG001|Overall Study|Lost to Follow-up|2|||
143338201|NCT05007392|516781574|FG000|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|0|||
143338202|NCT05007392|516781575|FG001|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|1|||
143338203|NCT05007392|516781574|FG000|Overall Study|Use of prohibited concomitant drug|1|||
143338204|NCT05007392|516781575|FG001|Overall Study|Use of prohibited concomitant drug|1|||
143338205|NCT05007392|516781574|FG000|Overall Study|Inadequate therapeutic effect or progression of disease|1|||
143338206|NCT05007392|516781575|FG001|Overall Study|Inadequate therapeutic effect or progression of disease|0|||
143338207|NCT05007392|516781574|FG000|Overall Study|Adverse Event|10|||
143338208|NCT05007392|516781575|FG001|Overall Study|Adverse Event|6|||
143338209|NCT05007392|516781574|FG000|Overall Study|Participant choice|5|||
143338210|NCT05007392|516781575|FG001|Overall Study|Participant choice|10|||
143338211|NCT05007392|516781574|FG000|Overall Study|Withdrawal of consent|5|||
143338212|NCT05007392|516781575|FG001|Overall Study|Withdrawal of consent|4|||
143338213|NCT01218126|516781578|FG000|Overall Study|Adverse Event|8|||
143338214|NCT01218126|516781579|FG001|Overall Study|Adverse Event|10|||
143338215|NCT01218126|516781580|FG002|Overall Study|Adverse Event|12|||
143338216|NCT01218126|516781581|FG003|Overall Study|Adverse Event|16|||
143338217|NCT01218126|516781578|FG000|Overall Study|Lack of Efficacy|7|||
143338218|NCT01218126|516781579|FG001|Overall Study|Lack of Efficacy|2|||
143338219|NCT01218126|516781580|FG002|Overall Study|Lack of Efficacy|2|||
143338220|NCT01218126|516781581|FG003|Overall Study|Lack of Efficacy|6|||
143338221|NCT01218126|516781578|FG000|Overall Study|Protocol Violation|5|||
143338222|NCT01218126|516781579|FG001|Overall Study|Protocol Violation|2|||
143338223|NCT01218126|516781580|FG002|Overall Study|Protocol Violation|2|||
143338224|NCT01218126|516781581|FG003|Overall Study|Protocol Violation|3|||
143338225|NCT01218126|516781578|FG000|Overall Study|Protocol-defined stopping criteria|1|||
143338226|NCT01218126|516781579|FG001|Overall Study|Protocol-defined stopping criteria|1|||
143338227|NCT01218126|516781580|FG002|Overall Study|Protocol-defined stopping criteria|0|||
143338228|NCT01218126|516781581|FG003|Overall Study|Protocol-defined stopping criteria|0|||
143389403|NCT01261312|516973891|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
143389404|NCT01261312|516973892|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
143389405|NCT01261312|516973893|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
143389406|NCT01261312|516973894|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
143389407|NCT01261312|516973895|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
143389408|NCT01261312|516973883|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
143389409|NCT01261312|516973884|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
143389410|NCT01261312|516973885|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
143389411|NCT01261312|516973886|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
143389412|NCT01261312|516973887|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
143389413|NCT01261312|516973888|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
143389414|NCT01261312|516973889|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
143389415|NCT01261312|516973890|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
143389416|NCT01261312|516973891|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
143389417|NCT01261312|516973892|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
143389418|NCT01261312|516973893|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
143389419|NCT01261312|516973894|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
143389420|NCT01261312|516973895|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
143389421|NCT01261312|516973883|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
143389422|NCT01261312|516973884|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
143389423|NCT01261312|516973885|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
143389424|NCT01261312|516973886|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
143389425|NCT01261312|516973887|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
143389426|NCT01261312|516973888|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
143389427|NCT01261312|516973889|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
143389428|NCT01261312|516973890|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
143389429|NCT01261312|516973891|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
143389430|NCT01261312|516973892|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
143389431|NCT01261312|516973893|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
143389432|NCT01261312|516973894|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
143389433|NCT01261312|516973895|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
143389434|NCT01261312|516973883|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
143389435|NCT01261312|516973884|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
143389436|NCT01261312|516973885|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
143389437|NCT01261312|516973886|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
143389438|NCT01261312|516973887|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
143389439|NCT01261312|516973888|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
143389440|NCT01261312|516973889|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
143389441|NCT01261312|516973890|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
143389442|NCT01261312|516973891|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
143389443|NCT01261312|516973892|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
143389444|NCT01261312|516973893|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
143389445|NCT01261312|516973894|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
143389446|NCT01261312|516973895|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
143389447|NCT01261312|516973883|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
143389448|NCT01261312|516973884|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
143389449|NCT01261312|516973885|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
143389450|NCT01261312|516973886|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
143389451|NCT01261312|516973887|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
143389452|NCT01261312|516973888|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
143389453|NCT01261312|516973889|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
143389454|NCT01261312|516973890|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
143389455|NCT01261312|516973891|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
143389456|NCT01261312|516973892|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
143389457|NCT01261312|516973893|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
143389458|NCT01261312|516973894|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
143389459|NCT01261312|516973895|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
143389460|NCT01261312|516973883|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
143389461|NCT01261312|516973884|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
143389462|NCT01261312|516973885|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
143389463|NCT01261312|516973886|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
143389464|NCT01261312|516973887|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
143389465|NCT01261312|516973888|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
143389466|NCT01261312|516973889|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
143389467|NCT01261312|516973890|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
143389468|NCT01261312|516973891|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
143389469|NCT01261312|516973892|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
143389470|NCT01261312|516973893|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
143389471|NCT01261312|516973894|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
143389472|NCT01261312|516973895|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
143389473|NCT01261312|516973883|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
143389474|NCT01261312|516973884|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
143389475|NCT01261312|516973885|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
143389476|NCT01261312|516973886|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
143389477|NCT01261312|516973887|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
143389478|NCT01261312|516973888|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
143389479|NCT01261312|516973889|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
143389480|NCT01261312|516973890|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
143389481|NCT01261312|516973891|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
143389482|NCT01261312|516973892|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
143389483|NCT01261312|516973893|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
143389484|NCT01261312|516973894|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
143389485|NCT01261312|516973895|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
143389486|NCT01261312|516973883|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
143389487|NCT01261312|516973884|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
143389488|NCT01261312|516973885|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
143389489|NCT01261312|516973886|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
143389490|NCT01261312|516973887|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
143389491|NCT01261312|516973888|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
143389492|NCT01261312|516973889|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
143389493|NCT01261312|516973890|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
143389494|NCT01261312|516973891|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
143389495|NCT01261312|516973892|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
143389496|NCT01261312|516973893|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
143389497|NCT01261312|516973894|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
143389498|NCT01261312|516973895|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
143389499|NCT01261312|516973883|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
143389500|NCT01261312|516973884|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
143389501|NCT01261312|516973885|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
143389502|NCT01261312|516973886|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
143389503|NCT01261312|516973887|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
143389504|NCT01261312|516973888|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
143389505|NCT01261312|516973889|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
143389506|NCT01261312|516973890|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
143389507|NCT01261312|516973891|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
143389508|NCT01261312|516973892|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
143389509|NCT01261312|516973893|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
143389510|NCT01261312|516973894|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
143389511|NCT01261312|516973895|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
143389512|NCT01261312|516973883|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
143389513|NCT01261312|516973884|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
143389514|NCT01261312|516973885|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
143389515|NCT01261312|516973886|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
143389516|NCT01261312|516973887|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
143389517|NCT01261312|516973888|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
143389518|NCT01261312|516973889|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
143389519|NCT01261312|516973890|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
143389520|NCT01261312|516973891|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
143389521|NCT01261312|516973892|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
143389522|NCT01261312|516973893|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
143389523|NCT01261312|516973894|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
143389524|NCT01261312|516973895|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
143389525|NCT01261312|516973883|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
143389526|NCT01261312|516973884|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
143389527|NCT01261312|516973885|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
143389528|NCT01261312|516973886|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
143389529|NCT01261312|516973887|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
143389530|NCT01261312|516973888|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
143389531|NCT01261312|516973889|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
143389532|NCT01261312|516973890|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
143389533|NCT01261312|516973891|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
143389534|NCT01261312|516973892|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
143389535|NCT01261312|516973893|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
143389536|NCT01261312|516973894|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
143389537|NCT01261312|516973895|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
143389538|NCT01261312|516973883|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
143389539|NCT01261312|516973884|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
143389540|NCT01261312|516973885|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
143389541|NCT01261312|516973886|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
143389542|NCT01261312|516973887|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
143389543|NCT01261312|516973888|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
143389544|NCT01261312|516973889|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
143389545|NCT01261312|516973890|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
143389546|NCT01261312|516973891|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
143389547|NCT01261312|516973892|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
143389548|NCT01261312|516973893|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
143389549|NCT01261312|516973894|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
143389550|NCT01261312|516973895|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
143389551|NCT01261312|516973883|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
143389552|NCT01261312|516973884|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
143389553|NCT01261312|516973885|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
143389554|NCT01261312|516973886|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
143389555|NCT01261312|516973887|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
143389556|NCT01261312|516973888|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
143389557|NCT01261312|516973889|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
143389558|NCT01261312|516973890|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
143389559|NCT01261312|516973891|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
143389560|NCT01261312|516973892|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
143389561|NCT01261312|516973893|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
143389562|NCT01261312|516973894|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
143389563|NCT01261312|516973895|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
143389564|NCT01261312|516973883|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
143389565|NCT01261312|516973884|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
143389566|NCT01261312|516973885|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
143389567|NCT01261312|516973886|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
143389568|NCT01261312|516973887|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
143389569|NCT01261312|516973888|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
143389570|NCT01261312|516973889|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
143389571|NCT01261312|516973890|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
143389572|NCT01261312|516973891|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
143389573|NCT01261312|516973892|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
143389574|NCT01261312|516973893|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
143389575|NCT01261312|516973894|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
143389576|NCT01261312|516973895|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
143389577|NCT04927065|516973896|FG000|First Booster|Adverse Event|1|||
143389578|NCT04927065|516973897|FG001|First Booster|Adverse Event|0|||
143389579|NCT04927065|516973898|FG002|First Booster|Adverse Event|0|||
143389580|NCT04927065|516973899|FG003|First Booster|Adverse Event|0|||
143389581|NCT04927065|516973900|FG004|First Booster|Adverse Event|0|||
143389582|NCT04927065|516973901|FG005|First Booster|Adverse Event|0|||
143389583|NCT04927065|516973902|FG006|First Booster|Adverse Event|0|||
143389584|NCT04927065|516973903|FG007|First Booster|Adverse Event|1|||
143389585|NCT04927065|516973904|FG008|First Booster|Adverse Event|0|||
143389586|NCT04927065|516973905|FG009|First Booster|Adverse Event|0|||
143389587|NCT04927065|516973906|FG010|First Booster|Adverse Event|0|||
143389588|NCT04927065|516973907|FG011|First Booster|Adverse Event|0|||
143389589|NCT04927065|516973908|FG012|First Booster|Adverse Event|0|||
143389590|NCT04927065|516973909|FG013|First Booster|Adverse Event|0|||
143389591|NCT04927065|516973910|FG014|First Booster|Adverse Event|0|||
143389592|NCT04927065|516973911|FG015|First Booster|Adverse Event|0|||
143389593|NCT04927065|516973896|FG000|First Booster|Death|1|||
143389594|NCT04927065|516973897|FG001|First Booster|Death|0|||
143389595|NCT04927065|516973898|FG002|First Booster|Death|0|||
143389596|NCT04927065|516973899|FG003|First Booster|Death|1|||
143389597|NCT04927065|516973900|FG004|First Booster|Death|0|||
143389598|NCT04927065|516973901|FG005|First Booster|Death|1|||
143389599|NCT04927065|516973902|FG006|First Booster|Death|0|||
143389600|NCT04927065|516973903|FG007|First Booster|Death|0|||
143389601|NCT04927065|516973904|FG008|First Booster|Death|0|||
143389602|NCT04927065|516973905|FG009|First Booster|Death|0|||
143389603|NCT04927065|516973906|FG010|First Booster|Death|0|||
143389604|NCT04927065|516973907|FG011|First Booster|Death|0|||
143389605|NCT04927065|516973908|FG012|First Booster|Death|0|||
143389606|NCT04927065|516973909|FG013|First Booster|Death|0|||
143389607|NCT04927065|516973910|FG014|First Booster|Death|0|||
143389608|NCT04927065|516973911|FG015|First Booster|Death|0|||
143389609|NCT04927065|516973896|FG000|First Booster|Lost to Follow-up|8|||
143389610|NCT04927065|516973897|FG001|First Booster|Lost to Follow-up|20|||
143389611|NCT04927065|516973898|FG002|First Booster|Lost to Follow-up|0|||
143389612|NCT04927065|516973899|FG003|First Booster|Lost to Follow-up|11|||
143389613|NCT04927065|516973900|FG004|First Booster|Lost to Follow-up|43|||
143389614|NCT04927065|516973901|FG005|First Booster|Lost to Follow-up|30|||
143389615|NCT04927065|516973902|FG006|First Booster|Lost to Follow-up|28|||
143389616|NCT04927065|516973903|FG007|First Booster|Lost to Follow-up|23|||
143389617|NCT04927065|516973904|FG008|First Booster|Lost to Follow-up|4|||
143389618|NCT04927065|516973905|FG009|First Booster|Lost to Follow-up|15|||
143389619|NCT04927065|516973906|FG010|First Booster|Lost to Follow-up|0|||
143389620|NCT04927065|516973907|FG011|First Booster|Lost to Follow-up|0|||
143389621|NCT04927065|516973908|FG012|First Booster|Lost to Follow-up|0|||
143389622|NCT04927065|516973909|FG013|First Booster|Lost to Follow-up|0|||
143389623|NCT04927065|516973910|FG014|First Booster|Lost to Follow-up|0|||
143389624|NCT04927065|516973911|FG015|First Booster|Lost to Follow-up|0|||
143389625|NCT04927065|516973896|FG000|First Booster|Physician Decision|1|||
143389626|NCT04927065|516973897|FG001|First Booster|Physician Decision|0|||
143389627|NCT04927065|516973898|FG002|First Booster|Physician Decision|0|||
143389628|NCT04927065|516973899|FG003|First Booster|Physician Decision|3|||
143389629|NCT04927065|516973900|FG004|First Booster|Physician Decision|1|||
143389630|NCT04927065|516973901|FG005|First Booster|Physician Decision|1|||
143389631|NCT04927065|516973902|FG006|First Booster|Physician Decision|0|||
143389632|NCT04927065|516973903|FG007|First Booster|Physician Decision|3|||
143389633|NCT04927065|516973904|FG008|First Booster|Physician Decision|0|||
143389634|NCT04927065|516973905|FG009|First Booster|Physician Decision|0|||
143389635|NCT04927065|516973906|FG010|First Booster|Physician Decision|0|||
143389636|NCT04927065|516973907|FG011|First Booster|Physician Decision|0|||
143389637|NCT04927065|516973908|FG012|First Booster|Physician Decision|0|||
143389638|NCT04927065|516973909|FG013|First Booster|Physician Decision|0|||
143389639|NCT04927065|516973910|FG014|First Booster|Physician Decision|0|||
143389640|NCT04927065|516973911|FG015|First Booster|Physician Decision|0|||
143389641|NCT04927065|516973896|FG000|First Booster|Protocol Violation|4|||
143389642|NCT04927065|516973897|FG001|First Booster|Protocol Violation|4|||
143389643|NCT04927065|516973898|FG002|First Booster|Protocol Violation|0|||
143389644|NCT04927065|516973899|FG003|First Booster|Protocol Violation|3|||
143389645|NCT04927065|516973900|FG004|First Booster|Protocol Violation|0|||
143389646|NCT04927065|516973901|FG005|First Booster|Protocol Violation|0|||
143389647|NCT04927065|516973902|FG006|First Booster|Protocol Violation|0|||
143389648|NCT04927065|516973903|FG007|First Booster|Protocol Violation|2|||
143389649|NCT04927065|516973904|FG008|First Booster|Protocol Violation|0|||
143389650|NCT04927065|516973905|FG009|First Booster|Protocol Violation|0|||
143389651|NCT04927065|516973906|FG010|First Booster|Protocol Violation|0|||
143389652|NCT04927065|516973907|FG011|First Booster|Protocol Violation|0|||
143389653|NCT04927065|516973908|FG012|First Booster|Protocol Violation|0|||
143389654|NCT04927065|516973909|FG013|First Booster|Protocol Violation|0|||
143389655|NCT04927065|516973910|FG014|First Booster|Protocol Violation|0|||
143389656|NCT04927065|516973911|FG015|First Booster|Protocol Violation|0|||
143389657|NCT04927065|516973896|FG000|First Booster|Withdrawal by Subject|8|||
143389658|NCT04927065|516973897|FG001|First Booster|Withdrawal by Subject|23|||
143389659|NCT04927065|516973898|FG002|First Booster|Withdrawal by Subject|0|||
143389660|NCT04927065|516973899|FG003|First Booster|Withdrawal by Subject|19|||
143389661|NCT04927065|516973900|FG004|First Booster|Withdrawal by Subject|20|||
143389662|NCT04927065|516973901|FG005|First Booster|Withdrawal by Subject|15|||
143389663|NCT04927065|516973902|FG006|First Booster|Withdrawal by Subject|6|||
143389664|NCT04927065|516973903|FG007|First Booster|Withdrawal by Subject|24|||
143389665|NCT04927065|516973904|FG008|First Booster|Withdrawal by Subject|0|||
143389666|NCT04927065|516973905|FG009|First Booster|Withdrawal by Subject|4|||
143389667|NCT04927065|516973906|FG010|First Booster|Withdrawal by Subject|0|||
143389668|NCT04927065|516973907|FG011|First Booster|Withdrawal by Subject|0|||
143389669|NCT04927065|516973908|FG012|First Booster|Withdrawal by Subject|0|||
143389670|NCT04927065|516973909|FG013|First Booster|Withdrawal by Subject|0|||
143389671|NCT04927065|516973910|FG014|First Booster|Withdrawal by Subject|0|||
143389672|NCT04927065|516973911|FG015|First Booster|Withdrawal by Subject|0|||
143389673|NCT04927065|516973896|FG000|First Booster|Other Than Specified|1|||
143389674|NCT04927065|516973897|FG001|First Booster|Other Than Specified|1|||
143389675|NCT04927065|516973898|FG002|First Booster|Other Than Specified|0|||
143389676|NCT04927065|516973899|FG003|First Booster|Other Than Specified|1|||
143389677|NCT04927065|516973900|FG004|First Booster|Other Than Specified|2|||
143389678|NCT04927065|516973901|FG005|First Booster|Other Than Specified|3|||
143389679|NCT04927065|516973902|FG006|First Booster|Other Than Specified|2|||
143389680|NCT04927065|516973903|FG007|First Booster|Other Than Specified|6|||
143389681|NCT04927065|516973904|FG008|First Booster|Other Than Specified|0|||
143389682|NCT04927065|516973905|FG009|First Booster|Other Than Specified|4|||
143389683|NCT04927065|516973906|FG010|First Booster|Other Than Specified|0|||
143389684|NCT04927065|516973907|FG011|First Booster|Other Than Specified|0|||
143389685|NCT04927065|516973908|FG012|First Booster|Other Than Specified|0|||
143389686|NCT04927065|516973909|FG013|First Booster|Other Than Specified|0|||
143454277|NCT00948766|517208181|FG000|Core Study|Death|1|||
143454278|NCT00948766|517208182|FG001|Core Study|Death|1|||
143454279|NCT00948766|517208181|FG000|Core Study|Protocol Deviation|8|||
143454280|NCT00948766|517208182|FG001|Core Study|Protocol Deviation|10|||
143454281|NCT00948766|517208181|FG000|Extension Study|Adverse Event|43|||
143454282|NCT00948766|517208182|FG001|Extension Study|Adverse Event|0|||
143454283|NCT00948766|517208181|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
143454284|NCT00948766|517208182|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
143454285|NCT00948766|517208181|FG000|Extension Study|Study Drug No Longer Required|1|||
143454286|NCT00948766|517208182|FG001|Extension Study|Study Drug No Longer Required|0|||
143454287|NCT00948766|517208181|FG000|Extension Study|Patient Withdrew Consent|32|||
143454288|NCT00948766|517208182|FG001|Extension Study|Patient Withdrew Consent|0|||
143454289|NCT00948766|517208181|FG000|Extension Study|Lost to Follow-up|8|||
143454290|NCT00948766|517208182|FG001|Extension Study|Lost to Follow-up|0|||
143454291|NCT00948766|517208181|FG000|Extension Study|Administrative Problems|1|||
143454292|NCT00948766|517208182|FG001|Extension Study|Administrative Problems|0|||
143454293|NCT00948766|517208181|FG000|Extension Study|Death|4|||
143454294|NCT00948766|517208182|FG001|Extension Study|Death|0|||
143454295|NCT03189745|517208183|FG000|Overall Study|Conflict in work schedule of participant|1|||
143454296|NCT03189745|517208184|FG001|Overall Study|Conflict in work schedule of participant|1|||
143454297|NCT05086276|517208185|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
143454298|NCT05086276|517208186|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
143454299|NCT00738894|517208188|FG000|Overall Study|Lost to Follow-up|23|||
143338229|NCT01218126|516781578|FG000|Overall Study|Lost to Follow-up|0|||
143338230|NCT01218126|516781579|FG001|Overall Study|Lost to Follow-up|0|||
143338231|NCT01218126|516781580|FG002|Overall Study|Lost to Follow-up|0|||
143338232|NCT01218126|516781581|FG003|Overall Study|Lost to Follow-up|2|||
143389687|NCT04927065|516973910|FG014|First Booster|Other Than Specified|0|||
143389688|NCT04927065|516973911|FG015|First Booster|Other Than Specified|0|||
143389689|NCT04927065|516973896|FG000|Second Booster|Death|0|||
143389690|NCT04927065|516973897|FG001|Second Booster|Death|0|||
143389691|NCT04927065|516973898|FG002|Second Booster|Death|0|||
143389692|NCT04927065|516973899|FG003|Second Booster|Death|0|||
143389693|NCT04927065|516973900|FG004|Second Booster|Death|0|||
143389694|NCT04927065|516973901|FG005|Second Booster|Death|0|||
143389695|NCT04927065|516973902|FG006|Second Booster|Death|0|||
143389696|NCT04927065|516973903|FG007|Second Booster|Death|0|||
143389697|NCT04927065|516973904|FG008|Second Booster|Death|0|||
143389698|NCT04927065|516973905|FG009|Second Booster|Death|0|||
143389699|NCT04927065|516973906|FG010|Second Booster|Death|2|||
143389700|NCT04927065|516973907|FG011|Second Booster|Death|0|||
143389701|NCT04927065|516973908|FG012|Second Booster|Death|2|||
143389702|NCT04927065|516973909|FG013|Second Booster|Death|2|||
143389703|NCT04927065|516973910|FG014|Second Booster|Death|0|||
143389704|NCT04927065|516973911|FG015|Second Booster|Death|0|||
143389705|NCT04927065|516973896|FG000|Second Booster|Lost to Follow-up|0|||
143389706|NCT04927065|516973897|FG001|Second Booster|Lost to Follow-up|0|||
143389707|NCT04927065|516973898|FG002|Second Booster|Lost to Follow-up|3|||
143389708|NCT04927065|516973899|FG003|Second Booster|Lost to Follow-up|0|||
143389709|NCT04927065|516973900|FG004|Second Booster|Lost to Follow-up|0|||
143389710|NCT04927065|516973901|FG005|Second Booster|Lost to Follow-up|0|||
143389711|NCT04927065|516973902|FG006|Second Booster|Lost to Follow-up|0|||
143389712|NCT04927065|516973903|FG007|Second Booster|Lost to Follow-up|0|||
143389713|NCT04927065|516973904|FG008|Second Booster|Lost to Follow-up|0|||
143389714|NCT04927065|516973905|FG009|Second Booster|Lost to Follow-up|0|||
143389715|NCT04927065|516973906|FG010|Second Booster|Lost to Follow-up|14|||
143389716|NCT04927065|516973907|FG011|Second Booster|Lost to Follow-up|10|||
143389717|NCT04927065|516973908|FG012|Second Booster|Lost to Follow-up|13|||
143389718|NCT04927065|516973909|FG013|Second Booster|Lost to Follow-up|16|||
143389719|NCT04927065|516973910|FG014|Second Booster|Lost to Follow-up|0|||
143389720|NCT04927065|516973911|FG015|Second Booster|Lost to Follow-up|0|||
143389721|NCT04927065|516973896|FG000|Second Booster|Physician Decision|0|||
143389722|NCT04927065|516973897|FG001|Second Booster|Physician Decision|0|||
143389723|NCT04927065|516973898|FG002|Second Booster|Physician Decision|0|||
143389724|NCT04927065|516973899|FG003|Second Booster|Physician Decision|0|||
143389725|NCT04927065|516973900|FG004|Second Booster|Physician Decision|0|||
143389726|NCT04927065|516973901|FG005|Second Booster|Physician Decision|0|||
143389727|NCT04927065|516973902|FG006|Second Booster|Physician Decision|0|||
143389728|NCT04927065|516973903|FG007|Second Booster|Physician Decision|0|||
143389729|NCT04927065|516973904|FG008|Second Booster|Physician Decision|0|||
143389730|NCT04927065|516973905|FG009|Second Booster|Physician Decision|0|||
143389731|NCT04927065|516973906|FG010|Second Booster|Physician Decision|0|||
143389732|NCT04927065|516973907|FG011|Second Booster|Physician Decision|3|||
143389733|NCT04927065|516973908|FG012|Second Booster|Physician Decision|0|||
143389734|NCT04927065|516973909|FG013|Second Booster|Physician Decision|1|||
143389735|NCT04927065|516973910|FG014|Second Booster|Physician Decision|0|||
143389736|NCT04927065|516973911|FG015|Second Booster|Physician Decision|0|||
143389737|NCT04927065|516973896|FG000|Second Booster|Withdrawal by Subject|0|||
143389738|NCT04927065|516973897|FG001|Second Booster|Withdrawal by Subject|0|||
143389739|NCT04927065|516973898|FG002|Second Booster|Withdrawal by Subject|4|||
143389740|NCT04927065|516973899|FG003|Second Booster|Withdrawal by Subject|0|||
143389741|NCT04927065|516973900|FG004|Second Booster|Withdrawal by Subject|0|||
143389742|NCT04927065|516973901|FG005|Second Booster|Withdrawal by Subject|0|||
143389743|NCT04927065|516973902|FG006|Second Booster|Withdrawal by Subject|0|||
143389744|NCT04927065|516973903|FG007|Second Booster|Withdrawal by Subject|0|||
143389745|NCT04927065|516973904|FG008|Second Booster|Withdrawal by Subject|0|||
143389746|NCT04927065|516973905|FG009|Second Booster|Withdrawal by Subject|0|||
143389747|NCT04927065|516973906|FG010|Second Booster|Withdrawal by Subject|3|||
143389748|NCT04927065|516973907|FG011|Second Booster|Withdrawal by Subject|16|||
143389749|NCT04927065|516973908|FG012|Second Booster|Withdrawal by Subject|13|||
143389750|NCT04927065|516973909|FG013|Second Booster|Withdrawal by Subject|9|||
143389751|NCT04927065|516973910|FG014|Second Booster|Withdrawal by Subject|0|||
143389752|NCT04927065|516973911|FG015|Second Booster|Withdrawal by Subject|0|||
143389753|NCT04927065|516973896|FG000|Second Booster|Other Than Specified|0|||
143389754|NCT04927065|516973897|FG001|Second Booster|Other Than Specified|0|||
143389755|NCT04927065|516973898|FG002|Second Booster|Other Than Specified|0|||
143389756|NCT04927065|516973899|FG003|Second Booster|Other Than Specified|0|||
143389757|NCT04927065|516973900|FG004|Second Booster|Other Than Specified|0|||
143389758|NCT04927065|516973901|FG005|Second Booster|Other Than Specified|0|||
143389759|NCT04927065|516973902|FG006|Second Booster|Other Than Specified|0|||
143389760|NCT04927065|516973903|FG007|Second Booster|Other Than Specified|0|||
143389761|NCT04927065|516973904|FG008|Second Booster|Other Than Specified|0|||
143389762|NCT04927065|516973905|FG009|Second Booster|Other Than Specified|0|||
143389763|NCT04927065|516973906|FG010|Second Booster|Other Than Specified|1|||
143389764|NCT04927065|516973907|FG011|Second Booster|Other Than Specified|1|||
143389765|NCT04927065|516973908|FG012|Second Booster|Other Than Specified|4|||
143389766|NCT04927065|516973909|FG013|Second Booster|Other Than Specified|0|||
143389767|NCT04927065|516973910|FG014|Second Booster|Other Than Specified|0|||
143389768|NCT04927065|516973911|FG015|Second Booster|Other Than Specified|0|||
143389769|NCT04927065|516973896|FG000|Third Booster|Lost to Follow-up|0|||
143389770|NCT04927065|516973897|FG001|Third Booster|Lost to Follow-up|0|||
143389771|NCT04927065|516973898|FG002|Third Booster|Lost to Follow-up|0|||
143389772|NCT04927065|516973899|FG003|Third Booster|Lost to Follow-up|0|||
143389773|NCT04927065|516973900|FG004|Third Booster|Lost to Follow-up|0|||
143389774|NCT04927065|516973901|FG005|Third Booster|Lost to Follow-up|0|||
143389775|NCT04927065|516973902|FG006|Third Booster|Lost to Follow-up|0|||
143389776|NCT04927065|516973903|FG007|Third Booster|Lost to Follow-up|0|||
143389777|NCT04927065|516973904|FG008|Third Booster|Lost to Follow-up|0|||
143389778|NCT04927065|516973905|FG009|Third Booster|Lost to Follow-up|0|||
143389779|NCT04927065|516973906|FG010|Third Booster|Lost to Follow-up|0|||
143389780|NCT04927065|516973907|FG011|Third Booster|Lost to Follow-up|0|||
143389781|NCT04927065|516973908|FG012|Third Booster|Lost to Follow-up|0|||
143389782|NCT04927065|516973909|FG013|Third Booster|Lost to Follow-up|0|||
143389783|NCT04927065|516973910|FG014|Third Booster|Lost to Follow-up|0|||
143389784|NCT04927065|516973911|FG015|Third Booster|Lost to Follow-up|1|||
143389785|NCT04927065|516973896|FG000|Third Booster|Withdrawal by Subject|0|||
143389786|NCT04927065|516973897|FG001|Third Booster|Withdrawal by Subject|0|||
143389787|NCT04927065|516973898|FG002|Third Booster|Withdrawal by Subject|0|||
143389788|NCT04927065|516973899|FG003|Third Booster|Withdrawal by Subject|0|||
143389789|NCT04927065|516973900|FG004|Third Booster|Withdrawal by Subject|0|||
143389790|NCT04927065|516973901|FG005|Third Booster|Withdrawal by Subject|0|||
143389791|NCT04927065|516973902|FG006|Third Booster|Withdrawal by Subject|0|||
143389792|NCT04927065|516973903|FG007|Third Booster|Withdrawal by Subject|0|||
143389793|NCT04927065|516973904|FG008|Third Booster|Withdrawal by Subject|0|||
143389794|NCT04927065|516973905|FG009|Third Booster|Withdrawal by Subject|0|||
143389795|NCT04927065|516973906|FG010|Third Booster|Withdrawal by Subject|0|||
143389796|NCT04927065|516973907|FG011|Third Booster|Withdrawal by Subject|0|||
143389797|NCT04927065|516973908|FG012|Third Booster|Withdrawal by Subject|0|||
143389798|NCT04927065|516973909|FG013|Third Booster|Withdrawal by Subject|0|||
143389799|NCT04927065|516973910|FG014|Third Booster|Withdrawal by Subject|0|||
143389800|NCT04927065|516973911|FG015|Third Booster|Withdrawal by Subject|1|||
143389801|NCT03406871|516973913|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
143389802|NCT03406871|516973914|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
143389803|NCT03406871|516973915|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
143389804|NCT03406871|516973913|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
143389805|NCT03406871|516973914|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
143389806|NCT03406871|516973915|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
143389807|NCT03406871|516973913|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
143389808|NCT03406871|516973914|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
143389809|NCT03406871|516973915|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
143389810|NCT03406871|516973913|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
143389811|NCT03406871|516973914|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
143389812|NCT03406871|516973915|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
143389813|NCT03406871|516973913|FG000|Expansion Cohort(Final Analysis)|Death|0|||
143389814|NCT03406871|516973914|FG001|Expansion Cohort(Final Analysis)|Death|1|||
143389815|NCT03406871|516973915|FG002|Expansion Cohort(Final Analysis)|Death|0|||
143389816|NCT03406871|516973913|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
143389817|NCT03406871|516973914|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
143389818|NCT03406871|516973915|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
143389819|NCT04005716|516973921|FG000|Overall Study|Death|175|||
143389820|NCT04005716|516973922|FG001|Overall Study|Death|196|||
143389821|NCT04005716|516973921|FG000|Overall Study|Withdrawal by Subject|1|||
143389822|NCT04005716|516973922|FG001|Overall Study|Withdrawal by Subject|6|||
143389823|NCT04005716|516973921|FG000|Overall Study|Lost to Follow-up|2|||
143389824|NCT04005716|516973922|FG001|Overall Study|Lost to Follow-up|2|||
143338233|NCT01218126|516781578|FG000|Overall Study|Physician Decision|1|||
143338234|NCT01218126|516781579|FG001|Overall Study|Physician Decision|2|||
143338235|NCT01218126|516781580|FG002|Overall Study|Physician Decision|4|||
143338236|NCT01218126|516781581|FG003|Overall Study|Physician Decision|2|||
143338237|NCT01218126|516781578|FG000|Overall Study|Withdrawal by Subject|2|||
143338238|NCT01218126|516781579|FG001|Overall Study|Withdrawal by Subject|5|||
143338239|NCT01218126|516781580|FG002|Overall Study|Withdrawal by Subject|4|||
143338240|NCT01218126|516781581|FG003|Overall Study|Withdrawal by Subject|6|||
143338241|NCT00696410|516781585|FG000|Overall Study|Lost to Follow-up|2|||
143338242|NCT00696410|516781586|FG001|Overall Study|Lost to Follow-up|0|||
143338243|NCT00696410|516781585|FG000|Overall Study|Withdrawal by Subject|8|||
143338244|NCT00696410|516781586|FG001|Overall Study|Withdrawal by Subject|0|||
143338245|NCT00696410|516781585|FG000|Overall Study|Physician Decision|3|||
143338246|NCT00696410|516781586|FG001|Overall Study|Physician Decision|0|||
143338247|NCT03184792|516781590|FG000|Overall Study|Pandemic|2|||
143338248|NCT03184792|516781591|FG001|Overall Study|Pandemic|2|||
143338249|NCT00265889|516781592|FG000|Overall Study|Physician Decision|1|||
143338250|NCT00265889|516781592|FG000|Overall Study|Protocol Violation|1|||
143338251|NCT00265889|516781592|FG000|Overall Study|Insurance denied the request|3|||
143338252|NCT03221387|516781597|FG000|Overall Study|Lost to Follow-up|1|||
143338253|NCT03221387|516781597|FG000|Overall Study|Lung transplant|1|||
143338254|NCT02365519|516781598|FG000|Randomized and Treated|Adverse Event|0|||
143338255|NCT02365519|516781599|FG001|Randomized and Treated|Adverse Event|1|||
143338256|NCT02365519|516781600|FG002|Randomized and Treated|Adverse Event|0|||
143338257|NCT02365519|516781598|FG000|Randomized and Treated|Withdrawal by Subject|0|||
143338258|NCT02365519|516781599|FG001|Randomized and Treated|Withdrawal by Subject|1|||
143338259|NCT02365519|516781600|FG002|Randomized and Treated|Withdrawal by Subject|1|||
143338260|NCT01971723|516781601|FG000|Overall Study|Withdrawal by Subject|1|||
143338261|NCT01971723|516781602|FG001|Overall Study|Withdrawal by Subject|1|||
143338262|NCT01971723|516781601|FG000|Overall Study|Protocol Violation|1|||
143338263|NCT01971723|516781602|FG001|Overall Study|Protocol Violation|2|||
143338264|NCT03188055|516781603|FG000|Overall Study|Unavailable for training|0|||
143338265|NCT03188055|516781604|FG001|Overall Study|Unavailable for training|0|||
143338266|NCT03188055|516781605|FG002|Overall Study|Unavailable for training|19|||
143338267|NCT03188055|516781606|FG003|Overall Study|Unavailable for training|0|||
143338268|NCT03188055|516781607|FG004|Overall Study|Unavailable for training|0|||
143338269|NCT03188055|516781608|FG005|Overall Study|Unavailable for training|0|||
143338270|NCT03188055|516781603|FG000|Overall Study|Lost to Follow-up|0|||
143338271|NCT03188055|516781604|FG001|Overall Study|Lost to Follow-up|18|||
143338272|NCT03188055|516781605|FG002|Overall Study|Lost to Follow-up|0|||
143338273|NCT03188055|516781606|FG003|Overall Study|Lost to Follow-up|11|||
143338274|NCT03188055|516781607|FG004|Overall Study|Lost to Follow-up|0|||
143338275|NCT03188055|516781608|FG005|Overall Study|Lost to Follow-up|0|||
143338276|NCT03188055|516781603|FG000|Overall Study|Withdrawal by Subject|0|||
143338277|NCT03188055|516781604|FG001|Overall Study|Withdrawal by Subject|1|||
143338278|NCT03188055|516781605|FG002|Overall Study|Withdrawal by Subject|0|||
143338279|NCT03188055|516781606|FG003|Overall Study|Withdrawal by Subject|1|||
143338280|NCT03188055|516781607|FG004|Overall Study|Withdrawal by Subject|0|||
143338281|NCT03188055|516781608|FG005|Overall Study|Withdrawal by Subject|0|||
143338282|NCT03657277|516781609|FG000|Overall Study|Physician Decision|2|||
143338283|NCT03657277|516781609|FG000|Overall Study|Lost to Follow-up|1|||
143338284|NCT03657277|516781609|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
143338285|NCT00657618|516781612|FG000|Overall Study|Adverse Event|32|||
143338286|NCT00657618|516781612|FG000|Overall Study|Withdrawal by Subject|8|||
143338287|NCT00657618|516781612|FG000|Overall Study|negative for leishmaniasis|2|||
143338288|NCT00657618|516781612|FG000|Overall Study|didn't start due to schedule conflicts|1|||
143338289|NCT05774197|516781613|FG000|Overall Study|Did not complete all the surveys required for study.|15|||
143338290|NCT03770494|516781616|FG000|Overall Study|Lost to Follow-up|0|||
143338291|NCT03770494|516781617|FG001|Overall Study|Lost to Follow-up|0|||
143338292|NCT03770494|516781618|FG002|Overall Study|Lost to Follow-up|1|||
143338293|NCT03770494|516781619|FG003|Overall Study|Lost to Follow-up|1|||
143338294|NCT03770494|516781620|FG004|Overall Study|Lost to Follow-up|1|||
143338295|NCT03770494|516781621|FG005|Overall Study|Lost to Follow-up|0|||
143338296|NCT03770494|516781622|FG006|Overall Study|Lost to Follow-up|0|||
143338297|NCT03770494|516781623|FG007|Overall Study|Lost to Follow-up|0|||
143338298|NCT03770494|516781624|FG008|Overall Study|Lost to Follow-up|0|||
143338299|NCT03770494|516781625|FG009|Overall Study|Lost to Follow-up|0|||
143338300|NCT03770494|516781626|FG010|Overall Study|Lost to Follow-up|0|||
143338301|NCT03770494|516781627|FG011|Overall Study|Lost to Follow-up|0|||
143338302|NCT03770494|516781628|FG012|Overall Study|Lost to Follow-up|0|||
143338303|NCT03770494|516781629|FG013|Overall Study|Lost to Follow-up|0|||
143338304|NCT03770494|516781616|FG000|Overall Study|Study terminated by sponsor|1|||
143338305|NCT03770494|516781617|FG001|Overall Study|Study terminated by sponsor|2|||
143338306|NCT03770494|516781618|FG002|Overall Study|Study terminated by sponsor|1|||
143338307|NCT03770494|516781619|FG003|Overall Study|Study terminated by sponsor|1|||
143338308|NCT03770494|516781620|FG004|Overall Study|Study terminated by sponsor|1|||
143338309|NCT03770494|516781621|FG005|Overall Study|Study terminated by sponsor|2|||
143389825|NCT04021602|516973923|FG000|Overall Study|Lost to Follow-up|3|||
143389826|NCT04021602|516973924|FG001|Overall Study|Lost to Follow-up|3|||
143389827|NCT04021602|516973925|FG002|Overall Study|Lost to Follow-up|1|||
143389828|NCT04021602|516973923|FG000|Overall Study|Adverse Event|1|||
143389829|NCT04021602|516973924|FG001|Overall Study|Adverse Event|0|||
143389830|NCT04021602|516973925|FG002|Overall Study|Adverse Event|1|||
143389831|NCT03892616|516973926|FG000|Washout Period 2|Met discontinuation criterion|0|||
143389832|NCT03892616|516973927|FG001|Washout Period 2|Met discontinuation criterion|0|||
143389833|NCT03892616|516973928|FG002|Washout Period 2|Met discontinuation criterion|0|||
143389834|NCT03892616|516973929|FG003|Washout Period 2|Met discontinuation criterion|0|||
143389835|NCT03892616|516973930|FG004|Washout Period 2|Met discontinuation criterion|0|||
143389836|NCT03892616|516973931|FG005|Washout Period 2|Met discontinuation criterion|0|||
143389837|NCT03892616|516973932|FG006|Washout Period 2|Met discontinuation criterion|0|||
143389838|NCT03892616|516973933|FG007|Washout Period 2|Met discontinuation criterion|0|||
143389839|NCT03892616|516973934|FG008|Washout Period 2|Met discontinuation criterion|1|||
143389840|NCT03892616|516973935|FG009|Washout Period 2|Met discontinuation criterion|0|||
143389841|NCT03892616|516973936|FG010|Washout Period 2|Met discontinuation criterion|0|||
143389842|NCT03892616|516973937|FG011|Washout Period 2|Met discontinuation criterion|0|||
143389843|NCT04229992|516973945|FG000|Overall Study|Withdrawal by Subject|0|||
143389844|NCT04229992|516973946|FG001|Overall Study|Withdrawal by Subject|2|||
143389845|NCT04229992|516973947|FG002|Overall Study|Withdrawal by Subject|1|||
143389846|NCT04229992|516973948|FG003|Overall Study|Withdrawal by Subject|1|||
143389847|NCT04229992|516973945|FG000|Overall Study|Adverse Event|1|||
143389848|NCT04229992|516973946|FG001|Overall Study|Adverse Event|1|||
143389849|NCT04229992|516973947|FG002|Overall Study|Adverse Event|3|||
143389850|NCT04229992|516973948|FG003|Overall Study|Adverse Event|1|||
143389851|NCT04229992|516973945|FG000|Overall Study|Lost to Follow-up|0|||
143389852|NCT04229992|516973946|FG001|Overall Study|Lost to Follow-up|0|||
143389853|NCT04229992|516973947|FG002|Overall Study|Lost to Follow-up|0|||
143389854|NCT04229992|516973948|FG003|Overall Study|Lost to Follow-up|1|||
143389855|NCT04610892|516973949|FG000|Overall Study|Adverse Event|1|||
143389856|NCT04610892|516973950|FG001|Overall Study|Adverse Event|0|||
143389857|NCT04610892|516973951|FG002|Overall Study|Adverse Event|0|||
143389858|NCT04610892|516973952|FG003|Overall Study|Adverse Event|1|||
143389859|NCT04610892|516973953|FG004|Overall Study|Adverse Event|3|||
143389860|NCT04610892|516973949|FG000|Overall Study|Death|0|||
143389861|NCT04610892|516973950|FG001|Overall Study|Death|1|||
143389862|NCT04610892|516973951|FG002|Overall Study|Death|0|||
143389863|NCT04610892|516973952|FG003|Overall Study|Death|1|||
143389864|NCT04610892|516973953|FG004|Overall Study|Death|0|||
143389865|NCT04610892|516973949|FG000|Overall Study|Withdrawal by Subject|3|||
143389866|NCT04610892|516973950|FG001|Overall Study|Withdrawal by Subject|2|||
143389867|NCT04610892|516973951|FG002|Overall Study|Withdrawal by Subject|0|||
143389868|NCT04610892|516973952|FG003|Overall Study|Withdrawal by Subject|6|||
143389869|NCT04610892|516973953|FG004|Overall Study|Withdrawal by Subject|6|||
143389870|NCT04610892|516973949|FG000|Overall Study|Subjects who did not receive treatment|1|||
143389871|NCT04610892|516973950|FG001|Overall Study|Subjects who did not receive treatment|0|||
143389872|NCT04610892|516973951|FG002|Overall Study|Subjects who did not receive treatment|0|||
143389873|NCT04610892|516973952|FG003|Overall Study|Subjects who did not receive treatment|0|||
143389874|NCT04610892|516973953|FG004|Overall Study|Subjects who did not receive treatment|2|||
143389875|NCT05520190|516973954|FG000|Overall Study|Lost to Follow-up|7|||
143389876|NCT05520190|516973954|FG000|Overall Study|Withdrawal by Subject|2|||
143389877|NCT01999075|516973955|FG000|Overall Study|Lost to Follow-up|0|||
143389878|NCT01999075|516973956|FG001|Overall Study|Lost to Follow-up|2|||
143389879|NCT01999075|516973955|FG000|Overall Study|Withdrawal by Subject|2|||
143389880|NCT01999075|516973956|FG001|Overall Study|Withdrawal by Subject|7|||
143389881|NCT01999075|516973955|FG000|Overall Study|Enrolled in drug trial|3|||
143389882|NCT01999075|516973956|FG001|Overall Study|Enrolled in drug trial|1|||
143389883|NCT01999075|516973955|FG000|Overall Study|Became ineligible|0|||
143389884|NCT01999075|516973956|FG001|Overall Study|Became ineligible|2|||
143389885|NCT03683719|516973957|FG000|Overall Study|Lack of Efficacy|1|||
143389886|NCT03683719|516973958|FG001|Overall Study|Lack of Efficacy|3|||
143389887|NCT03683719|516973959|FG002|Overall Study|Lack of Efficacy|4|||
143389888|NCT03683719|516973960|FG003|Overall Study|Lack of Efficacy|0|||
143389889|NCT03683719|516973961|FG004|Overall Study|Lack of Efficacy|4|||
143389890|NCT03683719|516973957|FG000|Overall Study|Adverse Event|6|||
143389891|NCT03683719|516973958|FG001|Overall Study|Adverse Event|6|||
143389892|NCT03683719|516973959|FG002|Overall Study|Adverse Event|0|||
143389893|NCT03683719|516973960|FG003|Overall Study|Adverse Event|1|||
143389894|NCT03683719|516973961|FG004|Overall Study|Adverse Event|3|||
143389895|NCT03683719|516973957|FG000|Overall Study|Withdrawal by Subject|4|||
143389896|NCT03683719|516973958|FG001|Overall Study|Withdrawal by Subject|4|||
143389897|NCT03683719|516973959|FG002|Overall Study|Withdrawal by Subject|3|||
143389898|NCT03683719|516973960|FG003|Overall Study|Withdrawal by Subject|5|||
143389899|NCT03683719|516973961|FG004|Overall Study|Withdrawal by Subject|5|||
143389900|NCT03683719|516973957|FG000|Overall Study|Lost to Follow-up|1|||
143389901|NCT03683719|516973958|FG001|Overall Study|Lost to Follow-up|0|||
143389902|NCT03683719|516973959|FG002|Overall Study|Lost to Follow-up|0|||
143389903|NCT03683719|516973960|FG003|Overall Study|Lost to Follow-up|1|||
143389904|NCT03683719|516973961|FG004|Overall Study|Lost to Follow-up|1|||
143389905|NCT03683719|516973957|FG000|Overall Study|Other personal reasons|0|||
143389906|NCT03683719|516973958|FG001|Overall Study|Other personal reasons|0|||
143389907|NCT03683719|516973959|FG002|Overall Study|Other personal reasons|1|||
143389908|NCT03683719|516973960|FG003|Overall Study|Other personal reasons|0|||
143389909|NCT03683719|516973961|FG004|Overall Study|Other personal reasons|1|||
143389910|NCT05369403|516973965|FG000|Treatment Period 1: Week 0 to Week 16|Adverse Event|5|||
143389911|NCT05369403|516973966|FG001|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
143389912|NCT05369403|516973967|FG002|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
143389913|NCT05369403|516973965|FG000|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|1|||
143389914|NCT05369403|516973966|FG001|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
143389915|NCT05369403|516973967|FG002|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
143389916|NCT05369403|516973965|FG000|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|1|||
143389917|NCT05369403|516973966|FG001|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
143389918|NCT05369403|516973967|FG002|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
143389919|NCT05369403|516973965|FG000|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|12|||
143389920|NCT05369403|516973966|FG001|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
143389921|NCT05369403|516973967|FG002|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
143389922|NCT05369403|516973965|FG000|Treatment Period 1: Week 0 to Week 16|Physician Decision|2|||
143389923|NCT05369403|516973966|FG001|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
143389924|NCT05369403|516973967|FG002|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
143389925|NCT05369403|516973965|FG000|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|4|||
143389926|NCT05369403|516973966|FG001|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
143389927|NCT05369403|516973967|FG002|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
143389928|NCT05369403|516973965|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|1|||
143389929|NCT05369403|516973966|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
143389930|NCT05369403|516973967|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
143389931|NCT05369403|516973965|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|1|||
143389932|NCT05369403|516973966|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
143389933|NCT05369403|516973967|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
143389934|NCT05369403|516973965|FG000|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|0|||
143389935|NCT05369403|516973966|FG001|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|1|||
143389936|NCT05369403|516973967|FG002|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|4|||
143389937|NCT05369403|516973965|FG000|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
143389938|NCT05369403|516973966|FG001|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|1|||
143389939|NCT05369403|516973967|FG002|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
143389940|NCT05369403|516973965|FG000|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
143389941|NCT05369403|516973966|FG001|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|1|||
143389942|NCT05369403|516973967|FG002|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
143389943|NCT01748448|516973973|FG000|Treatment Period|Consent withdrawn by subject|1|||
143389944|NCT01748448|516973974|FG001|Treatment Period|Consent withdrawn by subject|0|||
143389945|NCT01748448|516973973|FG000|Treatment Period|Adverse Event|1|||
143389946|NCT01748448|516973974|FG001|Treatment Period|Adverse Event|0|||
143389947|NCT01748448|516973973|FG000|Treatment Period|Personal|0|||
143389948|NCT01748448|516973974|FG001|Treatment Period|Personal|1|||
143389949|NCT02689284|516973975|FG000|Overall Study|Adverse Event|1|||
143389950|NCT02689284|516973976|FG001|Overall Study|Adverse Event|8|||
143389951|NCT02689284|516973975|FG000|Overall Study|Death|0|||
143389952|NCT02689284|516973976|FG001|Overall Study|Death|1|||
143389953|NCT02689284|516973975|FG000|Overall Study|Physician Decision|1|||
143389954|NCT02689284|516973976|FG001|Overall Study|Physician Decision|2|||
143389955|NCT02689284|516973975|FG000|Overall Study|Withdrawal by Subject|0|||
143389956|NCT02689284|516973976|FG001|Overall Study|Withdrawal by Subject|1|||
143389957|NCT02689284|516973975|FG000|Overall Study|progression of cancer|1|||
143389958|NCT02689284|516973976|FG001|Overall Study|progression of cancer|72|||
143389959|NCT02689284|516973975|FG000|Overall Study|decreased heart function|0|||
143389960|NCT02689284|516973976|FG001|Overall Study|decreased heart function|1|||
143389961|NCT02689284|516973975|FG000|Overall Study|concern for anemia|0|||
143389962|NCT02689284|516973976|FG001|Overall Study|concern for anemia|1|||
143389963|NCT02689284|516973975|FG000|Overall Study|no measurable cancer for evaluation|0|||
143389964|NCT02689284|516973976|FG001|Overall Study|no measurable cancer for evaluation|1|||
143389965|NCT05268393|516973977|FG000|Overall Study|Withdrawal by Subject|2|||
143389966|NCT05268393|516973978|FG001|Overall Study|Withdrawal by Subject|1|||
143389967|NCT05516147|516973979|FG000|Overall Study|Scheduling Conflicts Made it Impossible for them to participate|2|||
143389968|NCT00450658|516973980|FG000|Overall Study|Adverse Event|24|||
143389969|NCT00450658|516973981|FG001|Overall Study|Adverse Event|15|||
143389970|NCT00450658|516973980|FG000|Overall Study|Withdrawal by Subject|43|||
143389971|NCT00450658|516973981|FG001|Overall Study|Withdrawal by Subject|26|||
143389972|NCT00450658|516973980|FG000|Overall Study|Lost to Follow-up|22|||
143389973|NCT00450658|516973981|FG001|Overall Study|Lost to Follow-up|5|||
143389974|NCT00450658|516973980|FG000|Overall Study|UGI ulcer|33|||
143389975|NCT00450658|516973981|FG001|Overall Study|UGI ulcer|34|||
143389976|NCT00450658|516973980|FG000|Overall Study|misc|21|||
143389977|NCT00450658|516973981|FG001|Overall Study|misc|10|||
143389978|NCT01084876|516973982|FG000|Main Study Treatment Period|Adverse Event|12|||
143389979|NCT01084876|516973983|FG001|Main Study Treatment Period|Adverse Event|7|||
143389980|NCT01084876|516973982|FG000|Main Study Treatment Period|Disease Progression|41|||
143389981|NCT01084876|516973983|FG001|Main Study Treatment Period|Disease Progression|24|||
143389982|NCT01084876|516973982|FG000|Main Study Treatment Period|Physician Decision|2|||
143389983|NCT01084876|516973983|FG001|Main Study Treatment Period|Physician Decision|0|||
143389984|NCT01084876|516973982|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
143389985|NCT01084876|516973983|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
143389986|NCT01084876|516973982|FG000|Main Study Treatment Period|Other Reason|0|||
143389987|NCT01084876|516973983|FG001|Main Study Treatment Period|Other Reason|1|||
143389988|NCT01084876|516973982|FG000|Main Study Treatment Period|Other|0|||
143389989|NCT01084876|516973983|FG001|Main Study Treatment Period|Other|1|||
143389990|NCT01084876|516973982|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
143389991|NCT01084876|516973983|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
143389992|NCT01084876|516973982|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
143389993|NCT01084876|516973983|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
143389994|NCT01084876|516973982|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
143389995|NCT01084876|516973983|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
143389996|NCT01084876|516973982|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
143389997|NCT01084876|516973983|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
143389998|NCT01084876|516973982|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
143389999|NCT01084876|516973983|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
143390000|NCT01084876|516973982|FG000|Treatment Period Beyond Cycle 8|Other|6|||
143390001|NCT01084876|516973983|FG001|Treatment Period Beyond Cycle 8|Other|9|||
143390002|NCT05763823|516973984|FG000|Overall Study|Death|6|||
143390003|NCT05763823|516973984|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
143390004|NCT05763823|516973984|FG000|Overall Study|Withdrawal by Subject|6|||
143390005|NCT03850678|516973985|FG000|Overall Study|Withdrawal by Subject|3|||
143390006|NCT03850678|516973986|FG001|Overall Study|Withdrawal by Subject|0|||
143390007|NCT03850678|516973985|FG000|Overall Study|Experimenter Error|1|||
143390008|NCT03850678|516973986|FG001|Overall Study|Experimenter Error|1|||
143390009|NCT03850678|516973985|FG000|Overall Study|Did Not Condition To Experiment|7|||
143390010|NCT03850678|516973986|FG001|Overall Study|Did Not Condition To Experiment|2|||
143390011|NCT05311384|516973989|FG000|Overall Study|Uncontrolled health conditions|2|||
143390012|NCT05311384|516973989|FG000|Overall Study|Withdrawal by Subject|1|||
143390013|NCT01573442|516973990|FG000|Overall Study|Cancels|9|||
143390014|NCT01573442|516973991|FG001|Overall Study|Cancels|10|||
143390015|NCT05710107|516973995|FG000|Overall Study|Withdrawal by Subject|1|||
143390016|NCT05710107|516973996|FG001|Overall Study|Withdrawal by Subject|1|||
143390017|NCT05710107|516973995|FG000|Overall Study|Lost to Follow-up|8|||
143390018|NCT05710107|516973996|FG001|Overall Study|Lost to Follow-up|9|||
143390019|NCT05710107|516973995|FG000|Overall Study|Unable to place assigned block|2|||
143390020|NCT05710107|516973996|FG001|Overall Study|Unable to place assigned block|0|||
143390021|NCT05710107|516973995|FG000|Overall Study|Withdrawn by study team|0|||
143390022|NCT05710107|516973996|FG001|Overall Study|Withdrawn by study team|1|||
143390023|NCT04166773|516973997|FG000|Overall Study|Adverse Event|2|||
143390024|NCT04166773|516973998|FG001|Overall Study|Adverse Event|0|||
143390025|NCT04166773|516973999|FG002|Overall Study|Adverse Event|2|||
143390026|NCT04166773|516974000|FG003|Overall Study|Adverse Event|1|||
143390027|NCT04166773|516973997|FG000|Overall Study|Lost to Follow-up|4|||
143390028|NCT04166773|516973998|FG001|Overall Study|Lost to Follow-up|2|||
143390029|NCT04166773|516973999|FG002|Overall Study|Lost to Follow-up|1|||
143390030|NCT04166773|516974000|FG003|Overall Study|Lost to Follow-up|3|||
143390031|NCT04166773|516973997|FG000|Overall Study|Physician Decision|0|||
143390032|NCT04166773|516973998|FG001|Overall Study|Physician Decision|0|||
143390033|NCT04166773|516973999|FG002|Overall Study|Physician Decision|0|||
143390034|NCT04166773|516974000|FG003|Overall Study|Physician Decision|1|||
143390035|NCT04166773|516973997|FG000|Overall Study|Withdrawal by Subject|1|||
143390036|NCT04166773|516973998|FG001|Overall Study|Withdrawal by Subject|1|||
143390037|NCT04166773|516973999|FG002|Overall Study|Withdrawal by Subject|2|||
143390038|NCT04166773|516974000|FG003|Overall Study|Withdrawal by Subject|5|||
143390039|NCT03033576|516974003|FG000|Overall Study|Ineligible|1|||
143390040|NCT03033576|516974004|FG001|Overall Study|Ineligible|1|||
143390041|NCT03033576|516974003|FG000|Overall Study|Adverse Event|4|||
143390042|NCT03033576|516974004|FG001|Overall Study|Adverse Event|20|||
143390043|NCT03033576|516974003|FG000|Overall Study|Progression/relapse|9|||
143390044|NCT03033576|516974004|FG001|Overall Study|Progression/relapse|36|||
143390045|NCT03033576|516974003|FG000|Overall Study|Death|1|||
143390046|NCT03033576|516974004|FG001|Overall Study|Death|1|||
143390047|NCT03033576|516974003|FG000|Overall Study|Patient refusal|1|||
143390048|NCT03033576|516974004|FG001|Overall Study|Patient refusal|6|||
143390049|NCT03033576|516974003|FG000|Overall Study|Other, unspecified reasons|0|||
143390050|NCT03033576|516974004|FG001|Overall Study|Other, unspecified reasons|4|||
143390051|NCT03033576|516974003|FG000|Overall Study|Currently on protocol therapy|0|||
143390052|NCT03033576|516974004|FG001|Overall Study|Currently on protocol therapy|2|||
143390053|NCT03557697|516974005|FG000|Overall Study|Withdrawal by Subject|2|||
143390054|NCT03557697|516974006|FG001|Overall Study|Withdrawal by Subject|4|||
143390055|NCT06491433|516974007|FG000|Overall Study|Protocol Violation|51|||
143390056|NCT06491433|516974007|FG000|Overall Study|consent withdrawal|2|||
143390057|NCT06491433|516974007|FG000|Overall Study|screen failure|1|||
143390058|NCT03197662|516974014|FG000|Overall Study|Withdrawn by family|0|||
143390059|NCT03197662|516974015|FG001|Overall Study|Withdrawn by family|2|||
143390060|NCT01214616|516974016|FG000|Overall Study|Progressive disease|2|||
143390061|NCT01214616|516974017|FG001|Overall Study|Progressive disease|2|||
143390062|NCT01214616|516974018|FG002|Overall Study|Progressive disease|2|||
143390063|NCT01214616|516974019|FG003|Overall Study|Progressive disease|4|||
143390064|NCT01214616|516974016|FG000|Overall Study|Dose limiting toxicity|0|||
143390065|NCT01214616|516974017|FG001|Overall Study|Dose limiting toxicity|2|||
143390066|NCT01214616|516974018|FG002|Overall Study|Dose limiting toxicity|0|||
143390067|NCT01214616|516974019|FG003|Overall Study|Dose limiting toxicity|0|||
143390068|NCT01214616|516974016|FG000|Overall Study|Other adverse events|0|||
143390069|NCT01214616|516974017|FG001|Overall Study|Other adverse events|1|||
143390070|NCT01214616|516974018|FG002|Overall Study|Other adverse events|1|||
143390071|NCT01214616|516974019|FG003|Overall Study|Other adverse events|1|||
143390072|NCT01214616|516974016|FG000|Overall Study|Withdrawal by Subject|1|||
143390073|NCT01214616|516974017|FG001|Overall Study|Withdrawal by Subject|0|||
143390074|NCT01214616|516974018|FG002|Overall Study|Withdrawal by Subject|0|||
143390075|NCT01214616|516974019|FG003|Overall Study|Withdrawal by Subject|1|||
143390076|NCT02949362|516974022|FG000|Retrospective Period|Inform consent not signed by participant|4|||
143390077|NCT02949362|516974023|FG001|Retrospective Period|Inform consent not signed by participant|1|||
143390078|NCT02949362|516974024|FG002|Retrospective Period|Inform consent not signed by participant|0|||
143390079|NCT02949362|516974025|FG003|Retrospective Period|Inform consent not signed by participant|0|||
143390080|NCT02949362|516974022|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
143390081|NCT02949362|516974023|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
143390082|NCT02949362|516974024|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
143390083|NCT02949362|516974025|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
143390084|NCT02949362|516974022|FG000|Prospective Period|Other|0|||
143390085|NCT02949362|516974023|FG001|Prospective Period|Other|0|||
143390086|NCT02949362|516974024|FG002|Prospective Period|Other|0|||
143390087|NCT02949362|516974025|FG003|Prospective Period|Other|4|||
143390088|NCT03476460|516974026|FG000|Overall Study|Withdrawal by Subject|3|||
143390089|NCT03476460|516974027|FG001|Overall Study|Withdrawal by Subject|2|||
143390090|NCT03476460|516974026|FG000|Overall Study|Non-compliance with treatment|3|||
143390091|NCT03476460|516974027|FG001|Overall Study|Non-compliance with treatment|0|||
143390092|NCT03476460|516974026|FG000|Overall Study|Missing laboratory tests|5|||
143390093|NCT03476460|516974027|FG001|Overall Study|Missing laboratory tests|5|||
143390094|NCT03476460|516974026|FG000|Overall Study|Adverse Event|0|||
143390095|NCT03476460|516974027|FG001|Overall Study|Adverse Event|1|||
143390096|NCT03047928|516975583|FG000|Overall Study|Adverse Event|0|||
143390097|NCT03047928|516975584|FG001|Overall Study|Adverse Event|2|||
143390098|NCT03047928|516975585|FG002|Overall Study|Adverse Event|0|||
143390099|NCT03047928|516975583|FG000|Overall Study|Protocol Violation|0|||
143390100|NCT03047928|516975584|FG001|Overall Study|Protocol Violation|1|||
143390101|NCT03047928|516975585|FG002|Overall Study|Protocol Violation|0|||
143390102|NCT03047928|516975583|FG000|Overall Study|included in another protocol|0|||
143390103|NCT03047928|516975584|FG001|Overall Study|included in another protocol|1|||
143390104|NCT03047928|516975585|FG002|Overall Study|included in another protocol|0|||
143390105|NCT05273749|516975586|FG000|Overall Study|Adverse Event|14|||
143390106|NCT05273749|516975587|FG001|Overall Study|Adverse Event|8|||
143390107|NCT05273749|516975586|FG000|Overall Study|Lack of Efficacy|2|||
143390108|NCT05273749|516975587|FG001|Overall Study|Lack of Efficacy|8|||
143390109|NCT05273749|516975586|FG000|Overall Study|Physician Decision|0|||
143390110|NCT05273749|516975587|FG001|Overall Study|Physician Decision|2|||
143390111|NCT05273749|516975586|FG000|Overall Study|Withdrawal by Subject|14|||
143390112|NCT05273749|516975587|FG001|Overall Study|Withdrawal by Subject|16|||
143390113|NCT05273749|516975586|FG000|Overall Study|Lost to Follow-up|10|||
143390114|NCT05273749|516975587|FG001|Overall Study|Lost to Follow-up|10|||
143390115|NCT05273749|516975586|FG000|Overall Study|Pregnancy|1|||
143390116|NCT05273749|516975587|FG001|Overall Study|Pregnancy|0|||
143390117|NCT05273749|516975586|FG000|Overall Study|Non-Compliance|3|||
143390118|NCT05273749|516975587|FG001|Overall Study|Non-Compliance|2|||
143390119|NCT05273749|516975586|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
143390120|NCT05273749|516975587|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
143390121|NCT04806594|516975594|FG000|Overall Study|Withdrawal by Subject|2|||
143390122|NCT04806594|516975594|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
143390123|NCT02543281|516975597|FG000|Overall Study|Lost to Follow-up|0|||
143390124|NCT02543281|516975598|FG001|Overall Study|Lost to Follow-up|0|||
143390125|NCT02543281|516975599|FG002|Overall Study|Lost to Follow-up|1|||
143390126|NCT00378105|516975600|FG000|Overall Study|Adverse Event|3|||
143390127|NCT00378105|516975601|FG001|Overall Study|Adverse Event|1|||
143390128|NCT00378105|516975600|FG000|Overall Study|Withdrawal by Subject|3|||
143390129|NCT00378105|516975601|FG001|Overall Study|Withdrawal by Subject|3|||
143390130|NCT00378105|516975600|FG000|Overall Study|Death|1|||
143390131|NCT00378105|516975601|FG001|Overall Study|Death|0|||
143390132|NCT00378105|516975600|FG000|Overall Study|Going to transplant|7|||
143390133|NCT00378105|516975601|FG001|Overall Study|Going to transplant|8|||
143390134|NCT00378105|516975600|FG000|Overall Study|Progressive disease|3|||
143390135|NCT00378105|516975601|FG001|Overall Study|Progressive disease|3|||
143390136|NCT00378105|516975600|FG000|Overall Study|remain on study|3|||
143390137|NCT00378105|516975601|FG001|Overall Study|remain on study|11|||
143390138|NCT00378105|516975600|FG000|Overall Study|Physician Decision|0|||
143390139|NCT00378105|516975601|FG001|Overall Study|Physician Decision|2|||
143390140|NCT00378105|516975600|FG000|Overall Study|Going non-protocol therapy|0|||
143390141|NCT00378105|516975601|FG001|Overall Study|Going non-protocol therapy|1|||
143390142|NCT00378105|516975600|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
143390143|NCT00378105|516975601|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
143390144|NCT02120456|516975602|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
143390145|NCT02120456|516975603|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
143390146|NCT02120456|516975604|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
143390147|NCT02120456|516975605|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
143390148|NCT02120456|516975606|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
143390149|NCT02120456|516975607|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
143390150|NCT02120456|516975608|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
143390151|NCT02120456|516975609|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
143390152|NCT02120456|516975610|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
143390153|NCT02120456|516975602|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
143390154|NCT02120456|516975603|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
143390155|NCT02120456|516975604|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
143390156|NCT02120456|516975605|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
143390157|NCT02120456|516975606|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
143390158|NCT02120456|516975607|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
143390159|NCT02120456|516975608|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
143390160|NCT02120456|516975609|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
143390161|NCT02120456|516975610|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
143390162|NCT02120456|516975602|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
143390163|NCT02120456|516975603|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
143390164|NCT02120456|516975604|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
143390165|NCT02120456|516975605|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
143390166|NCT02120456|516975606|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
143390167|NCT02120456|516975607|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
143390168|NCT02120456|516975608|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
143390169|NCT02120456|516975609|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
143390170|NCT02120456|516975610|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
143390171|NCT05192200|516975611|FG000|Treatment Period|Other|1|||
143390172|NCT05192200|516975611|FG000|Treatment Period|Lack of Efficacy|1|||
143390173|NCT05192200|516975611|FG000|Treatment Period|Withdrawal by Subject|1|||
143390174|NCT05192200|516975611|FG000|Follow-up|Withdrawal by Subject|1|||
143390175|NCT03623321|516975612|FG000|Overall Study|Adverse Event|32|||
143390176|NCT03623321|516975612|FG000|Overall Study|Death|9|||
143390177|NCT03623321|516975612|FG000|Overall Study|Lack of Efficacy|9|||
143390178|NCT03623321|516975612|FG000|Overall Study|Lost to Follow-up|6|||
143390179|NCT03623321|516975612|FG000|Overall Study|Noncompliance with study drug|6|||
143390180|NCT03623321|516975612|FG000|Overall Study|Use of prohibited medication|3|||
143390181|NCT03623321|516975612|FG000|Overall Study|Physician Decision|5|||
143390182|NCT03623321|516975612|FG000|Overall Study|Protocol Violation|1|||
143390183|NCT03623321|516975612|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
143390184|NCT03623321|516975612|FG000|Overall Study|Not further specified|43|||
143390185|NCT04241068|516975616|FG000|Core Treatment Period|Adverse Event|91|||
143390186|NCT04241068|516975616|FG000|Core Treatment Period|Change of Treatment|4|||
143390187|NCT04241068|516975616|FG000|Core Treatment Period|Consent Withdrawn|143|||
143390188|NCT04241068|516975616|FG000|Core Treatment Period|Death|26|||
143390189|NCT04241068|516975616|FG000|Core Treatment Period|Disease Progression|67|||
143390190|NCT04241068|516975616|FG000|Core Treatment Period|Investigator Decision|40|||
143390191|NCT04241068|516975616|FG000|Core Treatment Period|Loss of Capacity|9|||
143390192|NCT04241068|516975616|FG000|Core Treatment Period|Lost to Follow-up|11|||
143390193|NCT04241068|516975616|FG000|Core Treatment Period|Relocation|4|||
143390194|NCT04241068|516975616|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
143390195|NCT04241068|516975616|FG000|Core Treatment Period|Study Visit Burden|40|||
143390196|NCT04241068|516975616|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
143390197|NCT04241068|516975616|FG000|Core Treatment Period|Missing|2|||
143390198|NCT04241068|516975616|FG000|Core Treatment Period|Reason Not Specified|41|||
143390199|NCT04241068|516975616|FG000|LTE Period|Adverse Event|19|||
143390200|NCT04241068|516975616|FG000|LTE Period|Change of Treatment|1|||
143390201|NCT04241068|516975616|FG000|LTE Period|Consent Withdrawn|71|||
143390202|NCT04241068|516975616|FG000|LTE Period|Death|8|||
143390203|NCT04241068|516975616|FG000|LTE Period|Disease Progression|11|||
143390204|NCT04241068|516975616|FG000|LTE Period|Investigator Decision|12|||
143390205|NCT04241068|516975616|FG000|LTE Period|Loss of Capacity|2|||
143390206|NCT04241068|516975616|FG000|LTE Period|Lost to Follow-up|7|||
143390207|NCT04241068|516975616|FG000|LTE Period|Relocation|6|||
143390208|NCT04241068|516975616|FG000|LTE Period|Site Terminated by Sponsor|26|||
143390209|NCT04241068|516975616|FG000|LTE Period|Study Terminated by Sponsor|276|||
143390210|NCT04241068|516975616|FG000|LTE Period|Study Visit Burden|10|||
143390211|NCT04241068|516975616|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
143390212|NCT04241068|516975616|FG000|LTE Period|Reason Not Specified|65|||
143390213|NCT03443323|516975617|FG000|Overall Study|Lost to Follow-up|2|||
143390214|NCT03443323|516975618|FG001|Overall Study|Lost to Follow-up|2|||
143390215|NCT03443323|516975617|FG000|Overall Study|PI withdrawal|1|||
143390216|NCT03443323|516975618|FG001|Overall Study|PI withdrawal|0|||
143390217|NCT04492007|516975622|FG000|Overall Study|Lost to Follow-up|1|||
143390218|NCT04492007|516975623|FG001|Overall Study|Lost to Follow-up|1|||
143390219|NCT04492007|516975624|FG002|Overall Study|Lost to Follow-up|2|||
143390220|NCT04492007|516975625|FG003|Overall Study|Lost to Follow-up|2|||
143390221|NCT04492007|516975622|FG000|Overall Study|Protocol Violation|1|||
143390222|NCT04492007|516975623|FG001|Overall Study|Protocol Violation|1|||
143390223|NCT04492007|516975624|FG002|Overall Study|Protocol Violation|1|||
143390224|NCT04492007|516975625|FG003|Overall Study|Protocol Violation|1|||
143390225|NCT04492007|516975622|FG000|Overall Study|Withdrawal by Subject|0|||
143390226|NCT04492007|516975623|FG001|Overall Study|Withdrawal by Subject|0|||
143390227|NCT04492007|516975624|FG002|Overall Study|Withdrawal by Subject|1|||
143390228|NCT04492007|516975625|FG003|Overall Study|Withdrawal by Subject|1|||
143390229|NCT05178316|516975626|FG000|Overall Study|Adverse Event|5|||
143390230|NCT05178316|516975627|FG001|Overall Study|Adverse Event|4|||
143390231|NCT05178316|516975628|FG002|Overall Study|Adverse Event|9|||
143390232|NCT05178316|516975626|FG000|Overall Study|Enrolled in Error|1|||
143390233|NCT05178316|516975627|FG001|Overall Study|Enrolled in Error|2|||
143390234|NCT05178316|516975628|FG002|Overall Study|Enrolled in Error|1|||
143390235|NCT05178316|516975626|FG000|Overall Study|Lost to Follow-up|3|||
143390236|NCT05178316|516975627|FG001|Overall Study|Lost to Follow-up|15|||
143390237|NCT05178316|516975628|FG002|Overall Study|Lost to Follow-up|11|||
143390238|NCT05178316|516975626|FG000|Overall Study|Noncompliance|1|||
143390239|NCT05178316|516975627|FG001|Overall Study|Noncompliance|3|||
143390240|NCT05178316|516975628|FG002|Overall Study|Noncompliance|1|||
143390241|NCT05178316|516975626|FG000|Overall Study|Other|0|||
143390242|NCT05178316|516975627|FG001|Overall Study|Other|1|||
143390243|NCT05178316|516975628|FG002|Overall Study|Other|0|||
143390244|NCT05178316|516975626|FG000|Overall Study|Physician Decision|0|||
143390245|NCT05178316|516975627|FG001|Overall Study|Physician Decision|3|||
143390246|NCT05178316|516975628|FG002|Overall Study|Physician Decision|2|||
143390247|NCT05178316|516975626|FG000|Overall Study|Protocol deviation|1|||
143390248|NCT05178316|516975627|FG001|Overall Study|Protocol deviation|0|||
143390249|NCT05178316|516975628|FG002|Overall Study|Protocol deviation|1|||
143390250|NCT05178316|516975626|FG000|Overall Study|Sponsor decision|1|||
143390251|NCT05178316|516975627|FG001|Overall Study|Sponsor decision|0|||
143390252|NCT05178316|516975628|FG002|Overall Study|Sponsor decision|1|||
143390253|NCT05178316|516975626|FG000|Overall Study|Withdrawal by Subject|5|||
143390254|NCT05178316|516975627|FG001|Overall Study|Withdrawal by Subject|11|||
143390255|NCT05178316|516975628|FG002|Overall Study|Withdrawal by Subject|5|||
143390256|NCT03770273|516975629|FG000|Overall Study|Adverse Event|2|||
143390257|NCT03770273|516975630|FG001|Overall Study|Adverse Event|0|||
143390258|NCT03770273|516975629|FG000|Overall Study|Lost to Follow-up|1|||
143390259|NCT03770273|516975630|FG001|Overall Study|Lost to Follow-up|1|||
143390260|NCT00418886|516975631|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
143390261|NCT00418886|516975632|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
143390262|NCT00418886|516975631|FG000|Randomized Period|Death|122|||
143390263|NCT00418886|516975632|FG001|Randomized Period|Death|147|||
143390264|NCT00418886|516975631|FG000|Randomized Period|Withdrawal by Subject|9|||
143390265|NCT00418886|516975632|FG001|Randomized Period|Withdrawal by Subject|10|||
143390266|NCT00418886|516975631|FG000|Randomized Period|Lost to Follow-up|4|||
143390267|NCT00418886|516975632|FG001|Randomized Period|Lost to Follow-up|6|||
143390268|NCT00418886|516975631|FG000|Randomized Period|withdrawn due to other reason|1|||
143390269|NCT00418886|516975632|FG001|Randomized Period|withdrawn due to other reason|0|||
143390270|NCT00418886|516975631|FG000|Randomized Period|randomised but no treatment received|0|||
143390271|NCT00418886|516975632|FG001|Randomized Period|randomised but no treatment received|1|||
143390272|NCT04060654|516975633|FG000|Overall Study|Withdrawal by Subject|1|||
143390273|NCT04060654|516975633|FG000|Overall Study|Lost to Follow-up|5|||
143390274|NCT03707951|516975634|FG000|Overall Study|Lost to Follow-up|8|||
143390275|NCT03707951|516975635|FG001|Overall Study|Lost to Follow-up|17|||
143390276|NCT03707951|516975634|FG000|Overall Study|Withdrawal by Subject|6|||
143390277|NCT03707951|516975635|FG001|Overall Study|Withdrawal by Subject|6|||
143390278|NCT04887129|516975636|FG000|Overall Study|Lost to Follow-up|0|||
143390279|NCT04887129|516975637|FG001|Overall Study|Lost to Follow-up|24|||
143390280|NCT04887129|516975636|FG000|Overall Study|Withdrawal by Subject|9|||
143390281|NCT04887129|516975637|FG001|Overall Study|Withdrawal by Subject|57|||
143390282|NCT04887129|516975636|FG000|Overall Study|Other|2|||
143390283|NCT04887129|516975637|FG001|Overall Study|Other|9|||
143390284|NCT01413100|516975639|FG000|Overall Study|Withdrawal by Subject|1|||
143390285|NCT03792256|516975640|FG000|Overall Study|Death|0|||
143390286|NCT03792256|516975641|FG001|Overall Study|Death|1|||
143390287|NCT03792256|516975640|FG000|Overall Study|Lack of Efficacy|0|||
143390288|NCT03792256|516975641|FG001|Overall Study|Lack of Efficacy|1|||
143390289|NCT03792256|516975640|FG000|Overall Study|Withdrawal by Subject|0|||
143390290|NCT03792256|516975641|FG001|Overall Study|Withdrawal by Subject|1|||
143390291|NCT04760678|516975647|FG000|Overall Study|Death|13|||
143390292|NCT04760678|516975647|FG000|Overall Study|Lost to Follow-up|48|||
143390293|NCT04760678|516975647|FG000|Overall Study|Withdrawal by Subject|1|||
143390294|NCT04896476|516975650|FG000|Overall Study|Withdrawal by Subject|1|||
143390295|NCT04896476|516975650|FG000|Overall Study|Lost to Follow-up|2|||
143390296|NCT04562649|516975651|FG000|Overall Study|Withdrawal by Subject|11|||
143390297|NCT04562649|516975652|FG001|Overall Study|Withdrawal by Subject|8|||
143390298|NCT04562649|516975651|FG000|Overall Study|Lost to Follow-up|26|||
143390299|NCT04562649|516975652|FG001|Overall Study|Lost to Follow-up|20|||
143390300|NCT03056040|516975653|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
143390301|NCT03056040|516975654|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
143390302|NCT03056040|516975653|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
143390303|NCT03056040|516975654|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
143390304|NCT03056040|516975653|FG000|Primary Evaluation Period|Pregnancy|0|||
143390305|NCT03056040|516975654|FG001|Primary Evaluation Period|Pregnancy|1|||
143390306|NCT03056040|516975653|FG000|Primary Evaluation Period|Randomized, not treated|1|||
143390307|NCT03056040|516975654|FG001|Primary Evaluation Period|Randomized, not treated|1|||
143390308|NCT03056040|516975653|FG000|Extension Period|Physician Decision|3|||
143390309|NCT03056040|516975654|FG001|Extension Period|Physician Decision|3|||
143390310|NCT03056040|516975653|FG000|Extension Period|Lost to Follow-up|0|||
143390311|NCT03056040|516975654|FG001|Extension Period|Lost to Follow-up|1|||
143390312|NCT03056040|516975653|FG000|Extension Period|Death|0|||
143390313|NCT03056040|516975654|FG001|Extension Period|Death|3|||
143390314|NCT03056040|516975653|FG000|Extension Period|Withdrawal by Subject|1|||
143390315|NCT03056040|516975654|FG001|Extension Period|Withdrawal by Subject|0|||
143390316|NCT03445988|516975657|FG000|Overall Study|Lost to Follow-up|14|||
143390317|NCT03445988|516975658|FG001|Overall Study|Lost to Follow-up|26|||
143390318|NCT03445988|516975659|FG002|Overall Study|Lost to Follow-up|27|||
143390319|NCT03445988|516975660|FG003|Overall Study|Lost to Follow-up|66|||
143390320|NCT03445988|516975657|FG000|Overall Study|Withdrawal by Subject|7|||
143390321|NCT03445988|516975658|FG001|Overall Study|Withdrawal by Subject|4|||
143390322|NCT03445988|516975659|FG002|Overall Study|Withdrawal by Subject|3|||
143390323|NCT03445988|516975660|FG003|Overall Study|Withdrawal by Subject|5|||
143390324|NCT03445988|516975657|FG000|Overall Study|Death (unrelated to study)|5|||
143390325|NCT03445988|516975658|FG001|Overall Study|Death (unrelated to study)|1|||
143390326|NCT03445988|516975659|FG002|Overall Study|Death (unrelated to study)|2|||
143390327|NCT03445988|516975660|FG003|Overall Study|Death (unrelated to study)|4|||
143390328|NCT05784662|516975661|FG000|Overall Study|Lost to Follow-up|21|||
143390329|NCT05784662|516975662|FG001|Overall Study|Lost to Follow-up|17|||
143390330|NCT03232138|516975665|FG000|Overall Study|Physician Decision|1|||
143390331|NCT03232138|516975666|FG001|Overall Study|Physician Decision|0|||
143390332|NCT03232138|516975665|FG000|Overall Study|Adverse Event|2|||
143390333|NCT03232138|516975666|FG001|Overall Study|Adverse Event|0|||
143390334|NCT03232138|516975665|FG000|Overall Study|Withdrawal by Subject|1|||
143390335|NCT03232138|516975666|FG001|Overall Study|Withdrawal by Subject|2|||
143390336|NCT03920111|516975667|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
143390337|NCT03920111|516975668|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
143390338|NCT03920111|516975669|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
143390339|NCT05177848|516975670|FG000|Overall Study|Lost to Follow-up|1|||
143390340|NCT05177848|516975671|FG001|Overall Study|Lost to Follow-up|4|||
143390341|NCT05177848|516975670|FG000|Overall Study|Discontinued|2|||
143390342|NCT05177848|516975671|FG001|Overall Study|Discontinued|1|||
143390343|NCT02035787|516975672|FG000|Overall Study- 12 Months|Adverse Event|3|||
143390344|NCT02035787|516975673|FG001|Overall Study- 12 Months|Adverse Event|0|||
143390345|NCT02035787|516975672|FG000|Overall Study- 12 Months|Complete response|4|||
143390346|NCT02035787|516975673|FG001|Overall Study- 12 Months|Complete response|1|||
143390347|NCT02035787|516975672|FG000|Overall Study- 12 Months|Protocol Violation|1|||
143390348|NCT02035787|516975673|FG001|Overall Study- 12 Months|Protocol Violation|1|||
143390349|NCT06414213|516975674|FG000|Overall Study|Lost to Follow-up|1|||
143390350|NCT06414213|516975675|FG001|Overall Study|Lost to Follow-up|1|||
143390351|NCT06414213|516975676|FG002|Overall Study|Lost to Follow-up|3|||
143390352|NCT03853746|516975678|FG000|Overall Study|Withdrawal by Subject|1|||
143390353|NCT02724631|516975683|FG000|Overall Study|unable to clear indwelling feeding tube device|1|||
143390354|NCT05076708|516975684|FG000|Overall Study|Withdrawal by Subject|4|||
143390355|NCT05076708|516975684|FG000|Overall Study|Lost to study during switch phase|8|||
143390356|NCT04952909|516975685|FG000|Overall Study|Death|3|||
143390357|NCT05308004|516975687|FG000|Overall Study|Not seen by Palliative Care NP|0|||
143390358|NCT05308004|516975688|FG001|Overall Study|Not seen by Palliative Care NP|1|||
143390359|NCT04359108|516975695|FG000|Overall Study|Withdrawal by Subject|1|||
143390360|NCT04359108|516975696|FG001|Overall Study|Withdrawal by Subject|0|||
143390361|NCT04359108|516975695|FG000|Overall Study|Unable or too feeble to walk independently|0|||
143390362|NCT04359108|516975696|FG001|Overall Study|Unable or too feeble to walk independently|2|||
143390363|NCT04359108|516975695|FG000|Overall Study|Argus II system stopped functioning|0|||
143390364|NCT04359108|516975696|FG001|Overall Study|Argus II system stopped functioning|1|||
143390365|NCT04359108|516975695|FG000|Overall Study|Died of natural causes unrelated to the study before study ended|0|||
143390366|NCT04359108|516975696|FG001|Overall Study|Died of natural causes unrelated to the study before study ended|2|||
143390367|NCT03903146|516975697|FG000|Overall Study|Lost to Follow-up|6|||
143390368|NCT03903146|516975698|FG001|Overall Study|Lost to Follow-up|4|||
143390369|NCT03903146|516975697|FG000|Overall Study|Withdrawal by Subject|0|||
143390370|NCT03903146|516975698|FG001|Overall Study|Withdrawal by Subject|1|||
143390371|NCT04176965|516975699|FG000|Overall Study|Death|1|||
143390372|NCT04176965|516975700|FG001|Overall Study|Death|2|||
143390373|NCT04176965|516975699|FG000|Overall Study|Lost to Follow-up|10|||
143390374|NCT04176965|516975700|FG001|Overall Study|Lost to Follow-up|2|||
143390375|NCT04176965|516975699|FG000|Overall Study|Withdrawal by Subject|6|||
143390376|NCT04176965|516975700|FG001|Overall Study|Withdrawal by Subject|1|||
143390377|NCT02919683|516975701|FG000|Post-Surgery Follow-Up|Death|2|||
143390378|NCT02919683|516975702|FG001|Post-Surgery Follow-Up|Death|2|||
143390379|NCT02919683|516975701|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
143390380|NCT02919683|516975702|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
143390381|NCT05434078|516975704|FG000|Overall Study|Lost to Follow-up|2|||
143390382|NCT05434078|516975705|FG001|Overall Study|Lost to Follow-up|1|||
143390383|NCT05434078|516975704|FG000|Overall Study|Withdrawal by Subject|1|||
143390384|NCT05434078|516975705|FG001|Overall Study|Withdrawal by Subject|0|||
143390385|NCT04072380|516975706|FG000|Overall Study|Adverse Event|4|||
143390386|NCT04072380|516975707|FG001|Overall Study|Adverse Event|6|||
143390387|NCT04072380|516975708|FG002|Overall Study|Adverse Event|0|||
143390388|NCT04072380|516975706|FG000|Overall Study|Withdrawal by Subject|3|||
143390389|NCT04072380|516975707|FG001|Overall Study|Withdrawal by Subject|1|||
143454300|NCT00738894|517208189|FG001|Overall Study|Lost to Follow-up|13|||
143454301|NCT00738894|517208188|FG000|Overall Study|Withdrawal by Subject|10|||
143454302|NCT00738894|517208189|FG001|Overall Study|Withdrawal by Subject|15|||
143454303|NCT00738894|517208188|FG000|Overall Study|Physician Decision|4|||
143390390|NCT04072380|516975708|FG002|Overall Study|Withdrawal by Subject|1|||
143390391|NCT04072380|516975706|FG000|Overall Study|Physician Decision|2|||
143390392|NCT04072380|516975707|FG001|Overall Study|Physician Decision|0|||
143390393|NCT04072380|516975708|FG002|Overall Study|Physician Decision|0|||
143390394|NCT04072380|516975706|FG000|Overall Study|Protocol Violation|0|||
143390395|NCT04072380|516975707|FG001|Overall Study|Protocol Violation|2|||
143390396|NCT04072380|516975708|FG002|Overall Study|Protocol Violation|3|||
143390397|NCT04072380|516975706|FG000|Overall Study|Intercurrent Illness and Others|3|||
143390398|NCT04072380|516975707|FG001|Overall Study|Intercurrent Illness and Others|5|||
143390399|NCT04072380|516975708|FG002|Overall Study|Intercurrent Illness and Others|6|||
143390400|NCT05894577|516975714|FG000|Overall Study|No receipt of study drug|14|||
143390401|NCT05894577|516975715|FG001|Overall Study|No receipt of study drug|13|||
143390402|NCT05894577|516975714|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
143390403|NCT05894577|516975715|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
143390404|NCT05894577|516975714|FG000|Overall Study|Screen Fail|2|||
143390405|NCT05894577|516975715|FG001|Overall Study|Screen Fail|0|||
143390406|NCT05894577|516975714|FG000|Overall Study|Study drug recall|86|||
143390407|NCT05894577|516975715|FG001|Overall Study|Study drug recall|63|||
143390408|NCT03721952|516975716|FG000|Overall Study|Lost to Follow-up|0|||
143390409|NCT03721952|516975717|FG001|Overall Study|Lost to Follow-up|0|||
143390410|NCT03721952|516975718|FG002|Overall Study|Lost to Follow-up|2|||
143390411|NCT03721952|516975719|FG003|Overall Study|Lost to Follow-up|0|||
143390412|NCT03721952|516975720|FG004|Overall Study|Lost to Follow-up|0|||
143390413|NCT03721952|516975716|FG000|Overall Study|Protocol Violation|0|||
143390414|NCT03721952|516975717|FG001|Overall Study|Protocol Violation|1|||
143390415|NCT03721952|516975718|FG002|Overall Study|Protocol Violation|0|||
143390416|NCT03721952|516975719|FG003|Overall Study|Protocol Violation|0|||
143390417|NCT03721952|516975720|FG004|Overall Study|Protocol Violation|0|||
143390418|NCT03721952|516975716|FG000|Overall Study|Withdrawal by Subject|1|||
143390419|NCT03721952|516975717|FG001|Overall Study|Withdrawal by Subject|0|||
143390420|NCT03721952|516975718|FG002|Overall Study|Withdrawal by Subject|40|||
143390421|NCT03721952|516975719|FG003|Overall Study|Withdrawal by Subject|28|||
143390422|NCT03721952|516975720|FG004|Overall Study|Withdrawal by Subject|0|||
143390423|NCT04015167|516975724|FG000|Overall Study|Lost to Follow-up|40|||
143390424|NCT04015167|516975724|FG000|Overall Study|Adverse Event|5|||
143390425|NCT04015167|516975724|FG000|Overall Study|Withdrawal by Subject|2|||
143390426|NCT04015167|516975724|FG000|Overall Study|Subject went to jail|1|||
143390427|NCT03640312|516975725|FG000|Overall Study|Lost to Follow-up|3|||
143390428|NCT03640312|516975726|FG001|Overall Study|Lost to Follow-up|6|||
143390429|NCT02761057|516975732|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
143390430|NCT02761057|516975733|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
143390431|NCT02761057|516975734|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
143390432|NCT02761057|516975735|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
143390433|NCT02761057|516975732|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
143390434|NCT02761057|516975733|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
143390435|NCT02761057|516975734|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
143390436|NCT02761057|516975735|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
143390437|NCT02761057|516975732|FG000|Overall Study|Currently On Study Treatment|0|||
143390438|NCT02761057|516975733|FG001|Overall Study|Currently On Study Treatment|3|||
143390439|NCT02761057|516975734|FG002|Overall Study|Currently On Study Treatment|0|||
143390440|NCT02761057|516975735|FG003|Overall Study|Currently On Study Treatment|0|||
143390441|NCT02761057|516975732|FG000|Overall Study|Adverse Event|11|||
143390442|NCT02761057|516975733|FG001|Overall Study|Adverse Event|9|||
143390443|NCT02761057|516975734|FG002|Overall Study|Adverse Event|5|||
143390444|NCT02761057|516975735|FG003|Overall Study|Adverse Event|3|||
143390445|NCT02761057|516975732|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
143390446|NCT02761057|516975733|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
143390447|NCT02761057|516975734|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
143390448|NCT02761057|516975735|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
143390449|NCT02761057|516975732|FG000|Overall Study|Progression/Relapse|29|||
143390450|NCT02761057|516975733|FG001|Overall Study|Progression/Relapse|27|||
143390451|NCT02761057|516975734|FG002|Overall Study|Progression/Relapse|20|||
143390452|NCT02761057|516975735|FG003|Overall Study|Progression/Relapse|23|||
143390453|NCT02761057|516975732|FG000|Overall Study|Death|2|||
143390454|NCT02761057|516975733|FG001|Overall Study|Death|2|||
143390455|NCT02761057|516975734|FG002|Overall Study|Death|1|||
143390456|NCT02761057|516975735|FG003|Overall Study|Death|1|||
143390457|NCT02761057|516975732|FG000|Overall Study|Other - Not Protocol Specified|2|||
143390458|NCT02761057|516975733|FG001|Overall Study|Other - Not Protocol Specified|1|||
143390459|NCT02761057|516975734|FG002|Overall Study|Other - Not Protocol Specified|2|||
143390460|NCT02761057|516975735|FG003|Overall Study|Other - Not Protocol Specified|0|||
143390461|NCT06037369|516975736|FG000|Overall Study|Lost to Follow-up|0|||
143390462|NCT06037369|516975737|FG001|Overall Study|Lost to Follow-up|1|||
143390463|NCT05008835|516975739|FG000|Overall Study|Adverse Event|5|||
143390464|NCT05008835|516975740|FG001|Overall Study|Adverse Event|2|||
143390465|NCT05008835|516975741|FG002|Overall Study|Adverse Event|1|||
143390466|NCT05008835|516975739|FG000|Overall Study|Lack of Efficacy|0|||
143390467|NCT05008835|516975740|FG001|Overall Study|Lack of Efficacy|0|||
143390468|NCT05008835|516975741|FG002|Overall Study|Lack of Efficacy|1|||
143390469|NCT05008835|516975739|FG000|Overall Study|Study terminated by sponsor|0|||
143390470|NCT05008835|516975740|FG001|Overall Study|Study terminated by sponsor|0|||
143390471|NCT05008835|516975741|FG002|Overall Study|Study terminated by sponsor|1|||
143390472|NCT05008835|516975739|FG000|Overall Study|Not further specified|3|||
143390473|NCT05008835|516975740|FG001|Overall Study|Not further specified|2|||
143390474|NCT05008835|516975741|FG002|Overall Study|Not further specified|1|||
143390475|NCT04505904|516975746|FG000|Overall Study|Withdrawal by Subject|1|||
143390476|NCT04505904|516975747|FG001|Overall Study|Withdrawal by Subject|2|||
143390477|NCT04505904|516975748|FG002|Overall Study|Withdrawal by Subject|0|||
143390478|NCT04505904|516975749|FG003|Overall Study|Withdrawal by Subject|0|||
143390479|NCT04505904|516975746|FG000|Overall Study|Physician Decision|1|||
143390480|NCT04505904|516975747|FG001|Overall Study|Physician Decision|0|||
143390481|NCT04505904|516975748|FG002|Overall Study|Physician Decision|0|||
143390482|NCT04505904|516975749|FG003|Overall Study|Physician Decision|0|||
143390483|NCT04505904|516975746|FG000|Overall Study|Adverse Event|0|||
143390484|NCT04505904|516975747|FG001|Overall Study|Adverse Event|1|||
143390485|NCT04505904|516975748|FG002|Overall Study|Adverse Event|0|||
143390486|NCT04505904|516975749|FG003|Overall Study|Adverse Event|0|||
143390487|NCT04876118|516975750|FG000|Overall Study|Pregnancy|1|||
143390488|NCT04876118|516975750|FG000|Overall Study|Withdrawal by Subject|14|||
143390489|NCT05609760|516975758|FG000|Overall Study|Lost to Follow-up|0|||
143390490|NCT05609760|516975759|FG001|Overall Study|Lost to Follow-up|1|||
143390491|NCT05609760|516975758|FG000|Overall Study|Withdrawal by Subject|1|||
143390492|NCT05609760|516975759|FG001|Overall Study|Withdrawal by Subject|0|||
143390493|NCT05351554|516975760|FG000|Overall Study|Study terminated by sponsor|1|||
143390494|NCT05093829|516975761|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
143390495|NCT05093829|516975762|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
143390496|NCT05093829|516975763|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
143390497|NCT05093829|516975764|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
143390498|NCT05093829|516975765|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
143390499|NCT04353661|516978424|FG000|Overall Study|Protocol Violation|0|||
143390500|NCT04353661|516978425|FG001|Overall Study|Protocol Violation|0|||
143390501|NCT04353661|516978426|FG002|Overall Study|Protocol Violation|1|||
143390502|NCT04353661|516978424|FG000|Overall Study|Study termination by the Sponsor|1|||
143390503|NCT04353661|516978425|FG001|Overall Study|Study termination by the Sponsor|1|||
143390504|NCT04353661|516978426|FG002|Overall Study|Study termination by the Sponsor|1|||
143390505|NCT00667251|516978427|FG000|Overall Study|Disease progression|232|||
143390506|NCT00667251|516978428|FG001|Overall Study|Disease progression|203|||
143390507|NCT00667251|516978427|FG000|Overall Study|Toxicity|44|||
143390508|NCT00667251|516978428|FG001|Overall Study|Toxicity|23|||
143390509|NCT00667251|516978427|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|18|||
143390510|NCT00667251|516978428|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|70|||
143390511|NCT00667251|516978427|FG000|Overall Study|Refused further treatment (not due to toxicity)|8|||
143390512|NCT00667251|516978428|FG001|Overall Study|Refused further treatment (not due to toxicity)|7|||
143390513|NCT00667251|516978427|FG000|Overall Study|Symptomatic progression|8|||
143390514|NCT00667251|516978428|FG001|Overall Study|Symptomatic progression|4|||
143390515|NCT00667251|516978427|FG000|Overall Study|Death|6|||
143390516|NCT00667251|516978428|FG001|Overall Study|Death|11|||
143390517|NCT00667251|516978427|FG000|Overall Study|Intercurrent illness|5|||
143390518|NCT00667251|516978428|FG001|Overall Study|Intercurrent illness|6|||
143390519|NCT00667251|516978427|FG000|Overall Study|Primary reason for withdrawal = missing|1|||
143390520|NCT00667251|516978428|FG001|Overall Study|Primary reason for withdrawal = missing|1|||
143390521|NCT00667251|516978427|FG000|Overall Study|Randomized not Treated|4|||
143390522|NCT00667251|516978428|FG001|Overall Study|Randomized not Treated|1|||
143390523|NCT02727699|516978430|FG000|Overall Study|Adverse Event|2|||
143390524|NCT02727699|516978431|FG001|Overall Study|Adverse Event|0|||
143390525|NCT02727699|516978430|FG000|Overall Study|Withdrawal by Subject|5|||
143390526|NCT02727699|516978431|FG001|Overall Study|Withdrawal by Subject|3|||
143390527|NCT02727699|516978430|FG000|Overall Study|Protocol Violation|0|||
143390528|NCT02727699|516978431|FG001|Overall Study|Protocol Violation|1|||
143390529|NCT02727699|516978430|FG000|Overall Study|Physician Decision|0|||
143390530|NCT02727699|516978431|FG001|Overall Study|Physician Decision|1|||
143390531|NCT02727699|516978430|FG000|Overall Study|Lost to Follow-up|1|||
143390532|NCT02727699|516978431|FG001|Overall Study|Lost to Follow-up|0|||
143390533|NCT02727699|516978430|FG000|Overall Study|Sponsor Decision|1|||
143390534|NCT02727699|516978431|FG001|Overall Study|Sponsor Decision|0|||
143390535|NCT03376321|516978443|FG000|Overall Study|Other|5|||
143390536|NCT03376321|516978444|FG001|Overall Study|Other|1|||
143390537|NCT03376321|516978443|FG000|Overall Study|Withdrawal by Subject|8|||
143390538|NCT03376321|516978444|FG001|Overall Study|Withdrawal by Subject|14|||
143390539|NCT03376321|516978443|FG000|Overall Study|Lost to Follow-up|1|||
143390540|NCT03376321|516978444|FG001|Overall Study|Lost to Follow-up|7|||
143390541|NCT03376321|516978443|FG000|Overall Study|Death|4|||
143390542|NCT03376321|516978444|FG001|Overall Study|Death|0|||
143390543|NCT03376321|516978443|FG000|Overall Study|Randomized, not treated|5|||
143390544|NCT03376321|516978444|FG001|Overall Study|Randomized, not treated|3|||
143390545|NCT02671903|516978445|FG000|Period 0 (Run-In)|Death|0|||
143390546|NCT02671903|516978446|FG001|Period 0 (Run-In)|Death|0|||
143390547|NCT02671903|516978447|FG002|Period 0 (Run-In)|Death|3|||
143390548|NCT02671903|516978445|FG000|Period 0 (Run-In)|Physician Decision|0|||
143390549|NCT02671903|516978446|FG001|Period 0 (Run-In)|Physician Decision|0|||
143390550|NCT02671903|516978447|FG002|Period 0 (Run-In)|Physician Decision|4|||
143390551|NCT02671903|516978445|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
143390552|NCT02671903|516978446|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
143390553|NCT02671903|516978447|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
143390554|NCT02671903|516978445|FG000|Period 0 (Run-In)|Protocol Violation|0|||
143390555|NCT02671903|516978446|FG001|Period 0 (Run-In)|Protocol Violation|0|||
143390556|NCT02671903|516978447|FG002|Period 0 (Run-In)|Protocol Violation|1|||
143390557|NCT02671903|516978445|FG000|Period 0 (Run-In)|Adverse Event|0|||
143390558|NCT02671903|516978446|FG001|Period 0 (Run-In)|Adverse Event|0|||
143390559|NCT02671903|516978447|FG002|Period 0 (Run-In)|Adverse Event|1|||
143390560|NCT02671903|516978445|FG000|Period 0 (Run-In)|Implantation Failure|0|||
143390561|NCT02671903|516978446|FG001|Period 0 (Run-In)|Implantation Failure|0|||
143390562|NCT02671903|516978447|FG002|Period 0 (Run-In)|Implantation Failure|2|||
143390563|NCT02671903|516978445|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
143390564|NCT02671903|516978446|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
143390565|NCT02671903|516978447|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
143390566|NCT02992925|516978448|FG000|Cohort 2|Physician Decision|0|||
143390567|NCT02992925|516978449|FG001|Cohort 2|Physician Decision|0|||
143390568|NCT02992925|516978450|FG002|Cohort 2|Physician Decision|1|||
143390569|NCT02992925|516978451|FG003|Cohort 2|Physician Decision|0|||
143390570|NCT02992925|516978448|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
143390571|NCT02992925|516978449|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
143390572|NCT02992925|516978450|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
143390573|NCT02992925|516978451|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
143390574|NCT02995434|516978452|FG000|Overall Study|Adverse Event|1|||
143390575|NCT02995434|516978453|FG001|Overall Study|Adverse Event|0|||
143390576|NCT02995434|516978452|FG000|Overall Study|Withdrawal by Subject|6|||
143390577|NCT02995434|516978453|FG001|Overall Study|Withdrawal by Subject|3|||
143390578|NCT04318548|516978454|FG000|Overall Study|Adverse Event|0|||
143390579|NCT04318548|516978455|FG001|Overall Study|Adverse Event|0|||
143390580|NCT04318548|516978456|FG002|Overall Study|Adverse Event|1|||
143390581|NCT04318548|516978454|FG000|Overall Study|Lost to Follow-up|6|||
143390582|NCT04318548|516978455|FG001|Overall Study|Lost to Follow-up|13|||
143390583|NCT04318548|516978456|FG002|Overall Study|Lost to Follow-up|9|||
143390584|NCT04318548|516978454|FG000|Overall Study|Protocol Violation|1|||
143390585|NCT04318548|516978455|FG001|Overall Study|Protocol Violation|0|||
143390586|NCT04318548|516978456|FG002|Overall Study|Protocol Violation|2|||
143390587|NCT04318548|516978454|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|5|||
143390588|NCT04318548|516978455|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|9|||
143390589|NCT04318548|516978456|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
143390590|NCT04318548|516978454|FG000|Overall Study|Migrated / moved from the study area|0|||
143390591|NCT04318548|516978455|FG001|Overall Study|Migrated / moved from the study area|0|||
143390592|NCT04318548|516978456|FG002|Overall Study|Migrated / moved from the study area|1|||
143390593|NCT04318548|516978454|FG000|Overall Study|Other|1|||
143390594|NCT04318548|516978455|FG001|Overall Study|Other|2|||
143390595|NCT04318548|516978456|FG002|Overall Study|Other|3|||
143390596|NCT05247489|516978457|FG000|Overall Study|Lost to Follow-up|5|||
143390597|NCT05247489|516978458|FG001|Overall Study|Lost to Follow-up|1|||
143390598|NCT05247489|516978457|FG000|Overall Study|Withdrawal by Subject|6|||
143390599|NCT05247489|516978458|FG001|Overall Study|Withdrawal by Subject|7|||
143390600|NCT05247489|516978457|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
143390601|NCT05247489|516978458|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
143390602|NCT05247489|516978457|FG000|Overall Study|Left Country|1|||
143390603|NCT05247489|516978458|FG001|Overall Study|Left Country|0|||
143390604|NCT05247489|516978457|FG000|Overall Study|Noncompliance with Investigational Product|1|||
143390605|NCT05247489|516978458|FG001|Overall Study|Noncompliance with Investigational Product|0|||
143390606|NCT05247489|516978457|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
143390607|NCT05247489|516978458|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
143390608|NCT05215314|516978465|FG000|Overall Study|Lost to Follow-up|2|||
143390609|NCT05215314|516978466|FG001|Overall Study|Lost to Follow-up|2|||
143390610|NCT05215314|516978465|FG000|Overall Study|Withdrawal by Subject|2|||
143390611|NCT05215314|516978466|FG001|Overall Study|Withdrawal by Subject|0|||
143390612|NCT05215314|516978465|FG000|Overall Study|Physician Decision|1|||
143390613|NCT05215314|516978466|FG001|Overall Study|Physician Decision|0|||
143390614|NCT04179500|516978467|FG000|Treatment|Withdrawal by Subject|1|||
143390615|NCT04179500|516978467|FG000|Treatment|Adverse Event|2|||
143390616|NCT04179500|516978467|FG000|Treatment|pyrazinamide resistance|1|||
143390617|NCT03366649|516978472|FG000|Overall Study|Failed preoperative screening|4|||
143390618|NCT03366649|516978473|FG001|Overall Study|Failed preoperative screening|0|||
143390619|NCT03366649|516978474|FG002|Overall Study|Failed preoperative screening|0|||
143390620|NCT03366649|516978472|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
143390621|NCT03366649|516978473|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
143390622|NCT03366649|516978474|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
143390623|NCT03673111|516978475|FG000|Overall Study|Protocol Violation|0|||
143390624|NCT03673111|516978476|FG001|Overall Study|Protocol Violation|0|||
143390625|NCT03673111|516978477|FG002|Overall Study|Protocol Violation|0|||
143390626|NCT03673111|516978478|FG003|Overall Study|Protocol Violation|0|||
143390627|NCT03673111|516978479|FG004|Overall Study|Protocol Violation|0|||
143390628|NCT03673111|516978480|FG005|Overall Study|Protocol Violation|0|||
143390629|NCT03673111|516978481|FG006|Overall Study|Protocol Violation|0|||
143390630|NCT03673111|516978482|FG007|Overall Study|Protocol Violation|0|||
143390631|NCT03673111|516978483|FG008|Overall Study|Protocol Violation|0|||
143390632|NCT03673111|516978484|FG009|Overall Study|Protocol Violation|0|||
143390633|NCT03673111|516978485|FG010|Overall Study|Protocol Violation|1|||
143390634|NCT03673111|516978486|FG011|Overall Study|Protocol Violation|0|||
143390635|NCT03673111|516978487|FG012|Overall Study|Protocol Violation|0|||
143390636|NCT03673111|516978488|FG013|Overall Study|Protocol Violation|0|||
143390637|NCT03673111|516978475|FG000|Overall Study|Adverse Event|1|||
143390638|NCT03673111|516978476|FG001|Overall Study|Adverse Event|0|||
143390639|NCT03673111|516978477|FG002|Overall Study|Adverse Event|0|||
143390640|NCT03673111|516978478|FG003|Overall Study|Adverse Event|0|||
143390641|NCT03673111|516978479|FG004|Overall Study|Adverse Event|0|||
143390642|NCT03673111|516978480|FG005|Overall Study|Adverse Event|0|||
143390643|NCT03673111|516978481|FG006|Overall Study|Adverse Event|0|||
143390644|NCT03673111|516978482|FG007|Overall Study|Adverse Event|0|||
143390645|NCT03673111|516978483|FG008|Overall Study|Adverse Event|0|||
143390646|NCT03673111|516978484|FG009|Overall Study|Adverse Event|0|||
143390647|NCT03673111|516978485|FG010|Overall Study|Adverse Event|0|||
143390648|NCT03673111|516978486|FG011|Overall Study|Adverse Event|0|||
143390649|NCT03673111|516978487|FG012|Overall Study|Adverse Event|0|||
143390650|NCT03673111|516978488|FG013|Overall Study|Adverse Event|0|||
143390651|NCT03792555|516978489|FG000|Titration Period: up to 9 Weeks|COVID-19|0|||
143390652|NCT03792555|516978490|FG001|Titration Period: up to 9 Weeks|COVID-19|0|||
143390653|NCT03792555|516978491|FG002|Titration Period: up to 9 Weeks|COVID-19|1|||
143390654|NCT03792555|516978489|FG000|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
143390655|NCT03792555|516978490|FG001|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
143390656|NCT03792555|516978491|FG002|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|5|||
143390657|NCT03792555|516978489|FG000|Follow-up Period: up to 4 Weeks|COVID-19|0|||
143390658|NCT03792555|516978490|FG001|Follow-up Period: up to 4 Weeks|COVID-19|1|||
143390659|NCT03792555|516978491|FG002|Follow-up Period: up to 4 Weeks|COVID-19|0|||
143390660|NCT04485039|516978492|FG000|TPOXX Only|Adverse Event|2|||
143390661|NCT04485039|516978492|FG000|TPOXX Only|Physician Decision|1|||
143390662|NCT04485039|516978492|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
143390663|NCT04485039|516978492|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
143390664|NCT03476187|516978495|FG000|Overall Study|Protocol Violation|7|||
143338310|NCT03770494|516781622|FG006|Overall Study|Study terminated by sponsor|1|||
143338311|NCT03770494|516781623|FG007|Overall Study|Study terminated by sponsor|2|||
143338312|NCT03770494|516781624|FG008|Overall Study|Study terminated by sponsor|1|||
143338313|NCT03770494|516781625|FG009|Overall Study|Study terminated by sponsor|2|||
143338314|NCT03770494|516781626|FG010|Overall Study|Study terminated by sponsor|1|||
143338315|NCT03770494|516781627|FG011|Overall Study|Study terminated by sponsor|2|||
143338316|NCT03770494|516781628|FG012|Overall Study|Study terminated by sponsor|0|||
143338317|NCT03770494|516781629|FG013|Overall Study|Study terminated by sponsor|0|||
143338318|NCT03770494|516781616|FG000|Overall Study|Withdrawal by Subject|1|||
143338319|NCT03770494|516781617|FG001|Overall Study|Withdrawal by Subject|1|||
143338320|NCT03770494|516781618|FG002|Overall Study|Withdrawal by Subject|0|||
143338321|NCT03770494|516781619|FG003|Overall Study|Withdrawal by Subject|0|||
143338322|NCT03770494|516781620|FG004|Overall Study|Withdrawal by Subject|2|||
143338323|NCT03770494|516781621|FG005|Overall Study|Withdrawal by Subject|2|||
143338324|NCT03770494|516781622|FG006|Overall Study|Withdrawal by Subject|2|||
143338325|NCT03770494|516781623|FG007|Overall Study|Withdrawal by Subject|0|||
143338326|NCT03770494|516781624|FG008|Overall Study|Withdrawal by Subject|2|||
143338327|NCT03770494|516781625|FG009|Overall Study|Withdrawal by Subject|3|||
143338328|NCT03770494|516781626|FG010|Overall Study|Withdrawal by Subject|1|||
143338329|NCT03770494|516781627|FG011|Overall Study|Withdrawal by Subject|0|||
143338330|NCT03770494|516781628|FG012|Overall Study|Withdrawal by Subject|0|||
143338331|NCT03770494|516781629|FG013|Overall Study|Withdrawal by Subject|0|||
143338332|NCT01345630|516782912|FG000|Overall Study|Adverse Event|22|||
143338333|NCT01345630|516782913|FG001|Overall Study|Adverse Event|23|||
143338334|NCT01345630|516782912|FG000|Overall Study|Lost to Follow-up|17|||
143338335|NCT01345630|516782913|FG001|Overall Study|Lost to Follow-up|16|||
143338336|NCT01345630|516782912|FG000|Overall Study|Protocol Violation|4|||
143338337|NCT01345630|516782913|FG001|Overall Study|Protocol Violation|1|||
143338338|NCT01345630|516782912|FG000|Overall Study|Medication error without associated AE|0|||
143338339|NCT01345630|516782913|FG001|Overall Study|Medication error without associated AE|1|||
143338340|NCT01345630|516782912|FG000|Overall Study|Study terminated by sponsor|254|||
143338341|NCT01345630|516782913|FG001|Overall Study|Study terminated by sponsor|285|||
143338342|NCT01345630|516782912|FG000|Overall Study|Other reasons|6|||
143338343|NCT01345630|516782913|FG001|Overall Study|Other reasons|8|||
143338344|NCT01345630|516782912|FG000|Overall Study|Withdrawn due to pregnancy|1|||
143338345|NCT01345630|516782913|FG001|Overall Study|Withdrawn due to pregnancy|2|||
143338346|NCT01345630|516782912|FG000|Overall Study|No longer willing to participate|9|||
143338347|NCT01345630|516782913|FG001|Overall Study|No longer willing to participate|12|||
143338348|NCT01345630|516782912|FG000|Overall Study|Insufficient clinical response|48|||
143338349|NCT01345630|516782913|FG001|Overall Study|Insufficient clinical response|11|||
143338350|NCT00939484|516782914|FG000|Overall Study|Progression/Relapse|8|||
143338351|NCT00939484|516782915|FG001|Overall Study|Progression/Relapse|20|||
143338352|NCT00939484|516782916|FG002|Overall Study|Progression/Relapse|3|||
143338353|NCT03938454|516782917|FG000|Overall Study|Protocol Violation|1|||
143338354|NCT03938454|516782917|FG000|Overall Study|Withdrawal by Subject|2|||
143338355|NCT03938454|516782917|FG000|Overall Study|Lost to Follow-up|3|||
143338356|NCT01142388|516782918|FG000|Overall Study|Lack of Efficacy|21|||
143338357|NCT01142388|516782919|FG001|Overall Study|Lack of Efficacy|31|||
143338358|NCT01142388|516782918|FG000|Overall Study|Adverse Event|9|||
143338359|NCT01142388|516782919|FG001|Overall Study|Adverse Event|5|||
143338360|NCT01142388|516782918|FG000|Overall Study|Death|3|||
143338361|NCT01142388|516782919|FG001|Overall Study|Death|2|||
143338362|NCT01142388|516782918|FG000|Overall Study|Withdrawal by Subject|5|||
143338363|NCT01142388|516782919|FG001|Overall Study|Withdrawal by Subject|3|||
143338364|NCT01142388|516782918|FG000|Overall Study|Alternative therapy|1|||
143338365|NCT01142388|516782919|FG001|Overall Study|Alternative therapy|0|||
143338366|NCT01142388|516782918|FG000|Overall Study|Other complications|0|||
143338367|NCT01142388|516782919|FG001|Overall Study|Other complications|2|||
143338368|NCT01142388|516782918|FG000|Overall Study|Other|1|||
143338369|NCT01142388|516782919|FG001|Overall Study|Other|1|||
143338370|NCT01142388|516782918|FG000|Overall Study|Never started therapy|7|||
143338371|NCT01142388|516782919|FG001|Overall Study|Never started therapy|3|||
143338372|NCT01289418|516782926|FG000|Day 8 Survey|email address invalid|283|||
143338373|NCT01289418|516782926|FG000|Day 8 Survey|participants did not complete the survey|1935|||
143338374|NCT01289418|516782926|FG000|Day 29 Survey|email address invalid|283|||
143338375|NCT01289418|516782926|FG000|Day 29 Survey|participants did not complete the survey|2185|||
143338376|NCT04525547|516782928|FG000|Overall Study|Not treated with Ofev|2|||
143338377|NCT04525547|516782928|FG000|Overall Study|Off-label use|2|||
143338378|NCT04525547|516782928|FG000|Overall Study|Lost to Follow-up|1|||
143338379|NCT01493687|516782935|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
143338380|NCT01493687|516782936|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
143338381|NCT01493687|516782935|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
143338382|NCT01493687|516782936|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
143338383|NCT01493687|516782935|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
143338384|NCT01493687|516782936|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
143338385|NCT01493687|516782935|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
143338386|NCT01493687|516782936|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
143338387|NCT01493687|516782935|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
143338388|NCT01493687|516782936|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
143338389|NCT01493687|516782935|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
143390665|NCT03476187|516978495|FG000|Overall Study|Physician Decision|5|||
143390666|NCT05948670|516978497|FG000|Overall Study|Protocol Violation|6|||
143390667|NCT05948670|516978498|FG001|Overall Study|Protocol Violation|8|||
143390668|NCT05948670|516978497|FG000|Overall Study|Withdrawal by Subject|0|||
143390669|NCT05948670|516978498|FG001|Overall Study|Withdrawal by Subject|1|||
143390670|NCT04274764|516978513|FG000|Overall Study|Date of scheduled followup visit was after trial stop date|62|||
143390671|NCT04274764|516978514|FG001|Overall Study|Date of scheduled followup visit was after trial stop date|70|||
143390672|NCT02677298|516978519|FG000|Double Blind Phase|Adverse Event|2|||
143390673|NCT02677298|516978520|FG001|Double Blind Phase|Adverse Event|1|||
143390674|NCT02677298|516978521|FG002|Double Blind Phase|Adverse Event|0|||
143390675|NCT02677298|516978519|FG000|Double Blind Phase|Physician Decision|5|||
143390676|NCT02677298|516978520|FG001|Double Blind Phase|Physician Decision|0|||
143390677|NCT02677298|516978521|FG002|Double Blind Phase|Physician Decision|0|||
143390678|NCT02677298|516978519|FG000|Double Blind Phase|Lost to Follow-up|11|||
143390679|NCT02677298|516978520|FG001|Double Blind Phase|Lost to Follow-up|7|||
143390680|NCT02677298|516978521|FG002|Double Blind Phase|Lost to Follow-up|0|||
143390681|NCT02677298|516978519|FG000|Double Blind Phase|Withdrawal by Subject|11|||
143390682|NCT02677298|516978520|FG001|Double Blind Phase|Withdrawal by Subject|8|||
143390683|NCT02677298|516978521|FG002|Double Blind Phase|Withdrawal by Subject|0|||
143390684|NCT02677298|516978519|FG000|Double Blind Phase|No study drug available at site|0|||
143390685|NCT02677298|516978520|FG001|Double Blind Phase|No study drug available at site|1|||
143390686|NCT02677298|516978521|FG002|Double Blind Phase|No study drug available at site|0|||
143390687|NCT02677298|516978519|FG000|Open Label Phase|Adverse Event|0|||
143390688|NCT02677298|516978520|FG001|Open Label Phase|Adverse Event|0|||
143390689|NCT02677298|516978521|FG002|Open Label Phase|Adverse Event|4|||
143390690|NCT02677298|516978519|FG000|Open Label Phase|Physician Decision|0|||
143390691|NCT02677298|516978520|FG001|Open Label Phase|Physician Decision|0|||
143390692|NCT02677298|516978521|FG002|Open Label Phase|Physician Decision|1|||
143390693|NCT02677298|516978519|FG000|Open Label Phase|Lost to Follow-up|0|||
143390694|NCT02677298|516978520|FG001|Open Label Phase|Lost to Follow-up|0|||
143390695|NCT02677298|516978521|FG002|Open Label Phase|Lost to Follow-up|17|||
143390696|NCT02677298|516978519|FG000|Open Label Phase|Withdrawal by Subject|0|||
143390697|NCT02677298|516978520|FG001|Open Label Phase|Withdrawal by Subject|0|||
143390698|NCT02677298|516978521|FG002|Open Label Phase|Withdrawal by Subject|38|||
143390699|NCT03611621|516978535|FG000|Overall Study|Graft loss|3|||
143390700|NCT03611621|516978535|FG000|Overall Study|Death|3|||
143390701|NCT03611621|516978535|FG000|Overall Study|Lost to Follow-up|1|||
143390702|NCT03988608|516978538|FG000|Overall Study|Adverse Event|1|||
143390703|NCT03988608|516978538|FG000|Overall Study|Lost to Follow-up|1|||
143390704|NCT03988608|516978538|FG000|Overall Study|Withdrawal by Subject|3|||
143390705|NCT03988608|516978538|FG000|Overall Study|Death|1|||
143390706|NCT03338933|516978549|FG000|Screening Visit|Lost to Follow-up|1|||
143390707|NCT03338933|516978550|FG001|Screening Visit|Lost to Follow-up|3|||
143390708|NCT03338933|516978551|FG002|Screening Visit|Lost to Follow-up|1|||
143390709|NCT03338933|516978552|FG003|Screening Visit|Lost to Follow-up|4|||
143390710|NCT03338933|516978549|FG000|Screening Visit|Screen fail after consent|2|||
143390711|NCT03338933|516978550|FG001|Screening Visit|Screen fail after consent|7|||
143390712|NCT03338933|516978551|FG002|Screening Visit|Screen fail after consent|1|||
143390713|NCT03338933|516978552|FG003|Screening Visit|Screen fail after consent|4|||
143390714|NCT03338933|516978549|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
143390715|NCT03338933|516978550|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
143390716|NCT03338933|516978551|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
143390717|NCT03338933|516978552|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
143390718|NCT03338933|516978549|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
143390719|NCT03338933|516978550|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
143390720|NCT03338933|516978551|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
143390721|NCT03338933|516978552|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
143390722|NCT03338933|516978549|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
143390723|NCT03338933|516978550|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
143390724|NCT03338933|516978551|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
143390725|NCT03338933|516978552|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
143390726|NCT04971395|516978553|FG000|Overall Study|Withdrawal by Subject|0|||
143390727|NCT04971395|516978554|FG001|Overall Study|Withdrawal by Subject|1|||
143390728|NCT04971395|516978555|FG002|Overall Study|Withdrawal by Subject|0|||
143390729|NCT03269136|516978556|FG000|Part 1: Dose Escalation|Other|0|||
143390730|NCT03269136|516978557|FG001|Part 1: Dose Escalation|Other|0|||
143390731|NCT03269136|516978558|FG002|Part 1: Dose Escalation|Other|0|||
143390732|NCT03269136|516978559|FG003|Part 1: Dose Escalation|Other|0|||
143390733|NCT03269136|516978560|FG004|Part 1: Dose Escalation|Other|0|||
143390734|NCT03269136|516978561|FG005|Part 1: Dose Escalation|Other|0|||
143390735|NCT03269136|516978562|FG006|Part 1: Dose Escalation|Other|0|||
143390736|NCT03269136|516978563|FG007|Part 1: Dose Escalation|Other|0|||
143390737|NCT03269136|516978564|FG008|Part 1: Dose Escalation|Other|0|||
143390738|NCT03269136|516978565|FG009|Part 1: Dose Escalation|Other|0|||
143390739|NCT03269136|516978566|FG010|Part 1: Dose Escalation|Other|1|||
143390740|NCT03269136|516978567|FG011|Part 1: Dose Escalation|Other|1|||
143390741|NCT03269136|516978568|FG012|Part 1: Dose Escalation|Other|1|||
143390742|NCT03269136|516978569|FG013|Part 1: Dose Escalation|Other|0|||
143390743|NCT03269136|516978570|FG014|Part 1: Dose Escalation|Other|3|||
143390744|NCT03269136|516978571|FG015|Part 1: Dose Escalation|Other|1|||
143390745|NCT03269136|516978572|FG016|Part 1: Dose Escalation|Other|1|||
143390746|NCT03269136|516978573|FG017|Part 1: Dose Escalation|Other|0|||
143390747|NCT03269136|516978556|FG000|Part 1: Dose Escalation|Refused Further Treatment|0|||
143390748|NCT03269136|516978557|FG001|Part 1: Dose Escalation|Refused Further Treatment|0|||
143390749|NCT03269136|516978558|FG002|Part 1: Dose Escalation|Refused Further Treatment|0|||
143390750|NCT03269136|516978559|FG003|Part 1: Dose Escalation|Refused Further Treatment|0|||
143390751|NCT03269136|516978560|FG004|Part 1: Dose Escalation|Refused Further Treatment|0|||
143390752|NCT03269136|516978561|FG005|Part 1: Dose Escalation|Refused Further Treatment|0|||
143390753|NCT03269136|516978562|FG006|Part 1: Dose Escalation|Refused Further Treatment|1|||
143390754|NCT03269136|516978563|FG007|Part 1: Dose Escalation|Refused Further Treatment|0|||
143390755|NCT03269136|516978564|FG008|Part 1: Dose Escalation|Refused Further Treatment|1|||
143390756|NCT03269136|516978565|FG009|Part 1: Dose Escalation|Refused Further Treatment|0|||
143390757|NCT03269136|516978566|FG010|Part 1: Dose Escalation|Refused Further Treatment|0|||
143390758|NCT03269136|516978567|FG011|Part 1: Dose Escalation|Refused Further Treatment|0|||
143390759|NCT03269136|516978568|FG012|Part 1: Dose Escalation|Refused Further Treatment|1|||
143390760|NCT03269136|516978569|FG013|Part 1: Dose Escalation|Refused Further Treatment|0|||
143390761|NCT03269136|516978570|FG014|Part 1: Dose Escalation|Refused Further Treatment|0|||
143390762|NCT03269136|516978571|FG015|Part 1: Dose Escalation|Refused Further Treatment|0|||
143390763|NCT03269136|516978572|FG016|Part 1: Dose Escalation|Refused Further Treatment|0|||
143390764|NCT03269136|516978573|FG017|Part 1: Dose Escalation|Refused Further Treatment|0|||
143390765|NCT03269136|516978556|FG000|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
143390766|NCT03269136|516978557|FG001|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
143390767|NCT03269136|516978558|FG002|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
143390768|NCT03269136|516978559|FG003|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
143390769|NCT03269136|516978560|FG004|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
143390770|NCT03269136|516978561|FG005|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
143390771|NCT03269136|516978562|FG006|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
143390772|NCT03269136|516978563|FG007|Part 1: Dose Escalation|Global Deterioration of Health Status|1|||
143390773|NCT03269136|516978564|FG008|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
143390774|NCT03269136|516978565|FG009|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
143390775|NCT03269136|516978566|FG010|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
143390776|NCT03269136|516978567|FG011|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
143390777|NCT03269136|516978568|FG012|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
143390778|NCT03269136|516978569|FG013|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
143390779|NCT03269136|516978570|FG014|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
143390780|NCT03269136|516978571|FG015|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
143390781|NCT03269136|516978572|FG016|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
143390782|NCT03269136|516978573|FG017|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
143390783|NCT03269136|516978556|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
143390784|NCT03269136|516978557|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
143390785|NCT03269136|516978558|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
143390786|NCT03269136|516978559|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
143390787|NCT03269136|516978560|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
143390788|NCT03269136|516978561|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
143390789|NCT03269136|516978562|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
143390790|NCT03269136|516978563|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
143390791|NCT03269136|516978564|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
143390792|NCT03269136|516978565|FG009|Part 1: Dose Escalation|Lost to Follow-up|1|||
143390793|NCT03269136|516978566|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
143390794|NCT03269136|516978567|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
143390795|NCT03269136|516978568|FG012|Part 1: Dose Escalation|Lost to Follow-up|0|||
143390796|NCT03269136|516978569|FG013|Part 1: Dose Escalation|Lost to Follow-up|0|||
143390797|NCT03269136|516978570|FG014|Part 1: Dose Escalation|Lost to Follow-up|0|||
143390798|NCT03269136|516978571|FG015|Part 1: Dose Escalation|Lost to Follow-up|0|||
143390799|NCT03269136|516978572|FG016|Part 1: Dose Escalation|Lost to Follow-up|0|||
143390800|NCT03269136|516978573|FG017|Part 1: Dose Escalation|Lost to Follow-up|0|||
143390801|NCT03269136|516978556|FG000|Part 1: Dose Escalation|Death|0|||
143390802|NCT03269136|516978557|FG001|Part 1: Dose Escalation|Death|0|||
143390803|NCT03269136|516978558|FG002|Part 1: Dose Escalation|Death|0|||
143390804|NCT03269136|516978559|FG003|Part 1: Dose Escalation|Death|0|||
143390805|NCT03269136|516978560|FG004|Part 1: Dose Escalation|Death|0|||
143390806|NCT03269136|516978561|FG005|Part 1: Dose Escalation|Death|0|||
143390807|NCT03269136|516978562|FG006|Part 1: Dose Escalation|Death|0|||
143390808|NCT03269136|516978563|FG007|Part 1: Dose Escalation|Death|0|||
143338390|NCT01493687|516782936|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
143338391|NCT01493687|516782935|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
143338392|NCT01493687|516782936|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
143338393|NCT01493687|516782935|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
143338394|NCT01493687|516782936|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
143338395|NCT01493687|516782935|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
143338396|NCT01493687|516782936|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
143338397|NCT01493687|516782935|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
143338398|NCT01493687|516782936|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
143338399|NCT01493687|516782935|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
143338400|NCT01493687|516782936|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
143338401|NCT01493687|516782935|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
143338402|NCT01493687|516782936|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
143338403|NCT01493687|516782935|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
143390809|NCT03269136|516978564|FG008|Part 1: Dose Escalation|Death|0|||
143338404|NCT01493687|516782936|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
143338405|NCT01493687|516782935|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
143390810|NCT03269136|516978565|FG009|Part 1: Dose Escalation|Death|1|||
143338406|NCT01493687|516782936|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
143338407|NCT01493687|516782935|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
143338408|NCT01493687|516782936|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
143338409|NCT04791761|516782941|FG000|Overall Study|Lost to Follow-up|8|||
143338410|NCT04791761|516782942|FG001|Overall Study|Lost to Follow-up|6|||
143338411|NCT04791761|516782943|FG002|Overall Study|Lost to Follow-up|10|||
143338412|NCT04791761|516782941|FG000|Overall Study|Withdrawal by Subject|0|||
143338413|NCT04791761|516782942|FG001|Overall Study|Withdrawal by Subject|1|||
143338414|NCT04791761|516782943|FG002|Overall Study|Withdrawal by Subject|1|||
143338415|NCT04791761|516782941|FG000|Overall Study|Protocol Violation|0|||
143338416|NCT04791761|516782942|FG001|Overall Study|Protocol Violation|1|||
143390811|NCT03269136|516978566|FG010|Part 1: Dose Escalation|Death|0|||
143390812|NCT03269136|516978567|FG011|Part 1: Dose Escalation|Death|1|||
143390813|NCT03269136|516978568|FG012|Part 1: Dose Escalation|Death|0|||
143390814|NCT03269136|516978569|FG013|Part 1: Dose Escalation|Death|1|||
143390815|NCT03269136|516978570|FG014|Part 1: Dose Escalation|Death|0|||
143390816|NCT03269136|516978571|FG015|Part 1: Dose Escalation|Death|0|||
143390817|NCT03269136|516978572|FG016|Part 1: Dose Escalation|Death|2|||
143390818|NCT03269136|516978573|FG017|Part 1: Dose Escalation|Death|0|||
143390819|NCT03269136|516978556|FG000|Part 1: Dose Escalation|Disease Relapse|0|||
143390820|NCT03269136|516978557|FG001|Part 1: Dose Escalation|Disease Relapse|0|||
143390821|NCT03269136|516978558|FG002|Part 1: Dose Escalation|Disease Relapse|0|||
143390822|NCT03269136|516978559|FG003|Part 1: Dose Escalation|Disease Relapse|0|||
143390823|NCT03269136|516978560|FG004|Part 1: Dose Escalation|Disease Relapse|0|||
143390824|NCT03269136|516978561|FG005|Part 1: Dose Escalation|Disease Relapse|0|||
143390825|NCT03269136|516978562|FG006|Part 1: Dose Escalation|Disease Relapse|0|||
143390826|NCT03269136|516978563|FG007|Part 1: Dose Escalation|Disease Relapse|0|||
143390827|NCT03269136|516978564|FG008|Part 1: Dose Escalation|Disease Relapse|0|||
143390828|NCT03269136|516978565|FG009|Part 1: Dose Escalation|Disease Relapse|1|||
143390829|NCT03269136|516978566|FG010|Part 1: Dose Escalation|Disease Relapse|0|||
143390830|NCT03269136|516978567|FG011|Part 1: Dose Escalation|Disease Relapse|0|||
143390831|NCT03269136|516978568|FG012|Part 1: Dose Escalation|Disease Relapse|0|||
143390832|NCT03269136|516978569|FG013|Part 1: Dose Escalation|Disease Relapse|0|||
143390833|NCT03269136|516978570|FG014|Part 1: Dose Escalation|Disease Relapse|0|||
143390834|NCT03269136|516978571|FG015|Part 1: Dose Escalation|Disease Relapse|0|||
143390835|NCT03269136|516978572|FG016|Part 1: Dose Escalation|Disease Relapse|0|||
143390836|NCT03269136|516978573|FG017|Part 1: Dose Escalation|Disease Relapse|0|||
143390837|NCT03269136|516978556|FG000|Part 1: Dose Escalation|Adverse Event|0|||
143390838|NCT03269136|516978557|FG001|Part 1: Dose Escalation|Adverse Event|0|||
143390839|NCT03269136|516978558|FG002|Part 1: Dose Escalation|Adverse Event|0|||
143390840|NCT03269136|516978559|FG003|Part 1: Dose Escalation|Adverse Event|0|||
143390841|NCT03269136|516978560|FG004|Part 1: Dose Escalation|Adverse Event|0|||
143390842|NCT03269136|516978561|FG005|Part 1: Dose Escalation|Adverse Event|0|||
143390843|NCT03269136|516978562|FG006|Part 1: Dose Escalation|Adverse Event|2|||
143390844|NCT03269136|516978563|FG007|Part 1: Dose Escalation|Adverse Event|0|||
143390845|NCT03269136|516978564|FG008|Part 1: Dose Escalation|Adverse Event|0|||
143390846|NCT03269136|516978565|FG009|Part 1: Dose Escalation|Adverse Event|0|||
143390847|NCT03269136|516978566|FG010|Part 1: Dose Escalation|Adverse Event|1|||
143390848|NCT03269136|516978567|FG011|Part 1: Dose Escalation|Adverse Event|2|||
143338417|NCT04791761|516782943|FG002|Overall Study|Protocol Violation|1|||
143338418|NCT01197508|516782945|FG000|Overall Study|Withdrawal by Subject|8|||
143338419|NCT01197508|516782946|FG001|Overall Study|Withdrawal by Subject|7|||
143390849|NCT03269136|516978568|FG012|Part 1: Dose Escalation|Adverse Event|0|||
143390850|NCT03269136|516978569|FG013|Part 1: Dose Escalation|Adverse Event|1|||
143390851|NCT03269136|516978570|FG014|Part 1: Dose Escalation|Adverse Event|0|||
143390852|NCT03269136|516978571|FG015|Part 1: Dose Escalation|Adverse Event|0|||
143390853|NCT03269136|516978572|FG016|Part 1: Dose Escalation|Adverse Event|1|||
143390854|NCT03269136|516978573|FG017|Part 1: Dose Escalation|Adverse Event|0|||
143390855|NCT03269136|516978556|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
143390856|NCT03269136|516978557|FG001|Part 1: Dose Escalation|Progressive Disease|3|||
143390857|NCT03269136|516978558|FG002|Part 1: Dose Escalation|Progressive Disease|2|||
143390858|NCT03269136|516978559|FG003|Part 1: Dose Escalation|Progressive Disease|3|||
143390859|NCT03269136|516978560|FG004|Part 1: Dose Escalation|Progressive Disease|2|||
143390860|NCT03269136|516978561|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
143390861|NCT03269136|516978562|FG006|Part 1: Dose Escalation|Progressive Disease|3|||
143390862|NCT03269136|516978563|FG007|Part 1: Dose Escalation|Progressive Disease|5|||
143390863|NCT03269136|516978564|FG008|Part 1: Dose Escalation|Progressive Disease|3|||
143390864|NCT03269136|516978565|FG009|Part 1: Dose Escalation|Progressive Disease|1|||
143390865|NCT03269136|516978566|FG010|Part 1: Dose Escalation|Progressive Disease|2|||
143390866|NCT03269136|516978567|FG011|Part 1: Dose Escalation|Progressive Disease|2|||
143390867|NCT03269136|516978568|FG012|Part 1: Dose Escalation|Progressive Disease|3|||
143390868|NCT03269136|516978569|FG013|Part 1: Dose Escalation|Progressive Disease|3|||
143390869|NCT03269136|516978570|FG014|Part 1: Dose Escalation|Progressive Disease|8|||
143390870|NCT03269136|516978571|FG015|Part 1: Dose Escalation|Progressive Disease|3|||
143390871|NCT03269136|516978572|FG016|Part 1: Dose Escalation|Progressive Disease|4|||
143390872|NCT03269136|516978573|FG017|Part 1: Dose Escalation|Progressive Disease|0|||
143390873|NCT03269136|516978556|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
143390874|NCT03269136|516978557|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
143390875|NCT03269136|516978558|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
143390876|NCT03269136|516978559|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
143390877|NCT03269136|516978560|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
143390878|NCT03269136|516978561|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
143390879|NCT03269136|516978562|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
143390880|NCT03269136|516978563|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
143390881|NCT03269136|516978564|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
143390882|NCT03269136|516978565|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
143390883|NCT03269136|516978566|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
143390884|NCT03269136|516978567|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
143390885|NCT03269136|516978568|FG012|Part 1: Dose Escalation|Withdrawal by Subject|1|||
143390886|NCT03269136|516978569|FG013|Part 1: Dose Escalation|Withdrawal by Subject|2|||
143390887|NCT03269136|516978570|FG014|Part 1: Dose Escalation|Withdrawal by Subject|2|||
143390888|NCT03269136|516978571|FG015|Part 1: Dose Escalation|Withdrawal by Subject|0|||
143390889|NCT03269136|516978572|FG016|Part 1: Dose Escalation|Withdrawal by Subject|1|||
143390890|NCT03269136|516978573|FG017|Part 1: Dose Escalation|Withdrawal by Subject|0|||
143390891|NCT03269136|516978556|FG000|Part 2A: Dose Expansion|Other|0|||
143390892|NCT03269136|516978557|FG001|Part 2A: Dose Expansion|Other|0|||
143390893|NCT03269136|516978558|FG002|Part 2A: Dose Expansion|Other|0|||
143390894|NCT03269136|516978559|FG003|Part 2A: Dose Expansion|Other|0|||
143390895|NCT03269136|516978560|FG004|Part 2A: Dose Expansion|Other|0|||
143390896|NCT03269136|516978561|FG005|Part 2A: Dose Expansion|Other|0|||
143390897|NCT03269136|516978562|FG006|Part 2A: Dose Expansion|Other|0|||
143390898|NCT03269136|516978563|FG007|Part 2A: Dose Expansion|Other|0|||
143390899|NCT03269136|516978564|FG008|Part 2A: Dose Expansion|Other|0|||
143390900|NCT03269136|516978565|FG009|Part 2A: Dose Expansion|Other|0|||
143390901|NCT03269136|516978566|FG010|Part 2A: Dose Expansion|Other|0|||
143390902|NCT03269136|516978567|FG011|Part 2A: Dose Expansion|Other|0|||
143390903|NCT03269136|516978568|FG012|Part 2A: Dose Expansion|Other|0|||
143390904|NCT03269136|516978569|FG013|Part 2A: Dose Expansion|Other|0|||
143390905|NCT03269136|516978570|FG014|Part 2A: Dose Expansion|Other|0|||
143390906|NCT03269136|516978571|FG015|Part 2A: Dose Expansion|Other|0|||
143390907|NCT03269136|516978572|FG016|Part 2A: Dose Expansion|Other|0|||
143390908|NCT03269136|516978573|FG017|Part 2A: Dose Expansion|Other|1|||
143390909|NCT03269136|516978556|FG000|Part 2A: Dose Expansion|Refused Further Treatment|0|||
143390910|NCT03269136|516978557|FG001|Part 2A: Dose Expansion|Refused Further Treatment|0|||
143390911|NCT03269136|516978558|FG002|Part 2A: Dose Expansion|Refused Further Treatment|0|||
143390912|NCT03269136|516978559|FG003|Part 2A: Dose Expansion|Refused Further Treatment|0|||
143390913|NCT03269136|516978560|FG004|Part 2A: Dose Expansion|Refused Further Treatment|0|||
143390914|NCT03269136|516978561|FG005|Part 2A: Dose Expansion|Refused Further Treatment|0|||
143390915|NCT03269136|516978562|FG006|Part 2A: Dose Expansion|Refused Further Treatment|0|||
143390916|NCT03269136|516978563|FG007|Part 2A: Dose Expansion|Refused Further Treatment|0|||
143390917|NCT03269136|516978564|FG008|Part 2A: Dose Expansion|Refused Further Treatment|0|||
143390918|NCT03269136|516978565|FG009|Part 2A: Dose Expansion|Refused Further Treatment|0|||
143390919|NCT03269136|516978566|FG010|Part 2A: Dose Expansion|Refused Further Treatment|0|||
143390920|NCT03269136|516978567|FG011|Part 2A: Dose Expansion|Refused Further Treatment|0|||
143390921|NCT03269136|516978568|FG012|Part 2A: Dose Expansion|Refused Further Treatment|0|||
143390922|NCT03269136|516978569|FG013|Part 2A: Dose Expansion|Refused Further Treatment|0|||
143390923|NCT03269136|516978570|FG014|Part 2A: Dose Expansion|Refused Further Treatment|0|||
143390924|NCT03269136|516978571|FG015|Part 2A: Dose Expansion|Refused Further Treatment|0|||
143390925|NCT03269136|516978572|FG016|Part 2A: Dose Expansion|Refused Further Treatment|0|||
143390926|NCT03269136|516978573|FG017|Part 2A: Dose Expansion|Refused Further Treatment|2|||
143454304|NCT00738894|517208189|FG001|Overall Study|Physician Decision|5|||
143338420|NCT01197508|516782947|FG002|Overall Study|Withdrawal by Subject|15|||
143338421|NCT01197508|516782948|FG003|Overall Study|Withdrawal by Subject|4|||
143338422|NCT01197508|516782945|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
143338423|NCT01197508|516782946|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
143338424|NCT01197508|516782947|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
143338425|NCT01197508|516782948|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
143338426|NCT01197508|516782945|FG000|Overall Study|Adverse Event|10|||
143338427|NCT01197508|516782946|FG001|Overall Study|Adverse Event|13|||
143338428|NCT01197508|516782947|FG002|Overall Study|Adverse Event|23|||
143338429|NCT01197508|516782948|FG003|Overall Study|Adverse Event|3|||
143338430|NCT01197508|516782945|FG000|Overall Study|Severe non-compliance to protocol|0|||
143338431|NCT01197508|516782946|FG001|Overall Study|Severe non-compliance to protocol|3|||
143338432|NCT01197508|516782947|FG002|Overall Study|Severe non-compliance to protocol|1|||
143338433|NCT01197508|516782948|FG003|Overall Study|Severe non-compliance to protocol|3|||
143338434|NCT01197508|516782945|FG000|Overall Study|Condition under investigation worsened|1|||
143338435|NCT01197508|516782946|FG001|Overall Study|Condition under investigation worsened|1|||
143338436|NCT01197508|516782947|FG002|Overall Study|Condition under investigation worsened|1|||
143338437|NCT01197508|516782948|FG003|Overall Study|Condition under investigation worsened|1|||
143338438|NCT01197508|516782945|FG000|Overall Study|Lack of Efficacy|1|||
143338439|NCT01197508|516782946|FG001|Overall Study|Lack of Efficacy|2|||
143338440|NCT01197508|516782947|FG002|Overall Study|Lack of Efficacy|2|||
143338441|NCT01197508|516782948|FG003|Overall Study|Lack of Efficacy|1|||
143338442|NCT01197508|516782945|FG000|Overall Study|Study-specific withdrawal criteria|0|||
143338443|NCT01197508|516782946|FG001|Overall Study|Study-specific withdrawal criteria|0|||
143338444|NCT01197508|516782947|FG002|Overall Study|Study-specific withdrawal criteria|1|||
143338445|NCT01197508|516782948|FG003|Overall Study|Study-specific withdrawal criteria|2|||
143338446|NCT01197508|516782945|FG000|Overall Study|Lost to Follow-up|1|||
143338447|NCT01197508|516782946|FG001|Overall Study|Lost to Follow-up|1|||
143338448|NCT01197508|516782947|FG002|Overall Study|Lost to Follow-up|2|||
143338449|NCT01197508|516782948|FG003|Overall Study|Lost to Follow-up|0|||
143338450|NCT01197508|516782945|FG000|Overall Study|Other|2|||
143338451|NCT01197508|516782946|FG001|Overall Study|Other|3|||
143338452|NCT01197508|516782947|FG002|Overall Study|Other|2|||
143338453|NCT01197508|516782948|FG003|Overall Study|Other|2|||
143338454|NCT01662063|516782949|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
143338455|NCT01662063|516782950|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
143338456|NCT01662063|516782951|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
143338457|NCT01662063|516782949|FG000|Overall Study|Lack of Efficacy|1|||
143338458|NCT01662063|516782950|FG001|Overall Study|Lack of Efficacy|6|||
143338459|NCT01662063|516782951|FG002|Overall Study|Lack of Efficacy|0|||
143338460|NCT01662063|516782949|FG000|Overall Study|Lost to Follow-up|0|||
143338461|NCT01662063|516782950|FG001|Overall Study|Lost to Follow-up|4|||
143338462|NCT01662063|516782951|FG002|Overall Study|Lost to Follow-up|0|||
143338463|NCT01662063|516782949|FG000|Overall Study|Protocol Violation|1|||
143338464|NCT01662063|516782950|FG001|Overall Study|Protocol Violation|0|||
143338465|NCT01662063|516782951|FG002|Overall Study|Protocol Violation|0|||
143338466|NCT01662063|516782949|FG000|Overall Study|Withdrawal by Subject|2|||
143338467|NCT01662063|516782950|FG001|Overall Study|Withdrawal by Subject|4|||
143338468|NCT01662063|516782951|FG002|Overall Study|Withdrawal by Subject|1|||
143338469|NCT01662063|516782949|FG000|Overall Study|Physician Decision|0|||
143338470|NCT01662063|516782950|FG001|Overall Study|Physician Decision|2|||
143338471|NCT01662063|516782951|FG002|Overall Study|Physician Decision|0|||
143338472|NCT01662063|516782949|FG000|Overall Study|Other|0|||
143338473|NCT01662063|516782950|FG001|Overall Study|Other|1|||
143338474|NCT01662063|516782951|FG002|Overall Study|Other|0|||
143338475|NCT01949870|516782952|FG000|Overall Study|Lack of Efficacy|2|||
143338476|NCT01949870|516782952|FG000|Overall Study|Adverse Event|1|||
143338477|NCT01949870|516782952|FG000|Overall Study|Study termination|1|||
143338478|NCT01949870|516782952|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
143338479|NCT00293267|516782953|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
143338480|NCT00293267|516782954|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
143338481|NCT00293267|516782953|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
143338482|NCT00293267|516782954|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
143338483|NCT00293267|516782953|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
143338484|NCT00293267|516782954|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
143338485|NCT00293267|516782953|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
143338486|NCT00293267|516782954|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
143338487|NCT00293267|516782953|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
143338488|NCT00293267|516782954|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
143338489|NCT00293267|516782953|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
143338490|NCT00293267|516782954|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
143338491|NCT00293267|516782953|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
143338492|NCT00293267|516782954|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
143390927|NCT03269136|516978556|FG000|Part 2A: Dose Expansion|Disease Relapse|0|||
143390928|NCT03269136|516978557|FG001|Part 2A: Dose Expansion|Disease Relapse|0|||
143390929|NCT03269136|516978558|FG002|Part 2A: Dose Expansion|Disease Relapse|0|||
143390930|NCT03269136|516978559|FG003|Part 2A: Dose Expansion|Disease Relapse|0|||
143390931|NCT03269136|516978560|FG004|Part 2A: Dose Expansion|Disease Relapse|0|||
143390932|NCT03269136|516978561|FG005|Part 2A: Dose Expansion|Disease Relapse|0|||
143390933|NCT03269136|516978562|FG006|Part 2A: Dose Expansion|Disease Relapse|0|||
143390934|NCT03269136|516978563|FG007|Part 2A: Dose Expansion|Disease Relapse|0|||
143390935|NCT03269136|516978564|FG008|Part 2A: Dose Expansion|Disease Relapse|0|||
143390936|NCT03269136|516978565|FG009|Part 2A: Dose Expansion|Disease Relapse|0|||
143390937|NCT03269136|516978566|FG010|Part 2A: Dose Expansion|Disease Relapse|0|||
143390938|NCT03269136|516978567|FG011|Part 2A: Dose Expansion|Disease Relapse|0|||
143390939|NCT03269136|516978568|FG012|Part 2A: Dose Expansion|Disease Relapse|0|||
143390940|NCT03269136|516978569|FG013|Part 2A: Dose Expansion|Disease Relapse|0|||
143390941|NCT03269136|516978570|FG014|Part 2A: Dose Expansion|Disease Relapse|0|||
143390942|NCT03269136|516978571|FG015|Part 2A: Dose Expansion|Disease Relapse|0|||
143390943|NCT03269136|516978572|FG016|Part 2A: Dose Expansion|Disease Relapse|0|||
143390944|NCT03269136|516978573|FG017|Part 2A: Dose Expansion|Disease Relapse|1|||
143390945|NCT03269136|516978556|FG000|Part 2A: Dose Expansion|Progressive Disease|0|||
143390946|NCT03269136|516978557|FG001|Part 2A: Dose Expansion|Progressive Disease|0|||
143390947|NCT03269136|516978558|FG002|Part 2A: Dose Expansion|Progressive Disease|0|||
143390948|NCT03269136|516978559|FG003|Part 2A: Dose Expansion|Progressive Disease|0|||
143390949|NCT03269136|516978560|FG004|Part 2A: Dose Expansion|Progressive Disease|0|||
143390950|NCT03269136|516978561|FG005|Part 2A: Dose Expansion|Progressive Disease|0|||
143390951|NCT03269136|516978562|FG006|Part 2A: Dose Expansion|Progressive Disease|0|||
143390952|NCT03269136|516978563|FG007|Part 2A: Dose Expansion|Progressive Disease|0|||
143390953|NCT03269136|516978564|FG008|Part 2A: Dose Expansion|Progressive Disease|0|||
143390954|NCT03269136|516978565|FG009|Part 2A: Dose Expansion|Progressive Disease|0|||
143390955|NCT03269136|516978566|FG010|Part 2A: Dose Expansion|Progressive Disease|0|||
143390956|NCT03269136|516978567|FG011|Part 2A: Dose Expansion|Progressive Disease|0|||
143390957|NCT03269136|516978568|FG012|Part 2A: Dose Expansion|Progressive Disease|0|||
143390958|NCT03269136|516978569|FG013|Part 2A: Dose Expansion|Progressive Disease|0|||
143390959|NCT03269136|516978570|FG014|Part 2A: Dose Expansion|Progressive Disease|0|||
143390960|NCT03269136|516978571|FG015|Part 2A: Dose Expansion|Progressive Disease|0|||
143390961|NCT03269136|516978572|FG016|Part 2A: Dose Expansion|Progressive Disease|0|||
143390962|NCT03269136|516978573|FG017|Part 2A: Dose Expansion|Progressive Disease|9|||
143390963|NCT03269136|516978556|FG000|Part 2A: Dose Expansion|Adverse Event|0|||
143390964|NCT03269136|516978557|FG001|Part 2A: Dose Expansion|Adverse Event|0|||
143390965|NCT03269136|516978558|FG002|Part 2A: Dose Expansion|Adverse Event|0|||
143390966|NCT03269136|516978559|FG003|Part 2A: Dose Expansion|Adverse Event|0|||
143390967|NCT03269136|516978560|FG004|Part 2A: Dose Expansion|Adverse Event|0|||
143390968|NCT03269136|516978561|FG005|Part 2A: Dose Expansion|Adverse Event|0|||
143390969|NCT03269136|516978562|FG006|Part 2A: Dose Expansion|Adverse Event|0|||
143390970|NCT03269136|516978563|FG007|Part 2A: Dose Expansion|Adverse Event|0|||
143390971|NCT03269136|516978564|FG008|Part 2A: Dose Expansion|Adverse Event|0|||
143390972|NCT03269136|516978565|FG009|Part 2A: Dose Expansion|Adverse Event|0|||
143390973|NCT03269136|516978566|FG010|Part 2A: Dose Expansion|Adverse Event|0|||
143390974|NCT03269136|516978567|FG011|Part 2A: Dose Expansion|Adverse Event|0|||
143390975|NCT03269136|516978568|FG012|Part 2A: Dose Expansion|Adverse Event|0|||
143390976|NCT03269136|516978569|FG013|Part 2A: Dose Expansion|Adverse Event|0|||
143390977|NCT03269136|516978570|FG014|Part 2A: Dose Expansion|Adverse Event|0|||
143390978|NCT03269136|516978571|FG015|Part 2A: Dose Expansion|Adverse Event|0|||
143390979|NCT03269136|516978572|FG016|Part 2A: Dose Expansion|Adverse Event|0|||
143390980|NCT03269136|516978573|FG017|Part 2A: Dose Expansion|Adverse Event|2|||
143390981|NCT04717492|516978574|FG000|Overall Study|Withdrawal by Subject|2|||
143390982|NCT04717492|516978575|FG001|Overall Study|Withdrawal by Subject|13|||
143390983|NCT04717492|516978574|FG000|Overall Study|Lost to Follow-up|2|||
143390984|NCT04717492|516978575|FG001|Overall Study|Lost to Follow-up|9|||
143390985|NCT02924272|516978579|FG000|Overall Study|Site Terminated by Sponsor|4|||
143390986|NCT02924272|516978580|FG001|Overall Study|Site Terminated by Sponsor|1|||
143390987|NCT02924272|516978579|FG000|Overall Study|Withdrawal by Subject|2|||
143390988|NCT02924272|516978580|FG001|Overall Study|Withdrawal by Subject|0|||
143390989|NCT02924272|516978579|FG000|Overall Study|Adverse Event|3|||
143390990|NCT02924272|516978580|FG001|Overall Study|Adverse Event|0|||
143390991|NCT02924272|516978579|FG000|Overall Study|Progressive Disease|11|||
143390992|NCT02924272|516978580|FG001|Overall Study|Progressive Disease|8|||
143390993|NCT02924272|516978579|FG000|Overall Study|Clinical Deterioration|1|||
143390994|NCT02924272|516978580|FG001|Overall Study|Clinical Deterioration|0|||
143390995|NCT02924272|516978579|FG000|Overall Study|Death|1|||
143390996|NCT02924272|516978580|FG001|Overall Study|Death|0|||
143390997|NCT02924272|516978579|FG000|Overall Study|Reason Not Specified|1|||
143390998|NCT02924272|516978580|FG001|Overall Study|Reason Not Specified|0|||
143390999|NCT05071807|516978585|FG000|Overall Study|Withdrawal by Subject|4|||
143391000|NCT05071807|516978586|FG001|Overall Study|Withdrawal by Subject|0|||
143391001|NCT05071807|516978585|FG000|Overall Study|Unrelated medical issues|3|||
143391002|NCT05071807|516978586|FG001|Overall Study|Unrelated medical issues|0|||
143391003|NCT05071807|516978585|FG000|Overall Study|Relocated|0|||
143391004|NCT05071807|516978586|FG001|Overall Study|Relocated|1|||
143391005|NCT04552223|516978593|FG000|Overall Study|Withdrawal by Subject|1|||
143391006|NCT04856163|516978594|FG000|Overall Study|Lost to Follow-up|97|||
143391007|NCT04856163|516978595|FG001|Overall Study|Lost to Follow-up|100|||
143391008|NCT05116787|516978600|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
143391009|NCT05116787|516978601|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
143391010|NCT05116787|516978600|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
143391011|NCT05116787|516978601|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
143391012|NCT05116787|516978600|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
143391013|NCT05116787|516978601|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
143391014|NCT05116787|516978600|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
143391015|NCT05116787|516978601|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
143391016|NCT06393088|516978603|FG000|Overall Study|Withdrawal by Subject|0|||
143391017|NCT06393088|516978604|FG001|Overall Study|Withdrawal by Subject|2|||
143391018|NCT02515773|516978605|FG000|Overall Study|Withdrawal by Subject|12|||
143391019|NCT02515773|516978606|FG001|Overall Study|Withdrawal by Subject|2|||
143391020|NCT02515773|516978605|FG000|Overall Study|Lost to Follow-up|119|||
143391021|NCT02515773|516978606|FG001|Overall Study|Lost to Follow-up|126|||
143391022|NCT02515773|516978605|FG000|Overall Study|Discharged from Clinic Services|53|||
143391023|NCT02515773|516978606|FG001|Overall Study|Discharged from Clinic Services|84|||
143391024|NCT02515773|516978605|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
143391025|NCT02515773|516978606|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
143391026|NCT02515773|516978605|FG000|Overall Study|Follow-up at non-study site|8|||
143391027|NCT02515773|516978606|FG001|Overall Study|Follow-up at non-study site|16|||
143391028|NCT02515773|516978605|FG000|Overall Study|Moved from area|9|||
143391029|NCT02515773|516978606|FG001|Overall Study|Moved from area|14|||
143391030|NCT05551637|516978607|FG000|Overall Study|Lack of Efficacy|0|||
143391031|NCT05551637|516978608|FG001|Overall Study|Lack of Efficacy|6|||
143391032|NCT05551637|516978607|FG000|Overall Study|Lost to Follow-up|1|||
143391033|NCT05551637|516978608|FG001|Overall Study|Lost to Follow-up|1|||
143391034|NCT03829410|516978609|FG000|Overall Study|Adverse Event|1|||
143391035|NCT03829410|516978610|FG001|Overall Study|Adverse Event|0|||
143391036|NCT03829410|516978611|FG002|Overall Study|Adverse Event|1|||
143391037|NCT03829410|516978612|FG003|Overall Study|Adverse Event|4|||
143391038|NCT03829410|516978609|FG000|Overall Study|Physician Decision|0|||
143391039|NCT03829410|516978610|FG001|Overall Study|Physician Decision|0|||
143391040|NCT03829410|516978611|FG002|Overall Study|Physician Decision|0|||
143391041|NCT03829410|516978612|FG003|Overall Study|Physician Decision|2|||
143391042|NCT03829410|516978609|FG000|Overall Study|Disease Progressing|3|||
143391043|NCT03829410|516978610|FG001|Overall Study|Disease Progressing|4|||
143391044|NCT03829410|516978611|FG002|Overall Study|Disease Progressing|2|||
143391045|NCT03829410|516978612|FG003|Overall Study|Disease Progressing|31|||
143391046|NCT03829410|516978609|FG000|Overall Study|Miscellaneous|2|||
143391047|NCT03829410|516978610|FG001|Overall Study|Miscellaneous|4|||
143391048|NCT03829410|516978611|FG002|Overall Study|Miscellaneous|3|||
143391049|NCT03829410|516978612|FG003|Overall Study|Miscellaneous|10|||
143391050|NCT03719443|516978613|FG000|Overall Study|Lost to Follow-up|0|||
143391051|NCT03719443|516978614|FG001|Overall Study|Lost to Follow-up|0|||
143391052|NCT03719443|516978615|FG002|Overall Study|Lost to Follow-up|1|||
143391053|NCT03719443|516978616|FG003|Overall Study|Lost to Follow-up|0|||
143391054|NCT03719443|516978617|FG004|Overall Study|Lost to Follow-up|1|||
143391055|NCT03719443|516978618|FG005|Overall Study|Lost to Follow-up|0|||
143391056|NCT03719443|516978619|FG006|Overall Study|Lost to Follow-up|1|||
143391057|NCT03719443|516978613|FG000|Overall Study|Withdrawal by Subject|0|||
143391058|NCT03719443|516978614|FG001|Overall Study|Withdrawal by Subject|0|||
143391059|NCT03719443|516978615|FG002|Overall Study|Withdrawal by Subject|1|||
143391060|NCT03719443|516978616|FG003|Overall Study|Withdrawal by Subject|0|||
143391061|NCT03719443|516978617|FG004|Overall Study|Withdrawal by Subject|0|||
143391062|NCT03719443|516978618|FG005|Overall Study|Withdrawal by Subject|0|||
143391063|NCT03719443|516978619|FG006|Overall Study|Withdrawal by Subject|0|||
143391064|NCT04782973|516978620|FG000|Overall Study|Withdrawal by Subject|5|||
143391065|NCT04782973|516978620|FG000|Overall Study|Protocol Violation|6|||
143391066|NCT04782973|516978620|FG000|Overall Study|No Longer Eligible Post-Consent|8|||
143391067|NCT04924660|516978621|FG000|United States|Death|29|||
143391068|NCT04924660|516978622|FG001|United States|Death|32|||
143391069|NCT04924660|516978623|FG002|United States|Death|34|||
143391070|NCT04924660|516978624|FG003|United States|Death|25|||
143391071|NCT04924660|516978625|FG004|United States|Death|26|||
143391072|NCT04924660|516978626|FG005|United States|Death|23|||
143391073|NCT04924660|516978621|FG000|United States|Lost to Follow-up|15|||
143391074|NCT04924660|516978622|FG001|United States|Lost to Follow-up|10|||
143391075|NCT04924660|516978623|FG002|United States|Lost to Follow-up|13|||
143391076|NCT04924660|516978624|FG003|United States|Lost to Follow-up|5|||
143391077|NCT04924660|516978625|FG004|United States|Lost to Follow-up|19|||
143391078|NCT04924660|516978626|FG005|United States|Lost to Follow-up|20|||
143391079|NCT04924660|516978621|FG000|United States|Withdrawal by Subject|8|||
143391080|NCT04924660|516978622|FG001|United States|Withdrawal by Subject|3|||
143391081|NCT04924660|516978623|FG002|United States|Withdrawal by Subject|3|||
143391082|NCT04924660|516978624|FG003|United States|Withdrawal by Subject|3|||
143391083|NCT04924660|516978625|FG004|United States|Withdrawal by Subject|8|||
143391084|NCT04924660|516978626|FG005|United States|Withdrawal by Subject|4|||
143391085|NCT04924660|516978621|FG000|Spain|Death|0|||
143391086|NCT04924660|516978622|FG001|Spain|Death|0|||
143391087|NCT04924660|516978623|FG002|Spain|Death|0|||
143391088|NCT04924660|516978624|FG003|Spain|Death|0|||
143391089|NCT04924660|516978625|FG004|Spain|Death|0|||
143391090|NCT04924660|516978626|FG005|Spain|Death|2|||
143391091|NCT04924660|516978621|FG000|Spain|Lost to Follow-up|0|||
143391092|NCT04924660|516978622|FG001|Spain|Lost to Follow-up|0|||
143391093|NCT04924660|516978623|FG002|Spain|Lost to Follow-up|0|||
143391094|NCT04924660|516978624|FG003|Spain|Lost to Follow-up|0|||
143391095|NCT04924660|516978625|FG004|Spain|Lost to Follow-up|1|||
143391096|NCT04924660|516978626|FG005|Spain|Lost to Follow-up|0|||
143391097|NCT04924660|516978621|FG000|Brazil|Death|0|||
143391098|NCT04924660|516978622|FG001|Brazil|Death|0|||
143391099|NCT04924660|516978623|FG002|Brazil|Death|0|||
143391100|NCT04924660|516978624|FG003|Brazil|Death|0|||
143391101|NCT04924660|516978625|FG004|Brazil|Death|1|||
143391102|NCT04924660|516978626|FG005|Brazil|Death|0|||
143391103|NCT04924660|516978621|FG000|Italy|Lost to Follow-up|0|||
143391104|NCT04924660|516978622|FG001|Italy|Lost to Follow-up|0|||
143391105|NCT04924660|516978623|FG002|Italy|Lost to Follow-up|0|||
143391106|NCT04924660|516978624|FG003|Italy|Lost to Follow-up|0|||
143391107|NCT04924660|516978625|FG004|Italy|Lost to Follow-up|0|||
143391108|NCT04924660|516978626|FG005|Italy|Lost to Follow-up|1|||
143391109|NCT04924660|516978621|FG000|South Africa|Death|0|||
143391110|NCT04924660|516978622|FG001|South Africa|Death|0|||
143391111|NCT04924660|516978623|FG002|South Africa|Death|0|||
143391112|NCT04924660|516978624|FG003|South Africa|Death|0|||
143391113|NCT04924660|516978625|FG004|South Africa|Death|0|||
143391114|NCT04924660|516978626|FG005|South Africa|Death|1|||
143391115|NCT04924660|516978621|FG000|South Africa|Lost to Follow-up|0|||
143391116|NCT04924660|516978622|FG001|South Africa|Lost to Follow-up|0|||
143391117|NCT04924660|516978623|FG002|South Africa|Lost to Follow-up|0|||
143391118|NCT04924660|516978624|FG003|South Africa|Lost to Follow-up|0|||
143391119|NCT04924660|516978625|FG004|South Africa|Lost to Follow-up|0|||
143391120|NCT04924660|516978626|FG005|South Africa|Lost to Follow-up|1|||
143391121|NCT02577835|516978628|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
143391122|NCT05794243|516978642|FG000|Overall Study|Withdrawal by Subject|1|||
143391123|NCT05794243|516978643|FG001|Overall Study|Withdrawal by Subject|0|||
143391124|NCT05794243|516978644|FG002|Overall Study|Withdrawal by Subject|1|||
143391125|NCT05794243|516978642|FG000|Overall Study|Physician Decision|0|||
143391126|NCT05794243|516978643|FG001|Overall Study|Physician Decision|3|||
143391127|NCT05794243|516978644|FG002|Overall Study|Physician Decision|1|||
143391128|NCT04209465|516978645|FG000|Overall Study|Adverse Event|0|||
143391129|NCT04209465|516978646|FG001|Overall Study|Adverse Event|0|||
143391130|NCT04209465|516978647|FG002|Overall Study|Adverse Event|0|||
143391131|NCT04209465|516978648|FG003|Overall Study|Adverse Event|0|||
143391132|NCT04209465|516978649|FG004|Overall Study|Adverse Event|0|||
143391133|NCT04209465|516978650|FG005|Overall Study|Adverse Event|1|||
143391134|NCT04209465|516978651|FG006|Overall Study|Adverse Event|0|||
143391135|NCT04209465|516978652|FG007|Overall Study|Adverse Event|0|||
143391136|NCT04209465|516978653|FG008|Overall Study|Adverse Event|1|||
143391137|NCT04209465|516978654|FG009|Overall Study|Adverse Event|0|||
143391138|NCT04209465|516978655|FG010|Overall Study|Adverse Event|2|||
143391139|NCT04209465|516978656|FG011|Overall Study|Adverse Event|1|||
143391140|NCT04209465|516978657|FG012|Overall Study|Adverse Event|1|||
143391141|NCT04209465|516978645|FG000|Overall Study|Death|1|||
143391142|NCT04209465|516978646|FG001|Overall Study|Death|0|||
143391143|NCT04209465|516978647|FG002|Overall Study|Death|0|||
143391144|NCT04209465|516978648|FG003|Overall Study|Death|0|||
143391145|NCT04209465|516978649|FG004|Overall Study|Death|2|||
143391146|NCT04209465|516978650|FG005|Overall Study|Death|7|||
143391147|NCT04209465|516978651|FG006|Overall Study|Death|2|||
143391148|NCT04209465|516978652|FG007|Overall Study|Death|2|||
143338493|NCT00293267|516782953|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
143338494|NCT00293267|516782954|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
143338495|NCT00293267|516782953|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
143338496|NCT00293267|516782954|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
143338497|NCT00293267|516782953|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
143338498|NCT00293267|516782954|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
143338499|NCT00293267|516782953|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
143338500|NCT00293267|516782954|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
143338501|NCT00293267|516782953|FG000|Extension - Double-Blind Week 49-156|Death|3|||
143338502|NCT00293267|516782954|FG001|Extension - Double-Blind Week 49-156|Death|0|||
143338503|NCT00293267|516782953|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
143338504|NCT00293267|516782954|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
143338505|NCT00293267|516782953|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
143338506|NCT00293267|516782954|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
143338507|NCT00293267|516782953|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
143338508|NCT00293267|516782954|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
143338509|NCT00293267|516782953|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
143338510|NCT00293267|516782954|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
143338511|NCT00293267|516782953|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
143338512|NCT00293267|516782954|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
143338513|NCT00293267|516782953|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
143338514|NCT00293267|516782954|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
143338515|NCT00293267|516782953|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
143338516|NCT00293267|516782954|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
143338517|NCT00293267|516782953|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
143338518|NCT00293267|516782954|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
143338519|NCT00293267|516782953|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
143338520|NCT00293267|516782954|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
143338521|NCT00293267|516782953|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
143338522|NCT00293267|516782954|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
143338523|NCT00293267|516782953|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
143338524|NCT00293267|516782954|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
143338525|NCT00293267|516782953|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
143338526|NCT00293267|516782954|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
143338527|NCT00293267|516782953|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
143338528|NCT00293267|516782954|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
143338529|NCT00293267|516782953|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
143338530|NCT00293267|516782954|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
143338531|NCT00293267|516782953|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
143338532|NCT00293267|516782954|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
143338533|NCT00293267|516782953|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
143338534|NCT00293267|516782954|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
143338535|NCT03086330|516782955|FG000|Overall Study|Withdrawal by Subject|3|||
143338536|NCT03086330|516782956|FG001|Overall Study|Withdrawal by Subject|2|||
143338537|NCT03086330|516782955|FG000|Overall Study|Lost to Follow-up|1|||
143338538|NCT03086330|516782956|FG001|Overall Study|Lost to Follow-up|2|||
143338539|NCT02182973|516782959|FG000|Overall Study|Withdrawal by Subject|3|||
143338540|NCT02182973|516782960|FG001|Overall Study|Withdrawal by Subject|0|||
143338541|NCT01235546|516782961|FG000|Overall Study|Staff error, medication not administered|1|||
143338542|NCT01235546|516782962|FG001|Overall Study|Staff error, medication not administered|0|||
143338543|NCT01235546|516782961|FG000|Overall Study|Protocol Violation|1|||
143338544|NCT01235546|516782962|FG001|Overall Study|Protocol Violation|1|||
143338545|NCT01123382|516782963|FG000|Overall Study|Withdrawal by Subject|1|||
143338546|NCT01123382|516782964|FG001|Overall Study|Withdrawal by Subject|4|||
143338547|NCT01123382|516782963|FG000|Overall Study|Lost to Follow-up|1|||
143338548|NCT01123382|516782964|FG001|Overall Study|Lost to Follow-up|2|||
143338549|NCT02740049|516782965|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
143338550|NCT02274857|516782966|FG000|Overall Study|Adverse Event|1|||
143338551|NCT02274857|516782967|FG001|Overall Study|Adverse Event|0|||
143338552|NCT02274857|516782966|FG000|Overall Study|Death|1|||
143338553|NCT02274857|516782967|FG001|Overall Study|Death|2|||
143338554|NCT02274857|516782966|FG000|Overall Study|Lost to Follow-up|3|||
143338555|NCT02274857|516782967|FG001|Overall Study|Lost to Follow-up|0|||
143338556|NCT02274857|516782966|FG000|Overall Study|Physician Decision|2|||
143338557|NCT02274857|516782967|FG001|Overall Study|Physician Decision|0|||
143338558|NCT02274857|516782966|FG000|Overall Study|Trial screen failure|0|||
143338559|NCT02274857|516782967|FG001|Overall Study|Trial screen failure|2|||
143338560|NCT02274857|516782966|FG000|Overall Study|Withdrawal by Subject|11|||
143391149|NCT04209465|516978653|FG008|Overall Study|Death|1|||
143391150|NCT04209465|516978654|FG009|Overall Study|Death|1|||
143391151|NCT04209465|516978655|FG010|Overall Study|Death|1|||
143391152|NCT04209465|516978656|FG011|Overall Study|Death|0|||
143391153|NCT04209465|516978657|FG012|Overall Study|Death|10|||
143391154|NCT04209465|516978645|FG000|Overall Study|Physician Decision|0|||
143391155|NCT04209465|516978646|FG001|Overall Study|Physician Decision|1|||
143391156|NCT04209465|516978647|FG002|Overall Study|Physician Decision|0|||
143391157|NCT04209465|516978648|FG003|Overall Study|Physician Decision|0|||
143391158|NCT04209465|516978649|FG004|Overall Study|Physician Decision|0|||
143391159|NCT04209465|516978650|FG005|Overall Study|Physician Decision|0|||
143391160|NCT04209465|516978651|FG006|Overall Study|Physician Decision|0|||
143391161|NCT04209465|516978652|FG007|Overall Study|Physician Decision|0|||
143391162|NCT04209465|516978653|FG008|Overall Study|Physician Decision|0|||
143391163|NCT04209465|516978654|FG009|Overall Study|Physician Decision|0|||
143391164|NCT04209465|516978655|FG010|Overall Study|Physician Decision|0|||
143391165|NCT04209465|516978656|FG011|Overall Study|Physician Decision|0|||
143391166|NCT04209465|516978657|FG012|Overall Study|Physician Decision|0|||
143391167|NCT04209465|516978645|FG000|Overall Study|Progressive Disease|0|||
143391168|NCT04209465|516978646|FG001|Overall Study|Progressive Disease|0|||
143391169|NCT04209465|516978647|FG002|Overall Study|Progressive Disease|1|||
143391170|NCT04209465|516978648|FG003|Overall Study|Progressive Disease|2|||
143391171|NCT04209465|516978649|FG004|Overall Study|Progressive Disease|8|||
143391172|NCT04209465|516978650|FG005|Overall Study|Progressive Disease|5|||
143391173|NCT04209465|516978651|FG006|Overall Study|Progressive Disease|3|||
143391174|NCT04209465|516978652|FG007|Overall Study|Progressive Disease|4|||
143391175|NCT04209465|516978653|FG008|Overall Study|Progressive Disease|1|||
143391176|NCT04209465|516978654|FG009|Overall Study|Progressive Disease|3|||
143391177|NCT04209465|516978655|FG010|Overall Study|Progressive Disease|2|||
143391178|NCT04209465|516978656|FG011|Overall Study|Progressive Disease|1|||
143391179|NCT04209465|516978657|FG012|Overall Study|Progressive Disease|0|||
143391180|NCT04209465|516978645|FG000|Overall Study|Withdrawal by Subject|0|||
143391181|NCT04209465|516978646|FG001|Overall Study|Withdrawal by Subject|0|||
143391182|NCT04209465|516978647|FG002|Overall Study|Withdrawal by Subject|0|||
143391183|NCT04209465|516978648|FG003|Overall Study|Withdrawal by Subject|0|||
143391184|NCT04209465|516978649|FG004|Overall Study|Withdrawal by Subject|0|||
143391185|NCT04209465|516978650|FG005|Overall Study|Withdrawal by Subject|1|||
143391186|NCT04209465|516978651|FG006|Overall Study|Withdrawal by Subject|2|||
143391187|NCT04209465|516978652|FG007|Overall Study|Withdrawal by Subject|0|||
143391188|NCT04209465|516978653|FG008|Overall Study|Withdrawal by Subject|1|||
143391189|NCT04209465|516978654|FG009|Overall Study|Withdrawal by Subject|0|||
143391190|NCT04209465|516978655|FG010|Overall Study|Withdrawal by Subject|0|||
143391191|NCT04209465|516978656|FG011|Overall Study|Withdrawal by Subject|2|||
143391192|NCT04209465|516978657|FG012|Overall Study|Withdrawal by Subject|2|||
143391193|NCT04209465|516978645|FG000|Overall Study|Lost to Follow-up|0|||
143391194|NCT04209465|516978646|FG001|Overall Study|Lost to Follow-up|0|||
143391195|NCT04209465|516978647|FG002|Overall Study|Lost to Follow-up|0|||
143391196|NCT04209465|516978648|FG003|Overall Study|Lost to Follow-up|0|||
143391197|NCT04209465|516978649|FG004|Overall Study|Lost to Follow-up|0|||
143391198|NCT04209465|516978650|FG005|Overall Study|Lost to Follow-up|1|||
143391199|NCT04209465|516978651|FG006|Overall Study|Lost to Follow-up|0|||
143391200|NCT04209465|516978652|FG007|Overall Study|Lost to Follow-up|0|||
143391201|NCT04209465|516978653|FG008|Overall Study|Lost to Follow-up|1|||
143391202|NCT04209465|516978654|FG009|Overall Study|Lost to Follow-up|0|||
143391203|NCT04209465|516978655|FG010|Overall Study|Lost to Follow-up|0|||
143391204|NCT04209465|516978656|FG011|Overall Study|Lost to Follow-up|1|||
143391205|NCT04209465|516978657|FG012|Overall Study|Lost to Follow-up|0|||
143391206|NCT04209465|516978645|FG000|Overall Study|Started new therapy|0|||
143391207|NCT04209465|516978646|FG001|Overall Study|Started new therapy|0|||
143391208|NCT04209465|516978647|FG002|Overall Study|Started new therapy|0|||
143391209|NCT04209465|516978648|FG003|Overall Study|Started new therapy|0|||
143391210|NCT04209465|516978649|FG004|Overall Study|Started new therapy|0|||
143391211|NCT04209465|516978650|FG005|Overall Study|Started new therapy|1|||
143391212|NCT04209465|516978651|FG006|Overall Study|Started new therapy|0|||
143391213|NCT04209465|516978652|FG007|Overall Study|Started new therapy|0|||
143391214|NCT04209465|516978653|FG008|Overall Study|Started new therapy|0|||
143391215|NCT04209465|516978654|FG009|Overall Study|Started new therapy|0|||
143391216|NCT04209465|516978655|FG010|Overall Study|Started new therapy|0|||
143391217|NCT04209465|516978656|FG011|Overall Study|Started new therapy|0|||
143391218|NCT04209465|516978657|FG012|Overall Study|Started new therapy|0|||
143391219|NCT04209465|516978645|FG000|Overall Study|Study terminated early by sponsor|0|||
143391220|NCT04209465|516978646|FG001|Overall Study|Study terminated early by sponsor|0|||
143391221|NCT04209465|516978647|FG002|Overall Study|Study terminated early by sponsor|0|||
143391222|NCT04209465|516978648|FG003|Overall Study|Study terminated early by sponsor|0|||
143391223|NCT04209465|516978649|FG004|Overall Study|Study terminated early by sponsor|0|||
143391224|NCT04209465|516978650|FG005|Overall Study|Study terminated early by sponsor|0|||
143391225|NCT04209465|516978651|FG006|Overall Study|Study terminated early by sponsor|3|||
143391226|NCT04209465|516978652|FG007|Overall Study|Study terminated early by sponsor|0|||
143391227|NCT04209465|516978653|FG008|Overall Study|Study terminated early by sponsor|0|||
143391228|NCT04209465|516978654|FG009|Overall Study|Study terminated early by sponsor|0|||
143338561|NCT02274857|516782967|FG001|Overall Study|Withdrawal by Subject|2|||
143338562|NCT02274857|516782966|FG000|Overall Study|Other|2|||
143338563|NCT02274857|516782967|FG001|Overall Study|Other|0|||
143338564|NCT01445652|516782970|FG000|Overall Study|Not comfortable in lenses|5|||
143338565|NCT01445652|516782971|FG001|Overall Study|Not comfortable in lenses|0|||
143338566|NCT01445652|516782970|FG000|Overall Study|Failed to attend scheduled visit|2|||
143338567|NCT01445652|516782971|FG001|Overall Study|Failed to attend scheduled visit|3|||
143338568|NCT01445652|516782970|FG000|Overall Study|Failed teach session|2|||
143338569|NCT01445652|516782971|FG001|Overall Study|Failed teach session|0|||
143338570|NCT01445652|516782970|FG000|Overall Study|Adverse Event|1|||
143338571|NCT01445652|516782971|FG001|Overall Study|Adverse Event|0|||
143338572|NCT01755702|516782973|FG000|Wash Out Period I|Other Reason|3|||
143338573|NCT01755702|516782973|FG000|Washout Period II|Other Reason|5|||
143338574|NCT03338829|516782977|FG000|Overall Study|Lost to Follow-up|4|||
143338575|NCT03338829|516782978|FG001|Overall Study|Lost to Follow-up|2|||
143338576|NCT03338829|516782979|FG002|Overall Study|Lost to Follow-up|4|||
143338577|NCT03338829|516782977|FG000|Overall Study|Pregnancy loss|1|||
143338578|NCT03338829|516782978|FG001|Overall Study|Pregnancy loss|1|||
143338579|NCT03338829|516782979|FG002|Overall Study|Pregnancy loss|0|||
143338580|NCT03338829|516782977|FG000|Overall Study|Protocol Violation|0|||
143338581|NCT03338829|516782978|FG001|Overall Study|Protocol Violation|1|||
143338582|NCT03338829|516782979|FG002|Overall Study|Protocol Violation|0|||
143338583|NCT02340026|516782980|FG000|Treatment Phase|Withdrawal by Subject|2|||
143338584|NCT02340026|516782981|FG001|Treatment Phase|Withdrawal by Subject|2|||
143338585|NCT02340026|516782980|FG000|Follow-up Phase|Lost to Follow-up|1|||
143338586|NCT02340026|516782981|FG001|Follow-up Phase|Lost to Follow-up|0|||
143338587|NCT03078816|516782989|FG000|Overall Study|Withdrawal by Subject|1|||
143338588|NCT02114151|516782990|FG000|Overall Study|Death|1|||
143338589|NCT02114151|516782990|FG000|Overall Study|Lost to Follow-up|1|||
143338590|NCT02114151|516782990|FG000|Overall Study|Withdrawal by Subject|5|||
143338591|NCT01666808|516782991|FG000|Overall Study|Lost to Follow-up|9|||
143338592|NCT01666808|516782992|FG001|Overall Study|Lost to Follow-up|15|||
143338593|NCT01666808|516782991|FG000|Overall Study|Withdrawal by Subject|3|||
143338594|NCT01666808|516782992|FG001|Overall Study|Withdrawal by Subject|1|||
143338595|NCT01666808|516782991|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
143338596|NCT01666808|516782992|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
143338597|NCT03933826|516782993|FG000|Overall Study|Withdrawal by Subject|8|||
143338598|NCT03933826|516782994|FG001|Overall Study|Withdrawal by Subject|1|||
143338599|NCT03933826|516782993|FG000|Overall Study|Death|19|||
143338600|NCT03933826|516782994|FG001|Overall Study|Death|11|||
143338601|NCT03933826|516782993|FG000|Overall Study|Lost to Follow-up|41|||
143338602|NCT03933826|516782994|FG001|Overall Study|Lost to Follow-up|13|||
143338603|NCT01860703|516782995|FG000|Overall Study|Adverse Event|1|||
143338604|NCT01860703|516782996|FG001|Overall Study|Adverse Event|4|||
143338605|NCT01860703|516782997|FG002|Overall Study|Adverse Event|0|||
143338606|NCT01860703|516782998|FG003|Overall Study|Adverse Event|2|||
143338607|NCT01860703|516782995|FG000|Overall Study|Withdrawal by Subject|0|||
143338608|NCT01860703|516782996|FG001|Overall Study|Withdrawal by Subject|1|||
143338609|NCT01860703|516782997|FG002|Overall Study|Withdrawal by Subject|0|||
143338610|NCT01860703|516782998|FG003|Overall Study|Withdrawal by Subject|0|||
143338611|NCT01860703|516782995|FG000|Overall Study|Personal reason|1|||
143338612|NCT01860703|516782996|FG001|Overall Study|Personal reason|0|||
143338613|NCT01860703|516782997|FG002|Overall Study|Personal reason|1|||
143338614|NCT01860703|516782998|FG003|Overall Study|Personal reason|0|||
143338615|NCT02134587|516783000|FG000|Overall Study|Did not completed all meetings|30|||
143338616|NCT01515748|516783006|FG000|Overall Study|Withdrawal by Subject|32|||
143338617|NCT01515748|516783007|FG001|Overall Study|Withdrawal by Subject|41|||
143338618|NCT01515748|516783006|FG000|Overall Study|Lost to Follow-up|2|||
143338619|NCT01515748|516783007|FG001|Overall Study|Lost to Follow-up|4|||
143338620|NCT01515748|516783006|FG000|Overall Study|Other than specified above|5|||
143338621|NCT01515748|516783007|FG001|Overall Study|Other than specified above|10|||
143338622|NCT02286089|516783011|FG000|Overall Study|Ongoing in Study|1|||
143338623|NCT02286089|516783012|FG001|Overall Study|Ongoing in Study|1|||
143338624|NCT02286089|516783013|FG002|Overall Study|Ongoing in Study|4|||
143338625|NCT02286089|516783014|FG003|Overall Study|Ongoing in Study|10|||
143338626|NCT02286089|516783011|FG000|Overall Study|Withdrawal by Subject|0|||
143338627|NCT02286089|516783012|FG001|Overall Study|Withdrawal by Subject|0|||
143338628|NCT02286089|516783013|FG002|Overall Study|Withdrawal by Subject|2|||
143338629|NCT02286089|516783014|FG003|Overall Study|Withdrawal by Subject|2|||
143338630|NCT05073133|516783015|FG000|Overall Study|Death|2|||
143338631|NCT05002218|516783016|FG000|Overall Study|Lost to Follow-up|5|||
143338632|NCT05002218|516783017|FG001|Overall Study|Lost to Follow-up|6|||
143338633|NCT04120233|516783018|FG000|Overall Study|Adverse Event|0|||
143338634|NCT04120233|516783019|FG001|Overall Study|Adverse Event|0|||
143338635|NCT04120233|516783020|FG002|Overall Study|Adverse Event|0|||
143338636|NCT04120233|516783021|FG003|Overall Study|Adverse Event|0|||
143338637|NCT04120233|516783022|FG004|Overall Study|Adverse Event|1|||
143338638|NCT04120233|516783023|FG005|Overall Study|Adverse Event|0|||
143338639|NCT02553460|516783026|FG000|Overall Study|Death|3|||
143338640|NCT02553460|516783026|FG000|Overall Study|Withdrawal by Subject|1|||
143338641|NCT02553460|516783026|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
143338642|NCT02553460|516783026|FG000|Overall Study|Relapse or Transplant|14|||
143338643|NCT02553460|516783026|FG000|Overall Study|No response to treatment|2|||
143338644|NCT02553460|516783026|FG000|Overall Study|CAR T cells|2|||
143338645|NCT02240108|516784150|FG000|Overall Study|Other than specified|8|||
143338646|NCT02240108|516784151|FG001|Overall Study|Other than specified|6|||
143338647|NCT02240108|516784150|FG000|Overall Study|Adverse Event|1|||
143338648|NCT02240108|516784151|FG001|Overall Study|Adverse Event|9|||
143338649|NCT02240108|516784150|FG000|Overall Study|Pregnancy|1|||
143338650|NCT02240108|516784151|FG001|Overall Study|Pregnancy|0|||
143338651|NCT02240108|516784150|FG000|Overall Study|Withdrawal by Subject|4|||
143338652|NCT02240108|516784151|FG001|Overall Study|Withdrawal by Subject|9|||
143338653|NCT02240108|516784150|FG000|Overall Study|StudyTerminated by Sponsor|0|||
143338654|NCT02240108|516784151|FG001|Overall Study|StudyTerminated by Sponsor|1|||
143338655|NCT03092375|516784152|FG000|Overall Study|Lack of Efficacy|0|||
143338656|NCT03092375|516784153|FG001|Overall Study|Lack of Efficacy|1|||
143338657|NCT03092375|516784154|FG002|Overall Study|Lack of Efficacy|1|||
143338658|NCT03092375|516784155|FG003|Overall Study|Lack of Efficacy|0|||
143338659|NCT00553501|516784156|FG000|Overall Study|Adverse Event|2|||
143338660|NCT00553501|516784156|FG000|Overall Study|Death|1|||
143338661|NCT00553501|516784156|FG000|Overall Study|Progression|1|||
143338662|NCT01464021|516784157|FG000|Overall Study|Withdrawal by Subject|13|||
143338663|NCT01464021|516784157|FG000|Overall Study|Lost to Follow-up|1|||
143338664|NCT01464021|516784157|FG000|Overall Study|Lack of Efficacy|1|||
143338665|NCT01464021|516784157|FG000|Overall Study|various|11|||
143338666|NCT00949715|516784158|FG000|Overall Study|Physician Decision|1|||
143338667|NCT00949715|516784159|FG001|Overall Study|Physician Decision|0|||
143338668|NCT00949715|516784158|FG000|Overall Study|Lost to Follow-up|1|||
143338669|NCT00949715|516784159|FG001|Overall Study|Lost to Follow-up|0|||
143338670|NCT00949715|516784158|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
143338671|NCT00949715|516784159|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
143338672|NCT00861614|516784161|FG000|Overall Study|Disease Progression|182|||
143338673|NCT00861614|516784162|FG001|Overall Study|Disease Progression|263|||
143338674|NCT00861614|516784161|FG000|Overall Study|Study Drug Toxicity|79|||
143338675|NCT00861614|516784162|FG001|Overall Study|Study Drug Toxicity|6|||
143338676|NCT00861614|516784161|FG000|Overall Study|Death|32|||
143338677|NCT00861614|516784162|FG001|Overall Study|Death|19|||
143338678|NCT00861614|516784161|FG000|Overall Study|Adverse Event|27|||
143338679|NCT00861614|516784162|FG001|Overall Study|Adverse Event|23|||
143338680|NCT00861614|516784161|FG000|Overall Study|Withdrawal by Subject|34|||
143338681|NCT00861614|516784162|FG001|Overall Study|Withdrawal by Subject|35|||
143338682|NCT00861614|516784161|FG000|Overall Study|Other|17|||
143338683|NCT00861614|516784162|FG001|Overall Study|Other|22|||
143338684|NCT01255592|516784163|FG000|Overall Study|Adverse Event|5|||
143338685|NCT01255592|516784164|FG001|Overall Study|Adverse Event|0|||
143338686|NCT01255592|516784163|FG000|Overall Study|Withdrawal by Subject|1|||
143338687|NCT01255592|516784164|FG001|Overall Study|Withdrawal by Subject|0|||
143338688|NCT01255592|516784163|FG000|Overall Study|Other|0|||
143338689|NCT01255592|516784164|FG001|Overall Study|Other|1|||
143338690|NCT01352585|516784165|FG000|Overall Study|Adverse Event|2|||
143338691|NCT01352585|516784166|FG001|Overall Study|Adverse Event|1|||
143338692|NCT01352585|516784165|FG000|Overall Study|Lost to Follow-up|1|||
143338693|NCT01352585|516784166|FG001|Overall Study|Lost to Follow-up|0|||
143338694|NCT01352585|516784165|FG000|Overall Study|Other|5|||
143338695|NCT01352585|516784166|FG001|Overall Study|Other|2|||
143338696|NCT02243280|516784169|FG000|Treated|Adverse Event|1|||
143338697|NCT02243280|516784170|FG001|Treated|Adverse Event|0|||
143338698|NCT02243280|516784171|FG002|Treated|Adverse Event|0|||
143338699|NCT02243280|516784172|FG003|Treated|Adverse Event|0|||
143338700|NCT02243280|516784173|FG004|Treated|Adverse Event|0|||
143338701|NCT02243280|516784174|FG005|Treated|Adverse Event|0|||
143338702|NCT02243280|516784175|FG006|Treated|Adverse Event|0|||
143338703|NCT02243280|516784176|FG007|Treated|Adverse Event|0|||
143338704|NCT02243280|516784177|FG008|Treated|Adverse Event|0|||
143338705|NCT02243280|516784178|FG009|Treated|Adverse Event|0|||
143338706|NCT02243280|516784179|FG010|Treated|Adverse Event|1|||
143338707|NCT02243280|516784169|FG000|Treated|Lost to Follow-up|0|||
143338708|NCT02243280|516784170|FG001|Treated|Lost to Follow-up|0|||
143338709|NCT02243280|516784171|FG002|Treated|Lost to Follow-up|0|||
143391229|NCT04209465|516978655|FG010|Overall Study|Study terminated early by sponsor|0|||
143391230|NCT04209465|516978656|FG011|Overall Study|Study terminated early by sponsor|0|||
143391231|NCT04209465|516978657|FG012|Overall Study|Study terminated early by sponsor|3|||
143391232|NCT04209465|516978645|FG000|Overall Study|Other|0|||
143391233|NCT04209465|516978646|FG001|Overall Study|Other|0|||
143391234|NCT04209465|516978647|FG002|Overall Study|Other|0|||
143391235|NCT04209465|516978648|FG003|Overall Study|Other|0|||
143391236|NCT04209465|516978649|FG004|Overall Study|Other|0|||
143391237|NCT04209465|516978650|FG005|Overall Study|Other|0|||
143391238|NCT04209465|516978651|FG006|Overall Study|Other|0|||
143391239|NCT04209465|516978652|FG007|Overall Study|Other|0|||
143391240|NCT04209465|516978653|FG008|Overall Study|Other|1|||
143391241|NCT04209465|516978654|FG009|Overall Study|Other|0|||
143391242|NCT04209465|516978655|FG010|Overall Study|Other|0|||
143391243|NCT04209465|516978656|FG011|Overall Study|Other|0|||
143391244|NCT04209465|516978657|FG012|Overall Study|Other|0|||
143391245|NCT05603143|516978658|FG000|Overall Study|Withdrew consent|6|||
143391246|NCT05603143|516978659|FG001|Overall Study|Withdrew consent|2|||
143391247|NCT05603143|516978658|FG000|Overall Study|Randomized but never treated|0|||
143391248|NCT05603143|516978659|FG001|Overall Study|Randomized but never treated|3|||
143391249|NCT05603143|516978658|FG000|Overall Study|Adverse Event|2|||
143391250|NCT05603143|516978659|FG001|Overall Study|Adverse Event|0|||
143391251|NCT05603143|516978658|FG000|Overall Study|Death|0|||
143391252|NCT05603143|516978659|FG001|Overall Study|Death|1|||
143391253|NCT05603143|516978658|FG000|Overall Study|Investigator's discretion|1|||
143391254|NCT05603143|516978659|FG001|Overall Study|Investigator's discretion|0|||
143391255|NCT05603143|516978658|FG000|Overall Study|Lost to Follow-up|0|||
143391256|NCT05603143|516978659|FG001|Overall Study|Lost to Follow-up|1|||
143391257|NCT05603143|516978658|FG000|Overall Study|Protocol Violation|0|||
143391258|NCT05603143|516978659|FG001|Overall Study|Protocol Violation|1|||
143391259|NCT05783102|516978660|FG000|Overall Study|Lost to Follow-up|1|||
143391260|NCT05783102|516978660|FG000|Overall Study|Withdrawal by Subject|2|||
143391261|NCT04277442|516978663|FG000|Overall Study|Death|1|||
143391262|NCT05302596|516978666|FG000|Overall Study|Withdrawal by Subject|1|||
143391263|NCT05302596|516978667|FG001|Overall Study|Withdrawal by Subject|1|||
143391264|NCT03457142|516980487|FG000|Overall Study|Death|1|||
143391265|NCT05368103|516980489|FG000|Overall Study|Withdrawal by Subject|4|||
143391266|NCT05368103|516980489|FG000|Overall Study|Lost to Follow-up|1|||
143391267|NCT05368103|516980489|FG000|Overall Study|Lack of Efficacy|3|||
143391268|NCT03675282|516980492|FG000|Overall Study|Lost to Follow-up|4|||
143391269|NCT03675282|516980493|FG001|Overall Study|Lost to Follow-up|8|||
143391270|NCT03675282|516980494|FG002|Overall Study|Lost to Follow-up|1|||
143391271|NCT03675282|516980495|FG003|Overall Study|Lost to Follow-up|0|||
143391272|NCT03675282|516980496|FG004|Overall Study|Lost to Follow-up|2|||
143391273|NCT03675282|516980497|FG005|Overall Study|Lost to Follow-up|7|||
143391274|NCT03675282|516980492|FG000|Overall Study|received clinical care that was exclusionary to the study|0|||
143391275|NCT03675282|516980493|FG001|Overall Study|received clinical care that was exclusionary to the study|2|||
143391276|NCT03675282|516980494|FG002|Overall Study|received clinical care that was exclusionary to the study|0|||
143391277|NCT03675282|516980495|FG003|Overall Study|received clinical care that was exclusionary to the study|0|||
143391278|NCT03675282|516980496|FG004|Overall Study|received clinical care that was exclusionary to the study|0|||
143391279|NCT03675282|516980497|FG005|Overall Study|received clinical care that was exclusionary to the study|0|||
143391280|NCT03675282|516980492|FG000|Overall Study|Physician Decision|1|||
143391281|NCT03675282|516980493|FG001|Overall Study|Physician Decision|0|||
143391282|NCT03675282|516980494|FG002|Overall Study|Physician Decision|0|||
143391283|NCT03675282|516980495|FG003|Overall Study|Physician Decision|0|||
143391284|NCT03675282|516980496|FG004|Overall Study|Physician Decision|0|||
143391285|NCT03675282|516980497|FG005|Overall Study|Physician Decision|0|||
143391286|NCT02921230|516980501|FG000|Overall Study|Withdrawal by Subject|20|||
143391287|NCT02921230|516980502|FG001|Overall Study|Withdrawal by Subject|8|||
143391288|NCT02921230|516980501|FG000|Overall Study|Death|12|||
143391289|NCT02921230|516980502|FG001|Overall Study|Death|3|||
143391290|NCT02921230|516980501|FG000|Overall Study|Protocol Violation|17|||
143391291|NCT02921230|516980502|FG001|Overall Study|Protocol Violation|6|||
143391292|NCT02921230|516980501|FG000|Overall Study|Early completion|5|||
143391293|NCT02921230|516980502|FG001|Overall Study|Early completion|1|||
143391294|NCT02921230|516980501|FG000|Overall Study|Pending data entry|1|||
143391295|NCT02921230|516980502|FG001|Overall Study|Pending data entry|0|||
143391296|NCT04977947|516980503|FG000|Overall Study|Lost to Follow-up|1|||
143391297|NCT04977947|516980504|FG001|Overall Study|Lost to Follow-up|1|||
143391298|NCT00999804|516980507|FG000|Overall Study|Lack of Efficacy|9|||
143391299|NCT00999804|516980508|FG001|Overall Study|Lack of Efficacy|2|||
143391300|NCT00999804|516980507|FG000|Overall Study|Adverse Event|4|||
143391301|NCT00999804|516980508|FG001|Overall Study|Adverse Event|3|||
143391302|NCT00999804|516980507|FG000|Overall Study|Withdrawal by Subject|4|||
143391303|NCT00999804|516980508|FG001|Overall Study|Withdrawal by Subject|0|||
143391304|NCT00999804|516980507|FG000|Overall Study|Death|1|||
143391305|NCT00999804|516980508|FG001|Overall Study|Death|0|||
143391306|NCT00999804|516980507|FG000|Overall Study|Ineligible|3|||
143391307|NCT00999804|516980508|FG001|Overall Study|Ineligible|0|||
143391308|NCT04256941|516980517|FG000|Overall Study|Withdrawal by Subject|0|||
143391309|NCT04256941|516980518|FG001|Overall Study|Withdrawal by Subject|1|||
143391310|NCT04256941|516980517|FG000|Overall Study|Death|1|||
143391311|NCT04256941|516980518|FG001|Overall Study|Death|0|||
143391312|NCT04256941|516980517|FG000|Overall Study|Disease Progession|0|||
143391313|NCT04256941|516980518|FG001|Overall Study|Disease Progession|2|||
143391314|NCT02908477|516980533|FG000|Overall Study|Withdrawal by Subject|8|||
143391315|NCT02908477|516980534|FG001|Overall Study|Withdrawal by Subject|28|||
143391316|NCT04456517|516980539|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
143391317|NCT04456517|516980540|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
143391318|NCT03766009|516980541|FG000|Usual Care|Death|0|||
143391319|NCT03766009|516980542|FG001|Usual Care|Death|0|||
143391320|NCT03766009|516980543|FG002|Usual Care|Death|0|||
143391321|NCT03766009|516980544|FG003|Usual Care|Death|1|||
143391322|NCT03766009|516980545|FG004|Usual Care|Death|0|||
143391323|NCT03766009|516980546|FG005|Usual Care|Death|0|||
143391324|NCT03766009|516980541|FG000|Usual Care|Lost to Follow-up|0|||
143391325|NCT03766009|516980542|FG001|Usual Care|Lost to Follow-up|0|||
143391326|NCT03766009|516980543|FG002|Usual Care|Lost to Follow-up|0|||
143391327|NCT03766009|516980544|FG003|Usual Care|Lost to Follow-up|1|||
143391328|NCT03766009|516980545|FG004|Usual Care|Lost to Follow-up|0|||
143391329|NCT03766009|516980546|FG005|Usual Care|Lost to Follow-up|0|||
143391330|NCT03766009|516980541|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
143391331|NCT03766009|516980542|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
143391332|NCT03766009|516980543|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
143391333|NCT03766009|516980544|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
143391334|NCT03766009|516980545|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
143391335|NCT03766009|516980546|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
143391336|NCT03766009|516980541|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
143391337|NCT03766009|516980542|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
143391338|NCT03766009|516980543|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
143391339|NCT03766009|516980544|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
143391340|NCT03766009|516980545|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
143391341|NCT03766009|516980546|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
143391342|NCT03766009|516980541|FG000|Usual Care|No treatment or declined surgery|0|||
143391343|NCT03766009|516980542|FG001|Usual Care|No treatment or declined surgery|0|||
143391344|NCT03766009|516980543|FG002|Usual Care|No treatment or declined surgery|0|||
143391345|NCT03766009|516980544|FG003|Usual Care|No treatment or declined surgery|2|||
143391346|NCT03766009|516980545|FG004|Usual Care|No treatment or declined surgery|0|||
143391347|NCT03766009|516980546|FG005|Usual Care|No treatment or declined surgery|0|||
143391348|NCT03766009|516980541|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
143391349|NCT03766009|516980542|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
143391350|NCT03766009|516980543|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
143391351|NCT03766009|516980544|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
143391352|NCT03766009|516980545|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
143391353|NCT03766009|516980546|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
143391354|NCT03766009|516980541|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
143391355|NCT03766009|516980542|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
143391356|NCT03766009|516980543|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
143391357|NCT03766009|516980544|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
143391358|NCT03766009|516980545|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
143391359|NCT03766009|516980546|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
143391360|NCT03766009|516980541|FG000|Usual Care|Ineligible|0|||
143391361|NCT03766009|516980542|FG001|Usual Care|Ineligible|1|||
143391362|NCT03766009|516980543|FG002|Usual Care|Ineligible|0|||
143391363|NCT03766009|516980544|FG003|Usual Care|Ineligible|0|||
143391364|NCT03766009|516980545|FG004|Usual Care|Ineligible|0|||
143391365|NCT03766009|516980546|FG005|Usual Care|Ineligible|0|||
143391366|NCT03766009|516980541|FG000|Usual Care|Other: Staff turnover|0|||
143391367|NCT03766009|516980542|FG001|Usual Care|Other: Staff turnover|0|||
143338710|NCT02243280|516784172|FG003|Treated|Lost to Follow-up|0|||
143338711|NCT02243280|516784173|FG004|Treated|Lost to Follow-up|0|||
143338712|NCT02243280|516784174|FG005|Treated|Lost to Follow-up|0|||
143391368|NCT03766009|516980543|FG002|Usual Care|Other: Staff turnover|0|||
143391369|NCT03766009|516980544|FG003|Usual Care|Other: Staff turnover|0|||
143391370|NCT03766009|516980545|FG004|Usual Care|Other: Staff turnover|0|||
143391371|NCT03766009|516980546|FG005|Usual Care|Other: Staff turnover|2|||
143391372|NCT03150810|516980548|FG000|Overall Study|Death|4|||
143391373|NCT03150810|516980549|FG001|Overall Study|Death|8|||
143391374|NCT03150810|516980550|FG002|Overall Study|Death|7|||
143391375|NCT03150810|516980551|FG003|Overall Study|Death|2|||
143391376|NCT03150810|516980552|FG004|Overall Study|Death|2|||
143391377|NCT03150810|516980553|FG005|Overall Study|Death|10|||
143391378|NCT03150810|516980554|FG006|Overall Study|Death|8|||
143391379|NCT03150810|516980555|FG007|Overall Study|Death|6|||
143391380|NCT03150810|516980556|FG008|Overall Study|Death|18|||
143391381|NCT03150810|516980557|FG009|Overall Study|Death|3|||
143391382|NCT03150810|516980558|FG010|Overall Study|Death|19|||
143391383|NCT03150810|516980559|FG011|Overall Study|Death|1|||
143391384|NCT03150810|516980560|FG012|Overall Study|Death|19|||
143391385|NCT03150810|516980548|FG000|Overall Study|Withdrawal by Subject|0|||
143391386|NCT03150810|516980549|FG001|Overall Study|Withdrawal by Subject|1|||
143391387|NCT03150810|516980550|FG002|Overall Study|Withdrawal by Subject|1|||
143391388|NCT03150810|516980551|FG003|Overall Study|Withdrawal by Subject|1|||
143391389|NCT03150810|516980552|FG004|Overall Study|Withdrawal by Subject|0|||
143391390|NCT03150810|516980553|FG005|Overall Study|Withdrawal by Subject|0|||
143391391|NCT03150810|516980554|FG006|Overall Study|Withdrawal by Subject|2|||
143391392|NCT03150810|516980555|FG007|Overall Study|Withdrawal by Subject|0|||
143391393|NCT03150810|516980556|FG008|Overall Study|Withdrawal by Subject|2|||
143391394|NCT03150810|516980557|FG009|Overall Study|Withdrawal by Subject|0|||
143391395|NCT03150810|516980558|FG010|Overall Study|Withdrawal by Subject|1|||
143391396|NCT03150810|516980559|FG011|Overall Study|Withdrawal by Subject|0|||
143391397|NCT03150810|516980560|FG012|Overall Study|Withdrawal by Subject|1|||
143391398|NCT03150810|516980548|FG000|Overall Study|Sponsor Decision|0|||
143391399|NCT03150810|516980549|FG001|Overall Study|Sponsor Decision|2|||
143391400|NCT03150810|516980550|FG002|Overall Study|Sponsor Decision|0|||
143391401|NCT03150810|516980551|FG003|Overall Study|Sponsor Decision|0|||
143391402|NCT03150810|516980552|FG004|Overall Study|Sponsor Decision|1|||
143391403|NCT03150810|516980553|FG005|Overall Study|Sponsor Decision|1|||
143391404|NCT03150810|516980554|FG006|Overall Study|Sponsor Decision|0|||
143391405|NCT03150810|516980555|FG007|Overall Study|Sponsor Decision|0|||
143391406|NCT03150810|516980556|FG008|Overall Study|Sponsor Decision|1|||
143391407|NCT03150810|516980557|FG009|Overall Study|Sponsor Decision|0|||
143391408|NCT03150810|516980558|FG010|Overall Study|Sponsor Decision|0|||
143391409|NCT03150810|516980559|FG011|Overall Study|Sponsor Decision|0|||
143391410|NCT03150810|516980560|FG012|Overall Study|Sponsor Decision|5|||
143391411|NCT03150810|516980548|FG000|Overall Study|Lost to Follow-up|0|||
143391412|NCT03150810|516980549|FG001|Overall Study|Lost to Follow-up|1|||
143391413|NCT03150810|516980550|FG002|Overall Study|Lost to Follow-up|1|||
143391414|NCT03150810|516980551|FG003|Overall Study|Lost to Follow-up|0|||
143391415|NCT03150810|516980552|FG004|Overall Study|Lost to Follow-up|0|||
143391416|NCT03150810|516980553|FG005|Overall Study|Lost to Follow-up|0|||
143391417|NCT03150810|516980554|FG006|Overall Study|Lost to Follow-up|1|||
143391418|NCT03150810|516980555|FG007|Overall Study|Lost to Follow-up|0|||
143391419|NCT03150810|516980556|FG008|Overall Study|Lost to Follow-up|0|||
143391420|NCT03150810|516980557|FG009|Overall Study|Lost to Follow-up|0|||
143391421|NCT03150810|516980558|FG010|Overall Study|Lost to Follow-up|1|||
143391422|NCT03150810|516980559|FG011|Overall Study|Lost to Follow-up|0|||
143391423|NCT03150810|516980560|FG012|Overall Study|Lost to Follow-up|0|||
143391424|NCT03150810|516980548|FG000|Overall Study|Physician Decision|0|||
143391425|NCT03150810|516980549|FG001|Overall Study|Physician Decision|0|||
143391426|NCT03150810|516980550|FG002|Overall Study|Physician Decision|0|||
143391427|NCT03150810|516980551|FG003|Overall Study|Physician Decision|0|||
143391428|NCT03150810|516980552|FG004|Overall Study|Physician Decision|0|||
143391429|NCT03150810|516980553|FG005|Overall Study|Physician Decision|1|||
143391430|NCT03150810|516980554|FG006|Overall Study|Physician Decision|1|||
143391431|NCT03150810|516980555|FG007|Overall Study|Physician Decision|0|||
143391432|NCT03150810|516980556|FG008|Overall Study|Physician Decision|0|||
143391433|NCT03150810|516980557|FG009|Overall Study|Physician Decision|0|||
143391434|NCT03150810|516980558|FG010|Overall Study|Physician Decision|0|||
143391435|NCT03150810|516980559|FG011|Overall Study|Physician Decision|0|||
143391436|NCT03150810|516980560|FG012|Overall Study|Physician Decision|0|||
143391437|NCT03150810|516980548|FG000|Overall Study|Site withdrawal from study|0|||
143391438|NCT03150810|516980549|FG001|Overall Study|Site withdrawal from study|1|||
143391439|NCT03150810|516980550|FG002|Overall Study|Site withdrawal from study|0|||
143391440|NCT03150810|516980551|FG003|Overall Study|Site withdrawal from study|0|||
143391441|NCT03150810|516980552|FG004|Overall Study|Site withdrawal from study|0|||
143391442|NCT03150810|516980553|FG005|Overall Study|Site withdrawal from study|0|||
143391443|NCT03150810|516980554|FG006|Overall Study|Site withdrawal from study|0|||
143391444|NCT03150810|516980555|FG007|Overall Study|Site withdrawal from study|0|||
143391445|NCT03150810|516980556|FG008|Overall Study|Site withdrawal from study|0|||
143391446|NCT03150810|516980557|FG009|Overall Study|Site withdrawal from study|1|||
143391447|NCT03150810|516980558|FG010|Overall Study|Site withdrawal from study|1|||
143391448|NCT03150810|516980559|FG011|Overall Study|Site withdrawal from study|0|||
143391449|NCT03150810|516980560|FG012|Overall Study|Site withdrawal from study|0|||
143391450|NCT03150810|516980548|FG000|Overall Study|Hospice|0|||
143391451|NCT03150810|516980549|FG001|Overall Study|Hospice|0|||
143391452|NCT03150810|516980550|FG002|Overall Study|Hospice|0|||
143391453|NCT03150810|516980551|FG003|Overall Study|Hospice|0|||
143391454|NCT03150810|516980552|FG004|Overall Study|Hospice|0|||
143391455|NCT03150810|516980553|FG005|Overall Study|Hospice|1|||
143391456|NCT03150810|516980554|FG006|Overall Study|Hospice|0|||
143391457|NCT03150810|516980555|FG007|Overall Study|Hospice|0|||
143391458|NCT03150810|516980556|FG008|Overall Study|Hospice|0|||
143391459|NCT03150810|516980557|FG009|Overall Study|Hospice|0|||
143391460|NCT03150810|516980558|FG010|Overall Study|Hospice|0|||
143391461|NCT03150810|516980559|FG011|Overall Study|Hospice|0|||
143391462|NCT03150810|516980560|FG012|Overall Study|Hospice|0|||
143391463|NCT03150810|516980548|FG000|Overall Study|Participant relocated abroad.|0|||
143391464|NCT03150810|516980549|FG001|Overall Study|Participant relocated abroad.|0|||
143391465|NCT03150810|516980550|FG002|Overall Study|Participant relocated abroad.|0|||
143391466|NCT03150810|516980551|FG003|Overall Study|Participant relocated abroad.|0|||
143391467|NCT03150810|516980552|FG004|Overall Study|Participant relocated abroad.|0|||
143391468|NCT03150810|516980553|FG005|Overall Study|Participant relocated abroad.|1|||
143391469|NCT03150810|516980554|FG006|Overall Study|Participant relocated abroad.|0|||
143391470|NCT03150810|516980555|FG007|Overall Study|Participant relocated abroad.|0|||
143391471|NCT03150810|516980556|FG008|Overall Study|Participant relocated abroad.|0|||
143391472|NCT03150810|516980557|FG009|Overall Study|Participant relocated abroad.|0|||
143391473|NCT03150810|516980558|FG010|Overall Study|Participant relocated abroad.|0|||
143391474|NCT03150810|516980559|FG011|Overall Study|Participant relocated abroad.|0|||
143391475|NCT03150810|516980560|FG012|Overall Study|Participant relocated abroad.|0|||
143391476|NCT03150810|516980548|FG000|Overall Study|Transferred care to oncologist|0|||
143391477|NCT03150810|516980549|FG001|Overall Study|Transferred care to oncologist|0|||
143391478|NCT03150810|516980550|FG002|Overall Study|Transferred care to oncologist|0|||
143391479|NCT03150810|516980551|FG003|Overall Study|Transferred care to oncologist|0|||
143391480|NCT03150810|516980552|FG004|Overall Study|Transferred care to oncologist|0|||
143391481|NCT03150810|516980553|FG005|Overall Study|Transferred care to oncologist|0|||
143391482|NCT03150810|516980554|FG006|Overall Study|Transferred care to oncologist|2|||
143391483|NCT03150810|516980555|FG007|Overall Study|Transferred care to oncologist|0|||
143391484|NCT03150810|516980556|FG008|Overall Study|Transferred care to oncologist|0|||
143391485|NCT03150810|516980557|FG009|Overall Study|Transferred care to oncologist|0|||
143391486|NCT03150810|516980558|FG010|Overall Study|Transferred care to oncologist|0|||
143391487|NCT03150810|516980559|FG011|Overall Study|Transferred care to oncologist|0|||
143391488|NCT03150810|516980560|FG012|Overall Study|Transferred care to oncologist|0|||
143391489|NCT04526704|516980561|FG000|Overall Study|Adverse Event|1|||
143391490|NCT04526704|516980562|FG001|Overall Study|Adverse Event|0|||
143391491|NCT04526704|516980561|FG000|Overall Study|Physician Decision|1|||
143391492|NCT04526704|516980562|FG001|Overall Study|Physician Decision|0|||
143391493|NCT04526704|516980561|FG000|Overall Study|Withdrawal by Subject|2|||
143391494|NCT04526704|516980562|FG001|Overall Study|Withdrawal by Subject|0|||
143391495|NCT00881621|516980563|FG000|Overall Study|Physician Decision|34|||
143391496|NCT02737436|516980564|FG000|Washout Period|Lost to Follow-up|5|||
143391497|NCT02737436|516980565|FG001|Washout Period|Lost to Follow-up|11|||
143391498|NCT02737436|516980564|FG000|Data Analysis|Scanning data problems|5|||
143391499|NCT02737436|516980565|FG001|Data Analysis|Scanning data problems|8|||
143391500|NCT03936322|516980566|FG000|Overall Study|Lost to Follow-up|1|||
143391501|NCT03936322|516980566|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
143391502|NCT03158129|516980567|FG000|Overall Study|Adverse Event|0|||
143391503|NCT03158129|516980568|FG001|Overall Study|Adverse Event|1|||
143391504|NCT03158129|516980569|FG002|Overall Study|Adverse Event|0|||
143391505|NCT03158129|516980570|FG003|Overall Study|Adverse Event|0|||
143391506|NCT03158129|516980567|FG000|Overall Study|Death|0|||
143391507|NCT03158129|516980568|FG001|Overall Study|Death|0|||
143391508|NCT03158129|516980569|FG002|Overall Study|Death|0|||
143391509|NCT03158129|516980570|FG003|Overall Study|Death|1|||
143391510|NCT03158129|516980567|FG000|Overall Study|High surgical risk|1|||
143391511|NCT03158129|516980568|FG001|Overall Study|High surgical risk|1|||
143391512|NCT03158129|516980569|FG002|Overall Study|High surgical risk|0|||
143391513|NCT03158129|516980570|FG003|Overall Study|High surgical risk|0|||
143391514|NCT03158129|516980567|FG000|Overall Study|Progression|1|||
143391515|NCT03158129|516980568|FG001|Overall Study|Progression|1|||
143391516|NCT03158129|516980569|FG002|Overall Study|Progression|0|||
143391517|NCT03158129|516980570|FG003|Overall Study|Progression|0|||
143391518|NCT03158129|516980567|FG000|Overall Study|Lack of resectability|0|||
143391519|NCT03158129|516980568|FG001|Overall Study|Lack of resectability|1|||
143391520|NCT03158129|516980569|FG002|Overall Study|Lack of resectability|0|||
143391521|NCT03158129|516980570|FG003|Overall Study|Lack of resectability|0|||
143391522|NCT03158129|516980567|FG000|Overall Study|Declined surgery|0|||
143391523|NCT03158129|516980568|FG001|Overall Study|Declined surgery|1|||
143391524|NCT03158129|516980569|FG002|Overall Study|Declined surgery|0|||
143391525|NCT03158129|516980570|FG003|Overall Study|Declined surgery|0|||
143391526|NCT03158129|516980567|FG000|Overall Study|No longer surgical candidate|0|||
143391527|NCT03158129|516980568|FG001|Overall Study|No longer surgical candidate|0|||
143391528|NCT03158129|516980569|FG002|Overall Study|No longer surgical candidate|0|||
143391529|NCT03158129|516980570|FG003|Overall Study|No longer surgical candidate|1|||
143391530|NCT05051124|516980571|FG000|Overall Study|Lost to Follow-up|2|||
143391531|NCT05051124|516980571|FG000|Overall Study|Withdrawal by Subject|1|||
143391532|NCT05051124|516980571|FG000|Overall Study|Residential relocation|2|||
143391533|NCT05051124|516980571|FG000|Overall Study|Death|1|||
143391534|NCT00554788|516980572|FG000|Overall Study|Adverse Event|0|||
143391535|NCT00554788|516980573|FG001|Overall Study|Adverse Event|1|||
143391536|NCT00554788|516980574|FG002|Overall Study|Adverse Event|2|||
143391537|NCT00554788|516980572|FG000|Overall Study|Lost to Follow-up|4|||
143391538|NCT00554788|516980573|FG001|Overall Study|Lost to Follow-up|3|||
143391539|NCT00554788|516980574|FG002|Overall Study|Lost to Follow-up|3|||
143391540|NCT00554788|516980572|FG000|Overall Study|Physician Decision|1|||
143391541|NCT00554788|516980573|FG001|Overall Study|Physician Decision|1|||
143391542|NCT00554788|516980574|FG002|Overall Study|Physician Decision|3|||
143391543|NCT00554788|516980572|FG000|Overall Study|Withdrawal by Subject|0|||
143391544|NCT00554788|516980573|FG001|Overall Study|Withdrawal by Subject|0|||
143391545|NCT00554788|516980574|FG002|Overall Study|Withdrawal by Subject|1|||
143391546|NCT00554788|516980572|FG000|Overall Study|Refusal of further protocol therapy|0|||
143391547|NCT00554788|516980573|FG001|Overall Study|Refusal of further protocol therapy|1|||
143391548|NCT00554788|516980574|FG002|Overall Study|Refusal of further protocol therapy|1|||
143391549|NCT00554788|516980572|FG000|Overall Study|Progressive disease|0|||
143391550|NCT00554788|516980573|FG001|Overall Study|Progressive disease|0|||
143391551|NCT00554788|516980574|FG002|Overall Study|Progressive disease|3|||
143391552|NCT00554788|516980572|FG000|Overall Study|Ineligible|2|||
143391553|NCT00554788|516980573|FG001|Overall Study|Ineligible|0|||
143391554|NCT00554788|516980574|FG002|Overall Study|Ineligible|1|||
143391555|NCT06205407|516980575|FG000|Period 2|Withdrawal by Subject|0|||
143391556|NCT06205407|516980576|FG001|Period 2|Withdrawal by Subject|1|||
143391557|NCT06205407|516980575|FG000|Period 2|Adverse Event|2|||
143391558|NCT06205407|516980576|FG001|Period 2|Adverse Event|1|||
143391559|NCT04749615|516980577|FG000|Overall Study|Lost to Follow-up|6|||
143391560|NCT04749615|516980578|FG001|Overall Study|Lost to Follow-up|10|||
143391561|NCT03611491|516980579|FG000|Overall Study|Lost to Follow-up|1|||
143391562|NCT04676022|516980580|FG000|Overall Study|Screen Failure/|1|||
143391563|NCT04676022|516980581|FG001|Overall Study|Screen Failure/|1|||
143391564|NCT04676022|516980582|FG002|Overall Study|Screen Failure/|85|||
143391565|NCT04676022|516980580|FG000|Overall Study|Lost to Follow-up|1|||
143391566|NCT04676022|516980581|FG001|Overall Study|Lost to Follow-up|1|||
143391567|NCT04676022|516980582|FG002|Overall Study|Lost to Follow-up|0|||
143391568|NCT04676022|516980580|FG000|Overall Study|Adverse Event|2|||
143391569|NCT04676022|516980581|FG001|Overall Study|Adverse Event|0|||
143391570|NCT04676022|516980582|FG002|Overall Study|Adverse Event|1|||
143391571|NCT04676022|516980580|FG000|Overall Study|Physician Decision|2|||
143391572|NCT04676022|516980581|FG001|Overall Study|Physician Decision|0|||
143391573|NCT04676022|516980582|FG002|Overall Study|Physician Decision|1|||
143391574|NCT04676022|516980580|FG000|Overall Study|Withdrawal by Subject|3|||
143391575|NCT04676022|516980581|FG001|Overall Study|Withdrawal by Subject|1|||
143391576|NCT04676022|516980582|FG002|Overall Study|Withdrawal by Subject|6|||
143391577|NCT04676022|516980580|FG000|Overall Study|Will not move forward with permanent implant|6|||
143391578|NCT04676022|516980581|FG001|Overall Study|Will not move forward with permanent implant|0|||
143391579|NCT04676022|516980582|FG002|Overall Study|Will not move forward with permanent implant|0|||
143391580|NCT04676022|516980580|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
143391581|NCT04676022|516980581|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
143391582|NCT04676022|516980582|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
143391583|NCT02274662|516980586|FG000|Overall Study|Death|1|||
143391584|NCT02274662|516980586|FG000|Overall Study|Lost to Follow-up|3|||
143391585|NCT02962895|516980587|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
143391586|NCT02962895|516980588|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
143391587|NCT02962895|516980589|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
143391588|NCT02962895|516980590|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
143391589|NCT02962895|516980591|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
143391590|NCT02962895|516980592|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
143391591|NCT02962895|516980593|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
143391592|NCT02962895|516980587|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
143391593|NCT02962895|516980588|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
143391594|NCT02962895|516980589|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
143391595|NCT02962895|516980590|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
143391596|NCT02962895|516980591|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
143391597|NCT02962895|516980592|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
143391598|NCT02962895|516980593|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
143391599|NCT02962895|516980587|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
143391600|NCT02962895|516980588|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
143391601|NCT02962895|516980589|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
143391602|NCT02962895|516980590|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
143391603|NCT02962895|516980591|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
143391604|NCT02962895|516980592|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
143391605|NCT02962895|516980593|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
143391606|NCT02962895|516980587|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
143391607|NCT02962895|516980588|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
143391608|NCT02962895|516980589|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
143391609|NCT02962895|516980590|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
143391610|NCT02962895|516980591|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
143391611|NCT02962895|516980592|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
143391612|NCT02962895|516980593|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
143391613|NCT02962895|516980587|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
143391614|NCT02962895|516980588|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
143391615|NCT02962895|516980589|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
143391616|NCT02962895|516980590|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
143391617|NCT02962895|516980591|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
143391618|NCT02962895|516980592|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
143391619|NCT02962895|516980593|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
143391620|NCT02962895|516980587|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
143391621|NCT02962895|516980588|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
143391622|NCT02962895|516980589|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
143391623|NCT02962895|516980590|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
143391624|NCT02962895|516980591|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
143391625|NCT02962895|516980592|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
143391626|NCT02962895|516980593|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
143391627|NCT02962895|516980587|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
143391628|NCT02962895|516980588|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
143391629|NCT02962895|516980589|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
143391630|NCT02962895|516980590|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
143391631|NCT02962895|516980591|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
143391632|NCT02962895|516980592|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
143391633|NCT02962895|516980593|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
143391634|NCT02962895|516980587|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
143391635|NCT02962895|516980588|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
143391636|NCT02962895|516980589|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
143391637|NCT02962895|516980590|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
143391638|NCT02962895|516980591|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
143391639|NCT02962895|516980592|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
143391640|NCT02962895|516980593|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
143391641|NCT02962895|516980587|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
143391642|NCT02962895|516980588|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
143391643|NCT02962895|516980589|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
143391644|NCT02962895|516980590|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
143391645|NCT02962895|516980591|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
143391646|NCT02962895|516980592|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
143391647|NCT02962895|516980593|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
143391648|NCT02962895|516980587|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
143391649|NCT02962895|516980588|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
143391650|NCT02962895|516980589|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
143391651|NCT02962895|516980590|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
143391652|NCT02962895|516980591|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
143391653|NCT02962895|516980592|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
143391654|NCT02962895|516980593|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
143391655|NCT02962895|516980587|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
143391656|NCT02962895|516980588|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
143391657|NCT02962895|516980589|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
143391658|NCT02962895|516980590|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
143391659|NCT02962895|516980591|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
143391660|NCT02962895|516980592|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
143391661|NCT02962895|516980593|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
143391662|NCT02962895|516980587|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
143391663|NCT02962895|516980588|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
143391664|NCT02962895|516980589|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
143391665|NCT02962895|516980590|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
143391666|NCT02962895|516980591|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
143391667|NCT02962895|516980592|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
143391668|NCT02962895|516980593|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
143391669|NCT02962895|516980587|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
143391670|NCT02962895|516980588|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
143391671|NCT02962895|516980589|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
143391672|NCT02962895|516980590|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
143391673|NCT02962895|516980591|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
143391674|NCT02962895|516980592|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
143391675|NCT02962895|516980593|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
143391676|NCT02962895|516980587|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
143391677|NCT02962895|516980588|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
143391678|NCT02962895|516980589|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
143391679|NCT02962895|516980590|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
143391680|NCT02962895|516980591|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
143391681|NCT02962895|516980592|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
143391682|NCT02962895|516980593|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
143391683|NCT05835336|516980594|FG000|Overall Study|Withdrawal by Subject|5|||
143391684|NCT05835336|516980594|FG000|Overall Study|Did not complete the personalization process|3|||
143391685|NCT02936752|516980595|FG000|Overall Study|Death|2|||
143391686|NCT02936752|516980596|FG001|Overall Study|Death|1|||
143391687|NCT02936752|516980595|FG000|Overall Study|Physician Decision|4|||
143338713|NCT02243280|516784175|FG006|Treated|Lost to Follow-up|0|||
143338714|NCT02243280|516784176|FG007|Treated|Lost to Follow-up|0|||
143338715|NCT02243280|516784177|FG008|Treated|Lost to Follow-up|1|||
143338716|NCT02243280|516784178|FG009|Treated|Lost to Follow-up|0|||
143338717|NCT02243280|516784179|FG010|Treated|Lost to Follow-up|2|||
143338718|NCT01807156|516784186|FG000|Overall Study|Physician Decision|1|||
143338719|NCT03928028|516784187|FG000|Overall Study|Physician Decision|9|||
143338720|NCT03928028|516784188|FG001|Overall Study|Physician Decision|6|||
143338721|NCT03928028|516784189|FG002|Overall Study|Physician Decision|3|||
143338722|NCT03928028|516784187|FG000|Overall Study|Withdrawal by Subject|12|||
143338723|NCT03928028|516784188|FG001|Overall Study|Withdrawal by Subject|3|||
143338724|NCT03928028|516784189|FG002|Overall Study|Withdrawal by Subject|3|||
143338725|NCT01370525|516784191|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
143338726|NCT01370525|516784192|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
143338727|NCT01370525|516784191|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
143338728|NCT01370525|516784192|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
143338729|NCT01370525|516784191|FG000|Overall Study|Adverse Event|0|||
143338730|NCT01370525|516784192|FG001|Overall Study|Adverse Event|1|||
143338731|NCT01370525|516784191|FG000|Overall Study|Protocol Violation|2|||
143338732|NCT01370525|516784192|FG001|Overall Study|Protocol Violation|1|||
143338733|NCT01370525|516784191|FG000|Overall Study|Lost to follow up|2|||
143338734|NCT01370525|516784192|FG001|Overall Study|Lost to follow up|6|||
143338735|NCT02459262|516784193|FG000|Overall Study|Withdrawal by Subject|0|||
143338736|NCT02459262|516784194|FG001|Overall Study|Withdrawal by Subject|0|||
143338737|NCT02459262|516784195|FG002|Overall Study|Withdrawal by Subject|0|||
143338738|NCT02459262|516784196|FG003|Overall Study|Withdrawal by Subject|0|||
143338739|NCT02459262|516784197|FG004|Overall Study|Withdrawal by Subject|0|||
143338740|NCT02459262|516784198|FG005|Overall Study|Withdrawal by Subject|0|||
143338741|NCT02459262|516784199|FG006|Overall Study|Withdrawal by Subject|0|||
143338742|NCT02459262|516784200|FG007|Overall Study|Withdrawal by Subject|0|||
143338743|NCT02459262|516784201|FG008|Overall Study|Withdrawal by Subject|0|||
143338744|NCT02459262|516784202|FG009|Overall Study|Withdrawal by Subject|1|||
143338745|NCT02459262|516784203|FG010|Overall Study|Withdrawal by Subject|0|||
143338746|NCT00549757|516784210|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
143338747|NCT00549757|516784211|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
143338748|NCT00549757|516784210|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
143338749|NCT00549757|516784211|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
143338750|NCT00549757|516784210|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
143338751|NCT00549757|516784211|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
143338752|NCT00549757|516784210|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
143338753|NCT00549757|516784211|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
143338754|NCT00549757|516784210|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
143338755|NCT00549757|516784211|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
143338756|NCT00549757|516784210|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
143338757|NCT00549757|516784211|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
143338758|NCT00549757|516784210|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
143338759|NCT00549757|516784211|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
143338760|NCT00549757|516784210|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
143338761|NCT00549757|516784211|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
143338762|NCT00549757|516784210|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
143338763|NCT00549757|516784211|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
143338764|NCT00549757|516784210|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
143338765|NCT00549757|516784211|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
143338766|NCT00549757|516784210|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
143338767|NCT00549757|516784211|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
143338768|NCT00549757|516784210|FG000|Extension Period (in Average 9 Months)|Death|143|||
143338769|NCT00549757|516784211|FG001|Extension Period (in Average 9 Months)|Death|136|||
143338770|NCT00549757|516784210|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
143338771|NCT00549757|516784211|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
143338772|NCT00549757|516784210|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
143338773|NCT00549757|516784211|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
143338774|NCT00549757|516784210|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
143391688|NCT02936752|516980596|FG001|Overall Study|Physician Decision|0|||
143391689|NCT02936752|516980595|FG000|Overall Study|Withdrawal by Subject|0|||
143391690|NCT02936752|516980596|FG001|Overall Study|Withdrawal by Subject|2|||
143391691|NCT05292365|516980609|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
143391692|NCT05292365|516980610|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
143391693|NCT05292365|516980611|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
143391694|NCT05292365|516980612|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
143391695|NCT05282173|516980613|FG000|Overall Study|Missed|3|||
143391696|NCT05282173|516980614|FG001|Overall Study|Missed|2|||
143391697|NCT05282173|516980615|FG002|Overall Study|Missed|4|||
143391698|NCT04495894|516980625|FG000|Overall Study|Withdrawal by Subject|2|||
143391699|NCT04495894|516980626|FG001|Overall Study|Withdrawal by Subject|0|||
143391700|NCT04495894|516980627|FG002|Overall Study|Withdrawal by Subject|2|||
143391701|NCT04495894|516980628|FG003|Overall Study|Withdrawal by Subject|3|||
143391702|NCT04495894|516980625|FG000|Overall Study|Early termination|0|||
143391703|NCT04495894|516980626|FG001|Overall Study|Early termination|0|||
143391704|NCT04495894|516980627|FG002|Overall Study|Early termination|3|||
143391705|NCT04495894|516980628|FG003|Overall Study|Early termination|0|||
143391706|NCT03364647|516980629|FG000|Overall Study|Withdrawal by Subject|3|||
143391707|NCT03364647|516980630|FG001|Overall Study|Withdrawal by Subject|1|||
143391708|NCT01000961|516980631|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
143391709|NCT01000961|516980632|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
143391710|NCT01000961|516980631|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
143391711|NCT01000961|516980632|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
143391712|NCT03896789|516980648|FG000|Baseline|Lost to Follow-up|1|||
143391713|NCT03896789|516980649|FG001|Baseline|Lost to Follow-up|2|||
143391714|NCT03896789|516980648|FG000|Baseline|Death|3|||
143391715|NCT03896789|516980649|FG001|Baseline|Death|6|||
143391716|NCT03896789|516980648|FG000|Post-Randomization|Lost to Follow-up|12|||
143391717|NCT03896789|516980649|FG001|Post-Randomization|Lost to Follow-up|11|||
143391718|NCT03896789|516980648|FG000|Post-Randomization|Death|12|||
143391719|NCT03896789|516980649|FG001|Post-Randomization|Death|13|||
143391720|NCT04592549|516980651|FG000|Overall Study|Withdrawal by Subject|0|||
143391721|NCT04592549|516980652|FG001|Overall Study|Withdrawal by Subject|1|||
143391722|NCT04592549|516980653|FG002|Overall Study|Withdrawal by Subject|0|||
143391723|NCT04592549|516980654|FG003|Overall Study|Withdrawal by Subject|1|||
143391724|NCT04592549|516980655|FG004|Overall Study|Withdrawal by Subject|1|||
143391725|NCT04592549|516980656|FG005|Overall Study|Withdrawal by Subject|0|||
143391726|NCT04592549|516980651|FG000|Overall Study|Lost to Follow-up|2|||
143391727|NCT04592549|516980652|FG001|Overall Study|Lost to Follow-up|0|||
143391728|NCT04592549|516980653|FG002|Overall Study|Lost to Follow-up|0|||
143391729|NCT04592549|516980654|FG003|Overall Study|Lost to Follow-up|1|||
143391730|NCT04592549|516980655|FG004|Overall Study|Lost to Follow-up|1|||
143391731|NCT04592549|516980656|FG005|Overall Study|Lost to Follow-up|1|||
143391732|NCT04624633|516980657|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
143391733|NCT04624633|516980658|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
143391734|NCT04624633|516980657|FG000|Overall Study|Death|1|||
143391735|NCT04624633|516980658|FG001|Overall Study|Death|0|||
143391736|NCT05780437|516980659|FG000|Overall Study|Withdrawal by Subject|22|||
143391737|NCT05780437|516980660|FG001|Overall Study|Withdrawal by Subject|16|||
143391738|NCT03382652|516980663|FG000|Overall Study|Lost to Follow-up|6|||
143391739|NCT03382652|516980663|FG000|Overall Study|Death|4|||
143391740|NCT03382652|516980663|FG000|Overall Study|Revision|5|||
143391741|NCT03382652|516980663|FG000|Overall Study|Patient withdrew|3|||
143391742|NCT03382652|516980663|FG000|Overall Study|Other reasons|21|||
143391743|NCT04810650|516980665|FG000|Overall Study|Disenrolled in error|0|||
143391744|NCT04810650|516980666|FG001|Overall Study|Disenrolled in error|0|||
143391745|NCT04810650|516980667|FG002|Overall Study|Disenrolled in error|0|||
143391746|NCT04810650|516980668|FG003|Overall Study|Disenrolled in error|0|||
143391747|NCT04810650|516980669|FG004|Overall Study|Disenrolled in error|0|||
143391748|NCT04810650|516980670|FG005|Overall Study|Disenrolled in error|0|||
143391749|NCT04810650|516980671|FG006|Overall Study|Disenrolled in error|0|||
143391750|NCT04810650|516980672|FG007|Overall Study|Disenrolled in error|0|||
143391751|NCT04810650|516980673|FG008|Overall Study|Disenrolled in error|1|||
143391752|NCT04810650|516980674|FG009|Overall Study|Disenrolled in error|0|||
143391753|NCT04810650|516980675|FG010|Overall Study|Disenrolled in error|0|||
143391754|NCT04810650|516980676|FG011|Overall Study|Disenrolled in error|0|||
143391755|NCT04810650|516980677|FG012|Overall Study|Disenrolled in error|0|||
143391756|NCT04810650|516980678|FG013|Overall Study|Disenrolled in error|0|||
143391757|NCT04810650|516980665|FG000|Overall Study|Death|0|||
143391758|NCT04810650|516980666|FG001|Overall Study|Death|0|||
143391759|NCT04810650|516980667|FG002|Overall Study|Death|0|||
143391760|NCT04810650|516980668|FG003|Overall Study|Death|0|||
143391761|NCT04810650|516980669|FG004|Overall Study|Death|0|||
143391762|NCT04810650|516980670|FG005|Overall Study|Death|0|||
143391763|NCT04810650|516980671|FG006|Overall Study|Death|2|||
143391764|NCT04810650|516980672|FG007|Overall Study|Death|2|||
143391765|NCT04810650|516980673|FG008|Overall Study|Death|0|||
143338775|NCT00549757|516784211|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
143338776|NCT02641392|516784214|FG000|Overall Study|Lost to Follow-up|0|||
143338777|NCT02641392|516784215|FG001|Overall Study|Lost to Follow-up|0|||
143338778|NCT02641392|516784216|FG002|Overall Study|Lost to Follow-up|2|||
143338779|NCT02641392|516784214|FG000|Overall Study|Withdrawal by Subject|0|||
143338780|NCT02641392|516784215|FG001|Overall Study|Withdrawal by Subject|0|||
143338781|NCT02641392|516784216|FG002|Overall Study|Withdrawal by Subject|17|||
143338782|NCT02641392|516784214|FG000|Overall Study|Adverse Event|0|||
143338783|NCT02641392|516784215|FG001|Overall Study|Adverse Event|1|||
143338784|NCT02641392|516784216|FG002|Overall Study|Adverse Event|25|||
143338785|NCT02641392|516784214|FG000|Overall Study|Study Terminated by Sponsor|4|||
143338786|NCT02641392|516784215|FG001|Overall Study|Study Terminated by Sponsor|12|||
143338787|NCT02641392|516784216|FG002|Overall Study|Study Terminated by Sponsor|144|||
143338788|NCT02641392|516784214|FG000|Overall Study|Lack of Efficacy|0|||
143338789|NCT02641392|516784215|FG001|Overall Study|Lack of Efficacy|0|||
143338790|NCT02641392|516784216|FG002|Overall Study|Lack of Efficacy|101|||
143338791|NCT02641392|516784214|FG000|Overall Study|Miscellaneous|0|||
143338792|NCT02641392|516784215|FG001|Overall Study|Miscellaneous|0|||
143338793|NCT02641392|516784216|FG002|Overall Study|Miscellaneous|3|||
143338794|NCT02641392|516784214|FG000|Overall Study|Death|0|||
143338795|NCT02641392|516784215|FG001|Overall Study|Death|0|||
143338796|NCT02641392|516784216|FG002|Overall Study|Death|1|||
143338797|NCT03518125|516784219|FG000|Overall Study|Lost to Follow-up|0|||
143338798|NCT03518125|516784220|FG001|Overall Study|Lost to Follow-up|2|||
143338799|NCT03518125|516784221|FG002|Overall Study|Lost to Follow-up|0|||
143338800|NCT03518125|516784222|FG003|Overall Study|Lost to Follow-up|0|||
143338801|NCT03518125|516784223|FG004|Overall Study|Lost to Follow-up|3|||
143391766|NCT04810650|516980674|FG009|Overall Study|Death|1|||
143391767|NCT04810650|516980675|FG010|Overall Study|Death|0|||
143391768|NCT04810650|516980676|FG011|Overall Study|Death|0|||
143391769|NCT04810650|516980677|FG012|Overall Study|Death|2|||
143391770|NCT04810650|516980678|FG013|Overall Study|Death|1|||
143391771|NCT04810650|516980665|FG000|Overall Study|Moved/transferred care|0|||
143391772|NCT04810650|516980666|FG001|Overall Study|Moved/transferred care|0|||
143391773|NCT04810650|516980667|FG002|Overall Study|Moved/transferred care|0|||
143391774|NCT04810650|516980668|FG003|Overall Study|Moved/transferred care|0|||
143391775|NCT04810650|516980669|FG004|Overall Study|Moved/transferred care|0|||
143391776|NCT04810650|516980670|FG005|Overall Study|Moved/transferred care|0|||
143391777|NCT04810650|516980671|FG006|Overall Study|Moved/transferred care|0|||
143391778|NCT04810650|516980672|FG007|Overall Study|Moved/transferred care|1|||
143391779|NCT04810650|516980673|FG008|Overall Study|Moved/transferred care|12|||
143391780|NCT04810650|516980674|FG009|Overall Study|Moved/transferred care|10|||
143391781|NCT04810650|516980675|FG010|Overall Study|Moved/transferred care|0|||
143391782|NCT04810650|516980676|FG011|Overall Study|Moved/transferred care|0|||
143391783|NCT04810650|516980677|FG012|Overall Study|Moved/transferred care|0|||
143391784|NCT04810650|516980678|FG013|Overall Study|Moved/transferred care|0|||
143391785|NCT04810650|516980665|FG000|Overall Study|Lost to Follow-up|15|||
143391786|NCT04810650|516980666|FG001|Overall Study|Lost to Follow-up|12|||
143391787|NCT04810650|516980667|FG002|Overall Study|Lost to Follow-up|7|||
143391788|NCT04810650|516980668|FG003|Overall Study|Lost to Follow-up|9|||
143391789|NCT04810650|516980669|FG004|Overall Study|Lost to Follow-up|10|||
143391790|NCT04810650|516980670|FG005|Overall Study|Lost to Follow-up|6|||
143391791|NCT04810650|516980671|FG006|Overall Study|Lost to Follow-up|0|||
143391792|NCT04810650|516980672|FG007|Overall Study|Lost to Follow-up|0|||
143391793|NCT04810650|516980673|FG008|Overall Study|Lost to Follow-up|0|||
143391794|NCT04810650|516980674|FG009|Overall Study|Lost to Follow-up|0|||
143391795|NCT04810650|516980675|FG010|Overall Study|Lost to Follow-up|1|||
143391796|NCT04810650|516980676|FG011|Overall Study|Lost to Follow-up|0|||
143391797|NCT04810650|516980677|FG012|Overall Study|Lost to Follow-up|3|||
143391798|NCT04810650|516980678|FG013|Overall Study|Lost to Follow-up|9|||
143391799|NCT04810650|516980665|FG000|Overall Study|Participant declined|0|||
143391800|NCT04810650|516980666|FG001|Overall Study|Participant declined|0|||
143391801|NCT04810650|516980667|FG002|Overall Study|Participant declined|0|||
143391802|NCT04810650|516980668|FG003|Overall Study|Participant declined|0|||
143391803|NCT04810650|516980669|FG004|Overall Study|Participant declined|0|||
143391804|NCT04810650|516980670|FG005|Overall Study|Participant declined|0|||
143391805|NCT04810650|516980671|FG006|Overall Study|Participant declined|0|||
143391806|NCT04810650|516980672|FG007|Overall Study|Participant declined|0|||
143391807|NCT04810650|516980673|FG008|Overall Study|Participant declined|0|||
143391808|NCT04810650|516980674|FG009|Overall Study|Participant declined|0|||
143391809|NCT04810650|516980675|FG010|Overall Study|Participant declined|2|||
143391810|NCT04810650|516980676|FG011|Overall Study|Participant declined|0|||
143391811|NCT04810650|516980677|FG012|Overall Study|Participant declined|0|||
143391812|NCT04810650|516980678|FG013|Overall Study|Participant declined|0|||
143391813|NCT04788511|516980679|FG000|Overall Study|Withdrawal by Subject|2|||
143391814|NCT04788511|516980680|FG001|Overall Study|Withdrawal by Subject|1|||
143391815|NCT04788511|516980679|FG000|Overall Study|Lost to Follow-up|2|||
143391816|NCT04788511|516980680|FG001|Overall Study|Lost to Follow-up|7|||
143391817|NCT04788511|516980679|FG000|Overall Study|Death|3|||
143391818|NCT04788511|516980680|FG001|Overall Study|Death|4|||
143391819|NCT04652700|516980683|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
143391820|NCT04652700|516980684|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
143391821|NCT04652700|516980683|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
143391822|NCT04652700|516980684|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
143391823|NCT04652700|516980683|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
143391824|NCT04652700|516980684|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
143391825|NCT04652700|516980683|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
143391826|NCT04652700|516980684|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
143391827|NCT04652700|516980683|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
143391828|NCT04652700|516980684|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
143391829|NCT04652700|516980683|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
143391830|NCT04652700|516980684|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
143391831|NCT04652700|516980683|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
143391832|NCT04652700|516980684|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
143391833|NCT04652700|516980683|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
143391834|NCT04652700|516980684|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
143391835|NCT04652700|516980683|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
143391836|NCT04652700|516980684|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
143391837|NCT04187833|516980685|FG000|Overall Study|Withdrawal by Subject|1|||
143391838|NCT03097549|516980688|FG000|Overall Study|Withdrawal by Subject|1|||
143391839|NCT03097549|516980689|FG001|Overall Study|Withdrawal by Subject|0|||
143391840|NCT03097549|516980688|FG000|Overall Study|Lost to Follow-up|1|||
143391841|NCT03097549|516980689|FG001|Overall Study|Lost to Follow-up|0|||
143391842|NCT05084508|516980692|FG000|Overall Study|Lost to Follow-up|6|||
143391843|NCT05084508|516980693|FG001|Overall Study|Lost to Follow-up|3|||
143391844|NCT05084508|516980694|FG002|Overall Study|Lost to Follow-up|7|||
143391845|NCT05084508|516980695|FG003|Overall Study|Lost to Follow-up|3|||
143391846|NCT05084508|516980692|FG000|Overall Study|Withdrawal by Subject|0|||
143391847|NCT05084508|516980693|FG001|Overall Study|Withdrawal by Subject|2|||
143391848|NCT05084508|516980694|FG002|Overall Study|Withdrawal by Subject|3|||
143391849|NCT05084508|516980695|FG003|Overall Study|Withdrawal by Subject|1|||
143391850|NCT05084508|516980692|FG000|Overall Study|Other|0|||
143391851|NCT05084508|516980693|FG001|Overall Study|Other|0|||
143391852|NCT05084508|516980694|FG002|Overall Study|Other|0|||
143391853|NCT05084508|516980695|FG003|Overall Study|Other|1|||
143391854|NCT01744782|516982621|FG000|Overall Study|Death|1|||
143391855|NCT01785719|516982622|FG000|4-week Baseline Evaluation|Physician Decision|1|||
143391856|NCT01785719|516982623|FG001|4-week Baseline Evaluation|Physician Decision|0|||
143391857|NCT01785719|516982622|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
143391858|NCT01785719|516982623|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
143391859|NCT01785719|516982622|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
143391860|NCT01785719|516982623|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
143391861|NCT01785719|516982622|FG000|4-week Baseline Evaluation|Pregnancy|0|||
143391862|NCT01785719|516982623|FG001|4-week Baseline Evaluation|Pregnancy|2|||
143391863|NCT01785719|516982622|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
143391864|NCT01785719|516982623|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
143391865|NCT01785719|516982622|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
143391866|NCT01785719|516982623|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
143391867|NCT01785719|516982622|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
143391868|NCT01785719|516982623|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
143391869|NCT01785719|516982622|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
143391870|NCT01785719|516982623|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
143391871|NCT01785719|516982622|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
143391872|NCT01785719|516982623|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
143391873|NCT01785719|516982622|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
143391874|NCT01785719|516982623|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
143391875|NCT01785719|516982622|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
143391876|NCT01785719|516982623|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
143391877|NCT01785719|516982622|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
143391878|NCT01785719|516982623|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
143391879|NCT01785719|516982622|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
143391880|NCT01785719|516982623|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
143391881|NCT01785719|516982622|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
143391882|NCT01785719|516982623|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
143391883|NCT01785719|516982622|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
143391884|NCT01785719|516982623|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
143391885|NCT04029688|516982624|FG000|Overall Study|Death|8|||
143391886|NCT04029688|516982625|FG001|Overall Study|Death|3|||
143391887|NCT04029688|516982626|FG002|Overall Study|Death|6|||
143391888|NCT04029688|516982627|FG003|Overall Study|Death|2|||
143391889|NCT04029688|516982628|FG004|Overall Study|Death|5|||
143391890|NCT04029688|516982629|FG005|Overall Study|Death|0|||
143391891|NCT04029688|516982630|FG006|Overall Study|Death|2|||
143391892|NCT04029688|516982631|FG007|Overall Study|Death|3|||
143391893|NCT04029688|516982624|FG000|Overall Study|Study Terminated by Sponsor|0|||
143391894|NCT04029688|516982625|FG001|Overall Study|Study Terminated by Sponsor|0|||
143391895|NCT04029688|516982626|FG002|Overall Study|Study Terminated by Sponsor|0|||
143391896|NCT04029688|516982627|FG003|Overall Study|Study Terminated by Sponsor|0|||
143391897|NCT04029688|516982628|FG004|Overall Study|Study Terminated by Sponsor|1|||
143391898|NCT04029688|516982629|FG005|Overall Study|Study Terminated by Sponsor|3|||
143391899|NCT04029688|516982630|FG006|Overall Study|Study Terminated by Sponsor|1|||
143391900|NCT04029688|516982631|FG007|Overall Study|Study Terminated by Sponsor|3|||
143391901|NCT04029688|516982624|FG000|Overall Study|Withdrawal by Subject|0|||
143391902|NCT04029688|516982625|FG001|Overall Study|Withdrawal by Subject|0|||
143391903|NCT04029688|516982626|FG002|Overall Study|Withdrawal by Subject|0|||
143391904|NCT04029688|516982627|FG003|Overall Study|Withdrawal by Subject|1|||
143391905|NCT04029688|516982628|FG004|Overall Study|Withdrawal by Subject|0|||
143391906|NCT04029688|516982629|FG005|Overall Study|Withdrawal by Subject|0|||
143391907|NCT04029688|516982630|FG006|Overall Study|Withdrawal by Subject|0|||
143391908|NCT04029688|516982631|FG007|Overall Study|Withdrawal by Subject|0|||
143391909|NCT05875142|516982632|FG000|Overall Study|Lost to Follow-up|0|||
143391910|NCT05875142|516982633|FG001|Overall Study|Lost to Follow-up|1|||
143391911|NCT05875142|516982634|FG002|Overall Study|Lost to Follow-up|1|||
143391912|NCT03436290|516982635|FG000|Overall Study|Post-randomization Exclusion|1|||
143391913|NCT03436290|516982636|FG001|Overall Study|Post-randomization Exclusion|0|||
143391914|NCT03436290|516982635|FG000|Overall Study|Death|6|||
143391915|NCT03436290|516982636|FG001|Overall Study|Death|0|||
143391916|NCT03436290|516982635|FG000|Overall Study|Withdrawal by Subject|4|||
143391917|NCT03436290|516982636|FG001|Overall Study|Withdrawal by Subject|0|||
143391918|NCT03436290|516982635|FG000|Overall Study|Protocol Violation|30|||
143391919|NCT03436290|516982636|FG001|Overall Study|Protocol Violation|0|||
143391920|NCT04130438|516982637|FG000|Overall Study|Lost to Follow-up|0|||
143391921|NCT04130438|516982638|FG001|Overall Study|Lost to Follow-up|0|||
143391922|NCT04130438|516982639|FG002|Overall Study|Lost to Follow-up|1|||
143391923|NCT04764448|516982641|FG000|Overall Study|Study terminated by sponsor|2|||
143391924|NCT04764448|516982642|FG001|Overall Study|Study terminated by sponsor|2|||
143391925|NCT04764448|516982643|FG002|Overall Study|Study terminated by sponsor|5|||
143391926|NCT04764448|516982641|FG000|Overall Study|Withdrawal by Subject|3|||
143391927|NCT04764448|516982642|FG001|Overall Study|Withdrawal by Subject|3|||
143391928|NCT04764448|516982643|FG002|Overall Study|Withdrawal by Subject|1|||
143391929|NCT03891667|516982648|FG000|Overall Study|Physician Decision|1|||
143391930|NCT03891667|516982649|FG001|Overall Study|Physician Decision|1|||
143391931|NCT03891667|516982648|FG000|Overall Study|COVID related pause|1|||
143391932|NCT03891667|516982649|FG001|Overall Study|COVID related pause|0|||
143391933|NCT03891667|516982648|FG000|Overall Study|Withdrawal by Subject|0|||
143391934|NCT03891667|516982649|FG001|Overall Study|Withdrawal by Subject|1|||
143391935|NCT03891667|516982648|FG000|Overall Study|Adverse Event|0|||
143391936|NCT03891667|516982649|FG001|Overall Study|Adverse Event|1|||
143391937|NCT05486078|516982650|FG000|Overall Study|4 drop out and one withdrawn|5|||
143391938|NCT02100813|516982651|FG000|Overall Study|Adverse Event|0|||
143391939|NCT02100813|516982652|FG001|Overall Study|Adverse Event|0|||
143391940|NCT02100813|516982653|FG002|Overall Study|Adverse Event|0|||
143391941|NCT02100813|516982654|FG003|Overall Study|Adverse Event|0|||
143391942|NCT02100813|516982655|FG004|Overall Study|Adverse Event|0|||
143391943|NCT02100813|516982656|FG005|Overall Study|Adverse Event|0|||
143391944|NCT02100813|516982657|FG006|Overall Study|Adverse Event|0|||
143391945|NCT02100813|516982658|FG007|Overall Study|Adverse Event|1|||
143391946|NCT03575897|516982659|FG000|Overall Study|Lost to Follow-up|12|||
143391947|NCT03575897|516982660|FG001|Overall Study|Lost to Follow-up|13|||
143391948|NCT02734290|516982663|FG000|Overall Study|Adverse Event|1|||
143391949|NCT02734290|516982664|FG001|Overall Study|Adverse Event|0|||
143391950|NCT02734290|516982663|FG000|Overall Study|Death|1|||
143391951|NCT02734290|516982664|FG001|Overall Study|Death|0|||
143391952|NCT05179837|516982665|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
143391953|NCT05179837|516982665|FG000|Overall Study|Device malfunctioned|1|||
143391954|NCT05179837|516982665|FG000|Overall Study|Image quality too low|2|||
143391955|NCT03134196|516982675|FG000|Overall Study|Death|2|||
143391956|NCT03134196|516982676|FG001|Overall Study|Death|1|||
143391957|NCT03134196|516982675|FG000|Overall Study|Lost to Follow-up|13|||
143391958|NCT03134196|516982676|FG001|Overall Study|Lost to Follow-up|15|||
143391959|NCT03134196|516982675|FG000|Overall Study|Physician Decision|0|||
143391960|NCT03134196|516982676|FG001|Overall Study|Physician Decision|1|||
143391961|NCT03134196|516982675|FG000|Overall Study|Withdrawal by Subject|19|||
143391962|NCT03134196|516982676|FG001|Overall Study|Withdrawal by Subject|12|||
143391963|NCT03134196|516982675|FG000|Overall Study|Site Unable to Contact Participant|2|||
143391964|NCT03134196|516982676|FG001|Overall Study|Site Unable to Contact Participant|0|||
143391965|NCT03134196|516982675|FG000|Overall Study|Site Closed Scheduling Conflict|1|||
143391966|NCT03134196|516982676|FG001|Overall Study|Site Closed Scheduling Conflict|0|||
143391967|NCT03134196|516982675|FG000|Overall Study|Scheduling Conflict|1|||
143391968|NCT03134196|516982676|FG001|Overall Study|Scheduling Conflict|0|||
143391969|NCT04059484|516982682|FG000|Overall Study|Adverse Event|2|||
143391970|NCT04059484|516982683|FG001|Overall Study|Adverse Event|5|||
143391971|NCT04059484|516982682|FG000|Overall Study|Withdrawal by Subject|5|||
143391972|NCT04059484|516982683|FG001|Overall Study|Withdrawal by Subject|3|||
143391973|NCT04059484|516982682|FG000|Overall Study|Progressive disease|112|||
143391974|NCT04059484|516982683|FG001|Overall Study|Progressive disease|112|||
143391975|NCT04059484|516982682|FG000|Overall Study|Other|8|||
143391976|NCT04059484|516982683|FG001|Overall Study|Other|3|||
143391977|NCT04059484|516982682|FG000|Overall Study|Ongoing|20|||
143391978|NCT04059484|516982683|FG001|Overall Study|Ongoing|20|||
143391979|NCT04292223|516982684|FG000|Overall Study|Adverse Event|1|||
143391980|NCT04292223|516982684|FG000|Overall Study|Lost to Follow-up|1|||
143391981|NCT04292223|516982684|FG000|Overall Study|Noncompliance with study drug|2|||
143391982|NCT04292223|516982684|FG000|Overall Study|Patient moved out of the state|1|||
143391983|NCT04719390|516982685|FG000|Overall Study|Withdrawal by Subject|1|||
143391984|NCT05746455|516982686|FG000|Overall Study|Discharged from Clinical Service|1|||
143391985|NCT05746455|516982686|FG000|Overall Study|Lost to Follow-up|1|||
143391986|NCT02023866|516982687|FG000|Overall Study|Non-compliance|2|||
143391987|NCT02023866|516982687|FG000|Overall Study|Adverse Event|3|||
143391988|NCT02023866|516982687|FG000|Overall Study|Withdrawal by Subject|1|||
143391989|NCT03307343|516982688|FG000|Overall Study|Withdrawal by Subject|1|||
143391990|NCT03307343|516982689|FG001|Overall Study|Withdrawal by Subject|2|||
143391991|NCT03307343|516982688|FG000|Overall Study|Pregnancy|0|||
143391992|NCT03307343|516982689|FG001|Overall Study|Pregnancy|2|||
143391993|NCT03307343|516982688|FG000|Overall Study|Physician Decision|1|||
143391994|NCT03307343|516982689|FG001|Overall Study|Physician Decision|0|||
143391995|NCT03307343|516982688|FG000|Overall Study|Lost to Follow-up|0|||
143391996|NCT03307343|516982689|FG001|Overall Study|Lost to Follow-up|2|||
143391997|NCT03016754|516982692|FG000|Overall Study|Death|5|||
143391998|NCT03016754|516982693|FG001|Overall Study|Death|4|||
143391999|NCT03016754|516982694|FG002|Overall Study|Death|5|||
143392000|NCT03016754|516982695|FG003|Overall Study|Death|1|||
143392001|NCT03016754|516982692|FG000|Overall Study|Lost to Follow-up|23|||
143392002|NCT03016754|516982693|FG001|Overall Study|Lost to Follow-up|17|||
143392003|NCT03016754|516982694|FG002|Overall Study|Lost to Follow-up|4|||
143392004|NCT03016754|516982695|FG003|Overall Study|Lost to Follow-up|2|||
143392005|NCT03016754|516982692|FG000|Overall Study|Withdrawal by Subject|6|||
143392006|NCT03016754|516982693|FG001|Overall Study|Withdrawal by Subject|6|||
143392007|NCT03016754|516982694|FG002|Overall Study|Withdrawal by Subject|2|||
143392008|NCT03016754|516982695|FG003|Overall Study|Withdrawal by Subject|2|||
143392009|NCT03016754|516982692|FG000|Overall Study|Other/Unknown|2|||
143392010|NCT03016754|516982693|FG001|Overall Study|Other/Unknown|4|||
143392011|NCT03016754|516982694|FG002|Overall Study|Other/Unknown|2|||
143392012|NCT03016754|516982695|FG003|Overall Study|Other/Unknown|1|||
143392013|NCT03016754|516982692|FG000|Overall Study|Protocol Violation|0|||
143392014|NCT03016754|516982693|FG001|Overall Study|Protocol Violation|0|||
143392015|NCT03016754|516982694|FG002|Overall Study|Protocol Violation|0|||
143392016|NCT03016754|516982695|FG003|Overall Study|Protocol Violation|4|||
143392017|NCT04185298|516982702|FG000|Overall Study|Lost to Follow-up|1|||
143392018|NCT04185298|516982703|FG001|Overall Study|Lost to Follow-up|3|||
143392019|NCT04185298|516982702|FG000|Overall Study|Withdrawal by Subject|0|||
143392020|NCT04185298|516982703|FG001|Overall Study|Withdrawal by Subject|3|||
143392021|NCT01798498|516982704|FG000|Overall Study|Lost to Follow-up|1|||
143392022|NCT03447470|516982709|FG000|Overall Study|Death|0|||
143392023|NCT03447470|516982710|FG001|Overall Study|Death|1|||
143392024|NCT03447470|516982711|FG002|Overall Study|Death|3|||
143392025|NCT03447470|516982712|FG003|Overall Study|Death|0|||
143392026|NCT03447470|516982713|FG004|Overall Study|Death|1|||
143392027|NCT03447470|516982714|FG005|Overall Study|Death|0|||
143392028|NCT03447470|516982715|FG006|Overall Study|Death|3|||
143392029|NCT03447470|516982716|FG007|Overall Study|Death|3|||
143392030|NCT03447470|516982717|FG008|Overall Study|Death|1|||
143392031|NCT03447470|516982709|FG000|Overall Study|Withdrawal by Subject|1|||
143392032|NCT03447470|516982710|FG001|Overall Study|Withdrawal by Subject|0|||
143392033|NCT03447470|516982711|FG002|Overall Study|Withdrawal by Subject|0|||
143392034|NCT03447470|516982712|FG003|Overall Study|Withdrawal by Subject|0|||
143392035|NCT03447470|516982713|FG004|Overall Study|Withdrawal by Subject|1|||
143392036|NCT03447470|516982714|FG005|Overall Study|Withdrawal by Subject|0|||
143392037|NCT03447470|516982715|FG006|Overall Study|Withdrawal by Subject|1|||
143392038|NCT03447470|516982716|FG007|Overall Study|Withdrawal by Subject|1|||
143392039|NCT03447470|516982717|FG008|Overall Study|Withdrawal by Subject|3|||
143392040|NCT03447470|516982709|FG000|Overall Study|Treatment discontinued|3|||
143392041|NCT03447470|516982710|FG001|Overall Study|Treatment discontinued|2|||
143392042|NCT03447470|516982711|FG002|Overall Study|Treatment discontinued|4|||
143392043|NCT03447470|516982712|FG003|Overall Study|Treatment discontinued|6|||
143392044|NCT03447470|516982713|FG004|Overall Study|Treatment discontinued|2|||
143392045|NCT03447470|516982714|FG005|Overall Study|Treatment discontinued|1|||
143392046|NCT03447470|516982715|FG006|Overall Study|Treatment discontinued|2|||
143392047|NCT03447470|516982716|FG007|Overall Study|Treatment discontinued|4|||
143392048|NCT03447470|516982717|FG008|Overall Study|Treatment discontinued|3|||
143392049|NCT01606215|516982718|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
143392050|NCT01606215|516982719|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
143392051|NCT05184192|516982721|FG000|Overall Study|Lost to Follow-up|4|||
143392052|NCT05184192|516982722|FG001|Overall Study|Lost to Follow-up|7|||
143392053|NCT05184192|516982721|FG000|Overall Study|Adverse Event|1|||
143392054|NCT05184192|516982722|FG001|Overall Study|Adverse Event|4|||
143392055|NCT05184192|516982721|FG000|Overall Study|PI withdrawal|1|||
143392056|NCT05184192|516982722|FG001|Overall Study|PI withdrawal|2|||
143392057|NCT05184192|516982721|FG000|Overall Study|Withdrew due to adverse effect|1|||
143392058|NCT05184192|516982722|FG001|Overall Study|Withdrew due to adverse effect|0|||
143392059|NCT05184192|516982721|FG000|Overall Study|Medication schedule|1|||
143392060|NCT05184192|516982722|FG001|Overall Study|Medication schedule|0|||
143392061|NCT05184192|516982721|FG000|Overall Study|Concern for adverse effects|0|||
143392062|NCT05184192|516982722|FG001|Overall Study|Concern for adverse effects|4|||
143392063|NCT04295798|516982730|FG000|Overall Study|Lost to Follow-up|1|||
143392064|NCT04927364|516982731|FG000|Overall Study|Withdrawal by Subject|3|||
143392065|NCT04927364|516982731|FG000|Overall Study|Unable to complete preassessment MRI|1|||
143392066|NCT05087992|516982738|FG000|Overall Study|Adverse Event|0|||
143392067|NCT05087992|516982739|FG001|Overall Study|Adverse Event|1|||
143392068|NCT05087992|516982740|FG002|Overall Study|Adverse Event|0|||
143392069|NCT05087992|516982738|FG000|Overall Study|Withdrawal by Subject|2|||
143392070|NCT05087992|516982739|FG001|Overall Study|Withdrawal by Subject|0|||
143392071|NCT05087992|516982740|FG002|Overall Study|Withdrawal by Subject|0|||
143392072|NCT05087992|516982738|FG000|Overall Study|clinical disease progression|3|||
143392073|NCT05087992|516982739|FG001|Overall Study|clinical disease progression|1|||
143392074|NCT05087992|516982740|FG002|Overall Study|clinical disease progression|0|||
143392075|NCT05087992|516982738|FG000|Overall Study|objective disease progression|4|||
143392076|NCT05087992|516982739|FG001|Overall Study|objective disease progression|1|||
143392077|NCT05087992|516982740|FG002|Overall Study|objective disease progression|0|||
143392078|NCT01959425|516982741|FG000|Overall Study|Withdrawal by Subject|5|||
143392079|NCT01959425|516982742|FG001|Overall Study|Withdrawal by Subject|4|||
143392080|NCT01959425|516982741|FG000|Overall Study|Lost to Follow-up|1|||
143392081|NCT01959425|516982742|FG001|Overall Study|Lost to Follow-up|0|||
143392082|NCT01959425|516982741|FG000|Overall Study|Discontinued Subjects|6|||
143392083|NCT01959425|516982742|FG001|Overall Study|Discontinued Subjects|4|||
143392084|NCT01902173|516982743|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
143392085|NCT01902173|516982744|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
143392086|NCT01902173|516982745|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
143392087|NCT01902173|516982746|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
143392088|NCT01902173|516982747|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
143392089|NCT01902173|516982748|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
143392090|NCT01902173|516982743|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
143392091|NCT01902173|516982744|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
143392092|NCT01902173|516982745|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
143392093|NCT01902173|516982746|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
143392094|NCT01902173|516982747|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
143392095|NCT01902173|516982748|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
143392096|NCT01902173|516982743|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
143392097|NCT01902173|516982744|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
143392098|NCT01902173|516982745|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
143392099|NCT01902173|516982746|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
143392100|NCT01902173|516982747|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
143392101|NCT01902173|516982748|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
143392102|NCT01902173|516982743|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
143392103|NCT01902173|516982744|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
143392104|NCT01902173|516982745|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
143392105|NCT01902173|516982746|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
143392106|NCT01902173|516982747|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
143392107|NCT01902173|516982748|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
143392108|NCT01902173|516982743|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
143392109|NCT01902173|516982744|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
143392110|NCT01902173|516982745|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
143392111|NCT01902173|516982746|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
143392112|NCT01902173|516982747|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
143392113|NCT01902173|516982748|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
143392114|NCT01902173|516982743|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
143392115|NCT01902173|516982744|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
143392116|NCT01902173|516982745|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
143392117|NCT01902173|516982746|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
143392118|NCT01902173|516982747|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
143392119|NCT01902173|516982748|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
143392120|NCT01902173|516982743|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
143392121|NCT01902173|516982744|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
143392122|NCT01902173|516982745|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
143392123|NCT01902173|516982746|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
143392124|NCT01902173|516982747|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
143392125|NCT01902173|516982748|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
143392126|NCT01902173|516982743|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
143392127|NCT01902173|516982744|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
143392128|NCT01902173|516982745|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
143392129|NCT01902173|516982746|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
143392130|NCT01902173|516982747|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
143392131|NCT01902173|516982748|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
143392132|NCT01902173|516982743|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
143392133|NCT01902173|516982744|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
143392134|NCT01902173|516982745|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
143392135|NCT01902173|516982746|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
143392136|NCT01902173|516982747|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
143392137|NCT01902173|516982748|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
143392138|NCT01902173|516982743|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
143392139|NCT01902173|516982744|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
143392140|NCT01902173|516982745|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
143392141|NCT01902173|516982746|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
143392142|NCT01902173|516982747|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
143392143|NCT01902173|516982748|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
143392144|NCT01902173|516982743|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
143392145|NCT01902173|516982744|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
143392146|NCT01902173|516982745|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
143392147|NCT01902173|516982746|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
143392148|NCT01902173|516982747|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
143392149|NCT01902173|516982748|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
143392150|NCT01902173|516982743|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
143392151|NCT01902173|516982744|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
143392152|NCT01902173|516982745|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
143392153|NCT01902173|516982746|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
143392154|NCT01902173|516982747|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
143392155|NCT01902173|516982748|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
143392156|NCT01902173|516982743|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
143392157|NCT01902173|516982744|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
143392158|NCT01902173|516982745|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
143392159|NCT01902173|516982746|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
143392160|NCT01902173|516982747|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
143392161|NCT01902173|516982748|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
143392162|NCT01902173|516982743|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
143392163|NCT01902173|516982744|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
143392164|NCT01902173|516982745|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
143392165|NCT01902173|516982746|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
143392166|NCT01902173|516982747|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
143392167|NCT01902173|516982748|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
143392168|NCT04625283|516982750|FG000|Overall Study|post randomization exclusion|28|||
143392169|NCT04625283|516982751|FG001|Overall Study|post randomization exclusion|20|||
143392170|NCT02262728|516982752|FG000|Follow-up Phase (3 Years)|Death|0|||
143392171|NCT02262728|516982753|FG001|Follow-up Phase (3 Years)|Death|1|||
143392172|NCT02262728|516982752|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
143392173|NCT02262728|516982753|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
143392174|NCT02262728|516982752|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
143392175|NCT02262728|516982753|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
143392176|NCT01824394|516982756|FG000|Overall Study|Early Termination|1|||
143392177|NCT01824394|516982757|FG001|Overall Study|Early Termination|1|||
143392178|NCT01824394|516982758|FG002|Overall Study|Early Termination|3|||
143392179|NCT01824394|516982756|FG000|Overall Study|Withdrawn due to Study Termination|91|||
143392180|NCT01824394|516982757|FG001|Overall Study|Withdrawn due to Study Termination|83|||
143392181|NCT01824394|516982758|FG002|Overall Study|Withdrawn due to Study Termination|41|||
143392182|NCT01824394|516982756|FG000|Overall Study|Lost to Follow-up|0|||
143392183|NCT01824394|516982757|FG001|Overall Study|Lost to Follow-up|9|||
143392184|NCT01824394|516982758|FG002|Overall Study|Lost to Follow-up|3|||
143392185|NCT01824394|516982756|FG000|Overall Study|Death|3|||
143392186|NCT01824394|516982757|FG001|Overall Study|Death|2|||
143392187|NCT01824394|516982758|FG002|Overall Study|Death|4|||
143392188|NCT01824394|516982756|FG000|Overall Study|Discontinued Subjects|1|||
143392189|NCT01824394|516982757|FG001|Overall Study|Discontinued Subjects|1|||
143392190|NCT01824394|516982758|FG002|Overall Study|Discontinued Subjects|2|||
143392191|NCT01824394|516982756|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
143392192|NCT01824394|516982757|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
143392193|NCT01824394|516982758|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
143392194|NCT02619838|516982759|FG000|Overall Study|Lost to Follow-up|9|||
143392195|NCT02619838|516982759|FG000|Overall Study|Withdrawal by Subject|15|||
143392196|NCT00227344|516982760|FG000|Overall Study|study terminated early|12|||
143392197|NCT00227344|516982761|FG001|Overall Study|study terminated early|5|||
143392198|NCT05020249|516982762|FG000|Overall Study|Protocol Violation|1|||
143392199|NCT05020249|516982763|FG001|Overall Study|Protocol Violation|0|||
143392200|NCT05364671|516982764|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
143392201|NCT05364671|516982765|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
143392202|NCT05364671|516982764|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
143392203|NCT05364671|516982765|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
143392204|NCT05364671|516982764|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
143392205|NCT05364671|516982765|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
143392206|NCT05364671|516982764|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
143392207|NCT05364671|516982765|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
143392208|NCT05364671|516982764|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
143392209|NCT05364671|516982765|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
143392210|NCT03536754|516982768|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
143392211|NCT03536754|516982769|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
143392212|NCT03536754|516982770|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
143392213|NCT03536754|516982771|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
143392214|NCT03536754|516982772|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
143392215|NCT03536754|516982768|FG000|Open Label Extension|Other|0|||
143392216|NCT03536754|516982769|FG001|Open Label Extension|Other|0|||
143392217|NCT03536754|516982770|FG002|Open Label Extension|Other|0|||
143392218|NCT03536754|516982771|FG003|Open Label Extension|Other|0|||
143392219|NCT03536754|516982772|FG004|Open Label Extension|Other|1|||
143392220|NCT05006872|516982776|FG000|Overall Study|Lost to Follow-up|37|||
143392221|NCT05006872|516982777|FG001|Overall Study|Lost to Follow-up|31|||
143392222|NCT00686335|516982780|FG000|Run-in Period|Adverse Event|1|||
143392223|NCT00686335|516982780|FG000|Run-in Period|asthma exacerbation|1|||
143392224|NCT00686335|516982780|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
143392225|NCT04142788|516984765|FG000|Overall Study|Trial terminated prematurely|2|||
143392226|NCT04142788|516984766|FG001|Overall Study|Trial terminated prematurely|2|||
143392227|NCT01396278|516984767|FG000|Overall Study|Adverse Event|0|||
143392228|NCT01396278|516984768|FG001|Overall Study|Adverse Event|0|||
143392229|NCT01396278|516984769|FG002|Overall Study|Adverse Event|0|||
143392230|NCT01396278|516984770|FG003|Overall Study|Adverse Event|2|||
143392231|NCT01396278|516984771|FG004|Overall Study|Adverse Event|0|||
143392232|NCT01396278|516984767|FG000|Overall Study|Withdraw due to trial termination|2|||
143392233|NCT01396278|516984768|FG001|Overall Study|Withdraw due to trial termination|1|||
143392234|NCT01396278|516984769|FG002|Overall Study|Withdraw due to trial termination|1|||
143392235|NCT01396278|516984770|FG003|Overall Study|Withdraw due to trial termination|0|||
143392236|NCT01396278|516984771|FG004|Overall Study|Withdraw due to trial termination|2|||
143392237|NCT04515576|516984774|FG000|Overall Study|Withdrawal by Subject|0|||
143392238|NCT04515576|516984775|FG001|Overall Study|Withdrawal by Subject|0|||
143392239|NCT04515576|516984776|FG002|Overall Study|Withdrawal by Subject|0|||
143392240|NCT04515576|516984777|FG003|Overall Study|Withdrawal by Subject|0|||
143392241|NCT04515576|516984778|FG004|Overall Study|Withdrawal by Subject|0|||
143392242|NCT04515576|516984779|FG005|Overall Study|Withdrawal by Subject|1|||
143392243|NCT03812679|516984780|FG000|Overall Study|Adverse Event|2|||
143392244|NCT03812679|516984780|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
143392245|NCT03812679|516984780|FG000|Overall Study|Renal transplant|1|||
143392246|NCT03812679|516984780|FG000|Overall Study|Withdrawal by Subject|1|||
143392247|NCT03812679|516984780|FG000|Overall Study|Termination of study|2|||
143392248|NCT03812679|516984780|FG000|Overall Study|Water device replacement|1|||
143392249|NCT05653427|516984781|FG000|Overall Study|Study Terminated by Sponsor|13|||
143392250|NCT02140554|516984785|FG000|Overall Study|Withdrawal of consent|1|||
143392251|NCT02140554|516984786|FG001|Overall Study|Withdrawal of consent|0|||
143392252|NCT02140554|516984787|FG002|Overall Study|Withdrawal of consent|4|||
143392253|NCT02140554|516984785|FG000|Overall Study|Physician Decision|1|||
143392254|NCT02140554|516984786|FG001|Overall Study|Physician Decision|0|||
143392255|NCT02140554|516984787|FG002|Overall Study|Physician Decision|2|||
143392256|NCT02140554|516984785|FG000|Overall Study|Death|0|||
143392257|NCT02140554|516984786|FG001|Overall Study|Death|0|||
143392258|NCT02140554|516984787|FG002|Overall Study|Death|1|||
143392259|NCT02140554|516984785|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
143392260|NCT02140554|516984786|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
143392261|NCT02140554|516984787|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
143392262|NCT05590403|516984788|FG000|Overall Study|Lost to Follow-up|13|||
143392263|NCT05590403|516984789|FG001|Overall Study|Lost to Follow-up|1|||
143392264|NCT05590403|516984790|FG002|Overall Study|Lost to Follow-up|7|||
143392265|NCT05590403|516984791|FG003|Overall Study|Lost to Follow-up|3|||
143392266|NCT05590403|516984792|FG004|Overall Study|Lost to Follow-up|4|||
143392267|NCT05590403|516984788|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
143392268|NCT05590403|516984789|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
143392269|NCT05590403|516984790|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
143392270|NCT05590403|516984791|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
143392271|NCT05590403|516984792|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
143392272|NCT05590403|516984788|FG000|Overall Study|Other|2|||
143392273|NCT05590403|516984789|FG001|Overall Study|Other|0|||
143392274|NCT05590403|516984790|FG002|Overall Study|Other|2|||
143392275|NCT05590403|516984791|FG003|Overall Study|Other|2|||
143392276|NCT05590403|516984792|FG004|Overall Study|Other|0|||
143392277|NCT05590403|516984788|FG000|Overall Study|Migrated / moved from the study area|1|||
143392278|NCT05590403|516984789|FG001|Overall Study|Migrated / moved from the study area|1|||
143392279|NCT05590403|516984790|FG002|Overall Study|Migrated / moved from the study area|0|||
143392280|NCT05590403|516984791|FG003|Overall Study|Migrated / moved from the study area|3|||
143392281|NCT05590403|516984792|FG004|Overall Study|Migrated / moved from the study area|1|||
143392282|NCT05590403|516984788|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
143392283|NCT05590403|516984789|FG001|Overall Study|Adverse event requiring expedited reporting|0|||
143392284|NCT05590403|516984790|FG002|Overall Study|Adverse event requiring expedited reporting|4|||
143392285|NCT05590403|516984791|FG003|Overall Study|Adverse event requiring expedited reporting|1|||
143392286|NCT05590403|516984792|FG004|Overall Study|Adverse event requiring expedited reporting|0|||
143392287|NCT01160211|516984794|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
143392288|NCT01160211|516984795|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
143392289|NCT01160211|516984796|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|59|||
143392290|NCT01160211|516984794|FG000|Overall Study|Lost to Follow-up|4|||
143392291|NCT01160211|516984795|FG001|Overall Study|Lost to Follow-up|8|||
143392292|NCT01160211|516984796|FG002|Overall Study|Lost to Follow-up|4|||
143392293|NCT01160211|516984794|FG000|Overall Study|Physician Decision|1|||
143392294|NCT01160211|516984795|FG001|Overall Study|Physician Decision|0|||
143392295|NCT01160211|516984796|FG002|Overall Study|Physician Decision|0|||
143392296|NCT01160211|516984794|FG000|Overall Study|Withdrawal by Subject|4|||
143392297|NCT01160211|516984795|FG001|Overall Study|Withdrawal by Subject|2|||
143392298|NCT01160211|516984796|FG002|Overall Study|Withdrawal by Subject|2|||
143392299|NCT01160211|516984794|FG000|Overall Study|Data unavailable due to regulatory issues|2|||
143392300|NCT01160211|516984795|FG001|Overall Study|Data unavailable due to regulatory issues|0|||
143392301|NCT01160211|516984796|FG002|Overall Study|Data unavailable due to regulatory issues|2|||
143392302|NCT05409183|516984802|FG000|Complete Study|Adverse Event|1|||
143392303|NCT05409183|516984803|FG001|Complete Study|Adverse Event|2|||
143392304|NCT05409183|516984802|FG000|Complete Study|Withdrawal by Subject|3|||
143392305|NCT05409183|516984803|FG001|Complete Study|Withdrawal by Subject|0|||
143392306|NCT03194217|516984804|FG000|Overall Study|Adverse Event|0|||
143392307|NCT03194217|516984805|FG001|Overall Study|Adverse Event|2|||
143392308|NCT03194217|516984806|FG002|Overall Study|Adverse Event|3|||
143392309|NCT03194217|516984807|FG003|Overall Study|Adverse Event|3|||
143392310|NCT03194217|516984804|FG000|Overall Study|Failure to meet randomisation criteria|0|||
143392311|NCT03194217|516984805|FG001|Overall Study|Failure to meet randomisation criteria|0|||
143392312|NCT03194217|516984806|FG002|Overall Study|Failure to meet randomisation criteria|0|||
143392313|NCT03194217|516984807|FG003|Overall Study|Failure to meet randomisation criteria|1|||
143392314|NCT03194217|516984804|FG000|Overall Study|Other|0|||
143392315|NCT03194217|516984805|FG001|Overall Study|Other|1|||
143392316|NCT03194217|516984806|FG002|Overall Study|Other|1|||
143392317|NCT03194217|516984807|FG003|Overall Study|Other|0|||
143392318|NCT04806451|516984808|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
143392319|NCT04806451|516984809|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
143392320|NCT04806451|516984808|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
143392321|NCT04806451|516984809|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
143392322|NCT04806451|516984808|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
143392323|NCT04806451|516984809|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
143392324|NCT04064164|516984814|FG000|Overall Study|Withdrawal by Subject|8|||
143392325|NCT04064164|516984815|FG001|Overall Study|Withdrawal by Subject|8|||
143392326|NCT03839940|516984817|FG000|Overall Study|Withdrawal by Subject|3|||
143392327|NCT03839940|516984818|FG001|Overall Study|Withdrawal by Subject|0|||
143392328|NCT03839940|516984817|FG000|Overall Study|Protocol Violation|0|||
143392329|NCT03839940|516984818|FG001|Overall Study|Protocol Violation|1|||
143392330|NCT03839940|516984817|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
143392331|NCT03839940|516984818|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
143392332|NCT03241745|516984819|FG000|Overall Study|Adverse Event|7|||
143392333|NCT03241745|516984819|FG000|Overall Study|Death|1|||
143392334|NCT03241745|516984819|FG000|Overall Study|Withdrawal by Subject|5|||
143392335|NCT03241745|516984819|FG000|Overall Study|Treatment delay >28 days|2|||
143392336|NCT03241745|516984819|FG000|Overall Study|Lack of Efficacy|14|||
143392337|NCT04019873|516984821|FG000|Overall Study|Discontinued from the treatment|1|||
143392338|NCT04019873|516984822|FG001|Overall Study|Discontinued from the treatment|39|||
143392339|NCT04019873|516984823|FG002|Overall Study|Discontinued from the treatment|2|||
143392340|NCT04683744|516984824|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
143392341|NCT04683744|516984825|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
143392342|NCT04683744|516984826|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
143392343|NCT04316871|516984828|FG000|Overall Study|Protocol Violation|2|||
143392344|NCT04316871|516984829|FG001|Overall Study|Protocol Violation|2|||
143392345|NCT04316871|516984830|FG002|Overall Study|Protocol Violation|2|||
143392346|NCT04316871|516984831|FG003|Overall Study|Protocol Violation|2|||
143392347|NCT04650269|516984832|FG000|Overall Study|Death|3|||
143392348|NCT04650269|516984832|FG000|Overall Study|Lost to Follow-up|6|||
143392349|NCT01437709|516984833|FG000|Overall Study|Adverse Event|0|||
143392350|NCT01437709|516984834|FG001|Overall Study|Adverse Event|1|||
143392351|NCT01437709|516984835|FG002|Overall Study|Adverse Event|0|||
143392352|NCT01437709|516984833|FG000|Overall Study|Pt trasnferred care|0|||
143392353|NCT01437709|516984834|FG001|Overall Study|Pt trasnferred care|1|||
143392354|NCT01437709|516984835|FG002|Overall Study|Pt trasnferred care|0|||
143392355|NCT04091750|516984836|FG000|Overall Study|Adverse Event|4|||
143392356|NCT04091750|516984836|FG000|Overall Study|Withdrawal by Subject|1|||
143392357|NCT01842542|516984837|FG000|Overall Study|Withdrawal by Subject|2|||
143338802|NCT03518125|516784224|FG005|Overall Study|Lost to Follow-up|5|||
143338803|NCT03518125|516784219|FG000|Overall Study|Physician Decision|0|||
143338804|NCT03518125|516784220|FG001|Overall Study|Physician Decision|1|||
143338805|NCT03518125|516784221|FG002|Overall Study|Physician Decision|0|||
143338806|NCT03518125|516784222|FG003|Overall Study|Physician Decision|0|||
143338807|NCT03518125|516784223|FG004|Overall Study|Physician Decision|0|||
143338808|NCT03518125|516784224|FG005|Overall Study|Physician Decision|0|||
143338809|NCT03518125|516784219|FG000|Overall Study|Withdrawal by Subject|1|||
143338810|NCT03518125|516784220|FG001|Overall Study|Withdrawal by Subject|1|||
143338811|NCT03518125|516784221|FG002|Overall Study|Withdrawal by Subject|0|||
143338812|NCT03518125|516784222|FG003|Overall Study|Withdrawal by Subject|1|||
143338813|NCT03518125|516784223|FG004|Overall Study|Withdrawal by Subject|1|||
143338814|NCT03518125|516784224|FG005|Overall Study|Withdrawal by Subject|3|||
143338815|NCT03518125|516784219|FG000|Overall Study|Missed Day 394 Visit|1|||
143338816|NCT03518125|516784220|FG001|Overall Study|Missed Day 394 Visit|0|||
143338817|NCT03518125|516784221|FG002|Overall Study|Missed Day 394 Visit|0|||
143338818|NCT03518125|516784222|FG003|Overall Study|Missed Day 394 Visit|0|||
143338819|NCT03518125|516784223|FG004|Overall Study|Missed Day 394 Visit|0|||
143338820|NCT03518125|516784224|FG005|Overall Study|Missed Day 394 Visit|0|||
143338821|NCT01119768|516784225|FG000|Treatment Period|Lack of Efficacy|18|||
143338822|NCT01119768|516784226|FG001|Treatment Period|Lack of Efficacy|25|||
143338823|NCT01301391|516784227|FG000|Overall Study|Death|13|||
143338824|NCT01301391|516784227|FG000|Overall Study|Lost to Follow-up|3|||
143338825|NCT01301391|516784227|FG000|Overall Study|Physician Decision|2|||
143338826|NCT01301391|516784227|FG000|Overall Study|Sponsor's decision|8|||
143338827|NCT01477853|516784230|FG000|Phase A|Adverse Event|1|||
143338828|NCT01477853|516784231|FG001|Phase A|Adverse Event|2|||
143338829|NCT01477853|516784232|FG002|Phase A|Adverse Event|2|||
143338830|NCT01477853|516784230|FG000|Phase A|Lost to Follow-up|4|||
143338831|NCT01477853|516784231|FG001|Phase A|Lost to Follow-up|3|||
143338832|NCT01477853|516784232|FG002|Phase A|Lost to Follow-up|2|||
143338833|NCT01477853|516784230|FG000|Phase A|Physician Decision|1|||
143338834|NCT01477853|516784231|FG001|Phase A|Physician Decision|0|||
143338835|NCT01477853|516784232|FG002|Phase A|Physician Decision|1|||
143338836|NCT01477853|516784230|FG000|Phase A|Study terminated by sponsor|37|||
143338837|NCT01477853|516784231|FG001|Phase A|Study terminated by sponsor|40|||
143338838|NCT01477853|516784232|FG002|Phase A|Study terminated by sponsor|39|||
143338839|NCT01477853|516784230|FG000|Phase B|Lost to Follow-up|0|||
143338840|NCT01477853|516784231|FG001|Phase B|Lost to Follow-up|1|||
143338841|NCT01477853|516784232|FG002|Phase B|Lost to Follow-up|0|||
143338842|NCT01477853|516784230|FG000|Phase B|Study terminated by sponsor|12|||
143338843|NCT01477853|516784231|FG001|Phase B|Study terminated by sponsor|10|||
143338844|NCT01477853|516784232|FG002|Phase B|Study terminated by sponsor|11|||
143338845|NCT00677352|516784236|FG000|Treatment Phase|Adverse Event|14|||
143338846|NCT00677352|516784237|FG001|Treatment Phase|Adverse Event|22|||
143338847|NCT00677352|516784236|FG000|Treatment Phase|Lack of Efficacy|2|||
143338848|NCT00677352|516784237|FG001|Treatment Phase|Lack of Efficacy|3|||
143338849|NCT00677352|516784236|FG000|Treatment Phase|Lost to Follow-up|0|||
143338850|NCT00677352|516784237|FG001|Treatment Phase|Lost to Follow-up|1|||
143338851|NCT00677352|516784236|FG000|Treatment Phase|Withdrawal by Subject|7|||
143338852|NCT00677352|516784237|FG001|Treatment Phase|Withdrawal by Subject|7|||
143338853|NCT00677352|516784236|FG000|Treatment Phase|Physician Decision|1|||
143338854|NCT00677352|516784237|FG001|Treatment Phase|Physician Decision|0|||
143338855|NCT00677352|516784236|FG000|Treatment Phase|Pregnancy|0|||
143338856|NCT00677352|516784237|FG001|Treatment Phase|Pregnancy|1|||
143338857|NCT00677352|516784236|FG000|Treatment Phase|Protocol Violation|1|||
143338858|NCT00677352|516784237|FG001|Treatment Phase|Protocol Violation|1|||
143338859|NCT00677352|516784236|FG000|Treatment Phase|Transference or work related matter|0|||
143338860|NCT00677352|516784237|FG001|Treatment Phase|Transference or work related matter|5|||
143338861|NCT00677352|516784236|FG000|Treatment Phase|Not treated|0|||
143338862|NCT00677352|516784237|FG001|Treatment Phase|Not treated|2|||
143392358|NCT01842542|516984837|FG000|Overall Study|Lack of Efficacy|1|||
143392359|NCT01842542|516984837|FG000|Overall Study|Protocol Non-compliance|2|||
143392360|NCT01842542|516984837|FG000|Overall Study|Lost to Follow-up|1|||
143392361|NCT02919306|516984838|FG000|Overall Study|Withdrawal by Subject|1|||
143392362|NCT02919306|516984839|FG001|Overall Study|Withdrawal by Subject|0|||
143392363|NCT02919306|516984838|FG000|Overall Study|Protocol Violation|1|||
143392364|NCT02919306|516984839|FG001|Overall Study|Protocol Violation|0|||
143392365|NCT04473222|516984840|FG000|Overall Study|Lost to Follow-up|13|||
143392366|NCT04473222|516984841|FG001|Overall Study|Lost to Follow-up|13|||
143392367|NCT04473222|516984840|FG000|Overall Study|Withdrawal by Subject|0|||
143392368|NCT04473222|516984841|FG001|Overall Study|Withdrawal by Subject|1|||
143392369|NCT04473222|516984840|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
143392370|NCT04473222|516984841|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
143392371|NCT03560609|516984842|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
143392372|NCT03560609|516984843|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
143392373|NCT04293055|516984844|FG000|Overall Study|Lost to Follow-up|1|||
143392374|NCT04293055|516984845|FG001|Overall Study|Lost to Follow-up|1|||
143392375|NCT04293055|516984844|FG000|Overall Study|Did not trigger randomization|6|||
143392376|NCT04293055|516984845|FG001|Overall Study|Did not trigger randomization|5|||
143392377|NCT04908722|516984854|FG000|Overall Study|Protocol deviation|1|||
143392378|NCT04908722|516984855|FG001|Overall Study|Protocol deviation|0|||
143392379|NCT04908722|516984856|FG002|Overall Study|Protocol deviation|0|||
143392380|NCT04908722|516984857|FG003|Overall Study|Protocol deviation|0|||
143392381|NCT04908722|516984858|FG004|Overall Study|Protocol deviation|0|||
143392382|NCT04908722|516984859|FG005|Overall Study|Protocol deviation|1|||
143392383|NCT04908722|516984854|FG000|Overall Study|Lost to Follow-up|33|||
143392384|NCT04908722|516984855|FG001|Overall Study|Lost to Follow-up|33|||
143392385|NCT04908722|516984856|FG002|Overall Study|Lost to Follow-up|36|||
143392386|NCT04908722|516984857|FG003|Overall Study|Lost to Follow-up|30|||
143392387|NCT04908722|516984858|FG004|Overall Study|Lost to Follow-up|32|||
143392388|NCT04908722|516984859|FG005|Overall Study|Lost to Follow-up|34|||
143392389|NCT04908722|516984854|FG000|Overall Study|Physician Decision|1|||
143392390|NCT04908722|516984855|FG001|Overall Study|Physician Decision|1|||
143392391|NCT04908722|516984856|FG002|Overall Study|Physician Decision|1|||
143392392|NCT04908722|516984857|FG003|Overall Study|Physician Decision|2|||
143392393|NCT04908722|516984858|FG004|Overall Study|Physician Decision|0|||
143392394|NCT04908722|516984859|FG005|Overall Study|Physician Decision|0|||
143392395|NCT04908722|516984854|FG000|Overall Study|Death|1|||
143392396|NCT04908722|516984855|FG001|Overall Study|Death|0|||
143392397|NCT04908722|516984856|FG002|Overall Study|Death|0|||
143392398|NCT04908722|516984857|FG003|Overall Study|Death|0|||
143392399|NCT04908722|516984858|FG004|Overall Study|Death|0|||
143392400|NCT04908722|516984859|FG005|Overall Study|Death|1|||
143392401|NCT04908722|516984854|FG000|Overall Study|Withdrawal by Subject|12|||
143392402|NCT04908722|516984855|FG001|Overall Study|Withdrawal by Subject|8|||
143392403|NCT04908722|516984856|FG002|Overall Study|Withdrawal by Subject|7|||
143392404|NCT04908722|516984857|FG003|Overall Study|Withdrawal by Subject|6|||
143392405|NCT04908722|516984858|FG004|Overall Study|Withdrawal by Subject|12|||
143392406|NCT04908722|516984859|FG005|Overall Study|Withdrawal by Subject|14|||
143392407|NCT04908722|516984854|FG000|Overall Study|Other|3|||
143392408|NCT04908722|516984855|FG001|Overall Study|Other|1|||
143392409|NCT04908722|516984856|FG002|Overall Study|Other|3|||
143392410|NCT04908722|516984857|FG003|Overall Study|Other|2|||
143392411|NCT04908722|516984858|FG004|Overall Study|Other|4|||
143392412|NCT04908722|516984859|FG005|Overall Study|Other|1|||
143392413|NCT04908722|516984854|FG000|Overall Study|Initiated prohibited medication|0|||
143392414|NCT04908722|516984855|FG001|Overall Study|Initiated prohibited medication|0|||
143392415|NCT04908722|516984856|FG002|Overall Study|Initiated prohibited medication|0|||
143392416|NCT04908722|516984857|FG003|Overall Study|Initiated prohibited medication|1|||
143392417|NCT04908722|516984858|FG004|Overall Study|Initiated prohibited medication|0|||
143392418|NCT04908722|516984859|FG005|Overall Study|Initiated prohibited medication|1|||
143392419|NCT04908722|516984854|FG000|Overall Study|Randomized but not vaccinated|3|||
143338863|NCT00677352|516784236|FG000|Tapering Phase|Adverse Event|1|||
143392420|NCT04908722|516984855|FG001|Overall Study|Randomized but not vaccinated|1|||
143392421|NCT04908722|516984856|FG002|Overall Study|Randomized but not vaccinated|2|||
143392422|NCT04908722|516984857|FG003|Overall Study|Randomized but not vaccinated|2|||
143338864|NCT00677352|516784237|FG001|Tapering Phase|Adverse Event|5|||
143338865|NCT00677352|516784236|FG000|Tapering Phase|Withdrawal by Subject|5|||
143338866|NCT00677352|516784237|FG001|Tapering Phase|Withdrawal by Subject|3|||
143338867|NCT00677352|516784236|FG000|Tapering Phase|Pregnancy|0|||
143338868|NCT00677352|516784237|FG001|Tapering Phase|Pregnancy|1|||
143338869|NCT00677352|516784236|FG000|Tapering Phase|Job transfer|0|||
143338870|NCT00677352|516784237|FG001|Tapering Phase|Job transfer|1|||
143338871|NCT01820559|516784238|FG000|Overall Study|Adverse Event|4|||
143338872|NCT01820559|516784239|FG001|Overall Study|Adverse Event|6|||
143392423|NCT04908722|516984858|FG004|Overall Study|Randomized but not vaccinated|3|||
143392424|NCT04908722|516984859|FG005|Overall Study|Randomized but not vaccinated|4|||
143392425|NCT01369355|516984864|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
143392426|NCT01369355|516984865|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
143392427|NCT01369355|516984866|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
143392428|NCT01369355|516984867|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
143392429|NCT01369355|516984868|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
143392430|NCT01369355|516984869|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
143392431|NCT01369355|516984870|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
143392432|NCT01369355|516984871|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
143392433|NCT01369355|516984872|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
143392434|NCT01369355|516984864|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
143392435|NCT01369355|516984865|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
143392436|NCT01369355|516984866|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
143392437|NCT01369355|516984867|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
143392438|NCT01369355|516984868|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
143392439|NCT01369355|516984869|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
143392440|NCT01369355|516984870|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
143392441|NCT01369355|516984871|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
143392442|NCT01369355|516984872|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
143392443|NCT01369355|516984864|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
143392444|NCT01369355|516984865|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
143392445|NCT01369355|516984866|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
143392446|NCT01369355|516984867|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
143392447|NCT01369355|516984868|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
143392448|NCT01369355|516984869|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
143392449|NCT01369355|516984870|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
143392450|NCT01369355|516984871|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
143392451|NCT01369355|516984872|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
143392452|NCT01369355|516984864|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
143392453|NCT01369355|516984865|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
143392454|NCT01369355|516984866|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
143392455|NCT01369355|516984867|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
143392456|NCT01369355|516984868|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
143392457|NCT01369355|516984869|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
143392458|NCT01369355|516984870|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
143392459|NCT01369355|516984871|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
143392460|NCT01369355|516984872|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
143392461|NCT01369355|516984864|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
143392462|NCT01369355|516984865|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
143392463|NCT01369355|516984866|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
143392464|NCT01369355|516984867|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
143392465|NCT01369355|516984868|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
143392466|NCT01369355|516984869|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
143392467|NCT01369355|516984870|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
143392468|NCT01369355|516984871|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
143392469|NCT01369355|516984872|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
143392470|NCT01369355|516984864|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
143392471|NCT01369355|516984865|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
143392472|NCT01369355|516984866|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
143392473|NCT01369355|516984867|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
143392474|NCT01369355|516984868|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
143392475|NCT01369355|516984869|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
143392476|NCT01369355|516984870|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
143392477|NCT01369355|516984871|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
143392478|NCT01369355|516984872|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
143392479|NCT01369355|516984864|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
143392480|NCT01369355|516984865|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
143392481|NCT01369355|516984866|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
143392482|NCT01369355|516984867|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
143392483|NCT01369355|516984868|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
143392484|NCT01369355|516984869|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
143392485|NCT01369355|516984870|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
143392486|NCT01369355|516984871|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
143392487|NCT01369355|516984872|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
143392488|NCT01369355|516984864|FG000|Long-term Extension (Week 44-272)|Death|0|||
143392489|NCT01369355|516984865|FG001|Long-term Extension (Week 44-272)|Death|0|||
143392490|NCT01369355|516984866|FG002|Long-term Extension (Week 44-272)|Death|0|||
143392491|NCT01369355|516984867|FG003|Long-term Extension (Week 44-272)|Death|0|||
143392492|NCT01369355|516984868|FG004|Long-term Extension (Week 44-272)|Death|0|||
143338873|NCT01820559|516784240|FG002|Overall Study|Adverse Event|13|||
143338874|NCT01820559|516784238|FG000|Overall Study|Withdrawal by Subject|1|||
143338875|NCT01820559|516784239|FG001|Overall Study|Withdrawal by Subject|2|||
143338876|NCT01820559|516784240|FG002|Overall Study|Withdrawal by Subject|5|||
143338877|NCT01820559|516784238|FG000|Overall Study|Protocol Violation|2|||
143338878|NCT01820559|516784239|FG001|Overall Study|Protocol Violation|1|||
143338879|NCT01820559|516784240|FG002|Overall Study|Protocol Violation|3|||
143338880|NCT01820559|516784238|FG000|Overall Study|Subject's non-compliance|1|||
143338881|NCT01820559|516784239|FG001|Overall Study|Subject's non-compliance|0|||
143338882|NCT01820559|516784240|FG002|Overall Study|Subject's non-compliance|2|||
143338883|NCT01820559|516784238|FG000|Overall Study|Lost to Follow-up|3|||
143338884|NCT01820559|516784239|FG001|Overall Study|Lost to Follow-up|2|||
143338885|NCT01820559|516784240|FG002|Overall Study|Lost to Follow-up|2|||
143338886|NCT01820559|516784238|FG000|Overall Study|At sponsor request|0|||
143338887|NCT01820559|516784239|FG001|Overall Study|At sponsor request|0|||
143338888|NCT01820559|516784240|FG002|Overall Study|At sponsor request|1|||
143338889|NCT01820559|516784238|FG000|Overall Study|Lack of Efficacy|3|||
143338890|NCT01820559|516784239|FG001|Overall Study|Lack of Efficacy|2|||
143338891|NCT01820559|516784240|FG002|Overall Study|Lack of Efficacy|3|||
143338892|NCT03033225|516784245|FG000|Overall Study|Withdrawal by Subject|5|||
143338893|NCT03434678|516784246|FG000|Overall Study|Withdrawal by Subject|13|||
143338894|NCT03434678|516784247|FG001|Overall Study|Withdrawal by Subject|13|||
143338895|NCT03434678|516784246|FG000|Overall Study|Found to be ineligible post randomization|2|||
143338896|NCT03434678|516784247|FG001|Overall Study|Found to be ineligible post randomization|1|||
143338897|NCT01648348|516784259|FG000|Overall Study|Cancel|1|||
143338898|NCT01648348|516784260|FG001|Overall Study|Cancel|0|||
143338899|NCT01648348|516784261|FG002|Overall Study|Cancel|0|||
143338900|NCT01648348|516784262|FG003|Overall Study|Cancel|0|||
143338901|NCT01648348|516784263|FG004|Overall Study|Cancel|3|||
143338902|NCT01648348|516784264|FG005|Overall Study|Cancel|6|||
143338903|NCT01648348|516784259|FG000|Overall Study|Replaced for MTD analysis|1|||
143338904|NCT01648348|516784260|FG001|Overall Study|Replaced for MTD analysis|0|||
143338905|NCT01648348|516784261|FG002|Overall Study|Replaced for MTD analysis|1|||
143338906|NCT01648348|516784262|FG003|Overall Study|Replaced for MTD analysis|0|||
143338907|NCT01648348|516784263|FG004|Overall Study|Replaced for MTD analysis|0|||
143338908|NCT01648348|516784264|FG005|Overall Study|Replaced for MTD analysis|0|||
143338909|NCT02495025|516784269|FG000|Overall Study|Lost to Follow-up|21|||
143338910|NCT02495025|516784270|FG001|Overall Study|Lost to Follow-up|14|||
143338911|NCT02495025|516784269|FG000|Overall Study|Withdrawal by Subject|5|||
143338912|NCT02495025|516784270|FG001|Overall Study|Withdrawal by Subject|0|||
143338913|NCT02778100|516784273|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
143338914|NCT02778100|516784274|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
143338915|NCT03419364|516784279|FG000|Overall Study|Delivery due to maternal condition|2|||
143338916|NCT03419364|516784280|FG001|Overall Study|Delivery due to maternal condition|0|||
143338917|NCT03419364|516784281|FG002|Overall Study|Delivery due to maternal condition|0|||
143338918|NCT00552084|516784282|FG000|Overall Study|Adverse Event|2|||
143338919|NCT00552084|516784283|FG001|Overall Study|Adverse Event|3|||
143338920|NCT00552084|516784282|FG000|Overall Study|Withdrawal by Subject|4|||
143338921|NCT00552084|516784283|FG001|Overall Study|Withdrawal by Subject|5|||
143338922|NCT00552084|516784282|FG000|Overall Study|Protocol Violation|1|||
143338923|NCT00552084|516784283|FG001|Overall Study|Protocol Violation|0|||
143338924|NCT00552084|516784282|FG000|Overall Study|change in anti-arrythmic drug|1|||
143338925|NCT00552084|516784283|FG001|Overall Study|change in anti-arrythmic drug|1|||
143338926|NCT01338025|516784284|FG000|Overall Study|Unexpected closure of study|10|||
143338927|NCT01338025|516784285|FG001|Overall Study|Unexpected closure of study|9|||
143338928|NCT01338025|516784284|FG000|Overall Study|Withdrawal by Subject|0|||
143338929|NCT01338025|516784285|FG001|Overall Study|Withdrawal by Subject|2|||
143338930|NCT01338025|516784284|FG000|Overall Study|Found ineligible after starting|1|||
143338931|NCT01338025|516784285|FG001|Overall Study|Found ineligible after starting|0|||
143338932|NCT03017079|516784286|FG000|Overall Study|Physician Decision|1|||
143338933|NCT03017079|516784287|FG001|Overall Study|Physician Decision|1|||
143338934|NCT03017079|516784286|FG000|Overall Study|Death|3|||
143338935|NCT03017079|516784287|FG001|Overall Study|Death|2|||
143338936|NCT03017079|516784286|FG000|Overall Study|Lack of Efficacy|2|||
143338937|NCT03017079|516784287|FG001|Overall Study|Lack of Efficacy|2|||
143338938|NCT03017079|516784286|FG000|Overall Study|Protocol Violation|0|||
143338939|NCT03017079|516784287|FG001|Overall Study|Protocol Violation|1|||
143338940|NCT04349280|516784288|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
143338941|NCT04349280|516784289|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
143338942|NCT04349280|516784288|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
143338943|NCT04349280|516784289|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
143338944|NCT04349280|516784288|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
143338945|NCT04349280|516784289|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
143338946|NCT03779906|516784290|FG000|Overall Study|Lost to Follow-up|7|||
143338947|NCT03779906|516784290|FG000|Overall Study|COVID pandemic|1|||
143338948|NCT01582789|516786072|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
143338949|NCT01582789|516786073|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
143338950|NCT05050578|516786074|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
143338951|NCT05050578|516786075|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
143338952|NCT05050578|516786074|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
143338953|NCT05050578|516786075|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
143338954|NCT05050578|516786074|FG000|Period 2, 30 Days|Protocol Violation|0|||
143338955|NCT05050578|516786075|FG001|Period 2, 30 Days|Protocol Violation|1|||
143338956|NCT03386032|516786076|FG000|Overall Study|Lack of Efficacy|6|||
143338957|NCT03386032|516786077|FG001|Overall Study|Lack of Efficacy|2|||
143338958|NCT03386032|516786078|FG002|Overall Study|Lack of Efficacy|0|||
143338959|NCT03386032|516786076|FG000|Overall Study|Adverse Event|2|||
143338960|NCT03386032|516786077|FG001|Overall Study|Adverse Event|2|||
143338961|NCT03386032|516786078|FG002|Overall Study|Adverse Event|0|||
143338962|NCT03386032|516786076|FG000|Overall Study|Withdrawal by Subject|1|||
143338963|NCT03386032|516786077|FG001|Overall Study|Withdrawal by Subject|0|||
143338964|NCT03386032|516786078|FG002|Overall Study|Withdrawal by Subject|0|||
143338965|NCT03386032|516786076|FG000|Overall Study|Lost to Follow-up|9|||
143338966|NCT03386032|516786077|FG001|Overall Study|Lost to Follow-up|3|||
143392493|NCT01369355|516984869|FG005|Long-term Extension (Week 44-272)|Death|0|||
143392494|NCT01369355|516984870|FG006|Long-term Extension (Week 44-272)|Death|0|||
143392495|NCT01369355|516984871|FG007|Long-term Extension (Week 44-272)|Death|1|||
143392496|NCT01369355|516984872|FG008|Long-term Extension (Week 44-272)|Death|3|||
143392497|NCT01369355|516984864|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
143392498|NCT01369355|516984865|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
143392499|NCT01369355|516984866|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
143392500|NCT01369355|516984867|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
143392501|NCT01369355|516984868|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
143392502|NCT01369355|516984869|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
143392503|NCT01369355|516984870|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
143392504|NCT01369355|516984871|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
143392505|NCT01369355|516984872|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
143392506|NCT01369355|516984864|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
143392507|NCT01369355|516984865|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
143392508|NCT01369355|516984866|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
143392509|NCT01369355|516984867|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
143392510|NCT01369355|516984868|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
143392511|NCT01369355|516984869|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
143392512|NCT01369355|516984870|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
143392513|NCT01369355|516984871|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
143392514|NCT01369355|516984872|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
143338967|NCT03386032|516786078|FG002|Overall Study|Lost to Follow-up|0|||
143338968|NCT02710292|516786090|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
143338969|NCT02710292|516786091|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
143338970|NCT02710292|516786090|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
143338971|NCT02710292|516786091|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
143338972|NCT03122119|516786092|FG000|Overall Study|Did not meet eligibility critria|1|||
143338973|NCT00800202|516786093|FG000|Overall Study|Adverse Event|7|||
143338974|NCT00800202|516786094|FG001|Overall Study|Adverse Event|6|||
143338975|NCT00800202|516786093|FG000|Overall Study|Death|1|||
143338976|NCT00800202|516786094|FG001|Overall Study|Death|0|||
143338977|NCT00800202|516786093|FG000|Overall Study|Other|5|||
143338978|NCT00800202|516786094|FG001|Overall Study|Other|0|||
143338979|NCT00800202|516786093|FG000|Overall Study|Disease Progression|54|||
143338980|NCT00800202|516786094|FG001|Overall Study|Disease Progression|18|||
143338981|NCT02364180|516786103|FG000|Overall Study|Screen Fail|1|||
143338982|NCT02323646|516786104|FG000|Treatment Course 1|Adverse Event|1|||
143338983|NCT02323646|516786105|FG001|Treatment Course 1|Adverse Event|0|||
143338984|NCT02323646|516786106|FG002|Treatment Course 1|Adverse Event|1|||
143338985|NCT02323646|516786104|FG000|Treatment Course 1|Heavy Bleeding|1|||
143338986|NCT02323646|516786105|FG001|Treatment Course 1|Heavy Bleeding|1|||
143338987|NCT02323646|516786106|FG002|Treatment Course 1|Heavy Bleeding|0|||
143338988|NCT02323646|516786104|FG000|Treatment Course 1|Lost to Follow-up|1|||
143338989|NCT02323646|516786105|FG001|Treatment Course 1|Lost to Follow-up|0|||
143338990|NCT02323646|516786106|FG002|Treatment Course 1|Lost to Follow-up|2|||
143338991|NCT02323646|516786104|FG000|Treatment Course 1|Withdrawal by Subject|0|||
143338992|NCT02323646|516786105|FG001|Treatment Course 1|Withdrawal by Subject|2|||
143338993|NCT02323646|516786106|FG002|Treatment Course 1|Withdrawal by Subject|0|||
143338994|NCT02323646|516786104|FG000|Treatment Course 2|Adverse Event|1|||
143338995|NCT02323646|516786105|FG001|Treatment Course 2|Adverse Event|0|||
143338996|NCT02323646|516786106|FG002|Treatment Course 2|Adverse Event|1|||
143338997|NCT02323646|516786104|FG000|Treatment Course 2|Lost to Follow-up|0|||
143338998|NCT02323646|516786105|FG001|Treatment Course 2|Lost to Follow-up|0|||
143338999|NCT02323646|516786106|FG002|Treatment Course 2|Lost to Follow-up|1|||
143339000|NCT02323646|516786104|FG000|Treatment Course 2|Non-compliance|0|||
143339001|NCT02323646|516786105|FG001|Treatment Course 2|Non-compliance|1|||
143339002|NCT02323646|516786106|FG002|Treatment Course 2|Non-compliance|1|||
143339003|NCT00521144|516786107|FG000|Overall Study|Not Treated|0|||
143339004|NCT00521144|516786108|FG001|Overall Study|Not Treated|0|||
143339005|NCT00521144|516786109|FG002|Overall Study|Not Treated|0|||
143339006|NCT00521144|516786110|FG003|Overall Study|Not Treated|1|||
143339007|NCT00521144|516786111|FG004|Overall Study|Not Treated|0|||
143339008|NCT00521144|516786107|FG000|Overall Study|Adverse Event|0|||
143339009|NCT00521144|516786108|FG001|Overall Study|Adverse Event|1|||
143339010|NCT00521144|516786109|FG002|Overall Study|Adverse Event|0|||
143339011|NCT00521144|516786110|FG003|Overall Study|Adverse Event|0|||
143339012|NCT00521144|516786111|FG004|Overall Study|Adverse Event|1|||
143339013|NCT00521144|516786107|FG000|Overall Study|Progressive Disease|4|||
143339014|NCT00521144|516786108|FG001|Overall Study|Progressive Disease|2|||
143339015|NCT00521144|516786109|FG002|Overall Study|Progressive Disease|2|||
143339016|NCT00521144|516786110|FG003|Overall Study|Progressive Disease|0|||
143339017|NCT00521144|516786111|FG004|Overall Study|Progressive Disease|6|||
143339018|NCT00508261|516786114|FG000|Overall Study|Other|0|||
143339019|NCT00508261|516786115|FG001|Overall Study|Other|1|||
143339020|NCT00508261|516786116|FG002|Overall Study|Other|1|||
143339021|NCT00508261|516786117|FG003|Overall Study|Other|0|||
143339022|NCT00508261|516786114|FG000|Overall Study|Serious Adverse Event|0|||
143339023|NCT00508261|516786115|FG001|Overall Study|Serious Adverse Event|1|||
143339024|NCT00508261|516786116|FG002|Overall Study|Serious Adverse Event|0|||
143339025|NCT00508261|516786117|FG003|Overall Study|Serious Adverse Event|0|||
143339026|NCT00508261|516786114|FG000|Overall Study|Withdrawal by Subject|3|||
143339027|NCT00508261|516786115|FG001|Overall Study|Withdrawal by Subject|4|||
143339028|NCT00508261|516786116|FG002|Overall Study|Withdrawal by Subject|4|||
143339029|NCT00508261|516786117|FG003|Overall Study|Withdrawal by Subject|0|||
143339030|NCT00508261|516786114|FG000|Overall Study|Migrated/ moved from study area|0|||
143339031|NCT00508261|516786115|FG001|Overall Study|Migrated/ moved from study area|1|||
143339032|NCT00508261|516786116|FG002|Overall Study|Migrated/ moved from study area|0|||
143339033|NCT00508261|516786117|FG003|Overall Study|Migrated/ moved from study area|0|||
143339034|NCT00508261|516786114|FG000|Overall Study|Lost to Follow-up|0|||
143339035|NCT00508261|516786115|FG001|Overall Study|Lost to Follow-up|1|||
143339036|NCT00508261|516786116|FG002|Overall Study|Lost to Follow-up|1|||
143339037|NCT00508261|516786117|FG003|Overall Study|Lost to Follow-up|1|||
143339038|NCT00180479|516786118|FG000|Overall Study|Death|4|||
143339039|NCT00180479|516786119|FG001|Overall Study|Death|2|||
143339040|NCT00180479|516786118|FG000|Overall Study|Lost to Follow-up|9|||
143339041|NCT00180479|516786119|FG001|Overall Study|Lost to Follow-up|7|||
143339042|NCT00180479|516786118|FG000|Overall Study|Withdrawal by Subject|3|||
143339043|NCT00180479|516786119|FG001|Overall Study|Withdrawal by Subject|3|||
143339044|NCT00180479|516786118|FG000|Overall Study|Informed consent not signed|0|||
143339045|NCT00180479|516786119|FG001|Overall Study|Informed consent not signed|1|||
143339046|NCT00526630|516786124|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
143339047|NCT00526630|516786125|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
143339048|NCT00526630|516786124|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
143339049|NCT00526630|516786125|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
143339050|NCT02313909|516786134|FG000|Overall Study|Consent withdrawn by participant|33|||
143339051|NCT02313909|516786135|FG001|Overall Study|Consent withdrawn by participant|33|||
143392515|NCT01369355|516984864|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
143392516|NCT01369355|516984865|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
143392517|NCT01369355|516984866|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
143392518|NCT01369355|516984867|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
143392519|NCT01369355|516984868|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
143392520|NCT01369355|516984869|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
143392521|NCT01369355|516984870|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
143392522|NCT01369355|516984871|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
143392523|NCT01369355|516984872|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
143392524|NCT01369355|516984864|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
143392525|NCT01369355|516984865|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
143392526|NCT01369355|516984866|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
143392527|NCT01369355|516984867|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
143392528|NCT01369355|516984868|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
143392529|NCT01369355|516984869|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
143392530|NCT01369355|516984870|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
143392531|NCT01369355|516984871|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
143392532|NCT01369355|516984872|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
143392533|NCT01369355|516984864|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
143392534|NCT01369355|516984865|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
143392535|NCT01369355|516984866|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
143392536|NCT01369355|516984867|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
143392537|NCT01369355|516984868|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
143392538|NCT01369355|516984869|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
143392539|NCT01369355|516984870|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
143392540|NCT01369355|516984871|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
143392541|NCT01369355|516984872|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
143392542|NCT01369355|516984864|FG000|Long-term Extension (Week 44-272)|Other|0|||
143392543|NCT01369355|516984865|FG001|Long-term Extension (Week 44-272)|Other|0|||
143392544|NCT01369355|516984866|FG002|Long-term Extension (Week 44-272)|Other|0|||
143392545|NCT01369355|516984867|FG003|Long-term Extension (Week 44-272)|Other|0|||
143392546|NCT01369355|516984868|FG004|Long-term Extension (Week 44-272)|Other|0|||
143392547|NCT01369355|516984869|FG005|Long-term Extension (Week 44-272)|Other|0|||
143392548|NCT01369355|516984870|FG006|Long-term Extension (Week 44-272)|Other|110|||
143392549|NCT01369355|516984871|FG007|Long-term Extension (Week 44-272)|Other|9|||
143392550|NCT01369355|516984872|FG008|Long-term Extension (Week 44-272)|Other|17|||
143392551|NCT02319759|516984873|FG000|Week 0 - 16|Lack of Efficacy|1|||
143392552|NCT02319759|516984874|FG001|Week 0 - 16|Lack of Efficacy|0|||
143392553|NCT02319759|516984875|FG002|Week 0 - 16|Lack of Efficacy|0|||
143392554|NCT02319759|516984876|FG003|Week 0 - 16|Lack of Efficacy|0|||
143392555|NCT02319759|516984877|FG004|Week 0 - 16|Lack of Efficacy|0|||
143392556|NCT02319759|516984873|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
143392557|NCT02319759|516984874|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
143392558|NCT02319759|516984875|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
143392559|NCT02319759|516984876|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
143392560|NCT02319759|516984877|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
143392561|NCT02319759|516984873|FG000|Week 16 - 24|Lack of Efficacy|1|||
143392562|NCT02319759|516984874|FG001|Week 16 - 24|Lack of Efficacy|0|||
143392563|NCT02319759|516984875|FG002|Week 16 - 24|Lack of Efficacy|1|||
143392564|NCT02319759|516984876|FG003|Week 16 - 24|Lack of Efficacy|0|||
143392565|NCT02319759|516984877|FG004|Week 16 - 24|Lack of Efficacy|0|||
143392566|NCT02319759|516984873|FG000|Week 16 - 24|Lost to Follow-up|1|||
143392567|NCT02319759|516984874|FG001|Week 16 - 24|Lost to Follow-up|0|||
143392568|NCT02319759|516984875|FG002|Week 16 - 24|Lost to Follow-up|0|||
143392569|NCT02319759|516984876|FG003|Week 16 - 24|Lost to Follow-up|0|||
143392570|NCT02319759|516984877|FG004|Week 16 - 24|Lost to Follow-up|0|||
143392571|NCT02319759|516984873|FG000|Week 16 - 24|Withdrawal by Subject|0|||
143392572|NCT02319759|516984874|FG001|Week 16 - 24|Withdrawal by Subject|0|||
143392573|NCT02319759|516984875|FG002|Week 16 - 24|Withdrawal by Subject|2|||
143392574|NCT02319759|516984876|FG003|Week 16 - 24|Withdrawal by Subject|0|||
143392575|NCT02319759|516984877|FG004|Week 16 - 24|Withdrawal by Subject|0|||
143392576|NCT02319759|516984873|FG000|Week 24 - 56|Adverse Event|0|||
143392577|NCT02319759|516984874|FG001|Week 24 - 56|Adverse Event|0|||
143392578|NCT02319759|516984875|FG002|Week 24 - 56|Adverse Event|2|||
143392579|NCT02319759|516984876|FG003|Week 24 - 56|Adverse Event|0|||
143392580|NCT02319759|516984877|FG004|Week 24 - 56|Adverse Event|0|||
143392581|NCT02319759|516984873|FG000|Week 24 - 56|Lack of Efficacy|0|||
143392582|NCT02319759|516984874|FG001|Week 24 - 56|Lack of Efficacy|0|||
143392583|NCT02319759|516984875|FG002|Week 24 - 56|Lack of Efficacy|0|||
143392584|NCT02319759|516984876|FG003|Week 24 - 56|Lack of Efficacy|2|||
143392585|NCT02319759|516984877|FG004|Week 24 - 56|Lack of Efficacy|1|||
143392586|NCT02319759|516984873|FG000|Week 24 - 56|Withdrawal by Subject|0|||
143392587|NCT02319759|516984874|FG001|Week 24 - 56|Withdrawal by Subject|1|||
143392588|NCT02319759|516984875|FG002|Week 24 - 56|Withdrawal by Subject|0|||
143392589|NCT02319759|516984876|FG003|Week 24 - 56|Withdrawal by Subject|0|||
143392590|NCT02319759|516984877|FG004|Week 24 - 56|Withdrawal by Subject|0|||
143392591|NCT02319759|516984873|FG000|Week 24 - 56|Lost to Follow-up|0|||
143392592|NCT02319759|516984874|FG001|Week 24 - 56|Lost to Follow-up|0|||
143392593|NCT02319759|516984875|FG002|Week 24 - 56|Lost to Follow-up|0|||
143392594|NCT02319759|516984876|FG003|Week 24 - 56|Lost to Follow-up|0|||
143392595|NCT02319759|516984877|FG004|Week 24 - 56|Lost to Follow-up|1|||
143392596|NCT06424236|516984880|FG000|Overall Study|Adverse Event|0|||
143392597|NCT06424236|516984881|FG001|Overall Study|Adverse Event|1|||
143392598|NCT06424236|516984882|FG002|Overall Study|Adverse Event|0|||
143392599|NCT06424236|516984880|FG000|Overall Study|Withdrawal by Subject|3|||
143392600|NCT06424236|516984881|FG001|Overall Study|Withdrawal by Subject|1|||
143392601|NCT06424236|516984882|FG002|Overall Study|Withdrawal by Subject|2|||
143392602|NCT06424236|516984880|FG000|Overall Study|Physician Decision|0|||
143392603|NCT06424236|516984881|FG001|Overall Study|Physician Decision|1|||
143392604|NCT06424236|516984882|FG002|Overall Study|Physician Decision|0|||
143392605|NCT06424236|516984880|FG000|Overall Study|Study Terminated by Sponsor|11|||
143392606|NCT06424236|516984881|FG001|Overall Study|Study Terminated by Sponsor|20|||
143392607|NCT06424236|516984882|FG002|Overall Study|Study Terminated by Sponsor|16|||
143392608|NCT06424236|516984880|FG000|Overall Study|Lost to Follow-up|0|||
143392609|NCT06424236|516984881|FG001|Overall Study|Lost to Follow-up|1|||
143392610|NCT06424236|516984882|FG002|Overall Study|Lost to Follow-up|0|||
143392611|NCT06424236|516984880|FG000|Overall Study|Disease Progression|0|||
143392612|NCT06424236|516984881|FG001|Overall Study|Disease Progression|1|||
143392613|NCT06424236|516984882|FG002|Overall Study|Disease Progression|2|||
143392614|NCT06424236|516984880|FG000|Overall Study|Other|0|||
143392615|NCT06424236|516984881|FG001|Overall Study|Other|0|||
143392616|NCT06424236|516984882|FG002|Overall Study|Other|1|||
143392617|NCT01987895|516984884|FG000|Overall Study|Withdrawal by Subject|12|||
143392618|NCT01987895|516984885|FG001|Overall Study|Withdrawal by Subject|7|||
143392619|NCT01987895|516984884|FG000|Overall Study|Physician Decision|8|||
143392620|NCT01987895|516984885|FG001|Overall Study|Physician Decision|10|||
143392621|NCT01987895|516984884|FG000|Overall Study|Death|7|||
143392622|NCT01987895|516984885|FG001|Overall Study|Death|7|||
143392623|NCT01987895|516984884|FG000|Overall Study|Lost to Follow-up|3|||
143392624|NCT01987895|516984885|FG001|Overall Study|Lost to Follow-up|5|||
143392625|NCT01987895|516984884|FG000|Overall Study|randomized before giving IC|0|||
143392626|NCT01987895|516984885|FG001|Overall Study|randomized before giving IC|1|||
143392627|NCT03452579|516984892|FG000|Overall Study|Death|0|||
143392628|NCT03452579|516984893|FG001|Overall Study|Death|1|||
143392629|NCT03452579|516984892|FG000|Overall Study|Withdrawal by Subject|2|||
143392630|NCT03452579|516984893|FG001|Overall Study|Withdrawal by Subject|0|||
143392631|NCT03452579|516984892|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
143392632|NCT03452579|516984893|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
143392633|NCT03452579|516984892|FG000|Overall Study|Physician Decision|1|||
143392634|NCT03452579|516984893|FG001|Overall Study|Physician Decision|1|||
143392635|NCT03452579|516984892|FG000|Overall Study|Adverse Event|1|||
143392636|NCT03452579|516984893|FG001|Overall Study|Adverse Event|4|||
143392637|NCT02573493|516984896|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
143392638|NCT02573493|516984897|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
143392639|NCT02573493|516984898|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
143392640|NCT02573493|516984899|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
143392641|NCT04971681|516984900|FG000|Followup|Lost to Follow-up|1|||
143392642|NCT04971681|516984901|FG001|Followup|Lost to Follow-up|0|||
143392643|NCT06181760|516984902|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
143392644|NCT06181760|516984903|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
143392645|NCT06181760|516984904|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
143392646|NCT06181760|516984905|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
143392647|NCT03524612|516984906|FG000|Overall Study|Lack of Efficacy|10|||
143392648|NCT03524612|516984906|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
143392649|NCT03524612|516984906|FG000|Overall Study|Adverse Event|10|||
143392650|NCT03524612|516984906|FG000|Overall Study|Withdrawal by Subject|7|||
143392651|NCT03524612|516984906|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
143392652|NCT03524612|516984906|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
143392653|NCT03524612|516984906|FG000|Overall Study|New therapy for study indication|6|||
143392654|NCT03524612|516984906|FG000|Overall Study|Death|3|||
143392655|NCT03524612|516984906|FG000|Overall Study|Lost to Follow-up|2|||
143392656|NCT03524612|516984906|FG000|Overall Study|Protocol Violation|1|||
143392657|NCT04025554|516984907|FG000|Overall Study|Adverse Event|3|||
143392658|NCT03115476|516984908|FG000|LP0084-1369|Death|1|||
143392659|NCT03115476|516984909|FG001|LP0084-1369|Death|0|||
143392660|NCT03115476|516984910|FG002|LP0084-1369|Death|2|||
143392661|NCT03115476|516984908|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
143392662|NCT03115476|516984909|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
143392663|NCT03115476|516984910|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
143392664|NCT05257486|516984914|FG000|Overall Study|Protocol Violation|3|||
143392665|NCT00613106|516984915|FG000|Overall Study|Adverse Event|3|||
143392666|NCT00613106|516984916|FG001|Overall Study|Adverse Event|1|||
143392667|NCT00613106|516984915|FG000|Overall Study|Withdrawal by Subject|6|||
143392668|NCT00613106|516984916|FG001|Overall Study|Withdrawal by Subject|3|||
143392669|NCT00613106|516984915|FG000|Overall Study|Lost to Follow-up|7|||
143392670|NCT00613106|516984916|FG001|Overall Study|Lost to Follow-up|2|||
143392671|NCT00613106|516984915|FG000|Overall Study|misc|4|||
143392672|NCT00613106|516984916|FG001|Overall Study|misc|3|||
143392673|NCT03865498|516984919|FG000|Overall Study|Lack of Efficacy|12|||
143392674|NCT03865498|516984920|FG001|Overall Study|Lack of Efficacy|11|||
143392675|NCT03865498|516984919|FG000|Overall Study|Lost to Follow-up|125|||
143392676|NCT03865498|516984920|FG001|Overall Study|Lost to Follow-up|133|||
143392677|NCT03865498|516984919|FG000|Overall Study|Withdrawal by Subject|2|||
143392678|NCT03865498|516984920|FG001|Overall Study|Withdrawal by Subject|4|||
143392679|NCT01648023|516984923|FG000|Overall Study|Screen Fail Post Randomization|1|||
143392680|NCT01648023|516984924|FG001|Overall Study|Screen Fail Post Randomization|2|||
143392681|NCT05296525|516984929|FG000|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
143392682|NCT05296525|516984930|FG001|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
143392683|NCT05296525|516984931|FG002|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
143392684|NCT05296525|516984932|FG003|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|3|||
143392685|NCT01420237|516984937|FG000|Overall Study|Death|13|||
143392686|NCT01420237|516984937|FG000|Overall Study|Withdrawal by Subject|41|||
143392687|NCT01420237|516984937|FG000|Overall Study|Lost to Follow-up|32|||
143392688|NCT01420237|516984937|FG000|Overall Study|Adverse Event|10|||
143392689|NCT01420237|516984937|FG000|Overall Study|Investigative Site Termination|43|||
143392690|NCT01420237|516984937|FG000|Overall Study|Censored because study device not implanted|21|||
143392691|NCT01420237|516984937|FG000|Overall Study|Censored because surgery not performed|2|||
143392692|NCT01420237|516984937|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
143392693|NCT01420237|516984937|FG000|Overall Study|Sponsor terminated study early|127|||
143392694|NCT04338061|516984938|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
143392695|NCT04338061|516984939|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
143392696|NCT04338061|516984938|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
143392697|NCT04338061|516984939|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
143392698|NCT04338061|516984938|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
143392699|NCT04338061|516984939|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
143392700|NCT04338061|516984938|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
143392701|NCT04338061|516984939|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
143392702|NCT04338061|516984938|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
143392703|NCT04338061|516984939|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
143392704|NCT04338061|516984938|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
143392705|NCT04338061|516984939|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
143392706|NCT04338061|516984938|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
143392707|NCT04338061|516984939|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
143392708|NCT04338061|516984938|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
143392709|NCT04338061|516984939|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
143392710|NCT04338061|516984938|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
143392711|NCT04338061|516984939|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
143392712|NCT04338061|516984938|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
143392713|NCT04338061|516984939|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
143392714|NCT04338061|516984938|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
143392715|NCT04338061|516984939|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
143392716|NCT04338061|516984938|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
143392717|NCT04338061|516984939|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
143392718|NCT04492722|516984940|FG000|Overall Study|Adverse Event|7|||
143392719|NCT04492722|516984941|FG001|Overall Study|Adverse Event|2|||
143392720|NCT04492722|516984942|FG002|Overall Study|Adverse Event|3|||
143392721|NCT04492722|516984943|FG003|Overall Study|Adverse Event|0|||
143392722|NCT04492722|516984940|FG000|Overall Study|Death|0|||
143392723|NCT04492722|516984941|FG001|Overall Study|Death|0|||
143392724|NCT04492722|516984942|FG002|Overall Study|Death|0|||
143392725|NCT04492722|516984943|FG003|Overall Study|Death|1|||
143392726|NCT04492722|516984940|FG000|Overall Study|Lost to Follow-up|0|||
143392727|NCT04492722|516984941|FG001|Overall Study|Lost to Follow-up|1|||
143392728|NCT04492722|516984942|FG002|Overall Study|Lost to Follow-up|0|||
143392729|NCT04492722|516984943|FG003|Overall Study|Lost to Follow-up|1|||
143392730|NCT04492722|516984940|FG000|Overall Study|Physician Decision|0|||
143392731|NCT04492722|516984941|FG001|Overall Study|Physician Decision|3|||
143339052|NCT02313909|516786134|FG000|Overall Study|Lost to Follow-up|24|||
143339053|NCT02313909|516786135|FG001|Overall Study|Lost to Follow-up|17|||
143339054|NCT01814748|516786143|FG000|Overall Study|Lost to Follow-up|1|||
143339055|NCT01814748|516786144|FG001|Overall Study|Lost to Follow-up|2|||
143339056|NCT01814748|516786143|FG000|Overall Study|Study site terminated by sponsor|1|||
143339057|NCT01814748|516786144|FG001|Overall Study|Study site terminated by sponsor|1|||
143339058|NCT01814748|516786143|FG000|Overall Study|Withdrawal by Subject|6|||
143339059|NCT01814748|516786144|FG001|Overall Study|Withdrawal by Subject|4|||
143339060|NCT04044456|516786145|FG000|Overall Study|Lost to Follow-up|4|||
143339061|NCT04044456|516786146|FG001|Overall Study|Lost to Follow-up|1|||
143339062|NCT04044456|516786145|FG000|Overall Study|Withdrawal by Subject|1|||
143339063|NCT04044456|516786146|FG001|Overall Study|Withdrawal by Subject|0|||
143339064|NCT00330174|516786148|FG000|Overall Study|Withdrawal by Subject|7|||
143339065|NCT00330174|516786149|FG001|Overall Study|Withdrawal by Subject|7|||
143339066|NCT00330174|516786148|FG000|Overall Study|Lost to Follow-up|4|||
143339067|NCT00330174|516786149|FG001|Overall Study|Lost to Follow-up|1|||
143339068|NCT00330174|516786148|FG000|Overall Study|Clinical deterioration|1|||
143339069|NCT00330174|516786149|FG001|Overall Study|Clinical deterioration|2|||
143339070|NCT00330174|516786148|FG000|Overall Study|Excessive missed visits|3|||
143339071|NCT00330174|516786149|FG001|Overall Study|Excessive missed visits|8|||
143339072|NCT00330174|516786148|FG000|Overall Study|Miscellaneous reasons|7|||
143339073|NCT00330174|516786149|FG001|Overall Study|Miscellaneous reasons|1|||
143339074|NCT02316769|516786152|FG000|Overall Study|Physician Decision|1|||
143339075|NCT02316769|516786153|FG001|Overall Study|Physician Decision|0|||
143339076|NCT02316769|516786152|FG000|Overall Study|Withdrawal by Subject|1|||
143339077|NCT02316769|516786153|FG001|Overall Study|Withdrawal by Subject|0|||
143339078|NCT02403180|516786154|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
143339079|NCT02403180|516786155|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
143339080|NCT02403180|516786154|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
143339081|NCT02403180|516786155|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
143339082|NCT00645164|516786159|FG000|Overall Study|Lost to Follow-up|2|||
143339083|NCT00645164|516786159|FG000|Overall Study|Withdrawal by Subject|4|||
143339084|NCT00645164|516786159|FG000|Overall Study|Protocol Violation|1|||
143339085|NCT01201811|516786160|FG000|Overall Study|Adverse Event|6|||
143339086|NCT01201811|516786160|FG000|Overall Study|Disease progression|3|||
143339087|NCT01201811|516786160|FG000|Overall Study|Withdrawal by Subject|3|||
143339088|NCT01201811|516786160|FG000|Overall Study|Death|4|||
143339089|NCT01201811|516786160|FG000|Overall Study|Treatment Failure|2|||
143339090|NCT01201811|516786160|FG000|Overall Study|Physician Decision|1|||
143339091|NCT03641313|516786163|FG000|Overall Study|Death|1|||
143339092|NCT03641313|516786163|FG000|Overall Study|Withdrawal by Subject|2|||
143339093|NCT03641313|516786163|FG000|Overall Study|Declining health|1|||
143339094|NCT03641313|516786163|FG000|Overall Study|Adverse Event|1|||
143339095|NCT00946296|516786164|FG000|Overall Study|Physician Decision|3|||
143339096|NCT00946296|516786165|FG001|Overall Study|Physician Decision|0|||
143339097|NCT06060457|516786168|FG000|Overall Study|Adverse Event|1|||
143339098|NCT06060457|516786169|FG001|Overall Study|Adverse Event|1|||
143339099|NCT06060457|516786168|FG000|Overall Study|Death|2|||
143339100|NCT06060457|516786169|FG001|Overall Study|Death|2|||
143339101|NCT06060457|516786168|FG000|Overall Study|Lost to Follow-up|17|||
143339102|NCT06060457|516786169|FG001|Overall Study|Lost to Follow-up|19|||
143339103|NCT06060457|516786168|FG000|Overall Study|Physician Decision|0|||
143339104|NCT06060457|516786169|FG001|Overall Study|Physician Decision|1|||
143339105|NCT06060457|516786168|FG000|Overall Study|Protocol Violation|1|||
143339106|NCT06060457|516786169|FG001|Overall Study|Protocol Violation|1|||
143339107|NCT06060457|516786168|FG000|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
143339108|NCT06060457|516786169|FG001|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
143339109|NCT06060457|516786168|FG000|Overall Study|Withdrawal by Subject|12|||
143339110|NCT06060457|516786169|FG001|Overall Study|Withdrawal by Subject|15|||
143339111|NCT06060457|516786168|FG000|Overall Study|Other Than Specified|2|||
143339112|NCT06060457|516786169|FG001|Overall Study|Other Than Specified|1|||
143339113|NCT02061202|516786170|FG000|Overall Study|Lost to Follow-up|1|||
143339114|NCT02061202|516786171|FG001|Overall Study|Lost to Follow-up|1|||
143339115|NCT01533493|516786172|FG000|Overall Study|Adverse Event|2|||
143339116|NCT01533493|516786173|FG001|Overall Study|Adverse Event|1|||
143339117|NCT01533493|516786172|FG000|Overall Study|Withdrawal by Subject|1|||
143339118|NCT01533493|516786173|FG001|Overall Study|Withdrawal by Subject|2|||
143339119|NCT01533493|516786172|FG000|Overall Study|Lost to Follow-up|2|||
143339120|NCT01533493|516786173|FG001|Overall Study|Lost to Follow-up|0|||
143339121|NCT05163522|516786181|FG000|Overall Study|Withdrawal by Subject|0|||
143339122|NCT05163522|516786182|FG001|Overall Study|Withdrawal by Subject|0|||
143339123|NCT05163522|516786183|FG002|Overall Study|Withdrawal by Subject|1|||
143339124|NCT05163522|516786184|FG003|Overall Study|Withdrawal by Subject|0|||
143392732|NCT04492722|516984942|FG002|Overall Study|Physician Decision|1|||
143392733|NCT04492722|516984943|FG003|Overall Study|Physician Decision|1|||
143392734|NCT04492722|516984940|FG000|Overall Study|Withdrawal by Subject|6|||
143392735|NCT04492722|516984941|FG001|Overall Study|Withdrawal by Subject|6|||
143392736|NCT04492722|516984942|FG002|Overall Study|Withdrawal by Subject|0|||
143392737|NCT04492722|516984943|FG003|Overall Study|Withdrawal by Subject|3|||
143392738|NCT04492722|516984940|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
143392739|NCT04492722|516984941|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
143392740|NCT04492722|516984942|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
143392741|NCT04492722|516984943|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
143392742|NCT04492722|516984940|FG000|Overall Study|Due to Covid-19 pandemic|7|||
143392743|NCT04492722|516984941|FG001|Overall Study|Due to Covid-19 pandemic|3|||
143392744|NCT04492722|516984942|FG002|Overall Study|Due to Covid-19 pandemic|7|||
143392745|NCT04492722|516984943|FG003|Overall Study|Due to Covid-19 pandemic|6|||
143392746|NCT04492722|516984940|FG000|Overall Study|Failure to meet randomisation criteria|2|||
143392747|NCT04492722|516984941|FG001|Overall Study|Failure to meet randomisation criteria|3|||
143392748|NCT04492722|516984942|FG002|Overall Study|Failure to meet randomisation criteria|4|||
143392749|NCT04492722|516984943|FG003|Overall Study|Failure to meet randomisation criteria|2|||
143392750|NCT04492722|516984940|FG000|Overall Study|Early termination from the study|54|||
143392751|NCT04492722|516984941|FG001|Overall Study|Early termination from the study|51|||
143392752|NCT04492722|516984942|FG002|Overall Study|Early termination from the study|50|||
143392753|NCT04492722|516984943|FG003|Overall Study|Early termination from the study|50|||
143392754|NCT04492722|516984940|FG000|Overall Study|Missing|3|||
143392755|NCT04492722|516984941|FG001|Overall Study|Missing|0|||
143392756|NCT04492722|516984942|FG002|Overall Study|Missing|0|||
143392757|NCT04492722|516984943|FG003|Overall Study|Missing|5|||
143392758|NCT04492722|516984940|FG000|Overall Study|Participants who did not receive treatment|0|||
143392759|NCT04492722|516984941|FG001|Overall Study|Participants who did not receive treatment|1|||
143392760|NCT04492722|516984942|FG002|Overall Study|Participants who did not receive treatment|4|||
143392761|NCT04492722|516984943|FG003|Overall Study|Participants who did not receive treatment|0|||
143392762|NCT03631784|516984945|FG000|Overall Study|Participants Ongoing|1|||
143392763|NCT03631784|516984946|FG001|Overall Study|Participants Ongoing|0|||
143392764|NCT03631784|516984945|FG000|Overall Study|Withdrawal by Subject|3|||
143392765|NCT03631784|516984946|FG001|Overall Study|Withdrawal by Subject|3|||
143392766|NCT03631784|516984945|FG000|Overall Study|Sponsor's Decision|36|||
143392767|NCT03631784|516984946|FG001|Overall Study|Sponsor's Decision|52|||
143392768|NCT03631784|516984945|FG000|Overall Study|Lost to Follow-up|1|||
143392769|NCT03631784|516984946|FG001|Overall Study|Lost to Follow-up|0|||
143392770|NCT03631784|516984945|FG000|Overall Study|Death|71|||
143392771|NCT03631784|516984946|FG001|Overall Study|Death|49|||
143392772|NCT03931174|516984947|FG000|Providers|Staff left organization|26|||
143392773|NCT03931174|516984948|FG001|Providers|Staff left organization|25|||
143392774|NCT03931174|516984947|FG000|Providers|Staff on leave/no longer engaged in implementation initiative|11|||
143392775|NCT03931174|516984948|FG001|Providers|Staff on leave/no longer engaged in implementation initiative|4|||
143392776|NCT03931174|516984947|FG000|Providers|Lost to Follow-up|4|||
143392777|NCT03931174|516984948|FG001|Providers|Lost to Follow-up|4|||
143392778|NCT03931174|516984947|FG000|Patients|Post-consent screening failure|1|||
143392779|NCT03931174|516984948|FG001|Patients|Post-consent screening failure|1|||
143392780|NCT03931174|516984947|FG000|Patients|Death|1|||
143392781|NCT03931174|516984948|FG001|Patients|Death|1|||
143392782|NCT03931174|516984947|FG000|Patients|Lost to Follow-up|60|||
143392783|NCT03931174|516984948|FG001|Patients|Lost to Follow-up|89|||
143392784|NCT04049643|516984949|FG000|Overall Study|Lack of Efficacy|1|||
143392785|NCT04049643|516984950|FG001|Overall Study|Lack of Efficacy|1|||
143392786|NCT04049643|516984951|FG002|Overall Study|Lack of Efficacy|0|||
143392787|NCT04049643|516984949|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
143392788|NCT04049643|516984950|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
143392789|NCT04049643|516984951|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
143392790|NCT05659537|516987531|FG000|Overall Study|Adverse Event|5|||
143392791|NCT05659537|516987531|FG000|Overall Study|Lost to Follow-up|4|||
143392792|NCT05659537|516987531|FG000|Overall Study|Withdrawal by Subject|13|||
143392793|NCT05659537|516987531|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
143392794|NCT05659537|516987531|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
143392795|NCT05659537|516987531|FG000|Overall Study|Participant was suffering from anaemia|1|||
143392796|NCT03953508|516987535|FG000|Baseline|Lost to Follow-up|3|||
143392797|NCT03953508|516987536|FG001|Baseline|Lost to Follow-up|2|||
143392798|NCT03953508|516987535|FG000|6-month Follow-up|Lost to Follow-up|62|||
143392799|NCT03953508|516987536|FG001|6-month Follow-up|Lost to Follow-up|70|||
143392800|NCT03771417|516987537|FG000|Overall Study|Withdrawal by Subject|1|||
143392801|NCT03771417|516987538|FG001|Overall Study|Withdrawal by Subject|0|||
143392802|NCT03771417|516987539|FG002|Overall Study|Withdrawal by Subject|0|||
143392803|NCT03771417|516987537|FG000|Overall Study|Covid-19 Shutdown|0|||
143392804|NCT03771417|516987538|FG001|Overall Study|Covid-19 Shutdown|1|||
143392805|NCT03771417|516987539|FG002|Overall Study|Covid-19 Shutdown|0|||
143392806|NCT00506519|516987547|FG000|Overall Study|Death|4|||
143392807|NCT00506519|516987548|FG001|Overall Study|Death|6|||
143392808|NCT00506519|516987549|FG002|Overall Study|Death|0|||
143392809|NCT00506519|516987547|FG000|Overall Study|Adverse Event|1|||
143392810|NCT00506519|516987548|FG001|Overall Study|Adverse Event|0|||
143392811|NCT00506519|516987549|FG002|Overall Study|Adverse Event|0|||
143392812|NCT02975882|516987550|FG000|Overall Study|Adverse Event|1|||
143392813|NCT02975882|516987551|FG001|Overall Study|Adverse Event|2|||
143392814|NCT02975882|516987552|FG002|Overall Study|Adverse Event|1|||
143392815|NCT02975882|516987553|FG003|Overall Study|Adverse Event|1|||
143392816|NCT02975882|516987550|FG000|Overall Study|Death|0|||
143392817|NCT02975882|516987551|FG001|Overall Study|Death|1|||
143392818|NCT02975882|516987552|FG002|Overall Study|Death|0|||
143392819|NCT02975882|516987553|FG003|Overall Study|Death|0|||
143392820|NCT02975882|516987550|FG000|Overall Study|Lack of Efficacy|3|||
143392821|NCT02975882|516987551|FG001|Overall Study|Lack of Efficacy|7|||
143392822|NCT02975882|516987552|FG002|Overall Study|Lack of Efficacy|4|||
143392823|NCT02975882|516987553|FG003|Overall Study|Lack of Efficacy|3|||
143392824|NCT02975882|516987550|FG000|Overall Study|Physician Decision|0|||
143392825|NCT02975882|516987551|FG001|Overall Study|Physician Decision|2|||
143392826|NCT02975882|516987552|FG002|Overall Study|Physician Decision|4|||
143392827|NCT02975882|516987553|FG003|Overall Study|Physician Decision|2|||
143392828|NCT02975882|516987550|FG000|Overall Study|Ineligible|0|||
143392829|NCT02975882|516987551|FG001|Overall Study|Ineligible|1|||
143392830|NCT02975882|516987552|FG002|Overall Study|Ineligible|0|||
143392831|NCT02975882|516987553|FG003|Overall Study|Ineligible|0|||
143392832|NCT02105766|516987554|FG000|Overall Study|Physician Decision|1|||
143392833|NCT02105766|516987555|FG001|Overall Study|Physician Decision|1|||
143392834|NCT02105766|516987556|FG002|Overall Study|Physician Decision|0|||
143392835|NCT02105766|516987554|FG000|Overall Study|Lost to Follow-up|2|||
143392836|NCT02105766|516987555|FG001|Overall Study|Lost to Follow-up|0|||
143392837|NCT02105766|516987556|FG002|Overall Study|Lost to Follow-up|0|||
143392838|NCT02105766|516987554|FG000|Overall Study|Death|1|||
143392839|NCT02105766|516987555|FG001|Overall Study|Death|1|||
143392840|NCT02105766|516987556|FG002|Overall Study|Death|0|||
143392841|NCT02985957|516987558|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
143392842|NCT02985957|516987559|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
143392843|NCT02985957|516987560|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
143392844|NCT02985957|516987561|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
143392845|NCT02985957|516987562|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
143392846|NCT02985957|516987563|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
143392847|NCT02985957|516987564|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
143392848|NCT02985957|516987558|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
143392849|NCT02985957|516987559|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
143392850|NCT02985957|516987560|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
143392851|NCT02985957|516987561|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
143392852|NCT02985957|516987562|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
143392853|NCT02985957|516987563|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
143392854|NCT02985957|516987564|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
143392855|NCT02985957|516987558|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
143392856|NCT02985957|516987559|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
143392857|NCT02985957|516987560|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
143392858|NCT02985957|516987561|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
143392859|NCT02985957|516987562|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
143392860|NCT02985957|516987563|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
143392861|NCT02985957|516987564|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
143392862|NCT02985957|516987558|FG000|Treatment Period|Death|0|||
143392863|NCT02985957|516987559|FG001|Treatment Period|Death|0|||
143392864|NCT02985957|516987560|FG002|Treatment Period|Death|0|||
143392865|NCT02985957|516987561|FG003|Treatment Period|Death|0|||
143392866|NCT02985957|516987562|FG004|Treatment Period|Death|1|||
143392867|NCT02985957|516987563|FG005|Treatment Period|Death|0|||
143392868|NCT02985957|516987564|FG006|Treatment Period|Death|0|||
143392869|NCT02985957|516987558|FG000|Treatment Period|Participant withdrew consent|0|||
143392870|NCT02985957|516987559|FG001|Treatment Period|Participant withdrew consent|0|||
143392871|NCT02985957|516987560|FG002|Treatment Period|Participant withdrew consent|0|||
143392872|NCT02985957|516987561|FG003|Treatment Period|Participant withdrew consent|1|||
143392873|NCT02985957|516987562|FG004|Treatment Period|Participant withdrew consent|3|||
143392874|NCT02985957|516987563|FG005|Treatment Period|Participant withdrew consent|0|||
143392875|NCT02985957|516987564|FG006|Treatment Period|Participant withdrew consent|1|||
143392876|NCT02985957|516987558|FG000|Treatment Period|Lost to Follow-up|0|||
143392877|NCT02985957|516987559|FG001|Treatment Period|Lost to Follow-up|0|||
143392878|NCT02985957|516987560|FG002|Treatment Period|Lost to Follow-up|0|||
143392879|NCT02985957|516987561|FG003|Treatment Period|Lost to Follow-up|0|||
143392880|NCT02985957|516987562|FG004|Treatment Period|Lost to Follow-up|1|||
143454305|NCT00738894|517208188|FG000|Overall Study|Death|2|||
143454306|NCT00738894|517208189|FG001|Overall Study|Death|0|||
143454307|NCT05017103|517208190|FG000|Overall Study|Death|2|||
143454308|NCT02656329|517208191|FG000|Overall Study|Lost to Follow-up|2|||
143454309|NCT02656329|517208192|FG001|Overall Study|Lost to Follow-up|3|||
143454310|NCT02656329|517208191|FG000|Overall Study|Withdrawal by Subject|7|||
143454311|NCT02656329|517208192|FG001|Overall Study|Withdrawal by Subject|6|||
143454312|NCT02656329|517208191|FG000|Overall Study|Study termination by Sponsor|150|||
143454313|NCT02656329|517208192|FG001|Overall Study|Study termination by Sponsor|142|||
143454314|NCT02656329|517208191|FG000|Overall Study|Other than specified above|5|||
143454315|NCT02656329|517208192|FG001|Overall Study|Other than specified above|6|||
143454316|NCT01747551|517208198|FG000|Overall Study|Progressive Disease|24|||
143454317|NCT01747551|517208199|FG001|Overall Study|Progressive Disease|17|||
143454318|NCT01747551|517208198|FG000|Overall Study|Death|3|||
143454319|NCT01747551|517208199|FG001|Overall Study|Death|1|||
143454320|NCT01747551|517208198|FG000|Overall Study|Adverse Event|7|||
143454321|NCT01747551|517208199|FG001|Overall Study|Adverse Event|1|||
143454322|NCT01747551|517208198|FG000|Overall Study|Prolonged Treatment Delay|2|||
143454323|NCT01747551|517208199|FG001|Overall Study|Prolonged Treatment Delay|0|||
143454324|NCT01747551|517208198|FG000|Overall Study|Withdrawal by Subject|3|||
143454325|NCT01747551|517208199|FG001|Overall Study|Withdrawal by Subject|1|||
143454326|NCT01747551|517208198|FG000|Overall Study|Physician Decision|2|||
143454327|NCT01747551|517208199|FG001|Overall Study|Physician Decision|1|||
143454328|NCT01747551|517208198|FG000|Overall Study|Other|2|||
143454329|NCT01747551|517208199|FG001|Overall Study|Other|0|||
143454330|NCT02091206|517208201|FG000|Treatment Period|Adverse Event|0|||
143454331|NCT02091206|517208202|FG001|Treatment Period|Adverse Event|1|||
143454332|NCT02091206|517208203|FG002|Treatment Period|Adverse Event|0|||
143454333|NCT02091206|517208204|FG003|Treatment Period|Adverse Event|0|||
143454334|NCT02091206|517208201|FG000|Treatment Period|Met withdrawal criteria|0|||
143454335|NCT02091206|517208202|FG001|Treatment Period|Met withdrawal criteria|0|||
143454336|NCT02091206|517208203|FG002|Treatment Period|Met withdrawal criteria|1|||
143454337|NCT02091206|517208204|FG003|Treatment Period|Met withdrawal criteria|0|||
143454338|NCT02091206|517208201|FG000|Taper Period|Participant refused study drug|1|||
143454339|NCT02091206|517208202|FG001|Taper Period|Participant refused study drug|0|||
143454340|NCT02091206|517208203|FG002|Taper Period|Participant refused study drug|0|||
143454341|NCT02091206|517208204|FG003|Taper Period|Participant refused study drug|1|||
143454342|NCT02091206|517208201|FG000|Taper Period|Lost to Follow-up|0|||
143454343|NCT02091206|517208202|FG001|Taper Period|Lost to Follow-up|0|||
143454344|NCT02091206|517208203|FG002|Taper Period|Lost to Follow-up|0|||
143454345|NCT02091206|517208204|FG003|Taper Period|Lost to Follow-up|1|||
143454346|NCT03117998|517208210|FG000|Overall Study|Adverse Event|1|||
143454347|NCT03117998|517208211|FG001|Overall Study|Adverse Event|0|||
143454348|NCT03117998|517208212|FG002|Overall Study|Adverse Event|0|||
143454349|NCT03117998|517208213|FG003|Overall Study|Adverse Event|0|||
143454350|NCT03117998|517208214|FG004|Overall Study|Adverse Event|0|||
143454351|NCT03117998|517208215|FG005|Overall Study|Adverse Event|0|||
143454352|NCT03117998|517208210|FG000|Overall Study|Withdrawal by Subject|0|||
143454353|NCT03117998|517208211|FG001|Overall Study|Withdrawal by Subject|0|||
143339125|NCT05163522|516786185|FG004|Overall Study|Withdrawal by Subject|0|||
143339126|NCT05163522|516786186|FG005|Overall Study|Withdrawal by Subject|0|||
143339127|NCT05163522|516786187|FG006|Overall Study|Withdrawal by Subject|0|||
143339128|NCT05163522|516786188|FG007|Overall Study|Withdrawal by Subject|0|||
143339129|NCT05163522|516786189|FG008|Overall Study|Withdrawal by Subject|0|||
143339130|NCT05163522|516786190|FG009|Overall Study|Withdrawal by Subject|0|||
143339131|NCT05163522|516786191|FG010|Overall Study|Withdrawal by Subject|0|||
143339132|NCT00715429|516786193|FG000|Overall Study|Did not complete the study diary|0|||
143339133|NCT00715429|516786194|FG001|Overall Study|Did not complete the study diary|1|||
143339134|NCT04899245|516786202|FG000|Overall Study|Withdrawal by Subject|3|||
143339135|NCT04899245|516786203|FG001|Overall Study|Withdrawal by Subject|5|||
143339136|NCT04899245|516786204|FG002|Overall Study|Withdrawal by Subject|2|||
143339137|NCT04899245|516786202|FG000|Overall Study|No longer eligible - Left staff position|0|||
143339138|NCT04899245|516786203|FG001|Overall Study|No longer eligible - Left staff position|0|||
143339139|NCT04899245|516786204|FG002|Overall Study|No longer eligible - Left staff position|1|||
143339140|NCT04899245|516786202|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
143339141|NCT04899245|516786203|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
143339142|NCT04899245|516786204|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
143339143|NCT04899245|516786202|FG000|Overall Study|No longer eligible - Moved away from area|2|||
143339144|NCT04899245|516786203|FG001|Overall Study|No longer eligible - Moved away from area|2|||
143339145|NCT04899245|516786204|FG002|Overall Study|No longer eligible - Moved away from area|0|||
143339146|NCT01570868|516786207|FG000|Overall Study|Adverse Event|8|||
143339147|NCT01570868|516786208|FG001|Overall Study|Adverse Event|1|||
143339148|NCT01570868|516786207|FG000|Overall Study|FDA Recommendation|23|||
143339149|NCT01570868|516786208|FG001|Overall Study|FDA Recommendation|3|||
143339150|NCT01570868|516786207|FG000|Overall Study|Physician Decision|10|||
143339151|NCT01570868|516786208|FG001|Overall Study|Physician Decision|4|||
143339152|NCT01570868|516786207|FG000|Overall Study|Lost to Follow-up|1|||
143339153|NCT01570868|516786208|FG001|Overall Study|Lost to Follow-up|0|||
143339154|NCT01570868|516786207|FG000|Overall Study|Withdrawal by Subject|1|||
143339155|NCT01570868|516786208|FG001|Overall Study|Withdrawal by Subject|0|||
143339156|NCT02515279|516786212|FG000|Overall Study|Adverse Event|7|||
143339157|NCT02515279|516786212|FG000|Overall Study|Lack of Efficacy|31|||
143339158|NCT02515279|516786212|FG000|Overall Study|Lost to Follow-up|9|||
143339159|NCT02515279|516786212|FG000|Overall Study|Withdrawal by Subject|18|||
143339160|NCT02515279|516786212|FG000|Overall Study|End-of-treatment visit not attended|17|||
143339161|NCT02515279|516786212|FG000|Overall Study|Other|22|||
143339162|NCT00386022|516786219|FG000|Plus Estrogen|Lost to Follow-up|2|||
143339163|NCT00386022|516786220|FG001|Plus Estrogen|Lost to Follow-up|0|||
143339164|NCT00386022|516786219|FG000|Plus Estrogen|Adverse Event|0|||
143339165|NCT00386022|516786220|FG001|Plus Estrogen|Adverse Event|1|||
143339166|NCT00504426|516786228|FG000|Overall Study|Adverse Event|0|||
143339167|NCT00504426|516786229|FG001|Overall Study|Adverse Event|0|||
143339168|NCT00504426|516786230|FG002|Overall Study|Adverse Event|2|||
143339169|NCT00504426|516786231|FG003|Overall Study|Adverse Event|0|||
143339170|NCT00504426|516786228|FG000|Overall Study|Protocol Violation|1|||
143339171|NCT00504426|516786229|FG001|Overall Study|Protocol Violation|1|||
143339172|NCT00504426|516786230|FG002|Overall Study|Protocol Violation|2|||
143339173|NCT00504426|516786231|FG003|Overall Study|Protocol Violation|0|||
143339174|NCT00504426|516786228|FG000|Overall Study|Withdrawal by Subject|2|||
143339175|NCT00504426|516786229|FG001|Overall Study|Withdrawal by Subject|0|||
143339176|NCT00504426|516786230|FG002|Overall Study|Withdrawal by Subject|0|||
143339177|NCT00504426|516786231|FG003|Overall Study|Withdrawal by Subject|0|||
143339178|NCT00031486|516786237|FG000|Overall Study|Adverse Event|1|||
143339179|NCT00031486|516786238|FG001|Overall Study|Adverse Event|0|||
143339180|NCT00031486|516786237|FG000|Overall Study|Lost to Follow-up|0|||
143339181|NCT00031486|516786238|FG001|Overall Study|Lost to Follow-up|1|||
143339182|NCT00031486|516786237|FG000|Overall Study|Withdrawal by Subject|3|||
143339183|NCT00031486|516786238|FG001|Overall Study|Withdrawal by Subject|2|||
143339184|NCT00031486|516786237|FG000|Overall Study|Death|0|||
143339185|NCT00031486|516786238|FG001|Overall Study|Death|3|||
143339186|NCT00031486|516786237|FG000|Overall Study|Non-compliant|0|||
143339187|NCT00031486|516786238|FG001|Overall Study|Non-compliant|4|||
143339188|NCT00031486|516786237|FG000|Overall Study|Did not meet eligibility requirement|2|||
143339189|NCT00031486|516786238|FG001|Overall Study|Did not meet eligibility requirement|1|||
143339190|NCT00031486|516786237|FG000|Overall Study|Other|1|||
143339191|NCT00031486|516786238|FG001|Overall Study|Other|1|||
143339192|NCT03685591|516786239|FG000|Overall Study|Global Deterioration of Health Status|0|||
143339193|NCT03685591|516786240|FG001|Overall Study|Global Deterioration of Health Status|0|||
143339194|NCT03685591|516786241|FG002|Overall Study|Global Deterioration of Health Status|0|||
143339195|NCT03685591|516786242|FG003|Overall Study|Global Deterioration of Health Status|1|||
143339196|NCT03685591|516786243|FG004|Overall Study|Global Deterioration of Health Status|2|||
143339197|NCT03685591|516786244|FG005|Overall Study|Global Deterioration of Health Status|4|||
143339198|NCT03685591|516786245|FG006|Overall Study|Global Deterioration of Health Status|1|||
143339199|NCT03685591|516786246|FG007|Overall Study|Global Deterioration of Health Status|1|||
143339200|NCT03685591|516786247|FG008|Overall Study|Global Deterioration of Health Status|0|||
143339201|NCT03685591|516786239|FG000|Overall Study|Progressive Disease|1|||
143339202|NCT03685591|516786240|FG001|Overall Study|Progressive Disease|1|||
143339203|NCT03685591|516786241|FG002|Overall Study|Progressive Disease|0|||
143339204|NCT03685591|516786242|FG003|Overall Study|Progressive Disease|3|||
143339205|NCT03685591|516786243|FG004|Overall Study|Progressive Disease|5|||
143339206|NCT03685591|516786244|FG005|Overall Study|Progressive Disease|4|||
143339207|NCT03685591|516786245|FG006|Overall Study|Progressive Disease|3|||
143339208|NCT03685591|516786246|FG007|Overall Study|Progressive Disease|2|||
143339209|NCT03685591|516786247|FG008|Overall Study|Progressive Disease|1|||
143339210|NCT03685591|516786239|FG000|Overall Study|Other|0|||
143339211|NCT03685591|516786240|FG001|Overall Study|Other|0|||
143339212|NCT03685591|516786241|FG002|Overall Study|Other|1|||
143339213|NCT03685591|516786242|FG003|Overall Study|Other|0|||
143339214|NCT03685591|516786243|FG004|Overall Study|Other|2|||
143339215|NCT03685591|516786244|FG005|Overall Study|Other|3|||
143339216|NCT03685591|516786245|FG006|Overall Study|Other|0|||
143339217|NCT03685591|516786246|FG007|Overall Study|Other|0|||
143339218|NCT03685591|516786247|FG008|Overall Study|Other|0|||
143339219|NCT03685591|516786239|FG000|Overall Study|Withdrawal by Subject|0|||
143339220|NCT03685591|516786240|FG001|Overall Study|Withdrawal by Subject|0|||
143339221|NCT03685591|516786241|FG002|Overall Study|Withdrawal by Subject|0|||
143339222|NCT03685591|516786242|FG003|Overall Study|Withdrawal by Subject|0|||
143339223|NCT03685591|516786243|FG004|Overall Study|Withdrawal by Subject|3|||
143339224|NCT03685591|516786244|FG005|Overall Study|Withdrawal by Subject|2|||
143339225|NCT03685591|516786245|FG006|Overall Study|Withdrawal by Subject|0|||
143339226|NCT03685591|516786246|FG007|Overall Study|Withdrawal by Subject|0|||
143339227|NCT03685591|516786247|FG008|Overall Study|Withdrawal by Subject|1|||
143339228|NCT03685591|516786239|FG000|Overall Study|Adverse Event|0|||
143339229|NCT03685591|516786240|FG001|Overall Study|Adverse Event|0|||
143339230|NCT03685591|516786241|FG002|Overall Study|Adverse Event|0|||
143339231|NCT03685591|516786242|FG003|Overall Study|Adverse Event|1|||
143339232|NCT03685591|516786243|FG004|Overall Study|Adverse Event|1|||
143339233|NCT03685591|516786244|FG005|Overall Study|Adverse Event|4|||
143339234|NCT03685591|516786245|FG006|Overall Study|Adverse Event|0|||
143339235|NCT03685591|516786246|FG007|Overall Study|Adverse Event|1|||
143339236|NCT03685591|516786247|FG008|Overall Study|Adverse Event|1|||
143339237|NCT01685138|516786250|FG000|Overall Study|Lost to Follow-up|1|||
143339238|NCT01685138|516786250|FG000|Overall Study|Protocol Violation|1|||
143339239|NCT01685138|516786250|FG000|Overall Study|No longer requires treatment|1|||
143339240|NCT01685138|516786250|FG000|Overall Study|Subject/guardian decision|2|||
143339241|NCT01685138|516786250|FG000|Overall Study|Physician Decision|6|||
143339242|NCT01685138|516786250|FG000|Overall Study|Death|10|||
143339243|NCT01685138|516786250|FG000|Overall Study|Adverse Event|18|||
143339244|NCT01685138|516786250|FG000|Overall Study|Progressive disease|53|||
143339245|NCT01984697|516788157|FG000|Overall Study|Adverse Event|0|||
143339246|NCT01984697|516788158|FG001|Overall Study|Adverse Event|0|||
143339247|NCT01984697|516788159|FG002|Overall Study|Adverse Event|2|||
143339248|NCT01984697|516788160|FG003|Overall Study|Adverse Event|0|||
143339249|NCT01984697|516788161|FG004|Overall Study|Adverse Event|0|||
143339250|NCT01984697|516788157|FG000|Overall Study|Lost to Follow-up|14|||
143339251|NCT01984697|516788158|FG001|Overall Study|Lost to Follow-up|5|||
143339252|NCT01984697|516788159|FG002|Overall Study|Lost to Follow-up|10|||
143339253|NCT01984697|516788160|FG003|Overall Study|Lost to Follow-up|6|||
143339254|NCT01984697|516788161|FG004|Overall Study|Lost to Follow-up|21|||
143339255|NCT01984697|516788157|FG000|Overall Study|Physician Decision|3|||
143339256|NCT01984697|516788158|FG001|Overall Study|Physician Decision|0|||
143339257|NCT01984697|516788159|FG002|Overall Study|Physician Decision|0|||
143339258|NCT01984697|516788160|FG003|Overall Study|Physician Decision|1|||
143339259|NCT01984697|516788161|FG004|Overall Study|Physician Decision|0|||
143339260|NCT01984697|516788157|FG000|Overall Study|Protocol Violation|8|||
143339261|NCT01984697|516788158|FG001|Overall Study|Protocol Violation|5|||
143339262|NCT01984697|516788159|FG002|Overall Study|Protocol Violation|3|||
143339263|NCT01984697|516788160|FG003|Overall Study|Protocol Violation|2|||
143339264|NCT01984697|516788161|FG004|Overall Study|Protocol Violation|0|||
143339265|NCT01984697|516788157|FG000|Overall Study|Withdrawal by Subject|15|||
143339266|NCT01984697|516788158|FG001|Overall Study|Withdrawal by Subject|21|||
143339267|NCT01984697|516788159|FG002|Overall Study|Withdrawal by Subject|13|||
143339268|NCT01984697|516788160|FG003|Overall Study|Withdrawal by Subject|11|||
143339269|NCT01984697|516788161|FG004|Overall Study|Withdrawal by Subject|13|||
143339270|NCT01984697|516788157|FG000|Overall Study|Missed last follow-up visit|1|||
143339271|NCT01984697|516788158|FG001|Overall Study|Missed last follow-up visit|0|||
143339272|NCT01984697|516788159|FG002|Overall Study|Missed last follow-up visit|0|||
143339273|NCT01984697|516788160|FG003|Overall Study|Missed last follow-up visit|0|||
143392881|NCT02985957|516987563|FG005|Treatment Period|Lost to Follow-up|0|||
143392882|NCT02985957|516987564|FG006|Treatment Period|Lost to Follow-up|0|||
143392883|NCT02985957|516987558|FG000|Treatment Period|Other reasons|0|||
143392884|NCT02985957|516987559|FG001|Treatment Period|Other reasons|0|||
143392885|NCT02985957|516987560|FG002|Treatment Period|Other reasons|1|||
143392886|NCT02985957|516987561|FG003|Treatment Period|Other reasons|3|||
143392887|NCT02985957|516987562|FG004|Treatment Period|Other reasons|6|||
143392888|NCT02985957|516987563|FG005|Treatment Period|Other reasons|0|||
143392889|NCT02985957|516987564|FG006|Treatment Period|Other reasons|1|||
143392890|NCT02985957|516987558|FG000|Treatment Period|Not reported|0|||
143392891|NCT02985957|516987559|FG001|Treatment Period|Not reported|1|||
143392892|NCT02985957|516987560|FG002|Treatment Period|Not reported|2|||
143392893|NCT02985957|516987561|FG003|Treatment Period|Not reported|5|||
143392894|NCT02985957|516987562|FG004|Treatment Period|Not reported|0|||
143392895|NCT02985957|516987563|FG005|Treatment Period|Not reported|0|||
143392896|NCT02985957|516987564|FG006|Treatment Period|Not reported|0|||
143392897|NCT02985957|516987558|FG000|Treatment Period|Maximum clinical benefit|0|||
143392898|NCT02985957|516987559|FG001|Treatment Period|Maximum clinical benefit|0|||
143392899|NCT02985957|516987560|FG002|Treatment Period|Maximum clinical benefit|1|||
143392900|NCT02985957|516987561|FG003|Treatment Period|Maximum clinical benefit|1|||
143392901|NCT02985957|516987562|FG004|Treatment Period|Maximum clinical benefit|0|||
143392902|NCT02985957|516987563|FG005|Treatment Period|Maximum clinical benefit|0|||
143392903|NCT02985957|516987564|FG006|Treatment Period|Maximum clinical benefit|2|||
143392904|NCT02985957|516987558|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
143392905|NCT02985957|516987559|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
143392906|NCT02985957|516987560|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
143392907|NCT02985957|516987561|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
143392908|NCT02985957|516987562|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
143392909|NCT02985957|516987563|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
143392910|NCT02985957|516987564|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
143392911|NCT02985957|516987558|FG000|Treatment Period|Study drug toxicity|1|||
143392912|NCT02985957|516987559|FG001|Treatment Period|Study drug toxicity|23|||
143392913|NCT02985957|516987560|FG002|Treatment Period|Study drug toxicity|20|||
143392914|NCT02985957|516987561|FG003|Treatment Period|Study drug toxicity|11|||
143392915|NCT02985957|516987562|FG004|Treatment Period|Study drug toxicity|19|||
143392916|NCT02985957|516987563|FG005|Treatment Period|Study drug toxicity|3|||
143392917|NCT02985957|516987564|FG006|Treatment Period|Study drug toxicity|5|||
143392918|NCT02985957|516987558|FG000|Treatment Period|Disease progression|0|||
143392919|NCT02985957|516987559|FG001|Treatment Period|Disease progression|16|||
143392920|NCT02985957|516987560|FG002|Treatment Period|Disease progression|20|||
143392921|NCT02985957|516987561|FG003|Treatment Period|Disease progression|39|||
143392922|NCT02985957|516987562|FG004|Treatment Period|Disease progression|29|||
143392923|NCT02985957|516987563|FG005|Treatment Period|Disease progression|11|||
143392924|NCT02985957|516987564|FG006|Treatment Period|Disease progression|28|||
143392925|NCT02985957|516987558|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
143392926|NCT02985957|516987559|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
143392927|NCT02985957|516987560|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
143392928|NCT02985957|516987561|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
143392929|NCT02985957|516987562|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
143392930|NCT02985957|516987563|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
143392931|NCT02985957|516987564|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
143392932|NCT02985957|516987558|FG000|Treatment Period|Poor/Non-Compliance|0|||
143392933|NCT02985957|516987559|FG001|Treatment Period|Poor/Non-Compliance|0|||
143392934|NCT02985957|516987560|FG002|Treatment Period|Poor/Non-Compliance|0|||
143392935|NCT02985957|516987561|FG003|Treatment Period|Poor/Non-Compliance|0|||
143392936|NCT02985957|516987562|FG004|Treatment Period|Poor/Non-Compliance|1|||
143392937|NCT02985957|516987563|FG005|Treatment Period|Poor/Non-Compliance|1|||
143392938|NCT02985957|516987564|FG006|Treatment Period|Poor/Non-Compliance|0|||
143392939|NCT02985957|516987558|FG000|Treatment Period|Continuing in Treatment Period|0|||
143392940|NCT02985957|516987559|FG001|Treatment Period|Continuing in Treatment Period|1|||
143392941|NCT02985957|516987560|FG002|Treatment Period|Continuing in Treatment Period|0|||
143392942|NCT02985957|516987561|FG003|Treatment Period|Continuing in Treatment Period|4|||
143392943|NCT02985957|516987562|FG004|Treatment Period|Continuing in Treatment Period|4|||
143392944|NCT02985957|516987563|FG005|Treatment Period|Continuing in Treatment Period|0|||
143392945|NCT02985957|516987564|FG006|Treatment Period|Continuing in Treatment Period|0|||
143392946|NCT04342494|516987565|FG000|Overall Study|Questionnaire partially completed|1|||
143392947|NCT04342494|516987566|FG001|Overall Study|Questionnaire partially completed|0|||
143392948|NCT04342494|516987567|FG002|Overall Study|Questionnaire partially completed|2|||
143392949|NCT04342494|516987568|FG003|Overall Study|Questionnaire partially completed|0|||
143392950|NCT04342494|516987569|FG004|Overall Study|Questionnaire partially completed|1|||
143392951|NCT04342494|516987565|FG000|Overall Study|Lost to Follow-up|49|||
143392952|NCT04342494|516987566|FG001|Overall Study|Lost to Follow-up|38|||
143392953|NCT04342494|516987567|FG002|Overall Study|Lost to Follow-up|34|||
143392954|NCT04342494|516987568|FG003|Overall Study|Lost to Follow-up|34|||
143392955|NCT04342494|516987569|FG004|Overall Study|Lost to Follow-up|35|||
143392956|NCT05119023|516987570|FG000|Characterization of Learning-visits 1&2|Withdrawal by Subject|1|||
143392957|NCT05119023|516987570|FG000|Characterization of Learning-visits 1&2|Change in health status unrelated to study rendered unable to participate|2|||
143392958|NCT05119023|516987570|FG000|Characterization of Learning-visits 1&2|Lost to Follow-up|1|||
143392959|NCT04489771|516987574|FG000|Overall Study|Death|27|||
143392960|NCT04489771|516987575|FG001|Overall Study|Death|25|||
143392961|NCT04489771|516987574|FG000|Overall Study|Withdrawal by Subject|1|||
143392962|NCT04489771|516987575|FG001|Overall Study|Withdrawal by Subject|0|||
143392963|NCT04489771|516987574|FG000|Overall Study|Participants Ongoing in Study|50|||
143392964|NCT04489771|516987575|FG001|Overall Study|Participants Ongoing in Study|51|||
143392965|NCT04509674|516987578|FG000|Overall Study|Not treated|33|||
143392966|NCT04509674|516987579|FG001|Overall Study|Not treated|26|||
143392967|NCT04509674|516987578|FG000|Overall Study|Protocol Violation|9|||
143392968|NCT04509674|516987579|FG001|Overall Study|Protocol Violation|10|||
143392969|NCT04509674|516987578|FG000|Overall Study|Lost to Follow-up|31|||
143392970|NCT04509674|516987579|FG001|Overall Study|Lost to Follow-up|39|||
143339274|NCT01984697|516788161|FG004|Overall Study|Missed last follow-up visit|0|||
143339275|NCT01984697|516788157|FG000|Overall Study|Death|0|||
143339276|NCT01984697|516788158|FG001|Overall Study|Death|0|||
143339277|NCT01984697|516788159|FG002|Overall Study|Death|0|||
143339278|NCT01984697|516788160|FG003|Overall Study|Death|1|||
143339279|NCT01984697|516788161|FG004|Overall Study|Death|0|||
143339280|NCT01984697|516788157|FG000|Overall Study|Pregnancy|2|||
143339281|NCT01984697|516788158|FG001|Overall Study|Pregnancy|0|||
143339282|NCT01984697|516788159|FG002|Overall Study|Pregnancy|1|||
143339283|NCT01984697|516788160|FG003|Overall Study|Pregnancy|0|||
143339284|NCT01984697|516788161|FG004|Overall Study|Pregnancy|1|||
143339285|NCT04737109|516788163|FG000|Study Treatment|Disease Progression|5|||
143339286|NCT04737109|516788164|FG001|Study Treatment|Disease Progression|0|||
143339287|NCT04737109|516788165|FG002|Study Treatment|Disease Progression|0|||
143339288|NCT04737109|516788166|FG003|Study Treatment|Disease Progression|0|||
143339289|NCT04737109|516788163|FG000|Study Treatment|Death on study|1|||
143339290|NCT04737109|516788164|FG001|Study Treatment|Death on study|0|||
143339291|NCT04737109|516788165|FG002|Study Treatment|Death on study|0|||
143339292|NCT04737109|516788166|FG003|Study Treatment|Death on study|0|||
143339293|NCT02276066|516788167|FG000|Overall Study|Lost to Follow-up|21|||
143339294|NCT02276066|516788168|FG001|Overall Study|Lost to Follow-up|11|||
143339295|NCT01783418|516788172|FG000|Overall Study|Withdrawal by Subject|1|||
143339296|NCT01783418|516788173|FG001|Overall Study|Withdrawal by Subject|0|||
143339297|NCT00089141|516788174|FG000|Overall Study|Termination of trial|18|||
143339298|NCT00089141|516788175|FG001|Overall Study|Termination of trial|24|||
143392971|NCT04509674|516987578|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
143339299|NCT05168579|516788176|FG000|Overall Study|Lack of Consent|1|||
143339300|NCT05168579|516788177|FG001|Overall Study|Lack of Consent|0|||
143339301|NCT05168579|516788176|FG000|Overall Study|Conflicts with time|2|||
143339302|NCT05168579|516788177|FG001|Overall Study|Conflicts with time|0|||
143339303|NCT05168579|516788176|FG000|Overall Study|Time slots were full|3|||
143339304|NCT05168579|516788177|FG001|Overall Study|Time slots were full|0|||
143392972|NCT04509674|516987579|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
143392973|NCT04509674|516987578|FG000|Overall Study|Adverse event, serious fatal event|11|||
143392974|NCT04509674|516987579|FG001|Overall Study|Adverse event, serious fatal event|4|||
143392975|NCT04509674|516987578|FG000|Overall Study|Adverse event, non-fatal event|107|||
143392976|NCT04509674|516987579|FG001|Overall Study|Adverse event, non-fatal event|118|||
143392977|NCT04509674|516987578|FG000|Overall Study|Other reason than listed|106|||
143392978|NCT04509674|516987579|FG001|Overall Study|Other reason than listed|95|||
143392979|NCT06190691|516987581|FG000|Overall Study|Adverse Event|2|||
143392980|NCT06190691|516987582|FG001|Overall Study|Adverse Event|0|||
143392981|NCT06190691|516987583|FG002|Overall Study|Adverse Event|0|||
143392982|NCT06190691|516987584|FG003|Overall Study|Adverse Event|0|||
143392983|NCT04799899|516987586|FG000|Overall Study|Lost to Follow-up|2|||
143392984|NCT04799899|516987587|FG001|Overall Study|Lost to Follow-up|4|||
143392985|NCT04632992|516987588|FG000|Overall Study|Adverse Event|0|||
143392986|NCT04632992|516987589|FG001|Overall Study|Adverse Event|0|||
143392987|NCT04632992|516987590|FG002|Overall Study|Adverse Event|0|||
143392988|NCT04632992|516987591|FG003|Overall Study|Adverse Event|0|||
143392989|NCT04632992|516987592|FG004|Overall Study|Adverse Event|0|||
143392990|NCT04632992|516987593|FG005|Overall Study|Adverse Event|0|||
143392991|NCT04632992|516987594|FG006|Overall Study|Adverse Event|0|||
143392992|NCT04632992|516987595|FG007|Overall Study|Adverse Event|0|||
143392993|NCT04632992|516987596|FG008|Overall Study|Adverse Event|0|||
143392994|NCT04632992|516987597|FG009|Overall Study|Adverse Event|0|||
143392995|NCT04632992|516987598|FG010|Overall Study|Adverse Event|0|||
143392996|NCT04632992|516987599|FG011|Overall Study|Adverse Event|0|||
143392997|NCT04632992|516987600|FG012|Overall Study|Adverse Event|1|||
143392998|NCT04632992|516987601|FG013|Overall Study|Adverse Event|0|||
143392999|NCT04632992|516987588|FG000|Overall Study|Death|17|||
143393000|NCT04632992|516987589|FG001|Overall Study|Death|1|||
143393001|NCT04632992|516987590|FG002|Overall Study|Death|14|||
143393002|NCT04632992|516987591|FG003|Overall Study|Death|14|||
143393003|NCT04632992|516987592|FG004|Overall Study|Death|13|||
143393004|NCT04632992|516987593|FG005|Overall Study|Death|6|||
143393005|NCT04632992|516987594|FG006|Overall Study|Death|7|||
143393006|NCT04632992|516987595|FG007|Overall Study|Death|12|||
143393007|NCT04632992|516987596|FG008|Overall Study|Death|15|||
143393008|NCT04632992|516987597|FG009|Overall Study|Death|20|||
143393009|NCT04632992|516987598|FG010|Overall Study|Death|8|||
143393010|NCT04632992|516987599|FG011|Overall Study|Death|2|||
143393011|NCT04632992|516987600|FG012|Overall Study|Death|10|||
143393012|NCT04632992|516987601|FG013|Overall Study|Death|1|||
143393013|NCT04632992|516987588|FG000|Overall Study|Lost to Follow-up|1|||
143393014|NCT04632992|516987589|FG001|Overall Study|Lost to Follow-up|0|||
143393015|NCT04632992|516987590|FG002|Overall Study|Lost to Follow-up|1|||
143393016|NCT04632992|516987591|FG003|Overall Study|Lost to Follow-up|0|||
143393017|NCT04632992|516987592|FG004|Overall Study|Lost to Follow-up|2|||
143393018|NCT04632992|516987593|FG005|Overall Study|Lost to Follow-up|0|||
143393019|NCT04632992|516987594|FG006|Overall Study|Lost to Follow-up|1|||
143393020|NCT04632992|516987595|FG007|Overall Study|Lost to Follow-up|1|||
143393021|NCT04632992|516987596|FG008|Overall Study|Lost to Follow-up|1|||
143393022|NCT04632992|516987597|FG009|Overall Study|Lost to Follow-up|1|||
143393023|NCT04632992|516987598|FG010|Overall Study|Lost to Follow-up|2|||
143393024|NCT04632992|516987599|FG011|Overall Study|Lost to Follow-up|0|||
143393025|NCT04632992|516987600|FG012|Overall Study|Lost to Follow-up|0|||
143393026|NCT04632992|516987601|FG013|Overall Study|Lost to Follow-up|0|||
143393027|NCT04632992|516987588|FG000|Overall Study|Reason not Specified|2|||
143393028|NCT04632992|516987589|FG001|Overall Study|Reason not Specified|0|||
143393029|NCT04632992|516987590|FG002|Overall Study|Reason not Specified|1|||
143393030|NCT04632992|516987591|FG003|Overall Study|Reason not Specified|1|||
143393031|NCT04632992|516987592|FG004|Overall Study|Reason not Specified|0|||
143393032|NCT04632992|516987593|FG005|Overall Study|Reason not Specified|0|||
143393033|NCT04632992|516987594|FG006|Overall Study|Reason not Specified|0|||
143393034|NCT04632992|516987595|FG007|Overall Study|Reason not Specified|0|||
143393035|NCT04632992|516987596|FG008|Overall Study|Reason not Specified|0|||
143393036|NCT04632992|516987597|FG009|Overall Study|Reason not Specified|0|||
143393037|NCT04632992|516987598|FG010|Overall Study|Reason not Specified|1|||
143393038|NCT04632992|516987599|FG011|Overall Study|Reason not Specified|0|||
143393039|NCT04632992|516987600|FG012|Overall Study|Reason not Specified|0|||
143393040|NCT04632992|516987601|FG013|Overall Study|Reason not Specified|0|||
143393041|NCT04632992|516987588|FG000|Overall Study|Physician Decision|0|||
143393042|NCT04632992|516987589|FG001|Overall Study|Physician Decision|0|||
143393043|NCT04632992|516987590|FG002|Overall Study|Physician Decision|0|||
143393044|NCT04632992|516987591|FG003|Overall Study|Physician Decision|2|||
143393045|NCT04632992|516987592|FG004|Overall Study|Physician Decision|1|||
143393046|NCT04632992|516987593|FG005|Overall Study|Physician Decision|0|||
143393047|NCT04632992|516987594|FG006|Overall Study|Physician Decision|0|||
143393048|NCT04632992|516987595|FG007|Overall Study|Physician Decision|0|||
143393049|NCT04632992|516987596|FG008|Overall Study|Physician Decision|0|||
143393050|NCT04632992|516987597|FG009|Overall Study|Physician Decision|0|||
143393051|NCT04632992|516987598|FG010|Overall Study|Physician Decision|0|||
143393052|NCT04632992|516987599|FG011|Overall Study|Physician Decision|0|||
143393053|NCT04632992|516987600|FG012|Overall Study|Physician Decision|3|||
143393054|NCT04632992|516987601|FG013|Overall Study|Physician Decision|0|||
143393055|NCT04632992|516987588|FG000|Overall Study|Progressive Disease|0|||
143393056|NCT04632992|516987589|FG001|Overall Study|Progressive Disease|0|||
143393057|NCT04632992|516987590|FG002|Overall Study|Progressive Disease|0|||
143393058|NCT04632992|516987591|FG003|Overall Study|Progressive Disease|0|||
143393059|NCT04632992|516987592|FG004|Overall Study|Progressive Disease|1|||
143393060|NCT04632992|516987593|FG005|Overall Study|Progressive Disease|0|||
143393061|NCT04632992|516987594|FG006|Overall Study|Progressive Disease|0|||
143393062|NCT04632992|516987595|FG007|Overall Study|Progressive Disease|0|||
143393063|NCT04632992|516987596|FG008|Overall Study|Progressive Disease|0|||
143393064|NCT04632992|516987597|FG009|Overall Study|Progressive Disease|1|||
143393065|NCT04632992|516987598|FG010|Overall Study|Progressive Disease|1|||
143393066|NCT04632992|516987599|FG011|Overall Study|Progressive Disease|0|||
143393067|NCT04632992|516987600|FG012|Overall Study|Progressive Disease|2|||
143393068|NCT04632992|516987601|FG013|Overall Study|Progressive Disease|0|||
143393069|NCT04632992|516987588|FG000|Overall Study|Withdrawal by Subject|4|||
143393070|NCT04632992|516987589|FG001|Overall Study|Withdrawal by Subject|1|||
143393071|NCT04632992|516987590|FG002|Overall Study|Withdrawal by Subject|5|||
143393072|NCT04632992|516987591|FG003|Overall Study|Withdrawal by Subject|4|||
143393073|NCT04632992|516987592|FG004|Overall Study|Withdrawal by Subject|3|||
143393074|NCT04632992|516987593|FG005|Overall Study|Withdrawal by Subject|3|||
143393075|NCT04632992|516987594|FG006|Overall Study|Withdrawal by Subject|0|||
143393076|NCT04632992|516987595|FG007|Overall Study|Withdrawal by Subject|5|||
143393077|NCT04632992|516987596|FG008|Overall Study|Withdrawal by Subject|0|||
143393078|NCT04632992|516987597|FG009|Overall Study|Withdrawal by Subject|2|||
143393079|NCT04632992|516987598|FG010|Overall Study|Withdrawal by Subject|8|||
143393080|NCT04632992|516987599|FG011|Overall Study|Withdrawal by Subject|0|||
143393081|NCT04632992|516987600|FG012|Overall Study|Withdrawal by Subject|1|||
143393082|NCT04632992|516987601|FG013|Overall Study|Withdrawal by Subject|1|||
143393083|NCT05647304|516987603|FG000|Overall Study|Withdrawal by Subject|1|||
143393084|NCT05647304|516987604|FG001|Overall Study|Withdrawal by Subject|0|||
143393085|NCT03544281|516987605|FG000|Main Study Phase|Death|3|||
143393086|NCT03544281|516987606|FG001|Main Study Phase|Death|2|||
143393087|NCT03544281|516987607|FG002|Main Study Phase|Death|6|||
143393088|NCT03544281|516987608|FG003|Main Study Phase|Death|8|||
143393089|NCT03544281|516987609|FG004|Main Study Phase|Death|4|||
143393090|NCT03544281|516987610|FG005|Main Study Phase|Death|2|||
143393091|NCT03544281|516987611|FG006|Main Study Phase|Death|4|||
143393092|NCT03544281|516987612|FG007|Main Study Phase|Death|5|||
143393093|NCT03544281|516987613|FG008|Main Study Phase|Death|5|||
143393094|NCT03544281|516987614|FG009|Main Study Phase|Death|8|||
143393095|NCT03544281|516987615|FG010|Main Study Phase|Death|6|||
143393096|NCT03544281|516987616|FG011|Main Study Phase|Death|4|||
143393097|NCT03544281|516987617|FG012|Main Study Phase|Death|0|||
143393098|NCT03544281|516987618|FG013|Main Study Phase|Death|0|||
143393099|NCT03544281|516987619|FG014|Main Study Phase|Death|0|||
143393100|NCT03544281|516987620|FG015|Main Study Phase|Death|0|||
143393101|NCT03544281|516987621|FG016|Main Study Phase|Death|0|||
143393102|NCT03544281|516987622|FG017|Main Study Phase|Death|0|||
143393103|NCT03544281|516987623|FG018|Main Study Phase|Death|0|||
143393104|NCT03544281|516987624|FG019|Main Study Phase|Death|0|||
143393105|NCT03544281|516987625|FG020|Main Study Phase|Death|0|||
143393106|NCT03544281|516987626|FG021|Main Study Phase|Death|0|||
143393107|NCT03544281|516987605|FG000|Main Study Phase|Lost to Follow-up|0|||
143393108|NCT03544281|516987606|FG001|Main Study Phase|Lost to Follow-up|0|||
143393109|NCT03544281|516987607|FG002|Main Study Phase|Lost to Follow-up|0|||
143393110|NCT03544281|516987608|FG003|Main Study Phase|Lost to Follow-up|0|||
143393111|NCT03544281|516987609|FG004|Main Study Phase|Lost to Follow-up|0|||
143393112|NCT03544281|516987610|FG005|Main Study Phase|Lost to Follow-up|0|||
143393113|NCT03544281|516987611|FG006|Main Study Phase|Lost to Follow-up|0|||
143393114|NCT03544281|516987612|FG007|Main Study Phase|Lost to Follow-up|0|||
143393115|NCT03544281|516987613|FG008|Main Study Phase|Lost to Follow-up|0|||
143393116|NCT03544281|516987614|FG009|Main Study Phase|Lost to Follow-up|0|||
143393117|NCT03544281|516987615|FG010|Main Study Phase|Lost to Follow-up|1|||
143393118|NCT03544281|516987616|FG011|Main Study Phase|Lost to Follow-up|0|||
143393119|NCT03544281|516987617|FG012|Main Study Phase|Lost to Follow-up|0|||
143393120|NCT03544281|516987618|FG013|Main Study Phase|Lost to Follow-up|0|||
143393121|NCT03544281|516987619|FG014|Main Study Phase|Lost to Follow-up|0|||
143393122|NCT03544281|516987620|FG015|Main Study Phase|Lost to Follow-up|0|||
143393123|NCT03544281|516987621|FG016|Main Study Phase|Lost to Follow-up|0|||
143393124|NCT03544281|516987622|FG017|Main Study Phase|Lost to Follow-up|0|||
143393125|NCT03544281|516987623|FG018|Main Study Phase|Lost to Follow-up|0|||
143393126|NCT03544281|516987624|FG019|Main Study Phase|Lost to Follow-up|0|||
143393127|NCT03544281|516987625|FG020|Main Study Phase|Lost to Follow-up|0|||
143393128|NCT03544281|516987626|FG021|Main Study Phase|Lost to Follow-up|0|||
143393129|NCT03544281|516987605|FG000|Main Study Phase|Physician Decision|0|||
143393130|NCT03544281|516987606|FG001|Main Study Phase|Physician Decision|0|||
143393131|NCT03544281|516987607|FG002|Main Study Phase|Physician Decision|0|||
143393132|NCT03544281|516987608|FG003|Main Study Phase|Physician Decision|0|||
143393133|NCT03544281|516987609|FG004|Main Study Phase|Physician Decision|0|||
143393134|NCT03544281|516987610|FG005|Main Study Phase|Physician Decision|0|||
143393135|NCT03544281|516987611|FG006|Main Study Phase|Physician Decision|0|||
143393136|NCT03544281|516987612|FG007|Main Study Phase|Physician Decision|1|||
143393137|NCT03544281|516987613|FG008|Main Study Phase|Physician Decision|0|||
143393138|NCT03544281|516987614|FG009|Main Study Phase|Physician Decision|0|||
143393139|NCT03544281|516987615|FG010|Main Study Phase|Physician Decision|0|||
143393140|NCT03544281|516987616|FG011|Main Study Phase|Physician Decision|0|||
143393141|NCT03544281|516987617|FG012|Main Study Phase|Physician Decision|0|||
143393142|NCT03544281|516987618|FG013|Main Study Phase|Physician Decision|0|||
143393143|NCT03544281|516987619|FG014|Main Study Phase|Physician Decision|0|||
143393144|NCT03544281|516987620|FG015|Main Study Phase|Physician Decision|0|||
143393145|NCT03544281|516987621|FG016|Main Study Phase|Physician Decision|0|||
143393146|NCT03544281|516987622|FG017|Main Study Phase|Physician Decision|0|||
143393147|NCT03544281|516987623|FG018|Main Study Phase|Physician Decision|0|||
143393148|NCT03544281|516987624|FG019|Main Study Phase|Physician Decision|0|||
143393149|NCT03544281|516987625|FG020|Main Study Phase|Physician Decision|0|||
143393150|NCT03544281|516987626|FG021|Main Study Phase|Physician Decision|0|||
143393151|NCT03544281|516987605|FG000|Main Study Phase|Withdrawal by Subject|2|||
143393152|NCT03544281|516987606|FG001|Main Study Phase|Withdrawal by Subject|0|||
143393153|NCT03544281|516987607|FG002|Main Study Phase|Withdrawal by Subject|1|||
143393154|NCT03544281|516987608|FG003|Main Study Phase|Withdrawal by Subject|2|||
143393155|NCT03544281|516987609|FG004|Main Study Phase|Withdrawal by Subject|0|||
143393156|NCT03544281|516987610|FG005|Main Study Phase|Withdrawal by Subject|0|||
143393157|NCT03544281|516987611|FG006|Main Study Phase|Withdrawal by Subject|0|||
143393158|NCT03544281|516987612|FG007|Main Study Phase|Withdrawal by Subject|0|||
143393159|NCT03544281|516987613|FG008|Main Study Phase|Withdrawal by Subject|2|||
143393160|NCT03544281|516987614|FG009|Main Study Phase|Withdrawal by Subject|3|||
143393161|NCT03544281|516987615|FG010|Main Study Phase|Withdrawal by Subject|0|||
143393162|NCT03544281|516987616|FG011|Main Study Phase|Withdrawal by Subject|4|||
143393163|NCT03544281|516987617|FG012|Main Study Phase|Withdrawal by Subject|0|||
143393164|NCT03544281|516987618|FG013|Main Study Phase|Withdrawal by Subject|0|||
143393165|NCT03544281|516987619|FG014|Main Study Phase|Withdrawal by Subject|0|||
143393166|NCT03544281|516987620|FG015|Main Study Phase|Withdrawal by Subject|0|||
143393167|NCT03544281|516987621|FG016|Main Study Phase|Withdrawal by Subject|0|||
143393168|NCT03544281|516987622|FG017|Main Study Phase|Withdrawal by Subject|0|||
143393169|NCT03544281|516987623|FG018|Main Study Phase|Withdrawal by Subject|0|||
143393170|NCT03544281|516987624|FG019|Main Study Phase|Withdrawal by Subject|0|||
143393171|NCT03544281|516987625|FG020|Main Study Phase|Withdrawal by Subject|0|||
143393172|NCT03544281|516987626|FG021|Main Study Phase|Withdrawal by Subject|0|||
143393173|NCT03544281|516987605|FG000|Main Study Phase|Ongoing|3|||
143393174|NCT03544281|516987606|FG001|Main Study Phase|Ongoing|1|||
143393175|NCT03544281|516987607|FG002|Main Study Phase|Ongoing|2|||
143393176|NCT03544281|516987608|FG003|Main Study Phase|Ongoing|4|||
143393177|NCT03544281|516987609|FG004|Main Study Phase|Ongoing|2|||
143393178|NCT03544281|516987610|FG005|Main Study Phase|Ongoing|4|||
143393179|NCT03544281|516987611|FG006|Main Study Phase|Ongoing|4|||
143393180|NCT03544281|516987612|FG007|Main Study Phase|Ongoing|0|||
143393181|NCT03544281|516987613|FG008|Main Study Phase|Ongoing|2|||
143393182|NCT03544281|516987614|FG009|Main Study Phase|Ongoing|2|||
143393183|NCT03544281|516987615|FG010|Main Study Phase|Ongoing|1|||
143393184|NCT03544281|516987616|FG011|Main Study Phase|Ongoing|0|||
143393185|NCT03544281|516987617|FG012|Main Study Phase|Ongoing|0|||
143393186|NCT03544281|516987618|FG013|Main Study Phase|Ongoing|0|||
143393187|NCT03544281|516987619|FG014|Main Study Phase|Ongoing|0|||
143393188|NCT03544281|516987620|FG015|Main Study Phase|Ongoing|0|||
143393189|NCT03544281|516987621|FG016|Main Study Phase|Ongoing|0|||
143393190|NCT03544281|516987622|FG017|Main Study Phase|Ongoing|0|||
143393191|NCT03544281|516987623|FG018|Main Study Phase|Ongoing|0|||
143393192|NCT03544281|516987624|FG019|Main Study Phase|Ongoing|0|||
143393193|NCT03544281|516987625|FG020|Main Study Phase|Ongoing|0|||
143393194|NCT03544281|516987626|FG021|Main Study Phase|Ongoing|0|||
143393195|NCT03544281|516987605|FG000|Main Study Phase|Investigator Site Closed|0|||
143393196|NCT03544281|516987606|FG001|Main Study Phase|Investigator Site Closed|0|||
143393197|NCT03544281|516987607|FG002|Main Study Phase|Investigator Site Closed|0|||
143393198|NCT03544281|516987608|FG003|Main Study Phase|Investigator Site Closed|0|||
143393199|NCT03544281|516987609|FG004|Main Study Phase|Investigator Site Closed|0|||
143393200|NCT03544281|516987610|FG005|Main Study Phase|Investigator Site Closed|0|||
143393201|NCT03544281|516987611|FG006|Main Study Phase|Investigator Site Closed|0|||
143393202|NCT03544281|516987612|FG007|Main Study Phase|Investigator Site Closed|0|||
143393203|NCT03544281|516987613|FG008|Main Study Phase|Investigator Site Closed|0|||
143393204|NCT03544281|516987614|FG009|Main Study Phase|Investigator Site Closed|1|||
143393205|NCT03544281|516987615|FG010|Main Study Phase|Investigator Site Closed|0|||
143393206|NCT03544281|516987616|FG011|Main Study Phase|Investigator Site Closed|0|||
143393207|NCT03544281|516987617|FG012|Main Study Phase|Investigator Site Closed|0|||
143393208|NCT03544281|516987618|FG013|Main Study Phase|Investigator Site Closed|0|||
143393209|NCT03544281|516987619|FG014|Main Study Phase|Investigator Site Closed|0|||
143393210|NCT03544281|516987620|FG015|Main Study Phase|Investigator Site Closed|0|||
143393211|NCT03544281|516987621|FG016|Main Study Phase|Investigator Site Closed|0|||
143393212|NCT03544281|516987622|FG017|Main Study Phase|Investigator Site Closed|0|||
143393213|NCT03544281|516987623|FG018|Main Study Phase|Investigator Site Closed|0|||
143393214|NCT03544281|516987624|FG019|Main Study Phase|Investigator Site Closed|0|||
143393215|NCT03544281|516987625|FG020|Main Study Phase|Investigator Site Closed|0|||
143393216|NCT03544281|516987626|FG021|Main Study Phase|Investigator Site Closed|0|||
143393217|NCT03544281|516987605|FG000|Main Study Phase|Did not receive study treatment|0|||
143393218|NCT03544281|516987606|FG001|Main Study Phase|Did not receive study treatment|0|||
143393219|NCT03544281|516987607|FG002|Main Study Phase|Did not receive study treatment|0|||
143393220|NCT03544281|516987608|FG003|Main Study Phase|Did not receive study treatment|0|||
143393221|NCT03544281|516987609|FG004|Main Study Phase|Did not receive study treatment|0|||
143393222|NCT03544281|516987610|FG005|Main Study Phase|Did not receive study treatment|0|||
143393223|NCT03544281|516987611|FG006|Main Study Phase|Did not receive study treatment|1|||
143393224|NCT03544281|516987612|FG007|Main Study Phase|Did not receive study treatment|0|||
143393225|NCT03544281|516987613|FG008|Main Study Phase|Did not receive study treatment|0|||
143393226|NCT03544281|516987614|FG009|Main Study Phase|Did not receive study treatment|0|||
143393227|NCT03544281|516987615|FG010|Main Study Phase|Did not receive study treatment|0|||
143393228|NCT03544281|516987616|FG011|Main Study Phase|Did not receive study treatment|0|||
143393229|NCT03544281|516987617|FG012|Main Study Phase|Did not receive study treatment|0|||
143393230|NCT03544281|516987618|FG013|Main Study Phase|Did not receive study treatment|0|||
143393231|NCT03544281|516987619|FG014|Main Study Phase|Did not receive study treatment|0|||
143393232|NCT03544281|516987620|FG015|Main Study Phase|Did not receive study treatment|0|||
143393233|NCT03544281|516987621|FG016|Main Study Phase|Did not receive study treatment|0|||
143393234|NCT03544281|516987622|FG017|Main Study Phase|Did not receive study treatment|0|||
143393235|NCT03544281|516987623|FG018|Main Study Phase|Did not receive study treatment|0|||
143393236|NCT03544281|516987624|FG019|Main Study Phase|Did not receive study treatment|0|||
143393237|NCT03544281|516987625|FG020|Main Study Phase|Did not receive study treatment|0|||
143393238|NCT03544281|516987626|FG021|Main Study Phase|Did not receive study treatment|0|||
143393239|NCT03544281|516987605|FG000|PACT Phase|Adverse Event|0|||
143393240|NCT03544281|516987606|FG001|PACT Phase|Adverse Event|0|||
143393241|NCT03544281|516987607|FG002|PACT Phase|Adverse Event|0|||
143393242|NCT03544281|516987608|FG003|PACT Phase|Adverse Event|0|||
143393243|NCT03544281|516987609|FG004|PACT Phase|Adverse Event|0|||
143393244|NCT03544281|516987610|FG005|PACT Phase|Adverse Event|0|||
143393245|NCT03544281|516987611|FG006|PACT Phase|Adverse Event|0|||
143393246|NCT03544281|516987612|FG007|PACT Phase|Adverse Event|0|||
143393247|NCT03544281|516987613|FG008|PACT Phase|Adverse Event|0|||
143393248|NCT03544281|516987614|FG009|PACT Phase|Adverse Event|0|||
143393249|NCT03544281|516987615|FG010|PACT Phase|Adverse Event|0|||
143393250|NCT03544281|516987616|FG011|PACT Phase|Adverse Event|0|||
143393251|NCT03544281|516987617|FG012|PACT Phase|Adverse Event|1|||
143393252|NCT03544281|516987618|FG013|PACT Phase|Adverse Event|0|||
143393253|NCT03544281|516987619|FG014|PACT Phase|Adverse Event|0|||
143393254|NCT03544281|516987620|FG015|PACT Phase|Adverse Event|0|||
143393255|NCT03544281|516987621|FG016|PACT Phase|Adverse Event|0|||
143393256|NCT03544281|516987622|FG017|PACT Phase|Adverse Event|1|||
143393257|NCT03544281|516987623|FG018|PACT Phase|Adverse Event|1|||
143393258|NCT03544281|516987624|FG019|PACT Phase|Adverse Event|0|||
143393259|NCT03544281|516987625|FG020|PACT Phase|Adverse Event|0|||
143393260|NCT03544281|516987626|FG021|PACT Phase|Adverse Event|0|||
143393261|NCT04282148|516987627|FG000|Overall Study|Death|7|||
143393262|NCT04282148|516987627|FG000|Overall Study|Withdrawal by Subject|1|||
143393263|NCT04282148|516987627|FG000|Overall Study|Physician Decision|1|||
143393264|NCT04938492|516987628|FG000|Overall Study|Lost to Follow-up|17|||
143393265|NCT04938492|516987629|FG001|Overall Study|Lost to Follow-up|18|||
143393266|NCT04074759|516987634|FG000|Overall Study|Withdrawal by Subject|0|||
143393267|NCT04074759|516987635|FG001|Overall Study|Withdrawal by Subject|0|||
143393268|NCT04074759|516987636|FG002|Overall Study|Withdrawal by Subject|0|||
143393269|NCT04074759|516987637|FG003|Overall Study|Withdrawal by Subject|0|||
143393270|NCT04074759|516987638|FG004|Overall Study|Withdrawal by Subject|0|||
143393271|NCT04074759|516987639|FG005|Overall Study|Withdrawal by Subject|2|||
143393272|NCT04074759|516987640|FG006|Overall Study|Withdrawal by Subject|0|||
143393273|NCT04074759|516987641|FG007|Overall Study|Withdrawal by Subject|2|||
143393274|NCT04074759|516987642|FG008|Overall Study|Withdrawal by Subject|1|||
143393275|NCT04074759|516987643|FG009|Overall Study|Withdrawal by Subject|2|||
143393276|NCT04074759|516987644|FG010|Overall Study|Withdrawal by Subject|9|||
143393277|NCT04074759|516987645|FG011|Overall Study|Withdrawal by Subject|2|||
143393278|NCT04074759|516987646|FG012|Overall Study|Withdrawal by Subject|1|||
143393279|NCT04074759|516987647|FG013|Overall Study|Withdrawal by Subject|3|||
143393280|NCT04074759|516987648|FG014|Overall Study|Withdrawal by Subject|2|||
143393281|NCT04074759|516987649|FG015|Overall Study|Withdrawal by Subject|0|||
143393282|NCT04074759|516987650|FG016|Overall Study|Withdrawal by Subject|0|||
143393283|NCT04074759|516987651|FG017|Overall Study|Withdrawal by Subject|3|||
143393284|NCT04074759|516987652|FG018|Overall Study|Withdrawal by Subject|1|||
143393285|NCT04074759|516987634|FG000|Overall Study|Death|1|||
143393286|NCT04074759|516987635|FG001|Overall Study|Death|0|||
143393287|NCT04074759|516987636|FG002|Overall Study|Death|1|||
143393288|NCT04074759|516987637|FG003|Overall Study|Death|1|||
143393289|NCT04074759|516987638|FG004|Overall Study|Death|2|||
143393290|NCT04074759|516987639|FG005|Overall Study|Death|0|||
143393291|NCT04074759|516987640|FG006|Overall Study|Death|1|||
143393292|NCT04074759|516987641|FG007|Overall Study|Death|0|||
143393293|NCT04074759|516987642|FG008|Overall Study|Death|3|||
143393294|NCT04074759|516987643|FG009|Overall Study|Death|2|||
143393295|NCT04074759|516987644|FG010|Overall Study|Death|4|||
143393296|NCT04074759|516987645|FG011|Overall Study|Death|1|||
143393297|NCT04074759|516987646|FG012|Overall Study|Death|0|||
143393298|NCT04074759|516987647|FG013|Overall Study|Death|2|||
143393299|NCT04074759|516987648|FG014|Overall Study|Death|1|||
143393300|NCT04074759|516987649|FG015|Overall Study|Death|0|||
143393301|NCT04074759|516987650|FG016|Overall Study|Death|1|||
143393302|NCT04074759|516987651|FG017|Overall Study|Death|0|||
143393303|NCT04074759|516987652|FG018|Overall Study|Death|1|||
143393304|NCT04074759|516987634|FG000|Overall Study|Lost to Follow-up|0|||
143393305|NCT04074759|516987635|FG001|Overall Study|Lost to Follow-up|0|||
143393306|NCT04074759|516987636|FG002|Overall Study|Lost to Follow-up|0|||
143393307|NCT04074759|516987637|FG003|Overall Study|Lost to Follow-up|0|||
143393308|NCT04074759|516987638|FG004|Overall Study|Lost to Follow-up|0|||
143393309|NCT04074759|516987639|FG005|Overall Study|Lost to Follow-up|0|||
143393310|NCT04074759|516987640|FG006|Overall Study|Lost to Follow-up|0|||
143393311|NCT04074759|516987641|FG007|Overall Study|Lost to Follow-up|0|||
143393312|NCT04074759|516987642|FG008|Overall Study|Lost to Follow-up|0|||
143393313|NCT04074759|516987643|FG009|Overall Study|Lost to Follow-up|0|||
143393314|NCT04074759|516987644|FG010|Overall Study|Lost to Follow-up|1|||
143393315|NCT04074759|516987645|FG011|Overall Study|Lost to Follow-up|0|||
143393316|NCT04074759|516987646|FG012|Overall Study|Lost to Follow-up|0|||
143393317|NCT04074759|516987647|FG013|Overall Study|Lost to Follow-up|0|||
143393318|NCT04074759|516987648|FG014|Overall Study|Lost to Follow-up|0|||
143393319|NCT04074759|516987649|FG015|Overall Study|Lost to Follow-up|0|||
143393320|NCT04074759|516987650|FG016|Overall Study|Lost to Follow-up|1|||
143393321|NCT04074759|516987651|FG017|Overall Study|Lost to Follow-up|0|||
143393322|NCT04074759|516987652|FG018|Overall Study|Lost to Follow-up|1|||
143393323|NCT04074759|516987634|FG000|Overall Study|Other|0|||
143393324|NCT04074759|516987635|FG001|Overall Study|Other|1|||
143393325|NCT04074759|516987636|FG002|Overall Study|Other|1|||
143393326|NCT04074759|516987637|FG003|Overall Study|Other|0|||
143393327|NCT04074759|516987638|FG004|Overall Study|Other|2|||
143393328|NCT04074759|516987639|FG005|Overall Study|Other|1|||
143393329|NCT04074759|516987640|FG006|Overall Study|Other|2|||
143393330|NCT04074759|516987641|FG007|Overall Study|Other|1|||
143393331|NCT04074759|516987642|FG008|Overall Study|Other|1|||
143393332|NCT04074759|516987643|FG009|Overall Study|Other|4|||
143393333|NCT04074759|516987644|FG010|Overall Study|Other|4|||
143393334|NCT04074759|516987645|FG011|Overall Study|Other|2|||
143393335|NCT04074759|516987646|FG012|Overall Study|Other|0|||
143393336|NCT04074759|516987647|FG013|Overall Study|Other|0|||
143393337|NCT04074759|516987648|FG014|Overall Study|Other|0|||
143393338|NCT04074759|516987649|FG015|Overall Study|Other|1|||
143393339|NCT04074759|516987650|FG016|Overall Study|Other|0|||
143393340|NCT04074759|516987651|FG017|Overall Study|Other|0|||
143393341|NCT04074759|516987652|FG018|Overall Study|Other|0|||
143393342|NCT04074759|516987634|FG000|Overall Study|Missing end of study status|0|||
143393343|NCT04074759|516987635|FG001|Overall Study|Missing end of study status|0|||
143393344|NCT04074759|516987636|FG002|Overall Study|Missing end of study status|0|||
143393345|NCT04074759|516987637|FG003|Overall Study|Missing end of study status|0|||
143393346|NCT04074759|516987638|FG004|Overall Study|Missing end of study status|0|||
143393347|NCT04074759|516987639|FG005|Overall Study|Missing end of study status|0|||
143393348|NCT04074759|516987640|FG006|Overall Study|Missing end of study status|0|||
143393349|NCT04074759|516987641|FG007|Overall Study|Missing end of study status|0|||
143393350|NCT04074759|516987642|FG008|Overall Study|Missing end of study status|0|||
143393351|NCT04074759|516987643|FG009|Overall Study|Missing end of study status|0|||
143393352|NCT04074759|516987644|FG010|Overall Study|Missing end of study status|2|||
143393353|NCT04074759|516987645|FG011|Overall Study|Missing end of study status|0|||
143393354|NCT04074759|516987646|FG012|Overall Study|Missing end of study status|0|||
143393355|NCT04074759|516987647|FG013|Overall Study|Missing end of study status|0|||
143393356|NCT04074759|516987648|FG014|Overall Study|Missing end of study status|0|||
143393357|NCT04074759|516987649|FG015|Overall Study|Missing end of study status|0|||
143393358|NCT04074759|516987650|FG016|Overall Study|Missing end of study status|1|||
143393359|NCT04074759|516987651|FG017|Overall Study|Missing end of study status|0|||
143393360|NCT04074759|516987652|FG018|Overall Study|Missing end of study status|0|||
143393361|NCT05329220|516987653|FG000|Active Trial Period|Adverse Event|0|||
143393362|NCT05329220|516987654|FG001|Active Trial Period|Adverse Event|0|||
143393363|NCT05329220|516987655|FG002|Active Trial Period|Adverse Event|0|||
143393364|NCT05329220|516987656|FG003|Active Trial Period|Adverse Event|0|||
143393365|NCT05329220|516987657|FG004|Active Trial Period|Adverse Event|1|||
143393366|NCT05329220|516987658|FG005|Active Trial Period|Adverse Event|0|||
143393367|NCT05329220|516987653|FG000|Active Trial Period|Lost to Follow-up|0|||
143393368|NCT05329220|516987654|FG001|Active Trial Period|Lost to Follow-up|0|||
143393369|NCT05329220|516987655|FG002|Active Trial Period|Lost to Follow-up|0|||
143393370|NCT05329220|516987656|FG003|Active Trial Period|Lost to Follow-up|0|||
143393371|NCT05329220|516987657|FG004|Active Trial Period|Lost to Follow-up|32|||
143393372|NCT05329220|516987658|FG005|Active Trial Period|Lost to Follow-up|28|||
143393373|NCT05329220|516987653|FG000|Active Trial Period|Physician Decision|0|||
143393374|NCT05329220|516987654|FG001|Active Trial Period|Physician Decision|0|||
143393375|NCT05329220|516987655|FG002|Active Trial Period|Physician Decision|0|||
143393376|NCT05329220|516987656|FG003|Active Trial Period|Physician Decision|0|||
143393377|NCT05329220|516987657|FG004|Active Trial Period|Physician Decision|2|||
143393378|NCT05329220|516987658|FG005|Active Trial Period|Physician Decision|0|||
143393379|NCT05329220|516987653|FG000|Active Trial Period|Protocol Violation|0|||
143393380|NCT05329220|516987654|FG001|Active Trial Period|Protocol Violation|0|||
143393381|NCT05329220|516987655|FG002|Active Trial Period|Protocol Violation|0|||
143393382|NCT05329220|516987656|FG003|Active Trial Period|Protocol Violation|0|||
143393383|NCT05329220|516987657|FG004|Active Trial Period|Protocol Violation|1|||
143393384|NCT05329220|516987658|FG005|Active Trial Period|Protocol Violation|3|||
143393385|NCT05329220|516987653|FG000|Active Trial Period|Withdrawal by Subject|0|||
143393386|NCT05329220|516987654|FG001|Active Trial Period|Withdrawal by Subject|0|||
143393387|NCT05329220|516987655|FG002|Active Trial Period|Withdrawal by Subject|0|||
143393388|NCT05329220|516987656|FG003|Active Trial Period|Withdrawal by Subject|1|||
143393389|NCT05329220|516987657|FG004|Active Trial Period|Withdrawal by Subject|12|||
143393390|NCT05329220|516987658|FG005|Active Trial Period|Withdrawal by Subject|13|||
143393391|NCT05329220|516987653|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
143393392|NCT05329220|516987654|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
143393393|NCT05329220|516987655|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
143393394|NCT05329220|516987656|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
143393395|NCT05329220|516987657|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
143393396|NCT05329220|516987658|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
143393397|NCT05329220|516987653|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
143393398|NCT05329220|516987654|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
143393399|NCT05329220|516987655|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
143393400|NCT05329220|516987656|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
143393401|NCT05329220|516987657|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
143393402|NCT05329220|516987658|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
143393403|NCT05329220|516987653|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
143393404|NCT05329220|516987654|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
143393405|NCT05329220|516987655|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
143393406|NCT05329220|516987656|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
143393407|NCT05329220|516987657|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
143393408|NCT05329220|516987658|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
143393409|NCT05329220|516987653|FG000|Follow-up Period|Adverse Event|0|||
143393410|NCT05329220|516987654|FG001|Follow-up Period|Adverse Event|0|||
143393411|NCT05329220|516987655|FG002|Follow-up Period|Adverse Event|0|||
143393412|NCT05329220|516987656|FG003|Follow-up Period|Adverse Event|0|||
143393413|NCT05329220|516987657|FG004|Follow-up Period|Adverse Event|2|||
143393414|NCT05329220|516987658|FG005|Follow-up Period|Adverse Event|1|||
143393415|NCT05329220|516987653|FG000|Follow-up Period|Death|0|||
143393416|NCT05329220|516987654|FG001|Follow-up Period|Death|0|||
143393417|NCT05329220|516987655|FG002|Follow-up Period|Death|1|||
143393418|NCT05329220|516987656|FG003|Follow-up Period|Death|1|||
143393419|NCT05329220|516987657|FG004|Follow-up Period|Death|0|||
143393420|NCT05329220|516987658|FG005|Follow-up Period|Death|1|||
143393421|NCT05329220|516987653|FG000|Follow-up Period|Lost to Follow-up|0|||
143393422|NCT05329220|516987654|FG001|Follow-up Period|Lost to Follow-up|1|||
143393423|NCT05329220|516987655|FG002|Follow-up Period|Lost to Follow-up|2|||
143393424|NCT05329220|516987656|FG003|Follow-up Period|Lost to Follow-up|2|||
143393425|NCT05329220|516987657|FG004|Follow-up Period|Lost to Follow-up|113|||
143393426|NCT05329220|516987658|FG005|Follow-up Period|Lost to Follow-up|89|||
143393427|NCT05329220|516987653|FG000|Follow-up Period|Physician Decision|0|||
143393428|NCT05329220|516987654|FG001|Follow-up Period|Physician Decision|0|||
143393429|NCT05329220|516987655|FG002|Follow-up Period|Physician Decision|0|||
143393430|NCT05329220|516987656|FG003|Follow-up Period|Physician Decision|0|||
143393431|NCT05329220|516987657|FG004|Follow-up Period|Physician Decision|2|||
143393432|NCT05329220|516987658|FG005|Follow-up Period|Physician Decision|2|||
143393433|NCT05329220|516987653|FG000|Follow-up Period|Protocol Violation|0|||
143393434|NCT05329220|516987654|FG001|Follow-up Period|Protocol Violation|0|||
143393435|NCT05329220|516987655|FG002|Follow-up Period|Protocol Violation|0|||
143393436|NCT05329220|516987656|FG003|Follow-up Period|Protocol Violation|0|||
143393437|NCT05329220|516987657|FG004|Follow-up Period|Protocol Violation|0|||
143393438|NCT05329220|516987658|FG005|Follow-up Period|Protocol Violation|1|||
143393439|NCT05329220|516987653|FG000|Follow-up Period|Withdrawal by Subject|0|||
143393440|NCT05329220|516987654|FG001|Follow-up Period|Withdrawal by Subject|0|||
143393441|NCT05329220|516987655|FG002|Follow-up Period|Withdrawal by Subject|1|||
143393442|NCT05329220|516987656|FG003|Follow-up Period|Withdrawal by Subject|1|||
143393443|NCT05329220|516987657|FG004|Follow-up Period|Withdrawal by Subject|34|||
143393444|NCT05329220|516987658|FG005|Follow-up Period|Withdrawal by Subject|35|||
143393445|NCT05329220|516987653|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
143393446|NCT05329220|516987654|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
143393447|NCT05329220|516987655|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
143393448|NCT05329220|516987656|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
143393449|NCT05329220|516987657|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
143393450|NCT05329220|516987658|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
143393451|NCT05329220|516987653|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
143393452|NCT05329220|516987654|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
143393453|NCT05329220|516987655|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
143393454|NCT05329220|516987656|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
143393455|NCT05329220|516987657|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
143393456|NCT05329220|516987658|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
143393457|NCT05329220|516987653|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
143393458|NCT05329220|516987654|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
143393459|NCT05329220|516987655|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
143393460|NCT05329220|516987656|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
143393461|NCT05329220|516987657|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
143393462|NCT05329220|516987658|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
143393463|NCT05329220|516987653|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
143393464|NCT05329220|516987654|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
143393465|NCT05329220|516987655|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
143393466|NCT05329220|516987656|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
143393467|NCT05329220|516987657|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
143393468|NCT05329220|516987658|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
143393469|NCT05329220|516987653|FG000|Follow-up Period|EARLY TERMINATION|0|||
143393470|NCT05329220|516987654|FG001|Follow-up Period|EARLY TERMINATION|0|||
143393471|NCT05329220|516987655|FG002|Follow-up Period|EARLY TERMINATION|0|||
143393472|NCT05329220|516987656|FG003|Follow-up Period|EARLY TERMINATION|0|||
143393473|NCT05329220|516987657|FG004|Follow-up Period|EARLY TERMINATION|0|||
143393474|NCT05329220|516987658|FG005|Follow-up Period|EARLY TERMINATION|1|||
143393475|NCT05329220|516987653|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
143393476|NCT05329220|516987654|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
143339305|NCT05168579|516788176|FG000|Overall Study|Lost to Follow-up|0|||
143339306|NCT05168579|516788177|FG001|Overall Study|Lost to Follow-up|15|||
143339307|NCT01242748|516788178|FG000|Overall Study|Adverse Event|10|||
143339308|NCT01242748|516788179|FG001|Overall Study|Adverse Event|5|||
143339309|NCT01242748|516788178|FG000|Overall Study|Lost to Follow-up|6|||
143339310|NCT01242748|516788179|FG001|Overall Study|Lost to Follow-up|2|||
143339311|NCT01242748|516788178|FG000|Overall Study|Physician Decision|3|||
143339312|NCT01242748|516788179|FG001|Overall Study|Physician Decision|2|||
143339313|NCT01242748|516788178|FG000|Overall Study|Protocol Violation|1|||
143339314|NCT01242748|516788179|FG001|Overall Study|Protocol Violation|0|||
143339315|NCT01242748|516788178|FG000|Overall Study|Withdrawal by Subject|10|||
143339316|NCT01242748|516788179|FG001|Overall Study|Withdrawal by Subject|2|||
143339317|NCT01242748|516788178|FG000|Overall Study|Miscellaneous reasons|8|||
143339318|NCT01242748|516788179|FG001|Overall Study|Miscellaneous reasons|3|||
143339319|NCT00840801|516788180|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
143339320|NCT00840801|516788181|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
143339321|NCT00840801|516788182|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
143339322|NCT00840801|516788180|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
143339323|NCT00840801|516788181|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
143339324|NCT00840801|516788182|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
143339325|NCT00840801|516788180|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
143339326|NCT00840801|516788181|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
143339327|NCT00840801|516788182|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
143339328|NCT00840801|516788180|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
143339329|NCT00840801|516788181|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
143339330|NCT00840801|516788182|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
143339331|NCT00335452|516788183|FG000|Overall Study|Death|156|||
143339332|NCT00335452|516788184|FG001|Overall Study|Death|144|||
143339333|NCT00335452|516788185|FG002|Overall Study|Death|158|||
143339334|NCT00335452|516788186|FG003|Overall Study|Death|129|||
143339335|NCT00335452|516788183|FG000|Overall Study|Lost to Follow-up|2|||
143339336|NCT00335452|516788184|FG001|Overall Study|Lost to Follow-up|3|||
143339337|NCT00335452|516788185|FG002|Overall Study|Lost to Follow-up|1|||
143339338|NCT00335452|516788186|FG003|Overall Study|Lost to Follow-up|2|||
143339339|NCT02736825|516788188|FG000|Overall Study|Lost to Follow-up|10|||
143339340|NCT02736825|516788189|FG001|Overall Study|Lost to Follow-up|11|||
143339341|NCT02736825|516788188|FG000|Overall Study|Early Termination|0|||
143339342|NCT02736825|516788189|FG001|Overall Study|Early Termination|1|||
143339343|NCT00790452|516788190|FG000|Overall Study|Drug supply issue|1|||
143339344|NCT00790452|516788191|FG001|Overall Study|Drug supply issue|0|||
143339345|NCT02940574|516788192|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
143339346|NCT02940574|516788193|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
143339347|NCT02940574|516788192|FG000|1-year Follow-up|Lost to Follow-up|3|||
143339348|NCT02940574|516788193|FG001|1-year Follow-up|Lost to Follow-up|4|||
143339349|NCT01750879|516788196|FG000|Overall Study|Adverse Event|8|||
143339350|NCT01750879|516788197|FG001|Overall Study|Adverse Event|0|||
143339351|NCT01750879|516788196|FG000|Overall Study|Lack of Efficacy|1|||
143339352|NCT01750879|516788197|FG001|Overall Study|Lack of Efficacy|0|||
143339353|NCT01750879|516788196|FG000|Overall Study|Withdrawal by Subject|1|||
143339354|NCT01750879|516788197|FG001|Overall Study|Withdrawal by Subject|0|||
143339355|NCT01750879|516788196|FG000|Overall Study|Did not complete per protocol|0|||
143339356|NCT01750879|516788197|FG001|Overall Study|Did not complete per protocol|3|||
143339357|NCT04810221|516788198|FG000|Overall Study|Physician Decision|3|||
143339358|NCT03642938|516788199|FG000|Overall Study|Withdrawal by Subject|0|||
143339359|NCT03642938|516788200|FG001|Overall Study|Withdrawal by Subject|0|||
143339360|NCT03642938|516788201|FG002|Overall Study|Withdrawal by Subject|0|||
143339361|NCT03642938|516788202|FG003|Overall Study|Withdrawal by Subject|1|||
143339362|NCT00105235|516788203|FG000|Overall Study|Death|4|||
143339363|NCT00105235|516788203|FG000|Overall Study|Physician Decision|1|||
143339364|NCT00105235|516788203|FG000|Overall Study|Withdrawal by Subject|2|||
143339365|NCT01964326|516788204|FG000|Overall Study|Adverse Event|48|||
143339366|NCT01964326|516788204|FG000|Overall Study|Death|2|||
143339367|NCT01964326|516788204|FG000|Overall Study|Protocol Violation|4|||
143339368|NCT01964326|516788204|FG000|Overall Study|Lost to Follow-up|88|||
143339369|NCT01964326|516788204|FG000|Overall Study|Withdrawal by Subject|87|||
143339370|NCT01964326|516788204|FG000|Overall Study|Pregnancy|1|||
143339371|NCT01964326|516788204|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
143339372|NCT01964326|516788204|FG000|Overall Study|Physician Decision|55|||
143339373|NCT01964326|516788204|FG000|Overall Study|Investigator Discretion|1|||
143339374|NCT01964326|516788204|FG000|Overall Study|Other|9|||
143339375|NCT01964326|516788204|FG000|Overall Study|Did not meet eligibility criteria|1|||
143339376|NCT02347657|516788205|FG000|Overall Study|Physician Decision|0|||
143339377|NCT02347657|516788206|FG001|Overall Study|Physician Decision|1|||
143339378|NCT02347657|516788205|FG000|Overall Study|Adverse Event|8|||
143339379|NCT02347657|516788206|FG001|Overall Study|Adverse Event|4|||
143339380|NCT02347657|516788205|FG000|Overall Study|Withdrawal by Subject|6|||
143339381|NCT02347657|516788206|FG001|Overall Study|Withdrawal by Subject|7|||
143339382|NCT02347657|516788205|FG000|Overall Study|Randomized but not treated|1|||
143339383|NCT02347657|516788206|FG001|Overall Study|Randomized but not treated|0|||
143339384|NCT02347657|516788205|FG000|Overall Study|Other|3|||
143339385|NCT02347657|516788206|FG001|Overall Study|Other|3|||
143339386|NCT02093663|516788211|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
143339387|NCT02093663|516788212|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
143339388|NCT02093663|516788213|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
143339389|NCT02093663|516788214|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
143339390|NCT02093663|516788215|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
143339391|NCT02093663|516788211|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
143339392|NCT02093663|516788212|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
143339393|NCT02093663|516788213|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
143339394|NCT02093663|516788214|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
143339395|NCT02093663|516788215|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
143339396|NCT02093663|516788211|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
143339397|NCT02093663|516788212|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
143339398|NCT02093663|516788213|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
143339399|NCT02093663|516788214|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
143339400|NCT02093663|516788215|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
143339401|NCT02093663|516788211|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
143339402|NCT02093663|516788212|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
143339403|NCT02093663|516788213|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
143339404|NCT02093663|516788214|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
143339405|NCT02093663|516788215|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
143339406|NCT02093663|516788211|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
143339407|NCT02093663|516788212|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
143339408|NCT02093663|516788213|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
143339409|NCT02093663|516788214|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
143339410|NCT02093663|516788215|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
143339411|NCT02093663|516788211|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
143339412|NCT02093663|516788212|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
143339413|NCT02093663|516788213|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
143339414|NCT02093663|516788214|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
143339415|NCT02093663|516788215|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
143339416|NCT02093663|516788211|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
143339417|NCT02093663|516788212|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
143393477|NCT05329220|516987655|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
143393478|NCT05329220|516987656|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
143393479|NCT05329220|516987657|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
143393480|NCT05329220|516987658|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
143393481|NCT05329220|516987653|FG000|Follow-up Period|DROPPED|0|||
143393482|NCT05329220|516987654|FG001|Follow-up Period|DROPPED|0|||
143393483|NCT05329220|516987655|FG002|Follow-up Period|DROPPED|0|||
143393484|NCT05329220|516987656|FG003|Follow-up Period|DROPPED|0|||
143393485|NCT05329220|516987657|FG004|Follow-up Period|DROPPED|0|||
143393486|NCT05329220|516987658|FG005|Follow-up Period|DROPPED|1|||
143393487|NCT05329220|516987653|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
143393488|NCT05329220|516987654|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
143393489|NCT05329220|516987655|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
143393490|NCT05329220|516987656|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
143393491|NCT05329220|516987657|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
143393492|NCT05329220|516987658|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
143393493|NCT02465268|516987660|FG000|Overall Study|Withdrawal by Subject|4|||
143393494|NCT02465268|516987661|FG001|Overall Study|Withdrawal by Subject|3|||
143393495|NCT02465268|516987662|FG002|Overall Study|Withdrawal by Subject|1|||
143393496|NCT02465268|516987660|FG000|Overall Study|Not evaluable per protocol criteria|3|||
143393497|NCT02465268|516987661|FG001|Overall Study|Not evaluable per protocol criteria|2|||
143393498|NCT02465268|516987662|FG002|Overall Study|Not evaluable per protocol criteria|1|||
143393499|NCT02465268|516987660|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
143393500|NCT02465268|516987661|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
143393501|NCT02465268|516987662|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
143393502|NCT02465268|516987660|FG000|Overall Study|Study drug did not pass QA/QC|1|||
143393503|NCT02465268|516987661|FG001|Overall Study|Study drug did not pass QA/QC|0|||
143393504|NCT02465268|516987662|FG002|Overall Study|Study drug did not pass QA/QC|0|||
143393505|NCT02465268|516987660|FG000|Overall Study|Adverse Event|0|||
143393506|NCT02465268|516987661|FG001|Overall Study|Adverse Event|1|||
143393507|NCT02465268|516987662|FG002|Overall Study|Adverse Event|0|||
143393508|NCT02465268|516987660|FG000|Overall Study|Physician Decision|0|||
143393509|NCT02465268|516987661|FG001|Overall Study|Physician Decision|1|||
143393510|NCT02465268|516987662|FG002|Overall Study|Physician Decision|0|||
143393511|NCT02547363|516987665|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
143393512|NCT02547363|516987666|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
143393513|NCT02547363|516987665|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
143393514|NCT02547363|516987666|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
143393515|NCT02547363|516987665|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
143393516|NCT02547363|516987666|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
143393517|NCT02547363|516987665|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
143393518|NCT02547363|516987666|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
143393519|NCT02547363|516987665|FG000|12-month Follow-up|Withdrawal by Subject|4|||
143393520|NCT02547363|516987666|FG001|12-month Follow-up|Withdrawal by Subject|3|||
143393521|NCT02547363|516987665|FG000|12-month Follow-up|Lost to Follow-up|4|||
143393522|NCT02547363|516987666|FG001|12-month Follow-up|Lost to Follow-up|1|||
143393523|NCT02547363|516987665|FG000|12-month Follow-up|Lack of Efficacy|1|||
143393524|NCT02547363|516987666|FG001|12-month Follow-up|Lack of Efficacy|1|||
143393525|NCT02547363|516987665|FG000|12-month Follow-up|Other|1|||
143393526|NCT02547363|516987666|FG001|12-month Follow-up|Other|0|||
143393527|NCT04436276|516987667|FG000|Overall Study|Adverse Event|0|||
143393528|NCT04436276|516987668|FG001|Overall Study|Adverse Event|0|||
143393529|NCT04436276|516987669|FG002|Overall Study|Adverse Event|0|||
143393530|NCT04436276|516987670|FG003|Overall Study|Adverse Event|0|||
143393531|NCT04436276|516987671|FG004|Overall Study|Adverse Event|0|||
143393532|NCT04436276|516987672|FG005|Overall Study|Adverse Event|0|||
143393533|NCT04436276|516987673|FG006|Overall Study|Adverse Event|0|||
143393534|NCT04436276|516987674|FG007|Overall Study|Adverse Event|0|||
143393535|NCT04436276|516987675|FG008|Overall Study|Adverse Event|0|||
143393536|NCT04436276|516987676|FG009|Overall Study|Adverse Event|0|||
143393537|NCT04436276|516987677|FG010|Overall Study|Adverse Event|0|||
143393538|NCT04436276|516987678|FG011|Overall Study|Adverse Event|0|||
143393539|NCT04436276|516987679|FG012|Overall Study|Adverse Event|0|||
143393540|NCT04436276|516987680|FG013|Overall Study|Adverse Event|0|||
143393541|NCT04436276|516987681|FG014|Overall Study|Adverse Event|0|||
143393542|NCT04436276|516987682|FG015|Overall Study|Adverse Event|0|||
143393543|NCT04436276|516987683|FG016|Overall Study|Adverse Event|1|||
143393544|NCT04436276|516987684|FG017|Overall Study|Adverse Event|0|||
143393545|NCT04436276|516987685|FG018|Overall Study|Adverse Event|0|||
143393546|NCT04436276|516987686|FG019|Overall Study|Adverse Event|0|||
143393547|NCT04436276|516987687|FG020|Overall Study|Adverse Event|0|||
143393548|NCT04436276|516987688|FG021|Overall Study|Adverse Event|0|||
143393549|NCT04436276|516987689|FG022|Overall Study|Adverse Event|0|||
143393550|NCT04436276|516987667|FG000|Overall Study|Death|0|||
143393551|NCT04436276|516987668|FG001|Overall Study|Death|0|||
143393552|NCT04436276|516987669|FG002|Overall Study|Death|0|||
143393553|NCT04436276|516987670|FG003|Overall Study|Death|0|||
143393554|NCT04436276|516987671|FG004|Overall Study|Death|0|||
143393555|NCT04436276|516987672|FG005|Overall Study|Death|0|||
143393556|NCT04436276|516987673|FG006|Overall Study|Death|0|||
143393557|NCT04436276|516987674|FG007|Overall Study|Death|0|||
143393558|NCT04436276|516987675|FG008|Overall Study|Death|0|||
143393559|NCT04436276|516987676|FG009|Overall Study|Death|0|||
143393560|NCT04436276|516987677|FG010|Overall Study|Death|0|||
143393561|NCT04436276|516987678|FG011|Overall Study|Death|0|||
143393562|NCT04436276|516987679|FG012|Overall Study|Death|1|||
143393563|NCT04436276|516987680|FG013|Overall Study|Death|0|||
143393564|NCT04436276|516987681|FG014|Overall Study|Death|1|||
143393565|NCT04436276|516987682|FG015|Overall Study|Death|0|||
143393566|NCT04436276|516987683|FG016|Overall Study|Death|0|||
143393567|NCT04436276|516987684|FG017|Overall Study|Death|0|||
143393568|NCT04436276|516987685|FG018|Overall Study|Death|0|||
143393569|NCT04436276|516987686|FG019|Overall Study|Death|2|||
143393570|NCT04436276|516987687|FG020|Overall Study|Death|0|||
143393571|NCT04436276|516987688|FG021|Overall Study|Death|1|||
143393572|NCT04436276|516987689|FG022|Overall Study|Death|0|||
143393573|NCT04436276|516987667|FG000|Overall Study|Lost to Follow-up|0|||
143393574|NCT04436276|516987668|FG001|Overall Study|Lost to Follow-up|2|||
143393575|NCT04436276|516987669|FG002|Overall Study|Lost to Follow-up|2|||
143393576|NCT04436276|516987670|FG003|Overall Study|Lost to Follow-up|1|||
143393577|NCT04436276|516987671|FG004|Overall Study|Lost to Follow-up|4|||
143393578|NCT04436276|516987672|FG005|Overall Study|Lost to Follow-up|1|||
143393579|NCT04436276|516987673|FG006|Overall Study|Lost to Follow-up|0|||
143393580|NCT04436276|516987674|FG007|Overall Study|Lost to Follow-up|0|||
143393581|NCT04436276|516987675|FG008|Overall Study|Lost to Follow-up|1|||
143393582|NCT04436276|516987676|FG009|Overall Study|Lost to Follow-up|0|||
143393583|NCT04436276|516987677|FG010|Overall Study|Lost to Follow-up|5|||
143393584|NCT04436276|516987678|FG011|Overall Study|Lost to Follow-up|5|||
143393585|NCT04436276|516987679|FG012|Overall Study|Lost to Follow-up|4|||
143393586|NCT04436276|516987680|FG013|Overall Study|Lost to Follow-up|1|||
143393587|NCT04436276|516987681|FG014|Overall Study|Lost to Follow-up|7|||
143393588|NCT04436276|516987682|FG015|Overall Study|Lost to Follow-up|7|||
143393589|NCT04436276|516987683|FG016|Overall Study|Lost to Follow-up|1|||
143393590|NCT04436276|516987684|FG017|Overall Study|Lost to Follow-up|0|||
143393591|NCT04436276|516987685|FG018|Overall Study|Lost to Follow-up|1|||
143393592|NCT04436276|516987686|FG019|Overall Study|Lost to Follow-up|1|||
143393593|NCT04436276|516987687|FG020|Overall Study|Lost to Follow-up|2|||
143393594|NCT04436276|516987688|FG021|Overall Study|Lost to Follow-up|1|||
143393595|NCT04436276|516987689|FG022|Overall Study|Lost to Follow-up|1|||
143393596|NCT04436276|516987667|FG000|Overall Study|Physician Decision|1|||
143393597|NCT04436276|516987668|FG001|Overall Study|Physician Decision|0|||
143393598|NCT04436276|516987669|FG002|Overall Study|Physician Decision|2|||
143393599|NCT04436276|516987670|FG003|Overall Study|Physician Decision|1|||
143393600|NCT04436276|516987671|FG004|Overall Study|Physician Decision|0|||
143393601|NCT04436276|516987672|FG005|Overall Study|Physician Decision|0|||
143393602|NCT04436276|516987673|FG006|Overall Study|Physician Decision|0|||
143393603|NCT04436276|516987674|FG007|Overall Study|Physician Decision|0|||
143393604|NCT04436276|516987675|FG008|Overall Study|Physician Decision|0|||
143393605|NCT04436276|516987676|FG009|Overall Study|Physician Decision|0|||
143393606|NCT04436276|516987677|FG010|Overall Study|Physician Decision|0|||
143393607|NCT04436276|516987678|FG011|Overall Study|Physician Decision|1|||
143393608|NCT04436276|516987679|FG012|Overall Study|Physician Decision|2|||
143393609|NCT04436276|516987680|FG013|Overall Study|Physician Decision|0|||
143393610|NCT04436276|516987681|FG014|Overall Study|Physician Decision|0|||
143393611|NCT04436276|516987682|FG015|Overall Study|Physician Decision|0|||
143393612|NCT04436276|516987683|FG016|Overall Study|Physician Decision|0|||
143393613|NCT04436276|516987684|FG017|Overall Study|Physician Decision|0|||
143393614|NCT04436276|516987685|FG018|Overall Study|Physician Decision|0|||
143393615|NCT04436276|516987686|FG019|Overall Study|Physician Decision|0|||
143393616|NCT04436276|516987687|FG020|Overall Study|Physician Decision|1|||
143393617|NCT04436276|516987688|FG021|Overall Study|Physician Decision|2|||
143393618|NCT04436276|516987689|FG022|Overall Study|Physician Decision|0|||
143393619|NCT04436276|516987667|FG000|Overall Study|Protocol Violation|0|||
143393620|NCT04436276|516987668|FG001|Overall Study|Protocol Violation|0|||
143393621|NCT04436276|516987669|FG002|Overall Study|Protocol Violation|0|||
143393622|NCT04436276|516987670|FG003|Overall Study|Protocol Violation|0|||
143393623|NCT04436276|516987671|FG004|Overall Study|Protocol Violation|0|||
143393624|NCT04436276|516987672|FG005|Overall Study|Protocol Violation|0|||
143393625|NCT04436276|516987673|FG006|Overall Study|Protocol Violation|0|||
143393626|NCT04436276|516987674|FG007|Overall Study|Protocol Violation|0|||
143393627|NCT04436276|516987675|FG008|Overall Study|Protocol Violation|0|||
143393628|NCT04436276|516987676|FG009|Overall Study|Protocol Violation|0|||
143393629|NCT04436276|516987677|FG010|Overall Study|Protocol Violation|0|||
143393630|NCT04436276|516987678|FG011|Overall Study|Protocol Violation|0|||
143393631|NCT04436276|516987679|FG012|Overall Study|Protocol Violation|0|||
143393632|NCT04436276|516987680|FG013|Overall Study|Protocol Violation|1|||
143393633|NCT04436276|516987681|FG014|Overall Study|Protocol Violation|0|||
143393634|NCT04436276|516987682|FG015|Overall Study|Protocol Violation|1|||
143393635|NCT04436276|516987683|FG016|Overall Study|Protocol Violation|0|||
143393636|NCT04436276|516987684|FG017|Overall Study|Protocol Violation|0|||
143393637|NCT04436276|516987685|FG018|Overall Study|Protocol Violation|0|||
143393638|NCT04436276|516987686|FG019|Overall Study|Protocol Violation|0|||
143393639|NCT04436276|516987687|FG020|Overall Study|Protocol Violation|0|||
143393640|NCT04436276|516987688|FG021|Overall Study|Protocol Violation|0|||
143393641|NCT04436276|516987689|FG022|Overall Study|Protocol Violation|0|||
143393642|NCT04436276|516987667|FG000|Overall Study|Withdrawal by Subject|25|||
143393643|NCT04436276|516987668|FG001|Overall Study|Withdrawal by Subject|22|||
143393644|NCT04436276|516987669|FG002|Overall Study|Withdrawal by Subject|24|||
143393645|NCT04436276|516987670|FG003|Overall Study|Withdrawal by Subject|23|||
143393646|NCT04436276|516987671|FG004|Overall Study|Withdrawal by Subject|14|||
143393647|NCT04436276|516987672|FG005|Overall Study|Withdrawal by Subject|0|||
143393648|NCT04436276|516987673|FG006|Overall Study|Withdrawal by Subject|0|||
143393649|NCT04436276|516987674|FG007|Overall Study|Withdrawal by Subject|1|||
143393650|NCT04436276|516987675|FG008|Overall Study|Withdrawal by Subject|0|||
143393651|NCT04436276|516987676|FG009|Overall Study|Withdrawal by Subject|1|||
143393652|NCT04436276|516987677|FG010|Overall Study|Withdrawal by Subject|17|||
143393653|NCT04436276|516987678|FG011|Overall Study|Withdrawal by Subject|7|||
143393654|NCT04436276|516987679|FG012|Overall Study|Withdrawal by Subject|10|||
143393655|NCT04436276|516987680|FG013|Overall Study|Withdrawal by Subject|6|||
143393656|NCT04436276|516987681|FG014|Overall Study|Withdrawal by Subject|20|||
143393657|NCT04436276|516987682|FG015|Overall Study|Withdrawal by Subject|6|||
143393658|NCT04436276|516987683|FG016|Overall Study|Withdrawal by Subject|11|||
143393659|NCT04436276|516987684|FG017|Overall Study|Withdrawal by Subject|4|||
143393660|NCT04436276|516987685|FG018|Overall Study|Withdrawal by Subject|14|||
143393661|NCT04436276|516987686|FG019|Overall Study|Withdrawal by Subject|24|||
143393662|NCT04436276|516987687|FG020|Overall Study|Withdrawal by Subject|24|||
143393663|NCT04436276|516987688|FG021|Overall Study|Withdrawal by Subject|16|||
143393664|NCT04436276|516987689|FG022|Overall Study|Withdrawal by Subject|14|||
143393665|NCT04436276|516987667|FG000|Overall Study|Other|3|||
143393666|NCT04436276|516987668|FG001|Overall Study|Other|2|||
143393667|NCT04436276|516987669|FG002|Overall Study|Other|5|||
143393668|NCT04436276|516987670|FG003|Overall Study|Other|9|||
143393669|NCT04436276|516987671|FG004|Overall Study|Other|23|||
143393670|NCT04436276|516987672|FG005|Overall Study|Other|1|||
143393671|NCT04436276|516987673|FG006|Overall Study|Other|0|||
143393672|NCT04436276|516987674|FG007|Overall Study|Other|0|||
143393673|NCT04436276|516987675|FG008|Overall Study|Other|0|||
143393674|NCT04436276|516987676|FG009|Overall Study|Other|0|||
143393675|NCT04436276|516987677|FG010|Overall Study|Other|3|||
143393676|NCT04436276|516987678|FG011|Overall Study|Other|1|||
143393677|NCT04436276|516987679|FG012|Overall Study|Other|1|||
143393678|NCT04436276|516987680|FG013|Overall Study|Other|2|||
143393679|NCT04436276|516987681|FG014|Overall Study|Other|3|||
143393680|NCT04436276|516987682|FG015|Overall Study|Other|0|||
143393681|NCT04436276|516987683|FG016|Overall Study|Other|0|||
143393682|NCT04436276|516987684|FG017|Overall Study|Other|6|||
143393683|NCT04436276|516987685|FG018|Overall Study|Other|1|||
143393684|NCT04436276|516987686|FG019|Overall Study|Other|0|||
143393685|NCT04436276|516987687|FG020|Overall Study|Other|2|||
143393686|NCT04436276|516987688|FG021|Overall Study|Other|2|||
143393687|NCT04436276|516987689|FG022|Overall Study|Other|60|||
143393688|NCT00324805|516987690|FG000|Overall Study|Adverse Event|62|||
143393689|NCT00324805|516987691|FG001|Overall Study|Adverse Event|203|||
143393690|NCT00324805|516987690|FG000|Overall Study|Progression|7|||
143393691|NCT00324805|516987691|FG001|Overall Study|Progression|35|||
143393692|NCT00324805|516987690|FG000|Overall Study|Withdrawal by Subject|51|||
143393693|NCT00324805|516987691|FG001|Overall Study|Withdrawal by Subject|174|||
143393694|NCT00324805|516987690|FG000|Overall Study|Death|6|||
143393695|NCT00324805|516987691|FG001|Overall Study|Death|9|||
143393696|NCT00324805|516987690|FG000|Overall Study|Alternative therapy|4|||
143393697|NCT00324805|516987691|FG001|Overall Study|Alternative therapy|8|||
143393698|NCT00324805|516987690|FG000|Overall Study|Other complicating disease|1|||
143393699|NCT00324805|516987691|FG001|Overall Study|Other complicating disease|9|||
143393700|NCT00324805|516987690|FG000|Overall Study|Other reasons|7|||
143393701|NCT00324805|516987691|FG001|Overall Study|Other reasons|26|||
143393702|NCT00324805|516987690|FG000|Overall Study|Other|0|||
143393703|NCT00324805|516987691|FG001|Overall Study|Other|2|||
143393704|NCT00324805|516987690|FG000|Overall Study|Did not start therapy|12|||
143393705|NCT00324805|516987691|FG001|Overall Study|Did not start therapy|17|||
143393706|NCT05386030|516987695|FG000|Overall Study|Death|1|||
143393707|NCT05386030|516987696|FG001|Overall Study|Death|0|||
143393708|NCT05386030|516987695|FG000|Overall Study|Physician Decision|2|||
143393709|NCT05386030|516987696|FG001|Overall Study|Physician Decision|1|||
143393710|NCT05386030|516987695|FG000|Overall Study|Lost to Follow-up|19|||
143393711|NCT05386030|516987696|FG001|Overall Study|Lost to Follow-up|7|||
143393712|NCT05386030|516987695|FG000|Overall Study|Withdrawal by Subject|20|||
143393713|NCT05386030|516987696|FG001|Overall Study|Withdrawal by Subject|10|||
143393714|NCT05386030|516987695|FG000|Overall Study|Eligibility criteria violation|1|||
143393715|NCT05386030|516987696|FG001|Overall Study|Eligibility criteria violation|1|||
143393716|NCT05386030|516987695|FG000|Overall Study|Personal Reasons|1|||
143393717|NCT05386030|516987696|FG001|Overall Study|Personal Reasons|0|||
143393718|NCT03213691|516987697|FG000|Overall Study|Adverse Event|2|||
143393719|NCT03213691|516987697|FG000|Overall Study|Death|3|||
143393720|NCT03213691|516987697|FG000|Overall Study|Physician Decision|1|||
143393721|NCT03213691|516987697|FG000|Overall Study|Progressive Disease|14|||
143393722|NCT03213691|516987697|FG000|Overall Study|Ineligible|1|||
143393723|NCT03161028|516987698|FG000|Overall Study|Withdrawal by Subject|6|||
143393724|NCT03161028|516987699|FG001|Overall Study|Withdrawal by Subject|4|||
143393725|NCT03161028|516987698|FG000|Overall Study|Adverse Event|5|||
143393726|NCT03161028|516987699|FG001|Overall Study|Adverse Event|1|||
143393727|NCT03161028|516987698|FG000|Overall Study|Study drug side effects|2|||
143393728|NCT03161028|516987699|FG001|Overall Study|Study drug side effects|2|||
143393729|NCT03161028|516987698|FG000|Overall Study|Administrative PD/UP|4|||
143393730|NCT03161028|516987699|FG001|Overall Study|Administrative PD/UP|2|||
143393731|NCT03161028|516987698|FG000|Overall Study|Lost to Follow-up|2|||
143393732|NCT03161028|516987699|FG001|Overall Study|Lost to Follow-up|0|||
143393733|NCT03161028|516987698|FG000|Overall Study|Unable to comply with procedures|1|||
143393734|NCT03161028|516987699|FG001|Overall Study|Unable to comply with procedures|1|||
143393735|NCT00736723|516987700|FG000|Overall Study|Withdrawal by Subject|4|||
143393736|NCT00736723|516987701|FG001|Overall Study|Withdrawal by Subject|3|||
143393737|NCT04797897|516987704|FG000|Overall Study|Study Termination by Sponsor|1|||
143393738|NCT04797897|516987705|FG001|Overall Study|Study Termination by Sponsor|1|||
143393739|NCT01799265|516987707|FG000|Overall Study|Lost to Follow-up|1|||
143393740|NCT01799265|516987708|FG001|Overall Study|Lost to Follow-up|0|||
143393741|NCT01799265|516987707|FG000|Overall Study|Protocol Violation|2|||
143393742|NCT01799265|516987708|FG001|Overall Study|Protocol Violation|1|||
143393743|NCT01799265|516987707|FG000|Overall Study|inadequate sleep study|0|||
143393744|NCT01799265|516987708|FG001|Overall Study|inadequate sleep study|2|||
143393745|NCT03774082|516987714|FG000|Overall Study|Death|6|||
143393746|NCT03774082|516987715|FG001|Overall Study|Death|3|||
143393747|NCT03774082|516987716|FG002|Overall Study|Death|2|||
143393748|NCT03774082|516987714|FG000|Overall Study|Subject decision|0|||
143393749|NCT03774082|516987715|FG001|Overall Study|Subject decision|3|||
143393750|NCT03774082|516987716|FG002|Overall Study|Subject decision|0|||
143393751|NCT03774082|516987714|FG000|Overall Study|Lost to Follow-up|2|||
143393752|NCT03774082|516987715|FG001|Overall Study|Lost to Follow-up|0|||
143393753|NCT03774082|516987716|FG002|Overall Study|Lost to Follow-up|0|||
143393754|NCT03774082|516987714|FG000|Overall Study|Guardian decision|0|||
143393755|NCT03774082|516987715|FG001|Overall Study|Guardian decision|0|||
143393756|NCT03774082|516987716|FG002|Overall Study|Guardian decision|1|||
143393757|NCT03774082|516987714|FG000|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
143393758|NCT03774082|516987715|FG001|Overall Study|Enrolled but received treatment beyond protocol requirement|1|||
143393759|NCT03774082|516987716|FG002|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
143393760|NCT05030233|516987717|FG000|Overall Study|withdrawn for transfer|1|||
143393761|NCT05030233|516987718|FG001|Overall Study|withdrawn for transfer|0|||
143393762|NCT04728347|516989448|FG000|Overall Study|Sponsor decision|0|||
143393763|NCT04728347|516989449|FG001|Overall Study|Sponsor decision|0|||
143393764|NCT04728347|516989450|FG002|Overall Study|Sponsor decision|1|||
143393765|NCT04728347|516989451|FG003|Overall Study|Sponsor decision|0|||
143393766|NCT03867500|516989453|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
143393767|NCT00753545|516989456|FG000|Overall Study|Death|98|||
143393768|NCT00753545|516989457|FG001|Overall Study|Death|112|||
143393769|NCT00753545|516989456|FG000|Overall Study|Lost to Follow-up|2|||
143393770|NCT00753545|516989457|FG001|Overall Study|Lost to Follow-up|3|||
143393771|NCT00753545|516989456|FG000|Overall Study|Protocol Violation|1|||
143393772|NCT00753545|516989457|FG001|Overall Study|Protocol Violation|0|||
143393773|NCT00753545|516989456|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
143393774|NCT00753545|516989457|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
143393775|NCT02485938|516989458|FG000|Overall Study|Withdrawal of consent|2|||
143393776|NCT02485938|516989459|FG001|Overall Study|Withdrawal of consent|0|||
143393777|NCT04633122|516989460|FG000|Overall Study|Remained on treatment|19|||
143393778|NCT04633122|516989461|FG001|Overall Study|Remained on treatment|14|||
143393779|NCT04633122|516989460|FG000|Overall Study|Survival follow-up stopped|22|||
143393780|NCT04633122|516989461|FG001|Overall Study|Survival follow-up stopped|25|||
143393781|NCT03524118|516989463|FG000|Overall Study|Lost to Follow-up|0|||
143393782|NCT03524118|516989464|FG001|Overall Study|Lost to Follow-up|0|||
143393783|NCT03524118|516989465|FG002|Overall Study|Lost to Follow-up|0|||
143393784|NCT03524118|516989466|FG003|Overall Study|Lost to Follow-up|0|||
143393785|NCT03524118|516989467|FG004|Overall Study|Lost to Follow-up|1|||
143393786|NCT03524118|516989468|FG005|Overall Study|Lost to Follow-up|0|||
143393787|NCT03524118|516989463|FG000|Overall Study|Other|0|||
143393788|NCT03524118|516989464|FG001|Overall Study|Other|1|||
143393789|NCT03524118|516989465|FG002|Overall Study|Other|0|||
143393790|NCT03524118|516989466|FG003|Overall Study|Other|0|||
143393791|NCT03524118|516989467|FG004|Overall Study|Other|1|||
143393792|NCT03524118|516989468|FG005|Overall Study|Other|1|||
143393793|NCT03524118|516989463|FG000|Overall Study|Physician Decision|0|||
143393794|NCT03524118|516989464|FG001|Overall Study|Physician Decision|0|||
143393795|NCT03524118|516989465|FG002|Overall Study|Physician Decision|0|||
143393796|NCT03524118|516989466|FG003|Overall Study|Physician Decision|0|||
143393797|NCT03524118|516989467|FG004|Overall Study|Physician Decision|1|||
143393798|NCT03524118|516989468|FG005|Overall Study|Physician Decision|0|||
143393799|NCT03524118|516989463|FG000|Overall Study|Protocol Violation|0|||
143393800|NCT03524118|516989464|FG001|Overall Study|Protocol Violation|0|||
143393801|NCT03524118|516989465|FG002|Overall Study|Protocol Violation|1|||
143393802|NCT03524118|516989466|FG003|Overall Study|Protocol Violation|0|||
143393803|NCT03524118|516989467|FG004|Overall Study|Protocol Violation|1|||
143393804|NCT03524118|516989468|FG005|Overall Study|Protocol Violation|0|||
143393805|NCT03524118|516989463|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
143393806|NCT03524118|516989464|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
143393807|NCT03524118|516989465|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
143393808|NCT03524118|516989466|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
143393809|NCT03524118|516989467|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
143393810|NCT03524118|516989468|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
143393811|NCT03339713|516989471|FG000|Overall Study|Lost to Follow-up|2|||
143393812|NCT03339713|516989472|FG001|Overall Study|Lost to Follow-up|1|||
143393813|NCT03339713|516989471|FG000|Overall Study|Protocol Violation|1|||
143393814|NCT03339713|516989472|FG001|Overall Study|Protocol Violation|0|||
143393815|NCT03339713|516989471|FG000|Overall Study|Withdrawal by Subject|1|||
143393816|NCT03339713|516989472|FG001|Overall Study|Withdrawal by Subject|1|||
143393817|NCT01715285|516989473|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
143393818|NCT01715285|516989474|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
143393819|NCT01715285|516989475|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
143393820|NCT01715285|516989473|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
143393821|NCT01715285|516989474|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
143393822|NCT01715285|516989475|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
143393823|NCT01715285|516989473|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
143393824|NCT01715285|516989474|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
143393825|NCT01715285|516989475|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
143393826|NCT01715285|516989473|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
143393827|NCT01715285|516989474|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
143393828|NCT01715285|516989475|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
143393829|NCT01715285|516989473|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
143393830|NCT01715285|516989474|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
143393831|NCT01715285|516989475|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
143393832|NCT01715285|516989473|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
143339418|NCT02093663|516788213|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
143339419|NCT02093663|516788214|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
143339420|NCT02093663|516788215|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
143339421|NCT02093663|516788211|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
143339422|NCT02093663|516788212|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
143339423|NCT02093663|516788213|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
143339424|NCT02093663|516788214|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
143339425|NCT02093663|516788215|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
143339426|NCT02093663|516788211|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
143339427|NCT02093663|516788212|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
143339428|NCT02093663|516788213|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
143393833|NCT01715285|516989474|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
143393834|NCT01715285|516989475|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
143393835|NCT01715285|516989473|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
143393836|NCT01715285|516989474|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
143393837|NCT01715285|516989475|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
143393838|NCT01715285|516989473|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
143393839|NCT01715285|516989474|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
143393840|NCT01715285|516989475|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
143393841|NCT01715285|516989473|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
143393842|NCT01715285|516989474|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
143393843|NCT01715285|516989475|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
143393844|NCT01715285|516989473|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
143393845|NCT01715285|516989474|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
143393846|NCT01715285|516989475|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
143393847|NCT01715285|516989473|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
143393848|NCT01715285|516989474|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
143393849|NCT01715285|516989475|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
143393850|NCT01715285|516989473|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
143393851|NCT01715285|516989474|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
143393852|NCT01715285|516989475|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
143393853|NCT01715285|516989473|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
143393854|NCT01715285|516989474|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
143393855|NCT01715285|516989475|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
143393856|NCT01715285|516989473|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
143393857|NCT01715285|516989474|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
143393858|NCT01715285|516989475|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
143393859|NCT04858321|516989477|FG000|Overall Study|Withdrawal by Subject|3|||
143393860|NCT01539083|516989478|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
143393861|NCT01539083|516989479|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
143393862|NCT01539083|516989480|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
143393863|NCT01539083|516989478|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
143393864|NCT01539083|516989479|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
143393865|NCT01539083|516989480|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
143393866|NCT01539083|516989478|FG000|Before Randomization (VCD Induction)|Death|6|||
143393867|NCT01539083|516989479|FG001|Before Randomization (VCD Induction)|Death|0|||
143393868|NCT01539083|516989480|FG002|Before Randomization (VCD Induction)|Death|0|||
143393869|NCT01539083|516989478|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
143393870|NCT01539083|516989479|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
143393871|NCT01539083|516989480|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
143393872|NCT01539083|516989478|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
143393873|NCT01539083|516989479|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
143393874|NCT01539083|516989480|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
143393875|NCT01539083|516989478|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
143393876|NCT01539083|516989479|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
143393877|NCT01539083|516989480|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
143393878|NCT01539083|516989478|FG000|Before Randomization (VCD Induction)|Other|5|||
143393879|NCT01539083|516989479|FG001|Before Randomization (VCD Induction)|Other|0|||
143393880|NCT01539083|516989480|FG002|Before Randomization (VCD Induction)|Other|0|||
143393881|NCT01539083|516989478|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
143393882|NCT01539083|516989479|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
143393883|NCT01539083|516989480|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
143393884|NCT01539083|516989478|FG000|After Randomization (TP and VTP)|Other|0|||
143393885|NCT01539083|516989479|FG001|After Randomization (TP and VTP)|Other|1|||
143393886|NCT01539083|516989480|FG002|After Randomization (TP and VTP)|Other|1|||
143393887|NCT01539083|516989478|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
143393888|NCT01539083|516989479|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
143393889|NCT01539083|516989480|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
143393890|NCT01539083|516989478|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
143393891|NCT01539083|516989479|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
143393892|NCT01539083|516989480|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
143393893|NCT01539083|516989478|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
143393894|NCT01539083|516989479|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
143393895|NCT01539083|516989480|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
143393896|NCT01539083|516989478|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
143393897|NCT01539083|516989479|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
143393898|NCT01539083|516989480|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
143393899|NCT01539083|516989478|FG000|After Randomization (TP and VTP)|Death|0|||
143393900|NCT01539083|516989479|FG001|After Randomization (TP and VTP)|Death|6|||
143393901|NCT01539083|516989480|FG002|After Randomization (TP and VTP)|Death|11|||
143393902|NCT02677805|516989487|FG000|Double Blind Phase|Lost to Follow-up|8|||
143393903|NCT02677805|516989488|FG001|Double Blind Phase|Lost to Follow-up|3|||
143393904|NCT02677805|516989489|FG002|Double Blind Phase|Lost to Follow-up|0|||
143393905|NCT02677805|516989487|FG000|Double Blind Phase|Withdrawal by Subject|5|||
143393906|NCT02677805|516989488|FG001|Double Blind Phase|Withdrawal by Subject|2|||
143393907|NCT02677805|516989489|FG002|Double Blind Phase|Withdrawal by Subject|0|||
143393908|NCT02677805|516989487|FG000|Open Label Phase|Lost to Follow-up|0|||
143393909|NCT02677805|516989488|FG001|Open Label Phase|Lost to Follow-up|0|||
143393910|NCT02677805|516989489|FG002|Open Label Phase|Lost to Follow-up|10|||
143393911|NCT02677805|516989487|FG000|Open Label Phase|Withdrawal by Subject|0|||
143393912|NCT02677805|516989488|FG001|Open Label Phase|Withdrawal by Subject|0|||
143393913|NCT02677805|516989489|FG002|Open Label Phase|Withdrawal by Subject|6|||
143393914|NCT04111536|516989494|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
143393915|NCT04111536|516989495|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
143393916|NCT04111536|516989494|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
143393917|NCT04111536|516989495|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
143393918|NCT04111536|516989494|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
143393919|NCT04111536|516989495|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
143393920|NCT04111536|516989494|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
143393921|NCT04111536|516989495|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
143393922|NCT04350463|516989496|FG000|Overall Study|Other reason|0|||
143393923|NCT04350463|516989497|FG001|Overall Study|Other reason|0|||
143393924|NCT04350463|516989498|FG002|Overall Study|Other reason|0|||
143393925|NCT04350463|516989499|FG003|Overall Study|Other reason|1|||
143393926|NCT04350463|516989496|FG000|Overall Study|Lost to Follow-up|0|||
143393927|NCT04350463|516989497|FG001|Overall Study|Lost to Follow-up|0|||
143393928|NCT04350463|516989498|FG002|Overall Study|Lost to Follow-up|0|||
143393929|NCT04350463|516989499|FG003|Overall Study|Lost to Follow-up|2|||
143393930|NCT04350463|516989496|FG000|Overall Study|Withdrawal by Subject|4|||
143393931|NCT04350463|516989497|FG001|Overall Study|Withdrawal by Subject|0|||
143393932|NCT04350463|516989498|FG002|Overall Study|Withdrawal by Subject|1|||
143393933|NCT04350463|516989499|FG003|Overall Study|Withdrawal by Subject|4|||
143393934|NCT04350463|516989496|FG000|Overall Study|Adverse Event|0|||
143393935|NCT04350463|516989497|FG001|Overall Study|Adverse Event|0|||
143393936|NCT04350463|516989498|FG002|Overall Study|Adverse Event|0|||
143393937|NCT04350463|516989499|FG003|Overall Study|Adverse Event|2|||
143393938|NCT04350463|516989496|FG000|Overall Study|Death|27|||
143393939|NCT04350463|516989497|FG001|Overall Study|Death|2|||
143393940|NCT04350463|516989498|FG002|Overall Study|Death|13|||
143393941|NCT04350463|516989499|FG003|Overall Study|Death|26|||
143393942|NCT04171999|516989500|FG000|Overall Study|deemed ineligible after randomization|2|||
143393943|NCT04171999|516989501|FG001|Overall Study|deemed ineligible after randomization|1|||
143393944|NCT05170009|516989504|FG000|Overall Study|Physician Decision|0|||
143393945|NCT05170009|516989505|FG001|Overall Study|Physician Decision|1|||
143393946|NCT04925986|516989506|FG000|Overall Study|Death|0|||
143393947|NCT04925986|516989507|FG001|Overall Study|Death|0|||
143393948|NCT04925986|516989508|FG002|Overall Study|Death|2|||
143393949|NCT04925986|516989509|FG003|Overall Study|Death|0|||
143393950|NCT04925986|516989506|FG000|Overall Study|Lack of Efficacy|1|||
143393951|NCT04925986|516989507|FG001|Overall Study|Lack of Efficacy|2|||
143393952|NCT04925986|516989508|FG002|Overall Study|Lack of Efficacy|0|||
143393953|NCT04925986|516989509|FG003|Overall Study|Lack of Efficacy|1|||
143393954|NCT04925986|516989506|FG000|Overall Study|Withdrawal by Subject|0|||
143393955|NCT04925986|516989507|FG001|Overall Study|Withdrawal by Subject|0|||
143393956|NCT04925986|516989508|FG002|Overall Study|Withdrawal by Subject|1|||
143393957|NCT04925986|516989509|FG003|Overall Study|Withdrawal by Subject|2|||
143393958|NCT04770532|516989511|FG000|Overall Study|Withdrawal by Subject|0|||
143393959|NCT04770532|516989512|FG001|Overall Study|Withdrawal by Subject|3|||
143393960|NCT04770532|516989511|FG000|Overall Study|Physician Decision|1|||
143393961|NCT04770532|516989512|FG001|Overall Study|Physician Decision|0|||
143393962|NCT04770532|516989511|FG000|Overall Study|Death|2|||
143393963|NCT04770532|516989512|FG001|Overall Study|Death|2|||
143393964|NCT05457647|516989514|FG000|Overall Study|Lost to Follow-up|3|||
143393965|NCT02683447|516989515|FG000|Overall Study|Lost to Follow-up|2|||
143393966|NCT04623671|516989517|FG000|Overall Study|Adverse Event|0|||
143393967|NCT04623671|516989518|FG001|Overall Study|Adverse Event|1|||
143393968|NCT04623671|516989517|FG000|Overall Study|Lost to Follow-up|2|||
143393969|NCT04623671|516989518|FG001|Overall Study|Lost to Follow-up|1|||
143393970|NCT04623671|516989517|FG000|Overall Study|Death|5|||
143393971|NCT04623671|516989518|FG001|Overall Study|Death|5|||
143393972|NCT03448107|516989519|FG000|Overall Study|Lost to Follow-up|229|||
143393973|NCT03448107|516989520|FG001|Overall Study|Lost to Follow-up|258|||
143393974|NCT01943409|516989524|FG000|Overall Study|resumed oral/entral|24|||
143393975|NCT01943409|516989525|FG001|Overall Study|resumed oral/entral|20|||
143393976|NCT01943409|516989524|FG000|Overall Study|Protocol Violation|14|||
143393977|NCT01943409|516989525|FG001|Overall Study|Protocol Violation|24|||
143393978|NCT01943409|516989524|FG000|Overall Study|Death|3|||
143393979|NCT01943409|516989525|FG001|Overall Study|Death|1|||
143393980|NCT01943409|516989524|FG000|Overall Study|Withdrawal by Subject|4|||
143393981|NCT01943409|516989525|FG001|Overall Study|Withdrawal by Subject|3|||
143393982|NCT02489903|516989526|FG000|Screening|Screen Failure|24|||
143393983|NCT02489903|516989527|FG001|Screening|Screen Failure|0|||
143393984|NCT02489903|516989528|FG002|Screening|Screen Failure|0|||
143393985|NCT02489903|516989529|FG003|Screening|Screen Failure|8|||
143393986|NCT02489903|516989526|FG000|Randomized and Received Treatment|Protocol Violation|0|||
143393987|NCT02489903|516989527|FG001|Randomized and Received Treatment|Protocol Violation|1|||
143393988|NCT02489903|516989528|FG002|Randomized and Received Treatment|Protocol Violation|0|||
143393989|NCT02489903|516989529|FG003|Randomized and Received Treatment|Protocol Violation|0|||
143393990|NCT02489903|516989526|FG000|Randomized and Received Treatment|Baseline Drop Out|3|||
143393991|NCT02489903|516989527|FG001|Randomized and Received Treatment|Baseline Drop Out|0|||
143393992|NCT02489903|516989528|FG002|Randomized and Received Treatment|Baseline Drop Out|0|||
143393993|NCT02489903|516989529|FG003|Randomized and Received Treatment|Baseline Drop Out|0|||
143393994|NCT02489903|516989526|FG000|Randomized and Received Treatment|Withdrawal by Subject|6|||
143393995|NCT02489903|516989527|FG001|Randomized and Received Treatment|Withdrawal by Subject|2|||
143393996|NCT02489903|516989528|FG002|Randomized and Received Treatment|Withdrawal by Subject|0|||
143393997|NCT02489903|516989529|FG003|Randomized and Received Treatment|Withdrawal by Subject|0|||
143393998|NCT02489903|516989526|FG000|Randomized and Received Treatment|Death|10|||
143393999|NCT02489903|516989527|FG001|Randomized and Received Treatment|Death|1|||
143394000|NCT02489903|516989528|FG002|Randomized and Received Treatment|Death|0|||
143394001|NCT02489903|516989529|FG003|Randomized and Received Treatment|Death|0|||
143394002|NCT04542317|516989530|FG000|Overall Study|Care recipients passed away|18|||
143394003|NCT04542317|516989531|FG001|Overall Study|Care recipients passed away|13|||
143394004|NCT04542317|516989530|FG000|Overall Study|No longer a primary caregiver|5|||
143394005|NCT04542317|516989531|FG001|Overall Study|No longer a primary caregiver|1|||
143394006|NCT04542317|516989530|FG000|Overall Study|Withdrawal by Subject|4|||
143394007|NCT04542317|516989531|FG001|Overall Study|Withdrawal by Subject|2|||
143394008|NCT04542317|516989530|FG000|Overall Study|Caregivers passed away|0|||
143394009|NCT04542317|516989531|FG001|Overall Study|Caregivers passed away|2|||
143394010|NCT02310646|516989532|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
143394011|NCT02310646|516989533|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
143394012|NCT02310646|516989532|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
143394013|NCT02310646|516989533|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
143394014|NCT03021096|516989536|FG000|Overall Study|Lost to Follow-up|4|||
143394015|NCT03021096|516989536|FG000|Overall Study|Protocol Violation|2|||
143394016|NCT04700163|516989537|FG000|Overall Study|Lost to Follow-up|0|||
143394017|NCT04700163|516989538|FG001|Overall Study|Lost to Follow-up|0|||
143394018|NCT04700163|516989539|FG002|Overall Study|Lost to Follow-up|0|||
143394019|NCT04700163|516989540|FG003|Overall Study|Lost to Follow-up|0|||
143394020|NCT04700163|516989541|FG004|Overall Study|Lost to Follow-up|0|||
143394021|NCT04700163|516989542|FG005|Overall Study|Lost to Follow-up|1|||
143394022|NCT00764751|516989551|FG000|Overall Study|Adverse Event|1|||
143394023|NCT00764751|516989552|FG001|Overall Study|Adverse Event|1|||
143394024|NCT00764751|516989551|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
143394025|NCT00764751|516989552|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
143394026|NCT04137289|516989568|FG000|Overall Study|Death|0|||
143394027|NCT04137289|516989569|FG001|Overall Study|Death|0|||
143394028|NCT04137289|516989570|FG002|Overall Study|Death|0|||
143394029|NCT04137289|516989571|FG003|Overall Study|Death|0|||
143394030|NCT04137289|516989572|FG004|Overall Study|Death|0|||
143394031|NCT04137289|516989573|FG005|Overall Study|Death|0|||
143394032|NCT04137289|516989574|FG006|Overall Study|Death|1|||
143394033|NCT04137289|516989575|FG007|Overall Study|Death|0|||
143394034|NCT04137289|516989576|FG008|Overall Study|Death|0|||
143394035|NCT04137289|516989568|FG000|Overall Study|Clinical disease progression|0|||
143394036|NCT04137289|516989569|FG001|Overall Study|Clinical disease progression|0|||
143394037|NCT04137289|516989570|FG002|Overall Study|Clinical disease progression|0|||
143394038|NCT04137289|516989571|FG003|Overall Study|Clinical disease progression|4|||
143394039|NCT04137289|516989572|FG004|Overall Study|Clinical disease progression|4|||
143394040|NCT04137289|516989573|FG005|Overall Study|Clinical disease progression|2|||
143394041|NCT04137289|516989574|FG006|Overall Study|Clinical disease progression|5|||
143394042|NCT04137289|516989575|FG007|Overall Study|Clinical disease progression|1|||
143394043|NCT04137289|516989576|FG008|Overall Study|Clinical disease progression|0|||
143394044|NCT04137289|516989568|FG000|Overall Study|Lost to Follow-up|0|||
143394045|NCT04137289|516989569|FG001|Overall Study|Lost to Follow-up|0|||
143394046|NCT04137289|516989570|FG002|Overall Study|Lost to Follow-up|0|||
143394047|NCT04137289|516989571|FG003|Overall Study|Lost to Follow-up|1|||
143394048|NCT04137289|516989572|FG004|Overall Study|Lost to Follow-up|0|||
143394049|NCT04137289|516989573|FG005|Overall Study|Lost to Follow-up|0|||
143394050|NCT04137289|516989574|FG006|Overall Study|Lost to Follow-up|0|||
143394051|NCT04137289|516989575|FG007|Overall Study|Lost to Follow-up|0|||
143394052|NCT04137289|516989576|FG008|Overall Study|Lost to Follow-up|0|||
143394053|NCT04137289|516989568|FG000|Overall Study|Adverse Event|0|||
143394054|NCT04137289|516989569|FG001|Overall Study|Adverse Event|0|||
143394055|NCT04137289|516989570|FG002|Overall Study|Adverse Event|1|||
143394056|NCT04137289|516989571|FG003|Overall Study|Adverse Event|0|||
143394057|NCT04137289|516989572|FG004|Overall Study|Adverse Event|0|||
143394058|NCT04137289|516989573|FG005|Overall Study|Adverse Event|1|||
143394059|NCT04137289|516989574|FG006|Overall Study|Adverse Event|0|||
143394060|NCT04137289|516989575|FG007|Overall Study|Adverse Event|0|||
143394061|NCT04137289|516989576|FG008|Overall Study|Adverse Event|0|||
143394062|NCT04137289|516989568|FG000|Overall Study|Lack of clinical benefit|0|||
143394063|NCT04137289|516989569|FG001|Overall Study|Lack of clinical benefit|0|||
143394064|NCT04137289|516989570|FG002|Overall Study|Lack of clinical benefit|0|||
143394065|NCT04137289|516989571|FG003|Overall Study|Lack of clinical benefit|0|||
143394066|NCT04137289|516989572|FG004|Overall Study|Lack of clinical benefit|0|||
143394067|NCT04137289|516989573|FG005|Overall Study|Lack of clinical benefit|0|||
143394068|NCT04137289|516989574|FG006|Overall Study|Lack of clinical benefit|0|||
143394069|NCT04137289|516989575|FG007|Overall Study|Lack of clinical benefit|0|||
143394070|NCT04137289|516989576|FG008|Overall Study|Lack of clinical benefit|1|||
143394071|NCT04137289|516989568|FG000|Overall Study|Objective disease progression|1|||
143394072|NCT04137289|516989569|FG001|Overall Study|Objective disease progression|1|||
143394073|NCT04137289|516989570|FG002|Overall Study|Objective disease progression|6|||
143394074|NCT04137289|516989571|FG003|Overall Study|Objective disease progression|18|||
143394075|NCT04137289|516989572|FG004|Overall Study|Objective disease progression|12|||
143394076|NCT04137289|516989573|FG005|Overall Study|Objective disease progression|20|||
143394077|NCT04137289|516989574|FG006|Overall Study|Objective disease progression|18|||
143394078|NCT04137289|516989575|FG007|Overall Study|Objective disease progression|7|||
143394079|NCT04137289|516989576|FG008|Overall Study|Objective disease progression|6|||
143394080|NCT04307355|516989577|FG000|Overall Study|Non-Compliance|3|||
143394081|NCT04307355|516989578|FG001|Overall Study|Non-Compliance|3|||
143394082|NCT04307355|516989579|FG002|Overall Study|Non-Compliance|0|||
143394083|NCT04948697|516989580|FG000|Overall Study|Progressive disease|27|||
143394084|NCT04948697|516989581|FG001|Overall Study|Progressive disease|18|||
143394085|NCT04948697|516989580|FG000|Overall Study|Adverse Event|14|||
143394086|NCT04948697|516989581|FG001|Overall Study|Adverse Event|4|||
143394087|NCT04948697|516989580|FG000|Overall Study|Participant moved to long term extension study|7|||
143394088|NCT04948697|516989581|FG001|Overall Study|Participant moved to long term extension study|4|||
143394089|NCT04948697|516989580|FG000|Overall Study|Withdrawal by Subject|10|||
143394090|NCT04948697|516989581|FG001|Overall Study|Withdrawal by Subject|0|||
143394091|NCT04948697|516989580|FG000|Overall Study|Closed by Sponsor|3|||
143394092|NCT04948697|516989581|FG001|Overall Study|Closed by Sponsor|2|||
143394093|NCT04948697|516989580|FG000|Overall Study|Physician Decision|0|||
143394094|NCT04948697|516989581|FG001|Overall Study|Physician Decision|2|||
143394095|NCT04948697|516989580|FG000|Overall Study|Lost to Follow-up|0|||
143394096|NCT04948697|516989581|FG001|Overall Study|Lost to Follow-up|1|||
143394097|NCT04948697|516989580|FG000|Overall Study|Other-Miscellaneous|1|||
143394098|NCT04948697|516989581|FG001|Overall Study|Other-Miscellaneous|0|||
143394099|NCT04948697|516989580|FG000|Overall Study|Randomized but not treated|0|||
143394100|NCT04948697|516989581|FG001|Overall Study|Randomized but not treated|1|||
143394101|NCT04599062|516989582|FG000|Overall Study|Physician Decision|1|||
143394102|NCT04599062|516989583|FG001|Overall Study|Physician Decision|0|||
143394103|NCT03322267|516989586|FG000|Overall Study|Lack of Efficacy|11|||
143394104|NCT03322267|516989586|FG000|Overall Study|Adverse Event|1|||
143394105|NCT03322267|516989586|FG000|Overall Study|Withdrawal by Subject|2|||
143394106|NCT05792085|516989587|FG000|Overall Study|Death|0|||
143394107|NCT05792085|516989588|FG001|Overall Study|Death|0|||
143394108|NCT05792085|516989589|FG002|Overall Study|Death|0|||
143394109|NCT05792085|516989590|FG003|Overall Study|Death|0|||
143394110|NCT05792085|516989591|FG004|Overall Study|Death|1|||
143394111|NCT03852472|516989598|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
143394112|NCT03852472|516989599|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
143394113|NCT03852472|516989600|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
143394114|NCT03852472|516989601|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
143394115|NCT03852472|516989602|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
143394116|NCT03852472|516989598|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
143394117|NCT03852472|516989599|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
143454354|NCT03117998|517208212|FG002|Overall Study|Withdrawal by Subject|2|||
143394118|NCT03852472|516989600|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
143394119|NCT03852472|516989601|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
143394120|NCT03852472|516989602|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
143394121|NCT03852472|516989598|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
143394122|NCT03852472|516989599|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
143394123|NCT03852472|516989600|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
143394124|NCT03852472|516989601|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
143394125|NCT03852472|516989602|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
143394126|NCT03852472|516989598|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
143394127|NCT03852472|516989599|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
143394128|NCT03852472|516989600|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
143394129|NCT03852472|516989601|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
143394130|NCT03852472|516989602|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
143394131|NCT03852472|516989598|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
143394132|NCT03852472|516989599|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
143394133|NCT03852472|516989600|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
143394134|NCT03852472|516989601|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
143394135|NCT03852472|516989602|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
143394136|NCT03852472|516989598|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
143394137|NCT03852472|516989599|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
143394138|NCT03852472|516989600|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
143394139|NCT03852472|516989601|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
143394140|NCT03852472|516989602|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
143394141|NCT03852472|516989598|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
143394142|NCT03852472|516989599|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
143394143|NCT03852472|516989600|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
143394144|NCT03852472|516989601|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
143394145|NCT03852472|516989602|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
143394146|NCT03852472|516989598|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
143394147|NCT03852472|516989599|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
143394148|NCT03852472|516989600|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
143394149|NCT03852472|516989601|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
143394150|NCT03852472|516989602|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
143394151|NCT03852472|516989598|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
143394152|NCT03852472|516989599|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
143394153|NCT03852472|516989600|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
143394154|NCT03852472|516989601|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
143394155|NCT03852472|516989602|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
143394156|NCT03852472|516989598|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
143394157|NCT03852472|516989599|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
143394158|NCT03852472|516989600|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
143394159|NCT03852472|516989601|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
143394160|NCT03852472|516989602|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
143394161|NCT03852472|516989598|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
143394162|NCT03852472|516989599|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
143394163|NCT03852472|516989600|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
143394164|NCT03852472|516989601|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
143394165|NCT03852472|516989602|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
143394166|NCT03852472|516989598|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
143394167|NCT03852472|516989599|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
143394168|NCT03852472|516989600|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
143394169|NCT03852472|516989601|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
143394170|NCT03852472|516989602|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
143394171|NCT03852472|516989598|FG000|Period 2 - Week 44|Adverse Event|0|||
143394172|NCT03852472|516989599|FG001|Period 2 - Week 44|Adverse Event|3|||
143394173|NCT03852472|516989600|FG002|Period 2 - Week 44|Adverse Event|1|||
143394174|NCT03852472|516989601|FG003|Period 2 - Week 44|Adverse Event|2|||
143394175|NCT03852472|516989602|FG004|Period 2 - Week 44|Adverse Event|2|||
143394176|NCT03852472|516989598|FG000|Period 2 - Week 44|COVID-19 Related|0|||
143394177|NCT03852472|516989599|FG001|Period 2 - Week 44|COVID-19 Related|0|||
143394178|NCT03852472|516989600|FG002|Period 2 - Week 44|COVID-19 Related|0|||
143394179|NCT03852472|516989601|FG003|Period 2 - Week 44|COVID-19 Related|1|||
143394180|NCT03852472|516989602|FG004|Period 2 - Week 44|COVID-19 Related|0|||
143394181|NCT03852472|516989598|FG000|Period 2 - Week 44|Reason not stated|0|||
143394182|NCT03852472|516989599|FG001|Period 2 - Week 44|Reason not stated|0|||
143394183|NCT03852472|516989600|FG002|Period 2 - Week 44|Reason not stated|0|||
143394184|NCT03852472|516989601|FG003|Period 2 - Week 44|Reason not stated|0|||
143394185|NCT03852472|516989602|FG004|Period 2 - Week 44|Reason not stated|1|||
143394186|NCT01919554|516989603|FG000|Overall Study|Withdrawal by Subject|0|||
143394187|NCT01919554|516989604|FG001|Overall Study|Withdrawal by Subject|0|||
143394188|NCT01919554|516989605|FG002|Overall Study|Withdrawal by Subject|1|||
143394189|NCT01919554|516989606|FG003|Overall Study|Withdrawal by Subject|1|||
143394190|NCT05977530|516989607|FG000|Overall Study|Withdrawal by Subject|1|||
143394191|NCT05977530|516989607|FG000|Overall Study|injury unrelated to research participation. Unable to enter swimming pool to participate in protocol|1|||
143394192|NCT04719832|516989610|FG000|Overall Study|Adverse Event|2|||
143394193|NCT04719832|516989611|FG001|Overall Study|Adverse Event|0|||
143394194|NCT04719832|516989610|FG000|Overall Study|Lack of Efficacy|2|||
143394195|NCT04719832|516989611|FG001|Overall Study|Lack of Efficacy|4|||
143394196|NCT04719832|516989610|FG000|Overall Study|Lost to Follow-up|0|||
143394197|NCT04719832|516989611|FG001|Overall Study|Lost to Follow-up|2|||
143394198|NCT04719832|516989610|FG000|Overall Study|Physician Decision|0|||
143394199|NCT04719832|516989611|FG001|Overall Study|Physician Decision|1|||
143394200|NCT04719832|516989610|FG000|Overall Study|Pregnancy|1|||
143394201|NCT04719832|516989611|FG001|Overall Study|Pregnancy|1|||
143394202|NCT04719832|516989610|FG000|Overall Study|Withdrawal by Subject|5|||
143394203|NCT04719832|516989611|FG001|Overall Study|Withdrawal by Subject|5|||
143394204|NCT04719832|516989610|FG000|Overall Study|Randomized, not treated|0|||
143394205|NCT04719832|516989611|FG001|Overall Study|Randomized, not treated|2|||
143394206|NCT04719832|516989610|FG000|Overall Study|GCP violations|4|||
143394207|NCT04719832|516989611|FG001|Overall Study|GCP violations|7|||
143394208|NCT05228457|516989612|FG000|Overall Study|Withdrawal by Subject|1|||
143394209|NCT05228457|516989613|FG001|Overall Study|Withdrawal by Subject|1|||
143394210|NCT03492216|516989620|FG000|Overall Study|Death|1|||
143394211|NCT03492216|516989621|FG001|Overall Study|Death|0|||
143394212|NCT03492216|516989622|FG002|Overall Study|Death|4|||
143394213|NCT03492216|516989623|FG003|Overall Study|Death|0|||
143394214|NCT03492216|516989620|FG000|Overall Study|Withdrawal by Subject|5|||
143394215|NCT03492216|516989621|FG001|Overall Study|Withdrawal by Subject|3|||
143394216|NCT03492216|516989622|FG002|Overall Study|Withdrawal by Subject|1|||
143394217|NCT03492216|516989623|FG003|Overall Study|Withdrawal by Subject|1|||
143394218|NCT03492216|516989620|FG000|Overall Study|Lost to Follow-up|9|||
143394219|NCT03492216|516989621|FG001|Overall Study|Lost to Follow-up|2|||
143394220|NCT03492216|516989622|FG002|Overall Study|Lost to Follow-up|7|||
143394221|NCT03492216|516989623|FG003|Overall Study|Lost to Follow-up|8|||
143394222|NCT03492216|516989620|FG000|Overall Study|Moved|5|||
143394223|NCT03492216|516989621|FG001|Overall Study|Moved|3|||
143394224|NCT03492216|516989622|FG002|Overall Study|Moved|3|||
143394225|NCT03492216|516989623|FG003|Overall Study|Moved|5|||
143394226|NCT03492216|516989620|FG000|Overall Study|Too ill|0|||
143394227|NCT03492216|516989621|FG001|Overall Study|Too ill|1|||
143394228|NCT03492216|516989622|FG002|Overall Study|Too ill|0|||
143394229|NCT03492216|516989623|FG003|Overall Study|Too ill|0|||
143394230|NCT03492216|516989620|FG000|Overall Study|Incarcerated|0|||
143394231|NCT03492216|516989621|FG001|Overall Study|Incarcerated|0|||
143394232|NCT03492216|516989622|FG002|Overall Study|Incarcerated|2|||
143394233|NCT03492216|516989623|FG003|Overall Study|Incarcerated|0|||
143394234|NCT04437615|516989624|FG000|Overall Study|Screen Fails/Withdrawal|1089|||
143394235|NCT04828005|516989625|FG000|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|2|||
143394236|NCT04828005|516989626|FG001|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
143394237|NCT04828005|516989627|FG002|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
143394238|NCT04828005|516989628|FG003|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
143394239|NCT04828005|516989625|FG000|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
143394240|NCT04828005|516989626|FG001|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
143394241|NCT04828005|516989627|FG002|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|2|||
143394242|NCT04828005|516989628|FG003|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|1|||
143394243|NCT04828005|516989625|FG000|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
143394244|NCT04828005|516989626|FG001|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
143394245|NCT04828005|516989627|FG002|Part 2: 1st Treatment (1 Day)|Adverse Event|3|||
143394246|NCT04828005|516989628|FG003|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
143394247|NCT04828005|516989625|FG000|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
143394248|NCT04828005|516989626|FG001|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
143394249|NCT04828005|516989627|FG002|Part 2: 1st Treatment (1 Day)|Protocol Violation|2|||
143394250|NCT04828005|516989628|FG003|Part 2: 1st Treatment (1 Day)|Protocol Violation|1|||
143394251|NCT04828005|516989625|FG000|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
143394252|NCT04828005|516989626|FG001|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
143394253|NCT04828005|516989627|FG002|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
143394254|NCT04828005|516989628|FG003|Part 2: 1st Treatment (1 Day)|Equipment failure|1|||
143394255|NCT04828005|516989625|FG000|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
143394256|NCT04828005|516989626|FG001|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
143394257|NCT04828005|516989627|FG002|Part 2: Washout (4 Days)|Withdrawal by Subject|2|||
143394258|NCT04828005|516989628|FG003|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
143394259|NCT04828005|516989625|FG000|Part 2: Washout (4 Days)|Physician Decision|0|||
143394260|NCT04828005|516989626|FG001|Part 2: Washout (4 Days)|Physician Decision|0|||
143394261|NCT04828005|516989627|FG002|Part 2: Washout (4 Days)|Physician Decision|0|||
143394262|NCT04828005|516989628|FG003|Part 2: Washout (4 Days)|Physician Decision|2|||
143394263|NCT04828005|516989625|FG000|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
143394264|NCT04828005|516989626|FG001|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
143394265|NCT04828005|516989627|FG002|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
143394266|NCT04828005|516989628|FG003|Part 2: 2nd Treatment (1 Day)|Protocol Violation|2|||
143394267|NCT04828005|516989625|FG000|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
143394268|NCT04828005|516989626|FG001|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
143394269|NCT04828005|516989627|FG002|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
143394270|NCT04828005|516989628|FG003|Part 2: 2nd Treatment (1 Day)|Adverse Event|1|||
143394271|NCT05028634|516991388|FG000|Overall Study|Withdrawal by Subject|0|||
143394272|NCT05028634|516991389|FG001|Overall Study|Withdrawal by Subject|1|||
143394273|NCT06516705|516991391|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
143394274|NCT06516705|516991392|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
143394275|NCT06516705|516991391|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
143394276|NCT06516705|516991392|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
143394277|NCT06516705|516991391|FG000|T3 ( 3 Month After Education)|covid-19|1|||
143394278|NCT06516705|516991392|FG001|T3 ( 3 Month After Education)|covid-19|2|||
143394279|NCT06516705|516991391|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
143394280|NCT06516705|516991392|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
143394281|NCT06516705|516991391|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
143394282|NCT06516705|516991392|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
143394283|NCT06516705|516991391|FG000|T4 ( 6 Month After Education)|covid-19|3|||
143394284|NCT06516705|516991392|FG001|T4 ( 6 Month After Education)|covid-19|2|||
143394285|NCT06516705|516991391|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
143394286|NCT06516705|516991392|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
143394287|NCT05579899|516991393|FG000|Overall Study|Lost to Follow-up|3|||
143394288|NCT05579899|516991394|FG001|Overall Study|Lost to Follow-up|1|||
143394289|NCT05579899|516991393|FG000|Overall Study|Adverse Event|0|||
143394290|NCT05579899|516991394|FG001|Overall Study|Adverse Event|3|||
143394291|NCT05579899|516991393|FG000|Overall Study|Pregnancy|0|||
143394292|NCT05579899|516991394|FG001|Overall Study|Pregnancy|1|||
143394293|NCT05579899|516991393|FG000|Overall Study|Withdrawal by Subject|0|||
143394294|NCT05579899|516991394|FG001|Overall Study|Withdrawal by Subject|3|||
143394295|NCT05453773|516991395|FG000|Overall Study|Withdrawal by Subject|3|||
143394296|NCT05453773|516991395|FG000|Overall Study|Lost to Follow-up|3|||
143394297|NCT05453773|516991395|FG000|Overall Study|Difficult Blood Draw|3|||
143394298|NCT03023410|516991398|FG000|Overall Study|study termination|0|||
143394299|NCT03023410|516991399|FG001|Overall Study|study termination|1|||
143394300|NCT04963270|516991401|FG000|Double-Blind Period (24 Weeks)|Adverse Event|1|||
143394301|NCT04963270|516991402|FG001|Double-Blind Period (24 Weeks)|Adverse Event|2|||
143394302|NCT04963270|516991403|FG002|Double-Blind Period (24 Weeks)|Adverse Event|0|||
143394303|NCT04963270|516991404|FG003|Double-Blind Period (24 Weeks)|Adverse Event|0|||
143394304|NCT04963270|516991401|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
143394305|NCT04963270|516991402|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|1|||
143394306|NCT04963270|516991403|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
143394307|NCT04963270|516991404|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
143394308|NCT04963270|516991401|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
143394309|NCT04963270|516991402|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
143394310|NCT04963270|516991403|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
143394311|NCT04963270|516991404|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
143394312|NCT04963270|516991401|FG000|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|2|||
143394313|NCT04963270|516991402|FG001|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
143394314|NCT04963270|516991403|FG002|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
143394315|NCT04963270|516991404|FG003|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
143394316|NCT04963270|516991401|FG000|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
143394317|NCT04963270|516991402|FG001|Double-Blind Period (24 Weeks)|Reason Not Specified|1|||
143394318|NCT04963270|516991403|FG002|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
143394319|NCT04963270|516991404|FG003|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
143394320|NCT04963270|516991401|FG000|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
143394321|NCT04963270|516991402|FG001|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
143394322|NCT04963270|516991403|FG002|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
143394323|NCT04963270|516991404|FG003|Open Label Extension Period (92 Weeks)|Lack of Efficacy|1|||
143394324|NCT04963270|516991401|FG000|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
143394325|NCT04963270|516991402|FG001|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
143394326|NCT04963270|516991403|FG002|Open Label Extension Period (92 Weeks)|Lost to Follow-up|2|||
143394327|NCT04963270|516991404|FG003|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
143394328|NCT04963270|516991401|FG000|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
143394329|NCT04963270|516991402|FG001|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
143394330|NCT04963270|516991403|FG002|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|2|||
143394331|NCT04963270|516991404|FG003|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|6|||
143394332|NCT04963270|516991401|FG000|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
143394333|NCT04963270|516991402|FG001|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
143394334|NCT04963270|516991403|FG002|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
143394335|NCT04963270|516991404|FG003|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
143394336|NCT04963270|516991401|FG000|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
143394337|NCT04963270|516991402|FG001|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
143394338|NCT04963270|516991403|FG002|Open Label Extension Period (92 Weeks)|Pregnancy|1|||
143394339|NCT04963270|516991404|FG003|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
143394340|NCT04963270|516991401|FG000|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
143394341|NCT04963270|516991402|FG001|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
143394342|NCT04963270|516991403|FG002|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|82|||
143454355|NCT03117998|517208213|FG003|Overall Study|Withdrawal by Subject|3|||
143394343|NCT04963270|516991404|FG003|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|81|||
143394344|NCT04963270|516991401|FG000|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
143394345|NCT04963270|516991402|FG001|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
143394346|NCT04963270|516991403|FG002|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
143394347|NCT04963270|516991404|FG003|Open Label Extension Period (92 Weeks)|Reason Not Specified|1|||
143394348|NCT04963270|516991401|FG000|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
143394349|NCT04963270|516991402|FG001|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
143394350|NCT04963270|516991403|FG002|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
143394351|NCT04963270|516991404|FG003|Open Label Extension Period (92 Weeks)|Reason Unknown|1|||
143394352|NCT04963270|516991401|FG000|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
143394353|NCT04963270|516991402|FG001|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
143394354|NCT04963270|516991403|FG002|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
143394355|NCT04963270|516991404|FG003|Open Label Extension Period (92 Weeks)|Adverse Event|1|||
143394356|NCT04802967|516991405|FG000|Part B|Withdrawal by Subject|0|||
143394357|NCT04802967|516991406|FG001|Part B|Withdrawal by Subject|0|||
143394358|NCT04802967|516991407|FG002|Part B|Withdrawal by Subject|0|||
143394359|NCT04802967|516991408|FG003|Part B|Withdrawal by Subject|0|||
143394360|NCT04802967|516991409|FG004|Part B|Withdrawal by Subject|0|||
143394361|NCT04802967|516991410|FG005|Part B|Withdrawal by Subject|1|||
143394362|NCT04802967|516991411|FG006|Part B|Withdrawal by Subject|0|||
143394363|NCT04802967|516991412|FG007|Part B|Withdrawal by Subject|0|||
143394364|NCT04802967|516991413|FG008|Part B|Withdrawal by Subject|0|||
143394365|NCT04802967|516991414|FG009|Part B|Withdrawal by Subject|0|||
143394366|NCT03474679|516991421|FG000|Overall Study|Death|7|||
143394367|NCT03474679|516991421|FG000|Overall Study|Withdrawal by Subject|1|||
143394368|NCT05499377|516991435|FG000|Overall Study|Withdrawal by Subject|2|||
143394369|NCT05499377|516991436|FG001|Overall Study|Withdrawal by Subject|0|||
143394370|NCT05499377|516991435|FG000|Overall Study|Physician Decision|1|||
143394371|NCT05499377|516991436|FG001|Overall Study|Physician Decision|0|||
143394372|NCT04149704|516991439|FG000|Three Month Follow-up|Death|2|||
143394373|NCT04149704|516991440|FG001|Three Month Follow-up|Death|0|||
143394374|NCT04149704|516991441|FG002|Three Month Follow-up|Death|0|||
143394375|NCT04149704|516991442|FG003|Three Month Follow-up|Death|0|||
143394376|NCT04149704|516991439|FG000|Three Month Follow-up|Lost to Follow-up|1|||
143394377|NCT04149704|516991440|FG001|Three Month Follow-up|Lost to Follow-up|4|||
143394378|NCT04149704|516991441|FG002|Three Month Follow-up|Lost to Follow-up|5|||
143394379|NCT04149704|516991442|FG003|Three Month Follow-up|Lost to Follow-up|5|||
143394380|NCT04149704|516991439|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
143394381|NCT04149704|516991440|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
143394382|NCT04149704|516991441|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
143394383|NCT04149704|516991442|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
143394384|NCT04149704|516991439|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
143394385|NCT04149704|516991440|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
143394386|NCT04149704|516991441|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
143394387|NCT04149704|516991442|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
143394388|NCT02268253|516991445|FG000|Stage 1|Withdrawal by Subject|1|||
143394389|NCT02268253|516991446|FG001|Stage 1|Withdrawal by Subject|0|||
143394390|NCT02268253|516991447|FG002|Stage 1|Withdrawal by Subject|0|||
143394391|NCT02268253|516991448|FG003|Stage 1|Withdrawal by Subject|0|||
143394392|NCT02268253|516991449|FG004|Stage 1|Withdrawal by Subject|0|||
143394393|NCT02268253|516991450|FG005|Stage 1|Withdrawal by Subject|0|||
143394394|NCT02268253|516991451|FG006|Stage 1|Withdrawal by Subject|0|||
143394395|NCT02268253|516991445|FG000|Stage 1|Death|0|||
143394396|NCT02268253|516991446|FG001|Stage 1|Death|2|||
143394397|NCT02268253|516991447|FG002|Stage 1|Death|2|||
143394398|NCT02268253|516991448|FG003|Stage 1|Death|2|||
143394399|NCT02268253|516991449|FG004|Stage 1|Death|1|||
143394400|NCT02268253|516991450|FG005|Stage 1|Death|1|||
143394401|NCT02268253|516991451|FG006|Stage 1|Death|0|||
143394402|NCT02268253|516991445|FG000|Stage 2|Disease Recurrence/ Progression|0|||
143394403|NCT02268253|516991446|FG001|Stage 2|Disease Recurrence/ Progression|0|||
143394404|NCT02268253|516991447|FG002|Stage 2|Disease Recurrence/ Progression|1|||
143394405|NCT02268253|516991448|FG003|Stage 2|Disease Recurrence/ Progression|0|||
143394406|NCT02268253|516991449|FG004|Stage 2|Disease Recurrence/ Progression|0|||
143394407|NCT02268253|516991450|FG005|Stage 2|Disease Recurrence/ Progression|0|||
143394408|NCT02268253|516991451|FG006|Stage 2|Disease Recurrence/ Progression|0|||
143394409|NCT02268253|516991445|FG000|Stage 2|Withdrawal by Subject|0|||
143394410|NCT02268253|516991446|FG001|Stage 2|Withdrawal by Subject|0|||
143394411|NCT02268253|516991447|FG002|Stage 2|Withdrawal by Subject|2|||
143394412|NCT02268253|516991448|FG003|Stage 2|Withdrawal by Subject|0|||
143394413|NCT02268253|516991449|FG004|Stage 2|Withdrawal by Subject|0|||
143394414|NCT02268253|516991450|FG005|Stage 2|Withdrawal by Subject|2|||
143394415|NCT02268253|516991451|FG006|Stage 2|Withdrawal by Subject|0|||
143394416|NCT02268253|516991445|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
143394417|NCT02268253|516991446|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
143394418|NCT02268253|516991447|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
143394419|NCT02268253|516991448|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
143394420|NCT02268253|516991449|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
143394421|NCT02268253|516991450|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
143394422|NCT02268253|516991451|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
143394423|NCT02268253|516991445|FG000|Stage 2|Death|0|||
143394424|NCT02268253|516991446|FG001|Stage 2|Death|0|||
143394425|NCT02268253|516991447|FG002|Stage 2|Death|19|||
143394426|NCT02268253|516991448|FG003|Stage 2|Death|0|||
143394427|NCT02268253|516991449|FG004|Stage 2|Death|0|||
143394428|NCT02268253|516991450|FG005|Stage 2|Death|20|||
143394429|NCT02268253|516991451|FG006|Stage 2|Death|1|||
143394430|NCT02268253|516991445|FG000|Stage 2|Lost to Follow-up|0|||
143394431|NCT02268253|516991446|FG001|Stage 2|Lost to Follow-up|0|||
143394432|NCT02268253|516991447|FG002|Stage 2|Lost to Follow-up|0|||
143394433|NCT02268253|516991448|FG003|Stage 2|Lost to Follow-up|0|||
143394434|NCT02268253|516991449|FG004|Stage 2|Lost to Follow-up|0|||
143394435|NCT02268253|516991450|FG005|Stage 2|Lost to Follow-up|4|||
143394436|NCT02268253|516991451|FG006|Stage 2|Lost to Follow-up|0|||
143394437|NCT02268253|516991445|FG000|Stage 2|Transferred to Hospice|0|||
143394438|NCT02268253|516991446|FG001|Stage 2|Transferred to Hospice|0|||
143394439|NCT02268253|516991447|FG002|Stage 2|Transferred to Hospice|0|||
143394440|NCT02268253|516991448|FG003|Stage 2|Transferred to Hospice|0|||
143394441|NCT02268253|516991449|FG004|Stage 2|Transferred to Hospice|0|||
143394442|NCT02268253|516991450|FG005|Stage 2|Transferred to Hospice|2|||
143394443|NCT02268253|516991451|FG006|Stage 2|Transferred to Hospice|0|||
143394444|NCT02268253|516991445|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
143394445|NCT02268253|516991446|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
143394446|NCT02268253|516991447|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
143394447|NCT02268253|516991448|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
143394448|NCT02268253|516991449|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
143394449|NCT02268253|516991450|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
143394450|NCT02268253|516991451|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
143394451|NCT02268253|516991445|FG000|Stage 3A|Withdrawal by Subject|0|||
143394452|NCT02268253|516991446|FG001|Stage 3A|Withdrawal by Subject|0|||
143394453|NCT02268253|516991447|FG002|Stage 3A|Withdrawal by Subject|2|||
143394454|NCT02268253|516991448|FG003|Stage 3A|Withdrawal by Subject|0|||
143394455|NCT02268253|516991449|FG004|Stage 3A|Withdrawal by Subject|0|||
143394456|NCT02268253|516991450|FG005|Stage 3A|Withdrawal by Subject|0|||
143394457|NCT02268253|516991451|FG006|Stage 3A|Withdrawal by Subject|0|||
143394458|NCT02268253|516991445|FG000|Stage 3A|Physician Decision|0|||
143394459|NCT02268253|516991446|FG001|Stage 3A|Physician Decision|0|||
143394460|NCT02268253|516991447|FG002|Stage 3A|Physician Decision|2|||
143394461|NCT02268253|516991448|FG003|Stage 3A|Physician Decision|0|||
143394462|NCT02268253|516991449|FG004|Stage 3A|Physician Decision|0|||
143394463|NCT02268253|516991450|FG005|Stage 3A|Physician Decision|0|||
143394464|NCT02268253|516991451|FG006|Stage 3A|Physician Decision|0|||
143394465|NCT02268253|516991445|FG000|Stage 3A|Study Terminated by Sponsor|0|||
143394466|NCT02268253|516991446|FG001|Stage 3A|Study Terminated by Sponsor|0|||
143394467|NCT02268253|516991447|FG002|Stage 3A|Study Terminated by Sponsor|2|||
143394468|NCT02268253|516991448|FG003|Stage 3A|Study Terminated by Sponsor|0|||
143394469|NCT02268253|516991449|FG004|Stage 3A|Study Terminated by Sponsor|0|||
143394470|NCT02268253|516991450|FG005|Stage 3A|Study Terminated by Sponsor|0|||
143394471|NCT02268253|516991451|FG006|Stage 3A|Study Terminated by Sponsor|0|||
143394472|NCT02268253|516991445|FG000|Stage 3A|Lost to Follow-up|0|||
143394473|NCT02268253|516991446|FG001|Stage 3A|Lost to Follow-up|0|||
143394474|NCT02268253|516991447|FG002|Stage 3A|Lost to Follow-up|1|||
143394475|NCT02268253|516991448|FG003|Stage 3A|Lost to Follow-up|0|||
143394476|NCT02268253|516991449|FG004|Stage 3A|Lost to Follow-up|0|||
143394477|NCT02268253|516991450|FG005|Stage 3A|Lost to Follow-up|0|||
143394478|NCT02268253|516991451|FG006|Stage 3A|Lost to Follow-up|0|||
143394479|NCT02268253|516991445|FG000|Stage 3A|Death|0|||
143394480|NCT02268253|516991446|FG001|Stage 3A|Death|0|||
143394481|NCT02268253|516991447|FG002|Stage 3A|Death|5|||
143394482|NCT02268253|516991448|FG003|Stage 3A|Death|0|||
143394483|NCT02268253|516991449|FG004|Stage 3A|Death|0|||
143394484|NCT02268253|516991450|FG005|Stage 3A|Death|0|||
143394485|NCT02268253|516991451|FG006|Stage 3A|Death|0|||
143394486|NCT05714761|516991452|FG000|Overall Study|Lost to Follow-up|3|||
143394487|NCT05714761|516991452|FG000|Overall Study|Withdrawal by Subject|3|||
143394488|NCT05714761|516991452|FG000|Overall Study|unblinding of sensor data|1|||
143394489|NCT05714761|516991452|FG000|Overall Study|did not complete routine postpartum OGTT|9|||
143394490|NCT05714761|516991452|FG000|Overall Study|did not return second CGM sensor|4|||
143394491|NCT03092518|516991454|FG000|Overall Study|Ineligible|2|||
143394492|NCT02547987|516991455|FG000|Overall Study|Withdrawal by Subject|1|||
143394493|NCT02547987|516991455|FG000|Overall Study|Adverse Event|2|||
143394494|NCT05362487|516991456|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
143394495|NCT02146378|516991457|FG000|Overall Study|No information of administration|2|||
143394496|NCT04096040|516991467|FG000|Overall Study|Protocol Violation|12|||
143394497|NCT04096040|516991467|FG000|Overall Study|Non-compliant site|4|||
143394498|NCT03603600|516991470|FG000|Overall Study|Withdrawal by Subject|5|||
143394499|NCT03603600|516991471|FG001|Overall Study|Withdrawal by Subject|7|||
143394500|NCT03603600|516991470|FG000|Overall Study|Lost to Follow-up|2|||
143394501|NCT03603600|516991471|FG001|Overall Study|Lost to Follow-up|3|||
143394502|NCT03603600|516991470|FG000|Overall Study|Death|3|||
143394503|NCT03603600|516991471|FG001|Overall Study|Death|1|||
143394504|NCT03603600|516991470|FG000|Overall Study|Physician Decision|2|||
143394505|NCT03603600|516991471|FG001|Overall Study|Physician Decision|1|||
143394506|NCT03603600|516991470|FG000|Overall Study|Other reason|1|||
143394507|NCT03603600|516991471|FG001|Overall Study|Other reason|0|||
143394508|NCT04973254|516991472|FG000|Overall Study|Not adherent|0|||
143394509|NCT04973254|516991473|FG001|Overall Study|Not adherent|1|||
143394510|NCT04973254|516991474|FG002|Overall Study|Not adherent|0|||
143394511|NCT04044768|516991475|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
143394512|NCT04044768|516991476|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
143394513|NCT05089019|516991480|FG000|Period 1|Withdrawal by Subject|0|||
143394514|NCT05089019|516991481|FG001|Period 1|Withdrawal by Subject|1|||
143394515|NCT05089019|516991480|FG000|Washout Period|Adverse Event|3|||
143394516|NCT05089019|516991481|FG001|Washout Period|Adverse Event|4|||
143394517|NCT05089019|516991480|FG000|Washout Period|Lost to Follow-up|1|||
143394518|NCT05089019|516991481|FG001|Washout Period|Lost to Follow-up|0|||
143394519|NCT05089019|516991480|FG000|Washout Period|Physician Decision|2|||
143394520|NCT05089019|516991481|FG001|Washout Period|Physician Decision|0|||
143394521|NCT05089019|516991480|FG000|Washout Period|Withdrawal by Subject|6|||
143394522|NCT05089019|516991481|FG001|Washout Period|Withdrawal by Subject|3|||
143394523|NCT05089019|516991480|FG000|Period 2|Adverse Event|4|||
143394524|NCT05089019|516991481|FG001|Period 2|Adverse Event|2|||
143394525|NCT05089019|516991480|FG000|Period 2|Lost to Follow-up|1|||
143394526|NCT05089019|516991481|FG001|Period 2|Lost to Follow-up|0|||
143394527|NCT05089019|516991480|FG000|Period 2|Withdrawal by Subject|0|||
143394528|NCT05089019|516991481|FG001|Period 2|Withdrawal by Subject|1|||
143394529|NCT03808818|516991486|FG000|Overall Study|Death|6|||
143394530|NCT03808818|516991487|FG001|Overall Study|Death|6|||
143394531|NCT03808818|516991486|FG000|Overall Study|Withdrawal by Subject|7|||
143394532|NCT03808818|516991487|FG001|Overall Study|Withdrawal by Subject|18|||
143394533|NCT03808818|516991486|FG000|Overall Study|Lost to Follow-up|31|||
143394534|NCT03808818|516991487|FG001|Overall Study|Lost to Follow-up|33|||
143394535|NCT05415722|516991488|FG000|Overall Study|Lost to Follow-up|0|||
143394536|NCT05415722|516991489|FG001|Overall Study|Lost to Follow-up|2|||
143394537|NCT05415722|516991490|FG002|Overall Study|Lost to Follow-up|0|||
143394538|NCT05415722|516991491|FG003|Overall Study|Lost to Follow-up|1|||
143394539|NCT05415722|516991492|FG004|Overall Study|Lost to Follow-up|0|||
143394540|NCT05415722|516991493|FG005|Overall Study|Lost to Follow-up|0|||
143394541|NCT05415722|516991494|FG006|Overall Study|Lost to Follow-up|1|||
143394542|NCT05415722|516991488|FG000|Overall Study|Physician Decision|0|||
143394543|NCT05415722|516991489|FG001|Overall Study|Physician Decision|0|||
143394544|NCT05415722|516991490|FG002|Overall Study|Physician Decision|0|||
143394545|NCT05415722|516991491|FG003|Overall Study|Physician Decision|1|||
143394546|NCT05415722|516991492|FG004|Overall Study|Physician Decision|0|||
143394547|NCT05415722|516991493|FG005|Overall Study|Physician Decision|0|||
143394548|NCT05415722|516991494|FG006|Overall Study|Physician Decision|1|||
143394549|NCT05415722|516991488|FG000|Overall Study|Protocol Violation|0|||
143394550|NCT05415722|516991489|FG001|Overall Study|Protocol Violation|0|||
143394551|NCT05415722|516991490|FG002|Overall Study|Protocol Violation|0|||
143394552|NCT05415722|516991491|FG003|Overall Study|Protocol Violation|1|||
143394553|NCT05415722|516991492|FG004|Overall Study|Protocol Violation|0|||
143394554|NCT05415722|516991493|FG005|Overall Study|Protocol Violation|0|||
143394555|NCT05415722|516991494|FG006|Overall Study|Protocol Violation|0|||
143394556|NCT05415722|516991488|FG000|Overall Study|Sponsor Discretion|0|||
143394557|NCT05415722|516991489|FG001|Overall Study|Sponsor Discretion|0|||
143394558|NCT05415722|516991490|FG002|Overall Study|Sponsor Discretion|0|||
143394559|NCT05415722|516991491|FG003|Overall Study|Sponsor Discretion|0|||
143394560|NCT05415722|516991492|FG004|Overall Study|Sponsor Discretion|1|||
143394561|NCT05415722|516991493|FG005|Overall Study|Sponsor Discretion|1|||
143394562|NCT05415722|516991494|FG006|Overall Study|Sponsor Discretion|0|||
143394563|NCT05415722|516991488|FG000|Overall Study|Withdrawal by Subject|0|||
143394564|NCT05415722|516991489|FG001|Overall Study|Withdrawal by Subject|1|||
143394565|NCT05415722|516991490|FG002|Overall Study|Withdrawal by Subject|0|||
143394566|NCT05415722|516991491|FG003|Overall Study|Withdrawal by Subject|1|||
143394567|NCT05415722|516991492|FG004|Overall Study|Withdrawal by Subject|1|||
143394568|NCT05415722|516991493|FG005|Overall Study|Withdrawal by Subject|0|||
143394569|NCT05415722|516991494|FG006|Overall Study|Withdrawal by Subject|1|||
143394570|NCT04629716|516991500|FG000|Overall Study|Lost to Follow-up|7|||
143394571|NCT04629716|516991501|FG001|Overall Study|Lost to Follow-up|3|||
143394572|NCT04537715|516991502|FG000|Overall Study|Death|3|||
143394573|NCT04537715|516991503|FG001|Overall Study|Death|1|||
143394574|NCT04537715|516991502|FG000|Overall Study|Withdrawal by Subject|3|||
143394575|NCT04537715|516991503|FG001|Overall Study|Withdrawal by Subject|1|||
143394576|NCT04537715|516991502|FG000|Overall Study|Other|4|||
143394577|NCT04537715|516991503|FG001|Overall Study|Other|3|||
143394578|NCT04537715|516991502|FG000|Overall Study|Progressive disease|1|||
143394579|NCT04537715|516991503|FG001|Overall Study|Progressive disease|0|||
143394580|NCT03496168|516991505|FG000|Overall Study|Other Reasons|1|||
143394581|NCT03496168|516991505|FG000|Overall Study|Adverse Event|1|||
143394582|NCT05543629|516991510|FG000|Overall Study|Death|1|||
143394583|NCT05543629|516991511|FG001|Overall Study|Death|0|||
143394584|NCT05543629|516991512|FG002|Overall Study|Death|1|||
143394585|NCT05543629|516991513|FG003|Overall Study|Death|0|||
143394586|NCT05543629|516991514|FG004|Overall Study|Death|0|||
143394587|NCT05543629|516991515|FG005|Overall Study|Death|1|||
143394588|NCT05543629|516991516|FG006|Overall Study|Death|2|||
143394589|NCT05543629|516991517|FG007|Overall Study|Death|2|||
143394590|NCT05543629|516991510|FG000|Overall Study|Other Reasons|0|||
143394591|NCT05543629|516991511|FG001|Overall Study|Other Reasons|0|||
143394592|NCT05543629|516991512|FG002|Overall Study|Other Reasons|0|||
143394593|NCT05543629|516991513|FG003|Overall Study|Other Reasons|0|||
143394594|NCT05543629|516991514|FG004|Overall Study|Other Reasons|1|||
143394595|NCT05543629|516991515|FG005|Overall Study|Other Reasons|0|||
143394596|NCT05543629|516991516|FG006|Overall Study|Other Reasons|0|||
143394597|NCT05543629|516991517|FG007|Overall Study|Other Reasons|0|||
143394598|NCT05543629|516991510|FG000|Overall Study|Physician Decision|0|||
143394599|NCT05543629|516991511|FG001|Overall Study|Physician Decision|0|||
143394600|NCT05543629|516991512|FG002|Overall Study|Physician Decision|3|||
143394601|NCT05543629|516991513|FG003|Overall Study|Physician Decision|0|||
143394602|NCT05543629|516991514|FG004|Overall Study|Physician Decision|0|||
143394603|NCT05543629|516991515|FG005|Overall Study|Physician Decision|0|||
143394604|NCT05543629|516991516|FG006|Overall Study|Physician Decision|1|||
143394605|NCT05543629|516991517|FG007|Overall Study|Physician Decision|0|||
143394606|NCT05543629|516991510|FG000|Overall Study|Study terminated by Sponsor|1|||
143394607|NCT05543629|516991511|FG001|Overall Study|Study terminated by Sponsor|0|||
143394608|NCT05543629|516991512|FG002|Overall Study|Study terminated by Sponsor|0|||
143394609|NCT05543629|516991513|FG003|Overall Study|Study terminated by Sponsor|1|||
143394610|NCT05543629|516991514|FG004|Overall Study|Study terminated by Sponsor|0|||
143394611|NCT05543629|516991515|FG005|Overall Study|Study terminated by Sponsor|4|||
143394612|NCT05543629|516991516|FG006|Overall Study|Study terminated by Sponsor|1|||
143394613|NCT05543629|516991517|FG007|Overall Study|Study terminated by Sponsor|0|||
143394614|NCT05543629|516991510|FG000|Overall Study|Withdrawal by Subject|1|||
143394615|NCT05543629|516991511|FG001|Overall Study|Withdrawal by Subject|1|||
143394616|NCT05543629|516991512|FG002|Overall Study|Withdrawal by Subject|0|||
143394617|NCT05543629|516991513|FG003|Overall Study|Withdrawal by Subject|2|||
143394618|NCT05543629|516991514|FG004|Overall Study|Withdrawal by Subject|1|||
143394619|NCT05543629|516991515|FG005|Overall Study|Withdrawal by Subject|1|||
143394620|NCT05543629|516991516|FG006|Overall Study|Withdrawal by Subject|1|||
143394621|NCT05543629|516991517|FG007|Overall Study|Withdrawal by Subject|1|||
143394622|NCT05543629|516991510|FG000|Overall Study|Not Reported|2|||
143394623|NCT05543629|516991511|FG001|Overall Study|Not Reported|2|||
143394624|NCT05543629|516991512|FG002|Overall Study|Not Reported|0|||
143394625|NCT05543629|516991513|FG003|Overall Study|Not Reported|0|||
143394626|NCT05543629|516991514|FG004|Overall Study|Not Reported|1|||
143394627|NCT05543629|516991515|FG005|Overall Study|Not Reported|1|||
143394628|NCT05543629|516991516|FG006|Overall Study|Not Reported|3|||
143394629|NCT05543629|516991517|FG007|Overall Study|Not Reported|0|||
143394630|NCT04564742|516991518|FG000|Overall Study|Lost to Follow-up|1|||
143394631|NCT04564742|516991519|FG001|Overall Study|Lost to Follow-up|0|||
143394632|NCT04564742|516991518|FG000|Overall Study|Consent Withdrawal|4|||
143394633|NCT04564742|516991519|FG001|Overall Study|Consent Withdrawal|4|||
143394634|NCT03313076|516991523|FG000|Overall Study|Withdrawal by Subject|2|||
143394635|NCT03313076|516991524|FG001|Overall Study|Withdrawal by Subject|0|||
143394636|NCT03313076|516991525|FG002|Overall Study|Withdrawal by Subject|0|||
143394637|NCT03313076|516991526|FG003|Overall Study|Withdrawal by Subject|0|||
143394638|NCT03313076|516991523|FG000|Overall Study|Lost to Follow-up|0|||
143394639|NCT03313076|516991524|FG001|Overall Study|Lost to Follow-up|2|||
143394640|NCT03313076|516991525|FG002|Overall Study|Lost to Follow-up|2|||
143394641|NCT03313076|516991526|FG003|Overall Study|Lost to Follow-up|2|||
143394642|NCT05869383|516991527|FG000|Overall Study|Withdrawal by Subject|2|||
143394643|NCT05869383|516991528|FG001|Overall Study|Withdrawal by Subject|0|||
143394644|NCT05126433|516991535|FG000|Overall Study|Withdrawal by Subject|3|||
143394645|NCT05126433|516991536|FG001|Overall Study|Withdrawal by Subject|0|||
143394646|NCT05126433|516991537|FG002|Overall Study|Withdrawal by Subject|4|||
143394647|NCT05126433|516991535|FG000|Overall Study|Death|9|||
143394648|NCT05126433|516991536|FG001|Overall Study|Death|3|||
143394649|NCT05126433|516991537|FG002|Overall Study|Death|5|||
143394650|NCT05126433|516991535|FG000|Overall Study|Study Terminated by sponsor|0|||
143394651|NCT05126433|516991536|FG001|Overall Study|Study Terminated by sponsor|1|||
143394652|NCT05126433|516991537|FG002|Overall Study|Study Terminated by sponsor|2|||
143394653|NCT05126433|516991535|FG000|Overall Study|Progressive Disease|1|||
143394654|NCT05126433|516991536|FG001|Overall Study|Progressive Disease|4|||
143394655|NCT05126433|516991537|FG002|Overall Study|Progressive Disease|3|||
143394656|NCT05126433|516991535|FG000|Overall Study|Sponsor decision- no further OS follow up required|2|||
143394657|NCT05126433|516991536|FG001|Overall Study|Sponsor decision- no further OS follow up required|4|||
143394658|NCT05126433|516991537|FG002|Overall Study|Sponsor decision- no further OS follow up required|6|||
143394659|NCT04137367|516991538|FG000|Overall Study|Lost to Follow-up|8|||
143394660|NCT04137367|516991539|FG001|Overall Study|Lost to Follow-up|6|||
143394661|NCT04137367|516991540|FG002|Overall Study|Lost to Follow-up|4|||
143394662|NCT03270501|516991541|FG000|Overall Study|Screen failure|6|||
143394663|NCT03270501|516991541|FG000|Overall Study|Lost to Follow-up|2|||
143394664|NCT03270501|516991541|FG000|Overall Study|Adverse Event|1|||
143394665|NCT04065841|516991542|FG000|Overall Study|Adverse Event|4|||
143394666|NCT04065841|516991543|FG001|Overall Study|Adverse Event|2|||
143394667|NCT04065841|516991544|FG002|Overall Study|Adverse Event|10|||
143394668|NCT04065841|516991545|FG003|Overall Study|Adverse Event|1|||
143394669|NCT04065841|516991542|FG000|Overall Study|Lost to Follow-up|1|||
143394670|NCT04065841|516991543|FG001|Overall Study|Lost to Follow-up|2|||
143394671|NCT04065841|516991544|FG002|Overall Study|Lost to Follow-up|2|||
143394672|NCT04065841|516991545|FG003|Overall Study|Lost to Follow-up|2|||
143394673|NCT04065841|516991542|FG000|Overall Study|Physician Decision|1|||
143394674|NCT04065841|516991543|FG001|Overall Study|Physician Decision|0|||
143394675|NCT04065841|516991544|FG002|Overall Study|Physician Decision|0|||
143394676|NCT04065841|516991545|FG003|Overall Study|Physician Decision|0|||
143394677|NCT04065841|516991542|FG000|Overall Study|Protocol Violation|0|||
143394678|NCT04065841|516991543|FG001|Overall Study|Protocol Violation|1|||
143394679|NCT04065841|516991544|FG002|Overall Study|Protocol Violation|0|||
143394680|NCT04065841|516991545|FG003|Overall Study|Protocol Violation|0|||
143394681|NCT04065841|516991542|FG000|Overall Study|Study terminated by Sponsor|22|||
143394682|NCT04065841|516991543|FG001|Overall Study|Study terminated by Sponsor|16|||
143394683|NCT04065841|516991544|FG002|Overall Study|Study terminated by Sponsor|28|||
143394684|NCT04065841|516991545|FG003|Overall Study|Study terminated by Sponsor|17|||
143394685|NCT04065841|516991542|FG000|Overall Study|Withdrawal by Subject|1|||
143394686|NCT04065841|516991543|FG001|Overall Study|Withdrawal by Subject|1|||
143394687|NCT04065841|516991544|FG002|Overall Study|Withdrawal by Subject|2|||
143394688|NCT04065841|516991545|FG003|Overall Study|Withdrawal by Subject|0|||
143394689|NCT02998268|516991549|FG000|Overall Study|Adverse Event|0|||
143394690|NCT02998268|516991550|FG001|Overall Study|Adverse Event|2|||
143394691|NCT02998268|516991549|FG000|Overall Study|Withdrawal by Subject|0|||
143394692|NCT02998268|516991550|FG001|Overall Study|Withdrawal by Subject|1|||
143394693|NCT04225273|516991552|FG000|Overall Study|Lost to Follow-up|3|||
143394694|NCT05269667|516991553|FG000|Overall Study|Study Terminated by Sponsor|4|||
143394695|NCT05270408|516991555|FG000|Started Treatment|Withdrawal by Subject|0|||
143394696|NCT05270408|516991556|FG001|Started Treatment|Withdrawal by Subject|0|||
143394697|NCT05270408|516991557|FG002|Started Treatment|Withdrawal by Subject|3|||
143394698|NCT05270408|516991555|FG000|Started Treatment|Adverse Event|0|||
143394699|NCT05270408|516991556|FG001|Started Treatment|Adverse Event|0|||
143394700|NCT05270408|516991557|FG002|Started Treatment|Adverse Event|1|||
143394701|NCT05270408|516991555|FG000|Follow-Up at 2 Months|Lost to Follow-up|1|||
143394702|NCT05270408|516991556|FG001|Follow-Up at 2 Months|Lost to Follow-up|0|||
143394703|NCT05270408|516991557|FG002|Follow-Up at 2 Months|Lost to Follow-up|0|||
143394704|NCT03768505|516991558|FG000|Overall Study|sponsor decision|76|||
143394705|NCT03768505|516991558|FG000|Overall Study|Death|35|||
143394706|NCT03768505|516991558|FG000|Overall Study|Other -Various|30|||
143394707|NCT03768505|516991558|FG000|Overall Study|Withdrawal by Subject|22|||
143394708|NCT03768505|516991558|FG000|Overall Study|Lost to Follow-up|6|||
143394709|NCT03084536|516991563|FG000|Overall Study|Determined to be ineligible|0|||
143394710|NCT03084536|516991564|FG001|Overall Study|Determined to be ineligible|0|||
143394711|NCT03084536|516991565|FG002|Overall Study|Determined to be ineligible|16|||
143394712|NCT03084536|516991563|FG000|Overall Study|Withdrawal by Subject|0|||
143394713|NCT03084536|516991564|FG001|Overall Study|Withdrawal by Subject|0|||
143394714|NCT03084536|516991565|FG002|Overall Study|Withdrawal by Subject|4|||
143394715|NCT03084536|516991563|FG000|Overall Study|Physician Decision|0|||
143394716|NCT03084536|516991564|FG001|Overall Study|Physician Decision|0|||
143339429|NCT02093663|516788214|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
143339430|NCT02093663|516788215|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
143339431|NCT00508404|516788216|FG000|Overall Study|Ongoing at Data Cut-off|12|||
143339432|NCT00508404|516788216|FG000|Overall Study|Adverse Event|2|||
143339433|NCT00508404|516788216|FG000|Overall Study|Death|16|||
143339434|NCT00508404|516788216|FG000|Overall Study|Physician Decision|2|||
143339435|NCT00508404|516788216|FG000|Overall Study|Withdrawal by Subject|3|||
143339436|NCT00508404|516788216|FG000|Overall Study|Protocol-specified Criteria|2|||
143339437|NCT00508404|516788216|FG000|Overall Study|Lost to Follow-up|2|||
143339438|NCT00508404|516788216|FG000|Overall Study|Other - Not Specified|3|||
143339439|NCT01424930|516788217|FG000|Overall Study|Adverse Event|0|||
143339440|NCT01424930|516788218|FG001|Overall Study|Adverse Event|1|||
143339441|NCT01424930|516788217|FG000|Overall Study|Death|1|||
143339442|NCT01424930|516788218|FG001|Overall Study|Death|0|||
143339443|NCT01424930|516788217|FG000|Overall Study|Progressive Disease|3|||
143339444|NCT01424930|516788218|FG001|Overall Study|Progressive Disease|6|||
143339445|NCT01424930|516788217|FG000|Overall Study|Screen Failure|0|||
143339446|NCT01424930|516788218|FG001|Overall Study|Screen Failure|1|||
143339447|NCT01424930|516788217|FG000|Overall Study|Reason not specified|0|||
143339448|NCT01424930|516788218|FG001|Overall Study|Reason not specified|6|||
143339449|NCT01078155|516788223|FG000|Overall Study|Adverse Event|7|||
143339450|NCT01078155|516788223|FG000|Overall Study|Lack of Efficacy|16|||
143339451|NCT01078155|516788223|FG000|Overall Study|Participant's Decision|6|||
143339452|NCT01078155|516788223|FG000|Overall Study|Lost to Follow-up|15|||
143339453|NCT03286751|516788224|FG000|Washout Period 1|Withdrawal by Subject|0|||
143339454|NCT03286751|516788225|FG001|Washout Period 1|Withdrawal by Subject|0|||
143339455|NCT03286751|516788226|FG002|Washout Period 1|Withdrawal by Subject|0|||
143339456|NCT03286751|516788227|FG003|Washout Period 1|Withdrawal by Subject|0|||
143339457|NCT03286751|516788228|FG004|Washout Period 1|Withdrawal by Subject|1|||
143339458|NCT03286751|516788229|FG005|Washout Period 1|Withdrawal by Subject|0|||
143339459|NCT03286751|516788224|FG000|Washout Period 2|Personal Reasons|0|||
143339460|NCT03286751|516788225|FG001|Washout Period 2|Personal Reasons|1|||
143339461|NCT03286751|516788226|FG002|Washout Period 2|Personal Reasons|0|||
143339462|NCT03286751|516788227|FG003|Washout Period 2|Personal Reasons|0|||
143339463|NCT03286751|516788228|FG004|Washout Period 2|Personal Reasons|0|||
143339464|NCT03286751|516788229|FG005|Washout Period 2|Personal Reasons|0|||
143339465|NCT03286751|516788224|FG000|Washout Period 5|Adverse Event|0|||
143339466|NCT03286751|516788225|FG001|Washout Period 5|Adverse Event|0|||
143339467|NCT03286751|516788226|FG002|Washout Period 5|Adverse Event|0|||
143339468|NCT03286751|516788227|FG003|Washout Period 5|Adverse Event|0|||
143339469|NCT03286751|516788228|FG004|Washout Period 5|Adverse Event|1|||
143339470|NCT03286751|516788229|FG005|Washout Period 5|Adverse Event|0|||
143339471|NCT01059643|516788230|FG000|Overall Study|Adverse Event|3|||
143339472|NCT01059643|516788230|FG000|Overall Study|Withdrawal by Subject|2|||
143339473|NCT01059643|516788230|FG000|Overall Study|Physician Decision|1|||
143339474|NCT01621880|516788231|FG000|Overall Study|Adverse Event|5|||
143339475|NCT01621880|516788232|FG001|Overall Study|Adverse Event|1|||
143339476|NCT01621880|516788231|FG000|Overall Study|Withdrawal by Subject|5|||
143339477|NCT01621880|516788232|FG001|Overall Study|Withdrawal by Subject|4|||
143339478|NCT00643123|516788242|FG000|Overall Study|Lost to Follow-up|4|||
143339479|NCT00643123|516788243|FG001|Overall Study|Lost to Follow-up|0|||
143339480|NCT00643123|516788242|FG000|Overall Study|Withdrawal by Subject|1|||
143339481|NCT00643123|516788243|FG001|Overall Study|Withdrawal by Subject|1|||
143339482|NCT02309112|516788244|FG000|Overall Study|Withdrawal by Subject|1|||
143339483|NCT02309112|516788245|FG001|Overall Study|Withdrawal by Subject|0|||
143339484|NCT02309112|516788246|FG002|Overall Study|Withdrawal by Subject|1|||
143339485|NCT02309112|516788244|FG000|Overall Study|Lost to Follow-up|0|||
143339486|NCT02309112|516788245|FG001|Overall Study|Lost to Follow-up|1|||
143339487|NCT02309112|516788246|FG002|Overall Study|Lost to Follow-up|0|||
143339488|NCT01972529|516788247|FG000|Overall Study|Adverse Event|0|||
143339489|NCT01972529|516788248|FG001|Overall Study|Adverse Event|1|||
143339490|NCT01972529|516788249|FG002|Overall Study|Adverse Event|0|||
143339491|NCT01972529|516788250|FG003|Overall Study|Adverse Event|0|||
143339492|NCT01972529|516788247|FG000|Overall Study|Lost to Follow-up|1|||
143339493|NCT01972529|516788248|FG001|Overall Study|Lost to Follow-up|0|||
143339494|NCT01972529|516788249|FG002|Overall Study|Lost to Follow-up|0|||
143339495|NCT01972529|516788250|FG003|Overall Study|Lost to Follow-up|0|||
143339496|NCT01972529|516788247|FG000|Overall Study|Participant Choice|0|||
143339497|NCT01972529|516788248|FG001|Overall Study|Participant Choice|1|||
143339498|NCT01972529|516788249|FG002|Overall Study|Participant Choice|0|||
143339499|NCT01972529|516788250|FG003|Overall Study|Participant Choice|0|||
143339500|NCT01972529|516788247|FG000|Overall Study|Withdrawl of Consent|1|||
143339501|NCT01972529|516788248|FG001|Overall Study|Withdrawl of Consent|2|||
143339502|NCT01972529|516788249|FG002|Overall Study|Withdrawl of Consent|0|||
143339503|NCT01972529|516788250|FG003|Overall Study|Withdrawl of Consent|1|||
143339504|NCT01972529|516788247|FG000|Overall Study|Other|0|||
143339505|NCT01972529|516788248|FG001|Overall Study|Other|0|||
143339506|NCT01972529|516788249|FG002|Overall Study|Other|0|||
143339507|NCT01972529|516788250|FG003|Overall Study|Other|2|||
143339508|NCT01972529|516788247|FG000|Overall Study|Not treated|0|||
143339509|NCT01972529|516788248|FG001|Overall Study|Not treated|1|||
143339510|NCT01972529|516788249|FG002|Overall Study|Not treated|2|||
143339511|NCT01972529|516788250|FG003|Overall Study|Not treated|1|||
143339512|NCT01780935|516788254|FG000|Overall Study|Admin problems due to early termination|321|||
143339513|NCT01780935|516788255|FG001|Overall Study|Admin problems due to early termination|309|||
143339514|NCT01780935|516788254|FG000|Overall Study|Adverse Event|2|||
143339515|NCT01780935|516788255|FG001|Overall Study|Adverse Event|4|||
143339516|NCT01780935|516788254|FG000|Overall Study|Death|1|||
143339517|NCT01780935|516788255|FG001|Overall Study|Death|6|||
143339518|NCT01780935|516788254|FG000|Overall Study|Lost to Follow-up|2|||
143339519|NCT01780935|516788255|FG001|Overall Study|Lost to Follow-up|6|||
143339520|NCT01780935|516788254|FG000|Overall Study|Physician Decision|1|||
143339521|NCT01780935|516788255|FG001|Overall Study|Physician Decision|1|||
143339522|NCT01780935|516788254|FG000|Overall Study|Protocol deviation|0|||
143339523|NCT01780935|516788255|FG001|Overall Study|Protocol deviation|1|||
143339524|NCT01780935|516788254|FG000|Overall Study|Patient withdrew consent|8|||
143339525|NCT01780935|516788255|FG001|Overall Study|Patient withdrew consent|9|||
143339526|NCT02831257|516788256|FG000|Overall Study|Lack of Efficacy|3|||
143339527|NCT02831257|516788256|FG000|Overall Study|Adverse Event|2|||
143339528|NCT02831257|516788256|FG000|Overall Study|Physician Decision|1|||
143339529|NCT02831257|516788256|FG000|Overall Study|Withdrawal by Subject|6|||
143339530|NCT00855595|516788257|FG000|Overall Study|Withdrawal by Subject|1|||
143339531|NCT00855595|516788258|FG001|Overall Study|Withdrawal by Subject|2|||
143339532|NCT00855595|516788257|FG000|Overall Study|Lost to Follow-up|3|||
143339533|NCT00855595|516788258|FG001|Overall Study|Lost to Follow-up|3|||
143339534|NCT00855595|516788257|FG000|Overall Study|Adverse Event|1|||
143339535|NCT00855595|516788258|FG001|Overall Study|Adverse Event|1|||
143339536|NCT00855595|516788257|FG000|Overall Study|patient moved out of state|1|||
143339537|NCT00855595|516788258|FG001|Overall Study|patient moved out of state|0|||
143339538|NCT00855595|516788257|FG000|Overall Study|patient left country|0|||
143339539|NCT00855595|516788258|FG001|Overall Study|patient left country|1|||
143339540|NCT01844284|516788259|FG000|Overall Study|Lost to Follow-up|12|||
143339541|NCT01844284|516788260|FG001|Overall Study|Lost to Follow-up|7|||
143339542|NCT00611858|516788261|FG000|Overall Study|Adverse Event|2|||
143339543|NCT00611858|516788261|FG000|Overall Study|Withdrawal by Subject|2|||
143339544|NCT01058304|516788263|FG000|Overall Study|Withdrawal by Subject|8|||
143339545|NCT01058304|516788264|FG001|Overall Study|Withdrawal by Subject|5|||
143339546|NCT01058304|516788263|FG000|Overall Study|Lost to Follow-up|13|||
143339547|NCT01058304|516788264|FG001|Overall Study|Lost to Follow-up|16|||
143339548|NCT01058304|516788263|FG000|Overall Study|Developed exclusion criterion|6|||
143339549|NCT01058304|516788264|FG001|Overall Study|Developed exclusion criterion|12|||
143339550|NCT02755597|516788265|FG000|Overall Study|Withdrew consent|27|||
143339551|NCT02755597|516788266|FG001|Overall Study|Withdrew consent|11|||
143339552|NCT02755597|516788265|FG000|Overall Study|Lost to Follow-up|1|||
143339553|NCT02755597|516788266|FG001|Overall Study|Lost to Follow-up|0|||
143339554|NCT02755597|516788265|FG000|Overall Study|Death|78|||
143339555|NCT02755597|516788266|FG001|Overall Study|Death|36|||
143339556|NCT02755597|516788265|FG000|Overall Study|Study terminated by Sponsor|67|||
143339557|NCT02755597|516788266|FG001|Overall Study|Study terminated by Sponsor|47|||
143339558|NCT02755597|516788265|FG000|Overall Study|Other, not specified|20|||
143339559|NCT02755597|516788266|FG001|Overall Study|Other, not specified|3|||
143339560|NCT02755597|516788265|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
143339561|NCT02755597|516788266|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
143339562|NCT02496767|516788268|FG000|Open-label Lead-in Phase|Adverse Event|176|||
143339563|NCT02496767|516788269|FG001|Open-label Lead-in Phase|Adverse Event|0|||
143339564|NCT02496767|516788270|FG002|Open-label Lead-in Phase|Adverse Event|0|||
143339565|NCT02496767|516788271|FG003|Open-label Lead-in Phase|Adverse Event|0|||
143339566|NCT02496767|516788272|FG004|Open-label Lead-in Phase|Adverse Event|0|||
143339567|NCT02496767|516788273|FG005|Open-label Lead-in Phase|Adverse Event|0|||
143339568|NCT02496767|516788274|FG006|Open-label Lead-in Phase|Adverse Event|0|||
143339569|NCT02496767|516788275|FG007|Open-label Lead-in Phase|Adverse Event|0|||
143339570|NCT02496767|516788268|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
143339571|NCT02496767|516788269|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
143339572|NCT02496767|516788270|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
143339573|NCT02496767|516788271|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
143339574|NCT02496767|516788272|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
143339575|NCT02496767|516788273|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
143339576|NCT02496767|516788274|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
143339577|NCT02496767|516788275|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
143339578|NCT02496767|516788268|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
143339579|NCT02496767|516788269|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
143339580|NCT02496767|516788270|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
143339581|NCT02496767|516788271|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
143394717|NCT03084536|516991565|FG002|Overall Study|Physician Decision|3|||
143339582|NCT02496767|516788272|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
143339583|NCT02496767|516788273|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
143339584|NCT02496767|516788274|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
143339585|NCT02496767|516788275|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
143339586|NCT02496767|516788268|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
143339587|NCT02496767|516788269|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
143339588|NCT02496767|516788270|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
143339589|NCT02496767|516788271|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
143339590|NCT02496767|516788272|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
143339591|NCT02496767|516788273|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
143339592|NCT02496767|516788274|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
143339593|NCT02496767|516788275|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
143339594|NCT02496767|516788268|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
143339595|NCT02496767|516788269|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
143339596|NCT02496767|516788270|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
143339597|NCT02496767|516788271|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
143339598|NCT02496767|516788272|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
143339599|NCT02496767|516788273|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
143339600|NCT02496767|516788274|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
143339601|NCT02496767|516788275|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
143339602|NCT02496767|516788268|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
143339603|NCT02496767|516788269|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
143339604|NCT02496767|516788270|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
143339605|NCT02496767|516788271|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
143339606|NCT02496767|516788272|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
143339607|NCT02496767|516788273|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
143339608|NCT02496767|516788274|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
143339609|NCT02496767|516788275|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
143339610|NCT02496767|516788268|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
143339611|NCT02496767|516788269|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
143339612|NCT02496767|516788270|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
143339613|NCT02496767|516788271|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
143339614|NCT02496767|516788272|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
143339615|NCT02496767|516788273|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
143339616|NCT02496767|516788274|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
143339617|NCT02496767|516788275|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
143339618|NCT02496767|516788268|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
143339619|NCT02496767|516788269|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
143339620|NCT02496767|516788270|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
143339621|NCT02496767|516788271|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
143339622|NCT02496767|516788272|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
143339623|NCT02496767|516788273|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
143339624|NCT02496767|516788274|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
143339625|NCT02496767|516788275|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
143339626|NCT02496767|516788268|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
143339627|NCT02496767|516788269|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
143339628|NCT02496767|516788270|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
143339629|NCT02496767|516788271|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
143339630|NCT02496767|516788272|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
143339631|NCT02496767|516788273|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
143339632|NCT02496767|516788274|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
143339633|NCT02496767|516788275|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
143339634|NCT02496767|516788268|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
143339635|NCT02496767|516788269|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
143339636|NCT02496767|516788270|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
143339637|NCT02496767|516788271|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
143339638|NCT02496767|516788272|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
143339639|NCT02496767|516788273|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
143339640|NCT02496767|516788274|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
143339641|NCT02496767|516788275|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
143339642|NCT02496767|516788268|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
143339643|NCT02496767|516788269|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
143339644|NCT02496767|516788270|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
143339645|NCT02496767|516788271|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
143339646|NCT02496767|516788272|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
143339647|NCT02496767|516788273|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
143339648|NCT02496767|516788274|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
143339649|NCT02496767|516788275|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
143339650|NCT02496767|516788268|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
143339651|NCT02496767|516788269|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
143339652|NCT02496767|516788270|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
143339653|NCT02496767|516788271|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
143339654|NCT02496767|516788272|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
143339655|NCT02496767|516788273|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
143339656|NCT02496767|516788274|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
143339657|NCT02496767|516788275|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
143339658|NCT02496767|516788268|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
143339659|NCT02496767|516788269|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
143339660|NCT02496767|516788270|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
143339661|NCT02496767|516788271|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
143339662|NCT02496767|516788272|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
143339663|NCT02496767|516788273|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
143339664|NCT02496767|516788274|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
143339665|NCT02496767|516788275|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
143339666|NCT02496767|516788268|FG000|Double-blind, Withdrawal Phase|Death|0|||
143339667|NCT02496767|516788269|FG001|Double-blind, Withdrawal Phase|Death|0|||
143339668|NCT02496767|516788270|FG002|Double-blind, Withdrawal Phase|Death|0|||
143339669|NCT02496767|516788271|FG003|Double-blind, Withdrawal Phase|Death|0|||
143339670|NCT02496767|516788272|FG004|Double-blind, Withdrawal Phase|Death|0|||
143339671|NCT02496767|516788273|FG005|Double-blind, Withdrawal Phase|Death|0|||
143339672|NCT02496767|516788274|FG006|Double-blind, Withdrawal Phase|Death|1|||
143339673|NCT02496767|516788275|FG007|Double-blind, Withdrawal Phase|Death|2|||
143339674|NCT02496767|516788268|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
143339675|NCT02496767|516788269|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
143339676|NCT02496767|516788270|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
143339677|NCT02496767|516788271|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
143339678|NCT02496767|516788272|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
143339679|NCT02496767|516788273|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
143339680|NCT02496767|516788274|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
143339681|NCT02496767|516788275|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
143339682|NCT00166296|516788276|FG000|Overall Study|Withdrawal by Subject|1|||
143339683|NCT00166296|516788277|FG001|Overall Study|Withdrawal by Subject|3|||
143339684|NCT00166296|516788276|FG000|Overall Study|Adverse Event|2|||
143339685|NCT00166296|516788277|FG001|Overall Study|Adverse Event|4|||
143339686|NCT00166296|516788276|FG000|Overall Study|Lost to Follow-up|4|||
143339687|NCT00166296|516788277|FG001|Overall Study|Lost to Follow-up|2|||
143339688|NCT02889133|516788278|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
143339689|NCT02889133|516788279|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
143339690|NCT02889133|516788278|FG000|Completed Primary Outcome|Manufacturing error|3|||
143339691|NCT02889133|516788279|FG001|Completed Primary Outcome|Manufacturing error|8|||
143339692|NCT02889133|516788278|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
143339693|NCT02889133|516788279|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
143339694|NCT02889133|516788278|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
143339695|NCT02889133|516788279|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
143339696|NCT02889133|516788278|FG000|Completed Primary Outcome|Protocol Violation|1|||
143339697|NCT02889133|516788279|FG001|Completed Primary Outcome|Protocol Violation|0|||
143339698|NCT02889133|516788278|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
143339699|NCT02889133|516788279|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
143339700|NCT02889133|516788278|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
143339701|NCT02889133|516788279|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
143339702|NCT02889133|516788278|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
143339703|NCT02889133|516788279|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
143339704|NCT02889133|516788278|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
143339705|NCT02889133|516788279|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
143339706|NCT02889133|516788278|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
143339707|NCT02889133|516788279|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
143339708|NCT04035200|516788285|FG000|Overall Study|Lost to Follow-up|0|||
143339709|NCT04035200|516788286|FG001|Overall Study|Lost to Follow-up|1|||
143339710|NCT04035200|516788287|FG002|Overall Study|Lost to Follow-up|0|||
143339711|NCT04035200|516788285|FG000|Overall Study|Withdrawal by Subject|1|||
143339712|NCT04035200|516788286|FG001|Overall Study|Withdrawal by Subject|4|||
143339713|NCT04035200|516788287|FG002|Overall Study|Withdrawal by Subject|4|||
143339714|NCT04035200|516788285|FG000|Overall Study|COVID-19|1|||
143339715|NCT04035200|516788286|FG001|Overall Study|COVID-19|0|||
143339716|NCT04035200|516788287|FG002|Overall Study|COVID-19|0|||
143339717|NCT04035200|516788285|FG000|Overall Study|Early Termination|0|||
143339718|NCT04035200|516788286|FG001|Overall Study|Early Termination|1|||
143339719|NCT04035200|516788287|FG002|Overall Study|Early Termination|0|||
143339720|NCT04035200|516788285|FG000|Overall Study|Non-compliance|0|||
143339721|NCT04035200|516788286|FG001|Overall Study|Non-compliance|1|||
143339722|NCT04035200|516788287|FG002|Overall Study|Non-compliance|0|||
143339723|NCT02277990|516788288|FG000|Overall Study|Death|170|||
143339724|NCT02277990|516788289|FG001|Overall Study|Death|188|||
143339725|NCT02277990|516788288|FG000|Overall Study|Withdrawal by Subject|64|||
143339726|NCT02277990|516788289|FG001|Overall Study|Withdrawal by Subject|53|||
143339727|NCT02277990|516788288|FG000|Overall Study|Physician Decision|40|||
143339728|NCT02277990|516788289|FG001|Overall Study|Physician Decision|34|||
143339729|NCT02277990|516788288|FG000|Overall Study|Lost to Follow-up|66|||
143339730|NCT02277990|516788289|FG001|Overall Study|Lost to Follow-up|69|||
143339731|NCT02277990|516788288|FG000|Overall Study|Had other reason|26|||
143339732|NCT02277990|516788289|FG001|Overall Study|Had other reason|32|||
143339733|NCT03351738|516788290|FG000|Overall Study|Withdrawal by Subject|0|||
143339734|NCT03351738|516788291|FG001|Overall Study|Withdrawal by Subject|1|||
143339735|NCT03351738|516788292|FG002|Overall Study|Withdrawal by Subject|0|||
143339736|NCT03351738|516788293|FG003|Overall Study|Withdrawal by Subject|1|||
143339737|NCT03351738|516788294|FG004|Overall Study|Withdrawal by Subject|0|||
143339738|NCT03351738|516788295|FG005|Overall Study|Withdrawal by Subject|0|||
143339739|NCT05479604|516788300|FG000|Overall Study|Lost to Follow-up|1|||
143339740|NCT05479604|516788301|FG001|Overall Study|Lost to Follow-up|5|||
143339741|NCT03138733|516788302|FG000|Overall Study|Death|17|||
143339742|NCT03138733|516788303|FG001|Overall Study|Death|18|||
143339743|NCT03138733|516788302|FG000|Overall Study|Withdrawal by Subject|11|||
143339744|NCT03138733|516788303|FG001|Overall Study|Withdrawal by Subject|6|||
143339745|NCT03138733|516788302|FG000|Overall Study|Lost to Follow-up|3|||
143339746|NCT03138733|516788303|FG001|Overall Study|Lost to Follow-up|2|||
143339747|NCT03138733|516788302|FG000|Overall Study|Adverse Event|1|||
143339748|NCT03138733|516788303|FG001|Overall Study|Adverse Event|0|||
143339749|NCT03138733|516788302|FG000|Overall Study|Protocol Violation|1|||
143339750|NCT03138733|516788303|FG001|Overall Study|Protocol Violation|3|||
143339751|NCT03138733|516788302|FG000|Overall Study|Administrative or logistical reason|1|||
143339752|NCT03138733|516788303|FG001|Overall Study|Administrative or logistical reason|0|||
143339753|NCT03138733|516788302|FG000|Overall Study|The patient was transferred to another hospital|1|||
143339754|NCT03138733|516788303|FG001|Overall Study|The patient was transferred to another hospital|0|||
143339755|NCT02521285|516788312|FG000|Overall Study|Lost to Follow-up|1|||
143339756|NCT02521285|516788313|FG001|Overall Study|Lost to Follow-up|1|||
143339757|NCT02521285|516788312|FG000|Overall Study|Withdrawal by Subject|1|||
143339758|NCT02521285|516788313|FG001|Overall Study|Withdrawal by Subject|1|||
143339759|NCT02521285|516788312|FG000|Overall Study|Adverse Event|0|||
143339760|NCT02521285|516788313|FG001|Overall Study|Adverse Event|1|||
143339761|NCT02753595|516788315|FG000|Overall Study|Sponsor termination|2|||
143339762|NCT02753595|516788316|FG001|Overall Study|Sponsor termination|2|||
143339763|NCT01800968|516788319|FG000|Overall Study|Death|23|||
143339764|NCT01800968|516788320|FG001|Overall Study|Death|16|||
143339765|NCT01800968|516788319|FG000|Overall Study|Lost to Follow-up|5|||
143339766|NCT01800968|516788320|FG001|Overall Study|Lost to Follow-up|7|||
143339767|NCT01800968|516788319|FG000|Overall Study|Withdrawal by Subject|7|||
143339768|NCT01800968|516788320|FG001|Overall Study|Withdrawal by Subject|9|||
143339769|NCT01800968|516788319|FG000|Overall Study|Physician Decision|1|||
143339770|NCT01800968|516788320|FG001|Overall Study|Physician Decision|0|||
143339771|NCT03185481|516788322|FG000|Overall Study|Adverse Event|1|||
143339772|NCT03185481|516788322|FG000|Overall Study|Study Terminated by Sponsor|4|||
143339773|NCT00701038|516788325|FG000|Overall Study|study amended pilot group of patients|4|||
143339774|NCT00701038|516788326|FG001|Overall Study|study amended pilot group of patients|4|||
143339775|NCT03371940|516788327|FG000|Overall Study|Withdrawal by Subject|8|||
143339776|NCT03371940|516788328|FG001|Overall Study|Withdrawal by Subject|1|||
143339777|NCT03371940|516788329|FG002|Overall Study|Withdrawal by Subject|3|||
143339778|NCT03371940|516788330|FG003|Overall Study|Withdrawal by Subject|4|||
143339779|NCT05099926|516788336|FG000|Overall Study|Lost to Follow-up|1|||
143339780|NCT00689026|516788339|FG000|Overall Study|Withdrawal by Subject|13|||
143339781|NCT00689026|516788340|FG001|Overall Study|Withdrawal by Subject|6|||
143339782|NCT03988166|516788341|FG000|Overall Study|Lost to Follow-up|2|||
143339783|NCT03988166|516788341|FG000|Overall Study|Death|1|||
143339784|NCT00717860|516788342|FG000|Overall Study|Clinical adverse experience|5|||
143339785|NCT00717860|516788343|FG001|Overall Study|Clinical adverse experience|9|||
143339786|NCT00717860|516788342|FG000|Overall Study|Laboratory adverse experience|2|||
143339787|NCT00717860|516788343|FG001|Overall Study|Laboratory adverse experience|2|||
143339788|NCT00717860|516788342|FG000|Overall Study|Lack of Efficacy|7|||
143339789|NCT00717860|516788343|FG001|Overall Study|Lack of Efficacy|13|||
143339790|NCT00717860|516788342|FG000|Overall Study|Discontinued for other reason|6|||
143339791|NCT00717860|516788343|FG001|Overall Study|Discontinued for other reason|1|||
143339792|NCT00717860|516788342|FG000|Overall Study|Withdrew consent|7|||
143339793|NCT00717860|516788343|FG001|Overall Study|Withdrew consent|3|||
143339794|NCT01564368|516789871|FG000|Overall Study|Ineligible|18|||
143339795|NCT01564368|516789871|FG000|Overall Study|Not Randomized in Parent study|116|||
143339796|NCT01564368|516789871|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
143339797|NCT01564368|516789871|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
143339798|NCT01802437|516789875|FG000|Overall Study|Lost to Follow-up|1|||
143339799|NCT01802437|516789876|FG001|Overall Study|Lost to Follow-up|0|||
143339800|NCT01802437|516789875|FG000|Overall Study|Withdrawal by Subject|3|||
143339801|NCT01802437|516789876|FG001|Overall Study|Withdrawal by Subject|4|||
143339802|NCT02901626|516789877|FG000|Overall Study|Lost to Follow-up|1|||
143339803|NCT02901626|516789878|FG001|Overall Study|Lost to Follow-up|1|||
143339804|NCT04082884|516789879|FG000|Overall Study|Withdrawal by Subject|1|||
143339805|NCT04857034|516789881|FG000|Placebo-Controlled Period|Request to discontinue|2|||
143339806|NCT04857034|516789882|FG001|Placebo-Controlled Period|Request to discontinue|2|||
143339807|NCT04857034|516789883|FG002|Placebo-Controlled Period|Request to discontinue|0|||
143339808|NCT04857034|516789884|FG003|Placebo-Controlled Period|Request to discontinue|0|||
143339809|NCT04857034|516789885|FG004|Placebo-Controlled Period|Request to discontinue|0|||
143339810|NCT04857034|516789881|FG000|Placebo-Controlled Period|withdrew consent|1|||
143339811|NCT04857034|516789882|FG001|Placebo-Controlled Period|withdrew consent|1|||
143339812|NCT04857034|516789883|FG002|Placebo-Controlled Period|withdrew consent|2|||
143339813|NCT04857034|516789884|FG003|Placebo-Controlled Period|withdrew consent|0|||
143339814|NCT04857034|516789885|FG004|Placebo-Controlled Period|withdrew consent|0|||
143339815|NCT04857034|516789881|FG000|Placebo-Controlled Period|Pregnancy|1|||
143339816|NCT04857034|516789882|FG001|Placebo-Controlled Period|Pregnancy|1|||
143339817|NCT04857034|516789883|FG002|Placebo-Controlled Period|Pregnancy|0|||
143339818|NCT04857034|516789884|FG003|Placebo-Controlled Period|Pregnancy|0|||
143339819|NCT04857034|516789885|FG004|Placebo-Controlled Period|Pregnancy|0|||
143339820|NCT04857034|516789881|FG000|Placebo-Controlled Period|Ongoing study period|0|||
143339821|NCT04857034|516789882|FG001|Placebo-Controlled Period|Ongoing study period|1|||
143339822|NCT04857034|516789883|FG002|Placebo-Controlled Period|Ongoing study period|0|||
143339823|NCT04857034|516789884|FG003|Placebo-Controlled Period|Ongoing study period|0|||
143339824|NCT04857034|516789885|FG004|Placebo-Controlled Period|Ongoing study period|0|||
143339825|NCT04857034|516789881|FG000|Active Treatment Period|Lack of Efficacy|1|||
143339826|NCT04857034|516789882|FG001|Active Treatment Period|Lack of Efficacy|0|||
143339827|NCT04857034|516789883|FG002|Active Treatment Period|Lack of Efficacy|0|||
143339828|NCT04857034|516789884|FG003|Active Treatment Period|Lack of Efficacy|0|||
143339829|NCT04857034|516789885|FG004|Active Treatment Period|Lack of Efficacy|0|||
143339830|NCT04857034|516789881|FG000|Active Treatment Period|request to discontinue|0|||
143339831|NCT04857034|516789882|FG001|Active Treatment Period|request to discontinue|1|||
143339832|NCT04857034|516789883|FG002|Active Treatment Period|request to discontinue|0|||
143339833|NCT04857034|516789884|FG003|Active Treatment Period|request to discontinue|1|||
143339834|NCT04857034|516789885|FG004|Active Treatment Period|request to discontinue|0|||
143339835|NCT04857034|516789881|FG000|Active Treatment Period|administrative reason by sponsor|1|||
143339836|NCT04857034|516789882|FG001|Active Treatment Period|administrative reason by sponsor|5|||
143339837|NCT04857034|516789883|FG002|Active Treatment Period|administrative reason by sponsor|0|||
143339838|NCT04857034|516789884|FG003|Active Treatment Period|administrative reason by sponsor|2|||
143339839|NCT04857034|516789885|FG004|Active Treatment Period|administrative reason by sponsor|2|||
143339840|NCT04857034|516789881|FG000|Active Treatment Period|other reasons|1|||
143339841|NCT04857034|516789882|FG001|Active Treatment Period|other reasons|1|||
143339842|NCT04857034|516789883|FG002|Active Treatment Period|other reasons|0|||
143339843|NCT04857034|516789884|FG003|Active Treatment Period|other reasons|0|||
143339844|NCT04857034|516789885|FG004|Active Treatment Period|other reasons|1|||
143339845|NCT04857034|516789881|FG000|Active Treatment Period|Ongoing Study Period|2|||
143339846|NCT04857034|516789882|FG001|Active Treatment Period|Ongoing Study Period|4|||
143339847|NCT04857034|516789883|FG002|Active Treatment Period|Ongoing Study Period|0|||
143339848|NCT04857034|516789884|FG003|Active Treatment Period|Ongoing Study Period|1|||
143339849|NCT04857034|516789885|FG004|Active Treatment Period|Ongoing Study Period|0|||
143339850|NCT00387894|516789886|FG000|Overall Study|Withdrawal by Subject|1|||
143339851|NCT00659490|516789887|FG000|Overall Study|Lost to Follow-up|2|||
143339852|NCT00659490|516789888|FG001|Overall Study|Lost to Follow-up|0|||
143339853|NCT00659490|516789889|FG002|Overall Study|Lost to Follow-up|1|||
143339854|NCT00827541|516789890|FG000|Overall Study|Exitus|1|||
143339855|NCT00827541|516789891|FG001|Overall Study|Exitus|8|||
143339856|NCT00827541|516789890|FG000|Overall Study|Other|1|||
143339857|NCT00827541|516789891|FG001|Overall Study|Other|3|||
143339858|NCT00827541|516789890|FG000|Overall Study|Pathogen not susceptible|1|||
143339859|NCT00827541|516789891|FG001|Overall Study|Pathogen not susceptible|0|||
143339860|NCT00827541|516789890|FG000|Overall Study|Lack of effectiveness|1|||
143339861|NCT00827541|516789891|FG001|Overall Study|Lack of effectiveness|0|||
143339862|NCT01649232|516789892|FG000|Overall Study|Physician Decision|2|||
143339863|NCT01649232|516789893|FG001|Overall Study|Physician Decision|0|||
143339864|NCT02421666|516789894|FG000|6-month Follow-up|Lost to Follow-up|8|||
143339865|NCT02421666|516789895|FG001|6-month Follow-up|Lost to Follow-up|7|||
143339866|NCT02421666|516789894|FG000|6-month Follow-up|Withdrawal by Subject|5|||
143339867|NCT02421666|516789895|FG001|6-month Follow-up|Withdrawal by Subject|6|||
143339868|NCT02421666|516789894|FG000|12-month Follow-up|Lost to Follow-up|5|||
143339869|NCT02421666|516789895|FG001|12-month Follow-up|Lost to Follow-up|5|||
143339870|NCT02421666|516789894|FG000|12-month Follow-up|Withdrawal by Subject|6|||
143339871|NCT02421666|516789895|FG001|12-month Follow-up|Withdrawal by Subject|11|||
143339872|NCT00106184|516789897|FG000|Overall Study|Withdrawal by Subject|3|||
143339873|NCT00106184|516789898|FG001|Overall Study|Withdrawal by Subject|2|||
143339874|NCT02133872|516789899|FG000|Overall Study|Withdrawal by Subject|5|||
143339875|NCT02133872|516789900|FG001|Overall Study|Withdrawal by Subject|3|||
143339876|NCT02133872|516789901|FG002|Overall Study|Withdrawal by Subject|0|||
143339877|NCT02923739|516789902|FG000|Overall Study|Withdrawal by Subject|2|||
143339878|NCT02923739|516789903|FG001|Overall Study|Withdrawal by Subject|0|||
143339879|NCT02923739|516789904|FG002|Overall Study|Withdrawal by Subject|0|||
143339880|NCT02923739|516789905|FG003|Overall Study|Withdrawal by Subject|0|||
143339881|NCT02923739|516789902|FG000|Overall Study|Failed Screening|3|||
143339882|NCT02923739|516789903|FG001|Overall Study|Failed Screening|0|||
143339883|NCT02923739|516789904|FG002|Overall Study|Failed Screening|0|||
143339884|NCT02923739|516789905|FG003|Overall Study|Failed Screening|0|||
143339885|NCT00118716|516789912|FG000|Overall Study|Adverse Event|2|||
143339886|NCT00118716|516789913|FG001|Overall Study|Adverse Event|7|||
143339887|NCT00118716|516789912|FG000|Overall Study|Protocol Violation|5|||
143339888|NCT00118716|516789913|FG001|Overall Study|Protocol Violation|4|||
143339889|NCT00118716|516789912|FG000|Overall Study|Withdrawal by Subject|0|||
143339890|NCT00118716|516789913|FG001|Overall Study|Withdrawal by Subject|1|||
143339891|NCT00118716|516789912|FG000|Overall Study|Exacerbation|2|||
143339892|NCT00118716|516789913|FG001|Overall Study|Exacerbation|2|||
143339893|NCT00118716|516789912|FG000|Overall Study|Discontinued by sponsor|1|||
143339894|NCT00118716|516789913|FG001|Overall Study|Discontinued by sponsor|1|||
143339895|NCT00118716|516789912|FG000|Overall Study|Non-compliance|1|||
143339896|NCT00118716|516789913|FG001|Overall Study|Non-compliance|3|||
143339897|NCT00118716|516789912|FG000|Overall Study|misrandomized|1|||
143339898|NCT00118716|516789913|FG001|Overall Study|misrandomized|1|||
143339899|NCT00118716|516789912|FG000|Overall Study|Expired drug use|1|||
143339900|NCT00118716|516789913|FG001|Overall Study|Expired drug use|2|||
143339901|NCT00118716|516789912|FG000|Overall Study|Investigator discretion|0|||
143339902|NCT00118716|516789913|FG001|Overall Study|Investigator discretion|1|||
143339903|NCT00855062|516789915|FG000|Step1|Early Study Closure|5|||
143339904|NCT00855062|516789916|FG001|Step1|Early Study Closure|7|||
143339905|NCT00855062|516789915|FG000|Step1|Adverse Event|1|||
143339906|NCT00855062|516789916|FG001|Step1|Adverse Event|1|||
143394718|NCT03084536|516991563|FG000|Overall Study|Death|0|||
143394719|NCT03084536|516991564|FG001|Overall Study|Death|0|||
143394720|NCT03084536|516991565|FG002|Overall Study|Death|1|||
143394721|NCT03084536|516991563|FG000|Overall Study|Lost to Follow-up|0|||
143394722|NCT03084536|516991564|FG001|Overall Study|Lost to Follow-up|0|||
143394723|NCT03084536|516991565|FG002|Overall Study|Lost to Follow-up|1|||
143394724|NCT03084536|516991563|FG000|Overall Study|Protocol Violation|0|||
143394725|NCT03084536|516991564|FG001|Overall Study|Protocol Violation|0|||
143394726|NCT03084536|516991565|FG002|Overall Study|Protocol Violation|1|||
143394727|NCT03084536|516991563|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
143394728|NCT03084536|516991564|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
143339907|NCT00855062|516789915|FG000|Step1|Protocol Violation|1|||
143339908|NCT00855062|516789916|FG001|Step1|Protocol Violation|0|||
143339909|NCT00855062|516789915|FG000|Step1|Pregnancy|1|||
143339910|NCT00855062|516789916|FG001|Step1|Pregnancy|0|||
143339911|NCT00855062|516789915|FG000|Step1|Withdrawal by Subject|2|||
143339912|NCT00855062|516789916|FG001|Step1|Withdrawal by Subject|3|||
143339913|NCT00855062|516789915|FG000|Step2|Early Study Closure|6|||
143339914|NCT00855062|516789916|FG001|Step2|Early Study Closure|2|||
143339915|NCT00855062|516789915|FG000|Step2|Adverse Event|0|||
143339916|NCT00855062|516789916|FG001|Step2|Adverse Event|3|||
143339917|NCT00855062|516789915|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
143339918|NCT00855062|516789916|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
143339919|NCT00454571|516789920|FG000|Overall Study|Adverse Event|2|||
143339920|NCT00454571|516789921|FG001|Overall Study|Adverse Event|0|||
143339921|NCT00454571|516789920|FG000|Overall Study|Physician Decision|0|||
143339922|NCT00454571|516789921|FG001|Overall Study|Physician Decision|1|||
143339923|NCT00454571|516789920|FG000|Overall Study|Protocol Violation|1|||
143339924|NCT00454571|516789921|FG001|Overall Study|Protocol Violation|0|||
143339925|NCT00454571|516789920|FG000|Overall Study|Withdrawal by Subject|10|||
143339926|NCT00454571|516789921|FG001|Overall Study|Withdrawal by Subject|5|||
143339927|NCT01376323|516789922|FG000|Overall Study|Adverse Event|1|||
143394729|NCT03084536|516991565|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
143339928|NCT01376323|516789923|FG001|Overall Study|Adverse Event|0|||
143339929|NCT01376323|516789924|FG002|Overall Study|Adverse Event|0|||
143339930|NCT01376323|516789925|FG003|Overall Study|Adverse Event|2|||
143339931|NCT01376323|516789926|FG004|Overall Study|Adverse Event|0|||
143339932|NCT01376323|516789922|FG000|Overall Study|Lost to Follow-up|0|||
143339933|NCT01376323|516789923|FG001|Overall Study|Lost to Follow-up|0|||
143339934|NCT01376323|516789924|FG002|Overall Study|Lost to Follow-up|0|||
143339935|NCT01376323|516789925|FG003|Overall Study|Lost to Follow-up|2|||
143339936|NCT01376323|516789926|FG004|Overall Study|Lost to Follow-up|0|||
143339937|NCT01376323|516789922|FG000|Overall Study|Physician Decision|1|||
143339938|NCT01376323|516789923|FG001|Overall Study|Physician Decision|0|||
143339939|NCT01376323|516789924|FG002|Overall Study|Physician Decision|2|||
143339940|NCT01376323|516789925|FG003|Overall Study|Physician Decision|1|||
143339941|NCT01376323|516789926|FG004|Overall Study|Physician Decision|1|||
143339942|NCT01376323|516789922|FG000|Overall Study|Withdrawal by Subject|0|||
143339943|NCT01376323|516789923|FG001|Overall Study|Withdrawal by Subject|1|||
143339944|NCT01376323|516789924|FG002|Overall Study|Withdrawal by Subject|1|||
143339945|NCT01376323|516789925|FG003|Overall Study|Withdrawal by Subject|0|||
143339946|NCT01376323|516789926|FG004|Overall Study|Withdrawal by Subject|0|||
143394730|NCT04081103|516991572|FG000|Overall Study|Adverse Event|1|||
143394731|NCT04081103|516991573|FG001|Overall Study|Adverse Event|1|||
143394732|NCT04081103|516991574|FG002|Overall Study|Adverse Event|1|||
143394733|NCT04081103|516991572|FG000|Overall Study|Physician Decision|0|||
143394734|NCT04081103|516991573|FG001|Overall Study|Physician Decision|0|||
143394735|NCT04081103|516991574|FG002|Overall Study|Physician Decision|1|||
143394736|NCT03869866|516993018|FG000|Overall Study|Protocol Violation|1|||
143394737|NCT03869866|516993018|FG000|Overall Study|Withdrawal by Subject|3|||
143394738|NCT01186367|516993019|FG000|Overall Study|Lost to Follow-up|7|||
143394739|NCT01186367|516993020|FG001|Overall Study|Lost to Follow-up|4|||
143394740|NCT01186367|516993021|FG002|Overall Study|Lost to Follow-up|7|||
143394741|NCT01186367|516993019|FG000|Overall Study|Did not receive study treatment|0|||
143394742|NCT01186367|516993020|FG001|Overall Study|Did not receive study treatment|1|||
143394743|NCT01186367|516993021|FG002|Overall Study|Did not receive study treatment|0|||
143394744|NCT00470704|516993022|FG000|Overall Study|Withdrawal by Subject|4|||
143394745|NCT00470704|516993023|FG001|Overall Study|Withdrawal by Subject|3|||
143394746|NCT00470704|516993022|FG000|Overall Study|Relapse/Progression|37|||
143394747|NCT00470704|516993023|FG001|Overall Study|Relapse/Progression|42|||
143394748|NCT00470704|516993022|FG000|Overall Study|toxicity|0|||
143394749|NCT00470704|516993023|FG001|Overall Study|toxicity|1|||
143394750|NCT04987320|516993029|FG000|Overall Study|Withdrawal by Subject|0|||
143394751|NCT04987320|516993030|FG001|Overall Study|Withdrawal by Subject|1|||
143394752|NCT00085735|516993031|FG000|Overall Study|Adverse Event|1|||
143394753|NCT00085735|516993032|FG001|Overall Study|Adverse Event|0|||
143394754|NCT00085735|516993033|FG002|Overall Study|Adverse Event|0|||
143394755|NCT00085735|516993034|FG003|Overall Study|Adverse Event|0|||
143394756|NCT00085735|516993035|FG004|Overall Study|Adverse Event|0|||
143394757|NCT00085735|516993036|FG005|Overall Study|Adverse Event|0|||
143394758|NCT00085735|516993031|FG000|Overall Study|Lack of Efficacy|2|||
143394759|NCT00085735|516993032|FG001|Overall Study|Lack of Efficacy|4|||
143394760|NCT00085735|516993033|FG002|Overall Study|Lack of Efficacy|6|||
143394761|NCT00085735|516993034|FG003|Overall Study|Lack of Efficacy|3|||
143394762|NCT00085735|516993035|FG004|Overall Study|Lack of Efficacy|4|||
143394763|NCT00085735|516993036|FG005|Overall Study|Lack of Efficacy|3|||
143394764|NCT00085735|516993031|FG000|Overall Study|Lost to Follow-up|0|||
143394765|NCT00085735|516993032|FG001|Overall Study|Lost to Follow-up|1|||
143394766|NCT00085735|516993033|FG002|Overall Study|Lost to Follow-up|0|||
143394767|NCT00085735|516993034|FG003|Overall Study|Lost to Follow-up|0|||
143394768|NCT00085735|516993035|FG004|Overall Study|Lost to Follow-up|1|||
143394769|NCT00085735|516993036|FG005|Overall Study|Lost to Follow-up|0|||
143394770|NCT00085735|516993031|FG000|Overall Study|Physician Decision|2|||
143394771|NCT00085735|516993032|FG001|Overall Study|Physician Decision|3|||
143394772|NCT00085735|516993033|FG002|Overall Study|Physician Decision|2|||
143394773|NCT00085735|516993034|FG003|Overall Study|Physician Decision|3|||
143394774|NCT00085735|516993035|FG004|Overall Study|Physician Decision|11|||
143394775|NCT00085735|516993036|FG005|Overall Study|Physician Decision|8|||
143339947|NCT04681729|516789927|FG000|Overall Study|Lack of Efficacy|2|||
143339948|NCT04681729|516789928|FG001|Overall Study|Lack of Efficacy|2|||
143339949|NCT04681729|516789927|FG000|Overall Study|Withdrawal by Subject|8|||
143339950|NCT04681729|516789928|FG001|Overall Study|Withdrawal by Subject|9|||
143339951|NCT02436811|516789929|FG000|Overall Study|Lost to Follow-up|2|||
143394776|NCT00085735|516993031|FG000|Overall Study|Protocol Violation|1|||
143394777|NCT00085735|516993032|FG001|Overall Study|Protocol Violation|0|||
143394778|NCT00085735|516993033|FG002|Overall Study|Protocol Violation|0|||
143339952|NCT02436811|516789930|FG001|Overall Study|Lost to Follow-up|9|||
143394779|NCT00085735|516993034|FG003|Overall Study|Protocol Violation|0|||
143394780|NCT00085735|516993035|FG004|Overall Study|Protocol Violation|0|||
143394781|NCT00085735|516993036|FG005|Overall Study|Protocol Violation|0|||
143394782|NCT00085735|516993031|FG000|Overall Study|Withdrawal by Subject|1|||
143394783|NCT00085735|516993032|FG001|Overall Study|Withdrawal by Subject|0|||
143394784|NCT00085735|516993033|FG002|Overall Study|Withdrawal by Subject|4|||
143394785|NCT00085735|516993034|FG003|Overall Study|Withdrawal by Subject|5|||
143394786|NCT00085735|516993035|FG004|Overall Study|Withdrawal by Subject|7|||
143394787|NCT00085735|516993036|FG005|Overall Study|Withdrawal by Subject|8|||
143394788|NCT00085735|516993031|FG000|Overall Study|Patient ineligible|1|||
143394789|NCT00085735|516993032|FG001|Overall Study|Patient ineligible|0|||
143394790|NCT00085735|516993033|FG002|Overall Study|Patient ineligible|3|||
143394791|NCT00085735|516993034|FG003|Overall Study|Patient ineligible|7|||
143394792|NCT00085735|516993035|FG004|Overall Study|Patient ineligible|17|||
143394793|NCT00085735|516993036|FG005|Overall Study|Patient ineligible|8|||
143394794|NCT00085735|516993031|FG000|Overall Study|Excess residual disease|2|||
143394795|NCT00085735|516993032|FG001|Overall Study|Excess residual disease|2|||
143394796|NCT00085735|516993033|FG002|Overall Study|Excess residual disease|1|||
143394797|NCT00085735|516993034|FG003|Overall Study|Excess residual disease|1|||
143394798|NCT00085735|516993035|FG004|Overall Study|Excess residual disease|1|||
143394799|NCT00085735|516993036|FG005|Overall Study|Excess residual disease|4|||
143394800|NCT00085735|516993031|FG000|Overall Study|Reason not documented|1|||
143394801|NCT00085735|516993032|FG001|Overall Study|Reason not documented|0|||
143394802|NCT00085735|516993033|FG002|Overall Study|Reason not documented|1|||
143394803|NCT00085735|516993034|FG003|Overall Study|Reason not documented|0|||
143394804|NCT00085735|516993035|FG004|Overall Study|Reason not documented|1|||
143394805|NCT00085735|516993036|FG005|Overall Study|Reason not documented|0|||
143394806|NCT00085735|516993031|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
143394807|NCT00085735|516993032|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
143394808|NCT00085735|516993033|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
143394809|NCT00085735|516993034|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
143394810|NCT00085735|516993035|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
143394811|NCT00085735|516993036|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
143394812|NCT01824875|516993037|FG000|Overall Study|Disease progression|22|||
143394813|NCT01824875|516993038|FG001|Overall Study|Disease progression|15|||
143394814|NCT01824875|516993037|FG000|Overall Study|Withdrawal by Subject|5|||
143394815|NCT01824875|516993038|FG001|Overall Study|Withdrawal by Subject|4|||
143394816|NCT01824875|516993037|FG000|Overall Study|Adverse Event|4|||
143394817|NCT01824875|516993038|FG001|Overall Study|Adverse Event|10|||
143394818|NCT01824875|516993037|FG000|Overall Study|Alternative therapy|3|||
143394819|NCT01824875|516993038|FG001|Overall Study|Alternative therapy|0|||
143394820|NCT01824875|516993037|FG000|Overall Study|Complicating disease|1|||
143394821|NCT01824875|516993038|FG001|Overall Study|Complicating disease|0|||
143394822|NCT01824875|516993037|FG000|Overall Study|Physician Decision|0|||
143394823|NCT01824875|516993038|FG001|Overall Study|Physician Decision|1|||
143394824|NCT01824875|516993037|FG000|Overall Study|Non-compliance|1|||
143394825|NCT01824875|516993038|FG001|Overall Study|Non-compliance|1|||
143394826|NCT01824875|516993037|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
143394827|NCT01824875|516993038|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
143394828|NCT01824875|516993037|FG000|Overall Study|Administrative issues|0|||
143394829|NCT01824875|516993038|FG001|Overall Study|Administrative issues|2|||
143394830|NCT01824875|516993037|FG000|Overall Study|Ineligible or never started treatment|9|||
143394831|NCT01824875|516993038|FG001|Overall Study|Ineligible or never started treatment|5|||
143394832|NCT01824875|516993037|FG000|Overall Study|Other|0|||
143394833|NCT01824875|516993038|FG001|Overall Study|Other|2|||
143394834|NCT04195698|516993039|FG000|Overall Study|Adverse Event|4|||
143394835|NCT04195698|516993040|FG001|Overall Study|Adverse Event|11|||
143394836|NCT04195698|516993039|FG000|Overall Study|Withdrawal by Subject|9|||
143394837|NCT04195698|516993040|FG001|Overall Study|Withdrawal by Subject|10|||
143394838|NCT04195698|516993039|FG000|Overall Study|Lost to Follow-up|5|||
143394839|NCT04195698|516993040|FG001|Overall Study|Lost to Follow-up|4|||
143394840|NCT04195698|516993039|FG000|Overall Study|Lack of Efficacy|2|||
143394841|NCT04195698|516993040|FG001|Overall Study|Lack of Efficacy|10|||
143394842|NCT04195698|516993039|FG000|Overall Study|Other|5|||
143394843|NCT04195698|516993040|FG001|Overall Study|Other|4|||
143394844|NCT01098812|516993041|FG000|Overall Study|Death|2|||
143394845|NCT01098812|516993042|FG001|Overall Study|Death|0|||
143394846|NCT01098812|516993043|FG002|Overall Study|Death|1|||
143394847|NCT01098812|516993041|FG000|Overall Study|Lost to Follow-up|0|||
143394848|NCT01098812|516993042|FG001|Overall Study|Lost to Follow-up|1|||
143394849|NCT01098812|516993043|FG002|Overall Study|Lost to Follow-up|0|||
143394850|NCT05459688|516993044|FG000|Overall Study|Lost to Follow-up|6|||
143394851|NCT05459688|516993044|FG000|Overall Study|Physician Decision|1|||
143394852|NCT05459688|516993044|FG000|Overall Study|Withdrawal by Subject|19|||
143394853|NCT05459688|516993044|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
143394854|NCT01129102|516993045|FG000|Overall Study|No study drug treatment|2|||
143394855|NCT01129102|516993046|FG001|Overall Study|No study drug treatment|3|||
143394856|NCT01129102|516993047|FG002|Overall Study|No study drug treatment|1|||
143394857|NCT01129102|516993045|FG000|Overall Study|Withdrawal by Subject|2|||
143394858|NCT01129102|516993046|FG001|Overall Study|Withdrawal by Subject|0|||
143394859|NCT01129102|516993047|FG002|Overall Study|Withdrawal by Subject|3|||
143394860|NCT01129102|516993045|FG000|Overall Study|Protocol Violation|0|||
143394861|NCT01129102|516993046|FG001|Overall Study|Protocol Violation|1|||
143394862|NCT01129102|516993047|FG002|Overall Study|Protocol Violation|1|||
143394863|NCT01129102|516993045|FG000|Overall Study|Pregnancy|0|||
143394864|NCT01129102|516993046|FG001|Overall Study|Pregnancy|0|||
143394865|NCT01129102|516993047|FG002|Overall Study|Pregnancy|1|||
143394866|NCT01129102|516993045|FG000|Overall Study|Adverse Event|2|||
143394867|NCT01129102|516993046|FG001|Overall Study|Adverse Event|2|||
143394868|NCT01129102|516993047|FG002|Overall Study|Adverse Event|1|||
143394869|NCT01129102|516993045|FG000|Overall Study|Lost to Follow-up|2|||
143394870|NCT01129102|516993046|FG001|Overall Study|Lost to Follow-up|0|||
143394871|NCT01129102|516993047|FG002|Overall Study|Lost to Follow-up|0|||
143394872|NCT03379675|516993054|FG000|Overall Study|Lost to Follow-up|0|||
143394873|NCT03379675|516993055|FG001|Overall Study|Lost to Follow-up|1|||
143394874|NCT03379675|516993056|FG002|Overall Study|Lost to Follow-up|0|||
143394875|NCT03379675|516993054|FG000|Overall Study|Adverse Event|2|||
143394876|NCT03379675|516993055|FG001|Overall Study|Adverse Event|0|||
143394877|NCT03379675|516993056|FG002|Overall Study|Adverse Event|0|||
143394878|NCT03379675|516993054|FG000|Overall Study|Withdrawal by Subject|2|||
143394879|NCT03379675|516993055|FG001|Overall Study|Withdrawal by Subject|1|||
143394880|NCT03379675|516993056|FG002|Overall Study|Withdrawal by Subject|2|||
143394881|NCT04332926|516993077|FG000|Overall Study|Withdrawal by Subject|6|||
143394882|NCT04332926|516993077|FG000|Overall Study|Physician Decision|6|||
143394883|NCT04376502|516993082|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
143394884|NCT05672069|516993083|FG000|Overall Study|Implant removal|1|||
143394885|NCT05672069|516993083|FG000|Overall Study|Lost to Follow-up|2|||
143394886|NCT02547233|516993086|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
143394887|NCT02547233|516993087|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
143394888|NCT02547233|516993086|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
143394889|NCT02547233|516993087|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
143339953|NCT02436811|516789931|FG002|Overall Study|Lost to Follow-up|7|||
143339954|NCT03595332|516789932|FG000|Overall Study|Lost to Follow-up|16|||
143339955|NCT03595332|516789933|FG001|Overall Study|Lost to Follow-up|22|||
143339956|NCT03595332|516789932|FG000|Overall Study|Unable to retrieve ID from school|0|||
143339957|NCT03595332|516789933|FG001|Overall Study|Unable to retrieve ID from school|2|||
143339958|NCT02227875|516789934|FG000|Overall Study|Protocol Violation|10|||
143339959|NCT02227875|516789935|FG001|Overall Study|Protocol Violation|7|||
143339960|NCT02227875|516789934|FG000|Overall Study|Other|1|||
143339961|NCT02227875|516789935|FG001|Overall Study|Other|3|||
143339962|NCT02227875|516789934|FG000|Overall Study|Physician Decision|1|||
143339963|NCT02227875|516789935|FG001|Overall Study|Physician Decision|0|||
143339964|NCT02227875|516789934|FG000|Overall Study|Adverse Event|3|||
143339965|NCT02227875|516789935|FG001|Overall Study|Adverse Event|0|||
143339966|NCT02227875|516789934|FG000|Overall Study|Withdrawal by Subject|12|||
143339967|NCT02227875|516789935|FG001|Overall Study|Withdrawal by Subject|13|||
143339968|NCT02227875|516789934|FG000|Overall Study|Lost to Follow-up|10|||
143339969|NCT02227875|516789935|FG001|Overall Study|Lost to Follow-up|10|||
143339970|NCT04209725|516789936|FG000|Overall Study|Adverse Event|1|||
143394890|NCT02547233|516993086|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
143394891|NCT02547233|516993087|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
143394892|NCT02547233|516993086|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
143394893|NCT02547233|516993087|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
143394894|NCT02547233|516993086|FG000|12-month Follow-up|Withdrawal by Subject|10|||
143394895|NCT02547233|516993087|FG001|12-month Follow-up|Withdrawal by Subject|10|||
143339971|NCT02657317|516789939|FG000|Overall Study|Withdrawal by Subject|2|||
143394896|NCT02547233|516993086|FG000|12-month Follow-up|Lost to Follow-up|3|||
143394897|NCT02547233|516993087|FG001|12-month Follow-up|Lost to Follow-up|3|||
143394898|NCT02547233|516993086|FG000|12-month Follow-up|Lack of Efficacy|1|||
143394899|NCT02547233|516993087|FG001|12-month Follow-up|Lack of Efficacy|2|||
143394900|NCT02547233|516993086|FG000|12-month Follow-up|Protocol Violation|0|||
143339972|NCT02657317|516789940|FG001|Overall Study|Withdrawal by Subject|0|||
143339973|NCT02657317|516789939|FG000|Overall Study|Lost to Follow-up|3|||
143339974|NCT02657317|516789940|FG001|Overall Study|Lost to Follow-up|3|||
143339975|NCT01089374|516789941|FG000|Overall Study|Lost to Follow-up|3|||
143339976|NCT01089374|516789942|FG001|Overall Study|Lost to Follow-up|0|||
143339977|NCT01089374|516789941|FG000|Overall Study|Withdrawal by Subject|1|||
143339978|NCT01089374|516789942|FG001|Overall Study|Withdrawal by Subject|0|||
143339979|NCT01089374|516789941|FG000|Overall Study|Study closed early - low accrual|6|||
143339980|NCT01089374|516789942|FG001|Overall Study|Study closed early - low accrual|0|||
143339981|NCT03494166|516789943|FG000|Overall Study|Death|0|||
143339982|NCT03494166|516789944|FG001|Overall Study|Death|0|||
143339983|NCT03494166|516789945|FG002|Overall Study|Death|0|||
143339984|NCT03494166|516789946|FG003|Overall Study|Death|1|||
143339985|NCT03494166|516789947|FG004|Overall Study|Death|3|||
143339986|NCT03494166|516789948|FG005|Overall Study|Death|0|||
143339987|NCT03494166|516789943|FG000|Overall Study|Lost to Follow-up|2|||
143339988|NCT03494166|516789944|FG001|Overall Study|Lost to Follow-up|2|||
143339989|NCT03494166|516789945|FG002|Overall Study|Lost to Follow-up|2|||
143339990|NCT03494166|516789946|FG003|Overall Study|Lost to Follow-up|2|||
143339991|NCT03494166|516789947|FG004|Overall Study|Lost to Follow-up|14|||
143339992|NCT03494166|516789948|FG005|Overall Study|Lost to Follow-up|0|||
143339993|NCT03494166|516789943|FG000|Overall Study|Withdrawal by Subject|10|||
143339994|NCT03494166|516789944|FG001|Overall Study|Withdrawal by Subject|7|||
143339995|NCT03494166|516789945|FG002|Overall Study|Withdrawal by Subject|0|||
143339996|NCT03494166|516789946|FG003|Overall Study|Withdrawal by Subject|5|||
143339997|NCT03494166|516789947|FG004|Overall Study|Withdrawal by Subject|3|||
143339998|NCT03494166|516789948|FG005|Overall Study|Withdrawal by Subject|17|||
143339999|NCT03494166|516789943|FG000|Overall Study|Screen failure|1|||
143340000|NCT03494166|516789944|FG001|Overall Study|Screen failure|0|||
143340001|NCT03494166|516789945|FG002|Overall Study|Screen failure|0|||
143340002|NCT03494166|516789946|FG003|Overall Study|Screen failure|0|||
143340003|NCT03494166|516789947|FG004|Overall Study|Screen failure|1|||
143340004|NCT03494166|516789948|FG005|Overall Study|Screen failure|0|||
143340005|NCT02857426|516789949|FG000|Overall Study|Disease progression|34|||
143340006|NCT02857426|516789950|FG001|Overall Study|Disease progression|13|||
143340007|NCT02857426|516789949|FG000|Overall Study|Study drug toxicity|4|||
143340008|NCT02857426|516789950|FG001|Overall Study|Study drug toxicity|1|||
143340009|NCT02857426|516789949|FG000|Overall Study|Death|1|||
143340010|NCT02857426|516789950|FG001|Overall Study|Death|0|||
143340011|NCT02857426|516789949|FG000|Overall Study|Adverse event unrelated to study drug|6|||
143340012|NCT02857426|516789950|FG001|Overall Study|Adverse event unrelated to study drug|2|||
143340013|NCT02857426|516789949|FG000|Overall Study|Participant withdrew consent|1|||
143340014|NCT02857426|516789950|FG001|Overall Study|Participant withdrew consent|1|||
143340015|NCT02857426|516789949|FG000|Overall Study|Maximum clinical benefit|1|||
143340016|NCT02857426|516789950|FG001|Overall Study|Maximum clinical benefit|0|||
143340017|NCT02857426|516789949|FG000|Overall Study|Completed treatment|0|||
143340018|NCT02857426|516789950|FG001|Overall Study|Completed treatment|2|||
143340019|NCT01960725|516789951|FG000|Overall Study|Lost to Follow-up|4|||
143340020|NCT01960725|516789952|FG001|Overall Study|Lost to Follow-up|3|||
143340021|NCT01960725|516789951|FG000|Overall Study|Withdrawal by Subject|1|||
143340022|NCT01960725|516789952|FG001|Overall Study|Withdrawal by Subject|0|||
143394901|NCT02547233|516993087|FG001|12-month Follow-up|Protocol Violation|1|||
143340023|NCT01960725|516789951|FG000|Overall Study|unable to obtain blood sample|1|||
143340024|NCT01960725|516789952|FG001|Overall Study|unable to obtain blood sample|2|||
143340025|NCT02634788|516789954|FG000|Overall Study|Adverse Event|0|||
143340026|NCT02634788|516789955|FG001|Overall Study|Adverse Event|8|||
143340027|NCT02634788|516789956|FG002|Overall Study|Adverse Event|3|||
143340028|NCT02634788|516789957|FG003|Overall Study|Adverse Event|1|||
143340029|NCT02634788|516789954|FG000|Overall Study|Lack of Efficacy|4|||
143340030|NCT02634788|516789955|FG001|Overall Study|Lack of Efficacy|0|||
143340031|NCT02634788|516789956|FG002|Overall Study|Lack of Efficacy|1|||
143340032|NCT02634788|516789957|FG003|Overall Study|Lack of Efficacy|4|||
143340033|NCT02634788|516789954|FG000|Overall Study|Lost to Follow-up|0|||
143340034|NCT02634788|516789955|FG001|Overall Study|Lost to Follow-up|1|||
143340035|NCT02634788|516789956|FG002|Overall Study|Lost to Follow-up|0|||
143340036|NCT02634788|516789957|FG003|Overall Study|Lost to Follow-up|0|||
143340037|NCT02634788|516789954|FG000|Overall Study|Withdrawal by Subject|0|||
143340038|NCT02634788|516789955|FG001|Overall Study|Withdrawal by Subject|1|||
143340039|NCT02634788|516789956|FG002|Overall Study|Withdrawal by Subject|1|||
143340040|NCT02634788|516789957|FG003|Overall Study|Withdrawal by Subject|0|||
143340041|NCT02068495|516789963|FG000|Overall Study|Case Report Forms Uncollected|60|||
143340042|NCT02068495|516789963|FG000|Overall Study|Protocol Deviation|49|||
143340043|NCT02220894|516789965|FG000|Overall Study|Adverse Event|127|||
143340044|NCT02220894|516789966|FG001|Overall Study|Adverse Event|74|||
143340045|NCT02220894|516789965|FG000|Overall Study|Death|418|||
143340046|NCT02220894|516789966|FG001|Overall Study|Death|508|||
143340047|NCT02220894|516789965|FG000|Overall Study|Lost to Follow-up|0|||
143340048|NCT02220894|516789966|FG001|Overall Study|Lost to Follow-up|4|||
143340049|NCT02220894|516789965|FG000|Overall Study|Site Terminated by Sponsor|2|||
143340050|NCT02220894|516789966|FG001|Overall Study|Site Terminated by Sponsor|0|||
143340051|NCT02220894|516789965|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
143340052|NCT02220894|516789966|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
143340053|NCT02220894|516789965|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
143340054|NCT02220894|516789966|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
143340055|NCT02220894|516789965|FG000|Overall Study|Withdrawal by Subject|10|||
143340056|NCT02220894|516789966|FG001|Overall Study|Withdrawal by Subject|9|||
143340057|NCT04992546|516789967|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
143340058|NCT04992546|516789967|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
143340059|NCT04992546|516789967|FG000|Open-Label Treatment Period|Adverse Event|3|||
143340060|NCT04992546|516789967|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
143394902|NCT02547233|516993086|FG000|12-month Follow-up|Other|0|||
143394903|NCT02547233|516993087|FG001|12-month Follow-up|Other|1|||
143394904|NCT06019559|516993088|FG000|Overall Study|Withdrawal by Subject|7|||
143394905|NCT06019559|516993089|FG001|Overall Study|Withdrawal by Subject|6|||
143394906|NCT06019559|516993090|FG002|Overall Study|Withdrawal by Subject|5|||
143394907|NCT06019559|516993088|FG000|Overall Study|Lost to Follow-up|2|||
143394908|NCT06019559|516993089|FG001|Overall Study|Lost to Follow-up|0|||
143394909|NCT06019559|516993090|FG002|Overall Study|Lost to Follow-up|3|||
143394910|NCT05949788|516993091|FG000|Overall Study|severe birth deformity|2|||
143394911|NCT05949788|516993092|FG001|Overall Study|severe birth deformity|7|||
143394912|NCT05949788|516993091|FG000|Overall Study|twin-twin transfusion syndrome|2|||
143394913|NCT05949788|516993092|FG001|Overall Study|twin-twin transfusion syndrome|7|||
143394914|NCT05949788|516993091|FG000|Overall Study|neonatal hemolytic disease|3|||
143340061|NCT02703922|516789970|FG000|Overall Study|Death|5|||
143394915|NCT05949788|516993092|FG001|Overall Study|neonatal hemolytic disease|8|||
143340062|NCT02703922|516789971|FG001|Overall Study|Death|8|||
143340063|NCT02703922|516789970|FG000|Overall Study|Lost to Follow-up|10|||
143340064|NCT02703922|516789971|FG001|Overall Study|Lost to Follow-up|10|||
143394916|NCT05949788|516993091|FG000|Overall Study|death within 14 days after birth|2|||
143394917|NCT05949788|516993092|FG001|Overall Study|death within 14 days after birth|6|||
143394918|NCT05949788|516993091|FG000|Overall Study|transfer to another hospital|2|||
143340065|NCT00500903|516789973|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
143340066|NCT00500903|516789974|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
143394919|NCT05949788|516993092|FG001|Overall Study|transfer to another hospital|6|||
143394920|NCT05213390|516993093|FG000|Overall Study|Withdrawal by Subject|2|||
143394921|NCT05213390|516993093|FG000|Overall Study|Lost to Follow-up|12|||
143394922|NCT05213390|516993093|FG000|Overall Study|Protocol Violation|9|||
143394923|NCT01824537|516993094|FG000|Overall Study|Lost to Follow-up|78|||
143394924|NCT01824537|516993095|FG001|Overall Study|Lost to Follow-up|87|||
143394925|NCT06215521|516993096|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
143340067|NCT00500903|516789975|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
143340068|NCT00500903|516789973|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
143340069|NCT00500903|516789974|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
143340070|NCT00500903|516789975|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
143340071|NCT00500903|516789973|FG000|Overall Study|Progressive Disease|41|||
143340072|NCT00500903|516789974|FG001|Overall Study|Progressive Disease|2|||
143340073|NCT00500903|516789975|FG002|Overall Study|Progressive Disease|15|||
143340074|NCT00500903|516789973|FG000|Overall Study|Patient Declined Further Treatment|0|||
143340075|NCT00500903|516789974|FG001|Overall Study|Patient Declined Further Treatment|0|||
143340076|NCT00500903|516789975|FG002|Overall Study|Patient Declined Further Treatment|3|||
143394926|NCT06215521|516993097|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
143394927|NCT06215521|516993098|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
143394928|NCT06215521|516993099|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
143394929|NCT06215521|516993100|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
143340077|NCT00500903|516789973|FG000|Overall Study|Symptomatic Deterioration|2|||
143340078|NCT00500903|516789974|FG001|Overall Study|Symptomatic Deterioration|0|||
143340079|NCT00500903|516789975|FG002|Overall Study|Symptomatic Deterioration|0|||
143340080|NCT00500903|516789973|FG000|Overall Study|Reason Not Specified|10|||
143394930|NCT06215521|516993101|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
143394931|NCT02191618|516993102|FG000|Overall Study|Withdrawal by Subject|3|||
143394932|NCT02191618|516993102|FG000|Overall Study|Missed Visit|4|||
143340081|NCT00500903|516789974|FG001|Overall Study|Reason Not Specified|0|||
143394933|NCT03031470|516993103|FG000|Overall Study|Adverse Event|3|||
143394934|NCT03031470|516993104|FG001|Overall Study|Adverse Event|0|||
143394935|NCT03031470|516993103|FG000|Overall Study|Death|3|||
143340082|NCT00500903|516789975|FG002|Overall Study|Reason Not Specified|2|||
143340083|NCT04058353|516789979|FG000|Overall Study|Adverse Event|2|||
143340084|NCT04058353|516789980|FG001|Overall Study|Adverse Event|1|||
143340085|NCT04058353|516789979|FG000|Overall Study|Physician Decision|1|||
143340086|NCT04058353|516789980|FG001|Overall Study|Physician Decision|0|||
143340087|NCT04058353|516789979|FG000|Overall Study|Other|1|||
143340088|NCT04058353|516789980|FG001|Overall Study|Other|0|||
143340089|NCT02390531|516789981|FG000|Overall Study|Death|0|||
143340090|NCT02390531|516789982|FG001|Overall Study|Death|2|||
143340091|NCT02390531|516789983|FG002|Overall Study|Death|0|||
143340092|NCT02390531|516789984|FG003|Overall Study|Death|1|||
143340093|NCT02390531|516789985|FG004|Overall Study|Death|0|||
143340094|NCT02390531|516789986|FG005|Overall Study|Death|0|||
143340095|NCT02390531|516789987|FG006|Overall Study|Death|0|||
143340096|NCT02390531|516789988|FG007|Overall Study|Death|1|||
143394936|NCT03031470|516993104|FG001|Overall Study|Death|1|||
143394937|NCT03031470|516993103|FG000|Overall Study|Lost to Follow-up|1|||
143394938|NCT03031470|516993104|FG001|Overall Study|Lost to Follow-up|1|||
143394939|NCT03031470|516993103|FG000|Overall Study|Withdrawal by Subject|1|||
143394940|NCT03031470|516993104|FG001|Overall Study|Withdrawal by Subject|0|||
143394941|NCT03031470|516993103|FG000|Overall Study|Protocol entry criteria not met|0|||
143394942|NCT03031470|516993104|FG001|Overall Study|Protocol entry criteria not met|1|||
143394943|NCT03031470|516993103|FG000|Overall Study|Cancel the operation|0|||
143394944|NCT03031470|516993104|FG001|Overall Study|Cancel the operation|1|||
143394945|NCT03848065|516993106|FG000|Overall Study|Death|0|||
143394946|NCT03848065|516993107|FG001|Overall Study|Death|1|||
143394947|NCT03848065|516993108|FG002|Overall Study|Death|0|||
143394948|NCT03848065|516993106|FG000|Overall Study|Lost to Follow-up|0|||
143394949|NCT03848065|516993107|FG001|Overall Study|Lost to Follow-up|0|||
143394950|NCT03848065|516993108|FG002|Overall Study|Lost to Follow-up|1|||
143394951|NCT03848065|516993106|FG000|Overall Study|Physician Decision|0|||
143394952|NCT03848065|516993107|FG001|Overall Study|Physician Decision|0|||
143394953|NCT03848065|516993108|FG002|Overall Study|Physician Decision|1|||
143340097|NCT02390531|516789981|FG000|Overall Study|Protocol Violation|0|||
143394954|NCT02043678|516993109|FG000|Overall Study|Never treated|11|||
143394955|NCT02043678|516993110|FG001|Overall Study|Never treated|9|||
143394956|NCT02043678|516993109|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
143340098|NCT02390531|516789982|FG001|Overall Study|Protocol Violation|0|||
143340099|NCT02390531|516789983|FG002|Overall Study|Protocol Violation|0|||
143340100|NCT02390531|516789984|FG003|Overall Study|Protocol Violation|0|||
143340101|NCT02390531|516789985|FG004|Overall Study|Protocol Violation|1|||
143394957|NCT02043678|516993110|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
143340102|NCT02390531|516789986|FG005|Overall Study|Protocol Violation|0|||
143340103|NCT02390531|516789987|FG006|Overall Study|Protocol Violation|2|||
143394958|NCT02043678|516993109|FG000|Overall Study|AE without clinical PD|54|||
143394959|NCT02043678|516993110|FG001|Overall Study|AE without clinical PD|36|||
143394960|NCT02043678|516993109|FG000|Overall Study|Lost to Follow-up|1|||
143394961|NCT02043678|516993110|FG001|Overall Study|Lost to Follow-up|1|||
143394962|NCT02043678|516993109|FG000|Overall Study|Other|10|||
143394963|NCT02043678|516993110|FG001|Overall Study|Other|14|||
143394964|NCT02043678|516993109|FG000|Overall Study|Clinical PD|114|||
143394965|NCT02043678|516993110|FG001|Overall Study|Clinical PD|148|||
143394966|NCT02043678|516993109|FG000|Overall Study|Radiological PD|100|||
143394967|NCT02043678|516993110|FG001|Overall Study|Radiological PD|90|||
143394968|NCT02043678|516993109|FG000|Overall Study|Protocol-driven decision point|59|||
143394969|NCT02043678|516993110|FG001|Overall Study|Protocol-driven decision point|58|||
143394970|NCT02043678|516993109|FG000|Overall Study|Withdrawal by Subject|16|||
143394971|NCT02043678|516993110|FG001|Overall Study|Withdrawal by Subject|20|||
143394972|NCT02043678|516993109|FG000|Overall Study|Protocol Violation|1|||
143340104|NCT02390531|516789988|FG007|Overall Study|Protocol Violation|0|||
143340105|NCT02618616|516789989|FG000|Overall Study|Lack of Efficacy|4|||
143394973|NCT02043678|516993110|FG001|Overall Study|Protocol Violation|0|||
143394974|NCT02043678|516993109|FG000|Overall Study|Deterioration of general conditions|1|||
143394975|NCT02043678|516993110|FG001|Overall Study|Deterioration of general conditions|1|||
143394976|NCT02043678|516993109|FG000|Overall Study|Logistical difficulties|2|||
143394977|NCT02043678|516993110|FG001|Overall Study|Logistical difficulties|0|||
143394978|NCT02043678|516993109|FG000|Overall Study|Non-compliance with study drug|3|||
143394979|NCT02043678|516993110|FG001|Overall Study|Non-compliance with study drug|1|||
143340106|NCT02618616|516789990|FG001|Overall Study|Lack of Efficacy|0|||
143340107|NCT02618616|516789989|FG000|Overall Study|Pregnancy|0|||
143340108|NCT02618616|516789990|FG001|Overall Study|Pregnancy|1|||
143340109|NCT02618616|516789989|FG000|Overall Study|Adverse Event|8|||
143340110|NCT02618616|516789990|FG001|Overall Study|Adverse Event|0|||
143340111|NCT02618616|516789989|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
143340112|NCT02618616|516789990|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
143340113|NCT02618616|516789989|FG000|Overall Study|Consent withdrawn by subject|8|||
143340114|NCT02618616|516789990|FG001|Overall Study|Consent withdrawn by subject|5|||
143340115|NCT02618616|516789989|FG000|Overall Study|Lost to Follow-up|0|||
143340116|NCT02618616|516789990|FG001|Overall Study|Lost to Follow-up|1|||
143340117|NCT01951638|516789991|FG000|Treatment Period|Protocol Violation|0|||
143340118|NCT01951638|516789992|FG001|Treatment Period|Protocol Violation|0|||
143340119|NCT01951638|516789993|FG002|Treatment Period|Protocol Violation|0|||
143340120|NCT01951638|516789994|FG003|Treatment Period|Protocol Violation|2|||
143340121|NCT01951638|516789995|FG004|Treatment Period|Protocol Violation|0|||
143340122|NCT01951638|516789991|FG000|Treatment Period|Protocol-driven decision point|1|||
143340123|NCT01951638|516789992|FG001|Treatment Period|Protocol-driven decision point|3|||
143340124|NCT01951638|516789993|FG002|Treatment Period|Protocol-driven decision point|0|||
143340125|NCT01951638|516789994|FG003|Treatment Period|Protocol-driven decision point|0|||
143340126|NCT01951638|516789995|FG004|Treatment Period|Protocol-driven decision point|0|||
143394980|NCT02043678|516993109|FG000|Overall Study|Physician Decision|4|||
143394981|NCT02043678|516993110|FG001|Overall Study|Physician Decision|3|||
143394982|NCT02043678|516993109|FG000|Overall Study|Subject decision|0|||
143394983|NCT02043678|516993110|FG001|Overall Study|Subject decision|1|||
143394984|NCT02043678|516993109|FG000|Overall Study|Switching to other therapy|3|||
143394985|NCT02043678|516993110|FG001|Overall Study|Switching to other therapy|2|||
143340127|NCT01951638|516789991|FG000|Treatment Period|Logistical difficulties|0|||
143340128|NCT01951638|516789992|FG001|Treatment Period|Logistical difficulties|1|||
143394986|NCT02043678|516993109|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
143394987|NCT02043678|516993110|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
143394988|NCT02043678|516993109|FG000|Overall Study|Missing|1|||
143394989|NCT02043678|516993110|FG001|Overall Study|Missing|0|||
143394990|NCT02043678|516993109|FG000|Overall Study|Adverse Event|0|||
143394991|NCT02043678|516993110|FG001|Overall Study|Adverse Event|1|||
143394992|NCT06103188|516993111|FG000|Overall Study|Lost to Follow-up|1|||
143394993|NCT06103188|516993112|FG001|Overall Study|Lost to Follow-up|6|||
143394994|NCT06103188|516993113|FG002|Overall Study|Lost to Follow-up|4|||
143394995|NCT01175356|516993118|FG000|Overall Study|Death|1|||
143394996|NCT01175356|516993118|FG000|Overall Study|Lack of Efficacy|12|||
143394997|NCT01175356|516993118|FG000|Overall Study|Lost to Follow-up|1|||
143394998|NCT01175356|516993118|FG000|Overall Study|Physician Decision|23|||
143394999|NCT01175356|516993118|FG000|Overall Study|Ineligible|1|||
143395000|NCT01175356|516993118|FG000|Overall Study|Treatment Slot Not Available|18|||
143395001|NCT01175356|516993118|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
143395002|NCT01175356|516993118|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
143395003|NCT01175356|516993118|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
143395004|NCT01175356|516993118|FG000|Overall Study|Inadequate stem cell for transplant|1|||
143395005|NCT01175356|516993118|FG000|Overall Study|Initiation other tx prior to completion|9|||
143395006|NCT06457802|516993123|FG000|Overall Study|Early termination of study prior to participant completion|2|||
143395007|NCT06457802|516993124|FG001|Overall Study|Early termination of study prior to participant completion|2|||
143395008|NCT04898673|516993133|FG000|Overall Study|Screenfail|1|||
143395009|NCT04898673|516993134|FG001|Overall Study|Screenfail|0|||
143395010|NCT01152450|516993135|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
143395011|NCT01152450|516993136|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
143395012|NCT01152450|516993137|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
143395013|NCT01152450|516993138|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
143395014|NCT01152450|516993139|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
143395015|NCT01152450|516993140|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
143395016|NCT01152450|516993135|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
143395017|NCT01152450|516993136|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
143395018|NCT01152450|516993137|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
143395019|NCT01152450|516993138|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
143395020|NCT01152450|516993139|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
143395021|NCT01152450|516993140|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
143395022|NCT01152450|516993135|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
143395023|NCT01152450|516993136|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
143395024|NCT01152450|516993137|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
143395025|NCT01152450|516993138|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
143395026|NCT01152450|516993139|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
143395027|NCT01152450|516993140|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
143395028|NCT01544114|516993141|FG000|Overall Study|Withdrawal by Subject|0|||
143395029|NCT01544114|516993142|FG001|Overall Study|Withdrawal by Subject|0|||
143395030|NCT01544114|516993143|FG002|Overall Study|Withdrawal by Subject|3|||
143395031|NCT01544114|516993141|FG000|Overall Study|Lost to Follow-up|0|||
143395032|NCT01544114|516993142|FG001|Overall Study|Lost to Follow-up|2|||
143395033|NCT01544114|516993143|FG002|Overall Study|Lost to Follow-up|0|||
143395034|NCT01544114|516993141|FG000|Overall Study|Adverse Event|1|||
143395035|NCT01544114|516993142|FG001|Overall Study|Adverse Event|1|||
143395036|NCT01544114|516993143|FG002|Overall Study|Adverse Event|2|||
143395037|NCT01544114|516993141|FG000|Overall Study|Protocol Violation|0|||
143395038|NCT01544114|516993142|FG001|Overall Study|Protocol Violation|1|||
143395039|NCT01544114|516993143|FG002|Overall Study|Protocol Violation|0|||
143395040|NCT03058289|516993144|FG000|Overall Study|Radiographic Deterioration|0|||
143395041|NCT03058289|516993145|FG001|Overall Study|Radiographic Deterioration|3|||
143395042|NCT03058289|516993146|FG002|Overall Study|Radiographic Deterioration|1|||
143395043|NCT03058289|516993147|FG003|Overall Study|Radiographic Deterioration|2|||
143395044|NCT03058289|516993148|FG004|Overall Study|Radiographic Deterioration|6|||
143395045|NCT03058289|516993149|FG005|Overall Study|Radiographic Deterioration|3|||
143395046|NCT03058289|516993150|FG006|Overall Study|Radiographic Deterioration|0|||
143395047|NCT03058289|516993151|FG007|Overall Study|Radiographic Deterioration|4|||
143395048|NCT03058289|516993152|FG008|Overall Study|Radiographic Deterioration|2|||
143395049|NCT03058289|516993144|FG000|Overall Study|Adverse Event|2|||
143395050|NCT03058289|516993145|FG001|Overall Study|Adverse Event|0|||
143395051|NCT03058289|516993146|FG002|Overall Study|Adverse Event|1|||
143395052|NCT03058289|516993147|FG003|Overall Study|Adverse Event|3|||
143395053|NCT03058289|516993148|FG004|Overall Study|Adverse Event|1|||
143395054|NCT03058289|516993149|FG005|Overall Study|Adverse Event|0|||
143395055|NCT03058289|516993150|FG006|Overall Study|Adverse Event|1|||
143395056|NCT03058289|516993151|FG007|Overall Study|Adverse Event|3|||
143395057|NCT03058289|516993152|FG008|Overall Study|Adverse Event|0|||
143395058|NCT03058289|516993144|FG000|Overall Study|Withdrawal by Subject|0|||
143395059|NCT03058289|516993145|FG001|Overall Study|Withdrawal by Subject|0|||
143395060|NCT03058289|516993146|FG002|Overall Study|Withdrawal by Subject|0|||
143395061|NCT03058289|516993147|FG003|Overall Study|Withdrawal by Subject|2|||
143395062|NCT03058289|516993148|FG004|Overall Study|Withdrawal by Subject|0|||
143395063|NCT03058289|516993149|FG005|Overall Study|Withdrawal by Subject|2|||
143395064|NCT03058289|516993150|FG006|Overall Study|Withdrawal by Subject|0|||
143395065|NCT03058289|516993151|FG007|Overall Study|Withdrawal by Subject|4|||
143395066|NCT03058289|516993152|FG008|Overall Study|Withdrawal by Subject|1|||
143395067|NCT03058289|516993144|FG000|Overall Study|Physician Decision|1|||
143395068|NCT03058289|516993145|FG001|Overall Study|Physician Decision|0|||
143395069|NCT03058289|516993146|FG002|Overall Study|Physician Decision|0|||
143395070|NCT03058289|516993147|FG003|Overall Study|Physician Decision|2|||
143395071|NCT03058289|516993148|FG004|Overall Study|Physician Decision|1|||
143395072|NCT03058289|516993149|FG005|Overall Study|Physician Decision|0|||
143395073|NCT03058289|516993150|FG006|Overall Study|Physician Decision|2|||
143395074|NCT03058289|516993151|FG007|Overall Study|Physician Decision|3|||
143395075|NCT03058289|516993152|FG008|Overall Study|Physician Decision|0|||
143395076|NCT03058289|516993144|FG000|Overall Study|Clinical Deterioration|2|||
143395077|NCT03058289|516993145|FG001|Overall Study|Clinical Deterioration|0|||
143395078|NCT03058289|516993146|FG002|Overall Study|Clinical Deterioration|0|||
143395079|NCT03058289|516993147|FG003|Overall Study|Clinical Deterioration|2|||
143395080|NCT03058289|516993148|FG004|Overall Study|Clinical Deterioration|1|||
143395081|NCT03058289|516993149|FG005|Overall Study|Clinical Deterioration|1|||
143395082|NCT03058289|516993150|FG006|Overall Study|Clinical Deterioration|0|||
143395083|NCT03058289|516993151|FG007|Overall Study|Clinical Deterioration|3|||
143395084|NCT03058289|516993152|FG008|Overall Study|Clinical Deterioration|2|||
143395085|NCT03058289|516993144|FG000|Overall Study|Lost to Follow-up|0|||
143395086|NCT03058289|516993145|FG001|Overall Study|Lost to Follow-up|0|||
143395087|NCT03058289|516993146|FG002|Overall Study|Lost to Follow-up|0|||
143395088|NCT03058289|516993147|FG003|Overall Study|Lost to Follow-up|0|||
143395089|NCT03058289|516993148|FG004|Overall Study|Lost to Follow-up|1|||
143395090|NCT03058289|516993149|FG005|Overall Study|Lost to Follow-up|0|||
143395091|NCT03058289|516993150|FG006|Overall Study|Lost to Follow-up|0|||
143395092|NCT03058289|516993151|FG007|Overall Study|Lost to Follow-up|0|||
143395093|NCT03058289|516993152|FG008|Overall Study|Lost to Follow-up|0|||
143395094|NCT03058289|516993144|FG000|Overall Study|Refused Further Treatment|0|||
143395095|NCT03058289|516993145|FG001|Overall Study|Refused Further Treatment|0|||
143395096|NCT03058289|516993146|FG002|Overall Study|Refused Further Treatment|1|||
143395097|NCT03058289|516993147|FG003|Overall Study|Refused Further Treatment|0|||
143395098|NCT03058289|516993148|FG004|Overall Study|Refused Further Treatment|1|||
143395099|NCT03058289|516993149|FG005|Overall Study|Refused Further Treatment|0|||
143395100|NCT03058289|516993150|FG006|Overall Study|Refused Further Treatment|0|||
143395101|NCT03058289|516993151|FG007|Overall Study|Refused Further Treatment|0|||
143340129|NCT01951638|516789993|FG002|Treatment Period|Logistical difficulties|1|||
143340130|NCT01951638|516789994|FG003|Treatment Period|Logistical difficulties|0|||
143340131|NCT01951638|516789995|FG004|Treatment Period|Logistical difficulties|0|||
143340132|NCT01951638|516789991|FG000|Treatment Period|Withdrawal by Subject|9|||
143340133|NCT01951638|516789992|FG001|Treatment Period|Withdrawal by Subject|6|||
143340134|NCT01951638|516789993|FG002|Treatment Period|Withdrawal by Subject|4|||
143340135|NCT01951638|516789994|FG003|Treatment Period|Withdrawal by Subject|5|||
143340136|NCT01951638|516789995|FG004|Treatment Period|Withdrawal by Subject|4|||
143340137|NCT01951638|516789991|FG000|Treatment Period|Death|0|||
143340138|NCT01951638|516789992|FG001|Treatment Period|Death|0|||
143340139|NCT01951638|516789993|FG002|Treatment Period|Death|0|||
143340140|NCT01951638|516789994|FG003|Treatment Period|Death|3|||
143340141|NCT01951638|516789995|FG004|Treatment Period|Death|1|||
143340142|NCT01951638|516789991|FG000|Treatment Period|Adverse Event|3|||
143340143|NCT01951638|516789992|FG001|Treatment Period|Adverse Event|4|||
143340144|NCT01951638|516789993|FG002|Treatment Period|Adverse Event|8|||
143395102|NCT03058289|516993152|FG008|Overall Study|Refused Further Treatment|0|||
143395103|NCT03058289|516993144|FG000|Overall Study|Rapid Progression of Disease|0|||
143395104|NCT03058289|516993145|FG001|Overall Study|Rapid Progression of Disease|0|||
143395105|NCT03058289|516993146|FG002|Overall Study|Rapid Progression of Disease|0|||
143395106|NCT03058289|516993147|FG003|Overall Study|Rapid Progression of Disease|1|||
143395107|NCT03058289|516993148|FG004|Overall Study|Rapid Progression of Disease|0|||
143395108|NCT03058289|516993149|FG005|Overall Study|Rapid Progression of Disease|0|||
143395109|NCT03058289|516993150|FG006|Overall Study|Rapid Progression of Disease|0|||
143395110|NCT03058289|516993151|FG007|Overall Study|Rapid Progression of Disease|0|||
143395111|NCT03058289|516993152|FG008|Overall Study|Rapid Progression of Disease|0|||
143395112|NCT03024437|516993153|FG000|Overall Study|Adverse Event|0|||
143395113|NCT03024437|516993154|FG001|Overall Study|Adverse Event|1|||
143395114|NCT03024437|516993155|FG002|Overall Study|Adverse Event|3|||
143395115|NCT03024437|516993156|FG003|Overall Study|Adverse Event|5|||
143340145|NCT01951638|516789994|FG003|Treatment Period|Adverse Event|6|||
143340146|NCT01951638|516789995|FG004|Treatment Period|Adverse Event|5|||
143340147|NCT01951638|516789991|FG000|Follow-up Period|Protocol Violation|0|||
143340148|NCT01951638|516789992|FG001|Follow-up Period|Protocol Violation|0|||
143395116|NCT03024437|516993157|FG004|Overall Study|Adverse Event|0|||
143395117|NCT03024437|516993153|FG000|Overall Study|Physician Decision|1|||
143395118|NCT03024437|516993154|FG001|Overall Study|Physician Decision|0|||
143395119|NCT03024437|516993155|FG002|Overall Study|Physician Decision|0|||
143395120|NCT03024437|516993156|FG003|Overall Study|Physician Decision|1|||
143395121|NCT03024437|516993157|FG004|Overall Study|Physician Decision|0|||
143395122|NCT03024437|516993153|FG000|Overall Study|Disease progression, relapse|1|||
143395123|NCT03024437|516993154|FG001|Overall Study|Disease progression, relapse|0|||
143395124|NCT03024437|516993155|FG002|Overall Study|Disease progression, relapse|0|||
143395125|NCT03024437|516993156|FG003|Overall Study|Disease progression, relapse|3|||
143395126|NCT03024437|516993157|FG004|Overall Study|Disease progression, relapse|0|||
143395127|NCT03024437|516993153|FG000|Overall Study|Disease progression, refractory disease|4|||
143395128|NCT03024437|516993154|FG001|Overall Study|Disease progression, refractory disease|4|||
143395129|NCT03024437|516993155|FG002|Overall Study|Disease progression, refractory disease|2|||
143395130|NCT03024437|516993156|FG003|Overall Study|Disease progression, refractory disease|2|||
143395131|NCT03024437|516993157|FG004|Overall Study|Disease progression, refractory disease|1|||
143395132|NCT03024437|516993153|FG000|Overall Study|Newly diagnosed cancer|0|||
143340149|NCT01951638|516789993|FG002|Follow-up Period|Protocol Violation|0|||
143340150|NCT01951638|516789994|FG003|Follow-up Period|Protocol Violation|1|||
143340151|NCT01951638|516789995|FG004|Follow-up Period|Protocol Violation|0|||
143340152|NCT01951638|516789991|FG000|Follow-up Period|Logistical difficulties|0|||
143340153|NCT01951638|516789992|FG001|Follow-up Period|Logistical difficulties|2|||
143340154|NCT01951638|516789993|FG002|Follow-up Period|Logistical difficulties|0|||
143340155|NCT01951638|516789994|FG003|Follow-up Period|Logistical difficulties|0|||
143340156|NCT01951638|516789995|FG004|Follow-up Period|Logistical difficulties|1|||
143340157|NCT01951638|516789991|FG000|Follow-up Period|Withdrawal by Subject|1|||
143340158|NCT01951638|516789992|FG001|Follow-up Period|Withdrawal by Subject|5|||
143340159|NCT01951638|516789993|FG002|Follow-up Period|Withdrawal by Subject|2|||
143340160|NCT01951638|516789994|FG003|Follow-up Period|Withdrawal by Subject|1|||
143340161|NCT01951638|516789995|FG004|Follow-up Period|Withdrawal by Subject|2|||
143340162|NCT01951638|516789991|FG000|Follow-up Period|Lost to Follow-up|0|||
143340163|NCT01951638|516789992|FG001|Follow-up Period|Lost to Follow-up|1|||
143340164|NCT01951638|516789993|FG002|Follow-up Period|Lost to Follow-up|0|||
143340165|NCT01951638|516789994|FG003|Follow-up Period|Lost to Follow-up|1|||
143340166|NCT01951638|516789995|FG004|Follow-up Period|Lost to Follow-up|0|||
143340167|NCT01951638|516789991|FG000|Follow-up Period|Death|1|||
143340168|NCT01951638|516789992|FG001|Follow-up Period|Death|0|||
143340169|NCT01951638|516789993|FG002|Follow-up Period|Death|1|||
143340170|NCT01951638|516789994|FG003|Follow-up Period|Death|4|||
143340171|NCT01951638|516789995|FG004|Follow-up Period|Death|1|||
143340172|NCT01951638|516789991|FG000|Follow-up Period|Adverse Event|0|||
143340173|NCT01951638|516789992|FG001|Follow-up Period|Adverse Event|1|||
143340174|NCT01951638|516789993|FG002|Follow-up Period|Adverse Event|2|||
143340175|NCT01951638|516789994|FG003|Follow-up Period|Adverse Event|1|||
143340176|NCT01951638|516789995|FG004|Follow-up Period|Adverse Event|1|||
143340177|NCT04225988|516789996|FG000|Overall Study|Withdrawal by Subject|2|||
143340178|NCT04225988|516789997|FG001|Overall Study|Withdrawal by Subject|0|||
143340179|NCT00514683|516791355|FG000|Overall Study|Not treated|2|||
143340180|NCT00514683|516791356|FG001|Overall Study|Not treated|1|||
143340181|NCT00514683|516791357|FG002|Overall Study|Not treated|0|||
143340182|NCT00514683|516791358|FG003|Overall Study|Not treated|0|||
143340183|NCT00514683|516791359|FG004|Overall Study|Not treated|1|||
143340184|NCT00514683|516791355|FG000|Overall Study|Adverse Event|21|||
143340185|NCT00514683|516791356|FG001|Overall Study|Adverse Event|20|||
143340186|NCT00514683|516791357|FG002|Overall Study|Adverse Event|15|||
143340187|NCT00514683|516791358|FG003|Overall Study|Adverse Event|13|||
143340188|NCT00514683|516791359|FG004|Overall Study|Adverse Event|27|||
143340189|NCT00514683|516791355|FG000|Overall Study|Protocol Violation|1|||
143340190|NCT00514683|516791356|FG001|Overall Study|Protocol Violation|1|||
143340191|NCT00514683|516791357|FG002|Overall Study|Protocol Violation|0|||
143340192|NCT00514683|516791358|FG003|Overall Study|Protocol Violation|1|||
143340193|NCT00514683|516791359|FG004|Overall Study|Protocol Violation|0|||
143340194|NCT00514683|516791355|FG000|Overall Study|Withdrawal by Subject|2|||
143340195|NCT00514683|516791356|FG001|Overall Study|Withdrawal by Subject|2|||
143340196|NCT00514683|516791357|FG002|Overall Study|Withdrawal by Subject|1|||
143340197|NCT00514683|516791358|FG003|Overall Study|Withdrawal by Subject|0|||
143340198|NCT00514683|516791359|FG004|Overall Study|Withdrawal by Subject|4|||
143340199|NCT00514683|516791355|FG000|Overall Study|Reason other than listed above|0|||
143340200|NCT00514683|516791356|FG001|Overall Study|Reason other than listed above|1|||
143340201|NCT00514683|516791357|FG002|Overall Study|Reason other than listed above|2|||
143340202|NCT00514683|516791358|FG003|Overall Study|Reason other than listed above|0|||
143340203|NCT00514683|516791359|FG004|Overall Study|Reason other than listed above|1|||
143340204|NCT05674890|516791360|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
143340205|NCT05674890|516791361|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
143395133|NCT03024437|516993154|FG001|Overall Study|Newly diagnosed cancer|0|||
143395134|NCT03024437|516993155|FG002|Overall Study|Newly diagnosed cancer|0|||
143395135|NCT03024437|516993156|FG003|Overall Study|Newly diagnosed cancer|1|||
143340206|NCT05674890|516791360|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
143340207|NCT05674890|516791361|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
143340208|NCT05674890|516791360|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
143340209|NCT05674890|516791361|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
143340210|NCT02228967|516791362|FG000|Overall Study|Lost to Follow-up|146|||
143340211|NCT02228967|516791363|FG001|Overall Study|Lost to Follow-up|142|||
143340212|NCT02228967|516791362|FG000|Overall Study|Withdrawal by Subject|13|||
143340213|NCT02228967|516791363|FG001|Overall Study|Withdrawal by Subject|18|||
143340214|NCT00520975|516791364|FG000|Overall Study|Disease progression|31|||
143340215|NCT00520975|516791365|FG001|Overall Study|Disease progression|23|||
143340216|NCT00520975|516791364|FG000|Overall Study|Adverse Event|7|||
143340217|NCT00520975|516791365|FG001|Overall Study|Adverse Event|10|||
143340218|NCT00520975|516791364|FG000|Overall Study|Death|0|||
143340219|NCT00520975|516791365|FG001|Overall Study|Death|2|||
143340220|NCT00520975|516791364|FG000|Overall Study|Withdrawal by Subject|3|||
143340221|NCT00520975|516791365|FG001|Overall Study|Withdrawal by Subject|5|||
143340222|NCT00520975|516791364|FG000|Overall Study|Other therapy|2|||
143340223|NCT00520975|516791365|FG001|Overall Study|Other therapy|4|||
143340224|NCT00520975|516791364|FG000|Overall Study|Other reasons|4|||
143340225|NCT00520975|516791365|FG001|Overall Study|Other reasons|2|||
143340226|NCT00520975|516791364|FG000|Overall Study|Not start protocol therapy|1|||
143340227|NCT00520975|516791365|FG001|Overall Study|Not start protocol therapy|2|||
143340228|NCT04998604|516791366|FG000|Overall Study|Adverse Event|3|||
143340229|NCT04998604|516791367|FG001|Overall Study|Adverse Event|2|||
143340230|NCT04998604|516791366|FG000|Overall Study|Withdrawal by Subject|2|||
143340231|NCT04998604|516791367|FG001|Overall Study|Withdrawal by Subject|4|||
143340232|NCT04998604|516791366|FG000|Overall Study|Not related to coronavirus disease 2019 pandemic|2|||
143340233|NCT04998604|516791367|FG001|Overall Study|Not related to coronavirus disease 2019 pandemic|8|||
143340234|NCT00642902|516791368|FG000|Overall Study|Adverse Event|0|||
143340235|NCT00642902|516791369|FG001|Overall Study|Adverse Event|1|||
143340236|NCT00642902|516791370|FG002|Overall Study|Adverse Event|3|||
143340237|NCT00642902|516791371|FG003|Overall Study|Adverse Event|1|||
143340238|NCT00642902|516791368|FG000|Overall Study|Lost to Follow-up|1|||
143340239|NCT00642902|516791369|FG001|Overall Study|Lost to Follow-up|1|||
143340240|NCT00642902|516791370|FG002|Overall Study|Lost to Follow-up|0|||
143340241|NCT00642902|516791371|FG003|Overall Study|Lost to Follow-up|0|||
143340242|NCT00642902|516791368|FG000|Overall Study|Lack of Efficacy|0|||
143340243|NCT00642902|516791369|FG001|Overall Study|Lack of Efficacy|3|||
143340244|NCT00642902|516791370|FG002|Overall Study|Lack of Efficacy|3|||
143340245|NCT00642902|516791371|FG003|Overall Study|Lack of Efficacy|0|||
143340246|NCT00642902|516791368|FG000|Overall Study|Death|1|||
143340247|NCT00642902|516791369|FG001|Overall Study|Death|0|||
143340248|NCT00642902|516791370|FG002|Overall Study|Death|0|||
143340249|NCT00642902|516791371|FG003|Overall Study|Death|0|||
143340250|NCT00642902|516791368|FG000|Overall Study|Premature termination of clinical trial|37|||
143340251|NCT00642902|516791369|FG001|Overall Study|Premature termination of clinical trial|32|||
143340252|NCT00642902|516791370|FG002|Overall Study|Premature termination of clinical trial|35|||
143340253|NCT00642902|516791371|FG003|Overall Study|Premature termination of clinical trial|35|||
143340254|NCT00642902|516791368|FG000|Overall Study|Randomized, but not treated|0|||
143340255|NCT00642902|516791369|FG001|Overall Study|Randomized, but not treated|0|||
143340256|NCT00642902|516791370|FG002|Overall Study|Randomized, but not treated|1|||
143340257|NCT00642902|516791371|FG003|Overall Study|Randomized, but not treated|0|||
143340258|NCT00642902|516791368|FG000|Overall Study|Other|1|||
143340259|NCT00642902|516791369|FG001|Overall Study|Other|5|||
143340260|NCT00642902|516791370|FG002|Overall Study|Other|1|||
143340261|NCT00642902|516791371|FG003|Overall Study|Other|4|||
143340262|NCT00429663|516791372|FG000|Overall Study|Lost to Follow-up|24|||
143340263|NCT00429663|516791373|FG001|Overall Study|Lost to Follow-up|31|||
143340264|NCT00429663|516791372|FG000|Overall Study|Physician Decision|6|||
143340265|NCT00429663|516791373|FG001|Overall Study|Physician Decision|3|||
143340266|NCT00429663|516791372|FG000|Overall Study|Withdrawal by Subject|2|||
143340267|NCT00429663|516791373|FG001|Overall Study|Withdrawal by Subject|5|||
143340268|NCT00429663|516791372|FG000|Overall Study|Death|4|||
143340269|NCT00429663|516791373|FG001|Overall Study|Death|0|||
143340270|NCT03953898|516791379|FG000|Overall Study|Lack of Efficacy|8|||
143340271|NCT03953898|516791379|FG000|Overall Study|Death|3|||
143340272|NCT03953898|516791379|FG000|Overall Study|Withdrawal by Subject|2|||
143340273|NCT03953898|516791379|FG000|Overall Study|Adverse Event|1|||
143340274|NCT03261271|516791380|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
143340275|NCT03261271|516791381|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
143340276|NCT03420781|516791382|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
143340277|NCT03420781|516791383|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
143340278|NCT03420781|516791384|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
143340279|NCT03420781|516791385|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
143340280|NCT03420781|516791386|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
143340281|NCT03420781|516791382|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
143340282|NCT03420781|516791383|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
143340283|NCT03420781|516791384|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
143340284|NCT03420781|516791385|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
143340285|NCT03420781|516791386|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
143340286|NCT03420781|516791382|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
143340287|NCT03420781|516791383|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
143340288|NCT03420781|516791384|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
143340289|NCT03420781|516791385|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
143340290|NCT03420781|516791386|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
143340291|NCT03420781|516791382|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
143340292|NCT03420781|516791383|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
143340293|NCT03420781|516791384|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
143340294|NCT03420781|516791385|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
143340295|NCT03420781|516791386|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
143340296|NCT03420781|516791382|FG000|Treatment Period (40 Weeks)|Death|2|||
143340297|NCT03420781|516791383|FG001|Treatment Period (40 Weeks)|Death|2|||
143340298|NCT03420781|516791384|FG002|Treatment Period (40 Weeks)|Death|0|||
143340299|NCT03420781|516791385|FG003|Treatment Period (40 Weeks)|Death|0|||
143340300|NCT03420781|516791386|FG004|Treatment Period (40 Weeks)|Death|0|||
143340301|NCT03420781|516791382|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
143340302|NCT03420781|516791383|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
143340303|NCT03420781|516791384|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
143340304|NCT03420781|516791385|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
143340305|NCT03420781|516791386|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
143340306|NCT03420781|516791382|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
143340307|NCT03420781|516791383|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
143340308|NCT03420781|516791384|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
143340309|NCT03420781|516791385|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
143340310|NCT03420781|516791386|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
143340311|NCT03420781|516791382|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
143340312|NCT03420781|516791383|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
143340313|NCT03420781|516791384|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
143340314|NCT03420781|516791385|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
143340315|NCT03420781|516791386|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
143340316|NCT03420781|516791382|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
143340317|NCT03420781|516791383|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
143340318|NCT03420781|516791384|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
143340319|NCT03420781|516791385|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
143340320|NCT03420781|516791386|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
143340321|NCT03420781|516791382|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
143340322|NCT03420781|516791383|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
143340323|NCT03420781|516791384|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
143340324|NCT03420781|516791385|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
143340325|NCT03420781|516791386|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
143340326|NCT03420781|516791382|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
143340327|NCT03420781|516791383|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
143340328|NCT03420781|516791384|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
143340329|NCT03420781|516791385|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
143340330|NCT03420781|516791386|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
143340331|NCT03420781|516791382|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
143340332|NCT03420781|516791383|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
143340333|NCT03420781|516791384|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
143340334|NCT03420781|516791385|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
143340335|NCT03420781|516791386|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
143340336|NCT03420781|516791382|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
143340337|NCT03420781|516791383|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
143340338|NCT03420781|516791384|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
143340339|NCT03420781|516791385|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
143340340|NCT03420781|516791386|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
143340341|NCT00246337|516791387|FG000|Overall Study|Lost to Follow-up|3|||
143340342|NCT00246337|516791388|FG001|Overall Study|Lost to Follow-up|0|||
143340343|NCT00246337|516791389|FG002|Overall Study|Lost to Follow-up|0|||
143340344|NCT00246337|516791390|FG003|Overall Study|Lost to Follow-up|0|||
143340345|NCT00246337|516791391|FG004|Overall Study|Lost to Follow-up|2|||
143340346|NCT00246337|516791392|FG005|Overall Study|Lost to Follow-up|2|||
143340347|NCT00246337|516791393|FG006|Overall Study|Lost to Follow-up|1|||
143340348|NCT00246337|516791394|FG007|Overall Study|Lost to Follow-up|2|||
143340349|NCT00246337|516791395|FG008|Overall Study|Lost to Follow-up|0|||
143340350|NCT00246337|516791387|FG000|Overall Study|Protocol Violation|1|||
143340351|NCT00246337|516791388|FG001|Overall Study|Protocol Violation|0|||
143340352|NCT00246337|516791389|FG002|Overall Study|Protocol Violation|0|||
143340353|NCT00246337|516791390|FG003|Overall Study|Protocol Violation|0|||
143340354|NCT00246337|516791391|FG004|Overall Study|Protocol Violation|1|||
143340355|NCT00246337|516791392|FG005|Overall Study|Protocol Violation|0|||
143340356|NCT00246337|516791393|FG006|Overall Study|Protocol Violation|1|||
143340357|NCT00246337|516791394|FG007|Overall Study|Protocol Violation|1|||
143340358|NCT00246337|516791395|FG008|Overall Study|Protocol Violation|0|||
143340359|NCT00246337|516791387|FG000|Overall Study|Withdrawal by Subject|2|||
143340360|NCT00246337|516791388|FG001|Overall Study|Withdrawal by Subject|0|||
143340361|NCT00246337|516791389|FG002|Overall Study|Withdrawal by Subject|0|||
143340362|NCT00246337|516791390|FG003|Overall Study|Withdrawal by Subject|0|||
143340363|NCT00246337|516791391|FG004|Overall Study|Withdrawal by Subject|0|||
143340364|NCT00246337|516791392|FG005|Overall Study|Withdrawal by Subject|0|||
143340365|NCT00246337|516791393|FG006|Overall Study|Withdrawal by Subject|1|||
143340366|NCT00246337|516791394|FG007|Overall Study|Withdrawal by Subject|1|||
143340367|NCT00246337|516791395|FG008|Overall Study|Withdrawal by Subject|0|||
143340368|NCT00246337|516791387|FG000|Overall Study|Lack of Qualifying Event|8|||
143340369|NCT00246337|516791388|FG001|Overall Study|Lack of Qualifying Event|2|||
143340370|NCT00246337|516791389|FG002|Overall Study|Lack of Qualifying Event|1|||
143340371|NCT00246337|516791390|FG003|Overall Study|Lack of Qualifying Event|1|||
143340372|NCT00246337|516791391|FG004|Overall Study|Lack of Qualifying Event|1|||
143340373|NCT00246337|516791392|FG005|Overall Study|Lack of Qualifying Event|3|||
143340374|NCT00246337|516791393|FG006|Overall Study|Lack of Qualifying Event|3|||
143340375|NCT00246337|516791394|FG007|Overall Study|Lack of Qualifying Event|2|||
143340376|NCT00246337|516791395|FG008|Overall Study|Lack of Qualifying Event|5|||
143340377|NCT00246337|516791387|FG000|Overall Study|Site Terminated|10|||
143340378|NCT00246337|516791388|FG001|Overall Study|Site Terminated|0|||
143340379|NCT00246337|516791389|FG002|Overall Study|Site Terminated|0|||
143340380|NCT00246337|516791390|FG003|Overall Study|Site Terminated|0|||
143340381|NCT00246337|516791391|FG004|Overall Study|Site Terminated|0|||
143340382|NCT00246337|516791392|FG005|Overall Study|Site Terminated|7|||
143340383|NCT00246337|516791393|FG006|Overall Study|Site Terminated|1|||
143340384|NCT00246337|516791394|FG007|Overall Study|Site Terminated|6|||
143340385|NCT00246337|516791395|FG008|Overall Study|Site Terminated|2|||
143340386|NCT00246337|516791387|FG000|Overall Study|Abnormal baseline lab values|7|||
143340387|NCT00246337|516791388|FG001|Overall Study|Abnormal baseline lab values|0|||
143340388|NCT00246337|516791389|FG002|Overall Study|Abnormal baseline lab values|2|||
143340389|NCT00246337|516791390|FG003|Overall Study|Abnormal baseline lab values|0|||
143340390|NCT00246337|516791391|FG004|Overall Study|Abnormal baseline lab values|0|||
143340391|NCT00246337|516791392|FG005|Overall Study|Abnormal baseline lab values|2|||
143340392|NCT00246337|516791393|FG006|Overall Study|Abnormal baseline lab values|2|||
143340393|NCT00246337|516791394|FG007|Overall Study|Abnormal baseline lab values|0|||
143340394|NCT00246337|516791395|FG008|Overall Study|Abnormal baseline lab values|4|||
143340395|NCT00246337|516791387|FG000|Overall Study|Overwhelmed|0|||
143340396|NCT00246337|516791388|FG001|Overall Study|Overwhelmed|0|||
143340397|NCT00246337|516791389|FG002|Overall Study|Overwhelmed|0|||
143340398|NCT00246337|516791390|FG003|Overall Study|Overwhelmed|0|||
143395136|NCT03024437|516993157|FG004|Overall Study|Newly diagnosed cancer|0|||
143395137|NCT03024437|516993153|FG000|Overall Study|Moved out of state|0|||
143395138|NCT03024437|516993154|FG001|Overall Study|Moved out of state|1|||
143395139|NCT03024437|516993155|FG002|Overall Study|Moved out of state|0|||
143395140|NCT03024437|516993156|FG003|Overall Study|Moved out of state|0|||
143395141|NCT03024437|516993157|FG004|Overall Study|Moved out of state|0|||
143340399|NCT00246337|516791391|FG004|Overall Study|Overwhelmed|0|||
143340400|NCT00246337|516791392|FG005|Overall Study|Overwhelmed|1|||
143340401|NCT00246337|516791393|FG006|Overall Study|Overwhelmed|0|||
143340402|NCT00246337|516791394|FG007|Overall Study|Overwhelmed|0|||
143340403|NCT00246337|516791395|FG008|Overall Study|Overwhelmed|0|||
143340404|NCT00246337|516791387|FG000|Overall Study|Protocol Violator|1|||
143395142|NCT03024437|516993153|FG000|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
143340405|NCT00246337|516791388|FG001|Overall Study|Protocol Violator|0|||
143340406|NCT00246337|516791389|FG002|Overall Study|Protocol Violator|0|||
143340407|NCT00246337|516791390|FG003|Overall Study|Protocol Violator|0|||
143340408|NCT00246337|516791391|FG004|Overall Study|Protocol Violator|0|||
143340409|NCT00246337|516791392|FG005|Overall Study|Protocol Violator|0|||
143340410|NCT00246337|516791393|FG006|Overall Study|Protocol Violator|0|||
143340411|NCT00246337|516791394|FG007|Overall Study|Protocol Violator|0|||
143340412|NCT00246337|516791395|FG008|Overall Study|Protocol Violator|0|||
143340413|NCT00246337|516791387|FG000|Overall Study|Reported as completing trial in error|0|||
143340414|NCT00246337|516791388|FG001|Overall Study|Reported as completing trial in error|0|||
143340415|NCT00246337|516791389|FG002|Overall Study|Reported as completing trial in error|0|||
143340416|NCT00246337|516791390|FG003|Overall Study|Reported as completing trial in error|0|||
143395143|NCT03024437|516993154|FG001|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
143395144|NCT03024437|516993155|FG002|Overall Study|Needed an alternative therapy prohibited by protocol|1|||
143395145|NCT03024437|516993156|FG003|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
143395146|NCT03024437|516993157|FG004|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
143395147|NCT03800654|516993158|FG000|Overall Study|Time constraints|3|||
143395148|NCT03800654|516993159|FG001|Overall Study|Time constraints|3|||
143395149|NCT03800654|516993160|FG002|Overall Study|Time constraints|3|||
143395150|NCT03800654|516993158|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
143395151|NCT03800654|516993159|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
143395152|NCT03800654|516993160|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
143395153|NCT03800654|516993158|FG000|Overall Study|Lost to Follow-up|2|||
143395154|NCT03800654|516993159|FG001|Overall Study|Lost to Follow-up|1|||
143395155|NCT03800654|516993160|FG002|Overall Study|Lost to Follow-up|6|||
143395156|NCT03800654|516993158|FG000|Overall Study|Medical Health Issue|0|||
143395157|NCT03800654|516993159|FG001|Overall Study|Medical Health Issue|0|||
143395158|NCT03800654|516993160|FG002|Overall Study|Medical Health Issue|1|||
143395159|NCT03800654|516993158|FG000|Overall Study|Personal Issues|0|||
143395160|NCT03800654|516993159|FG001|Overall Study|Personal Issues|2|||
143395161|NCT03800654|516993160|FG002|Overall Study|Personal Issues|0|||
143395162|NCT03800654|516993158|FG000|Overall Study|Protocol Violation|0|||
143395163|NCT03800654|516993159|FG001|Overall Study|Protocol Violation|1|||
143395164|NCT03800654|516993160|FG002|Overall Study|Protocol Violation|0|||
143395165|NCT03459729|516993161|FG000|Overall Study|Physician Decision|2|||
143395166|NCT05704543|516993163|FG000|Overall Study|Withdrawal by Subject|1|||
143395167|NCT05704543|516993164|FG001|Overall Study|Withdrawal by Subject|1|||
143395168|NCT05704543|516993165|FG002|Overall Study|Withdrawal by Subject|0|||
143395169|NCT05704543|516993166|FG003|Overall Study|Withdrawal by Subject|2|||
143395170|NCT05704543|516993163|FG000|Overall Study|Lost to Follow-up|1|||
143395171|NCT05704543|516993164|FG001|Overall Study|Lost to Follow-up|2|||
143395172|NCT05704543|516993165|FG002|Overall Study|Lost to Follow-up|0|||
143395173|NCT05704543|516993166|FG003|Overall Study|Lost to Follow-up|0|||
143395174|NCT03365882|516993169|FG000|Randomization|Still Receiving Protocol Treatment|2|||
143395175|NCT03365882|516993170|FG001|Randomization|Still Receiving Protocol Treatment|0|||
143395176|NCT03365882|516993169|FG000|Randomization|Adverse Event|1|||
143395177|NCT03365882|516993170|FG001|Randomization|Adverse Event|2|||
143395178|NCT03365882|516993169|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
143395179|NCT03365882|516993170|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
143395180|NCT03365882|516993169|FG000|Randomization|Progression/Relapse|21|||
143395181|NCT03365882|516993170|FG001|Randomization|Progression/Relapse|3|||
143395182|NCT03365882|516993169|FG000|Randomization|Death|1|||
143395183|NCT03365882|516993170|FG001|Randomization|Death|0|||
143395184|NCT03365882|516993169|FG000|Randomization|Other - Not Protocol Specified|1|||
143395185|NCT03365882|516993170|FG001|Randomization|Other - Not Protocol Specified|1|||
143395186|NCT03365882|516993169|FG000|Randomization|Major Protocol Deviation|0|||
143395187|NCT03365882|516993170|FG001|Randomization|Major Protocol Deviation|1|||
143395188|NCT03365882|516993169|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
143395189|NCT03365882|516993170|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
143395190|NCT03365882|516993169|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
143395191|NCT03365882|516993170|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
143395192|NCT03365882|516993169|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
143395193|NCT03365882|516993170|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
143395194|NCT03365882|516993169|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
143395195|NCT03365882|516993170|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
143395196|NCT02696707|516994862|FG000|Per Protocol Population|Physician Decision|2|||
143395197|NCT02696707|516994863|FG001|Per Protocol Population|Physician Decision|1|||
143395198|NCT02696707|516994862|FG000|Per Protocol Population|Participant Decision|0|||
143395199|NCT02696707|516994863|FG001|Per Protocol Population|Participant Decision|2|||
143395200|NCT02696707|516994862|FG000|Completed Study as Planned|Reason = LVEF|2|||
143395201|NCT02696707|516994863|FG001|Completed Study as Planned|Reason = LVEF|2|||
143395202|NCT02696707|516994862|FG000|Completed Study as Planned|Protocol Violation|2|||
143395203|NCT02696707|516994863|FG001|Completed Study as Planned|Protocol Violation|6|||
143395204|NCT02696707|516994862|FG000|Completed Study as Planned|Metastatic disease|3|||
143395205|NCT02696707|516994863|FG001|Completed Study as Planned|Metastatic disease|0|||
143395206|NCT02696707|516994862|FG000|Completed Study as Planned|Location|1|||
143395207|NCT02696707|516994863|FG001|Completed Study as Planned|Location|1|||
143395208|NCT02817776|516994868|FG000|Overall Study|Excluded|33|||
143395209|NCT02817776|516994868|FG000|Overall Study|Lost to Follow-up|20|||
143395210|NCT02817776|516994868|FG000|Overall Study|Withdrawal by Subject|33|||
143395211|NCT02817776|516994868|FG000|Overall Study|Death|2|||
143395212|NCT05540665|516994869|FG000|Overall Study|Study terminated by sponsor|6|||
143395213|NCT05540665|516994870|FG001|Overall Study|Study terminated by sponsor|6|||
143395214|NCT05540665|516994871|FG002|Overall Study|Study terminated by sponsor|7|||
143395215|NCT03462030|516994876|FG000|Overall Study|Withdrawal by Subject|1|||
143395216|NCT03462030|516994877|FG001|Overall Study|Withdrawal by Subject|1|||
143395217|NCT02675751|516994878|FG000|Overall Study|Lost to Follow-up|16|||
143395218|NCT03371381|516994879|FG000|Overall Study|Death|5|||
143395219|NCT03371381|516994879|FG000|Overall Study|Study terminated by sponsor|3|||
143395220|NCT03371381|516994879|FG000|Overall Study|Other|4|||
143395221|NCT02598388|516994880|FG000|Overall Study|Lost to Follow-up|1|||
143395222|NCT02598388|516994881|FG001|Overall Study|Lost to Follow-up|0|||
143395223|NCT02598388|516994882|FG002|Overall Study|Lost to Follow-up|1|||
143395224|NCT02598388|516994883|FG003|Overall Study|Lost to Follow-up|0|||
143395225|NCT02598388|516994884|FG004|Overall Study|Lost to Follow-up|5|||
143395226|NCT02598388|516994885|FG005|Overall Study|Lost to Follow-up|1|||
143395227|NCT02598388|516994886|FG006|Overall Study|Lost to Follow-up|2|||
143395228|NCT02598388|516994887|FG007|Overall Study|Lost to Follow-up|1|||
143395229|NCT02598388|516994888|FG008|Overall Study|Lost to Follow-up|0|||
143395230|NCT02598388|516994889|FG009|Overall Study|Lost to Follow-up|0|||
143395231|NCT02598388|516994890|FG010|Overall Study|Lost to Follow-up|1|||
143395232|NCT02598388|516994891|FG011|Overall Study|Lost to Follow-up|0|||
143395233|NCT02598388|516994880|FG000|Overall Study|Withdrawal by Subject|0|||
143395234|NCT02598388|516994881|FG001|Overall Study|Withdrawal by Subject|0|||
143395235|NCT02598388|516994882|FG002|Overall Study|Withdrawal by Subject|0|||
143395236|NCT02598388|516994883|FG003|Overall Study|Withdrawal by Subject|0|||
143395237|NCT02598388|516994884|FG004|Overall Study|Withdrawal by Subject|2|||
143395238|NCT02598388|516994885|FG005|Overall Study|Withdrawal by Subject|0|||
143395239|NCT02598388|516994886|FG006|Overall Study|Withdrawal by Subject|2|||
143395240|NCT02598388|516994887|FG007|Overall Study|Withdrawal by Subject|0|||
143395241|NCT02598388|516994888|FG008|Overall Study|Withdrawal by Subject|0|||
143395242|NCT02598388|516994889|FG009|Overall Study|Withdrawal by Subject|1|||
143395243|NCT02598388|516994890|FG010|Overall Study|Withdrawal by Subject|0|||
143395244|NCT02598388|516994891|FG011|Overall Study|Withdrawal by Subject|0|||
143395245|NCT02598388|516994880|FG000|Overall Study|Other|0|||
143395246|NCT02598388|516994881|FG001|Overall Study|Other|0|||
143395247|NCT02598388|516994882|FG002|Overall Study|Other|1|||
143395248|NCT02598388|516994883|FG003|Overall Study|Other|0|||
143395249|NCT02598388|516994884|FG004|Overall Study|Other|3|||
143395250|NCT02598388|516994885|FG005|Overall Study|Other|0|||
143395251|NCT02598388|516994886|FG006|Overall Study|Other|1|||
143395252|NCT02598388|516994887|FG007|Overall Study|Other|0|||
143395253|NCT02598388|516994888|FG008|Overall Study|Other|0|||
143395254|NCT02598388|516994889|FG009|Overall Study|Other|0|||
143395255|NCT02598388|516994890|FG010|Overall Study|Other|0|||
143395256|NCT02598388|516994891|FG011|Overall Study|Other|0|||
143395257|NCT02979327|516994892|FG000|First Intervention|Protocol Violation|1|||
143395258|NCT02979327|516994893|FG001|First Intervention|Protocol Violation|0|||
143395259|NCT02359890|516994897|FG000|Overall Study|Not meeting eligibility|4|||
143395260|NCT02359890|516994897|FG000|Overall Study|Never treated with study catheter|6|||
143395261|NCT03628924|516994898|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
143395262|NCT03628924|516994899|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
143395263|NCT03628924|516994900|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
143395264|NCT03628924|516994901|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
143395265|NCT03628924|516994902|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
143395266|NCT03628924|516994903|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
143395267|NCT03628924|516994904|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
143395268|NCT03628924|516994898|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
143395269|NCT03628924|516994899|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
143395270|NCT03628924|516994900|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
143395271|NCT03628924|516994901|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
143395272|NCT03628924|516994902|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
143395273|NCT03628924|516994903|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
143395274|NCT03628924|516994904|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
143395275|NCT03628924|516994898|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
143395276|NCT03628924|516994899|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
143395277|NCT03628924|516994900|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
143395278|NCT03628924|516994901|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
143395279|NCT03628924|516994902|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
143395280|NCT03628924|516994903|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
143395281|NCT03628924|516994904|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
143395282|NCT03628924|516994898|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
143395283|NCT03628924|516994899|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
143395284|NCT03628924|516994900|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
143395285|NCT03628924|516994901|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
143395286|NCT03628924|516994902|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
143395287|NCT03628924|516994903|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
143340417|NCT00246337|516791391|FG004|Overall Study|Reported as completing trial in error|0|||
143340418|NCT00246337|516791392|FG005|Overall Study|Reported as completing trial in error|0|||
143340419|NCT00246337|516791393|FG006|Overall Study|Reported as completing trial in error|0|||
143340420|NCT00246337|516791394|FG007|Overall Study|Reported as completing trial in error|1|||
143340421|NCT00246337|516791395|FG008|Overall Study|Reported as completing trial in error|0|||
143340422|NCT01226511|516791398|FG000|Acute Treatment Period|Adverse Event|7|||
143340423|NCT01226511|516791399|FG001|Acute Treatment Period|Adverse Event|6|||
143340424|NCT01226511|516791398|FG000|Acute Treatment Period|Lack of Efficacy|2|||
143340425|NCT01226511|516791399|FG001|Acute Treatment Period|Lack of Efficacy|1|||
143340426|NCT01226511|516791398|FG000|Acute Treatment Period|Lost to Follow-up|3|||
143340427|NCT01226511|516791399|FG001|Acute Treatment Period|Lost to Follow-up|6|||
143340428|NCT01226511|516791398|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
143340429|NCT01226511|516791399|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
143340430|NCT01226511|516791398|FG000|Acute Treatment Period|Protocol Violation|5|||
143340431|NCT01226511|516791399|FG001|Acute Treatment Period|Protocol Violation|5|||
143340432|NCT01226511|516791398|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
143340433|NCT01226511|516791399|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
143340434|NCT01226511|516791398|FG000|Extension Treatment Period|Adverse Event|8|||
143340435|NCT01226511|516791399|FG001|Extension Treatment Period|Adverse Event|8|||
143340436|NCT01226511|516791398|FG000|Extension Treatment Period|Lack of Efficacy|3|||
143340437|NCT01226511|516791399|FG001|Extension Treatment Period|Lack of Efficacy|2|||
143340438|NCT01226511|516791398|FG000|Extension Treatment Period|Lost to Follow-up|4|||
143340439|NCT01226511|516791399|FG001|Extension Treatment Period|Lost to Follow-up|3|||
143340440|NCT01226511|516791398|FG000|Extension Treatment Period|Protocol Violation|2|||
143340441|NCT01226511|516791399|FG001|Extension Treatment Period|Protocol Violation|2|||
143340442|NCT01226511|516791398|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
143340443|NCT01226511|516791399|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
143340444|NCT01226511|516791398|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
143340445|NCT01226511|516791399|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
143340446|NCT01226511|516791398|FG000|Extension Treatment Period|Sponsor Decision|1|||
143340447|NCT01226511|516791399|FG001|Extension Treatment Period|Sponsor Decision|1|||
143340448|NCT01226511|516791398|FG000|Taper Period|Adverse Event|1|||
143340449|NCT01226511|516791399|FG001|Taper Period|Adverse Event|0|||
143340450|NCT01226511|516791398|FG000|Taper Period|Lost to Follow-up|2|||
143340451|NCT01226511|516791399|FG001|Taper Period|Lost to Follow-up|2|||
143340452|NCT01226511|516791398|FG000|Taper Period|Protocol Violation|1|||
143340453|NCT01226511|516791399|FG001|Taper Period|Protocol Violation|0|||
143340454|NCT01226511|516791398|FG000|Taper Period|Parent/Caregiver Decision|1|||
143340455|NCT01226511|516791399|FG001|Taper Period|Parent/Caregiver Decision|1|||
143340456|NCT05267600|516791400|FG000|Overall Study|Adverse Event|1|||
143340457|NCT05267600|516791401|FG001|Overall Study|Adverse Event|4|||
143340458|NCT05267600|516791400|FG000|Overall Study|Death|1|||
143340459|NCT05267600|516791401|FG001|Overall Study|Death|2|||
143340460|NCT05267600|516791400|FG000|Overall Study|Lack of Efficacy|1|||
143340461|NCT05267600|516791401|FG001|Overall Study|Lack of Efficacy|2|||
143340462|NCT05267600|516791400|FG000|Overall Study|Lost to Follow-up|3|||
143340463|NCT05267600|516791401|FG001|Overall Study|Lost to Follow-up|0|||
143340464|NCT05267600|516791400|FG000|Overall Study|Physician Decision|4|||
143340465|NCT05267600|516791401|FG001|Overall Study|Physician Decision|0|||
143340466|NCT05267600|516791400|FG000|Overall Study|Treatment Unblinded|0|||
143340467|NCT05267600|516791401|FG001|Overall Study|Treatment Unblinded|1|||
143340468|NCT05267600|516791400|FG000|Overall Study|Withdrawal by Subject|5|||
143340469|NCT05267600|516791401|FG001|Overall Study|Withdrawal by Subject|4|||
143340470|NCT04067401|516791402|FG000|Overall Study|Withdrawal by Subject|7|||
143340471|NCT04067401|516791403|FG001|Overall Study|Withdrawal by Subject|0|||
143340472|NCT04067401|516791402|FG000|Overall Study|no data provided|1|||
143340473|NCT04067401|516791403|FG001|Overall Study|no data provided|0|||
143340474|NCT05292534|516791406|FG000|Overall Study|Protocol Violation|3|||
143340475|NCT05292534|516791407|FG001|Overall Study|Protocol Violation|4|||
143340476|NCT05292534|516791406|FG000|Overall Study|Withdrawal by Subject|0|||
143340477|NCT05292534|516791407|FG001|Overall Study|Withdrawal by Subject|1|||
143340478|NCT01538472|516791408|FG000|Overall Study|Disease Progression|3|||
143340479|NCT01538472|516791408|FG000|Overall Study|Death|1|||
143340480|NCT00948974|516791409|FG000|Overall Study|Lost to Follow-up|23|||
143340481|NCT00948974|516791410|FG001|Overall Study|Lost to Follow-up|20|||
143340482|NCT00238433|516791412|FG000|Overall Study|Screen failure|1|||
143340483|NCT00238433|516791412|FG000|Overall Study|Lost to Follow-up|1|||
143340484|NCT00238433|516791412|FG000|Overall Study|Death|1|||
143340485|NCT01591382|516791413|FG000|Overall Study|Discharged Prior to Study Completion|2|||
143340486|NCT01591382|516791414|FG001|Overall Study|Discharged Prior to Study Completion|1|||
143340487|NCT01591382|516791413|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
143340488|NCT01591382|516791414|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
143340489|NCT00409682|516791427|FG000|Open-label Induction Period|Adverse Event|1|||
143340490|NCT00409682|516791428|FG001|Open-label Induction Period|Adverse Event|0|||
143340491|NCT00409682|516791429|FG002|Open-label Induction Period|Adverse Event|0|||
143340492|NCT00409682|516791427|FG000|Open-label Induction Period|Lack of Efficacy|1|||
143340493|NCT00409682|516791428|FG001|Open-label Induction Period|Lack of Efficacy|0|||
143340494|NCT00409682|516791429|FG002|Open-label Induction Period|Lack of Efficacy|0|||
143340495|NCT00409682|516791427|FG000|Open-label Induction Period|Protocol Violation|1|||
143340496|NCT00409682|516791428|FG001|Open-label Induction Period|Protocol Violation|0|||
143340497|NCT00409682|516791429|FG002|Open-label Induction Period|Protocol Violation|0|||
143340498|NCT00409682|516791427|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
143340499|NCT00409682|516791428|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
143340500|NCT00409682|516791429|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
143340501|NCT00409682|516791427|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
143340502|NCT00409682|516791428|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
143340503|NCT00409682|516791429|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
143340504|NCT00409682|516791427|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
143340505|NCT00409682|516791428|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
143340506|NCT00409682|516791429|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
143340507|NCT00409682|516791427|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
143340508|NCT00409682|516791428|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
143340509|NCT00409682|516791429|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
143340510|NCT00409682|516791427|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
143395288|NCT03628924|516994904|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
143395289|NCT03628924|516994898|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
143395290|NCT03628924|516994899|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
143395291|NCT03628924|516994900|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
143395292|NCT03628924|516994901|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
143395293|NCT03628924|516994902|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
143395294|NCT03628924|516994903|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
143395295|NCT03628924|516994904|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
143395296|NCT03628924|516994898|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
143395297|NCT03628924|516994899|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
143395298|NCT03628924|516994900|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
143395299|NCT03628924|516994901|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
143395300|NCT03628924|516994902|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
143395301|NCT03628924|516994903|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
143395302|NCT03628924|516994904|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
143395303|NCT03628924|516994898|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
143395304|NCT03628924|516994899|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
143395305|NCT03628924|516994900|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
143340511|NCT00409682|516791428|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
143340512|NCT00409682|516791429|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
143340513|NCT00409682|516791427|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
143340514|NCT00409682|516791428|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
143340515|NCT00409682|516791429|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
143340516|NCT00409682|516791427|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
143340517|NCT00409682|516791428|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
143340518|NCT00409682|516791429|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
143340519|NCT01896869|516791431|FG000|Overall Study|Withdrawal by Subject|0|||
143340520|NCT01896869|516791432|FG001|Overall Study|Withdrawal by Subject|6|||
143340521|NCT01896869|516791431|FG000|Overall Study|Lost to Follow-up|1|||
143340522|NCT01896869|516791432|FG001|Overall Study|Lost to Follow-up|0|||
143340523|NCT04710927|516791438|FG000|Overall Study|Lost to Follow-up|7|||
143340524|NCT04710927|516791439|FG001|Overall Study|Lost to Follow-up|6|||
143340525|NCT04710927|516791440|FG002|Overall Study|Lost to Follow-up|5|||
143340526|NCT02856113|516791443|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
143340527|NCT02856113|516791444|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
143340528|NCT02856113|516791443|FG000|Overall Study|Significant Protocol Deviation|1|||
143340529|NCT02856113|516791444|FG001|Overall Study|Significant Protocol Deviation|0|||
143340530|NCT02856113|516791443|FG000|Overall Study|Lost to Follow-up|3|||
143340531|NCT02856113|516791444|FG001|Overall Study|Lost to Follow-up|5|||
143340532|NCT02856113|516791443|FG000|Overall Study|Voluntary Withdrawal|3|||
143340533|NCT02856113|516791444|FG001|Overall Study|Voluntary Withdrawal|5|||
143340534|NCT02856113|516791443|FG000|Overall Study|Pregnancy|0|||
143340535|NCT02856113|516791444|FG001|Overall Study|Pregnancy|1|||
143340536|NCT02856113|516791443|FG000|Overall Study|Principal Investigator Discretion|2|||
143340537|NCT02856113|516791444|FG001|Overall Study|Principal Investigator Discretion|1|||
143340538|NCT02856113|516791443|FG000|Overall Study|Randomized but not Treated|1|||
143340539|NCT02856113|516791444|FG001|Overall Study|Randomized but not Treated|0|||
143340540|NCT02856113|516791443|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
143340541|NCT02856113|516791444|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
143340542|NCT02110901|516791445|FG000|Overall Study|Death|6|||
143340543|NCT02110901|516791446|FG001|Overall Study|Death|3|||
143340544|NCT02110901|516791445|FG000|Overall Study|Lost to Follow-up|12|||
143340545|NCT02110901|516791446|FG001|Overall Study|Lost to Follow-up|8|||
143340546|NCT02110901|516791445|FG000|Overall Study|Withdrawal by Subject|7|||
143340547|NCT02110901|516791446|FG001|Overall Study|Withdrawal by Subject|3|||
143340548|NCT02110901|516791445|FG000|Overall Study|received a kidney transplant|5|||
143340549|NCT02110901|516791446|FG001|Overall Study|received a kidney transplant|0|||
143340550|NCT00758459|516791447|FG000|Overall Study|Adverse Event|3|||
143340551|NCT00758459|516791448|FG001|Overall Study|Adverse Event|2|||
143340552|NCT00758459|516791447|FG000|Overall Study|Protocol Violation|0|||
143340553|NCT00758459|516791448|FG001|Overall Study|Protocol Violation|1|||
143340554|NCT00758459|516791447|FG000|Overall Study|Withdrawal by Subject|0|||
143340555|NCT00758459|516791448|FG001|Overall Study|Withdrawal by Subject|1|||
143340556|NCT01281202|516791459|FG000|Overall Study|Adverse Event|2|||
143340557|NCT01281202|516791460|FG001|Overall Study|Adverse Event|0|||
143340558|NCT01281202|516791459|FG000|Overall Study|Withdrawal by Subject|2|||
143340559|NCT01281202|516791460|FG001|Overall Study|Withdrawal by Subject|2|||
143340560|NCT01281202|516791459|FG000|Overall Study|Protocol Violation|11|||
143340561|NCT01281202|516791460|FG001|Overall Study|Protocol Violation|10|||
143340562|NCT01281202|516791459|FG000|Overall Study|Administrative|2|||
143340563|NCT01281202|516791460|FG001|Overall Study|Administrative|8|||
143340564|NCT01281202|516791459|FG000|Overall Study|Lost to Follow-up|11|||
143340565|NCT01281202|516791460|FG001|Overall Study|Lost to Follow-up|13|||
143340566|NCT01281202|516791459|FG000|Overall Study|Incarceration|0|||
143340567|NCT01281202|516791460|FG001|Overall Study|Incarceration|3|||
143340568|NCT04711603|516791464|FG000|Double-blind Period (6 Weeks)|Adverse Event|4|||
143340569|NCT04711603|516791465|FG001|Double-blind Period (6 Weeks)|Adverse Event|3|||
143340570|NCT04711603|516791466|FG002|Double-blind Period (6 Weeks)|Adverse Event|0|||
143340571|NCT04711603|516791467|FG003|Double-blind Period (6 Weeks)|Adverse Event|0|||
143340572|NCT04711603|516791464|FG000|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
143340573|NCT04711603|516791465|FG001|Double-blind Period (6 Weeks)|Lack of Efficacy|1|||
143340574|NCT04711603|516791466|FG002|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
143340575|NCT04711603|516791467|FG003|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
143340576|NCT04711603|516791464|FG000|Double-blind Period (6 Weeks)|Protocol Violation|0|||
143340577|NCT04711603|516791465|FG001|Double-blind Period (6 Weeks)|Protocol Violation|1|||
143340578|NCT04711603|516791466|FG002|Double-blind Period (6 Weeks)|Protocol Violation|0|||
143340579|NCT04711603|516791467|FG003|Double-blind Period (6 Weeks)|Protocol Violation|0|||
143340580|NCT04711603|516791464|FG000|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
143340581|NCT04711603|516791465|FG001|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|1|||
143340582|NCT04711603|516791466|FG002|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
143340583|NCT04711603|516791467|FG003|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
143340584|NCT04711603|516791464|FG000|Extension Period (52 Weeks)|Adverse Event|0|||
143340585|NCT04711603|516791465|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
143340586|NCT04711603|516791466|FG002|Extension Period (52 Weeks)|Adverse Event|6|||
143340587|NCT04711603|516791467|FG003|Extension Period (52 Weeks)|Adverse Event|18|||
143340588|NCT04711603|516791464|FG000|Extension Period (52 Weeks)|Lack of Efficacy|0|||
143340589|NCT04711603|516791465|FG001|Extension Period (52 Weeks)|Lack of Efficacy|0|||
143340590|NCT04711603|516791466|FG002|Extension Period (52 Weeks)|Lack of Efficacy|0|||
143340591|NCT04711603|516791467|FG003|Extension Period (52 Weeks)|Lack of Efficacy|1|||
143340592|NCT04711603|516791464|FG000|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
143340593|NCT04711603|516791465|FG001|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
143340594|NCT04711603|516791466|FG002|Extension Period (52 Weeks)|Withdrawal by Subject|4|||
143340595|NCT04711603|516791467|FG003|Extension Period (52 Weeks)|Withdrawal by Subject|5|||
143340596|NCT04711603|516791464|FG000|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
143340597|NCT04711603|516791465|FG001|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
143340598|NCT04711603|516791466|FG002|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|5|||
143340599|NCT04711603|516791467|FG003|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|2|||
143340600|NCT04711603|516791464|FG000|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
143340601|NCT04711603|516791465|FG001|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
143340602|NCT04711603|516791466|FG002|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
143340603|NCT04711603|516791467|FG003|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|1|||
143340604|NCT04711603|516791464|FG000|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
143340605|NCT04711603|516791465|FG001|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
143340606|NCT04711603|516791466|FG002|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
143340607|NCT04711603|516791467|FG003|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|1|||
143340608|NCT04711603|516791464|FG000|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
143395306|NCT03628924|516994901|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
143395307|NCT03628924|516994902|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
143340609|NCT04711603|516791465|FG001|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
143340610|NCT04711603|516791466|FG002|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
143340611|NCT04711603|516791467|FG003|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|1|||
143340612|NCT04711603|516791464|FG000|Extension Period (52 Weeks)|Transferred to another hospital|0|||
143340613|NCT04711603|516791465|FG001|Extension Period (52 Weeks)|Transferred to another hospital|0|||
143340614|NCT04711603|516791466|FG002|Extension Period (52 Weeks)|Transferred to another hospital|2|||
143340615|NCT04711603|516791467|FG003|Extension Period (52 Weeks)|Transferred to another hospital|0|||
143340616|NCT04252742|516791470|FG000|Overall Study|Decision by sponsor|0|||
143340617|NCT04252742|516791471|FG001|Overall Study|Decision by sponsor|2|||
143340618|NCT04252742|516791470|FG000|Overall Study|Withdrawal by Subject|15|||
143340619|NCT04252742|516791471|FG001|Overall Study|Withdrawal by Subject|9|||
143340620|NCT04252742|516791470|FG000|Overall Study|Lost to Follow-up|0|||
143340621|NCT04252742|516791471|FG001|Overall Study|Lost to Follow-up|1|||
143340622|NCT00698646|516791474|FG000|Overall Study|Adverse Event|8|||
143340623|NCT00698646|516791475|FG001|Overall Study|Adverse Event|7|||
143340624|NCT00698646|516791476|FG002|Overall Study|Adverse Event|8|||
143340625|NCT00698646|516791474|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
143340626|NCT00698646|516791475|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
143340627|NCT00698646|516791476|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
143340628|NCT00698646|516791474|FG000|Overall Study|Protocol Deviation|6|||
143340629|NCT00698646|516791475|FG001|Overall Study|Protocol Deviation|2|||
143340630|NCT00698646|516791476|FG002|Overall Study|Protocol Deviation|3|||
143340631|NCT00698646|516791474|FG000|Overall Study|Withdrawal by Subject|10|||
143340632|NCT00698646|516791475|FG001|Overall Study|Withdrawal by Subject|11|||
143340633|NCT00698646|516791476|FG002|Overall Study|Withdrawal by Subject|8|||
143340634|NCT00698646|516791474|FG000|Overall Study|Lost to Follow-up|0|||
143340635|NCT00698646|516791475|FG001|Overall Study|Lost to Follow-up|0|||
143340636|NCT00698646|516791476|FG002|Overall Study|Lost to Follow-up|2|||
143340637|NCT00698646|516791474|FG000|Overall Study|Administrative problems|1|||
143340638|NCT00698646|516791475|FG001|Overall Study|Administrative problems|0|||
143340639|NCT00698646|516791476|FG002|Overall Study|Administrative problems|1|||
143395308|NCT03628924|516994903|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
143395309|NCT03628924|516994904|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
143395310|NCT03628924|516994898|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
143395311|NCT03628924|516994899|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
143395312|NCT03628924|516994900|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
143395313|NCT03628924|516994901|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
143395314|NCT03628924|516994902|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
143395315|NCT03628924|516994903|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
143395316|NCT03628924|516994904|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
143395317|NCT03628924|516994898|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
143395318|NCT03628924|516994899|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
143395319|NCT03628924|516994900|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
143395320|NCT03628924|516994901|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
143395321|NCT03628924|516994902|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
143395322|NCT03628924|516994903|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
143395323|NCT03628924|516994904|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
143395324|NCT03628924|516994898|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
143395325|NCT03628924|516994899|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
143395326|NCT03628924|516994900|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
143395327|NCT03628924|516994901|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
143395328|NCT03628924|516994902|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
143395329|NCT03628924|516994903|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
143395330|NCT03628924|516994904|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
143395331|NCT05256017|516994905|FG000|Treatment Period|Withdrawal by Subject|1|||
143395332|NCT05256017|516994906|FG001|Treatment Period|Withdrawal by Subject|1|||
143395333|NCT05256017|516994905|FG000|Follow-up|Lost to Follow-up|7|||
143395334|NCT05256017|516994906|FG001|Follow-up|Lost to Follow-up|1|||
143395335|NCT05256017|516994905|FG000|Follow-up|Withdrawal by Subject|1|||
143395336|NCT05256017|516994906|FG001|Follow-up|Withdrawal by Subject|0|||
143395337|NCT05256017|516994905|FG000|Follow-up|Death|0|||
143395338|NCT05256017|516994906|FG001|Follow-up|Death|1|||
143395339|NCT01073566|516994907|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
143340640|NCT00459342|516791481|FG000|Overall Study|Not eligible|1|||
143340641|NCT01678131|516791482|FG000|Overall Study|Adverse Event|0|||
143340642|NCT01678131|516791483|FG001|Overall Study|Adverse Event|1|||
143340643|NCT01678131|516791484|FG002|Overall Study|Adverse Event|0|||
143340644|NCT01678131|516791482|FG000|Overall Study|Withdrawal by Subject|0|||
143340645|NCT01678131|516791483|FG001|Overall Study|Withdrawal by Subject|0|||
143340646|NCT01678131|516791484|FG002|Overall Study|Withdrawal by Subject|2|||
143395340|NCT01073566|516994908|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
143340647|NCT02027402|516791485|FG000|Overall Study|Withdrawal by Subject|4|||
143340648|NCT02027402|516791486|FG001|Overall Study|Withdrawal by Subject|1|||
143340649|NCT00404495|516791487|FG000|Overall Study|Death|37|||
143340650|NCT00404495|516791488|FG001|Overall Study|Death|11|||
143395341|NCT03748953|516994913|FG000|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|0|||
143395342|NCT03748953|516994914|FG001|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|2|||
143340651|NCT00404495|516791487|FG000|Overall Study|Lost to Follow-up|5|||
143340652|NCT00404495|516791488|FG001|Overall Study|Lost to Follow-up|0|||
143340653|NCT00404495|516791487|FG000|Overall Study|Other|1|||
143340654|NCT00404495|516791488|FG001|Overall Study|Other|0|||
143340655|NCT00404495|516791487|FG000|Overall Study|Withdrawal by Subject|1|||
143340656|NCT00404495|516791488|FG001|Overall Study|Withdrawal by Subject|0|||
143340657|NCT03904043|516791489|FG000|Overall Study|Adverse Event|1|||
143340658|NCT03904043|516791490|FG001|Overall Study|Adverse Event|1|||
143340659|NCT03904043|516791489|FG000|Overall Study|Withdrawal by Subject|1|||
143340660|NCT03904043|516791490|FG001|Overall Study|Withdrawal by Subject|0|||
143340661|NCT03904043|516791489|FG000|Overall Study|Non-compliance|1|||
143395343|NCT03748953|516994913|FG000|Treatment Prior to Amendment 08|Reason not Specified|0|||
143395344|NCT03748953|516994914|FG001|Treatment Prior to Amendment 08|Reason not Specified|2|||
143395345|NCT03748953|516994913|FG000|Treatment Post Amendment 08|Withdrawal by Subject|18|||
143395346|NCT03748953|516994914|FG001|Treatment Post Amendment 08|Withdrawal by Subject|0|||
143395347|NCT03748953|516994913|FG000|Treatment Post Amendment 08|Reason not Specified|16|||
143395348|NCT03748953|516994914|FG001|Treatment Post Amendment 08|Reason not Specified|0|||
143395349|NCT03748953|516994913|FG000|Treatment Post Amendment 08|Lost to Follow-up|1|||
143395350|NCT03748953|516994914|FG001|Treatment Post Amendment 08|Lost to Follow-up|0|||
143395351|NCT04016662|516994915|FG000|Run-In Phase|Death|1|||
143395352|NCT04016662|516994915|FG000|Run-In Phase|Withdrawal by Subject|11|||
143340662|NCT03904043|516791490|FG001|Overall Study|Non-compliance|0|||
143340663|NCT03904043|516791489|FG000|Overall Study|Did not start treatment|1|||
143340664|NCT03904043|516791490|FG001|Overall Study|Did not start treatment|0|||
143340665|NCT05619003|516791491|FG000|Overall Study|Adverse Event|1|||
143340666|NCT00766675|516793204|FG000|Overall Study|Adverse Event|16|||
143340667|NCT00766675|516793204|FG000|Overall Study|Lost to Follow-up|2|||
143340668|NCT00766675|516793204|FG000|Overall Study|Withdrawal by Subject|11|||
143340669|NCT00766675|516793204|FG000|Overall Study|Protocol Violation|8|||
143340670|NCT00766675|516793204|FG000|Overall Study|Participant took prohibited medication|1|||
143340671|NCT00766675|516793204|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
143395353|NCT04016662|516994915|FG000|Run-In Phase|Not meeting screening eligibility|9|||
143395354|NCT04016662|516994915|FG000|Run-In Phase|Physician Decision|3|||
143395355|NCT04016662|516994915|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
143395356|NCT04016662|516994915|FG000|PLGS (12 Weeks)|Death|1|||
143395357|NCT04016662|516994915|FG000|SAP (12 Weeks)|Death|1|||
143395358|NCT01802788|516994916|FG000|Overall Study|Withdrawal by Subject|102|||
143395359|NCT01802788|516994917|FG001|Overall Study|Withdrawal by Subject|5|||
143395360|NCT01802788|516994916|FG000|Overall Study|Death|382|||
143395361|NCT01802788|516994917|FG001|Overall Study|Death|18|||
143395362|NCT01802788|516994916|FG000|Overall Study|Lost to Follow-up|31|||
143395363|NCT01802788|516994917|FG001|Overall Study|Lost to Follow-up|2|||
143395364|NCT01802788|516994916|FG000|Overall Study|Physician Decision|3|||
143395365|NCT01802788|516994917|FG001|Overall Study|Physician Decision|0|||
143395366|NCT01802788|516994916|FG000|Overall Study|Patient Non-Compliance|1|||
143340672|NCT00766675|516793204|FG000|Overall Study|Insufficient therapy|1|||
143340673|NCT03308825|516793205|FG000|Overall Study|Lost to Follow-up|2|||
143340674|NCT03308825|516793206|FG001|Overall Study|Lost to Follow-up|2|||
143340675|NCT03308825|516793207|FG002|Overall Study|Lost to Follow-up|1|||
143340676|NCT03308825|516793208|FG003|Overall Study|Lost to Follow-up|0|||
143340677|NCT03308825|516793205|FG000|Overall Study|Protocol Violation|0|||
143340678|NCT03308825|516793206|FG001|Overall Study|Protocol Violation|2|||
143340679|NCT03308825|516793207|FG002|Overall Study|Protocol Violation|0|||
143340680|NCT03308825|516793208|FG003|Overall Study|Protocol Violation|0|||
143340681|NCT00685945|516793209|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
143340682|NCT00847405|516793210|FG000|First Intervention|Adverse Event|0|||
143340683|NCT00847405|516793211|FG001|First Intervention|Adverse Event|1|||
143340684|NCT00847405|516793210|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
143340685|NCT00847405|516793211|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
143340686|NCT04277455|516793214|FG000|Overall Study|Lost to Follow-up|1|||
143340687|NCT01679301|516793215|FG000|Screening Period|screen failure|3|||
143395367|NCT01802788|516994917|FG001|Overall Study|Patient Non-Compliance|0|||
143395368|NCT01802788|516994916|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
143395369|NCT01802788|516994917|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
143395370|NCT01802788|516994916|FG000|Overall Study|Other Reasons|19|||
143340688|NCT01679301|516793216|FG001|Screening Period|screen failure|0|||
143340689|NCT01679301|516793217|FG002|Screening Period|screen failure|0|||
143340690|NCT04770753|516793218|FG000|Overall Study|Randomized, never treated|1|||
143340691|NCT04770753|516793219|FG001|Overall Study|Randomized, never treated|1|||
143340692|NCT04770753|516793218|FG000|Overall Study|Withdrawal by Subject|3|||
143340693|NCT04770753|516793219|FG001|Overall Study|Withdrawal by Subject|1|||
143340694|NCT04770753|516793218|FG000|Overall Study|Adverse Event|2|||
143340695|NCT04770753|516793219|FG001|Overall Study|Adverse Event|0|||
143340696|NCT04770753|516793218|FG000|Overall Study|Pregnancy|1|||
143340697|NCT04770753|516793219|FG001|Overall Study|Pregnancy|0|||
143340698|NCT04770753|516793218|FG000|Overall Study|Other un-specified|1|||
143340699|NCT04770753|516793219|FG001|Overall Study|Other un-specified|0|||
143340700|NCT02882282|516793220|FG000|Overall Study|Adverse Event|1|||
143340701|NCT02882282|516793221|FG001|Overall Study|Adverse Event|0|||
143340702|NCT04425902|516793222|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
143340703|NCT01191840|516793224|FG000|Overall Study|withdrew consent|2|||
143340704|NCT01191840|516793225|FG001|Overall Study|withdrew consent|1|||
143340705|NCT01191840|516793224|FG000|Overall Study|Subject discontinued treatment|1|||
143340706|NCT01191840|516793225|FG001|Overall Study|Subject discontinued treatment|2|||
143340707|NCT01191840|516793224|FG000|Overall Study|Lost to Follow-up|4|||
143340708|NCT01191840|516793225|FG001|Overall Study|Lost to Follow-up|6|||
143340709|NCT01191840|516793224|FG000|Overall Study|Non Staph Infection|4|||
143340710|NCT01191840|516793225|FG001|Overall Study|Non Staph Infection|3|||
143340711|NCT01191840|516793224|FG000|Overall Study|ineligible at enrollment|1|||
143340712|NCT01191840|516793225|FG001|Overall Study|ineligible at enrollment|0|||
143340713|NCT01191840|516793224|FG000|Overall Study|IRB approval lapse|0|||
143340714|NCT01191840|516793225|FG001|Overall Study|IRB approval lapse|2|||
143340715|NCT01191840|516793224|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
143340716|NCT01191840|516793225|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
143340717|NCT01191840|516793224|FG000|Overall Study|Withdrawal by Subject|2|||
143340718|NCT01191840|516793225|FG001|Overall Study|Withdrawal by Subject|0|||
143340719|NCT04669600|516793226|FG000|Overall Study|Withdrawal by Subject|1|||
143340720|NCT04669600|516793226|FG000|Overall Study|Other|6|||
143340721|NCT00710606|516793229|FG000|Overall Study|Adverse Event|0|||
143340722|NCT00710606|516793230|FG001|Overall Study|Adverse Event|2|||
143340723|NCT01682213|516793239|FG000|Overall Study|Withdrawal by Subject|2|||
143340724|NCT01181726|516793240|FG000|First Intervention|Adverse Event|1|||
143340725|NCT01181726|516793241|FG001|First Intervention|Adverse Event|0|||
143340726|NCT01995539|516793242|FG000|Overall Study|Screening Failure|1|||
143340727|NCT01995539|516793242|FG000|Overall Study|Withdrawal by Investigator|15|||
143340728|NCT01995539|516793242|FG000|Overall Study|Withdrawal by Subject|11|||
143340729|NCT01995539|516793242|FG000|Overall Study|Lost to Follow-up|5|||
143340730|NCT01995539|516793242|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
143340731|NCT01264380|516793243|FG000|Period C|Disease Progression|0|||
143340732|NCT01264380|516793244|FG001|Period C|Disease Progression|0|||
143340733|NCT01264380|516793245|FG002|Period C|Disease Progression|4|||
143340734|NCT01264380|516793243|FG000|Period C|Death|0|||
143340735|NCT01264380|516793244|FG001|Period C|Death|0|||
143340736|NCT01264380|516793245|FG002|Period C|Death|2|||
143340737|NCT01264380|516793243|FG000|Period C|Follow-up for survival status|0|||
143340738|NCT01264380|516793244|FG001|Period C|Follow-up for survival status|0|||
143340739|NCT01264380|516793245|FG002|Period C|Follow-up for survival status|6|||
143340740|NCT01264380|516793243|FG000|Period C|Withdrawal by Subject|0|||
143340741|NCT01264380|516793244|FG001|Period C|Withdrawal by Subject|0|||
143340742|NCT01264380|516793245|FG002|Period C|Withdrawal by Subject|1|||
143340743|NCT01264380|516793243|FG000|Period C|Adverse Event|0|||
143340744|NCT01264380|516793244|FG001|Period C|Adverse Event|0|||
143340745|NCT01264380|516793245|FG002|Period C|Adverse Event|1|||
143340746|NCT01147822|516793246|FG000|Overall Study|Lost to Follow-up|14|||
143340747|NCT01147822|516793247|FG001|Overall Study|Lost to Follow-up|6|||
143340748|NCT01147822|516793246|FG000|Overall Study|Withdrawal by Subject|10|||
143340749|NCT01147822|516793247|FG001|Overall Study|Withdrawal by Subject|16|||
143340750|NCT01147822|516793246|FG000|Overall Study|Physician Decision|9|||
143340751|NCT01147822|516793247|FG001|Overall Study|Physician Decision|8|||
143340752|NCT01147822|516793246|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|4|||
143340753|NCT01147822|516793247|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|5|||
143340754|NCT01147822|516793246|FG000|Overall Study|Protocol Violation|1|||
143340755|NCT01147822|516793247|FG001|Overall Study|Protocol Violation|1|||
143340756|NCT03815019|516793251|FG000|Overall Study|Withdrawal by Subject|6|||
143340757|NCT03815019|516793252|FG001|Overall Study|Withdrawal by Subject|8|||
143340758|NCT05398796|516793253|FG000|Overall Study|Participant moved from the area|0|||
143340759|NCT05398796|516793254|FG001|Overall Study|Participant moved from the area|1|||
143340760|NCT05398796|516793255|FG002|Overall Study|Participant moved from the area|0|||
143340761|NCT05398796|516793256|FG003|Overall Study|Participant moved from the area|0|||
143340762|NCT04179032|516793258|FG000|Part B (Up to Week 52)|Adverse Event|1|||
143340763|NCT04179032|516793258|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
143340764|NCT04179032|516793258|FG000|Access Extension Phase|Ongoing|11|||
143340765|NCT04270747|516793259|FG000|Through Week 16|Adverse Event|1|||
143340766|NCT04270747|516793260|FG001|Through Week 16|Adverse Event|2|||
143340767|NCT04270747|516793261|FG002|Through Week 16|Adverse Event|0|||
143340768|NCT04270747|516793259|FG000|Through Week 16|Death|0|||
143340769|NCT04270747|516793260|FG001|Through Week 16|Death|2|||
143340770|NCT04270747|516793261|FG002|Through Week 16|Death|0|||
143340771|NCT04270747|516793259|FG000|Through Week 16|Consent Withdrawn|3|||
143340772|NCT04270747|516793260|FG001|Through Week 16|Consent Withdrawn|3|||
143340773|NCT04270747|516793261|FG002|Through Week 16|Consent Withdrawn|0|||
143340774|NCT04270747|516793259|FG000|Through Week 16|Physician Decision|1|||
143340775|NCT04270747|516793260|FG001|Through Week 16|Physician Decision|1|||
143340776|NCT04270747|516793261|FG002|Through Week 16|Physician Decision|0|||
143340777|NCT04270747|516793259|FG000|Through Week 16|Lost to Follow-up|2|||
143340778|NCT04270747|516793260|FG001|Through Week 16|Lost to Follow-up|0|||
143340779|NCT04270747|516793261|FG002|Through Week 16|Lost to Follow-up|0|||
143340780|NCT04270747|516793259|FG000|Through Week 16|Protocol Violation|1|||
143340781|NCT04270747|516793260|FG001|Through Week 16|Protocol Violation|2|||
143340782|NCT04270747|516793261|FG002|Through Week 16|Protocol Violation|0|||
143340783|NCT04270747|516793259|FG000|Through Week 16|Protocol Specified Criteria|6|||
143340784|NCT04270747|516793260|FG001|Through Week 16|Protocol Specified Criteria|7|||
143340785|NCT04270747|516793261|FG002|Through Week 16|Protocol Specified Criteria|0|||
143340786|NCT04270747|516793259|FG000|Through Week 16|Miscellaneous|1|||
143340787|NCT04270747|516793260|FG001|Through Week 16|Miscellaneous|1|||
143340788|NCT04270747|516793261|FG002|Through Week 16|Miscellaneous|0|||
143340789|NCT04270747|516793259|FG000|Post Week 16|Adverse Event|7|||
143340790|NCT04270747|516793260|FG001|Post Week 16|Adverse Event|5|||
143340791|NCT04270747|516793261|FG002|Post Week 16|Adverse Event|1|||
143340792|NCT04270747|516793259|FG000|Post Week 16|Death|2|||
143340793|NCT04270747|516793260|FG001|Post Week 16|Death|0|||
143340794|NCT04270747|516793261|FG002|Post Week 16|Death|2|||
143340795|NCT04270747|516793259|FG000|Post Week 16|Consent Withdrawn|4|||
143340796|NCT04270747|516793260|FG001|Post Week 16|Consent Withdrawn|3|||
143340797|NCT04270747|516793261|FG002|Post Week 16|Consent Withdrawn|6|||
143340798|NCT04270747|516793259|FG000|Post Week 16|Physician Decision|3|||
143340799|NCT04270747|516793260|FG001|Post Week 16|Physician Decision|1|||
143340800|NCT04270747|516793261|FG002|Post Week 16|Physician Decision|1|||
143340801|NCT04270747|516793259|FG000|Post Week 16|Lost to Follow-up|2|||
143340802|NCT04270747|516793260|FG001|Post Week 16|Lost to Follow-up|1|||
143340803|NCT04270747|516793261|FG002|Post Week 16|Lost to Follow-up|0|||
143340804|NCT04270747|516793259|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
143340805|NCT04270747|516793260|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
143340806|NCT04270747|516793261|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
143340807|NCT04270747|516793259|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
143340808|NCT04270747|516793260|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
143340809|NCT04270747|516793261|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
143340810|NCT04270747|516793259|FG000|Post Week 16|Miscellaneous|1|||
143340811|NCT04270747|516793260|FG001|Post Week 16|Miscellaneous|0|||
143340812|NCT04270747|516793261|FG002|Post Week 16|Miscellaneous|1|||
143340813|NCT05960097|516793263|FG000|Overall Study|Lost to Follow-up|3|||
143340814|NCT05960097|516793264|FG001|Overall Study|Lost to Follow-up|1|||
143340815|NCT05960097|516793265|FG002|Overall Study|Lost to Follow-up|1|||
143340816|NCT05960097|516793266|FG003|Overall Study|Lost to Follow-up|2|||
143340817|NCT05960097|516793267|FG004|Overall Study|Lost to Follow-up|1|||
143340818|NCT05960097|516793268|FG005|Overall Study|Lost to Follow-up|1|||
143340819|NCT05960097|516793269|FG006|Overall Study|Lost to Follow-up|2|||
143340820|NCT05960097|516793270|FG007|Overall Study|Lost to Follow-up|3|||
143340821|NCT05960097|516793263|FG000|Overall Study|Physician Decision|0|||
143340822|NCT05960097|516793264|FG001|Overall Study|Physician Decision|0|||
143340823|NCT05960097|516793265|FG002|Overall Study|Physician Decision|0|||
143340824|NCT05960097|516793266|FG003|Overall Study|Physician Decision|0|||
143340825|NCT05960097|516793267|FG004|Overall Study|Physician Decision|0|||
143340826|NCT05960097|516793268|FG005|Overall Study|Physician Decision|0|||
143340827|NCT05960097|516793269|FG006|Overall Study|Physician Decision|1|||
143340828|NCT05960097|516793270|FG007|Overall Study|Physician Decision|0|||
143340829|NCT05960097|516793263|FG000|Overall Study|Withdrawal by Subject|1|||
143340830|NCT05960097|516793264|FG001|Overall Study|Withdrawal by Subject|0|||
143340831|NCT05960097|516793265|FG002|Overall Study|Withdrawal by Subject|0|||
143340832|NCT05960097|516793266|FG003|Overall Study|Withdrawal by Subject|1|||
143340833|NCT05960097|516793267|FG004|Overall Study|Withdrawal by Subject|1|||
143340834|NCT05960097|516793268|FG005|Overall Study|Withdrawal by Subject|0|||
143340835|NCT05960097|516793269|FG006|Overall Study|Withdrawal by Subject|0|||
143340836|NCT05960097|516793270|FG007|Overall Study|Withdrawal by Subject|0|||
143340837|NCT05960097|516793263|FG000|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
143340838|NCT05960097|516793264|FG001|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
143340839|NCT05960097|516793265|FG002|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|1|||
143340840|NCT05960097|516793266|FG003|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
143340841|NCT05960097|516793267|FG004|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
143340842|NCT05960097|516793268|FG005|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
143340843|NCT05960097|516793269|FG006|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
143340844|NCT05960097|516793270|FG007|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
143340845|NCT02597036|516793271|FG000|Overall Study|Progressive Disease|0|||
143340846|NCT02597036|516793272|FG001|Overall Study|Progressive Disease|0|||
143340847|NCT02597036|516793273|FG002|Overall Study|Progressive Disease|0|||
143340848|NCT02597036|516793274|FG003|Overall Study|Progressive Disease|0|||
143340849|NCT02597036|516793275|FG004|Overall Study|Progressive Disease|1|||
143340850|NCT02597036|516793276|FG005|Overall Study|Progressive Disease|1|||
143340851|NCT02597036|516793277|FG006|Overall Study|Progressive Disease|1|||
143340852|NCT02597036|516793278|FG007|Overall Study|Progressive Disease|0|||
143340853|NCT02597036|516793279|FG008|Overall Study|Progressive Disease|0|||
143340854|NCT02597036|516793280|FG009|Overall Study|Progressive Disease|0|||
143340855|NCT02597036|516793281|FG010|Overall Study|Progressive Disease|0|||
143340856|NCT02597036|516793282|FG011|Overall Study|Progressive Disease|0|||
143340857|NCT02597036|516793271|FG000|Overall Study|Adverse Event|0|||
143340858|NCT02597036|516793272|FG001|Overall Study|Adverse Event|0|||
143340859|NCT02597036|516793273|FG002|Overall Study|Adverse Event|0|||
143340860|NCT02597036|516793274|FG003|Overall Study|Adverse Event|0|||
143340861|NCT02597036|516793275|FG004|Overall Study|Adverse Event|0|||
143340862|NCT02597036|516793276|FG005|Overall Study|Adverse Event|0|||
143340863|NCT02597036|516793277|FG006|Overall Study|Adverse Event|0|||
143340864|NCT02597036|516793278|FG007|Overall Study|Adverse Event|1|||
143340865|NCT02597036|516793279|FG008|Overall Study|Adverse Event|0|||
143340866|NCT02597036|516793280|FG009|Overall Study|Adverse Event|0|||
143340867|NCT02597036|516793281|FG010|Overall Study|Adverse Event|0|||
143340868|NCT02597036|516793282|FG011|Overall Study|Adverse Event|1|||
143340869|NCT02597036|516793271|FG000|Overall Study|Death|0|||
143340870|NCT02597036|516793272|FG001|Overall Study|Death|0|||
143340871|NCT02597036|516793273|FG002|Overall Study|Death|0|||
143340872|NCT02597036|516793274|FG003|Overall Study|Death|0|||
143340873|NCT02597036|516793275|FG004|Overall Study|Death|0|||
143340874|NCT02597036|516793276|FG005|Overall Study|Death|0|||
143340875|NCT02597036|516793277|FG006|Overall Study|Death|0|||
143340876|NCT02597036|516793278|FG007|Overall Study|Death|0|||
143340877|NCT02597036|516793279|FG008|Overall Study|Death|0|||
143340878|NCT02597036|516793280|FG009|Overall Study|Death|1|||
143340879|NCT02597036|516793281|FG010|Overall Study|Death|1|||
143340880|NCT02597036|516793282|FG011|Overall Study|Death|0|||
143340881|NCT02597036|516793271|FG000|Overall Study|Lost to Follow-up|0|||
143340882|NCT02597036|516793272|FG001|Overall Study|Lost to Follow-up|0|||
143340883|NCT02597036|516793273|FG002|Overall Study|Lost to Follow-up|0|||
143340884|NCT02597036|516793274|FG003|Overall Study|Lost to Follow-up|0|||
143340885|NCT02597036|516793275|FG004|Overall Study|Lost to Follow-up|0|||
143340886|NCT02597036|516793276|FG005|Overall Study|Lost to Follow-up|0|||
143340887|NCT02597036|516793277|FG006|Overall Study|Lost to Follow-up|0|||
143340888|NCT02597036|516793278|FG007|Overall Study|Lost to Follow-up|0|||
143340889|NCT02597036|516793279|FG008|Overall Study|Lost to Follow-up|0|||
143340890|NCT02597036|516793280|FG009|Overall Study|Lost to Follow-up|0|||
143340891|NCT02597036|516793281|FG010|Overall Study|Lost to Follow-up|1|||
143340892|NCT02597036|516793282|FG011|Overall Study|Lost to Follow-up|0|||
143340893|NCT02597036|516793271|FG000|Overall Study|Withdrawal by Subject|0|||
143340894|NCT02597036|516793272|FG001|Overall Study|Withdrawal by Subject|0|||
143340895|NCT02597036|516793273|FG002|Overall Study|Withdrawal by Subject|0|||
143340896|NCT02597036|516793274|FG003|Overall Study|Withdrawal by Subject|0|||
143340897|NCT02597036|516793275|FG004|Overall Study|Withdrawal by Subject|0|||
143340898|NCT02597036|516793276|FG005|Overall Study|Withdrawal by Subject|0|||
143340899|NCT02597036|516793277|FG006|Overall Study|Withdrawal by Subject|0|||
143340900|NCT02597036|516793278|FG007|Overall Study|Withdrawal by Subject|0|||
143340901|NCT02597036|516793279|FG008|Overall Study|Withdrawal by Subject|0|||
143340902|NCT02597036|516793280|FG009|Overall Study|Withdrawal by Subject|0|||
143340903|NCT02597036|516793281|FG010|Overall Study|Withdrawal by Subject|0|||
143340904|NCT02597036|516793282|FG011|Overall Study|Withdrawal by Subject|1|||
143340905|NCT06351371|516793285|FG000|Overall Study|Mutation Status Not Confirmed|9|||
143340906|NCT06351371|516793285|FG000|Overall Study|Ineligible|1|||
143340907|NCT06351371|516793285|FG000|Overall Study|Adverse Event|4|||
143340908|NCT06351371|516793285|FG000|Overall Study|Death|1|||
143340909|NCT06351371|516793285|FG000|Overall Study|Disease progression|14|||
143340910|NCT06351371|516793285|FG000|Overall Study|Withdrawal by Subject|3|||
143340911|NCT06351371|516793285|FG000|Overall Study|Physician Decision|3|||
143340912|NCT05614089|516793286|FG000|Overall Study|Pregnancy|5|||
143340913|NCT05614089|516793287|FG001|Overall Study|Pregnancy|2|||
143340914|NCT05614089|516793286|FG000|Overall Study|Lost to Follow-up|5|||
143340915|NCT05614089|516793287|FG001|Overall Study|Lost to Follow-up|1|||
143340916|NCT05614089|516793286|FG000|Overall Study|Death|0|||
143340917|NCT05614089|516793287|FG001|Overall Study|Death|1|||
143340918|NCT05614089|516793286|FG000|Overall Study|Adverse Event|1|||
143340919|NCT05614089|516793287|FG001|Overall Study|Adverse Event|0|||
143340920|NCT05701995|516793290|FG000|Pre-Treatment|Randomization Error|1|||
143340921|NCT05701995|516793291|FG001|Pre-Treatment|Randomization Error|1|||
143340922|NCT05701995|516793290|FG000|Treatment|Withdrawal by Subject|8|||
143340923|NCT05701995|516793291|FG001|Treatment|Withdrawal by Subject|4|||
143340924|NCT05701995|516793290|FG000|Treatment|Lost to Follow-up|2|||
143340925|NCT05701995|516793291|FG001|Treatment|Lost to Follow-up|3|||
143340926|NCT05701995|516793290|FG000|Treatment|Adverse Event|3|||
143340927|NCT05701995|516793291|FG001|Treatment|Adverse Event|1|||
143340928|NCT05701995|516793290|FG000|Treatment|Other Reason|1|||
143340929|NCT05701995|516793291|FG001|Treatment|Other Reason|1|||
143340930|NCT05701995|516793290|FG000|Treatment|Death|1|||
143340931|NCT05701995|516793291|FG001|Treatment|Death|0|||
143340932|NCT05701995|516793290|FG000|Treatment|Physician Decision|0|||
143340933|NCT05701995|516793291|FG001|Treatment|Physician Decision|1|||
143340934|NCT04359784|516793292|FG000|Overall Study|Death|2|||
143340935|NCT03937219|516793296|FG000|Overall Study|Death|223|||
143340936|NCT03937219|516793297|FG001|Overall Study|Death|211|||
143340937|NCT03937219|516793296|FG000|Overall Study|Withdrawal by Subject|17|||
143340938|NCT03937219|516793297|FG001|Overall Study|Withdrawal by Subject|25|||
143340939|NCT03937219|516793296|FG000|Overall Study|Lost to Follow-up|3|||
143340940|NCT03937219|516793297|FG001|Overall Study|Lost to Follow-up|4|||
143340941|NCT03217747|516793300|FG000|Overall Study|Adverse Event|0|||
143340942|NCT03217747|516793301|FG001|Overall Study|Adverse Event|1|||
143340943|NCT03217747|516793302|FG002|Overall Study|Adverse Event|0|||
143340944|NCT03217747|516793303|FG003|Overall Study|Adverse Event|0|||
143340945|NCT03217747|516793304|FG004|Overall Study|Adverse Event|0|||
143340946|NCT03217747|516793305|FG005|Overall Study|Adverse Event|0|||
143340947|NCT03217747|516793306|FG006|Overall Study|Adverse Event|0|||
143340948|NCT03217747|516793307|FG007|Overall Study|Adverse Event|0|||
143340949|NCT03217747|516793308|FG008|Overall Study|Adverse Event|0|||
143340950|NCT03217747|516793309|FG009|Overall Study|Adverse Event|0|||
143340951|NCT03217747|516793310|FG010|Overall Study|Adverse Event|0|||
143340952|NCT03217747|516793311|FG011|Overall Study|Adverse Event|0|||
143340953|NCT03217747|516793312|FG012|Overall Study|Adverse Event|1|||
143340954|NCT03217747|516793313|FG013|Overall Study|Adverse Event|1|||
143340955|NCT03217747|516793300|FG000|Overall Study|Death|0|||
143340956|NCT03217747|516793301|FG001|Overall Study|Death|0|||
143340957|NCT03217747|516793302|FG002|Overall Study|Death|0|||
143340958|NCT03217747|516793303|FG003|Overall Study|Death|0|||
143340959|NCT03217747|516793304|FG004|Overall Study|Death|0|||
143340960|NCT03217747|516793305|FG005|Overall Study|Death|0|||
143340961|NCT03217747|516793306|FG006|Overall Study|Death|0|||
143340962|NCT03217747|516793307|FG007|Overall Study|Death|0|||
143340963|NCT03217747|516793308|FG008|Overall Study|Death|1|||
143340964|NCT03217747|516793309|FG009|Overall Study|Death|0|||
143340965|NCT03217747|516793310|FG010|Overall Study|Death|0|||
143340966|NCT03217747|516793311|FG011|Overall Study|Death|0|||
143340967|NCT03217747|516793312|FG012|Overall Study|Death|0|||
143340968|NCT03217747|516793313|FG013|Overall Study|Death|0|||
143340969|NCT03217747|516793300|FG000|Overall Study|Lack of Efficacy|12|||
143340970|NCT03217747|516793301|FG001|Overall Study|Lack of Efficacy|6|||
143340971|NCT03217747|516793302|FG002|Overall Study|Lack of Efficacy|15|||
143340972|NCT03217747|516793303|FG003|Overall Study|Lack of Efficacy|11|||
143340973|NCT03217747|516793304|FG004|Overall Study|Lack of Efficacy|3|||
143340974|NCT03217747|516793305|FG005|Overall Study|Lack of Efficacy|14|||
143340975|NCT03217747|516793306|FG006|Overall Study|Lack of Efficacy|10|||
143340976|NCT03217747|516793307|FG007|Overall Study|Lack of Efficacy|4|||
143340977|NCT03217747|516793308|FG008|Overall Study|Lack of Efficacy|2|||
143340978|NCT03217747|516793309|FG009|Overall Study|Lack of Efficacy|7|||
143340979|NCT03217747|516793310|FG010|Overall Study|Lack of Efficacy|3|||
143340980|NCT03217747|516793311|FG011|Overall Study|Lack of Efficacy|1|||
143340981|NCT03217747|516793312|FG012|Overall Study|Lack of Efficacy|3|||
143340982|NCT03217747|516793313|FG013|Overall Study|Lack of Efficacy|1|||
143340983|NCT03217747|516793300|FG000|Overall Study|Withdrawal by Subject|2|||
143340984|NCT03217747|516793301|FG001|Overall Study|Withdrawal by Subject|1|||
143340985|NCT03217747|516793302|FG002|Overall Study|Withdrawal by Subject|1|||
143340986|NCT03217747|516793303|FG003|Overall Study|Withdrawal by Subject|1|||
143340987|NCT03217747|516793304|FG004|Overall Study|Withdrawal by Subject|1|||
143340988|NCT03217747|516793305|FG005|Overall Study|Withdrawal by Subject|2|||
143340989|NCT03217747|516793306|FG006|Overall Study|Withdrawal by Subject|1|||
143340990|NCT03217747|516793307|FG007|Overall Study|Withdrawal by Subject|0|||
143340991|NCT03217747|516793308|FG008|Overall Study|Withdrawal by Subject|0|||
143340992|NCT03217747|516793309|FG009|Overall Study|Withdrawal by Subject|0|||
143340993|NCT03217747|516793310|FG010|Overall Study|Withdrawal by Subject|0|||
143340994|NCT03217747|516793311|FG011|Overall Study|Withdrawal by Subject|1|||
143340995|NCT03217747|516793312|FG012|Overall Study|Withdrawal by Subject|0|||
143340996|NCT03217747|516793313|FG013|Overall Study|Withdrawal by Subject|1|||
143340997|NCT03217747|516793300|FG000|Overall Study|Toxicity and progression|1|||
143340998|NCT03217747|516793301|FG001|Overall Study|Toxicity and progression|0|||
143340999|NCT03217747|516793302|FG002|Overall Study|Toxicity and progression|0|||
143341000|NCT03217747|516793303|FG003|Overall Study|Toxicity and progression|0|||
143341001|NCT03217747|516793304|FG004|Overall Study|Toxicity and progression|0|||
143341002|NCT03217747|516793305|FG005|Overall Study|Toxicity and progression|0|||
143341003|NCT03217747|516793306|FG006|Overall Study|Toxicity and progression|0|||
143341004|NCT03217747|516793307|FG007|Overall Study|Toxicity and progression|0|||
143341005|NCT03217747|516793308|FG008|Overall Study|Toxicity and progression|0|||
143341006|NCT03217747|516793309|FG009|Overall Study|Toxicity and progression|0|||
143341007|NCT03217747|516793310|FG010|Overall Study|Toxicity and progression|0|||
143341008|NCT03217747|516793311|FG011|Overall Study|Toxicity and progression|0|||
143341009|NCT03217747|516793312|FG012|Overall Study|Toxicity and progression|0|||
143341010|NCT03217747|516793313|FG013|Overall Study|Toxicity and progression|0|||
143341011|NCT03217747|516793300|FG000|Overall Study|Removal of sole target lesion|1|||
143341012|NCT03217747|516793301|FG001|Overall Study|Removal of sole target lesion|0|||
143341013|NCT03217747|516793302|FG002|Overall Study|Removal of sole target lesion|0|||
143341014|NCT03217747|516793303|FG003|Overall Study|Removal of sole target lesion|0|||
143341015|NCT03217747|516793304|FG004|Overall Study|Removal of sole target lesion|0|||
143341016|NCT03217747|516793305|FG005|Overall Study|Removal of sole target lesion|0|||
143341017|NCT03217747|516793306|FG006|Overall Study|Removal of sole target lesion|0|||
143341018|NCT03217747|516793307|FG007|Overall Study|Removal of sole target lesion|0|||
143341019|NCT03217747|516793308|FG008|Overall Study|Removal of sole target lesion|0|||
143341020|NCT03217747|516793309|FG009|Overall Study|Removal of sole target lesion|0|||
143341021|NCT03217747|516793310|FG010|Overall Study|Removal of sole target lesion|0|||
143341022|NCT03217747|516793311|FG011|Overall Study|Removal of sole target lesion|0|||
143341023|NCT03217747|516793312|FG012|Overall Study|Removal of sole target lesion|0|||
143341024|NCT03217747|516793313|FG013|Overall Study|Removal of sole target lesion|0|||
143341025|NCT03217747|516793300|FG000|Overall Study|Stroke|0|||
143341026|NCT03217747|516793301|FG001|Overall Study|Stroke|0|||
143341027|NCT03217747|516793302|FG002|Overall Study|Stroke|0|||
143341028|NCT03217747|516793303|FG003|Overall Study|Stroke|0|||
143341029|NCT03217747|516793304|FG004|Overall Study|Stroke|0|||
143341030|NCT03217747|516793305|FG005|Overall Study|Stroke|1|||
143341031|NCT03217747|516793306|FG006|Overall Study|Stroke|0|||
143341032|NCT03217747|516793307|FG007|Overall Study|Stroke|0|||
143341033|NCT03217747|516793308|FG008|Overall Study|Stroke|0|||
143341034|NCT03217747|516793309|FG009|Overall Study|Stroke|0|||
143341035|NCT03217747|516793310|FG010|Overall Study|Stroke|0|||
143341036|NCT03217747|516793311|FG011|Overall Study|Stroke|1|||
143341037|NCT03217747|516793312|FG012|Overall Study|Stroke|0|||
143341038|NCT03217747|516793313|FG013|Overall Study|Stroke|0|||
143341039|NCT03996291|516793314|FG000|Part A (Double-blind Period):39 Weeks|Other|1|||
143341040|NCT03996291|516793315|FG001|Part A (Double-blind Period):39 Weeks|Other|0|||
143341041|NCT03996291|516793316|FG002|Part A (Double-blind Period):39 Weeks|Other|0|||
143341042|NCT03996291|516793317|FG003|Part A (Double-blind Period):39 Weeks|Other|0|||
143341043|NCT03996291|516793318|FG004|Part A (Double-blind Period):39 Weeks|Other|0|||
143341044|NCT03996291|516793319|FG005|Part A (Double-blind Period):39 Weeks|Other|0|||
143341045|NCT03996291|516793320|FG006|Part A (Double-blind Period):39 Weeks|Other|0|||
143341046|NCT03996291|516793321|FG007|Part A (Double-blind Period):39 Weeks|Other|0|||
143341047|NCT03996291|516793314|FG000|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
143341048|NCT03996291|516793315|FG001|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
143341049|NCT03996291|516793316|FG002|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
143341050|NCT03996291|516793317|FG003|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
143341051|NCT03996291|516793318|FG004|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
143341052|NCT03996291|516793319|FG005|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
143341053|NCT03996291|516793320|FG006|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
143341054|NCT03996291|516793321|FG007|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
143341055|NCT03996291|516793314|FG000|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
143341056|NCT03996291|516793315|FG001|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
143341057|NCT03996291|516793316|FG002|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
143341058|NCT03996291|516793317|FG003|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
143341059|NCT03996291|516793318|FG004|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
143341060|NCT03996291|516793319|FG005|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
143341061|NCT03996291|516793320|FG006|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
143341062|NCT03996291|516793321|FG007|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
143341063|NCT03996291|516793314|FG000|Part B (Open-label Period):222 Weeks|Other|0|||
143341064|NCT03996291|516793315|FG001|Part B (Open-label Period):222 Weeks|Other|0|||
143341065|NCT03996291|516793316|FG002|Part B (Open-label Period):222 Weeks|Other|0|||
143341066|NCT03996291|516793317|FG003|Part B (Open-label Period):222 Weeks|Other|0|||
143341067|NCT03996291|516793318|FG004|Part B (Open-label Period):222 Weeks|Other|8|||
143341068|NCT03996291|516793319|FG005|Part B (Open-label Period):222 Weeks|Other|7|||
143341069|NCT03996291|516793320|FG006|Part B (Open-label Period):222 Weeks|Other|10|||
143341070|NCT03996291|516793321|FG007|Part B (Open-label Period):222 Weeks|Other|5|||
143341071|NCT03996291|516793314|FG000|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
143341072|NCT03996291|516793315|FG001|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
143341073|NCT03996291|516793316|FG002|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
143341074|NCT03996291|516793317|FG003|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
143341075|NCT03996291|516793318|FG004|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|1|||
143341076|NCT03996291|516793319|FG005|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
143341077|NCT03996291|516793320|FG006|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
143341078|NCT03996291|516793321|FG007|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
143395371|NCT01802788|516994917|FG001|Overall Study|Other Reasons|0|||
143395372|NCT03907878|516994918|FG000|Treatment Period|Withdrawal by Subject|5|||
143395373|NCT03907878|516994918|FG000|Treatment Period|Adverse Event|4|||
143395374|NCT03907878|516994918|FG000|Treatment Period|Lack of Efficacy|1|||
143395375|NCT03907878|516994918|FG000|Treatment Period|Protocol Violation|1|||
143395376|NCT03907878|516994918|FG000|Follow-up Period|Adverse Event|3|||
143395377|NCT03907878|516994918|FG000|Follow-up Period|Withdrawal by Subject|3|||
143395378|NCT03011333|516994928|FG000|Overall Study|Lost to Follow-up|0|||
143395379|NCT03011333|516994929|FG001|Overall Study|Lost to Follow-up|1|||
143395380|NCT03011333|516994930|FG002|Overall Study|Lost to Follow-up|0|||
143395381|NCT03011333|516994931|FG003|Overall Study|Lost to Follow-up|1|||
143395382|NCT03011333|516994932|FG004|Overall Study|Lost to Follow-up|4|||
143395383|NCT03011333|516994933|FG005|Overall Study|Lost to Follow-up|4|||
143395384|NCT03011333|516994934|FG006|Overall Study|Lost to Follow-up|5|||
143395385|NCT02861300|516994935|FG000|Overall Study|Death|0|||
143395386|NCT02861300|516994936|FG001|Overall Study|Death|0|||
143395387|NCT02861300|516994937|FG002|Overall Study|Death|0|||
143395388|NCT02861300|516994938|FG003|Overall Study|Death|0|||
143341079|NCT03248375|516793322|FG000|Overall Study|Lost to Follow-up|5|||
143341080|NCT04098250|516793323|FG000|Overall Study|Withdrawal by Subject|1|||
143341081|NCT04098250|516793324|FG001|Overall Study|Withdrawal by Subject|0|||
143341082|NCT04098250|516793323|FG000|Overall Study|Lost to Follow-up|0|||
143341083|NCT04098250|516793324|FG001|Overall Study|Lost to Follow-up|1|||
143341084|NCT00394355|516793325|FG000|Overall Study|Adverse Event|10|||
143341085|NCT00394355|516793326|FG001|Overall Study|Adverse Event|6|||
143341086|NCT00394355|516793327|FG002|Overall Study|Adverse Event|7|||
143341087|NCT00394355|516793328|FG003|Overall Study|Adverse Event|8|||
143341088|NCT00394355|516793325|FG000|Overall Study|Did not meet protocol eligibility|1|||
143341089|NCT00394355|516793326|FG001|Overall Study|Did not meet protocol eligibility|5|||
143341090|NCT00394355|516793327|FG002|Overall Study|Did not meet protocol eligibility|4|||
143341091|NCT00394355|516793328|FG003|Overall Study|Did not meet protocol eligibility|2|||
143341092|NCT00394355|516793325|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
143341093|NCT00394355|516793326|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
143341094|NCT00394355|516793327|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
143341095|NCT00394355|516793328|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
143341096|NCT00394355|516793325|FG000|Overall Study|Subject withdrawal - related to drug|1|||
143341097|NCT00394355|516793326|FG001|Overall Study|Subject withdrawal - related to drug|0|||
143341098|NCT00394355|516793327|FG002|Overall Study|Subject withdrawal - related to drug|0|||
143341099|NCT00394355|516793328|FG003|Overall Study|Subject withdrawal - related to drug|0|||
143341100|NCT00394355|516793325|FG000|Overall Study|Lost to Follow-up|7|||
143341101|NCT00394355|516793326|FG001|Overall Study|Lost to Follow-up|5|||
143341102|NCT00394355|516793327|FG002|Overall Study|Lost to Follow-up|4|||
143341103|NCT00394355|516793328|FG003|Overall Study|Lost to Follow-up|3|||
143341104|NCT00394355|516793325|FG000|Overall Study|Noncompliance with protocol|4|||
143341105|NCT00394355|516793326|FG001|Overall Study|Noncompliance with protocol|3|||
143341106|NCT00394355|516793327|FG002|Overall Study|Noncompliance with protocol|10|||
143341107|NCT00394355|516793328|FG003|Overall Study|Noncompliance with protocol|8|||
143341108|NCT00394355|516793325|FG000|Overall Study|Administrative|0|||
143341109|NCT00394355|516793326|FG001|Overall Study|Administrative|1|||
143341110|NCT00394355|516793327|FG002|Overall Study|Administrative|1|||
143341111|NCT00394355|516793328|FG003|Overall Study|Administrative|1|||
143341112|NCT00394355|516793325|FG000|Overall Study|Lack of Efficacy|0|||
143341113|NCT00394355|516793326|FG001|Overall Study|Lack of Efficacy|0|||
143341114|NCT00394355|516793327|FG002|Overall Study|Lack of Efficacy|2|||
143341115|NCT00394355|516793328|FG003|Overall Study|Lack of Efficacy|3|||
143341116|NCT05805657|516793331|FG000|Overall Study|Patients lost to post or 6-month follow-up|12|||
143341117|NCT05805657|516793332|FG001|Overall Study|Patients lost to post or 6-month follow-up|64|||
143341118|NCT00511875|516793333|FG000|Overall Study|Lost to Follow-up|4|||
143341119|NCT00511875|516793334|FG001|Overall Study|Lost to Follow-up|0|||
143341120|NCT00511875|516793333|FG000|Overall Study|Missing variables|1|||
143341121|NCT00511875|516793334|FG001|Overall Study|Missing variables|0|||
143395389|NCT02861300|516994939|FG004|Overall Study|Death|0|||
143395390|NCT02861300|516994940|FG005|Overall Study|Death|0|||
143395391|NCT02861300|516994941|FG006|Overall Study|Death|24|||
143395392|NCT02861300|516994935|FG000|Overall Study|Delay in treatment|0|||
143395393|NCT02861300|516994936|FG001|Overall Study|Delay in treatment|0|||
143395394|NCT02861300|516994937|FG002|Overall Study|Delay in treatment|0|||
143395395|NCT02861300|516994938|FG003|Overall Study|Delay in treatment|0|||
143395396|NCT02861300|516994939|FG004|Overall Study|Delay in treatment|0|||
143341122|NCT02686034|516793335|FG000|Run-In Period 1|Eligibility|12|||
143341123|NCT02686034|516793336|FG001|Run-In Period 1|Eligibility|10|||
143341124|NCT02686034|516793335|FG000|Run-In Period 1|Withdrawal by Subject|4|||
143341125|NCT02686034|516793336|FG001|Run-In Period 1|Withdrawal by Subject|3|||
143341126|NCT02686034|516793335|FG000|Run-In Period 1|Lost to Follow-up|4|||
143341127|NCT02686034|516793336|FG001|Run-In Period 1|Lost to Follow-up|4|||
143341128|NCT02686034|516793335|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
143341129|NCT02686034|516793336|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
143341130|NCT02686034|516793335|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
143341131|NCT02686034|516793336|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
143341132|NCT02686034|516793335|FG000|Randomized Controlled Period 2|Adverse Event|0|||
143341133|NCT02686034|516793336|FG001|Randomized Controlled Period 2|Adverse Event|2|||
143341134|NCT02686034|516793335|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
143341135|NCT02686034|516793336|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
143341136|NCT02686034|516793335|FG000|Open Label Period 3|Lost to Follow-up|0|||
143341137|NCT02686034|516793336|FG001|Open Label Period 3|Lost to Follow-up|1|||
143341138|NCT00542880|516793337|FG000|Period 1|Eligibility criteria not fulfilled|2|||
143341139|NCT00542880|516793338|FG001|Period 1|Eligibility criteria not fulfilled|6|||
143341140|NCT00542880|516793337|FG000|Period 1|Adverse Event|2|||
143341141|NCT00542880|516793338|FG001|Period 1|Adverse Event|2|||
143341142|NCT00542880|516793337|FG000|Period 1|Development of study-specific criteria|1|||
143341143|NCT00542880|516793338|FG001|Period 1|Development of study-specific criteria|2|||
143341144|NCT00542880|516793337|FG000|Period 1|Withdrawal by Subject|1|||
143341145|NCT00542880|516793338|FG001|Period 1|Withdrawal by Subject|1|||
143341146|NCT00542880|516793337|FG000|Period 1|Protocol Violation|0|||
143341147|NCT00542880|516793338|FG001|Period 1|Protocol Violation|1|||
143341148|NCT00542880|516793337|FG000|Period 2|Adverse Event|5|||
143341149|NCT00542880|516793338|FG001|Period 2|Adverse Event|7|||
143341150|NCT00542880|516793337|FG000|Period 2|Eligibility not fulfilled|0|||
143341151|NCT00542880|516793338|FG001|Period 2|Eligibility not fulfilled|1|||
143341152|NCT00542880|516793337|FG000|Period 2|Discontinuation criteria|2|||
143341153|NCT00542880|516793338|FG001|Period 2|Discontinuation criteria|0|||
143341154|NCT00542880|516793337|FG000|Period 2|Severe non-compliance|0|||
143341155|NCT00542880|516793338|FG001|Period 2|Severe non-compliance|1|||
143341156|NCT00542880|516793337|FG000|Period 2|Other|0|||
143341157|NCT00542880|516793338|FG001|Period 2|Other|1|||
143341158|NCT00542880|516793337|FG000|Period 3|Adverse Event|0|||
143341159|NCT00542880|516793338|FG001|Period 3|Adverse Event|2|||
143341160|NCT00696384|516793339|FG000|Open Label Phase|Adverse Event|27|||
143341161|NCT00696384|516793340|FG001|Open Label Phase|Adverse Event|0|||
143341162|NCT00696384|516793341|FG002|Open Label Phase|Adverse Event|0|||
143341163|NCT00696384|516793339|FG000|Open Label Phase|Protocol Violation|18|||
143341164|NCT00696384|516793340|FG001|Open Label Phase|Protocol Violation|0|||
143341165|NCT00696384|516793341|FG002|Open Label Phase|Protocol Violation|0|||
143341166|NCT00696384|516793339|FG000|Open Label Phase|Lost to Follow-up|24|||
143341167|NCT00696384|516793340|FG001|Open Label Phase|Lost to Follow-up|0|||
143341168|NCT00696384|516793341|FG002|Open Label Phase|Lost to Follow-up|0|||
143341169|NCT00696384|516793339|FG000|Open Label Phase|Withdrawal by Subject|37|||
143341170|NCT00696384|516793340|FG001|Open Label Phase|Withdrawal by Subject|0|||
143341171|NCT00696384|516793341|FG002|Open Label Phase|Withdrawal by Subject|0|||
143341172|NCT00696384|516793339|FG000|Open Label Phase|Other|6|||
143341173|NCT00696384|516793340|FG001|Open Label Phase|Other|0|||
143341174|NCT00696384|516793341|FG002|Open Label Phase|Other|0|||
143341175|NCT00696384|516793339|FG000|Open Label Phase|Lack of Efficacy|3|||
143341176|NCT00696384|516793340|FG001|Open Label Phase|Lack of Efficacy|0|||
143341177|NCT00696384|516793341|FG002|Open Label Phase|Lack of Efficacy|0|||
143341178|NCT00696384|516793339|FG000|Open Label Phase|Physician Decision|4|||
143341179|NCT00696384|516793340|FG001|Open Label Phase|Physician Decision|0|||
143341180|NCT00696384|516793341|FG002|Open Label Phase|Physician Decision|0|||
143341181|NCT00696384|516793339|FG000|Double Blind Phase|Adverse Event|0|||
143341182|NCT00696384|516793340|FG001|Double Blind Phase|Adverse Event|2|||
143341183|NCT00696384|516793341|FG002|Double Blind Phase|Adverse Event|2|||
143341184|NCT00696384|516793339|FG000|Double Blind Phase|Lost to Follow-up|0|||
143395397|NCT02861300|516994940|FG005|Overall Study|Delay in treatment|1|||
143395398|NCT02861300|516994941|FG006|Overall Study|Delay in treatment|0|||
143341185|NCT00696384|516793340|FG001|Double Blind Phase|Lost to Follow-up|2|||
143341186|NCT00696384|516793341|FG002|Double Blind Phase|Lost to Follow-up|1|||
143341187|NCT00696384|516793339|FG000|Double Blind Phase|Withdrawal by Subject|0|||
143341188|NCT00696384|516793340|FG001|Double Blind Phase|Withdrawal by Subject|4|||
143341189|NCT00696384|516793341|FG002|Double Blind Phase|Withdrawal by Subject|3|||
143341190|NCT00696384|516793339|FG000|Double Blind Phase|Lack of Efficacy|0|||
143341191|NCT00696384|516793340|FG001|Double Blind Phase|Lack of Efficacy|1|||
143341192|NCT00696384|516793341|FG002|Double Blind Phase|Lack of Efficacy|0|||
143341193|NCT00696384|516793339|FG000|Double Blind Phase|Physician Decision|0|||
143341194|NCT00696384|516793340|FG001|Double Blind Phase|Physician Decision|2|||
143341195|NCT00696384|516793341|FG002|Double Blind Phase|Physician Decision|0|||
143341196|NCT00558064|516793343|FG000|Overall Study|Adverse Event|3|||
143341197|NCT00558064|516793344|FG001|Overall Study|Adverse Event|2|||
143341198|NCT00558064|516793343|FG000|Overall Study|Lack of Efficacy|0|||
143341199|NCT00558064|516793344|FG001|Overall Study|Lack of Efficacy|1|||
143341200|NCT00558064|516793343|FG000|Overall Study|Protocol Violation|1|||
143341201|NCT00558064|516793344|FG001|Overall Study|Protocol Violation|0|||
143341202|NCT00558064|516793343|FG000|Overall Study|Lost to Follow-up|0|||
143341203|NCT00558064|516793344|FG001|Overall Study|Lost to Follow-up|1|||
143341204|NCT00558064|516793343|FG000|Overall Study|Withdrawal by Subject|0|||
143341205|NCT00558064|516793344|FG001|Overall Study|Withdrawal by Subject|1|||
143341206|NCT00558064|516793343|FG000|Overall Study|No visit within allowance period|1|||
143341207|NCT00558064|516793344|FG001|Overall Study|No visit within allowance period|0|||
143341208|NCT00941798|516793347|FG000|Overall Study|Withdrawal by Subject|72|||
143341209|NCT00941798|516793348|FG001|Overall Study|Withdrawal by Subject|74|||
143341210|NCT00941798|516793347|FG000|Overall Study|Adverse Event|43|||
143341211|NCT00941798|516793348|FG001|Overall Study|Adverse Event|23|||
143341212|NCT00941798|516793347|FG000|Overall Study|Lost to Follow-up|29|||
143341213|NCT00941798|516793348|FG001|Overall Study|Lost to Follow-up|23|||
143341214|NCT00941798|516793347|FG000|Overall Study|Protocol Violation|17|||
143341215|NCT00941798|516793348|FG001|Overall Study|Protocol Violation|20|||
143341216|NCT00941798|516793347|FG000|Overall Study|Administrative problems|13|||
143341217|NCT00941798|516793348|FG001|Overall Study|Administrative problems|23|||
143341218|NCT00941798|516793347|FG000|Overall Study|Lack of Efficacy|10|||
143341219|NCT00941798|516793348|FG001|Overall Study|Lack of Efficacy|17|||
143341220|NCT00941798|516793347|FG000|Overall Study|Patient's inability to use device|6|||
143341221|NCT00941798|516793348|FG001|Overall Study|Patient's inability to use device|1|||
143341222|NCT00941798|516793347|FG000|Overall Study|Abnormal test procedure results|3|||
143341223|NCT00941798|516793348|FG001|Overall Study|Abnormal test procedure results|1|||
143341224|NCT00941798|516793347|FG000|Overall Study|Abnormal laboratory values|1|||
143341225|NCT00941798|516793348|FG001|Overall Study|Abnormal laboratory values|2|||
143341226|NCT00941798|516793347|FG000|Overall Study|Death|0|||
143341227|NCT00941798|516793348|FG001|Overall Study|Death|1|||
143341228|NCT04179721|516793351|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
143341229|NCT04179721|516793352|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
143341230|NCT04179721|516793351|FG000|Overall Study|Lost to Follow-up|0|||
143341231|NCT04179721|516793352|FG001|Overall Study|Lost to Follow-up|1|||
143341232|NCT01489189|516793353|FG000|Overall Study|Withdrawal by Subject|20|||
143341233|NCT01489189|516793354|FG001|Overall Study|Withdrawal by Subject|23|||
143341234|NCT01489189|516793353|FG000|Overall Study|Death|10|||
143341235|NCT01489189|516793354|FG001|Overall Study|Death|8|||
143341236|NCT01489189|516793353|FG000|Overall Study|Missed Visit|1|||
143341237|NCT01489189|516793354|FG001|Overall Study|Missed Visit|4|||
143341238|NCT00112580|516793355|FG000|Overall Study|Adverse Event|1|||
143341239|NCT00112580|516793356|FG001|Overall Study|Adverse Event|2|||
143341240|NCT00112580|516793355|FG000|Overall Study|Disease progression|5|||
143341241|NCT00112580|516793356|FG001|Overall Study|Disease progression|16|||
143341242|NCT00112580|516793355|FG000|Overall Study|Participant withdrew consent|2|||
143341243|NCT00112580|516793356|FG001|Overall Study|Participant withdrew consent|1|||
143341244|NCT05597722|516793359|FG000|Overall Study|Study was terminated|6|||
143341245|NCT05597722|516793360|FG001|Overall Study|Study was terminated|1|||
143341246|NCT03538951|516793365|FG000|Overall Study|Withdrawal by Subject|1|||
143341247|NCT03538951|516793366|FG001|Overall Study|Withdrawal by Subject|2|||
143341248|NCT02044848|516794664|FG000|Overall Study|Administrative Problems|2|||
143341249|NCT02044848|516794665|FG001|Overall Study|Administrative Problems|3|||
143341250|NCT00045708|516794666|FG000|Phase 1|early progressive disease|0|||
143341251|NCT00045708|516794667|FG001|Phase 1|early progressive disease|1|||
143341252|NCT00045708|516794668|FG002|Phase 1|early progressive disease|0|||
143341253|NCT03183388|516794670|FG000|Overall Study|Lost to Follow-up|3|||
143341254|NCT03183388|516794671|FG001|Overall Study|Lost to Follow-up|5|||
143341255|NCT03183388|516794670|FG000|Overall Study|Physician Decision|1|||
143341256|NCT03183388|516794671|FG001|Overall Study|Physician Decision|4|||
143341257|NCT03183388|516794670|FG000|Overall Study|Withdrawal by Subject|4|||
143341258|NCT03183388|516794671|FG001|Overall Study|Withdrawal by Subject|1|||
143341259|NCT03183388|516794670|FG000|Overall Study|Moved|1|||
143341260|NCT03183388|516794671|FG001|Overall Study|Moved|0|||
143395399|NCT02861300|516994935|FG000|Overall Study|Disease Progression|0|||
143341261|NCT03183388|516794670|FG000|Overall Study|Met Exclusion Criteria|2|||
143341262|NCT03183388|516794671|FG001|Overall Study|Met Exclusion Criteria|2|||
143341263|NCT03183388|516794670|FG000|Overall Study|COVID Pandemic Related|2|||
143341264|NCT03183388|516794671|FG001|Overall Study|COVID Pandemic Related|4|||
143341265|NCT01493960|516794674|FG000|Overall Study|Adverse Event|0|||
143341266|NCT01493960|516794675|FG001|Overall Study|Adverse Event|1|||
143341267|NCT01493960|516794674|FG000|Overall Study|Lack of Efficacy|15|||
143341268|NCT01493960|516794675|FG001|Overall Study|Lack of Efficacy|9|||
143341269|NCT01493960|516794674|FG000|Overall Study|Protocol Violation|3|||
143341270|NCT01493960|516794675|FG001|Overall Study|Protocol Violation|0|||
143341271|NCT01493960|516794674|FG000|Overall Study|Withdrawal by Subject|10|||
143341272|NCT01493960|516794675|FG001|Overall Study|Withdrawal by Subject|4|||
143341273|NCT01493960|516794674|FG000|Overall Study|Non-specified|4|||
143341274|NCT01493960|516794675|FG001|Overall Study|Non-specified|4|||
143341275|NCT01679236|516794680|FG000|Overall Study|Lost to Follow-up|15|||
143341276|NCT01679236|516794681|FG001|Overall Study|Lost to Follow-up|15|||
143341277|NCT00284141|516794682|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
143341278|NCT00284141|516794682|FG000|Overall Study|Adverse Event|19|||
143341279|NCT00284141|516794682|FG000|Overall Study|Participant's request|9|||
143341280|NCT00284141|516794682|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
143341281|NCT00284141|516794682|FG000|Overall Study|Clinical deterioration / death|2|||
143341282|NCT00284141|516794682|FG000|Overall Study|General decline|1|||
143341283|NCT00284141|516794682|FG000|Overall Study|Pneumonia|1|||
143341284|NCT00284141|516794682|FG000|Overall Study|Did not take study medication|2|||
143341285|NCT00284141|516794682|FG000|Overall Study|Ongoing treatment|2|||
143341286|NCT03935217|516794686|FG000|Overall Study|Adverse Event|1|||
143341287|NCT03935217|516794687|FG001|Overall Study|Adverse Event|0|||
143341288|NCT03935217|516794686|FG000|Overall Study|Lost to Follow-up|0|||
143341289|NCT03935217|516794687|FG001|Overall Study|Lost to Follow-up|1|||
143341290|NCT03935217|516794686|FG000|Overall Study|Withdrawal by Subject|0|||
143341291|NCT03935217|516794687|FG001|Overall Study|Withdrawal by Subject|2|||
143341292|NCT01728792|516794688|FG000|Overall Study|Withdrawal of Consent|1|||
143341293|NCT01728792|516794689|FG001|Overall Study|Withdrawal of Consent|1|||
143341294|NCT01728792|516794690|FG002|Overall Study|Withdrawal of Consent|0|||
143341295|NCT01728792|516794691|FG003|Overall Study|Withdrawal of Consent|1|||
143341296|NCT01728792|516794692|FG004|Overall Study|Withdrawal of Consent|0|||
143341297|NCT01728792|516794688|FG000|Overall Study|Lost to Follow-up|2|||
143341298|NCT01728792|516794689|FG001|Overall Study|Lost to Follow-up|1|||
143341299|NCT01728792|516794690|FG002|Overall Study|Lost to Follow-up|4|||
143341300|NCT01728792|516794691|FG003|Overall Study|Lost to Follow-up|2|||
143341301|NCT01728792|516794692|FG004|Overall Study|Lost to Follow-up|0|||
143341302|NCT03559218|516794693|FG000|Overall Study|Withdrawal by Subject|1|||
143341303|NCT03559218|516794694|FG001|Overall Study|Withdrawal by Subject|0|||
143341304|NCT01782742|516794698|FG000|Double-blind Treatment Phase|Adverse Event|1|||
143341305|NCT01782742|516794699|FG001|Double-blind Treatment Phase|Adverse Event|0|||
143341306|NCT00676130|516794700|FG000|Overall Study|Lost to Follow-up|0|||
143341307|NCT00676130|516794701|FG001|Overall Study|Lost to Follow-up|1|||
143341308|NCT00676130|516794700|FG000|Overall Study|Found ineligible|3|||
143341309|NCT00676130|516794701|FG001|Overall Study|Found ineligible|2|||
143341310|NCT00676130|516794700|FG000|Overall Study|Withdrawal by Subject|0|||
143341311|NCT00676130|516794701|FG001|Overall Study|Withdrawal by Subject|1|||
143341312|NCT00331344|516794704|FG000|Phase I|Adverse Event|0|||
143341313|NCT00331344|516794705|FG001|Phase I|Adverse Event|0|||
143341314|NCT00331344|516794706|FG002|Phase I|Adverse Event|0|||
143341315|NCT00331344|516794707|FG003|Phase I|Adverse Event|1|||
143341316|NCT00331344|516794708|FG004|Phase I|Adverse Event|2|||
143341317|NCT00331344|516794709|FG005|Phase I|Adverse Event|2|||
143341318|NCT00331344|516794710|FG006|Phase I|Adverse Event|0|||
143341319|NCT00331344|516794711|FG007|Phase I|Adverse Event|1|||
143341320|NCT00331344|516794712|FG008|Phase I|Adverse Event|0|||
143341321|NCT00331344|516794704|FG000|Phase II|Death|0|||
143341322|NCT00331344|516794705|FG001|Phase II|Death|0|||
143341323|NCT00331344|516794706|FG002|Phase II|Death|0|||
143341324|NCT00331344|516794707|FG003|Phase II|Death|0|||
143341325|NCT00331344|516794708|FG004|Phase II|Death|0|||
143341326|NCT00331344|516794709|FG005|Phase II|Death|0|||
143341327|NCT00331344|516794710|FG006|Phase II|Death|0|||
143341328|NCT00331344|516794711|FG007|Phase II|Death|0|||
143341329|NCT00331344|516794712|FG008|Phase II|Death|4|||
143341330|NCT01373931|516794718|FG000|Lead-in Period|Adverse Event|2|||
143341331|NCT01373931|516794719|FG001|Lead-in Period|Adverse Event|0|||
143341332|NCT01373931|516794718|FG000|Period 1|Adverse Event|2|||
143341333|NCT01373931|516794719|FG001|Period 1|Adverse Event|0|||
143341334|NCT01373931|516794718|FG000|Period 1|Withdrawal by Subject|0|||
143341335|NCT01373931|516794719|FG001|Period 1|Withdrawal by Subject|2|||
143341336|NCT04538144|516794720|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
143341337|NCT04538144|516794721|FG001|Washout (1 Week)|Withdrawal by Subject|0|||
143341338|NCT04538144|516794722|FG002|Washout (1 Week)|Withdrawal by Subject|0|||
143341339|NCT04538144|516794723|FG003|Washout (1 Week)|Withdrawal by Subject|1|||
143341340|NCT00261495|516794727|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
143341341|NCT00261495|516794728|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
143341342|NCT00261495|516794727|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
143341343|NCT00261495|516794728|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
143341344|NCT00261495|516794727|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
143341345|NCT00261495|516794728|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
143341346|NCT00261495|516794727|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
143341347|NCT00261495|516794728|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
143341348|NCT00261495|516794727|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
143341349|NCT00261495|516794728|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
143341350|NCT00261495|516794727|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
143341351|NCT00261495|516794728|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
143341352|NCT00261495|516794727|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
143341353|NCT00261495|516794728|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
143341354|NCT00261495|516794727|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
143341355|NCT00261495|516794728|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
143341356|NCT00261495|516794727|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
143341357|NCT00261495|516794728|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
143341358|NCT00261495|516794727|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
143341359|NCT00261495|516794728|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
143341360|NCT00261495|516794727|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
143341361|NCT00261495|516794728|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
143341362|NCT00261495|516794727|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
143341363|NCT00261495|516794728|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
143341364|NCT00261495|516794727|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
143341365|NCT00261495|516794728|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
143341366|NCT00261495|516794727|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
143341367|NCT00261495|516794728|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
143341368|NCT00261495|516794727|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
143341369|NCT00261495|516794728|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
143341370|NCT00261495|516794727|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
143395400|NCT02861300|516994936|FG001|Overall Study|Disease Progression|1|||
143395401|NCT02861300|516994937|FG002|Overall Study|Disease Progression|0|||
143341371|NCT00261495|516794728|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
143395402|NCT02861300|516994938|FG003|Overall Study|Disease Progression|0|||
143395403|NCT02861300|516994939|FG004|Overall Study|Disease Progression|0|||
143395404|NCT02861300|516994940|FG005|Overall Study|Disease Progression|0|||
143395405|NCT02861300|516994941|FG006|Overall Study|Disease Progression|2|||
143395406|NCT02861300|516994935|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
143395407|NCT02861300|516994936|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
143395408|NCT02861300|516994937|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
143395409|NCT02861300|516994938|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
143395410|NCT02861300|516994939|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
143395411|NCT02861300|516994940|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
143395412|NCT02861300|516994941|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
143395413|NCT02861300|516994935|FG000|Overall Study|Clinical Complications|0|||
143395414|NCT02861300|516994936|FG001|Overall Study|Clinical Complications|0|||
143395415|NCT02861300|516994937|FG002|Overall Study|Clinical Complications|0|||
143395416|NCT02861300|516994938|FG003|Overall Study|Clinical Complications|0|||
143395417|NCT02861300|516994939|FG004|Overall Study|Clinical Complications|0|||
143395418|NCT02861300|516994940|FG005|Overall Study|Clinical Complications|0|||
143395419|NCT02861300|516994941|FG006|Overall Study|Clinical Complications|1|||
143395420|NCT05399459|516994944|FG000|Overall Study|Randomized but not treated|29|||
143341372|NCT00261495|516794727|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
143341373|NCT00261495|516794728|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
143341374|NCT00261495|516794727|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
143341375|NCT00261495|516794728|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
143341376|NCT00261495|516794727|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
143341377|NCT00261495|516794728|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
143341378|NCT00261495|516794727|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
143341379|NCT00261495|516794728|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
143341380|NCT00261495|516794727|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
143395421|NCT05399459|516994945|FG001|Overall Study|Randomized but not treated|30|||
143395422|NCT05399459|516994946|FG002|Overall Study|Randomized but not treated|38|||
143395423|NCT05399459|516994944|FG000|Overall Study|Lost to Follow-up|1|||
143395424|NCT05399459|516994945|FG001|Overall Study|Lost to Follow-up|0|||
143341381|NCT00261495|516794728|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
143341382|NCT03474107|516794729|FG000|Overall Study|Adverse Event|42|||
143341383|NCT03474107|516794730|FG001|Overall Study|Adverse Event|46|||
143341384|NCT03474107|516794729|FG000|Overall Study|Death|2|||
143341385|NCT03474107|516794730|FG001|Overall Study|Death|2|||
143341386|NCT03474107|516794729|FG000|Overall Study|Lost to Follow-up|0|||
143341387|NCT03474107|516794730|FG001|Overall Study|Lost to Follow-up|1|||
143341388|NCT03474107|516794729|FG000|Overall Study|Progressive Disease|177|||
143341389|NCT03474107|516794730|FG001|Overall Study|Progressive Disease|180|||
143341390|NCT03474107|516794729|FG000|Overall Study|Protocol Violation|1|||
143341391|NCT03474107|516794730|FG001|Overall Study|Protocol Violation|1|||
143341392|NCT03474107|516794729|FG000|Overall Study|Withdrawal by Subject|15|||
143341393|NCT03474107|516794730|FG001|Overall Study|Withdrawal by Subject|27|||
143341394|NCT03474107|516794729|FG000|Overall Study|Physician Decision|7|||
143341395|NCT03474107|516794730|FG001|Overall Study|Physician Decision|22|||
143341396|NCT03474107|516794729|FG000|Overall Study|Miscellaneous|1|||
143341397|NCT03474107|516794730|FG001|Overall Study|Miscellaneous|6|||
143341398|NCT01932697|516794731|FG000|Overall Study|Received a different amount of tx|1|||
143341399|NCT01932697|516794732|FG001|Overall Study|Received a different amount of tx|0|||
143341400|NCT01932697|516794731|FG000|Overall Study|Ineligible|1|||
143341401|NCT01932697|516794732|FG001|Overall Study|Ineligible|0|||
143341402|NCT01330316|516794733|FG000|Overall Study|Adverse Event|2|||
143341403|NCT01330316|516794734|FG001|Overall Study|Adverse Event|2|||
143341404|NCT01330316|516794733|FG000|Overall Study|Lack of Efficacy|0|||
143341405|NCT01330316|516794734|FG001|Overall Study|Lack of Efficacy|10|||
143341406|NCT01330316|516794733|FG000|Overall Study|Lost to Follow-up|0|||
143341407|NCT01330316|516794734|FG001|Overall Study|Lost to Follow-up|1|||
143341408|NCT01330316|516794733|FG000|Overall Study|Withdrawal by Subject|0|||
143341409|NCT01330316|516794734|FG001|Overall Study|Withdrawal by Subject|1|||
143341410|NCT01330316|516794733|FG000|Overall Study|other than above|0|||
143341411|NCT01330316|516794734|FG001|Overall Study|other than above|1|||
143341412|NCT02696564|516794736|FG000|Overall Study|Death|1|||
143341413|NCT02696564|516794737|FG001|Overall Study|Death|2|||
143341414|NCT02696564|516794736|FG000|Overall Study|Withdrawal by Subject|3|||
143341415|NCT02696564|516794737|FG001|Overall Study|Withdrawal by Subject|2|||
143341416|NCT02696564|516794736|FG000|Overall Study|Lost to Follow-up|3|||
143341417|NCT02696564|516794737|FG001|Overall Study|Lost to Follow-up|3|||
143341418|NCT02696564|516794736|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
143341419|NCT02696564|516794737|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
143341420|NCT02696564|516794736|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
143341421|NCT02696564|516794737|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
143341422|NCT02696564|516794736|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
143341423|NCT02696564|516794737|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
143341424|NCT02696564|516794736|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
143341425|NCT02696564|516794737|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
143341426|NCT02696564|516794736|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
143341427|NCT02696564|516794737|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
143341428|NCT01337986|516794738|FG000|Overall Study|Adverse Event|2|||
143341429|NCT01337986|516794739|FG001|Overall Study|Adverse Event|2|||
143341430|NCT01337986|516794738|FG000|Overall Study|Lost to Follow-up|1|||
143341431|NCT01337986|516794739|FG001|Overall Study|Lost to Follow-up|0|||
143341432|NCT01337986|516794738|FG000|Overall Study|Protocol Violation|0|||
143341433|NCT01337986|516794739|FG001|Overall Study|Protocol Violation|3|||
143341434|NCT03633929|516794740|FG000|Overall Study|Lost to Follow-up|1|||
143341435|NCT03633929|516794740|FG000|Overall Study|Did not login to software. Did not participate|3|||
143341436|NCT01520402|516794742|FG000|Overall Study|Withdrawal by Subject|2|||
143341437|NCT01520402|516794742|FG000|Overall Study|Physician Decision|3|||
143341438|NCT01722162|516794743|FG000|Overall Study|Withdrawal by Subject|1|||
143341439|NCT01722162|516794744|FG001|Overall Study|Withdrawal by Subject|1|||
143341440|NCT01722162|516794743|FG000|Overall Study|Found ineligible|1|||
143341441|NCT01722162|516794744|FG001|Overall Study|Found ineligible|0|||
143341442|NCT01722162|516794743|FG000|Overall Study|Unrelated to study adverse event|2|||
143341443|NCT01722162|516794744|FG001|Overall Study|Unrelated to study adverse event|2|||
143341444|NCT01722162|516794743|FG000|Overall Study|Adverse Event|1|||
143341445|NCT01722162|516794744|FG001|Overall Study|Adverse Event|1|||
143341446|NCT01722162|516794743|FG000|Overall Study|Insurance denial post enrollment|0|||
143341447|NCT01722162|516794744|FG001|Overall Study|Insurance denial post enrollment|1|||
143341448|NCT01722162|516794743|FG000|Overall Study|Noncompliance|0|||
143341449|NCT01722162|516794744|FG001|Overall Study|Noncompliance|1|||
143341450|NCT03086018|516794746|FG000|Final Testing for End of Trial|Adverse Event|1|||
143341451|NCT03086018|516794746|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
143341452|NCT04026165|516794748|FG000|Run-in Placebo Period|Enrollment Error|13|||
143341453|NCT04026165|516794749|FG001|Run-in Placebo Period|Enrollment Error|0|||
143341454|NCT04026165|516794750|FG002|Run-in Placebo Period|Enrollment Error|0|||
143341455|NCT04026165|516794751|FG003|Run-in Placebo Period|Enrollment Error|0|||
143341456|NCT04026165|516794748|FG000|Run-in Placebo Period|Run-in Failure|4|||
143341457|NCT04026165|516794749|FG001|Run-in Placebo Period|Run-in Failure|0|||
143341458|NCT04026165|516794750|FG002|Run-in Placebo Period|Run-in Failure|0|||
143341459|NCT04026165|516794751|FG003|Run-in Placebo Period|Run-in Failure|0|||
143341460|NCT04026165|516794748|FG000|Run-in Placebo Period|Protocol Violation|2|||
143341461|NCT04026165|516794749|FG001|Run-in Placebo Period|Protocol Violation|0|||
143341462|NCT04026165|516794750|FG002|Run-in Placebo Period|Protocol Violation|0|||
143341463|NCT04026165|516794751|FG003|Run-in Placebo Period|Protocol Violation|0|||
143341464|NCT04026165|516794748|FG000|Run-in Placebo Period|Withdrew Consent|2|||
143341465|NCT04026165|516794749|FG001|Run-in Placebo Period|Withdrew Consent|0|||
143341466|NCT04026165|516794750|FG002|Run-in Placebo Period|Withdrew Consent|0|||
143341467|NCT04026165|516794751|FG003|Run-in Placebo Period|Withdrew Consent|0|||
143341468|NCT04026165|516794748|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
143341469|NCT04026165|516794749|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
143341470|NCT04026165|516794750|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
143341471|NCT04026165|516794751|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
143341472|NCT04026165|516794748|FG000|Run-in SEL Period|Run-in Failure|0|||
143341473|NCT04026165|516794749|FG001|Run-in SEL Period|Run-in Failure|26|||
143341474|NCT04026165|516794750|FG002|Run-in SEL Period|Run-in Failure|0|||
143341475|NCT04026165|516794751|FG003|Run-in SEL Period|Run-in Failure|0|||
143341476|NCT04026165|516794748|FG000|Run-in SEL Period|Withdrew Consent|0|||
143341477|NCT04026165|516794749|FG001|Run-in SEL Period|Withdrew Consent|10|||
143341478|NCT04026165|516794750|FG002|Run-in SEL Period|Withdrew Consent|0|||
143341479|NCT04026165|516794751|FG003|Run-in SEL Period|Withdrew Consent|0|||
143341480|NCT04026165|516794748|FG000|Run-in SEL Period|Enrollment Error|0|||
143341481|NCT04026165|516794749|FG001|Run-in SEL Period|Enrollment Error|4|||
143341482|NCT04026165|516794750|FG002|Run-in SEL Period|Enrollment Error|0|||
143341483|NCT04026165|516794751|FG003|Run-in SEL Period|Enrollment Error|0|||
143341484|NCT04026165|516794748|FG000|Run-in SEL Period|Protocol Violation|0|||
143341485|NCT04026165|516794749|FG001|Run-in SEL Period|Protocol Violation|3|||
143341486|NCT04026165|516794750|FG002|Run-in SEL Period|Protocol Violation|0|||
143341487|NCT04026165|516794751|FG003|Run-in SEL Period|Protocol Violation|0|||
143341488|NCT04026165|516794748|FG000|Run-in SEL Period|Investigator's Discretion|0|||
143341489|NCT04026165|516794749|FG001|Run-in SEL Period|Investigator's Discretion|2|||
143341490|NCT04026165|516794750|FG002|Run-in SEL Period|Investigator's Discretion|0|||
143341491|NCT04026165|516794751|FG003|Run-in SEL Period|Investigator's Discretion|0|||
143341492|NCT04026165|516794748|FG000|Run-in SEL Period|Death|0|||
143341493|NCT04026165|516794749|FG001|Run-in SEL Period|Death|1|||
143341494|NCT04026165|516794750|FG002|Run-in SEL Period|Death|0|||
143341495|NCT04026165|516794751|FG003|Run-in SEL Period|Death|0|||
143341496|NCT04026165|516794748|FG000|Randomized Period|Withdrew Consent|0|||
143341497|NCT04026165|516794749|FG001|Randomized Period|Withdrew Consent|0|||
143341498|NCT04026165|516794750|FG002|Randomized Period|Withdrew Consent|5|||
143341499|NCT04026165|516794751|FG003|Randomized Period|Withdrew Consent|8|||
143341500|NCT04026165|516794748|FG000|Randomized Period|Death|0|||
143341501|NCT04026165|516794749|FG001|Randomized Period|Death|0|||
143341502|NCT04026165|516794750|FG002|Randomized Period|Death|5|||
143341503|NCT04026165|516794751|FG003|Randomized Period|Death|7|||
143341504|NCT04026165|516794748|FG000|Randomized Period|Investigator's Discretion|0|||
143341505|NCT04026165|516794749|FG001|Randomized Period|Investigator's Discretion|0|||
143341506|NCT04026165|516794750|FG002|Randomized Period|Investigator's Discretion|2|||
143341507|NCT04026165|516794751|FG003|Randomized Period|Investigator's Discretion|2|||
143341508|NCT04026165|516794748|FG000|Randomized Period|Lost to Follow-up|0|||
143341509|NCT04026165|516794749|FG001|Randomized Period|Lost to Follow-up|0|||
143341510|NCT04026165|516794750|FG002|Randomized Period|Lost to Follow-up|2|||
143341511|NCT04026165|516794751|FG003|Randomized Period|Lost to Follow-up|2|||
143341512|NCT02487810|516794752|FG000|Overall Study|Withdrawal by Subject|1|||
143341513|NCT02487810|516794753|FG001|Overall Study|Withdrawal by Subject|0|||
143341514|NCT01889186|516794754|FG000|Overall Study|Adverse event- not related to progression|18|||
143341515|NCT01889186|516794755|FG001|Overall Study|Adverse event- not related to progression|5|||
143341516|NCT01889186|516794754|FG000|Overall Study|Adverse event- related to progression|7|||
143341517|NCT01889186|516794755|FG001|Overall Study|Adverse event- related to progression|2|||
143341518|NCT01889186|516794754|FG000|Overall Study|COVID-19 logistical restrictions|1|||
143341519|NCT01889186|516794755|FG001|Overall Study|COVID-19 logistical restrictions|0|||
143341520|NCT01889186|516794754|FG000|Overall Study|Investigator request|1|||
143341521|NCT01889186|516794755|FG001|Overall Study|Investigator request|1|||
143341522|NCT01889186|516794754|FG000|Overall Study|Progressive disease- Richter's|12|||
143341523|NCT01889186|516794755|FG001|Overall Study|Progressive disease- Richter's|7|||
143341524|NCT01889186|516794754|FG000|Overall Study|Progressive disease per protocol|46|||
143341525|NCT01889186|516794755|FG001|Overall Study|Progressive disease per protocol|17|||
143341526|NCT01889186|516794754|FG000|Overall Study|Stem cell transplant|2|||
143341527|NCT01889186|516794755|FG001|Overall Study|Stem cell transplant|1|||
143341528|NCT01889186|516794754|FG000|Overall Study|Withdrew consent|2|||
143341529|NCT01889186|516794755|FG001|Overall Study|Withdrew consent|3|||
143341530|NCT01889186|516794754|FG000|Overall Study|Other, not specified|18|||
143341531|NCT01889186|516794755|FG001|Overall Study|Other, not specified|15|||
143341532|NCT00077064|516794758|FG000|Overall Study|Adverse Event|0|||
143341533|NCT00077064|516794759|FG001|Overall Study|Adverse Event|4|||
143341534|NCT00077064|516794758|FG000|Overall Study|Patient refusal|0|||
143341535|NCT00077064|516794759|FG001|Overall Study|Patient refusal|2|||
143341536|NCT00621543|516794760|FG000|Overall Study|Lost to Follow-up|23|||
143341537|NCT02192970|516794761|FG000|Overall Study|Lost to Follow-up|6|||
143341538|NCT02192970|516794762|FG001|Overall Study|Lost to Follow-up|0|||
143341539|NCT00499863|516794765|FG000|Overall Study|Lack of Efficacy|21|||
143341540|NCT00499863|516794766|FG001|Overall Study|Lack of Efficacy|27|||
143341541|NCT00499863|516794765|FG000|Overall Study|Protocol Violation|12|||
143341542|NCT00499863|516794766|FG001|Overall Study|Protocol Violation|7|||
143341543|NCT00499863|516794765|FG000|Overall Study|Withdrawal by Subject|6|||
143341544|NCT00499863|516794766|FG001|Overall Study|Withdrawal by Subject|4|||
143341545|NCT00499863|516794765|FG000|Overall Study|Adverse Event|8|||
143395425|NCT05399459|516994946|FG002|Overall Study|Lost to Follow-up|0|||
143395426|NCT04992520|516994947|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
143395427|NCT04992520|516994948|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
143395428|NCT04992520|516994949|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
143395429|NCT04992520|516994950|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
143395430|NCT04992520|516994951|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
143395431|NCT04992520|516994952|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
143395432|NCT04992520|516994947|FG000|Part A: First Challenge|Non-compliance|0|||
143395433|NCT04992520|516994948|FG001|Part A: First Challenge|Non-compliance|0|||
143395434|NCT04992520|516994949|FG002|Part A: First Challenge|Non-compliance|0|||
143395435|NCT04992520|516994950|FG003|Part A: First Challenge|Non-compliance|1|||
143395436|NCT04992520|516994951|FG004|Part A: First Challenge|Non-compliance|0|||
143395437|NCT04992520|516994952|FG005|Part A: First Challenge|Non-compliance|0|||
143395438|NCT04992520|516994947|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
143395439|NCT04992520|516994948|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
143395440|NCT04992520|516994949|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
143395441|NCT04992520|516994950|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
143395442|NCT04992520|516994951|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
143341546|NCT00499863|516794766|FG001|Overall Study|Adverse Event|2|||
143341547|NCT00499863|516794765|FG000|Overall Study|Sponsor decision|2|||
143341548|NCT00499863|516794766|FG001|Overall Study|Sponsor decision|2|||
143341549|NCT00499863|516794765|FG000|Overall Study|Lost to Follow-up|1|||
143341550|NCT00499863|516794766|FG001|Overall Study|Lost to Follow-up|1|||
143341551|NCT05031078|516794767|FG000|Overall Study|Withdrawal by Subject|0|||
143341552|NCT05031078|516794768|FG001|Overall Study|Withdrawal by Subject|1|||
143341553|NCT05031078|516794769|FG002|Overall Study|Withdrawal by Subject|0|||
143341554|NCT01784068|516794770|FG000|NTCS Phase|Adverse Event|5|||
143341555|NCT01784068|516794771|FG001|NTCS Phase|Adverse Event|0|||
143341556|NCT01784068|516794770|FG000|NTCS Phase|Physician Decision|2|||
143341557|NCT01784068|516794771|FG001|NTCS Phase|Physician Decision|0|||
143395443|NCT04992520|516994952|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
143395444|NCT04992520|516994947|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
143395445|NCT04992520|516994948|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
143395446|NCT04992520|516994949|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
143395447|NCT04992520|516994950|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
143395448|NCT04992520|516994951|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
143395449|NCT04992520|516994952|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
143395450|NCT03625167|516994954|FG000|Overall Study|Protocol Violation|5|||
143395451|NCT02231164|516994955|FG000|Overall Study|Adverse Event|1|||
143395452|NCT02231164|516994956|FG001|Overall Study|Adverse Event|1|||
143395453|NCT02231164|516994955|FG000|Overall Study|Lack of Efficacy|4|||
143341558|NCT01784068|516794770|FG000|NTCS Phase|Patient/guardian decision|3|||
143341559|NCT01784068|516794771|FG001|NTCS Phase|Patient/guardian decision|0|||
143341560|NCT01784068|516794770|FG000|NTCS Phase|Death|2|||
143395454|NCT02231164|516994956|FG001|Overall Study|Lack of Efficacy|3|||
143395455|NCT02231164|516994955|FG000|Overall Study|Withdrawal by Subject|1|||
143395456|NCT02231164|516994956|FG001|Overall Study|Withdrawal by Subject|2|||
143395457|NCT05201079|516994960|FG000|Overall Study|Adverse Event|7|||
143395458|NCT05201079|516994961|FG001|Overall Study|Adverse Event|11|||
143395459|NCT05201079|516994960|FG000|Overall Study|Death|1|||
143395460|NCT05201079|516994961|FG001|Overall Study|Death|1|||
143341561|NCT01784068|516794771|FG001|NTCS Phase|Death|0|||
143341562|NCT01784068|516794770|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
143341563|NCT01784068|516794771|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
143341564|NCT01784068|516794770|FG000|TFR Phase|Physician Decision|0|||
143341565|NCT01784068|516794771|FG001|TFR Phase|Physician Decision|1|||
143341566|NCT01784068|516794770|FG000|TFR Phase|Patient/guardian decision|0|||
143341567|NCT01784068|516794771|FG001|TFR Phase|Patient/guardian decision|3|||
143341568|NCT01784068|516794770|FG000|TFR Phase|Death|0|||
143341569|NCT01784068|516794771|FG001|TFR Phase|Death|1|||
143341570|NCT01784068|516794770|FG000|TFR Phase|Lack of Efficacy|0|||
143341571|NCT01784068|516794771|FG001|TFR Phase|Lack of Efficacy|88|||
143341572|NCT03759834|516794772|FG000|Overall Study|Withdrawal by Subject|1|||
143341573|NCT03764072|516794775|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
143341574|NCT03764072|516794776|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
143341575|NCT03764072|516794777|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
143341576|NCT03764072|516794778|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
143341577|NCT03764072|516794779|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
143341578|NCT03764072|516794780|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
143341579|NCT03764072|516794775|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
143341580|NCT03764072|516794776|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
143341581|NCT03764072|516794777|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
143341582|NCT03764072|516794778|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
143341583|NCT03764072|516794779|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
143341584|NCT03764072|516794780|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
143341585|NCT03764072|516794775|FG000|Overall Study|Lost to Follow-up|0|||
143341586|NCT03764072|516794776|FG001|Overall Study|Lost to Follow-up|0|||
143341587|NCT03764072|516794777|FG002|Overall Study|Lost to Follow-up|0|||
143341588|NCT03764072|516794778|FG003|Overall Study|Lost to Follow-up|0|||
143341589|NCT03764072|516794779|FG004|Overall Study|Lost to Follow-up|1|||
143341590|NCT03764072|516794780|FG005|Overall Study|Lost to Follow-up|0|||
143341591|NCT00982930|516794781|FG000|Overall Study|Adverse Event|1|||
143341592|NCT00982930|516794781|FG000|Overall Study|Withdrawal by Subject|1|||
143341593|NCT00982930|516794781|FG000|Overall Study|Administrative Problems|2|||
143341594|NCT05559866|516794782|FG000|Overall Study|Withdrawal by Subject|1|||
143341595|NCT05559866|516794783|FG001|Overall Study|Withdrawal by Subject|0|||
143341596|NCT07018999|516794787|FG000|Overall Study|Protocol Violation|0|||
143341597|NCT07018999|516794788|FG001|Overall Study|Protocol Violation|1|||
143341598|NCT07018999|516794787|FG000|Overall Study|Incomplete data entry|4|||
143341599|NCT07018999|516794788|FG001|Overall Study|Incomplete data entry|7|||
143341600|NCT03444376|516794789|FG000|Part A|Disease relapse or Progression|1|||
143341601|NCT03444376|516794789|FG000|Part A|Withdrawal by Subject|2|||
143341602|NCT03444376|516794789|FG000|Part A|Adverse Event|1|||
143341603|NCT03444376|516794789|FG000|Part B|Disease relapse or Progression|18|||
143341604|NCT03444376|516794789|FG000|Part B|Withdrawal by Subject|2|||
143341605|NCT03444376|516794789|FG000|Part B|Adverse Event|2|||
143341606|NCT03444376|516794789|FG000|Part B|Physician Decision|1|||
143341607|NCT03444376|516794789|FG000|Part C|Disease relapse or Progression|43|||
143341608|NCT03444376|516794789|FG000|Part C|Withdrawal by Subject|5|||
143341609|NCT03444376|516794789|FG000|Part C|Adverse Event|2|||
143341610|NCT03444376|516794789|FG000|Part C|Physician Decision|2|||
143341611|NCT03444376|516794789|FG000|Part C|Death|1|||
143341612|NCT00856167|516794793|FG000|Period 1|Withdrawal by Subject|1|||
143341613|NCT00856167|516794794|FG001|Period 1|Withdrawal by Subject|4|||
143341614|NCT00856167|516794795|FG002|Period 1|Withdrawal by Subject|0|||
143341615|NCT00856167|516794796|FG003|Period 1|Withdrawal by Subject|0|||
143341616|NCT00856167|516794793|FG000|Period 1|Lost to Follow-up|2|||
143341617|NCT00856167|516794794|FG001|Period 1|Lost to Follow-up|1|||
143341618|NCT00856167|516794795|FG002|Period 1|Lost to Follow-up|0|||
143341619|NCT00856167|516794796|FG003|Period 1|Lost to Follow-up|0|||
143341620|NCT00856167|516794793|FG000|Period 2|Lost to Follow-up|0|||
143341621|NCT00856167|516794794|FG001|Period 2|Lost to Follow-up|0|||
143341622|NCT00856167|516794795|FG002|Period 2|Lost to Follow-up|3|||
143341623|NCT00856167|516794796|FG003|Period 2|Lost to Follow-up|1|||
143341624|NCT00856167|516794793|FG000|Period 2|Withdrawal by Subject|0|||
143341625|NCT00856167|516794794|FG001|Period 2|Withdrawal by Subject|0|||
143341626|NCT00856167|516794795|FG002|Period 2|Withdrawal by Subject|2|||
143341627|NCT00856167|516794796|FG003|Period 2|Withdrawal by Subject|4|||
143341628|NCT06027619|516794799|FG000|Overall Study|Adverse Event|0|||
143341629|NCT06027619|516794800|FG001|Overall Study|Adverse Event|0|||
143341630|NCT06027619|516794801|FG002|Overall Study|Adverse Event|1|||
143341631|NCT01160484|516796526|FG000|Overall Study|Lack of Efficacy|9|||
143341632|NCT01160484|516796526|FG000|Overall Study|Adverse Event|6|||
143341633|NCT01160484|516796526|FG000|Overall Study|Withdrawal by Subject|2|||
143341634|NCT01160484|516796526|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
143341635|NCT00803101|516796527|FG000|Overall Study|Death / Serious Adverse Event|4|||
143341636|NCT00803101|516796528|FG001|Overall Study|Death / Serious Adverse Event|6|||
143341637|NCT00803101|516796527|FG000|Overall Study|Withdrawal by Subject|6|||
143341638|NCT00803101|516796528|FG001|Overall Study|Withdrawal by Subject|4|||
143341639|NCT00803101|516796527|FG000|Overall Study|Lost to Follow-up|2|||
143341640|NCT00803101|516796528|FG001|Overall Study|Lost to Follow-up|2|||
143341641|NCT00803101|516796527|FG000|Overall Study|Protocol Violation|1|||
143341642|NCT00803101|516796528|FG001|Overall Study|Protocol Violation|7|||
143341643|NCT00803101|516796527|FG000|Overall Study|Surgery finished outside protocol window|1|||
143341644|NCT00803101|516796528|FG001|Overall Study|Surgery finished outside protocol window|1|||
143341645|NCT00803101|516796527|FG000|Overall Study|Patient died outside SAE report period|1|||
143341646|NCT00803101|516796528|FG001|Overall Study|Patient died outside SAE report period|0|||
143341647|NCT00803101|516796527|FG000|Overall Study|Patient did not attend scheduled visit|2|||
143341648|NCT00803101|516796528|FG001|Overall Study|Patient did not attend scheduled visit|1|||
143341649|NCT00803101|516796527|FG000|Overall Study|Patient did not have surgery|1|||
143341650|NCT00803101|516796528|FG001|Overall Study|Patient did not have surgery|1|||
143341651|NCT01529008|516796531|FG000|Bone Marrow Harvesting|Physician Decision|1|||
143341652|NCT01529008|516796532|FG001|Bone Marrow Harvesting|Physician Decision|1|||
143341653|NCT01529008|516796531|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
143341654|NCT01529008|516796532|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
143341655|NCT01529008|516796531|FG000|Treatment|Adverse Event|6|||
143341656|NCT01529008|516796532|FG001|Treatment|Adverse Event|0|||
143341657|NCT01529008|516796531|FG000|Treatment|Other|3|||
143341658|NCT01529008|516796532|FG001|Treatment|Other|1|||
143341659|NCT01529008|516796531|FG000|Efficacy Analysis|Protocol Violation|2|||
143341660|NCT01529008|516796532|FG001|Efficacy Analysis|Protocol Violation|0|||
143341661|NCT01529008|516796531|FG000|Efficacy Analysis|Physician Decision|0|||
143341662|NCT01529008|516796532|FG001|Efficacy Analysis|Physician Decision|1|||
143341663|NCT01529008|516796531|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
143341664|NCT01529008|516796532|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
143341665|NCT00332332|516796533|FG000|Overall Study|Adverse Event|13|||
143341666|NCT00332332|516796533|FG000|Overall Study|Death|1|||
143341667|NCT00332332|516796533|FG000|Overall Study|Withdrawal by Subject|8|||
143341668|NCT00332332|516796533|FG000|Overall Study|Physician Decision|1|||
143341669|NCT00332332|516796533|FG000|Overall Study|Lost to Follow-up|3|||
143341670|NCT00332332|516796533|FG000|Overall Study|Protocol deviation|4|||
143341671|NCT00332332|516796533|FG000|Overall Study|Noncompliance|2|||
143341672|NCT00332332|516796533|FG000|Overall Study|Disease progression|2|||
143341673|NCT00332332|516796533|FG000|Overall Study|Other|18|||
143341674|NCT00332332|516796533|FG000|Overall Study|Did not receive study treatment|16|||
143341675|NCT01382602|516796534|FG000|Overall Study|Protocol Violation|0|||
143341676|NCT01382602|516796535|FG001|Overall Study|Protocol Violation|3|||
143341677|NCT01382602|516796534|FG000|Overall Study|Withdrawal by Subject|0|||
143341678|NCT01382602|516796535|FG001|Overall Study|Withdrawal by Subject|1|||
143341679|NCT02790073|516796538|FG000|Overall Study|Death|1|||
143341680|NCT02790073|516796538|FG000|Overall Study|Withdrawal from HD|1|||
143341681|NCT02790073|516796538|FG000|Overall Study|Withdrawal by Subject|1|||
143341682|NCT04170686|516796539|FG000|Screening|Physician Decision|12|||
143341683|NCT04170686|516796540|FG001|Screening|Physician Decision|13|||
143341684|NCT04170686|516796539|FG000|Randomization and Treatment|Lost to Follow-up|26|||
143341685|NCT04170686|516796540|FG001|Randomization and Treatment|Lost to Follow-up|15|||
143341686|NCT03328143|516796541|FG000|Overall Study|Declined|3|||
143341687|NCT03328143|516796541|FG000|Overall Study|Required increased sedation|4|||
143341688|NCT03328143|516796541|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
143341689|NCT03328143|516796541|FG000|Overall Study|Surgery cancelled|1|||
143341690|NCT02259517|516796542|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
143341691|NCT02259517|516796543|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
143341692|NCT02259517|516796544|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
143341693|NCT02259517|516796542|FG000|Overall Study|Withdrawal by Subject|0|||
143341694|NCT02259517|516796543|FG001|Overall Study|Withdrawal by Subject|0|||
143341695|NCT02259517|516796544|FG002|Overall Study|Withdrawal by Subject|3|||
143341696|NCT02305381|516796545|FG000|Overall Study|Unclassified|5|||
143341697|NCT02305381|516796546|FG001|Overall Study|Unclassified|5|||
143341698|NCT02305381|516796547|FG002|Overall Study|Unclassified|7|||
143341699|NCT01392300|516796556|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
143341700|NCT01392300|516796557|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
143341701|NCT01392300|516796558|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
143341702|NCT01392300|516796556|FG000|Main Period (MP)|Withdrawal by Subject|5|||
143341703|NCT01392300|516796557|FG001|Main Period (MP)|Withdrawal by Subject|1|||
143341704|NCT01392300|516796558|FG002|Main Period (MP)|Withdrawal by Subject|0|||
143341705|NCT01392300|516796556|FG000|Main Period (MP)|Lost to Follow-up|3|||
143341706|NCT01392300|516796557|FG001|Main Period (MP)|Lost to Follow-up|3|||
143341707|NCT01392300|516796558|FG002|Main Period (MP)|Lost to Follow-up|0|||
143341708|NCT01392300|516796556|FG000|Main Period (MP)|Non-compliance|1|||
143341709|NCT01392300|516796557|FG001|Main Period (MP)|Non-compliance|0|||
143341710|NCT01392300|516796558|FG002|Main Period (MP)|Non-compliance|0|||
143341711|NCT01392300|516796556|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
143341712|NCT01392300|516796557|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
143341713|NCT01392300|516796558|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
143341714|NCT01392300|516796556|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
143341715|NCT01392300|516796557|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
143341716|NCT01392300|516796558|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
143395461|NCT05201079|516994960|FG000|Overall Study|Lack of Efficacy|0|||
143341717|NCT01392300|516796556|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
143341718|NCT01392300|516796557|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
143395462|NCT05201079|516994961|FG001|Overall Study|Lack of Efficacy|2|||
143395463|NCT05201079|516994960|FG000|Overall Study|Lost to Follow-up|0|||
143395464|NCT05201079|516994961|FG001|Overall Study|Lost to Follow-up|1|||
143395465|NCT05201079|516994960|FG000|Overall Study|Physician Decision|1|||
143341719|NCT01392300|516796558|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
143341720|NCT01392300|516796556|FG000|Open Label Extension (OLEX) Period|Death|0|||
143341721|NCT01392300|516796557|FG001|Open Label Extension (OLEX) Period|Death|0|||
143341722|NCT01392300|516796558|FG002|Open Label Extension (OLEX) Period|Death|4|||
143341723|NCT01392300|516796556|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
143341724|NCT01392300|516796557|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
143341725|NCT01392300|516796558|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
143341726|NCT01392300|516796556|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
143341727|NCT01392300|516796557|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
143341728|NCT01392300|516796558|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
143341729|NCT01392300|516796556|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
143341730|NCT01392300|516796557|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
143341731|NCT01392300|516796558|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
143341732|NCT05056870|516796567|FG000|Period 1|Site COVID-19 Related|3|||
143341733|NCT05056870|516796568|FG001|Period 1|Site COVID-19 Related|3|||
143341734|NCT05056870|516796567|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
143341735|NCT05056870|516796568|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
143341736|NCT05056870|516796567|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
143341737|NCT05056870|516796568|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
143341738|NCT05056870|516796567|FG000|Period 2|COVID-19 Related|1|||
143341739|NCT05056870|516796568|FG001|Period 2|COVID-19 Related|0|||
143341740|NCT05056870|516796567|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
143341741|NCT05056870|516796568|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
143341742|NCT02487498|516796569|FG000|Period: Period 1|Adverse Event|2|||
143341743|NCT02487498|516796570|FG001|Period: Period 1|Adverse Event|4|||
143341744|NCT02487498|516796569|FG000|Period: Period 1|Subject/guardian decision|2|||
143341745|NCT02487498|516796570|FG001|Period: Period 1|Subject/guardian decision|4|||
143341746|NCT02487498|516796569|FG000|Period: Period 1|Lost to Follow-up|0|||
143341747|NCT02487498|516796570|FG001|Period: Period 1|Lost to Follow-up|2|||
143341748|NCT02487498|516796569|FG000|Period: Period 1|Lack of Efficacy|1|||
143341749|NCT02487498|516796570|FG001|Period: Period 1|Lack of Efficacy|0|||
143341750|NCT02487498|516796569|FG000|Period: Period 1|Physician Decision|0|||
143341751|NCT02487498|516796570|FG001|Period: Period 1|Physician Decision|1|||
143341752|NCT02487498|516796569|FG000|Period: Period 1|Protocol deviation|1|||
143341753|NCT02487498|516796570|FG001|Period: Period 1|Protocol deviation|0|||
143341754|NCT02487498|516796569|FG000|Period: Washout|Subject/guardian decision|0|||
143341755|NCT02487498|516796570|FG001|Period: Washout|Subject/guardian decision|5|||
143341756|NCT02487498|516796569|FG000|Period: Washout|Lack of Efficacy|1|||
143341757|NCT02487498|516796570|FG001|Period: Washout|Lack of Efficacy|1|||
143341758|NCT02487498|516796569|FG000|Period: Washout|Physician Decision|1|||
143341759|NCT02487498|516796570|FG001|Period: Washout|Physician Decision|0|||
143341760|NCT02487498|516796569|FG000|Period: Washout|Non-compliance with study treatment|0|||
143341761|NCT02487498|516796570|FG001|Period: Washout|Non-compliance with study treatment|1|||
143341762|NCT02487498|516796569|FG000|Period: Period 2|Adverse Event|2|||
143341763|NCT02487498|516796570|FG001|Period: Period 2|Adverse Event|2|||
143341764|NCT02487498|516796569|FG000|Period: Period 2|Subject/guardian decision|2|||
143341765|NCT02487498|516796570|FG001|Period: Period 2|Subject/guardian decision|1|||
143341766|NCT02487498|516796569|FG000|Period: Period 2|Lost to Follow-up|1|||
143341767|NCT02487498|516796570|FG001|Period: Period 2|Lost to Follow-up|1|||
143341768|NCT02487498|516796569|FG000|Period: Period 2|Death|0|||
143341769|NCT02487498|516796570|FG001|Period: Period 2|Death|1|||
143341770|NCT02487498|516796569|FG000|Period: Period 2|Physician Decision|1|||
143341771|NCT02487498|516796570|FG001|Period: Period 2|Physician Decision|0|||
143341772|NCT02798211|516796573|FG000|Period 1|Adverse Event|1|||
143341773|NCT02798211|516796574|FG001|Period 1|Adverse Event|1|||
143341774|NCT02798211|516796575|FG002|Period 1|Adverse Event|0|||
143341775|NCT02798211|516796576|FG003|Period 1|Adverse Event|0|||
143341776|NCT02798211|516796577|FG004|Period 1|Adverse Event|0|||
143395466|NCT05201079|516994961|FG001|Overall Study|Physician Decision|1|||
143395467|NCT05201079|516994960|FG000|Overall Study|Protocol Violation|1|||
143395468|NCT05201079|516994961|FG001|Overall Study|Protocol Violation|0|||
143395469|NCT05201079|516994960|FG000|Overall Study|Withdrawal by Subject|1|||
143341777|NCT02798211|516796578|FG005|Period 1|Adverse Event|0|||
143395470|NCT05201079|516994961|FG001|Overall Study|Withdrawal by Subject|0|||
143395471|NCT05201079|516994960|FG000|Overall Study|Forbidden medication|9|||
143395472|NCT05201079|516994961|FG001|Overall Study|Forbidden medication|5|||
143395473|NCT05201079|516994960|FG000|Overall Study|Transfer to another hospital|0|||
143395474|NCT05201079|516994961|FG001|Overall Study|Transfer to another hospital|1|||
143395475|NCT05201079|516994960|FG000|Overall Study|Clinical condition|1|||
143395476|NCT05201079|516994961|FG001|Overall Study|Clinical condition|0|||
143395477|NCT05201079|516994960|FG000|Overall Study|SAE and sepsis|1|||
143395478|NCT05201079|516994961|FG001|Overall Study|SAE and sepsis|0|||
143395479|NCT04145440|516994962|FG000|Overall Study|Physician Decision|3|||
143395480|NCT04145440|516994963|FG001|Overall Study|Physician Decision|0|||
143395481|NCT04145440|516994962|FG000|Overall Study|Use of prohibited therapy|2|||
143395482|NCT04145440|516994963|FG001|Overall Study|Use of prohibited therapy|3|||
143395483|NCT05281562|516994966|FG000|Overall Study|Ineligible patient|1|||
143395484|NCT05281562|516994967|FG001|Overall Study|Ineligible patient|0|||
143395485|NCT04524442|516994969|FG000|Overall Study|Subject Decision|1|||
143395486|NCT04880863|516994970|FG000|Overall Study|Adverse Event|1|||
143395487|NCT04880863|516994970|FG000|Overall Study|Patient decision|2|||
143395488|NCT04880863|516994970|FG000|Overall Study|Confirmed Disease Progression|15|||
143395489|NCT04880863|516994970|FG000|Overall Study|Death|3|||
143395490|NCT04880863|516994970|FG000|Overall Study|Physician Decision|4|||
143395491|NCT04880863|516994970|FG000|Overall Study|Unconfirmed Disease Progression|4|||
143395492|NCT04880863|516994970|FG000|Overall Study|Withdrawal by Subject|2|||
143395493|NCT04880863|516994970|FG000|Overall Study|Study discontinuation by the sponsor|4|||
143395494|NCT04880863|516994970|FG000|Overall Study|Progression disease identified by lumbar puncture|1|||
143395495|NCT04880863|516994970|FG000|Overall Study|Not received study drug NAP|2|||
143395496|NCT01733316|516994978|FG000|RP103 Phase|Non-compliance|1|||
143395497|NCT01733316|516994978|FG000|Long Term Extension Phase|Adverse Event|1|||
143395498|NCT01733316|516994978|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
143395499|NCT01733316|516994978|FG000|Long Term Extension Phase|Sponsor Decision|2|||
143395500|NCT05526430|516994979|FG000|Overall Study|Withdrawal by Subject|0|||
143395501|NCT05526430|516994980|FG001|Overall Study|Withdrawal by Subject|2|||
143395502|NCT05526430|516994981|FG002|Overall Study|Withdrawal by Subject|0|||
143395503|NCT05526430|516994982|FG003|Overall Study|Withdrawal by Subject|0|||
143395504|NCT02601313|516994995|FG000|Overall Study|Death|2|||
143395505|NCT02601313|516994996|FG001|Overall Study|Death|41|||
143395506|NCT02601313|516994997|FG002|Overall Study|Death|6|||
143395507|NCT02601313|516994995|FG000|Overall Study|Enrolled but never treated|0|||
143395508|NCT02601313|516994996|FG001|Overall Study|Enrolled but never treated|6|||
143395509|NCT02601313|516994997|FG002|Overall Study|Enrolled but never treated|3|||
143395510|NCT02601313|516994995|FG000|Overall Study|Enrolled, did not initiate AC|4|||
143395511|NCT02601313|516994996|FG001|Overall Study|Enrolled, did not initiate AC|0|||
143395512|NCT02601313|516994997|FG002|Overall Study|Enrolled, did not initiate AC|0|||
143395513|NCT02601313|516994995|FG000|Overall Study|Full consent withdrawal|0|||
143395514|NCT02601313|516994996|FG001|Overall Study|Full consent withdrawal|3|||
143395515|NCT02601313|516994997|FG002|Overall Study|Full consent withdrawal|2|||
143395516|NCT02601313|516994995|FG000|Overall Study|Lost to Follow-up|0|||
143395517|NCT02601313|516994996|FG001|Overall Study|Lost to Follow-up|1|||
143395518|NCT02601313|516994997|FG002|Overall Study|Lost to Follow-up|1|||
143395519|NCT05239455|516994998|FG000|Overall Study|Adverse Event|1|||
143395520|NCT05239455|516994998|FG000|Overall Study|Sponsor Decision|5|||
143395521|NCT05239455|516994998|FG000|Overall Study|Incomplete Blood Collection|1|||
143395522|NCT04054193|516994999|FG000|Cycle 1|Physician Decision|1|||
143395523|NCT04054193|516994999|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
143341778|NCT02798211|516796573|FG000|Period 1|Lost to Follow-up|2|||
143341779|NCT02798211|516796574|FG001|Period 1|Lost to Follow-up|1|||
143341780|NCT02798211|516796575|FG002|Period 1|Lost to Follow-up|0|||
143341781|NCT02798211|516796576|FG003|Period 1|Lost to Follow-up|0|||
143341782|NCT02798211|516796577|FG004|Period 1|Lost to Follow-up|0|||
143341783|NCT02798211|516796578|FG005|Period 1|Lost to Follow-up|0|||
143341784|NCT02798211|516796573|FG000|Period 1|Protocol Violation|0|||
143341785|NCT02798211|516796574|FG001|Period 1|Protocol Violation|0|||
143341786|NCT02798211|516796575|FG002|Period 1|Protocol Violation|2|||
143341787|NCT02798211|516796576|FG003|Period 1|Protocol Violation|0|||
143341788|NCT02798211|516796577|FG004|Period 1|Protocol Violation|0|||
143341789|NCT02798211|516796578|FG005|Period 1|Protocol Violation|0|||
143341790|NCT02798211|516796573|FG000|Period 1|Withdrawal by Subject|1|||
143341791|NCT02798211|516796574|FG001|Period 1|Withdrawal by Subject|1|||
143341792|NCT02798211|516796575|FG002|Period 1|Withdrawal by Subject|0|||
143341793|NCT02798211|516796576|FG003|Period 1|Withdrawal by Subject|0|||
143341794|NCT02798211|516796577|FG004|Period 1|Withdrawal by Subject|0|||
143341795|NCT02798211|516796578|FG005|Period 1|Withdrawal by Subject|0|||
143341796|NCT02798211|516796573|FG000|Period 1|Death|0|||
143341797|NCT02798211|516796574|FG001|Period 1|Death|0|||
143341798|NCT02798211|516796575|FG002|Period 1|Death|1|||
143341799|NCT02798211|516796576|FG003|Period 1|Death|0|||
143395524|NCT04054193|516994999|FG000|Cycle 1|Allocated but not treated|3|||
143395525|NCT04054193|516994999|FG000|Cycles 2-3|Physician Decision|2|||
143395526|NCT04054193|516994999|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
143395527|NCT04054193|516994999|FG000|Cycles 2-3|Various reasons|17|||
143395528|NCT06182033|516995000|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
143341800|NCT02798211|516796577|FG004|Period 1|Death|0|||
143341801|NCT02798211|516796578|FG005|Period 1|Death|0|||
143395529|NCT06182033|516995001|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
143395530|NCT06182033|516995000|FG000|Overall Study|Target child relocation|1|||
143395531|NCT06182033|516995001|FG001|Overall Study|Target child relocation|1|||
143395532|NCT06182033|516995000|FG000|Overall Study|Withdrawal by Subject|1|||
143395533|NCT06182033|516995001|FG001|Overall Study|Withdrawal by Subject|0|||
143395534|NCT02151981|516995012|FG000|Overall Study|Death|184|||
143395535|NCT02151981|516995013|FG001|Overall Study|Death|88|||
143395536|NCT02151981|516995012|FG000|Overall Study|Lost to Follow-up|7|||
143395537|NCT02151981|516995013|FG001|Overall Study|Lost to Follow-up|1|||
143395538|NCT02151981|516995012|FG000|Overall Study|Withdrawal by Subject|27|||
143395539|NCT02151981|516995013|FG001|Overall Study|Withdrawal by Subject|21|||
143395540|NCT02151981|516995012|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
143395541|NCT02151981|516995013|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
143395542|NCT02151981|516995012|FG000|Overall Study|Other reasons|1|||
143395543|NCT02151981|516995013|FG001|Overall Study|Other reasons|2|||
143395544|NCT05576155|516995023|FG000|Overall Study|Withdrawal by Subject|1|||
143395545|NCT05576155|516995024|FG001|Overall Study|Withdrawal by Subject|1|||
143395546|NCT05192109|516995025|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
143395547|NCT05192109|516995026|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
143395548|NCT05192109|516995027|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
143395549|NCT05192109|516995028|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
143395550|NCT05192109|516995025|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
143395551|NCT05192109|516995026|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
143395552|NCT05192109|516995027|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
143395553|NCT05192109|516995028|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
143395554|NCT04515849|516995029|FG000|Overall Study|Adverse Event|0|||
143395555|NCT04515849|516995030|FG001|Overall Study|Adverse Event|0|||
143395556|NCT04515849|516995031|FG002|Overall Study|Adverse Event|0|||
143395557|NCT04515849|516995032|FG003|Overall Study|Adverse Event|1|||
143395558|NCT04515849|516995033|FG004|Overall Study|Adverse Event|2|||
143395559|NCT04515849|516995029|FG000|Overall Study|Death|2|||
143395560|NCT04515849|516995030|FG001|Overall Study|Death|0|||
143395561|NCT04515849|516995031|FG002|Overall Study|Death|0|||
143395562|NCT04515849|516995032|FG003|Overall Study|Death|0|||
143395563|NCT04515849|516995033|FG004|Overall Study|Death|0|||
143395564|NCT04515849|516995029|FG000|Overall Study|Other:family emergency|0|||
143395565|NCT04515849|516995030|FG001|Overall Study|Other:family emergency|0|||
143395566|NCT04515849|516995031|FG002|Overall Study|Other:family emergency|0|||
143395567|NCT04515849|516995032|FG003|Overall Study|Other:family emergency|1|||
143395568|NCT04515849|516995033|FG004|Overall Study|Other:family emergency|0|||
143395569|NCT04515849|516995029|FG000|Overall Study|Other:randomised by error|0|||
143395570|NCT04515849|516995030|FG001|Overall Study|Other:randomised by error|1|||
143395571|NCT04515849|516995031|FG002|Overall Study|Other:randomised by error|0|||
143395572|NCT04515849|516995032|FG003|Overall Study|Other:randomised by error|0|||
143395573|NCT04515849|516995033|FG004|Overall Study|Other:randomised by error|0|||
143395574|NCT04515849|516995029|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
143395575|NCT04515849|516995030|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
143395576|NCT04515849|516995031|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
143395577|NCT04515849|516995032|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
143395578|NCT04515849|516995033|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
143395579|NCT04515849|516995029|FG000|Overall Study|Physician Decision|0|||
143395580|NCT04515849|516995030|FG001|Overall Study|Physician Decision|1|||
143395581|NCT04515849|516995031|FG002|Overall Study|Physician Decision|0|||
143341802|NCT02798211|516796573|FG000|Period 1|Withdrawal of Informed Consent|2|||
143341803|NCT02798211|516796574|FG001|Period 1|Withdrawal of Informed Consent|7|||
143341804|NCT02798211|516796575|FG002|Period 1|Withdrawal of Informed Consent|3|||
143341805|NCT02798211|516796576|FG003|Period 1|Withdrawal of Informed Consent|0|||
143341806|NCT02798211|516796577|FG004|Period 1|Withdrawal of Informed Consent|0|||
143341807|NCT02798211|516796578|FG005|Period 1|Withdrawal of Informed Consent|0|||
143341808|NCT02798211|516796573|FG000|Period 2|Withdrawal by Subject|2|||
143395582|NCT04515849|516995032|FG003|Overall Study|Physician Decision|0|||
143395583|NCT04515849|516995033|FG004|Overall Study|Physician Decision|0|||
143395584|NCT04515849|516995029|FG000|Overall Study|Withdrawal by Subject|1|||
143395585|NCT04515849|516995030|FG001|Overall Study|Withdrawal by Subject|2|||
143395586|NCT04515849|516995031|FG002|Overall Study|Withdrawal by Subject|1|||
143395587|NCT04515849|516995032|FG003|Overall Study|Withdrawal by Subject|0|||
143395588|NCT04515849|516995033|FG004|Overall Study|Withdrawal by Subject|0|||
143395589|NCT03287817|516997511|FG000|Overall Study|Progressive disease|4|||
143395590|NCT03287817|516997512|FG001|Overall Study|Progressive disease|2|||
143395591|NCT03287817|516997513|FG002|Overall Study|Progressive disease|3|||
143341809|NCT02798211|516796574|FG001|Period 2|Withdrawal by Subject|0|||
143341810|NCT02798211|516796575|FG002|Period 2|Withdrawal by Subject|0|||
143341811|NCT02798211|516796576|FG003|Period 2|Withdrawal by Subject|0|||
143341812|NCT02798211|516796577|FG004|Period 2|Withdrawal by Subject|2|||
143395592|NCT03287817|516997514|FG003|Overall Study|Progressive disease|10|||
143395593|NCT03287817|516997515|FG004|Overall Study|Progressive disease|8|||
143395594|NCT03287817|516997511|FG000|Overall Study|Death|0|||
143395595|NCT03287817|516997512|FG001|Overall Study|Death|0|||
143395596|NCT03287817|516997513|FG002|Overall Study|Death|2|||
143395597|NCT03287817|516997514|FG003|Overall Study|Death|3|||
143395598|NCT03287817|516997515|FG004|Overall Study|Death|4|||
143395599|NCT03287817|516997511|FG000|Overall Study|Physician Decision|0|||
143395600|NCT03287817|516997512|FG001|Overall Study|Physician Decision|0|||
143395601|NCT03287817|516997513|FG002|Overall Study|Physician Decision|0|||
143395602|NCT03287817|516997514|FG003|Overall Study|Physician Decision|1|||
143395603|NCT03287817|516997515|FG004|Overall Study|Physician Decision|0|||
143395604|NCT03287817|516997511|FG000|Overall Study|Withdrawal by Subject|0|||
143395605|NCT03287817|516997512|FG001|Overall Study|Withdrawal by Subject|0|||
143395606|NCT03287817|516997513|FG002|Overall Study|Withdrawal by Subject|0|||
143395607|NCT03287817|516997514|FG003|Overall Study|Withdrawal by Subject|0|||
143395608|NCT03287817|516997515|FG004|Overall Study|Withdrawal by Subject|4|||
143395609|NCT05251909|516997516|FG000|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
143395610|NCT05251909|516997517|FG001|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
143395611|NCT06181227|516997518|FG000|Overall Study|Study terminated by sponsor|7|||
143395612|NCT06181227|516997519|FG001|Overall Study|Study terminated by sponsor|9|||
143395613|NCT05543915|516997520|FG000|Overall Study|Lost to Follow-up|0|||
143395614|NCT05543915|516997521|FG001|Overall Study|Lost to Follow-up|1|||
143395615|NCT02561247|516997524|FG000|Overall Study|Protocol Violation|1|||
143395616|NCT02561247|516997524|FG000|Overall Study|Withdrawal by Subject|1|||
143395617|NCT02561247|516997524|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
143395618|NCT00433329|516997525|FG000|Overall Study|Adverse Event|9|||
143395619|NCT00433329|516997525|FG000|Overall Study|Death|4|||
143395620|NCT00433329|516997525|FG000|Overall Study|Withdrew consent|3|||
143395621|NCT00433329|516997525|FG000|Overall Study|Discontinued sildenafil|2|||
143395622|NCT00433329|516997525|FG000|Overall Study|Moved out of state|1|||
143395623|NCT00433329|516997525|FG000|Overall Study|Lost to Follow-up|1|||
143395624|NCT00433329|516997525|FG000|Overall Study|Physician Decision|1|||
143395625|NCT03854227|516997526|FG000|Overall Study|Adverse Event|0|||
143395626|NCT03854227|516997527|FG001|Overall Study|Adverse Event|0|||
143395627|NCT03854227|516997528|FG002|Overall Study|Adverse Event|0|||
143395628|NCT03854227|516997529|FG003|Overall Study|Adverse Event|1|||
143395629|NCT03854227|516997530|FG004|Overall Study|Adverse Event|0|||
143395630|NCT03854227|516997531|FG005|Overall Study|Adverse Event|0|||
143395631|NCT03854227|516997532|FG006|Overall Study|Adverse Event|1|||
143395632|NCT03854227|516997533|FG007|Overall Study|Adverse Event|0|||
143395633|NCT03854227|516997534|FG008|Overall Study|Adverse Event|0|||
143395634|NCT03854227|516997535|FG009|Overall Study|Adverse Event|3|||
143395635|NCT03854227|516997536|FG010|Overall Study|Adverse Event|0|||
143395636|NCT03854227|516997537|FG011|Overall Study|Adverse Event|1|||
143395637|NCT03854227|516997526|FG000|Overall Study|Death|0|||
143395638|NCT03854227|516997527|FG001|Overall Study|Death|0|||
143395639|NCT03854227|516997528|FG002|Overall Study|Death|0|||
143395640|NCT03854227|516997529|FG003|Overall Study|Death|0|||
143395641|NCT03854227|516997530|FG004|Overall Study|Death|0|||
143395642|NCT03854227|516997531|FG005|Overall Study|Death|1|||
143395643|NCT03854227|516997532|FG006|Overall Study|Death|0|||
143395644|NCT03854227|516997533|FG007|Overall Study|Death|0|||
143395645|NCT03854227|516997534|FG008|Overall Study|Death|0|||
143395646|NCT03854227|516997535|FG009|Overall Study|Death|1|||
143395647|NCT03854227|516997536|FG010|Overall Study|Death|0|||
143395648|NCT03854227|516997537|FG011|Overall Study|Death|1|||
143395649|NCT03854227|516997526|FG000|Overall Study|Physician Decision|0|||
143395650|NCT03854227|516997527|FG001|Overall Study|Physician Decision|0|||
143395651|NCT03854227|516997528|FG002|Overall Study|Physician Decision|0|||
143395652|NCT03854227|516997529|FG003|Overall Study|Physician Decision|0|||
143395653|NCT03854227|516997530|FG004|Overall Study|Physician Decision|0|||
143395654|NCT03854227|516997531|FG005|Overall Study|Physician Decision|1|||
143395655|NCT03854227|516997532|FG006|Overall Study|Physician Decision|0|||
143395656|NCT03854227|516997533|FG007|Overall Study|Physician Decision|0|||
143395657|NCT03854227|516997534|FG008|Overall Study|Physician Decision|1|||
143395658|NCT03854227|516997535|FG009|Overall Study|Physician Decision|1|||
143395659|NCT03854227|516997536|FG010|Overall Study|Physician Decision|0|||
143395660|NCT03854227|516997537|FG011|Overall Study|Physician Decision|1|||
143395661|NCT03854227|516997526|FG000|Overall Study|Progressive disease|1|||
143395662|NCT03854227|516997527|FG001|Overall Study|Progressive disease|1|||
143395663|NCT03854227|516997528|FG002|Overall Study|Progressive disease|1|||
143395664|NCT03854227|516997529|FG003|Overall Study|Progressive disease|2|||
143395665|NCT03854227|516997530|FG004|Overall Study|Progressive disease|3|||
143395666|NCT03854227|516997531|FG005|Overall Study|Progressive disease|1|||
143395667|NCT03854227|516997532|FG006|Overall Study|Progressive disease|2|||
143395668|NCT03854227|516997533|FG007|Overall Study|Progressive disease|5|||
143395669|NCT03854227|516997534|FG008|Overall Study|Progressive disease|2|||
143395670|NCT03854227|516997535|FG009|Overall Study|Progressive disease|5|||
143395671|NCT03854227|516997536|FG010|Overall Study|Progressive disease|1|||
143395672|NCT03854227|516997537|FG011|Overall Study|Progressive disease|6|||
143395673|NCT03854227|516997526|FG000|Overall Study|Study terminated by sponsor|0|||
143395674|NCT03854227|516997527|FG001|Overall Study|Study terminated by sponsor|0|||
143395675|NCT03854227|516997528|FG002|Overall Study|Study terminated by sponsor|0|||
143395676|NCT03854227|516997529|FG003|Overall Study|Study terminated by sponsor|0|||
143395677|NCT03854227|516997530|FG004|Overall Study|Study terminated by sponsor|0|||
143395678|NCT03854227|516997531|FG005|Overall Study|Study terminated by sponsor|0|||
143395679|NCT03854227|516997532|FG006|Overall Study|Study terminated by sponsor|0|||
143395680|NCT03854227|516997533|FG007|Overall Study|Study terminated by sponsor|0|||
143395681|NCT03854227|516997534|FG008|Overall Study|Study terminated by sponsor|0|||
143395682|NCT03854227|516997535|FG009|Overall Study|Study terminated by sponsor|1|||
143395683|NCT03854227|516997536|FG010|Overall Study|Study terminated by sponsor|0|||
143395684|NCT03854227|516997537|FG011|Overall Study|Study terminated by sponsor|0|||
143395685|NCT03854227|516997526|FG000|Overall Study|Withdrawal by Subject|0|||
143395686|NCT03854227|516997527|FG001|Overall Study|Withdrawal by Subject|0|||
143395687|NCT03854227|516997528|FG002|Overall Study|Withdrawal by Subject|1|||
143395688|NCT03854227|516997529|FG003|Overall Study|Withdrawal by Subject|0|||
143395689|NCT03854227|516997530|FG004|Overall Study|Withdrawal by Subject|0|||
143395690|NCT03854227|516997531|FG005|Overall Study|Withdrawal by Subject|0|||
143395691|NCT03854227|516997532|FG006|Overall Study|Withdrawal by Subject|0|||
143395692|NCT03854227|516997533|FG007|Overall Study|Withdrawal by Subject|0|||
143395693|NCT03854227|516997534|FG008|Overall Study|Withdrawal by Subject|0|||
143395694|NCT03854227|516997535|FG009|Overall Study|Withdrawal by Subject|1|||
143395695|NCT03854227|516997536|FG010|Overall Study|Withdrawal by Subject|1|||
143395696|NCT03854227|516997537|FG011|Overall Study|Withdrawal by Subject|0|||
143395697|NCT03854227|516997526|FG000|Overall Study|Disease relapse|0|||
143395698|NCT03854227|516997527|FG001|Overall Study|Disease relapse|0|||
143395699|NCT03854227|516997528|FG002|Overall Study|Disease relapse|0|||
143395700|NCT03854227|516997529|FG003|Overall Study|Disease relapse|0|||
143395701|NCT03854227|516997530|FG004|Overall Study|Disease relapse|0|||
143395702|NCT03854227|516997531|FG005|Overall Study|Disease relapse|0|||
143395703|NCT03854227|516997532|FG006|Overall Study|Disease relapse|0|||
143395704|NCT03854227|516997533|FG007|Overall Study|Disease relapse|0|||
143395705|NCT03854227|516997534|FG008|Overall Study|Disease relapse|1|||
143395706|NCT03854227|516997535|FG009|Overall Study|Disease relapse|0|||
143395707|NCT03854227|516997536|FG010|Overall Study|Disease relapse|0|||
143395708|NCT03854227|516997537|FG011|Overall Study|Disease relapse|0|||
143395709|NCT03854227|516997526|FG000|Overall Study|Global deterioration of health status|0|||
143395710|NCT03854227|516997527|FG001|Overall Study|Global deterioration of health status|0|||
143395711|NCT03854227|516997528|FG002|Overall Study|Global deterioration of health status|0|||
143395712|NCT03854227|516997529|FG003|Overall Study|Global deterioration of health status|0|||
143395713|NCT03854227|516997530|FG004|Overall Study|Global deterioration of health status|0|||
143395714|NCT03854227|516997531|FG005|Overall Study|Global deterioration of health status|1|||
143395715|NCT03854227|516997532|FG006|Overall Study|Global deterioration of health status|0|||
143395716|NCT03854227|516997533|FG007|Overall Study|Global deterioration of health status|1|||
143395717|NCT03854227|516997534|FG008|Overall Study|Global deterioration of health status|0|||
143395718|NCT03854227|516997535|FG009|Overall Study|Global deterioration of health status|0|||
143395719|NCT03854227|516997536|FG010|Overall Study|Global deterioration of health status|0|||
143395720|NCT03854227|516997537|FG011|Overall Study|Global deterioration of health status|0|||
143395721|NCT03854227|516997526|FG000|Overall Study|Refused further treatment|0|||
143395722|NCT03854227|516997527|FG001|Overall Study|Refused further treatment|0|||
143395723|NCT03854227|516997528|FG002|Overall Study|Refused further treatment|0|||
143395724|NCT03854227|516997529|FG003|Overall Study|Refused further treatment|0|||
143395725|NCT03854227|516997530|FG004|Overall Study|Refused further treatment|0|||
143395726|NCT03854227|516997531|FG005|Overall Study|Refused further treatment|0|||
143395727|NCT03854227|516997532|FG006|Overall Study|Refused further treatment|0|||
143395728|NCT03854227|516997533|FG007|Overall Study|Refused further treatment|0|||
143395729|NCT03854227|516997534|FG008|Overall Study|Refused further treatment|0|||
143395730|NCT03854227|516997535|FG009|Overall Study|Refused further treatment|1|||
143395731|NCT03854227|516997536|FG010|Overall Study|Refused further treatment|0|||
143395732|NCT03854227|516997537|FG011|Overall Study|Refused further treatment|1|||
143395733|NCT03854227|516997526|FG000|Overall Study|Other|0|||
143395734|NCT03854227|516997527|FG001|Overall Study|Other|0|||
143395735|NCT03854227|516997528|FG002|Overall Study|Other|0|||
143395736|NCT03854227|516997529|FG003|Overall Study|Other|0|||
143395737|NCT03854227|516997530|FG004|Overall Study|Other|0|||
143395738|NCT03854227|516997531|FG005|Overall Study|Other|0|||
143395739|NCT03854227|516997532|FG006|Overall Study|Other|0|||
143395740|NCT03854227|516997533|FG007|Overall Study|Other|0|||
143395741|NCT03854227|516997534|FG008|Overall Study|Other|1|||
143395742|NCT03854227|516997535|FG009|Overall Study|Other|1|||
143395743|NCT03854227|516997536|FG010|Overall Study|Other|0|||
143395744|NCT03854227|516997537|FG011|Overall Study|Other|0|||
143395745|NCT02276885|516997538|FG000|Overall Study|Withdrawal by Subject|2|||
143395746|NCT02276885|516997539|FG001|Overall Study|Withdrawal by Subject|0|||
143395747|NCT02276885|516997538|FG000|Overall Study|Lost to Follow-up|5|||
143395748|NCT02276885|516997539|FG001|Overall Study|Lost to Follow-up|2|||
143395749|NCT03150173|516997541|FG000|Overall Study|Lost to Follow-up|13|||
143395750|NCT03150173|516997542|FG001|Overall Study|Lost to Follow-up|5|||
143395751|NCT03461276|516997549|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
143395752|NCT03461276|516997550|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
143395753|NCT03461276|516997549|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
143395754|NCT03461276|516997550|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
143395755|NCT03461276|516997549|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
143395756|NCT03461276|516997550|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
143395757|NCT03461276|516997549|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
143395758|NCT03461276|516997550|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
143395759|NCT03461276|516997549|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
143395760|NCT03461276|516997550|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
143395761|NCT03461276|516997549|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
143395762|NCT03461276|516997550|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
143395763|NCT03461276|516997549|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
143395764|NCT03461276|516997550|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
143395765|NCT03461276|516997549|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
143395766|NCT03461276|516997550|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
143395767|NCT03461276|516997549|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
143395768|NCT03461276|516997550|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
143395769|NCT03461276|516997549|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
143395770|NCT03461276|516997550|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
143395771|NCT01593917|516997551|FG000|Overall Study|Death|67|||
143395772|NCT01593917|516997551|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
143395773|NCT01593917|516997551|FG000|Overall Study|Withdrawal by Subject|23|||
143395774|NCT01593917|516997551|FG000|Overall Study|Lost to Follow-up|12|||
143395775|NCT01593917|516997551|FG000|Overall Study|Protocol Violation|5|||
143395776|NCT01593917|516997551|FG000|Overall Study|Physician Decision|3|||
143395777|NCT04663737|516997554|FG000|Overall Study|Withdrawal by Subject|2|||
143395778|NCT04663737|516997555|FG001|Overall Study|Withdrawal by Subject|0|||
143395779|NCT03216057|516997556|FG000|Overall Study|Lost to Follow-up|2|||
143395780|NCT03216057|516997557|FG001|Overall Study|Lost to Follow-up|2|||
143395781|NCT04568603|516997558|FG000|Overall Study|Physician Decision|1|||
143395782|NCT05144009|516997559|FG000|Overall Study|Lost to Follow-up|0|||
143395783|NCT05144009|516997560|FG001|Overall Study|Lost to Follow-up|1|||
143395784|NCT05144009|516997559|FG000|Overall Study|Study Termination by the Sponsor|11|||
143395785|NCT05144009|516997560|FG001|Overall Study|Study Termination by the Sponsor|11|||
143395786|NCT05144009|516997559|FG000|Overall Study|Disease Progression|1|||
143395787|NCT05144009|516997560|FG001|Overall Study|Disease Progression|0|||
143395788|NCT05144009|516997559|FG000|Overall Study|Participant Decision|0|||
143395789|NCT05144009|516997560|FG001|Overall Study|Participant Decision|2|||
143395790|NCT05144009|516997559|FG000|Overall Study|Death|5|||
143395791|NCT05144009|516997560|FG001|Overall Study|Death|10|||
143395792|NCT04499924|516997561|FG000|Overall Study|Study termination by sponsor|4|||
143395793|NCT04499924|516997562|FG001|Overall Study|Study termination by sponsor|6|||
143395794|NCT04499924|516997561|FG000|Overall Study|Withdrawal by Subject|1|||
143395795|NCT04499924|516997562|FG001|Overall Study|Withdrawal by Subject|3|||
143395796|NCT03904147|516997567|FG000|Overall Study|Death|15|||
143395797|NCT03904147|516997568|FG001|Overall Study|Death|13|||
143395798|NCT03904147|516997569|FG002|Overall Study|Death|15|||
143395799|NCT03904147|516997567|FG000|Overall Study|Withdrawal by Subject|7|||
143395800|NCT03904147|516997568|FG001|Overall Study|Withdrawal by Subject|12|||
143395801|NCT03904147|516997569|FG002|Overall Study|Withdrawal by Subject|1|||
143395802|NCT03904147|516997567|FG000|Overall Study|1Y visit completed after 365 days|1|||
143395803|NCT03904147|516997568|FG001|Overall Study|1Y visit completed after 365 days|1|||
143395804|NCT03904147|516997569|FG002|Overall Study|1Y visit completed after 365 days|0|||
143395805|NCT04413708|516997570|FG000|Overall Study|Lost to Follow-up|1|||
143395806|NCT04413708|516997571|FG001|Overall Study|Lost to Follow-up|2|||
143395807|NCT02815566|516997575|FG000|Overall Study|Adverse Event|1|||
143395808|NCT02815566|516997576|FG001|Overall Study|Adverse Event|1|||
143395809|NCT02815566|516997575|FG000|Overall Study|Withdrawal by Subject|1|||
143395810|NCT02815566|516997576|FG001|Overall Study|Withdrawal by Subject|0|||
143395811|NCT02815566|516997575|FG000|Overall Study|Lost to Follow-up|0|||
143395812|NCT02815566|516997576|FG001|Overall Study|Lost to Follow-up|1|||
143395813|NCT04032704|516997577|FG000|Part A|Withdrawal by Subject|0|||
143395814|NCT04032704|516997578|FG001|Part A|Withdrawal by Subject|0|||
143395815|NCT04032704|516997579|FG002|Part A|Withdrawal by Subject|3|||
143395816|NCT04032704|516997580|FG003|Part A|Withdrawal by Subject|0|||
143395817|NCT04032704|516997581|FG004|Part A|Withdrawal by Subject|1|||
143395818|NCT04032704|516997582|FG005|Part A|Withdrawal by Subject|7|||
143395819|NCT04032704|516997583|FG006|Part A|Withdrawal by Subject|0|||
143395820|NCT04032704|516997584|FG007|Part A|Withdrawal by Subject|0|||
143395821|NCT04032704|516997585|FG008|Part A|Withdrawal by Subject|0|||
143395822|NCT04032704|516997586|FG009|Part A|Withdrawal by Subject|0|||
143395823|NCT04032704|516997587|FG010|Part A|Withdrawal by Subject|0|||
143395824|NCT04032704|516997588|FG011|Part A|Withdrawal by Subject|0|||
143395825|NCT04032704|516997589|FG012|Part A|Withdrawal by Subject|0|||
143395826|NCT04032704|516997590|FG013|Part A|Withdrawal by Subject|0|||
143395827|NCT04032704|516997591|FG014|Part A|Withdrawal by Subject|0|||
143395828|NCT04032704|516997592|FG015|Part A|Withdrawal by Subject|0|||
143395829|NCT04032704|516997593|FG016|Part A|Withdrawal by Subject|0|||
143395830|NCT04032704|516997594|FG017|Part A|Withdrawal by Subject|0|||
143395831|NCT04032704|516997577|FG000|Part A|Lost to Follow-up|1|||
143395832|NCT04032704|516997578|FG001|Part A|Lost to Follow-up|0|||
143395833|NCT04032704|516997579|FG002|Part A|Lost to Follow-up|0|||
143395834|NCT04032704|516997580|FG003|Part A|Lost to Follow-up|0|||
143395835|NCT04032704|516997581|FG004|Part A|Lost to Follow-up|0|||
143395836|NCT04032704|516997582|FG005|Part A|Lost to Follow-up|0|||
143395837|NCT04032704|516997583|FG006|Part A|Lost to Follow-up|0|||
143395838|NCT04032704|516997584|FG007|Part A|Lost to Follow-up|0|||
143395839|NCT04032704|516997585|FG008|Part A|Lost to Follow-up|0|||
143395840|NCT04032704|516997586|FG009|Part A|Lost to Follow-up|0|||
143395841|NCT04032704|516997587|FG010|Part A|Lost to Follow-up|0|||
143395842|NCT04032704|516997588|FG011|Part A|Lost to Follow-up|0|||
143395843|NCT04032704|516997589|FG012|Part A|Lost to Follow-up|0|||
143395844|NCT04032704|516997590|FG013|Part A|Lost to Follow-up|0|||
143395845|NCT04032704|516997591|FG014|Part A|Lost to Follow-up|0|||
143395846|NCT04032704|516997592|FG015|Part A|Lost to Follow-up|0|||
143395847|NCT04032704|516997593|FG016|Part A|Lost to Follow-up|0|||
143395848|NCT04032704|516997594|FG017|Part A|Lost to Follow-up|0|||
143395849|NCT04032704|516997577|FG000|Part A|Death|9|||
143395850|NCT04032704|516997578|FG001|Part A|Death|2|||
143395851|NCT04032704|516997579|FG002|Part A|Death|10|||
143395852|NCT04032704|516997580|FG003|Part A|Death|7|||
143395853|NCT04032704|516997581|FG004|Part A|Death|4|||
143395854|NCT04032704|516997582|FG005|Part A|Death|5|||
143395855|NCT04032704|516997583|FG006|Part A|Death|0|||
143395856|NCT04032704|516997584|FG007|Part A|Death|0|||
143395857|NCT04032704|516997585|FG008|Part A|Death|0|||
143395858|NCT04032704|516997586|FG009|Part A|Death|0|||
143395859|NCT04032704|516997587|FG010|Part A|Death|0|||
143395860|NCT04032704|516997588|FG011|Part A|Death|0|||
143395861|NCT04032704|516997589|FG012|Part A|Death|0|||
143395862|NCT04032704|516997590|FG013|Part A|Death|0|||
143395863|NCT04032704|516997591|FG014|Part A|Death|0|||
143395864|NCT04032704|516997592|FG015|Part A|Death|0|||
143395865|NCT04032704|516997593|FG016|Part A|Death|0|||
143395866|NCT04032704|516997594|FG017|Part A|Death|0|||
143395867|NCT04032704|516997577|FG000|Part B|Other|0|||
143395868|NCT04032704|516997578|FG001|Part B|Other|0|||
143395869|NCT04032704|516997579|FG002|Part B|Other|0|||
143395870|NCT04032704|516997580|FG003|Part B|Other|0|||
143395871|NCT04032704|516997581|FG004|Part B|Other|0|||
143395872|NCT04032704|516997582|FG005|Part B|Other|0|||
143395873|NCT04032704|516997583|FG006|Part B|Other|0|||
143395874|NCT04032704|516997584|FG007|Part B|Other|1|||
143395875|NCT04032704|516997585|FG008|Part B|Other|2|||
143395876|NCT04032704|516997586|FG009|Part B|Other|1|||
143395877|NCT04032704|516997587|FG010|Part B|Other|1|||
143395878|NCT04032704|516997588|FG011|Part B|Other|1|||
143395879|NCT04032704|516997589|FG012|Part B|Other|5|||
143395880|NCT04032704|516997590|FG013|Part B|Other|13|||
143395881|NCT04032704|516997591|FG014|Part B|Other|0|||
143395882|NCT04032704|516997592|FG015|Part B|Other|0|||
143395883|NCT04032704|516997593|FG016|Part B|Other|0|||
143395884|NCT04032704|516997594|FG017|Part B|Other|0|||
143395885|NCT04032704|516997577|FG000|Part B|Study termination by Sponsor|0|||
143395886|NCT04032704|516997578|FG001|Part B|Study termination by Sponsor|0|||
143395887|NCT04032704|516997579|FG002|Part B|Study termination by Sponsor|0|||
143395888|NCT04032704|516997580|FG003|Part B|Study termination by Sponsor|0|||
143395889|NCT04032704|516997581|FG004|Part B|Study termination by Sponsor|0|||
143395890|NCT04032704|516997582|FG005|Part B|Study termination by Sponsor|0|||
143395891|NCT04032704|516997583|FG006|Part B|Study termination by Sponsor|0|||
143395892|NCT04032704|516997584|FG007|Part B|Study termination by Sponsor|0|||
143395893|NCT04032704|516997585|FG008|Part B|Study termination by Sponsor|1|||
143395894|NCT04032704|516997586|FG009|Part B|Study termination by Sponsor|0|||
143395895|NCT04032704|516997587|FG010|Part B|Study termination by Sponsor|0|||
143395896|NCT04032704|516997588|FG011|Part B|Study termination by Sponsor|0|||
143395897|NCT04032704|516997589|FG012|Part B|Study termination by Sponsor|0|||
143395898|NCT04032704|516997590|FG013|Part B|Study termination by Sponsor|0|||
143395899|NCT04032704|516997591|FG014|Part B|Study termination by Sponsor|0|||
143395900|NCT04032704|516997592|FG015|Part B|Study termination by Sponsor|0|||
143395901|NCT04032704|516997593|FG016|Part B|Study termination by Sponsor|0|||
143395902|NCT04032704|516997594|FG017|Part B|Study termination by Sponsor|0|||
143395903|NCT04032704|516997577|FG000|Part B|Withdrawal by Subject|0|||
143395904|NCT04032704|516997578|FG001|Part B|Withdrawal by Subject|0|||
143395905|NCT04032704|516997579|FG002|Part B|Withdrawal by Subject|0|||
143395906|NCT04032704|516997580|FG003|Part B|Withdrawal by Subject|0|||
143395907|NCT04032704|516997581|FG004|Part B|Withdrawal by Subject|0|||
143395908|NCT04032704|516997582|FG005|Part B|Withdrawal by Subject|0|||
143395909|NCT04032704|516997583|FG006|Part B|Withdrawal by Subject|3|||
143395910|NCT04032704|516997584|FG007|Part B|Withdrawal by Subject|2|||
143395911|NCT04032704|516997585|FG008|Part B|Withdrawal by Subject|2|||
143395912|NCT04032704|516997586|FG009|Part B|Withdrawal by Subject|1|||
143395913|NCT04032704|516997587|FG010|Part B|Withdrawal by Subject|4|||
143395914|NCT04032704|516997588|FG011|Part B|Withdrawal by Subject|6|||
143395915|NCT04032704|516997589|FG012|Part B|Withdrawal by Subject|2|||
143395916|NCT04032704|516997590|FG013|Part B|Withdrawal by Subject|1|||
143395917|NCT04032704|516997591|FG014|Part B|Withdrawal by Subject|0|||
143395918|NCT04032704|516997592|FG015|Part B|Withdrawal by Subject|1|||
143395919|NCT04032704|516997593|FG016|Part B|Withdrawal by Subject|0|||
143395920|NCT04032704|516997594|FG017|Part B|Withdrawal by Subject|0|||
143395921|NCT04032704|516997577|FG000|Part B|Lost to Follow-up|0|||
143395922|NCT04032704|516997578|FG001|Part B|Lost to Follow-up|0|||
143395923|NCT04032704|516997579|FG002|Part B|Lost to Follow-up|0|||
143395924|NCT04032704|516997580|FG003|Part B|Lost to Follow-up|0|||
143395925|NCT04032704|516997581|FG004|Part B|Lost to Follow-up|0|||
143395926|NCT04032704|516997582|FG005|Part B|Lost to Follow-up|0|||
143395927|NCT04032704|516997583|FG006|Part B|Lost to Follow-up|0|||
143395928|NCT04032704|516997584|FG007|Part B|Lost to Follow-up|0|||
143395929|NCT04032704|516997585|FG008|Part B|Lost to Follow-up|0|||
143395930|NCT04032704|516997586|FG009|Part B|Lost to Follow-up|0|||
143395931|NCT04032704|516997587|FG010|Part B|Lost to Follow-up|0|||
143395932|NCT04032704|516997588|FG011|Part B|Lost to Follow-up|1|||
143395933|NCT04032704|516997589|FG012|Part B|Lost to Follow-up|0|||
143395934|NCT04032704|516997590|FG013|Part B|Lost to Follow-up|0|||
143395935|NCT04032704|516997591|FG014|Part B|Lost to Follow-up|0|||
143395936|NCT04032704|516997592|FG015|Part B|Lost to Follow-up|0|||
143395937|NCT04032704|516997593|FG016|Part B|Lost to Follow-up|0|||
143395938|NCT04032704|516997594|FG017|Part B|Lost to Follow-up|0|||
143395939|NCT04032704|516997577|FG000|Part B|Death|0|||
143395940|NCT04032704|516997578|FG001|Part B|Death|0|||
143395941|NCT04032704|516997579|FG002|Part B|Death|0|||
143395942|NCT04032704|516997580|FG003|Part B|Death|0|||
143395943|NCT04032704|516997581|FG004|Part B|Death|0|||
143395944|NCT04032704|516997582|FG005|Part B|Death|0|||
143395945|NCT04032704|516997583|FG006|Part B|Death|13|||
143395946|NCT04032704|516997584|FG007|Part B|Death|13|||
143395947|NCT04032704|516997585|FG008|Part B|Death|14|||
143395948|NCT04032704|516997586|FG009|Part B|Death|12|||
143395949|NCT04032704|516997587|FG010|Part B|Death|12|||
143395950|NCT04032704|516997588|FG011|Part B|Death|13|||
143395951|NCT04032704|516997589|FG012|Part B|Death|7|||
143395952|NCT04032704|516997590|FG013|Part B|Death|17|||
143395953|NCT04032704|516997591|FG014|Part B|Death|2|||
143395954|NCT04032704|516997592|FG015|Part B|Death|1|||
143395955|NCT04032704|516997593|FG016|Part B|Death|2|||
143395956|NCT04032704|516997594|FG017|Part B|Death|2|||
143395957|NCT03133546|516997600|FG000|Overall Study|Death|46|||
143395958|NCT03133546|516997601|FG001|Overall Study|Death|43|||
143395959|NCT03133546|516997600|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
143395960|NCT03133546|516997601|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
143395961|NCT01501955|516997605|FG000|Overall Study|Withdrawal by Subject|1|||
143395962|NCT01501955|516997606|FG001|Overall Study|Withdrawal by Subject|0|||
143395963|NCT01501955|516997605|FG000|Overall Study|Adverse Event|1|||
143395964|NCT01501955|516997606|FG001|Overall Study|Adverse Event|3|||
143395965|NCT05034328|516997607|FG000|Overall Study|Protocol Violation|1|||
143395966|NCT05034328|516997608|FG001|Overall Study|Protocol Violation|0|||
143395967|NCT05034328|516997607|FG000|Overall Study|Lost to Follow-up|0|||
143395968|NCT05034328|516997608|FG001|Overall Study|Lost to Follow-up|10|||
143395969|NCT02993159|516997609|FG000|Overall Study|Withdrawal by Subject|1|||
143395970|NCT02993159|516997610|FG001|Overall Study|Withdrawal by Subject|3|||
143395971|NCT02993159|516997609|FG000|Overall Study|Protocol Violation|1|||
143395972|NCT02993159|516997610|FG001|Overall Study|Protocol Violation|0|||
143395973|NCT02993159|516997609|FG000|Overall Study|Opted out of surgery|2|||
143395974|NCT02993159|516997610|FG001|Overall Study|Opted out of surgery|0|||
143395975|NCT02993159|516997609|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
143395976|NCT02993159|516997610|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
143395977|NCT02993159|516997609|FG000|Overall Study|Physician Decision|0|||
143395978|NCT02993159|516997610|FG001|Overall Study|Physician Decision|1|||
143395979|NCT02969707|516997611|FG000|Overall Study|Withdrawal by Subject|6|||
143395980|NCT02969707|516997612|FG001|Overall Study|Withdrawal by Subject|5|||
143395981|NCT02969707|516997611|FG000|Overall Study|Severe anxiety|0|||
143395982|NCT02969707|516997612|FG001|Overall Study|Severe anxiety|1|||
143395983|NCT02969707|516997611|FG000|Overall Study|Positive toxicology screen|0|||
143395984|NCT02969707|516997612|FG001|Overall Study|Positive toxicology screen|2|||
143395985|NCT02969707|516997611|FG000|Overall Study|Claustrophobia|2|||
143395986|NCT02969707|516997612|FG001|Overall Study|Claustrophobia|2|||
143395987|NCT02969707|516997611|FG000|Overall Study|Non-compliance|1|||
143395988|NCT02969707|516997612|FG001|Overall Study|Non-compliance|2|||
143341813|NCT02798211|516796578|FG005|Period 2|Withdrawal by Subject|2|||
143341814|NCT02798211|516796573|FG000|Period 2|Adverse Event|5|||
143341815|NCT02798211|516796574|FG001|Period 2|Adverse Event|0|||
143341816|NCT02798211|516796575|FG002|Period 2|Adverse Event|0|||
143341817|NCT02798211|516796576|FG003|Period 2|Adverse Event|0|||
143341818|NCT02798211|516796577|FG004|Period 2|Adverse Event|1|||
143341819|NCT02798211|516796578|FG005|Period 2|Adverse Event|0|||
143341820|NCT02798211|516796573|FG000|Period 2|Lack of Efficacy|1|||
143341821|NCT02798211|516796574|FG001|Period 2|Lack of Efficacy|0|||
143341822|NCT02798211|516796575|FG002|Period 2|Lack of Efficacy|0|||
143341823|NCT02798211|516796576|FG003|Period 2|Lack of Efficacy|1|||
143341824|NCT02798211|516796577|FG004|Period 2|Lack of Efficacy|0|||
143341825|NCT02798211|516796578|FG005|Period 2|Lack of Efficacy|1|||
143341826|NCT02798211|516796573|FG000|Period 2|Lost to Follow-up|3|||
143341827|NCT02798211|516796574|FG001|Period 2|Lost to Follow-up|0|||
143341828|NCT02798211|516796575|FG002|Period 2|Lost to Follow-up|0|||
143341829|NCT02798211|516796576|FG003|Period 2|Lost to Follow-up|0|||
143341830|NCT02798211|516796577|FG004|Period 2|Lost to Follow-up|2|||
143341831|NCT02798211|516796578|FG005|Period 2|Lost to Follow-up|0|||
143341832|NCT02798211|516796573|FG000|Period 2|Physician Decision|1|||
143341833|NCT02798211|516796574|FG001|Period 2|Physician Decision|0|||
143341834|NCT02798211|516796575|FG002|Period 2|Physician Decision|0|||
143341835|NCT02798211|516796576|FG003|Period 2|Physician Decision|1|||
143341836|NCT02798211|516796577|FG004|Period 2|Physician Decision|1|||
143341837|NCT02798211|516796578|FG005|Period 2|Physician Decision|0|||
143341838|NCT02798211|516796573|FG000|Period 2|Pregnancy|0|||
143341839|NCT02798211|516796574|FG001|Period 2|Pregnancy|0|||
143341840|NCT02798211|516796575|FG002|Period 2|Pregnancy|0|||
143341841|NCT02798211|516796576|FG003|Period 2|Pregnancy|2|||
143341842|NCT02798211|516796577|FG004|Period 2|Pregnancy|0|||
143341843|NCT02798211|516796578|FG005|Period 2|Pregnancy|0|||
143341844|NCT02798211|516796573|FG000|Period 2|Technical problems|1|||
143341845|NCT02798211|516796574|FG001|Period 2|Technical problems|0|||
143341846|NCT02798211|516796575|FG002|Period 2|Technical problems|0|||
143341847|NCT02798211|516796576|FG003|Period 2|Technical problems|1|||
143341848|NCT02798211|516796577|FG004|Period 2|Technical problems|0|||
143341849|NCT02798211|516796578|FG005|Period 2|Technical problems|0|||
143341850|NCT02798211|516796573|FG000|Period 2|Withdrawal of Informed Consent|1|||
143341851|NCT02798211|516796574|FG001|Period 2|Withdrawal of Informed Consent|0|||
143341852|NCT02798211|516796575|FG002|Period 2|Withdrawal of Informed Consent|0|||
143341853|NCT02798211|516796576|FG003|Period 2|Withdrawal of Informed Consent|2|||
143341854|NCT02798211|516796577|FG004|Period 2|Withdrawal of Informed Consent|2|||
143341855|NCT02798211|516796578|FG005|Period 2|Withdrawal of Informed Consent|3|||
143341856|NCT01782872|516796579|FG000|Overall Study|Protocol Violation|0|||
143341857|NCT01782872|516796580|FG001|Overall Study|Protocol Violation|0|||
143341858|NCT01782872|516796581|FG002|Overall Study|Protocol Violation|0|||
143341859|NCT01782872|516796582|FG003|Overall Study|Protocol Violation|1|||
143341860|NCT01782872|516796579|FG000|Overall Study|Withdrawal by Subject|0|||
143341861|NCT01782872|516796580|FG001|Overall Study|Withdrawal by Subject|1|||
143341862|NCT01782872|516796581|FG002|Overall Study|Withdrawal by Subject|0|||
143341863|NCT01782872|516796582|FG003|Overall Study|Withdrawal by Subject|0|||
143341864|NCT01892345|516796583|FG000|Overall Study|Adverse Event|0|||
143341865|NCT01892345|516796584|FG001|Overall Study|Adverse Event|2|||
143341866|NCT01892345|516796583|FG000|Overall Study|Death|1|||
143341867|NCT01892345|516796584|FG001|Overall Study|Death|0|||
143341868|NCT01892345|516796583|FG000|Overall Study|Lost to Follow-up|3|||
143341869|NCT01892345|516796584|FG001|Overall Study|Lost to Follow-up|0|||
143341870|NCT01892345|516796583|FG000|Overall Study|Withdrawal by Subject|12|||
143341871|NCT01892345|516796584|FG001|Overall Study|Withdrawal by Subject|1|||
143341872|NCT03505476|516796585|FG000|Overall Study|Physician Decision|18|||
143341873|NCT03505476|516796585|FG000|Overall Study|Device Malfunctioned|101|||
143341874|NCT03505476|516796585|FG000|Overall Study|Data Corrupt|6|||
143341875|NCT03505476|516796585|FG000|Overall Study|Device application insufficiant|3|||
143341876|NCT01059630|516796586|FG000|Overall Study|Death|100|||
143341877|NCT01059630|516796587|FG001|Overall Study|Death|84|||
143341878|NCT01059630|516796586|FG000|Overall Study|Lost to Follow-up|4|||
143341879|NCT01059630|516796587|FG001|Overall Study|Lost to Follow-up|1|||
143341880|NCT01059630|516796586|FG000|Overall Study|Physician Decision|2|||
143341881|NCT01059630|516796587|FG001|Overall Study|Physician Decision|4|||
143341882|NCT01059630|516796586|FG000|Overall Study|Withdrawal by Subject|21|||
143341883|NCT01059630|516796587|FG001|Overall Study|Withdrawal by Subject|14|||
143341884|NCT03170375|516796588|FG000|Phase 1 - 4 Weeks|Withdrawal by Subject|5|||
143341885|NCT03170375|516796589|FG001|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
143341886|NCT03170375|516796590|FG002|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
143341887|NCT03170375|516796588|FG000|Phase 2 - 6 Months|Withdrawal by Subject|0|||
143341888|NCT03170375|516796589|FG001|Phase 2 - 6 Months|Withdrawal by Subject|3|||
143341889|NCT03170375|516796590|FG002|Phase 2 - 6 Months|Withdrawal by Subject|2|||
143341890|NCT00441701|516796591|FG000|Overall Study|Adverse Event|3|||
143395989|NCT04313972|516997613|FG000|Overall Study|Withdrawal by Subject|0|||
143395990|NCT04313972|516997614|FG001|Overall Study|Withdrawal by Subject|1|||
143395991|NCT04314713|516997615|FG000|Overall Study|Lost to Follow-up|0|||
143395992|NCT04314713|516997616|FG001|Overall Study|Lost to Follow-up|0|||
143395993|NCT04314713|516997617|FG002|Overall Study|Lost to Follow-up|0|||
143395994|NCT04314713|516997618|FG003|Overall Study|Lost to Follow-up|1|||
143395995|NCT04314713|516997619|FG004|Overall Study|Lost to Follow-up|0|||
143395996|NCT04314713|516997620|FG005|Overall Study|Lost to Follow-up|0|||
143395997|NCT05477186|516997639|FG000|Overall Study|Vaccine not administered|0|||
143395998|NCT05477186|516997640|FG001|Overall Study|Vaccine not administered|2|||
143395999|NCT05477186|516997641|FG002|Overall Study|Vaccine not administered|1|||
143396000|NCT05477186|516997642|FG003|Overall Study|Vaccine not administered|0|||
143396001|NCT05477186|516997643|FG004|Overall Study|Vaccine not administered|1|||
143396002|NCT05477186|516997644|FG005|Overall Study|Vaccine not administered|0|||
143396003|NCT05477186|516997645|FG006|Overall Study|Vaccine not administered|0|||
143396004|NCT05477186|516997639|FG000|Overall Study|Withdrawal by Subject|1|||
143396005|NCT05477186|516997640|FG001|Overall Study|Withdrawal by Subject|0|||
143396006|NCT05477186|516997641|FG002|Overall Study|Withdrawal by Subject|0|||
143396007|NCT05477186|516997642|FG003|Overall Study|Withdrawal by Subject|0|||
143396008|NCT05477186|516997643|FG004|Overall Study|Withdrawal by Subject|0|||
143396009|NCT05477186|516997644|FG005|Overall Study|Withdrawal by Subject|1|||
143396010|NCT05477186|516997645|FG006|Overall Study|Withdrawal by Subject|0|||
143396011|NCT05477186|516997639|FG000|Overall Study|Lost to Follow-up|1|||
143396012|NCT05477186|516997640|FG001|Overall Study|Lost to Follow-up|0|||
143396013|NCT05477186|516997641|FG002|Overall Study|Lost to Follow-up|2|||
143396014|NCT05477186|516997642|FG003|Overall Study|Lost to Follow-up|1|||
143396015|NCT05477186|516997643|FG004|Overall Study|Lost to Follow-up|1|||
143396016|NCT05477186|516997644|FG005|Overall Study|Lost to Follow-up|0|||
143396017|NCT05477186|516997645|FG006|Overall Study|Lost to Follow-up|2|||
143396018|NCT05566639|516997653|FG000|Overall Study|Adverse Event|1|||
143396019|NCT05566639|516997654|FG001|Overall Study|Adverse Event|1|||
143396020|NCT05566639|516997653|FG000|Overall Study|Serious Adverse Event|1|||
143396021|NCT05566639|516997654|FG001|Overall Study|Serious Adverse Event|3|||
143396022|NCT05566639|516997653|FG000|Overall Study|Death|44|||
143396023|NCT05566639|516997654|FG001|Overall Study|Death|45|||
143396024|NCT05566639|516997653|FG000|Overall Study|Lost to Follow-up|467|||
143396025|NCT05566639|516997654|FG001|Overall Study|Lost to Follow-up|461|||
143396026|NCT05566639|516997653|FG000|Overall Study|Physician Decision|45|||
143396027|NCT05566639|516997654|FG001|Overall Study|Physician Decision|44|||
143396028|NCT05566639|516997653|FG000|Overall Study|Protocol Deviation|4|||
143396029|NCT05566639|516997654|FG001|Overall Study|Protocol Deviation|4|||
143396030|NCT05566639|516997653|FG000|Overall Study|Withdrawal by Subject|277|||
143396031|NCT05566639|516997654|FG001|Overall Study|Withdrawal by Subject|271|||
143396032|NCT05566639|516997653|FG000|Overall Study|Other Than Specified|52|||
143396033|NCT05566639|516997654|FG001|Overall Study|Other Than Specified|64|||
143396034|NCT04830800|516997664|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
143396035|NCT04830800|516997665|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
143396036|NCT04830800|516997666|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
143396037|NCT04830800|516997667|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
143396038|NCT04830800|516997668|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
143396039|NCT02626533|516997669|FG000|Overall Study|Protocol Violation|14|||
143396040|NCT02626533|516997669|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
143396041|NCT02626533|516997669|FG000|Overall Study|Withdrawal by Subject|1|||
143396042|NCT04753697|516997670|FG000|Induction Phase|Withdrawal by Subject|12|||
143396043|NCT04753697|516997671|FG001|Induction Phase|Withdrawal by Subject|5|||
143396044|NCT04753697|516997672|FG002|Induction Phase|Withdrawal by Subject|6|||
143396045|NCT04753697|516997670|FG000|Induction Phase|Physician Decision|1|||
143396046|NCT04753697|516997671|FG001|Induction Phase|Physician Decision|0|||
143396047|NCT04753697|516997672|FG002|Induction Phase|Physician Decision|0|||
143396048|NCT04753697|516997670|FG000|Induction Phase|Lost to Follow-up|2|||
143396049|NCT04753697|516997671|FG001|Induction Phase|Lost to Follow-up|2|||
143396050|NCT04753697|516997672|FG002|Induction Phase|Lost to Follow-up|1|||
143396051|NCT04753697|516997670|FG000|Induction Phase|Lack of Efficacy|1|||
143396052|NCT04753697|516997671|FG001|Induction Phase|Lack of Efficacy|0|||
143396053|NCT04753697|516997672|FG002|Induction Phase|Lack of Efficacy|0|||
143396054|NCT04753697|516997670|FG000|Maintenance Phase|Physician Decision|0|||
143396055|NCT04753697|516997671|FG001|Maintenance Phase|Physician Decision|0|||
143396056|NCT04753697|516997672|FG002|Maintenance Phase|Physician Decision|1|||
143396057|NCT04753697|516997670|FG000|Maintenance Phase|Withdrawal by Subject|3|||
143396058|NCT04753697|516997671|FG001|Maintenance Phase|Withdrawal by Subject|4|||
143396059|NCT04753697|516997672|FG002|Maintenance Phase|Withdrawal by Subject|6|||
143396060|NCT04753697|516997670|FG000|Maintenance Phase|Lost to Follow-up|2|||
143396061|NCT04753697|516997671|FG001|Maintenance Phase|Lost to Follow-up|2|||
143396062|NCT04753697|516997672|FG002|Maintenance Phase|Lost to Follow-up|0|||
143396063|NCT04753697|516997670|FG000|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|1|||
143396064|NCT04753697|516997671|FG001|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
143396065|NCT04753697|516997672|FG002|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
143341891|NCT00441701|516796592|FG001|Overall Study|Adverse Event|2|||
143341892|NCT00441701|516796593|FG002|Overall Study|Adverse Event|1|||
143341893|NCT00441701|516796594|FG003|Overall Study|Adverse Event|0|||
143341894|NCT00441701|516796595|FG004|Overall Study|Adverse Event|2|||
143341895|NCT00441701|516796596|FG005|Overall Study|Adverse Event|2|||
143341896|NCT00441701|516796597|FG006|Overall Study|Adverse Event|0|||
143341897|NCT00441701|516796598|FG007|Overall Study|Adverse Event|0|||
143341898|NCT00441701|516796599|FG008|Overall Study|Adverse Event|0|||
143341899|NCT00441701|516796600|FG009|Overall Study|Adverse Event|0|||
143341900|NCT00441701|516796591|FG000|Overall Study|Lack of Efficacy|2|||
143341901|NCT00441701|516796592|FG001|Overall Study|Lack of Efficacy|0|||
143341902|NCT00441701|516796593|FG002|Overall Study|Lack of Efficacy|2|||
143341903|NCT00441701|516796594|FG003|Overall Study|Lack of Efficacy|2|||
143341904|NCT00441701|516796595|FG004|Overall Study|Lack of Efficacy|0|||
143341905|NCT00441701|516796596|FG005|Overall Study|Lack of Efficacy|1|||
143341906|NCT00441701|516796597|FG006|Overall Study|Lack of Efficacy|0|||
143341907|NCT00441701|516796598|FG007|Overall Study|Lack of Efficacy|0|||
143341908|NCT00441701|516796599|FG008|Overall Study|Lack of Efficacy|0|||
143341909|NCT00441701|516796600|FG009|Overall Study|Lack of Efficacy|0|||
143341910|NCT00441701|516796591|FG000|Overall Study|Withdrawal by Subject|0|||
143341911|NCT00441701|516796592|FG001|Overall Study|Withdrawal by Subject|2|||
143341912|NCT00441701|516796593|FG002|Overall Study|Withdrawal by Subject|1|||
143341913|NCT00441701|516796594|FG003|Overall Study|Withdrawal by Subject|1|||
143341914|NCT00441701|516796595|FG004|Overall Study|Withdrawal by Subject|0|||
143341915|NCT00441701|516796596|FG005|Overall Study|Withdrawal by Subject|0|||
143341916|NCT00441701|516796597|FG006|Overall Study|Withdrawal by Subject|0|||
143341917|NCT00441701|516796598|FG007|Overall Study|Withdrawal by Subject|0|||
143341918|NCT00441701|516796599|FG008|Overall Study|Withdrawal by Subject|0|||
143341919|NCT00441701|516796600|FG009|Overall Study|Withdrawal by Subject|0|||
143341920|NCT02007434|516796606|FG000|Overall Study|Lost to Follow-up|0|||
143341921|NCT02007434|516796607|FG001|Overall Study|Lost to Follow-up|1|||
143341922|NCT02007434|516796608|FG002|Overall Study|Lost to Follow-up|0|||
143341923|NCT02007434|516796609|FG003|Overall Study|Lost to Follow-up|0|||
143341924|NCT02007434|516796610|FG004|Overall Study|Lost to Follow-up|0|||
143341925|NCT02007434|516796611|FG005|Overall Study|Lost to Follow-up|0|||
143341926|NCT02007434|516796612|FG006|Overall Study|Lost to Follow-up|0|||
143341927|NCT02007434|516796613|FG007|Overall Study|Lost to Follow-up|0|||
143341928|NCT02007434|516796606|FG000|Overall Study|Non-compliance|1|||
143341929|NCT02007434|516796607|FG001|Overall Study|Non-compliance|0|||
143341930|NCT02007434|516796608|FG002|Overall Study|Non-compliance|1|||
143341931|NCT02007434|516796609|FG003|Overall Study|Non-compliance|0|||
143341932|NCT02007434|516796610|FG004|Overall Study|Non-compliance|0|||
143341933|NCT02007434|516796611|FG005|Overall Study|Non-compliance|0|||
143341934|NCT02007434|516796612|FG006|Overall Study|Non-compliance|0|||
143341935|NCT02007434|516796613|FG007|Overall Study|Non-compliance|0|||
143341936|NCT01287611|516796614|FG000|Overall Study|Lost to Follow-up|29|||
143341937|NCT01287611|516796615|FG001|Overall Study|Lost to Follow-up|16|||
143341938|NCT01287611|516796614|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
143341939|NCT01287611|516796615|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
143341940|NCT00763958|516796616|FG000|Overall Study|did not meet final criteria|4|||
143341941|NCT00763958|516796617|FG001|Overall Study|did not meet final criteria|4|||
143341942|NCT00763958|516796616|FG000|Overall Study|Lost to Follow-up|10|||
143341943|NCT00763958|516796617|FG001|Overall Study|Lost to Follow-up|2|||
143341944|NCT00763958|516796616|FG000|Overall Study|Believed they were receiving placebo|0|||
143341945|NCT00763958|516796617|FG001|Overall Study|Believed they were receiving placebo|5|||
143341946|NCT04074590|516796618|FG000|Overall Study|Adverse Event|1|||
143341947|NCT04074590|516796619|FG001|Overall Study|Adverse Event|0|||
143341948|NCT04074590|516796618|FG000|Overall Study|Physician Decision|1|||
143341949|NCT04074590|516796619|FG001|Overall Study|Physician Decision|0|||
143341950|NCT04074590|516796618|FG000|Overall Study|Withdrawal by Subject|2|||
143341951|NCT04074590|516796619|FG001|Overall Study|Withdrawal by Subject|0|||
143341952|NCT03745222|516796623|FG000|Overall Study|Withdrawal by Subject|0|||
143341953|NCT03745222|516796624|FG001|Overall Study|Withdrawal by Subject|1|||
143341954|NCT03745222|516796625|FG002|Overall Study|Withdrawal by Subject|0|||
143341955|NCT02709005|516796626|FG000|Overall Study|Lost to Follow-up|1|||
143341956|NCT02709005|516796627|FG001|Overall Study|Lost to Follow-up|1|||
143341957|NCT02709005|516796626|FG000|Overall Study|Withdrawal by Subject|3|||
143341958|NCT02709005|516796627|FG001|Overall Study|Withdrawal by Subject|0|||
143341959|NCT02535364|516796629|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
143396066|NCT04753697|516997670|FG000|Maintenance Phase|Adverse Event|0|||
143396067|NCT04753697|516997671|FG001|Maintenance Phase|Adverse Event|1|||
143396068|NCT04753697|516997672|FG002|Maintenance Phase|Adverse Event|1|||
143396069|NCT04753697|516997670|FG000|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|1|||
143396070|NCT04753697|516997671|FG001|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
143396071|NCT04753697|516997672|FG002|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
143396072|NCT03701763|516997675|FG000|Placebo-controlled Phase|Adverse Event|1|||
143396073|NCT03701763|516997676|FG001|Placebo-controlled Phase|Adverse Event|5|||
143396074|NCT03701763|516997677|FG002|Placebo-controlled Phase|Adverse Event|0|||
143396075|NCT03701763|516997678|FG003|Placebo-controlled Phase|Adverse Event|0|||
143396076|NCT03701763|516997675|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
143396077|NCT03701763|516997676|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
143396078|NCT03701763|516997677|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
143396079|NCT03701763|516997678|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
143396080|NCT03701763|516997675|FG000|Placebo-controlled Phase|Miscellaneous|2|||
143396081|NCT03701763|516997676|FG001|Placebo-controlled Phase|Miscellaneous|0|||
143396082|NCT03701763|516997677|FG002|Placebo-controlled Phase|Miscellaneous|0|||
143396083|NCT03701763|516997678|FG003|Placebo-controlled Phase|Miscellaneous|0|||
143396084|NCT03701763|516997675|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
143396085|NCT03701763|516997676|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
143396086|NCT03701763|516997677|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
143396087|NCT03701763|516997678|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
143396088|NCT03701763|516997675|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
143396089|NCT03701763|516997676|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
143396090|NCT03701763|516997677|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
143396091|NCT03701763|516997678|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
143396092|NCT03701763|516997675|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
143396093|NCT03701763|516997676|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
143396094|NCT03701763|516997677|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
143396095|NCT03701763|516997678|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
143396096|NCT03701763|516997675|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
143396097|NCT03701763|516997676|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
143396098|NCT03701763|516997677|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
143396099|NCT03701763|516997678|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
143396100|NCT03701763|516997675|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
143396101|NCT03701763|516997676|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
143396102|NCT03701763|516997677|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
143396103|NCT03701763|516997678|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
143396104|NCT03701763|516997675|FG000|Apremilast Extension Phase|Adverse Event|0|||
143396105|NCT03701763|516997676|FG001|Apremilast Extension Phase|Adverse Event|0|||
143396106|NCT03701763|516997677|FG002|Apremilast Extension Phase|Adverse Event|3|||
143396107|NCT03701763|516997678|FG003|Apremilast Extension Phase|Adverse Event|1|||
143396108|NCT03701763|516997675|FG000|Apremilast Extension Phase|Miscellaneous|0|||
143396109|NCT03701763|516997676|FG001|Apremilast Extension Phase|Miscellaneous|0|||
143396110|NCT03701763|516997677|FG002|Apremilast Extension Phase|Miscellaneous|2|||
143396111|NCT03701763|516997678|FG003|Apremilast Extension Phase|Miscellaneous|1|||
143396112|NCT03701763|516997675|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
143396113|NCT03701763|516997676|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
143396114|NCT03701763|516997677|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
143396115|NCT03701763|516997678|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
143396116|NCT03701763|516997675|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
143341960|NCT02535364|516796629|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
143341961|NCT02535364|516796629|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
143341962|NCT02535364|516796629|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
143341963|NCT02535364|516796629|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
143341964|NCT02535364|516796629|FG000|Part B Screening|Death|2|||
143341965|NCT02535364|516796629|FG000|Part B Screening|Physician Decision|1|||
143341966|NCT02535364|516796629|FG000|Part B Screening|Withdrawal by Subject|1|||
143341967|NCT02535364|516796629|FG000|Part B Screening|Adverse Event|1|||
143341968|NCT02535364|516796629|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
143341969|NCT02535364|516796629|FG000|Study Treatment|Death|1|||
143341970|NCT02535364|516796629|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
143341971|NCT02535364|516796629|FG000|12-Month Follow-up Period|Disease progression|22|||
143341972|NCT02535364|516796629|FG000|12-Month Follow-up Period|Death|5|||
143341973|NCT02535364|516796629|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
143341974|NCT02535364|516796629|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
143341975|NCT02535364|516796629|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
143341976|NCT00571701|516796630|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
143341977|NCT00571701|516796631|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
143396117|NCT03701763|516997676|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
143396118|NCT03701763|516997677|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
143341978|NCT00571701|516796630|FG000|First Intervention 12 Months|Death|1|||
143341979|NCT00571701|516796631|FG001|First Intervention 12 Months|Death|0|||
143341980|NCT00571701|516796630|FG000|Second Intervention 12 Months|Adverse Event|0|||
143341981|NCT00571701|516796631|FG001|Second Intervention 12 Months|Adverse Event|1|||
143341982|NCT00571701|516796630|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
143341983|NCT00571701|516796631|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
143341984|NCT00691132|516796632|FG000|Overall Study|Adverse Event|2|||
143341985|NCT00691132|516796633|FG001|Overall Study|Adverse Event|3|||
143341986|NCT00691132|516796632|FG000|Overall Study|Withdrawal by Subject|10|||
143341987|NCT00691132|516796633|FG001|Overall Study|Withdrawal by Subject|10|||
143341988|NCT04766086|516796634|FG000|Overall Study|Lost to Follow-up|3|||
143341989|NCT04766086|516796635|FG001|Overall Study|Lost to Follow-up|5|||
143341990|NCT04766086|516796636|FG002|Overall Study|Lost to Follow-up|3|||
143341991|NCT04766086|516796634|FG000|Overall Study|Withdrawal by Subject|1|||
143341992|NCT04766086|516796635|FG001|Overall Study|Withdrawal by Subject|1|||
143341993|NCT04766086|516796636|FG002|Overall Study|Withdrawal by Subject|2|||
143341994|NCT04766086|516796634|FG000|Overall Study|Other|0|||
143341995|NCT04766086|516796635|FG001|Overall Study|Other|0|||
143341996|NCT04766086|516796636|FG002|Overall Study|Other|1|||
143341997|NCT01959347|516796639|FG000|Overall Study|Protocol Violation|9|||
143341998|NCT01959347|516796640|FG001|Overall Study|Protocol Violation|7|||
143341999|NCT03541044|516796641|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
143342000|NCT03541044|516796642|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
143342001|NCT03541044|516796641|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
143342002|NCT03541044|516796642|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
143342003|NCT00860067|516796645|FG000|Overall Study|Lost to Follow-up|46|||
143342004|NCT00860067|516796646|FG001|Overall Study|Lost to Follow-up|9|||
143342005|NCT00860067|516796647|FG002|Overall Study|Lost to Follow-up|9|||
143342006|NCT00860067|516796645|FG000|Overall Study|Withdrawal by Subject|4|||
143342007|NCT00860067|516796646|FG001|Overall Study|Withdrawal by Subject|0|||
143342008|NCT00860067|516796647|FG002|Overall Study|Withdrawal by Subject|0|||
143342009|NCT00860067|516796645|FG000|Overall Study|Pregnancy|1|||
143342010|NCT00860067|516796646|FG001|Overall Study|Pregnancy|0|||
143342011|NCT00860067|516796647|FG002|Overall Study|Pregnancy|0|||
143342012|NCT01282801|516796648|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
143342013|NCT01282801|516796649|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
143342014|NCT03333928|516796650|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
143342015|NCT03333928|516796651|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
143342016|NCT03333928|516796652|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
143342017|NCT03333928|516796650|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
143342018|NCT03333928|516796651|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
143342019|NCT03333928|516796652|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
143342020|NCT03333928|516796650|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
143342021|NCT03333928|516796651|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
143342022|NCT03333928|516796652|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
143342023|NCT03333928|516796650|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
143342024|NCT03333928|516796651|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
143342025|NCT03333928|516796652|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
143342026|NCT03333928|516796650|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
143342027|NCT03333928|516796651|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
143342028|NCT03333928|516796652|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
143342029|NCT03333928|516796650|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
143342030|NCT03333928|516796651|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
143342031|NCT03333928|516796652|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
143342032|NCT03333928|516796650|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
143342033|NCT03333928|516796651|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
143342034|NCT03333928|516796652|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
143342035|NCT03333928|516796650|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
143342036|NCT03333928|516796651|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
143342037|NCT03333928|516796652|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
143342038|NCT01375205|516796653|FG000|Overall Study|Lost to Follow-up|15|||
143342039|NCT01375205|516796654|FG001|Overall Study|Lost to Follow-up|12|||
143342040|NCT01375205|516796653|FG000|Overall Study|Withdrawal by Subject|6|||
143342041|NCT01375205|516796654|FG001|Overall Study|Withdrawal by Subject|1|||
143342042|NCT05687032|516796655|FG000|Treatment Phase|Adverse Event|13|||
143342043|NCT05687032|516796655|FG000|Treatment Phase|Death|1|||
143342044|NCT05687032|516796655|FG000|Treatment Phase|Physician Decision|3|||
143342045|NCT05687032|516796655|FG000|Treatment Phase|Progressive disease|9|||
143342046|NCT05687032|516796655|FG000|Treatment Phase|Withdrawal by Subject|5|||
143342047|NCT05687032|516796655|FG000|Follow-Up Phase|Death|16|||
143342048|NCT05687032|516796655|FG000|Follow-Up Phase|Ongoing|26|||
143342049|NCT03056534|516796658|FG000|Overall Study|Participant withdrew consent|8|||
143342050|NCT03056534|516796658|FG000|Overall Study|Participant not able to return|6|||
143342051|NCT03056534|516796658|FG000|Overall Study|Lost to Follow-up|37|||
143342052|NCT03056534|516796658|FG000|Overall Study|Investigator judgment|1|||
143342053|NCT03056534|516796658|FG000|Overall Study|Death|4|||
143342054|NCT03056534|516796658|FG000|Overall Study|Adverse Event|1|||
143342055|NCT03056534|516796658|FG000|Overall Study|Screen fail due to femoral stem implanted not being allowed per protocol|1|||
143342056|NCT02675465|516796659|FG000|Stage 3: 2 Year Treatment|Adverse Event|0|||
143342057|NCT02675465|516796660|FG001|Stage 3: 2 Year Treatment|Adverse Event|0|||
143342058|NCT02675465|516796661|FG002|Stage 3: 2 Year Treatment|Adverse Event|1|||
143342059|NCT02675465|516796662|FG003|Stage 3: 2 Year Treatment|Adverse Event|1|||
143342060|NCT02675465|516796663|FG004|Stage 3: 2 Year Treatment|Adverse Event|0|||
143342061|NCT02675465|516796664|FG005|Stage 3: 2 Year Treatment|Adverse Event|0|||
143342062|NCT02675465|516796659|FG000|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
143342063|NCT02675465|516796660|FG001|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
143342064|NCT02675465|516796661|FG002|Stage 3: 2 Year Treatment|Withdrawal by Subject|1|||
143342065|NCT02675465|516796662|FG003|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
143342066|NCT02675465|516796663|FG004|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
143342067|NCT02675465|516796664|FG005|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
143342068|NCT02675465|516796659|FG000|Stage 4: Long Term Extension|Physician Decision|0|||
143342069|NCT02675465|516796660|FG001|Stage 4: Long Term Extension|Physician Decision|0|||
143342070|NCT02675465|516796661|FG002|Stage 4: Long Term Extension|Physician Decision|1|||
143342071|NCT02675465|516796662|FG003|Stage 4: Long Term Extension|Physician Decision|0|||
143342072|NCT02675465|516796663|FG004|Stage 4: Long Term Extension|Physician Decision|0|||
143342073|NCT02675465|516796664|FG005|Stage 4: Long Term Extension|Physician Decision|0|||
143342074|NCT02675465|516796659|FG000|Stage 4: Long Term Extension|Death|0|||
143342075|NCT02675465|516796660|FG001|Stage 4: Long Term Extension|Death|0|||
143342076|NCT02675465|516796661|FG002|Stage 4: Long Term Extension|Death|0|||
143342077|NCT02675465|516796662|FG003|Stage 4: Long Term Extension|Death|1|||
143342078|NCT02675465|516796663|FG004|Stage 4: Long Term Extension|Death|0|||
143342079|NCT02675465|516796664|FG005|Stage 4: Long Term Extension|Death|0|||
143342080|NCT04987762|516796665|FG000|Overall Study|Study was Terminated by Sponsor|103|||
143342081|NCT00316173|516796668|FG000|Run-in Phase|Adverse Event|1|||
143342082|NCT00316173|516796669|FG001|Run-in Phase|Adverse Event|0|||
143342083|NCT00316173|516796668|FG000|Run-in Phase|Protocol Violation|1|||
143342084|NCT00316173|516796669|FG001|Run-in Phase|Protocol Violation|0|||
143342085|NCT00316173|516796668|FG000|Run-in Phase|Study Follow-up Stopped|5|||
143342086|NCT00316173|516796669|FG001|Run-in Phase|Study Follow-up Stopped|0|||
143342087|NCT00316173|516796668|FG000|Treatment Phase|Adverse Event|0|||
143342088|NCT00316173|516796669|FG001|Treatment Phase|Adverse Event|1|||
143342089|NCT00316173|516796668|FG000|Treatment Phase|Lack of Efficacy|0|||
143342090|NCT00316173|516796669|FG001|Treatment Phase|Lack of Efficacy|3|||
143342091|NCT00316173|516796668|FG000|Treatment Phase|Lost to Follow-up|0|||
143342092|NCT00316173|516796669|FG001|Treatment Phase|Lost to Follow-up|3|||
143342093|NCT00316173|516796668|FG000|Treatment Phase|Withdrawal by Subject|0|||
143342094|NCT00316173|516796669|FG001|Treatment Phase|Withdrawal by Subject|1|||
143342095|NCT00316173|516796668|FG000|Treatment Phase|Study Follow-up Stopped|0|||
143342096|NCT00316173|516796669|FG001|Treatment Phase|Study Follow-up Stopped|34|||
143342097|NCT04108000|516796678|FG000|Overall Study|Death of patient|1|||
143342098|NCT04108000|516796679|FG001|Overall Study|Death of patient|0|||
143342099|NCT04108000|516796680|FG002|Overall Study|Death of patient|1|||
143342100|NCT04108000|516796681|FG003|Overall Study|Death of patient|0|||
143342101|NCT04108000|516796678|FG000|Overall Study|Withdrawal by Subject|2|||
143342102|NCT04108000|516796679|FG001|Overall Study|Withdrawal by Subject|2|||
143342103|NCT04108000|516796680|FG002|Overall Study|Withdrawal by Subject|0|||
143342104|NCT04108000|516796681|FG003|Overall Study|Withdrawal by Subject|0|||
143342105|NCT04108000|516796678|FG000|Overall Study|Death of surrogate partner|0|||
143342106|NCT04108000|516796679|FG001|Overall Study|Death of surrogate partner|1|||
143342107|NCT04108000|516796680|FG002|Overall Study|Death of surrogate partner|0|||
143342108|NCT04108000|516796681|FG003|Overall Study|Death of surrogate partner|1|||
143342109|NCT03750006|516796682|FG000|Overall Study|Withdrawal by Subject|8|||
143342110|NCT03750006|516796682|FG000|Overall Study|COVID PANDEMIC|11|||
143342111|NCT03881696|516796686|FG000|Overall Study|Adverse Event|2|||
143342112|NCT03881696|516796687|FG001|Overall Study|Adverse Event|0|||
143342113|NCT03881696|516796686|FG000|Overall Study|Withdrawal by Subject|2|||
143342114|NCT03881696|516796687|FG001|Overall Study|Withdrawal by Subject|0|||
143342115|NCT03881696|516796686|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
143342116|NCT03881696|516796687|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
143342117|NCT03881696|516796686|FG000|Overall Study|Failure to meet continuation criteria|1|||
143342118|NCT03881696|516796687|FG001|Overall Study|Failure to meet continuation criteria|0|||
143342119|NCT00742079|516798611|FG000|Overall Study|Lost to Follow-up|0|||
143342120|NCT00742079|516798612|FG001|Overall Study|Lost to Follow-up|1|||
143342121|NCT02173054|516798618|FG000|Overall Study|lack of compliance|1|||
143342122|NCT02173054|516798619|FG001|Overall Study|lack of compliance|0|||
143342123|NCT02173054|516798620|FG002|Overall Study|lack of compliance|0|||
143342124|NCT02173054|516798618|FG000|Overall Study|Withdrawal by Subject|0|||
143342125|NCT02173054|516798619|FG001|Overall Study|Withdrawal by Subject|0|||
143342126|NCT02173054|516798620|FG002|Overall Study|Withdrawal by Subject|1|||
143342127|NCT01114204|516798621|FG000|Overall Study|Adverse Event|3|||
143342128|NCT01114204|516798622|FG001|Overall Study|Adverse Event|2|||
143342129|NCT01114204|516798621|FG000|Overall Study|Lost to Follow-up|1|||
143342130|NCT01114204|516798622|FG001|Overall Study|Lost to Follow-up|0|||
143342131|NCT01114204|516798621|FG000|Overall Study|Withdrawal by Subject|10|||
143342132|NCT01114204|516798622|FG001|Overall Study|Withdrawal by Subject|6|||
143342133|NCT01114204|516798621|FG000|Overall Study|Death|1|||
143342134|NCT01114204|516798622|FG001|Overall Study|Death|0|||
143342135|NCT01114204|516798621|FG000|Overall Study|Other-Personal reasons|2|||
143342136|NCT01114204|516798622|FG001|Overall Study|Other-Personal reasons|0|||
143342137|NCT01114204|516798621|FG000|Overall Study|Other-Medical monitor request|1|||
143342138|NCT01114204|516798622|FG001|Overall Study|Other-Medical monitor request|0|||
143342139|NCT01114204|516798621|FG000|Overall Study|Other-Participant request|2|||
143342140|NCT01114204|516798622|FG001|Overall Study|Other-Participant request|0|||
143342141|NCT01114204|516798621|FG000|Overall Study|Other-Protocol Violation|1|||
143342142|NCT01114204|516798622|FG001|Overall Study|Other-Protocol Violation|0|||
143342143|NCT02748694|516798630|FG000|Overall Study|Voluntary Withdrawal|0|||
143342144|NCT02748694|516798631|FG001|Overall Study|Voluntary Withdrawal|0|||
143342145|NCT02748694|516798632|FG002|Overall Study|Voluntary Withdrawal|0|||
143342146|NCT02748694|516798633|FG003|Overall Study|Voluntary Withdrawal|0|||
143342147|NCT02748694|516798634|FG004|Overall Study|Voluntary Withdrawal|0|||
143342148|NCT02748694|516798635|FG005|Overall Study|Voluntary Withdrawal|0|||
143342149|NCT02748694|516798636|FG006|Overall Study|Voluntary Withdrawal|0|||
143342150|NCT02748694|516798637|FG007|Overall Study|Voluntary Withdrawal|0|||
143342151|NCT02748694|516798638|FG008|Overall Study|Voluntary Withdrawal|0|||
143342152|NCT02748694|516798639|FG009|Overall Study|Voluntary Withdrawal|0|||
143342153|NCT02748694|516798640|FG010|Overall Study|Voluntary Withdrawal|0|||
143342154|NCT02748694|516798641|FG011|Overall Study|Voluntary Withdrawal|0|||
143342155|NCT02748694|516798642|FG012|Overall Study|Voluntary Withdrawal|0|||
143342156|NCT02748694|516798643|FG013|Overall Study|Voluntary Withdrawal|0|||
143342157|NCT02748694|516798644|FG014|Overall Study|Voluntary Withdrawal|2|||
143342158|NCT00659984|516798647|FG000|Overall Study|Adverse Event|1|||
143342159|NCT00792103|516798662|FG000|Overall Study|Enrolled, not treated|15|||
143342160|NCT00792103|516798662|FG000|Overall Study|Lost to Follow-up|17|||
143342161|NCT00792103|516798662|FG000|Overall Study|Adverse Event|25|||
143342162|NCT00792103|516798662|FG000|Overall Study|Withdrawal by Subject|52|||
143342163|NCT00792103|516798662|FG000|Overall Study|Protocol Violation|10|||
143342164|NCT00792103|516798662|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
143342165|NCT03299686|516798663|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
143342166|NCT03299686|516798664|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
143342167|NCT03299686|516798663|FG000|Treatment Epoch|Physician Decision|1|||
143342168|NCT03299686|516798664|FG001|Treatment Epoch|Physician Decision|0|||
143342169|NCT03299686|516798663|FG000|Treatment Epoch|Adverse Event|8|||
143342170|NCT03299686|516798664|FG001|Treatment Epoch|Adverse Event|4|||
143342171|NCT03299686|516798663|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
143342172|NCT03299686|516798664|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
143342173|NCT01060553|516798671|FG000|Overall Study|Lost to Follow-up|3|||
143342174|NCT01060553|516798672|FG001|Overall Study|Lost to Follow-up|5|||
143342175|NCT01060553|516798671|FG000|Overall Study|Withdrawal by Subject|5|||
143342176|NCT01060553|516798672|FG001|Overall Study|Withdrawal by Subject|5|||
143342177|NCT01060553|516798671|FG000|Overall Study|Lack of Efficacy|1|||
143342178|NCT01060553|516798672|FG001|Overall Study|Lack of Efficacy|0|||
143342179|NCT01498822|516798673|FG000|Overall Study|Protocol Violation|8|||
143342180|NCT01498822|516798674|FG001|Overall Study|Protocol Violation|4|||
143342181|NCT01498822|516798673|FG000|Overall Study|Other Reason|5|||
143342182|NCT01498822|516798674|FG001|Overall Study|Other Reason|2|||
143342183|NCT01498822|516798673|FG000|Overall Study|Lack of Efficacy|7|||
143342184|NCT01498822|516798674|FG001|Overall Study|Lack of Efficacy|2|||
143342185|NCT01498822|516798673|FG000|Overall Study|AE, non-serious non-fatal|8|||
143342186|NCT01498822|516798674|FG001|Overall Study|AE, non-serious non-fatal|17|||
143342187|NCT01498822|516798673|FG000|Overall Study|SAE, non-fatal|2|||
143342188|NCT01498822|516798674|FG001|Overall Study|SAE, non-fatal|2|||
143342189|NCT01498822|516798673|FG000|Overall Study|Adverse Event, serious fatal|1|||
143342190|NCT01498822|516798674|FG001|Overall Study|Adverse Event, serious fatal|1|||
143342191|NCT01498822|516798673|FG000|Overall Study|Withdrawal by Subject|15|||
143342192|NCT01498822|516798674|FG001|Overall Study|Withdrawal by Subject|25|||
143342193|NCT01498822|516798673|FG000|Overall Study|Lost to Follow-up|8|||
143342194|NCT01498822|516798674|FG001|Overall Study|Lost to Follow-up|3|||
143342195|NCT01862796|516798675|FG000|Overall Study|Prohibited medications|0|||
143342196|NCT01862796|516798676|FG001|Overall Study|Prohibited medications|0|||
143342197|NCT01862796|516798677|FG002|Overall Study|Prohibited medications|1|||
143342198|NCT01148862|516798682|FG000|Second Intervention|Withdrawal by Subject|0|||
143342199|NCT01148862|516798683|FG001|Second Intervention|Withdrawal by Subject|2|||
143342200|NCT03728972|516798685|FG000|Overall Study|Death|1|||
143396119|NCT03701763|516997678|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
143396120|NCT03701763|516997675|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
143396121|NCT03701763|516997676|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
143396122|NCT03701763|516997677|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
143396123|NCT03701763|516997678|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
143396124|NCT03701763|516997675|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
143396125|NCT03701763|516997676|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
143396126|NCT03701763|516997677|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
143396127|NCT03701763|516997678|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
143396128|NCT03701763|516997675|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
143396129|NCT03701763|516997676|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
143396130|NCT03701763|516997677|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
143396131|NCT03701763|516997678|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
143396132|NCT03701763|516997675|FG000|14-Week Observational Follow-up Phase|Other|0|||
143396133|NCT03701763|516997676|FG001|14-Week Observational Follow-up Phase|Other|0|||
143396134|NCT03701763|516997677|FG002|14-Week Observational Follow-up Phase|Other|1|||
143396135|NCT03701763|516997678|FG003|14-Week Observational Follow-up Phase|Other|0|||
143396136|NCT03701763|516997675|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
143396137|NCT03701763|516997676|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
143396138|NCT03701763|516997677|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
143396139|NCT03701763|516997678|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
143396140|NCT03701763|516997675|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
143396141|NCT03701763|516997676|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
143396142|NCT03701763|516997677|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
143396143|NCT03701763|516997678|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
143396144|NCT04200456|516997679|FG000|Overall Study|Physician Decision|0|||
143396145|NCT04200456|516997680|FG001|Overall Study|Physician Decision|1|||
143396146|NCT04200456|516997679|FG000|Overall Study|Withdrawal by Subject|2|||
143396147|NCT04200456|516997680|FG001|Overall Study|Withdrawal by Subject|2|||
143396148|NCT04200456|516997679|FG000|Overall Study|Lack of Efficacy|1|||
143396149|NCT04200456|516997680|FG001|Overall Study|Lack of Efficacy|1|||
143396150|NCT04200456|516997679|FG000|Overall Study|Adverse event, non-fatal|0|||
143396151|NCT04200456|516997680|FG001|Overall Study|Adverse event, non-fatal|1|||
143396152|NCT04200456|516997679|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
143396153|NCT04200456|516997680|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
143396154|NCT04068181|516997682|FG000|Overall Study|Death|17|||
143396155|NCT04068181|516997683|FG001|Overall Study|Death|12|||
143396156|NCT04068181|516997684|FG002|Overall Study|Death|4|||
143396157|NCT04068181|516997685|FG003|Overall Study|Death|7|||
143396158|NCT04068181|516997682|FG000|Overall Study|Lost to Follow-up|1|||
143396159|NCT04068181|516997683|FG001|Overall Study|Lost to Follow-up|0|||
143396160|NCT04068181|516997684|FG002|Overall Study|Lost to Follow-up|0|||
143396161|NCT04068181|516997685|FG003|Overall Study|Lost to Follow-up|0|||
143396162|NCT04068181|516997682|FG000|Overall Study|Withdrawal of consent from study|3|||
143396163|NCT04068181|516997683|FG001|Overall Study|Withdrawal of consent from study|0|||
143396164|NCT04068181|516997684|FG002|Overall Study|Withdrawal of consent from study|0|||
143396165|NCT04068181|516997685|FG003|Overall Study|Withdrawal of consent from study|0|||
143396166|NCT03785964|516997688|FG000|Overall Study|Adverse Event|14|||
143396167|NCT03785964|516997689|FG001|Overall Study|Adverse Event|1|||
143396168|NCT03785964|516997688|FG000|Overall Study|Unqualified Clinical Progression|1|||
143396169|NCT03785964|516997689|FG001|Overall Study|Unqualified Clinical Progression|1|||
143396170|NCT03785964|516997688|FG000|Overall Study|Participant non-compliance|1|||
143396171|NCT03785964|516997689|FG001|Overall Study|Participant non-compliance|1|||
143396172|NCT03785964|516997688|FG000|Overall Study|Not treated|1|||
143396173|NCT03785964|516997689|FG001|Overall Study|Not treated|0|||
143396174|NCT03785964|516997688|FG000|Overall Study|Other reason|5|||
143396175|NCT03785964|516997689|FG001|Overall Study|Other reason|11|||
143396176|NCT03785964|516997688|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
143396177|NCT03785964|516997689|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
143396178|NCT02723591|516997690|FG000|Overall Study|Adverse Event|48|||
143396179|NCT02723591|516997691|FG001|Overall Study|Adverse Event|40|||
143396180|NCT02723591|516997690|FG000|Overall Study|Death|2|||
143396181|NCT02723591|516997691|FG001|Overall Study|Death|2|||
143396182|NCT02723591|516997690|FG000|Overall Study|Lack of Efficacy|4|||
143396183|NCT02723591|516997691|FG001|Overall Study|Lack of Efficacy|3|||
143396184|NCT02723591|516997690|FG000|Overall Study|Lost to Follow-up|1|||
143396185|NCT02723591|516997691|FG001|Overall Study|Lost to Follow-up|7|||
143396186|NCT02723591|516997690|FG000|Overall Study|Protocol Violation|20|||
143396187|NCT02723591|516997691|FG001|Overall Study|Protocol Violation|23|||
143396188|NCT02723591|516997690|FG000|Overall Study|Withdrawal by Subject|4|||
143396189|NCT02723591|516997691|FG001|Overall Study|Withdrawal by Subject|8|||
143396190|NCT02723591|516997690|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
143396191|NCT02723591|516997691|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
143396192|NCT02723591|516997690|FG000|Overall Study|Miscellaneous|5|||
143396193|NCT02723591|516997691|FG001|Overall Study|Miscellaneous|6|||
143396194|NCT05070728|516997692|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
143396195|NCT05070728|516997693|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
143396196|NCT03691935|516997694|FG000|Overall Study|Physician Decision|2|||
143396197|NCT03691935|516997695|FG001|Overall Study|Physician Decision|1|||
143396198|NCT03691935|516997694|FG000|Overall Study|Adverse Event|3|||
143396199|NCT03691935|516997695|FG001|Overall Study|Adverse Event|0|||
143396200|NCT05446168|516997696|FG000|Overall Study|Physician Decision|0|||
143396201|NCT05446168|516997697|FG001|Overall Study|Physician Decision|1|||
143396202|NCT01275677|516997705|FG000|Overall Study|Not at risk for recurrence.|1|||
143396203|NCT01275677|516997706|FG001|Overall Study|Not at risk for recurrence.|1|||
143396204|NCT01275677|516997705|FG000|Overall Study|No follow-up|26|||
143396205|NCT01275677|516997706|FG001|Overall Study|No follow-up|37|||
143396206|NCT01275677|516997705|FG000|Overall Study|No clinical follow up.|1|||
143396207|NCT01275677|516997706|FG001|Overall Study|No clinical follow up.|4|||
143396208|NCT03478956|516997710|FG000|Randomized Treatment Period|Adverse Event|1|||
143396209|NCT03478956|516997711|FG001|Randomized Treatment Period|Adverse Event|0|||
143396210|NCT03478956|516997712|FG002|Randomized Treatment Period|Adverse Event|0|||
143396211|NCT03478956|516997713|FG003|Randomized Treatment Period|Adverse Event|0|||
143396212|NCT03478956|516997710|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
143396213|NCT03478956|516997711|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
143396214|NCT03478956|516997712|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
143396215|NCT03478956|516997713|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
143396216|NCT03478956|516997710|FG000|Open Label Extension Period|Adverse Event|0|||
143396217|NCT03478956|516997711|FG001|Open Label Extension Period|Adverse Event|0|||
143396218|NCT03478956|516997712|FG002|Open Label Extension Period|Adverse Event|4|||
143396219|NCT03478956|516997713|FG003|Open Label Extension Period|Adverse Event|0|||
143396220|NCT03478956|516997710|FG000|Open Label Extension Period|Lack of Efficacy|0|||
143396221|NCT03478956|516997711|FG001|Open Label Extension Period|Lack of Efficacy|0|||
143396222|NCT03478956|516997712|FG002|Open Label Extension Period|Lack of Efficacy|8|||
143396223|NCT03478956|516997713|FG003|Open Label Extension Period|Lack of Efficacy|0|||
143396224|NCT03478956|516997710|FG000|Open Label Extension Period|Reason Not Provided|0|||
143396225|NCT03478956|516997711|FG001|Open Label Extension Period|Reason Not Provided|0|||
143396226|NCT03478956|516997712|FG002|Open Label Extension Period|Reason Not Provided|1|||
143396227|NCT03478956|516997713|FG003|Open Label Extension Period|Reason Not Provided|0|||
143396228|NCT03478956|516997710|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
143396229|NCT03478956|516997711|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
143396230|NCT03478956|516997712|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
143396231|NCT03478956|516997713|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
143396232|NCT03478956|516997710|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
143396233|NCT03478956|516997711|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
143396234|NCT03478956|516997712|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
143396235|NCT03478956|516997713|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
143396236|NCT03478956|516997710|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
143396237|NCT03478956|516997711|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
143396238|NCT03478956|516997712|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
143396239|NCT03478956|516997713|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
143396240|NCT04865289|516997714|FG000|Overall Study|Participant ongoing in study|47|||
143396241|NCT04865289|516997715|FG001|Overall Study|Participant ongoing in study|35|||
143396242|NCT04865289|516997714|FG000|Overall Study|Death|27|||
143396243|NCT04865289|516997715|FG001|Overall Study|Death|21|||
143396244|NCT02733159|516997716|FG000|Overall Study|Adverse Event|1|||
143396245|NCT02733159|516997716|FG000|Overall Study|Lack of disease progression|1|||
143396246|NCT03257410|516999449|FG000|Overall Study|Adverse Event|2|||
143396247|NCT03257410|516999450|FG001|Overall Study|Adverse Event|3|||
143396248|NCT03257410|516999449|FG000|Overall Study|Protocol Violation|1|||
143396249|NCT03257410|516999450|FG001|Overall Study|Protocol Violation|2|||
143396250|NCT03257410|516999449|FG000|Overall Study|Lost to Follow-up|1|||
143396251|NCT03257410|516999450|FG001|Overall Study|Lost to Follow-up|0|||
143396252|NCT03257410|516999449|FG000|Overall Study|Withdrawal by Subject|1|||
143396253|NCT03257410|516999450|FG001|Overall Study|Withdrawal by Subject|2|||
143396254|NCT03257410|516999449|FG000|Overall Study|Physician Decision|1|||
143396255|NCT03257410|516999450|FG001|Overall Study|Physician Decision|1|||
143396256|NCT03257410|516999449|FG000|Overall Study|Renal transplantation|2|||
143396257|NCT03257410|516999450|FG001|Overall Study|Renal transplantation|0|||
143396258|NCT03257410|516999449|FG000|Overall Study|Switch to peritoneal dialysis|1|||
143396259|NCT03257410|516999450|FG001|Overall Study|Switch to peritoneal dialysis|0|||
143396260|NCT03257410|516999449|FG000|Overall Study|Death|3|||
143396261|NCT03257410|516999450|FG001|Overall Study|Death|2|||
143396262|NCT03257410|516999449|FG000|Overall Study|Change to another dialysis center|2|||
143396263|NCT03257410|516999450|FG001|Overall Study|Change to another dialysis center|2|||
143396264|NCT03257410|516999449|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
143396265|NCT03257410|516999450|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
143396266|NCT03257410|516999449|FG000|Overall Study|Miscellaneous|2|||
143396267|NCT03257410|516999450|FG001|Overall Study|Miscellaneous|2|||
143396268|NCT03257410|516999449|FG000|Overall Study|Other|0|||
143396269|NCT03257410|516999450|FG001|Overall Study|Other|1|||
143396270|NCT03381196|516999451|FG000|Overall Study|Withdrawal by Subject|7|||
143396271|NCT03381196|516999452|FG001|Overall Study|Withdrawal by Subject|7|||
143396272|NCT03381196|516999451|FG000|Overall Study|Other|0|||
143396273|NCT03381196|516999452|FG001|Overall Study|Other|1|||
143396274|NCT03381196|516999451|FG000|Overall Study|Lost to Follow-up|5|||
143396275|NCT03381196|516999452|FG001|Overall Study|Lost to Follow-up|4|||
143396276|NCT03381196|516999451|FG000|Overall Study|Death|0|||
143396277|NCT03381196|516999452|FG001|Overall Study|Death|1|||
143396278|NCT03381196|516999451|FG000|Overall Study|Adverse Event|1|||
143396279|NCT03381196|516999452|FG001|Overall Study|Adverse Event|0|||
143396280|NCT03381196|516999451|FG000|Overall Study|Randomized, not treated|3|||
143396281|NCT03381196|516999452|FG001|Overall Study|Randomized, not treated|6|||
143396282|NCT03668236|516999453|FG000|90-day Follow-up|Withdrawal by Subject|3|||
143396283|NCT03668236|516999454|FG001|90-day Follow-up|Withdrawal by Subject|2|||
143396284|NCT03668236|516999453|FG000|90-day Follow-up|Lost to Follow-up|3|||
143396285|NCT03668236|516999454|FG001|90-day Follow-up|Lost to Follow-up|1|||
143396286|NCT03668236|516999453|FG000|Baseline Characteristics|Lost to Follow-up|9|||
143396287|NCT03668236|516999454|FG001|Baseline Characteristics|Lost to Follow-up|5|||
143396288|NCT03668236|516999453|FG000|1-year Follow-up|Withdrawal by Subject|17|||
143396289|NCT03668236|516999454|FG001|1-year Follow-up|Withdrawal by Subject|15|||
143396290|NCT06132282|516999455|FG000|Overall Study|Lost to Follow-up|31|||
143396291|NCT03858634|516999456|FG000|Overall Study|Withdrawal by Subject|1|||
143396292|NCT03858634|516999457|FG001|Overall Study|Withdrawal by Subject|0|||
143396293|NCT03858634|516999456|FG000|Overall Study|Adverse Event|1|||
143396294|NCT03858634|516999457|FG001|Overall Study|Adverse Event|0|||
143396295|NCT03858634|516999456|FG000|Overall Study|Lost to Follow-up|0|||
143396296|NCT03858634|516999457|FG001|Overall Study|Lost to Follow-up|1|||
143396297|NCT03858634|516999456|FG000|Overall Study|Other, Not Specified|1|||
143396298|NCT03858634|516999457|FG001|Overall Study|Other, Not Specified|1|||
143396299|NCT02841579|516999458|FG000|Overall Study|Death|1|||
143396300|NCT02841579|516999458|FG000|Overall Study|Adverse Event|1|||
143396301|NCT02841579|516999458|FG000|Overall Study|Lack of Efficacy|9|||
143396302|NCT03652389|516999459|FG000|Overall Study|Lost to Follow-up|1|||
143396303|NCT03652389|516999460|FG001|Overall Study|Lost to Follow-up|5|||
143396304|NCT03652389|516999459|FG000|Overall Study|Withdrawal by Subject|5|||
143396305|NCT03652389|516999460|FG001|Overall Study|Withdrawal by Subject|1|||
143396306|NCT03652389|516999459|FG000|Overall Study|New diagnosis|2|||
143396307|NCT03652389|516999460|FG001|Overall Study|New diagnosis|0|||
143396308|NCT03020199|516999465|FG000|Treatment Period|Adverse Event|0|||
143396309|NCT03020199|516999466|FG001|Treatment Period|Adverse Event|2|||
143396310|NCT03020199|516999465|FG000|Treatment Period|Lack of Efficacy|1|||
143396311|NCT03020199|516999466|FG001|Treatment Period|Lack of Efficacy|6|||
143396312|NCT03020199|516999465|FG000|Treatment Period|Lost to Follow-up|1|||
143396313|NCT03020199|516999466|FG001|Treatment Period|Lost to Follow-up|6|||
143396314|NCT03020199|516999465|FG000|Treatment Period|Physician Decision|0|||
143396315|NCT03020199|516999466|FG001|Treatment Period|Physician Decision|1|||
143396316|NCT03020199|516999465|FG000|Treatment Period|Subject/guardian decision|8|||
143396317|NCT03020199|516999466|FG001|Treatment Period|Subject/guardian decision|15|||
143396318|NCT03020199|516999465|FG000|Treatment Period|Subjects not treated|3|||
143396319|NCT03020199|516999466|FG001|Treatment Period|Subjects not treated|4|||
143396320|NCT03020199|516999465|FG000|Follow-up Period|Disease relapse|32|||
143396321|NCT03020199|516999466|FG001|Follow-up Period|Disease relapse|7|||
143396322|NCT03020199|516999465|FG000|Follow-up Period|Lack of Efficacy|1|||
143396323|NCT03020199|516999466|FG001|Follow-up Period|Lack of Efficacy|2|||
143396324|NCT03020199|516999465|FG000|Follow-up Period|Lost to Follow-up|4|||
143396325|NCT03020199|516999466|FG001|Follow-up Period|Lost to Follow-up|6|||
143396326|NCT03020199|516999465|FG000|Follow-up Period|Physician Decision|2|||
143396327|NCT03020199|516999466|FG001|Follow-up Period|Physician Decision|2|||
143396328|NCT03020199|516999465|FG000|Follow-up Period|Protocol Violation|1|||
143396329|NCT03020199|516999466|FG001|Follow-up Period|Protocol Violation|2|||
143396330|NCT03020199|516999465|FG000|Follow-up Period|Study terminated by Sponsor|6|||
143396331|NCT03020199|516999466|FG001|Follow-up Period|Study terminated by Sponsor|3|||
143396332|NCT03020199|516999465|FG000|Follow-up Period|Subject/guardian decision|14|||
143396333|NCT03020199|516999466|FG001|Follow-up Period|Subject/guardian decision|9|||
143396334|NCT05583578|516999467|FG000|Overall Study|Withdrawal by Subject|2|||
143396335|NCT05583578|516999468|FG001|Overall Study|Withdrawal by Subject|0|||
143342201|NCT03728972|516798686|FG001|Overall Study|Death|0|||
143342202|NCT03728972|516798685|FG000|Overall Study|Lack of Efficacy|1|||
143342203|NCT03728972|516798686|FG001|Overall Study|Lack of Efficacy|0|||
143342204|NCT03728972|516798685|FG000|Overall Study|Physician Decision|3|||
143342205|NCT03728972|516798686|FG001|Overall Study|Physician Decision|0|||
143342206|NCT03728972|516798685|FG000|Overall Study|Disease progression|4|||
143342207|NCT03728972|516798686|FG001|Overall Study|Disease progression|3|||
143342208|NCT04543188|516798687|FG000|Phase 1a|Adverse Event|0|||
143342209|NCT04543188|516798688|FG001|Phase 1a|Adverse Event|0|||
143342210|NCT04543188|516798689|FG002|Phase 1a|Adverse Event|0|||
143342211|NCT04543188|516798690|FG003|Phase 1a|Adverse Event|1|||
143342212|NCT04543188|516798691|FG004|Phase 1a|Adverse Event|0|||
143342213|NCT04543188|516798692|FG005|Phase 1a|Adverse Event|0|||
143342214|NCT04543188|516798693|FG006|Phase 1a|Adverse Event|1|||
143342215|NCT04543188|516798694|FG007|Phase 1a|Adverse Event|0|||
143342216|NCT04543188|516798695|FG008|Phase 1a|Adverse Event|0|||
143342217|NCT04543188|516798696|FG009|Phase 1a|Adverse Event|0|||
143342218|NCT04543188|516798697|FG010|Phase 1a|Adverse Event|0|||
143342219|NCT04543188|516798698|FG011|Phase 1a|Adverse Event|0|||
143342220|NCT04543188|516798699|FG012|Phase 1a|Adverse Event|0|||
143342221|NCT04543188|516798700|FG013|Phase 1a|Adverse Event|0|||
143342222|NCT04543188|516798701|FG014|Phase 1a|Adverse Event|0|||
143342223|NCT04543188|516798687|FG000|Phase 1a|Other (Death)|0|||
143342224|NCT04543188|516798688|FG001|Phase 1a|Other (Death)|1|||
143342225|NCT04543188|516798689|FG002|Phase 1a|Other (Death)|0|||
143342226|NCT04543188|516798690|FG003|Phase 1a|Other (Death)|0|||
143342227|NCT04543188|516798691|FG004|Phase 1a|Other (Death)|1|||
143342228|NCT04543188|516798692|FG005|Phase 1a|Other (Death)|0|||
143342229|NCT04543188|516798693|FG006|Phase 1a|Other (Death)|0|||
143342230|NCT04543188|516798694|FG007|Phase 1a|Other (Death)|0|||
143342231|NCT04543188|516798695|FG008|Phase 1a|Other (Death)|0|||
143342232|NCT04543188|516798696|FG009|Phase 1a|Other (Death)|1|||
143342233|NCT04543188|516798697|FG010|Phase 1a|Other (Death)|0|||
143342234|NCT04543188|516798698|FG011|Phase 1a|Other (Death)|0|||
143342235|NCT04543188|516798699|FG012|Phase 1a|Other (Death)|0|||
143342236|NCT04543188|516798700|FG013|Phase 1a|Other (Death)|0|||
143342237|NCT04543188|516798701|FG014|Phase 1a|Other (Death)|0|||
143342238|NCT04543188|516798687|FG000|Phase 1a|Lost to Follow-up|0|||
143342239|NCT04543188|516798688|FG001|Phase 1a|Lost to Follow-up|0|||
143342240|NCT04543188|516798689|FG002|Phase 1a|Lost to Follow-up|0|||
143342241|NCT04543188|516798690|FG003|Phase 1a|Lost to Follow-up|0|||
143342242|NCT04543188|516798691|FG004|Phase 1a|Lost to Follow-up|0|||
143342243|NCT04543188|516798692|FG005|Phase 1a|Lost to Follow-up|0|||
143342244|NCT04543188|516798693|FG006|Phase 1a|Lost to Follow-up|0|||
143342245|NCT04543188|516798694|FG007|Phase 1a|Lost to Follow-up|0|||
143342246|NCT04543188|516798695|FG008|Phase 1a|Lost to Follow-up|0|||
143342247|NCT04543188|516798696|FG009|Phase 1a|Lost to Follow-up|0|||
143342248|NCT04543188|516798697|FG010|Phase 1a|Lost to Follow-up|1|||
143342249|NCT04543188|516798698|FG011|Phase 1a|Lost to Follow-up|0|||
143342250|NCT04543188|516798699|FG012|Phase 1a|Lost to Follow-up|0|||
143342251|NCT04543188|516798700|FG013|Phase 1a|Lost to Follow-up|0|||
143342252|NCT04543188|516798701|FG014|Phase 1a|Lost to Follow-up|0|||
143342253|NCT04543188|516798687|FG000|Phase 1a|Progressive Disease|2|||
143342254|NCT04543188|516798688|FG001|Phase 1a|Progressive Disease|2|||
143342255|NCT04543188|516798689|FG002|Phase 1a|Progressive Disease|3|||
143342256|NCT04543188|516798690|FG003|Phase 1a|Progressive Disease|1|||
143342257|NCT04543188|516798691|FG004|Phase 1a|Progressive Disease|4|||
143342258|NCT04543188|516798692|FG005|Phase 1a|Progressive Disease|2|||
143342259|NCT04543188|516798693|FG006|Phase 1a|Progressive Disease|3|||
143342260|NCT04543188|516798694|FG007|Phase 1a|Progressive Disease|4|||
143342261|NCT04543188|516798695|FG008|Phase 1a|Progressive Disease|1|||
143342262|NCT04543188|516798696|FG009|Phase 1a|Progressive Disease|0|||
143342263|NCT04543188|516798697|FG010|Phase 1a|Progressive Disease|4|||
143342264|NCT04543188|516798698|FG011|Phase 1a|Progressive Disease|0|||
143342265|NCT04543188|516798699|FG012|Phase 1a|Progressive Disease|0|||
143342266|NCT04543188|516798700|FG013|Phase 1a|Progressive Disease|0|||
143342267|NCT04543188|516798701|FG014|Phase 1a|Progressive Disease|0|||
143342268|NCT04543188|516798687|FG000|Phase 1a|Study terminated by sponsor|0|||
143342269|NCT04543188|516798688|FG001|Phase 1a|Study terminated by sponsor|0|||
143342270|NCT04543188|516798689|FG002|Phase 1a|Study terminated by sponsor|0|||
143342271|NCT04543188|516798690|FG003|Phase 1a|Study terminated by sponsor|0|||
143342272|NCT04543188|516798691|FG004|Phase 1a|Study terminated by sponsor|1|||
143342273|NCT04543188|516798692|FG005|Phase 1a|Study terminated by sponsor|0|||
143342274|NCT04543188|516798693|FG006|Phase 1a|Study terminated by sponsor|0|||
143342275|NCT04543188|516798694|FG007|Phase 1a|Study terminated by sponsor|0|||
143342276|NCT04543188|516798695|FG008|Phase 1a|Study terminated by sponsor|0|||
143342277|NCT04543188|516798696|FG009|Phase 1a|Study terminated by sponsor|0|||
143342278|NCT04543188|516798697|FG010|Phase 1a|Study terminated by sponsor|1|||
143342279|NCT04543188|516798698|FG011|Phase 1a|Study terminated by sponsor|0|||
143342280|NCT04543188|516798699|FG012|Phase 1a|Study terminated by sponsor|0|||
143342281|NCT04543188|516798700|FG013|Phase 1a|Study terminated by sponsor|0|||
143342282|NCT04543188|516798701|FG014|Phase 1a|Study terminated by sponsor|0|||
143342283|NCT04543188|516798687|FG000|Phase 1a|Withdrawal by Subject|0|||
143342284|NCT04543188|516798688|FG001|Phase 1a|Withdrawal by Subject|0|||
143342285|NCT04543188|516798689|FG002|Phase 1a|Withdrawal by Subject|0|||
143342286|NCT04543188|516798690|FG003|Phase 1a|Withdrawal by Subject|0|||
143342287|NCT04543188|516798691|FG004|Phase 1a|Withdrawal by Subject|3|||
143342288|NCT04543188|516798692|FG005|Phase 1a|Withdrawal by Subject|0|||
143342289|NCT04543188|516798693|FG006|Phase 1a|Withdrawal by Subject|0|||
143342290|NCT04543188|516798694|FG007|Phase 1a|Withdrawal by Subject|0|||
143342291|NCT04543188|516798695|FG008|Phase 1a|Withdrawal by Subject|1|||
143342292|NCT04543188|516798696|FG009|Phase 1a|Withdrawal by Subject|1|||
143342293|NCT04543188|516798697|FG010|Phase 1a|Withdrawal by Subject|2|||
143342294|NCT04543188|516798698|FG011|Phase 1a|Withdrawal by Subject|0|||
143342295|NCT04543188|516798699|FG012|Phase 1a|Withdrawal by Subject|0|||
143342296|NCT04543188|516798700|FG013|Phase 1a|Withdrawal by Subject|0|||
143342297|NCT04543188|516798701|FG014|Phase 1a|Withdrawal by Subject|0|||
143342298|NCT04543188|516798687|FG000|Phase 1a|Global Deterioration Of Health Status|0|||
143342299|NCT04543188|516798688|FG001|Phase 1a|Global Deterioration Of Health Status|1|||
143342300|NCT04543188|516798689|FG002|Phase 1a|Global Deterioration Of Health Status|0|||
143342301|NCT04543188|516798690|FG003|Phase 1a|Global Deterioration Of Health Status|1|||
143342302|NCT04543188|516798691|FG004|Phase 1a|Global Deterioration Of Health Status|1|||
143342303|NCT04543188|516798692|FG005|Phase 1a|Global Deterioration Of Health Status|1|||
143342304|NCT04543188|516798693|FG006|Phase 1a|Global Deterioration Of Health Status|0|||
143342305|NCT04543188|516798694|FG007|Phase 1a|Global Deterioration Of Health Status|0|||
143342306|NCT04543188|516798695|FG008|Phase 1a|Global Deterioration Of Health Status|0|||
143342307|NCT04543188|516798696|FG009|Phase 1a|Global Deterioration Of Health Status|2|||
143342308|NCT04543188|516798697|FG010|Phase 1a|Global Deterioration Of Health Status|0|||
143342309|NCT04543188|516798698|FG011|Phase 1a|Global Deterioration Of Health Status|0|||
143342310|NCT04543188|516798699|FG012|Phase 1a|Global Deterioration Of Health Status|0|||
143342311|NCT04543188|516798700|FG013|Phase 1a|Global Deterioration Of Health Status|0|||
143342312|NCT04543188|516798701|FG014|Phase 1a|Global Deterioration Of Health Status|0|||
143342313|NCT04543188|516798687|FG000|Phase 1a|Other|0|||
143342314|NCT04543188|516798688|FG001|Phase 1a|Other|0|||
143342315|NCT04543188|516798689|FG002|Phase 1a|Other|0|||
143396336|NCT00248287|516999470|FG000|Overall Study|Adverse Event|11|||
143396337|NCT00248287|516999471|FG001|Overall Study|Adverse Event|10|||
143396338|NCT00248287|516999470|FG000|Overall Study|Death|1|||
143396339|NCT00248287|516999471|FG001|Overall Study|Death|0|||
143396340|NCT00248287|516999470|FG000|Overall Study|Lost to Follow-up|0|||
143396341|NCT00248287|516999471|FG001|Overall Study|Lost to Follow-up|1|||
143396342|NCT00248287|516999470|FG000|Overall Study|Investigator Request|4|||
143396343|NCT00248287|516999471|FG001|Overall Study|Investigator Request|3|||
143396344|NCT00248287|516999470|FG000|Overall Study|Patient Request|5|||
143396345|NCT00248287|516999471|FG001|Overall Study|Patient Request|3|||
143396346|NCT00248287|516999470|FG000|Overall Study|Other|3|||
143396347|NCT00248287|516999471|FG001|Overall Study|Other|2|||
143396348|NCT02714257|516999472|FG000|Overall Study|Withdrawal by Subject|6|||
143396349|NCT02714257|516999473|FG001|Overall Study|Withdrawal by Subject|11|||
143396350|NCT02714257|516999472|FG000|Overall Study|Death|3|||
143396351|NCT02714257|516999473|FG001|Overall Study|Death|4|||
143396352|NCT02714257|516999472|FG000|Overall Study|Lost to Follow-up|1|||
143396353|NCT02714257|516999473|FG001|Overall Study|Lost to Follow-up|6|||
143396354|NCT04103580|516999476|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
143396355|NCT04103580|516999477|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
143396356|NCT04103580|516999476|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
143396357|NCT04103580|516999477|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
143396358|NCT04103580|516999476|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
143396359|NCT04103580|516999477|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
143396360|NCT04103580|516999476|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
143396361|NCT04103580|516999477|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
143396362|NCT04103580|516999476|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
143396363|NCT04103580|516999477|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
143396364|NCT04103580|516999476|FG000|Phase 1 Active Caregiving|Other|3|||
143396365|NCT04103580|516999477|FG001|Phase 1 Active Caregiving|Other|3|||
143342316|NCT04543188|516798690|FG003|Phase 1a|Other|0|||
143342317|NCT04543188|516798691|FG004|Phase 1a|Other|0|||
143342318|NCT04543188|516798692|FG005|Phase 1a|Other|0|||
143342319|NCT04543188|516798693|FG006|Phase 1a|Other|0|||
143342320|NCT04543188|516798694|FG007|Phase 1a|Other|0|||
143396366|NCT04103580|516999476|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
143396367|NCT04103580|516999477|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
143396368|NCT04103580|516999476|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
143342321|NCT04543188|516798695|FG008|Phase 1a|Other|0|||
143342322|NCT04543188|516798696|FG009|Phase 1a|Other|1|||
143342323|NCT04543188|516798697|FG010|Phase 1a|Other|0|||
143342324|NCT04543188|516798698|FG011|Phase 1a|Other|0|||
143342325|NCT04543188|516798699|FG012|Phase 1a|Other|0|||
143342326|NCT04543188|516798700|FG013|Phase 1a|Other|0|||
143342327|NCT04543188|516798701|FG014|Phase 1a|Other|0|||
143342328|NCT04543188|516798687|FG000|Phase 1b|Adverse Event|0|||
143342329|NCT04543188|516798688|FG001|Phase 1b|Adverse Event|0|||
143342330|NCT04543188|516798689|FG002|Phase 1b|Adverse Event|0|||
143342331|NCT04543188|516798690|FG003|Phase 1b|Adverse Event|0|||
143342332|NCT04543188|516798691|FG004|Phase 1b|Adverse Event|0|||
143342333|NCT04543188|516798692|FG005|Phase 1b|Adverse Event|0|||
143342334|NCT04543188|516798693|FG006|Phase 1b|Adverse Event|0|||
143342335|NCT04543188|516798694|FG007|Phase 1b|Adverse Event|0|||
143342336|NCT04543188|516798695|FG008|Phase 1b|Adverse Event|0|||
143342337|NCT04543188|516798696|FG009|Phase 1b|Adverse Event|0|||
143342338|NCT04543188|516798697|FG010|Phase 1b|Adverse Event|0|||
143342339|NCT04543188|516798698|FG011|Phase 1b|Adverse Event|0|||
143342340|NCT04543188|516798699|FG012|Phase 1b|Adverse Event|0|||
143342341|NCT04543188|516798700|FG013|Phase 1b|Adverse Event|0|||
143342342|NCT04543188|516798701|FG014|Phase 1b|Adverse Event|2|||
143342343|NCT04543188|516798687|FG000|Phase 1b|Other (Death)|0|||
143342344|NCT04543188|516798688|FG001|Phase 1b|Other (Death)|0|||
143342345|NCT04543188|516798689|FG002|Phase 1b|Other (Death)|0|||
143342346|NCT04543188|516798690|FG003|Phase 1b|Other (Death)|0|||
143342347|NCT04543188|516798691|FG004|Phase 1b|Other (Death)|0|||
143342348|NCT04543188|516798692|FG005|Phase 1b|Other (Death)|0|||
143342349|NCT04543188|516798693|FG006|Phase 1b|Other (Death)|0|||
143342350|NCT04543188|516798694|FG007|Phase 1b|Other (Death)|0|||
143342351|NCT04543188|516798695|FG008|Phase 1b|Other (Death)|0|||
143342352|NCT04543188|516798696|FG009|Phase 1b|Other (Death)|0|||
143342353|NCT04543188|516798697|FG010|Phase 1b|Other (Death)|0|||
143342354|NCT04543188|516798698|FG011|Phase 1b|Other (Death)|0|||
143342355|NCT04543188|516798699|FG012|Phase 1b|Other (Death)|1|||
143342356|NCT04543188|516798700|FG013|Phase 1b|Other (Death)|0|||
143342357|NCT04543188|516798701|FG014|Phase 1b|Other (Death)|1|||
143342358|NCT04543188|516798687|FG000|Phase 1b|Progressive Disease|0|||
143342359|NCT04543188|516798688|FG001|Phase 1b|Progressive Disease|0|||
143342360|NCT04543188|516798689|FG002|Phase 1b|Progressive Disease|0|||
143342361|NCT04543188|516798690|FG003|Phase 1b|Progressive Disease|0|||
143342362|NCT04543188|516798691|FG004|Phase 1b|Progressive Disease|0|||
143342363|NCT04543188|516798692|FG005|Phase 1b|Progressive Disease|0|||
143342364|NCT04543188|516798693|FG006|Phase 1b|Progressive Disease|0|||
143342365|NCT04543188|516798694|FG007|Phase 1b|Progressive Disease|0|||
143342366|NCT04543188|516798695|FG008|Phase 1b|Progressive Disease|0|||
143342367|NCT04543188|516798696|FG009|Phase 1b|Progressive Disease|0|||
143342368|NCT04543188|516798697|FG010|Phase 1b|Progressive Disease|0|||
143342369|NCT04543188|516798698|FG011|Phase 1b|Progressive Disease|0|||
143342370|NCT04543188|516798699|FG012|Phase 1b|Progressive Disease|2|||
143342371|NCT04543188|516798700|FG013|Phase 1b|Progressive Disease|1|||
143342372|NCT04543188|516798701|FG014|Phase 1b|Progressive Disease|5|||
143342373|NCT04543188|516798687|FG000|Phase 1b|Study Terminated By Sponsor|0|||
143342374|NCT04543188|516798688|FG001|Phase 1b|Study Terminated By Sponsor|0|||
143342375|NCT04543188|516798689|FG002|Phase 1b|Study Terminated By Sponsor|0|||
143342376|NCT04543188|516798690|FG003|Phase 1b|Study Terminated By Sponsor|0|||
143342377|NCT04543188|516798691|FG004|Phase 1b|Study Terminated By Sponsor|0|||
143342378|NCT04543188|516798692|FG005|Phase 1b|Study Terminated By Sponsor|0|||
143342379|NCT04543188|516798693|FG006|Phase 1b|Study Terminated By Sponsor|0|||
143342380|NCT04543188|516798694|FG007|Phase 1b|Study Terminated By Sponsor|0|||
143342381|NCT04543188|516798695|FG008|Phase 1b|Study Terminated By Sponsor|0|||
143342382|NCT04543188|516798696|FG009|Phase 1b|Study Terminated By Sponsor|0|||
143342383|NCT04543188|516798697|FG010|Phase 1b|Study Terminated By Sponsor|0|||
143342384|NCT04543188|516798698|FG011|Phase 1b|Study Terminated By Sponsor|1|||
143342385|NCT04543188|516798699|FG012|Phase 1b|Study Terminated By Sponsor|1|||
143342386|NCT04543188|516798700|FG013|Phase 1b|Study Terminated By Sponsor|0|||
143342387|NCT04543188|516798701|FG014|Phase 1b|Study Terminated By Sponsor|1|||
143342388|NCT04543188|516798687|FG000|Phase 1b|Withdrawal by Subject|0|||
143342389|NCT04543188|516798688|FG001|Phase 1b|Withdrawal by Subject|0|||
143342390|NCT04543188|516798689|FG002|Phase 1b|Withdrawal by Subject|0|||
143342391|NCT04543188|516798690|FG003|Phase 1b|Withdrawal by Subject|0|||
143342392|NCT04543188|516798691|FG004|Phase 1b|Withdrawal by Subject|0|||
143342393|NCT04543188|516798692|FG005|Phase 1b|Withdrawal by Subject|0|||
143342394|NCT04543188|516798693|FG006|Phase 1b|Withdrawal by Subject|0|||
143342395|NCT04543188|516798694|FG007|Phase 1b|Withdrawal by Subject|0|||
143342396|NCT04543188|516798695|FG008|Phase 1b|Withdrawal by Subject|0|||
143342397|NCT04543188|516798696|FG009|Phase 1b|Withdrawal by Subject|0|||
143342398|NCT04543188|516798697|FG010|Phase 1b|Withdrawal by Subject|0|||
143396369|NCT04103580|516999477|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
143396370|NCT04103580|516999476|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
143396371|NCT04103580|516999477|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
143396372|NCT04103580|516999476|FG000|Phase 2 Bereavement|Other|8|||
143396373|NCT04103580|516999477|FG001|Phase 2 Bereavement|Other|6|||
143396374|NCT04568486|516999478|FG000|Overall Study|Withdrawal by Subject|26|||
143396375|NCT04568486|516999478|FG000|Overall Study|Lost to Follow-up|7|||
143396376|NCT04248725|516999479|FG000|Post-Treatment|Lost to Follow-up|6|||
143396377|NCT04248725|516999480|FG001|Post-Treatment|Lost to Follow-up|5|||
143396378|NCT04248725|516999479|FG000|6-Month Follow Up|Lost to Follow-up|9|||
143396379|NCT04248725|516999480|FG001|6-Month Follow Up|Lost to Follow-up|8|||
143396380|NCT01210807|516999483|FG000|Overall Study|Lost to Follow-up|1|||
143396381|NCT01210807|516999484|FG001|Overall Study|Lost to Follow-up|2|||
143396382|NCT01210807|516999483|FG000|Overall Study|Not implanted bilaterally|2|||
143396383|NCT01210807|516999484|FG001|Overall Study|Not implanted bilaterally|1|||
143396384|NCT05940194|516999498|FG000|Overall Study|Adverse Event|0|||
143396385|NCT05940194|516999499|FG001|Overall Study|Adverse Event|1|||
143342399|NCT04543188|516798698|FG011|Phase 1b|Withdrawal by Subject|0|||
143342400|NCT04543188|516798699|FG012|Phase 1b|Withdrawal by Subject|0|||
143342401|NCT04543188|516798700|FG013|Phase 1b|Withdrawal by Subject|0|||
143342402|NCT04543188|516798701|FG014|Phase 1b|Withdrawal by Subject|2|||
143342403|NCT00728962|516798704|FG000|Implant Placement Surgery|Adverse Event|8|||
143342404|NCT00728962|516798704|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
143342405|NCT00728962|516798704|FG000|Implant Placement Surgery|Protocol Violation|1|||
143342406|NCT00728962|516798704|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
143342407|NCT00728962|516798704|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
143342408|NCT04954586|516798705|FG000|Overall Study|Withdrawal by Subject|5|||
143342409|NCT02063828|516798706|FG000|Overall Study|Withdrawal by Subject|4|||
143342410|NCT02063828|516798707|FG001|Overall Study|Withdrawal by Subject|6|||
143342411|NCT02063828|516798708|FG002|Overall Study|Withdrawal by Subject|3|||
143342412|NCT02063828|516798706|FG000|Overall Study|Death|0|||
143342413|NCT02063828|516798707|FG001|Overall Study|Death|0|||
143342414|NCT02063828|516798708|FG002|Overall Study|Death|1|||
143342415|NCT00532155|516798709|FG000|Overall Study|Adverse Event|66|||
143342416|NCT00532155|516798710|FG001|Overall Study|Adverse Event|123|||
143342417|NCT00532155|516798709|FG000|Overall Study|Lack of Efficacy|332|||
143342418|NCT00532155|516798710|FG001|Overall Study|Lack of Efficacy|255|||
143342419|NCT00532155|516798709|FG000|Overall Study|Protocol Violation|1|||
143342420|NCT00532155|516798710|FG001|Overall Study|Protocol Violation|3|||
143342421|NCT00532155|516798709|FG000|Overall Study|Lost to Follow-up|2|||
143342422|NCT00532155|516798710|FG001|Overall Study|Lost to Follow-up|0|||
143342423|NCT00532155|516798709|FG000|Overall Study|Physician Decision|16|||
143342424|NCT00532155|516798710|FG001|Overall Study|Physician Decision|15|||
143342425|NCT00532155|516798709|FG000|Overall Study|Withdrawal by Subject|23|||
143342426|NCT00532155|516798710|FG001|Overall Study|Withdrawal by Subject|44|||
143342427|NCT00532155|516798709|FG000|Overall Study|Consent withdrawn|5|||
143342428|NCT00532155|516798710|FG001|Overall Study|Consent withdrawn|7|||
143342429|NCT00532155|516798709|FG000|Overall Study|Moved|1|||
143342430|NCT00532155|516798710|FG001|Overall Study|Moved|0|||
143342431|NCT00532155|516798709|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
143342432|NCT00532155|516798710|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
143342433|NCT00532155|516798709|FG000|Overall Study|Occurence of a second cancer|0|||
143342434|NCT00532155|516798710|FG001|Overall Study|Occurence of a second cancer|1|||
143342435|NCT00532155|516798709|FG000|Overall Study|Occurence of a secondary cancer|0|||
143342436|NCT00532155|516798710|FG001|Overall Study|Occurence of a secondary cancer|1|||
143342437|NCT00532155|516798709|FG000|Overall Study|Promotor ended study|1|||
143342438|NCT00532155|516798710|FG001|Overall Study|Promotor ended study|0|||
143342439|NCT00532155|516798709|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
143342440|NCT00532155|516798710|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
143342441|NCT00532155|516798709|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
143342442|NCT00532155|516798710|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
143342443|NCT00532155|516798709|FG000|Overall Study|Study stopped|1|||
143342444|NCT00532155|516798710|FG001|Overall Study|Study stopped|0|||
143342445|NCT00532155|516798709|FG000|Overall Study|Study terminated by sponsor|1|||
143342446|NCT00532155|516798710|FG001|Overall Study|Study terminated by sponsor|0|||
143342447|NCT00532155|516798709|FG000|Overall Study|Study termination stop further treatment|4|||
143342448|NCT00532155|516798710|FG001|Overall Study|Study termination stop further treatment|0|||
143342449|NCT00532155|516798709|FG000|Overall Study|Did not receive study medication|2|||
143342450|NCT00532155|516798710|FG001|Overall Study|Did not receive study medication|6|||
143342451|NCT03483038|516798711|FG000|Overall Study|Subjects still in follow-up|18|||
143342452|NCT02134925|516798712|FG000|Overall Study|Withdrawal by Subject|1|||
143342453|NCT02134925|516798713|FG001|Overall Study|Withdrawal by Subject|0|||
143342454|NCT02134925|516798712|FG000|Overall Study|Cancel|1|||
143342455|NCT02134925|516798713|FG001|Overall Study|Cancel|6|||
143396386|NCT05940194|516999500|FG002|Overall Study|Adverse Event|0|||
143342456|NCT01064297|516798714|FG000|Overall Study|Lost to Follow-up|791|||
143342457|NCT01064297|516798715|FG001|Overall Study|Lost to Follow-up|48|||
143342458|NCT01064297|516798716|FG002|Overall Study|Lost to Follow-up|133|||
143396387|NCT05940194|516999498|FG000|Overall Study|Migrated/Moved from the study area|2|||
143396388|NCT05940194|516999499|FG001|Overall Study|Migrated/Moved from the study area|2|||
143396389|NCT05940194|516999500|FG002|Overall Study|Migrated/Moved from the study area|4|||
143396390|NCT04914676|516999501|FG000|Overall Study|Study termination|3|||
143396391|NCT04914676|516999502|FG001|Overall Study|Study termination|0|||
143396392|NCT03085810|516999503|FG000|Main Study|Withdrawal by Subject|77|||
143396393|NCT03085810|516999504|FG001|Main Study|Withdrawal by Subject|0|||
143396394|NCT03085810|516999505|FG002|Main Study|Withdrawal by Subject|0|||
143396395|NCT03085810|516999503|FG000|Main Study|Terminated By Sponsor|14|||
143396396|NCT03085810|516999504|FG001|Main Study|Terminated By Sponsor|0|||
143396397|NCT03085810|516999505|FG002|Main Study|Terminated By Sponsor|0|||
143396398|NCT03085810|516999503|FG000|Main Study|Protocol Violation|15|||
143396399|NCT03085810|516999504|FG001|Main Study|Protocol Violation|0|||
143396400|NCT03085810|516999505|FG002|Main Study|Protocol Violation|0|||
143396401|NCT03085810|516999503|FG000|Main Study|Physician Decision|13|||
143396402|NCT03085810|516999504|FG001|Main Study|Physician Decision|0|||
143396403|NCT03085810|516999505|FG002|Main Study|Physician Decision|0|||
143396404|NCT03085810|516999503|FG000|Main Study|Lost to Follow-up|17|||
143396405|NCT03085810|516999504|FG001|Main Study|Lost to Follow-up|0|||
143396406|NCT03085810|516999505|FG002|Main Study|Lost to Follow-up|0|||
143396407|NCT03085810|516999503|FG000|Main Study|Adverse Event|25|||
143396408|NCT03085810|516999504|FG001|Main Study|Adverse Event|0|||
143396409|NCT03085810|516999505|FG002|Main Study|Adverse Event|0|||
143396410|NCT03085810|516999503|FG000|Main Study|Pregnancy|7|||
143396411|NCT03085810|516999504|FG001|Main Study|Pregnancy|0|||
143396412|NCT03085810|516999505|FG002|Main Study|Pregnancy|0|||
143396413|NCT03085810|516999503|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
143396414|NCT03085810|516999504|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
143396415|NCT03085810|516999505|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
143396416|NCT03085810|516999503|FG000|Main Study|Lack of Efficacy|10|||
143396417|NCT03085810|516999504|FG001|Main Study|Lack of Efficacy|0|||
143396418|NCT03085810|516999505|FG002|Main Study|Lack of Efficacy|0|||
143396419|NCT03085810|516999503|FG000|Main Study|Death|12|||
143396420|NCT03085810|516999504|FG001|Main Study|Death|0|||
143396421|NCT03085810|516999505|FG002|Main Study|Death|0|||
143396422|NCT03085810|516999503|FG000|Main Study|Disease progression|1|||
143396423|NCT03085810|516999504|FG001|Main Study|Disease progression|0|||
143396424|NCT03085810|516999505|FG002|Main Study|Disease progression|0|||
143396425|NCT03085810|516999503|FG000|Main Study|Site Closure|3|||
143396426|NCT03085810|516999504|FG001|Main Study|Site Closure|0|||
143396427|NCT03085810|516999505|FG002|Main Study|Site Closure|0|||
143396428|NCT03085810|516999503|FG000|Main Study|Planned pregnancy|17|||
143396429|NCT03085810|516999504|FG001|Main Study|Planned pregnancy|0|||
143396430|NCT03085810|516999505|FG002|Main Study|Planned pregnancy|0|||
143396431|NCT03085810|516999503|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
143396432|NCT03085810|516999504|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
143396433|NCT03085810|516999505|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
143396434|NCT03085810|516999503|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
143396435|NCT03085810|516999504|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
143396436|NCT03085810|516999505|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
143396437|NCT03085810|516999503|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
143396438|NCT03085810|516999504|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
143396439|NCT03085810|516999505|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
143396440|NCT03085810|516999503|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
143396441|NCT03085810|516999504|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
143396442|NCT03085810|516999505|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
143396443|NCT02606422|516999508|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
143396444|NCT02606422|516999509|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
143396445|NCT02606422|516999508|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
143396446|NCT02606422|516999509|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
143396447|NCT02606422|516999508|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
143396448|NCT02606422|516999509|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
143396449|NCT02606422|516999508|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
143396450|NCT02606422|516999509|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
143396451|NCT04625465|516999510|FG000|Overall Study|Lost to Follow-up|2|||
143396452|NCT04625465|516999511|FG001|Overall Study|Lost to Follow-up|2|||
143396453|NCT04625465|516999512|FG002|Overall Study|Lost to Follow-up|1|||
143396454|NCT04625465|516999513|FG003|Overall Study|Lost to Follow-up|0|||
143396455|NCT04625465|516999514|FG004|Overall Study|Lost to Follow-up|0|||
143396456|NCT04625465|516999515|FG005|Overall Study|Lost to Follow-up|2|||
143396457|NCT04625465|516999516|FG006|Overall Study|Lost to Follow-up|0|||
143396458|NCT04625465|516999517|FG007|Overall Study|Lost to Follow-up|0|||
143396459|NCT04625465|516999510|FG000|Overall Study|Death|1|||
143396460|NCT04625465|516999511|FG001|Overall Study|Death|0|||
143396461|NCT04625465|516999512|FG002|Overall Study|Death|0|||
143396462|NCT04625465|516999513|FG003|Overall Study|Death|0|||
143396463|NCT04625465|516999514|FG004|Overall Study|Death|0|||
143396464|NCT04625465|516999515|FG005|Overall Study|Death|0|||
143396465|NCT04625465|516999516|FG006|Overall Study|Death|0|||
143396466|NCT04625465|516999517|FG007|Overall Study|Death|0|||
143396467|NCT04625465|516999510|FG000|Overall Study|Withdrawal by Subject|1|||
143396468|NCT04625465|516999511|FG001|Overall Study|Withdrawal by Subject|0|||
143396469|NCT04625465|516999512|FG002|Overall Study|Withdrawal by Subject|4|||
143396470|NCT04625465|516999513|FG003|Overall Study|Withdrawal by Subject|4|||
143396471|NCT04625465|516999514|FG004|Overall Study|Withdrawal by Subject|4|||
143396472|NCT04625465|516999515|FG005|Overall Study|Withdrawal by Subject|0|||
143396473|NCT04625465|516999516|FG006|Overall Study|Withdrawal by Subject|0|||
143396474|NCT04625465|516999517|FG007|Overall Study|Withdrawal by Subject|0|||
143396475|NCT03710603|516999519|FG000|Overall Study|Adverse Event|1|||
143396476|NCT03710603|516999520|FG001|Overall Study|Adverse Event|0|||
143396477|NCT03710603|516999519|FG000|Overall Study|Death|44|||
143396478|NCT03710603|516999520|FG001|Overall Study|Death|34|||
143396479|NCT03710603|516999519|FG000|Overall Study|Lost to Follow-up|3|||
143396480|NCT03710603|516999520|FG001|Overall Study|Lost to Follow-up|5|||
143396481|NCT03710603|516999519|FG000|Overall Study|Withdrawal by Subject|11|||
143396482|NCT03710603|516999520|FG001|Overall Study|Withdrawal by Subject|10|||
143396483|NCT05002088|516999521|FG000|Overall Study|Withdrawal by Subject|9|||
143396484|NCT05002088|516999522|FG001|Overall Study|Withdrawal by Subject|0|||
143396485|NCT05002088|516999521|FG000|Overall Study|Lost to Follow-up|0|||
143396486|NCT05002088|516999522|FG001|Overall Study|Lost to Follow-up|1|||
143396487|NCT05002088|516999521|FG000|Overall Study|Death|16|||
143396488|NCT05002088|516999522|FG001|Overall Study|Death|2|||
143396489|NCT05002088|516999521|FG000|Overall Study|Protocol Violation|25|||
143396490|NCT05002088|516999522|FG001|Overall Study|Protocol Violation|7|||
143396491|NCT03905798|516999528|FG000|Overall Study|No informed consent for notification/publication of study results|94|||
143396492|NCT06473662|516999529|FG000|Overall Study|Withdrawal by Subject|1|||
143396493|NCT06473662|516999530|FG001|Overall Study|Withdrawal by Subject|6|||
143396494|NCT06473662|516999531|FG002|Overall Study|Withdrawal by Subject|5|||
143396495|NCT06473662|516999529|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
143396496|NCT06473662|516999530|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
143396497|NCT06473662|516999531|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
143396498|NCT06473662|516999529|FG000|Overall Study|Starting HbA1c below 7%|0|||
143396499|NCT06473662|516999530|FG001|Overall Study|Starting HbA1c below 7%|1|||
143396500|NCT06473662|516999531|FG002|Overall Study|Starting HbA1c below 7%|1|||
143396501|NCT06473662|516999529|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
143396502|NCT06473662|516999530|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
143396503|NCT06473662|516999531|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
143396504|NCT06473662|516999529|FG000|Overall Study|Did not take medication|2|||
143396505|NCT06473662|516999530|FG001|Overall Study|Did not take medication|3|||
143396506|NCT06473662|516999531|FG002|Overall Study|Did not take medication|2|||
143396507|NCT03463044|516999534|FG000|Overall Study|Lost to Follow-up|0|||
143396508|NCT03463044|516999535|FG001|Overall Study|Lost to Follow-up|0|||
143396509|NCT03463044|516999536|FG002|Overall Study|Lost to Follow-up|0|||
143396510|NCT03463044|516999537|FG003|Overall Study|Lost to Follow-up|0|||
143396511|NCT03463044|516999538|FG004|Overall Study|Lost to Follow-up|0|||
143396512|NCT03463044|516999539|FG005|Overall Study|Lost to Follow-up|0|||
143396513|NCT03463044|516999540|FG006|Overall Study|Lost to Follow-up|0|||
143396514|NCT03463044|516999541|FG007|Overall Study|Lost to Follow-up|1|||
143396515|NCT03463044|516999542|FG008|Overall Study|Lost to Follow-up|0|||
143396516|NCT04498390|516999543|FG000|Overall Study|Adverse Event|0|||
143396517|NCT04498390|516999544|FG001|Overall Study|Adverse Event|0|||
143396518|NCT04498390|516999545|FG002|Overall Study|Adverse Event|1|||
143396519|NCT04498390|516999546|FG003|Overall Study|Adverse Event|0|||
143396520|NCT04498390|516999547|FG004|Overall Study|Adverse Event|0|||
143396521|NCT04498390|516999543|FG000|Overall Study|Withdrawal by Subject|0|||
143396522|NCT04498390|516999544|FG001|Overall Study|Withdrawal by Subject|0|||
143396523|NCT04498390|516999545|FG002|Overall Study|Withdrawal by Subject|0|||
143396524|NCT04498390|516999546|FG003|Overall Study|Withdrawal by Subject|1|||
143396525|NCT04498390|516999547|FG004|Overall Study|Withdrawal by Subject|0|||
143396526|NCT04577963|516999560|FG000|Part 2|Death|0|||
143396527|NCT04577963|516999561|FG001|Part 2|Death|1|||
143396528|NCT04577963|516999562|FG002|Part 2|Death|8|||
143396529|NCT04577963|516999563|FG003|Part 2|Death|0|||
143396530|NCT04577963|516999564|FG004|Part 2|Death|20|||
143396531|NCT04577963|516999560|FG000|Part 2|Lost to Follow-up|0|||
143396532|NCT04577963|516999561|FG001|Part 2|Lost to Follow-up|0|||
143396533|NCT04577963|516999562|FG002|Part 2|Lost to Follow-up|0|||
143396534|NCT04577963|516999563|FG003|Part 2|Lost to Follow-up|0|||
143396535|NCT04577963|516999564|FG004|Part 2|Lost to Follow-up|2|||
143396536|NCT04577963|516999560|FG000|Part 2|Withdrawal by Subject|0|||
143396537|NCT04577963|516999561|FG001|Part 2|Withdrawal by Subject|0|||
143396538|NCT04577963|516999562|FG002|Part 2|Withdrawal by Subject|0|||
143396539|NCT04577963|516999563|FG003|Part 2|Withdrawal by Subject|0|||
143396540|NCT04577963|516999564|FG004|Part 2|Withdrawal by Subject|10|||
143396541|NCT04577963|516999560|FG000|Part 2|Progressive disease|0|||
143396542|NCT04577963|516999561|FG001|Part 2|Progressive disease|0|||
143396543|NCT04577963|516999562|FG002|Part 2|Progressive disease|0|||
143396544|NCT04577963|516999563|FG003|Part 2|Progressive disease|0|||
143396545|NCT04577963|516999564|FG004|Part 2|Progressive disease|2|||
143396546|NCT04577963|516999560|FG000|Part 2|Investigator decision|0|||
143396547|NCT04577963|516999561|FG001|Part 2|Investigator decision|0|||
143396548|NCT04577963|516999562|FG002|Part 2|Investigator decision|0|||
143396549|NCT04577963|516999563|FG003|Part 2|Investigator decision|0|||
143396550|NCT04577963|516999564|FG004|Part 2|Investigator decision|1|||
143396551|NCT04577963|516999560|FG000|Part 2|Sponsor terminated study|0|||
143396552|NCT04577963|516999561|FG001|Part 2|Sponsor terminated study|0|||
143396553|NCT04577963|516999562|FG002|Part 2|Sponsor terminated study|3|||
143396554|NCT04577963|516999563|FG003|Part 2|Sponsor terminated study|1|||
143396555|NCT04577963|516999564|FG004|Part 2|Sponsor terminated study|4|||
143396556|NCT02709161|516999565|FG000|Overall Study|Withdrawal by Subject|1|||
143396557|NCT02709161|516999566|FG001|Overall Study|Withdrawal by Subject|0|||
143396558|NCT05309291|516999567|FG000|Overall Study|Adverse Event|0|||
143396559|NCT05309291|516999568|FG001|Overall Study|Adverse Event|1|||
143396560|NCT05209152|516999569|FG000|Overall Study|Sponsor decision|1|||
143396561|NCT05209152|516999570|FG001|Overall Study|Sponsor decision|2|||
143396562|NCT05209152|516999569|FG000|Overall Study|Death|3|||
143396563|NCT05209152|516999570|FG001|Overall Study|Death|1|||
143396564|NCT01574274|517000682|FG000|Overall Study|Ineligible|0|||
143396565|NCT01574274|517000683|FG001|Overall Study|Ineligible|1|||
143396566|NCT01574274|517000682|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
143396567|NCT01574274|517000683|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
143396568|NCT01574274|517000682|FG000|Overall Study|Ph+ B-ALL|3|||
143396569|NCT01574274|517000683|FG001|Overall Study|Ph+ B-ALL|4|||
143396570|NCT01574274|517000682|FG000|Overall Study|Induction Death|2|||
143396571|NCT01574274|517000683|FG001|Overall Study|Induction Death|0|||
143396572|NCT01574274|517000682|FG000|Overall Study|Induction Failure|4|||
143396573|NCT01574274|517000683|FG001|Overall Study|Induction Failure|1|||
143396574|NCT01574274|517000682|FG000|Overall Study|Adverse Event|16|||
143396575|NCT01574274|517000683|FG001|Overall Study|Adverse Event|13|||
143396576|NCT01574274|517000682|FG000|Overall Study|Remission Death|1|||
143396577|NCT01574274|517000683|FG001|Overall Study|Remission Death|0|||
143396578|NCT01574274|517000682|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
143396579|NCT01574274|517000683|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
143396580|NCT01574274|517000682|FG000|Overall Study|Other, unknown|3|||
143396581|NCT01574274|517000683|FG001|Overall Study|Other, unknown|2|||
143396582|NCT04676763|517000684|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
143396583|NCT04676763|517000685|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
143396584|NCT04676763|517000686|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
143396585|NCT04676763|517000684|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
143396586|NCT04676763|517000685|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
143396587|NCT04676763|517000686|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
143396588|NCT04676763|517000684|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
143396589|NCT04676763|517000685|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
143396590|NCT04676763|517000686|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
143342459|NCT04027348|516798719|FG000|Overall Study|Adverse Event|2|||
143342460|NCT02158884|516798720|FG000|Baseline Assessment|Missed performance assessment|3|||
143342461|NCT02158884|516798720|FG000|Baseline Assessment|Missed SMFA|1|||
143342462|NCT02158884|516798720|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
143342463|NCT02158884|516798720|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
143342464|NCT02158884|516798720|FG000|6 Month Assessment|Missed SMFA|20|||
143342465|NCT02158884|516798720|FG000|12 Month Assessment|Missed SMFA|17|||
143342466|NCT02487472|516798721|FG000|Overall Study|Did not complete telephonic interviews|9|||
143342467|NCT02487472|516798721|FG000|Overall Study|Other|2|||
143342468|NCT01313286|516798726|FG000|Period 1|Withdrawal by Subject|2|||
143342469|NCT01313286|516798727|FG001|Period 1|Withdrawal by Subject|0|||
143342470|NCT02034708|516798730|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
143342471|NCT02034708|516798731|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
143342472|NCT02034708|516798730|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
143342473|NCT02034708|516798731|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
143342474|NCT02034708|516798730|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
143342475|NCT02034708|516798731|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
143342476|NCT02034708|516798730|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
143342477|NCT02034708|516798731|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
143342478|NCT00654901|516798734|FG000|Overall Study|Lost to Follow-up|1|||
143342479|NCT00654901|516798735|FG001|Overall Study|Lost to Follow-up|0|||
143342480|NCT00654901|516798736|FG002|Overall Study|Lost to Follow-up|1|||
143342481|NCT00654901|516798737|FG003|Overall Study|Lost to Follow-up|0|||
143342482|NCT00654901|516798734|FG000|Overall Study|Withdrawal by Subject|3|||
143342483|NCT00654901|516798735|FG001|Overall Study|Withdrawal by Subject|0|||
143342484|NCT00654901|516798736|FG002|Overall Study|Withdrawal by Subject|1|||
143342485|NCT00654901|516798737|FG003|Overall Study|Withdrawal by Subject|0|||
143342486|NCT04843930|516798738|FG000|Randomization|Withdrawal by Subject|6|||
143342487|NCT04843930|516798739|FG001|Randomization|Withdrawal by Subject|6|||
143342488|NCT04843930|516798740|FG002|Randomization|Withdrawal by Subject|0|||
143342489|NCT04843930|516798741|FG003|Randomization|Withdrawal by Subject|0|||
143342490|NCT04843930|516798738|FG000|Week 6 Assessment|Adverse Event|3|||
143342491|NCT04843930|516798739|FG001|Week 6 Assessment|Adverse Event|0|||
143342492|NCT04843930|516798740|FG002|Week 6 Assessment|Adverse Event|0|||
143342493|NCT04843930|516798741|FG003|Week 6 Assessment|Adverse Event|0|||
143342494|NCT04843930|516798738|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
143342495|NCT04843930|516798739|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
143342496|NCT04843930|516798740|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
143342497|NCT04843930|516798741|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
143342498|NCT04843930|516798738|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
143342499|NCT04843930|516798739|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
143342500|NCT04843930|516798740|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
143342501|NCT04843930|516798741|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
143342502|NCT02552238|516798746|FG000|Overall Study|Withdrawal by Subject|2|||
143342503|NCT02552238|516798746|FG000|Overall Study|Adverse Event|2|||
143342504|NCT02036645|516798749|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
143342505|NCT02036645|516798750|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
143342506|NCT02036645|516798751|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
143342507|NCT02036645|516798752|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
143342508|NCT02036645|516798753|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
143342509|NCT02036645|516798754|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
143342510|NCT02036645|516798755|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
143342511|NCT02036645|516798756|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
143342512|NCT02036645|516798757|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
143342513|NCT02036645|516798758|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
143342514|NCT02036645|516798759|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
143342515|NCT02036645|516798760|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
143342516|NCT02036645|516798749|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
143342517|NCT02036645|516798750|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
143342518|NCT02036645|516798751|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
143342519|NCT02036645|516798752|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
143342520|NCT02036645|516798753|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
143342521|NCT02036645|516798754|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
143342522|NCT02036645|516798755|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
143342523|NCT02036645|516798756|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
143342524|NCT02036645|516798757|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
143342525|NCT02036645|516798758|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
143342526|NCT02036645|516798759|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
143342527|NCT02036645|516798760|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
143342528|NCT03324880|516798761|FG000|Overall Study|Adverse Event|0|||
143342529|NCT03324880|516798762|FG001|Overall Study|Adverse Event|2|||
143396591|NCT03252847|517000691|FG000|Overall Study|Withdrawal by Subject|0|||
143396592|NCT03252847|517000692|FG001|Overall Study|Withdrawal by Subject|0|||
143396593|NCT03252847|517000693|FG002|Overall Study|Withdrawal by Subject|1|||
143396594|NCT03252847|517000694|FG003|Overall Study|Withdrawal by Subject|0|||
143396595|NCT03252847|517000695|FG004|Overall Study|Withdrawal by Subject|0|||
143396596|NCT03252847|517000696|FG005|Overall Study|Withdrawal by Subject|0|||
143396597|NCT03252847|517000697|FG006|Overall Study|Withdrawal by Subject|0|||
143396598|NCT03252847|517000691|FG000|Overall Study|Other: Patient decision|0|||
143396599|NCT03252847|517000692|FG001|Overall Study|Other: Patient decision|0|||
143396600|NCT03252847|517000693|FG002|Overall Study|Other: Patient decision|0|||
143396601|NCT03252847|517000694|FG003|Overall Study|Other: Patient decision|0|||
143396602|NCT03252847|517000695|FG004|Overall Study|Other: Patient decision|1|||
143396603|NCT03252847|517000696|FG005|Overall Study|Other: Patient decision|0|||
143396604|NCT03252847|517000697|FG006|Overall Study|Other: Patient decision|0|||
143396605|NCT05808257|517000705|FG000|Overall Study|Lost to Follow-up|8|||
143396606|NCT05808257|517000706|FG001|Overall Study|Lost to Follow-up|8|||
143396607|NCT04042233|517000707|FG000|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|1|||
143396608|NCT04042233|517000708|FG001|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|0|||
143396609|NCT04042233|517000707|FG000|Overall Study|Protocol Violation|0|||
143396610|NCT04042233|517000708|FG001|Overall Study|Protocol Violation|2|||
143396611|NCT04907851|517000711|FG000|Overall Study|Consent withdrawn|1|||
143396612|NCT04907851|517000712|FG001|Overall Study|Consent withdrawn|2|||
143396613|NCT04907851|517000713|FG002|Overall Study|Consent withdrawn|0|||
143396614|NCT04907851|517000711|FG000|Overall Study|Death|5|||
143396615|NCT04907851|517000712|FG001|Overall Study|Death|15|||
143396616|NCT04907851|517000713|FG002|Overall Study|Death|10|||
143396617|NCT05297565|517000724|FG000|Overall Study|Other Reasons|0|||
143396618|NCT05297565|517000725|FG001|Overall Study|Other Reasons|1|||
143396619|NCT05297565|517000724|FG000|Overall Study|Physician Decision|0|||
143396620|NCT05297565|517000725|FG001|Overall Study|Physician Decision|1|||
143396621|NCT05297565|517000724|FG000|Overall Study|Disease recurrence|1|||
143396622|NCT05297565|517000725|FG001|Overall Study|Disease recurrence|0|||
143396623|NCT05496231|517000726|FG000|Overall Study|Adverse Event|1|||
143396624|NCT05496231|517000727|FG001|Overall Study|Adverse Event|1|||
143396625|NCT05496231|517000728|FG002|Overall Study|Adverse Event|0|||
143396626|NCT05496231|517000729|FG003|Overall Study|Adverse Event|4|||
143396627|NCT05496231|517000726|FG000|Overall Study|Withdrawal by Subject|5|||
143396628|NCT05496231|517000727|FG001|Overall Study|Withdrawal by Subject|5|||
143396629|NCT05496231|517000728|FG002|Overall Study|Withdrawal by Subject|4|||
143396630|NCT05496231|517000729|FG003|Overall Study|Withdrawal by Subject|11|||
143396631|NCT05496231|517000726|FG000|Overall Study|Migrated/moved from the study area|3|||
143396632|NCT05496231|517000727|FG001|Overall Study|Migrated/moved from the study area|5|||
143396633|NCT05496231|517000728|FG002|Overall Study|Migrated/moved from the study area|3|||
143396634|NCT05496231|517000729|FG003|Overall Study|Migrated/moved from the study area|3|||
143396635|NCT05496231|517000726|FG000|Overall Study|Lost to Follow-up|13|||
143396636|NCT05496231|517000727|FG001|Overall Study|Lost to Follow-up|6|||
143396637|NCT05496231|517000728|FG002|Overall Study|Lost to Follow-up|11|||
143396638|NCT05496231|517000729|FG003|Overall Study|Lost to Follow-up|6|||
143396639|NCT05496231|517000726|FG000|Overall Study|Other|9|||
143396640|NCT05496231|517000727|FG001|Overall Study|Other|7|||
143396641|NCT05496231|517000728|FG002|Overall Study|Other|7|||
143396642|NCT05496231|517000729|FG003|Overall Study|Other|8|||
143396643|NCT03819153|517000732|FG000|Overall Study|Withdrawal by Subject|20|||
143396644|NCT03819153|517000733|FG001|Overall Study|Withdrawal by Subject|28|||
143396645|NCT03819153|517000732|FG000|Overall Study|Lost to Follow-up|23|||
143396646|NCT03819153|517000733|FG001|Overall Study|Lost to Follow-up|30|||
143396647|NCT03974178|517000734|FG000|Overall Study|Death|0|||
143396648|NCT03974178|517000735|FG001|Overall Study|Death|1|||
143396649|NCT05670587|517000738|FG000|Overall Study|Withdrawal by Subject|3|||
143396650|NCT04508309|517000741|FG000|Overall Study|Death|0|||
143396651|NCT04508309|517000742|FG001|Overall Study|Death|0|||
143396652|NCT04508309|517000743|FG002|Overall Study|Death|0|||
143396653|NCT04508309|517000744|FG003|Overall Study|Death|0|||
143396654|NCT04508309|517000745|FG004|Overall Study|Death|1|||
143396655|NCT04508309|517000741|FG000|Overall Study|Lost to Follow-up|0|||
143396656|NCT04508309|517000742|FG001|Overall Study|Lost to Follow-up|0|||
143396657|NCT04508309|517000743|FG002|Overall Study|Lost to Follow-up|1|||
143396658|NCT04508309|517000744|FG003|Overall Study|Lost to Follow-up|1|||
143396659|NCT04508309|517000745|FG004|Overall Study|Lost to Follow-up|0|||
143396660|NCT04508309|517000741|FG000|Overall Study|Withdrawal by Subject|0|||
143396661|NCT04508309|517000742|FG001|Overall Study|Withdrawal by Subject|0|||
143396662|NCT04508309|517000743|FG002|Overall Study|Withdrawal by Subject|0|||
143396663|NCT04508309|517000744|FG003|Overall Study|Withdrawal by Subject|0|||
143396664|NCT04508309|517000745|FG004|Overall Study|Withdrawal by Subject|1|||
143396665|NCT02305888|517000746|FG000|Overall Study|Lost to Follow-up|0|||
143396666|NCT02305888|517000747|FG001|Overall Study|Lost to Follow-up|0|||
143396667|NCT02305888|517000748|FG002|Overall Study|Lost to Follow-up|1|||
143396668|NCT02305888|517000746|FG000|Overall Study|Adverse Event|0|||
143396669|NCT02305888|517000747|FG001|Overall Study|Adverse Event|1|||
143396670|NCT02305888|517000748|FG002|Overall Study|Adverse Event|0|||
143396671|NCT02966873|517000750|FG000|Overall Study|Lost to Follow-up|16|||
143396672|NCT02966873|517000751|FG001|Overall Study|Lost to Follow-up|15|||
143396673|NCT01456949|517000752|FG000|Enrollment|PI death- incomplete data|6|||
143396674|NCT01456949|517000752|FG000|Enrollment|Death|1|||
143396675|NCT01456949|517000752|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
143396676|NCT01456949|517000752|FG000|Enrollment|Physician Decision|10|||
143396677|NCT01456949|517000752|FG000|Enrollment|Withdrawal by Subject|7|||
143396678|NCT01456949|517000752|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
143396679|NCT01456949|517000752|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
143396680|NCT01456949|517000752|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
143396681|NCT01456949|517000752|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
143396682|NCT01456949|517000752|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
143396683|NCT01456949|517000752|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
143396684|NCT01456949|517000752|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
143396685|NCT01456949|517000752|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
143396686|NCT03511664|517000754|FG000|Overall Study|Death|457|||
143396687|NCT03511664|517000755|FG001|Overall Study|Death|201|||
143396688|NCT03511664|517000756|FG002|Overall Study|Death|21|||
143396689|NCT03511664|517000754|FG000|Overall Study|Withdrew consent|40|||
143396690|NCT03511664|517000755|FG001|Overall Study|Withdrew consent|63|||
143396691|NCT03511664|517000756|FG002|Overall Study|Withdrew consent|3|||
143396692|NCT03511664|517000754|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
143396693|NCT03511664|517000755|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
143396694|NCT03511664|517000756|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
143396695|NCT03511664|517000754|FG000|Overall Study|Lost to Follow-up|8|||
143396696|NCT03511664|517000755|FG001|Overall Study|Lost to Follow-up|5|||
143396697|NCT03511664|517000756|FG002|Overall Study|Lost to Follow-up|0|||
143396698|NCT03511664|517000754|FG000|Overall Study|Physician Decision|2|||
143396699|NCT03511664|517000755|FG001|Overall Study|Physician Decision|1|||
143396700|NCT03511664|517000756|FG002|Overall Study|Physician Decision|0|||
143396701|NCT03511664|517000754|FG000|Overall Study|Patient non-compliance|1|||
143396702|NCT03511664|517000755|FG001|Overall Study|Patient non-compliance|0|||
143396703|NCT03511664|517000756|FG002|Overall Study|Patient non-compliance|0|||
143396704|NCT02052882|517000771|FG000|Overall Study|Not treated|11|||
143396705|NCT02052882|517000771|FG000|Overall Study|Protocol Violation|1|||
143396706|NCT02052882|517000771|FG000|Overall Study|Inadequate testing|1|||
143396707|NCT05123586|517000774|FG000|Overall Study|Physician Decision|1|||
143396708|NCT05123586|517000775|FG001|Overall Study|Physician Decision|1|||
143396709|NCT05123586|517000774|FG000|Overall Study|Withdrawal by Subject|0|||
143396710|NCT05123586|517000775|FG001|Overall Study|Withdrawal by Subject|3|||
143396711|NCT01346540|517000776|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
143396712|NCT01346540|517000777|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
143396713|NCT01346540|517000776|FG000|Overall Study|Adverse Event|0|||
143396714|NCT01346540|517000777|FG001|Overall Study|Adverse Event|4|||
143396715|NCT03362476|517000778|FG000|Overall Study|Withdrawal by Subject|0|||
143396716|NCT03362476|517000779|FG001|Overall Study|Withdrawal by Subject|1|||
143396717|NCT05216406|517000780|FG000|Overall Study|Lost to Follow-up|8|||
143396718|NCT05216406|517000781|FG001|Overall Study|Lost to Follow-up|9|||
143396719|NCT04690582|517000782|FG000|Overall Study|Withdrawal by Subject|6|||
143396720|NCT04690582|517000783|FG001|Overall Study|Withdrawal by Subject|4|||
143396721|NCT04270942|517000787|FG000|Overall Study|Death|1|||
143396722|NCT04857723|517000798|FG000|Overall Study|Withdrawal by Subject|2|||
143396723|NCT03221426|517000799|FG000|Overall Study|Ongoing in study|212|||
143396724|NCT03221426|517000800|FG001|Overall Study|Ongoing in study|193|||
143396725|NCT03221426|517000801|FG002|Overall Study|Ongoing in study|61|||
143396726|NCT03221426|517000802|FG003|Overall Study|Ongoing in study|55|||
143396727|NCT03221426|517000799|FG000|Overall Study|Withdrawal by Subject|12|||
143396728|NCT03221426|517000800|FG001|Overall Study|Withdrawal by Subject|4|||
143396729|NCT03221426|517000801|FG002|Overall Study|Withdrawal by Subject|2|||
143396730|NCT03221426|517000802|FG003|Overall Study|Withdrawal by Subject|3|||
143396731|NCT03221426|517000799|FG000|Overall Study|Lost to Follow-up|4|||
143396732|NCT03221426|517000800|FG001|Overall Study|Lost to Follow-up|1|||
143396733|NCT03221426|517000801|FG002|Overall Study|Lost to Follow-up|1|||
143396734|NCT03221426|517000802|FG003|Overall Study|Lost to Follow-up|0|||
143396735|NCT03221426|517000799|FG000|Overall Study|Death|174|||
143396736|NCT03221426|517000800|FG001|Overall Study|Death|204|||
143396737|NCT03221426|517000801|FG002|Overall Study|Death|36|||
143396738|NCT03221426|517000802|FG003|Overall Study|Death|45|||
143396739|NCT04171141|517002943|FG000|Overall Study|Adverse Event|0|||
143396740|NCT04171141|517002944|FG001|Overall Study|Adverse Event|0|||
143396741|NCT04171141|517002945|FG002|Overall Study|Adverse Event|2|||
143396742|NCT04171141|517002946|FG003|Overall Study|Adverse Event|0|||
143396743|NCT04171141|517002947|FG004|Overall Study|Adverse Event|0|||
143396744|NCT04171141|517002948|FG005|Overall Study|Adverse Event|0|||
143396745|NCT04171141|517002949|FG006|Overall Study|Adverse Event|0|||
143396746|NCT04171141|517002950|FG007|Overall Study|Adverse Event|0|||
143396747|NCT04171141|517002951|FG008|Overall Study|Adverse Event|0|||
143396748|NCT04171141|517002952|FG009|Overall Study|Adverse Event|0|||
143396749|NCT04171141|517002953|FG010|Overall Study|Adverse Event|0|||
143396750|NCT04171141|517002954|FG011|Overall Study|Adverse Event|0|||
143396751|NCT04171141|517002955|FG012|Overall Study|Adverse Event|0|||
143396752|NCT04171141|517002956|FG013|Overall Study|Adverse Event|2|||
143396753|NCT04171141|517002957|FG014|Overall Study|Adverse Event|0|||
143396754|NCT04171141|517002958|FG015|Overall Study|Adverse Event|0|||
143396755|NCT04171141|517002943|FG000|Overall Study|Physician Decision|0|||
143396756|NCT04171141|517002944|FG001|Overall Study|Physician Decision|0|||
143396757|NCT04171141|517002945|FG002|Overall Study|Physician Decision|0|||
143396758|NCT04171141|517002946|FG003|Overall Study|Physician Decision|0|||
143396759|NCT04171141|517002947|FG004|Overall Study|Physician Decision|1|||
143396760|NCT04171141|517002948|FG005|Overall Study|Physician Decision|0|||
143396761|NCT04171141|517002949|FG006|Overall Study|Physician Decision|0|||
143396762|NCT04171141|517002950|FG007|Overall Study|Physician Decision|0|||
143396763|NCT04171141|517002951|FG008|Overall Study|Physician Decision|0|||
143396764|NCT04171141|517002952|FG009|Overall Study|Physician Decision|0|||
143396765|NCT04171141|517002953|FG010|Overall Study|Physician Decision|0|||
143396766|NCT04171141|517002954|FG011|Overall Study|Physician Decision|0|||
143396767|NCT04171141|517002955|FG012|Overall Study|Physician Decision|0|||
143396768|NCT04171141|517002956|FG013|Overall Study|Physician Decision|0|||
143396769|NCT04171141|517002957|FG014|Overall Study|Physician Decision|0|||
143396770|NCT04171141|517002958|FG015|Overall Study|Physician Decision|1|||
143396771|NCT04171141|517002943|FG000|Overall Study|Progressive disease|2|||
143396772|NCT04171141|517002944|FG001|Overall Study|Progressive disease|3|||
143396773|NCT04171141|517002945|FG002|Overall Study|Progressive disease|4|||
143396774|NCT04171141|517002946|FG003|Overall Study|Progressive disease|7|||
143396775|NCT04171141|517002947|FG004|Overall Study|Progressive disease|1|||
143396776|NCT04171141|517002948|FG005|Overall Study|Progressive disease|8|||
143396777|NCT04171141|517002949|FG006|Overall Study|Progressive disease|4|||
143396778|NCT04171141|517002950|FG007|Overall Study|Progressive disease|6|||
143396779|NCT04171141|517002951|FG008|Overall Study|Progressive disease|7|||
143396780|NCT04171141|517002952|FG009|Overall Study|Progressive disease|3|||
143396781|NCT04171141|517002953|FG010|Overall Study|Progressive disease|4|||
143396782|NCT04171141|517002954|FG011|Overall Study|Progressive disease|3|||
143396783|NCT04171141|517002955|FG012|Overall Study|Progressive disease|4|||
143396784|NCT04171141|517002956|FG013|Overall Study|Progressive disease|2|||
143396785|NCT04171141|517002957|FG014|Overall Study|Progressive disease|4|||
143396786|NCT04171141|517002958|FG015|Overall Study|Progressive disease|1|||
143396787|NCT04171141|517002943|FG000|Overall Study|Withdrawal by Subject|0|||
143396788|NCT04171141|517002944|FG001|Overall Study|Withdrawal by Subject|0|||
143396789|NCT04171141|517002945|FG002|Overall Study|Withdrawal by Subject|0|||
143396790|NCT04171141|517002946|FG003|Overall Study|Withdrawal by Subject|1|||
143396791|NCT04171141|517002947|FG004|Overall Study|Withdrawal by Subject|0|||
143396792|NCT04171141|517002948|FG005|Overall Study|Withdrawal by Subject|0|||
143396793|NCT04171141|517002949|FG006|Overall Study|Withdrawal by Subject|1|||
143396794|NCT04171141|517002950|FG007|Overall Study|Withdrawal by Subject|0|||
143396795|NCT04171141|517002951|FG008|Overall Study|Withdrawal by Subject|0|||
143396796|NCT04171141|517002952|FG009|Overall Study|Withdrawal by Subject|1|||
143396797|NCT04171141|517002953|FG010|Overall Study|Withdrawal by Subject|0|||
143396798|NCT04171141|517002954|FG011|Overall Study|Withdrawal by Subject|0|||
143396799|NCT04171141|517002955|FG012|Overall Study|Withdrawal by Subject|0|||
143396800|NCT04171141|517002956|FG013|Overall Study|Withdrawal by Subject|0|||
143396801|NCT04171141|517002957|FG014|Overall Study|Withdrawal by Subject|0|||
143396802|NCT04171141|517002958|FG015|Overall Study|Withdrawal by Subject|0|||
143396803|NCT04171141|517002943|FG000|Overall Study|Global deterioration of health status|0|||
143396804|NCT04171141|517002944|FG001|Overall Study|Global deterioration of health status|0|||
143396805|NCT04171141|517002945|FG002|Overall Study|Global deterioration of health status|0|||
143396806|NCT04171141|517002946|FG003|Overall Study|Global deterioration of health status|1|||
143396807|NCT04171141|517002947|FG004|Overall Study|Global deterioration of health status|0|||
143396808|NCT04171141|517002948|FG005|Overall Study|Global deterioration of health status|2|||
143396809|NCT04171141|517002949|FG006|Overall Study|Global deterioration of health status|1|||
143396810|NCT04171141|517002950|FG007|Overall Study|Global deterioration of health status|0|||
143342530|NCT03324880|516798761|FG000|Overall Study|Withdrawal by Subject|2|||
143342531|NCT03324880|516798762|FG001|Overall Study|Withdrawal by Subject|2|||
143342532|NCT03324880|516798761|FG000|Overall Study|Lost to Follow-up|0|||
143342533|NCT03324880|516798762|FG001|Overall Study|Lost to Follow-up|1|||
143342534|NCT03324880|516798761|FG000|Overall Study|Product Recall|0|||
143342535|NCT03324880|516798762|FG001|Overall Study|Product Recall|1|||
143342536|NCT01547299|516798763|FG000|Overall Study|Withdrawal by Subject|2|||
143342537|NCT01547299|516798764|FG001|Overall Study|Withdrawal by Subject|2|||
143342538|NCT03692052|516798765|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
143342539|NCT03692052|516798765|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
143342540|NCT03692052|516798765|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
143396811|NCT04171141|517002951|FG008|Overall Study|Global deterioration of health status|1|||
143342541|NCT03692052|516798765|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
143342542|NCT00633464|516798770|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
143396812|NCT04171141|517002952|FG009|Overall Study|Global deterioration of health status|0|||
143396813|NCT04171141|517002953|FG010|Overall Study|Global deterioration of health status|0|||
143396814|NCT04171141|517002954|FG011|Overall Study|Global deterioration of health status|0|||
143396815|NCT04171141|517002955|FG012|Overall Study|Global deterioration of health status|0|||
143396816|NCT04171141|517002956|FG013|Overall Study|Global deterioration of health status|0|||
143396817|NCT04171141|517002957|FG014|Overall Study|Global deterioration of health status|1|||
143396818|NCT04171141|517002958|FG015|Overall Study|Global deterioration of health status|1|||
143396819|NCT04858451|517002963|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
143396820|NCT04858451|517002964|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
143396821|NCT04858451|517002965|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
143396822|NCT04858451|517002966|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
143396823|NCT04858451|517002967|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
143396824|NCT04858451|517002968|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
143396825|NCT04858451|517002969|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
143396826|NCT04858451|517002970|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
143396827|NCT04858451|517002971|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
143396828|NCT04858451|517002963|FG000|Part 2|Discontinued|0|||
143396829|NCT04858451|517002964|FG001|Part 2|Discontinued|0|||
143396830|NCT04858451|517002965|FG002|Part 2|Discontinued|0|||
143396831|NCT04858451|517002966|FG003|Part 2|Discontinued|0|||
143396832|NCT04858451|517002967|FG004|Part 2|Discontinued|0|||
143396833|NCT04858451|517002968|FG005|Part 2|Discontinued|0|||
143396834|NCT04858451|517002969|FG006|Part 2|Discontinued|0|||
143396835|NCT04858451|517002970|FG007|Part 2|Discontinued|0|||
143396836|NCT04858451|517002971|FG008|Part 2|Discontinued|63|||
143396837|NCT03314454|517002972|FG000|Overall Study|Protocol Violation|1|||
143396838|NCT04119843|517002973|FG000|Overall Study|Adverse Event|3|||
143396839|NCT04119843|517002973|FG000|Overall Study|Death|1|||
143396840|NCT04233216|517002975|FG000|Overall Study|Lost to Follow-up|1|||
143396841|NCT04233216|517002976|FG001|Overall Study|Lost to Follow-up|0|||
143396842|NCT04233216|517002977|FG002|Overall Study|Lost to Follow-up|2|||
143396843|NCT04233216|517002978|FG003|Overall Study|Lost to Follow-up|0|||
143396844|NCT04233216|517002975|FG000|Overall Study|Physician Decision|0|||
143396845|NCT04233216|517002976|FG001|Overall Study|Physician Decision|3|||
143396846|NCT04233216|517002977|FG002|Overall Study|Physician Decision|0|||
143396847|NCT04233216|517002978|FG003|Overall Study|Physician Decision|2|||
143396848|NCT04233216|517002975|FG000|Overall Study|Withdrawal by Subject|0|||
143396849|NCT04233216|517002976|FG001|Overall Study|Withdrawal by Subject|2|||
143396850|NCT04233216|517002977|FG002|Overall Study|Withdrawal by Subject|1|||
143396851|NCT04233216|517002978|FG003|Overall Study|Withdrawal by Subject|0|||
143396852|NCT03663569|517002979|FG000|Overall Study|Discontinuation of study|11|||
143396853|NCT03663569|517002979|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
143396854|NCT03663569|517002979|FG000|Overall Study|Deceased patient|6|||
143396855|NCT03663569|517002979|FG000|Overall Study|Lost to Follow-up|18|||
143396856|NCT03663569|517002979|FG000|Overall Study|Withdrawal of consent|5|||
143396857|NCT03663569|517002979|FG000|Overall Study|Patient's request|11|||
143396858|NCT03663569|517002979|FG000|Overall Study|Adverse Event|4|||
143396859|NCT03663569|517002979|FG000|Overall Study|Not come to second visit|3|||
143396860|NCT03663569|517002979|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
143396861|NCT03663569|517002979|FG000|Overall Study|Serious adverse event|1|||
143396862|NCT04231149|517002980|FG000|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
143396863|NCT04231149|517002981|FG001|Washout (Minimum 5 Days)|Withdrawal by Subject|1|||
143396864|NCT04231149|517002982|FG002|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
143396865|NCT04231149|517002983|FG003|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
143396866|NCT04231149|517002984|FG004|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
143396867|NCT04979442|517002985|FG000|Overall Study|Death|43|||
143396868|NCT04979442|517002986|FG001|Overall Study|Death|30|||
143396869|NCT04979442|517002985|FG000|Overall Study|Withdrawal by Subject|8|||
143396870|NCT04979442|517002986|FG001|Overall Study|Withdrawal by Subject|13|||
143396871|NCT04979442|517002985|FG000|Overall Study|Physician Decision|1|||
143396872|NCT04979442|517002986|FG001|Overall Study|Physician Decision|1|||
143396873|NCT04979442|517002985|FG000|Overall Study|Lost to Follow-up|0|||
143396874|NCT04979442|517002986|FG001|Overall Study|Lost to Follow-up|2|||
143396875|NCT04979442|517002985|FG000|Overall Study|do not want to continue|0|||
143396876|NCT04979442|517002986|FG001|Overall Study|do not want to continue|1|||
143396877|NCT04298983|517002991|FG000|Overall Study|Adverse Event|4|||
143396878|NCT04298983|517002991|FG000|Overall Study|Lack of Efficacy|3|||
143396879|NCT04005794|517002992|FG000|Overall Study|Lost to Follow-up|0|||
143396880|NCT04005794|517002993|FG001|Overall Study|Lost to Follow-up|4|||
143396881|NCT04005794|517002994|FG002|Overall Study|Lost to Follow-up|0|||
143396882|NCT05877976|517002995|FG000|Overall Study|Lost to Follow-up|31|||
143396883|NCT03656510|517003006|FG000|Overall Study|Lost to Follow-up|1|||
143396884|NCT03656510|517003007|FG001|Overall Study|Lost to Follow-up|0|||
143396885|NCT03656510|517003008|FG002|Overall Study|Lost to Follow-up|0|||
143396886|NCT03656510|517003009|FG003|Overall Study|Lost to Follow-up|0|||
143396887|NCT03656510|517003010|FG004|Overall Study|Lost to Follow-up|0|||
143396888|NCT03656510|517003011|FG005|Overall Study|Lost to Follow-up|0|||
143396889|NCT03656510|517003006|FG000|Overall Study|Withdrawal by Subject|1|||
143396890|NCT03656510|517003007|FG001|Overall Study|Withdrawal by Subject|1|||
143396891|NCT03656510|517003008|FG002|Overall Study|Withdrawal by Subject|0|||
143396892|NCT03656510|517003009|FG003|Overall Study|Withdrawal by Subject|1|||
143396893|NCT03656510|517003010|FG004|Overall Study|Withdrawal by Subject|0|||
143396894|NCT03656510|517003011|FG005|Overall Study|Withdrawal by Subject|0|||
143396895|NCT05029622|517003014|FG000|Overall Study|Lost to Follow-up|1|||
143396896|NCT03899259|517003021|FG000|Overall Study|Adverse Event|5|||
143342543|NCT00633464|516798771|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
143342544|NCT00633464|516798770|FG000|Overall Study|Never Treated (Randomized in error)|0|||
143342545|NCT00633464|516798771|FG001|Overall Study|Never Treated (Randomized in error)|1|||
143342546|NCT04241094|516798772|FG000|Overall Study|Dropped out of treatment|4|||
143342547|NCT04241094|516798772|FG000|Overall Study|Ineligible after clinical assessment|2|||
143342548|NCT04241094|516798772|FG000|Overall Study|Lost to Follow-up|2|||
143342549|NCT02612064|516798773|FG000|Overall Study|Withdrawal by Subject|1|||
143342550|NCT02612064|516798774|FG001|Overall Study|Withdrawal by Subject|1|||
143342551|NCT02612064|516798773|FG000|Overall Study|Other|0|||
143342552|NCT02612064|516798774|FG001|Overall Study|Other|2|||
143342553|NCT05918978|516798777|FG000|Overall Study|Study Terminated by Sponsor|17|||
143342554|NCT05918978|516798778|FG001|Overall Study|Study Terminated by Sponsor|11|||
143342555|NCT05918978|516798777|FG000|Overall Study|Withdrawal by Subject|1|||
143342556|NCT05918978|516798778|FG001|Overall Study|Withdrawal by Subject|1|||
143342557|NCT05918978|516798777|FG000|Overall Study|Adverse Event|1|||
143342558|NCT05918978|516798778|FG001|Overall Study|Adverse Event|0|||
143342559|NCT05918978|516798777|FG000|Overall Study|Other|0|||
143342560|NCT05918978|516798778|FG001|Overall Study|Other|1|||
143342561|NCT04739761|516798779|FG000|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|167|||
143342562|NCT04739761|516798780|FG001|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|189|||
143342563|NCT04739761|516798779|FG000|Overall Study|By complete response from the participant|1|||
143342564|NCT04739761|516798780|FG001|Overall Study|By complete response from the participant|0|||
143342565|NCT04739761|516798779|FG000|Overall Study|Lost to Follow-up|3|||
143342566|NCT04739761|516798780|FG001|Overall Study|Lost to Follow-up|3|||
143342567|NCT04739761|516798779|FG000|Overall Study|Death|13|||
143342568|NCT04739761|516798780|FG001|Overall Study|Death|13|||
143342569|NCT04739761|516798779|FG000|Overall Study|Participant reports worsening of the general critical condition and will not continue|0|||
143342570|NCT04739761|516798780|FG001|Overall Study|Participant reports worsening of the general critical condition and will not continue|1|||
143342571|NCT04739761|516798779|FG000|Overall Study|Participant is in poor health and will not come to the study site|0|||
143342572|NCT04739761|516798780|FG001|Overall Study|Participant is in poor health and will not come to the study site|1|||
143342573|NCT04739761|516798779|FG000|Overall Study|Progression confirmed in magnetic resonance imaging|0|||
143342574|NCT04739761|516798780|FG001|Overall Study|Progression confirmed in magnetic resonance imaging|1|||
143342575|NCT04739761|516798779|FG000|Overall Study|Adverse Event|0|||
143342576|NCT04739761|516798780|FG001|Overall Study|Adverse Event|3|||
143342577|NCT04739761|516798779|FG000|Overall Study|Participant decision|1|||
143342578|NCT04739761|516798780|FG001|Overall Study|Participant decision|0|||
143342579|NCT04739761|516798779|FG000|Overall Study|Sub investigator decision approved by medical monitor|1|||
143342580|NCT04739761|516798780|FG001|Overall Study|Sub investigator decision approved by medical monitor|0|||
143342581|NCT04739761|516798779|FG000|Overall Study|Participant immediately started next line of treatment|1|||
143342582|NCT04739761|516798780|FG001|Overall Study|Participant immediately started next line of treatment|0|||
143342583|NCT04739761|516798779|FG000|Overall Study|Participant's decision because the treatment makes them anxious|1|||
143342584|NCT04739761|516798780|FG001|Overall Study|Participant's decision because the treatment makes them anxious|0|||
143342585|NCT04739761|516798779|FG000|Overall Study|Lack of clinical benefit|1|||
143342586|NCT04739761|516798780|FG001|Overall Study|Lack of clinical benefit|0|||
143342587|NCT04739761|516798779|FG000|Overall Study|Disease progression|5|||
143342588|NCT04739761|516798780|FG001|Overall Study|Disease progression|5|||
143342589|NCT04739761|516798779|FG000|Overall Study|Withdrawal by Subject|14|||
143342590|NCT04739761|516798780|FG001|Overall Study|Withdrawal by Subject|13|||
143342591|NCT04739761|516798779|FG000|Overall Study|Protocol Violation|1|||
143342592|NCT04739761|516798780|FG001|Overall Study|Protocol Violation|0|||
143342593|NCT04739761|516798779|FG000|Overall Study|Physician Decision|2|||
143342594|NCT04739761|516798780|FG001|Overall Study|Physician Decision|0|||
143342595|NCT01061333|516798781|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
143342596|NCT01061333|516798782|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
143342597|NCT01108458|516800715|FG000|Overall Study|Withdrawal by Subject|1|||
143342598|NCT05044325|516800723|FG000|Part A:Treatment Period 1|Adverse Event|0|||
143342599|NCT05044325|516800724|FG001|Part A:Treatment Period 1|Adverse Event|0|||
143342600|NCT05044325|516800725|FG002|Part A:Treatment Period 1|Adverse Event|0|||
143342601|NCT05044325|516800726|FG003|Part A:Treatment Period 1|Adverse Event|0|||
143342602|NCT05044325|516800727|FG004|Part A:Treatment Period 1|Adverse Event|0|||
143342603|NCT05044325|516800728|FG005|Part A:Treatment Period 1|Adverse Event|1|||
143342604|NCT05044325|516800729|FG006|Part A:Treatment Period 1|Adverse Event|0|||
143342605|NCT05044325|516800730|FG007|Part A:Treatment Period 1|Adverse Event|1|||
143342606|NCT05044325|516800731|FG008|Part A:Treatment Period 1|Adverse Event|0|||
143342607|NCT05044325|516800732|FG009|Part A:Treatment Period 1|Adverse Event|0|||
143342608|NCT05044325|516800723|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
143342609|NCT05044325|516800724|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
143342610|NCT05044325|516800725|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
143342611|NCT05044325|516800726|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
143342612|NCT05044325|516800727|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
143342613|NCT05044325|516800728|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
143342614|NCT05044325|516800729|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
143342615|NCT05044325|516800730|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
143342616|NCT05044325|516800731|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
143342617|NCT05044325|516800732|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
143342618|NCT05044325|516800723|FG000|Part A:Treatment Period 1|Physician Decision|0|||
143342619|NCT05044325|516800724|FG001|Part A:Treatment Period 1|Physician Decision|0|||
143342620|NCT05044325|516800725|FG002|Part A:Treatment Period 1|Physician Decision|0|||
143342621|NCT05044325|516800726|FG003|Part A:Treatment Period 1|Physician Decision|0|||
143342622|NCT05044325|516800727|FG004|Part A:Treatment Period 1|Physician Decision|0|||
143342623|NCT05044325|516800728|FG005|Part A:Treatment Period 1|Physician Decision|0|||
143342624|NCT05044325|516800729|FG006|Part A:Treatment Period 1|Physician Decision|1|||
143342625|NCT05044325|516800730|FG007|Part A:Treatment Period 1|Physician Decision|0|||
143342626|NCT05044325|516800731|FG008|Part A:Treatment Period 1|Physician Decision|0|||
143342627|NCT05044325|516800732|FG009|Part A:Treatment Period 1|Physician Decision|0|||
143342628|NCT05044325|516800723|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
143342629|NCT05044325|516800724|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
143342630|NCT05044325|516800725|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
143342631|NCT05044325|516800726|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
143342632|NCT05044325|516800727|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
143342633|NCT05044325|516800728|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
143342634|NCT05044325|516800729|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
143342635|NCT05044325|516800730|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
143342636|NCT05044325|516800731|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
143342637|NCT05044325|516800732|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
143342638|NCT05044325|516800723|FG000|Part A:Treatment Period 2|Adverse Event|0|||
143342639|NCT05044325|516800724|FG001|Part A:Treatment Period 2|Adverse Event|1|||
143342640|NCT05044325|516800725|FG002|Part A:Treatment Period 2|Adverse Event|0|||
143342641|NCT05044325|516800726|FG003|Part A:Treatment Period 2|Adverse Event|0|||
143342642|NCT05044325|516800727|FG004|Part A:Treatment Period 2|Adverse Event|1|||
143342643|NCT05044325|516800728|FG005|Part A:Treatment Period 2|Adverse Event|1|||
143342644|NCT05044325|516800729|FG006|Part A:Treatment Period 2|Adverse Event|0|||
143342645|NCT05044325|516800730|FG007|Part A:Treatment Period 2|Adverse Event|0|||
143342646|NCT05044325|516800731|FG008|Part A:Treatment Period 2|Adverse Event|0|||
143342647|NCT05044325|516800732|FG009|Part A:Treatment Period 2|Adverse Event|0|||
143342648|NCT05044325|516800723|FG000|Part A:Treatment Period 2|Physician Decision|0|||
143342649|NCT05044325|516800724|FG001|Part A:Treatment Period 2|Physician Decision|0|||
143342650|NCT05044325|516800725|FG002|Part A:Treatment Period 2|Physician Decision|0|||
143342651|NCT05044325|516800726|FG003|Part A:Treatment Period 2|Physician Decision|0|||
143342652|NCT05044325|516800727|FG004|Part A:Treatment Period 2|Physician Decision|0|||
143342653|NCT05044325|516800728|FG005|Part A:Treatment Period 2|Physician Decision|1|||
143342654|NCT05044325|516800729|FG006|Part A:Treatment Period 2|Physician Decision|0|||
143342655|NCT05044325|516800730|FG007|Part A:Treatment Period 2|Physician Decision|0|||
143342656|NCT05044325|516800731|FG008|Part A:Treatment Period 2|Physician Decision|0|||
143342657|NCT05044325|516800732|FG009|Part A:Treatment Period 2|Physician Decision|0|||
143342658|NCT05044325|516800723|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
143342659|NCT05044325|516800724|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
143342660|NCT05044325|516800725|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
143342661|NCT05044325|516800726|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
143342662|NCT05044325|516800727|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
143342663|NCT05044325|516800728|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
143342664|NCT05044325|516800729|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
143342665|NCT05044325|516800730|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
143342666|NCT05044325|516800731|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
143342667|NCT05044325|516800732|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
143342668|NCT00755222|516800733|FG000|Overall Study|Withdrawal by Subject|4|||
143342669|NCT00755222|516800734|FG001|Overall Study|Withdrawal by Subject|2|||
143342670|NCT00755222|516800733|FG000|Overall Study|Adverse Event|2|||
143342671|NCT00755222|516800734|FG001|Overall Study|Adverse Event|0|||
143342672|NCT00755222|516800733|FG000|Overall Study|Protocol Violation|2|||
143342673|NCT00755222|516800734|FG001|Overall Study|Protocol Violation|0|||
143342674|NCT02243202|516800735|FG000|Overall Study|Adverse Event|5|||
143342675|NCT02243202|516800736|FG001|Overall Study|Adverse Event|6|||
143342676|NCT02243202|516800737|FG002|Overall Study|Adverse Event|10|||
143342677|NCT02243202|516800738|FG003|Overall Study|Adverse Event|4|||
143342678|NCT02243202|516800735|FG000|Overall Study|Lost to Follow-up|9|||
143342679|NCT02243202|516800736|FG001|Overall Study|Lost to Follow-up|9|||
143342680|NCT02243202|516800737|FG002|Overall Study|Lost to Follow-up|14|||
143342681|NCT02243202|516800738|FG003|Overall Study|Lost to Follow-up|11|||
143342682|NCT02243202|516800735|FG000|Overall Study|Protocol Violation|3|||
143342683|NCT02243202|516800736|FG001|Overall Study|Protocol Violation|1|||
143342684|NCT02243202|516800737|FG002|Overall Study|Protocol Violation|2|||
143342685|NCT02243202|516800738|FG003|Overall Study|Protocol Violation|1|||
143342686|NCT02243202|516800735|FG000|Overall Study|Withdrawal by Subject|7|||
143342687|NCT02243202|516800736|FG001|Overall Study|Withdrawal by Subject|6|||
143342688|NCT02243202|516800737|FG002|Overall Study|Withdrawal by Subject|4|||
143342689|NCT02243202|516800738|FG003|Overall Study|Withdrawal by Subject|4|||
143342690|NCT02243202|516800735|FG000|Overall Study|Other|1|||
143342691|NCT02243202|516800736|FG001|Overall Study|Other|3|||
143342692|NCT02243202|516800737|FG002|Overall Study|Other|1|||
143342693|NCT02243202|516800738|FG003|Overall Study|Other|2|||
143342694|NCT02243202|516800735|FG000|Overall Study|Randomized but not received treatment|0|||
143342695|NCT02243202|516800736|FG001|Overall Study|Randomized but not received treatment|0|||
143342696|NCT02243202|516800737|FG002|Overall Study|Randomized but not received treatment|0|||
143342697|NCT02243202|516800738|FG003|Overall Study|Randomized but not received treatment|1|||
143342698|NCT04382924|516800739|FG000|Overall Study|Death|2|||
143342699|NCT04382924|516800740|FG001|Overall Study|Death|5|||
143342700|NCT04382924|516800741|FG002|Overall Study|Death|4|||
143342701|NCT04382924|516800739|FG000|Overall Study|Protocol Violation|0|||
143342702|NCT04382924|516800740|FG001|Overall Study|Protocol Violation|1|||
143342703|NCT04382924|516800741|FG002|Overall Study|Protocol Violation|1|||
143342704|NCT04382924|516800739|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
143342705|NCT04382924|516800740|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
143342706|NCT04382924|516800741|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
143342707|NCT04382924|516800739|FG000|Overall Study|Withdrawal by Subject|6|||
143342708|NCT04382924|516800740|FG001|Overall Study|Withdrawal by Subject|3|||
143342709|NCT04382924|516800741|FG002|Overall Study|Withdrawal by Subject|6|||
143342710|NCT04207840|516800742|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
143342711|NCT04207840|516800743|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
143342712|NCT04207840|516800744|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
143342713|NCT04207840|516800742|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
143342714|NCT04207840|516800743|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
143342715|NCT04207840|516800744|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
143342716|NCT00991341|516800745|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
143342717|NCT00991341|516800746|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
143342718|NCT00991341|516800745|FG000|Overall Study|Death|3|||
143342719|NCT00991341|516800746|FG001|Overall Study|Death|0|||
143342720|NCT00991341|516800745|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
143342721|NCT00991341|516800746|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
143342722|NCT00991341|516800745|FG000|Overall Study|Physician Decision|1|||
143342723|NCT00991341|516800746|FG001|Overall Study|Physician Decision|2|||
143342724|NCT00991341|516800745|FG000|Overall Study|Withdrawal by Subject|3|||
143342725|NCT00991341|516800746|FG001|Overall Study|Withdrawal by Subject|4|||
143342726|NCT03010462|516800761|FG000|Overall Study|Withdrawal by Subject|3|||
143342727|NCT03010462|516800762|FG001|Overall Study|Withdrawal by Subject|1|||
143342728|NCT02799472|516800765|FG000|Overall Study|Withdrawal by Subject|2|||
143342729|NCT02799472|516800766|FG001|Overall Study|Withdrawal by Subject|4|||
143342730|NCT02799472|516800765|FG000|Overall Study|Lack of Efficacy|2|||
143342731|NCT02799472|516800766|FG001|Overall Study|Lack of Efficacy|0|||
143342732|NCT02799472|516800765|FG000|Overall Study|Lost to Follow-up|0|||
143342733|NCT02799472|516800766|FG001|Overall Study|Lost to Follow-up|1|||
143342734|NCT02287584|516800767|FG000|the Double-blind Phase|Adverse Event|17|||
143342735|NCT02287584|516800768|FG001|the Double-blind Phase|Adverse Event|17|||
143342736|NCT02287584|516800769|FG002|the Double-blind Phase|Adverse Event|12|||
143342737|NCT02287584|516800770|FG003|the Double-blind Phase|Adverse Event|0|||
143342738|NCT02287584|516800771|FG004|the Double-blind Phase|Adverse Event|0|||
143342739|NCT02287584|516800772|FG005|the Double-blind Phase|Adverse Event|0|||
143342740|NCT02287584|516800767|FG000|the Double-blind Phase|Lack of Efficacy|18|||
143342741|NCT02287584|516800768|FG001|the Double-blind Phase|Lack of Efficacy|8|||
143342742|NCT02287584|516800769|FG002|the Double-blind Phase|Lack of Efficacy|8|||
143342743|NCT02287584|516800770|FG003|the Double-blind Phase|Lack of Efficacy|0|||
143342744|NCT02287584|516800771|FG004|the Double-blind Phase|Lack of Efficacy|0|||
143342745|NCT02287584|516800772|FG005|the Double-blind Phase|Lack of Efficacy|0|||
143342746|NCT02287584|516800767|FG000|the Double-blind Phase|Lost to Follow-up|0|||
143342747|NCT02287584|516800768|FG001|the Double-blind Phase|Lost to Follow-up|1|||
143342748|NCT02287584|516800769|FG002|the Double-blind Phase|Lost to Follow-up|1|||
143342749|NCT02287584|516800770|FG003|the Double-blind Phase|Lost to Follow-up|0|||
143342750|NCT02287584|516800771|FG004|the Double-blind Phase|Lost to Follow-up|0|||
143342751|NCT02287584|516800772|FG005|the Double-blind Phase|Lost to Follow-up|0|||
143342752|NCT02287584|516800767|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
143342753|NCT02287584|516800768|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
143342754|NCT02287584|516800769|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
143342755|NCT02287584|516800770|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
143342756|NCT02287584|516800771|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
143342757|NCT02287584|516800772|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
143342758|NCT02287584|516800767|FG000|the Double-blind Phase|Pregnancy|0|||
143342759|NCT02287584|516800768|FG001|the Double-blind Phase|Pregnancy|1|||
143342760|NCT02287584|516800769|FG002|the Double-blind Phase|Pregnancy|0|||
143342761|NCT02287584|516800770|FG003|the Double-blind Phase|Pregnancy|0|||
143342762|NCT02287584|516800771|FG004|the Double-blind Phase|Pregnancy|0|||
143342763|NCT02287584|516800772|FG005|the Double-blind Phase|Pregnancy|0|||
143342764|NCT02287584|516800767|FG000|the Double-blind Phase|Protocol Violation|0|||
143342765|NCT02287584|516800768|FG001|the Double-blind Phase|Protocol Violation|3|||
143342766|NCT02287584|516800769|FG002|the Double-blind Phase|Protocol Violation|0|||
143342767|NCT02287584|516800770|FG003|the Double-blind Phase|Protocol Violation|0|||
143342768|NCT02287584|516800771|FG004|the Double-blind Phase|Protocol Violation|0|||
143342769|NCT02287584|516800772|FG005|the Double-blind Phase|Protocol Violation|0|||
143342770|NCT02287584|516800767|FG000|the Double-blind Phase|other reasons|0|||
143342771|NCT02287584|516800768|FG001|the Double-blind Phase|other reasons|0|||
143342772|NCT02287584|516800769|FG002|the Double-blind Phase|other reasons|1|||
143342773|NCT02287584|516800770|FG003|the Double-blind Phase|other reasons|0|||
143342774|NCT02287584|516800771|FG004|the Double-blind Phase|other reasons|0|||
143342775|NCT02287584|516800772|FG005|the Double-blind Phase|other reasons|0|||
143342776|NCT02287584|516800767|FG000|the Open-label Phase|Did not receive drug|0|||
143342777|NCT02287584|516800768|FG001|the Open-label Phase|Did not receive drug|0|||
143342778|NCT02287584|516800769|FG002|the Open-label Phase|Did not receive drug|0|||
143342779|NCT02287584|516800770|FG003|the Open-label Phase|Did not receive drug|7|||
143342780|NCT02287584|516800771|FG004|the Open-label Phase|Did not receive drug|6|||
143342781|NCT02287584|516800772|FG005|the Open-label Phase|Did not receive drug|4|||
143342782|NCT02287584|516800767|FG000|the Open-label Phase|Adverse Event|0|||
143342783|NCT02287584|516800768|FG001|the Open-label Phase|Adverse Event|0|||
143342784|NCT02287584|516800769|FG002|the Open-label Phase|Adverse Event|0|||
143342785|NCT02287584|516800770|FG003|the Open-label Phase|Adverse Event|15|||
143342786|NCT02287584|516800771|FG004|the Open-label Phase|Adverse Event|12|||
143342787|NCT02287584|516800772|FG005|the Open-label Phase|Adverse Event|16|||
143342788|NCT02287584|516800767|FG000|the Open-label Phase|Lack of Efficacy|0|||
143342789|NCT02287584|516800768|FG001|the Open-label Phase|Lack of Efficacy|0|||
143342790|NCT02287584|516800769|FG002|the Open-label Phase|Lack of Efficacy|0|||
143342791|NCT02287584|516800770|FG003|the Open-label Phase|Lack of Efficacy|8|||
143342792|NCT02287584|516800771|FG004|the Open-label Phase|Lack of Efficacy|3|||
143342793|NCT02287584|516800772|FG005|the Open-label Phase|Lack of Efficacy|7|||
143342794|NCT02287584|516800767|FG000|the Open-label Phase|Lost to Follow-up|0|||
143342795|NCT02287584|516800768|FG001|the Open-label Phase|Lost to Follow-up|0|||
143342796|NCT02287584|516800769|FG002|the Open-label Phase|Lost to Follow-up|0|||
143342797|NCT02287584|516800770|FG003|the Open-label Phase|Lost to Follow-up|4|||
143342798|NCT02287584|516800771|FG004|the Open-label Phase|Lost to Follow-up|1|||
143342799|NCT02287584|516800772|FG005|the Open-label Phase|Lost to Follow-up|2|||
143342800|NCT02287584|516800767|FG000|the Open-label Phase|Withdrawal by Subject|0|||
143342801|NCT02287584|516800768|FG001|the Open-label Phase|Withdrawal by Subject|0|||
143342802|NCT02287584|516800769|FG002|the Open-label Phase|Withdrawal by Subject|0|||
143342803|NCT02287584|516800770|FG003|the Open-label Phase|Withdrawal by Subject|18|||
143342804|NCT02287584|516800771|FG004|the Open-label Phase|Withdrawal by Subject|29|||
143342805|NCT02287584|516800772|FG005|the Open-label Phase|Withdrawal by Subject|21|||
143342806|NCT02287584|516800767|FG000|the Open-label Phase|non-compliance|0|||
143342807|NCT02287584|516800768|FG001|the Open-label Phase|non-compliance|0|||
143342808|NCT02287584|516800769|FG002|the Open-label Phase|non-compliance|0|||
143342809|NCT02287584|516800770|FG003|the Open-label Phase|non-compliance|2|||
143342810|NCT02287584|516800771|FG004|the Open-label Phase|non-compliance|5|||
143342811|NCT02287584|516800772|FG005|the Open-label Phase|non-compliance|1|||
143342812|NCT02287584|516800767|FG000|the Open-label Phase|other reasons|0|||
143342813|NCT02287584|516800768|FG001|the Open-label Phase|other reasons|0|||
143342814|NCT02287584|516800769|FG002|the Open-label Phase|other reasons|0|||
143342815|NCT02287584|516800770|FG003|the Open-label Phase|other reasons|3|||
143342816|NCT02287584|516800771|FG004|the Open-label Phase|other reasons|6|||
143342817|NCT02287584|516800772|FG005|the Open-label Phase|other reasons|6|||
143342818|NCT01492686|516800775|FG000|Double-blind Phase|Adverse Event|0|||
143342819|NCT01492686|516800776|FG001|Double-blind Phase|Adverse Event|2|||
143342820|NCT01492686|516800775|FG000|Double-blind Phase|Physician Decision|0|||
143342821|NCT01492686|516800776|FG001|Double-blind Phase|Physician Decision|1|||
143342822|NCT01492686|516800775|FG000|Double-blind Phase|Withdrawal by Subject|0|||
143342823|NCT01492686|516800776|FG001|Double-blind Phase|Withdrawal by Subject|2|||
143342824|NCT01492686|516800775|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
143342825|NCT01492686|516800776|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
143342826|NCT01492686|516800775|FG000|Open-label Phase|Adverse Event|1|||
143342827|NCT01492686|516800776|FG001|Open-label Phase|Adverse Event|2|||
143342828|NCT01492686|516800775|FG000|Open-label Phase|Physician Decision|1|||
143342829|NCT01492686|516800776|FG001|Open-label Phase|Physician Decision|0|||
143342830|NCT01492686|516800775|FG000|Open-label Phase|Withdrawal by Subject|6|||
143342831|NCT01492686|516800776|FG001|Open-label Phase|Withdrawal by Subject|7|||
143342832|NCT01492686|516800775|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
143342833|NCT01492686|516800776|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
143342834|NCT03430063|516800784|FG000|Overall Study|Adverse Event|0|||
143342835|NCT03430063|516800785|FG001|Overall Study|Adverse Event|1|||
143342836|NCT03430063|516800786|FG002|Overall Study|Adverse Event|0|||
143342837|NCT03430063|516800784|FG000|Overall Study|Death|3|||
143342838|NCT03430063|516800785|FG001|Overall Study|Death|2|||
143342839|NCT03430063|516800786|FG002|Overall Study|Death|3|||
143342840|NCT03430063|516800784|FG000|Overall Study|Lost to Follow-up|0|||
143342841|NCT03430063|516800785|FG001|Overall Study|Lost to Follow-up|1|||
143342842|NCT03430063|516800786|FG002|Overall Study|Lost to Follow-up|0|||
143342843|NCT03430063|516800784|FG000|Overall Study|Withdrawal by Subject|0|||
143342844|NCT03430063|516800785|FG001|Overall Study|Withdrawal by Subject|0|||
143342845|NCT03430063|516800786|FG002|Overall Study|Withdrawal by Subject|1|||
143342846|NCT03430063|516800784|FG000|Overall Study|Withdrawal of consent|3|||
143342847|NCT03430063|516800785|FG001|Overall Study|Withdrawal of consent|1|||
143342848|NCT03430063|516800786|FG002|Overall Study|Withdrawal of consent|2|||
143342849|NCT03430063|516800784|FG000|Overall Study|Progressive disease|1|||
143342850|NCT03430063|516800785|FG001|Overall Study|Progressive disease|2|||
143342851|NCT03430063|516800786|FG002|Overall Study|Progressive disease|1|||
143342852|NCT03430063|516800784|FG000|Overall Study|Other un-specified|1|||
143342853|NCT03430063|516800785|FG001|Overall Study|Other un-specified|1|||
143342854|NCT03430063|516800786|FG002|Overall Study|Other un-specified|0|||
143342855|NCT03430063|516800784|FG000|Overall Study|Randomized, but never treated|0|||
143342856|NCT03430063|516800785|FG001|Overall Study|Randomized, but never treated|0|||
143342857|NCT03430063|516800786|FG002|Overall Study|Randomized, but never treated|1|||
143342858|NCT03124199|516800787|FG000|Overall Study|Lost to Follow-up|4|||
143342859|NCT02396537|516800788|FG000|Overall Study|Protocol Violation|0|||
143342860|NCT02396537|516800789|FG001|Overall Study|Protocol Violation|1|||
143342861|NCT01982435|516800790|FG000|Overall Study|Adverse Event|1|||
143342862|NCT01982435|516800791|FG001|Overall Study|Adverse Event|0|||
143342863|NCT00871403|516800792|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
143342864|NCT00871403|516800793|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
143342865|NCT00871403|516800794|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
143342866|NCT00871403|516800792|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
143342867|NCT00871403|516800793|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
143342868|NCT00871403|516800794|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
143342869|NCT00871403|516800792|FG000|Combination Treatment Phase|Adverse Event|0|||
143342870|NCT00871403|516800793|FG001|Combination Treatment Phase|Adverse Event|17|||
143342871|NCT00871403|516800794|FG002|Combination Treatment Phase|Adverse Event|2|||
143342872|NCT00871403|516800792|FG000|Combination Treatment Phase|Disease Progression|0|||
143342873|NCT00871403|516800793|FG001|Combination Treatment Phase|Disease Progression|8|||
143342874|NCT00871403|516800794|FG002|Combination Treatment Phase|Disease Progression|5|||
143342875|NCT00871403|516800792|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
143342876|NCT00871403|516800793|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
143342877|NCT00871403|516800794|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
143342878|NCT00871403|516800792|FG000|Combination Treatment Phase|Physician Decision|0|||
143342879|NCT00871403|516800793|FG001|Combination Treatment Phase|Physician Decision|1|||
143342880|NCT00871403|516800794|FG002|Combination Treatment Phase|Physician Decision|3|||
143342881|NCT00871403|516800792|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
143342882|NCT00871403|516800793|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
143342883|NCT00871403|516800794|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
143342884|NCT00871403|516800792|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
143342885|NCT00871403|516800793|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
143342886|NCT00871403|516800794|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
143342887|NCT03075904|516800795|FG000|Overall Study|Physician Decision|3|||
143342888|NCT03075904|516800795|FG000|Overall Study|Need for Medication not Permitted|1|||
143342889|NCT03954743|516800796|FG000|Overall Study|Adverse Event|1|||
143342890|NCT03954743|516800797|FG001|Overall Study|Adverse Event|0|||
143342891|NCT03954743|516800796|FG000|Overall Study|Lost to Follow-up|6|||
143342892|NCT03954743|516800797|FG001|Overall Study|Lost to Follow-up|4|||
143342893|NCT03954743|516800796|FG000|Overall Study|Protocol Violation|1|||
143342894|NCT03954743|516800797|FG001|Overall Study|Protocol Violation|0|||
143342895|NCT03954743|516800796|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
143342896|NCT03954743|516800797|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
143342897|NCT03954743|516800796|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
143342898|NCT03954743|516800797|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
143342899|NCT02387996|516800812|FG000|Overall Study|Disease Progression|167|||
143342900|NCT02387996|516800812|FG000|Overall Study|Study Drug Toxicity|31|||
143342901|NCT02387996|516800812|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
143342902|NCT02387996|516800812|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
143342903|NCT02387996|516800812|FG000|Overall Study|Subject Withdrew Consent|5|||
143342904|NCT02387996|516800812|FG000|Overall Study|Lost to Follow-up|1|||
143342905|NCT02387996|516800812|FG000|Overall Study|Poor/Non-Compliance|1|||
143342906|NCT02387996|516800812|FG000|Overall Study|Other Reasons|5|||
143342907|NCT02387996|516800812|FG000|Overall Study|Death|1|||
143342908|NCT01446796|516800813|FG000|Overall Study|Withdrawal by Subject|1|||
143342909|NCT01446796|516800814|FG001|Overall Study|Withdrawal by Subject|0|||
143342910|NCT01781390|516800816|FG000|Overall Study|Withdrawal of Consent|0|||
143342911|NCT01781390|516800817|FG001|Overall Study|Withdrawal of Consent|3|||
143342912|NCT01781390|516800818|FG002|Overall Study|Withdrawal of Consent|1|||
143342913|NCT01781390|516800816|FG000|Overall Study|Lost to Follow-up|1|||
143342914|NCT01781390|516800817|FG001|Overall Study|Lost to Follow-up|1|||
143342915|NCT01781390|516800818|FG002|Overall Study|Lost to Follow-up|1|||
143342916|NCT01781390|516800816|FG000|Overall Study|Adverse Event|1|||
143342917|NCT01781390|516800817|FG001|Overall Study|Adverse Event|2|||
143342918|NCT01781390|516800818|FG002|Overall Study|Adverse Event|1|||
143342919|NCT01781390|516800816|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
143342920|NCT01781390|516800817|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
143342921|NCT01781390|516800818|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
143342922|NCT03131960|516800819|FG000|Overall Study|Adverse Event|0|||
143342923|NCT03131960|516800820|FG001|Overall Study|Adverse Event|1|||
143342924|NCT04707196|516800821|FG000|Overall Study|Withdrawal by Subject|9|||
143342925|NCT04707196|516800822|FG001|Overall Study|Withdrawal by Subject|6|||
143342926|NCT04707196|516800821|FG000|Overall Study|Lost to Follow-up|1|||
143342927|NCT04707196|516800822|FG001|Overall Study|Lost to Follow-up|0|||
143342928|NCT04707196|516800821|FG000|Overall Study|Protocol Violation|4|||
143342929|NCT04707196|516800822|FG001|Overall Study|Protocol Violation|1|||
143342930|NCT04707196|516800821|FG000|Overall Study|Adverse Event|2|||
143342931|NCT04707196|516800822|FG001|Overall Study|Adverse Event|2|||
143342932|NCT04707196|516800821|FG000|Overall Study|Death|3|||
143342933|NCT04707196|516800822|FG001|Overall Study|Death|1|||
143342934|NCT04707196|516800821|FG000|Overall Study|Non-compliance with study drug|1|||
143342935|NCT04707196|516800822|FG001|Overall Study|Non-compliance with study drug|0|||
143342936|NCT04707196|516800821|FG000|Overall Study|Progressive disease|9|||
143342937|NCT04707196|516800822|FG001|Overall Study|Progressive disease|10|||
143342938|NCT00622713|516800823|FG000|Overall Study|Adverse Event|35|||
143342939|NCT00622713|516800823|FG000|Overall Study|Administrative problems|4|||
143342940|NCT00622713|516800823|FG000|Overall Study|Withdrawal by Subject|11|||
143342941|NCT00622713|516800823|FG000|Overall Study|Lost to Follow-up|5|||
143342942|NCT00622713|516800823|FG000|Overall Study|Death|2|||
143342943|NCT00622713|516800823|FG000|Overall Study|Subject no longer required study drug|1|||
143342944|NCT00622713|516800823|FG000|Overall Study|Did not meet eligibility criteria|1|||
143342945|NCT01462162|516800827|FG000|Overall Study|Adverse Event|5|||
143342946|NCT01462162|516800827|FG000|Overall Study|Lack of Efficacy|4|||
143342947|NCT01462162|516800827|FG000|Overall Study|Abnormal laboratory parameters|1|||
143342948|NCT01462162|516800827|FG000|Overall Study|Other|2|||
143342949|NCT04404478|516800828|FG000|Overall Study|Withdrawal by Subject|1|||
143342950|NCT04404478|516800829|FG001|Overall Study|Withdrawal by Subject|3|||
143342951|NCT03485911|516800830|FG000|Part 1|Perceived lack of efficacy|1|||
143342952|NCT03485911|516800831|FG001|Part 1|Perceived lack of efficacy|1|||
143342953|NCT03485911|516800832|FG002|Part 1|Perceived lack of efficacy|2|||
143342954|NCT03485911|516800833|FG003|Part 1|Perceived lack of efficacy|0|||
143342955|NCT03485911|516800830|FG000|Part 1|Subject withdrew consent|0|||
143342956|NCT03485911|516800831|FG001|Part 1|Subject withdrew consent|1|||
143342957|NCT03485911|516800832|FG002|Part 1|Subject withdrew consent|0|||
143342958|NCT03485911|516800833|FG003|Part 1|Subject withdrew consent|1|||
143342959|NCT03485911|516800830|FG000|Part 1|Lab abnormalities/AEs|3|||
143342960|NCT03485911|516800831|FG001|Part 1|Lab abnormalities/AEs|1|||
143342961|NCT03485911|516800832|FG002|Part 1|Lab abnormalities/AEs|1|||
143342962|NCT03485911|516800833|FG003|Part 1|Lab abnormalities/AEs|0|||
143342963|NCT03485911|516800830|FG000|Part 1|Withdrew Consent prior to dosing|0|||
143342964|NCT03485911|516800831|FG001|Part 1|Withdrew Consent prior to dosing|0|||
143342965|NCT03485911|516800832|FG002|Part 1|Withdrew Consent prior to dosing|0|||
143342966|NCT03485911|516800833|FG003|Part 1|Withdrew Consent prior to dosing|1|||
143342967|NCT03485911|516800830|FG000|Part 1|Other NOS|0|||
143342968|NCT03485911|516800831|FG001|Part 1|Other NOS|0|||
143342969|NCT03485911|516800832|FG002|Part 1|Other NOS|0|||
143342970|NCT03485911|516800833|FG003|Part 1|Other NOS|1|||
143342971|NCT03485911|516800830|FG000|Part 2|Perceived lack of efficacy|5|||
143342972|NCT03485911|516800831|FG001|Part 2|Perceived lack of efficacy|3|||
143342973|NCT03485911|516800832|FG002|Part 2|Perceived lack of efficacy|0|||
143342974|NCT03485911|516800833|FG003|Part 2|Perceived lack of efficacy|2|||
143342975|NCT03485911|516800830|FG000|Part 2|Subject withdrew consent|1|||
143342976|NCT03485911|516800831|FG001|Part 2|Subject withdrew consent|0|||
143342977|NCT03485911|516800832|FG002|Part 2|Subject withdrew consent|2|||
143342978|NCT03485911|516800833|FG003|Part 2|Subject withdrew consent|1|||
143342979|NCT03485911|516800830|FG000|Part 2|Lab abnormalities/AEs|1|||
143342980|NCT03485911|516800831|FG001|Part 2|Lab abnormalities/AEs|2|||
143342981|NCT03485911|516800832|FG002|Part 2|Lab abnormalities/AEs|0|||
143342982|NCT03485911|516800833|FG003|Part 2|Lab abnormalities/AEs|0|||
143342983|NCT03485911|516800830|FG000|Part 2|Other NOS|0|||
143342984|NCT03485911|516800831|FG001|Part 2|Other NOS|1|||
143342985|NCT03485911|516800832|FG002|Part 2|Other NOS|0|||
143342986|NCT03485911|516800833|FG003|Part 2|Other NOS|0|||
143342987|NCT03485911|516800830|FG000|Part 2|Intercurrent illness/new medical condition|1|||
143342988|NCT03485911|516800831|FG001|Part 2|Intercurrent illness/new medical condition|0|||
143342989|NCT03485911|516800832|FG002|Part 2|Intercurrent illness/new medical condition|0|||
143342990|NCT03485911|516800833|FG003|Part 2|Intercurrent illness/new medical condition|0|||
143342991|NCT03485911|516800830|FG000|Part 2|Investigator judgement|1|||
143342992|NCT03485911|516800831|FG001|Part 2|Investigator judgement|0|||
143342993|NCT03485911|516800832|FG002|Part 2|Investigator judgement|0|||
143342994|NCT03485911|516800833|FG003|Part 2|Investigator judgement|0|||
143342995|NCT03485911|516800830|FG000|Part 3|Perceived lack of efficacy|2|||
143342996|NCT03485911|516800831|FG001|Part 3|Perceived lack of efficacy|2|||
143342997|NCT03485911|516800832|FG002|Part 3|Perceived lack of efficacy|2|||
143342998|NCT03485911|516800833|FG003|Part 3|Perceived lack of efficacy|0|||
143342999|NCT03485911|516800830|FG000|Part 3|Subject withdrew consent|1|||
143343000|NCT03485911|516800831|FG001|Part 3|Subject withdrew consent|4|||
143343001|NCT03485911|516800832|FG002|Part 3|Subject withdrew consent|0|||
143343002|NCT03485911|516800833|FG003|Part 3|Subject withdrew consent|1|||
143343003|NCT03485911|516800830|FG000|Part 3|Lab abnormalities/AEs|1|||
143343004|NCT03485911|516800831|FG001|Part 3|Lab abnormalities/AEs|1|||
143343005|NCT03485911|516800832|FG002|Part 3|Lab abnormalities/AEs|0|||
143343006|NCT03485911|516800833|FG003|Part 3|Lab abnormalities/AEs|2|||
143343007|NCT03485911|516800830|FG000|Part 3|Other NOS|1|||
143343008|NCT03485911|516800831|FG001|Part 3|Other NOS|1|||
143343009|NCT03485911|516800832|FG002|Part 3|Other NOS|0|||
143343010|NCT03485911|516800833|FG003|Part 3|Other NOS|0|||
143343011|NCT03485911|516800830|FG000|Part 3|Intercurrent illness/new medical condition|0|||
143343012|NCT03485911|516800831|FG001|Part 3|Intercurrent illness/new medical condition|1|||
143343013|NCT03485911|516800832|FG002|Part 3|Intercurrent illness/new medical condition|1|||
143343014|NCT03485911|516800833|FG003|Part 3|Intercurrent illness/new medical condition|0|||
143343015|NCT03485911|516800830|FG000|Part 3|Sponsor discontinuation|1|||
143343016|NCT03485911|516800831|FG001|Part 3|Sponsor discontinuation|0|||
143343017|NCT03485911|516800832|FG002|Part 3|Sponsor discontinuation|0|||
143343018|NCT03485911|516800833|FG003|Part 3|Sponsor discontinuation|0|||
143343019|NCT03485911|516800830|FG000|Part 3|Berotralstat provided by alternative means|13|||
143343020|NCT03485911|516800831|FG001|Part 3|Berotralstat provided by alternative means|13|||
143343021|NCT03485911|516800832|FG002|Part 3|Berotralstat provided by alternative means|7|||
143343022|NCT03485911|516800833|FG003|Part 3|Berotralstat provided by alternative means|7|||
143343023|NCT01215357|516800834|FG000|Overall Study|Withdrawal by Subject|3|||
143343024|NCT01215357|516800834|FG000|Overall Study|Protocol Violation|9|||
143343025|NCT01719237|516800841|FG000|Overall Study|Physician Decision|0|||
143343026|NCT01719237|516800842|FG001|Overall Study|Physician Decision|1|||
143343027|NCT01674621|516800846|FG000|Overall Study|Adverse Event|3|||
143343028|NCT01674621|516800847|FG001|Overall Study|Adverse Event|2|||
143343029|NCT01674621|516800848|FG002|Overall Study|Adverse Event|5|||
143343030|NCT01674621|516800849|FG003|Overall Study|Adverse Event|5|||
143343031|NCT01674621|516800850|FG004|Overall Study|Adverse Event|1|||
143343032|NCT01674621|516800846|FG000|Overall Study|Inability to Complete Study Procedures|0|||
143343033|NCT01674621|516800847|FG001|Overall Study|Inability to Complete Study Procedures|0|||
143343034|NCT01674621|516800848|FG002|Overall Study|Inability to Complete Study Procedures|0|||
143343035|NCT01674621|516800849|FG003|Overall Study|Inability to Complete Study Procedures|0|||
143343036|NCT01674621|516800850|FG004|Overall Study|Inability to Complete Study Procedures|2|||
143343037|NCT01674621|516800846|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
143343038|NCT01674621|516800847|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
143343039|NCT01674621|516800848|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
143343040|NCT01674621|516800849|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
143343041|NCT01674621|516800850|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
143343042|NCT01674621|516800846|FG000|Overall Study|Withdrawal by Subject|2|||
143343043|NCT01674621|516800847|FG001|Overall Study|Withdrawal by Subject|5|||
143343044|NCT01674621|516800848|FG002|Overall Study|Withdrawal by Subject|2|||
143343045|NCT01674621|516800849|FG003|Overall Study|Withdrawal by Subject|0|||
143343046|NCT01674621|516800850|FG004|Overall Study|Withdrawal by Subject|1|||
143343047|NCT01674621|516800846|FG000|Overall Study|Other than specified|0|||
143343048|NCT01674621|516800847|FG001|Overall Study|Other than specified|1|||
143343049|NCT01674621|516800848|FG002|Overall Study|Other than specified|0|||
143343050|NCT01674621|516800849|FG003|Overall Study|Other than specified|0|||
143343051|NCT01674621|516800850|FG004|Overall Study|Other than specified|2|||
143343052|NCT01320943|516800861|FG000|Overall Study|Lost to Follow-up|1|||
143343053|NCT01320943|516800862|FG001|Overall Study|Lost to Follow-up|0|||
143343054|NCT01320943|516800861|FG000|Overall Study|Physician Decision|0|||
143343055|NCT01320943|516800862|FG001|Overall Study|Physician Decision|1|||
143343056|NCT01320943|516800861|FG000|Overall Study|Randomized but not Treated|0|||
143343057|NCT01320943|516800862|FG001|Overall Study|Randomized but not Treated|1|||
143343058|NCT03489057|516800866|FG000|Overall Study|Lost to Follow-up|16|||
143343059|NCT03489057|516800867|FG001|Overall Study|Lost to Follow-up|16|||
143343060|NCT03489057|516800868|FG002|Overall Study|Lost to Follow-up|14|||
143343061|NCT03489057|516800869|FG003|Overall Study|Lost to Follow-up|14|||
143343062|NCT03489057|516800866|FG000|Overall Study|Withdrawal by Subject|12|||
143343063|NCT03489057|516800867|FG001|Overall Study|Withdrawal by Subject|12|||
143343064|NCT03489057|516800868|FG002|Overall Study|Withdrawal by Subject|8|||
143343065|NCT03489057|516800869|FG003|Overall Study|Withdrawal by Subject|8|||
143343066|NCT03489057|516800866|FG000|Overall Study|Protocol Violation|7|||
143343067|NCT03489057|516800867|FG001|Overall Study|Protocol Violation|7|||
143343068|NCT03489057|516800868|FG002|Overall Study|Protocol Violation|2|||
143343069|NCT03489057|516800869|FG003|Overall Study|Protocol Violation|2|||
143343070|NCT04770779|516800870|FG000|Overall Study|Randomized, never treated|0|||
143343071|NCT04770779|516800871|FG001|Overall Study|Randomized, never treated|1|||
143343072|NCT04770779|516800870|FG000|Overall Study|Adverse Event|9|||
143343073|NCT04770779|516800871|FG001|Overall Study|Adverse Event|1|||
143343074|NCT04770779|516800870|FG000|Overall Study|Withdrawal by Subject|7|||
143343075|NCT04770779|516800871|FG001|Overall Study|Withdrawal by Subject|1|||
143343076|NCT04770779|516800870|FG000|Overall Study|Pregnancy|0|||
143343077|NCT04770779|516800871|FG001|Overall Study|Pregnancy|1|||
143343078|NCT01669798|516800872|FG000|Overall Study|Physician Decision|5|||
143343079|NCT00622180|516800874|FG000|Overall Study|Lost to Follow-up|1|||
143343080|NCT00622180|516800875|FG001|Overall Study|Lost to Follow-up|2|||
143343081|NCT06387472|516800878|FG000|Overall Study|Withdrawal by Subject|1|||
143343082|NCT06387472|516800878|FG000|Overall Study|Lost to Follow-up|2|||
143343083|NCT06387472|516800878|FG000|Overall Study|Physician Decision|1|||
143343084|NCT02332590|516800881|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
143343085|NCT02332590|516800882|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
143343086|NCT02332590|516800881|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
143343087|NCT02332590|516800882|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
143343088|NCT02332590|516800881|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
143343089|NCT02332590|516800882|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
143396897|NCT03899259|517003022|FG001|Overall Study|Adverse Event|4|||
143396898|NCT03899259|517003023|FG002|Overall Study|Adverse Event|6|||
143396899|NCT03899259|517003021|FG000|Overall Study|Lack of Efficacy|5|||
143396900|NCT03899259|517003022|FG001|Overall Study|Lack of Efficacy|0|||
143396901|NCT03899259|517003023|FG002|Overall Study|Lack of Efficacy|2|||
143396902|NCT03899259|517003021|FG000|Overall Study|Pregnancy|3|||
143396903|NCT03899259|517003022|FG001|Overall Study|Pregnancy|0|||
143396904|NCT03899259|517003023|FG002|Overall Study|Pregnancy|1|||
143396905|NCT03899259|517003021|FG000|Overall Study|Physician Decision|0|||
143396906|NCT03899259|517003022|FG001|Overall Study|Physician Decision|1|||
143396907|NCT03899259|517003023|FG002|Overall Study|Physician Decision|0|||
143396908|NCT03899259|517003021|FG000|Overall Study|Protocol Deviation|1|||
143396909|NCT03899259|517003022|FG001|Overall Study|Protocol Deviation|1|||
143396910|NCT03899259|517003023|FG002|Overall Study|Protocol Deviation|1|||
143396911|NCT03899259|517003021|FG000|Overall Study|Withdrawal by Subject|8|||
143396912|NCT03899259|517003022|FG001|Overall Study|Withdrawal by Subject|10|||
143396913|NCT03899259|517003023|FG002|Overall Study|Withdrawal by Subject|12|||
143396914|NCT03899259|517003021|FG000|Overall Study|Lost to Follow-up|5|||
143343090|NCT02332590|516800881|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
143343091|NCT02332590|516800882|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
143396915|NCT03899259|517003022|FG001|Overall Study|Lost to Follow-up|6|||
143396916|NCT03899259|517003023|FG002|Overall Study|Lost to Follow-up|2|||
143396917|NCT03899259|517003021|FG000|Overall Study|Lack of Adherence|1|||
143396918|NCT03899259|517003022|FG001|Overall Study|Lack of Adherence|0|||
143396919|NCT03899259|517003023|FG002|Overall Study|Lack of Adherence|0|||
143396920|NCT03899259|517003021|FG000|Overall Study|Screen Failure|1|||
143396921|NCT03899259|517003022|FG001|Overall Study|Screen Failure|0|||
143396922|NCT03899259|517003023|FG002|Overall Study|Screen Failure|0|||
143396923|NCT03899259|517003021|FG000|Overall Study|Ongoing Study Participation|127|||
143396924|NCT03899259|517003022|FG001|Overall Study|Ongoing Study Participation|134|||
143396925|NCT03899259|517003023|FG002|Overall Study|Ongoing Study Participation|210|||
143396926|NCT05139810|517003024|FG000|Overall Study|Voluntary Withdrawal|2|||
143396927|NCT05139810|517003025|FG001|Overall Study|Voluntary Withdrawal|1|||
143396928|NCT05139810|517003026|FG002|Overall Study|Voluntary Withdrawal|0|||
143343092|NCT02332590|516800881|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
143343093|NCT02332590|516800882|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
143343094|NCT02332590|516800881|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
143343095|NCT02332590|516800882|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
143343096|NCT02332590|516800881|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
143343097|NCT02332590|516800882|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
143343098|NCT02332590|516800881|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
143343099|NCT02332590|516800882|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
143343100|NCT02332590|516800881|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
143343101|NCT02332590|516800882|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
143343102|NCT00279201|516800883|FG000|Initiation|Death|1|||
143343103|NCT00279201|516800884|FG001|Initiation|Death|5|||
143343104|NCT00279201|516800885|FG002|Initiation|Death|0|||
143343105|NCT00279201|516800886|FG003|Initiation|Death|0|||
143343106|NCT00279201|516800887|FG004|Initiation|Death|0|||
143343107|NCT00279201|516800888|FG005|Initiation|Death|0|||
143343108|NCT00279201|516800883|FG000|Initiation|Adverse Event|6|||
143343109|NCT00279201|516800884|FG001|Initiation|Adverse Event|15|||
143343110|NCT00279201|516800885|FG002|Initiation|Adverse Event|0|||
143343111|NCT00279201|516800886|FG003|Initiation|Adverse Event|0|||
143343112|NCT00279201|516800887|FG004|Initiation|Adverse Event|0|||
143343113|NCT00279201|516800888|FG005|Initiation|Adverse Event|0|||
143343114|NCT00279201|516800883|FG000|Initiation|Lost to Follow-up|42|||
143343115|NCT00279201|516800884|FG001|Initiation|Lost to Follow-up|41|||
143343116|NCT00279201|516800885|FG002|Initiation|Lost to Follow-up|0|||
143343117|NCT00279201|516800886|FG003|Initiation|Lost to Follow-up|0|||
143343118|NCT00279201|516800887|FG004|Initiation|Lost to Follow-up|0|||
143343119|NCT00279201|516800888|FG005|Initiation|Lost to Follow-up|0|||
143343120|NCT00279201|516800883|FG000|Initiation|Entry Criteria Exclusion|7|||
143343121|NCT00279201|516800884|FG001|Initiation|Entry Criteria Exclusion|9|||
143343122|NCT00279201|516800885|FG002|Initiation|Entry Criteria Exclusion|0|||
143343123|NCT00279201|516800886|FG003|Initiation|Entry Criteria Exclusion|0|||
143343124|NCT00279201|516800887|FG004|Initiation|Entry Criteria Exclusion|0|||
143343125|NCT00279201|516800888|FG005|Initiation|Entry Criteria Exclusion|0|||
143343126|NCT00279201|516800883|FG000|Initiation|Protocol Violation|9|||
143343127|NCT00279201|516800884|FG001|Initiation|Protocol Violation|10|||
143343128|NCT00279201|516800885|FG002|Initiation|Protocol Violation|0|||
143343129|NCT00279201|516800886|FG003|Initiation|Protocol Violation|0|||
143343130|NCT00279201|516800887|FG004|Initiation|Protocol Violation|0|||
143343131|NCT00279201|516800888|FG005|Initiation|Protocol Violation|0|||
143343132|NCT00279201|516800883|FG000|Initiation|Withdrawal by Subject|35|||
143343133|NCT00279201|516800884|FG001|Initiation|Withdrawal by Subject|41|||
143343134|NCT00279201|516800885|FG002|Initiation|Withdrawal by Subject|0|||
143343135|NCT00279201|516800886|FG003|Initiation|Withdrawal by Subject|0|||
143343136|NCT00279201|516800887|FG004|Initiation|Withdrawal by Subject|0|||
143343137|NCT00279201|516800888|FG005|Initiation|Withdrawal by Subject|0|||
143396929|NCT05139810|517003024|FG000|Overall Study|Pregnancy|1|||
143396930|NCT05139810|517003025|FG001|Overall Study|Pregnancy|0|||
143343138|NCT00279201|516800883|FG000|Initiation|Physician Decision|15|||
143343139|NCT00279201|516800884|FG001|Initiation|Physician Decision|18|||
143396931|NCT05139810|517003026|FG002|Overall Study|Pregnancy|0|||
143396932|NCT05139810|517003024|FG000|Overall Study|Roll Over to CS7|19|||
143396933|NCT05139810|517003025|FG001|Overall Study|Roll Over to CS7|44|||
143396934|NCT05139810|517003026|FG002|Overall Study|Roll Over to CS7|20|||
143396935|NCT05546411|517003027|FG000|Overall Study|Progressive Disease|1|||
143396936|NCT05546411|517003028|FG001|Overall Study|Progressive Disease|0|||
143396937|NCT05546411|517003027|FG000|Overall Study|Adverse Event|0|||
143396938|NCT05546411|517003028|FG001|Overall Study|Adverse Event|1|||
143396939|NCT05546411|517003027|FG000|Overall Study|Metastatic disease|1|||
143396940|NCT05546411|517003028|FG001|Overall Study|Metastatic disease|0|||
143396941|NCT03235544|517003029|FG000|Overall Study|Death|11|||
143396942|NCT03235544|517003030|FG001|Overall Study|Death|31|||
143396943|NCT03235544|517003031|FG002|Overall Study|Death|19|||
143396944|NCT03235544|517003032|FG003|Overall Study|Death|34|||
143396945|NCT03235544|517003029|FG000|Overall Study|Lost to Follow-up|0|||
143396946|NCT03235544|517003030|FG001|Overall Study|Lost to Follow-up|1|||
143396947|NCT03235544|517003031|FG002|Overall Study|Lost to Follow-up|1|||
143396948|NCT03235544|517003032|FG003|Overall Study|Lost to Follow-up|1|||
143396949|NCT03235544|517003029|FG000|Overall Study|Withdrawal by Subject|0|||
143396950|NCT03235544|517003030|FG001|Overall Study|Withdrawal by Subject|3|||
143396951|NCT03235544|517003031|FG002|Overall Study|Withdrawal by Subject|1|||
143396952|NCT03235544|517003032|FG003|Overall Study|Withdrawal by Subject|5|||
143396953|NCT03235544|517003029|FG000|Overall Study|Disease Progression|0|||
143396954|NCT03235544|517003030|FG001|Overall Study|Disease Progression|1|||
143396955|NCT03235544|517003031|FG002|Overall Study|Disease Progression|0|||
143396956|NCT03235544|517003032|FG003|Overall Study|Disease Progression|2|||
143396957|NCT03235544|517003029|FG000|Overall Study|Participant Transitioned to Rollover Protocol|0|||
143396958|NCT03235544|517003030|FG001|Overall Study|Participant Transitioned to Rollover Protocol|0|||
143396959|NCT03235544|517003031|FG002|Overall Study|Participant Transitioned to Rollover Protocol|2|||
143396960|NCT03235544|517003032|FG003|Overall Study|Participant Transitioned to Rollover Protocol|5|||
143396961|NCT03235544|517003029|FG000|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
143396962|NCT03235544|517003030|FG001|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
143396963|NCT03235544|517003031|FG002|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
143396964|NCT03235544|517003032|FG003|Overall Study|Discomfort, Pain, and Radiographic Advancement|1|||
143396965|NCT00950742|517003033|FG000|Overall Study|Other Adverse Event|1|||
143396966|NCT00950742|517003034|FG001|Overall Study|Other Adverse Event|0|||
143396967|NCT00950742|517003033|FG000|Overall Study|Withdrawal by Subject|3|||
143396968|NCT00950742|517003034|FG001|Overall Study|Withdrawal by Subject|0|||
143396969|NCT00950742|517003033|FG000|Overall Study|Progressive Disease|6|||
143396970|NCT00950742|517003034|FG001|Overall Study|Progressive Disease|2|||
143396971|NCT00950742|517003033|FG000|Overall Study|Dose limiting toxicity|6|||
143396972|NCT00950742|517003034|FG001|Overall Study|Dose limiting toxicity|0|||
143396973|NCT05436262|517003038|FG000|Pre-Randomization|Withdrawal by Subject|1|||
143396974|NCT05436262|517003039|FG001|Pre-Randomization|Withdrawal by Subject|0|||
143396975|NCT05436262|517003040|FG002|Pre-Randomization|Withdrawal by Subject|0|||
143396976|NCT05436262|517003038|FG000|Randomization|Withdrawal by Subject|0|||
143396977|NCT05436262|517003039|FG001|Randomization|Withdrawal by Subject|1|||
143396978|NCT05436262|517003040|FG002|Randomization|Withdrawal by Subject|0|||
143396979|NCT02433379|517003041|FG000|Overall Study|Screen Failures|55|||
143396980|NCT02433379|517003041|FG000|Overall Study|Death|57|||
143396981|NCT02433379|517003041|FG000|Overall Study|Total Withdrawals|209|||
143396982|NCT04850898|517003042|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
143396983|NCT04850898|517003043|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
143396984|NCT04770402|517003052|FG000|Overall Study|Lost to Follow-up|1|||
143396985|NCT04770402|517003053|FG001|Overall Study|Lost to Follow-up|2|||
143396986|NCT04770402|517003052|FG000|Overall Study|Non-compliance|1|||
143396987|NCT04770402|517003053|FG001|Overall Study|Non-compliance|0|||
143396988|NCT04770402|517003052|FG000|Overall Study|Withdrawal by Subject|0|||
143396989|NCT04770402|517003053|FG001|Overall Study|Withdrawal by Subject|1|||
143396990|NCT03599661|517003055|FG000|Overall Study|Lost to Follow-up|9|||
143396991|NCT01946789|517003069|FG000|Overall Study|Death|0|||
143396992|NCT01946789|517003070|FG001|Overall Study|Death|2|||
143396993|NCT01946789|517003071|FG002|Overall Study|Death|1|||
143396994|NCT01946789|517003072|FG003|Overall Study|Death|1|||
143396995|NCT01946789|517003073|FG004|Overall Study|Death|1|||
143396996|NCT01946789|517003074|FG005|Overall Study|Death|1|||
143396997|NCT01946789|517003075|FG006|Overall Study|Death|3|||
143396998|NCT01946789|517003076|FG007|Overall Study|Death|1|||
143396999|NCT01946789|517003077|FG008|Overall Study|Death|2|||
143397000|NCT01946789|517003069|FG000|Overall Study|Progressive Disease|0|||
143397001|NCT01946789|517003070|FG001|Overall Study|Progressive Disease|0|||
143397002|NCT01946789|517003071|FG002|Overall Study|Progressive Disease|1|||
143397003|NCT01946789|517003072|FG003|Overall Study|Progressive Disease|0|||
143397004|NCT01946789|517003073|FG004|Overall Study|Progressive Disease|0|||
143343140|NCT00279201|516800885|FG002|Initiation|Physician Decision|0|||
143343141|NCT00279201|516800886|FG003|Initiation|Physician Decision|0|||
143343142|NCT00279201|516800887|FG004|Initiation|Physician Decision|0|||
143343143|NCT00279201|516800888|FG005|Initiation|Physician Decision|0|||
143343144|NCT00279201|516800883|FG000|Initiation|Sponsor Decision|13|||
143343145|NCT00279201|516800884|FG001|Initiation|Sponsor Decision|5|||
143343146|NCT00279201|516800885|FG002|Initiation|Sponsor Decision|0|||
143343147|NCT00279201|516800886|FG003|Initiation|Sponsor Decision|0|||
143343148|NCT00279201|516800887|FG004|Initiation|Sponsor Decision|0|||
143343149|NCT00279201|516800888|FG005|Initiation|Sponsor Decision|0|||
143343150|NCT00279201|516800883|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
143343151|NCT00279201|516800884|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
143343152|NCT00279201|516800885|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
143397005|NCT01946789|517003074|FG005|Overall Study|Progressive Disease|2|||
143397006|NCT01946789|517003075|FG006|Overall Study|Progressive Disease|0|||
143397007|NCT01946789|517003076|FG007|Overall Study|Progressive Disease|0|||
143397008|NCT01946789|517003077|FG008|Overall Study|Progressive Disease|0|||
143397009|NCT01946789|517003069|FG000|Overall Study|Withdrawal by Subject|0|||
143343153|NCT00279201|516800886|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
143343154|NCT00279201|516800887|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
143343155|NCT00279201|516800888|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
143343156|NCT00279201|516800883|FG000|Maintenance|Lack of Efficacy|32|||
143343157|NCT00279201|516800884|FG001|Maintenance|Lack of Efficacy|30|||
143343158|NCT00279201|516800885|FG002|Maintenance|Lack of Efficacy|0|||
143343159|NCT00279201|516800886|FG003|Maintenance|Lack of Efficacy|0|||
143343160|NCT00279201|516800887|FG004|Maintenance|Lack of Efficacy|0|||
143343161|NCT00279201|516800888|FG005|Maintenance|Lack of Efficacy|0|||
143343162|NCT00279201|516800883|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
143343163|NCT00279201|516800884|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
143343164|NCT00279201|516800885|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
143343165|NCT00279201|516800886|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
143343166|NCT00279201|516800887|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
143343167|NCT00279201|516800888|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
143343168|NCT00279201|516800883|FG000|Maintenance|Adverse Event|4|||
143343169|NCT00279201|516800884|FG001|Maintenance|Adverse Event|4|||
143343170|NCT00279201|516800885|FG002|Maintenance|Adverse Event|0|||
143343171|NCT00279201|516800886|FG003|Maintenance|Adverse Event|0|||
143343172|NCT00279201|516800887|FG004|Maintenance|Adverse Event|0|||
143343173|NCT00279201|516800888|FG005|Maintenance|Adverse Event|0|||
143343174|NCT00279201|516800883|FG000|Maintenance|Death|4|||
143343175|NCT00279201|516800884|FG001|Maintenance|Death|4|||
143397010|NCT01946789|517003070|FG001|Overall Study|Withdrawal by Subject|0|||
143397011|NCT01946789|517003071|FG002|Overall Study|Withdrawal by Subject|0|||
143397012|NCT01946789|517003072|FG003|Overall Study|Withdrawal by Subject|2|||
143397013|NCT01946789|517003073|FG004|Overall Study|Withdrawal by Subject|1|||
143397014|NCT01946789|517003074|FG005|Overall Study|Withdrawal by Subject|0|||
143397015|NCT01946789|517003075|FG006|Overall Study|Withdrawal by Subject|1|||
143397016|NCT01946789|517003076|FG007|Overall Study|Withdrawal by Subject|0|||
143397017|NCT01946789|517003077|FG008|Overall Study|Withdrawal by Subject|0|||
143397018|NCT05374798|517003082|FG000|Overall Study|Lost to Follow-up|2|||
143397019|NCT05374798|517003082|FG000|Overall Study|Withdrawal by Subject|2|||
143397020|NCT05374798|517003082|FG000|Overall Study|Withdrawn by Principal Investigator.|2|||
143397021|NCT04707625|517003083|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
143397022|NCT03334630|517003084|FG000|Overall Study|Withdrawal by Subject|7|||
143397023|NCT03334630|517003085|FG001|Overall Study|Withdrawal by Subject|7|||
143397024|NCT03334630|517003084|FG000|Overall Study|Lost to Follow-up|3|||
143397025|NCT03334630|517003085|FG001|Overall Study|Lost to Follow-up|1|||
143397026|NCT03334630|517003084|FG000|Overall Study|Adverse Event|0|||
143397027|NCT03334630|517003085|FG001|Overall Study|Adverse Event|1|||
143397028|NCT03334630|517003084|FG000|Overall Study|Physician Decision|1|||
143397029|NCT03334630|517003085|FG001|Overall Study|Physician Decision|1|||
143397030|NCT03334630|517003084|FG000|Overall Study|Enrollment closed|2|||
143397031|NCT03334630|517003085|FG001|Overall Study|Enrollment closed|1|||
143397032|NCT03334630|517003084|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
143397033|NCT03334630|517003085|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
143397034|NCT03334630|517003084|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
143397035|NCT03334630|517003085|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
143397036|NCT04079218|517003090|FG000|Overall Study|Death|1|||
143397037|NCT04079218|517003091|FG001|Overall Study|Death|0|||
143397038|NCT04079218|517003090|FG000|Overall Study|Withdrawal by Subject|3|||
143397039|NCT04079218|517003091|FG001|Overall Study|Withdrawal by Subject|0|||
143397040|NCT04079218|517003090|FG000|Overall Study|Physician Decision|4|||
143397041|NCT04079218|517003091|FG001|Overall Study|Physician Decision|0|||
143397042|NCT04079218|517003090|FG000|Overall Study|Lost to Follow-up|0|||
143397043|NCT04079218|517003091|FG001|Overall Study|Lost to Follow-up|1|||
143397044|NCT05170841|517003100|FG000|Single Dose Phase|Adverse Event|1|||
143343176|NCT00279201|516800885|FG002|Maintenance|Death|0|||
143343177|NCT00279201|516800886|FG003|Maintenance|Death|0|||
143343178|NCT00279201|516800887|FG004|Maintenance|Death|0|||
143343179|NCT00279201|516800888|FG005|Maintenance|Death|0|||
143397045|NCT05170841|517003101|FG001|Single Dose Phase|Adverse Event|2|||
143397046|NCT05170841|517003102|FG002|Single Dose Phase|Adverse Event|0|||
143397047|NCT05170841|517003103|FG003|Single Dose Phase|Adverse Event|2|||
143397048|NCT05170841|517003100|FG000|Multiple Dose Phase|Adverse Event|1|||
143397049|NCT05170841|517003101|FG001|Multiple Dose Phase|Adverse Event|2|||
143397050|NCT05170841|517003102|FG002|Multiple Dose Phase|Adverse Event|1|||
143397051|NCT05170841|517003103|FG003|Multiple Dose Phase|Adverse Event|4|||
143397052|NCT05170841|517003100|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
143397053|NCT05170841|517003101|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
143397054|NCT05170841|517003102|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
143397055|NCT05170841|517003103|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
143397056|NCT03734679|517003104|FG000|Overall Study|Missed Visit|1|||
143397057|NCT04797195|517003116|FG000|Overall Study|Death|8|||
143397058|NCT04797195|517003117|FG001|Overall Study|Death|15|||
143397059|NCT04797195|517003116|FG000|Overall Study|Change from PD|15|||
143397060|NCT04797195|517003117|FG001|Overall Study|Change from PD|15|||
143397061|NCT04797195|517003116|FG000|Overall Study|Withdrawal by Subject|3|||
143397062|NCT04797195|517003117|FG001|Overall Study|Withdrawal by Subject|2|||
143397063|NCT04059185|517003122|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
143397064|NCT04059185|517003123|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
143397065|NCT04059185|517003124|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
143397066|NCT04059185|517003122|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
143397067|NCT04059185|517003123|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
143397068|NCT04059185|517003124|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
143397069|NCT04059185|517003122|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
143397070|NCT04059185|517003123|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
143397071|NCT04059185|517003124|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
143397072|NCT04059185|517003122|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
143397073|NCT04059185|517003123|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
143397074|NCT04059185|517003124|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
143397075|NCT04059185|517003122|FG000|Longitudinal Assessment-Adults Only|Death|4|||
143397076|NCT04059185|517003123|FG001|Longitudinal Assessment-Adults Only|Death|4|||
143397077|NCT04059185|517003124|FG002|Longitudinal Assessment-Adults Only|Death|3|||
143397078|NCT04587453|517003125|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
143397079|NCT04587453|517003126|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
143397080|NCT02116530|517004583|FG000|Overall Study|Withdrawal by Subject|1|||
143397081|NCT02116530|517004584|FG001|Overall Study|Withdrawal by Subject|2|||
143397082|NCT02116530|517004583|FG000|Overall Study|Adverse Event|4|||
143397083|NCT02116530|517004584|FG001|Overall Study|Adverse Event|0|||
143397084|NCT02116530|517004583|FG000|Overall Study|Physician Decision|1|||
143397085|NCT02116530|517004584|FG001|Overall Study|Physician Decision|0|||
143397086|NCT02116530|517004583|FG000|Overall Study|Lost to Follow-up|1|||
143397087|NCT02116530|517004584|FG001|Overall Study|Lost to Follow-up|0|||
143397088|NCT02116530|517004583|FG000|Overall Study|Other Medical Problems|2|||
143397089|NCT02116530|517004584|FG001|Overall Study|Other Medical Problems|2|||
143397090|NCT03766685|517004585|FG000|Overall Study|Lost to Follow-up|1|||
143397091|NCT03766685|517004586|FG001|Overall Study|Lost to Follow-up|1|||
143397092|NCT03766685|517004587|FG002|Overall Study|Lost to Follow-up|0|||
143397093|NCT03766685|517004588|FG003|Overall Study|Lost to Follow-up|0|||
143397094|NCT03766685|517004585|FG000|Overall Study|Adverse Event, not fatal|0|||
143397095|NCT03766685|517004586|FG001|Overall Study|Adverse Event, not fatal|1|||
143397096|NCT03766685|517004587|FG002|Overall Study|Adverse Event, not fatal|0|||
143397097|NCT03766685|517004588|FG003|Overall Study|Adverse Event, not fatal|1|||
143397098|NCT03766685|517004585|FG000|Overall Study|Withdrawal by Subject|0|||
143397099|NCT03766685|517004586|FG001|Overall Study|Withdrawal by Subject|2|||
143397100|NCT03766685|517004587|FG002|Overall Study|Withdrawal by Subject|0|||
143397101|NCT03766685|517004588|FG003|Overall Study|Withdrawal by Subject|0|||
143397102|NCT03766685|517004585|FG000|Overall Study|Protocol Violation|0|||
143397103|NCT03766685|517004586|FG001|Overall Study|Protocol Violation|1|||
143397104|NCT03766685|517004587|FG002|Overall Study|Protocol Violation|0|||
143397105|NCT03766685|517004588|FG003|Overall Study|Protocol Violation|0|||
143397106|NCT03766685|517004585|FG000|Overall Study|Non-compliance|0|||
143397107|NCT03766685|517004586|FG001|Overall Study|Non-compliance|2|||
143397108|NCT03766685|517004587|FG002|Overall Study|Non-compliance|0|||
143397109|NCT03766685|517004588|FG003|Overall Study|Non-compliance|0|||
143397110|NCT02927236|517004591|FG000|Characterization Phase|Physician Decision|0|||
143397111|NCT02927236|517004592|FG001|Characterization Phase|Physician Decision|3|||
143397112|NCT02927236|517004593|FG002|Characterization Phase|Physician Decision|0|||
143397113|NCT02927236|517004594|FG003|Characterization Phase|Physician Decision|2|||
143397114|NCT02927236|517004591|FG000|Characterization Phase|Lost to Follow-up|0|||
143397115|NCT02927236|517004592|FG001|Characterization Phase|Lost to Follow-up|0|||
143397116|NCT02927236|517004593|FG002|Characterization Phase|Lost to Follow-up|0|||
143397117|NCT02927236|517004594|FG003|Characterization Phase|Lost to Follow-up|3|||
143397118|NCT02927236|517004591|FG000|Characterization Phase|Withdrawal by Subject|1|||
143397119|NCT02927236|517004592|FG001|Characterization Phase|Withdrawal by Subject|0|||
143397120|NCT02927236|517004593|FG002|Characterization Phase|Withdrawal by Subject|0|||
143397121|NCT02927236|517004594|FG003|Characterization Phase|Withdrawal by Subject|1|||
143397122|NCT02927236|517004591|FG000|Treatment Phase|Adverse Event|1|||
143343180|NCT00279201|516800883|FG000|Maintenance|Lost to Follow-up|17|||
143343181|NCT00279201|516800884|FG001|Maintenance|Lost to Follow-up|13|||
143397123|NCT02927236|517004592|FG001|Treatment Phase|Adverse Event|0|||
143397124|NCT02927236|517004593|FG002|Treatment Phase|Adverse Event|1|||
143397125|NCT02927236|517004594|FG003|Treatment Phase|Adverse Event|1|||
143397126|NCT02927236|517004591|FG000|Treatment Phase|Protocol Violation|3|||
143397127|NCT02927236|517004592|FG001|Treatment Phase|Protocol Violation|0|||
143397128|NCT02927236|517004593|FG002|Treatment Phase|Protocol Violation|0|||
143397129|NCT02927236|517004594|FG003|Treatment Phase|Protocol Violation|1|||
143397130|NCT02927236|517004591|FG000|Treatment Phase|Lost to Follow-up|1|||
143397131|NCT02927236|517004592|FG001|Treatment Phase|Lost to Follow-up|0|||
143397132|NCT02927236|517004593|FG002|Treatment Phase|Lost to Follow-up|0|||
143397133|NCT02927236|517004594|FG003|Treatment Phase|Lost to Follow-up|0|||
143397134|NCT02927236|517004591|FG000|Follow-up Phase|Lost to Follow-up|1|||
143397135|NCT02927236|517004592|FG001|Follow-up Phase|Lost to Follow-up|0|||
143397136|NCT02927236|517004593|FG002|Follow-up Phase|Lost to Follow-up|1|||
143397137|NCT02927236|517004594|FG003|Follow-up Phase|Lost to Follow-up|0|||
143397138|NCT02844465|517004595|FG000|Overall Study|Screen Failure|36|||
143397139|NCT02844465|517004595|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
143397140|NCT02844465|517004595|FG000|Overall Study|Withdrawal by Subject|5|||
143397141|NCT02844465|517004595|FG000|Overall Study|Lost to Follow-up|1|||
143397142|NCT02844465|517004595|FG000|Overall Study|Retreatment|1|||
143397143|NCT01197378|517004599|FG000|Overall Study|Adverse Event|3|||
143397144|NCT01197378|517004599|FG000|Overall Study|Withdrawal by Subject|1|||
143397145|NCT01197378|517004599|FG000|Overall Study|Physician Decision|1|||
143397146|NCT01197378|517004599|FG000|Overall Study|Other|2|||
143397147|NCT06232590|517004600|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
143397148|NCT06232590|517004601|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
143397149|NCT03240016|517004602|FG000|Overall Study|Adverse Event|9|||
143397150|NCT03240016|517004602|FG000|Overall Study|Withdrawal by Subject|7|||
143397151|NCT03240016|517004602|FG000|Overall Study|Death|1|||
143397152|NCT03240016|517004602|FG000|Overall Study|Physician Decision|2|||
143397153|NCT05200403|517004603|FG000|Overall Study|Withdrawal by Subject|4|||
143397154|NCT05200403|517004604|FG001|Overall Study|Withdrawal by Subject|2|||
143397155|NCT05200403|517004605|FG002|Overall Study|Withdrawal by Subject|6|||
143397156|NCT05299723|517004606|FG000|Overall Study|Withdrawal by Subject|0|||
143397157|NCT05299723|517004607|FG001|Overall Study|Withdrawal by Subject|2|||
143397158|NCT05299723|517004608|FG002|Overall Study|Withdrawal by Subject|0|||
143397159|NCT01959607|517004609|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
143397160|NCT01959607|517004610|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
143397161|NCT01959607|517004611|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
143397162|NCT01959607|517004612|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
143397163|NCT03913442|517004613|FG000|Overall Study|Adverse Event|0|||
143397164|NCT03913442|517004614|FG001|Overall Study|Adverse Event|3|||
143397165|NCT03913442|517004613|FG000|Overall Study|Withdrawal by Subject|5|||
143397166|NCT03913442|517004614|FG001|Overall Study|Withdrawal by Subject|5|||
143397167|NCT03913442|517004613|FG000|Overall Study|Terminations|2|||
143343182|NCT00279201|516800885|FG002|Maintenance|Lost to Follow-up|0|||
143343183|NCT00279201|516800886|FG003|Maintenance|Lost to Follow-up|0|||
143343184|NCT00279201|516800887|FG004|Maintenance|Lost to Follow-up|0|||
143343185|NCT00279201|516800888|FG005|Maintenance|Lost to Follow-up|0|||
143343186|NCT00279201|516800883|FG000|Maintenance|Entry Criteria Exclusion|1|||
143343187|NCT00279201|516800884|FG001|Maintenance|Entry Criteria Exclusion|4|||
143343188|NCT00279201|516800885|FG002|Maintenance|Entry Criteria Exclusion|0|||
143343189|NCT00279201|516800886|FG003|Maintenance|Entry Criteria Exclusion|0|||
143343190|NCT00279201|516800887|FG004|Maintenance|Entry Criteria Exclusion|0|||
143343191|NCT00279201|516800888|FG005|Maintenance|Entry Criteria Exclusion|0|||
143343192|NCT00279201|516800883|FG000|Maintenance|Protocol Violation|16|||
143343193|NCT00279201|516800884|FG001|Maintenance|Protocol Violation|24|||
143397168|NCT03913442|517004614|FG001|Overall Study|Terminations|1|||
143397169|NCT03913442|517004613|FG000|Overall Study|Lost to Follow-up|2|||
143397170|NCT03913442|517004614|FG001|Overall Study|Lost to Follow-up|2|||
143397171|NCT00592852|517004616|FG000|Overall Study|Non-compliance|1|||
143397172|NCT00592852|517004616|FG000|Overall Study|Adverse Event|3|||
143397173|NCT00592852|517004616|FG000|Overall Study|Found ineligible|1|||
143397174|NCT00592852|517004616|FG000|Overall Study|Withdrawal by Subject|1|||
143397175|NCT02589795|517004617|FG000|Overall Study|Lost to Follow-up|1|||
143397176|NCT02589795|517004618|FG001|Overall Study|Lost to Follow-up|0|||
143343194|NCT00279201|516800885|FG002|Maintenance|Protocol Violation|0|||
143397177|NCT02589795|517004619|FG002|Overall Study|Lost to Follow-up|0|||
143397178|NCT02589795|517004617|FG000|Overall Study|Withdrawal by Subject|0|||
143397179|NCT02589795|517004618|FG001|Overall Study|Withdrawal by Subject|0|||
143397180|NCT02589795|517004619|FG002|Overall Study|Withdrawal by Subject|2|||
143397181|NCT02589795|517004617|FG000|Overall Study|Protocol Violation|0|||
143397182|NCT02589795|517004618|FG001|Overall Study|Protocol Violation|0|||
143397183|NCT02589795|517004619|FG002|Overall Study|Protocol Violation|1|||
143397184|NCT04117347|517004620|FG000|Overall Study|Adverse Event|0|||
143397185|NCT04117347|517004621|FG001|Overall Study|Adverse Event|0|||
143397186|NCT04117347|517004622|FG002|Overall Study|Adverse Event|1|||
143397187|NCT04117347|517004620|FG000|Overall Study|No time for study|0|||
143397188|NCT04117347|517004621|FG001|Overall Study|No time for study|2|||
143397189|NCT04117347|517004622|FG002|Overall Study|No time for study|0|||
143397190|NCT04117347|517004620|FG000|Overall Study|Family emergency|1|||
143397191|NCT04117347|517004621|FG001|Overall Study|Family emergency|0|||
143397192|NCT04117347|517004622|FG002|Overall Study|Family emergency|0|||
143397193|NCT02505984|517004623|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
143397194|NCT02505984|517004624|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
143397195|NCT02505984|517004623|FG000|Overall Study|Unreliable self-report data|1|||
143397196|NCT02505984|517004624|FG001|Overall Study|Unreliable self-report data|0|||
143397197|NCT02505984|517004623|FG000|Overall Study|Study blind opened during assessment|0|||
143397198|NCT02505984|517004624|FG001|Overall Study|Study blind opened during assessment|1|||
143397199|NCT02505984|517004623|FG000|Overall Study|Noncompliance with study protocol|0|||
143397200|NCT02505984|517004624|FG001|Overall Study|Noncompliance with study protocol|1|||
143397201|NCT03687086|517004625|FG000|Overall Study|Withdrawal by Subject|3|||
143397202|NCT03687086|517004626|FG001|Overall Study|Withdrawal by Subject|4|||
143397203|NCT03687086|517004625|FG000|Overall Study|Lost to Follow-up|1|||
143397204|NCT03687086|517004626|FG001|Overall Study|Lost to Follow-up|1|||
143397205|NCT03687086|517004625|FG000|Overall Study|Death|1|||
143397206|NCT03687086|517004626|FG001|Overall Study|Death|0|||
143397207|NCT03687086|517004625|FG000|Overall Study|Incomplete assessment|0|||
143397208|NCT03687086|517004626|FG001|Overall Study|Incomplete assessment|2|||
143397209|NCT05194956|517004627|FG000|Washout Period|Withdrawal by Subject|0|||
143397210|NCT05194956|517004628|FG001|Washout Period|Withdrawal by Subject|2|||
143397211|NCT01928394|517004630|FG000|Treatment Period|Disease progression|17|||
143397212|NCT01928394|517004631|FG001|Treatment Period|Disease progression|2|||
143397213|NCT01928394|517004632|FG002|Treatment Period|Disease progression|12|||
143397214|NCT01928394|517004633|FG003|Treatment Period|Disease progression|48|||
143397215|NCT01928394|517004634|FG004|Treatment Period|Disease progression|3|||
143397216|NCT01928394|517004635|FG005|Treatment Period|Disease progression|25|||
143397217|NCT01928394|517004636|FG006|Treatment Period|Disease progression|38|||
143397218|NCT01928394|517004637|FG007|Treatment Period|Disease progression|16|||
143397219|NCT01928394|517004638|FG008|Treatment Period|Disease progression|3|||
143397220|NCT01928394|517004639|FG009|Treatment Period|Disease progression|11|||
143397221|NCT01928394|517004640|FG010|Treatment Period|Disease progression|22|||
143397222|NCT01928394|517004641|FG011|Treatment Period|Disease progression|73|||
143397223|NCT01928394|517004642|FG012|Treatment Period|Disease progression|38|||
143397224|NCT01928394|517004643|FG013|Treatment Period|Disease progression|118|||
143397225|NCT01928394|517004644|FG014|Treatment Period|Disease progression|59|||
143397226|NCT01928394|517004645|FG015|Treatment Period|Disease progression|1|||
143397227|NCT01928394|517004646|FG016|Treatment Period|Disease progression|43|||
143397228|NCT01928394|517004647|FG017|Treatment Period|Disease progression|56|||
143397229|NCT01928394|517004648|FG018|Treatment Period|Disease progression|50|||
143397230|NCT01928394|517004649|FG019|Treatment Period|Disease progression|71|||
143397231|NCT01928394|517004650|FG020|Treatment Period|Disease progression|30|||
143397232|NCT01928394|517004651|FG021|Treatment Period|Disease progression|31|||
143397233|NCT01928394|517004652|FG022|Treatment Period|Disease progression|31|||
143397234|NCT01928394|517004630|FG000|Treatment Period|Study drug toxicity|1|||
143397235|NCT01928394|517004631|FG001|Treatment Period|Study drug toxicity|1|||
143397236|NCT01928394|517004632|FG002|Treatment Period|Study drug toxicity|3|||
143397237|NCT01928394|517004633|FG003|Treatment Period|Study drug toxicity|3|||
143397238|NCT01928394|517004634|FG004|Treatment Period|Study drug toxicity|0|||
143397239|NCT01928394|517004635|FG005|Treatment Period|Study drug toxicity|9|||
143397240|NCT01928394|517004636|FG006|Treatment Period|Study drug toxicity|7|||
143397241|NCT01928394|517004637|FG007|Treatment Period|Study drug toxicity|1|||
143397242|NCT01928394|517004638|FG008|Treatment Period|Study drug toxicity|0|||
143397243|NCT01928394|517004639|FG009|Treatment Period|Study drug toxicity|5|||
143397244|NCT01928394|517004640|FG010|Treatment Period|Study drug toxicity|2|||
143397245|NCT01928394|517004641|FG011|Treatment Period|Study drug toxicity|3|||
143397246|NCT01928394|517004642|FG012|Treatment Period|Study drug toxicity|7|||
143397247|NCT01928394|517004643|FG013|Treatment Period|Study drug toxicity|5|||
143397248|NCT01928394|517004644|FG014|Treatment Period|Study drug toxicity|12|||
143397249|NCT01928394|517004645|FG015|Treatment Period|Study drug toxicity|0|||
143397250|NCT01928394|517004646|FG016|Treatment Period|Study drug toxicity|3|||
143397251|NCT01928394|517004647|FG017|Treatment Period|Study drug toxicity|3|||
143397252|NCT01928394|517004648|FG018|Treatment Period|Study drug toxicity|12|||
143397253|NCT01928394|517004649|FG019|Treatment Period|Study drug toxicity|15|||
143397254|NCT01928394|517004650|FG020|Treatment Period|Study drug toxicity|4|||
143397255|NCT01928394|517004651|FG021|Treatment Period|Study drug toxicity|7|||
143397256|NCT01928394|517004652|FG022|Treatment Period|Study drug toxicity|4|||
143397257|NCT01928394|517004630|FG000|Treatment Period|AE unrelated to study drug|0|||
143397258|NCT01928394|517004631|FG001|Treatment Period|AE unrelated to study drug|0|||
143397259|NCT01928394|517004632|FG002|Treatment Period|AE unrelated to study drug|2|||
143397260|NCT01928394|517004633|FG003|Treatment Period|AE unrelated to study drug|3|||
143397261|NCT01928394|517004634|FG004|Treatment Period|AE unrelated to study drug|0|||
143397262|NCT01928394|517004635|FG005|Treatment Period|AE unrelated to study drug|5|||
143397263|NCT01928394|517004636|FG006|Treatment Period|AE unrelated to study drug|1|||
143397264|NCT01928394|517004637|FG007|Treatment Period|AE unrelated to study drug|0|||
143397265|NCT01928394|517004638|FG008|Treatment Period|AE unrelated to study drug|0|||
143397266|NCT01928394|517004639|FG009|Treatment Period|AE unrelated to study drug|2|||
143397267|NCT01928394|517004640|FG010|Treatment Period|AE unrelated to study drug|0|||
143397268|NCT01928394|517004641|FG011|Treatment Period|AE unrelated to study drug|12|||
143397269|NCT01928394|517004642|FG012|Treatment Period|AE unrelated to study drug|6|||
143397270|NCT01928394|517004643|FG013|Treatment Period|AE unrelated to study drug|13|||
143397271|NCT01928394|517004644|FG014|Treatment Period|AE unrelated to study drug|6|||
143397272|NCT01928394|517004645|FG015|Treatment Period|AE unrelated to study drug|1|||
143397273|NCT01928394|517004646|FG016|Treatment Period|AE unrelated to study drug|1|||
143397274|NCT01928394|517004647|FG017|Treatment Period|AE unrelated to study drug|6|||
143397275|NCT01928394|517004648|FG018|Treatment Period|AE unrelated to study drug|3|||
143397276|NCT01928394|517004649|FG019|Treatment Period|AE unrelated to study drug|5|||
143397277|NCT01928394|517004650|FG020|Treatment Period|AE unrelated to study drug|1|||
143397278|NCT01928394|517004651|FG021|Treatment Period|AE unrelated to study drug|1|||
143397279|NCT01928394|517004652|FG022|Treatment Period|AE unrelated to study drug|0|||
143397280|NCT01928394|517004630|FG000|Treatment Period|Participant request to stop therapy|0|||
143397281|NCT01928394|517004631|FG001|Treatment Period|Participant request to stop therapy|0|||
143397282|NCT01928394|517004632|FG002|Treatment Period|Participant request to stop therapy|0|||
143397283|NCT01928394|517004633|FG003|Treatment Period|Participant request to stop therapy|0|||
143397284|NCT01928394|517004634|FG004|Treatment Period|Participant request to stop therapy|0|||
143397285|NCT01928394|517004635|FG005|Treatment Period|Participant request to stop therapy|3|||
143397286|NCT01928394|517004636|FG006|Treatment Period|Participant request to stop therapy|3|||
143397287|NCT01928394|517004637|FG007|Treatment Period|Participant request to stop therapy|0|||
143397288|NCT01928394|517004638|FG008|Treatment Period|Participant request to stop therapy|0|||
143397289|NCT01928394|517004639|FG009|Treatment Period|Participant request to stop therapy|0|||
143397290|NCT01928394|517004640|FG010|Treatment Period|Participant request to stop therapy|3|||
143397291|NCT01928394|517004641|FG011|Treatment Period|Participant request to stop therapy|2|||
143397292|NCT01928394|517004642|FG012|Treatment Period|Participant request to stop therapy|1|||
143397293|NCT01928394|517004643|FG013|Treatment Period|Participant request to stop therapy|2|||
143397294|NCT01928394|517004644|FG014|Treatment Period|Participant request to stop therapy|4|||
143397295|NCT01928394|517004645|FG015|Treatment Period|Participant request to stop therapy|0|||
143397296|NCT01928394|517004646|FG016|Treatment Period|Participant request to stop therapy|1|||
143397297|NCT01928394|517004647|FG017|Treatment Period|Participant request to stop therapy|3|||
143397298|NCT01928394|517004648|FG018|Treatment Period|Participant request to stop therapy|1|||
143397299|NCT01928394|517004649|FG019|Treatment Period|Participant request to stop therapy|1|||
143397300|NCT01928394|517004650|FG020|Treatment Period|Participant request to stop therapy|3|||
143397301|NCT01928394|517004651|FG021|Treatment Period|Participant request to stop therapy|1|||
143397302|NCT01928394|517004652|FG022|Treatment Period|Participant request to stop therapy|3|||
143397303|NCT01928394|517004630|FG000|Treatment Period|Participant withdrew consent|0|||
143397304|NCT01928394|517004631|FG001|Treatment Period|Participant withdrew consent|0|||
143397305|NCT01928394|517004632|FG002|Treatment Period|Participant withdrew consent|1|||
143397306|NCT01928394|517004633|FG003|Treatment Period|Participant withdrew consent|1|||
143397307|NCT01928394|517004634|FG004|Treatment Period|Participant withdrew consent|0|||
143397308|NCT01928394|517004635|FG005|Treatment Period|Participant withdrew consent|1|||
143397309|NCT01928394|517004636|FG006|Treatment Period|Participant withdrew consent|0|||
143397310|NCT01928394|517004637|FG007|Treatment Period|Participant withdrew consent|1|||
143397311|NCT01928394|517004638|FG008|Treatment Period|Participant withdrew consent|0|||
143397312|NCT01928394|517004639|FG009|Treatment Period|Participant withdrew consent|0|||
143397313|NCT01928394|517004640|FG010|Treatment Period|Participant withdrew consent|1|||
143397314|NCT01928394|517004641|FG011|Treatment Period|Participant withdrew consent|1|||
143397315|NCT01928394|517004642|FG012|Treatment Period|Participant withdrew consent|1|||
143397316|NCT01928394|517004643|FG013|Treatment Period|Participant withdrew consent|0|||
143397317|NCT01928394|517004644|FG014|Treatment Period|Participant withdrew consent|2|||
143397318|NCT01928394|517004645|FG015|Treatment Period|Participant withdrew consent|0|||
143397319|NCT01928394|517004646|FG016|Treatment Period|Participant withdrew consent|2|||
143397320|NCT01928394|517004647|FG017|Treatment Period|Participant withdrew consent|1|||
143397321|NCT01928394|517004648|FG018|Treatment Period|Participant withdrew consent|1|||
143397322|NCT01928394|517004649|FG019|Treatment Period|Participant withdrew consent|1|||
143397323|NCT01928394|517004650|FG020|Treatment Period|Participant withdrew consent|0|||
143397324|NCT01928394|517004651|FG021|Treatment Period|Participant withdrew consent|2|||
143397325|NCT01928394|517004652|FG022|Treatment Period|Participant withdrew consent|0|||
143397326|NCT01928394|517004630|FG000|Treatment Period|Poor/non-compliance|0|||
143397327|NCT01928394|517004631|FG001|Treatment Period|Poor/non-compliance|0|||
143397328|NCT01928394|517004632|FG002|Treatment Period|Poor/non-compliance|0|||
143397329|NCT01928394|517004633|FG003|Treatment Period|Poor/non-compliance|1|||
143397330|NCT01928394|517004634|FG004|Treatment Period|Poor/non-compliance|0|||
143397331|NCT01928394|517004635|FG005|Treatment Period|Poor/non-compliance|0|||
143397332|NCT01928394|517004636|FG006|Treatment Period|Poor/non-compliance|0|||
143397333|NCT01928394|517004637|FG007|Treatment Period|Poor/non-compliance|0|||
143397334|NCT01928394|517004638|FG008|Treatment Period|Poor/non-compliance|0|||
143397335|NCT01928394|517004639|FG009|Treatment Period|Poor/non-compliance|0|||
143397336|NCT01928394|517004640|FG010|Treatment Period|Poor/non-compliance|0|||
143397337|NCT01928394|517004641|FG011|Treatment Period|Poor/non-compliance|0|||
143397338|NCT01928394|517004642|FG012|Treatment Period|Poor/non-compliance|1|||
143397339|NCT01928394|517004643|FG013|Treatment Period|Poor/non-compliance|0|||
143397340|NCT01928394|517004644|FG014|Treatment Period|Poor/non-compliance|1|||
143397341|NCT01928394|517004645|FG015|Treatment Period|Poor/non-compliance|0|||
143397342|NCT01928394|517004646|FG016|Treatment Period|Poor/non-compliance|0|||
143397343|NCT01928394|517004647|FG017|Treatment Period|Poor/non-compliance|1|||
143397344|NCT01928394|517004648|FG018|Treatment Period|Poor/non-compliance|0|||
143397345|NCT01928394|517004649|FG019|Treatment Period|Poor/non-compliance|1|||
143397346|NCT01928394|517004650|FG020|Treatment Period|Poor/non-compliance|0|||
143397347|NCT01928394|517004651|FG021|Treatment Period|Poor/non-compliance|0|||
143397348|NCT01928394|517004652|FG022|Treatment Period|Poor/non-compliance|0|||
143397349|NCT01928394|517004630|FG000|Treatment Period|other reason|0|||
143397350|NCT01928394|517004631|FG001|Treatment Period|other reason|0|||
143397351|NCT01928394|517004632|FG002|Treatment Period|other reason|0|||
143397352|NCT01928394|517004633|FG003|Treatment Period|other reason|0|||
143397353|NCT01928394|517004634|FG004|Treatment Period|other reason|0|||
143397354|NCT01928394|517004635|FG005|Treatment Period|other reason|0|||
143397355|NCT01928394|517004636|FG006|Treatment Period|other reason|0|||
143397356|NCT01928394|517004637|FG007|Treatment Period|other reason|0|||
143397357|NCT01928394|517004638|FG008|Treatment Period|other reason|0|||
143397358|NCT01928394|517004639|FG009|Treatment Period|other reason|0|||
143397359|NCT01928394|517004640|FG010|Treatment Period|other reason|1|||
143397360|NCT01928394|517004641|FG011|Treatment Period|other reason|1|||
143397361|NCT01928394|517004642|FG012|Treatment Period|other reason|1|||
143397362|NCT01928394|517004643|FG013|Treatment Period|other reason|0|||
143397363|NCT01928394|517004644|FG014|Treatment Period|other reason|1|||
143397364|NCT01928394|517004645|FG015|Treatment Period|other reason|0|||
143397365|NCT01928394|517004646|FG016|Treatment Period|other reason|0|||
143397366|NCT01928394|517004647|FG017|Treatment Period|other reason|0|||
143397367|NCT01928394|517004648|FG018|Treatment Period|other reason|2|||
143397368|NCT01928394|517004649|FG019|Treatment Period|other reason|2|||
143397369|NCT01928394|517004650|FG020|Treatment Period|other reason|0|||
143397370|NCT01928394|517004651|FG021|Treatment Period|other reason|0|||
143397371|NCT01928394|517004652|FG022|Treatment Period|other reason|0|||
143397372|NCT01928394|517004630|FG000|Treatment Period|Maximum clinical benefit|0|||
143397373|NCT01928394|517004631|FG001|Treatment Period|Maximum clinical benefit|0|||
143397374|NCT01928394|517004632|FG002|Treatment Period|Maximum clinical benefit|0|||
143397375|NCT01928394|517004633|FG003|Treatment Period|Maximum clinical benefit|0|||
143397376|NCT01928394|517004634|FG004|Treatment Period|Maximum clinical benefit|0|||
143397377|NCT01928394|517004635|FG005|Treatment Period|Maximum clinical benefit|0|||
143397378|NCT01928394|517004636|FG006|Treatment Period|Maximum clinical benefit|0|||
143397379|NCT01928394|517004637|FG007|Treatment Period|Maximum clinical benefit|0|||
143397380|NCT01928394|517004638|FG008|Treatment Period|Maximum clinical benefit|0|||
143397381|NCT01928394|517004639|FG009|Treatment Period|Maximum clinical benefit|0|||
143343195|NCT00279201|516800886|FG003|Maintenance|Protocol Violation|0|||
143343196|NCT00279201|516800887|FG004|Maintenance|Protocol Violation|0|||
143343197|NCT00279201|516800888|FG005|Maintenance|Protocol Violation|0|||
143343198|NCT00279201|516800883|FG000|Maintenance|Withdrawal by Subject|18|||
143343199|NCT00279201|516800884|FG001|Maintenance|Withdrawal by Subject|18|||
143343200|NCT00279201|516800885|FG002|Maintenance|Withdrawal by Subject|0|||
143343201|NCT00279201|516800886|FG003|Maintenance|Withdrawal by Subject|0|||
143343202|NCT00279201|516800887|FG004|Maintenance|Withdrawal by Subject|0|||
143343203|NCT00279201|516800888|FG005|Maintenance|Withdrawal by Subject|0|||
143343204|NCT00279201|516800883|FG000|Maintenance|Physician Decision|9|||
143343205|NCT00279201|516800884|FG001|Maintenance|Physician Decision|9|||
143343206|NCT00279201|516800885|FG002|Maintenance|Physician Decision|0|||
143343207|NCT00279201|516800886|FG003|Maintenance|Physician Decision|0|||
143343208|NCT00279201|516800887|FG004|Maintenance|Physician Decision|0|||
143343209|NCT00279201|516800888|FG005|Maintenance|Physician Decision|0|||
143343210|NCT00279201|516800883|FG000|Maintenance|Sponsor Decision|4|||
143343211|NCT00279201|516800884|FG001|Maintenance|Sponsor Decision|0|||
143343212|NCT00279201|516800885|FG002|Maintenance|Sponsor Decision|0|||
143343213|NCT00279201|516800886|FG003|Maintenance|Sponsor Decision|0|||
143343214|NCT00279201|516800887|FG004|Maintenance|Sponsor Decision|0|||
143343215|NCT00279201|516800888|FG005|Maintenance|Sponsor Decision|0|||
143343216|NCT00279201|516800883|FG000|Maintenance|HbA1c>7.5%|123|||
143343217|NCT00279201|516800884|FG001|Maintenance|HbA1c>7.5%|126|||
143343218|NCT00279201|516800885|FG002|Maintenance|HbA1c>7.5%|0|||
143343219|NCT00279201|516800886|FG003|Maintenance|HbA1c>7.5%|0|||
143343220|NCT00279201|516800887|FG004|Maintenance|HbA1c>7.5%|0|||
143343221|NCT00279201|516800888|FG005|Maintenance|HbA1c>7.5%|0|||
143343222|NCT00279201|516800883|FG000|Intensification Addendum|Withdrawal by Subject|0|||
143343223|NCT00279201|516800884|FG001|Intensification Addendum|Withdrawal by Subject|0|||
143343224|NCT00279201|516800885|FG002|Intensification Addendum|Withdrawal by Subject|12|||
143343225|NCT00279201|516800886|FG003|Intensification Addendum|Withdrawal by Subject|14|||
143343226|NCT00279201|516800887|FG004|Intensification Addendum|Withdrawal by Subject|9|||
143343227|NCT00279201|516800888|FG005|Intensification Addendum|Withdrawal by Subject|18|||
143343228|NCT00279201|516800883|FG000|Intensification Addendum|Lost to Follow-up|0|||
143343229|NCT00279201|516800884|FG001|Intensification Addendum|Lost to Follow-up|0|||
143343230|NCT00279201|516800885|FG002|Intensification Addendum|Lost to Follow-up|4|||
143343231|NCT00279201|516800886|FG003|Intensification Addendum|Lost to Follow-up|6|||
143343232|NCT00279201|516800887|FG004|Intensification Addendum|Lost to Follow-up|7|||
143343233|NCT00279201|516800888|FG005|Intensification Addendum|Lost to Follow-up|7|||
143343234|NCT00279201|516800883|FG000|Intensification Addendum|Protocol Violation|0|||
143343235|NCT00279201|516800884|FG001|Intensification Addendum|Protocol Violation|0|||
143343236|NCT00279201|516800885|FG002|Intensification Addendum|Protocol Violation|2|||
143343237|NCT00279201|516800886|FG003|Intensification Addendum|Protocol Violation|2|||
143343238|NCT00279201|516800887|FG004|Intensification Addendum|Protocol Violation|6|||
143343239|NCT00279201|516800888|FG005|Intensification Addendum|Protocol Violation|6|||
143343240|NCT00279201|516800883|FG000|Intensification Addendum|Adverse Event|0|||
143343241|NCT00279201|516800884|FG001|Intensification Addendum|Adverse Event|0|||
143343242|NCT00279201|516800885|FG002|Intensification Addendum|Adverse Event|0|||
143343243|NCT00279201|516800886|FG003|Intensification Addendum|Adverse Event|4|||
143343244|NCT00279201|516800887|FG004|Intensification Addendum|Adverse Event|1|||
143343245|NCT00279201|516800888|FG005|Intensification Addendum|Adverse Event|3|||
143343246|NCT00279201|516800883|FG000|Intensification Addendum|Physician Decision|0|||
143343247|NCT00279201|516800884|FG001|Intensification Addendum|Physician Decision|0|||
143343248|NCT00279201|516800885|FG002|Intensification Addendum|Physician Decision|4|||
143343249|NCT00279201|516800886|FG003|Intensification Addendum|Physician Decision|1|||
143343250|NCT00279201|516800887|FG004|Intensification Addendum|Physician Decision|3|||
143343251|NCT00279201|516800888|FG005|Intensification Addendum|Physician Decision|2|||
143343252|NCT00279201|516800883|FG000|Intensification Addendum|Sponsor Decision|0|||
143343253|NCT00279201|516800884|FG001|Intensification Addendum|Sponsor Decision|0|||
143343254|NCT00279201|516800885|FG002|Intensification Addendum|Sponsor Decision|0|||
143343255|NCT00279201|516800886|FG003|Intensification Addendum|Sponsor Decision|0|||
143343256|NCT00279201|516800887|FG004|Intensification Addendum|Sponsor Decision|1|||
143343257|NCT00279201|516800888|FG005|Intensification Addendum|Sponsor Decision|1|||
143343258|NCT00279201|516800883|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
143343259|NCT00279201|516800884|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
143343260|NCT00279201|516800885|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
143343261|NCT00279201|516800886|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
143343262|NCT00279201|516800887|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
143343263|NCT00279201|516800888|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
143343264|NCT00279201|516800883|FG000|Intensification Addendum|Lack of Efficacy|0|||
143343265|NCT00279201|516800884|FG001|Intensification Addendum|Lack of Efficacy|0|||
143343266|NCT00279201|516800885|FG002|Intensification Addendum|Lack of Efficacy|0|||
143343267|NCT00279201|516800886|FG003|Intensification Addendum|Lack of Efficacy|1|||
143343268|NCT00279201|516800887|FG004|Intensification Addendum|Lack of Efficacy|1|||
143397382|NCT01928394|517004640|FG010|Treatment Period|Maximum clinical benefit|1|||
143397383|NCT01928394|517004641|FG011|Treatment Period|Maximum clinical benefit|1|||
143397384|NCT01928394|517004642|FG012|Treatment Period|Maximum clinical benefit|0|||
143397385|NCT01928394|517004643|FG013|Treatment Period|Maximum clinical benefit|0|||
143397386|NCT01928394|517004644|FG014|Treatment Period|Maximum clinical benefit|1|||
143397387|NCT01928394|517004645|FG015|Treatment Period|Maximum clinical benefit|0|||
143397388|NCT01928394|517004646|FG016|Treatment Period|Maximum clinical benefit|0|||
143397389|NCT01928394|517004647|FG017|Treatment Period|Maximum clinical benefit|1|||
143397390|NCT01928394|517004648|FG018|Treatment Period|Maximum clinical benefit|1|||
143397391|NCT01928394|517004649|FG019|Treatment Period|Maximum clinical benefit|0|||
143397392|NCT01928394|517004650|FG020|Treatment Period|Maximum clinical benefit|2|||
143397393|NCT01928394|517004651|FG021|Treatment Period|Maximum clinical benefit|0|||
143397394|NCT01928394|517004652|FG022|Treatment Period|Maximum clinical benefit|0|||
143397395|NCT01928394|517004630|FG000|Treatment Period|Lost to Follow-up|0|||
143397396|NCT01928394|517004631|FG001|Treatment Period|Lost to Follow-up|0|||
143397397|NCT01928394|517004632|FG002|Treatment Period|Lost to Follow-up|0|||
143397398|NCT01928394|517004633|FG003|Treatment Period|Lost to Follow-up|0|||
143397399|NCT01928394|517004634|FG004|Treatment Period|Lost to Follow-up|0|||
143397400|NCT01928394|517004635|FG005|Treatment Period|Lost to Follow-up|0|||
143397401|NCT01928394|517004636|FG006|Treatment Period|Lost to Follow-up|0|||
143397402|NCT01928394|517004637|FG007|Treatment Period|Lost to Follow-up|0|||
143397403|NCT01928394|517004638|FG008|Treatment Period|Lost to Follow-up|0|||
143397404|NCT01928394|517004639|FG009|Treatment Period|Lost to Follow-up|0|||
143397405|NCT01928394|517004640|FG010|Treatment Period|Lost to Follow-up|0|||
143397406|NCT01928394|517004641|FG011|Treatment Period|Lost to Follow-up|0|||
143397407|NCT01928394|517004642|FG012|Treatment Period|Lost to Follow-up|0|||
143397408|NCT01928394|517004643|FG013|Treatment Period|Lost to Follow-up|0|||
143397409|NCT01928394|517004644|FG014|Treatment Period|Lost to Follow-up|0|||
143397410|NCT01928394|517004645|FG015|Treatment Period|Lost to Follow-up|0|||
143397411|NCT01928394|517004646|FG016|Treatment Period|Lost to Follow-up|0|||
143397412|NCT01928394|517004647|FG017|Treatment Period|Lost to Follow-up|0|||
143397413|NCT01928394|517004648|FG018|Treatment Period|Lost to Follow-up|0|||
143397414|NCT01928394|517004649|FG019|Treatment Period|Lost to Follow-up|0|||
143397415|NCT01928394|517004650|FG020|Treatment Period|Lost to Follow-up|0|||
143397416|NCT01928394|517004651|FG021|Treatment Period|Lost to Follow-up|0|||
143397417|NCT01928394|517004652|FG022|Treatment Period|Lost to Follow-up|1|||
143397418|NCT01928394|517004630|FG000|Treatment Period|Death|0|||
143397419|NCT01928394|517004631|FG001|Treatment Period|Death|0|||
143397420|NCT01928394|517004632|FG002|Treatment Period|Death|0|||
143397421|NCT01928394|517004633|FG003|Treatment Period|Death|0|||
143397422|NCT01928394|517004634|FG004|Treatment Period|Death|0|||
143397423|NCT01928394|517004635|FG005|Treatment Period|Death|0|||
143397424|NCT01928394|517004636|FG006|Treatment Period|Death|0|||
143397425|NCT01928394|517004637|FG007|Treatment Period|Death|0|||
143397426|NCT01928394|517004638|FG008|Treatment Period|Death|0|||
143397427|NCT01928394|517004639|FG009|Treatment Period|Death|0|||
143397428|NCT01928394|517004640|FG010|Treatment Period|Death|0|||
143397429|NCT01928394|517004641|FG011|Treatment Period|Death|0|||
143397430|NCT01928394|517004642|FG012|Treatment Period|Death|0|||
143397431|NCT01928394|517004643|FG013|Treatment Period|Death|1|||
143397432|NCT01928394|517004644|FG014|Treatment Period|Death|2|||
143397433|NCT01928394|517004645|FG015|Treatment Period|Death|0|||
143397434|NCT01928394|517004646|FG016|Treatment Period|Death|0|||
143397435|NCT01928394|517004647|FG017|Treatment Period|Death|0|||
143397436|NCT01928394|517004648|FG018|Treatment Period|Death|0|||
143397437|NCT01928394|517004649|FG019|Treatment Period|Death|0|||
143397438|NCT01928394|517004650|FG020|Treatment Period|Death|0|||
143397439|NCT01928394|517004651|FG021|Treatment Period|Death|0|||
143397440|NCT01928394|517004652|FG022|Treatment Period|Death|0|||
143397441|NCT01928394|517004630|FG000|Follow-up Period|Participant withdrew consent|3|||
143397442|NCT01928394|517004631|FG001|Follow-up Period|Participant withdrew consent|0|||
143397443|NCT01928394|517004632|FG002|Follow-up Period|Participant withdrew consent|1|||
143397444|NCT01928394|517004633|FG003|Follow-up Period|Participant withdrew consent|4|||
143397445|NCT01928394|517004634|FG004|Follow-up Period|Participant withdrew consent|0|||
143397446|NCT01928394|517004635|FG005|Follow-up Period|Participant withdrew consent|2|||
143397447|NCT01928394|517004636|FG006|Follow-up Period|Participant withdrew consent|5|||
143397448|NCT01928394|517004637|FG007|Follow-up Period|Participant withdrew consent|1|||
143397449|NCT01928394|517004638|FG008|Follow-up Period|Participant withdrew consent|0|||
143397450|NCT01928394|517004639|FG009|Follow-up Period|Participant withdrew consent|0|||
143397451|NCT01928394|517004640|FG010|Follow-up Period|Participant withdrew consent|5|||
143397452|NCT01928394|517004641|FG011|Follow-up Period|Participant withdrew consent|8|||
143397453|NCT01928394|517004642|FG012|Follow-up Period|Participant withdrew consent|2|||
143397454|NCT01928394|517004643|FG013|Follow-up Period|Participant withdrew consent|12|||
143397455|NCT01928394|517004644|FG014|Follow-up Period|Participant withdrew consent|7|||
143397456|NCT01928394|517004645|FG015|Follow-up Period|Participant withdrew consent|0|||
143397457|NCT01928394|517004646|FG016|Follow-up Period|Participant withdrew consent|5|||
143397458|NCT01928394|517004647|FG017|Follow-up Period|Participant withdrew consent|3|||
143397459|NCT01928394|517004648|FG018|Follow-up Period|Participant withdrew consent|2|||
143397460|NCT01928394|517004649|FG019|Follow-up Period|Participant withdrew consent|7|||
143397461|NCT01928394|517004650|FG020|Follow-up Period|Participant withdrew consent|4|||
143397462|NCT01928394|517004651|FG021|Follow-up Period|Participant withdrew consent|6|||
143397463|NCT01928394|517004652|FG022|Follow-up Period|Participant withdrew consent|2|||
143397464|NCT01928394|517004630|FG000|Follow-up Period|Death|0|||
143397465|NCT01928394|517004631|FG001|Follow-up Period|Death|0|||
143397466|NCT01928394|517004632|FG002|Follow-up Period|Death|2|||
143397467|NCT01928394|517004633|FG003|Follow-up Period|Death|6|||
143397468|NCT01928394|517004634|FG004|Follow-up Period|Death|0|||
143397469|NCT01928394|517004635|FG005|Follow-up Period|Death|6|||
143397470|NCT01928394|517004636|FG006|Follow-up Period|Death|6|||
143397471|NCT01928394|517004637|FG007|Follow-up Period|Death|2|||
143397472|NCT01928394|517004638|FG008|Follow-up Period|Death|1|||
143397473|NCT01928394|517004639|FG009|Follow-up Period|Death|2|||
143397474|NCT01928394|517004640|FG010|Follow-up Period|Death|4|||
143397475|NCT01928394|517004641|FG011|Follow-up Period|Death|12|||
143397476|NCT01928394|517004642|FG012|Follow-up Period|Death|11|||
143397477|NCT01928394|517004643|FG013|Follow-up Period|Death|25|||
143397478|NCT01928394|517004644|FG014|Follow-up Period|Death|18|||
143397479|NCT01928394|517004645|FG015|Follow-up Period|Death|0|||
143397480|NCT01928394|517004646|FG016|Follow-up Period|Death|6|||
143397481|NCT01928394|517004647|FG017|Follow-up Period|Death|5|||
143397482|NCT01928394|517004648|FG018|Follow-up Period|Death|13|||
143397483|NCT01928394|517004649|FG019|Follow-up Period|Death|13|||
143397484|NCT01928394|517004650|FG020|Follow-up Period|Death|5|||
143397485|NCT01928394|517004651|FG021|Follow-up Period|Death|3|||
143397486|NCT01928394|517004652|FG022|Follow-up Period|Death|2|||
143397487|NCT01928394|517004630|FG000|Follow-up Period|other reason|0|||
143397488|NCT01928394|517004631|FG001|Follow-up Period|other reason|0|||
143397489|NCT01928394|517004632|FG002|Follow-up Period|other reason|0|||
143397490|NCT01928394|517004633|FG003|Follow-up Period|other reason|0|||
143397491|NCT01928394|517004634|FG004|Follow-up Period|other reason|0|||
143397492|NCT01928394|517004635|FG005|Follow-up Period|other reason|0|||
143397493|NCT01928394|517004636|FG006|Follow-up Period|other reason|1|||
143397494|NCT01928394|517004637|FG007|Follow-up Period|other reason|3|||
143397495|NCT01928394|517004638|FG008|Follow-up Period|other reason|0|||
143397496|NCT01928394|517004639|FG009|Follow-up Period|other reason|0|||
143397497|NCT01928394|517004640|FG010|Follow-up Period|other reason|2|||
143397498|NCT01928394|517004641|FG011|Follow-up Period|other reason|1|||
143397499|NCT01928394|517004642|FG012|Follow-up Period|other reason|0|||
143397500|NCT01928394|517004643|FG013|Follow-up Period|other reason|1|||
143397501|NCT01928394|517004644|FG014|Follow-up Period|other reason|4|||
143397502|NCT01928394|517004645|FG015|Follow-up Period|other reason|0|||
143397503|NCT01928394|517004646|FG016|Follow-up Period|other reason|2|||
143397504|NCT01928394|517004647|FG017|Follow-up Period|other reason|0|||
143397505|NCT01928394|517004648|FG018|Follow-up Period|other reason|1|||
143397506|NCT01928394|517004649|FG019|Follow-up Period|other reason|1|||
143397507|NCT01928394|517004650|FG020|Follow-up Period|other reason|0|||
143397508|NCT01928394|517004651|FG021|Follow-up Period|other reason|0|||
143397509|NCT01928394|517004652|FG022|Follow-up Period|other reason|1|||
143397510|NCT01928394|517004630|FG000|Follow-up Period|Lost to Follow-up|0|||
143397511|NCT01928394|517004631|FG001|Follow-up Period|Lost to Follow-up|0|||
143397512|NCT01928394|517004632|FG002|Follow-up Period|Lost to Follow-up|0|||
143397513|NCT01928394|517004633|FG003|Follow-up Period|Lost to Follow-up|0|||
143397514|NCT01928394|517004634|FG004|Follow-up Period|Lost to Follow-up|0|||
143397515|NCT01928394|517004635|FG005|Follow-up Period|Lost to Follow-up|0|||
143397516|NCT01928394|517004636|FG006|Follow-up Period|Lost to Follow-up|0|||
143397517|NCT01928394|517004637|FG007|Follow-up Period|Lost to Follow-up|0|||
143397518|NCT01928394|517004638|FG008|Follow-up Period|Lost to Follow-up|0|||
143397519|NCT01928394|517004639|FG009|Follow-up Period|Lost to Follow-up|0|||
143397520|NCT01928394|517004640|FG010|Follow-up Period|Lost to Follow-up|0|||
143397521|NCT01928394|517004641|FG011|Follow-up Period|Lost to Follow-up|1|||
143397522|NCT01928394|517004642|FG012|Follow-up Period|Lost to Follow-up|1|||
143397523|NCT01928394|517004643|FG013|Follow-up Period|Lost to Follow-up|0|||
143397524|NCT01928394|517004644|FG014|Follow-up Period|Lost to Follow-up|1|||
143397525|NCT01928394|517004645|FG015|Follow-up Period|Lost to Follow-up|0|||
143397526|NCT01928394|517004646|FG016|Follow-up Period|Lost to Follow-up|1|||
143397527|NCT01928394|517004647|FG017|Follow-up Period|Lost to Follow-up|0|||
143397528|NCT01928394|517004648|FG018|Follow-up Period|Lost to Follow-up|0|||
143397529|NCT01928394|517004649|FG019|Follow-up Period|Lost to Follow-up|0|||
143397530|NCT01928394|517004650|FG020|Follow-up Period|Lost to Follow-up|0|||
143397531|NCT01928394|517004651|FG021|Follow-up Period|Lost to Follow-up|0|||
143397532|NCT01928394|517004652|FG022|Follow-up Period|Lost to Follow-up|1|||
143397533|NCT05764525|517004653|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
143397534|NCT05764525|517004654|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
143397535|NCT05764525|517004653|FG000|Overall Study|Withdrawal by Subject|4|||
143397536|NCT05764525|517004654|FG001|Overall Study|Withdrawal by Subject|8|||
143397537|NCT05764525|517004653|FG000|Overall Study|Physician Decision|1|||
143397538|NCT05764525|517004654|FG001|Overall Study|Physician Decision|0|||
143397539|NCT05907174|517004657|FG000|3-Month Assessment|Withdrawal by Subject|0|||
143397540|NCT05907174|517004658|FG001|3-Month Assessment|Withdrawal by Subject|0|||
143397541|NCT05907174|517004659|FG002|3-Month Assessment|Withdrawal by Subject|0|||
143397542|NCT05907174|517004660|FG003|3-Month Assessment|Withdrawal by Subject|1|||
143397543|NCT05907174|517004657|FG000|3-Month Assessment|Lost to Follow-up|1|||
143397544|NCT05907174|517004658|FG001|3-Month Assessment|Lost to Follow-up|1|||
143397545|NCT05907174|517004659|FG002|3-Month Assessment|Lost to Follow-up|1|||
143397546|NCT05907174|517004660|FG003|3-Month Assessment|Lost to Follow-up|1|||
143397547|NCT05907174|517004657|FG000|6-Month Assessment|Death|0|||
143397548|NCT05907174|517004658|FG001|6-Month Assessment|Death|0|||
143397549|NCT05907174|517004659|FG002|6-Month Assessment|Death|3|||
143397550|NCT05907174|517004660|FG003|6-Month Assessment|Death|0|||
143397551|NCT05907174|517004657|FG000|6-Month Assessment|Withdrawal by Subject|0|||
143397552|NCT05907174|517004658|FG001|6-Month Assessment|Withdrawal by Subject|0|||
143397553|NCT05907174|517004659|FG002|6-Month Assessment|Withdrawal by Subject|1|||
143397554|NCT05907174|517004660|FG003|6-Month Assessment|Withdrawal by Subject|1|||
143397555|NCT05907174|517004657|FG000|6-Month Assessment|Lost to Follow-up|0|||
143397556|NCT05907174|517004658|FG001|6-Month Assessment|Lost to Follow-up|1|||
143397557|NCT05907174|517004659|FG002|6-Month Assessment|Lost to Follow-up|1|||
143397558|NCT05907174|517004660|FG003|6-Month Assessment|Lost to Follow-up|1|||
143397559|NCT05093842|517004665|FG000|Overall Study|Pregnancy loss|1|||
143397560|NCT05093842|517004666|FG001|Overall Study|Pregnancy loss|1|||
143397561|NCT05093842|517004665|FG000|Overall Study|Lost to Follow-up|6|||
143397562|NCT05093842|517004666|FG001|Overall Study|Lost to Follow-up|0|||
143397563|NCT05093842|517004665|FG000|Overall Study|Physician Decision|0|||
143397564|NCT05093842|517004666|FG001|Overall Study|Physician Decision|1|||
143397565|NCT04800211|517004675|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|4|||
143397566|NCT04800211|517004676|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|1|||
143397567|NCT04800211|517004677|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|0|||
143397568|NCT04800211|517004675|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|1|||
143397569|NCT04800211|517004676|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
143397570|NCT04800211|517004677|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
143397571|NCT04800211|517004675|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
143397572|NCT04800211|517004676|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
143397573|NCT04800211|517004677|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|2|||
143397574|NCT04800211|517004675|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|8|||
143397575|NCT04800211|517004676|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|7|||
143397576|NCT04800211|517004677|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|2|||
143397577|NCT04800211|517004675|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Other|1|||
143397578|NCT04800211|517004676|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
143397579|NCT04800211|517004677|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
143397580|NCT04800211|517004675|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
143397581|NCT04800211|517004676|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
143397582|NCT04800211|517004677|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|1|||
143397583|NCT04800211|517004675|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
143397584|NCT04800211|517004676|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
143397585|NCT04800211|517004677|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|1|||
143397586|NCT04800211|517004675|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|8|||
143397587|NCT04800211|517004676|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|7|||
143397588|NCT04800211|517004677|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|5|||
143397589|NCT04800211|517004675|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
143397590|NCT04800211|517004676|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
143397591|NCT04800211|517004677|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|1|||
143397592|NCT04800211|517004675|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
143397593|NCT04800211|517004676|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
143397594|NCT04800211|517004677|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Other|2|||
143397595|NCT04800211|517004675|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|1|||
143397596|NCT04800211|517004676|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
143397597|NCT04800211|517004677|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
143397598|NCT03088878|517004693|FG000|Overall Study|Adverse Event|0|||
143397599|NCT03088878|517004694|FG001|Overall Study|Adverse Event|0|||
143397600|NCT03088878|517004695|FG002|Overall Study|Adverse Event|0|||
143397601|NCT03088878|517004696|FG003|Overall Study|Adverse Event|0|||
143397602|NCT03088878|517004697|FG004|Overall Study|Adverse Event|4|||
143397603|NCT03088878|517004698|FG005|Overall Study|Adverse Event|2|||
143397604|NCT03088878|517004699|FG006|Overall Study|Adverse Event|1|||
143397605|NCT03088878|517004700|FG007|Overall Study|Adverse Event|0|||
143397606|NCT03088878|517004701|FG008|Overall Study|Adverse Event|0|||
143397607|NCT03088878|517004702|FG009|Overall Study|Adverse Event|0|||
143397608|NCT03088878|517004703|FG010|Overall Study|Adverse Event|0|||
143397609|NCT03088878|517004704|FG011|Overall Study|Adverse Event|0|||
143397610|NCT03088878|517004705|FG012|Overall Study|Adverse Event|5|||
143397611|NCT03088878|517004706|FG013|Overall Study|Adverse Event|3|||
143397612|NCT03088878|517004693|FG000|Overall Study|Clinical Progression|0|||
143397613|NCT03088878|517004694|FG001|Overall Study|Clinical Progression|0|||
143397614|NCT03088878|517004695|FG002|Overall Study|Clinical Progression|0|||
143397615|NCT03088878|517004696|FG003|Overall Study|Clinical Progression|0|||
143397616|NCT03088878|517004697|FG004|Overall Study|Clinical Progression|2|||
143397617|NCT03088878|517004698|FG005|Overall Study|Clinical Progression|0|||
143397618|NCT03088878|517004699|FG006|Overall Study|Clinical Progression|0|||
143397619|NCT03088878|517004700|FG007|Overall Study|Clinical Progression|0|||
143397620|NCT03088878|517004701|FG008|Overall Study|Clinical Progression|0|||
143397621|NCT03088878|517004702|FG009|Overall Study|Clinical Progression|0|||
143397622|NCT03088878|517004703|FG010|Overall Study|Clinical Progression|0|||
143397623|NCT03088878|517004704|FG011|Overall Study|Clinical Progression|0|||
143397624|NCT03088878|517004705|FG012|Overall Study|Clinical Progression|0|||
143397625|NCT03088878|517004706|FG013|Overall Study|Clinical Progression|0|||
143397626|NCT03088878|517004693|FG000|Overall Study|Death|0|||
143397627|NCT03088878|517004694|FG001|Overall Study|Death|0|||
143397628|NCT03088878|517004695|FG002|Overall Study|Death|0|||
143397629|NCT03088878|517004696|FG003|Overall Study|Death|0|||
143397630|NCT03088878|517004697|FG004|Overall Study|Death|2|||
143397631|NCT03088878|517004698|FG005|Overall Study|Death|0|||
143397632|NCT03088878|517004699|FG006|Overall Study|Death|0|||
143397633|NCT03088878|517004700|FG007|Overall Study|Death|0|||
143397634|NCT03088878|517004701|FG008|Overall Study|Death|0|||
143397635|NCT03088878|517004702|FG009|Overall Study|Death|0|||
143397636|NCT03088878|517004703|FG010|Overall Study|Death|0|||
143397637|NCT03088878|517004704|FG011|Overall Study|Death|1|||
143397638|NCT03088878|517004705|FG012|Overall Study|Death|0|||
143397639|NCT03088878|517004706|FG013|Overall Study|Death|0|||
143397640|NCT03088878|517004693|FG000|Overall Study|Disease Progression|1|||
143397641|NCT03088878|517004694|FG001|Overall Study|Disease Progression|2|||
143397642|NCT03088878|517004695|FG002|Overall Study|Disease Progression|3|||
143397643|NCT03088878|517004696|FG003|Overall Study|Disease Progression|0|||
143397644|NCT03088878|517004697|FG004|Overall Study|Disease Progression|3|||
143397645|NCT03088878|517004698|FG005|Overall Study|Disease Progression|0|||
143397646|NCT03088878|517004699|FG006|Overall Study|Disease Progression|0|||
143397647|NCT03088878|517004700|FG007|Overall Study|Disease Progression|0|||
143397648|NCT03088878|517004701|FG008|Overall Study|Disease Progression|0|||
143397649|NCT03088878|517004702|FG009|Overall Study|Disease Progression|0|||
143397650|NCT03088878|517004703|FG010|Overall Study|Disease Progression|0|||
143397651|NCT03088878|517004704|FG011|Overall Study|Disease Progression|0|||
143397652|NCT03088878|517004705|FG012|Overall Study|Disease Progression|1|||
143397653|NCT03088878|517004706|FG013|Overall Study|Disease Progression|1|||
143397654|NCT03088878|517004693|FG000|Overall Study|Initiation of Alternative Treatment|0|||
143397655|NCT03088878|517004694|FG001|Overall Study|Initiation of Alternative Treatment|0|||
143397656|NCT03088878|517004695|FG002|Overall Study|Initiation of Alternative Treatment|0|||
143397657|NCT03088878|517004696|FG003|Overall Study|Initiation of Alternative Treatment|1|||
143397658|NCT03088878|517004697|FG004|Overall Study|Initiation of Alternative Treatment|0|||
143397659|NCT03088878|517004698|FG005|Overall Study|Initiation of Alternative Treatment|0|||
143397660|NCT03088878|517004699|FG006|Overall Study|Initiation of Alternative Treatment|0|||
143397661|NCT03088878|517004700|FG007|Overall Study|Initiation of Alternative Treatment|1|||
143397662|NCT03088878|517004701|FG008|Overall Study|Initiation of Alternative Treatment|1|||
143397663|NCT03088878|517004702|FG009|Overall Study|Initiation of Alternative Treatment|0|||
143397664|NCT03088878|517004703|FG010|Overall Study|Initiation of Alternative Treatment|0|||
143397665|NCT03088878|517004704|FG011|Overall Study|Initiation of Alternative Treatment|0|||
143397666|NCT03088878|517004705|FG012|Overall Study|Initiation of Alternative Treatment|0|||
143397667|NCT03088878|517004706|FG013|Overall Study|Initiation of Alternative Treatment|0|||
143397668|NCT03088878|517004693|FG000|Overall Study|Withdrawal by Subject|0|||
143397669|NCT03088878|517004694|FG001|Overall Study|Withdrawal by Subject|0|||
143397670|NCT03088878|517004695|FG002|Overall Study|Withdrawal by Subject|0|||
143397671|NCT03088878|517004696|FG003|Overall Study|Withdrawal by Subject|1|||
143397672|NCT03088878|517004697|FG004|Overall Study|Withdrawal by Subject|4|||
143397673|NCT03088878|517004698|FG005|Overall Study|Withdrawal by Subject|1|||
143397674|NCT03088878|517004699|FG006|Overall Study|Withdrawal by Subject|1|||
143397675|NCT03088878|517004700|FG007|Overall Study|Withdrawal by Subject|0|||
143397676|NCT03088878|517004701|FG008|Overall Study|Withdrawal by Subject|1|||
143397677|NCT03088878|517004702|FG009|Overall Study|Withdrawal by Subject|2|||
143397678|NCT03088878|517004703|FG010|Overall Study|Withdrawal by Subject|0|||
143397679|NCT03088878|517004704|FG011|Overall Study|Withdrawal by Subject|2|||
143397680|NCT03088878|517004705|FG012|Overall Study|Withdrawal by Subject|1|||
143397681|NCT03088878|517004706|FG013|Overall Study|Withdrawal by Subject|0|||
143397682|NCT03088878|517004693|FG000|Overall Study|Terminated by Sponsor|2|||
143397683|NCT03088878|517004694|FG001|Overall Study|Terminated by Sponsor|1|||
143397684|NCT03088878|517004695|FG002|Overall Study|Terminated by Sponsor|0|||
143397685|NCT03088878|517004696|FG003|Overall Study|Terminated by Sponsor|1|||
143397686|NCT03088878|517004697|FG004|Overall Study|Terminated by Sponsor|6|||
143397687|NCT03088878|517004698|FG005|Overall Study|Terminated by Sponsor|0|||
143397688|NCT03088878|517004699|FG006|Overall Study|Terminated by Sponsor|0|||
143397689|NCT03088878|517004700|FG007|Overall Study|Terminated by Sponsor|0|||
143397690|NCT03088878|517004701|FG008|Overall Study|Terminated by Sponsor|0|||
143397691|NCT03088878|517004702|FG009|Overall Study|Terminated by Sponsor|0|||
143397692|NCT03088878|517004703|FG010|Overall Study|Terminated by Sponsor|3|||
143397693|NCT03088878|517004704|FG011|Overall Study|Terminated by Sponsor|13|||
143397694|NCT03088878|517004705|FG012|Overall Study|Terminated by Sponsor|2|||
143397695|NCT03088878|517004706|FG013|Overall Study|Terminated by Sponsor|1|||
143397696|NCT03088878|517004693|FG000|Overall Study|Completed 2 years of Treatment|0|||
143397697|NCT03088878|517004694|FG001|Overall Study|Completed 2 years of Treatment|0|||
143397698|NCT03088878|517004695|FG002|Overall Study|Completed 2 years of Treatment|0|||
143397699|NCT03088878|517004696|FG003|Overall Study|Completed 2 years of Treatment|0|||
143397700|NCT03088878|517004697|FG004|Overall Study|Completed 2 years of Treatment|0|||
143397701|NCT03088878|517004698|FG005|Overall Study|Completed 2 years of Treatment|0|||
143397702|NCT03088878|517004699|FG006|Overall Study|Completed 2 years of Treatment|1|||
143397703|NCT03088878|517004700|FG007|Overall Study|Completed 2 years of Treatment|0|||
143397704|NCT03088878|517004701|FG008|Overall Study|Completed 2 years of Treatment|0|||
143397705|NCT03088878|517004702|FG009|Overall Study|Completed 2 years of Treatment|1|||
143397706|NCT03088878|517004703|FG010|Overall Study|Completed 2 years of Treatment|0|||
143397707|NCT03088878|517004704|FG011|Overall Study|Completed 2 years of Treatment|0|||
143397708|NCT03088878|517004705|FG012|Overall Study|Completed 2 years of Treatment|8|||
143397709|NCT03088878|517004706|FG013|Overall Study|Completed 2 years of Treatment|3|||
143397710|NCT03088878|517004693|FG000|Overall Study|Physician Decision|0|||
143397711|NCT03088878|517004694|FG001|Overall Study|Physician Decision|0|||
143397712|NCT03088878|517004695|FG002|Overall Study|Physician Decision|0|||
143397713|NCT03088878|517004696|FG003|Overall Study|Physician Decision|0|||
143397714|NCT03088878|517004697|FG004|Overall Study|Physician Decision|0|||
143397715|NCT03088878|517004698|FG005|Overall Study|Physician Decision|0|||
143397716|NCT03088878|517004699|FG006|Overall Study|Physician Decision|0|||
143397717|NCT03088878|517004700|FG007|Overall Study|Physician Decision|2|||
143397718|NCT03088878|517004701|FG008|Overall Study|Physician Decision|1|||
143397719|NCT03088878|517004702|FG009|Overall Study|Physician Decision|0|||
143397720|NCT03088878|517004703|FG010|Overall Study|Physician Decision|0|||
143397721|NCT03088878|517004704|FG011|Overall Study|Physician Decision|0|||
143397722|NCT03088878|517004705|FG012|Overall Study|Physician Decision|0|||
143397723|NCT03088878|517004706|FG013|Overall Study|Physician Decision|1|||
143397724|NCT03088878|517004693|FG000|Overall Study|COVID Related noncompliance|0|||
143397725|NCT03088878|517004694|FG001|Overall Study|COVID Related noncompliance|0|||
143397726|NCT03088878|517004695|FG002|Overall Study|COVID Related noncompliance|0|||
143397727|NCT03088878|517004696|FG003|Overall Study|COVID Related noncompliance|0|||
143397728|NCT03088878|517004697|FG004|Overall Study|COVID Related noncompliance|0|||
143397729|NCT03088878|517004698|FG005|Overall Study|COVID Related noncompliance|0|||
143397730|NCT03088878|517004699|FG006|Overall Study|COVID Related noncompliance|0|||
143397731|NCT03088878|517004700|FG007|Overall Study|COVID Related noncompliance|0|||
143397732|NCT03088878|517004701|FG008|Overall Study|COVID Related noncompliance|0|||
143397733|NCT03088878|517004702|FG009|Overall Study|COVID Related noncompliance|0|||
143397734|NCT03088878|517004703|FG010|Overall Study|COVID Related noncompliance|0|||
143397735|NCT03088878|517004704|FG011|Overall Study|COVID Related noncompliance|0|||
143397736|NCT03088878|517004705|FG012|Overall Study|COVID Related noncompliance|0|||
143343269|NCT00279201|516800888|FG005|Intensification Addendum|Lack of Efficacy|0|||
143343270|NCT00279201|516800883|FG000|Intensification Addendum|Death|0|||
143343271|NCT00279201|516800884|FG001|Intensification Addendum|Death|0|||
143343272|NCT00279201|516800885|FG002|Intensification Addendum|Death|0|||
143343273|NCT00279201|516800886|FG003|Intensification Addendum|Death|0|||
143343274|NCT00279201|516800887|FG004|Intensification Addendum|Death|1|||
143343275|NCT00279201|516800888|FG005|Intensification Addendum|Death|0|||
143397737|NCT03088878|517004706|FG013|Overall Study|COVID Related noncompliance|1|||
143397738|NCT03088878|517004693|FG000|Overall Study|Drug or Study Noncompliance|0|||
143397739|NCT03088878|517004694|FG001|Overall Study|Drug or Study Noncompliance|0|||
143397740|NCT03088878|517004695|FG002|Overall Study|Drug or Study Noncompliance|0|||
143397741|NCT03088878|517004696|FG003|Overall Study|Drug or Study Noncompliance|0|||
143397742|NCT03088878|517004697|FG004|Overall Study|Drug or Study Noncompliance|0|||
143397743|NCT03088878|517004698|FG005|Overall Study|Drug or Study Noncompliance|0|||
143397744|NCT03088878|517004699|FG006|Overall Study|Drug or Study Noncompliance|0|||
143397745|NCT03088878|517004700|FG007|Overall Study|Drug or Study Noncompliance|0|||
143397746|NCT03088878|517004701|FG008|Overall Study|Drug or Study Noncompliance|0|||
143397747|NCT03088878|517004702|FG009|Overall Study|Drug or Study Noncompliance|0|||
143397748|NCT03088878|517004703|FG010|Overall Study|Drug or Study Noncompliance|0|||
143397749|NCT03088878|517004704|FG011|Overall Study|Drug or Study Noncompliance|0|||
143397750|NCT03088878|517004705|FG012|Overall Study|Drug or Study Noncompliance|1|||
143397751|NCT03088878|517004706|FG013|Overall Study|Drug or Study Noncompliance|0|||
143397752|NCT02724969|517004707|FG000|Overall Study|Lost to Follow-up|12|||
143397753|NCT02724969|517004708|FG001|Overall Study|Lost to Follow-up|6|||
143397754|NCT02724969|517004707|FG000|Overall Study|Withdrawal by Subject|3|||
143397755|NCT02724969|517004708|FG001|Overall Study|Withdrawal by Subject|3|||
143397756|NCT02724969|517004707|FG000|Overall Study|Infant demise|0|||
143397757|NCT02724969|517004708|FG001|Overall Study|Infant demise|2|||
143397758|NCT03672916|517004715|FG000|Overall Study|Death|6|||
143397759|NCT03672916|517004715|FG000|Overall Study|Lost to Follow-up|29|||
143397760|NCT03672916|517004715|FG000|Overall Study|Adverse Event|6|||
143397761|NCT03672916|517004715|FG000|Overall Study|Withdrawal by Subject|11|||
143397762|NCT01236781|517004716|FG000|Overall Study|Ineligible|2|||
143397763|NCT01236781|517004717|FG001|Overall Study|Ineligible|1|||
143397764|NCT01236781|517004716|FG000|Overall Study|Did not complete study imaging|5|||
143397765|NCT01236781|517004717|FG001|Overall Study|Did not complete study imaging|0|||
143397766|NCT05623228|517004722|FG000|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|1|||
143397767|NCT05623228|517004723|FG001|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
143397768|NCT05623228|517004724|FG002|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
143397769|NCT05623228|517004725|FG003|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
143397770|NCT05623228|517004726|FG004|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
143397771|NCT05623228|517004727|FG005|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
143397772|NCT05623228|517004728|FG006|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
143397773|NCT05623228|517004729|FG007|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
143397774|NCT05623228|517004722|FG000|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
143397775|NCT05623228|517004723|FG001|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
143397776|NCT05623228|517004724|FG002|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
143397777|NCT05623228|517004725|FG003|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
143397778|NCT05623228|517004726|FG004|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
143397779|NCT05623228|517004727|FG005|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
143397780|NCT05623228|517004728|FG006|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
143397781|NCT05623228|517004729|FG007|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
143397782|NCT04737330|517004731|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
143397783|NCT04737330|517004732|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
143397784|NCT04737330|517004731|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
143397785|NCT04737330|517004732|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
143397786|NCT04737330|517004731|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
143397787|NCT04737330|517004732|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
143397788|NCT04737330|517004731|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
143397789|NCT04737330|517004732|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
143397790|NCT04737330|517004731|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
143397791|NCT04737330|517004732|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
143397792|NCT04737330|517004731|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
143397793|NCT04737330|517004732|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
143397794|NCT03034356|517004738|FG000|Baseline|Lost to Follow-up|2|||
143397795|NCT03034356|517004739|FG001|Baseline|Lost to Follow-up|4|||
143397796|NCT03034356|517004738|FG000|Baseline|Withdrawal by Subject|2|||
143397797|NCT03034356|517004739|FG001|Baseline|Withdrawal by Subject|0|||
143397798|NCT03034356|517004738|FG000|Baseline|Physician Decision|0|||
143397799|NCT03034356|517004739|FG001|Baseline|Physician Decision|1|||
143397800|NCT03034356|517004738|FG000|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
143397801|NCT03034356|517004739|FG001|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
143397802|NCT03034356|517004738|FG000|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|1|||
143397803|NCT03034356|517004739|FG001|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|2|||
143397804|NCT03034356|517004738|FG000|Post-Intervention 1 (4 Weeks)|Physician Decision|1|||
143397805|NCT03034356|517004739|FG001|Post-Intervention 1 (4 Weeks)|Physician Decision|0|||
143397806|NCT03034356|517004738|FG000|Post-Washout (4 Weeks)|Withdrawal by Subject|2|||
143397807|NCT03034356|517004739|FG001|Post-Washout (4 Weeks)|Withdrawal by Subject|0|||
143397808|NCT02684227|517004740|FG000|Overall Study|Adverse Event|1|||
143397809|NCT02684227|517004741|FG001|Overall Study|Adverse Event|7|||
143397810|NCT02684227|517004740|FG000|Overall Study|Death|0|||
143397811|NCT02684227|517004741|FG001|Overall Study|Death|2|||
143397812|NCT02684227|517004740|FG000|Overall Study|Withdrawal by Subject|0|||
143397813|NCT02684227|517004741|FG001|Overall Study|Withdrawal by Subject|1|||
143397814|NCT02684227|517004740|FG000|Overall Study|Progressive Disease|0|||
143397815|NCT02684227|517004741|FG001|Overall Study|Progressive Disease|2|||
143397816|NCT04689256|517004743|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
143397817|NCT04689256|517004744|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
143397818|NCT04428203|517004747|FG000|Overall Study|Adverse Event|1|||
143397819|NCT04428203|517004748|FG001|Overall Study|Adverse Event|0|||
143397820|NCT04428203|517004749|FG002|Overall Study|Adverse Event|0|||
143397821|NCT04428203|517004747|FG000|Overall Study|Withdrawal by Subject|1|||
143397822|NCT04428203|517004748|FG001|Overall Study|Withdrawal by Subject|0|||
143397823|NCT04428203|517004749|FG002|Overall Study|Withdrawal by Subject|1|||
143397824|NCT02823145|517004750|FG000|Enrollment|Other|1|||
143397825|NCT02823145|517004751|FG001|Enrollment|Other|0|||
143397826|NCT02823145|517004750|FG000|Treatment|Adverse Event|0|||
143397827|NCT02823145|517004751|FG001|Treatment|Adverse Event|11|||
143397828|NCT02823145|517004750|FG000|Treatment|Death|0|||
143397829|NCT02823145|517004751|FG001|Treatment|Death|3|||
143397830|NCT02823145|517004750|FG000|Treatment|Family Decision|0|||
143397831|NCT02823145|517004751|FG001|Treatment|Family Decision|1|||
143397832|NCT02823145|517004750|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
143397833|NCT02823145|517004751|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
143397834|NCT02823145|517004750|FG000|Treatment|Lack of Efficacy|0|||
143397835|NCT02823145|517004751|FG001|Treatment|Lack of Efficacy|48|||
143397836|NCT02823145|517004750|FG000|Treatment|Non-Compliance With E-Diary|0|||
143397837|NCT02823145|517004751|FG001|Treatment|Non-Compliance With E-Diary|1|||
143397838|NCT02823145|517004750|FG000|Treatment|Physician Decision|0|||
143397839|NCT02823145|517004751|FG001|Treatment|Physician Decision|2|||
143397840|NCT02823145|517004750|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
143397841|NCT02823145|517004751|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
143397842|NCT02823145|517004750|FG000|Treatment|Subject needed to take prohibited medication|0|||
143397843|NCT02823145|517004751|FG001|Treatment|Subject needed to take prohibited medication|1|||
143397844|NCT02823145|517004750|FG000|Treatment|Subject transferred to direct access programme|0|||
143397845|NCT02823145|517004751|FG001|Treatment|Subject transferred to direct access programme|1|||
143397846|NCT02823145|517004750|FG000|Treatment|Switching to commercially available drug|0|||
143397847|NCT02823145|517004751|FG001|Treatment|Switching to commercially available drug|11|||
143397848|NCT02823145|517004750|FG000|Treatment|Transitioned to commercial supply of medication|0|||
143397849|NCT02823145|517004751|FG001|Treatment|Transitioned to commercial supply of medication|1|||
143397850|NCT02823145|517004750|FG000|Treatment|Withdrawal By Caregiver|0|||
143397851|NCT02823145|517004751|FG001|Treatment|Withdrawal By Caregiver|1|||
143397852|NCT02823145|517004750|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
143397853|NCT02823145|517004751|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
143397854|NCT02823145|517004750|FG000|Treatment|Withdrawal by Subject|0|||
143397855|NCT02823145|517004751|FG001|Treatment|Withdrawal by Subject|16|||
143397856|NCT02823145|517004750|FG000|Treatment|Reason unknown|0|||
143397857|NCT02823145|517004751|FG001|Treatment|Reason unknown|1|||
143397858|NCT04741776|517004752|FG000|Overall Study|Withdrawal by Subject|7|||
143397859|NCT04741776|517004753|FG001|Overall Study|Withdrawal by Subject|10|||
143397860|NCT04741776|517004754|FG002|Overall Study|Withdrawal by Subject|10|||
143397861|NCT04741776|517004755|FG003|Overall Study|Withdrawal by Subject|17|||
143397862|NCT04741776|517004752|FG000|Overall Study|Death|0|||
143397863|NCT04741776|517004753|FG001|Overall Study|Death|0|||
143397864|NCT04741776|517004754|FG002|Overall Study|Death|1|||
143397865|NCT04741776|517004755|FG003|Overall Study|Death|0|||
143397866|NCT02852655|517004771|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
143397867|NCT02852655|517004772|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
143397868|NCT02852655|517004773|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
143397869|NCT02852655|517004771|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
143397870|NCT02852655|517004772|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
143397871|NCT02852655|517004773|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
143397872|NCT02852655|517004771|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
143397873|NCT02852655|517004772|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
143397874|NCT02852655|517004773|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
143397875|NCT02852655|517004771|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
143397876|NCT02852655|517004772|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
143397877|NCT02852655|517004773|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
143397878|NCT02852655|517004771|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
143397879|NCT02852655|517004772|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
143397880|NCT02852655|517004773|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
143397881|NCT02852655|517004771|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
143397882|NCT02852655|517004772|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
143397883|NCT02852655|517004773|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
143397884|NCT02852655|517004771|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
143397885|NCT02852655|517004772|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
143397886|NCT02852655|517004773|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
143397887|NCT02852655|517004771|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
143397888|NCT02852655|517004772|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
143397889|NCT02852655|517004773|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
143397890|NCT02852655|517004771|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
143397891|NCT02852655|517004772|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
143397892|NCT02852655|517004773|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
143397893|NCT05292391|517004774|FG000|Overall Study|Lost to Follow-up|0|||
143397894|NCT05292391|517004775|FG001|Overall Study|Lost to Follow-up|0|||
143397895|NCT05292391|517004776|FG002|Overall Study|Lost to Follow-up|0|||
143397896|NCT05292391|517004777|FG003|Overall Study|Lost to Follow-up|1|||
143397897|NCT05292391|517004778|FG004|Overall Study|Lost to Follow-up|0|||
143397898|NCT05809453|517006609|FG000|Overall Study|Withdrawal by Subject|1|||
143397899|NCT05809453|517006610|FG001|Overall Study|Withdrawal by Subject|0|||
143397900|NCT05809453|517006611|FG002|Overall Study|Withdrawal by Subject|0|||
143397901|NCT05809453|517006612|FG003|Overall Study|Withdrawal by Subject|0|||
143397902|NCT00104676|517006614|FG000|Overall Study|Death|3|||
143397903|NCT00104676|517006615|FG001|Overall Study|Death|2|||
143397904|NCT00104676|517006614|FG000|Overall Study|Withdrawal by Subject|0|||
143397905|NCT00104676|517006615|FG001|Overall Study|Withdrawal by Subject|2|||
143397906|NCT00104676|517006614|FG000|Overall Study|treatment interruption|4|||
143397907|NCT00104676|517006615|FG001|Overall Study|treatment interruption|10|||
143397908|NCT03916185|517006616|FG000|Overall Study|Lost to Follow-up|0|||
143397909|NCT03916185|517006617|FG001|Overall Study|Lost to Follow-up|1|||
143397910|NCT03916185|517006618|FG002|Overall Study|Lost to Follow-up|0|||
143397911|NCT03916185|517006619|FG003|Overall Study|Lost to Follow-up|0|||
143397912|NCT03916185|517006616|FG000|Overall Study|Moved|1|||
143397913|NCT03916185|517006617|FG001|Overall Study|Moved|0|||
143397914|NCT03916185|517006618|FG002|Overall Study|Moved|0|||
143397915|NCT03916185|517006619|FG003|Overall Study|Moved|1|||
143397916|NCT03916185|517006616|FG000|Overall Study|Not Able to Get to Clinic|1|||
143397917|NCT03916185|517006617|FG001|Overall Study|Not Able to Get to Clinic|0|||
143397918|NCT03916185|517006618|FG002|Overall Study|Not Able to Get to Clinic|0|||
143397919|NCT03916185|517006619|FG003|Overall Study|Not Able to Get to Clinic|0|||
143397920|NCT05671653|517006620|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
143397921|NCT05671653|517006621|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
143397922|NCT05671653|517006622|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
143397923|NCT05671653|517006623|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
143397924|NCT05671653|517006624|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
143397925|NCT05671653|517006625|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
143397926|NCT05671653|517006626|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
143397927|NCT05671653|517006627|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
143397928|NCT05671653|517006628|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
143397929|NCT05671653|517006629|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
143397930|NCT05671653|517006630|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
143397931|NCT05671653|517006631|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
143397932|NCT05671653|517006632|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
143397933|NCT05671653|517006620|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
143397934|NCT05671653|517006621|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
143397935|NCT05671653|517006622|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
143397936|NCT05671653|517006623|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
143397937|NCT05671653|517006624|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
143397938|NCT05671653|517006625|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
143397939|NCT05671653|517006626|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
143397940|NCT05671653|517006627|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
143397941|NCT05671653|517006628|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
143397942|NCT05671653|517006629|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
143397943|NCT05671653|517006630|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
143397944|NCT05671653|517006631|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
143397945|NCT05671653|517006632|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
143397946|NCT05671653|517006620|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
143397947|NCT05671653|517006621|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
143397948|NCT05671653|517006622|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
143397949|NCT05671653|517006623|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
143397950|NCT05671653|517006624|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
143397951|NCT05671653|517006625|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
143397952|NCT05671653|517006626|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
143397953|NCT05671653|517006627|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
143397954|NCT05671653|517006628|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
143397955|NCT05671653|517006629|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
143397956|NCT05671653|517006630|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
143397957|NCT05671653|517006631|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
143397958|NCT05671653|517006632|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
143397959|NCT05671653|517006620|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
143397960|NCT05671653|517006621|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
143397961|NCT05671653|517006622|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
143397962|NCT05671653|517006623|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
143397963|NCT05671653|517006624|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
143397964|NCT05671653|517006625|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
143397965|NCT05671653|517006626|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
143397966|NCT05671653|517006627|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
143397967|NCT05671653|517006628|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
143397968|NCT05671653|517006629|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
143397969|NCT05671653|517006630|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
143397970|NCT05671653|517006631|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
143397971|NCT05671653|517006632|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
143397972|NCT05671653|517006620|FG000|Cohort 2 Period 2|Adverse Event|0|||
143397973|NCT05671653|517006621|FG001|Cohort 2 Period 2|Adverse Event|0|||
143397974|NCT05671653|517006622|FG002|Cohort 2 Period 2|Adverse Event|0|||
143397975|NCT05671653|517006623|FG003|Cohort 2 Period 2|Adverse Event|0|||
143397976|NCT05671653|517006624|FG004|Cohort 2 Period 2|Adverse Event|0|||
143397977|NCT05671653|517006625|FG005|Cohort 2 Period 2|Adverse Event|0|||
143397978|NCT05671653|517006626|FG006|Cohort 2 Period 2|Adverse Event|0|||
143397979|NCT05671653|517006627|FG007|Cohort 2 Period 2|Adverse Event|0|||
143397980|NCT05671653|517006628|FG008|Cohort 2 Period 2|Adverse Event|0|||
143397981|NCT05671653|517006629|FG009|Cohort 2 Period 2|Adverse Event|0|||
143397982|NCT05671653|517006630|FG010|Cohort 2 Period 2|Adverse Event|1|||
143397983|NCT05671653|517006631|FG011|Cohort 2 Period 2|Adverse Event|0|||
143397984|NCT05671653|517006632|FG012|Cohort 2 Period 2|Adverse Event|0|||
143397985|NCT05671653|517006620|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
143397986|NCT05671653|517006621|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
143397987|NCT05671653|517006622|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
143397988|NCT05671653|517006623|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
143397989|NCT05671653|517006624|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
143397990|NCT05671653|517006625|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
143397991|NCT05671653|517006626|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
143397992|NCT05671653|517006627|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
143397993|NCT05671653|517006628|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
143397994|NCT05671653|517006629|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
143397995|NCT05671653|517006630|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
143397996|NCT05671653|517006631|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
143397997|NCT05671653|517006632|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
143397998|NCT05671653|517006620|FG000|Cohort 2 Period 2|Pregnancy|0|||
143397999|NCT05671653|517006621|FG001|Cohort 2 Period 2|Pregnancy|0|||
143398000|NCT05671653|517006622|FG002|Cohort 2 Period 2|Pregnancy|0|||
143398001|NCT05671653|517006623|FG003|Cohort 2 Period 2|Pregnancy|0|||
143398002|NCT05671653|517006624|FG004|Cohort 2 Period 2|Pregnancy|0|||
143398003|NCT05671653|517006625|FG005|Cohort 2 Period 2|Pregnancy|0|||
143398004|NCT05671653|517006626|FG006|Cohort 2 Period 2|Pregnancy|0|||
143398005|NCT05671653|517006627|FG007|Cohort 2 Period 2|Pregnancy|0|||
143398006|NCT05671653|517006628|FG008|Cohort 2 Period 2|Pregnancy|0|||
143398007|NCT05671653|517006629|FG009|Cohort 2 Period 2|Pregnancy|0|||
143398008|NCT05671653|517006630|FG010|Cohort 2 Period 2|Pregnancy|1|||
143398009|NCT05671653|517006631|FG011|Cohort 2 Period 2|Pregnancy|0|||
143398010|NCT05671653|517006632|FG012|Cohort 2 Period 2|Pregnancy|0|||
143398011|NCT05671653|517006620|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
143398012|NCT05671653|517006621|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
143398013|NCT05671653|517006622|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
143398014|NCT05671653|517006623|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
143398015|NCT05671653|517006624|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
143398016|NCT05671653|517006625|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
143398017|NCT05671653|517006626|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
143398018|NCT05671653|517006627|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
143398019|NCT05671653|517006628|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
143398020|NCT05671653|517006629|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
143398021|NCT05671653|517006630|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
143398022|NCT05671653|517006631|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
143398023|NCT05671653|517006632|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
143398024|NCT05671653|517006620|FG000|Cohort 2 Period 2|Other|0|||
143398025|NCT05671653|517006621|FG001|Cohort 2 Period 2|Other|0|||
143398026|NCT05671653|517006622|FG002|Cohort 2 Period 2|Other|0|||
143398027|NCT05671653|517006623|FG003|Cohort 2 Period 2|Other|0|||
143398028|NCT05671653|517006624|FG004|Cohort 2 Period 2|Other|0|||
143398029|NCT05671653|517006625|FG005|Cohort 2 Period 2|Other|0|||
143398030|NCT05671653|517006626|FG006|Cohort 2 Period 2|Other|0|||
143398031|NCT05671653|517006627|FG007|Cohort 2 Period 2|Other|0|||
143398032|NCT05671653|517006628|FG008|Cohort 2 Period 2|Other|0|||
143398033|NCT05671653|517006629|FG009|Cohort 2 Period 2|Other|0|||
143398034|NCT05671653|517006630|FG010|Cohort 2 Period 2|Other|1|||
143398035|NCT05671653|517006631|FG011|Cohort 2 Period 2|Other|0|||
143398036|NCT05671653|517006632|FG012|Cohort 2 Period 2|Other|0|||
143398037|NCT05671653|517006620|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
143398038|NCT05671653|517006621|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
143398039|NCT05671653|517006622|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
143398040|NCT05671653|517006623|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
143398041|NCT05671653|517006624|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
143398042|NCT05671653|517006625|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
143398043|NCT05671653|517006626|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
143398044|NCT05671653|517006627|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
143398045|NCT05671653|517006628|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
143398046|NCT05671653|517006629|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
143398047|NCT05671653|517006630|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
143398048|NCT05671653|517006631|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
143398049|NCT05671653|517006632|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
143398050|NCT05274074|517006638|FG000|Overall Study|Lost to Follow-up|2|||
143398051|NCT05274074|517006639|FG001|Overall Study|Lost to Follow-up|3|||
143398052|NCT05274074|517006638|FG000|Overall Study|Withdrawal by Subject|1|||
143398053|NCT05274074|517006639|FG001|Overall Study|Withdrawal by Subject|2|||
143398054|NCT02593773|517006641|FG000|Overall Study|Voluntary Withdrawal|3|||
143398055|NCT02593773|517006641|FG000|Overall Study|Study Terminated by Sponsor|31|||
143398056|NCT02593773|517006641|FG000|Overall Study|Death|1|||
143398057|NCT05934942|517006647|FG000|Run-in Period|Not treated|1|||
143398058|NCT05934942|517006647|FG000|Run-in Period|Withdrawal by Subject|1|||
143398059|NCT00539591|517006648|FG000|Overall Study|Toxicity|3|||
143398060|NCT00539591|517006649|FG001|Overall Study|Toxicity|0|||
143398061|NCT00539591|517006650|FG002|Overall Study|Toxicity|0|||
143398062|NCT00539591|517006648|FG000|Overall Study|Disease progression|2|||
143398063|NCT00539591|517006649|FG001|Overall Study|Disease progression|2|||
143398064|NCT00539591|517006650|FG002|Overall Study|Disease progression|3|||
143398065|NCT04362254|517006651|FG000|Overall Study|Adverse Event|1|||
143398066|NCT04362254|517006651|FG000|Overall Study|Protocol Violation|1|||
143398067|NCT04362254|517006651|FG000|Overall Study|Due to early termination of the trial|10|||
143398068|NCT04568434|517006652|FG000|Overall Study|Voluntary Withdrawal|0|||
143398069|NCT04568434|517006653|FG001|Overall Study|Voluntary Withdrawal|1|||
143398070|NCT04568434|517006654|FG002|Overall Study|Voluntary Withdrawal|1|||
143398071|NCT04568434|517006652|FG000|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|0|||
143398072|NCT04568434|517006653|FG001|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|1|||
143398073|NCT04568434|517006654|FG002|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|2|||
143398074|NCT04568434|517006652|FG000|Overall Study|Investigator Judgement|1|||
143398075|NCT04568434|517006653|FG001|Overall Study|Investigator Judgement|0|||
143398076|NCT04568434|517006654|FG002|Overall Study|Investigator Judgement|0|||
143398077|NCT05469464|517006655|FG000|Overall Study|Withdrawal by Subject|8|||
143398078|NCT05469464|517006656|FG001|Overall Study|Withdrawal by Subject|7|||
143398079|NCT05469464|517006657|FG002|Overall Study|Withdrawal by Subject|4|||
143398080|NCT05469464|517006658|FG003|Overall Study|Withdrawal by Subject|5|||
143398081|NCT05469464|517006655|FG000|Overall Study|Adverse Event|8|||
143398082|NCT05469464|517006656|FG001|Overall Study|Adverse Event|14|||
143398083|NCT05469464|517006657|FG002|Overall Study|Adverse Event|13|||
143398084|NCT05469464|517006658|FG003|Overall Study|Adverse Event|2|||
143398085|NCT05469464|517006655|FG000|Overall Study|Lost to Follow-up|2|||
143398086|NCT05469464|517006656|FG001|Overall Study|Lost to Follow-up|5|||
143398087|NCT05469464|517006657|FG002|Overall Study|Lost to Follow-up|3|||
143398088|NCT05469464|517006658|FG003|Overall Study|Lost to Follow-up|3|||
143398089|NCT05469464|517006655|FG000|Overall Study|Lack of Efficacy|4|||
143398090|NCT05469464|517006656|FG001|Overall Study|Lack of Efficacy|1|||
143398091|NCT05469464|517006657|FG002|Overall Study|Lack of Efficacy|2|||
143398092|NCT05469464|517006658|FG003|Overall Study|Lack of Efficacy|2|||
143398093|NCT05469464|517006655|FG000|Overall Study|Physician Decision|0|||
143398094|NCT05469464|517006656|FG001|Overall Study|Physician Decision|0|||
143398095|NCT05469464|517006657|FG002|Overall Study|Physician Decision|0|||
143398096|NCT05469464|517006658|FG003|Overall Study|Physician Decision|1|||
143398097|NCT05485779|517006661|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
143398098|NCT05485779|517006662|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
143398099|NCT05485779|517006663|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
143398100|NCT05485779|517006664|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
143398101|NCT05485779|517006665|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
143398102|NCT05485779|517006666|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
143398103|NCT05485779|517006667|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
143398104|NCT05485779|517006668|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
143398105|NCT05485779|517006669|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
143398106|NCT05485779|517006670|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
143398107|NCT05485779|517006671|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
143398108|NCT05485779|517006661|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
143398109|NCT05485779|517006662|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
143398110|NCT05485779|517006663|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
143398111|NCT05485779|517006664|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
143398112|NCT05485779|517006665|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
143398113|NCT05485779|517006666|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
143398114|NCT05485779|517006667|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
143398115|NCT05485779|517006668|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
143398116|NCT05485779|517006669|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
143398117|NCT05485779|517006670|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
143398118|NCT05485779|517006671|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
143398119|NCT05485779|517006661|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
143398120|NCT05485779|517006662|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
143398121|NCT05485779|517006663|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
143398122|NCT05485779|517006664|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
143398123|NCT05485779|517006665|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
143398124|NCT05485779|517006666|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
143398125|NCT05485779|517006667|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
143398126|NCT05485779|517006668|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
143398127|NCT05485779|517006669|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
143398128|NCT05485779|517006670|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
143398129|NCT05485779|517006671|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
143398130|NCT02038777|517006672|FG000|Overall Study|Death|0|||
143398131|NCT02038777|517006673|FG001|Overall Study|Death|2|||
143398132|NCT02038777|517006674|FG002|Overall Study|Death|0|||
143398133|NCT02038777|517006675|FG003|Overall Study|Death|1|||
143398134|NCT02038777|517006676|FG004|Overall Study|Death|2|||
143398135|NCT02038777|517006677|FG005|Overall Study|Death|4|||
143398136|NCT02038777|517006678|FG006|Overall Study|Death|0|||
143398137|NCT02038777|517006679|FG007|Overall Study|Death|11|||
143398138|NCT02038777|517006672|FG000|Overall Study|Lost to Follow-up|0|||
143398139|NCT02038777|517006673|FG001|Overall Study|Lost to Follow-up|0|||
143398140|NCT02038777|517006674|FG002|Overall Study|Lost to Follow-up|0|||
143398141|NCT02038777|517006675|FG003|Overall Study|Lost to Follow-up|1|||
143398142|NCT02038777|517006676|FG004|Overall Study|Lost to Follow-up|0|||
143398143|NCT02038777|517006677|FG005|Overall Study|Lost to Follow-up|0|||
143398144|NCT02038777|517006678|FG006|Overall Study|Lost to Follow-up|0|||
143398145|NCT02038777|517006679|FG007|Overall Study|Lost to Follow-up|0|||
143398146|NCT02038777|517006672|FG000|Overall Study|Other|0|||
143398147|NCT02038777|517006673|FG001|Overall Study|Other|1|||
143398148|NCT02038777|517006674|FG002|Overall Study|Other|0|||
143398149|NCT02038777|517006675|FG003|Overall Study|Other|2|||
143398150|NCT02038777|517006676|FG004|Overall Study|Other|1|||
143398151|NCT02038777|517006677|FG005|Overall Study|Other|0|||
143398152|NCT02038777|517006678|FG006|Overall Study|Other|0|||
143398153|NCT02038777|517006679|FG007|Overall Study|Other|0|||
143398154|NCT02038777|517006672|FG000|Overall Study|Randomized but not treated|0|||
143398155|NCT02038777|517006673|FG001|Overall Study|Randomized but not treated|1|||
143398156|NCT02038777|517006674|FG002|Overall Study|Randomized but not treated|0|||
143398157|NCT02038777|517006675|FG003|Overall Study|Randomized but not treated|0|||
143398158|NCT02038777|517006676|FG004|Overall Study|Randomized but not treated|0|||
143398159|NCT02038777|517006677|FG005|Overall Study|Randomized but not treated|0|||
143398160|NCT02038777|517006678|FG006|Overall Study|Randomized but not treated|0|||
143398161|NCT02038777|517006679|FG007|Overall Study|Randomized but not treated|0|||
143398162|NCT02038777|517006672|FG000|Overall Study|Started Chemotherapy|1|||
143398163|NCT02038777|517006673|FG001|Overall Study|Started Chemotherapy|0|||
143398164|NCT02038777|517006674|FG002|Overall Study|Started Chemotherapy|3|||
143398165|NCT02038777|517006675|FG003|Overall Study|Started Chemotherapy|0|||
143398166|NCT02038777|517006676|FG004|Overall Study|Started Chemotherapy|0|||
143398167|NCT02038777|517006677|FG005|Overall Study|Started Chemotherapy|0|||
143398168|NCT02038777|517006678|FG006|Overall Study|Started Chemotherapy|0|||
143398169|NCT02038777|517006679|FG007|Overall Study|Started Chemotherapy|0|||
143398170|NCT02038777|517006672|FG000|Overall Study|participation terminated by sponsor|0|||
143398171|NCT02038777|517006673|FG001|Overall Study|participation terminated by sponsor|0|||
143398172|NCT02038777|517006674|FG002|Overall Study|participation terminated by sponsor|0|||
143398173|NCT02038777|517006675|FG003|Overall Study|participation terminated by sponsor|0|||
143398174|NCT02038777|517006676|FG004|Overall Study|participation terminated by sponsor|0|||
143398175|NCT02038777|517006677|FG005|Overall Study|participation terminated by sponsor|0|||
143398176|NCT02038777|517006678|FG006|Overall Study|participation terminated by sponsor|1|||
143398177|NCT02038777|517006679|FG007|Overall Study|participation terminated by sponsor|1|||
143398178|NCT04299464|517006680|FG000|Overall Study|Adverse Event|1|||
143398179|NCT04299464|517006681|FG001|Overall Study|Adverse Event|0|||
143398180|NCT04299464|517006682|FG002|Overall Study|Adverse Event|2|||
143398181|NCT04299464|517006680|FG000|Overall Study|Non-compliance with Study Drug|1|||
143398182|NCT04299464|517006681|FG001|Overall Study|Non-compliance with Study Drug|0|||
143398183|NCT04299464|517006682|FG002|Overall Study|Non-compliance with Study Drug|0|||
143398184|NCT04299464|517006680|FG000|Overall Study|Reason not Specified|0|||
143398185|NCT04299464|517006681|FG001|Overall Study|Reason not Specified|1|||
143398186|NCT04299464|517006682|FG002|Overall Study|Reason not Specified|3|||
143398187|NCT04299464|517006680|FG000|Overall Study|Physician Decision|0|||
143398188|NCT04299464|517006681|FG001|Overall Study|Physician Decision|1|||
143398189|NCT04299464|517006682|FG002|Overall Study|Physician Decision|1|||
143398190|NCT04299464|517006680|FG000|Overall Study|Withdrawal by Subject|0|||
143398191|NCT04299464|517006681|FG001|Overall Study|Withdrawal by Subject|2|||
143398192|NCT04299464|517006682|FG002|Overall Study|Withdrawal by Subject|1|||
143398193|NCT04471246|517006683|FG000|Overall Study|Lost to Follow-up|2|||
143398194|NCT04471246|517006684|FG001|Overall Study|Lost to Follow-up|2|||
143398195|NCT03030261|517006685|FG000|Overall Study|Still receiving continuation therapy|5|||
143398196|NCT04971109|517006690|FG000|Overall Study|Adverse Event|4|||
143398197|NCT04971109|517006691|FG001|Overall Study|Adverse Event|3|||
143398198|NCT04971109|517006690|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
143398199|NCT04971109|517006691|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
143398200|NCT04971109|517006690|FG000|Overall Study|Lost to Follow-up|8|||
143398201|NCT04971109|517006691|FG001|Overall Study|Lost to Follow-up|2|||
143398202|NCT04971109|517006690|FG000|Overall Study|Physician Decision|5|||
143398203|NCT04971109|517006691|FG001|Overall Study|Physician Decision|0|||
143398204|NCT04971109|517006690|FG000|Overall Study|Protocol Violation|0|||
143398205|NCT04971109|517006691|FG001|Overall Study|Protocol Violation|1|||
143398206|NCT04971109|517006690|FG000|Overall Study|Withdrawal by Subject|18|||
143398207|NCT04971109|517006691|FG001|Overall Study|Withdrawal by Subject|3|||
143398208|NCT04971109|517006690|FG000|Overall Study|Subject was randomized in error|1|||
143398209|NCT04971109|517006691|FG001|Overall Study|Subject was randomized in error|0|||
143398210|NCT03910478|517006692|FG000|Overall Study|Death|13|||
143398211|NCT03910478|517006693|FG001|Overall Study|Death|6|||
143398212|NCT03910478|517006692|FG000|Overall Study|Withdrawal by Subject|23|||
143398213|NCT03910478|517006693|FG001|Overall Study|Withdrawal by Subject|2|||
143398214|NCT03910478|517006692|FG000|Overall Study|Physician Decision|5|||
143398215|NCT03910478|517006693|FG001|Overall Study|Physician Decision|0|||
143398216|NCT03910478|517006692|FG000|Overall Study|Protocol Violation|1|||
143398217|NCT03910478|517006693|FG001|Overall Study|Protocol Violation|0|||
143398218|NCT03910478|517006692|FG000|Overall Study|Failure to meet continuation criteria|2|||
143398219|NCT03910478|517006693|FG001|Overall Study|Failure to meet continuation criteria|0|||
143398220|NCT03910478|517006692|FG000|Overall Study|Wouldn't proceed DBS portion, data collection only|1|||
143398221|NCT03910478|517006693|FG001|Overall Study|Wouldn't proceed DBS portion, data collection only|0|||
143398222|NCT05293171|517006694|FG000|Washout 5 to 7 Days|Adverse Event|1|||
143398223|NCT05293171|517006695|FG001|Washout 5 to 7 Days|Adverse Event|1|||
143398224|NCT05293171|517006696|FG002|Washout 5 to 7 Days|Adverse Event|0|||
143398225|NCT05293171|517006697|FG003|Washout 5 to 7 Days|Adverse Event|0|||
143398226|NCT05293171|517006698|FG004|Washout 5 to 7 Days|Adverse Event|0|||
143398227|NCT05293171|517006699|FG005|Washout 5 to 7 Days|Adverse Event|0|||
143398228|NCT05293171|517006700|FG006|Washout 5 to 7 Days|Adverse Event|0|||
143398229|NCT05293171|517006701|FG007|Washout 5 to 7 Days|Adverse Event|0|||
143398230|NCT05293171|517006702|FG008|Washout 5 to 7 Days|Adverse Event|0|||
143398231|NCT05293171|517006703|FG009|Washout 5 to 7 Days|Adverse Event|0|||
143398232|NCT05293171|517006704|FG010|Washout 5 to 7 Days|Adverse Event|0|||
143398233|NCT05293171|517006705|FG011|Washout 5 to 7 Days|Adverse Event|0|||
143398234|NCT05293171|517006694|FG000|Washout 5 to 7 Days|Adverse Event|0|||
143398235|NCT05293171|517006695|FG001|Washout 5 to 7 Days|Adverse Event|0|||
143398236|NCT05293171|517006696|FG002|Washout 5 to 7 Days|Adverse Event|0|||
143398237|NCT05293171|517006697|FG003|Washout 5 to 7 Days|Adverse Event|0|||
143398238|NCT05293171|517006698|FG004|Washout 5 to 7 Days|Adverse Event|0|||
143398239|NCT05293171|517006699|FG005|Washout 5 to 7 Days|Adverse Event|1|||
143398240|NCT05293171|517006700|FG006|Washout 5 to 7 Days|Adverse Event|0|||
143398241|NCT05293171|517006701|FG007|Washout 5 to 7 Days|Adverse Event|0|||
143398242|NCT05293171|517006702|FG008|Washout 5 to 7 Days|Adverse Event|0|||
143398243|NCT05293171|517006703|FG009|Washout 5 to 7 Days|Adverse Event|0|||
143398244|NCT05293171|517006704|FG010|Washout 5 to 7 Days|Adverse Event|0|||
143398245|NCT05293171|517006705|FG011|Washout 5 to 7 Days|Adverse Event|0|||
143398246|NCT03987022|517006706|FG000|Overall Study|Lost to Follow-up|2|||
143398247|NCT03987022|517006707|FG001|Overall Study|Lost to Follow-up|2|||
143398248|NCT03987022|517006706|FG000|Overall Study|Withdrawal by Subject|1|||
143398249|NCT03987022|517006707|FG001|Overall Study|Withdrawal by Subject|0|||
143398250|NCT04024020|517006712|FG000|Overall Study|Withdrawal by Subject|2|||
143398251|NCT04024020|517006713|FG001|Overall Study|Withdrawal by Subject|2|||
143398252|NCT02240238|517006714|FG000|Phase 1|Adverse Event|0|||
143398253|NCT02240238|517006715|FG001|Phase 1|Adverse Event|0|||
143398254|NCT02240238|517006716|FG002|Phase 1|Adverse Event|0|||
143398255|NCT02240238|517006717|FG003|Phase 1|Adverse Event|0|||
143398256|NCT02240238|517006718|FG004|Phase 1|Adverse Event|0|||
143398257|NCT02240238|517006719|FG005|Phase 1|Adverse Event|0|||
143398258|NCT02240238|517006720|FG006|Phase 1|Adverse Event|3|||
143398259|NCT02240238|517006721|FG007|Phase 1|Adverse Event|1|||
143398260|NCT02240238|517006722|FG008|Phase 1|Adverse Event|0|||
143398261|NCT02240238|517006723|FG009|Phase 1|Adverse Event|0|||
143398262|NCT02240238|517006724|FG010|Phase 1|Adverse Event|0|||
143398263|NCT02240238|517006725|FG011|Phase 1|Adverse Event|0|||
143398264|NCT02240238|517006714|FG000|Phase 1|Death|0|||
143398265|NCT02240238|517006715|FG001|Phase 1|Death|0|||
143398266|NCT02240238|517006716|FG002|Phase 1|Death|0|||
143398267|NCT02240238|517006717|FG003|Phase 1|Death|0|||
143398268|NCT02240238|517006718|FG004|Phase 1|Death|0|||
143398269|NCT02240238|517006719|FG005|Phase 1|Death|1|||
143398270|NCT02240238|517006720|FG006|Phase 1|Death|0|||
143398271|NCT02240238|517006721|FG007|Phase 1|Death|0|||
143398272|NCT02240238|517006722|FG008|Phase 1|Death|0|||
143398273|NCT02240238|517006723|FG009|Phase 1|Death|0|||
143398274|NCT02240238|517006724|FG010|Phase 1|Death|0|||
143398275|NCT02240238|517006725|FG011|Phase 1|Death|0|||
143398276|NCT02240238|517006714|FG000|Phase 1|Sponsor termination|0|||
143398277|NCT02240238|517006715|FG001|Phase 1|Sponsor termination|0|||
143398278|NCT02240238|517006716|FG002|Phase 1|Sponsor termination|0|||
143398279|NCT02240238|517006717|FG003|Phase 1|Sponsor termination|0|||
143398280|NCT02240238|517006718|FG004|Phase 1|Sponsor termination|0|||
143398281|NCT02240238|517006719|FG005|Phase 1|Sponsor termination|1|||
143398282|NCT02240238|517006720|FG006|Phase 1|Sponsor termination|0|||
143398283|NCT02240238|517006721|FG007|Phase 1|Sponsor termination|0|||
143398284|NCT02240238|517006722|FG008|Phase 1|Sponsor termination|0|||
143398285|NCT02240238|517006723|FG009|Phase 1|Sponsor termination|0|||
143398286|NCT02240238|517006724|FG010|Phase 1|Sponsor termination|0|||
143398287|NCT02240238|517006725|FG011|Phase 1|Sponsor termination|0|||
143398288|NCT02240238|517006714|FG000|Phase 1|Withdrawal by Subject|0|||
143398289|NCT02240238|517006715|FG001|Phase 1|Withdrawal by Subject|0|||
143398290|NCT02240238|517006716|FG002|Phase 1|Withdrawal by Subject|0|||
143398291|NCT02240238|517006717|FG003|Phase 1|Withdrawal by Subject|0|||
143398292|NCT02240238|517006718|FG004|Phase 1|Withdrawal by Subject|0|||
143398293|NCT02240238|517006719|FG005|Phase 1|Withdrawal by Subject|2|||
143398294|NCT02240238|517006720|FG006|Phase 1|Withdrawal by Subject|0|||
143398295|NCT02240238|517006721|FG007|Phase 1|Withdrawal by Subject|0|||
143398296|NCT02240238|517006722|FG008|Phase 1|Withdrawal by Subject|0|||
143398297|NCT02240238|517006723|FG009|Phase 1|Withdrawal by Subject|0|||
143398298|NCT02240238|517006724|FG010|Phase 1|Withdrawal by Subject|0|||
143398299|NCT02240238|517006725|FG011|Phase 1|Withdrawal by Subject|0|||
143398300|NCT02240238|517006714|FG000|Phase 1|Physician Decision|0|||
143398301|NCT02240238|517006715|FG001|Phase 1|Physician Decision|0|||
143398302|NCT02240238|517006716|FG002|Phase 1|Physician Decision|0|||
143398303|NCT02240238|517006717|FG003|Phase 1|Physician Decision|0|||
143398304|NCT02240238|517006718|FG004|Phase 1|Physician Decision|0|||
143398305|NCT02240238|517006719|FG005|Phase 1|Physician Decision|2|||
143398306|NCT02240238|517006720|FG006|Phase 1|Physician Decision|0|||
143398307|NCT02240238|517006721|FG007|Phase 1|Physician Decision|0|||
143398308|NCT02240238|517006722|FG008|Phase 1|Physician Decision|0|||
143398309|NCT02240238|517006723|FG009|Phase 1|Physician Decision|0|||
143398310|NCT02240238|517006724|FG010|Phase 1|Physician Decision|0|||
143398311|NCT02240238|517006725|FG011|Phase 1|Physician Decision|0|||
143398312|NCT02240238|517006714|FG000|Phase 2|Adverse Event|0|||
143398313|NCT02240238|517006715|FG001|Phase 2|Adverse Event|0|||
143398314|NCT02240238|517006716|FG002|Phase 2|Adverse Event|0|||
143398315|NCT02240238|517006717|FG003|Phase 2|Adverse Event|0|||
143398316|NCT02240238|517006718|FG004|Phase 2|Adverse Event|0|||
143398317|NCT02240238|517006719|FG005|Phase 2|Adverse Event|0|||
143398318|NCT02240238|517006720|FG006|Phase 2|Adverse Event|0|||
143398319|NCT02240238|517006721|FG007|Phase 2|Adverse Event|0|||
143398320|NCT02240238|517006722|FG008|Phase 2|Adverse Event|0|||
143398321|NCT02240238|517006723|FG009|Phase 2|Adverse Event|7|||
143398322|NCT02240238|517006724|FG010|Phase 2|Adverse Event|14|||
143398323|NCT02240238|517006725|FG011|Phase 2|Adverse Event|2|||
143398324|NCT02240238|517006714|FG000|Phase 2|Death|0|||
143398325|NCT02240238|517006715|FG001|Phase 2|Death|0|||
143398326|NCT02240238|517006716|FG002|Phase 2|Death|0|||
143398327|NCT02240238|517006717|FG003|Phase 2|Death|0|||
143398328|NCT02240238|517006718|FG004|Phase 2|Death|0|||
143398329|NCT02240238|517006719|FG005|Phase 2|Death|0|||
143398330|NCT02240238|517006720|FG006|Phase 2|Death|0|||
143398331|NCT02240238|517006721|FG007|Phase 2|Death|0|||
143398332|NCT02240238|517006722|FG008|Phase 2|Death|0|||
143398333|NCT02240238|517006723|FG009|Phase 2|Death|3|||
143398334|NCT02240238|517006724|FG010|Phase 2|Death|2|||
143398335|NCT02240238|517006725|FG011|Phase 2|Death|1|||
143398336|NCT02240238|517006714|FG000|Phase 2|Disease progression|0|||
143398337|NCT02240238|517006715|FG001|Phase 2|Disease progression|0|||
143398338|NCT02240238|517006716|FG002|Phase 2|Disease progression|0|||
143398339|NCT02240238|517006717|FG003|Phase 2|Disease progression|0|||
143398340|NCT02240238|517006718|FG004|Phase 2|Disease progression|0|||
143398341|NCT02240238|517006719|FG005|Phase 2|Disease progression|0|||
143398342|NCT02240238|517006720|FG006|Phase 2|Disease progression|0|||
143398343|NCT02240238|517006721|FG007|Phase 2|Disease progression|0|||
143398344|NCT02240238|517006722|FG008|Phase 2|Disease progression|0|||
143398345|NCT02240238|517006723|FG009|Phase 2|Disease progression|5|||
143398346|NCT02240238|517006724|FG010|Phase 2|Disease progression|11|||
143398347|NCT02240238|517006725|FG011|Phase 2|Disease progression|1|||
143398348|NCT02240238|517006714|FG000|Phase 2|Withdrawal by Subject|0|||
143398349|NCT02240238|517006715|FG001|Phase 2|Withdrawal by Subject|0|||
143398350|NCT02240238|517006716|FG002|Phase 2|Withdrawal by Subject|0|||
143398351|NCT02240238|517006717|FG003|Phase 2|Withdrawal by Subject|0|||
143398352|NCT02240238|517006718|FG004|Phase 2|Withdrawal by Subject|0|||
143398353|NCT02240238|517006719|FG005|Phase 2|Withdrawal by Subject|0|||
143398354|NCT02240238|517006720|FG006|Phase 2|Withdrawal by Subject|0|||
143398355|NCT02240238|517006721|FG007|Phase 2|Withdrawal by Subject|0|||
143398356|NCT02240238|517006722|FG008|Phase 2|Withdrawal by Subject|0|||
143398357|NCT02240238|517006723|FG009|Phase 2|Withdrawal by Subject|1|||
143398358|NCT02240238|517006724|FG010|Phase 2|Withdrawal by Subject|1|||
143398359|NCT02240238|517006725|FG011|Phase 2|Withdrawal by Subject|0|||
143398360|NCT02240238|517006714|FG000|Phase 2|Physician Decision|0|||
143398361|NCT02240238|517006715|FG001|Phase 2|Physician Decision|0|||
143398362|NCT02240238|517006716|FG002|Phase 2|Physician Decision|0|||
143398363|NCT02240238|517006717|FG003|Phase 2|Physician Decision|0|||
143398364|NCT02240238|517006718|FG004|Phase 2|Physician Decision|0|||
143398365|NCT02240238|517006719|FG005|Phase 2|Physician Decision|0|||
143398366|NCT02240238|517006720|FG006|Phase 2|Physician Decision|0|||
143398367|NCT02240238|517006721|FG007|Phase 2|Physician Decision|0|||
143398368|NCT02240238|517006722|FG008|Phase 2|Physician Decision|0|||
143398369|NCT02240238|517006723|FG009|Phase 2|Physician Decision|1|||
143398370|NCT02240238|517006724|FG010|Phase 2|Physician Decision|3|||
143398371|NCT02240238|517006725|FG011|Phase 2|Physician Decision|0|||
143398372|NCT02240238|517006714|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
143398373|NCT02240238|517006715|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
143398374|NCT02240238|517006716|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
143398375|NCT02240238|517006717|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
143398376|NCT02240238|517006718|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
143398377|NCT02240238|517006719|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
143398378|NCT02240238|517006720|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
143398379|NCT02240238|517006721|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
143398380|NCT02240238|517006722|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
143398381|NCT02240238|517006723|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
143398382|NCT02240238|517006724|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
143398383|NCT02240238|517006725|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
143398384|NCT02240238|517006714|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
143398385|NCT02240238|517006715|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
143398386|NCT02240238|517006716|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
143398387|NCT02240238|517006717|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
143398388|NCT02240238|517006718|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
143398389|NCT02240238|517006719|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
143398390|NCT02240238|517006720|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
143398391|NCT02240238|517006721|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
143398392|NCT02240238|517006722|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
143398393|NCT02240238|517006723|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
143398394|NCT02240238|517006724|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
143398395|NCT02240238|517006725|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
143398396|NCT02240238|517006714|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
143398397|NCT02240238|517006715|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
143398398|NCT02240238|517006716|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
143398399|NCT02240238|517006717|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
143398400|NCT02240238|517006718|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
143398401|NCT02240238|517006719|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
143398402|NCT02240238|517006720|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
143398403|NCT02240238|517006721|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
143398404|NCT02240238|517006722|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
143398405|NCT02240238|517006723|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
143398406|NCT02240238|517006724|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
143398407|NCT02240238|517006725|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
143398408|NCT02240238|517006714|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
143398409|NCT02240238|517006715|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
143398410|NCT02240238|517006716|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
143398411|NCT02240238|517006717|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
143398412|NCT02240238|517006718|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
143398413|NCT02240238|517006719|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
143398414|NCT02240238|517006720|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
143398415|NCT02240238|517006721|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
143398416|NCT02240238|517006722|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
143398417|NCT02240238|517006723|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
143398418|NCT02240238|517006724|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
143398419|NCT02240238|517006725|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
143398420|NCT02240238|517006714|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
143398421|NCT02240238|517006715|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
143398422|NCT02240238|517006716|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
143398423|NCT02240238|517006717|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
143398424|NCT02240238|517006718|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
143398425|NCT02240238|517006719|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
143398426|NCT02240238|517006720|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
143398427|NCT02240238|517006721|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
143398428|NCT02240238|517006722|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
143398429|NCT02240238|517006723|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
143398430|NCT02240238|517006724|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
143398431|NCT02240238|517006725|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
143398432|NCT02240238|517006714|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
143398433|NCT02240238|517006715|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
143454356|NCT03117998|517208214|FG004|Overall Study|Withdrawal by Subject|3|||
143398434|NCT02240238|517006716|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
143398435|NCT02240238|517006717|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
143398436|NCT02240238|517006718|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
143398437|NCT02240238|517006719|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
143398438|NCT02240238|517006720|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
143398439|NCT02240238|517006721|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
143398440|NCT02240238|517006722|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
143398441|NCT02240238|517006723|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
143398442|NCT02240238|517006724|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
143398443|NCT02240238|517006725|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
143398444|NCT02240238|517006714|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
143398445|NCT02240238|517006715|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
143398446|NCT02240238|517006716|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
143398447|NCT02240238|517006717|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
143398448|NCT02240238|517006718|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
143398449|NCT02240238|517006719|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
143398450|NCT02240238|517006720|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
143398451|NCT02240238|517006721|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
143398452|NCT02240238|517006722|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
143398453|NCT02240238|517006723|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
143398454|NCT02240238|517006724|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
143398455|NCT02240238|517006725|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
143398456|NCT02240238|517006714|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
143398457|NCT02240238|517006715|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
143398458|NCT02240238|517006716|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
143398459|NCT02240238|517006717|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
143398460|NCT02240238|517006718|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
143398461|NCT02240238|517006719|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
143398462|NCT02240238|517006720|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
143398463|NCT02240238|517006721|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
143398464|NCT02240238|517006722|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
143398465|NCT02240238|517006723|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
143398466|NCT02240238|517006724|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
143398467|NCT02240238|517006725|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
143398468|NCT02887521|517006730|FG000|Overall Study|Withdrawal by Subject|0|||
143398469|NCT02887521|517006731|FG001|Overall Study|Withdrawal by Subject|3|||
143398470|NCT05167864|517006734|FG000|Overall Study|Lost to Follow-up|7|||
143398471|NCT05167864|517006735|FG001|Overall Study|Lost to Follow-up|6|||
143398472|NCT05167864|517006736|FG002|Overall Study|Lost to Follow-up|7|||
143398473|NCT05167864|517006737|FG003|Overall Study|Lost to Follow-up|9|||
143398474|NCT00746096|517006738|FG000|Overall Study|Adverse Event|1|||
143398475|NCT00746096|517006739|FG001|Overall Study|Adverse Event|0|||
143398476|NCT00746096|517006738|FG000|Overall Study|Withdrawal by Subject|5|||
143398477|NCT00746096|517006739|FG001|Overall Study|Withdrawal by Subject|1|||
143398478|NCT00746096|517006738|FG000|Overall Study|Lost to Follow-up|2|||
143398479|NCT00746096|517006739|FG001|Overall Study|Lost to Follow-up|1|||
143398480|NCT00746096|517006738|FG000|Overall Study|Protocol Violation|1|||
143398481|NCT00746096|517006739|FG001|Overall Study|Protocol Violation|0|||
143398482|NCT00746096|517006738|FG000|Overall Study|No study drug treatment|1|||
143398483|NCT00746096|517006739|FG001|Overall Study|No study drug treatment|1|||
143398484|NCT03571581|517006743|FG000|Overall Study|Death|2|||
143398485|NCT03571581|517006743|FG000|Overall Study|Withdrawal by Subject|2|||
143398486|NCT01651403|517006746|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
143398487|NCT01651403|517006747|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
143398488|NCT01651403|517006746|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
143398489|NCT01651403|517006747|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
143398490|NCT01651403|517006746|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
143398491|NCT01651403|517006747|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
143398492|NCT01651403|517006746|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
143398493|NCT01651403|517006747|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
143398494|NCT01651403|517006746|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
143398495|NCT01651403|517006747|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
143398496|NCT01651403|517006746|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
143398497|NCT01651403|517006747|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
143398498|NCT04032847|517006750|FG000|Overall Study|Study termination by sponsor|8|||
143398499|NCT04032847|517006751|FG001|Overall Study|Study termination by sponsor|0|||
143398500|NCT04032847|517006752|FG002|Overall Study|Study termination by sponsor|4|||
143398501|NCT04032847|517006750|FG000|Overall Study|Death|12|||
143398502|NCT04032847|517006751|FG001|Overall Study|Death|0|||
143398503|NCT04032847|517006752|FG002|Overall Study|Death|0|||
143398504|NCT04032847|517006750|FG000|Overall Study|Progressive disease|2|||
143398505|NCT04032847|517006751|FG001|Overall Study|Progressive disease|0|||
143398506|NCT04032847|517006752|FG002|Overall Study|Progressive disease|1|||
143398507|NCT05104463|517006753|FG000|Overall Study|Adverse Event|1|||
143398508|NCT05104463|517006754|FG001|Overall Study|Adverse Event|1|||
143398509|NCT05104463|517006753|FG000|Overall Study|Lost to Follow-up|1|||
143398510|NCT05104463|517006754|FG001|Overall Study|Lost to Follow-up|1|||
143398511|NCT05104463|517006753|FG000|Overall Study|Physician Decision|1|||
143398512|NCT05104463|517006754|FG001|Overall Study|Physician Decision|0|||
143398513|NCT05104463|517006753|FG000|Overall Study|Protocol Violation|0|||
143398514|NCT05104463|517006754|FG001|Overall Study|Protocol Violation|2|||
143398515|NCT05104463|517006753|FG000|Overall Study|Withdrawal by Subject|1|||
143398516|NCT05104463|517006754|FG001|Overall Study|Withdrawal by Subject|1|||
143398517|NCT04571619|517006755|FG000|Phase 1|Death|22|||
143398518|NCT04571619|517006756|FG001|Phase 1|Death|18|||
143398519|NCT04571619|517006755|FG000|Phase 1|Withdrawal by Subject|7|||
143398520|NCT04571619|517006756|FG001|Phase 1|Withdrawal by Subject|2|||
143398521|NCT04571619|517006755|FG000|Phase 2|Death|13|||
143398522|NCT04571619|517006756|FG001|Phase 2|Death|16|||
143398523|NCT04571619|517006755|FG000|Phase 2|Withdrawal by Subject|6|||
143398524|NCT04571619|517006756|FG001|Phase 2|Withdrawal by Subject|4|||
143398525|NCT02361216|517006757|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
143398526|NCT02361216|517006758|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
143398527|NCT02361216|517006757|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
143398528|NCT02361216|517006758|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
143398529|NCT02361216|517006757|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
143398530|NCT02361216|517006758|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
143398531|NCT02361216|517006757|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
143398532|NCT02361216|517006758|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
143398533|NCT02361216|517006757|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
143398534|NCT02361216|517006758|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
143398535|NCT02361216|517006757|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
143398536|NCT02361216|517006758|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
143398537|NCT00323856|517006759|FG000|Overall Study|Withdrawal by Subject|1|||
143398538|NCT00323856|517006759|FG000|Overall Study|Was uncooperative and noncompliant|1|||
143398539|NCT00323856|517006759|FG000|Overall Study|Reason not specified|1|||
143398540|NCT00323856|517006759|FG000|Overall Study|Missing|2|||
143398541|NCT04086121|517006760|FG000|Overall Study|Other than listed|8|||
143398542|NCT04086121|517006760|FG000|Overall Study|Withdrawal by Subject|3|||
143398543|NCT04086121|517006760|FG000|Overall Study|Lost to Follow-up|2|||
143398544|NCT04086121|517006760|FG000|Overall Study|Adverse Event|1|||
143398545|NCT05622812|517008375|FG000|Overall Study|Withdrawal by Subject|1|||
143398546|NCT05622812|517008376|FG001|Overall Study|Withdrawal by Subject|4|||
143398547|NCT05622812|517008375|FG000|Overall Study|Lost to Follow-up|2|||
143398548|NCT05622812|517008376|FG001|Overall Study|Lost to Follow-up|1|||
143398549|NCT04811040|517008395|FG000|Overall Study|Lost to Follow-up|2|||
143398550|NCT04811040|517008396|FG001|Overall Study|Lost to Follow-up|0|||
143398551|NCT04811040|517008397|FG002|Overall Study|Lost to Follow-up|0|||
143398552|NCT04811040|517008398|FG003|Overall Study|Lost to Follow-up|0|||
143398553|NCT04811040|517008395|FG000|Overall Study|Withdrew consent|1|||
143398554|NCT04811040|517008396|FG001|Overall Study|Withdrew consent|1|||
143398555|NCT04811040|517008397|FG002|Overall Study|Withdrew consent|0|||
143398556|NCT04811040|517008398|FG003|Overall Study|Withdrew consent|0|||
143398557|NCT01828099|517008400|FG000|Treatment Period|Adverse Event|24|||
143398558|NCT01828099|517008401|FG001|Treatment Period|Adverse Event|23|||
143398559|NCT01828099|517008400|FG000|Treatment Period|Death|10|||
143398560|NCT01828099|517008401|FG001|Treatment Period|Death|12|||
143398561|NCT01828099|517008400|FG000|Treatment Period|Lost to Follow-up|2|||
143398562|NCT01828099|517008401|FG001|Treatment Period|Lost to Follow-up|1|||
143398563|NCT01828099|517008400|FG000|Treatment Period|Non-compliance with study treatment|1|||
143398564|NCT01828099|517008401|FG001|Treatment Period|Non-compliance with study treatment|0|||
143398565|NCT01828099|517008400|FG000|Treatment Period|Physician Decision|17|||
143398566|NCT01828099|517008401|FG001|Treatment Period|Physician Decision|16|||
143398567|NCT01828099|517008400|FG000|Treatment Period|Progressive disease|99|||
143398568|NCT01828099|517008401|FG001|Treatment Period|Progressive disease|107|||
143398569|NCT01828099|517008400|FG000|Treatment Period|Subject/guardian decision|22|||
143398570|NCT01828099|517008401|FG001|Treatment Period|Subject/guardian decision|26|||
143398571|NCT01828099|517008400|FG000|Treatment Period|Study terminated by Sponsor|13|||
143398572|NCT01828099|517008401|FG001|Treatment Period|Study terminated by Sponsor|1|||
143398573|NCT01828099|517008400|FG000|Treatment Period|Protocol deviation|1|||
143398574|NCT01828099|517008401|FG001|Treatment Period|Protocol deviation|0|||
143398575|NCT01828099|517008400|FG000|Treatment Period|No longer requires treatment|0|||
143398576|NCT01828099|517008401|FG001|Treatment Period|No longer requires treatment|1|||
143398577|NCT01828099|517008400|FG000|Extension-treatment Phase|Adverse Event|0|||
143398578|NCT01828099|517008401|FG001|Extension-treatment Phase|Adverse Event|17|||
143398579|NCT01828099|517008400|FG000|Extension-treatment Phase|Death|0|||
143398580|NCT01828099|517008401|FG001|Extension-treatment Phase|Death|11|||
143398581|NCT01828099|517008400|FG000|Extension-treatment Phase|Physician Decision|0|||
143398582|NCT01828099|517008401|FG001|Extension-treatment Phase|Physician Decision|5|||
143398583|NCT01828099|517008400|FG000|Extension-treatment Phase|Progressive disease|0|||
143398584|NCT01828099|517008401|FG001|Extension-treatment Phase|Progressive disease|54|||
143398585|NCT01828099|517008400|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
143398586|NCT01828099|517008401|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
143398587|NCT01828099|517008400|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
143398588|NCT01828099|517008401|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
143398589|NCT05645757|517008402|FG000|Overall Study|Enrolled but treatment not administered|0|||
143398590|NCT05645757|517008403|FG001|Overall Study|Enrolled but treatment not administered|0|||
143398591|NCT05645757|517008404|FG002|Overall Study|Enrolled but treatment not administered|0|||
143398592|NCT05645757|517008405|FG003|Overall Study|Enrolled but treatment not administered|0|||
143398593|NCT05645757|517008406|FG004|Overall Study|Enrolled but treatment not administered|1|||
143398594|NCT05645757|517008407|FG005|Overall Study|Enrolled but treatment not administered|1|||
143398595|NCT05645757|517008408|FG006|Overall Study|Enrolled but treatment not administered|0|||
143398596|NCT05645757|517008409|FG007|Overall Study|Enrolled but treatment not administered|0|||
143398597|NCT03924635|517008410|FG000|Overall Study|Withdrawal by Subject|2|||
143398598|NCT03924635|517008411|FG001|Overall Study|Withdrawal by Subject|4|||
143398599|NCT04447040|517008412|FG000|Overall Study|Lost to Follow-up|2|||
143398600|NCT04447040|517008413|FG001|Overall Study|Lost to Follow-up|1|||
143398601|NCT04447040|517008414|FG002|Overall Study|Lost to Follow-up|3|||
143398602|NCT04447040|517008415|FG003|Overall Study|Lost to Follow-up|3|||
143398603|NCT04447040|517008416|FG004|Overall Study|Lost to Follow-up|1|||
143398604|NCT04447040|517008417|FG005|Overall Study|Lost to Follow-up|3|||
143398605|NCT04447040|517008412|FG000|Overall Study|Withdrawal by Subject|0|||
143398606|NCT04447040|517008413|FG001|Overall Study|Withdrawal by Subject|1|||
143398607|NCT04447040|517008414|FG002|Overall Study|Withdrawal by Subject|1|||
143398608|NCT04447040|517008415|FG003|Overall Study|Withdrawal by Subject|1|||
143398609|NCT04447040|517008416|FG004|Overall Study|Withdrawal by Subject|0|||
143398610|NCT04447040|517008417|FG005|Overall Study|Withdrawal by Subject|0|||
143398611|NCT04076618|517008418|FG000|Overall Study|Lost to Follow-up|2|||
143398612|NCT04076618|517008419|FG001|Overall Study|Lost to Follow-up|1|||
143398613|NCT04076618|517008420|FG002|Overall Study|Lost to Follow-up|3|||
143398614|NCT04076618|517008418|FG000|Overall Study|Withdrawal by Subject|3|||
143398615|NCT04076618|517008419|FG001|Overall Study|Withdrawal by Subject|1|||
143398616|NCT04076618|517008420|FG002|Overall Study|Withdrawal by Subject|2|||
143398617|NCT04076618|517008418|FG000|Overall Study|Relocated out of state|0|||
143398618|NCT04076618|517008419|FG001|Overall Study|Relocated out of state|2|||
143398619|NCT04076618|517008420|FG002|Overall Study|Relocated out of state|0|||
143398620|NCT04076618|517008418|FG000|Overall Study|COVID concerns|0|||
143398621|NCT04076618|517008419|FG001|Overall Study|COVID concerns|1|||
143398622|NCT04076618|517008420|FG002|Overall Study|COVID concerns|0|||
143398623|NCT04076618|517008418|FG000|Overall Study|Adverse Event|0|||
143398624|NCT04076618|517008419|FG001|Overall Study|Adverse Event|0|||
143398625|NCT04076618|517008420|FG002|Overall Study|Adverse Event|2|||
143398626|NCT00321048|517008421|FG000|Overall Study|Withdrawal by Subject|6|||
143398627|NCT00321048|517008422|FG001|Overall Study|Withdrawal by Subject|8|||
143398628|NCT04826471|517008425|FG000|Overall Study|Lost to Follow-up|2|||
143398629|NCT04826471|517008425|FG000|Overall Study|Protocol Violation|3|||
143398630|NCT04826471|517008425|FG000|Overall Study|Withdrawal by Subject|1|||
143398631|NCT03386578|517008427|FG000|PK Component|Lost to Follow-up|0|||
143398632|NCT03386578|517008428|FG001|PK Component|Lost to Follow-up|1|||
143398633|NCT03386578|517008429|FG002|PK Component|Lost to Follow-up|0|||
143398634|NCT03386578|517008430|FG003|PK Component|Lost to Follow-up|0|||
143398635|NCT03386578|517008431|FG004|PK Component|Lost to Follow-up|0|||
143398636|NCT03386578|517008432|FG005|PK Component|Lost to Follow-up|0|||
143398637|NCT03386578|517008433|FG006|PK Component|Lost to Follow-up|1|||
143398638|NCT03386578|517008434|FG007|PK Component|Lost to Follow-up|0|||
143398639|NCT03386578|517008435|FG008|PK Component|Lost to Follow-up|0|||
143398640|NCT03386578|517008436|FG009|PK Component|Lost to Follow-up|0|||
143398641|NCT03386578|517008427|FG000|PK Component|Stillbirth/Abortion|0|||
143398642|NCT03386578|517008428|FG001|PK Component|Stillbirth/Abortion|0|||
143398643|NCT03386578|517008429|FG002|PK Component|Stillbirth/Abortion|0|||
143398644|NCT03386578|517008430|FG003|PK Component|Stillbirth/Abortion|0|||
143398645|NCT03386578|517008431|FG004|PK Component|Stillbirth/Abortion|0|||
143398646|NCT03386578|517008432|FG005|PK Component|Stillbirth/Abortion|2|||
143398647|NCT03386578|517008433|FG006|PK Component|Stillbirth/Abortion|0|||
143398648|NCT03386578|517008434|FG007|PK Component|Stillbirth/Abortion|0|||
143398649|NCT03386578|517008435|FG008|PK Component|Stillbirth/Abortion|0|||
143398650|NCT03386578|517008436|FG009|PK Component|Stillbirth/Abortion|0|||
143398651|NCT03386578|517008427|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
143398652|NCT03386578|517008428|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
143398653|NCT03386578|517008429|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
143398654|NCT03386578|517008430|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
143398655|NCT03386578|517008431|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
143398656|NCT03386578|517008432|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
143398657|NCT03386578|517008433|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
143398658|NCT03386578|517008434|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
143398659|NCT03386578|517008435|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
143398660|NCT03386578|517008436|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
143398661|NCT03386578|517008427|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
143398662|NCT03386578|517008428|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
143398663|NCT03386578|517008429|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
143398664|NCT03386578|517008430|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
143398665|NCT03386578|517008431|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
143398666|NCT03386578|517008432|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
143398667|NCT03386578|517008433|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
143398668|NCT03386578|517008434|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
143398669|NCT03386578|517008435|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
143398670|NCT03386578|517008436|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
143398671|NCT03386578|517008427|FG000|PrEP Comparison Component Step 1|Death|0|||
143398672|NCT03386578|517008428|FG001|PrEP Comparison Component Step 1|Death|0|||
143398673|NCT03386578|517008429|FG002|PrEP Comparison Component Step 1|Death|1|||
143398674|NCT03386578|517008430|FG003|PrEP Comparison Component Step 1|Death|0|||
143398675|NCT03386578|517008431|FG004|PrEP Comparison Component Step 1|Death|0|||
143398676|NCT03386578|517008432|FG005|PrEP Comparison Component Step 1|Death|0|||
143398677|NCT03386578|517008433|FG006|PrEP Comparison Component Step 1|Death|0|||
143398678|NCT03386578|517008434|FG007|PrEP Comparison Component Step 1|Death|9|||
143398679|NCT03386578|517008435|FG008|PrEP Comparison Component Step 1|Death|5|||
143398680|NCT03386578|517008436|FG009|PrEP Comparison Component Step 1|Death|0|||
143398681|NCT03386578|517008427|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
143398682|NCT03386578|517008428|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
143398683|NCT03386578|517008429|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
143398684|NCT03386578|517008430|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
143398685|NCT03386578|517008431|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
143398686|NCT03386578|517008432|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
143398687|NCT03386578|517008433|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
143398688|NCT03386578|517008434|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
143398689|NCT03386578|517008435|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
143398690|NCT03386578|517008436|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
143398691|NCT03386578|517008427|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
143398692|NCT03386578|517008428|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
143398693|NCT03386578|517008429|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
143398694|NCT03386578|517008430|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
143398695|NCT03386578|517008431|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
143398696|NCT03386578|517008432|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
143398697|NCT03386578|517008433|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
143398698|NCT03386578|517008434|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
143398699|NCT03386578|517008435|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
143398700|NCT03386578|517008436|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
143398701|NCT03386578|517008427|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
143398702|NCT03386578|517008428|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
143398703|NCT03386578|517008429|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
143398704|NCT03386578|517008430|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
143398705|NCT03386578|517008431|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
143398706|NCT03386578|517008432|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
143398707|NCT03386578|517008433|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
143398708|NCT03386578|517008434|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
143398709|NCT03386578|517008435|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
143398710|NCT03386578|517008436|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
143398711|NCT02694822|517008437|FG000|Phase 1|Death|2|||
143398712|NCT02694822|517008438|FG001|Phase 1|Death|1|||
143398713|NCT02694822|517008439|FG002|Phase 1|Death|6|||
143398714|NCT02694822|517008440|FG003|Phase 1|Death|6|||
143398715|NCT02694822|517008441|FG004|Phase 1|Death|3|||
143398716|NCT02694822|517008442|FG005|Phase 1|Death|0|||
143398717|NCT02694822|517008437|FG000|Phase 1|Withdrawal by Subject|2|||
143398718|NCT02694822|517008438|FG001|Phase 1|Withdrawal by Subject|2|||
143398719|NCT02694822|517008439|FG002|Phase 1|Withdrawal by Subject|4|||
143398720|NCT02694822|517008440|FG003|Phase 1|Withdrawal by Subject|8|||
143398721|NCT02694822|517008441|FG004|Phase 1|Withdrawal by Subject|1|||
143398722|NCT02694822|517008442|FG005|Phase 1|Withdrawal by Subject|0|||
143398723|NCT02694822|517008437|FG000|Phase 2|Death|0|||
143398724|NCT02694822|517008438|FG001|Phase 2|Death|0|||
143398725|NCT02694822|517008439|FG002|Phase 2|Death|0|||
143398726|NCT02694822|517008440|FG003|Phase 2|Death|0|||
143398727|NCT02694822|517008441|FG004|Phase 2|Death|0|||
143398728|NCT02694822|517008442|FG005|Phase 2|Death|26|||
143398729|NCT02694822|517008437|FG000|Phase 2|Withdrawal by Subject|0|||
143398730|NCT02694822|517008438|FG001|Phase 2|Withdrawal by Subject|0|||
143398731|NCT02694822|517008439|FG002|Phase 2|Withdrawal by Subject|0|||
143398732|NCT02694822|517008440|FG003|Phase 2|Withdrawal by Subject|0|||
143398733|NCT02694822|517008441|FG004|Phase 2|Withdrawal by Subject|0|||
143398734|NCT02694822|517008442|FG005|Phase 2|Withdrawal by Subject|13|||
143398735|NCT02694822|517008437|FG000|Phase 2|Administrative Study Closure|0|||
143398736|NCT02694822|517008438|FG001|Phase 2|Administrative Study Closure|0|||
143398737|NCT02694822|517008439|FG002|Phase 2|Administrative Study Closure|0|||
143398738|NCT02694822|517008440|FG003|Phase 2|Administrative Study Closure|0|||
143398739|NCT02694822|517008441|FG004|Phase 2|Administrative Study Closure|0|||
143398740|NCT02694822|517008442|FG005|Phase 2|Administrative Study Closure|2|||
143398741|NCT02694822|517008437|FG000|Phase 2|Lost to Follow-up|0|||
143398742|NCT02694822|517008438|FG001|Phase 2|Lost to Follow-up|0|||
143398743|NCT02694822|517008439|FG002|Phase 2|Lost to Follow-up|0|||
143398744|NCT02694822|517008440|FG003|Phase 2|Lost to Follow-up|0|||
143398745|NCT02694822|517008441|FG004|Phase 2|Lost to Follow-up|0|||
143398746|NCT02694822|517008442|FG005|Phase 2|Lost to Follow-up|1|||
143398747|NCT02694822|517008437|FG000|Phase 2|Participant Transferred to Another Site|0|||
143398748|NCT02694822|517008438|FG001|Phase 2|Participant Transferred to Another Site|0|||
143398749|NCT02694822|517008439|FG002|Phase 2|Participant Transferred to Another Site|0|||
143398750|NCT02694822|517008440|FG003|Phase 2|Participant Transferred to Another Site|0|||
143398751|NCT02694822|517008441|FG004|Phase 2|Participant Transferred to Another Site|0|||
143398752|NCT02694822|517008442|FG005|Phase 2|Participant Transferred to Another Site|1|||
143398753|NCT02424617|517008443|FG000|Overall Study|Adverse Event|0|||
143398754|NCT02424617|517008444|FG001|Overall Study|Adverse Event|1|||
143398755|NCT02424617|517008445|FG002|Overall Study|Adverse Event|0|||
143398756|NCT02424617|517008446|FG003|Overall Study|Adverse Event|0|||
143398757|NCT02424617|517008443|FG000|Overall Study|Investigator Decision|0|||
143398758|NCT02424617|517008444|FG001|Overall Study|Investigator Decision|0|||
143398759|NCT02424617|517008445|FG002|Overall Study|Investigator Decision|0|||
143398760|NCT02424617|517008446|FG003|Overall Study|Investigator Decision|1|||
143398761|NCT02424617|517008443|FG000|Overall Study|Withdrawal by Subject|1|||
143398762|NCT02424617|517008444|FG001|Overall Study|Withdrawal by Subject|1|||
143398763|NCT02424617|517008445|FG002|Overall Study|Withdrawal by Subject|0|||
143398764|NCT02424617|517008446|FG003|Overall Study|Withdrawal by Subject|1|||
143398765|NCT02424617|517008443|FG000|Overall Study|Progressive Disease|7|||
143398766|NCT02424617|517008444|FG001|Overall Study|Progressive Disease|6|||
143398767|NCT02424617|517008445|FG002|Overall Study|Progressive Disease|11|||
143398768|NCT02424617|517008446|FG003|Overall Study|Progressive Disease|10|||
143398769|NCT02424617|517008443|FG000|Overall Study|Other|0|||
143398770|NCT02424617|517008444|FG001|Overall Study|Other|0|||
143398771|NCT02424617|517008445|FG002|Overall Study|Other|0|||
143398772|NCT02424617|517008446|FG003|Overall Study|Other|1|||
143398773|NCT01868997|517008447|FG000|Overall Study|Adverse Event|2|||
143398774|NCT01868997|517008448|FG001|Overall Study|Adverse Event|5|||
143398775|NCT01868997|517008447|FG000|Overall Study|Lack of Efficacy|2|||
143398776|NCT01868997|517008448|FG001|Overall Study|Lack of Efficacy|0|||
143398777|NCT01868997|517008447|FG000|Overall Study|Other|3|||
143398778|NCT01868997|517008448|FG001|Overall Study|Other|1|||
143398779|NCT01960452|517008449|FG000|Overall Study|Withdrawal by Subject|2|||
143398780|NCT01960452|517008450|FG001|Overall Study|Withdrawal by Subject|1|||
143398781|NCT01960452|517008449|FG000|Overall Study|Sleep apnea in Night 1|1|||
143398782|NCT01960452|517008450|FG001|Overall Study|Sleep apnea in Night 1|0|||
143398783|NCT01960452|517008449|FG000|Overall Study|Poor Sleep in Night 1|0|||
143398784|NCT01960452|517008450|FG001|Overall Study|Poor Sleep in Night 1|2|||
143398785|NCT01960452|517008449|FG000|Overall Study|No Sex/Age Match Night 1|1|||
143398786|NCT01960452|517008450|FG001|Overall Study|No Sex/Age Match Night 1|0|||
143398787|NCT01960452|517008449|FG000|Overall Study|No Sex/Age Match Night 2|0|||
143398788|NCT01960452|517008450|FG001|Overall Study|No Sex/Age Match Night 2|2|||
143398789|NCT01960452|517008449|FG000|Overall Study|Technical Difficulties Night 2|2|||
143398790|NCT01960452|517008450|FG001|Overall Study|Technical Difficulties Night 2|0|||
143398791|NCT05370040|517008451|FG000|Overall Study|Lost to Follow-up|0|||
143398792|NCT05370040|517008452|FG001|Overall Study|Lost to Follow-up|0|||
143398793|NCT05370040|517008453|FG002|Overall Study|Lost to Follow-up|1|||
143398794|NCT05370040|517008454|FG003|Overall Study|Lost to Follow-up|0|||
143398795|NCT05370040|517008455|FG004|Overall Study|Lost to Follow-up|1|||
143398796|NCT05370040|517008456|FG005|Overall Study|Lost to Follow-up|0|||
143398797|NCT03209973|517008457|FG000|Overall Study|Withdrawal by Subject|7|||
143398798|NCT03209973|517008457|FG000|Overall Study|Lost to Follow-up|2|||
143398799|NCT03209973|517008457|FG000|Overall Study|Death|8|||
143398800|NCT03209973|517008457|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
143398801|NCT03209973|517008457|FG000|Overall Study|Sponsor Decision|18|||
143398802|NCT03209973|517008457|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
143398803|NCT03209973|517008457|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
143398804|NCT03711474|517008465|FG000|Overall Study|Physician Decision|2|||
143398805|NCT03711474|517008466|FG001|Overall Study|Physician Decision|0|||
143398806|NCT05974501|517008467|FG000|Overall Study|Physician Decision|0|||
143398807|NCT05974501|517008468|FG001|Overall Study|Physician Decision|1|||
143398808|NCT04295512|517008471|FG000|Overall Study|Lack of family response to schedule assessment|0|||
143398809|NCT04295512|517008472|FG001|Overall Study|Lack of family response to schedule assessment|0|||
143398810|NCT04295512|517008473|FG002|Overall Study|Lack of family response to schedule assessment|0|||
143398811|NCT04295512|517008474|FG003|Overall Study|Lack of family response to schedule assessment|2|||
143398812|NCT04295512|517008471|FG000|Overall Study|Therapist did not refer eligible family|7|||
143398813|NCT04295512|517008472|FG001|Overall Study|Therapist did not refer eligible family|7|||
143398814|NCT04295512|517008473|FG002|Overall Study|Therapist did not refer eligible family|0|||
143398815|NCT04295512|517008474|FG003|Overall Study|Therapist did not refer eligible family|0|||
143398816|NCT02296684|517008475|FG000|Overall Study|Withdrawal by Subject|0|||
143398817|NCT02296684|517008476|FG001|Overall Study|Withdrawal by Subject|1|||
143398818|NCT02296684|517008477|FG002|Overall Study|Withdrawal by Subject|1|||
143398819|NCT02296684|517008475|FG000|Overall Study|Death|2|||
143398820|NCT02296684|517008476|FG001|Overall Study|Death|0|||
143398821|NCT02296684|517008477|FG002|Overall Study|Death|0|||
143398822|NCT04141891|517008480|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
143398823|NCT04141891|517008481|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
143398824|NCT04141891|517008480|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
143398825|NCT04141891|517008481|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
143398826|NCT04141891|517008480|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
143398827|NCT04141891|517008481|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
143398828|NCT04141891|517008480|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
143398829|NCT04141891|517008481|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
143398830|NCT04141891|517008480|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
143398831|NCT04141891|517008481|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
143398832|NCT04141891|517008480|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
143398833|NCT04141891|517008481|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
143398834|NCT04141891|517008480|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
143398835|NCT04141891|517008481|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
143398836|NCT04141891|517008480|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
143398837|NCT04141891|517008481|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
143398838|NCT04141891|517008480|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
143398839|NCT04141891|517008481|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
143398840|NCT04141891|517008480|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
143398841|NCT04141891|517008481|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
143398842|NCT04141891|517008480|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
143398843|NCT04141891|517008481|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
143398844|NCT04141891|517008480|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
143398845|NCT04141891|517008481|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
143398846|NCT04141891|517008480|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
143398847|NCT04141891|517008481|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
143398848|NCT04141891|517008480|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
143398849|NCT04141891|517008481|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
143398850|NCT03626220|517008482|FG000|Overall Study|Withdrawal by Subject|2|||
143398851|NCT03626220|517008483|FG001|Overall Study|Withdrawal by Subject|0|||
143398852|NCT05090683|517008489|FG000|Overall Study|Lost to Follow-up|10|||
143398853|NCT05090683|517008490|FG001|Overall Study|Lost to Follow-up|2|||
143398854|NCT05090683|517008489|FG000|Overall Study|Withdrawal by Subject|15|||
143398855|NCT05090683|517008490|FG001|Overall Study|Withdrawal by Subject|0|||
143398856|NCT03325985|517008491|FG000|Overall Study|Lost to Follow-up|122|||
143398857|NCT03325985|517008492|FG001|Overall Study|Lost to Follow-up|26|||
143398858|NCT03325985|517008493|FG002|Overall Study|Lost to Follow-up|141|||
143398859|NCT03325985|517008494|FG003|Overall Study|Lost to Follow-up|28|||
143398860|NCT03325985|517008491|FG000|Overall Study|Death|99|||
143398861|NCT03325985|517008492|FG001|Overall Study|Death|36|||
143398862|NCT03325985|517008493|FG002|Overall Study|Death|94|||
143398863|NCT03325985|517008494|FG003|Overall Study|Death|32|||
143398864|NCT03213665|517008495|FG000|Overall Study|Adverse Event|1|||
143398865|NCT03213665|517008495|FG000|Overall Study|Physician Decision|2|||
143398866|NCT03213665|517008495|FG000|Overall Study|Withdrawal by Subject|3|||
143398867|NCT03213665|517008495|FG000|Overall Study|Progressive Disease|13|||
143398868|NCT03056573|517008496|FG000|Overall Study|Death|2|||
143398869|NCT03056573|517008497|FG001|Overall Study|Death|4|||
143398870|NCT03056573|517008496|FG000|Overall Study|Withdrawal by Subject|2|||
143398871|NCT03056573|517008497|FG001|Overall Study|Withdrawal by Subject|0|||
143398872|NCT03056573|517008496|FG000|Overall Study|Lost to Follow-up|1|||
143398873|NCT03056573|517008497|FG001|Overall Study|Lost to Follow-up|1|||
143398874|NCT00696111|517010065|FG000|Overall Study|Withdrawal by Subject|17|||
143398875|NCT03952338|517010066|FG000|Overall Study|Lost to Follow-up|11|||
143398876|NCT03952338|517010067|FG001|Overall Study|Lost to Follow-up|17|||
143398877|NCT03952338|517010066|FG000|Overall Study|Withdrawal by Subject|1|||
143398878|NCT03952338|517010067|FG001|Overall Study|Withdrawal by Subject|1|||
143398879|NCT03952338|517010066|FG000|Overall Study|Protocol Violation|1|||
143398880|NCT03952338|517010067|FG001|Overall Study|Protocol Violation|0|||
143398881|NCT04909801|517010068|FG000|Overall Study|Lack of Efficacy|2|||
143398882|NCT04909801|517010069|FG001|Overall Study|Lack of Efficacy|1|||
143398883|NCT04909801|517010068|FG000|Overall Study|Adverse Event|1|||
143398884|NCT04909801|517010069|FG001|Overall Study|Adverse Event|2|||
143398885|NCT04909801|517010068|FG000|Overall Study|Participant request to discontinue study treatment|1|||
143398886|NCT04909801|517010069|FG001|Overall Study|Participant request to discontinue study treatment|2|||
143398887|NCT04909801|517010068|FG000|Overall Study|Withdrawal by Subject|2|||
143398888|NCT04909801|517010069|FG001|Overall Study|Withdrawal by Subject|1|||
143398889|NCT04909801|517010068|FG000|Overall Study|other reasons|1|||
143398890|NCT04909801|517010069|FG001|Overall Study|other reasons|1|||
143398891|NCT04550221|517010070|FG000|Overall Study|Lost to Follow-up|0|||
143398892|NCT04550221|517010071|FG001|Overall Study|Lost to Follow-up|4|||
143398893|NCT04550221|517010070|FG000|Overall Study|Withdrawn|3|||
143398894|NCT04550221|517010071|FG001|Overall Study|Withdrawn|0|||
143398895|NCT04550221|517010070|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
143398896|NCT04550221|517010071|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
143398897|NCT05452460|517010072|FG000|Overall Study|Lost to Follow-up|3|||
143398898|NCT05452460|517010073|FG001|Overall Study|Lost to Follow-up|3|||
143398899|NCT05452460|517010072|FG000|Overall Study|Did not receive intervention|1|||
143398900|NCT05452460|517010073|FG001|Overall Study|Did not receive intervention|0|||
143398901|NCT04433208|517010074|FG000|Overall Study|Withdrawal by Subject|0|||
143398902|NCT04433208|517010075|FG001|Overall Study|Withdrawal by Subject|1|||
143398903|NCT04433208|517010076|FG002|Overall Study|Withdrawal by Subject|1|||
143398904|NCT04433208|517010077|FG003|Overall Study|Withdrawal by Subject|0|||
143398905|NCT04433208|517010078|FG004|Overall Study|Withdrawal by Subject|2|||
143398906|NCT04433208|517010079|FG005|Overall Study|Withdrawal by Subject|1|||
143398907|NCT04433208|517010074|FG000|Overall Study|Lost to Follow-up|0|||
143398908|NCT04433208|517010075|FG001|Overall Study|Lost to Follow-up|0|||
143398909|NCT04433208|517010076|FG002|Overall Study|Lost to Follow-up|0|||
143398910|NCT04433208|517010077|FG003|Overall Study|Lost to Follow-up|0|||
143398911|NCT04433208|517010078|FG004|Overall Study|Lost to Follow-up|0|||
143398912|NCT04433208|517010079|FG005|Overall Study|Lost to Follow-up|1|||
143398913|NCT03676192|517010082|FG000|Induction Study Period|Adverse Event|21|||
143398914|NCT03676192|517010083|FG001|Induction Study Period|Adverse Event|20|||
143398915|NCT03676192|517010082|FG000|Induction Study Period|Death|23|||
143398916|NCT03676192|517010083|FG001|Induction Study Period|Death|20|||
143398917|NCT03676192|517010082|FG000|Induction Study Period|Lost to Follow-up|3|||
143398918|NCT03676192|517010083|FG001|Induction Study Period|Lost to Follow-up|3|||
143398919|NCT03676192|517010082|FG000|Induction Study Period|Physician Decision|6|||
143398920|NCT03676192|517010083|FG001|Induction Study Period|Physician Decision|3|||
143398921|NCT03676192|517010082|FG000|Induction Study Period|Progressive Disease|32|||
143398922|NCT03676192|517010083|FG001|Induction Study Period|Progressive Disease|21|||
143398923|NCT03676192|517010082|FG000|Induction Study Period|Protocol Violation|1|||
143398924|NCT03676192|517010083|FG001|Induction Study Period|Protocol Violation|2|||
143398925|NCT03676192|517010082|FG000|Induction Study Period|Withdrawal by Subject|20|||
143398926|NCT03676192|517010083|FG001|Induction Study Period|Withdrawal by Subject|15|||
143398927|NCT01627574|517010085|FG000|Overall Study|Withdrawal by Subject|8|||
143398928|NCT01627574|517010086|FG001|Overall Study|Withdrawal by Subject|5|||
143398929|NCT01627574|517010085|FG000|Overall Study|Lost to Follow-up|13|||
143398930|NCT01627574|517010086|FG001|Overall Study|Lost to Follow-up|13|||
143398931|NCT03249090|517010096|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
143398932|NCT03249090|517010097|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
143398933|NCT03249090|517010096|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
143398934|NCT03249090|517010097|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
143398935|NCT03249090|517010096|FG000|3 Month Time Point|Voluntary withdrawal|6|||
143398936|NCT03249090|517010097|FG001|3 Month Time Point|Voluntary withdrawal|3|||
143398937|NCT03249090|517010096|FG000|3 Month Time Point|Changed oncology practice|4|||
143398938|NCT03249090|517010097|FG001|3 Month Time Point|Changed oncology practice|2|||
143398939|NCT03249090|517010096|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
143398940|NCT03249090|517010097|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
143398941|NCT03249090|517010096|FG000|12 Month Time Point|Voluntary withdrawal|35|||
143398942|NCT03249090|517010097|FG001|12 Month Time Point|Voluntary withdrawal|4|||
143398943|NCT03249090|517010096|FG000|12 Month Time Point|Changed oncology practice|20|||
143398944|NCT03249090|517010097|FG001|12 Month Time Point|Changed oncology practice|9|||
143398945|NCT04359654|517010099|FG000|Overall Study|Withdrawal by Subject|1|||
143398946|NCT04359654|517010100|FG001|Overall Study|Withdrawal by Subject|0|||
143398947|NCT04359654|517010099|FG000|Overall Study|Adverse Event|0|||
143398948|NCT04359654|517010100|FG001|Overall Study|Adverse Event|1|||
143398949|NCT06122194|517010101|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
143398950|NCT06122194|517010102|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
143398951|NCT06122194|517010103|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
143398952|NCT06122194|517010104|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
143398953|NCT04314778|517010105|FG000|Overall Study|Lost to Follow-up|5|||
143398954|NCT04314778|517010106|FG001|Overall Study|Lost to Follow-up|3|||
143398955|NCT05646355|517010107|FG000|Overall Study|Lost to Follow-up|1|||
143398956|NCT05646355|517010108|FG001|Overall Study|Lost to Follow-up|0|||
143398957|NCT05646355|517010107|FG000|Overall Study|translated materials not available for pilot|2|||
143398958|NCT05646355|517010108|FG001|Overall Study|translated materials not available for pilot|0|||
143398959|NCT05646355|517010107|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
143398960|NCT05646355|517010108|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
143398961|NCT04685135|517010112|FG000|Overall Study|Death|126|||
143398962|NCT04685135|517010113|FG001|Overall Study|Death|53|||
143398963|NCT04685135|517010112|FG000|Overall Study|Withdrawal by Subject|12|||
143398964|NCT04685135|517010113|FG001|Overall Study|Withdrawal by Subject|16|||
143398965|NCT05863156|517010114|FG000|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
143398966|NCT05863156|517010115|FG001|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
143398967|NCT05863156|517010116|FG002|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|23|||
143398968|NCT03513302|517010117|FG000|First Intervention (14 Days)|Screen failure|15|||
143398969|NCT03513302|517010118|FG001|First Intervention (14 Days)|Screen failure|16|||
143398970|NCT04862416|517010119|FG000|Overall Study|Withdrawal by Subject|0|||
143398971|NCT04862416|517010120|FG001|Overall Study|Withdrawal by Subject|1|||
143398972|NCT04862416|517010121|FG002|Overall Study|Withdrawal by Subject|0|||
143398973|NCT04862416|517010122|FG003|Overall Study|Withdrawal by Subject|1|||
143398974|NCT04862416|517010123|FG004|Overall Study|Withdrawal by Subject|0|||
143398975|NCT04862416|517010124|FG005|Overall Study|Withdrawal by Subject|0|||
143398976|NCT04862416|517010125|FG006|Overall Study|Withdrawal by Subject|0|||
143398977|NCT04862416|517010126|FG007|Overall Study|Withdrawal by Subject|0|||
143398978|NCT03852550|517010127|FG000|Overall Study|Lost to Follow-up|4|||
143398979|NCT03852550|517010128|FG001|Overall Study|Lost to Follow-up|3|||
143398980|NCT03852550|517010127|FG000|Overall Study|Only parent outcomes completed|0|||
143398981|NCT03852550|517010128|FG001|Overall Study|Only parent outcomes completed|1|||
143398982|NCT03852550|517010127|FG000|Overall Study|Withdrawal by Subject|1|||
143398983|NCT03852550|517010128|FG001|Overall Study|Withdrawal by Subject|0|||
143398984|NCT03756662|517010129|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
143398985|NCT01309672|517010134|FG000|Overall Study|Lack of Efficacy|20|||
143398986|NCT01309672|517010134|FG000|Overall Study|Other|9|||
143398987|NCT01309672|517010134|FG000|Overall Study|Adverse Event|5|||
143398988|NCT01309672|517010134|FG000|Overall Study|Withdrawal by Subject|3|||
143398989|NCT01254864|517010135|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
143398990|NCT01254864|517010136|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
143398991|NCT01254864|517010137|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
143398992|NCT01254864|517010135|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
143398993|NCT01254864|517010136|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
143398994|NCT01254864|517010137|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
143398995|NCT01254864|517010135|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
143398996|NCT01254864|517010136|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
143398997|NCT01254864|517010137|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
143398998|NCT01254864|517010135|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
143398999|NCT01254864|517010136|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
143399000|NCT01254864|517010137|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
143399001|NCT01254864|517010135|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
143399002|NCT01254864|517010136|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
143399003|NCT01254864|517010137|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
143399004|NCT01254864|517010135|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
143399005|NCT01254864|517010136|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
143399006|NCT01254864|517010137|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
143399007|NCT01254864|517010135|FG000|Randomization Phase|Adverse Event|0|||
143399008|NCT01254864|517010136|FG001|Randomization Phase|Adverse Event|5|||
143399009|NCT01254864|517010137|FG002|Randomization Phase|Adverse Event|17|||
143399010|NCT01254864|517010135|FG000|Randomization Phase|Death|0|||
143399011|NCT01254864|517010136|FG001|Randomization Phase|Death|1|||
143399012|NCT01254864|517010137|FG002|Randomization Phase|Death|0|||
143399013|NCT01254864|517010135|FG000|Randomization Phase|Lost to Follow-up|0|||
143399014|NCT01254864|517010136|FG001|Randomization Phase|Lost to Follow-up|0|||
143399015|NCT01254864|517010137|FG002|Randomization Phase|Lost to Follow-up|1|||
143399016|NCT01254864|517010135|FG000|Randomization Phase|Physician Decision|0|||
143399017|NCT01254864|517010136|FG001|Randomization Phase|Physician Decision|20|||
143399018|NCT01254864|517010137|FG002|Randomization Phase|Physician Decision|25|||
143399019|NCT01254864|517010135|FG000|Randomization Phase|Withdrawal by Subject|0|||
143399020|NCT01254864|517010136|FG001|Randomization Phase|Withdrawal by Subject|4|||
143399021|NCT01254864|517010137|FG002|Randomization Phase|Withdrawal by Subject|2|||
143399022|NCT01254864|517010135|FG000|Randomization Phase|Non-Compliance|0|||
143399023|NCT01254864|517010136|FG001|Randomization Phase|Non-Compliance|1|||
143399024|NCT01254864|517010137|FG002|Randomization Phase|Non-Compliance|0|||
143399025|NCT01254864|517010135|FG000|Randomization Phase|Comorbidities|0|||
143399026|NCT01254864|517010136|FG001|Randomization Phase|Comorbidities|2|||
143399027|NCT01254864|517010137|FG002|Randomization Phase|Comorbidities|1|||
143399028|NCT05565820|517010147|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
143399029|NCT05565820|517010148|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
143399030|NCT05565820|517010147|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
143399031|NCT05565820|517010148|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
143399032|NCT03295721|517010149|FG000|Overall Study|Adverse Event|1|||
143399033|NCT03295721|517010150|FG001|Overall Study|Adverse Event|0|||
143399034|NCT03295721|517010151|FG002|Overall Study|Adverse Event|0|||
143399035|NCT03295721|517010149|FG000|Overall Study|Lost to Follow-up|1|||
143399036|NCT03295721|517010150|FG001|Overall Study|Lost to Follow-up|1|||
143399037|NCT03295721|517010151|FG002|Overall Study|Lost to Follow-up|1|||
143399038|NCT03295721|517010149|FG000|Overall Study|Withdrawal by Subject|1|||
143399039|NCT03295721|517010150|FG001|Overall Study|Withdrawal by Subject|0|||
143399040|NCT03295721|517010151|FG002|Overall Study|Withdrawal by Subject|1|||
143399041|NCT03295721|517010149|FG000|Overall Study|Death|0|||
143399042|NCT03295721|517010150|FG001|Overall Study|Death|0|||
143399043|NCT03295721|517010151|FG002|Overall Study|Death|1|||
143399044|NCT00429364|517010153|FG000|Overall Study|Withdrawal by Subject|11|||
143399045|NCT00429364|517010154|FG001|Overall Study|Withdrawal by Subject|5|||
143399046|NCT00429364|517010153|FG000|Overall Study|Physician Decision|4|||
143399047|NCT00429364|517010154|FG001|Overall Study|Physician Decision|2|||
143399048|NCT00429364|517010153|FG000|Overall Study|Lost to Follow-up|7|||
143399049|NCT00429364|517010154|FG001|Overall Study|Lost to Follow-up|6|||
143399050|NCT00429364|517010153|FG000|Overall Study|Death|0|||
143399051|NCT00429364|517010154|FG001|Overall Study|Death|1|||
143399052|NCT00429364|517010153|FG000|Overall Study|Underwent aortic root surgery|10|||
143399053|NCT00429364|517010154|FG001|Overall Study|Underwent aortic root surgery|18|||
143399054|NCT00429364|517010153|FG000|Overall Study|Pregnancy|0|||
143399055|NCT00429364|517010154|FG001|Overall Study|Pregnancy|1|||
143399056|NCT04871529|517010155|FG000|Overall Study|Withdrawal by Subject|0|||
143399057|NCT04871529|517010156|FG001|Overall Study|Withdrawal by Subject|1|||
143399058|NCT04871529|517010155|FG000|Overall Study|Death|0|||
143399059|NCT04871529|517010156|FG001|Overall Study|Death|1|||
143399060|NCT04871529|517010155|FG000|Overall Study|Not protocol specified|0|||
143399061|NCT04871529|517010156|FG001|Overall Study|Not protocol specified|1|||
143399062|NCT05184452|517010157|FG000|Overall Study|Lost to Follow-up|0|||
143399063|NCT05184452|517010158|FG001|Overall Study|Lost to Follow-up|0|||
143399064|NCT05184452|517010159|FG002|Overall Study|Lost to Follow-up|0|||
143399065|NCT05184452|517010160|FG003|Overall Study|Lost to Follow-up|0|||
143399066|NCT05184452|517010161|FG004|Overall Study|Lost to Follow-up|0|||
143399067|NCT05184452|517010162|FG005|Overall Study|Lost to Follow-up|2|||
143399068|NCT05184452|517010163|FG006|Overall Study|Lost to Follow-up|0|||
143399069|NCT05184452|517010164|FG007|Overall Study|Lost to Follow-up|0|||
143399070|NCT05184452|517010165|FG008|Overall Study|Lost to Follow-up|0|||
143399071|NCT05184452|517010166|FG009|Overall Study|Lost to Follow-up|1|||
143399072|NCT05184452|517010157|FG000|Overall Study|Withdrawal by Subject|0|||
143399073|NCT05184452|517010158|FG001|Overall Study|Withdrawal by Subject|0|||
143399074|NCT05184452|517010159|FG002|Overall Study|Withdrawal by Subject|0|||
143399075|NCT05184452|517010160|FG003|Overall Study|Withdrawal by Subject|0|||
143399076|NCT05184452|517010161|FG004|Overall Study|Withdrawal by Subject|0|||
143399077|NCT05184452|517010162|FG005|Overall Study|Withdrawal by Subject|1|||
143399078|NCT05184452|517010163|FG006|Overall Study|Withdrawal by Subject|0|||
143399079|NCT05184452|517010164|FG007|Overall Study|Withdrawal by Subject|0|||
143399080|NCT05184452|517010165|FG008|Overall Study|Withdrawal by Subject|0|||
143399081|NCT05184452|517010166|FG009|Overall Study|Withdrawal by Subject|1|||
143399082|NCT05586490|517010167|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
143399083|NCT05586490|517010168|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
143399084|NCT05586490|517010169|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
143399085|NCT05586490|517010170|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
143399086|NCT05586490|517010171|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
143399087|NCT05586490|517010167|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
143399088|NCT05586490|517010168|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
143399089|NCT05586490|517010169|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
143399090|NCT05586490|517010170|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
143399091|NCT05586490|517010171|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
143399092|NCT05586490|517010167|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
143399093|NCT05586490|517010168|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
143399094|NCT05586490|517010169|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
143399095|NCT05586490|517010170|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
143399096|NCT05586490|517010171|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
143399097|NCT05873556|517010172|FG000|Overall Study|Lost to Follow-up|4|||
143399098|NCT05873556|517010173|FG001|Overall Study|Lost to Follow-up|1|||
143399099|NCT03606408|517010174|FG000|Overall Study|Adverse Event|13|||
143399100|NCT03606408|517010174|FG000|Overall Study|Withdrawal by Subject|7|||
143399101|NCT03606408|517010174|FG000|Overall Study|Physician Decision|4|||
143399102|NCT03606408|517010174|FG000|Overall Study|Lack of Efficacy|2|||
143399103|NCT03606408|517010174|FG000|Overall Study|Death|1|||
143399104|NCT03606408|517010174|FG000|Overall Study|new therapy for study indication|1|||
143399105|NCT03556293|517010175|FG000|Overall Study|Ineligible for analysis|1904|||
143399106|NCT03556293|517010176|FG001|Overall Study|Ineligible for analysis|1471|||
143399107|NCT03556293|517010177|FG002|Overall Study|Ineligible for analysis|1091|||
143399108|NCT03556293|517010178|FG003|Overall Study|Ineligible for analysis|1269|||
143399109|NCT05267470|517010181|FG000|Overall Study|Decision by sponsor|0|||
143399110|NCT05267470|517010182|FG001|Overall Study|Decision by sponsor|3|||
143399111|NCT05267470|517010183|FG002|Overall Study|Decision by sponsor|19|||
143399112|NCT05267470|517010184|FG003|Overall Study|Decision by sponsor|7|||
143399113|NCT05267470|517010185|FG004|Overall Study|Decision by sponsor|3|||
143399114|NCT05267470|517010181|FG000|Overall Study|Withdrawal by Subject|1|||
143399115|NCT05267470|517010182|FG001|Overall Study|Withdrawal by Subject|1|||
143399116|NCT05267470|517010183|FG002|Overall Study|Withdrawal by Subject|2|||
143399117|NCT05267470|517010184|FG003|Overall Study|Withdrawal by Subject|2|||
143399118|NCT05267470|517010185|FG004|Overall Study|Withdrawal by Subject|0|||
143399119|NCT05267470|517010181|FG000|Overall Study|Death|3|||
143399120|NCT05267470|517010182|FG001|Overall Study|Death|5|||
143399121|NCT05267470|517010183|FG002|Overall Study|Death|8|||
143399122|NCT05267470|517010184|FG003|Overall Study|Death|18|||
143399123|NCT05267470|517010185|FG004|Overall Study|Death|1|||
143399124|NCT05267470|517010181|FG000|Overall Study|Lost to Follow-up|0|||
143399125|NCT05267470|517010182|FG001|Overall Study|Lost to Follow-up|0|||
143399126|NCT05267470|517010183|FG002|Overall Study|Lost to Follow-up|0|||
143399127|NCT05267470|517010184|FG003|Overall Study|Lost to Follow-up|1|||
143399128|NCT05267470|517010185|FG004|Overall Study|Lost to Follow-up|0|||
143399129|NCT05828017|517010186|FG000|Review of Intake and Hearing Test Result|Removed by Investigator due to hearing loss change and no longer meeting study criteria.|1|||
143399130|NCT04132518|517010189|FG000|Overall Study|Prematurely withdrawn from the study|0|||
143399131|NCT04132518|517010190|FG001|Overall Study|Prematurely withdrawn from the study|9|||
143399132|NCT04132518|517010191|FG002|Overall Study|Prematurely withdrawn from the study|1|||
143399133|NCT05425420|517010193|FG000|Overall Study|Physician Decision|1|||
143399134|NCT05425420|517010193|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
143399135|NCT04056611|517010199|FG000|Overall Study|Physician Decision|1|||
143399136|NCT03733925|517010200|FG000|Overall Study|Lost to Follow-up|1|||
143399137|NCT03733925|517010200|FG000|Overall Study|Withdrawal by Subject|2|||
143399138|NCT03733925|517010200|FG000|Overall Study|Adverse Event|2|||
143399139|NCT03733925|517010200|FG000|Overall Study|Non-Compliance with Study Drug|1|||
143399140|NCT02631746|517010201|FG000|Overall Study|Lack of Efficacy|3|||
143399141|NCT05069896|517010202|FG000|Overall Study|Adverse Event|0|||
143399142|NCT05069896|517010203|FG001|Overall Study|Adverse Event|1|||
143399143|NCT05069896|517010204|FG002|Overall Study|Adverse Event|1|||
143399144|NCT05069896|517010205|FG003|Overall Study|Adverse Event|0|||
143399145|NCT05069896|517010206|FG004|Overall Study|Adverse Event|0|||
143399146|NCT05069896|517010207|FG005|Overall Study|Adverse Event|0|||
143399147|NCT05069896|517010202|FG000|Overall Study|Lost to Follow-up|0|||
143399148|NCT05069896|517010203|FG001|Overall Study|Lost to Follow-up|0|||
143399149|NCT05069896|517010204|FG002|Overall Study|Lost to Follow-up|1|||
143399150|NCT05069896|517010205|FG003|Overall Study|Lost to Follow-up|0|||
143399151|NCT05069896|517010206|FG004|Overall Study|Lost to Follow-up|1|||
143399152|NCT05069896|517010207|FG005|Overall Study|Lost to Follow-up|2|||
143399153|NCT04068831|517010208|FG000|Overall Study|Disease Progression|10|||
143399154|NCT04068831|517010209|FG001|Overall Study|Disease Progression|8|||
143399155|NCT04167553|517010214|FG000|Overall Study|Withdrawal by Subject|1|||
143399156|NCT04167553|517010215|FG001|Overall Study|Withdrawal by Subject|0|||
143399157|NCT04167553|517010216|FG002|Overall Study|Withdrawal by Subject|1|||
143399158|NCT04167553|517010217|FG003|Overall Study|Withdrawal by Subject|2|||
143399159|NCT04167553|517010218|FG004|Overall Study|Withdrawal by Subject|1|||
143399160|NCT04167553|517010219|FG005|Overall Study|Withdrawal by Subject|0|||
143399161|NCT04167553|517010220|FG006|Overall Study|Withdrawal by Subject|0|||
143399162|NCT04167553|517010214|FG000|Overall Study|Physician Decision|0|||
143399163|NCT04167553|517010215|FG001|Overall Study|Physician Decision|0|||
143399164|NCT04167553|517010216|FG002|Overall Study|Physician Decision|0|||
143399165|NCT04167553|517010217|FG003|Overall Study|Physician Decision|0|||
143399166|NCT04167553|517010218|FG004|Overall Study|Physician Decision|2|||
143399167|NCT04167553|517010219|FG005|Overall Study|Physician Decision|2|||
143399168|NCT04167553|517010220|FG006|Overall Study|Physician Decision|0|||
143399169|NCT04167553|517010214|FG000|Overall Study|Lost to Follow-up|0|||
143399170|NCT04167553|517010215|FG001|Overall Study|Lost to Follow-up|0|||
143399171|NCT04167553|517010216|FG002|Overall Study|Lost to Follow-up|2|||
143399172|NCT04167553|517010217|FG003|Overall Study|Lost to Follow-up|0|||
143399173|NCT04167553|517010218|FG004|Overall Study|Lost to Follow-up|0|||
143399174|NCT04167553|517010219|FG005|Overall Study|Lost to Follow-up|0|||
143399175|NCT04167553|517010220|FG006|Overall Study|Lost to Follow-up|0|||
143399176|NCT05660434|517010222|FG000|Overall Study|Never obtained study materials|2|||
143399177|NCT05660434|517010223|FG001|Overall Study|Never obtained study materials|1|||
143399178|NCT02460458|517011936|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
143399179|NCT02460458|517011936|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
143399180|NCT02460458|517011936|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
143399181|NCT02460458|517011936|FG000|First Prospective Phase|Lost to Follow-up|84|||
143399182|NCT02460458|517011936|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
143399183|NCT03220035|517011937|FG000|Overall Study|Adverse Event|1|||
143399184|NCT03220035|517011937|FG000|Overall Study|Protocol Violation|1|||
143399185|NCT03220035|517011937|FG000|Overall Study|Progressive Disease|2|||
143399186|NCT05299073|517011938|FG000|Overall Study|Withdrawal by Subject|0|||
143399187|NCT05299073|517011939|FG001|Overall Study|Withdrawal by Subject|0|||
143399188|NCT05299073|517011940|FG002|Overall Study|Withdrawal by Subject|1|||
143399189|NCT05299073|517011938|FG000|Overall Study|Adverse Event|0|||
143399190|NCT05299073|517011939|FG001|Overall Study|Adverse Event|1|||
143399191|NCT05299073|517011940|FG002|Overall Study|Adverse Event|0|||
143399192|NCT05299073|517011938|FG000|Overall Study|Lost to Follow-up|0|||
143399193|NCT05299073|517011939|FG001|Overall Study|Lost to Follow-up|1|||
143399194|NCT05299073|517011940|FG002|Overall Study|Lost to Follow-up|0|||
143399195|NCT01208662|517011941|FG000|Induction and Consolidation|Disease Progression|23|||
143399196|NCT01208662|517011942|FG001|Induction and Consolidation|Disease Progression|13|||
143399197|NCT01208662|517011943|FG002|Induction and Consolidation|Disease Progression|0|||
143399198|NCT01208662|517011941|FG000|Induction and Consolidation|Adverse Event|16|||
143399199|NCT01208662|517011942|FG001|Induction and Consolidation|Adverse Event|18|||
143399200|NCT01208662|517011943|FG002|Induction and Consolidation|Adverse Event|2|||
143399201|NCT01208662|517011941|FG000|Induction and Consolidation|MD or Participant Decision|16|||
143399202|NCT01208662|517011942|FG001|Induction and Consolidation|MD or Participant Decision|34|||
143399203|NCT01208662|517011943|FG002|Induction and Consolidation|MD or Participant Decision|4|||
143399204|NCT01208662|517011941|FG000|Induction and Consolidation|Death|1|||
143399205|NCT01208662|517011942|FG001|Induction and Consolidation|Death|3|||
143399206|NCT01208662|517011943|FG002|Induction and Consolidation|Death|1|||
143399207|NCT01208662|517011941|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
143399208|NCT01208662|517011942|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
143399209|NCT01208662|517011943|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
143399210|NCT01208662|517011941|FG000|Maintenance|Disease Progression|156|||
143399211|NCT01208662|517011942|FG001|Maintenance|Disease Progression|102|||
143399212|NCT01208662|517011943|FG002|Maintenance|Disease Progression|0|||
143399213|NCT01208662|517011941|FG000|Maintenance|Adverse Event|12|||
143399214|NCT01208662|517011942|FG001|Maintenance|Adverse Event|28|||
143399215|NCT01208662|517011943|FG002|Maintenance|Adverse Event|0|||
143399216|NCT01208662|517011941|FG000|Maintenance|MD or Participant Decision|24|||
143399217|NCT01208662|517011942|FG001|Maintenance|MD or Participant Decision|36|||
143399218|NCT01208662|517011943|FG002|Maintenance|MD or Participant Decision|0|||
143399219|NCT01208662|517011941|FG000|Maintenance|Death|0|||
143399220|NCT01208662|517011942|FG001|Maintenance|Death|3|||
143399221|NCT01208662|517011943|FG002|Maintenance|Death|0|||
143399222|NCT01208662|517011941|FG000|Maintenance|Discontinued for other reasons|21|||
143399223|NCT01208662|517011942|FG001|Maintenance|Discontinued for other reasons|31|||
143399224|NCT01208662|517011943|FG002|Maintenance|Discontinued for other reasons|0|||
143399225|NCT01208662|517011941|FG000|Maintenance|Still on Treatment|78|||
143399226|NCT01208662|517011942|FG001|Maintenance|Still on Treatment|89|||
143399227|NCT01208662|517011943|FG002|Maintenance|Still on Treatment|0|||
143399228|NCT04066205|517011946|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
143399229|NCT04066205|517011947|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
143399230|NCT04066205|517011946|FG000|T2 Immediate Post-Intervention|did not respond|5|||
143399231|NCT04066205|517011947|FG001|T2 Immediate Post-Intervention|did not respond|3|||
143399232|NCT04778397|517011948|FG000|Overall Study|Death|59|||
143399233|NCT04778397|517011949|FG001|Overall Study|Death|54|||
143399234|NCT04778397|517011950|FG002|Overall Study|Death|11|||
143399235|NCT04778397|517011951|FG003|Overall Study|Death|9|||
143399236|NCT04778397|517011948|FG000|Overall Study|Study Terminated by Sponsor|34|||
143399237|NCT04778397|517011949|FG001|Overall Study|Study Terminated by Sponsor|42|||
143399238|NCT04778397|517011950|FG002|Overall Study|Study Terminated by Sponsor|15|||
143399239|NCT04778397|517011951|FG003|Overall Study|Study Terminated by Sponsor|12|||
143399240|NCT04778397|517011948|FG000|Overall Study|Withdrew Consent|5|||
143399241|NCT04778397|517011949|FG001|Overall Study|Withdrew Consent|4|||
143399242|NCT04778397|517011950|FG002|Overall Study|Withdrew Consent|1|||
143399243|NCT04778397|517011951|FG003|Overall Study|Withdrew Consent|1|||
143399244|NCT04778397|517011948|FG000|Overall Study|Reason Not Specified|1|||
143399245|NCT04778397|517011949|FG001|Overall Study|Reason Not Specified|3|||
143399246|NCT04778397|517011950|FG002|Overall Study|Reason Not Specified|0|||
143399247|NCT04778397|517011951|FG003|Overall Study|Reason Not Specified|2|||
143399248|NCT04778397|517011948|FG000|Overall Study|Lost to Follow-up|2|||
143399249|NCT04778397|517011949|FG001|Overall Study|Lost to Follow-up|1|||
143399250|NCT04778397|517011950|FG002|Overall Study|Lost to Follow-up|0|||
143399251|NCT04778397|517011951|FG003|Overall Study|Lost to Follow-up|1|||
143399252|NCT04294641|517011952|FG000|Overall Study|Screen failure|4|||
143399253|NCT04730739|517011953|FG000|Overall Study|Death|1|||
143399254|NCT03308877|517011954|FG000|Overall Study|Lost to Follow-up|32|||
143399255|NCT03308877|517011955|FG001|Overall Study|Lost to Follow-up|28|||
143399256|NCT05218096|517011968|FG000|Primary Evaluation|Withdrawal by Subject|0|||
143399257|NCT05218096|517011969|FG001|Primary Evaluation|Withdrawal by Subject|0|||
143399258|NCT05218096|517011970|FG002|Primary Evaluation|Withdrawal by Subject|2|||
143399259|NCT05218096|517011971|FG003|Primary Evaluation|Withdrawal by Subject|0|||
143399260|NCT05218096|517011972|FG004|Primary Evaluation|Withdrawal by Subject|0|||
143399261|NCT05218096|517011968|FG000|Primary Evaluation|Physician Decision|1|||
143399262|NCT05218096|517011969|FG001|Primary Evaluation|Physician Decision|0|||
143399263|NCT05218096|517011970|FG002|Primary Evaluation|Physician Decision|0|||
143399264|NCT05218096|517011971|FG003|Primary Evaluation|Physician Decision|0|||
143399265|NCT05218096|517011972|FG004|Primary Evaluation|Physician Decision|0|||
143399266|NCT05218096|517011968|FG000|Extended Treatment|Clinical Deterioration|1|||
143399267|NCT05218096|517011969|FG001|Extended Treatment|Clinical Deterioration|1|||
143399268|NCT05218096|517011970|FG002|Extended Treatment|Clinical Deterioration|0|||
143399269|NCT05218096|517011971|FG003|Extended Treatment|Clinical Deterioration|0|||
143399270|NCT05218096|517011972|FG004|Extended Treatment|Clinical Deterioration|0|||
143399271|NCT05218096|517011968|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
143399272|NCT05218096|517011969|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
143399273|NCT05218096|517011970|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
143399274|NCT05218096|517011971|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
143399275|NCT05218096|517011972|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
143399276|NCT05218096|517011968|FG000|Extended Treatment|Withdrawal by Subject|1|||
143399277|NCT05218096|517011969|FG001|Extended Treatment|Withdrawal by Subject|3|||
143399278|NCT05218096|517011970|FG002|Extended Treatment|Withdrawal by Subject|0|||
143399279|NCT05218096|517011971|FG003|Extended Treatment|Withdrawal by Subject|2|||
143399280|NCT05218096|517011972|FG004|Extended Treatment|Withdrawal by Subject|2|||
143399281|NCT05218096|517011968|FG000|Extended Treatment|Lack of Efficacy|3|||
143399282|NCT05218096|517011969|FG001|Extended Treatment|Lack of Efficacy|0|||
143399283|NCT05218096|517011970|FG002|Extended Treatment|Lack of Efficacy|0|||
143399284|NCT05218096|517011971|FG003|Extended Treatment|Lack of Efficacy|0|||
143399285|NCT05218096|517011972|FG004|Extended Treatment|Lack of Efficacy|0|||
143399286|NCT05218096|517011968|FG000|Extended Treatment|Physician Decision|0|||
143399287|NCT05218096|517011969|FG001|Extended Treatment|Physician Decision|1|||
143399288|NCT05218096|517011970|FG002|Extended Treatment|Physician Decision|0|||
143399289|NCT05218096|517011971|FG003|Extended Treatment|Physician Decision|0|||
143399290|NCT05218096|517011972|FG004|Extended Treatment|Physician Decision|0|||
143399291|NCT05218096|517011968|FG000|Open-label Extension|Adverse Event|1|||
143399292|NCT05218096|517011969|FG001|Open-label Extension|Adverse Event|0|||
143399293|NCT05218096|517011970|FG002|Open-label Extension|Adverse Event|0|||
143399294|NCT05218096|517011971|FG003|Open-label Extension|Adverse Event|0|||
143399295|NCT05218096|517011972|FG004|Open-label Extension|Adverse Event|1|||
143399296|NCT05218096|517011968|FG000|Open-label Extension|Pregnancy|0|||
143399297|NCT05218096|517011969|FG001|Open-label Extension|Pregnancy|0|||
143399298|NCT05218096|517011970|FG002|Open-label Extension|Pregnancy|0|||
143399299|NCT05218096|517011971|FG003|Open-label Extension|Pregnancy|0|||
143399300|NCT05218096|517011972|FG004|Open-label Extension|Pregnancy|1|||
143399301|NCT05218096|517011968|FG000|Open-label Extension|Lack of Efficacy|1|||
143399302|NCT05218096|517011969|FG001|Open-label Extension|Lack of Efficacy|2|||
143399303|NCT05218096|517011970|FG002|Open-label Extension|Lack of Efficacy|0|||
143399304|NCT05218096|517011971|FG003|Open-label Extension|Lack of Efficacy|0|||
143399305|NCT05218096|517011972|FG004|Open-label Extension|Lack of Efficacy|0|||
143399306|NCT05218096|517011968|FG000|Open-label Extension|Lost to Follow-up|1|||
143399307|NCT05218096|517011969|FG001|Open-label Extension|Lost to Follow-up|0|||
143399308|NCT05218096|517011970|FG002|Open-label Extension|Lost to Follow-up|0|||
143399309|NCT05218096|517011971|FG003|Open-label Extension|Lost to Follow-up|0|||
143399310|NCT05218096|517011972|FG004|Open-label Extension|Lost to Follow-up|0|||
143399311|NCT05218096|517011968|FG000|Open-label Extension|Death|0|||
143399312|NCT05218096|517011969|FG001|Open-label Extension|Death|0|||
143399313|NCT05218096|517011970|FG002|Open-label Extension|Death|0|||
143399314|NCT05218096|517011971|FG003|Open-label Extension|Death|1|||
143399315|NCT05218096|517011972|FG004|Open-label Extension|Death|0|||
143399316|NCT05218096|517011968|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
143399317|NCT05218096|517011969|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
143399318|NCT05218096|517011970|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
143399319|NCT05218096|517011971|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
143399320|NCT05218096|517011972|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
143399321|NCT05147116|517011977|FG000|Overall Study|Withdrawal by Subject|0|||
143399322|NCT05147116|517011978|FG001|Overall Study|Withdrawal by Subject|1|||
143399323|NCT03625115|517011979|FG000|Overall Study|Withdrawal by Subject|4|||
143399324|NCT03625115|517011980|FG001|Overall Study|Withdrawal by Subject|7|||
143399325|NCT03625115|517011979|FG000|Overall Study|Lost to Follow-up|17|||
143399326|NCT03625115|517011980|FG001|Overall Study|Lost to Follow-up|24|||
143399327|NCT04197336|517011981|FG000|Overall Study|Withdrawal by Subject|1|||
143399328|NCT04101357|517011982|FG000|Overall Study|Death|1|||
143399329|NCT04101357|517011983|FG001|Overall Study|Death|1|||
143399330|NCT04101357|517011984|FG002|Overall Study|Death|1|||
143399331|NCT04101357|517011985|FG003|Overall Study|Death|2|||
143399332|NCT04101357|517011986|FG004|Overall Study|Death|4|||
143399333|NCT04101357|517011987|FG005|Overall Study|Death|11|||
143399334|NCT04101357|517011988|FG006|Overall Study|Death|4|||
143399335|NCT04101357|517011989|FG007|Overall Study|Death|4|||
143399336|NCT04101357|517011990|FG008|Overall Study|Death|5|||
143399337|NCT04101357|517011991|FG009|Overall Study|Death|2|||
143399338|NCT04101357|517011992|FG010|Overall Study|Death|3|||
143399339|NCT04101357|517011982|FG000|Overall Study|Trial closure|0|||
143399340|NCT04101357|517011983|FG001|Overall Study|Trial closure|0|||
143399341|NCT04101357|517011984|FG002|Overall Study|Trial closure|0|||
143399342|NCT04101357|517011985|FG003|Overall Study|Trial closure|0|||
143399343|NCT04101357|517011986|FG004|Overall Study|Trial closure|0|||
143399344|NCT04101357|517011987|FG005|Overall Study|Trial closure|2|||
143399345|NCT04101357|517011988|FG006|Overall Study|Trial closure|2|||
143399346|NCT04101357|517011989|FG007|Overall Study|Trial closure|0|||
143399347|NCT04101357|517011990|FG008|Overall Study|Trial closure|0|||
143399348|NCT04101357|517011991|FG009|Overall Study|Trial closure|0|||
143399349|NCT04101357|517011992|FG010|Overall Study|Trial closure|1|||
143399350|NCT04101357|517011982|FG000|Overall Study|Lost to Follow-up|0|||
143399351|NCT04101357|517011983|FG001|Overall Study|Lost to Follow-up|0|||
143399352|NCT04101357|517011984|FG002|Overall Study|Lost to Follow-up|0|||
143399353|NCT04101357|517011985|FG003|Overall Study|Lost to Follow-up|1|||
143399354|NCT04101357|517011986|FG004|Overall Study|Lost to Follow-up|0|||
143399355|NCT04101357|517011987|FG005|Overall Study|Lost to Follow-up|0|||
143399356|NCT04101357|517011988|FG006|Overall Study|Lost to Follow-up|0|||
143399357|NCT04101357|517011989|FG007|Overall Study|Lost to Follow-up|1|||
143399358|NCT04101357|517011990|FG008|Overall Study|Lost to Follow-up|0|||
143399359|NCT04101357|517011991|FG009|Overall Study|Lost to Follow-up|0|||
143399360|NCT04101357|517011992|FG010|Overall Study|Lost to Follow-up|0|||
143399361|NCT04101357|517011982|FG000|Overall Study|Withdrawal by Subject|1|||
143399362|NCT04101357|517011983|FG001|Overall Study|Withdrawal by Subject|0|||
143399363|NCT04101357|517011984|FG002|Overall Study|Withdrawal by Subject|0|||
143399364|NCT04101357|517011985|FG003|Overall Study|Withdrawal by Subject|0|||
143399365|NCT04101357|517011986|FG004|Overall Study|Withdrawal by Subject|0|||
143399366|NCT04101357|517011987|FG005|Overall Study|Withdrawal by Subject|0|||
143399367|NCT04101357|517011988|FG006|Overall Study|Withdrawal by Subject|0|||
143399368|NCT04101357|517011989|FG007|Overall Study|Withdrawal by Subject|0|||
143399369|NCT04101357|517011990|FG008|Overall Study|Withdrawal by Subject|1|||
143399370|NCT04101357|517011991|FG009|Overall Study|Withdrawal by Subject|1|||
143399371|NCT04101357|517011992|FG010|Overall Study|Withdrawal by Subject|0|||
143399372|NCT04101357|517011982|FG000|Overall Study|Other|0|||
143399373|NCT04101357|517011983|FG001|Overall Study|Other|0|||
143399374|NCT04101357|517011984|FG002|Overall Study|Other|0|||
143399375|NCT04101357|517011985|FG003|Overall Study|Other|0|||
143399376|NCT04101357|517011986|FG004|Overall Study|Other|0|||
143399377|NCT04101357|517011987|FG005|Overall Study|Other|1|||
143399378|NCT04101357|517011988|FG006|Overall Study|Other|2|||
143399379|NCT04101357|517011989|FG007|Overall Study|Other|1|||
143399380|NCT04101357|517011990|FG008|Overall Study|Other|0|||
143399381|NCT04101357|517011991|FG009|Overall Study|Other|0|||
143399382|NCT04101357|517011992|FG010|Overall Study|Other|0|||
143399383|NCT04101357|517011982|FG000|Overall Study|Enrolled but not treated|0|||
143399384|NCT04101357|517011983|FG001|Overall Study|Enrolled but not treated|0|||
143399385|NCT04101357|517011984|FG002|Overall Study|Enrolled but not treated|0|||
143399386|NCT04101357|517011985|FG003|Overall Study|Enrolled but not treated|0|||
143399387|NCT04101357|517011986|FG004|Overall Study|Enrolled but not treated|0|||
143399388|NCT04101357|517011987|FG005|Overall Study|Enrolled but not treated|1|||
143399389|NCT04101357|517011988|FG006|Overall Study|Enrolled but not treated|1|||
143399390|NCT04101357|517011989|FG007|Overall Study|Enrolled but not treated|0|||
143399391|NCT04101357|517011990|FG008|Overall Study|Enrolled but not treated|0|||
143399392|NCT04101357|517011991|FG009|Overall Study|Enrolled but not treated|0|||
143399393|NCT04101357|517011992|FG010|Overall Study|Enrolled but not treated|0|||
143399394|NCT05868382|517011993|FG000|Overall Study|Lost to Follow-up|5|||
143399395|NCT05868382|517011994|FG001|Overall Study|Lost to Follow-up|0|||
143399396|NCT05868382|517011995|FG002|Overall Study|Lost to Follow-up|6|||
143399397|NCT05868382|517011996|FG003|Overall Study|Lost to Follow-up|4|||
143399398|NCT05868382|517011997|FG004|Overall Study|Lost to Follow-up|2|||
143399399|NCT05868382|517011998|FG005|Overall Study|Lost to Follow-up|6|||
143399400|NCT05868382|517011993|FG000|Overall Study|Withdrawal by Subject|1|||
143399401|NCT05868382|517011994|FG001|Overall Study|Withdrawal by Subject|0|||
143399402|NCT05868382|517011995|FG002|Overall Study|Withdrawal by Subject|0|||
143399403|NCT05868382|517011996|FG003|Overall Study|Withdrawal by Subject|0|||
143399404|NCT05868382|517011997|FG004|Overall Study|Withdrawal by Subject|1|||
143399405|NCT05868382|517011998|FG005|Overall Study|Withdrawal by Subject|0|||
143399406|NCT04585815|517011999|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
143399407|NCT04585815|517012000|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
143399408|NCT04585815|517012001|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
143399409|NCT04585815|517012002|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
143399410|NCT04585815|517012003|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
143399411|NCT04585815|517012004|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
143399412|NCT04585815|517012005|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
143399413|NCT04585815|517011999|FG000|Sub-study A- Treatment Phase|Death|0|||
143399414|NCT04585815|517012000|FG001|Sub-study A- Treatment Phase|Death|1|||
143399415|NCT04585815|517012001|FG002|Sub-study A- Treatment Phase|Death|0|||
143399416|NCT04585815|517012002|FG003|Sub-study A- Treatment Phase|Death|0|||
143399417|NCT04585815|517012003|FG004|Sub-study A- Treatment Phase|Death|0|||
143399418|NCT04585815|517012004|FG005|Sub-study A- Treatment Phase|Death|0|||
143399419|NCT04585815|517012005|FG006|Sub-study A- Treatment Phase|Death|0|||
143399420|NCT04585815|517011999|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
143399421|NCT04585815|517012000|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
143399422|NCT04585815|517012001|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
143399423|NCT04585815|517012002|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
143399424|NCT04585815|517012003|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
143399425|NCT04585815|517012004|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
143399426|NCT04585815|517012005|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
143399427|NCT04585815|517011999|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
143399428|NCT04585815|517012000|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
143399429|NCT04585815|517012001|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
143399430|NCT04585815|517012002|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
143399431|NCT04585815|517012003|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
143399432|NCT04585815|517012004|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
143399433|NCT04585815|517012005|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
143399434|NCT04585815|517011999|FG000|Sub-study A- Treatment Phase|Other|1|||
143399435|NCT04585815|517012000|FG001|Sub-study A- Treatment Phase|Other|0|||
143399436|NCT04585815|517012001|FG002|Sub-study A- Treatment Phase|Other|0|||
143399437|NCT04585815|517012002|FG003|Sub-study A- Treatment Phase|Other|0|||
143399438|NCT04585815|517012003|FG004|Sub-study A- Treatment Phase|Other|0|||
143399439|NCT04585815|517012004|FG005|Sub-study A- Treatment Phase|Other|0|||
143399440|NCT04585815|517012005|FG006|Sub-study A- Treatment Phase|Other|0|||
143399441|NCT04585815|517011999|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
143399442|NCT04585815|517012000|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
143399443|NCT04585815|517012001|FG002|Sub-study A- Treatment Phase|Ongoing treatment|0|||
143399444|NCT04585815|517012002|FG003|Sub-study A- Treatment Phase|Ongoing treatment|0|||
143399445|NCT04585815|517012003|FG004|Sub-study A- Treatment Phase|Ongoing treatment|0|||
143399446|NCT04585815|517012004|FG005|Sub-study A- Treatment Phase|Ongoing treatment|0|||
143399447|NCT04585815|517012005|FG006|Sub-study A- Treatment Phase|Ongoing treatment|0|||
143399448|NCT04585815|517011999|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
143399449|NCT04585815|517012000|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
143399450|NCT04585815|517012001|FG002|Sub-study A- Follow-up Phase|Ongoing in study|0|||
143399451|NCT04585815|517012002|FG003|Sub-study A- Follow-up Phase|Ongoing in study|0|||
143399452|NCT04585815|517012003|FG004|Sub-study A- Follow-up Phase|Ongoing in study|0|||
143399453|NCT04585815|517012004|FG005|Sub-study A- Follow-up Phase|Ongoing in study|0|||
143399454|NCT04585815|517012005|FG006|Sub-study A- Follow-up Phase|Ongoing in study|0|||
143399455|NCT04585815|517011999|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
143399456|NCT04585815|517012000|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
143399457|NCT04585815|517012001|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
143399458|NCT04585815|517012002|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
143399459|NCT04585815|517012003|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
143399460|NCT04585815|517012004|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
143399461|NCT04585815|517012005|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
143399462|NCT04585815|517011999|FG000|Sub-study B- Treatment Phase|Death|0|||
143399463|NCT04585815|517012000|FG001|Sub-study B- Treatment Phase|Death|0|||
143399464|NCT04585815|517012001|FG002|Sub-study B- Treatment Phase|Death|0|||
143399465|NCT04585815|517012002|FG003|Sub-study B- Treatment Phase|Death|1|||
143399466|NCT04585815|517012003|FG004|Sub-study B- Treatment Phase|Death|0|||
143399467|NCT04585815|517012004|FG005|Sub-study B- Treatment Phase|Death|0|||
143399468|NCT04585815|517012005|FG006|Sub-study B- Treatment Phase|Death|0|||
143399469|NCT04585815|517011999|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
143399470|NCT04585815|517012000|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
143399471|NCT04585815|517012001|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
143399472|NCT04585815|517012002|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
143399473|NCT04585815|517012003|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
143399474|NCT04585815|517012004|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
143399475|NCT04585815|517012005|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
143399476|NCT04585815|517011999|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
143399477|NCT04585815|517012000|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
143399478|NCT04585815|517012001|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
143399479|NCT04585815|517012002|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
143399480|NCT04585815|517012003|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
143399481|NCT04585815|517012004|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
143399482|NCT04585815|517012005|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
143399483|NCT04585815|517011999|FG000|Sub-study B- Treatment Phase|Ongoing treatment|0|||
143399484|NCT04585815|517012000|FG001|Sub-study B- Treatment Phase|Ongoing treatment|0|||
143399485|NCT04585815|517012001|FG002|Sub-study B- Treatment Phase|Ongoing treatment|0|||
143399486|NCT04585815|517012002|FG003|Sub-study B- Treatment Phase|Ongoing treatment|0|||
143399487|NCT04585815|517012003|FG004|Sub-study B- Treatment Phase|Ongoing treatment|0|||
143399488|NCT04585815|517012004|FG005|Sub-study B- Treatment Phase|Ongoing treatment|0|||
143399489|NCT04585815|517012005|FG006|Sub-study B- Treatment Phase|Ongoing treatment|1|||
143399490|NCT04585815|517011999|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
143399491|NCT04585815|517012000|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
143399492|NCT04585815|517012001|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
143399493|NCT04585815|517012002|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
143399494|NCT04585815|517012003|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
143399495|NCT04585815|517012004|FG005|Sub-study B- Treatment Phase|Progressive disease|0|||
143399496|NCT04585815|517012005|FG006|Sub-study B- Treatment Phase|Progressive disease|4|||
143399497|NCT04585815|517011999|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
143399498|NCT04585815|517012000|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
143399499|NCT04585815|517012001|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
143399500|NCT04585815|517012002|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
143399501|NCT04585815|517012003|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
143399502|NCT04585815|517012004|FG005|Sub-study B- Treatment Phase|Physician Decision|1|||
143399503|NCT04585815|517012005|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
143399504|NCT04585815|517011999|FG000|Sub-study B- Follow-up Phase|Ongoing in study|0|||
143399505|NCT04585815|517012000|FG001|Sub-study B- Follow-up Phase|Ongoing in study|0|||
143399506|NCT04585815|517012001|FG002|Sub-study B- Follow-up Phase|Ongoing in study|0|||
143399507|NCT04585815|517012002|FG003|Sub-study B- Follow-up Phase|Ongoing in study|0|||
143399508|NCT04585815|517012003|FG004|Sub-study B- Follow-up Phase|Ongoing in study|1|||
143399509|NCT04585815|517012004|FG005|Sub-study B- Follow-up Phase|Ongoing in study|1|||
143399510|NCT04585815|517012005|FG006|Sub-study B- Follow-up Phase|Ongoing in study|3|||
143399511|NCT04585815|517011999|FG000|Sub-study B- Follow-up Phase|Death|0|||
143399512|NCT04585815|517012000|FG001|Sub-study B- Follow-up Phase|Death|0|||
143399513|NCT04585815|517012001|FG002|Sub-study B- Follow-up Phase|Death|1|||
143399514|NCT04585815|517012002|FG003|Sub-study B- Follow-up Phase|Death|3|||
143399515|NCT04585815|517012003|FG004|Sub-study B- Follow-up Phase|Death|0|||
143399516|NCT04585815|517012004|FG005|Sub-study B- Follow-up Phase|Death|0|||
143399517|NCT04585815|517012005|FG006|Sub-study B- Follow-up Phase|Death|1|||
143399518|NCT05256654|517012008|FG000|Overall Study|Adverse Event|0|||
143399519|NCT05256654|517012009|FG001|Overall Study|Adverse Event|0|||
143399520|NCT05256654|517012010|FG002|Overall Study|Adverse Event|1|||
143399521|NCT05256654|517012011|FG003|Overall Study|Adverse Event|0|||
143399522|NCT05256654|517012008|FG000|Overall Study|Lost to Follow-up|0|||
143399523|NCT05256654|517012009|FG001|Overall Study|Lost to Follow-up|0|||
143399524|NCT05256654|517012010|FG002|Overall Study|Lost to Follow-up|0|||
143399525|NCT05256654|517012011|FG003|Overall Study|Lost to Follow-up|1|||
143399526|NCT05256654|517012008|FG000|Overall Study|Withdrawal by Subject|1|||
143399527|NCT05256654|517012009|FG001|Overall Study|Withdrawal by Subject|2|||
143399528|NCT05256654|517012010|FG002|Overall Study|Withdrawal by Subject|1|||
143399529|NCT05256654|517012011|FG003|Overall Study|Withdrawal by Subject|3|||
143399530|NCT05256654|517012008|FG000|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
143399531|NCT05256654|517012009|FG001|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
143399532|NCT05256654|517012010|FG002|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
143399533|NCT05256654|517012011|FG003|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
143399534|NCT05256654|517012008|FG000|Overall Study|Other|0|||
143399535|NCT05256654|517012009|FG001|Overall Study|Other|0|||
143399536|NCT05256654|517012010|FG002|Overall Study|Other|0|||
143399537|NCT05256654|517012011|FG003|Overall Study|Other|1|||
143399538|NCT05618587|517012012|FG000|Overall Study|Lost to Follow-up|2|||
143399539|NCT05618587|517012013|FG001|Overall Study|Lost to Follow-up|0|||
143399540|NCT03442309|517012025|FG000|Overall Study|Lost to Follow-up|1676|||
143399541|NCT03442309|517012026|FG001|Overall Study|Lost to Follow-up|1642|||
143399542|NCT05204654|517012027|FG000|Overall Study|Study terminated due to time restraint|2|||
143399543|NCT05204654|517012028|FG001|Overall Study|Study terminated due to time restraint|2|||
143399544|NCT01221948|517012029|FG000|Overall Study|Physician Decision|5|||
143399545|NCT01221948|517012029|FG000|Overall Study|Withdrawal by Subject|2|||
143399546|NCT01221948|517012029|FG000|Overall Study|not disclosed|2|||
143399547|NCT01221948|517012029|FG000|Overall Study|Death|1|||
143399548|NCT01221948|517012029|FG000|Overall Study|Protocol Violation|4|||
143399549|NCT05207956|517012038|FG000|Overall Study|Lost to follow up|1|||
143399550|NCT05207956|517012039|FG001|Overall Study|Lost to follow up|2|||
143399551|NCT01009788|517012040|FG000|Overall Study|Withdrawal by Subject|1|||
143399552|NCT01009788|517012041|FG001|Overall Study|Withdrawal by Subject|0|||
143399553|NCT04625725|517012042|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
143399554|NCT04625725|517012043|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
143399555|NCT04625725|517012044|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
143399556|NCT04625725|517012045|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
143399557|NCT04625725|517012046|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
143399558|NCT04625725|517012047|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
143399559|NCT04625725|517012042|FG000|Provent Main Study|Withdrawal by Subject|242|||
143399560|NCT04625725|517012043|FG001|Provent Main Study|Withdrawal by Subject|144|||
143399561|NCT04625725|517012044|FG002|Provent Main Study|Withdrawal by Subject|0|||
143399562|NCT04625725|517012045|FG003|Provent Main Study|Withdrawal by Subject|0|||
143399563|NCT04625725|517012046|FG004|Provent Main Study|Withdrawal by Subject|0|||
143399564|NCT04625725|517012047|FG005|Provent Main Study|Withdrawal by Subject|0|||
143399565|NCT04625725|517012042|FG000|Provent Main Study|Physician Decision|5|||
143399566|NCT04625725|517012043|FG001|Provent Main Study|Physician Decision|0|||
143399567|NCT04625725|517012044|FG002|Provent Main Study|Physician Decision|0|||
143399568|NCT04625725|517012045|FG003|Provent Main Study|Physician Decision|0|||
143399569|NCT04625725|517012046|FG004|Provent Main Study|Physician Decision|0|||
143399570|NCT04625725|517012047|FG005|Provent Main Study|Physician Decision|0|||
143399571|NCT04625725|517012042|FG000|Provent Main Study|Protocol Violation|1|||
143399572|NCT04625725|517012043|FG001|Provent Main Study|Protocol Violation|0|||
143399573|NCT04625725|517012044|FG002|Provent Main Study|Protocol Violation|0|||
143399574|NCT04625725|517012045|FG003|Provent Main Study|Protocol Violation|0|||
143399575|NCT04625725|517012046|FG004|Provent Main Study|Protocol Violation|0|||
143399576|NCT04625725|517012047|FG005|Provent Main Study|Protocol Violation|0|||
143399577|NCT04625725|517012042|FG000|Provent Main Study|Lost to Follow-up|357|||
143399578|NCT04625725|517012043|FG001|Provent Main Study|Lost to Follow-up|200|||
143399579|NCT04625725|517012044|FG002|Provent Main Study|Lost to Follow-up|0|||
143399580|NCT04625725|517012045|FG003|Provent Main Study|Lost to Follow-up|0|||
143399581|NCT04625725|517012046|FG004|Provent Main Study|Lost to Follow-up|0|||
143399582|NCT04625725|517012047|FG005|Provent Main Study|Lost to Follow-up|0|||
143399583|NCT04625725|517012042|FG000|Provent Main Study|Death|22|||
143399584|NCT04625725|517012043|FG001|Provent Main Study|Death|10|||
143399585|NCT04625725|517012044|FG002|Provent Main Study|Death|0|||
143399586|NCT04625725|517012045|FG003|Provent Main Study|Death|0|||
143399587|NCT04625725|517012046|FG004|Provent Main Study|Death|0|||
143399588|NCT04625725|517012047|FG005|Provent Main Study|Death|0|||
143399589|NCT04625725|517012042|FG000|Provent Main Study|Adverse Event|2|||
143399590|NCT04625725|517012043|FG001|Provent Main Study|Adverse Event|1|||
143399591|NCT04625725|517012044|FG002|Provent Main Study|Adverse Event|0|||
143399592|NCT04625725|517012045|FG003|Provent Main Study|Adverse Event|0|||
143399593|NCT04625725|517012046|FG004|Provent Main Study|Adverse Event|0|||
143399594|NCT04625725|517012047|FG005|Provent Main Study|Adverse Event|0|||
143399595|NCT04625725|517012042|FG000|Provent Main Study|Participants dosed in sub-study|310|||
143399596|NCT04625725|517012043|FG001|Provent Main Study|Participants dosed in sub-study|193|||
143399597|NCT04625725|517012044|FG002|Provent Main Study|Participants dosed in sub-study|0|||
143399598|NCT04625725|517012045|FG003|Provent Main Study|Participants dosed in sub-study|0|||
143399599|NCT04625725|517012046|FG004|Provent Main Study|Participants dosed in sub-study|0|||
143399600|NCT04625725|517012047|FG005|Provent Main Study|Participants dosed in sub-study|0|||
143399601|NCT04625725|517012042|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
143399602|NCT04625725|517012043|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
143399603|NCT04625725|517012044|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
143399604|NCT04625725|517012045|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
143399605|NCT04625725|517012046|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
143399606|NCT04625725|517012047|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
143399607|NCT04625725|517012042|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
143399608|NCT04625725|517012043|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
143399609|NCT04625725|517012044|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
143399610|NCT04625725|517012045|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
143399611|NCT04625725|517012046|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
143399612|NCT04625725|517012047|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
143399613|NCT04625725|517012042|FG000|Provent Main Study|INCARCERATION|3|||
143399614|NCT04625725|517012043|FG001|Provent Main Study|INCARCERATION|0|||
143399615|NCT04625725|517012044|FG002|Provent Main Study|INCARCERATION|0|||
143399616|NCT04625725|517012045|FG003|Provent Main Study|INCARCERATION|0|||
143399617|NCT04625725|517012046|FG004|Provent Main Study|INCARCERATION|0|||
143399618|NCT04625725|517012047|FG005|Provent Main Study|INCARCERATION|0|||
143399619|NCT04625725|517012042|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
143399620|NCT04625725|517012043|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
143399621|NCT04625725|517012044|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
143399622|NCT04625725|517012045|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
143399623|NCT04625725|517012046|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
143399624|NCT04625725|517012047|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
143399625|NCT04625725|517012042|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
143399626|NCT04625725|517012043|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
143399627|NCT04625725|517012044|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
143399628|NCT04625725|517012045|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
143399629|NCT04625725|517012046|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
143399630|NCT04625725|517012047|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
143399631|NCT04625725|517012042|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
143399632|NCT04625725|517012043|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
143399633|NCT04625725|517012044|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
143399634|NCT04625725|517012045|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
143399635|NCT04625725|517012046|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
143399636|NCT04625725|517012047|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
143399637|NCT04625725|517012042|FG000|Provent Main Study|MISSING REASON|0|||
143399638|NCT04625725|517012043|FG001|Provent Main Study|MISSING REASON|1|||
143399639|NCT04625725|517012044|FG002|Provent Main Study|MISSING REASON|0|||
143399640|NCT04625725|517012045|FG003|Provent Main Study|MISSING REASON|0|||
143399641|NCT04625725|517012046|FG004|Provent Main Study|MISSING REASON|0|||
143399642|NCT04625725|517012047|FG005|Provent Main Study|MISSING REASON|0|||
143399643|NCT04625725|517012042|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
143399644|NCT04625725|517012043|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
143399645|NCT04625725|517012044|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
143399646|NCT04625725|517012045|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
143399647|NCT04625725|517012046|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
143399648|NCT04625725|517012047|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
143399649|NCT04625725|517012042|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
143399650|NCT04625725|517012043|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
143399651|NCT04625725|517012044|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
143399652|NCT04625725|517012045|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
143399653|NCT04625725|517012046|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
143399654|NCT04625725|517012047|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
143399655|NCT04625725|517012042|FG000|Provent Sub Study|Lost to Follow-up|0|||
143399656|NCT04625725|517012043|FG001|Provent Sub Study|Lost to Follow-up|0|||
143399657|NCT04625725|517012044|FG002|Provent Sub Study|Lost to Follow-up|20|||
143399658|NCT04625725|517012045|FG003|Provent Sub Study|Lost to Follow-up|10|||
143399659|NCT04625725|517012046|FG004|Provent Sub Study|Lost to Follow-up|6|||
143399660|NCT04625725|517012047|FG005|Provent Sub Study|Lost to Follow-up|4|||
143399661|NCT04625725|517012042|FG000|Provent Sub Study|Death|0|||
143399662|NCT04625725|517012043|FG001|Provent Sub Study|Death|0|||
143399663|NCT04625725|517012044|FG002|Provent Sub Study|Death|8|||
143399664|NCT04625725|517012045|FG003|Provent Sub Study|Death|5|||
143399665|NCT04625725|517012046|FG004|Provent Sub Study|Death|0|||
143399666|NCT04625725|517012047|FG005|Provent Sub Study|Death|1|||
143399667|NCT04625725|517012042|FG000|Provent Sub Study|Adverse Event|0|||
143399668|NCT04625725|517012043|FG001|Provent Sub Study|Adverse Event|0|||
143399669|NCT04625725|517012044|FG002|Provent Sub Study|Adverse Event|0|||
143399670|NCT04625725|517012045|FG003|Provent Sub Study|Adverse Event|0|||
143399671|NCT04625725|517012046|FG004|Provent Sub Study|Adverse Event|0|||
143399672|NCT04625725|517012047|FG005|Provent Sub Study|Adverse Event|1|||
143399673|NCT04625725|517012042|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
143399674|NCT04625725|517012043|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
143399675|NCT04625725|517012044|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
143399676|NCT04625725|517012045|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
143399677|NCT04625725|517012046|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
143399678|NCT04625725|517012047|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
143399679|NCT04625725|517012042|FG000|Provent Sub Study|Withdrawal by Subject|0|||
143399680|NCT04625725|517012043|FG001|Provent Sub Study|Withdrawal by Subject|0|||
143399681|NCT04625725|517012044|FG002|Provent Sub Study|Withdrawal by Subject|11|||
143399682|NCT04625725|517012045|FG003|Provent Sub Study|Withdrawal by Subject|13|||
143399683|NCT04625725|517012046|FG004|Provent Sub Study|Withdrawal by Subject|5|||
143399684|NCT04625725|517012047|FG005|Provent Sub Study|Withdrawal by Subject|6|||
143399685|NCT04625725|517012042|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
143399686|NCT04625725|517012043|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
143399687|NCT04625725|517012044|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
143399688|NCT04625725|517012045|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
143399689|NCT04625725|517012046|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
143399690|NCT04625725|517012047|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
143399691|NCT05012163|517012056|FG000|Overall Study|Protocol Violation|0|||
143399692|NCT05012163|517012057|FG001|Overall Study|Protocol Violation|0|||
143399693|NCT05012163|517012058|FG002|Overall Study|Protocol Violation|1|||
143399694|NCT05012163|517012059|FG003|Overall Study|Protocol Violation|1|||
143399695|NCT05524402|517012068|FG000|Overall Study|Withdrawal by Subject|3|||
143399696|NCT05524402|517012069|FG001|Overall Study|Withdrawal by Subject|1|||
143399697|NCT05524402|517012068|FG000|Overall Study|Lost to Follow-up|2|||
143399698|NCT05524402|517012069|FG001|Overall Study|Lost to Follow-up|1|||
143399699|NCT03381586|517012070|FG000|Overall Study|Adverse Event|1|||
143399700|NCT03381586|517012071|FG001|Overall Study|Adverse Event|1|||
143399701|NCT03381586|517012070|FG000|Overall Study|Protocol Violation|1|||
143399702|NCT03381586|517012071|FG001|Overall Study|Protocol Violation|0|||
143399703|NCT03381586|517012070|FG000|Overall Study|Withdrawal by Subject|1|||
143399704|NCT03381586|517012071|FG001|Overall Study|Withdrawal by Subject|2|||
143399705|NCT05237284|517012075|FG000|Part A (Double-blind Period: 24 Weeks)|Other|0|||
143399706|NCT05237284|517012076|FG001|Part A (Double-blind Period: 24 Weeks)|Other|2|||
143399707|NCT05237284|517012077|FG002|Part A (Double-blind Period: 24 Weeks)|Other|0|||
143399708|NCT05237284|517012078|FG003|Part A (Double-blind Period: 24 Weeks)|Other|0|||
143399709|NCT05237284|517012075|FG000|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|8|||
143399710|NCT05237284|517012076|FG001|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|13|||
143399711|NCT05237284|517012077|FG002|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
143399712|NCT05237284|517012078|FG003|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
143399713|NCT05237284|517012075|FG000|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
143399714|NCT05237284|517012076|FG001|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|1|||
143399715|NCT05237284|517012077|FG002|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
143399716|NCT05237284|517012078|FG003|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
143399717|NCT05237284|517012075|FG000|Part A (Double-blind Period: 24 Weeks)|Adverse Event|6|||
143399718|NCT05237284|517012076|FG001|Part A (Double-blind Period: 24 Weeks)|Adverse Event|20|||
143399719|NCT05237284|517012077|FG002|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
143399720|NCT05237284|517012078|FG003|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
143399721|NCT05237284|517012075|FG000|Part B (Open-label Period: 80 Weeks)|Other|0|||
143399722|NCT05237284|517012076|FG001|Part B (Open-label Period: 80 Weeks)|Other|0|||
143399723|NCT05237284|517012077|FG002|Part B (Open-label Period: 80 Weeks)|Other|0|||
143399724|NCT05237284|517012078|FG003|Part B (Open-label Period: 80 Weeks)|Other|3|||
143399725|NCT05237284|517012075|FG000|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
143399726|NCT05237284|517012076|FG001|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
143399727|NCT05237284|517012077|FG002|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|64|||
143399728|NCT05237284|517012078|FG003|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|126|||
143399729|NCT05237284|517012075|FG000|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
143399730|NCT05237284|517012076|FG001|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
143399731|NCT05237284|517012077|FG002|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|11|||
143399732|NCT05237284|517012078|FG003|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|21|||
143399733|NCT05237284|517012075|FG000|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
143399734|NCT05237284|517012076|FG001|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
143399735|NCT05237284|517012077|FG002|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
143399736|NCT05237284|517012078|FG003|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|1|||
143399737|NCT05237284|517012075|FG000|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
143399738|NCT05237284|517012076|FG001|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
143399739|NCT05237284|517012077|FG002|Part B (Open-label Period: 80 Weeks)|Adverse Event|13|||
143399740|NCT05237284|517012078|FG003|Part B (Open-label Period: 80 Weeks)|Adverse Event|16|||
143399741|NCT04599634|517012079|FG000|Overall Study|Dose limiting toxicity|0|||
143399742|NCT04599634|517012080|FG001|Overall Study|Dose limiting toxicity|0|||
143399743|NCT04599634|517012081|FG002|Overall Study|Dose limiting toxicity|2|||
143399744|NCT04599634|517012082|FG003|Overall Study|Dose limiting toxicity|0|||
143399745|NCT03714815|517012085|FG000|Overall Study|Physician Decision|2|||
143399746|NCT03714815|517012085|FG000|Overall Study|Withdrawal by Subject|2|||
143399747|NCT03714815|517012085|FG000|Overall Study|Death|11|||
143399748|NCT03276676|517012087|FG000|Overall Study|Withdrawal by Subject|2|||
143399749|NCT03276676|517012088|FG001|Overall Study|Withdrawal by Subject|1|||
143399750|NCT02988661|517012091|FG000|Overall Study|Death|2|||
143399751|NCT02988661|517012092|FG001|Overall Study|Death|18|||
143399752|NCT02988661|517012091|FG000|Overall Study|Lost to Follow-up|0|||
143399753|NCT02988661|517012092|FG001|Overall Study|Lost to Follow-up|33|||
143399754|NCT02988661|517012091|FG000|Overall Study|Withdrawal by Subject|0|||
143399755|NCT02988661|517012092|FG001|Overall Study|Withdrawal by Subject|6|||
143399756|NCT02988661|517012091|FG000|Overall Study|Unable to complete the 18-month survey|1|||
143399757|NCT02988661|517012092|FG001|Overall Study|Unable to complete the 18-month survey|27|||
143399758|NCT02839265|517012093|FG000|Overall Study|Screen Failure|2|||
143399759|NCT02839265|517012093|FG000|Overall Study|Death|1|||
143399760|NCT02839265|517012093|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
143399761|NCT02413489|517012108|FG000|Overall Study|Death|11|||
143399762|NCT02413489|517012109|FG001|Overall Study|Death|3|||
143399763|NCT02413489|517012110|FG002|Overall Study|Death|4|||
143399764|NCT02413489|517012108|FG000|Overall Study|Withdrawal by Subject|2|||
143399765|NCT02413489|517012109|FG001|Overall Study|Withdrawal by Subject|0|||
143399766|NCT02413489|517012110|FG002|Overall Study|Withdrawal by Subject|0|||
143399767|NCT02413489|517012108|FG000|Overall Study|Study Terminated By Sponsor|2|||
143399768|NCT02413489|517012109|FG001|Overall Study|Study Terminated By Sponsor|13|||
143399769|NCT02413489|517012110|FG002|Overall Study|Study Terminated By Sponsor|1|||
143399770|NCT05736458|517012111|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
143399771|NCT05736458|517012112|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
143399772|NCT05736458|517012113|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
143399773|NCT05736458|517012111|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
143399774|NCT05736458|517012112|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
143399775|NCT05736458|517012113|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
143399776|NCT05736458|517012111|FG000|TMS/fMRI #1|Physician Decision|0|||
143399777|NCT05736458|517012112|FG001|TMS/fMRI #1|Physician Decision|0|||
143399778|NCT05736458|517012113|FG002|TMS/fMRI #1|Physician Decision|2|||
143399779|NCT05736458|517012111|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
143399780|NCT05736458|517012112|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
143399781|NCT05736458|517012113|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
143399782|NCT04479761|517012115|FG000|Overall Study|could not perform the balance tasks|1|||
143399783|NCT04479761|517012116|FG001|Overall Study|could not perform the balance tasks|0|||
143399784|NCT04479761|517012117|FG002|Overall Study|could not perform the balance tasks|0|||
143399785|NCT04479761|517012115|FG000|Overall Study|Adverse Event|1|||
143399786|NCT04479761|517012116|FG001|Overall Study|Adverse Event|0|||
143399787|NCT04479761|517012117|FG002|Overall Study|Adverse Event|0|||
143399788|NCT04479761|517012115|FG000|Overall Study|one control did not meet screening criteria|0|||
143399789|NCT04479761|517012116|FG001|Overall Study|one control did not meet screening criteria|0|||
143399790|NCT04479761|517012117|FG002|Overall Study|one control did not meet screening criteria|1|||
143399791|NCT04479761|517012115|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
143399792|NCT04479761|517012116|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
143399793|NCT04479761|517012117|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
143399794|NCT05100628|517012118|FG000|Overall Study|Progressive Disease|1|||
143399795|NCT05100628|517012119|FG001|Overall Study|Progressive Disease|0|||
143399796|NCT05100628|517012120|FG002|Overall Study|Progressive Disease|0|||
143399797|NCT05100628|517012121|FG003|Overall Study|Progressive Disease|0|||
143399798|NCT05100628|517012118|FG000|Overall Study|Study Terminated by Sponsor|0|||
143399799|NCT05100628|517012119|FG001|Overall Study|Study Terminated by Sponsor|0|||
143399800|NCT05100628|517012120|FG002|Overall Study|Study Terminated by Sponsor|3|||
143399801|NCT05100628|517012121|FG003|Overall Study|Study Terminated by Sponsor|0|||
143399802|NCT05100628|517012118|FG000|Overall Study|unkown|0|||
143399803|NCT05100628|517012119|FG001|Overall Study|unkown|1|||
143399804|NCT05100628|517012120|FG002|Overall Study|unkown|0|||
143399805|NCT05100628|517012121|FG003|Overall Study|unkown|0|||
143399806|NCT02575950|517012124|FG000|Overall Study|Withdrawal by Subject|0|||
143399807|NCT02575950|517012125|FG001|Overall Study|Withdrawal by Subject|0|||
143399808|NCT02575950|517012126|FG002|Overall Study|Withdrawal by Subject|0|||
143399809|NCT02575950|517012127|FG003|Overall Study|Withdrawal by Subject|2|||
143399810|NCT02575950|517012124|FG000|Overall Study|Lost to Follow-up|0|||
143399811|NCT02575950|517012125|FG001|Overall Study|Lost to Follow-up|1|||
143399812|NCT02575950|517012126|FG002|Overall Study|Lost to Follow-up|0|||
143399813|NCT02575950|517012127|FG003|Overall Study|Lost to Follow-up|3|||
143399814|NCT04230681|517012128|FG000|Overall Study|Physician Decision|2|||
143399815|NCT04230681|517012129|FG001|Overall Study|Physician Decision|3|||
143399816|NCT04230681|517012128|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
143399817|NCT04230681|517012129|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
143399818|NCT04230681|517012128|FG000|Overall Study|IV inadvertently removed|0|||
143399819|NCT04230681|517012129|FG001|Overall Study|IV inadvertently removed|1|||
143454107|NCT02544451|517206869|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
143454108|NCT02544451|517206870|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
143454109|NCT02544451|517206871|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
143454110|NCT02544451|517206872|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
143454111|NCT02544451|517206869|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
143454112|NCT02544451|517206870|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
143454113|NCT02544451|517206871|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
143454114|NCT02544451|517206872|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
143454115|NCT02544451|517206869|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
143454116|NCT02544451|517206870|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
143454117|NCT02544451|517206871|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
143454118|NCT02544451|517206872|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
143454119|NCT02544451|517206869|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
143454120|NCT02544451|517206870|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
143454121|NCT02544451|517206871|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
143454122|NCT02544451|517206872|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
143454123|NCT02544451|517206869|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
143454124|NCT02544451|517206870|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
143454125|NCT02544451|517206871|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
143454126|NCT02544451|517206872|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
143454127|NCT03590366|517206873|FG000|Overall Study|Adverse Event|0|||
143454128|NCT03590366|517206874|FG001|Overall Study|Adverse Event|3|||
143454129|NCT03590366|517206873|FG000|Overall Study|Lost to Follow-up|3|||
143454130|NCT03590366|517206874|FG001|Overall Study|Lost to Follow-up|3|||
143454131|NCT03590366|517206873|FG000|Overall Study|Withdrawal by Subject|0|||
143454132|NCT03590366|517206874|FG001|Overall Study|Withdrawal by Subject|2|||
143399820|NCT04183283|517013817|FG000|Period 1|Withdrawal by Subject|0|||
143399821|NCT04183283|517013818|FG001|Period 1|Withdrawal by Subject|1|||
143399822|NCT04183283|517013819|FG002|Period 1|Withdrawal by Subject|0|||
143399823|NCT04183283|517013820|FG003|Period 1|Withdrawal by Subject|0|||
143399824|NCT04183283|517013817|FG000|Washout 1(14 Days)|Positive Drug Screen|0|||
143399825|NCT04183283|517013818|FG001|Washout 1(14 Days)|Positive Drug Screen|0|||
143399826|NCT04183283|517013819|FG002|Washout 1(14 Days)|Positive Drug Screen|0|||
143399827|NCT04183283|517013820|FG003|Washout 1(14 Days)|Positive Drug Screen|1|||
143399828|NCT04414722|517013823|FG000|Overall Study|Lost to Follow-up|3|||
143399829|NCT04414722|517013824|FG001|Overall Study|Lost to Follow-up|4|||
143399830|NCT04414722|517013825|FG002|Overall Study|Lost to Follow-up|3|||
143399831|NCT04414722|517013826|FG003|Overall Study|Lost to Follow-up|2|||
143399832|NCT04414722|517013827|FG004|Overall Study|Lost to Follow-up|3|||
143399833|NCT04414722|517013823|FG000|Overall Study|Withdrawal by Subject|6|||
143399834|NCT04414722|517013824|FG001|Overall Study|Withdrawal by Subject|3|||
143399835|NCT04414722|517013825|FG002|Overall Study|Withdrawal by Subject|1|||
143399836|NCT04414722|517013826|FG003|Overall Study|Withdrawal by Subject|5|||
143399837|NCT04414722|517013827|FG004|Overall Study|Withdrawal by Subject|1|||
143399838|NCT04414722|517013823|FG000|Overall Study|Physician Decision|0|||
143399839|NCT04414722|517013824|FG001|Overall Study|Physician Decision|1|||
143399840|NCT04414722|517013825|FG002|Overall Study|Physician Decision|2|||
143399841|NCT04414722|517013826|FG003|Overall Study|Physician Decision|0|||
143399842|NCT04414722|517013827|FG004|Overall Study|Physician Decision|0|||
143399843|NCT04414722|517013823|FG000|Overall Study|Non-participatory|0|||
143399844|NCT04414722|517013824|FG001|Overall Study|Non-participatory|1|||
143399845|NCT04414722|517013825|FG002|Overall Study|Non-participatory|1|||
143399846|NCT04414722|517013826|FG003|Overall Study|Non-participatory|0|||
143399847|NCT04414722|517013827|FG004|Overall Study|Non-participatory|0|||
143399848|NCT02315703|517013847|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
143399849|NCT02315703|517013848|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
143399850|NCT02315703|517013849|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
143399851|NCT02315703|517013850|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
143399852|NCT02315703|517013851|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
143399853|NCT02315703|517013852|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
143399854|NCT02315703|517013853|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
143399855|NCT02315703|517013854|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
143399856|NCT02315703|517013847|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
143399857|NCT02315703|517013848|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
143399858|NCT02315703|517013849|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
143399859|NCT02315703|517013850|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
143399860|NCT02315703|517013851|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
143399861|NCT02315703|517013852|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
143399862|NCT02315703|517013853|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
143399863|NCT02315703|517013854|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
143399864|NCT02315703|517013847|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
143399865|NCT02315703|517013848|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
143399866|NCT02315703|517013849|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
143399867|NCT02315703|517013850|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
143399868|NCT02315703|517013851|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
143399869|NCT02315703|517013852|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
143399870|NCT02315703|517013853|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
143399871|NCT02315703|517013854|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
143399872|NCT02315703|517013847|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
143399873|NCT02315703|517013848|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
143399874|NCT02315703|517013849|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
143399875|NCT02315703|517013850|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
143399876|NCT02315703|517013851|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
143399877|NCT02315703|517013852|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
143399878|NCT02315703|517013853|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
143399879|NCT02315703|517013854|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
143399880|NCT02315703|517013847|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
143399881|NCT02315703|517013848|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
143399882|NCT02315703|517013849|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
143399883|NCT02315703|517013850|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
143399884|NCT02315703|517013851|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
143399885|NCT02315703|517013852|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
143399886|NCT02315703|517013853|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
143399887|NCT02315703|517013854|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
143399888|NCT02315703|517013847|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
143399889|NCT02315703|517013848|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
143399890|NCT02315703|517013849|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
143399891|NCT02315703|517013850|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
143399892|NCT02315703|517013851|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
143399893|NCT02315703|517013852|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
143399894|NCT02315703|517013853|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
143399895|NCT02315703|517013854|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
143399896|NCT02315703|517013847|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
143399897|NCT02315703|517013848|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
143399898|NCT02315703|517013849|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
143399899|NCT02315703|517013850|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
143399900|NCT02315703|517013851|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
143399901|NCT02315703|517013852|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
143399902|NCT02315703|517013853|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
143399903|NCT02315703|517013854|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
143399904|NCT02315703|517013847|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
143399905|NCT02315703|517013848|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
143399906|NCT02315703|517013849|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
143399907|NCT02315703|517013850|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
143399908|NCT02315703|517013851|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
143399909|NCT02315703|517013852|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
143399910|NCT02315703|517013853|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
143399911|NCT02315703|517013854|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
143399912|NCT02315703|517013847|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
143399913|NCT02315703|517013848|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
143399914|NCT02315703|517013849|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
143399915|NCT02315703|517013850|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
143399916|NCT02315703|517013851|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
143399917|NCT02315703|517013852|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
143399918|NCT02315703|517013853|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
143399919|NCT02315703|517013854|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
143399920|NCT03476343|517013855|FG000|Overall Study|Clinical exam moved to another scanner|7|||
143399921|NCT03476343|517013855|FG000|Overall Study|Clinical order cancelled|4|||
143399922|NCT03476343|517013855|FG000|Overall Study|Neonate did not settle down for the scan|1|||
143399923|NCT04304144|517013856|FG000|DLT Observation Period|Physician Decision|0|||
143399924|NCT04304144|517013857|FG001|DLT Observation Period|Physician Decision|1|||
143399925|NCT04304144|517013858|FG002|DLT Observation Period|Physician Decision|0|||
143399926|NCT04304144|517013859|FG003|DLT Observation Period|Physician Decision|0|||
143399927|NCT04304144|517013856|FG000|Continued Treatment Period|Adverse Event|0|||
143399928|NCT04304144|517013857|FG001|Continued Treatment Period|Adverse Event|1|||
143399929|NCT04304144|517013858|FG002|Continued Treatment Period|Adverse Event|0|||
143399930|NCT04304144|517013859|FG003|Continued Treatment Period|Adverse Event|0|||
143399931|NCT04304144|517013856|FG000|Continued Treatment Period|Death|0|||
143399932|NCT04304144|517013857|FG001|Continued Treatment Period|Death|0|||
143399933|NCT04304144|517013858|FG002|Continued Treatment Period|Death|1|||
143399934|NCT04304144|517013859|FG003|Continued Treatment Period|Death|2|||
143399935|NCT04304144|517013856|FG000|Continued Treatment Period|Withdrawal by Subject|1|||
143399936|NCT04304144|517013857|FG001|Continued Treatment Period|Withdrawal by Subject|0|||
143399937|NCT04304144|517013858|FG002|Continued Treatment Period|Withdrawal by Subject|0|||
143399938|NCT04304144|517013859|FG003|Continued Treatment Period|Withdrawal by Subject|3|||
143399939|NCT04304144|517013856|FG000|Continued Treatment Period|Other than specified|2|||
143399940|NCT04304144|517013857|FG001|Continued Treatment Period|Other than specified|0|||
143399941|NCT04304144|517013858|FG002|Continued Treatment Period|Other than specified|1|||
143399942|NCT04304144|517013859|FG003|Continued Treatment Period|Other than specified|1|||
143399943|NCT02497950|517013862|FG000|Overall Study|Death|209|||
143399944|NCT02497950|517013862|FG000|Overall Study|Transplanted|85|||
143399945|NCT02497950|517013862|FG000|Overall Study|Explanted|8|||
143399946|NCT02497950|517013862|FG000|Overall Study|Device Permanently Deactivated|4|||
143399947|NCT02497950|517013862|FG000|Overall Study|Implanted/Exchanged to an LVAD other than HM3|1|||
143399948|NCT02497950|517013862|FG000|Overall Study|Lost to Follow-up|6|||
143399949|NCT02497950|517013862|FG000|Overall Study|Withdrawal by Subject|2|||
143399950|NCT02497950|517013862|FG000|Overall Study|Center Did Not Participate in Long-Term FU|4|||
143399951|NCT02497950|517013862|FG000|Overall Study|Refused Consent to Long-Term FU|13|||
143399952|NCT04660539|517013863|FG000|Overall Study|Adverse Event|10|||
143399953|NCT04660539|517013863|FG000|Overall Study|Lack of Efficacy|4|||
143399954|NCT04660539|517013863|FG000|Overall Study|Lost to Follow-up|5|||
143399955|NCT04660539|517013863|FG000|Overall Study|Non-Compliance With Study Drug|3|||
143399956|NCT04660539|517013863|FG000|Overall Study|Reason not Specified|12|||
143399957|NCT04660539|517013863|FG000|Overall Study|Pregnancy|2|||
143399958|NCT04660539|517013863|FG000|Overall Study|Protocol Violation|2|||
143399959|NCT04660539|517013863|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
143399960|NCT04660539|517013863|FG000|Overall Study|Withdrawal by Subject|21|||
143399961|NCT03655028|517013864|FG000|12-weeks Follow up|Death|1|||
143399962|NCT03655028|517013865|FG001|12-weeks Follow up|Death|0|||
143399963|NCT03655028|517013864|FG000|12-weeks Follow up|Physician Decision|3|||
143399964|NCT03655028|517013865|FG001|12-weeks Follow up|Physician Decision|3|||
143399965|NCT03655028|517013864|FG000|12-weeks Follow up|Withdrawal by Subject|2|||
143399966|NCT03655028|517013865|FG001|12-weeks Follow up|Withdrawal by Subject|0|||
143399967|NCT03655028|517013864|FG000|12-weeks Follow up|Lost to Follow-up|4|||
143399968|NCT03655028|517013865|FG001|12-weeks Follow up|Lost to Follow-up|4|||
143399969|NCT03655028|517013864|FG000|24-weeks|Lost to Follow-up|1|||
143399970|NCT03655028|517013865|FG001|24-weeks|Lost to Follow-up|1|||
143399971|NCT03655028|517013864|FG000|24-weeks|Death|0|||
143399972|NCT03655028|517013865|FG001|24-weeks|Death|1|||
143399973|NCT01828112|517013872|FG000|Treatment Phase|Adverse Event|7|||
143399974|NCT01828112|517013873|FG001|Treatment Phase|Adverse Event|8|||
143399975|NCT01828112|517013874|FG002|Treatment Phase|Adverse Event|0|||
143399976|NCT01828112|517013872|FG000|Treatment Phase|Death|9|||
143399977|NCT01828112|517013873|FG001|Treatment Phase|Death|5|||
143399978|NCT01828112|517013874|FG002|Treatment Phase|Death|0|||
143399979|NCT01828112|517013872|FG000|Treatment Phase|No longer required treatment|0|||
143399980|NCT01828112|517013873|FG001|Treatment Phase|No longer required treatment|1|||
143399981|NCT01828112|517013874|FG002|Treatment Phase|No longer required treatment|0|||
143399982|NCT01828112|517013872|FG000|Treatment Phase|Physician Decision|6|||
143399983|NCT01828112|517013873|FG001|Treatment Phase|Physician Decision|7|||
143399984|NCT01828112|517013874|FG002|Treatment Phase|Physician Decision|0|||
143399985|NCT01828112|517013872|FG000|Treatment Phase|Pregnancy|1|||
143399986|NCT01828112|517013873|FG001|Treatment Phase|Pregnancy|0|||
143399987|NCT01828112|517013874|FG002|Treatment Phase|Pregnancy|0|||
143399988|NCT01828112|517013872|FG000|Treatment Phase|Progressive disease|79|||
143399989|NCT01828112|517013873|FG001|Treatment Phase|Progressive disease|87|||
143399990|NCT01828112|517013874|FG002|Treatment Phase|Progressive disease|0|||
143399991|NCT01828112|517013872|FG000|Treatment Phase|Study terminated by sponsor|1|||
143399992|NCT01828112|517013873|FG001|Treatment Phase|Study terminated by sponsor|0|||
143399993|NCT01828112|517013874|FG002|Treatment Phase|Study terminated by sponsor|0|||
143399994|NCT01828112|517013872|FG000|Treatment Phase|Subject/guardian decision|12|||
143399995|NCT01828112|517013873|FG001|Treatment Phase|Subject/guardian decision|8|||
143399996|NCT01828112|517013874|FG002|Treatment Phase|Subject/guardian decision|0|||
143399997|NCT01828112|517013872|FG000|Extension Treatment Phase|Adverse Event|0|||
143399998|NCT01828112|517013873|FG001|Extension Treatment Phase|Adverse Event|0|||
143399999|NCT01828112|517013874|FG002|Extension Treatment Phase|Adverse Event|6|||
143400000|NCT01828112|517013872|FG000|Extension Treatment Phase|Death|0|||
143400001|NCT01828112|517013873|FG001|Extension Treatment Phase|Death|0|||
143400002|NCT01828112|517013874|FG002|Extension Treatment Phase|Death|17|||
143400003|NCT01828112|517013872|FG000|Extension Treatment Phase|Physician Decision|0|||
143400004|NCT01828112|517013873|FG001|Extension Treatment Phase|Physician Decision|0|||
143400005|NCT01828112|517013874|FG002|Extension Treatment Phase|Physician Decision|5|||
143400006|NCT01828112|517013872|FG000|Extension Treatment Phase|Progressive disease|0|||
143400007|NCT01828112|517013873|FG001|Extension Treatment Phase|Progressive disease|0|||
143400008|NCT01828112|517013874|FG002|Extension Treatment Phase|Progressive disease|46|||
143400009|NCT01828112|517013872|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
143400010|NCT01828112|517013873|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
143400011|NCT01828112|517013874|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
143400012|NCT01828112|517013872|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
143400013|NCT01828112|517013873|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
143400014|NCT01828112|517013874|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
143400015|NCT04308681|517013879|FG000|Pre-Treatment|Not reported|1|||
143400016|NCT04308681|517013880|FG001|Pre-Treatment|Not reported|1|||
143400017|NCT04308681|517013881|FG002|Pre-Treatment|Not reported|0|||
143400018|NCT04308681|517013882|FG003|Pre-Treatment|Not reported|0|||
143400019|NCT04308681|517013883|FG004|Pre-Treatment|Not reported|0|||
143400020|NCT04308681|517013884|FG005|Pre-Treatment|Not reported|2|||
143400021|NCT04308681|517013885|FG006|Pre-Treatment|Not reported|0|||
143400022|NCT04308681|517013886|FG007|Pre-Treatment|Not reported|0|||
143400023|NCT04308681|517013879|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
143400024|NCT04308681|517013880|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
143400025|NCT04308681|517013881|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
143400026|NCT04308681|517013882|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
143400027|NCT04308681|517013883|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
143400028|NCT04308681|517013884|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
143400029|NCT04308681|517013885|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
143400030|NCT04308681|517013886|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
143400031|NCT04308681|517013879|FG000|Treatment up to Week 26|Other reasons|2|||
143400032|NCT04308681|517013880|FG001|Treatment up to Week 26|Other reasons|0|||
143400033|NCT04308681|517013881|FG002|Treatment up to Week 26|Other reasons|0|||
143400034|NCT04308681|517013882|FG003|Treatment up to Week 26|Other reasons|0|||
143400035|NCT04308681|517013883|FG004|Treatment up to Week 26|Other reasons|1|||
143400036|NCT04308681|517013884|FG005|Treatment up to Week 26|Other reasons|1|||
143400037|NCT04308681|517013885|FG006|Treatment up to Week 26|Other reasons|0|||
143400038|NCT04308681|517013886|FG007|Treatment up to Week 26|Other reasons|0|||
143400039|NCT04308681|517013879|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
143400040|NCT04308681|517013880|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
143400041|NCT04308681|517013881|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
143400042|NCT04308681|517013882|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
143400043|NCT04308681|517013883|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
143400044|NCT04308681|517013884|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
143400045|NCT04308681|517013885|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
143400046|NCT04308681|517013886|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
143400047|NCT04308681|517013879|FG000|Treatment up to Week 26|Adverse Event|6|||
143400048|NCT04308681|517013880|FG001|Treatment up to Week 26|Adverse Event|5|||
143400049|NCT04308681|517013881|FG002|Treatment up to Week 26|Adverse Event|5|||
143400050|NCT04308681|517013882|FG003|Treatment up to Week 26|Adverse Event|0|||
143400051|NCT04308681|517013883|FG004|Treatment up to Week 26|Adverse Event|6|||
143400052|NCT04308681|517013884|FG005|Treatment up to Week 26|Adverse Event|1|||
143400053|NCT04308681|517013885|FG006|Treatment up to Week 26|Adverse Event|0|||
143400054|NCT04308681|517013886|FG007|Treatment up to Week 26|Adverse Event|0|||
143400055|NCT04308681|517013879|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
143400056|NCT04308681|517013880|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
143400057|NCT04308681|517013881|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
143400058|NCT04308681|517013882|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
143400059|NCT04308681|517013883|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
143400060|NCT04308681|517013884|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
143400061|NCT04308681|517013885|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
143400062|NCT04308681|517013886|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
143400063|NCT04308681|517013879|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
143400064|NCT04308681|517013880|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
143400065|NCT04308681|517013881|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
143400066|NCT04308681|517013882|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
143400067|NCT04308681|517013883|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
143400068|NCT04308681|517013884|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
143400069|NCT04308681|517013885|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
143400070|NCT04308681|517013886|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
143400071|NCT04308681|517013879|FG000|OTE - 26 Weeks|Death|0|||
143400072|NCT04308681|517013880|FG001|OTE - 26 Weeks|Death|1|||
143400073|NCT04308681|517013881|FG002|OTE - 26 Weeks|Death|0|||
143400074|NCT04308681|517013882|FG003|OTE - 26 Weeks|Death|0|||
143400075|NCT04308681|517013883|FG004|OTE - 26 Weeks|Death|0|||
143400076|NCT04308681|517013884|FG005|OTE - 26 Weeks|Death|0|||
143400077|NCT04308681|517013885|FG006|OTE - 26 Weeks|Death|1|||
143400078|NCT04308681|517013886|FG007|OTE - 26 Weeks|Death|0|||
143400079|NCT04308681|517013879|FG000|OTE - 26 Weeks|Adverse Event|0|||
143400080|NCT04308681|517013880|FG001|OTE - 26 Weeks|Adverse Event|2|||
143400081|NCT04308681|517013881|FG002|OTE - 26 Weeks|Adverse Event|8|||
143400082|NCT04308681|517013882|FG003|OTE - 26 Weeks|Adverse Event|3|||
143400083|NCT04308681|517013883|FG004|OTE - 26 Weeks|Adverse Event|0|||
143400084|NCT04308681|517013884|FG005|OTE - 26 Weeks|Adverse Event|1|||
143400085|NCT04308681|517013885|FG006|OTE - 26 Weeks|Adverse Event|2|||
143400086|NCT04308681|517013886|FG007|OTE - 26 Weeks|Adverse Event|0|||
143400087|NCT04308681|517013879|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
143400088|NCT04308681|517013880|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
143400089|NCT04308681|517013881|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
143400090|NCT04308681|517013882|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
143400091|NCT04308681|517013883|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
143400092|NCT04308681|517013884|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
143400093|NCT04308681|517013885|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
143400094|NCT04308681|517013886|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
143400095|NCT03292484|517013892|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
143400096|NCT03292484|517013892|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
143400097|NCT03292484|517013892|FG000|Overall Study|Protocol Violation|2|||
143400098|NCT03292484|517013892|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
143400099|NCT03292484|517013892|FG000|Overall Study|Sponsor decision|349|||
143400100|NCT03292484|517013892|FG000|Overall Study|Lost to Follow-up|7|||
143400101|NCT03292484|517013892|FG000|Overall Study|Coronavirus Disease 2019|1|||
143400102|NCT03292484|517013892|FG000|Overall Study|Other|20|||
143400103|NCT05290493|517013899|FG000|Overall Study|Withdrawal by Subject|2|||
143400104|NCT05290493|517013900|FG001|Overall Study|Withdrawal by Subject|2|||
143400105|NCT05290493|517013899|FG000|Overall Study|Adverse Event|1|||
143400106|NCT05290493|517013900|FG001|Overall Study|Adverse Event|0|||
143400107|NCT04003246|517013901|FG000|Overall Study|Death|9|||
143400108|NCT03673501|517013909|FG000|Overall Study|Participants ongoing.|36|||
143400109|NCT03673501|517013910|FG001|Overall Study|Participants ongoing.|24|||
143400110|NCT05838027|517013911|FG000|Overall Study|Lost to Follow-up|5|||
143400111|NCT05838027|517013912|FG001|Overall Study|Lost to Follow-up|1|||
143400112|NCT05838027|517013911|FG000|Overall Study|Withdrawal by Subject|1|||
143400113|NCT05838027|517013912|FG001|Overall Study|Withdrawal by Subject|0|||
143400114|NCT02224144|517013914|FG000|Overall Study|Lost to Follow-up|3|||
143400115|NCT02224144|517013915|FG001|Overall Study|Lost to Follow-up|1|||
143400116|NCT02224144|517013914|FG000|Overall Study|Death|2|||
143400117|NCT02224144|517013915|FG001|Overall Study|Death|0|||
143400118|NCT02224144|517013914|FG000|Overall Study|Withdrawal by Subject|0|||
143400119|NCT02224144|517013915|FG001|Overall Study|Withdrawal by Subject|1|||
143400120|NCT03505008|517013916|FG000|Before Week 24 Randomization|Withdrawal by Subject|24|||
143400121|NCT03505008|517013917|FG001|Before Week 24 Randomization|Withdrawal by Subject|0|||
143400122|NCT03505008|517013918|FG002|Before Week 24 Randomization|Withdrawal by Subject|0|||
143400123|NCT03505008|517013919|FG003|Before Week 24 Randomization|Withdrawal by Subject|0|||
143400124|NCT03505008|517013916|FG000|Before Week 24 Randomization|Adverse Event|10|||
143400125|NCT03505008|517013917|FG001|Before Week 24 Randomization|Adverse Event|0|||
143400126|NCT03505008|517013918|FG002|Before Week 24 Randomization|Adverse Event|0|||
143400127|NCT03505008|517013919|FG003|Before Week 24 Randomization|Adverse Event|0|||
143400128|NCT03505008|517013916|FG000|Before Week 24 Randomization|Lack of Efficacy|8|||
143400129|NCT03505008|517013917|FG001|Before Week 24 Randomization|Lack of Efficacy|0|||
143400130|NCT03505008|517013918|FG002|Before Week 24 Randomization|Lack of Efficacy|0|||
143400131|NCT03505008|517013919|FG003|Before Week 24 Randomization|Lack of Efficacy|0|||
143400132|NCT03505008|517013916|FG000|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|5|||
143400133|NCT03505008|517013917|FG001|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
143400134|NCT03505008|517013918|FG002|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
143400135|NCT03505008|517013919|FG003|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
143400136|NCT03505008|517013916|FG000|Before Week 24 Randomization|Physician Decision|2|||
143400137|NCT03505008|517013917|FG001|Before Week 24 Randomization|Physician Decision|0|||
143400138|NCT03505008|517013918|FG002|Before Week 24 Randomization|Physician Decision|0|||
143400139|NCT03505008|517013919|FG003|Before Week 24 Randomization|Physician Decision|0|||
143400140|NCT03505008|517013916|FG000|Before Week 24 Randomization|Lost to Follow-up|1|||
143400141|NCT03505008|517013917|FG001|Before Week 24 Randomization|Lost to Follow-up|0|||
143400142|NCT03505008|517013918|FG002|Before Week 24 Randomization|Lost to Follow-up|0|||
143400143|NCT03505008|517013919|FG003|Before Week 24 Randomization|Lost to Follow-up|0|||
143400144|NCT03505008|517013916|FG000|Before Week 24 Randomization|Inadequate Methotrexate Adherence|1|||
143400145|NCT03505008|517013917|FG001|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
143400146|NCT03505008|517013918|FG002|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
143400147|NCT03505008|517013919|FG003|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
143400148|NCT03505008|517013916|FG000|Before Week 24 Randomization|Complication|1|||
143400149|NCT03505008|517013917|FG001|Before Week 24 Randomization|Complication|0|||
143400150|NCT03505008|517013918|FG002|Before Week 24 Randomization|Complication|0|||
143400151|NCT03505008|517013919|FG003|Before Week 24 Randomization|Complication|0|||
143400152|NCT03505008|517013916|FG000|After Week 24 Randomization|Withdrawal by Subject|0|||
143400153|NCT03505008|517013917|FG001|After Week 24 Randomization|Withdrawal by Subject|0|||
143400154|NCT03505008|517013918|FG002|After Week 24 Randomization|Withdrawal by Subject|3|||
143400155|NCT03505008|517013919|FG003|After Week 24 Randomization|Withdrawal by Subject|3|||
143400156|NCT03505008|517013916|FG000|After Week 24 Randomization|Lack of Efficacy|0|||
143400157|NCT03505008|517013917|FG001|After Week 24 Randomization|Lack of Efficacy|2|||
143400158|NCT03505008|517013918|FG002|After Week 24 Randomization|Lack of Efficacy|3|||
143400159|NCT03505008|517013919|FG003|After Week 24 Randomization|Lack of Efficacy|1|||
143400160|NCT03505008|517013916|FG000|After Week 24 Randomization|Adverse Event|0|||
143400161|NCT03505008|517013917|FG001|After Week 24 Randomization|Adverse Event|1|||
143400162|NCT03505008|517013918|FG002|After Week 24 Randomization|Adverse Event|2|||
143400163|NCT03505008|517013919|FG003|After Week 24 Randomization|Adverse Event|2|||
143400164|NCT03505008|517013916|FG000|After Week 24 Randomization|Lost to Follow-up|0|||
143400165|NCT03505008|517013917|FG001|After Week 24 Randomization|Lost to Follow-up|1|||
143400166|NCT03505008|517013918|FG002|After Week 24 Randomization|Lost to Follow-up|0|||
143400167|NCT03505008|517013919|FG003|After Week 24 Randomization|Lost to Follow-up|2|||
143400168|NCT03505008|517013916|FG000|After Week 24 Randomization|Protocol Violation|0|||
143400169|NCT03505008|517013917|FG001|After Week 24 Randomization|Protocol Violation|0|||
143400170|NCT03505008|517013918|FG002|After Week 24 Randomization|Protocol Violation|1|||
143400171|NCT03505008|517013919|FG003|After Week 24 Randomization|Protocol Violation|0|||
143400172|NCT02962076|517013922|FG000|Overall Study|MHED tracer not available|5|||
143400173|NCT02962076|517013922|FG000|Overall Study|Protocol Violation|1|||
143400174|NCT02962076|517013922|FG000|Overall Study|Physician Decision|1|||
143400175|NCT03583333|517013923|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
143400176|NCT03583333|517013924|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
143400177|NCT03583333|517013923|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
143400178|NCT03583333|517013924|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
143400179|NCT03583333|517013923|FG000|Overall Study|Withdrawal by Subject|9|||
143400180|NCT03583333|517013924|FG001|Overall Study|Withdrawal by Subject|5|||
143400181|NCT03583333|517013923|FG000|Overall Study|Physician Decision|3|||
143400182|NCT03583333|517013924|FG001|Overall Study|Physician Decision|2|||
143400183|NCT03583333|517013923|FG000|Overall Study|Death|12|||
143400184|NCT03583333|517013924|FG001|Overall Study|Death|7|||
143400185|NCT03926130|517013925|FG000|Overall Study|Adverse Event|9|||
143400186|NCT03926130|517013926|FG001|Overall Study|Adverse Event|11|||
143400187|NCT03926130|517013927|FG002|Overall Study|Adverse Event|2|||
143400188|NCT03926130|517013928|FG003|Overall Study|Adverse Event|0|||
143400189|NCT03926130|517013925|FG000|Overall Study|Death|2|||
143400190|NCT03926130|517013926|FG001|Overall Study|Death|0|||
143400191|NCT03926130|517013927|FG002|Overall Study|Death|1|||
143400192|NCT03926130|517013928|FG003|Overall Study|Death|0|||
143400193|NCT03926130|517013925|FG000|Overall Study|Lack of Efficacy|14|||
143400194|NCT03926130|517013926|FG001|Overall Study|Lack of Efficacy|11|||
143400195|NCT03926130|517013927|FG002|Overall Study|Lack of Efficacy|7|||
143400196|NCT03926130|517013928|FG003|Overall Study|Lack of Efficacy|1|||
143400197|NCT03926130|517013925|FG000|Overall Study|Lost to Follow-up|0|||
143400198|NCT03926130|517013926|FG001|Overall Study|Lost to Follow-up|7|||
143400199|NCT03926130|517013927|FG002|Overall Study|Lost to Follow-up|1|||
143400200|NCT03926130|517013928|FG003|Overall Study|Lost to Follow-up|0|||
143400201|NCT03926130|517013925|FG000|Overall Study|As Reported by Investigator|2|||
143400202|NCT03926130|517013926|FG001|Overall Study|As Reported by Investigator|6|||
143400203|NCT03926130|517013927|FG002|Overall Study|As Reported by Investigator|6|||
143400204|NCT03926130|517013928|FG003|Overall Study|As Reported by Investigator|0|||
143400205|NCT03926130|517013925|FG000|Overall Study|Physician Decision|3|||
143400206|NCT03926130|517013926|FG001|Overall Study|Physician Decision|2|||
143400207|NCT03926130|517013927|FG002|Overall Study|Physician Decision|1|||
143400208|NCT03926130|517013928|FG003|Overall Study|Physician Decision|0|||
143400209|NCT03926130|517013925|FG000|Overall Study|Pregnancy|2|||
143400210|NCT03926130|517013926|FG001|Overall Study|Pregnancy|2|||
143400211|NCT03926130|517013927|FG002|Overall Study|Pregnancy|1|||
143400212|NCT03926130|517013928|FG003|Overall Study|Pregnancy|0|||
143400213|NCT03926130|517013925|FG000|Overall Study|Withdrawal by Subject|20|||
143400214|NCT03926130|517013926|FG001|Overall Study|Withdrawal by Subject|28|||
143400215|NCT03926130|517013927|FG002|Overall Study|Withdrawal by Subject|18|||
143400216|NCT03926130|517013928|FG003|Overall Study|Withdrawal by Subject|1|||
143400217|NCT03926130|517013925|FG000|Overall Study|Non-Compliance|1|||
143400218|NCT03926130|517013926|FG001|Overall Study|Non-Compliance|1|||
143400219|NCT03926130|517013927|FG002|Overall Study|Non-Compliance|0|||
143400220|NCT03926130|517013928|FG003|Overall Study|Non-Compliance|0|||
143400221|NCT03926130|517013925|FG000|Overall Study|Disposition Not Captured|0|||
143400222|NCT03926130|517013926|FG001|Overall Study|Disposition Not Captured|2|||
143400223|NCT03926130|517013927|FG002|Overall Study|Disposition Not Captured|1|||
143400224|NCT03926130|517013928|FG003|Overall Study|Disposition Not Captured|0|||
143400225|NCT04544007|517013941|FG000|Overall Study|Withdrawal by Subject|1|||
143400226|NCT04544007|517013941|FG000|Overall Study|Confirmed Progressive Disease|1|||
143400227|NCT03485729|517013942|FG000|Overall Study|Withdrawal by Subject|0|||
143400228|NCT03485729|517013943|FG001|Overall Study|Withdrawal by Subject|0|||
143400229|NCT03485729|517013944|FG002|Overall Study|Withdrawal by Subject|1|||
143400230|NCT03485729|517013942|FG000|Overall Study|Disease progression|8|||
143400231|NCT03485729|517013943|FG001|Overall Study|Disease progression|13|||
143400232|NCT03485729|517013944|FG002|Overall Study|Disease progression|1|||
143400233|NCT03485729|517013942|FG000|Overall Study|Hospice care|1|||
143400234|NCT03485729|517013943|FG001|Overall Study|Hospice care|0|||
143400235|NCT03485729|517013944|FG002|Overall Study|Hospice care|0|||
143400236|NCT03485729|517013942|FG000|Overall Study|Poor performance status|1|||
143400237|NCT03485729|517013943|FG001|Overall Study|Poor performance status|0|||
143400238|NCT03485729|517013944|FG002|Overall Study|Poor performance status|0|||
143400239|NCT03485729|517013942|FG000|Overall Study|Illness|0|||
143400240|NCT03485729|517013943|FG001|Overall Study|Illness|1|||
143400241|NCT03485729|517013944|FG002|Overall Study|Illness|0|||
143400242|NCT05856435|517013945|FG000|Overall Study|Lost to Follow-up|6|||
143400243|NCT02323880|517013946|FG000|Overall Study|Adverse Event|2|||
143400244|NCT02323880|517013947|FG001|Overall Study|Adverse Event|0|||
143400245|NCT02323880|517013948|FG002|Overall Study|Adverse Event|1|||
143400246|NCT02323880|517013949|FG003|Overall Study|Adverse Event|1|||
143400247|NCT02323880|517013950|FG004|Overall Study|Adverse Event|1|||
143400248|NCT02323880|517013951|FG005|Overall Study|Adverse Event|0|||
143400249|NCT02323880|517013952|FG006|Overall Study|Adverse Event|1|||
143400250|NCT02323880|517013953|FG007|Overall Study|Adverse Event|0|||
143400251|NCT02323880|517013946|FG000|Overall Study|Death|0|||
143400252|NCT02323880|517013947|FG001|Overall Study|Death|0|||
143400253|NCT02323880|517013948|FG002|Overall Study|Death|0|||
143400254|NCT02323880|517013949|FG003|Overall Study|Death|0|||
143400255|NCT02323880|517013950|FG004|Overall Study|Death|0|||
143400256|NCT02323880|517013951|FG005|Overall Study|Death|1|||
143400257|NCT02323880|517013952|FG006|Overall Study|Death|0|||
143400258|NCT02323880|517013953|FG007|Overall Study|Death|0|||
143400259|NCT02323880|517013946|FG000|Overall Study|Lack of Efficacy|4|||
143400260|NCT02323880|517013947|FG001|Overall Study|Lack of Efficacy|11|||
143400261|NCT02323880|517013948|FG002|Overall Study|Lack of Efficacy|5|||
143400262|NCT02323880|517013949|FG003|Overall Study|Lack of Efficacy|5|||
143400263|NCT02323880|517013950|FG004|Overall Study|Lack of Efficacy|4|||
143400264|NCT02323880|517013951|FG005|Overall Study|Lack of Efficacy|8|||
143400265|NCT02323880|517013952|FG006|Overall Study|Lack of Efficacy|4|||
143400266|NCT02323880|517013953|FG007|Overall Study|Lack of Efficacy|6|||
143400267|NCT02323880|517013946|FG000|Overall Study|Physician Decision|0|||
143400268|NCT02323880|517013947|FG001|Overall Study|Physician Decision|0|||
143400269|NCT02323880|517013948|FG002|Overall Study|Physician Decision|0|||
143400270|NCT02323880|517013949|FG003|Overall Study|Physician Decision|0|||
143400271|NCT02323880|517013950|FG004|Overall Study|Physician Decision|1|||
143400272|NCT02323880|517013951|FG005|Overall Study|Physician Decision|1|||
143400273|NCT02323880|517013952|FG006|Overall Study|Physician Decision|1|||
143400274|NCT02323880|517013953|FG007|Overall Study|Physician Decision|0|||
143400275|NCT02323880|517013946|FG000|Overall Study|Withdrawal by Subject|0|||
143400276|NCT02323880|517013947|FG001|Overall Study|Withdrawal by Subject|2|||
143400277|NCT02323880|517013948|FG002|Overall Study|Withdrawal by Subject|0|||
143400278|NCT02323880|517013949|FG003|Overall Study|Withdrawal by Subject|0|||
143400279|NCT02323880|517013950|FG004|Overall Study|Withdrawal by Subject|0|||
143400280|NCT02323880|517013951|FG005|Overall Study|Withdrawal by Subject|0|||
143400281|NCT02323880|517013952|FG006|Overall Study|Withdrawal by Subject|0|||
143400282|NCT02323880|517013953|FG007|Overall Study|Withdrawal by Subject|0|||
143400283|NCT01447719|517013959|FG000|Overall Study|Image acquisition failure|2|||
143400284|NCT01447719|517013959|FG000|Overall Study|Invalid image or not imaged|3|||
143400285|NCT01447719|517013959|FG000|Overall Study|Subject still living at end of study|79|||
143400286|NCT01447719|517013959|FG000|Overall Study|Withdrawal by Subject|2|||
143400287|NCT01447719|517013959|FG000|Overall Study|Family withdrew autopsy consent|7|||
143400288|NCT04271046|517013960|FG000|Overall Study|Death|0|||
143400289|NCT04271046|517013961|FG001|Overall Study|Death|2|||
143400290|NCT04271046|517013962|FG002|Overall Study|Death|0|||
143400291|NCT04271046|517013963|FG003|Overall Study|Death|2|||
143400292|NCT04271046|517013960|FG000|Overall Study|Lost to Follow-up|12|||
143400293|NCT04271046|517013961|FG001|Overall Study|Lost to Follow-up|12|||
143400294|NCT04271046|517013962|FG002|Overall Study|Lost to Follow-up|11|||
143400295|NCT04271046|517013963|FG003|Overall Study|Lost to Follow-up|11|||
143400296|NCT04271046|517013960|FG000|Overall Study|Patient with Dementia Died|2|||
143400297|NCT04271046|517013961|FG001|Overall Study|Patient with Dementia Died|0|||
143400298|NCT04271046|517013962|FG002|Overall Study|Patient with Dementia Died|2|||
143400299|NCT04271046|517013963|FG003|Overall Study|Patient with Dementia Died|0|||
143400300|NCT04271046|517013960|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
143400301|NCT04271046|517013961|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
143400302|NCT04271046|517013962|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
143400303|NCT04271046|517013963|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
143400304|NCT03106740|517015148|FG000|Overall Study|Lost to Follow-up|2|||
143400305|NCT03106740|517015149|FG001|Overall Study|Lost to Follow-up|2|||
143400306|NCT03106740|517015148|FG000|Overall Study|Withdrawal by Subject|2|||
143400307|NCT03106740|517015149|FG001|Overall Study|Withdrawal by Subject|4|||
143400308|NCT03106740|517015148|FG000|Overall Study|Physician Decision|0|||
143400309|NCT03106740|517015149|FG001|Overall Study|Physician Decision|1|||
143400310|NCT03106740|517015148|FG000|Overall Study|Partial data|1|||
143400311|NCT03106740|517015149|FG001|Overall Study|Partial data|0|||
143400312|NCT04565990|517015150|FG000|Overall Study|Death|5|||
143400313|NCT04565990|517015150|FG000|Overall Study|Lost to Follow-up|1|||
143400314|NCT04565990|517015150|FG000|Overall Study|Withdrawal by Subject|1|||
143400315|NCT04797858|517015151|FG000|Overall Study|Withdrawal by Subject|0|||
143400316|NCT04797858|517015152|FG001|Overall Study|Withdrawal by Subject|1|||
143400317|NCT04797858|517015151|FG000|Overall Study|Excluded due to administrative error|7|||
143400318|NCT04797858|517015152|FG001|Overall Study|Excluded due to administrative error|8|||
143400319|NCT04766892|517015155|FG000|Overall Study|Withdrawal by Subject|1|||
143400320|NCT04766892|517015155|FG000|Overall Study|Lost to Follow-up|1|||
143400321|NCT04766892|517015155|FG000|Overall Study|Adverse Event|3|||
143400322|NCT04766892|517015155|FG000|Overall Study|Left ventricular ejection fraction (LVEF) Criteria Met|1|||
143400323|NCT05906784|517015156|FG000|Overall Study|Lost to Follow-up|2|||
143400324|NCT05906784|517015157|FG001|Overall Study|Lost to Follow-up|1|||
143400325|NCT05906784|517015158|FG002|Overall Study|Lost to Follow-up|1|||
143400326|NCT05906784|517015159|FG003|Overall Study|Lost to Follow-up|1|||
143400327|NCT02668692|517015160|FG000|Overall Study|Adverse Event|1|||
143400328|NCT02668692|517015161|FG001|Overall Study|Adverse Event|0|||
143400329|NCT03523572|517015162|FG000|Dose Escalation|Progressive disease|1|||
143400330|NCT03523572|517015163|FG001|Dose Escalation|Progressive disease|0|||
143400331|NCT03523572|517015164|FG002|Dose Escalation|Progressive disease|0|||
143400332|NCT03523572|517015165|FG003|Dose Escalation|Progressive disease|0|||
143400333|NCT03523572|517015166|FG004|Dose Escalation|Progressive disease|0|||
143400334|NCT03523572|517015167|FG005|Dose Escalation|Progressive disease|0|||
143400335|NCT03523572|517015162|FG000|Dose Escalation|Clinical Progression|0|||
143400336|NCT03523572|517015163|FG001|Dose Escalation|Clinical Progression|1|||
143400337|NCT03523572|517015164|FG002|Dose Escalation|Clinical Progression|0|||
143400338|NCT03523572|517015165|FG003|Dose Escalation|Clinical Progression|0|||
143400339|NCT03523572|517015166|FG004|Dose Escalation|Clinical Progression|0|||
143400340|NCT03523572|517015167|FG005|Dose Escalation|Clinical Progression|0|||
143400341|NCT03523572|517015162|FG000|Dose Escalation|Adverse Event|2|||
143400342|NCT03523572|517015163|FG001|Dose Escalation|Adverse Event|0|||
143400343|NCT03523572|517015164|FG002|Dose Escalation|Adverse Event|0|||
143400344|NCT03523572|517015165|FG003|Dose Escalation|Adverse Event|0|||
143400345|NCT03523572|517015166|FG004|Dose Escalation|Adverse Event|0|||
143400346|NCT03523572|517015167|FG005|Dose Escalation|Adverse Event|0|||
143400347|NCT03523572|517015162|FG000|Dose Escalation|Physician Decision|1|||
143400348|NCT03523572|517015163|FG001|Dose Escalation|Physician Decision|1|||
143400349|NCT03523572|517015164|FG002|Dose Escalation|Physician Decision|0|||
143400350|NCT03523572|517015165|FG003|Dose Escalation|Physician Decision|0|||
143400351|NCT03523572|517015166|FG004|Dose Escalation|Physician Decision|0|||
143400352|NCT03523572|517015167|FG005|Dose Escalation|Physician Decision|0|||
143400353|NCT03523572|517015162|FG000|Dose Expansion|Progressive Disease|0|||
143400354|NCT03523572|517015163|FG001|Dose Expansion|Progressive Disease|0|||
143400355|NCT03523572|517015164|FG002|Dose Expansion|Progressive Disease|9|||
143400356|NCT03523572|517015165|FG003|Dose Expansion|Progressive Disease|11|||
143400357|NCT03523572|517015166|FG004|Dose Expansion|Progressive Disease|15|||
143400358|NCT03523572|517015167|FG005|Dose Expansion|Progressive Disease|2|||
143400359|NCT03523572|517015162|FG000|Dose Expansion|Clinical Progression|0|||
143400360|NCT03523572|517015163|FG001|Dose Expansion|Clinical Progression|0|||
143400361|NCT03523572|517015164|FG002|Dose Expansion|Clinical Progression|2|||
143400362|NCT03523572|517015165|FG003|Dose Expansion|Clinical Progression|2|||
143400363|NCT03523572|517015166|FG004|Dose Expansion|Clinical Progression|2|||
143400364|NCT03523572|517015167|FG005|Dose Expansion|Clinical Progression|0|||
143400365|NCT03523572|517015162|FG000|Dose Expansion|Adverse Event|0|||
143400366|NCT03523572|517015163|FG001|Dose Expansion|Adverse Event|0|||
143400367|NCT03523572|517015164|FG002|Dose Expansion|Adverse Event|10|||
143400368|NCT03523572|517015165|FG003|Dose Expansion|Adverse Event|1|||
143400369|NCT03523572|517015166|FG004|Dose Expansion|Adverse Event|5|||
143400370|NCT03523572|517015167|FG005|Dose Expansion|Adverse Event|2|||
143400371|NCT03523572|517015162|FG000|Dose Expansion|Withdrawal by Subject|0|||
143400372|NCT03523572|517015163|FG001|Dose Expansion|Withdrawal by Subject|0|||
143400373|NCT03523572|517015164|FG002|Dose Expansion|Withdrawal by Subject|1|||
143400374|NCT03523572|517015165|FG003|Dose Expansion|Withdrawal by Subject|1|||
143400375|NCT03523572|517015166|FG004|Dose Expansion|Withdrawal by Subject|0|||
143400376|NCT03523572|517015167|FG005|Dose Expansion|Withdrawal by Subject|0|||
143400377|NCT03523572|517015162|FG000|Dose Expansion|Physician Decision|0|||
143400378|NCT03523572|517015163|FG001|Dose Expansion|Physician Decision|0|||
143400379|NCT03523572|517015164|FG002|Dose Expansion|Physician Decision|1|||
143400380|NCT03523572|517015165|FG003|Dose Expansion|Physician Decision|0|||
143400381|NCT03523572|517015166|FG004|Dose Expansion|Physician Decision|1|||
143400382|NCT03523572|517015167|FG005|Dose Expansion|Physician Decision|0|||
143400383|NCT03523572|517015162|FG000|Dose Expansion|Miscellaneous|0|||
143400384|NCT03523572|517015163|FG001|Dose Expansion|Miscellaneous|0|||
143400385|NCT03523572|517015164|FG002|Dose Expansion|Miscellaneous|0|||
143400386|NCT03523572|517015165|FG003|Dose Expansion|Miscellaneous|0|||
143400387|NCT03523572|517015166|FG004|Dose Expansion|Miscellaneous|3|||
143400388|NCT03523572|517015167|FG005|Dose Expansion|Miscellaneous|0|||
143400389|NCT05269966|517015168|FG000|Overall Study|Adverse Event|4|||
143400390|NCT05269966|517015168|FG000|Overall Study|Withdrawal by Subject|1|||
143400391|NCT05269966|517015168|FG000|Overall Study|Lost to Follow-up|4|||
143400392|NCT05269966|517015168|FG000|Overall Study|Physician Decision|1|||
143400393|NCT02446236|517015171|FG000|Overall Study|Screen Failure|1|||
143400394|NCT02446236|517015172|FG001|Overall Study|Screen Failure|0|||
143400395|NCT02446236|517015173|FG002|Overall Study|Screen Failure|1|||
143400396|NCT02446236|517015171|FG000|Overall Study|Actively Receiving Therapy|0|||
143400397|NCT02446236|517015172|FG001|Overall Study|Actively Receiving Therapy|0|||
143400398|NCT02446236|517015173|FG002|Overall Study|Actively Receiving Therapy|1|||
143400399|NCT04862234|517015176|FG000|Overall Study|Surgery cancellation|1|||
143400400|NCT04862234|517015177|FG001|Overall Study|Surgery cancellation|2|||
143400401|NCT04862234|517015176|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
143400402|NCT04862234|517015177|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
143400403|NCT04862234|517015176|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
143400404|NCT04862234|517015177|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
143400405|NCT05280574|517015178|FG000|Overall Study|Withdrawal by Subject|0|||
143400406|NCT05280574|517015179|FG001|Overall Study|Withdrawal by Subject|2|||
143400407|NCT05280574|517015180|FG002|Overall Study|Withdrawal by Subject|0|||
143400408|NCT03213873|517015181|FG000|Overall Study|Withdrawal by Subject|8|||
143400409|NCT03213873|517015182|FG001|Overall Study|Withdrawal by Subject|9|||
143400410|NCT03213873|517015181|FG000|Overall Study|Diagnosed w atypical PD after randomization|0|||
143400411|NCT03213873|517015182|FG001|Overall Study|Diagnosed w atypical PD after randomization|1|||
143400412|NCT03213873|517015181|FG000|Overall Study|Lost to Follow-up|0|||
143400413|NCT03213873|517015182|FG001|Overall Study|Lost to Follow-up|2|||
143400414|NCT04709419|517015189|FG000|Overall Study|Physician Decision|1|||
143400415|NCT04709419|517015190|FG001|Overall Study|Physician Decision|0|||
143400416|NCT05683340|517015191|FG000|Overall Study|Adverse Event|1|||
143400417|NCT05683340|517015192|FG001|Overall Study|Adverse Event|1|||
143400418|NCT05683340|517015191|FG000|Overall Study|Protocol Violation|1|||
143400419|NCT05683340|517015192|FG001|Overall Study|Protocol Violation|0|||
143400420|NCT05683340|517015191|FG000|Overall Study|Withdrawal by Subject|0|||
143400421|NCT05683340|517015192|FG001|Overall Study|Withdrawal by Subject|2|||
143400422|NCT02780700|517015193|FG000|Overall Study|Progressive disease|1|||
143400423|NCT03824366|517015198|FG000|Overall Study|Death|1|||
143400424|NCT03824366|517015198|FG000|Overall Study|Previously unidentified metal artifact|1|||
143400425|NCT03824366|517015198|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
143400426|NCT03824366|517015198|FG000|Overall Study|Withdrawal by Subject|1|||
143400427|NCT02998528|517015203|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
143400428|NCT02998528|517015204|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
143400429|NCT02998528|517015205|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
143400430|NCT02998528|517015203|FG000|Randomization Period|Participant withdrew consent|0|||
143400431|NCT02998528|517015204|FG001|Randomization Period|Participant withdrew consent|3|||
143400432|NCT02998528|517015205|FG002|Randomization Period|Participant withdrew consent|0|||
143400433|NCT02998528|517015203|FG000|Randomization Period|Participant no longer meets study criteria|1|||
143400434|NCT02998528|517015204|FG001|Randomization Period|Participant no longer meets study criteria|3|||
143400435|NCT02998528|517015205|FG002|Randomization Period|Participant no longer meets study criteria|2|||
143400436|NCT02998528|517015203|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
143400437|NCT02998528|517015204|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
143400438|NCT02998528|517015205|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
143400439|NCT02998528|517015203|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
143400440|NCT02998528|517015204|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
143400441|NCT02998528|517015205|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
143400442|NCT02998528|517015203|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
143400443|NCT02998528|517015204|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
143400444|NCT02998528|517015205|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
143400445|NCT02998528|517015203|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
143400446|NCT02998528|517015204|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
143400447|NCT02998528|517015205|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
143400448|NCT02998528|517015203|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
143400449|NCT02998528|517015204|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
143400450|NCT02998528|517015205|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
143400451|NCT02998528|517015203|FG000|Neoadjuvant Treatment Period|Death|1|||
143400452|NCT02998528|517015204|FG001|Neoadjuvant Treatment Period|Death|0|||
143400453|NCT02998528|517015205|FG002|Neoadjuvant Treatment Period|Death|0|||
143400454|NCT02998528|517015203|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
143400455|NCT02998528|517015204|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
143400456|NCT02998528|517015205|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
143400457|NCT02998528|517015203|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
143400458|NCT02998528|517015204|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
143400459|NCT02998528|517015205|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
143400460|NCT02998528|517015203|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
143400461|NCT02998528|517015204|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
143400462|NCT02998528|517015205|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
143400463|NCT02998528|517015203|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
143400464|NCT02998528|517015204|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
143400465|NCT02998528|517015205|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
143400466|NCT02998528|517015203|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
143400467|NCT02998528|517015204|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
143400468|NCT02998528|517015205|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
143400469|NCT02998528|517015203|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
143400470|NCT02998528|517015204|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
143400471|NCT02998528|517015205|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
143400472|NCT05035654|517015207|FG000|Overall Study|Physician Decision|0|||
143400473|NCT05035654|517015208|FG001|Overall Study|Physician Decision|1|||
143400474|NCT05035654|517015209|FG002|Overall Study|Physician Decision|0|||
143400475|NCT05035654|517015207|FG000|Overall Study|Adverse Event|0|||
143400476|NCT05035654|517015208|FG001|Overall Study|Adverse Event|1|||
143400477|NCT05035654|517015209|FG002|Overall Study|Adverse Event|0|||
143400478|NCT05035654|517015207|FG000|Overall Study|Withdrawal by Subject|0|||
143400479|NCT05035654|517015208|FG001|Overall Study|Withdrawal by Subject|0|||
143400480|NCT05035654|517015209|FG002|Overall Study|Withdrawal by Subject|4|||
143400481|NCT05035654|517015207|FG000|Overall Study|Bilateral Dislodgement|1|||
143400482|NCT05035654|517015208|FG001|Overall Study|Bilateral Dislodgement|0|||
143400483|NCT05035654|517015209|FG002|Overall Study|Bilateral Dislodgement|0|||
143400484|NCT04880733|517015210|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
143400485|NCT04880733|517015211|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
143400486|NCT04880733|517015212|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
143400487|NCT04880733|517015210|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
143400488|NCT04880733|517015211|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
143400489|NCT04880733|517015212|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
143400490|NCT04880733|517015210|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
143400491|NCT04880733|517015211|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
143400492|NCT04880733|517015212|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
143400493|NCT04880733|517015210|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
143400494|NCT04880733|517015211|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
143400495|NCT04880733|517015212|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
143400496|NCT04880733|517015210|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
143400497|NCT04880733|517015211|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
143400498|NCT04880733|517015212|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
143400499|NCT04934072|517015220|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
143400500|NCT04934072|517015221|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
143400501|NCT04934072|517015222|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
143400502|NCT04934072|517015223|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
143400503|NCT04934072|517015224|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
143400504|NCT04934072|517015220|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
143400505|NCT04934072|517015221|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
143400506|NCT04934072|517015222|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
143400507|NCT04934072|517015223|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
143400508|NCT04934072|517015224|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
143400509|NCT04934072|517015220|FG000|Day 0 to Week 52|Other|3|||
143400510|NCT04934072|517015221|FG001|Day 0 to Week 52|Other|1|||
143400511|NCT04934072|517015222|FG002|Day 0 to Week 52|Other|0|||
143400512|NCT04934072|517015223|FG003|Day 0 to Week 52|Other|0|||
143400513|NCT04934072|517015224|FG004|Day 0 to Week 52|Other|0|||
143400514|NCT04934072|517015220|FG000|Day 0 to Week 52|Adverse Event|1|||
143400515|NCT04934072|517015221|FG001|Day 0 to Week 52|Adverse Event|3|||
143400516|NCT04934072|517015222|FG002|Day 0 to Week 52|Adverse Event|0|||
143400517|NCT04934072|517015223|FG003|Day 0 to Week 52|Adverse Event|0|||
143400518|NCT04934072|517015224|FG004|Day 0 to Week 52|Adverse Event|0|||
143400519|NCT04934072|517015220|FG000|Week 52 to Week 78|Adverse Event|0|||
143400520|NCT04934072|517015221|FG001|Week 52 to Week 78|Adverse Event|0|||
143400521|NCT04934072|517015222|FG002|Week 52 to Week 78|Adverse Event|0|||
143400522|NCT04934072|517015223|FG003|Week 52 to Week 78|Adverse Event|1|||
143400523|NCT04934072|517015224|FG004|Week 52 to Week 78|Adverse Event|1|||
143400524|NCT04934072|517015220|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
143400525|NCT04934072|517015221|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
143400526|NCT04934072|517015222|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
143400527|NCT04934072|517015223|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
143400528|NCT04934072|517015224|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
143400529|NCT04934072|517015220|FG000|Week 52 to Week 78|Other|0|||
143400530|NCT04934072|517015221|FG001|Week 52 to Week 78|Other|0|||
143400531|NCT04934072|517015222|FG002|Week 52 to Week 78|Other|1|||
143400532|NCT04934072|517015223|FG003|Week 52 to Week 78|Other|0|||
143400533|NCT04934072|517015224|FG004|Week 52 to Week 78|Other|0|||
143400534|NCT02828358|517015234|FG000|Overall Study|Physician Decision|7|||
143400535|NCT02828358|517015235|FG001|Overall Study|Physician Decision|1|||
143400536|NCT02828358|517015234|FG000|Overall Study|Treatment Failure|6|||
143400537|NCT02828358|517015235|FG001|Overall Study|Treatment Failure|0|||
143400538|NCT02828358|517015234|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
143400539|NCT02828358|517015235|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
143400540|NCT02828358|517015234|FG000|Overall Study|Refusal of further protocol therapy|2|||
143400541|NCT02828358|517015235|FG001|Overall Study|Refusal of further protocol therapy|0|||
143400542|NCT02828358|517015234|FG000|Overall Study|Relapse|25|||
143400543|NCT02828358|517015235|FG001|Overall Study|Relapse|0|||
143400544|NCT02828358|517015234|FG000|Overall Study|Still on therapy|5|||
143400545|NCT02828358|517015235|FG001|Overall Study|Still on therapy|0|||
143400546|NCT03213678|517015237|FG000|Overall Study|Death|1|||
143400547|NCT03213678|517015237|FG000|Overall Study|Physician Decision|1|||
143400548|NCT03213678|517015237|FG000|Overall Study|Progressive disease|16|||
143400549|NCT04218851|517015238|FG000|Overall Study|Death|1|||
143400550|NCT04218851|517015239|FG001|Overall Study|Death|3|||
143400551|NCT03174275|517015242|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
143400552|NCT03174275|517015242|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
143400553|NCT03174275|517015242|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
143400554|NCT03174275|517015242|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
143400555|NCT03174275|517015242|FG000|Adjuvant Chemotherapy|Progression|1|||
143400556|NCT03174275|517015242|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
143400557|NCT03174275|517015242|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
143400558|NCT03174275|517015242|FG000|Adjuvant Durvalumab|Progression|1|||
143400559|NCT03174275|517015242|FG000|Adjuvant Durvalumab|Adverse Event|3|||
143400560|NCT03174275|517015242|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
143400561|NCT03174275|517015242|FG000|Adjuvant Radiotherapy|Progression|1|||
143400562|NCT03174275|517015242|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
143400563|NCT05285137|517015243|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
143400564|NCT05285137|517015244|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
143400565|NCT05285137|517015245|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
143400566|NCT05285137|517015246|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
143400567|NCT05285137|517015247|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
143400568|NCT05285137|517015248|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
143400569|NCT05285137|517015249|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
143400570|NCT05285137|517015250|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
143400571|NCT05285137|517015251|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
143400572|NCT05285137|517015243|FG000|Overall Study|Lost to Follow-up|0|||
143400573|NCT05285137|517015244|FG001|Overall Study|Lost to Follow-up|0|||
143400574|NCT05285137|517015245|FG002|Overall Study|Lost to Follow-up|1|||
143400575|NCT05285137|517015246|FG003|Overall Study|Lost to Follow-up|3|||
143400576|NCT05285137|517015247|FG004|Overall Study|Lost to Follow-up|0|||
143400577|NCT05285137|517015248|FG005|Overall Study|Lost to Follow-up|0|||
143400578|NCT05285137|517015249|FG006|Overall Study|Lost to Follow-up|1|||
143400579|NCT05285137|517015250|FG007|Overall Study|Lost to Follow-up|0|||
143400580|NCT05285137|517015251|FG008|Overall Study|Lost to Follow-up|0|||
143400581|NCT05285137|517015243|FG000|Overall Study|Physician Decision|0|||
143400582|NCT05285137|517015244|FG001|Overall Study|Physician Decision|1|||
143400583|NCT05285137|517015245|FG002|Overall Study|Physician Decision|0|||
143400584|NCT05285137|517015246|FG003|Overall Study|Physician Decision|0|||
143400585|NCT05285137|517015247|FG004|Overall Study|Physician Decision|0|||
143400586|NCT05285137|517015248|FG005|Overall Study|Physician Decision|0|||
143400587|NCT05285137|517015249|FG006|Overall Study|Physician Decision|0|||
143400588|NCT05285137|517015250|FG007|Overall Study|Physician Decision|0|||
143400589|NCT05285137|517015251|FG008|Overall Study|Physician Decision|0|||
143400590|NCT05285137|517015243|FG000|Overall Study|Pregnancy|0|||
143400591|NCT05285137|517015244|FG001|Overall Study|Pregnancy|0|||
143400592|NCT05285137|517015245|FG002|Overall Study|Pregnancy|0|||
143400593|NCT05285137|517015246|FG003|Overall Study|Pregnancy|0|||
143400594|NCT05285137|517015247|FG004|Overall Study|Pregnancy|0|||
143400595|NCT05285137|517015248|FG005|Overall Study|Pregnancy|0|||
143400596|NCT05285137|517015249|FG006|Overall Study|Pregnancy|1|||
143400597|NCT05285137|517015250|FG007|Overall Study|Pregnancy|0|||
143400598|NCT05285137|517015251|FG008|Overall Study|Pregnancy|0|||
143400599|NCT05285137|517015243|FG000|Overall Study|Withdrawal by Subject|0|||
143400600|NCT05285137|517015244|FG001|Overall Study|Withdrawal by Subject|1|||
143400601|NCT05285137|517015245|FG002|Overall Study|Withdrawal by Subject|2|||
143400602|NCT05285137|517015246|FG003|Overall Study|Withdrawal by Subject|1|||
143400603|NCT05285137|517015247|FG004|Overall Study|Withdrawal by Subject|0|||
143400604|NCT05285137|517015248|FG005|Overall Study|Withdrawal by Subject|0|||
143400605|NCT05285137|517015249|FG006|Overall Study|Withdrawal by Subject|0|||
143400606|NCT05285137|517015250|FG007|Overall Study|Withdrawal by Subject|0|||
143400607|NCT05285137|517015251|FG008|Overall Study|Withdrawal by Subject|1|||
143400608|NCT03717935|517015256|FG000|Overall Study|Withdrawal by Subject|0|||
143400609|NCT03717935|517015257|FG001|Overall Study|Withdrawal by Subject|2|||
143400610|NCT01820611|517015258|FG000|Overall Study|Death|8|||
143400611|NCT01820611|517015258|FG000|Overall Study|Adverse Event|1|||
143400612|NCT01820611|517015258|FG000|Overall Study|Withdrawal by Subject|9|||
143400613|NCT04456296|517015259|FG000|Overall Study|Withdrawal by Subject|14|||
143400614|NCT04456296|517015260|FG001|Overall Study|Withdrawal by Subject|21|||
143400615|NCT04456296|517015261|FG002|Overall Study|Withdrawal by Subject|21|||
143400616|NCT04456296|517015259|FG000|Overall Study|Adverse Event|2|||
143400617|NCT04456296|517015260|FG001|Overall Study|Adverse Event|2|||
143400618|NCT04456296|517015261|FG002|Overall Study|Adverse Event|2|||
143400619|NCT04456296|517015259|FG000|Overall Study|Death|1|||
143400620|NCT04456296|517015260|FG001|Overall Study|Death|0|||
143400621|NCT04456296|517015261|FG002|Overall Study|Death|0|||
143400622|NCT04456296|517015259|FG000|Overall Study|Lost to Follow-up|3|||
143400623|NCT04456296|517015260|FG001|Overall Study|Lost to Follow-up|5|||
143400624|NCT04456296|517015261|FG002|Overall Study|Lost to Follow-up|6|||
143400625|NCT04456296|517015259|FG000|Overall Study|Other than specified|0|||
143400626|NCT04456296|517015260|FG001|Overall Study|Other than specified|1|||
143400627|NCT04456296|517015261|FG002|Overall Study|Other than specified|4|||
143400628|NCT04456296|517015259|FG000|Overall Study|Randomized, not treated|2|||
143400629|NCT04456296|517015260|FG001|Overall Study|Randomized, not treated|1|||
143400630|NCT04456296|517015261|FG002|Overall Study|Randomized, not treated|0|||
143400631|NCT03252288|517015268|FG000|Overall Study|Death|1|||
143400632|NCT03252288|517015269|FG001|Overall Study|Death|0|||
143400633|NCT03252288|517015270|FG002|Overall Study|Death|0|||
143400634|NCT03252288|517015268|FG000|Overall Study|Death|11|||
143400635|NCT03252288|517015269|FG001|Overall Study|Death|0|||
143400636|NCT03252288|517015270|FG002|Overall Study|Death|0|||
143400637|NCT03252288|517015268|FG000|Overall Study|Withdrawal by Subject|2|||
143400638|NCT03252288|517015269|FG001|Overall Study|Withdrawal by Subject|0|||
143400639|NCT03252288|517015270|FG002|Overall Study|Withdrawal by Subject|0|||
143400640|NCT03252288|517015268|FG000|Overall Study|Lost to Follow-up|79|||
143400641|NCT03252288|517015269|FG001|Overall Study|Lost to Follow-up|0|||
143400642|NCT03252288|517015270|FG002|Overall Study|Lost to Follow-up|0|||
143400643|NCT03252288|517015268|FG000|Overall Study|Loss of baseline data on tablets|6|||
143400644|NCT03252288|517015269|FG001|Overall Study|Loss of baseline data on tablets|0|||
143400645|NCT03252288|517015270|FG002|Overall Study|Loss of baseline data on tablets|0|||
143400646|NCT01314105|517016314|FG000|Overall Study|Progressive Disease|6|||
143400647|NCT01314105|517016315|FG001|Overall Study|Progressive Disease|10|||
143400648|NCT01314105|517016314|FG000|Overall Study|Refused to continue taking medication|0|||
143400649|NCT01314105|517016315|FG001|Overall Study|Refused to continue taking medication|1|||
143400650|NCT01314105|517016314|FG000|Overall Study|Other Adverse Event|1|||
143400651|NCT01314105|517016315|FG001|Overall Study|Other Adverse Event|1|||
143400652|NCT04820322|517016319|FG000|Overall Study|Adverse Event|1|||
143400653|NCT04820322|517016320|FG001|Overall Study|Adverse Event|0|||
143400654|NCT03156465|517016321|FG000|Overall Study|Withdrawal by Subject|2|||
143400655|NCT03640286|517016322|FG000|Overall Study|Adverse Event|6|||
143400656|NCT03640286|517016323|FG001|Overall Study|Adverse Event|6|||
143400657|NCT03640286|517016322|FG000|Overall Study|Lost to Follow-up|3|||
143400658|NCT03640286|517016323|FG001|Overall Study|Lost to Follow-up|6|||
143400659|NCT03640286|517016322|FG000|Overall Study|Pregnancy|1|||
143400660|NCT03640286|517016323|FG001|Overall Study|Pregnancy|0|||
143400661|NCT03640286|517016322|FG000|Overall Study|Withdrawal by Subject|10|||
143400662|NCT03640286|517016323|FG001|Overall Study|Withdrawal by Subject|10|||
143400663|NCT03640286|517016322|FG000|Overall Study|Non-compliance|4|||
143400664|NCT03640286|517016323|FG001|Overall Study|Non-compliance|10|||
143400665|NCT03640286|517016322|FG000|Overall Study|Medication change|1|||
143400666|NCT03640286|517016323|FG001|Overall Study|Medication change|0|||
143400667|NCT03640286|517016322|FG000|Overall Study|Other|1|||
143400668|NCT03640286|517016323|FG001|Overall Study|Other|2|||
143400669|NCT03640286|517016322|FG000|Overall Study|Joined another lifestyle program|0|||
143400670|NCT03640286|517016323|FG001|Overall Study|Joined another lifestyle program|1|||
143400671|NCT03181516|517016325|FG000|Overall Study|Withdrawal by Subject|14|||
143400672|NCT03181516|517016326|FG001|Overall Study|Withdrawal by Subject|7|||
143400673|NCT03181516|517016325|FG000|Overall Study|Lost to Follow-up|2|||
143400674|NCT03181516|517016326|FG001|Overall Study|Lost to Follow-up|2|||
143400675|NCT04580914|517016329|FG000|Overall Study|Withdrawal by Subject|6|||
143400676|NCT04580914|517016329|FG000|Overall Study|Lost to Follow-up|2|||
143400677|NCT05715528|517016330|FG000|Overall Study|Randomized but never treated|11|||
143400678|NCT05715528|517016331|FG001|Overall Study|Randomized but never treated|13|||
143400679|NCT05715528|517016330|FG000|Overall Study|Withdrew consent|7|||
143400680|NCT05715528|517016331|FG001|Overall Study|Withdrew consent|15|||
143400681|NCT05715528|517016330|FG000|Overall Study|Lost to Follow-up|5|||
143400682|NCT05715528|517016331|FG001|Overall Study|Lost to Follow-up|13|||
143400683|NCT05715528|517016330|FG000|Overall Study|Investigator's discretion|3|||
143400684|NCT05715528|517016331|FG001|Overall Study|Investigator's discretion|1|||
143400685|NCT05715528|517016330|FG000|Overall Study|Protocol Violation|2|||
143400686|NCT05715528|517016331|FG001|Overall Study|Protocol Violation|0|||
143400687|NCT05715528|517016330|FG000|Overall Study|Non-compliance with study drug|0|||
143400688|NCT05715528|517016331|FG001|Overall Study|Non-compliance with study drug|1|||
143400689|NCT03118518|517016332|FG000|Overall Study|Early Exit after treatment|2|||
143400690|NCT03118518|517016333|FG001|Overall Study|Early Exit after treatment|8|||
143400691|NCT03118518|517016332|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
143400692|NCT03118518|517016333|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
143400693|NCT05533190|517016346|FG000|Overall Study|Lost to Follow-up|19|||
143400694|NCT05533190|517016347|FG001|Overall Study|Lost to Follow-up|7|||
143400695|NCT05533190|517016346|FG000|Overall Study|Failed to download app|1|||
143400696|NCT05533190|517016347|FG001|Overall Study|Failed to download app|0|||
143400697|NCT05533190|517016346|FG000|Overall Study|Thought app was a scam|1|||
143400698|NCT05533190|517016347|FG001|Overall Study|Thought app was a scam|0|||
143400699|NCT05533190|517016346|FG000|Overall Study|Withdrawal by Subject|2|||
143400700|NCT05533190|517016347|FG001|Overall Study|Withdrawal by Subject|0|||
143400701|NCT02909686|517016348|FG000|Overall Study|Physician Decision|3|||
143400702|NCT02909686|517016348|FG000|Overall Study|Withdrawal by Subject|2|||
143400703|NCT02473445|517016349|FG000|Overall Study|Withdrawal by Subject|2|||
143400704|NCT02473445|517016349|FG000|Overall Study|Sponsor Decision|20|||
143400705|NCT03484819|517016350|FG000|Overall Study|Death|2|||
143400706|NCT03484819|517016350|FG000|Overall Study|Adverse Event|2|||
143400707|NCT03484819|517016350|FG000|Overall Study|Physician Decision|1|||
143400708|NCT03484819|517016350|FG000|Overall Study|Withdrawal by Subject|2|||
143400709|NCT03484819|517016350|FG000|Overall Study|Disease Progression|4|||
143400710|NCT03484819|517016350|FG000|Overall Study|Complicating Condition|1|||
143400711|NCT05970861|517016351|FG000|Overall Study|Physician Decision|4|||
143400712|NCT05970861|517016352|FG001|Overall Study|Physician Decision|4|||
143400713|NCT05970861|517016351|FG000|Overall Study|Lost to Follow-up|4|||
143400714|NCT05970861|517016352|FG001|Overall Study|Lost to Follow-up|3|||
143400715|NCT02990338|517016353|FG000|Overall Study|Randomized and not treated|4|||
143400716|NCT02990338|517016354|FG001|Overall Study|Randomized and not treated|2|||
143400717|NCT02990338|517016353|FG000|Overall Study|Adverse Event|23|||
143400718|NCT02990338|517016354|FG001|Overall Study|Adverse Event|22|||
143400719|NCT02990338|517016353|FG000|Overall Study|Progressive disease|118|||
143400720|NCT02990338|517016354|FG001|Overall Study|Progressive disease|107|||
143400721|NCT02990338|517016353|FG000|Overall Study|Poor compliance to protocol|0|||
143400722|NCT02990338|517016354|FG001|Overall Study|Poor compliance to protocol|1|||
143400723|NCT02990338|517016353|FG000|Overall Study|Withdrawal by Subject|6|||
143400724|NCT02990338|517016354|FG001|Overall Study|Withdrawal by Subject|8|||
143400725|NCT02990338|517016353|FG000|Overall Study|Physician's decision|2|||
143400726|NCT02990338|517016354|FG001|Overall Study|Physician's decision|6|||
143400727|NCT02990338|517016353|FG000|Overall Study|Treatment extension study|0|||
143400728|NCT02990338|517016354|FG001|Overall Study|Treatment extension study|6|||
143400729|NCT02990338|517016353|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
143400730|NCT02990338|517016354|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
143400731|NCT02990338|517016353|FG000|Overall Study|Continue with therapy available commercially|0|||
143400732|NCT02990338|517016354|FG001|Overall Study|Continue with therapy available commercially|1|||
143400733|NCT04186819|517016355|FG000|Overall Study|Adverse Event|1|||
143400734|NCT04186819|517016355|FG000|Overall Study|Lost to Follow-up|1|||
143400735|NCT04186819|517016355|FG000|Overall Study|Opted for EBRT|1|||
143400736|NCT04186819|517016355|FG000|Overall Study|Opted SBRT|1|||
143400737|NCT04186819|517016355|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
143400738|NCT04186819|517016355|FG000|Overall Study|Physician Decision|1|||
143400739|NCT04186819|517016355|FG000|Overall Study|RP Delayed|1|||
143400740|NCT04186819|517016355|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
143400741|NCT04186819|517016355|FG000|Overall Study|Subject declined for financial reasons|1|||
143400742|NCT04186819|517016355|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
143400743|NCT04186819|517016355|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
143400744|NCT04186819|517016355|FG000|Overall Study|The subject opted for other treatment option|2|||
143400745|NCT04186819|517016355|FG000|Overall Study|The subject opted for other treatment options|1|||
143400746|NCT04186819|517016355|FG000|Overall Study|Withdrawal by Subject|3|||
143400747|NCT04186819|517016355|FG000|Overall Study|Reason not specified|1|||
143400748|NCT01199133|517016359|FG000|Year 1|Adverse Event|16|||
143400749|NCT01199133|517016360|FG001|Year 1|Adverse Event|4|||
143400750|NCT01199133|517016359|FG000|Year 1|Withdrawal by Subject|8|||
143400751|NCT01199133|517016360|FG001|Year 1|Withdrawal by Subject|4|||
143400752|NCT01199133|517016359|FG000|Year 1|Any other reason not above-mentioned|6|||
143400753|NCT01199133|517016360|FG001|Year 1|Any other reason not above-mentioned|7|||
143400754|NCT01199133|517016359|FG000|Year 2|Adverse Event|1|||
143400755|NCT01199133|517016360|FG001|Year 2|Adverse Event|0|||
143400756|NCT01199133|517016359|FG000|Year 2|Withdrawal by Subject|1|||
143400757|NCT01199133|517016360|FG001|Year 2|Withdrawal by Subject|1|||
143400758|NCT01199133|517016359|FG000|Year 2|Any other reason not above-mentioned|1|||
143400759|NCT01199133|517016360|FG001|Year 2|Any other reason not above-mentioned|2|||
143400760|NCT03988621|517016362|FG000|Overall Study|Lost to Follow-up|16|||
143400761|NCT03988621|517016363|FG001|Overall Study|Lost to Follow-up|17|||
143400762|NCT03988621|517016362|FG000|Overall Study|Withdrawal by Subject|14|||
143400763|NCT03988621|517016363|FG001|Overall Study|Withdrawal by Subject|7|||
143400764|NCT03988621|517016362|FG000|Overall Study|Patient Lost to Follow Up|15|||
143400765|NCT03988621|517016363|FG001|Overall Study|Patient Lost to Follow Up|15|||
143400766|NCT03988621|517016362|FG000|Overall Study|Patient death|1|||
143400767|NCT03988621|517016363|FG001|Overall Study|Patient death|5|||
143400768|NCT05013385|517016364|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
143400769|NCT04247802|517016365|FG000|Overall Study|Withdrawal by Subject|1|||
143400770|NCT04247802|517016366|FG001|Overall Study|Withdrawal by Subject|3|||
143400771|NCT04247802|517016365|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
143400772|NCT04247802|517016366|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
143400773|NCT04102111|517016367|FG000|Overall Study|Withdrawal by Subject|2|||
143400774|NCT04102111|517016368|FG001|Overall Study|Withdrawal by Subject|3|||
143400775|NCT04102111|517016367|FG000|Overall Study|Adverse Event|1|||
143400776|NCT04102111|517016368|FG001|Overall Study|Adverse Event|1|||
143400777|NCT04102111|517016367|FG000|Overall Study|Study terminated by sponsor|1|||
143400778|NCT04102111|517016368|FG001|Overall Study|Study terminated by sponsor|3|||
143400779|NCT00631475|517016369|FG000|Overall Study|Death|18|||
143400780|NCT00631475|517016369|FG000|Overall Study|Adverse Event|14|||
143400781|NCT00631475|517016369|FG000|Overall Study|Withdrew consent|5|||
143400782|NCT00631475|517016369|FG000|Overall Study|Preparation for lung transplant|8|||
143400783|NCT00303459|517016370|FG000|Overall Study|Death|33|||
143400784|NCT00303459|517016371|FG001|Overall Study|Death|44|||
143400785|NCT00303459|517016370|FG000|Overall Study|Withdrawal of consent|32|||
143400786|NCT00303459|517016371|FG001|Overall Study|Withdrawal of consent|26|||
143400787|NCT00303459|517016370|FG000|Overall Study|Lost to Follow-up|5|||
143400788|NCT00303459|517016371|FG001|Overall Study|Lost to Follow-up|4|||
143400789|NCT00303459|517016370|FG000|Overall Study|Administrative reason|7|||
143400790|NCT00303459|517016371|FG001|Overall Study|Administrative reason|7|||
143400791|NCT00303459|517016370|FG000|Overall Study|Decision by the investigator|5|||
143400792|NCT00303459|517016371|FG001|Overall Study|Decision by the investigator|7|||
143400793|NCT00303459|517016370|FG000|Overall Study|Lung transplantation|1|||
143400794|NCT00303459|517016371|FG001|Overall Study|Lung transplantation|1|||
143400795|NCT04129554|517016372|FG000|Overall Study|Withdrawal by Subject|4|||
143400796|NCT04129554|517016373|FG001|Overall Study|Withdrawal by Subject|3|||
143400797|NCT04129554|517016372|FG000|Overall Study|Other|0|||
143400798|NCT04129554|517016373|FG001|Overall Study|Other|2|||
143400799|NCT03606512|517016374|FG000|Overall Study|Lost to Follow-up|0|||
143400800|NCT03606512|517016375|FG001|Overall Study|Lost to Follow-up|1|||
143400801|NCT03606512|517016374|FG000|Overall Study|'moved from study area|0|||
143400802|NCT03606512|517016375|FG001|Overall Study|'moved from study area|1|||
143400803|NCT05513937|517016376|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
143400804|NCT05513937|517016377|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
143400805|NCT05513937|517016378|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
143400806|NCT05513937|517016379|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
143400807|NCT05513937|517016376|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
143400808|NCT05513937|517016377|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
143400809|NCT05513937|517016378|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
143400810|NCT05513937|517016379|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
143400811|NCT05513937|517016376|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
143400812|NCT05513937|517016377|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
143400813|NCT05513937|517016378|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
143400814|NCT05513937|517016379|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
143400815|NCT05513937|517016376|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
143400816|NCT05513937|517016377|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
143400817|NCT05513937|517016378|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
143400818|NCT05513937|517016379|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
143400819|NCT05513937|517016376|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
143400820|NCT05513937|517016377|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
143400821|NCT05513937|517016378|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
143400822|NCT05513937|517016379|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
143400823|NCT05513937|517016376|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
143400824|NCT05513937|517016377|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
143400825|NCT05513937|517016378|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
143400826|NCT05513937|517016379|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
143400827|NCT02846545|517016380|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
143400828|NCT02846545|517016381|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
143400829|NCT02846545|517016380|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
143400830|NCT02846545|517016381|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
143400831|NCT02846545|517016380|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
143400832|NCT02846545|517016381|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
143400833|NCT02846545|517016380|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
143400834|NCT02846545|517016381|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
143400835|NCT02846545|517016380|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
143400836|NCT02846545|517016381|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
143400837|NCT03691298|517016384|FG000|Overall Study|Lost to Follow-up|8|||
143400838|NCT03691298|517016384|FG000|Overall Study|Sponsor terminated study|2|||
143400839|NCT03993392|517016390|FG000|Overall Study|Withdrawal by Subject|3|||
143400840|NCT03993392|517016390|FG000|Overall Study|Lost to Follow-up|2|||
143400841|NCT03993392|517016390|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
143400842|NCT02518048|517016391|FG000|Overall Study|Withdrawal by Subject|1|||
143400843|NCT05654662|517016392|FG000|Overall Study|Withdrawal by Subject|1|||
143400844|NCT05654662|517016393|FG001|Overall Study|Withdrawal by Subject|0|||
143400845|NCT05654662|517016392|FG000|Overall Study|A death in the family|1|||
143400846|NCT05654662|517016393|FG001|Overall Study|A death in the family|0|||
143400847|NCT05962814|517016394|FG000|Overall Study|failed eligibility|1|||
143400848|NCT03057054|517016395|FG000|Overall Study|Death|4|||
143400849|NCT03057054|517016396|FG001|Overall Study|Death|4|||
143400850|NCT03057054|517016395|FG000|Overall Study|Withdrawal by Subject|6|||
143400851|NCT03057054|517016396|FG001|Overall Study|Withdrawal by Subject|3|||
143400852|NCT03057054|517016395|FG000|Overall Study|Ineligible|1|||
143400853|NCT03057054|517016396|FG001|Overall Study|Ineligible|1|||
143400854|NCT06262477|517018174|FG000|Overall Study|Withdrawal by Subject|1|||
143400855|NCT06262477|517018175|FG001|Overall Study|Withdrawal by Subject|0|||
143400856|NCT06262477|517018174|FG000|Overall Study|Adverse Event|0|||
143400857|NCT06262477|517018175|FG001|Overall Study|Adverse Event|1|||
143400858|NCT06262477|517018174|FG000|Overall Study|Lost to Follow-up|0|||
143400859|NCT06262477|517018175|FG001|Overall Study|Lost to Follow-up|1|||
143400860|NCT04108130|517018176|FG000|Overall Study|Verbal Agreement Withdrawn|4|||
143400861|NCT04108130|517018177|FG001|Overall Study|Verbal Agreement Withdrawn|2|||
143400862|NCT04108130|517018176|FG000|Overall Study|Consent Withdrawn|9|||
143400863|NCT04108130|517018177|FG001|Overall Study|Consent Withdrawn|6|||
143400864|NCT04108130|517018176|FG000|Overall Study|Surgery Cancelled|4|||
143400865|NCT04108130|517018177|FG001|Overall Study|Surgery Cancelled|4|||
143400866|NCT04108130|517018176|FG000|Overall Study|Found Ineligible for Study|4|||
143400867|NCT04108130|517018177|FG001|Overall Study|Found Ineligible for Study|3|||
143400868|NCT04108130|517018176|FG000|Overall Study|Consent Not Obtained for Other Reasons|3|||
143400869|NCT04108130|517018177|FG001|Overall Study|Consent Not Obtained for Other Reasons|3|||
143400870|NCT04108130|517018176|FG000|Overall Study|Intervention Not Done and No Data Collected|0|||
143400871|NCT04108130|517018177|FG001|Overall Study|Intervention Not Done and No Data Collected|1|||
143400872|NCT05507333|517018178|FG000|Overall Study|Protocol Violation|1|||
143400873|NCT04136912|517018189|FG000|Overall Study|Operational reasons|0|||
143400874|NCT04136912|517018190|FG001|Overall Study|Operational reasons|0|||
143400875|NCT04136912|517018191|FG002|Overall Study|Operational reasons|2|||
143400876|NCT04615273|517018192|FG000|Overall Study|Withdrawal by Subject|3|||
143400877|NCT04615273|517018193|FG001|Overall Study|Withdrawal by Subject|1|||
143400878|NCT04615273|517018194|FG002|Overall Study|Withdrawal by Subject|2|||
143400879|NCT04615273|517018192|FG000|Overall Study|Adverse Event|1|||
143400880|NCT04615273|517018193|FG001|Overall Study|Adverse Event|0|||
143400881|NCT04615273|517018194|FG002|Overall Study|Adverse Event|1|||
143400882|NCT04615273|517018192|FG000|Overall Study|Lost to Follow-up|0|||
143400883|NCT04615273|517018193|FG001|Overall Study|Lost to Follow-up|1|||
143400884|NCT04615273|517018194|FG002|Overall Study|Lost to Follow-up|0|||
143400885|NCT04615273|517018192|FG000|Overall Study|Physician Decision|0|||
143400886|NCT04615273|517018193|FG001|Overall Study|Physician Decision|0|||
143400887|NCT04615273|517018194|FG002|Overall Study|Physician Decision|1|||
143400888|NCT04615273|517018192|FG000|Overall Study|Other|0|||
143400889|NCT04615273|517018193|FG001|Overall Study|Other|1|||
143400890|NCT04615273|517018194|FG002|Overall Study|Other|0|||
143400891|NCT04615273|517018192|FG000|Overall Study|Randomized but not treated|1|||
143400892|NCT04615273|517018193|FG001|Overall Study|Randomized but not treated|3|||
143400893|NCT04615273|517018194|FG002|Overall Study|Randomized but not treated|1|||
143400894|NCT03677141|517018195|FG000|Overall Study|Death|2|||
143400895|NCT03677141|517018196|FG001|Overall Study|Death|1|||
143400896|NCT03677141|517018197|FG002|Overall Study|Death|6|||
143400897|NCT03677141|517018198|FG003|Overall Study|Death|9|||
143400898|NCT03677141|517018199|FG004|Overall Study|Death|5|||
143400899|NCT03677141|517018200|FG005|Overall Study|Death|3|||
143400900|NCT03677141|517018195|FG000|Overall Study|Lost to Follow-up|0|||
143400901|NCT03677141|517018196|FG001|Overall Study|Lost to Follow-up|0|||
143400902|NCT03677141|517018197|FG002|Overall Study|Lost to Follow-up|0|||
143400903|NCT03677141|517018198|FG003|Overall Study|Lost to Follow-up|2|||
143400904|NCT03677141|517018199|FG004|Overall Study|Lost to Follow-up|0|||
143400905|NCT03677141|517018200|FG005|Overall Study|Lost to Follow-up|0|||
143400906|NCT03677141|517018195|FG000|Overall Study|Screen failure or enrolled in error|0|||
143400907|NCT03677141|517018196|FG001|Overall Study|Screen failure or enrolled in error|0|||
143400908|NCT03677141|517018197|FG002|Overall Study|Screen failure or enrolled in error|0|||
143400909|NCT03677141|517018198|FG003|Overall Study|Screen failure or enrolled in error|0|||
143400910|NCT03677141|517018199|FG004|Overall Study|Screen failure or enrolled in error|2|||
143400911|NCT03677141|517018200|FG005|Overall Study|Screen failure or enrolled in error|0|||
143400912|NCT03677141|517018195|FG000|Overall Study|Physician Decision|0|||
143400913|NCT03677141|517018196|FG001|Overall Study|Physician Decision|0|||
143400914|NCT03677141|517018197|FG002|Overall Study|Physician Decision|0|||
143400915|NCT03677141|517018198|FG003|Overall Study|Physician Decision|0|||
143400916|NCT03677141|517018199|FG004|Overall Study|Physician Decision|1|||
143400917|NCT03677141|517018200|FG005|Overall Study|Physician Decision|0|||
143400918|NCT03677141|517018195|FG000|Overall Study|Withdrawal by Subject|0|||
143400919|NCT03677141|517018196|FG001|Overall Study|Withdrawal by Subject|0|||
143400920|NCT03677141|517018197|FG002|Overall Study|Withdrawal by Subject|1|||
143400921|NCT03677141|517018198|FG003|Overall Study|Withdrawal by Subject|1|||
143400922|NCT03677141|517018199|FG004|Overall Study|Withdrawal by Subject|1|||
143400923|NCT03677141|517018200|FG005|Overall Study|Withdrawal by Subject|0|||
143400924|NCT05976334|517018208|FG000|Part B|Death|0|||
143400925|NCT05976334|517018209|FG001|Part B|Death|1|||
143400926|NCT05976334|517018208|FG000|Part B|Study Terminated by Sponsor|0|||
143400927|NCT05976334|517018209|FG001|Part B|Study Terminated by Sponsor|1|||
143400928|NCT05976334|517018208|FG000|Part B|Reason Not Specified|0|||
143400929|NCT05976334|517018209|FG001|Part B|Reason Not Specified|1|||
143400930|NCT05363163|517018210|FG000|Overall Study|Withdrawal by Subject|13|||
143400931|NCT02437136|517018219|FG000|Dose Escalation/Confirmation (Phase 1b)|Death|4|||
143400932|NCT02437136|517018220|FG001|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
143400933|NCT02437136|517018221|FG002|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
143400934|NCT02437136|517018222|FG003|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
143400935|NCT02437136|517018223|FG004|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
143400936|NCT02437136|517018224|FG005|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
143400937|NCT02437136|517018225|FG006|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
143400938|NCT02437136|517018219|FG000|Expansion (Phase 2)|Death|0|||
143400939|NCT02437136|517018220|FG001|Expansion (Phase 2)|Death|0|||
143400940|NCT02437136|517018221|FG002|Expansion (Phase 2)|Death|0|||
143400941|NCT02437136|517018222|FG003|Expansion (Phase 2)|Death|6|||
143400942|NCT02437136|517018223|FG004|Expansion (Phase 2)|Death|37|||
143400943|NCT02437136|517018224|FG005|Expansion (Phase 2)|Death|29|||
143400944|NCT02437136|517018225|FG006|Expansion (Phase 2)|Death|24|||
143400945|NCT02437136|517018219|FG000|Expansion (Phase 2)|Withdrawal by Subject|0|||
143400946|NCT02437136|517018220|FG001|Expansion (Phase 2)|Withdrawal by Subject|0|||
143400947|NCT02437136|517018221|FG002|Expansion (Phase 2)|Withdrawal by Subject|0|||
143400948|NCT02437136|517018222|FG003|Expansion (Phase 2)|Withdrawal by Subject|7|||
143400949|NCT02437136|517018223|FG004|Expansion (Phase 2)|Withdrawal by Subject|25|||
143400950|NCT02437136|517018224|FG005|Expansion (Phase 2)|Withdrawal by Subject|4|||
143400951|NCT02437136|517018225|FG006|Expansion (Phase 2)|Withdrawal by Subject|2|||
143400952|NCT02437136|517018219|FG000|Expansion (Phase 2)|Lost to Follow-up|0|||
143400953|NCT02437136|517018220|FG001|Expansion (Phase 2)|Lost to Follow-up|0|||
143400954|NCT02437136|517018221|FG002|Expansion (Phase 2)|Lost to Follow-up|0|||
143400955|NCT02437136|517018222|FG003|Expansion (Phase 2)|Lost to Follow-up|0|||
143400956|NCT02437136|517018223|FG004|Expansion (Phase 2)|Lost to Follow-up|3|||
143400957|NCT02437136|517018224|FG005|Expansion (Phase 2)|Lost to Follow-up|3|||
143400958|NCT02437136|517018225|FG006|Expansion (Phase 2)|Lost to Follow-up|2|||
143400959|NCT02056834|517018228|FG000|Overall Study|Lost to Follow-up|7|||
143400960|NCT06106022|517018230|FG000|Overall Study|Lost to Follow-up|1|||
143400961|NCT06106022|517018231|FG001|Overall Study|Lost to Follow-up|0|||
143400962|NCT06106022|517018230|FG000|Overall Study|Voluntary Withdrawal|0|||
143400963|NCT06106022|517018231|FG001|Overall Study|Voluntary Withdrawal|2|||
143400964|NCT04526886|517018232|FG000|Overall Study|Physician Decision|4|||
143400965|NCT04089865|517018234|FG000|Overall Study|Withdrawal by Subject|2|||
143400966|NCT04089865|517018235|FG001|Overall Study|Withdrawal by Subject|2|||
143400967|NCT04089865|517018236|FG002|Overall Study|Withdrawal by Subject|7|||
143400968|NCT04089865|517018237|FG003|Overall Study|Withdrawal by Subject|2|||
143400969|NCT05524116|517018259|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
143400970|NCT05524116|517018260|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
143400971|NCT05524116|517018259|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
143400972|NCT05524116|517018260|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
143400973|NCT05524116|517018259|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
143400974|NCT05524116|517018260|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
143400975|NCT05524116|517018259|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
143400976|NCT05524116|517018260|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
143400977|NCT05524116|517018259|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
143400978|NCT05524116|517018260|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
143400979|NCT03580356|517018262|FG000|Treatment Period|Withdrawal by Subject|13|||
143400980|NCT03580356|517018263|FG001|Treatment Period|Withdrawal by Subject|0|||
143400981|NCT03580356|517018264|FG002|Treatment Period|Withdrawal by Subject|13|||
143400982|NCT03580356|517018265|FG003|Treatment Period|Withdrawal by Subject|1|||
143400983|NCT03580356|517018266|FG004|Treatment Period|Withdrawal by Subject|17|||
143400984|NCT03580356|517018267|FG005|Treatment Period|Withdrawal by Subject|0|||
143400985|NCT03580356|517018268|FG006|Treatment Period|Withdrawal by Subject|5|||
143400986|NCT03580356|517018269|FG007|Treatment Period|Withdrawal by Subject|0|||
143400987|NCT03580356|517018262|FG000|Treatment Period|Adverse Event|10|||
143400988|NCT03580356|517018263|FG001|Treatment Period|Adverse Event|0|||
143400989|NCT03580356|517018264|FG002|Treatment Period|Adverse Event|13|||
143400990|NCT03580356|517018265|FG003|Treatment Period|Adverse Event|0|||
143400991|NCT03580356|517018266|FG004|Treatment Period|Adverse Event|5|||
143400992|NCT03580356|517018267|FG005|Treatment Period|Adverse Event|0|||
143400993|NCT03580356|517018268|FG006|Treatment Period|Adverse Event|8|||
143400994|NCT03580356|517018269|FG007|Treatment Period|Adverse Event|0|||
143400995|NCT03580356|517018262|FG000|Treatment Period|Protocol Violation|5|||
143400996|NCT03580356|517018263|FG001|Treatment Period|Protocol Violation|0|||
143400997|NCT03580356|517018264|FG002|Treatment Period|Protocol Violation|6|||
143400998|NCT03580356|517018265|FG003|Treatment Period|Protocol Violation|1|||
143400999|NCT03580356|517018266|FG004|Treatment Period|Protocol Violation|9|||
143401000|NCT03580356|517018267|FG005|Treatment Period|Protocol Violation|1|||
143401001|NCT03580356|517018268|FG006|Treatment Period|Protocol Violation|1|||
143401002|NCT03580356|517018269|FG007|Treatment Period|Protocol Violation|0|||
143401003|NCT03580356|517018262|FG000|Treatment Period|Lack of Efficacy|6|||
143401004|NCT03580356|517018263|FG001|Treatment Period|Lack of Efficacy|0|||
143401005|NCT03580356|517018264|FG002|Treatment Period|Lack of Efficacy|2|||
143401006|NCT03580356|517018265|FG003|Treatment Period|Lack of Efficacy|0|||
143401007|NCT03580356|517018266|FG004|Treatment Period|Lack of Efficacy|3|||
143401008|NCT03580356|517018267|FG005|Treatment Period|Lack of Efficacy|0|||
143401009|NCT03580356|517018268|FG006|Treatment Period|Lack of Efficacy|3|||
143401010|NCT03580356|517018269|FG007|Treatment Period|Lack of Efficacy|0|||
143401011|NCT03580356|517018262|FG000|Treatment Period|Pregnancy|1|||
143401012|NCT03580356|517018263|FG001|Treatment Period|Pregnancy|0|||
143401013|NCT03580356|517018264|FG002|Treatment Period|Pregnancy|7|||
143401014|NCT03580356|517018265|FG003|Treatment Period|Pregnancy|0|||
143401015|NCT03580356|517018266|FG004|Treatment Period|Pregnancy|2|||
143401016|NCT03580356|517018267|FG005|Treatment Period|Pregnancy|0|||
143401017|NCT03580356|517018268|FG006|Treatment Period|Pregnancy|1|||
143401018|NCT03580356|517018269|FG007|Treatment Period|Pregnancy|0|||
143401019|NCT03580356|517018262|FG000|Treatment Period|Physician Decision|2|||
143401020|NCT03580356|517018263|FG001|Treatment Period|Physician Decision|0|||
143401021|NCT03580356|517018264|FG002|Treatment Period|Physician Decision|1|||
143401022|NCT03580356|517018265|FG003|Treatment Period|Physician Decision|0|||
143401023|NCT03580356|517018266|FG004|Treatment Period|Physician Decision|4|||
143401024|NCT03580356|517018267|FG005|Treatment Period|Physician Decision|0|||
143401025|NCT03580356|517018268|FG006|Treatment Period|Physician Decision|2|||
143401026|NCT03580356|517018269|FG007|Treatment Period|Physician Decision|0|||
143401027|NCT03580356|517018262|FG000|Treatment Period|Lost to Follow-up|1|||
143401028|NCT03580356|517018263|FG001|Treatment Period|Lost to Follow-up|1|||
143401029|NCT03580356|517018264|FG002|Treatment Period|Lost to Follow-up|1|||
143401030|NCT03580356|517018265|FG003|Treatment Period|Lost to Follow-up|0|||
143401031|NCT03580356|517018266|FG004|Treatment Period|Lost to Follow-up|3|||
143401032|NCT03580356|517018267|FG005|Treatment Period|Lost to Follow-up|0|||
143401033|NCT03580356|517018268|FG006|Treatment Period|Lost to Follow-up|1|||
143401034|NCT03580356|517018269|FG007|Treatment Period|Lost to Follow-up|0|||
143401035|NCT03580356|517018262|FG000|Treatment Period|Death|0|||
143401036|NCT03580356|517018263|FG001|Treatment Period|Death|0|||
143401037|NCT03580356|517018264|FG002|Treatment Period|Death|1|||
143401038|NCT03580356|517018265|FG003|Treatment Period|Death|0|||
143401039|NCT03580356|517018266|FG004|Treatment Period|Death|0|||
143401040|NCT03580356|517018267|FG005|Treatment Period|Death|0|||
143401041|NCT03580356|517018268|FG006|Treatment Period|Death|0|||
143401042|NCT03580356|517018269|FG007|Treatment Period|Death|0|||
143401043|NCT03580356|517018262|FG000|Treatment Period|Technical problems|0|||
143401044|NCT03580356|517018263|FG001|Treatment Period|Technical problems|0|||
143401045|NCT03580356|517018264|FG002|Treatment Period|Technical problems|0|||
143401046|NCT03580356|517018265|FG003|Treatment Period|Technical problems|0|||
143401047|NCT03580356|517018266|FG004|Treatment Period|Technical problems|1|||
143401048|NCT03580356|517018267|FG005|Treatment Period|Technical problems|0|||
143401049|NCT03580356|517018268|FG006|Treatment Period|Technical problems|0|||
143401050|NCT03580356|517018269|FG007|Treatment Period|Technical problems|0|||
143401051|NCT03580356|517018262|FG000|Treatment Period|Misrandomized, no treatment|0|||
143401052|NCT03580356|517018263|FG001|Treatment Period|Misrandomized, no treatment|0|||
143401053|NCT03580356|517018264|FG002|Treatment Period|Misrandomized, no treatment|1|||
143401054|NCT03580356|517018265|FG003|Treatment Period|Misrandomized, no treatment|0|||
143401055|NCT03580356|517018266|FG004|Treatment Period|Misrandomized, no treatment|2|||
143401056|NCT03580356|517018267|FG005|Treatment Period|Misrandomized, no treatment|0|||
143401057|NCT03580356|517018268|FG006|Treatment Period|Misrandomized, no treatment|0|||
143401058|NCT03580356|517018269|FG007|Treatment Period|Misrandomized, no treatment|0|||
143401059|NCT03580356|517018262|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
143401060|NCT03580356|517018263|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
143401061|NCT03580356|517018264|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
143401062|NCT03580356|517018265|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
143401063|NCT03580356|517018266|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
143401064|NCT03580356|517018267|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
143401065|NCT03580356|517018268|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
143401066|NCT03580356|517018269|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
143401067|NCT03580356|517018262|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
143401068|NCT03580356|517018263|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
143401069|NCT03580356|517018264|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
143401070|NCT03580356|517018265|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
143401071|NCT03580356|517018266|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
143401072|NCT03580356|517018267|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
143401073|NCT03580356|517018268|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
143401074|NCT03580356|517018269|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
143401075|NCT03580356|517018262|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
143401076|NCT03580356|517018263|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
143401077|NCT03580356|517018264|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
143401078|NCT03580356|517018265|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
143401079|NCT03580356|517018266|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
143401080|NCT03580356|517018267|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
143401081|NCT03580356|517018268|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
143401082|NCT03580356|517018269|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
143401083|NCT03580356|517018262|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
143401084|NCT03580356|517018263|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
143401085|NCT03580356|517018264|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
143401086|NCT03580356|517018265|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
143401087|NCT03580356|517018266|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
143401088|NCT03580356|517018267|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
143401089|NCT03580356|517018268|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
143401090|NCT03580356|517018269|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
143401091|NCT03580356|517018262|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
143401092|NCT03580356|517018263|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
143401093|NCT03580356|517018264|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
143401094|NCT03580356|517018265|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
143401095|NCT03580356|517018266|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
143401096|NCT03580356|517018267|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
143401097|NCT03580356|517018268|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
143401098|NCT03580356|517018269|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
143401099|NCT03580356|517018262|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
143401100|NCT03580356|517018263|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
143401101|NCT03580356|517018264|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
143401102|NCT03580356|517018265|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
143401103|NCT03580356|517018266|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
143401104|NCT03580356|517018267|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
143401105|NCT03580356|517018268|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
143401106|NCT03580356|517018269|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
143401107|NCT03580356|517018262|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
143401108|NCT03580356|517018263|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
143401109|NCT03580356|517018264|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
143401110|NCT03580356|517018265|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
143401111|NCT03580356|517018266|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
143401112|NCT03580356|517018267|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
143401113|NCT03580356|517018268|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
143401114|NCT03580356|517018269|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
143401115|NCT02834390|517018270|FG000|Induction Phase|Progressive disease|0|||
143401116|NCT02834390|517018271|FG001|Induction Phase|Progressive disease|1|||
143401117|NCT02834390|517018270|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
143401118|NCT02834390|517018271|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
143401119|NCT02834390|517018270|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
143401120|NCT02834390|517018271|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
143401121|NCT02834390|517018270|FG000|Consolidation Phase|Physician Decision|1|||
143401122|NCT02834390|517018271|FG001|Consolidation Phase|Physician Decision|1|||
143401123|NCT03536884|517018272|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
143401124|NCT03536884|517018273|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
143401125|NCT03536884|517018274|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
143401126|NCT03536884|517018275|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
143401127|NCT03536884|517018276|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
143401128|NCT03536884|517018277|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
143401129|NCT03536884|517018278|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
143401130|NCT03536884|517018279|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
143401131|NCT03536884|517018280|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
143401132|NCT03536884|517018281|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
143401133|NCT03536884|517018282|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
143401134|NCT03536884|517018283|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
143401135|NCT03536884|517018272|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
143401136|NCT03536884|517018273|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
143401137|NCT03536884|517018274|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
143401138|NCT03536884|517018275|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
143401139|NCT03536884|517018276|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
143401140|NCT03536884|517018277|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
143401141|NCT03536884|517018278|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
143401142|NCT03536884|517018279|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
143401143|NCT03536884|517018280|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
143401144|NCT03536884|517018281|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
143401145|NCT03536884|517018282|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
143401146|NCT03536884|517018283|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
143401147|NCT03536884|517018272|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
143401148|NCT03536884|517018273|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
143401149|NCT03536884|517018274|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
143401150|NCT03536884|517018275|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
143401151|NCT03536884|517018276|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
143401152|NCT03536884|517018277|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
143401153|NCT03536884|517018278|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
143401154|NCT03536884|517018279|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
143401155|NCT03536884|517018280|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
143401156|NCT03536884|517018281|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
143401157|NCT03536884|517018282|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
143401158|NCT03536884|517018283|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
143401159|NCT03536884|517018272|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
143401160|NCT03536884|517018273|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
143401161|NCT03536884|517018274|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
143401162|NCT03536884|517018275|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
143401163|NCT03536884|517018276|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
143401164|NCT03536884|517018277|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
143401165|NCT03536884|517018278|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
143401166|NCT03536884|517018279|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
143401167|NCT03536884|517018280|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
143401168|NCT03536884|517018281|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
143401169|NCT03536884|517018282|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
143401170|NCT03536884|517018283|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
143401171|NCT03536884|517018272|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
143401172|NCT03536884|517018273|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
143454133|NCT01081665|517206875|FG000|Overall Study|Death|41|||
143454134|NCT01081665|517206875|FG000|Overall Study|Lost to Follow-up|18|||
143454135|NCT01081665|517206875|FG000|Overall Study|Withdrawal by Subject|17|||
143454136|NCT01081665|517206875|FG000|Overall Study|Change of dialysis unit|10|||
143454137|NCT01081665|517206875|FG000|Overall Study|Regulation of iPTH|5|||
143454138|NCT01081665|517206875|FG000|Overall Study|Change in renal replacement therapy|2|||
143454139|NCT01081665|517206875|FG000|Overall Study|Adverse Event|1|||
143454140|NCT01081665|517206875|FG000|Overall Study|Lack of Efficacy|1|||
143454141|NCT03381339|517206884|FG000|Overall Study|Protocol Violation|4|||
143454142|NCT03381339|517206885|FG001|Overall Study|Protocol Violation|3|||
143454143|NCT03381339|517206884|FG000|Overall Study|Lost to Follow-up|0|||
143454144|NCT03381339|517206885|FG001|Overall Study|Lost to Follow-up|1|||
143454145|NCT01865747|517206888|FG000|Overall Study (ITT)|Adverse Event|32|||
143454146|NCT01865747|517206889|FG001|Overall Study (ITT)|Adverse Event|31|||
143454147|NCT01865747|517206888|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
143454148|NCT01865747|517206889|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
143454149|NCT01865747|517206888|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
143454150|NCT01865747|517206889|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
143454151|NCT01865747|517206888|FG000|Overall Study (ITT)|Protocol Violation|1|||
143454152|NCT01865747|517206889|FG001|Overall Study (ITT)|Protocol Violation|1|||
143454153|NCT01865747|517206888|FG000|Overall Study (ITT)|Physician Decision|5|||
143454154|NCT01865747|517206889|FG001|Overall Study (ITT)|Physician Decision|2|||
143454155|NCT01865747|517206888|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
143454156|NCT01865747|517206889|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
143454157|NCT01865747|517206888|FG000|Overall Study (ITT)|Sponsor Decision|0|||
143454158|NCT01865747|517206889|FG001|Overall Study (ITT)|Sponsor Decision|1|||
143454159|NCT01865747|517206888|FG000|Overall Study (ITT)|Progressive Disease|122|||
143454160|NCT01865747|517206889|FG001|Overall Study (ITT)|Progressive Disease|158|||
143454161|NCT01865747|517206888|FG000|Overall Study (ITT)|Reason Not Provided|0|||
143454162|NCT01865747|517206889|FG001|Overall Study (ITT)|Reason Not Provided|1|||
143454163|NCT01865747|517206888|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
143454164|NCT01865747|517206889|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
143401173|NCT03536884|517018274|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
143401174|NCT03536884|517018275|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
143401175|NCT03536884|517018276|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
143401176|NCT03536884|517018277|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
143401177|NCT03536884|517018278|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
143401178|NCT03536884|517018279|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
143401179|NCT03536884|517018280|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
143401180|NCT03536884|517018281|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
143401181|NCT03536884|517018282|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
143401182|NCT03536884|517018283|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
143401183|NCT03536884|517018272|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
143401184|NCT03536884|517018273|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
143401185|NCT03536884|517018274|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
143401186|NCT03536884|517018275|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
143401187|NCT03536884|517018276|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
143401188|NCT03536884|517018277|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
143401189|NCT03536884|517018278|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
143401190|NCT03536884|517018279|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
143401191|NCT03536884|517018280|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
143401192|NCT03536884|517018281|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
143401193|NCT03536884|517018282|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
143401194|NCT03536884|517018283|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
143401195|NCT03536884|517018272|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
143401196|NCT03536884|517018273|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
143401197|NCT03536884|517018274|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
143401198|NCT03536884|517018275|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
143401199|NCT03536884|517018276|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
143401200|NCT03536884|517018277|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
143401201|NCT03536884|517018278|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
143401202|NCT03536884|517018279|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
143401203|NCT03536884|517018280|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
143401204|NCT03536884|517018281|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
143401205|NCT03536884|517018282|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
143401206|NCT03536884|517018283|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
143401207|NCT03536884|517018272|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
143401208|NCT03536884|517018273|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
143401209|NCT03536884|517018274|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
143401210|NCT03536884|517018275|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
143401211|NCT03536884|517018276|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
143401212|NCT03536884|517018277|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
143401213|NCT03536884|517018278|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
143401214|NCT03536884|517018279|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
143401215|NCT03536884|517018280|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
143401216|NCT03536884|517018281|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
143401217|NCT03536884|517018282|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
143401218|NCT03536884|517018283|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
143401219|NCT03536884|517018272|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
143401220|NCT03536884|517018273|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
143401221|NCT03536884|517018274|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
143401222|NCT03536884|517018275|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
143401223|NCT03536884|517018276|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
143401224|NCT03536884|517018277|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
143401225|NCT03536884|517018278|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
143401226|NCT03536884|517018279|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
143401227|NCT03536884|517018280|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
143401228|NCT03536884|517018281|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
143401229|NCT03536884|517018282|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
143401230|NCT03536884|517018283|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
143401231|NCT03536884|517018272|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
143401232|NCT03536884|517018273|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
143401233|NCT03536884|517018274|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
143401234|NCT03536884|517018275|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
143401235|NCT03536884|517018276|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
143401236|NCT03536884|517018277|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
143401237|NCT03536884|517018278|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
143401238|NCT03536884|517018279|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
143401239|NCT03536884|517018280|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
143401240|NCT03536884|517018281|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
143401241|NCT03536884|517018282|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
143401242|NCT03536884|517018283|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
143401243|NCT03536884|517018272|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
143401244|NCT03536884|517018273|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
143401245|NCT03536884|517018274|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
143401246|NCT03536884|517018275|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
143401247|NCT03536884|517018276|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
143401248|NCT03536884|517018277|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
143401249|NCT03536884|517018278|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
143401250|NCT03536884|517018279|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
143401251|NCT03536884|517018280|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
143401252|NCT03536884|517018281|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
143401253|NCT03536884|517018282|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
143401254|NCT03536884|517018283|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
143401255|NCT03536884|517018272|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
143401256|NCT03536884|517018273|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
143401257|NCT03536884|517018274|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
143401258|NCT03536884|517018275|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
143401259|NCT03536884|517018276|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
143401260|NCT03536884|517018277|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
143401261|NCT03536884|517018278|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
143401262|NCT03536884|517018279|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
143401263|NCT03536884|517018280|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
143401264|NCT03536884|517018281|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
143401265|NCT03536884|517018282|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
143401266|NCT03536884|517018283|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
143401267|NCT03536884|517018272|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
143401268|NCT03536884|517018273|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
143401269|NCT03536884|517018274|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
143401270|NCT03536884|517018275|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
143401271|NCT03536884|517018276|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
143401272|NCT03536884|517018277|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
143401273|NCT03536884|517018278|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
143401274|NCT03536884|517018279|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
143401275|NCT03536884|517018280|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
143401276|NCT03536884|517018281|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
143401277|NCT03536884|517018282|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
143401278|NCT03536884|517018283|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
143401279|NCT03536884|517018272|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
143401280|NCT03536884|517018273|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
143401281|NCT03536884|517018274|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
143401282|NCT03536884|517018275|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
143401283|NCT03536884|517018276|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
143401284|NCT03536884|517018277|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
143401285|NCT03536884|517018278|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
143401286|NCT03536884|517018279|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
143401287|NCT03536884|517018280|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
143401288|NCT03536884|517018281|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
143401289|NCT03536884|517018282|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
143401290|NCT03536884|517018283|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
143401291|NCT03536884|517018272|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
143401292|NCT03536884|517018273|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
143401293|NCT03536884|517018274|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
143401294|NCT03536884|517018275|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
143401295|NCT03536884|517018276|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
143401296|NCT03536884|517018277|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
143401297|NCT03536884|517018278|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
143401298|NCT03536884|517018279|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
143401299|NCT03536884|517018280|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
143401300|NCT03536884|517018281|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
143401301|NCT03536884|517018282|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
143401302|NCT03536884|517018283|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
143401303|NCT03536884|517018272|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
143401304|NCT03536884|517018273|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
143401305|NCT03536884|517018274|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
143401306|NCT03536884|517018275|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
143401307|NCT03536884|517018276|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
143401308|NCT03536884|517018277|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
143401309|NCT03536884|517018278|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
143401310|NCT03536884|517018279|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
143401311|NCT03536884|517018280|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
143401312|NCT03536884|517018281|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
143401313|NCT03536884|517018282|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
143401314|NCT03536884|517018283|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
143401315|NCT03536884|517018272|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
143401316|NCT03536884|517018273|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
143401317|NCT03536884|517018274|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
143401318|NCT03536884|517018275|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
143401319|NCT03536884|517018276|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
143401320|NCT03536884|517018277|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
143401321|NCT03536884|517018278|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
143401322|NCT03536884|517018279|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
143401323|NCT03536884|517018280|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
143401324|NCT03536884|517018281|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
143401325|NCT03536884|517018282|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
143401326|NCT03536884|517018283|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
143401327|NCT03536884|517018272|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
143401328|NCT03536884|517018273|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
143401329|NCT03536884|517018274|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
143401330|NCT03536884|517018275|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
143401331|NCT03536884|517018276|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
143401332|NCT03536884|517018277|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
143401333|NCT03536884|517018278|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
143401334|NCT03536884|517018279|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
143401335|NCT03536884|517018280|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
143401336|NCT03536884|517018281|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
143401337|NCT03536884|517018282|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
143401338|NCT03536884|517018283|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
143401339|NCT03536884|517018272|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
143401340|NCT03536884|517018273|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
143401341|NCT03536884|517018274|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
143401342|NCT03536884|517018275|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
143401343|NCT03536884|517018276|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
143401344|NCT03536884|517018277|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
143401345|NCT03536884|517018278|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
143401346|NCT03536884|517018279|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
143401347|NCT03536884|517018280|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
143401348|NCT03536884|517018281|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
143401349|NCT03536884|517018282|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
143401350|NCT03536884|517018283|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
143401351|NCT03536884|517018272|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
143401352|NCT03536884|517018273|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
143401353|NCT03536884|517018274|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
143401354|NCT03536884|517018275|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
143401355|NCT03536884|517018276|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
143401356|NCT03536884|517018277|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
143401357|NCT03536884|517018278|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
143401358|NCT03536884|517018279|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
143401359|NCT03536884|517018280|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
143401360|NCT03536884|517018281|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
143401361|NCT03536884|517018282|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
143401362|NCT03536884|517018283|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
143401363|NCT03536884|517018272|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
143401364|NCT03536884|517018273|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
143401365|NCT03536884|517018274|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
143401366|NCT03536884|517018275|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
143401367|NCT03536884|517018276|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
143401368|NCT03536884|517018277|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
143401369|NCT03536884|517018278|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
143401370|NCT03536884|517018279|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
143401371|NCT03536884|517018280|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
143401372|NCT03536884|517018281|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
143401373|NCT03536884|517018282|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
143401374|NCT03536884|517018283|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
143401375|NCT03536884|517018272|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
143401376|NCT03536884|517018273|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
143401377|NCT03536884|517018274|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
143401378|NCT03536884|517018275|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
143401379|NCT03536884|517018276|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
143401380|NCT03536884|517018277|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
143401381|NCT03536884|517018278|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
143401382|NCT03536884|517018279|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
143401383|NCT03536884|517018280|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
143401384|NCT03536884|517018281|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
143401385|NCT03536884|517018282|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
143401386|NCT03536884|517018283|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
143401387|NCT03536884|517018272|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
143401388|NCT03536884|517018273|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
143401389|NCT03536884|517018274|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
143401390|NCT03536884|517018275|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
143401391|NCT03536884|517018276|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
143401392|NCT03536884|517018277|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
143401393|NCT03536884|517018278|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
143401394|NCT03536884|517018279|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
143401395|NCT03536884|517018280|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
143401396|NCT03536884|517018281|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
143401397|NCT03536884|517018282|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
143401398|NCT03536884|517018283|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
143401399|NCT03536884|517018272|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
143401400|NCT03536884|517018273|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
143401401|NCT03536884|517018274|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
143401402|NCT03536884|517018275|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
143401403|NCT03536884|517018276|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
143401404|NCT03536884|517018277|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
143401405|NCT03536884|517018278|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
143401406|NCT03536884|517018279|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
143401407|NCT03536884|517018280|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
143401408|NCT03536884|517018281|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
143401409|NCT03536884|517018282|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
143401410|NCT03536884|517018283|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
143401411|NCT03536884|517018272|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
143401412|NCT03536884|517018273|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
143401413|NCT03536884|517018274|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
143401414|NCT03536884|517018275|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
143401415|NCT03536884|517018276|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
143401416|NCT03536884|517018277|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
143401417|NCT03536884|517018278|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
143401418|NCT03536884|517018279|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
143401419|NCT03536884|517018280|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
143401420|NCT03536884|517018281|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
143401421|NCT03536884|517018282|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
143401422|NCT03536884|517018283|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
143401423|NCT03536884|517018272|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
143401424|NCT03536884|517018273|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
143401425|NCT03536884|517018274|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
143401426|NCT03536884|517018275|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
143401427|NCT03536884|517018276|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
143401428|NCT03536884|517018277|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
143401429|NCT03536884|517018278|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
143401430|NCT03536884|517018279|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
143401431|NCT03536884|517018280|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
143401432|NCT03536884|517018281|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
143401433|NCT03536884|517018282|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
143401434|NCT03536884|517018283|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
143401435|NCT00677365|517018303|FG000|Overall Study|Adverse Event|2|||
143401436|NCT00677365|517018304|FG001|Overall Study|Adverse Event|1|||
143401437|NCT00677365|517018305|FG002|Overall Study|Adverse Event|1|||
143401438|NCT00677365|517018306|FG003|Overall Study|Adverse Event|2|||
143401439|NCT00677365|517018303|FG000|Overall Study|Withdrawal by Subject|0|||
143401440|NCT00677365|517018304|FG001|Overall Study|Withdrawal by Subject|0|||
143401441|NCT00677365|517018305|FG002|Overall Study|Withdrawal by Subject|1|||
143401442|NCT00677365|517018306|FG003|Overall Study|Withdrawal by Subject|0|||
143401443|NCT00677365|517018303|FG000|Overall Study|Other reason|0|||
143401444|NCT00677365|517018304|FG001|Overall Study|Other reason|0|||
143401445|NCT00677365|517018305|FG002|Overall Study|Other reason|0|||
143401446|NCT00677365|517018306|FG003|Overall Study|Other reason|1|||
143401447|NCT05900154|517018307|FG000|Follow-Up Period|Lost to Follow-up|1|||
143401448|NCT05900154|517018308|FG001|Follow-Up Period|Lost to Follow-up|2|||
143401449|NCT05900154|517018309|FG002|Follow-Up Period|Lost to Follow-up|1|||
143401450|NCT05900154|517018310|FG003|Follow-Up Period|Lost to Follow-up|0|||
143401451|NCT05900154|517018311|FG004|Follow-Up Period|Lost to Follow-up|1|||
143401452|NCT05900154|517018312|FG005|Follow-Up Period|Lost to Follow-up|1|||
143401453|NCT02905331|517018313|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
143401454|NCT02905331|517018314|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
143401455|NCT02905331|517018315|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
143401456|NCT02905331|517018313|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
143401457|NCT02905331|517018314|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
143401458|NCT02905331|517018315|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
143401459|NCT02905331|517018313|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
143401460|NCT02905331|517018314|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
143401461|NCT02905331|517018315|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
143401462|NCT02905331|517018313|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
143401463|NCT02905331|517018314|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
143401464|NCT02905331|517018315|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
143401465|NCT02905331|517018313|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
143401466|NCT02905331|517018314|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
143401467|NCT02905331|517018315|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
143401468|NCT02542631|517018323|FG000|Overall Study|Adverse Event|1|||
143401469|NCT02542631|517018324|FG001|Overall Study|Adverse Event|1|||
143401470|NCT02542631|517018323|FG000|Overall Study|Sponsor Termination|1|||
143401471|NCT02542631|517018324|FG001|Overall Study|Sponsor Termination|0|||
143401472|NCT02542631|517018323|FG000|Overall Study|Withdrawal by Subject|11|||
143401473|NCT02542631|517018324|FG001|Overall Study|Withdrawal by Subject|16|||
143401474|NCT02542631|517018323|FG000|Overall Study|Protocol Violation|1|||
143401475|NCT02542631|517018324|FG001|Overall Study|Protocol Violation|1|||
143401476|NCT02542631|517018323|FG000|Overall Study|Physician Decision|6|||
143401477|NCT02542631|517018324|FG001|Overall Study|Physician Decision|4|||
143401478|NCT02542631|517018323|FG000|Overall Study|Lost to Follow-up|6|||
143401479|NCT02542631|517018324|FG001|Overall Study|Lost to Follow-up|5|||
143401480|NCT02542631|517018323|FG000|Overall Study|Death|1|||
143401481|NCT02542631|517018324|FG001|Overall Study|Death|2|||
143401482|NCT02542631|517018323|FG000|Overall Study|Other|2|||
143401483|NCT02542631|517018324|FG001|Overall Study|Other|1|||
143401484|NCT02542631|517018323|FG000|Overall Study|Used Prohibited Medication|2|||
143401485|NCT02542631|517018324|FG001|Overall Study|Used Prohibited Medication|1|||
143401486|NCT03334695|517018325|FG000|Overall Study|Lost to Follow-up|3|||
143401487|NCT03334695|517018326|FG001|Overall Study|Lost to Follow-up|3|||
143401488|NCT03334695|517018325|FG000|Overall Study|Physician Decision|1|||
143401489|NCT03334695|517018326|FG001|Overall Study|Physician Decision|2|||
143401490|NCT03334695|517018325|FG000|Overall Study|Protocol Violation|0|||
143401491|NCT03334695|517018326|FG001|Overall Study|Protocol Violation|1|||
143401492|NCT02641730|517018327|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
143401493|NCT02641730|517018328|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
143401494|NCT02641730|517018329|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
143401495|NCT02641730|517018330|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
143401496|NCT02641730|517018331|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
143401497|NCT02641730|517018327|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
143401498|NCT02641730|517018328|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
143401499|NCT02641730|517018329|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
143401500|NCT02641730|517018330|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
143401501|NCT02641730|517018331|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
143401502|NCT02641730|517018327|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
143401503|NCT02641730|517018328|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
143401504|NCT02641730|517018329|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
143401505|NCT02641730|517018330|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
143401506|NCT02641730|517018331|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
143401507|NCT02641730|517018327|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
143401508|NCT02641730|517018328|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
143401509|NCT02641730|517018329|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
143401510|NCT02641730|517018330|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
143401511|NCT02641730|517018331|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
143401512|NCT02641730|517018327|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
143401513|NCT02641730|517018328|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
143401514|NCT02641730|517018329|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
143401515|NCT02641730|517018330|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
143401516|NCT02641730|517018331|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
143401517|NCT02641730|517018327|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
143401518|NCT02641730|517018328|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
143401519|NCT02641730|517018329|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
143401520|NCT02641730|517018330|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
143401521|NCT02641730|517018331|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
143401522|NCT05460871|517018332|FG000|Overall Study|Withdrawal by Subject|1|||
143401523|NCT05460871|517018333|FG001|Overall Study|Withdrawal by Subject|2|||
143401524|NCT02938923|517018334|FG000|Overall Study|Death|1|||
143401525|NCT02938923|517018335|FG001|Overall Study|Death|0|||
143401526|NCT02938923|517018336|FG002|Overall Study|Death|0|||
143401527|NCT02938923|517018334|FG000|Overall Study|Physician Decision|0|||
143401528|NCT02938923|517018335|FG001|Overall Study|Physician Decision|2|||
143401529|NCT02938923|517018336|FG002|Overall Study|Physician Decision|0|||
143401530|NCT02938923|517018334|FG000|Overall Study|Withdrawal by Subject|0|||
143401531|NCT02938923|517018335|FG001|Overall Study|Withdrawal by Subject|1|||
143401532|NCT02938923|517018336|FG002|Overall Study|Withdrawal by Subject|1|||
143401533|NCT00721149|517018337|FG000|Overall Study|Physician Decision|1|||
143401534|NCT04583280|517018340|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
143401535|NCT04583280|517018341|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
143401536|NCT04614948|517018342|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
143401537|NCT04614948|517018343|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
143401538|NCT04614948|517018344|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
143401539|NCT04614948|517018342|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
143401540|NCT04614948|517018343|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
143401541|NCT04614948|517018344|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
143401542|NCT04614948|517018342|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
143401543|NCT04614948|517018343|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
143401544|NCT04614948|517018344|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
143401545|NCT04614948|517018342|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
143401546|NCT04614948|517018343|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
143401547|NCT04614948|517018344|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
143401548|NCT04614948|517018342|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
143401549|NCT04614948|517018343|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
143401550|NCT04614948|517018344|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
143401551|NCT04614948|517018342|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
143401552|NCT04614948|517018343|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
143401553|NCT04614948|517018344|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
143401554|NCT04614948|517018342|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
143401555|NCT04614948|517018343|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
143401556|NCT04614948|517018344|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
143401557|NCT04614948|517018342|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
143401558|NCT04614948|517018343|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
143401559|NCT04614948|517018344|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
143401560|NCT04614948|517018342|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
143401561|NCT04614948|517018343|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
143401562|NCT04614948|517018344|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
143401563|NCT04614948|517018342|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
143401564|NCT04614948|517018343|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
143401565|NCT04614948|517018344|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
143401566|NCT04614948|517018342|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
143401567|NCT04614948|517018343|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
143401568|NCT04614948|517018344|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
143401569|NCT04614948|517018342|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
143401570|NCT04614948|517018343|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
143401571|NCT04614948|517018344|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
143401572|NCT04614948|517018342|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
143401573|NCT04614948|517018343|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
143401574|NCT04614948|517018344|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
143401575|NCT04614948|517018342|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
143401576|NCT04614948|517018343|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
143401577|NCT04614948|517018344|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
143401578|NCT04614948|517018342|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
143401579|NCT04614948|517018343|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
143401580|NCT04614948|517018344|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
143401581|NCT04614948|517018342|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
143401582|NCT04614948|517018343|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
143401583|NCT04614948|517018344|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
143401584|NCT04614948|517018342|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
143401585|NCT04614948|517018343|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
143401586|NCT04614948|517018344|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
143401587|NCT04614948|517018342|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
143401588|NCT04614948|517018343|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
143401589|NCT04614948|517018344|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
143401590|NCT04614948|517018342|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
143401591|NCT04614948|517018343|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
143401592|NCT04614948|517018344|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
143401593|NCT04614948|517018342|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
143401594|NCT04614948|517018343|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
143401595|NCT04614948|517018344|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
143401596|NCT04614948|517018342|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
143401597|NCT04614948|517018343|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
143401598|NCT04614948|517018344|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
143401599|NCT04614948|517018342|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
143401600|NCT04614948|517018343|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
143401601|NCT04614948|517018344|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
143401602|NCT04614948|517018342|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
143401603|NCT04614948|517018343|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
143401604|NCT04614948|517018344|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
143401605|NCT01570361|517018345|FG000|Overall Study|Subject discontinued|1|||
143401606|NCT01570361|517018346|FG001|Overall Study|Subject discontinued|2|||
143401607|NCT01570361|517018345|FG000|Overall Study|Sponsor closing the study|51|||
143401608|NCT01570361|517018346|FG001|Overall Study|Sponsor closing the study|50|||
143401609|NCT01570361|517018345|FG000|Overall Study|Subject excluded|5|||
143401610|NCT01570361|517018346|FG001|Overall Study|Subject excluded|3|||
143401611|NCT01570361|517018345|FG000|Overall Study|Subject withdrew consent|14|||
143401612|NCT01570361|517018346|FG001|Overall Study|Subject withdrew consent|9|||
143401613|NCT01570361|517018345|FG000|Overall Study|Adverse Event|2|||
143401614|NCT01570361|517018346|FG001|Overall Study|Adverse Event|1|||
143401615|NCT01570361|517018345|FG000|Overall Study|Lost to Follow-up|4|||
143401616|NCT01570361|517018346|FG001|Overall Study|Lost to Follow-up|4|||
143401617|NCT01570361|517018345|FG000|Overall Study|Death|5|||
143401618|NCT01570361|517018346|FG001|Overall Study|Death|4|||
143401619|NCT01570361|517018345|FG000|Overall Study|Other|0|||
143401620|NCT01570361|517018346|FG001|Overall Study|Other|2|||
143401621|NCT05158504|517018351|FG000|Overall Study|Lost to Follow-up|2|||
143401622|NCT05158504|517018352|FG001|Overall Study|Lost to Follow-up|3|||
143401623|NCT02492711|517018353|FG000|Overall Study|Adverse Event|9|||
143401624|NCT02492711|517018354|FG001|Overall Study|Adverse Event|9|||
143401625|NCT02492711|517018355|FG002|Overall Study|Adverse Event|2|||
143401626|NCT02492711|517018353|FG000|Overall Study|Death|3|||
143401627|NCT02492711|517018354|FG001|Overall Study|Death|3|||
143401628|NCT02492711|517018355|FG002|Overall Study|Death|0|||
143401629|NCT02492711|517018353|FG000|Overall Study|Withdrawal by Subject|10|||
143401630|NCT02492711|517018354|FG001|Overall Study|Withdrawal by Subject|16|||
143401631|NCT02492711|517018355|FG002|Overall Study|Withdrawal by Subject|5|||
143401632|NCT02492711|517018353|FG000|Overall Study|Physician Decision|10|||
143401633|NCT02492711|517018354|FG001|Overall Study|Physician Decision|6|||
143401634|NCT02492711|517018355|FG002|Overall Study|Physician Decision|4|||
143401635|NCT02492711|517018353|FG000|Overall Study|Lost to Follow-up|0|||
143401636|NCT02492711|517018354|FG001|Overall Study|Lost to Follow-up|0|||
143401637|NCT02492711|517018355|FG002|Overall Study|Lost to Follow-up|1|||
143401638|NCT02492711|517018353|FG000|Overall Study|study treatment delay|2|||
143401639|NCT02492711|517018354|FG001|Overall Study|study treatment delay|1|||
143401640|NCT02492711|517018355|FG002|Overall Study|study treatment delay|0|||
143401641|NCT02492711|517018353|FG000|Overall Study|change in chemotherapy|0|||
143401642|NCT02492711|517018354|FG001|Overall Study|change in chemotherapy|1|||
143401643|NCT02492711|517018355|FG002|Overall Study|change in chemotherapy|0|||
143401644|NCT02492711|517018353|FG000|Overall Study|never treated|2|||
143401645|NCT02492711|517018354|FG001|Overall Study|never treated|4|||
143401646|NCT02492711|517018355|FG002|Overall Study|never treated|0|||
143401647|NCT02492711|517018353|FG000|Overall Study|Other|0|||
143401648|NCT02492711|517018354|FG001|Overall Study|Other|0|||
143401649|NCT02492711|517018355|FG002|Overall Study|Other|1|||
143401650|NCT03663205|517018356|FG000|Overall Study|Death|144|||
143401651|NCT03663205|517018357|FG001|Overall Study|Death|69|||
143401652|NCT03663205|517018356|FG000|Overall Study|Sponsor decision|53|||
143401653|NCT03663205|517018357|FG001|Overall Study|Sponsor decision|19|||
143401654|NCT03663205|517018356|FG000|Overall Study|Withdrawal by Subject|8|||
143401655|NCT03663205|517018357|FG001|Overall Study|Withdrawal by Subject|11|||
143401656|NCT03663205|517018356|FG000|Overall Study|Lost to Follow-up|7|||
143401657|NCT03663205|517018357|FG001|Overall Study|Lost to Follow-up|9|||
143401658|NCT03663205|517018356|FG000|Overall Study|Transferred to long term extension study|11|||
143401659|NCT03663205|517018357|FG001|Overall Study|Transferred to long term extension study|3|||
143401660|NCT01130883|517019844|FG000|Overall Study|Patient Noncompliance|6|||
143401661|NCT01130883|517019844|FG000|Overall Study|Reason Unknown|1|||
143401662|NCT01130883|517019844|FG000|Overall Study|Adverse Event|3|||
143401663|NCT02585323|517019845|FG000|Week 13 (RCT Period)|Withdrawal by Subject|2|||
143401664|NCT02585323|517019846|FG001|Week 13 (RCT Period)|Withdrawal by Subject|0|||
143401665|NCT02585323|517019845|FG000|Week 13 (RCT Period)|Participant refused assessment|0|||
143401666|NCT02585323|517019846|FG001|Week 13 (RCT Period)|Participant refused assessment|1|||
143401667|NCT02585323|517019845|FG000|Week 26 (All Received Intervention)|Withdrawal by Subject|2|||
143401668|NCT02585323|517019846|FG001|Week 26 (All Received Intervention)|Withdrawal by Subject|0|||
143401669|NCT02585323|517019845|FG000|Week 39 (All Received Intervention)|Withdrawal by Subject|2|||
143401670|NCT02585323|517019846|FG001|Week 39 (All Received Intervention)|Withdrawal by Subject|0|||
143401671|NCT01880515|517019847|FG000|Overall Study|Lost to Follow-up|3|||
143401672|NCT01880515|517019848|FG001|Overall Study|Lost to Follow-up|2|||
143401673|NCT01880515|517019847|FG000|Overall Study|Disease Progression|5|||
143401674|NCT01880515|517019848|FG001|Overall Study|Disease Progression|7|||
143401675|NCT05247034|517019849|FG000|Overall Study|Lost to Follow-up|3|||
143401676|NCT05247034|517019850|FG001|Overall Study|Lost to Follow-up|2|||
143401677|NCT05247034|517019849|FG000|Overall Study|Organizational problems when attending appointments|1|||
143401678|NCT05247034|517019850|FG001|Overall Study|Organizational problems when attending appointments|0|||
143401679|NCT03981926|517019853|FG000|Overall Study|Lost to Follow-up|5|||
143401680|NCT03981926|517019854|FG001|Overall Study|Lost to Follow-up|9|||
143401681|NCT06262347|517019855|FG000|Overall Study|Lost to Follow-up|4|||
143401682|NCT06262347|517019856|FG001|Overall Study|Lost to Follow-up|3|||
143401683|NCT06262347|517019855|FG000|Overall Study|Withdrawal by Subject|0|||
143401684|NCT06262347|517019856|FG001|Overall Study|Withdrawal by Subject|1|||
143401685|NCT05464069|517019857|FG000|Overall Study|Protocol Violation|3|||
143401686|NCT05464069|517019858|FG001|Overall Study|Protocol Violation|2|||
143401687|NCT04999111|517019861|FG000|Overall Study|Lost to Follow-up|21|||
143401688|NCT04999111|517019862|FG001|Overall Study|Lost to Follow-up|16|||
143401689|NCT04999111|517019863|FG002|Overall Study|Lost to Follow-up|2|||
143401690|NCT04999111|517019864|FG003|Overall Study|Lost to Follow-up|26|||
143401691|NCT04999111|517019865|FG004|Overall Study|Lost to Follow-up|30|||
143401692|NCT04999111|517019866|FG005|Overall Study|Lost to Follow-up|6|||
143401693|NCT04999111|517019861|FG000|Overall Study|Physician Decision|1|||
143401694|NCT04999111|517019862|FG001|Overall Study|Physician Decision|3|||
143401695|NCT04999111|517019863|FG002|Overall Study|Physician Decision|0|||
143401696|NCT04999111|517019864|FG003|Overall Study|Physician Decision|1|||
143401697|NCT04999111|517019865|FG004|Overall Study|Physician Decision|2|||
143401698|NCT04999111|517019866|FG005|Overall Study|Physician Decision|0|||
143401699|NCT04999111|517019861|FG000|Overall Study|Withdrawal by Subject|23|||
143401700|NCT04999111|517019862|FG001|Overall Study|Withdrawal by Subject|29|||
143401701|NCT04999111|517019863|FG002|Overall Study|Withdrawal by Subject|15|||
143401702|NCT04999111|517019864|FG003|Overall Study|Withdrawal by Subject|30|||
143401703|NCT04999111|517019865|FG004|Overall Study|Withdrawal by Subject|35|||
143401704|NCT04999111|517019866|FG005|Overall Study|Withdrawal by Subject|10|||
143401705|NCT04999111|517019861|FG000|Overall Study|Other|6|||
143401706|NCT04999111|517019862|FG001|Overall Study|Other|6|||
143401707|NCT04999111|517019863|FG002|Overall Study|Other|3|||
143401708|NCT04999111|517019864|FG003|Overall Study|Other|8|||
143401709|NCT04999111|517019865|FG004|Overall Study|Other|8|||
143401710|NCT04999111|517019866|FG005|Overall Study|Other|5|||
143401711|NCT04999111|517019861|FG000|Overall Study|Non-compliance with study schedule|1|||
143401712|NCT04999111|517019862|FG001|Overall Study|Non-compliance with study schedule|0|||
143401713|NCT04999111|517019863|FG002|Overall Study|Non-compliance with study schedule|0|||
143401714|NCT04999111|517019864|FG003|Overall Study|Non-compliance with study schedule|1|||
143401715|NCT04999111|517019865|FG004|Overall Study|Non-compliance with study schedule|1|||
143401716|NCT04999111|517019866|FG005|Overall Study|Non-compliance with study schedule|1|||
143401717|NCT04999111|517019861|FG000|Overall Study|Randomized but not vaccinated|1|||
143401718|NCT04999111|517019862|FG001|Overall Study|Randomized but not vaccinated|2|||
143401719|NCT04999111|517019863|FG002|Overall Study|Randomized but not vaccinated|0|||
143401720|NCT04999111|517019864|FG003|Overall Study|Randomized but not vaccinated|3|||
143401721|NCT04999111|517019865|FG004|Overall Study|Randomized but not vaccinated|3|||
143401722|NCT04999111|517019866|FG005|Overall Study|Randomized but not vaccinated|0|||
143401723|NCT04999111|517019861|FG000|Overall Study|Adverse Event|1|||
143401724|NCT04999111|517019862|FG001|Overall Study|Adverse Event|1|||
143401725|NCT04999111|517019863|FG002|Overall Study|Adverse Event|0|||
143401726|NCT04999111|517019864|FG003|Overall Study|Adverse Event|0|||
143401727|NCT04999111|517019865|FG004|Overall Study|Adverse Event|0|||
143401728|NCT04999111|517019866|FG005|Overall Study|Adverse Event|0|||
143401729|NCT04999111|517019861|FG000|Overall Study|Initiated prohibited medication|0|||
143401730|NCT04999111|517019862|FG001|Overall Study|Initiated prohibited medication|0|||
143401731|NCT04999111|517019863|FG002|Overall Study|Initiated prohibited medication|0|||
143401732|NCT04999111|517019864|FG003|Overall Study|Initiated prohibited medication|0|||
143401733|NCT04999111|517019865|FG004|Overall Study|Initiated prohibited medication|1|||
143401734|NCT04999111|517019866|FG005|Overall Study|Initiated prohibited medication|0|||
143401735|NCT05424380|517019876|FG000|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|1|||
143401736|NCT05424380|517019877|FG001|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
143401737|NCT05424380|517019878|FG002|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
143401738|NCT05424380|517019879|FG003|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
143401739|NCT05424380|517019880|FG004|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
143401740|NCT05424380|517019881|FG005|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
143401741|NCT05424380|517019876|FG000|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|1|||
143401742|NCT05424380|517019877|FG001|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
143401743|NCT05424380|517019878|FG002|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
143401744|NCT05424380|517019879|FG003|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
143401745|NCT05424380|517019880|FG004|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
143401746|NCT05424380|517019881|FG005|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
143401747|NCT05424380|517019876|FG000|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|1|||
143401748|NCT05424380|517019877|FG001|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
143401749|NCT05424380|517019878|FG002|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
143401750|NCT05424380|517019879|FG003|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
143401751|NCT05424380|517019880|FG004|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
143401752|NCT05424380|517019881|FG005|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
143401753|NCT05424380|517019876|FG000|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
143401754|NCT05424380|517019877|FG001|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|1|||
143401755|NCT05424380|517019878|FG002|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
143401756|NCT05424380|517019879|FG003|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
143401757|NCT05424380|517019880|FG004|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
143401758|NCT05424380|517019881|FG005|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
143401759|NCT05424380|517019876|FG000|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
143401760|NCT05424380|517019877|FG001|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|1|||
143401761|NCT05424380|517019878|FG002|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
143401762|NCT05424380|517019879|FG003|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
143401763|NCT05424380|517019880|FG004|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
143401764|NCT05424380|517019881|FG005|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
143401765|NCT05424380|517019876|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
143401766|NCT05424380|517019877|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
143401767|NCT05424380|517019878|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|1|||
143401768|NCT05424380|517019879|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
143401769|NCT05424380|517019880|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
143401770|NCT05424380|517019881|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
143401771|NCT05424380|517019876|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
143401772|NCT05424380|517019877|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
143401773|NCT05424380|517019878|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|1|||
143401774|NCT05424380|517019879|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
143401775|NCT05424380|517019880|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
143401776|NCT05424380|517019881|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
143401777|NCT05424380|517019876|FG000|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
143401778|NCT05424380|517019877|FG001|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
143401779|NCT05424380|517019878|FG002|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|1|||
143401780|NCT05424380|517019879|FG003|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
143401781|NCT05424380|517019880|FG004|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
143401782|NCT05424380|517019881|FG005|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
143401783|NCT05424380|517019876|FG000|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
143401784|NCT05424380|517019877|FG001|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
143401785|NCT05424380|517019878|FG002|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
143401786|NCT05424380|517019879|FG003|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|1|||
143401787|NCT05424380|517019880|FG004|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
143401788|NCT05424380|517019881|FG005|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
143401789|NCT05424380|517019876|FG000|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
143401790|NCT05424380|517019877|FG001|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
143401791|NCT05424380|517019878|FG002|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
143401792|NCT05424380|517019879|FG003|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|1|||
143401793|NCT05424380|517019880|FG004|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
143401794|NCT05424380|517019881|FG005|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
143401795|NCT05424380|517019876|FG000|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
143401796|NCT05424380|517019877|FG001|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
143401797|NCT05424380|517019878|FG002|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
143401798|NCT05424380|517019879|FG003|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|1|||
143401799|NCT05424380|517019880|FG004|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
143401800|NCT05424380|517019881|FG005|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
143401801|NCT05424380|517019876|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
143401802|NCT05424380|517019877|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
143401803|NCT05424380|517019878|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
143401804|NCT05424380|517019879|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
143401805|NCT05424380|517019880|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|3|||
143401806|NCT05424380|517019881|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
143401807|NCT05424380|517019876|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
143401808|NCT05424380|517019877|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
143401809|NCT05424380|517019878|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
143401810|NCT05424380|517019879|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
143401811|NCT05424380|517019880|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|1|||
143401812|NCT05424380|517019881|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
143401813|NCT05424380|517019876|FG000|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
143401814|NCT05424380|517019877|FG001|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
143401815|NCT05424380|517019878|FG002|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
143401816|NCT05424380|517019879|FG003|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
143401817|NCT05424380|517019880|FG004|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|1|||
143401818|NCT05424380|517019881|FG005|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
143401819|NCT03015532|517019882|FG000|Overall Study|Adverse Event|0|||
143401820|NCT03015532|517019883|FG001|Overall Study|Adverse Event|0|||
143401821|NCT03015532|517019884|FG002|Overall Study|Adverse Event|0|||
143401822|NCT03015532|517019885|FG003|Overall Study|Adverse Event|0|||
143401823|NCT03015532|517019886|FG004|Overall Study|Adverse Event|0|||
143401824|NCT03015532|517019887|FG005|Overall Study|Adverse Event|2|||
143401825|NCT03015532|517019888|FG006|Overall Study|Adverse Event|1|||
143401826|NCT03015532|517019889|FG007|Overall Study|Adverse Event|0|||
143401827|NCT03015532|517019882|FG000|Overall Study|Withdrawal by Subject|0|||
143401828|NCT03015532|517019883|FG001|Overall Study|Withdrawal by Subject|0|||
143401829|NCT03015532|517019884|FG002|Overall Study|Withdrawal by Subject|0|||
143401830|NCT03015532|517019885|FG003|Overall Study|Withdrawal by Subject|0|||
143401831|NCT03015532|517019886|FG004|Overall Study|Withdrawal by Subject|0|||
143401832|NCT03015532|517019887|FG005|Overall Study|Withdrawal by Subject|0|||
143401833|NCT03015532|517019888|FG006|Overall Study|Withdrawal by Subject|1|||
143401834|NCT03015532|517019889|FG007|Overall Study|Withdrawal by Subject|0|||
143401835|NCT04629339|517019890|FG000|Overall Study|Death|1|||
143401836|NCT04629339|517019891|FG001|Overall Study|Death|0|||
143401837|NCT04629339|517019892|FG002|Overall Study|Death|2|||
143401838|NCT04629339|517019893|FG003|Overall Study|Death|2|||
143401839|NCT04629339|517019894|FG004|Overall Study|Death|0|||
143401840|NCT04629339|517019890|FG000|Overall Study|Disease Progression|0|||
143401841|NCT04629339|517019891|FG001|Overall Study|Disease Progression|0|||
143401842|NCT04629339|517019892|FG002|Overall Study|Disease Progression|1|||
143401843|NCT04629339|517019893|FG003|Overall Study|Disease Progression|1|||
143401844|NCT04629339|517019894|FG004|Overall Study|Disease Progression|0|||
143401845|NCT04629339|517019890|FG000|Overall Study|Lost to Follow-up|0|||
143401846|NCT04629339|517019891|FG001|Overall Study|Lost to Follow-up|0|||
143401847|NCT04629339|517019892|FG002|Overall Study|Lost to Follow-up|0|||
143401848|NCT04629339|517019893|FG003|Overall Study|Lost to Follow-up|1|||
143401849|NCT04629339|517019894|FG004|Overall Study|Lost to Follow-up|0|||
143401850|NCT04629339|517019890|FG000|Overall Study|Physician Decision|0|||
143401851|NCT04629339|517019891|FG001|Overall Study|Physician Decision|1|||
143401852|NCT04629339|517019892|FG002|Overall Study|Physician Decision|0|||
143401853|NCT04629339|517019893|FG003|Overall Study|Physician Decision|0|||
143401854|NCT04629339|517019894|FG004|Overall Study|Physician Decision|0|||
143401855|NCT04629339|517019890|FG000|Overall Study|Study Terminated by Sponsor|0|||
143401856|NCT04629339|517019891|FG001|Overall Study|Study Terminated by Sponsor|0|||
143401857|NCT04629339|517019892|FG002|Overall Study|Study Terminated by Sponsor|0|||
143401858|NCT04629339|517019893|FG003|Overall Study|Study Terminated by Sponsor|1|||
143401859|NCT04629339|517019894|FG004|Overall Study|Study Terminated by Sponsor|0|||
143401860|NCT04629339|517019890|FG000|Overall Study|Withdrawal by Subject|0|||
143401861|NCT04629339|517019891|FG001|Overall Study|Withdrawal by Subject|0|||
143401862|NCT04629339|517019892|FG002|Overall Study|Withdrawal by Subject|2|||
143401863|NCT04629339|517019893|FG003|Overall Study|Withdrawal by Subject|2|||
143401864|NCT04629339|517019894|FG004|Overall Study|Withdrawal by Subject|0|||
143401865|NCT03914469|517019895|FG000|Overall Study|Lost to Follow-up|1|||
143401866|NCT03914469|517019896|FG001|Overall Study|Lost to Follow-up|4|||
143401867|NCT04778410|517019897|FG000|Safety Run-in Period|Death|5|||
143401868|NCT04778410|517019898|FG001|Safety Run-in Period|Death|6|||
143401869|NCT04778410|517019899|FG002|Safety Run-in Period|Death|0|||
143401870|NCT04778410|517019900|FG003|Safety Run-in Period|Death|0|||
143401871|NCT04778410|517019901|FG004|Safety Run-in Period|Death|0|||
143401872|NCT04778410|517019902|FG005|Safety Run-in Period|Death|0|||
143401873|NCT04778410|517019897|FG000|Phase 2 Period|Death|0|||
143401874|NCT04778410|517019898|FG001|Phase 2 Period|Death|0|||
143401875|NCT04778410|517019899|FG002|Phase 2 Period|Death|0|||
143401876|NCT04778410|517019900|FG003|Phase 2 Period|Death|5|||
143401877|NCT04778410|517019901|FG004|Phase 2 Period|Death|18|||
143401878|NCT04778410|517019902|FG005|Phase 2 Period|Death|0|||
143401879|NCT04778410|517019897|FG000|Phase 2 Period|Lost to Follow-up|0|||
143401880|NCT04778410|517019898|FG001|Phase 2 Period|Lost to Follow-up|0|||
143401881|NCT04778410|517019899|FG002|Phase 2 Period|Lost to Follow-up|0|||
143401882|NCT04778410|517019900|FG003|Phase 2 Period|Lost to Follow-up|1|||
143401883|NCT04778410|517019901|FG004|Phase 2 Period|Lost to Follow-up|1|||
143401884|NCT04778410|517019902|FG005|Phase 2 Period|Lost to Follow-up|0|||
143401885|NCT04778410|517019897|FG000|Phase 2 Period|Study Terminated By Sponsor|0|||
143401886|NCT04778410|517019898|FG001|Phase 2 Period|Study Terminated By Sponsor|0|||
143401887|NCT04778410|517019899|FG002|Phase 2 Period|Study Terminated By Sponsor|0|||
143401888|NCT04778410|517019900|FG003|Phase 2 Period|Study Terminated By Sponsor|1|||
143401889|NCT04778410|517019901|FG004|Phase 2 Period|Study Terminated By Sponsor|0|||
143401890|NCT04778410|517019902|FG005|Phase 2 Period|Study Terminated By Sponsor|0|||
143401891|NCT04778410|517019897|FG000|Phase 2 Period|Withdrew Consent|0|||
143401892|NCT04778410|517019898|FG001|Phase 2 Period|Withdrew Consent|0|||
143401893|NCT04778410|517019899|FG002|Phase 2 Period|Withdrew Consent|0|||
143401894|NCT04778410|517019900|FG003|Phase 2 Period|Withdrew Consent|0|||
143401895|NCT04778410|517019901|FG004|Phase 2 Period|Withdrew Consent|2|||
143401896|NCT04778410|517019902|FG005|Phase 2 Period|Withdrew Consent|0|||
143401897|NCT01121588|517019903|FG000|Overall Study|Death|5|||
143401898|NCT01121588|517019904|FG001|Overall Study|Death|3|||
143401899|NCT01121588|517019905|FG002|Overall Study|Death|13|||
143401900|NCT01121588|517019903|FG000|Overall Study|Study Terminated by Sponsor|1|||
143401901|NCT01121588|517019904|FG001|Overall Study|Study Terminated by Sponsor|1|||
143401902|NCT01121588|517019905|FG002|Overall Study|Study Terminated by Sponsor|0|||
143401903|NCT01121588|517019903|FG000|Overall Study|Participant Refused Further Followup|2|||
143401904|NCT01121588|517019904|FG001|Overall Study|Participant Refused Further Followup|0|||
143401905|NCT01121588|517019905|FG002|Overall Study|Participant Refused Further Followup|2|||
143401906|NCT01121588|517019903|FG000|Overall Study|Lost to Follow-up|0|||
143401907|NCT01121588|517019904|FG001|Overall Study|Lost to Follow-up|1|||
143401908|NCT01121588|517019905|FG002|Overall Study|Lost to Follow-up|1|||
143401909|NCT01121588|517019903|FG000|Overall Study|Non-Specified Reasons|9|||
143401910|NCT01121588|517019904|FG001|Overall Study|Non-Specified Reasons|4|||
143401911|NCT01121588|517019905|FG002|Overall Study|Non-Specified Reasons|2|||
143401912|NCT02944968|517019908|FG000|Overall Study|Subject excluded before study procedure|1|||
143401913|NCT02944968|517019908|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
143401914|NCT04633538|517019913|FG000|Overall Study|Death|1|||
143401915|NCT04633538|517019913|FG000|Overall Study|Lost to Follow-up|3|||
143401916|NCT04633538|517019913|FG000|Overall Study|Withdrawal by Subject|1|||
143401917|NCT02938520|517019914|FG000|Overall Study|On-going at the time of analysis|258|||
143401918|NCT02938520|517019915|FG001|Overall Study|On-going at the time of analysis|261|||
143401919|NCT02938520|517019914|FG000|Overall Study|Physician Decision|2|||
143401920|NCT02938520|517019915|FG001|Overall Study|Physician Decision|5|||
143401921|NCT02938520|517019914|FG000|Overall Study|Lost to Follow-up|2|||
143401922|NCT02938520|517019915|FG001|Overall Study|Lost to Follow-up|2|||
143401923|NCT02938520|517019914|FG000|Overall Study|Withdrawal by Subject|7|||
143401924|NCT02938520|517019915|FG001|Overall Study|Withdrawal by Subject|7|||
143401925|NCT02938520|517019914|FG000|Overall Study|Protocol Violation|0|||
143401926|NCT02938520|517019915|FG001|Overall Study|Protocol Violation|1|||
143401927|NCT02938520|517019914|FG000|Overall Study|Lack of Efficacy|5|||
143401928|NCT02938520|517019915|FG001|Overall Study|Lack of Efficacy|3|||
143401929|NCT02938520|517019914|FG000|Overall Study|Adverse Event|9|||
143401930|NCT02938520|517019915|FG001|Overall Study|Adverse Event|4|||
143401931|NCT03245840|517019916|FG000|Overall Study|Adverse Event|6|||
143401932|NCT03245840|517019917|FG001|Overall Study|Adverse Event|0|||
143401933|NCT03245840|517019916|FG000|Overall Study|Death|2|||
143401934|NCT03245840|517019917|FG001|Overall Study|Death|0|||
143401935|NCT03245840|517019916|FG000|Overall Study|Withdrawal by Subject|31|||
143401936|NCT03245840|517019917|FG001|Overall Study|Withdrawal by Subject|1|||
143401937|NCT03245840|517019916|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
143401938|NCT03245840|517019917|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
143401939|NCT03245840|517019916|FG000|Overall Study|Physician Decision|4|||
143401940|NCT03245840|517019917|FG001|Overall Study|Physician Decision|1|||
143401941|NCT03245840|517019916|FG000|Overall Study|Study Terminated by Sponsor|56|||
143401942|NCT03245840|517019917|FG001|Overall Study|Study Terminated by Sponsor|6|||
143401943|NCT03245840|517019916|FG000|Overall Study|Site Terminated by Sponsor|4|||
143401944|NCT03245840|517019917|FG001|Overall Study|Site Terminated by Sponsor|0|||
143401945|NCT03245840|517019916|FG000|Overall Study|Lost to Follow-up|12|||
143401946|NCT03245840|517019917|FG001|Overall Study|Lost to Follow-up|2|||
143401947|NCT03245840|517019916|FG000|Overall Study|Pregnancy|2|||
143401948|NCT03245840|517019917|FG001|Overall Study|Pregnancy|0|||
143401949|NCT03245840|517019916|FG000|Overall Study|Non-Compliance with Study Drug|2|||
143401950|NCT03245840|517019917|FG001|Overall Study|Non-Compliance with Study Drug|0|||
143401951|NCT03245840|517019916|FG000|Overall Study|Not treated|1|||
143401952|NCT03245840|517019917|FG001|Overall Study|Not treated|1|||
143401953|NCT05953740|517019926|FG000|Period 1|Physician Decision|0|||
143401954|NCT05953740|517019927|FG001|Period 1|Physician Decision|1|||
143401955|NCT05953740|517019928|FG002|Period 1|Physician Decision|0|||
143401956|NCT05953740|517019929|FG003|Period 1|Physician Decision|0|||
143401957|NCT05953740|517019930|FG004|Period 1|Physician Decision|0|||
143401958|NCT05953740|517019931|FG005|Period 1|Physician Decision|0|||
143401959|NCT05953740|517019932|FG006|Period 1|Physician Decision|0|||
143401960|NCT05953740|517019933|FG007|Period 1|Physician Decision|0|||
143401961|NCT05953740|517019926|FG000|Period 2|Withdrawal by Subject|0|||
143401962|NCT05953740|517019927|FG001|Period 2|Withdrawal by Subject|1|||
143401963|NCT05953740|517019928|FG002|Period 2|Withdrawal by Subject|1|||
143401964|NCT05953740|517019929|FG003|Period 2|Withdrawal by Subject|0|||
143401965|NCT05953740|517019930|FG004|Period 2|Withdrawal by Subject|0|||
143401966|NCT05953740|517019931|FG005|Period 2|Withdrawal by Subject|0|||
143401967|NCT05953740|517019932|FG006|Period 2|Withdrawal by Subject|0|||
143401968|NCT05953740|517019933|FG007|Period 2|Withdrawal by Subject|0|||
143401969|NCT04206787|517019934|FG000|Overall Study|Other than listed|2|||
143401970|NCT04206787|517019934|FG000|Overall Study|Investigator decision|1|||
143401971|NCT04206787|517019934|FG000|Overall Study|Death|25|||
143401972|NCT04206787|517019934|FG000|Overall Study|Lost to Follow-up|9|||
143401973|NCT04206787|517019934|FG000|Overall Study|Withdrawal of consent|9|||
143401974|NCT04505410|517019938|FG000|Overall Study|Adverse Event|2|||
143401975|NCT04505410|517019939|FG001|Overall Study|Adverse Event|0|||
143401976|NCT04505410|517019938|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
143401977|NCT04505410|517019939|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
143401978|NCT04505410|517019938|FG000|Overall Study|did not want to follow diet|1|||
143401979|NCT04505410|517019939|FG001|Overall Study|did not want to follow diet|0|||
143401980|NCT04505410|517019938|FG000|Overall Study|flare up of ulcerative colitis|0|||
143401981|NCT04505410|517019939|FG001|Overall Study|flare up of ulcerative colitis|1|||
143401982|NCT04505410|517019938|FG000|Overall Study|Lost to Follow-up|0|||
143401983|NCT04505410|517019939|FG001|Overall Study|Lost to Follow-up|2|||
143401984|NCT04505410|517019938|FG000|Overall Study|Lost to Follow-up|1|||
143401985|NCT04505410|517019939|FG001|Overall Study|Lost to Follow-up|0|||
143401986|NCT04505410|517019938|FG000|Overall Study|initiated another diet on their own|0|||
143401987|NCT04505410|517019939|FG001|Overall Study|initiated another diet on their own|2|||
143401988|NCT05507437|517021483|FG000|Overall Study|Withdrawal by Subject|1|||
143401989|NCT05507437|517021484|FG001|Overall Study|Withdrawal by Subject|1|||
143401990|NCT05507437|517021483|FG000|Overall Study|Death|3|||
143401991|NCT05507437|517021484|FG001|Overall Study|Death|0|||
143401992|NCT01064440|517021485|FG000|Overall Study|Lost to Follow-up|1|||
143401993|NCT01064440|517021486|FG001|Overall Study|Lost to Follow-up|1|||
143401994|NCT01064440|517021487|FG002|Overall Study|Lost to Follow-up|1|||
143401995|NCT01064440|517021485|FG000|Overall Study|Non-compliance|0|||
143401996|NCT01064440|517021486|FG001|Overall Study|Non-compliance|1|||
143401997|NCT01064440|517021487|FG002|Overall Study|Non-compliance|0|||
143401998|NCT01064440|517021485|FG000|Overall Study|Death|1|||
143401999|NCT01064440|517021486|FG001|Overall Study|Death|0|||
143402000|NCT01064440|517021487|FG002|Overall Study|Death|1|||
143402001|NCT01064440|517021485|FG000|Overall Study|Withdrawal by Subject|0|||
143402002|NCT01064440|517021486|FG001|Overall Study|Withdrawal by Subject|1|||
143402003|NCT01064440|517021487|FG002|Overall Study|Withdrawal by Subject|1|||
143402004|NCT01064440|517021485|FG000|Overall Study|Other: amputation|1|||
143402005|NCT01064440|517021486|FG001|Overall Study|Other: amputation|0|||
143402006|NCT01064440|517021487|FG002|Overall Study|Other: amputation|0|||
143402007|NCT03972150|517021489|FG000|Overall Study|Adverse Event|0|||
143402008|NCT03972150|517021490|FG001|Overall Study|Adverse Event|1|||
143402009|NCT03972150|517021491|FG002|Overall Study|Adverse Event|1|||
143402010|NCT03972150|517021492|FG003|Overall Study|Adverse Event|0|||
143402011|NCT03972150|517021493|FG004|Overall Study|Adverse Event|0|||
143402012|NCT03972150|517021489|FG000|Overall Study|Progressive disease|3|||
143402013|NCT03972150|517021490|FG001|Overall Study|Progressive disease|5|||
143402014|NCT03972150|517021491|FG002|Overall Study|Progressive disease|2|||
143402015|NCT03972150|517021492|FG003|Overall Study|Progressive disease|2|||
143402016|NCT03972150|517021493|FG004|Overall Study|Progressive disease|3|||
143402017|NCT03505710|517021494|FG000|Overall Study|Progressive Disease|24|||
143402018|NCT03505710|517021495|FG001|Overall Study|Progressive Disease|17|||
143402019|NCT03505710|517021496|FG002|Overall Study|Progressive Disease|43|||
143402020|NCT03505710|517021494|FG000|Overall Study|Clinical Progression|6|||
143402021|NCT03505710|517021495|FG001|Overall Study|Clinical Progression|8|||
143402022|NCT03505710|517021496|FG002|Overall Study|Clinical Progression|3|||
143402023|NCT03505710|517021494|FG000|Overall Study|Adverse Event|12|||
143402024|NCT03505710|517021495|FG001|Overall Study|Adverse Event|6|||
143402025|NCT03505710|517021496|FG002|Overall Study|Adverse Event|28|||
143402026|NCT03505710|517021494|FG000|Overall Study|Withdrawal by Subject|1|||
143402027|NCT03505710|517021495|FG001|Overall Study|Withdrawal by Subject|3|||
143402028|NCT03505710|517021496|FG002|Overall Study|Withdrawal by Subject|7|||
143402029|NCT03505710|517021494|FG000|Overall Study|Physician Decision|1|||
143402030|NCT03505710|517021495|FG001|Overall Study|Physician Decision|1|||
143402031|NCT03505710|517021496|FG002|Overall Study|Physician Decision|2|||
143402032|NCT03505710|517021494|FG000|Overall Study|Death|4|||
143402033|NCT03505710|517021495|FG001|Overall Study|Death|5|||
143402034|NCT03505710|517021496|FG002|Overall Study|Death|6|||
143402035|NCT03505710|517021494|FG000|Overall Study|Other Reasons|1|||
143402036|NCT03505710|517021495|FG001|Overall Study|Other Reasons|1|||
143402037|NCT03505710|517021496|FG002|Overall Study|Other Reasons|1|||
143402038|NCT03505710|517021494|FG000|Overall Study|Study Terminated by Sponsor|0|||
143402039|NCT03505710|517021495|FG001|Overall Study|Study Terminated by Sponsor|0|||
143402040|NCT03505710|517021496|FG002|Overall Study|Study Terminated by Sponsor|1|||
143402041|NCT04389957|517021509|FG000|Overall Study|Providers without data in the post intervention timeframe.|7|||
143402042|NCT04389957|517021510|FG001|Overall Study|Providers without data in the post intervention timeframe.|7|||
143402043|NCT04389957|517021511|FG002|Overall Study|Providers without data in the post intervention timeframe.|12|||
143402044|NCT04389957|517021512|FG003|Overall Study|Providers without data in the post intervention timeframe.|20|||
143402045|NCT04389957|517021513|FG004|Overall Study|Providers without data in the post intervention timeframe.|7|||
143402046|NCT05552508|517021514|FG000|Overall Study|Adverse Event|3|||
143402047|NCT03571386|517021515|FG000|Overall Study|scheduling conflict|4|||
143402048|NCT03571386|517021516|FG001|Overall Study|scheduling conflict|0|||
143402049|NCT03571386|517021515|FG000|Overall Study|Withdrawal by Subject|15|||
143402050|NCT03571386|517021516|FG001|Overall Study|Withdrawal by Subject|5|||
143402051|NCT04605159|517021517|FG000|Overall Study|Adverse Event|6|||
143402052|NCT04605159|517021518|FG001|Overall Study|Adverse Event|3|||
143402053|NCT04605159|517021519|FG002|Overall Study|Adverse Event|21|||
143402054|NCT04605159|517021520|FG003|Overall Study|Adverse Event|4|||
143402055|NCT04605159|517021517|FG000|Overall Study|Lost to Follow-up|74|||
143402056|NCT04605159|517021518|FG001|Overall Study|Lost to Follow-up|45|||
143402057|NCT04605159|517021519|FG002|Overall Study|Lost to Follow-up|119|||
143402058|NCT04605159|517021520|FG003|Overall Study|Lost to Follow-up|80|||
143402059|NCT04605159|517021517|FG000|Overall Study|Protocol Violation|4|||
143402060|NCT04605159|517021518|FG001|Overall Study|Protocol Violation|5|||
143402061|NCT04605159|517021519|FG002|Overall Study|Protocol Violation|2|||
143402062|NCT04605159|517021520|FG003|Overall Study|Protocol Violation|0|||
143402063|NCT04605159|517021517|FG000|Overall Study|Withdrawal by Subject|66|||
143402064|NCT04605159|517021518|FG001|Overall Study|Withdrawal by Subject|37|||
143402065|NCT04605159|517021519|FG002|Overall Study|Withdrawal by Subject|68|||
143402066|NCT04605159|517021520|FG003|Overall Study|Withdrawal by Subject|50|||
143402067|NCT04605159|517021517|FG000|Overall Study|Migrated / moved from the study area|32|||
143402068|NCT04605159|517021518|FG001|Overall Study|Migrated / moved from the study area|22|||
143402069|NCT04605159|517021519|FG002|Overall Study|Migrated / moved from the study area|41|||
143402070|NCT04605159|517021520|FG003|Overall Study|Migrated / moved from the study area|21|||
143402071|NCT04605159|517021517|FG000|Overall Study|Other|1|||
143402072|NCT04605159|517021518|FG001|Overall Study|Other|2|||
143402073|NCT04605159|517021519|FG002|Overall Study|Other|7|||
143402074|NCT04605159|517021520|FG003|Overall Study|Other|3|||
143402075|NCT02278211|517021521|FG000|Overall Study|Unable to analyse PET scan|2|||
143402076|NCT03858517|517021528|FG000|Overall Study|Adverse Event|1|||
143402077|NCT03858517|517021528|FG000|Overall Study|Lost to Follow-up|1|||
143402078|NCT03858517|517021528|FG000|Overall Study|removed for being incarcerated|1|||
143402079|NCT03858517|517021528|FG000|Overall Study|Sponsor Closure|48|||
143402080|NCT06037668|517021531|FG000|Overall Study|Lost to Follow-up|1|||
143402081|NCT06037668|517021532|FG001|Overall Study|Lost to Follow-up|1|||
143402082|NCT06037668|517021531|FG000|Overall Study|Protocol Violation|1|||
143402083|NCT06037668|517021532|FG001|Overall Study|Protocol Violation|0|||
143402084|NCT06037668|517021531|FG000|Overall Study|Withdrawal by Subject|1|||
143402085|NCT06037668|517021532|FG001|Overall Study|Withdrawal by Subject|0|||
143402086|NCT06037668|517021531|FG000|Overall Study|Other Study Discontinuation Reason|1|||
143402087|NCT06037668|517021532|FG001|Overall Study|Other Study Discontinuation Reason|0|||
143402088|NCT05224544|517021533|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
143402089|NCT05224544|517021534|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
143402090|NCT04804540|517021535|FG000|Overall Study|Adverse Event|26|||
143402091|NCT04804540|517021536|FG001|Overall Study|Adverse Event|13|||
143402092|NCT05172232|517021537|FG000|Overall Study|Lost to Follow-up|3|||
143402093|NCT01828021|517021538|FG000|Overall Study|Adverse Event|5|||
143402094|NCT01828021|517021538|FG000|Overall Study|Lack of Efficacy|17|||
143402095|NCT01828021|517021538|FG000|Overall Study|Withdrawal by Subject|2|||
143402096|NCT01828021|517021538|FG000|Overall Study|Ileal obstruction, unrelated|1|||
143402097|NCT00844415|517021539|FG000|Overall Study|Withdrawal by Subject|1|||
143402098|NCT04881461|517021541|FG000|Overall Study|Adverse Event|2|||
143402099|NCT04881461|517021542|FG001|Overall Study|Adverse Event|4|||
143402100|NCT04881461|517021541|FG000|Overall Study|Withdrawal by Subject|19|||
143402101|NCT04881461|517021542|FG001|Overall Study|Withdrawal by Subject|19|||
143402102|NCT04881461|517021541|FG000|Overall Study|Lost to Follow-up|4|||
143402103|NCT04881461|517021542|FG001|Overall Study|Lost to Follow-up|4|||
143402104|NCT04881461|517021541|FG000|Overall Study|Lack of Efficacy|1|||
143402105|NCT04881461|517021542|FG001|Overall Study|Lack of Efficacy|0|||
143402106|NCT04881461|517021541|FG000|Overall Study|"Reason stated as other in CRF"|1|||
143402107|NCT04881461|517021542|FG001|Overall Study|"Reason stated as other in CRF"|2|||
143402108|NCT04084574|517021548|FG000|Overall Study|Lost to Follow-up|1|||
143402109|NCT04084574|517021549|FG001|Overall Study|Lost to Follow-up|0|||
143402110|NCT04084574|517021548|FG000|Overall Study|Physician Decision|1|||
143402111|NCT04084574|517021549|FG001|Overall Study|Physician Decision|0|||
143402112|NCT04084574|517021548|FG000|Overall Study|Relocated out of state|1|||
143402113|NCT04084574|517021549|FG001|Overall Study|Relocated out of state|0|||
143402114|NCT02874742|517021550|FG000|Overall Study|Death|0|||
143402115|NCT02874742|517021551|FG001|Overall Study|Death|1|||
143402116|NCT02874742|517021552|FG002|Overall Study|Death|0|||
143402117|NCT02874742|517021550|FG000|Overall Study|Lost to Follow-up|5|||
143402118|NCT02874742|517021551|FG001|Overall Study|Lost to Follow-up|4|||
143402119|NCT02874742|517021552|FG002|Overall Study|Lost to Follow-up|1|||
143402120|NCT02874742|517021550|FG000|Overall Study|Withdrawal by Subject|17|||
143402121|NCT02874742|517021551|FG001|Overall Study|Withdrawal by Subject|8|||
143402122|NCT02874742|517021552|FG002|Overall Study|Withdrawal by Subject|0|||
143402123|NCT02874742|517021550|FG000|Overall Study|Other|4|||
143402124|NCT02874742|517021551|FG001|Overall Study|Other|1|||
143402125|NCT02874742|517021552|FG002|Overall Study|Other|0|||
143402126|NCT02874742|517021550|FG000|Overall Study|Progressive Disease|1|||
143402127|NCT02874742|517021551|FG001|Overall Study|Progressive Disease|0|||
143402128|NCT02874742|517021552|FG002|Overall Study|Progressive Disease|0|||
143402129|NCT02874742|517021550|FG000|Overall Study|Screen Failure|0|||
143402130|NCT02874742|517021551|FG001|Overall Study|Screen Failure|2|||
143402131|NCT02874742|517021552|FG002|Overall Study|Screen Failure|0|||
143402132|NCT00964392|517021555|FG000|Overall Study|Withdrawal by Subject|4|||
143402133|NCT00964392|517021556|FG001|Overall Study|Withdrawal by Subject|6|||
143402134|NCT00964392|517021555|FG000|Overall Study|Lost to Follow-up|4|||
143402135|NCT00964392|517021556|FG001|Overall Study|Lost to Follow-up|10|||
143402136|NCT00964392|517021555|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
143402137|NCT00964392|517021556|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
143402138|NCT00964392|517021555|FG000|Overall Study|Not completed|44|||
143402139|NCT00964392|517021556|FG001|Overall Study|Not completed|168|||
143402140|NCT02577354|517021559|FG000|Overall Study|Lack of Efficacy|4|||
143402141|NCT02577354|517021560|FG001|Overall Study|Lack of Efficacy|4|||
143402142|NCT02577354|517021559|FG000|Overall Study|Lost to Follow-up|3|||
143402143|NCT02577354|517021560|FG001|Overall Study|Lost to Follow-up|1|||
143402144|NCT02577354|517021559|FG000|Overall Study|Missed Visit|4|||
143402145|NCT02577354|517021560|FG001|Overall Study|Missed Visit|3|||
143402146|NCT02577354|517021559|FG000|Overall Study|Adverse Event|4|||
143402147|NCT02577354|517021560|FG001|Overall Study|Adverse Event|5|||
143402148|NCT04924400|517021569|FG000|Overall Study|Lost to Follow-up|3|||
143402149|NCT04924400|517021570|FG001|Overall Study|Lost to Follow-up|0|||
143402150|NCT04424316|517021571|FG000|Overall Study|Adverse Event|0|||
143402151|NCT04424316|517021572|FG001|Overall Study|Adverse Event|1|||
143402152|NCT04424316|517021573|FG002|Overall Study|Adverse Event|0|||
143402153|NCT04424316|517021574|FG003|Overall Study|Adverse Event|0|||
143402154|NCT04424316|517021571|FG000|Overall Study|Death|1|||
143402155|NCT04424316|517021572|FG001|Overall Study|Death|0|||
143402156|NCT04424316|517021573|FG002|Overall Study|Death|8|||
143402157|NCT04424316|517021574|FG003|Overall Study|Death|14|||
143402158|NCT04424316|517021571|FG000|Overall Study|Lost to Follow-up|93|||
143402159|NCT04424316|517021572|FG001|Overall Study|Lost to Follow-up|88|||
143402160|NCT04424316|517021573|FG002|Overall Study|Lost to Follow-up|224|||
143402161|NCT04424316|517021574|FG003|Overall Study|Lost to Follow-up|211|||
143402162|NCT04424316|517021571|FG000|Overall Study|No longer met eligibility criteria|1|||
143402163|NCT04424316|517021572|FG001|Overall Study|No longer met eligibility criteria|0|||
143402164|NCT04424316|517021573|FG002|Overall Study|No longer met eligibility criteria|0|||
143402165|NCT04424316|517021574|FG003|Overall Study|No longer met eligibility criteria|0|||
143402166|NCT04424316|517021571|FG000|Overall Study|Other|15|||
143402167|NCT04424316|517021572|FG001|Overall Study|Other|11|||
143402168|NCT04424316|517021573|FG002|Overall Study|Other|34|||
143402169|NCT04424316|517021574|FG003|Overall Study|Other|45|||
143402170|NCT04424316|517021571|FG000|Overall Study|Physician Decision|1|||
143402171|NCT04424316|517021572|FG001|Overall Study|Physician Decision|0|||
143402172|NCT04424316|517021573|FG002|Overall Study|Physician Decision|1|||
143402173|NCT04424316|517021574|FG003|Overall Study|Physician Decision|1|||
143402174|NCT04424316|517021571|FG000|Overall Study|Protocol Violation|0|||
143402175|NCT04424316|517021572|FG001|Overall Study|Protocol Violation|1|||
143402176|NCT04424316|517021573|FG002|Overall Study|Protocol Violation|0|||
143402177|NCT04424316|517021574|FG003|Overall Study|Protocol Violation|0|||
143402178|NCT04424316|517021571|FG000|Overall Study|Withdrawal by Subject|71|||
143402179|NCT04424316|517021572|FG001|Overall Study|Withdrawal by Subject|77|||
143402180|NCT04424316|517021573|FG002|Overall Study|Withdrawal by Subject|0|||
143402181|NCT04424316|517021574|FG003|Overall Study|Withdrawal by Subject|0|||
143402182|NCT04424316|517021571|FG000|Overall Study|Withdrawal by parent/guardian|0|||
143402183|NCT04424316|517021572|FG001|Overall Study|Withdrawal by parent/guardian|0|||
143402184|NCT04424316|517021573|FG002|Overall Study|Withdrawal by parent/guardian|74|||
143402185|NCT04424316|517021574|FG003|Overall Study|Withdrawal by parent/guardian|81|||
143402186|NCT04424316|517021571|FG000|Overall Study|Randomized but not vaccinated|13|||
143402187|NCT04424316|517021572|FG001|Overall Study|Randomized but not vaccinated|21|||
143402188|NCT04424316|517021573|FG002|Overall Study|Randomized but not vaccinated|0|||
143402189|NCT04424316|517021574|FG003|Overall Study|Randomized but not vaccinated|0|||
143402190|NCT04424316|517021571|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
143402191|NCT04424316|517021572|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
143402192|NCT04424316|517021573|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
143402193|NCT04424316|517021574|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
143402194|NCT05070741|517021575|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
143402195|NCT04109066|517021576|FG000|Pre-treatment|Participant withdrew consent|2|||
143402196|NCT04109066|517021577|FG001|Pre-treatment|Participant withdrew consent|0|||
143402197|NCT04109066|517021576|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
143402198|NCT04109066|517021577|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
143402199|NCT04109066|517021576|FG000|Treatment|Lack of Efficacy|2|||
143402200|NCT04109066|517021577|FG001|Treatment|Lack of Efficacy|4|||
143402201|NCT04109066|517021576|FG000|Treatment|Adverse Event|23|||
143402202|NCT04109066|517021577|FG001|Treatment|Adverse Event|7|||
143402203|NCT04109066|517021576|FG000|Treatment|Participant request to discontinue Study treatment|15|||
143402204|NCT04109066|517021577|FG001|Treatment|Participant request to discontinue Study treatment|14|||
143402205|NCT04109066|517021576|FG000|Treatment|Withdrawal by Subject|8|||
143402206|NCT04109066|517021577|FG001|Treatment|Withdrawal by Subject|8|||
143402207|NCT04109066|517021576|FG000|Treatment|Death|3|||
143402208|NCT04109066|517021577|FG001|Treatment|Death|0|||
143402209|NCT04109066|517021576|FG000|Treatment|Participant no longer meets study criteria|2|||
143402210|NCT04109066|517021577|FG001|Treatment|Participant no longer meets study criteria|2|||
143402211|NCT04109066|517021576|FG000|Treatment|Administrative reasons by sponsor|2|||
143402212|NCT04109066|517021577|FG001|Treatment|Administrative reasons by sponsor|3|||
143402213|NCT04109066|517021576|FG000|Treatment|Other reasons|17|||
143402214|NCT04109066|517021577|FG001|Treatment|Other reasons|23|||
143402215|NCT04109066|517021576|FG000|Treatment|Disease Progression|4|||
143402216|NCT04109066|517021577|FG001|Treatment|Disease Progression|7|||
143402217|NCT04109066|517021576|FG000|Treatment|Study drug toxicity|12|||
143402218|NCT04109066|517021577|FG001|Treatment|Study drug toxicity|5|||
143402219|NCT04109066|517021576|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
143402220|NCT04109066|517021577|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
143402221|NCT04109066|517021576|FG000|Treatment|Disease Recurrence|0|||
143402222|NCT04109066|517021577|FG001|Treatment|Disease Recurrence|2|||
143402223|NCT04109066|517021576|FG000|Treatment|Not reported|4|||
143402224|NCT04109066|517021577|FG001|Treatment|Not reported|8|||
143402225|NCT05890105|517021578|FG000|Overall Study|Adverse Event|1|||
143402226|NCT05890105|517021579|FG001|Overall Study|Adverse Event|0|||
143402227|NCT05890105|517021580|FG002|Overall Study|Adverse Event|0|||
143402228|NCT05890105|517021578|FG000|Overall Study|Other|1|||
143402229|NCT05890105|517021579|FG001|Overall Study|Other|2|||
143402230|NCT05890105|517021580|FG002|Overall Study|Other|0|||
143402231|NCT05123027|517021585|FG000|Overall Study|Lost to Follow-up|17|||
143402232|NCT05123027|517021586|FG001|Overall Study|Lost to Follow-up|22|||
143402233|NCT05123027|517021585|FG000|Overall Study|Incarceration|3|||
143402234|NCT05123027|517021586|FG001|Overall Study|Incarceration|4|||
143402235|NCT05123027|517021585|FG000|Overall Study|Death|2|||
143402236|NCT05123027|517021586|FG001|Overall Study|Death|2|||
143402237|NCT05123027|517021585|FG000|Overall Study|Other|2|||
143402238|NCT05123027|517021586|FG001|Overall Study|Other|0|||
143402239|NCT02039401|517021588|FG000|Overall Study|Adverse Event|0|||
143402240|NCT02039401|517021589|FG001|Overall Study|Adverse Event|1|||
143402241|NCT02865538|517021590|FG000|Overall Study|Withdrawal by Subject|0|||
143402242|NCT02865538|517021591|FG001|Overall Study|Withdrawal by Subject|0|||
143402243|NCT02865538|517021592|FG002|Overall Study|Withdrawal by Subject|1|||
143402244|NCT02865538|517021593|FG003|Overall Study|Withdrawal by Subject|0|||
143402245|NCT02865538|517021594|FG004|Overall Study|Withdrawal by Subject|0|||
143402246|NCT02865538|517021590|FG000|Overall Study|Lost to Follow-up|1|||
143402247|NCT02865538|517021591|FG001|Overall Study|Lost to Follow-up|0|||
143402248|NCT02865538|517021592|FG002|Overall Study|Lost to Follow-up|0|||
143402249|NCT02865538|517021593|FG003|Overall Study|Lost to Follow-up|0|||
143402250|NCT02865538|517021594|FG004|Overall Study|Lost to Follow-up|0|||
143402251|NCT04678856|517021595|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
143402252|NCT04678856|517021596|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
143402253|NCT04678856|517021595|FG000|Overall Study|Withdrawal by Subject|5|||
143402254|NCT04678856|517021596|FG001|Overall Study|Withdrawal by Subject|1|||
143402255|NCT05311176|517022510|FG000|Overall Study|Death|6|||
143402256|NCT05311176|517022510|FG000|Overall Study|Sponsor discontinued the study|1|||
143402257|NCT05405985|517022513|FG000|Overall Study|Withdrawal by Subject|1|||
143402258|NCT05405985|517022514|FG001|Overall Study|Withdrawal by Subject|0|||
143402259|NCT01917084|517022515|FG000|Overall Study|Withdrawal by Subject|1|||
143402260|NCT04451772|517022516|FG000|Overall Study|Adverse Event|1|||
143402261|NCT04451772|517022517|FG001|Overall Study|Adverse Event|0|||
143402262|NCT04451772|517022518|FG002|Overall Study|Adverse Event|1|||
143402263|NCT04451772|517022519|FG003|Overall Study|Adverse Event|1|||
143402264|NCT04451772|517022520|FG004|Overall Study|Adverse Event|0|||
143402265|NCT04451772|517022521|FG005|Overall Study|Adverse Event|3|||
143402266|NCT04451772|517022516|FG000|Overall Study|Withdrawal by Subject|2|||
143402267|NCT04451772|517022517|FG001|Overall Study|Withdrawal by Subject|7|||
143402268|NCT04451772|517022518|FG002|Overall Study|Withdrawal by Subject|2|||
143402269|NCT04451772|517022519|FG003|Overall Study|Withdrawal by Subject|1|||
143402270|NCT04451772|517022520|FG004|Overall Study|Withdrawal by Subject|1|||
143402271|NCT04451772|517022521|FG005|Overall Study|Withdrawal by Subject|0|||
143402272|NCT04451772|517022516|FG000|Overall Study|Other, not specified|1|||
143402273|NCT04451772|517022517|FG001|Overall Study|Other, not specified|2|||
143402274|NCT04451772|517022518|FG002|Overall Study|Other, not specified|1|||
143402275|NCT04451772|517022519|FG003|Overall Study|Other, not specified|0|||
143402276|NCT04451772|517022520|FG004|Overall Study|Other, not specified|0|||
143402277|NCT04451772|517022521|FG005|Overall Study|Other, not specified|1|||
143402278|NCT04451772|517022516|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
143402279|NCT04451772|517022517|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
143402280|NCT04451772|517022518|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
143402281|NCT04451772|517022519|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
143402282|NCT04451772|517022520|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
143402283|NCT04451772|517022521|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
143402284|NCT04311632|517022522|FG000|Overall Study|Withdrawal by Subject|0|||
143402285|NCT04311632|517022523|FG001|Overall Study|Withdrawal by Subject|0|||
143402286|NCT04311632|517022524|FG002|Overall Study|Withdrawal by Subject|1|||
143402287|NCT04632225|517022525|FG000|Overall Study|Withdrawal by Subject|2|||
143402288|NCT04632225|517022526|FG001|Overall Study|Withdrawal by Subject|2|||
143402289|NCT02997202|517022527|FG000|Overall Study|Miscellaneous|2|||
143402290|NCT02997202|517022528|FG001|Overall Study|Miscellaneous|2|||
143402291|NCT02997202|517022527|FG000|Overall Study|Withdrawal by Subject|8|||
143402292|NCT02997202|517022528|FG001|Overall Study|Withdrawal by Subject|12|||
143402293|NCT02997202|517022527|FG000|Overall Study|Lost to Follow-up|5|||
143402294|NCT02997202|517022528|FG001|Overall Study|Lost to Follow-up|3|||
143402295|NCT02997202|517022527|FG000|Overall Study|Death|41|||
143402296|NCT02997202|517022528|FG001|Overall Study|Death|45|||
143402297|NCT04158739|517022540|FG000|Overall Study|Adverse Event|1|||
143402298|NCT04158739|517022541|FG001|Overall Study|Adverse Event|0|||
143402299|NCT04158739|517022540|FG000|Overall Study|Death|0|||
143402300|NCT04158739|517022541|FG001|Overall Study|Death|1|||
143402301|NCT04158739|517022540|FG000|Overall Study|Lack of Efficacy|3|||
143402302|NCT04158739|517022541|FG001|Overall Study|Lack of Efficacy|7|||
143402303|NCT04158739|517022540|FG000|Overall Study|Physician Decision|0|||
143402304|NCT04158739|517022541|FG001|Overall Study|Physician Decision|1|||
143402305|NCT04158739|517022540|FG000|Overall Study|Withdrawal by Subject|3|||
143402306|NCT04158739|517022541|FG001|Overall Study|Withdrawal by Subject|0|||
143402307|NCT00942877|517022544|FG000|Overall Study|Refused further treatment|1|||
143402308|NCT00942877|517022545|FG001|Overall Study|Refused further treatment|1|||
143402309|NCT00942877|517022544|FG000|Overall Study|Patient was not treated|1|||
143402310|NCT00942877|517022545|FG001|Overall Study|Patient was not treated|0|||
143402311|NCT00942877|517022544|FG000|Overall Study|Adverse Event|1|||
143402312|NCT00942877|517022545|FG001|Overall Study|Adverse Event|0|||
143402313|NCT00942877|517022544|FG000|Overall Study|Progressive disease|42|||
143402314|NCT00942877|517022545|FG001|Overall Study|Progressive disease|3|||
143402315|NCT01385202|517022546|FG000|Overall Study|Lost to Follow-up|6|||
143402316|NCT01385202|517022546|FG000|Overall Study|Not Eligible|11|||
143402317|NCT01385202|517022546|FG000|Overall Study|Withdrawn|1|||
143402318|NCT03681262|517022547|FG000|Overall Study|Continuing on study|3|||
143402319|NCT03681262|517022548|FG001|Overall Study|Continuing on study|3|||
143402320|NCT03681262|517022547|FG000|Overall Study|Lost to Follow-up|1|||
143402321|NCT03681262|517022548|FG001|Overall Study|Lost to Follow-up|0|||
143402322|NCT04055012|517022549|FG000|Overall Study|Withdrawal by Subject|1|||
143402323|NCT04055012|517022550|FG001|Overall Study|Withdrawal by Subject|3|||
143402324|NCT04055012|517022551|FG002|Overall Study|Withdrawal by Subject|1|||
143402325|NCT04055012|517022552|FG003|Overall Study|Withdrawal by Subject|0|||
143402326|NCT04055012|517022549|FG000|Overall Study|Metformin Recall|1|||
143402327|NCT04055012|517022550|FG001|Overall Study|Metformin Recall|1|||
143402328|NCT04055012|517022551|FG002|Overall Study|Metformin Recall|1|||
143402329|NCT04055012|517022552|FG003|Overall Study|Metformin Recall|0|||
143402330|NCT03652272|517022555|FG000|3 Month|Withdrawal by Subject|1|||
143402331|NCT03652272|517022556|FG001|3 Month|Withdrawal by Subject|1|||
143402332|NCT03652272|517022555|FG000|3 Month|Lost to Follow-up|16|||
143402333|NCT03652272|517022556|FG001|3 Month|Lost to Follow-up|14|||
143402334|NCT02326974|517022557|FG000|Overall Study|Withdrawal by Subject|2|||
143402335|NCT02326974|517022557|FG000|Overall Study|failed heterogenity evaluation|5|||
143402336|NCT03582033|517022561|FG000|Part A|Other|0|||
143402337|NCT03582033|517022562|FG001|Part A|Other|0|||
143402338|NCT03582033|517022563|FG002|Part A|Other|0|||
143402339|NCT03582033|517022564|FG003|Part A|Other|0|||
143402340|NCT03582033|517022565|FG004|Part A|Other|2|||
143402341|NCT03582033|517022566|FG005|Part A|Other|0|||
143402342|NCT03582033|517022567|FG006|Part A|Other|0|||
143402343|NCT03582033|517022568|FG007|Part A|Other|0|||
143402344|NCT03582033|517022569|FG008|Part A|Other|0|||
143402345|NCT03582033|517022570|FG009|Part A|Other|0|||
143402346|NCT03582033|517022561|FG000|Part A|Death|1|||
143402347|NCT03582033|517022562|FG001|Part A|Death|1|||
143402348|NCT03582033|517022563|FG002|Part A|Death|2|||
143402349|NCT03582033|517022564|FG003|Part A|Death|4|||
143402350|NCT03582033|517022565|FG004|Part A|Death|11|||
143402351|NCT03582033|517022566|FG005|Part A|Death|0|||
143402352|NCT03582033|517022567|FG006|Part A|Death|0|||
143402353|NCT03582033|517022568|FG007|Part A|Death|0|||
143402354|NCT03582033|517022569|FG008|Part A|Death|0|||
143402355|NCT03582033|517022570|FG009|Part A|Death|0|||
143402356|NCT03582033|517022561|FG000|Part A|Lost to Follow-up|0|||
143402357|NCT03582033|517022562|FG001|Part A|Lost to Follow-up|0|||
143402358|NCT03582033|517022563|FG002|Part A|Lost to Follow-up|0|||
143402359|NCT03582033|517022564|FG003|Part A|Lost to Follow-up|0|||
143402360|NCT03582033|517022565|FG004|Part A|Lost to Follow-up|1|||
143402361|NCT03582033|517022566|FG005|Part A|Lost to Follow-up|0|||
143402362|NCT03582033|517022567|FG006|Part A|Lost to Follow-up|0|||
143402363|NCT03582033|517022568|FG007|Part A|Lost to Follow-up|0|||
143402364|NCT03582033|517022569|FG008|Part A|Lost to Follow-up|0|||
143402365|NCT03582033|517022570|FG009|Part A|Lost to Follow-up|0|||
143402366|NCT03582033|517022561|FG000|Part A|Study terminated by sponsor|0|||
143402367|NCT03582033|517022562|FG001|Part A|Study terminated by sponsor|0|||
143402368|NCT03582033|517022563|FG002|Part A|Study terminated by sponsor|0|||
143402369|NCT03582033|517022564|FG003|Part A|Study terminated by sponsor|2|||
143402370|NCT03582033|517022565|FG004|Part A|Study terminated by sponsor|1|||
143402371|NCT03582033|517022566|FG005|Part A|Study terminated by sponsor|0|||
143402372|NCT03582033|517022567|FG006|Part A|Study terminated by sponsor|0|||
143402373|NCT03582033|517022568|FG007|Part A|Study terminated by sponsor|0|||
143402374|NCT03582033|517022569|FG008|Part A|Study terminated by sponsor|0|||
143402375|NCT03582033|517022570|FG009|Part A|Study terminated by sponsor|0|||
143402376|NCT03582033|517022561|FG000|Part A|Withdrawal by Subject|1|||
143402377|NCT03582033|517022562|FG001|Part A|Withdrawal by Subject|1|||
143402378|NCT03582033|517022563|FG002|Part A|Withdrawal by Subject|0|||
143402379|NCT03582033|517022564|FG003|Part A|Withdrawal by Subject|1|||
143402380|NCT03582033|517022565|FG004|Part A|Withdrawal by Subject|7|||
143402381|NCT03582033|517022566|FG005|Part A|Withdrawal by Subject|0|||
143402382|NCT03582033|517022567|FG006|Part A|Withdrawal by Subject|0|||
143402383|NCT03582033|517022568|FG007|Part A|Withdrawal by Subject|0|||
143402384|NCT03582033|517022569|FG008|Part A|Withdrawal by Subject|0|||
143402385|NCT03582033|517022570|FG009|Part A|Withdrawal by Subject|0|||
143402386|NCT03582033|517022561|FG000|Part B|Death|0|||
143402387|NCT03582033|517022562|FG001|Part B|Death|0|||
143402388|NCT03582033|517022563|FG002|Part B|Death|0|||
143402389|NCT03582033|517022564|FG003|Part B|Death|0|||
143402390|NCT03582033|517022565|FG004|Part B|Death|0|||
143402391|NCT03582033|517022566|FG005|Part B|Death|2|||
143402392|NCT03582033|517022567|FG006|Part B|Death|0|||
143402393|NCT03582033|517022568|FG007|Part B|Death|0|||
143402394|NCT03582033|517022569|FG008|Part B|Death|0|||
143402395|NCT03582033|517022570|FG009|Part B|Death|0|||
143402396|NCT03582033|517022561|FG000|Part B|Study terminated by sponsor|0|||
143402397|NCT03582033|517022562|FG001|Part B|Study terminated by sponsor|0|||
143402398|NCT03582033|517022563|FG002|Part B|Study terminated by sponsor|0|||
143402399|NCT03582033|517022564|FG003|Part B|Study terminated by sponsor|0|||
143402400|NCT03582033|517022565|FG004|Part B|Study terminated by sponsor|0|||
143402401|NCT03582033|517022566|FG005|Part B|Study terminated by sponsor|12|||
143402402|NCT03582033|517022567|FG006|Part B|Study terminated by sponsor|0|||
143402403|NCT03582033|517022568|FG007|Part B|Study terminated by sponsor|0|||
143402404|NCT03582033|517022569|FG008|Part B|Study terminated by sponsor|0|||
143402405|NCT03582033|517022570|FG009|Part B|Study terminated by sponsor|0|||
143402406|NCT03582033|517022561|FG000|Part B|Withdrawal by Subject|0|||
143402407|NCT03582033|517022562|FG001|Part B|Withdrawal by Subject|0|||
143402408|NCT03582033|517022563|FG002|Part B|Withdrawal by Subject|0|||
143402409|NCT03582033|517022564|FG003|Part B|Withdrawal by Subject|0|||
143402410|NCT03582033|517022565|FG004|Part B|Withdrawal by Subject|0|||
143402411|NCT03582033|517022566|FG005|Part B|Withdrawal by Subject|6|||
143402412|NCT03582033|517022567|FG006|Part B|Withdrawal by Subject|0|||
143402413|NCT03582033|517022568|FG007|Part B|Withdrawal by Subject|0|||
143402414|NCT03582033|517022569|FG008|Part B|Withdrawal by Subject|0|||
143402415|NCT03582033|517022570|FG009|Part B|Withdrawal by Subject|0|||
143402416|NCT03582033|517022561|FG000|Part C|Other|0|||
143402417|NCT03582033|517022562|FG001|Part C|Other|0|||
143402418|NCT03582033|517022563|FG002|Part C|Other|0|||
143402419|NCT03582033|517022564|FG003|Part C|Other|0|||
143402420|NCT03582033|517022565|FG004|Part C|Other|0|||
143402421|NCT03582033|517022566|FG005|Part C|Other|0|||
143402422|NCT03582033|517022567|FG006|Part C|Other|2|||
143402423|NCT03582033|517022568|FG007|Part C|Other|0|||
143402424|NCT03582033|517022569|FG008|Part C|Other|0|||
143402425|NCT03582033|517022570|FG009|Part C|Other|0|||
143402426|NCT03582033|517022561|FG000|Part C|Death|0|||
143402427|NCT03582033|517022562|FG001|Part C|Death|0|||
143402428|NCT03582033|517022563|FG002|Part C|Death|0|||
143402429|NCT03582033|517022564|FG003|Part C|Death|0|||
143402430|NCT03582033|517022565|FG004|Part C|Death|0|||
143402431|NCT03582033|517022566|FG005|Part C|Death|0|||
143402432|NCT03582033|517022567|FG006|Part C|Death|6|||
143402433|NCT03582033|517022568|FG007|Part C|Death|1|||
143402434|NCT03582033|517022569|FG008|Part C|Death|2|||
143402435|NCT03582033|517022570|FG009|Part C|Death|0|||
143402436|NCT03582033|517022561|FG000|Part C|Study terminated by sponsor|0|||
143402437|NCT03582033|517022562|FG001|Part C|Study terminated by sponsor|0|||
143402438|NCT03582033|517022563|FG002|Part C|Study terminated by sponsor|0|||
143402439|NCT03582033|517022564|FG003|Part C|Study terminated by sponsor|0|||
143402440|NCT03582033|517022565|FG004|Part C|Study terminated by sponsor|0|||
143402441|NCT03582033|517022566|FG005|Part C|Study terminated by sponsor|0|||
143402442|NCT03582033|517022567|FG006|Part C|Study terminated by sponsor|3|||
143402443|NCT03582033|517022568|FG007|Part C|Study terminated by sponsor|3|||
143402444|NCT03582033|517022569|FG008|Part C|Study terminated by sponsor|2|||
143402445|NCT03582033|517022570|FG009|Part C|Study terminated by sponsor|0|||
143402446|NCT03582033|517022561|FG000|Part C|Withdrawal by Subject|0|||
143402447|NCT03582033|517022562|FG001|Part C|Withdrawal by Subject|0|||
143402448|NCT03582033|517022563|FG002|Part C|Withdrawal by Subject|0|||
143402449|NCT03582033|517022564|FG003|Part C|Withdrawal by Subject|0|||
143402450|NCT03582033|517022565|FG004|Part C|Withdrawal by Subject|0|||
143402451|NCT03582033|517022566|FG005|Part C|Withdrawal by Subject|0|||
143402452|NCT03582033|517022567|FG006|Part C|Withdrawal by Subject|1|||
143402453|NCT03582033|517022568|FG007|Part C|Withdrawal by Subject|2|||
143402454|NCT03582033|517022569|FG008|Part C|Withdrawal by Subject|1|||
143402455|NCT03582033|517022570|FG009|Part C|Withdrawal by Subject|0|||
143402456|NCT03582033|517022561|FG000|Part D|Death|0|||
143402457|NCT03582033|517022562|FG001|Part D|Death|0|||
143402458|NCT03582033|517022563|FG002|Part D|Death|0|||
143402459|NCT03582033|517022564|FG003|Part D|Death|0|||
143402460|NCT03582033|517022565|FG004|Part D|Death|0|||
143402461|NCT03582033|517022566|FG005|Part D|Death|0|||
143402462|NCT03582033|517022567|FG006|Part D|Death|0|||
143402463|NCT03582033|517022568|FG007|Part D|Death|0|||
143402464|NCT03582033|517022569|FG008|Part D|Death|0|||
143402465|NCT03582033|517022570|FG009|Part D|Death|1|||
143402466|NCT03582033|517022561|FG000|Part D|Study terminated by sponsor|0|||
143402467|NCT03582033|517022562|FG001|Part D|Study terminated by sponsor|0|||
143402468|NCT03582033|517022563|FG002|Part D|Study terminated by sponsor|0|||
143402469|NCT03582033|517022564|FG003|Part D|Study terminated by sponsor|0|||
143402470|NCT03582033|517022565|FG004|Part D|Study terminated by sponsor|0|||
143402471|NCT03582033|517022566|FG005|Part D|Study terminated by sponsor|0|||
143402472|NCT03582033|517022567|FG006|Part D|Study terminated by sponsor|0|||
143402473|NCT03582033|517022568|FG007|Part D|Study terminated by sponsor|0|||
143402474|NCT03582033|517022569|FG008|Part D|Study terminated by sponsor|0|||
143402475|NCT03582033|517022570|FG009|Part D|Study terminated by sponsor|4|||
143402476|NCT06010836|517022573|FG000|Overall Study|Lost to Follow-up|2|||
143402477|NCT06010836|517022574|FG001|Overall Study|Lost to Follow-up|2|||
143402478|NCT06010836|517022573|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
143402479|NCT06010836|517022574|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
143402480|NCT06010836|517022573|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
143402481|NCT06010836|517022574|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
143402482|NCT06010836|517022573|FG000|Overall Study|Did not receive intervention discussion|0|||
143402483|NCT06010836|517022574|FG001|Overall Study|Did not receive intervention discussion|4|||
143402484|NCT05205161|517022575|FG000|Overall Study|Study terminated by sponsor|3|||
143402485|NCT05205161|517022576|FG001|Overall Study|Study terminated by sponsor|3|||
143402486|NCT05205161|517022577|FG002|Overall Study|Study terminated by sponsor|1|||
143402487|NCT05652010|517022578|FG000|First Intervention|Withdrawal by Subject|0|||
143402488|NCT05652010|517022579|FG001|First Intervention|Withdrawal by Subject|1|||
143402489|NCT05652010|517022578|FG000|Second Intervention|Withdrawal by Subject|1|||
143402490|NCT05652010|517022579|FG001|Second Intervention|Withdrawal by Subject|0|||
143402491|NCT02510235|517022584|FG000|Overall Study|Withdrawal by Subject|1|||
143402492|NCT02510235|517022585|FG001|Overall Study|Withdrawal by Subject|0|||
143402493|NCT03735979|517022587|FG000|Overall Study|Lost to Follow-up|1|||
143402494|NCT03735979|517022588|FG001|Overall Study|Lost to Follow-up|12|||
143402495|NCT03735979|517022589|FG002|Overall Study|Lost to Follow-up|14|||
143402496|NCT03735979|517022587|FG000|Overall Study|Withdrawal by Subject|1|||
143402497|NCT03735979|517022588|FG001|Overall Study|Withdrawal by Subject|5|||
143402498|NCT03735979|517022589|FG002|Overall Study|Withdrawal by Subject|2|||
143402499|NCT03735979|517022587|FG000|Overall Study|Not due to the above reasons|1|||
143402500|NCT03735979|517022588|FG001|Overall Study|Not due to the above reasons|0|||
143402501|NCT03735979|517022589|FG002|Overall Study|Not due to the above reasons|0|||
143402502|NCT00319111|517022592|FG000|Overall Study|Adverse Event|20|||
143402503|NCT00319111|517022592|FG000|Overall Study|Withdrawal of consent|11|||
143402504|NCT00319111|517022592|FG000|Overall Study|Death|9|||
143402505|NCT00319111|517022592|FG000|Overall Study|Lack of clinical improvement|4|||
143402506|NCT00319111|517022592|FG000|Overall Study|Administrative|2|||
143402507|NCT00319111|517022592|FG000|Overall Study|Treatment failure|1|||
143402508|NCT04743973|517022594|FG000|Overall Study|Withdrawal by Subject|5|||
143402509|NCT03165955|517022595|FG000|Treatment|Withdrawal by Subject|3|||
143402510|NCT03165955|517022595|FG000|Treatment|Death|1|||
143402511|NCT03165955|517022595|FG000|Treatment|Adverse Event|1|||
143402512|NCT03165955|517022595|FG000|Treatment|Progressive disease|3|||
143402513|NCT04499521|517022600|FG000|Overall Study|Disease Progression|1|||
143402514|NCT04499521|517022601|FG001|Overall Study|Disease Progression|0|||
143402515|NCT05525104|517022602|FG000|Overall Study|Failed caudal analgesia|1|||
143402516|NCT05525104|517022603|FG001|Overall Study|Failed caudal analgesia|3|||
143402517|NCT05525104|517022602|FG000|Overall Study|Premedication needed|0|||
143402518|NCT05525104|517022603|FG001|Overall Study|Premedication needed|1|||
143402519|NCT05525104|517022602|FG000|Overall Study|Protocol Violation|10|||
143402520|NCT05525104|517022603|FG001|Overall Study|Protocol Violation|0|||
143402521|NCT05525104|517022602|FG000|Overall Study|Cancelled operation|1|||
143402522|NCT05525104|517022603|FG001|Overall Study|Cancelled operation|0|||
143402523|NCT03734029|517022604|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
143402524|NCT03734029|517022605|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
143402525|NCT03734029|517022604|FG000|Overall Study|Adverse Event|60|||
143402526|NCT03734029|517022605|FG001|Overall Study|Adverse Event|14|||
143402527|NCT03734029|517022604|FG000|Overall Study|Withdrawal by Subject|12|||
143402528|NCT03734029|517022605|FG001|Overall Study|Withdrawal by Subject|11|||
143402529|NCT03734029|517022604|FG000|Overall Study|Clinical progression by investigator|10|||
143402530|NCT03734029|517022605|FG001|Overall Study|Clinical progression by investigator|8|||
143402531|NCT03734029|517022604|FG000|Overall Study|Death|5|||
143402532|NCT03734029|517022605|FG001|Overall Study|Death|2|||
143402533|NCT03734029|517022604|FG000|Overall Study|Physician Decision|4|||
143402534|NCT03734029|517022605|FG001|Overall Study|Physician Decision|3|||
143402535|NCT03734029|517022604|FG000|Overall Study|Other|2|||
143402536|NCT03734029|517022605|FG001|Overall Study|Other|0|||
143402537|NCT03734029|517022604|FG000|Overall Study|Lost to Follow-up|0|||
143402538|NCT03734029|517022605|FG001|Overall Study|Lost to Follow-up|1|||
143402539|NCT03734029|517022604|FG000|Overall Study|Randomized, but not treated|2|||
143402540|NCT03734029|517022605|FG001|Overall Study|Randomized, but not treated|12|||
143402541|NCT04427007|517023684|FG000|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|0|||
143402542|NCT04427007|517023685|FG001|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|1|||
143402543|NCT05422885|517023698|FG000|Overall Study|Lost to Follow-up|1|||
143402544|NCT05422885|517023698|FG000|Overall Study|Withdrawal by Subject|2|||
143402545|NCT02782676|517023700|FG000|Overall Study|Lost to Follow-up|0|||
143402546|NCT02782676|517023701|FG001|Overall Study|Lost to Follow-up|1|||
143402547|NCT05007080|517023702|FG000|Overall Study|Lost to Follow-up|0|||
143402548|NCT05007080|517023703|FG001|Overall Study|Lost to Follow-up|1|||
143402549|NCT05007080|517023704|FG002|Overall Study|Lost to Follow-up|0|||
143402550|NCT05007080|517023705|FG003|Overall Study|Lost to Follow-up|1|||
143402551|NCT05007080|517023706|FG004|Overall Study|Lost to Follow-up|1|||
143402552|NCT05007080|517023707|FG005|Overall Study|Lost to Follow-up|1|||
143402553|NCT05007080|517023702|FG000|Overall Study|Death|0|||
143402554|NCT05007080|517023703|FG001|Overall Study|Death|1|||
143402555|NCT05007080|517023704|FG002|Overall Study|Death|0|||
143402556|NCT05007080|517023705|FG003|Overall Study|Death|0|||
143402557|NCT05007080|517023706|FG004|Overall Study|Death|0|||
143402558|NCT05007080|517023707|FG005|Overall Study|Death|0|||
143402559|NCT05007080|517023702|FG000|Overall Study|Withdrawal by Subject|1|||
143402560|NCT05007080|517023703|FG001|Overall Study|Withdrawal by Subject|2|||
143402561|NCT05007080|517023704|FG002|Overall Study|Withdrawal by Subject|0|||
143402562|NCT05007080|517023705|FG003|Overall Study|Withdrawal by Subject|2|||
143402563|NCT05007080|517023706|FG004|Overall Study|Withdrawal by Subject|1|||
143402564|NCT05007080|517023707|FG005|Overall Study|Withdrawal by Subject|1|||
143402565|NCT05007080|517023702|FG000|Overall Study|Other|1|||
143402566|NCT05007080|517023703|FG001|Overall Study|Other|0|||
143402567|NCT05007080|517023704|FG002|Overall Study|Other|1|||
143402568|NCT05007080|517023705|FG003|Overall Study|Other|1|||
143402569|NCT05007080|517023706|FG004|Overall Study|Other|0|||
143402570|NCT05007080|517023707|FG005|Overall Study|Other|2|||
143402571|NCT05007080|517023702|FG000|Overall Study|Randomized not vaccinated|0|||
143402572|NCT05007080|517023703|FG001|Overall Study|Randomized not vaccinated|0|||
143402573|NCT05007080|517023704|FG002|Overall Study|Randomized not vaccinated|0|||
143402574|NCT05007080|517023705|FG003|Overall Study|Randomized not vaccinated|0|||
143402575|NCT05007080|517023706|FG004|Overall Study|Randomized not vaccinated|0|||
143402576|NCT05007080|517023707|FG005|Overall Study|Randomized not vaccinated|1|||
143402577|NCT04173247|517023708|FG000|Overall Study|Withdrawal by Subject|0|||
143402578|NCT04173247|517023709|FG001|Overall Study|Withdrawal by Subject|2|||
143402579|NCT04173247|517023708|FG000|Overall Study|Death|1|||
143402580|NCT04173247|517023709|FG001|Overall Study|Death|0|||
143402581|NCT04173247|517023708|FG000|Overall Study|Physician Decision|1|||
143402582|NCT04173247|517023709|FG001|Overall Study|Physician Decision|0|||
143402583|NCT04214834|517023714|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|4|||
143402584|NCT04214834|517023715|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
143402585|NCT03812614|517023720|FG000|Intervention|Withdrawal by Subject|7|||
143402586|NCT03812614|517023721|FG001|Intervention|Withdrawal by Subject|2|||
143402587|NCT03812614|517023722|FG002|Intervention|Withdrawal by Subject|7|||
143402588|NCT03812614|517023723|FG003|Intervention|Withdrawal by Subject|2|||
143402589|NCT03812614|517023720|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
143402590|NCT03812614|517023721|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
143402591|NCT03812614|517023722|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
143402592|NCT03812614|517023723|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
143402593|NCT03812614|517023720|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
143402594|NCT03812614|517023721|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
143402595|NCT03812614|517023722|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
143402596|NCT03812614|517023723|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
143402597|NCT03812614|517023720|FG000|6-month Follow-up|Lost to Follow-up|0|||
143402598|NCT03812614|517023721|FG001|6-month Follow-up|Lost to Follow-up|0|||
143402599|NCT03812614|517023722|FG002|6-month Follow-up|Lost to Follow-up|12|||
143402600|NCT03812614|517023723|FG003|6-month Follow-up|Lost to Follow-up|8|||
143402601|NCT03812614|517023720|FG000|12-month Follow-up|Lost to Follow-up|18|||
143402602|NCT03812614|517023721|FG001|12-month Follow-up|Lost to Follow-up|17|||
143402603|NCT03812614|517023722|FG002|12-month Follow-up|Lost to Follow-up|5|||
143402604|NCT03812614|517023723|FG003|12-month Follow-up|Lost to Follow-up|2|||
143402605|NCT05451693|517023725|FG000|Overall Study|Withdrawal by Subject|1|||
143402606|NCT05451693|517023726|FG001|Overall Study|Withdrawal by Subject|1|||
143402607|NCT05741294|517023727|FG000|Overall Study|Lost to Follow-up|3|||
143402608|NCT05741294|517023727|FG000|Overall Study|Protocol deviation|3|||
143402609|NCT05741294|517023727|FG000|Overall Study|Withdrawal by Subject|1|||
143402610|NCT04707768|517023742|FG000|Overall Study|Adverse Event|9|||
143402611|NCT04707768|517023743|FG001|Overall Study|Adverse Event|18|||
143402612|NCT04707768|517023744|FG002|Overall Study|Adverse Event|3|||
143402613|NCT04707768|517023742|FG000|Overall Study|Investigator's Discretion|8|||
143402614|NCT04707768|517023743|FG001|Overall Study|Investigator's Discretion|4|||
143402615|NCT04707768|517023744|FG002|Overall Study|Investigator's Discretion|3|||
143402616|NCT04707768|517023742|FG000|Overall Study|Withdrawal by Subject|6|||
143402617|NCT04707768|517023743|FG001|Overall Study|Withdrawal by Subject|8|||
143402618|NCT04707768|517023744|FG002|Overall Study|Withdrawal by Subject|2|||
143402619|NCT04707768|517023742|FG000|Overall Study|Lack of Efficacy|1|||
143402620|NCT04707768|517023743|FG001|Overall Study|Lack of Efficacy|3|||
143402621|NCT04707768|517023744|FG002|Overall Study|Lack of Efficacy|0|||
143402622|NCT04707768|517023742|FG000|Overall Study|Lost to Follow-up|0|||
143402623|NCT04707768|517023743|FG001|Overall Study|Lost to Follow-up|0|||
143402624|NCT04707768|517023744|FG002|Overall Study|Lost to Follow-up|3|||
143402625|NCT04707768|517023742|FG000|Overall Study|Death|13|||
143402626|NCT04707768|517023743|FG001|Overall Study|Death|11|||
143402627|NCT04707768|517023744|FG002|Overall Study|Death|13|||
143402628|NCT04707768|517023742|FG000|Overall Study|Protocol Violation|2|||
143402629|NCT04707768|517023743|FG001|Overall Study|Protocol Violation|1|||
143402630|NCT04707768|517023744|FG002|Overall Study|Protocol Violation|0|||
143402631|NCT04707768|517023742|FG000|Overall Study|Non Compliance with Study Drug|1|||
143402632|NCT04707768|517023743|FG001|Overall Study|Non Compliance with Study Drug|0|||
143402633|NCT04707768|517023744|FG002|Overall Study|Non Compliance with Study Drug|0|||
143402634|NCT04707768|517023742|FG000|Overall Study|Transplant|4|||
143402635|NCT04707768|517023743|FG001|Overall Study|Transplant|4|||
143402636|NCT04707768|517023744|FG002|Overall Study|Transplant|8|||
143402637|NCT04707768|517023742|FG000|Overall Study|Other|9|||
143402638|NCT04707768|517023743|FG001|Overall Study|Other|5|||
143402639|NCT04707768|517023744|FG002|Overall Study|Other|2|||
143402640|NCT04490109|517023745|FG000|Overall Study|Lost to Follow-up|3|||
143402641|NCT04490109|517023746|FG001|Overall Study|Lost to Follow-up|10|||
143402642|NCT04490109|517023747|FG002|Overall Study|Lost to Follow-up|4|||
143402643|NCT04490109|517023745|FG000|Overall Study|Withdrawal by Subject|8|||
143402644|NCT04490109|517023746|FG001|Overall Study|Withdrawal by Subject|6|||
143402645|NCT04490109|517023747|FG002|Overall Study|Withdrawal by Subject|9|||
143402646|NCT04490109|517023745|FG000|Overall Study|Physician Decision|0|||
143402647|NCT04490109|517023746|FG001|Overall Study|Physician Decision|2|||
143402648|NCT04490109|517023747|FG002|Overall Study|Physician Decision|3|||
143402649|NCT04490109|517023745|FG000|Overall Study|Adverse Event|2|||
143402650|NCT04490109|517023746|FG001|Overall Study|Adverse Event|1|||
143402651|NCT04490109|517023747|FG002|Overall Study|Adverse Event|0|||
143402652|NCT04490109|517023745|FG000|Overall Study|Significant Non-Compliance|2|||
143402653|NCT04490109|517023746|FG001|Overall Study|Significant Non-Compliance|4|||
143402654|NCT04490109|517023747|FG002|Overall Study|Significant Non-Compliance|4|||
143402655|NCT04490109|517023745|FG000|Overall Study|Significant Clinical Event|0|||
143402656|NCT04490109|517023746|FG001|Overall Study|Significant Clinical Event|1|||
143402657|NCT04490109|517023747|FG002|Overall Study|Significant Clinical Event|0|||
143402658|NCT04490109|517023745|FG000|Overall Study|Other Reason|4|||
143402659|NCT04490109|517023746|FG001|Overall Study|Other Reason|1|||
143402660|NCT04490109|517023747|FG002|Overall Study|Other Reason|1|||
143402661|NCT04163991|517023748|FG000|Overall Study|Adverse Event|0|||
143402662|NCT04163991|517023749|FG001|Overall Study|Adverse Event|0|||
143402663|NCT04163991|517023750|FG002|Overall Study|Adverse Event|0|||
143402664|NCT04163991|517023751|FG003|Overall Study|Adverse Event|1|||
143402665|NCT04163991|517023752|FG004|Overall Study|Adverse Event|0|||
143402666|NCT04163991|517023748|FG000|Overall Study|Death|0|||
143402667|NCT04163991|517023749|FG001|Overall Study|Death|0|||
143402668|NCT04163991|517023750|FG002|Overall Study|Death|1|||
143402669|NCT04163991|517023751|FG003|Overall Study|Death|0|||
143402670|NCT04163991|517023752|FG004|Overall Study|Death|0|||
143402671|NCT04163991|517023748|FG000|Overall Study|Lost to Follow-up|0|||
143402672|NCT04163991|517023749|FG001|Overall Study|Lost to Follow-up|1|||
143402673|NCT04163991|517023750|FG002|Overall Study|Lost to Follow-up|0|||
143402674|NCT04163991|517023751|FG003|Overall Study|Lost to Follow-up|0|||
143402675|NCT04163991|517023752|FG004|Overall Study|Lost to Follow-up|0|||
143402676|NCT04163991|517023748|FG000|Overall Study|Withdrawal by Subject|1|||
143402677|NCT04163991|517023749|FG001|Overall Study|Withdrawal by Subject|1|||
143402678|NCT04163991|517023750|FG002|Overall Study|Withdrawal by Subject|3|||
143402679|NCT04163991|517023751|FG003|Overall Study|Withdrawal by Subject|1|||
143402680|NCT04163991|517023752|FG004|Overall Study|Withdrawal by Subject|1|||
143402681|NCT04163991|517023748|FG000|Overall Study|Other, Not Specified|0|||
143402682|NCT04163991|517023749|FG001|Overall Study|Other, Not Specified|1|||
143402683|NCT04163991|517023750|FG002|Overall Study|Other, Not Specified|1|||
143402684|NCT04163991|517023751|FG003|Overall Study|Other, Not Specified|1|||
143402685|NCT04163991|517023752|FG004|Overall Study|Other, Not Specified|0|||
143402686|NCT03372057|517023753|FG000|Dose Optimization Phase|Withdrawal by Subject|1|||
143402687|NCT03372057|517023754|FG001|Dose Optimization Phase|Withdrawal by Subject|1|||
143402688|NCT03372057|517023755|FG002|Dose Optimization Phase|Withdrawal by Subject|0|||
143402689|NCT03372057|517023753|FG000|Dose Optimization Phase|Closure Of The Study By The Sponsor|3|||
143402690|NCT03372057|517023754|FG001|Dose Optimization Phase|Closure Of The Study By The Sponsor|1|||
143402691|NCT03372057|517023755|FG002|Dose Optimization Phase|Closure Of The Study By The Sponsor|0|||
143402692|NCT03372057|517023753|FG000|Dose Optimization Phase|Death|16|||
143402693|NCT03372057|517023754|FG001|Dose Optimization Phase|Death|11|||
143402694|NCT03372057|517023755|FG002|Dose Optimization Phase|Death|0|||
143402695|NCT03372057|517023753|FG000|Expansion Phase|Withdrawal by Subject|0|||
143402696|NCT03372057|517023754|FG001|Expansion Phase|Withdrawal by Subject|0|||
143402697|NCT03372057|517023755|FG002|Expansion Phase|Withdrawal by Subject|4|||
143402698|NCT03372057|517023753|FG000|Expansion Phase|Closure Of The Study By The Sponsor|0|||
143402699|NCT03372057|517023754|FG001|Expansion Phase|Closure Of The Study By The Sponsor|0|||
143402700|NCT03372057|517023755|FG002|Expansion Phase|Closure Of The Study By The Sponsor|39|||
143402701|NCT03372057|517023753|FG000|Expansion Phase|Death|0|||
143402702|NCT03372057|517023754|FG001|Expansion Phase|Death|0|||
143402703|NCT03372057|517023755|FG002|Expansion Phase|Death|78|||
143402704|NCT03372057|517023753|FG000|Expansion Phase|Progressive Disease|0|||
143402705|NCT03372057|517023754|FG001|Expansion Phase|Progressive Disease|0|||
143402706|NCT03372057|517023755|FG002|Expansion Phase|Progressive Disease|1|||
143402707|NCT03372057|517023753|FG000|Expansion Phase|Adverse Event|0|||
143402708|NCT03372057|517023754|FG001|Expansion Phase|Adverse Event|0|||
143402709|NCT03372057|517023755|FG002|Expansion Phase|Adverse Event|1|||
143402710|NCT03817983|517023756|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
143402711|NCT03817983|517023757|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
143402712|NCT03817983|517023758|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
143402713|NCT03744676|517023759|FG000|Pre-Treatment Phase|Disease related complications|2|||
143402714|NCT03744676|517023759|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
143402715|NCT03744676|517023759|FG000|Pre-Treatment Phase|Death|7|||
143402716|NCT03744676|517023759|FG000|Pre-Treatment Phase|Other Reasons|7|||
143402717|NCT03744676|517023759|FG000|Treatment Phase|Participant withdrew consent|8|||
143402718|NCT03744676|517023759|FG000|Treatment Phase|Death|33|||
143402719|NCT03744676|517023759|FG000|Treatment Phase|other reasons|6|||
143402720|NCT04078152|517023760|FG000|Overall Study|Other|83|||
143402721|NCT04078152|517023761|FG001|Overall Study|Other|22|||
143402722|NCT04078152|517023762|FG002|Overall Study|Other|25|||
143402723|NCT04078152|517023760|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
143402724|NCT04078152|517023761|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
143402725|NCT04078152|517023762|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
143402726|NCT04078152|517023760|FG000|Overall Study|Withdrawal by Subject|5|||
143402727|NCT04078152|517023761|FG001|Overall Study|Withdrawal by Subject|0|||
143402728|NCT04078152|517023762|FG002|Overall Study|Withdrawal by Subject|1|||
143402729|NCT04078152|517023760|FG000|Overall Study|Death|10|||
143402730|NCT04078152|517023761|FG001|Overall Study|Death|2|||
143402731|NCT04078152|517023762|FG002|Overall Study|Death|12|||
143402732|NCT04078152|517023760|FG000|Overall Study|Adverse Event|1|||
143402733|NCT04078152|517023761|FG001|Overall Study|Adverse Event|0|||
143402734|NCT04078152|517023762|FG002|Overall Study|Adverse Event|0|||
143402735|NCT00450216|517023764|FG000|Overall Study|Adverse Event|38|||
143402736|NCT00450216|517023765|FG001|Overall Study|Adverse Event|23|||
143402737|NCT00450216|517023764|FG000|Overall Study|Withdrawal by Subject|48|||
143402738|NCT00450216|517023765|FG001|Overall Study|Withdrawal by Subject|26|||
143402739|NCT00450216|517023764|FG000|Overall Study|Lost to Follow-up|16|||
143402740|NCT00450216|517023765|FG001|Overall Study|Lost to Follow-up|9|||
143402741|NCT00450216|517023764|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
143402742|NCT00450216|517023765|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
143402743|NCT00450216|517023764|FG000|Overall Study|misc|21|||
143402744|NCT00450216|517023765|FG001|Overall Study|misc|20|||
143402745|NCT05008055|517023766|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
143402746|NCT05008055|517023767|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
143402747|NCT05008055|517023768|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
143402748|NCT03011034|517023776|FG000|Overall Study|Adverse Event|1|||
143402749|NCT03011034|517023777|FG001|Overall Study|Adverse Event|0|||
143402750|NCT05112900|517023778|FG000|Overall Study|Withdrawal by Subject|960|||
143402751|NCT05112900|517023779|FG001|Overall Study|Withdrawal by Subject|921|||
143402752|NCT05112900|517023780|FG002|Overall Study|Withdrawal by Subject|968|||
143402753|NCT02919917|517023781|FG000|Overall Study|Withdrawal by Subject|4|||
143402754|NCT02919917|517023782|FG001|Overall Study|Withdrawal by Subject|8|||
143402755|NCT03279978|517023783|FG000|Overall Study|Withdrawal by Subject|0|||
143402756|NCT03279978|517023784|FG001|Overall Study|Withdrawal by Subject|1|||
143402757|NCT03279978|517023785|FG002|Overall Study|Withdrawal by Subject|0|||
143402758|NCT03279978|517023786|FG003|Overall Study|Withdrawal by Subject|0|||
143402759|NCT03279978|517023787|FG004|Overall Study|Withdrawal by Subject|0|||
143402760|NCT03279978|517023788|FG005|Overall Study|Withdrawal by Subject|0|||
143402761|NCT03279978|517023789|FG006|Overall Study|Withdrawal by Subject|0|||
143402762|NCT03279978|517023790|FG007|Overall Study|Withdrawal by Subject|0|||
143402763|NCT03279978|517023791|FG008|Overall Study|Withdrawal by Subject|0|||
143402764|NCT03279978|517023792|FG009|Overall Study|Withdrawal by Subject|1|||
143402765|NCT03279978|517023783|FG000|Overall Study|Lost to Follow-up|1|||
143402766|NCT03279978|517023784|FG001|Overall Study|Lost to Follow-up|0|||
143402767|NCT03279978|517023785|FG002|Overall Study|Lost to Follow-up|1|||
143402768|NCT03279978|517023786|FG003|Overall Study|Lost to Follow-up|0|||
143402769|NCT03279978|517023787|FG004|Overall Study|Lost to Follow-up|0|||
143402770|NCT03279978|517023788|FG005|Overall Study|Lost to Follow-up|0|||
143402771|NCT03279978|517023789|FG006|Overall Study|Lost to Follow-up|0|||
143402772|NCT03279978|517023790|FG007|Overall Study|Lost to Follow-up|0|||
143402773|NCT03279978|517023791|FG008|Overall Study|Lost to Follow-up|0|||
143402774|NCT03279978|517023792|FG009|Overall Study|Lost to Follow-up|0|||
143402775|NCT03279978|517023783|FG000|Overall Study|Other than stated above|0|||
143402776|NCT03279978|517023784|FG001|Overall Study|Other than stated above|0|||
143402777|NCT03279978|517023785|FG002|Overall Study|Other than stated above|0|||
143402778|NCT03279978|517023786|FG003|Overall Study|Other than stated above|0|||
143402779|NCT03279978|517023787|FG004|Overall Study|Other than stated above|0|||
143402780|NCT03279978|517023788|FG005|Overall Study|Other than stated above|0|||
143402781|NCT03279978|517023789|FG006|Overall Study|Other than stated above|1|||
143402782|NCT03279978|517023790|FG007|Overall Study|Other than stated above|0|||
143402783|NCT03279978|517023791|FG008|Overall Study|Other than stated above|0|||
143402784|NCT03279978|517023792|FG009|Overall Study|Other than stated above|0|||
143402785|NCT04330040|517023793|FG000|Overall Study|Other: Adverse event|5|||
143402786|NCT04330040|517023794|FG001|Overall Study|Other: Adverse event|0|||
143402787|NCT04330040|517023795|FG002|Overall Study|Other: Adverse event|0|||
143402788|NCT04330040|517023793|FG000|Overall Study|Disease progression|38|||
143402789|NCT04330040|517023794|FG001|Overall Study|Disease progression|10|||
143402790|NCT04330040|517023795|FG002|Overall Study|Disease progression|0|||
143402791|NCT04330040|517023793|FG000|Overall Study|Physician Decision|5|||
143402792|NCT04330040|517023794|FG001|Overall Study|Physician Decision|3|||
143402793|NCT04330040|517023795|FG002|Overall Study|Physician Decision|0|||
143402794|NCT04330040|517023793|FG000|Overall Study|Lost to Follow-up|1|||
143402795|NCT04330040|517023794|FG001|Overall Study|Lost to Follow-up|1|||
143402796|NCT04330040|517023795|FG002|Overall Study|Lost to Follow-up|0|||
143402797|NCT04330040|517023793|FG000|Overall Study|Death|2|||
143402798|NCT04330040|517023794|FG001|Overall Study|Death|1|||
143402799|NCT04330040|517023795|FG002|Overall Study|Death|0|||
143402800|NCT04330040|517023793|FG000|Overall Study|Withdrawal by Subject|3|||
143402801|NCT04330040|517023794|FG001|Overall Study|Withdrawal by Subject|3|||
143402802|NCT04330040|517023795|FG002|Overall Study|Withdrawal by Subject|0|||
143402803|NCT04330040|517023793|FG000|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
143402804|NCT04330040|517023794|FG001|Overall Study|Other: Increased QTc interval and clinical progression found|1|||
143402805|NCT04330040|517023795|FG002|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
143402806|NCT04330040|517023793|FG000|Overall Study|Other: Progressive disease (no confirming documents)|0|||
143402807|NCT04330040|517023794|FG001|Overall Study|Other: Progressive disease (no confirming documents)|1|||
143402808|NCT04330040|517023795|FG002|Overall Study|Other: Progressive disease (no confirming documents)|0|||
143402809|NCT04330040|517023793|FG000|Overall Study|Other: Disease progression|1|||
143402810|NCT04330040|517023794|FG001|Overall Study|Other: Disease progression|0|||
143402811|NCT04330040|517023795|FG002|Overall Study|Other: Disease progression|0|||
143402812|NCT04330040|517023793|FG000|Overall Study|Other: Due to anemia the investigator decided not to continue|1|||
143402813|NCT04330040|517023794|FG001|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
143402814|NCT04330040|517023795|FG002|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
143402815|NCT04330040|517023793|FG000|Overall Study|Other: Due to disease progression and could not tolerate the dose|1|||
143402816|NCT04330040|517023794|FG001|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
143402817|NCT04330040|517023795|FG002|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
143402818|NCT04330040|517023793|FG000|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|2|||
143402819|NCT04330040|517023794|FG001|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
143402820|NCT04330040|517023795|FG002|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
143402821|NCT04464564|517024615|FG000|Period A (Placebo lead-in)|Other|5|||
143402822|NCT04464564|517024616|FG001|Period A (Placebo lead-in)|Other|0|||
143402823|NCT04464564|517024617|FG002|Period A (Placebo lead-in)|Other|0|||
143402824|NCT04464564|517024618|FG003|Period A (Placebo lead-in)|Other|0|||
143402825|NCT04464564|517024615|FG000|Period B (Randomization Period)|Adverse Event|0|||
143402826|NCT04464564|517024616|FG001|Period B (Randomization Period)|Adverse Event|1|||
143402827|NCT04464564|517024617|FG002|Period B (Randomization Period)|Adverse Event|2|||
143402828|NCT04464564|517024618|FG003|Period B (Randomization Period)|Adverse Event|8|||
143402829|NCT04464564|517024615|FG000|Period B (Randomization Period)|Lack of Efficacy|0|||
143402830|NCT04464564|517024616|FG001|Period B (Randomization Period)|Lack of Efficacy|1|||
143402831|NCT04464564|517024617|FG002|Period B (Randomization Period)|Lack of Efficacy|0|||
143402832|NCT04464564|517024618|FG003|Period B (Randomization Period)|Lack of Efficacy|0|||
143402833|NCT04464564|517024615|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
143402834|NCT04464564|517024616|FG001|Period B (Randomization Period)|Lost to Follow-up|0|||
143402835|NCT04464564|517024617|FG002|Period B (Randomization Period)|Lost to Follow-up|0|||
143402836|NCT04464564|517024618|FG003|Period B (Randomization Period)|Lost to Follow-up|1|||
143402837|NCT04464564|517024615|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
143402838|NCT04464564|517024616|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
143402839|NCT04464564|517024617|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
143402840|NCT04464564|517024618|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|5|||
143402841|NCT04464564|517024615|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
143402842|NCT04464564|517024616|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
143402843|NCT04464564|517024617|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
143402844|NCT04464564|517024618|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|7|||
143402845|NCT04464564|517024615|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
143402846|NCT04464564|517024616|FG001|Period B (Randomization Period)|Withdrawal by Subject|2|||
143402847|NCT04464564|517024617|FG002|Period B (Randomization Period)|Withdrawal by Subject|4|||
143402848|NCT04464564|517024618|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
143402849|NCT04464564|517024615|FG000|Period B (Randomization Period)|Reason not Specified|0|||
143402850|NCT04464564|517024616|FG001|Period B (Randomization Period)|Reason not Specified|3|||
143402851|NCT04464564|517024617|FG002|Period B (Randomization Period)|Reason not Specified|3|||
143402852|NCT04464564|517024618|FG003|Period B (Randomization Period)|Reason not Specified|3|||
143402853|NCT04282980|517024619|FG000|Overall Study|Remained on treatment|6|||
143402854|NCT04282980|517024619|FG000|Overall Study|Survival follow-up|11|||
143402855|NCT04282980|517024619|FG000|Overall Study|Withdrawal of informed consent|1|||
143402856|NCT04282980|517024619|FG000|Overall Study|Lost to Follow-up|1|||
143402857|NCT02095691|517024620|FG000|Overall Study|Physician Decision|1|||
143402858|NCT00887198|517024621|FG000|Randomized Period|Ongoing|42|||
143402859|NCT00887198|517024622|FG001|Randomized Period|Ongoing|0|||
143402860|NCT00887198|517024623|FG002|Randomized Period|Ongoing|0|||
143402861|NCT00887198|517024621|FG000|Randomized Period|Adverse Event|50|||
143402862|NCT00887198|517024622|FG001|Randomized Period|Adverse Event|33|||
143402863|NCT00887198|517024623|FG002|Randomized Period|Adverse Event|0|||
143402864|NCT00887198|517024621|FG000|Randomized Period|Lost to Follow-up|1|||
143402865|NCT00887198|517024622|FG001|Randomized Period|Lost to Follow-up|0|||
143402866|NCT00887198|517024623|FG002|Randomized Period|Lost to Follow-up|0|||
143402867|NCT00887198|517024621|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
143402868|NCT00887198|517024622|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
143402869|NCT00887198|517024623|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
143402870|NCT00887198|517024621|FG000|Randomized Period|Withdrawal by Subject|41|||
143402871|NCT00887198|517024622|FG001|Randomized Period|Withdrawal by Subject|56|||
143402872|NCT00887198|517024623|FG002|Randomized Period|Withdrawal by Subject|0|||
143402873|NCT00887198|517024621|FG000|Randomized Period|Progressive disease|366|||
143402874|NCT00887198|517024622|FG001|Randomized Period|Progressive disease|370|||
143402875|NCT00887198|517024623|FG002|Randomized Period|Progressive disease|0|||
143402876|NCT00887198|517024621|FG000|Randomized Period|Other|42|||
143402877|NCT00887198|517024622|FG001|Randomized Period|Other|30|||
143402878|NCT00887198|517024623|FG002|Randomized Period|Other|0|||
143402879|NCT00887198|517024621|FG000|Randomized Period|Randomized, Not treated|4|||
143402880|NCT00887198|517024622|FG001|Randomized Period|Randomized, Not treated|2|||
143402881|NCT00887198|517024623|FG002|Randomized Period|Randomized, Not treated|0|||
143402882|NCT00887198|517024621|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
143402883|NCT00887198|517024622|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
143402884|NCT00887198|517024623|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
143402885|NCT00887198|517024621|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
143402886|NCT00887198|517024622|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
143402887|NCT00887198|517024623|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
143402888|NCT00887198|517024621|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
143402889|NCT00887198|517024622|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
143402890|NCT00887198|517024623|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
143402891|NCT00887198|517024621|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
143402892|NCT00887198|517024622|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
143402893|NCT00887198|517024623|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
143402894|NCT00887198|517024621|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
143402895|NCT00887198|517024622|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
143402896|NCT00887198|517024623|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
143402897|NCT00887198|517024621|FG000|Cross Over (Placebo to AA)|Other|0|||
143402898|NCT00887198|517024622|FG001|Cross Over (Placebo to AA)|Other|0|||
143402899|NCT00887198|517024623|FG002|Cross Over (Placebo to AA)|Other|19|||
143402900|NCT05830799|517024631|FG000|Overall Study|Withdrawal by Subject|1|||
143402901|NCT03884101|517024632|FG000|Overall Study|Participant Ongoing in Study|202|||
143402902|NCT03884101|517024633|FG001|Overall Study|Participant Ongoing in Study|186|||
143402903|NCT03884101|517024632|FG000|Overall Study|Death|212|||
143402904|NCT03884101|517024633|FG001|Overall Study|Death|224|||
143402905|NCT03884101|517024632|FG000|Overall Study|Lost to Follow-up|0|||
143402906|NCT03884101|517024633|FG001|Overall Study|Lost to Follow-up|1|||
143402907|NCT03884101|517024632|FG000|Overall Study|Withdrawal by Subject|6|||
143402908|NCT03884101|517024633|FG001|Overall Study|Withdrawal by Subject|11|||
143402909|NCT03370913|517024634|FG000|Overall Study|Death|1|||
143402910|NCT03370913|517024634|FG000|Overall Study|Lost to Follow-up|1|||
143402911|NCT04631016|517024635|FG000|Overall Study|Adverse Event|3|||
143402912|NCT04631016|517024636|FG001|Overall Study|Adverse Event|0|||
143402913|NCT04631016|517024635|FG000|Overall Study|Withdrawal by Subject|5|||
143402914|NCT04631016|517024636|FG001|Overall Study|Withdrawal by Subject|4|||
143402915|NCT04631016|517024635|FG000|Overall Study|Reason unspecified|1|||
143402916|NCT04631016|517024636|FG001|Overall Study|Reason unspecified|0|||
143402917|NCT04631016|517024635|FG000|Overall Study|Failure to meet randomization criteria|2|||
143402918|NCT04631016|517024636|FG001|Overall Study|Failure to meet randomization criteria|1|||
143402919|NCT04967599|517024637|FG000|Overall Study|Lost to Follow-up|35|||
143402920|NCT04967599|517024638|FG001|Overall Study|Lost to Follow-up|19|||
143402921|NCT04967599|517024639|FG002|Overall Study|Lost to Follow-up|23|||
143402922|NCT03880955|517024640|FG000|Overall Study|Adverse Event|1|||
143402923|NCT03880955|517024640|FG000|Overall Study|Death|1|||
143402924|NCT03880955|517024640|FG000|Overall Study|Lost to Follow-up|12|||
143402925|NCT03880955|517024640|FG000|Overall Study|Withdrawal by Subject|4|||
143402926|NCT03880955|517024640|FG000|Overall Study|Missing- Study Site Closed|27|||
143402927|NCT01438853|517024647|FG000|Overall Study|Death|0|||
143402928|NCT01438853|517024648|FG001|Overall Study|Death|0|||
143402929|NCT01438853|517024649|FG002|Overall Study|Death|0|||
143402930|NCT01438853|517024650|FG003|Overall Study|Death|1|||
143402931|NCT01438853|517024647|FG000|Overall Study|Withdrawal by Subject|0|||
143402932|NCT01438853|517024648|FG001|Overall Study|Withdrawal by Subject|0|||
143402933|NCT01438853|517024649|FG002|Overall Study|Withdrawal by Subject|1|||
143402934|NCT01438853|517024650|FG003|Overall Study|Withdrawal by Subject|0|||
143402935|NCT02461134|517024651|FG000|Overall Study|Adverse Event|1|||
143402936|NCT04761198|517024652|FG000|Overall Study|Progressive Disease|1|||
143402937|NCT04761198|517024653|FG001|Overall Study|Progressive Disease|0|||
143402938|NCT04761198|517024654|FG002|Overall Study|Progressive Disease|0|||
143402939|NCT04761198|517024655|FG003|Overall Study|Progressive Disease|1|||
143402940|NCT04761198|517024656|FG004|Overall Study|Progressive Disease|4|||
143402941|NCT04761198|517024657|FG005|Overall Study|Progressive Disease|1|||
143402942|NCT04761198|517024658|FG006|Overall Study|Progressive Disease|2|||
143402943|NCT04761198|517024652|FG000|Overall Study|Protocol Violation|0|||
143402944|NCT04761198|517024653|FG001|Overall Study|Protocol Violation|0|||
143402945|NCT04761198|517024654|FG002|Overall Study|Protocol Violation|0|||
143402946|NCT04761198|517024655|FG003|Overall Study|Protocol Violation|0|||
143402947|NCT04761198|517024656|FG004|Overall Study|Protocol Violation|1|||
143402948|NCT04761198|517024657|FG005|Overall Study|Protocol Violation|0|||
143402949|NCT04761198|517024658|FG006|Overall Study|Protocol Violation|0|||
143402950|NCT04761198|517024652|FG000|Overall Study|Death|2|||
143402951|NCT04761198|517024653|FG001|Overall Study|Death|1|||
143402952|NCT04761198|517024654|FG002|Overall Study|Death|2|||
143402953|NCT04761198|517024655|FG003|Overall Study|Death|5|||
143402954|NCT04761198|517024656|FG004|Overall Study|Death|14|||
143402955|NCT04761198|517024657|FG005|Overall Study|Death|2|||
143402956|NCT04761198|517024658|FG006|Overall Study|Death|5|||
143402957|NCT04761198|517024652|FG000|Overall Study|Lost to Follow-up|0|||
143402958|NCT04761198|517024653|FG001|Overall Study|Lost to Follow-up|0|||
143402959|NCT04761198|517024654|FG002|Overall Study|Lost to Follow-up|0|||
143402960|NCT04761198|517024655|FG003|Overall Study|Lost to Follow-up|0|||
143402961|NCT04761198|517024656|FG004|Overall Study|Lost to Follow-up|1|||
143402962|NCT04761198|517024657|FG005|Overall Study|Lost to Follow-up|0|||
143402963|NCT04761198|517024658|FG006|Overall Study|Lost to Follow-up|0|||
143402964|NCT04761198|517024652|FG000|Overall Study|Withdrawal by Subject|2|||
143402965|NCT04761198|517024653|FG001|Overall Study|Withdrawal by Subject|0|||
143402966|NCT04761198|517024654|FG002|Overall Study|Withdrawal by Subject|1|||
143402967|NCT04761198|517024655|FG003|Overall Study|Withdrawal by Subject|0|||
143402968|NCT04761198|517024656|FG004|Overall Study|Withdrawal by Subject|2|||
143402969|NCT04761198|517024657|FG005|Overall Study|Withdrawal by Subject|0|||
143402970|NCT04761198|517024658|FG006|Overall Study|Withdrawal by Subject|1|||
143402971|NCT04761198|517024652|FG000|Overall Study|Study Terminated by Sponsor|6|||
143402972|NCT04761198|517024653|FG001|Overall Study|Study Terminated by Sponsor|0|||
143402973|NCT04761198|517024654|FG002|Overall Study|Study Terminated by Sponsor|5|||
143402974|NCT04761198|517024655|FG003|Overall Study|Study Terminated by Sponsor|3|||
143402975|NCT04761198|517024656|FG004|Overall Study|Study Terminated by Sponsor|10|||
143402976|NCT04761198|517024657|FG005|Overall Study|Study Terminated by Sponsor|1|||
143402977|NCT04761198|517024658|FG006|Overall Study|Study Terminated by Sponsor|2|||
143402978|NCT02994927|517024659|FG000|Overall Study|Withdrawal by parent/guardian|0|||
143402979|NCT02994927|517024660|FG001|Overall Study|Withdrawal by parent/guardian|1|||
143402980|NCT02994927|517024659|FG000|Overall Study|Did not meet eligibility criteria|0|||
143402981|NCT02994927|517024660|FG001|Overall Study|Did not meet eligibility criteria|1|||
143402982|NCT02994927|517024659|FG000|Overall Study|Physician Decision|4|||
143402983|NCT02994927|517024660|FG001|Overall Study|Physician Decision|3|||
143402984|NCT02994927|517024659|FG000|Overall Study|Death|4|||
143402985|NCT02994927|517024660|FG001|Overall Study|Death|2|||
143402986|NCT02994927|517024659|FG000|Overall Study|Adverse Event|2|||
143402987|NCT02994927|517024660|FG001|Overall Study|Adverse Event|1|||
143402988|NCT02994927|517024659|FG000|Overall Study|Withdrawal by Subject|3|||
143402989|NCT02994927|517024660|FG001|Overall Study|Withdrawal by Subject|6|||
143402990|NCT02994927|517024659|FG000|Overall Study|Lost to Follow-up|2|||
143402991|NCT02994927|517024660|FG001|Overall Study|Lost to Follow-up|1|||
143402992|NCT00626795|517024661|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
143402993|NCT00626795|517024662|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
143402994|NCT00626795|517024663|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
143402995|NCT00626795|517024661|FG000|Blinded Treatment|Lack of Efficacy|2|||
143402996|NCT00626795|517024662|FG001|Blinded Treatment|Lack of Efficacy|0|||
143402997|NCT00626795|517024663|FG002|Blinded Treatment|Lack of Efficacy|0|||
143402998|NCT00626795|517024661|FG000|Blinded Treatment|Unacceptable adverse event|0|||
143402999|NCT00626795|517024662|FG001|Blinded Treatment|Unacceptable adverse event|0|||
143403000|NCT00626795|517024663|FG002|Blinded Treatment|Unacceptable adverse event|1|||
143403001|NCT00626795|517024661|FG000|Blinded Treatment|Protocol Violation|0|||
143403002|NCT00626795|517024662|FG001|Blinded Treatment|Protocol Violation|1|||
143403003|NCT00626795|517024663|FG002|Blinded Treatment|Protocol Violation|1|||
143403004|NCT00626795|517024661|FG000|Blinded Treatment|Withdrawal by Subject|1|||
143403005|NCT00626795|517024662|FG001|Blinded Treatment|Withdrawal by Subject|1|||
143403006|NCT00626795|517024663|FG002|Blinded Treatment|Withdrawal by Subject|0|||
143403007|NCT00626795|517024661|FG000|Blinded Treatment|Other reasons|2|||
143403008|NCT00626795|517024662|FG001|Blinded Treatment|Other reasons|0|||
143403009|NCT00626795|517024663|FG002|Blinded Treatment|Other reasons|2|||
143403010|NCT00626795|517024661|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
143403011|NCT00626795|517024662|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
143403012|NCT00626795|517024663|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
143403013|NCT03533257|517024671|FG000|Overall Study|Adverse Event|4|||
143403014|NCT03533257|517024672|FG001|Overall Study|Adverse Event|2|||
143403015|NCT03533257|517024671|FG000|Overall Study|Enrolled in other study, terminated by Sponsor, other|6|||
143403016|NCT03533257|517024672|FG001|Overall Study|Enrolled in other study, terminated by Sponsor, other|0|||
143403017|NCT04159519|517024673|FG000|Overall Study|Adverse Event|1|||
143403018|NCT04159519|517024674|FG001|Overall Study|Adverse Event|1|||
143403019|NCT04159519|517024673|FG000|Overall Study|Lack of Efficacy|1|||
143403020|NCT04159519|517024674|FG001|Overall Study|Lack of Efficacy|0|||
143403021|NCT04159519|517024673|FG000|Overall Study|Discontinued from study|1|||
143403022|NCT04159519|517024674|FG001|Overall Study|Discontinued from study|0|||
143403023|NCT04159519|517024673|FG000|Overall Study|Protocol Violation|1|||
143403024|NCT04159519|517024674|FG001|Overall Study|Protocol Violation|1|||
143403025|NCT04159519|517024673|FG000|Overall Study|Withdrawal by Subject|4|||
143403026|NCT04159519|517024674|FG001|Overall Study|Withdrawal by Subject|4|||
143403027|NCT03493542|517024675|FG000|Base Study|Withdrawal by Subject|0|||
143403028|NCT03493542|517024676|FG001|Base Study|Withdrawal by Subject|4|||
143403029|NCT03493542|517024677|FG002|Base Study|Withdrawal by Subject|0|||
143403030|NCT03493542|517024675|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
143403031|NCT03493542|517024676|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
143403032|NCT03493542|517024677|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
143403033|NCT03493542|517024675|FG000|Extension Study|Withdrawal by Subject|0|||
143403034|NCT03493542|517024676|FG001|Extension Study|Withdrawal by Subject|0|||
143403035|NCT03493542|517024677|FG002|Extension Study|Withdrawal by Subject|25|||
143403036|NCT01756300|517024683|FG000|Overall Study|Death|1|||
143403037|NCT01756300|517024683|FG000|Overall Study|Withdrawal by Subject|1|||
143403038|NCT04244175|517025318|FG000|Overall Study|Adverse Event|3|||
143403039|NCT04244175|517025319|FG001|Overall Study|Adverse Event|2|||
143403040|NCT04244175|517025320|FG002|Overall Study|Adverse Event|5|||
143403041|NCT04244175|517025318|FG000|Overall Study|Lack of Efficacy|1|||
143403042|NCT04244175|517025319|FG001|Overall Study|Lack of Efficacy|0|||
143403043|NCT04244175|517025320|FG002|Overall Study|Lack of Efficacy|1|||
143403044|NCT04244175|517025318|FG000|Overall Study|Lost to Follow-up|1|||
143403045|NCT04244175|517025319|FG001|Overall Study|Lost to Follow-up|0|||
143403046|NCT04244175|517025320|FG002|Overall Study|Lost to Follow-up|0|||
143403047|NCT04244175|517025318|FG000|Overall Study|Non-compliance with study drug|1|||
143403048|NCT04244175|517025319|FG001|Overall Study|Non-compliance with study drug|0|||
143403049|NCT04244175|517025320|FG002|Overall Study|Non-compliance with study drug|1|||
143403050|NCT04244175|517025318|FG000|Overall Study|Protocol deviation|0|||
143403051|NCT04244175|517025319|FG001|Overall Study|Protocol deviation|1|||
143403052|NCT04244175|517025320|FG002|Overall Study|Protocol deviation|0|||
143403053|NCT04244175|517025318|FG000|Overall Study|Withdrawal by Subject|1|||
143403054|NCT04244175|517025319|FG001|Overall Study|Withdrawal by Subject|3|||
143403055|NCT04244175|517025320|FG002|Overall Study|Withdrawal by Subject|1|||
143403056|NCT04244175|517025318|FG000|Overall Study|Other, not specified|0|||
143403057|NCT04244175|517025319|FG001|Overall Study|Other, not specified|1|||
143403058|NCT04244175|517025320|FG002|Overall Study|Other, not specified|2|||
143403059|NCT02163694|517025324|FG000|Overall Study|Adverse event- related to progression|4|||
143403060|NCT02163694|517025325|FG001|Overall Study|Adverse event- related to progression|10|||
143403061|NCT02163694|517025324|FG000|Overall Study|Adverse event- not related to progression|7|||
143403062|NCT02163694|517025325|FG001|Overall Study|Adverse event- not related to progression|22|||
143403063|NCT02163694|517025324|FG000|Overall Study|Withdrew consent|13|||
143403064|NCT02163694|517025325|FG001|Overall Study|Withdrew consent|28|||
143403065|NCT02163694|517025324|FG000|Overall Study|Lost to Follow-up|2|||
143403066|NCT02163694|517025325|FG001|Overall Study|Lost to Follow-up|2|||
143403067|NCT02163694|517025324|FG000|Overall Study|Sponsor discontinued study|3|||
143403068|NCT02163694|517025325|FG001|Overall Study|Sponsor discontinued study|29|||
143403069|NCT02163694|517025324|FG000|Overall Study|Progressive disease per protocol|125|||
143403070|NCT02163694|517025325|FG001|Overall Study|Progressive disease per protocol|224|||
143403071|NCT02163694|517025324|FG000|Overall Study|Other, not specified|17|||
143403072|NCT02163694|517025325|FG001|Overall Study|Other, not specified|22|||
143403073|NCT02163694|517025324|FG000|Overall Study|Randomized but Not Treated|1|||
143403074|NCT02163694|517025325|FG001|Overall Study|Randomized but Not Treated|0|||
143403075|NCT02163694|517025324|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
143403076|NCT02163694|517025325|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
143403077|NCT04560179|517025332|FG000|Overall Study|Physician Decision|1|||
143403078|NCT04560179|517025333|FG001|Overall Study|Physician Decision|0|||
143403079|NCT04560179|517025334|FG002|Overall Study|Physician Decision|0|||
143403080|NCT04560179|517025335|FG003|Overall Study|Physician Decision|0|||
143403081|NCT04560179|517025336|FG004|Overall Study|Physician Decision|0|||
143403082|NCT04560179|517025332|FG000|Overall Study|Adverse Event|0|||
143403083|NCT04560179|517025333|FG001|Overall Study|Adverse Event|0|||
143403084|NCT04560179|517025334|FG002|Overall Study|Adverse Event|0|||
143403085|NCT04560179|517025335|FG003|Overall Study|Adverse Event|1|||
143403086|NCT04560179|517025336|FG004|Overall Study|Adverse Event|0|||
143403087|NCT02624050|517025347|FG000|Overall Study|Physician Decision|4|||
143403088|NCT02624050|517025348|FG001|Overall Study|Physician Decision|0|||
143403089|NCT02624050|517025347|FG000|Overall Study|Protocol Violation|2|||
143403090|NCT02624050|517025348|FG001|Overall Study|Protocol Violation|0|||
143403091|NCT01897441|517025350|FG000|Overall Study|Lost to Follow-up|0|||
143403092|NCT01897441|517025351|FG001|Overall Study|Lost to Follow-up|0|||
143403093|NCT01897441|517025352|FG002|Overall Study|Lost to Follow-up|1|||
143403094|NCT01897441|517025353|FG003|Overall Study|Lost to Follow-up|0|||
143403095|NCT01897441|517025354|FG004|Overall Study|Lost to Follow-up|0|||
143403096|NCT01897441|517025355|FG005|Overall Study|Lost to Follow-up|0|||
143403097|NCT01897441|517025350|FG000|Overall Study|Withdrawal by Subject|0|||
143403098|NCT01897441|517025351|FG001|Overall Study|Withdrawal by Subject|0|||
143403099|NCT01897441|517025352|FG002|Overall Study|Withdrawal by Subject|0|||
143403100|NCT01897441|517025353|FG003|Overall Study|Withdrawal by Subject|0|||
143403101|NCT01897441|517025354|FG004|Overall Study|Withdrawal by Subject|1|||
143403102|NCT01897441|517025355|FG005|Overall Study|Withdrawal by Subject|0|||
143403103|NCT01897441|517025350|FG000|Overall Study|Withdrawn by Provider|0|||
143403104|NCT01897441|517025351|FG001|Overall Study|Withdrawn by Provider|2|||
143403105|NCT01897441|517025352|FG002|Overall Study|Withdrawn by Provider|0|||
143403106|NCT01897441|517025353|FG003|Overall Study|Withdrawn by Provider|0|||
143403107|NCT01897441|517025354|FG004|Overall Study|Withdrawn by Provider|0|||
143403108|NCT01897441|517025355|FG005|Overall Study|Withdrawn by Provider|0|||
143403109|NCT04157517|517025356|FG000|Overall Study|Death|1|||
143403110|NCT04157517|517025357|FG001|Overall Study|Death|2|||
143403111|NCT04157517|517025358|FG002|Overall Study|Death|2|||
143403112|NCT04157517|517025359|FG003|Overall Study|Death|3|||
143403113|NCT04157517|517025360|FG004|Overall Study|Death|3|||
143403114|NCT04157517|517025361|FG005|Overall Study|Death|4|||
143403115|NCT04157517|517025362|FG006|Overall Study|Death|1|||
143403116|NCT04157517|517025363|FG007|Overall Study|Death|2|||
143403117|NCT04157517|517025364|FG008|Overall Study|Death|4|||
143403118|NCT04157517|517025365|FG009|Overall Study|Death|0|||
143403119|NCT04157517|517025356|FG000|Overall Study|Withdrawal by Subject|1|||
143403120|NCT04157517|517025357|FG001|Overall Study|Withdrawal by Subject|1|||
143403121|NCT04157517|517025358|FG002|Overall Study|Withdrawal by Subject|1|||
143403122|NCT04157517|517025359|FG003|Overall Study|Withdrawal by Subject|0|||
143403123|NCT04157517|517025360|FG004|Overall Study|Withdrawal by Subject|0|||
143403124|NCT04157517|517025361|FG005|Overall Study|Withdrawal by Subject|1|||
143403125|NCT04157517|517025362|FG006|Overall Study|Withdrawal by Subject|0|||
143403126|NCT04157517|517025363|FG007|Overall Study|Withdrawal by Subject|0|||
143403127|NCT04157517|517025364|FG008|Overall Study|Withdrawal by Subject|1|||
143403128|NCT04157517|517025365|FG009|Overall Study|Withdrawal by Subject|0|||
143403129|NCT04157517|517025356|FG000|Overall Study|Other|1|||
143403130|NCT04157517|517025357|FG001|Overall Study|Other|0|||
143403131|NCT04157517|517025358|FG002|Overall Study|Other|0|||
143403132|NCT04157517|517025359|FG003|Overall Study|Other|0|||
143403133|NCT04157517|517025360|FG004|Overall Study|Other|0|||
143403134|NCT04157517|517025361|FG005|Overall Study|Other|1|||
143403135|NCT04157517|517025362|FG006|Overall Study|Other|2|||
143403136|NCT04157517|517025363|FG007|Overall Study|Other|7|||
143403137|NCT04157517|517025364|FG008|Overall Study|Other|7|||
143403138|NCT04157517|517025365|FG009|Overall Study|Other|0|||
143403139|NCT01651000|517025366|FG000|Overall Study|Adverse Event|2|||
143403140|NCT01651000|517025367|FG001|Overall Study|Adverse Event|8|||
143403141|NCT01651000|517025366|FG000|Overall Study|Lost to Follow-up|3|||
143403142|NCT01651000|517025367|FG001|Overall Study|Lost to Follow-up|2|||
143403143|NCT01651000|517025366|FG000|Overall Study|Protocol Violation|0|||
143403144|NCT01651000|517025367|FG001|Overall Study|Protocol Violation|3|||
143403145|NCT01651000|517025366|FG000|Overall Study|Withdrawal by Subject|2|||
143403146|NCT01651000|517025367|FG001|Overall Study|Withdrawal by Subject|10|||
143403147|NCT01651000|517025366|FG000|Overall Study|Subject noncompliance|0|||
143403148|NCT01651000|517025367|FG001|Overall Study|Subject noncompliance|3|||
143403149|NCT01651000|517025366|FG000|Overall Study|Lack of Efficacy|1|||
143403150|NCT01651000|517025367|FG001|Overall Study|Lack of Efficacy|1|||
143403151|NCT01651000|517025366|FG000|Overall Study|Physician Decision|1|||
143403152|NCT01651000|517025367|FG001|Overall Study|Physician Decision|0|||
143403153|NCT01651000|517025366|FG000|Overall Study|Administrative reason|1|||
143403154|NCT01651000|517025367|FG001|Overall Study|Administrative reason|0|||
143403155|NCT01651000|517025366|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
143403156|NCT01651000|517025367|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
143403157|NCT02765412|517025368|FG000|Overall Study|Death|482|||
143403158|NCT02765412|517025369|FG001|Overall Study|Death|855|||
143403159|NCT02076009|517026143|FG000|Overall Study|Death|172|||
143403160|NCT02076009|517026144|FG001|Overall Study|Death|153|||
143403161|NCT02076009|517026143|FG000|Overall Study|Withdrawal by Subject|16|||
143403162|NCT02076009|517026144|FG001|Overall Study|Withdrawal by Subject|12|||
143403163|NCT02076009|517026143|FG000|Overall Study|Lost to Follow-up|4|||
143403164|NCT02076009|517026144|FG001|Overall Study|Lost to Follow-up|2|||
143403165|NCT02076009|517026143|FG000|Overall Study|Progressive Disease|1|||
143403166|NCT02076009|517026144|FG001|Overall Study|Progressive Disease|0|||
143403167|NCT02076009|517026143|FG000|Overall Study|Physician Decision|0|||
143403168|NCT02076009|517026144|FG001|Overall Study|Physician Decision|1|||
143403169|NCT02076009|517026143|FG000|Overall Study|End of data collection|90|||
143403170|NCT02076009|517026144|FG001|Overall Study|End of data collection|118|||
143403171|NCT04165213|517026145|FG000|Clinician Enrollment|Did not deliver COPE to dyads|1|||
143403172|NCT04165213|517026146|FG001|Clinician Enrollment|Did not deliver COPE to dyads|2|||
143403173|NCT04165213|517026145|FG000|Clinician Enrollment|Withdrawal by Subject|6|||
143403174|NCT04165213|517026146|FG001|Clinician Enrollment|Withdrawal by Subject|0|||
143403175|NCT04165213|517026145|FG000|Clinician Enrollment|Termination from site|0|||
143403176|NCT04165213|517026146|FG001|Clinician Enrollment|Termination from site|1|||
143403177|NCT04165213|517026145|FG000|Caregiver Enrollment|Withdrawal by Subject|0|||
143403178|NCT04165213|517026146|FG001|Caregiver Enrollment|Withdrawal by Subject|5|||
143403179|NCT04165213|517026145|FG000|Caregiver Enrollment|Lost to Follow-up|1|||
143403180|NCT04165213|517026146|FG001|Caregiver Enrollment|Lost to Follow-up|1|||
143403181|NCT04165213|517026145|FG000|Caregiver Enrollment|Physician Decision|1|||
143403182|NCT04165213|517026146|FG001|Caregiver Enrollment|Physician Decision|0|||
143403183|NCT04165213|517026145|FG000|Caregiver Enrollment|PLWD entered long term care, no longer eligible|1|||
143403184|NCT04165213|517026146|FG001|Caregiver Enrollment|PLWD entered long term care, no longer eligible|0|||
143403185|NCT04165213|517026145|FG000|Caregiver Enrollment|PLWD death|2|||
143403186|NCT04165213|517026146|FG001|Caregiver Enrollment|PLWD death|0|||
143403187|NCT04165213|517026145|FG000|Caregiver Enrollment|Did not receive minimal dose of COPE|0|||
143403188|NCT04165213|517026146|FG001|Caregiver Enrollment|Did not receive minimal dose of COPE|4|||
143403189|NCT04165213|517026145|FG000|PLWD Enrollment|Withdrawal by Subject|0|||
143403190|NCT04165213|517026146|FG001|PLWD Enrollment|Withdrawal by Subject|5|||
143403191|NCT04165213|517026145|FG000|PLWD Enrollment|Lost to Follow-up|1|||
143403192|NCT04165213|517026146|FG001|PLWD Enrollment|Lost to Follow-up|1|||
143403193|NCT04165213|517026145|FG000|PLWD Enrollment|Physician Decision|1|||
143403194|NCT04165213|517026146|FG001|PLWD Enrollment|Physician Decision|0|||
143403195|NCT04165213|517026145|FG000|PLWD Enrollment|Entered long term care, no longer eligible|1|||
143403196|NCT04165213|517026146|FG001|PLWD Enrollment|Entered long term care, no longer eligible|0|||
143403197|NCT04165213|517026145|FG000|PLWD Enrollment|Death|2|||
143403198|NCT04165213|517026146|FG001|PLWD Enrollment|Death|0|||
143403199|NCT04165213|517026145|FG000|PLWD Enrollment|Did not receive minimal dose of COPE|0|||
143403200|NCT04165213|517026146|FG001|PLWD Enrollment|Did not receive minimal dose of COPE|4|||
143403201|NCT05147584|517026147|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
143403202|NCT00412607|517026158|FG000|Overall Study|Withdrawal by Subject|9|||
143403203|NCT00412607|517026158|FG000|Overall Study|Lost to Follow-up|19|||
143403204|NCT00412607|517026158|FG000|Overall Study|Death|61|||
143403205|NCT00412607|517026158|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
143403206|NCT04496752|517026165|FG000|Second Assessment|Lost to Follow-up|3|||
143403207|NCT04496752|517026166|FG001|Second Assessment|Lost to Follow-up|3|||
143403208|NCT04496752|517026165|FG000|Second Assessment|Adverse Event|2|||
143403209|NCT04496752|517026166|FG001|Second Assessment|Adverse Event|0|||
143403210|NCT04369911|517026169|FG000|Overall Study|Lost to Follow-up|3|||
143403211|NCT04369911|517026170|FG001|Overall Study|Lost to Follow-up|3|||
143403212|NCT04369911|517026169|FG000|Overall Study|Withdrawal by Subject|1|||
143403213|NCT04369911|517026170|FG001|Overall Study|Withdrawal by Subject|2|||
143403214|NCT03662022|517026171|FG000|Year 1 2019|prevalent case|83|||
143403215|NCT03662022|517026172|FG001|Year 1 2019|prevalent case|116|||
143403216|NCT03662022|517026173|FG002|Year 1 2019|prevalent case|158|||
143403217|NCT03662022|517026174|FG003|Year 1 2019|prevalent case|99|||
143403218|NCT03662022|517026171|FG000|Year 2 2020|incident case|18|||
143403219|NCT03662022|517026172|FG001|Year 2 2020|incident case|18|||
143403220|NCT03662022|517026173|FG002|Year 2 2020|incident case|16|||
143403221|NCT03662022|517026174|FG003|Year 2 2020|incident case|26|||
143403222|NCT03662022|517026171|FG000|Year 2 2020|other case|18|||
143403223|NCT03662022|517026172|FG001|Year 2 2020|other case|16|||
143403224|NCT03662022|517026173|FG002|Year 2 2020|other case|16|||
143403225|NCT03662022|517026174|FG003|Year 2 2020|other case|24|||
143403226|NCT03662022|517026171|FG000|Year 2 2020|Lost to Follow-up|1633|||
143403227|NCT03662022|517026172|FG001|Year 2 2020|Lost to Follow-up|1183|||
143403228|NCT03662022|517026173|FG002|Year 2 2020|Lost to Follow-up|1381|||
143403229|NCT03662022|517026174|FG003|Year 2 2020|Lost to Follow-up|2858|||
143403230|NCT03662022|517026171|FG000|Year 3 2021|incident case|24|||
143403231|NCT03662022|517026172|FG001|Year 3 2021|incident case|27|||
143403232|NCT03662022|517026173|FG002|Year 3 2021|incident case|24|||
143403233|NCT03662022|517026174|FG003|Year 3 2021|incident case|11|||
143403234|NCT03662022|517026171|FG000|Year 3 2021|other case|4|||
143403235|NCT03662022|517026172|FG001|Year 3 2021|other case|15|||
143403236|NCT03662022|517026173|FG002|Year 3 2021|other case|10|||
143403237|NCT03662022|517026174|FG003|Year 3 2021|other case|14|||
143403238|NCT03662022|517026171|FG000|Year 3 2021|Lost to Follow-up|179|||
143403239|NCT03662022|517026172|FG001|Year 3 2021|Lost to Follow-up|244|||
143403240|NCT03662022|517026173|FG002|Year 3 2021|Lost to Follow-up|480|||
143403241|NCT03662022|517026174|FG003|Year 3 2021|Lost to Follow-up|477|||
143403242|NCT03662022|517026171|FG000|Year 4 2022|incident case|25|||
143403243|NCT03662022|517026172|FG001|Year 4 2022|incident case|41|||
143403244|NCT03662022|517026173|FG002|Year 4 2022|incident case|28|||
143403245|NCT03662022|517026174|FG003|Year 4 2022|incident case|7|||
143403246|NCT03662022|517026171|FG000|Year 4 2022|other case|8|||
143403247|NCT03662022|517026172|FG001|Year 4 2022|other case|19|||
143403248|NCT03662022|517026173|FG002|Year 4 2022|other case|13|||
143403249|NCT03662022|517026174|FG003|Year 4 2022|other case|7|||
143403250|NCT03662022|517026171|FG000|Year 4 2022|Lost to Follow-up|986|||
143403251|NCT03662022|517026172|FG001|Year 4 2022|Lost to Follow-up|1079|||
143403252|NCT03662022|517026173|FG002|Year 4 2022|Lost to Follow-up|1236|||
143403253|NCT03662022|517026174|FG003|Year 4 2022|Lost to Follow-up|1826|||
143403254|NCT04675034|517026175|FG000|Overall Study|Lost to Follow-up|1|||
143403255|NCT04675034|517026176|FG001|Overall Study|Lost to Follow-up|1|||
143403256|NCT04675034|517026177|FG002|Overall Study|Lost to Follow-up|0|||
143403257|NCT04675034|517026178|FG003|Overall Study|Lost to Follow-up|2|||
143403258|NCT04675034|517026179|FG004|Overall Study|Lost to Follow-up|0|||
143403259|NCT04675034|517026175|FG000|Overall Study|Protocol Violation|1|||
143403260|NCT04675034|517026176|FG001|Overall Study|Protocol Violation|0|||
143403261|NCT04675034|517026177|FG002|Overall Study|Protocol Violation|0|||
143403262|NCT04675034|517026178|FG003|Overall Study|Protocol Violation|1|||
143403263|NCT04675034|517026179|FG004|Overall Study|Protocol Violation|3|||
143403264|NCT04675034|517026175|FG000|Overall Study|Withdrawal by Subject|9|||
143403265|NCT04675034|517026176|FG001|Overall Study|Withdrawal by Subject|3|||
143403266|NCT04675034|517026177|FG002|Overall Study|Withdrawal by Subject|4|||
143403267|NCT04675034|517026178|FG003|Overall Study|Withdrawal by Subject|8|||
143403268|NCT04675034|517026179|FG004|Overall Study|Withdrawal by Subject|6|||
143403269|NCT04214418|517026180|FG000|Overall Study|Withdrawal by Subject|1|||
143403270|NCT04214418|517026181|FG001|Overall Study|Withdrawal by Subject|0|||
143403271|NCT04214418|517026182|FG002|Overall Study|Withdrawal by Subject|0|||
143403272|NCT04214418|517026183|FG003|Overall Study|Withdrawal by Subject|0|||
143403273|NCT04214418|517026184|FG004|Overall Study|Withdrawal by Subject|0|||
143403274|NCT04214418|517026185|FG005|Overall Study|Withdrawal by Subject|0|||
143403275|NCT04214418|517026180|FG000|Overall Study|Adverse Event|0|||
143403276|NCT04214418|517026181|FG001|Overall Study|Adverse Event|2|||
143403277|NCT04214418|517026182|FG002|Overall Study|Adverse Event|0|||
143403278|NCT04214418|517026183|FG003|Overall Study|Adverse Event|0|||
143403279|NCT04214418|517026184|FG004|Overall Study|Adverse Event|0|||
143403280|NCT04214418|517026185|FG005|Overall Study|Adverse Event|0|||
143403281|NCT04214418|517026180|FG000|Overall Study|Death|1|||
143403282|NCT04214418|517026181|FG001|Overall Study|Death|0|||
143403283|NCT04214418|517026182|FG002|Overall Study|Death|0|||
143403284|NCT04214418|517026183|FG003|Overall Study|Death|0|||
143403285|NCT04214418|517026184|FG004|Overall Study|Death|0|||
143403286|NCT04214418|517026185|FG005|Overall Study|Death|0|||
143403287|NCT03248479|517026188|FG000|Overall Study|Death|12|||
143403288|NCT03248479|517026189|FG001|Overall Study|Death|44|||
143403289|NCT03248479|517026190|FG002|Overall Study|Death|1|||
143403290|NCT03248479|517026191|FG003|Overall Study|Death|72|||
143403291|NCT03248479|517026192|FG004|Overall Study|Death|17|||
143403292|NCT03248479|517026193|FG005|Overall Study|Death|6|||
143403293|NCT03248479|517026194|FG006|Overall Study|Death|1|||
143403294|NCT03248479|517026195|FG007|Overall Study|Death|14|||
143403295|NCT03248479|517026196|FG008|Overall Study|Death|3|||
143403296|NCT03248479|517026197|FG009|Overall Study|Death|7|||
143403297|NCT03248479|517026198|FG010|Overall Study|Death|3|||
143403298|NCT03248479|517026199|FG011|Overall Study|Death|1|||
143403299|NCT03248479|517026200|FG012|Overall Study|Death|1|||
143403300|NCT03248479|517026188|FG000|Overall Study|Study terminated by sponsor|12|||
143403301|NCT03248479|517026189|FG001|Overall Study|Study terminated by sponsor|15|||
143403302|NCT03248479|517026190|FG002|Overall Study|Study terminated by sponsor|0|||
143403303|NCT03248479|517026191|FG003|Overall Study|Study terminated by sponsor|5|||
143403304|NCT03248479|517026192|FG004|Overall Study|Study terminated by sponsor|0|||
143403305|NCT03248479|517026193|FG005|Overall Study|Study terminated by sponsor|0|||
143403306|NCT03248479|517026194|FG006|Overall Study|Study terminated by sponsor|0|||
143403307|NCT03248479|517026195|FG007|Overall Study|Study terminated by sponsor|1|||
143403308|NCT03248479|517026196|FG008|Overall Study|Study terminated by sponsor|1|||
143403309|NCT03248479|517026197|FG009|Overall Study|Study terminated by sponsor|0|||
143403310|NCT03248479|517026198|FG010|Overall Study|Study terminated by sponsor|5|||
143403311|NCT03248479|517026199|FG011|Overall Study|Study terminated by sponsor|4|||
143403312|NCT03248479|517026200|FG012|Overall Study|Study terminated by sponsor|0|||
143403313|NCT03248479|517026188|FG000|Overall Study|Consent withdrawn|6|||
143403314|NCT03248479|517026189|FG001|Overall Study|Consent withdrawn|3|||
143403315|NCT03248479|517026190|FG002|Overall Study|Consent withdrawn|0|||
143403316|NCT03248479|517026191|FG003|Overall Study|Consent withdrawn|9|||
143403317|NCT03248479|517026192|FG004|Overall Study|Consent withdrawn|1|||
143403318|NCT03248479|517026193|FG005|Overall Study|Consent withdrawn|0|||
143403319|NCT03248479|517026194|FG006|Overall Study|Consent withdrawn|0|||
143403320|NCT03248479|517026195|FG007|Overall Study|Consent withdrawn|1|||
143403321|NCT03248479|517026196|FG008|Overall Study|Consent withdrawn|0|||
143403322|NCT03248479|517026197|FG009|Overall Study|Consent withdrawn|3|||
143403323|NCT03248479|517026198|FG010|Overall Study|Consent withdrawn|1|||
143403324|NCT03248479|517026199|FG011|Overall Study|Consent withdrawn|0|||
143403325|NCT03248479|517026200|FG012|Overall Study|Consent withdrawn|1|||
143403326|NCT03248479|517026188|FG000|Overall Study|Lost to Follow-up|2|||
143403327|NCT03248479|517026189|FG001|Overall Study|Lost to Follow-up|1|||
143403328|NCT03248479|517026190|FG002|Overall Study|Lost to Follow-up|0|||
143403329|NCT03248479|517026191|FG003|Overall Study|Lost to Follow-up|0|||
143403330|NCT03248479|517026192|FG004|Overall Study|Lost to Follow-up|0|||
143403331|NCT03248479|517026193|FG005|Overall Study|Lost to Follow-up|0|||
143403332|NCT03248479|517026194|FG006|Overall Study|Lost to Follow-up|0|||
143403333|NCT03248479|517026195|FG007|Overall Study|Lost to Follow-up|0|||
143403334|NCT03248479|517026196|FG008|Overall Study|Lost to Follow-up|0|||
143403335|NCT03248479|517026197|FG009|Overall Study|Lost to Follow-up|0|||
143403336|NCT03248479|517026198|FG010|Overall Study|Lost to Follow-up|0|||
143403337|NCT03248479|517026199|FG011|Overall Study|Lost to Follow-up|0|||
143403338|NCT03248479|517026200|FG012|Overall Study|Lost to Follow-up|1|||
143403339|NCT03248479|517026188|FG000|Overall Study|Not reported|0|||
143403340|NCT03248479|517026189|FG001|Overall Study|Not reported|0|||
143403341|NCT03248479|517026190|FG002|Overall Study|Not reported|0|||
143403342|NCT03248479|517026191|FG003|Overall Study|Not reported|1|||
143403343|NCT03248479|517026192|FG004|Overall Study|Not reported|1|||
143403344|NCT03248479|517026193|FG005|Overall Study|Not reported|0|||
143403345|NCT03248479|517026194|FG006|Overall Study|Not reported|0|||
143403346|NCT03248479|517026195|FG007|Overall Study|Not reported|1|||
143403347|NCT03248479|517026196|FG008|Overall Study|Not reported|1|||
143403348|NCT03248479|517026197|FG009|Overall Study|Not reported|0|||
143403349|NCT03248479|517026198|FG010|Overall Study|Not reported|0|||
143403350|NCT03248479|517026199|FG011|Overall Study|Not reported|0|||
143403351|NCT03248479|517026200|FG012|Overall Study|Not reported|0|||
143403352|NCT04679389|517026201|FG000|Overall Study|Adverse Event|1|||
143403353|NCT04679389|517026202|FG001|Overall Study|Adverse Event|0|||
143403354|NCT04679389|517026201|FG000|Overall Study|Protocol Violation|2|||
143403355|NCT04679389|517026202|FG001|Overall Study|Protocol Violation|0|||
143403356|NCT04679389|517026201|FG000|Overall Study|Physician Decision|3|||
143403357|NCT04679389|517026202|FG001|Overall Study|Physician Decision|5|||
143403358|NCT04679389|517026201|FG000|Overall Study|Withdrawal by Subject|5|||
143403359|NCT04679389|517026202|FG001|Overall Study|Withdrawal by Subject|7|||
143403360|NCT05454514|517026205|FG000|Overall Study|Withdrawal by Subject|4|||
143403361|NCT05541484|517026211|FG000|Overall Study|Withdrawal by Subject|1|||
143403362|NCT05541484|517026212|FG001|Overall Study|Withdrawal by Subject|0|||
143403363|NCT05785130|517026213|FG000|Overall Study|Withdrawal by Subject|1|||
143403364|NCT05785130|517026214|FG001|Overall Study|Withdrawal by Subject|0|||
143403365|NCT05785130|517026213|FG000|Overall Study|Lack of Efficacy|0|||
143403366|NCT05785130|517026214|FG001|Overall Study|Lack of Efficacy|1|||
143403367|NCT03904576|517026218|FG000|Washout Period|Protocol Violation|1|||
143403368|NCT03904576|517026219|FG001|Washout Period|Protocol Violation|1|||
143403369|NCT01475786|517026224|FG000|Overall Study|Adverse Event|0|||
143403370|NCT01475786|517026225|FG001|Overall Study|Adverse Event|1|||
143403371|NCT01475786|517026226|FG002|Overall Study|Adverse Event|0|||
143403372|NCT01475786|517026224|FG000|Overall Study|Lost to Follow-up|1|||
143403373|NCT01475786|517026225|FG001|Overall Study|Lost to Follow-up|2|||
143403374|NCT01475786|517026226|FG002|Overall Study|Lost to Follow-up|1|||
143403375|NCT01475786|517026224|FG000|Overall Study|Withdrawal by Subject|0|||
143403376|NCT01475786|517026225|FG001|Overall Study|Withdrawal by Subject|1|||
143403377|NCT01475786|517026226|FG002|Overall Study|Withdrawal by Subject|1|||
143403378|NCT01475786|517026224|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
143403379|NCT01475786|517026225|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
143403380|NCT01475786|517026226|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
143403381|NCT04780581|517026231|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
143403382|NCT04780581|517026232|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
143403383|NCT04780581|517026231|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
143403384|NCT04780581|517026232|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
143403385|NCT03781089|517027089|FG000|Overall Study|Constipation|1|||
143403386|NCT03781089|517027090|FG001|Overall Study|Constipation|0|||
143403387|NCT03781089|517027089|FG000|Overall Study|Positive pregnancy test|0|||
143403388|NCT03781089|517027090|FG001|Overall Study|Positive pregnancy test|1|||
143403389|NCT03417284|517027091|FG000|Overall Study|Inadequate supply on study drug|1|||
143403390|NCT03417284|517027092|FG001|Overall Study|Inadequate supply on study drug|0|||
143403391|NCT03417284|517027093|FG002|Overall Study|Inadequate supply on study drug|0|||
143403392|NCT03417284|517027094|FG003|Overall Study|Inadequate supply on study drug|0|||
143403393|NCT03417284|517027091|FG000|Overall Study|Disease Progression|0|||
143403394|NCT03417284|517027092|FG001|Overall Study|Disease Progression|0|||
143403395|NCT03417284|517027093|FG002|Overall Study|Disease Progression|1|||
143403396|NCT03417284|517027094|FG003|Overall Study|Disease Progression|0|||
143403397|NCT05132400|517027095|FG000|Overall Study|Withdrawal by Subject|14|||
143403398|NCT05132400|517027096|FG001|Overall Study|Withdrawal by Subject|8|||
143403399|NCT05132400|517027095|FG000|Overall Study|Lost to Follow-up|132|||
143403400|NCT05132400|517027096|FG001|Overall Study|Lost to Follow-up|121|||
143403401|NCT04633278|517027097|FG000|Overall Study|Adverse Event|1|||
143403402|NCT04633278|517027098|FG001|Overall Study|Adverse Event|0|||
143403403|NCT04633278|517027097|FG000|Overall Study|Withdrawal by Subject|1|||
143403404|NCT04633278|517027098|FG001|Overall Study|Withdrawal by Subject|0|||
143403405|NCT04633278|517027097|FG000|Overall Study|Death|11|||
143403406|NCT04633278|517027098|FG001|Overall Study|Death|7|||
143403407|NCT04633278|517027097|FG000|Overall Study|Sponsor Decision|3|||
143403408|NCT04633278|517027098|FG001|Overall Study|Sponsor Decision|0|||
143403409|NCT04633278|517027097|FG000|Overall Study|Not Listed|1|||
143403410|NCT04633278|517027098|FG001|Overall Study|Not Listed|0|||
143403411|NCT03636490|517027099|FG000|Overall Study|Dropped out or incomplete data|141|||
143403412|NCT02246127|517027100|FG000|First Course Treatment|Adverse Event|9|||
143403413|NCT02246127|517027101|FG001|First Course Treatment|Adverse Event|7|||
143403414|NCT02246127|517027100|FG000|First Course Treatment|Withdrawal by Subject|6|||
143403415|NCT02246127|517027101|FG001|First Course Treatment|Withdrawal by Subject|7|||
143403416|NCT02246127|517027100|FG000|First Course Treatment|Physician Decision|9|||
143403417|NCT02246127|517027101|FG001|First Course Treatment|Physician Decision|9|||
143403418|NCT02246127|517027100|FG000|First Course Treatment|Death|3|||
143403419|NCT02246127|517027101|FG001|First Course Treatment|Death|3|||
143403420|NCT02246127|517027100|FG000|First Course Treatment|Not reported reasons|6|||
143403421|NCT02246127|517027101|FG001|First Course Treatment|Not reported reasons|7|||
143403422|NCT02246127|517027100|FG000|First Course Treatment|Not treated|3|||
143403423|NCT02246127|517027101|FG001|First Course Treatment|Not treated|3|||
143403424|NCT03884439|517027113|FG000|Overall Study|No informed consent for publication of study results|38|||
143403425|NCT03884439|517027113|FG000|Overall Study|Contract violation/deficiency|7|||
143403426|NCT03547271|517027116|FG000|Overall Study|Adverse Event|1|||
143403427|NCT03547271|517027117|FG001|Overall Study|Adverse Event|1|||
143403428|NCT03547271|517027118|FG002|Overall Study|Adverse Event|0|||
143403429|NCT03547271|517027119|FG003|Overall Study|Adverse Event|0|||
143403430|NCT03547271|517027116|FG000|Overall Study|Protocol deviation|5|||
143403431|NCT03547271|517027117|FG001|Overall Study|Protocol deviation|7|||
143403432|NCT03547271|517027118|FG002|Overall Study|Protocol deviation|3|||
143403433|NCT03547271|517027119|FG003|Overall Study|Protocol deviation|0|||
143403434|NCT03547271|517027116|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
143403435|NCT03547271|517027117|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
143403436|NCT03547271|517027118|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
143403437|NCT03547271|517027119|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
143403438|NCT03547271|517027116|FG000|Overall Study|Lost to Follow-up|3|||
143403439|NCT03547271|517027117|FG001|Overall Study|Lost to Follow-up|3|||
143403440|NCT03547271|517027118|FG002|Overall Study|Lost to Follow-up|1|||
143403441|NCT03547271|517027119|FG003|Overall Study|Lost to Follow-up|0|||
143403442|NCT03522298|517027128|FG000|Overall Study|Adverse Event|1|||
143403443|NCT03522298|517027129|FG001|Overall Study|Adverse Event|0|||
143403444|NCT03522298|517027130|FG002|Overall Study|Adverse Event|0|||
143403445|NCT03522298|517027131|FG003|Overall Study|Adverse Event|1|||
143403446|NCT03522298|517027128|FG000|Overall Study|Death|2|||
143403447|NCT03522298|517027129|FG001|Overall Study|Death|4|||
143403448|NCT03522298|517027130|FG002|Overall Study|Death|8|||
143403449|NCT03522298|517027131|FG003|Overall Study|Death|8|||
143403450|NCT03522298|517027128|FG000|Overall Study|Patient decision|0|||
143403451|NCT03522298|517027129|FG001|Overall Study|Patient decision|2|||
143403452|NCT03522298|517027130|FG002|Overall Study|Patient decision|2|||
143403453|NCT03522298|517027131|FG003|Overall Study|Patient decision|2|||
143403454|NCT04795245|517027132|FG000|Overall Study|Unkown reason|7|||
143403455|NCT04795245|517027132|FG000|Overall Study|Death|17|||
143403456|NCT04795245|517027132|FG000|Overall Study|Other than listed|19|||
143403457|NCT04795245|517027132|FG000|Overall Study|Adverse Event|143|||
143403458|NCT04795245|517027132|FG000|Overall Study|Progressive disease|512|||
143403459|NCT04795245|517027132|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
143403460|NCT03418740|517027133|FG000|Overall Study|Lost to Follow-up|13|||
143403461|NCT03418740|517027133|FG000|Overall Study|Scheduling Issues|7|||
143403462|NCT03418740|517027133|FG000|Overall Study|Withdrawal by Subject|2|||
143403463|NCT03418740|517027133|FG000|Overall Study|Unable to Continue Consent|1|||
143403464|NCT05215054|517027134|FG000|Overall Study|Lost to Follow-up|1|||
143403465|NCT05215054|517027135|FG001|Overall Study|Lost to Follow-up|1|||
143403466|NCT05215054|517027134|FG000|Overall Study|Protocol Violation|1|||
143403467|NCT05215054|517027135|FG001|Overall Study|Protocol Violation|1|||
143403468|NCT05215054|517027134|FG000|Overall Study|Withdrawal by Subject|4|||
143403469|NCT05215054|517027135|FG001|Overall Study|Withdrawal by Subject|4|||
143403470|NCT03982186|517027136|FG000|Overall Study|Lost to Follow-up|0|||
143403471|NCT03982186|517027137|FG001|Overall Study|Lost to Follow-up|1|||
143403472|NCT03982186|517027138|FG002|Overall Study|Lost to Follow-up|2|||
143403473|NCT03982186|517027139|FG003|Overall Study|Lost to Follow-up|1|||
143403474|NCT03982186|517027140|FG004|Overall Study|Lost to Follow-up|1|||
143403475|NCT03982186|517027141|FG005|Overall Study|Lost to Follow-up|0|||
143403476|NCT03982186|517027136|FG000|Overall Study|Physician Decision|0|||
143403477|NCT03982186|517027137|FG001|Overall Study|Physician Decision|1|||
143403478|NCT03982186|517027138|FG002|Overall Study|Physician Decision|0|||
143403479|NCT03982186|517027139|FG003|Overall Study|Physician Decision|0|||
143403480|NCT03982186|517027140|FG004|Overall Study|Physician Decision|0|||
143403481|NCT03982186|517027141|FG005|Overall Study|Physician Decision|0|||
143403482|NCT03982186|517027136|FG000|Overall Study|Withdrawal by Subject|3|||
143403483|NCT03982186|517027137|FG001|Overall Study|Withdrawal by Subject|4|||
143403484|NCT03982186|517027138|FG002|Overall Study|Withdrawal by Subject|1|||
143403485|NCT03982186|517027139|FG003|Overall Study|Withdrawal by Subject|7|||
143403486|NCT03982186|517027140|FG004|Overall Study|Withdrawal by Subject|2|||
143403487|NCT03982186|517027141|FG005|Overall Study|Withdrawal by Subject|0|||
143403488|NCT03982186|517027136|FG000|Overall Study|Randomized and not treated|0|||
143403489|NCT03982186|517027137|FG001|Overall Study|Randomized and not treated|0|||
143403490|NCT03982186|517027138|FG002|Overall Study|Randomized and not treated|0|||
143403491|NCT03982186|517027139|FG003|Overall Study|Randomized and not treated|1|||
143403492|NCT03982186|517027140|FG004|Overall Study|Randomized and not treated|0|||
143403493|NCT03982186|517027141|FG005|Overall Study|Randomized and not treated|0|||
143403494|NCT03990883|517027142|FG000|Blinded Treatment Phase|Adverse Event|1|||
143403495|NCT03990883|517027143|FG001|Blinded Treatment Phase|Adverse Event|1|||
143403496|NCT03990883|517027144|FG002|Blinded Treatment Phase|Adverse Event|0|||
143403497|NCT03990883|517027142|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
143403498|NCT03990883|517027143|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
143403499|NCT03990883|517027144|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
143403500|NCT03990883|517027142|FG000|Blinded Treatment Phase|Physician Decision|1|||
143403501|NCT03990883|517027143|FG001|Blinded Treatment Phase|Physician Decision|0|||
143403502|NCT03990883|517027144|FG002|Blinded Treatment Phase|Physician Decision|0|||
143403503|NCT03990883|517027142|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
143403504|NCT03990883|517027143|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
143403505|NCT03990883|517027144|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
143403506|NCT03990883|517027142|FG000|Blinded Treatment Phase|COVID-19|3|||
143403507|NCT03990883|517027143|FG001|Blinded Treatment Phase|COVID-19|2|||
143403508|NCT03990883|517027144|FG002|Blinded Treatment Phase|COVID-19|0|||
143403509|NCT03990883|517027142|FG000|Blinded Treatment Phase|Personal Reasons|6|||
143403510|NCT03990883|517027143|FG001|Blinded Treatment Phase|Personal Reasons|3|||
143403511|NCT03990883|517027144|FG002|Blinded Treatment Phase|Personal Reasons|0|||
143403512|NCT03990883|517027142|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
143403513|NCT03990883|517027143|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
143403514|NCT03990883|517027144|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
143403515|NCT03990883|517027142|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
143403516|NCT03990883|517027143|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
143403517|NCT03990883|517027144|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
143403518|NCT03990883|517027142|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
143403519|NCT03990883|517027143|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
143403520|NCT03990883|517027144|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
143403521|NCT03635567|517027849|FG000|Overall Study|Lost to Follow-up|4|||
143403522|NCT03635567|517027850|FG001|Overall Study|Lost to Follow-up|1|||
143403523|NCT03635567|517027849|FG000|Overall Study|Withdrawal by Subject|11|||
143403524|NCT03635567|517027850|FG001|Overall Study|Withdrawal by Subject|16|||
143403525|NCT03635567|517027849|FG000|Overall Study|Sponsor Decision|99|||
143403526|NCT03635567|517027850|FG001|Overall Study|Sponsor Decision|57|||
143403527|NCT03635567|517027849|FG000|Overall Study|Death|194|||
143403528|NCT03635567|517027850|FG001|Overall Study|Death|235|||
143403529|NCT04772534|517027851|FG000|Overall Study|Physician Decision|1|||
143403530|NCT04772534|517027852|FG001|Overall Study|Physician Decision|0|||
143403531|NCT04772534|517027853|FG002|Overall Study|Physician Decision|0|||
143403532|NCT04772534|517027851|FG000|Overall Study|Withdrawal by Subject|3|||
143403533|NCT04772534|517027852|FG001|Overall Study|Withdrawal by Subject|0|||
143403534|NCT04772534|517027853|FG002|Overall Study|Withdrawal by Subject|1|||
143403535|NCT03786926|517027854|FG000|Overall Study|Adverse Event|0|||
143403536|NCT03786926|517027855|FG001|Overall Study|Adverse Event|0|||
143403537|NCT03786926|517027856|FG002|Overall Study|Adverse Event|0|||
143403538|NCT03786926|517027857|FG003|Overall Study|Adverse Event|0|||
143403539|NCT03786926|517027858|FG004|Overall Study|Adverse Event|0|||
143403540|NCT03786926|517027859|FG005|Overall Study|Adverse Event|0|||
143403541|NCT03786926|517027860|FG006|Overall Study|Adverse Event|0|||
143403542|NCT03786926|517027861|FG007|Overall Study|Adverse Event|1|||
143403543|NCT03786926|517027862|FG008|Overall Study|Adverse Event|1|||
143403544|NCT03786926|517027863|FG009|Overall Study|Adverse Event|0|||
143403545|NCT03786926|517027864|FG010|Overall Study|Adverse Event|1|||
143403546|NCT03786926|517027854|FG000|Overall Study|Progressive disease|3|||
143403547|NCT03786926|517027855|FG001|Overall Study|Progressive disease|0|||
143403548|NCT03786926|517027856|FG002|Overall Study|Progressive disease|3|||
143403549|NCT03786926|517027857|FG003|Overall Study|Progressive disease|1|||
143403550|NCT03786926|517027858|FG004|Overall Study|Progressive disease|2|||
143403551|NCT03786926|517027859|FG005|Overall Study|Progressive disease|2|||
143403552|NCT03786926|517027860|FG006|Overall Study|Progressive disease|1|||
143403553|NCT03786926|517027861|FG007|Overall Study|Progressive disease|6|||
143403554|NCT03786926|517027862|FG008|Overall Study|Progressive disease|1|||
143403555|NCT03786926|517027863|FG009|Overall Study|Progressive disease|1|||
143403556|NCT03786926|517027864|FG010|Overall Study|Progressive disease|1|||
143403557|NCT03786926|517027854|FG000|Overall Study|Death|0|||
143403558|NCT03786926|517027855|FG001|Overall Study|Death|1|||
143403559|NCT03786926|517027856|FG002|Overall Study|Death|1|||
143403560|NCT03786926|517027857|FG003|Overall Study|Death|0|||
143403561|NCT03786926|517027858|FG004|Overall Study|Death|0|||
143403562|NCT03786926|517027859|FG005|Overall Study|Death|0|||
143403563|NCT03786926|517027860|FG006|Overall Study|Death|0|||
143403564|NCT03786926|517027861|FG007|Overall Study|Death|0|||
143403565|NCT03786926|517027862|FG008|Overall Study|Death|0|||
143403566|NCT03786926|517027863|FG009|Overall Study|Death|1|||
143403567|NCT03786926|517027864|FG010|Overall Study|Death|2|||
143403568|NCT03786926|517027854|FG000|Overall Study|Physician Decision|0|||
143403569|NCT03786926|517027855|FG001|Overall Study|Physician Decision|1|||
143403570|NCT03786926|517027856|FG002|Overall Study|Physician Decision|0|||
143403571|NCT03786926|517027857|FG003|Overall Study|Physician Decision|1|||
143403572|NCT03786926|517027858|FG004|Overall Study|Physician Decision|2|||
143403573|NCT03786926|517027859|FG005|Overall Study|Physician Decision|0|||
143403574|NCT03786926|517027860|FG006|Overall Study|Physician Decision|0|||
143403575|NCT03786926|517027861|FG007|Overall Study|Physician Decision|2|||
143403576|NCT03786926|517027862|FG008|Overall Study|Physician Decision|1|||
143403577|NCT03786926|517027863|FG009|Overall Study|Physician Decision|1|||
143403578|NCT03786926|517027864|FG010|Overall Study|Physician Decision|0|||
143403579|NCT03786926|517027854|FG000|Overall Study|Withdrawal by Subject|0|||
143403580|NCT03786926|517027855|FG001|Overall Study|Withdrawal by Subject|1|||
143403581|NCT03786926|517027856|FG002|Overall Study|Withdrawal by Subject|1|||
143403582|NCT03786926|517027857|FG003|Overall Study|Withdrawal by Subject|0|||
143403583|NCT03786926|517027858|FG004|Overall Study|Withdrawal by Subject|0|||
143403584|NCT03786926|517027859|FG005|Overall Study|Withdrawal by Subject|0|||
143403585|NCT03786926|517027860|FG006|Overall Study|Withdrawal by Subject|1|||
143403586|NCT03786926|517027861|FG007|Overall Study|Withdrawal by Subject|0|||
143403587|NCT03786926|517027862|FG008|Overall Study|Withdrawal by Subject|1|||
143403588|NCT03786926|517027863|FG009|Overall Study|Withdrawal by Subject|0|||
143403589|NCT03786926|517027864|FG010|Overall Study|Withdrawal by Subject|1|||
143403590|NCT03786926|517027854|FG000|Overall Study|Study terminated by Sponsor|0|||
143403591|NCT03786926|517027855|FG001|Overall Study|Study terminated by Sponsor|0|||
143403592|NCT03786926|517027856|FG002|Overall Study|Study terminated by Sponsor|0|||
143403593|NCT03786926|517027857|FG003|Overall Study|Study terminated by Sponsor|0|||
143403594|NCT03786926|517027858|FG004|Overall Study|Study terminated by Sponsor|1|||
143403595|NCT03786926|517027859|FG005|Overall Study|Study terminated by Sponsor|0|||
143403596|NCT03786926|517027860|FG006|Overall Study|Study terminated by Sponsor|0|||
143403597|NCT03786926|517027861|FG007|Overall Study|Study terminated by Sponsor|4|||
143403598|NCT03786926|517027862|FG008|Overall Study|Study terminated by Sponsor|0|||
143403599|NCT03786926|517027863|FG009|Overall Study|Study terminated by Sponsor|0|||
143403600|NCT03786926|517027864|FG010|Overall Study|Study terminated by Sponsor|0|||
143403601|NCT03786926|517027854|FG000|Overall Study|Anti-neoplasm treatment|0|||
143403602|NCT03786926|517027855|FG001|Overall Study|Anti-neoplasm treatment|0|||
143403603|NCT03786926|517027856|FG002|Overall Study|Anti-neoplasm treatment|0|||
143403604|NCT03786926|517027857|FG003|Overall Study|Anti-neoplasm treatment|0|||
143403605|NCT03786926|517027858|FG004|Overall Study|Anti-neoplasm treatment|1|||
143403606|NCT03786926|517027859|FG005|Overall Study|Anti-neoplasm treatment|0|||
143403607|NCT03786926|517027860|FG006|Overall Study|Anti-neoplasm treatment|1|||
143403608|NCT03786926|517027861|FG007|Overall Study|Anti-neoplasm treatment|0|||
143403609|NCT03786926|517027862|FG008|Overall Study|Anti-neoplasm treatment|0|||
143403610|NCT03786926|517027863|FG009|Overall Study|Anti-neoplasm treatment|0|||
143403611|NCT03786926|517027864|FG010|Overall Study|Anti-neoplasm treatment|0|||
143403612|NCT03786926|517027854|FG000|Overall Study|Other|0|||
143403613|NCT03786926|517027855|FG001|Overall Study|Other|0|||
143403614|NCT03786926|517027856|FG002|Overall Study|Other|0|||
143403615|NCT03786926|517027857|FG003|Overall Study|Other|1|||
143403616|NCT03786926|517027858|FG004|Overall Study|Other|0|||
143403617|NCT03786926|517027859|FG005|Overall Study|Other|1|||
143403618|NCT03786926|517027860|FG006|Overall Study|Other|0|||
143403619|NCT03786926|517027861|FG007|Overall Study|Other|0|||
143403620|NCT03786926|517027862|FG008|Overall Study|Other|2|||
143403621|NCT03786926|517027863|FG009|Overall Study|Other|0|||
143403622|NCT03786926|517027864|FG010|Overall Study|Other|0|||
143403623|NCT00942734|517027872|FG000|Overall Study|Adverse Event|2|||
143403624|NCT00942734|517027872|FG000|Overall Study|Protocol Violation|3|||
143403625|NCT00942734|517027872|FG000|Overall Study|Disease Progression|2|||
143403626|NCT00942734|517027872|FG000|Overall Study|Physician Decision|1|||
143403627|NCT06655818|517027873|FG000|Overall Study|Withdrawal by Subject|1|||
143403628|NCT00319046|517027874|FG000|Overall Study|withdrawal of subject's consent|7|||
143403629|NCT00319046|517027874|FG000|Overall Study|administrative reason|1|||
143403630|NCT05718687|517027884|FG000|Overall Study|Withdrawal by Subject|3|||
143403631|NCT02933489|517027885|FG000|Overall Study|Ineligible|3|||
143403632|NCT02933489|517027886|FG001|Overall Study|Ineligible|3|||
143403633|NCT02933489|517027885|FG000|Overall Study|Withdrawal by Subject|27|||
143403634|NCT02933489|517027886|FG001|Overall Study|Withdrawal by Subject|18|||
143403635|NCT02933489|517027885|FG000|Overall Study|Unable to complete exams (other)|14|||
143403636|NCT02933489|517027886|FG001|Overall Study|Unable to complete exams (other)|7|||
143403637|NCT04093869|517027888|FG000|Overall Study|Death|0|||
143403638|NCT04093869|517027889|FG001|Overall Study|Death|1|||
143403639|NCT04093869|517027888|FG000|Overall Study|Withdrawal by Subject|1|||
143403640|NCT04093869|517027889|FG001|Overall Study|Withdrawal by Subject|0|||
143403641|NCT01499368|517027896|FG000|Overall Study|Did not meet I/E criteria|8|||
143403642|NCT01499368|517027897|FG001|Overall Study|Did not meet I/E criteria|4|||
143403643|NCT01499368|517027898|FG002|Overall Study|Did not meet I/E criteria|4|||
143403644|NCT01499368|517027896|FG000|Overall Study|Prohibited Concomitant medication|1|||
143403645|NCT01499368|517027897|FG001|Overall Study|Prohibited Concomitant medication|1|||
143403646|NCT01499368|517027898|FG002|Overall Study|Prohibited Concomitant medication|0|||
143403647|NCT01499368|517027896|FG000|Overall Study|Withdrawal by Subject|11|||
143403648|NCT01499368|517027897|FG001|Overall Study|Withdrawal by Subject|10|||
143403649|NCT01499368|517027898|FG002|Overall Study|Withdrawal by Subject|8|||
143403650|NCT01499368|517027896|FG000|Overall Study|Lost to Follow-up|3|||
143403651|NCT01499368|517027897|FG001|Overall Study|Lost to Follow-up|2|||
143403652|NCT01499368|517027898|FG002|Overall Study|Lost to Follow-up|5|||
143403653|NCT01499368|517027896|FG000|Overall Study|Adverse Event|4|||
143403654|NCT01499368|517027897|FG001|Overall Study|Adverse Event|0|||
143403655|NCT01499368|517027898|FG002|Overall Study|Adverse Event|2|||
143403656|NCT01499368|517027896|FG000|Overall Study|Physician Decision|0|||
143403657|NCT01499368|517027897|FG001|Overall Study|Physician Decision|1|||
143403658|NCT01499368|517027898|FG002|Overall Study|Physician Decision|0|||
143403659|NCT01499368|517027896|FG000|Overall Study|Deviation from visit window|0|||
143403660|NCT01499368|517027897|FG001|Overall Study|Deviation from visit window|0|||
143403661|NCT01499368|517027898|FG002|Overall Study|Deviation from visit window|1|||
143403662|NCT01499368|517027896|FG000|Overall Study|Error of Prescriptions|0|||
143403663|NCT01499368|517027897|FG001|Overall Study|Error of Prescriptions|0|||
143403664|NCT01499368|517027898|FG002|Overall Study|Error of Prescriptions|1|||
143403665|NCT03092674|517027899|FG000|Overall Study|Adverse Event or Side Effects|1|||
143403666|NCT03092674|517027900|FG001|Overall Study|Adverse Event or Side Effects|4|||
143403667|NCT03092674|517027901|FG002|Overall Study|Adverse Event or Side Effects|4|||
143403668|NCT03092674|517027899|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
143403669|NCT03092674|517027900|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
143403670|NCT03092674|517027901|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
143403671|NCT03092674|517027899|FG000|Overall Study|Progression/Relapse|5|||
143403672|NCT03092674|517027900|FG001|Overall Study|Progression/Relapse|4|||
143403673|NCT03092674|517027901|FG002|Overall Study|Progression/Relapse|8|||
143403674|NCT03092674|517027899|FG000|Overall Study|Death|4|||
143403675|NCT03092674|517027900|FG001|Overall Study|Death|8|||
143403676|NCT03092674|517027901|FG002|Overall Study|Death|2|||
143403677|NCT03092674|517027899|FG000|Overall Study|Other - Not Protocol Specified|11|||
143403678|NCT03092674|517027900|FG001|Overall Study|Other - Not Protocol Specified|8|||
143403679|NCT03092674|517027901|FG002|Overall Study|Other - Not Protocol Specified|8|||
143403680|NCT01527188|517027902|FG000|Overall Study|Adverse Event|5|||
143403681|NCT01527188|517027903|FG001|Overall Study|Adverse Event|5|||
143403682|NCT01527188|517027904|FG002|Overall Study|Adverse Event|11|||
143403683|NCT01527188|517027905|FG003|Overall Study|Adverse Event|0|||
143403684|NCT01527188|517027902|FG000|Overall Study|Withdrawal by Subject|3|||
143403685|NCT01527188|517027903|FG001|Overall Study|Withdrawal by Subject|6|||
143403686|NCT01527188|517027904|FG002|Overall Study|Withdrawal by Subject|4|||
143403687|NCT01527188|517027905|FG003|Overall Study|Withdrawal by Subject|4|||
143403688|NCT01527188|517027902|FG000|Overall Study|Any other reason not above-mentioned|6|||
143403689|NCT01527188|517027903|FG001|Overall Study|Any other reason not above-mentioned|7|||
143403690|NCT01527188|517027904|FG002|Overall Study|Any other reason not above-mentioned|8|||
143403691|NCT01527188|517027905|FG003|Overall Study|Any other reason not above-mentioned|8|||
143403692|NCT04626427|517027908|FG000|Overall Study|Death|1|||
143403693|NCT04626427|517027908|FG000|Overall Study|Withdrawal by Subject|1|||
143403694|NCT04626427|517027908|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
143403695|NCT04626427|517027908|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
143403696|NCT01553149|517027909|FG000|Overall Study|Adverse Event|0|||
143403697|NCT01553149|517027910|FG001|Overall Study|Adverse Event|9|||
143403698|NCT01553149|517027909|FG000|Overall Study|Physician Decision|5|||
143403699|NCT01553149|517027910|FG001|Overall Study|Physician Decision|10|||
143403700|NCT01553149|517027909|FG000|Overall Study|Ineligible|0|||
143403701|NCT01553149|517027910|FG001|Overall Study|Ineligible|1|||
143403702|NCT02325154|517027911|FG000|Overall Study|Physician Decision|1|||
143403703|NCT01265537|517027912|FG000|Overall Study|Adverse Event|2|||
143403704|NCT01265537|517027913|FG001|Overall Study|Adverse Event|1|||
143403705|NCT01265537|517027912|FG000|Overall Study|Physician Decision|0|||
143403706|NCT01265537|517027913|FG001|Overall Study|Physician Decision|1|||
143403707|NCT05866926|517027914|FG000|Overall Study|Death|16|||
143403708|NCT05866926|517027915|FG001|Overall Study|Death|9|||
143403709|NCT05866926|517027914|FG000|Overall Study|Lost to Follow-up|0|||
143403710|NCT05866926|517027915|FG001|Overall Study|Lost to Follow-up|1|||
143403711|NCT05866926|517027914|FG000|Overall Study|Adverse Event|1|||
143403712|NCT05866926|517027915|FG001|Overall Study|Adverse Event|0|||
143403713|NCT05866926|517027914|FG000|Overall Study|Withdrawal by Subject|5|||
143403714|NCT05866926|517027915|FG001|Overall Study|Withdrawal by Subject|1|||
143403715|NCT05866926|517027914|FG000|Overall Study|Disease progression|1|||
143403716|NCT05866926|517027915|FG001|Overall Study|Disease progression|0|||
143403717|NCT05866926|517027914|FG000|Overall Study|other causes|2|||
143403718|NCT05866926|517027915|FG001|Overall Study|other causes|1|||
143403719|NCT04595331|517028781|FG000|Overall Study|Withdrawal by Subject|0|||
143403720|NCT04595331|517028782|FG001|Overall Study|Withdrawal by Subject|1|||
143403721|NCT04595331|517028781|FG000|Overall Study|Lost to Follow-up|0|||
143403722|NCT04595331|517028782|FG001|Overall Study|Lost to Follow-up|5|||
143403723|NCT04595331|517028781|FG000|Overall Study|Medical reason|0|||
143403724|NCT04595331|517028782|FG001|Overall Study|Medical reason|1|||
143403725|NCT05412004|517028784|FG000|Overall Study|Adverse Event|0|||
143403726|NCT05412004|517028785|FG001|Overall Study|Adverse Event|2|||
143403727|NCT05412004|517028786|FG002|Overall Study|Adverse Event|1|||
143403728|NCT05412004|517028787|FG003|Overall Study|Adverse Event|5|||
143403729|NCT05412004|517028784|FG000|Overall Study|Assigned Treatment by Mistake|5|||
143403730|NCT05412004|517028785|FG001|Overall Study|Assigned Treatment by Mistake|10|||
143403731|NCT05412004|517028786|FG002|Overall Study|Assigned Treatment by Mistake|2|||
143403732|NCT05412004|517028787|FG003|Overall Study|Assigned Treatment by Mistake|5|||
143403733|NCT05412004|517028784|FG000|Overall Study|Lost to Follow-up|3|||
143403734|NCT05412004|517028785|FG001|Overall Study|Lost to Follow-up|0|||
143403735|NCT05412004|517028786|FG002|Overall Study|Lost to Follow-up|0|||
143403736|NCT05412004|517028787|FG003|Overall Study|Lost to Follow-up|0|||
143403737|NCT05412004|517028784|FG000|Overall Study|Patient could not travel to site|0|||
143403738|NCT05412004|517028785|FG001|Overall Study|Patient could not travel to site|1|||
143403739|NCT05412004|517028786|FG002|Overall Study|Patient could not travel to site|0|||
143403740|NCT05412004|517028787|FG003|Overall Study|Patient could not travel to site|0|||
143403741|NCT05412004|517028784|FG000|Overall Study|Physician Decision|0|||
143403742|NCT05412004|517028785|FG001|Overall Study|Physician Decision|1|||
143403743|NCT05412004|517028786|FG002|Overall Study|Physician Decision|0|||
143403744|NCT05412004|517028787|FG003|Overall Study|Physician Decision|0|||
143403745|NCT05412004|517028784|FG000|Overall Study|Pregnancy|0|||
143403746|NCT05412004|517028785|FG001|Overall Study|Pregnancy|1|||
143403747|NCT05412004|517028786|FG002|Overall Study|Pregnancy|0|||
143403748|NCT05412004|517028787|FG003|Overall Study|Pregnancy|0|||
143403749|NCT05412004|517028784|FG000|Overall Study|Protocol Violation|1|||
143403750|NCT05412004|517028785|FG001|Overall Study|Protocol Violation|0|||
143403751|NCT05412004|517028786|FG002|Overall Study|Protocol Violation|0|||
143403752|NCT05412004|517028787|FG003|Overall Study|Protocol Violation|0|||
143403753|NCT05412004|517028784|FG000|Overall Study|Withdrawal by Subject|4|||
143403754|NCT05412004|517028785|FG001|Overall Study|Withdrawal by Subject|19|||
143403755|NCT05412004|517028786|FG002|Overall Study|Withdrawal by Subject|4|||
143403756|NCT05412004|517028787|FG003|Overall Study|Withdrawal by Subject|14|||
143403757|NCT05412004|517028784|FG000|Overall Study|Screen Failure|0|||
143403758|NCT05412004|517028785|FG001|Overall Study|Screen Failure|0|||
143403759|NCT05412004|517028786|FG002|Overall Study|Screen Failure|0|||
143403760|NCT05412004|517028787|FG003|Overall Study|Screen Failure|1|||
143403761|NCT05412004|517028784|FG000|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
143403762|NCT05412004|517028785|FG001|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
143403763|NCT05412004|517028786|FG002|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
143403764|NCT05412004|517028787|FG003|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|1|||
143403765|NCT04644029|517028788|FG000|Overall Study|Death|1|||
143403766|NCT04644029|517028789|FG001|Overall Study|Death|0|||
143403767|NCT04644029|517028788|FG000|Overall Study|Physician Decision|1|||
143403768|NCT04644029|517028789|FG001|Overall Study|Physician Decision|2|||
143403769|NCT04644029|517028788|FG000|Overall Study|Withdrawal by Subject|21|||
143403770|NCT04644029|517028789|FG001|Overall Study|Withdrawal by Subject|19|||
143403771|NCT04644029|517028788|FG000|Overall Study|Lost to Follow-up|31|||
143403772|NCT04644029|517028789|FG001|Overall Study|Lost to Follow-up|34|||
143403773|NCT04644029|517028788|FG000|Overall Study|Study Terminated by Sponsor|308|||
143403774|NCT04644029|517028789|FG001|Overall Study|Study Terminated by Sponsor|309|||
143403775|NCT04644029|517028788|FG000|Overall Study|Randomized in Error|2|||
143403776|NCT04644029|517028789|FG001|Overall Study|Randomized in Error|1|||
143403777|NCT04644029|517028788|FG000|Overall Study|Other|0|||
143403778|NCT04644029|517028789|FG001|Overall Study|Other|1|||
143403779|NCT05020353|517028790|FG000|Overall Study|Protocol Violation|7|||
143403780|NCT05020353|517028790|FG000|Overall Study|Withdrawal by Subject|33|||
143403781|NCT02611687|517028793|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
143403782|NCT02611687|517028794|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
143403783|NCT05157841|517028797|FG000|Part A (14 Days)|Withdrawal by Subject|0|||
143403784|NCT05157841|517028798|FG001|Part A (14 Days)|Withdrawal by Subject|1|||
143403785|NCT05157841|517028799|FG002|Part A (14 Days)|Withdrawal by Subject|2|||
143403786|NCT05157841|517028797|FG000|Part A (14 Days)|Adverse Event|1|||
143403787|NCT05157841|517028798|FG001|Part A (14 Days)|Adverse Event|0|||
143403788|NCT05157841|517028799|FG002|Part A (14 Days)|Adverse Event|0|||
143403789|NCT05157841|517028797|FG000|Part A (14 Days)|Failure to meet continuation criteria|0|||
143403790|NCT05157841|517028798|FG001|Part A (14 Days)|Failure to meet continuation criteria|0|||
143403791|NCT05157841|517028799|FG002|Part A (14 Days)|Failure to meet continuation criteria|1|||
143403792|NCT04933474|517028800|FG000|Overall Study|Discontinued Intervention Prior to End of Follow-up|2|||
143403793|NCT04933474|517028801|FG001|Overall Study|Discontinued Intervention Prior to End of Follow-up|1|||
143403794|NCT04933474|517028800|FG000|Overall Study|Lost to Follow-up|19|||
143403795|NCT04933474|517028801|FG001|Overall Study|Lost to Follow-up|9|||
143403796|NCT04933474|517028800|FG000|Overall Study|Life Burden - unable to participate|6|||
143403797|NCT04933474|517028801|FG001|Overall Study|Life Burden - unable to participate|2|||
143403798|NCT04933474|517028800|FG000|Overall Study|Disease Burden - unable to participate|4|||
143403799|NCT04933474|517028801|FG001|Overall Study|Disease Burden - unable to participate|1|||
143403800|NCT04933474|517028800|FG000|Overall Study|Surgery/Hospitalization|1|||
143403801|NCT04933474|517028801|FG001|Overall Study|Surgery/Hospitalization|2|||
143403802|NCT04933474|517028800|FG000|Overall Study|Dissatisfied with Intervention|1|||
143403803|NCT04933474|517028801|FG001|Overall Study|Dissatisfied with Intervention|1|||
143403804|NCT04933474|517028800|FG000|Overall Study|Withdrew interest in participation|1|||
143403805|NCT04933474|517028801|FG001|Overall Study|Withdrew interest in participation|0|||
143403806|NCT04933474|517028800|FG000|Overall Study|Had previously enrolled in the study|0|||
143403807|NCT04933474|517028801|FG001|Overall Study|Had previously enrolled in the study|1|||
143403808|NCT05988398|517028818|FG000|Overall Study|Lack of time|21|||
143403809|NCT05988398|517028819|FG001|Overall Study|Lack of time|0|||
143403810|NCT05988398|517028818|FG000|Overall Study|Absent from school|0|||
143403811|NCT05988398|517028819|FG001|Overall Study|Absent from school|38|||
143403812|NCT05988398|517028818|FG000|Overall Study|Chose not to participate|0|||
143403813|NCT05988398|517028819|FG001|Overall Study|Chose not to participate|42|||
143403814|NCT05988398|517028818|FG000|Overall Study|Other commitments (e.g., sports)|0|||
143403815|NCT05988398|517028819|FG001|Overall Study|Other commitments (e.g., sports)|25|||
143403816|NCT04908930|517028832|FG000|Overall Study|Lost to Follow-up|1|||
143403817|NCT04908930|517028833|FG001|Overall Study|Lost to Follow-up|1|||
143403818|NCT04908930|517028834|FG002|Overall Study|Lost to Follow-up|0|||
143403819|NCT04908930|517028835|FG003|Overall Study|Lost to Follow-up|0|||
143403820|NCT04908930|517028836|FG004|Overall Study|Lost to Follow-up|0|||
143403821|NCT04908930|517028832|FG000|Overall Study|hardware in mouth|1|||
143403822|NCT04908930|517028833|FG001|Overall Study|hardware in mouth|1|||
143403823|NCT04908930|517028834|FG002|Overall Study|hardware in mouth|0|||
143403824|NCT04908930|517028835|FG003|Overall Study|hardware in mouth|0|||
143403825|NCT04908930|517028836|FG004|Overall Study|hardware in mouth|0|||
143403826|NCT04908930|517028832|FG000|Overall Study|wrong team|1|||
143403827|NCT04908930|517028833|FG001|Overall Study|wrong team|0|||
143403828|NCT04908930|517028834|FG002|Overall Study|wrong team|0|||
143403829|NCT04908930|517028835|FG003|Overall Study|wrong team|0|||
143403830|NCT04908930|517028836|FG004|Overall Study|wrong team|0|||
143403831|NCT04908930|517028832|FG000|Overall Study|quit team|2|||
143403832|NCT04908930|517028833|FG001|Overall Study|quit team|4|||
143403833|NCT04908930|517028834|FG002|Overall Study|quit team|0|||
143403834|NCT04908930|517028835|FG003|Overall Study|quit team|0|||
143403835|NCT04908930|517028836|FG004|Overall Study|quit team|0|||
143403836|NCT04908930|517028832|FG000|Overall Study|Withdrawal by Subject|1|||
143403837|NCT04908930|517028833|FG001|Overall Study|Withdrawal by Subject|2|||
143403838|NCT04908930|517028834|FG002|Overall Study|Withdrawal by Subject|0|||
143403839|NCT04908930|517028835|FG003|Overall Study|Withdrawal by Subject|0|||
143403840|NCT04908930|517028836|FG004|Overall Study|Withdrawal by Subject|0|||
143403841|NCT04908930|517028832|FG000|Overall Study|parent not liking program|0|||
143403842|NCT04908930|517028833|FG001|Overall Study|parent not liking program|1|||
143403843|NCT04908930|517028834|FG002|Overall Study|parent not liking program|0|||
143403844|NCT04908930|517028835|FG003|Overall Study|parent not liking program|0|||
143403845|NCT04908930|517028836|FG004|Overall Study|parent not liking program|0|||
143403846|NCT02777593|517028839|FG000|Overall Study|Still in study|1|||
143403847|NCT02777593|517028840|FG001|Overall Study|Still in study|32|||
143403848|NCT02777593|517028841|FG002|Overall Study|Still in study|3|||
143403849|NCT02777593|517028842|FG003|Overall Study|Still in study|6|||
143403850|NCT02777593|517028843|FG004|Overall Study|Still in study|5|||
143403851|NCT02777593|517028839|FG000|Overall Study|Death|21|||
143403852|NCT02777593|517028840|FG001|Overall Study|Death|28|||
143403853|NCT02777593|517028841|FG002|Overall Study|Death|0|||
143403854|NCT02777593|517028842|FG003|Overall Study|Death|5|||
143403855|NCT02777593|517028843|FG004|Overall Study|Death|0|||
143403856|NCT02777593|517028839|FG000|Overall Study|Withdrawal by Subject|8|||
143403857|NCT02777593|517028840|FG001|Overall Study|Withdrawal by Subject|4|||
143403858|NCT02777593|517028841|FG002|Overall Study|Withdrawal by Subject|1|||
143403859|NCT02777593|517028842|FG003|Overall Study|Withdrawal by Subject|1|||
143403860|NCT02777593|517028843|FG004|Overall Study|Withdrawal by Subject|0|||
143403861|NCT02777593|517028839|FG000|Overall Study|Lost to Follow-up|8|||
143403862|NCT02777593|517028840|FG001|Overall Study|Lost to Follow-up|16|||
143403863|NCT02777593|517028841|FG002|Overall Study|Lost to Follow-up|5|||
143403864|NCT02777593|517028842|FG003|Overall Study|Lost to Follow-up|0|||
143403865|NCT02777593|517028843|FG004|Overall Study|Lost to Follow-up|1|||
143403866|NCT02777593|517028839|FG000|Overall Study|Physician Decision|2|||
143403867|NCT02777593|517028840|FG001|Overall Study|Physician Decision|2|||
143403868|NCT02777593|517028841|FG002|Overall Study|Physician Decision|0|||
143403869|NCT02777593|517028842|FG003|Overall Study|Physician Decision|0|||
143403870|NCT02777593|517028843|FG004|Overall Study|Physician Decision|0|||
143403871|NCT02777593|517028839|FG000|Overall Study|Discontinued due to Other|1|||
143403872|NCT02777593|517028840|FG001|Overall Study|Discontinued due to Other|0|||
143403873|NCT02777593|517028841|FG002|Overall Study|Discontinued due to Other|0|||
143403874|NCT02777593|517028842|FG003|Overall Study|Discontinued due to Other|0|||
143403875|NCT02777593|517028843|FG004|Overall Study|Discontinued due to Other|0|||
143403876|NCT06065735|517028847|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
143403877|NCT06065735|517028848|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
143403878|NCT06065735|517028849|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
143403879|NCT06065735|517028847|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
143403880|NCT06065735|517028848|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
143403881|NCT06065735|517028849|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
143403882|NCT06065735|517028847|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
143403883|NCT06065735|517028848|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
143403884|NCT06065735|517028849|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
143403885|NCT06065735|517028847|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
143403886|NCT06065735|517028848|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
143403887|NCT06065735|517028849|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
143403888|NCT06065735|517028847|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
143403889|NCT06065735|517028848|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
143403890|NCT06065735|517028849|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
143403891|NCT02532621|517028850|FG000|Overall Study|Death|3|||
143403892|NCT02532621|517028850|FG000|Overall Study|Lost to Follow-up|3|||
143403893|NCT02532621|517028850|FG000|Overall Study|Withdrawal by Subject|6|||
143403894|NCT02532621|517028850|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
143403895|NCT02532621|517028850|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
143403896|NCT05485935|517028855|FG000|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
143403897|NCT05485935|517028856|FG001|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
143403898|NCT05485935|517028855|FG000|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|3|||
143403899|NCT05485935|517028856|FG001|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|0|||
143403900|NCT05485935|517028855|FG000|Period 2 (T2 and V3)|Adverse Event|0|||
143403901|NCT05485935|517028856|FG001|Period 2 (T2 and V3)|Adverse Event|1|||
143403902|NCT05485935|517028855|FG000|Period 2 (T2 and V3)|loss of contact|0|||
143403903|NCT05485935|517028856|FG001|Period 2 (T2 and V3)|loss of contact|1|||
143403904|NCT02806726|517028857|FG000|Overall Study|Lost to Follow-up|1|||
143403905|NCT03250676|517028858|FG000|Overall Study|Adverse Event|0|||
143403906|NCT03250676|517028859|FG001|Overall Study|Adverse Event|0|||
143403907|NCT03250676|517028860|FG002|Overall Study|Adverse Event|0|||
143403908|NCT03250676|517028861|FG003|Overall Study|Adverse Event|1|||
143403909|NCT03250676|517028862|FG004|Overall Study|Adverse Event|2|||
143403910|NCT03250676|517028863|FG005|Overall Study|Adverse Event|9|||
143403911|NCT03250676|517028858|FG000|Overall Study|Withdrawal by Subject|1|||
143403912|NCT03250676|517028859|FG001|Overall Study|Withdrawal by Subject|0|||
143403913|NCT03250676|517028860|FG002|Overall Study|Withdrawal by Subject|0|||
143403914|NCT03250676|517028861|FG003|Overall Study|Withdrawal by Subject|1|||
143403915|NCT03250676|517028862|FG004|Overall Study|Withdrawal by Subject|1|||
143403916|NCT03250676|517028863|FG005|Overall Study|Withdrawal by Subject|2|||
143403917|NCT03250676|517028858|FG000|Overall Study|Physician Decision|0|||
143403918|NCT03250676|517028859|FG001|Overall Study|Physician Decision|0|||
143403919|NCT03250676|517028860|FG002|Overall Study|Physician Decision|0|||
143403920|NCT03250676|517028861|FG003|Overall Study|Physician Decision|2|||
143403921|NCT03250676|517028862|FG004|Overall Study|Physician Decision|0|||
143403922|NCT03250676|517028863|FG005|Overall Study|Physician Decision|3|||
143403923|NCT03250676|517028858|FG000|Overall Study|Withdrawal of consent|0|||
143403924|NCT03250676|517028859|FG001|Overall Study|Withdrawal of consent|0|||
143403925|NCT03250676|517028860|FG002|Overall Study|Withdrawal of consent|2|||
143403926|NCT03250676|517028861|FG003|Overall Study|Withdrawal of consent|0|||
143403927|NCT03250676|517028862|FG004|Overall Study|Withdrawal of consent|0|||
143403928|NCT03250676|517028863|FG005|Overall Study|Withdrawal of consent|2|||
143403929|NCT03250676|517028858|FG000|Overall Study|Other|1|||
143403930|NCT03250676|517028859|FG001|Overall Study|Other|0|||
143403931|NCT03250676|517028860|FG002|Overall Study|Other|0|||
143403932|NCT03250676|517028861|FG003|Overall Study|Other|0|||
143403933|NCT03250676|517028862|FG004|Overall Study|Other|0|||
143403934|NCT03250676|517028863|FG005|Overall Study|Other|0|||
143403935|NCT03250676|517028858|FG000|Overall Study|Disease progression|4|||
143403936|NCT03250676|517028859|FG001|Overall Study|Disease progression|12|||
143403937|NCT03250676|517028860|FG002|Overall Study|Disease progression|9|||
143403938|NCT03250676|517028861|FG003|Overall Study|Disease progression|7|||
143403939|NCT03250676|517028862|FG004|Overall Study|Disease progression|4|||
143403940|NCT03250676|517028863|FG005|Overall Study|Disease progression|88|||
143403941|NCT05129501|517028864|FG000|Overall Study|Lost to Follow-up|54|||
143403942|NCT05129501|517028865|FG001|Overall Study|Lost to Follow-up|41|||
143403943|NCT03587805|517028868|FG000|Overall Study|Adverse Event|72|||
143403944|NCT03587805|517028868|FG000|Overall Study|Death|1|||
143403945|NCT03587805|517028868|FG000|Overall Study|Lost to Follow-up|78|||
143403946|NCT03587805|517028868|FG000|Overall Study|Withdrawal by Subject|105|||
143403947|NCT03587805|517028868|FG000|Overall Study|Lack of Efficacy|119|||
143403948|NCT03587805|517028868|FG000|Overall Study|Reason unknown|26|||
143403949|NCT03587805|517028868|FG000|Overall Study|COVID_19 pandemic|4|||
143403950|NCT03587805|517028868|FG000|Overall Study|Various reasons|121|||
143403951|NCT03587805|517028868|FG000|Overall Study|Withdrawal by parent/guardian|3|||
143403952|NCT05267639|517029427|FG000|Overall Study|Withdrawal by Subject|1|||
143403953|NCT05267639|517029428|FG001|Overall Study|Withdrawal by Subject|0|||
143403954|NCT03512301|517029438|FG000|Overall Study|Protocol Violation|2|||
143403955|NCT03512301|517029438|FG000|Overall Study|Did Not Qualify|3|||
143403956|NCT03512301|517029438|FG000|Overall Study|Age-ineligible|1|||
143403957|NCT03512301|517029438|FG000|Overall Study|Inadequate fluency with the English language|3|||
143403958|NCT05875701|517029449|FG000|Overall Study|Lost to Follow-up|2|||
143403959|NCT05875701|517029450|FG001|Overall Study|Lost to Follow-up|0|||
143403960|NCT05875701|517029449|FG000|Overall Study|Withdrawal by Subject|1|||
143403961|NCT05875701|517029450|FG001|Overall Study|Withdrawal by Subject|1|||
143403962|NCT04408755|517029461|FG000|Period A (Placebo lead-in)|Other|11|||
143403963|NCT04408755|517029462|FG001|Period A (Placebo lead-in)|Other|0|||
143403964|NCT04408755|517029463|FG002|Period A (Placebo lead-in)|Other|0|||
143403965|NCT04408755|517029464|FG003|Period A (Placebo lead-in)|Other|0|||
143403966|NCT04408755|517029461|FG000|Period B (Randomization Period)|Adverse Event|0|||
143403967|NCT04408755|517029462|FG001|Period B (Randomization Period)|Adverse Event|3|||
143403968|NCT04408755|517029463|FG002|Period B (Randomization Period)|Adverse Event|0|||
143403969|NCT04408755|517029464|FG003|Period B (Randomization Period)|Adverse Event|1|||
143403970|NCT04408755|517029461|FG000|Period B (Randomization Period)|Death|0|||
143403971|NCT04408755|517029462|FG001|Period B (Randomization Period)|Death|0|||
143403972|NCT04408755|517029463|FG002|Period B (Randomization Period)|Death|1|||
143403973|NCT04408755|517029464|FG003|Period B (Randomization Period)|Death|0|||
143403974|NCT04408755|517029461|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
143403975|NCT04408755|517029462|FG001|Period B (Randomization Period)|Lost to Follow-up|1|||
143403976|NCT04408755|517029463|FG002|Period B (Randomization Period)|Lost to Follow-up|1|||
143403977|NCT04408755|517029464|FG003|Period B (Randomization Period)|Lost to Follow-up|0|||
143403978|NCT04408755|517029461|FG000|Period B (Randomization Period)|Physician Decision|0|||
143403979|NCT04408755|517029462|FG001|Period B (Randomization Period)|Physician Decision|0|||
143403980|NCT04408755|517029463|FG002|Period B (Randomization Period)|Physician Decision|1|||
143403981|NCT04408755|517029464|FG003|Period B (Randomization Period)|Physician Decision|0|||
143403982|NCT04408755|517029461|FG000|Period B (Randomization Period)|Protocol Deviation|0|||
143403983|NCT04408755|517029462|FG001|Period B (Randomization Period)|Protocol Deviation|1|||
143403984|NCT04408755|517029463|FG002|Period B (Randomization Period)|Protocol Deviation|0|||
143403985|NCT04408755|517029464|FG003|Period B (Randomization Period)|Protocol Deviation|0|||
143403986|NCT04408755|517029461|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
143403987|NCT04408755|517029462|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
143403988|NCT04408755|517029463|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
143403989|NCT04408755|517029464|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
143403990|NCT04408755|517029461|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
143403991|NCT04408755|517029462|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|1|||
143403992|NCT04408755|517029463|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|5|||
143403993|NCT04408755|517029464|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|3|||
143403994|NCT04408755|517029461|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
143403995|NCT04408755|517029462|FG001|Period B (Randomization Period)|Withdrawal by Subject|3|||
143403996|NCT04408755|517029463|FG002|Period B (Randomization Period)|Withdrawal by Subject|2|||
143403997|NCT04408755|517029464|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
143403998|NCT04408755|517029461|FG000|Period B (Randomization Period)|Reason not Specified|0|||
143403999|NCT04408755|517029462|FG001|Period B (Randomization Period)|Reason not Specified|1|||
143404000|NCT04408755|517029463|FG002|Period B (Randomization Period)|Reason not Specified|0|||
143404001|NCT04408755|517029464|FG003|Period B (Randomization Period)|Reason not Specified|2|||
143404002|NCT00308997|517029465|FG000|Overall Study|Subject feigned clinical data|0|||
143404003|NCT00308997|517029466|FG001|Overall Study|Subject feigned clinical data|1|||
143404004|NCT00308997|517029465|FG000|Overall Study|Unable to tolerate intervention|1|||
143404005|NCT00308997|517029466|FG001|Overall Study|Unable to tolerate intervention|0|||
143404006|NCT04490356|517029468|FG000|Overall Study|Lost to Follow-up|1|||
143404007|NCT03733626|517029469|FG000|Overall Study|Physician Decision|4|||
143404008|NCT03733626|517029470|FG001|Overall Study|Physician Decision|4|||
143404009|NCT03816397|517029471|FG000|Overall Study|Censored at interim analysis date.|13|||
143404010|NCT03816397|517029472|FG001|Overall Study|Censored at interim analysis date.|6|||
143404011|NCT03816397|517029471|FG000|Overall Study|Withdrawal by Subject|1|||
143404012|NCT03816397|517029472|FG001|Overall Study|Withdrawal by Subject|1|||
143404013|NCT05836012|517029481|FG000|Overall Study|Lost to Follow-up|1|||
143404014|NCT05836012|517029482|FG001|Overall Study|Lost to Follow-up|0|||
143404015|NCT05836012|517029481|FG000|Overall Study|Withdrawal by Subject|1|||
143404016|NCT05836012|517029482|FG001|Overall Study|Withdrawal by Subject|3|||
143404017|NCT05836012|517029481|FG000|Overall Study|Reason not included in pre-specified categories|2|||
143404018|NCT05836012|517029482|FG001|Overall Study|Reason not included in pre-specified categories|1|||
143404019|NCT05985395|517029483|FG000|Overall Study|Physician Decision|2|||
143404020|NCT05985395|517029484|FG001|Overall Study|Physician Decision|1|||
143404021|NCT05985395|517029483|FG000|Overall Study|Withdrawal by Subject|1|||
143404022|NCT05985395|517029484|FG001|Overall Study|Withdrawal by Subject|0|||
143404023|NCT01220531|517029485|FG000|Overall Study|Death|7|||
143404024|NCT01220531|517029485|FG000|Overall Study|Lost to Follow-up|1|||
143404025|NCT03008382|517029488|FG000|Overall Study|Withdrawal by Subject|2|||
143404026|NCT03008382|517029489|FG001|Overall Study|Withdrawal by Subject|5|||
143404027|NCT03008382|517029490|FG002|Overall Study|Withdrawal by Subject|2|||
143404028|NCT03008382|517029491|FG003|Overall Study|Withdrawal by Subject|0|||
143404029|NCT03008382|517029488|FG000|Overall Study|Protocol Violation|1|||
143404030|NCT03008382|517029489|FG001|Overall Study|Protocol Violation|0|||
143404031|NCT03008382|517029490|FG002|Overall Study|Protocol Violation|0|||
143404032|NCT03008382|517029491|FG003|Overall Study|Protocol Violation|0|||
143404033|NCT03008382|517029488|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
143404034|NCT03008382|517029489|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
143404035|NCT03008382|517029490|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
143404036|NCT03008382|517029491|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
143404037|NCT03008382|517029488|FG000|Overall Study|Lost to Follow-up|0|||
143404038|NCT03008382|517029489|FG001|Overall Study|Lost to Follow-up|0|||
143404039|NCT03008382|517029490|FG002|Overall Study|Lost to Follow-up|1|||
143404040|NCT03008382|517029491|FG003|Overall Study|Lost to Follow-up|0|||
143404041|NCT03008382|517029488|FG000|Overall Study|Screenfail|0|||
143404042|NCT03008382|517029489|FG001|Overall Study|Screenfail|0|||
143404043|NCT03008382|517029490|FG002|Overall Study|Screenfail|2|||
143404044|NCT03008382|517029491|FG003|Overall Study|Screenfail|0|||
143404045|NCT03215706|517029492|FG000|Randomization|Adverse Event unrelated to study drug|1|||
143404046|NCT03215706|517029493|FG001|Randomization|Adverse Event unrelated to study drug|0|||
143404047|NCT03215706|517029492|FG000|Randomization|participant withdrew consent|1|||
143404048|NCT03215706|517029493|FG001|Randomization|participant withdrew consent|3|||
143404049|NCT03215706|517029492|FG000|Randomization|no longer meets study criteria|1|||
143404050|NCT03215706|517029493|FG001|Randomization|no longer meets study criteria|4|||
143404051|NCT03215706|517029492|FG000|Randomization|other reasons|0|||
143404052|NCT03215706|517029493|FG001|Randomization|other reasons|2|||
143404053|NCT03215706|517029492|FG000|Treatment Period|Disease Progression|150|||
143404054|NCT03215706|517029493|FG001|Treatment Period|Disease Progression|142|||
143404055|NCT03215706|517029492|FG000|Treatment Period|Study Drug Toxicity|53|||
143404056|NCT03215706|517029493|FG001|Treatment Period|Study Drug Toxicity|21|||
143404057|NCT03215706|517029492|FG000|Treatment Period|Death|2|||
143404058|NCT03215706|517029493|FG001|Treatment Period|Death|1|||
143404059|NCT03215706|517029492|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
143404060|NCT03215706|517029493|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
143404061|NCT03215706|517029492|FG000|Treatment Period|Request to D/C treatment|1|||
143404062|NCT03215706|517029493|FG001|Treatment Period|Request to D/C treatment|6|||
143404063|NCT03215706|517029492|FG000|Treatment Period|Participant withdrew consent|3|||
143404064|NCT03215706|517029493|FG001|Treatment Period|Participant withdrew consent|4|||
143404065|NCT03215706|517029492|FG000|Treatment Period|Lost to Follow-up|0|||
143404066|NCT03215706|517029493|FG001|Treatment Period|Lost to Follow-up|1|||
143404067|NCT03215706|517029492|FG000|Treatment Period|Other Reasons|4|||
143404068|NCT03215706|517029493|FG001|Treatment Period|Other Reasons|5|||
143404069|NCT03215706|517029492|FG000|Treatment Period|Ongoing in the treatment period|105|||
143404070|NCT03215706|517029493|FG001|Treatment Period|Ongoing in the treatment period|43|||
143404071|NCT00945724|517029494|FG000|Overall Study|Withdrawal by Subject|2|||
143404072|NCT00945724|517029494|FG000|Overall Study|Physician Decision|1|||
143404073|NCT00945724|517029494|FG000|Overall Study|Adverse Event|5|||
143404074|NCT00945724|517029494|FG000|Overall Study|Second malignancy|1|||
143404075|NCT03705793|517030239|FG000|Overall Study|Lost to Follow-up|3|||
143404076|NCT03705793|517030240|FG001|Overall Study|Lost to Follow-up|4|||
143404077|NCT03705793|517030239|FG000|Overall Study|Withdrawal by Subject|2|||
143404078|NCT03705793|517030240|FG001|Overall Study|Withdrawal by Subject|1|||
143404079|NCT03934931|517030241|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
143404080|NCT03934931|517030242|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
143404081|NCT03934931|517030243|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
143404082|NCT00447980|517030244|FG000|Overall Study|Withdrawal by Subject|1|||
143404083|NCT00447980|517030245|FG001|Overall Study|Withdrawal by Subject|1|||
143404084|NCT00447980|517030246|FG002|Overall Study|Withdrawal by Subject|4|||
143404085|NCT00447980|517030247|FG003|Overall Study|Withdrawal by Subject|4|||
143404086|NCT00447980|517030244|FG000|Overall Study|Lost to Follow-up|1|||
143404087|NCT00447980|517030245|FG001|Overall Study|Lost to Follow-up|1|||
143404088|NCT00447980|517030246|FG002|Overall Study|Lost to Follow-up|0|||
143404089|NCT00447980|517030247|FG003|Overall Study|Lost to Follow-up|0|||
143404090|NCT00447980|517030244|FG000|Overall Study|Did not proceed with surgery|3|||
143404091|NCT00447980|517030245|FG001|Overall Study|Did not proceed with surgery|3|||
143404092|NCT00447980|517030246|FG002|Overall Study|Did not proceed with surgery|2|||
143404093|NCT00447980|517030247|FG003|Overall Study|Did not proceed with surgery|2|||
143404094|NCT02720068|517030248|FG000|Overall Study|Adverse Event|0|||
143404095|NCT02720068|517030249|FG001|Overall Study|Adverse Event|0|||
143404096|NCT02720068|517030250|FG002|Overall Study|Adverse Event|0|||
143404097|NCT02720068|517030251|FG003|Overall Study|Adverse Event|0|||
143404098|NCT02720068|517030252|FG004|Overall Study|Adverse Event|0|||
143404099|NCT02720068|517030253|FG005|Overall Study|Adverse Event|0|||
143404100|NCT02720068|517030254|FG006|Overall Study|Adverse Event|0|||
143404101|NCT02720068|517030255|FG007|Overall Study|Adverse Event|0|||
143404102|NCT02720068|517030256|FG008|Overall Study|Adverse Event|0|||
143404103|NCT02720068|517030257|FG009|Overall Study|Adverse Event|0|||
143404104|NCT02720068|517030258|FG010|Overall Study|Adverse Event|0|||
143404105|NCT02720068|517030259|FG011|Overall Study|Adverse Event|1|||
143404106|NCT02720068|517030260|FG012|Overall Study|Adverse Event|0|||
143404107|NCT02720068|517030261|FG013|Overall Study|Adverse Event|0|||
143404108|NCT02720068|517030262|FG014|Overall Study|Adverse Event|0|||
143404109|NCT02720068|517030263|FG015|Overall Study|Adverse Event|0|||
143404110|NCT02720068|517030264|FG016|Overall Study|Adverse Event|0|||
143404111|NCT02720068|517030265|FG017|Overall Study|Adverse Event|0|||
143404112|NCT02720068|517030248|FG000|Overall Study|Death|1|||
143404113|NCT02720068|517030249|FG001|Overall Study|Death|3|||
143404114|NCT02720068|517030250|FG002|Overall Study|Death|2|||
143404115|NCT02720068|517030251|FG003|Overall Study|Death|1|||
143404116|NCT02720068|517030252|FG004|Overall Study|Death|2|||
143404117|NCT02720068|517030253|FG005|Overall Study|Death|1|||
143404118|NCT02720068|517030254|FG006|Overall Study|Death|2|||
143404119|NCT02720068|517030255|FG007|Overall Study|Death|2|||
143404120|NCT02720068|517030256|FG008|Overall Study|Death|3|||
143404121|NCT02720068|517030257|FG009|Overall Study|Death|1|||
143404122|NCT02720068|517030258|FG010|Overall Study|Death|20|||
143404123|NCT02720068|517030259|FG011|Overall Study|Death|166|||
143404124|NCT02720068|517030260|FG012|Overall Study|Death|34|||
143404125|NCT02720068|517030261|FG013|Overall Study|Death|30|||
143404126|NCT02720068|517030262|FG014|Overall Study|Death|45|||
143404127|NCT02720068|517030263|FG015|Overall Study|Death|16|||
143404128|NCT02720068|517030264|FG016|Overall Study|Death|20|||
143404129|NCT02720068|517030265|FG017|Overall Study|Death|28|||
143404130|NCT02720068|517030248|FG000|Overall Study|Lost to Follow-up|0|||
143404131|NCT02720068|517030249|FG001|Overall Study|Lost to Follow-up|0|||
143404132|NCT02720068|517030250|FG002|Overall Study|Lost to Follow-up|0|||
143404133|NCT02720068|517030251|FG003|Overall Study|Lost to Follow-up|0|||
143404134|NCT02720068|517030252|FG004|Overall Study|Lost to Follow-up|0|||
143404135|NCT02720068|517030253|FG005|Overall Study|Lost to Follow-up|0|||
143404136|NCT02720068|517030254|FG006|Overall Study|Lost to Follow-up|0|||
143404137|NCT02720068|517030255|FG007|Overall Study|Lost to Follow-up|0|||
143404138|NCT02720068|517030256|FG008|Overall Study|Lost to Follow-up|0|||
143404139|NCT02720068|517030257|FG009|Overall Study|Lost to Follow-up|0|||
143404140|NCT02720068|517030258|FG010|Overall Study|Lost to Follow-up|0|||
143404141|NCT02720068|517030259|FG011|Overall Study|Lost to Follow-up|1|||
143404142|NCT02720068|517030260|FG012|Overall Study|Lost to Follow-up|0|||
143404143|NCT02720068|517030261|FG013|Overall Study|Lost to Follow-up|1|||
143404144|NCT02720068|517030262|FG014|Overall Study|Lost to Follow-up|2|||
143404145|NCT02720068|517030263|FG015|Overall Study|Lost to Follow-up|0|||
143404146|NCT02720068|517030264|FG016|Overall Study|Lost to Follow-up|0|||
143404147|NCT02720068|517030265|FG017|Overall Study|Lost to Follow-up|1|||
143404148|NCT02720068|517030248|FG000|Overall Study|Physician Decision|0|||
143404149|NCT02720068|517030249|FG001|Overall Study|Physician Decision|0|||
143404150|NCT02720068|517030250|FG002|Overall Study|Physician Decision|0|||
143404151|NCT02720068|517030251|FG003|Overall Study|Physician Decision|1|||
143404152|NCT02720068|517030252|FG004|Overall Study|Physician Decision|0|||
143404153|NCT02720068|517030253|FG005|Overall Study|Physician Decision|0|||
143404154|NCT02720068|517030254|FG006|Overall Study|Physician Decision|0|||
143404155|NCT02720068|517030255|FG007|Overall Study|Physician Decision|0|||
143404156|NCT02720068|517030256|FG008|Overall Study|Physician Decision|0|||
143404157|NCT02720068|517030257|FG009|Overall Study|Physician Decision|0|||
143404158|NCT02720068|517030258|FG010|Overall Study|Physician Decision|0|||
143404159|NCT02720068|517030259|FG011|Overall Study|Physician Decision|1|||
143404160|NCT02720068|517030260|FG012|Overall Study|Physician Decision|0|||
143404161|NCT02720068|517030261|FG013|Overall Study|Physician Decision|0|||
143404162|NCT02720068|517030262|FG014|Overall Study|Physician Decision|0|||
143404163|NCT02720068|517030263|FG015|Overall Study|Physician Decision|0|||
143404164|NCT02720068|517030264|FG016|Overall Study|Physician Decision|0|||
143404165|NCT02720068|517030265|FG017|Overall Study|Physician Decision|1|||
143404166|NCT02720068|517030248|FG000|Overall Study|Progressive Disease|2|||
143404167|NCT02720068|517030249|FG001|Overall Study|Progressive Disease|3|||
143404168|NCT02720068|517030250|FG002|Overall Study|Progressive Disease|1|||
143404169|NCT02720068|517030251|FG003|Overall Study|Progressive Disease|1|||
143404170|NCT02720068|517030252|FG004|Overall Study|Progressive Disease|1|||
143404171|NCT02720068|517030253|FG005|Overall Study|Progressive Disease|2|||
143404172|NCT02720068|517030254|FG006|Overall Study|Progressive Disease|1|||
143404173|NCT02720068|517030255|FG007|Overall Study|Progressive Disease|1|||
143404174|NCT02720068|517030256|FG008|Overall Study|Progressive Disease|0|||
143404175|NCT02720068|517030257|FG009|Overall Study|Progressive Disease|1|||
143404176|NCT02720068|517030258|FG010|Overall Study|Progressive Disease|0|||
143404177|NCT02720068|517030259|FG011|Overall Study|Progressive Disease|4|||
143404178|NCT02720068|517030260|FG012|Overall Study|Progressive Disease|1|||
143404179|NCT02720068|517030261|FG013|Overall Study|Progressive Disease|0|||
143404180|NCT02720068|517030262|FG014|Overall Study|Progressive Disease|0|||
143404181|NCT02720068|517030263|FG015|Overall Study|Progressive Disease|0|||
143404182|NCT02720068|517030264|FG016|Overall Study|Progressive Disease|0|||
143404183|NCT02720068|517030265|FG017|Overall Study|Progressive Disease|0|||
143404184|NCT02720068|517030248|FG000|Overall Study|Sponsor Decision|0|||
143404185|NCT02720068|517030249|FG001|Overall Study|Sponsor Decision|0|||
143404186|NCT02720068|517030250|FG002|Overall Study|Sponsor Decision|0|||
143404187|NCT02720068|517030251|FG003|Overall Study|Sponsor Decision|0|||
143404188|NCT02720068|517030252|FG004|Overall Study|Sponsor Decision|0|||
143404189|NCT02720068|517030253|FG005|Overall Study|Sponsor Decision|0|||
143404190|NCT02720068|517030254|FG006|Overall Study|Sponsor Decision|0|||
143404191|NCT02720068|517030255|FG007|Overall Study|Sponsor Decision|0|||
143404192|NCT02720068|517030256|FG008|Overall Study|Sponsor Decision|0|||
143404193|NCT02720068|517030257|FG009|Overall Study|Sponsor Decision|0|||
143404194|NCT02720068|517030258|FG010|Overall Study|Sponsor Decision|0|||
143404195|NCT02720068|517030259|FG011|Overall Study|Sponsor Decision|6|||
143404196|NCT02720068|517030260|FG012|Overall Study|Sponsor Decision|3|||
143404197|NCT02720068|517030261|FG013|Overall Study|Sponsor Decision|2|||
143404198|NCT02720068|517030262|FG014|Overall Study|Sponsor Decision|4|||
143404199|NCT02720068|517030263|FG015|Overall Study|Sponsor Decision|4|||
143404200|NCT02720068|517030264|FG016|Overall Study|Sponsor Decision|0|||
143404201|NCT02720068|517030265|FG017|Overall Study|Sponsor Decision|8|||
143404202|NCT02720068|517030248|FG000|Overall Study|Withdrawal by Subject|0|||
143404203|NCT02720068|517030249|FG001|Overall Study|Withdrawal by Subject|0|||
143404204|NCT02720068|517030250|FG002|Overall Study|Withdrawal by Subject|0|||
143404205|NCT02720068|517030251|FG003|Overall Study|Withdrawal by Subject|0|||
143404206|NCT02720068|517030252|FG004|Overall Study|Withdrawal by Subject|0|||
143404207|NCT02720068|517030253|FG005|Overall Study|Withdrawal by Subject|0|||
143404208|NCT02720068|517030254|FG006|Overall Study|Withdrawal by Subject|0|||
143404209|NCT02720068|517030255|FG007|Overall Study|Withdrawal by Subject|0|||
143404210|NCT02720068|517030256|FG008|Overall Study|Withdrawal by Subject|0|||
143404211|NCT02720068|517030257|FG009|Overall Study|Withdrawal by Subject|1|||
143404212|NCT02720068|517030258|FG010|Overall Study|Withdrawal by Subject|0|||
143404213|NCT02720068|517030259|FG011|Overall Study|Withdrawal by Subject|27|||
143404214|NCT02720068|517030260|FG012|Overall Study|Withdrawal by Subject|2|||
143404215|NCT02720068|517030261|FG013|Overall Study|Withdrawal by Subject|8|||
143404216|NCT02720068|517030262|FG014|Overall Study|Withdrawal by Subject|7|||
143404217|NCT02720068|517030263|FG015|Overall Study|Withdrawal by Subject|0|||
143404218|NCT02720068|517030264|FG016|Overall Study|Withdrawal by Subject|0|||
143404219|NCT02720068|517030265|FG017|Overall Study|Withdrawal by Subject|2|||
143404220|NCT02720068|517030248|FG000|Overall Study|Protocol Violation|0|||
143404221|NCT02720068|517030249|FG001|Overall Study|Protocol Violation|0|||
143404222|NCT02720068|517030250|FG002|Overall Study|Protocol Violation|0|||
143404223|NCT02720068|517030251|FG003|Overall Study|Protocol Violation|0|||
143404224|NCT02720068|517030252|FG004|Overall Study|Protocol Violation|0|||
143404225|NCT02720068|517030253|FG005|Overall Study|Protocol Violation|0|||
143404226|NCT02720068|517030254|FG006|Overall Study|Protocol Violation|0|||
143404227|NCT02720068|517030255|FG007|Overall Study|Protocol Violation|0|||
143404228|NCT02720068|517030256|FG008|Overall Study|Protocol Violation|0|||
143404229|NCT02720068|517030257|FG009|Overall Study|Protocol Violation|0|||
143404230|NCT02720068|517030258|FG010|Overall Study|Protocol Violation|1|||
143404231|NCT02720068|517030259|FG011|Overall Study|Protocol Violation|0|||
143404232|NCT02720068|517030260|FG012|Overall Study|Protocol Violation|0|||
143404233|NCT02720068|517030261|FG013|Overall Study|Protocol Violation|0|||
143404234|NCT02720068|517030262|FG014|Overall Study|Protocol Violation|1|||
143404235|NCT02720068|517030263|FG015|Overall Study|Protocol Violation|0|||
143404236|NCT02720068|517030264|FG016|Overall Study|Protocol Violation|1|||
143404237|NCT02720068|517030265|FG017|Overall Study|Protocol Violation|0|||
143404238|NCT02467270|517030278|FG000|Overall Study|Participants Never Treated|0|||
143404239|NCT02467270|517030279|FG001|Overall Study|Participants Never Treated|1|||
143404240|NCT02467270|517030280|FG002|Overall Study|Participants Never Treated|0|||
143404241|NCT02467270|517030278|FG000|Overall Study|Ongoing|50|||
143404242|NCT02467270|517030279|FG001|Overall Study|Ongoing|41|||
143404243|NCT02467270|517030280|FG002|Overall Study|Ongoing|43|||
143404244|NCT02467270|517030278|FG000|Overall Study|Adverse Event|16|||
143404245|NCT02467270|517030279|FG001|Overall Study|Adverse Event|15|||
143404246|NCT02467270|517030280|FG002|Overall Study|Adverse Event|14|||
143404247|NCT02467270|517030278|FG000|Overall Study|Progressive Disease|7|||
143404248|NCT02467270|517030279|FG001|Overall Study|Progressive Disease|7|||
143404249|NCT02467270|517030280|FG002|Overall Study|Progressive Disease|4|||
143404250|NCT02467270|517030278|FG000|Overall Study|Death|2|||
143404251|NCT02467270|517030279|FG001|Overall Study|Death|0|||
143404252|NCT02467270|517030280|FG002|Overall Study|Death|2|||
143404253|NCT02467270|517030278|FG000|Overall Study|Lack of Efficacy|12|||
143404254|NCT02467270|517030279|FG001|Overall Study|Lack of Efficacy|18|||
143404255|NCT02467270|517030280|FG002|Overall Study|Lack of Efficacy|23|||
143404256|NCT02467270|517030278|FG000|Overall Study|Non-compliance With Study Drug|0|||
143404257|NCT02467270|517030279|FG001|Overall Study|Non-compliance With Study Drug|2|||
143404258|NCT02467270|517030280|FG002|Overall Study|Non-compliance With Study Drug|1|||
143404259|NCT02467270|517030278|FG000|Overall Study|Lost to Follow-up|2|||
143404260|NCT02467270|517030279|FG001|Overall Study|Lost to Follow-up|1|||
143404261|NCT02467270|517030280|FG002|Overall Study|Lost to Follow-up|0|||
143404262|NCT02467270|517030278|FG000|Overall Study|Pregnancy|0|||
143404263|NCT02467270|517030279|FG001|Overall Study|Pregnancy|1|||
143404264|NCT02467270|517030280|FG002|Overall Study|Pregnancy|0|||
143404265|NCT02467270|517030278|FG000|Overall Study|Physician Decision|0|||
143404266|NCT02467270|517030279|FG001|Overall Study|Physician Decision|4|||
143404267|NCT02467270|517030280|FG002|Overall Study|Physician Decision|1|||
143404268|NCT02467270|517030278|FG000|Overall Study|Withdrawal by Subject|4|||
143404269|NCT02467270|517030279|FG001|Overall Study|Withdrawal by Subject|3|||
143404270|NCT02467270|517030280|FG002|Overall Study|Withdrawal by Subject|5|||
143404271|NCT02467270|517030278|FG000|Overall Study|Reason not Specified|1|||
143404272|NCT02467270|517030279|FG001|Overall Study|Reason not Specified|2|||
143404273|NCT02467270|517030280|FG002|Overall Study|Reason not Specified|1|||
143404274|NCT02075554|517030286|FG000|Overall Study|Lost to Follow-up|7|||
143404275|NCT02075554|517030286|FG000|Overall Study|Withdrawal by Subject|5|||
143404276|NCT02075554|517030286|FG000|Overall Study|Physician Decision|3|||
143404277|NCT04993677|517030292|FG000|Overall Study|Lost to Follow-up|1|||
143404278|NCT04993677|517030293|FG001|Overall Study|Lost to Follow-up|0|||
143404279|NCT04993677|517030294|FG002|Overall Study|Lost to Follow-up|0|||
143404280|NCT04993677|517030295|FG003|Overall Study|Lost to Follow-up|0|||
143404281|NCT04993677|517030292|FG000|Overall Study|Death|11|||
143404282|NCT04993677|517030293|FG001|Overall Study|Death|8|||
143404283|NCT04993677|517030294|FG002|Overall Study|Death|3|||
143404284|NCT04993677|517030295|FG003|Overall Study|Death|1|||
143404285|NCT04993677|517030292|FG000|Overall Study|Subject withdrawal of consent|4|||
143404286|NCT04993677|517030293|FG001|Overall Study|Subject withdrawal of consent|3|||
143404287|NCT04993677|517030294|FG002|Overall Study|Subject withdrawal of consent|0|||
143404288|NCT04993677|517030295|FG003|Overall Study|Subject withdrawal of consent|2|||
143404289|NCT04993677|517030292|FG000|Overall Study|Study termination by sponsor|3|||
143404290|NCT04993677|517030293|FG001|Overall Study|Study termination by sponsor|25|||
143404291|NCT04993677|517030294|FG002|Overall Study|Study termination by sponsor|3|||
143404292|NCT04993677|517030295|FG003|Overall Study|Study termination by sponsor|3|||
143404293|NCT04993677|517030292|FG000|Overall Study|Other|2|||
143404294|NCT04993677|517030293|FG001|Overall Study|Other|3|||
143404295|NCT04993677|517030294|FG002|Overall Study|Other|3|||
143404296|NCT04993677|517030295|FG003|Overall Study|Other|2|||
143404297|NCT04174170|517030296|FG000|Placebo Run-in Period|Not Randomized|38|||
143404298|NCT04174170|517030297|FG001|Placebo Run-in Period|Not Randomized|0|||
143404299|NCT04174170|517030298|FG002|Placebo Run-in Period|Not Randomized|0|||
143404300|NCT04174170|517030299|FG003|Placebo Run-in Period|Not Randomized|0|||
143404301|NCT04174170|517030296|FG000|Double Blind Treatment Period|Adverse Event|0|||
143404302|NCT04174170|517030297|FG001|Double Blind Treatment Period|Adverse Event|9|||
143404303|NCT04174170|517030298|FG002|Double Blind Treatment Period|Adverse Event|9|||
143404304|NCT04174170|517030299|FG003|Double Blind Treatment Period|Adverse Event|8|||
143404305|NCT04174170|517030296|FG000|Double Blind Treatment Period|Death|0|||
143404306|NCT04174170|517030297|FG001|Double Blind Treatment Period|Death|1|||
143404307|NCT04174170|517030298|FG002|Double Blind Treatment Period|Death|0|||
143404308|NCT04174170|517030299|FG003|Double Blind Treatment Period|Death|0|||
143404309|NCT04174170|517030296|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
143404310|NCT04174170|517030297|FG001|Double Blind Treatment Period|Lost to Follow-up|22|||
143404311|NCT04174170|517030298|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
143404312|NCT04174170|517030299|FG003|Double Blind Treatment Period|Lost to Follow-up|25|||
143404313|NCT04174170|517030296|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
143404314|NCT04174170|517030297|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
143404315|NCT04174170|517030298|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
143404316|NCT04174170|517030299|FG003|Double Blind Treatment Period|Non-Compliance With Study Drug|2|||
143404317|NCT04174170|517030296|FG000|Double Blind Treatment Period|Physician Decision|0|||
143404318|NCT04174170|517030297|FG001|Double Blind Treatment Period|Physician Decision|1|||
143404319|NCT04174170|517030298|FG002|Double Blind Treatment Period|Physician Decision|0|||
143404320|NCT04174170|517030299|FG003|Double Blind Treatment Period|Physician Decision|1|||
143404321|NCT04174170|517030296|FG000|Double Blind Treatment Period|Pregnancy|0|||
143404322|NCT04174170|517030297|FG001|Double Blind Treatment Period|Pregnancy|1|||
143404323|NCT04174170|517030298|FG002|Double Blind Treatment Period|Pregnancy|0|||
143404324|NCT04174170|517030299|FG003|Double Blind Treatment Period|Pregnancy|1|||
143404325|NCT04174170|517030296|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
143404326|NCT04174170|517030297|FG001|Double Blind Treatment Period|Protocol Deviation|7|||
143404327|NCT04174170|517030298|FG002|Double Blind Treatment Period|Protocol Deviation|6|||
143404328|NCT04174170|517030299|FG003|Double Blind Treatment Period|Protocol Deviation|4|||
143404329|NCT04174170|517030296|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
143404330|NCT04174170|517030297|FG001|Double Blind Treatment Period|Withdrawal by Subject|19|||
143404331|NCT04174170|517030298|FG002|Double Blind Treatment Period|Withdrawal by Subject|29|||
143404332|NCT04174170|517030299|FG003|Double Blind Treatment Period|Withdrawal by Subject|14|||
143404333|NCT04174170|517030296|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
143404334|NCT04174170|517030297|FG001|Double Blind Treatment Period|Reason Not Specified|1|||
143404335|NCT04174170|517030298|FG002|Double Blind Treatment Period|Reason Not Specified|3|||
143404336|NCT04174170|517030299|FG003|Double Blind Treatment Period|Reason Not Specified|6|||
143404337|NCT04664881|517030300|FG000|Overall Study|Withdrawal by Subject|1|||
143404338|NCT04664881|517030301|FG001|Overall Study|Withdrawal by Subject|8|||
143404339|NCT04664881|517030300|FG000|Overall Study|Physician Decision|0|||
143404340|NCT04664881|517030301|FG001|Overall Study|Physician Decision|5|||
143404341|NCT04664881|517030300|FG000|Overall Study|Lost to Follow-up|1|||
143404342|NCT04664881|517030301|FG001|Overall Study|Lost to Follow-up|0|||
143404343|NCT03201939|517030303|FG000|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|32|||
143404344|NCT03201939|517030304|FG001|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|34|||
143404345|NCT03333915|517030305|FG000|Overall Study|Lost to Follow-up|0|||
143404346|NCT03333915|517030306|FG001|Overall Study|Lost to Follow-up|0|||
143404347|NCT03333915|517030307|FG002|Overall Study|Lost to Follow-up|1|||
143404348|NCT03333915|517030308|FG003|Overall Study|Lost to Follow-up|0|||
143404349|NCT03333915|517030309|FG004|Overall Study|Lost to Follow-up|0|||
143404350|NCT03333915|517030305|FG000|Overall Study|Disease Progression|0|||
143404351|NCT03333915|517030306|FG001|Overall Study|Disease Progression|1|||
143404352|NCT03333915|517030307|FG002|Overall Study|Disease Progression|0|||
143404353|NCT03333915|517030308|FG003|Overall Study|Disease Progression|0|||
143404354|NCT03333915|517030309|FG004|Overall Study|Disease Progression|0|||
143404355|NCT03333915|517030305|FG000|Overall Study|Death|0|||
143404356|NCT03333915|517030306|FG001|Overall Study|Death|0|||
143404357|NCT03333915|517030307|FG002|Overall Study|Death|0|||
143404358|NCT03333915|517030308|FG003|Overall Study|Death|37|||
143404359|NCT03333915|517030309|FG004|Overall Study|Death|18|||
143404360|NCT03333915|517030305|FG000|Overall Study|Sponsor's Decision|0|||
143404361|NCT03333915|517030306|FG001|Overall Study|Sponsor's Decision|0|||
143404362|NCT03333915|517030307|FG002|Overall Study|Sponsor's Decision|0|||
143404363|NCT03333915|517030308|FG003|Overall Study|Sponsor's Decision|48|||
143404364|NCT03333915|517030309|FG004|Overall Study|Sponsor's Decision|4|||
143404365|NCT03333915|517030305|FG000|Overall Study|Withdrawal by Subject|0|||
143404366|NCT03333915|517030306|FG001|Overall Study|Withdrawal by Subject|0|||
143404367|NCT03333915|517030307|FG002|Overall Study|Withdrawal by Subject|0|||
143404368|NCT03333915|517030308|FG003|Overall Study|Withdrawal by Subject|5|||
143404369|NCT03333915|517030309|FG004|Overall Study|Withdrawal by Subject|1|||
143404370|NCT04281498|517030311|FG000|Overall Study|Progression of disease|1|||
143404371|NCT04281498|517030311|FG000|Overall Study|Planned SCT|1|||
143404372|NCT04281498|517030311|FG000|Overall Study|Alternative Treatment|1|||
143404373|NCT00709956|517030312|FG000|Overall Study|Withdrawal by Subject|1|||
143404374|NCT00709956|517030313|FG001|Overall Study|Withdrawal by Subject|1|||
143404375|NCT00709956|517030312|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
143404376|NCT00709956|517030313|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
143404377|NCT01105091|517030314|FG000|Overall Study|Death|2|||
143404378|NCT01105091|517030315|FG001|Overall Study|Death|0|||
143404379|NCT05180539|517030991|FG000|Overall Study|Lost to Follow-up|27|||
143404380|NCT05180539|517030992|FG001|Overall Study|Lost to Follow-up|30|||
143404381|NCT00994643|517030995|FG000|Overall Study|Withdrawal by Subject|1|||
143404382|NCT04518943|517030997|FG000|Consent Through Baseline|Walked too many steps at baseline|3|||
143404383|NCT04518943|517030998|FG001|Consent Through Baseline|Walked too many steps at baseline|1|||
143404384|NCT04518943|517030999|FG002|Consent Through Baseline|Walked too many steps at baseline|4|||
143404385|NCT04518943|517031000|FG003|Consent Through Baseline|Walked too many steps at baseline|5|||
143404386|NCT04518943|517031001|FG004|Consent Through Baseline|Walked too many steps at baseline|3|||
143404387|NCT04518943|517031002|FG005|Consent Through Baseline|Walked too many steps at baseline|3|||
143404388|NCT04518943|517031003|FG006|Consent Through Baseline|Walked too many steps at baseline|4|||
143404389|NCT04518943|517031004|FG007|Consent Through Baseline|Walked too many steps at baseline|7|||
143404390|NCT04518943|517031005|FG008|Consent Through Baseline|Walked too many steps at baseline|4|||
143404391|NCT04518943|517031006|FG009|Consent Through Baseline|Walked too many steps at baseline|1|||
143404392|NCT04518943|517031007|FG010|Consent Through Baseline|Walked too many steps at baseline|3|||
143404393|NCT04518943|517031008|FG011|Consent Through Baseline|Walked too many steps at baseline|1|||
143404394|NCT04518943|517031009|FG012|Consent Through Baseline|Walked too many steps at baseline|4|||
143404395|NCT04518943|517031010|FG013|Consent Through Baseline|Walked too many steps at baseline|5|||
143404396|NCT04518943|517031011|FG014|Consent Through Baseline|Walked too many steps at baseline|4|||
143404397|NCT04518943|517031012|FG015|Consent Through Baseline|Walked too many steps at baseline|4|||
143404398|NCT00968149|517031013|FG000|Overall Study|Adverse Event|5|||
143404399|NCT00968149|517031014|FG001|Overall Study|Adverse Event|1|||
143404400|NCT00968149|517031013|FG000|Overall Study|Lack of Efficacy|0|||
143404401|NCT00968149|517031014|FG001|Overall Study|Lack of Efficacy|4|||
143404402|NCT00968149|517031013|FG000|Overall Study|Lost to Follow-up|0|||
143404403|NCT00968149|517031014|FG001|Overall Study|Lost to Follow-up|1|||
143404404|NCT00968149|517031013|FG000|Overall Study|Protocol Violation|4|||
143404405|NCT00968149|517031014|FG001|Overall Study|Protocol Violation|0|||
143404406|NCT00968149|517031013|FG000|Overall Study|Withdrawal by Subject|2|||
143404407|NCT00968149|517031014|FG001|Overall Study|Withdrawal by Subject|0|||
143404408|NCT00113360|517031018|FG000|Overall Study|Adverse Event|3|||
143404409|NCT00113360|517031018|FG000|Overall Study|Subject required surgery|1|||
143404410|NCT00113360|517031018|FG000|Overall Study|Did not meet eligibility criteria|3|||
143404411|NCT00739908|517031019|FG000|Overall Study|Adverse Event|5|||
143404412|NCT00739908|517031020|FG001|Overall Study|Adverse Event|6|||
143404413|NCT00739908|517031019|FG000|Overall Study|Withdrawal by Subject|4|||
143404414|NCT00739908|517031020|FG001|Overall Study|Withdrawal by Subject|2|||
143404415|NCT00739908|517031019|FG000|Overall Study|Lost to Follow-up|14|||
143404416|NCT00739908|517031020|FG001|Overall Study|Lost to Follow-up|9|||
143404417|NCT00739908|517031019|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
143404418|NCT00739908|517031020|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
143404419|NCT00739908|517031019|FG000|Overall Study|Non-Compliance With Study Medication|0|||
143404420|NCT00739908|517031020|FG001|Overall Study|Non-Compliance With Study Medication|3|||
143404421|NCT00739908|517031019|FG000|Overall Study|Lack of Efficacy|0|||
143404422|NCT00739908|517031020|FG001|Overall Study|Lack of Efficacy|1|||
143404423|NCT00739908|517031019|FG000|Overall Study|Relocation|0|||
143404424|NCT00739908|517031020|FG001|Overall Study|Relocation|1|||
143404425|NCT01773993|517031023|FG000|Overall Study|No Visit After Treatment|35|||
143404426|NCT02231749|517031031|FG000|Overall Study|Disease progression|229|||
143404427|NCT02231749|517031032|FG001|Overall Study|Disease progression|297|||
143404428|NCT02231749|517031031|FG000|Overall Study|Study Drug Toxicity|134|||
143404429|NCT02231749|517031032|FG001|Overall Study|Study Drug Toxicity|63|||
143404430|NCT02231749|517031031|FG000|Overall Study|Death|1|||
143404431|NCT02231749|517031032|FG001|Overall Study|Death|1|||
143404432|NCT02231749|517031031|FG000|Overall Study|AE unrelated to Study drug|32|||
143404433|NCT02231749|517031032|FG001|Overall Study|AE unrelated to Study drug|31|||
143404434|NCT02231749|517031031|FG000|Overall Study|Participant's request to discontinue|10|||
143404435|NCT02231749|517031032|FG001|Overall Study|Participant's request to discontinue|21|||
143404436|NCT02231749|517031031|FG000|Overall Study|Participant withdrew Consent|8|||
143404437|NCT02231749|517031032|FG001|Overall Study|Participant withdrew Consent|15|||
143404438|NCT02231749|517031031|FG000|Overall Study|Lost to Follow-up|1|||
143404439|NCT02231749|517031032|FG001|Overall Study|Lost to Follow-up|2|||
143404440|NCT02231749|517031031|FG000|Overall Study|Maximum Clinical Benefit|5|||
143404441|NCT02231749|517031032|FG001|Overall Study|Maximum Clinical Benefit|8|||
143404442|NCT02231749|517031031|FG000|Overall Study|Poor/Non-Compliance|0|||
143404443|NCT02231749|517031032|FG001|Overall Study|Poor/Non-Compliance|3|||
143404444|NCT02231749|517031031|FG000|Overall Study|Pregnancy|1|||
143404445|NCT02231749|517031032|FG001|Overall Study|Pregnancy|0|||
143404446|NCT02231749|517031031|FG000|Overall Study|other|0|||
143404447|NCT02231749|517031032|FG001|Overall Study|other|8|||
143404448|NCT02231749|517031031|FG000|Overall Study|No longer meets Study Criteria|1|||
143404449|NCT02231749|517031032|FG001|Overall Study|No longer meets Study Criteria|0|||
143404450|NCT04194450|517031033|FG000|Overall Study|not eligible|1|||
143404451|NCT04194450|517031034|FG001|Overall Study|not eligible|0|||
143404452|NCT04757753|517031035|FG000|Overall Study|Lost to Follow-up|7|||
143404453|NCT04757753|517031036|FG001|Overall Study|Lost to Follow-up|7|||
143404454|NCT04757753|517031035|FG000|Overall Study|Withdrawal by Subject|0|||
143404455|NCT04757753|517031036|FG001|Overall Study|Withdrawal by Subject|3|||
143404456|NCT04757753|517031035|FG000|Overall Study|Endodontic treatment failure|1|||
143404457|NCT04757753|517031036|FG001|Overall Study|Endodontic treatment failure|2|||
143404458|NCT04757753|517031035|FG000|Overall Study|Tooth fracture/extraction|3|||
143404459|NCT04757753|517031036|FG001|Overall Study|Tooth fracture/extraction|0|||
143404460|NCT03142009|517031044|FG000|Overall Study|Lost to Follow-up|45|||
143404461|NCT03142009|517031045|FG001|Overall Study|Lost to Follow-up|30|||
143404462|NCT03872466|517031046|FG000|Overall Study|Withdrawal by Subject|1|||
143404463|NCT03872466|517031047|FG001|Overall Study|Withdrawal by Subject|0|||
143404464|NCT03872466|517031046|FG000|Overall Study|Physician Decision|2|||
143404465|NCT03872466|517031047|FG001|Overall Study|Physician Decision|0|||
143404466|NCT04012567|517031048|FG000|Overall Study|Lost to Follow-up|0|||
143404467|NCT04012567|517031049|FG001|Overall Study|Lost to Follow-up|1|||
143404468|NCT04012567|517031048|FG000|Overall Study|Withdrawal by Subject|1|||
143404469|NCT04012567|517031049|FG001|Overall Study|Withdrawal by Subject|0|||
143404470|NCT02206828|517031065|FG000|Overall Study|Lost to Follow-up|7|||
143404471|NCT00328783|517031574|FG000|Overall Study|Could not tolerate ABC|21|||
143404472|NCT00328783|517031574|FG000|Overall Study|No heart in RT field|4|||
143404473|NCT00328783|517031574|FG000|Overall Study|Withdrawal by Subject|1|||
143404474|NCT03660930|517031576|FG000|Overall Study|Adverse Event|0|||
143404475|NCT03660930|517031577|FG001|Overall Study|Adverse Event|0|||
143404476|NCT03660930|517031578|FG002|Overall Study|Adverse Event|0|||
143404477|NCT03660930|517031579|FG003|Overall Study|Adverse Event|2|||
143404478|NCT03660930|517031580|FG004|Overall Study|Adverse Event|0|||
143404479|NCT03660930|517031581|FG005|Overall Study|Adverse Event|1|||
143404480|NCT03660930|517031582|FG006|Overall Study|Adverse Event|0|||
143404481|NCT03660930|517031583|FG007|Overall Study|Adverse Event|0|||
143404482|NCT03660930|517031576|FG000|Overall Study|Withdrawal by Subject|0|||
143404483|NCT03660930|517031577|FG001|Overall Study|Withdrawal by Subject|0|||
143404484|NCT03660930|517031578|FG002|Overall Study|Withdrawal by Subject|0|||
143404485|NCT03660930|517031579|FG003|Overall Study|Withdrawal by Subject|0|||
143404486|NCT03660930|517031580|FG004|Overall Study|Withdrawal by Subject|0|||
143404487|NCT03660930|517031581|FG005|Overall Study|Withdrawal by Subject|1|||
143404488|NCT03660930|517031582|FG006|Overall Study|Withdrawal by Subject|0|||
143404489|NCT03660930|517031583|FG007|Overall Study|Withdrawal by Subject|0|||
143404490|NCT02656706|517031586|FG000|Overall Study|Insurance Denial|1|||
143404491|NCT03725332|517031587|FG000|Overall Study|Adverse Event|5|||
143404492|NCT03725332|517031588|FG001|Overall Study|Adverse Event|10|||
143404493|NCT03725332|517031587|FG000|Overall Study|Death|1|||
143404494|NCT03725332|517031588|FG001|Overall Study|Death|3|||
143404495|NCT03725332|517031587|FG000|Overall Study|Lost to Follow-up|43|||
143404496|NCT03725332|517031588|FG001|Overall Study|Lost to Follow-up|122|||
143404497|NCT03725332|517031587|FG000|Overall Study|Withdrawal by Subject|0|||
143404498|NCT03725332|517031588|FG001|Overall Study|Withdrawal by Subject|1|||
143404499|NCT03725332|517031587|FG000|Overall Study|Duplicate enrollment|0|||
143404500|NCT03725332|517031588|FG001|Overall Study|Duplicate enrollment|1|||
143404501|NCT03725332|517031587|FG000|Overall Study|Did not consent|0|||
143404502|NCT03725332|517031588|FG001|Overall Study|Did not consent|1|||
143404503|NCT03242915|517031595|FG000|Overall Study|Adverse Event|5|||
143404504|NCT03242915|517031596|FG001|Overall Study|Adverse Event|1|||
143404505|NCT03242915|517031595|FG000|Overall Study|Withdrawal by Subject|0|||
143404506|NCT03242915|517031596|FG001|Overall Study|Withdrawal by Subject|2|||
143404507|NCT03242915|517031595|FG000|Overall Study|Physician Decision|4|||
143404508|NCT03242915|517031596|FG001|Overall Study|Physician Decision|1|||
143404509|NCT02726386|517031597|FG000|Overall Study|Adverse Event|17|||
143404510|NCT02726386|517031598|FG001|Overall Study|Adverse Event|20|||
143404511|NCT02726386|517031597|FG000|Overall Study|Withdrawal by Subject|14|||
143404512|NCT02726386|517031598|FG001|Overall Study|Withdrawal by Subject|28|||
143404513|NCT02726386|517031597|FG000|Overall Study|Other reasons|7|||
143404514|NCT02726386|517031598|FG001|Overall Study|Other reasons|8|||
143404515|NCT05424718|517031614|FG000|Overall Study|Lost to Follow-up|5|||
143404516|NCT05424718|517031615|FG001|Overall Study|Lost to Follow-up|4|||
143404517|NCT01778686|517031616|FG000|Overall Study|Adverse Event|0|||
143404518|NCT01778686|517031617|FG001|Overall Study|Adverse Event|0|||
143404519|NCT01778686|517031618|FG002|Overall Study|Adverse Event|1|||
143404520|NCT06059443|517031619|FG000|Overall Study|Withdrawal by Subject|2|||
143404521|NCT06059443|517031620|FG001|Overall Study|Withdrawal by Subject|0|||
143404522|NCT06059443|517031619|FG000|Overall Study|Lost to Follow-up|2|||
143404523|NCT06059443|517031620|FG001|Overall Study|Lost to Follow-up|2|||
143404524|NCT05771467|517031622|FG000|Overall Study|Lost to Follow-up|6|||
143404525|NCT05771467|517031623|FG001|Overall Study|Lost to Follow-up|3|||
143404526|NCT04940624|517031624|FG000|Overall Study|Adverse Event|4|||
143404527|NCT04940624|517031625|FG001|Overall Study|Adverse Event|11|||
143404528|NCT04940624|517031624|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
143404529|NCT04940624|517031625|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
143404530|NCT04940624|517031624|FG000|Overall Study|Physician Decision|1|||
143404531|NCT04940624|517031625|FG001|Overall Study|Physician Decision|0|||
143404532|NCT04940624|517031624|FG000|Overall Study|Lost to Follow-up|1|||
143404533|NCT04940624|517031625|FG001|Overall Study|Lost to Follow-up|0|||
143404534|NCT04940624|517031624|FG000|Overall Study|Reason Not Specified|1|||
143404535|NCT04940624|517031625|FG001|Overall Study|Reason Not Specified|0|||
143404536|NCT03782116|517031626|FG000|Completed Intervetion|Lost to Follow-up|11|||
143404537|NCT03782116|517031627|FG001|Completed Intervetion|Lost to Follow-up|7|||
143404538|NCT03782116|517031626|FG000|Completed Intervetion|Withdrawal by Subject|6|||
143404539|NCT03782116|517031627|FG001|Completed Intervetion|Withdrawal by Subject|5|||
143404540|NCT03782116|517031626|FG000|Included in Analysis|Protocol Violation|5|||
143404541|NCT03782116|517031627|FG001|Included in Analysis|Protocol Violation|5|||
143404542|NCT04039113|517031629|FG000|Overall Study|Withdrawal by Subject|8|||
143404543|NCT04039113|517031630|FG001|Overall Study|Withdrawal by Subject|11|||
143404544|NCT04039113|517031629|FG000|Overall Study|Lost to Follow-up|1|||
143404545|NCT04039113|517031630|FG001|Overall Study|Lost to Follow-up|1|||
143404546|NCT04039113|517031629|FG000|Overall Study|Adverse Event|2|||
143404547|NCT04039113|517031630|FG001|Overall Study|Adverse Event|2|||
143404548|NCT04039113|517031629|FG000|Overall Study|Death|2|||
143404549|NCT04039113|517031630|FG001|Overall Study|Death|4|||
143404550|NCT04039113|517031629|FG000|Overall Study|Site Closure|6|||
143404551|NCT04039113|517031630|FG001|Overall Study|Site Closure|0|||
143404552|NCT04039113|517031629|FG000|Overall Study|Failure to meet randomisation criteria|4|||
143404553|NCT04039113|517031630|FG001|Overall Study|Failure to meet randomisation criteria|0|||
143404554|NCT00353496|517031631|FG000|Overall Study|Adverse Event|1|||
143404555|NCT00353496|517031632|FG001|Overall Study|Adverse Event|0|||
143404556|NCT00353496|517031631|FG000|Overall Study|Protocol Violation|2|||
143404557|NCT00353496|517031632|FG001|Overall Study|Protocol Violation|2|||
143404558|NCT00353496|517031631|FG000|Overall Study|Withdrawal by Subject|3|||
143404559|NCT00353496|517031632|FG001|Overall Study|Withdrawal by Subject|4|||
143404560|NCT00353496|517031631|FG000|Overall Study|Physician Decision|6|||
143404561|NCT00353496|517031632|FG001|Overall Study|Physician Decision|9|||
143404562|NCT00353496|517031631|FG000|Overall Study|Not otherwise specified|4|||
143404563|NCT00353496|517031632|FG001|Overall Study|Not otherwise specified|2|||
143404564|NCT03705390|517032028|FG000|10 Week Initial Treatment Period|Trial suspended prior to completion|2|||
143404565|NCT03705390|517032028|FG000|Treatment Extension|Trial closed early due to COVID-19 pandemic|1|||
143404566|NCT05934292|517032037|FG000|Overall Study|Lost to Follow-up|0|||
143404567|NCT05934292|517032038|FG001|Overall Study|Lost to Follow-up|0|||
143404568|NCT05934292|517032039|FG002|Overall Study|Lost to Follow-up|1|||
143404569|NCT05934292|517032040|FG003|Overall Study|Lost to Follow-up|0|||
143404570|NCT04479787|517032041|FG000|Through 6 Months|Withdrawal by Subject|16|||
143404571|NCT04479787|517032042|FG001|Through 6 Months|Withdrawal by Subject|14|||
143404572|NCT04479787|517032041|FG000|Through 6 Months|Unsuccessful Trial|17|||
143404573|NCT04479787|517032042|FG001|Through 6 Months|Unsuccessful Trial|0|||
143404574|NCT04479787|517032041|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
143404575|NCT04479787|517032042|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
143404576|NCT04479787|517032041|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
143404577|NCT04479787|517032042|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
143404578|NCT04479787|517032041|FG000|Through 6 Months|Lost to Follow-up|3|||
143404579|NCT04479787|517032042|FG001|Through 6 Months|Lost to Follow-up|2|||
143404580|NCT04479787|517032041|FG000|Through 6 Months|Death|3|||
143404581|NCT04479787|517032042|FG001|Through 6 Months|Death|0|||
143404582|NCT04479787|517032041|FG000|Through 6 Months|Inclusion/Exclusion|2|||
143404583|NCT04479787|517032042|FG001|Through 6 Months|Inclusion/Exclusion|1|||
143404584|NCT04479787|517032041|FG000|Through 6 Months|Subject Became Pregnant|1|||
143404585|NCT04479787|517032042|FG001|Through 6 Months|Subject Became Pregnant|1|||
143404586|NCT04479787|517032041|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
143404587|NCT04479787|517032042|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
143404588|NCT04479787|517032041|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
143404589|NCT04479787|517032042|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
143404590|NCT04479787|517032041|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
143404591|NCT04479787|517032042|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
143404592|NCT04479787|517032041|FG000|After 6 Months|Withdrawal by Subject|3|||
143404593|NCT04479787|517032042|FG001|After 6 Months|Withdrawal by Subject|13|||
143404594|NCT04479787|517032041|FG000|After 6 Months|Unsuccessful Trial|0|||
143404595|NCT04479787|517032042|FG001|After 6 Months|Unsuccessful Trial|7|||
143404596|NCT04479787|517032041|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
143404597|NCT04479787|517032042|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
143404598|NCT04479787|517032041|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
143404599|NCT04479787|517032042|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
143404600|NCT04479787|517032041|FG000|After 6 Months|Death|2|||
143404601|NCT04479787|517032042|FG001|After 6 Months|Death|0|||
143404602|NCT04479787|517032041|FG000|After 6 Months|Lost to Follow-up|1|||
143404603|NCT04479787|517032042|FG001|After 6 Months|Lost to Follow-up|1|||
143404604|NCT04479787|517032041|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
143404605|NCT04479787|517032042|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
143404606|NCT04479787|517032041|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
143404607|NCT04479787|517032042|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
143404608|NCT04479787|517032041|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
143404609|NCT04479787|517032042|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
143404610|NCT04479787|517032041|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
143404611|NCT04479787|517032042|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
143404612|NCT04899674|517032045|FG000|Test|Adverse Event|1|||
143404613|NCT03774472|517032046|FG000|Overall Study|Physician Decision|1|||
143404614|NCT03774472|517032047|FG001|Overall Study|Physician Decision|0|||
143404615|NCT03774472|517032048|FG002|Overall Study|Physician Decision|0|||
143404616|NCT03774472|517032046|FG000|Overall Study|Progression prior to 4 weeks|0|||
143404617|NCT03774472|517032047|FG001|Overall Study|Progression prior to 4 weeks|1|||
143404618|NCT03774472|517032048|FG002|Overall Study|Progression prior to 4 weeks|0|||
143404619|NCT03774472|517032046|FG000|Overall Study|Withdrawal by Subject|0|||
143404620|NCT03774472|517032047|FG001|Overall Study|Withdrawal by Subject|1|||
143404621|NCT03774472|517032048|FG002|Overall Study|Withdrawal by Subject|0|||
143404622|NCT03150862|517032049|FG000|Overall Study|Death|2|||
143404623|NCT03150862|517032050|FG001|Overall Study|Death|7|||
143404624|NCT03150862|517032051|FG002|Overall Study|Death|8|||
143404625|NCT03150862|517032052|FG003|Overall Study|Death|27|||
143404626|NCT03150862|517032053|FG004|Overall Study|Death|4|||
143404627|NCT03150862|517032054|FG005|Overall Study|Death|8|||
143404628|NCT03150862|517032055|FG006|Overall Study|Death|6|||
143404629|NCT03150862|517032056|FG007|Overall Study|Death|21|||
143404630|NCT03150862|517032049|FG000|Overall Study|Withdrawal by Subject|1|||
143404631|NCT03150862|517032050|FG001|Overall Study|Withdrawal by Subject|1|||
143404632|NCT03150862|517032051|FG002|Overall Study|Withdrawal by Subject|0|||
143404633|NCT03150862|517032052|FG003|Overall Study|Withdrawal by Subject|3|||
143404634|NCT03150862|517032053|FG004|Overall Study|Withdrawal by Subject|1|||
143404635|NCT03150862|517032054|FG005|Overall Study|Withdrawal by Subject|1|||
143404636|NCT03150862|517032055|FG006|Overall Study|Withdrawal by Subject|1|||
143404637|NCT03150862|517032056|FG007|Overall Study|Withdrawal by Subject|3|||
143404638|NCT03150862|517032049|FG000|Overall Study|Lost to Follow-up|0|||
143404639|NCT03150862|517032050|FG001|Overall Study|Lost to Follow-up|0|||
143404640|NCT03150862|517032051|FG002|Overall Study|Lost to Follow-up|1|||
143404641|NCT03150862|517032052|FG003|Overall Study|Lost to Follow-up|0|||
143404642|NCT03150862|517032053|FG004|Overall Study|Lost to Follow-up|0|||
143404643|NCT03150862|517032054|FG005|Overall Study|Lost to Follow-up|0|||
143404644|NCT03150862|517032055|FG006|Overall Study|Lost to Follow-up|0|||
143404645|NCT03150862|517032056|FG007|Overall Study|Lost to Follow-up|2|||
143404646|NCT03150862|517032049|FG000|Overall Study|Sponsor's decision|0|||
143404647|NCT03150862|517032050|FG001|Overall Study|Sponsor's decision|0|||
143404648|NCT03150862|517032051|FG002|Overall Study|Sponsor's decision|0|||
143404649|NCT03150862|517032052|FG003|Overall Study|Sponsor's decision|10|||
143404650|NCT03150862|517032053|FG004|Overall Study|Sponsor's decision|3|||
143404651|NCT03150862|517032054|FG005|Overall Study|Sponsor's decision|0|||
143404652|NCT03150862|517032055|FG006|Overall Study|Sponsor's decision|1|||
143404653|NCT03150862|517032056|FG007|Overall Study|Sponsor's decision|1|||
143404654|NCT03150862|517032049|FG000|Overall Study|Change in Methylation status|0|||
143404655|NCT03150862|517032050|FG001|Overall Study|Change in Methylation status|0|||
143404656|NCT03150862|517032051|FG002|Overall Study|Change in Methylation status|0|||
143404657|NCT03150862|517032052|FG003|Overall Study|Change in Methylation status|0|||
143404658|NCT03150862|517032053|FG004|Overall Study|Change in Methylation status|1|||
143404659|NCT03150862|517032054|FG005|Overall Study|Change in Methylation status|0|||
143404660|NCT03150862|517032055|FG006|Overall Study|Change in Methylation status|0|||
143404661|NCT03150862|517032056|FG007|Overall Study|Change in Methylation status|0|||
143404662|NCT03150862|517032049|FG000|Overall Study|Roll over in to Long Term Extension|0|||
143404663|NCT03150862|517032050|FG001|Overall Study|Roll over in to Long Term Extension|0|||
143404664|NCT03150862|517032051|FG002|Overall Study|Roll over in to Long Term Extension|0|||
143404665|NCT03150862|517032052|FG003|Overall Study|Roll over in to Long Term Extension|0|||
143404666|NCT03150862|517032053|FG004|Overall Study|Roll over in to Long Term Extension|0|||
143404667|NCT03150862|517032054|FG005|Overall Study|Roll over in to Long Term Extension|0|||
143404668|NCT03150862|517032055|FG006|Overall Study|Roll over in to Long Term Extension|0|||
143404669|NCT03150862|517032056|FG007|Overall Study|Roll over in to Long Term Extension|1|||
143404670|NCT03150862|517032049|FG000|Overall Study|Progressive Disease|0|||
143404671|NCT03150862|517032050|FG001|Overall Study|Progressive Disease|0|||
143404672|NCT03150862|517032051|FG002|Overall Study|Progressive Disease|0|||
143404673|NCT03150862|517032052|FG003|Overall Study|Progressive Disease|0|||
143404674|NCT03150862|517032053|FG004|Overall Study|Progressive Disease|0|||
143404675|NCT03150862|517032054|FG005|Overall Study|Progressive Disease|0|||
143404676|NCT03150862|517032055|FG006|Overall Study|Progressive Disease|0|||
143404677|NCT03150862|517032056|FG007|Overall Study|Progressive Disease|2|||
143404678|NCT05039021|517032898|FG000|Overall Study|Death|1|||
143404679|NCT05039021|517032898|FG000|Overall Study|Lost to Follow-up|3|||
143404680|NCT02566889|517032901|FG000|Overall Study|Withdrawal by Subject|3|||
143404681|NCT02566889|517032902|FG001|Overall Study|Withdrawal by Subject|1|||
143404682|NCT02566889|517032901|FG000|Overall Study|Adverse Event|4|||
143404683|NCT02566889|517032902|FG001|Overall Study|Adverse Event|2|||
143404684|NCT02566889|517032901|FG000|Overall Study|Other|6|||
143404685|NCT02566889|517032902|FG001|Overall Study|Other|2|||
143404686|NCT02719574|517032903|FG000|Phase 1 (Dose Escalation)|Other|0|||
143404687|NCT02719574|517032904|FG001|Phase 1 (Dose Escalation)|Other|2|||
143404688|NCT02719574|517032905|FG002|Phase 1 (Dose Escalation)|Other|1|||
143404689|NCT02719574|517032906|FG003|Phase 1 (Dose Escalation)|Other|2|||
143404690|NCT02719574|517032907|FG004|Phase 1 (Dose Escalation)|Other|2|||
143404691|NCT02719574|517032908|FG005|Phase 1 (Dose Escalation)|Other|0|||
143404692|NCT02719574|517032909|FG006|Phase 1 (Dose Escalation)|Other|0|||
143404693|NCT02719574|517032910|FG007|Phase 1 (Dose Escalation)|Other|0|||
143404694|NCT02719574|517032911|FG008|Phase 1 (Dose Escalation)|Other|0|||
143404695|NCT02719574|517032912|FG009|Phase 1 (Dose Escalation)|Other|0|||
143404696|NCT02719574|517032913|FG010|Phase 1 (Dose Escalation)|Other|0|||
143404697|NCT02719574|517032914|FG011|Phase 1 (Dose Escalation)|Other|0|||
143404698|NCT02719574|517032915|FG012|Phase 1 (Dose Escalation)|Other|0|||
143404699|NCT02719574|517032916|FG013|Phase 1 (Dose Escalation)|Other|0|||
143404700|NCT02719574|517032917|FG014|Phase 1 (Dose Escalation)|Other|0|||
143404701|NCT02719574|517032918|FG015|Phase 1 (Dose Escalation)|Other|0|||
143404702|NCT02719574|517032919|FG016|Phase 1 (Dose Escalation)|Other|0|||
143404703|NCT02719574|517032903|FG000|Phase 1 (Dose Escalation)|Progressive Disease|1|||
143404704|NCT02719574|517032904|FG001|Phase 1 (Dose Escalation)|Progressive Disease|3|||
143404705|NCT02719574|517032905|FG002|Phase 1 (Dose Escalation)|Progressive Disease|2|||
143404706|NCT02719574|517032906|FG003|Phase 1 (Dose Escalation)|Progressive Disease|2|||
143404707|NCT02719574|517032907|FG004|Phase 1 (Dose Escalation)|Progressive Disease|1|||
143404708|NCT02719574|517032908|FG005|Phase 1 (Dose Escalation)|Progressive Disease|3|||
143404709|NCT02719574|517032909|FG006|Phase 1 (Dose Escalation)|Progressive Disease|0|||
143404710|NCT02719574|517032910|FG007|Phase 1 (Dose Escalation)|Progressive Disease|0|||
143404711|NCT02719574|517032911|FG008|Phase 1 (Dose Escalation)|Progressive Disease|0|||
143404712|NCT02719574|517032912|FG009|Phase 1 (Dose Escalation)|Progressive Disease|0|||
143404713|NCT02719574|517032913|FG010|Phase 1 (Dose Escalation)|Progressive Disease|0|||
143404714|NCT02719574|517032914|FG011|Phase 1 (Dose Escalation)|Progressive Disease|0|||
143404715|NCT02719574|517032915|FG012|Phase 1 (Dose Escalation)|Progressive Disease|0|||
143404716|NCT02719574|517032916|FG013|Phase 1 (Dose Escalation)|Progressive Disease|0|||
143404717|NCT02719574|517032917|FG014|Phase 1 (Dose Escalation)|Progressive Disease|0|||
143404718|NCT02719574|517032918|FG015|Phase 1 (Dose Escalation)|Progressive Disease|0|||
143404719|NCT02719574|517032919|FG016|Phase 1 (Dose Escalation)|Progressive Disease|0|||
143404720|NCT02719574|517032903|FG000|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
143404721|NCT02719574|517032904|FG001|Phase 1 (Dose Escalation)|HSCT Transplant|1|||
143404722|NCT02719574|517032905|FG002|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
143404723|NCT02719574|517032906|FG003|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
143404724|NCT02719574|517032907|FG004|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
143404725|NCT02719574|517032908|FG005|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
143404726|NCT02719574|517032909|FG006|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
143404727|NCT02719574|517032910|FG007|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
143404728|NCT02719574|517032911|FG008|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
143404729|NCT02719574|517032912|FG009|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
143404730|NCT02719574|517032913|FG010|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
143404731|NCT02719574|517032914|FG011|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
143404732|NCT02719574|517032915|FG012|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
143404733|NCT02719574|517032916|FG013|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
143404734|NCT02719574|517032917|FG014|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
143404735|NCT02719574|517032918|FG015|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
143404736|NCT02719574|517032919|FG016|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
143404737|NCT02719574|517032903|FG000|Phase 1 (Dose Escalation)|Death|2|||
143404738|NCT02719574|517032904|FG001|Phase 1 (Dose Escalation)|Death|1|||
143404739|NCT02719574|517032905|FG002|Phase 1 (Dose Escalation)|Death|1|||
143404740|NCT02719574|517032906|FG003|Phase 1 (Dose Escalation)|Death|0|||
143404741|NCT02719574|517032907|FG004|Phase 1 (Dose Escalation)|Death|0|||
143404742|NCT02719574|517032908|FG005|Phase 1 (Dose Escalation)|Death|0|||
143404743|NCT02719574|517032909|FG006|Phase 1 (Dose Escalation)|Death|0|||
143404744|NCT02719574|517032910|FG007|Phase 1 (Dose Escalation)|Death|0|||
143404745|NCT02719574|517032911|FG008|Phase 1 (Dose Escalation)|Death|0|||
143404746|NCT02719574|517032912|FG009|Phase 1 (Dose Escalation)|Death|0|||
143404747|NCT02719574|517032913|FG010|Phase 1 (Dose Escalation)|Death|0|||
143404748|NCT02719574|517032914|FG011|Phase 1 (Dose Escalation)|Death|0|||
143404749|NCT02719574|517032915|FG012|Phase 1 (Dose Escalation)|Death|0|||
143404750|NCT02719574|517032916|FG013|Phase 1 (Dose Escalation)|Death|0|||
143404751|NCT02719574|517032917|FG014|Phase 1 (Dose Escalation)|Death|0|||
143404752|NCT02719574|517032918|FG015|Phase 1 (Dose Escalation)|Death|0|||
143404753|NCT02719574|517032919|FG016|Phase 1 (Dose Escalation)|Death|0|||
143404754|NCT02719574|517032903|FG000|Phase 1 (Dose Escalation)|Adverse Event|0|||
143404755|NCT02719574|517032904|FG001|Phase 1 (Dose Escalation)|Adverse Event|1|||
143404756|NCT02719574|517032905|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
143404757|NCT02719574|517032906|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
143404758|NCT02719574|517032907|FG004|Phase 1 (Dose Escalation)|Adverse Event|1|||
143404759|NCT02719574|517032908|FG005|Phase 1 (Dose Escalation)|Adverse Event|1|||
143404760|NCT02719574|517032909|FG006|Phase 1 (Dose Escalation)|Adverse Event|0|||
143404761|NCT02719574|517032910|FG007|Phase 1 (Dose Escalation)|Adverse Event|0|||
143404762|NCT02719574|517032911|FG008|Phase 1 (Dose Escalation)|Adverse Event|0|||
143404763|NCT02719574|517032912|FG009|Phase 1 (Dose Escalation)|Adverse Event|0|||
143404764|NCT02719574|517032913|FG010|Phase 1 (Dose Escalation)|Adverse Event|0|||
143404765|NCT02719574|517032914|FG011|Phase 1 (Dose Escalation)|Adverse Event|0|||
143404766|NCT02719574|517032915|FG012|Phase 1 (Dose Escalation)|Adverse Event|0|||
143404767|NCT02719574|517032916|FG013|Phase 1 (Dose Escalation)|Adverse Event|0|||
143404768|NCT02719574|517032917|FG014|Phase 1 (Dose Escalation)|Adverse Event|0|||
143404769|NCT02719574|517032918|FG015|Phase 1 (Dose Escalation)|Adverse Event|0|||
143404770|NCT02719574|517032919|FG016|Phase 1 (Dose Escalation)|Adverse Event|0|||
143404771|NCT02719574|517032903|FG000|Phase 1 (Dose Escalation)|Physician Decision|0|||
143404772|NCT02719574|517032904|FG001|Phase 1 (Dose Escalation)|Physician Decision|0|||
143404773|NCT02719574|517032905|FG002|Phase 1 (Dose Escalation)|Physician Decision|0|||
143404774|NCT02719574|517032906|FG003|Phase 1 (Dose Escalation)|Physician Decision|0|||
143404775|NCT02719574|517032907|FG004|Phase 1 (Dose Escalation)|Physician Decision|1|||
143404776|NCT02719574|517032908|FG005|Phase 1 (Dose Escalation)|Physician Decision|2|||
143404777|NCT02719574|517032909|FG006|Phase 1 (Dose Escalation)|Physician Decision|0|||
143404778|NCT02719574|517032910|FG007|Phase 1 (Dose Escalation)|Physician Decision|0|||
143404779|NCT02719574|517032911|FG008|Phase 1 (Dose Escalation)|Physician Decision|0|||
143404780|NCT02719574|517032912|FG009|Phase 1 (Dose Escalation)|Physician Decision|0|||
143404781|NCT02719574|517032913|FG010|Phase 1 (Dose Escalation)|Physician Decision|0|||
143404782|NCT02719574|517032914|FG011|Phase 1 (Dose Escalation)|Physician Decision|0|||
143404783|NCT02719574|517032915|FG012|Phase 1 (Dose Escalation)|Physician Decision|0|||
143404784|NCT02719574|517032916|FG013|Phase 1 (Dose Escalation)|Physician Decision|0|||
143404785|NCT02719574|517032917|FG014|Phase 1 (Dose Escalation)|Physician Decision|0|||
143404786|NCT02719574|517032918|FG015|Phase 1 (Dose Escalation)|Physician Decision|0|||
143404787|NCT02719574|517032919|FG016|Phase 1 (Dose Escalation)|Physician Decision|0|||
143404788|NCT02719574|517032903|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
143404789|NCT02719574|517032904|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
143404790|NCT02719574|517032905|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|1|||
143404791|NCT02719574|517032906|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
143404792|NCT02719574|517032907|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
143404793|NCT02719574|517032908|FG005|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
143404794|NCT02719574|517032909|FG006|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
143404795|NCT02719574|517032910|FG007|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
143404796|NCT02719574|517032911|FG008|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
143404797|NCT02719574|517032912|FG009|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
143404798|NCT02719574|517032913|FG010|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
143404799|NCT02719574|517032914|FG011|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
143404800|NCT02719574|517032915|FG012|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
143404801|NCT02719574|517032916|FG013|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
143404802|NCT02719574|517032917|FG014|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
143404803|NCT02719574|517032918|FG015|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
143404804|NCT02719574|517032919|FG016|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
143404805|NCT02719574|517032903|FG000|Phase 1 (Dose Expansion)|Progressive Disease|0|||
143404806|NCT02719574|517032904|FG001|Phase 1 (Dose Expansion)|Progressive Disease|0|||
143404807|NCT02719574|517032905|FG002|Phase 1 (Dose Expansion)|Progressive Disease|0|||
143404808|NCT02719574|517032906|FG003|Phase 1 (Dose Expansion)|Progressive Disease|0|||
143404809|NCT02719574|517032907|FG004|Phase 1 (Dose Expansion)|Progressive Disease|0|||
143404810|NCT02719574|517032908|FG005|Phase 1 (Dose Expansion)|Progressive Disease|0|||
143404811|NCT02719574|517032909|FG006|Phase 1 (Dose Expansion)|Progressive Disease|3|||
143404812|NCT02719574|517032910|FG007|Phase 1 (Dose Expansion)|Progressive Disease|10|||
143404813|NCT02719574|517032911|FG008|Phase 1 (Dose Expansion)|Progressive Disease|1|||
143404814|NCT02719574|517032912|FG009|Phase 1 (Dose Expansion)|Progressive Disease|0|||
143404815|NCT02719574|517032913|FG010|Phase 1 (Dose Expansion)|Progressive Disease|0|||
143404816|NCT02719574|517032914|FG011|Phase 1 (Dose Expansion)|Progressive Disease|0|||
143404817|NCT02719574|517032915|FG012|Phase 1 (Dose Expansion)|Progressive Disease|0|||
143404818|NCT02719574|517032916|FG013|Phase 1 (Dose Expansion)|Progressive Disease|0|||
143404819|NCT02719574|517032917|FG014|Phase 1 (Dose Expansion)|Progressive Disease|0|||
143404820|NCT02719574|517032918|FG015|Phase 1 (Dose Expansion)|Progressive Disease|0|||
143404821|NCT02719574|517032919|FG016|Phase 1 (Dose Expansion)|Progressive Disease|0|||
143404822|NCT02719574|517032903|FG000|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
143404823|NCT02719574|517032904|FG001|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
143404824|NCT02719574|517032905|FG002|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
143404825|NCT02719574|517032906|FG003|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
143404826|NCT02719574|517032907|FG004|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
143404827|NCT02719574|517032908|FG005|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
143404828|NCT02719574|517032909|FG006|Phase 1 (Dose Expansion)|HSCT Transplant|1|||
143404829|NCT02719574|517032910|FG007|Phase 1 (Dose Expansion)|HSCT Transplant|5|||
143404830|NCT02719574|517032911|FG008|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
143404831|NCT02719574|517032912|FG009|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
143404832|NCT02719574|517032913|FG010|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
143404833|NCT02719574|517032914|FG011|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
143404834|NCT02719574|517032915|FG012|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
143404835|NCT02719574|517032916|FG013|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
143404836|NCT02719574|517032917|FG014|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
143404837|NCT02719574|517032918|FG015|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
143404838|NCT02719574|517032919|FG016|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
143404839|NCT02719574|517032903|FG000|Phase 1 (Dose Expansion)|Death|0|||
143404840|NCT02719574|517032904|FG001|Phase 1 (Dose Expansion)|Death|0|||
143404841|NCT02719574|517032905|FG002|Phase 1 (Dose Expansion)|Death|0|||
143404842|NCT02719574|517032906|FG003|Phase 1 (Dose Expansion)|Death|0|||
143404843|NCT02719574|517032907|FG004|Phase 1 (Dose Expansion)|Death|0|||
143404844|NCT02719574|517032908|FG005|Phase 1 (Dose Expansion)|Death|0|||
143404845|NCT02719574|517032909|FG006|Phase 1 (Dose Expansion)|Death|1|||
143404846|NCT02719574|517032910|FG007|Phase 1 (Dose Expansion)|Death|6|||
143404847|NCT02719574|517032911|FG008|Phase 1 (Dose Expansion)|Death|0|||
143404848|NCT02719574|517032912|FG009|Phase 1 (Dose Expansion)|Death|0|||
143404849|NCT02719574|517032913|FG010|Phase 1 (Dose Expansion)|Death|0|||
143404850|NCT02719574|517032914|FG011|Phase 1 (Dose Expansion)|Death|0|||
143404851|NCT02719574|517032915|FG012|Phase 1 (Dose Expansion)|Death|0|||
143404852|NCT02719574|517032916|FG013|Phase 1 (Dose Expansion)|Death|0|||
143404853|NCT02719574|517032917|FG014|Phase 1 (Dose Expansion)|Death|0|||
143404854|NCT02719574|517032918|FG015|Phase 1 (Dose Expansion)|Death|0|||
143404855|NCT02719574|517032919|FG016|Phase 1 (Dose Expansion)|Death|0|||
143404856|NCT02719574|517032903|FG000|Phase 1 (Dose Expansion)|Adverse Event|0|||
143404857|NCT02719574|517032904|FG001|Phase 1 (Dose Expansion)|Adverse Event|0|||
143404858|NCT02719574|517032905|FG002|Phase 1 (Dose Expansion)|Adverse Event|0|||
143404859|NCT02719574|517032906|FG003|Phase 1 (Dose Expansion)|Adverse Event|0|||
143404860|NCT02719574|517032907|FG004|Phase 1 (Dose Expansion)|Adverse Event|0|||
143404861|NCT02719574|517032908|FG005|Phase 1 (Dose Expansion)|Adverse Event|0|||
143404862|NCT02719574|517032909|FG006|Phase 1 (Dose Expansion)|Adverse Event|2|||
143404863|NCT02719574|517032910|FG007|Phase 1 (Dose Expansion)|Adverse Event|1|||
143404864|NCT02719574|517032911|FG008|Phase 1 (Dose Expansion)|Adverse Event|0|||
143404865|NCT02719574|517032912|FG009|Phase 1 (Dose Expansion)|Adverse Event|0|||
143404866|NCT02719574|517032913|FG010|Phase 1 (Dose Expansion)|Adverse Event|0|||
143404867|NCT02719574|517032914|FG011|Phase 1 (Dose Expansion)|Adverse Event|0|||
143404868|NCT02719574|517032915|FG012|Phase 1 (Dose Expansion)|Adverse Event|0|||
143404869|NCT02719574|517032916|FG013|Phase 1 (Dose Expansion)|Adverse Event|0|||
143404870|NCT02719574|517032917|FG014|Phase 1 (Dose Expansion)|Adverse Event|0|||
143404871|NCT02719574|517032918|FG015|Phase 1 (Dose Expansion)|Adverse Event|0|||
143404872|NCT02719574|517032919|FG016|Phase 1 (Dose Expansion)|Adverse Event|0|||
143404873|NCT02719574|517032903|FG000|Phase 1 (Dose Expansion)|Physician Decision|0|||
143404874|NCT02719574|517032904|FG001|Phase 1 (Dose Expansion)|Physician Decision|0|||
143404875|NCT02719574|517032905|FG002|Phase 1 (Dose Expansion)|Physician Decision|0|||
143404876|NCT02719574|517032906|FG003|Phase 1 (Dose Expansion)|Physician Decision|0|||
143404877|NCT02719574|517032907|FG004|Phase 1 (Dose Expansion)|Physician Decision|0|||
143404878|NCT02719574|517032908|FG005|Phase 1 (Dose Expansion)|Physician Decision|0|||
143404879|NCT02719574|517032909|FG006|Phase 1 (Dose Expansion)|Physician Decision|1|||
143404880|NCT02719574|517032910|FG007|Phase 1 (Dose Expansion)|Physician Decision|2|||
143404881|NCT02719574|517032911|FG008|Phase 1 (Dose Expansion)|Physician Decision|0|||
143404882|NCT02719574|517032912|FG009|Phase 1 (Dose Expansion)|Physician Decision|0|||
143404883|NCT02719574|517032913|FG010|Phase 1 (Dose Expansion)|Physician Decision|0|||
143404884|NCT02719574|517032914|FG011|Phase 1 (Dose Expansion)|Physician Decision|0|||
143404885|NCT02719574|517032915|FG012|Phase 1 (Dose Expansion)|Physician Decision|0|||
143404886|NCT02719574|517032916|FG013|Phase 1 (Dose Expansion)|Physician Decision|0|||
143404887|NCT02719574|517032917|FG014|Phase 1 (Dose Expansion)|Physician Decision|0|||
143404888|NCT02719574|517032918|FG015|Phase 1 (Dose Expansion)|Physician Decision|0|||
143404889|NCT02719574|517032919|FG016|Phase 1 (Dose Expansion)|Physician Decision|0|||
143404890|NCT02719574|517032903|FG000|Phase 1 (Dose Expansion)|Other|0|||
143404891|NCT02719574|517032904|FG001|Phase 1 (Dose Expansion)|Other|0|||
143404892|NCT02719574|517032905|FG002|Phase 1 (Dose Expansion)|Other|0|||
143404893|NCT02719574|517032906|FG003|Phase 1 (Dose Expansion)|Other|0|||
143404894|NCT02719574|517032907|FG004|Phase 1 (Dose Expansion)|Other|0|||
143404895|NCT02719574|517032908|FG005|Phase 1 (Dose Expansion)|Other|0|||
143404896|NCT02719574|517032909|FG006|Phase 1 (Dose Expansion)|Other|1|||
143404897|NCT02719574|517032910|FG007|Phase 1 (Dose Expansion)|Other|7|||
143404898|NCT02719574|517032911|FG008|Phase 1 (Dose Expansion)|Other|0|||
143404899|NCT02719574|517032912|FG009|Phase 1 (Dose Expansion)|Other|0|||
143404900|NCT02719574|517032913|FG010|Phase 1 (Dose Expansion)|Other|0|||
143404901|NCT02719574|517032914|FG011|Phase 1 (Dose Expansion)|Other|0|||
143404902|NCT02719574|517032915|FG012|Phase 1 (Dose Expansion)|Other|0|||
143404903|NCT02719574|517032916|FG013|Phase 1 (Dose Expansion)|Other|0|||
143404904|NCT02719574|517032917|FG014|Phase 1 (Dose Expansion)|Other|0|||
143404905|NCT02719574|517032918|FG015|Phase 1 (Dose Expansion)|Other|0|||
143404906|NCT02719574|517032919|FG016|Phase 1 (Dose Expansion)|Other|0|||
143404907|NCT02719574|517032903|FG000|Phase 2|Protocol Defined Disease Progression|0|||
143404908|NCT02719574|517032904|FG001|Phase 2|Protocol Defined Disease Progression|0|||
143404909|NCT02719574|517032905|FG002|Phase 2|Protocol Defined Disease Progression|0|||
143404910|NCT02719574|517032906|FG003|Phase 2|Protocol Defined Disease Progression|0|||
143404911|NCT02719574|517032907|FG004|Phase 2|Protocol Defined Disease Progression|0|||
143404912|NCT02719574|517032908|FG005|Phase 2|Protocol Defined Disease Progression|0|||
143404913|NCT02719574|517032909|FG006|Phase 2|Protocol Defined Disease Progression|0|||
143404914|NCT02719574|517032910|FG007|Phase 2|Protocol Defined Disease Progression|0|||
143404915|NCT02719574|517032911|FG008|Phase 2|Protocol Defined Disease Progression|0|||
143404916|NCT02719574|517032912|FG009|Phase 2|Protocol Defined Disease Progression|65|||
143404917|NCT02719574|517032913|FG010|Phase 2|Protocol Defined Disease Progression|8|||
143404918|NCT02719574|517032914|FG011|Phase 2|Protocol Defined Disease Progression|2|||
143404919|NCT02719574|517032915|FG012|Phase 2|Protocol Defined Disease Progression|4|||
143404920|NCT02719574|517032916|FG013|Phase 2|Protocol Defined Disease Progression|9|||
143404921|NCT02719574|517032917|FG014|Phase 2|Protocol Defined Disease Progression|11|||
143404922|NCT02719574|517032918|FG015|Phase 2|Protocol Defined Disease Progression|3|||
143404923|NCT02719574|517032919|FG016|Phase 2|Protocol Defined Disease Progression|4|||
143404924|NCT02719574|517032903|FG000|Phase 2|Adverse Event|0|||
143404925|NCT02719574|517032904|FG001|Phase 2|Adverse Event|0|||
143404926|NCT02719574|517032905|FG002|Phase 2|Adverse Event|0|||
143404927|NCT02719574|517032906|FG003|Phase 2|Adverse Event|0|||
143404928|NCT02719574|517032907|FG004|Phase 2|Adverse Event|0|||
143404929|NCT02719574|517032908|FG005|Phase 2|Adverse Event|0|||
143404930|NCT02719574|517032909|FG006|Phase 2|Adverse Event|0|||
143404931|NCT02719574|517032910|FG007|Phase 2|Adverse Event|0|||
143404932|NCT02719574|517032911|FG008|Phase 2|Adverse Event|0|||
143404933|NCT02719574|517032912|FG009|Phase 2|Adverse Event|27|||
143404934|NCT02719574|517032913|FG010|Phase 2|Adverse Event|0|||
143404935|NCT02719574|517032914|FG011|Phase 2|Adverse Event|1|||
143404936|NCT02719574|517032915|FG012|Phase 2|Adverse Event|1|||
143404937|NCT02719574|517032916|FG013|Phase 2|Adverse Event|1|||
143404938|NCT02719574|517032917|FG014|Phase 2|Adverse Event|2|||
143404939|NCT02719574|517032918|FG015|Phase 2|Adverse Event|2|||
143404940|NCT02719574|517032919|FG016|Phase 2|Adverse Event|3|||
143404941|NCT02719574|517032903|FG000|Phase 2|Other|0|||
143404942|NCT02719574|517032904|FG001|Phase 2|Other|0|||
143404943|NCT02719574|517032905|FG002|Phase 2|Other|0|||
143404944|NCT02719574|517032906|FG003|Phase 2|Other|0|||
143404945|NCT02719574|517032907|FG004|Phase 2|Other|0|||
143404946|NCT02719574|517032908|FG005|Phase 2|Other|0|||
143404947|NCT02719574|517032909|FG006|Phase 2|Other|0|||
143404948|NCT02719574|517032910|FG007|Phase 2|Other|0|||
143404949|NCT02719574|517032911|FG008|Phase 2|Other|0|||
143404950|NCT02719574|517032912|FG009|Phase 2|Other|20|||
143404951|NCT02719574|517032913|FG010|Phase 2|Other|7|||
143404952|NCT02719574|517032914|FG011|Phase 2|Other|0|||
143404953|NCT02719574|517032915|FG012|Phase 2|Other|5|||
143404954|NCT02719574|517032916|FG013|Phase 2|Other|7|||
143404955|NCT02719574|517032917|FG014|Phase 2|Other|0|||
143404956|NCT02719574|517032918|FG015|Phase 2|Other|1|||
143404957|NCT02719574|517032919|FG016|Phase 2|Other|4|||
143404958|NCT02719574|517032903|FG000|Phase 2|Transplant|0|||
143404959|NCT02719574|517032904|FG001|Phase 2|Transplant|0|||
143404960|NCT02719574|517032905|FG002|Phase 2|Transplant|0|||
143404961|NCT02719574|517032906|FG003|Phase 2|Transplant|0|||
143404962|NCT02719574|517032907|FG004|Phase 2|Transplant|0|||
143404963|NCT02719574|517032908|FG005|Phase 2|Transplant|0|||
143404964|NCT02719574|517032909|FG006|Phase 2|Transplant|0|||
143404965|NCT02719574|517032910|FG007|Phase 2|Transplant|0|||
143404966|NCT02719574|517032911|FG008|Phase 2|Transplant|0|||
143404967|NCT02719574|517032912|FG009|Phase 2|Transplant|15|||
143404968|NCT02719574|517032913|FG010|Phase 2|Transplant|2|||
143404969|NCT02719574|517032914|FG011|Phase 2|Transplant|0|||
143404970|NCT02719574|517032915|FG012|Phase 2|Transplant|6|||
143404971|NCT02719574|517032916|FG013|Phase 2|Transplant|1|||
143404972|NCT02719574|517032917|FG014|Phase 2|Transplant|1|||
143404973|NCT02719574|517032918|FG015|Phase 2|Transplant|0|||
143404974|NCT02719574|517032919|FG016|Phase 2|Transplant|0|||
143404975|NCT02719574|517032903|FG000|Phase 2|Death|0|||
143404976|NCT02719574|517032904|FG001|Phase 2|Death|0|||
143404977|NCT02719574|517032905|FG002|Phase 2|Death|0|||
143404978|NCT02719574|517032906|FG003|Phase 2|Death|0|||
143404979|NCT02719574|517032907|FG004|Phase 2|Death|0|||
143404980|NCT02719574|517032908|FG005|Phase 2|Death|0|||
143404981|NCT02719574|517032909|FG006|Phase 2|Death|0|||
143404982|NCT02719574|517032910|FG007|Phase 2|Death|0|||
143404983|NCT02719574|517032911|FG008|Phase 2|Death|0|||
143404984|NCT02719574|517032912|FG009|Phase 2|Death|14|||
143404985|NCT02719574|517032913|FG010|Phase 2|Death|0|||
143404986|NCT02719574|517032914|FG011|Phase 2|Death|0|||
143404987|NCT02719574|517032915|FG012|Phase 2|Death|1|||
143404988|NCT02719574|517032916|FG013|Phase 2|Death|1|||
143404989|NCT02719574|517032917|FG014|Phase 2|Death|2|||
143404990|NCT02719574|517032918|FG015|Phase 2|Death|0|||
143404991|NCT02719574|517032919|FG016|Phase 2|Death|0|||
143404992|NCT02719574|517032903|FG000|Phase 2|Investigator Decision|0|||
143404993|NCT02719574|517032904|FG001|Phase 2|Investigator Decision|0|||
143404994|NCT02719574|517032905|FG002|Phase 2|Investigator Decision|0|||
143404995|NCT02719574|517032906|FG003|Phase 2|Investigator Decision|0|||
143404996|NCT02719574|517032907|FG004|Phase 2|Investigator Decision|0|||
143404997|NCT02719574|517032908|FG005|Phase 2|Investigator Decision|0|||
143404998|NCT02719574|517032909|FG006|Phase 2|Investigator Decision|0|||
143404999|NCT02719574|517032910|FG007|Phase 2|Investigator Decision|0|||
143405000|NCT02719574|517032911|FG008|Phase 2|Investigator Decision|0|||
143405001|NCT02719574|517032912|FG009|Phase 2|Investigator Decision|6|||
143405002|NCT02719574|517032913|FG010|Phase 2|Investigator Decision|1|||
143405003|NCT02719574|517032914|FG011|Phase 2|Investigator Decision|2|||
143405004|NCT02719574|517032915|FG012|Phase 2|Investigator Decision|3|||
143405005|NCT02719574|517032916|FG013|Phase 2|Investigator Decision|1|||
143405006|NCT02719574|517032917|FG014|Phase 2|Investigator Decision|3|||
143405007|NCT02719574|517032918|FG015|Phase 2|Investigator Decision|2|||
143405008|NCT02719574|517032919|FG016|Phase 2|Investigator Decision|0|||
143405009|NCT02719574|517032903|FG000|Phase 2|Withdrawal by Subject|0|||
143405010|NCT02719574|517032904|FG001|Phase 2|Withdrawal by Subject|0|||
143405011|NCT02719574|517032905|FG002|Phase 2|Withdrawal by Subject|0|||
143405012|NCT02719574|517032906|FG003|Phase 2|Withdrawal by Subject|0|||
143405013|NCT02719574|517032907|FG004|Phase 2|Withdrawal by Subject|0|||
143405014|NCT02719574|517032908|FG005|Phase 2|Withdrawal by Subject|0|||
143405015|NCT02719574|517032909|FG006|Phase 2|Withdrawal by Subject|0|||
143405016|NCT02719574|517032910|FG007|Phase 2|Withdrawal by Subject|0|||
143405017|NCT02719574|517032911|FG008|Phase 2|Withdrawal by Subject|0|||
143405018|NCT02719574|517032912|FG009|Phase 2|Withdrawal by Subject|5|||
143405019|NCT02719574|517032913|FG010|Phase 2|Withdrawal by Subject|0|||
143405020|NCT02719574|517032914|FG011|Phase 2|Withdrawal by Subject|0|||
143405021|NCT02719574|517032915|FG012|Phase 2|Withdrawal by Subject|0|||
143405022|NCT02719574|517032916|FG013|Phase 2|Withdrawal by Subject|1|||
143405023|NCT02719574|517032917|FG014|Phase 2|Withdrawal by Subject|1|||
143405024|NCT02719574|517032918|FG015|Phase 2|Withdrawal by Subject|2|||
143405025|NCT02719574|517032919|FG016|Phase 2|Withdrawal by Subject|0|||
143405026|NCT02719574|517032903|FG000|Phase 2|Protocol Violation|0|||
143405027|NCT02719574|517032904|FG001|Phase 2|Protocol Violation|0|||
143405028|NCT02719574|517032905|FG002|Phase 2|Protocol Violation|0|||
143405029|NCT02719574|517032906|FG003|Phase 2|Protocol Violation|0|||
143405030|NCT02719574|517032907|FG004|Phase 2|Protocol Violation|0|||
143405031|NCT02719574|517032908|FG005|Phase 2|Protocol Violation|0|||
143405032|NCT02719574|517032909|FG006|Phase 2|Protocol Violation|0|||
143405033|NCT02719574|517032910|FG007|Phase 2|Protocol Violation|0|||
143405034|NCT02719574|517032911|FG008|Phase 2|Protocol Violation|0|||
143405035|NCT02719574|517032912|FG009|Phase 2|Protocol Violation|1|||
143405036|NCT02719574|517032913|FG010|Phase 2|Protocol Violation|0|||
143405037|NCT02719574|517032914|FG011|Phase 2|Protocol Violation|0|||
143405038|NCT02719574|517032915|FG012|Phase 2|Protocol Violation|0|||
143405039|NCT02719574|517032916|FG013|Phase 2|Protocol Violation|0|||
143405040|NCT02719574|517032917|FG014|Phase 2|Protocol Violation|0|||
143405041|NCT02719574|517032918|FG015|Phase 2|Protocol Violation|0|||
143405042|NCT02719574|517032919|FG016|Phase 2|Protocol Violation|0|||
143405043|NCT00495677|517032924|FG000|Stage 1 (25 Days)|Adverse Event|0|||
143405044|NCT00495677|517032925|FG001|Stage 1 (25 Days)|Adverse Event|0|||
143405045|NCT00495677|517032926|FG002|Stage 1 (25 Days)|Adverse Event|1|||
143405046|NCT00495677|517032927|FG003|Stage 1 (25 Days)|Adverse Event|0|||
143405047|NCT00495677|517032928|FG004|Stage 1 (25 Days)|Adverse Event|0|||
143405048|NCT00495677|517032929|FG005|Stage 1 (25 Days)|Adverse Event|0|||
143405049|NCT00495677|517032930|FG006|Stage 1 (25 Days)|Adverse Event|0|||
143405050|NCT04129164|517032937|FG000|Overall Study|Non-compliance with procedures|0|||
143405051|NCT04129164|517032938|FG001|Overall Study|Non-compliance with procedures|0|||
143405052|NCT04129164|517032939|FG002|Overall Study|Non-compliance with procedures|2|||
143405053|NCT04129164|517032940|FG003|Overall Study|Non-compliance with procedures|0|||
143405054|NCT04129164|517032937|FG000|Overall Study|Adverse Event|0|||
143405055|NCT04129164|517032938|FG001|Overall Study|Adverse Event|0|||
143405056|NCT04129164|517032939|FG002|Overall Study|Adverse Event|2|||
143405057|NCT04129164|517032940|FG003|Overall Study|Adverse Event|0|||
143405058|NCT04129164|517032937|FG000|Overall Study|Pregnancy|0|||
143405059|NCT04129164|517032938|FG001|Overall Study|Pregnancy|0|||
143405060|NCT04129164|517032939|FG002|Overall Study|Pregnancy|0|||
143405061|NCT04129164|517032940|FG003|Overall Study|Pregnancy|1|||
143405062|NCT04129164|517032937|FG000|Overall Study|Withdrawal by Subject|3|||
143405063|NCT04129164|517032938|FG001|Overall Study|Withdrawal by Subject|2|||
143405064|NCT04129164|517032939|FG002|Overall Study|Withdrawal by Subject|4|||
143405065|NCT04129164|517032940|FG003|Overall Study|Withdrawal by Subject|6|||
143405066|NCT04129164|517032937|FG000|Overall Study|Death|0|||
143405067|NCT04129164|517032938|FG001|Overall Study|Death|1|||
143405068|NCT04129164|517032939|FG002|Overall Study|Death|0|||
143405069|NCT04129164|517032940|FG003|Overall Study|Death|0|||
143405070|NCT04129164|517032937|FG000|Overall Study|Lost to Follow-up|0|||
143405071|NCT04129164|517032938|FG001|Overall Study|Lost to Follow-up|1|||
143405072|NCT04129164|517032939|FG002|Overall Study|Lost to Follow-up|0|||
143405073|NCT04129164|517032940|FG003|Overall Study|Lost to Follow-up|0|||
143405074|NCT03653364|517032943|FG000|Overall Study|Withdrawal by Subject|1|||
143405075|NCT03653364|517032943|FG000|Overall Study|Enrolled in Error|1|||
143405076|NCT03653364|517032943|FG000|Overall Study|Death|1|||
143405077|NCT03983382|517032946|FG000|Overall Study|Death|1|||
143405078|NCT03983382|517032946|FG000|Overall Study|Lost to Follow-up|3|||
143405079|NCT03983382|517032946|FG000|Overall Study|Physician Decision|2|||
143405080|NCT03983382|517032946|FG000|Overall Study|Withdrawal by Subject|10|||
143405081|NCT03983382|517032946|FG000|Overall Study|Change in cancer treatment|2|||
143405082|NCT01260896|517032950|FG000|First Intervention|Withdrawn Due to Emesis|2|||
143405083|NCT01260896|517032951|FG001|First Intervention|Withdrawn Due to Emesis|0|||
143405084|NCT03248492|517032965|FG000|Overall Study|Progressive Disease|24|||
143405085|NCT03248492|517032966|FG001|Overall Study|Progressive Disease|23|||
143405086|NCT03248492|517032967|FG002|Overall Study|Progressive Disease|11|||
143405087|NCT03248492|517032968|FG003|Overall Study|Progressive Disease|66|||
143405088|NCT03248492|517032969|FG004|Overall Study|Progressive Disease|1|||
143405089|NCT03248492|517032965|FG000|Overall Study|Adverse Event|14|||
143405090|NCT03248492|517032966|FG001|Overall Study|Adverse Event|13|||
143405091|NCT03248492|517032967|FG002|Overall Study|Adverse Event|9|||
143405092|NCT03248492|517032968|FG003|Overall Study|Adverse Event|22|||
143405093|NCT03248492|517032969|FG004|Overall Study|Adverse Event|2|||
143405094|NCT03248492|517032965|FG000|Overall Study|Withdrawal by Subject|5|||
143405095|NCT03248492|517032966|FG001|Overall Study|Withdrawal by Subject|4|||
143405096|NCT03248492|517032967|FG002|Overall Study|Withdrawal by Subject|0|||
143405097|NCT03248492|517032968|FG003|Overall Study|Withdrawal by Subject|8|||
143405098|NCT03248492|517032969|FG004|Overall Study|Withdrawal by Subject|1|||
143405099|NCT03248492|517032965|FG000|Overall Study|Physician Decision|1|||
143405100|NCT03248492|517032966|FG001|Overall Study|Physician Decision|1|||
143405101|NCT03248492|517032967|FG002|Overall Study|Physician Decision|1|||
143405102|NCT03248492|517032968|FG003|Overall Study|Physician Decision|7|||
143405103|NCT03248492|517032969|FG004|Overall Study|Physician Decision|0|||
143405104|NCT03248492|517032965|FG000|Overall Study|Death|1|||
143405105|NCT03248492|517032966|FG001|Overall Study|Death|1|||
143405106|NCT03248492|517032967|FG002|Overall Study|Death|0|||
143405107|NCT03248492|517032968|FG003|Overall Study|Death|6|||
143405108|NCT03248492|517032969|FG004|Overall Study|Death|0|||
143405109|NCT03248492|517032965|FG000|Overall Study|Study Terminated by Sponsor|3|||
143405110|NCT03248492|517032966|FG001|Overall Study|Study Terminated by Sponsor|1|||
143405111|NCT03248492|517032967|FG002|Overall Study|Study Terminated by Sponsor|0|||
143405112|NCT03248492|517032968|FG003|Overall Study|Study Terminated by Sponsor|7|||
143405113|NCT03248492|517032969|FG004|Overall Study|Study Terminated by Sponsor|0|||
143405114|NCT03248492|517032965|FG000|Overall Study|Other|2|||
143405115|NCT03248492|517032966|FG001|Overall Study|Other|5|||
143405116|NCT03248492|517032967|FG002|Overall Study|Other|0|||
143405117|NCT03248492|517032968|FG003|Overall Study|Other|14|||
143405118|NCT03248492|517032969|FG004|Overall Study|Other|0|||
143405119|NCT03767335|517032973|FG000|Overall Study|Physician Decision|1|||
143405120|NCT03767335|517032974|FG001|Overall Study|Physician Decision|1|||
143405121|NCT03767335|517032975|FG002|Overall Study|Physician Decision|0|||
143405122|NCT03767335|517032973|FG000|Overall Study|Withdrawal by Subject|0|||
143405123|NCT03767335|517032974|FG001|Overall Study|Withdrawal by Subject|0|||
143405124|NCT03767335|517032975|FG002|Overall Study|Withdrawal by Subject|6|||
143405125|NCT03767335|517032973|FG000|Overall Study|Participant excluded from efficacy population|0|||
143405126|NCT03767335|517032974|FG001|Overall Study|Participant excluded from efficacy population|0|||
143405127|NCT03767335|517032975|FG002|Overall Study|Participant excluded from efficacy population|1|||
143405128|NCT03767335|517032973|FG000|Overall Study|Death|0|||
143405129|NCT03767335|517032974|FG001|Overall Study|Death|0|||
143405130|NCT03767335|517032975|FG002|Overall Study|Death|2|||
143405131|NCT03767335|517032973|FG000|Overall Study|Progressive Disease|2|||
143405132|NCT03767335|517032974|FG001|Overall Study|Progressive Disease|2|||
143405133|NCT03767335|517032975|FG002|Overall Study|Progressive Disease|2|||
143405134|NCT03767335|517032973|FG000|Overall Study|Disease progression needing additional medication|0|||
143405135|NCT03767335|517032974|FG001|Overall Study|Disease progression needing additional medication|0|||
143405136|NCT03767335|517032975|FG002|Overall Study|Disease progression needing additional medication|17|||
143405137|NCT03767335|517032973|FG000|Overall Study|Sponsor decision|0|||
143405138|NCT03767335|517032974|FG001|Overall Study|Sponsor decision|0|||
143405139|NCT03767335|517032975|FG002|Overall Study|Sponsor decision|2|||
143405140|NCT03767335|517032973|FG000|Overall Study|Other Medical Reasons|0|||
143405141|NCT03767335|517032974|FG001|Overall Study|Other Medical Reasons|0|||
143405142|NCT03767335|517032975|FG002|Overall Study|Other Medical Reasons|3|||
143405143|NCT01315132|517032976|FG000|Overall Study|not treated due to disease progression|1|||
143405144|NCT01313559|517032977|FG000|Overall Study|Withdrawal by Subject|1|||
143405145|NCT01313559|517032978|FG001|Overall Study|Withdrawal by Subject|2|||
143405146|NCT01313559|517032977|FG000|Overall Study|Disease progression|1|||
143405147|NCT01313559|517032978|FG001|Overall Study|Disease progression|0|||
143405148|NCT01313559|517032977|FG000|Overall Study|Rising PSA|2|||
143405149|NCT01313559|517032978|FG001|Overall Study|Rising PSA|0|||
143405150|NCT02989662|517032979|FG000|Overall Study|Lost to Follow-up|0|||
143405151|NCT02989662|517032980|FG001|Overall Study|Lost to Follow-up|0|||
143405152|NCT02989662|517032981|FG002|Overall Study|Lost to Follow-up|0|||
143405153|NCT02989662|517032982|FG003|Overall Study|Lost to Follow-up|2|||
143405154|NCT02989662|517032979|FG000|Overall Study|Physician Decision|3|||
143405155|NCT02989662|517032980|FG001|Overall Study|Physician Decision|0|||
143405156|NCT02989662|517032981|FG002|Overall Study|Physician Decision|0|||
143405157|NCT02989662|517032982|FG003|Overall Study|Physician Decision|0|||
143405158|NCT02989662|517032979|FG000|Overall Study|Withdrawal by Subject|1|||
143405159|NCT02989662|517032980|FG001|Overall Study|Withdrawal by Subject|0|||
143405160|NCT02989662|517032981|FG002|Overall Study|Withdrawal by Subject|0|||
143405161|NCT02989662|517032982|FG003|Overall Study|Withdrawal by Subject|0|||
143405162|NCT00357682|517032983|FG000|Overall Study|Did not receive allocated Treatment|10|||
143405163|NCT00357682|517032984|FG001|Overall Study|Did not receive allocated Treatment|9|||
143405164|NCT00357682|517032985|FG002|Overall Study|Did not receive allocated Treatment|9|||
143405165|NCT00357682|517032986|FG003|Overall Study|Did not receive allocated Treatment|10|||
143405166|NCT00357682|517032983|FG000|Overall Study|Withdrew consent|6|||
143405167|NCT00357682|517032984|FG001|Overall Study|Withdrew consent|6|||
143405168|NCT00357682|517032985|FG002|Overall Study|Withdrew consent|5|||
143405169|NCT00357682|517032986|FG003|Overall Study|Withdrew consent|5|||
143405170|NCT00357682|517032983|FG000|Overall Study|Lost to Follow-up|39|||
143405171|NCT00357682|517032984|FG001|Overall Study|Lost to Follow-up|33|||
143405172|NCT00357682|517032985|FG002|Overall Study|Lost to Follow-up|26|||
143405173|NCT00357682|517032986|FG003|Overall Study|Lost to Follow-up|35|||
143405174|NCT00357682|517032983|FG000|Overall Study|Adverse Event|24|||
143405175|NCT00357682|517032984|FG001|Overall Study|Adverse Event|32|||
143405176|NCT00357682|517032985|FG002|Overall Study|Adverse Event|22|||
143405177|NCT00357682|517032986|FG003|Overall Study|Adverse Event|27|||
143405178|NCT00357682|517032983|FG000|Overall Study|Physician Decision|32|||
143405179|NCT00357682|517032984|FG001|Overall Study|Physician Decision|20|||
143405180|NCT00357682|517032985|FG002|Overall Study|Physician Decision|24|||
143405181|NCT00357682|517032986|FG003|Overall Study|Physician Decision|30|||
143405182|NCT00357682|517032983|FG000|Overall Study|Patient decision|73|||
143405183|NCT00357682|517032984|FG001|Overall Study|Patient decision|80|||
143405184|NCT00357682|517032985|FG002|Overall Study|Patient decision|51|||
143405185|NCT00357682|517032986|FG003|Overall Study|Patient decision|59|||
143405186|NCT00357682|517032983|FG000|Overall Study|Other reason|157|||
143405187|NCT00357682|517032984|FG001|Overall Study|Other reason|130|||
143405188|NCT00357682|517032985|FG002|Overall Study|Other reason|114|||
143405189|NCT00357682|517032986|FG003|Overall Study|Other reason|99|||
143405190|NCT04174560|517032991|FG000|Overall Study|Lost to Follow-up|1|||
143405191|NCT04174560|517032992|FG001|Overall Study|Lost to Follow-up|0|||
143405192|NCT04174560|517032993|FG002|Overall Study|Lost to Follow-up|0|||
143405193|NCT04174560|517032994|FG003|Overall Study|Lost to Follow-up|0|||
143405194|NCT04174560|517032991|FG000|Overall Study|Withdrawal by Subject|0|||
143405195|NCT04174560|517032992|FG001|Overall Study|Withdrawal by Subject|0|||
143405196|NCT04174560|517032993|FG002|Overall Study|Withdrawal by Subject|2|||
143405197|NCT04174560|517032994|FG003|Overall Study|Withdrawal by Subject|0|||
143405198|NCT04046549|517032996|FG000|Overall Study|Adverse Event|1|||
143405199|NCT04046549|517032996|FG000|Overall Study|Physician Decision|1|||
143405200|NCT04046549|517032996|FG000|Overall Study|Withdrawal by Subject|3|||
143405201|NCT04046549|517032996|FG000|Overall Study|Other, Not Specified|5|||
143405202|NCT04908514|517032997|FG000|Overall Study|Lost to Follow-up|2|||
143405203|NCT04908514|517032997|FG000|Overall Study|Withdrawal by Subject|1|||
143405204|NCT03473223|517032999|FG000|Overall Study|Lost to Follow-up|1|||
143405205|NCT03473223|517033000|FG001|Overall Study|Lost to Follow-up|1|||
143405206|NCT03473223|517032999|FG000|Overall Study|Withdrawal by Subject|47|||
143405207|NCT03473223|517033000|FG001|Overall Study|Withdrawal by Subject|42|||
143405208|NCT03473223|517032999|FG000|Overall Study|Indirect contact|32|||
143405209|NCT03473223|517033000|FG001|Overall Study|Indirect contact|29|||
143405210|NCT03473223|517032999|FG000|Overall Study|Other (Not specified)|32|||
143405211|NCT03473223|517033000|FG001|Overall Study|Other (Not specified)|20|||
143405212|NCT02111096|517033267|FG000|Overall Study|Adverse Event|4|||
143405213|NCT02111096|517033268|FG001|Overall Study|Adverse Event|1|||
143405214|NCT02111096|517033269|FG002|Overall Study|Adverse Event|2|||
143405215|NCT02111096|517033267|FG000|Overall Study|Non-Compliance with Study Drug|1|||
143405216|NCT02111096|517033268|FG001|Overall Study|Non-Compliance with Study Drug|1|||
143405217|NCT02111096|517033269|FG002|Overall Study|Non-Compliance with Study Drug|0|||
143405218|NCT02111096|517033267|FG000|Overall Study|Lost to Follow Up|1|||
143405219|NCT02111096|517033268|FG001|Overall Study|Lost to Follow Up|1|||
143405220|NCT02111096|517033269|FG002|Overall Study|Lost to Follow Up|1|||
143405221|NCT02111096|517033267|FG000|Overall Study|Physician Decision|0|||
143405222|NCT02111096|517033268|FG001|Overall Study|Physician Decision|1|||
143405223|NCT02111096|517033269|FG002|Overall Study|Physician Decision|0|||
143405224|NCT02111096|517033267|FG000|Overall Study|Protocol Violation|1|||
143405225|NCT02111096|517033268|FG001|Overall Study|Protocol Violation|0|||
143405226|NCT02111096|517033269|FG002|Overall Study|Protocol Violation|1|||
143405227|NCT02111096|517033267|FG000|Overall Study|Terminated by Sponsor|53|||
143405228|NCT02111096|517033268|FG001|Overall Study|Terminated by Sponsor|35|||
143405229|NCT02111096|517033269|FG002|Overall Study|Terminated by Sponsor|54|||
143405230|NCT02111096|517033267|FG000|Overall Study|Withdrawal by Subject|4|||
143405231|NCT02111096|517033268|FG001|Overall Study|Withdrawal by Subject|2|||
143405232|NCT02111096|517033269|FG002|Overall Study|Withdrawal by Subject|8|||
143405233|NCT00686595|517033270|FG000|Overall Study|Adverse Event|3|||
143405234|NCT00686595|517033270|FG000|Overall Study|Protocol Violation|1|||
143405235|NCT00686595|517033270|FG000|Overall Study|Lost to Follow-up|1|||
143405236|NCT00686595|517033270|FG000|Overall Study|Lack of Efficacy|1|||
143405237|NCT00686595|517033270|FG000|Overall Study|Poor Compliance|1|||
143405238|NCT03286114|517033273|FG000|Overall Study|Adverse Event|6|||
143405239|NCT03286114|517033273|FG000|Overall Study|Death|3|||
143405240|NCT00003222|517033276|FG000|Overall Study|Physician Decision|0|||
143405241|NCT00003222|517033277|FG001|Overall Study|Physician Decision|1|||
143405242|NCT05714059|517033279|FG000|Overall Study|Withdrawal by Subject|2|||
143405243|NCT05714059|517033280|FG001|Overall Study|Withdrawal by Subject|2|||
143405244|NCT05714059|517033279|FG000|Overall Study|Adverse Event|0|||
143405245|NCT05714059|517033280|FG001|Overall Study|Adverse Event|1|||
143405246|NCT05714059|517033279|FG000|Overall Study|Lost to Follow-up|0|||
143405247|NCT05714059|517033280|FG001|Overall Study|Lost to Follow-up|1|||
143405248|NCT05714059|517033279|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
143405249|NCT05714059|517033280|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
143405250|NCT05714059|517033279|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
143405251|NCT05714059|517033280|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
143405252|NCT04755595|517033281|FG000|Overall Study|Lost to Follow-up|1|||
143405253|NCT04977583|517034430|FG000|Overall Study|Lost to Follow-up|8|||
143405254|NCT04977583|517034431|FG001|Overall Study|Lost to Follow-up|4|||
143405255|NCT04977583|517034432|FG002|Overall Study|Lost to Follow-up|13|||
143405256|NCT04977583|517034430|FG000|Overall Study|Withdrawal by Subject|3|||
143405257|NCT04977583|517034431|FG001|Overall Study|Withdrawal by Subject|2|||
143405258|NCT04977583|517034432|FG002|Overall Study|Withdrawal by Subject|1|||
143405259|NCT00655499|517034434|FG000|Overall Study|not eligible|4|||
143405260|NCT03140670|517034435|FG000|Overall Study|Withdrawal by Subject|2|||
143405261|NCT03140670|517034435|FG000|Overall Study|Lost to Follow-up|1|||
143405262|NCT03140670|517034435|FG000|Overall Study|Physician Decision|1|||
143405263|NCT00220805|517034436|FG000|Overall Study|Adverse Event|1|||
143405264|NCT00220805|517034437|FG001|Overall Study|Adverse Event|3|||
143405265|NCT00220805|517034436|FG000|Overall Study|Withdrawal by Subject|3|||
143405266|NCT00220805|517034437|FG001|Overall Study|Withdrawal by Subject|0|||
143405267|NCT00220805|517034436|FG000|Overall Study|Lack of Efficacy|1|||
143405268|NCT00220805|517034437|FG001|Overall Study|Lack of Efficacy|0|||
143405269|NCT00220805|517034436|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
143405270|NCT00220805|517034437|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
143405271|NCT02325466|517034438|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
143405272|NCT02325466|517034439|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
143405273|NCT02325466|517034440|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
143405274|NCT02325466|517034438|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
143405275|NCT02325466|517034439|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
143405276|NCT02325466|517034440|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
143405277|NCT02325466|517034438|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
143405278|NCT02325466|517034439|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
143405279|NCT02325466|517034440|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
143405280|NCT02325466|517034438|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
143405281|NCT02325466|517034439|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
143405282|NCT02325466|517034440|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
143405283|NCT02325466|517034438|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
143405284|NCT02325466|517034439|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
143405285|NCT02325466|517034440|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
143405286|NCT02325466|517034438|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
143405287|NCT02325466|517034439|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
143405288|NCT02325466|517034440|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
143405289|NCT02325466|517034438|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
143405290|NCT02325466|517034439|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
143405291|NCT02325466|517034440|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
143405292|NCT02325466|517034438|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
143405293|NCT02325466|517034439|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
143405294|NCT02325466|517034440|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
143405295|NCT02325466|517034438|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
143405296|NCT02325466|517034439|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
143405297|NCT02325466|517034440|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
143405298|NCT03699163|517034441|FG000|Overall Study|Physician Decision|12|||
143405299|NCT03699163|517034442|FG001|Overall Study|Physician Decision|0|||
143405300|NCT03699163|517034441|FG000|Overall Study|failed QC measures|205|||
143405301|NCT03699163|517034442|FG001|Overall Study|failed QC measures|206|||
143405302|NCT01288443|517034450|FG000|Overall Study|Adverse Event|0|||
143405303|NCT01288443|517034451|FG001|Overall Study|Adverse Event|0|||
143405304|NCT01288443|517034452|FG002|Overall Study|Adverse Event|1|||
143405305|NCT01288443|517034453|FG003|Overall Study|Adverse Event|1|||
143405306|NCT01288443|517034454|FG004|Overall Study|Adverse Event|3|||
143405307|NCT01288443|517034455|FG005|Overall Study|Adverse Event|1|||
143405308|NCT01288443|517034450|FG000|Overall Study|Poor compliance to protocol|0|||
143405309|NCT01288443|517034451|FG001|Overall Study|Poor compliance to protocol|0|||
143405310|NCT01288443|517034452|FG002|Overall Study|Poor compliance to protocol|0|||
143405311|NCT01288443|517034453|FG003|Overall Study|Poor compliance to protocol|0|||
143405312|NCT01288443|517034454|FG004|Overall Study|Poor compliance to protocol|0|||
143405313|NCT01288443|517034455|FG005|Overall Study|Poor compliance to protocol|1|||
143405314|NCT01288443|517034450|FG000|Overall Study|Participant Moved|0|||
143405315|NCT01288443|517034451|FG001|Overall Study|Participant Moved|0|||
143405316|NCT01288443|517034452|FG002|Overall Study|Participant Moved|0|||
143405317|NCT01288443|517034453|FG003|Overall Study|Participant Moved|1|||
143405318|NCT01288443|517034454|FG004|Overall Study|Participant Moved|2|||
143405319|NCT01288443|517034455|FG005|Overall Study|Participant Moved|1|||
143405320|NCT01288443|517034450|FG000|Overall Study|Consent withdrawn by Participant|0|||
143405321|NCT01288443|517034451|FG001|Overall Study|Consent withdrawn by Participant|0|||
143405322|NCT01288443|517034452|FG002|Overall Study|Consent withdrawn by Participant|0|||
143405323|NCT01288443|517034453|FG003|Overall Study|Consent withdrawn by Participant|0|||
143405324|NCT01288443|517034454|FG004|Overall Study|Consent withdrawn by Participant|0|||
143405325|NCT01288443|517034455|FG005|Overall Study|Consent withdrawn by Participant|1|||
143405326|NCT01288443|517034450|FG000|Overall Study|Lost to Follow-up|0|||
143405327|NCT01288443|517034451|FG001|Overall Study|Lost to Follow-up|1|||
143405328|NCT01288443|517034452|FG002|Overall Study|Lost to Follow-up|0|||
143405329|NCT01288443|517034453|FG003|Overall Study|Lost to Follow-up|0|||
143405330|NCT01288443|517034454|FG004|Overall Study|Lost to Follow-up|0|||
143405331|NCT01288443|517034455|FG005|Overall Study|Lost to Follow-up|0|||
143405332|NCT01288443|517034450|FG000|Overall Study|Study drug auto-injector administration|0|||
143405333|NCT01288443|517034451|FG001|Overall Study|Study drug auto-injector administration|0|||
143405334|NCT01288443|517034452|FG002|Overall Study|Study drug auto-injector administration|0|||
143405335|NCT01288443|517034453|FG003|Overall Study|Study drug auto-injector administration|0|||
143405336|NCT01288443|517034454|FG004|Overall Study|Study drug auto-injector administration|1|||
143405337|NCT01288443|517034455|FG005|Overall Study|Study drug auto-injector administration|1|||
143405338|NCT01288443|517034450|FG000|Overall Study|Other than above|0|||
143405339|NCT01288443|517034451|FG001|Overall Study|Other than above|0|||
143405340|NCT01288443|517034452|FG002|Overall Study|Other than above|0|||
143405341|NCT01288443|517034453|FG003|Overall Study|Other than above|2|||
143405342|NCT01288443|517034454|FG004|Overall Study|Other than above|1|||
143405343|NCT01288443|517034455|FG005|Overall Study|Other than above|0|||
143405344|NCT01596972|517034456|FG000|Overall Study|Physician Decision|1|||
143405345|NCT01596972|517034457|FG001|Overall Study|Physician Decision|9|||
143405346|NCT01596972|517034456|FG000|Overall Study|Lost to Follow-up|0|||
143405347|NCT01596972|517034457|FG001|Overall Study|Lost to Follow-up|4|||
143405348|NCT01596972|517034456|FG000|Overall Study|Withdrawal by Subject|0|||
143405349|NCT01596972|517034457|FG001|Overall Study|Withdrawal by Subject|1|||
143405350|NCT01639131|517034459|FG000|Overall Study|Disease Progression|6|||
143405351|NCT01964300|517034461|FG000|Overall Study|Ineligible after enrollment|0|||
143405352|NCT01964300|517034462|FG001|Overall Study|Ineligible after enrollment|1|||
143405353|NCT01964300|517034461|FG000|Overall Study|Adverse Event|1|||
143405354|NCT01964300|517034462|FG001|Overall Study|Adverse Event|1|||
143405355|NCT01964300|517034461|FG000|Overall Study|Lack of Efficacy|3|||
143405356|NCT01964300|517034462|FG001|Overall Study|Lack of Efficacy|5|||
143405357|NCT01964300|517034461|FG000|Overall Study|Withdrawal by Subject|0|||
143405358|NCT01964300|517034462|FG001|Overall Study|Withdrawal by Subject|1|||
143405359|NCT01964300|517034461|FG000|Overall Study|To receive alternative therapy|1|||
143405360|NCT01964300|517034462|FG001|Overall Study|To receive alternative therapy|2|||
143405361|NCT01964300|517034461|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
143405362|NCT01964300|517034462|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
143405363|NCT01964300|517034461|FG000|Overall Study|Weight criteria not met|0|||
143405364|NCT01964300|517034462|FG001|Overall Study|Weight criteria not met|1|||
143405365|NCT00557492|517034463|FG000|Overall Study|Change in health insurance|1|||
143405366|NCT03621735|517034465|FG000|Overall Study|Withdrawal by Subject|13|||
143405367|NCT03621735|517034466|FG001|Overall Study|Withdrawal by Subject|13|||
143405368|NCT03875313|517034470|FG000|Overall Study|Withdrawal by Subject|1|||
143405369|NCT03875313|517034471|FG001|Overall Study|Withdrawal by Subject|3|||
143405370|NCT03875313|517034472|FG002|Overall Study|Withdrawal by Subject|0|||
143405371|NCT03875313|517034473|FG003|Overall Study|Withdrawal by Subject|0|||
143405372|NCT03875313|517034474|FG004|Overall Study|Withdrawal by Subject|0|||
143405373|NCT03875313|517034470|FG000|Overall Study|Death|0|||
143405374|NCT03875313|517034471|FG001|Overall Study|Death|0|||
143405375|NCT03875313|517034472|FG002|Overall Study|Death|0|||
143405376|NCT03875313|517034473|FG003|Overall Study|Death|0|||
143405377|NCT03875313|517034474|FG004|Overall Study|Death|1|||
143405378|NCT03875313|517034470|FG000|Overall Study|Lost to Follow-up|0|||
143405379|NCT03875313|517034471|FG001|Overall Study|Lost to Follow-up|0|||
143405380|NCT03875313|517034472|FG002|Overall Study|Lost to Follow-up|0|||
143405381|NCT03875313|517034473|FG003|Overall Study|Lost to Follow-up|0|||
143405382|NCT03875313|517034474|FG004|Overall Study|Lost to Follow-up|1|||
143405383|NCT03875313|517034470|FG000|Overall Study|Study Termination by Sponsor|0|||
143405384|NCT03875313|517034471|FG001|Overall Study|Study Termination by Sponsor|1|||
143405385|NCT03875313|517034472|FG002|Overall Study|Study Termination by Sponsor|1|||
143405386|NCT03875313|517034473|FG003|Overall Study|Study Termination by Sponsor|0|||
143405387|NCT03875313|517034474|FG004|Overall Study|Study Termination by Sponsor|1|||
143405388|NCT03875313|517034470|FG000|Overall Study|New Anticancer Treatment|0|||
143405389|NCT03875313|517034471|FG001|Overall Study|New Anticancer Treatment|1|||
143405390|NCT03875313|517034472|FG002|Overall Study|New Anticancer Treatment|2|||
143405391|NCT03875313|517034473|FG003|Overall Study|New Anticancer Treatment|1|||
143405392|NCT03875313|517034474|FG004|Overall Study|New Anticancer Treatment|0|||
143405393|NCT03875313|517034470|FG000|Overall Study|Other, Not Specified|2|||
143405394|NCT03875313|517034471|FG001|Overall Study|Other, Not Specified|11|||
143405395|NCT03875313|517034472|FG002|Overall Study|Other, Not Specified|3|||
143405396|NCT03875313|517034473|FG003|Overall Study|Other, Not Specified|3|||
143405397|NCT03875313|517034474|FG004|Overall Study|Other, Not Specified|1|||
143405398|NCT04121546|517034475|FG000|Overall Study|Lost to Follow-up|1|||
143405399|NCT04121546|517034476|FG001|Overall Study|Lost to Follow-up|3|||
143405400|NCT04495621|517034487|FG000|Overall Study|Withdrawal by Subject|0|||
143405401|NCT04495621|517034488|FG001|Overall Study|Withdrawal by Subject|3|||
143405402|NCT04495621|517034487|FG000|Overall Study|Death|7|||
143405403|NCT04495621|517034488|FG001|Overall Study|Death|11|||
143405404|NCT04495621|517034487|FG000|Overall Study|Investigator Decision|0|||
143405405|NCT04495621|517034488|FG001|Overall Study|Investigator Decision|7|||
143405406|NCT04495621|517034487|FG000|Overall Study|Lost to Follow-up|0|||
143405407|NCT04495621|517034488|FG001|Overall Study|Lost to Follow-up|1|||
143405408|NCT02754596|517034494|FG000|Overall Study|Withdrawal by Subject|3|||
143405409|NCT02754596|517034495|FG001|Overall Study|Withdrawal by Subject|4|||
143405410|NCT02754596|517034496|FG002|Overall Study|Withdrawal by Subject|0|||
143405411|NCT02754596|517034494|FG000|Overall Study|Physician Decision|1|||
143405412|NCT02754596|517034495|FG001|Overall Study|Physician Decision|1|||
143405413|NCT02754596|517034496|FG002|Overall Study|Physician Decision|1|||
143405414|NCT02754596|517034494|FG000|Overall Study|Lost to Follow-up|1|||
143405415|NCT02754596|517034495|FG001|Overall Study|Lost to Follow-up|1|||
143405416|NCT02754596|517034496|FG002|Overall Study|Lost to Follow-up|2|||
143405417|NCT02754596|517034494|FG000|Overall Study|Death|0|||
143405418|NCT02754596|517034495|FG001|Overall Study|Death|2|||
143405419|NCT02754596|517034496|FG002|Overall Study|Death|0|||
143405420|NCT02754596|517034494|FG000|Overall Study|Adverse Event|1|||
143405421|NCT02754596|517034495|FG001|Overall Study|Adverse Event|0|||
143405422|NCT02754596|517034496|FG002|Overall Study|Adverse Event|1|||
143405423|NCT02754596|517034494|FG000|Overall Study|Other|1|||
143405424|NCT02754596|517034495|FG001|Overall Study|Other|0|||
143405425|NCT02754596|517034496|FG002|Overall Study|Other|0|||
143405426|NCT05707351|517034498|FG000|Overall Study|Withdrawal by Subject|2|||
143405427|NCT05707351|517034498|FG000|Overall Study|Reason Not Specified|1|||
143405428|NCT03213457|517034503|FG000|Screening Period|Withdrawal by Subject|0|||
143405429|NCT03213457|517034504|FG001|Screening Period|Withdrawal by Subject|1|||
143405430|NCT03213457|517034505|FG002|Screening Period|Withdrawal by Subject|0|||
143405431|NCT03213457|517034503|FG000|Screening Period|Other|1|||
143405432|NCT03213457|517034504|FG001|Screening Period|Other|0|||
143405433|NCT03213457|517034505|FG002|Screening Period|Other|0|||
143405434|NCT03213457|517034503|FG000|Double-Blind Period|Adverse Event|3|||
143405435|NCT03213457|517034504|FG001|Double-Blind Period|Adverse Event|2|||
143405436|NCT03213457|517034505|FG002|Double-Blind Period|Adverse Event|7|||
143405437|NCT03213457|517034503|FG000|Double-Blind Period|Withdrawal by Subject|14|||
143405438|NCT03213457|517034504|FG001|Double-Blind Period|Withdrawal by Subject|2|||
143405439|NCT03213457|517034505|FG002|Double-Blind Period|Withdrawal by Subject|14|||
143405440|NCT03213457|517034503|FG000|Double-Blind Period|Lost to Follow-up|2|||
143405441|NCT03213457|517034504|FG001|Double-Blind Period|Lost to Follow-up|3|||
143405442|NCT03213457|517034505|FG002|Double-Blind Period|Lost to Follow-up|9|||
143405443|NCT03213457|517034503|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
143405444|NCT03213457|517034504|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
143405445|NCT03213457|517034505|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
143405446|NCT03213457|517034503|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
143405447|NCT03213457|517034504|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
143405448|NCT03213457|517034505|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
143405449|NCT03213457|517034503|FG000|Double-Blind Period|Pregnancy|5|||
143405450|NCT03213457|517034504|FG001|Double-Blind Period|Pregnancy|0|||
143405451|NCT03213457|517034505|FG002|Double-Blind Period|Pregnancy|0|||
143405452|NCT03213457|517034503|FG000|Double-Blind Period|Other|10|||
143405453|NCT03213457|517034504|FG001|Double-Blind Period|Other|3|||
143405454|NCT03213457|517034505|FG002|Double-Blind Period|Other|17|||
143405455|NCT03213457|517034503|FG000|Open-Label Period|Adverse Event|1|||
143405456|NCT03213457|517034504|FG001|Open-Label Period|Adverse Event|2|||
143405457|NCT03213457|517034505|FG002|Open-Label Period|Adverse Event|2|||
143405458|NCT03213457|517034503|FG000|Open-Label Period|Withdrawal by Subject|12|||
143405459|NCT03213457|517034504|FG001|Open-Label Period|Withdrawal by Subject|5|||
143405460|NCT03213457|517034505|FG002|Open-Label Period|Withdrawal by Subject|24|||
143405461|NCT03213457|517034503|FG000|Open-Label Period|Lost to Follow-up|1|||
143405462|NCT03213457|517034504|FG001|Open-Label Period|Lost to Follow-up|2|||
143405463|NCT03213457|517034505|FG002|Open-Label Period|Lost to Follow-up|8|||
143405464|NCT03213457|517034503|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
143405465|NCT03213457|517034504|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
143405466|NCT03213457|517034505|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
143405467|NCT03213457|517034503|FG000|Open-Label Period|Non-compliance with study procedures|1|||
143405468|NCT03213457|517034504|FG001|Open-Label Period|Non-compliance with study procedures|1|||
143405469|NCT03213457|517034505|FG002|Open-Label Period|Non-compliance with study procedures|2|||
143405470|NCT03213457|517034503|FG000|Open-Label Period|Exclusionary medications|0|||
143405471|NCT03213457|517034504|FG001|Open-Label Period|Exclusionary medications|0|||
143405472|NCT03213457|517034505|FG002|Open-Label Period|Exclusionary medications|1|||
143405473|NCT03213457|517034503|FG000|Open-Label Period|Other|1|||
143405474|NCT03213457|517034504|FG001|Open-Label Period|Other|1|||
143405475|NCT03213457|517034505|FG002|Open-Label Period|Other|6|||
143405476|NCT03213457|517034503|FG000|Follow-Up Period|Adverse Event|16|||
143405477|NCT03213457|517034504|FG001|Follow-Up Period|Adverse Event|8|||
143405478|NCT03213457|517034505|FG002|Follow-Up Period|Adverse Event|37|||
143405479|NCT03213457|517034503|FG000|Follow-Up Period|Withdrawal by Subject|18|||
143405480|NCT03213457|517034504|FG001|Follow-Up Period|Withdrawal by Subject|11|||
143405481|NCT03213457|517034505|FG002|Follow-Up Period|Withdrawal by Subject|55|||
143405482|NCT03213457|517034503|FG000|Follow-Up Period|Lost to Follow-up|28|||
143405483|NCT03213457|517034504|FG001|Follow-Up Period|Lost to Follow-up|15|||
143405484|NCT03213457|517034505|FG002|Follow-Up Period|Lost to Follow-up|50|||
143405485|NCT03213457|517034503|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
143405486|NCT03213457|517034504|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
143405487|NCT03213457|517034505|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
143405488|NCT03213457|517034503|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
143405489|NCT03213457|517034504|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
143405490|NCT03213457|517034505|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
143405491|NCT03213457|517034503|FG000|Follow-Up Period|Pregnancy|7|||
143405492|NCT03213457|517034504|FG001|Follow-Up Period|Pregnancy|0|||
143405493|NCT03213457|517034505|FG002|Follow-Up Period|Pregnancy|18|||
143405494|NCT03213457|517034503|FG000|Follow-Up Period|Exclusionary medications|1|||
143405495|NCT03213457|517034504|FG001|Follow-Up Period|Exclusionary medications|1|||
143405496|NCT03213457|517034505|FG002|Follow-Up Period|Exclusionary medications|5|||
143405497|NCT03213457|517034503|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
143405498|NCT03213457|517034504|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
143405499|NCT03213457|517034505|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
143405500|NCT03213457|517034503|FG000|Follow-Up Period|Other|14|||
143405501|NCT03213457|517034504|FG001|Follow-Up Period|Other|10|||
143405502|NCT03213457|517034505|FG002|Follow-Up Period|Other|31|||
143405503|NCT02951052|517034506|FG000|Overall Study|Adverse Event|13|||
143405504|NCT02951052|517034507|FG001|Overall Study|Adverse Event|5|||
143405505|NCT02951052|517034506|FG000|Overall Study|Withdrawal by Subject|1|||
143405506|NCT02951052|517034507|FG001|Overall Study|Withdrawal by Subject|5|||
143405507|NCT02951052|517034506|FG000|Overall Study|Physician Decision|2|||
143405508|NCT02951052|517034507|FG001|Overall Study|Physician Decision|0|||
143405509|NCT02951052|517034506|FG000|Overall Study|Lost to Follow-up|1|||
143405510|NCT02951052|517034507|FG001|Overall Study|Lost to Follow-up|1|||
143405511|NCT02951052|517034506|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
143405512|NCT02951052|517034507|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
143405513|NCT02951052|517034506|FG000|Overall Study|Protocol Violation|5|||
143405514|NCT02951052|517034507|FG001|Overall Study|Protocol Violation|3|||
143405515|NCT02951052|517034506|FG000|Overall Study|Lack of Efficacy|3|||
143405516|NCT02951052|517034507|FG001|Overall Study|Lack of Efficacy|4|||
143405517|NCT02951052|517034506|FG000|Overall Study|Ongoing|1|||
143405518|NCT02951052|517034507|FG001|Overall Study|Ongoing|0|||
143405519|NCT01830595|517034508|FG000|First Period|Withdrawal by Subject|1|||
143405520|NCT01830595|517034509|FG001|First Period|Withdrawal by Subject|3|||
143405521|NCT01830595|517034508|FG000|Washout|Withdrawal by Subject|2|||
143405522|NCT01830595|517034509|FG001|Washout|Withdrawal by Subject|2|||
143405523|NCT04059406|517034518|FG000|Overall Study|Early Treatment Termination|5|||
143405524|NCT04059406|517034519|FG001|Overall Study|Early Treatment Termination|5|||
143405525|NCT04059406|517034520|FG002|Overall Study|Early Treatment Termination|15|||
143405526|NCT05155306|517034521|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
143405527|NCT05155306|517034522|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
143405528|NCT05155306|517034523|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
143405529|NCT05155306|517034524|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
143405530|NCT05155306|517034521|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
143405531|NCT05155306|517034522|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
143405532|NCT05155306|517034523|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
143405533|NCT05155306|517034524|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
143405534|NCT05116774|517034525|FG000|Part 1 (up to 24 Weeks)|Withdrawal by Subject|0|||
143405535|NCT05116774|517034526|FG001|Part 1 (up to 24 Weeks)|Withdrawal by Subject|1|||
143405536|NCT05116774|517034525|FG000|Part 1 (up to 24 Weeks)|Adverse Event|1|||
143405537|NCT05116774|517034526|FG001|Part 1 (up to 24 Weeks)|Adverse Event|0|||
143405538|NCT05116774|517034525|FG000|Part 2 (up to 52 Weeks)|Adverse Event|1|||
143405539|NCT05116774|517034526|FG001|Part 2 (up to 52 Weeks)|Adverse Event|0|||
143405540|NCT05116774|517034525|FG000|Part 2 (up to 52 Weeks)|Miscellaneous|3|||
143405541|NCT05116774|517034526|FG001|Part 2 (up to 52 Weeks)|Miscellaneous|1|||
143405542|NCT00319696|517034528|FG000|Overall Study|Adverse Event|36|||
143405543|NCT00319696|517034528|FG000|Overall Study|withdrawal of consent|14|||
143405544|NCT00319696|517034528|FG000|Overall Study|administrative|7|||
143405545|NCT00319696|517034528|FG000|Overall Study|Lost to Follow-up|3|||
143405546|NCT02500576|517034530|FG000|Overall Study|Adverse Event|0|||
143405547|NCT02500576|517034531|FG001|Overall Study|Adverse Event|1|||
143405548|NCT02500576|517034530|FG000|Overall Study|Death|2|||
143405549|NCT02500576|517034531|FG001|Overall Study|Death|1|||
143405550|NCT02500576|517034530|FG000|Overall Study|Lack of Efficacy|5|||
143405551|NCT02500576|517034531|FG001|Overall Study|Lack of Efficacy|5|||
143405552|NCT02500576|517034530|FG000|Overall Study|Withdrawal by Subject|1|||
143405553|NCT02500576|517034531|FG001|Overall Study|Withdrawal by Subject|1|||
143405554|NCT05827068|517034537|FG000|Overall Study|Lost to Follow-up|1|||
143405555|NCT05827068|517034538|FG001|Overall Study|Lost to Follow-up|4|||
143405556|NCT05827068|517034539|FG002|Overall Study|Lost to Follow-up|1|||
143405557|NCT05827068|517034540|FG003|Overall Study|Lost to Follow-up|1|||
143405558|NCT05827068|517034541|FG004|Overall Study|Lost to Follow-up|2|||
143405559|NCT05827068|517034542|FG005|Overall Study|Lost to Follow-up|4|||
143405560|NCT05827068|517034543|FG006|Overall Study|Lost to Follow-up|1|||
143405561|NCT05827068|517034537|FG000|Overall Study|Withdrawal by Subject|4|||
143405562|NCT05827068|517034538|FG001|Overall Study|Withdrawal by Subject|0|||
143405563|NCT05827068|517034539|FG002|Overall Study|Withdrawal by Subject|1|||
143405564|NCT05827068|517034540|FG003|Overall Study|Withdrawal by Subject|2|||
143405565|NCT05827068|517034541|FG004|Overall Study|Withdrawal by Subject|3|||
143405566|NCT05827068|517034542|FG005|Overall Study|Withdrawal by Subject|0|||
143405567|NCT05827068|517034543|FG006|Overall Study|Withdrawal by Subject|1|||
143405568|NCT05827068|517034537|FG000|Overall Study|Physician Decision|0|||
143405569|NCT05827068|517034538|FG001|Overall Study|Physician Decision|0|||
143405570|NCT05827068|517034539|FG002|Overall Study|Physician Decision|0|||
143405571|NCT05827068|517034540|FG003|Overall Study|Physician Decision|0|||
143405572|NCT05827068|517034541|FG004|Overall Study|Physician Decision|1|||
143405573|NCT05827068|517034542|FG005|Overall Study|Physician Decision|0|||
143405574|NCT05827068|517034543|FG006|Overall Study|Physician Decision|1|||
143405575|NCT05827068|517034537|FG000|Overall Study|Other Than Specified|0|||
143405576|NCT05827068|517034538|FG001|Overall Study|Other Than Specified|1|||
143405577|NCT05827068|517034539|FG002|Overall Study|Other Than Specified|0|||
143405578|NCT05827068|517034540|FG003|Overall Study|Other Than Specified|0|||
143405579|NCT05827068|517034541|FG004|Overall Study|Other Than Specified|0|||
143405580|NCT05827068|517034542|FG005|Overall Study|Other Than Specified|0|||
143405581|NCT05827068|517034543|FG006|Overall Study|Other Than Specified|0|||
143405582|NCT00982644|517035295|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
143405583|NCT00982644|517035296|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
143405584|NCT00982644|517035295|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
143405585|NCT00982644|517035296|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
143405586|NCT00982644|517035295|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
143405587|NCT00982644|517035296|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
143405588|NCT00982644|517035295|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
143405589|NCT00982644|517035296|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
143405590|NCT00982644|517035295|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
143405591|NCT00982644|517035296|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
143405592|NCT00982644|517035295|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
143405593|NCT00982644|517035296|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
143405594|NCT00982644|517035295|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
143405595|NCT00982644|517035296|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
143405596|NCT00982644|517035295|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
143405597|NCT00982644|517035296|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
143405598|NCT00982644|517035295|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
143405599|NCT00982644|517035296|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
143405600|NCT00982644|517035295|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
143405601|NCT00982644|517035296|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
143405602|NCT00943917|517035297|FG000|Stage I|Adverse Event|1|||
143405603|NCT00943917|517035298|FG001|Stage I|Adverse Event|2|||
143405604|NCT00943917|517035299|FG002|Stage I|Adverse Event|2|||
143405605|NCT00943917|517035300|FG003|Stage I|Adverse Event|0|||
143405606|NCT00943917|517035301|FG004|Stage I|Adverse Event|0|||
143405607|NCT00943917|517035302|FG005|Stage I|Adverse Event|0|||
143405608|NCT00943917|517035303|FG006|Stage I|Adverse Event|0|||
143405609|NCT00943917|517035304|FG007|Stage I|Adverse Event|0|||
143405610|NCT00943917|517035305|FG008|Stage I|Adverse Event|0|||
143405611|NCT00943917|517035306|FG009|Stage I|Adverse Event|0|||
143405612|NCT00943917|517035307|FG010|Stage I|Adverse Event|0|||
143405613|NCT00943917|517035308|FG011|Stage I|Adverse Event|0|||
143405614|NCT00943917|517035309|FG012|Stage I|Adverse Event|0|||
143405615|NCT00943917|517035310|FG013|Stage I|Adverse Event|0|||
143405616|NCT00943917|517035311|FG014|Stage I|Adverse Event|0|||
143405617|NCT00943917|517035297|FG000|Stage I|Lost to Follow-up|0|||
143405618|NCT00943917|517035298|FG001|Stage I|Lost to Follow-up|0|||
143405619|NCT00943917|517035299|FG002|Stage I|Lost to Follow-up|1|||
143405620|NCT00943917|517035300|FG003|Stage I|Lost to Follow-up|0|||
143405621|NCT00943917|517035301|FG004|Stage I|Lost to Follow-up|0|||
143405622|NCT00943917|517035302|FG005|Stage I|Lost to Follow-up|0|||
143405623|NCT00943917|517035303|FG006|Stage I|Lost to Follow-up|0|||
143405624|NCT00943917|517035304|FG007|Stage I|Lost to Follow-up|0|||
143405625|NCT00943917|517035305|FG008|Stage I|Lost to Follow-up|0|||
143405626|NCT00943917|517035306|FG009|Stage I|Lost to Follow-up|0|||
143405627|NCT00943917|517035307|FG010|Stage I|Lost to Follow-up|0|||
143405628|NCT00943917|517035308|FG011|Stage I|Lost to Follow-up|0|||
143405629|NCT00943917|517035309|FG012|Stage I|Lost to Follow-up|0|||
143405630|NCT00943917|517035310|FG013|Stage I|Lost to Follow-up|0|||
143405631|NCT00943917|517035311|FG014|Stage I|Lost to Follow-up|0|||
143405632|NCT00943917|517035297|FG000|Stage I|hyperglycemia|0|||
143405633|NCT00943917|517035298|FG001|Stage I|hyperglycemia|0|||
143405634|NCT00943917|517035299|FG002|Stage I|hyperglycemia|1|||
143405635|NCT00943917|517035300|FG003|Stage I|hyperglycemia|0|||
143405636|NCT00943917|517035301|FG004|Stage I|hyperglycemia|0|||
143405637|NCT00943917|517035302|FG005|Stage I|hyperglycemia|0|||
143405638|NCT00943917|517035303|FG006|Stage I|hyperglycemia|0|||
143405639|NCT00943917|517035304|FG007|Stage I|hyperglycemia|0|||
143405640|NCT00943917|517035305|FG008|Stage I|hyperglycemia|0|||
143405641|NCT00943917|517035306|FG009|Stage I|hyperglycemia|0|||
143405642|NCT00943917|517035307|FG010|Stage I|hyperglycemia|0|||
143405643|NCT00943917|517035308|FG011|Stage I|hyperglycemia|0|||
143405644|NCT00943917|517035309|FG012|Stage I|hyperglycemia|0|||
143405645|NCT00943917|517035310|FG013|Stage I|hyperglycemia|0|||
143405646|NCT00943917|517035311|FG014|Stage I|hyperglycemia|0|||
143405647|NCT00943917|517035297|FG000|Stage I|A1C elevation|1|||
143405648|NCT00943917|517035298|FG001|Stage I|A1C elevation|0|||
143405649|NCT00943917|517035299|FG002|Stage I|A1C elevation|0|||
143405650|NCT00943917|517035300|FG003|Stage I|A1C elevation|0|||
143405651|NCT00943917|517035301|FG004|Stage I|A1C elevation|0|||
143405652|NCT00943917|517035302|FG005|Stage I|A1C elevation|0|||
143405653|NCT00943917|517035303|FG006|Stage I|A1C elevation|0|||
143405654|NCT00943917|517035304|FG007|Stage I|A1C elevation|0|||
143405655|NCT00943917|517035305|FG008|Stage I|A1C elevation|0|||
143405656|NCT00943917|517035306|FG009|Stage I|A1C elevation|0|||
143405657|NCT00943917|517035307|FG010|Stage I|A1C elevation|0|||
143405658|NCT00943917|517035308|FG011|Stage I|A1C elevation|0|||
143405659|NCT00943917|517035309|FG012|Stage I|A1C elevation|0|||
143405660|NCT00943917|517035310|FG013|Stage I|A1C elevation|0|||
143405661|NCT00943917|517035311|FG014|Stage I|A1C elevation|0|||
143405662|NCT00943917|517035297|FG000|Stage I|Withdrawal by Subject|2|||
143405663|NCT00943917|517035298|FG001|Stage I|Withdrawal by Subject|1|||
143405664|NCT00943917|517035299|FG002|Stage I|Withdrawal by Subject|2|||
143405665|NCT00943917|517035300|FG003|Stage I|Withdrawal by Subject|0|||
143405666|NCT00943917|517035301|FG004|Stage I|Withdrawal by Subject|0|||
143405667|NCT00943917|517035302|FG005|Stage I|Withdrawal by Subject|0|||
143405668|NCT00943917|517035303|FG006|Stage I|Withdrawal by Subject|0|||
143405669|NCT00943917|517035304|FG007|Stage I|Withdrawal by Subject|0|||
143405670|NCT00943917|517035305|FG008|Stage I|Withdrawal by Subject|0|||
143405671|NCT00943917|517035306|FG009|Stage I|Withdrawal by Subject|0|||
143405672|NCT00943917|517035307|FG010|Stage I|Withdrawal by Subject|0|||
143405673|NCT00943917|517035308|FG011|Stage I|Withdrawal by Subject|0|||
143405674|NCT00943917|517035309|FG012|Stage I|Withdrawal by Subject|0|||
143405675|NCT00943917|517035310|FG013|Stage I|Withdrawal by Subject|0|||
143405676|NCT00943917|517035311|FG014|Stage I|Withdrawal by Subject|0|||
143405677|NCT00943917|517035297|FG000|Stage II|Adverse Event|0|||
143405678|NCT00943917|517035298|FG001|Stage II|Adverse Event|0|||
143405679|NCT00943917|517035299|FG002|Stage II|Adverse Event|0|||
143405680|NCT00943917|517035300|FG003|Stage II|Adverse Event|0|||
143405681|NCT00943917|517035301|FG004|Stage II|Adverse Event|0|||
143405682|NCT00943917|517035302|FG005|Stage II|Adverse Event|1|||
143405683|NCT00943917|517035303|FG006|Stage II|Adverse Event|3|||
143405684|NCT00943917|517035304|FG007|Stage II|Adverse Event|0|||
143405685|NCT00943917|517035305|FG008|Stage II|Adverse Event|1|||
143405686|NCT00943917|517035306|FG009|Stage II|Adverse Event|0|||
143405687|NCT00943917|517035307|FG010|Stage II|Adverse Event|0|||
143405688|NCT00943917|517035308|FG011|Stage II|Adverse Event|0|||
143405689|NCT00943917|517035309|FG012|Stage II|Adverse Event|0|||
143405690|NCT00943917|517035310|FG013|Stage II|Adverse Event|0|||
143405691|NCT00943917|517035311|FG014|Stage II|Adverse Event|0|||
143405692|NCT00943917|517035297|FG000|Stage II|Withdrawal by Subject|0|||
143405693|NCT00943917|517035298|FG001|Stage II|Withdrawal by Subject|0|||
143405694|NCT00943917|517035299|FG002|Stage II|Withdrawal by Subject|0|||
143405695|NCT00943917|517035300|FG003|Stage II|Withdrawal by Subject|0|||
143405696|NCT00943917|517035301|FG004|Stage II|Withdrawal by Subject|0|||
143405697|NCT00943917|517035302|FG005|Stage II|Withdrawal by Subject|1|||
143405698|NCT00943917|517035303|FG006|Stage II|Withdrawal by Subject|0|||
143405699|NCT00943917|517035304|FG007|Stage II|Withdrawal by Subject|0|||
143405700|NCT00943917|517035305|FG008|Stage II|Withdrawal by Subject|0|||
143405701|NCT00943917|517035306|FG009|Stage II|Withdrawal by Subject|0|||
143405702|NCT00943917|517035307|FG010|Stage II|Withdrawal by Subject|0|||
143405703|NCT00943917|517035308|FG011|Stage II|Withdrawal by Subject|0|||
143405704|NCT00943917|517035309|FG012|Stage II|Withdrawal by Subject|0|||
143405705|NCT00943917|517035310|FG013|Stage II|Withdrawal by Subject|0|||
143405706|NCT00943917|517035311|FG014|Stage II|Withdrawal by Subject|0|||
143405707|NCT00943917|517035297|FG000|Stage II|Pregnancy|0|||
143405708|NCT00943917|517035298|FG001|Stage II|Pregnancy|0|||
143405709|NCT00943917|517035299|FG002|Stage II|Pregnancy|0|||
143405710|NCT00943917|517035300|FG003|Stage II|Pregnancy|0|||
143405711|NCT00943917|517035301|FG004|Stage II|Pregnancy|0|||
143405712|NCT00943917|517035302|FG005|Stage II|Pregnancy|1|||
143405713|NCT00943917|517035303|FG006|Stage II|Pregnancy|0|||
143405714|NCT00943917|517035304|FG007|Stage II|Pregnancy|0|||
143405715|NCT00943917|517035305|FG008|Stage II|Pregnancy|0|||
143405716|NCT00943917|517035306|FG009|Stage II|Pregnancy|0|||
143405717|NCT00943917|517035307|FG010|Stage II|Pregnancy|0|||
143405718|NCT00943917|517035308|FG011|Stage II|Pregnancy|0|||
143405719|NCT00943917|517035309|FG012|Stage II|Pregnancy|0|||
143405720|NCT00943917|517035310|FG013|Stage II|Pregnancy|0|||
143405721|NCT00943917|517035311|FG014|Stage II|Pregnancy|0|||
143405722|NCT00943917|517035297|FG000|Stage II Continuation|Adverse Event|0|||
143405723|NCT00943917|517035298|FG001|Stage II Continuation|Adverse Event|0|||
143405724|NCT00943917|517035299|FG002|Stage II Continuation|Adverse Event|0|||
143405725|NCT00943917|517035300|FG003|Stage II Continuation|Adverse Event|0|||
143405726|NCT00943917|517035301|FG004|Stage II Continuation|Adverse Event|0|||
143405727|NCT00943917|517035302|FG005|Stage II Continuation|Adverse Event|0|||
143405728|NCT00943917|517035303|FG006|Stage II Continuation|Adverse Event|0|||
143405729|NCT00943917|517035304|FG007|Stage II Continuation|Adverse Event|0|||
143405730|NCT00943917|517035305|FG008|Stage II Continuation|Adverse Event|0|||
143405731|NCT00943917|517035306|FG009|Stage II Continuation|Adverse Event|0|||
143405732|NCT00943917|517035307|FG010|Stage II Continuation|Adverse Event|0|||
143405733|NCT00943917|517035308|FG011|Stage II Continuation|Adverse Event|1|||
143405734|NCT00943917|517035309|FG012|Stage II Continuation|Adverse Event|2|||
143405735|NCT00943917|517035310|FG013|Stage II Continuation|Adverse Event|1|||
143405736|NCT00943917|517035311|FG014|Stage II Continuation|Adverse Event|1|||
143405737|NCT00943917|517035297|FG000|Stage II Continuation|Withdrawal by Subject|0|||
143405738|NCT00943917|517035298|FG001|Stage II Continuation|Withdrawal by Subject|0|||
143405739|NCT00943917|517035299|FG002|Stage II Continuation|Withdrawal by Subject|0|||
143405740|NCT00943917|517035300|FG003|Stage II Continuation|Withdrawal by Subject|0|||
143405741|NCT00943917|517035301|FG004|Stage II Continuation|Withdrawal by Subject|0|||
143405742|NCT00943917|517035302|FG005|Stage II Continuation|Withdrawal by Subject|0|||
143405743|NCT00943917|517035303|FG006|Stage II Continuation|Withdrawal by Subject|0|||
143405744|NCT00943917|517035304|FG007|Stage II Continuation|Withdrawal by Subject|0|||
143405745|NCT00943917|517035305|FG008|Stage II Continuation|Withdrawal by Subject|0|||
143405746|NCT00943917|517035306|FG009|Stage II Continuation|Withdrawal by Subject|0|||
143405747|NCT00943917|517035307|FG010|Stage II Continuation|Withdrawal by Subject|0|||
143405748|NCT00943917|517035308|FG011|Stage II Continuation|Withdrawal by Subject|0|||
143405749|NCT00943917|517035309|FG012|Stage II Continuation|Withdrawal by Subject|0|||
143405750|NCT00943917|517035310|FG013|Stage II Continuation|Withdrawal by Subject|1|||
143405751|NCT00943917|517035311|FG014|Stage II Continuation|Withdrawal by Subject|3|||
143405752|NCT00943917|517035297|FG000|Stage II Continuation|Protocol Violation|0|||
143405753|NCT00943917|517035298|FG001|Stage II Continuation|Protocol Violation|0|||
143405754|NCT00943917|517035299|FG002|Stage II Continuation|Protocol Violation|0|||
143405755|NCT00943917|517035300|FG003|Stage II Continuation|Protocol Violation|0|||
143405756|NCT00943917|517035301|FG004|Stage II Continuation|Protocol Violation|0|||
143405757|NCT00943917|517035302|FG005|Stage II Continuation|Protocol Violation|0|||
143405758|NCT00943917|517035303|FG006|Stage II Continuation|Protocol Violation|0|||
143405759|NCT00943917|517035304|FG007|Stage II Continuation|Protocol Violation|0|||
143405760|NCT00943917|517035305|FG008|Stage II Continuation|Protocol Violation|0|||
143405761|NCT00943917|517035306|FG009|Stage II Continuation|Protocol Violation|1|||
143405762|NCT00943917|517035307|FG010|Stage II Continuation|Protocol Violation|0|||
143405763|NCT00943917|517035308|FG011|Stage II Continuation|Protocol Violation|1|||
143405764|NCT00943917|517035309|FG012|Stage II Continuation|Protocol Violation|0|||
143405765|NCT00943917|517035310|FG013|Stage II Continuation|Protocol Violation|0|||
143405766|NCT00943917|517035311|FG014|Stage II Continuation|Protocol Violation|0|||
143405767|NCT00943917|517035297|FG000|Stage II Continuation|hypoglycemia|0|||
143405768|NCT00943917|517035298|FG001|Stage II Continuation|hypoglycemia|0|||
143405769|NCT00943917|517035299|FG002|Stage II Continuation|hypoglycemia|0|||
143405770|NCT00943917|517035300|FG003|Stage II Continuation|hypoglycemia|0|||
143405771|NCT00943917|517035301|FG004|Stage II Continuation|hypoglycemia|0|||
143405772|NCT00943917|517035302|FG005|Stage II Continuation|hypoglycemia|0|||
143405773|NCT00943917|517035303|FG006|Stage II Continuation|hypoglycemia|0|||
143405774|NCT00943917|517035304|FG007|Stage II Continuation|hypoglycemia|0|||
143405775|NCT00943917|517035305|FG008|Stage II Continuation|hypoglycemia|0|||
143405776|NCT00943917|517035306|FG009|Stage II Continuation|hypoglycemia|0|||
143405777|NCT00943917|517035307|FG010|Stage II Continuation|hypoglycemia|0|||
143405778|NCT00943917|517035308|FG011|Stage II Continuation|hypoglycemia|0|||
143405779|NCT00943917|517035309|FG012|Stage II Continuation|hypoglycemia|1|||
143405780|NCT00943917|517035310|FG013|Stage II Continuation|hypoglycemia|0|||
143405781|NCT00943917|517035311|FG014|Stage II Continuation|hypoglycemia|0|||
143405782|NCT00943917|517035297|FG000|Stage II Continuation|A1C elevation|0|||
143405783|NCT00943917|517035298|FG001|Stage II Continuation|A1C elevation|0|||
143405784|NCT00943917|517035299|FG002|Stage II Continuation|A1C elevation|0|||
143405785|NCT00943917|517035300|FG003|Stage II Continuation|A1C elevation|0|||
143405786|NCT00943917|517035301|FG004|Stage II Continuation|A1C elevation|0|||
143405787|NCT00943917|517035302|FG005|Stage II Continuation|A1C elevation|0|||
143405788|NCT00943917|517035303|FG006|Stage II Continuation|A1C elevation|0|||
143405789|NCT00943917|517035304|FG007|Stage II Continuation|A1C elevation|0|||
143405790|NCT00943917|517035305|FG008|Stage II Continuation|A1C elevation|0|||
143405791|NCT00943917|517035306|FG009|Stage II Continuation|A1C elevation|0|||
143405792|NCT00943917|517035307|FG010|Stage II Continuation|A1C elevation|0|||
143405793|NCT00943917|517035308|FG011|Stage II Continuation|A1C elevation|0|||
143405794|NCT00943917|517035309|FG012|Stage II Continuation|A1C elevation|0|||
143405795|NCT00943917|517035310|FG013|Stage II Continuation|A1C elevation|1|||
143405796|NCT00943917|517035311|FG014|Stage II Continuation|A1C elevation|0|||
143405797|NCT01171976|517035312|FG000|Overall Study|Protocol Violation|0|||
143405798|NCT01171976|517035313|FG001|Overall Study|Protocol Violation|0|||
143405799|NCT01171976|517035314|FG002|Overall Study|Protocol Violation|1|||
143405800|NCT01171976|517035312|FG000|Overall Study|Death|2|||
143405801|NCT01171976|517035313|FG001|Overall Study|Death|4|||
143405802|NCT01171976|517035314|FG002|Overall Study|Death|1|||
143405803|NCT01171976|517035312|FG000|Overall Study|Lost to Follow-up|4|||
143405804|NCT01171976|517035313|FG001|Overall Study|Lost to Follow-up|0|||
143405805|NCT01171976|517035314|FG002|Overall Study|Lost to Follow-up|2|||
143405806|NCT01171976|517035312|FG000|Overall Study|Withdrawal by Subject|1|||
143405807|NCT01171976|517035313|FG001|Overall Study|Withdrawal by Subject|5|||
143405808|NCT01171976|517035314|FG002|Overall Study|Withdrawal by Subject|6|||
143405809|NCT01171976|517035312|FG000|Overall Study|Abnormal test result|1|||
143405810|NCT01171976|517035313|FG001|Overall Study|Abnormal test result|0|||
143405811|NCT01171976|517035314|FG002|Overall Study|Abnormal test result|0|||
143405812|NCT01171976|517035312|FG000|Overall Study|Adverse Event|6|||
143405813|NCT01171976|517035313|FG001|Overall Study|Adverse Event|2|||
143405814|NCT01171976|517035314|FG002|Overall Study|Adverse Event|5|||
143405815|NCT00087685|517035320|FG000|Overall Study|Adverse Event|5|||
143405816|NCT00087685|517035320|FG000|Overall Study|Non-Compliance|1|||
143405817|NCT00087685|517035320|FG000|Overall Study|Progressive Disease|5|||
143405818|NCT00087685|517035320|FG000|Overall Study|Withdrawal by Subject|3|||
143405819|NCT04018495|517035321|FG000|Overall Study|Physician Decision|1|||
143405820|NCT04158141|517035331|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
143405821|NCT04158141|517035332|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
143405822|NCT04158141|517035333|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
143405823|NCT04158141|517035331|FG000|Step 1: Registration|Adverse Event|1|||
143405824|NCT04158141|517035332|FG001|Step 1: Registration|Adverse Event|0|||
143405825|NCT04158141|517035333|FG002|Step 1: Registration|Adverse Event|0|||
143405826|NCT04158141|517035331|FG000|Step 1: Registration|Withdrawal by Subject|1|||
143405827|NCT04158141|517035332|FG001|Step 1: Registration|Withdrawal by Subject|0|||
143405828|NCT04158141|517035333|FG002|Step 1: Registration|Withdrawal by Subject|0|||
143405829|NCT04158141|517035331|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
143405830|NCT04158141|517035332|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
143405831|NCT04158141|517035333|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
143405832|NCT04121741|517035334|FG000|Overall Study|Protocol Violation|1|||
143405833|NCT04121741|517035335|FG001|Overall Study|Protocol Violation|0|||
143405834|NCT04121741|517035336|FG002|Overall Study|Protocol Violation|0|||
143405835|NCT04121741|517035337|FG003|Overall Study|Protocol Violation|0|||
143405836|NCT04121741|517035338|FG004|Overall Study|Protocol Violation|0|||
143405837|NCT04121741|517035339|FG005|Overall Study|Protocol Violation|0|||
143405838|NCT01084863|517035340|FG000|Main Study Treatment Period|Disease progression|11|||
143405839|NCT01084863|517035341|FG001|Main Study Treatment Period|Disease progression|7|||
143405840|NCT01084863|517035340|FG000|Main Study Treatment Period|Adverse Event|5|||
143405841|NCT01084863|517035341|FG001|Main Study Treatment Period|Adverse Event|3|||
143405842|NCT01084863|517035340|FG000|Main Study Treatment Period|Other Reason|0|||
143405843|NCT01084863|517035341|FG001|Main Study Treatment Period|Other Reason|1|||
143405844|NCT01084863|517035340|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
143405845|NCT01084863|517035341|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
143405846|NCT01084863|517035340|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
143405847|NCT01084863|517035341|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
143405848|NCT01084863|517035340|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
143405849|NCT01084863|517035341|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
143405850|NCT01084863|517035340|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
143405851|NCT01084863|517035341|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
143405852|NCT01084863|517035340|FG000|Treatment Period Beyond Cycle 8|Other|0|||
143405853|NCT01084863|517035341|FG001|Treatment Period Beyond Cycle 8|Other|1|||
143405854|NCT01084863|517035340|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
143405855|NCT01084863|517035341|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
143405856|NCT04505722|517035342|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
143405857|NCT04505722|517035343|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
143405858|NCT04505722|517035344|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
143405859|NCT04505722|517035342|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
143405860|NCT04505722|517035343|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
143405861|NCT04505722|517035344|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
143405862|NCT04505722|517035342|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
143405863|NCT04505722|517035343|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
143405864|NCT04505722|517035344|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
143405865|NCT04505722|517035342|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
143405866|NCT04505722|517035343|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
143405867|NCT04505722|517035344|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
143405868|NCT04505722|517035342|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
143405869|NCT04505722|517035343|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
143405870|NCT04505722|517035344|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
143405871|NCT04505722|517035342|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
143405872|NCT04505722|517035343|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
143405873|NCT04505722|517035344|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
143405874|NCT04505722|517035342|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
143405875|NCT04505722|517035343|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
143405876|NCT04505722|517035344|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
143405877|NCT04505722|517035342|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
143405878|NCT04505722|517035343|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
143405879|NCT04505722|517035344|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
143405880|NCT04505722|517035342|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
143405881|NCT04505722|517035343|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
143405882|NCT04505722|517035344|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
143405883|NCT04505722|517035342|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
143405884|NCT04505722|517035343|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
143405885|NCT04505722|517035344|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
143405886|NCT04505722|517035342|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
143405887|NCT04505722|517035343|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
143405888|NCT04505722|517035344|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
143405889|NCT04505722|517035342|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
143405890|NCT04505722|517035343|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
143405891|NCT04505722|517035344|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
143405892|NCT04505722|517035342|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
143405893|NCT04505722|517035343|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
143405894|NCT04505722|517035344|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
143405895|NCT04505722|517035342|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
143405896|NCT04505722|517035343|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
143405897|NCT04505722|517035344|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
143405898|NCT04505722|517035342|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
143405899|NCT04505722|517035343|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
143405900|NCT04505722|517035344|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
143405901|NCT03275285|517035345|FG000|Overall Study|Ongoing|45|||
143405902|NCT03275285|517035346|FG001|Overall Study|Ongoing|69|||
143405903|NCT00115934|517035347|FG000|Overall Study|Lost to Follow-up|1|||
143405904|NCT00115934|517035348|FG001|Overall Study|Lost to Follow-up|0|||
143405905|NCT00115934|517035347|FG000|Overall Study|Did not receive intervention|3|||
143405906|NCT00115934|517035348|FG001|Overall Study|Did not receive intervention|2|||
143405907|NCT04882917|517035351|FG000|Overall Study|Adverse Event|0|||
143405908|NCT04882917|517035352|FG001|Overall Study|Adverse Event|1|||
143405909|NCT04882917|517035353|FG002|Overall Study|Adverse Event|2|||
143405910|NCT04882917|517035354|FG003|Overall Study|Adverse Event|2|||
143405911|NCT04882917|517035351|FG000|Overall Study|Withdrawal by Subject|1|||
143405912|NCT04882917|517035352|FG001|Overall Study|Withdrawal by Subject|0|||
143405913|NCT04882917|517035353|FG002|Overall Study|Withdrawal by Subject|2|||
143405914|NCT04882917|517035354|FG003|Overall Study|Withdrawal by Subject|1|||
143405915|NCT04882917|517035351|FG000|Overall Study|COVID-19-related and COVID-19-non-related|1|||
143405916|NCT04882917|517035352|FG001|Overall Study|COVID-19-related and COVID-19-non-related|0|||
143405917|NCT04882917|517035353|FG002|Overall Study|COVID-19-related and COVID-19-non-related|0|||
143405918|NCT04882917|517035354|FG003|Overall Study|COVID-19-related and COVID-19-non-related|0|||
143405919|NCT01470144|517035364|FG000|Overall Study|Adverse Event|2|||
143405920|NCT01470144|517035364|FG000|Overall Study|Death|1|||
143405921|NCT01470144|517035364|FG000|Overall Study|Lung transplant|6|||
143405922|NCT01470144|517035364|FG000|Overall Study|Patient's and investigator's decision|1|||
143405923|NCT02285270|517036168|FG000|Overall Study|Lost to Follow-up|1|||
143405924|NCT02285270|517036168|FG000|Overall Study|Physician Decision|3|||
143405925|NCT02285270|517036168|FG000|Overall Study|Determined to be ineligible|1|||
143405926|NCT00439270|517036169|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
143405927|NCT00439270|517036170|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
143405928|NCT00439270|517036171|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
143405929|NCT00439270|517036172|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
143405930|NCT00439270|517036173|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
143405931|NCT00439270|517036169|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
143405932|NCT00439270|517036170|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
143405933|NCT00439270|517036171|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
143405934|NCT00439270|517036172|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
143405935|NCT00439270|517036173|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
143405936|NCT00439270|517036169|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
143405937|NCT00439270|517036170|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
143405938|NCT00439270|517036171|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
143405939|NCT00439270|517036172|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
143405940|NCT00439270|517036173|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
143405941|NCT00439270|517036169|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
143405942|NCT00439270|517036170|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
143405943|NCT00439270|517036171|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
143405944|NCT00439270|517036172|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
143405945|NCT00439270|517036173|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
143405946|NCT00439270|517036169|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
143405947|NCT00439270|517036170|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
143405948|NCT00439270|517036171|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
143405949|NCT00439270|517036172|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
143405950|NCT00439270|517036173|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
143405951|NCT00439270|517036169|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
143405952|NCT00439270|517036170|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
143405953|NCT00439270|517036171|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
143405954|NCT00439270|517036172|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
143405955|NCT00439270|517036173|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
143405956|NCT00439270|517036169|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
143405957|NCT00439270|517036170|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
143405958|NCT00439270|517036171|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
143405959|NCT00439270|517036172|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
143405960|NCT00439270|517036173|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
143405961|NCT00439270|517036169|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
143405962|NCT00439270|517036170|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
143405963|NCT00439270|517036171|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
143405964|NCT00439270|517036172|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
143405965|NCT00439270|517036173|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
143405966|NCT00439270|517036169|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
143405967|NCT00439270|517036170|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
143405968|NCT00439270|517036171|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
143405969|NCT00439270|517036172|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
143405970|NCT00439270|517036173|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
143405971|NCT00439270|517036169|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
143405972|NCT00439270|517036170|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
143405973|NCT00439270|517036171|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
143405974|NCT00439270|517036172|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
143405975|NCT00439270|517036173|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
143405976|NCT01268306|517036174|FG000|Overall Study|Lost to Follow-up|1|||
143405977|NCT04334317|517036175|FG000|Overall Study|Adverse Event|1|||
143405978|NCT04334317|517036176|FG001|Overall Study|Adverse Event|2|||
143405979|NCT04334317|517036177|FG002|Overall Study|Adverse Event|0|||
143405980|NCT04334317|517036178|FG003|Overall Study|Adverse Event|0|||
143405981|NCT04334317|517036175|FG000|Overall Study|Protocol Deviation|0|||
143405982|NCT04334317|517036176|FG001|Overall Study|Protocol Deviation|1|||
143405983|NCT04334317|517036177|FG002|Overall Study|Protocol Deviation|0|||
143405984|NCT04334317|517036178|FG003|Overall Study|Protocol Deviation|0|||
143405985|NCT04334317|517036175|FG000|Overall Study|Withdrawal by Subject|2|||
143405986|NCT04334317|517036176|FG001|Overall Study|Withdrawal by Subject|2|||
143405987|NCT04334317|517036177|FG002|Overall Study|Withdrawal by Subject|0|||
143405988|NCT04334317|517036178|FG003|Overall Study|Withdrawal by Subject|0|||
143405989|NCT03709706|517036180|FG000|Overall Study|Adverse Event|0|||
143405990|NCT03709706|517036181|FG001|Overall Study|Adverse Event|1|||
143405991|NCT03709706|517036180|FG000|Overall Study|Physician Decision|14|||
143405992|NCT03709706|517036181|FG001|Overall Study|Physician Decision|8|||
143405993|NCT03709706|517036180|FG000|Overall Study|Withdrawal by Subject|2|||
143405994|NCT03709706|517036181|FG001|Overall Study|Withdrawal by Subject|1|||
143405995|NCT03709706|517036180|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
143405996|NCT03709706|517036181|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
143405997|NCT01105975|517036182|FG000|Overall Study|Adverse Event|2|||
143405998|NCT01105975|517036183|FG001|Overall Study|Adverse Event|1|||
143405999|NCT01105975|517036184|FG002|Overall Study|Adverse Event|5|||
143406000|NCT01105975|517036185|FG003|Overall Study|Adverse Event|1|||
143406001|NCT01105975|517036186|FG004|Overall Study|Adverse Event|0|||
143406002|NCT01105975|517036187|FG005|Overall Study|Adverse Event|1|||
143406003|NCT01105975|517036188|FG006|Overall Study|Adverse Event|2|||
143406004|NCT01105975|517036189|FG007|Overall Study|Adverse Event|4|||
143406005|NCT01105975|517036190|FG008|Overall Study|Adverse Event|1|||
143406006|NCT01105975|517036191|FG009|Overall Study|Adverse Event|4|||
143406007|NCT01105975|517036182|FG000|Overall Study|Withdrawal by Subject|2|||
143406008|NCT01105975|517036183|FG001|Overall Study|Withdrawal by Subject|2|||
143406009|NCT01105975|517036184|FG002|Overall Study|Withdrawal by Subject|2|||
143406010|NCT01105975|517036185|FG003|Overall Study|Withdrawal by Subject|0|||
143406011|NCT01105975|517036186|FG004|Overall Study|Withdrawal by Subject|4|||
143406012|NCT01105975|517036187|FG005|Overall Study|Withdrawal by Subject|1|||
143406013|NCT01105975|517036188|FG006|Overall Study|Withdrawal by Subject|2|||
143406014|NCT01105975|517036189|FG007|Overall Study|Withdrawal by Subject|1|||
143406015|NCT01105975|517036190|FG008|Overall Study|Withdrawal by Subject|0|||
143406016|NCT01105975|517036191|FG009|Overall Study|Withdrawal by Subject|3|||
143406017|NCT01105975|517036182|FG000|Overall Study|Lost to Follow-up|1|||
143406018|NCT01105975|517036183|FG001|Overall Study|Lost to Follow-up|0|||
143406019|NCT01105975|517036184|FG002|Overall Study|Lost to Follow-up|0|||
143406020|NCT01105975|517036185|FG003|Overall Study|Lost to Follow-up|1|||
143406021|NCT01105975|517036186|FG004|Overall Study|Lost to Follow-up|1|||
143406022|NCT01105975|517036187|FG005|Overall Study|Lost to Follow-up|0|||
143406023|NCT01105975|517036188|FG006|Overall Study|Lost to Follow-up|0|||
143406024|NCT01105975|517036189|FG007|Overall Study|Lost to Follow-up|0|||
143406025|NCT01105975|517036190|FG008|Overall Study|Lost to Follow-up|1|||
143406026|NCT01105975|517036191|FG009|Overall Study|Lost to Follow-up|0|||
143406027|NCT01105975|517036182|FG000|Overall Study|Physician Decision|0|||
143406028|NCT01105975|517036183|FG001|Overall Study|Physician Decision|0|||
143406029|NCT01105975|517036184|FG002|Overall Study|Physician Decision|0|||
143406030|NCT01105975|517036185|FG003|Overall Study|Physician Decision|0|||
143406031|NCT01105975|517036186|FG004|Overall Study|Physician Decision|0|||
143406032|NCT01105975|517036187|FG005|Overall Study|Physician Decision|0|||
143406033|NCT01105975|517036188|FG006|Overall Study|Physician Decision|2|||
143406034|NCT01105975|517036189|FG007|Overall Study|Physician Decision|0|||
143406035|NCT01105975|517036190|FG008|Overall Study|Physician Decision|0|||
143406036|NCT01105975|517036191|FG009|Overall Study|Physician Decision|0|||
143406037|NCT01105975|517036182|FG000|Overall Study|Protocol Violation|0|||
143406038|NCT01105975|517036183|FG001|Overall Study|Protocol Violation|2|||
143406039|NCT01105975|517036184|FG002|Overall Study|Protocol Violation|2|||
143406040|NCT01105975|517036185|FG003|Overall Study|Protocol Violation|0|||
143406041|NCT01105975|517036186|FG004|Overall Study|Protocol Violation|1|||
143406042|NCT01105975|517036187|FG005|Overall Study|Protocol Violation|1|||
143406043|NCT01105975|517036188|FG006|Overall Study|Protocol Violation|1|||
143406044|NCT01105975|517036189|FG007|Overall Study|Protocol Violation|1|||
143406045|NCT01105975|517036190|FG008|Overall Study|Protocol Violation|2|||
143406046|NCT01105975|517036191|FG009|Overall Study|Protocol Violation|2|||
143406047|NCT01105975|517036182|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
143406048|NCT01105975|517036183|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
143406049|NCT01105975|517036184|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
143406050|NCT01105975|517036185|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
143406051|NCT01105975|517036186|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
143406052|NCT01105975|517036187|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
143406053|NCT01105975|517036188|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
143406054|NCT01105975|517036189|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
143406055|NCT01105975|517036190|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
143406056|NCT01105975|517036191|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
143406057|NCT04868617|517036192|FG000|Overall Study|Death|1|||
143406058|NCT04868617|517036193|FG001|Overall Study|Death|0|||
143406059|NCT04868617|517036192|FG000|Overall Study|Adverse Event|1|||
143406060|NCT04868617|517036193|FG001|Overall Study|Adverse Event|0|||
143406061|NCT04868617|517036192|FG000|Overall Study|Withdrawal by Subject|1|||
143406062|NCT04868617|517036193|FG001|Overall Study|Withdrawal by Subject|0|||
143406063|NCT04868617|517036192|FG000|Overall Study|Device deficiency|1|||
143406064|NCT04868617|517036193|FG001|Overall Study|Device deficiency|0|||
143406065|NCT03183050|517036194|FG000|Overall Study|Lost to Follow-up|23|||
143406066|NCT02797132|517036195|FG000|Part A (15 Days)|Adverse Event|1|||
143406067|NCT02797132|517036195|FG000|Part B (24 Weeks)|Adverse Event|3|||
143406068|NCT00312208|517036198|FG000|Overall Study|Adverse Event|97|||
143406069|NCT00312208|517036199|FG001|Overall Study|Adverse Event|61|||
143406070|NCT00312208|517036198|FG000|Overall Study|Protocol Violation|5|||
143406071|NCT00312208|517036199|FG001|Overall Study|Protocol Violation|3|||
143406072|NCT00312208|517036198|FG000|Overall Study|Death|2|||
143406073|NCT00312208|517036199|FG001|Overall Study|Death|1|||
143406074|NCT00312208|517036198|FG000|Overall Study|Lack of Efficacy|7|||
143406075|NCT00312208|517036199|FG001|Overall Study|Lack of Efficacy|4|||
143406076|NCT00312208|517036198|FG000|Overall Study|Lost to Follow-up|3|||
143406077|NCT00312208|517036199|FG001|Overall Study|Lost to Follow-up|5|||
143406078|NCT00312208|517036198|FG000|Overall Study|Withdrawal by Subject|53|||
143406079|NCT00312208|517036199|FG001|Overall Study|Withdrawal by Subject|42|||
143406080|NCT00312208|517036198|FG000|Overall Study|Other|5|||
143406081|NCT00312208|517036199|FG001|Overall Study|Other|7|||
143406082|NCT02284113|517036200|FG000|Overall Study|Adverse Event|1|||
143406083|NCT02284113|517036201|FG001|Overall Study|Adverse Event|0|||
143406084|NCT02284113|517036200|FG000|Overall Study|non-compliance|0|||
143406085|NCT02284113|517036201|FG001|Overall Study|non-compliance|1|||
143406086|NCT02284113|517036200|FG000|Overall Study|Withdrawal by Subject|0|||
143406087|NCT02284113|517036201|FG001|Overall Study|Withdrawal by Subject|1|||
143406088|NCT02284113|517036200|FG000|Overall Study|not provided|0|||
143406089|NCT02284113|517036201|FG001|Overall Study|not provided|1|||
143406090|NCT02284113|517036200|FG000|Overall Study|surgery cancelled|2|||
143406091|NCT02284113|517036201|FG001|Overall Study|surgery cancelled|0|||
143406092|NCT04191824|517036202|FG000|Overall Study|Death|13|||
143406093|NCT04191824|517036203|FG001|Overall Study|Death|12|||
143406094|NCT04191824|517036202|FG000|Overall Study|Lost to Follow-up|456|||
143406095|NCT04191824|517036203|FG001|Overall Study|Lost to Follow-up|435|||
143406096|NCT04191824|517036202|FG000|Overall Study|Physician Decision|2|||
143406097|NCT04191824|517036203|FG001|Overall Study|Physician Decision|1|||
143406098|NCT04191824|517036202|FG000|Overall Study|Protocol Violation|0|||
143406099|NCT04191824|517036203|FG001|Overall Study|Protocol Violation|2|||
143406100|NCT04191824|517036202|FG000|Overall Study|Withdrawal by Subject|16|||
143406101|NCT04191824|517036203|FG001|Overall Study|Withdrawal by Subject|18|||
143406102|NCT04191824|517036202|FG000|Overall Study|Early site closure|24|||
143406103|NCT04191824|517036203|FG001|Overall Study|Early site closure|22|||
143406104|NCT01218009|517036204|FG000|Overall Study|Protocol Violation|2|||
143406105|NCT01218009|517036205|FG001|Overall Study|Protocol Violation|1|||
143406106|NCT01218009|517036204|FG000|Overall Study|Withdrawal by Subject|3|||
143406107|NCT01218009|517036205|FG001|Overall Study|Withdrawal by Subject|1|||
143406108|NCT01218009|517036204|FG000|Overall Study|Sponsor terminated study|161|||
143406109|NCT01218009|517036205|FG001|Overall Study|Sponsor terminated study|163|||
143406110|NCT01324310|517036206|FG000|Overall Study|Adverse Event|1|||
143406111|NCT01324310|517036206|FG000|Overall Study|Disease Progression|1|||
143406112|NCT03170882|517036207|FG000|Overall Study|Death|17|||
143406113|NCT03170882|517036208|FG001|Overall Study|Death|29|||
143406114|NCT03170882|517036207|FG000|Overall Study|Lost to Follow-up|0|||
143406115|NCT03170882|517036208|FG001|Overall Study|Lost to Follow-up|1|||
143406116|NCT03170882|517036207|FG000|Overall Study|Withdrawal by Subject|4|||
143406117|NCT03170882|517036208|FG001|Overall Study|Withdrawal by Subject|7|||
143406118|NCT03170882|517036207|FG000|Overall Study|Reason not Specified|28|||
143406119|NCT03170882|517036208|FG001|Overall Study|Reason not Specified|36|||
143406120|NCT05521516|517036211|FG000|Overall Study|Withdrawal by Subject|1|||
143406121|NCT05521516|517036212|FG001|Overall Study|Withdrawal by Subject|1|||
143406122|NCT04305327|517036213|FG000|Overall Study|Study early termination|2|||
143406123|NCT04305327|517036214|FG001|Overall Study|Study early termination|5|||
143406124|NCT04305327|517036215|FG002|Overall Study|Study early termination|2|||
143406125|NCT04305327|517036216|FG003|Overall Study|Study early termination|2|||
143406126|NCT04305327|517036213|FG000|Overall Study|Withdrawal by Subject|0|||
143406127|NCT04305327|517036214|FG001|Overall Study|Withdrawal by Subject|1|||
143406128|NCT04305327|517036215|FG002|Overall Study|Withdrawal by Subject|0|||
143406129|NCT04305327|517036216|FG003|Overall Study|Withdrawal by Subject|0|||
143406130|NCT03891758|517036217|FG000|Overall Study|Adverse Event|2|||
143406131|NCT03891758|517036218|FG001|Overall Study|Adverse Event|0|||
143406132|NCT03891758|517036217|FG000|Overall Study|Withdrawal by parent/guardian|0|||
143406133|NCT03891758|517036218|FG001|Overall Study|Withdrawal by parent/guardian|2|||
143406134|NCT00747565|517036219|FG000|Overall Study|Withdrawal by Subject|10|||
143406135|NCT00747565|517036220|FG001|Overall Study|Withdrawal by Subject|6|||
143406136|NCT00747565|517036219|FG000|Overall Study|Lost to Follow-up|4|||
143406137|NCT00747565|517036220|FG001|Overall Study|Lost to Follow-up|1|||
143406138|NCT01983683|517036221|FG000|Overall Study|Withdrawal by Subject|14|||
143406139|NCT01983683|517036222|FG001|Overall Study|Withdrawal by Subject|18|||
143406140|NCT01983683|517036221|FG000|Overall Study|Death|11|||
143406141|NCT01983683|517036222|FG001|Overall Study|Death|15|||
143406142|NCT01983683|517036221|FG000|Overall Study|Physician Decision|8|||
143406143|NCT01983683|517036222|FG001|Overall Study|Physician Decision|9|||
143406144|NCT01983683|517036221|FG000|Overall Study|Lost to Follow-up|4|||
143406145|NCT01983683|517036222|FG001|Overall Study|Lost to Follow-up|8|||
143406146|NCT01983683|517036221|FG000|Overall Study|Sponsor Decision|1|||
143406147|NCT01983683|517036222|FG001|Overall Study|Sponsor Decision|1|||
143406148|NCT00319020|517036230|FG000|Overall Study|Death|2|||
143406149|NCT00319020|517036231|FG001|Overall Study|Death|2|||
143406150|NCT00319020|517036230|FG000|Overall Study|Withdrawal by Subject|4|||
143406151|NCT00319020|517036231|FG001|Overall Study|Withdrawal by Subject|1|||
143406152|NCT00319020|517036230|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
143406153|NCT00319020|517036231|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
143406154|NCT00319020|517036230|FG000|Overall Study|Administrative reason|0|||
143406155|NCT00319020|517036231|FG001|Overall Study|Administrative reason|5|||
143406156|NCT00319020|517036230|FG000|Overall Study|Disease progression|0|||
143406157|NCT00319020|517036231|FG001|Overall Study|Disease progression|2|||
143406158|NCT00319020|517036230|FG000|Overall Study|Transplant|0|||
143406159|NCT00319020|517036231|FG001|Overall Study|Transplant|1|||
143406160|NCT00319020|517036230|FG000|Overall Study|Treatment failure|0|||
143406161|NCT00319020|517036231|FG001|Overall Study|Treatment failure|1|||
143406162|NCT00319020|517036230|FG000|Overall Study|Adverse Event|0|||
143406163|NCT00319020|517036231|FG001|Overall Study|Adverse Event|1|||
143406164|NCT00227266|517036232|FG000|Overall Study|Withdrawal by Subject|0|||
143406165|NCT00227266|517036233|FG001|Overall Study|Withdrawal by Subject|0|||
143406166|NCT00227266|517036234|FG002|Overall Study|Withdrawal by Subject|1|||
143406167|NCT00227266|517036232|FG000|Overall Study|Protocol Violation|1|||
143406168|NCT00227266|517036233|FG001|Overall Study|Protocol Violation|0|||
143406169|NCT00227266|517036234|FG002|Overall Study|Protocol Violation|1|||
143406170|NCT00227266|517036232|FG000|Overall Study|Excessive weight gain|0|||
143406171|NCT00227266|517036233|FG001|Overall Study|Excessive weight gain|0|||
143406172|NCT00227266|517036234|FG002|Overall Study|Excessive weight gain|2|||
143406173|NCT04926740|517036239|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
143406174|NCT04926740|517036240|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
143406175|NCT04926740|517036239|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
143406176|NCT04926740|517036240|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
143406177|NCT04980300|517036241|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
143406178|NCT04980300|517036242|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
143406179|NCT04980300|517036241|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
143406180|NCT04980300|517036242|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
143406181|NCT04980300|517036241|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
143406182|NCT04980300|517036242|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
143406183|NCT04980300|517036241|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
143406184|NCT04980300|517036242|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
143406185|NCT05864209|517036741|FG000|Overall Study|Lost to Follow-up|2|||
143406186|NCT05864209|517036742|FG001|Overall Study|Lost to Follow-up|3|||
143406187|NCT04530487|517036743|FG000|Overall Study|Death|1|||
143406188|NCT02422615|517036749|FG000|Treatment Period|Progressive disease|314|||
143406189|NCT02422615|517036750|FG001|Treatment Period|Progressive disease|200|||
143406190|NCT02422615|517036749|FG000|Treatment Period|Adverse Event|51|||
143406191|NCT02422615|517036750|FG001|Treatment Period|Adverse Event|9|||
143406192|NCT02422615|517036749|FG000|Treatment Period|Physician Decision|32|||
143406193|NCT02422615|517036750|FG001|Treatment Period|Physician Decision|8|||
143406194|NCT02422615|517036749|FG000|Treatment Period|Subject/guardian decision|38|||
143406195|NCT02422615|517036750|FG001|Treatment Period|Subject/guardian decision|8|||
143406196|NCT02422615|517036749|FG000|Treatment Period|Death|2|||
143406197|NCT02422615|517036750|FG001|Treatment Period|Death|1|||
143406198|NCT02422615|517036749|FG000|Treatment Period|Technical problems|0|||
143406199|NCT02422615|517036750|FG001|Treatment Period|Technical problems|1|||
143406200|NCT02422615|517036749|FG000|Treatment Period|Protocol deviation|1|||
143406201|NCT02422615|517036750|FG001|Treatment Period|Protocol deviation|1|||
143406202|NCT02422615|517036749|FG000|Treatment Period|Study terminated as per protocol|46|||
143406203|NCT02422615|517036750|FG001|Treatment Period|Study terminated as per protocol|14|||
143406204|NCT02422615|517036749|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
143406205|NCT02422615|517036750|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
143406206|NCT02422615|517036749|FG000|Post-treatment Efficacy Follow-up|Death|2|||
143406207|NCT02422615|517036750|FG001|Post-treatment Efficacy Follow-up|Death|1|||
143406208|NCT02422615|517036749|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
143406209|NCT02422615|517036750|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
143406210|NCT02422615|517036749|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
143406211|NCT02422615|517036750|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
143406212|NCT02422615|517036749|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
143406213|NCT02422615|517036750|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
143406214|NCT02422615|517036749|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
143406215|NCT02422615|517036750|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
143406216|NCT01574716|517036754|FG000|Part 1|Death|3|||
143406217|NCT01574716|517036755|FG001|Part 1|Death|1|||
143406218|NCT01574716|517036756|FG002|Part 1|Death|8|||
143406219|NCT01574716|517036757|FG003|Part 1|Death|0|||
143406220|NCT01574716|517036758|FG004|Part 1|Death|0|||
143406221|NCT01574716|517036754|FG000|Part 1|Discontinuation of study by sponsor|0|||
143406222|NCT01574716|517036755|FG001|Part 1|Discontinuation of study by sponsor|0|||
143406223|NCT01574716|517036756|FG002|Part 1|Discontinuation of study by sponsor|1|||
143406224|NCT01574716|517036757|FG003|Part 1|Discontinuation of study by sponsor|0|||
143406225|NCT01574716|517036758|FG004|Part 1|Discontinuation of study by sponsor|0|||
143406226|NCT01574716|517036754|FG000|Part 1|Withdrawal by Subject|0|||
143406227|NCT01574716|517036755|FG001|Part 1|Withdrawal by Subject|2|||
143406228|NCT01574716|517036756|FG002|Part 1|Withdrawal by Subject|0|||
143406229|NCT01574716|517036757|FG003|Part 1|Withdrawal by Subject|0|||
143406230|NCT01574716|517036758|FG004|Part 1|Withdrawal by Subject|0|||
143406231|NCT01574716|517036754|FG000|Part 1|Lost to Follow-up|0|||
143406232|NCT01574716|517036755|FG001|Part 1|Lost to Follow-up|1|||
143406233|NCT01574716|517036756|FG002|Part 1|Lost to Follow-up|0|||
143406234|NCT01574716|517036757|FG003|Part 1|Lost to Follow-up|0|||
143406235|NCT01574716|517036758|FG004|Part 1|Lost to Follow-up|0|||
143406236|NCT01574716|517036754|FG000|Part 2|Progressive disease|0|||
143406237|NCT01574716|517036755|FG001|Part 2|Progressive disease|0|||
143406238|NCT01574716|517036756|FG002|Part 2|Progressive disease|0|||
143406239|NCT01574716|517036757|FG003|Part 2|Progressive disease|1|||
143406240|NCT01574716|517036758|FG004|Part 2|Progressive disease|0|||
143406241|NCT01574716|517036754|FG000|Part 2|Death|0|||
143406242|NCT01574716|517036755|FG001|Part 2|Death|0|||
143406243|NCT01574716|517036756|FG002|Part 2|Death|0|||
143406244|NCT01574716|517036757|FG003|Part 2|Death|76|||
143406245|NCT01574716|517036758|FG004|Part 2|Death|35|||
143406246|NCT01574716|517036754|FG000|Part 2|Discontinuation of study by sponsor|0|||
143406247|NCT01574716|517036755|FG001|Part 2|Discontinuation of study by sponsor|0|||
143406248|NCT01574716|517036756|FG002|Part 2|Discontinuation of study by sponsor|0|||
143406249|NCT01574716|517036757|FG003|Part 2|Discontinuation of study by sponsor|51|||
143406250|NCT01574716|517036758|FG004|Part 2|Discontinuation of study by sponsor|31|||
143406251|NCT01574716|517036754|FG000|Part 2|Withdrawal by Subject|0|||
143406252|NCT01574716|517036755|FG001|Part 2|Withdrawal by Subject|0|||
143406253|NCT01574716|517036756|FG002|Part 2|Withdrawal by Subject|0|||
143406254|NCT01574716|517036757|FG003|Part 2|Withdrawal by Subject|5|||
143406255|NCT01574716|517036758|FG004|Part 2|Withdrawal by Subject|4|||
143406256|NCT01574716|517036754|FG000|Part 2|Brain metastases|0|||
143406257|NCT01574716|517036755|FG001|Part 2|Brain metastases|0|||
143406258|NCT01574716|517036756|FG002|Part 2|Brain metastases|0|||
143406259|NCT01574716|517036757|FG003|Part 2|Brain metastases|1|||
143406260|NCT01574716|517036758|FG004|Part 2|Brain metastases|0|||
143406261|NCT01574716|517036754|FG000|Part 2|Lost to Follow-up|0|||
143406262|NCT01574716|517036755|FG001|Part 2|Lost to Follow-up|0|||
143406263|NCT01574716|517036756|FG002|Part 2|Lost to Follow-up|0|||
143406264|NCT01574716|517036757|FG003|Part 2|Lost to Follow-up|3|||
143406265|NCT01574716|517036758|FG004|Part 2|Lost to Follow-up|0|||
143406266|NCT02438137|517036759|FG000|Overall Study|Lost to Follow-up|3|||
143406267|NCT02438137|517036760|FG001|Overall Study|Lost to Follow-up|2|||
143406268|NCT02438137|517036759|FG000|Overall Study|Adverse Event|1|||
143406269|NCT02438137|517036760|FG001|Overall Study|Adverse Event|0|||
143406270|NCT02438137|517036759|FG000|Overall Study|Withdrawal by Subject|4|||
143406271|NCT02438137|517036760|FG001|Overall Study|Withdrawal by Subject|3|||
143406272|NCT02438137|517036759|FG000|Overall Study|Physician Decision|0|||
143406273|NCT02438137|517036760|FG001|Overall Study|Physician Decision|1|||
143406274|NCT01371994|517036764|FG000|Overall Study|Adverse Event|3|||
143406275|NCT01371994|517036765|FG001|Overall Study|Adverse Event|6|||
143406276|NCT01371994|517036764|FG000|Overall Study|Lack of Efficacy|3|||
143406277|NCT01371994|517036765|FG001|Overall Study|Lack of Efficacy|0|||
143406278|NCT01371994|517036764|FG000|Overall Study|Withdrawal by Subject|13|||
143406279|NCT01371994|517036765|FG001|Overall Study|Withdrawal by Subject|7|||
143406280|NCT01371994|517036764|FG000|Overall Study|Lost to Follow-up|1|||
143406281|NCT01371994|517036765|FG001|Overall Study|Lost to Follow-up|1|||
143406282|NCT01371994|517036764|FG000|Overall Study|Protocol Violation|24|||
143406283|NCT01371994|517036765|FG001|Overall Study|Protocol Violation|17|||
143406284|NCT01371994|517036764|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
143406285|NCT01371994|517036765|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
143406286|NCT01371994|517036764|FG000|Overall Study|Physician Decision|1|||
143406287|NCT01371994|517036765|FG001|Overall Study|Physician Decision|1|||
143406288|NCT01371994|517036764|FG000|Overall Study|Miscellaneous Reasons|6|||
143406289|NCT01371994|517036765|FG001|Overall Study|Miscellaneous Reasons|4|||
143406290|NCT05018143|517036766|FG000|Overall Study|Lost to Follow-up|5|||
143406291|NCT05018143|517036767|FG001|Overall Study|Lost to Follow-up|4|||
143406292|NCT05018143|517036766|FG000|Overall Study|Withdrawal by Subject|0|||
143406293|NCT05018143|517036767|FG001|Overall Study|Withdrawal by Subject|1|||
143406294|NCT05601882|517036768|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
143406295|NCT05601882|517036769|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
143406296|NCT05601882|517036770|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
143406297|NCT05601882|517036771|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
143406298|NCT05601882|517036768|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
143406299|NCT05601882|517036769|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
143406300|NCT05601882|517036770|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
143406301|NCT05601882|517036771|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
143406302|NCT05601882|517036768|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
143406303|NCT05601882|517036769|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
143406304|NCT05601882|517036770|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
143406305|NCT05601882|517036771|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
143406306|NCT05601882|517036768|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
143406307|NCT05601882|517036769|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
143406308|NCT05601882|517036770|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
143406309|NCT05601882|517036771|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
143406310|NCT05601882|517036768|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
143406311|NCT05601882|517036769|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
143406312|NCT05601882|517036770|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
143406313|NCT05601882|517036771|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
143406314|NCT05601882|517036768|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
143406315|NCT05601882|517036769|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
143406316|NCT05601882|517036770|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
143406317|NCT05601882|517036771|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
143406318|NCT03222609|517036772|FG000|Overall Study|Withdrew consent|2|||
143406319|NCT03222609|517036773|FG001|Overall Study|Withdrew consent|3|||
143406320|NCT03222609|517036774|FG002|Overall Study|Withdrew consent|4|||
143406321|NCT03222609|517036775|FG003|Overall Study|Withdrew consent|2|||
143406322|NCT03222609|517036772|FG000|Overall Study|Lost to Follow-up|1|||
143406323|NCT03222609|517036773|FG001|Overall Study|Lost to Follow-up|0|||
143406324|NCT03222609|517036774|FG002|Overall Study|Lost to Follow-up|0|||
143406325|NCT03222609|517036775|FG003|Overall Study|Lost to Follow-up|0|||
143406326|NCT03222609|517036772|FG000|Overall Study|Death|16|||
143406327|NCT03222609|517036773|FG001|Overall Study|Death|13|||
143406328|NCT03222609|517036774|FG002|Overall Study|Death|9|||
143406329|NCT03222609|517036775|FG003|Overall Study|Death|6|||
143406330|NCT03222609|517036772|FG000|Overall Study|Remains on treatment or in study follow-up|15|||
143406331|NCT03222609|517036773|FG001|Overall Study|Remains on treatment or in study follow-up|75|||
143406332|NCT03222609|517036774|FG002|Overall Study|Remains on treatment or in study follow-up|21|||
143406333|NCT03222609|517036775|FG003|Overall Study|Remains on treatment or in study follow-up|24|||
143406334|NCT03777657|517036779|FG000|Overall Study|Death|397|||
143406335|NCT03777657|517036780|FG001|Overall Study|Death|431|||
143406336|NCT03777657|517036779|FG000|Overall Study|Study Closed by Sponsor|77|||
143406337|NCT03777657|517036780|FG001|Overall Study|Study Closed by Sponsor|38|||
143406338|NCT03777657|517036779|FG000|Overall Study|Withdrawal by Subject|20|||
143406339|NCT03777657|517036780|FG001|Overall Study|Withdrawal by Subject|17|||
143406340|NCT03777657|517036779|FG000|Overall Study|Lost to Follow-up|6|||
143406341|NCT03777657|517036780|FG001|Overall Study|Lost to Follow-up|10|||
143406342|NCT00545545|517036781|FG000|Overall Study|Progressive Neoplastic Disease|1|||
143406343|NCT00545545|517036782|FG001|Overall Study|Progressive Neoplastic Disease|5|||
143406344|NCT00545545|517036783|FG002|Overall Study|Progressive Neoplastic Disease|0|||
143406345|NCT00545545|517036784|FG003|Overall Study|Progressive Neoplastic Disease|4|||
143406346|NCT00545545|517036785|FG004|Overall Study|Progressive Neoplastic Disease|8|||
143406347|NCT00545545|517036786|FG005|Overall Study|Progressive Neoplastic Disease|7|||
143406348|NCT00545545|517036781|FG000|Overall Study|Withdrawal by Subject|0|||
143406349|NCT00545545|517036782|FG001|Overall Study|Withdrawal by Subject|1|||
143406350|NCT00545545|517036783|FG002|Overall Study|Withdrawal by Subject|0|||
143406351|NCT00545545|517036784|FG003|Overall Study|Withdrawal by Subject|0|||
143406352|NCT00545545|517036785|FG004|Overall Study|Withdrawal by Subject|0|||
143406353|NCT00545545|517036786|FG005|Overall Study|Withdrawal by Subject|0|||
143406354|NCT00545545|517036781|FG000|Overall Study|Physician Decision|1|||
143406355|NCT00545545|517036782|FG001|Overall Study|Physician Decision|0|||
143406356|NCT00545545|517036783|FG002|Overall Study|Physician Decision|0|||
143406357|NCT00545545|517036784|FG003|Overall Study|Physician Decision|0|||
143406358|NCT00545545|517036785|FG004|Overall Study|Physician Decision|0|||
143406359|NCT00545545|517036786|FG005|Overall Study|Physician Decision|1|||
143406360|NCT00545545|517036781|FG000|Overall Study|Irinotecan intolerance|1|||
143406361|NCT00545545|517036782|FG001|Overall Study|Irinotecan intolerance|1|||
143406362|NCT00545545|517036783|FG002|Overall Study|Irinotecan intolerance|0|||
143406363|NCT00545545|517036784|FG003|Overall Study|Irinotecan intolerance|0|||
143406364|NCT00545545|517036785|FG004|Overall Study|Irinotecan intolerance|0|||
143406365|NCT00545545|517036786|FG005|Overall Study|Irinotecan intolerance|0|||
143406366|NCT00545545|517036781|FG000|Overall Study|No target lesions to track post surgery|0|||
143406367|NCT00545545|517036782|FG001|Overall Study|No target lesions to track post surgery|0|||
143406368|NCT00545545|517036783|FG002|Overall Study|No target lesions to track post surgery|0|||
143406369|NCT00545545|517036784|FG003|Overall Study|No target lesions to track post surgery|0|||
143406370|NCT00545545|517036785|FG004|Overall Study|No target lesions to track post surgery|1|||
143406371|NCT00545545|517036786|FG005|Overall Study|No target lesions to track post surgery|1|||
143406372|NCT03691493|517036787|FG000|Overall Study|Withdrawal by Subject|1|||
143406373|NCT03876457|517037984|FG000|Overall Study|Lost to Follow-up|1|||
143406374|NCT03876457|517037985|FG001|Overall Study|Lost to Follow-up|3|||
143406375|NCT01036724|517037986|FG000|Overall Study|Adverse Event|1|||
143406376|NCT01036724|517037987|FG001|Overall Study|Adverse Event|2|||
143406377|NCT01036724|517037986|FG000|Overall Study|Lack of Efficacy|1|||
143406378|NCT01036724|517037987|FG001|Overall Study|Lack of Efficacy|1|||
143406379|NCT01036724|517037986|FG000|Overall Study|Protocol Violation|4|||
143406380|NCT01036724|517037987|FG001|Overall Study|Protocol Violation|5|||
143406381|NCT00945321|517037990|FG000|Period 1|Adverse Event|0|||
143406382|NCT00945321|517037991|FG001|Period 1|Adverse Event|0|||
143406383|NCT00945321|517037992|FG002|Period 1|Adverse Event|0|||
143406384|NCT00945321|517037993|FG003|Period 1|Adverse Event|0|||
143406385|NCT00945321|517037994|FG004|Period 1|Adverse Event|1|||
143406386|NCT00945321|517037995|FG005|Period 1|Adverse Event|0|||
143406387|NCT00945321|517037990|FG000|Period 4|Lost to Follow-up|0|||
143406388|NCT00945321|517037991|FG001|Period 4|Lost to Follow-up|0|||
143406389|NCT00945321|517037992|FG002|Period 4|Lost to Follow-up|0|||
143406390|NCT00945321|517037993|FG003|Period 4|Lost to Follow-up|0|||
143406391|NCT00945321|517037994|FG004|Period 4|Lost to Follow-up|0|||
143406392|NCT00945321|517037995|FG005|Period 4|Lost to Follow-up|1|||
143406393|NCT00692913|517037996|FG000|Overall Study|Adverse Event|8|||
143406394|NCT00692913|517037997|FG001|Overall Study|Adverse Event|4|||
143406395|NCT00692913|517037996|FG000|Overall Study|Lost to Follow-up|3|||
143406396|NCT00692913|517037997|FG001|Overall Study|Lost to Follow-up|5|||
143406397|NCT00692913|517037996|FG000|Overall Study|Physician Decision|2|||
143406398|NCT00692913|517037997|FG001|Overall Study|Physician Decision|0|||
143406399|NCT00692913|517037996|FG000|Overall Study|Protocol Violation|1|||
143406400|NCT00692913|517037997|FG001|Overall Study|Protocol Violation|1|||
143406401|NCT00692913|517037996|FG000|Overall Study|Withdrawal by Subject|15|||
143406402|NCT00692913|517037997|FG001|Overall Study|Withdrawal by Subject|20|||
143406403|NCT04017611|517037998|FG000|Overall Study|Withdrawn prior to completion|1|||
143406404|NCT02291913|517038007|FG000|Overall Study|Progressive Disease|32|||
143406405|NCT02291913|517038007|FG000|Overall Study|Adverse Event|11|||
143406406|NCT02291913|517038007|FG000|Overall Study|Death|2|||
143406407|NCT02291913|517038007|FG000|Overall Study|Physician Decision|1|||
143406408|NCT02291913|517038007|FG000|Overall Study|Withdrawal by Subject|1|||
143406409|NCT02291913|517038007|FG000|Overall Study|Protocol Violation|1|||
143406410|NCT01637402|517038008|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
143406411|NCT01637402|517038009|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
143406412|NCT01637402|517038008|FG000|Standard Dose Regimen|Adverse Event|1|||
143406413|NCT01637402|517038009|FG001|Standard Dose Regimen|Adverse Event|0|||
143406414|NCT01637402|517038008|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
143406415|NCT01637402|517038009|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
143406416|NCT01637402|517038008|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
143406417|NCT01637402|517038009|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
143406418|NCT01637402|517038008|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
143406419|NCT01637402|517038009|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
143406420|NCT01637402|517038008|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
143406421|NCT01637402|517038009|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
143406422|NCT04876417|517038012|FG000|Overall Study|Lost to Follow-up|5|||
143406423|NCT04876417|517038013|FG001|Overall Study|Lost to Follow-up|8|||
143406424|NCT04876417|517038014|FG002|Overall Study|Lost to Follow-up|0|||
143406425|NCT04876417|517038015|FG003|Overall Study|Lost to Follow-up|0|||
143406426|NCT03801148|517038016|FG000|Period 1 (2 Days)|Adverse Event|1|||
143406427|NCT03801148|517038017|FG001|Period 1 (2 Days)|Adverse Event|1|||
143406428|NCT03801148|517038018|FG002|Period 1 (2 Days)|Adverse Event|0|||
143406429|NCT03801148|517038019|FG003|Period 1 (2 Days)|Adverse Event|0|||
143406430|NCT03801148|517038016|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
143406431|NCT03801148|517038017|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
143406432|NCT03801148|517038018|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
143406433|NCT03801148|517038019|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
143406434|NCT03801148|517038016|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
143406435|NCT03801148|517038017|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
143406436|NCT03801148|517038018|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
143406437|NCT03801148|517038019|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
143406438|NCT03801148|517038016|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
143406439|NCT03801148|517038017|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
143406440|NCT03801148|517038018|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
143406441|NCT03801148|517038019|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
143406442|NCT01128595|517038026|FG000|Treatment Period 3|Withdrawal by Subject|0|||
143406443|NCT01128595|517038027|FG001|Treatment Period 3|Withdrawal by Subject|1|||
143406444|NCT01128595|517038028|FG002|Treatment Period 3|Withdrawal by Subject|0|||
143406445|NCT01128595|517038029|FG003|Treatment Period 3|Withdrawal by Subject|0|||
143406446|NCT00605306|517038030|FG000|Overall Study|Adverse Event|0|||
143406447|NCT00605306|517038031|FG001|Overall Study|Adverse Event|1|||
143406448|NCT00724126|517038033|FG000|Overall Study|Adverse Event|2|||
143406449|NCT00724126|517038034|FG001|Overall Study|Adverse Event|0|||
143406450|NCT00724126|517038033|FG000|Overall Study|Withdrawal by Subject|8|||
143406451|NCT00724126|517038034|FG001|Overall Study|Withdrawal by Subject|6|||
143406452|NCT00724126|517038033|FG000|Overall Study|Lost to Follow-up|6|||
143406453|NCT00724126|517038034|FG001|Overall Study|Lost to Follow-up|6|||
143406454|NCT00724126|517038033|FG000|Overall Study|Noncompliance|2|||
143406455|NCT00724126|517038034|FG001|Overall Study|Noncompliance|1|||
143406456|NCT00724126|517038033|FG000|Overall Study|Subject randomized although ineligible|1|||
143406457|NCT00724126|517038034|FG001|Overall Study|Subject randomized although ineligible|1|||
143406458|NCT00724126|517038033|FG000|Overall Study|Subject had to leave vicinity of site|0|||
143406459|NCT00724126|517038034|FG001|Overall Study|Subject had to leave vicinity of site|1|||
143406460|NCT00739934|517038035|FG000|Voriconazole IV|Adverse Event|6|||
143406461|NCT00739934|517038035|FG000|Voriconazole Oral|Other|3|||
143406462|NCT02502526|517038036|FG000|Overall Study|Lost to Follow-up|2|||
143406463|NCT02502526|517038037|FG001|Overall Study|Lost to Follow-up|2|||
143406464|NCT02502526|517038038|FG002|Overall Study|Lost to Follow-up|3|||
143406465|NCT02502526|517038036|FG000|Overall Study|Withdrawal by Subject|0|||
143406466|NCT02502526|517038037|FG001|Overall Study|Withdrawal by Subject|1|||
143406467|NCT02502526|517038038|FG002|Overall Study|Withdrawal by Subject|1|||
143406468|NCT02502526|517038036|FG000|Overall Study|Disqualified due to cataract grading|0|||
143406469|NCT02502526|517038037|FG001|Overall Study|Disqualified due to cataract grading|0|||
143406470|NCT02502526|517038038|FG002|Overall Study|Disqualified due to cataract grading|1|||
143406471|NCT02502526|517038036|FG000|Overall Study|Enrollment suspension|4|||
143406472|NCT02502526|517038037|FG001|Overall Study|Enrollment suspension|1|||
143406473|NCT02502526|517038038|FG002|Overall Study|Enrollment suspension|1|||
143406474|NCT01342367|517038039|FG000|Overall Study|Death|1|||
143406475|NCT01342367|517038040|FG001|Overall Study|Death|0|||
143406476|NCT01342367|517038039|FG000|Overall Study|Withdrawal by Subject|1|||
143406477|NCT01342367|517038040|FG001|Overall Study|Withdrawal by Subject|2|||
143406478|NCT02964741|517038041|FG000|Overall Study|Protocol Violation|1|||
143406479|NCT02964741|517038042|FG001|Overall Study|Protocol Violation|0|||
143406480|NCT02964741|517038043|FG002|Overall Study|Protocol Violation|0|||
143406481|NCT02964741|517038041|FG000|Overall Study|Withdrawal by Subject|0|||
143406482|NCT02964741|517038042|FG001|Overall Study|Withdrawal by Subject|1|||
143406483|NCT02964741|517038043|FG002|Overall Study|Withdrawal by Subject|0|||
143406484|NCT02964741|517038041|FG000|Overall Study|claustrophobia|1|||
143406485|NCT02964741|517038042|FG001|Overall Study|claustrophobia|0|||
143406486|NCT02964741|517038043|FG002|Overall Study|claustrophobia|0|||
143406487|NCT01074294|517038047|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
143406488|NCT01074294|517038048|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
143406489|NCT01074294|517038049|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
143406490|NCT01074294|517038050|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
143406491|NCT01074294|517038047|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
143406492|NCT01074294|517038048|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
143406493|NCT01074294|517038049|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
143406494|NCT01074294|517038050|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
143406495|NCT01074294|517038047|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
143406496|NCT01074294|517038048|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
143406497|NCT01074294|517038049|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
143406498|NCT01074294|517038050|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
143406499|NCT01074294|517038047|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
143406500|NCT01074294|517038048|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
143406501|NCT01074294|517038049|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
143406502|NCT01074294|517038050|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
143406503|NCT01074294|517038047|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
143406504|NCT01074294|517038048|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
143406505|NCT01074294|517038049|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
143406506|NCT01074294|517038050|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
143406507|NCT01074294|517038047|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
143406508|NCT01074294|517038048|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
143406509|NCT01074294|517038049|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
143406510|NCT01074294|517038050|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
143406511|NCT01074294|517038047|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
143406512|NCT01074294|517038048|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
143406513|NCT01074294|517038049|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
143406514|NCT01074294|517038050|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
143406515|NCT01074294|517038047|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
143406516|NCT01074294|517038048|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
143406517|NCT01074294|517038049|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
143406518|NCT01074294|517038050|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
143406519|NCT01074294|517038047|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
143406520|NCT01074294|517038048|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
143406521|NCT01074294|517038049|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
143406522|NCT01074294|517038050|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
143406523|NCT01074294|517038047|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
143406524|NCT01074294|517038048|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
143406525|NCT01074294|517038049|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
143454165|NCT01865747|517206888|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
143454166|NCT01865747|517206889|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
143454167|NCT01865747|517206888|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
143454168|NCT01865747|517206889|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
143454169|NCT01865747|517206888|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
143454170|NCT01865747|517206889|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
143454171|NCT01865747|517206888|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
143406526|NCT01074294|517038050|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
143406527|NCT01074294|517038047|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
143406528|NCT01074294|517038048|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
143406529|NCT01074294|517038049|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
143406530|NCT01074294|517038050|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
143406531|NCT01074294|517038047|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
143406532|NCT01074294|517038048|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
143406533|NCT01074294|517038049|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
143406534|NCT01074294|517038050|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
143406535|NCT01074294|517038047|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
143406536|NCT01074294|517038048|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
143406537|NCT01074294|517038049|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
143406538|NCT01074294|517038050|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
143406539|NCT00640159|517038051|FG000|Overall Study|Lost to Follow-up|2|||
143406540|NCT00112359|517038052|FG000|Overall Study|Unrelated adverse event|16|||
143406541|NCT00112359|517038053|FG001|Overall Study|Unrelated adverse event|8|||
143406542|NCT00112359|517038052|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
143406543|NCT00112359|517038053|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
143406544|NCT00112359|517038052|FG000|Overall Study|Related adverse event|5|||
143406545|NCT00112359|517038053|FG001|Overall Study|Related adverse event|3|||
143406546|NCT00112359|517038052|FG000|Overall Study|Lost to Follow-up|0|||
143406547|NCT00112359|517038053|FG001|Overall Study|Lost to Follow-up|1|||
143406548|NCT00112359|517038052|FG000|Overall Study|Personal/administrative|1|||
143406549|NCT00112359|517038053|FG001|Overall Study|Personal/administrative|1|||
143406550|NCT00112359|517038052|FG000|Overall Study|Other|3|||
143406551|NCT00112359|517038053|FG001|Overall Study|Other|0|||
143406552|NCT00623194|517038054|FG000|Overall Study|Lack of Efficacy|1|||
143406553|NCT00623194|517038054|FG000|Overall Study|Protocol Violation|3|||
143406554|NCT00623194|517038054|FG000|Overall Study|Unclassified|1|||
143406555|NCT01952366|517038055|FG000|Overall Study|Death|22|||
143406556|NCT01952366|517038055|FG000|Overall Study|Withdrawal by Subject|9|||
143406557|NCT04860505|517038056|FG000|Overall Study|Lost to Follow-up|2|||
143406558|NCT00857766|517038057|FG000|Overall Study|Adverse Event|13|||
143406559|NCT00857766|517038058|FG001|Overall Study|Adverse Event|12|||
143406560|NCT00857766|517038057|FG000|Overall Study|Protocol Violation|11|||
143406561|NCT00857766|517038058|FG001|Overall Study|Protocol Violation|11|||
143406562|NCT00857766|517038057|FG000|Overall Study|Lost to Follow-up|1|||
143406563|NCT00857766|517038058|FG001|Overall Study|Lost to Follow-up|0|||
143406564|NCT00857766|517038057|FG000|Overall Study|Investigator Discretion|2|||
143406565|NCT00857766|517038058|FG001|Overall Study|Investigator Discretion|3|||
143406566|NCT00857766|517038057|FG000|Overall Study|Participant Withdrew Consent|4|||
143406567|NCT00857766|517038058|FG001|Overall Study|Participant Withdrew Consent|4|||
143406568|NCT01988402|517038059|FG000|Overall Study|Adverse Event|1|||
143406569|NCT01988402|517038060|FG001|Overall Study|Adverse Event|2|||
143406570|NCT01988402|517038059|FG000|Overall Study|Withdrawal by Subject|1|||
143406571|NCT01988402|517038060|FG001|Overall Study|Withdrawal by Subject|0|||
143406572|NCT01961609|517038061|FG000|Initiation|Missing|3|||
143406573|NCT01961609|517038062|FG001|Initiation|Missing|2|||
143406574|NCT01961609|517038063|FG002|Initiation|Missing|0|||
143406575|NCT01961609|517038064|FG003|Initiation|Missing|0|||
143406576|NCT01961609|517038061|FG000|Initiation|Protocol deviation|1|||
143406577|NCT01961609|517038062|FG001|Initiation|Protocol deviation|0|||
143406578|NCT01961609|517038063|FG002|Initiation|Protocol deviation|0|||
143406579|NCT01961609|517038064|FG003|Initiation|Protocol deviation|0|||
143406580|NCT01961609|517038061|FG000|Initiation|Death|0|||
143406581|NCT01961609|517038062|FG001|Initiation|Death|1|||
143406582|NCT01961609|517038063|FG002|Initiation|Death|0|||
143406583|NCT01961609|517038064|FG003|Initiation|Death|0|||
143406584|NCT01961609|517038061|FG000|Initiation|Administrative problems|1|||
143406585|NCT01961609|517038062|FG001|Initiation|Administrative problems|0|||
143406586|NCT01961609|517038063|FG002|Initiation|Administrative problems|0|||
143406587|NCT01961609|517038064|FG003|Initiation|Administrative problems|0|||
143406588|NCT01961609|517038061|FG000|Initiation|Withdrawal by Subject|1|||
143406589|NCT01961609|517038062|FG001|Initiation|Withdrawal by Subject|2|||
143406590|NCT01961609|517038063|FG002|Initiation|Withdrawal by Subject|0|||
143406591|NCT01961609|517038064|FG003|Initiation|Withdrawal by Subject|0|||
143406592|NCT01961609|517038061|FG000|Initiation|Lack of Efficacy|2|||
143406593|NCT01961609|517038062|FG001|Initiation|Lack of Efficacy|1|||
143406594|NCT01961609|517038063|FG002|Initiation|Lack of Efficacy|0|||
143406595|NCT01961609|517038064|FG003|Initiation|Lack of Efficacy|0|||
143406596|NCT01961609|517038061|FG000|Initiation|Abnormal lab values|0|||
143406597|NCT01961609|517038062|FG001|Initiation|Abnormal lab values|1|||
143406598|NCT01961609|517038063|FG002|Initiation|Abnormal lab values|0|||
143406599|NCT01961609|517038064|FG003|Initiation|Abnormal lab values|0|||
143406600|NCT01961609|517038061|FG000|Initiation|Adverse Event|3|||
143406601|NCT01961609|517038062|FG001|Initiation|Adverse Event|5|||
143406602|NCT01961609|517038063|FG002|Initiation|Adverse Event|0|||
143406603|NCT01961609|517038064|FG003|Initiation|Adverse Event|0|||
143406604|NCT01961609|517038061|FG000|Initiation|Randomized but not treated|1|||
143406605|NCT01961609|517038062|FG001|Initiation|Randomized but not treated|1|||
143406606|NCT01961609|517038063|FG002|Initiation|Randomized but not treated|0|||
143406607|NCT01961609|517038064|FG003|Initiation|Randomized but not treated|0|||
143406608|NCT01961609|517038061|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
143406609|NCT01961609|517038062|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
143406610|NCT01961609|517038063|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
143406611|NCT01961609|517038064|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
143406612|NCT01961609|517038061|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
143406613|NCT01961609|517038062|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
143406614|NCT01961609|517038063|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
143406615|NCT01961609|517038064|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
143406616|NCT01961609|517038061|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
143406617|NCT01961609|517038062|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
143406618|NCT01961609|517038063|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
143406619|NCT01961609|517038064|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
143406620|NCT01961609|517038061|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
143406621|NCT01961609|517038062|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
143406622|NCT01961609|517038063|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
143406623|NCT01961609|517038064|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
143406624|NCT01961609|517038061|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
143406625|NCT01961609|517038062|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
143406626|NCT01961609|517038063|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
143406627|NCT01961609|517038064|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
143406628|NCT01961609|517038061|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
143406629|NCT01961609|517038062|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
143406630|NCT01961609|517038063|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
143406631|NCT01961609|517038064|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
143406632|NCT01961609|517038061|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
143406633|NCT01961609|517038062|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
143406634|NCT01961609|517038063|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
143406635|NCT01961609|517038064|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
143406636|NCT01961609|517038061|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
143406637|NCT01961609|517038062|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
143406638|NCT01961609|517038063|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
143406639|NCT01961609|517038064|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
143406640|NCT01961609|517038061|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
143406641|NCT01961609|517038062|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
143406642|NCT01961609|517038063|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
143406643|NCT01961609|517038064|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
143406644|NCT01961609|517038061|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
143406645|NCT01961609|517038062|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
143406646|NCT01961609|517038063|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
143406647|NCT01961609|517038064|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
143406648|NCT01961609|517038061|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
143406649|NCT01961609|517038062|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
143406650|NCT01961609|517038063|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
143406651|NCT01961609|517038064|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
143406652|NCT01961609|517038061|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
143406653|NCT01961609|517038062|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
143406654|NCT01961609|517038063|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
143406655|NCT01961609|517038064|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
143406656|NCT03885232|517038087|FG000|Overall Study|Lost to Follow-up|74|||
143406657|NCT03885232|517038088|FG001|Overall Study|Lost to Follow-up|32|||
143406658|NCT03885232|517038087|FG000|Overall Study|Staff turnover at enrolled clinics|32|||
143406659|NCT03885232|517038088|FG001|Overall Study|Staff turnover at enrolled clinics|23|||
143406660|NCT03840902|517038089|FG000|Overall Study|Randomized but not treated|1|||
143406661|NCT03840902|517038090|FG001|Overall Study|Randomized but not treated|1|||
143406662|NCT03834740|517038091|FG000|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
143406663|NCT03834740|517038092|FG001|Ribo 600mg QD+Eve 70mg Once|Physician Decision|1|||
143406664|NCT03834740|517038093|FG002|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
143406665|NCT01208974|517038094|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
143406666|NCT01208974|517038095|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
143406667|NCT01208974|517038096|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
143406668|NCT01208974|517038097|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
143406669|NCT01208974|517038094|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
143406670|NCT01208974|517038095|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
143406671|NCT01208974|517038096|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
143406672|NCT01208974|517038097|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
143406673|NCT01208974|517038094|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
143406674|NCT01208974|517038095|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
143406675|NCT01208974|517038096|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
143406676|NCT01208974|517038097|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
143406677|NCT03593226|517038098|FG000|Overall Study|Disease progression|6|||
143406678|NCT03593226|517038099|FG001|Overall Study|Disease progression|13|||
143406679|NCT03593226|517038100|FG002|Overall Study|Disease progression|5|||
143406680|NCT03593226|517038101|FG003|Overall Study|Disease progression|6|||
143406681|NCT03593226|517038098|FG000|Overall Study|Adverse Event|0|||
143406682|NCT03593226|517038099|FG001|Overall Study|Adverse Event|1|||
143406683|NCT03593226|517038100|FG002|Overall Study|Adverse Event|0|||
143406684|NCT03593226|517038101|FG003|Overall Study|Adverse Event|0|||
143406685|NCT03593226|517038098|FG000|Overall Study|Withdrawal by Subject|0|||
143406686|NCT03593226|517038099|FG001|Overall Study|Withdrawal by Subject|4|||
143406687|NCT03593226|517038100|FG002|Overall Study|Withdrawal by Subject|1|||
143406688|NCT03593226|517038101|FG003|Overall Study|Withdrawal by Subject|0|||
143406689|NCT03593226|517038098|FG000|Overall Study|Physician Decision|0|||
143406690|NCT03593226|517038099|FG001|Overall Study|Physician Decision|1|||
143406691|NCT03593226|517038100|FG002|Overall Study|Physician Decision|0|||
143406692|NCT03593226|517038101|FG003|Overall Study|Physician Decision|0|||
143406693|NCT03593226|517038098|FG000|Overall Study|Clinical disease progression|0|||
143406694|NCT03593226|517038099|FG001|Overall Study|Clinical disease progression|0|||
143406695|NCT03593226|517038100|FG002|Overall Study|Clinical disease progression|1|||
143406696|NCT03593226|517038101|FG003|Overall Study|Clinical disease progression|0|||
143406697|NCT06191679|517038102|FG000|Baseline|Lost to Follow-up|1|||
143406698|NCT06191679|517038103|FG001|Baseline|Lost to Follow-up|0|||
143406699|NCT06191679|517038104|FG002|Baseline|Lost to Follow-up|1|||
143406700|NCT06191679|517038105|FG003|Baseline|Lost to Follow-up|0|||
143406701|NCT06191679|517038102|FG000|Allocation to Group|Withdrawal by Subject|0|||
143406702|NCT06191679|517038103|FG001|Allocation to Group|Withdrawal by Subject|1|||
143406703|NCT06191679|517038104|FG002|Allocation to Group|Withdrawal by Subject|2|||
143406704|NCT06191679|517038105|FG003|Allocation to Group|Withdrawal by Subject|0|||
143406705|NCT06191679|517038102|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
143406706|NCT06191679|517038103|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
143406707|NCT06191679|517038104|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
143406708|NCT06191679|517038105|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
143406709|NCT06191679|517038102|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
143406710|NCT06191679|517038103|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
143406711|NCT06191679|517038104|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
143406712|NCT06191679|517038105|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
143406713|NCT06191679|517038102|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
143406714|NCT06191679|517038103|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
143406715|NCT06191679|517038104|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
143406716|NCT06191679|517038105|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
143406717|NCT03211247|517038106|FG000|Overall Study|Adverse Event|8|||
143406718|NCT03211247|517038107|FG001|Overall Study|Adverse Event|0|||
143406719|NCT03211247|517038108|FG002|Overall Study|Adverse Event|1|||
143406720|NCT03211247|517038109|FG003|Overall Study|Adverse Event|0|||
143406721|NCT03211247|517038110|FG004|Overall Study|Adverse Event|0|||
143406722|NCT03211247|517038106|FG000|Overall Study|Lost to Follow-up|2|||
143406723|NCT03211247|517038107|FG001|Overall Study|Lost to Follow-up|1|||
143406724|NCT03211247|517038108|FG002|Overall Study|Lost to Follow-up|0|||
143406725|NCT03211247|517038109|FG003|Overall Study|Lost to Follow-up|0|||
143406726|NCT03211247|517038110|FG004|Overall Study|Lost to Follow-up|0|||
143406727|NCT03211247|517038106|FG000|Overall Study|Physician Decision|1|||
143406728|NCT03211247|517038107|FG001|Overall Study|Physician Decision|2|||
143406729|NCT03211247|517038108|FG002|Overall Study|Physician Decision|0|||
143406730|NCT03211247|517038109|FG003|Overall Study|Physician Decision|0|||
143406731|NCT03211247|517038110|FG004|Overall Study|Physician Decision|0|||
143406732|NCT03211247|517038106|FG000|Overall Study|Non-compliance with study drug|2|||
143406733|NCT03211247|517038107|FG001|Overall Study|Non-compliance with study drug|0|||
143406734|NCT03211247|517038108|FG002|Overall Study|Non-compliance with study drug|0|||
143406735|NCT03211247|517038109|FG003|Overall Study|Non-compliance with study drug|0|||
143406736|NCT03211247|517038110|FG004|Overall Study|Non-compliance with study drug|0|||
143406737|NCT03211247|517038106|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
143406738|NCT03211247|517038107|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
143406739|NCT03211247|517038108|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
143406740|NCT03211247|517038109|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
143406741|NCT03211247|517038110|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
143406742|NCT03211247|517038106|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
143406743|NCT03211247|517038107|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
143406744|NCT03211247|517038108|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
143406745|NCT03211247|517038109|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
143406746|NCT03211247|517038110|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
143406747|NCT03211247|517038106|FG000|Overall Study|Protocol Violation|0|||
143406748|NCT03211247|517038107|FG001|Overall Study|Protocol Violation|1|||
143406749|NCT03211247|517038108|FG002|Overall Study|Protocol Violation|0|||
143406750|NCT03211247|517038109|FG003|Overall Study|Protocol Violation|0|||
143406751|NCT03211247|517038110|FG004|Overall Study|Protocol Violation|0|||
143406752|NCT02415127|517038111|FG000|Overall Study|Adverse Event|1|||
143406753|NCT02415127|517038112|FG001|Overall Study|Adverse Event|0|||
143406754|NCT03789110|517038113|FG000|Overall Study|Adverse Event|2|||
143406755|NCT03789110|517038113|FG000|Overall Study|Physician Decision|1|||
143406756|NCT03789110|517038113|FG000|Overall Study|Withdrawal by Subject|2|||
143406757|NCT03789110|517038113|FG000|Overall Study|Lack of Efficacy|22|||
143406758|NCT03789110|517038113|FG000|Overall Study|still on treatment|3|||
143406759|NCT05464732|517038123|FG000|Overall Study|Lost to Follow-up|0|||
143406760|NCT05464732|517038124|FG001|Overall Study|Lost to Follow-up|1|||
143406761|NCT05464732|517038123|FG000|Overall Study|Adverse Event|1|||
143406762|NCT05464732|517038124|FG001|Overall Study|Adverse Event|0|||
143406763|NCT02678689|517038125|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
143406764|NCT02678689|517038126|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
143406765|NCT03959423|517038130|FG000|Overall Study|Withdrawal by Subject|2|||
143406766|NCT03959423|517038131|FG001|Overall Study|Withdrawal by Subject|3|||
143406767|NCT03959423|517038130|FG000|Overall Study|Physician Decision|0|||
143406768|NCT03959423|517038131|FG001|Overall Study|Physician Decision|1|||
143406769|NCT03959423|517038130|FG000|Overall Study|Lost to Follow-up|1|||
143406770|NCT03959423|517038131|FG001|Overall Study|Lost to Follow-up|0|||
143406771|NCT03959423|517038130|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
143406772|NCT03959423|517038131|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
143406773|NCT02549352|517038132|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
143406774|NCT02549352|517038133|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
143406775|NCT02549352|517038132|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
143406776|NCT02549352|517038133|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
143406777|NCT02549352|517038132|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
143406778|NCT02549352|517038133|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
143406779|NCT02549352|517038132|FG000|12-month Follow-up|Withdrawal by Subject|4|||
143406780|NCT02549352|517038133|FG001|12-month Follow-up|Withdrawal by Subject|5|||
143406781|NCT02549352|517038132|FG000|12-month Follow-up|Lost to Follow-up|3|||
143406782|NCT02549352|517038133|FG001|12-month Follow-up|Lost to Follow-up|2|||
143406783|NCT02549352|517038132|FG000|12-month Follow-up|Death|0|||
143406784|NCT02549352|517038133|FG001|12-month Follow-up|Death|1|||
143406785|NCT02549352|517038132|FG000|12-month Follow-up|Protocol Violation|0|||
143406786|NCT02549352|517038133|FG001|12-month Follow-up|Protocol Violation|1|||
143406787|NCT02549352|517038132|FG000|12-month Follow-up|Other|1|||
143406788|NCT02549352|517038133|FG001|12-month Follow-up|Other|3|||
143406789|NCT05704725|517038134|FG000|Overall Study|Lost to Follow-up|0|||
143406790|NCT05704725|517038135|FG001|Overall Study|Lost to Follow-up|1|||
143406791|NCT05704725|517038134|FG000|Overall Study|Withdrawal by Subject|1|||
143406792|NCT05704725|517038135|FG001|Overall Study|Withdrawal by Subject|0|||
143406793|NCT00593840|517038138|FG000|Overall Study|Withdrawal by Subject|1|||
143406794|NCT00210106|517039409|FG000|Overall Study|Death|1|||
143406795|NCT00210106|517039409|FG000|Overall Study|Protocol Violation|13|||
143406796|NCT01184326|517039410|FG000|Overall Study|Adverse Event|1|||
143406797|NCT01184326|517039411|FG001|Overall Study|Adverse Event|2|||
143406798|NCT01184326|517039412|FG002|Overall Study|Adverse Event|0|||
143406799|NCT01184326|517039410|FG000|Overall Study|Death|0|||
143406800|NCT01184326|517039411|FG001|Overall Study|Death|0|||
143406801|NCT01184326|517039412|FG002|Overall Study|Death|1|||
143406802|NCT01184326|517039410|FG000|Overall Study|Withdrawal by Subject|0|||
143406803|NCT01184326|517039411|FG001|Overall Study|Withdrawal by Subject|0|||
143406804|NCT01184326|517039412|FG002|Overall Study|Withdrawal by Subject|1|||
143406805|NCT01184326|517039410|FG000|Overall Study|Physician Decision|1|||
143406806|NCT01184326|517039411|FG001|Overall Study|Physician Decision|1|||
143406807|NCT01184326|517039412|FG002|Overall Study|Physician Decision|0|||
143406808|NCT01184326|517039410|FG000|Overall Study|Disease Progression|1|||
143406809|NCT01184326|517039411|FG001|Overall Study|Disease Progression|3|||
143406810|NCT01184326|517039412|FG002|Overall Study|Disease Progression|12|||
143406811|NCT00372775|517039415|FG000|Overall Study|Adverse Event|8|||
143406812|NCT00372775|517039415|FG000|Overall Study|Death|15|||
143406813|NCT00372775|517039415|FG000|Overall Study|Objective progression or relapse|30|||
143406814|NCT00372775|517039415|FG000|Overall Study|Global deterioration of health status|6|||
143406815|NCT00372775|517039415|FG000|Overall Study|Withdrawal by Subject|1|||
143406816|NCT00372775|517039415|FG000|Overall Study|Other|1|||
143406817|NCT00372775|517039415|FG000|Overall Study|Not Treated|2|||
143406818|NCT00336505|517039416|FG000|Overall Study|Adverse Event|10|||
143406819|NCT00336505|517039417|FG001|Overall Study|Adverse Event|9|||
143406820|NCT00336505|517039416|FG000|Overall Study|Lack of Efficacy|8|||
143406821|NCT00336505|517039417|FG001|Overall Study|Lack of Efficacy|4|||
143406822|NCT00336505|517039416|FG000|Overall Study|Lost to Follow-up|7|||
143406823|NCT00336505|517039417|FG001|Overall Study|Lost to Follow-up|4|||
143406824|NCT00336505|517039416|FG000|Overall Study|Withdrawal by Subject|5|||
143406825|NCT00336505|517039417|FG001|Overall Study|Withdrawal by Subject|3|||
143406826|NCT00336505|517039416|FG000|Overall Study|Other|7|||
143406827|NCT00336505|517039417|FG001|Overall Study|Other|7|||
143406828|NCT00246805|517039418|FG000|Phase 1|Lost to Follow-up|1|||
143406829|NCT00246805|517039419|FG001|Phase 1|Lost to Follow-up|0|||
143406830|NCT00609869|517039420|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
143406831|NCT00609869|517039420|FG000|Overall Study|Severe hematologic toxicity|1|||
143406832|NCT00609869|517039420|FG000|Overall Study|Withdrawal by Subject|1|||
143406833|NCT00609869|517039420|FG000|Overall Study|Seizures|1|||
143406834|NCT00609869|517039420|FG000|Overall Study|Severe tumor flare reaction|1|||
143406835|NCT00609869|517039420|FG000|Overall Study|Hepatitis B infection|1|||
143406836|NCT00609869|517039420|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
143406837|NCT00609869|517039420|FG000|Overall Study|Mantle cell: not evaluable|4|||
143406838|NCT03418922|517039424|FG000|Overall Study|Withdrawal by Subject|0|||
143406839|NCT03418922|517039425|FG001|Overall Study|Withdrawal by Subject|2|||
143406840|NCT03418922|517039424|FG000|Overall Study|Adverse Event|2|||
143406841|NCT03418922|517039425|FG001|Overall Study|Adverse Event|2|||
143406842|NCT03418922|517039424|FG000|Overall Study|Death|0|||
143406843|NCT03418922|517039425|FG001|Overall Study|Death|1|||
143406844|NCT03418922|517039424|FG000|Overall Study|Physician Decision|0|||
143406845|NCT03418922|517039425|FG001|Overall Study|Physician Decision|1|||
143406846|NCT03577106|517039426|FG000|Overall Study|Withdrawal by Subject|3|||
143406847|NCT01579318|517039429|FG000|Overall Study|Disease Progression|1|||
143406848|NCT02347332|517039432|FG000|Overall Study|Not treated|5|||
143406849|NCT02347332|517039433|FG001|Overall Study|Not treated|2|||
143406850|NCT02347332|517039432|FG000|Overall Study|Progressive disease|141|||
143406851|NCT02347332|517039433|FG001|Overall Study|Progressive disease|159|||
143406852|NCT02347332|517039432|FG000|Overall Study|Adverse Event|50|||
143406853|NCT02347332|517039433|FG001|Overall Study|Adverse Event|41|||
143406854|NCT02347332|517039432|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
143406855|NCT02347332|517039433|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
143406856|NCT02347332|517039432|FG000|Overall Study|Protocol Violation|1|||
143406857|NCT02347332|517039433|FG001|Overall Study|Protocol Violation|1|||
143406858|NCT02347332|517039432|FG000|Overall Study|Lost to Follow-up|2|||
143406859|NCT02347332|517039433|FG001|Overall Study|Lost to Follow-up|1|||
143406860|NCT02347332|517039432|FG000|Overall Study|Physician Decision|4|||
143406861|NCT02347332|517039433|FG001|Overall Study|Physician Decision|3|||
143406862|NCT02347332|517039432|FG000|Overall Study|Withdrawal by Subject|20|||
143406863|NCT02347332|517039433|FG001|Overall Study|Withdrawal by Subject|14|||
143406864|NCT02347332|517039432|FG000|Overall Study|Protocol requirement|1|||
143406865|NCT02347332|517039433|FG001|Overall Study|Protocol requirement|1|||
143406866|NCT02347332|517039432|FG000|Overall Study|Switch Post-Trial program|0|||
143406867|NCT02347332|517039433|FG001|Overall Study|Switch Post-Trial program|1|||
143406868|NCT01970007|517039435|FG000|Overall Study|Death|5|||
143406869|NCT01970007|517039435|FG000|Overall Study|Withdrawal by Subject|23|||
143406870|NCT01970007|517039435|FG000|Overall Study|Lost to Follow-up|24|||
143406871|NCT01970007|517039435|FG000|Overall Study|"Other endpoint"|3|||
143406872|NCT01500200|517039436|FG000|Stage 1|Adverse Event|1|||
143406873|NCT01500200|517039437|FG001|Stage 1|Adverse Event|4|||
143406874|NCT01500200|517039438|FG002|Stage 1|Adverse Event|5|||
143406875|NCT01500200|517039439|FG003|Stage 1|Adverse Event|0|||
143406876|NCT01500200|517039440|FG004|Stage 1|Adverse Event|0|||
143406877|NCT01500200|517039441|FG005|Stage 1|Adverse Event|0|||
143406878|NCT01500200|517039436|FG000|Stage 1|Lost to Follow-up|2|||
143406879|NCT01500200|517039437|FG001|Stage 1|Lost to Follow-up|2|||
143406880|NCT01500200|517039438|FG002|Stage 1|Lost to Follow-up|1|||
143406881|NCT01500200|517039439|FG003|Stage 1|Lost to Follow-up|0|||
143406882|NCT01500200|517039440|FG004|Stage 1|Lost to Follow-up|0|||
143406883|NCT01500200|517039441|FG005|Stage 1|Lost to Follow-up|0|||
143406884|NCT01500200|517039436|FG000|Stage 1|Withdrawal by Subject|3|||
143406885|NCT01500200|517039437|FG001|Stage 1|Withdrawal by Subject|0|||
143406886|NCT01500200|517039438|FG002|Stage 1|Withdrawal by Subject|0|||
143406887|NCT01500200|517039439|FG003|Stage 1|Withdrawal by Subject|0|||
143406888|NCT01500200|517039440|FG004|Stage 1|Withdrawal by Subject|0|||
143406889|NCT01500200|517039441|FG005|Stage 1|Withdrawal by Subject|0|||
143406890|NCT01500200|517039436|FG000|Stage 1|Noncompliance with Study Drug|1|||
143406891|NCT01500200|517039437|FG001|Stage 1|Noncompliance with Study Drug|0|||
143406892|NCT01500200|517039438|FG002|Stage 1|Noncompliance with Study Drug|0|||
143406893|NCT01500200|517039439|FG003|Stage 1|Noncompliance with Study Drug|0|||
143406894|NCT01500200|517039440|FG004|Stage 1|Noncompliance with Study Drug|0|||
143406895|NCT01500200|517039441|FG005|Stage 1|Noncompliance with Study Drug|0|||
143406896|NCT01500200|517039436|FG000|Stage 1|Physician Decision|1|||
143406897|NCT01500200|517039437|FG001|Stage 1|Physician Decision|0|||
143406898|NCT01500200|517039438|FG002|Stage 1|Physician Decision|0|||
143406899|NCT01500200|517039439|FG003|Stage 1|Physician Decision|0|||
143406900|NCT01500200|517039440|FG004|Stage 1|Physician Decision|0|||
143406901|NCT01500200|517039441|FG005|Stage 1|Physician Decision|0|||
143406902|NCT01500200|517039436|FG000|Stage 2|Adverse Event|0|||
143406903|NCT01500200|517039437|FG001|Stage 2|Adverse Event|0|||
143406904|NCT01500200|517039438|FG002|Stage 2|Adverse Event|0|||
143406905|NCT01500200|517039439|FG003|Stage 2|Adverse Event|0|||
143406906|NCT01500200|517039440|FG004|Stage 2|Adverse Event|5|||
143406907|NCT01500200|517039441|FG005|Stage 2|Adverse Event|4|||
143406908|NCT01212744|517039444|FG000|Overall Study|Withdrawal by Subject|1|||
143406909|NCT02167451|517039446|FG000|Overall Study|Withdrawal by Subject|1|||
143406910|NCT00571649|517039447|FG000|Treatment Period|Adverse Event|438|||
143406911|NCT00571649|517039448|FG001|Treatment Period|Adverse Event|385|||
143406912|NCT00571649|517039447|FG000|Treatment Period|Clinical endpoint reached|50|||
143406913|NCT00571649|517039448|FG001|Treatment Period|Clinical endpoint reached|56|||
143406914|NCT00571649|517039447|FG000|Treatment Period|Withdrawal by Subject|285|||
143406915|NCT00571649|517039448|FG001|Treatment Period|Withdrawal by Subject|255|||
143406916|NCT00571649|517039447|FG000|Treatment Period|Death|76|||
143406917|NCT00571649|517039448|FG001|Treatment Period|Death|59|||
143406918|NCT00571649|517039447|FG000|Treatment Period|Physician Decision|8|||
143406919|NCT00571649|517039448|FG001|Treatment Period|Physician Decision|9|||
143406920|NCT00571649|517039447|FG000|Treatment Period|Lost to Follow-up|43|||
143406921|NCT00571649|517039448|FG001|Treatment Period|Lost to Follow-up|41|||
143406922|NCT00571649|517039447|FG000|Treatment Period|Non-compliant with study medication|88|||
143406923|NCT00571649|517039448|FG001|Treatment Period|Non-compliant with study medication|89|||
143406924|NCT00571649|517039447|FG000|Treatment Period|Patient convenience|11|||
143406925|NCT00571649|517039448|FG001|Treatment Period|Patient convenience|13|||
143406926|NCT00571649|517039447|FG000|Treatment Period|Protocol Violation|90|||
143406927|NCT00571649|517039448|FG001|Treatment Period|Protocol Violation|92|||
143406928|NCT00571649|517039447|FG000|Treatment Period|Technical problems|3|||
143406929|NCT00571649|517039448|FG001|Treatment Period|Technical problems|5|||
143406930|NCT00571649|517039447|FG000|Follow-up Period|Adverse Event|46|||
143406931|NCT00571649|517039448|FG001|Follow-up Period|Adverse Event|40|||
143406932|NCT00571649|517039447|FG000|Follow-up Period|Clinical endpoint reached|5|||
143406933|NCT00571649|517039448|FG001|Follow-up Period|Clinical endpoint reached|2|||
143406934|NCT00571649|517039447|FG000|Follow-up Period|Withdrawal by Subject|119|||
143406935|NCT00571649|517039448|FG001|Follow-up Period|Withdrawal by Subject|115|||
143406936|NCT00571649|517039447|FG000|Follow-up Period|Death|132|||
143406937|NCT00571649|517039448|FG001|Follow-up Period|Death|133|||
143406938|NCT00571649|517039447|FG000|Follow-up Period|Physician Decision|7|||
143406939|NCT00571649|517039448|FG001|Follow-up Period|Physician Decision|13|||
143406940|NCT00571649|517039447|FG000|Follow-up Period|Lost to Follow-up|95|||
143406941|NCT00571649|517039448|FG001|Follow-up Period|Lost to Follow-up|92|||
143406942|NCT00571649|517039447|FG000|Follow-up Period|Patient convenience|136|||
143406943|NCT00571649|517039448|FG001|Follow-up Period|Patient convenience|121|||
143406944|NCT00571649|517039447|FG000|Follow-up Period|Protocol Violation|5|||
143406945|NCT00571649|517039448|FG001|Follow-up Period|Protocol Violation|12|||
143406946|NCT01218659|517039449|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
143406947|NCT01218659|517039450|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
143406948|NCT01218659|517039451|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
143406949|NCT01218659|517039449|FG000|18-Month Randomized Period|Did not receive study drug|0|||
143406950|NCT01218659|517039450|FG001|18-Month Randomized Period|Did not receive study drug|3|||
143406951|NCT01218659|517039451|FG002|18-Month Randomized Period|Did not receive study drug|0|||
143406952|NCT01218659|517039449|FG000|12-Month OLE|Withdrawal by Subject|0|||
143406953|NCT01218659|517039450|FG001|12-Month OLE|Withdrawal by Subject|0|||
143406954|NCT01218659|517039451|FG002|12-Month OLE|Withdrawal by Subject|2|||
143406955|NCT01218659|517039449|FG000|12-Month OLE|Physician Decision|0|||
143406956|NCT01218659|517039450|FG001|12-Month OLE|Physician Decision|0|||
143406957|NCT01218659|517039451|FG002|12-Month OLE|Physician Decision|1|||
143406958|NCT01218659|517039449|FG000|12-Month OLE|Lost to Follow-up|0|||
143406959|NCT01218659|517039450|FG001|12-Month OLE|Lost to Follow-up|0|||
143406960|NCT01218659|517039451|FG002|12-Month OLE|Lost to Follow-up|1|||
143406961|NCT01218659|517039449|FG000|12-Month OLE|Pregnancy|0|||
143406962|NCT01218659|517039450|FG001|12-Month OLE|Pregnancy|0|||
143406963|NCT01218659|517039451|FG002|12-Month OLE|Pregnancy|1|||
143406964|NCT01218659|517039449|FG000|12-Month OLE|Lack of Efficacy|0|||
143406965|NCT01218659|517039450|FG001|12-Month OLE|Lack of Efficacy|0|||
143406966|NCT01218659|517039451|FG002|12-Month OLE|Lack of Efficacy|1|||
143406967|NCT01218659|517039449|FG000|12-Month OLE|Declined to participate in the OLE|0|||
143406968|NCT01218659|517039450|FG001|12-Month OLE|Declined to participate in the OLE|0|||
143406969|NCT01218659|517039451|FG002|12-Month OLE|Declined to participate in the OLE|4|||
143406970|NCT03066609|517039458|FG000|INDUCTION|Pregnancy|0|||
143406971|NCT03066609|517039459|FG001|INDUCTION|Pregnancy|0|||
143406972|NCT03066609|517039460|FG002|INDUCTION|Pregnancy|1|||
143406973|NCT03066609|517039461|FG003|INDUCTION|Pregnancy|0|||
143406974|NCT03066609|517039458|FG000|INDUCTION|Lack of Efficacy|0|||
143406975|NCT03066609|517039459|FG001|INDUCTION|Lack of Efficacy|0|||
143406976|NCT03066609|517039460|FG002|INDUCTION|Lack of Efficacy|1|||
143406977|NCT03066609|517039461|FG003|INDUCTION|Lack of Efficacy|0|||
143406978|NCT03066609|517039458|FG000|INDUCTION|Adverse Event|2|||
143406979|NCT03066609|517039459|FG001|INDUCTION|Adverse Event|2|||
143406980|NCT03066609|517039460|FG002|INDUCTION|Adverse Event|0|||
143406981|NCT03066609|517039461|FG003|INDUCTION|Adverse Event|0|||
143406982|NCT03066609|517039458|FG000|MAINTENANCE|Adverse Event|0|||
143406983|NCT03066609|517039459|FG001|MAINTENANCE|Adverse Event|0|||
143406984|NCT03066609|517039460|FG002|MAINTENANCE|Adverse Event|0|||
143406985|NCT03066609|517039461|FG003|MAINTENANCE|Adverse Event|1|||
143406986|NCT03066609|517039458|FG000|MAINTENANCE|Withdrawal by Subject|4|||
143406987|NCT03066609|517039459|FG001|MAINTENANCE|Withdrawal by Subject|2|||
143406988|NCT03066609|517039460|FG002|MAINTENANCE|Withdrawal by Subject|1|||
143406989|NCT03066609|517039461|FG003|MAINTENANCE|Withdrawal by Subject|1|||
143406990|NCT03066609|517039458|FG000|MAINTENANCE|Lost to Follow-up|0|||
143406991|NCT03066609|517039459|FG001|MAINTENANCE|Lost to Follow-up|1|||
143406992|NCT03066609|517039460|FG002|MAINTENANCE|Lost to Follow-up|1|||
143406993|NCT03066609|517039461|FG003|MAINTENANCE|Lost to Follow-up|0|||
143406994|NCT03066609|517039458|FG000|MAINTENANCE|Pregnancy|1|||
143406995|NCT03066609|517039459|FG001|MAINTENANCE|Pregnancy|0|||
143406996|NCT03066609|517039460|FG002|MAINTENANCE|Pregnancy|0|||
143406997|NCT03066609|517039461|FG003|MAINTENANCE|Pregnancy|0|||
143406998|NCT03066609|517039458|FG000|MAINTENANCE|Lack of Efficacy|2|||
143406999|NCT03066609|517039459|FG001|MAINTENANCE|Lack of Efficacy|1|||
143407000|NCT03066609|517039460|FG002|MAINTENANCE|Lack of Efficacy|0|||
143407001|NCT03066609|517039461|FG003|MAINTENANCE|Lack of Efficacy|1|||
143407002|NCT03066609|517039458|FG000|OVERALL STUDY|Adverse Event|2|||
143407003|NCT03066609|517039459|FG001|OVERALL STUDY|Adverse Event|2|||
143407004|NCT03066609|517039460|FG002|OVERALL STUDY|Adverse Event|0|||
143407005|NCT03066609|517039461|FG003|OVERALL STUDY|Adverse Event|1|||
143407006|NCT03066609|517039458|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
143407007|NCT03066609|517039459|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
143407008|NCT03066609|517039460|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
143407009|NCT03066609|517039461|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
143407010|NCT03066609|517039458|FG000|OVERALL STUDY|Lost to Follow-up|1|||
143407011|NCT03066609|517039459|FG001|OVERALL STUDY|Lost to Follow-up|1|||
143407012|NCT03066609|517039460|FG002|OVERALL STUDY|Lost to Follow-up|1|||
143407013|NCT03066609|517039461|FG003|OVERALL STUDY|Lost to Follow-up|1|||
143407014|NCT03066609|517039458|FG000|OVERALL STUDY|Pregnancy|1|||
143407015|NCT03066609|517039459|FG001|OVERALL STUDY|Pregnancy|0|||
143407016|NCT03066609|517039460|FG002|OVERALL STUDY|Pregnancy|1|||
143407017|NCT03066609|517039461|FG003|OVERALL STUDY|Pregnancy|0|||
143407018|NCT03066609|517039458|FG000|OVERALL STUDY|Lack of Efficacy|2|||
143407019|NCT03066609|517039459|FG001|OVERALL STUDY|Lack of Efficacy|1|||
143407020|NCT03066609|517039460|FG002|OVERALL STUDY|Lack of Efficacy|1|||
143407021|NCT03066609|517039461|FG003|OVERALL STUDY|Lack of Efficacy|1|||
143407022|NCT03066609|517039458|FG000|OVERALL STUDY|discontinued follow up|0|||
143407023|NCT03066609|517039459|FG001|OVERALL STUDY|discontinued follow up|2|||
143407024|NCT03066609|517039460|FG002|OVERALL STUDY|discontinued follow up|0|||
143407025|NCT03066609|517039461|FG003|OVERALL STUDY|discontinued follow up|0|||
143407026|NCT03355573|517039462|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
143407027|NCT03355573|517039462|FG000|Overall Study|Sponsor's decision|1|||
143407028|NCT03355573|517039462|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
143407029|NCT03355573|517039462|FG000|Overall Study|PI's decision|2|||
143407030|NCT03355573|517039462|FG000|Overall Study|Withdrawal by Subject|23|||
143407031|NCT03355573|517039462|FG000|Overall Study|Lost to Follow-up|4|||
143407032|NCT03355573|517039462|FG000|Overall Study|Lack of Efficacy|2|||
143407033|NCT03355573|517039462|FG000|Overall Study|Adverse Event, non-fatal|17|||
143407034|NCT03355573|517039462|FG000|Overall Study|Adverse Event, serious fatal|2|||
143407035|NCT01566890|517039463|FG000|Overall Study|Adverse Event|1|||
143407036|NCT01566890|517039464|FG001|Overall Study|Adverse Event|0|||
143407037|NCT01566890|517039465|FG002|Overall Study|Adverse Event|0|||
143407038|NCT01566890|517039466|FG003|Overall Study|Adverse Event|0|||
143407039|NCT01566890|517039467|FG004|Overall Study|Adverse Event|0|||
143407040|NCT01566890|517039463|FG000|Overall Study|Withdrawal by Subject|3|||
143407041|NCT01566890|517039464|FG001|Overall Study|Withdrawal by Subject|1|||
143407042|NCT01566890|517039465|FG002|Overall Study|Withdrawal by Subject|1|||
143407043|NCT01566890|517039466|FG003|Overall Study|Withdrawal by Subject|1|||
143407044|NCT01566890|517039467|FG004|Overall Study|Withdrawal by Subject|0|||
143407045|NCT01566890|517039463|FG000|Overall Study|Screen failure|6|||
143407046|NCT01566890|517039464|FG001|Overall Study|Screen failure|0|||
143407047|NCT01566890|517039465|FG002|Overall Study|Screen failure|1|||
143407048|NCT01566890|517039466|FG003|Overall Study|Screen failure|1|||
143407049|NCT01566890|517039467|FG004|Overall Study|Screen failure|0|||
143407050|NCT01566890|517039463|FG000|Overall Study|Incomplete CEU data|1|||
143407051|NCT01566890|517039464|FG001|Overall Study|Incomplete CEU data|3|||
143407052|NCT01566890|517039465|FG002|Overall Study|Incomplete CEU data|5|||
143407053|NCT01566890|517039466|FG003|Overall Study|Incomplete CEU data|8|||
143407054|NCT01566890|517039467|FG004|Overall Study|Incomplete CEU data|0|||
143407055|NCT01566890|517039463|FG000|Overall Study|Lost to Follow-up|0|||
143407056|NCT01566890|517039464|FG001|Overall Study|Lost to Follow-up|0|||
143407057|NCT01566890|517039465|FG002|Overall Study|Lost to Follow-up|4|||
143407058|NCT01566890|517039466|FG003|Overall Study|Lost to Follow-up|4|||
143407059|NCT01566890|517039467|FG004|Overall Study|Lost to Follow-up|0|||
143407060|NCT01566890|517039463|FG000|Overall Study|Other|0|||
143407061|NCT01566890|517039464|FG001|Overall Study|Other|0|||
143407062|NCT01566890|517039465|FG002|Overall Study|Other|0|||
143407063|NCT01566890|517039466|FG003|Overall Study|Other|0|||
143407064|NCT01566890|517039467|FG004|Overall Study|Other|7|||
143407065|NCT00523419|517039478|FG000|Overall Study|Adverse Event|1|||
143407066|NCT00523419|517039478|FG000|Overall Study|Withdrawal by Subject|1|||
143407067|NCT00523419|517039478|FG000|Overall Study|Physician Decision|2|||
143407068|NCT00523419|517039478|FG000|Overall Study|Progressive Disease|22|||
143407069|NCT00523419|517039478|FG000|Overall Study|Death due to Study Disease|4|||
143407070|NCT00523419|517039478|FG000|Overall Study|Death due to Adverse Event|2|||
143407071|NCT01211184|517039479|FG000|Overall Study|Withdrawal by Subject|0|||
143407072|NCT01211184|517039480|FG001|Overall Study|Withdrawal by Subject|2|||
143407073|NCT01211184|517039481|FG002|Overall Study|Withdrawal by Subject|1|||
143407074|NCT01421667|517039482|FG000|Overall Study|Withdrawal by Subject|0|||
143407075|NCT01421667|517039483|FG001|Overall Study|Withdrawal by Subject|1|||
143407076|NCT01421667|517039484|FG002|Overall Study|Withdrawal by Subject|2|||
143407077|NCT01421667|517039485|FG003|Overall Study|Withdrawal by Subject|1|||
143407078|NCT01421667|517039482|FG000|Overall Study|Lost to Follow-up|0|||
143407079|NCT01421667|517039483|FG001|Overall Study|Lost to Follow-up|1|||
143407080|NCT01421667|517039484|FG002|Overall Study|Lost to Follow-up|0|||
143407081|NCT01421667|517039485|FG003|Overall Study|Lost to Follow-up|0|||
143407082|NCT00822120|517039486|FG000|Initial Registration|Adverse Event|1|||
143407083|NCT00822120|517039487|FG001|Initial Registration|Adverse Event|0|||
143407084|NCT00822120|517039488|FG002|Initial Registration|Adverse Event|0|||
143407085|NCT00822120|517039489|FG003|Initial Registration|Adverse Event|0|||
143407086|NCT00822120|517039490|FG004|Initial Registration|Adverse Event|0|||
143407087|NCT00822120|517039491|FG005|Initial Registration|Adverse Event|0|||
143407088|NCT00822120|517039486|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
143407089|NCT00822120|517039487|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
143407090|NCT00822120|517039488|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
143407091|NCT00822120|517039489|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
143407092|NCT00822120|517039490|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
143407093|NCT00822120|517039491|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
143407094|NCT00822120|517039486|FG000|Initial Registration|Reasons not Protocol Specified|2|||
143407095|NCT00822120|517039487|FG001|Initial Registration|Reasons not Protocol Specified|0|||
143407096|NCT00822120|517039488|FG002|Initial Registration|Reasons not Protocol Specified|0|||
143407097|NCT00822120|517039489|FG003|Initial Registration|Reasons not Protocol Specified|0|||
143407098|NCT00822120|517039490|FG004|Initial Registration|Reasons not Protocol Specified|0|||
143407099|NCT00822120|517039491|FG005|Initial Registration|Reasons not Protocol Specified|0|||
143407100|NCT00822120|517039486|FG000|Initial Registration|Ineligible|22|||
143407101|NCT00822120|517039487|FG001|Initial Registration|Ineligible|1|||
143407102|NCT00822120|517039488|FG002|Initial Registration|Ineligible|0|||
143407103|NCT00822120|517039489|FG003|Initial Registration|Ineligible|0|||
143407104|NCT00822120|517039490|FG004|Initial Registration|Ineligible|0|||
143407105|NCT00822120|517039491|FG005|Initial Registration|Ineligible|0|||
143407106|NCT00822120|517039486|FG000|PET-directed Therapy|Adverse Event|0|||
143407107|NCT00822120|517039487|FG001|PET-directed Therapy|Adverse Event|0|||
143407108|NCT00822120|517039488|FG002|PET-directed Therapy|Adverse Event|0|||
143407109|NCT00822120|517039489|FG003|PET-directed Therapy|Adverse Event|1|||
143407110|NCT00822120|517039490|FG004|PET-directed Therapy|Adverse Event|0|||
143407111|NCT00822120|517039491|FG005|PET-directed Therapy|Adverse Event|0|||
143407112|NCT00822120|517039486|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
143407113|NCT00822120|517039487|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
143407114|NCT00822120|517039488|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
143407115|NCT00822120|517039489|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
143407116|NCT00822120|517039490|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
143407117|NCT00822120|517039491|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
143407118|NCT00822120|517039486|FG000|PET-directed Therapy|Death|0|||
143407119|NCT00822120|517039487|FG001|PET-directed Therapy|Death|0|||
143407120|NCT00822120|517039488|FG002|PET-directed Therapy|Death|0|||
143407121|NCT00822120|517039489|FG003|PET-directed Therapy|Death|2|||
143407122|NCT00822120|517039490|FG004|PET-directed Therapy|Death|0|||
143407123|NCT00822120|517039491|FG005|PET-directed Therapy|Death|0|||
143407124|NCT00822120|517039486|FG000|PET-directed Therapy|Protocol Violation|0|||
143407125|NCT00822120|517039487|FG001|PET-directed Therapy|Protocol Violation|0|||
143407126|NCT00822120|517039488|FG002|PET-directed Therapy|Protocol Violation|0|||
143407127|NCT00822120|517039489|FG003|PET-directed Therapy|Protocol Violation|6|||
143407128|NCT00822120|517039490|FG004|PET-directed Therapy|Protocol Violation|0|||
143407129|NCT00822120|517039491|FG005|PET-directed Therapy|Protocol Violation|0|||
143407130|NCT04060212|517039493|FG000|Overall Study|Withdrawal by Subject|7|||
143407131|NCT00811941|517039497|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
143407132|NCT00811941|517039498|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
143407133|NCT00811941|517039497|FG000|All Treated Patients|Adverse Event|2|||
143407134|NCT00811941|517039498|FG001|All Treated Patients|Adverse Event|43|||
143407135|NCT00811941|517039497|FG000|All Treated Patients|Lack of Efficacy|2|||
143407136|NCT00811941|517039498|FG001|All Treated Patients|Lack of Efficacy|3|||
143407137|NCT00811941|517039497|FG000|All Treated Patients|Non-compliance|1|||
143407138|NCT00811941|517039498|FG001|All Treated Patients|Non-compliance|8|||
143407139|NCT00811941|517039497|FG000|All Treated Patients|Protocol Violation|5|||
143407140|NCT00811941|517039498|FG001|All Treated Patients|Protocol Violation|17|||
143407141|NCT00811941|517039497|FG000|All Treated Patients|Withdrawal by Subject|35|||
143407142|NCT00811941|517039498|FG001|All Treated Patients|Withdrawal by Subject|94|||
143407143|NCT00811941|517039497|FG000|All Treated Patients|Lost to Follow-up|3|||
143407144|NCT00811941|517039498|FG001|All Treated Patients|Lost to Follow-up|12|||
143407145|NCT00811941|517039497|FG000|All Treated Patients|Other Reason|4|||
143407146|NCT00811941|517039498|FG001|All Treated Patients|Other Reason|14|||
143407147|NCT02397096|517039499|FG000|Day 1 to Week 24|Adverse Event|7|||
143407148|NCT02397096|517039500|FG001|Day 1 to Week 24|Adverse Event|1|||
143407149|NCT02397096|517039499|FG000|Day 1 to Week 24|Death|1|||
143407150|NCT02397096|517039500|FG001|Day 1 to Week 24|Death|0|||
143407151|NCT02397096|517039499|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
143407152|NCT02397096|517039500|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
143407153|NCT02397096|517039499|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
143407154|NCT02397096|517039500|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
143407155|NCT02397096|517039499|FG000|Day 1 to Week 24|Physician Decision|2|||
143407156|NCT02397096|517039500|FG001|Day 1 to Week 24|Physician Decision|3|||
143407157|NCT02397096|517039499|FG000|Day 1 to Week 24|Protocol Violation|1|||
143407158|NCT02397096|517039500|FG001|Day 1 to Week 24|Protocol Violation|4|||
143407159|NCT02397096|517039499|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
143407160|NCT02397096|517039500|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
143407161|NCT02397096|517039499|FG000|Day 1 to Week 24|Randomized, not treated|3|||
143407162|NCT02397096|517039500|FG001|Day 1 to Week 24|Randomized, not treated|0|||
143407163|NCT02397096|517039499|FG000|Week 24 to Week 48|Adverse Event|6|||
143407164|NCT02397096|517039500|FG001|Week 24 to Week 48|Adverse Event|2|||
143407165|NCT02397096|517039499|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
143407166|NCT02397096|517039500|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
143407167|NCT02397096|517039499|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
143407168|NCT02397096|517039500|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
143407169|NCT02397096|517039499|FG000|Week 24 to Week 48|Physician Decision|2|||
143407170|NCT02397096|517039500|FG001|Week 24 to Week 48|Physician Decision|1|||
143407171|NCT02397096|517039499|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
143407172|NCT02397096|517039500|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
143407173|NCT02397096|517039499|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
143407174|NCT02397096|517039500|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
143407175|NCT02397096|517039499|FG000|Study Extension 1|Adverse Event|7|||
143407176|NCT02397096|517039500|FG001|Study Extension 1|Adverse Event|5|||
143407177|NCT02397096|517039499|FG000|Study Extension 1|Death|1|||
143407178|NCT02397096|517039500|FG001|Study Extension 1|Death|0|||
143407179|NCT02397096|517039499|FG000|Study Extension 1|Lack of Efficacy|2|||
143407180|NCT02397096|517039500|FG001|Study Extension 1|Lack of Efficacy|5|||
143407181|NCT02397096|517039499|FG000|Study Extension 1|Lost to Follow-up|2|||
143407182|NCT02397096|517039500|FG001|Study Extension 1|Lost to Follow-up|3|||
143407183|NCT02397096|517039499|FG000|Study Extension 1|Non-compliance with study drug|3|||
143407184|NCT02397096|517039500|FG001|Study Extension 1|Non-compliance with study drug|0|||
143407185|NCT02397096|517039499|FG000|Study Extension 1|Physician Decision|4|||
143407186|NCT02397096|517039500|FG001|Study Extension 1|Physician Decision|2|||
143407187|NCT02397096|517039499|FG000|Study Extension 1|Pregnancy|1|||
143407188|NCT02397096|517039500|FG001|Study Extension 1|Pregnancy|0|||
143407189|NCT02397096|517039499|FG000|Study Extension 1|Protocol Violation|0|||
143407190|NCT02397096|517039500|FG001|Study Extension 1|Protocol Violation|1|||
143407191|NCT02397096|517039499|FG000|Study Extension 1|Withdrawal by Subject|21|||
143407192|NCT02397096|517039500|FG001|Study Extension 1|Withdrawal by Subject|7|||
143407193|NCT02397096|517039499|FG000|Study Extension 2|Adverse Event|3|||
143407194|NCT02397096|517039500|FG001|Study Extension 2|Adverse Event|3|||
143407195|NCT02397096|517039499|FG000|Study Extension 2|Availability of study medication locally|152|||
143407196|NCT02397096|517039500|FG001|Study Extension 2|Availability of study medication locally|64|||
143407197|NCT02397096|517039499|FG000|Study Extension 2|Death|2|||
143407198|NCT02397096|517039500|FG001|Study Extension 2|Death|0|||
143407199|NCT02397096|517039499|FG000|Study Extension 2|Lack of Efficacy|1|||
143407200|NCT02397096|517039500|FG001|Study Extension 2|Lack of Efficacy|0|||
143407201|NCT02397096|517039499|FG000|Study Extension 2|Lost to Follow-up|2|||
143407202|NCT02397096|517039500|FG001|Study Extension 2|Lost to Follow-up|1|||
143407203|NCT02397096|517039499|FG000|Study Extension 2|Non-compliance with study drug|1|||
143407204|NCT02397096|517039500|FG001|Study Extension 2|Non-compliance with study drug|0|||
143407205|NCT02397096|517039499|FG000|Study Extension 2|Physician Decision|2|||
143407206|NCT02397096|517039500|FG001|Study Extension 2|Physician Decision|5|||
143407207|NCT02397096|517039499|FG000|Study Extension 2|Pregnancy|1|||
143407208|NCT02397096|517039500|FG001|Study Extension 2|Pregnancy|0|||
143407209|NCT02397096|517039499|FG000|Study Extension 2|Withdrawal by Subject|10|||
143407210|NCT02397096|517039500|FG001|Study Extension 2|Withdrawal by Subject|3|||
143407211|NCT02397096|517039499|FG000|Study Extension 3|Adverse Event|1|||
143407212|NCT02397096|517039500|FG001|Study Extension 3|Adverse Event|0|||
143407213|NCT02397096|517039499|FG000|Study Extension 3|Availability of study medication locally|11|||
143407214|NCT02397096|517039500|FG001|Study Extension 3|Availability of study medication locally|3|||
143407215|NCT02397096|517039499|FG000|Study Extension 3|Lost to Follow-up|1|||
143407216|NCT02397096|517039500|FG001|Study Extension 3|Lost to Follow-up|0|||
143407217|NCT02397096|517039499|FG000|Study Extension 3|Withdrawal by Subject|2|||
143407218|NCT02397096|517039500|FG001|Study Extension 3|Withdrawal by Subject|1|||
143407219|NCT06688357|517039502|FG000|Overall Study|Adverse Event|0|||
143407220|NCT06688357|517039503|FG001|Overall Study|Adverse Event|1|||
143407221|NCT05139992|517039506|FG000|Overall Study|Withdrawal by Subject|12|||
143407222|NCT05139992|517039506|FG000|Overall Study|Lost to Follow-up|6|||
143407223|NCT04517435|517039523|FG000|Overall Study|Withdrawal by Subject|0|||
143407224|NCT04517435|517039524|FG001|Overall Study|Withdrawal by Subject|0|||
143407225|NCT04517435|517039525|FG002|Overall Study|Withdrawal by Subject|1|||
143407226|NCT04517435|517039523|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
143407227|NCT04517435|517039524|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
143407228|NCT04517435|517039525|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
143407229|NCT03160885|517039528|FG000|Initial Treatment Period|Not dosed|2|||
143407230|NCT03160885|517039529|FG001|Initial Treatment Period|Not dosed|0|||
143407231|NCT03160885|517039530|FG002|Initial Treatment Period|Not dosed|0|||
143407232|NCT03160885|517039531|FG003|Initial Treatment Period|Not dosed|0|||
143407233|NCT03160885|517039532|FG004|Initial Treatment Period|Not dosed|0|||
143407234|NCT03160885|517039533|FG005|Initial Treatment Period|Not dosed|0|||
143407235|NCT03160885|517039534|FG006|Initial Treatment Period|Not dosed|0|||
143407236|NCT03160885|517039528|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
143407237|NCT03160885|517039529|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
143407238|NCT03160885|517039530|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
143407239|NCT03160885|517039531|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
143407240|NCT03160885|517039532|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
143407241|NCT03160885|517039533|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
143407242|NCT03160885|517039534|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
143407243|NCT03160885|517039528|FG000|Open-label Treatment|Not dosed|0|||
143407244|NCT03160885|517039529|FG001|Open-label Treatment|Not dosed|0|||
143407245|NCT03160885|517039530|FG002|Open-label Treatment|Not dosed|0|||
143407246|NCT03160885|517039531|FG003|Open-label Treatment|Not dosed|0|||
143407247|NCT03160885|517039532|FG004|Open-label Treatment|Not dosed|0|||
143407248|NCT03160885|517039533|FG005|Open-label Treatment|Not dosed|0|||
143407249|NCT03160885|517039534|FG006|Open-label Treatment|Not dosed|2|||
143407250|NCT03160885|517039528|FG000|Open-label Treatment|Discontinued IMP|0|||
143407251|NCT03160885|517039529|FG001|Open-label Treatment|Discontinued IMP|0|||
143407252|NCT03160885|517039530|FG002|Open-label Treatment|Discontinued IMP|0|||
143407253|NCT03160885|517039531|FG003|Open-label Treatment|Discontinued IMP|0|||
143407254|NCT03160885|517039532|FG004|Open-label Treatment|Discontinued IMP|0|||
143407255|NCT03160885|517039533|FG005|Open-label Treatment|Discontinued IMP|0|||
143407256|NCT03160885|517039534|FG006|Open-label Treatment|Discontinued IMP|131|||
143407257|NCT03160885|517039528|FG000|Open-label Treatment|Completed Week 50|0|||
143407258|NCT03160885|517039529|FG001|Open-label Treatment|Completed Week 50|0|||
143407259|NCT03160885|517039530|FG002|Open-label Treatment|Completed Week 50|0|||
143407260|NCT03160885|517039531|FG003|Open-label Treatment|Completed Week 50|0|||
143407261|NCT03160885|517039532|FG004|Open-label Treatment|Completed Week 50|0|||
143407262|NCT03160885|517039533|FG005|Open-label Treatment|Completed Week 50|0|||
143407263|NCT03160885|517039534|FG006|Open-label Treatment|Completed Week 50|4|||
143407264|NCT03160885|517039528|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
143407265|NCT03160885|517039529|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
143407266|NCT03160885|517039530|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
143407267|NCT03160885|517039531|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
143407268|NCT03160885|517039532|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
143407269|NCT03160885|517039533|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
143407270|NCT03160885|517039534|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
143407271|NCT03160885|517039528|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
143407272|NCT03160885|517039529|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
143407273|NCT03160885|517039530|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
143407274|NCT03160885|517039531|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
143407275|NCT03160885|517039532|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
143407276|NCT03160885|517039533|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
143407277|NCT03160885|517039534|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
143407278|NCT03160885|517039528|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
143407279|NCT03160885|517039529|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
143407280|NCT03160885|517039530|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
143407281|NCT03160885|517039531|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
143407282|NCT03160885|517039532|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
143407283|NCT03160885|517039533|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
143407284|NCT03160885|517039534|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
143407285|NCT03160885|517039528|FG000|Maintenance Treatment Period|Completed Week 50|0|||
143407286|NCT03160885|517039529|FG001|Maintenance Treatment Period|Completed Week 50|0|||
143407287|NCT03160885|517039530|FG002|Maintenance Treatment Period|Completed Week 50|1|||
143407288|NCT03160885|517039531|FG003|Maintenance Treatment Period|Completed Week 50|0|||
143407289|NCT03160885|517039532|FG004|Maintenance Treatment Period|Completed Week 50|0|||
143407290|NCT03160885|517039533|FG005|Maintenance Treatment Period|Completed Week 50|0|||
143407291|NCT03160885|517039534|FG006|Maintenance Treatment Period|Completed Week 50|0|||
143407292|NCT02761187|517039535|FG000|Overall Study|Too ill to Participate|13|||
143407293|NCT02761187|517039536|FG001|Overall Study|Too ill to Participate|8|||
143407294|NCT02761187|517039535|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
143407295|NCT02761187|517039536|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
143407296|NCT02761187|517039535|FG000|Overall Study|Patient withdrew consent|64|||
143407297|NCT02761187|517039536|FG001|Overall Study|Patient withdrew consent|58|||
143407298|NCT02761187|517039535|FG000|Overall Study|Physician discretion|4|||
143407299|NCT02761187|517039536|FG001|Overall Study|Physician discretion|8|||
143407300|NCT02761187|517039535|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
143407301|NCT02761187|517039536|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
143407302|NCT02761187|517039535|FG000|Overall Study|On Hospice|20|||
143407303|NCT02761187|517039536|FG001|Overall Study|On Hospice|26|||
143407304|NCT02761187|517039535|FG000|Overall Study|Deceased|474|||
143407305|NCT02761187|517039536|FG001|Overall Study|Deceased|642|||
143407306|NCT02761187|517039535|FG000|Overall Study|Lost to Follow-up|73|||
143407307|NCT02761187|517039536|FG001|Overall Study|Lost to Follow-up|63|||
143407308|NCT02761187|517039535|FG000|Overall Study|Due to study discontinued at site|100|||
143407309|NCT02761187|517039536|FG001|Overall Study|Due to study discontinued at site|85|||
143407310|NCT02761187|517039535|FG000|Overall Study|Reason not Specified|1484|||
143407311|NCT02761187|517039536|FG001|Overall Study|Reason not Specified|937|||
143407312|NCT03997474|517039539|FG000|Overall Study|Death|6|||
143407313|NCT03997474|517039540|FG001|Overall Study|Death|2|||
143407314|NCT03997474|517039541|FG002|Overall Study|Death|1|||
143407315|NCT03997474|517039539|FG000|Overall Study|Physician Decision|2|||
143407316|NCT03997474|517039540|FG001|Overall Study|Physician Decision|0|||
143407317|NCT03997474|517039541|FG002|Overall Study|Physician Decision|0|||
143407318|NCT03997474|517039539|FG000|Overall Study|study terminated by sponsor|1|||
143407319|NCT03997474|517039540|FG001|Overall Study|study terminated by sponsor|0|||
143407320|NCT03997474|517039541|FG002|Overall Study|study terminated by sponsor|1|||
143407321|NCT05786612|517039542|FG000|Overall Study|Adverse Event|1|||
143407322|NCT05786612|517039543|FG001|Overall Study|Adverse Event|2|||
143407323|NCT05786612|517039542|FG000|Overall Study|one screening failure|0|||
143407324|NCT05786612|517039543|FG001|Overall Study|one screening failure|2|||
143407325|NCT05630833|517039546|FG000|Overall Study|Adverse Event|3|||
143407326|NCT05630833|517039547|FG001|Overall Study|Adverse Event|0|||
143407327|NCT05630833|517039546|FG000|Overall Study|Lack of Efficacy|0|||
143407328|NCT05630833|517039547|FG001|Overall Study|Lack of Efficacy|1|||
143407329|NCT05630833|517039546|FG000|Overall Study|Lost to Follow-up|1|||
143407330|NCT05630833|517039547|FG001|Overall Study|Lost to Follow-up|0|||
143407331|NCT05630833|517039546|FG000|Overall Study|Withdrawal by Subject|3|||
143407332|NCT05630833|517039547|FG001|Overall Study|Withdrawal by Subject|1|||
143407333|NCT03459196|517041343|FG000|Overall Study|Subject didn't receive study catheter|2|||
143407334|NCT04503681|517041346|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
143407335|NCT04503681|517041347|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
143407336|NCT03752684|517041348|FG000|Overall Study|Lost to Follow-up|4|||
143407337|NCT03352713|517041351|FG000|Overall Study|Lost to Follow-up|8|||
143407338|NCT03352713|517041351|FG000|Overall Study|Withdrawn by investigator|5|||
143407339|NCT03352713|517041351|FG000|Overall Study|Completed 0 EMAs|8|||
143407340|NCT03352713|517041351|FG000|Overall Study|Device incompatible/stolen|5|||
143407341|NCT01812759|517041352|FG000|Overall Study|Physician Decision|0|||
143407342|NCT01812759|517041353|FG001|Overall Study|Physician Decision|0|||
143407343|NCT01812759|517041354|FG002|Overall Study|Physician Decision|1|||
143407344|NCT00536120|517041355|FG000|Overall Study|Lost to Follow-up|1|||
143407345|NCT00536120|517041356|FG001|Overall Study|Lost to Follow-up|0|||
143407346|NCT00536120|517041355|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
143407347|NCT00536120|517041356|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
143407348|NCT00536120|517041355|FG000|Overall Study|Non-compliance|1|||
143407349|NCT00536120|517041356|FG001|Overall Study|Non-compliance|0|||
143407350|NCT00536120|517041355|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
143407351|NCT00536120|517041356|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
143407352|NCT00536120|517041355|FG000|Overall Study|Steroid Use|0|||
143407353|NCT00536120|517041356|FG001|Overall Study|Steroid Use|2|||
143407354|NCT00536120|517041355|FG000|Overall Study|Missed Study Visit|0|||
143407355|NCT00536120|517041356|FG001|Overall Study|Missed Study Visit|1|||
143407356|NCT02722434|517041357|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
143407357|NCT02722434|517041358|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
143407358|NCT02722434|517041357|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
143407359|NCT02722434|517041358|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
143407360|NCT04559698|517041359|FG000|Overall Study|Lost to Follow-up|14|||
143407361|NCT04559698|517041360|FG001|Overall Study|Lost to Follow-up|15|||
143407362|NCT04559698|517041359|FG000|Overall Study|Withdrawal by Subject|0|||
143407363|NCT04559698|517041360|FG001|Overall Study|Withdrawal by Subject|1|||
143407364|NCT04989816|517041362|FG000|Overall Study|Death|77|||
143407365|NCT04989816|517041362|FG000|Overall Study|Lost to Follow-up|3|||
143407366|NCT03437733|517041363|FG000|Overall Study|Eligibility criteria not met|0|||
143407367|NCT03437733|517041364|FG001|Overall Study|Eligibility criteria not met|3|||
143407368|NCT01982682|517041365|FG000|Overall Study|Physician Decision|1|||
143407369|NCT02760654|517041366|FG000|Overall Study|Lost to Follow-up|3|||
143407370|NCT02760654|517041367|FG001|Overall Study|Lost to Follow-up|3|||
143407371|NCT02760654|517041366|FG000|Overall Study|Withdrawal by Subject|4|||
143407372|NCT02760654|517041367|FG001|Overall Study|Withdrawal by Subject|3|||
143407373|NCT00146172|517041368|FG000|Overall Study|Adverse Event|0|||
143407374|NCT00146172|517041369|FG001|Overall Study|Adverse Event|0|||
143407375|NCT00146172|517041370|FG002|Overall Study|Adverse Event|1|||
143407376|NCT00146172|517041371|FG003|Overall Study|Adverse Event|1|||
143407377|NCT00146172|517041372|FG004|Overall Study|Adverse Event|0|||
143407378|NCT00146172|517041373|FG005|Overall Study|Adverse Event|2|||
143407379|NCT00146172|517041374|FG006|Overall Study|Adverse Event|3|||
143407380|NCT00146172|517041375|FG007|Overall Study|Adverse Event|10|||
143407381|NCT00146172|517041368|FG000|Overall Study|Lost to Follow-up|0|||
143407382|NCT00146172|517041369|FG001|Overall Study|Lost to Follow-up|0|||
143407383|NCT00146172|517041370|FG002|Overall Study|Lost to Follow-up|0|||
143407384|NCT00146172|517041371|FG003|Overall Study|Lost to Follow-up|0|||
143407385|NCT00146172|517041372|FG004|Overall Study|Lost to Follow-up|0|||
143407386|NCT00146172|517041373|FG005|Overall Study|Lost to Follow-up|0|||
143407387|NCT00146172|517041374|FG006|Overall Study|Lost to Follow-up|0|||
143407388|NCT00146172|517041375|FG007|Overall Study|Lost to Follow-up|1|||
143407389|NCT00146172|517041368|FG000|Overall Study|Disease Progression|2|||
143407390|NCT00146172|517041369|FG001|Overall Study|Disease Progression|4|||
143407391|NCT00146172|517041370|FG002|Overall Study|Disease Progression|2|||
143407392|NCT00146172|517041371|FG003|Overall Study|Disease Progression|5|||
143407393|NCT00146172|517041372|FG004|Overall Study|Disease Progression|2|||
143407394|NCT00146172|517041373|FG005|Overall Study|Disease Progression|2|||
143407395|NCT00146172|517041374|FG006|Overall Study|Disease Progression|1|||
143407396|NCT00146172|517041375|FG007|Overall Study|Disease Progression|22|||
143407397|NCT00146172|517041368|FG000|Overall Study|Death|0|||
143407398|NCT00146172|517041369|FG001|Overall Study|Death|0|||
143407399|NCT00146172|517041370|FG002|Overall Study|Death|0|||
143407400|NCT00146172|517041371|FG003|Overall Study|Death|0|||
143407401|NCT00146172|517041372|FG004|Overall Study|Death|0|||
143407402|NCT00146172|517041373|FG005|Overall Study|Death|0|||
143407403|NCT00146172|517041374|FG006|Overall Study|Death|1|||
143407404|NCT00146172|517041375|FG007|Overall Study|Death|0|||
143407405|NCT00146172|517041368|FG000|Overall Study|Physician Decision|0|||
143407406|NCT00146172|517041369|FG001|Overall Study|Physician Decision|0|||
143407407|NCT00146172|517041370|FG002|Overall Study|Physician Decision|0|||
143407408|NCT00146172|517041371|FG003|Overall Study|Physician Decision|0|||
143407409|NCT00146172|517041372|FG004|Overall Study|Physician Decision|0|||
143407410|NCT00146172|517041373|FG005|Overall Study|Physician Decision|0|||
143407411|NCT00146172|517041374|FG006|Overall Study|Physician Decision|0|||
143407412|NCT00146172|517041375|FG007|Overall Study|Physician Decision|1|||
143407413|NCT00146172|517041368|FG000|Overall Study|Withdrawal by Subject|0|||
143407414|NCT00146172|517041369|FG001|Overall Study|Withdrawal by Subject|0|||
143407415|NCT00146172|517041370|FG002|Overall Study|Withdrawal by Subject|0|||
143407416|NCT00146172|517041371|FG003|Overall Study|Withdrawal by Subject|0|||
143407417|NCT00146172|517041372|FG004|Overall Study|Withdrawal by Subject|0|||
143407418|NCT00146172|517041373|FG005|Overall Study|Withdrawal by Subject|1|||
143407419|NCT00146172|517041374|FG006|Overall Study|Withdrawal by Subject|1|||
143407420|NCT00146172|517041375|FG007|Overall Study|Withdrawal by Subject|4|||
143407421|NCT00146172|517041368|FG000|Overall Study|Symptomatic Deterioration|1|||
143407422|NCT00146172|517041369|FG001|Overall Study|Symptomatic Deterioration|0|||
143407423|NCT00146172|517041370|FG002|Overall Study|Symptomatic Deterioration|1|||
143407424|NCT00146172|517041371|FG003|Overall Study|Symptomatic Deterioration|0|||
143407425|NCT00146172|517041372|FG004|Overall Study|Symptomatic Deterioration|1|||
143407426|NCT00146172|517041373|FG005|Overall Study|Symptomatic Deterioration|2|||
143407427|NCT00146172|517041374|FG006|Overall Study|Symptomatic Deterioration|0|||
143407428|NCT00146172|517041375|FG007|Overall Study|Symptomatic Deterioration|2|||
143407429|NCT00786864|517041376|FG000|Overall Study|Lost to Follow-up|0|||
143407430|NCT00786864|517041377|FG001|Overall Study|Lost to Follow-up|1|||
143407431|NCT00786864|517041376|FG000|Overall Study|Sustained serious back injury|1|||
143407432|NCT00786864|517041377|FG001|Overall Study|Sustained serious back injury|0|||
143407433|NCT01084694|517041379|FG000|Overall Study|Withdrawal by Subject|2|||
143407434|NCT01084694|517041380|FG001|Overall Study|Withdrawal by Subject|1|||
143407435|NCT01084694|517041379|FG000|Overall Study|Death|2|||
143407436|NCT01084694|517041380|FG001|Overall Study|Death|12|||
143407437|NCT01084694|517041379|FG000|Overall Study|eligibility not maintained|2|||
143407438|NCT01084694|517041380|FG001|Overall Study|eligibility not maintained|7|||
143407439|NCT04213807|517041384|FG000|Overall Study|Physician Decision|0|||
143407440|NCT04213807|517041385|FG001|Overall Study|Physician Decision|0|||
143407441|NCT04213807|517041386|FG002|Overall Study|Physician Decision|1|||
143407442|NCT01750684|517041387|FG000|Overall Study|Death|1|||
143407443|NCT01750684|517041388|FG001|Overall Study|Death|0|||
143407444|NCT01750684|517041387|FG000|Overall Study|Non-compliance with Study Drug|0|||
143407445|NCT01750684|517041388|FG001|Overall Study|Non-compliance with Study Drug|1|||
143407446|NCT01750684|517041387|FG000|Overall Study|Withdrawn by Sponsor|0|||
143407447|NCT01750684|517041388|FG001|Overall Study|Withdrawn by Sponsor|1|||
143407448|NCT01750684|517041387|FG000|Overall Study|Protocol Violation|1|||
143407449|NCT01750684|517041388|FG001|Overall Study|Protocol Violation|0|||
143407450|NCT02185794|517041391|FG000|Overall Study|Enrolled but Never Dosed|1|||
143407451|NCT02185794|517041392|FG001|Overall Study|Enrolled but Never Dosed|6|||
143407452|NCT02185794|517041393|FG002|Overall Study|Enrolled but Never Dosed|3|||
143407453|NCT02185794|517041394|FG003|Overall Study|Enrolled but Never Dosed|1|||
143407454|NCT02185794|517041395|FG004|Overall Study|Enrolled but Never Dosed|1|||
143407455|NCT02185794|517041396|FG005|Overall Study|Enrolled but Never Dosed|0|||
143407456|NCT02185794|517041391|FG000|Overall Study|Investigator's Discretion|1|||
143407457|NCT02185794|517041392|FG001|Overall Study|Investigator's Discretion|0|||
143407458|NCT02185794|517041393|FG002|Overall Study|Investigator's Discretion|1|||
143407459|NCT02185794|517041394|FG003|Overall Study|Investigator's Discretion|2|||
143407460|NCT02185794|517041395|FG004|Overall Study|Investigator's Discretion|2|||
143407461|NCT02185794|517041396|FG005|Overall Study|Investigator's Discretion|15|||
143407462|NCT02185794|517041391|FG000|Overall Study|Withdrew Consent|2|||
143407463|NCT02185794|517041392|FG001|Overall Study|Withdrew Consent|5|||
143407464|NCT02185794|517041393|FG002|Overall Study|Withdrew Consent|10|||
143407465|NCT02185794|517041394|FG003|Overall Study|Withdrew Consent|2|||
143407466|NCT02185794|517041395|FG004|Overall Study|Withdrew Consent|0|||
143407467|NCT02185794|517041396|FG005|Overall Study|Withdrew Consent|0|||
143407468|NCT02185794|517041391|FG000|Overall Study|Lost to Follow-up|1|||
143407469|NCT02185794|517041392|FG001|Overall Study|Lost to Follow-up|2|||
143407470|NCT02185794|517041393|FG002|Overall Study|Lost to Follow-up|2|||
143407471|NCT02185794|517041394|FG003|Overall Study|Lost to Follow-up|3|||
143407472|NCT02185794|517041395|FG004|Overall Study|Lost to Follow-up|0|||
143407473|NCT02185794|517041396|FG005|Overall Study|Lost to Follow-up|1|||
143407474|NCT01092416|517041397|FG000|Enrollment|Atherectomy device not inserted|3|||
143407475|NCT01092416|517041397|FG000|30-Day Follow-up|Death|2|||
143407476|NCT01092416|517041397|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
143407477|NCT01092416|517041397|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
143407478|NCT01092416|517041397|FG000|12-Month Follow-up|Death|16|||
143407479|NCT01092416|517041397|FG000|12-Month Follow-up|Lost to Follow-up|4|||
143407480|NCT01092416|517041397|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
143407481|NCT01092416|517041397|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
143407482|NCT01092416|517041397|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
143407483|NCT00366249|517041398|FG000|Overall Study|Adverse Event|53|||
143407484|NCT00366249|517041399|FG001|Overall Study|Adverse Event|28|||
143407485|NCT00366249|517041398|FG000|Overall Study|Death|0|||
143407486|NCT00366249|517041399|FG001|Overall Study|Death|1|||
143407487|NCT00366249|517041398|FG000|Overall Study|Physician Decision|5|||
143407488|NCT00366249|517041399|FG001|Overall Study|Physician Decision|2|||
143407489|NCT00366249|517041398|FG000|Overall Study|Lost to Follow-up|2|||
143407490|NCT00366249|517041399|FG001|Overall Study|Lost to Follow-up|0|||
143407491|NCT00366249|517041398|FG000|Overall Study|Protocol Violation|1|||
143407492|NCT00366249|517041399|FG001|Overall Study|Protocol Violation|2|||
143407493|NCT00366249|517041398|FG000|Overall Study|Withdrawal by Subject|18|||
143407494|NCT00366249|517041399|FG001|Overall Study|Withdrawal by Subject|4|||
143407495|NCT00366249|517041398|FG000|Overall Study|Lack of Efficacy|21|||
143407496|NCT00366249|517041399|FG001|Overall Study|Lack of Efficacy|21|||
143407497|NCT00366249|517041398|FG000|Overall Study|Most due to osteomylitis status|31|||
143407498|NCT00366249|517041399|FG001|Overall Study|Most due to osteomylitis status|20|||
143407499|NCT01561300|517041400|FG000|Run in on Placebo|Adverse Event|1|||
143407500|NCT01561300|517041401|FG001|Run in on Placebo|Adverse Event|0|||
143407501|NCT00777049|517041402|FG000|Overall Study|Withdrawal by Subject|1|||
143407502|NCT00777049|517041403|FG001|Overall Study|Withdrawal by Subject|0|||
143407503|NCT00777049|517041402|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
143407504|NCT00777049|517041403|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
143407505|NCT01627561|517041404|FG000|Overall Study|Lost to Follow-up|1|||
143407506|NCT01627561|517041405|FG001|Overall Study|Lost to Follow-up|0|||
143407507|NCT01627561|517041404|FG000|Overall Study|Withdrawal by Subject|0|||
143407508|NCT01627561|517041405|FG001|Overall Study|Withdrawal by Subject|1|||
143407509|NCT01627561|517041404|FG000|Overall Study|Migrated/moved from study area|0|||
143407510|NCT01627561|517041405|FG001|Overall Study|Migrated/moved from study area|2|||
143407511|NCT03478969|517041411|FG000|Overall Study|Withdrawal by Subject|4|||
143407512|NCT03478969|517041412|FG001|Overall Study|Withdrawal by Subject|7|||
143407513|NCT03478969|517041413|FG002|Overall Study|Withdrawal by Subject|6|||
143407514|NCT03478969|517041411|FG000|Overall Study|Adverse Event|2|||
143407515|NCT03478969|517041412|FG001|Overall Study|Adverse Event|0|||
143407516|NCT03478969|517041413|FG002|Overall Study|Adverse Event|1|||
143407517|NCT03478969|517041411|FG000|Overall Study|Pregnancy|1|||
143407518|NCT03478969|517041412|FG001|Overall Study|Pregnancy|0|||
143407519|NCT03478969|517041413|FG002|Overall Study|Pregnancy|0|||
143407520|NCT03478969|517041411|FG000|Overall Study|Personal Reasons|1|||
143407521|NCT03478969|517041412|FG001|Overall Study|Personal Reasons|0|||
143407522|NCT03478969|517041413|FG002|Overall Study|Personal Reasons|1|||
143407523|NCT03478969|517041411|FG000|Overall Study|Covid-19|1|||
143407524|NCT03478969|517041412|FG001|Overall Study|Covid-19|4|||
143407525|NCT03478969|517041413|FG002|Overall Study|Covid-19|3|||
143407526|NCT03478969|517041411|FG000|Overall Study|Multiple Reasons|0|||
143407527|NCT03478969|517041412|FG001|Overall Study|Multiple Reasons|1|||
143407528|NCT03478969|517041413|FG002|Overall Study|Multiple Reasons|1|||
143407529|NCT03478969|517041411|FG000|Overall Study|Eligibility Criteria|0|||
143407530|NCT03478969|517041412|FG001|Overall Study|Eligibility Criteria|0|||
143407531|NCT03478969|517041413|FG002|Overall Study|Eligibility Criteria|5|||
143407532|NCT03478969|517041411|FG000|Overall Study|Lost to Follow-up|0|||
143407533|NCT03478969|517041412|FG001|Overall Study|Lost to Follow-up|0|||
143407534|NCT03478969|517041413|FG002|Overall Study|Lost to Follow-up|1|||
143407535|NCT01185600|517041414|FG000|Overall Study|Adverse Event|1|||
143407536|NCT01185600|517041415|FG001|Overall Study|Adverse Event|1|||
143407537|NCT01185600|517041414|FG000|Overall Study|Death|0|||
143407538|NCT01185600|517041415|FG001|Overall Study|Death|1|||
143407539|NCT01185600|517041414|FG000|Overall Study|Lost to Follow-up|0|||
143407540|NCT01185600|517041415|FG001|Overall Study|Lost to Follow-up|5|||
143407541|NCT01185600|517041414|FG000|Overall Study|Physician Decision|29|||
143407542|NCT01185600|517041415|FG001|Overall Study|Physician Decision|35|||
143407543|NCT01185600|517041414|FG000|Overall Study|Withdrawal by Subject|1|||
143407544|NCT01185600|517041415|FG001|Overall Study|Withdrawal by Subject|1|||
143407545|NCT01185600|517041414|FG000|Overall Study|Hold by DSMB|1|||
143407546|NCT01185600|517041415|FG001|Overall Study|Hold by DSMB|2|||
143407547|NCT03802994|517041416|FG000|Overall Study|Lost to Follow-up|0|||
143407548|NCT03802994|517041417|FG001|Overall Study|Lost to Follow-up|2|||
143407549|NCT03802994|517041418|FG002|Overall Study|Lost to Follow-up|3|||
143407550|NCT03802994|517041419|FG003|Overall Study|Lost to Follow-up|2|||
143407551|NCT03802994|517041420|FG004|Overall Study|Lost to Follow-up|2|||
143407552|NCT03611556|517041421|FG000|Overall Study|Death|7|||
143407553|NCT03611556|517041422|FG001|Overall Study|Death|7|||
143407554|NCT03611556|517041423|FG002|Overall Study|Death|3|||
143407555|NCT03611556|517041424|FG003|Overall Study|Death|8|||
143407556|NCT03611556|517041425|FG004|Overall Study|Death|47|||
143407557|NCT03611556|517041426|FG005|Overall Study|Death|32|||
143407558|NCT03611556|517041427|FG006|Overall Study|Death|53|||
143407559|NCT03611556|517041421|FG000|Overall Study|Withdrawal by Subject|0|||
143407560|NCT03611556|517041422|FG001|Overall Study|Withdrawal by Subject|0|||
143407561|NCT03611556|517041423|FG002|Overall Study|Withdrawal by Subject|0|||
143407562|NCT03611556|517041424|FG003|Overall Study|Withdrawal by Subject|0|||
143407563|NCT03611556|517041425|FG004|Overall Study|Withdrawal by Subject|4|||
143407564|NCT03611556|517041426|FG005|Overall Study|Withdrawal by Subject|2|||
143407565|NCT03611556|517041427|FG006|Overall Study|Withdrawal by Subject|4|||
143407566|NCT03611556|517041421|FG000|Overall Study|Sponsor decision|0|||
143407567|NCT03611556|517041422|FG001|Overall Study|Sponsor decision|0|||
143407568|NCT03611556|517041423|FG002|Overall Study|Sponsor decision|0|||
143407569|NCT03611556|517041424|FG003|Overall Study|Sponsor decision|0|||
143407570|NCT03611556|517041425|FG004|Overall Study|Sponsor decision|9|||
143407571|NCT03611556|517041426|FG005|Overall Study|Sponsor decision|4|||
143407572|NCT03611556|517041427|FG006|Overall Study|Sponsor decision|12|||
143407573|NCT03611556|517041421|FG000|Overall Study|Reasons|0|||
143407574|NCT03611556|517041422|FG001|Overall Study|Reasons|0|||
143407575|NCT03611556|517041423|FG002|Overall Study|Reasons|0|||
143407576|NCT03611556|517041424|FG003|Overall Study|Reasons|0|||
143407577|NCT03611556|517041425|FG004|Overall Study|Reasons|2|||
143407578|NCT03611556|517041426|FG005|Overall Study|Reasons|0|||
143407579|NCT03611556|517041427|FG006|Overall Study|Reasons|1|||
143407580|NCT02646618|517041429|FG000|Overall Study|Lost to Follow-up|10|||
143407581|NCT02646618|517041430|FG001|Overall Study|Lost to Follow-up|14|||
143407582|NCT02844439|517041431|FG000|Overall Study|Withdrawal by Subject|1|||
143407583|NCT02844439|517041431|FG000|Overall Study|Lost to Follow-up|2|||
143407584|NCT02844439|517041431|FG000|Overall Study|Termination by Sponsor|4|||
143407585|NCT02844439|517041431|FG000|Overall Study|Death|28|||
143407586|NCT02844439|517041431|FG000|Overall Study|Other|5|||
143407587|NCT05580003|517041435|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
143407588|NCT05580003|517041436|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
143407589|NCT05580003|517041437|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
143407590|NCT05580003|517041438|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
143407591|NCT05580003|517041439|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
143407592|NCT05580003|517041440|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
143407593|NCT05580003|517041441|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
143407594|NCT05580003|517041442|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
143407595|NCT05580003|517041443|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
143407596|NCT05580003|517041444|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
143407597|NCT05580003|517041445|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
143407598|NCT05580003|517041446|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
143407599|NCT05580003|517041447|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
143407600|NCT05580003|517041448|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
143407601|NCT05580003|517041449|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
143407602|NCT05580003|517041450|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
143407603|NCT05580003|517041451|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
143407604|NCT05580003|517041452|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
143407605|NCT05580003|517041453|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
143407606|NCT05580003|517041454|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
143407607|NCT05580003|517041455|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
143407608|NCT05580003|517041456|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
143407609|NCT05580003|517041457|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
143407610|NCT05580003|517041458|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
143407611|NCT05580003|517041459|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
143407612|NCT05580003|517041460|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
143407613|NCT05580003|517041461|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
143407614|NCT05580003|517041462|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
143407615|NCT05580003|517041435|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
143407616|NCT05580003|517041436|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
143407617|NCT05580003|517041437|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
143407618|NCT05580003|517041438|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
143407619|NCT05580003|517041439|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
143407620|NCT05580003|517041440|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
143407621|NCT05580003|517041441|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
143407622|NCT05580003|517041442|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
143407623|NCT05580003|517041443|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
143407624|NCT05580003|517041444|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
143407625|NCT05580003|517041445|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
143407626|NCT05580003|517041446|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
143407627|NCT05580003|517041447|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
143407628|NCT05580003|517041448|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
143407629|NCT05580003|517041449|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
143407630|NCT05580003|517041450|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
143407631|NCT05580003|517041451|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
143407632|NCT05580003|517041452|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
143407633|NCT05580003|517041453|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
143407634|NCT05580003|517041454|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
143407635|NCT05580003|517041455|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
143407636|NCT05580003|517041456|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
143407637|NCT05580003|517041457|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
143407638|NCT05580003|517041458|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
143407639|NCT05580003|517041459|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
143407640|NCT05580003|517041460|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
143407641|NCT05580003|517041461|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
143407642|NCT05580003|517041462|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
143407643|NCT05580003|517041435|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
143407644|NCT05580003|517041436|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
143407645|NCT05580003|517041437|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
143407646|NCT05580003|517041438|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
143407647|NCT05580003|517041439|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
143407648|NCT05580003|517041440|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
143407649|NCT05580003|517041441|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
143407650|NCT05580003|517041442|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
143407651|NCT05580003|517041443|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
143407652|NCT05580003|517041444|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
143407653|NCT05580003|517041445|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
143407654|NCT05580003|517041446|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
143407655|NCT05580003|517041447|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
143407656|NCT05580003|517041448|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
143407657|NCT05580003|517041449|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
143407658|NCT05580003|517041450|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
143407659|NCT05580003|517041451|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
143407660|NCT05580003|517041452|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
143407661|NCT05580003|517041453|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
143407662|NCT05580003|517041454|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
143407663|NCT05580003|517041455|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
143407664|NCT05580003|517041456|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
143407665|NCT05580003|517041457|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
143407666|NCT05580003|517041458|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
143407667|NCT05580003|517041459|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
143407668|NCT05580003|517041460|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
143407669|NCT05580003|517041461|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
143407670|NCT05580003|517041462|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
143407671|NCT05580003|517041435|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
143407672|NCT05580003|517041436|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
143407673|NCT05580003|517041437|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
143407674|NCT05580003|517041438|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
143407675|NCT05580003|517041439|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
143407676|NCT05580003|517041440|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
143407677|NCT05580003|517041441|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
143407678|NCT05580003|517041442|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
143407679|NCT05580003|517041443|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
143407680|NCT05580003|517041444|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
143407681|NCT05580003|517041445|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
143407682|NCT05580003|517041446|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
143407683|NCT05580003|517041447|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
143407684|NCT05580003|517041448|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
143407685|NCT05580003|517041449|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
143407686|NCT05580003|517041450|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
143407687|NCT05580003|517041451|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
143407688|NCT05580003|517041452|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
143407689|NCT05580003|517041453|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
143407690|NCT05580003|517041454|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
143407691|NCT05580003|517041455|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
143407692|NCT05580003|517041456|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
143407693|NCT05580003|517041457|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
143407694|NCT05580003|517041458|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
143407695|NCT05580003|517041459|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
143407696|NCT05580003|517041460|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
143407697|NCT05580003|517041461|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
143407698|NCT05580003|517041462|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
143407699|NCT05580003|517041435|FG000|Part 2 (up to 10 Days)|Other|0|||
143407700|NCT05580003|517041436|FG001|Part 2 (up to 10 Days)|Other|0|||
143407701|NCT05580003|517041437|FG002|Part 2 (up to 10 Days)|Other|0|||
143407702|NCT05580003|517041438|FG003|Part 2 (up to 10 Days)|Other|0|||
143407703|NCT05580003|517041439|FG004|Part 2 (up to 10 Days)|Other|0|||
143407704|NCT05580003|517041440|FG005|Part 2 (up to 10 Days)|Other|0|||
143407705|NCT05580003|517041441|FG006|Part 2 (up to 10 Days)|Other|0|||
143407706|NCT05580003|517041442|FG007|Part 2 (up to 10 Days)|Other|0|||
143407707|NCT05580003|517041443|FG008|Part 2 (up to 10 Days)|Other|0|||
143407708|NCT05580003|517041444|FG009|Part 2 (up to 10 Days)|Other|1|||
143407709|NCT05580003|517041445|FG010|Part 2 (up to 10 Days)|Other|0|||
143407710|NCT05580003|517041446|FG011|Part 2 (up to 10 Days)|Other|0|||
143407711|NCT05580003|517041447|FG012|Part 2 (up to 10 Days)|Other|0|||
143407712|NCT05580003|517041448|FG013|Part 2 (up to 10 Days)|Other|0|||
143407713|NCT05580003|517041449|FG014|Part 2 (up to 10 Days)|Other|0|||
143407714|NCT05580003|517041450|FG015|Part 2 (up to 10 Days)|Other|0|||
143407715|NCT05580003|517041451|FG016|Part 2 (up to 10 Days)|Other|0|||
143407716|NCT05580003|517041452|FG017|Part 2 (up to 10 Days)|Other|0|||
143407717|NCT05580003|517041453|FG018|Part 2 (up to 10 Days)|Other|0|||
143407718|NCT05580003|517041454|FG019|Part 2 (up to 10 Days)|Other|0|||
143407719|NCT05580003|517041455|FG020|Part 2 (up to 10 Days)|Other|0|||
143407720|NCT05580003|517041456|FG021|Part 2 (up to 10 Days)|Other|0|||
143407721|NCT05580003|517041457|FG022|Part 2 (up to 10 Days)|Other|0|||
143407722|NCT05580003|517041458|FG023|Part 2 (up to 10 Days)|Other|0|||
143407723|NCT05580003|517041459|FG024|Part 2 (up to 10 Days)|Other|0|||
143407724|NCT05580003|517041460|FG025|Part 2 (up to 10 Days)|Other|0|||
143407725|NCT05580003|517041461|FG026|Part 2 (up to 10 Days)|Other|0|||
143407726|NCT05580003|517041462|FG027|Part 2 (up to 10 Days)|Other|0|||
143407727|NCT05580003|517041435|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
143407728|NCT05580003|517041436|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
143407729|NCT05580003|517041437|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
143407730|NCT05580003|517041438|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
143407731|NCT05580003|517041439|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
143407732|NCT05580003|517041440|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
143407733|NCT05580003|517041441|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
143407734|NCT05580003|517041442|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
143407735|NCT05580003|517041443|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
143407736|NCT05580003|517041444|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
143407737|NCT05580003|517041445|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
143407738|NCT05580003|517041446|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
143407739|NCT05580003|517041447|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
143407740|NCT05580003|517041448|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
143407741|NCT05580003|517041449|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
143407742|NCT05580003|517041450|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
143407743|NCT05580003|517041451|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
143407744|NCT05580003|517041452|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
143407745|NCT05580003|517041453|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
143407746|NCT05580003|517041454|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
143407747|NCT05580003|517041455|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
143407748|NCT05580003|517041456|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
143407749|NCT05580003|517041457|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
143407750|NCT05580003|517041458|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
143407751|NCT05580003|517041459|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
143407752|NCT05580003|517041460|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
143407753|NCT05580003|517041461|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
143407754|NCT05580003|517041462|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
143407755|NCT05580003|517041435|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
143407756|NCT05580003|517041436|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
143407757|NCT05580003|517041437|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
143407758|NCT05580003|517041438|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
143407759|NCT05580003|517041439|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
143407760|NCT05580003|517041440|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
143407761|NCT05580003|517041441|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
143407762|NCT05580003|517041442|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
143407763|NCT05580003|517041443|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
143407764|NCT05580003|517041444|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
143407765|NCT05580003|517041445|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
143407766|NCT05580003|517041446|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
143407767|NCT05580003|517041447|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
143407768|NCT05580003|517041448|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
143407769|NCT05580003|517041449|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
143407770|NCT05580003|517041450|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
143407771|NCT05580003|517041451|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
143407772|NCT05580003|517041452|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
143407773|NCT05580003|517041453|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
143407774|NCT05580003|517041454|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
143407775|NCT05580003|517041455|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
143407776|NCT05580003|517041456|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
143407777|NCT05580003|517041457|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
143407778|NCT05580003|517041458|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
143407779|NCT05580003|517041459|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
143407780|NCT05580003|517041460|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
143407781|NCT05580003|517041461|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
143407782|NCT05580003|517041462|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
143407783|NCT05580003|517041435|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
143407784|NCT05580003|517041436|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
143407785|NCT05580003|517041437|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
143407786|NCT05580003|517041438|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
143407787|NCT05580003|517041439|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
143407788|NCT05580003|517041440|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
143407789|NCT05580003|517041441|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
143407790|NCT05580003|517041442|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
143407791|NCT05580003|517041443|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
143407792|NCT05580003|517041444|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
143407793|NCT05580003|517041445|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
143407794|NCT05580003|517041446|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
143407795|NCT05580003|517041447|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
143407796|NCT05580003|517041448|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
143407797|NCT05580003|517041449|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
143407798|NCT05580003|517041450|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
143407799|NCT05580003|517041451|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
143407800|NCT05580003|517041452|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
143407801|NCT05580003|517041453|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
143407802|NCT05580003|517041454|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
143407803|NCT05580003|517041455|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
143407804|NCT05580003|517041456|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
143407805|NCT05580003|517041457|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
143407806|NCT05580003|517041458|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
143407807|NCT05580003|517041459|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
143407808|NCT05580003|517041460|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
143407809|NCT05580003|517041461|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
143407810|NCT05580003|517041462|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
143407811|NCT05580003|517041435|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
143407812|NCT05580003|517041436|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
143407813|NCT05580003|517041437|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
143407814|NCT05580003|517041438|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
143407815|NCT05580003|517041439|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
143407816|NCT05580003|517041440|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
143407817|NCT05580003|517041441|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
143407818|NCT05580003|517041442|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
143407819|NCT05580003|517041443|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
143407820|NCT05580003|517041444|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
143407821|NCT05580003|517041445|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
143407822|NCT05580003|517041446|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
143407823|NCT05580003|517041447|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
143407824|NCT05580003|517041448|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
143407825|NCT05580003|517041449|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
143407826|NCT05580003|517041450|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
143407827|NCT05580003|517041451|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
143407828|NCT05580003|517041452|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
143407829|NCT05580003|517041453|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
143407830|NCT05580003|517041454|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
143407831|NCT05580003|517041455|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
143407832|NCT05580003|517041456|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
143407833|NCT05580003|517041457|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
143407834|NCT05580003|517041458|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
143407835|NCT05580003|517041459|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
143407836|NCT05580003|517041460|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
143407837|NCT05580003|517041461|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
143407838|NCT05580003|517041462|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
143407839|NCT05580003|517041435|FG000|Part 6 Period 2 (Day 1)|Other|0|||
143407840|NCT05580003|517041436|FG001|Part 6 Period 2 (Day 1)|Other|0|||
143407841|NCT05580003|517041437|FG002|Part 6 Period 2 (Day 1)|Other|0|||
143407842|NCT05580003|517041438|FG003|Part 6 Period 2 (Day 1)|Other|0|||
143407843|NCT05580003|517041439|FG004|Part 6 Period 2 (Day 1)|Other|0|||
143407844|NCT05580003|517041440|FG005|Part 6 Period 2 (Day 1)|Other|0|||
143407845|NCT05580003|517041441|FG006|Part 6 Period 2 (Day 1)|Other|0|||
143407846|NCT05580003|517041442|FG007|Part 6 Period 2 (Day 1)|Other|0|||
143407847|NCT05580003|517041443|FG008|Part 6 Period 2 (Day 1)|Other|0|||
143407848|NCT05580003|517041444|FG009|Part 6 Period 2 (Day 1)|Other|0|||
143407849|NCT05580003|517041445|FG010|Part 6 Period 2 (Day 1)|Other|0|||
143407850|NCT05580003|517041446|FG011|Part 6 Period 2 (Day 1)|Other|0|||
143407851|NCT05580003|517041447|FG012|Part 6 Period 2 (Day 1)|Other|0|||
143407852|NCT05580003|517041448|FG013|Part 6 Period 2 (Day 1)|Other|0|||
143407853|NCT05580003|517041449|FG014|Part 6 Period 2 (Day 1)|Other|0|||
143407854|NCT05580003|517041450|FG015|Part 6 Period 2 (Day 1)|Other|0|||
143407855|NCT05580003|517041451|FG016|Part 6 Period 2 (Day 1)|Other|0|||
143407856|NCT05580003|517041452|FG017|Part 6 Period 2 (Day 1)|Other|0|||
143407857|NCT05580003|517041453|FG018|Part 6 Period 2 (Day 1)|Other|0|||
143407858|NCT05580003|517041454|FG019|Part 6 Period 2 (Day 1)|Other|0|||
143407859|NCT05580003|517041455|FG020|Part 6 Period 2 (Day 1)|Other|0|||
143407860|NCT05580003|517041456|FG021|Part 6 Period 2 (Day 1)|Other|0|||
143407861|NCT05580003|517041457|FG022|Part 6 Period 2 (Day 1)|Other|0|||
143407862|NCT05580003|517041458|FG023|Part 6 Period 2 (Day 1)|Other|0|||
143407863|NCT05580003|517041459|FG024|Part 6 Period 2 (Day 1)|Other|1|||
143407864|NCT05580003|517041460|FG025|Part 6 Period 2 (Day 1)|Other|0|||
143407865|NCT05580003|517041461|FG026|Part 6 Period 2 (Day 1)|Other|0|||
143407866|NCT05580003|517041462|FG027|Part 6 Period 2 (Day 1)|Other|0|||
143407867|NCT03170648|517041465|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
143407868|NCT03170648|517041465|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
143407869|NCT02052440|517041466|FG000|Overall Study|Withdrawal by Subject|0|||
143407870|NCT02052440|517041467|FG001|Overall Study|Withdrawal by Subject|1|||
143407871|NCT03500549|517041468|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
143407872|NCT03500549|517041469|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
143407873|NCT03500549|517041468|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
143407874|NCT03500549|517041469|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
143407875|NCT02107261|517041470|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
143407876|NCT02107261|517041471|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
143407877|NCT02107261|517041470|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
143407878|NCT02107261|517041471|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
143407879|NCT04337931|517041473|FG000|Overall Study|Death|4|||
143407880|NCT04337931|517041474|FG001|Overall Study|Death|1|||
143407881|NCT04337931|517041475|FG002|Overall Study|Death|7|||
143407882|NCT04337931|517041473|FG000|Overall Study|Withdrawal by Subject|0|||
143407883|NCT04337931|517041474|FG001|Overall Study|Withdrawal by Subject|1|||
143407884|NCT04337931|517041475|FG002|Overall Study|Withdrawal by Subject|0|||
143407885|NCT04337931|517041473|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
143407886|NCT04337931|517041474|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
143407887|NCT04337931|517041475|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
143407888|NCT04337931|517041473|FG000|Overall Study|Study terminated by sponsor|3|||
143407889|NCT04337931|517041474|FG001|Overall Study|Study terminated by sponsor|6|||
143407890|NCT04337931|517041475|FG002|Overall Study|Study terminated by sponsor|2|||
143407891|NCT04337931|517041473|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
143407892|NCT04337931|517041474|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
143407893|NCT04337931|517041475|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
143407894|NCT04337931|517041473|FG000|Overall Study|Colorectal cancer treatment|1|||
143407895|NCT04337931|517041474|FG001|Overall Study|Colorectal cancer treatment|0|||
143407896|NCT04337931|517041475|FG002|Overall Study|Colorectal cancer treatment|0|||
143407897|NCT04337931|517041473|FG000|Overall Study|Participant decision|0|||
143407898|NCT04337931|517041474|FG001|Overall Study|Participant decision|1|||
143407899|NCT04337931|517041475|FG002|Overall Study|Participant decision|0|||
143407900|NCT01738438|517041477|FG000|Overall Study|Disease Progression|32|||
143407901|NCT01738438|517041477|FG000|Overall Study|Adverse Event|3|||
143407902|NCT04436289|517041478|FG000|Overall Study|Death prior to hospital discharge|8|||
143407903|NCT04436289|517041479|FG001|Overall Study|Death prior to hospital discharge|5|||
143407904|NCT04436289|517041480|FG002|Overall Study|Death prior to hospital discharge|0|||
143407905|NCT04436289|517041481|FG003|Overall Study|Death prior to hospital discharge|1|||
143407906|NCT04436289|517041478|FG000|Overall Study|Withdrawal by Subject|0|||
143407907|NCT04436289|517041479|FG001|Overall Study|Withdrawal by Subject|1|||
143407908|NCT04436289|517041480|FG002|Overall Study|Withdrawal by Subject|4|||
143407909|NCT04436289|517041481|FG003|Overall Study|Withdrawal by Subject|0|||
143407910|NCT04436289|517041478|FG000|Overall Study|Extended hospital stay|0|||
143407911|NCT04436289|517041479|FG001|Overall Study|Extended hospital stay|1|||
143407912|NCT04436289|517041480|FG002|Overall Study|Extended hospital stay|0|||
143407913|NCT04436289|517041481|FG003|Overall Study|Extended hospital stay|0|||
143407914|NCT04436289|517041478|FG000|Overall Study|Lost to Follow-up|0|||
143407915|NCT04436289|517041479|FG001|Overall Study|Lost to Follow-up|4|||
143407916|NCT04436289|517041480|FG002|Overall Study|Lost to Follow-up|1|||
143407917|NCT04436289|517041481|FG003|Overall Study|Lost to Follow-up|3|||
143407918|NCT00918203|517041484|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
143407919|NCT00918203|517041485|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
143407920|NCT00918203|517041486|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
143407921|NCT00918203|517041484|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
143407922|NCT00918203|517041485|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
143407923|NCT00918203|517041486|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
143407924|NCT00918203|517041484|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
143407925|NCT00918203|517041485|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
143407926|NCT00918203|517041486|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
143407927|NCT00918203|517041484|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
143407928|NCT00918203|517041485|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
143407929|NCT00918203|517041486|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
143407930|NCT00309166|517041487|FG000|Overall Study|Adverse event, non-fatal|1|||
143407931|NCT00309166|517041488|FG001|Overall Study|Adverse event, non-fatal|0|||
143407932|NCT00309166|517041487|FG000|Overall Study|Withdrawal by Subject|4|||
143407933|NCT00309166|517041488|FG001|Overall Study|Withdrawal by Subject|3|||
143407934|NCT00701701|517041489|FG000|Overall Study|Withdrawal by Subject|0|||
143407935|NCT00701701|517041490|FG001|Overall Study|Withdrawal by Subject|1|||
143407936|NCT00701701|517041489|FG000|Overall Study|Adverse Event|0|||
143407937|NCT00701701|517041490|FG001|Overall Study|Adverse Event|1|||
143407938|NCT00589875|517041491|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
143407939|NCT00589875|517041491|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
143407940|NCT03357952|517041496|FG000|Overall Study|Withdrawal by Subject|0|||
143407941|NCT03357952|517041497|FG001|Overall Study|Withdrawal by Subject|1|||
143407942|NCT03357952|517041496|FG000|Overall Study|Sponsor Decision|9|||
143407943|NCT03357952|517041497|FG001|Overall Study|Sponsor Decision|0|||
143407944|NCT03280030|517041498|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
143407945|NCT03280030|517041499|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
143407946|NCT03280030|517041500|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
143407947|NCT03280030|517041498|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
143407948|NCT03280030|517041499|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
143407949|NCT03280030|517041500|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
143407950|NCT03280030|517041498|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
143407951|NCT03280030|517041499|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
143407952|NCT03280030|517041500|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
143407953|NCT03280030|517041498|FG000|Part 2 - Efficacy|Adverse Event|0|||
143407954|NCT03280030|517041499|FG001|Part 2 - Efficacy|Adverse Event|4|||
143407955|NCT03280030|517041500|FG002|Part 2 - Efficacy|Adverse Event|6|||
143407956|NCT03280030|517041498|FG000|Part 2 - Efficacy|Death|0|||
143407957|NCT03280030|517041499|FG001|Part 2 - Efficacy|Death|3|||
143407958|NCT03280030|517041500|FG002|Part 2 - Efficacy|Death|0|||
143407959|NCT03280030|517041498|FG000|Part 2 - Efficacy|Physician Decision|0|||
143407960|NCT03280030|517041499|FG001|Part 2 - Efficacy|Physician Decision|10|||
143407961|NCT03280030|517041500|FG002|Part 2 - Efficacy|Physician Decision|16|||
143407962|NCT03280030|517041498|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
143407963|NCT03280030|517041499|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
143407964|NCT03280030|517041500|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
143407965|NCT03280030|517041498|FG000|Part 2 - Efficacy|Progressive disease|0|||
143407966|NCT03280030|517041499|FG001|Part 2 - Efficacy|Progressive disease|7|||
143407967|NCT03280030|517041500|FG002|Part 2 - Efficacy|Progressive disease|5|||
143407968|NCT05485805|517041501|FG000|Overall Study|Withdrawal by Subject|1|||
143407969|NCT05485805|517041502|FG001|Overall Study|Withdrawal by Subject|2|||
143407970|NCT05485805|517041503|FG002|Overall Study|Withdrawal by Subject|2|||
143407971|NCT05485805|517041504|FG003|Overall Study|Withdrawal by Subject|0|||
143407972|NCT05485805|517041505|FG004|Overall Study|Withdrawal by Subject|2|||
143407973|NCT05485805|517041501|FG000|Overall Study|Adverse Event|0|||
143407974|NCT05485805|517041502|FG001|Overall Study|Adverse Event|1|||
143407975|NCT05485805|517041503|FG002|Overall Study|Adverse Event|0|||
143407976|NCT05485805|517041504|FG003|Overall Study|Adverse Event|0|||
143407977|NCT05485805|517041505|FG004|Overall Study|Adverse Event|0|||
143407978|NCT05485805|517041501|FG000|Overall Study|Lost to Follow-up|1|||
143407979|NCT05485805|517041502|FG001|Overall Study|Lost to Follow-up|1|||
143407980|NCT05485805|517041503|FG002|Overall Study|Lost to Follow-up|3|||
143407981|NCT05485805|517041504|FG003|Overall Study|Lost to Follow-up|1|||
143407982|NCT05485805|517041505|FG004|Overall Study|Lost to Follow-up|0|||
143407983|NCT00490139|517041506|FG000|Overall Study|Lost to Follow-up|249|||
143407984|NCT00490139|517041507|FG001|Overall Study|Lost to Follow-up|216|||
143407985|NCT00490139|517041508|FG002|Overall Study|Lost to Follow-up|205|||
143407986|NCT00490139|517041509|FG003|Overall Study|Lost to Follow-up|229|||
143407987|NCT00490139|517041506|FG000|Overall Study|Withdrawal by Subject|333|||
143407988|NCT00490139|517041507|FG001|Overall Study|Withdrawal by Subject|322|||
143407989|NCT00490139|517041508|FG002|Overall Study|Withdrawal by Subject|396|||
143407990|NCT00490139|517041509|FG003|Overall Study|Withdrawal by Subject|295|||
143407991|NCT00490139|517041506|FG000|Overall Study|Patient did not sign ICF 12|169|||
143407992|NCT00490139|517041507|FG001|Overall Study|Patient did not sign ICF 12|176|||
143407993|NCT00490139|517041508|FG002|Overall Study|Patient did not sign ICF 12|139|||
143407994|NCT00490139|517041509|FG003|Overall Study|Patient did not sign ICF 12|167|||
143407995|NCT00490139|517041506|FG000|Overall Study|Data unavailable due to regulatory issues|98|||
143407996|NCT00490139|517041507|FG001|Overall Study|Data unavailable due to regulatory issues|96|||
143407997|NCT00490139|517041508|FG002|Overall Study|Data unavailable due to regulatory issues|85|||
143407998|NCT00490139|517041509|FG003|Overall Study|Data unavailable due to regulatory issues|95|||
143407999|NCT00490139|517041506|FG000|Overall Study|Data unavailable due to lapsed ethical consent|14|||
143408000|NCT00490139|517041507|FG001|Overall Study|Data unavailable due to lapsed ethical consent|13|||
143408001|NCT00490139|517041508|FG002|Overall Study|Data unavailable due to lapsed ethical consent|14|||
143408002|NCT00490139|517041509|FG003|Overall Study|Data unavailable due to lapsed ethical consent|14|||
143408003|NCT00490139|517041506|FG000|Overall Study|Other reasons as defined per protocol|98|||
143408004|NCT00490139|517041507|FG001|Overall Study|Other reasons as defined per protocol|84|||
143408005|NCT00490139|517041508|FG002|Overall Study|Other reasons as defined per protocol|82|||
143408006|NCT00490139|517041509|FG003|Overall Study|Other reasons as defined per protocol|105|||
143408007|NCT06056310|517042700|FG000|Overall Study|Other Reasons|2|||
143408008|NCT06056310|517042700|FG000|Overall Study|Sponsor Request|16|||
143408009|NCT05250115|517042702|FG000|Overall Study|Premature study end|40|||
143408010|NCT05250115|517042702|FG000|Overall Study|Adverse Event|8|||
143408011|NCT05250115|517042702|FG000|Overall Study|Lost to Follow-up|7|||
143408012|NCT05250115|517042702|FG000|Overall Study|Withdrawal by Subject|6|||
143408013|NCT05250115|517042702|FG000|Overall Study|Withdrawal of informed consent|1|||
143408014|NCT05250115|517042702|FG000|Overall Study|Other|7|||
143408015|NCT00065182|517042713|FG000|Overall Study|Adverse Event|24|||
143408016|NCT00065182|517042714|FG001|Overall Study|Adverse Event|17|||
143408017|NCT00065182|517042713|FG000|Overall Study|Lost to Follow-up|0|||
143408018|NCT00065182|517042714|FG001|Overall Study|Lost to Follow-up|4|||
143408019|NCT00065182|517042713|FG000|Overall Study|Protocol Violation|3|||
143408020|NCT00065182|517042714|FG001|Overall Study|Protocol Violation|4|||
143408021|NCT00065182|517042713|FG000|Overall Study|Serious adverse events (SAE)|1|||
143408022|NCT00065182|517042714|FG001|Overall Study|Serious adverse events (SAE)|0|||
143408023|NCT00065182|517042713|FG000|Overall Study|Sponsor Decision|11|||
143408024|NCT00065182|517042714|FG001|Overall Study|Sponsor Decision|7|||
143408025|NCT00065182|517042713|FG000|Overall Study|Withdrawal by Subject|8|||
143408026|NCT00065182|517042714|FG001|Overall Study|Withdrawal by Subject|3|||
143408027|NCT00065182|517042713|FG000|Overall Study|No clinical benefit|1|||
143408028|NCT00065182|517042714|FG001|Overall Study|No clinical benefit|0|||
143408029|NCT00065182|517042713|FG000|Overall Study|Death|0|||
143408030|NCT00065182|517042714|FG001|Overall Study|Death|1|||
143408031|NCT00065182|517042713|FG000|Overall Study|Decline in Status|0|||
143408032|NCT00065182|517042714|FG001|Overall Study|Decline in Status|1|||
143408033|NCT02633215|517042715|FG000|Overall Study|Lost to Follow-up|2|||
143408034|NCT02633215|517042716|FG001|Overall Study|Lost to Follow-up|3|||
143408035|NCT00754325|517042717|FG000|Initial Treatment|Continuing Active Treatment|4|||
143408036|NCT00754325|517042718|FG001|Initial Treatment|Continuing Active Treatment|5|||
143408037|NCT00754325|517042717|FG000|Initial Treatment|Adverse Event|7|||
143408038|NCT00754325|517042718|FG001|Initial Treatment|Adverse Event|6|||
143408039|NCT00754325|517042717|FG000|Initial Treatment|Withdrawal by Subject|2|||
143408040|NCT00754325|517042718|FG001|Initial Treatment|Withdrawal by Subject|2|||
143408041|NCT00754325|517042717|FG000|Initial Treatment|Physician Decision|2|||
143408042|NCT00754325|517042718|FG001|Initial Treatment|Physician Decision|0|||
143408043|NCT00754325|517042717|FG000|Initial Treatment|Sponsor Request|0|||
143408044|NCT00754325|517042718|FG001|Initial Treatment|Sponsor Request|1|||
143408045|NCT00754325|517042717|FG000|Initial Treatment|Disease Progression|35|||
143408046|NCT00754325|517042718|FG001|Initial Treatment|Disease Progression|35|||
143408047|NCT03442777|517042719|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
143408048|NCT03442777|517042720|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
143408049|NCT03442777|517042721|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
143408050|NCT00890591|517042722|FG000|Overall Study|Lack of Efficacy|20|||
143408051|NCT01436175|517042723|FG000|Overall Study|Adverse Event|111|||
143408052|NCT01436175|517042723|FG000|Overall Study|Protocol Violation|49|||
143408053|NCT01436175|517042723|FG000|Overall Study|Withdrawal by Subject|108|||
143408054|NCT01436175|517042723|FG000|Overall Study|Lost to Follow-up|89|||
143408055|NCT01436175|517042723|FG000|Overall Study|Lack of Efficacy|24|||
143408056|NCT01436175|517042723|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
143408057|NCT01436175|517042723|FG000|Overall Study|Other|826|||
143408058|NCT05405244|517042724|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
143408059|NCT05405244|517042725|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
143408060|NCT05405244|517042724|FG000|Washout (2 Weeks)|Adverse Event|2|||
143408061|NCT05405244|517042725|FG001|Washout (2 Weeks)|Adverse Event|0|||
143408062|NCT05405244|517042724|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
143408063|NCT05405244|517042725|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
143408064|NCT00263757|517042726|FG000|Overall Study|Withdrawal by Subject|5|||
143408065|NCT00263757|517042727|FG001|Overall Study|Withdrawal by Subject|4|||
143408066|NCT00263757|517042726|FG000|Overall Study|Screen failure|0|||
143408067|NCT00263757|517042727|FG001|Overall Study|Screen failure|1|||
143408068|NCT00263757|517042726|FG000|Overall Study|Adverse Event|3|||
143408069|NCT00263757|517042727|FG001|Overall Study|Adverse Event|3|||
143408070|NCT02101775|517042731|FG000|Overall Study|Adverse Event|4|||
143408071|NCT02101775|517042732|FG001|Overall Study|Adverse Event|0|||
143408072|NCT02101775|517042733|FG002|Overall Study|Adverse Event|0|||
143408073|NCT02101775|517042731|FG000|Overall Study|Admission to Hospital|0|||
143408074|NCT02101775|517042732|FG001|Overall Study|Admission to Hospital|1|||
143408075|NCT02101775|517042733|FG002|Overall Study|Admission to Hospital|0|||
143408076|NCT00503906|517042734|FG000|Overall Study|Withdrawal by Subject|1|||
143408077|NCT01499849|517042735|FG000|Overall Study|Adverse Event|28|||
143408078|NCT01499849|517042736|FG001|Overall Study|Adverse Event|32|||
143408079|NCT01499849|517042735|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
143408080|NCT01499849|517042736|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
143408081|NCT01499849|517042735|FG000|Overall Study|Withdrawal by Subject|43|||
143408082|NCT01499849|517042736|FG001|Overall Study|Withdrawal by Subject|43|||
143408083|NCT01499849|517042735|FG000|Overall Study|Death|5|||
143408084|NCT01499849|517042736|FG001|Overall Study|Death|7|||
143408085|NCT01499849|517042735|FG000|Overall Study|Disease Progression|11|||
143408086|NCT01499849|517042736|FG001|Overall Study|Disease Progression|10|||
143408087|NCT01499849|517042735|FG000|Overall Study|Protocol Violation|11|||
143408088|NCT01499849|517042736|FG001|Overall Study|Protocol Violation|11|||
143408089|NCT01499849|517042735|FG000|Overall Study|Physician Decision|20|||
143408090|NCT01499849|517042736|FG001|Overall Study|Physician Decision|19|||
143408091|NCT01499849|517042735|FG000|Overall Study|Lack of Efficacy|3|||
143408092|NCT01499849|517042736|FG001|Overall Study|Lack of Efficacy|4|||
143408093|NCT01499849|517042735|FG000|Overall Study|Lost to Follow-up|6|||
143408094|NCT01499849|517042736|FG001|Overall Study|Lost to Follow-up|3|||
143408095|NCT01499849|517042735|FG000|Overall Study|Other Reasons|27|||
143408096|NCT01499849|517042736|FG001|Overall Study|Other Reasons|30|||
143408097|NCT00174252|517042737|FG000|Overall Study|Protocol Violation|2|||
143408098|NCT00622700|517042743|FG000|Core Treatment Period|Randomized but Not Treated|0|||
143408099|NCT00622700|517042744|FG001|Core Treatment Period|Randomized but Not Treated|2|||
143408100|NCT00622700|517042745|FG002|Core Treatment Period|Randomized but Not Treated|2|||
143408101|NCT00622700|517042746|FG003|Core Treatment Period|Randomized but Not Treated|0|||
143408102|NCT00622700|517042747|FG004|Core Treatment Period|Randomized but Not Treated|0|||
143408103|NCT00622700|517042748|FG005|Core Treatment Period|Randomized but Not Treated|0|||
143408104|NCT00622700|517042749|FG006|Core Treatment Period|Randomized but Not Treated|0|||
143408105|NCT00622700|517042743|FG000|Core Treatment Period|Adverse Event|18|||
143408106|NCT00622700|517042744|FG001|Core Treatment Period|Adverse Event|25|||
143408107|NCT00622700|517042745|FG002|Core Treatment Period|Adverse Event|18|||
143408108|NCT00622700|517042746|FG003|Core Treatment Period|Adverse Event|0|||
143408109|NCT00622700|517042747|FG004|Core Treatment Period|Adverse Event|0|||
143408110|NCT00622700|517042748|FG005|Core Treatment Period|Adverse Event|0|||
143408111|NCT00622700|517042749|FG006|Core Treatment Period|Adverse Event|0|||
143408112|NCT00622700|517042743|FG000|Core Treatment Period|Lack of Efficacy|19|||
143408113|NCT00622700|517042744|FG001|Core Treatment Period|Lack of Efficacy|6|||
143408114|NCT00622700|517042745|FG002|Core Treatment Period|Lack of Efficacy|12|||
143408115|NCT00622700|517042746|FG003|Core Treatment Period|Lack of Efficacy|0|||
143408116|NCT00622700|517042747|FG004|Core Treatment Period|Lack of Efficacy|0|||
143408117|NCT00622700|517042748|FG005|Core Treatment Period|Lack of Efficacy|0|||
143408118|NCT00622700|517042749|FG006|Core Treatment Period|Lack of Efficacy|0|||
143408119|NCT00622700|517042743|FG000|Core Treatment Period|Lost to Follow-up|1|||
143408120|NCT00622700|517042744|FG001|Core Treatment Period|Lost to Follow-up|1|||
143408121|NCT00622700|517042745|FG002|Core Treatment Period|Lost to Follow-up|1|||
143408122|NCT00622700|517042746|FG003|Core Treatment Period|Lost to Follow-up|0|||
143408123|NCT00622700|517042747|FG004|Core Treatment Period|Lost to Follow-up|0|||
143408124|NCT00622700|517042748|FG005|Core Treatment Period|Lost to Follow-up|0|||
143408125|NCT00622700|517042749|FG006|Core Treatment Period|Lost to Follow-up|0|||
143408126|NCT00622700|517042743|FG000|Core Treatment Period|Death|1|||
143408127|NCT00622700|517042744|FG001|Core Treatment Period|Death|0|||
143408128|NCT00622700|517042745|FG002|Core Treatment Period|Death|0|||
143408129|NCT00622700|517042746|FG003|Core Treatment Period|Death|0|||
143408130|NCT00622700|517042747|FG004|Core Treatment Period|Death|0|||
143408131|NCT00622700|517042748|FG005|Core Treatment Period|Death|0|||
143408132|NCT00622700|517042749|FG006|Core Treatment Period|Death|0|||
143408133|NCT00622700|517042743|FG000|Core Treatment Period|Progressive Disease|3|||
143408134|NCT00622700|517042744|FG001|Core Treatment Period|Progressive Disease|1|||
143408135|NCT00622700|517042745|FG002|Core Treatment Period|Progressive Disease|0|||
143408136|NCT00622700|517042746|FG003|Core Treatment Period|Progressive Disease|0|||
143408137|NCT00622700|517042747|FG004|Core Treatment Period|Progressive Disease|0|||
143408138|NCT00622700|517042748|FG005|Core Treatment Period|Progressive Disease|0|||
143408139|NCT00622700|517042749|FG006|Core Treatment Period|Progressive Disease|0|||
143408140|NCT00622700|517042743|FG000|Core Treatment Period|Withdrawal by Subject|12|||
143408141|NCT00622700|517042744|FG001|Core Treatment Period|Withdrawal by Subject|18|||
143408142|NCT00622700|517042745|FG002|Core Treatment Period|Withdrawal by Subject|15|||
143408143|NCT00622700|517042746|FG003|Core Treatment Period|Withdrawal by Subject|0|||
143408144|NCT00622700|517042747|FG004|Core Treatment Period|Withdrawal by Subject|0|||
143408145|NCT00622700|517042748|FG005|Core Treatment Period|Withdrawal by Subject|0|||
143408146|NCT00622700|517042749|FG006|Core Treatment Period|Withdrawal by Subject|0|||
143408147|NCT00622700|517042743|FG000|Core Treatment Period|Other than specified above|2|||
143408148|NCT00622700|517042744|FG001|Core Treatment Period|Other than specified above|2|||
143408149|NCT00622700|517042745|FG002|Core Treatment Period|Other than specified above|5|||
143408150|NCT00622700|517042746|FG003|Core Treatment Period|Other than specified above|0|||
143408151|NCT00622700|517042747|FG004|Core Treatment Period|Other than specified above|0|||
143408152|NCT00622700|517042748|FG005|Core Treatment Period|Other than specified above|0|||
143408153|NCT00622700|517042749|FG006|Core Treatment Period|Other than specified above|0|||
143408154|NCT00622700|517042743|FG000|Extension Treatment Period|Adverse Event|0|||
143408155|NCT00622700|517042744|FG001|Extension Treatment Period|Adverse Event|0|||
143408156|NCT00622700|517042745|FG002|Extension Treatment Period|Adverse Event|0|||
143408157|NCT00622700|517042746|FG003|Extension Treatment Period|Adverse Event|5|||
143408158|NCT00622700|517042747|FG004|Extension Treatment Period|Adverse Event|9|||
143408159|NCT00622700|517042748|FG005|Extension Treatment Period|Adverse Event|6|||
143408160|NCT00622700|517042749|FG006|Extension Treatment Period|Adverse Event|8|||
143408161|NCT00622700|517042743|FG000|Extension Treatment Period|Lack of Efficacy|0|||
143408162|NCT00622700|517042744|FG001|Extension Treatment Period|Lack of Efficacy|0|||
143408163|NCT00622700|517042745|FG002|Extension Treatment Period|Lack of Efficacy|0|||
143408164|NCT00622700|517042746|FG003|Extension Treatment Period|Lack of Efficacy|2|||
143408165|NCT00622700|517042747|FG004|Extension Treatment Period|Lack of Efficacy|8|||
143408166|NCT00622700|517042748|FG005|Extension Treatment Period|Lack of Efficacy|1|||
143408167|NCT00622700|517042749|FG006|Extension Treatment Period|Lack of Efficacy|9|||
143408168|NCT00622700|517042743|FG000|Extension Treatment Period|Protocol Violation|0|||
143408169|NCT00622700|517042744|FG001|Extension Treatment Period|Protocol Violation|0|||
143408170|NCT00622700|517042745|FG002|Extension Treatment Period|Protocol Violation|0|||
143408171|NCT00622700|517042746|FG003|Extension Treatment Period|Protocol Violation|0|||
143408172|NCT00622700|517042747|FG004|Extension Treatment Period|Protocol Violation|0|||
143408173|NCT00622700|517042748|FG005|Extension Treatment Period|Protocol Violation|2|||
143408174|NCT00622700|517042749|FG006|Extension Treatment Period|Protocol Violation|0|||
143408175|NCT00622700|517042743|FG000|Extension Treatment Period|Lost to Follow-up|0|||
143408176|NCT00622700|517042744|FG001|Extension Treatment Period|Lost to Follow-up|0|||
143408177|NCT00622700|517042745|FG002|Extension Treatment Period|Lost to Follow-up|0|||
143408178|NCT00622700|517042746|FG003|Extension Treatment Period|Lost to Follow-up|0|||
143408179|NCT00622700|517042747|FG004|Extension Treatment Period|Lost to Follow-up|1|||
143408180|NCT00622700|517042748|FG005|Extension Treatment Period|Lost to Follow-up|0|||
143408181|NCT00622700|517042749|FG006|Extension Treatment Period|Lost to Follow-up|0|||
143408182|NCT00622700|517042743|FG000|Extension Treatment Period|Progressive Disease|0|||
143408183|NCT00622700|517042744|FG001|Extension Treatment Period|Progressive Disease|0|||
143408184|NCT00622700|517042745|FG002|Extension Treatment Period|Progressive Disease|0|||
143408185|NCT00622700|517042746|FG003|Extension Treatment Period|Progressive Disease|1|||
143408186|NCT00622700|517042747|FG004|Extension Treatment Period|Progressive Disease|2|||
143408187|NCT00622700|517042748|FG005|Extension Treatment Period|Progressive Disease|0|||
143408188|NCT00622700|517042749|FG006|Extension Treatment Period|Progressive Disease|2|||
143408189|NCT00622700|517042743|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
143408190|NCT00622700|517042744|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
143408191|NCT00622700|517042745|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
143408192|NCT00622700|517042746|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
143408193|NCT00622700|517042747|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
143408194|NCT00622700|517042748|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
143408195|NCT00622700|517042749|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
143408196|NCT00622700|517042743|FG000|Extension Treatment Period|Missing|0|||
143408197|NCT00622700|517042744|FG001|Extension Treatment Period|Missing|0|||
143408198|NCT00622700|517042745|FG002|Extension Treatment Period|Missing|0|||
143408199|NCT00622700|517042746|FG003|Extension Treatment Period|Missing|2|||
143408200|NCT00622700|517042747|FG004|Extension Treatment Period|Missing|3|||
143408201|NCT00622700|517042748|FG005|Extension Treatment Period|Missing|1|||
143408202|NCT00622700|517042749|FG006|Extension Treatment Period|Missing|0|||
143408203|NCT00622700|517042743|FG000|Extension Treatment Period|Other than specified above|0|||
143408204|NCT00622700|517042744|FG001|Extension Treatment Period|Other than specified above|0|||
143408205|NCT00622700|517042745|FG002|Extension Treatment Period|Other than specified above|0|||
143408206|NCT00622700|517042746|FG003|Extension Treatment Period|Other than specified above|0|||
143408207|NCT00622700|517042747|FG004|Extension Treatment Period|Other than specified above|0|||
143408208|NCT00622700|517042748|FG005|Extension Treatment Period|Other than specified above|1|||
143408209|NCT00622700|517042749|FG006|Extension Treatment Period|Other than specified above|1|||
143408210|NCT00942266|517042750|FG000|Overall Study|Withdrawal by Subject|1|||
143408211|NCT00942266|517042751|FG001|Overall Study|Withdrawal by Subject|0|||
143408212|NCT00942266|517042750|FG000|Overall Study|Adverse Event|2|||
143408213|NCT00942266|517042751|FG001|Overall Study|Adverse Event|1|||
143408214|NCT00942266|517042750|FG000|Overall Study|Disease Progression|38|||
143408215|NCT00942266|517042751|FG001|Overall Study|Disease Progression|11|||
143408216|NCT00942266|517042750|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
143408217|NCT00942266|517042751|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
143408218|NCT00942266|517042750|FG000|Overall Study|Intercurrent illness|0|||
143408219|NCT00942266|517042751|FG001|Overall Study|Intercurrent illness|1|||
143408220|NCT00942266|517042750|FG000|Overall Study|Physician Decision|2|||
143408221|NCT00942266|517042751|FG001|Overall Study|Physician Decision|0|||
143408222|NCT00942266|517042750|FG000|Overall Study|medical deterioration (pneumonia)|0|||
143408223|NCT00942266|517042751|FG001|Overall Study|medical deterioration (pneumonia)|1|||
143408224|NCT04035447|517042758|FG000|Treatment Period|Lost to Follow-up|6|||
143408225|NCT04035447|517042759|FG001|Treatment Period|Lost to Follow-up|5|||
143408226|NCT04035447|517042758|FG000|Treatment Period|Physician Decision|0|||
143408227|NCT04035447|517042759|FG001|Treatment Period|Physician Decision|2|||
143408228|NCT01458366|517042762|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
143408229|NCT01458366|517042763|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
143408230|NCT01458366|517042764|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
143408231|NCT01458366|517042765|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
143408232|NCT01458366|517042766|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
143408233|NCT01458366|517042762|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
143408234|NCT01458366|517042763|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
143408235|NCT01458366|517042764|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
143408236|NCT01458366|517042765|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
143408237|NCT01458366|517042766|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
143408238|NCT02787005|517042767|FG000|Overall Study|Adverse Event|24|||
143408239|NCT02787005|517042768|FG001|Overall Study|Adverse Event|9|||
143408240|NCT02787005|517042769|FG002|Overall Study|Adverse Event|9|||
143408241|NCT02787005|517042770|FG003|Overall Study|Adverse Event|7|||
143408242|NCT02787005|517042771|FG004|Overall Study|Adverse Event|2|||
143408243|NCT02787005|517042767|FG000|Overall Study|Death|100|||
143408244|NCT02787005|517042768|FG001|Overall Study|Death|53|||
143408245|NCT02787005|517042769|FG002|Overall Study|Death|48|||
143408246|NCT02787005|517042770|FG003|Overall Study|Death|69|||
143408247|NCT02787005|517042771|FG004|Overall Study|Death|38|||
143408248|NCT02787005|517042767|FG000|Overall Study|Sponsor Decision|7|||
143408249|NCT02787005|517042768|FG001|Overall Study|Sponsor Decision|4|||
143408250|NCT02787005|517042769|FG002|Overall Study|Sponsor Decision|0|||
143408251|NCT02787005|517042770|FG003|Overall Study|Sponsor Decision|4|||
143408252|NCT02787005|517042771|FG004|Overall Study|Sponsor Decision|5|||
143408253|NCT02787005|517042767|FG000|Overall Study|Withdrawal by Subject|2|||
143408254|NCT02787005|517042768|FG001|Overall Study|Withdrawal by Subject|1|||
143408255|NCT02787005|517042769|FG002|Overall Study|Withdrawal by Subject|1|||
143408256|NCT02787005|517042770|FG003|Overall Study|Withdrawal by Subject|0|||
143408257|NCT02787005|517042771|FG004|Overall Study|Withdrawal by Subject|1|||
143408258|NCT02787005|517042767|FG000|Overall Study|Screen Failure|0|||
143408259|NCT02787005|517042768|FG001|Overall Study|Screen Failure|2|||
143408260|NCT02787005|517042769|FG002|Overall Study|Screen Failure|0|||
143408261|NCT02787005|517042770|FG003|Overall Study|Screen Failure|0|||
143408262|NCT02787005|517042771|FG004|Overall Study|Screen Failure|1|||
143408263|NCT02787005|517042767|FG000|Overall Study|Lost to Follow-up|0|||
143408264|NCT02787005|517042768|FG001|Overall Study|Lost to Follow-up|0|||
143408265|NCT02787005|517042769|FG002|Overall Study|Lost to Follow-up|0|||
143408266|NCT02787005|517042770|FG003|Overall Study|Lost to Follow-up|1|||
143408267|NCT02787005|517042771|FG004|Overall Study|Lost to Follow-up|0|||
143408268|NCT02392234|517042772|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
143408269|NCT02392234|517042773|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
143408270|NCT02392234|517042774|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
143408271|NCT02392234|517042775|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
143408272|NCT02392234|517042776|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
143408273|NCT02392234|517042777|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
143408274|NCT02392234|517042772|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
143408275|NCT02392234|517042773|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
143408276|NCT02392234|517042774|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
143408277|NCT02392234|517042775|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
143408278|NCT02392234|517042776|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
143408279|NCT02392234|517042777|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
143408280|NCT02392234|517042772|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
143408281|NCT02392234|517042773|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
143408282|NCT02392234|517042774|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
143408283|NCT02392234|517042775|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
143408284|NCT02392234|517042776|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
143408285|NCT02392234|517042777|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
143408286|NCT02392234|517042772|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
143408287|NCT02392234|517042773|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
143408288|NCT02392234|517042774|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
143408289|NCT02392234|517042775|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
143408290|NCT02392234|517042776|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
143408291|NCT02392234|517042777|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
143408292|NCT02392234|517042772|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
143408293|NCT02392234|517042773|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
143408294|NCT02392234|517042774|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
143408295|NCT02392234|517042775|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
143408296|NCT02392234|517042776|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
143408297|NCT02392234|517042777|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
143408298|NCT02392234|517042772|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
143408299|NCT02392234|517042773|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
143408300|NCT02392234|517042774|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
143408301|NCT02392234|517042775|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
143408302|NCT02392234|517042776|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
143408303|NCT02392234|517042777|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
143408304|NCT02392234|517042772|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
143408305|NCT02392234|517042773|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
143408306|NCT02392234|517042774|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
143408307|NCT02392234|517042775|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
143408308|NCT02392234|517042776|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
143408309|NCT02392234|517042777|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
143408310|NCT02392234|517042772|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
143408311|NCT02392234|517042773|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
143408312|NCT02392234|517042774|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
143408313|NCT02392234|517042775|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
143408314|NCT02392234|517042776|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
143408315|NCT02392234|517042777|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
143408316|NCT02029235|517042778|FG000|Overall Study|Non-compliance with study meds or diary|4|||
143408317|NCT02029235|517042779|FG001|Overall Study|Non-compliance with study meds or diary|1|||
143408318|NCT01387516|517042780|FG000|Overall Study|Lost to Follow-up|4|||
143408319|NCT01387516|517042781|FG001|Overall Study|Lost to Follow-up|4|||
143408320|NCT01387516|517042782|FG002|Overall Study|Lost to Follow-up|2|||
143408321|NCT01387516|517042783|FG003|Overall Study|Lost to Follow-up|3|||
143408322|NCT01387516|517042780|FG000|Overall Study|Withdrawal by Subject|1|||
143408323|NCT01387516|517042781|FG001|Overall Study|Withdrawal by Subject|1|||
143408324|NCT01387516|517042782|FG002|Overall Study|Withdrawal by Subject|2|||
143408325|NCT01387516|517042783|FG003|Overall Study|Withdrawal by Subject|0|||
143408326|NCT01387516|517042780|FG000|Overall Study|Death|0|||
143408327|NCT01387516|517042781|FG001|Overall Study|Death|0|||
143408328|NCT01387516|517042782|FG002|Overall Study|Death|0|||
143408329|NCT01387516|517042783|FG003|Overall Study|Death|1|||
143408330|NCT03509909|517042784|FG000|Overall Study|Withdrawal by Subject|16|||
143408331|NCT03509909|517042785|FG001|Overall Study|Withdrawal by Subject|9|||
143408332|NCT03509909|517042784|FG000|Overall Study|Lost to Follow-up|3|||
143408333|NCT03509909|517042785|FG001|Overall Study|Lost to Follow-up|4|||
143408334|NCT03509909|517042784|FG000|Overall Study|Adverse Event|2|||
143408335|NCT03509909|517042785|FG001|Overall Study|Adverse Event|0|||
143408336|NCT02130557|517042789|FG000|Overall Study|Withdrawal by Subject|12|||
143408337|NCT02130557|517042790|FG001|Overall Study|Withdrawal by Subject|12|||
143408338|NCT02130557|517042789|FG000|Overall Study|Investigator Request|0|||
143408339|NCT02130557|517042790|FG001|Overall Study|Investigator Request|2|||
143408340|NCT02130557|517042789|FG000|Overall Study|Deceased|14|||
143408341|NCT02130557|517042790|FG001|Overall Study|Deceased|14|||
143408342|NCT02130557|517042789|FG000|Overall Study|Lost to Follow-up|6|||
143408343|NCT02130557|517042790|FG001|Overall Study|Lost to Follow-up|7|||
143408344|NCT02130557|517042789|FG000|Overall Study|Other|2|||
143408345|NCT02130557|517042790|FG001|Overall Study|Other|1|||
143408346|NCT02130557|517042789|FG000|Overall Study|Missing|2|||
143408347|NCT02130557|517042790|FG001|Overall Study|Missing|1|||
143408348|NCT01532999|517042791|FG000|Overall Study|Lost to Follow-up|14|||
143408349|NCT01532999|517042792|FG001|Overall Study|Lost to Follow-up|8|||
143408350|NCT01532999|517042791|FG000|Overall Study|Physician Decision|1|||
143408351|NCT01532999|517042792|FG001|Overall Study|Physician Decision|2|||
143408352|NCT01532999|517042791|FG000|Overall Study|Withdrawal by Subject|5|||
143408353|NCT01532999|517042792|FG001|Overall Study|Withdrawal by Subject|0|||
143408354|NCT01532999|517042791|FG000|Overall Study|Relocated|2|||
143408355|NCT01532999|517042792|FG001|Overall Study|Relocated|0|||
143408356|NCT01532999|517042791|FG000|Overall Study|should not have been randomized|1|||
143408357|NCT01532999|517042792|FG001|Overall Study|should not have been randomized|0|||
143408358|NCT01532999|517042791|FG000|Overall Study|substantial noncompliance|2|||
143408359|NCT01532999|517042792|FG001|Overall Study|substantial noncompliance|0|||
143408360|NCT01532999|517042791|FG000|Overall Study|no show for week 9 assessments|6|||
143408361|NCT01532999|517042792|FG001|Overall Study|no show for week 9 assessments|4|||
143408362|NCT01532999|517042791|FG000|Overall Study|Adverse Event|0|||
143408363|NCT01532999|517042792|FG001|Overall Study|Adverse Event|1|||
143408364|NCT01532999|517042791|FG000|Overall Study|incarcerated|0|||
143408365|NCT01532999|517042792|FG001|Overall Study|incarcerated|1|||
143408366|NCT01532999|517042791|FG000|Overall Study|New job|0|||
143408367|NCT01532999|517042792|FG001|Overall Study|New job|2|||
143408368|NCT02928172|517042793|FG000|Overall Study|Device did not record data|1|||
143408369|NCT02408887|517042794|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
143408370|NCT02408887|517042795|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
143408371|NCT02408887|517042794|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
143408372|NCT02408887|517042795|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
143408373|NCT03333109|517042797|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
143408374|NCT03333109|517042798|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
143408375|NCT03333109|517042799|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
143408376|NCT03333109|517042797|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
143408377|NCT03333109|517042798|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
143408378|NCT03333109|517042799|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
143408379|NCT03333109|517042797|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
143408380|NCT03333109|517042798|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
143408381|NCT03333109|517042799|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
143408382|NCT03333109|517042797|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
143408383|NCT03333109|517042798|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
143408384|NCT03333109|517042799|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
143408385|NCT03333109|517042797|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
143408386|NCT03333109|517042798|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
143408387|NCT03333109|517042799|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
143408388|NCT03333109|517042797|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
143408389|NCT03333109|517042798|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
143408390|NCT03333109|517042799|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
143408391|NCT03333109|517042797|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
143408392|NCT03333109|517042798|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
143408393|NCT03333109|517042799|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
143408394|NCT03333109|517042797|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
143408395|NCT03333109|517042798|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
143408396|NCT03333109|517042799|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
143408397|NCT02016872|517042800|FG000|Overall Study|Withdrawal by Subject|10|||
143408398|NCT02016872|517042800|FG000|Overall Study|Death Progression|2|||
143408399|NCT02016872|517042800|FG000|Overall Study|No FMISO scan|1|||
143408400|NCT02016872|517042800|FG000|Overall Study|Ineligible|2|||
143408401|NCT04153890|517042801|FG000|Overall Study|Lost to Follow-up|9|||
143408402|NCT04153890|517042802|FG001|Overall Study|Lost to Follow-up|0|||
143408403|NCT04153890|517042803|FG002|Overall Study|Lost to Follow-up|9|||
143408404|NCT04153890|517042804|FG003|Overall Study|Lost to Follow-up|0|||
143408405|NCT04153890|517042801|FG000|Overall Study|Death|0|||
143408406|NCT04153890|517042802|FG001|Overall Study|Death|2|||
143408407|NCT04153890|517042803|FG002|Overall Study|Death|0|||
143408408|NCT04153890|517042804|FG003|Overall Study|Death|0|||
143408409|NCT04153890|517042801|FG000|Overall Study|Withdrawal by Subject|0|||
143408410|NCT04153890|517042802|FG001|Overall Study|Withdrawal by Subject|0|||
143408411|NCT04153890|517042803|FG002|Overall Study|Withdrawal by Subject|0|||
143408412|NCT04153890|517042804|FG003|Overall Study|Withdrawal by Subject|2|||
143408413|NCT03277989|517042807|FG000|Overall Study|Lost to Follow-up|6|||
143408414|NCT03277989|517042807|FG000|Overall Study|Adverse Event|6|||
143408415|NCT03277989|517042807|FG000|Overall Study|Withdrawal by Subject|3|||
143408416|NCT03277989|517042807|FG000|Overall Study|Didn't Receive Study Device|7|||
143408417|NCT03277989|517042807|FG000|Overall Study|Site Closure|26|||
143408418|NCT03277989|517042807|FG000|Overall Study|Sponsor Closure|107|||
143408419|NCT02798471|517042810|FG000|Overall Study|Adverse Event|7|||
143408420|NCT02798471|517042811|FG001|Overall Study|Adverse Event|2|||
143408421|NCT02798471|517042810|FG000|Overall Study|Physician Decision|3|||
143408422|NCT02798471|517042811|FG001|Overall Study|Physician Decision|7|||
143408423|NCT02798471|517042810|FG000|Overall Study|Death|2|||
143408424|NCT02798471|517042811|FG001|Overall Study|Death|3|||
143408425|NCT02798471|517042810|FG000|Overall Study|Lost to Follow-up|0|||
143408426|NCT02798471|517042811|FG001|Overall Study|Lost to Follow-up|1|||
143408427|NCT02798471|517042810|FG000|Overall Study|Other|5|||
143408428|NCT02798471|517042811|FG001|Overall Study|Other|3|||
143408429|NCT02798471|517042810|FG000|Overall Study|Subject withdrew consent|0|||
143408430|NCT02798471|517042811|FG001|Overall Study|Subject withdrew consent|6|||
143408431|NCT02798471|517042810|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
143408432|NCT02798471|517042811|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
143408433|NCT02798471|517042810|FG000|Overall Study|Randomized, but not treated|0|||
143408434|NCT02798471|517042811|FG001|Overall Study|Randomized, but not treated|2|||
143408435|NCT03083366|517044107|FG000|Screening Period|Did not meet criteria (screen fail)|1|||
143408436|NCT03083366|517044108|FG001|Screening Period|Did not meet criteria (screen fail)|0|||
143408437|NCT03083366|517044107|FG000|Enrollment Period|Lack of Efficacy|1|||
143408438|NCT03083366|517044108|FG001|Enrollment Period|Lack of Efficacy|0|||
143408439|NCT02702843|517044109|FG000|Overall Study|Insufficient data to analyze|15|||
143408440|NCT02702843|517044110|FG001|Overall Study|Insufficient data to analyze|23|||
143408441|NCT03758638|517044111|FG000|Overall Study|Pregnancy|17|||
143408442|NCT03758638|517044112|FG001|Overall Study|Pregnancy|25|||
143408443|NCT03758638|517044111|FG000|Overall Study|Lost to Follow-up|60|||
143408444|NCT03758638|517044112|FG001|Overall Study|Lost to Follow-up|54|||
143408445|NCT03758638|517044111|FG000|Overall Study|Protocol Violation|2|||
143408446|NCT03758638|517044112|FG001|Overall Study|Protocol Violation|0|||
143408447|NCT03758638|517044111|FG000|Overall Study|Withdrawal by Subject|8|||
143408448|NCT03758638|517044112|FG001|Overall Study|Withdrawal by Subject|2|||
143408449|NCT03758638|517044111|FG000|Overall Study|Providers not included in the primary outcome.|183|||
143408450|NCT03758638|517044112|FG001|Overall Study|Providers not included in the primary outcome.|128|||
143408451|NCT03253848|517044113|FG000|Overall Study|Adverse Event|7|||
143408452|NCT03253848|517044113|FG000|Overall Study|Death|5|||
143408453|NCT03253848|517044113|FG000|Overall Study|initiation of other treatments|3|||
143408454|NCT03253848|517044113|FG000|Overall Study|Other complicating disease|1|||
143408455|NCT03253848|517044113|FG000|Overall Study|Withdrawal by Subject|1|||
143408456|NCT03253848|517044113|FG000|Overall Study|Declining health|1|||
143408457|NCT01314118|517044114|FG000|Overall Study|Adverse Event|9|||
143408458|NCT01314118|517044114|FG000|Overall Study|Progressive disease|27|||
143408459|NCT01314118|517044114|FG000|Overall Study|Physician Decision|11|||
143408460|NCT01314118|517044114|FG000|Overall Study|Death|4|||
143408461|NCT01314118|517044114|FG000|Overall Study|Protocol Violation|5|||
143408462|NCT01314118|517044114|FG000|Overall Study|Withdrawal by Subject|11|||
143408463|NCT01314118|517044114|FG000|Overall Study|Other|2|||
143408464|NCT01314118|517044114|FG000|Overall Study|Ongoing|62|||
143408465|NCT02866942|517044115|FG000|Overall Study|Invalid consent|1|||
143408466|NCT01641900|517044116|FG000|Overall Study|Withdrawal by Subject|2|||
143408467|NCT01641900|517044117|FG001|Overall Study|Withdrawal by Subject|2|||
143408468|NCT00790569|517044118|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
143408469|NCT00790569|517044119|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
143408470|NCT00790569|517044120|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
143408471|NCT00790569|517044118|FG000|End of Treatment (6 Month Interview)|Death|0|||
143408472|NCT00790569|517044119|FG001|End of Treatment (6 Month Interview)|Death|2|||
143408473|NCT00790569|517044120|FG002|End of Treatment (6 Month Interview)|Death|1|||
143408474|NCT00790569|517044118|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
143408475|NCT00790569|517044119|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
143408476|NCT00790569|517044120|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
143408477|NCT00790569|517044118|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
143408478|NCT00790569|517044119|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
143408479|NCT00790569|517044120|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
143408480|NCT00790569|517044118|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
143408481|NCT00790569|517044119|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
143408482|NCT00790569|517044120|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
143408483|NCT00790569|517044118|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
143408484|NCT00790569|517044119|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
143408485|NCT00790569|517044120|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
143408486|NCT03244800|517044121|FG000|Overall Study|Adverse Event|0|||
143408487|NCT03244800|517044122|FG001|Overall Study|Adverse Event|1|||
143408488|NCT03244800|517044123|FG002|Overall Study|Adverse Event|0|||
143408489|NCT03244800|517044124|FG003|Overall Study|Adverse Event|1|||
143408490|NCT03244800|517044121|FG000|Overall Study|Withdrew treatment|0|||
143408491|NCT03244800|517044122|FG001|Overall Study|Withdrew treatment|0|||
143408492|NCT03244800|517044123|FG002|Overall Study|Withdrew treatment|0|||
143408493|NCT03244800|517044124|FG003|Overall Study|Withdrew treatment|1|||
143408494|NCT00371345|517044128|FG000|Overall Study|Disease Progression|21|||
143408495|NCT00371345|517044129|FG001|Overall Study|Disease Progression|35|||
143408496|NCT00371345|517044128|FG000|Overall Study|Study Drug Toxicity|1|||
143408497|NCT00371345|517044129|FG001|Overall Study|Study Drug Toxicity|7|||
143408498|NCT00371345|517044128|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
143408499|NCT00371345|517044129|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
143408500|NCT00371345|517044128|FG000|Overall Study|Participant Request|1|||
143408501|NCT00371345|517044129|FG001|Overall Study|Participant Request|1|||
143408502|NCT00371345|517044128|FG000|Overall Study|Participant Withdrew Consent|0|||
143408503|NCT00371345|517044129|FG001|Overall Study|Participant Withdrew Consent|1|||
143408504|NCT02941549|517044130|FG000|Overall Study|Adverse Event|1|||
143408505|NCT02941549|517044131|FG001|Overall Study|Adverse Event|0|||
143408506|NCT02941549|517044132|FG002|Overall Study|Adverse Event|0|||
143408507|NCT02941549|517044130|FG000|Overall Study|Withdrawal by Subject|2|||
143408508|NCT02941549|517044131|FG001|Overall Study|Withdrawal by Subject|1|||
143408509|NCT02941549|517044132|FG002|Overall Study|Withdrawal by Subject|2|||
143408510|NCT03451422|517044136|FG000|Overall Study|Lost to Follow-up|0|||
143408511|NCT03451422|517044137|FG001|Overall Study|Lost to Follow-up|0|||
143408512|NCT03451422|517044138|FG002|Overall Study|Lost to Follow-up|0|||
143408513|NCT03451422|517044139|FG003|Overall Study|Lost to Follow-up|0|||
143408514|NCT03451422|517044140|FG004|Overall Study|Lost to Follow-up|0|||
143408515|NCT03451422|517044141|FG005|Overall Study|Lost to Follow-up|1|||
143408516|NCT03451422|517044136|FG000|Overall Study|Decision by sponsor|1|||
143408517|NCT03451422|517044137|FG001|Overall Study|Decision by sponsor|0|||
143408518|NCT03451422|517044138|FG002|Overall Study|Decision by sponsor|1|||
143408519|NCT03451422|517044139|FG003|Overall Study|Decision by sponsor|0|||
143408520|NCT03451422|517044140|FG004|Overall Study|Decision by sponsor|0|||
143408521|NCT03451422|517044141|FG005|Overall Study|Decision by sponsor|0|||
143408522|NCT03451422|517044136|FG000|Overall Study|Withdrawal by Subject|0|||
143408523|NCT03451422|517044137|FG001|Overall Study|Withdrawal by Subject|0|||
143408524|NCT03451422|517044138|FG002|Overall Study|Withdrawal by Subject|2|||
143408525|NCT03451422|517044139|FG003|Overall Study|Withdrawal by Subject|3|||
143408526|NCT03451422|517044140|FG004|Overall Study|Withdrawal by Subject|2|||
143408527|NCT03451422|517044141|FG005|Overall Study|Withdrawal by Subject|1|||
143408528|NCT04527549|517044142|FG000|Overall Study|Withdrawal by Subject|1|||
143408529|NCT04527549|517044143|FG001|Overall Study|Withdrawal by Subject|1|||
143408530|NCT03601715|517044144|FG000|Second Intervention|Lost to Follow-up|1|||
143408531|NCT03601715|517044145|FG001|Second Intervention|Lost to Follow-up|1|||
143408532|NCT03601715|517044146|FG002|Second Intervention|Lost to Follow-up|0|||
143408533|NCT01478594|517044147|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
143408534|NCT01478594|517044148|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
143408535|NCT01478594|517044147|FG000|Overall Study|Death|45|||
143408536|NCT01478594|517044148|FG001|Overall Study|Death|18|||
143408537|NCT01478594|517044147|FG000|Overall Study|Lost to Follow-up|3|||
143408538|NCT01478594|517044148|FG001|Overall Study|Lost to Follow-up|1|||
143408539|NCT01478594|517044147|FG000|Overall Study|Withdrawal by Subject|9|||
143408540|NCT01478594|517044148|FG001|Overall Study|Withdrawal by Subject|3|||
143408541|NCT01478594|517044147|FG000|Overall Study|Study Closed by Sponsor|8|||
143408542|NCT01478594|517044148|FG001|Overall Study|Study Closed by Sponsor|5|||
143408543|NCT00918333|517044149|FG000|Overall Study|Drug not taken per protocol|1|||
143408544|NCT00918333|517044150|FG001|Overall Study|Drug not taken per protocol|0|||
143408545|NCT00918333|517044149|FG000|Overall Study|Inadequate amount of drugs provided|1|||
143408546|NCT00918333|517044150|FG001|Overall Study|Inadequate amount of drugs provided|4|||
143408547|NCT00918333|517044149|FG000|Overall Study|Ineligible|1|||
143408548|NCT00918333|517044150|FG001|Overall Study|Ineligible|0|||
143408549|NCT00918333|517044149|FG000|Overall Study|Withdrawal by Subject|0|||
143408550|NCT00918333|517044150|FG001|Overall Study|Withdrawal by Subject|1|||
143408551|NCT01313884|517044152|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
143408552|NCT00713596|517044153|FG000|Overall Study|Study was terminated|2|||
143408553|NCT00713596|517044154|FG001|Overall Study|Study was terminated|3|||
143408554|NCT00713596|517044155|FG002|Overall Study|Study was terminated|2|||
143408555|NCT04545619|517044156|FG000|Overall Study|due to equipment challenges|1|||
143408556|NCT02854436|517044157|FG000|Overall Study|Adverse Event|1|||
143408557|NCT02854436|517044157|FG000|Overall Study|Death|208|||
143408558|NCT02854436|517044157|FG000|Overall Study|Lost to Follow-up|5|||
143408559|NCT02854436|517044157|FG000|Overall Study|Withdrawal by Subject|24|||
143408560|NCT02854436|517044157|FG000|Overall Study|Other|45|||
143408561|NCT02854436|517044157|FG000|Overall Study|Physician Decision|6|||
143408562|NCT00754065|517044162|FG000|Overall Study|Never received treatment|12|||
143408563|NCT00754065|517044163|FG001|Overall Study|Never received treatment|2|||
143408564|NCT00754065|517044162|FG000|Overall Study|Adverse Event|19|||
143408565|NCT00754065|517044163|FG001|Overall Study|Adverse Event|25|||
143408566|NCT00754065|517044162|FG000|Overall Study|Lost to Follow-up|7|||
143408567|NCT00754065|517044163|FG001|Overall Study|Lost to Follow-up|11|||
143408568|NCT00754065|517044162|FG000|Overall Study|Protocol Violation|12|||
143408569|NCT00754065|517044163|FG001|Overall Study|Protocol Violation|10|||
143408570|NCT00754065|517044162|FG000|Overall Study|Withdrawal by Subject|4|||
143408571|NCT00754065|517044163|FG001|Overall Study|Withdrawal by Subject|5|||
143408572|NCT00754065|517044162|FG000|Overall Study|Pregnancy|6|||
143408573|NCT00754065|517044163|FG001|Overall Study|Pregnancy|0|||
143408574|NCT00754065|517044162|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
143408575|NCT00754065|517044163|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
143408576|NCT04033445|517044164|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
143408577|NCT04033445|517044165|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
143408578|NCT04033445|517044166|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
143408579|NCT04033445|517044167|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
143408580|NCT04033445|517044168|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
143408581|NCT04033445|517044169|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
143408582|NCT04033445|517044170|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
143408583|NCT04033445|517044171|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
143408584|NCT04033445|517044172|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
143408585|NCT04033445|517044173|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
143408586|NCT04033445|517044174|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
143408587|NCT04033445|517044175|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
143408588|NCT04033445|517044176|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
143408589|NCT04033445|517044177|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
143408590|NCT04033445|517044164|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
143408591|NCT04033445|517044165|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
143408592|NCT04033445|517044166|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
143408593|NCT04033445|517044167|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
143408594|NCT04033445|517044168|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
143408595|NCT04033445|517044169|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
143408596|NCT04033445|517044170|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
143408597|NCT04033445|517044171|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
143408598|NCT04033445|517044172|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
143408599|NCT04033445|517044173|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
143408600|NCT04033445|517044174|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
143408601|NCT04033445|517044175|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
143408602|NCT04033445|517044176|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
143408603|NCT04033445|517044177|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
143408604|NCT04033445|517044164|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
143408605|NCT04033445|517044165|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
143408606|NCT04033445|517044166|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
143408607|NCT04033445|517044167|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
143408608|NCT04033445|517044168|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
143408609|NCT04033445|517044169|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
143408610|NCT04033445|517044170|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
143408611|NCT04033445|517044171|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
143408612|NCT04033445|517044172|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
143408613|NCT04033445|517044173|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
143408614|NCT04033445|517044174|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
143408615|NCT04033445|517044175|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
143408616|NCT04033445|517044176|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
143408617|NCT04033445|517044177|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
143408618|NCT04033445|517044164|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
143408619|NCT04033445|517044165|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
143408620|NCT04033445|517044166|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
143408621|NCT04033445|517044167|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
143408622|NCT04033445|517044168|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
143408623|NCT04033445|517044169|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
143408624|NCT04033445|517044170|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
143408625|NCT04033445|517044171|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
143408626|NCT04033445|517044172|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
143408627|NCT04033445|517044173|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
143408628|NCT04033445|517044174|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
143408629|NCT04033445|517044175|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
143408630|NCT04033445|517044176|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
143408631|NCT04033445|517044177|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
143408632|NCT04033445|517044164|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
143408633|NCT04033445|517044165|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
143408634|NCT04033445|517044166|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
143408635|NCT04033445|517044167|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
143408636|NCT04033445|517044168|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
143408637|NCT04033445|517044169|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
143408638|NCT04033445|517044170|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
143408639|NCT04033445|517044171|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
143408640|NCT04033445|517044172|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
143408641|NCT04033445|517044173|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
143408642|NCT04033445|517044174|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
143408643|NCT04033445|517044175|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
143408644|NCT04033445|517044176|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
143408645|NCT04033445|517044177|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
143408646|NCT04033445|517044164|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
143408647|NCT04033445|517044165|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
143408648|NCT04033445|517044166|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
143408649|NCT04033445|517044167|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
143408650|NCT04033445|517044168|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
143408651|NCT04033445|517044169|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
143408652|NCT04033445|517044170|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
143408653|NCT04033445|517044171|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
143408654|NCT04033445|517044172|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
143408655|NCT04033445|517044173|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
143408656|NCT04033445|517044174|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
143408657|NCT04033445|517044175|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
143408658|NCT04033445|517044176|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
143408659|NCT04033445|517044177|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
143408660|NCT04033445|517044164|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
143408661|NCT04033445|517044165|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
143408662|NCT04033445|517044166|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
143408663|NCT04033445|517044167|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
143408664|NCT04033445|517044168|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
143408665|NCT04033445|517044169|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
143408666|NCT04033445|517044170|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
143408667|NCT04033445|517044171|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
143408668|NCT04033445|517044172|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
143408669|NCT04033445|517044173|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
143408670|NCT04033445|517044174|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
143408671|NCT04033445|517044175|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
143408672|NCT04033445|517044176|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
143408673|NCT04033445|517044177|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
143408674|NCT04033445|517044164|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
143408675|NCT04033445|517044165|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
143408676|NCT04033445|517044166|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
143408677|NCT04033445|517044167|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
143408678|NCT04033445|517044168|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
143408679|NCT04033445|517044169|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
143408680|NCT04033445|517044170|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
143408681|NCT04033445|517044171|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
143408682|NCT04033445|517044172|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
143408683|NCT04033445|517044173|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
143408684|NCT04033445|517044174|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
143408685|NCT04033445|517044175|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
143408686|NCT04033445|517044176|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
143408687|NCT04033445|517044177|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
143408688|NCT04033445|517044164|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
143408689|NCT04033445|517044165|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
143408690|NCT04033445|517044166|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
143408691|NCT04033445|517044167|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
143408692|NCT04033445|517044168|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
143408693|NCT04033445|517044169|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
143408694|NCT04033445|517044170|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
143408695|NCT04033445|517044171|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
143408696|NCT04033445|517044172|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
143408697|NCT04033445|517044173|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
143408698|NCT04033445|517044174|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
143408699|NCT04033445|517044175|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
143408700|NCT04033445|517044176|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
143408701|NCT04033445|517044177|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
143408702|NCT04033445|517044164|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
143408703|NCT04033445|517044165|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
143408704|NCT04033445|517044166|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
143408705|NCT04033445|517044167|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
143408706|NCT04033445|517044168|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
143408707|NCT04033445|517044169|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
143408708|NCT04033445|517044170|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
143408709|NCT04033445|517044171|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
143408710|NCT04033445|517044172|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
143408711|NCT04033445|517044173|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
143408712|NCT04033445|517044174|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
143408713|NCT04033445|517044175|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
143408714|NCT04033445|517044176|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
143408715|NCT04033445|517044177|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
143408716|NCT04033445|517044164|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
143408717|NCT04033445|517044165|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
143408718|NCT04033445|517044166|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
143408719|NCT04033445|517044167|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
143408720|NCT04033445|517044168|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
143408721|NCT04033445|517044169|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
143408722|NCT04033445|517044170|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
143408723|NCT04033445|517044171|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
143408724|NCT04033445|517044172|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
143408725|NCT04033445|517044173|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
143408726|NCT04033445|517044174|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
143408727|NCT04033445|517044175|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
143408728|NCT04033445|517044176|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
143408729|NCT04033445|517044177|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
143408730|NCT04033445|517044164|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
143408731|NCT04033445|517044165|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
143408732|NCT04033445|517044166|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
143408733|NCT04033445|517044167|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
143408734|NCT04033445|517044168|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
143408735|NCT04033445|517044169|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
143408736|NCT04033445|517044170|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
143408737|NCT04033445|517044171|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
143408738|NCT04033445|517044172|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
143408739|NCT04033445|517044173|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
143408740|NCT04033445|517044174|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
143408741|NCT04033445|517044175|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
143408742|NCT04033445|517044176|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
143408743|NCT04033445|517044177|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
143408744|NCT04033445|517044164|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
143408745|NCT04033445|517044165|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
143408746|NCT04033445|517044166|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
143408747|NCT04033445|517044167|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
143408748|NCT04033445|517044168|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
143408749|NCT04033445|517044169|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
143408750|NCT04033445|517044170|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
143408751|NCT04033445|517044171|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
143408752|NCT04033445|517044172|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
143408753|NCT04033445|517044173|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
143408754|NCT04033445|517044174|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
143408755|NCT04033445|517044175|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
143408756|NCT04033445|517044176|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
143408757|NCT04033445|517044177|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
143408758|NCT04033445|517044164|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
143408759|NCT04033445|517044165|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
143408760|NCT04033445|517044166|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
143408761|NCT04033445|517044167|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
143408762|NCT04033445|517044168|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
143408763|NCT04033445|517044169|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
143408764|NCT04033445|517044170|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
143408765|NCT04033445|517044171|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
143408766|NCT04033445|517044172|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
143408767|NCT04033445|517044173|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
143408768|NCT04033445|517044174|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
143408769|NCT04033445|517044175|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
143408770|NCT04033445|517044176|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
143408771|NCT04033445|517044177|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
143408772|NCT04033445|517044164|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
143408773|NCT04033445|517044165|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
143408774|NCT04033445|517044166|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
143408775|NCT04033445|517044167|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
143408776|NCT04033445|517044168|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
143408777|NCT04033445|517044169|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
143408778|NCT04033445|517044170|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
143408779|NCT04033445|517044171|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
143408780|NCT04033445|517044172|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
143408781|NCT04033445|517044173|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
143408782|NCT04033445|517044174|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
143408783|NCT04033445|517044175|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
143408784|NCT04033445|517044176|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
143408785|NCT04033445|517044177|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
143408786|NCT04033445|517044164|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
143408787|NCT04033445|517044165|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
143408788|NCT04033445|517044166|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
143408789|NCT04033445|517044167|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
143408790|NCT04033445|517044168|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
143408791|NCT04033445|517044169|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
143408792|NCT04033445|517044170|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
143408793|NCT04033445|517044171|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
143408794|NCT04033445|517044172|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
143408795|NCT04033445|517044173|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
143408796|NCT04033445|517044174|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
143408797|NCT04033445|517044175|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
143408798|NCT04033445|517044176|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
143408799|NCT04033445|517044177|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
143408800|NCT04033445|517044164|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
143408801|NCT04033445|517044165|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
143408802|NCT04033445|517044166|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
143408803|NCT04033445|517044167|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
143408804|NCT04033445|517044168|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
143408805|NCT04033445|517044169|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
143408806|NCT04033445|517044170|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
143408807|NCT04033445|517044171|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
143408808|NCT04033445|517044172|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
143408809|NCT04033445|517044173|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
143408810|NCT04033445|517044174|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
143408811|NCT04033445|517044175|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
143408812|NCT04033445|517044176|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
143408813|NCT04033445|517044177|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
143408814|NCT04033445|517044164|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
143408815|NCT04033445|517044165|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
143408816|NCT04033445|517044166|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
143408817|NCT04033445|517044167|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
143408818|NCT04033445|517044168|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
143408819|NCT04033445|517044169|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
143408820|NCT04033445|517044170|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
143408821|NCT04033445|517044171|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
143408822|NCT04033445|517044172|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
143408823|NCT04033445|517044173|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
143408824|NCT04033445|517044174|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
143408825|NCT04033445|517044175|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
143408826|NCT04033445|517044176|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
143408827|NCT04033445|517044177|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
143408828|NCT04033445|517044164|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
143408829|NCT04033445|517044165|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
143408830|NCT04033445|517044166|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
143408831|NCT04033445|517044167|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
143408832|NCT04033445|517044168|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
143408833|NCT04033445|517044169|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
143408834|NCT04033445|517044170|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
143408835|NCT04033445|517044171|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
143408836|NCT04033445|517044172|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
143408837|NCT04033445|517044173|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
143408838|NCT04033445|517044174|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
143408839|NCT04033445|517044175|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
143408840|NCT04033445|517044176|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
143408841|NCT04033445|517044177|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
143408842|NCT04033445|517044164|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
143408843|NCT04033445|517044165|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
143408844|NCT04033445|517044166|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
143408845|NCT04033445|517044167|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
143408846|NCT04033445|517044168|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
143408847|NCT04033445|517044169|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
143408848|NCT04033445|517044170|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
143408849|NCT04033445|517044171|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
143408850|NCT04033445|517044172|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
143408851|NCT04033445|517044173|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
143408852|NCT04033445|517044174|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
143408853|NCT04033445|517044175|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
143408854|NCT04033445|517044176|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
143408855|NCT04033445|517044177|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
143408856|NCT04033445|517044164|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
143408857|NCT04033445|517044165|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
143408858|NCT04033445|517044166|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
143408859|NCT04033445|517044167|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
143408860|NCT04033445|517044168|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
143408861|NCT04033445|517044169|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
143408862|NCT04033445|517044170|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
143408863|NCT04033445|517044171|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
143408864|NCT04033445|517044172|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
143408865|NCT04033445|517044173|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
143408866|NCT04033445|517044174|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
143408867|NCT04033445|517044175|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
143408868|NCT04033445|517044176|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
143408869|NCT04033445|517044177|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
143408870|NCT04033445|517044164|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
143408871|NCT04033445|517044165|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
143408872|NCT04033445|517044166|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
143408873|NCT04033445|517044167|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
143408874|NCT04033445|517044168|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
143408875|NCT04033445|517044169|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
143408876|NCT04033445|517044170|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
143408877|NCT04033445|517044171|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
143408878|NCT04033445|517044172|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
143408879|NCT04033445|517044173|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
143408880|NCT04033445|517044174|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
143408881|NCT04033445|517044175|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
143408882|NCT04033445|517044176|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
143408883|NCT04033445|517044177|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
143408884|NCT04033445|517044164|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
143408885|NCT04033445|517044165|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
143408886|NCT04033445|517044166|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
143408887|NCT04033445|517044167|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
143408888|NCT04033445|517044168|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
143408889|NCT04033445|517044169|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
143408890|NCT04033445|517044170|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
143408891|NCT04033445|517044171|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
143408892|NCT04033445|517044172|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
143408893|NCT04033445|517044173|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
143408894|NCT04033445|517044174|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
143408895|NCT04033445|517044175|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
143408896|NCT04033445|517044176|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
143408897|NCT04033445|517044177|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
143408898|NCT04353492|517044180|FG000|Overall Study|Subject decision|24|||
143408899|NCT04353492|517044180|FG000|Overall Study|Physician Decision|5|||
143408900|NCT04353492|517044180|FG000|Overall Study|Adverse Event|3|||
143408901|NCT04353492|517044180|FG000|Overall Study|Pregnancy|3|||
143408902|NCT04353492|517044180|FG000|Overall Study|Lost to Follow-up|2|||
143408903|NCT04353492|517044180|FG000|Overall Study|Protocol deviation|1|||
143408904|NCT04353492|517044180|FG000|Overall Study|Technical problems|1|||
143408905|NCT04250194|517044181|FG000|Overall Study|Declined to schedule biopsy|6|||
143408906|NCT04250194|517044182|FG001|Overall Study|Declined to schedule biopsy|10|||
143408907|NCT04250194|517044181|FG000|Overall Study|Medically Unfit for Biopsy|2|||
143408908|NCT04250194|517044182|FG001|Overall Study|Medically Unfit for Biopsy|1|||
143408909|NCT04250194|517044181|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|0|||
143408910|NCT04250194|517044182|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|2|||
143408911|NCT04250194|517044181|FG000|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|0|||
143408912|NCT04250194|517044182|FG001|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|2|||
143408913|NCT04250194|517044181|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|0|||
143408914|NCT04250194|517044182|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|1|||
143408915|NCT00776009|517044185|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
143408916|NCT00776009|517044186|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
143408917|NCT00776009|517044187|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
143408918|NCT00776009|517044188|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
143408919|NCT00776009|517044189|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
143408920|NCT00776009|517044190|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
143408921|NCT00776009|517044185|FG000|Period 1: First Intervention|Protocol Violation|0|||
143408922|NCT00776009|517044186|FG001|Period 1: First Intervention|Protocol Violation|1|||
143408923|NCT00776009|517044187|FG002|Period 1: First Intervention|Protocol Violation|0|||
143408924|NCT00776009|517044188|FG003|Period 1: First Intervention|Protocol Violation|0|||
143408925|NCT00776009|517044189|FG004|Period 1: First Intervention|Protocol Violation|1|||
143408926|NCT00776009|517044190|FG005|Period 1: First Intervention|Protocol Violation|0|||
143408927|NCT00776009|517044185|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
143408928|NCT00776009|517044186|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
143408929|NCT00776009|517044187|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
143408930|NCT00776009|517044188|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
143408931|NCT00776009|517044189|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
143408932|NCT00776009|517044190|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
143408933|NCT00776009|517044185|FG000|Period 2: Second Intervention|Protocol Violation|1|||
143408934|NCT00776009|517044186|FG001|Period 2: Second Intervention|Protocol Violation|0|||
143408935|NCT00776009|517044187|FG002|Period 2: Second Intervention|Protocol Violation|1|||
143408936|NCT00776009|517044188|FG003|Period 2: Second Intervention|Protocol Violation|0|||
143408937|NCT00776009|517044189|FG004|Period 2: Second Intervention|Protocol Violation|0|||
143408938|NCT00776009|517044190|FG005|Period 2: Second Intervention|Protocol Violation|0|||
143408939|NCT00776009|517044185|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
143408940|NCT00776009|517044186|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
143408941|NCT00776009|517044187|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
143408942|NCT00776009|517044188|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
143408943|NCT00776009|517044189|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
143408944|NCT00776009|517044190|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
143408945|NCT00582972|517044191|FG000|Overall Study|Protocol Violation|2|||
143408946|NCT03304587|517044194|FG000|Overall Study|Headache after intervention|0|||
143408947|NCT03304587|517044195|FG001|Overall Study|Headache after intervention|1|||
143408948|NCT03304587|517044194|FG000|Overall Study|Withdrawal by Subject|1|||
143408949|NCT03304587|517044195|FG001|Overall Study|Withdrawal by Subject|0|||
143408950|NCT01753999|517044196|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
143408951|NCT01753999|517044197|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
143408952|NCT01753999|517044196|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
143408953|NCT01753999|517044197|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
143408954|NCT01753999|517044196|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
143408955|NCT01753999|517044197|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
143408956|NCT01753999|517044196|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
143408957|NCT01753999|517044197|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
143408958|NCT01753999|517044196|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
143408959|NCT01753999|517044197|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
143408960|NCT01753999|517044196|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
143408961|NCT01753999|517044197|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
143408962|NCT04066075|517044198|FG000|Overall Study|Lost to Follow-up|3|||
143408963|NCT04066075|517044199|FG001|Overall Study|Lost to Follow-up|3|||
143408964|NCT04066075|517044198|FG000|Overall Study|no longer eligible or technical issue with intervention or data|4|||
143408965|NCT04066075|517044199|FG001|Overall Study|no longer eligible or technical issue with intervention or data|0|||
143408966|NCT04066075|517044198|FG000|Overall Study|Withdrawal by Subject|2|||
143408967|NCT04066075|517044199|FG001|Overall Study|Withdrawal by Subject|2|||
143408968|NCT02078648|517044202|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
143408969|NCT02078648|517044203|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
143408970|NCT02078648|517044202|FG000|Overall Study|Adverse Event|0|||
143408971|NCT02078648|517044203|FG001|Overall Study|Adverse Event|1|||
143408972|NCT02078648|517044202|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
143408973|NCT02078648|517044203|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
143408974|NCT02078648|517044202|FG000|Overall Study|Withdrawal by Subject|3|||
143408975|NCT02078648|517044203|FG001|Overall Study|Withdrawal by Subject|1|||
143408976|NCT02078648|517044202|FG000|Overall Study|Investigator Decision|5|||
143408977|NCT02078648|517044203|FG001|Overall Study|Investigator Decision|7|||
143408978|NCT02078648|517044202|FG000|Overall Study|Death|1|||
143408979|NCT02078648|517044203|FG001|Overall Study|Death|1|||
143408980|NCT02078648|517044202|FG000|Overall Study|Undefined|0|||
143408981|NCT02078648|517044203|FG001|Overall Study|Undefined|1|||
143408982|NCT04088227|517044204|FG000|Overall Study|Withdrawal by Subject|1|||
143408983|NCT04088227|517044205|FG001|Overall Study|Withdrawal by Subject|0|||
143408984|NCT04088227|517044204|FG000|Overall Study|Surgery postponed >5weeks|1|||
143408985|NCT04088227|517044205|FG001|Overall Study|Surgery postponed >5weeks|0|||
143408986|NCT01675492|517044206|FG000|Overall Study|study completed early - product approval|42|||
143408987|NCT04306367|517044207|FG000|Overall Study|Progression of Disease|9|||
143408988|NCT04306367|517044207|FG000|Overall Study|Adverse Event|3|||
143408989|NCT04306367|517044207|FG000|Overall Study|Withdrawal by Subject|1|||
143408990|NCT05349838|517044208|FG000|Overall Study|Virological Failure|1|||
143408991|NCT05349838|517044209|FG001|Overall Study|Virological Failure|2|||
143408992|NCT05349838|517044208|FG000|Overall Study|Withdrawal by Subject|2|||
143408993|NCT05349838|517044209|FG001|Overall Study|Withdrawal by Subject|3|||
143408994|NCT05349838|517044208|FG000|Overall Study|Adverse Event|3|||
143408995|NCT05349838|517044209|FG001|Overall Study|Adverse Event|1|||
143408996|NCT05349838|517044208|FG000|Overall Study|Lost to Follow-up|1|||
143408997|NCT05349838|517044209|FG001|Overall Study|Lost to Follow-up|2|||
143408998|NCT05349838|517044208|FG000|Overall Study|Other reasons|5|||
143408999|NCT05349838|517044209|FG001|Overall Study|Other reasons|1|||
143409000|NCT04484623|517044211|FG000|Overall Study|Lost to Follow-up|0|||
143409001|NCT04484623|517044212|FG001|Overall Study|Lost to Follow-up|1|||
143409002|NCT04484623|517044211|FG000|Overall Study|Protocol Deviation|1|||
143409003|NCT04484623|517044212|FG001|Overall Study|Protocol Deviation|0|||
143409004|NCT04484623|517044211|FG000|Overall Study|Physician Decision|1|||
143409005|NCT04484623|517044212|FG001|Overall Study|Physician Decision|0|||
143409006|NCT04484623|517044211|FG000|Overall Study|Withdrawal by Subject|11|||
143409007|NCT04484623|517044212|FG001|Overall Study|Withdrawal by Subject|8|||
143409008|NCT04484623|517044211|FG000|Overall Study|Ongoing|94|||
143409009|NCT04484623|517044212|FG001|Overall Study|Ongoing|84|||
143409010|NCT03664804|517044214|FG000|Overall Study|Withdrawal by Subject|7|||
143409011|NCT05529992|517044215|FG000|Overall Study|Withdrawal by Subject|1|||
143409012|NCT06140290|517044216|FG000|Period 1|Adverse Event|1|||
143409013|NCT06140290|517044217|FG001|Period 1|Adverse Event|0|||
143409014|NCT06140290|517044216|FG000|Period 2|Assigned but not treated|0|||
143409015|NCT06140290|517044217|FG001|Period 2|Assigned but not treated|1|||
143409016|NCT06140290|517044216|FG000|Period 2|Withdrawal by Subject|0|||
143409017|NCT06140290|517044217|FG001|Period 2|Withdrawal by Subject|1|||
143409018|NCT03367156|517045340|FG000|Overall Study|Lack of interest|3|||
143409019|NCT03367156|517045341|FG001|Overall Study|Lack of interest|1|||
143409020|NCT03367156|517045340|FG000|Overall Study|Death|2|||
143409021|NCT03367156|517045341|FG001|Overall Study|Death|0|||
143409022|NCT03367156|517045340|FG000|Overall Study|Lost to Follow-up|2|||
143409023|NCT03367156|517045341|FG001|Overall Study|Lost to Follow-up|1|||
143409024|NCT03367156|517045340|FG000|Overall Study|Became ineligible|1|||
143409025|NCT03367156|517045341|FG001|Overall Study|Became ineligible|2|||
143409026|NCT03367156|517045340|FG000|Overall Study|Hospitalization|1|||
143409027|NCT03367156|517045341|FG001|Overall Study|Hospitalization|0|||
143409028|NCT03367156|517045340|FG000|Overall Study|Concerned about Treatment|11|||
143409029|NCT03367156|517045341|FG001|Overall Study|Concerned about Treatment|3|||
143409030|NCT03367156|517045340|FG000|Overall Study|Started new treatment|4|||
143409031|NCT03367156|517045341|FG001|Overall Study|Started new treatment|1|||
143409032|NCT03595124|517045342|FG000|Overall Study|Physician Decision|1|||
143409033|NCT03595124|517045343|FG001|Overall Study|Physician Decision|1|||
143409034|NCT03595124|517045344|FG002|Overall Study|Physician Decision|1|||
143409035|NCT03595124|517045342|FG000|Overall Study|Ineligible|1|||
143409036|NCT03595124|517045343|FG001|Overall Study|Ineligible|1|||
143409037|NCT03595124|517045344|FG002|Overall Study|Ineligible|0|||
143409038|NCT03595124|517045342|FG000|Overall Study|Disease Progression|4|||
143409039|NCT03595124|517045343|FG001|Overall Study|Disease Progression|1|||
143409040|NCT03595124|517045344|FG002|Overall Study|Disease Progression|4|||
143409041|NCT04162210|517045348|FG000|Overall Study|Lost to Follow-up|4|||
143409042|NCT04162210|517045349|FG001|Overall Study|Lost to Follow-up|1|||
143409043|NCT04162210|517045348|FG000|Overall Study|Withdrawal by Subject|17|||
143409044|NCT04162210|517045349|FG001|Overall Study|Withdrawal by Subject|9|||
143409045|NCT04162210|517045348|FG000|Overall Study|Ongoing|113|||
143409046|NCT04162210|517045349|FG001|Overall Study|Ongoing|59|||
143409047|NCT02568215|517045350|FG000|Overall Study|Death|1|||
143409048|NCT02568215|517045351|FG001|Overall Study|Death|2|||
143409049|NCT02568215|517045352|FG002|Overall Study|Death|0|||
143409050|NCT02568215|517045350|FG000|Overall Study|Physician Decision|2|||
143409051|NCT02568215|517045351|FG001|Overall Study|Physician Decision|2|||
143409052|NCT02568215|517045352|FG002|Overall Study|Physician Decision|2|||
143409053|NCT02568215|517045350|FG000|Overall Study|Lost to Follow-up|29|||
143409054|NCT02568215|517045351|FG001|Overall Study|Lost to Follow-up|32|||
143409055|NCT02568215|517045352|FG002|Overall Study|Lost to Follow-up|41|||
143409056|NCT02568215|517045350|FG000|Overall Study|Withdrawal by Subject|21|||
143409057|NCT02568215|517045351|FG001|Overall Study|Withdrawal by Subject|19|||
143409058|NCT02568215|517045352|FG002|Overall Study|Withdrawal by Subject|22|||
143409059|NCT02568215|517045350|FG000|Overall Study|Protocol Violation|1|||
143409060|NCT02568215|517045351|FG001|Overall Study|Protocol Violation|1|||
143409061|NCT02568215|517045352|FG002|Overall Study|Protocol Violation|0|||
143409062|NCT02568215|517045350|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
143409063|NCT02568215|517045351|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
143409064|NCT02568215|517045352|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
143409065|NCT02568215|517045350|FG000|Overall Study|Other|0|||
143409066|NCT02568215|517045351|FG001|Overall Study|Other|1|||
143409067|NCT02568215|517045352|FG002|Overall Study|Other|4|||
143409068|NCT04384172|517045358|FG000|Overall Study|Lost to Follow-up|0|||
143409069|NCT04384172|517045359|FG001|Overall Study|Lost to Follow-up|2|||
143409070|NCT04384172|517045358|FG000|Overall Study|Pregnancy|1|||
143409071|NCT04384172|517045359|FG001|Overall Study|Pregnancy|0|||
143409072|NCT04384172|517045358|FG000|Overall Study|Withdrawal by Subject|0|||
143409073|NCT04384172|517045359|FG001|Overall Study|Withdrawal by Subject|1|||
143409074|NCT02463448|517045360|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
143409075|NCT02463448|517045360|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
143409076|NCT02463448|517045360|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
143409077|NCT02463448|517045360|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
143409078|NCT01640951|517045361|FG000|Overall Study|Adverse Event|8|||
143409079|NCT01640951|517045362|FG001|Overall Study|Adverse Event|3|||
143409080|NCT01640951|517045363|FG002|Overall Study|Adverse Event|10|||
143409081|NCT01640951|517045364|FG003|Overall Study|Adverse Event|6|||
143409082|NCT01640951|517045365|FG004|Overall Study|Adverse Event|1|||
143409083|NCT01640951|517045366|FG005|Overall Study|Adverse Event|11|||
143409084|NCT01640951|517045367|FG006|Overall Study|Adverse Event|1|||
143409085|NCT01640951|517045368|FG007|Overall Study|Adverse Event|3|||
143409086|NCT01640951|517045361|FG000|Overall Study|Lack of Efficacy|20|||
143409087|NCT01640951|517045362|FG001|Overall Study|Lack of Efficacy|1|||
143409088|NCT01640951|517045363|FG002|Overall Study|Lack of Efficacy|7|||
143409089|NCT01640951|517045364|FG003|Overall Study|Lack of Efficacy|14|||
143409090|NCT01640951|517045365|FG004|Overall Study|Lack of Efficacy|0|||
143409091|NCT01640951|517045366|FG005|Overall Study|Lack of Efficacy|6|||
143409092|NCT01640951|517045367|FG006|Overall Study|Lack of Efficacy|5|||
143409093|NCT01640951|517045368|FG007|Overall Study|Lack of Efficacy|6|||
143409094|NCT01640951|517045361|FG000|Overall Study|Lost to Follow-up|1|||
143409095|NCT01640951|517045362|FG001|Overall Study|Lost to Follow-up|0|||
143409096|NCT01640951|517045363|FG002|Overall Study|Lost to Follow-up|6|||
143409097|NCT01640951|517045364|FG003|Overall Study|Lost to Follow-up|2|||
143409098|NCT01640951|517045365|FG004|Overall Study|Lost to Follow-up|2|||
143409099|NCT01640951|517045366|FG005|Overall Study|Lost to Follow-up|3|||
143409100|NCT01640951|517045367|FG006|Overall Study|Lost to Follow-up|1|||
143409101|NCT01640951|517045368|FG007|Overall Study|Lost to Follow-up|1|||
143409102|NCT01640951|517045361|FG000|Overall Study|Non-compliance with study treatment|0|||
143409103|NCT01640951|517045362|FG001|Overall Study|Non-compliance with study treatment|0|||
143409104|NCT01640951|517045363|FG002|Overall Study|Non-compliance with study treatment|1|||
143409105|NCT01640951|517045364|FG003|Overall Study|Non-compliance with study treatment|1|||
143409106|NCT01640951|517045365|FG004|Overall Study|Non-compliance with study treatment|1|||
143409107|NCT01640951|517045366|FG005|Overall Study|Non-compliance with study treatment|4|||
143409108|NCT01640951|517045367|FG006|Overall Study|Non-compliance with study treatment|1|||
143409109|NCT01640951|517045368|FG007|Overall Study|Non-compliance with study treatment|0|||
143409110|NCT01640951|517045361|FG000|Overall Study|Physician Decision|2|||
143409111|NCT01640951|517045362|FG001|Overall Study|Physician Decision|5|||
143409112|NCT01640951|517045363|FG002|Overall Study|Physician Decision|2|||
143409113|NCT01640951|517045364|FG003|Overall Study|Physician Decision|2|||
143409114|NCT01640951|517045365|FG004|Overall Study|Physician Decision|2|||
143409115|NCT01640951|517045366|FG005|Overall Study|Physician Decision|3|||
143409116|NCT01640951|517045367|FG006|Overall Study|Physician Decision|3|||
143409117|NCT01640951|517045368|FG007|Overall Study|Physician Decision|0|||
143409118|NCT01640951|517045361|FG000|Overall Study|Pregnancy|3|||
143409119|NCT01640951|517045362|FG001|Overall Study|Pregnancy|0|||
143409120|NCT01640951|517045363|FG002|Overall Study|Pregnancy|0|||
143409121|NCT01640951|517045364|FG003|Overall Study|Pregnancy|4|||
143409122|NCT01640951|517045365|FG004|Overall Study|Pregnancy|0|||
143409123|NCT01640951|517045366|FG005|Overall Study|Pregnancy|0|||
143409124|NCT01640951|517045367|FG006|Overall Study|Pregnancy|2|||
143409125|NCT01640951|517045368|FG007|Overall Study|Pregnancy|0|||
143409126|NCT01640951|517045361|FG000|Overall Study|Protocol Deviation|0|||
143409127|NCT01640951|517045362|FG001|Overall Study|Protocol Deviation|1|||
143409128|NCT01640951|517045363|FG002|Overall Study|Protocol Deviation|2|||
143409129|NCT01640951|517045364|FG003|Overall Study|Protocol Deviation|1|||
143409130|NCT01640951|517045365|FG004|Overall Study|Protocol Deviation|0|||
143409131|NCT01640951|517045366|FG005|Overall Study|Protocol Deviation|1|||
143409132|NCT01640951|517045367|FG006|Overall Study|Protocol Deviation|0|||
143409133|NCT01640951|517045368|FG007|Overall Study|Protocol Deviation|0|||
143409134|NCT01640951|517045361|FG000|Overall Study|Subject/Guardian decision|12|||
143409135|NCT01640951|517045362|FG001|Overall Study|Subject/Guardian decision|4|||
143409136|NCT01640951|517045363|FG002|Overall Study|Subject/Guardian decision|13|||
143409137|NCT01640951|517045364|FG003|Overall Study|Subject/Guardian decision|15|||
143409138|NCT01640951|517045365|FG004|Overall Study|Subject/Guardian decision|7|||
143409139|NCT01640951|517045366|FG005|Overall Study|Subject/Guardian decision|19|||
143409140|NCT01640951|517045367|FG006|Overall Study|Subject/Guardian decision|5|||
143409141|NCT01640951|517045368|FG007|Overall Study|Subject/Guardian decision|4|||
143409142|NCT01640951|517045361|FG000|Overall Study|Death|0|||
143409143|NCT01640951|517045362|FG001|Overall Study|Death|1|||
143409144|NCT01640951|517045363|FG002|Overall Study|Death|1|||
143409145|NCT01640951|517045364|FG003|Overall Study|Death|0|||
143409146|NCT01640951|517045365|FG004|Overall Study|Death|0|||
143409147|NCT01640951|517045366|FG005|Overall Study|Death|0|||
143409148|NCT01640951|517045367|FG006|Overall Study|Death|0|||
143409149|NCT01640951|517045368|FG007|Overall Study|Death|2|||
143409150|NCT04949542|517045369|FG000|Overall Study|Lost to Follow-up|4|||
143409151|NCT04949542|517045370|FG001|Overall Study|Lost to Follow-up|1|||
143409152|NCT01536093|517045371|FG000|Overall Study|Death|1|||
143409153|NCT01536093|517045372|FG001|Overall Study|Death|2|||
143409154|NCT01536093|517045371|FG000|Overall Study|absence of maternal colostrum|2|||
143409155|NCT01536093|517045372|FG001|Overall Study|absence of maternal colostrum|0|||
143409156|NCT01536093|517045371|FG000|Overall Study|Withdrawal by Subject|0|||
143409157|NCT01536093|517045372|FG001|Overall Study|Withdrawal by Subject|1|||
143409158|NCT02275611|517045373|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
143409159|NCT02275611|517045374|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
143409160|NCT02275611|517045375|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
143409161|NCT02275611|517045376|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
143409162|NCT00293397|517045382|FG000|Overall Study|Death|2|||
143409163|NCT01759862|517045385|FG000|Overall Study|Physician Decision|3|||
143409164|NCT01759862|517045386|FG001|Overall Study|Physician Decision|1|||
143409165|NCT01759862|517045385|FG000|Overall Study|Adverse Event|0|||
143409166|NCT01759862|517045386|FG001|Overall Study|Adverse Event|1|||
143409167|NCT03631407|517045387|FG000|Overall Study|Withdrawal by Subject|3|||
143409168|NCT03631407|517045388|FG001|Overall Study|Withdrawal by Subject|2|||
143409169|NCT03631407|517045387|FG000|Overall Study|Sponsor Decision|0|||
143409170|NCT03631407|517045388|FG001|Overall Study|Sponsor Decision|2|||
143409171|NCT03631407|517045387|FG000|Overall Study|Death|16|||
143409172|NCT03631407|517045388|FG001|Overall Study|Death|16|||
143409173|NCT03631407|517045387|FG000|Overall Study|Randomized by mistake without study treatment|1|||
143409174|NCT03631407|517045388|FG001|Overall Study|Randomized by mistake without study treatment|0|||
143409175|NCT01437319|517045389|FG000|Phase I|Lost to Follow-up|2|||
143409176|NCT01437319|517045390|FG001|Phase I|Lost to Follow-up|0|||
143409177|NCT01437319|517045391|FG002|Phase I|Lost to Follow-up|0|||
143409178|NCT01437319|517045389|FG000|Phase I|Protocol Violation|1|||
143409179|NCT01437319|517045390|FG001|Phase I|Protocol Violation|0|||
143409180|NCT01437319|517045391|FG002|Phase I|Protocol Violation|0|||
143409181|NCT01437319|517045389|FG000|Phase I|Study related symptoms/complaints|27|||
143409182|NCT01437319|517045390|FG001|Phase I|Study related symptoms/complaints|0|||
143409183|NCT01437319|517045391|FG002|Phase I|Study related symptoms/complaints|0|||
143409184|NCT01437319|517045389|FG000|Phase I|Withdrawal by Subject|25|||
143409185|NCT01437319|517045390|FG001|Phase I|Withdrawal by Subject|0|||
143409186|NCT01437319|517045391|FG002|Phase I|Withdrawal by Subject|0|||
143409187|NCT01437319|517045389|FG000|Phase II|Withdrawal by Subject|0|||
143409188|NCT01437319|517045390|FG001|Phase II|Withdrawal by Subject|8|||
143409189|NCT01437319|517045391|FG002|Phase II|Withdrawal by Subject|16|||
143409190|NCT01437319|517045389|FG000|Phase II|Lost to Follow-up|0|||
143409191|NCT01437319|517045390|FG001|Phase II|Lost to Follow-up|7|||
143409192|NCT01437319|517045391|FG002|Phase II|Lost to Follow-up|2|||
143409193|NCT01437319|517045389|FG000|Phase II|Study related symptoms/complaints|0|||
143409194|NCT01437319|517045390|FG001|Phase II|Study related symptoms/complaints|28|||
143409195|NCT01437319|517045391|FG002|Phase II|Study related symptoms/complaints|19|||
143409196|NCT01437319|517045389|FG000|Phase II|Protocol Violation|0|||
143409197|NCT01437319|517045390|FG001|Phase II|Protocol Violation|1|||
143409198|NCT01437319|517045391|FG002|Phase II|Protocol Violation|0|||
143409199|NCT00756574|517045392|FG000|Overall Study|Withdrawal by Subject|9|||
143409200|NCT00756574|517045393|FG001|Overall Study|Withdrawal by Subject|7|||
143409201|NCT00756574|517045392|FG000|Overall Study|Lost to Follow-up|4|||
143409202|NCT00756574|517045393|FG001|Overall Study|Lost to Follow-up|4|||
143409203|NCT04622332|517045394|FG000|Overall Study|Withdrawal by Subject|4|||
143409204|NCT04622332|517045395|FG001|Overall Study|Withdrawal by Subject|2|||
143409205|NCT04622332|517045394|FG000|Overall Study|Physician Decision|1|||
143409206|NCT04622332|517045395|FG001|Overall Study|Physician Decision|1|||
143409207|NCT04622332|517045394|FG000|Overall Study|Adverse Event|0|||
143409208|NCT04622332|517045395|FG001|Overall Study|Adverse Event|2|||
143409209|NCT04622332|517045394|FG000|Overall Study|Protocol Violation|0|||
143409210|NCT04622332|517045395|FG001|Overall Study|Protocol Violation|1|||
143409211|NCT03473743|517045396|FG000|Overall Study|Withdrawal by Subject|0|||
143409212|NCT03473743|517045397|FG001|Overall Study|Withdrawal by Subject|0|||
143409213|NCT03473743|517045398|FG002|Overall Study|Withdrawal by Subject|0|||
143409214|NCT03473743|517045399|FG003|Overall Study|Withdrawal by Subject|0|||
143409215|NCT03473743|517045400|FG004|Overall Study|Withdrawal by Subject|0|||
143409216|NCT03473743|517045401|FG005|Overall Study|Withdrawal by Subject|0|||
143409217|NCT03473743|517045402|FG006|Overall Study|Withdrawal by Subject|0|||
143409218|NCT03473743|517045403|FG007|Overall Study|Withdrawal by Subject|3|||
143409219|NCT03473743|517045396|FG000|Overall Study|Other|0|||
143409220|NCT03473743|517045397|FG001|Overall Study|Other|0|||
143409221|NCT03473743|517045398|FG002|Overall Study|Other|0|||
143409222|NCT03473743|517045399|FG003|Overall Study|Other|1|||
143409223|NCT03473743|517045400|FG004|Overall Study|Other|0|||
143409224|NCT03473743|517045401|FG005|Overall Study|Other|0|||
143409225|NCT03473743|517045402|FG006|Overall Study|Other|0|||
143409226|NCT03473743|517045403|FG007|Overall Study|Other|0|||
143409227|NCT03473743|517045396|FG000|Overall Study|Ongoing|0|||
143409228|NCT03473743|517045397|FG001|Overall Study|Ongoing|0|||
143409229|NCT03473743|517045398|FG002|Overall Study|Ongoing|6|||
143409230|NCT03473743|517045399|FG003|Overall Study|Ongoing|8|||
143409231|NCT03473743|517045400|FG004|Overall Study|Ongoing|1|||
143409232|NCT03473743|517045401|FG005|Overall Study|Ongoing|1|||
143409233|NCT03473743|517045402|FG006|Overall Study|Ongoing|22|||
143409234|NCT03473743|517045403|FG007|Overall Study|Ongoing|24|||
143409235|NCT03473743|517045396|FG000|Overall Study|Randomized but not treated|0|||
143409236|NCT03473743|517045397|FG001|Overall Study|Randomized but not treated|0|||
143409237|NCT03473743|517045398|FG002|Overall Study|Randomized but not treated|0|||
143409238|NCT03473743|517045399|FG003|Overall Study|Randomized but not treated|0|||
143409239|NCT03473743|517045400|FG004|Overall Study|Randomized but not treated|0|||
143409240|NCT03473743|517045401|FG005|Overall Study|Randomized but not treated|0|||
143409241|NCT03473743|517045402|FG006|Overall Study|Randomized but not treated|1|||
143409242|NCT03473743|517045403|FG007|Overall Study|Randomized but not treated|1|||
143409243|NCT00980954|517045404|FG000|Overall Study|Protocol Violation|9|||
143409244|NCT00980954|517045405|FG001|Overall Study|Protocol Violation|15|||
143409245|NCT03375320|517045411|FG000|Overall Study|Adverse Event|34|||
143409246|NCT03375320|517045412|FG001|Overall Study|Adverse Event|9|||
143409247|NCT03375320|517045413|FG002|Overall Study|Adverse Event|10|||
143409248|NCT03375320|517045414|FG003|Overall Study|Adverse Event|0|||
143409249|NCT03375320|517045411|FG000|Overall Study|Death|6|||
143409250|NCT03375320|517045412|FG001|Overall Study|Death|3|||
143409251|NCT03375320|517045413|FG002|Overall Study|Death|0|||
143409252|NCT03375320|517045414|FG003|Overall Study|Death|0|||
143409253|NCT03375320|517045411|FG000|Overall Study|Withdrawal by Subject|7|||
143409254|NCT03375320|517045412|FG001|Overall Study|Withdrawal by Subject|4|||
143409255|NCT03375320|517045413|FG002|Overall Study|Withdrawal by Subject|5|||
143409256|NCT03375320|517045414|FG003|Overall Study|Withdrawal by Subject|4|||
143409257|NCT03375320|517045411|FG000|Overall Study|Progressive disease|55|||
143409258|NCT03375320|517045412|FG001|Overall Study|Progressive disease|41|||
143409259|NCT03375320|517045413|FG002|Overall Study|Progressive disease|29|||
143409260|NCT03375320|517045414|FG003|Overall Study|Progressive disease|24|||
143409261|NCT03375320|517045411|FG000|Overall Study|Alternative treatment|6|||
143409262|NCT03375320|517045412|FG001|Overall Study|Alternative treatment|1|||
143409263|NCT03375320|517045413|FG002|Overall Study|Alternative treatment|1|||
143409264|NCT03375320|517045414|FG003|Overall Study|Alternative treatment|0|||
143409265|NCT03375320|517045411|FG000|Overall Study|Other disease|1|||
143409266|NCT03375320|517045412|FG001|Overall Study|Other disease|1|||
143409267|NCT03375320|517045413|FG002|Overall Study|Other disease|3|||
143409268|NCT03375320|517045414|FG003|Overall Study|Other disease|0|||
143409269|NCT03375320|517045411|FG000|Overall Study|Withdrawal prior to initiation|2|||
143409270|NCT03375320|517045412|FG001|Overall Study|Withdrawal prior to initiation|2|||
143409271|NCT03375320|517045413|FG002|Overall Study|Withdrawal prior to initiation|1|||
143409272|NCT03375320|517045414|FG003|Overall Study|Withdrawal prior to initiation|0|||
143409273|NCT03375320|517045411|FG000|Overall Study|Physician Decision|1|||
143409274|NCT03375320|517045412|FG001|Overall Study|Physician Decision|1|||
143409275|NCT03375320|517045413|FG002|Overall Study|Physician Decision|1|||
143409276|NCT03375320|517045414|FG003|Overall Study|Physician Decision|1|||
143409277|NCT03375320|517045411|FG000|Overall Study|Non-compliance|1|||
143409278|NCT03375320|517045412|FG001|Overall Study|Non-compliance|0|||
143409279|NCT03375320|517045413|FG002|Overall Study|Non-compliance|0|||
143409280|NCT03375320|517045414|FG003|Overall Study|Non-compliance|0|||
143409281|NCT03348631|517045415|FG000|Overall Study|Not Eligible, No treatment|0|||
143409282|NCT03348631|517045416|FG001|Overall Study|Not Eligible, No treatment|1|||
143409283|NCT03348631|517045415|FG000|Overall Study|Not Eligible, Treated|2|||
143409284|NCT03348631|517045416|FG001|Overall Study|Not Eligible, Treated|0|||
143409285|NCT03348631|517045415|FG000|Overall Study|Eligible, No Treatment|1|||
143409286|NCT03348631|517045416|FG001|Overall Study|Eligible, No Treatment|0|||
143409287|NCT00274261|517045421|FG000|Overall Study|Adverse Event|19|||
143409288|NCT00274261|517045422|FG001|Overall Study|Adverse Event|11|||
143409289|NCT00274261|517045421|FG000|Overall Study|Pregnancy|114|||
143409290|NCT00274261|517045422|FG001|Overall Study|Pregnancy|83|||
143409291|NCT00274261|517045421|FG000|Overall Study|Withdrawal by Subject|179|||
143409292|NCT00274261|517045422|FG001|Overall Study|Withdrawal by Subject|126|||
143409293|NCT00274261|517045421|FG000|Overall Study|Protocol Violation|71|||
143409294|NCT00274261|517045422|FG001|Overall Study|Protocol Violation|42|||
143409295|NCT00274261|517045421|FG000|Overall Study|Lost to Follow-up|106|||
143409296|NCT00274261|517045422|FG001|Overall Study|Lost to Follow-up|75|||
143409297|NCT03431350|517045423|FG000|Overall Study|ONGOING|0|||
143409298|NCT03431350|517045424|FG001|Overall Study|ONGOING|0|||
143409299|NCT03431350|517045425|FG002|Overall Study|ONGOING|2|||
143409300|NCT03431350|517045426|FG003|Overall Study|ONGOING|0|||
143409301|NCT03431350|517045427|FG004|Overall Study|ONGOING|1|||
143409302|NCT03431350|517045428|FG005|Overall Study|ONGOING|3|||
143409303|NCT03431350|517045429|FG006|Overall Study|ONGOING|0|||
143409304|NCT03431350|517045430|FG007|Overall Study|ONGOING|1|||
143409305|NCT03431350|517045431|FG008|Overall Study|ONGOING|3|||
143409306|NCT03431350|517045432|FG009|Overall Study|ONGOING|4|||
143409307|NCT03431350|517045433|FG010|Overall Study|ONGOING|2|||
143409308|NCT03431350|517045434|FG011|Overall Study|ONGOING|1|||
143409309|NCT03431350|517045423|FG000|Overall Study|Death|6|||
143409310|NCT03431350|517045424|FG001|Overall Study|Death|5|||
143409311|NCT03431350|517045425|FG002|Overall Study|Death|18|||
143409312|NCT03431350|517045426|FG003|Overall Study|Death|7|||
143409313|NCT03431350|517045427|FG004|Overall Study|Death|4|||
143409314|NCT03431350|517045428|FG005|Overall Study|Death|3|||
143409315|NCT03431350|517045429|FG006|Overall Study|Death|2|||
143409316|NCT03431350|517045430|FG007|Overall Study|Death|0|||
143409317|NCT03431350|517045431|FG008|Overall Study|Death|0|||
143409318|NCT03431350|517045432|FG009|Overall Study|Death|0|||
143409319|NCT03431350|517045433|FG010|Overall Study|Death|4|||
143409320|NCT03431350|517045434|FG011|Overall Study|Death|0|||
143409321|NCT03431350|517045423|FG000|Overall Study|Lost to Follow-up|0|||
143409322|NCT03431350|517045424|FG001|Overall Study|Lost to Follow-up|1|||
143409323|NCT03431350|517045425|FG002|Overall Study|Lost to Follow-up|0|||
143409324|NCT03431350|517045426|FG003|Overall Study|Lost to Follow-up|0|||
143409325|NCT03431350|517045427|FG004|Overall Study|Lost to Follow-up|0|||
143409326|NCT03431350|517045428|FG005|Overall Study|Lost to Follow-up|0|||
143409327|NCT03431350|517045429|FG006|Overall Study|Lost to Follow-up|0|||
143409328|NCT03431350|517045430|FG007|Overall Study|Lost to Follow-up|0|||
143409329|NCT03431350|517045431|FG008|Overall Study|Lost to Follow-up|0|||
143409330|NCT03431350|517045432|FG009|Overall Study|Lost to Follow-up|0|||
143409331|NCT03431350|517045433|FG010|Overall Study|Lost to Follow-up|0|||
143409332|NCT03431350|517045434|FG011|Overall Study|Lost to Follow-up|0|||
143409333|NCT03431350|517045423|FG000|Overall Study|Withdrawal by Subject|0|||
143409334|NCT03431350|517045424|FG001|Overall Study|Withdrawal by Subject|0|||
143409335|NCT03431350|517045425|FG002|Overall Study|Withdrawal by Subject|0|||
143409336|NCT03431350|517045426|FG003|Overall Study|Withdrawal by Subject|1|||
143409337|NCT03431350|517045427|FG004|Overall Study|Withdrawal by Subject|1|||
143409338|NCT03431350|517045428|FG005|Overall Study|Withdrawal by Subject|1|||
143409339|NCT03431350|517045429|FG006|Overall Study|Withdrawal by Subject|0|||
143409340|NCT03431350|517045430|FG007|Overall Study|Withdrawal by Subject|0|||
143409341|NCT03431350|517045431|FG008|Overall Study|Withdrawal by Subject|0|||
143409342|NCT03431350|517045432|FG009|Overall Study|Withdrawal by Subject|2|||
143409343|NCT03431350|517045433|FG010|Overall Study|Withdrawal by Subject|0|||
143409344|NCT03431350|517045434|FG011|Overall Study|Withdrawal by Subject|1|||
143409345|NCT03431350|517045423|FG000|Overall Study|Other|0|||
143409346|NCT03431350|517045424|FG001|Overall Study|Other|0|||
143409347|NCT03431350|517045425|FG002|Overall Study|Other|1|||
143409348|NCT03431350|517045426|FG003|Overall Study|Other|3|||
143409349|NCT03431350|517045427|FG004|Overall Study|Other|2|||
143409350|NCT03431350|517045428|FG005|Overall Study|Other|2|||
143409351|NCT03431350|517045429|FG006|Overall Study|Other|4|||
143409352|NCT03431350|517045430|FG007|Overall Study|Other|0|||
143409353|NCT03431350|517045431|FG008|Overall Study|Other|14|||
143409354|NCT03431350|517045432|FG009|Overall Study|Other|11|||
143409355|NCT03431350|517045433|FG010|Overall Study|Other|11|||
143409356|NCT03431350|517045434|FG011|Overall Study|Other|15|||
143409357|NCT05076266|517045435|FG000|Overall Study|Survey not complete - Participant refusal|2|||
143409358|NCT05076266|517045436|FG001|Overall Study|Survey not complete - Participant refusal|0|||
143409359|NCT04325828|517045437|FG000|Overall Study|Ongoing|26|||
143409360|NCT05509816|517045438|FG000|Overall Study|Lost to Follow-up|1|||
143409361|NCT03492177|517045440|FG000|Overall Study|Adverse Event|1|||
143409362|NCT03492177|517045441|FG001|Overall Study|Adverse Event|0|||
143409363|NCT03492177|517045442|FG002|Overall Study|Adverse Event|0|||
143409364|NCT03492177|517045440|FG000|Overall Study|Death|3|||
143409365|NCT03492177|517045441|FG001|Overall Study|Death|0|||
143409366|NCT03492177|517045442|FG002|Overall Study|Death|3|||
143409367|NCT03492177|517045440|FG000|Overall Study|Lack of Efficacy|1|||
143409368|NCT03492177|517045441|FG001|Overall Study|Lack of Efficacy|2|||
143409369|NCT03492177|517045442|FG002|Overall Study|Lack of Efficacy|0|||
143409370|NCT03492177|517045440|FG000|Overall Study|Other|1|||
143409371|NCT03492177|517045441|FG001|Overall Study|Other|0|||
143409372|NCT03492177|517045442|FG002|Overall Study|Other|0|||
143409373|NCT03492177|517045440|FG000|Overall Study|Ongoing|16|||
143409374|NCT03492177|517045441|FG001|Overall Study|Ongoing|19|||
143409375|NCT03492177|517045442|FG002|Overall Study|Ongoing|17|||
143409376|NCT04801420|517045447|FG000|Overall Study|Other|1|||
143409377|NCT04801420|517045448|FG001|Overall Study|Other|2|||
143409378|NCT04801420|517045449|FG002|Overall Study|Other|1|||
143409379|NCT04801420|517045447|FG000|Overall Study|Lost to Follow-up|7|||
143409380|NCT04801420|517045448|FG001|Overall Study|Lost to Follow-up|9|||
143409381|NCT04801420|517045449|FG002|Overall Study|Lost to Follow-up|10|||
143409382|NCT04801420|517045447|FG000|Overall Study|Moved from study area|0|||
143409383|NCT04801420|517045448|FG001|Overall Study|Moved from study area|1|||
143409384|NCT04801420|517045449|FG002|Overall Study|Moved from study area|1|||
143409385|NCT04801420|517045447|FG000|Overall Study|Withdrawal by Subject|5|||
143409386|NCT04801420|517045448|FG001|Overall Study|Withdrawal by Subject|1|||
143409387|NCT04801420|517045449|FG002|Overall Study|Withdrawal by Subject|4|||
143409388|NCT04801420|517045447|FG000|Overall Study|Individual stopping criteria reached|0|||
143409389|NCT04801420|517045448|FG001|Overall Study|Individual stopping criteria reached|1|||
143409390|NCT04801420|517045449|FG002|Overall Study|Individual stopping criteria reached|0|||
143409391|NCT04801420|517045447|FG000|Overall Study|Ongoing in the study|195|||
143409392|NCT04801420|517045448|FG001|Overall Study|Ongoing in the study|195|||
143409393|NCT04801420|517045449|FG002|Overall Study|Ongoing in the study|192|||
143409394|NCT02401815|517045459|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
143409395|NCT02401815|517045460|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
143409396|NCT02401815|517045461|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
143409397|NCT02401815|517045462|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
143409398|NCT02401815|517045463|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
143409399|NCT02401815|517045464|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
143409400|NCT02401815|517045465|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
143409401|NCT02401815|517045466|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
143409402|NCT02401815|517045467|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
143409403|NCT02401815|517045468|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
143409404|NCT02401815|517045459|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
143409405|NCT02401815|517045460|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
143409406|NCT02401815|517045461|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
143409407|NCT02401815|517045462|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
143409408|NCT02401815|517045463|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
143409409|NCT02401815|517045464|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
143409410|NCT02401815|517045465|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
143409411|NCT02401815|517045466|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
143409412|NCT02401815|517045467|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
143409413|NCT02401815|517045468|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
143409414|NCT02401815|517045459|FG000|Dose Escalation (up to 670 Days)|Death|1|||
143409415|NCT02401815|517045460|FG001|Dose Escalation (up to 670 Days)|Death|2|||
143409416|NCT02401815|517045461|FG002|Dose Escalation (up to 670 Days)|Death|3|||
143409417|NCT02401815|517045462|FG003|Dose Escalation (up to 670 Days)|Death|5|||
143409418|NCT02401815|517045463|FG004|Dose Escalation (up to 670 Days)|Death|4|||
143409419|NCT02401815|517045464|FG005|Dose Escalation (up to 670 Days)|Death|0|||
143409420|NCT02401815|517045465|FG006|Dose Escalation (up to 670 Days)|Death|0|||
143409421|NCT02401815|517045466|FG007|Dose Escalation (up to 670 Days)|Death|0|||
143409422|NCT02401815|517045467|FG008|Dose Escalation (up to 670 Days)|Death|0|||
143409423|NCT02401815|517045468|FG009|Dose Escalation (up to 670 Days)|Death|0|||
143409424|NCT02401815|517045459|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
143409425|NCT02401815|517045460|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
143409426|NCT02401815|517045461|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
143409427|NCT02401815|517045462|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
143409428|NCT02401815|517045463|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
143409429|NCT02401815|517045464|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
143409430|NCT02401815|517045465|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
143409431|NCT02401815|517045466|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
143409432|NCT02401815|517045467|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
143409433|NCT02401815|517045468|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
143409434|NCT02401815|517045459|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
143409435|NCT02401815|517045460|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
143409436|NCT02401815|517045461|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
143409437|NCT02401815|517045462|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
143409438|NCT02401815|517045463|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
143409439|NCT02401815|517045464|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
143409440|NCT02401815|517045465|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
143409441|NCT02401815|517045466|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
143409442|NCT02401815|517045467|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
143409443|NCT02401815|517045468|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
143409444|NCT02401815|517045459|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
143409445|NCT02401815|517045460|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
143409446|NCT02401815|517045461|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
143409447|NCT02401815|517045462|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
143409448|NCT02401815|517045463|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
143409449|NCT02401815|517045464|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
143409450|NCT02401815|517045465|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
143409451|NCT02401815|517045466|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
143409452|NCT02401815|517045467|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
143409453|NCT02401815|517045468|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
143409454|NCT02401815|517045459|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
143409455|NCT02401815|517045460|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
143409456|NCT02401815|517045461|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
143409457|NCT02401815|517045462|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
143409458|NCT02401815|517045463|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
143409459|NCT02401815|517045464|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
143409460|NCT02401815|517045465|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
143409461|NCT02401815|517045466|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
143409462|NCT02401815|517045467|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
143409463|NCT02401815|517045468|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
143409464|NCT02401815|517045459|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
143409465|NCT02401815|517045460|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
143409466|NCT02401815|517045461|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
143409467|NCT02401815|517045462|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
143409468|NCT02401815|517045463|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
143409469|NCT02401815|517045464|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
143409470|NCT02401815|517045465|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
143409471|NCT02401815|517045466|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
143409472|NCT02401815|517045467|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
143409473|NCT02401815|517045468|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
143409474|NCT02401815|517045459|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
143409475|NCT02401815|517045460|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
143409476|NCT02401815|517045461|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
143409477|NCT02401815|517045462|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
143409478|NCT02401815|517045463|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
143409479|NCT02401815|517045464|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
143409480|NCT02401815|517045465|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
143409481|NCT02401815|517045466|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
143409482|NCT02401815|517045467|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
143409483|NCT02401815|517045468|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
143409484|NCT02401815|517045459|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
143409485|NCT02401815|517045460|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
143409486|NCT02401815|517045461|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
143409487|NCT02401815|517045462|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
143409488|NCT02401815|517045463|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
143409489|NCT02401815|517045464|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
143409490|NCT02401815|517045465|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
143409491|NCT02401815|517045466|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
143409492|NCT02401815|517045467|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
143409493|NCT02401815|517045468|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
143409494|NCT02401815|517045459|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
143409495|NCT02401815|517045460|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
143409496|NCT02401815|517045461|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
143409497|NCT02401815|517045462|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
143409498|NCT02401815|517045463|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
143409499|NCT02401815|517045464|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
143409500|NCT02401815|517045465|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
143409501|NCT02401815|517045466|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
143409502|NCT02401815|517045467|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
143409503|NCT02401815|517045468|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
143409504|NCT02401815|517045459|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
143409505|NCT02401815|517045460|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
143409506|NCT02401815|517045461|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
143409507|NCT02401815|517045462|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
143409508|NCT02401815|517045463|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
143409509|NCT02401815|517045464|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
143409510|NCT02401815|517045465|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
143409511|NCT02401815|517045466|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
143409512|NCT02401815|517045467|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
143409513|NCT02401815|517045468|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
143409514|NCT02401815|517045459|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
143409515|NCT02401815|517045460|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
143409516|NCT02401815|517045461|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
143409517|NCT02401815|517045462|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
143409518|NCT02401815|517045463|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
143409519|NCT02401815|517045464|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
143409520|NCT02401815|517045465|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
143409521|NCT02401815|517045466|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
143409522|NCT02401815|517045467|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
143409523|NCT02401815|517045468|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
143409524|NCT02401815|517045459|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
143409525|NCT02401815|517045460|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
143409526|NCT02401815|517045461|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
143409527|NCT02401815|517045462|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
143409528|NCT02401815|517045463|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
143409529|NCT02401815|517045464|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
143409530|NCT02401815|517045465|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
143409531|NCT02401815|517045466|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
143409532|NCT02401815|517045467|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
143409533|NCT02401815|517045468|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
143409534|NCT02751528|517045469|FG000|Overall Study|Withdrawal by Subject|1|||
143409535|NCT02751528|517045469|FG000|Overall Study|Adverse Event|1|||
143409536|NCT04218357|517045470|FG000|1st Allocation|Withdrawal by Subject|1|||
143409537|NCT04218357|517045471|FG001|1st Allocation|Withdrawal by Subject|0|||
143409538|NCT05071430|517045473|FG000|Overall Study|Adverse Event|1|||
143409539|NCT05071430|517045474|FG001|Overall Study|Adverse Event|2|||
143409540|NCT05071430|517045473|FG000|Overall Study|Lost to Follow-up|4|||
143409541|NCT05071430|517045474|FG001|Overall Study|Lost to Follow-up|4|||
143409542|NCT05071430|517045473|FG000|Overall Study|Protocol Violation|1|||
143409543|NCT05071430|517045474|FG001|Overall Study|Protocol Violation|0|||
143409544|NCT05071430|517045473|FG000|Overall Study|Withdrawal by Subject|3|||
143409545|NCT05071430|517045474|FG001|Overall Study|Withdrawal by Subject|2|||
143409546|NCT05071430|517045473|FG000|Overall Study|Other|1|||
143409547|NCT05071430|517045474|FG001|Overall Study|Other|1|||
143409548|NCT01958021|517045475|FG000|Treatment|Progressive disease|206|||
143409549|NCT01958021|517045476|FG001|Treatment|Progressive disease|265|||
143409550|NCT01958021|517045475|FG000|Treatment|Adverse Event|38|||
143409551|NCT01958021|517045476|FG001|Treatment|Adverse Event|10|||
143409552|NCT01958021|517045475|FG000|Treatment|Subject/guardian decision|29|||
143409553|NCT01958021|517045476|FG001|Treatment|Subject/guardian decision|25|||
143409554|NCT01958021|517045475|FG000|Treatment|Physician Decision|28|||
143409555|NCT01958021|517045476|FG001|Treatment|Physician Decision|21|||
143409556|NCT01958021|517045475|FG000|Treatment|Death|6|||
143409557|NCT01958021|517045476|FG001|Treatment|Death|1|||
143409558|NCT01958021|517045475|FG000|Treatment|Protocol deviation|3|||
143409559|NCT01958021|517045476|FG001|Treatment|Protocol deviation|1|||
143409560|NCT01958021|517045475|FG000|Treatment|Sponsor decision|24|||
143409561|NCT01958021|517045476|FG001|Treatment|Sponsor decision|11|||
143409562|NCT01958021|517045475|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
143409563|NCT01958021|517045476|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
143409564|NCT01958021|517045475|FG000|Post-treatment Efficacy Follow-up|Death|1|||
143409565|NCT01958021|517045476|FG001|Post-treatment Efficacy Follow-up|Death|0|||
143409566|NCT01958021|517045475|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
143409567|NCT01958021|517045476|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
143409568|NCT01958021|517045475|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
143409569|NCT01958021|517045476|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
143409570|NCT01958021|517045475|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
143409571|NCT01958021|517045476|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
143409572|NCT01958021|517045475|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|5|||
143409573|NCT01958021|517045476|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|2|||
143409574|NCT01958021|517045475|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian decision|4|||
143409575|NCT01958021|517045476|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian decision|2|||
143409576|NCT07204444|517045486|FG000|Overall Study|Medical/Hospitalization|6|||
143409577|NCT07204444|517045487|FG001|Overall Study|Medical/Hospitalization|9|||
143409578|NCT07204444|517045488|FG002|Overall Study|Medical/Hospitalization|6|||
143409579|NCT07204444|517045486|FG000|Overall Study|Treatment Provider Issue|1|||
143409580|NCT07204444|517045487|FG001|Overall Study|Treatment Provider Issue|3|||
143409581|NCT07204444|517045488|FG002|Overall Study|Treatment Provider Issue|0|||
143409582|NCT07204444|517045486|FG000|Overall Study|Withdrawal by Subject|11|||
143409583|NCT07204444|517045487|FG001|Overall Study|Withdrawal by Subject|5|||
143409584|NCT07204444|517045488|FG002|Overall Study|Withdrawal by Subject|5|||
143409585|NCT07204444|517045486|FG000|Overall Study|Death|3|||
143409586|NCT07204444|517045487|FG001|Overall Study|Death|6|||
143409587|NCT07204444|517045488|FG002|Overall Study|Death|1|||
143409588|NCT07204444|517045486|FG000|Overall Study|Unable To Reach|29|||
143409589|NCT07204444|517045487|FG001|Overall Study|Unable To Reach|26|||
143409590|NCT07204444|517045488|FG002|Overall Study|Unable To Reach|17|||
143409591|NCT07204444|517045486|FG000|Overall Study|Protocol Deviation|3|||
143409592|NCT07204444|517045487|FG001|Overall Study|Protocol Deviation|2|||
143409593|NCT07204444|517045488|FG002|Overall Study|Protocol Deviation|0|||
143409594|NCT05199571|517046854|FG000|Treatment Period|Participant decision|3|||
143409595|NCT05199571|517046854|FG000|Treatment Period|Physician Decision|1|||
143409596|NCT05199571|517046854|FG000|Post-treatment Follow up Period|Participant decision|3|||
143409597|NCT00092534|517046855|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
143409598|NCT00092534|517046856|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
143409599|NCT00092534|517046857|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
143409600|NCT00092534|517046858|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
143409601|NCT00092534|517046859|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
143409602|NCT00092534|517046855|FG000|Base Study Vaccination Period|Adverse Event|3|||
143409603|NCT00092534|517046856|FG001|Base Study Vaccination Period|Adverse Event|1|||
143409604|NCT00092534|517046857|FG002|Base Study Vaccination Period|Adverse Event|0|||
143409605|NCT00092534|517046858|FG003|Base Study Vaccination Period|Adverse Event|0|||
143409606|NCT00092534|517046859|FG004|Base Study Vaccination Period|Adverse Event|0|||
143409607|NCT00092534|517046855|FG000|Base Study Vaccination Period|Death|5|||
143409608|NCT00092534|517046856|FG001|Base Study Vaccination Period|Death|4|||
143409609|NCT00092534|517046857|FG002|Base Study Vaccination Period|Death|0|||
143409610|NCT00092534|517046858|FG003|Base Study Vaccination Period|Death|0|||
143409611|NCT00092534|517046859|FG004|Base Study Vaccination Period|Death|0|||
143409612|NCT00092534|517046855|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
143409613|NCT00092534|517046856|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
143409614|NCT00092534|517046857|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
143409615|NCT00092534|517046858|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
143409616|NCT00092534|517046859|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
143409617|NCT00092534|517046855|FG000|Base Study Vaccination Period|Physician Decision|1|||
143409618|NCT00092534|517046856|FG001|Base Study Vaccination Period|Physician Decision|0|||
143409619|NCT00092534|517046857|FG002|Base Study Vaccination Period|Physician Decision|0|||
143409620|NCT00092534|517046858|FG003|Base Study Vaccination Period|Physician Decision|0|||
143409621|NCT00092534|517046859|FG004|Base Study Vaccination Period|Physician Decision|0|||
143409622|NCT00092534|517046855|FG000|Base Study Vaccination Period|Pregnancy|9|||
143409623|NCT00092534|517046856|FG001|Base Study Vaccination Period|Pregnancy|7|||
143409624|NCT00092534|517046857|FG002|Base Study Vaccination Period|Pregnancy|0|||
143409625|NCT00092534|517046858|FG003|Base Study Vaccination Period|Pregnancy|0|||
143409626|NCT00092534|517046859|FG004|Base Study Vaccination Period|Pregnancy|0|||
143409627|NCT00092534|517046855|FG000|Base Study Vaccination Period|Protocol Violation|2|||
143409628|NCT00092534|517046856|FG001|Base Study Vaccination Period|Protocol Violation|1|||
143409629|NCT00092534|517046857|FG002|Base Study Vaccination Period|Protocol Violation|0|||
143409630|NCT00092534|517046858|FG003|Base Study Vaccination Period|Protocol Violation|0|||
143409631|NCT00092534|517046859|FG004|Base Study Vaccination Period|Protocol Violation|0|||
143409632|NCT00092534|517046855|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
143409633|NCT00092534|517046856|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
143409634|NCT00092534|517046857|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
143409635|NCT00092534|517046858|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
143409636|NCT00092534|517046859|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
143409637|NCT00092534|517046855|FG000|Base Study Vaccination Period|Moved|14|||
143409638|NCT00092534|517046856|FG001|Base Study Vaccination Period|Moved|12|||
143409639|NCT00092534|517046857|FG002|Base Study Vaccination Period|Moved|0|||
143409640|NCT00092534|517046858|FG003|Base Study Vaccination Period|Moved|0|||
143409641|NCT00092534|517046859|FG004|Base Study Vaccination Period|Moved|0|||
143409642|NCT00092534|517046855|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
143409643|NCT00092534|517046856|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
143409644|NCT00092534|517046857|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
143409645|NCT00092534|517046858|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
143409646|NCT00092534|517046859|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
143409647|NCT00092534|517046855|FG000|Base Study Vaccination Period|Travel|1|||
143409648|NCT00092534|517046856|FG001|Base Study Vaccination Period|Travel|0|||
143409649|NCT00092534|517046857|FG002|Base Study Vaccination Period|Travel|0|||
143409650|NCT00092534|517046858|FG003|Base Study Vaccination Period|Travel|0|||
143409651|NCT00092534|517046859|FG004|Base Study Vaccination Period|Travel|0|||
143409652|NCT00092534|517046855|FG000|Base Study Vaccination Period|Site Closed|0|||
143409653|NCT00092534|517046856|FG001|Base Study Vaccination Period|Site Closed|1|||
143409654|NCT00092534|517046857|FG002|Base Study Vaccination Period|Site Closed|0|||
143409655|NCT00092534|517046858|FG003|Base Study Vaccination Period|Site Closed|0|||
143409656|NCT00092534|517046859|FG004|Base Study Vaccination Period|Site Closed|0|||
143409657|NCT00092534|517046855|FG000|Base Study Follow-Up Period|Adverse Event|2|||
143409658|NCT00092534|517046856|FG001|Base Study Follow-Up Period|Adverse Event|4|||
143409659|NCT00092534|517046857|FG002|Base Study Follow-Up Period|Adverse Event|0|||
143409660|NCT00092534|517046858|FG003|Base Study Follow-Up Period|Adverse Event|0|||
143409661|NCT00092534|517046859|FG004|Base Study Follow-Up Period|Adverse Event|0|||
143409662|NCT00092534|517046855|FG000|Base Study Follow-Up Period|Death|2|||
143409663|NCT00092534|517046856|FG001|Base Study Follow-Up Period|Death|1|||
143409664|NCT00092534|517046857|FG002|Base Study Follow-Up Period|Death|0|||
143409665|NCT00092534|517046858|FG003|Base Study Follow-Up Period|Death|0|||
143409666|NCT00092534|517046859|FG004|Base Study Follow-Up Period|Death|0|||
143409667|NCT00092534|517046855|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
143409668|NCT00092534|517046856|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
143409669|NCT00092534|517046857|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
143409670|NCT00092534|517046858|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
143409671|NCT00092534|517046859|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
143409672|NCT00092534|517046855|FG000|Base Study Follow-Up Period|Pregnancy|6|||
143409673|NCT00092534|517046856|FG001|Base Study Follow-Up Period|Pregnancy|10|||
143409674|NCT00092534|517046857|FG002|Base Study Follow-Up Period|Pregnancy|0|||
143409675|NCT00092534|517046858|FG003|Base Study Follow-Up Period|Pregnancy|0|||
143409676|NCT00092534|517046859|FG004|Base Study Follow-Up Period|Pregnancy|0|||
143409677|NCT00092534|517046855|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
143409678|NCT00092534|517046856|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
143409679|NCT00092534|517046857|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
143409680|NCT00092534|517046858|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
143409681|NCT00092534|517046859|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
143409682|NCT00092534|517046855|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
143409683|NCT00092534|517046856|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
143409684|NCT00092534|517046857|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
143409685|NCT00092534|517046858|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
143409686|NCT00092534|517046859|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
143409687|NCT00092534|517046855|FG000|Base Study Follow-Up Period|Moved|62|||
143409688|NCT00092534|517046856|FG001|Base Study Follow-Up Period|Moved|58|||
143409689|NCT00092534|517046857|FG002|Base Study Follow-Up Period|Moved|0|||
143409690|NCT00092534|517046858|FG003|Base Study Follow-Up Period|Moved|0|||
143409691|NCT00092534|517046859|FG004|Base Study Follow-Up Period|Moved|0|||
143409692|NCT00092534|517046855|FG000|Base Study Follow-Up Period|Travel|10|||
143409693|NCT00092534|517046856|FG001|Base Study Follow-Up Period|Travel|7|||
143409694|NCT00092534|517046857|FG002|Base Study Follow-Up Period|Travel|0|||
143409695|NCT00092534|517046858|FG003|Base Study Follow-Up Period|Travel|0|||
143409696|NCT00092534|517046859|FG004|Base Study Follow-Up Period|Travel|0|||
143409697|NCT00092534|517046855|FG000|Base Study Follow-Up Period|Site Closed|0|||
143409698|NCT00092534|517046856|FG001|Base Study Follow-Up Period|Site Closed|2|||
143409699|NCT00092534|517046857|FG002|Base Study Follow-Up Period|Site Closed|0|||
143409700|NCT00092534|517046858|FG003|Base Study Follow-Up Period|Site Closed|0|||
143409701|NCT00092534|517046859|FG004|Base Study Follow-Up Period|Site Closed|0|||
143409702|NCT00092534|517046855|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
143409703|NCT00092534|517046856|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
143409704|NCT00092534|517046857|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
143409705|NCT00092534|517046858|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
143409706|NCT00092534|517046859|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
143409707|NCT00092534|517046855|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
143409708|NCT00092534|517046856|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
143409709|NCT00092534|517046857|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
143409710|NCT00092534|517046858|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
143409711|NCT00092534|517046859|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
143409712|NCT00092534|517046855|FG000|Base Study EXT|Lost to Follow-up|0|||
143409713|NCT00092534|517046856|FG001|Base Study EXT|Lost to Follow-up|0|||
143409714|NCT00092534|517046857|FG002|Base Study EXT|Lost to Follow-up|41|||
143409715|NCT00092534|517046858|FG003|Base Study EXT|Lost to Follow-up|0|||
143409716|NCT00092534|517046859|FG004|Base Study EXT|Lost to Follow-up|0|||
143409717|NCT00092534|517046855|FG000|Base Study EXT|Physician Decision|0|||
143409718|NCT00092534|517046856|FG001|Base Study EXT|Physician Decision|0|||
143409719|NCT00092534|517046857|FG002|Base Study EXT|Physician Decision|1|||
143409720|NCT00092534|517046858|FG003|Base Study EXT|Physician Decision|0|||
143409721|NCT00092534|517046859|FG004|Base Study EXT|Physician Decision|0|||
143409722|NCT00092534|517046855|FG000|Base Study EXT|Pregnancy|0|||
143409723|NCT00092534|517046856|FG001|Base Study EXT|Pregnancy|0|||
143409724|NCT00092534|517046857|FG002|Base Study EXT|Pregnancy|12|||
143409725|NCT00092534|517046858|FG003|Base Study EXT|Pregnancy|0|||
143409726|NCT00092534|517046859|FG004|Base Study EXT|Pregnancy|0|||
143409727|NCT00092534|517046855|FG000|Base Study EXT|Withdrawal by Subject|0|||
143409728|NCT00092534|517046856|FG001|Base Study EXT|Withdrawal by Subject|0|||
143409729|NCT00092534|517046857|FG002|Base Study EXT|Withdrawal by Subject|18|||
143409730|NCT00092534|517046858|FG003|Base Study EXT|Withdrawal by Subject|0|||
143409731|NCT00092534|517046859|FG004|Base Study EXT|Withdrawal by Subject|0|||
143409732|NCT00092534|517046855|FG000|Base Study EXT|Participant moved|0|||
143409733|NCT00092534|517046856|FG001|Base Study EXT|Participant moved|0|||
143409734|NCT00092534|517046857|FG002|Base Study EXT|Participant moved|6|||
143409735|NCT00092534|517046858|FG003|Base Study EXT|Participant moved|0|||
143409736|NCT00092534|517046859|FG004|Base Study EXT|Participant moved|0|||
143409737|NCT00092534|517046855|FG000|Base Study EXT|Travel|0|||
143409738|NCT00092534|517046856|FG001|Base Study EXT|Travel|0|||
143409739|NCT00092534|517046857|FG002|Base Study EXT|Travel|2|||
143409740|NCT00092534|517046858|FG003|Base Study EXT|Travel|0|||
143409741|NCT00092534|517046859|FG004|Base Study EXT|Travel|0|||
143409742|NCT00092534|517046855|FG000|Base Study EXT|Site closed|0|||
143409743|NCT00092534|517046856|FG001|Base Study EXT|Site closed|0|||
143409744|NCT00092534|517046857|FG002|Base Study EXT|Site closed|21|||
143409745|NCT00092534|517046858|FG003|Base Study EXT|Site closed|0|||
143409746|NCT00092534|517046859|FG004|Base Study EXT|Site closed|0|||
143409747|NCT00092534|517046855|FG000|Base Study EXT|Study ended|0|||
143409748|NCT00092534|517046856|FG001|Base Study EXT|Study ended|0|||
143409749|NCT00092534|517046857|FG002|Base Study EXT|Study ended|29|||
143409750|NCT00092534|517046858|FG003|Base Study EXT|Study ended|0|||
143409751|NCT00092534|517046859|FG004|Base Study EXT|Study ended|0|||
143409752|NCT00092534|517046855|FG000|Base Study EXT|Protocol Violation|0|||
143409753|NCT00092534|517046856|FG001|Base Study EXT|Protocol Violation|0|||
143409754|NCT00092534|517046857|FG002|Base Study EXT|Protocol Violation|15|||
143409755|NCT00092534|517046858|FG003|Base Study EXT|Protocol Violation|0|||
143409756|NCT00092534|517046859|FG004|Base Study EXT|Protocol Violation|0|||
143409757|NCT00092534|517046855|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
143409758|NCT00092534|517046856|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
143409759|NCT00092534|517046857|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
143409760|NCT00092534|517046858|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
143409761|NCT00092534|517046859|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
143409762|NCT04001829|517046863|FG000|Overall Study|Never start protocol therapy|5|||
143409763|NCT04001829|517046864|FG001|Overall Study|Never start protocol therapy|5|||
143409764|NCT04001829|517046863|FG000|Overall Study|Adverse Event|11|||
143409765|NCT04001829|517046864|FG001|Overall Study|Adverse Event|7|||
143409766|NCT04001829|517046863|FG000|Overall Study|Alternative therapy|1|||
143409767|NCT04001829|517046864|FG001|Overall Study|Alternative therapy|2|||
143409768|NCT04001829|517046863|FG000|Overall Study|Disease progression/relapse|2|||
143409769|NCT04001829|517046864|FG001|Overall Study|Disease progression/relapse|1|||
143409770|NCT04001829|517046863|FG000|Overall Study|Other complicating disease|1|||
143409771|NCT04001829|517046864|FG001|Overall Study|Other complicating disease|0|||
143409772|NCT04001829|517046863|FG000|Overall Study|Withdrawal by Subject|1|||
143409773|NCT04001829|517046864|FG001|Overall Study|Withdrawal by Subject|4|||
143409774|NCT04001829|517046863|FG000|Overall Study|Ineligible|2|||
143409775|NCT04001829|517046864|FG001|Overall Study|Ineligible|2|||
143409776|NCT04001829|517046863|FG000|Overall Study|Reason missing due to delinquent data|1|||
143409777|NCT04001829|517046864|FG001|Overall Study|Reason missing due to delinquent data|0|||
143409778|NCT01171898|517046865|FG000|Overall Study|Death|0|||
143409779|NCT01171898|517046866|FG001|Overall Study|Death|0|||
143409780|NCT01171898|517046867|FG002|Overall Study|Death|2|||
143409781|NCT01171898|517046868|FG003|Overall Study|Death|0|||
143409782|NCT01171898|517046865|FG000|Overall Study|Lost to Follow-up|0|||
143409783|NCT01171898|517046866|FG001|Overall Study|Lost to Follow-up|1|||
143409784|NCT01171898|517046867|FG002|Overall Study|Lost to Follow-up|1|||
143409785|NCT01171898|517046868|FG003|Overall Study|Lost to Follow-up|1|||
143409786|NCT01171898|517046865|FG000|Overall Study|Withdrawal by Subject|1|||
143409787|NCT01171898|517046866|FG001|Overall Study|Withdrawal by Subject|4|||
143409788|NCT01171898|517046867|FG002|Overall Study|Withdrawal by Subject|6|||
143409789|NCT01171898|517046868|FG003|Overall Study|Withdrawal by Subject|3|||
143409790|NCT01171898|517046865|FG000|Overall Study|Terminated by Sponsor|1|||
143409791|NCT01171898|517046866|FG001|Overall Study|Terminated by Sponsor|0|||
143409792|NCT01171898|517046867|FG002|Overall Study|Terminated by Sponsor|0|||
143409793|NCT01171898|517046868|FG003|Overall Study|Terminated by Sponsor|0|||
143409794|NCT01171898|517046865|FG000|Overall Study|Ongoing|1|||
143409795|NCT01171898|517046866|FG001|Overall Study|Ongoing|9|||
143409796|NCT01171898|517046867|FG002|Overall Study|Ongoing|3|||
143409797|NCT01171898|517046868|FG003|Overall Study|Ongoing|0|||
143409798|NCT01171898|517046865|FG000|Overall Study|Other|1|||
143409799|NCT01171898|517046866|FG001|Overall Study|Other|5|||
143409800|NCT01171898|517046867|FG002|Overall Study|Other|0|||
143409801|NCT01171898|517046868|FG003|Overall Study|Other|2|||
143409802|NCT05802173|517046869|FG000|Overall Study|Withdrawal by Subject|2|||
143409803|NCT05802173|517046870|FG001|Overall Study|Withdrawal by Subject|0|||
143409804|NCT05802173|517046871|FG002|Overall Study|Withdrawal by Subject|0|||
143409805|NCT05802173|517046869|FG000|Overall Study|Protocol Violation|1|||
143409806|NCT05802173|517046870|FG001|Overall Study|Protocol Violation|0|||
143409807|NCT05802173|517046871|FG002|Overall Study|Protocol Violation|0|||
143409808|NCT05802173|517046869|FG000|Overall Study|Lost to Follow-up|0|||
143409809|NCT05802173|517046870|FG001|Overall Study|Lost to Follow-up|6|||
143409810|NCT05802173|517046871|FG002|Overall Study|Lost to Follow-up|4|||
143409811|NCT05802173|517046869|FG000|Overall Study|non-compliance|0|||
143409812|NCT05802173|517046870|FG001|Overall Study|non-compliance|1|||
143409813|NCT05802173|517046871|FG002|Overall Study|non-compliance|0|||
143409814|NCT02932410|517046872|FG000|Overall Study|Death|7|||
143409815|NCT02932410|517046873|FG001|Overall Study|Death|6|||
143409816|NCT02932410|517046874|FG002|Overall Study|Death|0|||
143409817|NCT02932410|517046875|FG003|Overall Study|Death|0|||
143409818|NCT02932410|517046872|FG000|Overall Study|Lost to Follow-up|1|||
143409819|NCT02932410|517046873|FG001|Overall Study|Lost to Follow-up|2|||
143409820|NCT02932410|517046874|FG002|Overall Study|Lost to Follow-up|0|||
143409821|NCT02932410|517046875|FG003|Overall Study|Lost to Follow-up|0|||
143409822|NCT02932410|517046872|FG000|Overall Study|Parent/Subjects decision|6|||
143409823|NCT02932410|517046873|FG001|Overall Study|Parent/Subjects decision|6|||
143409824|NCT02932410|517046874|FG002|Overall Study|Parent/Subjects decision|1|||
143409825|NCT02932410|517046875|FG003|Overall Study|Parent/Subjects decision|0|||
143409826|NCT02932410|517046872|FG000|Overall Study|Physician Decision|0|||
143409827|NCT02932410|517046873|FG001|Overall Study|Physician Decision|1|||
143409828|NCT02932410|517046874|FG002|Overall Study|Physician Decision|0|||
143409829|NCT02932410|517046875|FG003|Overall Study|Physician Decision|0|||
143409830|NCT00360269|517046878|FG000|Overall Study|Lost to Follow-up|7|||
143409831|NCT00360269|517046879|FG001|Overall Study|Lost to Follow-up|9|||
143409832|NCT00360269|517046878|FG000|Overall Study|Physician Decision|1|||
143409833|NCT00360269|517046879|FG001|Overall Study|Physician Decision|2|||
143409834|NCT00360269|517046878|FG000|Overall Study|Adverse Event|1|||
143409835|NCT00360269|517046879|FG001|Overall Study|Adverse Event|0|||
143409836|NCT00360269|517046878|FG000|Overall Study|Withdrawal by Subject|1|||
143409837|NCT00360269|517046879|FG001|Overall Study|Withdrawal by Subject|1|||
143409838|NCT03002194|517046880|FG000|Overall Study|Lost to Follow-up|6|||
143409839|NCT03002194|517046880|FG000|Overall Study|Adverse Event|1|||
143409840|NCT03002194|517046880|FG000|Overall Study|Lack of Efficacy|1|||
143409841|NCT03002194|517046880|FG000|Overall Study|Withdrawal by Subject|2|||
143409842|NCT00048932|517046883|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
143409843|NCT00048932|517046884|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
143409844|NCT00048932|517046885|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
143409845|NCT00048932|517046883|FG000|Double Blind Period (DB)|Adverse Event|51|||
143409846|NCT00048932|517046884|FG001|Double Blind Period (DB)|Adverse Event|19|||
143409847|NCT00048932|517046885|FG002|Double Blind Period (DB)|Adverse Event|0|||
143409848|NCT00048932|517046883|FG000|Double Blind Period (DB)|Death|5|||
143409849|NCT00048932|517046884|FG001|Double Blind Period (DB)|Death|3|||
143409850|NCT00048932|517046885|FG002|Double Blind Period (DB)|Death|0|||
143409851|NCT00048932|517046883|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
143409852|NCT00048932|517046884|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
143409853|NCT00048932|517046885|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
143409854|NCT00048932|517046883|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
143409855|NCT00048932|517046884|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
143409856|NCT00048932|517046885|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
143409857|NCT00048932|517046883|FG000|Double Blind Period (DB)|Relocation|1|||
143409858|NCT00048932|517046884|FG001|Double Blind Period (DB)|Relocation|0|||
143409859|NCT00048932|517046885|FG002|Double Blind Period (DB)|Relocation|0|||
143409860|NCT00048932|517046883|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
143409861|NCT00048932|517046884|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
143409862|NCT00048932|517046885|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
143409863|NCT00048932|517046883|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
143409864|NCT00048932|517046884|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
143409865|NCT00048932|517046885|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
143409866|NCT00048932|517046883|FG000|Double Blind Period (DB)|Pregnancy|1|||
143409867|NCT00048932|517046884|FG001|Double Blind Period (DB)|Pregnancy|0|||
143409868|NCT00048932|517046885|FG002|Double Blind Period (DB)|Pregnancy|0|||
143409869|NCT00048932|517046883|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
143409870|NCT00048932|517046884|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
143409871|NCT00048932|517046885|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
143409872|NCT00048932|517046883|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
143409873|NCT00048932|517046884|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
143409874|NCT00048932|517046885|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
143409875|NCT00048932|517046883|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
143409876|NCT00048932|517046884|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
143409877|NCT00048932|517046885|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
143409878|NCT00048932|517046883|FG000|Open Label Period (OL)|Death|0|||
143409879|NCT00048932|517046884|FG001|Open Label Period (OL)|Death|0|||
143409880|NCT00048932|517046885|FG002|Open Label Period (OL)|Death|25|||
143409881|NCT00048932|517046883|FG000|Open Label Period (OL)|Adverse Event|0|||
143409882|NCT00048932|517046884|FG001|Open Label Period (OL)|Adverse Event|0|||
143409883|NCT00048932|517046885|FG002|Open Label Period (OL)|Adverse Event|103|||
143409884|NCT00048932|517046883|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
143409885|NCT00048932|517046884|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
143409886|NCT00048932|517046885|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
143409887|NCT00048932|517046883|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
143409888|NCT00048932|517046884|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
143409889|NCT00048932|517046885|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
143409890|NCT00048932|517046883|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
143409891|NCT00048932|517046884|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
143409892|NCT00048932|517046885|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
143409893|NCT00048932|517046883|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
143409894|NCT00048932|517046884|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
143409895|NCT00048932|517046885|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
143409896|NCT00048932|517046883|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
143409897|NCT00048932|517046884|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
143409898|NCT00048932|517046885|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
143409899|NCT00048932|517046883|FG000|Open Label Period (OL)|Pregnancy|0|||
143409900|NCT00048932|517046884|FG001|Open Label Period (OL)|Pregnancy|0|||
143409901|NCT00048932|517046885|FG002|Open Label Period (OL)|Pregnancy|6|||
143409902|NCT00048932|517046883|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
143409903|NCT00048932|517046884|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
143409904|NCT00048932|517046885|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
143409905|NCT00048932|517046883|FG000|Open Label Period (OL)|Investigator Retiring|0|||
143409906|NCT00048932|517046884|FG001|Open Label Period (OL)|Investigator Retiring|0|||
143409907|NCT00048932|517046885|FG002|Open Label Period (OL)|Investigator Retiring|2|||
143409908|NCT00048932|517046883|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
143409909|NCT00048932|517046884|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
143409910|NCT00048932|517046885|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
143409911|NCT00048932|517046883|FG000|Open Label Period (OL)|Participant Relocated|0|||
143409912|NCT00048932|517046884|FG001|Open Label Period (OL)|Participant Relocated|0|||
143409913|NCT00048932|517046885|FG002|Open Label Period (OL)|Participant Relocated|6|||
143409914|NCT00048932|517046883|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
143409915|NCT00048932|517046884|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
143409916|NCT00048932|517046885|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
143409917|NCT00048932|517046883|FG000|Open Label Period (OL)|Site Closure|0|||
143409918|NCT00048932|517046884|FG001|Open Label Period (OL)|Site Closure|0|||
143409919|NCT00048932|517046885|FG002|Open Label Period (OL)|Site Closure|3|||
143409920|NCT00048932|517046883|FG000|Open Label Period (OL)|Trial Terminated|0|||
143409921|NCT00048932|517046884|FG001|Open Label Period (OL)|Trial Terminated|0|||
143409922|NCT00048932|517046885|FG002|Open Label Period (OL)|Trial Terminated|1|||
143409923|NCT00048932|517046883|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
143409924|NCT00048932|517046884|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
143409925|NCT00048932|517046885|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
143409926|NCT00048932|517046883|FG000|Open Label Period (OL)|Patient Decision|0|||
143409927|NCT00048932|517046884|FG001|Open Label Period (OL)|Patient Decision|0|||
143409928|NCT00048932|517046885|FG002|Open Label Period (OL)|Patient Decision|4|||
143409929|NCT00048932|517046883|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
143409930|NCT00048932|517046884|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
143409931|NCT00048932|517046885|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
143409932|NCT00048932|517046883|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
143409933|NCT00048932|517046884|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
143409934|NCT00048932|517046885|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
143409935|NCT00048932|517046883|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
143409936|NCT00048932|517046884|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
143409937|NCT00048932|517046885|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
143409938|NCT00048932|517046883|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
143409939|NCT00048932|517046884|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
143409940|NCT00048932|517046885|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
143409941|NCT00048932|517046883|FG000|Open Label Period (OL)|Investigator Decision|0|||
143409942|NCT00048932|517046884|FG001|Open Label Period (OL)|Investigator Decision|0|||
143409943|NCT00048932|517046885|FG002|Open Label Period (OL)|Investigator Decision|4|||
143409944|NCT00048932|517046883|FG000|Open Label Period (OL)|Site Staff Issues|0|||
143409945|NCT00048932|517046884|FG001|Open Label Period (OL)|Site Staff Issues|0|||
143409946|NCT00048932|517046885|FG002|Open Label Period (OL)|Site Staff Issues|2|||
143409947|NCT00048932|517046883|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
143409948|NCT00048932|517046884|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
143409949|NCT00048932|517046885|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
143409950|NCT00048932|517046883|FG000|Open Label Period (OL)|Participant Surgery|0|||
143409951|NCT00048932|517046884|FG001|Open Label Period (OL)|Participant Surgery|0|||
143409952|NCT00048932|517046885|FG002|Open Label Period (OL)|Participant Surgery|1|||
143409953|NCT02232737|517046886|FG000|Overall Study|Lost to Follow-up|18|||
143409954|NCT02232737|517046887|FG001|Overall Study|Lost to Follow-up|28|||
143409955|NCT02232737|517046888|FG002|Overall Study|Lost to Follow-up|33|||
143409956|NCT02232737|517046886|FG000|Overall Study|Personal reasons|7|||
143409957|NCT02232737|517046887|FG001|Overall Study|Personal reasons|8|||
143409958|NCT02232737|517046888|FG002|Overall Study|Personal reasons|14|||
143409959|NCT02232737|517046886|FG000|Overall Study|Adverse Event|6|||
143409960|NCT02232737|517046887|FG001|Overall Study|Adverse Event|3|||
143409961|NCT02232737|517046888|FG002|Overall Study|Adverse Event|8|||
143409962|NCT02232737|517046886|FG000|Overall Study|Incarcerated|2|||
143409963|NCT02232737|517046887|FG001|Overall Study|Incarcerated|1|||
143409964|NCT02232737|517046888|FG002|Overall Study|Incarcerated|2|||
143409965|NCT02232737|517046886|FG000|Overall Study|Withdrawal by Subject|0|||
143409966|NCT02232737|517046887|FG001|Overall Study|Withdrawal by Subject|1|||
143409967|NCT02232737|517046888|FG002|Overall Study|Withdrawal by Subject|2|||
143409968|NCT02232737|517046886|FG000|Overall Study|Death|0|||
143409969|NCT02232737|517046887|FG001|Overall Study|Death|1|||
143409970|NCT02232737|517046888|FG002|Overall Study|Death|1|||
143409971|NCT02232737|517046886|FG000|Overall Study|Physician Decision|1|||
143409972|NCT02232737|517046887|FG001|Overall Study|Physician Decision|3|||
143409973|NCT02232737|517046888|FG002|Overall Study|Physician Decision|1|||
143409974|NCT02232737|517046886|FG000|Overall Study|Protocol Violation|1|||
143409975|NCT02232737|517046887|FG001|Overall Study|Protocol Violation|0|||
143409976|NCT02232737|517046888|FG002|Overall Study|Protocol Violation|1|||
143409977|NCT02232737|517046886|FG000|Overall Study|Reason unknown|1|||
143409978|NCT02232737|517046887|FG001|Overall Study|Reason unknown|0|||
143409979|NCT02232737|517046888|FG002|Overall Study|Reason unknown|0|||
143409980|NCT02200705|517046889|FG000|Overall Study|Excluded|12|||
143409981|NCT02200705|517046889|FG000|Overall Study|Death|21|||
143409982|NCT02200705|517046889|FG000|Overall Study|Withdrawal by Subject|22|||
143409983|NCT02200705|517046889|FG000|Overall Study|Lost to Follow-up|13|||
143409984|NCT02200705|517046889|FG000|Overall Study|Physician Decision|5|||
143409985|NCT02200705|517046889|FG000|Overall Study|Adverse Event|2|||
143409986|NCT04083976|517046890|FG000|Overall Study|Lost to Follow-up|3|||
143409987|NCT04083976|517046891|FG001|Overall Study|Lost to Follow-up|0|||
143409988|NCT04083976|517046892|FG002|Overall Study|Lost to Follow-up|0|||
143409989|NCT04083976|517046893|FG003|Overall Study|Lost to Follow-up|1|||
143409990|NCT04083976|517046890|FG000|Overall Study|Withdrawal by Subject|16|||
143409991|NCT04083976|517046891|FG001|Overall Study|Withdrawal by Subject|1|||
143409992|NCT04083976|517046892|FG002|Overall Study|Withdrawal by Subject|9|||
143409993|NCT04083976|517046893|FG003|Overall Study|Withdrawal by Subject|0|||
143409994|NCT04083976|517046890|FG000|Overall Study|Sponsor Decision|14|||
143409995|NCT04083976|517046891|FG001|Overall Study|Sponsor Decision|0|||
143409996|NCT04083976|517046892|FG002|Overall Study|Sponsor Decision|0|||
143409997|NCT04083976|517046893|FG003|Overall Study|Sponsor Decision|7|||
143409998|NCT04083976|517046890|FG000|Overall Study|Other|1|||
143409999|NCT04083976|517046891|FG001|Overall Study|Other|0|||
143410000|NCT04083976|517046892|FG002|Overall Study|Other|1|||
143410001|NCT04083976|517046893|FG003|Overall Study|Other|0|||
143410002|NCT03738228|517046896|FG000|Overall Study|Never received study treatment|2|||
143410003|NCT03738228|517046897|FG001|Overall Study|Never received study treatment|2|||
143410004|NCT06212752|517046898|FG000|Overall Study|Death|5|||
143410005|NCT06212752|517046899|FG001|Overall Study|Death|3|||
143410006|NCT06212752|517046898|FG000|Overall Study|Participants ongoing|23|||
143410007|NCT06212752|517046899|FG001|Overall Study|Participants ongoing|8|||
143410008|NCT03021993|517046900|FG000|Overall Study|Withdrawal by Subject|4|||
143410009|NCT03021993|517046900|FG000|Overall Study|Physician Decision|1|||
143410010|NCT03021993|517046900|FG000|Overall Study|enrolled but were not treated|1|||
143410011|NCT03021993|517046900|FG000|Overall Study|Death|3|||
143410012|NCT02365597|517046901|FG000|Overall Study|Lost to Follow-up|0|||
143410013|NCT02365597|517046902|FG001|Overall Study|Lost to Follow-up|1|||
143410014|NCT02365597|517046903|FG002|Overall Study|Lost to Follow-up|0|||
143410015|NCT02365597|517046904|FG003|Overall Study|Lost to Follow-up|1|||
143410016|NCT02365597|517046901|FG000|Overall Study|Withdrawal by Subject|1|||
143410017|NCT02365597|517046902|FG001|Overall Study|Withdrawal by Subject|8|||
143410018|NCT02365597|517046903|FG002|Overall Study|Withdrawal by Subject|5|||
143410019|NCT02365597|517046904|FG003|Overall Study|Withdrawal by Subject|1|||
143410020|NCT02365597|517046901|FG000|Overall Study|Sponsor's decision|1|||
143410021|NCT02365597|517046902|FG001|Overall Study|Sponsor's decision|3|||
143410022|NCT02365597|517046903|FG002|Overall Study|Sponsor's decision|13|||
143410023|NCT02365597|517046904|FG003|Overall Study|Sponsor's decision|0|||
143410024|NCT02365597|517046901|FG000|Overall Study|Other|0|||
143410025|NCT02365597|517046902|FG001|Overall Study|Other|4|||
143410026|NCT02365597|517046903|FG002|Overall Study|Other|0|||
143410027|NCT02365597|517046904|FG003|Overall Study|Other|0|||
143410028|NCT02365597|517046901|FG000|Overall Study|Enrolled but not treated|0|||
143410029|NCT02365597|517046902|FG001|Overall Study|Enrolled but not treated|1|||
143410030|NCT02365597|517046903|FG002|Overall Study|Enrolled but not treated|1|||
143410031|NCT02365597|517046904|FG003|Overall Study|Enrolled but not treated|0|||
143410032|NCT02365597|517046901|FG000|Overall Study|Ongoing|0|||
143410033|NCT02365597|517046902|FG001|Overall Study|Ongoing|0|||
143410034|NCT02365597|517046903|FG002|Overall Study|Ongoing|0|||
143410035|NCT02365597|517046904|FG003|Overall Study|Ongoing|17|||
143410036|NCT00983294|517046905|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
143410037|NCT00983294|517046905|FG000|Colchicine With Azithromycin|Adverse Event|1|||
143410038|NCT00390884|517046908|FG000|Overall Study|Withdrawal by Subject|2|||
143410039|NCT00390884|517046909|FG001|Overall Study|Withdrawal by Subject|2|||
143410040|NCT05966155|517046910|FG000|Overall Study|Death|1|||
143410041|NCT05966155|517046911|FG001|Overall Study|Death|2|||
143410042|NCT05966155|517046910|FG000|Overall Study|Lost to Follow-up|63|||
143410043|NCT05966155|517046911|FG001|Overall Study|Lost to Follow-up|67|||
143410044|NCT05966155|517046910|FG000|Overall Study|Protocol Violation|1|||
143410045|NCT05966155|517046911|FG001|Overall Study|Protocol Violation|0|||
143410046|NCT05966155|517046910|FG000|Overall Study|Withdrawal by Subject|8|||
143410047|NCT05966155|517046911|FG001|Overall Study|Withdrawal by Subject|9|||
143410048|NCT05966155|517046910|FG000|Overall Study|Enrolled Erroneously|0|||
143410049|NCT05966155|517046911|FG001|Overall Study|Enrolled Erroneously|1|||
143410050|NCT05966155|517046910|FG000|Overall Study|Follow-up Incorrectly Scheduled|0|||
143410051|NCT05966155|517046911|FG001|Overall Study|Follow-up Incorrectly Scheduled|1|||
143410052|NCT04221438|517046914|FG000|Overall Study|Adverse Event|1|||
143410053|NCT04221438|517046914|FG000|Overall Study|No surgery within required timeframe due to Covid diagnosis|1|||
143410054|NCT05036278|517046915|FG000|Overall Study|Withdrawal by Subject|1|||
143410055|NCT05036278|517046915|FG000|Overall Study|Adverse Event|1|||
143410056|NCT04647487|517046916|FG000|Overall Study|Protocol Deviation|0|||
143410057|NCT04647487|517046917|FG001|Overall Study|Protocol Deviation|0|||
143410058|NCT04647487|517046918|FG002|Overall Study|Protocol Deviation|1|||
143410059|NCT04647487|517046916|FG000|Overall Study|Withdrawal by Subject|1|||
143410060|NCT04647487|517046917|FG001|Overall Study|Withdrawal by Subject|0|||
143410061|NCT04647487|517046918|FG002|Overall Study|Withdrawal by Subject|2|||
143410062|NCT01946204|517046921|FG000|Overall Study|Death|38|||
143410063|NCT01946204|517046922|FG001|Overall Study|Death|59|||
143410064|NCT01946204|517046921|FG000|Overall Study|Withdrawal by Subject|37|||
143410065|NCT01946204|517046922|FG001|Overall Study|Withdrawal by Subject|50|||
143410066|NCT01946204|517046921|FG000|Overall Study|Lost to Follow-up|3|||
143410067|NCT01946204|517046922|FG001|Overall Study|Lost to Follow-up|7|||
143410068|NCT01946204|517046921|FG000|Overall Study|Ongoing|316|||
143410069|NCT01946204|517046922|FG001|Overall Study|Ongoing|687|||
143410070|NCT01946204|517046921|FG000|Overall Study|Other|7|||
143410071|NCT01946204|517046922|FG001|Overall Study|Other|3|||
143410072|NCT03466411|517046923|FG000|Overall Study|Lost to Follow-up|0|||
143410073|NCT03466411|517046924|FG001|Overall Study|Lost to Follow-up|1|||
143410074|NCT03466411|517046925|FG002|Overall Study|Lost to Follow-up|1|||
143410075|NCT03466411|517046926|FG003|Overall Study|Lost to Follow-up|0|||
143410076|NCT03466411|517046927|FG004|Overall Study|Lost to Follow-up|0|||
143410077|NCT03466411|517046928|FG005|Overall Study|Lost to Follow-up|0|||
143410078|NCT03466411|517046929|FG006|Overall Study|Lost to Follow-up|1|||
143410079|NCT03466411|517046930|FG007|Overall Study|Lost to Follow-up|1|||
143410080|NCT03466411|517046931|FG008|Overall Study|Lost to Follow-up|0|||
143410081|NCT03466411|517046932|FG009|Overall Study|Lost to Follow-up|1|||
143410082|NCT03466411|517046933|FG010|Overall Study|Lost to Follow-up|1|||
143410083|NCT03466411|517046934|FG011|Overall Study|Lost to Follow-up|1|||
143410084|NCT03466411|517046935|FG012|Overall Study|Lost to Follow-up|0|||
143410085|NCT03466411|517046923|FG000|Overall Study|Withdrawal by Subject|14|||
143410086|NCT03466411|517046924|FG001|Overall Study|Withdrawal by Subject|7|||
143410087|NCT03466411|517046925|FG002|Overall Study|Withdrawal by Subject|8|||
143410088|NCT03466411|517046926|FG003|Overall Study|Withdrawal by Subject|4|||
143410089|NCT03466411|517046927|FG004|Overall Study|Withdrawal by Subject|6|||
143410090|NCT03466411|517046928|FG005|Overall Study|Withdrawal by Subject|3|||
143410091|NCT03466411|517046929|FG006|Overall Study|Withdrawal by Subject|6|||
143410092|NCT03466411|517046930|FG007|Overall Study|Withdrawal by Subject|9|||
143410093|NCT03466411|517046931|FG008|Overall Study|Withdrawal by Subject|6|||
143410094|NCT03466411|517046932|FG009|Overall Study|Withdrawal by Subject|11|||
143410095|NCT03466411|517046933|FG010|Overall Study|Withdrawal by Subject|14|||
143410096|NCT03466411|517046934|FG011|Overall Study|Withdrawal by Subject|12|||
143410097|NCT03466411|517046935|FG012|Overall Study|Withdrawal by Subject|7|||
143410098|NCT03466411|517046923|FG000|Overall Study|Other|1|||
143410099|NCT03466411|517046924|FG001|Overall Study|Other|1|||
143410100|NCT03466411|517046925|FG002|Overall Study|Other|0|||
143410101|NCT03466411|517046926|FG003|Overall Study|Other|1|||
143410102|NCT03466411|517046927|FG004|Overall Study|Other|2|||
143410103|NCT03466411|517046928|FG005|Overall Study|Other|0|||
143410104|NCT03466411|517046929|FG006|Overall Study|Other|0|||
143410105|NCT03466411|517046930|FG007|Overall Study|Other|0|||
143410106|NCT03466411|517046931|FG008|Overall Study|Other|0|||
143410107|NCT03466411|517046932|FG009|Overall Study|Other|1|||
143410108|NCT03466411|517046933|FG010|Overall Study|Other|2|||
143410109|NCT03466411|517046934|FG011|Overall Study|Other|0|||
143410110|NCT03466411|517046935|FG012|Overall Study|Other|0|||
143410111|NCT03466411|517046923|FG000|Overall Study|Randomized but not Treated|0|||
143410112|NCT03466411|517046924|FG001|Overall Study|Randomized but not Treated|0|||
143410113|NCT03466411|517046925|FG002|Overall Study|Randomized but not Treated|0|||
143410114|NCT03466411|517046926|FG003|Overall Study|Randomized but not Treated|0|||
143410115|NCT03466411|517046927|FG004|Overall Study|Randomized but not Treated|0|||
143410116|NCT03466411|517046928|FG005|Overall Study|Randomized but not Treated|0|||
143410117|NCT03466411|517046929|FG006|Overall Study|Randomized but not Treated|1|||
143410118|NCT03466411|517046930|FG007|Overall Study|Randomized but not Treated|0|||
143410119|NCT03466411|517046931|FG008|Overall Study|Randomized but not Treated|0|||
143410120|NCT03466411|517046932|FG009|Overall Study|Randomized but not Treated|0|||
143410121|NCT03466411|517046933|FG010|Overall Study|Randomized but not Treated|0|||
143410122|NCT03466411|517046934|FG011|Overall Study|Randomized but not Treated|0|||
143410123|NCT03466411|517046935|FG012|Overall Study|Randomized but not Treated|0|||
143410124|NCT03516812|517046942|FG000|Overall Study|Adverse Event|4|||
143410125|NCT03516812|517046942|FG000|Overall Study|Lack of Efficacy|2|||
143410126|NCT04795167|517046943|FG000|Overall Study|Death|1|||
143410127|NCT04795167|517046944|FG001|Overall Study|Death|18|||
143410128|NCT04795167|517046945|FG002|Overall Study|Death|1|||
143410129|NCT04795167|517046943|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
143410130|NCT04795167|517046944|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
143410131|NCT04795167|517046945|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
143410132|NCT03582475|517046955|FG000|Treatment Period|Withdrawal by Subject|0|||
143410133|NCT03582475|517046956|FG001|Treatment Period|Withdrawal by Subject|1|||
143410134|NCT03582475|517046955|FG000|Follow-up Period|Withdrawal by Subject|0|||
143410135|NCT03582475|517046956|FG001|Follow-up Period|Withdrawal by Subject|1|||
143410136|NCT02257736|517046957|FG000|Overall Study|Progressive disease|365|||
143410137|NCT02257736|517046958|FG001|Overall Study|Progressive disease|327|||
143410138|NCT02257736|517046957|FG000|Overall Study|Adverse Event|45|||
143410139|NCT02257736|517046958|FG001|Overall Study|Adverse Event|56|||
143410140|NCT02257736|517046957|FG000|Overall Study|Withdrawal by Subject|21|||
143410141|NCT02257736|517046958|FG001|Overall Study|Withdrawal by Subject|38|||
143410142|NCT02257736|517046957|FG000|Overall Study|Death|11|||
143410143|NCT02257736|517046958|FG001|Overall Study|Death|6|||
143410144|NCT02257736|517046957|FG000|Overall Study|Physician Decision|5|||
143410145|NCT02257736|517046958|FG001|Overall Study|Physician Decision|9|||
143410146|NCT02257736|517046957|FG000|Overall Study|Non-Compliance with study drug|1|||
143410147|NCT02257736|517046958|FG001|Overall Study|Non-Compliance with study drug|2|||
143410148|NCT02257736|517046957|FG000|Overall Study|Protocol Violation|1|||
143410149|NCT02257736|517046958|FG001|Overall Study|Protocol Violation|0|||
143410150|NCT02257736|517046957|FG000|Overall Study|Other|1|||
143410151|NCT02257736|517046958|FG001|Overall Study|Other|7|||
143410152|NCT02257736|517046957|FG000|Overall Study|Randomized, not treated|1|||
143410153|NCT02257736|517046958|FG001|Overall Study|Randomized, not treated|2|||
143410154|NCT05628103|517046960|FG000|Overall Study|Adverse Event|7|||
143410155|NCT05628103|517046960|FG000|Overall Study|Withdrawal by Subject|3|||
143410156|NCT05628103|517046960|FG000|Overall Study|Lost to Follow-up|3|||
143410157|NCT05628103|517046960|FG000|Overall Study|Lack of Efficacy|1|||
143410158|NCT05628103|517046960|FG000|Overall Study|Non-Compliance With Study Drug|4|||
143410159|NCT02499328|517046961|FG000|Overall Study|Withdrawal by Subject|1|||
143410160|NCT02499328|517046962|FG001|Overall Study|Withdrawal by Subject|1|||
143410161|NCT02499328|517046963|FG002|Overall Study|Withdrawal by Subject|5|||
143410162|NCT02499328|517046964|FG003|Overall Study|Withdrawal by Subject|3|||
143410163|NCT02499328|517046965|FG004|Overall Study|Withdrawal by Subject|5|||
143410164|NCT02499328|517046966|FG005|Overall Study|Withdrawal by Subject|0|||
143410165|NCT02499328|517046967|FG006|Overall Study|Withdrawal by Subject|0|||
143410166|NCT02499328|517046968|FG007|Overall Study|Withdrawal by Subject|0|||
143410167|NCT02499328|517046969|FG008|Overall Study|Withdrawal by Subject|2|||
143410168|NCT02499328|517046970|FG009|Overall Study|Withdrawal by Subject|2|||
143410169|NCT02499328|517046971|FG010|Overall Study|Withdrawal by Subject|0|||
143410170|NCT02499328|517046972|FG011|Overall Study|Withdrawal by Subject|3|||
143410171|NCT02499328|517046973|FG012|Overall Study|Withdrawal by Subject|7|||
143410172|NCT02499328|517046974|FG013|Overall Study|Withdrawal by Subject|3|||
143410173|NCT02499328|517046975|FG014|Overall Study|Withdrawal by Subject|1|||
143410174|NCT02499328|517046976|FG015|Overall Study|Withdrawal by Subject|0|||
143410175|NCT02499328|517046977|FG016|Overall Study|Withdrawal by Subject|0|||
143410176|NCT02499328|517046978|FG017|Overall Study|Withdrawal by Subject|3|||
143410177|NCT02499328|517046979|FG018|Overall Study|Withdrawal by Subject|0|||
143410178|NCT02499328|517046961|FG000|Overall Study|Lost to Follow-up|0|||
143410179|NCT02499328|517046962|FG001|Overall Study|Lost to Follow-up|1|||
143410180|NCT02499328|517046963|FG002|Overall Study|Lost to Follow-up|1|||
143410181|NCT02499328|517046964|FG003|Overall Study|Lost to Follow-up|2|||
143410182|NCT02499328|517046965|FG004|Overall Study|Lost to Follow-up|0|||
143410183|NCT02499328|517046966|FG005|Overall Study|Lost to Follow-up|0|||
143410184|NCT02499328|517046967|FG006|Overall Study|Lost to Follow-up|0|||
143410185|NCT02499328|517046968|FG007|Overall Study|Lost to Follow-up|2|||
143410186|NCT02499328|517046969|FG008|Overall Study|Lost to Follow-up|3|||
143410187|NCT02499328|517046970|FG009|Overall Study|Lost to Follow-up|0|||
143410188|NCT02499328|517046971|FG010|Overall Study|Lost to Follow-up|0|||
143410189|NCT02499328|517046972|FG011|Overall Study|Lost to Follow-up|0|||
143410190|NCT02499328|517046973|FG012|Overall Study|Lost to Follow-up|0|||
143410191|NCT02499328|517046974|FG013|Overall Study|Lost to Follow-up|0|||
143410192|NCT02499328|517046975|FG014|Overall Study|Lost to Follow-up|0|||
143410193|NCT02499328|517046976|FG015|Overall Study|Lost to Follow-up|0|||
143410194|NCT02499328|517046977|FG016|Overall Study|Lost to Follow-up|0|||
143410195|NCT02499328|517046978|FG017|Overall Study|Lost to Follow-up|0|||
143410196|NCT02499328|517046979|FG018|Overall Study|Lost to Follow-up|1|||
143410197|NCT02499328|517046961|FG000|Overall Study|Death|0|||
143410198|NCT02499328|517046962|FG001|Overall Study|Death|3|||
143410199|NCT02499328|517046963|FG002|Overall Study|Death|3|||
143410200|NCT02499328|517046964|FG003|Overall Study|Death|2|||
143410201|NCT02499328|517046965|FG004|Overall Study|Death|4|||
143410202|NCT02499328|517046966|FG005|Overall Study|Death|7|||
143410203|NCT02499328|517046967|FG006|Overall Study|Death|3|||
143410204|NCT02499328|517046968|FG007|Overall Study|Death|0|||
143410205|NCT02499328|517046969|FG008|Overall Study|Death|2|||
143410206|NCT02499328|517046970|FG009|Overall Study|Death|6|||
143410207|NCT02499328|517046971|FG010|Overall Study|Death|6|||
143410208|NCT02499328|517046972|FG011|Overall Study|Death|20|||
143410209|NCT02499328|517046973|FG012|Overall Study|Death|9|||
143410210|NCT02499328|517046974|FG013|Overall Study|Death|7|||
143410211|NCT02499328|517046975|FG014|Overall Study|Death|3|||
143410212|NCT02499328|517046976|FG015|Overall Study|Death|1|||
143410213|NCT02499328|517046977|FG016|Overall Study|Death|1|||
143410214|NCT02499328|517046978|FG017|Overall Study|Death|16|||
143410215|NCT02499328|517046979|FG018|Overall Study|Death|5|||
143410216|NCT02499328|517046961|FG000|Overall Study|"Other"|2|||
143410217|NCT02499328|517046962|FG001|Overall Study|"Other"|2|||
143410218|NCT02499328|517046963|FG002|Overall Study|"Other"|1|||
143410219|NCT02499328|517046964|FG003|Overall Study|"Other"|3|||
143410220|NCT02499328|517046965|FG004|Overall Study|"Other"|6|||
143410221|NCT02499328|517046966|FG005|Overall Study|"Other"|2|||
143410222|NCT02499328|517046967|FG006|Overall Study|"Other"|3|||
143410223|NCT02499328|517046968|FG007|Overall Study|"Other"|4|||
143410224|NCT02499328|517046969|FG008|Overall Study|"Other"|6|||
143410225|NCT02499328|517046970|FG009|Overall Study|"Other"|16|||
143410226|NCT02499328|517046971|FG010|Overall Study|"Other"|13|||
143410227|NCT02499328|517046972|FG011|Overall Study|"Other"|31|||
143410228|NCT02499328|517046973|FG012|Overall Study|"Other"|8|||
143410229|NCT02499328|517046974|FG013|Overall Study|"Other"|7|||
143410230|NCT02499328|517046975|FG014|Overall Study|"Other"|6|||
143410231|NCT02499328|517046976|FG015|Overall Study|"Other"|0|||
143410232|NCT02499328|517046977|FG016|Overall Study|"Other"|0|||
143410233|NCT02499328|517046978|FG017|Overall Study|"Other"|34|||
143410234|NCT02499328|517046979|FG018|Overall Study|"Other"|43|||
143410235|NCT02499328|517046961|FG000|Overall Study|Disease Progression|0|||
143410236|NCT02499328|517046962|FG001|Overall Study|Disease Progression|0|||
143410237|NCT02499328|517046963|FG002|Overall Study|Disease Progression|0|||
143410238|NCT02499328|517046964|FG003|Overall Study|Disease Progression|0|||
143410239|NCT02499328|517046965|FG004|Overall Study|Disease Progression|0|||
143410240|NCT02499328|517046966|FG005|Overall Study|Disease Progression|0|||
143410241|NCT02499328|517046967|FG006|Overall Study|Disease Progression|1|||
143410242|NCT02499328|517046968|FG007|Overall Study|Disease Progression|0|||
143410243|NCT02499328|517046969|FG008|Overall Study|Disease Progression|1|||
143410244|NCT02499328|517046970|FG009|Overall Study|Disease Progression|0|||
143410245|NCT02499328|517046971|FG010|Overall Study|Disease Progression|1|||
143410246|NCT02499328|517046972|FG011|Overall Study|Disease Progression|0|||
143410247|NCT02499328|517046973|FG012|Overall Study|Disease Progression|0|||
143410248|NCT02499328|517046974|FG013|Overall Study|Disease Progression|0|||
143410249|NCT02499328|517046975|FG014|Overall Study|Disease Progression|0|||
143410250|NCT02499328|517046976|FG015|Overall Study|Disease Progression|0|||
143410251|NCT02499328|517046977|FG016|Overall Study|Disease Progression|0|||
143410252|NCT02499328|517046978|FG017|Overall Study|Disease Progression|2|||
143410253|NCT02499328|517046979|FG018|Overall Study|Disease Progression|0|||
143410254|NCT02499328|517046961|FG000|Overall Study|Adverse Event|1|||
143410255|NCT02499328|517046962|FG001|Overall Study|Adverse Event|0|||
143410256|NCT02499328|517046963|FG002|Overall Study|Adverse Event|0|||
143410257|NCT02499328|517046964|FG003|Overall Study|Adverse Event|1|||
143410258|NCT02499328|517046965|FG004|Overall Study|Adverse Event|0|||
143410259|NCT02499328|517046966|FG005|Overall Study|Adverse Event|0|||
143410260|NCT02499328|517046967|FG006|Overall Study|Adverse Event|0|||
143410261|NCT02499328|517046968|FG007|Overall Study|Adverse Event|0|||
143410262|NCT02499328|517046969|FG008|Overall Study|Adverse Event|0|||
143410263|NCT02499328|517046970|FG009|Overall Study|Adverse Event|0|||
143410264|NCT02499328|517046971|FG010|Overall Study|Adverse Event|0|||
143410265|NCT02499328|517046972|FG011|Overall Study|Adverse Event|0|||
143410266|NCT02499328|517046973|FG012|Overall Study|Adverse Event|1|||
143410267|NCT02499328|517046974|FG013|Overall Study|Adverse Event|0|||
143410268|NCT02499328|517046975|FG014|Overall Study|Adverse Event|0|||
143410269|NCT02499328|517046976|FG015|Overall Study|Adverse Event|0|||
143410270|NCT02499328|517046977|FG016|Overall Study|Adverse Event|0|||
143410271|NCT02499328|517046978|FG017|Overall Study|Adverse Event|0|||
143410272|NCT02499328|517046979|FG018|Overall Study|Adverse Event|0|||
143410273|NCT05663866|517046982|FG000|Overall Study|Adverse Event|0|||
143410274|NCT05663866|517046983|FG001|Overall Study|Adverse Event|0|||
143410275|NCT05663866|517046984|FG002|Overall Study|Adverse Event|1|||
143410276|NCT05663866|517046985|FG003|Overall Study|Adverse Event|0|||
143410277|NCT05663866|517046982|FG000|Overall Study|Physician Decision|0|||
143410278|NCT05663866|517046983|FG001|Overall Study|Physician Decision|0|||
143410279|NCT05663866|517046984|FG002|Overall Study|Physician Decision|0|||
143410280|NCT05663866|517046985|FG003|Overall Study|Physician Decision|1|||
143410281|NCT05663866|517046982|FG000|Overall Study|Withdrawal by Subject|0|||
143410282|NCT05663866|517046983|FG001|Overall Study|Withdrawal by Subject|2|||
143410283|NCT05663866|517046984|FG002|Overall Study|Withdrawal by Subject|1|||
143410284|NCT05663866|517046985|FG003|Overall Study|Withdrawal by Subject|2|||
143410285|NCT05663866|517046982|FG000|Overall Study|Progressive disease|4|||
143410286|NCT05663866|517046983|FG001|Overall Study|Progressive disease|8|||
143410287|NCT05663866|517046984|FG002|Overall Study|Progressive disease|5|||
143410288|NCT05663866|517046985|FG003|Overall Study|Progressive disease|2|||
143410289|NCT05663866|517046982|FG000|Overall Study|Other|1|||
143410290|NCT05663866|517046983|FG001|Overall Study|Other|0|||
143410291|NCT05663866|517046984|FG002|Overall Study|Other|0|||
143410292|NCT05663866|517046985|FG003|Overall Study|Other|0|||
143410293|NCT05663866|517046982|FG000|Overall Study|Ongoing|1|||
143410294|NCT05663866|517046983|FG001|Overall Study|Ongoing|27|||
143410295|NCT05663866|517046984|FG002|Overall Study|Ongoing|6|||
143410296|NCT05663866|517046985|FG003|Overall Study|Ongoing|1|||
143410297|NCT03598907|517046988|FG000|Overall Study|Physician Decision|14|||
143410298|NCT03598907|517046989|FG001|Overall Study|Physician Decision|19|||
143410299|NCT05741528|517046990|FG000|Overall Study|Withdrawal by Subject|11|||
143410300|NCT05741528|517046990|FG000|Overall Study|Lost to Follow-up|3|||
143410301|NCT05741528|517046990|FG000|Overall Study|Adverse Event|2|||
143410302|NCT05741528|517046990|FG000|Overall Study|Non-Compliance With Study Drug|2|||
143410303|NCT05741528|517046990|FG000|Overall Study|Reason Not Specified|1|||
143410304|NCT03907488|517046991|FG000|Overall Study|Adverse Event|20|||
143410305|NCT03907488|517046992|FG001|Overall Study|Adverse Event|20|||
143410306|NCT03907488|517046991|FG000|Overall Study|Withdrawal by Subject|9|||
143410307|NCT03907488|517046992|FG001|Overall Study|Withdrawal by Subject|13|||
143410308|NCT03907488|517046991|FG000|Overall Study|Lack of Efficacy|0|||
143410309|NCT03907488|517046992|FG001|Overall Study|Lack of Efficacy|9|||
143410310|NCT03907488|517046991|FG000|Overall Study|Death|3|||
143410311|NCT03907488|517046992|FG001|Overall Study|Death|8|||
143410312|NCT03907488|517046991|FG000|Overall Study|not protocol specified|5|||
143410313|NCT03907488|517046992|FG001|Overall Study|not protocol specified|8|||
143410314|NCT03907488|517046991|FG000|Overall Study|Ineligible|9|||
143410315|NCT03907488|517046992|FG001|Overall Study|Ineligible|15|||
143410316|NCT03414684|517046993|FG000|First-course Treatment|Complete response|0|||
143410317|NCT03414684|517046994|FG001|First-course Treatment|Complete response|1|||
143410318|NCT03414684|517046993|FG000|First-course Treatment|Intercurrent illness|1|||
143410319|NCT03414684|517046994|FG001|First-course Treatment|Intercurrent illness|0|||
143410320|NCT03414684|517046993|FG000|First-course Treatment|Progressive Disease|31|||
143410321|NCT03414684|517046994|FG001|First-course Treatment|Progressive Disease|32|||
143410322|NCT03414684|517046993|FG000|First-course Treatment|Adverse Event|1|||
143410323|NCT03414684|517046994|FG001|First-course Treatment|Adverse Event|2|||
143410324|NCT03414684|517046993|FG000|First-course Treatment|Physician Decision|0|||
143410325|NCT03414684|517046994|FG001|First-course Treatment|Physician Decision|1|||
143410326|NCT03414684|517046993|FG000|First-course Treatment|Withdrawal by Subject|0|||
143410327|NCT03414684|517046994|FG001|First-course Treatment|Withdrawal by Subject|1|||
143410328|NCT03414684|517046993|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
143410329|NCT03414684|517046994|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
143410330|NCT03414684|517046993|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
143410331|NCT03414684|517046994|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
143410332|NCT03414684|517046993|FG000|First-course Treatment|Still on treatment|3|||
143410333|NCT03414684|517046994|FG001|First-course Treatment|Still on treatment|0|||
143410334|NCT03414684|517046993|FG000|First-course Treatment|Never started protocol therapy|2|||
143410335|NCT03414684|517046994|FG001|First-course Treatment|Never started protocol therapy|1|||
143410336|NCT03414684|517046993|FG000|Crossover Treatment|Progressive disease|0|||
143410337|NCT03414684|517046994|FG001|Crossover Treatment|Progressive disease|12|||
143410338|NCT03414684|517046993|FG000|Crossover Treatment|Adverse Event|0|||
143410339|NCT03414684|517046994|FG001|Crossover Treatment|Adverse Event|3|||
143410340|NCT03414684|517046993|FG000|Crossover Treatment|Physician Decision|0|||
143410341|NCT03414684|517046994|FG001|Crossover Treatment|Physician Decision|1|||
143410342|NCT03414684|517046993|FG000|Crossover Treatment|Still on treatment|0|||
143410343|NCT03414684|517046994|FG001|Crossover Treatment|Still on treatment|2|||
143410344|NCT03477175|517046997|FG000|Overall Study|Unable to travel due to COVID-19|0|||
143410345|NCT03477175|517046998|FG001|Overall Study|Unable to travel due to COVID-19|1|||
143410346|NCT03477175|517046997|FG000|Overall Study|Physician Decision|1|||
143410347|NCT03477175|517046998|FG001|Overall Study|Physician Decision|0|||
143410348|NCT03477175|517046997|FG000|Overall Study|Transitioned to commercial drug|6|||
143410349|NCT03477175|517046998|FG001|Overall Study|Transitioned to commercial drug|6|||
143410350|NCT03477175|517046997|FG000|Overall Study|Lost to Follow-up|1|||
143410351|NCT03477175|517046998|FG001|Overall Study|Lost to Follow-up|1|||
143410352|NCT03477175|517046997|FG000|Overall Study|Withdrawal by Subject|3|||
143410353|NCT03477175|517046998|FG001|Overall Study|Withdrawal by Subject|1|||
143410354|NCT03477175|517046997|FG000|Overall Study|Adverse Event|1|||
143410355|NCT03477175|517046998|FG001|Overall Study|Adverse Event|5|||
143410356|NCT03477175|517046997|FG000|Overall Study|Disease Progression|7|||
143410357|NCT03477175|517046998|FG001|Overall Study|Disease Progression|7|||
143410358|NCT03656718|517046999|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
143410359|NCT03656718|517047000|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
143410360|NCT03656718|517047001|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
143410361|NCT03656718|517047002|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
143410362|NCT03656718|517047003|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
143410363|NCT03656718|517047004|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
143410364|NCT03656718|517047005|FG006|Treatment Period Parts A, B, D, and E|Disease progression|21|||
143410365|NCT03656718|517046999|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
143410366|NCT03656718|517047000|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
143410367|NCT03656718|517047001|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
143410368|NCT03656718|517047002|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
143410369|NCT03656718|517047003|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
143410370|NCT03656718|517047004|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
143410371|NCT03656718|517047005|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
143410372|NCT03656718|517046999|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
143410373|NCT03656718|517047000|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
143410374|NCT03656718|517047001|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
143410375|NCT03656718|517047002|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
143410376|NCT03656718|517047003|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
143410377|NCT03656718|517047004|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
143410378|NCT03656718|517047005|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
143410379|NCT03656718|517046999|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
143410380|NCT03656718|517047000|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
143410381|NCT03656718|517047001|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
143410382|NCT03656718|517047002|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
143410383|NCT03656718|517047003|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
143410384|NCT03656718|517047004|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
143410385|NCT03656718|517047005|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|1|||
143410386|NCT03656718|517046999|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
143410387|NCT03656718|517047000|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
143410388|NCT03656718|517047001|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
143410389|NCT03656718|517047002|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
143410390|NCT03656718|517047003|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
143410391|NCT03656718|517047004|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
143410392|NCT03656718|517047005|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|2|||
143410393|NCT03656718|517046999|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
143410394|NCT03656718|517047000|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
143410395|NCT03656718|517047001|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
143410396|NCT03656718|517047002|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
143410397|NCT03656718|517047003|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
143410398|NCT03656718|517047004|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
143410399|NCT03656718|517047005|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
143410400|NCT03656718|517046999|FG000|Treatment Period Part C|Disease progression|0|||
143410401|NCT03656718|517047000|FG001|Treatment Period Part C|Disease progression|0|||
143410402|NCT03656718|517047001|FG002|Treatment Period Part C|Disease progression|0|||
143410403|NCT03656718|517047002|FG003|Treatment Period Part C|Disease progression|0|||
143410404|NCT03656718|517047003|FG004|Treatment Period Part C|Disease progression|12|||
143410405|NCT03656718|517047004|FG005|Treatment Period Part C|Disease progression|0|||
143410406|NCT03656718|517047005|FG006|Treatment Period Part C|Disease progression|0|||
143410407|NCT03656718|517046999|FG000|Treatment Period Part C|Death|0|||
143410408|NCT03656718|517047000|FG001|Treatment Period Part C|Death|0|||
143410409|NCT03656718|517047001|FG002|Treatment Period Part C|Death|0|||
143410410|NCT03656718|517047002|FG003|Treatment Period Part C|Death|0|||
143410411|NCT03656718|517047003|FG004|Treatment Period Part C|Death|1|||
143410412|NCT03656718|517047004|FG005|Treatment Period Part C|Death|0|||
143410413|NCT03656718|517047005|FG006|Treatment Period Part C|Death|0|||
143410414|NCT03656718|517046999|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
143410415|NCT03656718|517047000|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
143410416|NCT03656718|517047001|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
143410417|NCT03656718|517047002|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
143410418|NCT03656718|517047003|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
143410419|NCT03656718|517047004|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
143410420|NCT03656718|517047005|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
143410421|NCT03656718|517046999|FG000|Treatment Period Part C|Other reasons|0|||
143410422|NCT03656718|517047000|FG001|Treatment Period Part C|Other reasons|0|||
143410423|NCT03656718|517047001|FG002|Treatment Period Part C|Other reasons|0|||
143410424|NCT03656718|517047002|FG003|Treatment Period Part C|Other reasons|0|||
143410425|NCT03656718|517047003|FG004|Treatment Period Part C|Other reasons|1|||
143410426|NCT03656718|517047004|FG005|Treatment Period Part C|Other reasons|0|||
143410427|NCT03656718|517047005|FG006|Treatment Period Part C|Other reasons|0|||
143410428|NCT03656718|517046999|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
143410429|NCT03656718|517047000|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
143410430|NCT03656718|517047001|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
143410431|NCT03656718|517047002|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
143410432|NCT03656718|517047003|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
143410433|NCT03656718|517047004|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
143410434|NCT03656718|517047005|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
143410435|NCT03227861|517047012|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
143410436|NCT03227861|517047012|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
143410437|NCT03227861|517047012|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
143410438|NCT03227861|517047012|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
143410439|NCT03227861|517047012|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
143410440|NCT03227861|517047012|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
143410441|NCT03227861|517047012|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
143410442|NCT03227861|517047012|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
143410443|NCT03227861|517047012|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
143410444|NCT03227861|517047012|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
143410445|NCT03516942|517047013|FG000|Registration through baseline survey com|Withdrawal by Subject|36|||
143410446|NCT03516942|517047013|FG000|Registration through baseline survey com|Death|8|||
143410447|NCT03516942|517047013|FG000|Registration through baseline survey com|Could not contact patient after enrollment|58|||
143410448|NCT03516942|517047013|FG000|T0: Baseline|LOST|13|||
143410449|NCT03516942|517047013|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
143410450|NCT03516942|517047013|FG000|T1: 3 Months Survey|Death|10|||
143410451|NCT03516942|517047013|FG000|T1: 3 Months Survey|Lost|163|||
143410452|NCT03516942|517047013|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
143410453|NCT03516942|517047013|FG000|T2: 6 Month Survey|Death|14|||
143410454|NCT03516942|517047013|FG000|T2: 6 Month Survey|Lost|180|||
143410455|NCT03516942|517047013|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
143410456|NCT03516942|517047013|FG000|T3: 12 Month Survey|Death|19|||
143410457|NCT03516942|517047013|FG000|T3: 12 Month Survey|Lost|209|||
143410458|NCT00748709|517047014|FG000|Overall Study|Progressive disease|15|||
143410459|NCT00748709|517047014|FG000|Overall Study|Drug reducing Toxity|2|||
143410460|NCT00748709|517047014|FG000|Overall Study|Other Adverse Event|1|||
143410461|NCT00748709|517047014|FG000|Overall Study|Withdrawal by Subject|1|||
143410462|NCT00748709|517047014|FG000|Overall Study|Other Reasons|1|||
143410463|NCT03762850|517048240|FG000|Overall Study|Death|0|||
143410464|NCT03762850|517048241|FG001|Overall Study|Death|1|||
143410465|NCT03762850|517048240|FG000|Overall Study|Lost to Follow-up|0|||
143410466|NCT03762850|517048241|FG001|Overall Study|Lost to Follow-up|1|||
143410467|NCT03762850|517048240|FG000|Overall Study|Physician Decision|0|||
143410468|NCT03762850|517048241|FG001|Overall Study|Physician Decision|1|||
143410469|NCT03762850|517048240|FG000|Overall Study|Withdrawal by Subject|4|||
143410470|NCT03762850|517048241|FG001|Overall Study|Withdrawal by Subject|9|||
143410471|NCT02036970|517048244|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
143410472|NCT02036970|517048245|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
143410473|NCT02036970|517048246|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
143410474|NCT02036970|517048247|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
143410475|NCT02036970|517048248|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
143410476|NCT02036970|517048249|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
143410477|NCT02036970|517048250|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
143410478|NCT02036970|517048251|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
143410479|NCT02036970|517048252|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
143410480|NCT02036970|517048253|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
143410481|NCT02036970|517048244|FG000|Part 1: Day 1 Through Week 16|Death|0|||
143410482|NCT02036970|517048245|FG001|Part 1: Day 1 Through Week 16|Death|0|||
143410483|NCT02036970|517048246|FG002|Part 1: Day 1 Through Week 16|Death|0|||
143410484|NCT02036970|517048247|FG003|Part 1: Day 1 Through Week 16|Death|0|||
143410485|NCT02036970|517048248|FG004|Part 1: Day 1 Through Week 16|Death|0|||
143410486|NCT02036970|517048249|FG005|Part 1: Day 1 Through Week 16|Death|0|||
143410487|NCT02036970|517048250|FG006|Part 1: Day 1 Through Week 16|Death|0|||
143410488|NCT02036970|517048251|FG007|Part 1: Day 1 Through Week 16|Death|0|||
143410489|NCT02036970|517048252|FG008|Part 1: Day 1 Through Week 16|Death|1|||
143410490|NCT02036970|517048253|FG009|Part 1: Day 1 Through Week 16|Death|0|||
143410491|NCT02036970|517048244|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
143410492|NCT02036970|517048245|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
143410493|NCT02036970|517048246|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
143410494|NCT02036970|517048247|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
143410495|NCT02036970|517048248|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
143410496|NCT02036970|517048249|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
143410497|NCT02036970|517048250|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
143410498|NCT02036970|517048251|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
143410499|NCT02036970|517048252|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
143410500|NCT02036970|517048253|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
143410501|NCT02036970|517048244|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
143410502|NCT02036970|517048245|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
143410503|NCT02036970|517048246|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
143410504|NCT02036970|517048247|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
143410505|NCT02036970|517048248|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
143410506|NCT02036970|517048249|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
143410507|NCT02036970|517048250|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
143410508|NCT02036970|517048251|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
143410509|NCT02036970|517048252|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
143410510|NCT02036970|517048253|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
143410511|NCT02036970|517048244|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
143410512|NCT02036970|517048245|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
143410513|NCT02036970|517048246|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
143410514|NCT02036970|517048247|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
143410515|NCT02036970|517048248|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
143410516|NCT02036970|517048249|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
143410517|NCT02036970|517048250|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
143410518|NCT02036970|517048251|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
143410519|NCT02036970|517048252|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
143410520|NCT02036970|517048253|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
143410521|NCT02036970|517048244|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
143410522|NCT02036970|517048245|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
143410523|NCT02036970|517048246|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
143410524|NCT02036970|517048247|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
143410525|NCT02036970|517048248|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
143410526|NCT02036970|517048249|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
143410527|NCT02036970|517048250|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
143410528|NCT02036970|517048251|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
143410529|NCT02036970|517048252|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
143410530|NCT02036970|517048253|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
143410531|NCT02036970|517048244|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
143410532|NCT02036970|517048245|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
143410533|NCT02036970|517048246|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
143410534|NCT02036970|517048247|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
143410535|NCT02036970|517048248|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
143410536|NCT02036970|517048249|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
143410537|NCT02036970|517048250|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
143410538|NCT02036970|517048251|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
143410539|NCT02036970|517048252|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
143410540|NCT02036970|517048253|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
143410541|NCT02036970|517048244|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
143410542|NCT02036970|517048245|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
143410543|NCT02036970|517048246|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
143410544|NCT02036970|517048247|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
143410545|NCT02036970|517048248|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
143410546|NCT02036970|517048249|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
143410547|NCT02036970|517048250|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
143410548|NCT02036970|517048251|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
143410549|NCT02036970|517048252|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
143410550|NCT02036970|517048253|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
143410551|NCT02036970|517048244|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
143410552|NCT02036970|517048245|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
143410553|NCT02036970|517048246|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
143410554|NCT02036970|517048247|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
143410555|NCT02036970|517048248|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
143410556|NCT02036970|517048249|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
143410557|NCT02036970|517048250|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
143410558|NCT02036970|517048251|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
143410559|NCT02036970|517048252|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
143410560|NCT02036970|517048253|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
143410561|NCT00687219|517048258|FG000|Overall Study|Adverse Event|8|||
143410562|NCT00687219|517048258|FG000|Overall Study|Discontinuance criteria met|7|||
143410563|NCT00687219|517048258|FG000|Overall Study|HCV-RNA positive conversion|34|||
143410564|NCT00687219|517048258|FG000|Overall Study|Withdrawal by Subject|1|||
143410565|NCT00687219|517048258|FG000|Overall Study|Lack of Efficacy|1|||
143410566|NCT01588951|517048265|FG000|Overall Study|Ineligible in retrospect|0|||
143410567|NCT01588951|517048266|FG001|Overall Study|Ineligible in retrospect|0|||
143410568|NCT01588951|517048267|FG002|Overall Study|Ineligible in retrospect|1|||
143410569|NCT03683576|517048268|FG000|Overall Study|Withdrawal by Subject|2|||
143410570|NCT03683576|517048269|FG001|Overall Study|Withdrawal by Subject|0|||
143410571|NCT03683576|517048270|FG002|Overall Study|Withdrawal by Subject|8|||
143410572|NCT03683576|517048271|FG003|Overall Study|Withdrawal by Subject|3|||
143410573|NCT03683576|517048268|FG000|Overall Study|Adverse Event|3|||
143410574|NCT03683576|517048269|FG001|Overall Study|Adverse Event|0|||
143410575|NCT03683576|517048270|FG002|Overall Study|Adverse Event|0|||
143410576|NCT03683576|517048271|FG003|Overall Study|Adverse Event|4|||
143410577|NCT03683576|517048268|FG000|Overall Study|Lack of Efficacy|1|||
143410578|NCT03683576|517048269|FG001|Overall Study|Lack of Efficacy|0|||
143410579|NCT03683576|517048270|FG002|Overall Study|Lack of Efficacy|1|||
143410580|NCT03683576|517048271|FG003|Overall Study|Lack of Efficacy|1|||
143410581|NCT03683576|517048268|FG000|Overall Study|Lost to Follow-up|0|||
143410582|NCT03683576|517048269|FG001|Overall Study|Lost to Follow-up|1|||
143410583|NCT03683576|517048270|FG002|Overall Study|Lost to Follow-up|2|||
143410584|NCT03683576|517048271|FG003|Overall Study|Lost to Follow-up|0|||
143410585|NCT03683576|517048268|FG000|Overall Study|Other, Not Specified|0|||
143410586|NCT03683576|517048269|FG001|Overall Study|Other, Not Specified|2|||
143410587|NCT03683576|517048270|FG002|Overall Study|Other, Not Specified|0|||
143410588|NCT03683576|517048271|FG003|Overall Study|Other, Not Specified|0|||
143410589|NCT03683576|517048268|FG000|Overall Study|Protocol Violation|0|||
143410590|NCT03683576|517048269|FG001|Overall Study|Protocol Violation|1|||
143410591|NCT03683576|517048270|FG002|Overall Study|Protocol Violation|1|||
143410592|NCT03683576|517048271|FG003|Overall Study|Protocol Violation|0|||
143410593|NCT02628626|517048272|FG000|Overall Study|Withdrawal by Subject|2|||
143410594|NCT02628626|517048273|FG001|Overall Study|Withdrawal by Subject|2|||
143410595|NCT02744066|517048274|FG000|Overall Study|Withdrawal by parent|0|||
143410596|NCT02744066|517048275|FG001|Overall Study|Withdrawal by parent|1|||
143410597|NCT02744066|517048274|FG000|Overall Study|Discharged from NICU prior to completion|0|||
143410598|NCT02744066|517048275|FG001|Overall Study|Discharged from NICU prior to completion|4|||
143410599|NCT01400958|517048278|FG000|Overall Study|Physician Decision|0|||
143410600|NCT01400958|517048279|FG001|Overall Study|Physician Decision|1|||
143410601|NCT01400958|517048278|FG000|Overall Study|Withdrawal by Subject|0|||
143410602|NCT01400958|517048279|FG001|Overall Study|Withdrawal by Subject|1|||
143410603|NCT01400958|517048278|FG000|Overall Study|Adverse Event|1|||
143410604|NCT01400958|517048279|FG001|Overall Study|Adverse Event|0|||
143410605|NCT03102034|517048282|FG000|Overall Study|Withdrawal by Subject|1|||
143410606|NCT03102034|517048283|FG001|Overall Study|Withdrawal by Subject|0|||
143410607|NCT02972359|517048284|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
143410608|NCT02972359|517048284|FG000|Overall Study|Lack of Efficacy|1|||
143410609|NCT02972359|517048284|FG000|Overall Study|Adverse Event|4|||
143410610|NCT02972359|517048284|FG000|Overall Study|Death|1|||
143410611|NCT02972359|517048284|FG000|Overall Study|Withdrawal by Subject|30|||
143410612|NCT02972359|517048284|FG000|Overall Study|Protocol Violation|1|||
143410613|NCT02972359|517048284|FG000|Overall Study|Lost to Follow-up|26|||
143410614|NCT02972359|517048284|FG000|Overall Study|Other reasons|5|||
143410615|NCT02972359|517048284|FG000|Overall Study|Missing|1|||
143410616|NCT03371017|517048285|FG000|Overall Study|Physician Decision|0|||
143410617|NCT03371017|517048286|FG001|Overall Study|Physician Decision|1|||
143410618|NCT03371017|517048285|FG000|Overall Study|Reason not Specified|0|||
143410619|NCT03371017|517048286|FG001|Overall Study|Reason not Specified|1|||
143410620|NCT03371017|517048285|FG000|Overall Study|Lost to Follow-up|13|||
143410621|NCT03371017|517048286|FG001|Overall Study|Lost to Follow-up|16|||
143410622|NCT03371017|517048285|FG000|Overall Study|Death|228|||
143410623|NCT03371017|517048286|FG001|Overall Study|Death|215|||
143410624|NCT03371017|517048285|FG000|Overall Study|Withdrawal by Subject|20|||
143410625|NCT03371017|517048286|FG001|Overall Study|Withdrawal by Subject|25|||
143410626|NCT03371017|517048285|FG000|Overall Study|Study Ended by Sponsor|37|||
143410627|NCT03371017|517048286|FG001|Overall Study|Study Ended by Sponsor|38|||
143410628|NCT03371017|517048285|FG000|Overall Study|Protocol Deviation|0|||
143410629|NCT03371017|517048286|FG001|Overall Study|Protocol Deviation|1|||
143410630|NCT05379270|517048287|FG000|Overall Study|Withdrawal by Subject|1|||
143410631|NCT05379270|517048288|FG001|Overall Study|Withdrawal by Subject|1|||
143410632|NCT05251363|517048289|FG000|Implant|Subject did not meet LBBA implant criteria|8|||
143410633|NCT05251363|517048289|FG000|Overall Study After Implant Period|Death|9|||
143410634|NCT05251363|517048289|FG000|Overall Study After Implant Period|Solia S lead in LBBA Position Extracted|4|||
143410635|NCT05251363|517048289|FG000|Overall Study After Implant Period|Withdrawal by Subject|4|||
143410636|NCT05251363|517048289|FG000|Overall Study After Implant Period|Lost to Follow-up|2|||
143410637|NCT05251363|517048289|FG000|Overall Study After Implant Period|Physician Decision|1|||
143410638|NCT05251363|517048289|FG000|Overall Study After Implant Period|Subject Moved from Investigational Center|3|||
143410639|NCT03425682|517048290|FG000|Overall Study|Lost to Follow-up|2|||
143410640|NCT03425682|517048291|FG001|Overall Study|Lost to Follow-up|4|||
143410641|NCT03425682|517048290|FG000|Overall Study|Withdrawal by Subject|0|||
143410642|NCT03425682|517048291|FG001|Overall Study|Withdrawal by Subject|3|||
143410643|NCT03425682|517048290|FG000|Overall Study|Subject did not meet I/E|4|||
143410644|NCT03425682|517048291|FG001|Overall Study|Subject did not meet I/E|10|||
143410645|NCT03610581|517048292|FG000|Overall Study|Study terminated by sponsor|2|||
143410646|NCT03610581|517048293|FG001|Overall Study|Study terminated by sponsor|0|||
143410647|NCT03610581|517048292|FG000|Overall Study|Other|0|||
143410648|NCT03610581|517048293|FG001|Overall Study|Other|1|||
143410649|NCT03610581|517048292|FG000|Overall Study|Withdrawal by Subject|1|||
143410650|NCT03610581|517048293|FG001|Overall Study|Withdrawal by Subject|0|||
143410651|NCT00489307|517048296|FG000|Overall Study|Death|1|||
143410652|NCT00489307|517048297|FG001|Overall Study|Death|1|||
143410653|NCT00489307|517048296|FG000|Overall Study|Lost to Follow-up|2|||
143410654|NCT00489307|517048297|FG001|Overall Study|Lost to Follow-up|2|||
143410655|NCT00489307|517048296|FG000|Overall Study|Physician Decision|1|||
143410656|NCT00489307|517048297|FG001|Overall Study|Physician Decision|0|||
143410657|NCT00489307|517048296|FG000|Overall Study|Withdrawal by Subject|2|||
143410658|NCT00489307|517048297|FG001|Overall Study|Withdrawal by Subject|4|||
143410659|NCT00489307|517048296|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
143410660|NCT00489307|517048297|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
143410661|NCT00489307|517048296|FG000|Overall Study|Surgery after assignment|1|||
143410662|NCT00489307|517048297|FG001|Overall Study|Surgery after assignment|0|||
143410663|NCT00489307|517048296|FG000|Overall Study|Did not fill up the forms|2|||
143410664|NCT00489307|517048297|FG001|Overall Study|Did not fill up the forms|1|||
143410665|NCT00489307|517048296|FG000|Overall Study|Patient or family refusal|5|||
143410666|NCT00489307|517048297|FG001|Overall Study|Patient or family refusal|9|||
143410667|NCT02307682|517048298|FG000|Overall Study|Adverse Event|9|||
143410668|NCT02307682|517048299|FG001|Overall Study|Adverse Event|8|||
143410669|NCT02307682|517048300|FG002|Overall Study|Adverse Event|12|||
143410670|NCT02307682|517048298|FG000|Overall Study|Lack of Efficacy|1|||
143410671|NCT02307682|517048299|FG001|Overall Study|Lack of Efficacy|0|||
143410672|NCT02307682|517048300|FG002|Overall Study|Lack of Efficacy|1|||
143410673|NCT02307682|517048298|FG000|Overall Study|Physician Decision|2|||
143410674|NCT02307682|517048299|FG001|Overall Study|Physician Decision|2|||
143410675|NCT02307682|517048300|FG002|Overall Study|Physician Decision|8|||
143410676|NCT02307682|517048298|FG000|Overall Study|Progressive Disease|1|||
143410677|NCT02307682|517048299|FG001|Overall Study|Progressive Disease|0|||
143410678|NCT02307682|517048300|FG002|Overall Study|Progressive Disease|0|||
143410679|NCT02307682|517048298|FG000|Overall Study|Withdrawal by Subject|26|||
143410680|NCT02307682|517048299|FG001|Overall Study|Withdrawal by Subject|34|||
143410681|NCT02307682|517048300|FG002|Overall Study|Withdrawal by Subject|23|||
143410682|NCT02307682|517048298|FG000|Overall Study|Death|9|||
143410683|NCT02307682|517048299|FG001|Overall Study|Death|7|||
143410684|NCT02307682|517048300|FG002|Overall Study|Death|12|||
143410685|NCT02307682|517048298|FG000|Overall Study|Lost to Follow-up|1|||
143410686|NCT02307682|517048299|FG001|Overall Study|Lost to Follow-up|5|||
143410687|NCT02307682|517048300|FG002|Overall Study|Lost to Follow-up|6|||
143410688|NCT02307682|517048298|FG000|Overall Study|Protocol Deviation|0|||
143410689|NCT02307682|517048299|FG001|Overall Study|Protocol Deviation|0|||
143410690|NCT02307682|517048300|FG002|Overall Study|Protocol Deviation|2|||
143410691|NCT02307682|517048298|FG000|Overall Study|Other|1|||
143410692|NCT02307682|517048299|FG001|Overall Study|Other|1|||
143410693|NCT02307682|517048300|FG002|Overall Study|Other|0|||
143410694|NCT02517268|517048303|FG000|Overall Study|Withdrawal by Subject|1|||
143410695|NCT02517268|517048304|FG001|Overall Study|Withdrawal by Subject|0|||
143410696|NCT04686266|517048305|FG000|Overall Study|Withdrawal by Subject|0|||
143410697|NCT04686266|517048306|FG001|Overall Study|Withdrawal by Subject|1|||
143410698|NCT05810285|517048313|FG000|Overall Study|Death|4|||
143410699|NCT05810285|517048314|FG001|Overall Study|Death|21|||
143410700|NCT05810285|517048313|FG000|Overall Study|Adverse Event|18|||
143410701|NCT05810285|517048314|FG001|Overall Study|Adverse Event|16|||
143410702|NCT05470114|517048315|FG000|Overall Study|Withdrawal by Subject|1|||
143410703|NCT05470114|517048316|FG001|Overall Study|Withdrawal by Subject|0|||
143410704|NCT05470114|517048315|FG000|Overall Study|Lost to Follow-up|1|||
143410705|NCT05470114|517048316|FG001|Overall Study|Lost to Follow-up|0|||
143410706|NCT04649047|517048317|FG000|Overall Study|Withdrawal by Subject|3|||
143410707|NCT02488408|517048318|FG000|Part A|Adverse Event|2|||
143410708|NCT02488408|517048319|FG001|Part A|Adverse Event|0|||
143410709|NCT02488408|517048320|FG002|Part A|Adverse Event|0|||
143410710|NCT02488408|517048321|FG003|Part A|Adverse Event|0|||
143410711|NCT02488408|517048322|FG004|Part A|Adverse Event|0|||
143410712|NCT02488408|517048323|FG005|Part A|Adverse Event|0|||
143410713|NCT02488408|517048324|FG006|Part A|Adverse Event|0|||
143410714|NCT02488408|517048325|FG007|Part A|Adverse Event|0|||
143410715|NCT02488408|517048326|FG008|Part A|Adverse Event|0|||
143410716|NCT02488408|517048327|FG009|Part A|Adverse Event|0|||
143410717|NCT02488408|517048318|FG000|Part A|Death|1|||
143410718|NCT02488408|517048319|FG001|Part A|Death|5|||
143410719|NCT02488408|517048320|FG002|Part A|Death|0|||
143410720|NCT02488408|517048321|FG003|Part A|Death|0|||
143410721|NCT02488408|517048322|FG004|Part A|Death|3|||
143410722|NCT02488408|517048323|FG005|Part A|Death|0|||
143410723|NCT02488408|517048324|FG006|Part A|Death|0|||
143410724|NCT02488408|517048325|FG007|Part A|Death|0|||
143410725|NCT02488408|517048326|FG008|Part A|Death|0|||
143410726|NCT02488408|517048327|FG009|Part A|Death|0|||
143410727|NCT02488408|517048318|FG000|Part A|Disease Progression|2|||
143410728|NCT02488408|517048319|FG001|Part A|Disease Progression|8|||
143410729|NCT02488408|517048320|FG002|Part A|Disease Progression|2|||
143410730|NCT02488408|517048321|FG003|Part A|Disease Progression|3|||
143410731|NCT02488408|517048322|FG004|Part A|Disease Progression|4|||
143410732|NCT02488408|517048323|FG005|Part A|Disease Progression|0|||
143410733|NCT02488408|517048324|FG006|Part A|Disease Progression|0|||
143410734|NCT02488408|517048325|FG007|Part A|Disease Progression|0|||
143410735|NCT02488408|517048326|FG008|Part A|Disease Progression|0|||
143410736|NCT02488408|517048327|FG009|Part A|Disease Progression|0|||
143410737|NCT02488408|517048318|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
143410738|NCT02488408|517048319|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
143410739|NCT02488408|517048320|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
143410740|NCT02488408|517048321|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
143410741|NCT02488408|517048322|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
143410742|NCT02488408|517048323|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
143410743|NCT02488408|517048324|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
143410744|NCT02488408|517048325|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
143410745|NCT02488408|517048326|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
143410746|NCT02488408|517048327|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
143410747|NCT02488408|517048318|FG000|Part A|Investigator Decision|0|||
143410748|NCT02488408|517048319|FG001|Part A|Investigator Decision|1|||
143410749|NCT02488408|517048320|FG002|Part A|Investigator Decision|1|||
143410750|NCT02488408|517048321|FG003|Part A|Investigator Decision|0|||
143410751|NCT02488408|517048322|FG004|Part A|Investigator Decision|0|||
143410752|NCT02488408|517048323|FG005|Part A|Investigator Decision|0|||
143410753|NCT02488408|517048324|FG006|Part A|Investigator Decision|0|||
143410754|NCT02488408|517048325|FG007|Part A|Investigator Decision|0|||
143410755|NCT02488408|517048326|FG008|Part A|Investigator Decision|0|||
143410756|NCT02488408|517048327|FG009|Part A|Investigator Decision|0|||
143410757|NCT02488408|517048318|FG000|Part A|Withdrawal by Subject|0|||
143410758|NCT02488408|517048319|FG001|Part A|Withdrawal by Subject|0|||
143410759|NCT02488408|517048320|FG002|Part A|Withdrawal by Subject|2|||
143410760|NCT02488408|517048321|FG003|Part A|Withdrawal by Subject|0|||
143410761|NCT02488408|517048322|FG004|Part A|Withdrawal by Subject|0|||
143410762|NCT02488408|517048323|FG005|Part A|Withdrawal by Subject|0|||
143410763|NCT02488408|517048324|FG006|Part A|Withdrawal by Subject|0|||
143410764|NCT02488408|517048325|FG007|Part A|Withdrawal by Subject|0|||
143410765|NCT02488408|517048326|FG008|Part A|Withdrawal by Subject|0|||
143410766|NCT02488408|517048327|FG009|Part A|Withdrawal by Subject|0|||
143410767|NCT02488408|517048318|FG000|Part A|Other|1|||
143410768|NCT02488408|517048319|FG001|Part A|Other|0|||
143410769|NCT02488408|517048320|FG002|Part A|Other|0|||
143410770|NCT02488408|517048321|FG003|Part A|Other|0|||
143410771|NCT02488408|517048322|FG004|Part A|Other|0|||
143410772|NCT02488408|517048323|FG005|Part A|Other|0|||
143410773|NCT02488408|517048324|FG006|Part A|Other|0|||
143410774|NCT02488408|517048325|FG007|Part A|Other|0|||
143410775|NCT02488408|517048326|FG008|Part A|Other|0|||
143410776|NCT02488408|517048327|FG009|Part A|Other|0|||
143410777|NCT02488408|517048318|FG000|Part B|Adverse Event|0|||
143410778|NCT02488408|517048319|FG001|Part B|Adverse Event|0|||
143410779|NCT02488408|517048320|FG002|Part B|Adverse Event|0|||
143410780|NCT02488408|517048321|FG003|Part B|Adverse Event|0|||
143410781|NCT02488408|517048322|FG004|Part B|Adverse Event|0|||
143410782|NCT02488408|517048323|FG005|Part B|Adverse Event|2|||
143410783|NCT02488408|517048324|FG006|Part B|Adverse Event|2|||
143410784|NCT02488408|517048325|FG007|Part B|Adverse Event|7|||
143410785|NCT02488408|517048326|FG008|Part B|Adverse Event|2|||
143410786|NCT02488408|517048327|FG009|Part B|Adverse Event|2|||
143410787|NCT02488408|517048318|FG000|Part B|Death|0|||
143410788|NCT02488408|517048319|FG001|Part B|Death|0|||
143410789|NCT02488408|517048320|FG002|Part B|Death|0|||
143410790|NCT02488408|517048321|FG003|Part B|Death|0|||
143410791|NCT02488408|517048322|FG004|Part B|Death|0|||
143410792|NCT02488408|517048323|FG005|Part B|Death|3|||
143410793|NCT02488408|517048324|FG006|Part B|Death|1|||
143410794|NCT02488408|517048325|FG007|Part B|Death|2|||
143410795|NCT02488408|517048326|FG008|Part B|Death|2|||
143410796|NCT02488408|517048327|FG009|Part B|Death|2|||
143410797|NCT02488408|517048318|FG000|Part B|Death due to Disease Progression|0|||
143410798|NCT02488408|517048319|FG001|Part B|Death due to Disease Progression|0|||
143410799|NCT02488408|517048320|FG002|Part B|Death due to Disease Progression|0|||
143410800|NCT02488408|517048321|FG003|Part B|Death due to Disease Progression|0|||
143410801|NCT02488408|517048322|FG004|Part B|Death due to Disease Progression|0|||
143410802|NCT02488408|517048323|FG005|Part B|Death due to Disease Progression|2|||
143410803|NCT02488408|517048324|FG006|Part B|Death due to Disease Progression|2|||
143410804|NCT02488408|517048325|FG007|Part B|Death due to Disease Progression|1|||
143410805|NCT02488408|517048326|FG008|Part B|Death due to Disease Progression|1|||
143410806|NCT02488408|517048327|FG009|Part B|Death due to Disease Progression|1|||
143410807|NCT02488408|517048318|FG000|Part B|Disease Progression|0|||
143410808|NCT02488408|517048319|FG001|Part B|Disease Progression|0|||
143410809|NCT02488408|517048320|FG002|Part B|Disease Progression|0|||
143410810|NCT02488408|517048321|FG003|Part B|Disease Progression|0|||
143410811|NCT02488408|517048322|FG004|Part B|Disease Progression|0|||
143410812|NCT02488408|517048323|FG005|Part B|Disease Progression|6|||
143410813|NCT02488408|517048324|FG006|Part B|Disease Progression|9|||
143410814|NCT02488408|517048325|FG007|Part B|Disease Progression|7|||
143410815|NCT02488408|517048326|FG008|Part B|Disease Progression|9|||
143410816|NCT02488408|517048327|FG009|Part B|Disease Progression|11|||
143410817|NCT02488408|517048318|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
143410818|NCT02488408|517048319|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
143410819|NCT02488408|517048320|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
143410820|NCT02488408|517048321|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
143410821|NCT02488408|517048322|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
143410822|NCT02488408|517048323|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
143410823|NCT02488408|517048324|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
143410824|NCT02488408|517048325|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
143410825|NCT02488408|517048326|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
143410826|NCT02488408|517048327|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
143410827|NCT02488408|517048318|FG000|Part B|Investigator Decision|0|||
143410828|NCT02488408|517048319|FG001|Part B|Investigator Decision|0|||
143410829|NCT02488408|517048320|FG002|Part B|Investigator Decision|0|||
143410830|NCT02488408|517048321|FG003|Part B|Investigator Decision|0|||
143410831|NCT02488408|517048322|FG004|Part B|Investigator Decision|0|||
143410832|NCT02488408|517048323|FG005|Part B|Investigator Decision|0|||
143410833|NCT02488408|517048324|FG006|Part B|Investigator Decision|1|||
143410834|NCT02488408|517048325|FG007|Part B|Investigator Decision|0|||
143410835|NCT02488408|517048326|FG008|Part B|Investigator Decision|2|||
143410836|NCT02488408|517048327|FG009|Part B|Investigator Decision|1|||
143410837|NCT05037513|517048328|FG000|Intervention Period|Lost to Follow-up|1|||
143410838|NCT05037513|517048329|FG001|Intervention Period|Lost to Follow-up|2|||
143410839|NCT05037513|517048328|FG000|Follow Up Period|Lost to Follow-up|16|||
143410840|NCT05037513|517048329|FG001|Follow Up Period|Lost to Follow-up|21|||
143410841|NCT05037513|517048328|FG000|Follow Up Period|Death|0|||
143410842|NCT05037513|517048329|FG001|Follow Up Period|Death|1|||
143410843|NCT05037513|517048328|FG000|Follow Up Period|Incarcerated|4|||
143410844|NCT05037513|517048329|FG001|Follow Up Period|Incarcerated|2|||
143410845|NCT05886777|517048330|FG000|Overall Study|Lost to Follow-up|1|||
143410846|NCT05886777|517048331|FG001|Overall Study|Lost to Follow-up|0|||
143410847|NCT05886777|517048332|FG002|Overall Study|Lost to Follow-up|2|||
143410848|NCT05886777|517048333|FG003|Overall Study|Lost to Follow-up|1|||
143410849|NCT05886777|517048334|FG004|Overall Study|Lost to Follow-up|0|||
143410850|NCT05886777|517048335|FG005|Overall Study|Lost to Follow-up|2|||
143410851|NCT05886777|517048336|FG006|Overall Study|Lost to Follow-up|0|||
143410852|NCT05886777|517048330|FG000|Overall Study|Other|0|||
143410853|NCT05886777|517048331|FG001|Overall Study|Other|2|||
143410854|NCT05886777|517048332|FG002|Overall Study|Other|1|||
143410855|NCT05886777|517048333|FG003|Overall Study|Other|0|||
143410856|NCT05886777|517048334|FG004|Overall Study|Other|0|||
143410857|NCT05886777|517048335|FG005|Overall Study|Other|0|||
143410858|NCT05886777|517048336|FG006|Overall Study|Other|0|||
143410859|NCT05886777|517048330|FG000|Overall Study|Withdrawal by Subject|1|||
143410860|NCT05886777|517048331|FG001|Overall Study|Withdrawal by Subject|0|||
143410861|NCT05886777|517048332|FG002|Overall Study|Withdrawal by Subject|1|||
143410862|NCT05886777|517048333|FG003|Overall Study|Withdrawal by Subject|4|||
143410863|NCT05886777|517048334|FG004|Overall Study|Withdrawal by Subject|3|||
143410864|NCT05886777|517048335|FG005|Overall Study|Withdrawal by Subject|1|||
143410865|NCT05886777|517048336|FG006|Overall Study|Withdrawal by Subject|1|||
143410866|NCT05886777|517048330|FG000|Overall Study|Protocol Violation|0|||
143410867|NCT05886777|517048331|FG001|Overall Study|Protocol Violation|0|||
143410868|NCT05886777|517048332|FG002|Overall Study|Protocol Violation|1|||
143410869|NCT05886777|517048333|FG003|Overall Study|Protocol Violation|0|||
143410870|NCT05886777|517048334|FG004|Overall Study|Protocol Violation|0|||
143410871|NCT05886777|517048335|FG005|Overall Study|Protocol Violation|0|||
143410872|NCT05886777|517048336|FG006|Overall Study|Protocol Violation|0|||
143410873|NCT05886777|517048330|FG000|Overall Study|No longer met eligibility criteria|0|||
143410874|NCT05886777|517048331|FG001|Overall Study|No longer met eligibility criteria|1|||
143410875|NCT05886777|517048332|FG002|Overall Study|No longer met eligibility criteria|0|||
143410876|NCT05886777|517048333|FG003|Overall Study|No longer met eligibility criteria|0|||
143410877|NCT05886777|517048334|FG004|Overall Study|No longer met eligibility criteria|0|||
143410878|NCT05886777|517048335|FG005|Overall Study|No longer met eligibility criteria|0|||
143410879|NCT05886777|517048336|FG006|Overall Study|No longer met eligibility criteria|0|||
143410880|NCT03773107|517048337|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
143410881|NCT03773107|517048338|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
143410882|NCT03773107|517048339|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
143410883|NCT03773107|517048340|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
143410884|NCT04577651|517048342|FG000|Overall Study|Screen Failure|7|||
143410885|NCT04577651|517048342|FG000|Overall Study|Adverse Event|1|||
143410886|NCT04577651|517048342|FG000|Overall Study|Death|1|||
143410887|NCT04577651|517048342|FG000|Overall Study|Physician Decision|1|||
143410888|NCT04577651|517048342|FG000|Overall Study|Withdrawal by Subject|3|||
143410889|NCT00512252|517049432|FG000|Overall Study|Lost to Follow-up|0|||
143410890|NCT00512252|517049433|FG001|Overall Study|Lost to Follow-up|0|||
143410891|NCT00512252|517049434|FG002|Overall Study|Lost to Follow-up|1|||
143410892|NCT00512252|517049432|FG000|Overall Study|Protocol Violation|0|||
143410893|NCT00512252|517049433|FG001|Overall Study|Protocol Violation|0|||
143410894|NCT00512252|517049434|FG002|Overall Study|Protocol Violation|1|||
143410895|NCT00512252|517049432|FG000|Overall Study|Death|0|||
143410896|NCT00512252|517049433|FG001|Overall Study|Death|0|||
143410897|NCT00512252|517049434|FG002|Overall Study|Death|1|||
143410898|NCT00705406|517049435|FG000|Overall Study|Lost to Follow-up|3|||
143410899|NCT00705406|517049436|FG001|Overall Study|Lost to Follow-up|3|||
143410900|NCT00705406|517049435|FG000|Overall Study|Did not receive study drug|1|||
143410901|NCT00705406|517049436|FG001|Overall Study|Did not receive study drug|2|||
143410902|NCT02357966|517049437|FG000|Overall Study|Death|0|||
143410903|NCT02357966|517049438|FG001|Overall Study|Death|0|||
143410904|NCT02357966|517049439|FG002|Overall Study|Death|1|||
143410905|NCT02357966|517049440|FG003|Overall Study|Death|0|||
143410906|NCT02357966|517049441|FG004|Overall Study|Death|2|||
143410907|NCT02357966|517049442|FG005|Overall Study|Death|0|||
143410908|NCT02357966|517049437|FG000|Overall Study|Physician Decision|1|||
143410909|NCT02357966|517049438|FG001|Overall Study|Physician Decision|0|||
143410910|NCT02357966|517049439|FG002|Overall Study|Physician Decision|0|||
143410911|NCT02357966|517049440|FG003|Overall Study|Physician Decision|0|||
143410912|NCT02357966|517049441|FG004|Overall Study|Physician Decision|1|||
143410913|NCT02357966|517049442|FG005|Overall Study|Physician Decision|0|||
143410914|NCT01779700|517049443|FG000|Overall Study|Adverse Event|4|||
143410915|NCT01779700|517049444|FG001|Overall Study|Adverse Event|3|||
143410916|NCT01779700|517049443|FG000|Overall Study|Withdrawal by Subject|0|||
143410917|NCT01779700|517049444|FG001|Overall Study|Withdrawal by Subject|2|||
143410918|NCT00442104|517049448|FG000|Overall Study|Adverse Event|5|||
143410919|NCT00442104|517049448|FG000|Overall Study|Death|2|||
143410920|NCT00442104|517049448|FG000|Overall Study|Lost to Follow-up|3|||
143410921|NCT00442104|517049448|FG000|Overall Study|Withdrawal by Subject|5|||
143410922|NCT00442104|517049448|FG000|Overall Study|Insufficient Clinical Response|10|||
143410923|NCT00442104|517049448|FG000|Overall Study|Other|21|||
143410924|NCT00442104|517049448|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
143410925|NCT04608409|517049449|FG000|Overall Study|Physician Decision|1|||
143410926|NCT04608409|517049450|FG001|Overall Study|Physician Decision|1|||
143410927|NCT04608409|517049451|FG002|Overall Study|Physician Decision|2|||
143410928|NCT04497415|517049452|FG000|Overall Study|Lost to Follow-up|43|||
143410929|NCT04497415|517049453|FG001|Overall Study|Lost to Follow-up|27|||
143410930|NCT03712371|517049456|FG000|Overall Study|Lack of Efficacy|0|||
143410931|NCT03712371|517049457|FG001|Overall Study|Lack of Efficacy|0|||
143410932|NCT03712371|517049458|FG002|Overall Study|Lack of Efficacy|0|||
143410933|NCT03712371|517049459|FG003|Overall Study|Lack of Efficacy|1|||
143410934|NCT02362035|517049460|FG000|Overall Study|Death|67|||
143410935|NCT02362035|517049460|FG000|Overall Study|Lost to Follow-up|3|||
143410936|NCT02362035|517049460|FG000|Overall Study|Adverse Event|1|||
143410937|NCT02362035|517049460|FG000|Overall Study|Physician Decision|1|||
143410938|NCT02362035|517049460|FG000|Overall Study|Subject started another cancer therapy|10|||
143410939|NCT02362035|517049460|FG000|Overall Study|Study terminated by sponsor|45|||
143410940|NCT02362035|517049460|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
143410941|NCT02362035|517049460|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
143410942|NCT02362035|517049460|FG000|Overall Study|Disease progression|11|||
143410943|NCT02362035|517049460|FG000|Overall Study|Withdrawal by Subject|20|||
143410944|NCT00463229|517049468|FG000|Overall Study|Lost to Follow-up|5|||
143410945|NCT00463229|517049469|FG001|Overall Study|Lost to Follow-up|7|||
143410946|NCT00463229|517049468|FG000|Overall Study|Death|4|||
143410947|NCT00463229|517049469|FG001|Overall Study|Death|3|||
143410948|NCT01932970|517049470|FG000|Overall Study|Withdrawal by Subject|5|||
143410949|NCT01932970|517049470|FG000|Overall Study|Death|1|||
143410950|NCT01932970|517049470|FG000|Overall Study|Lost to Follow-up|2|||
143410951|NCT01932970|517049470|FG000|Overall Study|Protocol Specified Criteria|10|||
143410952|NCT01767467|517049477|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
143410953|NCT01767467|517049478|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
143410954|NCT01767467|517049477|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
143410955|NCT01767467|517049478|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
143410956|NCT01767467|517049477|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
143410957|NCT01767467|517049478|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
143410958|NCT01767467|517049477|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
143410959|NCT01767467|517049478|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
143410960|NCT01767467|517049477|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
143410961|NCT01767467|517049478|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
143410962|NCT01767467|517049477|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
143410963|NCT01767467|517049478|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
143410964|NCT01767467|517049477|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
143410965|NCT01767467|517049478|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
143410966|NCT01767467|517049477|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
143410967|NCT01767467|517049478|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
143410968|NCT01767467|517049477|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
143410969|NCT01767467|517049478|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
143410970|NCT01767467|517049477|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
143410971|NCT01767467|517049478|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
143410972|NCT01767467|517049477|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
143410973|NCT01767467|517049478|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
143410974|NCT01767467|517049477|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
143410975|NCT01767467|517049478|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
143410976|NCT01767467|517049477|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
143410977|NCT01767467|517049478|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
143410978|NCT01767467|517049477|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
143410979|NCT01767467|517049478|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
143410980|NCT01359150|517049479|FG000|Overall Study|Lack of Efficacy|1|||
143410981|NCT01359150|517049480|FG001|Overall Study|Lack of Efficacy|1|||
143410982|NCT01359150|517049479|FG000|Overall Study|Withdrawal by Subject|1|||
143410983|NCT01359150|517049480|FG001|Overall Study|Withdrawal by Subject|1|||
143410984|NCT01359150|517049479|FG000|Overall Study|Adverse Event|4|||
143410985|NCT01359150|517049480|FG001|Overall Study|Adverse Event|3|||
143410986|NCT01359150|517049479|FG000|Overall Study|Other|1|||
143410987|NCT01359150|517049480|FG001|Overall Study|Other|0|||
143410988|NCT03041233|517049483|FG000|Overall Study|Death|5|||
143410989|NCT03041233|517049483|FG000|Overall Study|Physician Decision|1|||
143410990|NCT03041233|517049483|FG000|Overall Study|Lost to Follow-up|16|||
143410991|NCT03041233|517049483|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
143410992|NCT03041233|517049483|FG000|Overall Study|Sponsor Request|1|||
143410993|NCT03041233|517049483|FG000|Overall Study|Duplicate subject|1|||
143410994|NCT03041233|517049483|FG000|Overall Study|Re-ablation|1|||
143410995|NCT00853593|517049487|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
143410996|NCT00853593|517049487|FG000|Overall Study|Model 4396 lead not attempted|29|||
143410997|NCT00853593|517049487|FG000|Overall Study|Implant not attempted|4|||
143410998|NCT03890289|517049490|FG000|Overall Study|Adverse Event|1|||
143410999|NCT03890289|517049490|FG000|Overall Study|Physician Decision|1|||
143411000|NCT03890289|517049490|FG000|Overall Study|Lack of Efficacy|2|||
143411001|NCT03362190|517049497|FG000|Overall Study|Adverse Event|0|||
143411002|NCT03362190|517049498|FG001|Overall Study|Adverse Event|0|||
143411003|NCT03362190|517049499|FG002|Overall Study|Adverse Event|0|||
143411004|NCT03362190|517049500|FG003|Overall Study|Adverse Event|1|||
143411005|NCT03362190|517049497|FG000|Overall Study|Withdrawal by Subject|0|||
143411006|NCT03362190|517049498|FG001|Overall Study|Withdrawal by Subject|0|||
143411007|NCT03362190|517049499|FG002|Overall Study|Withdrawal by Subject|0|||
143411008|NCT03362190|517049500|FG003|Overall Study|Withdrawal by Subject|1|||
143411009|NCT02235298|517049505|FG000|Overall Study|Lost to Follow-up|6|||
143411010|NCT02235298|517049506|FG001|Overall Study|Lost to Follow-up|5|||
143411011|NCT02235298|517049505|FG000|Overall Study|Adverse Event|2|||
143411012|NCT02235298|517049506|FG001|Overall Study|Adverse Event|2|||
143411013|NCT02235298|517049505|FG000|Overall Study|Withdrawal by Subject|0|||
143411014|NCT02235298|517049506|FG001|Overall Study|Withdrawal by Subject|1|||
143411015|NCT01593020|517049511|FG000|Overall Study|Adverse Event|1|||
143411016|NCT01593020|517049512|FG001|Overall Study|Adverse Event|1|||
143411017|NCT01593020|517049511|FG000|Overall Study|Death|0|||
143411018|NCT01593020|517049512|FG001|Overall Study|Death|1|||
143411019|NCT01593020|517049511|FG000|Overall Study|Ineligible|1|||
143411020|NCT01593020|517049512|FG001|Overall Study|Ineligible|0|||
143411021|NCT02350634|517049513|FG000|Overall Study|subject survived greater than 6 months following dosing|1|||
143411022|NCT00914966|517049527|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
143411023|NCT00914966|517049527|FG000|Step 1: 1500 Units|Physician Decision|1|||
143411024|NCT00914966|517049527|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
143411025|NCT03488719|517049528|FG000|Overall Study|Adverse Event|0|||
143411026|NCT03488719|517049529|FG001|Overall Study|Adverse Event|4|||
143411027|NCT03488719|517049530|FG002|Overall Study|Adverse Event|2|||
143411028|NCT03488719|517049528|FG000|Overall Study|Other|0|||
143411029|NCT03488719|517049529|FG001|Overall Study|Other|0|||
143411030|NCT03488719|517049530|FG002|Overall Study|Other|5|||
143411031|NCT01855750|517049531|FG000|Overall Study|Death|78|||
143411032|NCT01855750|517049532|FG001|Overall Study|Death|78|||
143411033|NCT01855750|517049531|FG000|Overall Study|Lost to Follow-up|9|||
143411034|NCT01855750|517049532|FG001|Overall Study|Lost to Follow-up|23|||
143411035|NCT01855750|517049531|FG000|Overall Study|Withdrawal by Subject|35|||
143411036|NCT01855750|517049532|FG001|Overall Study|Withdrawal by Subject|28|||
143411037|NCT01855750|517049531|FG000|Overall Study|Sponsor ends the study|297|||
143411038|NCT01855750|517049532|FG001|Overall Study|Sponsor ends the study|290|||
143411039|NCT04300023|517049533|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
143411040|NCT04300023|517049534|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
143411041|NCT05525572|517049535|FG000|Overall Study|Lost to Follow-up|2|||
143411042|NCT05025384|517049536|FG000|Overall Study|Physician Decision|5|||
143411043|NCT05025384|517049537|FG001|Overall Study|Physician Decision|6|||
143411044|NCT04057131|517049538|FG000|Overall Study|Protocol Violation|24|||
143411045|NCT00719888|517049546|FG000|Overall Study|Death|24|||
143411046|NCT00719888|517049547|FG001|Overall Study|Death|9|||
143411047|NCT00719888|517049546|FG000|Overall Study|Relapse|8|||
143411048|NCT00719888|517049547|FG001|Overall Study|Relapse|3|||
143411049|NCT00719888|517049546|FG000|Overall Study|Physician Decision|1|||
143411050|NCT00719888|517049547|FG001|Overall Study|Physician Decision|0|||
143411051|NCT00719888|517049546|FG000|Overall Study|Withdrawal by Subject|1|||
143411052|NCT00719888|517049547|FG001|Overall Study|Withdrawal by Subject|0|||
143411053|NCT04701203|517049548|FG000|Blinded Period (Weeks 0 to 26)|Death|1|||
143411054|NCT04701203|517049549|FG001|Blinded Period (Weeks 0 to 26)|Death|0|||
143411055|NCT04701203|517049550|FG002|Blinded Period (Weeks 0 to 26)|Death|0|||
143411056|NCT04701203|517049548|FG000|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
143411057|NCT04701203|517049549|FG001|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|1|||
143411058|NCT04701203|517049550|FG002|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
143411059|NCT04701203|517049548|FG000|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
143411060|NCT04701203|517049549|FG001|Blinded Period (Weeks 0 to 26)|Adverse Event|1|||
143411061|NCT04701203|517049550|FG002|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
143411062|NCT04701203|517049548|FG000|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
143411063|NCT04701203|517049549|FG001|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
143411064|NCT04701203|517049550|FG002|Open-Label Period (Weeks 26 to 182)|Study Ongoing|79|||
143411065|NCT02386098|517051130|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
143411066|NCT02386098|517051131|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
143411067|NCT02386098|517051132|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
143411068|NCT02386098|517051133|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
143411069|NCT02386098|517051134|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
143411070|NCT02386098|517051130|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
143411071|NCT02386098|517051131|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
143411072|NCT02386098|517051132|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
143411073|NCT02386098|517051133|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
143411074|NCT02386098|517051134|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
143411075|NCT02386098|517051130|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
143411076|NCT02386098|517051131|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
143411077|NCT02386098|517051132|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
143411078|NCT02386098|517051133|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
143411079|NCT02386098|517051134|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
143411080|NCT02386098|517051130|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
143411081|NCT02386098|517051131|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
143411082|NCT02386098|517051132|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
143411083|NCT02386098|517051133|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
143411084|NCT02386098|517051134|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
143411085|NCT02386098|517051130|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
143411086|NCT02386098|517051131|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
143411087|NCT02386098|517051132|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
143411088|NCT02386098|517051133|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
143411089|NCT02386098|517051134|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
143411090|NCT02386098|517051130|FG000|Stage 1 (96 Weeks)|Other|1|||
143411091|NCT02386098|517051131|FG001|Stage 1 (96 Weeks)|Other|0|||
143411092|NCT02386098|517051132|FG002|Stage 1 (96 Weeks)|Other|0|||
143411093|NCT02386098|517051133|FG003|Stage 1 (96 Weeks)|Other|0|||
143411094|NCT02386098|517051134|FG004|Stage 1 (96 Weeks)|Other|0|||
143411095|NCT02386098|517051130|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
143411096|NCT02386098|517051131|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
143411097|NCT02386098|517051132|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
143411098|NCT02386098|517051133|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
143411099|NCT02386098|517051134|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
143411100|NCT03861052|517051135|FG000|Overall Study|Adverse Event|1|||
143411101|NCT03861052|517051136|FG001|Overall Study|Adverse Event|1|||
143411102|NCT03861052|517051137|FG002|Overall Study|Adverse Event|2|||
143411103|NCT03861052|517051138|FG003|Overall Study|Adverse Event|4|||
143411104|NCT03861052|517051135|FG000|Overall Study|Lost to Follow-up|0|||
143411105|NCT03861052|517051136|FG001|Overall Study|Lost to Follow-up|0|||
143411106|NCT03861052|517051137|FG002|Overall Study|Lost to Follow-up|0|||
143411107|NCT03861052|517051138|FG003|Overall Study|Lost to Follow-up|1|||
143411108|NCT03861052|517051135|FG000|Overall Study|Physician Decision|0|||
143411109|NCT03861052|517051136|FG001|Overall Study|Physician Decision|1|||
143411110|NCT03861052|517051137|FG002|Overall Study|Physician Decision|0|||
143411111|NCT03861052|517051138|FG003|Overall Study|Physician Decision|0|||
143411112|NCT03861052|517051135|FG000|Overall Study|Withdrawal by Subject|2|||
143411113|NCT03861052|517051136|FG001|Overall Study|Withdrawal by Subject|5|||
143411114|NCT03861052|517051137|FG002|Overall Study|Withdrawal by Subject|3|||
143411115|NCT03861052|517051138|FG003|Overall Study|Withdrawal by Subject|0|||
143411116|NCT03861052|517051135|FG000|Overall Study|Relocation to other city|1|||
143411117|NCT03861052|517051136|FG001|Overall Study|Relocation to other city|0|||
143411118|NCT03861052|517051137|FG002|Overall Study|Relocation to other city|0|||
143411119|NCT03861052|517051138|FG003|Overall Study|Relocation to other city|0|||
143411120|NCT03220724|517051147|FG000|Overall Study|Lost to Follow-up|2|||
143411121|NCT03220724|517051148|FG001|Overall Study|Lost to Follow-up|2|||
143411122|NCT03220724|517051149|FG002|Overall Study|Lost to Follow-up|0|||
143411123|NCT03220724|517051150|FG003|Overall Study|Lost to Follow-up|3|||
143411124|NCT03220724|517051151|FG004|Overall Study|Lost to Follow-up|1|||
143411125|NCT03220724|517051152|FG005|Overall Study|Lost to Follow-up|0|||
143411126|NCT03220724|517051153|FG006|Overall Study|Lost to Follow-up|2|||
143411127|NCT03220724|517051154|FG007|Overall Study|Lost to Follow-up|1|||
143411128|NCT03220724|517051155|FG008|Overall Study|Lost to Follow-up|0|||
143411129|NCT03220724|517051147|FG000|Overall Study|Withdrawal by Subject|1|||
143411130|NCT03220724|517051148|FG001|Overall Study|Withdrawal by Subject|0|||
143411131|NCT03220724|517051149|FG002|Overall Study|Withdrawal by Subject|1|||
143411132|NCT03220724|517051150|FG003|Overall Study|Withdrawal by Subject|0|||
143411133|NCT03220724|517051151|FG004|Overall Study|Withdrawal by Subject|0|||
143411134|NCT03220724|517051152|FG005|Overall Study|Withdrawal by Subject|0|||
143411135|NCT03220724|517051153|FG006|Overall Study|Withdrawal by Subject|0|||
143411136|NCT03220724|517051154|FG007|Overall Study|Withdrawal by Subject|0|||
143411137|NCT03220724|517051155|FG008|Overall Study|Withdrawal by Subject|0|||
143411138|NCT00229658|517051165|FG000|Overall Study|Administrative|2|||
143411139|NCT00229658|517051166|FG001|Overall Study|Administrative|1|||
143411140|NCT00229658|517051165|FG000|Overall Study|Investigator decision|13|||
143411141|NCT00229658|517051166|FG001|Overall Study|Investigator decision|10|||
143411142|NCT00229658|517051165|FG000|Overall Study|Other|80|||
143411143|NCT00229658|517051166|FG001|Overall Study|Other|60|||
143411144|NCT00229658|517051165|FG000|Overall Study|Lost to Follow-up|82|||
143411145|NCT00229658|517051166|FG001|Overall Study|Lost to Follow-up|55|||
143411146|NCT00229658|517051165|FG000|Overall Study|Serious Adverse Event|2|||
143411147|NCT00229658|517051166|FG001|Overall Study|Serious Adverse Event|2|||
143411148|NCT00229658|517051165|FG000|Overall Study|Withdrawal of consent|46|||
143411149|NCT00229658|517051166|FG001|Overall Study|Withdrawal of consent|39|||
143411150|NCT02157116|517051167|FG000|Overall Study|Withdrawal by Subject|4|||
143411151|NCT02157116|517051167|FG000|Overall Study|Physician Decision|3|||
143411152|NCT02157116|517051167|FG000|Overall Study|Failed Screening|2|||
143411153|NCT00093496|517051168|FG000|Overall Study|Protocol Violation|1|||
143411154|NCT00093496|517051169|FG001|Overall Study|Protocol Violation|3|||
143411155|NCT00975585|517051170|FG000|Overall Study|Adverse Event|0|||
143411156|NCT00975585|517051171|FG001|Overall Study|Adverse Event|4|||
143411157|NCT00975585|517051170|FG000|Overall Study|Lost to Follow-up|3|||
143411158|NCT00975585|517051171|FG001|Overall Study|Lost to Follow-up|5|||
143411159|NCT00975585|517051170|FG000|Overall Study|Withdrawal by Subject|2|||
143411160|NCT00975585|517051171|FG001|Overall Study|Withdrawal by Subject|1|||
143411161|NCT00975585|517051170|FG000|Overall Study|Lens issue|2|||
143411162|NCT00975585|517051171|FG001|Overall Study|Lens issue|2|||
143411163|NCT01953224|517051172|FG000|Overall Study|Lost to Follow-up|1|||
143411164|NCT01953224|517051173|FG001|Overall Study|Lost to Follow-up|1|||
143411165|NCT01953224|517051172|FG000|Overall Study|Withdrawal by Subject|1|||
143411166|NCT01953224|517051173|FG001|Overall Study|Withdrawal by Subject|2|||
143411167|NCT00683800|517051174|FG000|Overall Study|Adverse Event|195|||
143411168|NCT00683800|517051175|FG001|Overall Study|Adverse Event|102|||
143411169|NCT00683800|517051174|FG000|Overall Study|Death|0|||
143411170|NCT00683800|517051175|FG001|Overall Study|Death|1|||
143411171|NCT00683800|517051174|FG000|Overall Study|Lost to Follow-up|57|||
143411172|NCT00683800|517051175|FG001|Overall Study|Lost to Follow-up|44|||
143411173|NCT00683800|517051174|FG000|Overall Study|Other|5|||
143411174|NCT00683800|517051175|FG001|Overall Study|Other|2|||
143411175|NCT00683800|517051174|FG000|Overall Study|Protocol Violation|13|||
143411176|NCT00683800|517051175|FG001|Overall Study|Protocol Violation|16|||
143411177|NCT00683800|517051174|FG000|Overall Study|Withdrawal by Subject|66|||
143411178|NCT00683800|517051175|FG001|Overall Study|Withdrawal by Subject|64|||
143411179|NCT00683800|517051174|FG000|Overall Study|Lack of Efficacy|61|||
143411180|NCT00683800|517051175|FG001|Overall Study|Lack of Efficacy|104|||
143411181|NCT00683800|517051174|FG000|Overall Study|Randomized, not treated|35|||
143411182|NCT00683800|517051175|FG001|Overall Study|Randomized, not treated|33|||
143411183|NCT00205179|517051178|FG000|Overall Study|Death|0|||
143411184|NCT00205179|517051179|FG001|Overall Study|Death|2|||
143411185|NCT00205179|517051178|FG000|Overall Study|Physician Decision|1|||
143411186|NCT00205179|517051179|FG001|Overall Study|Physician Decision|1|||
143411187|NCT00205179|517051178|FG000|Overall Study|Adverse Event|1|||
143411188|NCT00205179|517051179|FG001|Overall Study|Adverse Event|1|||
143411189|NCT00853580|517051180|FG000|Overall Study|Lost to Follow-up|3|||
143411190|NCT00853580|517051181|FG001|Overall Study|Lost to Follow-up|5|||
143411191|NCT00853580|517051180|FG000|Overall Study|Protocol Violation|2|||
143411192|NCT00853580|517051181|FG001|Overall Study|Protocol Violation|1|||
143411193|NCT00853580|517051180|FG000|Overall Study|Withdrawal by Subject|2|||
143411194|NCT00853580|517051181|FG001|Overall Study|Withdrawal by Subject|8|||
143411195|NCT00853580|517051180|FG000|Overall Study|Commenced contraindicated therapy|0|||
143411196|NCT00853580|517051181|FG001|Overall Study|Commenced contraindicated therapy|2|||
143411197|NCT01700205|517051182|FG000|Overall Study|Withdrawal by Subject|13|||
143411198|NCT01700205|517051183|FG001|Overall Study|Withdrawal by Subject|13|||
143411199|NCT01700205|517051182|FG000|Overall Study|Protocol Violation|2|||
143411200|NCT01700205|517051183|FG001|Overall Study|Protocol Violation|2|||
143411201|NCT03113409|517051184|FG000|Overall Study|Withdrawal by Subject|5|||
143411202|NCT03113409|517051185|FG001|Overall Study|Withdrawal by Subject|0|||
143411203|NCT03113409|517051186|FG002|Overall Study|Withdrawal by Subject|0|||
143411204|NCT01787032|517051187|FG000|Overall Study|Protocol Violation|0|||
143411205|NCT01787032|517051188|FG001|Overall Study|Protocol Violation|0|||
143411206|NCT01787032|517051189|FG002|Overall Study|Protocol Violation|0|||
143411207|NCT01787032|517051190|FG003|Overall Study|Protocol Violation|0|||
143411208|NCT01787032|517051191|FG004|Overall Study|Protocol Violation|1|||
143411209|NCT01787032|517051192|FG005|Overall Study|Protocol Violation|1|||
143411210|NCT02040870|517051195|FG000|Overall Study|Completed treatment phase|6|||
143411211|NCT02040870|517051195|FG000|Overall Study|Adverse Event|7|||
143411212|NCT02040870|517051195|FG000|Overall Study|Progressive disease|58|||
143411213|NCT02040870|517051195|FG000|Overall Study|Physician Decision|6|||
143411214|NCT02040870|517051195|FG000|Overall Study|Subject/guardian decision|10|||
143411215|NCT02040870|517051195|FG000|Overall Study|Lost to Follow-up|3|||
143411216|NCT02040870|517051195|FG000|Overall Study|Death|13|||
143411217|NCT03335488|517051198|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
143411218|NCT03335488|517051199|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
143411219|NCT03335488|517051198|FG000|Safety Extension Period|Adverse Event|1|||
143411220|NCT03335488|517051199|FG001|Safety Extension Period|Adverse Event|0|||
143411221|NCT03335488|517051198|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
143411222|NCT03335488|517051199|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
143411223|NCT00388726|517051200|FG000|Overall Study|Adverse Event|50|||
143411224|NCT00388726|517051201|FG001|Overall Study|Adverse Event|24|||
143411225|NCT00388726|517051200|FG000|Overall Study|Progressive Disease|336|||
143411226|NCT00388726|517051201|FG001|Overall Study|Progressive Disease|153|||
143411227|NCT00388726|517051200|FG000|Overall Study|Clinical Progression|61|||
143411228|NCT00388726|517051201|FG001|Overall Study|Clinical Progression|36|||
143411229|NCT00388726|517051200|FG000|Overall Study|Withdrawal by Subject|10|||
143411230|NCT00388726|517051201|FG001|Overall Study|Withdrawal by Subject|7|||
143411231|NCT00388726|517051200|FG000|Overall Study|Administrative|6|||
143411232|NCT00388726|517051201|FG001|Overall Study|Administrative|9|||
143411233|NCT00388726|517051200|FG000|Overall Study|Physician Decision|18|||
143411234|NCT00388726|517051201|FG001|Overall Study|Physician Decision|13|||
143411235|NCT00388726|517051200|FG000|Overall Study|Death|3|||
143411236|NCT00388726|517051201|FG001|Overall Study|Death|2|||
143411237|NCT04971733|517051202|FG000|Overall Study|Adverse Event|1|||
143411238|NCT04971733|517051203|FG001|Overall Study|Adverse Event|1|||
143411239|NCT04971733|517051202|FG000|Overall Study|Subject choice|2|||
143411240|NCT04971733|517051203|FG001|Overall Study|Subject choice|0|||
143411241|NCT04971733|517051202|FG000|Overall Study|Withdrawal by Subject|1|||
143411242|NCT04971733|517051203|FG001|Overall Study|Withdrawal by Subject|0|||
143411243|NCT04971733|517051202|FG000|Overall Study|Other|1|||
143411244|NCT04971733|517051203|FG001|Overall Study|Other|0|||
143411245|NCT03229408|517051205|FG000|Overall Study|Withdrawal by Subject|4|||
143411246|NCT03229408|517051206|FG001|Overall Study|Withdrawal by Subject|1|||
143411247|NCT03229408|517051205|FG000|Overall Study|Adverse Event|2|||
143411248|NCT03229408|517051206|FG001|Overall Study|Adverse Event|0|||
143411249|NCT03229408|517051205|FG000|Overall Study|Pregnancy|0|||
143411250|NCT03229408|517051206|FG001|Overall Study|Pregnancy|1|||
143411251|NCT03229408|517051205|FG000|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
143411252|NCT03229408|517051206|FG001|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
143411253|NCT04200664|517051207|FG000|Overall Study|Withdrawal by Subject|1|||
143411254|NCT04200664|517051208|FG001|Overall Study|Withdrawal by Subject|0|||
143411255|NCT04200664|517051209|FG002|Overall Study|Withdrawal by Subject|0|||
143411256|NCT02816398|517051214|FG000|Overall Study|Death|5|||
143411257|NCT02816398|517051214|FG000|Overall Study|Lack of Efficacy|8|||
143411258|NCT02816398|517051214|FG000|Overall Study|Lost to Follow-up|1|||
143411259|NCT01367236|517051215|FG000|Overall Study|Withdrawal by Subject|3|||
143411260|NCT01367236|517051216|FG001|Overall Study|Withdrawal by Subject|1|||
143411261|NCT02063659|517051217|FG000|Double-Blind Treatment Period|Adverse Event|1|||
143411262|NCT02063659|517051218|FG001|Double-Blind Treatment Period|Adverse Event|2|||
143411263|NCT02063659|517051219|FG002|Double-Blind Treatment Period|Adverse Event|0|||
143411264|NCT02063659|517051220|FG003|Double-Blind Treatment Period|Adverse Event|0|||
143411265|NCT02063659|517051217|FG000|Double-Blind Treatment Period|Physician Decision|1|||
143411266|NCT02063659|517051218|FG001|Double-Blind Treatment Period|Physician Decision|0|||
143411267|NCT02063659|517051219|FG002|Double-Blind Treatment Period|Physician Decision|0|||
143411268|NCT02063659|517051220|FG003|Double-Blind Treatment Period|Physician Decision|0|||
143411269|NCT02063659|517051217|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
143411270|NCT02063659|517051218|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
143411271|NCT02063659|517051219|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
143411272|NCT02063659|517051220|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
143411273|NCT02063659|517051217|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
143411274|NCT02063659|517051218|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
143411275|NCT02063659|517051219|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
143411276|NCT02063659|517051220|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
143411277|NCT02063659|517051217|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
143411278|NCT02063659|517051218|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
143411279|NCT02063659|517051219|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
143411280|NCT02063659|517051220|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
143411281|NCT02063659|517051217|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
143411282|NCT02063659|517051218|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
143411283|NCT02063659|517051219|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
143411284|NCT02063659|517051220|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
143411285|NCT02063659|517051217|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
143411286|NCT02063659|517051218|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
143411287|NCT02063659|517051219|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
143411288|NCT02063659|517051220|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
143411289|NCT02063659|517051217|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
143411290|NCT02063659|517051218|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
143411291|NCT02063659|517051219|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
143411292|NCT02063659|517051220|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
143411293|NCT04038580|517051223|FG000|Washout 1|Death|0|||
143411294|NCT04038580|517051224|FG001|Washout 1|Death|0|||
143411295|NCT04038580|517051225|FG002|Washout 1|Death|0|||
143411296|NCT04038580|517051226|FG003|Washout 1|Death|1|||
143411297|NCT04038580|517051227|FG004|Washout 1|Death|0|||
143411298|NCT04038580|517051228|FG005|Washout 1|Death|0|||
143411299|NCT04038580|517051223|FG000|Washout 1|Withdrawal by Subject|0|||
143411300|NCT04038580|517051224|FG001|Washout 1|Withdrawal by Subject|0|||
143411301|NCT04038580|517051225|FG002|Washout 1|Withdrawal by Subject|0|||
143411302|NCT04038580|517051226|FG003|Washout 1|Withdrawal by Subject|0|||
143411303|NCT04038580|517051227|FG004|Washout 1|Withdrawal by Subject|1|||
143411304|NCT04038580|517051228|FG005|Washout 1|Withdrawal by Subject|0|||
143411305|NCT04038580|517051223|FG000|Wash-out 2|Withdrawal by Subject|1|||
143411306|NCT04038580|517051224|FG001|Wash-out 2|Withdrawal by Subject|0|||
143411307|NCT04038580|517051225|FG002|Wash-out 2|Withdrawal by Subject|0|||
143411308|NCT04038580|517051226|FG003|Wash-out 2|Withdrawal by Subject|2|||
143411309|NCT04038580|517051227|FG004|Wash-out 2|Withdrawal by Subject|0|||
143411310|NCT04038580|517051228|FG005|Wash-out 2|Withdrawal by Subject|1|||
143411311|NCT04038580|517051223|FG000|Experimental Socket #2|Withdrawal by Subject|0|||
143411312|NCT04038580|517051224|FG001|Experimental Socket #2|Withdrawal by Subject|1|||
143411313|NCT04038580|517051225|FG002|Experimental Socket #2|Withdrawal by Subject|0|||
143411314|NCT04038580|517051226|FG003|Experimental Socket #2|Withdrawal by Subject|0|||
143411315|NCT04038580|517051227|FG004|Experimental Socket #2|Withdrawal by Subject|0|||
143411316|NCT04038580|517051228|FG005|Experimental Socket #2|Withdrawal by Subject|0|||
143411317|NCT04038580|517051223|FG000|Wash-out 3|Withdrawal by Subject|1|||
143411318|NCT04038580|517051224|FG001|Wash-out 3|Withdrawal by Subject|0|||
143411319|NCT04038580|517051225|FG002|Wash-out 3|Withdrawal by Subject|2|||
143411320|NCT04038580|517051226|FG003|Wash-out 3|Withdrawal by Subject|0|||
143411321|NCT04038580|517051227|FG004|Wash-out 3|Withdrawal by Subject|0|||
143411322|NCT04038580|517051228|FG005|Wash-out 3|Withdrawal by Subject|0|||
143411323|NCT04021862|517051229|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
143411324|NCT04021862|517051230|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
143411325|NCT04021862|517051231|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
143411326|NCT04021862|517051232|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
143411327|NCT04021862|517051233|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
143411328|NCT04021862|517051234|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
143411329|NCT04021862|517051229|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
143411330|NCT04021862|517051230|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
143411331|NCT04021862|517051231|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
143411332|NCT04021862|517051232|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
143411333|NCT04021862|517051233|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
143411334|NCT04021862|517051234|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
143411335|NCT04021862|517051229|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
143411336|NCT04021862|517051230|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
143411337|NCT04021862|517051231|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
143411338|NCT04021862|517051232|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
143411339|NCT04021862|517051233|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
143411340|NCT04021862|517051234|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
143411341|NCT04021862|517051229|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
143411342|NCT04021862|517051230|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
143411343|NCT04021862|517051231|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
143411344|NCT04021862|517051232|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
143411345|NCT04021862|517051233|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
143411346|NCT04021862|517051234|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
143411347|NCT04021862|517051229|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
143411348|NCT04021862|517051230|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
143411349|NCT04021862|517051231|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
143411350|NCT04021862|517051232|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
143411351|NCT04021862|517051233|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
143411352|NCT04021862|517051234|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
143411353|NCT03835754|517051235|FG000|Overall Study|Death|4|||
143411354|NCT02830204|517051236|FG000|Overall Study|Death|9|||
143411355|NCT02830204|517051236|FG000|Overall Study|Withdrawal by Subject|1|||
143411356|NCT04445831|517051239|FG000|Overall Study|Withdrawal by Subject|2|||
143411357|NCT04445831|517051240|FG001|Overall Study|Withdrawal by Subject|1|||
143411358|NCT04445831|517051241|FG002|Overall Study|Withdrawal by Subject|1|||
143411359|NCT04445831|517051242|FG003|Overall Study|Withdrawal by Subject|0|||
143411360|NCT04445831|517051243|FG004|Overall Study|Withdrawal by Subject|0|||
143411361|NCT04445831|517051244|FG005|Overall Study|Withdrawal by Subject|0|||
143411362|NCT04445831|517051245|FG006|Overall Study|Withdrawal by Subject|0|||
143411363|NCT04445831|517051239|FG000|Overall Study|Subject withdrawal by caregiver|0|||
143411364|NCT04445831|517051240|FG001|Overall Study|Subject withdrawal by caregiver|1|||
143411365|NCT04445831|517051241|FG002|Overall Study|Subject withdrawal by caregiver|0|||
143411366|NCT04445831|517051242|FG003|Overall Study|Subject withdrawal by caregiver|0|||
143411367|NCT04445831|517051243|FG004|Overall Study|Subject withdrawal by caregiver|0|||
143411368|NCT04445831|517051244|FG005|Overall Study|Subject withdrawal by caregiver|0|||
143411369|NCT04445831|517051245|FG006|Overall Study|Subject withdrawal by caregiver|0|||
143411370|NCT05613907|517051246|FG000|Overall Study|Lost to Follow-up|5|||
143411371|NCT05613907|517051246|FG000|Overall Study|Death|3|||
143411372|NCT05613907|517051246|FG000|Overall Study|Withdrawal by Subject|2|||
143411373|NCT05422339|517052118|FG000|Overall Study|Withdrawal by Subject|17|||
143411374|NCT05422339|517052119|FG001|Overall Study|Withdrawal by Subject|15|||
143411375|NCT04172675|517052120|FG000|Overall Study|Withdrawal by Subject|7|||
143411376|NCT04172675|517052121|FG001|Overall Study|Withdrawal by Subject|5|||
143411377|NCT04172675|517052122|FG002|Overall Study|Withdrawal by Subject|1|||
143411378|NCT04172675|517052123|FG003|Overall Study|Withdrawal by Subject|4|||
143411379|NCT03070392|517052124|FG000|Overall Study|Not Treated|7|||
143411380|NCT03070392|517052125|FG001|Overall Study|Not Treated|0|||
143411381|NCT03070392|517052126|FG002|Overall Study|Not Treated|3|||
143411382|NCT03070392|517052127|FG003|Overall Study|Not Treated|12|||
143411383|NCT03070392|517052124|FG000|Overall Study|Death|3|||
143411384|NCT03070392|517052125|FG001|Overall Study|Death|0|||
143411385|NCT03070392|517052126|FG002|Overall Study|Death|0|||
143411386|NCT03070392|517052127|FG003|Overall Study|Death|1|||
143411387|NCT03070392|517052124|FG000|Overall Study|Withdrawal by Subject|7|||
143411388|NCT03070392|517052125|FG001|Overall Study|Withdrawal by Subject|0|||
143411389|NCT03070392|517052126|FG002|Overall Study|Withdrawal by Subject|0|||
143411390|NCT03070392|517052127|FG003|Overall Study|Withdrawal by Subject|3|||
143411391|NCT03070392|517052124|FG000|Overall Study|Physician Decision|1|||
143411392|NCT03070392|517052125|FG001|Overall Study|Physician Decision|0|||
143411393|NCT03070392|517052126|FG002|Overall Study|Physician Decision|0|||
143411394|NCT03070392|517052127|FG003|Overall Study|Physician Decision|2|||
143411395|NCT03070392|517052124|FG000|Overall Study|Progressive Disease|154|||
143411396|NCT03070392|517052125|FG001|Overall Study|Progressive Disease|6|||
143411397|NCT03070392|517052126|FG002|Overall Study|Progressive Disease|2|||
143411398|NCT03070392|517052127|FG003|Overall Study|Progressive Disease|70|||
143411399|NCT03070392|517052124|FG000|Overall Study|Adverse Event|6|||
143411400|NCT03070392|517052125|FG001|Overall Study|Adverse Event|1|||
143411401|NCT03070392|517052126|FG002|Overall Study|Adverse Event|1|||
143411402|NCT03070392|517052127|FG003|Overall Study|Adverse Event|3|||
143411403|NCT03070392|517052124|FG000|Overall Study|Alternate anticancer treatment|1|||
143411404|NCT03070392|517052125|FG001|Overall Study|Alternate anticancer treatment|0|||
143411405|NCT03070392|517052126|FG002|Overall Study|Alternate anticancer treatment|0|||
143411406|NCT03070392|517052127|FG003|Overall Study|Alternate anticancer treatment|1|||
143411407|NCT03070392|517052124|FG000|Overall Study|Ongoing|73|||
143411408|NCT03070392|517052125|FG001|Overall Study|Ongoing|0|||
143411409|NCT03070392|517052126|FG002|Overall Study|Ongoing|0|||
143411410|NCT03070392|517052127|FG003|Overall Study|Ongoing|11|||
143411411|NCT01278030|517052128|FG000|Overall Study|Withdrawal by Subject|8|||
143411412|NCT01278030|517052129|FG001|Overall Study|Withdrawal by Subject|4|||
143411413|NCT00458783|517052130|FG000|Overall Study|Protocol Violation|1228|||
143411414|NCT00458783|517052131|FG001|Overall Study|Protocol Violation|1220|||
143411415|NCT01737398|517052132|FG000|Overall Study|Adverse event or SAE|16|||
143411416|NCT01737398|517052133|FG001|Overall Study|Adverse event or SAE|1|||
143411417|NCT01737398|517052132|FG000|Overall Study|Stopping rule met|2|||
143411418|NCT01737398|517052133|FG001|Overall Study|Stopping rule met|1|||
143411419|NCT01737398|517052132|FG000|Overall Study|Voluntary withdrawal|2|||
143411420|NCT01737398|517052133|FG001|Overall Study|Voluntary withdrawal|3|||
143411421|NCT01737398|517052132|FG000|Overall Study|Ineligibility|1|||
143411422|NCT01737398|517052133|FG001|Overall Study|Ineligibility|0|||
143411423|NCT01737398|517052132|FG000|Overall Study|Liver transplant|1|||
143411424|NCT01737398|517052133|FG001|Overall Study|Liver transplant|0|||
143411425|NCT01737398|517052132|FG000|Overall Study|Disease progression|2|||
143411426|NCT01737398|517052133|FG001|Overall Study|Disease progression|3|||
143411427|NCT01737398|517052132|FG000|Overall Study|Sponsor's decision|2|||
143411428|NCT01737398|517052133|FG001|Overall Study|Sponsor's decision|0|||
143411429|NCT00599196|517052134|FG000|Overall Study|Lack of Efficacy|22|||
143411430|NCT00599196|517052134|FG000|Overall Study|Adverse Event|93|||
143411431|NCT00599196|517052134|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
143411432|NCT00599196|517052134|FG000|Overall Study|Subject withdrew consent|43|||
143411433|NCT00599196|517052134|FG000|Overall Study|Study ended per sponsor|197|||
143411434|NCT00599196|517052134|FG000|Overall Study|Lost to Follow-up|17|||
143411435|NCT00599196|517052134|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
143411436|NCT00599196|517052134|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
143411437|NCT00599196|517052134|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
143411438|NCT00599196|517052134|FG000|Overall Study|Other: Pt Moved To Australia|1|||
143411439|NCT00599196|517052134|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
143411440|NCT00599196|517052134|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
143411441|NCT01728324|517052145|FG000|Termination of DBV|Adverse Event|14|||
143411442|NCT01728324|517052146|FG001|Termination of DBV|Adverse Event|13|||
143411443|NCT01728324|517052147|FG002|Termination of DBV|Adverse Event|4|||
143411444|NCT01728324|517052145|FG000|Termination of DBV|Lack of Efficacy|14|||
143411445|NCT01728324|517052146|FG001|Termination of DBV|Lack of Efficacy|12|||
143411446|NCT01728324|517052147|FG002|Termination of DBV|Lack of Efficacy|8|||
143411447|NCT01728324|517052145|FG000|Termination of DBV|Withdrawal by Subject|9|||
143411448|NCT01728324|517052146|FG001|Termination of DBV|Withdrawal by Subject|6|||
143411449|NCT01728324|517052147|FG002|Termination of DBV|Withdrawal by Subject|2|||
143411450|NCT01728324|517052145|FG000|Termination of DBV|Other than stated|1|||
143411451|NCT01728324|517052146|FG001|Termination of DBV|Other than stated|3|||
143411452|NCT01728324|517052147|FG002|Termination of DBV|Other than stated|0|||
143411453|NCT01728324|517052145|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
143411454|NCT01728324|517052146|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
143411455|NCT01728324|517052147|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
143411456|NCT01728324|517052145|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
143411457|NCT01728324|517052146|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
143411458|NCT01728324|517052147|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
143411459|NCT01728324|517052145|FG000|Termination of FDV|Adverse Event|14|||
143411460|NCT01728324|517052146|FG001|Termination of FDV|Adverse Event|13|||
143411461|NCT01728324|517052147|FG002|Termination of FDV|Adverse Event|4|||
143411462|NCT01728324|517052145|FG000|Termination of FDV|Lack of Efficacy|14|||
143411463|NCT01728324|517052146|FG001|Termination of FDV|Lack of Efficacy|12|||
143411464|NCT01728324|517052147|FG002|Termination of FDV|Lack of Efficacy|8|||
143411465|NCT01728324|517052145|FG000|Termination of FDV|Withdrawal by Subject|9|||
143411466|NCT01728324|517052146|FG001|Termination of FDV|Withdrawal by Subject|6|||
143411467|NCT01728324|517052147|FG002|Termination of FDV|Withdrawal by Subject|2|||
143411468|NCT01728324|517052145|FG000|Termination of FDV|Other than stated|1|||
143411469|NCT01728324|517052146|FG001|Termination of FDV|Other than stated|3|||
143411470|NCT01728324|517052147|FG002|Termination of FDV|Other than stated|0|||
143411471|NCT01728324|517052145|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
143411472|NCT01728324|517052146|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
143411473|NCT01728324|517052147|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
143411474|NCT01728324|517052145|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
143411475|NCT01728324|517052146|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
143411476|NCT01728324|517052147|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
143411477|NCT01728324|517052145|FG000|Termination of RBV|Adverse Event|15|||
143411478|NCT01728324|517052146|FG001|Termination of RBV|Adverse Event|16|||
143411479|NCT01728324|517052147|FG002|Termination of RBV|Adverse Event|5|||
143411480|NCT01728324|517052145|FG000|Termination of RBV|Lack of Efficacy|14|||
143411481|NCT01728324|517052146|FG001|Termination of RBV|Lack of Efficacy|11|||
143411482|NCT01728324|517052147|FG002|Termination of RBV|Lack of Efficacy|7|||
143411483|NCT01728324|517052145|FG000|Termination of RBV|Withdrawal by Subject|9|||
143411484|NCT01728324|517052146|FG001|Termination of RBV|Withdrawal by Subject|5|||
143411485|NCT01728324|517052147|FG002|Termination of RBV|Withdrawal by Subject|2|||
143411486|NCT01728324|517052145|FG000|Termination of RBV|Other than stated|1|||
143411487|NCT01728324|517052146|FG001|Termination of RBV|Other than stated|3|||
143411488|NCT01728324|517052147|FG002|Termination of RBV|Other than stated|1|||
143411489|NCT01728324|517052145|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
143411490|NCT01728324|517052146|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
143411491|NCT01728324|517052147|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
143411492|NCT01728324|517052145|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
143411493|NCT01728324|517052146|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
143411494|NCT01728324|517052147|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
143411495|NCT02406092|517052159|FG000|Overall Study|Screen failure|10|||
143411496|NCT02406092|517052160|FG001|Overall Study|Screen failure|7|||
143411497|NCT02406092|517052159|FG000|Overall Study|Death|22|||
143411498|NCT02406092|517052160|FG001|Overall Study|Death|5|||
143411499|NCT02406092|517052159|FG000|Overall Study|Lost to Follow-up|4|||
143411500|NCT02406092|517052160|FG001|Overall Study|Lost to Follow-up|1|||
143411501|NCT02406092|517052159|FG000|Overall Study|Adverse Event|1|||
143411502|NCT02406092|517052160|FG001|Overall Study|Adverse Event|0|||
143411503|NCT02406092|517052159|FG000|Overall Study|Withdrawal by Subject|1|||
143411504|NCT02406092|517052160|FG001|Overall Study|Withdrawal by Subject|0|||
143411505|NCT00600353|517052164|FG000|Overall Study|history of malignancy within 5 years|1|||
143411506|NCT00600353|517052165|FG001|Overall Study|history of malignancy within 5 years|0|||
143411507|NCT00600353|517052164|FG000|Overall Study|History of prepartive regimen|0|||
143411508|NCT00600353|517052165|FG001|Overall Study|History of prepartive regimen|1|||
143411509|NCT04941482|517052166|FG000|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|9|||
143411510|NCT04941482|517052167|FG001|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|3|||
143411511|NCT03745313|517052168|FG000|At 30 Days Follow-up|Death|2|||
143411512|NCT03745313|517052168|FG000|At 6 Months Follow-up|Death|1|||
143411513|NCT03745313|517052168|FG000|At 6 Months Follow-up|Missed Visit|1|||
143411514|NCT03745313|517052168|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
143411515|NCT03745313|517052168|FG000|At 1 Year Follow-up|Death|2|||
143411516|NCT03745313|517052168|FG000|At 1 Year Follow-up|Missed Visit|2|||
143411517|NCT03745313|517052168|FG000|At 2 Year Follow-up|Missed Visit|1|||
143411518|NCT03611075|517052170|FG000|Overall Study|Physician Decision|0|||
143411519|NCT03611075|517052171|FG001|Overall Study|Physician Decision|1|||
143411520|NCT03611075|517052172|FG002|Overall Study|Physician Decision|1|||
143411521|NCT03611075|517052173|FG003|Overall Study|Physician Decision|0|||
143411522|NCT03611075|517052174|FG004|Overall Study|Physician Decision|0|||
143411523|NCT03611075|517052175|FG005|Overall Study|Physician Decision|0|||
143411524|NCT03611075|517052176|FG006|Overall Study|Physician Decision|0|||
143411525|NCT03611075|517052177|FG007|Overall Study|Physician Decision|0|||
143411526|NCT03611075|517052178|FG008|Overall Study|Physician Decision|0|||
143411527|NCT03611075|517052170|FG000|Overall Study|Lost to Follow-up|1|||
143411528|NCT03611075|517052171|FG001|Overall Study|Lost to Follow-up|0|||
143411529|NCT03611075|517052172|FG002|Overall Study|Lost to Follow-up|0|||
143411530|NCT03611075|517052173|FG003|Overall Study|Lost to Follow-up|2|||
143411531|NCT03611075|517052174|FG004|Overall Study|Lost to Follow-up|0|||
143411532|NCT03611075|517052175|FG005|Overall Study|Lost to Follow-up|0|||
143411533|NCT03611075|517052176|FG006|Overall Study|Lost to Follow-up|0|||
143411534|NCT03611075|517052177|FG007|Overall Study|Lost to Follow-up|0|||
143411535|NCT03611075|517052178|FG008|Overall Study|Lost to Follow-up|0|||
143411536|NCT03611075|517052170|FG000|Overall Study|Withdrawal by Subject|0|||
143411537|NCT03611075|517052171|FG001|Overall Study|Withdrawal by Subject|1|||
143411538|NCT03611075|517052172|FG002|Overall Study|Withdrawal by Subject|1|||
143411539|NCT03611075|517052173|FG003|Overall Study|Withdrawal by Subject|1|||
143411540|NCT03611075|517052174|FG004|Overall Study|Withdrawal by Subject|0|||
143411541|NCT03611075|517052175|FG005|Overall Study|Withdrawal by Subject|0|||
143411542|NCT03611075|517052176|FG006|Overall Study|Withdrawal by Subject|1|||
143411543|NCT03611075|517052177|FG007|Overall Study|Withdrawal by Subject|0|||
143411544|NCT03611075|517052178|FG008|Overall Study|Withdrawal by Subject|0|||
143411545|NCT03611075|517052170|FG000|Overall Study|Reason unknown|0|||
143411546|NCT03611075|517052171|FG001|Overall Study|Reason unknown|0|||
143411547|NCT03611075|517052172|FG002|Overall Study|Reason unknown|0|||
143411548|NCT03611075|517052173|FG003|Overall Study|Reason unknown|1|||
143411549|NCT03611075|517052174|FG004|Overall Study|Reason unknown|0|||
143411550|NCT03611075|517052175|FG005|Overall Study|Reason unknown|0|||
143411551|NCT03611075|517052176|FG006|Overall Study|Reason unknown|1|||
143411552|NCT03611075|517052177|FG007|Overall Study|Reason unknown|0|||
143411553|NCT03611075|517052178|FG008|Overall Study|Reason unknown|0|||
143411554|NCT01701401|517052179|FG000|Overall Study|Randomized But Not Treated|3|||
143411555|NCT01701401|517052180|FG001|Overall Study|Randomized But Not Treated|1|||
143411556|NCT01701401|517052181|FG002|Overall Study|Randomized But Not Treated|0|||
143411557|NCT01701401|517052182|FG003|Overall Study|Randomized But Not Treated|1|||
143411558|NCT01701401|517052179|FG000|Overall Study|Lost to Follow-up|5|||
143411559|NCT01701401|517052180|FG001|Overall Study|Lost to Follow-up|5|||
143411560|NCT01701401|517052181|FG002|Overall Study|Lost to Follow-up|1|||
143411561|NCT01701401|517052182|FG003|Overall Study|Lost to Follow-up|3|||
143411562|NCT01701401|517052179|FG000|Overall Study|Withdrew Consent|0|||
143411563|NCT01701401|517052180|FG001|Overall Study|Withdrew Consent|3|||
143411564|NCT01701401|517052181|FG002|Overall Study|Withdrew Consent|1|||
143411565|NCT01701401|517052182|FG003|Overall Study|Withdrew Consent|2|||
143411566|NCT01701401|517052179|FG000|Overall Study|Lack of Efficacy|1|||
143411567|NCT01701401|517052180|FG001|Overall Study|Lack of Efficacy|0|||
143411568|NCT01701401|517052181|FG002|Overall Study|Lack of Efficacy|2|||
143411569|NCT01701401|517052182|FG003|Overall Study|Lack of Efficacy|0|||
143411570|NCT01701401|517052179|FG000|Overall Study|Adverse Event|1|||
143411571|NCT01701401|517052180|FG001|Overall Study|Adverse Event|0|||
143411572|NCT01701401|517052181|FG002|Overall Study|Adverse Event|0|||
143411573|NCT01701401|517052182|FG003|Overall Study|Adverse Event|0|||
143411574|NCT01701401|517052179|FG000|Overall Study|Protocol Violation|0|||
143411575|NCT01701401|517052180|FG001|Overall Study|Protocol Violation|0|||
143411576|NCT01701401|517052181|FG002|Overall Study|Protocol Violation|1|||
143411577|NCT01701401|517052182|FG003|Overall Study|Protocol Violation|0|||
143411578|NCT04827732|517052191|FG000|Overall Study|Did not start treatment|0|||
143411579|NCT04827732|517052192|FG001|Overall Study|Did not start treatment|1|||
143411580|NCT04827732|517052193|FG002|Overall Study|Did not start treatment|0|||
143411581|NCT04827732|517052194|FG003|Overall Study|Did not start treatment|1|||
143411582|NCT01690624|517052196|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
143411583|NCT01690624|517052197|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
143411584|NCT01690624|517052198|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
143411585|NCT01690624|517052199|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
143411586|NCT01690624|517052196|FG000|Overall Study|Adverse event (other than DLT)|3|||
143411587|NCT01690624|517052197|FG001|Overall Study|Adverse event (other than DLT)|1|||
143411588|NCT01690624|517052198|FG002|Overall Study|Adverse event (other than DLT)|1|||
143411589|NCT01690624|517052199|FG003|Overall Study|Adverse event (other than DLT)|1|||
143411590|NCT01690624|517052196|FG000|Overall Study|Withdrawal by Subject|0|||
143411591|NCT01690624|517052197|FG001|Overall Study|Withdrawal by Subject|0|||
143411592|NCT01690624|517052198|FG002|Overall Study|Withdrawal by Subject|1|||
143411593|NCT01690624|517052199|FG003|Overall Study|Withdrawal by Subject|0|||
143411594|NCT01690624|517052196|FG000|Overall Study|Sponsor is ending trial|0|||
143411595|NCT01690624|517052197|FG001|Overall Study|Sponsor is ending trial|0|||
143411596|NCT01690624|517052198|FG002|Overall Study|Sponsor is ending trial|0|||
143411597|NCT01690624|517052199|FG003|Overall Study|Sponsor is ending trial|1|||
143411598|NCT01690624|517052196|FG000|Overall Study|Physician Decision|0|||
143411599|NCT01690624|517052197|FG001|Overall Study|Physician Decision|0|||
143411600|NCT01690624|517052198|FG002|Overall Study|Physician Decision|0|||
143411601|NCT01690624|517052199|FG003|Overall Study|Physician Decision|1|||
143411602|NCT01690624|517052196|FG000|Overall Study|Withdrawal by Subject|0|||
143411603|NCT01690624|517052197|FG001|Overall Study|Withdrawal by Subject|1|||
143411604|NCT01690624|517052198|FG002|Overall Study|Withdrawal by Subject|0|||
143411605|NCT01690624|517052199|FG003|Overall Study|Withdrawal by Subject|0|||
143411606|NCT01690624|517052196|FG000|Overall Study|Lack of Efficacy|1|||
143411607|NCT01690624|517052197|FG001|Overall Study|Lack of Efficacy|1|||
143411608|NCT01690624|517052198|FG002|Overall Study|Lack of Efficacy|3|||
143411609|NCT01690624|517052199|FG003|Overall Study|Lack of Efficacy|0|||
143411610|NCT04912856|517052202|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
143411611|NCT04912856|517052203|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
143411612|NCT04912856|517052202|FG000|Overall Study|Not reported in synoptic CSR.|0|||
143411613|NCT04912856|517052203|FG001|Overall Study|Not reported in synoptic CSR.|1|||
143411614|NCT05293717|517052207|FG000|Overall Study|Physician Decision|1|||
143411615|NCT03147287|517052208|FG000|Overall Study|Randomized Not Treated|2|||
143411616|NCT03147287|517052209|FG001|Overall Study|Randomized Not Treated|1|||
143411617|NCT03147287|517052210|FG002|Overall Study|Randomized Not Treated|1|||
143411618|NCT03147287|517052208|FG000|Overall Study|Progressive Disease RECIST|31|||
143411619|NCT03147287|517052209|FG001|Overall Study|Progressive Disease RECIST|72|||
143411620|NCT03147287|517052210|FG002|Overall Study|Progressive Disease RECIST|32|||
143411621|NCT03147287|517052208|FG000|Overall Study|Progressive Disease not RECIST|13|||
143411622|NCT03147287|517052209|FG001|Overall Study|Progressive Disease not RECIST|21|||
143411623|NCT03147287|517052210|FG002|Overall Study|Progressive Disease not RECIST|13|||
143411624|NCT03147287|517052208|FG000|Overall Study|Physician Decision|1|||
143411625|NCT03147287|517052209|FG001|Overall Study|Physician Decision|2|||
143411626|NCT03147287|517052210|FG002|Overall Study|Physician Decision|1|||
143411627|NCT03147287|517052208|FG000|Overall Study|Intercurrent illness|0|||
143411628|NCT03147287|517052209|FG001|Overall Study|Intercurrent illness|1|||
143411629|NCT03147287|517052210|FG002|Overall Study|Intercurrent illness|0|||
143411630|NCT03147287|517052208|FG000|Overall Study|Withdrawal by Subject|2|||
143411631|NCT03147287|517052209|FG001|Overall Study|Withdrawal by Subject|3|||
143411632|NCT03147287|517052210|FG002|Overall Study|Withdrawal by Subject|2|||
143411633|NCT03147287|517052208|FG000|Overall Study|Patient Non-Compliance|0|||
143411634|NCT03147287|517052209|FG001|Overall Study|Patient Non-Compliance|2|||
143411635|NCT03147287|517052210|FG002|Overall Study|Patient Non-Compliance|0|||
143411636|NCT03147287|517052208|FG000|Overall Study|Patient moved|0|||
143411637|NCT03147287|517052209|FG001|Overall Study|Patient moved|1|||
143411638|NCT03147287|517052210|FG002|Overall Study|Patient moved|0|||
143411639|NCT03147287|517052208|FG000|Overall Study|Arm A crossover without PD|1|||
143411640|NCT03147287|517052209|FG001|Overall Study|Arm A crossover without PD|0|||
143411641|NCT03147287|517052210|FG002|Overall Study|Arm A crossover without PD|0|||
143411642|NCT03147287|517052208|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
143411643|NCT03147287|517052209|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
143411644|NCT03147287|517052210|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
143411645|NCT02328014|517053388|FG000|Overall Study|Adverse Event|1|||
143411646|NCT02328014|517053389|FG001|Overall Study|Adverse Event|0|||
143411647|NCT02328014|517053390|FG002|Overall Study|Adverse Event|0|||
143411648|NCT02328014|517053391|FG003|Overall Study|Adverse Event|1|||
143411649|NCT02328014|517053388|FG000|Overall Study|Death|0|||
143411650|NCT02328014|517053389|FG001|Overall Study|Death|0|||
143411651|NCT02328014|517053390|FG002|Overall Study|Death|0|||
143411652|NCT02328014|517053391|FG003|Overall Study|Death|4|||
143411653|NCT02328014|517053388|FG000|Overall Study|Physician Decision|0|||
143411654|NCT02328014|517053389|FG001|Overall Study|Physician Decision|0|||
143411655|NCT02328014|517053390|FG002|Overall Study|Physician Decision|0|||
143411656|NCT02328014|517053391|FG003|Overall Study|Physician Decision|1|||
143411657|NCT02328014|517053388|FG000|Overall Study|Disease Progression|1|||
143411658|NCT02328014|517053389|FG001|Overall Study|Disease Progression|0|||
143411659|NCT02328014|517053390|FG002|Overall Study|Disease Progression|1|||
143411660|NCT02328014|517053391|FG003|Overall Study|Disease Progression|3|||
143411661|NCT02328014|517053388|FG000|Overall Study|Study Terminated by Sponsor|4|||
143411662|NCT02328014|517053389|FG001|Overall Study|Study Terminated by Sponsor|1|||
143411663|NCT02328014|517053390|FG002|Overall Study|Study Terminated by Sponsor|1|||
143411664|NCT02328014|517053391|FG003|Overall Study|Study Terminated by Sponsor|0|||
143411665|NCT02328014|517053388|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
143411666|NCT02328014|517053389|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
143411667|NCT02328014|517053390|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
143411668|NCT02328014|517053391|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
143411669|NCT02328014|517053388|FG000|Overall Study|Withdrawal by Subject|0|||
143411670|NCT02328014|517053389|FG001|Overall Study|Withdrawal by Subject|0|||
143411671|NCT02328014|517053390|FG002|Overall Study|Withdrawal by Subject|0|||
143411672|NCT02328014|517053391|FG003|Overall Study|Withdrawal by Subject|1|||
143411673|NCT05029284|517053398|FG000|Overall Study|Lost to Follow-up|1|||
143411674|NCT02972034|517053399|FG000|Overall Study|Death|11|||
143411675|NCT02972034|517053400|FG001|Overall Study|Death|1|||
143411676|NCT02972034|517053401|FG002|Overall Study|Death|3|||
143411677|NCT02972034|517053402|FG003|Overall Study|Death|3|||
143411678|NCT02972034|517053403|FG004|Overall Study|Death|2|||
143411679|NCT02972034|517053404|FG005|Overall Study|Death|2|||
143411680|NCT02972034|517053405|FG006|Overall Study|Death|3|||
143411681|NCT02972034|517053406|FG007|Overall Study|Death|4|||
143411682|NCT02972034|517053407|FG008|Overall Study|Death|8|||
143411683|NCT02972034|517053408|FG009|Overall Study|Death|11|||
143411684|NCT02972034|517053409|FG010|Overall Study|Death|3|||
143411685|NCT02972034|517053410|FG011|Overall Study|Death|2|||
143411686|NCT02972034|517053411|FG012|Overall Study|Death|11|||
143411687|NCT02972034|517053412|FG013|Overall Study|Death|10|||
143411688|NCT02972034|517053413|FG014|Overall Study|Death|9|||
143411689|NCT02972034|517053399|FG000|Overall Study|Lost to Follow-up|0|||
143411690|NCT02972034|517053400|FG001|Overall Study|Lost to Follow-up|0|||
143411691|NCT02972034|517053401|FG002|Overall Study|Lost to Follow-up|0|||
143411692|NCT02972034|517053402|FG003|Overall Study|Lost to Follow-up|0|||
143411693|NCT02972034|517053403|FG004|Overall Study|Lost to Follow-up|1|||
143411694|NCT02972034|517053404|FG005|Overall Study|Lost to Follow-up|0|||
143411695|NCT02972034|517053405|FG006|Overall Study|Lost to Follow-up|0|||
143411696|NCT02972034|517053406|FG007|Overall Study|Lost to Follow-up|1|||
143411697|NCT02972034|517053407|FG008|Overall Study|Lost to Follow-up|0|||
143411698|NCT02972034|517053408|FG009|Overall Study|Lost to Follow-up|0|||
143411699|NCT02972034|517053409|FG010|Overall Study|Lost to Follow-up|0|||
143411700|NCT02972034|517053410|FG011|Overall Study|Lost to Follow-up|0|||
143411701|NCT02972034|517053411|FG012|Overall Study|Lost to Follow-up|0|||
143411702|NCT02972034|517053412|FG013|Overall Study|Lost to Follow-up|0|||
143411703|NCT02972034|517053413|FG014|Overall Study|Lost to Follow-up|1|||
143411704|NCT02972034|517053399|FG000|Overall Study|Physician Decision|0|||
143411705|NCT02972034|517053400|FG001|Overall Study|Physician Decision|0|||
143411706|NCT02972034|517053401|FG002|Overall Study|Physician Decision|0|||
143411707|NCT02972034|517053402|FG003|Overall Study|Physician Decision|0|||
143411708|NCT02972034|517053403|FG004|Overall Study|Physician Decision|0|||
143411709|NCT02972034|517053404|FG005|Overall Study|Physician Decision|0|||
143411710|NCT02972034|517053405|FG006|Overall Study|Physician Decision|0|||
143411711|NCT02972034|517053406|FG007|Overall Study|Physician Decision|1|||
143411712|NCT02972034|517053407|FG008|Overall Study|Physician Decision|0|||
143411713|NCT02972034|517053408|FG009|Overall Study|Physician Decision|0|||
143411714|NCT02972034|517053409|FG010|Overall Study|Physician Decision|1|||
143411715|NCT02972034|517053410|FG011|Overall Study|Physician Decision|0|||
143411716|NCT02972034|517053411|FG012|Overall Study|Physician Decision|0|||
143411717|NCT02972034|517053412|FG013|Overall Study|Physician Decision|0|||
143411718|NCT02972034|517053413|FG014|Overall Study|Physician Decision|0|||
143411719|NCT02972034|517053399|FG000|Overall Study|Sponsor Decision|0|||
143411720|NCT02972034|517053400|FG001|Overall Study|Sponsor Decision|0|||
143411721|NCT02972034|517053401|FG002|Overall Study|Sponsor Decision|0|||
143411722|NCT02972034|517053402|FG003|Overall Study|Sponsor Decision|1|||
143411723|NCT02972034|517053403|FG004|Overall Study|Sponsor Decision|0|||
143411724|NCT02972034|517053404|FG005|Overall Study|Sponsor Decision|0|||
143411725|NCT02972034|517053405|FG006|Overall Study|Sponsor Decision|1|||
143411726|NCT02972034|517053406|FG007|Overall Study|Sponsor Decision|1|||
143411727|NCT02972034|517053407|FG008|Overall Study|Sponsor Decision|1|||
143411728|NCT02972034|517053408|FG009|Overall Study|Sponsor Decision|2|||
143411729|NCT02972034|517053409|FG010|Overall Study|Sponsor Decision|2|||
143411730|NCT02972034|517053410|FG011|Overall Study|Sponsor Decision|0|||
143411731|NCT02972034|517053411|FG012|Overall Study|Sponsor Decision|1|||
143411732|NCT02972034|517053412|FG013|Overall Study|Sponsor Decision|0|||
143411733|NCT02972034|517053413|FG014|Overall Study|Sponsor Decision|1|||
143411734|NCT02972034|517053399|FG000|Overall Study|Withdrawal by Subject|3|||
143411735|NCT02972034|517053400|FG001|Overall Study|Withdrawal by Subject|0|||
143411736|NCT02972034|517053401|FG002|Overall Study|Withdrawal by Subject|0|||
143411737|NCT02972034|517053402|FG003|Overall Study|Withdrawal by Subject|0|||
143411738|NCT02972034|517053403|FG004|Overall Study|Withdrawal by Subject|1|||
143411739|NCT02972034|517053404|FG005|Overall Study|Withdrawal by Subject|1|||
143411740|NCT02972034|517053405|FG006|Overall Study|Withdrawal by Subject|0|||
143411741|NCT02972034|517053406|FG007|Overall Study|Withdrawal by Subject|0|||
143411742|NCT02972034|517053407|FG008|Overall Study|Withdrawal by Subject|1|||
143411743|NCT02972034|517053408|FG009|Overall Study|Withdrawal by Subject|1|||
143411744|NCT02972034|517053409|FG010|Overall Study|Withdrawal by Subject|2|||
143411745|NCT02972034|517053410|FG011|Overall Study|Withdrawal by Subject|1|||
143411746|NCT02972034|517053411|FG012|Overall Study|Withdrawal by Subject|1|||
143411747|NCT02972034|517053412|FG013|Overall Study|Withdrawal by Subject|1|||
143411748|NCT02972034|517053413|FG014|Overall Study|Withdrawal by Subject|0|||
143411749|NCT02972034|517053399|FG000|Overall Study|Screen Failure|0|||
143411750|NCT02972034|517053400|FG001|Overall Study|Screen Failure|0|||
143411751|NCT02972034|517053401|FG002|Overall Study|Screen Failure|0|||
143411752|NCT02972034|517053402|FG003|Overall Study|Screen Failure|0|||
143411753|NCT02972034|517053403|FG004|Overall Study|Screen Failure|0|||
143411754|NCT02972034|517053404|FG005|Overall Study|Screen Failure|0|||
143411755|NCT02972034|517053405|FG006|Overall Study|Screen Failure|0|||
143411756|NCT02972034|517053406|FG007|Overall Study|Screen Failure|0|||
143411757|NCT02972034|517053407|FG008|Overall Study|Screen Failure|0|||
143411758|NCT02972034|517053408|FG009|Overall Study|Screen Failure|0|||
143411759|NCT02972034|517053409|FG010|Overall Study|Screen Failure|0|||
143411760|NCT02972034|517053410|FG011|Overall Study|Screen Failure|0|||
143411761|NCT02972034|517053411|FG012|Overall Study|Screen Failure|1|||
143411762|NCT02972034|517053412|FG013|Overall Study|Screen Failure|0|||
143411763|NCT02972034|517053413|FG014|Overall Study|Screen Failure|0|||
143411764|NCT03009344|517053414|FG000|Overall Study|Lack of Efficacy|5|||
143411765|NCT03009344|517053414|FG000|Overall Study|Withdrawal by Subject|1|||
143411766|NCT03009344|517053414|FG000|Overall Study|Adverse Event|1|||
143411767|NCT00378898|517053415|FG000|Overall Study|Withdrawal by Subject|10|||
143411768|NCT00378898|517053416|FG001|Overall Study|Withdrawal by Subject|5|||
143411769|NCT00378898|517053415|FG000|Overall Study|Protocol Violation|1|||
143411770|NCT00378898|517053416|FG001|Overall Study|Protocol Violation|1|||
143411771|NCT02534233|517053419|FG000|Overall Study|2 participants with protocol deviations didn't complete|2|||
143411772|NCT02278796|517053426|FG000|Overall Study|Death|2|||
143411773|NCT02278796|517053427|FG001|Overall Study|Death|3|||
143411774|NCT03214081|517053428|FG000|Overall Study|Case Report Forms Uncollected|9|||
143411775|NCT03214081|517053428|FG000|Overall Study|Protocol Deviation|54|||
143411776|NCT02962284|517053429|FG000|Overall Study|Death|2|||
143411777|NCT02962284|517053430|FG001|Overall Study|Death|0|||
143411778|NCT02962284|517053429|FG000|Overall Study|Progressive disease|2|||
143411779|NCT02962284|517053430|FG001|Overall Study|Progressive disease|3|||
143411780|NCT02962284|517053429|FG000|Overall Study|Withdrawal by Subject|1|||
143411781|NCT02962284|517053430|FG001|Overall Study|Withdrawal by Subject|0|||
143411782|NCT02372799|517053433|FG000|Treatment Period|Adverse Event|3|||
143411783|NCT02372799|517053434|FG001|Treatment Period|Adverse Event|10|||
143411784|NCT02372799|517053435|FG002|Treatment Period|Adverse Event|6|||
143411785|NCT02372799|517053433|FG000|Treatment Period|Insufficient therapeutic response|2|||
143411786|NCT02372799|517053434|FG001|Treatment Period|Insufficient therapeutic response|2|||
143411787|NCT02372799|517053435|FG002|Treatment Period|Insufficient therapeutic response|0|||
143411788|NCT02372799|517053433|FG000|Treatment Period|Withdrawal by Subject|10|||
143411789|NCT02372799|517053434|FG001|Treatment Period|Withdrawal by Subject|10|||
143411790|NCT02372799|517053435|FG002|Treatment Period|Withdrawal by Subject|2|||
143411791|NCT02372799|517053433|FG000|Treatment Period|Lost to Follow-up|11|||
143411792|NCT02372799|517053434|FG001|Treatment Period|Lost to Follow-up|5|||
143411793|NCT02372799|517053435|FG002|Treatment Period|Lost to Follow-up|3|||
143411794|NCT02372799|517053433|FG000|Treatment Period|Protocol Violation|3|||
143411795|NCT02372799|517053434|FG001|Treatment Period|Protocol Violation|0|||
143411796|NCT02372799|517053435|FG002|Treatment Period|Protocol Violation|0|||
143411797|NCT02372799|517053433|FG000|Treatment Period|Non-compliance with study drug|4|||
143411798|NCT02372799|517053434|FG001|Treatment Period|Non-compliance with study drug|4|||
143411799|NCT02372799|517053435|FG002|Treatment Period|Non-compliance with study drug|4|||
143411800|NCT02372799|517053433|FG000|Treatment Period|Miscellaneous Reasons|1|||
143411801|NCT02372799|517053434|FG001|Treatment Period|Miscellaneous Reasons|1|||
143411802|NCT02372799|517053435|FG002|Treatment Period|Miscellaneous Reasons|0|||
143411803|NCT02372799|517053433|FG000|Down-taper Period|Lost to Follow-up|1|||
143411804|NCT02372799|517053434|FG001|Down-taper Period|Lost to Follow-up|2|||
143411805|NCT02372799|517053435|FG002|Down-taper Period|Lost to Follow-up|2|||
143411806|NCT00089609|517053436|FG000|Overall Study|Withdrawal by Subject|3|||
143411807|NCT00089609|517053437|FG001|Overall Study|Withdrawal by Subject|1|||
143411808|NCT05815342|517053439|FG000|Baseline, Standard Therapy (2 Weeks)|Ineligible|4|||
143411809|NCT05815342|517053439|FG000|Baseline, Standard Therapy (2 Weeks)|Withdrawal by Subject|9|||
143411810|NCT05815342|517053439|FG000|Baseline, Standard Therapy (2 Weeks)|Lost to Follow-up|2|||
143411811|NCT05815342|517053439|FG000|Treatment Phase (13 Weeks)|Withdrawal by Subject|14|||
143411812|NCT05815342|517053439|FG000|Treatment Phase (13 Weeks)|Lost to Follow-up|2|||
143411813|NCT03732807|517053443|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
143411814|NCT03732807|517053444|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
143411815|NCT03732807|517053445|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
143411816|NCT03732807|517053446|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
143411817|NCT03732807|517053447|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
143411818|NCT03732807|517053448|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
143411819|NCT03732807|517053449|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
143411820|NCT03732807|517053443|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
143411821|NCT03732807|517053444|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
143411822|NCT03732807|517053445|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
143411823|NCT03732807|517053446|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
143411824|NCT03732807|517053447|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
143411825|NCT03732807|517053448|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
143411826|NCT03732807|517053449|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
143411827|NCT03732807|517053443|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
143411828|NCT03732807|517053444|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
143411829|NCT03732807|517053445|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
143411830|NCT03732807|517053446|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
143411831|NCT03732807|517053447|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
143411832|NCT03732807|517053448|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
143411833|NCT03732807|517053449|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
143411834|NCT03732807|517053443|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
143411835|NCT03732807|517053444|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
143411836|NCT03732807|517053445|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
143411837|NCT03732807|517053446|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
143411838|NCT03732807|517053447|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
143411839|NCT03732807|517053448|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
143411840|NCT03732807|517053449|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
143411841|NCT03732807|517053443|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
143411842|NCT03732807|517053444|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
143411843|NCT03732807|517053445|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
143411844|NCT03732807|517053446|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
143411845|NCT03732807|517053447|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
143411846|NCT03732807|517053448|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
143411847|NCT03732807|517053449|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
143411848|NCT03732807|517053443|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
143411849|NCT03732807|517053444|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
143411850|NCT03732807|517053445|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
143411851|NCT03732807|517053446|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
143411852|NCT03732807|517053447|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
143411853|NCT03732807|517053448|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
143411854|NCT03732807|517053449|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
143411855|NCT03732807|517053443|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
143411856|NCT03732807|517053444|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
143411857|NCT03732807|517053445|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
143411858|NCT03732807|517053446|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
143411859|NCT03732807|517053447|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
143411860|NCT03732807|517053448|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
143411861|NCT03732807|517053449|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
143411862|NCT03732807|517053443|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
143411863|NCT03732807|517053444|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
143411864|NCT03732807|517053445|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
143411865|NCT03732807|517053446|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
143411866|NCT03732807|517053447|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
143411867|NCT03732807|517053448|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
143411868|NCT03732807|517053449|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
143411869|NCT03732807|517053443|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
143411870|NCT03732807|517053444|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
143411871|NCT03732807|517053445|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
143411872|NCT03732807|517053446|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
143411873|NCT03732807|517053447|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
143411874|NCT03732807|517053448|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
143411875|NCT03732807|517053449|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
143411876|NCT03732807|517053443|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
143411877|NCT03732807|517053444|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
143411878|NCT03732807|517053445|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
143411879|NCT03732807|517053446|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
143411880|NCT03732807|517053447|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
143411881|NCT03732807|517053448|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
143411882|NCT03732807|517053449|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
143411883|NCT03732807|517053443|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
143411884|NCT03732807|517053444|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
143411885|NCT03732807|517053445|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
143411886|NCT03732807|517053446|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
143411887|NCT03732807|517053447|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
143411888|NCT03732807|517053448|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
143411889|NCT03732807|517053449|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
143411890|NCT03732807|517053443|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
143411891|NCT03732807|517053444|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
143411892|NCT03732807|517053445|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
143411893|NCT03732807|517053446|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
143411894|NCT03732807|517053447|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
143411895|NCT03732807|517053448|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
143411896|NCT03732807|517053449|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
143411897|NCT03732807|517053443|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
143411898|NCT03732807|517053444|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
143411899|NCT03732807|517053445|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
143411900|NCT03732807|517053446|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
143411901|NCT03732807|517053447|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
143411902|NCT03732807|517053448|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
143411903|NCT03732807|517053449|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
143411904|NCT03732807|517053443|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
143411905|NCT03732807|517053444|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
143411906|NCT03732807|517053445|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
143411907|NCT03732807|517053446|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
143411908|NCT03732807|517053447|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
143411909|NCT03732807|517053448|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
143411910|NCT03732807|517053449|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
143411911|NCT00019604|517053450|FG000|Overall Study|Death|1|||
143411912|NCT00019604|517053450|FG000|Overall Study|Progressive disease|23|||
143411913|NCT00019604|517053450|FG000|Overall Study|Refused treatment|1|||
143411914|NCT00019604|517053450|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
143411915|NCT00019604|517053450|FG000|Overall Study|Going to have liver transplant|1|||
143411916|NCT00019604|517053450|FG000|Overall Study|Move to a different study|1|||
143411917|NCT00019604|517053450|FG000|Overall Study|Non compliant on systemic CH|1|||
143411918|NCT00019604|517053450|FG000|Overall Study|Non compliant|1|||
143411919|NCT00019604|517053450|FG000|Overall Study|Resectable disease|1|||
143411920|NCT00019604|517053450|FG000|Overall Study|Started new chemo regimen|1|||
143411921|NCT00019604|517053450|FG000|Overall Study|Pt going to immunotherapy study|1|||
143411922|NCT00019604|517053450|FG000|Overall Study|Too much disease|1|||
143411923|NCT00019604|517053450|FG000|Overall Study|Unable to evaluate|1|||
143411924|NCT00019604|517053450|FG000|Overall Study|Details for other not available|4|||
143411925|NCT00454194|517053466|FG000|Overall Study|Adverse Event|7|||
143411926|NCT00454194|517053467|FG001|Overall Study|Adverse Event|2|||
143411927|NCT00454194|517053466|FG000|Overall Study|Withdrawal by Subject|12|||
143411928|NCT00454194|517053467|FG001|Overall Study|Withdrawal by Subject|8|||
143411929|NCT00454194|517053466|FG000|Overall Study|Other Medical Problems|1|||
143411930|NCT00454194|517053467|FG001|Overall Study|Other Medical Problems|2|||
143411931|NCT00454194|517053466|FG000|Overall Study|Other Unspecified Reason|2|||
143411932|NCT00454194|517053467|FG001|Overall Study|Other Unspecified Reason|2|||
143411933|NCT01170208|517053470|FG000|Overall Study|Withdrawal by Subject|5|||
143411934|NCT01170208|517053471|FG001|Overall Study|Withdrawal by Subject|0|||
143411935|NCT01170208|517053472|FG002|Overall Study|Withdrawal by Subject|1|||
143411936|NCT01170208|517053470|FG000|Overall Study|Protocol Violation|1|||
143411937|NCT01170208|517053471|FG001|Overall Study|Protocol Violation|0|||
143411938|NCT01170208|517053472|FG002|Overall Study|Protocol Violation|1|||
143411939|NCT01160354|517053475|FG000|Overall Study|Death|0|||
143411940|NCT01160354|517053476|FG001|Overall Study|Death|1|||
143411941|NCT01160354|517053477|FG002|Overall Study|Death|1|||
143411942|NCT02743819|517053479|FG000|Overall Study|Lack of Efficacy|5|||
143411943|NCT02743819|517053479|FG000|Overall Study|Death|2|||
143411944|NCT02743819|517053479|FG000|Overall Study|Adverse Event|1|||
143411945|NCT03389802|517053480|FG000|Overall Study|Lack of Efficacy|3|||
143411946|NCT03389802|517053481|FG001|Overall Study|Lack of Efficacy|3|||
143411947|NCT03389802|517053482|FG002|Overall Study|Lack of Efficacy|13|||
143411948|NCT03389802|517053483|FG003|Overall Study|Lack of Efficacy|6|||
143411949|NCT03389802|517053484|FG004|Overall Study|Lack of Efficacy|1|||
143411950|NCT03389802|517053480|FG000|Overall Study|Adverse Event|0|||
143411951|NCT03389802|517053481|FG001|Overall Study|Adverse Event|0|||
143411952|NCT03389802|517053482|FG002|Overall Study|Adverse Event|1|||
143411953|NCT03389802|517053483|FG003|Overall Study|Adverse Event|0|||
143411954|NCT03389802|517053484|FG004|Overall Study|Adverse Event|4|||
143411955|NCT03389802|517053480|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
143411956|NCT03389802|517053481|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
143411957|NCT03389802|517053482|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
143411958|NCT03389802|517053483|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
143411959|NCT03389802|517053484|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
143411960|NCT01706159|517053489|FG000|Overall Study|Withdrawal Criteria|2|||
143411961|NCT01706159|517053490|FG001|Overall Study|Withdrawal Criteria|1|||
143411962|NCT01706159|517053489|FG000|Overall Study|Unclassified|6|||
143411963|NCT01706159|517053490|FG001|Overall Study|Unclassified|1|||
143411964|NCT00553332|517053492|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
143411965|NCT02454959|517053494|FG000|Overall Study|Protocol-Specified Criteria|3|||
143411966|NCT02454959|517053494|FG000|Overall Study|Physician Decision|1|||
143411967|NCT02454959|517053494|FG000|Overall Study|Withdrawal by Subject|3|||
143411968|NCT02454959|517053494|FG000|Overall Study|Adverse Event|2|||
143411969|NCT05366751|517053498|FG000|Overall Study|Adverse Event|25|||
143411970|NCT05366751|517053498|FG000|Overall Study|Physician Decision|3|||
143411971|NCT05366751|517053498|FG000|Overall Study|Lost to Follow-up|2|||
143411972|NCT05366751|517053498|FG000|Overall Study|Withdrawal by Subject|14|||
143411973|NCT05366751|517053498|FG000|Overall Study|Study Terminated by Sponsor|50|||
143411974|NCT05366751|517053498|FG000|Overall Study|Site Terminated by Sponsor|3|||
143411975|NCT00491894|517053504|FG000|Overall Study|Adverse Event|14|||
143411976|NCT00491894|517053504|FG000|Overall Study|Withdrawal by Subject|5|||
143411977|NCT00491894|517053504|FG000|Overall Study|Death|3|||
143411978|NCT00491894|517053504|FG000|Overall Study|Lost to Follow-up|3|||
143411979|NCT00491894|517053504|FG000|Overall Study|Lack of Efficacy|2|||
143411980|NCT00491894|517053504|FG000|Overall Study|Other-Failed to meet any criteria|2|||
143411981|NCT00491894|517053504|FG000|Overall Study|Physician Decision|2|||
143411982|NCT00491894|517053504|FG000|Overall Study|Protocol Violation|2|||
143411983|NCT00491894|517053504|FG000|Overall Study|Other-Intake of prohibited medication|1|||
143411984|NCT01563185|517053505|FG000|Overall Study|Withdrawal by Subject|1|||
143411985|NCT01563185|517053505|FG000|Overall Study|Non-Compliance with study drug|1|||
143411986|NCT00925548|517054950|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
143411987|NCT00925548|517054951|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
143411988|NCT03116464|517054952|FG000|Overall Study|Insufficient enrollment for intervention development|4|||
143411989|NCT00747006|517054953|FG000|Overall Study|Adverse Event|1|||
143411990|NCT00747006|517054954|FG001|Overall Study|Adverse Event|0|||
143411991|NCT00747006|517054955|FG002|Overall Study|Adverse Event|0|||
143411992|NCT00747006|517054953|FG000|Overall Study|Lost to Follow-up|0|||
143411993|NCT00747006|517054954|FG001|Overall Study|Lost to Follow-up|1|||
143411994|NCT00747006|517054955|FG002|Overall Study|Lost to Follow-up|0|||
143411995|NCT00747006|517054953|FG000|Overall Study|Physician Decision|2|||
143411996|NCT00747006|517054954|FG001|Overall Study|Physician Decision|0|||
143411997|NCT00747006|517054955|FG002|Overall Study|Physician Decision|1|||
143411998|NCT00357994|517054956|FG000|Overall Study|Adverse Event|1|||
143411999|NCT00357994|517054957|FG001|Overall Study|Adverse Event|2|||
143412000|NCT00357994|517054956|FG000|Overall Study|Lack of Efficacy|0|||
143412001|NCT00357994|517054957|FG001|Overall Study|Lack of Efficacy|1|||
143412002|NCT00357994|517054956|FG000|Overall Study|Protocol Violation|1|||
143412003|NCT00357994|517054957|FG001|Overall Study|Protocol Violation|0|||
143412004|NCT00345046|517054962|FG000|Overall Study|Protocol Violation|1|||
143412005|NCT00345046|517054963|FG001|Overall Study|Protocol Violation|1|||
143412006|NCT00345046|517054964|FG002|Overall Study|Protocol Violation|2|||
143412007|NCT04652869|517054969|FG000|Overall Study|Withdrawal by Subject|0|||
143412008|NCT04652869|517054970|FG001|Overall Study|Withdrawal by Subject|2|||
143412009|NCT04652869|517054971|FG002|Overall Study|Withdrawal by Subject|0|||
143412010|NCT01372085|517054972|FG000|Washout Period 2|Physician Decision|0|||
143412011|NCT01372085|517054973|FG001|Washout Period 2|Physician Decision|0|||
143412012|NCT01372085|517054974|FG002|Washout Period 2|Physician Decision|0|||
143412013|NCT01372085|517054975|FG003|Washout Period 2|Physician Decision|0|||
143412014|NCT01372085|517054976|FG004|Washout Period 2|Physician Decision|1|||
143412015|NCT01372085|517054977|FG005|Washout Period 2|Physician Decision|0|||
143412016|NCT01372085|517054978|FG006|Washout Period 2|Physician Decision|0|||
143412017|NCT01372085|517054979|FG007|Washout Period 2|Physician Decision|0|||
143412018|NCT01372085|517054980|FG008|Washout Period 2|Physician Decision|0|||
143412019|NCT01372085|517054981|FG009|Washout Period 2|Physician Decision|0|||
143412020|NCT01372085|517054972|FG000|Washout Period 3|Withdrawal by Subject|0|||
143412021|NCT01372085|517054973|FG001|Washout Period 3|Withdrawal by Subject|0|||
143412022|NCT01372085|517054974|FG002|Washout Period 3|Withdrawal by Subject|0|||
143412023|NCT01372085|517054975|FG003|Washout Period 3|Withdrawal by Subject|0|||
143412024|NCT01372085|517054976|FG004|Washout Period 3|Withdrawal by Subject|0|||
143412025|NCT01372085|517054977|FG005|Washout Period 3|Withdrawal by Subject|2|||
143412026|NCT01372085|517054978|FG006|Washout Period 3|Withdrawal by Subject|0|||
143412027|NCT01372085|517054979|FG007|Washout Period 3|Withdrawal by Subject|0|||
143412028|NCT01372085|517054980|FG008|Washout Period 3|Withdrawal by Subject|0|||
143412029|NCT01372085|517054981|FG009|Washout Period 3|Withdrawal by Subject|0|||
143412030|NCT00562094|517054982|FG000|Overall Study|Lost to Follow-up|62|||
143412031|NCT03689946|517054985|FG000|Overall Study|Withdrawal by Subject|3|||
143412032|NCT03689946|517054985|FG000|Overall Study|Lost to Follow-up|3|||
143412033|NCT03689946|517054985|FG000|Overall Study|Data corruption|2|||
143412034|NCT01555138|517054986|FG000|Overall Study|Death|0|||
143412035|NCT01555138|517054987|FG001|Overall Study|Death|1|||
143412036|NCT01555138|517054986|FG000|Overall Study|Lost to Follow-up|1|||
143412037|NCT01555138|517054987|FG001|Overall Study|Lost to Follow-up|0|||
143412038|NCT01555138|517054986|FG000|Overall Study|Abnormal Lab reults|1|||
143412039|NCT01555138|517054987|FG001|Overall Study|Abnormal Lab reults|3|||
143412040|NCT01555138|517054986|FG000|Overall Study|Lack of Efficacy|2|||
143412041|NCT01555138|517054987|FG001|Overall Study|Lack of Efficacy|2|||
143412042|NCT01555138|517054986|FG000|Overall Study|Protocol Violation|5|||
143412043|NCT01555138|517054987|FG001|Overall Study|Protocol Violation|3|||
143412044|NCT01555138|517054986|FG000|Overall Study|Administrative problems|8|||
143412045|NCT01555138|517054987|FG001|Overall Study|Administrative problems|0|||
143412046|NCT01555138|517054986|FG000|Overall Study|Withdrawal by Subject|16|||
143412047|NCT01555138|517054987|FG001|Overall Study|Withdrawal by Subject|15|||
143412048|NCT01555138|517054986|FG000|Overall Study|Adverse Event|14|||
143412049|NCT01555138|517054987|FG001|Overall Study|Adverse Event|14|||
143412050|NCT01613417|517054988|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
143412051|NCT01613417|517054989|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
143412052|NCT02000752|517054990|FG000|Overall Study|Dystocic delivery|19|||
143412053|NCT02000752|517054991|FG001|Overall Study|Dystocic delivery|8|||
143412054|NCT02000752|517054990|FG000|Overall Study|Shift Changes|12|||
143412055|NCT02000752|517054991|FG001|Overall Study|Shift Changes|5|||
143412056|NCT01079806|517054994|FG000|Day 1 to Week 96|Adverse Event|0|||
143412057|NCT01079806|517054995|FG001|Day 1 to Week 96|Adverse Event|3|||
143412058|NCT01079806|517054994|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
143412059|NCT01079806|517054995|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
143412060|NCT01079806|517054994|FG000|Day 1 to Week 96|Pregnancy|0|||
143412061|NCT01079806|517054995|FG001|Day 1 to Week 96|Pregnancy|1|||
143412062|NCT01079806|517054994|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
143412063|NCT01079806|517054995|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
143412064|NCT01079806|517054994|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
143412065|NCT01079806|517054995|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
143412066|NCT01079806|517054994|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
143412067|NCT01079806|517054995|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
143412068|NCT01079806|517054994|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
143412069|NCT01079806|517054995|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
143412070|NCT01079806|517054994|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
143412071|NCT01079806|517054995|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
143412072|NCT01079806|517054994|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
143412073|NCT01079806|517054995|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
143412074|NCT01079806|517054994|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
143412075|NCT01079806|517054995|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
143412076|NCT01009645|517054998|FG000|Overall Study|Lost to Follow-up|2|||
143412077|NCT01009645|517054999|FG001|Overall Study|Lost to Follow-up|8|||
143412078|NCT01009645|517055000|FG002|Overall Study|Lost to Follow-up|4|||
143412079|NCT01009645|517055001|FG003|Overall Study|Lost to Follow-up|5|||
143412080|NCT03345979|517055002|FG000|Overall Study|Withdrawal by Subject|20|||
143412081|NCT03345979|517055003|FG001|Overall Study|Withdrawal by Subject|31|||
143412082|NCT03345979|517055002|FG000|Overall Study|Adverse Event|10|||
143412083|NCT03345979|517055003|FG001|Overall Study|Adverse Event|11|||
143412084|NCT03345979|517055002|FG000|Overall Study|Lost to Follow-up|8|||
143412085|NCT03345979|517055003|FG001|Overall Study|Lost to Follow-up|9|||
143412086|NCT03345979|517055002|FG000|Overall Study|Lack of Efficacy|4|||
143412087|NCT03345979|517055003|FG001|Overall Study|Lack of Efficacy|2|||
143412088|NCT03345979|517055002|FG000|Overall Study|Protocol Violation|1|||
143412089|NCT03345979|517055003|FG001|Overall Study|Protocol Violation|3|||
143412090|NCT03345979|517055002|FG000|Overall Study|Physician Decision|0|||
143412091|NCT03345979|517055003|FG001|Overall Study|Physician Decision|2|||
143412092|NCT00999596|517055004|FG000|Overall Study|Statistical population not required|101|||
143412093|NCT02085941|517055006|FG000|Overall Study|Lack of Efficacy|1|||
143412094|NCT02085941|517055007|FG001|Overall Study|Lack of Efficacy|0|||
143412095|NCT02085941|517055006|FG000|Overall Study|Death|6|||
143412096|NCT02085941|517055007|FG001|Overall Study|Death|1|||
143412097|NCT02085941|517055006|FG000|Overall Study|Lost to Follow-up|1|||
143412098|NCT02085941|517055007|FG001|Overall Study|Lost to Follow-up|0|||
143412099|NCT02085941|517055006|FG000|Overall Study|Physician Decision|0|||
143412100|NCT02085941|517055007|FG001|Overall Study|Physician Decision|2|||
143412101|NCT02788981|517055013|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
143412102|NCT02788981|517055014|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
143412103|NCT00249769|517055015|FG000|Overall Study|Withdrawal by Subject|1|||
143412104|NCT00249769|517055016|FG001|Overall Study|Withdrawal by Subject|10|||
143412105|NCT00249769|517055017|FG002|Overall Study|Withdrawal by Subject|6|||
143412106|NCT00249769|517055015|FG000|Overall Study|Migration from Study Area|1|||
143412107|NCT00249769|517055016|FG001|Overall Study|Migration from Study Area|3|||
143412108|NCT00249769|517055017|FG002|Overall Study|Migration from Study Area|14|||
143412109|NCT00249769|517055015|FG000|Overall Study|Miscellaneous|0|||
143412110|NCT00249769|517055016|FG001|Overall Study|Miscellaneous|2|||
143412111|NCT00249769|517055017|FG002|Overall Study|Miscellaneous|2|||
143412112|NCT00249769|517055015|FG000|Overall Study|Adverse Event|0|||
143412113|NCT00249769|517055016|FG001|Overall Study|Adverse Event|0|||
143412114|NCT00249769|517055017|FG002|Overall Study|Adverse Event|1|||
143412115|NCT00249769|517055015|FG000|Overall Study|Physician Decision|0|||
143412116|NCT00249769|517055016|FG001|Overall Study|Physician Decision|0|||
143412117|NCT00249769|517055017|FG002|Overall Study|Physician Decision|2|||
143412118|NCT00249769|517055015|FG000|Overall Study|Lost to Follow-up|0|||
143412119|NCT00249769|517055016|FG001|Overall Study|Lost to Follow-up|0|||
143412120|NCT00249769|517055017|FG002|Overall Study|Lost to Follow-up|3|||
143412121|NCT02022657|517055018|FG000|Overall Study|Withdrawal by Subject|2|||
143412122|NCT02022657|517055019|FG001|Overall Study|Withdrawal by Subject|0|||
143412123|NCT02022657|517055020|FG002|Overall Study|Withdrawal by Subject|1|||
143412124|NCT02022657|517055021|FG003|Overall Study|Withdrawal by Subject|0|||
143412125|NCT02022657|517055022|FG004|Overall Study|Withdrawal by Subject|0|||
143412126|NCT02022657|517055023|FG005|Overall Study|Withdrawal by Subject|0|||
143412127|NCT02022657|517055018|FG000|Overall Study|Physician Decision|0|||
143412128|NCT02022657|517055019|FG001|Overall Study|Physician Decision|0|||
143412129|NCT02022657|517055020|FG002|Overall Study|Physician Decision|0|||
143412130|NCT02022657|517055021|FG003|Overall Study|Physician Decision|0|||
143412131|NCT02022657|517055022|FG004|Overall Study|Physician Decision|0|||
143412132|NCT02022657|517055023|FG005|Overall Study|Physician Decision|1|||
143412133|NCT03274076|517055024|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
143412134|NCT03274076|517055025|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
143412135|NCT03274076|517055026|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
143412136|NCT03274076|517055027|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
143412137|NCT03274076|517055024|FG000|24 Weeks Open Label|Adverse Event|0|||
143412138|NCT03274076|517055025|FG001|24 Weeks Open Label|Adverse Event|0|||
143412139|NCT03274076|517055026|FG002|24 Weeks Open Label|Adverse Event|2|||
143412140|NCT03274076|517055027|FG003|24 Weeks Open Label|Adverse Event|0|||
143412141|NCT03274076|517055024|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
143412142|NCT03274076|517055025|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
143412143|NCT03274076|517055026|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
143412144|NCT03274076|517055027|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
143412145|NCT00586313|517055028|FG000|Overall Study|Lack of Efficacy|2|||
143412146|NCT03205566|517055031|FG000|Phase 1|Protocol Violation|1|||
143412147|NCT03205566|517055032|FG001|Phase 1|Protocol Violation|1|||
143412148|NCT03184987|517055033|FG000|Overall Study|Withdrawal by Subject|0|||
143412149|NCT03184987|517055034|FG001|Overall Study|Withdrawal by Subject|1|||
143412150|NCT03184987|517055035|FG002|Overall Study|Withdrawal by Subject|2|||
143412151|NCT03184987|517055033|FG000|Overall Study|Physician Decision|0|||
143412152|NCT03184987|517055034|FG001|Overall Study|Physician Decision|0|||
143412153|NCT03184987|517055035|FG002|Overall Study|Physician Decision|1|||
143412154|NCT03184987|517055033|FG000|Overall Study|Adverse Event|1|||
143412155|NCT03184987|517055034|FG001|Overall Study|Adverse Event|0|||
143412156|NCT03184987|517055035|FG002|Overall Study|Adverse Event|1|||
143412157|NCT03739866|517055036|FG000|Overall Study|Lost to Follow-up|0|||
143412158|NCT03739866|517055037|FG001|Overall Study|Lost to Follow-up|0|||
143412159|NCT03739866|517055038|FG002|Overall Study|Lost to Follow-up|0|||
143412160|NCT03739866|517055039|FG003|Overall Study|Lost to Follow-up|1|||
143412161|NCT03739866|517055040|FG004|Overall Study|Lost to Follow-up|0|||
143412162|NCT03739866|517055041|FG005|Overall Study|Lost to Follow-up|0|||
143412163|NCT03739866|517055042|FG006|Overall Study|Lost to Follow-up|0|||
143412164|NCT03739866|517055043|FG007|Overall Study|Lost to Follow-up|0|||
143412165|NCT03739866|517055036|FG000|Overall Study|Enrolled but not treated|0|||
143412166|NCT03739866|517055037|FG001|Overall Study|Enrolled but not treated|0|||
143412167|NCT03739866|517055038|FG002|Overall Study|Enrolled but not treated|1|||
143412168|NCT03739866|517055039|FG003|Overall Study|Enrolled but not treated|0|||
143412169|NCT03739866|517055040|FG004|Overall Study|Enrolled but not treated|1|||
143412170|NCT03739866|517055041|FG005|Overall Study|Enrolled but not treated|0|||
143412171|NCT03739866|517055042|FG006|Overall Study|Enrolled but not treated|0|||
143412172|NCT03739866|517055043|FG007|Overall Study|Enrolled but not treated|0|||
143412173|NCT01619059|517055044|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
143412174|NCT01619059|517055045|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
143412175|NCT01619059|517055044|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
143412176|NCT01619059|517055045|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
143412177|NCT01619059|517055044|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
143412178|NCT01619059|517055045|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
143412179|NCT01619059|517055044|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
143412180|NCT01619059|517055045|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
143412181|NCT01619059|517055044|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
143412182|NCT01619059|517055045|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
143412183|NCT01619059|517055044|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
143412184|NCT01619059|517055045|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
143412185|NCT01619059|517055044|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
143412186|NCT01619059|517055045|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
143412187|NCT01619059|517055044|FG000|Long-Term (LT) Treatment Period|Death|1|||
143412188|NCT01619059|517055045|FG001|Long-Term (LT) Treatment Period|Death|0|||
143412189|NCT01619059|517055044|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
143412190|NCT01619059|517055045|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
143412191|NCT01619059|517055044|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
143412192|NCT01619059|517055045|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
143412193|NCT03057600|517055046|FG000|Overall Study|Adverse Event|0|||
143412194|NCT03057600|517055047|FG001|Overall Study|Adverse Event|0|||
143412195|NCT03057600|517055048|FG002|Overall Study|Adverse Event|4|||
143412196|NCT03057600|517055049|FG003|Overall Study|Adverse Event|0|||
143412197|NCT03057600|517055046|FG000|Overall Study|Radiologic Disease Progression|8|||
143412198|NCT03057600|517055047|FG001|Overall Study|Radiologic Disease Progression|7|||
143412199|NCT03057600|517055048|FG002|Overall Study|Radiologic Disease Progression|13|||
143412200|NCT03057600|517055049|FG003|Overall Study|Radiologic Disease Progression|10|||
143412201|NCT03057600|517055046|FG000|Overall Study|Symptomatic Deterioration|0|||
143412202|NCT03057600|517055047|FG001|Overall Study|Symptomatic Deterioration|1|||
143412203|NCT03057600|517055048|FG002|Overall Study|Symptomatic Deterioration|1|||
143412204|NCT03057600|517055049|FG003|Overall Study|Symptomatic Deterioration|0|||
143412205|NCT03057600|517055046|FG000|Overall Study|Investigator Decision|0|||
143412206|NCT03057600|517055047|FG001|Overall Study|Investigator Decision|0|||
143412207|NCT03057600|517055048|FG002|Overall Study|Investigator Decision|1|||
143412208|NCT03057600|517055049|FG003|Overall Study|Investigator Decision|0|||
143412209|NCT03057600|517055046|FG000|Overall Study|Study Termination by Sponsor|0|||
143412210|NCT03057600|517055047|FG001|Overall Study|Study Termination by Sponsor|0|||
143412211|NCT03057600|517055048|FG002|Overall Study|Study Termination by Sponsor|0|||
143412212|NCT03057600|517055049|FG003|Overall Study|Study Termination by Sponsor|2|||
143412213|NCT03057600|517055046|FG000|Overall Study|Withdrawal by Subject|0|||
143412214|NCT03057600|517055047|FG001|Overall Study|Withdrawal by Subject|1|||
143412215|NCT03057600|517055048|FG002|Overall Study|Withdrawal by Subject|0|||
143412216|NCT03057600|517055049|FG003|Overall Study|Withdrawal by Subject|0|||
143412217|NCT03057600|517055046|FG000|Overall Study|Other, Not Specified|1|||
143412218|NCT03057600|517055047|FG001|Overall Study|Other, Not Specified|1|||
143412219|NCT03057600|517055048|FG002|Overall Study|Other, Not Specified|1|||
143412220|NCT03057600|517055049|FG003|Overall Study|Other, Not Specified|1|||
143412221|NCT01953692|517055056|FG000|Overall Study|Adverse Event|5|||
143412222|NCT01953692|517055057|FG001|Overall Study|Adverse Event|2|||
143412223|NCT01953692|517055058|FG002|Overall Study|Adverse Event|4|||
143412224|NCT01953692|517055059|FG003|Overall Study|Adverse Event|2|||
143412225|NCT01953692|517055060|FG004|Overall Study|Adverse Event|1|||
143412226|NCT01953692|517055061|FG005|Overall Study|Adverse Event|2|||
143412227|NCT01953692|517055062|FG006|Overall Study|Adverse Event|0|||
143412228|NCT01953692|517055063|FG007|Overall Study|Adverse Event|0|||
143412229|NCT01953692|517055064|FG008|Overall Study|Adverse Event|0|||
143412230|NCT01953692|517055056|FG000|Overall Study|Clinical Progression|0|||
143412231|NCT01953692|517055057|FG001|Overall Study|Clinical Progression|15|||
143412232|NCT01953692|517055058|FG002|Overall Study|Clinical Progression|7|||
143412233|NCT01953692|517055059|FG003|Overall Study|Clinical Progression|5|||
143412234|NCT01953692|517055060|FG004|Overall Study|Clinical Progression|0|||
143412235|NCT01953692|517055061|FG005|Overall Study|Clinical Progression|7|||
143412236|NCT01953692|517055062|FG006|Overall Study|Clinical Progression|20|||
143412237|NCT01953692|517055063|FG007|Overall Study|Clinical Progression|3|||
143412238|NCT01953692|517055064|FG008|Overall Study|Clinical Progression|3|||
143412239|NCT01953692|517055056|FG000|Overall Study|Death|5|||
143412240|NCT01953692|517055057|FG001|Overall Study|Death|0|||
143412241|NCT01953692|517055058|FG002|Overall Study|Death|2|||
143412242|NCT01953692|517055059|FG003|Overall Study|Death|2|||
143412243|NCT01953692|517055060|FG004|Overall Study|Death|1|||
143412244|NCT01953692|517055061|FG005|Overall Study|Death|3|||
143412245|NCT01953692|517055062|FG006|Overall Study|Death|6|||
143412246|NCT01953692|517055063|FG007|Overall Study|Death|2|||
143412247|NCT01953692|517055064|FG008|Overall Study|Death|1|||
143412248|NCT01953692|517055056|FG000|Overall Study|Excluded Medication|1|||
143412249|NCT01953692|517055057|FG001|Overall Study|Excluded Medication|0|||
143412250|NCT01953692|517055058|FG002|Overall Study|Excluded Medication|0|||
143412251|NCT01953692|517055059|FG003|Overall Study|Excluded Medication|0|||
143412252|NCT01953692|517055060|FG004|Overall Study|Excluded Medication|0|||
143412253|NCT01953692|517055061|FG005|Overall Study|Excluded Medication|0|||
143412254|NCT01953692|517055062|FG006|Overall Study|Excluded Medication|0|||
143412255|NCT01953692|517055063|FG007|Overall Study|Excluded Medication|0|||
143412256|NCT01953692|517055064|FG008|Overall Study|Excluded Medication|0|||
143412257|NCT01953692|517055056|FG000|Overall Study|Lost to Follow-up|1|||
143412258|NCT01953692|517055057|FG001|Overall Study|Lost to Follow-up|0|||
143412259|NCT01953692|517055058|FG002|Overall Study|Lost to Follow-up|3|||
143412260|NCT01953692|517055059|FG003|Overall Study|Lost to Follow-up|1|||
143412261|NCT01953692|517055060|FG004|Overall Study|Lost to Follow-up|0|||
143412262|NCT01953692|517055061|FG005|Overall Study|Lost to Follow-up|1|||
143412263|NCT01953692|517055062|FG006|Overall Study|Lost to Follow-up|0|||
143412264|NCT01953692|517055063|FG007|Overall Study|Lost to Follow-up|0|||
143412265|NCT01953692|517055064|FG008|Overall Study|Lost to Follow-up|0|||
143412266|NCT01953692|517055056|FG000|Overall Study|Physician Decision|11|||
143412267|NCT01953692|517055057|FG001|Overall Study|Physician Decision|4|||
143412268|NCT01953692|517055058|FG002|Overall Study|Physician Decision|2|||
143412269|NCT01953692|517055059|FG003|Overall Study|Physician Decision|2|||
143412270|NCT01953692|517055060|FG004|Overall Study|Physician Decision|1|||
143412271|NCT01953692|517055061|FG005|Overall Study|Physician Decision|2|||
143412272|NCT01953692|517055062|FG006|Overall Study|Physician Decision|4|||
143412273|NCT01953692|517055063|FG007|Overall Study|Physician Decision|1|||
143412274|NCT01953692|517055064|FG008|Overall Study|Physician Decision|0|||
143412275|NCT01953692|517055056|FG000|Overall Study|Protocol Violation|0|||
143412276|NCT01953692|517055057|FG001|Overall Study|Protocol Violation|2|||
143412277|NCT01953692|517055058|FG002|Overall Study|Protocol Violation|1|||
143412278|NCT01953692|517055059|FG003|Overall Study|Protocol Violation|0|||
143412279|NCT01953692|517055060|FG004|Overall Study|Protocol Violation|0|||
143412280|NCT01953692|517055061|FG005|Overall Study|Protocol Violation|0|||
143412281|NCT01953692|517055062|FG006|Overall Study|Protocol Violation|0|||
143412282|NCT01953692|517055063|FG007|Overall Study|Protocol Violation|1|||
143412283|NCT01953692|517055064|FG008|Overall Study|Protocol Violation|0|||
143412284|NCT01953692|517055056|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
143412285|NCT01953692|517055057|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
143412286|NCT01953692|517055058|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
143412287|NCT01953692|517055059|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
143412288|NCT01953692|517055060|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
143412289|NCT01953692|517055061|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
143412290|NCT01953692|517055062|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
143412291|NCT01953692|517055063|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
143412292|NCT01953692|517055064|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
143412293|NCT01953692|517055056|FG000|Overall Study|Withdrawal by Subject|4|||
143412294|NCT01953692|517055057|FG001|Overall Study|Withdrawal by Subject|2|||
143412295|NCT01953692|517055058|FG002|Overall Study|Withdrawal by Subject|1|||
143412296|NCT01953692|517055059|FG003|Overall Study|Withdrawal by Subject|2|||
143412297|NCT01953692|517055060|FG004|Overall Study|Withdrawal by Subject|0|||
143412298|NCT01953692|517055061|FG005|Overall Study|Withdrawal by Subject|3|||
143412299|NCT01953692|517055062|FG006|Overall Study|Withdrawal by Subject|2|||
143412300|NCT01953692|517055063|FG007|Overall Study|Withdrawal by Subject|1|||
143412301|NCT01953692|517055064|FG008|Overall Study|Withdrawal by Subject|1|||
143412302|NCT00641537|517055078|FG000|96-week Period|Adverse Event|0|||
143412303|NCT00641537|517055079|FG001|96-week Period|Adverse Event|1|||
143412304|NCT00641537|517055080|FG002|96-week Period|Adverse Event|3|||
143412305|NCT00641537|517055081|FG003|96-week Period|Adverse Event|0|||
143412306|NCT00641537|517055082|FG004|96-week Period|Adverse Event|2|||
143412307|NCT00641537|517055083|FG005|96-week Period|Adverse Event|0|||
143412308|NCT00641537|517055084|FG006|96-week Period|Adverse Event|0|||
143412309|NCT00641537|517055085|FG007|96-week Period|Adverse Event|0|||
143412310|NCT00641537|517055078|FG000|96-week Period|Lost to Follow-up|3|||
143412311|NCT00641537|517055079|FG001|96-week Period|Lost to Follow-up|1|||
143412312|NCT00641537|517055080|FG002|96-week Period|Lost to Follow-up|2|||
143412313|NCT00641537|517055081|FG003|96-week Period|Lost to Follow-up|2|||
143412314|NCT00641537|517055082|FG004|96-week Period|Lost to Follow-up|4|||
143412315|NCT00641537|517055083|FG005|96-week Period|Lost to Follow-up|0|||
143412316|NCT00641537|517055084|FG006|96-week Period|Lost to Follow-up|1|||
143412317|NCT00641537|517055085|FG007|96-week Period|Lost to Follow-up|0|||
143412318|NCT00641537|517055078|FG000|96-week Period|Protocol Violation|0|||
143412319|NCT00641537|517055079|FG001|96-week Period|Protocol Violation|1|||
143412320|NCT00641537|517055080|FG002|96-week Period|Protocol Violation|0|||
143412321|NCT00641537|517055081|FG003|96-week Period|Protocol Violation|1|||
143412322|NCT00641537|517055082|FG004|96-week Period|Protocol Violation|0|||
143412323|NCT00641537|517055083|FG005|96-week Period|Protocol Violation|1|||
143412324|NCT00641537|517055084|FG006|96-week Period|Protocol Violation|0|||
143412325|NCT00641537|517055085|FG007|96-week Period|Protocol Violation|0|||
143412326|NCT00641537|517055078|FG000|96-week Period|Death|2|||
143412327|NCT00641537|517055079|FG001|96-week Period|Death|0|||
143412328|NCT00641537|517055080|FG002|96-week Period|Death|1|||
143412329|NCT00641537|517055081|FG003|96-week Period|Death|0|||
143412330|NCT00641537|517055082|FG004|96-week Period|Death|0|||
143412331|NCT00641537|517055083|FG005|96-week Period|Death|0|||
143412332|NCT00641537|517055084|FG006|96-week Period|Death|0|||
143412333|NCT00641537|517055085|FG007|96-week Period|Death|0|||
143412334|NCT00641537|517055078|FG000|96-week Period|Other|4|||
143412335|NCT00641537|517055079|FG001|96-week Period|Other|7|||
143412336|NCT00641537|517055080|FG002|96-week Period|Other|14|||
143412337|NCT00641537|517055081|FG003|96-week Period|Other|9|||
143412338|NCT00641537|517055082|FG004|96-week Period|Other|11|||
143412339|NCT00641537|517055083|FG005|96-week Period|Other|6|||
143412340|NCT00641537|517055084|FG006|96-week Period|Other|4|||
143412341|NCT00641537|517055085|FG007|96-week Period|Other|6|||
143412342|NCT00641537|517055078|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
143412343|NCT00641537|517055079|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
143412344|NCT00641537|517055080|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
143412345|NCT00641537|517055081|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
143412346|NCT00641537|517055082|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
143412347|NCT00641537|517055083|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
143412348|NCT00641537|517055084|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
143412349|NCT00641537|517055085|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
143412350|NCT00641537|517055078|FG000|24-Week Supplemental Follow-up Period|Other|0|||
143412351|NCT00641537|517055079|FG001|24-Week Supplemental Follow-up Period|Other|2|||
143412352|NCT00641537|517055080|FG002|24-Week Supplemental Follow-up Period|Other|2|||
143412353|NCT00641537|517055081|FG003|24-Week Supplemental Follow-up Period|Other|1|||
143412354|NCT00641537|517055082|FG004|24-Week Supplemental Follow-up Period|Other|3|||
143412355|NCT00641537|517055083|FG005|24-Week Supplemental Follow-up Period|Other|0|||
143412356|NCT00641537|517055084|FG006|24-Week Supplemental Follow-up Period|Other|1|||
143412357|NCT00641537|517055085|FG007|24-Week Supplemental Follow-up Period|Other|1|||
143412358|NCT01801007|517055086|FG000|Overall Study|Adverse Event|2|||
143412359|NCT01801007|517055086|FG000|Overall Study|Lost to Follow-up|4|||
143412360|NCT01801007|517055086|FG000|Overall Study|Withdrawal by Subject|5|||
143412361|NCT00665392|517055087|FG000|Overall Study|not treated|1|||
143412362|NCT00989196|517055091|FG000|Treatment Period|Lost to Follow-up|1|||
143412363|NCT00989196|517055092|FG001|Treatment Period|Lost to Follow-up|0|||
143412364|NCT05824559|517055093|FG000|Overall Study|Adverse Event|2|||
143412365|NCT05824559|517055093|FG000|Overall Study|Physician Decision|2|||
143412366|NCT05824559|517055093|FG000|Overall Study|Progressive Disease|16|||
143412367|NCT05824559|517055093|FG000|Overall Study|Study Terminated by Sponsor|1|||
143412368|NCT05824559|517055093|FG000|Overall Study|Withdrawal by Subject|2|||
143412369|NCT02409680|517055094|FG000|Overall Study|Lost to Follow-up|15|||
143412370|NCT02409680|517055095|FG001|Overall Study|Lost to Follow-up|30|||
143412371|NCT03789656|517055096|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
143412372|NCT03789656|517055097|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
143412373|NCT03789656|517055098|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
143412374|NCT03789656|517055099|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
143412375|NCT03789656|517055100|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
143412376|NCT03789656|517055096|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
143412377|NCT03789656|517055097|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
143412378|NCT03789656|517055098|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
143412379|NCT03789656|517055099|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
143412380|NCT03789656|517055100|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
143412381|NCT03789656|517055096|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
143412382|NCT03789656|517055097|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
143412383|NCT03789656|517055098|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
143412384|NCT03789656|517055099|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
143412385|NCT03789656|517055100|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
143412386|NCT03789656|517055096|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
143412387|NCT03789656|517055097|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
143412388|NCT03789656|517055098|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
143412389|NCT03789656|517055099|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
143412390|NCT03789656|517055100|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
143412391|NCT05325294|517055105|FG000|Overall Study|Adverse Event|3|||
143412392|NCT05325294|517055106|FG001|Overall Study|Adverse Event|3|||
143412393|NCT05325294|517055105|FG000|Overall Study|Physician Decision|0|||
143412394|NCT05325294|517055106|FG001|Overall Study|Physician Decision|1|||
143412395|NCT05325294|517055105|FG000|Overall Study|Withdrawal by Subject|0|||
143412396|NCT05325294|517055106|FG001|Overall Study|Withdrawal by Subject|3|||
143412397|NCT05325294|517055105|FG000|Overall Study|Lost to Follow-up|1|||
143412398|NCT05325294|517055106|FG001|Overall Study|Lost to Follow-up|0|||
143412399|NCT05325294|517055105|FG000|Overall Study|Sponsor Request|0|||
143412400|NCT05325294|517055106|FG001|Overall Study|Sponsor Request|2|||
143412401|NCT02434328|517055107|FG000|Overall Study|Adverse Event|9|||
143412402|NCT02434328|517055108|FG001|Overall Study|Adverse Event|4|||
143412403|NCT02434328|517055107|FG000|Overall Study|Lack of Efficacy|0|||
143412404|NCT02434328|517055108|FG001|Overall Study|Lack of Efficacy|2|||
143412405|NCT02434328|517055107|FG000|Overall Study|Physician Decision|0|||
143412406|NCT02434328|517055108|FG001|Overall Study|Physician Decision|1|||
143412407|NCT02434328|517055107|FG000|Overall Study|Withdrawal by Subject|12|||
143412408|NCT02434328|517055108|FG001|Overall Study|Withdrawal by Subject|21|||
143412409|NCT02434328|517055107|FG000|Overall Study|Death|4|||
143412410|NCT02434328|517055108|FG001|Overall Study|Death|7|||
143412411|NCT02434328|517055107|FG000|Overall Study|Lost to Follow-up|1|||
143412412|NCT02434328|517055108|FG001|Overall Study|Lost to Follow-up|6|||
143412413|NCT02434328|517055107|FG000|Overall Study|Other|4|||
143412414|NCT02434328|517055108|FG001|Overall Study|Other|1|||
143412415|NCT00647387|517055111|FG000|Overall Study|Lost to Follow-up|6|||
143412416|NCT00647387|517055111|FG000|Overall Study|Unsuccessful implant|5|||
143412417|NCT00647387|517055111|FG000|Overall Study|Device explanted|3|||
143412418|NCT00647387|517055111|FG000|Overall Study|Other Reason|3|||
143412419|NCT00647387|517055111|FG000|Overall Study|Death|2|||
143412420|NCT05432986|517055115|FG000|Overall Study|Withdrawal by Subject|2|||
143412421|NCT05432986|517055115|FG000|Overall Study|incomplete measurement|7|||
143412422|NCT03678688|517057242|FG000|Overall Study|Reason not Specified|0|||
143412423|NCT03678688|517057243|FG001|Overall Study|Reason not Specified|0|||
143412424|NCT03678688|517057244|FG002|Overall Study|Reason not Specified|3|||
143412425|NCT03678688|517057245|FG003|Overall Study|Reason not Specified|0|||
143412426|NCT03678688|517057246|FG004|Overall Study|Reason not Specified|1|||
143412427|NCT03678688|517057247|FG005|Overall Study|Reason not Specified|0|||
143412428|NCT03678688|517057248|FG006|Overall Study|Reason not Specified|0|||
143412429|NCT03678688|517057249|FG007|Overall Study|Reason not Specified|0|||
143412430|NCT03678688|517057250|FG008|Overall Study|Reason not Specified|0|||
143412431|NCT03678688|517057242|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
143412432|NCT03678688|517057243|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
143412433|NCT03678688|517057244|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
143412434|NCT03678688|517057245|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
143412435|NCT03678688|517057246|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
143412436|NCT03678688|517057247|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
143412437|NCT03678688|517057248|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
143412438|NCT03678688|517057249|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
143412439|NCT03678688|517057250|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
143412440|NCT03678688|517057242|FG000|Overall Study|Covid Related Adverse Event|0|||
143412441|NCT03678688|517057243|FG001|Overall Study|Covid Related Adverse Event|0|||
143412442|NCT03678688|517057244|FG002|Overall Study|Covid Related Adverse Event|0|||
143412443|NCT03678688|517057245|FG003|Overall Study|Covid Related Adverse Event|0|||
143412444|NCT03678688|517057246|FG004|Overall Study|Covid Related Adverse Event|0|||
143412445|NCT03678688|517057247|FG005|Overall Study|Covid Related Adverse Event|3|||
143412446|NCT03678688|517057248|FG006|Overall Study|Covid Related Adverse Event|1|||
143412447|NCT03678688|517057249|FG007|Overall Study|Covid Related Adverse Event|1|||
143412448|NCT03678688|517057250|FG008|Overall Study|Covid Related Adverse Event|0|||
143412449|NCT03678688|517057242|FG000|Overall Study|Physician Decision|0|||
143412450|NCT03678688|517057243|FG001|Overall Study|Physician Decision|0|||
143412451|NCT03678688|517057244|FG002|Overall Study|Physician Decision|0|||
143412452|NCT03678688|517057245|FG003|Overall Study|Physician Decision|0|||
143412453|NCT03678688|517057246|FG004|Overall Study|Physician Decision|0|||
143412454|NCT03678688|517057247|FG005|Overall Study|Physician Decision|1|||
143412455|NCT03678688|517057248|FG006|Overall Study|Physician Decision|0|||
143412456|NCT03678688|517057249|FG007|Overall Study|Physician Decision|0|||
143412457|NCT03678688|517057250|FG008|Overall Study|Physician Decision|0|||
143412458|NCT03678688|517057242|FG000|Overall Study|Withdrawal by Subject|0|||
143412459|NCT03678688|517057243|FG001|Overall Study|Withdrawal by Subject|0|||
143412460|NCT03678688|517057244|FG002|Overall Study|Withdrawal by Subject|0|||
143412461|NCT03678688|517057245|FG003|Overall Study|Withdrawal by Subject|0|||
143412462|NCT03678688|517057246|FG004|Overall Study|Withdrawal by Subject|0|||
143412463|NCT03678688|517057247|FG005|Overall Study|Withdrawal by Subject|0|||
143412464|NCT03678688|517057248|FG006|Overall Study|Withdrawal by Subject|2|||
143412465|NCT03678688|517057249|FG007|Overall Study|Withdrawal by Subject|1|||
143412466|NCT03678688|517057250|FG008|Overall Study|Withdrawal by Subject|0|||
143412467|NCT03137459|517057251|FG000|2-month Assessment|Withdrawal by Subject|13|||
143412468|NCT03137459|517057252|FG001|2-month Assessment|Withdrawal by Subject|3|||
143412469|NCT03137459|517057251|FG000|2-month Assessment|Unable to reach|42|||
143412470|NCT03137459|517057252|FG001|2-month Assessment|Unable to reach|32|||
143412471|NCT03137459|517057251|FG000|2-month Assessment|Refused assessment|7|||
143412472|NCT03137459|517057252|FG001|2-month Assessment|Refused assessment|5|||
143412473|NCT03137459|517057251|FG000|2-month Assessment|Acutely ill|6|||
143412474|NCT03137459|517057252|FG001|2-month Assessment|Acutely ill|2|||
143412475|NCT03137459|517057251|FG000|4-month Assessment|Death|4|||
143412476|NCT03137459|517057252|FG001|4-month Assessment|Death|2|||
143412477|NCT03137459|517057251|FG000|4-month Assessment|Withdrawal by Subject|4|||
143412478|NCT03137459|517057252|FG001|4-month Assessment|Withdrawal by Subject|2|||
143412479|NCT03137459|517057251|FG000|4-month Assessment|Unable to reach|44|||
143412480|NCT03137459|517057252|FG001|4-month Assessment|Unable to reach|29|||
143412481|NCT03137459|517057251|FG000|4-month Assessment|Refused assessment|24|||
143412482|NCT03137459|517057252|FG001|4-month Assessment|Refused assessment|10|||
143412483|NCT03137459|517057251|FG000|4-month Assessment|Acutely ill|2|||
143412484|NCT03137459|517057252|FG001|4-month Assessment|Acutely ill|3|||
143412485|NCT03137459|517057251|FG000|6-months|Lost to Follow-up|14|||
143412486|NCT03137459|517057252|FG001|6-months|Lost to Follow-up|11|||
143412487|NCT03137459|517057251|FG000|6-months|Death|0|||
143412488|NCT03137459|517057252|FG001|6-months|Death|2|||
143412489|NCT03137459|517057251|FG000|6-months|Refused assessment|6|||
143412490|NCT03137459|517057252|FG001|6-months|Refused assessment|3|||
143412491|NCT03137459|517057251|FG000|6-months|Acutely ill|1|||
143412492|NCT03137459|517057252|FG001|6-months|Acutely ill|1|||
143412493|NCT01732757|517057253|FG000|Overall Study|Lost to Follow-up|1|||
143412494|NCT01732757|517057254|FG001|Overall Study|Lost to Follow-up|0|||
143412495|NCT01732757|517057255|FG002|Overall Study|Lost to Follow-up|0|||
143412496|NCT00491400|517057256|FG000|Overall Study|Withdrawal by Subject|5|||
143412497|NCT00491400|517057257|FG001|Overall Study|Withdrawal by Subject|4|||
143412498|NCT01583166|517057260|FG000|Overall Study|Withdrawal by Subject|4|||
143412499|NCT01583166|517057261|FG001|Overall Study|Withdrawal by Subject|6|||
143412500|NCT00887224|517057262|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
143412501|NCT00887224|517057263|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
143412502|NCT00887224|517057264|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
143412503|NCT00887224|517057262|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
143412504|NCT00887224|517057263|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
143412505|NCT00887224|517057264|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
143412506|NCT00887224|517057262|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
143412507|NCT00887224|517057263|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
143412508|NCT00887224|517057264|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
143412509|NCT00887224|517057262|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
143412510|NCT00887224|517057263|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
143412511|NCT00887224|517057264|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
143412512|NCT00887224|517057262|FG000|Open-label Response (OLR) Phase|Other|1|||
143412513|NCT00887224|517057263|FG001|Open-label Response (OLR) Phase|Other|0|||
143412514|NCT00887224|517057264|FG002|Open-label Response (OLR) Phase|Other|0|||
143412515|NCT00887224|517057262|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
143412516|NCT00887224|517057263|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
143412517|NCT00887224|517057264|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
143412518|NCT00887224|517057262|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
143412519|NCT00887224|517057263|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
143412520|NCT00887224|517057264|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
143412521|NCT00887224|517057262|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
143412522|NCT00887224|517057263|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
143412523|NCT00887224|517057264|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
143412524|NCT00887224|517057262|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
143412525|NCT00887224|517057263|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
143412526|NCT00887224|517057264|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
143412527|NCT00887224|517057262|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
143412528|NCT00887224|517057263|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
143412529|NCT00887224|517057264|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
143412530|NCT00887224|517057262|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
143412531|NCT00887224|517057263|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
143412532|NCT00887224|517057264|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
143412533|NCT00887224|517057262|FG000|Open-label Stability (OLS) Phase|Other|1|||
143412534|NCT00887224|517057263|FG001|Open-label Stability (OLS) Phase|Other|0|||
143412535|NCT00887224|517057264|FG002|Open-label Stability (OLS) Phase|Other|0|||
143412536|NCT00887224|517057262|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
143412537|NCT00887224|517057263|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
143412538|NCT00887224|517057264|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
143412539|NCT00887224|517057262|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
143412540|NCT00887224|517057263|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
143412541|NCT00887224|517057264|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
143412542|NCT00887224|517057262|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
143412543|NCT00887224|517057263|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
143412544|NCT00887224|517057264|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
143412545|NCT00887224|517057262|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
143412546|NCT00887224|517057263|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
143412547|NCT00887224|517057264|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
143412548|NCT00887224|517057262|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
143412549|NCT00887224|517057263|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
143412550|NCT00887224|517057264|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
143412551|NCT00887224|517057262|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
143412552|NCT00887224|517057263|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
143412553|NCT00887224|517057264|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
143412554|NCT00887224|517057262|FG000|OL Taper Phase / OL Follow Up|Other|30|||
143412555|NCT00887224|517057263|FG001|OL Taper Phase / OL Follow Up|Other|0|||
143412556|NCT00887224|517057264|FG002|OL Taper Phase / OL Follow Up|Other|0|||
143412557|NCT00887224|517057262|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
143412558|NCT00887224|517057263|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
143412559|NCT00887224|517057264|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
143412560|NCT00887224|517057262|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
143412561|NCT00887224|517057263|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
143412562|NCT00887224|517057264|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
143412563|NCT00887224|517057262|FG000|Double-blind (DB) Phase|Adverse Event|0|||
143412564|NCT00887224|517057263|FG001|Double-blind (DB) Phase|Adverse Event|7|||
143412565|NCT00887224|517057264|FG002|Double-blind (DB) Phase|Adverse Event|2|||
143412566|NCT00887224|517057262|FG000|Double-blind (DB) Phase|Failed to return|0|||
143412567|NCT00887224|517057263|FG001|Double-blind (DB) Phase|Failed to return|2|||
143412568|NCT00887224|517057264|FG002|Double-blind (DB) Phase|Failed to return|2|||
143412569|NCT00887224|517057262|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
143412570|NCT00887224|517057263|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
143412571|NCT00887224|517057264|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
143412572|NCT00887224|517057262|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
143412573|NCT00887224|517057263|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
143412574|NCT00887224|517057264|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
143412575|NCT00887224|517057262|FG000|Double-blind (DB) Phase|Other|0|||
143412576|NCT00887224|517057263|FG001|Double-blind (DB) Phase|Other|2|||
143412577|NCT00887224|517057264|FG002|Double-blind (DB) Phase|Other|0|||
143412578|NCT00887224|517057262|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
143412579|NCT00887224|517057263|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
143412580|NCT00887224|517057264|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
143412581|NCT00887224|517057262|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
143412582|NCT00887224|517057263|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
143412583|NCT00887224|517057264|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
143412584|NCT00887224|517057262|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
143412585|NCT00887224|517057263|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
143412586|NCT00887224|517057264|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
143412587|NCT00887224|517057262|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
143412588|NCT00887224|517057263|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
143412589|NCT00887224|517057264|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
143412590|NCT00887224|517057262|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
143412591|NCT00887224|517057263|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
143412592|NCT00887224|517057264|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
143412593|NCT00887224|517057262|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
143412594|NCT00887224|517057263|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
143412595|NCT00887224|517057264|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
143412596|NCT00887224|517057262|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
143412597|NCT00887224|517057263|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
143412598|NCT00887224|517057264|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
143412599|NCT00887224|517057262|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
143412600|NCT00887224|517057263|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
143412601|NCT00887224|517057264|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
143412602|NCT00887224|517057262|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
143412603|NCT00887224|517057263|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
143412604|NCT00887224|517057264|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
143412605|NCT00047385|517057268|FG000|Overall Study|Death before any screening|2|||
143412606|NCT00047385|517057269|FG001|Overall Study|Death before any screening|5|||
143412607|NCT00047385|517057268|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
143412608|NCT00047385|517057269|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
143412609|NCT00047385|517057268|FG000|Overall Study|Eligible for screening but had no screen|260|||
143412610|NCT00047385|517057269|FG001|Overall Study|Eligible for screening but had no screen|492|||
143412611|NCT03865732|517057270|FG000|Overall Study|Adverse Event|0|||
143412612|NCT03865732|517057271|FG001|Overall Study|Adverse Event|1|||
143412613|NCT03392194|517057272|FG000|Overall Study|Withdrawal by Subject|1|||
143412614|NCT03392194|517057273|FG001|Overall Study|Withdrawal by Subject|2|||
143412615|NCT03392194|517057272|FG000|Overall Study|Conflicts with personal schedule|1|||
143412616|NCT03392194|517057273|FG001|Overall Study|Conflicts with personal schedule|0|||
143412617|NCT00620854|517057277|FG000|Washout 1|Withdrawal by Subject|0|||
143412618|NCT00620854|517057278|FG001|Washout 1|Withdrawal by Subject|0|||
143412619|NCT00620854|517057279|FG002|Washout 1|Withdrawal by Subject|1|||
143412620|NCT00620854|517057280|FG003|Washout 1|Withdrawal by Subject|1|||
143412621|NCT00620854|517057281|FG004|Washout 1|Withdrawal by Subject|0|||
143412622|NCT00620854|517057282|FG005|Washout 1|Withdrawal by Subject|0|||
143412623|NCT00734578|517057284|FG000|Overall Study|Adverse Event|4|||
143412624|NCT00734578|517057285|FG001|Overall Study|Adverse Event|6|||
143412625|NCT00734578|517057286|FG002|Overall Study|Adverse Event|1|||
143412626|NCT00734578|517057284|FG000|Overall Study|Protocol Violation|8|||
143412627|NCT00734578|517057285|FG001|Overall Study|Protocol Violation|6|||
143412628|NCT00734578|517057286|FG002|Overall Study|Protocol Violation|3|||
143412629|NCT00734578|517057284|FG000|Overall Study|Withdrawal by Subject|7|||
143412630|NCT00734578|517057285|FG001|Overall Study|Withdrawal by Subject|8|||
143412631|NCT00734578|517057286|FG002|Overall Study|Withdrawal by Subject|11|||
143412632|NCT00734578|517057284|FG000|Overall Study|Lost to Follow-up|9|||
143412633|NCT00734578|517057285|FG001|Overall Study|Lost to Follow-up|3|||
143412634|NCT00734578|517057286|FG002|Overall Study|Lost to Follow-up|5|||
143412635|NCT00734578|517057284|FG000|Overall Study|Lack of Efficacy|3|||
143412636|NCT00734578|517057285|FG001|Overall Study|Lack of Efficacy|2|||
143412637|NCT00734578|517057286|FG002|Overall Study|Lack of Efficacy|5|||
143412638|NCT00734578|517057284|FG000|Overall Study|Randomized in error|1|||
143412639|NCT00734578|517057285|FG001|Overall Study|Randomized in error|0|||
143412640|NCT00734578|517057286|FG002|Overall Study|Randomized in error|0|||
143412641|NCT00734578|517057284|FG000|Overall Study|Exclusion criteria|1|||
143412642|NCT00734578|517057285|FG001|Overall Study|Exclusion criteria|0|||
143412643|NCT00734578|517057286|FG002|Overall Study|Exclusion criteria|0|||
143412644|NCT01698918|517057287|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
143412645|NCT01698918|517057287|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
143412646|NCT01698918|517057287|FG000|First Line Treatment (Core+Extension)|Death|2|||
143412647|NCT01698918|517057287|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
143412648|NCT01698918|517057287|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
143412649|NCT01698918|517057287|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
143412650|NCT01698918|517057287|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
143412651|NCT01698918|517057287|FG000|Second Line Treatment (Core+Extension)|Death|1|||
143412652|NCT01698918|517057287|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
143412653|NCT01698918|517057287|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
143412654|NCT02095145|517057288|FG000|Overall Study|Withdrawal by Subject|1|||
143412655|NCT02095145|517057289|FG001|Overall Study|Withdrawal by Subject|0|||
143412656|NCT04693637|517057292|FG000|Overall Study|Death|4|||
143412657|NCT04693637|517057292|FG000|Overall Study|Withdrawal by Subject|3|||
143412658|NCT04693637|517057292|FG000|Overall Study|Physician Decision|2|||
143412659|NCT04693637|517057292|FG000|Overall Study|Lost to Follow-up|1|||
143412660|NCT04885998|517057293|FG000|Overall Study|Withdrawal by Subject|0|||
143412661|NCT04885998|517057294|FG001|Overall Study|Withdrawal by Subject|2|||
143412662|NCT04885998|517057295|FG002|Overall Study|Withdrawal by Subject|0|||
143412663|NCT04885998|517057296|FG003|Overall Study|Withdrawal by Subject|3|||
143412664|NCT04885998|517057293|FG000|Overall Study|Lost to Follow-up|1|||
143412665|NCT04885998|517057294|FG001|Overall Study|Lost to Follow-up|1|||
143412666|NCT04885998|517057295|FG002|Overall Study|Lost to Follow-up|0|||
143412667|NCT04885998|517057296|FG003|Overall Study|Lost to Follow-up|0|||
143412668|NCT04885998|517057293|FG000|Overall Study|Death|2|||
143412669|NCT04885998|517057294|FG001|Overall Study|Death|1|||
143412670|NCT04885998|517057295|FG002|Overall Study|Death|2|||
143412671|NCT04885998|517057296|FG003|Overall Study|Death|2|||
143412672|NCT04885998|517057293|FG000|Overall Study|Decision by sponsor|1|||
143412673|NCT04885998|517057294|FG001|Overall Study|Decision by sponsor|1|||
143412674|NCT04885998|517057295|FG002|Overall Study|Decision by sponsor|0|||
143412675|NCT04885998|517057296|FG003|Overall Study|Decision by sponsor|0|||
143412676|NCT05553366|517057301|FG000|Overall Study|Withdrawal of Consent (not due to AE|4|||
143412677|NCT05553366|517057302|FG001|Overall Study|Withdrawal of Consent (not due to AE|8|||
143412678|NCT05553366|517057303|FG002|Overall Study|Withdrawal of Consent (not due to AE|5|||
143412679|NCT05553366|517057301|FG000|Overall Study|Lost to Follow-up|3|||
143412680|NCT05553366|517057302|FG001|Overall Study|Lost to Follow-up|3|||
143412681|NCT05553366|517057303|FG002|Overall Study|Lost to Follow-up|3|||
143412682|NCT05553366|517057301|FG000|Overall Study|Other non-compliance|1|||
143412683|NCT05553366|517057302|FG001|Overall Study|Other non-compliance|1|||
143412684|NCT05553366|517057303|FG002|Overall Study|Other non-compliance|0|||
143412685|NCT05553366|517057301|FG000|Overall Study|Randomized but not dosed|0|||
143412686|NCT05553366|517057302|FG001|Overall Study|Randomized but not dosed|0|||
143412687|NCT05553366|517057303|FG002|Overall Study|Randomized but not dosed|2|||
143412688|NCT00795184|517057309|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
143412689|NCT00795184|517057310|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
143412690|NCT02079649|517057311|FG000|Overall Study|Lost to Follow-up|0|||
143412691|NCT02079649|517057312|FG001|Overall Study|Lost to Follow-up|0|||
143412692|NCT02079649|517057313|FG002|Overall Study|Lost to Follow-up|0|||
143412693|NCT02079649|517057314|FG003|Overall Study|Lost to Follow-up|1|||
143412694|NCT02079649|517057311|FG000|Overall Study|Withdrawal by Subject|0|||
143412695|NCT02079649|517057312|FG001|Overall Study|Withdrawal by Subject|0|||
143412696|NCT02079649|517057313|FG002|Overall Study|Withdrawal by Subject|0|||
143412697|NCT02079649|517057314|FG003|Overall Study|Withdrawal by Subject|1|||
143412698|NCT02079649|517057311|FG000|Overall Study|Randomization error (prior to treatment)|1|||
143412699|NCT02079649|517057312|FG001|Overall Study|Randomization error (prior to treatment)|0|||
143412700|NCT02079649|517057313|FG002|Overall Study|Randomization error (prior to treatment)|1|||
143412701|NCT02079649|517057314|FG003|Overall Study|Randomization error (prior to treatment)|0|||
143412702|NCT01968967|517057339|FG000|Treatment Period|Other|22|||
143412703|NCT01968967|517057340|FG001|Treatment Period|Other|22|||
143412704|NCT01968967|517057341|FG002|Treatment Period|Other|0|||
143412705|NCT01968967|517057342|FG003|Treatment Period|Other|0|||
143412706|NCT01968967|517057343|FG004|Treatment Period|Other|0|||
143412707|NCT01968967|517057339|FG000|Treatment Period|Withdrawal by Subject|71|||
143412708|NCT01968967|517057340|FG001|Treatment Period|Withdrawal by Subject|61|||
143412709|NCT01968967|517057341|FG002|Treatment Period|Withdrawal by Subject|0|||
143412710|NCT01968967|517057342|FG003|Treatment Period|Withdrawal by Subject|0|||
143412711|NCT01968967|517057343|FG004|Treatment Period|Withdrawal by Subject|0|||
143412712|NCT01968967|517057339|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
143412713|NCT01968967|517057340|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
143412714|NCT01968967|517057341|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
143412715|NCT01968967|517057342|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
143412716|NCT01968967|517057343|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
143412717|NCT01968967|517057339|FG000|Treatment Period|Lost to Follow-up|26|||
143412718|NCT01968967|517057340|FG001|Treatment Period|Lost to Follow-up|31|||
143412719|NCT01968967|517057341|FG002|Treatment Period|Lost to Follow-up|0|||
143412720|NCT01968967|517057342|FG003|Treatment Period|Lost to Follow-up|0|||
143412721|NCT01968967|517057343|FG004|Treatment Period|Lost to Follow-up|0|||
143412722|NCT01968967|517057339|FG000|Treatment Period|Protocol Violation|1|||
143412723|NCT01968967|517057340|FG001|Treatment Period|Protocol Violation|2|||
143412724|NCT01968967|517057341|FG002|Treatment Period|Protocol Violation|0|||
143412725|NCT01968967|517057342|FG003|Treatment Period|Protocol Violation|0|||
143412726|NCT01968967|517057343|FG004|Treatment Period|Protocol Violation|0|||
143412727|NCT01968967|517057339|FG000|Treatment Period|Adverse Event|9|||
143412728|NCT01968967|517057340|FG001|Treatment Period|Adverse Event|8|||
143412729|NCT01968967|517057341|FG002|Treatment Period|Adverse Event|0|||
143412730|NCT01968967|517057342|FG003|Treatment Period|Adverse Event|0|||
143412731|NCT01968967|517057343|FG004|Treatment Period|Adverse Event|0|||
143412732|NCT01968967|517057339|FG000|Treatment Period|Death|9|||
143412733|NCT01968967|517057340|FG001|Treatment Period|Death|2|||
143412734|NCT01968967|517057341|FG002|Treatment Period|Death|0|||
143412735|NCT01968967|517057342|FG003|Treatment Period|Death|0|||
143412736|NCT01968967|517057343|FG004|Treatment Period|Death|0|||
143412737|NCT01968967|517057339|FG000|Treatment Period|Randomized Not Treated|6|||
143412738|NCT01968967|517057340|FG001|Treatment Period|Randomized Not Treated|5|||
143412739|NCT01968967|517057341|FG002|Treatment Period|Randomized Not Treated|0|||
143412740|NCT01968967|517057342|FG003|Treatment Period|Randomized Not Treated|0|||
143412741|NCT01968967|517057343|FG004|Treatment Period|Randomized Not Treated|0|||
143412742|NCT01968967|517057339|FG000|Extension Period|Withdrew Consent|0|||
143412743|NCT01968967|517057340|FG001|Extension Period|Withdrew Consent|0|||
143412744|NCT01968967|517057341|FG002|Extension Period|Withdrew Consent|2|||
143412745|NCT01968967|517057342|FG003|Extension Period|Withdrew Consent|0|||
143412746|NCT01968967|517057343|FG004|Extension Period|Withdrew Consent|5|||
143412747|NCT03489369|517057344|FG000|Overall Study|Documented Progressive Disease|3|||
143412748|NCT03489369|517057345|FG001|Overall Study|Documented Progressive Disease|2|||
143412749|NCT03489369|517057346|FG002|Overall Study|Documented Progressive Disease|3|||
143412750|NCT03489369|517057347|FG003|Overall Study|Documented Progressive Disease|6|||
143412751|NCT03489369|517057344|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
143412752|NCT03489369|517057345|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
143412753|NCT03489369|517057346|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
143412754|NCT03489369|517057347|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
143412755|NCT02022670|517057350|FG000|Overall Study|Adverse Event|1|||
143412756|NCT02022670|517057351|FG001|Overall Study|Adverse Event|0|||
143412757|NCT02022670|517057352|FG002|Overall Study|Adverse Event|1|||
143412758|NCT04399837|517057359|FG000|Overall Study|Other than listed|0|||
143412759|NCT04399837|517057360|FG001|Overall Study|Other than listed|2|||
143412760|NCT04399837|517057361|FG002|Overall Study|Other than listed|2|||
143412761|NCT04399837|517057362|FG003|Overall Study|Other than listed|3|||
143412762|NCT04399837|517057359|FG000|Overall Study|Withdrawal by Subject|1|||
143412763|NCT04399837|517057360|FG001|Overall Study|Withdrawal by Subject|2|||
143412764|NCT04399837|517057361|FG002|Overall Study|Withdrawal by Subject|1|||
143412765|NCT04399837|517057362|FG003|Overall Study|Withdrawal by Subject|1|||
143412766|NCT02426138|517057363|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
143412767|NCT02426138|517057364|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
143412768|NCT04677738|517057365|FG000|Overall Study|Withdrawal by Subject|4|||
143412769|NCT04677738|517057366|FG001|Overall Study|Withdrawal by Subject|2|||
143412770|NCT03697603|517057373|FG000|Overall Study|Adverse Event|3|||
143412771|NCT03697603|517057374|FG001|Overall Study|Adverse Event|18|||
143412772|NCT03697603|517057375|FG002|Overall Study|Adverse Event|3|||
143412773|NCT03697603|517057373|FG000|Overall Study|Physician Decision|1|||
143412774|NCT03697603|517057374|FG001|Overall Study|Physician Decision|0|||
143412775|NCT03697603|517057375|FG002|Overall Study|Physician Decision|2|||
143412776|NCT03697603|517057373|FG000|Overall Study|Protocol Violation|3|||
143412777|NCT03697603|517057374|FG001|Overall Study|Protocol Violation|8|||
143412778|NCT03697603|517057375|FG002|Overall Study|Protocol Violation|5|||
143412779|NCT03697603|517057373|FG000|Overall Study|Withdrawal by Subject|5|||
143412780|NCT03697603|517057374|FG001|Overall Study|Withdrawal by Subject|1|||
143412781|NCT03697603|517057375|FG002|Overall Study|Withdrawal by Subject|1|||
143412782|NCT03697603|517057373|FG000|Overall Study|Protocol Violation|0|||
143412783|NCT03697603|517057374|FG001|Overall Study|Protocol Violation|0|||
143412784|NCT03697603|517057375|FG002|Overall Study|Protocol Violation|1|||
143412785|NCT00467272|517057383|FG000|Overall Study|Pneumonia|2|||
143412786|NCT00467272|517057383|FG000|Overall Study|Thrombophlebitis|1|||
143412787|NCT05212285|517057386|FG000|Overall Study|Lack of Efficacy|12|||
143412788|NCT05212285|517057387|FG001|Overall Study|Lack of Efficacy|8|||
143412789|NCT05212285|517057386|FG000|Overall Study|Withdrawal by Subject|8|||
143412790|NCT05212285|517057387|FG001|Overall Study|Withdrawal by Subject|1|||
143412791|NCT05212285|517057386|FG000|Overall Study|Lost to Follow-up|13|||
143412792|NCT05212285|517057387|FG001|Overall Study|Lost to Follow-up|1|||
143412793|NCT05212285|517057386|FG000|Overall Study|miss data|21|||
143412794|NCT05212285|517057387|FG001|Overall Study|miss data|2|||
143412795|NCT02222493|517057388|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
143412796|NCT02222493|517057389|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
143412797|NCT02222493|517057388|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
143412798|NCT02222493|517057389|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
143412799|NCT02222493|517057388|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
143412800|NCT02222493|517057389|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
143412801|NCT02222493|517057388|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
143412802|NCT02222493|517057389|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
143412803|NCT02222493|517057388|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
143412804|NCT02222493|517057389|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
143412805|NCT02222493|517057388|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
143412806|NCT02222493|517057389|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
143412807|NCT02222493|517057388|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
143412808|NCT02222493|517057389|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
143412809|NCT02222493|517057388|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
143412810|NCT02222493|517057389|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
143412811|NCT02222493|517057388|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
143412812|NCT02222493|517057389|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
143412813|NCT02222493|517057388|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
143412814|NCT02222493|517057389|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
143412815|NCT02222493|517057388|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
143412816|NCT02222493|517057389|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
143412817|NCT02222493|517057388|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
143412818|NCT02222493|517057389|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
143412819|NCT02222493|517057388|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
143412820|NCT02222493|517057389|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
143412821|NCT02222493|517057388|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
143412822|NCT02222493|517057389|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
143412823|NCT02222493|517057388|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
143412824|NCT02222493|517057389|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
143412825|NCT02222493|517057388|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
143412826|NCT02222493|517057389|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
143412827|NCT02222493|517057388|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
143412828|NCT02222493|517057389|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
143412829|NCT02222493|517057388|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
143412830|NCT02222493|517057389|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
143412831|NCT02222493|517057388|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
143412832|NCT02222493|517057389|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
143412833|NCT02222493|517057388|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
143412834|NCT02222493|517057389|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
143412835|NCT02222493|517057388|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
143412836|NCT02222493|517057389|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
143412837|NCT02222493|517057388|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
143412838|NCT02222493|517057389|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
143412839|NCT00145470|517057390|FG000|Overall Study|Adverse Event|19|||
143412840|NCT00145470|517057391|FG001|Overall Study|Adverse Event|25|||
143412841|NCT00145470|517057390|FG000|Overall Study|Lack of Efficacy|27|||
143412842|NCT00145470|517057391|FG001|Overall Study|Lack of Efficacy|13|||
143412843|NCT00145470|517057390|FG000|Overall Study|Withdrawal by Subject|36|||
143412844|NCT00145470|517057391|FG001|Overall Study|Withdrawal by Subject|34|||
143412845|NCT00145470|517057390|FG000|Overall Study|Lost to Follow-up|21|||
143412846|NCT00145470|517057391|FG001|Overall Study|Lost to Follow-up|17|||
143412847|NCT00145470|517057390|FG000|Overall Study|Reason Not Reported|9|||
143412848|NCT00145470|517057391|FG001|Overall Study|Reason Not Reported|9|||
143412849|NCT00676091|517057394|FG000|Infant Series|Parent or legal guardian request|10|||
143412850|NCT00676091|517057395|FG001|Infant Series|Parent or legal guardian request|8|||
143412851|NCT00676091|517057394|FG000|Infant Series|Protocol Violation|6|||
143412852|NCT00676091|517057395|FG001|Infant Series|Protocol Violation|3|||
143412853|NCT00676091|517057394|FG000|Infant Series|Adverse Event|2|||
143412854|NCT00676091|517057395|FG001|Infant Series|Adverse Event|3|||
143412855|NCT00676091|517057394|FG000|Infant Series|Failed to return|1|||
143412856|NCT00676091|517057395|FG001|Infant Series|Failed to return|3|||
143412857|NCT00676091|517057394|FG000|Infant Series|Lost to Follow-up|1|||
143412858|NCT00676091|517057395|FG001|Infant Series|Lost to Follow-up|0|||
143412859|NCT00676091|517057394|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
143412860|NCT00676091|517057395|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
143412861|NCT00676091|517057394|FG000|After Infant Series|Adverse Event|0|||
143412862|NCT00676091|517057395|FG001|After Infant Series|Adverse Event|1|||
143412863|NCT00676091|517057394|FG000|After Infant Series|Protocol Violation|0|||
143412864|NCT00676091|517057395|FG001|After Infant Series|Protocol Violation|1|||
143412865|NCT00676091|517057394|FG000|After Infant Series|Failed to return|1|||
143412866|NCT00676091|517057395|FG001|After Infant Series|Failed to return|1|||
143412867|NCT00676091|517057394|FG000|Toddler Dose|Failed to return|2|||
143412868|NCT00676091|517057395|FG001|Toddler Dose|Failed to return|0|||
143412869|NCT00676091|517057394|FG000|Toddler Dose|Parent or legal guardian request|1|||
143412870|NCT00676091|517057395|FG001|Toddler Dose|Parent or legal guardian request|0|||
143412871|NCT00933270|517057399|FG000|Overall Study|Withdrawal by Subject|26|||
143412872|NCT00933270|517057399|FG000|Overall Study|Insufficient Follow-up|10|||
143412873|NCT00933270|517057399|FG000|Overall Study|Lost to Follow-up|14|||
143412874|NCT00933270|517057399|FG000|Overall Study|Adverse Event|1|||
143412875|NCT00933270|517057399|FG000|Overall Study|Missed Visit|2|||
143412876|NCT00933270|517057399|FG000|Overall Study|Death|24|||
143412877|NCT00933270|517057399|FG000|Overall Study|Moved or would not return|10|||
143412878|NCT01000805|517057400|FG000|Overall Study|Adverse Event|21|||
143412879|NCT01000805|517057401|FG001|Overall Study|Adverse Event|9|||
143412880|NCT01000805|517057400|FG000|Overall Study|Lack of Efficacy|5|||
143412881|NCT01000805|517057401|FG001|Overall Study|Lack of Efficacy|16|||
143412882|NCT01000805|517057400|FG000|Overall Study|Lost to Follow-up|16|||
143412883|NCT01000805|517057401|FG001|Overall Study|Lost to Follow-up|21|||
143412884|NCT01000805|517057400|FG000|Overall Study|Physician Decision|0|||
143412885|NCT01000805|517057401|FG001|Overall Study|Physician Decision|1|||
143412886|NCT01000805|517057400|FG000|Overall Study|Protocol Violation|12|||
143412887|NCT01000805|517057401|FG001|Overall Study|Protocol Violation|8|||
143412888|NCT01000805|517057400|FG000|Overall Study|Withdrawal by Subject|16|||
143412889|NCT01000805|517057401|FG001|Overall Study|Withdrawal by Subject|6|||
143412890|NCT01000805|517057400|FG000|Overall Study|Sponsor Decision|0|||
143412891|NCT01000805|517057401|FG001|Overall Study|Sponsor Decision|1|||
143412892|NCT03924869|517057405|FG000|Overall Study|Death|66|||
143412893|NCT03924869|517057406|FG001|Overall Study|Death|53|||
143412894|NCT03924869|517057405|FG000|Overall Study|Lost to Follow-up|2|||
143412895|NCT03924869|517057406|FG001|Overall Study|Lost to Follow-up|0|||
143412896|NCT03924869|517057405|FG000|Overall Study|Physician Decision|0|||
143412897|NCT03924869|517057406|FG001|Overall Study|Physician Decision|3|||
143412898|NCT03924869|517057405|FG000|Overall Study|Withdrawal by Subject|5|||
143412899|NCT03924869|517057406|FG001|Overall Study|Withdrawal by Subject|1|||
143412900|NCT03924869|517057405|FG000|Overall Study|Participants Ongoing|154|||
143412901|NCT03924869|517057406|FG001|Overall Study|Participants Ongoing|164|||
143412902|NCT02542943|517057407|FG000|Overall Study|Lost to Follow-up|1|||
143412903|NCT02542943|517057408|FG001|Overall Study|Lost to Follow-up|0|||
143412904|NCT02542943|517057409|FG002|Overall Study|Lost to Follow-up|0|||
143412905|NCT02542943|517057407|FG000|Overall Study|Withdrawal by Subject|0|||
143412906|NCT02542943|517057408|FG001|Overall Study|Withdrawal by Subject|1|||
143412907|NCT02542943|517057409|FG002|Overall Study|Withdrawal by Subject|0|||
143412908|NCT04762277|517057412|FG000|Overall Study|Withdrawal by Subject|0|||
143412909|NCT04762277|517057413|FG001|Overall Study|Withdrawal by Subject|2|||
143412910|NCT04762277|517057412|FG000|Overall Study|Protocol Violation|0|||
143412911|NCT04762277|517057413|FG001|Overall Study|Protocol Violation|1|||
143412912|NCT04762277|517057412|FG000|Overall Study|Adverse Event|1|||
143412913|NCT04762277|517057413|FG001|Overall Study|Adverse Event|0|||
143412914|NCT03343704|517057414|FG000|Overall Study|Refused to complete follow up|0|||
143412915|NCT03343704|517057415|FG001|Overall Study|Refused to complete follow up|1|||
143412916|NCT03343704|517057414|FG000|Overall Study|Death|0|||
143412917|NCT03343704|517057415|FG001|Overall Study|Death|1|||
143412918|NCT03343704|517057414|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
143412919|NCT03343704|517057415|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
143412920|NCT00302211|517057419|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
143412921|NCT00302211|517057420|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
143412922|NCT00302211|517057421|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
143412923|NCT00302211|517057422|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
143412924|NCT00302211|517057423|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
143412925|NCT00302211|517057419|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
143412926|NCT00302211|517057420|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
143412927|NCT00302211|517057421|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
143412928|NCT00302211|517057422|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
143412929|NCT00302211|517057423|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
143412930|NCT00302211|517057419|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
143412931|NCT00302211|517057420|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
143412932|NCT00302211|517057421|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
143412933|NCT00302211|517057422|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
143412934|NCT00302211|517057423|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
143412935|NCT00302211|517057419|FG000|Double Blind Period (New Patients)|Disease progression|0|||
143412936|NCT00302211|517057420|FG001|Double Blind Period (New Patients)|Disease progression|1|||
143412937|NCT00302211|517057421|FG002|Double Blind Period (New Patients)|Disease progression|1|||
143412938|NCT00302211|517057422|FG003|Double Blind Period (New Patients)|Disease progression|0|||
143412939|NCT00302211|517057423|FG004|Double Blind Period (New Patients)|Disease progression|0|||
143412940|NCT00302211|517057419|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
143412941|NCT00302211|517057420|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
143412942|NCT00302211|517057421|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
143412943|NCT00302211|517057422|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
143412944|NCT00302211|517057423|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
143412945|NCT00302211|517057419|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
143412946|NCT00302211|517057420|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
143412947|NCT00302211|517057421|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
143412948|NCT00302211|517057422|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
143412949|NCT00302211|517057423|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
143412950|NCT00302211|517057419|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
143412951|NCT00302211|517057420|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
143412952|NCT00302211|517057421|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
143412953|NCT00302211|517057422|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
143412954|NCT00302211|517057423|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
143412955|NCT00302211|517057419|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
143412956|NCT00302211|517057420|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
143412957|NCT00302211|517057421|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
143412958|NCT00302211|517057422|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
143412959|NCT00302211|517057423|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
143412960|NCT00302211|517057419|FG000|Open Label-Patients From Double-Blind|Death|0|||
143412961|NCT00302211|517057420|FG001|Open Label-Patients From Double-Blind|Death|0|||
143412962|NCT00302211|517057421|FG002|Open Label-Patients From Double-Blind|Death|0|||
143412963|NCT00302211|517057422|FG003|Open Label-Patients From Double-Blind|Death|1|||
143412964|NCT00302211|517057423|FG004|Open Label-Patients From Double-Blind|Death|1|||
143412965|NCT00302211|517057419|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
143412966|NCT00302211|517057420|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
143412967|NCT00302211|517057421|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
143412968|NCT00302211|517057422|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
143412969|NCT00302211|517057423|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
143412970|NCT00302211|517057419|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
143412971|NCT00302211|517057420|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
143412972|NCT00302211|517057421|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
143412973|NCT00302211|517057422|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
143412974|NCT00302211|517057423|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
143412975|NCT00302211|517057419|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
143412976|NCT00302211|517057420|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
143412977|NCT00302211|517057421|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
143412978|NCT00302211|517057422|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
143412979|NCT00302211|517057423|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
143412980|NCT05349721|517059138|FG000|Part A (24 Weeks)|Adverse Event|9|||
143412981|NCT05349721|517059139|FG001|Part A (24 Weeks)|Adverse Event|2|||
143412982|NCT05349721|517059138|FG000|Part A (24 Weeks)|Death|8|||
143412983|NCT05349721|517059139|FG001|Part A (24 Weeks)|Death|3|||
143412984|NCT05349721|517059138|FG000|Part A (24 Weeks)|Disease Progression|1|||
143412985|NCT05349721|517059139|FG001|Part A (24 Weeks)|Disease Progression|1|||
143412986|NCT05349721|517059138|FG000|Part A (24 Weeks)|Screen Failure|2|||
143412987|NCT05349721|517059139|FG001|Part A (24 Weeks)|Screen Failure|0|||
143412988|NCT05349721|517059138|FG000|Part A (24 Weeks)|Withdrawal by Subject|18|||
143412989|NCT05349721|517059139|FG001|Part A (24 Weeks)|Withdrawal by Subject|7|||
143412990|NCT05349721|517059138|FG000|Part A (24 Weeks)|Other Than Specified|5|||
143412991|NCT05349721|517059139|FG001|Part A (24 Weeks)|Other Than Specified|1|||
143412992|NCT05349721|517059138|FG000|Part B (28 Weeks)|Adverse Event|3|||
143412993|NCT05349721|517059139|FG001|Part B (28 Weeks)|Adverse Event|0|||
143412994|NCT05349721|517059138|FG000|Part B (28 Weeks)|Death|21|||
143412995|NCT05349721|517059139|FG001|Part B (28 Weeks)|Death|11|||
143412996|NCT05349721|517059138|FG000|Part B (28 Weeks)|Disease Progression|2|||
143412997|NCT05349721|517059139|FG001|Part B (28 Weeks)|Disease Progression|1|||
143412998|NCT05349721|517059138|FG000|Part B (28 Weeks)|Lost to Follow-up|2|||
143412999|NCT05349721|517059139|FG001|Part B (28 Weeks)|Lost to Follow-up|1|||
143413000|NCT05349721|517059138|FG000|Part B (28 Weeks)|Physician Decision|1|||
143413001|NCT05349721|517059139|FG001|Part B (28 Weeks)|Physician Decision|0|||
143413002|NCT05349721|517059138|FG000|Part B (28 Weeks)|Study terminated by sponsor|85|||
143413003|NCT05349721|517059139|FG001|Part B (28 Weeks)|Study terminated by sponsor|53|||
143413004|NCT05349721|517059138|FG000|Part B (28 Weeks)|Withdrawal by Subject|17|||
143413005|NCT05349721|517059139|FG001|Part B (28 Weeks)|Withdrawal by Subject|5|||
143413006|NCT05349721|517059138|FG000|Part B (28 Weeks)|Other Than Specified|4|||
143413007|NCT05349721|517059139|FG001|Part B (28 Weeks)|Other Than Specified|2|||
143413008|NCT05349721|517059138|FG000|Part C (108 Weeks)|Death|0|||
143413009|NCT05349721|517059139|FG001|Part C (108 Weeks)|Death|1|||
143413010|NCT05349721|517059138|FG000|Part C (108 Weeks)|Lost to Follow-up|0|||
143413011|NCT05349721|517059139|FG001|Part C (108 Weeks)|Lost to Follow-up|1|||
143413012|NCT05349721|517059138|FG000|Part C (108 Weeks)|Study terminated by sponsor|34|||
143413013|NCT05349721|517059139|FG001|Part C (108 Weeks)|Study terminated by sponsor|23|||
143413014|NCT05349721|517059138|FG000|Part C (108 Weeks)|Withdrawal by Subject|1|||
143413015|NCT05349721|517059139|FG001|Part C (108 Weeks)|Withdrawal by Subject|1|||
143413016|NCT03136159|517059141|FG000|Overall Study|chorioamnionitis|2|||
143413017|NCT03136159|517059142|FG001|Overall Study|chorioamnionitis|0|||
143413018|NCT03136159|517059141|FG000|Overall Study|vertical skin incision|1|||
143413019|NCT03136159|517059142|FG001|Overall Study|vertical skin incision|0|||
143413020|NCT03136159|517059141|FG000|Overall Study|additional dressing|1|||
143413021|NCT03136159|517059142|FG001|Overall Study|additional dressing|0|||
143413022|NCT03136159|517059141|FG000|Overall Study|never got dressing placed|1|||
143413023|NCT03136159|517059142|FG001|Overall Study|never got dressing placed|0|||
143413024|NCT03823703|517059143|FG000|Overall Study|Sponsor request|0|||
143413025|NCT03823703|517059144|FG001|Overall Study|Sponsor request|3|||
143413026|NCT03823703|517059145|FG002|Overall Study|Sponsor request|4|||
143413027|NCT03823703|517059143|FG000|Overall Study|Adverse Event|3|||
143413028|NCT03823703|517059144|FG001|Overall Study|Adverse Event|1|||
143413029|NCT03823703|517059145|FG002|Overall Study|Adverse Event|0|||
143413030|NCT03823703|517059143|FG000|Overall Study|Withdrawal by Subject|0|||
143413031|NCT03823703|517059144|FG001|Overall Study|Withdrawal by Subject|1|||
143413032|NCT03823703|517059145|FG002|Overall Study|Withdrawal by Subject|0|||
143413033|NCT00985088|517059146|FG000|Overall Study|Serious Adverse Event|1|||
143413034|NCT00985088|517059147|FG001|Overall Study|Serious Adverse Event|1|||
143413035|NCT00985088|517059148|FG002|Overall Study|Serious Adverse Event|0|||
143413036|NCT00985088|517059149|FG003|Overall Study|Serious Adverse Event|0|||
143413037|NCT00985088|517059150|FG004|Overall Study|Serious Adverse Event|0|||
143413038|NCT00985088|517059151|FG005|Overall Study|Serious Adverse Event|0|||
143413039|NCT00985088|517059152|FG006|Overall Study|Serious Adverse Event|0|||
143413040|NCT00985088|517059153|FG007|Overall Study|Serious Adverse Event|1|||
143413041|NCT00985088|517059146|FG000|Overall Study|Adverse Event|0|||
143413042|NCT00985088|517059147|FG001|Overall Study|Adverse Event|0|||
143413043|NCT00985088|517059148|FG002|Overall Study|Adverse Event|1|||
143413044|NCT00985088|517059149|FG003|Overall Study|Adverse Event|0|||
143413045|NCT00985088|517059150|FG004|Overall Study|Adverse Event|0|||
143413046|NCT00985088|517059151|FG005|Overall Study|Adverse Event|0|||
143413047|NCT00985088|517059152|FG006|Overall Study|Adverse Event|0|||
143413048|NCT00985088|517059153|FG007|Overall Study|Adverse Event|0|||
143413049|NCT00985088|517059146|FG000|Overall Study|Withdrawal by Subject|4|||
143413050|NCT00985088|517059147|FG001|Overall Study|Withdrawal by Subject|0|||
143413051|NCT00985088|517059148|FG002|Overall Study|Withdrawal by Subject|0|||
143413052|NCT00985088|517059149|FG003|Overall Study|Withdrawal by Subject|1|||
143413053|NCT00985088|517059150|FG004|Overall Study|Withdrawal by Subject|3|||
143413054|NCT00985088|517059151|FG005|Overall Study|Withdrawal by Subject|2|||
143413055|NCT00985088|517059152|FG006|Overall Study|Withdrawal by Subject|1|||
143413056|NCT00985088|517059153|FG007|Overall Study|Withdrawal by Subject|2|||
143413057|NCT00985088|517059146|FG000|Overall Study|Migrated/moved from study area|0|||
143413058|NCT00985088|517059147|FG001|Overall Study|Migrated/moved from study area|0|||
143413059|NCT00985088|517059148|FG002|Overall Study|Migrated/moved from study area|1|||
143413060|NCT00985088|517059149|FG003|Overall Study|Migrated/moved from study area|0|||
143413061|NCT00985088|517059150|FG004|Overall Study|Migrated/moved from study area|0|||
143413062|NCT00985088|517059151|FG005|Overall Study|Migrated/moved from study area|0|||
143413063|NCT00985088|517059152|FG006|Overall Study|Migrated/moved from study area|0|||
143413064|NCT00985088|517059153|FG007|Overall Study|Migrated/moved from study area|1|||
143413065|NCT00985088|517059146|FG000|Overall Study|Lost to Follow-up|6|||
143413066|NCT00985088|517059147|FG001|Overall Study|Lost to Follow-up|1|||
143413067|NCT00985088|517059148|FG002|Overall Study|Lost to Follow-up|2|||
143413068|NCT00985088|517059149|FG003|Overall Study|Lost to Follow-up|6|||
143413069|NCT00985088|517059150|FG004|Overall Study|Lost to Follow-up|6|||
143413070|NCT00985088|517059151|FG005|Overall Study|Lost to Follow-up|5|||
143413071|NCT00985088|517059152|FG006|Overall Study|Lost to Follow-up|3|||
143413072|NCT00985088|517059153|FG007|Overall Study|Lost to Follow-up|2|||
143413073|NCT01970878|517059154|FG000|Overall Study|Withdrawal by Subject|11|||
143413074|NCT01970878|517059155|FG001|Overall Study|Withdrawal by Subject|10|||
143413075|NCT01970878|517059156|FG002|Overall Study|Withdrawal by Subject|14|||
143413076|NCT01970878|517059157|FG003|Overall Study|Withdrawal by Subject|7|||
143413077|NCT01970878|517059154|FG000|Overall Study|Lost to Follow-up|1|||
143413078|NCT01970878|517059155|FG001|Overall Study|Lost to Follow-up|3|||
143413079|NCT01970878|517059156|FG002|Overall Study|Lost to Follow-up|2|||
143413080|NCT01970878|517059157|FG003|Overall Study|Lost to Follow-up|4|||
143413081|NCT01970878|517059154|FG000|Overall Study|Administrative Reasons|1|||
143413082|NCT01970878|517059155|FG001|Overall Study|Administrative Reasons|0|||
143413083|NCT01970878|517059156|FG002|Overall Study|Administrative Reasons|0|||
143413084|NCT01970878|517059157|FG003|Overall Study|Administrative Reasons|4|||
143413085|NCT01970878|517059154|FG000|Overall Study|Lack of Efficacy|2|||
143413086|NCT01970878|517059155|FG001|Overall Study|Lack of Efficacy|1|||
143413087|NCT01970878|517059156|FG002|Overall Study|Lack of Efficacy|2|||
143413088|NCT01970878|517059157|FG003|Overall Study|Lack of Efficacy|0|||
143413089|NCT01970878|517059154|FG000|Overall Study|Adverse Event|12|||
143413090|NCT01970878|517059155|FG001|Overall Study|Adverse Event|7|||
143413091|NCT01970878|517059156|FG002|Overall Study|Adverse Event|4|||
143413092|NCT01970878|517059157|FG003|Overall Study|Adverse Event|3|||
143413093|NCT01970878|517059154|FG000|Overall Study|Protocol Specified Criteria|10|||
143413094|NCT01970878|517059155|FG001|Overall Study|Protocol Specified Criteria|4|||
143413095|NCT01970878|517059156|FG002|Overall Study|Protocol Specified Criteria|3|||
143413096|NCT01970878|517059157|FG003|Overall Study|Protocol Specified Criteria|6|||
143413097|NCT01970878|517059154|FG000|Overall Study|Physician Decision|0|||
143413098|NCT01970878|517059155|FG001|Overall Study|Physician Decision|1|||
143413099|NCT01970878|517059156|FG002|Overall Study|Physician Decision|1|||
143413100|NCT01970878|517059157|FG003|Overall Study|Physician Decision|0|||
143413101|NCT01970878|517059154|FG000|Overall Study|No Completion Status|0|||
143413102|NCT01970878|517059155|FG001|Overall Study|No Completion Status|1|||
143413103|NCT01970878|517059156|FG002|Overall Study|No Completion Status|0|||
143413104|NCT01970878|517059157|FG003|Overall Study|No Completion Status|0|||
143413105|NCT06571695|517059159|FG000|Overall Study|Lost to Follow-up|1|||
143413106|NCT06571695|517059160|FG001|Overall Study|Lost to Follow-up|6|||
143413107|NCT04921358|517059161|FG000|Overall Study|Withdrawal by Subject|6|||
143413108|NCT04921358|517059162|FG001|Overall Study|Withdrawal by Subject|13|||
143413109|NCT04921358|517059161|FG000|Overall Study|Lost to Follow-up|3|||
143413110|NCT04921358|517059162|FG001|Overall Study|Lost to Follow-up|6|||
143413111|NCT04921358|517059161|FG000|Overall Study|Study Terminated by Sponsor|86|||
143413112|NCT04921358|517059162|FG001|Overall Study|Study Terminated by Sponsor|89|||
143413113|NCT04921358|517059161|FG000|Overall Study|Death|92|||
143413114|NCT04921358|517059162|FG001|Overall Study|Death|82|||
143413115|NCT04926857|517059163|FG000|Overall Study|Withdrawal by Subject|40|||
143413116|NCT04926857|517059163|FG000|Overall Study|Death|9|||
143413117|NCT04926857|517059163|FG000|Overall Study|Study product no longer in use|44|||
143413118|NCT04926857|517059163|FG000|Overall Study|Inadequate data to address primary objective|16|||
143413119|NCT02637063|517059164|FG000|Overall Study|Lost to Follow-up|3|||
143413120|NCT02637063|517059165|FG001|Overall Study|Lost to Follow-up|2|||
143413121|NCT02637063|517059166|FG002|Overall Study|Lost to Follow-up|3|||
143413122|NCT02637063|517059164|FG000|Overall Study|Withdrawal by Subject|2|||
143413123|NCT02637063|517059165|FG001|Overall Study|Withdrawal by Subject|2|||
143413124|NCT02637063|517059166|FG002|Overall Study|Withdrawal by Subject|3|||
143413125|NCT00597376|517059167|FG000|Overall Study|Withdrawal by Subject|4|||
143413126|NCT00597376|517059168|FG001|Overall Study|Withdrawal by Subject|3|||
143413127|NCT00597376|517059167|FG000|Overall Study|Adverse Event|4|||
143413128|NCT00597376|517059168|FG001|Overall Study|Adverse Event|1|||
143413129|NCT02634307|517059173|FG000|Overall Study|Adverse Event|50|||
143413130|NCT02634307|517059174|FG001|Overall Study|Adverse Event|24|||
143413131|NCT02634307|517059175|FG002|Overall Study|Adverse Event|14|||
143413132|NCT02634307|517059173|FG000|Overall Study|Lost to Follow-up|21|||
143413133|NCT02634307|517059174|FG001|Overall Study|Lost to Follow-up|5|||
143413134|NCT02634307|517059175|FG002|Overall Study|Lost to Follow-up|6|||
143413135|NCT02634307|517059173|FG000|Overall Study|Pregnancy|5|||
143413136|NCT02634307|517059174|FG001|Overall Study|Pregnancy|1|||
143413137|NCT02634307|517059175|FG002|Overall Study|Pregnancy|3|||
143413138|NCT02634307|517059173|FG000|Overall Study|Withdrawal by Subject|38|||
143413139|NCT02634307|517059174|FG001|Overall Study|Withdrawal by Subject|24|||
143413140|NCT02634307|517059175|FG002|Overall Study|Withdrawal by Subject|18|||
143413141|NCT02634307|517059173|FG000|Overall Study|Non-Compliance with Study Drug|0|||
143413142|NCT02634307|517059174|FG001|Overall Study|Non-Compliance with Study Drug|2|||
143413143|NCT02634307|517059175|FG002|Overall Study|Non-Compliance with Study Drug|2|||
143413144|NCT02634307|517059173|FG000|Overall Study|Lack of Efficacy|1|||
143413145|NCT02634307|517059174|FG001|Overall Study|Lack of Efficacy|5|||
143413146|NCT02634307|517059175|FG002|Overall Study|Lack of Efficacy|3|||
143413147|NCT02634307|517059173|FG000|Overall Study|Physician Decision|7|||
143413148|NCT02634307|517059174|FG001|Overall Study|Physician Decision|5|||
143413149|NCT02634307|517059175|FG002|Overall Study|Physician Decision|5|||
143413150|NCT02634307|517059173|FG000|Overall Study|Reason not Specified|3|||
143413151|NCT02634307|517059174|FG001|Overall Study|Reason not Specified|5|||
143413152|NCT02634307|517059175|FG002|Overall Study|Reason not Specified|10|||
143413153|NCT02132949|517059176|FG000|Overall Study|Death|7|||
143413154|NCT02132949|517059177|FG001|Overall Study|Death|13|||
143413155|NCT02132949|517059176|FG000|Overall Study|Lost to Follow-up|14|||
143413156|NCT02132949|517059177|FG001|Overall Study|Lost to Follow-up|4|||
143413157|NCT02132949|517059176|FG000|Overall Study|Withdrawal by Subject|6|||
143413158|NCT02132949|517059177|FG001|Overall Study|Withdrawal by Subject|5|||
143413159|NCT02132949|517059176|FG000|Overall Study|Noncompliance|5|||
143413160|NCT02132949|517059177|FG001|Overall Study|Noncompliance|1|||
143413161|NCT02132949|517059176|FG000|Overall Study|Physician Decision|3|||
143413162|NCT02132949|517059177|FG001|Overall Study|Physician Decision|1|||
143413163|NCT02132949|517059176|FG000|Overall Study|Disease Progression|3|||
143413164|NCT02132949|517059177|FG001|Overall Study|Disease Progression|0|||
143413165|NCT02132949|517059176|FG000|Overall Study|Adverse Event|2|||
143413166|NCT02132949|517059177|FG001|Overall Study|Adverse Event|1|||
143413167|NCT02132949|517059176|FG000|Overall Study|Withdrew Prior to Treatment|1|||
143413168|NCT02132949|517059177|FG001|Overall Study|Withdrew Prior to Treatment|2|||
143413169|NCT02132949|517059176|FG000|Overall Study|Reason Unspecified|0|||
143413170|NCT02132949|517059177|FG001|Overall Study|Reason Unspecified|1|||
143413171|NCT00667017|517059178|FG000|Overall Study|Withdrawal by Subject|1|||
143413172|NCT01823224|517059179|FG000|Overall Study|Lost to Follow-up|5|||
143413173|NCT01823224|517059180|FG001|Overall Study|Lost to Follow-up|6|||
143413174|NCT01823224|517059179|FG000|Overall Study|didn't qualify|1|||
143413175|NCT01823224|517059180|FG001|Overall Study|didn't qualify|2|||
143413176|NCT01823224|517059179|FG000|Overall Study|pharmacy error|0|||
143413177|NCT01823224|517059180|FG001|Overall Study|pharmacy error|1|||
143413178|NCT01823224|517059179|FG000|Overall Study|missed med dose|0|||
143413179|NCT01823224|517059180|FG001|Overall Study|missed med dose|1|||
143413180|NCT01823224|517059179|FG000|Overall Study|Withdrawal by Subject|0|||
143413181|NCT01823224|517059180|FG001|Overall Study|Withdrawal by Subject|1|||
143413182|NCT00745875|517059184|FG000|Overall Study|Continuing study treatment|4|||
143413183|NCT00745875|517059185|FG001|Overall Study|Continuing study treatment|4|||
143413184|NCT01532648|517059186|FG000|Overall Study|Lost to Follow-up|3|||
143413185|NCT01532648|517059187|FG001|Overall Study|Lost to Follow-up|4|||
143413186|NCT01532648|517059186|FG000|Overall Study|Lack of Efficacy|4|||
143413187|NCT01532648|517059187|FG001|Overall Study|Lack of Efficacy|1|||
143413188|NCT01532648|517059186|FG000|Overall Study|Protocol Violation|1|||
143413189|NCT01532648|517059187|FG001|Overall Study|Protocol Violation|1|||
143413190|NCT01532648|517059186|FG000|Overall Study|Adverse Event|12|||
143413191|NCT01532648|517059187|FG001|Overall Study|Adverse Event|9|||
143413192|NCT01532648|517059186|FG000|Overall Study|Withdrawal by Subject|16|||
143413193|NCT01532648|517059187|FG001|Overall Study|Withdrawal by Subject|2|||
143413194|NCT02310581|517059188|FG000|Overall Study|Adverse Event|1|||
143413195|NCT02310581|517059189|FG001|Overall Study|Adverse Event|1|||
143413196|NCT02310581|517059190|FG002|Overall Study|Adverse Event|1|||
143413197|NCT02310581|517059191|FG003|Overall Study|Adverse Event|0|||
143413198|NCT02310581|517059188|FG000|Overall Study|Withdrawal by Subject|2|||
143413199|NCT02310581|517059189|FG001|Overall Study|Withdrawal by Subject|1|||
143413200|NCT02310581|517059190|FG002|Overall Study|Withdrawal by Subject|0|||
143413201|NCT02310581|517059191|FG003|Overall Study|Withdrawal by Subject|1|||
143413202|NCT02824198|517059192|FG000|Overall Study|Non-compliance with the protocol|5|||
143413203|NCT02824198|517059193|FG001|Overall Study|Non-compliance with the protocol|1|||
143413204|NCT02824198|517059192|FG000|Overall Study|Lost to Follow-up|5|||
143413205|NCT02824198|517059193|FG001|Overall Study|Lost to Follow-up|2|||
143413206|NCT02824198|517059192|FG000|Overall Study|Withdrawal by Subject|5|||
143413207|NCT02824198|517059193|FG001|Overall Study|Withdrawal by Subject|0|||
143413208|NCT01833455|517059194|FG000|Overall Study|Withdrawal by Subject|1|||
143413209|NCT01833455|517059195|FG001|Overall Study|Withdrawal by Subject|0|||
143413210|NCT03883828|517059196|FG000|Overall Study|Did not start radiotherapy|1|||
143413211|NCT03883828|517059197|FG001|Overall Study|Did not start radiotherapy|2|||
143413212|NCT01256359|517059198|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
143413213|NCT01256359|517059199|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
143413214|NCT01256359|517059198|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
143413215|NCT01256359|517059199|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
143413216|NCT03781375|517059204|FG000|Double-blind Phase|Adverse Event|0|||
143413217|NCT03781375|517059205|FG001|Double-blind Phase|Adverse Event|1|||
143413218|NCT03781375|517059204|FG000|Double-blind Phase|Lack of Response|6|||
143413219|NCT03781375|517059205|FG001|Double-blind Phase|Lack of Response|2|||
143413220|NCT03781375|517059204|FG000|Double-blind Phase|Other|1|||
143413221|NCT03781375|517059205|FG001|Double-blind Phase|Other|3|||
143413222|NCT03781375|517059204|FG000|Open-label Phase|Protocol Issues|0|||
143413223|NCT03781375|517059205|FG001|Open-label Phase|Protocol Issues|1|||
143413224|NCT03781375|517059204|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
143413225|NCT03781375|517059205|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
143413226|NCT03781375|517059204|FG000|Open-label Phase|Other|2|||
143413227|NCT03781375|517059205|FG001|Open-label Phase|Other|2|||
143413228|NCT01034306|517059207|FG000|Overall Study|Adverse Event|1|||
143413229|NCT01034306|517059208|FG001|Overall Study|Adverse Event|0|||
143413230|NCT01034306|517059207|FG000|Overall Study|Lost to Follow-up|0|||
143413231|NCT01034306|517059208|FG001|Overall Study|Lost to Follow-up|1|||
143413232|NCT01034306|517059207|FG000|Overall Study|Withdrawal by Subject|2|||
143413233|NCT01034306|517059208|FG001|Overall Study|Withdrawal by Subject|2|||
143413234|NCT01034306|517059207|FG000|Overall Study|hospitalized and decided to stop|1|||
143413235|NCT01034306|517059208|FG001|Overall Study|hospitalized and decided to stop|0|||
143413236|NCT01034306|517059207|FG000|Overall Study|Noncomplience|1|||
143413237|NCT01034306|517059208|FG001|Overall Study|Noncomplience|0|||
143413238|NCT02203799|517059209|FG000|Overall Study|Withdrawal by Subject|3|||
143413239|NCT02384382|517059210|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
143413240|NCT02384382|517059210|FG000|Overall Study|Death|1|||
143413241|NCT02384382|517059210|FG000|Overall Study|Adverse Event|1|||
143413242|NCT02384382|517059210|FG000|Overall Study|Disease progression|16|||
143413243|NCT02113449|517059211|FG000|Overall Study|Adverse Event|4|||
143413244|NCT04638816|517059214|FG000|Overall Study|Withdrawal by Subject|0|||
143413245|NCT04638816|517059215|FG001|Overall Study|Withdrawal by Subject|1|||
143413246|NCT04638816|517059214|FG000|Overall Study|Lost to Follow-up|0|||
143413247|NCT04638816|517059215|FG001|Overall Study|Lost to Follow-up|1|||
143413248|NCT02251652|517059216|FG000|Overall Study|Withdrawal by Subject|1|||
143413249|NCT01074242|517059217|FG000|Overall Study|Case report before date of contract|40|||
143413250|NCT01074242|517059217|FG000|Overall Study|Lost to Follow-up|1|||
143413251|NCT01074242|517059217|FG000|Overall Study|Case report unclear|6|||
143413252|NCT01074242|517059217|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
143413253|NCT01074242|517059217|FG000|Overall Study|Duplicate Case Report Form|5|||
143413254|NCT00109031|517059218|FG000|Overall Study|Adverse Event|0|||
143413255|NCT00109031|517059219|FG001|Overall Study|Adverse Event|0|||
143413256|NCT00109031|517059220|FG002|Overall Study|Adverse Event|1|||
143413257|NCT00109031|517059221|FG003|Overall Study|Adverse Event|0|||
143413258|NCT00109031|517059218|FG000|Overall Study|Withdrawal by Subject|0|||
143413259|NCT00109031|517059219|FG001|Overall Study|Withdrawal by Subject|1|||
143413260|NCT00109031|517059220|FG002|Overall Study|Withdrawal by Subject|0|||
143413261|NCT00109031|517059221|FG003|Overall Study|Withdrawal by Subject|0|||
143413262|NCT00109031|517059218|FG000|Overall Study|Physician Decision|0|||
143413263|NCT00109031|517059219|FG001|Overall Study|Physician Decision|1|||
143413264|NCT00109031|517059220|FG002|Overall Study|Physician Decision|0|||
143413265|NCT00109031|517059221|FG003|Overall Study|Physician Decision|0|||
143413266|NCT00109031|517059218|FG000|Overall Study|Protocol Violation|0|||
143413267|NCT00109031|517059219|FG001|Overall Study|Protocol Violation|0|||
143413268|NCT00109031|517059220|FG002|Overall Study|Protocol Violation|1|||
143413269|NCT00109031|517059221|FG003|Overall Study|Protocol Violation|0|||
143413270|NCT01328496|517059222|FG000|Overall Study|Significant Change in Health Status|1|||
143413271|NCT01328496|517059223|FG001|Overall Study|Significant Change in Health Status|0|||
143413272|NCT02091752|517059226|FG000|Overall Study|Study terminated by Sponsor|2|||
143413273|NCT02091752|517059226|FG000|Overall Study|Adverse Event|1|||
143413274|NCT04029090|517059227|FG000|Overall Study|Protocol Violation|1|||
143413275|NCT04029090|517059228|FG001|Overall Study|Protocol Violation|0|||
143413276|NCT04029090|517059229|FG002|Overall Study|Protocol Violation|0|||
143413277|NCT04029090|517059227|FG000|Overall Study|Withdrawal by Subject|0|||
143413278|NCT04029090|517059228|FG001|Overall Study|Withdrawal by Subject|1|||
143413279|NCT04029090|517059229|FG002|Overall Study|Withdrawal by Subject|0|||
143413280|NCT01065779|517059230|FG000|Overall Study|Duplicate Investigation|1|||
143413281|NCT01065779|517059230|FG000|Overall Study|Investigation Before Contract Date|37|||
143413282|NCT01065779|517059230|FG000|Overall Study|Non-enrollment Period Administration|10|||
143413283|NCT01065779|517059230|FG000|Overall Study|Not Administered With Study Drug|17|||
143413284|NCT01065779|517059230|FG000|Overall Study|Failed to Follow-up|10|||
143413285|NCT01065779|517059230|FG000|Overall Study|Inclusion Criteria Violation|7|||
143413286|NCT02157948|517059231|FG000|Overall Study|Withdrawal by Subject|4|||
143413287|NCT02157948|517059232|FG001|Overall Study|Withdrawal by Subject|5|||
143413288|NCT02157948|517059231|FG000|Overall Study|Lost to Follow-up|3|||
143413289|NCT02157948|517059232|FG001|Overall Study|Lost to Follow-up|2|||
143413290|NCT02157948|517059231|FG000|Overall Study|Protocol Specified Criteria|2|||
143413291|NCT02157948|517059232|FG001|Overall Study|Protocol Specified Criteria|1|||
143413292|NCT02157948|517059231|FG000|Overall Study|Decision by Sponsor|0|||
143413293|NCT02157948|517059232|FG001|Overall Study|Decision by Sponsor|1|||
143413294|NCT01604824|517059233|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
143413295|NCT01604824|517059234|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
143413296|NCT01604824|517059235|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
143413297|NCT01604824|517059236|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
143413298|NCT01604824|517059237|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
143413299|NCT01604824|517059238|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
143413300|NCT01604824|517059233|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
143413301|NCT01604824|517059234|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
143413302|NCT01604824|517059235|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
143413303|NCT01604824|517059236|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
143413304|NCT01604824|517059237|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
143413305|NCT01604824|517059238|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
143413306|NCT02630966|517059239|FG000|Overall Study|Adverse Event|1|||
143413307|NCT02630966|517059240|FG001|Overall Study|Adverse Event|3|||
143413308|NCT02630966|517059239|FG000|Overall Study|Significant Protocol Deviation|0|||
143413309|NCT02630966|517059240|FG001|Overall Study|Significant Protocol Deviation|2|||
143413310|NCT02630966|517059239|FG000|Overall Study|Voluntary Withdrawal|1|||
143413311|NCT02630966|517059240|FG001|Overall Study|Voluntary Withdrawal|1|||
143413312|NCT02630966|517059239|FG000|Overall Study|Lack of Efficacy|0|||
143413313|NCT02630966|517059240|FG001|Overall Study|Lack of Efficacy|2|||
143413314|NCT03822832|517059245|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
143413315|NCT03822832|517059246|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
143413316|NCT03822832|517059245|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
143413317|NCT03822832|517059246|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
143413318|NCT03822832|517059245|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
143413319|NCT03822832|517059246|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
143413320|NCT03822832|517059245|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
143413321|NCT03822832|517059246|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
143413322|NCT03822832|517059245|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
143413323|NCT03822832|517059246|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
143413324|NCT03822832|517059245|FG000|Re-allocation|Not re-allocated to open label period|2|||
143413325|NCT03822832|517059246|FG001|Re-allocation|Not re-allocated to open label period|6|||
143413326|NCT03822832|517059245|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
143413327|NCT03822832|517059246|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
143413328|NCT03822832|517059245|FG000|Period 2 - Open Label Period|Adverse Event|0|||
143413329|NCT03822832|517059246|FG001|Period 2 - Open Label Period|Adverse Event|3|||
143413330|NCT04248803|517059248|FG000|Overall Study|Lost to Follow-up|7|||
143413331|NCT04248803|517059249|FG001|Overall Study|Lost to Follow-up|7|||
143413332|NCT04248803|517059250|FG002|Overall Study|Lost to Follow-up|7|||
143413333|NCT04248803|517059251|FG003|Overall Study|Lost to Follow-up|7|||
143413334|NCT04248803|517059252|FG004|Overall Study|Lost to Follow-up|7|||
143413335|NCT04248803|517059253|FG005|Overall Study|Lost to Follow-up|7|||
143413336|NCT05352230|517059254|FG000|First Intervention (3 Months)|study terminated|2|||
143413337|NCT05352230|517059255|FG001|First Intervention (3 Months)|study terminated|2|||
143413338|NCT01683409|517059256|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
143413339|NCT01683409|517059257|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
143413340|NCT01683409|517059258|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
143413341|NCT01683409|517059259|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
143413342|NCT01683409|517059260|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
143413343|NCT01683409|517059256|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
143413344|NCT01683409|517059257|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
143413345|NCT01683409|517059258|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
143413346|NCT01683409|517059259|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
143413347|NCT01683409|517059260|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
143413348|NCT01683409|517059256|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
143413349|NCT01683409|517059257|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
143413350|NCT01683409|517059258|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
143413351|NCT01683409|517059259|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
143413352|NCT01683409|517059260|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
143413353|NCT01683409|517059256|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
143413354|NCT01683409|517059257|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
143413355|NCT01683409|517059258|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
143413356|NCT01683409|517059259|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
143413357|NCT01683409|517059260|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
143413358|NCT01683409|517059256|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
143413359|NCT01683409|517059257|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
143413360|NCT01683409|517059258|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
143413361|NCT01683409|517059259|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
143413362|NCT01683409|517059260|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
143413363|NCT01683409|517059256|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
143413364|NCT01683409|517059257|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
143413365|NCT01683409|517059258|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
143413366|NCT01683409|517059259|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
143413367|NCT01683409|517059260|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
143413368|NCT01683409|517059256|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
143413369|NCT01683409|517059257|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
143413370|NCT01683409|517059258|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
143413371|NCT01683409|517059259|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
143413372|NCT01683409|517059260|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
143413373|NCT01683409|517059256|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
143413374|NCT01683409|517059257|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
143413375|NCT01683409|517059258|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
143413376|NCT01683409|517059259|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
143413377|NCT01683409|517059260|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
143413378|NCT01683409|517059256|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
143413379|NCT01683409|517059257|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
143413380|NCT01683409|517059258|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
143413381|NCT01683409|517059259|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
143413382|NCT01683409|517059260|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
143413383|NCT01683409|517059256|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
143413384|NCT01683409|517059257|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
143413385|NCT01683409|517059258|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
143413386|NCT01683409|517059259|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
143413387|NCT01683409|517059260|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
143413388|NCT01683409|517059256|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
143413389|NCT01683409|517059257|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
143413390|NCT01683409|517059258|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
143413391|NCT01683409|517059259|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
143413392|NCT01683409|517059260|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
143413393|NCT04218864|517059261|FG000|Overall Study|Lost to Follow-up|8|||
143413394|NCT04218864|517059262|FG001|Overall Study|Lost to Follow-up|4|||
143413395|NCT04218864|517059261|FG000|Overall Study|Withdrawal by Subject|1|||
143413396|NCT04218864|517059262|FG001|Overall Study|Withdrawal by Subject|3|||
143413397|NCT03520036|517059263|FG000|Overall Study|Adverse Event|1|||
143413398|NCT03520036|517059264|FG001|Overall Study|Adverse Event|2|||
143413399|NCT03520036|517059265|FG002|Overall Study|Adverse Event|0|||
143413400|NCT03520036|517059263|FG000|Overall Study|Protocol Violation|1|||
143413401|NCT03520036|517059264|FG001|Overall Study|Protocol Violation|0|||
143413402|NCT03520036|517059265|FG002|Overall Study|Protocol Violation|0|||
143413403|NCT03520036|517059263|FG000|Overall Study|Withdrawal by Subject|0|||
143413404|NCT03520036|517059264|FG001|Overall Study|Withdrawal by Subject|1|||
143413405|NCT03520036|517059265|FG002|Overall Study|Withdrawal by Subject|4|||
143413406|NCT03520036|517059263|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
143413407|NCT03520036|517059264|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
143413408|NCT03520036|517059265|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
143413409|NCT01227421|517059266|FG000|Overall Study|Lost to Follow-up|6|||
143413410|NCT01227421|517059267|FG001|Overall Study|Lost to Follow-up|7|||
143413411|NCT01227421|517059268|FG002|Overall Study|Lost to Follow-up|5|||
143413412|NCT01227421|517059266|FG000|Overall Study|Adverse Event|2|||
143413413|NCT01227421|517059267|FG001|Overall Study|Adverse Event|7|||
143413414|NCT01227421|517059268|FG002|Overall Study|Adverse Event|2|||
143413415|NCT01227421|517059266|FG000|Overall Study|Withdrawal by Subject|1|||
143413416|NCT01227421|517059267|FG001|Overall Study|Withdrawal by Subject|2|||
143413417|NCT01227421|517059268|FG002|Overall Study|Withdrawal by Subject|1|||
143413418|NCT01227421|517059266|FG000|Overall Study|Protocol Violation|1|||
143413419|NCT01227421|517059267|FG001|Overall Study|Protocol Violation|1|||
143413420|NCT01227421|517059268|FG002|Overall Study|Protocol Violation|2|||
143413421|NCT01227421|517059266|FG000|Overall Study|Randomized in error|1|||
143413422|NCT01227421|517059267|FG001|Overall Study|Randomized in error|1|||
143413423|NCT01227421|517059268|FG002|Overall Study|Randomized in error|0|||
143413424|NCT01827839|517059271|FG000|Overall Study|Adverse Event|1|||
143413425|NCT01827839|517059271|FG000|Overall Study|Consent Withdrawal|2|||
143413426|NCT00614614|517059274|FG000|Primary Vaccination Phase|Adverse Event|6|||
143413427|NCT00614614|517059275|FG001|Primary Vaccination Phase|Adverse Event|0|||
143413428|NCT00614614|517059276|FG002|Primary Vaccination Phase|Adverse Event|0|||
143413429|NCT00614614|517059277|FG003|Primary Vaccination Phase|Adverse Event|0|||
143413430|NCT00614614|517059278|FG004|Primary Vaccination Phase|Adverse Event|0|||
143413431|NCT00614614|517059274|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
143413432|NCT00614614|517059275|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
143413433|NCT00614614|517059276|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
143413434|NCT00614614|517059277|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
143413435|NCT00614614|517059278|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
143413436|NCT00614614|517059274|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
143413437|NCT00614614|517059275|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
143413438|NCT00614614|517059276|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
143413439|NCT00614614|517059277|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
143413440|NCT00614614|517059278|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
143413441|NCT00614614|517059274|FG000|Primary Vaccination Phase|Protocol Violation|9|||
143413442|NCT00614614|517059275|FG001|Primary Vaccination Phase|Protocol Violation|3|||
143413443|NCT00614614|517059276|FG002|Primary Vaccination Phase|Protocol Violation|0|||
143413444|NCT00614614|517059277|FG003|Primary Vaccination Phase|Protocol Violation|0|||
143413445|NCT00614614|517059278|FG004|Primary Vaccination Phase|Protocol Violation|0|||
143413446|NCT00614614|517059274|FG000|Primary Vaccination Phase|Other|4|||
143413447|NCT00614614|517059275|FG001|Primary Vaccination Phase|Other|0|||
143413448|NCT00614614|517059276|FG002|Primary Vaccination Phase|Other|0|||
143413449|NCT00614614|517059277|FG003|Primary Vaccination Phase|Other|0|||
143413450|NCT00614614|517059278|FG004|Primary Vaccination Phase|Other|0|||
143413451|NCT00614614|517059274|FG000|Booster Vaccination Phase|Adverse Event|0|||
143413452|NCT00614614|517059275|FG001|Booster Vaccination Phase|Adverse Event|0|||
143413453|NCT00614614|517059276|FG002|Booster Vaccination Phase|Adverse Event|1|||
143413454|NCT00614614|517059277|FG003|Booster Vaccination Phase|Adverse Event|1|||
143413455|NCT00614614|517059278|FG004|Booster Vaccination Phase|Adverse Event|0|||
143413456|NCT00614614|517059274|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
143413457|NCT00614614|517059275|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
143413458|NCT00614614|517059276|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
143413459|NCT00614614|517059277|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
143413460|NCT00614614|517059278|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
143413461|NCT00614614|517059274|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
143413462|NCT00614614|517059275|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
143413463|NCT00614614|517059276|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
143413464|NCT00614614|517059277|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
143413465|NCT00614614|517059278|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
143413466|NCT00614614|517059274|FG000|Booster Vaccination Phase|Protocol Violation|0|||
143413467|NCT00614614|517059275|FG001|Booster Vaccination Phase|Protocol Violation|0|||
143413468|NCT00614614|517059276|FG002|Booster Vaccination Phase|Protocol Violation|2|||
143413469|NCT00614614|517059277|FG003|Booster Vaccination Phase|Protocol Violation|3|||
143413470|NCT00614614|517059278|FG004|Booster Vaccination Phase|Protocol Violation|0|||
143413471|NCT00614614|517059274|FG000|Booster Vaccination Phase|Other|0|||
143413472|NCT00614614|517059275|FG001|Booster Vaccination Phase|Other|1|||
143413473|NCT00614614|517059276|FG002|Booster Vaccination Phase|Other|3|||
143413474|NCT00614614|517059277|FG003|Booster Vaccination Phase|Other|2|||
143413475|NCT00614614|517059278|FG004|Booster Vaccination Phase|Other|1|||
143413476|NCT04745676|517059279|FG000|Overall Study|Death|1|||
143413477|NCT04745676|517059280|FG001|Overall Study|Death|0|||
143413478|NCT04745676|517059281|FG002|Overall Study|Death|0|||
143413479|NCT05426109|517059282|FG000|Overall Study|Withdrawal by Subject|0|||
143413480|NCT05426109|517059283|FG001|Overall Study|Withdrawal by Subject|1|||
143413481|NCT03683030|517059284|FG000|Overall Study|Enrolled but screen failures|12|||
143413482|NCT03683030|517059285|FG001|Overall Study|Enrolled but screen failures|7|||
143413483|NCT03683030|517059284|FG000|Overall Study|Enrolled but no catheter inserted|11|||
143413484|NCT03683030|517059285|FG001|Overall Study|Enrolled but no catheter inserted|13|||
143413485|NCT03683030|517059284|FG000|Overall Study|Withdrawal by Subject|0|||
143413486|NCT03683030|517059285|FG001|Overall Study|Withdrawal by Subject|2|||
143413487|NCT03683030|517059284|FG000|Overall Study|Early termination by subject|1|||
143413488|NCT03683030|517059285|FG001|Overall Study|Early termination by subject|0|||
143413489|NCT03683030|517059284|FG000|Overall Study|Lost to Follow-up|0|||
143413490|NCT03683030|517059285|FG001|Overall Study|Lost to Follow-up|6|||
143413491|NCT03683030|517059284|FG000|Overall Study|Death|0|||
143413492|NCT03683030|517059285|FG001|Overall Study|Death|2|||
143413493|NCT03683030|517059284|FG000|Overall Study|Catheter inserted but did not undergo ablation|0|||
143413494|NCT03683030|517059285|FG001|Overall Study|Catheter inserted but did not undergo ablation|1|||
143413495|NCT01214200|517060406|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
143413496|NCT01214200|517060406|FG000|Overall Study|Withdrawal by Subject|2|||
143413497|NCT00022672|517060408|FG000|Main Phase: 24 Months|Adverse Event|6|||
143413498|NCT00022672|517060409|FG001|Main Phase: 24 Months|Adverse Event|0|||
143413499|NCT00022672|517060408|FG000|Main Phase: 24 Months|Death|0|||
143413500|NCT00022672|517060409|FG001|Main Phase: 24 Months|Death|3|||
143413501|NCT00022672|517060408|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
143413502|NCT00022672|517060409|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
143413503|NCT00022672|517060408|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
143413504|NCT00022672|517060409|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
143413505|NCT00022672|517060408|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
143413506|NCT00022672|517060409|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
143413507|NCT00022672|517060408|FG000|Main Phase: 24 Months|Refused Treatment|3|||
143413508|NCT00022672|517060409|FG001|Main Phase: 24 Months|Refused Treatment|4|||
143413509|NCT00022672|517060408|FG000|Main Phase: 24 Months|Failure to Return|1|||
143413510|NCT00022672|517060409|FG001|Main Phase: 24 Months|Failure to Return|1|||
143413511|NCT00022672|517060408|FG000|Main Phase: 24 Months|Other|1|||
143413512|NCT00022672|517060409|FG001|Main Phase: 24 Months|Other|0|||
143413513|NCT00022672|517060408|FG000|Extension Phase|Adverse Event|1|||
143413514|NCT00022672|517060409|FG001|Extension Phase|Adverse Event|3|||
143413515|NCT00022672|517060408|FG000|Extension Phase|Death|0|||
143413516|NCT00022672|517060409|FG001|Extension Phase|Death|1|||
143413517|NCT00022672|517060408|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
143413518|NCT00022672|517060409|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
143413519|NCT00022672|517060408|FG000|Extension Phase|Refused Treatment|0|||
143413520|NCT00022672|517060409|FG001|Extension Phase|Refused Treatment|2|||
143413521|NCT00022672|517060408|FG000|Extension Phase|Other|1|||
143413522|NCT00022672|517060409|FG001|Extension Phase|Other|1|||
143413523|NCT00403494|517060410|FG000|Overall Study|Adverse Event|10|||
143413524|NCT00403494|517060411|FG001|Overall Study|Adverse Event|8|||
143413525|NCT00403494|517060410|FG000|Overall Study|Withdrew Consent|3|||
143413526|NCT00403494|517060411|FG001|Overall Study|Withdrew Consent|2|||
143413527|NCT00403494|517060410|FG000|Overall Study|Inappropriately enrolled|0|||
143413528|NCT00403494|517060411|FG001|Overall Study|Inappropriately enrolled|1|||
143413529|NCT00403494|517060410|FG000|Overall Study|Lost to Follow-up|0|||
143413530|NCT00403494|517060411|FG001|Overall Study|Lost to Follow-up|2|||
143413531|NCT00403494|517060410|FG000|Overall Study|Protocol noncompliance|0|||
143413532|NCT00403494|517060411|FG001|Overall Study|Protocol noncompliance|1|||
143413533|NCT00403494|517060410|FG000|Overall Study|Death|1|||
143413534|NCT00403494|517060411|FG001|Overall Study|Death|0|||
143413535|NCT00403494|517060410|FG000|Overall Study|Sponsor Request|1|||
143413536|NCT00403494|517060411|FG001|Overall Study|Sponsor Request|0|||
143413537|NCT02575365|517060414|FG000|Overall Study|Lost to Follow-up|4|||
143413538|NCT00487240|517060418|FG000|Overall Study|Withdrawal by Subject|12|||
143413539|NCT00487240|517060419|FG001|Overall Study|Withdrawal by Subject|6|||
143413540|NCT00487240|517060418|FG000|Overall Study|Lost to Follow-up|7|||
143413541|NCT00487240|517060419|FG001|Overall Study|Lost to Follow-up|6|||
143413542|NCT00487240|517060418|FG000|Overall Study|Adverse Event|0|||
143413543|NCT00487240|517060419|FG001|Overall Study|Adverse Event|4|||
143413544|NCT00487240|517060418|FG000|Overall Study|Protocol Violation|5|||
143413545|NCT00487240|517060419|FG001|Overall Study|Protocol Violation|5|||
143413546|NCT00487240|517060418|FG000|Overall Study|Entry Criteria Not Met|3|||
143413547|NCT00487240|517060419|FG001|Overall Study|Entry Criteria Not Met|4|||
143413548|NCT00487240|517060418|FG000|Overall Study|Sponsor Decision|2|||
143413549|NCT00487240|517060419|FG001|Overall Study|Sponsor Decision|1|||
143413550|NCT00487240|517060418|FG000|Overall Study|Physician Decision|2|||
143413551|NCT00487240|517060419|FG001|Overall Study|Physician Decision|0|||
143413552|NCT01019135|517060420|FG000|Overall Study|Did not receive allocated intervention|12|||
143413553|NCT01019135|517060421|FG001|Overall Study|Did not receive allocated intervention|6|||
143413554|NCT01019135|517060422|FG002|Overall Study|Did not receive allocated intervention|25|||
143413555|NCT01019135|517060420|FG000|Overall Study|Did not attend CR|8|||
143413556|NCT01019135|517060421|FG001|Overall Study|Did not attend CR|13|||
143413557|NCT01019135|517060422|FG002|Overall Study|Did not attend CR|6|||
143413558|NCT04237792|517060423|FG000|Treatment (Day 1)|Adverse Event|1|||
143413559|NCT04237792|517060424|FG001|Treatment (Day 1)|Adverse Event|0|||
143413560|NCT04237792|517060425|FG002|Treatment (Day 1)|Adverse Event|0|||
143413561|NCT04237792|517060426|FG003|Treatment (Day 1)|Adverse Event|0|||
143413562|NCT04237792|517060427|FG004|Treatment (Day 1)|Adverse Event|1|||
143413563|NCT04237792|517060428|FG005|Treatment (Day 1)|Adverse Event|1|||
143413564|NCT04237792|517060423|FG000|Treatment (Day 1)|Other|0|||
143413565|NCT04237792|517060424|FG001|Treatment (Day 1)|Other|0|||
143413566|NCT04237792|517060425|FG002|Treatment (Day 1)|Other|1|||
143413567|NCT04237792|517060426|FG003|Treatment (Day 1)|Other|0|||
143413568|NCT04237792|517060427|FG004|Treatment (Day 1)|Other|0|||
143413569|NCT04237792|517060428|FG005|Treatment (Day 1)|Other|1|||
143413570|NCT04237792|517060423|FG000|Treatment (Day 1)|Not treated|1|||
143413571|NCT04237792|517060424|FG001|Treatment (Day 1)|Not treated|1|||
143413572|NCT04237792|517060425|FG002|Treatment (Day 1)|Not treated|2|||
143413573|NCT04237792|517060426|FG003|Treatment (Day 1)|Not treated|1|||
143413574|NCT04237792|517060427|FG004|Treatment (Day 1)|Not treated|0|||
143413575|NCT04237792|517060428|FG005|Treatment (Day 1)|Not treated|1|||
143413576|NCT00910962|517060429|FG000|Overall Study|Adverse Event|5|||
143413577|NCT00910962|517060430|FG001|Overall Study|Adverse Event|20|||
143413578|NCT00910962|517060431|FG002|Overall Study|Adverse Event|17|||
143413579|NCT00910962|517060429|FG000|Overall Study|Protocol Violation|1|||
143413580|NCT00910962|517060430|FG001|Overall Study|Protocol Violation|3|||
143413581|NCT00910962|517060431|FG002|Overall Study|Protocol Violation|3|||
143413582|NCT00910962|517060429|FG000|Overall Study|Lost to Follow-up|0|||
143413583|NCT00910962|517060430|FG001|Overall Study|Lost to Follow-up|3|||
143413584|NCT00910962|517060431|FG002|Overall Study|Lost to Follow-up|1|||
143413585|NCT00910962|517060429|FG000|Overall Study|Physician Decision|0|||
143413586|NCT00910962|517060430|FG001|Overall Study|Physician Decision|6|||
143413587|NCT00910962|517060431|FG002|Overall Study|Physician Decision|6|||
143413588|NCT00910962|517060429|FG000|Overall Study|Withdrawal by Subject|25|||
143413589|NCT00910962|517060430|FG001|Overall Study|Withdrawal by Subject|32|||
143413590|NCT00910962|517060431|FG002|Overall Study|Withdrawal by Subject|32|||
143413591|NCT00910962|517060429|FG000|Overall Study|Reached defined stopping criteria|12|||
143413592|NCT00910962|517060430|FG001|Overall Study|Reached defined stopping criteria|14|||
143413593|NCT00910962|517060431|FG002|Overall Study|Reached defined stopping criteria|17|||
143413594|NCT01485887|517060432|FG000|Overall Study|Withdrawal by Subject|2|||
143413595|NCT01485887|517060432|FG000|Overall Study|Adverse Event|8|||
143413596|NCT01485887|517060432|FG000|Overall Study|Deterioration of primary disease|1|||
143413597|NCT01485887|517060432|FG000|Overall Study|Primary disease markedly improved|1|||
143413598|NCT00836498|517060437|FG000|Overall Study|Adverse Event|1|||
143413599|NCT00836498|517060438|FG001|Overall Study|Adverse Event|0|||
143413600|NCT00836498|517060437|FG000|Overall Study|Lost to Follow-up|1|||
143413601|NCT00836498|517060438|FG001|Overall Study|Lost to Follow-up|0|||
143413602|NCT00836498|517060437|FG000|Overall Study|Withdrawal by Subject|2|||
143413603|NCT00836498|517060438|FG001|Overall Study|Withdrawal by Subject|1|||
143413604|NCT03418545|517060439|FG000|Overall Study|Withdrawal by Participant|2|||
143413605|NCT03418545|517060440|FG001|Overall Study|Withdrawal by Participant|4|||
143413606|NCT03418545|517060439|FG000|Overall Study|Lost to Follow-up|3|||
143413607|NCT03418545|517060440|FG001|Overall Study|Lost to Follow-up|5|||
143413608|NCT03418545|517060439|FG000|Overall Study|Reason Not Specified|0|||
143413609|NCT03418545|517060440|FG001|Overall Study|Reason Not Specified|1|||
143413610|NCT03418545|517060439|FG000|Overall Study|Missing Completion Status|0|||
143413611|NCT03418545|517060440|FG001|Overall Study|Missing Completion Status|1|||
143413612|NCT02106884|517060441|FG000|Overall Study|Change of diagnosis/exclusion|0|||
143413613|NCT02106884|517060442|FG001|Overall Study|Change of diagnosis/exclusion|1|||
143413614|NCT01822756|517060446|FG000|Overall Study|Adverse Event|0|||
143413615|NCT01822756|517060447|FG001|Overall Study|Adverse Event|0|||
143413616|NCT01822756|517060448|FG002|Overall Study|Adverse Event|0|||
143413617|NCT01822756|517060449|FG003|Overall Study|Adverse Event|2|||
143413618|NCT01822756|517060450|FG004|Overall Study|Adverse Event|0|||
143413619|NCT01822756|517060446|FG000|Overall Study|Disease progression|11|||
143413620|NCT01822756|517060447|FG001|Overall Study|Disease progression|1|||
143413621|NCT01822756|517060448|FG002|Overall Study|Disease progression|7|||
143413622|NCT01822756|517060449|FG003|Overall Study|Disease progression|2|||
143413623|NCT01822756|517060450|FG004|Overall Study|Disease progression|6|||
143413624|NCT01822756|517060446|FG000|Overall Study|Death|2|||
143413625|NCT01822756|517060447|FG001|Overall Study|Death|2|||
143413626|NCT01822756|517060448|FG002|Overall Study|Death|1|||
143413627|NCT01822756|517060449|FG003|Overall Study|Death|0|||
143413628|NCT01822756|517060450|FG004|Overall Study|Death|0|||
143413629|NCT01822756|517060446|FG000|Overall Study|Lost to Follow-up|1|||
143413630|NCT01822756|517060447|FG001|Overall Study|Lost to Follow-up|0|||
143413631|NCT01822756|517060448|FG002|Overall Study|Lost to Follow-up|1|||
143413632|NCT01822756|517060449|FG003|Overall Study|Lost to Follow-up|0|||
143413633|NCT01822756|517060450|FG004|Overall Study|Lost to Follow-up|1|||
143413634|NCT01822756|517060446|FG000|Overall Study|Physician Decision|0|||
143413635|NCT01822756|517060447|FG001|Overall Study|Physician Decision|1|||
143413636|NCT01822756|517060448|FG002|Overall Study|Physician Decision|0|||
143413637|NCT01822756|517060449|FG003|Overall Study|Physician Decision|0|||
143413638|NCT01822756|517060450|FG004|Overall Study|Physician Decision|0|||
143413639|NCT01822756|517060446|FG000|Overall Study|disease progression & patient preference|2|||
143413640|NCT01822756|517060447|FG001|Overall Study|disease progression & patient preference|0|||
143413641|NCT01822756|517060448|FG002|Overall Study|disease progression & patient preference|1|||
143413642|NCT01822756|517060449|FG003|Overall Study|disease progression & patient preference|0|||
143413643|NCT01822756|517060450|FG004|Overall Study|disease progression & patient preference|0|||
143413644|NCT02060487|517060459|FG000|Overall Study|Other|1|||
143413645|NCT02060487|517060460|FG001|Overall Study|Other|2|||
143413646|NCT02060487|517060461|FG002|Overall Study|Other|1|||
143413647|NCT02060487|517060459|FG000|Overall Study|Lack of Efficacy|0|||
143413648|NCT02060487|517060460|FG001|Overall Study|Lack of Efficacy|1|||
143413649|NCT02060487|517060461|FG002|Overall Study|Lack of Efficacy|0|||
143413650|NCT02060487|517060459|FG000|Overall Study|Withdrawal by Subject|3|||
143413651|NCT02060487|517060460|FG001|Overall Study|Withdrawal by Subject|10|||
143413652|NCT02060487|517060461|FG002|Overall Study|Withdrawal by Subject|4|||
143413653|NCT02060487|517060459|FG000|Overall Study|Study Terminated By Sponsor|87|||
143413654|NCT02060487|517060460|FG001|Overall Study|Study Terminated By Sponsor|89|||
143413655|NCT02060487|517060461|FG002|Overall Study|Study Terminated By Sponsor|100|||
143413656|NCT02060487|517060459|FG000|Overall Study|Randomized in error|1|||
143413657|NCT02060487|517060460|FG001|Overall Study|Randomized in error|0|||
143413658|NCT02060487|517060461|FG002|Overall Study|Randomized in error|0|||
143413659|NCT02060487|517060459|FG000|Overall Study|Protocol Violation|0|||
143413660|NCT02060487|517060460|FG001|Overall Study|Protocol Violation|1|||
143413661|NCT02060487|517060461|FG002|Overall Study|Protocol Violation|1|||
143413662|NCT02060487|517060459|FG000|Overall Study|Lost to Follow-up|3|||
143413663|NCT02060487|517060460|FG001|Overall Study|Lost to Follow-up|0|||
143413664|NCT02060487|517060461|FG002|Overall Study|Lost to Follow-up|2|||
143413665|NCT02060487|517060459|FG000|Overall Study|Death|34|||
143413666|NCT02060487|517060460|FG001|Overall Study|Death|25|||
143413667|NCT02060487|517060461|FG002|Overall Study|Death|19|||
143413668|NCT02060487|517060459|FG000|Overall Study|Adverse Event|0|||
143413669|NCT02060487|517060460|FG001|Overall Study|Adverse Event|0|||
143413670|NCT02060487|517060461|FG002|Overall Study|Adverse Event|1|||
143413671|NCT05182606|517060467|FG000|Post-implementation (12 Months After)|Did not participate in the post-implementation survey|30|||
143413672|NCT02686658|517060468|FG000|Overall Study|Adverse Event|0|||
143413673|NCT02686658|517060469|FG001|Overall Study|Adverse Event|0|||
143413674|NCT02686658|517060470|FG002|Overall Study|Adverse Event|1|||
143413675|NCT02686658|517060471|FG003|Overall Study|Adverse Event|1|||
143413676|NCT02686658|517060472|FG004|Overall Study|Adverse Event|2|||
143413677|NCT02686658|517060473|FG005|Overall Study|Adverse Event|1|||
143413678|NCT02686658|517060468|FG000|Overall Study|Investigator decision|0|||
143413679|NCT02686658|517060469|FG001|Overall Study|Investigator decision|0|||
143413680|NCT02686658|517060470|FG002|Overall Study|Investigator decision|0|||
143413681|NCT02686658|517060471|FG003|Overall Study|Investigator decision|1|||
143413682|NCT02686658|517060472|FG004|Overall Study|Investigator decision|2|||
143413683|NCT02686658|517060473|FG005|Overall Study|Investigator decision|1|||
143413684|NCT02686658|517060468|FG000|Overall Study|Sponsor decision|1|||
143413685|NCT02686658|517060469|FG001|Overall Study|Sponsor decision|2|||
143413686|NCT02686658|517060470|FG002|Overall Study|Sponsor decision|1|||
143413687|NCT02686658|517060471|FG003|Overall Study|Sponsor decision|5|||
143413688|NCT02686658|517060472|FG004|Overall Study|Sponsor decision|13|||
143413689|NCT02686658|517060473|FG005|Overall Study|Sponsor decision|2|||
143413690|NCT02686658|517060468|FG000|Overall Study|Lost to Follow-up|0|||
143413691|NCT02686658|517060469|FG001|Overall Study|Lost to Follow-up|0|||
143413692|NCT02686658|517060470|FG002|Overall Study|Lost to Follow-up|2|||
143413693|NCT02686658|517060471|FG003|Overall Study|Lost to Follow-up|0|||
143413694|NCT02686658|517060472|FG004|Overall Study|Lost to Follow-up|0|||
143413695|NCT02686658|517060473|FG005|Overall Study|Lost to Follow-up|1|||
143413696|NCT02686658|517060468|FG000|Overall Study|Death|1|||
143413697|NCT02686658|517060469|FG001|Overall Study|Death|0|||
143413698|NCT02686658|517060470|FG002|Overall Study|Death|0|||
143413699|NCT02686658|517060471|FG003|Overall Study|Death|1|||
143413700|NCT02686658|517060472|FG004|Overall Study|Death|1|||
143413701|NCT02686658|517060473|FG005|Overall Study|Death|1|||
143413702|NCT02686658|517060468|FG000|Overall Study|Withdrawal by Subject|2|||
143413703|NCT02686658|517060469|FG001|Overall Study|Withdrawal by Subject|5|||
143413704|NCT02686658|517060470|FG002|Overall Study|Withdrawal by Subject|4|||
143413705|NCT02686658|517060471|FG003|Overall Study|Withdrawal by Subject|4|||
143413706|NCT02686658|517060472|FG004|Overall Study|Withdrawal by Subject|17|||
143413707|NCT02686658|517060473|FG005|Overall Study|Withdrawal by Subject|8|||
143413708|NCT02686658|517060468|FG000|Overall Study|Placed in hospice care|0|||
143413709|NCT02686658|517060469|FG001|Overall Study|Placed in hospice care|0|||
143413710|NCT02686658|517060470|FG002|Overall Study|Placed in hospice care|1|||
143413711|NCT02686658|517060471|FG003|Overall Study|Placed in hospice care|0|||
143413712|NCT02686658|517060472|FG004|Overall Study|Placed in hospice care|0|||
143413713|NCT02686658|517060473|FG005|Overall Study|Placed in hospice care|0|||
143413714|NCT02686658|517060468|FG000|Overall Study|Participant non-compliance|0|||
143413715|NCT02686658|517060469|FG001|Overall Study|Participant non-compliance|0|||
143413716|NCT02686658|517060470|FG002|Overall Study|Participant non-compliance|0|||
143413717|NCT02686658|517060471|FG003|Overall Study|Participant non-compliance|0|||
143413718|NCT02686658|517060472|FG004|Overall Study|Participant non-compliance|0|||
143413719|NCT02686658|517060473|FG005|Overall Study|Participant non-compliance|1|||
143413720|NCT02686658|517060468|FG000|Overall Study|Concern over coronavirus disease care|0|||
143413721|NCT02686658|517060469|FG001|Overall Study|Concern over coronavirus disease care|0|||
143413722|NCT02686658|517060470|FG002|Overall Study|Concern over coronavirus disease care|0|||
143413723|NCT02686658|517060471|FG003|Overall Study|Concern over coronavirus disease care|0|||
143413724|NCT02686658|517060472|FG004|Overall Study|Concern over coronavirus disease care|2|||
143413725|NCT02686658|517060473|FG005|Overall Study|Concern over coronavirus disease care|1|||
143413726|NCT03476798|517060477|FG000|Overall Study|Death|1|||
143413727|NCT03476798|517060477|FG000|Overall Study|Withdrawal by Subject|2|||
143413728|NCT03476798|517060477|FG000|Overall Study|Protocol Violation|2|||
143413729|NCT06269003|517060478|FG000|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
143413730|NCT06269003|517060479|FG001|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
143413731|NCT06269003|517060480|FG002|Overall Study|One participant was excluded for being outside the eligible age range.|1|||
143413732|NCT06269003|517060481|FG003|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
143413733|NCT05865392|517060485|FG000|Overall Study|Withdrawal by Subject|4|||
143413734|NCT05865392|517060486|FG001|Overall Study|Withdrawal by Subject|0|||
143413735|NCT05865392|517060485|FG000|Overall Study|Didn't meet inclusion criteria|4|||
143413736|NCT05865392|517060486|FG001|Overall Study|Didn't meet inclusion criteria|0|||
143413737|NCT04447027|517060489|FG000|Dose Escalation|Withdrawal by Subject|1|||
143413738|NCT04447027|517060490|FG001|Dose Escalation|Withdrawal by Subject|4|||
143413739|NCT04447027|517060491|FG002|Dose Escalation|Withdrawal by Subject|3|||
143413740|NCT04447027|517060492|FG003|Dose Escalation|Withdrawal by Subject|3|||
143413741|NCT04447027|517060493|FG004|Dose Escalation|Withdrawal by Subject|1|||
143413742|NCT04447027|517060494|FG005|Dose Escalation|Withdrawal by Subject|0|||
143413743|NCT04447027|517060495|FG006|Dose Escalation|Withdrawal by Subject|0|||
143413744|NCT04447027|517060496|FG007|Dose Escalation|Withdrawal by Subject|0|||
143413745|NCT04447027|517060497|FG008|Dose Escalation|Withdrawal by Subject|0|||
143413746|NCT04447027|517060489|FG000|Dose Escalation|Refused further treatment|0|||
143413747|NCT04447027|517060490|FG001|Dose Escalation|Refused further treatment|1|||
143413748|NCT04447027|517060491|FG002|Dose Escalation|Refused further treatment|1|||
143413749|NCT04447027|517060492|FG003|Dose Escalation|Refused further treatment|0|||
143413750|NCT04447027|517060493|FG004|Dose Escalation|Refused further treatment|0|||
143413751|NCT04447027|517060494|FG005|Dose Escalation|Refused further treatment|0|||
143413752|NCT04447027|517060495|FG006|Dose Escalation|Refused further treatment|0|||
143413753|NCT04447027|517060496|FG007|Dose Escalation|Refused further treatment|0|||
143413754|NCT04447027|517060497|FG008|Dose Escalation|Refused further treatment|0|||
143413755|NCT04447027|517060489|FG000|Dose Expansion|Withdrawal by Subject|0|||
143413756|NCT04447027|517060490|FG001|Dose Expansion|Withdrawal by Subject|0|||
143413757|NCT04447027|517060491|FG002|Dose Expansion|Withdrawal by Subject|0|||
143413758|NCT04447027|517060492|FG003|Dose Expansion|Withdrawal by Subject|0|||
143413759|NCT04447027|517060493|FG004|Dose Expansion|Withdrawal by Subject|0|||
143413760|NCT04447027|517060494|FG005|Dose Expansion|Withdrawal by Subject|2|||
143413761|NCT04447027|517060495|FG006|Dose Expansion|Withdrawal by Subject|0|||
143413762|NCT04447027|517060496|FG007|Dose Expansion|Withdrawal by Subject|2|||
143413763|NCT04447027|517060497|FG008|Dose Expansion|Withdrawal by Subject|0|||
143413764|NCT02969356|517060503|FG000|Overall Study|Adverse Event|7|||
143413765|NCT02969356|517060503|FG000|Overall Study|Consent withdrawn|2|||
143413766|NCT02969356|517060503|FG000|Overall Study|Lost to Follow-up|3|||
143413767|NCT02969356|517060503|FG000|Overall Study|Did not need to be reinjected|6|||
143413768|NCT02969356|517060503|FG000|Overall Study|Personal reasons|5|||
143413769|NCT02556918|517061813|FG000|Overall Study|Protocol Violation|5|||
143413770|NCT02556918|517061814|FG001|Overall Study|Protocol Violation|6|||
143413771|NCT02556918|517061813|FG000|Overall Study|Withdrawal by Subject|4|||
143413772|NCT02556918|517061814|FG001|Overall Study|Withdrawal by Subject|4|||
143413773|NCT02180724|517061817|FG000|Overall Study|Death|26|||
143413774|NCT02180724|517061818|FG001|Overall Study|Death|1|||
143413775|NCT02180724|517061817|FG000|Overall Study|Lost to Follow-up|3|||
143413776|NCT02180724|517061818|FG001|Overall Study|Lost to Follow-up|1|||
143413777|NCT02180724|517061817|FG000|Overall Study|Withdrawal by Subject|4|||
143413778|NCT02180724|517061818|FG001|Overall Study|Withdrawal by Subject|2|||
143413779|NCT02180724|517061817|FG000|Overall Study|PI Decision|5|||
143413780|NCT02180724|517061818|FG001|Overall Study|PI Decision|2|||
143413781|NCT02180724|517061817|FG000|Overall Study|Study terminated by sponsor|54|||
143413782|NCT02180724|517061818|FG001|Overall Study|Study terminated by sponsor|8|||
143413783|NCT00551421|517061819|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
143413784|NCT00799409|517061821|FG000|Overall Study|Withdrawal by Subject|1|||
143413785|NCT00799409|517061822|FG001|Overall Study|Withdrawal by Subject|0|||
143413786|NCT00799409|517061823|FG002|Overall Study|Withdrawal by Subject|0|||
143413787|NCT00799409|517061821|FG000|Overall Study|Lost to Follow-up|1|||
143413788|NCT00799409|517061822|FG001|Overall Study|Lost to Follow-up|0|||
143413789|NCT00799409|517061823|FG002|Overall Study|Lost to Follow-up|0|||
143413790|NCT00799409|517061821|FG000|Overall Study|Optimal Dose Not Achieved|2|||
143413791|NCT00799409|517061822|FG001|Overall Study|Optimal Dose Not Achieved|0|||
143413792|NCT00799409|517061823|FG002|Overall Study|Optimal Dose Not Achieved|0|||
143413793|NCT00799409|517061821|FG000|Overall Study|Failure to follow study protocol)|1|||
143413794|NCT00799409|517061822|FG001|Overall Study|Failure to follow study protocol)|0|||
143413795|NCT00799409|517061823|FG002|Overall Study|Failure to follow study protocol)|0|||
143413796|NCT00799409|517061821|FG000|Overall Study|Did not attend lab school day 1|1|||
143413797|NCT00799409|517061822|FG001|Overall Study|Did not attend lab school day 1|0|||
143413798|NCT00799409|517061823|FG002|Overall Study|Did not attend lab school day 1|0|||
143413799|NCT00799409|517061821|FG000|Overall Study|medication compliance|1|||
143413800|NCT00799409|517061822|FG001|Overall Study|medication compliance|0|||
143413801|NCT00799409|517061823|FG002|Overall Study|medication compliance|0|||
143413802|NCT04323800|517061825|FG000|Overall Study|Withdrawal by Subject|4|||
143413803|NCT04323800|517061826|FG001|Overall Study|Withdrawal by Subject|4|||
143413804|NCT04323800|517061825|FG000|Overall Study|Incomplete transfusion|1|||
143413805|NCT04323800|517061826|FG001|Overall Study|Incomplete transfusion|0|||
143413806|NCT04323800|517061825|FG000|Overall Study|Other|0|||
143413807|NCT04323800|517061826|FG001|Overall Study|Other|1|||
143413808|NCT04323800|517061825|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
143413809|NCT04323800|517061826|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
143413810|NCT00489554|517061827|FG000|Overall Study|Adverse Event|2|||
143413811|NCT00489554|517061827|FG000|Overall Study|Withdrawal by Subject|1|||
143413812|NCT00489554|517061827|FG000|Overall Study|Lost to Follow-up|1|||
143413813|NCT00731692|517061828|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
143413814|NCT00731692|517061829|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
143413815|NCT00731692|517061830|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
143413816|NCT00731692|517061828|FG000|Core Study (36 Months)|Physician Decision|1|||
143413817|NCT00731692|517061829|FG001|Core Study (36 Months)|Physician Decision|0|||
143413818|NCT00731692|517061830|FG002|Core Study (36 Months)|Physician Decision|2|||
143413819|NCT00731692|517061828|FG000|Core Study (36 Months)|Death|2|||
143413820|NCT00731692|517061829|FG001|Core Study (36 Months)|Death|1|||
143413821|NCT00731692|517061830|FG002|Core Study (36 Months)|Death|2|||
143413822|NCT00731692|517061828|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
143413823|NCT00731692|517061829|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
143413824|NCT00731692|517061830|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
143413825|NCT00731692|517061828|FG000|Core Study (36 Months)|Administrative|2|||
143413826|NCT00731692|517061829|FG001|Core Study (36 Months)|Administrative|2|||
143413827|NCT00731692|517061830|FG002|Core Study (36 Months)|Administrative|6|||
143413828|NCT00731692|517061828|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
143413829|NCT00731692|517061829|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
143413830|NCT00731692|517061830|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
143413831|NCT00731692|517061828|FG000|Core Study (36 Months)|Protocol Violation|4|||
143413832|NCT00731692|517061829|FG001|Core Study (36 Months)|Protocol Violation|5|||
143413833|NCT00731692|517061830|FG002|Core Study (36 Months)|Protocol Violation|8|||
143413834|NCT00731692|517061828|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
143413835|NCT00731692|517061829|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
143413836|NCT00731692|517061830|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
143413837|NCT00731692|517061828|FG000|Core Study (36 Months)|Adverse Event|25|||
143413838|NCT00731692|517061829|FG001|Core Study (36 Months)|Adverse Event|28|||
143413839|NCT00731692|517061830|FG002|Core Study (36 Months)|Adverse Event|29|||
143413840|NCT00731692|517061828|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
143413841|NCT00731692|517061829|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
143413842|NCT00731692|517061830|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
143413843|NCT00731692|517061828|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
143413844|NCT00731692|517061829|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
143413845|NCT00731692|517061830|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
143413846|NCT00731692|517061828|FG000|Extension Phase|Abnormal test procedure|0|||
143413847|NCT00731692|517061829|FG001|Extension Phase|Abnormal test procedure|0|||
143413848|NCT00731692|517061830|FG002|Extension Phase|Abnormal test procedure|1|||
143413849|NCT00731692|517061828|FG000|Extension Phase|Abnormal lab values|0|||
143413850|NCT00731692|517061829|FG001|Extension Phase|Abnormal lab values|0|||
143413851|NCT00731692|517061830|FG002|Extension Phase|Abnormal lab values|1|||
143413852|NCT00731692|517061828|FG000|Extension Phase|Lost to Follow-up|0|||
143413853|NCT00731692|517061829|FG001|Extension Phase|Lost to Follow-up|1|||
143413854|NCT00731692|517061830|FG002|Extension Phase|Lost to Follow-up|4|||
143413855|NCT00731692|517061828|FG000|Extension Phase|Withdrawal by Subject|4|||
143413856|NCT00731692|517061829|FG001|Extension Phase|Withdrawal by Subject|5|||
143413857|NCT00731692|517061830|FG002|Extension Phase|Withdrawal by Subject|3|||
143413858|NCT00731692|517061828|FG000|Extension Phase|Adverse Event|1|||
143413859|NCT00731692|517061829|FG001|Extension Phase|Adverse Event|1|||
143413860|NCT00731692|517061830|FG002|Extension Phase|Adverse Event|15|||
143413861|NCT00670488|517061832|FG000|Overall Study|Adverse Event|0|||
143413862|NCT00670488|517061833|FG001|Overall Study|Adverse Event|7|||
143413863|NCT00670488|517061834|FG002|Overall Study|Adverse Event|0|||
143413864|NCT00670488|517061835|FG003|Overall Study|Adverse Event|3|||
143413865|NCT00670488|517061836|FG004|Overall Study|Adverse Event|1|||
143413866|NCT00670488|517061837|FG005|Overall Study|Adverse Event|1|||
143413867|NCT00670488|517061838|FG006|Overall Study|Adverse Event|5|||
143413868|NCT00670488|517061839|FG007|Overall Study|Adverse Event|1|||
143413869|NCT00670488|517061840|FG008|Overall Study|Adverse Event|0|||
143413870|NCT00670488|517061841|FG009|Overall Study|Adverse Event|1|||
143413871|NCT00670488|517061832|FG000|Overall Study|Physician Decision|1|||
143413872|NCT00670488|517061833|FG001|Overall Study|Physician Decision|9|||
143413873|NCT00670488|517061834|FG002|Overall Study|Physician Decision|0|||
143413874|NCT00670488|517061835|FG003|Overall Study|Physician Decision|1|||
143413875|NCT00670488|517061836|FG004|Overall Study|Physician Decision|0|||
143413876|NCT00670488|517061837|FG005|Overall Study|Physician Decision|0|||
143413877|NCT00670488|517061838|FG006|Overall Study|Physician Decision|0|||
143413878|NCT00670488|517061839|FG007|Overall Study|Physician Decision|0|||
143413879|NCT00670488|517061840|FG008|Overall Study|Physician Decision|0|||
143413880|NCT00670488|517061841|FG009|Overall Study|Physician Decision|0|||
143413881|NCT00670488|517061832|FG000|Overall Study|Progressive Disease|2|||
143413882|NCT00670488|517061833|FG001|Overall Study|Progressive Disease|41|||
143413883|NCT00670488|517061834|FG002|Overall Study|Progressive Disease|3|||
143413884|NCT00670488|517061835|FG003|Overall Study|Progressive Disease|2|||
143413885|NCT00670488|517061836|FG004|Overall Study|Progressive Disease|2|||
143413886|NCT00670488|517061837|FG005|Overall Study|Progressive Disease|4|||
143413887|NCT00670488|517061838|FG006|Overall Study|Progressive Disease|11|||
143413888|NCT00670488|517061839|FG007|Overall Study|Progressive Disease|2|||
143413889|NCT00670488|517061840|FG008|Overall Study|Progressive Disease|2|||
143413890|NCT00670488|517061841|FG009|Overall Study|Progressive Disease|1|||
143413891|NCT00670488|517061832|FG000|Overall Study|Withdrawal by Subject|0|||
143413892|NCT00670488|517061833|FG001|Overall Study|Withdrawal by Subject|1|||
143413893|NCT00670488|517061834|FG002|Overall Study|Withdrawal by Subject|0|||
143413894|NCT00670488|517061835|FG003|Overall Study|Withdrawal by Subject|1|||
143413895|NCT00670488|517061836|FG004|Overall Study|Withdrawal by Subject|0|||
143413896|NCT00670488|517061837|FG005|Overall Study|Withdrawal by Subject|0|||
143413897|NCT00670488|517061838|FG006|Overall Study|Withdrawal by Subject|1|||
143413898|NCT00670488|517061839|FG007|Overall Study|Withdrawal by Subject|0|||
143413899|NCT00670488|517061840|FG008|Overall Study|Withdrawal by Subject|1|||
143413900|NCT00670488|517061841|FG009|Overall Study|Withdrawal by Subject|0|||
143413901|NCT02708498|517061842|FG000|Overall Study|Death|20|||
143413902|NCT02708498|517061843|FG001|Overall Study|Death|19|||
143413903|NCT02708498|517061844|FG002|Overall Study|Death|0|||
143413904|NCT02708498|517061845|FG003|Overall Study|Death|0|||
143413905|NCT02708498|517061846|FG004|Overall Study|Death|1|||
143413906|NCT02708498|517061847|FG005|Overall Study|Death|0|||
143413907|NCT02708498|517061848|FG006|Overall Study|Death|0|||
143413908|NCT02708498|517061849|FG007|Overall Study|Death|0|||
143413909|NCT02708498|517061842|FG000|Overall Study|Unknown reason, missing data|0|||
143413910|NCT02708498|517061843|FG001|Overall Study|Unknown reason, missing data|0|||
143413911|NCT02708498|517061844|FG002|Overall Study|Unknown reason, missing data|62|||
143413912|NCT02708498|517061845|FG003|Overall Study|Unknown reason, missing data|51|||
143413913|NCT02708498|517061846|FG004|Overall Study|Unknown reason, missing data|195|||
143413914|NCT02708498|517061847|FG005|Overall Study|Unknown reason, missing data|132|||
143413915|NCT02708498|517061848|FG006|Overall Study|Unknown reason, missing data|0|||
143413916|NCT02708498|517061849|FG007|Overall Study|Unknown reason, missing data|0|||
143413917|NCT03052517|517061850|FG000|Overall Study|Study Terminated By Sponsor|928|||
143413918|NCT03052517|517061851|FG001|Overall Study|Study Terminated By Sponsor|938|||
143413919|NCT03052517|517061852|FG002|Overall Study|Study Terminated By Sponsor|296|||
143413920|NCT03052517|517061850|FG000|Overall Study|Subject/Guardian Decision|50|||
143413921|NCT03052517|517061851|FG001|Overall Study|Subject/Guardian Decision|45|||
143413922|NCT03052517|517061852|FG002|Overall Study|Subject/Guardian Decision|22|||
143413923|NCT03052517|517061850|FG000|Overall Study|Lack of Efficacy|23|||
143413924|NCT03052517|517061851|FG001|Overall Study|Lack of Efficacy|14|||
143413925|NCT03052517|517061852|FG002|Overall Study|Lack of Efficacy|7|||
143413926|NCT03052517|517061850|FG000|Overall Study|Adverse Event|6|||
143413927|NCT03052517|517061851|FG001|Overall Study|Adverse Event|5|||
143413928|NCT03052517|517061852|FG002|Overall Study|Adverse Event|0|||
143413929|NCT03052517|517061850|FG000|Overall Study|Physician Decision|4|||
143413930|NCT03052517|517061851|FG001|Overall Study|Physician Decision|5|||
143413931|NCT03052517|517061852|FG002|Overall Study|Physician Decision|1|||
143413932|NCT03052517|517061850|FG000|Overall Study|Death|3|||
143413933|NCT03052517|517061851|FG001|Overall Study|Death|0|||
143413934|NCT03052517|517061852|FG002|Overall Study|Death|1|||
143413935|NCT03052517|517061850|FG000|Overall Study|Lost to Follow-up|2|||
143413936|NCT03052517|517061851|FG001|Overall Study|Lost to Follow-up|4|||
143413937|NCT03052517|517061852|FG002|Overall Study|Lost to Follow-up|0|||
143413938|NCT03052517|517061850|FG000|Overall Study|Pregnancy|1|||
143413939|NCT03052517|517061851|FG001|Overall Study|Pregnancy|0|||
143413940|NCT03052517|517061852|FG002|Overall Study|Pregnancy|1|||
143413941|NCT03052517|517061850|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
143413942|NCT03052517|517061851|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
143413943|NCT03052517|517061852|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
143413944|NCT03052517|517061850|FG000|Overall Study|Technical Problems|0|||
143413945|NCT03052517|517061851|FG001|Overall Study|Technical Problems|1|||
143413946|NCT03052517|517061852|FG002|Overall Study|Technical Problems|0|||
143413947|NCT00195819|517061854|FG000|Double-Blind|Withdrawal by Subject|1|||
143413948|NCT00195819|517061855|FG001|Double-Blind|Withdrawal by Subject|0|||
143413949|NCT00195819|517061854|FG000|Double-Blind|Moved|1|||
143413950|NCT00195819|517061855|FG001|Double-Blind|Moved|0|||
143413951|NCT00195819|517061854|FG000|Open-label|Adverse Event|0|||
143413952|NCT00195819|517061855|FG001|Open-label|Adverse Event|9|||
143413953|NCT00195819|517061854|FG000|Open-label|Lack of Efficacy|0|||
143413954|NCT00195819|517061855|FG001|Open-label|Lack of Efficacy|2|||
143413955|NCT00195819|517061854|FG000|Open-label|Pregnancy|0|||
143413956|NCT00195819|517061855|FG001|Open-label|Pregnancy|1|||
143413957|NCT00195819|517061854|FG000|Open-label|Protocol Violation|0|||
143413958|NCT00195819|517061855|FG001|Open-label|Protocol Violation|2|||
143413959|NCT00195819|517061854|FG000|Open-label|Moved|0|||
143413960|NCT00195819|517061855|FG001|Open-label|Moved|1|||
143413961|NCT00195819|517061854|FG000|Open-label|Withdrawal by Subject|0|||
143413962|NCT00195819|517061855|FG001|Open-label|Withdrawal by Subject|5|||
143413963|NCT01124045|517061856|FG000|Overall Study|Lost to Follow-up|0|||
143413964|NCT01124045|517061857|FG001|Overall Study|Lost to Follow-up|1|||
143413965|NCT01124045|517061856|FG000|Overall Study|Physician Decision|0|||
143413966|NCT01124045|517061857|FG001|Overall Study|Physician Decision|2|||
143413967|NCT03298087|517061858|FG000|Overall Study|Withdrawal by Subject|4|||
143413968|NCT01530334|517061859|FG000|Overall Study|Adverse Event|3|||
143413969|NCT01530334|517061859|FG000|Overall Study|unknown reason|1|||
143413970|NCT01530334|517061859|FG000|Overall Study|Progressive disease|47|||
143413971|NCT01629589|517061860|FG000|Overall Study|Protocol Violation|4|||
143413972|NCT01629589|517061861|FG001|Overall Study|Protocol Violation|2|||
143413973|NCT01629589|517061860|FG000|Overall Study|Lost to Follow-up|2|||
143413974|NCT01629589|517061861|FG001|Overall Study|Lost to Follow-up|1|||
143413975|NCT01629589|517061860|FG000|Overall Study|Withdrawal by Subject|2|||
143413976|NCT01629589|517061861|FG001|Overall Study|Withdrawal by Subject|3|||
143413977|NCT01629589|517061860|FG000|Overall Study|Did not receive study vaccine|0|||
143413978|NCT01629589|517061861|FG001|Overall Study|Did not receive study vaccine|1|||
143413979|NCT01303510|517061862|FG000|Overall Study|Lost to Follow-up|1|||
143413980|NCT01303510|517061863|FG001|Overall Study|Lost to Follow-up|0|||
143413981|NCT00822900|517061865|FG000|Overall Study|Withdrawal by Subject|14|||
143413982|NCT00822900|517061866|FG001|Overall Study|Withdrawal by Subject|14|||
143413983|NCT00822900|517061865|FG000|Overall Study|Lost to Follow-up|9|||
143413984|NCT00822900|517061866|FG001|Overall Study|Lost to Follow-up|9|||
143413985|NCT00822900|517061865|FG000|Overall Study|Death|83|||
143413986|NCT00822900|517061866|FG001|Overall Study|Death|69|||
143413987|NCT00822900|517061865|FG000|Overall Study|Became a ward of the state|2|||
143413988|NCT00822900|517061866|FG001|Overall Study|Became a ward of the state|1|||
143413989|NCT02234141|517061867|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
143413990|NCT02234141|517061868|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
143413991|NCT02234141|517061869|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
143413992|NCT02234141|517061870|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
143413993|NCT02234141|517061871|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
143413994|NCT02234141|517061872|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
143413995|NCT02234141|517061873|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
143413996|NCT02234141|517061867|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
143413997|NCT02234141|517061868|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
143413998|NCT02234141|517061869|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
143413999|NCT02234141|517061870|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
143414000|NCT02234141|517061871|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
143414001|NCT02234141|517061872|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
143414002|NCT02234141|517061873|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
143414003|NCT02234141|517061867|FG000|Treatment Period (24 Weeks)|Death|1|||
143414004|NCT02234141|517061868|FG001|Treatment Period (24 Weeks)|Death|2|||
143414005|NCT02234141|517061869|FG002|Treatment Period (24 Weeks)|Death|0|||
143414006|NCT02234141|517061870|FG003|Treatment Period (24 Weeks)|Death|1|||
143414007|NCT02234141|517061871|FG004|Treatment Period (24 Weeks)|Death|0|||
143414008|NCT02234141|517061872|FG005|Treatment Period (24 Weeks)|Death|0|||
143414009|NCT02234141|517061873|FG006|Treatment Period (24 Weeks)|Death|0|||
143414010|NCT02234141|517061867|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
143414011|NCT02234141|517061868|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
143414012|NCT02234141|517061869|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
143414013|NCT02234141|517061870|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
143414014|NCT02234141|517061871|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
143414015|NCT02234141|517061872|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
143414016|NCT02234141|517061873|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
143414017|NCT02234141|517061867|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
143414018|NCT02234141|517061868|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
143414019|NCT02234141|517061869|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
143414020|NCT02234141|517061870|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
143414021|NCT02234141|517061871|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
143414022|NCT02234141|517061872|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
143414023|NCT02234141|517061873|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
143414024|NCT02234141|517061867|FG000|Long-Term Treatment Period|Death|0|||
143414025|NCT02234141|517061868|FG001|Long-Term Treatment Period|Death|0|||
143414026|NCT02234141|517061869|FG002|Long-Term Treatment Period|Death|0|||
143414027|NCT02234141|517061870|FG003|Long-Term Treatment Period|Death|0|||
143414028|NCT02234141|517061871|FG004|Long-Term Treatment Period|Death|0|||
143414029|NCT02234141|517061872|FG005|Long-Term Treatment Period|Death|1|||
143414030|NCT02234141|517061873|FG006|Long-Term Treatment Period|Death|0|||
143414031|NCT02234141|517061867|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
143414032|NCT02234141|517061868|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
143414033|NCT02234141|517061869|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
143414034|NCT02234141|517061870|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
143414035|NCT02234141|517061871|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
143414036|NCT02234141|517061872|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
143414037|NCT02234141|517061873|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
143414038|NCT02234141|517061867|FG000|Long-Term Treatment Period|Adverse Event|4|||
143414039|NCT02234141|517061868|FG001|Long-Term Treatment Period|Adverse Event|0|||
143414040|NCT02234141|517061869|FG002|Long-Term Treatment Period|Adverse Event|5|||
143414041|NCT02234141|517061870|FG003|Long-Term Treatment Period|Adverse Event|0|||
143414042|NCT02234141|517061871|FG004|Long-Term Treatment Period|Adverse Event|1|||
143414043|NCT02234141|517061872|FG005|Long-Term Treatment Period|Adverse Event|1|||
143414044|NCT02234141|517061873|FG006|Long-Term Treatment Period|Adverse Event|1|||
143414045|NCT02234141|517061867|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
143414046|NCT02234141|517061868|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
143414047|NCT02234141|517061869|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
143414048|NCT02234141|517061870|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
143414049|NCT02234141|517061871|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
143414050|NCT02234141|517061872|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
143414051|NCT02234141|517061873|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
143414052|NCT02234141|517061867|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
143414053|NCT02234141|517061868|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
143414054|NCT02234141|517061869|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
143414055|NCT02234141|517061870|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
143414056|NCT02234141|517061871|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
143414057|NCT02234141|517061872|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
143414058|NCT02234141|517061873|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
143414059|NCT03162614|517061874|FG000|Overall Study|Lost to Follow-up|2|||
143414060|NCT03162614|517061875|FG001|Overall Study|Lost to Follow-up|1|||
143414061|NCT03162614|517061876|FG002|Overall Study|Lost to Follow-up|1|||
143414062|NCT03162614|517061877|FG003|Overall Study|Lost to Follow-up|1|||
143414063|NCT03162614|517061878|FG004|Overall Study|Lost to Follow-up|2|||
143414064|NCT03162614|517061879|FG005|Overall Study|Lost to Follow-up|0|||
143414065|NCT03162614|517061874|FG000|Overall Study|Protocol Violation|0|||
143414066|NCT03162614|517061875|FG001|Overall Study|Protocol Violation|1|||
143414067|NCT03162614|517061876|FG002|Overall Study|Protocol Violation|0|||
143414068|NCT03162614|517061877|FG003|Overall Study|Protocol Violation|1|||
143414069|NCT03162614|517061878|FG004|Overall Study|Protocol Violation|0|||
143414070|NCT03162614|517061879|FG005|Overall Study|Protocol Violation|0|||
143414071|NCT03162614|517061874|FG000|Overall Study|Withdrawal by Subject|2|||
143414072|NCT03162614|517061875|FG001|Overall Study|Withdrawal by Subject|1|||
143414073|NCT03162614|517061876|FG002|Overall Study|Withdrawal by Subject|1|||
143414074|NCT03162614|517061877|FG003|Overall Study|Withdrawal by Subject|1|||
143414075|NCT03162614|517061878|FG004|Overall Study|Withdrawal by Subject|0|||
143414076|NCT03162614|517061879|FG005|Overall Study|Withdrawal by Subject|0|||
143414077|NCT03162614|517061874|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
143414078|NCT03162614|517061875|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
143414079|NCT03162614|517061876|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
143414080|NCT03162614|517061877|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
143414081|NCT03162614|517061878|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
143414082|NCT03162614|517061879|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
143414083|NCT01957163|517061880|FG000|Overall Study|Adverse Event|5|||
143414084|NCT01957163|517061881|FG001|Overall Study|Adverse Event|2|||
143414085|NCT01957163|517061882|FG002|Overall Study|Adverse Event|4|||
143414086|NCT01957163|517061880|FG000|Overall Study|Lack of Efficacy|5|||
143414087|NCT01957163|517061881|FG001|Overall Study|Lack of Efficacy|4|||
143414088|NCT01957163|517061882|FG002|Overall Study|Lack of Efficacy|9|||
143414089|NCT01957163|517061880|FG000|Overall Study|Protocol Violation|1|||
143414090|NCT01957163|517061881|FG001|Overall Study|Protocol Violation|2|||
143414091|NCT01957163|517061882|FG002|Overall Study|Protocol Violation|0|||
143414092|NCT01957163|517061880|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
143414093|NCT01957163|517061881|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
143414094|NCT01957163|517061882|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
143414095|NCT01957163|517061880|FG000|Overall Study|Lost to Follow-up|0|||
143414096|NCT01957163|517061881|FG001|Overall Study|Lost to Follow-up|1|||
143414097|NCT01957163|517061882|FG002|Overall Study|Lost to Follow-up|0|||
143414098|NCT01957163|517061880|FG000|Overall Study|Withdrawal by Subject|4|||
143414099|NCT01957163|517061881|FG001|Overall Study|Withdrawal by Subject|2|||
143414100|NCT01957163|517061882|FG002|Overall Study|Withdrawal by Subject|4|||
143414101|NCT00243867|517061887|FG000|Overall Study|Adverse Event|24|||
143414102|NCT00243867|517061888|FG001|Overall Study|Adverse Event|34|||
143414103|NCT00243867|517061887|FG000|Overall Study|Lack of Efficacy|115|||
143414104|NCT00243867|517061888|FG001|Overall Study|Lack of Efficacy|78|||
143414105|NCT00243867|517061887|FG000|Overall Study|Withdrawal by Subject|11|||
143414106|NCT00243867|517061888|FG001|Overall Study|Withdrawal by Subject|23|||
143414107|NCT00243867|517061887|FG000|Overall Study|Lost to Follow-up|2|||
143414108|NCT00243867|517061888|FG001|Overall Study|Lost to Follow-up|1|||
143414109|NCT00243867|517061887|FG000|Overall Study|Physician Decision|2|||
143414110|NCT00243867|517061888|FG001|Overall Study|Physician Decision|7|||
143414111|NCT00243867|517061887|FG000|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|22|||
143414112|NCT00243867|517061888|FG001|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|31|||
143414113|NCT01321073|517061894|FG000|Overall Study|Did not attempt implant|4|||
143414114|NCT01321073|517061894|FG000|Overall Study|Death|3|||
143414115|NCT02309294|517061904|FG000|Overall Study|Withdrawal by Subject|2|||
143414116|NCT00570505|517061905|FG000|Overall Study|Adverse Event|7|||
143414117|NCT00570505|517061905|FG000|Overall Study|Withdrawal by Subject|7|||
143414118|NCT00570505|517061905|FG000|Overall Study|Lost to Follow-up|23|||
143414119|NCT00570505|517061905|FG000|Overall Study|Other loss to follow-up|4|||
143414120|NCT04224272|517061914|FG000|Part 1 - Dose Finding|Death|4|||
143414121|NCT04224272|517061914|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
143414122|NCT04224272|517061914|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
143414123|NCT04224272|517061914|FG000|Part 2 - Dose Expansion|Death|10|||
143414124|NCT04224272|517061914|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
143414125|NCT02609048|517061915|FG000|Overall Study|Adverse Event|3|||
143414126|NCT02609048|517061916|FG001|Overall Study|Adverse Event|0|||
143414127|NCT02609048|517061917|FG002|Overall Study|Adverse Event|0|||
143414128|NCT02609048|517061915|FG000|Overall Study|Randomized but never treated|1|||
143414129|NCT02609048|517061916|FG001|Overall Study|Randomized but never treated|1|||
143414130|NCT02609048|517061917|FG002|Overall Study|Randomized but never treated|1|||
143414131|NCT02609048|517061915|FG000|Overall Study|Withdrawal of informed consent|1|||
143414132|NCT02609048|517061916|FG001|Overall Study|Withdrawal of informed consent|0|||
143414133|NCT02609048|517061917|FG002|Overall Study|Withdrawal of informed consent|0|||
143414134|NCT02609048|517061915|FG000|Overall Study|Reason not specified|6|||
143414135|NCT02609048|517061916|FG001|Overall Study|Reason not specified|9|||
143414136|NCT02609048|517061917|FG002|Overall Study|Reason not specified|9|||
143414137|NCT04186247|517061922|FG000|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|2|||
143414138|NCT04186247|517061923|FG001|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
143414139|NCT04186247|517061924|FG002|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
143414140|NCT04186247|517061925|FG003|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
143414141|NCT04186247|517061926|FG004|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
143414142|NCT04118894|517061927|FG000|Overall Study|Lost to Follow-up|21|||
143414143|NCT04118894|517061927|FG000|Overall Study|Withdrawal by Subject|10|||
143414144|NCT04118894|517061927|FG000|Overall Study|Adverse Event|4|||
143414145|NCT04511702|517063059|FG000|Overall Study|Lost to Follow-up|3|||
143414146|NCT04511702|517063060|FG001|Overall Study|Lost to Follow-up|0|||
143414147|NCT04511702|517063061|FG002|Overall Study|Lost to Follow-up|4|||
143414148|NCT04511702|517063059|FG000|Overall Study|Withdrawal by Subject|17|||
143414149|NCT04511702|517063060|FG001|Overall Study|Withdrawal by Subject|1|||
143414150|NCT04511702|517063061|FG002|Overall Study|Withdrawal by Subject|8|||
143414151|NCT04493424|517063062|FG000|Overall Study|Termination of the trial by the sponsor|89|||
143414152|NCT04493424|517063062|FG000|Overall Study|Withdrawal by Subject|9|||
143414153|NCT04493424|517063062|FG000|Overall Study|Lost to Follow-up|2|||
143414154|NCT04493424|517063062|FG000|Overall Study|Lack of Efficacy|3|||
143414155|NCT04493424|517063062|FG000|Overall Study|Adverse Event|5|||
143414156|NCT04992273|517063066|FG000|Overall Study|Lost to Follow-up|0|||
143414157|NCT04992273|517063067|FG001|Overall Study|Lost to Follow-up|1|||
143414158|NCT01364597|517063068|FG000|Overall Study|Adverse Event|4|||
143414159|NCT01364597|517063069|FG001|Overall Study|Adverse Event|5|||
143414160|NCT01364597|517063070|FG002|Overall Study|Adverse Event|16|||
143414161|NCT01364597|517063071|FG003|Overall Study|Adverse Event|7|||
143414162|NCT01364597|517063068|FG000|Overall Study|Lack of Efficacy|4|||
143414163|NCT01364597|517063069|FG001|Overall Study|Lack of Efficacy|4|||
143414164|NCT01364597|517063070|FG002|Overall Study|Lack of Efficacy|23|||
143414165|NCT01364597|517063071|FG003|Overall Study|Lack of Efficacy|8|||
143414166|NCT01364597|517063068|FG000|Overall Study|Protocol Violation|0|||
143414167|NCT01364597|517063069|FG001|Overall Study|Protocol Violation|0|||
143414168|NCT01364597|517063070|FG002|Overall Study|Protocol Violation|2|||
143414169|NCT01364597|517063071|FG003|Overall Study|Protocol Violation|0|||
143414170|NCT01364597|517063068|FG000|Overall Study|Lost to Follow-up|0|||
143414171|NCT01364597|517063069|FG001|Overall Study|Lost to Follow-up|0|||
143414172|NCT01364597|517063070|FG002|Overall Study|Lost to Follow-up|5|||
143414173|NCT01364597|517063071|FG003|Overall Study|Lost to Follow-up|3|||
143414174|NCT01364597|517063068|FG000|Overall Study|Withdrawal by Subject|4|||
143414175|NCT01364597|517063069|FG001|Overall Study|Withdrawal by Subject|1|||
143414176|NCT01364597|517063070|FG002|Overall Study|Withdrawal by Subject|18|||
143414177|NCT01364597|517063071|FG003|Overall Study|Withdrawal by Subject|6|||
143414178|NCT01364597|517063068|FG000|Overall Study|Non compliance|1|||
143414179|NCT01364597|517063069|FG001|Overall Study|Non compliance|0|||
143414180|NCT01364597|517063070|FG002|Overall Study|Non compliance|1|||
143414181|NCT01364597|517063071|FG003|Overall Study|Non compliance|0|||
143414182|NCT01364597|517063068|FG000|Overall Study|Lack of compliance|1|||
143414183|NCT01364597|517063069|FG001|Overall Study|Lack of compliance|0|||
143414184|NCT01364597|517063070|FG002|Overall Study|Lack of compliance|0|||
143414185|NCT01364597|517063071|FG003|Overall Study|Lack of compliance|0|||
143414186|NCT01364597|517063068|FG000|Overall Study|End of treatment epilepsy|1|||
143414187|NCT01364597|517063069|FG001|Overall Study|End of treatment epilepsy|0|||
143414188|NCT01364597|517063070|FG002|Overall Study|End of treatment epilepsy|0|||
143414189|NCT01364597|517063071|FG003|Overall Study|End of treatment epilepsy|0|||
143414190|NCT01364597|517063068|FG000|Overall Study|No Seizures|1|||
143414191|NCT01364597|517063069|FG001|Overall Study|No Seizures|0|||
143414192|NCT01364597|517063070|FG002|Overall Study|No Seizures|0|||
143414193|NCT01364597|517063071|FG003|Overall Study|No Seizures|0|||
143414194|NCT01364597|517063068|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
143414195|NCT01364597|517063069|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
143414196|NCT01364597|517063070|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
143414197|NCT01364597|517063071|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
143414198|NCT01364597|517063068|FG000|Overall Study|Cure|1|||
143414199|NCT01364597|517063069|FG001|Overall Study|Cure|0|||
143414200|NCT01364597|517063070|FG002|Overall Study|Cure|0|||
143414201|NCT01364597|517063071|FG003|Overall Study|Cure|0|||
143414202|NCT01364597|517063068|FG000|Overall Study|Patient was moving|0|||
143414203|NCT01364597|517063069|FG001|Overall Study|Patient was moving|1|||
143414204|NCT01364597|517063070|FG002|Overall Study|Patient was moving|0|||
143414205|NCT01364597|517063071|FG003|Overall Study|Patient was moving|0|||
143414206|NCT01364597|517063068|FG000|Overall Study|Seizures resolved|0|||
143414207|NCT01364597|517063069|FG001|Overall Study|Seizures resolved|0|||
143414208|NCT01364597|517063070|FG002|Overall Study|Seizures resolved|1|||
143414209|NCT01364597|517063071|FG003|Overall Study|Seizures resolved|0|||
143414210|NCT01364597|517063068|FG000|Overall Study|Patient became seizure-free after surgery|0|||
143414211|NCT01364597|517063069|FG001|Overall Study|Patient became seizure-free after surgery|0|||
143414212|NCT01364597|517063070|FG002|Overall Study|Patient became seizure-free after surgery|1|||
143414213|NCT01364597|517063071|FG003|Overall Study|Patient became seizure-free after surgery|0|||
143414214|NCT01364597|517063068|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
143414215|NCT01364597|517063069|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
143414216|NCT01364597|517063070|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
143414217|NCT01364597|517063071|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
143414218|NCT01364597|517063068|FG000|Overall Study|Patient cured from Epilepsy|0|||
143414219|NCT01364597|517063069|FG001|Overall Study|Patient cured from Epilepsy|0|||
143414220|NCT01364597|517063070|FG002|Overall Study|Patient cured from Epilepsy|1|||
143414221|NCT01364597|517063071|FG003|Overall Study|Patient cured from Epilepsy|0|||
143414222|NCT01364597|517063068|FG000|Overall Study|Investigator decision|0|||
143414223|NCT01364597|517063069|FG001|Overall Study|Investigator decision|0|||
143414224|NCT01364597|517063070|FG002|Overall Study|Investigator decision|1|||
143414225|NCT01364597|517063071|FG003|Overall Study|Investigator decision|0|||
143414226|NCT01364597|517063068|FG000|Overall Study|Sponsor recommended discontinuation|0|||
143414227|NCT01364597|517063069|FG001|Overall Study|Sponsor recommended discontinuation|0|||
143414228|NCT01364597|517063070|FG002|Overall Study|Sponsor recommended discontinuation|0|||
143414229|NCT01364597|517063071|FG003|Overall Study|Sponsor recommended discontinuation|1|||
143414230|NCT01364597|517063068|FG000|Overall Study|Parents went abroad with the patient|0|||
143414231|NCT01364597|517063069|FG001|Overall Study|Parents went abroad with the patient|0|||
143414232|NCT01364597|517063070|FG002|Overall Study|Parents went abroad with the patient|1|||
143414233|NCT01364597|517063071|FG003|Overall Study|Parents went abroad with the patient|0|||
143414234|NCT01364597|517063068|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
143414235|NCT01364597|517063069|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
143414236|NCT01364597|517063070|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
143414237|NCT01364597|517063071|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
143414238|NCT01364597|517063068|FG000|Overall Study|BRV administration dropout|0|||
143414239|NCT01364597|517063069|FG001|Overall Study|BRV administration dropout|0|||
143414240|NCT01364597|517063070|FG002|Overall Study|BRV administration dropout|1|||
143414241|NCT01364597|517063071|FG003|Overall Study|BRV administration dropout|0|||
143414242|NCT01364597|517063068|FG000|Overall Study|Dropout|0|||
143414243|NCT01364597|517063069|FG001|Overall Study|Dropout|0|||
143414244|NCT01364597|517063070|FG002|Overall Study|Dropout|3|||
143414245|NCT01364597|517063071|FG003|Overall Study|Dropout|1|||
143414246|NCT01364597|517063068|FG000|Overall Study|Unreliable subject|0|||
143414247|NCT01364597|517063069|FG001|Overall Study|Unreliable subject|0|||
143414248|NCT01364597|517063070|FG002|Overall Study|Unreliable subject|0|||
143414249|NCT01364597|517063071|FG003|Overall Study|Unreliable subject|1|||
143414250|NCT01364597|517063068|FG000|Overall Study|Other|0|||
143414251|NCT01364597|517063069|FG001|Overall Study|Other|0|||
143414252|NCT01364597|517063070|FG002|Overall Study|Other|0|||
143414253|NCT01364597|517063071|FG003|Overall Study|Other|1|||
143414254|NCT02713594|517063075|FG000|Overall Study|Withdrawal by Subject|32|||
143414255|NCT02713594|517063076|FG001|Overall Study|Withdrawal by Subject|22|||
143414256|NCT02713594|517063075|FG000|Overall Study|Lost to Follow-up|358|||
143414257|NCT02713594|517063076|FG001|Overall Study|Lost to Follow-up|374|||
143414258|NCT03493282|517063077|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
143414259|NCT03493282|517063078|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
143414260|NCT03493282|517063079|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
143414261|NCT03493282|517063077|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
143414262|NCT03493282|517063078|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
143414263|NCT03493282|517063079|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
143414264|NCT01380145|517063080|FG000|Overall Study|Progressive disease|4|||
143414265|NCT02698475|517063081|FG000|Main Study Period|Lack of Efficacy|1|||
143414266|NCT02698475|517063081|FG000|Main Study Period|Protocol Violation|2|||
143414267|NCT02698475|517063081|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
143414268|NCT02698475|517063081|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
143414269|NCT02698475|517063081|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
143414270|NCT02698475|517063081|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
143414271|NCT02698475|517063081|FG000|Long-Term Extension Period|Other|1|||
143414272|NCT02038049|517063082|FG000|Overall Study|Lost to Follow-up|1|||
143414273|NCT02038049|517063083|FG001|Overall Study|Lost to Follow-up|0|||
143414274|NCT02771366|517063084|FG000|Period 1|Withdrawal by Subject|0|||
143414275|NCT02771366|517063085|FG001|Period 1|Withdrawal by Subject|2|||
143414276|NCT02771366|517063084|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
143414277|NCT02771366|517063085|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
143414278|NCT00587171|517063088|FG000|Overall Study|Lost to Follow-up|1|||
143414279|NCT00587171|517063089|FG001|Overall Study|Lost to Follow-up|1|||
143414280|NCT02148705|517063093|FG000|Overall Study|Death|2|||
143414281|NCT02148705|517063094|FG001|Overall Study|Death|0|||
143414282|NCT02148705|517063095|FG002|Overall Study|Death|0|||
143414283|NCT02148705|517063093|FG000|Overall Study|Lost to Follow-up|13|||
143414284|NCT02148705|517063094|FG001|Overall Study|Lost to Follow-up|4|||
143414285|NCT02148705|517063095|FG002|Overall Study|Lost to Follow-up|10|||
143414286|NCT02148705|517063093|FG000|Overall Study|Withdrawal by Subject|3|||
143414287|NCT02148705|517063094|FG001|Overall Study|Withdrawal by Subject|0|||
143414288|NCT02148705|517063095|FG002|Overall Study|Withdrawal by Subject|2|||
143414289|NCT02148705|517063093|FG000|Overall Study|Not Treated|0|||
143414290|NCT02148705|517063094|FG001|Overall Study|Not Treated|1|||
143414291|NCT02148705|517063095|FG002|Overall Study|Not Treated|5|||
143414292|NCT01737021|517063098|FG000|Overall Study|Lost to Follow-up|5|||
143414293|NCT01737021|517063099|FG001|Overall Study|Lost to Follow-up|3|||
143414294|NCT01673594|517063100|FG000|Overall Study|Adverse Event|3|||
143414295|NCT01673594|517063101|FG001|Overall Study|Adverse Event|1|||
143414296|NCT01673594|517063100|FG000|Overall Study|Lost to Follow-up|1|||
143414297|NCT01673594|517063101|FG001|Overall Study|Lost to Follow-up|0|||
143414298|NCT01673594|517063100|FG000|Overall Study|Physician Decision|2|||
143414299|NCT01673594|517063101|FG001|Overall Study|Physician Decision|4|||
143414300|NCT01673594|517063100|FG000|Overall Study|Withdrawal by Subject|0|||
143414301|NCT01673594|517063101|FG001|Overall Study|Withdrawal by Subject|1|||
143414302|NCT02605174|517063105|FG000|Overall Study|Adverse Event|0|||
143414303|NCT02605174|517063106|FG001|Overall Study|Adverse Event|0|||
143414304|NCT02605174|517063107|FG002|Overall Study|Adverse Event|1|||
143414305|NCT02605174|517063108|FG003|Overall Study|Adverse Event|0|||
143414306|NCT02605174|517063109|FG004|Overall Study|Adverse Event|4|||
143414307|NCT02605174|517063110|FG005|Overall Study|Adverse Event|0|||
143414308|NCT02605174|517063111|FG006|Overall Study|Adverse Event|0|||
143414309|NCT02605174|517063105|FG000|Overall Study|Lost to Follow-up|20|||
143414310|NCT02605174|517063106|FG001|Overall Study|Lost to Follow-up|7|||
143414311|NCT02605174|517063107|FG002|Overall Study|Lost to Follow-up|27|||
143414312|NCT02605174|517063108|FG003|Overall Study|Lost to Follow-up|10|||
143414313|NCT02605174|517063109|FG004|Overall Study|Lost to Follow-up|20|||
143414314|NCT02605174|517063110|FG005|Overall Study|Lost to Follow-up|10|||
143414315|NCT02605174|517063111|FG006|Overall Study|Lost to Follow-up|29|||
143414316|NCT02605174|517063105|FG000|Overall Study|Protocol Violation|10|||
143414317|NCT02605174|517063106|FG001|Overall Study|Protocol Violation|4|||
143414318|NCT02605174|517063107|FG002|Overall Study|Protocol Violation|14|||
143414319|NCT02605174|517063108|FG003|Overall Study|Protocol Violation|6|||
143414320|NCT02605174|517063109|FG004|Overall Study|Protocol Violation|7|||
143414321|NCT02605174|517063110|FG005|Overall Study|Protocol Violation|7|||
143414322|NCT02605174|517063111|FG006|Overall Study|Protocol Violation|12|||
143414323|NCT02605174|517063105|FG000|Overall Study|Pregnancy|1|||
143414324|NCT02605174|517063106|FG001|Overall Study|Pregnancy|0|||
143414325|NCT02605174|517063107|FG002|Overall Study|Pregnancy|0|||
143414326|NCT02605174|517063108|FG003|Overall Study|Pregnancy|2|||
143414327|NCT02605174|517063109|FG004|Overall Study|Pregnancy|0|||
143414328|NCT02605174|517063110|FG005|Overall Study|Pregnancy|0|||
143414329|NCT02605174|517063111|FG006|Overall Study|Pregnancy|0|||
143414330|NCT02605174|517063105|FG000|Overall Study|Withdrawal by Subject|9|||
143414331|NCT02605174|517063106|FG001|Overall Study|Withdrawal by Subject|6|||
143414332|NCT02605174|517063107|FG002|Overall Study|Withdrawal by Subject|14|||
143414333|NCT02605174|517063108|FG003|Overall Study|Withdrawal by Subject|11|||
143414334|NCT02605174|517063109|FG004|Overall Study|Withdrawal by Subject|6|||
143414335|NCT02605174|517063110|FG005|Overall Study|Withdrawal by Subject|4|||
143414336|NCT02605174|517063111|FG006|Overall Study|Withdrawal by Subject|15|||
143414337|NCT02605174|517063105|FG000|Overall Study|Physician Decision|2|||
143414338|NCT02605174|517063106|FG001|Overall Study|Physician Decision|0|||
143414339|NCT02605174|517063107|FG002|Overall Study|Physician Decision|0|||
143414340|NCT02605174|517063108|FG003|Overall Study|Physician Decision|0|||
143414341|NCT02605174|517063109|FG004|Overall Study|Physician Decision|0|||
143414342|NCT02605174|517063110|FG005|Overall Study|Physician Decision|0|||
143414343|NCT02605174|517063111|FG006|Overall Study|Physician Decision|3|||
143414344|NCT02605174|517063105|FG000|Overall Study|Randomization Failure|22|||
143414345|NCT02605174|517063106|FG001|Overall Study|Randomization Failure|6|||
143414346|NCT02605174|517063107|FG002|Overall Study|Randomization Failure|20|||
143414347|NCT02605174|517063108|FG003|Overall Study|Randomization Failure|7|||
143414348|NCT02605174|517063109|FG004|Overall Study|Randomization Failure|16|||
143414349|NCT02605174|517063110|FG005|Overall Study|Randomization Failure|11|||
143414350|NCT02605174|517063111|FG006|Overall Study|Randomization Failure|30|||
143414351|NCT03960645|517063112|FG000|Overall Study|Protocol Violation|1|||
143414352|NCT03960645|517063113|FG001|Overall Study|Protocol Violation|0|||
143414353|NCT04938453|517063116|FG000|Washout Period 1|Adverse Event|1|||
143414354|NCT04938453|517063117|FG001|Washout Period 1|Adverse Event|0|||
143414355|NCT04938453|517063116|FG000|Washout Period 1|Physician Decision|0|||
143414356|NCT04938453|517063117|FG001|Washout Period 1|Physician Decision|1|||
143414357|NCT03292406|517063118|FG000|Overall Study|Progressive Disease|6|||
143414358|NCT03292406|517063119|FG001|Overall Study|Progressive Disease|3|||
143414359|NCT03292406|517063120|FG002|Overall Study|Progressive Disease|4|||
143414360|NCT03292406|517063118|FG000|Overall Study|Adverse Event|7|||
143414361|NCT03292406|517063119|FG001|Overall Study|Adverse Event|1|||
143414362|NCT03292406|517063120|FG002|Overall Study|Adverse Event|4|||
143414363|NCT03292406|517063118|FG000|Overall Study|Withdrawal by Subject|0|||
143414364|NCT03292406|517063119|FG001|Overall Study|Withdrawal by Subject|7|||
143414365|NCT03292406|517063120|FG002|Overall Study|Withdrawal by Subject|2|||
143414366|NCT03292406|517063118|FG000|Overall Study|Protocol Violation|0|||
143414367|NCT03292406|517063119|FG001|Overall Study|Protocol Violation|1|||
143414368|NCT03292406|517063120|FG002|Overall Study|Protocol Violation|1|||
143414369|NCT03292406|517063118|FG000|Overall Study|Other|0|||
143414370|NCT03292406|517063119|FG001|Overall Study|Other|1|||
143414371|NCT03292406|517063120|FG002|Overall Study|Other|2|||
143414372|NCT04658784|517063125|FG000|6-month Follow-up|Lost to Follow-up|2|||
143414373|NCT04658784|517063126|FG001|6-month Follow-up|Lost to Follow-up|5|||
143414374|NCT00273052|517063127|FG000|Overall Study|Withdrawal by Subject|16|||
143414375|NCT00273052|517063128|FG001|Overall Study|Withdrawal by Subject|19|||
143414376|NCT00273052|517063127|FG000|Overall Study|Adverse Event|21|||
143414377|NCT00273052|517063128|FG001|Overall Study|Adverse Event|19|||
143414378|NCT00273052|517063127|FG000|Overall Study|Protocol Violation|14|||
143414379|NCT00273052|517063128|FG001|Overall Study|Protocol Violation|18|||
143414380|NCT00273052|517063127|FG000|Overall Study|Lost to Follow-up|7|||
143414381|NCT00273052|517063128|FG001|Overall Study|Lost to Follow-up|25|||
143414382|NCT00273052|517063127|FG000|Overall Study|Lack of Efficacy|6|||
143414383|NCT00273052|517063128|FG001|Overall Study|Lack of Efficacy|4|||
143414384|NCT00273052|517063127|FG000|Overall Study|Non-Compliance|3|||
143414385|NCT00273052|517063128|FG001|Overall Study|Non-Compliance|1|||
143414386|NCT00273052|517063127|FG000|Overall Study|Other|2|||
143414387|NCT00273052|517063128|FG001|Overall Study|Other|0|||
143414388|NCT00273052|517063127|FG000|Overall Study|Worsening serum lipid levels|0|||
143414389|NCT00273052|517063128|FG001|Overall Study|Worsening serum lipid levels|2|||
143414390|NCT02224755|517063129|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
143414391|NCT02224755|517063130|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
143414392|NCT02224755|517063129|FG000|Two Year Follow up Post-implant|Death|103|||
143414393|NCT02224755|517063130|FG001|Two Year Follow up Post-implant|Death|98|||
143414394|NCT02224755|517063129|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
143414395|NCT02224755|517063130|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
143414396|NCT02224755|517063129|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
143414397|NCT02224755|517063130|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
143414398|NCT02224755|517063129|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
143414399|NCT02224755|517063130|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
143414400|NCT05260437|517063133|FG000|Overall Study|Lost to Follow-up|5|||
143414401|NCT05260437|517063134|FG001|Overall Study|Lost to Follow-up|2|||
143414402|NCT05260437|517063135|FG002|Overall Study|Lost to Follow-up|1|||
143414403|NCT05260437|517063136|FG003|Overall Study|Lost to Follow-up|2|||
143414404|NCT05260437|517063137|FG004|Overall Study|Lost to Follow-up|2|||
143414405|NCT05260437|517063133|FG000|Overall Study|Withdrawal by Subject|3|||
143414406|NCT05260437|517063134|FG001|Overall Study|Withdrawal by Subject|0|||
143414407|NCT05260437|517063135|FG002|Overall Study|Withdrawal by Subject|4|||
143414408|NCT05260437|517063136|FG003|Overall Study|Withdrawal by Subject|5|||
143414409|NCT05260437|517063137|FG004|Overall Study|Withdrawal by Subject|0|||
143414410|NCT05260437|517063133|FG000|Overall Study|Vaccine Not Administered|0|||
143414411|NCT05260437|517063134|FG001|Overall Study|Vaccine Not Administered|1|||
143414412|NCT05260437|517063135|FG002|Overall Study|Vaccine Not Administered|0|||
143414413|NCT05260437|517063136|FG003|Overall Study|Vaccine Not Administered|0|||
143414414|NCT05260437|517063137|FG004|Overall Study|Vaccine Not Administered|0|||
143414415|NCT01858688|517063138|FG000|Overall Study|Withdrawal by Subject|8|||
143414416|NCT01858688|517063138|FG000|Overall Study|Participant began another therapy|3|||
143414417|NCT01858688|517063138|FG000|Overall Study|Physician Decision|2|||
143414418|NCT01858688|517063138|FG000|Overall Study|Progressive Disease|2|||
143414419|NCT01858688|517063138|FG000|Overall Study|Reason not reproted|5|||
143414420|NCT00895245|517063142|FG000|Overall Study|Lack of Efficacy|6|||
143414421|NCT02095678|517063143|FG000|Overall Study|Withdrawal by Subject|0|||
143414422|NCT02095678|517063144|FG001|Overall Study|Withdrawal by Subject|1|||
143414423|NCT02095678|517063143|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
143414424|NCT02095678|517063144|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
143414425|NCT02095678|517063143|FG000|Overall Study|lesion impacted by previous treatment|1|||
143414426|NCT02095678|517063144|FG001|Overall Study|lesion impacted by previous treatment|1|||
143414427|NCT02095678|517063143|FG000|Overall Study|No Confirmed Diagnosis|0|||
143414428|NCT02095678|517063144|FG001|Overall Study|No Confirmed Diagnosis|3|||
143414429|NCT02095678|517063143|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
143414430|NCT02095678|517063144|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
143414431|NCT02095678|517063143|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
143414432|NCT02095678|517063144|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
143414433|NCT00681109|517063145|FG000|Overall Study|Lost to Follow-up|2|||
143414434|NCT00681109|517063146|FG001|Overall Study|Lost to Follow-up|6|||
143414435|NCT00681109|517063147|FG002|Overall Study|Lost to Follow-up|0|||
143414436|NCT03131713|517063148|FG000|Overall Study|Lost to Follow-up|5|||
143414437|NCT03131713|517063149|FG001|Overall Study|Lost to Follow-up|0|||
143414438|NCT00701415|517063154|FG000|Overall Study|Adverse Event|0|||
143414439|NCT00701415|517063155|FG001|Overall Study|Adverse Event|1|||
143414440|NCT00701415|517063154|FG000|Overall Study|Social/family issues and needle phobia|1|||
143414441|NCT00701415|517063155|FG001|Overall Study|Social/family issues and needle phobia|0|||
143414442|NCT02208843|517063156|FG000|Overall Study|Clinical symptoms of progression|2|||
143414443|NCT02208843|517063156|FG000|Overall Study|Progression disease according to RECIST|24|||
143414444|NCT02208843|517063156|FG000|Overall Study|Adverse Event|12|||
143414445|NCT02208843|517063156|FG000|Overall Study|Protocol Violation|1|||
143414446|NCT02208843|517063156|FG000|Overall Study|Withdrawal by Subject|1|||
143414447|NCT02208843|517063156|FG000|Overall Study|Switched to commercial afatinib|20|||
143414448|NCT01972776|517063165|FG000|Part 1|Withdrawal by Subject|0|||
143414449|NCT01972776|517063166|FG001|Part 1|Withdrawal by Subject|0|||
143414450|NCT01972776|517063167|FG002|Part 1|Withdrawal by Subject|1|||
143414451|NCT01972776|517063168|FG003|Part 1|Withdrawal by Subject|0|||
143414452|NCT01972776|517063169|FG004|Part 1|Withdrawal by Subject|0|||
143414453|NCT01972776|517063170|FG005|Part 1|Withdrawal by Subject|0|||
143414454|NCT01972776|517063165|FG000|Part 1|Adverse Event|0|||
143414455|NCT01972776|517063166|FG001|Part 1|Adverse Event|0|||
143414456|NCT01972776|517063167|FG002|Part 1|Adverse Event|1|||
143414457|NCT01972776|517063168|FG003|Part 1|Adverse Event|1|||
143414458|NCT01972776|517063169|FG004|Part 1|Adverse Event|0|||
143414459|NCT01972776|517063170|FG005|Part 1|Adverse Event|0|||
143414460|NCT01972776|517063165|FG000|Part 2|Adverse Event|0|||
143414461|NCT01972776|517063166|FG001|Part 2|Adverse Event|0|||
143414462|NCT01972776|517063167|FG002|Part 2|Adverse Event|0|||
143414463|NCT01972776|517063168|FG003|Part 2|Adverse Event|0|||
143414464|NCT01972776|517063169|FG004|Part 2|Adverse Event|3|||
143414465|NCT01972776|517063170|FG005|Part 2|Adverse Event|0|||
143414466|NCT01972776|517063165|FG000|Part 2|Administrative problems|0|||
143414467|NCT01972776|517063166|FG001|Part 2|Administrative problems|0|||
143414468|NCT01972776|517063167|FG002|Part 2|Administrative problems|0|||
143414469|NCT01972776|517063168|FG003|Part 2|Administrative problems|0|||
143414470|NCT01972776|517063169|FG004|Part 2|Administrative problems|10|||
143414471|NCT01972776|517063170|FG005|Part 2|Administrative problems|7|||
143414472|NCT02382640|517063184|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
143414473|NCT02382640|517063185|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
143414474|NCT02382640|517063186|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
143414475|NCT02382640|517063187|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
143414476|NCT01560429|517063188|FG000|Overall Study|Protocol Violation|3|||
143414477|NCT01560429|517063189|FG001|Overall Study|Protocol Violation|6|||
143414478|NCT02485925|517063190|FG000|Overall Study|Withdrawal by Subject|3|||
143414479|NCT02485925|517063190|FG000|Overall Study|Death|1|||
143414480|NCT02485925|517063190|FG000|Overall Study|Lost to Follow-up|11|||
143414481|NCT00949117|517065274|FG000|Overall Study|Lack of Efficacy|2|||
143414482|NCT00949117|517065275|FG001|Overall Study|Lack of Efficacy|3|||
143414483|NCT00949117|517065274|FG000|Overall Study|Protocol Violation|1|||
143414484|NCT00949117|517065275|FG001|Overall Study|Protocol Violation|1|||
143414485|NCT00949117|517065274|FG000|Overall Study|Adverse Event|0|||
143414486|NCT00949117|517065275|FG001|Overall Study|Adverse Event|1|||
143414487|NCT03769090|517065276|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
143414488|NCT03769090|517065277|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
143414489|NCT03769090|517065278|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
143414490|NCT03769090|517065276|FG000|Overall Study|Withdrawal by Subject|52|||
143414491|NCT03769090|517065277|FG001|Overall Study|Withdrawal by Subject|62|||
143414492|NCT03769090|517065278|FG002|Overall Study|Withdrawal by Subject|74|||
143414493|NCT03769090|517065276|FG000|Overall Study|Death|4|||
143414494|NCT03769090|517065277|FG001|Overall Study|Death|2|||
143414495|NCT03769090|517065278|FG002|Overall Study|Death|2|||
143414496|NCT03769090|517065276|FG000|Overall Study|Adverse Event|7|||
143414497|NCT03769090|517065277|FG001|Overall Study|Adverse Event|7|||
143414498|NCT03769090|517065278|FG002|Overall Study|Adverse Event|8|||
143414499|NCT03769090|517065276|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
143414500|NCT03769090|517065277|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
143414501|NCT03769090|517065278|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
143414502|NCT03769090|517065276|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
143414503|NCT03769090|517065277|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
143414504|NCT03769090|517065278|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
143414505|NCT03769090|517065276|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
143414506|NCT03769090|517065277|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
143414507|NCT03769090|517065278|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
143414508|NCT03769090|517065276|FG000|Overall Study|Protocol Violation|5|||
143414509|NCT03769090|517065277|FG001|Overall Study|Protocol Violation|6|||
143414510|NCT03769090|517065278|FG002|Overall Study|Protocol Violation|8|||
143414511|NCT03769090|517065276|FG000|Overall Study|Pregnancy|1|||
143414512|NCT03769090|517065277|FG001|Overall Study|Pregnancy|0|||
143414513|NCT03769090|517065278|FG002|Overall Study|Pregnancy|3|||
143414514|NCT03769090|517065276|FG000|Overall Study|Lost to Follow-up|19|||
143414515|NCT03769090|517065277|FG001|Overall Study|Lost to Follow-up|25|||
143414516|NCT03769090|517065278|FG002|Overall Study|Lost to Follow-up|21|||
143414517|NCT03769090|517065276|FG000|Overall Study|Condition under investigation worsened|2|||
143414518|NCT03769090|517065277|FG001|Overall Study|Condition under investigation worsened|0|||
143414519|NCT03769090|517065278|FG002|Overall Study|Condition under investigation worsened|1|||
143414520|NCT03769090|517065276|FG000|Overall Study|Lack of Efficacy|1|||
143414521|NCT03769090|517065277|FG001|Overall Study|Lack of Efficacy|2|||
143414522|NCT03769090|517065278|FG002|Overall Study|Lack of Efficacy|2|||
143414523|NCT03769090|517065276|FG000|Overall Study|Other reasons|8|||
143414524|NCT03769090|517065277|FG001|Overall Study|Other reasons|12|||
143414525|NCT03769090|517065278|FG002|Overall Study|Other reasons|15|||
143414526|NCT03964974|517065279|FG000|Overall Study|Lost to Follow-up|3|||
143414527|NCT03964974|517065280|FG001|Overall Study|Lost to Follow-up|2|||
143414528|NCT03964974|517065279|FG000|Overall Study|Withdrawal by Subject|0|||
143414529|NCT03964974|517065280|FG001|Overall Study|Withdrawal by Subject|3|||
143414530|NCT02014402|517065281|FG000|Overall Study|Adverse Event|1|||
143414531|NCT02014402|517065282|FG001|Overall Study|Adverse Event|0|||
143414532|NCT02014402|517065283|FG002|Overall Study|Adverse Event|0|||
143414533|NCT02014402|517065284|FG003|Overall Study|Adverse Event|0|||
143414534|NCT02014402|517065281|FG000|Overall Study|Withdrawal by Subject|1|||
143414535|NCT02014402|517065282|FG001|Overall Study|Withdrawal by Subject|2|||
143414536|NCT02014402|517065283|FG002|Overall Study|Withdrawal by Subject|2|||
143414537|NCT02014402|517065284|FG003|Overall Study|Withdrawal by Subject|1|||
143414538|NCT02014402|517065281|FG000|Overall Study|Subject did not have transportation|0|||
143414539|NCT02014402|517065282|FG001|Overall Study|Subject did not have transportation|1|||
143414540|NCT02014402|517065283|FG002|Overall Study|Subject did not have transportation|0|||
143414541|NCT02014402|517065284|FG003|Overall Study|Subject did not have transportation|0|||
143414542|NCT02014402|517065281|FG000|Overall Study|Lost to Follow-up|0|||
143414543|NCT02014402|517065282|FG001|Overall Study|Lost to Follow-up|0|||
143414544|NCT02014402|517065283|FG002|Overall Study|Lost to Follow-up|1|||
143414545|NCT02014402|517065284|FG003|Overall Study|Lost to Follow-up|2|||
143414546|NCT00108355|517065288|FG000|Overall Study|Peritonitis at index paracentesis|1|||
143414547|NCT00108355|517065289|FG001|Overall Study|Peritonitis at index paracentesis|1|||
143414548|NCT00108355|517065288|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
143414549|NCT00108355|517065289|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
143414550|NCT02660086|517065290|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
143414551|NCT02660086|517065291|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
143414552|NCT02660086|517065290|FG000|Overall Study- 12-month|Left full-time employment|12|||
143414553|NCT02660086|517065291|FG001|Overall Study- 12-month|Left full-time employment|20|||
143414554|NCT02660086|517065290|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
143414555|NCT02660086|517065291|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
143414556|NCT02660086|517065290|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
143414557|NCT02660086|517065291|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
143414558|NCT02660086|517065290|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
143414559|NCT02660086|517065291|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
143414560|NCT02660086|517065290|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
143414561|NCT02660086|517065291|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
143414562|NCT03928743|517065297|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
143414563|NCT03928743|517065298|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
143414564|NCT03928743|517065299|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
143414565|NCT03928743|517065297|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
143414566|NCT03928743|517065298|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
143414567|NCT03928743|517065299|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
143414568|NCT03928743|517065297|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
143414569|NCT03928743|517065298|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
143414570|NCT03928743|517065299|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
143414571|NCT03928743|517065297|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
143414572|NCT03928743|517065298|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
143414573|NCT03928743|517065299|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
143414574|NCT03928743|517065297|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
143414575|NCT03928743|517065298|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
143414576|NCT03928743|517065299|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
143414577|NCT03928743|517065297|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
143414578|NCT03928743|517065298|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
143414579|NCT03928743|517065299|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
143414580|NCT03928743|517065297|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
143414581|NCT03928743|517065298|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
143414582|NCT03928743|517065299|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
143414583|NCT03928743|517065297|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
143414584|NCT03928743|517065298|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
143414585|NCT03928743|517065299|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
143414586|NCT03928743|517065297|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
143414587|NCT03928743|517065298|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
143414588|NCT03928743|517065299|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
143414589|NCT03928743|517065297|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
143414590|NCT03928743|517065298|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
143414591|NCT03928743|517065299|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
143414592|NCT03928743|517065297|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
143414593|NCT03928743|517065298|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
143414594|NCT03928743|517065299|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
143414595|NCT04250636|517065300|FG000|Overall Study|Lost to Follow-up|2|||
143414596|NCT01779050|517065302|FG000|Overall Study|Withdrawal by Subject|1|||
143414597|NCT01779050|517065303|FG001|Overall Study|Withdrawal by Subject|0|||
143414598|NCT01353274|517065304|FG000|Overall Study|No case report form (CRF) collected|28|||
143414599|NCT03737110|517065307|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
143414600|NCT03737110|517065308|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
143414601|NCT03737110|517065309|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
143414602|NCT03737110|517065310|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
143414603|NCT03737110|517065311|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
143414604|NCT03737110|517065312|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
143414605|NCT03737110|517065307|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
143414606|NCT03737110|517065308|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
143414607|NCT03737110|517065309|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
143414608|NCT03737110|517065310|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
143414609|NCT03737110|517065311|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
143414610|NCT03737110|517065312|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
143414611|NCT03737110|517065307|FG000|Run-in (RI) Period|Adverse Event|4|||
143414612|NCT03737110|517065308|FG001|Run-in (RI) Period|Adverse Event|0|||
143414613|NCT03737110|517065309|FG002|Run-in (RI) Period|Adverse Event|0|||
143414614|NCT03737110|517065310|FG003|Run-in (RI) Period|Adverse Event|0|||
143414615|NCT03737110|517065311|FG004|Run-in (RI) Period|Adverse Event|0|||
143414616|NCT03737110|517065312|FG005|Run-in (RI) Period|Adverse Event|0|||
143414617|NCT03737110|517065307|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
143414618|NCT03737110|517065308|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
143414619|NCT03737110|517065309|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
143414620|NCT03737110|517065310|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
143414621|NCT03737110|517065311|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
143414622|NCT03737110|517065312|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
143414623|NCT03737110|517065307|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
143414624|NCT03737110|517065308|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
143414625|NCT03737110|517065309|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
143414626|NCT03737110|517065310|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
143414627|NCT03737110|517065311|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
143414628|NCT03737110|517065312|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
143414629|NCT03737110|517065307|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
143414630|NCT03737110|517065308|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
143414631|NCT03737110|517065309|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
143414632|NCT03737110|517065310|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
143414633|NCT03737110|517065311|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
143414634|NCT03737110|517065312|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
143414635|NCT03737110|517065307|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
143414636|NCT03737110|517065308|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
143414637|NCT03737110|517065309|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
143414638|NCT03737110|517065310|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
143414639|NCT03737110|517065311|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
143414640|NCT03737110|517065312|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
143414641|NCT03737110|517065307|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
143414642|NCT03737110|517065308|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
143414643|NCT03737110|517065309|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
143414644|NCT03737110|517065310|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
143414645|NCT03737110|517065311|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
143414646|NCT03737110|517065312|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
143414647|NCT03648541|517065313|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
143414648|NCT03648541|517065314|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
143414649|NCT03648541|517065313|FG000|Re-induction Period Only|Lack of Efficacy|7|||
143414650|NCT03648541|517065314|FG001|Re-induction Period Only|Lack of Efficacy|0|||
143414651|NCT03648541|517065313|FG000|Maintenance Period Only|Missing|0|||
143414652|NCT03648541|517065314|FG001|Maintenance Period Only|Missing|1|||
143414653|NCT03648541|517065313|FG000|Maintenance Period Only|Other not listed below|0|||
143414654|NCT03648541|517065314|FG001|Maintenance Period Only|Other not listed below|4|||
143414655|NCT03648541|517065313|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
143414656|NCT03648541|517065314|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
143414657|NCT03648541|517065313|FG000|Maintenance Period Only|Protocol Violation|0|||
143414658|NCT03648541|517065314|FG001|Maintenance Period Only|Protocol Violation|1|||
143414659|NCT03648541|517065313|FG000|Maintenance Period Only|Lack of Efficacy|0|||
143414660|NCT03648541|517065314|FG001|Maintenance Period Only|Lack of Efficacy|18|||
143414661|NCT03648541|517065313|FG000|Maintenance Period Only|Adverse Event|0|||
143414662|NCT03648541|517065314|FG001|Maintenance Period Only|Adverse Event|4|||
143414663|NCT03648541|517065313|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
143414664|NCT03648541|517065314|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
143414665|NCT01951703|517065328|FG000|First Intervention|Withdrawal by Subject|1|||
143414666|NCT01951703|517065329|FG001|First Intervention|Withdrawal by Subject|0|||
143414667|NCT01951703|517065328|FG000|First Intervention|Subject was not compliant|1|||
143414668|NCT01951703|517065329|FG001|First Intervention|Subject was not compliant|1|||
143414669|NCT01951703|517065328|FG000|First Intervention|Physician Decision|1|||
143414670|NCT01951703|517065329|FG001|First Intervention|Physician Decision|0|||
143414671|NCT01951703|517065328|FG000|Second Intervention|Protocol Violation|0|||
143414672|NCT01951703|517065329|FG001|Second Intervention|Protocol Violation|1|||
143414673|NCT01951703|517065328|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
143414674|NCT01951703|517065329|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
143414675|NCT02827201|517065330|FG000|Overall Study|Death|1|||
143414676|NCT02827201|517065331|FG001|Overall Study|Death|2|||
143414677|NCT02827201|517065330|FG000|Overall Study|Patients not treated|1|||
143414678|NCT02827201|517065331|FG001|Overall Study|Patients not treated|1|||
143414679|NCT02736188|517065334|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
143414680|NCT02736188|517065334|FG000|Overall Study|Adverse Event|1|||
143414681|NCT02736188|517065334|FG000|Overall Study|Withdrawal by Subject|1|||
143414682|NCT02736188|517065334|FG000|Overall Study|Other|6|||
143414683|NCT00240994|517065335|FG000|Overall Study|Lost to Follow-up|1|||
143414684|NCT00240994|517065335|FG000|Overall Study|Protocol Violation|1|||
143414685|NCT00240994|517065335|FG000|Overall Study|Graft failure|1|||
143414686|NCT02630186|517065336|FG000|Overall Study|Withdrawal by Subject|1|||
143414687|NCT00439218|517065337|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
143414688|NCT03176407|517065338|FG000|Overall Study|Protocol Violation|1|||
143414689|NCT03176407|517065338|FG000|Overall Study|human failure|1|||
143414690|NCT03176407|517065338|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
143414691|NCT05124210|517065339|FG000|Overall Study|Lost to Follow-up|1|||
143414692|NCT05124210|517065340|FG001|Overall Study|Lost to Follow-up|0|||
143414693|NCT05124210|517065339|FG000|Overall Study|Withdrawal by Subject|1|||
143414694|NCT05124210|517065340|FG001|Overall Study|Withdrawal by Subject|0|||
143414695|NCT01428583|517065341|FG000|Overall Study|Adverse Event|75|||
143414696|NCT01428583|517065341|FG000|Overall Study|Withdrawal by Subject|51|||
143414697|NCT01428583|517065341|FG000|Overall Study|Lack of Efficacy|37|||
143414698|NCT01428583|517065341|FG000|Overall Study|Lost to Follow-up|17|||
143414699|NCT01428583|517065341|FG000|Overall Study|Death|1|||
143414700|NCT01428583|517065341|FG000|Overall Study|Pregnancy|1|||
143414701|NCT01428583|517065341|FG000|Overall Study|Protocol Violation|1|||
143414702|NCT01428583|517065341|FG000|Overall Study|Physician Decision|12|||
143414703|NCT01428583|517065341|FG000|Overall Study|Non-compliant|25|||
143414704|NCT01428583|517065341|FG000|Overall Study|Confirmed positive urine drug test|8|||
143414705|NCT01428583|517065341|FG000|Overall Study|Sponsor's request|3|||
143414706|NCT01428583|517065341|FG000|Overall Study|Other|6|||
143414707|NCT00768755|517065344|FG000|Phase 1|Death|6|||
143414708|NCT00768755|517065345|FG001|Phase 1|Death|0|||
143414709|NCT00768755|517065346|FG002|Phase 1|Death|0|||
143414710|NCT00768755|517065347|FG003|Phase 1|Death|0|||
143414711|NCT00768755|517065344|FG000|Phase 1|Other|4|||
143414712|NCT00768755|517065345|FG001|Phase 1|Other|0|||
143414713|NCT00768755|517065346|FG002|Phase 1|Other|0|||
143414714|NCT00768755|517065347|FG003|Phase 1|Other|0|||
143414715|NCT00768755|517065344|FG000|Phase 2|Death|0|||
143414716|NCT00768755|517065345|FG001|Phase 2|Death|37|||
143414717|NCT00768755|517065346|FG002|Phase 2|Death|48|||
143414718|NCT00768755|517065347|FG003|Phase 2|Death|31|||
143414719|NCT00768755|517065344|FG000|Phase 2|Protocol Violation|0|||
143414720|NCT00768755|517065345|FG001|Phase 2|Protocol Violation|2|||
143414721|NCT00768755|517065346|FG002|Phase 2|Protocol Violation|0|||
143414722|NCT00768755|517065347|FG003|Phase 2|Protocol Violation|1|||
143414723|NCT00768755|517065344|FG000|Phase 2|Lost to Follow-up|0|||
143414724|NCT00768755|517065345|FG001|Phase 2|Lost to Follow-up|1|||
143414725|NCT00768755|517065346|FG002|Phase 2|Lost to Follow-up|1|||
143414726|NCT00768755|517065347|FG003|Phase 2|Lost to Follow-up|4|||
143414727|NCT00768755|517065344|FG000|Phase 2|Withdrawal by Subject|0|||
143414728|NCT00768755|517065345|FG001|Phase 2|Withdrawal by Subject|1|||
143414729|NCT00768755|517065346|FG002|Phase 2|Withdrawal by Subject|0|||
143414730|NCT00768755|517065347|FG003|Phase 2|Withdrawal by Subject|1|||
143414731|NCT00768755|517065344|FG000|Phase 2|Other|0|||
143414732|NCT00768755|517065345|FG001|Phase 2|Other|1|||
143414733|NCT00768755|517065346|FG002|Phase 2|Other|2|||
143414734|NCT00768755|517065347|FG003|Phase 2|Other|4|||
143414735|NCT00768755|517065344|FG000|Phase 2|Study Terminated by Sponsor|0|||
143414736|NCT00768755|517065345|FG001|Phase 2|Study Terminated by Sponsor|13|||
143414737|NCT00768755|517065346|FG002|Phase 2|Study Terminated by Sponsor|7|||
143414738|NCT00768755|517065347|FG003|Phase 2|Study Terminated by Sponsor|14|||
143414739|NCT00768755|517065344|FG000|Phase 2|Randomized but not treated|0|||
143414740|NCT00768755|517065345|FG001|Phase 2|Randomized but not treated|0|||
143414741|NCT00768755|517065346|FG002|Phase 2|Randomized but not treated|0|||
143414742|NCT00768755|517065347|FG003|Phase 2|Randomized but not treated|2|||
143414743|NCT03142932|517065349|FG000|Overall Study|Lost to Follow-up|2|||
143414744|NCT03142932|517065350|FG001|Overall Study|Lost to Follow-up|11|||
143414745|NCT02128269|517065353|FG000|Treatment Period|Adverse Event|1|||
143414746|NCT02128269|517065353|FG000|Treatment Period|Physician Decision|1|||
143414747|NCT00878189|517065354|FG000|Overall Study|Death|0|||
143414748|NCT00878189|517065355|FG001|Overall Study|Death|1|||
143414749|NCT00878189|517065356|FG002|Overall Study|Death|0|||
143414750|NCT00878189|517065357|FG003|Overall Study|Death|1|||
143414751|NCT00878189|517065358|FG004|Overall Study|Death|0|||
143414752|NCT00878189|517065359|FG005|Overall Study|Death|0|||
143414753|NCT00878189|517065360|FG006|Overall Study|Death|0|||
143414754|NCT00878189|517065361|FG007|Overall Study|Death|0|||
143414755|NCT00878189|517065362|FG008|Overall Study|Death|1|||
143414756|NCT00878189|517065354|FG000|Overall Study|Participant Refused to Follow-up|0|||
143414757|NCT00878189|517065355|FG001|Overall Study|Participant Refused to Follow-up|0|||
143414758|NCT00878189|517065356|FG002|Overall Study|Participant Refused to Follow-up|0|||
143414759|NCT00878189|517065357|FG003|Overall Study|Participant Refused to Follow-up|0|||
143414760|NCT00878189|517065358|FG004|Overall Study|Participant Refused to Follow-up|0|||
143414761|NCT00878189|517065359|FG005|Overall Study|Participant Refused to Follow-up|4|||
143414762|NCT00878189|517065360|FG006|Overall Study|Participant Refused to Follow-up|0|||
143414763|NCT00878189|517065361|FG007|Overall Study|Participant Refused to Follow-up|0|||
143414764|NCT00878189|517065362|FG008|Overall Study|Participant Refused to Follow-up|0|||
143414765|NCT00878189|517065354|FG000|Overall Study|Other|3|||
143414766|NCT00878189|517065355|FG001|Overall Study|Other|2|||
143414767|NCT00878189|517065356|FG002|Overall Study|Other|4|||
143414768|NCT00878189|517065357|FG003|Overall Study|Other|7|||
143414769|NCT00878189|517065358|FG004|Overall Study|Other|4|||
143414770|NCT00878189|517065359|FG005|Overall Study|Other|18|||
143414771|NCT00878189|517065360|FG006|Overall Study|Other|15|||
143414772|NCT00878189|517065361|FG007|Overall Study|Other|3|||
143414773|NCT00878189|517065362|FG008|Overall Study|Other|4|||
143414774|NCT00878189|517065354|FG000|Overall Study|Lost to Follow-up|0|||
143414775|NCT00878189|517065355|FG001|Overall Study|Lost to Follow-up|0|||
143414776|NCT00878189|517065356|FG002|Overall Study|Lost to Follow-up|0|||
143414777|NCT00878189|517065357|FG003|Overall Study|Lost to Follow-up|0|||
143414778|NCT00878189|517065358|FG004|Overall Study|Lost to Follow-up|0|||
143414779|NCT00878189|517065359|FG005|Overall Study|Lost to Follow-up|1|||
143414780|NCT00878189|517065360|FG006|Overall Study|Lost to Follow-up|1|||
143414781|NCT00878189|517065361|FG007|Overall Study|Lost to Follow-up|0|||
143414782|NCT00878189|517065362|FG008|Overall Study|Lost to Follow-up|0|||
143414783|NCT00878189|517065354|FG000|Overall Study|Objection Progression or Relapse|0|||
143414784|NCT00878189|517065355|FG001|Overall Study|Objection Progression or Relapse|0|||
143414785|NCT00878189|517065356|FG002|Overall Study|Objection Progression or Relapse|0|||
143414786|NCT00878189|517065357|FG003|Overall Study|Objection Progression or Relapse|0|||
143414787|NCT00878189|517065358|FG004|Overall Study|Objection Progression or Relapse|0|||
143414788|NCT00878189|517065359|FG005|Overall Study|Objection Progression or Relapse|0|||
143414789|NCT00878189|517065360|FG006|Overall Study|Objection Progression or Relapse|0|||
143414790|NCT00878189|517065361|FG007|Overall Study|Objection Progression or Relapse|0|||
143414791|NCT00878189|517065362|FG008|Overall Study|Objection Progression or Relapse|3|||
143414792|NCT02007070|517065363|FG000|Overall Study|Adverse Event|4|||
143414793|NCT02007070|517065363|FG000|Overall Study|Clinical Progression|4|||
143414794|NCT02007070|517065363|FG000|Overall Study|Death|1|||
143414795|NCT02007070|517065363|FG000|Overall Study|Protocol Violation|2|||
143414796|NCT02007070|517065363|FG000|Overall Study|Physician Decision|1|||
143414797|NCT02007070|517065363|FG000|Overall Study|Progressive Disease|21|||
143414798|NCT01480258|517065364|FG000|Infant Series|Protocol Violation|2|||
143414799|NCT01480258|517065365|FG001|Infant Series|Protocol Violation|0|||
143414800|NCT01480258|517065364|FG000|Infant Series|Physician Decision|0|||
143414801|NCT01480258|517065365|FG001|Infant Series|Physician Decision|1|||
143414802|NCT01480258|517065364|FG000|Infant Series|Not Vaccinated|3|||
143414803|NCT01480258|517065365|FG001|Infant Series|Not Vaccinated|0|||
143414804|NCT01480258|517065364|FG000|Infant Series|Adverse Event|1|||
143414805|NCT01480258|517065365|FG001|Infant Series|Adverse Event|1|||
143414806|NCT01480258|517065364|FG000|Infant Series|Withdrawal by Subject|1|||
143414807|NCT01480258|517065365|FG001|Infant Series|Withdrawal by Subject|6|||
143414808|NCT01480258|517065364|FG000|Interim Period|Lost to Follow-up|0|||
143414809|NCT01480258|517065365|FG001|Interim Period|Lost to Follow-up|2|||
143414810|NCT01480258|517065364|FG000|Interim Period|Physician Decision|1|||
143414811|NCT01480258|517065365|FG001|Interim Period|Physician Decision|0|||
143414812|NCT01480258|517065364|FG000|Interim Period|Protocol Violation|0|||
143414813|NCT01480258|517065365|FG001|Interim Period|Protocol Violation|1|||
143414814|NCT01480258|517065364|FG000|Interim Period|Withdrawal by Subject|9|||
143414815|NCT01480258|517065365|FG001|Interim Period|Withdrawal by Subject|6|||
143414816|NCT01640288|517065368|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
143414817|NCT01640288|517065369|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
143414818|NCT01640288|517065368|FG000|Overall Study|Screen Failure|20|||
143414819|NCT01640288|517065369|FG001|Overall Study|Screen Failure|18|||
143414820|NCT01640288|517065368|FG000|Overall Study|Withdrawn by PI|5|||
143414821|NCT01640288|517065369|FG001|Overall Study|Withdrawn by PI|0|||
143414822|NCT01640288|517065368|FG000|Overall Study|Withdrawal by Subject|1|||
143414823|NCT01640288|517065369|FG001|Overall Study|Withdrawal by Subject|0|||
143414824|NCT00787176|517065370|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
143414825|NCT00787176|517065371|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
143414826|NCT00787176|517065372|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
143414827|NCT00787176|517065373|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
143414828|NCT02706483|517065376|FG000|Overall Study|Adverse Event|97|||
143414829|NCT02706483|517065376|FG000|Overall Study|Death|1|||
143414830|NCT02706483|517065376|FG000|Overall Study|Lack of Efficacy|39|||
143414831|NCT02706483|517065376|FG000|Overall Study|Lost to Follow-up|101|||
143414832|NCT02706483|517065376|FG000|Overall Study|Non-compliance with study drug|15|||
143414833|NCT02706483|517065376|FG000|Overall Study|Physician Decision|6|||
143414834|NCT02706483|517065376|FG000|Overall Study|Pregnancy|6|||
143414835|NCT02706483|517065376|FG000|Overall Study|Protocol Violation|18|||
143414836|NCT02706483|517065376|FG000|Overall Study|Withdrawal by Subject|136|||
143414837|NCT02706483|517065376|FG000|Overall Study|Non-compliance with visits|6|||
143414838|NCT02706483|517065376|FG000|Overall Study|Site closure|4|||
143414839|NCT02706483|517065376|FG000|Overall Study|Subject moved|1|||
143414840|NCT04660799|517065377|FG000|Overall Study|Progressive Disease|1|||
143414841|NCT04660799|517065378|FG001|Overall Study|Progressive Disease|1|||
143414842|NCT04660799|517065377|FG000|Overall Study|Death|2|||
143414843|NCT04660799|517065378|FG001|Overall Study|Death|1|||
143414844|NCT04660799|517065377|FG000|Overall Study|Adverse Event|2|||
143414845|NCT04660799|517065378|FG001|Overall Study|Adverse Event|1|||
143414846|NCT04660799|517065377|FG000|Overall Study|Withdrawal by Subject|2|||
143414847|NCT04660799|517065378|FG001|Overall Study|Withdrawal by Subject|5|||
143414848|NCT00659373|517065380|FG000|Overall Study|Withdrawal by Subject|3|||
143414849|NCT00659373|517065381|FG001|Overall Study|Withdrawal by Subject|5|||
143414850|NCT00659373|517065380|FG000|Overall Study|Assessment Missed|2|||
143414851|NCT00659373|517065381|FG001|Overall Study|Assessment Missed|2|||
143414852|NCT03042767|517065382|FG000|Overall Study|Lost to Follow-up|1|||
143414853|NCT03042767|517065383|FG001|Overall Study|Lost to Follow-up|2|||
143414854|NCT01543204|517065384|FG000|Overall Study|Non-compliance|1|||
143414855|NCT01543204|517065384|FG000|Overall Study|Adverse Event|1|||
143414856|NCT01543204|517065384|FG000|Overall Study|Withdrawal by Subject|4|||
143414857|NCT01543204|517065384|FG000|Overall Study|Requirement for Alternative Therapy|1|||
143414858|NCT01543204|517065384|FG000|Overall Study|Lost to Follow-up|1|||
143414859|NCT01220999|517065385|FG000|Overall Study|Progressive disease|0|||
143414860|NCT01220999|517065386|FG001|Overall Study|Progressive disease|0|||
143414861|NCT01220999|517065387|FG002|Overall Study|Progressive disease|1|||
143414862|NCT01220999|517065388|FG003|Overall Study|Progressive disease|0|||
143414863|NCT01220999|517065389|FG004|Overall Study|Progressive disease|0|||
143414864|NCT03326856|517065391|FG000|Overall Study|Lost to Follow-up|1|||
143414865|NCT03326856|517065392|FG001|Overall Study|Lost to Follow-up|1|||
143414866|NCT03326856|517065393|FG002|Overall Study|Lost to Follow-up|0|||
143414867|NCT03326856|517065394|FG003|Overall Study|Lost to Follow-up|0|||
143414868|NCT03326856|517065395|FG004|Overall Study|Lost to Follow-up|0|||
143414869|NCT02037568|517065396|FG000|Overall Study|Withdrawal by Subject|17|||
143414870|NCT02037568|517065397|FG001|Overall Study|Withdrawal by Subject|24|||
143414871|NCT02037568|517065396|FG000|Overall Study|Lost to Follow-up|16|||
143414872|NCT02037568|517065397|FG001|Overall Study|Lost to Follow-up|13|||
143414873|NCT02037568|517065396|FG000|Overall Study|Screen Failure|3|||
143414874|NCT02037568|517065397|FG001|Overall Study|Screen Failure|1|||
143414875|NCT02037568|517065396|FG000|Overall Study|Patient did not receive transplant|0|||
143414876|NCT02037568|517065397|FG001|Overall Study|Patient did not receive transplant|1|||
143414877|NCT00721734|517065400|FG000|Overall Study|Progressive Disease|3|||
143414878|NCT00721734|517065401|FG001|Overall Study|Progressive Disease|10|||
143414879|NCT00721734|517065402|FG002|Overall Study|Progressive Disease|4|||
143414880|NCT00721734|517065403|FG003|Overall Study|Progressive Disease|5|||
143414881|NCT00721734|517065404|FG004|Overall Study|Progressive Disease|2|||
143414882|NCT00721734|517065400|FG000|Overall Study|Adverse Event|3|||
143414883|NCT00721734|517065401|FG001|Overall Study|Adverse Event|1|||
143414884|NCT00721734|517065402|FG002|Overall Study|Adverse Event|4|||
143414885|NCT00721734|517065403|FG003|Overall Study|Adverse Event|0|||
143414886|NCT00721734|517065404|FG004|Overall Study|Adverse Event|3|||
143414887|NCT00721734|517065400|FG000|Overall Study|Withdrawal by Subject|2|||
143414888|NCT00721734|517065401|FG001|Overall Study|Withdrawal by Subject|1|||
143414889|NCT00721734|517065402|FG002|Overall Study|Withdrawal by Subject|0|||
143414890|NCT00721734|517065403|FG003|Overall Study|Withdrawal by Subject|0|||
143414891|NCT00721734|517065404|FG004|Overall Study|Withdrawal by Subject|1|||
143414892|NCT00721734|517065400|FG000|Overall Study|Other|0|||
143414893|NCT00721734|517065401|FG001|Overall Study|Other|0|||
143414894|NCT00721734|517065402|FG002|Overall Study|Other|0|||
143414895|NCT00721734|517065403|FG003|Overall Study|Other|1|||
143414896|NCT00721734|517065404|FG004|Overall Study|Other|0|||
143414897|NCT02833948|517065407|FG000|Overall Study|Death|2|||
143414898|NCT02833948|517065408|FG001|Overall Study|Death|3|||
143414899|NCT02833948|517065407|FG000|Overall Study|were not scanned|8|||
143414900|NCT02833948|517065408|FG001|Overall Study|were not scanned|13|||
143414901|NCT02833948|517065407|FG000|Overall Study|scans could not be evaluated|5|||
143414902|NCT02833948|517065408|FG001|Overall Study|scans could not be evaluated|2|||
143414903|NCT05613088|517065412|FG000|Treatment|Ongoing Study Treatment|9|||
143414904|NCT05613088|517065413|FG001|Treatment|Ongoing Study Treatment|2|||
143414905|NCT05613088|517065412|FG000|Treatment|Adverse Event|3|||
143414906|NCT05613088|517065413|FG001|Treatment|Adverse Event|1|||
143414907|NCT05613088|517065412|FG000|Treatment|Other Reasons|0|||
143414908|NCT05613088|517065413|FG001|Treatment|Other Reasons|1|||
143414909|NCT05613088|517065412|FG000|Treatment|Progressive Disease|58|||
143414910|NCT05613088|517065413|FG001|Treatment|Progressive Disease|26|||
143414911|NCT05613088|517065412|FG000|Treatment|Withdrawal by Subject|0|||
143414912|NCT05613088|517065413|FG001|Treatment|Withdrawal by Subject|4|||
143414913|NCT05169684|517065414|FG000|Overall Study|Adverse Event|1|||
143414914|NCT05169684|517065415|FG001|Overall Study|Adverse Event|3|||
143414915|NCT05169684|517065414|FG000|Overall Study|Physician Decision|0|||
143414916|NCT05169684|517065415|FG001|Overall Study|Physician Decision|1|||
143414917|NCT05169684|517065414|FG000|Overall Study|Progressive Disease|1|||
143414918|NCT05169684|517065415|FG001|Overall Study|Progressive Disease|1|||
143414919|NCT05169684|517065414|FG000|Overall Study|Participant request to discontinue treatment|0|||
143414920|NCT05169684|517065415|FG001|Overall Study|Participant request to discontinue treatment|1|||
143414921|NCT05169684|517065414|FG000|Overall Study|Other Reason|0|||
143414922|NCT05169684|517065415|FG001|Overall Study|Other Reason|1|||
143414923|NCT01668719|517065416|FG000|Phase I|On treatment|1|||
143414924|NCT01668719|517065417|FG001|Phase I|On treatment|0|||
143414925|NCT01668719|517065418|FG002|Phase I|On treatment|0|||
143414926|NCT01668719|517065416|FG000|Phase I|Adverse Event|2|||
143414927|NCT01668719|517065417|FG001|Phase I|Adverse Event|0|||
143414928|NCT01668719|517065418|FG002|Phase I|Adverse Event|0|||
143414929|NCT01668719|517065416|FG000|Phase I|Progression/relapse|1|||
143414930|NCT01668719|517065417|FG001|Phase I|Progression/relapse|0|||
143414931|NCT01668719|517065418|FG002|Phase I|Progression/relapse|0|||
143414932|NCT01668719|517065416|FG000|Phase I|not protocol specified|2|||
143414933|NCT01668719|517065417|FG001|Phase I|not protocol specified|0|||
143414934|NCT01668719|517065418|FG002|Phase I|not protocol specified|0|||
143414935|NCT01668719|517065416|FG000|Phase II|On treatment|0|||
143414936|NCT01668719|517065417|FG001|Phase II|On treatment|4|||
143414937|NCT01668719|517065418|FG002|Phase II|On treatment|3|||
143414938|NCT01668719|517065416|FG000|Phase II|Adverse Event|0|||
143414939|NCT01668719|517065417|FG001|Phase II|Adverse Event|18|||
143414940|NCT01668719|517065418|FG002|Phase II|Adverse Event|18|||
143414941|NCT01668719|517065416|FG000|Phase II|Refusal unrelated to adverse event|0|||
143414942|NCT01668719|517065417|FG001|Phase II|Refusal unrelated to adverse event|4|||
143414943|NCT01668719|517065418|FG002|Phase II|Refusal unrelated to adverse event|1|||
143414944|NCT01668719|517065416|FG000|Phase II|Progression/relapse|0|||
143414945|NCT01668719|517065417|FG001|Phase II|Progression/relapse|13|||
143414946|NCT01668719|517065418|FG002|Phase II|Progression/relapse|17|||
143414947|NCT01668719|517065416|FG000|Phase II|Death|0|||
143414948|NCT01668719|517065417|FG001|Phase II|Death|0|||
143414949|NCT01668719|517065418|FG002|Phase II|Death|2|||
143414950|NCT01668719|517065416|FG000|Phase II|not protocol specified|0|||
143414951|NCT01668719|517065417|FG001|Phase II|not protocol specified|13|||
143414952|NCT01668719|517065418|FG002|Phase II|not protocol specified|7|||
143414953|NCT03539055|517065419|FG000|Overall Study|Death|4|||
143414954|NCT03539055|517065419|FG000|Overall Study|Lost to Follow-up|1|||
143414955|NCT03539055|517065419|FG000|Overall Study|Withdrawal by Subject|2|||
143414956|NCT03539055|517065419|FG000|Overall Study|Screen Fail|7|||
143414957|NCT03539055|517065419|FG000|Overall Study|Drug Intolerance|2|||
143414958|NCT01638000|517065428|FG000|Overall Study|Randomized but Never Received Drug|7|||
143414959|NCT01638000|517065429|FG001|Overall Study|Randomized but Never Received Drug|10|||
143414960|NCT01638000|517065428|FG000|Overall Study|Adverse Event|14|||
143414961|NCT01638000|517065429|FG001|Overall Study|Adverse Event|16|||
143414962|NCT01638000|517065428|FG000|Overall Study|Lack of Efficacy|5|||
143414963|NCT01638000|517065429|FG001|Overall Study|Lack of Efficacy|6|||
143414964|NCT01638000|517065428|FG000|Overall Study|Protocol Violation|11|||
143414965|NCT01638000|517065429|FG001|Overall Study|Protocol Violation|13|||
143414966|NCT01638000|517065428|FG000|Overall Study|Withdrawal by Subject|21|||
143414967|NCT01638000|517065429|FG001|Overall Study|Withdrawal by Subject|24|||
143414968|NCT01638000|517065428|FG000|Overall Study|Miscellaneous|2|||
143414969|NCT01638000|517065429|FG001|Overall Study|Miscellaneous|2|||
143414970|NCT05484661|517065430|FG000|Overall Study|Withdrawal by Subject|1|||
143414971|NCT05484661|517065431|FG001|Overall Study|Withdrawal by Subject|0|||
143414972|NCT03775213|517065432|FG000|Overall Study|Withdrawal by Subject|51|||
143414973|NCT03775213|517065433|FG001|Overall Study|Withdrawal by Subject|53|||
143414974|NCT03775213|517065432|FG000|Overall Study|Incomplete Survey|7|||
143414975|NCT03775213|517065433|FG001|Overall Study|Incomplete Survey|7|||
143414976|NCT00786188|517065434|FG000|Overall Study|Adverse Event|3|||
143414977|NCT00786188|517065435|FG001|Overall Study|Adverse Event|1|||
143414978|NCT00786188|517065434|FG000|Overall Study|Withdrawal by Subject|2|||
143414979|NCT00786188|517065435|FG001|Overall Study|Withdrawal by Subject|0|||
143414980|NCT05163353|517065436|FG000|Overall Study|Adverse Event|1|||
143414981|NCT05163353|517065437|FG001|Overall Study|Adverse Event|0|||
143414982|NCT05163353|517065436|FG000|Overall Study|Withdrawal by Subject|21|||
143414983|NCT05163353|517065437|FG001|Overall Study|Withdrawal by Subject|6|||
143414984|NCT05163353|517065436|FG000|Overall Study|Protocol Violation|0|||
143414985|NCT05163353|517065437|FG001|Overall Study|Protocol Violation|1|||
143414986|NCT05163353|517065436|FG000|Overall Study|Lost to Follow-up|13|||
143414987|NCT05163353|517065437|FG001|Overall Study|Lost to Follow-up|2|||
143414988|NCT06086028|517065439|FG000|Overall Study|Withdrawal by Subject|1|||
143414989|NCT06086028|517065440|FG001|Overall Study|Withdrawal by Subject|1|||
143414990|NCT06086028|517065439|FG000|Overall Study|Lost to Follow-up|2|||
143414991|NCT06086028|517065440|FG001|Overall Study|Lost to Follow-up|3|||
143414992|NCT04821271|517065441|FG000|Period 1|Withdrawal by Subject|2|||
143414993|NCT04821271|517065442|FG001|Period 1|Withdrawal by Subject|0|||
143414994|NCT02521493|517065444|FG000|Overall Study|Death|3|||
143414995|NCT02521493|517065445|FG001|Overall Study|Death|4|||
143414996|NCT02521493|517065446|FG002|Overall Study|Death|1|||
143414997|NCT02521493|517065444|FG000|Overall Study|Physician Decision|19|||
143414998|NCT02521493|517065445|FG001|Overall Study|Physician Decision|1|||
143414999|NCT02521493|517065446|FG002|Overall Study|Physician Decision|2|||
143415000|NCT02521493|517065444|FG000|Overall Study|Withdrawal by Subject|3|||
143415001|NCT02521493|517065445|FG001|Overall Study|Withdrawal by Subject|0|||
143415002|NCT02521493|517065446|FG002|Overall Study|Withdrawal by Subject|0|||
143415003|NCT02521493|517065444|FG000|Overall Study|Ineligible|0|||
143415004|NCT02521493|517065445|FG001|Overall Study|Ineligible|1|||
143415005|NCT02521493|517065446|FG002|Overall Study|Ineligible|0|||
143415006|NCT02521493|517065444|FG000|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
143415007|NCT02521493|517065445|FG001|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
143415008|NCT02521493|517065446|FG002|Overall Study|Post Amd4A (MRD < 0.05%)|115|||
143415009|NCT02521493|517065444|FG000|Overall Study|No MRD result|0|||
143415010|NCT02521493|517065445|FG001|Overall Study|No MRD result|0|||
143415011|NCT02521493|517065446|FG002|Overall Study|No MRD result|4|||
143415012|NCT05615363|517065447|FG000|Overall Study|Adverse Event|0|||
143415013|NCT05615363|517065448|FG001|Overall Study|Adverse Event|4|||
143415014|NCT05615363|517065449|FG002|Overall Study|Adverse Event|4|||
143415015|NCT05615363|517065450|FG003|Overall Study|Adverse Event|3|||
143415016|NCT05615363|517065451|FG004|Overall Study|Adverse Event|1|||
143415017|NCT05615363|517065447|FG000|Overall Study|Physician Decision|2|||
143415018|NCT05615363|517065448|FG001|Overall Study|Physician Decision|0|||
143415019|NCT05615363|517065449|FG002|Overall Study|Physician Decision|4|||
143415020|NCT05615363|517065450|FG003|Overall Study|Physician Decision|1|||
143415021|NCT05615363|517065451|FG004|Overall Study|Physician Decision|3|||
143415022|NCT05615363|517065447|FG000|Overall Study|Protocol Violation|2|||
143415023|NCT05615363|517065448|FG001|Overall Study|Protocol Violation|0|||
143415024|NCT05615363|517065449|FG002|Overall Study|Protocol Violation|0|||
143415025|NCT05615363|517065450|FG003|Overall Study|Protocol Violation|0|||
143415026|NCT05615363|517065451|FG004|Overall Study|Protocol Violation|1|||
143415027|NCT05615363|517065447|FG000|Overall Study|Withdrawal by Subject|0|||
143415028|NCT05615363|517065448|FG001|Overall Study|Withdrawal by Subject|0|||
143415029|NCT05615363|517065449|FG002|Overall Study|Withdrawal by Subject|1|||
143415030|NCT05615363|517065450|FG003|Overall Study|Withdrawal by Subject|0|||
143415031|NCT05615363|517065451|FG004|Overall Study|Withdrawal by Subject|0|||
143415032|NCT04924608|517067763|FG000|Overall Study|Adverse Event|10|||
143415033|NCT04924608|517067764|FG001|Overall Study|Adverse Event|6|||
143415034|NCT04924608|517067763|FG000|Overall Study|Lost to Follow-up|1|||
143415035|NCT04924608|517067764|FG001|Overall Study|Lost to Follow-up|1|||
143415036|NCT04924608|517067763|FG000|Overall Study|Ongoing at the data cut-off date|54|||
143415037|NCT04924608|517067764|FG001|Overall Study|Ongoing at the data cut-off date|60|||
143415038|NCT04924608|517067763|FG000|Overall Study|Progressive Disease|2|||
143415039|NCT04924608|517067764|FG001|Overall Study|Progressive Disease|0|||
143415040|NCT04924608|517067763|FG000|Overall Study|Withdrawal by Subject|3|||
143415041|NCT04924608|517067764|FG001|Overall Study|Withdrawal by Subject|6|||
143415042|NCT04924608|517067763|FG000|Overall Study|Other reason|1|||
143415043|NCT04924608|517067764|FG001|Overall Study|Other reason|1|||
143415044|NCT05005247|517067765|FG000|Overall Study|Withdrawal by Subject|0|||
143415045|NCT05005247|517067766|FG001|Overall Study|Withdrawal by Subject|1|||
143415046|NCT05005247|517067767|FG002|Overall Study|Withdrawal by Subject|0|||
143415047|NCT01450007|517067768|FG000|Overall Study|Late exclusion before treatment|2|||
143415048|NCT01450007|517067769|FG001|Overall Study|Late exclusion before treatment|3|||
143415049|NCT01450007|517067770|FG002|Overall Study|Late exclusion before treatment|2|||
143415050|NCT01450007|517067768|FG000|Overall Study|Protocol Violation|0|||
143415051|NCT01450007|517067769|FG001|Overall Study|Protocol Violation|1|||
143415052|NCT01450007|517067770|FG002|Overall Study|Protocol Violation|1|||
143415053|NCT01450007|517067768|FG000|Overall Study|Adverse Event|0|||
143415054|NCT01450007|517067769|FG001|Overall Study|Adverse Event|1|||
143415055|NCT01450007|517067770|FG002|Overall Study|Adverse Event|0|||
143415056|NCT02958553|517067771|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
143415057|NCT02958553|517067771|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
143415058|NCT01852045|517067772|FG000|Overall Study|Adverse Event|1|||
143415059|NCT01852045|517067773|FG001|Overall Study|Adverse Event|0|||
143415060|NCT01852045|517067774|FG002|Overall Study|Adverse Event|0|||
143415061|NCT01852045|517067772|FG000|Overall Study|Lack of Efficacy|3|||
143415062|NCT01852045|517067773|FG001|Overall Study|Lack of Efficacy|0|||
143415063|NCT01852045|517067774|FG002|Overall Study|Lack of Efficacy|0|||
143415064|NCT01852045|517067772|FG000|Overall Study|Lost to Follow-up|0|||
143415065|NCT01852045|517067773|FG001|Overall Study|Lost to Follow-up|1|||
143415066|NCT01852045|517067774|FG002|Overall Study|Lost to Follow-up|1|||
143415067|NCT01852045|517067772|FG000|Overall Study|Withdrawal by Subject|1|||
143415068|NCT01852045|517067773|FG001|Overall Study|Withdrawal by Subject|0|||
143415069|NCT01852045|517067774|FG002|Overall Study|Withdrawal by Subject|1|||
143415070|NCT01852045|517067772|FG000|Overall Study|Other Miscellaneous Reasons|1|||
143415071|NCT01852045|517067773|FG001|Overall Study|Other Miscellaneous Reasons|3|||
143415072|NCT01852045|517067774|FG002|Overall Study|Other Miscellaneous Reasons|2|||
143415073|NCT00638456|517067777|FG000|Overall Study|Withdrawal by Subject|6|||
143415074|NCT00638456|517067778|FG001|Overall Study|Withdrawal by Subject|2|||
143415075|NCT00703092|517067779|FG000|Overall Study|Withdrawal by Subject|2|||
143415076|NCT01021748|517067780|FG000|Overall Study|Adverse Event|2|||
143415077|NCT01021748|517067781|FG001|Overall Study|Adverse Event|1|||
143415078|NCT01021748|517067782|FG002|Overall Study|Adverse Event|2|||
143415079|NCT01021748|517067783|FG003|Overall Study|Adverse Event|0|||
143415080|NCT01021748|517067784|FG004|Overall Study|Adverse Event|2|||
143415081|NCT01021748|517067785|FG005|Overall Study|Adverse Event|0|||
143415082|NCT01021748|517067786|FG006|Overall Study|Adverse Event|1|||
143415083|NCT01021748|517067787|FG007|Overall Study|Adverse Event|0|||
143415084|NCT01021748|517067788|FG008|Overall Study|Adverse Event|7|||
143415085|NCT01021748|517067780|FG000|Overall Study|Physician Decision|1|||
143415086|NCT01021748|517067781|FG001|Overall Study|Physician Decision|0|||
143415087|NCT01021748|517067782|FG002|Overall Study|Physician Decision|1|||
143415088|NCT01021748|517067783|FG003|Overall Study|Physician Decision|1|||
143415089|NCT01021748|517067784|FG004|Overall Study|Physician Decision|0|||
143415090|NCT01021748|517067785|FG005|Overall Study|Physician Decision|0|||
143415091|NCT01021748|517067786|FG006|Overall Study|Physician Decision|1|||
143415092|NCT01021748|517067787|FG007|Overall Study|Physician Decision|1|||
143415093|NCT01021748|517067788|FG008|Overall Study|Physician Decision|2|||
143415094|NCT01021748|517067780|FG000|Overall Study|Progressive Disease|3|||
143415095|NCT01021748|517067781|FG001|Overall Study|Progressive Disease|3|||
143415096|NCT01021748|517067782|FG002|Overall Study|Progressive Disease|4|||
143415097|NCT01021748|517067783|FG003|Overall Study|Progressive Disease|6|||
143415098|NCT01021748|517067784|FG004|Overall Study|Progressive Disease|7|||
143415099|NCT01021748|517067785|FG005|Overall Study|Progressive Disease|3|||
143415100|NCT01021748|517067786|FG006|Overall Study|Progressive Disease|0|||
143415101|NCT01021748|517067787|FG007|Overall Study|Progressive Disease|5|||
143415102|NCT01021748|517067788|FG008|Overall Study|Progressive Disease|6|||
143415103|NCT01021748|517067780|FG000|Overall Study|Withdrawal by Subject|0|||
143415104|NCT01021748|517067781|FG001|Overall Study|Withdrawal by Subject|0|||
143415105|NCT01021748|517067782|FG002|Overall Study|Withdrawal by Subject|0|||
143415106|NCT01021748|517067783|FG003|Overall Study|Withdrawal by Subject|0|||
143415107|NCT01021748|517067784|FG004|Overall Study|Withdrawal by Subject|0|||
143415108|NCT01021748|517067785|FG005|Overall Study|Withdrawal by Subject|0|||
143415109|NCT01021748|517067786|FG006|Overall Study|Withdrawal by Subject|1|||
143415110|NCT01021748|517067787|FG007|Overall Study|Withdrawal by Subject|0|||
143415111|NCT01021748|517067788|FG008|Overall Study|Withdrawal by Subject|1|||
143415112|NCT01021748|517067780|FG000|Overall Study|Not Treated|0|||
143415113|NCT01021748|517067781|FG001|Overall Study|Not Treated|1|||
143415114|NCT01021748|517067782|FG002|Overall Study|Not Treated|0|||
143415115|NCT01021748|517067783|FG003|Overall Study|Not Treated|0|||
143415116|NCT01021748|517067784|FG004|Overall Study|Not Treated|0|||
143415117|NCT01021748|517067785|FG005|Overall Study|Not Treated|0|||
143415118|NCT01021748|517067786|FG006|Overall Study|Not Treated|0|||
143415119|NCT01021748|517067787|FG007|Overall Study|Not Treated|0|||
143415120|NCT01021748|517067788|FG008|Overall Study|Not Treated|0|||
143415121|NCT01829711|517067789|FG000|Overall Study|Lost to Follow-up|2|||
143415122|NCT01829711|517067789|FG000|Overall Study|Withdrawal by Subject|3|||
143415123|NCT01829711|517067789|FG000|Overall Study|Death|4|||
143415124|NCT01829711|517067789|FG000|Overall Study|Started new therapies|17|||
143415125|NCT01829711|517067789|FG000|Overall Study|Adverse Event|3|||
143415126|NCT01829711|517067789|FG000|Overall Study|Due to progression of disease|13|||
143415127|NCT01829711|517067789|FG000|Overall Study|Due to lack of response|1|||
143415128|NCT02935673|517067790|FG000|Overall Study|Adverse Event|0|||
143415129|NCT02935673|517067791|FG001|Overall Study|Adverse Event|1|||
143415130|NCT02935673|517067792|FG002|Overall Study|Adverse Event|0|||
143415131|NCT02935673|517067790|FG000|Overall Study|Withdrawal by Subject|1|||
143415132|NCT02935673|517067791|FG001|Overall Study|Withdrawal by Subject|2|||
143415133|NCT02935673|517067792|FG002|Overall Study|Withdrawal by Subject|0|||
143415134|NCT01228734|517067793|FG000|Overall Study|Randomized, but not treated|0|||
143415135|NCT01228734|517067794|FG001|Overall Study|Randomized, but not treated|4|||
143415136|NCT00089791|517067795|FG000|Overall Study|Physician Decision|6|||
143415137|NCT00089791|517067796|FG001|Overall Study|Physician Decision|3|||
143415138|NCT00089791|517067795|FG000|Overall Study|Adverse Event|81|||
143415139|NCT00089791|517067796|FG001|Overall Study|Adverse Event|93|||
143415140|NCT00089791|517067795|FG000|Overall Study|Withdrawal by Subject|403|||
143415141|NCT00089791|517067796|FG001|Overall Study|Withdrawal by Subject|344|||
143415142|NCT00089791|517067795|FG000|Overall Study|Death|78|||
143415143|NCT00089791|517067796|FG001|Overall Study|Death|62|||
143415144|NCT00089791|517067795|FG000|Overall Study|Disease progression|7|||
143415145|NCT00089791|517067796|FG001|Overall Study|Disease progression|3|||
143415146|NCT00089791|517067795|FG000|Overall Study|Ineligibility determined|12|||
143415147|NCT00089791|517067796|FG001|Overall Study|Ineligibility determined|9|||
143415148|NCT00089791|517067795|FG000|Overall Study|Lost to Follow-up|57|||
143415149|NCT00089791|517067796|FG001|Overall Study|Lost to Follow-up|57|||
143415150|NCT00089791|517067795|FG000|Overall Study|Noncompliance|17|||
143415151|NCT00089791|517067796|FG001|Overall Study|Noncompliance|13|||
143415152|NCT00089791|517067795|FG000|Overall Study|Other|20|||
143415153|NCT00089791|517067796|FG001|Overall Study|Other|32|||
143415154|NCT00089791|517067795|FG000|Overall Study|Protocol deviation|12|||
143415155|NCT00089791|517067796|FG001|Overall Study|Protocol deviation|10|||
143415156|NCT00089791|517067795|FG000|Overall Study|Requirement for alternative therapy|7|||
143415157|NCT00089791|517067796|FG001|Overall Study|Requirement for alternative therapy|4|||
143415158|NCT00621842|517067797|FG000|Overall Study|Adverse Event|6|||
143415159|NCT00621842|517067797|FG000|Overall Study|Withdrawal by Subject|7|||
143415160|NCT00621842|517067797|FG000|Overall Study|Protocol Violation|4|||
143415161|NCT00621842|517067797|FG000|Overall Study|Lack of Efficacy|2|||
143415162|NCT05074433|517067800|FG000|Overall Study|Adverse Event|0|||
143415163|NCT05074433|517067801|FG001|Overall Study|Adverse Event|2|||
143415164|NCT05074433|517067802|FG002|Overall Study|Adverse Event|0|||
143415165|NCT05074433|517067803|FG003|Overall Study|Adverse Event|1|||
143415166|NCT05074433|517067800|FG000|Overall Study|Sponsor Request|0|||
143415167|NCT05074433|517067801|FG001|Overall Study|Sponsor Request|1|||
143415168|NCT05074433|517067802|FG002|Overall Study|Sponsor Request|1|||
143415169|NCT05074433|517067803|FG003|Overall Study|Sponsor Request|0|||
143415170|NCT05074433|517067800|FG000|Overall Study|Death|1|||
143415171|NCT05074433|517067801|FG001|Overall Study|Death|0|||
143415172|NCT05074433|517067802|FG002|Overall Study|Death|0|||
143415173|NCT05074433|517067803|FG003|Overall Study|Death|0|||
143415174|NCT05074433|517067800|FG000|Overall Study|Lost to Follow-up|0|||
143415175|NCT05074433|517067801|FG001|Overall Study|Lost to Follow-up|0|||
143415176|NCT05074433|517067802|FG002|Overall Study|Lost to Follow-up|2|||
143415177|NCT05074433|517067803|FG003|Overall Study|Lost to Follow-up|0|||
143415178|NCT05074433|517067800|FG000|Overall Study|Subject Decision|8|||
143415179|NCT05074433|517067801|FG001|Overall Study|Subject Decision|6|||
143415180|NCT05074433|517067802|FG002|Overall Study|Subject Decision|4|||
143415181|NCT05074433|517067803|FG003|Overall Study|Subject Decision|5|||
143415182|NCT04397263|517067804|FG000|Overall Study|Withdrawal by Subject|2|||
143415183|NCT01989689|517067805|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
143415184|NCT01989689|517067806|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
143415185|NCT01989689|517067805|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
143415186|NCT01989689|517067806|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
143415187|NCT02066636|517067807|FG000|Overall Study|Disease progression|51|||
143415188|NCT02066636|517067808|FG001|Overall Study|Disease progression|60|||
143415189|NCT02066636|517067809|FG002|Overall Study|Disease progression|700|||
143415190|NCT02066636|517067807|FG000|Overall Study|Study drug toxicity|13|||
143415191|NCT02066636|517067808|FG001|Overall Study|Study drug toxicity|2|||
143415192|NCT02066636|517067809|FG002|Overall Study|Study drug toxicity|58|||
143415193|NCT02066636|517067807|FG000|Overall Study|Death|4|||
143415194|NCT02066636|517067808|FG001|Overall Study|Death|2|||
143415195|NCT02066636|517067809|FG002|Overall Study|Death|158|||
143415196|NCT02066636|517067807|FG000|Overall Study|Adverse event unrelated to study drug|6|||
143415197|NCT02066636|517067808|FG001|Overall Study|Adverse event unrelated to study drug|4|||
143415198|NCT02066636|517067809|FG002|Overall Study|Adverse event unrelated to study drug|45|||
143415199|NCT02066636|517067807|FG000|Overall Study|Participant request to discontinue treatment|12|||
143415200|NCT02066636|517067808|FG001|Overall Study|Participant request to discontinue treatment|12|||
143415201|NCT02066636|517067809|FG002|Overall Study|Participant request to discontinue treatment|70|||
143415202|NCT02066636|517067807|FG000|Overall Study|Participant withdrew consent|10|||
143415203|NCT02066636|517067808|FG001|Overall Study|Participant withdrew consent|18|||
143415204|NCT02066636|517067809|FG002|Overall Study|Participant withdrew consent|61|||
143415205|NCT02066636|517067807|FG000|Overall Study|Lost to Follow-up|0|||
143415206|NCT02066636|517067808|FG001|Overall Study|Lost to Follow-up|2|||
143415207|NCT02066636|517067809|FG002|Overall Study|Lost to Follow-up|2|||
143415208|NCT02066636|517067807|FG000|Overall Study|Maximum clinical benefit|2|||
143415209|NCT02066636|517067808|FG001|Overall Study|Maximum clinical benefit|2|||
143415210|NCT02066636|517067809|FG002|Overall Study|Maximum clinical benefit|3|||
143415211|NCT02066636|517067807|FG000|Overall Study|Poor/non-compliance|2|||
143415212|NCT02066636|517067808|FG001|Overall Study|Poor/non-compliance|1|||
143415213|NCT02066636|517067809|FG002|Overall Study|Poor/non-compliance|1|||
143415214|NCT02066636|517067807|FG000|Overall Study|Participant no loner meets study criteria|3|||
143415215|NCT02066636|517067808|FG001|Overall Study|Participant no loner meets study criteria|2|||
143415216|NCT02066636|517067809|FG002|Overall Study|Participant no loner meets study criteria|28|||
143415217|NCT02066636|517067807|FG000|Overall Study|Administrative reasons by sponsor|8|||
143415218|NCT02066636|517067808|FG001|Overall Study|Administrative reasons by sponsor|5|||
143415219|NCT02066636|517067809|FG002|Overall Study|Administrative reasons by sponsor|0|||
143415220|NCT02066636|517067807|FG000|Overall Study|Other reasons|16|||
143415221|NCT02066636|517067808|FG001|Overall Study|Other reasons|15|||
143415222|NCT02066636|517067809|FG002|Overall Study|Other reasons|50|||
143415223|NCT00391170|517067818|FG000|Overall Study|Withdrawal by Subject|1|||
143415224|NCT00391170|517067819|FG001|Overall Study|Withdrawal by Subject|0|||
143415225|NCT00391170|517067818|FG000|Overall Study|Adverse Event|3|||
143415226|NCT00391170|517067819|FG001|Overall Study|Adverse Event|2|||
143415227|NCT00391170|517067818|FG000|Overall Study|Physician Decision|2|||
143415228|NCT00391170|517067819|FG001|Overall Study|Physician Decision|2|||
143415229|NCT03567616|517067824|FG000|Overall Study|Disease progression|4|||
143415230|NCT03567616|517067824|FG000|Overall Study|Withdrawal by Subject|1|||
143415231|NCT03567616|517067824|FG000|Overall Study|Physician Decision|1|||
143415232|NCT03567616|517067824|FG000|Overall Study|Death|1|||
143415233|NCT03567616|517067824|FG000|Overall Study|Adverse Event|1|||
143415234|NCT00705159|517067832|FG000|Overall Study|Withdrawal by Subject|0|||
143415235|NCT00705159|517067833|FG001|Overall Study|Withdrawal by Subject|1|||
143415236|NCT00705159|517067834|FG002|Overall Study|Withdrawal by Subject|1|||
143415237|NCT00705159|517067835|FG003|Overall Study|Withdrawal by Subject|1|||
143415238|NCT00705159|517067832|FG000|Overall Study|Protocol Violation|0|||
143415239|NCT00705159|517067833|FG001|Overall Study|Protocol Violation|1|||
143415240|NCT00705159|517067834|FG002|Overall Study|Protocol Violation|0|||
143415241|NCT00705159|517067835|FG003|Overall Study|Protocol Violation|0|||
143415242|NCT00705159|517067832|FG000|Overall Study|Adverse Event|0|||
143415243|NCT00705159|517067833|FG001|Overall Study|Adverse Event|0|||
143415244|NCT00705159|517067834|FG002|Overall Study|Adverse Event|1|||
143415245|NCT00705159|517067835|FG003|Overall Study|Adverse Event|0|||
143415246|NCT00705159|517067832|FG000|Overall Study|Lost to Follow-up|0|||
143415247|NCT00705159|517067833|FG001|Overall Study|Lost to Follow-up|0|||
143415248|NCT00705159|517067834|FG002|Overall Study|Lost to Follow-up|3|||
143415249|NCT00705159|517067835|FG003|Overall Study|Lost to Follow-up|2|||
143415250|NCT00705159|517067832|FG000|Overall Study|Screen Failure|0|||
143415251|NCT00705159|517067833|FG001|Overall Study|Screen Failure|0|||
143415252|NCT00705159|517067834|FG002|Overall Study|Screen Failure|0|||
143415253|NCT00705159|517067835|FG003|Overall Study|Screen Failure|1|||
143415254|NCT03026166|517067836|FG000|Overall Study|Death|22|||
143415255|NCT03026166|517067837|FG001|Overall Study|Death|7|||
143415256|NCT03026166|517067836|FG000|Overall Study|Physician Decision|2|||
143415257|NCT03026166|517067837|FG001|Overall Study|Physician Decision|0|||
143415258|NCT03026166|517067836|FG000|Overall Study|Withdrawal by Subject|1|||
143415259|NCT03026166|517067837|FG001|Overall Study|Withdrawal by Subject|2|||
143415260|NCT03026166|517067836|FG000|Overall Study|Lost to Follow-up|1|||
143415261|NCT03026166|517067837|FG001|Overall Study|Lost to Follow-up|0|||
143415262|NCT03026166|517067836|FG000|Overall Study|Study Terminated by Sponsor|3|||
143415263|NCT03026166|517067837|FG001|Overall Study|Study Terminated by Sponsor|3|||
143415264|NCT03026166|517067836|FG000|Overall Study|Other|1|||
143415265|NCT03026166|517067837|FG001|Overall Study|Other|0|||
143415266|NCT05270460|517067840|FG000|Overall Study|Adverse Event|0|||
143415267|NCT05270460|517067841|FG001|Overall Study|Adverse Event|1|||
143415268|NCT05270460|517067842|FG002|Overall Study|Adverse Event|0|||
143415269|NCT05270460|517067840|FG000|Overall Study|Early Termination|0|||
143415270|NCT05270460|517067841|FG001|Overall Study|Early Termination|1|||
143415271|NCT05270460|517067842|FG002|Overall Study|Early Termination|0|||
143415272|NCT00380250|517067843|FG000|Overall Study|Withdrawal by Subject|39|||
143415273|NCT00380250|517067844|FG001|Overall Study|Withdrawal by Subject|28|||
143415274|NCT00380250|517067843|FG000|Overall Study|Adverse Event|20|||
143415275|NCT00380250|517067844|FG001|Overall Study|Adverse Event|9|||
143415276|NCT00380250|517067843|FG000|Overall Study|Lack of Efficacy|10|||
143415277|NCT00380250|517067844|FG001|Overall Study|Lack of Efficacy|8|||
143415278|NCT00380250|517067843|FG000|Overall Study|Protocol Violation|15|||
143415279|NCT00380250|517067844|FG001|Overall Study|Protocol Violation|5|||
143415280|NCT00380250|517067843|FG000|Overall Study|Lost to Follow-up|14|||
143415281|NCT00380250|517067844|FG001|Overall Study|Lost to Follow-up|5|||
143415282|NCT00380250|517067843|FG000|Overall Study|Physician Decision|1|||
143415283|NCT00380250|517067844|FG001|Overall Study|Physician Decision|0|||
143415284|NCT02538094|517067845|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
143415285|NCT02538094|517067846|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
143415286|NCT02538094|517067845|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
143415287|NCT02538094|517067846|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
143415288|NCT01989104|517067847|FG000|Overall Study|Withdrawal by Subject|3|||
143415289|NCT01989104|517067848|FG001|Overall Study|Withdrawal by Subject|0|||
143415290|NCT01989104|517067849|FG002|Overall Study|Withdrawal by Subject|0|||
143415291|NCT01989104|517067850|FG003|Overall Study|Withdrawal by Subject|0|||
143415292|NCT01989104|517067851|FG004|Overall Study|Withdrawal by Subject|0|||
143415293|NCT02691702|517067852|FG000|Overall Study|Adverse Event|1|||
143415294|NCT02691702|517067853|FG001|Overall Study|Adverse Event|0|||
143415295|NCT02691702|517067854|FG002|Overall Study|Adverse Event|0|||
143415296|NCT02691702|517067855|FG003|Overall Study|Adverse Event|0|||
143415297|NCT02691702|517067856|FG004|Overall Study|Adverse Event|0|||
143415298|NCT02691702|517067857|FG005|Overall Study|Adverse Event|0|||
143415299|NCT02691702|517067858|FG006|Overall Study|Adverse Event|0|||
143415300|NCT02691702|517067859|FG007|Overall Study|Adverse Event|0|||
143415301|NCT02691702|517067860|FG008|Overall Study|Adverse Event|1|||
143415302|NCT02691702|517067861|FG009|Overall Study|Adverse Event|0|||
143415303|NCT02691702|517067862|FG010|Overall Study|Adverse Event|1|||
143415304|NCT02691702|517067852|FG000|Overall Study|Lost to Follow-up|0|||
143415305|NCT02691702|517067853|FG001|Overall Study|Lost to Follow-up|0|||
143415306|NCT02691702|517067854|FG002|Overall Study|Lost to Follow-up|1|||
143415307|NCT02691702|517067855|FG003|Overall Study|Lost to Follow-up|0|||
143415308|NCT02691702|517067856|FG004|Overall Study|Lost to Follow-up|0|||
143415309|NCT02691702|517067857|FG005|Overall Study|Lost to Follow-up|2|||
143415310|NCT02691702|517067858|FG006|Overall Study|Lost to Follow-up|0|||
143415311|NCT02691702|517067859|FG007|Overall Study|Lost to Follow-up|0|||
143415312|NCT02691702|517067860|FG008|Overall Study|Lost to Follow-up|0|||
143415313|NCT02691702|517067861|FG009|Overall Study|Lost to Follow-up|0|||
143415314|NCT02691702|517067862|FG010|Overall Study|Lost to Follow-up|1|||
143415315|NCT02691702|517067852|FG000|Overall Study|Withdrawal by Subject|1|||
143415316|NCT02691702|517067853|FG001|Overall Study|Withdrawal by Subject|1|||
143415317|NCT02691702|517067854|FG002|Overall Study|Withdrawal by Subject|0|||
143415318|NCT02691702|517067855|FG003|Overall Study|Withdrawal by Subject|0|||
143415319|NCT02691702|517067856|FG004|Overall Study|Withdrawal by Subject|0|||
143415320|NCT02691702|517067857|FG005|Overall Study|Withdrawal by Subject|1|||
143415321|NCT02691702|517067858|FG006|Overall Study|Withdrawal by Subject|2|||
143415322|NCT02691702|517067859|FG007|Overall Study|Withdrawal by Subject|0|||
143415323|NCT02691702|517067860|FG008|Overall Study|Withdrawal by Subject|0|||
143415324|NCT02691702|517067861|FG009|Overall Study|Withdrawal by Subject|0|||
143415325|NCT02691702|517067862|FG010|Overall Study|Withdrawal by Subject|0|||
143415326|NCT02691702|517067852|FG000|Overall Study|Other|0|||
143415327|NCT02691702|517067853|FG001|Overall Study|Other|0|||
143415328|NCT02691702|517067854|FG002|Overall Study|Other|0|||
143415329|NCT02691702|517067855|FG003|Overall Study|Other|0|||
143415330|NCT02691702|517067856|FG004|Overall Study|Other|0|||
143415331|NCT02691702|517067857|FG005|Overall Study|Other|0|||
143415332|NCT02691702|517067858|FG006|Overall Study|Other|1|||
143415333|NCT02691702|517067859|FG007|Overall Study|Other|0|||
143415334|NCT02691702|517067860|FG008|Overall Study|Other|1|||
143415335|NCT02691702|517067861|FG009|Overall Study|Other|0|||
143415336|NCT02691702|517067862|FG010|Overall Study|Other|0|||
143415337|NCT02691702|517067852|FG000|Overall Study|Protocol Violation|0|||
143415338|NCT02691702|517067853|FG001|Overall Study|Protocol Violation|0|||
143415339|NCT02691702|517067854|FG002|Overall Study|Protocol Violation|0|||
143415340|NCT02691702|517067855|FG003|Overall Study|Protocol Violation|0|||
143415341|NCT02691702|517067856|FG004|Overall Study|Protocol Violation|0|||
143415342|NCT02691702|517067857|FG005|Overall Study|Protocol Violation|0|||
143415343|NCT02691702|517067858|FG006|Overall Study|Protocol Violation|0|||
143415344|NCT02691702|517067859|FG007|Overall Study|Protocol Violation|0|||
143415345|NCT02691702|517067860|FG008|Overall Study|Protocol Violation|0|||
143415346|NCT02691702|517067861|FG009|Overall Study|Protocol Violation|2|||
143415347|NCT02691702|517067862|FG010|Overall Study|Protocol Violation|0|||
143415348|NCT00875706|517067863|FG000|Overall Study|Withdrawal by Subject|1|||
143415349|NCT00875706|517067864|FG001|Overall Study|Withdrawal by Subject|0|||
143415350|NCT00875706|517067865|FG002|Overall Study|Withdrawal by Subject|0|||
143415351|NCT03205488|517067866|FG000|Overall Study|Adverse Event|1|||
143415352|NCT03205488|517067867|FG001|Overall Study|Adverse Event|2|||
143415353|NCT03205488|517067868|FG002|Overall Study|Adverse Event|4|||
143415354|NCT03205488|517067866|FG000|Overall Study|Protocol Violation|0|||
143415355|NCT03205488|517067867|FG001|Overall Study|Protocol Violation|0|||
143415356|NCT03205488|517067868|FG002|Overall Study|Protocol Violation|1|||
143415357|NCT04083781|517067869|FG000|Main Part|Physician Decision|0|||
143415358|NCT04083781|517067870|FG001|Main Part|Physician Decision|1|||
143415359|NCT04083781|517067871|FG002|Main Part|Physician Decision|2|||
143415360|NCT04083781|517067872|FG003|Main Part|Physician Decision|0|||
143415361|NCT04083781|517067869|FG000|Main Part|Death|1|||
143415362|NCT04083781|517067870|FG001|Main Part|Death|3|||
143415363|NCT04083781|517067871|FG002|Main Part|Death|1|||
143415364|NCT04083781|517067872|FG003|Main Part|Death|0|||
143415365|NCT04083781|517067869|FG000|Main Part|Withdrawal by Subject|5|||
143415366|NCT04083781|517067870|FG001|Main Part|Withdrawal by Subject|2|||
143415367|NCT04083781|517067871|FG002|Main Part|Withdrawal by Subject|3|||
143415368|NCT04083781|517067872|FG003|Main Part|Withdrawal by Subject|7|||
143415369|NCT04083781|517067869|FG000|Extension Part|Physician Decision|0|||
143415370|NCT04083781|517067870|FG001|Extension Part|Physician Decision|0|||
143415371|NCT04083781|517067871|FG002|Extension Part|Physician Decision|0|||
143415372|NCT04083781|517067872|FG003|Extension Part|Physician Decision|1|||
143415373|NCT04083781|517067869|FG000|Extension Part|Death|0|||
143415374|NCT04083781|517067870|FG001|Extension Part|Death|1|||
143415375|NCT04083781|517067871|FG002|Extension Part|Death|0|||
143415376|NCT04083781|517067872|FG003|Extension Part|Death|1|||
143415377|NCT04083781|517067869|FG000|Extension Part|Withdrawal by Subject|0|||
143415378|NCT04083781|517067870|FG001|Extension Part|Withdrawal by Subject|1|||
143415379|NCT04083781|517067871|FG002|Extension Part|Withdrawal by Subject|0|||
143415380|NCT04083781|517067872|FG003|Extension Part|Withdrawal by Subject|0|||
143415381|NCT04083781|517067869|FG000|Extension Part|Ongoing|13|||
143415382|NCT04083781|517067870|FG001|Extension Part|Ongoing|25|||
143415383|NCT04083781|517067871|FG002|Extension Part|Ongoing|15|||
143415384|NCT04083781|517067872|FG003|Extension Part|Ongoing|51|||
143415385|NCT01218594|517067873|FG000|Overall Study|Death|1|||
143415386|NCT01218594|517067873|FG000|Overall Study|Withdrawal by Subject|3|||
143415387|NCT01218594|517067873|FG000|Overall Study|Adverse Event|2|||
143415388|NCT01218594|517067873|FG000|Overall Study|Physician Decision|6|||
143415389|NCT04748341|517067874|FG000|Overall Study|Lost to Follow-up|1|||
143415390|NCT04748341|517067875|FG001|Overall Study|Lost to Follow-up|1|||
143415391|NCT04197713|517067878|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
143415392|NCT04197713|517067879|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
143415393|NCT02334215|517067884|FG000|Overall Study|Death|1|||
143415394|NCT02334215|517067885|FG001|Overall Study|Death|1|||
143415395|NCT02334215|517067886|FG002|Overall Study|Death|0|||
143415396|NCT02334215|517067884|FG000|Overall Study|Lost to Follow-up|1|||
143415397|NCT02334215|517067885|FG001|Overall Study|Lost to Follow-up|0|||
143415398|NCT02334215|517067886|FG002|Overall Study|Lost to Follow-up|4|||
143415399|NCT02334215|517067884|FG000|Overall Study|Withdrawal by Subject|2|||
143415400|NCT02334215|517067885|FG001|Overall Study|Withdrawal by Subject|2|||
143415401|NCT02334215|517067886|FG002|Overall Study|Withdrawal by Subject|1|||
143415402|NCT02334215|517067884|FG000|Overall Study|Not released from incarceration on time|3|||
143415403|NCT02334215|517067885|FG001|Overall Study|Not released from incarceration on time|3|||
143415404|NCT02334215|517067886|FG002|Overall Study|Not released from incarceration on time|3|||
143415405|NCT02334215|517067884|FG000|Overall Study|Incarcerated|0|||
143415406|NCT02334215|517067885|FG001|Overall Study|Incarcerated|0|||
143415407|NCT02334215|517067886|FG002|Overall Study|Incarcerated|7|||
143415408|NCT04602728|517067891|FG000|Overall Study|Lost to Follow-up|4|||
143415409|NCT04602728|517067892|FG001|Overall Study|Lost to Follow-up|4|||
143415410|NCT03905642|517067896|FG000|Overall Study|Withdrawal by Subject|3|||
143415411|NCT03905642|517067896|FG000|Overall Study|Pregnancy|1|||
143415412|NCT03905642|517067896|FG000|Overall Study|Adverse Event|1|||
143415413|NCT03905642|517067896|FG000|Overall Study|Lack of Efficacy|1|||
143415414|NCT03905642|517067896|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
143415415|NCT02159989|517067902|FG000|Overall Study|Adverse Event|1|||
143415416|NCT02159989|517067903|FG001|Overall Study|Adverse Event|0|||
143415417|NCT02159989|517067904|FG002|Overall Study|Adverse Event|0|||
143415418|NCT02159989|517067905|FG003|Overall Study|Adverse Event|0|||
143415419|NCT02159989|517067906|FG004|Overall Study|Adverse Event|1|||
143415420|NCT02159989|517067907|FG005|Overall Study|Adverse Event|0|||
143415421|NCT02159989|517067908|FG006|Overall Study|Adverse Event|1|||
143415422|NCT02159989|517067909|FG007|Overall Study|Adverse Event|2|||
143415423|NCT02159989|517067910|FG008|Overall Study|Adverse Event|0|||
143415424|NCT02159989|517067911|FG009|Overall Study|Adverse Event|2|||
143415425|NCT02159989|517067912|FG010|Overall Study|Adverse Event|1|||
143415426|NCT02159989|517067902|FG000|Overall Study|Death|0|||
143415427|NCT02159989|517067903|FG001|Overall Study|Death|0|||
143415428|NCT02159989|517067904|FG002|Overall Study|Death|0|||
143415429|NCT02159989|517067905|FG003|Overall Study|Death|0|||
143415430|NCT02159989|517067906|FG004|Overall Study|Death|0|||
143415431|NCT02159989|517067907|FG005|Overall Study|Death|0|||
143415432|NCT02159989|517067908|FG006|Overall Study|Death|0|||
143415433|NCT02159989|517067909|FG007|Overall Study|Death|0|||
143415434|NCT02159989|517067910|FG008|Overall Study|Death|0|||
143415435|NCT02159989|517067911|FG009|Overall Study|Death|0|||
143415436|NCT02159989|517067912|FG010|Overall Study|Death|1|||
143415437|NCT02159989|517067902|FG000|Overall Study|Lack of Efficacy|2|||
143415438|NCT02159989|517067903|FG001|Overall Study|Lack of Efficacy|3|||
143415439|NCT02159989|517067904|FG002|Overall Study|Lack of Efficacy|3|||
143415440|NCT02159989|517067905|FG003|Overall Study|Lack of Efficacy|0|||
143415441|NCT02159989|517067906|FG004|Overall Study|Lack of Efficacy|2|||
143415442|NCT02159989|517067907|FG005|Overall Study|Lack of Efficacy|3|||
143415443|NCT02159989|517067908|FG006|Overall Study|Lack of Efficacy|3|||
143415444|NCT02159989|517067909|FG007|Overall Study|Lack of Efficacy|1|||
143415445|NCT02159989|517067910|FG008|Overall Study|Lack of Efficacy|3|||
143415446|NCT02159989|517067911|FG009|Overall Study|Lack of Efficacy|6|||
143415447|NCT02159989|517067912|FG010|Overall Study|Lack of Efficacy|7|||
143415448|NCT02159989|517067902|FG000|Overall Study|Lost to Follow-up|0|||
143415449|NCT02159989|517067903|FG001|Overall Study|Lost to Follow-up|0|||
143415450|NCT02159989|517067904|FG002|Overall Study|Lost to Follow-up|0|||
143415451|NCT02159989|517067905|FG003|Overall Study|Lost to Follow-up|1|||
143415452|NCT02159989|517067906|FG004|Overall Study|Lost to Follow-up|0|||
143415453|NCT02159989|517067907|FG005|Overall Study|Lost to Follow-up|0|||
143415454|NCT02159989|517067908|FG006|Overall Study|Lost to Follow-up|0|||
143415455|NCT02159989|517067909|FG007|Overall Study|Lost to Follow-up|0|||
143415456|NCT02159989|517067910|FG008|Overall Study|Lost to Follow-up|0|||
143415457|NCT02159989|517067911|FG009|Overall Study|Lost to Follow-up|0|||
143415458|NCT02159989|517067912|FG010|Overall Study|Lost to Follow-up|1|||
143415459|NCT02159989|517067902|FG000|Overall Study|Withdrawal by Subject|2|||
143415460|NCT02159989|517067903|FG001|Overall Study|Withdrawal by Subject|0|||
143415461|NCT02159989|517067904|FG002|Overall Study|Withdrawal by Subject|0|||
143415462|NCT02159989|517067905|FG003|Overall Study|Withdrawal by Subject|2|||
143415463|NCT02159989|517067906|FG004|Overall Study|Withdrawal by Subject|1|||
143415464|NCT02159989|517067907|FG005|Overall Study|Withdrawal by Subject|0|||
143415465|NCT02159989|517067908|FG006|Overall Study|Withdrawal by Subject|3|||
143415466|NCT02159989|517067909|FG007|Overall Study|Withdrawal by Subject|1|||
143415467|NCT02159989|517067910|FG008|Overall Study|Withdrawal by Subject|0|||
143415468|NCT02159989|517067911|FG009|Overall Study|Withdrawal by Subject|0|||
143415469|NCT02159989|517067912|FG010|Overall Study|Withdrawal by Subject|0|||
143415470|NCT02159989|517067902|FG000|Overall Study|New treatment|0|||
143415471|NCT02159989|517067903|FG001|Overall Study|New treatment|1|||
143415472|NCT02159989|517067904|FG002|Overall Study|New treatment|0|||
143415473|NCT02159989|517067905|FG003|Overall Study|New treatment|0|||
143415474|NCT02159989|517067906|FG004|Overall Study|New treatment|0|||
143415475|NCT02159989|517067907|FG005|Overall Study|New treatment|0|||
143415476|NCT02159989|517067908|FG006|Overall Study|New treatment|0|||
143415477|NCT02159989|517067909|FG007|Overall Study|New treatment|0|||
143415478|NCT02159989|517067910|FG008|Overall Study|New treatment|0|||
143415479|NCT02159989|517067911|FG009|Overall Study|New treatment|0|||
143415480|NCT02159989|517067912|FG010|Overall Study|New treatment|0|||
143415481|NCT02159989|517067902|FG000|Overall Study|Insurance Issues|0|||
143415482|NCT02159989|517067903|FG001|Overall Study|Insurance Issues|0|||
143415483|NCT02159989|517067904|FG002|Overall Study|Insurance Issues|0|||
143415484|NCT02159989|517067905|FG003|Overall Study|Insurance Issues|0|||
143415485|NCT02159989|517067906|FG004|Overall Study|Insurance Issues|0|||
143415486|NCT02159989|517067907|FG005|Overall Study|Insurance Issues|0|||
143415487|NCT02159989|517067908|FG006|Overall Study|Insurance Issues|0|||
143415488|NCT02159989|517067909|FG007|Overall Study|Insurance Issues|0|||
143415489|NCT02159989|517067910|FG008|Overall Study|Insurance Issues|0|||
143415490|NCT02159989|517067911|FG009|Overall Study|Insurance Issues|1|||
143415491|NCT02159989|517067912|FG010|Overall Study|Insurance Issues|0|||
143415492|NCT05289037|517067916|FG000|Overall Study|Withdrawal by Subject|7|||
143415493|NCT05289037|517067917|FG001|Overall Study|Withdrawal by Subject|0|||
143415494|NCT05289037|517067918|FG002|Overall Study|Withdrawal by Subject|3|||
143415495|NCT05289037|517067919|FG003|Overall Study|Withdrawal by Subject|3|||
143415496|NCT05289037|517067920|FG004|Overall Study|Withdrawal by Subject|1|||
143415497|NCT05289037|517067921|FG005|Overall Study|Withdrawal by Subject|5|||
143415498|NCT05289037|517067922|FG006|Overall Study|Withdrawal by Subject|2|||
143415499|NCT05289037|517067923|FG007|Overall Study|Withdrawal by Subject|1|||
143415500|NCT05289037|517067924|FG008|Overall Study|Withdrawal by Subject|2|||
143415501|NCT05289037|517067925|FG009|Overall Study|Withdrawal by Subject|2|||
143415502|NCT05289037|517067926|FG010|Overall Study|Withdrawal by Subject|1|||
143415503|NCT05289037|517067927|FG011|Overall Study|Withdrawal by Subject|0|||
143415504|NCT05289037|517067928|FG012|Overall Study|Withdrawal by Subject|1|||
143415505|NCT05289037|517067929|FG013|Overall Study|Withdrawal by Subject|2|||
143415506|NCT05289037|517067930|FG014|Overall Study|Withdrawal by Subject|0|||
143415507|NCT05289037|517067931|FG015|Overall Study|Withdrawal by Subject|3|||
143415508|NCT05289037|517067932|FG016|Overall Study|Withdrawal by Subject|3|||
143415509|NCT05289037|517067916|FG000|Overall Study|Lost to Follow-up|1|||
143415510|NCT05289037|517067917|FG001|Overall Study|Lost to Follow-up|4|||
143415511|NCT05289037|517067918|FG002|Overall Study|Lost to Follow-up|3|||
143415512|NCT05289037|517067919|FG003|Overall Study|Lost to Follow-up|3|||
143415513|NCT05289037|517067920|FG004|Overall Study|Lost to Follow-up|3|||
143415514|NCT05289037|517067921|FG005|Overall Study|Lost to Follow-up|2|||
143415515|NCT05289037|517067922|FG006|Overall Study|Lost to Follow-up|3|||
143415516|NCT05289037|517067923|FG007|Overall Study|Lost to Follow-up|2|||
143415517|NCT05289037|517067924|FG008|Overall Study|Lost to Follow-up|2|||
143415518|NCT05289037|517067925|FG009|Overall Study|Lost to Follow-up|1|||
143415519|NCT05289037|517067926|FG010|Overall Study|Lost to Follow-up|3|||
143415520|NCT05289037|517067927|FG011|Overall Study|Lost to Follow-up|4|||
143415521|NCT05289037|517067928|FG012|Overall Study|Lost to Follow-up|2|||
143415522|NCT05289037|517067929|FG013|Overall Study|Lost to Follow-up|7|||
143415523|NCT05289037|517067930|FG014|Overall Study|Lost to Follow-up|4|||
143415524|NCT05289037|517067931|FG015|Overall Study|Lost to Follow-up|6|||
143415525|NCT05289037|517067932|FG016|Overall Study|Lost to Follow-up|4|||
143415526|NCT05289037|517067916|FG000|Overall Study|Death|0|||
143415527|NCT05289037|517067917|FG001|Overall Study|Death|0|||
143415528|NCT05289037|517067918|FG002|Overall Study|Death|0|||
143415529|NCT05289037|517067919|FG003|Overall Study|Death|0|||
143415530|NCT05289037|517067920|FG004|Overall Study|Death|0|||
143415531|NCT05289037|517067921|FG005|Overall Study|Death|1|||
143415532|NCT05289037|517067922|FG006|Overall Study|Death|0|||
143415533|NCT05289037|517067923|FG007|Overall Study|Death|0|||
143415534|NCT05289037|517067924|FG008|Overall Study|Death|0|||
143415535|NCT05289037|517067925|FG009|Overall Study|Death|0|||
143415536|NCT05289037|517067926|FG010|Overall Study|Death|0|||
143415537|NCT05289037|517067927|FG011|Overall Study|Death|0|||
143415538|NCT05289037|517067928|FG012|Overall Study|Death|0|||
143415539|NCT05289037|517067929|FG013|Overall Study|Death|0|||
143415540|NCT05289037|517067930|FG014|Overall Study|Death|1|||
143415541|NCT05289037|517067931|FG015|Overall Study|Death|0|||
143415542|NCT05289037|517067932|FG016|Overall Study|Death|0|||
143415543|NCT05289037|517067916|FG000|Overall Study|Did not receive vaccine|0|||
143415544|NCT05289037|517067917|FG001|Overall Study|Did not receive vaccine|3|||
143415545|NCT05289037|517067918|FG002|Overall Study|Did not receive vaccine|0|||
143415546|NCT05289037|517067919|FG003|Overall Study|Did not receive vaccine|0|||
143415547|NCT05289037|517067920|FG004|Overall Study|Did not receive vaccine|1|||
143415548|NCT05289037|517067921|FG005|Overall Study|Did not receive vaccine|1|||
143415549|NCT05289037|517067922|FG006|Overall Study|Did not receive vaccine|1|||
143415550|NCT05289037|517067923|FG007|Overall Study|Did not receive vaccine|0|||
143415551|NCT05289037|517067924|FG008|Overall Study|Did not receive vaccine|0|||
143415552|NCT05289037|517067925|FG009|Overall Study|Did not receive vaccine|0|||
143415553|NCT05289037|517067926|FG010|Overall Study|Did not receive vaccine|0|||
143415554|NCT05289037|517067927|FG011|Overall Study|Did not receive vaccine|0|||
143415555|NCT05289037|517067928|FG012|Overall Study|Did not receive vaccine|0|||
143415556|NCT05289037|517067929|FG013|Overall Study|Did not receive vaccine|0|||
143415557|NCT05289037|517067930|FG014|Overall Study|Did not receive vaccine|1|||
143415558|NCT05289037|517067931|FG015|Overall Study|Did not receive vaccine|0|||
143415559|NCT05289037|517067932|FG016|Overall Study|Did not receive vaccine|0|||
143415560|NCT05289037|517067916|FG000|Overall Study|Unable to make last visit|0|||
143415561|NCT05289037|517067917|FG001|Overall Study|Unable to make last visit|0|||
143415562|NCT05289037|517067918|FG002|Overall Study|Unable to make last visit|1|||
143415563|NCT05289037|517067919|FG003|Overall Study|Unable to make last visit|0|||
143415564|NCT05289037|517067920|FG004|Overall Study|Unable to make last visit|0|||
143415565|NCT05289037|517067921|FG005|Overall Study|Unable to make last visit|0|||
143415566|NCT05289037|517067922|FG006|Overall Study|Unable to make last visit|0|||
143415567|NCT05289037|517067923|FG007|Overall Study|Unable to make last visit|0|||
143415568|NCT05289037|517067924|FG008|Overall Study|Unable to make last visit|0|||
143415569|NCT05289037|517067925|FG009|Overall Study|Unable to make last visit|0|||
143415570|NCT05289037|517067926|FG010|Overall Study|Unable to make last visit|0|||
143415571|NCT05289037|517067927|FG011|Overall Study|Unable to make last visit|0|||
143415572|NCT05289037|517067928|FG012|Overall Study|Unable to make last visit|0|||
143415573|NCT05289037|517067929|FG013|Overall Study|Unable to make last visit|0|||
143415574|NCT05289037|517067930|FG014|Overall Study|Unable to make last visit|0|||
143415575|NCT05289037|517067931|FG015|Overall Study|Unable to make last visit|0|||
143415576|NCT05289037|517067932|FG016|Overall Study|Unable to make last visit|0|||
143415577|NCT05289037|517067916|FG000|Overall Study|Protocol deviation|0|||
143415578|NCT05289037|517067917|FG001|Overall Study|Protocol deviation|0|||
143415579|NCT05289037|517067918|FG002|Overall Study|Protocol deviation|0|||
143415580|NCT05289037|517067919|FG003|Overall Study|Protocol deviation|0|||
143415581|NCT05289037|517067920|FG004|Overall Study|Protocol deviation|0|||
143415582|NCT05289037|517067921|FG005|Overall Study|Protocol deviation|0|||
143415583|NCT05289037|517067922|FG006|Overall Study|Protocol deviation|0|||
143415584|NCT05289037|517067923|FG007|Overall Study|Protocol deviation|0|||
143415585|NCT05289037|517067924|FG008|Overall Study|Protocol deviation|0|||
143415586|NCT05289037|517067925|FG009|Overall Study|Protocol deviation|0|||
143415587|NCT05289037|517067926|FG010|Overall Study|Protocol deviation|0|||
143415588|NCT05289037|517067927|FG011|Overall Study|Protocol deviation|0|||
143415589|NCT05289037|517067928|FG012|Overall Study|Protocol deviation|0|||
143415590|NCT05289037|517067929|FG013|Overall Study|Protocol deviation|0|||
143415591|NCT05289037|517067930|FG014|Overall Study|Protocol deviation|0|||
143415592|NCT05289037|517067931|FG015|Overall Study|Protocol deviation|1|||
143415593|NCT05289037|517067932|FG016|Overall Study|Protocol deviation|0|||
143415594|NCT02831049|517067933|FG000|Overall Study|Lost to Follow-up|0|||
143415595|NCT02831049|517067934|FG001|Overall Study|Lost to Follow-up|0|||
143415596|NCT02831049|517067935|FG002|Overall Study|Lost to Follow-up|1|||
143415597|NCT02831049|517067933|FG000|Overall Study|Withdrawal by Subject|0|||
143415598|NCT02831049|517067934|FG001|Overall Study|Withdrawal by Subject|1|||
143415599|NCT02831049|517067935|FG002|Overall Study|Withdrawal by Subject|1|||
143415600|NCT02831049|517067933|FG000|Overall Study|Pandemic shutdown|1|||
143415601|NCT02831049|517067934|FG001|Overall Study|Pandemic shutdown|0|||
143415602|NCT02831049|517067935|FG002|Overall Study|Pandemic shutdown|0|||
143415603|NCT05995977|517067936|FG000|Overall Study|Withdrawal by Subject|1|||
143415604|NCT05995977|517067937|FG001|Overall Study|Withdrawal by Subject|4|||
143415605|NCT05995977|517067936|FG000|Overall Study|Lost to Follow-up|2|||
143415606|NCT05995977|517067937|FG001|Overall Study|Lost to Follow-up|0|||
143415607|NCT04181788|517067938|FG000|TREATMENT|Adverse Event|0|||
143415608|NCT04181788|517067939|FG001|TREATMENT|Adverse Event|2|||
143415609|NCT04181788|517067940|FG002|TREATMENT|Adverse Event|1|||
143415610|NCT04181788|517067941|FG003|TREATMENT|Adverse Event|0|||
143415611|NCT04181788|517067942|FG004|TREATMENT|Adverse Event|1|||
143415612|NCT04181788|517067943|FG005|TREATMENT|Adverse Event|3|||
143415613|NCT04181788|517067938|FG000|TREATMENT|Death|0|||
143415614|NCT04181788|517067939|FG001|TREATMENT|Death|0|||
143415615|NCT04181788|517067940|FG002|TREATMENT|Death|0|||
143415616|NCT04181788|517067941|FG003|TREATMENT|Death|0|||
143415617|NCT04181788|517067942|FG004|TREATMENT|Death|8|||
143415618|NCT04181788|517067943|FG005|TREATMENT|Death|8|||
143415619|NCT04181788|517067938|FG000|TREATMENT|Physician Decision|0|||
143415620|NCT04181788|517067939|FG001|TREATMENT|Physician Decision|0|||
143415621|NCT04181788|517067940|FG002|TREATMENT|Physician Decision|0|||
143415622|NCT04181788|517067941|FG003|TREATMENT|Physician Decision|0|||
143415623|NCT04181788|517067942|FG004|TREATMENT|Physician Decision|0|||
143415624|NCT04181788|517067943|FG005|TREATMENT|Physician Decision|1|||
143415625|NCT04181788|517067938|FG000|TREATMENT|Progressive disease|3|||
143415626|NCT04181788|517067939|FG001|TREATMENT|Progressive disease|3|||
143415627|NCT04181788|517067940|FG002|TREATMENT|Progressive disease|5|||
143415628|NCT04181788|517067941|FG003|TREATMENT|Progressive disease|7|||
143415629|NCT04181788|517067942|FG004|TREATMENT|Progressive disease|20|||
143415630|NCT04181788|517067943|FG005|TREATMENT|Progressive disease|38|||
143415631|NCT04181788|517067938|FG000|TREATMENT|Global deterioration of health status|0|||
143415632|NCT04181788|517067939|FG001|TREATMENT|Global deterioration of health status|2|||
143415633|NCT04181788|517067940|FG002|TREATMENT|Global deterioration of health status|0|||
143415634|NCT04181788|517067941|FG003|TREATMENT|Global deterioration of health status|0|||
143415635|NCT04181788|517067942|FG004|TREATMENT|Global deterioration of health status|2|||
143415636|NCT04181788|517067943|FG005|TREATMENT|Global deterioration of health status|8|||
143415637|NCT04181788|517067938|FG000|TREATMENT|Withdrawal by Subject|1|||
143415638|NCT04181788|517067939|FG001|TREATMENT|Withdrawal by Subject|2|||
143415639|NCT04181788|517067940|FG002|TREATMENT|Withdrawal by Subject|0|||
143415640|NCT04181788|517067941|FG003|TREATMENT|Withdrawal by Subject|0|||
143415641|NCT04181788|517067942|FG004|TREATMENT|Withdrawal by Subject|3|||
143415642|NCT04181788|517067943|FG005|TREATMENT|Withdrawal by Subject|5|||
143415643|NCT04181788|517067938|FG000|TREATMENT|Other unspecified|0|||
143415644|NCT04181788|517067939|FG001|TREATMENT|Other unspecified|0|||
143415645|NCT04181788|517067940|FG002|TREATMENT|Other unspecified|0|||
143415646|NCT04181788|517067941|FG003|TREATMENT|Other unspecified|0|||
143415647|NCT04181788|517067942|FG004|TREATMENT|Other unspecified|0|||
143415648|NCT04181788|517067943|FG005|TREATMENT|Other unspecified|2|||
143415649|NCT04181788|517067938|FG000|TREATMENT|Ongoing|0|||
143415650|NCT04181788|517067939|FG001|TREATMENT|Ongoing|3|||
143415651|NCT04181788|517067940|FG002|TREATMENT|Ongoing|0|||
143415652|NCT04181788|517067941|FG003|TREATMENT|Ongoing|5|||
143415653|NCT04181788|517067942|FG004|TREATMENT|Ongoing|7|||
143415654|NCT04181788|517067943|FG005|TREATMENT|Ongoing|15|||
143415655|NCT04181788|517067938|FG000|FOLLOW-UP|Death|0|||
143415656|NCT04181788|517067939|FG001|FOLLOW-UP|Death|0|||
143415657|NCT04181788|517067940|FG002|FOLLOW-UP|Death|1|||
143415658|NCT04181788|517067941|FG003|FOLLOW-UP|Death|2|||
143415659|NCT04181788|517067942|FG004|FOLLOW-UP|Death|8|||
143415660|NCT04181788|517067943|FG005|FOLLOW-UP|Death|20|||
143415661|NCT04181788|517067938|FG000|FOLLOW-UP|Lost to Follow-up|0|||
143415662|NCT04181788|517067939|FG001|FOLLOW-UP|Lost to Follow-up|0|||
143415663|NCT04181788|517067940|FG002|FOLLOW-UP|Lost to Follow-up|0|||
143415664|NCT04181788|517067941|FG003|FOLLOW-UP|Lost to Follow-up|0|||
143415665|NCT04181788|517067942|FG004|FOLLOW-UP|Lost to Follow-up|0|||
143415666|NCT04181788|517067943|FG005|FOLLOW-UP|Lost to Follow-up|2|||
143415667|NCT04181788|517067938|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
143415668|NCT04181788|517067939|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
143415669|NCT04181788|517067940|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
143415670|NCT04181788|517067941|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
143415671|NCT04181788|517067942|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
143415672|NCT04181788|517067943|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
143415673|NCT04181788|517067938|FG000|FOLLOW-UP|Other unspecified|0|||
143415674|NCT04181788|517067939|FG001|FOLLOW-UP|Other unspecified|1|||
143415675|NCT04181788|517067940|FG002|FOLLOW-UP|Other unspecified|0|||
143415676|NCT04181788|517067941|FG003|FOLLOW-UP|Other unspecified|0|||
143415677|NCT04181788|517067942|FG004|FOLLOW-UP|Other unspecified|0|||
143415678|NCT04181788|517067943|FG005|FOLLOW-UP|Other unspecified|3|||
143415679|NCT04181788|517067938|FG000|FOLLOW-UP|Ongoing|0|||
143415680|NCT04181788|517067939|FG001|FOLLOW-UP|Ongoing|0|||
143415681|NCT04181788|517067940|FG002|FOLLOW-UP|Ongoing|1|||
143415682|NCT04181788|517067941|FG003|FOLLOW-UP|Ongoing|3|||
143415683|NCT04181788|517067942|FG004|FOLLOW-UP|Ongoing|2|||
143415684|NCT04181788|517067943|FG005|FOLLOW-UP|Ongoing|2|||
143415685|NCT04937504|517067944|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
143415686|NCT04937504|517067945|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
143415687|NCT04937504|517067944|FG000|9 Months Assessment|Lost to Follow-up|3|||
143415688|NCT04937504|517067945|FG001|9 Months Assessment|Lost to Follow-up|2|||
143415689|NCT03662659|517067947|FG000|Pre-treatment|Participant no longer met study criteria|1|||
143415690|NCT03662659|517067948|FG001|Pre-treatment|Participant no longer met study criteria|1|||
143415691|NCT03662659|517067947|FG000|Pre-treatment|Other reasons|1|||
143415692|NCT03662659|517067948|FG001|Pre-treatment|Other reasons|0|||
143415693|NCT03662659|517067947|FG000|Treatment|Completed Treatment|0|||
143415694|NCT03662659|517067948|FG001|Treatment|Completed Treatment|2|||
143415695|NCT03662659|517067947|FG000|Treatment|Disease Progression|85|||
143415696|NCT03662659|517067948|FG001|Treatment|Disease Progression|97|||
143415697|NCT03662659|517067947|FG000|Treatment|Study Drug Toxicity|19|||
143415698|NCT03662659|517067948|FG001|Treatment|Study Drug Toxicity|9|||
143415699|NCT03662659|517067947|FG000|Treatment|Death|11|||
143415700|NCT03662659|517067948|FG001|Treatment|Death|9|||
143415701|NCT03662659|517067947|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
143415702|NCT03662659|517067948|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
143415703|NCT03662659|517067947|FG000|Treatment|Withdrawal by Subject|1|||
143415704|NCT03662659|517067948|FG001|Treatment|Withdrawal by Subject|1|||
143415705|NCT03662659|517067947|FG000|Treatment|Poor/Non-compliance|1|||
143415706|NCT03662659|517067948|FG001|Treatment|Poor/Non-compliance|0|||
143415707|NCT03662659|517067947|FG000|Treatment|Participant no longer meets study criteria|1|||
143415708|NCT03662659|517067948|FG001|Treatment|Participant no longer meets study criteria|0|||
143415709|NCT03662659|517067947|FG000|Treatment|Other reasons|10|||
143415710|NCT03662659|517067948|FG001|Treatment|Other reasons|8|||
143415711|NCT03662659|517067947|FG000|Treatment|Administrative reasons by sponsor|1|||
143415712|NCT03662659|517067948|FG001|Treatment|Administrative reasons by sponsor|0|||
143415713|NCT03662659|517067947|FG000|Treatment|maximum clinical benefit|0|||
143415714|NCT03662659|517067948|FG001|Treatment|maximum clinical benefit|2|||
143415715|NCT01668355|517069344|FG000|Overall Study|Death|3|||
143415716|NCT01668355|517069345|FG001|Overall Study|Death|1|||
143415717|NCT01668355|517069344|FG000|Overall Study|Withdrawal by Subject|6|||
143415718|NCT01668355|517069345|FG001|Overall Study|Withdrawal by Subject|1|||
143415719|NCT01277302|517069349|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
143415720|NCT01277302|517069350|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
143415721|NCT01277302|517069351|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
143415722|NCT01277302|517069349|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
143415723|NCT01277302|517069350|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
143415724|NCT01277302|517069351|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
143415725|NCT01277302|517069349|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
143415726|NCT01277302|517069350|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
143415727|NCT01277302|517069351|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
143415728|NCT01277302|517069349|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
143415729|NCT01277302|517069350|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
143415730|NCT01277302|517069351|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
143415731|NCT01277302|517069349|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
143415732|NCT01277302|517069350|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
143415733|NCT01277302|517069351|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
143415734|NCT01277302|517069349|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
143415735|NCT01277302|517069350|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
143415736|NCT01277302|517069351|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
143415737|NCT01277302|517069349|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
143415738|NCT01277302|517069350|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
143415739|NCT01277302|517069351|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
143415740|NCT01277302|517069349|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
143415741|NCT01277302|517069350|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
143415742|NCT01277302|517069351|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
143415743|NCT01277302|517069349|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
143415744|NCT01277302|517069350|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
143415745|NCT01277302|517069351|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
143415746|NCT02710669|517069354|FG000|Overall Study|Physician Decision|2|||
143415747|NCT02710669|517069355|FG001|Overall Study|Physician Decision|1|||
143415748|NCT02710669|517069356|FG002|Overall Study|Physician Decision|0|||
143415749|NCT02710669|517069354|FG000|Overall Study|Institutional delays (including COVID)|2|||
143415750|NCT02710669|517069355|FG001|Overall Study|Institutional delays (including COVID)|2|||
143415751|NCT02710669|517069356|FG002|Overall Study|Institutional delays (including COVID)|0|||
143415752|NCT02710669|517069354|FG000|Overall Study|arrived in afib/aflutter|10|||
143415753|NCT02710669|517069355|FG001|Overall Study|arrived in afib/aflutter|8|||
143415754|NCT02710669|517069356|FG002|Overall Study|arrived in afib/aflutter|2|||
143415755|NCT01190124|517069358|FG000|Overall Study|Death|3|||
143415756|NCT01190124|517069359|FG001|Overall Study|Death|0|||
143415757|NCT01190124|517069360|FG002|Overall Study|Death|0|||
143415758|NCT01190124|517069358|FG000|Overall Study|Therapeutic Failure|12|||
143415759|NCT01190124|517069359|FG001|Overall Study|Therapeutic Failure|0|||
143415760|NCT01190124|517069360|FG002|Overall Study|Therapeutic Failure|1|||
143415761|NCT01190124|517069358|FG000|Overall Study|Lost to Follow-up|2|||
143415762|NCT01190124|517069359|FG001|Overall Study|Lost to Follow-up|0|||
143415763|NCT01190124|517069360|FG002|Overall Study|Lost to Follow-up|0|||
143415764|NCT00070707|517069361|FG000|Overall Study|Adverse Event|1|||
143415765|NCT00070707|517069362|FG001|Overall Study|Adverse Event|2|||
143415766|NCT00070707|517069361|FG000|Overall Study|Lack of Efficacy|4|||
143415767|NCT00070707|517069362|FG001|Overall Study|Lack of Efficacy|1|||
143415768|NCT00070707|517069361|FG000|Overall Study|Protocol Violation|8|||
143415769|NCT00070707|517069362|FG001|Overall Study|Protocol Violation|4|||
143415770|NCT00070707|517069361|FG000|Overall Study|Unrelated to Study Medication|1|||
143415771|NCT00070707|517069362|FG001|Overall Study|Unrelated to Study Medication|0|||
143415772|NCT00670449|517069363|FG000|Overall Study|Adverse Event|6|||
143415773|NCT00670449|517069364|FG001|Overall Study|Adverse Event|2|||
143415774|NCT00670449|517069365|FG002|Overall Study|Adverse Event|8|||
143415775|NCT00670449|517069366|FG003|Overall Study|Adverse Event|5|||
143415776|NCT00670449|517069363|FG000|Overall Study|Protocol Deviation|1|||
143415777|NCT00670449|517069364|FG001|Overall Study|Protocol Deviation|2|||
143415778|NCT00670449|517069365|FG002|Overall Study|Protocol Deviation|0|||
143415779|NCT00670449|517069366|FG003|Overall Study|Protocol Deviation|1|||
143415780|NCT00670449|517069363|FG000|Overall Study|Administrative Problems|0|||
143415781|NCT00670449|517069364|FG001|Overall Study|Administrative Problems|2|||
143415782|NCT00670449|517069365|FG002|Overall Study|Administrative Problems|0|||
143415783|NCT00670449|517069366|FG003|Overall Study|Administrative Problems|1|||
143415784|NCT00670449|517069363|FG000|Overall Study|Subject Withdrew Consent|0|||
143415785|NCT00670449|517069364|FG001|Overall Study|Subject Withdrew Consent|2|||
143415786|NCT00670449|517069365|FG002|Overall Study|Subject Withdrew Consent|0|||
143415787|NCT00670449|517069366|FG003|Overall Study|Subject Withdrew Consent|1|||
143415788|NCT00670449|517069363|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
143415789|NCT00670449|517069364|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
143415790|NCT00670449|517069365|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
143415791|NCT00670449|517069366|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
143415792|NCT00670449|517069363|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
143415793|NCT00670449|517069364|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
143415794|NCT00670449|517069365|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
143415795|NCT00670449|517069366|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
143415796|NCT03690219|517069367|FG000|Overall Study|no injuries|9|||
143415797|NCT03690219|517069368|FG001|Overall Study|no injuries|20|||
143415798|NCT03690219|517069367|FG000|Overall Study|missing information|7|||
143415799|NCT03690219|517069368|FG001|Overall Study|missing information|7|||
143415800|NCT01523392|517069369|FG000|Treatment Period 1|Withdrawal by Subject|2|||
143415801|NCT01523392|517069370|FG001|Treatment Period 1|Withdrawal by Subject|0|||
143415802|NCT01523392|517069369|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
143415803|NCT01523392|517069370|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
143415804|NCT01523392|517069369|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
143415805|NCT01523392|517069370|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
143415806|NCT04809623|517069371|FG000|Overall Study|Study Terminated by Sponsor|1|||
143415807|NCT04809623|517069372|FG001|Overall Study|Study Terminated by Sponsor|0|||
143415808|NCT00413283|517069378|FG000|Overall Study|Withdrawal by Subject|1|||
143415809|NCT00413283|517069379|FG001|Overall Study|Withdrawal by Subject|0|||
143415810|NCT00413283|517069380|FG002|Overall Study|Withdrawal by Subject|0|||
143415811|NCT00413283|517069381|FG003|Overall Study|Withdrawal by Subject|1|||
143415812|NCT00413283|517069378|FG000|Overall Study|Death|0|||
143415813|NCT00413283|517069379|FG001|Overall Study|Death|0|||
143415814|NCT00413283|517069380|FG002|Overall Study|Death|1|||
143415815|NCT00413283|517069381|FG003|Overall Study|Death|1|||
143415816|NCT00413283|517069378|FG000|Overall Study|Adverse Event|0|||
143415817|NCT00413283|517069379|FG001|Overall Study|Adverse Event|0|||
143415818|NCT00413283|517069380|FG002|Overall Study|Adverse Event|0|||
143415819|NCT00413283|517069381|FG003|Overall Study|Adverse Event|1|||
143415820|NCT00413283|517069378|FG000|Overall Study|Ineligibility determined|0|||
143415821|NCT00413283|517069379|FG001|Overall Study|Ineligibility determined|0|||
143415822|NCT00413283|517069380|FG002|Overall Study|Ineligibility determined|0|||
143415823|NCT00413283|517069381|FG003|Overall Study|Ineligibility determined|1|||
143415824|NCT00413283|517069378|FG000|Overall Study|Protocol deviation|0|||
143415825|NCT00413283|517069379|FG001|Overall Study|Protocol deviation|1|||
143415826|NCT00413283|517069380|FG002|Overall Study|Protocol deviation|0|||
143415827|NCT00413283|517069381|FG003|Overall Study|Protocol deviation|0|||
143415828|NCT00413283|517069378|FG000|Overall Study|Requirement for alternative therapy|0|||
143415829|NCT00413283|517069379|FG001|Overall Study|Requirement for alternative therapy|2|||
143415830|NCT00413283|517069380|FG002|Overall Study|Requirement for alternative therapy|0|||
143415831|NCT00413283|517069381|FG003|Overall Study|Requirement for alternative therapy|0|||
143415832|NCT00413283|517069378|FG000|Overall Study|Other|0|||
143415833|NCT00413283|517069379|FG001|Overall Study|Other|0|||
143415834|NCT00413283|517069380|FG002|Overall Study|Other|1|||
143415835|NCT00413283|517069381|FG003|Overall Study|Other|0|||
143415836|NCT02002689|517069386|FG000|Overall Study|Disease Progression|7|||
143415837|NCT02002689|517069386|FG000|Overall Study|Adverse Event|3|||
143415838|NCT01808534|517069387|FG000|Overall Study|Disease progression|3|||
143415839|NCT01808534|517069387|FG000|Overall Study|Physician Decision|1|||
143415840|NCT00671853|517069388|FG000|Overall Study|Lack of Efficacy|3|||
143415841|NCT00671853|517069389|FG001|Overall Study|Lack of Efficacy|7|||
143415842|NCT00671853|517069388|FG000|Overall Study|Adverse Event|7|||
143415843|NCT00671853|517069389|FG001|Overall Study|Adverse Event|1|||
143415844|NCT00671853|517069388|FG000|Overall Study|Withdrawal by Subject|1|||
143415845|NCT00671853|517069389|FG001|Overall Study|Withdrawal by Subject|5|||
143415846|NCT00671853|517069388|FG000|Overall Study|Lost to Follow-up|8|||
143415847|NCT00671853|517069389|FG001|Overall Study|Lost to Follow-up|8|||
143415848|NCT00671853|517069388|FG000|Overall Study|Physician Decision|0|||
143415849|NCT00671853|517069389|FG001|Overall Study|Physician Decision|2|||
143415850|NCT00671853|517069388|FG000|Overall Study|Non-adherence with study procedures|1|||
143415851|NCT00671853|517069389|FG001|Overall Study|Non-adherence with study procedures|4|||
143415852|NCT02354417|517069390|FG000|Overall Study|Physician Decision|1|||
143415853|NCT01185340|517069393|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
143415854|NCT01185340|517069394|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
143415855|NCT01185340|517069395|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
143415856|NCT01185340|517069396|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
143415857|NCT01185340|517069393|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
143415858|NCT01185340|517069394|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
143415859|NCT01185340|517069395|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
143415860|NCT01185340|517069396|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
143415861|NCT01185340|517069393|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
143415862|NCT01185340|517069394|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
143415863|NCT01185340|517069395|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
143415864|NCT01185340|517069396|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
143415865|NCT01185340|517069393|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
143415866|NCT01185340|517069394|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
143415867|NCT01185340|517069395|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
143415868|NCT01185340|517069396|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
143415869|NCT01185340|517069393|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
143415870|NCT01185340|517069394|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
143415871|NCT01185340|517069395|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
143415872|NCT01185340|517069396|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
143415873|NCT01185340|517069393|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
143415874|NCT01185340|517069394|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
143415875|NCT01185340|517069395|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
143415876|NCT01185340|517069396|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
143415877|NCT01185340|517069393|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
143415878|NCT01185340|517069394|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
143415879|NCT01185340|517069395|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
143415880|NCT01185340|517069396|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
143415881|NCT01185340|517069393|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
143415882|NCT01185340|517069394|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
143415883|NCT01185340|517069395|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
143415884|NCT01185340|517069396|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
143415885|NCT01185340|517069393|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
143415886|NCT01185340|517069394|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
143415887|NCT01185340|517069395|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
143415888|NCT01185340|517069396|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
143415889|NCT01185340|517069393|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
143415890|NCT01185340|517069394|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
143415891|NCT01185340|517069395|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
143415892|NCT01185340|517069396|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
143415893|NCT01185340|517069393|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
143415894|NCT01185340|517069394|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
143415895|NCT01185340|517069395|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
143415896|NCT01185340|517069396|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
143415897|NCT01185340|517069393|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
143415898|NCT01185340|517069394|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
143415899|NCT01185340|517069395|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
143415900|NCT01185340|517069396|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
143415901|NCT01185340|517069393|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
143415902|NCT01185340|517069394|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
143415903|NCT01185340|517069395|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
143415904|NCT01185340|517069396|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
143415905|NCT01185340|517069393|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
143415906|NCT01185340|517069394|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
143415907|NCT01185340|517069395|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
143415908|NCT01185340|517069396|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
143415909|NCT01719172|517069397|FG000|Overall Study|Lost to Follow-up|1|||
143415910|NCT01719172|517069397|FG000|Overall Study|Death|1|||
143415911|NCT02236611|517069402|FG000|Overall Study|Adverse Event|10|||
143415912|NCT02236611|517069403|FG001|Overall Study|Adverse Event|16|||
143415913|NCT02236611|517069402|FG000|Overall Study|Lack of Efficacy|4|||
143415914|NCT02236611|517069403|FG001|Overall Study|Lack of Efficacy|7|||
143415915|NCT02236611|517069402|FG000|Overall Study|Lost to Follow-up|0|||
143415916|NCT02236611|517069403|FG001|Overall Study|Lost to Follow-up|2|||
143415917|NCT02236611|517069402|FG000|Overall Study|Protocol deviation|3|||
143415918|NCT02236611|517069403|FG001|Overall Study|Protocol deviation|5|||
143415919|NCT02236611|517069402|FG000|Overall Study|Withdrew consent|9|||
143415920|NCT02236611|517069403|FG001|Overall Study|Withdrew consent|4|||
143415921|NCT03041090|517069404|FG000|Overall Study|technical error|0|||
143415922|NCT03041090|517069405|FG001|Overall Study|technical error|3|||
143415923|NCT01128959|517069406|FG000|Lead in Period|Adverse Event|3|||
143415924|NCT01128959|517069406|FG000|Treatment Period|Adverse Event|3|||
143415925|NCT01128959|517069406|FG000|Treatment Period|Withdrawal by Subject|1|||
143415926|NCT02701296|517069407|FG000|Overall Study|Incomplete Data|0|||
143415927|NCT02701296|517069408|FG001|Overall Study|Incomplete Data|2|||
143415928|NCT01409837|517069409|FG000|Overall Study|Withdrawal by Subject|2|||
143415929|NCT01409837|517069410|FG001|Overall Study|Withdrawal by Subject|1|||
143415930|NCT01409837|517069409|FG000|Overall Study|Lost to Follow-up|1|||
143415931|NCT01409837|517069410|FG001|Overall Study|Lost to Follow-up|0|||
143415932|NCT01409837|517069409|FG000|Overall Study|Physician Decision|0|||
143415933|NCT01409837|517069410|FG001|Overall Study|Physician Decision|1|||
143415934|NCT03490032|517069414|FG000|Overall Study|family issue (child custody)|1|||
143415935|NCT03490032|517069415|FG001|Overall Study|family issue (child custody)|0|||
143415936|NCT03490032|517069416|FG002|Overall Study|family issue (child custody)|0|||
143415937|NCT00308308|517069417|FG000|Overall Study|Adverse Event|17|||
143415938|NCT00308308|517069418|FG001|Overall Study|Adverse Event|2|||
143415939|NCT00308308|517069417|FG000|Overall Study|Lost to Follow-up|5|||
143415940|NCT00308308|517069418|FG001|Overall Study|Lost to Follow-up|5|||
143415941|NCT00308308|517069417|FG000|Overall Study|Physician Decision|15|||
143415942|NCT00308308|517069418|FG001|Overall Study|Physician Decision|7|||
143415943|NCT00308308|517069417|FG000|Overall Study|Protocol Violation|3|||
143415944|NCT00308308|517069418|FG001|Overall Study|Protocol Violation|14|||
143415945|NCT00308308|517069417|FG000|Overall Study|Withdrawal by Subject|47|||
143415946|NCT00308308|517069418|FG001|Overall Study|Withdrawal by Subject|19|||
143415947|NCT00308308|517069417|FG000|Overall Study|Various|7|||
143415948|NCT00308308|517069418|FG001|Overall Study|Various|5|||
143415949|NCT00308308|517069417|FG000|Overall Study|Randomized but not dosed|8|||
143415950|NCT00308308|517069418|FG001|Overall Study|Randomized but not dosed|16|||
143415951|NCT00308308|517069417|FG000|Overall Study|Other|1|||
143415952|NCT00308308|517069418|FG001|Overall Study|Other|0|||
143415953|NCT04679675|517069423|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
143415954|NCT04679675|517069424|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
143415955|NCT04679675|517069425|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
143415956|NCT04679675|517069426|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
143415957|NCT04679675|517069423|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
143415958|NCT04679675|517069424|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
143415959|NCT04679675|517069425|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
143415960|NCT04679675|517069426|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
143415961|NCT02362789|517069432|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
143415962|NCT02362789|517069433|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
143415963|NCT02362789|517069434|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
143415964|NCT02362789|517069432|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
143415965|NCT02362789|517069433|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
143415966|NCT02362789|517069434|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
143415967|NCT02362789|517069432|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
143415968|NCT02362789|517069433|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
143415969|NCT02362789|517069434|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
143415970|NCT02362789|517069432|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
143415971|NCT02362789|517069433|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
143415972|NCT02362789|517069434|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
143415973|NCT02362789|517069432|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
143415974|NCT02362789|517069433|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
143415975|NCT02362789|517069434|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
143415976|NCT00526994|517069436|FG000|Overall Study|Lost to Follow-up|98|||
143415977|NCT00526994|517069437|FG001|Overall Study|Lost to Follow-up|108|||
143415978|NCT00526994|517069438|FG002|Overall Study|Lost to Follow-up|96|||
143415979|NCT00526994|517069436|FG000|Overall Study|Death|4|||
143415980|NCT00526994|517069437|FG001|Overall Study|Death|3|||
143415981|NCT00526994|517069438|FG002|Overall Study|Death|3|||
143415982|NCT00526994|517069436|FG000|Overall Study|Withdrawal by Subject|2|||
143415983|NCT00526994|517069437|FG001|Overall Study|Withdrawal by Subject|7|||
143415984|NCT00526994|517069438|FG002|Overall Study|Withdrawal by Subject|5|||
143415985|NCT00526994|517069436|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
143415986|NCT00526994|517069437|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
143415987|NCT00526994|517069438|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
143415988|NCT03035942|517069439|FG000|Overall Study|Adverse Event|8|||
143415989|NCT03035942|517069440|FG001|Overall Study|Adverse Event|4|||
143415990|NCT03035942|517069441|FG002|Overall Study|Adverse Event|5|||
143415991|NCT00326183|517069442|FG000|Overall Study|Lost to Follow-up|104|||
143415992|NCT00326183|517069443|FG001|Overall Study|Lost to Follow-up|56|||
143415993|NCT00326183|517069442|FG000|Overall Study|Protocol Violation|6|||
143415994|NCT00326183|517069443|FG001|Overall Study|Protocol Violation|3|||
143415995|NCT00326183|517069442|FG000|Overall Study|Withdrawal by Subject|35|||
143415996|NCT00326183|517069443|FG001|Overall Study|Withdrawal by Subject|7|||
143415997|NCT00326183|517069442|FG000|Overall Study|Subject Moved|7|||
143415998|NCT00326183|517069443|FG001|Overall Study|Subject Moved|4|||
143415999|NCT00326183|517069442|FG000|Overall Study|Other|47|||
143416000|NCT00326183|517069443|FG001|Overall Study|Other|13|||
143416001|NCT00326183|517069442|FG000|Overall Study|Adverse Event|1|||
143416002|NCT00326183|517069443|FG001|Overall Study|Adverse Event|0|||
143416003|NCT00824408|517069447|FG000|Run-in Phase|Progressive disease|4|||
143416004|NCT00824408|517069448|FG001|Run-in Phase|Progressive disease|4|||
143416005|NCT00824408|517069449|FG002|Run-in Phase|Progressive disease|0|||
143416006|NCT00824408|517069450|FG003|Run-in Phase|Progressive disease|0|||
143416007|NCT00824408|517069451|FG004|Run-in Phase|Progressive disease|0|||
143416008|NCT00824408|517069447|FG000|Run-in Phase|Adverse Event|1|||
143416009|NCT00824408|517069448|FG001|Run-in Phase|Adverse Event|1|||
143416010|NCT00824408|517069449|FG002|Run-in Phase|Adverse Event|0|||
143416011|NCT00824408|517069450|FG003|Run-in Phase|Adverse Event|0|||
143416012|NCT00824408|517069451|FG004|Run-in Phase|Adverse Event|0|||
143416013|NCT00824408|517069447|FG000|Run-in Phase|Refused to continue medication|1|||
143416014|NCT00824408|517069448|FG001|Run-in Phase|Refused to continue medication|0|||
143416015|NCT00824408|517069449|FG002|Run-in Phase|Refused to continue medication|0|||
143416016|NCT00824408|517069450|FG003|Run-in Phase|Refused to continue medication|0|||
143416017|NCT00824408|517069451|FG004|Run-in Phase|Refused to continue medication|0|||
143416018|NCT00824408|517069447|FG000|Run-in Phase|Other reason not defined above|0|||
143416019|NCT00824408|517069448|FG001|Run-in Phase|Other reason not defined above|1|||
143416020|NCT00824408|517069449|FG002|Run-in Phase|Other reason not defined above|0|||
143416021|NCT00824408|517069450|FG003|Run-in Phase|Other reason not defined above|0|||
143416022|NCT00824408|517069451|FG004|Run-in Phase|Other reason not defined above|0|||
143416023|NCT00824408|517069447|FG000|Randomized Phase|Not treated|0|||
143416024|NCT00824408|517069448|FG001|Randomized Phase|Not treated|0|||
143416025|NCT00824408|517069449|FG002|Randomized Phase|Not treated|1|||
143416026|NCT00824408|517069450|FG003|Randomized Phase|Not treated|1|||
143416027|NCT00824408|517069451|FG004|Randomized Phase|Not treated|1|||
143416028|NCT00824408|517069447|FG000|Randomized Phase|Progressive disease|0|||
143416029|NCT00824408|517069448|FG001|Randomized Phase|Progressive disease|0|||
143416030|NCT00824408|517069449|FG002|Randomized Phase|Progressive disease|25|||
143416031|NCT00824408|517069450|FG003|Randomized Phase|Progressive disease|36|||
143416032|NCT00824408|517069451|FG004|Randomized Phase|Progressive disease|34|||
143416033|NCT00824408|517069447|FG000|Randomized Phase|Adverse Event|0|||
143416034|NCT00824408|517069448|FG001|Randomized Phase|Adverse Event|0|||
143416035|NCT00824408|517069449|FG002|Randomized Phase|Adverse Event|4|||
143416036|NCT00824408|517069450|FG003|Randomized Phase|Adverse Event|5|||
143416037|NCT00824408|517069451|FG004|Randomized Phase|Adverse Event|5|||
143416038|NCT00824408|517069447|FG000|Randomized Phase|Refused to continue medication|0|||
143416039|NCT00824408|517069448|FG001|Randomized Phase|Refused to continue medication|0|||
143416040|NCT00824408|517069449|FG002|Randomized Phase|Refused to continue medication|2|||
143416041|NCT00824408|517069450|FG003|Randomized Phase|Refused to continue medication|2|||
143416042|NCT00824408|517069451|FG004|Randomized Phase|Refused to continue medication|2|||
143416043|NCT00824408|517069447|FG000|Randomized Phase|Other reason not defined above|0|||
143416044|NCT00824408|517069448|FG001|Randomized Phase|Other reason not defined above|0|||
143416045|NCT00824408|517069449|FG002|Randomized Phase|Other reason not defined above|4|||
143416046|NCT00824408|517069450|FG003|Randomized Phase|Other reason not defined above|2|||
143416047|NCT00824408|517069451|FG004|Randomized Phase|Other reason not defined above|4|||
143416048|NCT02203032|517069453|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
143416049|NCT02203032|517069454|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
143416050|NCT02203032|517069455|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
143416051|NCT02203032|517069456|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
143416052|NCT02203032|517069453|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
143416053|NCT02203032|517069454|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
143416054|NCT02203032|517069455|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
143416055|NCT02203032|517069456|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
143416056|NCT02203032|517069453|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
143416057|NCT02203032|517069454|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
143416058|NCT02203032|517069455|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
143416059|NCT02203032|517069456|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
143416060|NCT02203032|517069453|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
143416061|NCT02203032|517069454|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
143416062|NCT02203032|517069455|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
143416063|NCT02203032|517069456|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
143416064|NCT02203032|517069453|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
143416065|NCT02203032|517069454|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
143416066|NCT02203032|517069455|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
143416067|NCT02203032|517069456|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
143416068|NCT02203032|517069453|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
143416069|NCT02203032|517069454|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
143416070|NCT02203032|517069455|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
143416071|NCT02203032|517069456|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
143416072|NCT02203032|517069453|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
143416073|NCT02203032|517069454|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
143416074|NCT02203032|517069455|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
143416075|NCT02203032|517069456|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
143416076|NCT02203032|517069453|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
143416077|NCT02203032|517069454|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
143416078|NCT02203032|517069455|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
143416079|NCT02203032|517069456|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
143416080|NCT02203032|517069453|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
143416081|NCT02203032|517069454|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
143416082|NCT02203032|517069455|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
143416083|NCT02203032|517069456|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
143416084|NCT02203032|517069453|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
143416085|NCT02203032|517069454|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
143416086|NCT02203032|517069455|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
143416087|NCT02203032|517069456|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
143416088|NCT02203032|517069453|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
143416089|NCT02203032|517069454|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
143416090|NCT02203032|517069455|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
143416091|NCT02203032|517069456|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
143416092|NCT02203032|517069453|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
143416093|NCT02203032|517069454|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
143416094|NCT02203032|517069455|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
143416095|NCT02203032|517069456|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
143416096|NCT02241785|517069457|FG000|Overall Study|Sponsor Termination|43|||
143416097|NCT02241785|517069457|FG000|Overall Study|Withdrawal by Subject|1|||
143416098|NCT02241785|517069457|FG000|Overall Study|Lost to Follow-up|2|||
143416099|NCT02241785|517069457|FG000|Overall Study|Adverse Event|1|||
143416100|NCT00452114|517069460|FG000|Overall Study|Physician Decision|3|||
143416101|NCT00452114|517069461|FG001|Overall Study|Physician Decision|3|||
143416102|NCT05338476|517069462|FG000|Period 2|Adverse Event|0|||
143416103|NCT05338476|517069463|FG001|Period 2|Adverse Event|1|||
143416104|NCT04535414|517069466|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
143416105|NCT04535414|517069467|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
143416106|NCT04535414|517069466|FG000|Overall Study|Cancelled appointment|1|||
143416107|NCT04535414|517069467|FG001|Overall Study|Cancelled appointment|0|||
143416108|NCT04535414|517069466|FG000|Overall Study|cancelled - food in stomach|2|||
143416109|NCT04535414|517069467|FG001|Overall Study|cancelled - food in stomach|0|||
143416110|NCT04535414|517069466|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
143416111|NCT04535414|517069467|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
143416112|NCT04535414|517069466|FG000|Overall Study|Withdrawal by Subject|0|||
143416113|NCT04535414|517069467|FG001|Overall Study|Withdrawal by Subject|1|||
143416114|NCT01276509|517071434|FG000|Overall Study|Adverse Event|9|||
143416115|NCT01276509|517071435|FG001|Overall Study|Adverse Event|8|||
143416116|NCT01276509|517071436|FG002|Overall Study|Adverse Event|4|||
143416117|NCT01276509|517071437|FG003|Overall Study|Adverse Event|3|||
143416118|NCT01276509|517071434|FG000|Overall Study|Lack of Efficacy|2|||
143416119|NCT01276509|517071435|FG001|Overall Study|Lack of Efficacy|1|||
143416120|NCT01276509|517071436|FG002|Overall Study|Lack of Efficacy|1|||
143416121|NCT01276509|517071437|FG003|Overall Study|Lack of Efficacy|2|||
143416122|NCT01276509|517071434|FG000|Overall Study|Pregnancy|1|||
143416123|NCT01276509|517071435|FG001|Overall Study|Pregnancy|0|||
143416124|NCT01276509|517071436|FG002|Overall Study|Pregnancy|0|||
143416125|NCT01276509|517071437|FG003|Overall Study|Pregnancy|0|||
143416126|NCT01276509|517071434|FG000|Overall Study|Withdrawal by Subject|1|||
143416127|NCT01276509|517071435|FG001|Overall Study|Withdrawal by Subject|2|||
143416128|NCT01276509|517071436|FG002|Overall Study|Withdrawal by Subject|0|||
143416129|NCT01276509|517071437|FG003|Overall Study|Withdrawal by Subject|0|||
143416130|NCT01276509|517071434|FG000|Overall Study|Other|0|||
143416131|NCT01276509|517071435|FG001|Overall Study|Other|1|||
143416132|NCT01276509|517071436|FG002|Overall Study|Other|0|||
143416133|NCT01276509|517071437|FG003|Overall Study|Other|0|||
143416134|NCT00535626|517071442|FG000|Overall Study|Death|15|||
143416135|NCT00535626|517071442|FG000|Overall Study|Lost to Follow-up|29|||
143416136|NCT00535626|517071442|FG000|Overall Study|Withdrawal by Subject|20|||
143416137|NCT00535626|517071442|FG000|Overall Study|Removal/revision of study component|8|||
143416138|NCT00535626|517071442|FG000|Overall Study|Subject terminated|31|||
143416139|NCT00535626|517071442|FG000|Overall Study|Unable to return|2|||
143416140|NCT02830893|517071443|FG000|Overall Study|Relocation to out of the country|1|||
143416141|NCT02830893|517071444|FG001|Overall Study|Relocation to out of the country|0|||
143416142|NCT02830893|517071443|FG000|Overall Study|Lost to Follow-up|0|||
143416143|NCT02830893|517071444|FG001|Overall Study|Lost to Follow-up|2|||
143416144|NCT02830893|517071443|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
143416145|NCT02830893|517071444|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
143416146|NCT01567852|517071445|FG000|Overall Study|Withdrawal by Subject|3|||
143416147|NCT01567852|517071446|FG001|Overall Study|Withdrawal by Subject|6|||
143416148|NCT01567852|517071445|FG000|Overall Study|ECT discontinued|1|||
143416149|NCT01567852|517071446|FG001|Overall Study|ECT discontinued|1|||
143416150|NCT01848483|517071447|FG000|Overall Study|Death|2|||
143416151|NCT01848483|517071448|FG001|Overall Study|Death|1|||
143416152|NCT01848483|517071447|FG000|Overall Study|Lost to Follow-up|6|||
143416153|NCT01848483|517071448|FG001|Overall Study|Lost to Follow-up|8|||
143416154|NCT01848483|517071447|FG000|Overall Study|Withdrawal by Subject|1|||
143416155|NCT01848483|517071448|FG001|Overall Study|Withdrawal by Subject|0|||
143416156|NCT01848483|517071447|FG000|Overall Study|Incarceration|2|||
143416157|NCT01848483|517071448|FG001|Overall Study|Incarceration|2|||
143416158|NCT01148017|517071449|FG000|Overall Study|Withdrawal by Subject|31|||
143416159|NCT01148017|517071450|FG001|Overall Study|Withdrawal by Subject|14|||
143416160|NCT01148017|517071451|FG002|Overall Study|Withdrawal by Subject|0|||
143416161|NCT01148017|517071452|FG003|Overall Study|Withdrawal by Subject|0|||
143416162|NCT01148017|517071449|FG000|Overall Study|Lost to Follow-up|23|||
143416163|NCT01148017|517071450|FG001|Overall Study|Lost to Follow-up|10|||
143416164|NCT01148017|517071451|FG002|Overall Study|Lost to Follow-up|0|||
143416165|NCT01148017|517071452|FG003|Overall Study|Lost to Follow-up|0|||
143416166|NCT01148017|517071449|FG000|Overall Study|Inappropriate enrollment|1|||
143416167|NCT01148017|517071450|FG001|Overall Study|Inappropriate enrollment|0|||
143416168|NCT01148017|517071451|FG002|Overall Study|Inappropriate enrollment|0|||
143416169|NCT01148017|517071452|FG003|Overall Study|Inappropriate enrollment|0|||
143416170|NCT01148017|517071449|FG000|Overall Study|Administrative reason|22|||
143416171|NCT01148017|517071450|FG001|Overall Study|Administrative reason|9|||
143416172|NCT01148017|517071451|FG002|Overall Study|Administrative reason|0|||
143416173|NCT01148017|517071452|FG003|Overall Study|Administrative reason|0|||
143416174|NCT01148017|517071449|FG000|Overall Study|Unable to classify|3|||
143416175|NCT01148017|517071450|FG001|Overall Study|Unable to classify|1|||
143416176|NCT01148017|517071451|FG002|Overall Study|Unable to classify|0|||
143416177|NCT01148017|517071452|FG003|Overall Study|Unable to classify|0|||
143416178|NCT00246129|517071457|FG000|Overall Study|Lost to Follow-up|1|||
143416179|NCT00246129|517071458|FG001|Overall Study|Lost to Follow-up|0|||
143416180|NCT00246129|517071457|FG000|Overall Study|Death|2|||
143416181|NCT00246129|517071458|FG001|Overall Study|Death|1|||
143416182|NCT00246129|517071457|FG000|Overall Study|suffered primary non-function|1|||
143416183|NCT00246129|517071458|FG001|Overall Study|suffered primary non-function|0|||
143416184|NCT00246129|517071457|FG000|Overall Study|grafts failed|3|||
143416185|NCT00246129|517071458|FG001|Overall Study|grafts failed|1|||
143416186|NCT03740737|517071459|FG000|Overall Study|Protocol deviation|13|||
143416187|NCT03740737|517071460|FG001|Overall Study|Protocol deviation|0|||
143416188|NCT03740737|517071459|FG000|Overall Study|Adverse Event|2|||
143416189|NCT03740737|517071460|FG001|Overall Study|Adverse Event|0|||
143416190|NCT03740737|517071459|FG000|Overall Study|Lost to Follow-up|1|||
143416191|NCT03740737|517071460|FG001|Overall Study|Lost to Follow-up|0|||
143416192|NCT03740737|517071459|FG000|Overall Study|Randomization failure|1|||
143416193|NCT03740737|517071460|FG001|Overall Study|Randomization failure|0|||
143416194|NCT03740737|517071459|FG000|Overall Study|Participant withdrew consent|1|||
143416195|NCT03740737|517071460|FG001|Overall Study|Participant withdrew consent|0|||
143416196|NCT03740737|517071459|FG000|Overall Study|Participant withdrew from trial|2|||
143416197|NCT03740737|517071460|FG001|Overall Study|Participant withdrew from trial|1|||
143416198|NCT03469258|517071461|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
143416199|NCT02202317|517071465|FG000|Overall Study|Lost to Follow-up|1|||
143416200|NCT03403036|517071466|FG000|Overall Study|Lack of Efficacy|5|||
143416201|NCT02338999|517071467|FG000|First Intervention|Withdrawal by Subject|3|||
143416202|NCT02338999|517071468|FG001|First Intervention|Withdrawal by Subject|1|||
143416203|NCT02338999|517071467|FG000|Washout Period|Withdrawal by Subject|0|||
143416204|NCT02338999|517071468|FG001|Washout Period|Withdrawal by Subject|2|||
143416205|NCT02338999|517071467|FG000|Second Intervention|Withdrawal by Subject|0|||
143416206|NCT02338999|517071468|FG001|Second Intervention|Withdrawal by Subject|2|||
143416207|NCT00569166|517071472|FG000|Overall Study|Withdrawal by Subject|7|||
143416208|NCT00569166|517071473|FG001|Overall Study|Withdrawal by Subject|5|||
143416209|NCT00569166|517071474|FG002|Overall Study|Withdrawal by Subject|3|||
143416210|NCT00569166|517071472|FG000|Overall Study|Lost to Follow-up|2|||
143416211|NCT00569166|517071473|FG001|Overall Study|Lost to Follow-up|1|||
143416212|NCT00569166|517071474|FG002|Overall Study|Lost to Follow-up|1|||
143416213|NCT01536704|517071476|FG000|Washout Period 1|Withdrawal by Subject|1|||
143416214|NCT01536704|517071477|FG001|Washout Period 1|Withdrawal by Subject|2|||
143416215|NCT01536704|517071478|FG002|Washout Period 1|Withdrawal by Subject|0|||
143416216|NCT01536704|517071479|FG003|Washout Period 1|Withdrawal by Subject|0|||
143416217|NCT01536704|517071476|FG000|Washout Period 2|Adverse Event|1|||
143416218|NCT01536704|517071477|FG001|Washout Period 2|Adverse Event|0|||
143416219|NCT01536704|517071478|FG002|Washout Period 2|Adverse Event|0|||
143416220|NCT01536704|517071479|FG003|Washout Period 2|Adverse Event|0|||
143416221|NCT01536704|517071476|FG000|Washout Period 2|Withdrawal by Subject|0|||
143416222|NCT01536704|517071477|FG001|Washout Period 2|Withdrawal by Subject|0|||
143416223|NCT01536704|517071478|FG002|Washout Period 2|Withdrawal by Subject|0|||
143416224|NCT01536704|517071479|FG003|Washout Period 2|Withdrawal by Subject|1|||
143416225|NCT01536704|517071476|FG000|Period 3|Adverse Event|0|||
143416226|NCT01536704|517071477|FG001|Period 3|Adverse Event|0|||
143416227|NCT01536704|517071478|FG002|Period 3|Adverse Event|0|||
143416228|NCT01536704|517071479|FG003|Period 3|Adverse Event|1|||
143416229|NCT01536704|517071476|FG000|Washout Period 3|Adverse Event|0|||
143416230|NCT01536704|517071477|FG001|Washout Period 3|Adverse Event|0|||
143416231|NCT01536704|517071478|FG002|Washout Period 3|Adverse Event|1|||
143416232|NCT01536704|517071479|FG003|Washout Period 3|Adverse Event|0|||
143416233|NCT03236779|517071480|FG000|Overall Study|Lost to Follow-up|13|||
143416234|NCT03236779|517071481|FG001|Overall Study|Lost to Follow-up|21|||
143416235|NCT00929526|517071482|FG000|Overall Study|Withdrawal by Subject|1|||
143416236|NCT00929526|517071483|FG001|Overall Study|Withdrawal by Subject|11|||
143416237|NCT00929526|517071482|FG000|Overall Study|Lost to Follow-up|8|||
143416238|NCT00929526|517071483|FG001|Overall Study|Lost to Follow-up|12|||
143416239|NCT00929526|517071482|FG000|Overall Study|Other|8|||
143416240|NCT00929526|517071483|FG001|Overall Study|Other|6|||
143416241|NCT03316170|517071484|FG000|Overall Study|Death|1|||
143416242|NCT03316170|517071485|FG001|Overall Study|Death|0|||
143416243|NCT03316170|517071484|FG000|Overall Study|Lost to Follow-up|6|||
143416244|NCT03316170|517071485|FG001|Overall Study|Lost to Follow-up|7|||
143416245|NCT00578344|517071486|FG000|Overall Study|Insurance problems|1|||
143416246|NCT00578344|517071486|FG000|Overall Study|Graft failure|1|||
143416247|NCT02169414|517071487|FG000|Overall Study|Withdrawal by Subject|1|||
143416248|NCT02169414|517071488|FG001|Overall Study|Withdrawal by Subject|0|||
143416249|NCT02169414|517071489|FG002|Overall Study|Withdrawal by Subject|0|||
143416250|NCT02169414|517071490|FG003|Overall Study|Withdrawal by Subject|0|||
143416251|NCT02169414|517071487|FG000|Overall Study|Adverse Event|0|||
143416252|NCT02169414|517071488|FG001|Overall Study|Adverse Event|1|||
143416253|NCT02169414|517071489|FG002|Overall Study|Adverse Event|0|||
143416254|NCT02169414|517071490|FG003|Overall Study|Adverse Event|0|||
143416255|NCT01836523|517071491|FG000|Overall Study|Adverse Event|15|||
143416256|NCT01836523|517071492|FG001|Overall Study|Adverse Event|41|||
143416257|NCT01836523|517071493|FG002|Overall Study|Adverse Event|49|||
143416258|NCT01836523|517071494|FG003|Overall Study|Adverse Event|14|||
143416259|NCT01836523|517071491|FG000|Overall Study|Protocol Violation|6|||
143416260|NCT01836523|517071492|FG001|Overall Study|Protocol Violation|3|||
143416261|NCT01836523|517071493|FG002|Overall Study|Protocol Violation|2|||
143416262|NCT01836523|517071494|FG003|Overall Study|Protocol Violation|4|||
143416263|NCT01836523|517071491|FG000|Overall Study|Met Withdrawal Criteria|13|||
143416264|NCT01836523|517071492|FG001|Overall Study|Met Withdrawal Criteria|13|||
143416265|NCT01836523|517071493|FG002|Overall Study|Met Withdrawal Criteria|21|||
143416266|NCT01836523|517071494|FG003|Overall Study|Met Withdrawal Criteria|27|||
143416267|NCT01836523|517071491|FG000|Overall Study|Unclassified|17|||
143416268|NCT01836523|517071492|FG001|Overall Study|Unclassified|28|||
143416269|NCT01836523|517071493|FG002|Overall Study|Unclassified|19|||
143416270|NCT01836523|517071494|FG003|Overall Study|Unclassified|29|||
143416271|NCT04803734|517071495|FG000|Overall Study|Withdrawal by Subject|0|||
143416272|NCT04803734|517071496|FG001|Overall Study|Withdrawal by Subject|1|||
143416273|NCT04803734|517071495|FG000|Overall Study|Protocol Violation|0|||
143416274|NCT04803734|517071496|FG001|Overall Study|Protocol Violation|1|||
143416275|NCT02309515|517071498|FG000|Overall Study|Withdrawal by Subject|0|||
143416276|NCT02309515|517071499|FG001|Overall Study|Withdrawal by Subject|1|||
143416277|NCT04070105|517071503|FG000|Overall Study|Lost to Follow-up|0|||
143416278|NCT04070105|517071504|FG001|Overall Study|Lost to Follow-up|0|||
143416279|NCT04070105|517071505|FG002|Overall Study|Lost to Follow-up|0|||
143416280|NCT04070105|517071506|FG003|Overall Study|Lost to Follow-up|0|||
143416281|NCT04070105|517071507|FG004|Overall Study|Lost to Follow-up|0|||
143416282|NCT04070105|517071508|FG005|Overall Study|Lost to Follow-up|1|||
143416283|NCT00749944|517071509|FG000|Overall Study|Lost to Follow-up|2|||
143416284|NCT00749944|517071510|FG001|Overall Study|Lost to Follow-up|1|||
143416285|NCT00749944|517071509|FG000|Overall Study|Other|1|||
143416286|NCT00749944|517071510|FG001|Overall Study|Other|0|||
143416287|NCT00749944|517071509|FG000|Overall Study|Withdrawal by Subject|2|||
143416288|NCT00749944|517071510|FG001|Overall Study|Withdrawal by Subject|0|||
143416289|NCT02547974|517071511|FG000|Overall Study|Withdrawal by Subject|1|||
143416290|NCT02547974|517071512|FG001|Overall Study|Withdrawal by Subject|0|||
143416291|NCT02547974|517071513|FG002|Overall Study|Withdrawal by Subject|0|||
143416292|NCT02547974|517071514|FG003|Overall Study|Withdrawal by Subject|0|||
143416293|NCT02245620|517071520|FG000|Overall Study|Physician Decision|1|||
143416294|NCT02245620|517071521|FG001|Overall Study|Physician Decision|1|||
143416295|NCT01999335|517071522|FG000|Overall Study|Discontinued before receiving treatment|0|||
143416296|NCT01999335|517071523|FG001|Overall Study|Discontinued before receiving treatment|0|||
143416297|NCT01999335|517071524|FG002|Overall Study|Discontinued before receiving treatment|0|||
143416298|NCT01999335|517071525|FG003|Overall Study|Discontinued before receiving treatment|0|||
143416299|NCT01999335|517071526|FG004|Overall Study|Discontinued before receiving treatment|2|||
143416300|NCT03909100|517071527|FG000|Overall Study|Protocol Deviation|2|||
143416301|NCT03909100|517071527|FG000|Overall Study|Technical Problems|4|||
143416302|NCT03909100|517071527|FG000|Overall Study|Withdrawal by Subject|4|||
143416303|NCT03909100|517071527|FG000|Overall Study|Lost to Follow-up|1|||
143416304|NCT03909100|517071527|FG000|Overall Study|Reason not Specified|4|||
143416305|NCT03259568|517071528|FG000|Overall Study|Participant performance was low|3|||
143416306|NCT04248868|517071529|FG000|Overall Study|Death|1|||
143416307|NCT04248868|517071529|FG000|Overall Study|Lost to Follow-up|3|||
143416308|NCT04248868|517071529|FG000|Overall Study|Protocol Violation|2|||
143416309|NCT03128099|517071532|FG000|Overall Study|High dose task was too long|0|||
143416310|NCT03128099|517071533|FG001|Overall Study|High dose task was too long|4|||
143416311|NCT03128099|517071534|FG002|Overall Study|High dose task was too long|0|||
143416312|NCT03128099|517071532|FG000|Overall Study|Participant got a full time job.|1|||
143416313|NCT03128099|517071533|FG001|Overall Study|Participant got a full time job.|0|||
143416314|NCT03128099|517071534|FG002|Overall Study|Participant got a full time job.|0|||
143416315|NCT03128099|517071532|FG000|Overall Study|Became homeless and lost contact|1|||
143416316|NCT03128099|517071533|FG001|Overall Study|Became homeless and lost contact|0|||
143416317|NCT03128099|517071534|FG002|Overall Study|Became homeless and lost contact|0|||
143416318|NCT03128099|517071532|FG000|Overall Study|Did not complete all the assessments|0|||
143416319|NCT03128099|517071533|FG001|Overall Study|Did not complete all the assessments|0|||
143416320|NCT03128099|517071534|FG002|Overall Study|Did not complete all the assessments|1|||
143416321|NCT00148122|517071535|FG000|Overall Study|Withdrawal by Subject|2|||
143416322|NCT02449902|517071538|FG000|Overall Study|Adverse Event|0|||
143416323|NCT02449902|517071539|FG001|Overall Study|Adverse Event|1|||
143416324|NCT02449902|517071538|FG000|Overall Study|Withdrawal by Subject|0|||
143416325|NCT02449902|517071539|FG001|Overall Study|Withdrawal by Subject|1|||
143416326|NCT01365546|517071543|FG000|Overall Study|Withdrawal by Subject|1|||
143416327|NCT01365546|517071543|FG000|Overall Study|Screen failure|9|||
143416328|NCT01365546|517071543|FG000|Overall Study|Study termination|1|||
143416329|NCT03861234|517071545|FG000|Overall Study|Not treated|0|||
143416330|NCT03861234|517071546|FG001|Overall Study|Not treated|0|||
143416331|NCT03861234|517071547|FG002|Overall Study|Not treated|0|||
143416332|NCT03861234|517071548|FG003|Overall Study|Not treated|0|||
143416333|NCT03861234|517071549|FG004|Overall Study|Not treated|0|||
143416334|NCT03861234|517071550|FG005|Overall Study|Not treated|1|||
143416335|NCT03861234|517071551|FG006|Overall Study|Not treated|0|||
143416336|NCT03861234|517071552|FG007|Overall Study|Not treated|0|||
143416337|NCT03861234|517071545|FG000|Overall Study|Adverse Event|0|||
143416338|NCT03861234|517071546|FG001|Overall Study|Adverse Event|0|||
143416339|NCT03861234|517071547|FG002|Overall Study|Adverse Event|0|||
143416340|NCT03861234|517071548|FG003|Overall Study|Adverse Event|0|||
143416341|NCT03861234|517071549|FG004|Overall Study|Adverse Event|0|||
143416342|NCT03861234|517071550|FG005|Overall Study|Adverse Event|1|||
143416343|NCT03861234|517071551|FG006|Overall Study|Adverse Event|0|||
143416344|NCT03861234|517071552|FG007|Overall Study|Adverse Event|0|||
143416345|NCT03861234|517071545|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
143416346|NCT03861234|517071546|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
143416347|NCT03861234|517071547|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
143416348|NCT03861234|517071548|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
143416349|NCT03861234|517071549|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
143416350|NCT03861234|517071550|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
143416351|NCT03861234|517071551|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
143416352|NCT03861234|517071552|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
143416353|NCT03861234|517071545|FG000|Overall Study|As per sponsor decision|0|||
143416354|NCT03861234|517071546|FG001|Overall Study|As per sponsor decision|0|||
143416355|NCT03861234|517071547|FG002|Overall Study|As per sponsor decision|0|||
143416356|NCT03861234|517071548|FG003|Overall Study|As per sponsor decision|0|||
143416357|NCT03861234|517071549|FG004|Overall Study|As per sponsor decision|0|||
143416358|NCT03861234|517071550|FG005|Overall Study|As per sponsor decision|0|||
143416359|NCT03861234|517071551|FG006|Overall Study|As per sponsor decision|1|||
143416360|NCT03861234|517071552|FG007|Overall Study|As per sponsor decision|0|||
143416361|NCT03861234|517071545|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
143416362|NCT03861234|517071546|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
143416363|NCT03861234|517071547|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
143416364|NCT03861234|517071548|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
143416365|NCT03861234|517071549|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
143416366|NCT03861234|517071550|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
143416367|NCT03861234|517071551|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
143416368|NCT03861234|517071552|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
143416369|NCT00274287|517071553|FG000|Overall Study|Withdrawal by Subject|1|||
143416370|NCT00274287|517071553|FG000|Overall Study|subject non-compliance|1|||
143416371|NCT03200574|517071555|FG000|Overall Study|Death|4|||
143416372|NCT03200574|517071555|FG000|Overall Study|Withdrawal by Subject|8|||
143416373|NCT03200574|517071555|FG000|Overall Study|Long-Term need for anticoagulation|1|||
143416374|NCT03200574|517071555|FG000|Overall Study|Relocation|2|||
143416375|NCT03200574|517071555|FG000|Overall Study|Lost to Follow-up|2|||
143416376|NCT00680771|517071556|FG000|Overall Study|Withdrawal by Subject|1|||
143416377|NCT00680771|517071557|FG001|Overall Study|Withdrawal by Subject|0|||
143416378|NCT00680771|517071556|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
143416379|NCT00680771|517071557|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
143416380|NCT00680771|517071556|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
143416381|NCT00680771|517071557|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
143416382|NCT03652610|517071558|FG000|Overall Study|Lost to Follow-up|1|||
143416383|NCT03652610|517071559|FG001|Overall Study|Lost to Follow-up|0|||
143416384|NCT03652610|517071558|FG000|Overall Study|Withdrawal by Subject|3|||
143416385|NCT03652610|517071559|FG001|Overall Study|Withdrawal by Subject|5|||
143416386|NCT01860079|517071560|FG000|Overall Study|Physician Decision|14|||
143416387|NCT01860079|517071561|FG001|Overall Study|Physician Decision|22|||
143416388|NCT03803475|517071568|FG000|Overall Study|Physician Decision|1|||
143416389|NCT01880736|517071569|FG000|Overall Study|Adverse Event|0|||
143416390|NCT01880736|517071570|FG001|Overall Study|Adverse Event|0|||
143416391|NCT01880736|517071571|FG002|Overall Study|Adverse Event|0|||
143416392|NCT01880736|517071572|FG003|Overall Study|Adverse Event|1|||
143416393|NCT01880736|517071569|FG000|Overall Study|Withdrawal Criteria|1|||
143416394|NCT01880736|517071570|FG001|Overall Study|Withdrawal Criteria|2|||
143416395|NCT01880736|517071571|FG002|Overall Study|Withdrawal Criteria|1|||
143416396|NCT01880736|517071572|FG003|Overall Study|Withdrawal Criteria|5|||
143416397|NCT01263496|517071576|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
143416398|NCT01263496|517071577|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
143416399|NCT01263496|517071578|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
143416400|NCT01263496|517071579|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
143416401|NCT01263496|517071580|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
143416402|NCT01263496|517071581|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
143416403|NCT01263496|517071582|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
143416404|NCT01263496|517071583|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
143416405|NCT01263496|517071584|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
143416406|NCT01263496|517071576|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
143416407|NCT01263496|517071577|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
143416408|NCT01263496|517071578|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
143416409|NCT01263496|517071579|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
143416410|NCT01263496|517071580|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
143416411|NCT01263496|517071581|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
143416412|NCT01263496|517071582|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
143416413|NCT01263496|517071583|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
143416414|NCT01263496|517071584|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
143416415|NCT01263496|517071576|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
143416416|NCT01263496|517071577|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
143416417|NCT01263496|517071578|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
143416418|NCT01263496|517071579|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
143416419|NCT01263496|517071580|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
143416420|NCT01263496|517071581|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
143416421|NCT01263496|517071582|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
143416422|NCT01263496|517071583|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
143416423|NCT01263496|517071584|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
143416424|NCT01263496|517071576|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
143416425|NCT01263496|517071577|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
143416426|NCT01263496|517071578|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
143416427|NCT01263496|517071579|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
143416428|NCT01263496|517071580|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
143416429|NCT01263496|517071581|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
143416430|NCT01263496|517071582|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
143416431|NCT01263496|517071583|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
143416432|NCT01263496|517071584|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
143416433|NCT01263496|517071576|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
143416434|NCT01263496|517071577|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
143416435|NCT01263496|517071578|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
143416436|NCT01263496|517071579|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
143416437|NCT01263496|517071580|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
143416438|NCT01263496|517071581|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
143416439|NCT01263496|517071582|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
143416440|NCT01263496|517071583|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
143416441|NCT01263496|517071584|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
143416442|NCT01263496|517071576|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
143416443|NCT01263496|517071577|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
143416444|NCT01263496|517071578|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
143416445|NCT01263496|517071579|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
143416446|NCT01263496|517071580|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
143416447|NCT01263496|517071581|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
143416448|NCT01263496|517071582|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
143416449|NCT01263496|517071583|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
143416450|NCT01263496|517071584|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
143416451|NCT01263496|517071576|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
143416452|NCT01263496|517071577|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
143416453|NCT01263496|517071578|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
143416454|NCT01263496|517071579|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
143416455|NCT01263496|517071580|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
143416456|NCT01263496|517071581|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
143416457|NCT01263496|517071582|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
143416458|NCT01263496|517071583|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
143416459|NCT01263496|517071584|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
143416460|NCT00266656|517071588|FG000|Overall Study|Death|1|||
143416461|NCT00266656|517071589|FG001|Overall Study|Death|0|||
143416462|NCT00266656|517071588|FG000|Overall Study|Lost to Follow-up|4|||
143416463|NCT00266656|517071589|FG001|Overall Study|Lost to Follow-up|1|||
143416464|NCT00266656|517071588|FG000|Overall Study|Withdrawal by Subject|4|||
143416465|NCT00266656|517071589|FG001|Overall Study|Withdrawal by Subject|2|||
143416466|NCT00266656|517071588|FG000|Overall Study|Did Not Reach Final Height|4|||
143416467|NCT00266656|517071589|FG001|Overall Study|Did Not Reach Final Height|8|||
143416468|NCT00266656|517071588|FG000|Overall Study|Parent/Caregiver Decision|1|||
143416469|NCT00266656|517071589|FG001|Overall Study|Parent/Caregiver Decision|2|||
143416470|NCT04852978|517071590|FG000|Overall Study|Physician Decision|0|||
143416471|NCT04852978|517071591|FG001|Overall Study|Physician Decision|1|||
143416472|NCT04852978|517071592|FG002|Overall Study|Physician Decision|0|||
143416473|NCT04852978|517071593|FG003|Overall Study|Physician Decision|0|||
143416474|NCT04852978|517071594|FG004|Overall Study|Physician Decision|0|||
143416475|NCT04852978|517071595|FG005|Overall Study|Physician Decision|0|||
143416476|NCT04852978|517071596|FG006|Overall Study|Physician Decision|0|||
143416477|NCT04852978|517071597|FG007|Overall Study|Physician Decision|2|||
143416478|NCT04852978|517071598|FG008|Overall Study|Physician Decision|0|||
143416479|NCT04852978|517071590|FG000|Overall Study|Sponsor request|0|||
143416480|NCT04852978|517071591|FG001|Overall Study|Sponsor request|0|||
143416481|NCT04852978|517071592|FG002|Overall Study|Sponsor request|1|||
143416482|NCT04852978|517071593|FG003|Overall Study|Sponsor request|0|||
143416483|NCT04852978|517071594|FG004|Overall Study|Sponsor request|0|||
143416484|NCT04852978|517071595|FG005|Overall Study|Sponsor request|0|||
143416485|NCT04852978|517071596|FG006|Overall Study|Sponsor request|0|||
143416486|NCT04852978|517071597|FG007|Overall Study|Sponsor request|0|||
143416487|NCT04852978|517071598|FG008|Overall Study|Sponsor request|0|||
143416488|NCT04852978|517071590|FG000|Overall Study|Death|0|||
143416489|NCT04852978|517071591|FG001|Overall Study|Death|0|||
143416490|NCT04852978|517071592|FG002|Overall Study|Death|0|||
143416491|NCT04852978|517071593|FG003|Overall Study|Death|0|||
143416492|NCT04852978|517071594|FG004|Overall Study|Death|0|||
143416493|NCT04852978|517071595|FG005|Overall Study|Death|0|||
143416494|NCT04852978|517071596|FG006|Overall Study|Death|1|||
143416495|NCT04852978|517071597|FG007|Overall Study|Death|0|||
143416496|NCT04852978|517071598|FG008|Overall Study|Death|0|||
143416497|NCT04852978|517071590|FG000|Overall Study|Lost to Follow-up|3|||
143416498|NCT04852978|517071591|FG001|Overall Study|Lost to Follow-up|2|||
143416499|NCT04852978|517071592|FG002|Overall Study|Lost to Follow-up|2|||
143416500|NCT04852978|517071593|FG003|Overall Study|Lost to Follow-up|0|||
143416501|NCT04852978|517071594|FG004|Overall Study|Lost to Follow-up|2|||
143416502|NCT04852978|517071595|FG005|Overall Study|Lost to Follow-up|4|||
143416503|NCT04852978|517071596|FG006|Overall Study|Lost to Follow-up|1|||
143416504|NCT04852978|517071597|FG007|Overall Study|Lost to Follow-up|2|||
143416505|NCT04852978|517071598|FG008|Overall Study|Lost to Follow-up|2|||
143416506|NCT04852978|517071590|FG000|Overall Study|Withdrawal by Subject|4|||
143416507|NCT04852978|517071591|FG001|Overall Study|Withdrawal by Subject|2|||
143416508|NCT04852978|517071592|FG002|Overall Study|Withdrawal by Subject|2|||
143416509|NCT04852978|517071593|FG003|Overall Study|Withdrawal by Subject|1|||
143416510|NCT04852978|517071594|FG004|Overall Study|Withdrawal by Subject|5|||
143416511|NCT04852978|517071595|FG005|Overall Study|Withdrawal by Subject|3|||
143416512|NCT04852978|517071596|FG006|Overall Study|Withdrawal by Subject|2|||
143416513|NCT04852978|517071597|FG007|Overall Study|Withdrawal by Subject|2|||
143416514|NCT04852978|517071598|FG008|Overall Study|Withdrawal by Subject|1|||
143416515|NCT03332589|517073254|FG000|Overall Study|Lack of Efficacy|2|||
143416516|NCT03332589|517073255|FG001|Overall Study|Lack of Efficacy|0|||
143416517|NCT03332589|517073256|FG002|Overall Study|Lack of Efficacy|0|||
143416518|NCT03332589|517073254|FG000|Overall Study|Adverse Event|1|||
143416519|NCT03332589|517073255|FG001|Overall Study|Adverse Event|0|||
143416520|NCT03332589|517073256|FG002|Overall Study|Adverse Event|0|||
143416521|NCT03332589|517073254|FG000|Overall Study|Death|1|||
143416522|NCT03332589|517073255|FG001|Overall Study|Death|0|||
143416523|NCT03332589|517073256|FG002|Overall Study|Death|0|||
143416524|NCT00443820|517073257|FG000|Overall Study|Adverse Event|1|||
143416525|NCT00443820|517073258|FG001|Overall Study|Adverse Event|1|||
143416526|NCT00443820|517073259|FG002|Overall Study|Adverse Event|0|||
143416527|NCT00443820|517073260|FG003|Overall Study|Adverse Event|0|||
143416528|NCT00443820|517073257|FG000|Overall Study|Lack of Efficacy|3|||
143416529|NCT00443820|517073258|FG001|Overall Study|Lack of Efficacy|2|||
143416530|NCT00443820|517073259|FG002|Overall Study|Lack of Efficacy|1|||
143416531|NCT00443820|517073260|FG003|Overall Study|Lack of Efficacy|1|||
143416532|NCT00443820|517073257|FG000|Overall Study|Protocol Violation|2|||
143416533|NCT00443820|517073258|FG001|Overall Study|Protocol Violation|1|||
143416534|NCT00443820|517073259|FG002|Overall Study|Protocol Violation|2|||
143416535|NCT00443820|517073260|FG003|Overall Study|Protocol Violation|1|||
143416536|NCT00443820|517073257|FG000|Overall Study|Withdrawal by Subject|6|||
143416537|NCT00443820|517073258|FG001|Overall Study|Withdrawal by Subject|7|||
143416538|NCT00443820|517073259|FG002|Overall Study|Withdrawal by Subject|8|||
143416539|NCT00443820|517073260|FG003|Overall Study|Withdrawal by Subject|9|||
143416540|NCT00443820|517073257|FG000|Overall Study|Lost to Follow-up|9|||
143416541|NCT00443820|517073258|FG001|Overall Study|Lost to Follow-up|8|||
143416542|NCT00443820|517073259|FG002|Overall Study|Lost to Follow-up|6|||
143416543|NCT00443820|517073260|FG003|Overall Study|Lost to Follow-up|5|||
143416544|NCT00443820|517073257|FG000|Overall Study|Administrative problems|0|||
143416545|NCT00443820|517073258|FG001|Overall Study|Administrative problems|0|||
143416546|NCT00443820|517073259|FG002|Overall Study|Administrative problems|0|||
143416547|NCT00443820|517073260|FG003|Overall Study|Administrative problems|1|||
143416548|NCT00443820|517073257|FG000|Overall Study|Death|0|||
143416549|NCT00443820|517073258|FG001|Overall Study|Death|0|||
143416550|NCT00443820|517073259|FG002|Overall Study|Death|1|||
143416551|NCT00443820|517073260|FG003|Overall Study|Death|0|||
143416552|NCT04633200|517073261|FG000|Overall Study|Lost to Follow-up|3|||
143416553|NCT04633200|517073262|FG001|Overall Study|Lost to Follow-up|5|||
143416554|NCT02092285|517073263|FG000|Induction Phase|Adverse Event|7|||
143416555|NCT02092285|517073263|FG000|Induction Phase|Physician Decision|4|||
143416556|NCT02092285|517073263|FG000|Induction Phase|Pregnancy|1|||
143416557|NCT02092285|517073263|FG000|Induction Phase|Relapse/Recurrence|7|||
143416558|NCT02092285|517073263|FG000|Induction Phase|Withdrawal by Subject|2|||
143416559|NCT02092285|517073263|FG000|Induction Phase|Lack of Efficacy|14|||
143416560|NCT02092285|517073263|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
143416561|NCT02092285|517073263|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
143416562|NCT02092285|517073263|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
143416563|NCT02092285|517073263|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
143416564|NCT02092285|517073263|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
143416565|NCT02092285|517073263|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
143416566|NCT02092285|517073263|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
143416567|NCT02092285|517073263|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
143416568|NCT02092285|517073263|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
143416569|NCT01377844|517073264|FG000|Overall Study|Withdrawal by Subject|25|||
143416570|NCT01377844|517073265|FG001|Overall Study|Withdrawal by Subject|28|||
143416571|NCT01377844|517073264|FG000|Overall Study|Protocol Violation|2|||
143416572|NCT01377844|517073265|FG001|Overall Study|Protocol Violation|3|||
143416573|NCT01377844|517073264|FG000|Overall Study|Adverse Event|3|||
143416574|NCT01377844|517073265|FG001|Overall Study|Adverse Event|0|||
143416575|NCT01377844|517073264|FG000|Overall Study|Physician Decision|6|||
143416576|NCT01377844|517073265|FG001|Overall Study|Physician Decision|3|||
143416577|NCT01377844|517073264|FG000|Overall Study|Study terminated by Sponsor|0|||
143416578|NCT01377844|517073265|FG001|Overall Study|Study terminated by Sponsor|1|||
143416579|NCT00087516|517073266|FG000|Overall Study|Adverse Event|10|||
143416580|NCT00087516|517073267|FG001|Overall Study|Adverse Event|10|||
143416581|NCT00087516|517073268|FG002|Overall Study|Adverse Event|3|||
143416582|NCT00087516|517073269|FG003|Overall Study|Adverse Event|6|||
143416583|NCT00087516|517073266|FG000|Overall Study|Lack of Efficacy|82|||
143416584|NCT00087516|517073267|FG001|Overall Study|Lack of Efficacy|80|||
143416585|NCT00087516|517073268|FG002|Overall Study|Lack of Efficacy|39|||
143416586|NCT00087516|517073269|FG003|Overall Study|Lack of Efficacy|29|||
143416587|NCT00087516|517073266|FG000|Overall Study|Lost to Follow-up|8|||
143416588|NCT00087516|517073267|FG001|Overall Study|Lost to Follow-up|6|||
143416589|NCT00087516|517073268|FG002|Overall Study|Lost to Follow-up|5|||
143416590|NCT00087516|517073269|FG003|Overall Study|Lost to Follow-up|5|||
143416591|NCT00087516|517073266|FG000|Overall Study|Protocol Violation|4|||
143416592|NCT00087516|517073267|FG001|Overall Study|Protocol Violation|8|||
143416593|NCT00087516|517073268|FG002|Overall Study|Protocol Violation|3|||
143416594|NCT00087516|517073269|FG003|Overall Study|Protocol Violation|6|||
143416595|NCT00087516|517073266|FG000|Overall Study|Withdrawal by Subject|16|||
143416596|NCT00087516|517073267|FG001|Overall Study|Withdrawal by Subject|27|||
143416597|NCT00087516|517073268|FG002|Overall Study|Withdrawal by Subject|11|||
143416598|NCT00087516|517073269|FG003|Overall Study|Withdrawal by Subject|12|||
143416599|NCT00087516|517073266|FG000|Overall Study|Site terminated|0|||
143416600|NCT00087516|517073267|FG001|Overall Study|Site terminated|2|||
143416601|NCT00087516|517073268|FG002|Overall Study|Site terminated|1|||
143416602|NCT00087516|517073269|FG003|Overall Study|Site terminated|0|||
143416603|NCT00087516|517073266|FG000|Overall Study|Protocol specified discontinuation|35|||
143416604|NCT00087516|517073267|FG001|Overall Study|Protocol specified discontinuation|33|||
143416605|NCT00087516|517073268|FG002|Overall Study|Protocol specified discontinuation|33|||
143416606|NCT00087516|517073269|FG003|Overall Study|Protocol specified discontinuation|26|||
143416607|NCT00087516|517073266|FG000|Overall Study|Patient moved|3|||
143416608|NCT00087516|517073267|FG001|Overall Study|Patient moved|2|||
143416609|NCT00087516|517073268|FG002|Overall Study|Patient moved|1|||
143416610|NCT00087516|517073269|FG003|Overall Study|Patient moved|0|||
143416611|NCT00087516|517073266|FG000|Overall Study|Patient was non-compliant|3|||
143416612|NCT00087516|517073267|FG001|Overall Study|Patient was non-compliant|1|||
143416613|NCT00087516|517073268|FG002|Overall Study|Patient was non-compliant|0|||
143416614|NCT00087516|517073269|FG003|Overall Study|Patient was non-compliant|0|||
143416615|NCT00087516|517073266|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
143416616|NCT00087516|517073267|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
143416617|NCT00087516|517073268|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
143416618|NCT00087516|517073269|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
143416619|NCT00087516|517073266|FG000|Overall Study|Other|0|||
143416620|NCT00087516|517073267|FG001|Overall Study|Other|0|||
143416621|NCT00087516|517073268|FG002|Overall Study|Other|1|||
143416622|NCT00087516|517073269|FG003|Overall Study|Other|0|||
143416623|NCT00278395|517073272|FG000|Overall Study|Adverse Event|2|||
143416624|NCT00278395|517073272|FG000|Overall Study|Nonevaluable|1|||
143416625|NCT03851094|517073273|FG000|Overall Study|Withdrawal by Subject|0|||
143416626|NCT03851094|517073274|FG001|Overall Study|Withdrawal by Subject|1|||
143416627|NCT03851094|517073273|FG000|Overall Study|Participant lost device|0|||
143416628|NCT03851094|517073274|FG001|Overall Study|Participant lost device|1|||
143416629|NCT03851094|517073273|FG000|Overall Study|Participant returned device|0|||
143416630|NCT03851094|517073274|FG001|Overall Study|Participant returned device|2|||
143416631|NCT01332266|517073275|FG000|Phase 1b|Death|3|||
143416632|NCT01332266|517073276|FG001|Phase 1b|Death|3|||
143416633|NCT01332266|517073277|FG002|Phase 1b|Death|2|||
143416634|NCT01332266|517073278|FG003|Phase 1b|Death|0|||
143416635|NCT01332266|517073279|FG004|Phase 1b|Death|0|||
143416636|NCT01332266|517073275|FG000|Phase 1b|Lost to Follow-up|0|||
143416637|NCT01332266|517073276|FG001|Phase 1b|Lost to Follow-up|1|||
143416638|NCT01332266|517073277|FG002|Phase 1b|Lost to Follow-up|0|||
143416639|NCT01332266|517073278|FG003|Phase 1b|Lost to Follow-up|0|||
143416640|NCT01332266|517073279|FG004|Phase 1b|Lost to Follow-up|0|||
143416641|NCT01332266|517073275|FG000|Phase 1b|Withdrawal by Subject|1|||
143416642|NCT01332266|517073276|FG001|Phase 1b|Withdrawal by Subject|1|||
143416643|NCT01332266|517073277|FG002|Phase 1b|Withdrawal by Subject|1|||
143416644|NCT01332266|517073278|FG003|Phase 1b|Withdrawal by Subject|0|||
143416645|NCT01332266|517073279|FG004|Phase 1b|Withdrawal by Subject|0|||
143416646|NCT01332266|517073275|FG000|Phase 2|Death|0|||
143416647|NCT01332266|517073276|FG001|Phase 2|Death|0|||
143416648|NCT01332266|517073277|FG002|Phase 2|Death|0|||
143416649|NCT01332266|517073278|FG003|Phase 2|Death|33|||
143416650|NCT01332266|517073279|FG004|Phase 2|Death|36|||
143416651|NCT01332266|517073275|FG000|Phase 2|Lost to Follow-up|0|||
143416652|NCT01332266|517073276|FG001|Phase 2|Lost to Follow-up|0|||
143416653|NCT01332266|517073277|FG002|Phase 2|Lost to Follow-up|0|||
143416654|NCT01332266|517073278|FG003|Phase 2|Lost to Follow-up|2|||
143416655|NCT01332266|517073279|FG004|Phase 2|Lost to Follow-up|0|||
143416656|NCT01332266|517073275|FG000|Phase 2|Physician Decision|0|||
143416657|NCT01332266|517073276|FG001|Phase 2|Physician Decision|0|||
143416658|NCT01332266|517073277|FG002|Phase 2|Physician Decision|0|||
143416659|NCT01332266|517073278|FG003|Phase 2|Physician Decision|3|||
143416660|NCT01332266|517073279|FG004|Phase 2|Physician Decision|1|||
143416661|NCT01332266|517073275|FG000|Phase 2|Symptomatic deterioration|0|||
143416662|NCT01332266|517073276|FG001|Phase 2|Symptomatic deterioration|0|||
143416663|NCT01332266|517073277|FG002|Phase 2|Symptomatic deterioration|0|||
143416664|NCT01332266|517073278|FG003|Phase 2|Symptomatic deterioration|0|||
143416665|NCT01332266|517073279|FG004|Phase 2|Symptomatic deterioration|1|||
143416666|NCT01332266|517073275|FG000|Phase 2|Progression Disease|0|||
143416667|NCT01332266|517073276|FG001|Phase 2|Progression Disease|0|||
143416668|NCT01332266|517073277|FG002|Phase 2|Progression Disease|0|||
143416669|NCT01332266|517073278|FG003|Phase 2|Progression Disease|2|||
143416670|NCT01332266|517073279|FG004|Phase 2|Progression Disease|1|||
143416671|NCT01332266|517073275|FG000|Phase 2|Withdrawal by Subject|0|||
143416672|NCT01332266|517073276|FG001|Phase 2|Withdrawal by Subject|0|||
143416673|NCT01332266|517073277|FG002|Phase 2|Withdrawal by Subject|0|||
143416674|NCT01332266|517073278|FG003|Phase 2|Withdrawal by Subject|2|||
143416675|NCT01332266|517073279|FG004|Phase 2|Withdrawal by Subject|2|||
143416676|NCT02392507|517073282|FG000|Induction Regimen|Death|3|||
143416677|NCT02392507|517073282|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
143416678|NCT02392507|517073282|FG000|Induction Regimen|Physician Decision|1|||
143416679|NCT02392507|517073282|FG000|Induction Regimen|Withdrawal by Subject|2|||
143416680|NCT02392507|517073282|FG000|Maintenance Regimen|Death|1|||
143416681|NCT02392507|517073282|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
143416682|NCT01802333|517073283|FG000|Overall Study|Ineligible|2|||
143416683|NCT01802333|517073284|FG001|Overall Study|Ineligible|6|||
143416684|NCT01802333|517073285|FG002|Overall Study|Ineligible|8|||
143416685|NCT01802333|517073283|FG000|Overall Study|Adverse Event|1|||
143416686|NCT01802333|517073284|FG001|Overall Study|Adverse Event|8|||
143416687|NCT01802333|517073285|FG002|Overall Study|Adverse Event|8|||
143416688|NCT01802333|517073283|FG000|Overall Study|Withdrawal by Subject|6|||
143416689|NCT01802333|517073284|FG001|Overall Study|Withdrawal by Subject|6|||
143416690|NCT01802333|517073285|FG002|Overall Study|Withdrawal by Subject|5|||
143416691|NCT01802333|517073283|FG000|Overall Study|Progression/relapse|1|||
143416692|NCT01802333|517073284|FG001|Overall Study|Progression/relapse|3|||
143416693|NCT01802333|517073285|FG002|Overall Study|Progression/relapse|0|||
143416694|NCT01802333|517073283|FG000|Overall Study|Death|7|||
143416695|NCT01802333|517073284|FG001|Overall Study|Death|14|||
143416696|NCT01802333|517073285|FG002|Overall Study|Death|13|||
143416697|NCT01802333|517073283|FG000|Overall Study|Other - not protocol specified|32|||
143416698|NCT01802333|517073284|FG001|Overall Study|Other - not protocol specified|22|||
143416699|NCT01802333|517073285|FG002|Overall Study|Other - not protocol specified|24|||
143416700|NCT01802333|517073283|FG000|Overall Study|Did not start treatment|0|||
143416701|NCT01802333|517073284|FG001|Overall Study|Did not start treatment|2|||
143416702|NCT01802333|517073285|FG002|Overall Study|Did not start treatment|5|||
143416703|NCT01947491|517073286|FG000|Overall Study|Lost to Follow-up|5|||
143416704|NCT01947491|517073287|FG001|Overall Study|Lost to Follow-up|3|||
143416705|NCT01947491|517073288|FG002|Overall Study|Lost to Follow-up|1|||
143416706|NCT01947491|517073289|FG003|Overall Study|Lost to Follow-up|2|||
143416707|NCT01947491|517073286|FG000|Overall Study|Lack of Efficacy|1|||
143416708|NCT01947491|517073287|FG001|Overall Study|Lack of Efficacy|0|||
143416709|NCT01947491|517073288|FG002|Overall Study|Lack of Efficacy|0|||
143416710|NCT01947491|517073289|FG003|Overall Study|Lack of Efficacy|1|||
143416711|NCT01947491|517073286|FG000|Overall Study|Protocol Violation|1|||
143416712|NCT01947491|517073287|FG001|Overall Study|Protocol Violation|0|||
143416713|NCT01947491|517073288|FG002|Overall Study|Protocol Violation|0|||
143416714|NCT01947491|517073289|FG003|Overall Study|Protocol Violation|0|||
143416715|NCT01947491|517073286|FG000|Overall Study|Withdrawal by Subject|1|||
143416716|NCT01947491|517073287|FG001|Overall Study|Withdrawal by Subject|1|||
143416717|NCT01947491|517073288|FG002|Overall Study|Withdrawal by Subject|1|||
143416718|NCT01947491|517073289|FG003|Overall Study|Withdrawal by Subject|0|||
143416719|NCT01947491|517073286|FG000|Overall Study|Worsening of condition|0|||
143416720|NCT01947491|517073287|FG001|Overall Study|Worsening of condition|1|||
143416721|NCT01947491|517073288|FG002|Overall Study|Worsening of condition|0|||
143416722|NCT01947491|517073289|FG003|Overall Study|Worsening of condition|0|||
143416723|NCT01947491|517073286|FG000|Overall Study|Adverse Event|0|||
143416724|NCT01947491|517073287|FG001|Overall Study|Adverse Event|1|||
143416725|NCT01947491|517073288|FG002|Overall Study|Adverse Event|0|||
143416726|NCT01947491|517073289|FG003|Overall Study|Adverse Event|2|||
143416727|NCT02067663|517073291|FG000|Overall Study|Lost to Follow-up|13|||
143416728|NCT02067663|517073292|FG001|Overall Study|Lost to Follow-up|14|||
143416729|NCT00704340|517073293|FG000|Overall Study|Lost to Follow-up|2|||
143416730|NCT00704340|517073294|FG001|Overall Study|Lost to Follow-up|1|||
143416731|NCT00704340|517073293|FG000|Overall Study|Death|0|||
143416732|NCT00704340|517073294|FG001|Overall Study|Death|1|||
143416733|NCT03137784|517073295|FG000|Overall Study|Adverse Event|1|||
143416734|NCT03137784|517073296|FG001|Overall Study|Adverse Event|1|||
143416735|NCT03137784|517073297|FG002|Overall Study|Adverse Event|0|||
143416736|NCT03137784|517073298|FG003|Overall Study|Adverse Event|0|||
143416737|NCT03137784|517073299|FG004|Overall Study|Adverse Event|0|||
143416738|NCT03137784|517073300|FG005|Overall Study|Adverse Event|0|||
143416739|NCT03137784|517073295|FG000|Overall Study|Subject/guardian decision|1|||
143416740|NCT03137784|517073296|FG001|Overall Study|Subject/guardian decision|0|||
143416741|NCT03137784|517073297|FG002|Overall Study|Subject/guardian decision|0|||
143416742|NCT03137784|517073298|FG003|Overall Study|Subject/guardian decision|0|||
143416743|NCT03137784|517073299|FG004|Overall Study|Subject/guardian decision|0|||
143416744|NCT03137784|517073300|FG005|Overall Study|Subject/guardian decision|0|||
143416745|NCT03137784|517073295|FG000|Overall Study|Non-compliance with study treatment|0|||
143416746|NCT03137784|517073296|FG001|Overall Study|Non-compliance with study treatment|0|||
143416747|NCT03137784|517073297|FG002|Overall Study|Non-compliance with study treatment|0|||
143416748|NCT03137784|517073298|FG003|Overall Study|Non-compliance with study treatment|0|||
143416749|NCT03137784|517073299|FG004|Overall Study|Non-compliance with study treatment|1|||
143416750|NCT03137784|517073300|FG005|Overall Study|Non-compliance with study treatment|0|||
143416751|NCT00486954|517073305|FG000|Pilot Part|Adverse Event|4|||
143416752|NCT00486954|517073306|FG001|Pilot Part|Adverse Event|0|||
143416753|NCT00486954|517073307|FG002|Pilot Part|Adverse Event|5|||
143416754|NCT00486954|517073308|FG003|Pilot Part|Adverse Event|0|||
143416755|NCT00486954|517073309|FG004|Pilot Part|Adverse Event|0|||
143416756|NCT00486954|517073305|FG000|Pilot Part|Disease Progression|2|||
143416757|NCT00486954|517073306|FG001|Pilot Part|Disease Progression|0|||
143416758|NCT00486954|517073307|FG002|Pilot Part|Disease Progression|1|||
143416759|NCT00486954|517073308|FG003|Pilot Part|Disease Progression|0|||
143416760|NCT00486954|517073309|FG004|Pilot Part|Disease Progression|0|||
143416761|NCT00486954|517073305|FG000|Randomized Part|Lost to Follow-up|0|||
143416762|NCT00486954|517073306|FG001|Randomized Part|Lost to Follow-up|0|||
143416763|NCT00486954|517073307|FG002|Randomized Part|Lost to Follow-up|0|||
143416764|NCT00486954|517073308|FG003|Randomized Part|Lost to Follow-up|0|||
143416765|NCT00486954|517073309|FG004|Randomized Part|Lost to Follow-up|1|||
143416766|NCT00486954|517073305|FG000|Randomized Part|Withdrawal by Subject|0|||
143416767|NCT00486954|517073306|FG001|Randomized Part|Withdrawal by Subject|0|||
143416768|NCT00486954|517073307|FG002|Randomized Part|Withdrawal by Subject|0|||
143416769|NCT00486954|517073308|FG003|Randomized Part|Withdrawal by Subject|1|||
143416770|NCT00486954|517073309|FG004|Randomized Part|Withdrawal by Subject|0|||
143416771|NCT00486954|517073305|FG000|Randomized Part|Sponsor Terminated Study|0|||
143416772|NCT00486954|517073306|FG001|Randomized Part|Sponsor Terminated Study|0|||
143416773|NCT00486954|517073307|FG002|Randomized Part|Sponsor Terminated Study|0|||
143416774|NCT00486954|517073308|FG003|Randomized Part|Sponsor Terminated Study|19|||
143416775|NCT00486954|517073309|FG004|Randomized Part|Sponsor Terminated Study|13|||
143416776|NCT03374254|517073314|FG000|Overall Study|Death|5|||
143416777|NCT03374254|517073315|FG001|Overall Study|Death|16|||
143416778|NCT03374254|517073316|FG002|Overall Study|Death|13|||
143416779|NCT03374254|517073317|FG003|Overall Study|Death|11|||
143416780|NCT03374254|517073318|FG004|Overall Study|Death|9|||
143416781|NCT03374254|517073319|FG005|Overall Study|Death|12|||
143416782|NCT03374254|517073320|FG006|Overall Study|Death|11|||
143416783|NCT03374254|517073321|FG007|Overall Study|Death|6|||
143416784|NCT03374254|517073322|FG008|Overall Study|Death|7|||
143416785|NCT03374254|517073314|FG000|Overall Study|Lost to Follow-up|0|||
143416786|NCT03374254|517073315|FG001|Overall Study|Lost to Follow-up|0|||
143416787|NCT03374254|517073316|FG002|Overall Study|Lost to Follow-up|0|||
143416788|NCT03374254|517073317|FG003|Overall Study|Lost to Follow-up|0|||
143416789|NCT03374254|517073318|FG004|Overall Study|Lost to Follow-up|0|||
143416790|NCT03374254|517073319|FG005|Overall Study|Lost to Follow-up|0|||
143416791|NCT03374254|517073320|FG006|Overall Study|Lost to Follow-up|2|||
143416792|NCT03374254|517073321|FG007|Overall Study|Lost to Follow-up|0|||
143416793|NCT03374254|517073322|FG008|Overall Study|Lost to Follow-up|0|||
143416794|NCT03374254|517073314|FG000|Overall Study|Sponsor Decision|1|||
143416795|NCT03374254|517073315|FG001|Overall Study|Sponsor Decision|0|||
143416796|NCT03374254|517073316|FG002|Overall Study|Sponsor Decision|2|||
143416797|NCT03374254|517073317|FG003|Overall Study|Sponsor Decision|3|||
143416798|NCT03374254|517073318|FG004|Overall Study|Sponsor Decision|2|||
143416799|NCT03374254|517073319|FG005|Overall Study|Sponsor Decision|3|||
143416800|NCT03374254|517073320|FG006|Overall Study|Sponsor Decision|3|||
143416801|NCT03374254|517073321|FG007|Overall Study|Sponsor Decision|3|||
143416802|NCT03374254|517073322|FG008|Overall Study|Sponsor Decision|4|||
143416803|NCT03374254|517073314|FG000|Overall Study|Withdrawal by Subject|0|||
143416804|NCT03374254|517073315|FG001|Overall Study|Withdrawal by Subject|0|||
143416805|NCT03374254|517073316|FG002|Overall Study|Withdrawal by Subject|0|||
143416806|NCT03374254|517073317|FG003|Overall Study|Withdrawal by Subject|2|||
143416807|NCT03374254|517073318|FG004|Overall Study|Withdrawal by Subject|0|||
143416808|NCT03374254|517073319|FG005|Overall Study|Withdrawal by Subject|1|||
143416809|NCT03374254|517073320|FG006|Overall Study|Withdrawal by Subject|0|||
143416810|NCT03374254|517073321|FG007|Overall Study|Withdrawal by Subject|0|||
143416811|NCT03374254|517073322|FG008|Overall Study|Withdrawal by Subject|0|||
143416812|NCT01102426|517073332|FG000|Overall Study|Randomized but not treated|4|||
143416813|NCT01102426|517073333|FG001|Overall Study|Randomized but not treated|1|||
143416814|NCT01102426|517073332|FG000|Overall Study|Adverse Events (treatment-related)|15|||
143416815|NCT01102426|517073333|FG001|Overall Study|Adverse Events (treatment-related)|8|||
143416816|NCT01102426|517073332|FG000|Overall Study|Physician Decision|9|||
143416817|NCT01102426|517073333|FG001|Overall Study|Physician Decision|6|||
143416818|NCT01102426|517073332|FG000|Overall Study|Progressive Disease|85|||
143416819|NCT01102426|517073333|FG001|Overall Study|Progressive Disease|44|||
143416820|NCT01102426|517073332|FG000|Overall Study|Adverse Events (unrelated to|9|||
143416821|NCT01102426|517073333|FG001|Overall Study|Adverse Events (unrelated to|1|||
143416822|NCT01102426|517073332|FG000|Overall Study|Patient Refusal|24|||
143416823|NCT01102426|517073333|FG001|Overall Study|Patient Refusal|12|||
143416824|NCT01102426|517073332|FG000|Overall Study|Death (due to adverse events|0|||
143416825|NCT01102426|517073333|FG001|Overall Study|Death (due to adverse events|1|||
143416826|NCT01102426|517073332|FG000|Overall Study|Death (non-related to the study|19|||
143416827|NCT01102426|517073333|FG001|Overall Study|Death (non-related to the study|8|||
143416828|NCT01393964|517073344|FG000|Overall Study|Disease Progression|4|||
143416829|NCT01393964|517073345|FG001|Overall Study|Disease Progression|3|||
143416830|NCT01393964|517073346|FG002|Overall Study|Disease Progression|5|||
143416831|NCT01393964|517073344|FG000|Overall Study|Study drug toxicity|1|||
143416832|NCT01393964|517073345|FG001|Overall Study|Study drug toxicity|0|||
143416833|NCT01393964|517073346|FG002|Overall Study|Study drug toxicity|0|||
143416834|NCT01393964|517073344|FG000|Overall Study|Withdrawal by Subject|0|||
143416835|NCT01393964|517073345|FG001|Overall Study|Withdrawal by Subject|0|||
143416836|NCT01393964|517073346|FG002|Overall Study|Withdrawal by Subject|1|||
143416837|NCT01393964|517073344|FG000|Overall Study|Adverse event unrelated to study drug|0|||
143416838|NCT01393964|517073345|FG001|Overall Study|Adverse event unrelated to study drug|3|||
143416839|NCT01393964|517073346|FG002|Overall Study|Adverse event unrelated to study drug|0|||
143416840|NCT01393964|517073344|FG000|Overall Study|Subject request stop study treatment|0|||
143416841|NCT01393964|517073345|FG001|Overall Study|Subject request stop study treatment|1|||
143416842|NCT01393964|517073346|FG002|Overall Study|Subject request stop study treatment|0|||
143416843|NCT01393964|517073344|FG000|Overall Study|Subject decided to move to transplant|1|||
143416844|NCT01393964|517073345|FG001|Overall Study|Subject decided to move to transplant|0|||
143416845|NCT01393964|517073346|FG002|Overall Study|Subject decided to move to transplant|0|||
143416846|NCT01393964|517073344|FG000|Overall Study|Subject switched to commercial supply|1|||
143416847|NCT01393964|517073345|FG001|Overall Study|Subject switched to commercial supply|0|||
143416848|NCT01393964|517073346|FG002|Overall Study|Subject switched to commercial supply|2|||
143416849|NCT01393964|517073344|FG000|Overall Study|Subject plateaued in terms of effect|1|||
143416850|NCT01393964|517073345|FG001|Overall Study|Subject plateaued in terms of effect|0|||
143416851|NCT01393964|517073346|FG002|Overall Study|Subject plateaued in terms of effect|0|||
143416852|NCT01393964|517073344|FG000|Overall Study|Investigator removed subject from study|0|||
143416853|NCT01393964|517073345|FG001|Overall Study|Investigator removed subject from study|1|||
143416854|NCT01393964|517073346|FG002|Overall Study|Investigator removed subject from study|0|||
143416855|NCT01393964|517073344|FG000|Overall Study|Subject converted to roll-over study|0|||
143416856|NCT01393964|517073345|FG001|Overall Study|Subject converted to roll-over study|1|||
143416857|NCT01393964|517073346|FG002|Overall Study|Subject converted to roll-over study|0|||
143416858|NCT01393964|517073344|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
143416859|NCT01393964|517073345|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
143416860|NCT01393964|517073346|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
143416861|NCT02988713|517073350|FG000|Overall Study|Withdrawal by Subject|1|||
143416862|NCT02988713|517073350|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
143416863|NCT01918033|517073351|FG000|Overall Study|Adverse Event|1|||
143416864|NCT01918033|517073352|FG001|Overall Study|Adverse Event|0|||
143416865|NCT01918033|517073353|FG002|Overall Study|Adverse Event|2|||
143416866|NCT01918033|517073351|FG000|Overall Study|Lost to Follow-up|0|||
143416867|NCT01918033|517073352|FG001|Overall Study|Lost to Follow-up|1|||
143416868|NCT01918033|517073353|FG002|Overall Study|Lost to Follow-up|0|||
143416869|NCT01918033|517073351|FG000|Overall Study|Protocol Violation|2|||
143416870|NCT01918033|517073352|FG001|Overall Study|Protocol Violation|0|||
143416871|NCT01918033|517073353|FG002|Overall Study|Protocol Violation|1|||
143416872|NCT01918033|517073351|FG000|Overall Study|Withdrawal by Subject|2|||
143416873|NCT01918033|517073352|FG001|Overall Study|Withdrawal by Subject|1|||
143416874|NCT01918033|517073353|FG002|Overall Study|Withdrawal by Subject|0|||
143416875|NCT04492475|517073354|FG000|Overall Study|Enrolled but not treated|8|||
143416876|NCT04492475|517073355|FG001|Overall Study|Enrolled but not treated|8|||
143416877|NCT04492475|517073354|FG000|Overall Study|Withdrawal by Subject|4|||
143416878|NCT04492475|517073355|FG001|Overall Study|Withdrawal by Subject|0|||
143416879|NCT04492475|517073354|FG000|Overall Study|Became ineligible after enrollment|2|||
143416880|NCT04492475|517073355|FG001|Overall Study|Became ineligible after enrollment|0|||
143416881|NCT03938272|517073365|FG000|Overall Study|Withdrawal by Subject|1|||
143416882|NCT03938272|517073366|FG001|Overall Study|Withdrawal by Subject|0|||
143416883|NCT03938272|517073365|FG000|Overall Study|Physician Decision|0|||
143416884|NCT03938272|517073366|FG001|Overall Study|Physician Decision|2|||
143416885|NCT03938272|517073365|FG000|Overall Study|Study termination by sponsor|10|||
143416886|NCT03938272|517073366|FG001|Overall Study|Study termination by sponsor|8|||
143416887|NCT03692871|517073369|FG000|Overall Study|Death|1|||
143416888|NCT03692871|517073370|FG001|Overall Study|Death|1|||
143416889|NCT03692871|517073369|FG000|Overall Study|Lost to Follow-up|24|||
143416890|NCT03692871|517073370|FG001|Overall Study|Lost to Follow-up|9|||
143416891|NCT03692871|517073369|FG000|Overall Study|Physician Decision|22|||
143416892|NCT03692871|517073370|FG001|Overall Study|Physician Decision|7|||
143416893|NCT03692871|517073369|FG000|Overall Study|Protocol Deviation|1|||
143416894|NCT03692871|517073370|FG001|Overall Study|Protocol Deviation|0|||
143416895|NCT03692871|517073369|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
143416896|NCT03692871|517073370|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
143416897|NCT02852824|517073374|FG000|Overall Study|Withdrawal by Subject|1|||
143416898|NCT02852824|517073375|FG001|Overall Study|Withdrawal by Subject|0|||
143416899|NCT02852824|517073376|FG002|Overall Study|Withdrawal by Subject|0|||
143416900|NCT02852824|517073377|FG003|Overall Study|Withdrawal by Subject|0|||
143416901|NCT02852824|517073378|FG004|Overall Study|Withdrawal by Subject|0|||
143416902|NCT02852824|517073379|FG005|Overall Study|Withdrawal by Subject|0|||
143416903|NCT02852824|517073380|FG006|Overall Study|Withdrawal by Subject|0|||
143416904|NCT02852824|517073374|FG000|Overall Study|Adverse Event|0|||
143416905|NCT02852824|517073375|FG001|Overall Study|Adverse Event|0|||
143416906|NCT02852824|517073376|FG002|Overall Study|Adverse Event|0|||
143416907|NCT02852824|517073377|FG003|Overall Study|Adverse Event|0|||
143416908|NCT02852824|517073378|FG004|Overall Study|Adverse Event|2|||
143416909|NCT02852824|517073379|FG005|Overall Study|Adverse Event|0|||
143416910|NCT02852824|517073380|FG006|Overall Study|Adverse Event|0|||
143416911|NCT02950961|517073387|FG000|Overall Study|Study had to stop due to COVID.|7|||
143416912|NCT03055988|517073388|FG000|Period 1|Adverse Event|0|||
143416913|NCT03055988|517073389|FG001|Period 1|Adverse Event|1|||
143416914|NCT03055988|517073388|FG000|Period 1|Lost to Follow-up|1|||
143416915|NCT03055988|517073389|FG001|Period 1|Lost to Follow-up|0|||
143416916|NCT03055988|517073388|FG000|Period 1|Withdrawal by Subject|0|||
143416917|NCT03055988|517073389|FG001|Period 1|Withdrawal by Subject|4|||
143416918|NCT03055988|517073388|FG000|Period 2|Adverse Event|0|||
143416919|NCT03055988|517073389|FG001|Period 2|Adverse Event|1|||
143416920|NCT03055988|517073388|FG000|Period 2|Other than listed|1|||
143416921|NCT03055988|517073389|FG001|Period 2|Other than listed|1|||
143416922|NCT01915914|517073392|FG000|Acute Phase|Withdrawal by Subject|4|||
143416923|NCT01915914|517073393|FG001|Acute Phase|Withdrawal by Subject|0|||
143416924|NCT01915914|517073394|FG002|Acute Phase|Withdrawal by Subject|0|||
143416925|NCT01915914|517073395|FG003|Acute Phase|Withdrawal by Subject|0|||
143416926|NCT01915914|517073392|FG000|Acute Phase|Lost to Follow-up|4|||
143416927|NCT01915914|517073393|FG001|Acute Phase|Lost to Follow-up|0|||
143416928|NCT01915914|517073394|FG002|Acute Phase|Lost to Follow-up|0|||
143416929|NCT01915914|517073395|FG003|Acute Phase|Lost to Follow-up|0|||
143416930|NCT01915914|517073392|FG000|Acute Phase|Physician Decision|1|||
143416931|NCT01915914|517073393|FG001|Acute Phase|Physician Decision|0|||
143416932|NCT01915914|517073394|FG002|Acute Phase|Physician Decision|0|||
143416933|NCT01915914|517073395|FG003|Acute Phase|Physician Decision|0|||
143416934|NCT01915914|517073392|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
143416935|NCT01915914|517073393|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
143416936|NCT01915914|517073394|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
143416937|NCT01915914|517073395|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
143416938|NCT01915914|517073392|FG000|Acute Phase|"Not Achieved treatment success"|1|||
143416939|NCT01915914|517073393|FG001|Acute Phase|"Not Achieved treatment success"|0|||
143416940|NCT01915914|517073394|FG002|Acute Phase|"Not Achieved treatment success"|0|||
143416941|NCT01915914|517073395|FG003|Acute Phase|"Not Achieved treatment success"|0|||
143416942|NCT01915914|517073392|FG000|Acute Phase|Missing|1|||
143416943|NCT01915914|517073393|FG001|Acute Phase|Missing|0|||
143416944|NCT01915914|517073394|FG002|Acute Phase|Missing|0|||
143416945|NCT01915914|517073395|FG003|Acute Phase|Missing|0|||
143416946|NCT01915914|517073392|FG000|Maintenance Phase|Withdrawal by Subject|0|||
143416947|NCT01915914|517073393|FG001|Maintenance Phase|Withdrawal by Subject|1|||
143416948|NCT01915914|517073394|FG002|Maintenance Phase|Withdrawal by Subject|1|||
143416949|NCT01915914|517073395|FG003|Maintenance Phase|Withdrawal by Subject|0|||
143416950|NCT01915914|517073392|FG000|Maintenance Phase|Lost to Follow-up|0|||
143416951|NCT01915914|517073393|FG001|Maintenance Phase|Lost to Follow-up|4|||
143416952|NCT01915914|517073394|FG002|Maintenance Phase|Lost to Follow-up|1|||
143416953|NCT01915914|517073395|FG003|Maintenance Phase|Lost to Follow-up|0|||
143416954|NCT01915914|517073392|FG000|Maintenance Phase|Missing|0|||
143416955|NCT01915914|517073393|FG001|Maintenance Phase|Missing|1|||
143416956|NCT01915914|517073394|FG002|Maintenance Phase|Missing|0|||
143416957|NCT01915914|517073395|FG003|Maintenance Phase|Missing|0|||
143416958|NCT01915914|517073392|FG000|Follow-up Phase|Withdrawal by Subject|0|||
143416959|NCT01915914|517073393|FG001|Follow-up Phase|Withdrawal by Subject|0|||
143416960|NCT01915914|517073394|FG002|Follow-up Phase|Withdrawal by Subject|0|||
143416961|NCT01915914|517073395|FG003|Follow-up Phase|Withdrawal by Subject|1|||
143416962|NCT01915914|517073392|FG000|Follow-up Phase|Physician Decision|0|||
143416963|NCT01915914|517073393|FG001|Follow-up Phase|Physician Decision|0|||
143416964|NCT01915914|517073394|FG002|Follow-up Phase|Physician Decision|0|||
143416965|NCT01915914|517073395|FG003|Follow-up Phase|Physician Decision|1|||
143416966|NCT01736475|517073396|FG000|Overall Study|Adverse Event|4|||
143416967|NCT01736475|517073397|FG001|Overall Study|Adverse Event|0|||
143416968|NCT01736475|517073396|FG000|Overall Study|Withdrawal by Subject|2|||
143416969|NCT01736475|517073397|FG001|Overall Study|Withdrawal by Subject|0|||
143416970|NCT01736475|517073396|FG000|Overall Study|Protocol Violation|4|||
143416971|NCT01736475|517073397|FG001|Overall Study|Protocol Violation|0|||
143416972|NCT01736475|517073396|FG000|Overall Study|Other - Screen failure|1|||
143416973|NCT01736475|517073397|FG001|Overall Study|Other - Screen failure|0|||
143416974|NCT01736475|517073396|FG000|Overall Study|Other - Surgical procedure|1|||
143416975|NCT01736475|517073397|FG001|Overall Study|Other - Surgical procedure|0|||
143416976|NCT02807857|517073398|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
143416977|NCT02807857|517073398|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
143416978|NCT02807857|517073398|FG000|Follow-Up Set|Withdrawal by Subject|8|||
143416979|NCT02807857|517073398|FG000|Follow-Up Set|Lost to Follow-up|7|||
143416980|NCT02807857|517073398|FG000|Follow-Up Set|Physician Decision|6|||
143416981|NCT02807857|517073398|FG000|Follow-Up Set|Adverse Event|3|||
143416982|NCT02807857|517073398|FG000|Follow-Up Set|Death|27|||
143416983|NCT02807857|517073398|FG000|Follow-Up Set|Relocation|2|||
143416984|NCT00513071|517073401|FG000|Overall Study|Adverse Event|1|||
143416985|NCT00513071|517073401|FG000|Overall Study|Withdrawal by Subject|1|||
143416986|NCT00513071|517073401|FG000|Overall Study|Physician Decision|3|||
143416987|NCT02326220|517073402|FG000|Double-blind Treatment Period|Adverse Event|1|||
143416988|NCT02326220|517073403|FG001|Double-blind Treatment Period|Adverse Event|2|||
143416989|NCT02326220|517073404|FG002|Double-blind Treatment Period|Adverse Event|0|||
143416990|NCT02326220|517073402|FG000|Double-blind Treatment Period|Protocol Violation|0|||
143416991|NCT02326220|517073403|FG001|Double-blind Treatment Period|Protocol Violation|1|||
143416992|NCT02326220|517073404|FG002|Double-blind Treatment Period|Protocol Violation|0|||
143416993|NCT02326220|517073402|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
143416994|NCT02326220|517073403|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
143416995|NCT02326220|517073404|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
143416996|NCT02326220|517073402|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
143416997|NCT02326220|517073403|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
143416998|NCT02326220|517073404|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
143416999|NCT02326220|517073402|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
143417000|NCT02326220|517073403|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
143417001|NCT02326220|517073404|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
143417002|NCT00667732|517073408|FG000|Run -In (8 Weeks)|Adverse Event|4|||
143417003|NCT00667732|517073409|FG001|Run -In (8 Weeks)|Adverse Event|0|||
143417004|NCT00667732|517073410|FG002|Run -In (8 Weeks)|Adverse Event|0|||
143417005|NCT00667732|517073408|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
143417006|NCT00667732|517073409|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
143417007|NCT00667732|517073410|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
143417008|NCT00667732|517073408|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
143417009|NCT00667732|517073409|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
143417010|NCT00667732|517073410|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
143417011|NCT01240590|517073411|FG000|Phase I|Refused further treatment|0|||
143417012|NCT01240590|517073412|FG001|Phase I|Refused further treatment|0|||
143417013|NCT01240590|517073413|FG002|Phase I|Refused further treatment|3|||
143417014|NCT01240590|517073414|FG003|Phase I|Refused further treatment|0|||
143417015|NCT01240590|517073415|FG004|Phase I|Refused further treatment|0|||
143417016|NCT01240590|517073411|FG000|Phase II|Refused further treatment|0|||
143417017|NCT01240590|517073412|FG001|Phase II|Refused further treatment|0|||
143417018|NCT01240590|517073413|FG002|Phase II|Refused further treatment|0|||
143417019|NCT01240590|517073414|FG003|Phase II|Refused further treatment|2|||
143417020|NCT01240590|517073415|FG004|Phase II|Refused further treatment|1|||
143417021|NCT02659540|517073418|FG000|Overall Study|Adverse Event|3|||
143417022|NCT02659540|517073419|FG001|Overall Study|Adverse Event|2|||
143417023|NCT02659540|517073418|FG000|Overall Study|Death|1|||
143417024|NCT02659540|517073419|FG001|Overall Study|Death|0|||
143417025|NCT02659540|517073418|FG000|Overall Study|Progressive disease|2|||
143417026|NCT02659540|517073419|FG001|Overall Study|Progressive disease|6|||
143417027|NCT02106325|517073422|FG000|Phase 1|Lost to Follow-up|2|||
143417028|NCT02106325|517073423|FG001|Phase 1|Lost to Follow-up|2|||
143417029|NCT02106325|517073422|FG000|Phase 2|Lost to Follow-up|2|||
143417030|NCT02106325|517073423|FG001|Phase 2|Lost to Follow-up|3|||
143417031|NCT02106325|517073422|FG000|Phase 3|Lost to Follow-up|2|||
143417032|NCT02106325|517073423|FG001|Phase 3|Lost to Follow-up|1|||
143417033|NCT00824850|517073425|FG000|Overall Study|Withdrawal by Subject|0|||
143417034|NCT00824850|517073426|FG001|Overall Study|Withdrawal by Subject|1|||
143417035|NCT03242863|517073427|FG000|Study Week 1|Withdrawal by Subject|0|||
143417036|NCT03242863|517073428|FG001|Study Week 1|Withdrawal by Subject|1|||
143417037|NCT03242863|517073429|FG002|Study Week 1|Withdrawal by Subject|0|||
143417038|NCT03242863|517073430|FG003|Study Week 1|Withdrawal by Subject|0|||
143417039|NCT03242863|517073431|FG004|Study Week 1|Withdrawal by Subject|3|||
143417040|NCT03242863|517073432|FG005|Study Week 1|Withdrawal by Subject|0|||
143417041|NCT04820491|517073433|FG000|Overall Study|Withdrawal by Subject|1|||
143417042|NCT04820491|517073434|FG001|Overall Study|Withdrawal by Subject|0|||
143417043|NCT04369664|517075106|FG000|Overall Study|Physician Decision|1|||
143417044|NCT04369664|517075107|FG001|Overall Study|Physician Decision|0|||
143417045|NCT00215943|517075108|FG000|Overall Study|Disease Progression|3|||
143417046|NCT00215943|517075109|FG001|Overall Study|Disease Progression|5|||
143417047|NCT00215943|517075108|FG000|Overall Study|Alternate therapy|0|||
143417048|NCT00215943|517075109|FG001|Overall Study|Alternate therapy|1|||
143417049|NCT00215943|517075108|FG000|Overall Study|Adverse Event|3|||
143417050|NCT00215943|517075109|FG001|Overall Study|Adverse Event|6|||
143417051|NCT00215943|517075108|FG000|Overall Study|Other disease|0|||
143417052|NCT00215943|517075109|FG001|Overall Study|Other disease|1|||
143417053|NCT00215943|517075108|FG000|Overall Study|Other complications|3|||
143417054|NCT00215943|517075109|FG001|Overall Study|Other complications|1|||
143417055|NCT02507297|517075110|FG000|Overall Study|Withdrawal by Subject|1|||
143417056|NCT02507297|517075111|FG001|Overall Study|Withdrawal by Subject|0|||
143417057|NCT02507297|517075110|FG000|Overall Study|Lost to Follow-up|0|||
143417058|NCT02507297|517075111|FG001|Overall Study|Lost to Follow-up|1|||
143417059|NCT04909593|517075112|FG000|Overall Study|Withdrawal by Subject|1|||
143417060|NCT01018992|517075113|FG000|Overall Study|Adverse Event|8|||
143417061|NCT01018992|517075114|FG001|Overall Study|Adverse Event|3|||
143417062|NCT01018992|517075113|FG000|Overall Study|Withdrawal by Subject|3|||
143417063|NCT01018992|517075114|FG001|Overall Study|Withdrawal by Subject|8|||
143417064|NCT01018992|517075113|FG000|Overall Study|Protocol Violation|0|||
143417065|NCT01018992|517075114|FG001|Overall Study|Protocol Violation|4|||
143417066|NCT01018992|517075113|FG000|Overall Study|Lost to Follow-up|5|||
143417067|NCT01018992|517075114|FG001|Overall Study|Lost to Follow-up|1|||
143417068|NCT01825785|517075115|FG000|Overall Study|Adverse Event|0|||
143417069|NCT01825785|517075116|FG001|Overall Study|Adverse Event|0|||
143417070|NCT01825785|517075117|FG002|Overall Study|Adverse Event|0|||
143417071|NCT01825785|517075118|FG003|Overall Study|Adverse Event|0|||
143417072|NCT01825785|517075119|FG004|Overall Study|Adverse Event|1|||
143417073|NCT01825785|517075120|FG005|Overall Study|Adverse Event|0|||
143417074|NCT01825785|517075121|FG006|Overall Study|Adverse Event|0|||
143417075|NCT01825785|517075115|FG000|Overall Study|Withdrawal by Subject|0|||
143417076|NCT01825785|517075116|FG001|Overall Study|Withdrawal by Subject|0|||
143417077|NCT01825785|517075117|FG002|Overall Study|Withdrawal by Subject|0|||
143417078|NCT01825785|517075118|FG003|Overall Study|Withdrawal by Subject|0|||
143417079|NCT01825785|517075119|FG004|Overall Study|Withdrawal by Subject|1|||
143417080|NCT01825785|517075120|FG005|Overall Study|Withdrawal by Subject|1|||
143417081|NCT01825785|517075121|FG006|Overall Study|Withdrawal by Subject|0|||
143417082|NCT01304940|517075123|FG000|Overall Study|not meet symptom severity requirement|3|||
143417083|NCT01304940|517075124|FG001|Overall Study|not meet symptom severity requirement|0|||
143417084|NCT02065895|517075125|FG000|Overall Study|Protocol Violation|1|||
143417085|NCT02065895|517075126|FG001|Overall Study|Protocol Violation|0|||
143417086|NCT02065895|517075127|FG002|Overall Study|Protocol Violation|0|||
143417087|NCT02065895|517075128|FG003|Overall Study|Protocol Violation|1|||
143417088|NCT02065895|517075129|FG004|Overall Study|Protocol Violation|0|||
143417089|NCT02065895|517075130|FG005|Overall Study|Protocol Violation|0|||
143417090|NCT02065895|517075125|FG000|Overall Study|Scheduling conflicts|0|||
143417091|NCT02065895|517075126|FG001|Overall Study|Scheduling conflicts|1|||
143417092|NCT02065895|517075127|FG002|Overall Study|Scheduling conflicts|0|||
143417093|NCT02065895|517075128|FG003|Overall Study|Scheduling conflicts|0|||
143417094|NCT02065895|517075129|FG004|Overall Study|Scheduling conflicts|0|||
143417095|NCT02065895|517075130|FG005|Overall Study|Scheduling conflicts|0|||
143417096|NCT00484198|517075133|FG000|Overall Study|Participant Withdrew Consent|12|||
143417097|NCT00484198|517075134|FG001|Overall Study|Participant Withdrew Consent|21|||
143417098|NCT00484198|517075135|FG002|Overall Study|Participant Withdrew Consent|47|||
143417099|NCT00484198|517075136|FG003|Overall Study|Participant Withdrew Consent|59|||
143417100|NCT00484198|517075133|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
143417101|NCT00484198|517075134|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
143417102|NCT00484198|517075135|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
143417103|NCT00484198|517075136|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
143417104|NCT00484198|517075133|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
143417105|NCT00484198|517075134|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
143417106|NCT00484198|517075135|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
143417107|NCT00484198|517075136|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
143417108|NCT00484198|517075133|FG000|Overall Study|Adverse Event|3|||
143417109|NCT00484198|517075134|FG001|Overall Study|Adverse Event|11|||
143417110|NCT00484198|517075135|FG002|Overall Study|Adverse Event|32|||
143417111|NCT00484198|517075136|FG003|Overall Study|Adverse Event|31|||
143417112|NCT00484198|517075133|FG000|Overall Study|Protocol Violation|0|||
143417113|NCT00484198|517075134|FG001|Overall Study|Protocol Violation|5|||
143417114|NCT00484198|517075135|FG002|Overall Study|Protocol Violation|6|||
143417115|NCT00484198|517075136|FG003|Overall Study|Protocol Violation|8|||
143417116|NCT00484198|517075133|FG000|Overall Study|Other|7|||
143417117|NCT00484198|517075134|FG001|Overall Study|Other|10|||
143417118|NCT00484198|517075135|FG002|Overall Study|Other|31|||
143417119|NCT00484198|517075136|FG003|Overall Study|Other|28|||
143417120|NCT01686152|517075137|FG000|Overall Study|Withdrawal by Subject|11|||
143417121|NCT01686152|517075138|FG001|Overall Study|Withdrawal by Subject|11|||
143417122|NCT01686152|517075139|FG002|Overall Study|Withdrawal by Subject|3|||
143417123|NCT01686152|517075137|FG000|Overall Study|Drug Code Unblinded|0|||
143417124|NCT01686152|517075138|FG001|Overall Study|Drug Code Unblinded|1|||
143417125|NCT01686152|517075139|FG002|Overall Study|Drug Code Unblinded|0|||
143417126|NCT01686152|517075137|FG000|Overall Study|Protocol Violation|6|||
143417127|NCT01686152|517075138|FG001|Overall Study|Protocol Violation|1|||
143417128|NCT01686152|517075139|FG002|Overall Study|Protocol Violation|0|||
143417129|NCT01686152|517075137|FG000|Overall Study|Adverse Event|12|||
143417130|NCT01686152|517075138|FG001|Overall Study|Adverse Event|11|||
143417131|NCT01686152|517075139|FG002|Overall Study|Adverse Event|0|||
143417132|NCT01686152|517075137|FG000|Overall Study|Lack of Efficacy|0|||
143417133|NCT01686152|517075138|FG001|Overall Study|Lack of Efficacy|0|||
143417134|NCT01686152|517075139|FG002|Overall Study|Lack of Efficacy|1|||
143417135|NCT01686152|517075137|FG000|Overall Study|IP Non-compliance|5|||
143417136|NCT01686152|517075138|FG001|Overall Study|IP Non-compliance|5|||
143417137|NCT01686152|517075139|FG002|Overall Study|IP Non-compliance|0|||
143417138|NCT01686152|517075137|FG000|Overall Study|Lost to Follow-up|7|||
143417139|NCT01686152|517075138|FG001|Overall Study|Lost to Follow-up|6|||
143417140|NCT01686152|517075139|FG002|Overall Study|Lost to Follow-up|5|||
143417141|NCT01853384|517075140|FG000|Randomized|Adverse Event|5|||
143417142|NCT01853384|517075141|FG001|Randomized|Adverse Event|3|||
143417143|NCT01853384|517075140|FG000|Randomized|Death|1|||
143417144|NCT01853384|517075141|FG001|Randomized|Death|2|||
143417145|NCT01853384|517075140|FG000|Randomized|Lost to Follow-up|1|||
143417146|NCT01853384|517075141|FG001|Randomized|Lost to Follow-up|1|||
143417147|NCT01853384|517075140|FG000|Randomized|Withdrawal by Subject|5|||
143417148|NCT01853384|517075141|FG001|Randomized|Withdrawal by Subject|3|||
143417149|NCT01853384|517075140|FG000|Randomized|Sponsor Decision|47|||
143417150|NCT01853384|517075141|FG001|Randomized|Sponsor Decision|34|||
143417151|NCT01853384|517075140|FG000|Randomized|Other|3|||
143417152|NCT01853384|517075141|FG001|Randomized|Other|3|||
143417153|NCT01853384|517075140|FG000|Completed Follow up Visit 1|Early Termination|13|||
143417154|NCT01853384|517075141|FG001|Completed Follow up Visit 1|Early Termination|9|||
143417155|NCT01853384|517075140|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
143417156|NCT01853384|517075141|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
143417157|NCT01853384|517075140|FG000|Completed Follow up Visit 2|Adverse Event|1|||
143417158|NCT01853384|517075141|FG001|Completed Follow up Visit 2|Adverse Event|0|||
143417159|NCT01853384|517075140|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
143417160|NCT01853384|517075141|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
143417161|NCT01853384|517075140|FG000|Completed Follow up Visit 2|Death|1|||
143417162|NCT01853384|517075141|FG001|Completed Follow up Visit 2|Death|0|||
143417163|NCT01853384|517075140|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
143417164|NCT01853384|517075141|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
143417165|NCT01205126|517075142|FG000|Titration Phase|Adverse Event|5|||
143417166|NCT01205126|517075143|FG001|Titration Phase|Adverse Event|3|||
143417167|NCT01205126|517075142|FG000|Titration Phase|Withdrawal by Subject|5|||
143417168|NCT01205126|517075143|FG001|Titration Phase|Withdrawal by Subject|5|||
143417169|NCT01205126|517075142|FG000|Titration Phase|Lost to Follow-up|2|||
143417170|NCT01205126|517075143|FG001|Titration Phase|Lost to Follow-up|2|||
143417171|NCT01205126|517075142|FG000|Titration Phase|No stable titration dose|1|||
143417172|NCT01205126|517075143|FG001|Titration Phase|No stable titration dose|0|||
143417173|NCT01205126|517075142|FG000|Titration Phase|More than maximum dosage required|2|||
143417174|NCT01205126|517075143|FG001|Titration Phase|More than maximum dosage required|3|||
143417175|NCT01205126|517075142|FG000|Titration Phase|Other|8|||
143417176|NCT01205126|517075143|FG001|Titration Phase|Other|6|||
143417177|NCT01205126|517075142|FG000|Between Titration & Maintenance Phase|Other|0|||
143417178|NCT01205126|517075143|FG001|Between Titration & Maintenance Phase|Other|4|||
143417179|NCT01205126|517075142|FG000|Maintenance Phase|Adverse Event|3|||
143417180|NCT01205126|517075143|FG001|Maintenance Phase|Adverse Event|7|||
143417181|NCT01205126|517075142|FG000|Maintenance Phase|Death|4|||
143417182|NCT01205126|517075143|FG001|Maintenance Phase|Death|4|||
143417183|NCT01205126|517075142|FG000|Maintenance Phase|More than the maximum dosage required|5|||
143417184|NCT01205126|517075143|FG001|Maintenance Phase|More than the maximum dosage required|5|||
143417185|NCT01205126|517075142|FG000|Maintenance Phase|Prohibited drugs used|1|||
143417186|NCT01205126|517075143|FG001|Maintenance Phase|Prohibited drugs used|0|||
143417187|NCT01205126|517075142|FG000|Maintenance Phase|Other|11|||
143417188|NCT01205126|517075143|FG001|Maintenance Phase|Other|8|||
143417189|NCT01205126|517075142|FG000|Maintenance Phase|Lost to Follow-up|5|||
143417190|NCT01205126|517075143|FG001|Maintenance Phase|Lost to Follow-up|5|||
143417191|NCT01205126|517075142|FG000|Maintenance Phase|Withdrawal by Subject|8|||
143417192|NCT01205126|517075143|FG001|Maintenance Phase|Withdrawal by Subject|11|||
143417193|NCT00403845|517075146|FG000|Treatment Period 1|Subject withdrew consent|1|||
143417194|NCT00403845|517075147|FG001|Treatment Period 1|Subject withdrew consent|0|||
143417195|NCT00403845|517075148|FG002|Treatment Period 1|Subject withdrew consent|0|||
143417196|NCT00403845|517075149|FG003|Treatment Period 1|Subject withdrew consent|0|||
143417197|NCT00403845|517075146|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
143417198|NCT00403845|517075147|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
143417199|NCT00403845|517075148|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
143417200|NCT00403845|517075149|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
143417201|NCT00403845|517075146|FG000|Treatment Period 2|Subject withdrew consent|1|||
143417202|NCT00403845|517075147|FG001|Treatment Period 2|Subject withdrew consent|0|||
143417203|NCT00403845|517075148|FG002|Treatment Period 2|Subject withdrew consent|0|||
143417204|NCT00403845|517075149|FG003|Treatment Period 2|Subject withdrew consent|0|||
143417205|NCT00403845|517075146|FG000|Treatment Period 3|Subject withdrew consent|0|||
143417206|NCT00403845|517075147|FG001|Treatment Period 3|Subject withdrew consent|0|||
143417207|NCT00403845|517075148|FG002|Treatment Period 3|Subject withdrew consent|0|||
143417208|NCT00403845|517075149|FG003|Treatment Period 3|Subject withdrew consent|1|||
143417209|NCT00403845|517075146|FG000|Treatment Period 3|Adverse Event|0|||
143417210|NCT00403845|517075147|FG001|Treatment Period 3|Adverse Event|0|||
143417211|NCT00403845|517075148|FG002|Treatment Period 3|Adverse Event|0|||
143417212|NCT00403845|517075149|FG003|Treatment Period 3|Adverse Event|1|||
143417213|NCT00805792|517075150|FG000|Overall Study|Death|3|||
143417214|NCT00805792|517075150|FG000|Overall Study|Lost to Follow-up|2|||
143417215|NCT04328467|517075158|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
143417216|NCT04328467|517075159|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
143417217|NCT04328467|517075160|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
143417218|NCT01655498|517075161|FG000|Overall Study|Unrelated health issue|2|||
143417219|NCT01655498|517075161|FG000|Overall Study|Protocol Violation|2|||
143417220|NCT01655498|517075161|FG000|Overall Study|Withdrawal by Subject|1|||
143417221|NCT00624377|517075162|FG000|Overall Study|Lost to Follow-up|355|||
143417222|NCT00624377|517075162|FG000|Overall Study|Withdrawal by Subject|100|||
143417223|NCT00624377|517075162|FG000|Overall Study|Adverse Event|14|||
143417224|NCT00624377|517075162|FG000|Overall Study|Other|91|||
143417225|NCT00624377|517075162|FG000|Overall Study|Non-evaluable population|84|||
143417226|NCT00923078|517075166|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
143417227|NCT00923078|517075167|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
143417228|NCT00923078|517075168|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
143417229|NCT00923078|517075166|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
143417230|NCT00923078|517075167|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
143417231|NCT00923078|517075168|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
143417232|NCT01393600|517075169|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
143417233|NCT01393600|517075170|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
143417234|NCT01393600|517075171|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
143417235|NCT01393600|517075172|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
143417236|NCT01393600|517075169|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
143417237|NCT01393600|517075170|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
143417238|NCT01393600|517075171|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
143417239|NCT01393600|517075172|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
143417240|NCT01393600|517075169|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
143417241|NCT01393600|517075170|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
143417242|NCT01393600|517075171|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
143417243|NCT01393600|517075172|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
143417244|NCT01393600|517075169|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
143417245|NCT01393600|517075170|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
143417246|NCT01393600|517075171|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
143417247|NCT01393600|517075172|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
143417248|NCT01393600|517075169|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
143417249|NCT01393600|517075170|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
143417250|NCT01393600|517075171|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
143417251|NCT01393600|517075172|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
143417252|NCT01393600|517075169|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
143417253|NCT01393600|517075170|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
143417254|NCT01393600|517075171|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
143417255|NCT01393600|517075172|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
143417256|NCT01393600|517075169|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
143417257|NCT01393600|517075170|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
143417258|NCT01393600|517075171|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
143417259|NCT01393600|517075172|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
143417260|NCT01072149|517075173|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
143417261|NCT01072149|517075174|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
143417262|NCT01072149|517075175|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
143417263|NCT01072149|517075176|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
143417264|NCT01072149|517075177|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
143417265|NCT01072149|517075178|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
143417266|NCT01072149|517075179|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
143417267|NCT01072149|517075180|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
143417268|NCT01072149|517075181|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
143417269|NCT01072149|517075182|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
143417270|NCT01072149|517075183|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
143417271|NCT01072149|517075184|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
143417272|NCT01072149|517075185|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
143417273|NCT01072149|517075186|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
143417274|NCT01072149|517075187|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
143417275|NCT01072149|517075188|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
143417276|NCT01072149|517075189|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
143417277|NCT01072149|517075190|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
143417278|NCT01072149|517075173|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
143417279|NCT01072149|517075174|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
143417280|NCT01072149|517075175|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
143417281|NCT01072149|517075176|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
143417282|NCT01072149|517075177|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
143417283|NCT01072149|517075178|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
143417284|NCT01072149|517075179|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
143417285|NCT01072149|517075180|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
143417286|NCT01072149|517075181|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
143417287|NCT01072149|517075182|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
143417288|NCT01072149|517075183|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
143417289|NCT01072149|517075184|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
143417290|NCT01072149|517075185|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
143417291|NCT01072149|517075186|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
143417292|NCT01072149|517075187|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
143417293|NCT01072149|517075188|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
143417294|NCT01072149|517075189|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
143417295|NCT01072149|517075190|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
143417296|NCT01072149|517075173|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
143417297|NCT01072149|517075174|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
143417298|NCT01072149|517075175|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
143417299|NCT01072149|517075176|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
143417300|NCT01072149|517075177|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
143417301|NCT01072149|517075178|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
143417302|NCT01072149|517075179|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
143417303|NCT01072149|517075180|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
143417304|NCT01072149|517075181|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
143417305|NCT01072149|517075182|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
143417306|NCT01072149|517075183|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
143417307|NCT01072149|517075184|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
143417308|NCT01072149|517075185|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
143417309|NCT01072149|517075186|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
143417310|NCT01072149|517075187|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
143417311|NCT01072149|517075188|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
143417312|NCT01072149|517075189|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
143417313|NCT01072149|517075190|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
143417314|NCT01072149|517075173|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
143417315|NCT01072149|517075174|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
143417316|NCT01072149|517075175|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
143417317|NCT01072149|517075176|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
143417318|NCT01072149|517075177|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
143417319|NCT01072149|517075178|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
143417320|NCT01072149|517075179|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
143417321|NCT01072149|517075180|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
143417322|NCT01072149|517075181|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
143417323|NCT01072149|517075182|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
143417324|NCT01072149|517075183|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
143417325|NCT01072149|517075184|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
143417326|NCT01072149|517075185|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
143417327|NCT01072149|517075186|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
143417328|NCT01072149|517075187|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
143417329|NCT01072149|517075188|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
143417330|NCT01072149|517075189|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
143417331|NCT01072149|517075190|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
143417332|NCT01072149|517075173|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
143417333|NCT01072149|517075174|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
143417334|NCT01072149|517075175|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
143417335|NCT01072149|517075176|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
143417336|NCT01072149|517075177|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
143417337|NCT01072149|517075178|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
143417338|NCT01072149|517075179|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
143417339|NCT01072149|517075180|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
143417340|NCT01072149|517075181|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
143417341|NCT01072149|517075182|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
143417342|NCT01072149|517075183|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
143417343|NCT01072149|517075184|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
143417344|NCT01072149|517075185|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
143417345|NCT01072149|517075186|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
143417346|NCT01072149|517075187|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
143417347|NCT01072149|517075188|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
143417348|NCT01072149|517075189|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
143417349|NCT01072149|517075190|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
143417350|NCT01072149|517075173|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
143417351|NCT01072149|517075174|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
143417352|NCT01072149|517075175|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
143417353|NCT01072149|517075176|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
143417354|NCT01072149|517075177|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
143417355|NCT01072149|517075178|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
143417356|NCT01072149|517075179|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
143417357|NCT01072149|517075180|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
143417358|NCT01072149|517075181|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
143417359|NCT01072149|517075182|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
143417360|NCT01072149|517075183|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
143417361|NCT01072149|517075184|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
143417362|NCT01072149|517075185|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
143417363|NCT01072149|517075186|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
143417364|NCT01072149|517075187|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
143417365|NCT01072149|517075188|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
143417366|NCT01072149|517075189|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
143417367|NCT01072149|517075190|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
143417368|NCT01072149|517075173|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
143417369|NCT01072149|517075174|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
143417370|NCT01072149|517075175|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
143417371|NCT01072149|517075176|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
143417372|NCT01072149|517075177|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
143417373|NCT01072149|517075178|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
143417374|NCT01072149|517075179|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
143417375|NCT01072149|517075180|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
143417376|NCT01072149|517075181|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
143417377|NCT01072149|517075182|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
143417378|NCT01072149|517075183|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
143417379|NCT01072149|517075184|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
143417380|NCT01072149|517075185|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
143417381|NCT01072149|517075186|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
143417382|NCT01072149|517075187|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
143417383|NCT01072149|517075188|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
143417384|NCT01072149|517075189|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
143417385|NCT01072149|517075190|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
143417386|NCT01072149|517075173|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
143417387|NCT01072149|517075174|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
143417388|NCT01072149|517075175|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
143417389|NCT01072149|517075176|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
143417390|NCT01072149|517075177|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
143417391|NCT01072149|517075178|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
143417392|NCT01072149|517075179|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
143417393|NCT01072149|517075180|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
143417394|NCT01072149|517075181|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
143417395|NCT01072149|517075182|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
143417396|NCT01072149|517075183|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
143417397|NCT01072149|517075184|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
143417398|NCT01072149|517075185|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
143417399|NCT01072149|517075186|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
143417400|NCT01072149|517075187|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
143417401|NCT01072149|517075188|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
143417402|NCT01072149|517075189|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
143417403|NCT01072149|517075190|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
143417404|NCT01072149|517075173|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
143417405|NCT01072149|517075174|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
143417406|NCT01072149|517075175|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
143417407|NCT01072149|517075176|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
143417408|NCT01072149|517075177|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
143417409|NCT01072149|517075178|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
143417410|NCT01072149|517075179|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
143417411|NCT01072149|517075180|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
143417412|NCT01072149|517075181|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
143417413|NCT01072149|517075182|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
143417414|NCT01072149|517075183|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
143417415|NCT01072149|517075184|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
143417416|NCT01072149|517075185|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
143417417|NCT01072149|517075186|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
143417418|NCT01072149|517075187|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
143417419|NCT01072149|517075188|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
143417420|NCT01072149|517075189|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
143417421|NCT01072149|517075190|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
143417422|NCT01072149|517075173|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
143417423|NCT01072149|517075174|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
143417424|NCT01072149|517075175|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
143417425|NCT01072149|517075176|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
143417426|NCT01072149|517075177|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
143417427|NCT01072149|517075178|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
143417428|NCT01072149|517075179|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
143417429|NCT01072149|517075180|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
143417430|NCT01072149|517075181|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
143417431|NCT01072149|517075182|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
143417432|NCT01072149|517075183|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
143417433|NCT01072149|517075184|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
143417434|NCT01072149|517075185|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
143417435|NCT01072149|517075186|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
143417436|NCT01072149|517075187|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
143417437|NCT01072149|517075188|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
143417438|NCT01072149|517075189|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
143417439|NCT01072149|517075190|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
143417440|NCT01072149|517075173|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
143417441|NCT01072149|517075174|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
143417442|NCT01072149|517075175|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
143417443|NCT01072149|517075176|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
143417444|NCT01072149|517075177|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
143417445|NCT01072149|517075178|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
143417446|NCT01072149|517075179|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
143417447|NCT01072149|517075180|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
143417448|NCT01072149|517075181|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
143417449|NCT01072149|517075182|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
143417450|NCT01072149|517075183|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
143417451|NCT01072149|517075184|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
143417452|NCT01072149|517075185|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
143417453|NCT01072149|517075186|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
143417454|NCT01072149|517075187|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
143417455|NCT01072149|517075188|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
143417456|NCT01072149|517075189|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
143417457|NCT01072149|517075190|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
143417458|NCT02784834|517075191|FG000|Overall Study|Lack of Efficacy|1|||
143417459|NCT02143713|517075192|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
143417460|NCT02143713|517075193|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
143417461|NCT02143713|517075194|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
143417462|NCT02143713|517075195|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
143417463|NCT02143713|517075192|FG000|Treatment Period (6 Months)|Adverse Event|7|||
143417464|NCT02143713|517075193|FG001|Treatment Period (6 Months)|Adverse Event|8|||
143417465|NCT02143713|517075194|FG002|Treatment Period (6 Months)|Adverse Event|8|||
143417466|NCT02143713|517075195|FG003|Treatment Period (6 Months)|Adverse Event|9|||
143417467|NCT02143713|517075192|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
143417468|NCT02143713|517075193|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
143417469|NCT02143713|517075194|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
143417470|NCT02143713|517075195|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
143417471|NCT02143713|517075192|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
143417472|NCT02143713|517075193|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
143417473|NCT02143713|517075194|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
143417474|NCT02143713|517075195|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
143417475|NCT02143713|517075192|FG000|Treatment Period (6 Months)|Pregnancy|0|||
143417476|NCT02143713|517075193|FG001|Treatment Period (6 Months)|Pregnancy|2|||
143417477|NCT02143713|517075194|FG002|Treatment Period (6 Months)|Pregnancy|2|||
143417478|NCT02143713|517075195|FG003|Treatment Period (6 Months)|Pregnancy|0|||
143417479|NCT02143713|517075192|FG000|Treatment Period (6 Months)|Non-compliance|1|||
143417480|NCT02143713|517075193|FG001|Treatment Period (6 Months)|Non-compliance|0|||
143417481|NCT02143713|517075194|FG002|Treatment Period (6 Months)|Non-compliance|0|||
143417482|NCT02143713|517075195|FG003|Treatment Period (6 Months)|Non-compliance|3|||
143417483|NCT02143713|517075192|FG000|Treatment Period (6 Months)|Other|3|||
143417484|NCT02143713|517075193|FG001|Treatment Period (6 Months)|Other|0|||
143417485|NCT02143713|517075194|FG002|Treatment Period (6 Months)|Other|3|||
143417486|NCT02143713|517075195|FG003|Treatment Period (6 Months)|Other|2|||
143417487|NCT02143713|517075192|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
143417488|NCT02143713|517075193|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
143417489|NCT02143713|517075194|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
143417490|NCT02143713|517075195|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
143417491|NCT02143713|517075192|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
143417492|NCT02143713|517075193|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
143417493|NCT02143713|517075194|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
143417494|NCT02143713|517075195|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
143417495|NCT02143713|517075192|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
143417496|NCT02143713|517075193|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
143417497|NCT02143713|517075194|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
143417498|NCT02143713|517075195|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
143417499|NCT02143713|517075192|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
143417500|NCT02143713|517075193|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
143417501|NCT02143713|517075194|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
143417502|NCT02143713|517075195|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
143417503|NCT02143713|517075192|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
143417504|NCT02143713|517075193|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
143417505|NCT02143713|517075194|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
143417506|NCT02143713|517075195|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
143417507|NCT02143713|517075192|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
143417508|NCT02143713|517075193|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
143417509|NCT02143713|517075194|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
143417510|NCT02143713|517075195|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
143417511|NCT02143713|517075192|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
143417512|NCT02143713|517075193|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
143417513|NCT02143713|517075194|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
143417514|NCT02143713|517075195|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
143417515|NCT02143713|517075192|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
143417516|NCT02143713|517075193|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
143417517|NCT02143713|517075194|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
143417518|NCT02143713|517075195|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
143417519|NCT02143713|517075192|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
143417520|NCT02143713|517075193|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
143417521|NCT02143713|517075194|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
143417522|NCT02143713|517075195|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
143417523|NCT01768572|517075196|FG000|Overall Study|Adverse Event|7|||
143417524|NCT01768572|517075197|FG001|Overall Study|Adverse Event|8|||
143417525|NCT01768572|517075198|FG002|Overall Study|Adverse Event|4|||
143417526|NCT01768572|517075196|FG000|Overall Study|Lack of Efficacy|1|||
143417527|NCT01768572|517075197|FG001|Overall Study|Lack of Efficacy|3|||
143417528|NCT01768572|517075198|FG002|Overall Study|Lack of Efficacy|1|||
143417529|NCT01768572|517075196|FG000|Overall Study|Other, Not due to an adverse event|1|||
143417530|NCT01768572|517075197|FG001|Overall Study|Other, Not due to an adverse event|1|||
143417531|NCT01768572|517075198|FG002|Overall Study|Other, Not due to an adverse event|1|||
143417532|NCT04766996|517075201|FG000|Overall Study|Withdrawal by Subject|1|||
143417533|NCT04766996|517075202|FG001|Overall Study|Withdrawal by Subject|0|||
143417534|NCT04766996|517075203|FG002|Overall Study|Withdrawal by Subject|13|||
143417535|NCT02404441|517075207|FG000|Phase 1 Part|Adverse Event|1|||
143417536|NCT02404441|517075208|FG001|Phase 1 Part|Adverse Event|0|||
143417537|NCT02404441|517075209|FG002|Phase 1 Part|Adverse Event|0|||
143417538|NCT02404441|517075210|FG003|Phase 1 Part|Adverse Event|0|||
143417539|NCT02404441|517075211|FG004|Phase 1 Part|Adverse Event|0|||
143417540|NCT02404441|517075212|FG005|Phase 1 Part|Adverse Event|0|||
143417541|NCT02404441|517075213|FG006|Phase 1 Part|Adverse Event|0|||
143417542|NCT02404441|517075214|FG007|Phase 1 Part|Adverse Event|0|||
143417543|NCT02404441|517075215|FG008|Phase 1 Part|Adverse Event|0|||
143417544|NCT02404441|517075216|FG009|Phase 1 Part|Adverse Event|0|||
143417545|NCT02404441|517075207|FG000|Phase 1 Part|Physician Decision|0|||
143417546|NCT02404441|517075208|FG001|Phase 1 Part|Physician Decision|1|||
143417547|NCT02404441|517075209|FG002|Phase 1 Part|Physician Decision|0|||
143417548|NCT02404441|517075210|FG003|Phase 1 Part|Physician Decision|0|||
143417549|NCT02404441|517075211|FG004|Phase 1 Part|Physician Decision|0|||
143417550|NCT02404441|517075212|FG005|Phase 1 Part|Physician Decision|0|||
143417551|NCT02404441|517075213|FG006|Phase 1 Part|Physician Decision|0|||
143417552|NCT02404441|517075214|FG007|Phase 1 Part|Physician Decision|0|||
143417553|NCT02404441|517075215|FG008|Phase 1 Part|Physician Decision|0|||
143417554|NCT02404441|517075216|FG009|Phase 1 Part|Physician Decision|0|||
143417555|NCT02404441|517075207|FG000|Phase 1 Part|Progressive Disease|14|||
143417556|NCT02404441|517075208|FG001|Phase 1 Part|Progressive Disease|11|||
143417557|NCT02404441|517075209|FG002|Phase 1 Part|Progressive Disease|7|||
143417558|NCT02404441|517075210|FG003|Phase 1 Part|Progressive Disease|6|||
143417559|NCT02404441|517075211|FG004|Phase 1 Part|Progressive Disease|9|||
143417560|NCT02404441|517075212|FG005|Phase 1 Part|Progressive Disease|0|||
143417561|NCT02404441|517075213|FG006|Phase 1 Part|Progressive Disease|0|||
143417562|NCT02404441|517075214|FG007|Phase 1 Part|Progressive Disease|0|||
143417563|NCT02404441|517075215|FG008|Phase 1 Part|Progressive Disease|0|||
143417564|NCT02404441|517075216|FG009|Phase 1 Part|Progressive Disease|0|||
143417565|NCT02404441|517075207|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
143417566|NCT02404441|517075208|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
143417567|NCT02404441|517075209|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
143417568|NCT02404441|517075210|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
143417569|NCT02404441|517075211|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
143417570|NCT02404441|517075212|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
143417571|NCT02404441|517075213|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
143417572|NCT02404441|517075214|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
143417573|NCT02404441|517075215|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
143417574|NCT02404441|517075216|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
143417575|NCT02404441|517075207|FG000|Phase 1 Part|Death|1|||
143417576|NCT02404441|517075208|FG001|Phase 1 Part|Death|1|||
143417577|NCT02404441|517075209|FG002|Phase 1 Part|Death|1|||
143417578|NCT02404441|517075210|FG003|Phase 1 Part|Death|0|||
143417579|NCT02404441|517075211|FG004|Phase 1 Part|Death|1|||
143417580|NCT02404441|517075212|FG005|Phase 1 Part|Death|0|||
143417581|NCT02404441|517075213|FG006|Phase 1 Part|Death|0|||
143417582|NCT02404441|517075214|FG007|Phase 1 Part|Death|0|||
143417583|NCT02404441|517075215|FG008|Phase 1 Part|Death|0|||
143417584|NCT02404441|517075216|FG009|Phase 1 Part|Death|0|||
143417585|NCT02404441|517075207|FG000|Phase 2 Part|Adverse Event|0|||
143417586|NCT02404441|517075208|FG001|Phase 2 Part|Adverse Event|0|||
143417587|NCT02404441|517075209|FG002|Phase 2 Part|Adverse Event|0|||
143417588|NCT02404441|517075210|FG003|Phase 2 Part|Adverse Event|0|||
143417589|NCT02404441|517075211|FG004|Phase 2 Part|Adverse Event|0|||
143417590|NCT02404441|517075212|FG005|Phase 2 Part|Adverse Event|2|||
143417591|NCT02404441|517075213|FG006|Phase 2 Part|Adverse Event|3|||
143417592|NCT02404441|517075214|FG007|Phase 2 Part|Adverse Event|3|||
143417593|NCT02404441|517075215|FG008|Phase 2 Part|Adverse Event|6|||
143417594|NCT02404441|517075216|FG009|Phase 2 Part|Adverse Event|1|||
143417595|NCT02404441|517075207|FG000|Phase 2 Part|Physician Decision|0|||
143417596|NCT02404441|517075208|FG001|Phase 2 Part|Physician Decision|0|||
143417597|NCT02404441|517075209|FG002|Phase 2 Part|Physician Decision|0|||
143417598|NCT02404441|517075210|FG003|Phase 2 Part|Physician Decision|0|||
143417599|NCT02404441|517075211|FG004|Phase 2 Part|Physician Decision|0|||
143417600|NCT02404441|517075212|FG005|Phase 2 Part|Physician Decision|7|||
143417601|NCT02404441|517075213|FG006|Phase 2 Part|Physician Decision|9|||
143417602|NCT02404441|517075214|FG007|Phase 2 Part|Physician Decision|2|||
143417603|NCT02404441|517075215|FG008|Phase 2 Part|Physician Decision|1|||
143417604|NCT02404441|517075216|FG009|Phase 2 Part|Physician Decision|3|||
143417605|NCT02404441|517075207|FG000|Phase 2 Part|Progressive disease|0|||
143417606|NCT02404441|517075208|FG001|Phase 2 Part|Progressive disease|0|||
143417607|NCT02404441|517075209|FG002|Phase 2 Part|Progressive disease|0|||
143417608|NCT02404441|517075210|FG003|Phase 2 Part|Progressive disease|0|||
143417609|NCT02404441|517075211|FG004|Phase 2 Part|Progressive disease|0|||
143417610|NCT02404441|517075212|FG005|Phase 2 Part|Progressive disease|43|||
143417611|NCT02404441|517075213|FG006|Phase 2 Part|Progressive disease|32|||
143417612|NCT02404441|517075214|FG007|Phase 2 Part|Progressive disease|31|||
143417613|NCT02404441|517075215|FG008|Phase 2 Part|Progressive disease|39|||
143417614|NCT02404441|517075216|FG009|Phase 2 Part|Progressive disease|27|||
143417615|NCT02404441|517075207|FG000|Phase 2 Part|Subject/guardian decision|0|||
143417616|NCT02404441|517075208|FG001|Phase 2 Part|Subject/guardian decision|0|||
143417617|NCT02404441|517075209|FG002|Phase 2 Part|Subject/guardian decision|0|||
143417618|NCT02404441|517075210|FG003|Phase 2 Part|Subject/guardian decision|0|||
143417619|NCT02404441|517075211|FG004|Phase 2 Part|Subject/guardian decision|0|||
143417620|NCT02404441|517075212|FG005|Phase 2 Part|Subject/guardian decision|3|||
143417621|NCT02404441|517075213|FG006|Phase 2 Part|Subject/guardian decision|9|||
143417622|NCT02404441|517075214|FG007|Phase 2 Part|Subject/guardian decision|0|||
143417623|NCT02404441|517075215|FG008|Phase 2 Part|Subject/guardian decision|3|||
143417624|NCT02404441|517075216|FG009|Phase 2 Part|Subject/guardian decision|2|||
143417625|NCT02404441|517075207|FG000|Phase 2 Part|Death|0|||
143417626|NCT02404441|517075208|FG001|Phase 2 Part|Death|0|||
143417627|NCT02404441|517075209|FG002|Phase 2 Part|Death|0|||
143417628|NCT02404441|517075210|FG003|Phase 2 Part|Death|0|||
143417629|NCT02404441|517075211|FG004|Phase 2 Part|Death|0|||
143417630|NCT02404441|517075212|FG005|Phase 2 Part|Death|4|||
143417631|NCT02404441|517075213|FG006|Phase 2 Part|Death|8|||
143417632|NCT02404441|517075214|FG007|Phase 2 Part|Death|4|||
143417633|NCT02404441|517075215|FG008|Phase 2 Part|Death|10|||
143417634|NCT02404441|517075216|FG009|Phase 2 Part|Death|9|||
143417635|NCT03265132|517075217|FG000|Overall Study|Adverse Event|0|||
143417636|NCT03265132|517075218|FG001|Overall Study|Adverse Event|1|||
143417637|NCT03265132|517075217|FG000|Overall Study|Lack of Efficacy|0|||
143417638|NCT03265132|517075218|FG001|Overall Study|Lack of Efficacy|2|||
143417639|NCT03265132|517075217|FG000|Overall Study|Progressive disease|0|||
143417640|NCT03265132|517075218|FG001|Overall Study|Progressive disease|2|||
143417641|NCT03265132|517075217|FG000|Overall Study|Withdrawal by Subject|0|||
143417642|NCT03265132|517075218|FG001|Overall Study|Withdrawal by Subject|1|||
143417643|NCT01976507|517075222|FG000|Overall Study|Adverse Event|6|||
143417644|NCT01976507|517075222|FG000|Overall Study|ablation not done, drug not given|1|||
143417645|NCT01794299|517075224|FG000|Overall Study|ATIR manufacturing not possible|1|||
143417646|NCT01794299|517075224|FG000|Overall Study|Death|14|||
143417647|NCT01794299|517075224|FG000|Overall Study|Graft failure|1|||
143417648|NCT01794299|517075224|FG000|Overall Study|ATIR batch rejected|2|||
143417649|NCT01794299|517075224|FG000|Overall Study|Relapse|2|||
143417650|NCT01794299|517075224|FG000|Overall Study|Discontinued from active follow-up|1|||
143417651|NCT01794299|517075224|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
143417652|NCT03006393|517075225|FG000|Overall Study|Withdrawal by Subject|1|||
143417653|NCT03006393|517075226|FG001|Overall Study|Withdrawal by Subject|1|||
143417654|NCT03006393|517075225|FG000|Overall Study|Pregnancy|0|||
143417655|NCT03006393|517075226|FG001|Overall Study|Pregnancy|1|||
143417656|NCT03006393|517075225|FG000|Overall Study|Lost to Follow-up|0|||
143417657|NCT03006393|517075226|FG001|Overall Study|Lost to Follow-up|1|||
143417658|NCT02161458|517075227|FG000|Overall Study|Withdrawal by Subject|0|||
143417659|NCT02161458|517075228|FG001|Overall Study|Withdrawal by Subject|4|||
143417660|NCT02161458|517075229|FG002|Overall Study|Withdrawal by Subject|4|||
143417661|NCT02161458|517075230|FG003|Overall Study|Withdrawal by Subject|0|||
143417662|NCT02161458|517075227|FG000|Overall Study|Lost to Follow-up|0|||
143417663|NCT02161458|517075228|FG001|Overall Study|Lost to Follow-up|2|||
143417664|NCT02161458|517075229|FG002|Overall Study|Lost to Follow-up|1|||
143417665|NCT02161458|517075230|FG003|Overall Study|Lost to Follow-up|0|||
143417666|NCT03136861|517075234|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
143417667|NCT03136861|517075235|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
143417668|NCT03136861|517075236|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
143417669|NCT03136861|517075237|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
143417670|NCT03136861|517075238|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
143417671|NCT03136861|517075239|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
143417672|NCT03136861|517075240|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
143417673|NCT03136861|517075234|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
143417674|NCT03136861|517075235|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
143417675|NCT03136861|517075236|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
143417676|NCT03136861|517075237|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
143417677|NCT03136861|517075238|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
143417678|NCT03136861|517075239|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
143417679|NCT03136861|517075240|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
143417680|NCT03136861|517075234|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
143417681|NCT03136861|517075235|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
143417682|NCT03136861|517075236|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
143417683|NCT03136861|517075237|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
143417684|NCT03136861|517075238|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
143417685|NCT03136861|517075239|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
143417686|NCT03136861|517075240|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
143417687|NCT03136861|517075234|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
143417688|NCT03136861|517075235|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
143417689|NCT03136861|517075236|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
143417690|NCT03136861|517075237|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
143417691|NCT03136861|517075238|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
143417692|NCT03136861|517075239|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
143417693|NCT03136861|517075240|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
143417694|NCT03136861|517075234|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
143417695|NCT03136861|517075235|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
143417696|NCT03136861|517075236|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
143417697|NCT03136861|517075237|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
143417698|NCT03136861|517075238|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
143417699|NCT03136861|517075239|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
143417700|NCT03136861|517075240|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
143417701|NCT03136861|517075234|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
143417702|NCT03136861|517075235|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
143417703|NCT03136861|517075236|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
143417704|NCT03136861|517075237|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
143417705|NCT03136861|517075238|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
143417706|NCT03136861|517075239|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
143417707|NCT03136861|517075240|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
143417708|NCT03136861|517075234|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
143417709|NCT03136861|517075235|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
143417710|NCT03136861|517075236|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
143417711|NCT03136861|517075237|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
143417712|NCT03136861|517075238|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
143417713|NCT03136861|517075239|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
143417714|NCT03136861|517075240|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
143417715|NCT03136861|517075234|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
143417716|NCT03136861|517075235|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
143417717|NCT03136861|517075236|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
143417718|NCT03136861|517075237|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
143417719|NCT03136861|517075238|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
143417720|NCT03136861|517075239|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
143417721|NCT03136861|517075240|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
143417722|NCT03390166|517075241|FG000|Overall Study|Death|0|||
143417723|NCT03390166|517075242|FG001|Overall Study|Death|1|||
143417724|NCT03390166|517075241|FG000|Overall Study|Lost to Follow-up|6|||
143417725|NCT03390166|517075242|FG001|Overall Study|Lost to Follow-up|4|||
143417726|NCT03390166|517075241|FG000|Overall Study|Physician Decision|2|||
143417727|NCT03390166|517075242|FG001|Overall Study|Physician Decision|1|||
143417728|NCT03390166|517075241|FG000|Overall Study|Move from study area|3|||
143417729|NCT03390166|517075242|FG001|Overall Study|Move from study area|2|||
143417730|NCT03390166|517075241|FG000|Overall Study|To militarycamp for conscript|1|||
143417731|NCT03390166|517075242|FG001|Overall Study|To militarycamp for conscript|0|||
143417732|NCT03390166|517075241|FG000|Overall Study|To drug therapy course|0|||
143417733|NCT03390166|517075242|FG001|Overall Study|To drug therapy course|1|||
143417734|NCT03390166|517075241|FG000|Overall Study|Move to work oversea|0|||
143417735|NCT03390166|517075242|FG001|Overall Study|Move to work oversea|1|||
143417736|NCT05376397|517075248|FG000|Overall Study|Lost to Follow-up|1|||
143417737|NCT01328756|517075249|FG000|Overall Study|Protocol Violation|4|||
143417738|NCT01328756|517075249|FG000|Overall Study|Adverse Event|39|||
143417739|NCT01328756|517075249|FG000|Overall Study|Lack of Efficacy|5|||
143417740|NCT01328756|517075249|FG000|Overall Study|Withdrawal by Subject|41|||
143417741|NCT01328756|517075249|FG000|Overall Study|Lost to Follow-up|5|||
143417742|NCT01328756|517075249|FG000|Overall Study|Other|29|||
143417743|NCT01262456|517075252|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
143417744|NCT01262456|517075253|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
143417745|NCT01262456|517075254|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
143417746|NCT01262456|517075252|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
143417747|NCT01262456|517075253|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
143417748|NCT01262456|517075254|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
143417749|NCT01262456|517075252|FG000|3-Month Double-Blind Period|Adverse Event|6|||
143417750|NCT01262456|517075253|FG001|3-Month Double-Blind Period|Adverse Event|4|||
143417751|NCT01262456|517075254|FG002|3-Month Double-Blind Period|Adverse Event|8|||
143417752|NCT01262456|517075252|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
143417753|NCT01262456|517075253|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
143417754|NCT01262456|517075254|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
143417755|NCT01262456|517075252|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
143417756|NCT01262456|517075253|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
143417757|NCT01262456|517075254|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
143417758|NCT01262456|517075252|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
143417759|NCT01262456|517075253|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
143417760|NCT01262456|517075254|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
143417761|NCT01262456|517075252|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
143417762|NCT01262456|517075253|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
143417763|NCT01262456|517075254|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
143417764|NCT01262456|517075252|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
143417765|NCT01262456|517075253|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
143417766|NCT01262456|517075254|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
143417767|NCT01262456|517075252|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
143417768|NCT01262456|517075253|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
143417769|NCT01262456|517075254|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
143417770|NCT03989232|517075255|FG000|Overall Study|Lost to Follow-up|3|||
143417771|NCT03989232|517075256|FG001|Overall Study|Lost to Follow-up|10|||
143417772|NCT03989232|517075255|FG000|Overall Study|Withdrawal by Subject|6|||
143417773|NCT03989232|517075256|FG001|Overall Study|Withdrawal by Subject|6|||
143417774|NCT03989232|517075255|FG000|Overall Study|Death|1|||
143417775|NCT03989232|517075256|FG001|Overall Study|Death|2|||
143417776|NCT01316913|517075259|FG000|Overall Study|Adverse Event|17|||
143417777|NCT01316913|517075260|FG001|Overall Study|Adverse Event|20|||
143417778|NCT01316913|517075261|FG002|Overall Study|Adverse Event|15|||
143417779|NCT01316913|517075262|FG003|Overall Study|Adverse Event|11|||
143417780|NCT01316913|517075259|FG000|Overall Study|Lack of Efficacy|22|||
143417781|NCT01316913|517075260|FG001|Overall Study|Lack of Efficacy|12|||
143417782|NCT01316913|517075261|FG002|Overall Study|Lack of Efficacy|9|||
143417783|NCT01316913|517075262|FG003|Overall Study|Lack of Efficacy|13|||
143417784|NCT01316913|517075259|FG000|Overall Study|Protocol Violation|1|||
143417785|NCT01316913|517075260|FG001|Overall Study|Protocol Violation|4|||
143417786|NCT01316913|517075261|FG002|Overall Study|Protocol Violation|4|||
143417787|NCT01316913|517075262|FG003|Overall Study|Protocol Violation|1|||
143417788|NCT01316913|517075259|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
143417789|NCT01316913|517075260|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
143417790|NCT01316913|517075261|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
143417791|NCT01316913|517075262|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
143417792|NCT01316913|517075259|FG000|Overall Study|Lost to Follow-up|0|||
143417793|NCT01316913|517075260|FG001|Overall Study|Lost to Follow-up|1|||
143417794|NCT01316913|517075261|FG002|Overall Study|Lost to Follow-up|0|||
143417795|NCT01316913|517075262|FG003|Overall Study|Lost to Follow-up|2|||
143417796|NCT01316913|517075259|FG000|Overall Study|Withdrawal by Subject|10|||
143417797|NCT01316913|517075260|FG001|Overall Study|Withdrawal by Subject|9|||
143417798|NCT01316913|517075261|FG002|Overall Study|Withdrawal by Subject|10|||
143417799|NCT01316913|517075262|FG003|Overall Study|Withdrawal by Subject|6|||
143417800|NCT05445557|517075263|FG000|Double Blind Part|Lost to Follow-up|1|||
143417801|NCT01323790|517075264|FG000|Overall Study|Other|3|||
143417802|NCT01323790|517075265|FG001|Overall Study|Other|2|||
143417803|NCT01323790|517075266|FG002|Overall Study|Other|1|||
143417804|NCT01323790|517075264|FG000|Overall Study|Lost to Follow-up|11|||
143417805|NCT01323790|517075265|FG001|Overall Study|Lost to Follow-up|9|||
143417806|NCT01323790|517075266|FG002|Overall Study|Lost to Follow-up|9|||
143417807|NCT01323790|517075264|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
143417808|NCT01323790|517075265|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
143417809|NCT01323790|517075266|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
143417810|NCT01323790|517075264|FG000|Overall Study|Lack of Efficacy|3|||
143417811|NCT01323790|517075265|FG001|Overall Study|Lack of Efficacy|0|||
143417812|NCT01323790|517075266|FG002|Overall Study|Lack of Efficacy|3|||
143417813|NCT01323790|517075264|FG000|Overall Study|Adverse Event|11|||
143417814|NCT01323790|517075265|FG001|Overall Study|Adverse Event|24|||
143417815|NCT01323790|517075266|FG002|Overall Study|Adverse Event|12|||
143417816|NCT01323790|517075264|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
143417817|NCT01323790|517075265|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
143417818|NCT01323790|517075266|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
143417819|NCT01323790|517075264|FG000|Overall Study|Withdrawal by Subject|23|||
143417820|NCT01323790|517075265|FG001|Overall Study|Withdrawal by Subject|20|||
143417821|NCT01323790|517075266|FG002|Overall Study|Withdrawal by Subject|13|||
143417822|NCT01323790|517075264|FG000|Overall Study|Did Not Receive Treatment|2|||
143417823|NCT01323790|517075265|FG001|Overall Study|Did Not Receive Treatment|0|||
143417824|NCT01323790|517075266|FG002|Overall Study|Did Not Receive Treatment|1|||
143417825|NCT01323790|517075264|FG000|Overall Study|Severe non-compliance with protocol|2|||
143417826|NCT01323790|517075265|FG001|Overall Study|Severe non-compliance with protocol|2|||
143417827|NCT01323790|517075266|FG002|Overall Study|Severe non-compliance with protocol|2|||
143417828|NCT02915783|517075267|FG000|Overall Study|Death|21|||
143417829|NCT02915783|517075267|FG000|Overall Study|Lost to Follow-up|1|||
143417830|NCT02915783|517075267|FG000|Overall Study|Withdrawal by Subject|2|||
143417831|NCT00428714|517075269|FG000|Overall Study|Progressive Disease|28|||
143417832|NCT00428714|517075270|FG001|Overall Study|Progressive Disease|36|||
143417833|NCT00428714|517075269|FG000|Overall Study|Withdrawal by Subject|0|||
143417834|NCT00428714|517075270|FG001|Overall Study|Withdrawal by Subject|3|||
143417835|NCT00428714|517075269|FG000|Overall Study|Adverse Event|0|||
143417836|NCT00428714|517075270|FG001|Overall Study|Adverse Event|2|||
143417837|NCT00428714|517075269|FG000|Overall Study|Physician Decision|1|||
143417838|NCT00428714|517075270|FG001|Overall Study|Physician Decision|1|||
143417839|NCT00428714|517075269|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
143417840|NCT00428714|517075270|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
143417841|NCT00428714|517075269|FG000|Overall Study|Death due to other then PD|1|||
143417842|NCT00428714|517075270|FG001|Overall Study|Death due to other then PD|0|||
143417843|NCT02114515|517075273|FG000|Overall Study|Lost to Follow-up|52|||
143417844|NCT02114515|517075274|FG001|Overall Study|Lost to Follow-up|55|||
143417845|NCT02114515|517075273|FG000|Overall Study|Death|12|||
143417846|NCT02114515|517075274|FG001|Overall Study|Death|12|||
143417847|NCT02114515|517075273|FG000|Overall Study|Withdrawal by Subject|4|||
143417848|NCT02114515|517075274|FG001|Overall Study|Withdrawal by Subject|22|||
143417849|NCT02114515|517075273|FG000|Overall Study|Other|65|||
143417850|NCT02114515|517075274|FG001|Overall Study|Other|61|||
143417851|NCT02699099|517075275|FG000|Overall Study|Adverse Event|1|||
143417852|NCT02699099|517075276|FG001|Overall Study|Adverse Event|0|||
143417853|NCT02699099|517075277|FG002|Overall Study|Adverse Event|2|||
143417854|NCT02699099|517075275|FG000|Overall Study|Lost to Follow-up|0|||
143417855|NCT02699099|517075276|FG001|Overall Study|Lost to Follow-up|1|||
143417856|NCT02699099|517075277|FG002|Overall Study|Lost to Follow-up|0|||
143417857|NCT02699099|517075275|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
143417858|NCT02699099|517075276|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
143417859|NCT02699099|517075277|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
143417860|NCT00452452|517075280|FG000|Overall Study|Protocol Violation|0|||
143417861|NCT00452452|517075281|FG001|Overall Study|Protocol Violation|0|||
143417862|NCT00452452|517075282|FG002|Overall Study|Protocol Violation|1|||
143417863|NCT00452452|517075280|FG000|Overall Study|Withdrawal by Subject|1|||
143417864|NCT00452452|517075281|FG001|Overall Study|Withdrawal by Subject|0|||
143417865|NCT00452452|517075282|FG002|Overall Study|Withdrawal by Subject|0|||
143417866|NCT00452452|517075280|FG000|Overall Study|Lost to Follow-up|1|||
143417867|NCT00452452|517075281|FG001|Overall Study|Lost to Follow-up|0|||
143417868|NCT00452452|517075282|FG002|Overall Study|Lost to Follow-up|0|||
143417869|NCT02164578|517076257|FG000|Treatment Period|Withdrawal by Subject|3|||
143417870|NCT02164578|517076258|FG001|Treatment Period|Withdrawal by Subject|3|||
143417871|NCT02164578|517076257|FG000|Treatment Period|Adverse Event|13|||
143417872|NCT02164578|517076258|FG001|Treatment Period|Adverse Event|6|||
143417873|NCT02164578|517076257|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
143417874|NCT02164578|517076258|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
143417875|NCT02164578|517076257|FG000|Treatment Period|Protocol Violation|0|||
143417876|NCT02164578|517076258|FG001|Treatment Period|Protocol Violation|2|||
143417877|NCT02164578|517076257|FG000|Extension Period|Withdrawal by Subject|2|||
143417878|NCT02164578|517076258|FG001|Extension Period|Withdrawal by Subject|0|||
143417879|NCT02164578|517076257|FG000|Extension Period|Adverse Event|4|||
143417880|NCT02164578|517076258|FG001|Extension Period|Adverse Event|0|||
143417881|NCT02164578|517076257|FG000|Extension Period|Expiry of study medication|1|||
143417882|NCT02164578|517076258|FG001|Extension Period|Expiry of study medication|0|||
143417883|NCT02164578|517076257|FG000|Extension Period|Protocol Violation|0|||
143417884|NCT02164578|517076258|FG001|Extension Period|Protocol Violation|1|||
143417885|NCT02489799|517076259|FG000|Overall Study|Lost to Follow-up|4|||
143417886|NCT02489799|517076260|FG001|Overall Study|Lost to Follow-up|1|||
143417887|NCT02489799|517076259|FG000|Overall Study|Failure to Maintain Eligibility|4|||
143417888|NCT02489799|517076260|FG001|Overall Study|Failure to Maintain Eligibility|6|||
143417889|NCT02489799|517076259|FG000|Overall Study|Withdrawal by Subject|1|||
143417890|NCT02489799|517076260|FG001|Overall Study|Withdrawal by Subject|1|||
143417891|NCT02489799|517076259|FG000|Overall Study|Death|0|||
143417892|NCT02489799|517076260|FG001|Overall Study|Death|1|||
143417893|NCT00080119|517076263|FG000|Overall Study|Discontinued because of study closure|0|||
143417894|NCT00080119|517076264|FG001|Overall Study|Discontinued because of study closure|0|||
143417895|NCT00080119|517076265|FG002|Overall Study|Discontinued because of study closure|130|||
143417896|NCT00080119|517076266|FG003|Overall Study|Discontinued because of study closure|141|||
143417897|NCT00080119|517076263|FG000|Overall Study|Unable to get to clinic|24|||
143417898|NCT00080119|517076264|FG001|Overall Study|Unable to get to clinic|24|||
143417899|NCT00080119|517076265|FG002|Overall Study|Unable to get to clinic|7|||
143417900|NCT00080119|517076266|FG003|Overall Study|Unable to get to clinic|1|||
143417901|NCT00080119|517076263|FG000|Overall Study|Consent withdrawn|13|||
143417902|NCT00080119|517076264|FG001|Overall Study|Consent withdrawn|17|||
143417903|NCT00080119|517076265|FG002|Overall Study|Consent withdrawn|4|||
143417904|NCT00080119|517076266|FG003|Overall Study|Consent withdrawn|6|||
143417905|NCT00080119|517076263|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
143417906|NCT00080119|517076264|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
143417907|NCT00080119|517076265|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
143417908|NCT00080119|517076266|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
143417909|NCT00080119|517076263|FG000|Overall Study|Lost to Follow-up|16|||
143417910|NCT00080119|517076264|FG001|Overall Study|Lost to Follow-up|19|||
143417911|NCT00080119|517076265|FG002|Overall Study|Lost to Follow-up|19|||
143417912|NCT00080119|517076266|FG003|Overall Study|Lost to Follow-up|14|||
143417913|NCT01322386|517076268|FG000|Overall Study|Protocol Violation|0|||
143417914|NCT01322386|517076269|FG001|Overall Study|Protocol Violation|1|||
143417915|NCT01322386|517076268|FG000|Overall Study|Physician Decision|0|||
143417916|NCT01322386|517076269|FG001|Overall Study|Physician Decision|1|||
143417917|NCT00889863|517076276|FG000|Part I: Open Label|Death|1|||
143417918|NCT00889863|517076277|FG001|Part I: Open Label|Death|0|||
143417919|NCT00889863|517076276|FG000|Part I: Open Label|Adverse Event|4|||
143417920|NCT00889863|517076277|FG001|Part I: Open Label|Adverse Event|0|||
143417921|NCT00889863|517076276|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
143417922|NCT00889863|517076277|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
143417923|NCT00889863|517076276|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
143417924|NCT00889863|517076277|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
143417925|NCT00889863|517076276|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
143417926|NCT00889863|517076277|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
143417927|NCT00889863|517076276|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
143417928|NCT00889863|517076277|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
143417929|NCT00889863|517076276|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
143417930|NCT00889863|517076277|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
143417931|NCT02291861|517076279|FG000|Overall Study|Adverse Event|2|||
143417932|NCT02291861|517076280|FG001|Overall Study|Adverse Event|4|||
143417933|NCT02291861|517076281|FG002|Overall Study|Adverse Event|1|||
143417934|NCT02291861|517076282|FG003|Overall Study|Adverse Event|2|||
143417935|NCT02291861|517076279|FG000|Overall Study|Death|0|||
143417936|NCT02291861|517076280|FG001|Overall Study|Death|0|||
143417937|NCT02291861|517076281|FG002|Overall Study|Death|1|||
143417938|NCT02291861|517076282|FG003|Overall Study|Death|1|||
143417939|NCT02291861|517076279|FG000|Overall Study|Protocol Violation|1|||
143417940|NCT02291861|517076280|FG001|Overall Study|Protocol Violation|0|||
143417941|NCT02291861|517076281|FG002|Overall Study|Protocol Violation|0|||
143417942|NCT02291861|517076282|FG003|Overall Study|Protocol Violation|1|||
143417943|NCT02291861|517076279|FG000|Overall Study|Withdrawal by Subject|1|||
143417944|NCT02291861|517076280|FG001|Overall Study|Withdrawal by Subject|2|||
143417945|NCT02291861|517076281|FG002|Overall Study|Withdrawal by Subject|1|||
143417946|NCT02291861|517076282|FG003|Overall Study|Withdrawal by Subject|4|||
143417947|NCT02291861|517076279|FG000|Overall Study|Noncompliance|1|||
143417948|NCT02291861|517076280|FG001|Overall Study|Noncompliance|1|||
143417949|NCT02291861|517076281|FG002|Overall Study|Noncompliance|2|||
143417950|NCT02291861|517076282|FG003|Overall Study|Noncompliance|1|||
143417951|NCT02291861|517076279|FG000|Overall Study|Lost to Follow-up|2|||
143417952|NCT02291861|517076280|FG001|Overall Study|Lost to Follow-up|1|||
143417953|NCT02291861|517076281|FG002|Overall Study|Lost to Follow-up|4|||
143417954|NCT02291861|517076282|FG003|Overall Study|Lost to Follow-up|0|||
143417955|NCT02291861|517076279|FG000|Overall Study|Other|0|||
143417956|NCT02291861|517076280|FG001|Overall Study|Other|0|||
143417957|NCT02291861|517076281|FG002|Overall Study|Other|0|||
143417958|NCT02291861|517076282|FG003|Overall Study|Other|1|||
143417959|NCT04361617|517076283|FG000|Overall Study|Withdrawal by Subject|0|||
143417960|NCT04361617|517076284|FG001|Overall Study|Withdrawal by Subject|1|||
143417961|NCT03547154|517076289|FG000|Overall Study|Disease Progression/Recurrence|6|||
143417962|NCT03547154|517076290|FG001|Overall Study|Disease Progression/Recurrence|14|||
143417963|NCT03547154|517076289|FG000|Overall Study|Adverse Event|26|||
143417964|NCT03547154|517076290|FG001|Overall Study|Adverse Event|31|||
143417965|NCT03547154|517076289|FG000|Overall Study|Protocol Violation|6|||
143417966|NCT03547154|517076290|FG001|Overall Study|Protocol Violation|1|||
143417967|NCT03547154|517076289|FG000|Overall Study|Physician Decision|4|||
143417968|NCT03547154|517076290|FG001|Overall Study|Physician Decision|3|||
143417969|NCT03547154|517076289|FG000|Overall Study|Insufficient Therapeutic Response|13|||
143417970|NCT03547154|517076290|FG001|Overall Study|Insufficient Therapeutic Response|10|||
143417971|NCT03547154|517076289|FG000|Overall Study|Withdrawal by Subject|10|||
143417972|NCT03547154|517076290|FG001|Overall Study|Withdrawal by Subject|6|||
143417973|NCT03547154|517076289|FG000|Overall Study|Not Selected|0|||
143417974|NCT03547154|517076290|FG001|Overall Study|Not Selected|1|||
143417975|NCT03547154|517076289|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
143417976|NCT03547154|517076290|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
143417977|NCT00088166|517076295|FG000|Overall Study|Adverse Event|11|||
143417978|NCT00088166|517076296|FG001|Overall Study|Adverse Event|9|||
143417979|NCT00088166|517076295|FG000|Overall Study|Death|3|||
143417980|NCT00088166|517076296|FG001|Overall Study|Death|1|||
143417981|NCT00088166|517076295|FG000|Overall Study|Lost to Follow-up|0|||
143417982|NCT00088166|517076296|FG001|Overall Study|Lost to Follow-up|1|||
143417983|NCT00088166|517076295|FG000|Overall Study|Physician Decision|4|||
143417984|NCT00088166|517076296|FG001|Overall Study|Physician Decision|1|||
143417985|NCT00088166|517076295|FG000|Overall Study|Protocol Violation|1|||
143417986|NCT00088166|517076296|FG001|Overall Study|Protocol Violation|5|||
143417987|NCT00088166|517076295|FG000|Overall Study|Patient deterioration|29|||
143417988|NCT00088166|517076296|FG001|Overall Study|Patient deterioration|39|||
143417989|NCT00088166|517076295|FG000|Overall Study|Withdrawal by Subject|5|||
143417990|NCT00088166|517076296|FG001|Overall Study|Withdrawal by Subject|5|||
143417991|NCT00666705|517076300|FG000|Overall Study|Withdrawal by Subject|1|||
143417992|NCT01029704|517076303|FG000|Overall Study|Adverse Event|0|||
143417993|NCT01029704|517076304|FG001|Overall Study|Adverse Event|0|||
143417994|NCT01029704|517076305|FG002|Overall Study|Adverse Event|0|||
143417995|NCT01029704|517076306|FG003|Overall Study|Adverse Event|0|||
143417996|NCT01029704|517076307|FG004|Overall Study|Adverse Event|0|||
143417997|NCT01029704|517076308|FG005|Overall Study|Adverse Event|0|||
143417998|NCT01029704|517076309|FG006|Overall Study|Adverse Event|1|||
143417999|NCT01029704|517076310|FG007|Overall Study|Adverse Event|1|||
143418000|NCT01029704|517076311|FG008|Overall Study|Adverse Event|0|||
143418001|NCT01029704|517076303|FG000|Overall Study|Withdrawal by Subject|0|||
143418002|NCT01029704|517076304|FG001|Overall Study|Withdrawal by Subject|0|||
143418003|NCT01029704|517076305|FG002|Overall Study|Withdrawal by Subject|0|||
143418004|NCT01029704|517076306|FG003|Overall Study|Withdrawal by Subject|0|||
143418005|NCT01029704|517076307|FG004|Overall Study|Withdrawal by Subject|2|||
143418006|NCT01029704|517076308|FG005|Overall Study|Withdrawal by Subject|1|||
143418007|NCT01029704|517076309|FG006|Overall Study|Withdrawal by Subject|1|||
143418008|NCT01029704|517076310|FG007|Overall Study|Withdrawal by Subject|1|||
143418009|NCT01029704|517076311|FG008|Overall Study|Withdrawal by Subject|0|||
143418010|NCT01029704|517076303|FG000|Overall Study|Lost to Follow-up|0|||
143418011|NCT01029704|517076304|FG001|Overall Study|Lost to Follow-up|0|||
143418012|NCT01029704|517076305|FG002|Overall Study|Lost to Follow-up|0|||
143418013|NCT01029704|517076306|FG003|Overall Study|Lost to Follow-up|0|||
143418014|NCT01029704|517076307|FG004|Overall Study|Lost to Follow-up|0|||
143418015|NCT01029704|517076308|FG005|Overall Study|Lost to Follow-up|0|||
143418016|NCT01029704|517076309|FG006|Overall Study|Lost to Follow-up|1|||
143418017|NCT01029704|517076310|FG007|Overall Study|Lost to Follow-up|1|||
143418018|NCT01029704|517076311|FG008|Overall Study|Lost to Follow-up|1|||
143418019|NCT01029704|517076303|FG000|Overall Study|Lack of Efficacy|0|||
143418020|NCT01029704|517076304|FG001|Overall Study|Lack of Efficacy|0|||
143418021|NCT01029704|517076305|FG002|Overall Study|Lack of Efficacy|0|||
143418022|NCT01029704|517076306|FG003|Overall Study|Lack of Efficacy|0|||
143418023|NCT01029704|517076307|FG004|Overall Study|Lack of Efficacy|2|||
143418024|NCT01029704|517076308|FG005|Overall Study|Lack of Efficacy|3|||
143418025|NCT01029704|517076309|FG006|Overall Study|Lack of Efficacy|1|||
143418026|NCT01029704|517076310|FG007|Overall Study|Lack of Efficacy|2|||
143418027|NCT01029704|517076311|FG008|Overall Study|Lack of Efficacy|0|||
143418028|NCT01029704|517076303|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
143418029|NCT01029704|517076304|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
143418030|NCT01029704|517076305|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
143418031|NCT01029704|517076306|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
143418032|NCT01029704|517076307|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
143418033|NCT01029704|517076308|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
143418034|NCT01029704|517076309|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
143418035|NCT01029704|517076310|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
143418036|NCT01029704|517076311|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
143418037|NCT00687297|517076312|FG000|Randomization|Withdrawal by Subject|2|||
143418038|NCT00687297|517076313|FG001|Randomization|Withdrawal by Subject|0|||
143418039|NCT00687297|517076312|FG000|Randomization|Withdrew before treatment, ineligible|1|||
143418040|NCT00687297|517076313|FG001|Randomization|Withdrew before treatment, ineligible|1|||
143418041|NCT00687297|517076312|FG000|Induction|Withdrawal by Subject|4|||
143418042|NCT00687297|517076313|FG001|Induction|Withdrawal by Subject|4|||
143418043|NCT00687297|517076312|FG000|Induction|Adverse Event|16|||
143418044|NCT00687297|517076313|FG001|Induction|Adverse Event|15|||
143418045|NCT00687297|517076312|FG000|Induction|Death|7|||
143418046|NCT00687297|517076313|FG001|Induction|Death|11|||
143418047|NCT00687297|517076312|FG000|Induction|Lack of Efficacy|17|||
143418048|NCT00687297|517076313|FG001|Induction|Lack of Efficacy|21|||
143418049|NCT00687297|517076312|FG000|Induction|Ineligible|0|||
143418050|NCT00687297|517076313|FG001|Induction|Ineligible|1|||
143418051|NCT00687297|517076312|FG000|Induction|Patient Noncompliance|1|||
143418052|NCT00687297|517076313|FG001|Induction|Patient Noncompliance|0|||
143418053|NCT00687297|517076312|FG000|Induction|Physician Decision|0|||
143418054|NCT00687297|517076313|FG001|Induction|Physician Decision|2|||
143418055|NCT00687297|517076312|FG000|Induction|Other|0|||
143418056|NCT00687297|517076313|FG001|Induction|Other|1|||
143418057|NCT01535261|517076314|FG000|Overall Study|Physician Decision|8|||
143418058|NCT01535261|517076314|FG000|Overall Study|Protocol Violation|3|||
143418059|NCT01535261|517076314|FG000|Overall Study|Death|5|||
143418060|NCT01535261|517076314|FG000|Overall Study|Lost to Follow-up|8|||
143418061|NCT01535261|517076314|FG000|Overall Study|Withdrawal by Subject|14|||
143418062|NCT01535261|517076314|FG000|Overall Study|Adverse Event|12|||
143418063|NCT02525744|517076315|FG000|Period 1|Physician Decision|0|||
143418064|NCT02525744|517076316|FG001|Period 1|Physician Decision|0|||
143418065|NCT02525744|517076317|FG002|Period 1|Physician Decision|1|||
143418066|NCT02525744|517076318|FG003|Period 1|Physician Decision|0|||
143418067|NCT02525744|517076315|FG000|Period 3|Adverse Event|0|||
143418068|NCT02525744|517076316|FG001|Period 3|Adverse Event|1|||
143418069|NCT02525744|517076317|FG002|Period 3|Adverse Event|0|||
143418070|NCT02525744|517076318|FG003|Period 3|Adverse Event|0|||
143418071|NCT02525744|517076315|FG000|Period 4|Withdrawal by Subject|1|||
143418072|NCT02525744|517076316|FG001|Period 4|Withdrawal by Subject|0|||
143418073|NCT02525744|517076317|FG002|Period 4|Withdrawal by Subject|0|||
143418074|NCT02525744|517076318|FG003|Period 4|Withdrawal by Subject|0|||
143418075|NCT02525744|517076315|FG000|Period 5|Physician Decision|1|||
143418076|NCT02525744|517076316|FG001|Period 5|Physician Decision|0|||
143418077|NCT02525744|517076317|FG002|Period 5|Physician Decision|0|||
143418078|NCT02525744|517076318|FG003|Period 5|Physician Decision|0|||
143418079|NCT00472082|517076319|FG000|Overall Study|Study prematurely terminated|5|||
143418080|NCT02069379|517076320|FG000|Baseline Measurements|Lost to Follow-up|1|||
143418081|NCT02069379|517076321|FG001|Baseline Measurements|Lost to Follow-up|0|||
143418082|NCT02069379|517076322|FG002|Baseline Measurements|Lost to Follow-up|0|||
143418083|NCT02069379|517076323|FG003|Baseline Measurements|Lost to Follow-up|0|||
143418084|NCT02069379|517076320|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
143418085|NCT02069379|517076321|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
143418086|NCT02069379|517076322|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
143418087|NCT02069379|517076323|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
143418088|NCT02069379|517076320|FG000|First Treatment Arm|Lost to Follow-up|0|||
143418089|NCT02069379|517076321|FG001|First Treatment Arm|Lost to Follow-up|1|||
143418090|NCT02069379|517076322|FG002|First Treatment Arm|Lost to Follow-up|1|||
143418091|NCT02069379|517076323|FG003|First Treatment Arm|Lost to Follow-up|0|||
143418092|NCT02069379|517076320|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
143418093|NCT02069379|517076321|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
143418094|NCT02069379|517076322|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
143418095|NCT02069379|517076323|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
143418096|NCT02069379|517076320|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
143418097|NCT02069379|517076321|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
143418098|NCT02069379|517076322|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
143418099|NCT02069379|517076323|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
143418100|NCT02069379|517076320|FG000|Second Treatment Arm|Lost to Follow-up|0|||
143418101|NCT02069379|517076321|FG001|Second Treatment Arm|Lost to Follow-up|0|||
143418102|NCT02069379|517076322|FG002|Second Treatment Arm|Lost to Follow-up|1|||
143418103|NCT02069379|517076323|FG003|Second Treatment Arm|Lost to Follow-up|0|||
143418104|NCT04421456|517076324|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
143418105|NCT04421456|517076325|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
143418106|NCT04421456|517076326|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
143418107|NCT04421456|517076324|FG000|Randomized Treatment Period|Adverse Event|0|||
143418108|NCT04421456|517076325|FG001|Randomized Treatment Period|Adverse Event|1|||
143418109|NCT04421456|517076326|FG002|Randomized Treatment Period|Adverse Event|0|||
143418110|NCT04421456|517076324|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
143418111|NCT04421456|517076325|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
143418112|NCT04421456|517076326|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
143418113|NCT04421456|517076324|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
143418114|NCT04421456|517076325|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
143418115|NCT04421456|517076326|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
143418116|NCT04421456|517076324|FG000|Randomized Treatment Period|Participant non-compliance|1|||
143418117|NCT04421456|517076325|FG001|Randomized Treatment Period|Participant non-compliance|1|||
143418118|NCT04421456|517076326|FG002|Randomized Treatment Period|Participant non-compliance|2|||
143418119|NCT04421456|517076324|FG000|Randomized Treatment Period|Other|0|||
143418120|NCT04421456|517076325|FG001|Randomized Treatment Period|Other|1|||
143418121|NCT04421456|517076326|FG002|Randomized Treatment Period|Other|3|||
143418122|NCT04617847|517076327|FG000|Overall Study|Withdrawal by Subject|1|||
143418123|NCT04617847|517076328|FG001|Overall Study|Withdrawal by Subject|0|||
143418124|NCT04617847|517076327|FG000|Overall Study|Adverse Event|0|||
143418125|NCT04617847|517076328|FG001|Overall Study|Adverse Event|2|||
143418126|NCT04617847|517076327|FG000|Overall Study|Death|0|||
143418127|NCT04617847|517076328|FG001|Overall Study|Death|1|||
143418128|NCT04617847|517076327|FG000|Overall Study|Termination of Study by Sponsor|2|||
143418129|NCT04617847|517076328|FG001|Overall Study|Termination of Study by Sponsor|21|||
143418130|NCT00068107|517076329|FG000|Overall Study|end-stage renal disease|6|||
143418131|NCT00068107|517076329|FG000|Overall Study|Death|2|||
143418132|NCT00068107|517076329|FG000|Overall Study|Withdrawal by Subject|1|||
143418133|NCT03288506|517076330|FG000|Overall Study|Withdrawal by Subject|52|||
143418134|NCT02644122|517076334|FG000|Overall Study|Withdrawal by Subject|1|||
143418135|NCT01930188|517076335|FG000|Overall Study|unclassified|4|||
143418136|NCT01930188|517076336|FG001|Overall Study|unclassified|5|||
143418137|NCT01930188|517076337|FG002|Overall Study|unclassified|3|||
143418138|NCT01930188|517076335|FG000|Overall Study|Missing follow-up information|2|||
143418139|NCT01930188|517076336|FG001|Overall Study|Missing follow-up information|2|||
143418140|NCT01930188|517076337|FG002|Overall Study|Missing follow-up information|3|||
143418141|NCT01930188|517076335|FG000|Overall Study|Lost to Follow-up|5|||
143418142|NCT01930188|517076336|FG001|Overall Study|Lost to Follow-up|2|||
143418143|NCT01930188|517076337|FG002|Overall Study|Lost to Follow-up|2|||
143418144|NCT01930188|517076335|FG000|Overall Study|Death|2|||
143418145|NCT01930188|517076336|FG001|Overall Study|Death|1|||
143418146|NCT01930188|517076337|FG002|Overall Study|Death|3|||
143418147|NCT01930188|517076335|FG000|Overall Study|Withdrawal by Subject|9|||
143418148|NCT01930188|517076336|FG001|Overall Study|Withdrawal by Subject|11|||
143418149|NCT01930188|517076337|FG002|Overall Study|Withdrawal by Subject|8|||
143418150|NCT00337610|517076340|FG000|Overall Study|Adverse Event|2|||
143418151|NCT00337610|517076341|FG001|Overall Study|Adverse Event|2|||
143418152|NCT00337610|517076340|FG000|Overall Study|Death|0|||
143418153|NCT00337610|517076341|FG001|Overall Study|Death|1|||
143418154|NCT00337610|517076340|FG000|Overall Study|Lack of Efficacy|6|||
143418155|NCT00337610|517076341|FG001|Overall Study|Lack of Efficacy|3|||
143418156|NCT00337610|517076340|FG000|Overall Study|Lost to Follow-up|3|||
143418157|NCT00337610|517076341|FG001|Overall Study|Lost to Follow-up|3|||
143418158|NCT00337610|517076340|FG000|Overall Study|Withdrawal by Subject|6|||
143418159|NCT00337610|517076341|FG001|Overall Study|Withdrawal by Subject|5|||
143418160|NCT01681511|517076344|FG000|Overall Study|No Treatment Received|1|||
143418161|NCT01681511|517076345|FG001|Overall Study|No Treatment Received|3|||
143418162|NCT01681511|517076344|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
143418163|NCT01681511|517076345|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
143418164|NCT01681511|517076344|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
143418165|NCT01681511|517076345|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
143418166|NCT01681511|517076344|FG000|Overall Study|No Daily Urine Sample Collected|0|||
143418167|NCT01681511|517076345|FG001|Overall Study|No Daily Urine Sample Collected|1|||
143418168|NCT01681511|517076344|FG000|Overall Study|No post-catheter sample collected|11|||
143418169|NCT01681511|517076345|FG001|Overall Study|No post-catheter sample collected|4|||
143418170|NCT01156675|517076346|FG000|Overall Study|Death|5|||
143418171|NCT01156675|517076347|FG001|Overall Study|Death|3|||
143418172|NCT01156675|517076348|FG002|Overall Study|Death|0|||
143418173|NCT01156675|517076346|FG000|Overall Study|No data|29|||
143418174|NCT01156675|517076347|FG001|Overall Study|No data|22|||
143418175|NCT01156675|517076348|FG002|Overall Study|No data|2|||
143418176|NCT01075152|517076350|FG000|Overall Study|Withdrawal by Subject|1|||
143418177|NCT01075152|517076351|FG001|Overall Study|Withdrawal by Subject|0|||
143418178|NCT01079949|517076352|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
143418179|NCT01079949|517076353|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
143418180|NCT01079949|517076352|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
143418181|NCT01079949|517076353|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
143418182|NCT01079949|517076352|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
143418183|NCT01079949|517076353|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
143418184|NCT01079949|517076352|FG000|Overall Study|Randomized but not treated|1|||
143418185|NCT01079949|517076353|FG001|Overall Study|Randomized but not treated|0|||
143418186|NCT02144285|517076354|FG000|Overall Study|Withdrawal by Subject|0|||
143418187|NCT02144285|517076355|FG001|Overall Study|Withdrawal by Subject|0|||
143418188|NCT02144285|517076356|FG002|Overall Study|Withdrawal by Subject|0|||
143418189|NCT02144285|517076357|FG003|Overall Study|Withdrawal by Subject|0|||
143418190|NCT02144285|517076358|FG004|Overall Study|Withdrawal by Subject|1|||
143418191|NCT02144285|517076359|FG005|Overall Study|Withdrawal by Subject|0|||
143418192|NCT02144285|517076360|FG006|Overall Study|Withdrawal by Subject|0|||
143418193|NCT02144285|517076361|FG007|Overall Study|Withdrawal by Subject|0|||
143418194|NCT02144285|517076362|FG008|Overall Study|Withdrawal by Subject|0|||
143418195|NCT02144285|517076363|FG009|Overall Study|Withdrawal by Subject|0|||
143418196|NCT01529632|517076364|FG000|Overall Study|Administrative problem|2|||
143418197|NCT01529632|517076365|FG001|Overall Study|Administrative problem|1|||
143418198|NCT01529632|517076364|FG000|Overall Study|Protocol Violation|0|||
143418199|NCT01529632|517076365|FG001|Overall Study|Protocol Violation|1|||
143418200|NCT01529632|517076364|FG000|Overall Study|Adverse Event|1|||
143418201|NCT01529632|517076365|FG001|Overall Study|Adverse Event|1|||
143418202|NCT05184062|517076366|FG000|Overall Study|Lost to Follow-up|5|||
143418203|NCT05184062|517076367|FG001|Overall Study|Lost to Follow-up|1|||
143418204|NCT05184062|517076366|FG000|Overall Study|Withdrawal by Subject|1|||
143418205|NCT05184062|517076367|FG001|Overall Study|Withdrawal by Subject|0|||
143418206|NCT00747149|517078153|FG000|Overall Study|Adverse Event|0|||
143418207|NCT00747149|517078154|FG001|Overall Study|Adverse Event|15|||
143418208|NCT00747149|517078153|FG000|Overall Study|Lost to Follow-up|0|||
143418209|NCT00747149|517078154|FG001|Overall Study|Lost to Follow-up|10|||
143418210|NCT00747149|517078153|FG000|Overall Study|Withdrawal by Subject|0|||
143418211|NCT00747149|517078154|FG001|Overall Study|Withdrawal by Subject|6|||
143418212|NCT00747149|517078153|FG000|Overall Study|Did not receive treatment|0|||
143418213|NCT00747149|517078154|FG001|Overall Study|Did not receive treatment|1|||
143418214|NCT00747149|517078153|FG000|Overall Study|Incorrect enrollment|0|||
143418215|NCT00747149|517078154|FG001|Overall Study|Incorrect enrollment|6|||
143418216|NCT00747149|517078153|FG000|Overall Study|Severe non-compliance to protocol|0|||
143418217|NCT00747149|517078154|FG001|Overall Study|Severe non-compliance to protocol|1|||
143418218|NCT00747149|517078153|FG000|Overall Study|Not reported|1|||
143418219|NCT00747149|517078154|FG001|Overall Study|Not reported|4|||
143418220|NCT04620733|517078161|FG000|Overall Study|Adverse Event|4|||
143418221|NCT04620733|517078162|FG001|Overall Study|Adverse Event|3|||
143418222|NCT04620733|517078161|FG000|Overall Study|Withdrawal by Subject|2|||
143418223|NCT04620733|517078162|FG001|Overall Study|Withdrawal by Subject|5|||
143418224|NCT04620733|517078161|FG000|Overall Study|Lost to Follow-up|1|||
143418225|NCT04620733|517078162|FG001|Overall Study|Lost to Follow-up|1|||
143418226|NCT04620733|517078161|FG000|Overall Study|Protocol Deviation|1|||
143418227|NCT04620733|517078162|FG001|Overall Study|Protocol Deviation|1|||
143418228|NCT04620733|517078161|FG000|Overall Study|Reason Not Specified|0|||
143418229|NCT04620733|517078162|FG001|Overall Study|Reason Not Specified|1|||
143418230|NCT02196259|517078167|FG000|Overall Study|Researcher choice|0|||
143418231|NCT02196259|517078168|FG001|Overall Study|Researcher choice|0|||
143418232|NCT02196259|517078169|FG002|Overall Study|Researcher choice|1|||
143418233|NCT02196259|517078167|FG000|Overall Study|Partial data analysis|0|||
143418234|NCT02196259|517078168|FG001|Overall Study|Partial data analysis|3|||
143418235|NCT02196259|517078169|FG002|Overall Study|Partial data analysis|0|||
143418236|NCT00264576|517078170|FG000|Overall Study|Lost to Follow-up|1|||
143418237|NCT00264576|517078171|FG001|Overall Study|Lost to Follow-up|1|||
143418238|NCT00451906|517078177|FG000|Overall Study|Adverse Event|515|||
143418239|NCT00451906|517078177|FG000|Overall Study|Lost to Follow-up|31|||
143418240|NCT00451906|517078177|FG000|Overall Study|Withdrawal by Subject|111|||
143418241|NCT00451906|517078177|FG000|Overall Study|Protocol Violation|21|||
143418242|NCT00451906|517078177|FG000|Overall Study|Progressive disease|1328|||
143418243|NCT00451906|517078177|FG000|Overall Study|Termination of the study|108|||
143418244|NCT00451906|517078177|FG000|Overall Study|Other Reasons|121|||
143418245|NCT00451906|517078177|FG000|Overall Study|Did not complete final visit|4|||
143418246|NCT05066230|517078178|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
143418247|NCT05066230|517078179|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
143418248|NCT05066230|517078178|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
143418249|NCT05066230|517078179|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
143418250|NCT05066230|517078178|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
143418251|NCT05066230|517078179|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
143418252|NCT05066230|517078178|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
143418253|NCT05066230|517078179|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
143418254|NCT05066230|517078178|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
143418255|NCT05066230|517078179|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
143418256|NCT05066230|517078178|FG000|After Week 48|Adverse Event|1|||
143418257|NCT05066230|517078179|FG001|After Week 48|Adverse Event|0|||
143418258|NCT05066230|517078178|FG000|After Week 48|Non-compliance with study schedule|1|||
143418259|NCT05066230|517078179|FG001|After Week 48|Non-compliance with study schedule|0|||
143418260|NCT05066230|517078178|FG000|After Week 48|Withdrawal by Subject|0|||
143418261|NCT05066230|517078179|FG001|After Week 48|Withdrawal by Subject|1|||
143418262|NCT05066230|517078178|FG000|After Week 48|Lost to Follow-up|3|||
143418263|NCT05066230|517078179|FG001|After Week 48|Lost to Follow-up|3|||
143418264|NCT05066230|517078178|FG000|After Week 48|Sponsor Request|115|||
143418265|NCT05066230|517078179|FG001|After Week 48|Sponsor Request|111|||
143418266|NCT01241448|517078180|FG000|Overall Study|Adverse Event|1|||
143418267|NCT01241448|517078181|FG001|Overall Study|Adverse Event|0|||
143418268|NCT01241448|517078182|FG002|Overall Study|Adverse Event|2|||
143418269|NCT01241448|517078183|FG003|Overall Study|Adverse Event|2|||
143418270|NCT01241448|517078180|FG000|Overall Study|Lost to Follow-up|2|||
143418271|NCT01241448|517078181|FG001|Overall Study|Lost to Follow-up|1|||
143418272|NCT01241448|517078182|FG002|Overall Study|Lost to Follow-up|1|||
143418273|NCT01241448|517078183|FG003|Overall Study|Lost to Follow-up|1|||
143418274|NCT01241448|517078180|FG000|Overall Study|Physician Decision|0|||
143418275|NCT01241448|517078181|FG001|Overall Study|Physician Decision|2|||
143418276|NCT01241448|517078182|FG002|Overall Study|Physician Decision|0|||
143418277|NCT01241448|517078183|FG003|Overall Study|Physician Decision|0|||
143418278|NCT01241448|517078180|FG000|Overall Study|Protocol Violation|10|||
143418279|NCT01241448|517078181|FG001|Overall Study|Protocol Violation|5|||
143418280|NCT01241448|517078182|FG002|Overall Study|Protocol Violation|3|||
143418281|NCT01241448|517078183|FG003|Overall Study|Protocol Violation|6|||
143418282|NCT01241448|517078180|FG000|Overall Study|Sponsor Decision|17|||
143418283|NCT01241448|517078181|FG001|Overall Study|Sponsor Decision|14|||
143418284|NCT01241448|517078182|FG002|Overall Study|Sponsor Decision|12|||
143418285|NCT01241448|517078183|FG003|Overall Study|Sponsor Decision|6|||
143418286|NCT01241448|517078180|FG000|Overall Study|Withdrawal by Subject|4|||
143418287|NCT01241448|517078181|FG001|Overall Study|Withdrawal by Subject|5|||
143418288|NCT01241448|517078182|FG002|Overall Study|Withdrawal by Subject|3|||
143418289|NCT01241448|517078183|FG003|Overall Study|Withdrawal by Subject|6|||
143418290|NCT01241448|517078180|FG000|Overall Study|Excluded due to data integrity issues|3|||
143418291|NCT01241448|517078181|FG001|Overall Study|Excluded due to data integrity issues|2|||
143418292|NCT01241448|517078182|FG002|Overall Study|Excluded due to data integrity issues|2|||
143418293|NCT01241448|517078183|FG003|Overall Study|Excluded due to data integrity issues|2|||
143418294|NCT03340961|517078184|FG000|Overall Study|Adverse Event|1|||
143418295|NCT03340961|517078185|FG001|Overall Study|Adverse Event|3|||
143418296|NCT03340961|517078186|FG002|Overall Study|Adverse Event|2|||
143418297|NCT03340961|517078187|FG003|Overall Study|Adverse Event|4|||
143418298|NCT03340961|517078184|FG000|Overall Study|Lost to Follow-up|0|||
143418299|NCT03340961|517078185|FG001|Overall Study|Lost to Follow-up|1|||
143418300|NCT03340961|517078186|FG002|Overall Study|Lost to Follow-up|0|||
143418301|NCT03340961|517078187|FG003|Overall Study|Lost to Follow-up|1|||
143418302|NCT03340961|517078184|FG000|Overall Study|Withdrawal by Subject|3|||
143418303|NCT03340961|517078185|FG001|Overall Study|Withdrawal by Subject|2|||
143418304|NCT03340961|517078186|FG002|Overall Study|Withdrawal by Subject|4|||
143418305|NCT03340961|517078187|FG003|Overall Study|Withdrawal by Subject|7|||
143418306|NCT03340961|517078184|FG000|Overall Study|Use of prohibited treatment|0|||
143418307|NCT03340961|517078185|FG001|Overall Study|Use of prohibited treatment|3|||
143418308|NCT03340961|517078186|FG002|Overall Study|Use of prohibited treatment|2|||
143418309|NCT03340961|517078187|FG003|Overall Study|Use of prohibited treatment|4|||
143418310|NCT03340961|517078184|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
143418311|NCT03340961|517078185|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
143418312|NCT03340961|517078186|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
143418313|NCT03340961|517078187|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
143418314|NCT03340961|517078184|FG000|Overall Study|Subject developed an exclusion criterion|0|||
143418315|NCT03340961|517078185|FG001|Overall Study|Subject developed an exclusion criterion|1|||
143418316|NCT03340961|517078186|FG002|Overall Study|Subject developed an exclusion criterion|0|||
143418317|NCT03340961|517078187|FG003|Overall Study|Subject developed an exclusion criterion|0|||
143418318|NCT03340961|517078184|FG000|Overall Study|Protocol Violation|1|||
143418319|NCT03340961|517078185|FG001|Overall Study|Protocol Violation|0|||
143418320|NCT03340961|517078186|FG002|Overall Study|Protocol Violation|1|||
143418321|NCT03340961|517078187|FG003|Overall Study|Protocol Violation|0|||
143418322|NCT03340961|517078184|FG000|Overall Study|Adverse Event|1|||
143418323|NCT03340961|517078185|FG001|Overall Study|Adverse Event|1|||
143418324|NCT03340961|517078186|FG002|Overall Study|Adverse Event|0|||
143418325|NCT03340961|517078187|FG003|Overall Study|Adverse Event|0|||
143418326|NCT03340961|517078184|FG000|Overall Study|Lack of Efficacy|0|||
143418327|NCT03340961|517078185|FG001|Overall Study|Lack of Efficacy|0|||
143418328|NCT03340961|517078186|FG002|Overall Study|Lack of Efficacy|0|||
143418329|NCT03340961|517078187|FG003|Overall Study|Lack of Efficacy|1|||
143418330|NCT04311983|517078188|FG000|Overall Study|Lost to Follow-up|421|||
143418331|NCT04311983|517078189|FG001|Overall Study|Lost to Follow-up|456|||
143418332|NCT04311983|517078188|FG000|Overall Study|Incomplete survey|7|||
143418333|NCT04311983|517078189|FG001|Overall Study|Incomplete survey|9|||
143418334|NCT04311983|517078188|FG000|Overall Study|Death|1|||
143418335|NCT04311983|517078189|FG001|Overall Study|Death|0|||
143418336|NCT02165202|517078195|FG000|Oral Phase|Refused further participation|5|||
143418337|NCT02165202|517078196|FG001|Oral Phase|Refused further participation|1|||
143418338|NCT02165202|517078195|FG000|Oral Phase|Study product Related Toxicity|1|||
143418339|NCT02165202|517078196|FG001|Oral Phase|Study product Related Toxicity|0|||
143418340|NCT02165202|517078195|FG000|Oral Phase|Unable to contact Participant|1|||
143418341|NCT02165202|517078196|FG001|Oral Phase|Unable to contact Participant|1|||
143418342|NCT02165202|517078195|FG000|Oral Phase|Clinical reasons|1|||
143418343|NCT02165202|517078196|FG001|Oral Phase|Clinical reasons|0|||
143418344|NCT02165202|517078195|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
143418345|NCT02165202|517078196|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
143418346|NCT02165202|517078195|FG000|Oral Phase|CMC advised termination|1|||
143418347|NCT02165202|517078196|FG001|Oral Phase|CMC advised termination|0|||
143418348|NCT02165202|517078195|FG000|Oral Phase|Relocated, no follow-up planned|1|||
143418349|NCT02165202|517078196|FG001|Oral Phase|Relocated, no follow-up planned|0|||
143418350|NCT02165202|517078195|FG000|Oral Phase|Abnormal EKG|0|||
143418351|NCT02165202|517078196|FG001|Oral Phase|Abnormal EKG|1|||
143418352|NCT02165202|517078195|FG000|Injection Phase|Abnormal Lab Value|5|||
143418353|NCT02165202|517078196|FG001|Injection Phase|Abnormal Lab Value|1|||
143418354|NCT02165202|517078195|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
143418355|NCT02165202|517078196|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
143418356|NCT02165202|517078195|FG000|Injection Phase|Unable to attend within Visit Window|1|||
143418357|NCT02165202|517078196|FG001|Injection Phase|Unable to attend within Visit Window|0|||
143418358|NCT02165202|517078195|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
143418359|NCT02165202|517078196|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
143418360|NCT02165202|517078195|FG000|Injection Phase|End of Study|2|||
143418361|NCT02165202|517078196|FG001|Injection Phase|End of Study|1|||
143418362|NCT02165202|517078195|FG000|Injection Phase|Study Product related Toxicity|1|||
143418363|NCT02165202|517078196|FG001|Injection Phase|Study Product related Toxicity|0|||
143418364|NCT02165202|517078195|FG000|Injection Phase|No longer interested|0|||
143418365|NCT02165202|517078196|FG001|Injection Phase|No longer interested|1|||
143418366|NCT02165202|517078195|FG000|Injection Phase|Participant unwilling to comply|1|||
143418367|NCT02165202|517078196|FG001|Injection Phase|Participant unwilling to comply|0|||
143418368|NCT01975701|517078204|FG000|Overall Study|Lost to Follow-up|1|||
143418369|NCT01975701|517078204|FG000|Overall Study|Death|23|||
143418370|NCT01975701|517078204|FG000|Overall Study|Physician Decision|1|||
143418371|NCT02753075|517078205|FG000|Overall Study|Adverse Event|2|||
143418372|NCT02753075|517078206|FG001|Overall Study|Adverse Event|1|||
143418373|NCT02753075|517078207|FG002|Overall Study|Adverse Event|0|||
143418374|NCT02753075|517078205|FG000|Overall Study|Lost to Follow-up|2|||
143418375|NCT02753075|517078206|FG001|Overall Study|Lost to Follow-up|0|||
143418376|NCT02753075|517078207|FG002|Overall Study|Lost to Follow-up|0|||
143418377|NCT02753075|517078205|FG000|Overall Study|Withdrawal of Consent|1|||
143418378|NCT02753075|517078206|FG001|Overall Study|Withdrawal of Consent|1|||
143418379|NCT02753075|517078207|FG002|Overall Study|Withdrawal of Consent|3|||
143418380|NCT02753075|517078205|FG000|Overall Study|Physician Decision|3|||
143418381|NCT02753075|517078206|FG001|Overall Study|Physician Decision|1|||
143418382|NCT02753075|517078207|FG002|Overall Study|Physician Decision|0|||
143418383|NCT02152384|517078210|FG000|Period 1|Withdrawal by Subject|0|||
143418384|NCT02152384|517078211|FG001|Period 1|Withdrawal by Subject|1|||
143418385|NCT02152384|517078210|FG000|Period 1|Adverse Event|1|||
143418386|NCT02152384|517078211|FG001|Period 1|Adverse Event|1|||
143418387|NCT02446015|517078212|FG000|Overall Study|Adverse Event|0|||
143418388|NCT02446015|517078213|FG001|Overall Study|Adverse Event|1|||
143418389|NCT02446015|517078212|FG000|Overall Study|Withdrawal by Subject|1|||
143418390|NCT02446015|517078213|FG001|Overall Study|Withdrawal by Subject|0|||
143418391|NCT00603798|517078214|FG000|Overall Study|Adverse Event|4|||
143418392|NCT00603798|517078215|FG001|Overall Study|Adverse Event|2|||
143418393|NCT00603798|517078216|FG002|Overall Study|Adverse Event|1|||
143418394|NCT00603798|517078214|FG000|Overall Study|Withdrawal by Subject|4|||
143418395|NCT00603798|517078215|FG001|Overall Study|Withdrawal by Subject|3|||
143418396|NCT00603798|517078216|FG002|Overall Study|Withdrawal by Subject|4|||
143418397|NCT00603798|517078214|FG000|Overall Study|Lost to Follow-up|1|||
143418398|NCT00603798|517078215|FG001|Overall Study|Lost to Follow-up|0|||
143418399|NCT00603798|517078216|FG002|Overall Study|Lost to Follow-up|1|||
143418400|NCT00603798|517078214|FG000|Overall Study|Non-compliance with study procedures|0|||
143418401|NCT00603798|517078215|FG001|Overall Study|Non-compliance with study procedures|1|||
143418402|NCT00603798|517078216|FG002|Overall Study|Non-compliance with study procedures|0|||
143418403|NCT00603798|517078214|FG000|Overall Study|Not due to AE|1|||
143418404|NCT00603798|517078215|FG001|Overall Study|Not due to AE|1|||
143418405|NCT00603798|517078216|FG002|Overall Study|Not due to AE|4|||
143418406|NCT00871494|517078217|FG000|Overall Study|Protocol Violation|5|||
143418407|NCT00871494|517078217|FG000|Overall Study|Lack of Efficacy|4|||
143418408|NCT00871494|517078217|FG000|Overall Study|Adverse Event|4|||
143418409|NCT00871494|517078217|FG000|Overall Study|Lost to Follow-up|1|||
143418410|NCT01090739|517078221|FG000|Enrollment|Withdrawal by Subject|24|||
143418411|NCT01090739|517078221|FG000|Enrollment|Protocol Violation|14|||
143418412|NCT01090739|517078221|FG000|Enrollment|Lost to Follow-up|5|||
143418413|NCT01090739|517078221|FG000|Enrollment|Physician Decision|5|||
143418414|NCT01090739|517078221|FG000|Enrollment|Sponsor termination of site|4|||
143418415|NCT01090739|517078221|FG000|Enrollment|Study implant limit reached|2|||
143418416|NCT01090739|517078221|FG000|Enrollment|Adverse Event|1|||
143418417|NCT01090739|517078221|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
143418418|NCT01090739|517078221|FG000|12 Month Follow-up|Lost to Follow-up|1|||
143418419|NCT01090739|517078221|FG000|12 Month Follow-up|Physician Decision|1|||
143418420|NCT01090739|517078221|FG000|12 Month Follow-up|Death|1|||
143418421|NCT01090739|517078221|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
143418422|NCT01090739|517078221|FG000|24 Month Follow-up|Lost to Follow-up|1|||
143418423|NCT01090739|517078221|FG000|24 Month Follow-up|Death|1|||
143418424|NCT01090739|517078221|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
143418425|NCT01090739|517078221|FG000|36 Month Follow-up|Visit still pending|17|||
143418426|NCT00441168|517078222|FG000|Treatment Period|Death|3|||
143418427|NCT00441168|517078223|FG001|Treatment Period|Death|0|||
143418428|NCT00441168|517078222|FG000|Treatment Period|Adverse Event|1|||
143418429|NCT00441168|517078223|FG001|Treatment Period|Adverse Event|2|||
143418430|NCT00441168|517078222|FG000|Treatment Period|Progressive Disease|0|||
143418431|NCT00441168|517078223|FG001|Treatment Period|Progressive Disease|2|||
143418432|NCT00441168|517078222|FG000|Treatment Period|Protocol Violation|0|||
143418433|NCT00441168|517078223|FG001|Treatment Period|Protocol Violation|1|||
143418434|NCT00441168|517078222|FG000|Treatment Period|Lost to Follow-up|0|||
143418435|NCT00441168|517078223|FG001|Treatment Period|Lost to Follow-up|1|||
143418436|NCT00441168|517078222|FG000|Treatment Period|Withdrawal by Subject|3|||
143418437|NCT00441168|517078223|FG001|Treatment Period|Withdrawal by Subject|0|||
143418438|NCT00441168|517078222|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
143418439|NCT00441168|517078223|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
143418440|NCT00441168|517078222|FG000|Treatment Period|refractory disease|1|||
143418441|NCT00441168|517078223|FG001|Treatment Period|refractory disease|0|||
143418442|NCT00441168|517078222|FG000|Follow-up Period|Death|3|||
143418443|NCT00441168|517078223|FG001|Follow-up Period|Death|0|||
143418444|NCT00441168|517078222|FG000|Follow-up Period|Lost to Follow-up|5|||
143418445|NCT00441168|517078223|FG001|Follow-up Period|Lost to Follow-up|6|||
143418446|NCT00441168|517078222|FG000|Follow-up Period|Withdrawal by Subject|3|||
143418447|NCT00441168|517078223|FG001|Follow-up Period|Withdrawal by Subject|0|||
143418448|NCT00441168|517078222|FG000|Follow-up Period|Other|1|||
143418449|NCT00441168|517078223|FG001|Follow-up Period|Other|3|||
143418450|NCT00988429|517078224|FG000|Overall Study|Adverse Event|9|||
143418451|NCT00988429|517078225|FG001|Overall Study|Adverse Event|21|||
143418452|NCT00988429|517078226|FG002|Overall Study|Adverse Event|45|||
143418453|NCT00988429|517078224|FG000|Overall Study|Lack of Efficacy|0|||
143418454|NCT00988429|517078225|FG001|Overall Study|Lack of Efficacy|0|||
143418455|NCT00988429|517078226|FG002|Overall Study|Lack of Efficacy|1|||
143418456|NCT00988429|517078224|FG000|Overall Study|Non-Compliance with Study Drug|5|||
143418457|NCT00988429|517078225|FG001|Overall Study|Non-Compliance with Study Drug|1|||
143418458|NCT00988429|517078226|FG002|Overall Study|Non-Compliance with Study Drug|3|||
143418459|NCT00988429|517078224|FG000|Overall Study|Physician Decision|1|||
143418460|NCT00988429|517078225|FG001|Overall Study|Physician Decision|0|||
143418461|NCT00988429|517078226|FG002|Overall Study|Physician Decision|3|||
143418462|NCT00988429|517078224|FG000|Overall Study|Pregnancy|2|||
143418463|NCT00988429|517078225|FG001|Overall Study|Pregnancy|1|||
143418464|NCT00988429|517078226|FG002|Overall Study|Pregnancy|0|||
143418465|NCT00988429|517078224|FG000|Overall Study|Protocol Violation|4|||
143418466|NCT00988429|517078225|FG001|Overall Study|Protocol Violation|3|||
143418467|NCT00988429|517078226|FG002|Overall Study|Protocol Violation|3|||
143418468|NCT00988429|517078224|FG000|Overall Study|Withdrawal by Subject|7|||
143418469|NCT00988429|517078225|FG001|Overall Study|Withdrawal by Subject|7|||
143418470|NCT00988429|517078226|FG002|Overall Study|Withdrawal by Subject|12|||
143418471|NCT00988429|517078224|FG000|Overall Study|Administrative Reasons|1|||
143418472|NCT00988429|517078225|FG001|Overall Study|Administrative Reasons|2|||
143418473|NCT00988429|517078226|FG002|Overall Study|Administrative Reasons|1|||
143418474|NCT00988429|517078224|FG000|Overall Study|other reasons|8|||
143418475|NCT00988429|517078225|FG001|Overall Study|other reasons|8|||
143418476|NCT00988429|517078226|FG002|Overall Study|other reasons|1|||
143418477|NCT02964234|517078227|FG000|Overall Study|Lost to Follow-up|22|||
143418478|NCT02964234|517078228|FG001|Overall Study|Lost to Follow-up|13|||
143418479|NCT01799993|517078229|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
143418480|NCT01799993|517078230|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
143418481|NCT01799993|517078229|FG000|Overall Study|Death|61|||
143418482|NCT01799993|517078230|FG001|Overall Study|Death|45|||
143418483|NCT01799993|517078229|FG000|Overall Study|Withdrawal by Subject|23|||
143418484|NCT01799993|517078230|FG001|Overall Study|Withdrawal by Subject|24|||
143418485|NCT01799993|517078229|FG000|Overall Study|Lost to Follow-up|5|||
143418486|NCT01799993|517078230|FG001|Overall Study|Lost to Follow-up|8|||
143418487|NCT01799993|517078229|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
143418488|NCT01799993|517078230|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
143418489|NCT01799993|517078229|FG000|Overall Study|Protocol driven decision point|0|||
143418490|NCT01799993|517078230|FG001|Overall Study|Protocol driven decision point|3|||
143418491|NCT01799993|517078229|FG000|Overall Study|Protocol Violation|1|||
143418492|NCT01799993|517078230|FG001|Overall Study|Protocol Violation|1|||
143418493|NCT01799993|517078229|FG000|Overall Study|Deterioration of general conditions|2|||
143418494|NCT01799993|517078230|FG001|Overall Study|Deterioration of general conditions|0|||
143418495|NCT01799993|517078229|FG000|Overall Study|Screen failure|0|||
143418496|NCT01799993|517078230|FG001|Overall Study|Screen failure|1|||
143418497|NCT01799993|517078229|FG000|Overall Study|Adverse Event|1|||
143418498|NCT01799993|517078230|FG001|Overall Study|Adverse Event|0|||
143418499|NCT01799993|517078229|FG000|Overall Study|Lack of Efficacy|1|||
143418500|NCT01799993|517078230|FG001|Overall Study|Lack of Efficacy|0|||
143418501|NCT01799993|517078229|FG000|Overall Study|Recovery|0|||
143418502|NCT01799993|517078230|FG001|Overall Study|Recovery|1|||
143418503|NCT01799993|517078229|FG000|Overall Study|Logistical difficulties|1|||
143418504|NCT01799993|517078230|FG001|Overall Study|Logistical difficulties|0|||
143418505|NCT01799993|517078229|FG000|Overall Study|Protocol deviation|1|||
143418506|NCT01799993|517078230|FG001|Overall Study|Protocol deviation|0|||
143418507|NCT01799993|517078229|FG000|Overall Study|Non-compliance with medical device|1|||
143418508|NCT01799993|517078230|FG001|Overall Study|Non-compliance with medical device|0|||
143418509|NCT01799993|517078229|FG000|Overall Study|Withdrawal by parent/guardian|0|||
143418510|NCT01799993|517078230|FG001|Overall Study|Withdrawal by parent/guardian|1|||
143418511|NCT01799993|517078229|FG000|Overall Study|Other|1|||
143418512|NCT01799993|517078230|FG001|Overall Study|Other|0|||
143418513|NCT01799993|517078229|FG000|Overall Study|Subject didn't return for follow-up|0|||
143418514|NCT01799993|517078230|FG001|Overall Study|Subject didn't return for follow-up|1|||
143418515|NCT04410445|517078231|FG000|Overall Study|Lost to Follow-up|3|||
143418516|NCT04410445|517078232|FG001|Overall Study|Lost to Follow-up|9|||
143418517|NCT04410445|517078231|FG000|Overall Study|Withdrawal by Subject|27|||
143418518|NCT04410445|517078232|FG001|Overall Study|Withdrawal by Subject|15|||
143418519|NCT01320683|517078233|FG000|Overall Study|Positive antibody response|1|||
143418520|NCT02671266|517078239|FG000|Overall Study|Withdrawal by Subject|1|||
143418521|NCT02671266|517078240|FG001|Overall Study|Withdrawal by Subject|1|||
143418522|NCT03845517|517078241|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
143418523|NCT03845517|517078242|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
143418524|NCT03845517|517078243|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
143418525|NCT03845517|517078244|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
143418526|NCT03845517|517078241|FG000|Treatment Period (52 Weeks)|Death|0|||
143418527|NCT03845517|517078242|FG001|Treatment Period (52 Weeks)|Death|0|||
143418528|NCT03845517|517078243|FG002|Treatment Period (52 Weeks)|Death|1|||
143418529|NCT03845517|517078244|FG003|Treatment Period (52 Weeks)|Death|0|||
143418530|NCT03845517|517078241|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
143418531|NCT03845517|517078242|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
143418532|NCT03845517|517078243|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
143418533|NCT03845517|517078244|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
143418534|NCT03845517|517078241|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
143418535|NCT03845517|517078242|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
143418536|NCT03845517|517078243|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
143418537|NCT03845517|517078244|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
143418538|NCT03845517|517078241|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
143418539|NCT03845517|517078242|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
143418540|NCT03845517|517078243|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
143418541|NCT03845517|517078244|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
143418542|NCT03845517|517078241|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
143418543|NCT03845517|517078242|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
143418544|NCT03845517|517078243|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
143418545|NCT03845517|517078244|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
143418546|NCT03845517|517078241|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
143418547|NCT03845517|517078242|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
143418548|NCT03845517|517078243|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
143418549|NCT03845517|517078244|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
143418550|NCT03845517|517078241|FG000|Treatment Period (52 Weeks)|Other|2|||
143418551|NCT03845517|517078242|FG001|Treatment Period (52 Weeks)|Other|0|||
143418552|NCT03845517|517078243|FG002|Treatment Period (52 Weeks)|Other|0|||
143418553|NCT03845517|517078244|FG003|Treatment Period (52 Weeks)|Other|0|||
143418554|NCT03845517|517078241|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
143418555|NCT03845517|517078242|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
143418556|NCT03845517|517078243|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
143418557|NCT03845517|517078244|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
143418558|NCT03845517|517078241|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
143418559|NCT03845517|517078242|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
143418560|NCT03845517|517078243|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
143418561|NCT03845517|517078244|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
143418562|NCT03845517|517078241|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
143418563|NCT03845517|517078242|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
143418564|NCT03845517|517078243|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
143418565|NCT03845517|517078244|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
143418566|NCT03845517|517078241|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
143418567|NCT03845517|517078242|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
143418568|NCT03845517|517078243|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
143418569|NCT03845517|517078244|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
143418570|NCT03845517|517078241|FG000|Follow-up Period (4 Weeks)|Death|0|||
143418571|NCT03845517|517078242|FG001|Follow-up Period (4 Weeks)|Death|0|||
143418572|NCT03845517|517078243|FG002|Follow-up Period (4 Weeks)|Death|1|||
143418573|NCT03845517|517078244|FG003|Follow-up Period (4 Weeks)|Death|1|||
143418574|NCT03845517|517078241|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
143418575|NCT03845517|517078242|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
143418576|NCT03845517|517078243|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
143418577|NCT03845517|517078244|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
143418578|NCT03845517|517078241|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
143418579|NCT03845517|517078242|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
143418580|NCT03845517|517078243|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
143418581|NCT03845517|517078244|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
143418582|NCT03845517|517078241|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
143418583|NCT03845517|517078242|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
143418584|NCT03845517|517078243|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
143418585|NCT03845517|517078244|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
143418586|NCT03845517|517078241|FG000|Follow-up Period (4 Weeks)|Other|1|||
143418587|NCT03845517|517078242|FG001|Follow-up Period (4 Weeks)|Other|0|||
143418588|NCT03845517|517078243|FG002|Follow-up Period (4 Weeks)|Other|1|||
143418589|NCT03845517|517078244|FG003|Follow-up Period (4 Weeks)|Other|0|||
143418590|NCT03845517|517078241|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
143418591|NCT03845517|517078242|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
143418592|NCT03845517|517078243|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
143418593|NCT03845517|517078244|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
143418594|NCT03845517|517078241|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
143418595|NCT03845517|517078242|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
143418596|NCT03845517|517078243|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
143418597|NCT03845517|517078244|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
143418598|NCT03845517|517078241|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
143418599|NCT03845517|517078242|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
143418600|NCT03845517|517078243|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
143418601|NCT03845517|517078244|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
143418602|NCT01109979|517078245|FG000|Overall Study|Physician Decision|2|||
143418603|NCT01109979|517078246|FG001|Overall Study|Physician Decision|0|||
143418604|NCT01109979|517078245|FG000|Overall Study|Withdrawal by Subject|0|||
143418605|NCT01109979|517078246|FG001|Overall Study|Withdrawal by Subject|1|||
143418606|NCT00807599|517078250|FG000|Overall Study|Not treated on protocol study|0|||
143418607|NCT00807599|517078251|FG001|Overall Study|Not treated on protocol study|0|||
143418608|NCT00807599|517078252|FG002|Overall Study|Not treated on protocol study|2|||
143418609|NCT00807599|517078250|FG000|Overall Study|Adverse Event|0|||
143418610|NCT00807599|517078251|FG001|Overall Study|Adverse Event|0|||
143418611|NCT00807599|517078252|FG002|Overall Study|Adverse Event|5|||
143418612|NCT00807599|517078250|FG000|Overall Study|Inadequate response to induction|0|||
143418613|NCT00807599|517078251|FG001|Overall Study|Inadequate response to induction|0|||
143418614|NCT00807599|517078252|FG002|Overall Study|Inadequate response to induction|9|||
143418615|NCT00807599|517078250|FG000|Overall Study|Withdrawal by Subject|0|||
143418616|NCT00807599|517078251|FG001|Overall Study|Withdrawal by Subject|0|||
143418617|NCT00807599|517078252|FG002|Overall Study|Withdrawal by Subject|1|||
143418618|NCT01137682|517078255|FG000|Overall Study|Adverse Event-CORE|2|||
143418619|NCT01137682|517078256|FG001|Overall Study|Adverse Event-CORE|4|||
143418620|NCT01137682|517078257|FG002|Overall Study|Adverse Event-CORE|0|||
143418621|NCT01137682|517078255|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
143418622|NCT01137682|517078256|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
143418623|NCT01137682|517078257|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
143418624|NCT01137682|517078255|FG000|Overall Study|Administrative problems-CORE|2|||
143418625|NCT01137682|517078256|FG001|Overall Study|Administrative problems-CORE|1|||
143418626|NCT01137682|517078257|FG002|Overall Study|Administrative problems-CORE|0|||
143418627|NCT01137682|517078255|FG000|Overall Study|Protocol Violation-CORE|0|||
143418628|NCT01137682|517078256|FG001|Overall Study|Protocol Violation-CORE|1|||
143418629|NCT01137682|517078257|FG002|Overall Study|Protocol Violation-CORE|1|||
143418630|NCT01137682|517078255|FG000|Overall Study|Adverse Event-Extension|4|||
143418631|NCT01137682|517078256|FG001|Overall Study|Adverse Event-Extension|8|||
143418632|NCT01137682|517078257|FG002|Overall Study|Adverse Event-Extension|7|||
143418633|NCT01137682|517078255|FG000|Overall Study|Lack of Efficacy-Extension|15|||
143418634|NCT01137682|517078256|FG001|Overall Study|Lack of Efficacy-Extension|9|||
143418635|NCT01137682|517078257|FG002|Overall Study|Lack of Efficacy-Extension|13|||
143418636|NCT01137682|517078255|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
143418637|NCT01137682|517078256|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
143418638|NCT01137682|517078257|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
143418639|NCT01137682|517078255|FG000|Overall Study|Lost to Follow Up-Extension|0|||
143418640|NCT01137682|517078256|FG001|Overall Study|Lost to Follow Up-Extension|1|||
143418641|NCT01137682|517078257|FG002|Overall Study|Lost to Follow Up-Extension|0|||
143418642|NCT01137682|517078255|FG000|Overall Study|Administrative problems-Extension|0|||
143418643|NCT01137682|517078256|FG001|Overall Study|Administrative problems-Extension|2|||
143418644|NCT01137682|517078257|FG002|Overall Study|Administrative problems-Extension|0|||
143418645|NCT01137682|517078255|FG000|Overall Study|Death-Extension|2|||
143418646|NCT01137682|517078256|FG001|Overall Study|Death-Extension|0|||
143418647|NCT01137682|517078257|FG002|Overall Study|Death-Extension|0|||
143418648|NCT01137682|517078255|FG000|Overall Study|Protocol Violation-Extension|2|||
143418649|NCT01137682|517078256|FG001|Overall Study|Protocol Violation-Extension|1|||
143418650|NCT01137682|517078257|FG002|Overall Study|Protocol Violation-Extension|0|||
143418651|NCT01137682|517078255|FG000|Overall Study|Did not enter extension|2|||
143418652|NCT01137682|517078256|FG001|Overall Study|Did not enter extension|3|||
143418653|NCT01137682|517078257|FG002|Overall Study|Did not enter extension|2|||
143418654|NCT01137682|517078255|FG000|Overall Study|Did not receive treatment in extension|0|||
143418655|NCT01137682|517078256|FG001|Overall Study|Did not receive treatment in extension|0|||
143418656|NCT01137682|517078257|FG002|Overall Study|Did not receive treatment in extension|1|||
143418657|NCT02009332|517078260|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
143418658|NCT02009332|517078261|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
143418659|NCT02009332|517078262|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
143418660|NCT02009332|517078263|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
143418661|NCT02009332|517078264|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
143418662|NCT02009332|517078265|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
143418663|NCT02009332|517078260|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
143418664|NCT02009332|517078261|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
143418665|NCT02009332|517078262|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
143418666|NCT02009332|517078263|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
143418667|NCT02009332|517078264|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
143418668|NCT02009332|517078265|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
143418669|NCT02009332|517078260|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
143418670|NCT02009332|517078261|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
143418671|NCT02009332|517078262|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
143418672|NCT02009332|517078263|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
143418673|NCT02009332|517078264|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
143418674|NCT02009332|517078265|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
143418675|NCT01912599|517078267|FG000|Overall Study|Withdrawal by Subject|0|||
143418676|NCT01912599|517078268|FG001|Overall Study|Withdrawal by Subject|1|||
143418677|NCT03449979|517078275|FG000|Overall Study|Technical difficulty|0|||
143418678|NCT03449979|517078276|FG001|Overall Study|Technical difficulty|0|||
143418679|NCT03449979|517078277|FG002|Overall Study|Technical difficulty|0|||
143418680|NCT03449979|517078278|FG003|Overall Study|Technical difficulty|1|||
143418681|NCT04183491|517078279|FG000|Overall Study|Withdrawal by Subject|0|||
143418682|NCT04183491|517078280|FG001|Overall Study|Withdrawal by Subject|0|||
143418683|NCT04183491|517078281|FG002|Overall Study|Withdrawal by Subject|1|||
143418684|NCT04183491|517078282|FG003|Overall Study|Withdrawal by Subject|0|||
143418685|NCT04183491|517078283|FG004|Overall Study|Withdrawal by Subject|0|||
143418686|NCT04183491|517078284|FG005|Overall Study|Withdrawal by Subject|1|||
143418687|NCT04183491|517078285|FG006|Overall Study|Withdrawal by Subject|0|||
143418688|NCT04867382|517078289|FG000|Overall Study|Did not complete the survey|2|||
143418689|NCT04867382|517078290|FG001|Overall Study|Did not complete the survey|1|||
143418690|NCT02102724|517078295|FG000|Overall Study|Lost to Follow-up|1|||
143418691|NCT02102724|517078296|FG001|Overall Study|Lost to Follow-up|0|||
143418692|NCT02102724|517078295|FG000|Overall Study|surgery for brain aneurysm|1|||
143418693|NCT02102724|517078296|FG001|Overall Study|surgery for brain aneurysm|1|||
143418694|NCT02203513|517078300|FG000|Overall Study|Refused further treatment|2|||
143418695|NCT02203513|517078301|FG001|Overall Study|Refused further treatment|0|||
143418696|NCT02203513|517078302|FG002|Overall Study|Refused further treatment|1|||
143418697|NCT02203513|517078303|FG003|Overall Study|Refused further treatment|0|||
143418698|NCT02203513|517078304|FG004|Overall Study|Refused further treatment|0|||
143418699|NCT02203513|517078300|FG000|Overall Study|Switched to alternative treatment|3|||
143418700|NCT02203513|517078301|FG001|Overall Study|Switched to alternative treatment|4|||
143418701|NCT02203513|517078302|FG002|Overall Study|Switched to alternative treatment|0|||
143418702|NCT02203513|517078303|FG003|Overall Study|Switched to alternative treatment|0|||
143418703|NCT02203513|517078304|FG004|Overall Study|Switched to alternative treatment|4|||
143418704|NCT02203513|517078300|FG000|Overall Study|Did not receive investigational product (IP)|0|||
143418705|NCT02203513|517078301|FG001|Overall Study|Did not receive investigational product (IP)|1|||
143418706|NCT02203513|517078302|FG002|Overall Study|Did not receive investigational product (IP)|0|||
143418707|NCT02203513|517078303|FG003|Overall Study|Did not receive investigational product (IP)|0|||
143418708|NCT02203513|517078304|FG004|Overall Study|Did not receive investigational product (IP)|0|||
143418709|NCT02203513|517078300|FG000|Overall Study|Death (unrelated to study therapy)|1|||
143418710|NCT02203513|517078301|FG001|Overall Study|Death (unrelated to study therapy)|3|||
143418711|NCT02203513|517078302|FG002|Overall Study|Death (unrelated to study therapy)|1|||
143418712|NCT02203513|517078303|FG003|Overall Study|Death (unrelated to study therapy)|0|||
143418713|NCT02203513|517078304|FG004|Overall Study|Death (unrelated to study therapy)|2|||
143418714|NCT02203513|517078300|FG000|Overall Study|Lost to Follow-up|0|||
143418715|NCT02203513|517078301|FG001|Overall Study|Lost to Follow-up|0|||
143418716|NCT02203513|517078302|FG002|Overall Study|Lost to Follow-up|1|||
143418717|NCT02203513|517078303|FG003|Overall Study|Lost to Follow-up|1|||
143418718|NCT02203513|517078304|FG004|Overall Study|Lost to Follow-up|0|||
143418719|NCT02008916|517078305|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
143418720|NCT02008916|517078306|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
143418721|NCT02008916|517078307|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
143418722|NCT02008916|517078305|FG000|Week 16 - 156|Adverse Event|4|||
143418723|NCT02008916|517078306|FG001|Week 16 - 156|Adverse Event|2|||
143418724|NCT02008916|517078307|FG002|Week 16 - 156|Adverse Event|3|||
143418725|NCT02008916|517078305|FG000|Week 16 - 156|Withdrawal by Subject|7|||
143418726|NCT02008916|517078306|FG001|Week 16 - 156|Withdrawal by Subject|3|||
143418727|NCT02008916|517078307|FG002|Week 16 - 156|Withdrawal by Subject|5|||
143418728|NCT02008916|517078305|FG000|Week 16 - 156|No longer requires treatment|0|||
143418729|NCT02008916|517078306|FG001|Week 16 - 156|No longer requires treatment|1|||
143418730|NCT02008916|517078307|FG002|Week 16 - 156|No longer requires treatment|0|||
143418731|NCT02008916|517078305|FG000|Week 16 - 156|Lost to Follow-up|5|||
143418732|NCT02008916|517078306|FG001|Week 16 - 156|Lost to Follow-up|0|||
143418733|NCT02008916|517078307|FG002|Week 16 - 156|Lost to Follow-up|0|||
143418734|NCT02008916|517078305|FG000|Week 16 - 156|Lack of Efficacy|3|||
143418735|NCT02008916|517078306|FG001|Week 16 - 156|Lack of Efficacy|5|||
143418736|NCT02008916|517078307|FG002|Week 16 - 156|Lack of Efficacy|2|||
143418737|NCT02008916|517078305|FG000|Week 16 - 156|Pregnancy|0|||
143418738|NCT02008916|517078306|FG001|Week 16 - 156|Pregnancy|1|||
143418739|NCT02008916|517078307|FG002|Week 16 - 156|Pregnancy|0|||
143418740|NCT02008916|517078305|FG000|Week 16 - 156|Physician Decision|0|||
143418741|NCT02008916|517078306|FG001|Week 16 - 156|Physician Decision|1|||
143418742|NCT02008916|517078307|FG002|Week 16 - 156|Physician Decision|0|||
143418743|NCT01528605|517078308|FG000|Overall Study|Lost to Follow-up|1|||
143418744|NCT01528605|517078309|FG001|Overall Study|Lost to Follow-up|0|||
143418745|NCT01528605|517078310|FG002|Overall Study|Lost to Follow-up|1|||
143418746|NCT01528605|517078311|FG003|Overall Study|Lost to Follow-up|1|||
143418747|NCT01528605|517078312|FG004|Overall Study|Lost to Follow-up|0|||
143418748|NCT01528605|517078313|FG005|Overall Study|Lost to Follow-up|0|||
143418749|NCT01528605|517078308|FG000|Overall Study|Death|1|||
143418750|NCT01528605|517078309|FG001|Overall Study|Death|0|||
143418751|NCT01528605|517078310|FG002|Overall Study|Death|0|||
143418752|NCT01528605|517078311|FG003|Overall Study|Death|0|||
143418753|NCT01528605|517078312|FG004|Overall Study|Death|0|||
143418754|NCT01528605|517078313|FG005|Overall Study|Death|0|||
143418755|NCT02432274|517078327|FG000|Overall Study|Death|2|||
143418756|NCT02432274|517078328|FG001|Overall Study|Death|6|||
143418757|NCT02432274|517078329|FG002|Overall Study|Death|7|||
143418758|NCT02432274|517078330|FG003|Overall Study|Death|0|||
143418759|NCT02432274|517078331|FG004|Overall Study|Death|27|||
143418760|NCT02432274|517078332|FG005|Overall Study|Death|7|||
143418761|NCT02432274|517078333|FG006|Overall Study|Death|9|||
143418762|NCT02432274|517078334|FG007|Overall Study|Death|14|||
143418763|NCT02432274|517078327|FG000|Overall Study|Withdrawal of Consent|0|||
143418764|NCT02432274|517078328|FG001|Overall Study|Withdrawal of Consent|0|||
143418765|NCT02432274|517078329|FG002|Overall Study|Withdrawal of Consent|0|||
143418766|NCT02432274|517078330|FG003|Overall Study|Withdrawal of Consent|0|||
143418767|NCT02432274|517078331|FG004|Overall Study|Withdrawal of Consent|2|||
143418768|NCT02432274|517078332|FG005|Overall Study|Withdrawal of Consent|0|||
143418769|NCT02432274|517078333|FG006|Overall Study|Withdrawal of Consent|1|||
143418770|NCT02432274|517078334|FG007|Overall Study|Withdrawal of Consent|2|||
143418771|NCT00090519|517078335|FG000|Overall Study|Adverse Event|5|||
143418772|NCT00090519|517078336|FG001|Overall Study|Adverse Event|4|||
143418773|NCT00090519|517078335|FG000|Overall Study|Death|9|||
143418774|NCT00090519|517078336|FG001|Overall Study|Death|9|||
143418775|NCT00090519|517078335|FG000|Overall Study|Lost to Follow-up|26|||
143418776|NCT00090519|517078336|FG001|Overall Study|Lost to Follow-up|29|||
143418777|NCT00090519|517078335|FG000|Overall Study|Withdrawal by Subject|28|||
143418778|NCT00090519|517078336|FG001|Overall Study|Withdrawal by Subject|29|||
143418779|NCT00090519|517078335|FG000|Overall Study|Physician Decision|2|||
143418780|NCT00090519|517078336|FG001|Overall Study|Physician Decision|3|||
143418781|NCT00090519|517078335|FG000|Overall Study|Sponsor Decision|3|||
143418782|NCT00090519|517078336|FG001|Overall Study|Sponsor Decision|1|||
143418783|NCT00116649|517078337|FG000|Overall Study|Adverse Event|20|||
143418784|NCT00116649|517078337|FG000|Overall Study|Lack of Efficacy|1|||
143418785|NCT00116649|517078337|FG000|Overall Study|Lost to Follow-up|32|||
143418786|NCT00116649|517078337|FG000|Overall Study|Withdrawal by Subject|68|||
143418787|NCT00116649|517078337|FG000|Overall Study|Local Skin Reaction|9|||
143418788|NCT00116649|517078337|FG000|Overall Study|Various Reasons|18|||
143418789|NCT00116649|517078337|FG000|Overall Study|Protocol Specified|7|||
143418790|NCT02161146|517078338|FG000|Overall Study|Adverse Event|1|||
143418791|NCT02161146|517078339|FG001|Overall Study|Adverse Event|1|||
143418792|NCT02161146|517078340|FG002|Overall Study|Adverse Event|0|||
143418793|NCT02161146|517078341|FG003|Overall Study|Adverse Event|1|||
143418794|NCT02161146|517078342|FG004|Overall Study|Adverse Event|0|||
143418795|NCT02161146|517078338|FG000|Overall Study|Lost to Follow-up|0|||
143418796|NCT02161146|517078339|FG001|Overall Study|Lost to Follow-up|1|||
143418797|NCT02161146|517078340|FG002|Overall Study|Lost to Follow-up|0|||
143418798|NCT02161146|517078341|FG003|Overall Study|Lost to Follow-up|0|||
143418799|NCT02161146|517078342|FG004|Overall Study|Lost to Follow-up|0|||
143418800|NCT02161146|517078338|FG000|Overall Study|Personal Reasons|0|||
143418801|NCT02161146|517078339|FG001|Overall Study|Personal Reasons|1|||
143418802|NCT02161146|517078340|FG002|Overall Study|Personal Reasons|0|||
143418803|NCT02161146|517078341|FG003|Overall Study|Personal Reasons|2|||
143418804|NCT02161146|517078342|FG004|Overall Study|Personal Reasons|1|||
143418805|NCT02161146|517078338|FG000|Overall Study|Other Miscellaneous Reasons|0|||
143418806|NCT02161146|517078339|FG001|Overall Study|Other Miscellaneous Reasons|1|||
143418807|NCT02161146|517078340|FG002|Overall Study|Other Miscellaneous Reasons|0|||
143418808|NCT02161146|517078341|FG003|Overall Study|Other Miscellaneous Reasons|0|||
143418809|NCT02161146|517078342|FG004|Overall Study|Other Miscellaneous Reasons|0|||
143418810|NCT00845520|517078343|FG000|Overall Study|Death|1|||
143418811|NCT00845520|517078344|FG001|Overall Study|Death|2|||
143418812|NCT00845520|517078345|FG002|Overall Study|Death|0|||
143418813|NCT00845520|517078343|FG000|Overall Study|Lost to Follow-up|1|||
143418814|NCT00845520|517078344|FG001|Overall Study|Lost to Follow-up|0|||
143418815|NCT00845520|517078345|FG002|Overall Study|Lost to Follow-up|0|||
143418816|NCT00845520|517078343|FG000|Overall Study|Adverse Event|0|||
143418817|NCT00845520|517078344|FG001|Overall Study|Adverse Event|0|||
143418818|NCT00845520|517078345|FG002|Overall Study|Adverse Event|1|||
143418819|NCT02613403|517078346|FG000|Overall Study|Lost to Follow-up|0|||
143418820|NCT02613403|517078347|FG001|Overall Study|Lost to Follow-up|1|||
143418821|NCT02613403|517078348|FG002|Overall Study|Lost to Follow-up|0|||
143418822|NCT02613403|517078349|FG003|Overall Study|Lost to Follow-up|0|||
143418823|NCT02613403|517078350|FG004|Overall Study|Lost to Follow-up|0|||
143418824|NCT02613403|517078346|FG000|Overall Study|Withdrawal by Subject|2|||
143418825|NCT02613403|517078347|FG001|Overall Study|Withdrawal by Subject|0|||
143418826|NCT02613403|517078348|FG002|Overall Study|Withdrawal by Subject|0|||
143418827|NCT02613403|517078349|FG003|Overall Study|Withdrawal by Subject|0|||
143418828|NCT02613403|517078350|FG004|Overall Study|Withdrawal by Subject|0|||
143418829|NCT00800176|517078351|FG000|Overall Study|Adverse Event|2|||
143418830|NCT00800176|517078352|FG001|Overall Study|Adverse Event|1|||
143418831|NCT00800176|517078353|FG002|Overall Study|Adverse Event|0|||
143418832|NCT00800176|517078354|FG003|Overall Study|Adverse Event|2|||
143418833|NCT00800176|517078355|FG004|Overall Study|Adverse Event|1|||
143418834|NCT00800176|517078356|FG005|Overall Study|Adverse Event|1|||
143418835|NCT00800176|517078351|FG000|Overall Study|Refused treatment|3|||
143418836|NCT00800176|517078352|FG001|Overall Study|Refused treatment|2|||
143418837|NCT00800176|517078353|FG002|Overall Study|Refused treatment|0|||
143418838|NCT00800176|517078354|FG003|Overall Study|Refused treatment|0|||
143418839|NCT00800176|517078355|FG004|Overall Study|Refused treatment|1|||
143418840|NCT00800176|517078356|FG005|Overall Study|Refused treatment|4|||
143418841|NCT00800176|517078351|FG000|Overall Study|Failure to return|3|||
143418842|NCT00800176|517078352|FG001|Overall Study|Failure to return|3|||
143418843|NCT00800176|517078353|FG002|Overall Study|Failure to return|0|||
143418844|NCT00800176|517078354|FG003|Overall Study|Failure to return|2|||
143418845|NCT00800176|517078355|FG004|Overall Study|Failure to return|0|||
143418846|NCT00800176|517078356|FG005|Overall Study|Failure to return|0|||
143418847|NCT00800176|517078351|FG000|Overall Study|Other|1|||
143418848|NCT00800176|517078352|FG001|Overall Study|Other|0|||
143418849|NCT00800176|517078353|FG002|Overall Study|Other|0|||
143418850|NCT00800176|517078354|FG003|Overall Study|Other|0|||
143418851|NCT00800176|517078355|FG004|Overall Study|Other|2|||
143418852|NCT00800176|517078356|FG005|Overall Study|Other|0|||
143418853|NCT00805441|517078359|FG000|Overall Study|Adverse Event|5|||
143418854|NCT00805441|517078360|FG001|Overall Study|Adverse Event|2|||
143418855|NCT00805441|517078359|FG000|Overall Study|Lack of Efficacy|0|||
143418856|NCT00805441|517078360|FG001|Overall Study|Lack of Efficacy|2|||
143418857|NCT00805441|517078359|FG000|Overall Study|Protocol Violation|4|||
143418858|NCT00805441|517078360|FG001|Overall Study|Protocol Violation|8|||
143418859|NCT00805441|517078359|FG000|Overall Study|Lost to Follow-up|10|||
143418860|NCT00805441|517078360|FG001|Overall Study|Lost to Follow-up|13|||
143418861|NCT00805441|517078359|FG000|Overall Study|Withdrawal by Subject|15|||
143418862|NCT00805441|517078360|FG001|Overall Study|Withdrawal by Subject|9|||
143418863|NCT00805441|517078359|FG000|Overall Study|Physician Decision|0|||
143418864|NCT00805441|517078360|FG001|Overall Study|Physician Decision|1|||
143418865|NCT00805441|517078359|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
143418866|NCT00805441|517078360|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
143418867|NCT02935894|517078362|FG000|Overall Study|Subject dismissed|1|||
143418868|NCT03659136|517078367|FG000|Overall Study|Not treated|2|||
143418869|NCT03659136|517078368|FG001|Overall Study|Not treated|0|||
143418870|NCT03659136|517078367|FG000|Overall Study|Covid-19 related|1|||
143418871|NCT03659136|517078368|FG001|Overall Study|Covid-19 related|1|||
143418872|NCT03659136|517078367|FG000|Overall Study|Withdrawal by Subject|1|||
143418873|NCT03659136|517078368|FG001|Overall Study|Withdrawal by Subject|6|||
143418874|NCT03659136|517078367|FG000|Overall Study|Adverse Event|4|||
143418875|NCT03659136|517078368|FG001|Overall Study|Adverse Event|6|||
143418876|NCT03659136|517078367|FG000|Overall Study|Progressive disease|37|||
143418877|NCT03659136|517078368|FG001|Overall Study|Progressive disease|31|||
143418878|NCT03659136|517078367|FG000|Overall Study|Study closure|2|||
143418879|NCT03659136|517078368|FG001|Overall Study|Study closure|2|||
143418880|NCT03659136|517078367|FG000|Overall Study|Sponsor decision/recommendation|3|||
143418881|NCT03659136|517078368|FG001|Overall Study|Sponsor decision/recommendation|2|||
143418882|NCT03659136|517078367|FG000|Overall Study|Switched to other drug/therapy|2|||
143418883|NCT03659136|517078368|FG001|Overall Study|Switched to other drug/therapy|2|||
143418884|NCT03659136|517078367|FG000|Overall Study|Lack of clinical benefit|0|||
143418885|NCT03659136|517078368|FG001|Overall Study|Lack of clinical benefit|1|||
143418886|NCT03786471|517078369|FG000|Overall Study|Death|254|||
143418887|NCT03786471|517078370|FG001|Overall Study|Death|223|||
143418888|NCT03786471|517078371|FG002|Overall Study|Death|37|||
143418889|NCT03786471|517078369|FG000|Overall Study|Lost to Follow-up|63|||
143418890|NCT03786471|517078370|FG001|Overall Study|Lost to Follow-up|50|||
143418891|NCT03786471|517078371|FG002|Overall Study|Lost to Follow-up|15|||
143418892|NCT03786471|517078369|FG000|Overall Study|Withdrawal by Subject|99|||
143418893|NCT03786471|517078370|FG001|Overall Study|Withdrawal by Subject|81|||
143418894|NCT03786471|517078371|FG002|Overall Study|Withdrawal by Subject|11|||
143418895|NCT03840200|517080095|FG000|Overall Study|Death|6|||
143418896|NCT03840200|517080096|FG001|Overall Study|Death|3|||
143418897|NCT03840200|517080097|FG002|Overall Study|Death|6|||
143418898|NCT03840200|517080098|FG003|Overall Study|Death|10|||
143418899|NCT03840200|517080095|FG000|Overall Study|Reason Not Specified|2|||
143418900|NCT03840200|517080096|FG001|Overall Study|Reason Not Specified|2|||
143418901|NCT03840200|517080097|FG002|Overall Study|Reason Not Specified|1|||
143418902|NCT03840200|517080098|FG003|Overall Study|Reason Not Specified|15|||
143418903|NCT03840200|517080095|FG000|Overall Study|Physician Decision|0|||
143418904|NCT03840200|517080096|FG001|Overall Study|Physician Decision|0|||
143418905|NCT03840200|517080097|FG002|Overall Study|Physician Decision|0|||
143418906|NCT03840200|517080098|FG003|Overall Study|Physician Decision|2|||
143418907|NCT03840200|517080095|FG000|Overall Study|Progressive Disease|0|||
143418908|NCT03840200|517080096|FG001|Overall Study|Progressive Disease|0|||
143418909|NCT03840200|517080097|FG002|Overall Study|Progressive Disease|0|||
143418910|NCT03840200|517080098|FG003|Overall Study|Progressive Disease|1|||
143418911|NCT03840200|517080095|FG000|Overall Study|Withdrawal by Subject|0|||
143418912|NCT03840200|517080096|FG001|Overall Study|Withdrawal by Subject|1|||
143418913|NCT03840200|517080097|FG002|Overall Study|Withdrawal by Subject|0|||
143418914|NCT03840200|517080098|FG003|Overall Study|Withdrawal by Subject|2|||
143418915|NCT05522777|517080099|FG000|Overall Study|Lack of Efficacy|1|||
143418916|NCT05522777|517080099|FG000|Overall Study|Withdrawal by Subject|1|||
143418917|NCT05006703|517080100|FG000|Overall Study|Withdrawal by Subject|1|||
143418918|NCT05006703|517080101|FG001|Overall Study|Withdrawal by Subject|0|||
143418919|NCT05006703|517080100|FG000|Overall Study|Lost to Follow-up|13|||
143418920|NCT05006703|517080101|FG001|Overall Study|Lost to Follow-up|5|||
143418921|NCT02659059|517080102|FG000|Overall Study|Other reasons|6|||
143418922|NCT02659059|517080103|FG001|Overall Study|Other reasons|1|||
143418923|NCT02659059|517080102|FG000|Overall Study|Disease Progression|143|||
143418924|NCT02659059|517080103|FG001|Overall Study|Disease Progression|16|||
143418925|NCT02659059|517080102|FG000|Overall Study|Study Drug toxicity|56|||
143418926|NCT02659059|517080103|FG001|Overall Study|Study Drug toxicity|9|||
143418927|NCT02659059|517080102|FG000|Overall Study|Death|3|||
143418928|NCT02659059|517080103|FG001|Overall Study|Death|1|||
143418929|NCT02659059|517080102|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
143418930|NCT02659059|517080103|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
143418931|NCT02659059|517080102|FG000|Overall Study|Participant request to discontinue study treatment|5|||
143418932|NCT02659059|517080103|FG001|Overall Study|Participant request to discontinue study treatment|0|||
143418933|NCT02659059|517080102|FG000|Overall Study|Participant withdrew consent|6|||
143418934|NCT02659059|517080103|FG001|Overall Study|Participant withdrew consent|1|||
143418935|NCT00092456|517080106|FG000|Overall Study|Adverse Event|0|||
143418936|NCT00092456|517080107|FG001|Overall Study|Adverse Event|0|||
143418937|NCT00092456|517080108|FG002|Overall Study|Adverse Event|1|||
143418938|NCT00092456|517080109|FG003|Overall Study|Adverse Event|1|||
143418939|NCT00092456|517080106|FG000|Overall Study|Lost to Follow-up|2|||
143418940|NCT00092456|517080107|FG001|Overall Study|Lost to Follow-up|2|||
143418941|NCT00092456|517080108|FG002|Overall Study|Lost to Follow-up|1|||
143418942|NCT00092456|517080109|FG003|Overall Study|Lost to Follow-up|2|||
143418943|NCT00092456|517080106|FG000|Overall Study|Protocol Violation|5|||
143418944|NCT00092456|517080107|FG001|Overall Study|Protocol Violation|7|||
143418945|NCT00092456|517080108|FG002|Overall Study|Protocol Violation|8|||
143418946|NCT00092456|517080109|FG003|Overall Study|Protocol Violation|6|||
143418947|NCT00092456|517080106|FG000|Overall Study|Withdrawal by Subject|13|||
143418948|NCT00092456|517080107|FG001|Overall Study|Withdrawal by Subject|5|||
143418949|NCT00092456|517080108|FG002|Overall Study|Withdrawal by Subject|16|||
143418950|NCT00092456|517080109|FG003|Overall Study|Withdrawal by Subject|6|||
143418951|NCT00092456|517080106|FG000|Overall Study|Moved|1|||
143418952|NCT00092456|517080107|FG001|Overall Study|Moved|1|||
143418953|NCT00092456|517080108|FG002|Overall Study|Moved|0|||
143418954|NCT00092456|517080109|FG003|Overall Study|Moved|1|||
143418955|NCT00092456|517080106|FG000|Overall Study|Other|4|||
143418956|NCT00092456|517080107|FG001|Overall Study|Other|2|||
143418957|NCT00092456|517080108|FG002|Overall Study|Other|3|||
143418958|NCT00092456|517080109|FG003|Overall Study|Other|0|||
143418959|NCT04783389|517080110|FG000|Overall Study|Withdrawal by Subject|2|||
143418960|NCT04783389|517080111|FG001|Overall Study|Withdrawal by Subject|0|||
143418961|NCT04783389|517080112|FG002|Overall Study|Withdrawal by Subject|0|||
143418962|NCT04783389|517080110|FG000|Overall Study|Termination of Study by Sponsor|10|||
143418963|NCT04783389|517080111|FG001|Overall Study|Termination of Study by Sponsor|12|||
143418964|NCT04783389|517080112|FG002|Overall Study|Termination of Study by Sponsor|14|||
143418965|NCT03924193|517080118|FG000|Overall Study|Adverse Event|10|||
143418966|NCT03924193|517080119|FG001|Overall Study|Adverse Event|0|||
143418967|NCT03924193|517080120|FG002|Overall Study|Adverse Event|10|||
143418968|NCT03924193|517080118|FG000|Overall Study|Withdrawal by Subject|5|||
143418969|NCT03924193|517080119|FG001|Overall Study|Withdrawal by Subject|10|||
143418970|NCT03924193|517080120|FG002|Overall Study|Withdrawal by Subject|2|||
143418971|NCT00647699|517080121|FG000|Overall Study|Lost to Follow-up|5|||
143418972|NCT00647699|517080122|FG001|Overall Study|Lost to Follow-up|4|||
143418973|NCT00647699|517080121|FG000|Overall Study|Withdrawal by Subject|3|||
143418974|NCT00647699|517080122|FG001|Overall Study|Withdrawal by Subject|8|||
143418975|NCT03029585|517080123|FG000|Overall Study|Death|1|||
143418976|NCT03029585|517080124|FG001|Overall Study|Death|1|||
143418977|NCT03029585|517080123|FG000|Overall Study|Withdrawal by Subject|1|||
143418978|NCT03029585|517080124|FG001|Overall Study|Withdrawal by Subject|0|||
143418979|NCT04025762|517080125|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
143418980|NCT04025762|517080126|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
143418981|NCT01286311|517080128|FG000|Overall Study|Physician did not want outreach sent|14|||
143418982|NCT01286311|517080129|FG001|Overall Study|Physician did not want outreach sent|0|||
143418983|NCT00990184|517080132|FG000|Overall Study|Physician Decision|1|||
143418984|NCT02005484|517080134|FG000|Overall Study|Death|1|||
143418985|NCT02005484|517080134|FG000|Overall Study|Disease progression|1|||
143418986|NCT02005484|517080134|FG000|Overall Study|Changed to a Different Study|1|||
143418987|NCT02005484|517080134|FG000|Overall Study|Sponsor decision|1|||
143418988|NCT03695185|517080139|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
143418989|NCT03695185|517080139|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
143418990|NCT03695185|517080139|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
143418991|NCT03695185|517080139|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
143418992|NCT03695185|517080139|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
143418993|NCT03695185|517080139|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
143418994|NCT02137785|517080140|FG000|Overall Study|Lost to Follow-up|1|||
143418995|NCT02137785|517080141|FG001|Overall Study|Lost to Follow-up|0|||
143418996|NCT02137785|517080140|FG000|Overall Study|Withdrawal by Subject|1|||
143418997|NCT02137785|517080141|FG001|Overall Study|Withdrawal by Subject|4|||
143418998|NCT02137785|517080140|FG000|Overall Study|subject moved out of state|1|||
143418999|NCT02137785|517080141|FG001|Overall Study|subject moved out of state|0|||
143419000|NCT02584257|517080142|FG000|Period 1|Withdrawal by Subject|0|||
143419001|NCT02584257|517080143|FG001|Period 1|Withdrawal by Subject|0|||
143419002|NCT02584257|517080144|FG002|Period 1|Withdrawal by Subject|0|||
143419003|NCT02584257|517080145|FG003|Period 1|Withdrawal by Subject|0|||
143419004|NCT02584257|517080146|FG004|Period 1|Withdrawal by Subject|0|||
143419005|NCT02584257|517080147|FG005|Period 1|Withdrawal by Subject|0|||
143419006|NCT02584257|517080148|FG006|Period 1|Withdrawal by Subject|1|||
143419007|NCT02584257|517080149|FG007|Period 1|Withdrawal by Subject|0|||
143419008|NCT02584257|517080150|FG008|Period 1|Withdrawal by Subject|0|||
143419009|NCT02584257|517080142|FG000|Period 2|Physician Decision|1|||
143419010|NCT02584257|517080143|FG001|Period 2|Physician Decision|0|||
143419011|NCT02584257|517080144|FG002|Period 2|Physician Decision|0|||
143419012|NCT02584257|517080145|FG003|Period 2|Physician Decision|0|||
143419013|NCT02584257|517080146|FG004|Period 2|Physician Decision|0|||
143419014|NCT02584257|517080147|FG005|Period 2|Physician Decision|0|||
143419015|NCT02584257|517080148|FG006|Period 2|Physician Decision|0|||
143419016|NCT02584257|517080149|FG007|Period 2|Physician Decision|0|||
143419017|NCT02584257|517080150|FG008|Period 2|Physician Decision|0|||
143419018|NCT02584257|517080142|FG000|Period 2|Adverse Event|0|||
143419019|NCT02584257|517080143|FG001|Period 2|Adverse Event|1|||
143419020|NCT02584257|517080144|FG002|Period 2|Adverse Event|0|||
143419021|NCT02584257|517080145|FG003|Period 2|Adverse Event|0|||
143419022|NCT02584257|517080146|FG004|Period 2|Adverse Event|0|||
143419023|NCT02584257|517080147|FG005|Period 2|Adverse Event|0|||
143419024|NCT02584257|517080148|FG006|Period 2|Adverse Event|0|||
143419025|NCT02584257|517080149|FG007|Period 2|Adverse Event|0|||
143419026|NCT02584257|517080150|FG008|Period 2|Adverse Event|0|||
143419027|NCT01670877|517080151|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
143419028|NCT01670877|517080152|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
143419029|NCT01670877|517080153|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
143419030|NCT01670877|517080154|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
143419031|NCT01670877|517080155|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
143419032|NCT01670877|517080156|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
143419033|NCT01670877|517080151|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
143419034|NCT01670877|517080152|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
143419035|NCT01670877|517080153|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
143419036|NCT01670877|517080154|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
143419037|NCT01670877|517080155|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
143419038|NCT01670877|517080156|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
143419039|NCT01670877|517080151|FG000|Part I and Part 2|Grade 2 vomiting|0|||
143419040|NCT01670877|517080152|FG001|Part I and Part 2|Grade 2 vomiting|0|||
143419041|NCT01670877|517080153|FG002|Part I and Part 2|Grade 2 vomiting|0|||
143419042|NCT01670877|517080154|FG003|Part I and Part 2|Grade 2 vomiting|1|||
143419043|NCT01670877|517080155|FG004|Part I and Part 2|Grade 2 vomiting|0|||
143419044|NCT01670877|517080156|FG005|Part I and Part 2|Grade 2 vomiting|0|||
143419045|NCT01670877|517080151|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
143419046|NCT01670877|517080152|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
143419047|NCT01670877|517080153|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
143419048|NCT01670877|517080154|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
143419049|NCT01670877|517080155|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
143419050|NCT01670877|517080156|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
143419051|NCT01670877|517080151|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
143419052|NCT01670877|517080152|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
143419053|NCT01670877|517080153|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
143419054|NCT01670877|517080154|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
143419055|NCT01670877|517080155|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
143419056|NCT01670877|517080156|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
143419057|NCT00417885|517080157|FG000|Overall Study|Adverse Event|1|||
143419058|NCT00417885|517080157|FG000|Overall Study|Objective Progression or Relapse|3|||
143419059|NCT00417885|517080157|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
143419060|NCT02309892|517080158|FG000|Overall Study|Physician Decision|1|||
143419061|NCT02309892|517080159|FG001|Overall Study|Physician Decision|0|||
143419062|NCT02309892|517080160|FG002|Overall Study|Physician Decision|0|||
143419063|NCT02309892|517080161|FG003|Overall Study|Physician Decision|0|||
143419064|NCT02309892|517080162|FG004|Overall Study|Physician Decision|0|||
143419065|NCT02309892|517080163|FG005|Overall Study|Physician Decision|0|||
143419066|NCT02309892|517080164|FG006|Overall Study|Physician Decision|0|||
143419067|NCT02309892|517080158|FG000|Overall Study|Adverse Event|1|||
143419068|NCT02309892|517080159|FG001|Overall Study|Adverse Event|0|||
143419069|NCT02309892|517080160|FG002|Overall Study|Adverse Event|1|||
143419070|NCT02309892|517080161|FG003|Overall Study|Adverse Event|0|||
143419071|NCT02309892|517080162|FG004|Overall Study|Adverse Event|0|||
143419072|NCT02309892|517080163|FG005|Overall Study|Adverse Event|0|||
143419073|NCT02309892|517080164|FG006|Overall Study|Adverse Event|0|||
143419074|NCT02309892|517080158|FG000|Overall Study|Progressive Disease|0|||
143419075|NCT02309892|517080159|FG001|Overall Study|Progressive Disease|1|||
143419076|NCT02309892|517080160|FG002|Overall Study|Progressive Disease|0|||
143419077|NCT02309892|517080161|FG003|Overall Study|Progressive Disease|0|||
143419078|NCT02309892|517080162|FG004|Overall Study|Progressive Disease|1|||
143419079|NCT02309892|517080163|FG005|Overall Study|Progressive Disease|0|||
143419080|NCT02309892|517080164|FG006|Overall Study|Progressive Disease|0|||
143419081|NCT02309892|517080158|FG000|Overall Study|Death|0|||
143419082|NCT02309892|517080159|FG001|Overall Study|Death|0|||
143419083|NCT02309892|517080160|FG002|Overall Study|Death|0|||
143419084|NCT02309892|517080161|FG003|Overall Study|Death|0|||
143419085|NCT02309892|517080162|FG004|Overall Study|Death|0|||
143419086|NCT02309892|517080163|FG005|Overall Study|Death|1|||
143419087|NCT02309892|517080164|FG006|Overall Study|Death|0|||
143419088|NCT01584648|517080165|FG000|Overall Study|Death|136|||
143419089|NCT01584648|517080166|FG001|Overall Study|Death|146|||
143419090|NCT01584648|517080165|FG000|Overall Study|Lost to Follow-up|9|||
143419091|NCT01584648|517080166|FG001|Overall Study|Lost to Follow-up|9|||
143419092|NCT01584648|517080165|FG000|Overall Study|Investigator discretion|3|||
143419093|NCT01584648|517080166|FG001|Overall Study|Investigator discretion|2|||
143419094|NCT01584648|517080165|FG000|Overall Study|Withdrew consent|13|||
143419095|NCT01584648|517080166|FG001|Overall Study|Withdrew consent|4|||
143419096|NCT01584648|517080165|FG000|Overall Study|Study closed/terminated|50|||
143419097|NCT01584648|517080166|FG001|Overall Study|Study closed/terminated|23|||
143419098|NCT01584648|517080165|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
143419099|NCT01584648|517080166|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
143419100|NCT01722097|517080167|FG000|Overall Study|Patient sheets not returned|6|||
143419101|NCT01722097|517080168|FG001|Overall Study|Patient sheets not returned|5|||
143419102|NCT01757288|517080171|FG000|Overall Study|Consent withdrawal|0|||
143419103|NCT01757288|517080172|FG001|Overall Study|Consent withdrawal|4|||
143419104|NCT01757288|517080173|FG002|Overall Study|Consent withdrawal|4|||
143419105|NCT01757288|517080171|FG000|Overall Study|Patient off study, IRB hold.|0|||
143419106|NCT01757288|517080172|FG001|Overall Study|Patient off study, IRB hold.|0|||
143419107|NCT01757288|517080173|FG002|Overall Study|Patient off study, IRB hold.|1|||
143419108|NCT01757288|517080171|FG000|Overall Study|Patient death prior to starting treatment|0|||
143419109|NCT01757288|517080172|FG001|Overall Study|Patient death prior to starting treatment|0|||
143419110|NCT01757288|517080173|FG002|Overall Study|Patient death prior to starting treatment|1|||
143419111|NCT01757288|517080171|FG000|Overall Study|Wrong medication administered|0|||
143419112|NCT01757288|517080172|FG001|Overall Study|Wrong medication administered|1|||
143419113|NCT01757288|517080173|FG002|Overall Study|Wrong medication administered|0|||
143419114|NCT01757288|517080171|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
143419115|NCT01757288|517080172|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
143419116|NCT01757288|517080173|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
143419117|NCT01757288|517080171|FG000|Overall Study|Not meeting protocol constraints|0|||
143419118|NCT01757288|517080172|FG001|Overall Study|Not meeting protocol constraints|1|||
143419119|NCT01757288|517080173|FG002|Overall Study|Not meeting protocol constraints|1|||
143419120|NCT01757288|517080171|FG000|Overall Study|Multiple missed appointments|0|||
143419121|NCT01757288|517080172|FG001|Overall Study|Multiple missed appointments|1|||
143419122|NCT01757288|517080173|FG002|Overall Study|Multiple missed appointments|0|||
143419123|NCT01757288|517080171|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
143419124|NCT01757288|517080172|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
143419125|NCT01757288|517080173|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
143419126|NCT01757288|517080171|FG000|Overall Study|>2 weeks treatment break|0|||
143419127|NCT01757288|517080172|FG001|Overall Study|>2 weeks treatment break|0|||
143419128|NCT01757288|517080173|FG002|Overall Study|>2 weeks treatment break|1|||
143419129|NCT02825550|517080174|FG000|Overall Study|Physician Decision|1|||
143419130|NCT00042939|517080178|FG000|Overall Study|Adverse Event|6|||
143419131|NCT00042939|517080179|FG001|Overall Study|Adverse Event|7|||
143419132|NCT00042939|517080178|FG000|Overall Study|Death|3|||
143419133|NCT00042939|517080179|FG001|Overall Study|Death|2|||
143419134|NCT00042939|517080178|FG000|Overall Study|Withdrawal by Subject|3|||
143419135|NCT00042939|517080179|FG001|Overall Study|Withdrawal by Subject|4|||
143419136|NCT00042939|517080178|FG000|Overall Study|Other disease|1|||
143419137|NCT00042939|517080179|FG001|Overall Study|Other disease|0|||
143419138|NCT00042939|517080178|FG000|Overall Study|Ineligible|2|||
143419139|NCT00042939|517080179|FG001|Overall Study|Ineligible|2|||
143419140|NCT00042939|517080178|FG000|Overall Study|Deterioration of health|3|||
143419141|NCT00042939|517080179|FG001|Overall Study|Deterioration of health|4|||
143419142|NCT00042939|517080178|FG000|Overall Study|QOL diminished|1|||
143419143|NCT00042939|517080179|FG001|Overall Study|QOL diminished|0|||
143419144|NCT00042939|517080178|FG000|Overall Study|Rising ca 19-9|1|||
143419145|NCT00042939|517080179|FG001|Overall Study|Rising ca 19-9|0|||
143419146|NCT00042939|517080178|FG000|Overall Study|Patient non-compliance|1|||
143419147|NCT00042939|517080179|FG001|Overall Study|Patient non-compliance|0|||
143419148|NCT00042939|517080178|FG000|Overall Study|Still on treatment|1|||
143419149|NCT00042939|517080179|FG001|Overall Study|Still on treatment|0|||
143419150|NCT00042939|517080178|FG000|Overall Study|Treatment break > 4 weeks|0|||
143419151|NCT00042939|517080179|FG001|Overall Study|Treatment break > 4 weeks|1|||
143419152|NCT00042939|517080178|FG000|Overall Study|Did not start treatment|2|||
143419153|NCT00042939|517080179|FG001|Overall Study|Did not start treatment|1|||
143419154|NCT03349476|517080180|FG000|Overall Study|Physician Decision|3|||
143419155|NCT00795639|517080181|FG000|Overall Study|Death|1|||
143419156|NCT00795639|517080182|FG001|Overall Study|Death|6|||
143419157|NCT00795639|517080181|FG000|Overall Study|Withdrawal by Subject|1|||
143419158|NCT00795639|517080182|FG001|Overall Study|Withdrawal by Subject|3|||
143419159|NCT00795639|517080181|FG000|Overall Study|Pregnancy|1|||
143419160|NCT00795639|517080182|FG001|Overall Study|Pregnancy|0|||
143419161|NCT00795639|517080181|FG000|Overall Study|Adverse Event|5|||
143419162|NCT00795639|517080182|FG001|Overall Study|Adverse Event|2|||
143419163|NCT00795639|517080181|FG000|Overall Study|Other|0|||
143419164|NCT00795639|517080182|FG001|Overall Study|Other|2|||
143419165|NCT00795639|517080181|FG000|Overall Study|Terminated by sponsor|13|||
143419166|NCT00795639|517080182|FG001|Overall Study|Terminated by sponsor|12|||
143419167|NCT00795639|517080181|FG000|Overall Study|Randomized and not treated|0|||
143419168|NCT00795639|517080182|FG001|Overall Study|Randomized and not treated|1|||
143419169|NCT00248794|517080183|FG000|Overall Study|Lost to Follow-up|6|||
143419170|NCT00248794|517080184|FG001|Overall Study|Lost to Follow-up|8|||
143419171|NCT00248794|517080185|FG002|Overall Study|Lost to Follow-up|3|||
143419172|NCT01762345|517080188|FG000|Overall Study|Adverse Event|5|||
143419173|NCT01762345|517080188|FG000|Overall Study|Protocol Violation|2|||
143419174|NCT00244751|517080189|FG000|Overall Study|Adverse Event|7|||
143419175|NCT00244751|517080190|FG001|Overall Study|Adverse Event|7|||
143419176|NCT00244751|517080191|FG002|Overall Study|Adverse Event|5|||
143419177|NCT00244751|517080189|FG000|Overall Study|Lost to Follow-up|0|||
143419178|NCT00244751|517080190|FG001|Overall Study|Lost to Follow-up|1|||
143419179|NCT00244751|517080191|FG002|Overall Study|Lost to Follow-up|0|||
143419180|NCT00244751|517080189|FG000|Overall Study|Protocol Violation|1|||
143419181|NCT00244751|517080190|FG001|Overall Study|Protocol Violation|0|||
143419182|NCT00244751|517080191|FG002|Overall Study|Protocol Violation|1|||
143419183|NCT00244751|517080189|FG000|Overall Study|Withdrawal by Subject|7|||
143419184|NCT00244751|517080190|FG001|Overall Study|Withdrawal by Subject|5|||
143419185|NCT00244751|517080191|FG002|Overall Study|Withdrawal by Subject|3|||
143419186|NCT00244751|517080189|FG000|Overall Study|Elevated liver enzymes|1|||
143419187|NCT00244751|517080190|FG001|Overall Study|Elevated liver enzymes|0|||
143419188|NCT00244751|517080191|FG002|Overall Study|Elevated liver enzymes|0|||
143419189|NCT00244751|517080189|FG000|Overall Study|Lack of compliance with protocol|0|||
143419190|NCT00244751|517080190|FG001|Overall Study|Lack of compliance with protocol|1|||
143419191|NCT00244751|517080191|FG002|Overall Study|Lack of compliance with protocol|0|||
143419192|NCT00244751|517080189|FG000|Overall Study|Safety reasons|0|||
143419193|NCT00244751|517080190|FG001|Overall Study|Safety reasons|1|||
143419194|NCT00244751|517080191|FG002|Overall Study|Safety reasons|0|||
143419195|NCT00244751|517080189|FG000|Overall Study|Participant randomized by mistake|0|||
143419196|NCT00244751|517080190|FG001|Overall Study|Participant randomized by mistake|0|||
143419197|NCT00244751|517080191|FG002|Overall Study|Participant randomized by mistake|1|||
143419198|NCT02206607|517080194|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
143419199|NCT02206607|517080195|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
143419200|NCT02206607|517080196|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
143419201|NCT02206607|517080197|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
143419202|NCT02206607|517080198|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
143419203|NCT02206607|517080194|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
143419204|NCT02206607|517080195|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
143419205|NCT02206607|517080196|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
143419206|NCT02206607|517080197|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
143419207|NCT02206607|517080198|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
143419208|NCT00761267|517080199|FG000|Overall Study|Death|1|||
143419209|NCT00761267|517080200|FG001|Overall Study|Death|2|||
143419210|NCT00761267|517080201|FG002|Overall Study|Death|5|||
143419211|NCT00761267|517080199|FG000|Overall Study|Lost to Follow-up|0|||
143419212|NCT00761267|517080200|FG001|Overall Study|Lost to Follow-up|0|||
143419213|NCT00761267|517080201|FG002|Overall Study|Lost to Follow-up|1|||
143419214|NCT00761267|517080199|FG000|Overall Study|Randomized but not treated|1|||
143419215|NCT00761267|517080200|FG001|Overall Study|Randomized but not treated|1|||
143419216|NCT00761267|517080201|FG002|Overall Study|Randomized but not treated|0|||
143419217|NCT00761267|517080199|FG000|Overall Study|Withdrawal by Subject|0|||
143419218|NCT00761267|517080200|FG001|Overall Study|Withdrawal by Subject|1|||
143419219|NCT00761267|517080201|FG002|Overall Study|Withdrawal by Subject|0|||
143419220|NCT01419184|517080208|FG000|Overall Study|Site data not available|3|||
143419221|NCT01419184|517080209|FG001|Overall Study|Site data not available|2|||
143419222|NCT01419184|517080208|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
143419223|NCT01419184|517080209|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
143419224|NCT01419184|517080208|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
143419225|NCT01419184|517080209|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
143419226|NCT01419184|517080208|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
143419227|NCT01419184|517080209|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
143419228|NCT01419184|517080208|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
143419229|NCT01419184|517080209|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
143419230|NCT01419184|517080208|FG000|Overall Study|Participant randomized, not treated|1|||
143419231|NCT01419184|517080209|FG001|Overall Study|Participant randomized, not treated|0|||
143419232|NCT03122860|517080213|FG000|Overall Study|Discontinued Before Treatment|1|||
143419233|NCT03122860|517080214|FG001|Overall Study|Discontinued Before Treatment|1|||
143419234|NCT03122860|517080215|FG002|Overall Study|Discontinued Before Treatment|2|||
143419235|NCT03122860|517080216|FG003|Overall Study|Discontinued Before Treatment|0|||
143419236|NCT03122860|517080217|FG004|Overall Study|Discontinued Before Treatment|1|||
143419237|NCT03122860|517080218|FG005|Overall Study|Discontinued Before Treatment|0|||
143419238|NCT03122860|517080213|FG000|Overall Study|Adverse Event|1|||
143419239|NCT03122860|517080214|FG001|Overall Study|Adverse Event|0|||
143419240|NCT03122860|517080215|FG002|Overall Study|Adverse Event|1|||
143419241|NCT03122860|517080216|FG003|Overall Study|Adverse Event|1|||
143419242|NCT03122860|517080217|FG004|Overall Study|Adverse Event|0|||
143419243|NCT03122860|517080218|FG005|Overall Study|Adverse Event|0|||
143419244|NCT03122860|517080213|FG000|Overall Study|Lost to Follow-up|5|||
143419245|NCT03122860|517080214|FG001|Overall Study|Lost to Follow-up|2|||
143419246|NCT03122860|517080215|FG002|Overall Study|Lost to Follow-up|3|||
143419247|NCT03122860|517080216|FG003|Overall Study|Lost to Follow-up|3|||
143419248|NCT03122860|517080217|FG004|Overall Study|Lost to Follow-up|5|||
143419249|NCT03122860|517080218|FG005|Overall Study|Lost to Follow-up|4|||
143419250|NCT03122860|517080213|FG000|Overall Study|Subject Non-Compliance|0|||
143419251|NCT03122860|517080214|FG001|Overall Study|Subject Non-Compliance|0|||
143419252|NCT03122860|517080215|FG002|Overall Study|Subject Non-Compliance|1|||
143419253|NCT03122860|517080216|FG003|Overall Study|Subject Non-Compliance|0|||
143419254|NCT03122860|517080217|FG004|Overall Study|Subject Non-Compliance|0|||
143419255|NCT03122860|517080218|FG005|Overall Study|Subject Non-Compliance|0|||
143419256|NCT03122860|517080213|FG000|Overall Study|Withdrawal by Subject|3|||
143419257|NCT03122860|517080214|FG001|Overall Study|Withdrawal by Subject|2|||
143419258|NCT03122860|517080215|FG002|Overall Study|Withdrawal by Subject|5|||
143419259|NCT03122860|517080216|FG003|Overall Study|Withdrawal by Subject|7|||
143419260|NCT03122860|517080217|FG004|Overall Study|Withdrawal by Subject|9|||
143419261|NCT03122860|517080218|FG005|Overall Study|Withdrawal by Subject|8|||
143419262|NCT03979040|517080219|FG000|Overall Study|Withdrawal by Subject|24|||
143419263|NCT03979040|517080220|FG001|Overall Study|Withdrawal by Subject|32|||
143419264|NCT03979040|517080219|FG000|Overall Study|randomized but never started treatment|32|||
143419265|NCT03979040|517080220|FG001|Overall Study|randomized but never started treatment|39|||
143419266|NCT03979040|517080219|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
143419267|NCT03979040|517080220|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
143419268|NCT03541369|517080225|FG000|Overall Study|Death|0|||
143419269|NCT03541369|517080226|FG001|Overall Study|Death|0|||
143419270|NCT03541369|517080227|FG002|Overall Study|Death|0|||
143419271|NCT03541369|517080228|FG003|Overall Study|Death|0|||
143419272|NCT03541369|517080229|FG004|Overall Study|Death|1|||
143419273|NCT03541369|517080230|FG005|Overall Study|Death|1|||
143419274|NCT03541369|517080231|FG006|Overall Study|Death|0|||
143419275|NCT03541369|517080232|FG007|Overall Study|Death|2|||
143419276|NCT03541369|517080233|FG008|Overall Study|Death|1|||
143419277|NCT03541369|517080234|FG009|Overall Study|Death|2|||
143419278|NCT03541369|517080235|FG010|Overall Study|Death|1|||
143419279|NCT03541369|517080236|FG011|Overall Study|Death|0|||
143419280|NCT03541369|517080237|FG012|Overall Study|Death|2|||
143419281|NCT03541369|517080238|FG013|Overall Study|Death|1|||
143419282|NCT03541369|517080239|FG014|Overall Study|Death|1|||
143419283|NCT03541369|517080240|FG015|Overall Study|Death|1|||
143419284|NCT03541369|517080241|FG016|Overall Study|Death|0|||
143419285|NCT03541369|517080242|FG017|Overall Study|Death|1|||
143419286|NCT03541369|517080225|FG000|Overall Study|Decision by sponsor|0|||
143419287|NCT03541369|517080226|FG001|Overall Study|Decision by sponsor|0|||
143419288|NCT03541369|517080227|FG002|Overall Study|Decision by sponsor|0|||
143419289|NCT03541369|517080228|FG003|Overall Study|Decision by sponsor|1|||
143419290|NCT03541369|517080229|FG004|Overall Study|Decision by sponsor|0|||
143419291|NCT03541369|517080230|FG005|Overall Study|Decision by sponsor|2|||
143419292|NCT03541369|517080231|FG006|Overall Study|Decision by sponsor|0|||
143419293|NCT03541369|517080232|FG007|Overall Study|Decision by sponsor|1|||
143419294|NCT03541369|517080233|FG008|Overall Study|Decision by sponsor|2|||
143419295|NCT03541369|517080234|FG009|Overall Study|Decision by sponsor|0|||
143419296|NCT03541369|517080235|FG010|Overall Study|Decision by sponsor|0|||
143419297|NCT03541369|517080236|FG011|Overall Study|Decision by sponsor|0|||
143419298|NCT03541369|517080237|FG012|Overall Study|Decision by sponsor|2|||
143419299|NCT03541369|517080238|FG013|Overall Study|Decision by sponsor|2|||
143419300|NCT03541369|517080239|FG014|Overall Study|Decision by sponsor|0|||
143419301|NCT03541369|517080240|FG015|Overall Study|Decision by sponsor|1|||
143419302|NCT03541369|517080241|FG016|Overall Study|Decision by sponsor|1|||
143419303|NCT03541369|517080242|FG017|Overall Study|Decision by sponsor|1|||
143419304|NCT03541369|517080225|FG000|Overall Study|Withdrawal by Subject|0|||
143419305|NCT03541369|517080226|FG001|Overall Study|Withdrawal by Subject|0|||
143419306|NCT03541369|517080227|FG002|Overall Study|Withdrawal by Subject|0|||
143419307|NCT03541369|517080228|FG003|Overall Study|Withdrawal by Subject|0|||
143419308|NCT03541369|517080229|FG004|Overall Study|Withdrawal by Subject|0|||
143419309|NCT03541369|517080230|FG005|Overall Study|Withdrawal by Subject|0|||
143419310|NCT03541369|517080231|FG006|Overall Study|Withdrawal by Subject|1|||
143419311|NCT03541369|517080232|FG007|Overall Study|Withdrawal by Subject|0|||
143419312|NCT03541369|517080233|FG008|Overall Study|Withdrawal by Subject|0|||
143419313|NCT03541369|517080234|FG009|Overall Study|Withdrawal by Subject|0|||
143419314|NCT03541369|517080235|FG010|Overall Study|Withdrawal by Subject|0|||
143419315|NCT03541369|517080236|FG011|Overall Study|Withdrawal by Subject|1|||
143419316|NCT03541369|517080237|FG012|Overall Study|Withdrawal by Subject|0|||
143419317|NCT03541369|517080238|FG013|Overall Study|Withdrawal by Subject|0|||
143419318|NCT03541369|517080239|FG014|Overall Study|Withdrawal by Subject|3|||
143419319|NCT03541369|517080240|FG015|Overall Study|Withdrawal by Subject|0|||
143419320|NCT03541369|517080241|FG016|Overall Study|Withdrawal by Subject|4|||
143419321|NCT03541369|517080242|FG017|Overall Study|Withdrawal by Subject|2|||
143419322|NCT03541369|517080225|FG000|Overall Study|Lost to Follow-up|0|||
143419323|NCT03541369|517080226|FG001|Overall Study|Lost to Follow-up|0|||
143419324|NCT03541369|517080227|FG002|Overall Study|Lost to Follow-up|0|||
143419325|NCT03541369|517080228|FG003|Overall Study|Lost to Follow-up|0|||
143419326|NCT03541369|517080229|FG004|Overall Study|Lost to Follow-up|1|||
143419327|NCT03541369|517080230|FG005|Overall Study|Lost to Follow-up|0|||
143419328|NCT03541369|517080231|FG006|Overall Study|Lost to Follow-up|0|||
143419329|NCT03541369|517080232|FG007|Overall Study|Lost to Follow-up|0|||
143419330|NCT03541369|517080233|FG008|Overall Study|Lost to Follow-up|1|||
143419331|NCT03541369|517080234|FG009|Overall Study|Lost to Follow-up|0|||
143419332|NCT03541369|517080235|FG010|Overall Study|Lost to Follow-up|0|||
143419333|NCT03541369|517080236|FG011|Overall Study|Lost to Follow-up|0|||
143419334|NCT03541369|517080237|FG012|Overall Study|Lost to Follow-up|1|||
143419335|NCT03541369|517080238|FG013|Overall Study|Lost to Follow-up|0|||
143419336|NCT03541369|517080239|FG014|Overall Study|Lost to Follow-up|0|||
143419337|NCT03541369|517080240|FG015|Overall Study|Lost to Follow-up|0|||
143419338|NCT03541369|517080241|FG016|Overall Study|Lost to Follow-up|0|||
143419339|NCT03541369|517080242|FG017|Overall Study|Lost to Follow-up|0|||
143419340|NCT01856569|517080243|FG000|Overall Study|Other|1|||
143419341|NCT01856569|517080243|FG000|Overall Study|Changed Site/Structure|1|||
143419342|NCT01856569|517080243|FG000|Overall Study|Lost to Follow-up|3|||
143419343|NCT01856569|517080243|FG000|Overall Study|Did not met inclusion criteria|8|||
143419344|NCT00696241|517080246|FG000|Overall Study|Adverse Event|11|||
143419345|NCT00696241|517080247|FG001|Overall Study|Adverse Event|3|||
143419346|NCT00696241|517080248|FG002|Overall Study|Adverse Event|6|||
143419347|NCT00696241|517080249|FG003|Overall Study|Adverse Event|4|||
143419348|NCT00696241|517080250|FG004|Overall Study|Adverse Event|5|||
143419349|NCT00696241|517080246|FG000|Overall Study|Protocol Violation|1|||
143419350|NCT00696241|517080247|FG001|Overall Study|Protocol Violation|1|||
143419351|NCT00696241|517080248|FG002|Overall Study|Protocol Violation|2|||
143419352|NCT00696241|517080249|FG003|Overall Study|Protocol Violation|0|||
143419353|NCT00696241|517080250|FG004|Overall Study|Protocol Violation|3|||
143419354|NCT00696241|517080246|FG000|Overall Study|Lost to Follow-up|1|||
143419355|NCT00696241|517080247|FG001|Overall Study|Lost to Follow-up|4|||
143419356|NCT00696241|517080248|FG002|Overall Study|Lost to Follow-up|1|||
143419357|NCT00696241|517080249|FG003|Overall Study|Lost to Follow-up|2|||
143419358|NCT00696241|517080250|FG004|Overall Study|Lost to Follow-up|0|||
143419359|NCT00696241|517080246|FG000|Overall Study|Withdrawal by Subject|4|||
143419360|NCT00696241|517080247|FG001|Overall Study|Withdrawal by Subject|8|||
143419361|NCT00696241|517080248|FG002|Overall Study|Withdrawal by Subject|6|||
143419362|NCT00696241|517080249|FG003|Overall Study|Withdrawal by Subject|1|||
143419363|NCT00696241|517080250|FG004|Overall Study|Withdrawal by Subject|0|||
143419364|NCT00696241|517080246|FG000|Overall Study|Lack of Efficacy|1|||
143419365|NCT00696241|517080247|FG001|Overall Study|Lack of Efficacy|5|||
143419366|NCT00696241|517080248|FG002|Overall Study|Lack of Efficacy|4|||
143419367|NCT00696241|517080249|FG003|Overall Study|Lack of Efficacy|5|||
143419368|NCT00696241|517080250|FG004|Overall Study|Lack of Efficacy|3|||
143419369|NCT00696241|517080246|FG000|Overall Study|Other|6|||
143419370|NCT00696241|517080247|FG001|Overall Study|Other|1|||
143419371|NCT00696241|517080248|FG002|Overall Study|Other|5|||
143419372|NCT00696241|517080249|FG003|Overall Study|Other|2|||
143419373|NCT00696241|517080250|FG004|Overall Study|Other|1|||
143419374|NCT02279732|517080251|FG000|Overall Study|Death|23|||
143419375|NCT02279732|517080252|FG001|Overall Study|Death|20|||
143419376|NCT02279732|517080251|FG000|Overall Study|Disease Progression|13|||
143419377|NCT02279732|517080252|FG001|Overall Study|Disease Progression|3|||
143419378|NCT02279732|517080251|FG000|Overall Study|Withdrawal by Subject|2|||
143419379|NCT02279732|517080252|FG001|Overall Study|Withdrawal by Subject|7|||
143419380|NCT02279732|517080251|FG000|Overall Study|Adverse Event|1|||
143419381|NCT02279732|517080252|FG001|Overall Study|Adverse Event|2|||
143419382|NCT02279732|517080251|FG000|Overall Study|Administrative Reason By Sponsor|0|||
143419383|NCT02279732|517080252|FG001|Overall Study|Administrative Reason By Sponsor|2|||
143419384|NCT02279732|517080251|FG000|Overall Study|Study Drug Toxicity|2|||
143419385|NCT02279732|517080252|FG001|Overall Study|Study Drug Toxicity|0|||
143419386|NCT02279732|517080251|FG000|Overall Study|Lost to Follow-up|0|||
143419387|NCT02279732|517080252|FG001|Overall Study|Lost to Follow-up|1|||
143419388|NCT02279732|517080251|FG000|Overall Study|Maximum Clinical Benefit|1|||
143419389|NCT02279732|517080252|FG001|Overall Study|Maximum Clinical Benefit|0|||
143419390|NCT02279732|517080251|FG000|Overall Study|Subject Requested to Discontinue|0|||
143419391|NCT02279732|517080252|FG001|Overall Study|Subject Requested to Discontinue|1|||
143419392|NCT02279732|517080251|FG000|Overall Study|Other|53|||
143419393|NCT02279732|517080252|FG001|Overall Study|Other|67|||
143419394|NCT02279732|517080251|FG000|Overall Study|Other|3|||
143419395|NCT02279732|517080252|FG001|Overall Study|Other|3|||
143419396|NCT03072862|517080256|FG000|Overall Study|Withdrawal by Subject|4|||
143419397|NCT03072862|517080256|FG000|Overall Study|Lost to Follow-up|6|||
143419398|NCT03072862|517080256|FG000|Overall Study|Protocol Violation|4|||
143419399|NCT03072862|517080256|FG000|Overall Study|Physician Decision|2|||
143419400|NCT03072862|517080256|FG000|Overall Study|Death|1|||
143419401|NCT03072862|517080256|FG000|Overall Study|Adverse Event|1|||
143419402|NCT02513667|517080257|FG000|Overall Study|Withdrawal by Subject|0|||
143419403|NCT02513667|517080258|FG001|Overall Study|Withdrawal by Subject|1|||
143419404|NCT05487300|517081847|FG000|Overall Study|Withdrawal by Subject|1|||
143419405|NCT05487300|517081848|FG001|Overall Study|Withdrawal by Subject|0|||
143419406|NCT03976102|517081854|FG000|Overall Study|Withdrawal by Subject|4|||
143419407|NCT03976102|517081855|FG001|Overall Study|Withdrawal by Subject|4|||
143419408|NCT03976102|517081854|FG000|Overall Study|Adverse Event|2|||
143419409|NCT03976102|517081855|FG001|Overall Study|Adverse Event|4|||
143419410|NCT03976102|517081854|FG000|Overall Study|Not related to Covid-19|9|||
143419411|NCT03976102|517081855|FG001|Overall Study|Not related to Covid-19|13|||
143419412|NCT03976102|517081854|FG000|Overall Study|Lost to Follow-up|0|||
143419413|NCT03976102|517081855|FG001|Overall Study|Lost to Follow-up|2|||
143419414|NCT03976102|517081854|FG000|Overall Study|Death|3|||
143419415|NCT03976102|517081855|FG001|Overall Study|Death|2|||
143419416|NCT03976102|517081854|FG000|Overall Study|Physician Decision|1|||
143419417|NCT03976102|517081855|FG001|Overall Study|Physician Decision|1|||
143419418|NCT02121808|517081858|FG000|Overall Study|Technical problem|3|||
143419419|NCT03072238|517081859|FG000|Overall Study|Withdrawal by Subject|44|||
143419420|NCT03072238|517081860|FG001|Overall Study|Withdrawal by Subject|64|||
143419421|NCT03072238|517081859|FG000|Overall Study|Lost to Follow-up|14|||
143419422|NCT03072238|517081860|FG001|Overall Study|Lost to Follow-up|5|||
143419423|NCT03072238|517081859|FG000|Overall Study|Physician Decision|4|||
143419424|NCT03072238|517081860|FG001|Overall Study|Physician Decision|6|||
143419425|NCT03072238|517081859|FG000|Overall Study|Death|351|||
143419426|NCT03072238|517081860|FG001|Overall Study|Death|318|||
143419427|NCT03072238|517081859|FG000|Overall Study|Progressive Disease|3|||
143419428|NCT03072238|517081860|FG001|Overall Study|Progressive Disease|4|||
143419429|NCT03072238|517081859|FG000|Overall Study|Reason Not Specified|138|||
143419430|NCT03072238|517081860|FG001|Overall Study|Reason Not Specified|150|||
143419431|NCT00307489|517081861|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
143419432|NCT00307489|517081862|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
143419433|NCT00307489|517081861|FG000|Baseline Through Week 48|Physician Decision|1|||
143419434|NCT00307489|517081862|FG001|Baseline Through Week 48|Physician Decision|0|||
143419435|NCT00307489|517081861|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
143419436|NCT00307489|517081862|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
143419437|NCT00307489|517081861|FG000|Week 48 Through Week 168|Adverse Event|1|||
143419438|NCT00307489|517081862|FG001|Week 48 Through Week 168|Adverse Event|0|||
143419439|NCT00307489|517081861|FG000|Week 48 Through Week 168|Physician Decision|1|||
143419440|NCT00307489|517081862|FG001|Week 48 Through Week 168|Physician Decision|0|||
143419441|NCT00307489|517081861|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
143419442|NCT00307489|517081862|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
143419443|NCT00307489|517081861|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
143419444|NCT00307489|517081862|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
143419445|NCT00307489|517081861|FG000|Week 48 Through Week 168|Death|0|||
143419446|NCT00307489|517081862|FG001|Week 48 Through Week 168|Death|1|||
143419447|NCT00307489|517081861|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
143419448|NCT00307489|517081862|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
143419449|NCT00307489|517081861|FG000|Week 48 Through Week 168|Seroconversion|1|||
143419450|NCT00307489|517081862|FG001|Week 48 Through Week 168|Seroconversion|0|||
143419451|NCT01381549|517081866|FG000|Overall Study|Ineligible: No organisms isolated|0|||
143419452|NCT01381549|517081867|FG001|Overall Study|Ineligible: No organisms isolated|0|||
143419453|NCT01381549|517081868|FG002|Overall Study|Ineligible: No organisms isolated|1|||
143419454|NCT02981953|517081869|FG000|Overall Study|Death|9|||
143419455|NCT02981953|517081869|FG000|Overall Study|Withdrawal by Subject|1|||
143419456|NCT02981953|517081869|FG000|Overall Study|Withdrawal to non-compliance|1|||
143419457|NCT02889900|517081870|FG000|Overall Study|Adverse Event|11|||
143419458|NCT02889900|517081870|FG000|Overall Study|Condition under investigation worsened|32|||
143419459|NCT02889900|517081870|FG000|Overall Study|Other|5|||
143419460|NCT02889900|517081870|FG000|Overall Study|Withdrawal by Subject|7|||
143419461|NCT02889900|517081870|FG000|Overall Study|Not treated|2|||
143419462|NCT00813709|517081881|FG000|Double Blind Period|Adverse Event|4|||
143419463|NCT00813709|517081882|FG001|Double Blind Period|Adverse Event|1|||
143419464|NCT00813709|517081883|FG002|Double Blind Period|Adverse Event|4|||
143419465|NCT00813709|517081884|FG003|Double Blind Period|Adverse Event|0|||
143419466|NCT00813709|517081885|FG004|Double Blind Period|Adverse Event|0|||
143419467|NCT00813709|517081886|FG005|Double Blind Period|Adverse Event|0|||
143419468|NCT00813709|517081881|FG000|Double Blind Period|Lost to Follow-up|3|||
143419469|NCT00813709|517081882|FG001|Double Blind Period|Lost to Follow-up|2|||
143419470|NCT00813709|517081883|FG002|Double Blind Period|Lost to Follow-up|2|||
143419471|NCT00813709|517081884|FG003|Double Blind Period|Lost to Follow-up|0|||
143419472|NCT00813709|517081885|FG004|Double Blind Period|Lost to Follow-up|0|||
143419473|NCT00813709|517081886|FG005|Double Blind Period|Lost to Follow-up|0|||
143419474|NCT00813709|517081881|FG000|Double Blind Period|Switched to open label phase|9|||
143419475|NCT00813709|517081882|FG001|Double Blind Period|Switched to open label phase|26|||
143419476|NCT00813709|517081883|FG002|Double Blind Period|Switched to open label phase|18|||
143419477|NCT00813709|517081884|FG003|Double Blind Period|Switched to open label phase|0|||
143419478|NCT00813709|517081885|FG004|Double Blind Period|Switched to open label phase|0|||
143419479|NCT00813709|517081886|FG005|Double Blind Period|Switched to open label phase|0|||
143419480|NCT00813709|517081881|FG000|Double Blind Period|Randomized but not treated|1|||
143419481|NCT00813709|517081882|FG001|Double Blind Period|Randomized but not treated|3|||
143419482|NCT00813709|517081883|FG002|Double Blind Period|Randomized but not treated|1|||
143419483|NCT00813709|517081884|FG003|Double Blind Period|Randomized but not treated|0|||
143419484|NCT00813709|517081885|FG004|Double Blind Period|Randomized but not treated|0|||
143419485|NCT00813709|517081886|FG005|Double Blind Period|Randomized but not treated|0|||
143419486|NCT00813709|517081881|FG000|Double Blind Period|Other|14|||
143419487|NCT00813709|517081882|FG001|Double Blind Period|Other|9|||
143419488|NCT00813709|517081883|FG002|Double Blind Period|Other|6|||
143419489|NCT00813709|517081884|FG003|Double Blind Period|Other|0|||
143419490|NCT00813709|517081885|FG004|Double Blind Period|Other|0|||
143419491|NCT00813709|517081886|FG005|Double Blind Period|Other|0|||
143419492|NCT00813709|517081881|FG000|Open Label Period|Adverse Event|0|||
143419493|NCT00813709|517081882|FG001|Open Label Period|Adverse Event|0|||
143419494|NCT00813709|517081883|FG002|Open Label Period|Adverse Event|0|||
143419495|NCT00813709|517081884|FG003|Open Label Period|Adverse Event|5|||
143419496|NCT00813709|517081885|FG004|Open Label Period|Adverse Event|4|||
143419497|NCT00813709|517081886|FG005|Open Label Period|Adverse Event|3|||
143419498|NCT00813709|517081881|FG000|Open Label Period|Lack of Efficacy|0|||
143419499|NCT00813709|517081882|FG001|Open Label Period|Lack of Efficacy|0|||
143419500|NCT00813709|517081883|FG002|Open Label Period|Lack of Efficacy|0|||
143419501|NCT00813709|517081884|FG003|Open Label Period|Lack of Efficacy|3|||
143419502|NCT00813709|517081885|FG004|Open Label Period|Lack of Efficacy|1|||
143419503|NCT00813709|517081886|FG005|Open Label Period|Lack of Efficacy|1|||
143419504|NCT00813709|517081881|FG000|Open Label Period|Randomized but not treated|0|||
143419505|NCT00813709|517081882|FG001|Open Label Period|Randomized but not treated|0|||
143419506|NCT00813709|517081883|FG002|Open Label Period|Randomized but not treated|0|||
143419507|NCT00813709|517081884|FG003|Open Label Period|Randomized but not treated|1|||
143419508|NCT00813709|517081885|FG004|Open Label Period|Randomized but not treated|0|||
143419509|NCT00813709|517081886|FG005|Open Label Period|Randomized but not treated|1|||
143419510|NCT00813709|517081881|FG000|Open Label Period|Other|0|||
143419511|NCT00813709|517081882|FG001|Open Label Period|Other|0|||
143419512|NCT00813709|517081883|FG002|Open Label Period|Other|0|||
143419513|NCT00813709|517081884|FG003|Open Label Period|Other|11|||
143419514|NCT00813709|517081885|FG004|Open Label Period|Other|5|||
143419515|NCT00813709|517081886|FG005|Open Label Period|Other|6|||
143419516|NCT03840993|517081891|FG000|Overall Study|Adverse Event|1|||
143419517|NCT03840993|517081892|FG001|Overall Study|Adverse Event|0|||
143419518|NCT03840993|517081891|FG000|Overall Study|Lost to Follow-up|4|||
143419519|NCT03840993|517081892|FG001|Overall Study|Lost to Follow-up|0|||
143419520|NCT03840993|517081891|FG000|Overall Study|Physician Decision|0|||
143419521|NCT03840993|517081892|FG001|Overall Study|Physician Decision|1|||
143419522|NCT03840993|517081891|FG000|Overall Study|Pregnancy|0|||
143419523|NCT03840993|517081892|FG001|Overall Study|Pregnancy|1|||
143419524|NCT03840993|517081891|FG000|Overall Study|Withdrawal by Subject|1|||
143419525|NCT03840993|517081892|FG001|Overall Study|Withdrawal by Subject|3|||
143419526|NCT03840993|517081891|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
143419527|NCT03840993|517081892|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
143419528|NCT00759681|517081893|FG000|Overall Study|Death|2|||
143419529|NCT00759681|517081894|FG001|Overall Study|Death|5|||
143419530|NCT00759681|517081893|FG000|Overall Study|Lost to Follow-up|8|||
143419531|NCT00759681|517081894|FG001|Overall Study|Lost to Follow-up|5|||
143419532|NCT03386344|517081896|FG000|Overall Study|Adverse Event|6|||
143419533|NCT03386344|517081897|FG001|Overall Study|Adverse Event|3|||
143419534|NCT03386344|517081898|FG002|Overall Study|Adverse Event|1|||
143419535|NCT03386344|517081896|FG000|Overall Study|Poor Compliance to Protocol|0|||
143419536|NCT03386344|517081897|FG001|Overall Study|Poor Compliance to Protocol|1|||
143419537|NCT03386344|517081898|FG002|Overall Study|Poor Compliance to Protocol|0|||
143419538|NCT03386344|517081896|FG000|Overall Study|Study Terminated by Sponsor|101|||
143419539|NCT03386344|517081897|FG001|Overall Study|Study Terminated by Sponsor|102|||
143419540|NCT03386344|517081898|FG002|Overall Study|Study Terminated by Sponsor|106|||
143419541|NCT03386344|517081896|FG000|Overall Study|Lost to Follow-up|3|||
143419542|NCT03386344|517081897|FG001|Overall Study|Lost to Follow-up|2|||
143419543|NCT03386344|517081898|FG002|Overall Study|Lost to Follow-up|1|||
143419544|NCT03386344|517081896|FG000|Overall Study|At the Participant's own Request|7|||
143419545|NCT03386344|517081897|FG001|Overall Study|At the Participant's own Request|7|||
143419546|NCT03386344|517081898|FG002|Overall Study|At the Participant's own Request|8|||
143419547|NCT03386344|517081896|FG000|Overall Study|Reason not Specified|0|||
143419548|NCT03386344|517081897|FG001|Overall Study|Reason not Specified|1|||
143419549|NCT03386344|517081898|FG002|Overall Study|Reason not Specified|0|||
143419550|NCT03209492|517081902|FG000|Overall Study|Case Report Forms Uncollected|5|||
143419551|NCT01133678|517081905|FG000|Overall Study|Death|1|||
143419552|NCT01133678|517081906|FG001|Overall Study|Death|1|||
143419553|NCT00879710|517081907|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
143419554|NCT00879710|517081908|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
143419555|NCT00879710|517081909|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
143419556|NCT00879710|517081910|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
143419557|NCT00879710|517081907|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
143419558|NCT00879710|517081908|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
143419559|NCT00879710|517081909|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
143419560|NCT00879710|517081910|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
143419561|NCT01864200|517081911|FG000|Overall Study|Lost to Follow-up|1|||
143419562|NCT01864200|517081912|FG001|Overall Study|Lost to Follow-up|3|||
143419563|NCT01864200|517081911|FG000|Overall Study|Protocol Violation|1|||
143419564|NCT01864200|517081912|FG001|Overall Study|Protocol Violation|0|||
143419565|NCT01777932|517081916|FG000|Overall Study|Disease progression|136|||
143419566|NCT01777932|517081916|FG000|Overall Study|Death|3|||
143419567|NCT01777932|517081916|FG000|Overall Study|Adverse Event|34|||
143419568|NCT01777932|517081916|FG000|Overall Study|Lost to Follow-up|3|||
143419569|NCT01777932|517081916|FG000|Overall Study|Investigator decision|10|||
143419570|NCT01777932|517081916|FG000|Overall Study|Reimbursement limit|9|||
143419571|NCT01777932|517081916|FG000|Overall Study|Patient refused further treatment|10|||
143419572|NCT03031782|517081921|FG000|Treatment Period 1|Lack of Efficacy|3|||
143419573|NCT03031782|517081922|FG001|Treatment Period 1|Lack of Efficacy|0|||
143419574|NCT03031782|517081923|FG002|Treatment Period 1|Lack of Efficacy|0|||
143419575|NCT03031782|517081924|FG003|Treatment Period 1|Lack of Efficacy|0|||
143419576|NCT03031782|517081925|FG004|Treatment Period 1|Lack of Efficacy|0|||
143419577|NCT03031782|517081921|FG000|Treatment Period 2|Physician Decision|0|||
143419578|NCT03031782|517081922|FG001|Treatment Period 2|Physician Decision|1|||
143419579|NCT03031782|517081923|FG002|Treatment Period 2|Physician Decision|0|||
143419580|NCT03031782|517081924|FG003|Treatment Period 2|Physician Decision|0|||
143419581|NCT03031782|517081925|FG004|Treatment Period 2|Physician Decision|3|||
143419582|NCT03031782|517081921|FG000|Treatment Period 2|Lack of Efficacy|0|||
143419583|NCT03031782|517081922|FG001|Treatment Period 2|Lack of Efficacy|1|||
143419584|NCT03031782|517081923|FG002|Treatment Period 2|Lack of Efficacy|0|||
143419585|NCT03031782|517081924|FG003|Treatment Period 2|Lack of Efficacy|0|||
143419586|NCT03031782|517081925|FG004|Treatment Period 2|Lack of Efficacy|1|||
143419587|NCT03031782|517081921|FG000|Treatment Period 2|Withdrawal by Subject|0|||
143419588|NCT03031782|517081922|FG001|Treatment Period 2|Withdrawal by Subject|3|||
143419589|NCT03031782|517081923|FG002|Treatment Period 2|Withdrawal by Subject|0|||
143419590|NCT03031782|517081924|FG003|Treatment Period 2|Withdrawal by Subject|0|||
143419591|NCT03031782|517081925|FG004|Treatment Period 2|Withdrawal by Subject|1|||
143419592|NCT03031782|517081921|FG000|Treatment Period 2|Adverse Event|0|||
143419593|NCT03031782|517081922|FG001|Treatment Period 2|Adverse Event|1|||
143419594|NCT03031782|517081923|FG002|Treatment Period 2|Adverse Event|2|||
143419595|NCT03031782|517081924|FG003|Treatment Period 2|Adverse Event|0|||
143419596|NCT03031782|517081925|FG004|Treatment Period 2|Adverse Event|0|||
143419597|NCT03031782|517081921|FG000|Treatment Period 3|Withdrawal by Subject|0|||
143419598|NCT03031782|517081922|FG001|Treatment Period 3|Withdrawal by Subject|0|||
143419599|NCT03031782|517081923|FG002|Treatment Period 3|Withdrawal by Subject|0|||
143419600|NCT03031782|517081924|FG003|Treatment Period 3|Withdrawal by Subject|1|||
143419601|NCT03031782|517081925|FG004|Treatment Period 3|Withdrawal by Subject|0|||
143419602|NCT00424476|517081928|FG000|Overall Study|Withdrawal by Subject|7|||
143419603|NCT00424476|517081929|FG001|Overall Study|Withdrawal by Subject|6|||
143419604|NCT00424476|517081930|FG002|Overall Study|Withdrawal by Subject|3|||
143419605|NCT00424476|517081928|FG000|Overall Study|Adverse Event|19|||
143419606|NCT00424476|517081929|FG001|Overall Study|Adverse Event|16|||
143419607|NCT00424476|517081930|FG002|Overall Study|Adverse Event|15|||
143419608|NCT00424476|517081928|FG000|Overall Study|Lack of Efficacy|16|||
143419609|NCT00424476|517081929|FG001|Overall Study|Lack of Efficacy|12|||
143419610|NCT00424476|517081930|FG002|Overall Study|Lack of Efficacy|12|||
143419611|NCT00424476|517081928|FG000|Overall Study|Lack of Compliance|1|||
143419612|NCT00424476|517081929|FG001|Overall Study|Lack of Compliance|1|||
143419613|NCT00424476|517081930|FG002|Overall Study|Lack of Compliance|1|||
143419614|NCT00424476|517081928|FG000|Overall Study|Lost to Follow-up|4|||
143419615|NCT00424476|517081929|FG001|Overall Study|Lost to Follow-up|6|||
143419616|NCT00424476|517081930|FG002|Overall Study|Lost to Follow-up|3|||
143419617|NCT00424476|517081928|FG000|Overall Study|Protocol Violation|7|||
143419618|NCT00424476|517081929|FG001|Overall Study|Protocol Violation|2|||
143419619|NCT00424476|517081930|FG002|Overall Study|Protocol Violation|3|||
143419620|NCT00424476|517081928|FG000|Overall Study|Physician Decision|3|||
143419621|NCT00424476|517081929|FG001|Overall Study|Physician Decision|2|||
143419622|NCT00424476|517081930|FG002|Overall Study|Physician Decision|3|||
143419623|NCT00424476|517081928|FG000|Overall Study|Other|4|||
143419624|NCT00424476|517081929|FG001|Overall Study|Other|3|||
143419625|NCT00424476|517081930|FG002|Overall Study|Other|9|||
143419626|NCT02514824|517081931|FG000|Overall Study|Withdrawal by Subject|1|||
143419627|NCT02514824|517081932|FG001|Overall Study|Withdrawal by Subject|0|||
143419628|NCT02514824|517081933|FG002|Overall Study|Withdrawal by Subject|0|||
143419629|NCT02514824|517081934|FG003|Overall Study|Withdrawal by Subject|0|||
143419630|NCT02514824|517081931|FG000|Overall Study|Dose-Limiting Toxicity|0|||
143419631|NCT02514824|517081932|FG001|Overall Study|Dose-Limiting Toxicity|1|||
143419632|NCT02514824|517081933|FG002|Overall Study|Dose-Limiting Toxicity|0|||
143419633|NCT02514824|517081934|FG003|Overall Study|Dose-Limiting Toxicity|0|||
143419634|NCT02170207|517081937|FG000|Overall Study|Case report forms unavailable|5|||
143419635|NCT01138657|517081938|FG000|Overall Study|Adverse Event|3|||
143419636|NCT01138657|517081939|FG001|Overall Study|Adverse Event|10|||
143419637|NCT01138657|517081938|FG000|Overall Study|Lack of Efficacy|2|||
143419638|NCT01138657|517081939|FG001|Overall Study|Lack of Efficacy|1|||
143419639|NCT01138657|517081938|FG000|Overall Study|Lost to Follow-up|0|||
143419640|NCT01138657|517081939|FG001|Overall Study|Lost to Follow-up|3|||
143419641|NCT01138657|517081938|FG000|Overall Study|Miscellaneous Reasons|3|||
143419642|NCT01138657|517081939|FG001|Overall Study|Miscellaneous Reasons|4|||
143419643|NCT03875729|517081940|FG000|Overall Study|Adverse Event|0|||
143419644|NCT03875729|517081941|FG001|Overall Study|Adverse Event|5|||
143419645|NCT03875729|517081940|FG000|Overall Study|Withdrawal by Subject|8|||
143419646|NCT03875729|517081941|FG001|Overall Study|Withdrawal by Subject|11|||
143419647|NCT03875729|517081940|FG000|Overall Study|Pregnancy|0|||
143419648|NCT03875729|517081941|FG001|Overall Study|Pregnancy|1|||
143419649|NCT03875729|517081940|FG000|Overall Study|Lost to Follow-up|0|||
143419650|NCT03875729|517081941|FG001|Overall Study|Lost to Follow-up|5|||
143419651|NCT03875729|517081940|FG000|Overall Study|Personal reasons|2|||
143419652|NCT03875729|517081941|FG001|Overall Study|Personal reasons|0|||
143419653|NCT01916109|517081942|FG000|Overall Study|Withdrawal by Subject|1|||
143419654|NCT00103857|517081943|FG000|54-Week Base Study|Adverse Event|12|||
143419655|NCT00103857|517081944|FG001|54-Week Base Study|Adverse Event|9|||
143419656|NCT00103857|517081945|FG002|54-Week Base Study|Adverse Event|11|||
143419657|NCT00103857|517081946|FG003|54-Week Base Study|Adverse Event|6|||
143419658|NCT00103857|517081947|FG004|54-Week Base Study|Adverse Event|5|||
143419659|NCT00103857|517081948|FG005|54-Week Base Study|Adverse Event|11|||
143419660|NCT00103857|517081949|FG006|54-Week Base Study|Adverse Event|3|||
143419661|NCT00103857|517081943|FG000|54-Week Base Study|Death|0|||
143419662|NCT00103857|517081944|FG001|54-Week Base Study|Death|0|||
143419663|NCT00103857|517081945|FG002|54-Week Base Study|Death|0|||
143419664|NCT00103857|517081946|FG003|54-Week Base Study|Death|0|||
143419665|NCT00103857|517081947|FG004|54-Week Base Study|Death|1|||
143419666|NCT00103857|517081948|FG005|54-Week Base Study|Death|1|||
143419667|NCT00103857|517081949|FG006|54-Week Base Study|Death|0|||
143419668|NCT00103857|517081943|FG000|54-Week Base Study|Lack of Efficacy|11|||
143419669|NCT00103857|517081944|FG001|54-Week Base Study|Lack of Efficacy|14|||
143419670|NCT00103857|517081945|FG002|54-Week Base Study|Lack of Efficacy|8|||
143419671|NCT00103857|517081946|FG003|54-Week Base Study|Lack of Efficacy|4|||
143419672|NCT00103857|517081947|FG004|54-Week Base Study|Lack of Efficacy|3|||
143419673|NCT00103857|517081948|FG005|54-Week Base Study|Lack of Efficacy|14|||
143419674|NCT00103857|517081949|FG006|54-Week Base Study|Lack of Efficacy|19|||
143419675|NCT00103857|517081943|FG000|54-Week Base Study|Lost to Follow-up|5|||
143419676|NCT00103857|517081944|FG001|54-Week Base Study|Lost to Follow-up|4|||
143419677|NCT00103857|517081945|FG002|54-Week Base Study|Lost to Follow-up|7|||
143419678|NCT00103857|517081946|FG003|54-Week Base Study|Lost to Follow-up|5|||
143419679|NCT00103857|517081947|FG004|54-Week Base Study|Lost to Follow-up|10|||
143419680|NCT00103857|517081948|FG005|54-Week Base Study|Lost to Follow-up|9|||
143419681|NCT00103857|517081949|FG006|54-Week Base Study|Lost to Follow-up|3|||
143419682|NCT00103857|517081943|FG000|54-Week Base Study|Physician Decision|1|||
143419683|NCT00103857|517081944|FG001|54-Week Base Study|Physician Decision|1|||
143419684|NCT00103857|517081945|FG002|54-Week Base Study|Physician Decision|0|||
143419685|NCT00103857|517081946|FG003|54-Week Base Study|Physician Decision|0|||
143419686|NCT00103857|517081947|FG004|54-Week Base Study|Physician Decision|1|||
143419687|NCT00103857|517081948|FG005|54-Week Base Study|Physician Decision|0|||
143419688|NCT00103857|517081949|FG006|54-Week Base Study|Physician Decision|0|||
143419689|NCT00103857|517081943|FG000|54-Week Base Study|Pregnancy|1|||
143419690|NCT00103857|517081944|FG001|54-Week Base Study|Pregnancy|0|||
143419691|NCT00103857|517081945|FG002|54-Week Base Study|Pregnancy|0|||
143419692|NCT00103857|517081946|FG003|54-Week Base Study|Pregnancy|0|||
143419693|NCT00103857|517081947|FG004|54-Week Base Study|Pregnancy|1|||
143419694|NCT00103857|517081948|FG005|54-Week Base Study|Pregnancy|0|||
143419695|NCT00103857|517081949|FG006|54-Week Base Study|Pregnancy|1|||
143419696|NCT00103857|517081943|FG000|54-Week Base Study|Protocol Violation|6|||
143419697|NCT00103857|517081944|FG001|54-Week Base Study|Protocol Violation|4|||
143419698|NCT00103857|517081945|FG002|54-Week Base Study|Protocol Violation|2|||
143419699|NCT00103857|517081946|FG003|54-Week Base Study|Protocol Violation|4|||
143419700|NCT00103857|517081947|FG004|54-Week Base Study|Protocol Violation|0|||
143419701|NCT00103857|517081948|FG005|54-Week Base Study|Protocol Violation|3|||
143419702|NCT00103857|517081949|FG006|54-Week Base Study|Protocol Violation|3|||
143419703|NCT00103857|517081943|FG000|54-Week Base Study|Withdrawal by Subject|17|||
143419704|NCT00103857|517081944|FG001|54-Week Base Study|Withdrawal by Subject|16|||
143419705|NCT00103857|517081945|FG002|54-Week Base Study|Withdrawal by Subject|16|||
143419706|NCT00103857|517081946|FG003|54-Week Base Study|Withdrawal by Subject|15|||
143419707|NCT00103857|517081947|FG004|54-Week Base Study|Withdrawal by Subject|10|||
143419708|NCT00103857|517081948|FG005|54-Week Base Study|Withdrawal by Subject|15|||
143419709|NCT00103857|517081949|FG006|54-Week Base Study|Withdrawal by Subject|4|||
143419710|NCT00103857|517081943|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
143419711|NCT00103857|517081944|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
143419712|NCT00103857|517081945|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
143419713|NCT00103857|517081946|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
143419714|NCT00103857|517081947|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
143419715|NCT00103857|517081948|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
143419716|NCT00103857|517081949|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
143419717|NCT00103857|517081943|FG000|54-Week Base Study|patient moved|0|||
143419718|NCT00103857|517081944|FG001|54-Week Base Study|patient moved|1|||
143419719|NCT00103857|517081945|FG002|54-Week Base Study|patient moved|1|||
143419720|NCT00103857|517081946|FG003|54-Week Base Study|patient moved|2|||
143419721|NCT00103857|517081947|FG004|54-Week Base Study|patient moved|3|||
143419722|NCT00103857|517081948|FG005|54-Week Base Study|patient moved|1|||
143419723|NCT00103857|517081949|FG006|54-Week Base Study|patient moved|0|||
143419724|NCT00103857|517081943|FG000|54-Week Base Study|non-compliance with study procedures|1|||
143419725|NCT00103857|517081944|FG001|54-Week Base Study|non-compliance with study procedures|2|||
143419726|NCT00103857|517081945|FG002|54-Week Base Study|non-compliance with study procedures|0|||
143419727|NCT00103857|517081946|FG003|54-Week Base Study|non-compliance with study procedures|0|||
143419728|NCT00103857|517081947|FG004|54-Week Base Study|non-compliance with study procedures|0|||
143419729|NCT00103857|517081948|FG005|54-Week Base Study|non-compliance with study procedures|2|||
143419730|NCT00103857|517081949|FG006|54-Week Base Study|non-compliance with study procedures|0|||
143419731|NCT00103857|517081943|FG000|54-Week Base Study|patient incarcerated|0|||
143419732|NCT00103857|517081944|FG001|54-Week Base Study|patient incarcerated|0|||
143419733|NCT00103857|517081945|FG002|54-Week Base Study|patient incarcerated|0|||
143419734|NCT00103857|517081946|FG003|54-Week Base Study|patient incarcerated|0|||
143419735|NCT00103857|517081947|FG004|54-Week Base Study|patient incarcerated|1|||
143419736|NCT00103857|517081948|FG005|54-Week Base Study|patient incarcerated|1|||
143419737|NCT00103857|517081949|FG006|54-Week Base Study|patient incarcerated|0|||
143419738|NCT00103857|517081943|FG000|54-Week Base Study|laboratory reporting error|0|||
143419739|NCT00103857|517081944|FG001|54-Week Base Study|laboratory reporting error|0|||
143419740|NCT00103857|517081945|FG002|54-Week Base Study|laboratory reporting error|0|||
143419741|NCT00103857|517081946|FG003|54-Week Base Study|laboratory reporting error|0|||
143419742|NCT00103857|517081947|FG004|54-Week Base Study|laboratory reporting error|1|||
143419743|NCT00103857|517081948|FG005|54-Week Base Study|laboratory reporting error|0|||
143419744|NCT00103857|517081949|FG006|54-Week Base Study|laboratory reporting error|0|||
143419745|NCT00103857|517081943|FG000|54-Week Base Study|site error|0|||
143419746|NCT00103857|517081944|FG001|54-Week Base Study|site error|0|||
143419747|NCT00103857|517081945|FG002|54-Week Base Study|site error|0|||
143419748|NCT00103857|517081946|FG003|54-Week Base Study|site error|0|||
143419749|NCT00103857|517081947|FG004|54-Week Base Study|site error|0|||
143419750|NCT00103857|517081948|FG005|54-Week Base Study|site error|1|||
143419751|NCT00103857|517081949|FG006|54-Week Base Study|site error|0|||
143419752|NCT00103857|517081943|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
143419753|NCT00103857|517081944|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
143419754|NCT00103857|517081945|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
143419755|NCT00103857|517081946|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
143419756|NCT00103857|517081947|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
143419757|NCT00103857|517081948|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
143419758|NCT00103857|517081949|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
143419759|NCT00103857|517081943|FG000|50-Week Extension Study|Adverse Event|2|||
143419760|NCT00103857|517081944|FG001|50-Week Extension Study|Adverse Event|3|||
143419761|NCT00103857|517081945|FG002|50-Week Extension Study|Adverse Event|2|||
143419762|NCT00103857|517081946|FG003|50-Week Extension Study|Adverse Event|0|||
143419763|NCT00103857|517081947|FG004|50-Week Extension Study|Adverse Event|1|||
143419764|NCT00103857|517081948|FG005|50-Week Extension Study|Adverse Event|1|||
143419765|NCT00103857|517081949|FG006|50-Week Extension Study|Adverse Event|0|||
143419766|NCT00103857|517081943|FG000|50-Week Extension Study|Death|0|||
143419767|NCT00103857|517081944|FG001|50-Week Extension Study|Death|0|||
143419768|NCT00103857|517081945|FG002|50-Week Extension Study|Death|0|||
143419769|NCT00103857|517081946|FG003|50-Week Extension Study|Death|1|||
143419770|NCT00103857|517081947|FG004|50-Week Extension Study|Death|0|||
143419771|NCT00103857|517081948|FG005|50-Week Extension Study|Death|1|||
143419772|NCT00103857|517081949|FG006|50-Week Extension Study|Death|0|||
143419773|NCT00103857|517081943|FG000|50-Week Extension Study|Lack of Efficacy|26|||
143419774|NCT00103857|517081944|FG001|50-Week Extension Study|Lack of Efficacy|15|||
143419775|NCT00103857|517081945|FG002|50-Week Extension Study|Lack of Efficacy|13|||
143419776|NCT00103857|517081946|FG003|50-Week Extension Study|Lack of Efficacy|16|||
143419777|NCT00103857|517081947|FG004|50-Week Extension Study|Lack of Efficacy|8|||
143419778|NCT00103857|517081948|FG005|50-Week Extension Study|Lack of Efficacy|8|||
143419779|NCT00103857|517081949|FG006|50-Week Extension Study|Lack of Efficacy|0|||
143419780|NCT00103857|517081943|FG000|50-Week Extension Study|Lost to Follow-up|4|||
143419781|NCT00103857|517081944|FG001|50-Week Extension Study|Lost to Follow-up|0|||
143419782|NCT00103857|517081945|FG002|50-Week Extension Study|Lost to Follow-up|1|||
143419783|NCT00103857|517081946|FG003|50-Week Extension Study|Lost to Follow-up|4|||
143419784|NCT00103857|517081947|FG004|50-Week Extension Study|Lost to Follow-up|3|||
143419785|NCT00103857|517081948|FG005|50-Week Extension Study|Lost to Follow-up|3|||
143419786|NCT00103857|517081949|FG006|50-Week Extension Study|Lost to Follow-up|0|||
143419787|NCT00103857|517081943|FG000|50-Week Extension Study|Physician Decision|0|||
143419788|NCT00103857|517081944|FG001|50-Week Extension Study|Physician Decision|1|||
143419789|NCT00103857|517081945|FG002|50-Week Extension Study|Physician Decision|1|||
143419790|NCT00103857|517081946|FG003|50-Week Extension Study|Physician Decision|0|||
143419791|NCT00103857|517081947|FG004|50-Week Extension Study|Physician Decision|0|||
143419792|NCT00103857|517081948|FG005|50-Week Extension Study|Physician Decision|0|||
143419793|NCT00103857|517081949|FG006|50-Week Extension Study|Physician Decision|0|||
143419794|NCT00103857|517081943|FG000|50-Week Extension Study|Pregnancy|0|||
143419795|NCT00103857|517081944|FG001|50-Week Extension Study|Pregnancy|0|||
143419796|NCT00103857|517081945|FG002|50-Week Extension Study|Pregnancy|1|||
143419797|NCT00103857|517081946|FG003|50-Week Extension Study|Pregnancy|0|||
143419798|NCT00103857|517081947|FG004|50-Week Extension Study|Pregnancy|1|||
143419799|NCT00103857|517081948|FG005|50-Week Extension Study|Pregnancy|0|||
143419800|NCT00103857|517081949|FG006|50-Week Extension Study|Pregnancy|0|||
143419801|NCT00103857|517081943|FG000|50-Week Extension Study|Protocol Violation|1|||
143419802|NCT00103857|517081944|FG001|50-Week Extension Study|Protocol Violation|1|||
143419803|NCT00103857|517081945|FG002|50-Week Extension Study|Protocol Violation|1|||
143419804|NCT00103857|517081946|FG003|50-Week Extension Study|Protocol Violation|2|||
143419805|NCT00103857|517081947|FG004|50-Week Extension Study|Protocol Violation|0|||
143419806|NCT00103857|517081948|FG005|50-Week Extension Study|Protocol Violation|1|||
143419807|NCT00103857|517081949|FG006|50-Week Extension Study|Protocol Violation|0|||
143419808|NCT00103857|517081943|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
143419809|NCT00103857|517081944|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
143419810|NCT00103857|517081945|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
143419811|NCT00103857|517081946|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
143419812|NCT00103857|517081947|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
143419813|NCT00103857|517081948|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
143419814|NCT00103857|517081949|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
143419815|NCT00103857|517081943|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
143419816|NCT00103857|517081944|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
143419817|NCT00103857|517081945|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
143419818|NCT00103857|517081946|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
143419819|NCT00103857|517081947|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
143419820|NCT00103857|517081948|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
143419821|NCT00103857|517081949|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
143419822|NCT00103857|517081943|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
143419823|NCT00103857|517081944|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
143419824|NCT00103857|517081945|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
143419825|NCT00103857|517081946|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
143419826|NCT00103857|517081947|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
143419827|NCT00103857|517081948|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
143419828|NCT00103857|517081949|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
143419829|NCT00103857|517081943|FG000|50-Week Extension Study|patient moved|0|||
143419830|NCT00103857|517081944|FG001|50-Week Extension Study|patient moved|0|||
143419831|NCT00103857|517081945|FG002|50-Week Extension Study|patient moved|1|||
143419832|NCT00103857|517081946|FG003|50-Week Extension Study|patient moved|2|||
143419833|NCT00103857|517081947|FG004|50-Week Extension Study|patient moved|0|||
143419834|NCT00103857|517081948|FG005|50-Week Extension Study|patient moved|0|||
143419835|NCT00103857|517081949|FG006|50-Week Extension Study|patient moved|0|||
143419836|NCT00103857|517081943|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
143419837|NCT00103857|517081944|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
143419838|NCT00103857|517081945|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
143419839|NCT00103857|517081946|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
143419840|NCT00103857|517081947|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
143419841|NCT00103857|517081948|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
143419842|NCT00103857|517081949|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
143419843|NCT00103857|517081943|FG000|50-Week Extension Study|reason unspecified|0|||
143419844|NCT00103857|517081944|FG001|50-Week Extension Study|reason unspecified|0|||
143419845|NCT00103857|517081945|FG002|50-Week Extension Study|reason unspecified|0|||
143419846|NCT00103857|517081946|FG003|50-Week Extension Study|reason unspecified|0|||
143419847|NCT00103857|517081947|FG004|50-Week Extension Study|reason unspecified|1|||
143419848|NCT00103857|517081948|FG005|50-Week Extension Study|reason unspecified|0|||
143419849|NCT00103857|517081949|FG006|50-Week Extension Study|reason unspecified|0|||
143419850|NCT03065400|517081952|FG000|Overall Study|Adverse Event|1|||
143419851|NCT03065400|517081952|FG000|Overall Study|Physician Decision|3|||
143419852|NCT03065400|517081952|FG000|Overall Study|Withdrawal by Subject|1|||
143419853|NCT03065400|517081952|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
143419854|NCT01441596|517081953|FG000|Overall Study|Other reason not defined below|0|||
143419855|NCT01441596|517081954|FG001|Overall Study|Other reason not defined below|2|||
143419856|NCT01441596|517081955|FG002|Overall Study|Other reason not defined below|1|||
143419857|NCT01441596|517081953|FG000|Overall Study|Withdrawal by Subject|4|||
143419858|NCT01441596|517081954|FG001|Overall Study|Withdrawal by Subject|0|||
143419859|NCT01441596|517081955|FG002|Overall Study|Withdrawal by Subject|2|||
143419860|NCT01441596|517081953|FG000|Overall Study|Not treated|0|||
143419861|NCT01441596|517081954|FG001|Overall Study|Not treated|1|||
143419862|NCT01441596|517081955|FG002|Overall Study|Not treated|1|||
143419863|NCT03347396|517081956|FG000|Part A (26 Weeks)|Adverse Event|1|||
143419864|NCT03347396|517081957|FG001|Part A (26 Weeks)|Adverse Event|0|||
143419865|NCT03347396|517081956|FG000|Part A (26 Weeks)|Death|0|||
143419866|NCT03347396|517081957|FG001|Part A (26 Weeks)|Death|1|||
143419867|NCT03347396|517081956|FG000|Part B (149 Weeks)|Adverse Event|1|||
143419868|NCT03347396|517081957|FG001|Part B (149 Weeks)|Adverse Event|1|||
143419869|NCT03347396|517081956|FG000|Part B (149 Weeks)|Death|1|||
143419870|NCT03347396|517081957|FG001|Part B (149 Weeks)|Death|0|||
143419871|NCT01670526|517081964|FG000|Overall Study|Withdrawal by Subject|3|||
143419872|NCT01670526|517081965|FG001|Overall Study|Withdrawal by Subject|1|||
143419873|NCT01670526|517081964|FG000|Overall Study|Lost to Follow-up|9|||
143419874|NCT01670526|517081965|FG001|Overall Study|Lost to Follow-up|5|||
143419875|NCT03060525|517081966|FG000|Overall Study|moved out of state|1|||
143419876|NCT03060525|517081967|FG001|Overall Study|moved out of state|1|||
143419877|NCT03060525|517081968|FG002|Overall Study|moved out of state|1|||
143419878|NCT03060525|517081969|FG003|Overall Study|moved out of state|1|||
143419879|NCT03060525|517081966|FG000|Overall Study|unable to meet time commitment required of study|2|||
143419880|NCT03060525|517081967|FG001|Overall Study|unable to meet time commitment required of study|3|||
143419881|NCT03060525|517081968|FG002|Overall Study|unable to meet time commitment required of study|3|||
143419882|NCT03060525|517081969|FG003|Overall Study|unable to meet time commitment required of study|1|||
143419883|NCT03060525|517081966|FG000|Overall Study|no longer interested in doing intervention|0|||
143419884|NCT03060525|517081967|FG001|Overall Study|no longer interested in doing intervention|0|||
143419885|NCT03060525|517081968|FG002|Overall Study|no longer interested in doing intervention|0|||
143419886|NCT03060525|517081969|FG003|Overall Study|no longer interested in doing intervention|1|||
143419887|NCT03890484|517081979|FG000|Overall Study|Lost to Follow-up|1|||
143419888|NCT03890484|517081980|FG001|Overall Study|Lost to Follow-up|1|||
143419889|NCT00518206|517081981|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
143419890|NCT00518206|517081982|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
143419891|NCT00518206|517081981|FG000|Overall Study|Withdrawal by Subject|2|||
143419892|NCT00518206|517081982|FG001|Overall Study|Withdrawal by Subject|0|||
143419893|NCT00518206|517081981|FG000|Overall Study|Drug Supply Issue|1|||
143419894|NCT00518206|517081982|FG001|Overall Study|Drug Supply Issue|0|||
143419895|NCT00518206|517081981|FG000|Overall Study|Reason Unknown|1|||
143419896|NCT00518206|517081982|FG001|Overall Study|Reason Unknown|0|||
143419897|NCT00518206|517081981|FG000|Overall Study|Completion Status Unknown|1|||
143419898|NCT00518206|517081982|FG001|Overall Study|Completion Status Unknown|0|||
143419899|NCT01294644|517081983|FG000|Overall Study|Adverse Event|2|||
143419900|NCT01294644|517081984|FG001|Overall Study|Adverse Event|0|||
143419901|NCT01294644|517081985|FG002|Overall Study|Adverse Event|1|||
143419902|NCT01294644|517081983|FG000|Overall Study|Withdrawal by Subject|3|||
143419903|NCT01294644|517081984|FG001|Overall Study|Withdrawal by Subject|7|||
143419904|NCT01294644|517081985|FG002|Overall Study|Withdrawal by Subject|4|||
143419905|NCT01294644|517081983|FG000|Overall Study|Lost to Follow-up|3|||
143419906|NCT01294644|517081984|FG001|Overall Study|Lost to Follow-up|2|||
143419907|NCT01294644|517081985|FG002|Overall Study|Lost to Follow-up|5|||
143419908|NCT01294644|517081983|FG000|Overall Study|Miscellaneous Reason|2|||
143419909|NCT01294644|517081984|FG001|Overall Study|Miscellaneous Reason|1|||
143419910|NCT01294644|517081985|FG002|Overall Study|Miscellaneous Reason|4|||
143419911|NCT02188459|517081986|FG000|Overall Study|Lost to Follow-up|3|||
143419912|NCT02188459|517081987|FG001|Overall Study|Lost to Follow-up|4|||
143419913|NCT02188459|517081986|FG000|Overall Study|Early Termination|0|||
143419914|NCT02188459|517081987|FG001|Overall Study|Early Termination|3|||
143419915|NCT02548585|517081988|FG000|Overall Study|Withdrawal by Subject|0|||
143419916|NCT02548585|517081989|FG001|Overall Study|Withdrawal by Subject|0|||
143419917|NCT02548585|517081990|FG002|Overall Study|Withdrawal by Subject|0|||
143419918|NCT02548585|517081991|FG003|Overall Study|Withdrawal by Subject|0|||
143419919|NCT02548585|517081992|FG004|Overall Study|Withdrawal by Subject|0|||
143419920|NCT02548585|517081993|FG005|Overall Study|Withdrawal by Subject|1|||
143419921|NCT02548585|517081994|FG006|Overall Study|Withdrawal by Subject|0|||
143419922|NCT02548585|517081988|FG000|Overall Study|Lost to Follow-up|1|||
143419923|NCT02548585|517081989|FG001|Overall Study|Lost to Follow-up|0|||
143419924|NCT02548585|517081990|FG002|Overall Study|Lost to Follow-up|0|||
143419925|NCT02548585|517081991|FG003|Overall Study|Lost to Follow-up|0|||
143419926|NCT02548585|517081992|FG004|Overall Study|Lost to Follow-up|0|||
143419927|NCT02548585|517081993|FG005|Overall Study|Lost to Follow-up|0|||
143419928|NCT02548585|517081994|FG006|Overall Study|Lost to Follow-up|0|||
143419929|NCT02548585|517081988|FG000|Overall Study|Other|1|||
143419930|NCT02548585|517081989|FG001|Overall Study|Other|0|||
143419931|NCT02548585|517081990|FG002|Overall Study|Other|0|||
143419932|NCT02548585|517081991|FG003|Overall Study|Other|2|||
143419933|NCT02548585|517081992|FG004|Overall Study|Other|3|||
143419934|NCT02548585|517081993|FG005|Overall Study|Other|0|||
143419935|NCT02548585|517081994|FG006|Overall Study|Other|1|||
143419936|NCT02548585|517081988|FG000|Overall Study|Randomized but not treated|0|||
143419937|NCT02548585|517081989|FG001|Overall Study|Randomized but not treated|0|||
143419938|NCT02548585|517081990|FG002|Overall Study|Randomized but not treated|0|||
143419939|NCT02548585|517081991|FG003|Overall Study|Randomized but not treated|0|||
143419940|NCT02548585|517081992|FG004|Overall Study|Randomized but not treated|0|||
143419941|NCT02548585|517081993|FG005|Overall Study|Randomized but not treated|1|||
143419942|NCT02548585|517081994|FG006|Overall Study|Randomized but not treated|0|||
143419943|NCT01986348|517081995|FG000|Overall Study|Death|8|||
143419944|NCT01986348|517081996|FG001|Overall Study|Death|22|||
143419945|NCT01986348|517081997|FG002|Overall Study|Death|10|||
143419946|NCT01986348|517081998|FG003|Overall Study|Death|21|||
143419947|NCT01986348|517081995|FG000|Overall Study|Lost to Follow-up|0|||
143419948|NCT01986348|517081996|FG001|Overall Study|Lost to Follow-up|0|||
143419949|NCT01986348|517081997|FG002|Overall Study|Lost to Follow-up|0|||
143419950|NCT01986348|517081998|FG003|Overall Study|Lost to Follow-up|2|||
143419951|NCT01986348|517081995|FG000|Overall Study|Physician Decision|0|||
143419952|NCT01986348|517081996|FG001|Overall Study|Physician Decision|0|||
143419953|NCT01986348|517081997|FG002|Overall Study|Physician Decision|0|||
143419954|NCT01986348|517081998|FG003|Overall Study|Physician Decision|1|||
143419955|NCT01986348|517081995|FG000|Overall Study|Progressive Disease|0|||
143419956|NCT01986348|517081996|FG001|Overall Study|Progressive Disease|0|||
143419957|NCT01986348|517081997|FG002|Overall Study|Progressive Disease|2|||
143419958|NCT01986348|517081998|FG003|Overall Study|Progressive Disease|0|||
143419959|NCT01986348|517081995|FG000|Overall Study|Withdrawal by Participant|0|||
143419960|NCT01986348|517081996|FG001|Overall Study|Withdrawal by Participant|1|||
143419961|NCT01986348|517081997|FG002|Overall Study|Withdrawal by Participant|2|||
143419962|NCT01986348|517081998|FG003|Overall Study|Withdrawal by Participant|1|||
143419963|NCT01986348|517081995|FG000|Overall Study|Study Terminated by Sponsor|0|||
143419964|NCT01986348|517081996|FG001|Overall Study|Study Terminated by Sponsor|0|||
143419965|NCT01986348|517081997|FG002|Overall Study|Study Terminated by Sponsor|0|||
143419966|NCT01986348|517081998|FG003|Overall Study|Study Terminated by Sponsor|3|||
143419967|NCT01986348|517081995|FG000|Overall Study|Other-unspecified|0|||
143419968|NCT01986348|517081996|FG001|Overall Study|Other-unspecified|1|||
143419969|NCT01986348|517081997|FG002|Overall Study|Other-unspecified|0|||
143419970|NCT01986348|517081998|FG003|Overall Study|Other-unspecified|2|||
143419971|NCT02612285|517081999|FG000|Overall Study|Withdrawal by Subject|1|||
143419972|NCT04919499|517082000|FG000|Overall Study|Adverse Event|0|||
143419973|NCT04919499|517082001|FG001|Overall Study|Adverse Event|0|||
143419974|NCT04919499|517082002|FG002|Overall Study|Adverse Event|0|||
143419975|NCT04919499|517082003|FG003|Overall Study|Adverse Event|0|||
143419976|NCT04919499|517082004|FG004|Overall Study|Adverse Event|2|||
143419977|NCT04919499|517082000|FG000|Overall Study|Not treated|0|||
143419978|NCT04919499|517082001|FG001|Overall Study|Not treated|0|||
143419979|NCT04919499|517082002|FG002|Overall Study|Not treated|0|||
143419980|NCT04919499|517082003|FG003|Overall Study|Not treated|1|||
143419981|NCT04919499|517082004|FG004|Overall Study|Not treated|0|||
143419982|NCT04914897|517083780|FG000|Overall Study|Withdrawal by Subject|3|||
143419983|NCT04914897|517083781|FG001|Overall Study|Withdrawal by Subject|1|||
143419984|NCT04914897|517083782|FG002|Overall Study|Withdrawal by Subject|1|||
143419985|NCT04914897|517083783|FG003|Overall Study|Withdrawal by Subject|1|||
143419986|NCT04914897|517083780|FG000|Overall Study|Poor compliance to protocol|0|||
143419987|NCT04914897|517083781|FG001|Overall Study|Poor compliance to protocol|0|||
143419988|NCT04914897|517083782|FG002|Overall Study|Poor compliance to protocol|1|||
143419989|NCT04914897|517083783|FG003|Overall Study|Poor compliance to protocol|0|||
143419990|NCT04914897|517083780|FG000|Overall Study|Progressive disease|5|||
143419991|NCT04914897|517083781|FG001|Overall Study|Progressive disease|14|||
143419992|NCT04914897|517083782|FG002|Overall Study|Progressive disease|30|||
143419993|NCT04914897|517083783|FG003|Overall Study|Progressive disease|21|||
143419994|NCT04914897|517083780|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
143419995|NCT04914897|517083781|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
143419996|NCT04914897|517083782|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|7|||
143419997|NCT04914897|517083783|FG003|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|6|||
143419998|NCT04914897|517083780|FG000|Overall Study|Other|1|||
143419999|NCT04914897|517083781|FG001|Overall Study|Other|0|||
143420000|NCT04914897|517083782|FG002|Overall Study|Other|0|||
143420001|NCT04914897|517083783|FG003|Overall Study|Other|1|||
143420002|NCT03141177|517083784|FG000|Overall Study|Death|62|||
143420003|NCT03141177|517083785|FG001|Overall Study|Death|13|||
143420004|NCT03141177|517083786|FG002|Overall Study|Death|84|||
143420005|NCT03141177|517083784|FG000|Overall Study|Participant withdrew consent|9|||
143420006|NCT03141177|517083785|FG001|Overall Study|Participant withdrew consent|2|||
143420007|NCT03141177|517083786|FG002|Overall Study|Participant withdrew consent|13|||
143420008|NCT03141177|517083784|FG000|Overall Study|Not reported|1|||
143420009|NCT03141177|517083785|FG001|Overall Study|Not reported|0|||
143420010|NCT03141177|517083786|FG002|Overall Study|Not reported|1|||
143420011|NCT03141177|517083784|FG000|Overall Study|Lost to Follow-up|2|||
143420012|NCT03141177|517083785|FG001|Overall Study|Lost to Follow-up|1|||
143420013|NCT03141177|517083786|FG002|Overall Study|Lost to Follow-up|1|||
143420014|NCT03141177|517083784|FG000|Overall Study|Other reasons|4|||
143420015|NCT03141177|517083785|FG001|Overall Study|Other reasons|0|||
143420016|NCT03141177|517083786|FG002|Overall Study|Other reasons|11|||
143420017|NCT03141177|517083784|FG000|Overall Study|Participants did not start treatment period|3|||
143420018|NCT03141177|517083785|FG001|Overall Study|Participants did not start treatment period|0|||
143420019|NCT03141177|517083786|FG002|Overall Study|Participants did not start treatment period|8|||
143420020|NCT03020914|517083787|FG000|Overall Study|Surgery Cancelled|1|||
143420021|NCT03020914|517083788|FG001|Overall Study|Surgery Cancelled|0|||
143420022|NCT04820023|517083790|FG000|Overall Study|Death|0|||
143420023|NCT04820023|517083791|FG001|Overall Study|Death|0|||
143420024|NCT04820023|517083792|FG002|Overall Study|Death|0|||
143420025|NCT04820023|517083793|FG003|Overall Study|Death|0|||
143420026|NCT04820023|517083794|FG004|Overall Study|Death|0|||
143420027|NCT04820023|517083795|FG005|Overall Study|Death|0|||
143420028|NCT04820023|517083796|FG006|Overall Study|Death|1|||
143420029|NCT04820023|517083797|FG007|Overall Study|Death|0|||
143420030|NCT04820023|517083798|FG008|Overall Study|Death|1|||
143420031|NCT04820023|517083790|FG000|Overall Study|Withdrawal by Subject|1|||
143420032|NCT04820023|517083791|FG001|Overall Study|Withdrawal by Subject|2|||
143420033|NCT04820023|517083792|FG002|Overall Study|Withdrawal by Subject|2|||
143420034|NCT04820023|517083793|FG003|Overall Study|Withdrawal by Subject|1|||
143420035|NCT04820023|517083794|FG004|Overall Study|Withdrawal by Subject|4|||
143420036|NCT04820023|517083795|FG005|Overall Study|Withdrawal by Subject|3|||
143420037|NCT04820023|517083796|FG006|Overall Study|Withdrawal by Subject|3|||
143420038|NCT04820023|517083797|FG007|Overall Study|Withdrawal by Subject|6|||
143420039|NCT04820023|517083798|FG008|Overall Study|Withdrawal by Subject|5|||
143420040|NCT04820023|517083790|FG000|Overall Study|Progressive Disease|3|||
143420041|NCT04820023|517083791|FG001|Overall Study|Progressive Disease|0|||
143420042|NCT04820023|517083792|FG002|Overall Study|Progressive Disease|2|||
143420043|NCT04820023|517083793|FG003|Overall Study|Progressive Disease|2|||
143420044|NCT04820023|517083794|FG004|Overall Study|Progressive Disease|2|||
143420045|NCT04820023|517083795|FG005|Overall Study|Progressive Disease|0|||
143420046|NCT04820023|517083796|FG006|Overall Study|Progressive Disease|1|||
143420047|NCT04820023|517083797|FG007|Overall Study|Progressive Disease|1|||
143420048|NCT04820023|517083798|FG008|Overall Study|Progressive Disease|0|||
143420049|NCT04820023|517083790|FG000|Overall Study|New anti-cancer therapy|0|||
143420050|NCT04820023|517083791|FG001|Overall Study|New anti-cancer therapy|0|||
143420051|NCT04820023|517083792|FG002|Overall Study|New anti-cancer therapy|0|||
143420052|NCT04820023|517083793|FG003|Overall Study|New anti-cancer therapy|0|||
143420053|NCT04820023|517083794|FG004|Overall Study|New anti-cancer therapy|2|||
143420054|NCT04820023|517083795|FG005|Overall Study|New anti-cancer therapy|0|||
143420055|NCT04820023|517083796|FG006|Overall Study|New anti-cancer therapy|0|||
143420056|NCT04820023|517083797|FG007|Overall Study|New anti-cancer therapy|0|||
143420057|NCT04820023|517083798|FG008|Overall Study|New anti-cancer therapy|0|||
143420058|NCT04820023|517083790|FG000|Overall Study|Other|0|||
143420059|NCT04820023|517083791|FG001|Overall Study|Other|1|||
143420060|NCT04820023|517083792|FG002|Overall Study|Other|0|||
143420061|NCT04820023|517083793|FG003|Overall Study|Other|0|||
143420062|NCT04820023|517083794|FG004|Overall Study|Other|0|||
143420063|NCT04820023|517083795|FG005|Overall Study|Other|0|||
143420064|NCT04820023|517083796|FG006|Overall Study|Other|0|||
143420065|NCT04820023|517083797|FG007|Overall Study|Other|2|||
143420066|NCT04820023|517083798|FG008|Overall Study|Other|0|||
143420067|NCT01562275|517083804|FG000|Stage 1|Adverse Event|0|||
143420068|NCT01562275|517083805|FG001|Stage 1|Adverse Event|0|||
143420069|NCT01562275|517083806|FG002|Stage 1|Adverse Event|0|||
143420070|NCT01562275|517083807|FG003|Stage 1|Adverse Event|1|||
143420071|NCT01562275|517083808|FG004|Stage 1|Adverse Event|1|||
143420072|NCT01562275|517083809|FG005|Stage 1|Adverse Event|0|||
143420073|NCT01562275|517083810|FG006|Stage 1|Adverse Event|0|||
143420074|NCT01562275|517083811|FG007|Stage 1|Adverse Event|0|||
143420075|NCT01562275|517083812|FG008|Stage 1|Adverse Event|0|||
143420076|NCT01562275|517083813|FG009|Stage 1|Adverse Event|1|||
143420077|NCT01562275|517083814|FG010|Stage 1|Adverse Event|0|||
143420078|NCT01562275|517083815|FG011|Stage 1|Adverse Event|0|||
143420079|NCT01562275|517083816|FG012|Stage 1|Adverse Event|0|||
143420080|NCT01562275|517083804|FG000|Stage 1|Death|1|||
143420081|NCT01562275|517083805|FG001|Stage 1|Death|0|||
143420082|NCT01562275|517083806|FG002|Stage 1|Death|0|||
143420083|NCT01562275|517083807|FG003|Stage 1|Death|0|||
143420084|NCT01562275|517083808|FG004|Stage 1|Death|0|||
143420085|NCT01562275|517083809|FG005|Stage 1|Death|0|||
143420086|NCT01562275|517083810|FG006|Stage 1|Death|0|||
143420087|NCT01562275|517083811|FG007|Stage 1|Death|0|||
143420088|NCT01562275|517083812|FG008|Stage 1|Death|0|||
143420089|NCT01562275|517083813|FG009|Stage 1|Death|0|||
143420090|NCT01562275|517083814|FG010|Stage 1|Death|0|||
143420091|NCT01562275|517083815|FG011|Stage 1|Death|0|||
143420092|NCT01562275|517083816|FG012|Stage 1|Death|0|||
143420093|NCT01562275|517083804|FG000|Stage 1|Non Compliance|0|||
143420094|NCT01562275|517083805|FG001|Stage 1|Non Compliance|0|||
143420095|NCT01562275|517083806|FG002|Stage 1|Non Compliance|1|||
143420096|NCT01562275|517083807|FG003|Stage 1|Non Compliance|0|||
143420097|NCT01562275|517083808|FG004|Stage 1|Non Compliance|0|||
143420098|NCT01562275|517083809|FG005|Stage 1|Non Compliance|0|||
143420099|NCT01562275|517083810|FG006|Stage 1|Non Compliance|0|||
143420100|NCT01562275|517083811|FG007|Stage 1|Non Compliance|0|||
143420101|NCT01562275|517083812|FG008|Stage 1|Non Compliance|0|||
143420102|NCT01562275|517083813|FG009|Stage 1|Non Compliance|0|||
143420103|NCT01562275|517083814|FG010|Stage 1|Non Compliance|0|||
143420104|NCT01562275|517083815|FG011|Stage 1|Non Compliance|0|||
143420105|NCT01562275|517083816|FG012|Stage 1|Non Compliance|0|||
143420106|NCT01562275|517083804|FG000|Stage 1|Physician Decision|0|||
143420107|NCT01562275|517083805|FG001|Stage 1|Physician Decision|0|||
143420108|NCT01562275|517083806|FG002|Stage 1|Physician Decision|0|||
143420109|NCT01562275|517083807|FG003|Stage 1|Physician Decision|0|||
143420110|NCT01562275|517083808|FG004|Stage 1|Physician Decision|1|||
143420111|NCT01562275|517083809|FG005|Stage 1|Physician Decision|0|||
143420112|NCT01562275|517083810|FG006|Stage 1|Physician Decision|1|||
143420113|NCT01562275|517083811|FG007|Stage 1|Physician Decision|0|||
143420114|NCT01562275|517083812|FG008|Stage 1|Physician Decision|1|||
143420115|NCT01562275|517083813|FG009|Stage 1|Physician Decision|0|||
143420116|NCT01562275|517083814|FG010|Stage 1|Physician Decision|0|||
143420117|NCT01562275|517083815|FG011|Stage 1|Physician Decision|0|||
143420118|NCT01562275|517083816|FG012|Stage 1|Physician Decision|0|||
143420119|NCT01562275|517083804|FG000|Stage 1|Progression of Disease|2|||
143420120|NCT01562275|517083805|FG001|Stage 1|Progression of Disease|6|||
143420121|NCT01562275|517083806|FG002|Stage 1|Progression of Disease|2|||
143420122|NCT01562275|517083807|FG003|Stage 1|Progression of Disease|1|||
143420123|NCT01562275|517083808|FG004|Stage 1|Progression of Disease|2|||
143420124|NCT01562275|517083809|FG005|Stage 1|Progression of Disease|4|||
143420125|NCT01562275|517083810|FG006|Stage 1|Progression of Disease|1|||
143420126|NCT01562275|517083811|FG007|Stage 1|Progression of Disease|7|||
143420127|NCT01562275|517083812|FG008|Stage 1|Progression of Disease|2|||
143420128|NCT01562275|517083813|FG009|Stage 1|Progression of Disease|5|||
143420129|NCT01562275|517083814|FG010|Stage 1|Progression of Disease|3|||
143420130|NCT01562275|517083815|FG011|Stage 1|Progression of Disease|0|||
143420131|NCT01562275|517083816|FG012|Stage 1|Progression of Disease|0|||
143420132|NCT01562275|517083804|FG000|Stage 1|Withdrawal by Subject|0|||
143420133|NCT01562275|517083805|FG001|Stage 1|Withdrawal by Subject|1|||
143420134|NCT01562275|517083806|FG002|Stage 1|Withdrawal by Subject|0|||
143420135|NCT01562275|517083807|FG003|Stage 1|Withdrawal by Subject|2|||
143420136|NCT01562275|517083808|FG004|Stage 1|Withdrawal by Subject|0|||
143420137|NCT01562275|517083809|FG005|Stage 1|Withdrawal by Subject|0|||
143420138|NCT01562275|517083810|FG006|Stage 1|Withdrawal by Subject|1|||
143420139|NCT01562275|517083811|FG007|Stage 1|Withdrawal by Subject|0|||
143420140|NCT01562275|517083812|FG008|Stage 1|Withdrawal by Subject|0|||
143420141|NCT01562275|517083813|FG009|Stage 1|Withdrawal by Subject|1|||
143420142|NCT01562275|517083814|FG010|Stage 1|Withdrawal by Subject|0|||
143420143|NCT01562275|517083815|FG011|Stage 1|Withdrawal by Subject|0|||
143420144|NCT01562275|517083816|FG012|Stage 1|Withdrawal by Subject|0|||
143420145|NCT01562275|517083804|FG000|Stage 2|Death|0|||
143420146|NCT01562275|517083805|FG001|Stage 2|Death|0|||
143420147|NCT01562275|517083806|FG002|Stage 2|Death|0|||
143420148|NCT01562275|517083807|FG003|Stage 2|Death|0|||
143420149|NCT01562275|517083808|FG004|Stage 2|Death|0|||
143420150|NCT01562275|517083809|FG005|Stage 2|Death|0|||
143420151|NCT01562275|517083810|FG006|Stage 2|Death|0|||
143420152|NCT01562275|517083811|FG007|Stage 2|Death|0|||
143420153|NCT01562275|517083812|FG008|Stage 2|Death|0|||
143420154|NCT01562275|517083813|FG009|Stage 2|Death|0|||
143420155|NCT01562275|517083814|FG010|Stage 2|Death|0|||
143420156|NCT01562275|517083815|FG011|Stage 2|Death|2|||
143420157|NCT01562275|517083816|FG012|Stage 2|Death|1|||
143420158|NCT01562275|517083804|FG000|Stage 2|Progression of Disease|0|||
143420159|NCT01562275|517083805|FG001|Stage 2|Progression of Disease|0|||
143420160|NCT01562275|517083806|FG002|Stage 2|Progression of Disease|0|||
143420161|NCT01562275|517083807|FG003|Stage 2|Progression of Disease|0|||
143420162|NCT01562275|517083808|FG004|Stage 2|Progression of Disease|0|||
143420163|NCT01562275|517083809|FG005|Stage 2|Progression of Disease|0|||
143420164|NCT01562275|517083810|FG006|Stage 2|Progression of Disease|0|||
143420165|NCT01562275|517083811|FG007|Stage 2|Progression of Disease|0|||
143420166|NCT01562275|517083812|FG008|Stage 2|Progression of Disease|0|||
143420167|NCT01562275|517083813|FG009|Stage 2|Progression of Disease|0|||
143420168|NCT01562275|517083814|FG010|Stage 2|Progression of Disease|0|||
143420169|NCT01562275|517083815|FG011|Stage 2|Progression of Disease|12|||
143420170|NCT01562275|517083816|FG012|Stage 2|Progression of Disease|4|||
143420171|NCT01863368|517083817|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
143420172|NCT01863368|517083818|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
143420173|NCT01863368|517083817|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
143420174|NCT01863368|517083818|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
143420175|NCT01863368|517083817|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
143420176|NCT01863368|517083818|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
143420177|NCT01863368|517083817|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
143420178|NCT01863368|517083818|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
143420179|NCT01863368|517083817|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
143420180|NCT01863368|517083818|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
143420181|NCT01863368|517083817|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
143420182|NCT01863368|517083818|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
143420183|NCT00515112|517083820|FG000|Overall Study|Death|0|||
143420184|NCT00515112|517083821|FG001|Overall Study|Death|1|||
143420185|NCT00515112|517083820|FG000|Overall Study|The study was terminated|3|||
143420186|NCT00515112|517083821|FG001|Overall Study|The study was terminated|2|||
143420187|NCT01020487|517083822|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
143420188|NCT01020487|517083823|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
143420189|NCT01020487|517083824|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
143420190|NCT01020487|517083822|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
143420191|NCT01020487|517083823|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
143420192|NCT01020487|517083824|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
143420193|NCT01020487|517083822|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
143420194|NCT01020487|517083823|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
143420195|NCT01020487|517083824|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
143420196|NCT01020487|517083822|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
143420197|NCT01020487|517083823|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
143420198|NCT01020487|517083824|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
143420199|NCT01020487|517083822|FG000|Part 2 Open-label Period|Adverse Event|0|||
143420200|NCT01020487|517083823|FG001|Part 2 Open-label Period|Adverse Event|4|||
143420201|NCT01020487|517083824|FG002|Part 2 Open-label Period|Adverse Event|1|||
143420202|NCT04425252|517083827|FG000|Overall Study|Withdrawal by Subject|2|||
143420203|NCT04425252|517083828|FG001|Overall Study|Withdrawal by Subject|1|||
143420204|NCT04425252|517083827|FG000|Overall Study|Lost to Follow-up|1|||
143420205|NCT04425252|517083828|FG001|Overall Study|Lost to Follow-up|0|||
143420206|NCT04425252|517083827|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
143420207|NCT04425252|517083828|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
143420208|NCT00304278|517083829|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
143420209|NCT00304278|517083829|FG000|Overall Study|PT had medical condition preventing TX|1|||
143420210|NCT04271254|517083830|FG000|Overall Study|Withdrawal by Subject|3|||
143420211|NCT01123356|517083831|FG000|Overall Study|Adverse Event|2|||
143420212|NCT01123356|517083831|FG000|Overall Study|Lack of Efficacy|4|||
143420213|NCT01123356|517083831|FG000|Overall Study|Withdrawal by Subject|1|||
143420214|NCT00930644|517083832|FG000|Overall Study|Withdrawal by Subject|4|||
143420215|NCT00930644|517083832|FG000|Overall Study|Physician Decision|2|||
143420216|NCT00930644|517083832|FG000|Overall Study|Death|1|||
143420217|NCT00930644|517083832|FG000|Overall Study|Adverse Event|16|||
143420218|NCT01113541|517083839|FG000|Overall Study|Withdrawal by Subject|1|||
143420219|NCT01113541|517083839|FG000|Overall Study|Protocol Violation|1|||
143420220|NCT01113541|517083839|FG000|Overall Study|Study Terminated by Sponsor|7|||
143420221|NCT01113541|517083839|FG000|Overall Study|Adverse Event|4|||
143420222|NCT03745651|517083840|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
143420223|NCT03745651|517083841|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
143420224|NCT03745651|517083842|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
143420225|NCT03745651|517083843|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
143420226|NCT03745651|517083844|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
143420227|NCT03745651|517083845|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
143420228|NCT03745651|517083846|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
143420229|NCT03745651|517083840|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
143420230|NCT03745651|517083841|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
143420231|NCT03745651|517083842|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
143420232|NCT03745651|517083843|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
143420233|NCT03745651|517083844|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
143420234|NCT03745651|517083845|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
143420235|NCT03745651|517083846|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
143420236|NCT03745651|517083840|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
143420237|NCT03745651|517083841|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
143420238|NCT03745651|517083842|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
143420239|NCT03745651|517083843|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
143420240|NCT03745651|517083844|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
143420241|NCT03745651|517083845|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
143420242|NCT03745651|517083846|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
143420243|NCT03745651|517083840|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
143420244|NCT03745651|517083841|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
143420245|NCT03745651|517083842|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
143420246|NCT03745651|517083843|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
143420247|NCT03745651|517083844|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
143420248|NCT03745651|517083845|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
143420249|NCT03745651|517083846|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
143420250|NCT03745651|517083840|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
143420251|NCT03745651|517083841|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
143420252|NCT03745651|517083842|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
143420253|NCT03745651|517083843|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
143420254|NCT03745651|517083844|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
143420255|NCT03745651|517083845|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
143420256|NCT03745651|517083846|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
143420257|NCT03745651|517083840|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
143420258|NCT03745651|517083841|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
143420259|NCT03745651|517083842|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
143420260|NCT03745651|517083843|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
143420261|NCT03745651|517083844|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
143420262|NCT03745651|517083845|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
143420263|NCT03745651|517083846|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
143420264|NCT03745651|517083840|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
143420265|NCT03745651|517083841|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
143420266|NCT03745651|517083842|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
143420267|NCT03745651|517083843|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
143420268|NCT03745651|517083844|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
143420269|NCT03745651|517083845|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
143420270|NCT03745651|517083846|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
143420271|NCT03745651|517083840|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
143420272|NCT03745651|517083841|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
143420273|NCT03745651|517083842|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
143420274|NCT03745651|517083843|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
143420275|NCT03745651|517083844|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
143420276|NCT03745651|517083845|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
143420277|NCT03745651|517083846|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
143420278|NCT03745651|517083840|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
143420279|NCT03745651|517083841|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
143420280|NCT03745651|517083842|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
143420281|NCT03745651|517083843|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
143420282|NCT03745651|517083844|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
143420283|NCT03745651|517083845|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
143420284|NCT03745651|517083846|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
143420285|NCT03745651|517083840|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
143420286|NCT03745651|517083841|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
143420287|NCT03745651|517083842|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
143420288|NCT03745651|517083843|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
143420289|NCT03745651|517083844|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
143420290|NCT03745651|517083845|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
143420291|NCT03745651|517083846|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
143420292|NCT03745651|517083840|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
143420293|NCT03745651|517083841|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
143420294|NCT03745651|517083842|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
143420295|NCT03745651|517083843|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
143420296|NCT03745651|517083844|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
143420297|NCT03745651|517083845|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
143420298|NCT03745651|517083846|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
143420299|NCT03745651|517083840|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
143420300|NCT03745651|517083841|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
143420301|NCT03745651|517083842|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
143420302|NCT03745651|517083843|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
143420303|NCT03745651|517083844|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
143420304|NCT03745651|517083845|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
143420305|NCT03745651|517083846|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
143420306|NCT03745651|517083840|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
143420307|NCT03745651|517083841|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
143420308|NCT03745651|517083842|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
143420309|NCT03745651|517083843|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
143420310|NCT03745651|517083844|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
143420311|NCT03745651|517083845|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
143420312|NCT03745651|517083846|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
143420313|NCT03745651|517083840|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
143420314|NCT03745651|517083841|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
143420315|NCT03745651|517083842|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
143420316|NCT03745651|517083843|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
143420317|NCT03745651|517083844|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
143420318|NCT03745651|517083845|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
143420319|NCT03745651|517083846|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
143420320|NCT04175834|517083847|FG000|Overall Study|Withdrawal by Subject|1|||
143420321|NCT04175834|517083848|FG001|Overall Study|Withdrawal by Subject|0|||
143420322|NCT01494467|517083857|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
143420323|NCT01494467|517083858|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
143420324|NCT01494467|517083857|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
143420325|NCT01494467|517083858|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
143420326|NCT01494467|517083857|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
143420327|NCT01494467|517083858|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
143420328|NCT01494467|517083857|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
143420329|NCT01494467|517083858|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
143420330|NCT01494467|517083857|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
143420331|NCT01494467|517083858|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
143420332|NCT01494467|517083857|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
143420333|NCT01494467|517083858|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
143420334|NCT01494467|517083857|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
143420335|NCT01494467|517083858|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
143420336|NCT01494467|517083857|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
143420337|NCT01494467|517083858|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
143420338|NCT01494467|517083857|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
143420339|NCT01494467|517083858|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
143420340|NCT01494467|517083857|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
143420341|NCT01494467|517083858|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
143420342|NCT01494467|517083857|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
143420343|NCT01494467|517083858|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
143420344|NCT01494467|517083857|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
143420345|NCT01494467|517083858|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
143420346|NCT01494467|517083857|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
143420347|NCT01494467|517083858|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
143420348|NCT01494467|517083857|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
143420349|NCT01494467|517083858|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
143420350|NCT02410278|517083861|FG000|Run-in Period|Adverse Event|5|||
143420351|NCT02410278|517083862|FG001|Run-in Period|Adverse Event|0|||
143420352|NCT02410278|517083863|FG002|Run-in Period|Adverse Event|0|||
143420353|NCT02410278|517083861|FG000|Run-in Period|GSRS Threshold Not Met|30|||
143420354|NCT02410278|517083862|FG001|Run-in Period|GSRS Threshold Not Met|0|||
143420355|NCT02410278|517083863|FG002|Run-in Period|GSRS Threshold Not Met|0|||
143420356|NCT02410278|517083861|FG000|Run-in Period|Lost to Follow-up|1|||
143420357|NCT02410278|517083862|FG001|Run-in Period|Lost to Follow-up|0|||
143420358|NCT02410278|517083863|FG002|Run-in Period|Lost to Follow-up|0|||
143420359|NCT02410278|517083861|FG000|Run-in Period|Withdrawal by Subject|1|||
143420360|NCT02410278|517083862|FG001|Run-in Period|Withdrawal by Subject|0|||
143420361|NCT02410278|517083863|FG002|Run-in Period|Withdrawal by Subject|0|||
143420362|NCT02410278|517083861|FG000|Run-in Period|Pregnancy|1|||
143420363|NCT02410278|517083862|FG001|Run-in Period|Pregnancy|0|||
143420364|NCT02410278|517083863|FG002|Run-in Period|Pregnancy|0|||
143420365|NCT02410278|517083861|FG000|Study Treatment Period|Adverse Event|0|||
143420366|NCT02410278|517083862|FG001|Study Treatment Period|Adverse Event|6|||
143420367|NCT02410278|517083863|FG002|Study Treatment Period|Adverse Event|3|||
143420368|NCT02410278|517083861|FG000|Study Treatment Period|Physician Decision|0|||
143420369|NCT02410278|517083862|FG001|Study Treatment Period|Physician Decision|0|||
143420370|NCT02410278|517083863|FG002|Study Treatment Period|Physician Decision|1|||
143420371|NCT02410278|517083861|FG000|Study Treatment Period|Withdrawal by Subject|0|||
143420372|NCT02410278|517083862|FG001|Study Treatment Period|Withdrawal by Subject|1|||
143420373|NCT02410278|517083863|FG002|Study Treatment Period|Withdrawal by Subject|0|||
143420374|NCT02410278|517083861|FG000|Study Treatment Period|Other|0|||
143420375|NCT02410278|517083862|FG001|Study Treatment Period|Other|3|||
143420376|NCT02410278|517083863|FG002|Study Treatment Period|Other|0|||
143420377|NCT02410278|517083861|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
143420378|NCT02410278|517083862|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
143420379|NCT02410278|517083863|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
143420380|NCT03693989|517083864|FG000|Overall Study|Protocol Violation|3|||
143420381|NCT03693989|517083865|FG001|Overall Study|Protocol Violation|4|||
143420382|NCT01190436|517083866|FG000|Overall Study|Lost to Follow-up|35|||
143420383|NCT01190436|517083866|FG000|Overall Study|Other|4|||
143420384|NCT03146845|517083867|FG000|Overall Study|Reference ulcer healed|1|||
143420385|NCT03146845|517083868|FG001|Overall Study|Reference ulcer healed|0|||
143420386|NCT03146845|517083867|FG000|Overall Study|Physician Decision|1|||
143420387|NCT03146845|517083868|FG001|Overall Study|Physician Decision|0|||
143420388|NCT03146845|517083867|FG000|Overall Study|Adverse Event|1|||
143420389|NCT03146845|517083868|FG001|Overall Study|Adverse Event|0|||
143420390|NCT03146845|517083867|FG000|Overall Study|Withdrawal by Subject|2|||
143420391|NCT03146845|517083868|FG001|Overall Study|Withdrawal by Subject|0|||
143420392|NCT03146845|517083867|FG000|Overall Study|Noncompliance|0|||
143420393|NCT03146845|517083868|FG001|Overall Study|Noncompliance|1|||
143420394|NCT03146845|517083867|FG000|Overall Study|Protocol Violation|0|||
143420395|NCT03146845|517083868|FG001|Overall Study|Protocol Violation|2|||
143420396|NCT03146845|517083867|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
143420397|NCT03146845|517083868|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
143420398|NCT02721147|517083869|FG000|Overall Study|Lost to Follow-up|2|||
143420399|NCT02721147|517083870|FG001|Overall Study|Lost to Follow-up|0|||
143420400|NCT02721147|517083871|FG002|Overall Study|Lost to Follow-up|0|||
143420401|NCT00113529|517083875|FG000|Overall Study|Adverse Event|4|||
143420402|NCT00113529|517083875|FG000|Overall Study|Lack of Efficacy|20|||
143420403|NCT00113529|517083875|FG000|Overall Study|Decision of sponsor|6|||
143420404|NCT00113529|517083875|FG000|Overall Study|Withdrawal by Subject|4|||
143420405|NCT00648895|517083877|FG000|Overall Study|Lack of Efficacy|0|||
143420406|NCT00648895|517083878|FG001|Overall Study|Lack of Efficacy|1|||
143420407|NCT01077284|517083879|FG000|Overall Study|Adverse Event|2|||
143420408|NCT01077284|517083880|FG001|Overall Study|Adverse Event|0|||
143420409|NCT01077284|517083881|FG002|Overall Study|Adverse Event|1|||
143420410|NCT01077284|517083879|FG000|Overall Study|Lost to Follow-up|1|||
143420411|NCT01077284|517083880|FG001|Overall Study|Lost to Follow-up|2|||
143420412|NCT01077284|517083881|FG002|Overall Study|Lost to Follow-up|0|||
143420413|NCT01077284|517083879|FG000|Overall Study|Withdrawal by Subject|2|||
143420414|NCT01077284|517083880|FG001|Overall Study|Withdrawal by Subject|3|||
143420415|NCT01077284|517083881|FG002|Overall Study|Withdrawal by Subject|1|||
143420416|NCT01077284|517083879|FG000|Overall Study|Other|0|||
143420417|NCT01077284|517083880|FG001|Overall Study|Other|0|||
143420418|NCT01077284|517083881|FG002|Overall Study|Other|1|||
143420419|NCT01280721|517083882|FG000|Overall Study|Adverse Event|4|||
143420420|NCT01280721|517083882|FG000|Overall Study|Physician Decision|3|||
143420421|NCT01280721|517083882|FG000|Overall Study|Withdrawal by Subject|6|||
143420422|NCT01280721|517083882|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
143420423|NCT01280721|517083882|FG000|Overall Study|No tolerability for the lowest dose|2|||
143420424|NCT01180400|517083883|FG000|Overall Study|Withdrawal by Subject|5|||
143420425|NCT01180400|517083884|FG001|Overall Study|Withdrawal by Subject|6|||
143420426|NCT01180400|517083883|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
143420427|NCT01180400|517083884|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
143420428|NCT01180400|517083883|FG000|Overall Study|Adverse Event|12|||
143420429|NCT01180400|517083884|FG001|Overall Study|Adverse Event|10|||
143420430|NCT01180400|517083883|FG000|Overall Study|Severe non-compliance to protocol|1|||
143420431|NCT01180400|517083884|FG001|Overall Study|Severe non-compliance to protocol|2|||
143420432|NCT01180400|517083883|FG000|Overall Study|Condition under investigation worsened|2|||
143420433|NCT01180400|517083884|FG001|Overall Study|Condition under investigation worsened|1|||
143420434|NCT01180400|517083883|FG000|Overall Study|Lack of Efficacy|2|||
143420435|NCT01180400|517083884|FG001|Overall Study|Lack of Efficacy|0|||
143420436|NCT01180400|517083883|FG000|Overall Study|Study-specific withdrawal criteria|1|||
143420437|NCT01180400|517083884|FG001|Overall Study|Study-specific withdrawal criteria|2|||
143420438|NCT01180400|517083883|FG000|Overall Study|Lost to Follow-up|2|||
143420439|NCT01180400|517083884|FG001|Overall Study|Lost to Follow-up|3|||
143420440|NCT01180400|517083883|FG000|Overall Study|Other|0|||
143420441|NCT01180400|517083884|FG001|Overall Study|Other|1|||
143420442|NCT01182285|517083885|FG000|First Intervention Week 1-10|Disease progression|1|||
143420443|NCT01182285|517083886|FG001|First Intervention Week 1-10|Disease progression|0|||
143420444|NCT01182285|517083887|FG002|First Intervention Week 1-10|Disease progression|0|||
143420445|NCT01182285|517083885|FG000|First Intervention Week 1-10|Adverse Event|1|||
143420446|NCT01182285|517083886|FG001|First Intervention Week 1-10|Adverse Event|0|||
143420447|NCT01182285|517083887|FG002|First Intervention Week 1-10|Adverse Event|0|||
143420448|NCT01182285|517083885|FG000|First Intervention Week 1-10|Non-compliance|1|||
143420449|NCT01182285|517083886|FG001|First Intervention Week 1-10|Non-compliance|0|||
143420450|NCT01182285|517083887|FG002|First Intervention Week 1-10|Non-compliance|0|||
143420451|NCT01182285|517083885|FG000|Third Intervention Week 11-52|Disease Progression|0|||
143420452|NCT01182285|517083886|FG001|Third Intervention Week 11-52|Disease Progression|0|||
143420453|NCT01182285|517083887|FG002|Third Intervention Week 11-52|Disease Progression|6|||
143420454|NCT01182285|517083885|FG000|Third Intervention Week 11-52|Other|0|||
143420455|NCT01182285|517083886|FG001|Third Intervention Week 11-52|Other|0|||
143420456|NCT01182285|517083887|FG002|Third Intervention Week 11-52|Other|2|||
143420457|NCT02632747|517083888|FG000|Wash-out Period|Adverse Event|1|||
143420458|NCT02632747|517083889|FG001|Wash-out Period|Adverse Event|0|||
143420459|NCT01525875|517083890|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
143420460|NCT01525875|517083891|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
143420461|NCT01525875|517083890|FG000|Open-label Period|Lost to Follow-up|0|||
143420462|NCT01525875|517083891|FG001|Open-label Period|Lost to Follow-up|2|||
143420463|NCT00700999|517083892|FG000|Overall Study|Lost to Follow-up|7|||
143420464|NCT00700999|517083893|FG001|Overall Study|Lost to Follow-up|7|||
143420465|NCT00700999|517083892|FG000|Overall Study|Excluded - did not meet study criteria|0|||
143420466|NCT00700999|517083893|FG001|Overall Study|Excluded - did not meet study criteria|1|||
143420467|NCT00700999|517083892|FG000|Overall Study|Withdrawal by Subject|8|||
143420468|NCT00700999|517083893|FG001|Overall Study|Withdrawal by Subject|1|||
143420469|NCT02379078|517083894|FG000|Overall Study|Lost to Follow-up|33|||
143420470|NCT02379078|517083895|FG001|Overall Study|Lost to Follow-up|30|||
143420471|NCT02379078|517083894|FG000|Overall Study|Withdrawal by Subject|6|||
143420472|NCT02379078|517083895|FG001|Overall Study|Withdrawal by Subject|5|||
143420473|NCT03481725|517083896|FG000|Overall Study|Withdrawal by Subject|1|||
143420474|NCT03481725|517083897|FG001|Overall Study|Withdrawal by Subject|0|||
143420475|NCT01894620|517083898|FG000|Overall Study|Withdrawal by Subject|0|||
143420476|NCT01894620|517083899|FG001|Overall Study|Withdrawal by Subject|1|||
143420477|NCT02399449|517083908|FG000|Overall Study|Withdrawal by Subject|3|||
143420478|NCT02399449|517083909|FG001|Overall Study|Withdrawal by Subject|9|||
143420479|NCT02399449|517083908|FG000|Overall Study|Physician Decision|0|||
143420480|NCT02399449|517083909|FG001|Overall Study|Physician Decision|1|||
143420481|NCT02516202|517083910|FG000|Overall Study|Withdrawal by Subject|1|||
143420482|NCT02516202|517083911|FG001|Overall Study|Withdrawal by Subject|0|||
143420483|NCT02516202|517083912|FG002|Overall Study|Withdrawal by Subject|1|||
143420484|NCT02516202|517083910|FG000|Overall Study|Lost to Follow-up|1|||
143420485|NCT02516202|517083911|FG001|Overall Study|Lost to Follow-up|1|||
143420486|NCT02516202|517083912|FG002|Overall Study|Lost to Follow-up|1|||
143420487|NCT02516202|517083910|FG000|Overall Study|Stopped Follow-up|0|||
143420488|NCT02516202|517083911|FG001|Overall Study|Stopped Follow-up|0|||
143420489|NCT02516202|517083912|FG002|Overall Study|Stopped Follow-up|1|||
143420490|NCT02159352|517083915|FG000|Overall Study|Adverse Event|3|||
143420491|NCT02159352|517083916|FG001|Overall Study|Adverse Event|1|||
143420492|NCT02159352|517083915|FG000|Overall Study|Withdrawal by Subject|0|||
143420493|NCT02159352|517083916|FG001|Overall Study|Withdrawal by Subject|1|||
143420494|NCT00529529|517083917|FG000|Overall Study|Adverse Event|12|||
143420495|NCT00529529|517083918|FG001|Overall Study|Adverse Event|17|||
143420496|NCT00529529|517083919|FG002|Overall Study|Adverse Event|8|||
143420497|NCT00529529|517083917|FG000|Overall Study|Subject withdrew consent|12|||
143420498|NCT00529529|517083918|FG001|Overall Study|Subject withdrew consent|9|||
143420499|NCT00529529|517083919|FG002|Overall Study|Subject withdrew consent|12|||
143420500|NCT00529529|517083917|FG000|Overall Study|Protocol deviation|8|||
143420501|NCT00529529|517083918|FG001|Overall Study|Protocol deviation|12|||
143420502|NCT00529529|517083919|FG002|Overall Study|Protocol deviation|5|||
143420503|NCT00529529|517083917|FG000|Overall Study|Lost to Follow-up|5|||
143420504|NCT00529529|517083918|FG001|Overall Study|Lost to Follow-up|3|||
143420505|NCT00529529|517083919|FG002|Overall Study|Lost to Follow-up|1|||
143420506|NCT00529529|517083917|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
143420507|NCT00529529|517083918|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
143420508|NCT00529529|517083919|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
143420509|NCT00529529|517083917|FG000|Overall Study|Death|2|||
143420510|NCT00529529|517083918|FG001|Overall Study|Death|0|||
143420511|NCT00529529|517083919|FG002|Overall Study|Death|0|||
143420512|NCT00529529|517083917|FG000|Overall Study|Abnormal test procedure result(s)|1|||
143420513|NCT00529529|517083918|FG001|Overall Study|Abnormal test procedure result(s)|0|||
143420514|NCT00529529|517083919|FG002|Overall Study|Abnormal test procedure result(s)|0|||
143420515|NCT00529529|517083917|FG000|Overall Study|Administrative problems|1|||
143420516|NCT00529529|517083918|FG001|Overall Study|Administrative problems|0|||
143420517|NCT00529529|517083919|FG002|Overall Study|Administrative problems|3|||
143420518|NCT01020435|517083924|FG000|Overall Study|Lost to Follow-up|0|||
143420519|NCT01020435|517083925|FG001|Overall Study|Lost to Follow-up|1|||
143420520|NCT01000649|517083926|FG000|Overall Study|Adverse Event|5|||
143420521|NCT01000649|517083927|FG001|Overall Study|Adverse Event|1|||
143420522|NCT01000649|517083928|FG002|Overall Study|Adverse Event|2|||
143420523|NCT01000649|517083929|FG003|Overall Study|Adverse Event|4|||
143420524|NCT01000649|517083926|FG000|Overall Study|Lost to Follow-up|0|||
143420525|NCT01000649|517083927|FG001|Overall Study|Lost to Follow-up|2|||
143420526|NCT01000649|517083928|FG002|Overall Study|Lost to Follow-up|0|||
143420527|NCT01000649|517083929|FG003|Overall Study|Lost to Follow-up|2|||
143420528|NCT00346398|517083932|FG000|Overall Study|Lost to Follow-up|3|||
143420529|NCT00346398|517083933|FG001|Overall Study|Lost to Follow-up|0|||
143420530|NCT00346398|517083932|FG000|Overall Study|Withdrawal by Subject|0|||
143420531|NCT00346398|517083933|FG001|Overall Study|Withdrawal by Subject|2|||
143420532|NCT02707952|517083934|FG000|Overall Study|Adverse Event|1|||
143420533|NCT02707952|517083935|FG001|Overall Study|Adverse Event|0|||
143420534|NCT02707952|517083936|FG002|Overall Study|Adverse Event|0|||
143420535|NCT02707952|517083937|FG003|Overall Study|Adverse Event|0|||
143420536|NCT02707952|517083934|FG000|Overall Study|Lost to Follow-up|1|||
143420537|NCT02707952|517083935|FG001|Overall Study|Lost to Follow-up|0|||
143420538|NCT02707952|517083936|FG002|Overall Study|Lost to Follow-up|0|||
143420539|NCT02707952|517083937|FG003|Overall Study|Lost to Follow-up|0|||
143420540|NCT02707952|517083934|FG000|Overall Study|Withdrawal by Subject|0|||
143420541|NCT02707952|517083935|FG001|Overall Study|Withdrawal by Subject|1|||
143420542|NCT02707952|517083936|FG002|Overall Study|Withdrawal by Subject|2|||
143420543|NCT02707952|517083937|FG003|Overall Study|Withdrawal by Subject|0|||
143420544|NCT00871715|517083938|FG000|Overall Study|Withdrawal by Subject|6|||
143420545|NCT00871715|517083939|FG001|Overall Study|Withdrawal by Subject|10|||
143420546|NCT00871715|517083940|FG002|Overall Study|Withdrawal by Subject|15|||
143420547|NCT00871715|517083938|FG000|Overall Study|Physician Decision|6|||
143420548|NCT00871715|517083939|FG001|Overall Study|Physician Decision|0|||
143420549|NCT00871715|517083940|FG002|Overall Study|Physician Decision|2|||
143420550|NCT00871715|517083938|FG000|Overall Study|Lost to Follow-up|3|||
143420551|NCT00871715|517083939|FG001|Overall Study|Lost to Follow-up|6|||
143420552|NCT00871715|517083940|FG002|Overall Study|Lost to Follow-up|9|||
143420553|NCT00392197|517083941|FG000|Overall Study|Adverse Event|4|||
143420554|NCT00392197|517083942|FG001|Overall Study|Adverse Event|12|||
143420555|NCT00392197|517083941|FG000|Overall Study|Lack of Efficacy|3|||
143420556|NCT00392197|517083942|FG001|Overall Study|Lack of Efficacy|4|||
143420557|NCT00392197|517083941|FG000|Overall Study|Lost to Follow-up|0|||
143420558|NCT00392197|517083942|FG001|Overall Study|Lost to Follow-up|1|||
143420559|NCT00392197|517083941|FG000|Overall Study|Physician Decision|3|||
143420560|NCT00392197|517083942|FG001|Overall Study|Physician Decision|2|||
143420561|NCT00392197|517083941|FG000|Overall Study|Protocol Violation|7|||
143420562|NCT00392197|517083942|FG001|Overall Study|Protocol Violation|5|||
143420563|NCT00392197|517083941|FG000|Overall Study|Withdrawal by Subject|4|||
143420564|NCT00392197|517083942|FG001|Overall Study|Withdrawal by Subject|6|||
143420565|NCT01794689|517083943|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
143420566|NCT01794689|517083944|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
143420567|NCT01794689|517083945|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
143420568|NCT01794689|517083946|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
143420569|NCT01794689|517083943|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
143420570|NCT01794689|517083944|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
143420571|NCT01794689|517083945|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
143420572|NCT01794689|517083946|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
143420573|NCT01794689|517083943|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
143420574|NCT01794689|517083944|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
143420575|NCT01794689|517083945|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
143420576|NCT01794689|517083946|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
143420577|NCT01794689|517083943|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
143420578|NCT01794689|517083944|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
143420579|NCT01794689|517083945|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
143420580|NCT01794689|517083946|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
143420581|NCT01970527|517083948|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
143420582|NCT01970527|517083949|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
143420583|NCT01970527|517083948|FG000|Treatment|Disease progression|0|||
143420584|NCT01970527|517083949|FG001|Treatment|Disease progression|1|||
143420585|NCT01970527|517083948|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
143420586|NCT01970527|517083949|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
143420587|NCT01970527|517083948|FG000|Treatment|Death|0|||
143420588|NCT01970527|517083949|FG001|Treatment|Death|1|||
143420589|NCT01970527|517083948|FG000|Follow-up Clinic Visit|Disease progression|1|||
143420590|NCT01970527|517083949|FG001|Follow-up Clinic Visit|Disease progression|1|||
143420591|NCT01970527|517083948|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
143420592|NCT01970527|517083949|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
143420593|NCT01970527|517083948|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
143420594|NCT01970527|517083949|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
143420595|NCT02147093|517083950|FG000|Period 1|Lost to Follow-up|0|||
143420596|NCT02147093|517083951|FG001|Period 1|Lost to Follow-up|1|||
143420597|NCT02147093|517083950|FG000|Period 2|Protocol Violation|2|||
143420598|NCT02147093|517083951|FG001|Period 2|Protocol Violation|0|||
143420599|NCT01147471|517083952|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
143420600|NCT01147471|517083953|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
143420601|NCT01147471|517083952|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
143420602|NCT01147471|517083953|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
143420603|NCT01147471|517083952|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
143420604|NCT01147471|517083953|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
143420605|NCT01147471|517083952|FG000|3 Month Follow Up|Lost to Follow-up|1|||
143420606|NCT01147471|517083953|FG001|3 Month Follow Up|Lost to Follow-up|1|||
143420607|NCT01147471|517083952|FG000|3 Month Follow Up|Physician Decision|0|||
143420608|NCT01147471|517083953|FG001|3 Month Follow Up|Physician Decision|1|||
143420609|NCT01147471|517083952|FG000|6 Month Follow Up|Lost to Follow-up|4|||
143420610|NCT01147471|517083953|FG001|6 Month Follow Up|Lost to Follow-up|2|||
143420611|NCT00853957|517083958|FG000|Overall Study|Adverse Event|9|||
143420612|NCT00853957|517083959|FG001|Overall Study|Adverse Event|3|||
143420613|NCT00853957|517083958|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
143420614|NCT00853957|517083959|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
143420615|NCT00853957|517083958|FG000|Overall Study|Subject withdrew consent|4|||
143420616|NCT00853957|517083959|FG001|Overall Study|Subject withdrew consent|5|||
143420617|NCT00853957|517083958|FG000|Overall Study|Lost to Follow-up|1|||
143420618|NCT00853957|517083959|FG001|Overall Study|Lost to Follow-up|6|||
143420619|NCT00853957|517083958|FG000|Overall Study|Protocol deviation|0|||
143420620|NCT00853957|517083959|FG001|Overall Study|Protocol deviation|3|||
143420621|NCT02942771|517083960|FG000|Overall Study|Adverse Event|1|||
143420622|NCT02942771|517083961|FG001|Overall Study|Adverse Event|0|||
143420623|NCT02942771|517083962|FG002|Overall Study|Adverse Event|0|||
143420624|NCT02942771|517083963|FG003|Overall Study|Adverse Event|0|||
143420625|NCT02942771|517083964|FG004|Overall Study|Adverse Event|2|||
143420626|NCT02942771|517083960|FG000|Overall Study|Lost to Follow-up|1|||
143420627|NCT02942771|517083961|FG001|Overall Study|Lost to Follow-up|0|||
143420628|NCT02942771|517083962|FG002|Overall Study|Lost to Follow-up|0|||
143420629|NCT02942771|517083963|FG003|Overall Study|Lost to Follow-up|0|||
143420630|NCT02942771|517083964|FG004|Overall Study|Lost to Follow-up|0|||
143420631|NCT02942771|517083960|FG000|Overall Study|Withdrawal by Subject|1|||
143420632|NCT02942771|517083961|FG001|Overall Study|Withdrawal by Subject|0|||
143420633|NCT02942771|517083962|FG002|Overall Study|Withdrawal by Subject|0|||
143420634|NCT02942771|517083963|FG003|Overall Study|Withdrawal by Subject|0|||
143420635|NCT02942771|517083964|FG004|Overall Study|Withdrawal by Subject|2|||
143420636|NCT01945593|517085759|FG000|Overall Study|Adverse Event|0|||
143420637|NCT01945593|517085760|FG001|Overall Study|Adverse Event|0|||
143420638|NCT01945593|517085761|FG002|Overall Study|Adverse Event|0|||
143420639|NCT01945593|517085762|FG003|Overall Study|Adverse Event|5|||
143420640|NCT01945593|517085759|FG000|Overall Study|Physician Decision|0|||
143420641|NCT01945593|517085760|FG001|Overall Study|Physician Decision|0|||
143420642|NCT01945593|517085761|FG002|Overall Study|Physician Decision|1|||
143420643|NCT01945593|517085762|FG003|Overall Study|Physician Decision|1|||
143420644|NCT01945593|517085759|FG000|Overall Study|Withdrawal by Subject|0|||
143420645|NCT01945593|517085760|FG001|Overall Study|Withdrawal by Subject|2|||
143420646|NCT01945593|517085761|FG002|Overall Study|Withdrawal by Subject|0|||
143420647|NCT01945593|517085762|FG003|Overall Study|Withdrawal by Subject|4|||
143420648|NCT01945593|517085759|FG000|Overall Study|Protocol Violation|0|||
143420649|NCT01945593|517085760|FG001|Overall Study|Protocol Violation|2|||
143420650|NCT01945593|517085761|FG002|Overall Study|Protocol Violation|1|||
143420651|NCT01945593|517085762|FG003|Overall Study|Protocol Violation|3|||
143420652|NCT01945593|517085759|FG000|Overall Study|Death|0|||
143420653|NCT01945593|517085760|FG001|Overall Study|Death|0|||
143420654|NCT01945593|517085761|FG002|Overall Study|Death|1|||
143420655|NCT01945593|517085762|FG003|Overall Study|Death|0|||
143420656|NCT01945593|517085759|FG000|Overall Study|Other: Terminated|0|||
143420657|NCT01945593|517085760|FG001|Overall Study|Other: Terminated|0|||
143420658|NCT01945593|517085761|FG002|Overall Study|Other: Terminated|0|||
143420659|NCT01945593|517085762|FG003|Overall Study|Other: Terminated|1|||
143420660|NCT01945593|517085759|FG000|Overall Study|Other: Surgical Procedure|0|||
143420661|NCT01945593|517085760|FG001|Overall Study|Other: Surgical Procedure|2|||
143420662|NCT01945593|517085761|FG002|Overall Study|Other: Surgical Procedure|0|||
143420663|NCT01945593|517085762|FG003|Overall Study|Other: Surgical Procedure|6|||
143420664|NCT01945593|517085759|FG000|Overall Study|Other: Screen Failure|0|||
143420665|NCT01945593|517085760|FG001|Overall Study|Other: Screen Failure|2|||
143420666|NCT01945593|517085761|FG002|Overall Study|Other: Screen Failure|0|||
143420667|NCT01945593|517085762|FG003|Overall Study|Other: Screen Failure|0|||
143420668|NCT00228813|517085763|FG000|Overall Study|Death|4|||
143420669|NCT00507429|517085764|FG000|Treatment Phase|Disease Progression|12|||
143420670|NCT00507429|517085765|FG001|Treatment Phase|Disease Progression|5|||
143420671|NCT00507429|517085764|FG000|Treatment Phase|Adverse Event|12|||
143420672|NCT00507429|517085765|FG001|Treatment Phase|Adverse Event|5|||
143420673|NCT00507429|517085764|FG000|Treatment Phase|Withdrawal by Subject|3|||
143420674|NCT00507429|517085765|FG001|Treatment Phase|Withdrawal by Subject|3|||
143420675|NCT00507429|517085764|FG000|Treatment Phase|Physician Decision|4|||
143420676|NCT00507429|517085765|FG001|Treatment Phase|Physician Decision|2|||
143420677|NCT00507429|517085764|FG000|Treatment Phase|Other|6|||
143420678|NCT00507429|517085765|FG001|Treatment Phase|Other|3|||
143420679|NCT00507429|517085764|FG000|Maintenance Phase|Progressive Disease|14|||
143420680|NCT00507429|517085765|FG001|Maintenance Phase|Progressive Disease|0|||
143420681|NCT01437540|517085767|FG000|Overall Study|Not listed below|7|||
143420682|NCT01437540|517085768|FG001|Overall Study|Not listed below|6|||
143420683|NCT01437540|517085767|FG000|Overall Study|COPD exacerbation|13|||
143420684|NCT01437540|517085768|FG001|Overall Study|COPD exacerbation|3|||
143420685|NCT01437540|517085767|FG000|Overall Study|Lost to Follow-up|3|||
143420686|NCT01437540|517085768|FG001|Overall Study|Lost to Follow-up|5|||
143420687|NCT01437540|517085767|FG000|Overall Study|Lack of Efficacy|23|||
143420688|NCT01437540|517085768|FG001|Overall Study|Lack of Efficacy|11|||
143420689|NCT01437540|517085767|FG000|Overall Study|Protocol Violation|24|||
143420690|NCT01437540|517085768|FG001|Overall Study|Protocol Violation|12|||
143420691|NCT01437540|517085767|FG000|Overall Study|Adverse Event|26|||
143420692|NCT01437540|517085768|FG001|Overall Study|Adverse Event|13|||
143420693|NCT01437540|517085767|FG000|Overall Study|Withdrawal by Subject|31|||
143420694|NCT01437540|517085768|FG001|Overall Study|Withdrawal by Subject|15|||
143420695|NCT00608959|517085772|FG000|Part 1|Did not meet eligibility criteria|1|||
143420696|NCT01416285|517085773|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
143420697|NCT01416285|517085774|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
143420698|NCT01005602|517085776|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
143420699|NCT01005602|517085777|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
143420700|NCT01248715|517085778|FG000|Overall Study|Not influenza positive|501|||
143420701|NCT01248715|517085779|FG001|Overall Study|Not influenza positive|510|||
143420702|NCT01215253|517085783|FG000|Overall Study|Withdrawal by Subject|57|||
143420703|NCT01215253|517085784|FG001|Overall Study|Withdrawal by Subject|35|||
143420704|NCT01215253|517085783|FG000|Overall Study|Physician Decision|9|||
143420705|NCT01215253|517085784|FG001|Overall Study|Physician Decision|12|||
143420706|NCT01215253|517085783|FG000|Overall Study|Lost to Follow-up|6|||
143420707|NCT01215253|517085784|FG001|Overall Study|Lost to Follow-up|4|||
143420708|NCT01215253|517085783|FG000|Overall Study|Other|14|||
143420709|NCT01215253|517085784|FG001|Overall Study|Other|12|||
143420710|NCT01919489|517085785|FG000|Overall Study|Rejected the need of injections|4|||
143420711|NCT01919489|517085786|FG001|Overall Study|Rejected the need of injections|7|||
143420712|NCT01919489|517085785|FG000|Overall Study|Adverse Event|10|||
143420713|NCT01919489|517085786|FG001|Overall Study|Adverse Event|0|||
143420714|NCT01919489|517085785|FG000|Overall Study|Hospital readmission|2|||
143420715|NCT01919489|517085786|FG001|Overall Study|Hospital readmission|9|||
143420716|NCT01919489|517085785|FG000|Overall Study|Death|2|||
143420717|NCT01919489|517085786|FG001|Overall Study|Death|1|||
143420718|NCT01919489|517085785|FG000|Overall Study|Lost to Follow-up|38|||
143420719|NCT01919489|517085786|FG001|Overall Study|Lost to Follow-up|27|||
143420720|NCT03761849|517085787|FG000|Overall Study|transferred to OpenLabelExtension|35|||
143420721|NCT03761849|517085788|FG001|Overall Study|transferred to OpenLabelExtension|34|||
143420722|NCT03761849|517085789|FG002|Overall Study|transferred to OpenLabelExtension|36|||
143420723|NCT03761849|517085790|FG003|Overall Study|transferred to OpenLabelExtension|0|||
143420724|NCT03761849|517085791|FG004|Overall Study|transferred to OpenLabelExtension|0|||
143420725|NCT03761849|517085792|FG005|Overall Study|transferred to OpenLabelExtension|0|||
143420726|NCT03761849|517085787|FG000|Overall Study|Adverse Event|1|||
143420727|NCT03761849|517085788|FG001|Overall Study|Adverse Event|0|||
143420728|NCT03761849|517085789|FG002|Overall Study|Adverse Event|0|||
143420729|NCT03761849|517085790|FG003|Overall Study|Adverse Event|0|||
143420730|NCT03761849|517085791|FG004|Overall Study|Adverse Event|2|||
143420731|NCT03761849|517085792|FG005|Overall Study|Adverse Event|3|||
143420732|NCT03761849|517085787|FG000|Overall Study|Withdrawal by Subject|0|||
143420733|NCT03761849|517085788|FG001|Overall Study|Withdrawal by Subject|0|||
143420734|NCT03761849|517085789|FG002|Overall Study|Withdrawal by Subject|0|||
143420735|NCT03761849|517085790|FG003|Overall Study|Withdrawal by Subject|41|||
143420736|NCT03761849|517085791|FG004|Overall Study|Withdrawal by Subject|43|||
143420737|NCT03761849|517085792|FG005|Overall Study|Withdrawal by Subject|35|||
143420738|NCT03761849|517085787|FG000|Overall Study|Lost to Follow-up|0|||
143420739|NCT03761849|517085788|FG001|Overall Study|Lost to Follow-up|1|||
143420740|NCT03761849|517085789|FG002|Overall Study|Lost to Follow-up|0|||
143420741|NCT03761849|517085790|FG003|Overall Study|Lost to Follow-up|2|||
143420742|NCT03761849|517085791|FG004|Overall Study|Lost to Follow-up|4|||
143420743|NCT03761849|517085792|FG005|Overall Study|Lost to Follow-up|5|||
143420744|NCT03761849|517085787|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
143420745|NCT03761849|517085788|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
143420746|NCT03761849|517085789|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
143420747|NCT03761849|517085790|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
143420748|NCT03761849|517085791|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
143420749|NCT03761849|517085792|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
143420750|NCT03761849|517085787|FG000|Overall Study|Physician Decision|0|||
143420751|NCT03761849|517085788|FG001|Overall Study|Physician Decision|0|||
143420752|NCT03761849|517085789|FG002|Overall Study|Physician Decision|0|||
143420753|NCT03761849|517085790|FG003|Overall Study|Physician Decision|1|||
143420754|NCT03761849|517085791|FG004|Overall Study|Physician Decision|4|||
143420755|NCT03761849|517085792|FG005|Overall Study|Physician Decision|4|||
143420756|NCT03761849|517085787|FG000|Overall Study|Death|0|||
143420757|NCT03761849|517085788|FG001|Overall Study|Death|0|||
143420758|NCT03761849|517085789|FG002|Overall Study|Death|0|||
143420759|NCT03761849|517085790|FG003|Overall Study|Death|1|||
143420760|NCT03761849|517085791|FG004|Overall Study|Death|1|||
143420761|NCT03761849|517085792|FG005|Overall Study|Death|3|||
143420762|NCT03761849|517085787|FG000|Overall Study|Protocol Violation|0|||
143420763|NCT03761849|517085788|FG001|Overall Study|Protocol Violation|0|||
143420764|NCT03761849|517085789|FG002|Overall Study|Protocol Violation|0|||
143420765|NCT03761849|517085790|FG003|Overall Study|Protocol Violation|2|||
143420766|NCT03761849|517085791|FG004|Overall Study|Protocol Violation|2|||
143420767|NCT03761849|517085792|FG005|Overall Study|Protocol Violation|1|||
143420768|NCT03761849|517085787|FG000|Overall Study|Participant could not come to site|0|||
143420769|NCT03761849|517085788|FG001|Overall Study|Participant could not come to site|0|||
143420770|NCT03761849|517085789|FG002|Overall Study|Participant could not come to site|0|||
143420771|NCT03761849|517085790|FG003|Overall Study|Participant could not come to site|0|||
143420772|NCT03761849|517085791|FG004|Overall Study|Participant could not come to site|1|||
143420773|NCT03761849|517085792|FG005|Overall Study|Participant could not come to site|0|||
143420774|NCT03761849|517085787|FG000|Overall Study|SF- safety Finding|0|||
143420775|NCT03761849|517085788|FG001|Overall Study|SF- safety Finding|0|||
143420776|NCT03761849|517085789|FG002|Overall Study|SF- safety Finding|0|||
143420777|NCT03761849|517085790|FG003|Overall Study|SF- safety Finding|0|||
143420778|NCT03761849|517085791|FG004|Overall Study|SF- safety Finding|0|||
143420779|NCT03761849|517085792|FG005|Overall Study|SF- safety Finding|1|||
143420780|NCT03761849|517085787|FG000|Overall Study|Patient did not attend visit|0|||
143420781|NCT03761849|517085788|FG001|Overall Study|Patient did not attend visit|0|||
143420782|NCT03761849|517085789|FG002|Overall Study|Patient did not attend visit|0|||
143420783|NCT03761849|517085790|FG003|Overall Study|Patient did not attend visit|0|||
143420784|NCT03761849|517085791|FG004|Overall Study|Patient did not attend visit|0|||
143420785|NCT03761849|517085792|FG005|Overall Study|Patient did not attend visit|1|||
143420786|NCT01131325|517085793|FG000|Overall Study|Adverse Event|1|||
143420787|NCT01131325|517085793|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
143420788|NCT03884478|517085794|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
143420789|NCT03884478|517085795|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
143420790|NCT03884478|517085796|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
143420791|NCT03884478|517085794|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
143420792|NCT03884478|517085795|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
143420793|NCT03884478|517085796|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
143420794|NCT03884478|517085794|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
143420795|NCT03884478|517085795|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
143420796|NCT03884478|517085796|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
143420797|NCT03884478|517085794|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
143420798|NCT03884478|517085795|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
143420799|NCT03884478|517085796|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
143420800|NCT00828139|517085797|FG000|Overall Study|Adverse Event|8|||
143420801|NCT00828139|517085798|FG001|Overall Study|Adverse Event|1|||
143420802|NCT00828139|517085799|FG002|Overall Study|Adverse Event|10|||
143420803|NCT00828139|517085800|FG003|Overall Study|Adverse Event|5|||
143420804|NCT00828139|517085797|FG000|Overall Study|Death|2|||
143420805|NCT00828139|517085798|FG001|Overall Study|Death|1|||
143420806|NCT00828139|517085799|FG002|Overall Study|Death|0|||
143420807|NCT00828139|517085800|FG003|Overall Study|Death|2|||
143420808|NCT00828139|517085797|FG000|Overall Study|Refusal unrelated to toxicity|3|||
143420809|NCT00828139|517085798|FG001|Overall Study|Refusal unrelated to toxicity|4|||
143420810|NCT00828139|517085799|FG002|Overall Study|Refusal unrelated to toxicity|5|||
143420811|NCT00828139|517085800|FG003|Overall Study|Refusal unrelated to toxicity|3|||
143420812|NCT00828139|517085797|FG000|Overall Study|Disease Progression|24|||
143420813|NCT00828139|517085798|FG001|Overall Study|Disease Progression|33|||
143420814|NCT00828139|517085799|FG002|Overall Study|Disease Progression|35|||
143420815|NCT00828139|517085800|FG003|Overall Study|Disease Progression|39|||
143420816|NCT00828139|517085797|FG000|Overall Study|Other|4|||
143420817|NCT00828139|517085798|FG001|Overall Study|Other|2|||
143420818|NCT00828139|517085799|FG002|Overall Study|Other|5|||
143420819|NCT00828139|517085800|FG003|Overall Study|Other|2|||
143420820|NCT01714947|517085801|FG000|Part B|Progressive Disease|3|||
143420821|NCT04751929|517085802|FG000|Overall Study|Withdrawal by Subject|2|||
143420822|NCT04751929|517085803|FG001|Overall Study|Withdrawal by Subject|0|||
143420823|NCT04751929|517085804|FG002|Overall Study|Withdrawal by Subject|0|||
143420824|NCT04751929|517085805|FG003|Overall Study|Withdrawal by Subject|0|||
143420825|NCT04751929|517085802|FG000|Overall Study|Rising PSA|0|||
143420826|NCT04751929|517085803|FG001|Overall Study|Rising PSA|1|||
143420827|NCT04751929|517085804|FG002|Overall Study|Rising PSA|0|||
143420828|NCT04751929|517085805|FG003|Overall Study|Rising PSA|0|||
143420829|NCT04751929|517085802|FG000|Overall Study|Adverse Event|1|||
143420830|NCT04751929|517085803|FG001|Overall Study|Adverse Event|2|||
143420831|NCT04751929|517085804|FG002|Overall Study|Adverse Event|0|||
143420832|NCT04751929|517085805|FG003|Overall Study|Adverse Event|0|||
143420833|NCT04751929|517085802|FG000|Overall Study|Progressive Disease|3|||
143420834|NCT04751929|517085803|FG001|Overall Study|Progressive Disease|4|||
143420835|NCT04751929|517085804|FG002|Overall Study|Progressive Disease|4|||
143420836|NCT04751929|517085805|FG003|Overall Study|Progressive Disease|0|||
143420837|NCT04751929|517085802|FG000|Overall Study|Death|1|||
143420838|NCT04751929|517085803|FG001|Overall Study|Death|1|||
143420839|NCT04751929|517085804|FG002|Overall Study|Death|0|||
143420840|NCT04751929|517085805|FG003|Overall Study|Death|0|||
143420841|NCT05361304|517085806|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
143420842|NCT05361304|517085807|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
143420843|NCT05361304|517085806|FG000|Overall Study|COVID-19 Related|1|||
143420844|NCT05361304|517085807|FG001|Overall Study|COVID-19 Related|2|||
143420845|NCT05361304|517085806|FG000|Overall Study|Withdrawal by Subject|1|||
143420846|NCT05361304|517085807|FG001|Overall Study|Withdrawal by Subject|0|||
143420847|NCT00376259|517085810|FG000|Overall Study|Sponsor request - study termination|21|||
143420848|NCT00376259|517085811|FG001|Overall Study|Sponsor request - study termination|21|||
143420849|NCT00376259|517085810|FG000|Overall Study|Patient request|1|||
143420850|NCT00376259|517085811|FG001|Overall Study|Patient request|0|||
143420851|NCT01877720|517085812|FG000|Overall Study|Adverse Event|1|||
143420852|NCT01877720|517085813|FG001|Overall Study|Adverse Event|0|||
143420853|NCT02068352|517085814|FG000|Overall Study|Lost to Follow-up|0|||
143420854|NCT02068352|517085815|FG001|Overall Study|Lost to Follow-up|2|||
143420855|NCT02068352|517085816|FG002|Overall Study|Lost to Follow-up|0|||
143420856|NCT02068352|517085814|FG000|Overall Study|Adverse Event|4|||
143420857|NCT02068352|517085815|FG001|Overall Study|Adverse Event|2|||
143420858|NCT02068352|517085816|FG002|Overall Study|Adverse Event|7|||
143420859|NCT02068352|517085814|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
143420860|NCT02068352|517085815|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
143420861|NCT02068352|517085816|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
143420862|NCT02068352|517085814|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
143420863|NCT02068352|517085815|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
143420864|NCT02068352|517085816|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
143420865|NCT02068352|517085814|FG000|Overall Study|Protocol Deviation|0|||
143420866|NCT02068352|517085815|FG001|Overall Study|Protocol Deviation|0|||
143420867|NCT02068352|517085816|FG002|Overall Study|Protocol Deviation|1|||
143420868|NCT00473512|517085822|FG000|Period 1 (Phase 1)|Adverse Event|0|||
143420869|NCT00473512|517085823|FG001|Period 1 (Phase 1)|Adverse Event|0|||
143420870|NCT00473512|517085824|FG002|Period 1 (Phase 1)|Adverse Event|0|||
143420871|NCT00473512|517085825|FG003|Period 1 (Phase 1)|Adverse Event|5|||
143420872|NCT00473512|517085826|FG004|Period 1 (Phase 1)|Adverse Event|0|||
143420873|NCT00473512|517085822|FG000|Period 1 (Phase 1)|Death|0|||
143420874|NCT00473512|517085823|FG001|Period 1 (Phase 1)|Death|0|||
143420875|NCT00473512|517085824|FG002|Period 1 (Phase 1)|Death|0|||
143420876|NCT00473512|517085825|FG003|Period 1 (Phase 1)|Death|1|||
143420877|NCT00473512|517085826|FG004|Period 1 (Phase 1)|Death|0|||
143420878|NCT00473512|517085822|FG000|Period 1 (Phase 1)|Disease Progression|1|||
143420879|NCT00473512|517085823|FG001|Period 1 (Phase 1)|Disease Progression|1|||
143420880|NCT00473512|517085824|FG002|Period 1 (Phase 1)|Disease Progression|0|||
143420881|NCT00473512|517085825|FG003|Period 1 (Phase 1)|Disease Progression|10|||
143420882|NCT00473512|517085826|FG004|Period 1 (Phase 1)|Disease Progression|1|||
143420883|NCT00473512|517085822|FG000|Period 1 (Phase 1)|Other|0|||
143420884|NCT00473512|517085823|FG001|Period 1 (Phase 1)|Other|0|||
143420885|NCT00473512|517085824|FG002|Period 1 (Phase 1)|Other|0|||
143420886|NCT00473512|517085825|FG003|Period 1 (Phase 1)|Other|1|||
143420887|NCT00473512|517085826|FG004|Period 1 (Phase 1)|Other|0|||
143420888|NCT00473512|517085822|FG000|Period 2 (Phase 2)|Adverse Event|0|||
143420889|NCT00473512|517085823|FG001|Period 2 (Phase 2)|Adverse Event|0|||
143420890|NCT00473512|517085824|FG002|Period 2 (Phase 2)|Adverse Event|0|||
143420891|NCT00473512|517085825|FG003|Period 2 (Phase 2)|Adverse Event|1|||
143420892|NCT00473512|517085826|FG004|Period 2 (Phase 2)|Adverse Event|0|||
143420893|NCT00473512|517085822|FG000|Period 2 (Phase 2)|Death|0|||
143420894|NCT00473512|517085823|FG001|Period 2 (Phase 2)|Death|0|||
143420895|NCT00473512|517085824|FG002|Period 2 (Phase 2)|Death|0|||
143420896|NCT00473512|517085825|FG003|Period 2 (Phase 2)|Death|1|||
143420897|NCT00473512|517085826|FG004|Period 2 (Phase 2)|Death|1|||
143420898|NCT00473512|517085822|FG000|Period 2 (Phase 2)|Disease Progression|0|||
143420899|NCT00473512|517085823|FG001|Period 2 (Phase 2)|Disease Progression|2|||
143420900|NCT00473512|517085824|FG002|Period 2 (Phase 2)|Disease Progression|2|||
143420901|NCT00473512|517085825|FG003|Period 2 (Phase 2)|Disease Progression|17|||
143420902|NCT00473512|517085826|FG004|Period 2 (Phase 2)|Disease Progression|1|||
143420903|NCT00473512|517085822|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
143420904|NCT00473512|517085823|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
143420905|NCT00473512|517085824|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
143420906|NCT00473512|517085825|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
143420907|NCT00473512|517085826|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
143420908|NCT00473512|517085822|FG000|Period 2 (Phase 2)|Other|1|||
143420909|NCT00473512|517085823|FG001|Period 2 (Phase 2)|Other|0|||
143420910|NCT00473512|517085824|FG002|Period 2 (Phase 2)|Other|0|||
143420911|NCT00473512|517085825|FG003|Period 2 (Phase 2)|Other|3|||
143420912|NCT00473512|517085826|FG004|Period 2 (Phase 2)|Other|0|||
143420913|NCT00267956|517085827|FG000|Controlled Period|Adverse Event|4|||
143420914|NCT00267956|517085828|FG001|Controlled Period|Adverse Event|1|||
143420915|NCT00267956|517085829|FG002|Controlled Period|Adverse Event|0|||
143420916|NCT00267956|517085830|FG003|Controlled Period|Adverse Event|0|||
143420917|NCT00267956|517085827|FG000|Controlled Period|Lack of Efficacy|4|||
143420918|NCT00267956|517085828|FG001|Controlled Period|Lack of Efficacy|2|||
143420919|NCT00267956|517085829|FG002|Controlled Period|Lack of Efficacy|0|||
143420920|NCT00267956|517085830|FG003|Controlled Period|Lack of Efficacy|0|||
143420921|NCT00267956|517085827|FG000|Controlled Period|Lost to Follow-up|2|||
143420922|NCT00267956|517085828|FG001|Controlled Period|Lost to Follow-up|0|||
143420923|NCT00267956|517085829|FG002|Controlled Period|Lost to Follow-up|0|||
143420924|NCT00267956|517085830|FG003|Controlled Period|Lost to Follow-up|0|||
143420925|NCT00267956|517085827|FG000|Controlled Period|Withdrew consent|3|||
143420926|NCT00267956|517085828|FG001|Controlled Period|Withdrew consent|1|||
143420927|NCT00267956|517085829|FG002|Controlled Period|Withdrew consent|0|||
143420928|NCT00267956|517085830|FG003|Controlled Period|Withdrew consent|0|||
143420929|NCT00267956|517085827|FG000|After Controlled Period|Adverse Event|0|||
143420930|NCT00267956|517085828|FG001|After Controlled Period|Adverse Event|0|||
143420931|NCT00267956|517085829|FG002|After Controlled Period|Adverse Event|2|||
143420932|NCT00267956|517085830|FG003|After Controlled Period|Adverse Event|1|||
143420933|NCT00267956|517085827|FG000|After Controlled Period|Lack of Efficacy|0|||
143420934|NCT00267956|517085828|FG001|After Controlled Period|Lack of Efficacy|0|||
143420935|NCT00267956|517085829|FG002|After Controlled Period|Lack of Efficacy|1|||
143420936|NCT00267956|517085830|FG003|After Controlled Period|Lack of Efficacy|1|||
143420937|NCT00267956|517085827|FG000|After Controlled Period|Lost to Follow-up|0|||
143420938|NCT00267956|517085828|FG001|After Controlled Period|Lost to Follow-up|0|||
143420939|NCT00267956|517085829|FG002|After Controlled Period|Lost to Follow-up|1|||
143420940|NCT00267956|517085830|FG003|After Controlled Period|Lost to Follow-up|0|||
143420941|NCT00267956|517085827|FG000|After Controlled Period|Withdrew consent|0|||
143420942|NCT00267956|517085828|FG001|After Controlled Period|Withdrew consent|0|||
143420943|NCT00267956|517085829|FG002|After Controlled Period|Withdrew consent|1|||
143420944|NCT00267956|517085830|FG003|After Controlled Period|Withdrew consent|0|||
143420945|NCT01263223|517085831|FG000|Period 2|Withdrawal by Subject|0|||
143420946|NCT01263223|517085832|FG001|Period 2|Withdrawal by Subject|1|||
143420947|NCT01263223|517085831|FG000|7-day Follow-up|Withdrawal by Subject|0|||
143420948|NCT01263223|517085832|FG001|7-day Follow-up|Withdrawal by Subject|1|||
143420949|NCT01263223|517085831|FG000|7-day Follow-up|Lost to Follow-up|1|||
143420950|NCT01263223|517085832|FG001|7-day Follow-up|Lost to Follow-up|0|||
143420951|NCT01129011|517085833|FG000|Overall Study|Adverse Event|20|||
143420952|NCT01129011|517085834|FG001|Overall Study|Adverse Event|30|||
143420953|NCT01129011|517085833|FG000|Overall Study|Withdrawal by Subject|24|||
143420954|NCT01129011|517085834|FG001|Overall Study|Withdrawal by Subject|8|||
143420955|NCT01129011|517085833|FG000|Overall Study|Lost to Follow-up|6|||
143420956|NCT01129011|517085834|FG001|Overall Study|Lost to Follow-up|7|||
143420957|NCT01129011|517085833|FG000|Overall Study|Duodenal Ulcer|2|||
143420958|NCT01129011|517085834|FG001|Overall Study|Duodenal Ulcer|8|||
143420959|NCT01129011|517085833|FG000|Overall Study|misc|7|||
143420960|NCT01129011|517085834|FG001|Overall Study|misc|4|||
143420961|NCT02246647|517085838|FG000|Overall Study|Withdrawal by Subject|1|||
143420962|NCT02246647|517085839|FG001|Overall Study|Withdrawal by Subject|1|||
143420963|NCT02823574|517085842|FG000|Randomization|Disease Progression|0|||
143420964|NCT02823574|517085843|FG001|Randomization|Disease Progression|0|||
143420965|NCT02823574|517085844|FG002|Randomization|Disease Progression|1|||
143420966|NCT02823574|517085845|FG003|Randomization|Disease Progression|0|||
143420967|NCT02823574|517085842|FG000|Randomization|AE unrelated to Study Drug|1|||
143420968|NCT02823574|517085843|FG001|Randomization|AE unrelated to Study Drug|0|||
143420969|NCT02823574|517085844|FG002|Randomization|AE unrelated to Study Drug|0|||
143420970|NCT02823574|517085845|FG003|Randomization|AE unrelated to Study Drug|0|||
143420971|NCT02823574|517085842|FG000|Treatment Period|Poor/Non Compliance|1|||
143420972|NCT02823574|517085843|FG001|Treatment Period|Poor/Non Compliance|0|||
143420973|NCT02823574|517085844|FG002|Treatment Period|Poor/Non Compliance|0|||
143420974|NCT02823574|517085845|FG003|Treatment Period|Poor/Non Compliance|1|||
143420975|NCT02823574|517085842|FG000|Treatment Period|Maximum Clinical Benefit|8|||
143420976|NCT02823574|517085843|FG001|Treatment Period|Maximum Clinical Benefit|4|||
143420977|NCT02823574|517085844|FG002|Treatment Period|Maximum Clinical Benefit|7|||
143420978|NCT02823574|517085845|FG003|Treatment Period|Maximum Clinical Benefit|1|||
143420979|NCT02823574|517085842|FG000|Treatment Period|Lost to Follow-up|1|||
143420980|NCT02823574|517085843|FG001|Treatment Period|Lost to Follow-up|1|||
143420981|NCT02823574|517085844|FG002|Treatment Period|Lost to Follow-up|0|||
143420982|NCT02823574|517085845|FG003|Treatment Period|Lost to Follow-up|0|||
143420983|NCT02823574|517085842|FG000|Treatment Period|Participant withdrew consent|4|||
143420984|NCT02823574|517085843|FG001|Treatment Period|Participant withdrew consent|0|||
143420985|NCT02823574|517085844|FG002|Treatment Period|Participant withdrew consent|0|||
143420986|NCT02823574|517085845|FG003|Treatment Period|Participant withdrew consent|1|||
143420987|NCT02823574|517085842|FG000|Treatment Period|Participant request to discontinue|5|||
143420988|NCT02823574|517085843|FG001|Treatment Period|Participant request to discontinue|0|||
143420989|NCT02823574|517085844|FG002|Treatment Period|Participant request to discontinue|3|||
143420990|NCT02823574|517085845|FG003|Treatment Period|Participant request to discontinue|2|||
143420991|NCT02823574|517085842|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
143420992|NCT02823574|517085843|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
143420993|NCT02823574|517085844|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
143420994|NCT02823574|517085845|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
143420995|NCT02823574|517085842|FG000|Treatment Period|Study Drug Toxicity|11|||
143420996|NCT02823574|517085843|FG001|Treatment Period|Study Drug Toxicity|2|||
143420997|NCT02823574|517085844|FG002|Treatment Period|Study Drug Toxicity|14|||
143420998|NCT02823574|517085845|FG003|Treatment Period|Study Drug Toxicity|4|||
143420999|NCT02823574|517085842|FG000|Treatment Period|Disease Progression|113|||
143421000|NCT02823574|517085843|FG001|Treatment Period|Disease Progression|64|||
143421001|NCT02823574|517085844|FG002|Treatment Period|Disease Progression|82|||
143421002|NCT02823574|517085845|FG003|Treatment Period|Disease Progression|43|||
143421003|NCT02823574|517085842|FG000|Treatment Period|Other reasons|5|||
143421004|NCT02823574|517085843|FG001|Treatment Period|Other reasons|9|||
143421005|NCT02823574|517085844|FG002|Treatment Period|Other reasons|3|||
143421006|NCT02823574|517085845|FG003|Treatment Period|Other reasons|6|||
143421007|NCT02823574|517085842|FG000|Treatment Period|Participant no longer meets study criteria|0|||
143421008|NCT02823574|517085843|FG001|Treatment Period|Participant no longer meets study criteria|0|||
143421009|NCT02823574|517085844|FG002|Treatment Period|Participant no longer meets study criteria|1|||
143421010|NCT02823574|517085845|FG003|Treatment Period|Participant no longer meets study criteria|0|||
143421011|NCT02823574|517085842|FG000|Treatment Period|Death|0|||
143421012|NCT02823574|517085843|FG001|Treatment Period|Death|0|||
143421013|NCT02823574|517085844|FG002|Treatment Period|Death|3|||
143421014|NCT02823574|517085845|FG003|Treatment Period|Death|1|||
143421015|NCT00590759|517085846|FG000|Overall Study|Death|52|||
143421016|NCT00590759|517085846|FG000|Overall Study|Lost to Follow-up|28|||
143421017|NCT02542696|517085847|FG000|Overall Study|Adverse Event|167|||
143421018|NCT02542696|517085847|FG000|Overall Study|Lack of Efficacy|26|||
143421019|NCT02542696|517085847|FG000|Overall Study|Lost to Follow-up|6|||
143421020|NCT02542696|517085847|FG000|Overall Study|Withdrawal by Subject|104|||
143421021|NCT02542696|517085847|FG000|Overall Study|Protocol Violation|5|||
143421022|NCT02542696|517085847|FG000|Overall Study|Death|8|||
143421023|NCT02542696|517085847|FG000|Overall Study|DECREASED OFF TIME|1|||
143421024|NCT02542696|517085847|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
143421025|NCT02542696|517085847|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
143421026|NCT02542696|517085847|FG000|Overall Study|MEDICAL HISTORY|1|||
143421027|NCT02542696|517085847|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
143421028|NCT02542696|517085847|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
143421029|NCT02542696|517085847|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
143421030|NCT02542696|517085847|FG000|Overall Study|SPONSOR DECISION|3|||
143421031|NCT02542696|517085847|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
143421032|NCT02542696|517085847|FG000|Overall Study|SUBJECT DECISION|2|||
143421033|NCT03444155|517085848|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
143421034|NCT03444155|517085849|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
143421035|NCT02877680|517085850|FG000|Overall Study|Lost to Follow-up|1|||
143421036|NCT02877680|517085851|FG001|Overall Study|Lost to Follow-up|1|||
143421037|NCT02991118|517085852|FG000|Overall Study|Death|3|||
143421038|NCT02991118|517085853|FG001|Overall Study|Death|8|||
143421039|NCT02991118|517085852|FG000|Overall Study|Protocol Violation|0|||
143421040|NCT02991118|517085853|FG001|Overall Study|Protocol Violation|3|||
143421041|NCT02991118|517085852|FG000|Overall Study|Physician Decision|0|||
143421042|NCT02991118|517085853|FG001|Overall Study|Physician Decision|1|||
143421043|NCT02991118|517085852|FG000|Overall Study|Moved out of the country|0|||
143421044|NCT02991118|517085853|FG001|Overall Study|Moved out of the country|1|||
143421045|NCT02991118|517085852|FG000|Overall Study|Adverse Event|2|||
143421046|NCT02991118|517085853|FG001|Overall Study|Adverse Event|2|||
143421047|NCT02991118|517085852|FG000|Overall Study|Withdrawal by Subject|1|||
143421048|NCT02991118|517085853|FG001|Overall Study|Withdrawal by Subject|7|||
143421049|NCT02991118|517085852|FG000|Overall Study|Could not attend study visits|0|||
143421050|NCT02991118|517085853|FG001|Overall Study|Could not attend study visits|1|||
143421051|NCT02991118|517085852|FG000|Overall Study|Lost to Follow-up|1|||
143421052|NCT02991118|517085853|FG001|Overall Study|Lost to Follow-up|9|||
143421053|NCT02077374|517085854|FG000|Overall Study|Withdrawal by Subject|0|||
143421054|NCT02077374|517085855|FG001|Overall Study|Withdrawal by Subject|1|||
143421055|NCT02077374|517085854|FG000|Overall Study|Protocol Violation|0|||
143421056|NCT02077374|517085855|FG001|Overall Study|Protocol Violation|1|||
143421057|NCT00963924|517085856|FG000|Overall Study|Adverse Event|1|||
143421058|NCT00963924|517085857|FG001|Overall Study|Adverse Event|0|||
143421059|NCT00963924|517085856|FG000|Overall Study|Withdrawal by Subject|0|||
143421060|NCT00963924|517085857|FG001|Overall Study|Withdrawal by Subject|1|||
143421061|NCT00963924|517085856|FG000|Overall Study|Changed antipsychotic|0|||
143421062|NCT00963924|517085857|FG001|Overall Study|Changed antipsychotic|1|||
143421063|NCT00963924|517085856|FG000|Overall Study|Lost to Follow-up|0|||
143421064|NCT00963924|517085857|FG001|Overall Study|Lost to Follow-up|1|||
143421065|NCT00446095|517085858|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
143421066|NCT00446095|517085859|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
143421067|NCT00446095|517085860|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
143421068|NCT00446095|517085861|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
143421069|NCT00446095|517085862|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
143421070|NCT00446095|517085858|FG000|Phase II (8 Weeks)|Adverse Event|0|||
143421071|NCT00446095|517085859|FG001|Phase II (8 Weeks)|Adverse Event|1|||
143421072|NCT00446095|517085860|FG002|Phase II (8 Weeks)|Adverse Event|1|||
143421073|NCT00446095|517085861|FG003|Phase II (8 Weeks)|Adverse Event|0|||
143421074|NCT00446095|517085862|FG004|Phase II (8 Weeks)|Adverse Event|0|||
143421075|NCT00446095|517085858|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
143421076|NCT00446095|517085859|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
143421077|NCT00446095|517085860|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
143421078|NCT00446095|517085861|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
143421079|NCT00446095|517085862|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
143421080|NCT00446095|517085858|FG000|Phase II (8 Weeks)|Physician Decision|1|||
143421081|NCT00446095|517085859|FG001|Phase II (8 Weeks)|Physician Decision|0|||
143421082|NCT00446095|517085860|FG002|Phase II (8 Weeks)|Physician Decision|0|||
143421083|NCT00446095|517085861|FG003|Phase II (8 Weeks)|Physician Decision|0|||
143421084|NCT00446095|517085862|FG004|Phase II (8 Weeks)|Physician Decision|0|||
143421085|NCT00446095|517085858|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
143421086|NCT00446095|517085859|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
143421087|NCT00446095|517085860|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
143421088|NCT00446095|517085861|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
143421089|NCT00446095|517085862|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
143421090|NCT00446095|517085858|FG000|Phase II (8 Weeks)|Ongoing|0|||
143421091|NCT00446095|517085859|FG001|Phase II (8 Weeks)|Ongoing|0|||
143421092|NCT00446095|517085860|FG002|Phase II (8 Weeks)|Ongoing|1|||
143421093|NCT00446095|517085861|FG003|Phase II (8 Weeks)|Ongoing|0|||
143421094|NCT00446095|517085862|FG004|Phase II (8 Weeks)|Ongoing|0|||
143421095|NCT00446095|517085858|FG000|Phase I (28 Days)|Adverse Event|0|||
143421096|NCT00446095|517085859|FG001|Phase I (28 Days)|Adverse Event|0|||
143421097|NCT00446095|517085860|FG002|Phase I (28 Days)|Adverse Event|0|||
143421098|NCT00446095|517085861|FG003|Phase I (28 Days)|Adverse Event|1|||
143421099|NCT00446095|517085862|FG004|Phase I (28 Days)|Adverse Event|0|||
143421100|NCT00446095|517085858|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
143421101|NCT00446095|517085859|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
143421102|NCT00446095|517085860|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
143421103|NCT00446095|517085861|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
143421104|NCT00446095|517085862|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
143421105|NCT00657709|517085863|FG000|Overall Study|AE or Death|7|||
143421106|NCT00657709|517085864|FG001|Overall Study|AE or Death|7|||
143421107|NCT00657709|517085865|FG002|Overall Study|AE or Death|6|||
143421108|NCT00657709|517085866|FG003|Overall Study|AE or Death|7|||
143421109|NCT00657709|517085867|FG004|Overall Study|AE or Death|1|||
143421110|NCT00657709|517085863|FG000|Overall Study|Withdrawal by Subject|7|||
143421111|NCT00657709|517085864|FG001|Overall Study|Withdrawal by Subject|15|||
143421112|NCT00657709|517085865|FG002|Overall Study|Withdrawal by Subject|15|||
143421113|NCT00657709|517085866|FG003|Overall Study|Withdrawal by Subject|5|||
143421114|NCT00657709|517085867|FG004|Overall Study|Withdrawal by Subject|9|||
143421115|NCT00657709|517085863|FG000|Overall Study|Lost to Follow-up|9|||
143421116|NCT00657709|517085864|FG001|Overall Study|Lost to Follow-up|9|||
143421117|NCT00657709|517085865|FG002|Overall Study|Lost to Follow-up|7|||
143421118|NCT00657709|517085866|FG003|Overall Study|Lost to Follow-up|1|||
143421119|NCT00657709|517085867|FG004|Overall Study|Lost to Follow-up|21|||
143421120|NCT00657709|517085863|FG000|Overall Study|Protocol Violation|0|||
143421121|NCT00657709|517085864|FG001|Overall Study|Protocol Violation|2|||
143421122|NCT00657709|517085865|FG002|Overall Study|Protocol Violation|0|||
143421123|NCT00657709|517085866|FG003|Overall Study|Protocol Violation|1|||
143421124|NCT00657709|517085867|FG004|Overall Study|Protocol Violation|2|||
143421125|NCT00886834|517085868|FG000|Overall Study|Protocol Violation|0|||
143421126|NCT00886834|517085869|FG001|Overall Study|Protocol Violation|3|||
143421127|NCT02574286|517085870|FG000|Overall Study|Adverse Event|3|||
143421128|NCT02574286|517085870|FG000|Overall Study|Withdrawal by Subject|2|||
143421129|NCT02959866|517085871|FG000|Overall Study|Withdrawal by Subject|1|||
143421130|NCT00952523|517085872|FG000|Overall Study|Withdrawal by Subject|7|||
143421131|NCT04085614|517085873|FG000|Overall Study|Protocol Violation|9|||
143421132|NCT04085614|517085874|FG001|Overall Study|Protocol Violation|6|||
143421133|NCT03150589|517085875|FG000|Overall Study|Withdrawal by Subject|16|||
143421134|NCT03150589|517085876|FG001|Overall Study|Withdrawal by Subject|9|||
143421135|NCT03150589|517085875|FG000|Overall Study|Adverse Event|7|||
143421136|NCT03150589|517085876|FG001|Overall Study|Adverse Event|6|||
143421137|NCT03150589|517085875|FG000|Overall Study|Protocol Violation|4|||
143421138|NCT03150589|517085876|FG001|Overall Study|Protocol Violation|3|||
143421139|NCT03150589|517085875|FG000|Overall Study|Lost to Follow-up|3|||
143421140|NCT03150589|517085876|FG001|Overall Study|Lost to Follow-up|3|||
143421141|NCT03150589|517085875|FG000|Overall Study|Death|2|||
143421142|NCT03150589|517085876|FG001|Overall Study|Death|3|||
143421143|NCT03150589|517085875|FG000|Overall Study|IP non-compliance and other reasons|12|||
143421144|NCT03150589|517085876|FG001|Overall Study|IP non-compliance and other reasons|3|||
143421145|NCT05265247|517085877|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
143421146|NCT05265247|517085878|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
143421147|NCT05265247|517085877|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
143421148|NCT05265247|517085878|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
143421149|NCT05265247|517085877|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
143421150|NCT05265247|517085878|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
143421151|NCT01029925|517085879|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
143421152|NCT01029925|517085879|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
143421153|NCT01029925|517085879|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
143421154|NCT01405508|517085880|FG000|Overall Study|AE, non-serious non-fatal|1|||
143421155|NCT01405508|517085881|FG001|Overall Study|AE, non-serious non-fatal|1|||
143421156|NCT01405508|517085882|FG002|Overall Study|AE, non-serious non-fatal|0|||
143421157|NCT01405508|517085883|FG003|Overall Study|AE, non-serious non-fatal|0|||
143421158|NCT00476957|517085884|FG000|Overall Study|Lost to Follow-up|176|||
143421159|NCT00476957|517085885|FG001|Overall Study|Lost to Follow-up|193|||
143421160|NCT01697956|517085890|FG000|Overall Study|Protocol Violation|1|||
143421161|NCT01697956|517085891|FG001|Overall Study|Protocol Violation|1|||
143421162|NCT01964547|517085892|FG000|Overall Study|Adverse Event|8|||
143421163|NCT01964547|517085893|FG001|Overall Study|Adverse Event|2|||
143421164|NCT01964547|517085892|FG000|Overall Study|Withdrawal by Subject|4|||
143421165|NCT01964547|517085893|FG001|Overall Study|Withdrawal by Subject|7|||
143421166|NCT01964547|517085892|FG000|Overall Study|Lost to Follow-up|0|||
143421167|NCT01964547|517085893|FG001|Overall Study|Lost to Follow-up|1|||
143421168|NCT01964547|517085892|FG000|Overall Study|Withdrawal by Investigator|0|||
143421169|NCT01964547|517085893|FG001|Overall Study|Withdrawal by Investigator|1|||
143421170|NCT01115309|517085894|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
143421171|NCT01115309|517085894|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
143421172|NCT01115309|517085894|FG000|Long-term Follow-up|Lost to Follow-up|6|||
143421173|NCT05700851|517085895|FG000|Overall Study|Received a kidney transplant|1|||
143421174|NCT05700851|517085895|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
143421175|NCT05700851|517085895|FG000|Overall Study|Withdrawal by Subject|1|||
143421176|NCT03246724|517085896|FG000|Overall Study|Withdrawal by Subject|5|||
143421177|NCT03246724|517085897|FG001|Overall Study|Withdrawal by Subject|2|||
143421178|NCT03246724|517085898|FG002|Overall Study|Withdrawal by Subject|4|||
143421179|NCT03246724|517085899|FG003|Overall Study|Withdrawal by Subject|2|||
143421180|NCT03246724|517085896|FG000|Overall Study|Ineligible on day of surgery|7|||
143421181|NCT03246724|517085897|FG001|Overall Study|Ineligible on day of surgery|2|||
143421182|NCT03246724|517085898|FG002|Overall Study|Ineligible on day of surgery|0|||
143421183|NCT03246724|517085899|FG003|Overall Study|Ineligible on day of surgery|3|||
143421184|NCT03246724|517085896|FG000|Overall Study|Study completed before surgical date|2|||
143421185|NCT03246724|517085897|FG001|Overall Study|Study completed before surgical date|1|||
143421186|NCT03246724|517085898|FG002|Overall Study|Study completed before surgical date|8|||
143421187|NCT03246724|517085899|FG003|Overall Study|Study completed before surgical date|1|||
143421188|NCT03246724|517085896|FG000|Overall Study|Transferred to other arm|0|||
143421189|NCT03246724|517085897|FG001|Overall Study|Transferred to other arm|0|||
143421190|NCT03246724|517085898|FG002|Overall Study|Transferred to other arm|1|||
143421191|NCT03246724|517085899|FG003|Overall Study|Transferred to other arm|0|||
143421192|NCT03246724|517085896|FG000|Overall Study|Unable to obtain medication timely|0|||
143421193|NCT03246724|517085897|FG001|Overall Study|Unable to obtain medication timely|2|||
143421194|NCT03246724|517085898|FG002|Overall Study|Unable to obtain medication timely|2|||
143421195|NCT03246724|517085899|FG003|Overall Study|Unable to obtain medication timely|1|||
143421196|NCT03246724|517085896|FG000|Overall Study|Re-consented to participate|0|||
143421197|NCT03246724|517085897|FG001|Overall Study|Re-consented to participate|0|||
143421198|NCT03246724|517085898|FG002|Overall Study|Re-consented to participate|0|||
143421199|NCT03246724|517085899|FG003|Overall Study|Re-consented to participate|1|||
143421200|NCT02978716|517085900|FG000|Overall Study|Death|25|||
143421201|NCT02978716|517085901|FG001|Overall Study|Death|13|||
143421202|NCT02978716|517085902|FG002|Overall Study|Death|20|||
143421203|NCT02978716|517085900|FG000|Overall Study|Lost to Follow-up|0|||
143421204|NCT02978716|517085901|FG001|Overall Study|Lost to Follow-up|0|||
143421205|NCT02978716|517085902|FG002|Overall Study|Lost to Follow-up|1|||
143421206|NCT02978716|517085900|FG000|Overall Study|Withdrawal by Subject|6|||
143421207|NCT02978716|517085901|FG001|Overall Study|Withdrawal by Subject|4|||
143421208|NCT02978716|517085902|FG002|Overall Study|Withdrawal by Subject|5|||
143421209|NCT02978716|517085900|FG000|Overall Study|Sponsor terminated|2|||
143421210|NCT02978716|517085901|FG001|Overall Study|Sponsor terminated|13|||
143421211|NCT02978716|517085902|FG002|Overall Study|Sponsor terminated|9|||
143421212|NCT02978716|517085900|FG000|Overall Study|Other|1|||
143421213|NCT02978716|517085901|FG001|Overall Study|Other|3|||
143421214|NCT02978716|517085902|FG002|Overall Study|Other|0|||
143421215|NCT00589628|517085903|FG000|Overall Study|Lost to Follow-up|0|||
143421216|NCT00589628|517085904|FG001|Overall Study|Lost to Follow-up|1|||
143421217|NCT02189759|517085911|FG000|Overall Study|Lost to Follow-up|0|||
143421218|NCT02189759|517085912|FG001|Overall Study|Lost to Follow-up|0|||
143421219|NCT02189759|517085913|FG002|Overall Study|Lost to Follow-up|2|||
143421220|NCT02189759|517085914|FG003|Overall Study|Lost to Follow-up|5|||
143421221|NCT00689351|517085917|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
143421222|NCT00689351|517085918|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
143421223|NCT00689351|517085917|FG000|Infant Series of Dosing|Adverse Event|1|||
143421224|NCT00689351|517085918|FG001|Infant Series of Dosing|Adverse Event|0|||
143421225|NCT00689351|517085917|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
143421226|NCT00689351|517085918|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
143421227|NCT00689351|517085917|FG000|After Infant Series|Parent/legal guardian request|1|||
143421228|NCT00689351|517085918|FG001|After Infant Series|Parent/legal guardian request|0|||
143421229|NCT01766206|517085919|FG000|Overall Study|Withdrawal by Subject|22|||
143421230|NCT01766206|517085919|FG000|Overall Study|Lost to Follow-up|10|||
143421231|NCT01766206|517085919|FG000|Overall Study|Inappropriate enrollment|18|||
143421232|NCT01766206|517085919|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
143421233|NCT01313663|517085920|FG000|Overall Study|Study Closed/Terminated|2|||
143421234|NCT01313663|517085921|FG001|Overall Study|Study Closed/Terminated|4|||
143421235|NCT01313663|517085920|FG000|Overall Study|Lost to Follow-up|0|||
143421236|NCT01313663|517085921|FG001|Overall Study|Lost to Follow-up|1|||
143421237|NCT01313663|517085920|FG000|Overall Study|Physician Decision|0|||
143421238|NCT01313663|517085921|FG001|Overall Study|Physician Decision|2|||
143421239|NCT01313663|517085920|FG000|Overall Study|Withdrawal by Subject|2|||
143421240|NCT01313663|517085921|FG001|Overall Study|Withdrawal by Subject|1|||
143421241|NCT03075878|517085924|FG000|Overall Study|Physician Decision|1|||
143421242|NCT02158806|517085926|FG000|Overall Study|Death|2|||
143421243|NCT02158806|517085927|FG001|Overall Study|Death|0|||
143421244|NCT02158806|517085926|FG000|Overall Study|Withdrawal by Subject|2|||
143421245|NCT02158806|517085927|FG001|Overall Study|Withdrawal by Subject|0|||
143421246|NCT02158806|517085926|FG000|Overall Study|Lost to Follow-up|0|||
143421247|NCT02158806|517085927|FG001|Overall Study|Lost to Follow-up|3|||
143421248|NCT02158806|517085926|FG000|Overall Study|Moved out of area|0|||
143421249|NCT02158806|517085927|FG001|Overall Study|Moved out of area|1|||
143421250|NCT02158806|517085926|FG000|Overall Study|Transferred to palliative care|0|||
143421251|NCT02158806|517085927|FG001|Overall Study|Transferred to palliative care|1|||
143421252|NCT01898299|517085931|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
143421253|NCT01898299|517085932|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
143421254|NCT00760877|517087511|FG000|Overall Study|Protocol Violation|1|||
143421255|NCT00760877|517087512|FG001|Overall Study|Protocol Violation|0|||
143421256|NCT00760877|517087511|FG000|Overall Study|Non-compliance with protocol treatment|2|||
143421257|NCT00760877|517087512|FG001|Overall Study|Non-compliance with protocol treatment|1|||
143421258|NCT00760877|517087511|FG000|Overall Study|Pregnancy|1|||
143421259|NCT00760877|517087512|FG001|Overall Study|Pregnancy|4|||
143421260|NCT00760877|517087511|FG000|Overall Study|Death|2|||
143421261|NCT00760877|517087512|FG001|Overall Study|Death|1|||
143421262|NCT00760877|517087511|FG000|Overall Study|Withdrawal by Subject|7|||
143421263|NCT00760877|517087512|FG001|Overall Study|Withdrawal by Subject|3|||
143421264|NCT00760877|517087511|FG000|Overall Study|Adverse Event|19|||
143421265|NCT00760877|517087512|FG001|Overall Study|Adverse Event|12|||
143421266|NCT00760877|517087511|FG000|Overall Study|Participant diagnosed with AML|0|||
143421267|NCT00760877|517087512|FG001|Overall Study|Participant diagnosed with AML|1|||
143421268|NCT00760877|517087511|FG000|Overall Study|Participant not eligible to cross-over|0|||
143421269|NCT00760877|517087512|FG001|Overall Study|Participant not eligible to cross-over|1|||
143421270|NCT00760877|517087511|FG000|Overall Study|Physician Decision|1|||
143421271|NCT00760877|517087512|FG001|Overall Study|Physician Decision|2|||
143421272|NCT00760877|517087511|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
143421273|NCT00760877|517087512|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
143421274|NCT00760877|517087511|FG000|Overall Study|Treatment failure|1|||
143421275|NCT00760877|517087512|FG001|Overall Study|Treatment failure|0|||
143421276|NCT00711555|517087515|FG000|Overall Study|Adverse Event|3|||
143421277|NCT04049578|517087516|FG000|Overall Study|Physician Decision|1|||
143421278|NCT02400749|517087517|FG000|Week 0 -16|Withdrawal by Subject|5|||
143421279|NCT02400749|517087518|FG001|Week 0 -16|Withdrawal by Subject|5|||
143421280|NCT02400749|517087517|FG000|Week 0 -16|Adverse Event|3|||
143421281|NCT02400749|517087518|FG001|Week 0 -16|Adverse Event|1|||
143421282|NCT02400749|517087517|FG000|Week 0 -16|Lost to Follow-up|2|||
143421283|NCT02400749|517087518|FG001|Week 0 -16|Lost to Follow-up|0|||
143421284|NCT02400749|517087517|FG000|Week 0 -16|Protocol Violation|1|||
143421285|NCT02400749|517087518|FG001|Week 0 -16|Protocol Violation|0|||
143421286|NCT02400749|517087517|FG000|Week 17 - 32|Withdrawal by Subject|3|||
143421287|NCT02400749|517087518|FG001|Week 17 - 32|Withdrawal by Subject|2|||
143421288|NCT02400749|517087517|FG000|Week 17 - 32|Adverse Event|2|||
143421289|NCT02400749|517087518|FG001|Week 17 - 32|Adverse Event|1|||
143421290|NCT01279447|517087528|FG000|Overall Study|Lost to Follow-up|3|||
143421291|NCT01279447|517087529|FG001|Overall Study|Lost to Follow-up|1|||
143421292|NCT02213094|517087530|FG000|Overall Study|Adverse Event|1|||
143421293|NCT02213094|517087531|FG001|Overall Study|Adverse Event|0|||
143421294|NCT01807234|517087532|FG000|Overall Study|Lost to Follow-up|2|||
143421295|NCT01807234|517087533|FG001|Overall Study|Lost to Follow-up|5|||
143421296|NCT01807234|517087534|FG002|Overall Study|Lost to Follow-up|1|||
143421297|NCT01807234|517087535|FG003|Overall Study|Lost to Follow-up|1|||
143421298|NCT01807234|517087536|FG004|Overall Study|Lost to Follow-up|1|||
143421299|NCT01807234|517087537|FG005|Overall Study|Lost to Follow-up|2|||
143421300|NCT01807234|517087532|FG000|Overall Study|Withdrawal by Subject|3|||
143421301|NCT01807234|517087533|FG001|Overall Study|Withdrawal by Subject|1|||
143421302|NCT01807234|517087534|FG002|Overall Study|Withdrawal by Subject|1|||
143421303|NCT01807234|517087535|FG003|Overall Study|Withdrawal by Subject|1|||
143421304|NCT01807234|517087536|FG004|Overall Study|Withdrawal by Subject|2|||
143421305|NCT01807234|517087537|FG005|Overall Study|Withdrawal by Subject|1|||
143421306|NCT01807234|517087532|FG000|Overall Study|Lack of Efficacy|0|||
143421307|NCT01807234|517087533|FG001|Overall Study|Lack of Efficacy|0|||
143421308|NCT01807234|517087534|FG002|Overall Study|Lack of Efficacy|0|||
143421309|NCT01807234|517087535|FG003|Overall Study|Lack of Efficacy|0|||
143421310|NCT01807234|517087536|FG004|Overall Study|Lack of Efficacy|1|||
143421311|NCT01807234|517087537|FG005|Overall Study|Lack of Efficacy|1|||
143421312|NCT01074229|517087538|FG000|Overall Study|Lost to Follow-up|1|||
143421313|NCT01074229|517087539|FG001|Overall Study|Lost to Follow-up|0|||
143421314|NCT01074229|517087540|FG002|Overall Study|Lost to Follow-up|0|||
143421315|NCT01074229|517087538|FG000|Overall Study|Change to open surgical procedure|1|||
143421316|NCT01074229|517087539|FG001|Overall Study|Change to open surgical procedure|3|||
143421317|NCT01074229|517087540|FG002|Overall Study|Change to open surgical procedure|4|||
143421318|NCT02163499|517087543|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
143421319|NCT02163499|517087543|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
143421320|NCT02163499|517087543|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
143421321|NCT02163499|517087543|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
143421322|NCT02163499|517087543|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
143421323|NCT02163499|517087543|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
143421324|NCT02163499|517087543|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
143421325|NCT02163499|517087543|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
143421326|NCT02163499|517087543|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
143421327|NCT02163499|517087543|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
143421328|NCT02163499|517087543|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
143421329|NCT02163499|517087543|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
143421330|NCT02163499|517087543|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
143421331|NCT02163499|517087543|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
143421332|NCT02163499|517087543|FG000|Extended Dosing Phase: ZS|Death|8|||
143421333|NCT02163499|517087543|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
143421334|NCT02163499|517087543|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
143421335|NCT02163499|517087543|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
143421336|NCT01540474|517087544|FG000|Vaccination Period|Lost to Follow-up|0|||
143421337|NCT01540474|517087545|FG001|Vaccination Period|Lost to Follow-up|1|||
143421338|NCT01540474|517087546|FG002|Vaccination Period|Lost to Follow-up|0|||
143421339|NCT01540474|517087547|FG003|Vaccination Period|Lost to Follow-up|0|||
143421340|NCT00857311|517087548|FG000|Overall Study|Lost to Follow-up|1|||
143421341|NCT00857311|517087549|FG001|Overall Study|Lost to Follow-up|0|||
143421342|NCT00857311|517087550|FG002|Overall Study|Lost to Follow-up|0|||
143421343|NCT00857311|517087551|FG003|Overall Study|Lost to Follow-up|0|||
143421344|NCT01587703|517087552|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
143421345|NCT01587703|517087553|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
143421346|NCT01587703|517087554|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
143421347|NCT01587703|517087555|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
143421348|NCT01587703|517087556|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
143421349|NCT01587703|517087557|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
143421350|NCT01587703|517087558|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
143421351|NCT01587703|517087559|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
143421352|NCT01587703|517087560|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
143421353|NCT01587703|517087561|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
143421354|NCT01587703|517087562|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
143421355|NCT01587703|517087563|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
143421356|NCT01587703|517087564|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
143421357|NCT01587703|517087565|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
143421358|NCT01587703|517087566|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
143421359|NCT01587703|517087567|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
143421360|NCT01587703|517087568|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
143421361|NCT01587703|517087569|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
143421362|NCT01587703|517087570|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
143421363|NCT01587703|517087552|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
143421364|NCT01587703|517087553|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
143421365|NCT01587703|517087554|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
143421366|NCT01587703|517087555|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
143421367|NCT01587703|517087556|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
143421368|NCT01587703|517087557|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
143421369|NCT01587703|517087558|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
143421370|NCT01587703|517087559|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
143421371|NCT01587703|517087560|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
143421372|NCT01587703|517087561|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
143421373|NCT01587703|517087562|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
143421374|NCT01587703|517087563|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
143421375|NCT01587703|517087564|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
143421376|NCT01587703|517087565|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
143421377|NCT01587703|517087566|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
143421378|NCT01587703|517087567|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
143421379|NCT01587703|517087568|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
143421380|NCT01587703|517087569|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
143421381|NCT01587703|517087570|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
143421382|NCT01587703|517087552|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
143421383|NCT01587703|517087553|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
143421384|NCT01587703|517087554|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
143421385|NCT01587703|517087555|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
143421386|NCT01587703|517087556|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
143421387|NCT01587703|517087557|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
143421388|NCT01587703|517087558|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
143421389|NCT01587703|517087559|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
143421390|NCT01587703|517087560|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
143421391|NCT01587703|517087561|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
143421392|NCT01587703|517087562|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
143421393|NCT01587703|517087563|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
143421394|NCT01587703|517087564|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
143421395|NCT01587703|517087565|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
143421396|NCT01587703|517087566|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
143421397|NCT01587703|517087567|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
143421398|NCT01587703|517087568|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
143421399|NCT01587703|517087569|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
143421400|NCT01587703|517087570|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
143421401|NCT01587703|517087552|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
143421402|NCT01587703|517087553|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
143421403|NCT01587703|517087554|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
143421404|NCT01587703|517087555|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
143421405|NCT01587703|517087556|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
143421406|NCT01587703|517087557|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
143421407|NCT01587703|517087558|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
143421408|NCT01587703|517087559|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
143421409|NCT01587703|517087560|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
143421410|NCT01587703|517087561|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
143421411|NCT01587703|517087562|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
143421412|NCT01587703|517087563|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
143421413|NCT01587703|517087564|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
143421414|NCT01587703|517087565|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
143421415|NCT01587703|517087566|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
143421416|NCT01587703|517087567|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
143421417|NCT01587703|517087568|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
143421418|NCT01587703|517087569|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
143421419|NCT01587703|517087570|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
143421420|NCT01587703|517087552|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
143421421|NCT01587703|517087553|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
143421422|NCT01587703|517087554|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
143421423|NCT01587703|517087555|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
143421424|NCT01587703|517087556|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
143421425|NCT01587703|517087557|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
143421426|NCT01587703|517087558|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
143421427|NCT01587703|517087559|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
143421428|NCT01587703|517087560|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
143421429|NCT01587703|517087561|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
143421430|NCT01587703|517087562|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
143421431|NCT01587703|517087563|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
143421432|NCT01587703|517087564|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
143421433|NCT01587703|517087565|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
143421434|NCT01587703|517087566|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
143421435|NCT01587703|517087567|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
143421436|NCT01587703|517087568|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
143421437|NCT01587703|517087569|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
143421438|NCT01587703|517087570|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
143421439|NCT01587703|517087552|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
143421440|NCT01587703|517087553|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
143421441|NCT01587703|517087554|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
143421442|NCT01587703|517087555|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
143421443|NCT01587703|517087556|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
143421444|NCT01587703|517087557|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
143421445|NCT01587703|517087558|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
143421446|NCT01587703|517087559|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
143421447|NCT01587703|517087560|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
143421448|NCT01587703|517087561|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
143421449|NCT01587703|517087562|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
143421450|NCT01587703|517087563|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
143421451|NCT01587703|517087564|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
143421452|NCT01587703|517087565|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
143421453|NCT01587703|517087566|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
143421454|NCT01587703|517087567|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
143421455|NCT01587703|517087568|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
143421456|NCT01587703|517087569|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
143421457|NCT01587703|517087570|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
143421458|NCT01587703|517087552|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
143421459|NCT01587703|517087553|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
143421460|NCT01587703|517087554|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
143421461|NCT01587703|517087555|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
143421462|NCT01587703|517087556|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
143421463|NCT01587703|517087557|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
143421464|NCT01587703|517087558|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
143421465|NCT01587703|517087559|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
143421466|NCT01587703|517087560|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
143421467|NCT01587703|517087561|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
143421468|NCT01587703|517087562|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
143421469|NCT01587703|517087563|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
143421470|NCT01587703|517087564|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
143421471|NCT01587703|517087565|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
143421472|NCT01587703|517087566|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
143421473|NCT01587703|517087567|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
143421474|NCT01587703|517087568|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
143421475|NCT01587703|517087569|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
143421476|NCT01587703|517087570|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
143421477|NCT01587703|517087552|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
143421478|NCT01587703|517087553|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
143421479|NCT01587703|517087554|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
143421480|NCT01587703|517087555|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
143421481|NCT01587703|517087556|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
143421482|NCT01587703|517087557|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
143421483|NCT01587703|517087558|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
143421484|NCT01587703|517087559|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
143421485|NCT01587703|517087560|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
143421486|NCT01587703|517087561|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
143421487|NCT01587703|517087562|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
143421488|NCT01587703|517087563|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
143421489|NCT01587703|517087564|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
143421490|NCT01587703|517087565|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
143421491|NCT01587703|517087566|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
143421492|NCT01587703|517087567|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
143421493|NCT01587703|517087568|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
143421494|NCT01587703|517087569|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
143421495|NCT01587703|517087570|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
143421496|NCT01587703|517087552|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
143421497|NCT01587703|517087553|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
143421498|NCT01587703|517087554|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
143421499|NCT01587703|517087555|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
143421500|NCT01587703|517087556|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
143421501|NCT01587703|517087557|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
143421502|NCT01587703|517087558|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
143421503|NCT01587703|517087559|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
143421504|NCT01587703|517087560|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
143421505|NCT01587703|517087561|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
143421506|NCT01587703|517087562|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
143421507|NCT01587703|517087563|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
143421508|NCT01587703|517087564|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
143421509|NCT01587703|517087565|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
143421510|NCT01587703|517087566|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
143421511|NCT01587703|517087567|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
143421512|NCT01587703|517087568|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
143421513|NCT01587703|517087569|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
143421514|NCT01587703|517087570|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
143421515|NCT01587703|517087552|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
143421516|NCT01587703|517087553|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
143421517|NCT01587703|517087554|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
143421518|NCT01587703|517087555|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
143421519|NCT01587703|517087556|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
143421520|NCT01587703|517087557|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
143421521|NCT01587703|517087558|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
143421522|NCT01587703|517087559|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
143421523|NCT01587703|517087560|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
143421524|NCT01587703|517087561|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
143421525|NCT01587703|517087562|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
143421526|NCT01587703|517087563|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
143421527|NCT01587703|517087564|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
143421528|NCT01587703|517087565|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
143421529|NCT01587703|517087566|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
143421530|NCT01587703|517087567|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
143421531|NCT01587703|517087568|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
143421532|NCT01587703|517087569|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
143421533|NCT01587703|517087570|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
143421534|NCT01587703|517087552|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
143421535|NCT01587703|517087553|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
143421536|NCT01587703|517087554|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
143421537|NCT01587703|517087555|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
143421538|NCT01587703|517087556|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
143421539|NCT01587703|517087557|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
143421540|NCT01587703|517087558|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
143421541|NCT01587703|517087559|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
143421542|NCT01587703|517087560|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
143421543|NCT01587703|517087561|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
143421544|NCT01587703|517087562|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
143421545|NCT01587703|517087563|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
143421546|NCT01587703|517087564|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
143421547|NCT01587703|517087565|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
143421548|NCT01587703|517087566|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
143421549|NCT01587703|517087567|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
143421550|NCT01587703|517087568|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
143421551|NCT01587703|517087569|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
143421552|NCT01587703|517087570|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
143421553|NCT01587703|517087552|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
143421554|NCT01587703|517087553|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
143421555|NCT01587703|517087554|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
143421556|NCT01587703|517087555|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
143421557|NCT01587703|517087556|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
143421558|NCT01587703|517087557|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
143421559|NCT01587703|517087558|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
143421560|NCT01587703|517087559|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
143421561|NCT01587703|517087560|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
143421562|NCT01587703|517087561|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
143421563|NCT01587703|517087562|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
143421564|NCT01587703|517087563|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
143421565|NCT01587703|517087564|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
143421566|NCT01587703|517087565|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
143421567|NCT01587703|517087566|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
143421568|NCT01587703|517087567|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
143421569|NCT01587703|517087568|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
143421570|NCT01587703|517087569|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
143421571|NCT01587703|517087570|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
143421572|NCT01587703|517087552|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
143421573|NCT01587703|517087553|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
143421574|NCT01587703|517087554|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
143421575|NCT01587703|517087555|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
143421576|NCT01587703|517087556|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
143421577|NCT01587703|517087557|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
143421578|NCT01587703|517087558|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
143421579|NCT01587703|517087559|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
143421580|NCT01587703|517087560|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
143421581|NCT01587703|517087561|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
143421582|NCT01587703|517087562|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
143421583|NCT01587703|517087563|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
143421584|NCT01587703|517087564|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
143421585|NCT01587703|517087565|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
143421586|NCT01587703|517087566|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
143421587|NCT01587703|517087567|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
143421588|NCT01587703|517087568|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
143421589|NCT01587703|517087569|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
143421590|NCT01587703|517087570|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
143421591|NCT01587703|517087552|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
143421592|NCT01587703|517087553|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
143421593|NCT01587703|517087554|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
143421594|NCT01587703|517087555|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
143421595|NCT01587703|517087556|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
143421596|NCT01587703|517087557|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
143421597|NCT01587703|517087558|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
143421598|NCT01587703|517087559|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
143421599|NCT01587703|517087560|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
143421600|NCT01587703|517087561|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
143421601|NCT01587703|517087562|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
143421602|NCT01587703|517087563|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
143421603|NCT01587703|517087564|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
143421604|NCT01587703|517087565|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
143421605|NCT01587703|517087566|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
143421606|NCT01587703|517087567|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
143421607|NCT01587703|517087568|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
143421608|NCT01587703|517087569|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
143421609|NCT01587703|517087570|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
143421610|NCT01587703|517087552|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
143421611|NCT01587703|517087553|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
143421612|NCT01587703|517087554|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
143421613|NCT01587703|517087555|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
143421614|NCT01587703|517087556|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
143421615|NCT01587703|517087557|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
143421616|NCT01587703|517087558|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
143421617|NCT01587703|517087559|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
143421618|NCT01587703|517087560|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
143421619|NCT01587703|517087561|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
143421620|NCT01587703|517087562|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
143421621|NCT01587703|517087563|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
143421622|NCT01587703|517087564|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
143421623|NCT01587703|517087565|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
143421624|NCT01587703|517087566|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
143421625|NCT01587703|517087567|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
143421626|NCT01587703|517087568|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
143421627|NCT01587703|517087569|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
143421628|NCT01587703|517087570|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
143421629|NCT01922102|517087571|FG000|Overall Study|Withdrawal by Subject|7|||
143421630|NCT01922102|517087572|FG001|Overall Study|Withdrawal by Subject|3|||
143421631|NCT01922102|517087573|FG002|Overall Study|Withdrawal by Subject|7|||
143421632|NCT01922102|517087571|FG000|Overall Study|Physician Decision|0|||
143421633|NCT01922102|517087572|FG001|Overall Study|Physician Decision|2|||
143421634|NCT01922102|517087573|FG002|Overall Study|Physician Decision|1|||
143421635|NCT01922102|517087571|FG000|Overall Study|Adverse Event|1|||
143421636|NCT01922102|517087572|FG001|Overall Study|Adverse Event|2|||
143421637|NCT01922102|517087573|FG002|Overall Study|Adverse Event|0|||
143421638|NCT01922102|517087571|FG000|Overall Study|Lost to Follow-up|1|||
143421639|NCT01922102|517087572|FG001|Overall Study|Lost to Follow-up|0|||
143421640|NCT01922102|517087573|FG002|Overall Study|Lost to Follow-up|0|||
143421641|NCT01922102|517087571|FG000|Overall Study|Administrative problems|0|||
143421642|NCT01922102|517087572|FG001|Overall Study|Administrative problems|2|||
143421643|NCT01922102|517087573|FG002|Overall Study|Administrative problems|0|||
143421644|NCT01345253|517087581|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
143421645|NCT01345253|517087582|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
143421646|NCT01345253|517087581|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
143421647|NCT01345253|517087582|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
143421648|NCT01345253|517087581|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
143421649|NCT01345253|517087582|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
143421650|NCT01345253|517087581|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
143421651|NCT01345253|517087582|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
143421652|NCT01345253|517087581|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
143421653|NCT01345253|517087582|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
143421654|NCT01345253|517087581|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
143421655|NCT01345253|517087582|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
143421656|NCT01345253|517087581|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
143421657|NCT01345253|517087582|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
143421658|NCT01345253|517087581|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
143421659|NCT01345253|517087582|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
143421660|NCT01345253|517087581|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
143421661|NCT01345253|517087582|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
143421662|NCT01345253|517087581|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
143421663|NCT01345253|517087582|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
143421664|NCT01345253|517087581|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
143421665|NCT01345253|517087582|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
143421666|NCT01345253|517087581|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
143421667|NCT01345253|517087582|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
143421668|NCT01345253|517087581|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
143421669|NCT01345253|517087582|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
143421670|NCT01345253|517087581|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
143421671|NCT01345253|517087582|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
143421672|NCT01345253|517087581|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
143421673|NCT01345253|517087582|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
143421674|NCT00476151|517087586|FG000|Overall Study|Adverse Event|0|||
143421675|NCT00476151|517087587|FG001|Overall Study|Adverse Event|2|||
143421676|NCT00476151|517087586|FG000|Overall Study|Protocol Violation|1|||
143421677|NCT00476151|517087587|FG001|Overall Study|Protocol Violation|3|||
143421678|NCT00476151|517087586|FG000|Overall Study|Withdrawal by Subject|2|||
143421679|NCT00476151|517087587|FG001|Overall Study|Withdrawal by Subject|0|||
143421680|NCT00476151|517087586|FG000|Overall Study|Physician Decision|0|||
143421681|NCT00476151|517087587|FG001|Overall Study|Physician Decision|2|||
143421682|NCT00447499|517087588|FG000|Overall Study|Adverse Event|1|||
143421683|NCT00447499|517087588|FG000|Overall Study|Patient Decision|4|||
143421684|NCT00447499|517087588|FG000|Overall Study|Sponsor Decision|1|||
143421685|NCT00447499|517087588|FG000|Overall Study|Physician Decision|1|||
143421686|NCT01767376|517087590|FG000|Overall Study|Lost to Follow-up|3|||
143421687|NCT01767376|517087591|FG001|Overall Study|Lost to Follow-up|2|||
143421688|NCT01767376|517087592|FG002|Overall Study|Lost to Follow-up|0|||
143421689|NCT01767376|517087590|FG000|Overall Study|Withdrawal by Subject|1|||
143421690|NCT01767376|517087591|FG001|Overall Study|Withdrawal by Subject|1|||
143421691|NCT01767376|517087592|FG002|Overall Study|Withdrawal by Subject|0|||
143421692|NCT01012999|517087593|FG000|Overall Study|Protocol Violation|1|||
143421693|NCT03557307|517087594|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
143421694|NCT03557307|517087594|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
143421695|NCT03557307|517087594|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
143421696|NCT03557307|517087594|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
143421697|NCT03557307|517087594|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
143421698|NCT03557307|517087594|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
143421699|NCT03557307|517087594|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
143421700|NCT03557307|517087594|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
143421701|NCT03557307|517087594|FG000|Period 2: Maintenance Phase|Death|3|||
143421702|NCT03557307|517087594|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
143421703|NCT03557307|517087594|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
143421704|NCT03557307|517087594|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
143421705|NCT03557307|517087594|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
143421706|NCT03557307|517087594|FG000|Period 2: Maintenance Phase|other|3|||
143421707|NCT01322347|517087595|FG000|Overall Study|Adverse Event|7|||
143421708|NCT01322347|517087596|FG001|Overall Study|Adverse Event|2|||
143421709|NCT01322347|517087595|FG000|Overall Study|Death|5|||
143421710|NCT01322347|517087596|FG001|Overall Study|Death|3|||
143421711|NCT01322347|517087595|FG000|Overall Study|Physician Decision|2|||
143421712|NCT01322347|517087596|FG001|Overall Study|Physician Decision|1|||
143421713|NCT01322347|517087595|FG000|Overall Study|Protocol Violation|5|||
143421714|NCT01322347|517087596|FG001|Overall Study|Protocol Violation|2|||
143421715|NCT01322347|517087595|FG000|Overall Study|Withdrawal by Subject|1|||
143421716|NCT01322347|517087596|FG001|Overall Study|Withdrawal by Subject|4|||
143421717|NCT01322347|517087595|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
143421718|NCT01322347|517087596|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
143421719|NCT01322347|517087595|FG000|Overall Study|blood transfusion|5|||
143421720|NCT01322347|517087596|FG001|Overall Study|blood transfusion|5|||
143421721|NCT01322347|517087595|FG000|Overall Study|sponsor decision|1|||
143421722|NCT01322347|517087596|FG001|Overall Study|sponsor decision|3|||
143421723|NCT01322347|517087595|FG000|Overall Study|ineligible|6|||
143421724|NCT01322347|517087596|FG001|Overall Study|ineligible|3|||
143421725|NCT01322347|517087595|FG000|Overall Study|kidney transplant|3|||
143421726|NCT01322347|517087596|FG001|Overall Study|kidney transplant|1|||
143421727|NCT01322347|517087595|FG000|Overall Study|study drug withheld > 12 wks|0|||
143421728|NCT01322347|517087596|FG001|Overall Study|study drug withheld > 12 wks|1|||
143421729|NCT01322347|517087595|FG000|Overall Study|moved/changed dialysis|2|||
143421730|NCT01322347|517087596|FG001|Overall Study|moved/changed dialysis|4|||
143421731|NCT04883541|517087597|FG000|Overall Study|Not attending regular yoga class|16|||
143421732|NCT04883541|517087598|FG001|Overall Study|Not attending regular yoga class|0|||
143421733|NCT04883541|517087597|FG000|Overall Study|Not attending the pregnancy school|0|||
143421734|NCT04883541|517087598|FG001|Overall Study|Not attending the pregnancy school|9|||
143421735|NCT01369147|517087601|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
143421736|NCT01369147|517087602|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
143421737|NCT01369147|517087603|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
143421738|NCT04239911|517087604|FG000|Overall Study|Lost to Follow-up|2|||
143421739|NCT04239911|517087605|FG001|Overall Study|Lost to Follow-up|1|||
143421740|NCT03456856|517087606|FG000|Overall Study|Lost to Follow-up|2|||
143421741|NCT03456856|517087606|FG000|Overall Study|Withdrawal by Subject|1|||
143421742|NCT03262389|517087609|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
143421743|NCT03262389|517087609|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
143421744|NCT03262389|517087609|FG000|Overall Study|opted out of PET/MR|1|||
143421745|NCT01052272|517087610|FG000|Overall Study|Death|0|||
143421746|NCT01052272|517087611|FG001|Overall Study|Death|0|||
143421747|NCT01052272|517087612|FG002|Overall Study|Death|1|||
143421748|NCT01052272|517087613|FG003|Overall Study|Death|1|||
143421749|NCT01052272|517087610|FG000|Overall Study|Physician Decision|0|||
143421750|NCT01052272|517087611|FG001|Overall Study|Physician Decision|1|||
143421751|NCT01052272|517087612|FG002|Overall Study|Physician Decision|0|||
143421752|NCT01052272|517087613|FG003|Overall Study|Physician Decision|0|||
143421753|NCT01052272|517087610|FG000|Overall Study|patient refuses follow-up|5|||
143421754|NCT01052272|517087611|FG001|Overall Study|patient refuses follow-up|4|||
143421755|NCT01052272|517087612|FG002|Overall Study|patient refuses follow-up|2|||
143421756|NCT01052272|517087613|FG003|Overall Study|patient refuses follow-up|4|||
143421757|NCT01052272|517087610|FG000|Overall Study|Withdrawal by Subject|0|||
143421758|NCT01052272|517087611|FG001|Overall Study|Withdrawal by Subject|2|||
143421759|NCT01052272|517087612|FG002|Overall Study|Withdrawal by Subject|3|||
143421760|NCT01052272|517087613|FG003|Overall Study|Withdrawal by Subject|2|||
143421761|NCT01052272|517087610|FG000|Overall Study|placed in long-term care|0|||
143421762|NCT01052272|517087611|FG001|Overall Study|placed in long-term care|0|||
143421763|NCT01052272|517087612|FG002|Overall Study|placed in long-term care|1|||
143421764|NCT01052272|517087613|FG003|Overall Study|placed in long-term care|0|||
143421765|NCT01052272|517087610|FG000|Overall Study|decline in health|0|||
143421766|NCT01052272|517087611|FG001|Overall Study|decline in health|0|||
143421767|NCT01052272|517087612|FG002|Overall Study|decline in health|1|||
143421768|NCT01052272|517087613|FG003|Overall Study|decline in health|0|||
143421769|NCT00096278|517087614|FG000|Overall Study|No follow-up data|15|||
143421770|NCT00096278|517087615|FG001|Overall Study|No follow-up data|18|||
143421771|NCT00096278|517087614|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
143421772|NCT00096278|517087615|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
143421773|NCT04626128|517087616|FG000|Overall Study|Withdrawal by Subject|0|||
143421774|NCT04626128|517087617|FG001|Overall Study|Withdrawal by Subject|1|||
143421775|NCT04626128|517087618|FG002|Overall Study|Withdrawal by Subject|0|||
143421776|NCT04626128|517087619|FG003|Overall Study|Withdrawal by Subject|0|||
143421777|NCT00841321|517087620|FG000|Overall Study|Lost to Follow-up|1|||
143421778|NCT00841321|517087621|FG001|Overall Study|Lost to Follow-up|1|||
143421779|NCT00841321|517087620|FG000|Overall Study|Adverse Event|0|||
143421780|NCT00841321|517087621|FG001|Overall Study|Adverse Event|2|||
143421781|NCT00379210|517087624|FG000|Overall Study|Withdrawal by Subject|10|||
143421782|NCT00379210|517087625|FG001|Overall Study|Withdrawal by Subject|7|||
143421783|NCT04908488|517087628|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
143421784|NCT04908488|517087629|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
143421785|NCT04908488|517087628|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
143421786|NCT04908488|517087629|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
143421787|NCT01107912|517087630|FG000|Period 1|Adverse Event|0|||
143421788|NCT01107912|517087631|FG001|Period 1|Adverse Event|0|||
143421789|NCT01107912|517087632|FG002|Period 1|Adverse Event|0|||
143421790|NCT01107912|517087633|FG003|Period 1|Adverse Event|0|||
143421791|NCT01107912|517087634|FG004|Period 1|Adverse Event|2|||
143421792|NCT01107912|517087635|FG005|Period 1|Adverse Event|0|||
143421793|NCT01107912|517087630|FG000|Period 1|Physician Decision|0|||
143421794|NCT01107912|517087631|FG001|Period 1|Physician Decision|0|||
143421795|NCT01107912|517087632|FG002|Period 1|Physician Decision|0|||
143421796|NCT01107912|517087633|FG003|Period 1|Physician Decision|0|||
143421797|NCT01107912|517087634|FG004|Period 1|Physician Decision|1|||
143421798|NCT01107912|517087635|FG005|Period 1|Physician Decision|0|||
143421799|NCT01107912|517087630|FG000|Period 1|Withdrawal by Subject|1|||
143421800|NCT01107912|517087631|FG001|Period 1|Withdrawal by Subject|0|||
143421801|NCT01107912|517087632|FG002|Period 1|Withdrawal by Subject|0|||
143421802|NCT01107912|517087633|FG003|Period 1|Withdrawal by Subject|0|||
143421803|NCT01107912|517087634|FG004|Period 1|Withdrawal by Subject|0|||
143421804|NCT01107912|517087635|FG005|Period 1|Withdrawal by Subject|0|||
143421805|NCT01107912|517087630|FG000|Period 2|Physician Decision|0|||
143421806|NCT01107912|517087631|FG001|Period 2|Physician Decision|0|||
143421807|NCT01107912|517087632|FG002|Period 2|Physician Decision|1|||
143421808|NCT01107912|517087633|FG003|Period 2|Physician Decision|0|||
143421809|NCT01107912|517087634|FG004|Period 2|Physician Decision|0|||
143421810|NCT01107912|517087635|FG005|Period 2|Physician Decision|0|||
143421811|NCT01107912|517087630|FG000|Period 3|Adverse Event|0|||
143421812|NCT01107912|517087631|FG001|Period 3|Adverse Event|1|||
143421813|NCT01107912|517087632|FG002|Period 3|Adverse Event|1|||
143421814|NCT01107912|517087633|FG003|Period 3|Adverse Event|0|||
143421815|NCT01107912|517087634|FG004|Period 3|Adverse Event|0|||
143421816|NCT01107912|517087635|FG005|Period 3|Adverse Event|0|||
143421817|NCT01107912|517087630|FG000|Period 3|Withdrawal by Subject|0|||
143421818|NCT01107912|517087631|FG001|Period 3|Withdrawal by Subject|0|||
143421819|NCT01107912|517087632|FG002|Period 3|Withdrawal by Subject|0|||
143421820|NCT01107912|517087633|FG003|Period 3|Withdrawal by Subject|1|||
143421821|NCT01107912|517087634|FG004|Period 3|Withdrawal by Subject|0|||
143421822|NCT01107912|517087635|FG005|Period 3|Withdrawal by Subject|0|||
143421823|NCT02607956|517087644|FG000|Double-Blinded Phase|Withdrew Consent|17|||
143421824|NCT02607956|517087645|FG001|Double-Blinded Phase|Withdrew Consent|19|||
143421825|NCT02607956|517087646|FG002|Double-Blinded Phase|Withdrew Consent|0|||
143421826|NCT02607956|517087647|FG003|Double-Blinded Phase|Withdrew Consent|0|||
143421827|NCT02607956|517087644|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
143421828|NCT02607956|517087645|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
143421829|NCT02607956|517087646|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
143421830|NCT02607956|517087647|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
143421831|NCT02607956|517087644|FG000|Double-Blinded Phase|Randomized but never treated|7|||
143421832|NCT02607956|517087645|FG001|Double-Blinded Phase|Randomized but never treated|5|||
143421833|NCT02607956|517087646|FG002|Double-Blinded Phase|Randomized but never treated|0|||
143421834|NCT02607956|517087647|FG003|Double-Blinded Phase|Randomized but never treated|0|||
143421835|NCT02607956|517087644|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
143421836|NCT02607956|517087645|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
143421837|NCT02607956|517087646|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
143421838|NCT02607956|517087647|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
143421839|NCT02607956|517087644|FG000|Double-Blinded Phase|Death|4|||
143421840|NCT02607956|517087645|FG001|Double-Blinded Phase|Death|4|||
143421841|NCT02607956|517087646|FG002|Double-Blinded Phase|Death|0|||
143421842|NCT02607956|517087647|FG003|Double-Blinded Phase|Death|0|||
143421843|NCT02607956|517087644|FG000|Double-Blinded Phase|Adverse Event|4|||
143421844|NCT02607956|517087645|FG001|Double-Blinded Phase|Adverse Event|3|||
143421845|NCT02607956|517087646|FG002|Double-Blinded Phase|Adverse Event|0|||
143421846|NCT02607956|517087647|FG003|Double-Blinded Phase|Adverse Event|0|||
143421847|NCT02607956|517087644|FG000|Double-Blinded Phase|Protocol Violation|3|||
143421848|NCT02607956|517087645|FG001|Double-Blinded Phase|Protocol Violation|1|||
143421849|NCT02607956|517087646|FG002|Double-Blinded Phase|Protocol Violation|0|||
143421850|NCT02607956|517087647|FG003|Double-Blinded Phase|Protocol Violation|0|||
143421851|NCT02607956|517087644|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
143421852|NCT02607956|517087645|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
143421853|NCT02607956|517087646|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
143421854|NCT02607956|517087647|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
143421855|NCT02607956|517087644|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
143421856|NCT02607956|517087645|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
143421857|NCT02607956|517087646|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
143421858|NCT02607956|517087647|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
143421859|NCT02607956|517087644|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
143421860|NCT02607956|517087645|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
143421861|NCT02607956|517087646|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
143421862|NCT02607956|517087647|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
143421863|NCT02607956|517087644|FG000|Open-Label Extension Phase|Death|0|||
143421864|NCT02607956|517087645|FG001|Open-Label Extension Phase|Death|0|||
143421865|NCT02607956|517087646|FG002|Open-Label Extension Phase|Death|1|||
143421866|NCT02607956|517087647|FG003|Open-Label Extension Phase|Death|3|||
143421867|NCT02607956|517087644|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
143421868|NCT02607956|517087645|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
143421869|NCT02607956|517087646|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
143421870|NCT02607956|517087647|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
143421871|NCT02607956|517087644|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
143421872|NCT02607956|517087645|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
143421873|NCT02607956|517087646|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
143421874|NCT02607956|517087647|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
143421875|NCT02607956|517087644|FG000|Open-Label Extension Phase|Protocol Violation|0|||
143421876|NCT02607956|517087645|FG001|Open-Label Extension Phase|Protocol Violation|0|||
143421877|NCT02607956|517087646|FG002|Open-Label Extension Phase|Protocol Violation|0|||
143421878|NCT02607956|517087647|FG003|Open-Label Extension Phase|Protocol Violation|2|||
143421879|NCT02607956|517087644|FG000|Open-Label Extension Phase|Pregnancy|0|||
143421880|NCT02607956|517087645|FG001|Open-Label Extension Phase|Pregnancy|0|||
143421881|NCT02607956|517087646|FG002|Open-Label Extension Phase|Pregnancy|0|||
143421882|NCT02607956|517087647|FG003|Open-Label Extension Phase|Pregnancy|1|||
143421883|NCT00237809|517087649|FG000|Overall Study|Lost to Follow-up|11|||
143421884|NCT00237809|517087650|FG001|Overall Study|Lost to Follow-up|10|||
143421885|NCT00237809|517087651|FG002|Overall Study|Lost to Follow-up|9|||
143421886|NCT00237809|517087652|FG003|Overall Study|Lost to Follow-up|9|||
143421887|NCT02006641|517087653|FG000|Overall Study|Withdrawal before treatment|2|||
143421888|NCT02006641|517087654|FG001|Overall Study|Withdrawal before treatment|5|||
143421889|NCT02006641|517087655|FG002|Overall Study|Withdrawal before treatment|3|||
143421890|NCT02006641|517087653|FG000|Overall Study|Adverse Event|15|||
143421891|NCT02006641|517087654|FG001|Overall Study|Adverse Event|11|||
143421892|NCT02006641|517087655|FG002|Overall Study|Adverse Event|15|||
143421893|NCT02006641|517087653|FG000|Overall Study|Protocol Violation|0|||
143421894|NCT02006641|517087654|FG001|Overall Study|Protocol Violation|2|||
143421895|NCT02006641|517087655|FG002|Overall Study|Protocol Violation|2|||
143421896|NCT02006641|517087653|FG000|Overall Study|Lost to Follow-up|0|||
143421897|NCT02006641|517087654|FG001|Overall Study|Lost to Follow-up|1|||
143421898|NCT02006641|517087655|FG002|Overall Study|Lost to Follow-up|0|||
143421899|NCT02006641|517087653|FG000|Overall Study|Withdrawal by Subject|7|||
143421900|NCT02006641|517087654|FG001|Overall Study|Withdrawal by Subject|12|||
143421901|NCT02006641|517087655|FG002|Overall Study|Withdrawal by Subject|11|||
143421902|NCT02006641|517087653|FG000|Overall Study|Other reason: patient didn't show up|1|||
143421903|NCT02006641|517087654|FG001|Overall Study|Other reason: patient didn't show up|0|||
143421904|NCT02006641|517087655|FG002|Overall Study|Other reason: patient didn't show up|0|||
143421905|NCT02006641|517087653|FG000|Overall Study|Other reason:patient didn't want to come|0|||
143421906|NCT02006641|517087654|FG001|Overall Study|Other reason:patient didn't want to come|0|||
143421907|NCT02006641|517087655|FG002|Overall Study|Other reason:patient didn't want to come|1|||
143421908|NCT02006641|517087653|FG000|Overall Study|Other reason: patient has moved|1|||
143421909|NCT02006641|517087654|FG001|Overall Study|Other reason: patient has moved|0|||
143421910|NCT02006641|517087655|FG002|Overall Study|Other reason: patient has moved|1|||
143421911|NCT02006641|517087653|FG000|Overall Study|Other reason: caregiver in hospital|0|||
143421912|NCT02006641|517087654|FG001|Overall Study|Other reason: caregiver in hospital|1|||
143421913|NCT02006641|517087655|FG002|Overall Study|Other reason: caregiver in hospital|0|||
143421914|NCT02006641|517087653|FG000|Overall Study|Other reason: patient's wife has died|0|||
143421915|NCT02006641|517087654|FG001|Overall Study|Other reason: patient's wife has died|0|||
143421916|NCT02006641|517087655|FG002|Overall Study|Other reason: patient's wife has died|1|||
143421917|NCT02006641|517087653|FG000|Overall Study|Other reason: hospitalisation|0|||
143421918|NCT02006641|517087654|FG001|Overall Study|Other reason: hospitalisation|1|||
143421919|NCT02006641|517087655|FG002|Overall Study|Other reason: hospitalisation|0|||
143421920|NCT02006641|517087653|FG000|Overall Study|Other reason: caregiver impossibility|0|||
143421921|NCT02006641|517087654|FG001|Overall Study|Other reason: caregiver impossibility|0|||
143421922|NCT02006641|517087655|FG002|Overall Study|Other reason: caregiver impossibility|1|||
143421923|NCT02006641|517087653|FG000|Overall Study|Other reason: protocol non-compliance|0|||
143421924|NCT02006641|517087654|FG001|Overall Study|Other reason: protocol non-compliance|0|||
143421925|NCT02006641|517087655|FG002|Overall Study|Other reason: protocol non-compliance|1|||
143421926|NCT02132195|517087656|FG000|Initial Assignment|Relapsed|14|||
143421927|NCT02132195|517087657|FG001|Initial Assignment|Relapsed|0|||
143421928|NCT02132195|517087658|FG002|Initial Assignment|Relapsed|0|||
143421929|NCT02132195|517087656|FG000|Rescue Therapy|Relapsed|0|||
143421930|NCT02132195|517087657|FG001|Rescue Therapy|Relapsed|0|||
143421931|NCT02132195|517087658|FG002|Rescue Therapy|Relapsed|7|||
143421932|NCT02132195|517087656|FG000|Rescue Therapy|Physician Decision|0|||
143421933|NCT02132195|517087657|FG001|Rescue Therapy|Physician Decision|0|||
143421934|NCT02132195|517087658|FG002|Rescue Therapy|Physician Decision|1|||
143421935|NCT02132195|517087656|FG000|Rescue Therapy|Withdrawal by Subject|0|||
143421936|NCT02132195|517087657|FG001|Rescue Therapy|Withdrawal by Subject|0|||
143421937|NCT02132195|517087658|FG002|Rescue Therapy|Withdrawal by Subject|1|||
143421938|NCT02132195|517087656|FG000|Rescue Therapy|Adverse Event|0|||
143421939|NCT02132195|517087657|FG001|Rescue Therapy|Adverse Event|0|||
143421940|NCT02132195|517087658|FG002|Rescue Therapy|Adverse Event|2|||
143421941|NCT04749797|517087659|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
143421942|NCT04749797|517087660|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
143421943|NCT04749797|517087661|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
143421944|NCT05379400|517089382|FG000|Overall Study|Lost to Follow-up|1|||
143421945|NCT05379400|517089383|FG001|Overall Study|Lost to Follow-up|1|||
143421946|NCT00538629|517089387|FG000|Overall Study|At subject's request|1|||
143421947|NCT00538629|517089387|FG000|Overall Study|Adverse Event|2|||
143421948|NCT00538629|517089387|FG000|Overall Study|Lack of Efficacy|12|||
143421949|NCT00538629|517089387|FG000|Overall Study|Lost to Follow-up|6|||
143421950|NCT00538629|517089387|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
143421951|NCT00555620|517089388|FG000|Overall Study|Death|0|||
143421952|NCT00555620|517089389|FG001|Overall Study|Death|1|||
143421953|NCT00555620|517089390|FG002|Overall Study|Death|0|||
143421954|NCT00555620|517089391|FG003|Overall Study|Death|0|||
143421955|NCT00555620|517089392|FG004|Overall Study|Death|0|||
143421956|NCT00555620|517089393|FG005|Overall Study|Death|1|||
143421957|NCT00555620|517089388|FG000|Overall Study|Study terminated by sponsor|0|||
143421958|NCT00555620|517089389|FG001|Overall Study|Study terminated by sponsor|0|||
143421959|NCT00555620|517089390|FG002|Overall Study|Study terminated by sponsor|1|||
143421960|NCT00555620|517089391|FG003|Overall Study|Study terminated by sponsor|0|||
143421961|NCT00555620|517089392|FG004|Overall Study|Study terminated by sponsor|0|||
143421962|NCT00555620|517089393|FG005|Overall Study|Study terminated by sponsor|0|||
143421963|NCT00555620|517089388|FG000|Overall Study|Adverse Event|0|||
143421964|NCT00555620|517089389|FG001|Overall Study|Adverse Event|0|||
143421965|NCT00555620|517089390|FG002|Overall Study|Adverse Event|1|||
143421966|NCT00555620|517089391|FG003|Overall Study|Adverse Event|5|||
143421967|NCT00555620|517089392|FG004|Overall Study|Adverse Event|0|||
143421968|NCT00555620|517089393|FG005|Overall Study|Adverse Event|1|||
143421969|NCT00555620|517089388|FG000|Overall Study|Objective progression or relapse|6|||
143421970|NCT00555620|517089389|FG001|Overall Study|Objective progression or relapse|5|||
143421971|NCT00555620|517089390|FG002|Overall Study|Objective progression or relapse|12|||
143421972|NCT00555620|517089391|FG003|Overall Study|Objective progression or relapse|17|||
143421973|NCT00555620|517089392|FG004|Overall Study|Objective progression or relapse|3|||
143421974|NCT00555620|517089393|FG005|Overall Study|Objective progression or relapse|16|||
143421975|NCT00555620|517089388|FG000|Overall Study|Participant refused treatment|0|||
143421976|NCT00555620|517089389|FG001|Overall Study|Participant refused treatment|1|||
143421977|NCT00555620|517089390|FG002|Overall Study|Participant refused treatment|1|||
143421978|NCT00555620|517089391|FG003|Overall Study|Participant refused treatment|0|||
143421979|NCT00555620|517089392|FG004|Overall Study|Participant refused treatment|0|||
143421980|NCT00555620|517089393|FG005|Overall Study|Participant refused treatment|1|||
143421981|NCT00555620|517089388|FG000|Overall Study|Other|0|||
143421982|NCT00555620|517089389|FG001|Overall Study|Other|0|||
143421983|NCT00555620|517089390|FG002|Overall Study|Other|0|||
143421984|NCT00555620|517089391|FG003|Overall Study|Other|1|||
143421985|NCT00555620|517089392|FG004|Overall Study|Other|0|||
143421986|NCT00555620|517089393|FG005|Overall Study|Other|3|||
143421987|NCT00946088|517089394|FG000|Overall Study|Withdrawal by Subject|0|||
143421988|NCT00946088|517089395|FG001|Overall Study|Withdrawal by Subject|1|||
143421989|NCT03184519|517089397|FG000|Overall Study|Lost to Follow-up|6|||
143421990|NCT03184519|517089397|FG000|Overall Study|Physician Decision|21|||
143421991|NCT00595959|517089398|FG000|Overall Study|Withdrawal by Subject|1|||
143421992|NCT00595959|517089398|FG000|Overall Study|Lost to Follow-up|1|||
143421993|NCT00753896|517089401|FG000|Overall Study|Adverse Event|4|||
143421994|NCT00753896|517089401|FG000|Overall Study|Death|1|||
143421995|NCT00753896|517089401|FG000|Overall Study|Lost to Follow-up|2|||
143421996|NCT00753896|517089401|FG000|Overall Study|Protocol Violation|1|||
143421997|NCT00753896|517089401|FG000|Overall Study|Withdrawal by Subject|4|||
143421998|NCT00753896|517089401|FG000|Overall Study|Entry Criteria Not Met|4|||
143421999|NCT01280656|517089402|FG000|Overall Study|Adverse Event|1|||
143422000|NCT01280656|517089403|FG001|Overall Study|Adverse Event|14|||
143422001|NCT01280656|517089404|FG002|Overall Study|Adverse Event|13|||
143422002|NCT01280656|517089402|FG000|Overall Study|Lack of Efficacy|1|||
143422003|NCT01280656|517089403|FG001|Overall Study|Lack of Efficacy|22|||
143422004|NCT01280656|517089404|FG002|Overall Study|Lack of Efficacy|38|||
143422005|NCT01280656|517089402|FG000|Overall Study|Treatment shortening (RGT)|0|||
143422006|NCT01280656|517089403|FG001|Overall Study|Treatment shortening (RGT)|4|||
143422007|NCT01280656|517089404|FG002|Overall Study|Treatment shortening (RGT)|5|||
143422008|NCT01280656|517089402|FG000|Overall Study|Other|1|||
143422009|NCT01280656|517089403|FG001|Overall Study|Other|7|||
143422010|NCT01280656|517089404|FG002|Overall Study|Other|7|||
143422011|NCT03529942|517089405|FG000|Overall Study|Withdrawal by Subject|13|||
143422012|NCT03529942|517089405|FG000|Overall Study|Physician Decision|1|||
143422013|NCT03529942|517089405|FG000|Overall Study|Lost to Follow-up|7|||
143422014|NCT03529942|517089405|FG000|Overall Study|Needle inserted but no drug administered|1|||
143422015|NCT03529942|517089405|FG000|Overall Study|Personal reasons|1|||
143422016|NCT00409747|517089408|FG000|Overall Study|Withdrawal by Subject|1|||
143422017|NCT00636168|517089409|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
143422018|NCT00636168|517089410|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
143422019|NCT00636168|517089409|FG000|Randomized to Study Drug|Adverse Event|1|||
143422020|NCT00636168|517089410|FG001|Randomized to Study Drug|Adverse Event|0|||
143422021|NCT00636168|517089409|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
143422022|NCT00636168|517089410|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
143422023|NCT00636168|517089409|FG000|Treated With Study Drug|Recurrence of disease|135|||
143422024|NCT00636168|517089410|FG001|Treated With Study Drug|Recurrence of disease|282|||
143422025|NCT00636168|517089409|FG000|Treated With Study Drug|Adverse Event|250|||
143422026|NCT00636168|517089410|FG001|Treated With Study Drug|Adverse Event|22|||
143422027|NCT00636168|517089409|FG000|Treated With Study Drug|Participant withdrew consent|16|||
143422028|NCT00636168|517089410|FG001|Treated With Study Drug|Participant withdrew consent|21|||
143422029|NCT00636168|517089409|FG000|Treated With Study Drug|Poor/non-compliance|1|||
143422030|NCT00636168|517089410|FG001|Treated With Study Drug|Poor/non-compliance|3|||
143422031|NCT00636168|517089409|FG000|Treated With Study Drug|Death|3|||
143422032|NCT00636168|517089410|FG001|Treated With Study Drug|Death|0|||
143422033|NCT00636168|517089409|FG000|Treated With Study Drug|Pregnancy|1|||
143422034|NCT00636168|517089410|FG001|Treated With Study Drug|Pregnancy|0|||
143422035|NCT00636168|517089409|FG000|Treated With Study Drug|No longer meets study criteria|1|||
143422036|NCT00636168|517089410|FG001|Treated With Study Drug|No longer meets study criteria|0|||
143422037|NCT00636168|517089409|FG000|Treated With Study Drug|Other reason|1|||
143422038|NCT00636168|517089410|FG001|Treated With Study Drug|Other reason|3|||
143422039|NCT00636168|517089409|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
143422040|NCT00636168|517089410|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
143422041|NCT00636168|517089409|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
143422042|NCT00636168|517089410|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
143422043|NCT00636168|517089409|FG000|Long Term Follow-Up|Death|8|||
143422044|NCT00636168|517089410|FG001|Long Term Follow-Up|Death|9|||
143422045|NCT01005914|517089412|FG000|Overall Study|Adverse Event|4|||
143422046|NCT01005914|517089412|FG000|Overall Study|Death|4|||
143422047|NCT01005914|517089412|FG000|Overall Study|Lack of Efficacy|1|||
143422048|NCT01005914|517089412|FG000|Overall Study|Withdrawal by Subject|1|||
143422049|NCT01287832|517089413|FG000|Overall Study|Adverse Event|1|||
143422050|NCT01287832|517089414|FG001|Overall Study|Adverse Event|0|||
143422051|NCT01287832|517089413|FG000|Overall Study|Death|0|||
143422052|NCT01287832|517089414|FG001|Overall Study|Death|1|||
143422053|NCT00632736|517089415|FG000|Overall Study|Adverse Event|104|||
143422054|NCT00632736|517089415|FG000|Overall Study|Lost to Follow-up|15|||
143422055|NCT00632736|517089415|FG000|Overall Study|Protocol Violation|14|||
143422056|NCT00632736|517089415|FG000|Overall Study|Withdrawal by Subject|99|||
143422057|NCT00632736|517089415|FG000|Overall Study|Lack of Efficacy|5|||
143422058|NCT00632736|517089415|FG000|Overall Study|Sponsor terminated study|5|||
143422059|NCT00632736|517089415|FG000|Overall Study|Non-compliance|10|||
143422060|NCT00632736|517089415|FG000|Overall Study|Other|16|||
143422061|NCT03015220|517089422|FG000|Overall Study|Withdrawal by Subject|3|||
143422062|NCT03015220|517089423|FG001|Overall Study|Withdrawal by Subject|2|||
143422063|NCT03015220|517089424|FG002|Overall Study|Withdrawal by Subject|2|||
143422064|NCT03015220|517089425|FG003|Overall Study|Withdrawal by Subject|2|||
143422065|NCT03015220|517089422|FG000|Overall Study|Lost to Follow-up|0|||
143422066|NCT03015220|517089423|FG001|Overall Study|Lost to Follow-up|0|||
143422067|NCT03015220|517089424|FG002|Overall Study|Lost to Follow-up|1|||
143422068|NCT03015220|517089425|FG003|Overall Study|Lost to Follow-up|0|||
143422069|NCT02291549|517089426|FG000|Overall Study|Lost to Follow-up|1|||
143422070|NCT02291549|517089427|FG001|Overall Study|Lost to Follow-up|0|||
143422071|NCT02291549|517089426|FG000|Overall Study|Withdrawal by Subject|0|||
143422072|NCT02291549|517089427|FG001|Overall Study|Withdrawal by Subject|1|||
143422073|NCT00537914|517089428|FG000|Overall Study|Death|1|||
143422074|NCT00537914|517089428|FG000|Overall Study|Adverse Event|7|||
143422075|NCT00537914|517089428|FG000|Overall Study|Treatment failure|10|||
143422076|NCT00537914|517089428|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
143422077|NCT00537914|517089428|FG000|Overall Study|Lost to Follow-up|19|||
143422078|NCT00537914|517089428|FG000|Overall Study|Withdrawal of informed consent|59|||
143422079|NCT02312258|517089429|FG000|Overall Study|Lost to Follow-up|8|||
143422080|NCT02312258|517089430|FG001|Overall Study|Lost to Follow-up|8|||
143422081|NCT02312258|517089429|FG000|Overall Study|Withdrawal by Patient|49|||
143422082|NCT02312258|517089430|FG001|Overall Study|Withdrawal by Patient|76|||
143422083|NCT02312258|517089429|FG000|Overall Study|Reason not Specified|107|||
143422084|NCT02312258|517089430|FG001|Overall Study|Reason not Specified|159|||
143422085|NCT02312258|517089429|FG000|Overall Study|Missing|2|||
143422086|NCT02312258|517089430|FG001|Overall Study|Missing|1|||
143422087|NCT02312258|517089429|FG000|Overall Study|Death|115|||
143422088|NCT02312258|517089430|FG001|Overall Study|Death|181|||
143422089|NCT01468597|517089432|FG000|Overall Study|Found ineligible|17|||
143422090|NCT01468597|517089432|FG000|Overall Study|concomitant valves|12|||
143422091|NCT01468597|517089432|FG000|Overall Study|off-pump CABG|1|||
143422092|NCT01468597|517089432|FG000|Overall Study|no platelet function data|5|||
143422093|NCT00912964|517089433|FG000|Overall Study|Eligibility criterion not met|1|||
143422094|NCT00912964|517089434|FG001|Overall Study|Eligibility criterion not met|1|||
143422095|NCT00912964|517089435|FG002|Overall Study|Eligibility criterion not met|0|||
143422096|NCT00912964|517089433|FG000|Overall Study|Adverse Event|15|||
143422097|NCT00912964|517089434|FG001|Overall Study|Adverse Event|18|||
143422098|NCT00912964|517089435|FG002|Overall Study|Adverse Event|12|||
143422099|NCT00912964|517089433|FG000|Overall Study|Lack of Efficacy|11|||
143422100|NCT00912964|517089434|FG001|Overall Study|Lack of Efficacy|4|||
143422101|NCT00912964|517089435|FG002|Overall Study|Lack of Efficacy|3|||
143422102|NCT00912964|517089433|FG000|Overall Study|Withdrawal by Subject|20|||
143422103|NCT00912964|517089434|FG001|Overall Study|Withdrawal by Subject|12|||
143422104|NCT00912964|517089435|FG002|Overall Study|Withdrawal by Subject|18|||
143422105|NCT00912964|517089433|FG000|Overall Study|Lost to Follow-up|4|||
143422106|NCT00912964|517089434|FG001|Overall Study|Lost to Follow-up|3|||
143422107|NCT00912964|517089435|FG002|Overall Study|Lost to Follow-up|3|||
143422108|NCT00912964|517089433|FG000|Overall Study|Protocol Violation|5|||
143422109|NCT00912964|517089434|FG001|Overall Study|Protocol Violation|3|||
143422110|NCT00912964|517089435|FG002|Overall Study|Protocol Violation|8|||
143422111|NCT00912964|517089433|FG000|Overall Study|Taking exclusionary medications|7|||
143422112|NCT00912964|517089434|FG001|Overall Study|Taking exclusionary medications|4|||
143422113|NCT00912964|517089435|FG002|Overall Study|Taking exclusionary medications|8|||
143422114|NCT00912964|517089433|FG000|Overall Study|Medical History|1|||
143422115|NCT00912964|517089434|FG001|Overall Study|Medical History|0|||
143422116|NCT00912964|517089435|FG002|Overall Study|Medical History|0|||
143422117|NCT00912964|517089433|FG000|Overall Study|Non-compliance with study procedures|2|||
143422118|NCT00912964|517089434|FG001|Overall Study|Non-compliance with study procedures|0|||
143422119|NCT00912964|517089435|FG002|Overall Study|Non-compliance with study procedures|0|||
143422120|NCT00912964|517089433|FG000|Overall Study|Violation of exclusion criterion|0|||
143422121|NCT00912964|517089434|FG001|Overall Study|Violation of exclusion criterion|0|||
143422122|NCT00912964|517089435|FG002|Overall Study|Violation of exclusion criterion|2|||
143422123|NCT00912964|517089433|FG000|Overall Study|Randomized but never received study drug|0|||
143422124|NCT00912964|517089434|FG001|Overall Study|Randomized but never received study drug|1|||
143422125|NCT00912964|517089435|FG002|Overall Study|Randomized but never received study drug|0|||
143422126|NCT04447287|517089436|FG000|Period 1: Run-in Period|Adverse Event|3|||
143422127|NCT04447287|517089437|FG001|Period 1: Run-in Period|Adverse Event|0|||
143422128|NCT04447287|517089438|FG002|Period 1: Run-in Period|Adverse Event|0|||
143422129|NCT04447287|517089436|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
143422130|NCT04447287|517089437|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
143422131|NCT04447287|517089438|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
143422132|NCT04447287|517089436|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
143422133|NCT04447287|517089437|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
143422134|NCT04447287|517089438|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
143422135|NCT00655824|517089439|FG000|Overall Study|Adverse Event|3|||
143422136|NCT00655824|517089439|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
143422137|NCT00655824|517089439|FG000|Overall Study|Protocol Violation|1|||
143422138|NCT00655824|517089439|FG000|Overall Study|Withdrawal by Subject|4|||
143422139|NCT00655824|517089439|FG000|Overall Study|Deterioration of Trial Disease|2|||
143422140|NCT00960206|517089440|FG000|Overall Study|Death|7|||
143422141|NCT00960206|517089441|FG001|Overall Study|Death|4|||
143422142|NCT00960206|517089442|FG002|Overall Study|Death|1|||
143422143|NCT00960206|517089440|FG000|Overall Study|Unwilling/Unable to return|1|||
143422144|NCT00960206|517089441|FG001|Overall Study|Unwilling/Unable to return|2|||
143422145|NCT00960206|517089442|FG002|Overall Study|Unwilling/Unable to return|0|||
143422146|NCT00960206|517089440|FG000|Overall Study|Lost to Follow-up|8|||
143422147|NCT00960206|517089441|FG001|Overall Study|Lost to Follow-up|14|||
143422148|NCT00960206|517089442|FG002|Overall Study|Lost to Follow-up|8|||
143422149|NCT00960206|517089440|FG000|Overall Study|Withdrawal by Subject|2|||
143422150|NCT00960206|517089441|FG001|Overall Study|Withdrawal by Subject|4|||
143422151|NCT00960206|517089442|FG002|Overall Study|Withdrawal by Subject|0|||
143422152|NCT00960206|517089440|FG000|Overall Study|Revision of study component|2|||
143422153|NCT00960206|517089441|FG001|Overall Study|Revision of study component|2|||
143422154|NCT00960206|517089442|FG002|Overall Study|Revision of study component|2|||
143422155|NCT00960206|517089440|FG000|Overall Study|Missing 10 year data|20|||
143422156|NCT00960206|517089441|FG001|Overall Study|Missing 10 year data|1|||
143422157|NCT00960206|517089442|FG002|Overall Study|Missing 10 year data|1|||
143422158|NCT00736502|517089449|FG000|Overall Study|Adverse Event|22|||
143422159|NCT00736502|517089449|FG000|Overall Study|Lack of Efficacy|16|||
143422160|NCT00736502|517089449|FG000|Overall Study|Lost to Follow-up|27|||
143422161|NCT02470806|517089450|FG000|Overall Study|Lost to Follow-up|1|||
143422162|NCT02470806|517089451|FG001|Overall Study|Lost to Follow-up|1|||
143422163|NCT02470806|517089450|FG000|Overall Study|Adverse Event|5|||
143422164|NCT02470806|517089451|FG001|Overall Study|Adverse Event|2|||
143422165|NCT02470806|517089450|FG000|Overall Study|Protocol Violation|4|||
143422166|NCT02470806|517089451|FG001|Overall Study|Protocol Violation|11|||
143422167|NCT02470806|517089450|FG000|Overall Study|Physician Decision|0|||
143422168|NCT02470806|517089451|FG001|Overall Study|Physician Decision|3|||
143422169|NCT02470806|517089450|FG000|Overall Study|Withdrawal by Subject|3|||
143422170|NCT02470806|517089451|FG001|Overall Study|Withdrawal by Subject|10|||
143422171|NCT02470806|517089450|FG000|Overall Study|Lack of Efficacy|5|||
143422172|NCT02470806|517089451|FG001|Overall Study|Lack of Efficacy|15|||
143422173|NCT03032198|517089452|FG000|Overall Study|Screen Fail|1|||
143422174|NCT00866619|517089453|FG000|Overall Study|Adverse Event|112|||
143422175|NCT00866619|517089454|FG001|Overall Study|Adverse Event|106|||
143422176|NCT00866619|517089455|FG002|Overall Study|Adverse Event|47|||
143422177|NCT00866619|517089456|FG003|Overall Study|Adverse Event|44|||
143422178|NCT00866619|517089453|FG000|Overall Study|Protocol Violation|2|||
143422179|NCT00866619|517089454|FG001|Overall Study|Protocol Violation|39|||
143422180|NCT00866619|517089455|FG002|Overall Study|Protocol Violation|2|||
143422181|NCT00866619|517089456|FG003|Overall Study|Protocol Violation|17|||
143422182|NCT00866619|517089453|FG000|Overall Study|Withdrawal by Subject|587|||
143422183|NCT00866619|517089454|FG001|Overall Study|Withdrawal by Subject|295|||
143422184|NCT00866619|517089455|FG002|Overall Study|Withdrawal by Subject|272|||
143422185|NCT00866619|517089456|FG003|Overall Study|Withdrawal by Subject|144|||
143422186|NCT00866619|517089453|FG000|Overall Study|Lost to Follow-up|1145|||
143422187|NCT00866619|517089454|FG001|Overall Study|Lost to Follow-up|830|||
143422188|NCT00866619|517089455|FG002|Overall Study|Lost to Follow-up|568|||
143422189|NCT00866619|517089456|FG003|Overall Study|Lost to Follow-up|425|||
143422190|NCT01307800|517089458|FG000|Overall Study|Adverse Event|9|||
143422191|NCT01307800|517089459|FG001|Overall Study|Adverse Event|8|||
143422192|NCT01307800|517089460|FG002|Overall Study|Adverse Event|10|||
143422193|NCT01307800|517089461|FG003|Overall Study|Adverse Event|14|||
143422194|NCT01307800|517089458|FG000|Overall Study|Entry Criteria Not Met|0|||
143422195|NCT01307800|517089459|FG001|Overall Study|Entry Criteria Not Met|0|||
143422196|NCT01307800|517089460|FG002|Overall Study|Entry Criteria Not Met|0|||
143422197|NCT01307800|517089461|FG003|Overall Study|Entry Criteria Not Met|2|||
143422198|NCT01307800|517089458|FG000|Overall Study|Lost to Follow-up|5|||
143422199|NCT01307800|517089459|FG001|Overall Study|Lost to Follow-up|6|||
143422200|NCT01307800|517089460|FG002|Overall Study|Lost to Follow-up|2|||
143422201|NCT01307800|517089461|FG003|Overall Study|Lost to Follow-up|8|||
143422202|NCT01307800|517089458|FG000|Overall Study|Perceived Lack of Efficacy|24|||
143422203|NCT01307800|517089459|FG001|Overall Study|Perceived Lack of Efficacy|23|||
143422204|NCT01307800|517089460|FG002|Overall Study|Perceived Lack of Efficacy|20|||
143422205|NCT01307800|517089461|FG003|Overall Study|Perceived Lack of Efficacy|33|||
143422206|NCT01307800|517089458|FG000|Overall Study|Protocol Violation|0|||
143422207|NCT01307800|517089459|FG001|Overall Study|Protocol Violation|3|||
143422208|NCT01307800|517089460|FG002|Overall Study|Protocol Violation|4|||
143422209|NCT01307800|517089461|FG003|Overall Study|Protocol Violation|5|||
143422210|NCT01307800|517089458|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
143422211|NCT01307800|517089459|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
143422212|NCT01307800|517089460|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
143422213|NCT01307800|517089461|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
143422214|NCT01307800|517089458|FG000|Overall Study|Sponsor Decision|6|||
143422215|NCT01307800|517089459|FG001|Overall Study|Sponsor Decision|9|||
143422216|NCT01307800|517089460|FG002|Overall Study|Sponsor Decision|12|||
143422217|NCT01307800|517089461|FG003|Overall Study|Sponsor Decision|28|||
143422218|NCT01307800|517089458|FG000|Overall Study|Withdrawal by Subject|10|||
143422219|NCT01307800|517089459|FG001|Overall Study|Withdrawal by Subject|11|||
143422220|NCT01307800|517089460|FG002|Overall Study|Withdrawal by Subject|8|||
143422221|NCT01307800|517089461|FG003|Overall Study|Withdrawal by Subject|15|||
143422222|NCT01307800|517089458|FG000|Overall Study|Participant Moved|0|||
143422223|NCT01307800|517089459|FG001|Overall Study|Participant Moved|2|||
143422224|NCT01307800|517089460|FG002|Overall Study|Participant Moved|1|||
143422225|NCT01307800|517089461|FG003|Overall Study|Participant Moved|3|||
143422226|NCT02892019|517089462|FG000|Overall Study|randomized but not treated|0|||
143422227|NCT02892019|517089463|FG001|Overall Study|randomized but not treated|1|||
143422228|NCT02892019|517089462|FG000|Overall Study|Withdrawal by Subject|0|||
143422229|NCT02892019|517089463|FG001|Overall Study|Withdrawal by Subject|1|||
143422230|NCT02892019|517089462|FG000|Overall Study|Adverse Event|1|||
143422231|NCT02892019|517089463|FG001|Overall Study|Adverse Event|1|||
143422232|NCT01662505|517089464|FG000|Overall Study|Progressive disease|6|||
143422233|NCT01662505|517089465|FG001|Overall Study|Progressive disease|1|||
143422234|NCT01662505|517089466|FG002|Overall Study|Progressive disease|5|||
143422235|NCT01662505|517089464|FG000|Overall Study|Refused cont. medication|0|||
143422236|NCT01662505|517089465|FG001|Overall Study|Refused cont. medication|0|||
143422237|NCT01662505|517089466|FG002|Overall Study|Refused cont. medication|1|||
143422238|NCT01662505|517089464|FG000|Overall Study|Not specified above|1|||
143422239|NCT01662505|517089465|FG001|Overall Study|Not specified above|3|||
143422240|NCT01662505|517089466|FG002|Overall Study|Not specified above|2|||
143422241|NCT01661972|517089467|FG000|Overall Study|Adverse Event|1|||
143422242|NCT01661972|517089468|FG001|Overall Study|Adverse Event|2|||
143422243|NCT01661972|517089467|FG000|Overall Study|Death during Treatment period|1|||
143422244|NCT01661972|517089468|FG001|Overall Study|Death during Treatment period|1|||
143422245|NCT01661972|517089467|FG000|Overall Study|Withdrawal by Subject|0|||
143422246|NCT01661972|517089468|FG001|Overall Study|Withdrawal by Subject|1|||
143422247|NCT01229176|517089469|FG000|Overall Study|Withdrawal by Subject|0|||
143422248|NCT01229176|517089470|FG001|Overall Study|Withdrawal by Subject|0|||
143422249|NCT01229176|517089471|FG002|Overall Study|Withdrawal by Subject|0|||
143422250|NCT01229176|517089472|FG003|Overall Study|Withdrawal by Subject|1|||
143422251|NCT01229176|517089473|FG004|Overall Study|Withdrawal by Subject|1|||
143422252|NCT01229176|517089474|FG005|Overall Study|Withdrawal by Subject|1|||
143422253|NCT01229176|517089475|FG006|Overall Study|Withdrawal by Subject|0|||
143422254|NCT01229176|517089476|FG007|Overall Study|Withdrawal by Subject|1|||
143422255|NCT01229176|517089469|FG000|Overall Study|Lost to Follow-up|0|||
143422256|NCT01229176|517089470|FG001|Overall Study|Lost to Follow-up|3|||
143422257|NCT01229176|517089471|FG002|Overall Study|Lost to Follow-up|0|||
143422258|NCT01229176|517089472|FG003|Overall Study|Lost to Follow-up|0|||
143422259|NCT01229176|517089473|FG004|Overall Study|Lost to Follow-up|1|||
143422260|NCT01229176|517089474|FG005|Overall Study|Lost to Follow-up|1|||
143422261|NCT01229176|517089475|FG006|Overall Study|Lost to Follow-up|0|||
143422262|NCT01229176|517089476|FG007|Overall Study|Lost to Follow-up|2|||
143422263|NCT02138838|517089479|FG000|Overall Study|Study Closure|7|||
143422264|NCT02138838|517089480|FG001|Overall Study|Study Closure|6|||
143422265|NCT02138838|517089479|FG000|Overall Study|Withdrawal by Subject|1|||
143422266|NCT02138838|517089480|FG001|Overall Study|Withdrawal by Subject|5|||
143422267|NCT00882050|517089483|FG000|Overall Study|Physician Decision|1|||
143422268|NCT00882050|517089484|FG001|Overall Study|Physician Decision|0|||
143422269|NCT00882050|517089485|FG002|Overall Study|Physician Decision|0|||
143422270|NCT02010684|517089486|FG000|Overall Study|Lost to Follow-up|8|||
143422271|NCT02010684|517089487|FG001|Overall Study|Lost to Follow-up|18|||
143422272|NCT02010684|517089486|FG000|Overall Study|Withdrawal by Subject|4|||
143422273|NCT02010684|517089487|FG001|Overall Study|Withdrawal by Subject|5|||
143422274|NCT01884571|517089492|FG000|Overall Study|Adverse Event|1|||
143422275|NCT01884571|517089492|FG000|Overall Study|Death|2|||
143422276|NCT01884571|517089492|FG000|Overall Study|Withdrawal by Subject|2|||
143422277|NCT01884571|517089492|FG000|Overall Study|Disease progression|3|||
143422278|NCT02340806|517089493|FG000|Overall Study|Protocol Violation|2|||
143422279|NCT02340806|517089494|FG001|Overall Study|Protocol Violation|0|||
143422280|NCT02340806|517089493|FG000|Overall Study|epidural catheter replaced|2|||
143422281|NCT02340806|517089494|FG001|Overall Study|epidural catheter replaced|1|||
143422282|NCT02340806|517089493|FG000|Overall Study|history of chronic pain medication|1|||
143422283|NCT02340806|517089494|FG001|Overall Study|history of chronic pain medication|0|||
143422284|NCT02340806|517089493|FG000|Overall Study|re-dose < 90 min of CSE|1|||
143422285|NCT02340806|517089494|FG001|Overall Study|re-dose < 90 min of CSE|3|||
143422286|NCT01186809|517089495|FG000|Overall Study|Death|30|||
143422287|NCT04895085|517089496|FG000|Overall Study|Death|1|||
143422288|NCT04895085|517089496|FG000|Overall Study|Withdrawal by Subject|1|||
143422289|NCT04895085|517089496|FG000|Overall Study|No longer eligible: Moved from area|1|||
143422290|NCT04433091|517089498|FG000|Overall Study|Lost to Follow-up|1|||
143422291|NCT04433091|517089499|FG001|Overall Study|Lost to Follow-up|0|||
143422292|NCT04433091|517089498|FG000|Overall Study|Withdrawn .|2|||
143422293|NCT04433091|517089499|FG001|Overall Study|Withdrawn .|4|||
143422294|NCT00946998|517090795|FG000|Overall Study|Exited prior to first outcome assessment|5|||
143422295|NCT00946998|517090796|FG001|Overall Study|Exited prior to first outcome assessment|3|||
143422296|NCT01730118|517090797|FG000|Dose Escalation|Death on study|5|||
143422297|NCT01730118|517090798|FG001|Dose Escalation|Death on study|7|||
143422298|NCT01730118|517090799|FG002|Dose Escalation|Death on study|2|||
143422299|NCT01730118|517090800|FG003|Dose Escalation|Death on study|6|||
143422300|NCT01730118|517090801|FG004|Dose Escalation|Death on study|0|||
143422301|NCT01730118|517090802|FG005|Dose Escalation|Death on study|0|||
143422302|NCT01730118|517090803|FG006|Dose Escalation|Death on study|0|||
143422303|NCT01730118|517090797|FG000|Dose Escalation|Died before treatment|0|||
143422304|NCT01730118|517090798|FG001|Dose Escalation|Died before treatment|0|||
143422305|NCT01730118|517090799|FG002|Dose Escalation|Died before treatment|0|||
143422306|NCT01730118|517090800|FG003|Dose Escalation|Died before treatment|0|||
143422307|NCT01730118|517090801|FG004|Dose Escalation|Died before treatment|0|||
143422308|NCT01730118|517090802|FG005|Dose Escalation|Died before treatment|0|||
143422309|NCT01730118|517090803|FG006|Dose Escalation|Died before treatment|1|||
143422310|NCT01730118|517090797|FG000|Dose Escalation|Chose to start a different treatment|1|||
143422311|NCT01730118|517090798|FG001|Dose Escalation|Chose to start a different treatment|0|||
143422312|NCT01730118|517090799|FG002|Dose Escalation|Chose to start a different treatment|0|||
143422313|NCT01730118|517090800|FG003|Dose Escalation|Chose to start a different treatment|0|||
143422314|NCT01730118|517090801|FG004|Dose Escalation|Chose to start a different treatment|0|||
143422315|NCT01730118|517090802|FG005|Dose Escalation|Chose to start a different treatment|0|||
143422316|NCT01730118|517090803|FG006|Dose Escalation|Chose to start a different treatment|0|||
143422317|NCT01730118|517090797|FG000|Dose Escalation|Withdrawal by Subject|0|||
143422318|NCT01730118|517090798|FG001|Dose Escalation|Withdrawal by Subject|0|||
143422319|NCT01730118|517090799|FG002|Dose Escalation|Withdrawal by Subject|1|||
143422320|NCT01730118|517090800|FG003|Dose Escalation|Withdrawal by Subject|0|||
143422321|NCT01730118|517090801|FG004|Dose Escalation|Withdrawal by Subject|0|||
143422322|NCT01730118|517090802|FG005|Dose Escalation|Withdrawal by Subject|0|||
143422323|NCT01730118|517090803|FG006|Dose Escalation|Withdrawal by Subject|0|||
143422324|NCT01730118|517090797|FG000|Dose Escalation|Disease progression prior to treatment|0|||
143422325|NCT01730118|517090798|FG001|Dose Escalation|Disease progression prior to treatment|0|||
143422326|NCT01730118|517090799|FG002|Dose Escalation|Disease progression prior to treatment|0|||
143422327|NCT01730118|517090800|FG003|Dose Escalation|Disease progression prior to treatment|0|||
143422328|NCT01730118|517090801|FG004|Dose Escalation|Disease progression prior to treatment|0|||
143422329|NCT01730118|517090802|FG005|Dose Escalation|Disease progression prior to treatment|0|||
143422330|NCT01730118|517090803|FG006|Dose Escalation|Disease progression prior to treatment|1|||
143422331|NCT01730118|517090797|FG000|Dose Expansion|Death|0|||
143422332|NCT01730118|517090798|FG001|Dose Expansion|Death|0|||
143422333|NCT01730118|517090799|FG002|Dose Expansion|Death|0|||
143422334|NCT01730118|517090800|FG003|Dose Expansion|Death|0|||
143422335|NCT01730118|517090801|FG004|Dose Expansion|Death|1|||
143422336|NCT01730118|517090802|FG005|Dose Expansion|Death|0|||
143422337|NCT01730118|517090803|FG006|Dose Expansion|Death|0|||
143422338|NCT01730118|517090797|FG000|Dose Expansion|Other medical condition|0|||
143422339|NCT01730118|517090798|FG001|Dose Expansion|Other medical condition|0|||
143422340|NCT01730118|517090799|FG002|Dose Expansion|Other medical condition|0|||
143422341|NCT01730118|517090800|FG003|Dose Expansion|Other medical condition|0|||
143422342|NCT01730118|517090801|FG004|Dose Expansion|Other medical condition|1|||
143422343|NCT01730118|517090802|FG005|Dose Expansion|Other medical condition|0|||
143422344|NCT01730118|517090803|FG006|Dose Expansion|Other medical condition|0|||
143422345|NCT01730118|517090797|FG000|Dose Expansion|Withdrawal by Subject|0|||
143422346|NCT01730118|517090798|FG001|Dose Expansion|Withdrawal by Subject|0|||
143422347|NCT01730118|517090799|FG002|Dose Expansion|Withdrawal by Subject|0|||
143422348|NCT01730118|517090800|FG003|Dose Expansion|Withdrawal by Subject|0|||
143422349|NCT01730118|517090801|FG004|Dose Expansion|Withdrawal by Subject|1|||
143422350|NCT01730118|517090802|FG005|Dose Expansion|Withdrawal by Subject|0|||
143422351|NCT01730118|517090803|FG006|Dose Expansion|Withdrawal by Subject|0|||
143422352|NCT01730118|517090797|FG000|Dose Expansion|Disease progression|0|||
143422353|NCT01730118|517090798|FG001|Dose Expansion|Disease progression|0|||
143422354|NCT01730118|517090799|FG002|Dose Expansion|Disease progression|0|||
143422355|NCT01730118|517090800|FG003|Dose Expansion|Disease progression|0|||
143422356|NCT01730118|517090801|FG004|Dose Expansion|Disease progression|0|||
143422357|NCT01730118|517090802|FG005|Dose Expansion|Disease progression|1|||
143422358|NCT01730118|517090803|FG006|Dose Expansion|Disease progression|0|||
143422359|NCT01730118|517090797|FG000|Dose Expansion|Inability to return|0|||
143422360|NCT01730118|517090798|FG001|Dose Expansion|Inability to return|0|||
143422361|NCT01730118|517090799|FG002|Dose Expansion|Inability to return|0|||
143422362|NCT01730118|517090800|FG003|Dose Expansion|Inability to return|0|||
143422363|NCT01730118|517090801|FG004|Dose Expansion|Inability to return|0|||
143422364|NCT01730118|517090802|FG005|Dose Expansion|Inability to return|1|||
143422365|NCT01730118|517090803|FG006|Dose Expansion|Inability to return|0|||
143422366|NCT01730118|517090797|FG000|Dose Expansion|Physician Decision|0|||
143422367|NCT01730118|517090798|FG001|Dose Expansion|Physician Decision|0|||
143422368|NCT01730118|517090799|FG002|Dose Expansion|Physician Decision|0|||
143422369|NCT01730118|517090800|FG003|Dose Expansion|Physician Decision|0|||
143422370|NCT01730118|517090801|FG004|Dose Expansion|Physician Decision|0|||
143422371|NCT01730118|517090802|FG005|Dose Expansion|Physician Decision|1|||
143422372|NCT01730118|517090803|FG006|Dose Expansion|Physician Decision|0|||
143422373|NCT05356130|517090807|FG000|Overall Study|Withdrawal by Subject|0|||
143422374|NCT05356130|517090808|FG001|Overall Study|Withdrawal by Subject|0|||
143422375|NCT05356130|517090809|FG002|Overall Study|Withdrawal by Subject|3|||
143422376|NCT02880293|517090810|FG000|Overall Study|Inevaluable|5|||
143422377|NCT00668746|517090814|FG000|Overall Study|Lost to Follow-up|2|||
143422378|NCT00668746|517090815|FG001|Overall Study|Lost to Follow-up|1|||
143422379|NCT02109172|517090816|FG000|Overall Study|Withdrawal by Subject|1|||
143422380|NCT02109172|517090817|FG001|Overall Study|Withdrawal by Subject|0|||
143422381|NCT02109172|517090818|FG002|Overall Study|Withdrawal by Subject|0|||
143422382|NCT02109172|517090819|FG003|Overall Study|Withdrawal by Subject|1|||
143422383|NCT02109172|517090820|FG004|Overall Study|Withdrawal by Subject|0|||
143422384|NCT02109172|517090821|FG005|Overall Study|Withdrawal by Subject|0|||
143422385|NCT02109172|517090816|FG000|Overall Study|Adverse Event|0|||
143422386|NCT02109172|517090817|FG001|Overall Study|Adverse Event|0|||
143422387|NCT02109172|517090818|FG002|Overall Study|Adverse Event|1|||
143422388|NCT02109172|517090819|FG003|Overall Study|Adverse Event|0|||
143422389|NCT02109172|517090820|FG004|Overall Study|Adverse Event|0|||
143422390|NCT02109172|517090821|FG005|Overall Study|Adverse Event|1|||
143422391|NCT02109172|517090816|FG000|Overall Study|Death|0|||
143422392|NCT02109172|517090817|FG001|Overall Study|Death|0|||
143422393|NCT02109172|517090818|FG002|Overall Study|Death|0|||
143422394|NCT02109172|517090819|FG003|Overall Study|Death|0|||
143422395|NCT02109172|517090820|FG004|Overall Study|Death|1|||
143422396|NCT02109172|517090821|FG005|Overall Study|Death|0|||
143422397|NCT03409276|517090822|FG000|Overall Study|Withdrawal by Subject|0|||
143422398|NCT03409276|517090823|FG001|Overall Study|Withdrawal by Subject|0|||
143422399|NCT03409276|517090824|FG002|Overall Study|Withdrawal by Subject|0|||
143422400|NCT03409276|517090825|FG003|Overall Study|Withdrawal by Subject|0|||
143422401|NCT03409276|517090826|FG004|Overall Study|Withdrawal by Subject|1|||
143422402|NCT03409276|517090822|FG000|Overall Study|Lost to Follow-up|0|||
143422403|NCT03409276|517090823|FG001|Overall Study|Lost to Follow-up|0|||
143422404|NCT03409276|517090824|FG002|Overall Study|Lost to Follow-up|0|||
143422405|NCT03409276|517090825|FG003|Overall Study|Lost to Follow-up|2|||
143422406|NCT03409276|517090826|FG004|Overall Study|Lost to Follow-up|2|||
143422407|NCT03605745|517090828|FG000|Overall Study|Study was terminated for business reasons|47|||
143422408|NCT05203822|517090837|FG000|Overall Study|Adverse Event|1|||
143422409|NCT05203822|517090837|FG000|Overall Study|Withdrawal by Subject|1|||
143422410|NCT03320941|517090838|FG000|Overall Study|subject/guardian decision|0|||
143422411|NCT03320941|517090839|FG001|Overall Study|subject/guardian decision|0|||
143422412|NCT03320941|517090840|FG002|Overall Study|subject/guardian decision|0|||
143422413|NCT03320941|517090841|FG003|Overall Study|subject/guardian decision|1|||
143422414|NCT03320941|517090842|FG004|Overall Study|subject/guardian decision|0|||
143422415|NCT00584909|517090844|FG000|Overall Study|Adverse Event|4|||
143422416|NCT03345407|517090845|FG000|Overall Study|Withdrawal by Subject|11|||
143422417|NCT03345407|517090846|FG001|Overall Study|Withdrawal by Subject|1|||
143422418|NCT03345407|517090847|FG002|Overall Study|Withdrawal by Subject|5|||
143422419|NCT03345407|517090848|FG003|Overall Study|Withdrawal by Subject|6|||
143422420|NCT03345407|517090849|FG004|Overall Study|Withdrawal by Subject|3|||
143422421|NCT03345407|517090850|FG005|Overall Study|Withdrawal by Subject|6|||
143422422|NCT03345407|517090851|FG006|Overall Study|Withdrawal by Subject|16|||
143422423|NCT03345407|517090845|FG000|Overall Study|Physician Decision|3|||
143422424|NCT03345407|517090846|FG001|Overall Study|Physician Decision|1|||
143422425|NCT03345407|517090847|FG002|Overall Study|Physician Decision|0|||
143422426|NCT03345407|517090848|FG003|Overall Study|Physician Decision|0|||
143422427|NCT03345407|517090849|FG004|Overall Study|Physician Decision|1|||
143422428|NCT03345407|517090850|FG005|Overall Study|Physician Decision|2|||
143422429|NCT03345407|517090851|FG006|Overall Study|Physician Decision|3|||
143422430|NCT03345407|517090845|FG000|Overall Study|Lost to Follow-up|2|||
143422431|NCT03345407|517090846|FG001|Overall Study|Lost to Follow-up|0|||
143422432|NCT03345407|517090847|FG002|Overall Study|Lost to Follow-up|1|||
143422433|NCT03345407|517090848|FG003|Overall Study|Lost to Follow-up|0|||
143422434|NCT03345407|517090849|FG004|Overall Study|Lost to Follow-up|1|||
143422435|NCT03345407|517090850|FG005|Overall Study|Lost to Follow-up|2|||
143422436|NCT03345407|517090851|FG006|Overall Study|Lost to Follow-up|3|||
143422437|NCT03345407|517090845|FG000|Overall Study|Protocol-defined stopping criteria|9|||
143422438|NCT03345407|517090846|FG001|Overall Study|Protocol-defined stopping criteria|0|||
143422439|NCT03345407|517090847|FG002|Overall Study|Protocol-defined stopping criteria|0|||
143422440|NCT03345407|517090848|FG003|Overall Study|Protocol-defined stopping criteria|0|||
143422441|NCT03345407|517090849|FG004|Overall Study|Protocol-defined stopping criteria|2|||
143422442|NCT03345407|517090850|FG005|Overall Study|Protocol-defined stopping criteria|1|||
143422443|NCT03345407|517090851|FG006|Overall Study|Protocol-defined stopping criteria|1|||
143422444|NCT03345407|517090845|FG000|Overall Study|Protocol Violation|2|||
143422445|NCT03345407|517090846|FG001|Overall Study|Protocol Violation|0|||
143422446|NCT03345407|517090847|FG002|Overall Study|Protocol Violation|0|||
143422447|NCT03345407|517090848|FG003|Overall Study|Protocol Violation|0|||
143422448|NCT03345407|517090849|FG004|Overall Study|Protocol Violation|1|||
143422449|NCT03345407|517090850|FG005|Overall Study|Protocol Violation|0|||
143422450|NCT03345407|517090851|FG006|Overall Study|Protocol Violation|3|||
143422451|NCT03345407|517090845|FG000|Overall Study|Lack of Efficacy|1|||
143422452|NCT03345407|517090846|FG001|Overall Study|Lack of Efficacy|1|||
143422453|NCT03345407|517090847|FG002|Overall Study|Lack of Efficacy|1|||
143422454|NCT03345407|517090848|FG003|Overall Study|Lack of Efficacy|1|||
143422455|NCT03345407|517090849|FG004|Overall Study|Lack of Efficacy|1|||
143422456|NCT03345407|517090850|FG005|Overall Study|Lack of Efficacy|0|||
143422457|NCT03345407|517090851|FG006|Overall Study|Lack of Efficacy|3|||
143422458|NCT03345407|517090845|FG000|Overall Study|Adverse Event|4|||
143422459|NCT03345407|517090846|FG001|Overall Study|Adverse Event|0|||
143422460|NCT03345407|517090847|FG002|Overall Study|Adverse Event|5|||
143422461|NCT03345407|517090848|FG003|Overall Study|Adverse Event|4|||
143422462|NCT03345407|517090849|FG004|Overall Study|Adverse Event|6|||
143422463|NCT03345407|517090850|FG005|Overall Study|Adverse Event|5|||
143422464|NCT03345407|517090851|FG006|Overall Study|Adverse Event|16|||
143422465|NCT02092909|517090854|FG000|Overall Study|Adverse Event|0|||
143422466|NCT02092909|517090855|FG001|Overall Study|Adverse Event|0|||
143422467|NCT02092909|517090856|FG002|Overall Study|Adverse Event|4|||
143422468|NCT02092909|517090857|FG003|Overall Study|Adverse Event|2|||
143422469|NCT02092909|517090854|FG000|Overall Study|Lack of Efficacy|0|||
143422470|NCT02092909|517090855|FG001|Overall Study|Lack of Efficacy|2|||
143422471|NCT02092909|517090856|FG002|Overall Study|Lack of Efficacy|1|||
143422472|NCT02092909|517090857|FG003|Overall Study|Lack of Efficacy|0|||
143422473|NCT02092909|517090854|FG000|Overall Study|Withdrawal by Subject|0|||
143422474|NCT02092909|517090855|FG001|Overall Study|Withdrawal by Subject|0|||
143422475|NCT02092909|517090856|FG002|Overall Study|Withdrawal by Subject|2|||
143422476|NCT02092909|517090857|FG003|Overall Study|Withdrawal by Subject|1|||
143422477|NCT02092909|517090854|FG000|Overall Study|Study terminated by Sponsor|0|||
143422478|NCT02092909|517090855|FG001|Overall Study|Study terminated by Sponsor|0|||
143422479|NCT02092909|517090856|FG002|Overall Study|Study terminated by Sponsor|0|||
143422480|NCT02092909|517090857|FG003|Overall Study|Study terminated by Sponsor|2|||
143422481|NCT02092909|517090854|FG000|Overall Study|Miscellaneous|1|||
143422482|NCT02092909|517090855|FG001|Overall Study|Miscellaneous|1|||
143422483|NCT02092909|517090856|FG002|Overall Study|Miscellaneous|2|||
143422484|NCT02092909|517090857|FG003|Overall Study|Miscellaneous|1|||
143422485|NCT02865083|517090860|FG000|Overall Study|Early Termination|3|||
143422486|NCT02865083|517090861|FG001|Overall Study|Early Termination|1|||
143422487|NCT02727998|517090864|FG000|Overall Study|Lost to Follow-up|3|||
143422488|NCT02727998|517090865|FG001|Overall Study|Lost to Follow-up|3|||
143422489|NCT02727998|517090864|FG000|Overall Study|Withdrawal by Subject|0|||
143422490|NCT02727998|517090865|FG001|Overall Study|Withdrawal by Subject|1|||
143422491|NCT02105688|517090866|FG000|Part A: Double-Blind|Adverse Event|1|||
143422492|NCT02105688|517090867|FG001|Part A: Double-Blind|Adverse Event|0|||
143422493|NCT02105688|517090866|FG000|Part A: Double-Blind|Death|0|||
143422494|NCT02105688|517090867|FG001|Part A: Double-Blind|Death|1|||
143422495|NCT02105688|517090866|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
143422496|NCT02105688|517090867|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
143422497|NCT02105688|517090866|FG000|Part A: Double-Blind|Physician Decision|0|||
143422498|NCT02105688|517090867|FG001|Part A: Double-Blind|Physician Decision|1|||
143422499|NCT02105688|517090866|FG000|Part A: Double-Blind|Status Unknown|0|||
143422500|NCT02105688|517090867|FG001|Part A: Double-Blind|Status Unknown|2|||
143422501|NCT02105688|517090866|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
143422502|NCT02105688|517090867|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
143422503|NCT02105688|517090866|FG000|Part B: Observational Follow-up|Death|2|||
143422504|NCT02105688|517090867|FG001|Part B: Observational Follow-up|Death|1|||
143422505|NCT02105688|517090866|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
143422506|NCT02105688|517090867|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
143422507|NCT02105688|517090866|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
143422508|NCT02105688|517090867|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
143422509|NCT02105688|517090866|FG000|Part B: Observational Follow-up|Physician Decision|3|||
143422510|NCT02105688|517090867|FG001|Part B: Observational Follow-up|Physician Decision|1|||
143422511|NCT01358175|517090868|FG000|Overall Study|Death|1|||
143422512|NCT01358175|517090869|FG001|Overall Study|Death|0|||
143422513|NCT01358175|517090870|FG002|Overall Study|Death|1|||
143422514|NCT01358175|517090868|FG000|Overall Study|Withdrawal by Subject|9|||
143422515|NCT01358175|517090869|FG001|Overall Study|Withdrawal by Subject|5|||
143422516|NCT01358175|517090870|FG002|Overall Study|Withdrawal by Subject|10|||
143422517|NCT01358175|517090868|FG000|Overall Study|Technical issues|0|||
143422518|NCT01358175|517090869|FG001|Overall Study|Technical issues|1|||
143422519|NCT01358175|517090870|FG002|Overall Study|Technical issues|0|||
143422520|NCT01358175|517090868|FG000|Overall Study|Pregnancy|0|||
143422521|NCT01358175|517090869|FG001|Overall Study|Pregnancy|1|||
143422522|NCT01358175|517090870|FG002|Overall Study|Pregnancy|0|||
143422523|NCT01358175|517090868|FG000|Overall Study|Physician Decision|1|||
143422524|NCT01358175|517090869|FG001|Overall Study|Physician Decision|0|||
143422525|NCT01358175|517090870|FG002|Overall Study|Physician Decision|0|||
143422526|NCT01358175|517090868|FG000|Overall Study|Non Compliance with Study Treatment|0|||
143422527|NCT01358175|517090869|FG001|Overall Study|Non Compliance with Study Treatment|1|||
143422528|NCT01358175|517090870|FG002|Overall Study|Non Compliance with Study Treatment|1|||
143422529|NCT01358175|517090868|FG000|Overall Study|Lost to Follow-up|1|||
143422530|NCT01358175|517090869|FG001|Overall Study|Lost to Follow-up|1|||
143422531|NCT01358175|517090870|FG002|Overall Study|Lost to Follow-up|3|||
143422532|NCT01358175|517090868|FG000|Overall Study|Lack of Efficacy|3|||
143422533|NCT01358175|517090869|FG001|Overall Study|Lack of Efficacy|8|||
143422534|NCT01358175|517090870|FG002|Overall Study|Lack of Efficacy|6|||
143422535|NCT01358175|517090868|FG000|Overall Study|Adverse Event|6|||
143422536|NCT01358175|517090869|FG001|Overall Study|Adverse Event|11|||
143422537|NCT01358175|517090870|FG002|Overall Study|Adverse Event|11|||
143422538|NCT03651271|517090871|FG000|Overall Study|Death|4|||
143422539|NCT03651271|517090872|FG001|Overall Study|Death|37|||
143422540|NCT03651271|517090873|FG002|Overall Study|Death|0|||
143422541|NCT03651271|517090874|FG003|Overall Study|Death|2|||
143422542|NCT03651271|517090875|FG004|Overall Study|Death|6|||
143422543|NCT03651271|517090871|FG000|Overall Study|Lost to Follow-up|1|||
143422544|NCT03651271|517090872|FG001|Overall Study|Lost to Follow-up|5|||
143422545|NCT03651271|517090873|FG002|Overall Study|Lost to Follow-up|0|||
143422546|NCT03651271|517090874|FG003|Overall Study|Lost to Follow-up|1|||
143422547|NCT03651271|517090875|FG004|Overall Study|Lost to Follow-up|0|||
143422548|NCT03651271|517090871|FG000|Overall Study|Physician Decision|0|||
143422549|NCT03651271|517090872|FG001|Overall Study|Physician Decision|2|||
143422550|NCT03651271|517090873|FG002|Overall Study|Physician Decision|0|||
143422551|NCT03651271|517090874|FG003|Overall Study|Physician Decision|0|||
143422552|NCT03651271|517090875|FG004|Overall Study|Physician Decision|0|||
143422553|NCT03651271|517090871|FG000|Overall Study|Withdrawal by Subject|1|||
143422554|NCT03651271|517090872|FG001|Overall Study|Withdrawal by Subject|15|||
143422555|NCT03651271|517090873|FG002|Overall Study|Withdrawal by Subject|0|||
143422556|NCT03651271|517090874|FG003|Overall Study|Withdrawal by Subject|0|||
143422557|NCT03651271|517090875|FG004|Overall Study|Withdrawal by Subject|1|||
143422558|NCT03651271|517090871|FG000|Overall Study|Patient medically unable to continue|0|||
143422559|NCT03651271|517090872|FG001|Overall Study|Patient medically unable to continue|0|||
143422560|NCT03651271|517090873|FG002|Overall Study|Patient medically unable to continue|0|||
143422561|NCT03651271|517090874|FG003|Overall Study|Patient medically unable to continue|1|||
143422562|NCT03651271|517090875|FG004|Overall Study|Patient medically unable to continue|0|||
143422563|NCT05072795|517090876|FG000|Overall Study|Lost to Follow-up|5|||
143422564|NCT00821093|517090877|FG000|Overall Study|Adverse Event|20|||
143422565|NCT00821093|517090878|FG001|Overall Study|Adverse Event|12|||
143422566|NCT00821093|517090877|FG000|Overall Study|Withdrawal by Subject|9|||
143422567|NCT00821093|517090878|FG001|Overall Study|Withdrawal by Subject|13|||
143422568|NCT00821093|517090877|FG000|Overall Study|Lost to Follow-up|9|||
143422569|NCT00821093|517090878|FG001|Overall Study|Lost to Follow-up|3|||
143422570|NCT00821093|517090877|FG000|Overall Study|Protocol deviation|3|||
143422571|NCT00821093|517090878|FG001|Overall Study|Protocol deviation|6|||
143422572|NCT00821093|517090877|FG000|Overall Study|Abnormal laboratory value(s)|2|||
143422573|NCT00821093|517090878|FG001|Overall Study|Abnormal laboratory value(s)|0|||
143422574|NCT00821093|517090877|FG000|Overall Study|Lack of Efficacy|2|||
143422575|NCT00821093|517090878|FG001|Overall Study|Lack of Efficacy|2|||
143422576|NCT00821093|517090877|FG000|Overall Study|Death|2|||
143422577|NCT00821093|517090878|FG001|Overall Study|Death|1|||
143422578|NCT00821093|517090877|FG000|Overall Study|Abnormal test procedure result(s)|1|||
143422579|NCT00821093|517090878|FG001|Overall Study|Abnormal test procedure result(s)|1|||
143422580|NCT00821093|517090877|FG000|Overall Study|Administrative problems|1|||
143422581|NCT00821093|517090878|FG001|Overall Study|Administrative problems|2|||
143422582|NCT01601821|517090882|FG000|Overall Study|Death|2|||
143422583|NCT01601821|517090883|FG001|Overall Study|Death|5|||
143422584|NCT01601821|517090882|FG000|Overall Study|Protocol Violation|2|||
143422585|NCT01601821|517090883|FG001|Overall Study|Protocol Violation|2|||
143422586|NCT01601821|517090882|FG000|Overall Study|Lost to Follow-up|6|||
143422587|NCT01601821|517090883|FG001|Overall Study|Lost to Follow-up|14|||
143422588|NCT01601821|517090882|FG000|Overall Study|Withdrawal by Subject|1|||
143422589|NCT01601821|517090883|FG001|Overall Study|Withdrawal by Subject|0|||
143422590|NCT01601821|517090882|FG000|Overall Study|Graft Loss|6|||
143422591|NCT01601821|517090883|FG001|Overall Study|Graft Loss|6|||
143422592|NCT01601821|517090882|FG000|Overall Study|Study Events|7|||
143422593|NCT01601821|517090883|FG001|Overall Study|Study Events|1|||
143422594|NCT01601821|517090882|FG000|Overall Study|Other|5|||
143422595|NCT01601821|517090883|FG001|Overall Study|Other|1|||
143422596|NCT01901302|517090887|FG000|Overall Study|Adverse Event|2|||
143422597|NCT01901302|517090888|FG001|Overall Study|Adverse Event|1|||
143422598|NCT01901302|517090887|FG000|Overall Study|Lack of Efficacy|0|||
143422599|NCT01901302|517090888|FG001|Overall Study|Lack of Efficacy|2|||
143422600|NCT01901302|517090887|FG000|Overall Study|Study Terminated by Sponsor|23|||
143422601|NCT01901302|517090888|FG001|Overall Study|Study Terminated by Sponsor|20|||
143422602|NCT01901302|517090887|FG000|Overall Study|Withdrawal by Subject|2|||
143422603|NCT01901302|517090888|FG001|Overall Study|Withdrawal by Subject|0|||
143422604|NCT01124916|517090889|FG000|Overall Study|Lost to Follow-up|3|||
143422605|NCT01124916|517090890|FG001|Overall Study|Lost to Follow-up|2|||
143422606|NCT05104242|517090897|FG000|Overall Study|Withdrawal by Subject|1|||
143422607|NCT05104242|517090898|FG001|Overall Study|Withdrawal by Subject|5|||
143422608|NCT05104242|517090897|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
143422609|NCT05104242|517090898|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
143422610|NCT02469155|517090903|FG000|Overall Study|Adverse Event|6|||
143422611|NCT02469155|517090904|FG001|Overall Study|Adverse Event|0|||
143422612|NCT02469155|517090905|FG002|Overall Study|Adverse Event|1|||
143422613|NCT02469155|517090906|FG003|Overall Study|Adverse Event|10|||
143422614|NCT02469155|517090903|FG000|Overall Study|Lack of Efficacy|13|||
143422615|NCT02469155|517090904|FG001|Overall Study|Lack of Efficacy|10|||
143422616|NCT02469155|517090905|FG002|Overall Study|Lack of Efficacy|10|||
143422617|NCT02469155|517090906|FG003|Overall Study|Lack of Efficacy|8|||
143422618|NCT02469155|517090903|FG000|Overall Study|Death|0|||
143422619|NCT02469155|517090904|FG001|Overall Study|Death|0|||
143422620|NCT02469155|517090905|FG002|Overall Study|Death|0|||
143422621|NCT02469155|517090906|FG003|Overall Study|Death|1|||
143422622|NCT02469155|517090903|FG000|Overall Study|Lost to Follow-up|5|||
143422623|NCT02469155|517090904|FG001|Overall Study|Lost to Follow-up|2|||
143422624|NCT02469155|517090905|FG002|Overall Study|Lost to Follow-up|7|||
143422625|NCT02469155|517090906|FG003|Overall Study|Lost to Follow-up|2|||
143422626|NCT02469155|517090903|FG000|Overall Study|Physician Decision|0|||
143422627|NCT02469155|517090904|FG001|Overall Study|Physician Decision|0|||
143422628|NCT02469155|517090905|FG002|Overall Study|Physician Decision|1|||
143422629|NCT02469155|517090906|FG003|Overall Study|Physician Decision|0|||
143422630|NCT02469155|517090903|FG000|Overall Study|Withdrawal by Subject|34|||
143422631|NCT02469155|517090904|FG001|Overall Study|Withdrawal by Subject|30|||
143422632|NCT02469155|517090905|FG002|Overall Study|Withdrawal by Subject|20|||
143422633|NCT02469155|517090906|FG003|Overall Study|Withdrawal by Subject|37|||
143422634|NCT02469155|517090903|FG000|Overall Study|Other|3|||
143422635|NCT02469155|517090904|FG001|Overall Study|Other|3|||
143422636|NCT02469155|517090905|FG002|Overall Study|Other|2|||
143422637|NCT02469155|517090906|FG003|Overall Study|Other|10|||
143422638|NCT02469155|517090903|FG000|Overall Study|Protocol Violation|0|||
143422639|NCT02469155|517090904|FG001|Overall Study|Protocol Violation|1|||
143422640|NCT02469155|517090905|FG002|Overall Study|Protocol Violation|0|||
143422641|NCT02469155|517090906|FG003|Overall Study|Protocol Violation|1|||
143422642|NCT00901459|517090908|FG000|Overall Study|Withdrawal by Subject|6|||
143422643|NCT02764320|517090909|FG000|Overall Study|Withdrawal by Subject|35|||
143422644|NCT02764320|517090910|FG001|Overall Study|Withdrawal by Subject|38|||
143422645|NCT02764320|517090909|FG000|Overall Study|Protocol Violation|11|||
143422646|NCT02764320|517090910|FG001|Overall Study|Protocol Violation|6|||
143422647|NCT02764320|517090909|FG000|Overall Study|Adverse Event|2|||
143422648|NCT02764320|517090910|FG001|Overall Study|Adverse Event|0|||
143422649|NCT02764320|517090909|FG000|Overall Study|Health Issues unable to continue|2|||
143422650|NCT02764320|517090910|FG001|Overall Study|Health Issues unable to continue|0|||
143422651|NCT02764320|517090909|FG000|Overall Study|Did not meet inclusion criteria|1|||
143422652|NCT02764320|517090910|FG001|Overall Study|Did not meet inclusion criteria|0|||
143422653|NCT02764320|517090909|FG000|Overall Study|Subject moved|0|||
143422654|NCT02764320|517090910|FG001|Overall Study|Subject moved|2|||
143422655|NCT02764320|517090909|FG000|Overall Study|Overused medication unavailable|0|||
143422656|NCT02764320|517090910|FG001|Overall Study|Overused medication unavailable|1|||
143422657|NCT02764320|517090909|FG000|Overall Study|Seeking care outside site|0|||
143422658|NCT02764320|517090910|FG001|Overall Study|Seeking care outside site|1|||
143422659|NCT02764320|517090909|FG000|Overall Study|Technology barriers|0|||
143422660|NCT02764320|517090910|FG001|Overall Study|Technology barriers|1|||
143422661|NCT04765046|517090911|FG000|Overall Study|Screen Failure|2|||
143422662|NCT04765046|517090911|FG000|Overall Study|Withdrawal by Subject|4|||
143422663|NCT04765046|517090911|FG000|Overall Study|Physician Decision|4|||
143422664|NCT04765046|517090911|FG000|Overall Study|Surgery Cancelled|8|||
143422665|NCT04930263|517090919|FG000|Overall Study|Withdrawal by Subject|3|||
143422666|NCT04930263|517090920|FG001|Overall Study|Withdrawal by Subject|5|||
143422667|NCT02555397|517090921|FG000|Overall Study|Withdrawal by Subject|1|||
143422668|NCT02555397|517090922|FG001|Overall Study|Withdrawal by Subject|0|||
143422669|NCT02555397|517090923|FG002|Overall Study|Withdrawal by Subject|0|||
143422670|NCT02555397|517090924|FG003|Overall Study|Withdrawal by Subject|0|||
143422671|NCT02555397|517090925|FG004|Overall Study|Withdrawal by Subject|0|||
143422672|NCT02255474|517090929|FG000|Overall Study|Lost to Follow-up|1|||
143422673|NCT02255474|517090930|FG001|Overall Study|Lost to Follow-up|1|||
143422674|NCT02255474|517090931|FG002|Overall Study|Lost to Follow-up|3|||
143422675|NCT02255474|517090929|FG000|Overall Study|Withdrawal by Subject|1|||
143422676|NCT02255474|517090930|FG001|Overall Study|Withdrawal by Subject|1|||
143422677|NCT02255474|517090931|FG002|Overall Study|Withdrawal by Subject|0|||
143422678|NCT02367794|517090938|FG000|Overall Study|Death|252|||
143422679|NCT02367794|517090939|FG001|Overall Study|Death|245|||
143422680|NCT02367794|517090940|FG002|Overall Study|Death|243|||
143422681|NCT02367794|517090938|FG000|Overall Study|Lost to Follow-up|1|||
143422682|NCT02367794|517090939|FG001|Overall Study|Lost to Follow-up|2|||
143422683|NCT02367794|517090940|FG002|Overall Study|Lost to Follow-up|2|||
143422684|NCT02367794|517090938|FG000|Overall Study|Physician Decision|0|||
143422685|NCT02367794|517090939|FG001|Overall Study|Physician Decision|5|||
143422686|NCT02367794|517090940|FG002|Overall Study|Physician Decision|3|||
143422687|NCT02367794|517090938|FG000|Overall Study|Protocol Violation|1|||
143422688|NCT02367794|517090939|FG001|Overall Study|Protocol Violation|0|||
143422689|NCT02367794|517090940|FG002|Overall Study|Protocol Violation|1|||
143422690|NCT02367794|517090938|FG000|Overall Study|Withdrawal by Subject|25|||
143422691|NCT02367794|517090939|FG001|Overall Study|Withdrawal by Subject|12|||
143422692|NCT02367794|517090940|FG002|Overall Study|Withdrawal by Subject|20|||
143422693|NCT02367794|517090938|FG000|Overall Study|Brain metastasis|1|||
143422694|NCT02367794|517090939|FG001|Overall Study|Brain metastasis|0|||
143422695|NCT02367794|517090940|FG002|Overall Study|Brain metastasis|0|||
143422696|NCT02367794|517090938|FG000|Overall Study|Randomized in error|0|||
143422697|NCT02367794|517090939|FG001|Overall Study|Randomized in error|0|||
143422698|NCT02367794|517090940|FG002|Overall Study|Randomized in error|1|||
143422699|NCT02367794|517090938|FG000|Overall Study|Patient unable to receive carboplatin|0|||
143422700|NCT02367794|517090939|FG001|Overall Study|Patient unable to receive carboplatin|0|||
143422701|NCT02367794|517090940|FG002|Overall Study|Patient unable to receive carboplatin|1|||
143422702|NCT02367794|517090938|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
143422703|NCT02367794|517090939|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
143422704|NCT02367794|517090940|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
143422705|NCT02367794|517090938|FG000|Overall Study|Adverse Event|0|||
143422706|NCT02367794|517090939|FG001|Overall Study|Adverse Event|0|||
143422707|NCT02367794|517090940|FG002|Overall Study|Adverse Event|2|||
143422708|NCT02367794|517090938|FG000|Overall Study|Study Terminated By Sponsor|0|||
143422709|NCT02367794|517090939|FG001|Overall Study|Study Terminated By Sponsor|1|||
143422710|NCT02367794|517090940|FG002|Overall Study|Study Terminated By Sponsor|1|||
143422711|NCT02367794|517090938|FG000|Overall Study|Moved to Roll-Over Study|0|||
143422712|NCT02367794|517090939|FG001|Overall Study|Moved to Roll-Over Study|15|||
143422713|NCT02367794|517090940|FG002|Overall Study|Moved to Roll-Over Study|13|||
143422714|NCT02367794|517090938|FG000|Overall Study|Sponsor Request|60|||
143422715|NCT02367794|517090939|FG001|Overall Study|Sponsor Request|57|||
143422716|NCT02367794|517090940|FG002|Overall Study|Sponsor Request|45|||
143422717|NCT02367794|517090938|FG000|Overall Study|Moved into PTAP Study|0|||
143422718|NCT02367794|517090939|FG001|Overall Study|Moved into PTAP Study|2|||
143422719|NCT02367794|517090940|FG002|Overall Study|Moved into PTAP Study|3|||
143422720|NCT02367794|517090938|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
143422721|NCT02367794|517090939|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
143422722|NCT02367794|517090940|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
143422723|NCT02367794|517090938|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
143422724|NCT02367794|517090939|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
143422725|NCT02367794|517090940|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
143422726|NCT02367794|517090938|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
143422727|NCT02367794|517090939|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
143422728|NCT02367794|517090940|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
143422729|NCT02367794|517090938|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
143422730|NCT02367794|517090939|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
143422731|NCT02367794|517090940|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
143422732|NCT00091572|517090941|FG000|Overall Study|Lost to Follow-up|1|||
143422733|NCT00091572|517090942|FG001|Overall Study|Lost to Follow-up|1|||
143422734|NCT00091572|517090941|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
143422735|NCT00091572|517090942|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
143422736|NCT00091572|517090941|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
143422737|NCT00091572|517090942|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
143422738|NCT00091572|517090941|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
143422739|NCT00091572|517090942|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
143422740|NCT00091572|517090941|FG000|Overall Study|Other Reason|6|||
143422741|NCT00091572|517090942|FG001|Overall Study|Other Reason|13|||
143422742|NCT00091572|517090941|FG000|Overall Study|Ongoing (still on treatment)|8|||
143422743|NCT00091572|517090942|FG001|Overall Study|Ongoing (still on treatment)|12|||
143422744|NCT00091572|517090941|FG000|Overall Study|Major Protocol Violation|2|||
143422745|NCT00091572|517090942|FG001|Overall Study|Major Protocol Violation|0|||
143422746|NCT00091572|517090941|FG000|Overall Study|Toxicity (Related AE)|53|||
143422747|NCT00091572|517090942|FG001|Overall Study|Toxicity (Related AE)|9|||
143422748|NCT01199302|517090944|FG000|Overall Study|Adverse Event|1|||
143422749|NCT01199302|517090945|FG001|Overall Study|Adverse Event|1|||
143422750|NCT01199302|517090946|FG002|Overall Study|Adverse Event|2|||
143422751|NCT01199302|517090947|FG003|Overall Study|Adverse Event|0|||
143422752|NCT01199302|517090944|FG000|Overall Study|Withdrawal by Subject|2|||
143422753|NCT01199302|517090945|FG001|Overall Study|Withdrawal by Subject|2|||
143422754|NCT01199302|517090946|FG002|Overall Study|Withdrawal by Subject|3|||
143422755|NCT01199302|517090947|FG003|Overall Study|Withdrawal by Subject|0|||
143422756|NCT01199302|517090944|FG000|Overall Study|Disease Progression|3|||
143422757|NCT01199302|517090945|FG001|Overall Study|Disease Progression|4|||
143422758|NCT01199302|517090946|FG002|Overall Study|Disease Progression|4|||
143422759|NCT01199302|517090947|FG003|Overall Study|Disease Progression|2|||
143422760|NCT01199302|517090944|FG000|Overall Study|Study Termination|13|||
143422761|NCT01199302|517090945|FG001|Overall Study|Study Termination|8|||
143422762|NCT01199302|517090946|FG002|Overall Study|Study Termination|11|||
143422763|NCT01199302|517090947|FG003|Overall Study|Study Termination|9|||
143422764|NCT01199302|517090944|FG000|Overall Study|Lost to Follow-up|0|||
143422765|NCT01199302|517090945|FG001|Overall Study|Lost to Follow-up|1|||
143422766|NCT01199302|517090946|FG002|Overall Study|Lost to Follow-up|0|||
143422767|NCT01199302|517090947|FG003|Overall Study|Lost to Follow-up|0|||
143422768|NCT01199302|517090944|FG000|Overall Study|Other|1|||
143422769|NCT01199302|517090945|FG001|Overall Study|Other|0|||
143422770|NCT01199302|517090946|FG002|Overall Study|Other|0|||
143422771|NCT01199302|517090947|FG003|Overall Study|Other|0|||
143422772|NCT01159600|517090949|FG000|Overall Study|Not treated|0|||
143422773|NCT01159600|517090950|FG001|Overall Study|Not treated|0|||
143422774|NCT01159600|517090951|FG002|Overall Study|Not treated|1|||
143422775|NCT01159600|517090952|FG003|Overall Study|Not treated|0|||
143422776|NCT01159600|517090953|FG004|Overall Study|Not treated|0|||
143422777|NCT01159600|517090954|FG005|Overall Study|Not treated|1|||
143422778|NCT01159600|517090955|FG006|Overall Study|Not treated|2|||
143422779|NCT01159600|517090956|FG007|Overall Study|Not treated|2|||
143422780|NCT01159600|517090949|FG000|Overall Study|Adverse Event|7|||
143422781|NCT01159600|517090950|FG001|Overall Study|Adverse Event|2|||
143422782|NCT01159600|517090951|FG002|Overall Study|Adverse Event|5|||
143422783|NCT01159600|517090952|FG003|Overall Study|Adverse Event|1|||
143422784|NCT01159600|517090953|FG004|Overall Study|Adverse Event|8|||
143422785|NCT01159600|517090954|FG005|Overall Study|Adverse Event|6|||
143422786|NCT01159600|517090955|FG006|Overall Study|Adverse Event|7|||
143422787|NCT01159600|517090956|FG007|Overall Study|Adverse Event|5|||
143422788|NCT01159600|517090949|FG000|Overall Study|Lack of Efficacy|0|||
143422789|NCT01159600|517090950|FG001|Overall Study|Lack of Efficacy|0|||
143422790|NCT01159600|517090951|FG002|Overall Study|Lack of Efficacy|0|||
143422791|NCT01159600|517090952|FG003|Overall Study|Lack of Efficacy|0|||
143422792|NCT01159600|517090953|FG004|Overall Study|Lack of Efficacy|2|||
143422793|NCT01159600|517090954|FG005|Overall Study|Lack of Efficacy|0|||
143422794|NCT01159600|517090955|FG006|Overall Study|Lack of Efficacy|0|||
143422795|NCT01159600|517090956|FG007|Overall Study|Lack of Efficacy|1|||
143422796|NCT01159600|517090949|FG000|Overall Study|Non compliant with protocol|2|||
143422797|NCT01159600|517090950|FG001|Overall Study|Non compliant with protocol|1|||
143422798|NCT01159600|517090951|FG002|Overall Study|Non compliant with protocol|0|||
143422799|NCT01159600|517090952|FG003|Overall Study|Non compliant with protocol|0|||
143422800|NCT01159600|517090953|FG004|Overall Study|Non compliant with protocol|2|||
143422801|NCT01159600|517090954|FG005|Overall Study|Non compliant with protocol|0|||
143422802|NCT01159600|517090955|FG006|Overall Study|Non compliant with protocol|2|||
143422803|NCT01159600|517090956|FG007|Overall Study|Non compliant with protocol|0|||
143422804|NCT01159600|517090949|FG000|Overall Study|Lost to Follow-up|2|||
143422805|NCT01159600|517090950|FG001|Overall Study|Lost to Follow-up|3|||
143422806|NCT01159600|517090951|FG002|Overall Study|Lost to Follow-up|4|||
143422807|NCT01159600|517090952|FG003|Overall Study|Lost to Follow-up|3|||
143422808|NCT01159600|517090953|FG004|Overall Study|Lost to Follow-up|3|||
143422809|NCT01159600|517090954|FG005|Overall Study|Lost to Follow-up|0|||
143422810|NCT01159600|517090955|FG006|Overall Study|Lost to Follow-up|3|||
143422811|NCT01159600|517090956|FG007|Overall Study|Lost to Follow-up|2|||
143422812|NCT01159600|517090949|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
143422813|NCT01159600|517090950|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
143422814|NCT01159600|517090951|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
143422815|NCT01159600|517090952|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
143422816|NCT01159600|517090953|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
143422817|NCT01159600|517090954|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
143422818|NCT01159600|517090955|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
143422819|NCT01159600|517090956|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
143422820|NCT01159600|517090949|FG000|Overall Study|Other reason not defined above|3|||
143422821|NCT01159600|517090950|FG001|Overall Study|Other reason not defined above|0|||
143422822|NCT01159600|517090951|FG002|Overall Study|Other reason not defined above|4|||
143422823|NCT01159600|517090952|FG003|Overall Study|Other reason not defined above|2|||
143422824|NCT01159600|517090953|FG004|Overall Study|Other reason not defined above|5|||
143422825|NCT01159600|517090954|FG005|Overall Study|Other reason not defined above|7|||
143422826|NCT01159600|517090955|FG006|Overall Study|Other reason not defined above|3|||
143422827|NCT01159600|517090956|FG007|Overall Study|Other reason not defined above|3|||
143422828|NCT03360071|517091917|FG000|Overall Study|Lost to Follow-up|1|||
143422829|NCT03360071|517091918|FG001|Overall Study|Lost to Follow-up|0|||
143422830|NCT01193283|517091919|FG000|Overall Study|Death|1|||
143422831|NCT01183013|517091921|FG000|Overall Study|Adverse Event|6|||
143422832|NCT01183013|517091922|FG001|Overall Study|Adverse Event|8|||
143422833|NCT01183013|517091923|FG002|Overall Study|Adverse Event|5|||
143422834|NCT01183013|517091924|FG003|Overall Study|Adverse Event|5|||
143422835|NCT01183013|517091925|FG004|Overall Study|Adverse Event|10|||
143422836|NCT01183013|517091926|FG005|Overall Study|Adverse Event|10|||
143422837|NCT01183013|517091927|FG006|Overall Study|Adverse Event|6|||
143422838|NCT01183013|517091921|FG000|Overall Study|Lack of Efficacy|3|||
143422839|NCT01183013|517091922|FG001|Overall Study|Lack of Efficacy|2|||
143422840|NCT01183013|517091923|FG002|Overall Study|Lack of Efficacy|1|||
143422841|NCT01183013|517091924|FG003|Overall Study|Lack of Efficacy|2|||
143422842|NCT01183013|517091925|FG004|Overall Study|Lack of Efficacy|1|||
143422843|NCT01183013|517091926|FG005|Overall Study|Lack of Efficacy|2|||
143422844|NCT01183013|517091927|FG006|Overall Study|Lack of Efficacy|0|||
143422845|NCT01183013|517091921|FG000|Overall Study|Protocol Violation|5|||
143422846|NCT01183013|517091922|FG001|Overall Study|Protocol Violation|2|||
143422847|NCT01183013|517091923|FG002|Overall Study|Protocol Violation|4|||
143422848|NCT01183013|517091924|FG003|Overall Study|Protocol Violation|0|||
143422849|NCT01183013|517091925|FG004|Overall Study|Protocol Violation|4|||
143422850|NCT01183013|517091926|FG005|Overall Study|Protocol Violation|3|||
143422851|NCT01183013|517091927|FG006|Overall Study|Protocol Violation|3|||
143422852|NCT01183013|517091921|FG000|Overall Study|Lost to Follow-up|7|||
143422853|NCT01183013|517091922|FG001|Overall Study|Lost to Follow-up|3|||
143422854|NCT01183013|517091923|FG002|Overall Study|Lost to Follow-up|4|||
143422855|NCT01183013|517091924|FG003|Overall Study|Lost to Follow-up|3|||
143422856|NCT01183013|517091925|FG004|Overall Study|Lost to Follow-up|2|||
143422857|NCT01183013|517091926|FG005|Overall Study|Lost to Follow-up|6|||
143422858|NCT01183013|517091927|FG006|Overall Study|Lost to Follow-up|5|||
143422859|NCT01183013|517091921|FG000|Overall Study|Withdrawal by Subject|9|||
143422860|NCT01183013|517091922|FG001|Overall Study|Withdrawal by Subject|13|||
143422861|NCT01183013|517091923|FG002|Overall Study|Withdrawal by Subject|10|||
143422862|NCT01183013|517091924|FG003|Overall Study|Withdrawal by Subject|8|||
143422863|NCT01183013|517091925|FG004|Overall Study|Withdrawal by Subject|7|||
143422864|NCT01183013|517091926|FG005|Overall Study|Withdrawal by Subject|9|||
143422865|NCT01183013|517091927|FG006|Overall Study|Withdrawal by Subject|10|||
143422866|NCT01183013|517091921|FG000|Overall Study|Reasons other than stated above|15|||
143422867|NCT01183013|517091922|FG001|Overall Study|Reasons other than stated above|11|||
143422868|NCT01183013|517091923|FG002|Overall Study|Reasons other than stated above|17|||
143422869|NCT01183013|517091924|FG003|Overall Study|Reasons other than stated above|12|||
143422870|NCT01183013|517091925|FG004|Overall Study|Reasons other than stated above|12|||
143422871|NCT01183013|517091926|FG005|Overall Study|Reasons other than stated above|15|||
143422872|NCT01183013|517091927|FG006|Overall Study|Reasons other than stated above|13|||
143422873|NCT03436797|517091928|FG000|Main Study|Withdrawal by Subject|2|||
143422874|NCT03436797|517091928|FG000|Main Study|Adverse Event|4|||
143422875|NCT03436797|517091928|FG000|Main Study|Lost to Follow-up|1|||
143422876|NCT03436797|517091928|FG000|Main Study|Death|1|||
143422877|NCT03436797|517091928|FG000|Main Study|Non-Specific|2|||
143422878|NCT03436797|517091928|FG000|Extended Dosing|Patient decision|1|||
143422879|NCT01951105|517091929|FG000|Overall Study|Adverse Event|0|||
143422880|NCT01951105|517091930|FG001|Overall Study|Adverse Event|5|||
143422881|NCT01951105|517091931|FG002|Overall Study|Adverse Event|0|||
143422882|NCT01951105|517091929|FG000|Overall Study|Lost to Follow-up|0|||
143422883|NCT01951105|517091930|FG001|Overall Study|Lost to Follow-up|1|||
143422884|NCT01951105|517091931|FG002|Overall Study|Lost to Follow-up|0|||
143422885|NCT01951105|517091929|FG000|Overall Study|Protocol Violation|1|||
143422886|NCT01951105|517091930|FG001|Overall Study|Protocol Violation|1|||
143422887|NCT01951105|517091931|FG002|Overall Study|Protocol Violation|1|||
143422888|NCT01951105|517091929|FG000|Overall Study|Withdrawal by Subject|0|||
143422889|NCT01951105|517091930|FG001|Overall Study|Withdrawal by Subject|3|||
143422890|NCT01951105|517091931|FG002|Overall Study|Withdrawal by Subject|1|||
143422891|NCT04175392|517091932|FG000|Overall Study|Withdrawal by Subject|3|||
143422892|NCT04175392|517091933|FG001|Overall Study|Withdrawal by Subject|2|||
143422893|NCT02812706|517091934|FG000|Phase 1|Adverse Event|0|||
143422894|NCT02812706|517091935|FG001|Phase 1|Adverse Event|2|||
143422895|NCT02812706|517091936|FG002|Phase 1|Adverse Event|0|||
143422896|NCT02812706|517091934|FG000|Phase 1|Progressive disease|3|||
143422897|NCT02812706|517091935|FG001|Phase 1|Progressive disease|3|||
143422898|NCT02812706|517091936|FG002|Phase 1|Progressive disease|0|||
143422899|NCT02812706|517091934|FG000|Phase 2|Adverse Event|0|||
143422900|NCT02812706|517091935|FG001|Phase 2|Adverse Event|0|||
143422901|NCT02812706|517091936|FG002|Phase 2|Adverse Event|2|||
143422902|NCT02812706|517091934|FG000|Phase 2|Progressive disease|0|||
143422903|NCT02812706|517091935|FG001|Phase 2|Progressive disease|0|||
143422904|NCT02812706|517091936|FG002|Phase 2|Progressive disease|22|||
143422905|NCT02812706|517091934|FG000|Phase 2|Other-Unspecified|0|||
143422906|NCT02812706|517091935|FG001|Phase 2|Other-Unspecified|0|||
143422907|NCT02812706|517091936|FG002|Phase 2|Other-Unspecified|4|||
143422908|NCT00910871|517091942|FG000|Overall Study|Adverse Event|5|||
143422909|NCT00910871|517091942|FG000|Overall Study|Death|12|||
143422910|NCT00910871|517091942|FG000|Overall Study|Lost to Follow-up|8|||
143422911|NCT00910871|517091942|FG000|Overall Study|Protocol Violation|11|||
143422912|NCT00910871|517091942|FG000|Overall Study|Withdrawal by Subject|12|||
143422913|NCT00910871|517091942|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
143422914|NCT00910871|517091942|FG000|Overall Study|Undefined|1|||
143422915|NCT01989156|517091943|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
143422916|NCT01989156|517091944|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
143422917|NCT01989156|517091945|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
143422918|NCT01989156|517091943|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
143422919|NCT01989156|517091944|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
143422920|NCT01989156|517091945|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
143422921|NCT01989156|517091943|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
143422922|NCT01989156|517091944|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
143422923|NCT01989156|517091945|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
143422924|NCT01989156|517091943|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
143422925|NCT01989156|517091944|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
143422926|NCT01989156|517091945|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
143422927|NCT01989156|517091943|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
143422928|NCT01989156|517091944|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
143422929|NCT01989156|517091945|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
143422930|NCT01989156|517091943|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
143422931|NCT01989156|517091944|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
143422932|NCT01989156|517091945|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
143422933|NCT01989156|517091943|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
143422934|NCT01989156|517091944|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
143422935|NCT01989156|517091945|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
143422936|NCT01989156|517091943|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
143422937|NCT01989156|517091944|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
143422938|NCT01989156|517091945|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
143422939|NCT00850993|517091946|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
143422940|NCT00850993|517091947|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
143422941|NCT00850993|517091948|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
143422942|NCT00850993|517091949|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
143422943|NCT03839355|517091950|FG000|Overall Study|Withdrawal by Subject|1|||
143422944|NCT03839355|517091951|FG001|Overall Study|Withdrawal by Subject|0|||
143422945|NCT01721109|517091952|FG000|Overall Study|Lack of Efficacy|1|||
143422946|NCT01721109|517091952|FG000|Overall Study|Non- Compliance with Study Drug|3|||
143422947|NCT01721109|517091952|FG000|Overall Study|Withdrew Consent|1|||
143422948|NCT01721109|517091952|FG000|Overall Study|Lost to Follow-up|2|||
143422949|NCT04501614|517091958|FG000|Overall Study|Study Terminated by Sponsor|6|||
143422950|NCT04501614|517091959|FG001|Overall Study|Study Terminated by Sponsor|3|||
143422951|NCT04501614|517091958|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
143422952|NCT04501614|517091959|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
143422953|NCT04529941|517091960|FG000|Week 12/Month 3 Follow Up|Withdrawal by Subject|1|||
143422954|NCT04529941|517091961|FG001|Week 12/Month 3 Follow Up|Withdrawal by Subject|0|||
143422955|NCT01240785|517091962|FG000|Overall Study|Lost to Follow-up|1|||
143422956|NCT01240785|517091963|FG001|Overall Study|Lost to Follow-up|0|||
143422957|NCT01240785|517091962|FG000|Overall Study|Protocol Violation|0|||
143422958|NCT01240785|517091963|FG001|Overall Study|Protocol Violation|3|||
143422959|NCT01755598|517091965|FG000|Overall Study|Other|109|||
143422960|NCT01755598|517091966|FG001|Overall Study|Other|109|||
143422961|NCT01755598|517091965|FG000|Overall Study|Lost to Follow-up|32|||
143422962|NCT01755598|517091966|FG001|Overall Study|Lost to Follow-up|43|||
143422963|NCT01755598|517091965|FG000|Overall Study|Migrated/moved from study area|76|||
143422964|NCT01755598|517091966|FG001|Overall Study|Migrated/moved from study area|65|||
143422965|NCT01755598|517091965|FG000|Overall Study|Withdrawal by Subject|22|||
143422966|NCT01755598|517091966|FG001|Overall Study|Withdrawal by Subject|31|||
143422967|NCT01755598|517091965|FG000|Overall Study|Protocol Violation|7|||
143422968|NCT01755598|517091966|FG001|Overall Study|Protocol Violation|7|||
143422969|NCT01755598|517091965|FG000|Overall Study|Adverse Event|19|||
143422970|NCT01755598|517091966|FG001|Overall Study|Adverse Event|28|||
143422971|NCT02260154|517091967|FG000|Overall Study|Screening failure|2|||
143422972|NCT03905512|517091968|FG000|Overall Study|Withdrawal by Subject|9|||
143422973|NCT03905512|517091969|FG001|Overall Study|Withdrawal by Subject|8|||
143422974|NCT03905512|517091968|FG000|Overall Study|Adverse Event|1|||
143422975|NCT03905512|517091969|FG001|Overall Study|Adverse Event|2|||
143422976|NCT03905512|517091968|FG000|Overall Study|Lost to Follow-up|4|||
143422977|NCT03905512|517091969|FG001|Overall Study|Lost to Follow-up|3|||
143422978|NCT03905512|517091968|FG000|Overall Study|Other than Specified|7|||
143422979|NCT03905512|517091969|FG001|Overall Study|Other than Specified|4|||
143422980|NCT03547167|517091970|FG000|Overall Study|Withdrawal by Subject|34|||
143422981|NCT03547167|517091971|FG001|Overall Study|Withdrawal by Subject|12|||
143422982|NCT03547167|517091970|FG000|Overall Study|Screen Failure|0|||
143422983|NCT03547167|517091971|FG001|Overall Study|Screen Failure|1|||
143422984|NCT03547167|517091970|FG000|Overall Study|Lost to Follow-up|59|||
143422985|NCT03547167|517091971|FG001|Overall Study|Lost to Follow-up|15|||
143422986|NCT03547167|517091970|FG000|Overall Study|Death|4|||
143422987|NCT03547167|517091971|FG001|Overall Study|Death|2|||
143422988|NCT00070317|517091972|FG000|Overall Study|Inevaluable (Never Treated)|1|||
143422989|NCT00070317|517091972|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
143422990|NCT00070317|517091972|FG000|Overall Study|Ineligible required test not done|1|||
143422991|NCT00070317|517091972|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
143422992|NCT00070317|517091972|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
143422993|NCT00645411|517091973|FG000|Overall Study|Adverse Event|0|||
143422994|NCT00645411|517091974|FG001|Overall Study|Adverse Event|0|||
143422995|NCT00645411|517091975|FG002|Overall Study|Adverse Event|0|||
143422996|NCT00645411|517091976|FG003|Overall Study|Adverse Event|2|||
143422997|NCT00645411|517091973|FG000|Overall Study|Withdrawal by Subject|2|||
143422998|NCT00645411|517091974|FG001|Overall Study|Withdrawal by Subject|1|||
143422999|NCT00645411|517091975|FG002|Overall Study|Withdrawal by Subject|19|||
143423000|NCT00645411|517091976|FG003|Overall Study|Withdrawal by Subject|21|||
143423001|NCT00645411|517091973|FG000|Overall Study|Lost to Follow-up|10|||
143423002|NCT00645411|517091974|FG001|Overall Study|Lost to Follow-up|5|||
143423003|NCT00645411|517091975|FG002|Overall Study|Lost to Follow-up|124|||
143423004|NCT00645411|517091976|FG003|Overall Study|Lost to Follow-up|75|||
143423005|NCT00645411|517091973|FG000|Overall Study|Protocol Violation|1|||
143423006|NCT00645411|517091974|FG001|Overall Study|Protocol Violation|0|||
143423007|NCT00645411|517091975|FG002|Overall Study|Protocol Violation|1|||
143423008|NCT00645411|517091976|FG003|Overall Study|Protocol Violation|0|||
143423009|NCT00645411|517091973|FG000|Overall Study|Inappropriate enrollment|0|||
143423010|NCT00645411|517091974|FG001|Overall Study|Inappropriate enrollment|0|||
143423011|NCT00645411|517091975|FG002|Overall Study|Inappropriate enrollment|4|||
143423012|NCT00645411|517091976|FG003|Overall Study|Inappropriate enrollment|1|||
143423013|NCT00645411|517091973|FG000|Overall Study|Unable to classify|0|||
143423014|NCT00645411|517091974|FG001|Overall Study|Unable to classify|0|||
143423015|NCT00645411|517091975|FG002|Overall Study|Unable to classify|3|||
143423016|NCT00645411|517091976|FG003|Overall Study|Unable to classify|4|||
143423017|NCT02674399|517091977|FG000|Overall Study|Lost to Follow-up|2|||
143423018|NCT02674399|517091978|FG001|Overall Study|Lost to Follow-up|0|||
143423019|NCT00508144|517091979|FG000|Overall Study|Not eligible|6|||
143423020|NCT00508144|517091979|FG000|Overall Study|Death|5|||
143423021|NCT01084772|517091981|FG000|Baseline|Withdrawal by Subject|7|||
143423022|NCT01084772|517091982|FG001|Baseline|Withdrawal by Subject|6|||
143423023|NCT01084772|517091981|FG000|3 Months|Death|1|||
143423024|NCT01084772|517091982|FG001|3 Months|Death|0|||
143423025|NCT01084772|517091981|FG000|3 Months|Study Termination|2|||
143423026|NCT01084772|517091982|FG001|3 Months|Study Termination|2|||
143423027|NCT01084772|517091981|FG000|1 Year|Withdrawal by Subject|0|||
143423028|NCT01084772|517091982|FG001|1 Year|Withdrawal by Subject|1|||
143423029|NCT01084772|517091981|FG000|1 Year|Lost to Follow-up|3|||
143423030|NCT01084772|517091982|FG001|1 Year|Lost to Follow-up|0|||
143423031|NCT01084772|517091981|FG000|1 Year|Study Termination|0|||
143423032|NCT01084772|517091982|FG001|1 Year|Study Termination|7|||
143423033|NCT01084772|517091981|FG000|2 Years|Withdrawal by Subject|1|||
143423034|NCT01084772|517091982|FG001|2 Years|Withdrawal by Subject|0|||
143423035|NCT01084772|517091981|FG000|2 Years|Lost to Follow-up|5|||
143423036|NCT01084772|517091982|FG001|2 Years|Lost to Follow-up|2|||
143423037|NCT01084772|517091981|FG000|2 Years|Study Termination|3|||
143423038|NCT01084772|517091982|FG001|2 Years|Study Termination|2|||
143423039|NCT00525915|517091983|FG000|Overall Study|Non-Compliance|0|||
143423040|NCT00525915|517091984|FG001|Overall Study|Non-Compliance|1|||
143423041|NCT00525915|517091983|FG000|Overall Study|Disease Progression|5|||
143423042|NCT00525915|517091984|FG001|Overall Study|Disease Progression|6|||
143423043|NCT00525915|517091983|FG000|Overall Study|Withdrawal by Subject|1|||
143423044|NCT00525915|517091984|FG001|Overall Study|Withdrawal by Subject|0|||
143423045|NCT00525915|517091983|FG000|Overall Study|Refused Surgery|1|||
143423046|NCT00525915|517091984|FG001|Overall Study|Refused Surgery|2|||
143423047|NCT00525915|517091983|FG000|Overall Study|Unrelated illness|1|||
143423048|NCT00525915|517091984|FG001|Overall Study|Unrelated illness|0|||
143423049|NCT02332889|517091995|FG000|Overall Study|Physician Decision|1|||
143423050|NCT04097535|517091998|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
143423051|NCT03070301|517091999|FG000|Overall Study|Progression of disease|16|||
143423052|NCT03070301|517091999|FG000|Overall Study|Physician Decision|3|||
143423053|NCT03070301|517091999|FG000|Overall Study|Withdrawal by Subject|1|||
143423054|NCT04520256|517092001|FG000|Overall Study|Lost to Follow-up|6|||
143423055|NCT04520256|517092002|FG001|Overall Study|Lost to Follow-up|4|||
143423056|NCT04520256|517092003|FG002|Overall Study|Lost to Follow-up|2|||
143423057|NCT04520256|517092004|FG003|Overall Study|Lost to Follow-up|3|||
143423058|NCT04520256|517092005|FG004|Overall Study|Lost to Follow-up|6|||
143423059|NCT04520256|517092006|FG005|Overall Study|Lost to Follow-up|6|||
143423060|NCT04520256|517092007|FG006|Overall Study|Lost to Follow-up|4|||
143423061|NCT04520256|517092008|FG007|Overall Study|Lost to Follow-up|6|||
143423062|NCT04520256|517092009|FG008|Overall Study|Lost to Follow-up|1|||
143423063|NCT04520256|517092010|FG009|Overall Study|Lost to Follow-up|3|||
143423064|NCT04520256|517092011|FG010|Overall Study|Lost to Follow-up|3|||
143423065|NCT04520256|517092012|FG011|Overall Study|Lost to Follow-up|2|||
143423066|NCT04520256|517092013|FG012|Overall Study|Lost to Follow-up|5|||
143423067|NCT04520256|517092014|FG013|Overall Study|Lost to Follow-up|3|||
143423068|NCT04520256|517092015|FG014|Overall Study|Lost to Follow-up|3|||
143423069|NCT04520256|517092016|FG015|Overall Study|Lost to Follow-up|6|||
143423070|NCT04520256|517092017|FG016|Overall Study|Lost to Follow-up|6|||
143423071|NCT04520256|517092018|FG017|Overall Study|Lost to Follow-up|4|||
143423072|NCT04520256|517092019|FG018|Overall Study|Lost to Follow-up|3|||
143423073|NCT04520256|517092020|FG019|Overall Study|Lost to Follow-up|3|||
143423074|NCT04520256|517092021|FG020|Overall Study|Lost to Follow-up|7|||
143423075|NCT04520256|517092022|FG021|Overall Study|Lost to Follow-up|3|||
143423076|NCT04520256|517092023|FG022|Overall Study|Lost to Follow-up|3|||
143423077|NCT04520256|517092024|FG023|Overall Study|Lost to Follow-up|8|||
143423078|NCT04520256|517092025|FG024|Overall Study|Lost to Follow-up|5|||
143423079|NCT04520256|517092026|FG025|Overall Study|Lost to Follow-up|4|||
143423080|NCT04520256|517092027|FG026|Overall Study|Lost to Follow-up|3|||
143423081|NCT04520256|517092028|FG027|Overall Study|Lost to Follow-up|4|||
143423082|NCT04520256|517092029|FG028|Overall Study|Lost to Follow-up|3|||
143423083|NCT04520256|517092030|FG029|Overall Study|Lost to Follow-up|4|||
143423084|NCT04520256|517092031|FG030|Overall Study|Lost to Follow-up|4|||
143423085|NCT04520256|517092032|FG031|Overall Study|Lost to Follow-up|4|||
143423086|NCT03556891|517092033|FG000|Initial Pivotal Study|Adverse Event|4|||
143423087|NCT03556891|517092033|FG000|Initial Pivotal Study|MRI Need|3|||
143423088|NCT03556891|517092033|FG000|Initial Pivotal Study|Device Failure|1|||
143423089|NCT03556891|517092033|FG000|Initial Pivotal Study|Death|1|||
143423090|NCT03556891|517092033|FG000|Initial Pivotal Study|Lost to Follow-up|1|||
143423091|NCT03556891|517092033|FG000|Initial Pivotal Study|Missing at random|1|||
143423092|NCT03556891|517092033|FG000|Initial Pivotal Study|Missing due to COVID|1|||
143423093|NCT03556891|517092033|FG000|Initial Pivotal Study|Protocol Violation|1|||
143423094|NCT00489489|517092854|FG000|Overall Study|Not treated due to protocol violation|0|||
143423095|NCT00489489|517092855|FG001|Overall Study|Not treated due to protocol violation|1|||
143423096|NCT00489489|517092856|FG002|Overall Study|Not treated due to protocol violation|1|||
143423097|NCT00489489|517092854|FG000|Overall Study|Adverse Event|1|||
143423098|NCT00489489|517092855|FG001|Overall Study|Adverse Event|1|||
143423099|NCT00489489|517092856|FG002|Overall Study|Adverse Event|1|||
143423100|NCT00489489|517092854|FG000|Overall Study|Protocol Violation|1|||
143423101|NCT00489489|517092855|FG001|Overall Study|Protocol Violation|0|||
143423102|NCT00489489|517092856|FG002|Overall Study|Protocol Violation|1|||
143423103|NCT00489489|517092854|FG000|Overall Study|Progressive disease|0|||
143423104|NCT00489489|517092855|FG001|Overall Study|Progressive disease|1|||
143423105|NCT00489489|517092856|FG002|Overall Study|Progressive disease|0|||
143423106|NCT00489489|517092854|FG000|Overall Study|Participant did not wish to continue|1|||
143423107|NCT00489489|517092855|FG001|Overall Study|Participant did not wish to continue|1|||
143423108|NCT00489489|517092856|FG002|Overall Study|Participant did not wish to continue|0|||
143423109|NCT00489489|517092854|FG000|Overall Study|Other than above|0|||
143423110|NCT00489489|517092855|FG001|Overall Study|Other than above|1|||
143423111|NCT00489489|517092856|FG002|Overall Study|Other than above|0|||
143423112|NCT04851587|517092862|FG000|Overall Study|Lost to Follow-up|18|||
143423113|NCT04454125|517092867|FG000|Overall Study|Lost to Follow-up|0|||
143423114|NCT04454125|517092868|FG001|Overall Study|Lost to Follow-up|1|||
143423115|NCT03614923|517092871|FG000|Overall Study|Withdrawal by Subject|2|||
143423116|NCT03614923|517092872|FG001|Overall Study|Withdrawal by Subject|1|||
143423117|NCT03614923|517092873|FG002|Overall Study|Withdrawal by Subject|1|||
143423118|NCT03614923|517092871|FG000|Overall Study|Adverse Event|0|||
143423119|NCT03614923|517092872|FG001|Overall Study|Adverse Event|2|||
143423120|NCT03614923|517092873|FG002|Overall Study|Adverse Event|1|||
143423121|NCT03614923|517092871|FG000|Overall Study|Lost to Follow-up|1|||
143423122|NCT03614923|517092872|FG001|Overall Study|Lost to Follow-up|0|||
143423123|NCT03614923|517092873|FG002|Overall Study|Lost to Follow-up|1|||
143423124|NCT03614923|517092871|FG000|Overall Study|Lack of Efficacy|2|||
143423125|NCT03614923|517092872|FG001|Overall Study|Lack of Efficacy|0|||
143423126|NCT03614923|517092873|FG002|Overall Study|Lack of Efficacy|1|||
143423127|NCT03614923|517092871|FG000|Overall Study|Non-compliance|0|||
143423128|NCT03614923|517092872|FG001|Overall Study|Non-compliance|1|||
143423129|NCT03614923|517092873|FG002|Overall Study|Non-compliance|0|||
143423130|NCT03614923|517092871|FG000|Overall Study|Other|0|||
143423131|NCT03614923|517092872|FG001|Overall Study|Other|1|||
143423132|NCT03614923|517092873|FG002|Overall Study|Other|1|||
143423133|NCT01882088|517092874|FG000|Overall Study|Intolerance of esophageal manometry|1|||
143423134|NCT01882088|517092874|FG000|Overall Study|no possibility to place the catheter|1|||
143423135|NCT01882088|517092874|FG000|Overall Study|Protocol Violation|1|||
143423136|NCT01882088|517092874|FG000|Overall Study|inadequate pH-impedance tracings|2|||
143423137|NCT02256553|517092887|FG000|Period I|Adverse Event|5|||
143423138|NCT02256553|517092887|FG000|Period I|Protocol Violation|1|||
143423139|NCT02256553|517092887|FG000|Period II|Adverse Event|1|||
143423140|NCT02256553|517092887|FG000|Period II|Subject Moved|1|||
143423141|NCT02256553|517092887|FG000|Period III|Adverse Event|3|||
143423142|NCT04739306|517092888|FG000|Main Study Period|Adverse Event|6|||
143423143|NCT04739306|517092889|FG001|Main Study Period|Adverse Event|7|||
143423144|NCT04739306|517092888|FG000|Main Study Period|Lost to Follow-up|4|||
143423145|NCT04739306|517092889|FG001|Main Study Period|Lost to Follow-up|6|||
143423146|NCT04739306|517092888|FG000|Main Study Period|Physician Decision|1|||
143423147|NCT04739306|517092889|FG001|Main Study Period|Physician Decision|1|||
143423148|NCT04739306|517092888|FG000|Main Study Period|Withdrawal by Subject|8|||
143423149|NCT04739306|517092889|FG001|Main Study Period|Withdrawal by Subject|6|||
143423150|NCT04739306|517092888|FG000|Main Study Period|Protocol Violation|0|||
143423151|NCT04739306|517092889|FG001|Main Study Period|Protocol Violation|1|||
143423152|NCT04739306|517092888|FG000|Main Study Period|War in Ukraine|1|||
143423153|NCT04739306|517092889|FG001|Main Study Period|War in Ukraine|1|||
143423154|NCT01699178|517092894|FG000|Overall Study|Adverse Event|1|||
143423155|NCT01699178|517092895|FG001|Overall Study|Adverse Event|5|||
143423156|NCT01699178|517092894|FG000|Overall Study|Lost to Follow-up|1|||
143423157|NCT01699178|517092895|FG001|Overall Study|Lost to Follow-up|6|||
143423158|NCT01699178|517092894|FG000|Overall Study|Non-compliance with Study Drug|3|||
143423159|NCT01699178|517092895|FG001|Overall Study|Non-compliance with Study Drug|1|||
143423160|NCT01699178|517092894|FG000|Overall Study|Physician Decision|1|||
143423161|NCT01699178|517092895|FG001|Overall Study|Physician Decision|0|||
143423162|NCT01699178|517092894|FG000|Overall Study|Withdrawal by Subject|4|||
143423163|NCT01699178|517092895|FG001|Overall Study|Withdrawal by Subject|12|||
143423164|NCT01699178|517092894|FG000|Overall Study|Hematocrit >54%|1|||
143423165|NCT01699178|517092895|FG001|Overall Study|Hematocrit >54%|1|||
143423166|NCT01699178|517092894|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
143423167|NCT01699178|517092895|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
143423168|NCT01699178|517092894|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
143423169|NCT01699178|517092895|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
143423170|NCT00321555|517092896|FG000|Overall Study|Developed antibodies|1|||
143423171|NCT00321555|517092896|FG000|Overall Study|Switched to alternative treatment|3|||
143423172|NCT00321555|517092896|FG000|Overall Study|Physician Decision|1|||
143423173|NCT00321555|517092896|FG000|Overall Study|Disease progression on study|1|||
143423174|NCT01885559|517092906|FG000|Overall Study|Lost to Follow-up|15|||
143423175|NCT01885559|517092907|FG001|Overall Study|Lost to Follow-up|16|||
143423176|NCT01885559|517092906|FG000|Overall Study|Less than full participation|9|||
143423177|NCT01885559|517092907|FG001|Overall Study|Less than full participation|19|||
143423178|NCT01885559|517092906|FG000|Overall Study|Protocol Violation|0|||
143423179|NCT01885559|517092907|FG001|Overall Study|Protocol Violation|1|||
143423180|NCT03560206|517092909|FG000|Overall Study|Lost to Follow-up|19|||
143423181|NCT03560206|517092910|FG001|Overall Study|Lost to Follow-up|11|||
143423182|NCT03560206|517092909|FG000|Overall Study|Withdrawal by Subject|2|||
143423183|NCT03560206|517092910|FG001|Overall Study|Withdrawal by Subject|4|||
143423184|NCT03560206|517092909|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
143423185|NCT03560206|517092910|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
143423186|NCT03560206|517092909|FG000|Overall Study|Busy schedule|14|||
143423187|NCT03560206|517092910|FG001|Overall Study|Busy schedule|2|||
143423188|NCT03560206|517092909|FG000|Overall Study|patients' new health condition such as cancer|10|||
143423189|NCT03560206|517092910|FG001|Overall Study|patients' new health condition such as cancer|1|||
143423190|NCT03100370|517092911|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
143423191|NCT03100370|517092912|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
143423192|NCT03100370|517092913|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
143423193|NCT03100370|517092914|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
143423194|NCT03100370|517092915|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
143423195|NCT03100370|517092916|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
143423196|NCT03987074|517092917|FG000|Overall Study|Withdrew Consent|1|||
143423197|NCT03987074|517092918|FG001|Overall Study|Withdrew Consent|1|||
143423198|NCT03987074|517092919|FG002|Overall Study|Withdrew Consent|0|||
143423199|NCT03987074|517092920|FG003|Overall Study|Withdrew Consent|2|||
143423200|NCT03987074|517092921|FG004|Overall Study|Withdrew Consent|1|||
143423201|NCT03987074|517092917|FG000|Overall Study|Adverse Event|2|||
143423202|NCT03987074|517092918|FG001|Overall Study|Adverse Event|1|||
143423203|NCT03987074|517092919|FG002|Overall Study|Adverse Event|0|||
143423204|NCT03987074|517092920|FG003|Overall Study|Adverse Event|0|||
143423205|NCT03987074|517092921|FG004|Overall Study|Adverse Event|1|||
143423206|NCT03987074|517092917|FG000|Overall Study|Lost to Follow-up|0|||
143423207|NCT03987074|517092918|FG001|Overall Study|Lost to Follow-up|0|||
143423208|NCT03987074|517092919|FG002|Overall Study|Lost to Follow-up|1|||
143423209|NCT03987074|517092920|FG003|Overall Study|Lost to Follow-up|1|||
143423210|NCT03987074|517092921|FG004|Overall Study|Lost to Follow-up|0|||
143423211|NCT03987074|517092917|FG000|Overall Study|Investigator's Discretion|0|||
143423212|NCT03987074|517092918|FG001|Overall Study|Investigator's Discretion|0|||
143423213|NCT03987074|517092919|FG002|Overall Study|Investigator's Discretion|0|||
143423214|NCT03987074|517092920|FG003|Overall Study|Investigator's Discretion|1|||
143423215|NCT03987074|517092921|FG004|Overall Study|Investigator's Discretion|0|||
143423216|NCT02993926|517092926|FG000|Enantone Treatment Phase|Adverse Event|1|||
143423217|NCT02993926|517092927|FG001|Enantone Treatment Phase|Adverse Event|0|||
143423218|NCT02993926|517092928|FG002|Enantone Treatment Phase|Adverse Event|0|||
143423219|NCT02993926|517092926|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
143423220|NCT02993926|517092927|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
143423221|NCT02993926|517092928|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
143423222|NCT02993926|517092926|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
143423223|NCT02993926|517092927|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
143423224|NCT02993926|517092928|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
143423225|NCT02993926|517092926|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
143423226|NCT02993926|517092927|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
143423227|NCT02993926|517092928|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
143423228|NCT01867307|517092930|FG000|Overall Study|Protocol Violation|2|||
143423229|NCT01867307|517092931|FG001|Overall Study|Protocol Violation|0|||
143423230|NCT01867307|517092930|FG000|Overall Study|Other Adverse Event|1|||
143423231|NCT01867307|517092931|FG001|Overall Study|Other Adverse Event|3|||
143423232|NCT02009865|517092936|FG000|Overall Study|Adverse Event|0|||
143423233|NCT02009865|517092937|FG001|Overall Study|Adverse Event|2|||
143423234|NCT02009865|517092936|FG000|Overall Study|Protocol Violation|0|||
143423235|NCT02009865|517092937|FG001|Overall Study|Protocol Violation|2|||
143423236|NCT02009865|517092936|FG000|Overall Study|Withdrawal by Subject|1|||
143423237|NCT02009865|517092937|FG001|Overall Study|Withdrawal by Subject|1|||
143423238|NCT01517282|517092938|FG000|Overall Study|Consent withdrawn|0|||
143423239|NCT01517282|517092939|FG001|Overall Study|Consent withdrawn|1|||
143423240|NCT01517282|517092940|FG002|Overall Study|Consent withdrawn|1|||
143423241|NCT01517282|517092941|FG003|Overall Study|Consent withdrawn|1|||
143423242|NCT01517282|517092938|FG000|Overall Study|Physician Decision|1|||
143423243|NCT01517282|517092939|FG001|Overall Study|Physician Decision|0|||
143423244|NCT01517282|517092940|FG002|Overall Study|Physician Decision|0|||
143423245|NCT01517282|517092941|FG003|Overall Study|Physician Decision|0|||
143423246|NCT01634165|517092944|FG000|Period 2|Adverse Event|0|||
143423247|NCT01634165|517092945|FG001|Period 2|Adverse Event|1|||
143423248|NCT01634165|517092946|FG002|Period 2|Adverse Event|0|||
143423249|NCT01634165|517092947|FG003|Period 2|Adverse Event|0|||
143423250|NCT02135445|517092948|FG000|Overall Study|Lost to Follow-up|1|||
143423251|NCT02135445|517092949|FG001|Overall Study|Lost to Follow-up|0|||
143423252|NCT02135445|517092948|FG000|Overall Study|Withdrawal by Subject|1|||
143423253|NCT02135445|517092949|FG001|Overall Study|Withdrawal by Subject|0|||
143423254|NCT03820024|517092950|FG000|Overall Study|Physician Decision|1|||
143423255|NCT03820024|517092951|FG001|Overall Study|Physician Decision|2|||
143423256|NCT03978130|517094170|FG000|Overall Study|Lost to Follow-up|13|||
143423257|NCT03978130|517094171|FG001|Overall Study|Lost to Follow-up|14|||
143423258|NCT03978130|517094170|FG000|Overall Study|Withdrawal by Subject|12|||
143423259|NCT03978130|517094171|FG001|Overall Study|Withdrawal by Subject|2|||
143423260|NCT03978130|517094170|FG000|Overall Study|Adverse Event|2|||
143423261|NCT03978130|517094171|FG001|Overall Study|Adverse Event|1|||
143423262|NCT05927753|517094174|FG000|Overall Study|Withdrawal by Subject|0|||
143423263|NCT05927753|517094175|FG001|Overall Study|Withdrawal by Subject|2|||
143423264|NCT05927753|517094174|FG000|Overall Study|Physician Decision|0|||
143423265|NCT05927753|517094175|FG001|Overall Study|Physician Decision|1|||
143423266|NCT02101554|517094178|FG000|Overall Study|Protocol Violation|0|||
143423267|NCT02101554|517094179|FG001|Overall Study|Protocol Violation|1|||
143423268|NCT02101554|517094180|FG002|Overall Study|Protocol Violation|0|||
143423269|NCT02101554|517094178|FG000|Overall Study|Insufficient Clinical Response|0|||
143423270|NCT02101554|517094179|FG001|Overall Study|Insufficient Clinical Response|2|||
143423271|NCT02101554|517094180|FG002|Overall Study|Insufficient Clinical Response|0|||
143423272|NCT02101554|517094178|FG000|Overall Study|Adverse Event|2|||
143423273|NCT02101554|517094179|FG001|Overall Study|Adverse Event|1|||
143423274|NCT02101554|517094180|FG002|Overall Study|Adverse Event|1|||
143423275|NCT02101554|517094178|FG000|Overall Study|Lost to Follow-up|0|||
143423276|NCT02101554|517094179|FG001|Overall Study|Lost to Follow-up|1|||
143423277|NCT02101554|517094180|FG002|Overall Study|Lost to Follow-up|0|||
143423278|NCT02101554|517094178|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
143423279|NCT02101554|517094179|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
143423280|NCT02101554|517094180|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
143423281|NCT02136797|517094182|FG000|Overall Study|Not Treated|8|||
143423282|NCT04523571|517094183|FG000|Received 2 Doses|Withdrawal by Subject|0|||
143423283|NCT04523571|517094184|FG001|Received 2 Doses|Withdrawal by Subject|0|||
143423284|NCT04523571|517094185|FG002|Received 2 Doses|Withdrawal by Subject|0|||
143423285|NCT04523571|517094186|FG003|Received 2 Doses|Withdrawal by Subject|1|||
143423286|NCT04523571|517094187|FG004|Received 2 Doses|Withdrawal by Subject|1|||
143423287|NCT04523571|517094188|FG005|Received 2 Doses|Withdrawal by Subject|0|||
143423288|NCT04523571|517094183|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
143423289|NCT04523571|517094184|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
143423290|NCT04523571|517094185|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
143423291|NCT04523571|517094186|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
143423292|NCT04523571|517094187|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
143423293|NCT04523571|517094188|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
143423294|NCT04523571|517094183|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
143423295|NCT04523571|517094184|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
143423296|NCT04523571|517094185|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
143423297|NCT04523571|517094186|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
143423298|NCT04523571|517094187|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
143423299|NCT04523571|517094188|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
143423300|NCT04523571|517094183|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
143423301|NCT04523571|517094184|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
143423302|NCT04523571|517094185|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
143423303|NCT04523571|517094186|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
143423304|NCT04523571|517094187|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
143423305|NCT04523571|517094188|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
143423306|NCT04198428|517094189|FG000|Overall Study|Withdrawal by Subject|150|||
143423307|NCT04198428|517094190|FG001|Overall Study|Withdrawal by Subject|156|||
143423308|NCT03344458|517094193|FG000|Overall Study|Physician Decision|1|||
143423309|NCT03344458|517094193|FG000|Overall Study|Withdrawal by Subject|16|||
143423310|NCT03344458|517094193|FG000|Overall Study|Other reasons|10|||
143423311|NCT03344458|517094193|FG000|Overall Study|Lost to Follow-up|9|||
143423312|NCT03344458|517094193|FG000|Overall Study|Protocol Violation|3|||
143423313|NCT03696342|517094196|FG000|Overall Study|Lost to Follow-up|1|||
143423314|NCT03696342|517094197|FG001|Overall Study|Lost to Follow-up|0|||
143423315|NCT01816165|517094200|FG000|Overall Study|Adverse Event|1|||
143423316|NCT01816165|517094201|FG001|Overall Study|Adverse Event|0|||
143423317|NCT01816165|517094202|FG002|Overall Study|Adverse Event|0|||
143423318|NCT01816165|517094203|FG003|Overall Study|Adverse Event|0|||
143423319|NCT02409732|517094204|FG000|Overall Study|Withdrawal by Subject|4|||
143423320|NCT02409732|517094204|FG000|Overall Study|Lost to Follow-up|2|||
143423321|NCT03960437|517094206|FG000|Overall Study|Removed by PI|4|||
143423322|NCT03960437|517094206|FG000|Overall Study|Lost to Follow-up|2|||
143423323|NCT03960437|517094206|FG000|Overall Study|Withdrawal by Subject|1|||
143423324|NCT03960437|517094206|FG000|Overall Study|Death|2|||
143423325|NCT01838499|517094207|FG000|Overall Study|Protocol Violation|0|||
143423326|NCT01838499|517094208|FG001|Overall Study|Protocol Violation|1|||
143423327|NCT01838499|517094207|FG000|Overall Study|Lost to Follow-up|2|||
143423328|NCT01838499|517094208|FG001|Overall Study|Lost to Follow-up|4|||
143423329|NCT01838499|517094207|FG000|Overall Study|Lack of Efficacy|1|||
143423330|NCT01838499|517094208|FG001|Overall Study|Lack of Efficacy|2|||
143423331|NCT01838499|517094207|FG000|Overall Study|Adverse Event|2|||
143423332|NCT01838499|517094208|FG001|Overall Study|Adverse Event|1|||
143423333|NCT01838499|517094207|FG000|Overall Study|Withdrawal by Subject|19|||
143423334|NCT01838499|517094208|FG001|Overall Study|Withdrawal by Subject|9|||
143423335|NCT00168805|517094209|FG000|Overall Study|Adverse Event|7|||
143423336|NCT00168805|517094210|FG001|Overall Study|Adverse Event|11|||
143423337|NCT00168805|517094211|FG002|Overall Study|Adverse Event|16|||
143423338|NCT00168805|517094209|FG000|Overall Study|Protocol Violation|12|||
143423339|NCT00168805|517094210|FG001|Overall Study|Protocol Violation|11|||
143423340|NCT00168805|517094211|FG002|Overall Study|Protocol Violation|8|||
143423341|NCT00168805|517094209|FG000|Overall Study|Lost to Follow-up|12|||
143423342|NCT00168805|517094210|FG001|Overall Study|Lost to Follow-up|17|||
143423343|NCT00168805|517094211|FG002|Overall Study|Lost to Follow-up|11|||
143423344|NCT00168805|517094209|FG000|Overall Study|Withdrawal by Subject|16|||
143423345|NCT00168805|517094210|FG001|Overall Study|Withdrawal by Subject|18|||
143423346|NCT00168805|517094211|FG002|Overall Study|Withdrawal by Subject|21|||
143423347|NCT00168805|517094209|FG000|Overall Study|Other|24|||
143423348|NCT00168805|517094210|FG001|Overall Study|Other|21|||
143423349|NCT00168805|517094211|FG002|Overall Study|Other|22|||
143423350|NCT00168805|517094209|FG000|Treatment|Adverse Event|25|||
143423351|NCT00168805|517094210|FG001|Treatment|Adverse Event|26|||
143423352|NCT00168805|517094211|FG002|Treatment|Adverse Event|32|||
143423353|NCT00168805|517094209|FG000|Treatment|Protocol Violation|3|||
143423354|NCT00168805|517094210|FG001|Treatment|Protocol Violation|5|||
143423355|NCT00168805|517094211|FG002|Treatment|Protocol Violation|5|||
143423356|NCT00168805|517094209|FG000|Treatment|Withdrawal by Subject|3|||
143423357|NCT00168805|517094210|FG001|Treatment|Withdrawal by Subject|7|||
143423358|NCT00168805|517094211|FG002|Treatment|Withdrawal by Subject|8|||
143423359|NCT00168805|517094209|FG000|Treatment|Other|18|||
143423360|NCT00168805|517094210|FG001|Treatment|Other|18|||
143423361|NCT00168805|517094211|FG002|Treatment|Other|17|||
143423362|NCT01114217|517094212|FG000|Overall Study|Adverse Event|5|||
143423363|NCT01114217|517094213|FG001|Overall Study|Adverse Event|3|||
143423364|NCT01114217|517094212|FG000|Overall Study|Lost to Follow-up|17|||
143423365|NCT01114217|517094213|FG001|Overall Study|Lost to Follow-up|33|||
143423366|NCT01114217|517094212|FG000|Overall Study|Withdrawal by Subject|21|||
143423367|NCT01114217|517094213|FG001|Overall Study|Withdrawal by Subject|28|||
143423368|NCT01114217|517094212|FG000|Overall Study|Other-Clerical Error|3|||
143423369|NCT01114217|517094213|FG001|Overall Study|Other-Clerical Error|0|||
143423370|NCT01114217|517094212|FG000|Overall Study|Other-Early termination|6|||
143423371|NCT01114217|517094213|FG001|Overall Study|Other-Early termination|10|||
143423372|NCT01114217|517094212|FG000|Overall Study|Other-Procedure|1|||
143423373|NCT01114217|517094213|FG001|Overall Study|Other-Procedure|1|||
143423374|NCT01114217|517094212|FG000|Overall Study|Other-Pregnancy|2|||
143423375|NCT01114217|517094213|FG001|Overall Study|Other-Pregnancy|4|||
143423376|NCT01114217|517094212|FG000|Overall Study|Other-Protocol Violation|1|||
143423377|NCT01114217|517094213|FG001|Overall Study|Other-Protocol Violation|3|||
143423378|NCT01114217|517094212|FG000|Overall Study|Other-Lack of Efficacy|1|||
143423379|NCT01114217|517094213|FG001|Overall Study|Other-Lack of Efficacy|0|||
143423380|NCT01114217|517094212|FG000|Overall Study|Other-Non Compliance|2|||
143423381|NCT01114217|517094213|FG001|Overall Study|Other-Non Compliance|0|||
143423382|NCT01114217|517094212|FG000|Overall Study|Other-Physician Decision|1|||
143423383|NCT01114217|517094213|FG001|Overall Study|Other-Physician Decision|1|||
143423384|NCT01114217|517094212|FG000|Overall Study|Other-Sponsor Decision|10|||
143423385|NCT01114217|517094213|FG001|Overall Study|Other-Sponsor Decision|12|||
143423386|NCT01114217|517094212|FG000|Overall Study|Other-Study Termination|0|||
143423387|NCT01114217|517094213|FG001|Overall Study|Other-Study Termination|1|||
143423388|NCT01114217|517094212|FG000|Overall Study|Other-Study Withdrawn|1|||
143423389|NCT01114217|517094213|FG001|Overall Study|Other-Study Withdrawn|1|||
143423390|NCT01114217|517094212|FG000|Overall Study|Other-Site Stopped Communicating|2|||
143423391|NCT01114217|517094213|FG001|Overall Study|Other-Site Stopped Communicating|0|||
143423392|NCT01114217|517094212|FG000|Overall Study|Other-Lost to Follow-up|1|||
143423393|NCT01114217|517094213|FG001|Overall Study|Other-Lost to Follow-up|0|||
143423394|NCT01114217|517094212|FG000|Overall Study|Other-Withdrawal by Subject|1|||
143423395|NCT01114217|517094213|FG001|Overall Study|Other-Withdrawal by Subject|1|||
143423396|NCT03785210|517094214|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
143423397|NCT03785210|517094215|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
143423398|NCT02062827|517094218|FG000|Overall Study|Death|1|||
143423399|NCT02062827|517094219|FG001|Overall Study|Death|0|||
143423400|NCT02062827|517094220|FG002|Overall Study|Death|0|||
143423401|NCT02062827|517094221|FG003|Overall Study|Death|0|||
143423402|NCT02062827|517094222|FG004|Overall Study|Death|0|||
143423403|NCT02062827|517094223|FG005|Overall Study|Death|0|||
143423404|NCT02062827|517094224|FG006|Overall Study|Death|0|||
143423405|NCT02062827|517094225|FG007|Overall Study|Death|0|||
143423406|NCT02062827|517094218|FG000|Overall Study|Withdrawal by Subject|3|||
143423407|NCT02062827|517094219|FG001|Overall Study|Withdrawal by Subject|1|||
143423408|NCT02062827|517094220|FG002|Overall Study|Withdrawal by Subject|1|||
143423409|NCT02062827|517094221|FG003|Overall Study|Withdrawal by Subject|2|||
143423410|NCT02062827|517094222|FG004|Overall Study|Withdrawal by Subject|6|||
143423411|NCT02062827|517094223|FG005|Overall Study|Withdrawal by Subject|0|||
143423412|NCT02062827|517094224|FG006|Overall Study|Withdrawal by Subject|5|||
143423413|NCT02062827|517094225|FG007|Overall Study|Withdrawal by Subject|0|||
143423414|NCT02062827|517094218|FG000|Overall Study|Screen Fail|0|||
143423415|NCT02062827|517094219|FG001|Overall Study|Screen Fail|0|||
143423416|NCT02062827|517094220|FG002|Overall Study|Screen Fail|0|||
143423417|NCT02062827|517094221|FG003|Overall Study|Screen Fail|0|||
143423418|NCT02062827|517094222|FG004|Overall Study|Screen Fail|0|||
143423419|NCT02062827|517094223|FG005|Overall Study|Screen Fail|0|||
143423420|NCT02062827|517094224|FG006|Overall Study|Screen Fail|0|||
143423421|NCT02062827|517094225|FG007|Overall Study|Screen Fail|8|||
143423422|NCT03708744|517094226|FG000|Overall Study|Withdrawal by Subject|0|||
143423423|NCT03708744|517094227|FG001|Overall Study|Withdrawal by Subject|0|||
143423424|NCT03708744|517094228|FG002|Overall Study|Withdrawal by Subject|1|||
143423425|NCT03708744|517094229|FG003|Overall Study|Withdrawal by Subject|0|||
143423426|NCT02213458|517094232|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
143423427|NCT02213458|517094233|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
143423428|NCT02213458|517094232|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
143423429|NCT02213458|517094233|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
143423430|NCT02213458|517094232|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
143423431|NCT02213458|517094233|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
143423432|NCT02213458|517094232|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
143423433|NCT02213458|517094233|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
143423434|NCT02213458|517094232|FG000|Overall Study|Refused re-consent|6|||
143423435|NCT02213458|517094233|FG001|Overall Study|Refused re-consent|0|||
143423436|NCT02213458|517094232|FG000|Overall Study|Lost to Follow-up|2|||
143423437|NCT02213458|517094233|FG001|Overall Study|Lost to Follow-up|2|||
143423438|NCT02213458|517094232|FG000|Overall Study|Withdrawal by Subject|26|||
143423439|NCT02213458|517094233|FG001|Overall Study|Withdrawal by Subject|8|||
143423440|NCT05740371|517094234|FG000|Overall Study|Death|1|||
143423441|NCT01613599|517094237|FG000|Overall Study|Death|9|||
143423442|NCT01613599|517094237|FG000|Overall Study|Lost to Follow-up|5|||
143423443|NCT01613599|517094237|FG000|Overall Study|Withdrawal by Subject|8|||
143423444|NCT01613599|517094237|FG000|Overall Study|Reason not specified|3|||
143423445|NCT02991456|517094238|FG000|Overall Study|Adverse Event|2|||
143423446|NCT02991456|517094239|FG001|Overall Study|Adverse Event|0|||
143423447|NCT02991456|517094238|FG000|Overall Study|Lost to Follow-up|0|||
143423448|NCT02991456|517094239|FG001|Overall Study|Lost to Follow-up|2|||
143423449|NCT02991456|517094238|FG000|Overall Study|Withdrawal by Subject|1|||
143423450|NCT02991456|517094239|FG001|Overall Study|Withdrawal by Subject|0|||
143423451|NCT03503188|517094240|FG000|Overall Study|Non eligible in the sub study|0|||
143423452|NCT03503188|517094241|FG001|Overall Study|Non eligible in the sub study|1|||
143423453|NCT02066389|517094243|FG000|Overall Study|Adverse Event|1|||
143423454|NCT02066389|517094244|FG001|Overall Study|Adverse Event|1|||
143423455|NCT02066389|517094245|FG002|Overall Study|Adverse Event|1|||
143423456|NCT02066389|517094246|FG003|Overall Study|Adverse Event|1|||
143423457|NCT02066389|517094247|FG004|Overall Study|Adverse Event|5|||
143423458|NCT02066389|517094248|FG005|Overall Study|Adverse Event|1|||
143423459|NCT02066389|517094243|FG000|Overall Study|Withdrawal by Subject|4|||
143423460|NCT02066389|517094244|FG001|Overall Study|Withdrawal by Subject|0|||
143423461|NCT02066389|517094245|FG002|Overall Study|Withdrawal by Subject|5|||
143423462|NCT02066389|517094246|FG003|Overall Study|Withdrawal by Subject|1|||
143423463|NCT02066389|517094247|FG004|Overall Study|Withdrawal by Subject|1|||
143423464|NCT02066389|517094248|FG005|Overall Study|Withdrawal by Subject|2|||
143423465|NCT02066389|517094243|FG000|Overall Study|Lost to Follow-up|0|||
143423466|NCT02066389|517094244|FG001|Overall Study|Lost to Follow-up|0|||
143423467|NCT02066389|517094245|FG002|Overall Study|Lost to Follow-up|0|||
143423468|NCT02066389|517094246|FG003|Overall Study|Lost to Follow-up|1|||
143423469|NCT02066389|517094247|FG004|Overall Study|Lost to Follow-up|1|||
143423470|NCT02066389|517094248|FG005|Overall Study|Lost to Follow-up|1|||
143423471|NCT02066389|517094243|FG000|Overall Study|Randomized in Error|0|||
143423472|NCT02066389|517094244|FG001|Overall Study|Randomized in Error|0|||
143423473|NCT02066389|517094245|FG002|Overall Study|Randomized in Error|0|||
143423474|NCT02066389|517094246|FG003|Overall Study|Randomized in Error|0|||
143423475|NCT02066389|517094247|FG004|Overall Study|Randomized in Error|0|||
143423476|NCT02066389|517094248|FG005|Overall Study|Randomized in Error|1|||
143423477|NCT04016415|517094251|FG000|Overall Study|Adverse Event|2|||
143423478|NCT04016415|517094252|FG001|Overall Study|Adverse Event|1|||
143423479|NCT04016415|517094251|FG000|Overall Study|Lost to Follow-up|6|||
143423480|NCT04016415|517094252|FG001|Overall Study|Lost to Follow-up|2|||
143423481|NCT04016415|517094251|FG000|Overall Study|Physician Decision|5|||
143423482|NCT04016415|517094252|FG001|Overall Study|Physician Decision|1|||
143423483|NCT04016415|517094251|FG000|Overall Study|Pregnancy|0|||
143423484|NCT04016415|517094252|FG001|Overall Study|Pregnancy|1|||
143423485|NCT04016415|517094251|FG000|Overall Study|Withdrawal by Subject|24|||
143423486|NCT04016415|517094252|FG001|Overall Study|Withdrawal by Subject|27|||
143423487|NCT04016415|517094251|FG000|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|2|||
143423488|NCT04016415|517094252|FG001|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|0|||
143423489|NCT05615870|517094255|FG000|Overall Study|Lost to Follow-up|10|||
143423490|NCT05615870|517094256|FG001|Overall Study|Lost to Follow-up|13|||
143423491|NCT05615870|517094255|FG000|Overall Study|Physician Decision|2|||
143423492|NCT05615870|517094256|FG001|Overall Study|Physician Decision|0|||
143423493|NCT05615870|517094255|FG000|Overall Study|Withdrawal by Subject|0|||
143423494|NCT05615870|517094256|FG001|Overall Study|Withdrawal by Subject|2|||
143423495|NCT05615870|517094255|FG000|Overall Study|Protocol Violation|0|||
143423496|NCT05615870|517094256|FG001|Overall Study|Protocol Violation|3|||
143423497|NCT05615870|517094255|FG000|Overall Study|Unable to complete study activities after moving residences|0|||
143423498|NCT05615870|517094256|FG001|Overall Study|Unable to complete study activities after moving residences|2|||
143423499|NCT05615870|517094255|FG000|Overall Study|Terminated from the experimental or control intervention only and continued with the study|1|||
143423500|NCT05615870|517094256|FG001|Overall Study|Terminated from the experimental or control intervention only and continued with the study|0|||
143423501|NCT05615870|517094255|FG000|Overall Study|The participant thought the study was done and shipped the devices back.|0|||
143423502|NCT05615870|517094256|FG001|Overall Study|The participant thought the study was done and shipped the devices back.|1|||
143423503|NCT02561195|517094257|FG000|Vaccination 1 to 3|Adverse Event|4|||
143423504|NCT02561195|517094258|FG001|Vaccination 1 to 3|Adverse Event|5|||
143423505|NCT02561195|517094259|FG002|Vaccination 1 to 3|Adverse Event|0|||
143423506|NCT02561195|517094260|FG003|Vaccination 1 to 3|Adverse Event|3|||
143423507|NCT02561195|517094261|FG004|Vaccination 1 to 3|Adverse Event|4|||
143423508|NCT02561195|517094262|FG005|Vaccination 1 to 3|Adverse Event|0|||
143423509|NCT02561195|517094263|FG006|Vaccination 1 to 3|Adverse Event|0|||
143423510|NCT02561195|517094264|FG007|Vaccination 1 to 3|Adverse Event|0|||
143423511|NCT02561195|517094265|FG008|Vaccination 1 to 3|Adverse Event|0|||
143423512|NCT02561195|517094266|FG009|Vaccination 1 to 3|Adverse Event|0|||
143423513|NCT02561195|517094267|FG010|Vaccination 1 to 3|Adverse Event|0|||
143423514|NCT02561195|517094268|FG011|Vaccination 1 to 3|Adverse Event|0|||
143423515|NCT02561195|517094269|FG012|Vaccination 1 to 3|Adverse Event|0|||
143423516|NCT02561195|517094270|FG013|Vaccination 1 to 3|Adverse Event|0|||
143423517|NCT02561195|517094257|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
143423518|NCT02561195|517094258|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
143423519|NCT02561195|517094259|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
143423520|NCT02561195|517094260|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
143423521|NCT02561195|517094261|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
143423522|NCT02561195|517094262|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
143423523|NCT02561195|517094263|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
143423524|NCT02561195|517094264|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
143423525|NCT02561195|517094265|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
143423526|NCT02561195|517094266|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
143423527|NCT02561195|517094267|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
143423528|NCT02561195|517094268|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
143423529|NCT02561195|517094269|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
143423530|NCT02561195|517094270|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
143423531|NCT02561195|517094257|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
143423532|NCT02561195|517094258|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
143423533|NCT02561195|517094259|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
143423534|NCT02561195|517094260|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
143423535|NCT02561195|517094261|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
143423536|NCT02561195|517094262|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
143423537|NCT02561195|517094263|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
143423538|NCT02561195|517094264|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
143423539|NCT02561195|517094265|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
143423540|NCT02561195|517094266|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
143423541|NCT02561195|517094267|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
143423542|NCT02561195|517094268|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
143423543|NCT02561195|517094269|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
143423544|NCT02561195|517094270|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
143423545|NCT02561195|517094257|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
143423546|NCT02561195|517094258|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
143423547|NCT02561195|517094259|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
143423548|NCT02561195|517094260|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
143423549|NCT02561195|517094261|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
143423550|NCT02561195|517094262|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
143423551|NCT02561195|517094263|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
143423552|NCT02561195|517094264|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
143423553|NCT02561195|517094265|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
143423554|NCT02561195|517094266|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
143423555|NCT02561195|517094267|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
143423556|NCT02561195|517094268|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
143423557|NCT02561195|517094269|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
143423558|NCT02561195|517094270|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
143423559|NCT02561195|517094257|FG000|Vaccination 1 to 3|Other|7|||
143423560|NCT02561195|517094258|FG001|Vaccination 1 to 3|Other|3|||
143423561|NCT02561195|517094259|FG002|Vaccination 1 to 3|Other|1|||
143423562|NCT02561195|517094260|FG003|Vaccination 1 to 3|Other|7|||
143423563|NCT02561195|517094261|FG004|Vaccination 1 to 3|Other|5|||
143423564|NCT02561195|517094262|FG005|Vaccination 1 to 3|Other|1|||
143423565|NCT02561195|517094263|FG006|Vaccination 1 to 3|Other|0|||
143423566|NCT02561195|517094264|FG007|Vaccination 1 to 3|Other|0|||
143423567|NCT02561195|517094265|FG008|Vaccination 1 to 3|Other|0|||
143423568|NCT02561195|517094266|FG009|Vaccination 1 to 3|Other|0|||
143423569|NCT02561195|517094267|FG010|Vaccination 1 to 3|Other|0|||
143423570|NCT02561195|517094268|FG011|Vaccination 1 to 3|Other|0|||
143423571|NCT02561195|517094269|FG012|Vaccination 1 to 3|Other|0|||
143423572|NCT02561195|517094270|FG013|Vaccination 1 to 3|Other|0|||
143423573|NCT02561195|517094257|FG000|Vaccination 1 to 3|Protocol Violation|1|||
143423574|NCT02561195|517094258|FG001|Vaccination 1 to 3|Protocol Violation|0|||
143423575|NCT02561195|517094259|FG002|Vaccination 1 to 3|Protocol Violation|1|||
143423576|NCT02561195|517094260|FG003|Vaccination 1 to 3|Protocol Violation|2|||
143423577|NCT02561195|517094261|FG004|Vaccination 1 to 3|Protocol Violation|5|||
143423578|NCT02561195|517094262|FG005|Vaccination 1 to 3|Protocol Violation|2|||
143423579|NCT02561195|517094263|FG006|Vaccination 1 to 3|Protocol Violation|0|||
143423580|NCT02561195|517094264|FG007|Vaccination 1 to 3|Protocol Violation|0|||
143423581|NCT02561195|517094265|FG008|Vaccination 1 to 3|Protocol Violation|0|||
143423582|NCT02561195|517094266|FG009|Vaccination 1 to 3|Protocol Violation|0|||
143423583|NCT02561195|517094267|FG010|Vaccination 1 to 3|Protocol Violation|0|||
143423584|NCT02561195|517094268|FG011|Vaccination 1 to 3|Protocol Violation|0|||
143423585|NCT02561195|517094269|FG012|Vaccination 1 to 3|Protocol Violation|0|||
143423586|NCT02561195|517094270|FG013|Vaccination 1 to 3|Protocol Violation|0|||
143423587|NCT02561195|517094257|FG000|Vaccination 1 to 3|Death|2|||
143423588|NCT02561195|517094258|FG001|Vaccination 1 to 3|Death|1|||
143423589|NCT02561195|517094259|FG002|Vaccination 1 to 3|Death|0|||
143423590|NCT02561195|517094260|FG003|Vaccination 1 to 3|Death|2|||
143423591|NCT02561195|517094261|FG004|Vaccination 1 to 3|Death|0|||
143423592|NCT02561195|517094262|FG005|Vaccination 1 to 3|Death|0|||
143423593|NCT02561195|517094263|FG006|Vaccination 1 to 3|Death|0|||
143423594|NCT02561195|517094264|FG007|Vaccination 1 to 3|Death|0|||
143423595|NCT02561195|517094265|FG008|Vaccination 1 to 3|Death|0|||
143423596|NCT02561195|517094266|FG009|Vaccination 1 to 3|Death|0|||
143423597|NCT02561195|517094267|FG010|Vaccination 1 to 3|Death|0|||
143423598|NCT02561195|517094268|FG011|Vaccination 1 to 3|Death|0|||
143423599|NCT02561195|517094269|FG012|Vaccination 1 to 3|Death|0|||
143423600|NCT02561195|517094270|FG013|Vaccination 1 to 3|Death|0|||
143423601|NCT02561195|517094257|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
143423602|NCT02561195|517094258|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
143423603|NCT02561195|517094259|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
143423604|NCT02561195|517094260|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
143423605|NCT02561195|517094261|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
143423606|NCT02561195|517094262|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
143423607|NCT02561195|517094263|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
143423608|NCT02561195|517094264|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
143423609|NCT02561195|517094265|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
143423610|NCT02561195|517094266|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
143423611|NCT02561195|517094267|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
143423612|NCT02561195|517094268|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
143423613|NCT02561195|517094269|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
143423614|NCT02561195|517094270|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
143423615|NCT02561195|517094257|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
143423616|NCT02561195|517094258|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
143423617|NCT02561195|517094259|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
143423618|NCT02561195|517094260|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
143423619|NCT02561195|517094261|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
143423620|NCT02561195|517094262|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
143423621|NCT02561195|517094263|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
143423622|NCT02561195|517094264|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
143423623|NCT02561195|517094265|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
143423624|NCT02561195|517094266|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
143423625|NCT02561195|517094267|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
143423626|NCT02561195|517094268|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
143423627|NCT02561195|517094269|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
143423628|NCT02561195|517094270|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
143423629|NCT02561195|517094257|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
143423630|NCT02561195|517094258|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
143423631|NCT02561195|517094259|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
143423632|NCT02561195|517094260|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
143423633|NCT02561195|517094261|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
143423634|NCT02561195|517094262|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
143423635|NCT02561195|517094263|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
143423636|NCT02561195|517094264|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
143423637|NCT02561195|517094265|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
143423638|NCT02561195|517094266|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
143423639|NCT02561195|517094267|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
143423640|NCT02561195|517094268|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
143423641|NCT02561195|517094269|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
143423642|NCT02561195|517094270|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
143423643|NCT02561195|517094257|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
143423644|NCT02561195|517094258|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
143423645|NCT02561195|517094259|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
143423646|NCT02561195|517094260|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
143423647|NCT02561195|517094261|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
143423648|NCT02561195|517094262|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
143423649|NCT02561195|517094263|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
143423650|NCT02561195|517094264|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
143423651|NCT02561195|517094265|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
143423652|NCT02561195|517094266|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
143423653|NCT02561195|517094267|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
143423654|NCT02561195|517094268|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
143423655|NCT02561195|517094269|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
143423656|NCT02561195|517094270|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
143423657|NCT02561195|517094257|FG000|Extension Stage (Vaccination 4)|Death|0|||
143423658|NCT02561195|517094258|FG001|Extension Stage (Vaccination 4)|Death|0|||
143423659|NCT02561195|517094259|FG002|Extension Stage (Vaccination 4)|Death|0|||
143423660|NCT02561195|517094260|FG003|Extension Stage (Vaccination 4)|Death|0|||
143423661|NCT02561195|517094261|FG004|Extension Stage (Vaccination 4)|Death|0|||
143423662|NCT02561195|517094262|FG005|Extension Stage (Vaccination 4)|Death|0|||
143423663|NCT02561195|517094263|FG006|Extension Stage (Vaccination 4)|Death|0|||
143423664|NCT02561195|517094264|FG007|Extension Stage (Vaccination 4)|Death|0|||
143423665|NCT02561195|517094265|FG008|Extension Stage (Vaccination 4)|Death|0|||
143423666|NCT02561195|517094266|FG009|Extension Stage (Vaccination 4)|Death|1|||
143423667|NCT02561195|517094267|FG010|Extension Stage (Vaccination 4)|Death|0|||
143423668|NCT02561195|517094268|FG011|Extension Stage (Vaccination 4)|Death|0|||
143423669|NCT02561195|517094269|FG012|Extension Stage (Vaccination 4)|Death|0|||
143423670|NCT02561195|517094270|FG013|Extension Stage (Vaccination 4)|Death|0|||
143423671|NCT02561195|517094257|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
143423672|NCT02561195|517094258|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
143423673|NCT02561195|517094259|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
143423674|NCT02561195|517094260|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
143423675|NCT02561195|517094261|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
143423676|NCT02561195|517094262|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
143423677|NCT02561195|517094263|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
143423678|NCT02561195|517094264|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
143423679|NCT02561195|517094265|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
143423680|NCT02561195|517094266|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
143423681|NCT02561195|517094267|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
143423682|NCT02561195|517094268|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
143423683|NCT02561195|517094269|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
143423684|NCT02561195|517094270|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
143423685|NCT02561195|517094257|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
143423686|NCT02561195|517094258|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
143423687|NCT02561195|517094259|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
143423688|NCT02561195|517094260|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
143423689|NCT02561195|517094261|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
143423690|NCT02561195|517094262|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
143423691|NCT02561195|517094263|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
143423692|NCT02561195|517094264|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
143423693|NCT02561195|517094265|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
143423694|NCT02561195|517094266|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
143423695|NCT02561195|517094267|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
143423696|NCT02561195|517094268|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
143423697|NCT02561195|517094269|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
143423698|NCT02561195|517094270|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
143423699|NCT02561195|517094257|FG000|Extension Stage (Vaccination 4)|Other|0|||
143423700|NCT02561195|517094258|FG001|Extension Stage (Vaccination 4)|Other|0|||
143423701|NCT02561195|517094259|FG002|Extension Stage (Vaccination 4)|Other|0|||
143423702|NCT02561195|517094260|FG003|Extension Stage (Vaccination 4)|Other|0|||
143423703|NCT02561195|517094261|FG004|Extension Stage (Vaccination 4)|Other|0|||
143423704|NCT02561195|517094262|FG005|Extension Stage (Vaccination 4)|Other|0|||
143423705|NCT02561195|517094263|FG006|Extension Stage (Vaccination 4)|Other|0|||
143423706|NCT02561195|517094264|FG007|Extension Stage (Vaccination 4)|Other|0|||
143423707|NCT02561195|517094265|FG008|Extension Stage (Vaccination 4)|Other|0|||
143423708|NCT02561195|517094266|FG009|Extension Stage (Vaccination 4)|Other|0|||
143423709|NCT02561195|517094267|FG010|Extension Stage (Vaccination 4)|Other|2|||
143423710|NCT02561195|517094268|FG011|Extension Stage (Vaccination 4)|Other|2|||
143423711|NCT02561195|517094269|FG012|Extension Stage (Vaccination 4)|Other|1|||
143423712|NCT02561195|517094270|FG013|Extension Stage (Vaccination 4)|Other|0|||
143423713|NCT02561195|517094257|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
143423714|NCT02561195|517094258|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
143423715|NCT02561195|517094259|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
143423716|NCT02561195|517094260|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
143423717|NCT02561195|517094261|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
143423718|NCT02561195|517094262|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
143423719|NCT02561195|517094263|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
143423720|NCT02561195|517094264|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
143423721|NCT02561195|517094265|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
143423722|NCT02561195|517094266|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
143423723|NCT02561195|517094267|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
143423724|NCT02561195|517094268|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
143423725|NCT02561195|517094269|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
143423726|NCT02561195|517094270|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
143423727|NCT03394508|517094278|FG000|Overall Study|Protocol Violation|0|||
143423728|NCT03394508|517094279|FG001|Overall Study|Protocol Violation|3|||
143423729|NCT03394508|517094278|FG000|Overall Study|Lost to Follow-up|1|||
143423730|NCT03394508|517094279|FG001|Overall Study|Lost to Follow-up|0|||
143423731|NCT02819141|517094280|FG000|Overall Study|Extubated or discontinued prior to day 7|6|||
143423732|NCT02819141|517094281|FG001|Overall Study|Extubated or discontinued prior to day 7|20|||
143423733|NCT00409006|517095754|FG000|Overall Study|Death|15|||
143423734|NCT00409006|517095755|FG001|Overall Study|Death|6|||
143423735|NCT00409006|517095754|FG000|Overall Study|Lost to Follow-up|1|||
143423736|NCT00409006|517095755|FG001|Overall Study|Lost to Follow-up|2|||
143423737|NCT00409006|517095754|FG000|Overall Study|Withdrawal by Subject|3|||
143423738|NCT00409006|517095755|FG001|Overall Study|Withdrawal by Subject|2|||
143423739|NCT00409006|517095754|FG000|Overall Study|Physician Decision|1|||
143423740|NCT00409006|517095755|FG001|Overall Study|Physician Decision|2|||
143423741|NCT02011568|517095760|FG000|Overall Study|Withdrawal by Subject|8|||
143423742|NCT02011568|517095761|FG001|Overall Study|Withdrawal by Subject|10|||
143423743|NCT02011568|517095760|FG000|Overall Study|Physician Decision|1|||
143423744|NCT02011568|517095761|FG001|Overall Study|Physician Decision|3|||
143423745|NCT01107353|517095762|FG000|Overall Study|Positive Drug Screen|1|||
143423746|NCT01107353|517095763|FG001|Overall Study|Positive Drug Screen|0|||
143423747|NCT03034772|517095764|FG000|Overall Study|Adverse Event|0|||
143423748|NCT03034772|517095765|FG001|Overall Study|Adverse Event|1|||
143423749|NCT03034772|517095764|FG000|Overall Study|Withdrawal by Subject|0|||
143423750|NCT03034772|517095765|FG001|Overall Study|Withdrawal by Subject|1|||
143423751|NCT01136733|517095766|FG000|Phase 1b|Adverse Event|0|||
143423752|NCT01136733|517095767|FG001|Phase 1b|Adverse Event|3|||
143423753|NCT01136733|517095768|FG002|Phase 1b|Adverse Event|1|||
143423754|NCT01136733|517095769|FG003|Phase 1b|Adverse Event|0|||
143423755|NCT01136733|517095770|FG004|Phase 1b|Adverse Event|0|||
143423756|NCT01136733|517095771|FG005|Phase 1b|Adverse Event|0|||
143423757|NCT01136733|517095772|FG006|Phase 1b|Adverse Event|0|||
143423758|NCT01136733|517095766|FG000|Phase 1b|Participant Choice|0|||
143423759|NCT01136733|517095767|FG001|Phase 1b|Participant Choice|0|||
143423760|NCT01136733|517095768|FG002|Phase 1b|Participant Choice|1|||
143423761|NCT01136733|517095769|FG003|Phase 1b|Participant Choice|0|||
143423762|NCT01136733|517095770|FG004|Phase 1b|Participant Choice|0|||
143423763|NCT01136733|517095771|FG005|Phase 1b|Participant Choice|0|||
143423764|NCT01136733|517095772|FG006|Phase 1b|Participant Choice|0|||
143423765|NCT01136733|517095766|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
143423766|NCT01136733|517095767|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
143423767|NCT01136733|517095768|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
143423768|NCT01136733|517095769|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
143423769|NCT01136733|517095770|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
143423770|NCT01136733|517095771|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
143423771|NCT01136733|517095772|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
143423772|NCT01136733|517095766|FG000|Phase 1b|Clinical Progression|1|||
143423773|NCT01136733|517095767|FG001|Phase 1b|Clinical Progression|1|||
143423774|NCT01136733|517095768|FG002|Phase 1b|Clinical Progression|0|||
143423775|NCT01136733|517095769|FG003|Phase 1b|Clinical Progression|0|||
143423776|NCT01136733|517095770|FG004|Phase 1b|Clinical Progression|0|||
143423777|NCT01136733|517095771|FG005|Phase 1b|Clinical Progression|0|||
143423778|NCT01136733|517095772|FG006|Phase 1b|Clinical Progression|0|||
143423779|NCT01136733|517095766|FG000|Phase 2|Disease Progression|0|||
143423780|NCT01136733|517095767|FG001|Phase 2|Disease Progression|0|||
143423781|NCT01136733|517095768|FG002|Phase 2|Disease Progression|0|||
143423782|NCT01136733|517095769|FG003|Phase 2|Disease Progression|0|||
143423783|NCT01136733|517095770|FG004|Phase 2|Disease Progression|30|||
143423784|NCT01136733|517095771|FG005|Phase 2|Disease Progression|32|||
143423785|NCT01136733|517095772|FG006|Phase 2|Disease Progression|38|||
143423786|NCT01136733|517095766|FG000|Phase 2|Adverse Event|0|||
143423787|NCT01136733|517095767|FG001|Phase 2|Adverse Event|0|||
143423788|NCT01136733|517095768|FG002|Phase 2|Adverse Event|0|||
143423789|NCT01136733|517095769|FG003|Phase 2|Adverse Event|0|||
143423790|NCT01136733|517095770|FG004|Phase 2|Adverse Event|11|||
143423791|NCT01136733|517095771|FG005|Phase 2|Adverse Event|13|||
143423792|NCT01136733|517095772|FG006|Phase 2|Adverse Event|5|||
143423793|NCT01136733|517095766|FG000|Phase 2|Participant Choice|0|||
143423794|NCT01136733|517095767|FG001|Phase 2|Participant Choice|0|||
143423795|NCT01136733|517095768|FG002|Phase 2|Participant Choice|0|||
143423796|NCT01136733|517095769|FG003|Phase 2|Participant Choice|0|||
143423797|NCT01136733|517095770|FG004|Phase 2|Participant Choice|3|||
143423798|NCT01136733|517095771|FG005|Phase 2|Participant Choice|0|||
143423799|NCT01136733|517095772|FG006|Phase 2|Participant Choice|1|||
143423800|NCT01136733|517095766|FG000|Phase 2|Administrative-Withdrew Consent|0|||
143423801|NCT01136733|517095767|FG001|Phase 2|Administrative-Withdrew Consent|0|||
143423802|NCT01136733|517095768|FG002|Phase 2|Administrative-Withdrew Consent|0|||
143423803|NCT01136733|517095769|FG003|Phase 2|Administrative-Withdrew Consent|0|||
143423804|NCT01136733|517095770|FG004|Phase 2|Administrative-Withdrew Consent|1|||
143423805|NCT01136733|517095771|FG005|Phase 2|Administrative-Withdrew Consent|0|||
143423806|NCT01136733|517095772|FG006|Phase 2|Administrative-Withdrew Consent|0|||
143423807|NCT01136733|517095766|FG000|Phase 2|Other|0|||
143423808|NCT01136733|517095767|FG001|Phase 2|Other|0|||
143423809|NCT01136733|517095768|FG002|Phase 2|Other|0|||
143423810|NCT01136733|517095769|FG003|Phase 2|Other|0|||
143423811|NCT01136733|517095770|FG004|Phase 2|Other|6|||
143423812|NCT01136733|517095771|FG005|Phase 2|Other|7|||
143423813|NCT01136733|517095772|FG006|Phase 2|Other|6|||
143423814|NCT01745380|517095773|FG000|Overall Study|Lost to Follow-up|1|||
143423815|NCT01745380|517095774|FG001|Overall Study|Lost to Follow-up|0|||
143423816|NCT01745380|517095773|FG000|Overall Study|Lack of Efficacy|0|||
143423817|NCT01745380|517095774|FG001|Overall Study|Lack of Efficacy|1|||
143423818|NCT02368691|517095775|FG000|Overall Study|Death|13|||
143423819|NCT02368691|517095775|FG000|Overall Study|Lack of Efficacy|15|||
143423820|NCT02368691|517095775|FG000|Overall Study|Physician Decision|4|||
143423821|NCT02660034|517095776|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
143423822|NCT02660034|517095777|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
143423823|NCT02660034|517095778|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
143423824|NCT02660034|517095779|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
143423825|NCT02660034|517095780|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
143423826|NCT02660034|517095781|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
143423827|NCT02660034|517095782|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
143423828|NCT02660034|517095783|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
143423829|NCT02660034|517095784|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
143423830|NCT02660034|517095785|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
143423831|NCT02660034|517095786|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
143423832|NCT02660034|517095787|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
143423833|NCT02660034|517095788|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
143423834|NCT02660034|517095789|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
143423835|NCT02660034|517095776|FG000|Overall Study|Progressive Disease (Clinical)|7|||
143423836|NCT02660034|517095777|FG001|Overall Study|Progressive Disease (Clinical)|8|||
143423837|NCT02660034|517095778|FG002|Overall Study|Progressive Disease (Clinical)|3|||
143423838|NCT02660034|517095779|FG003|Overall Study|Progressive Disease (Clinical)|9|||
143423839|NCT02660034|517095780|FG004|Overall Study|Progressive Disease (Clinical)|3|||
143423840|NCT02660034|517095781|FG005|Overall Study|Progressive Disease (Clinical)|0|||
143423841|NCT02660034|517095782|FG006|Overall Study|Progressive Disease (Clinical)|0|||
143423842|NCT02660034|517095783|FG007|Overall Study|Progressive Disease (Clinical)|0|||
143423843|NCT02660034|517095784|FG008|Overall Study|Progressive Disease (Clinical)|0|||
143423844|NCT02660034|517095785|FG009|Overall Study|Progressive Disease (Clinical)|0|||
143423845|NCT02660034|517095786|FG010|Overall Study|Progressive Disease (Clinical)|0|||
143423846|NCT02660034|517095787|FG011|Overall Study|Progressive Disease (Clinical)|0|||
143423847|NCT02660034|517095788|FG012|Overall Study|Progressive Disease (Clinical)|0|||
143423848|NCT02660034|517095789|FG013|Overall Study|Progressive Disease (Clinical)|0|||
143423849|NCT02660034|517095776|FG000|Overall Study|Lost to Follow-up|0|||
143423850|NCT02660034|517095777|FG001|Overall Study|Lost to Follow-up|0|||
143423851|NCT02660034|517095778|FG002|Overall Study|Lost to Follow-up|1|||
143423852|NCT02660034|517095779|FG003|Overall Study|Lost to Follow-up|1|||
143423853|NCT02660034|517095780|FG004|Overall Study|Lost to Follow-up|0|||
143423854|NCT02660034|517095781|FG005|Overall Study|Lost to Follow-up|0|||
143423855|NCT02660034|517095782|FG006|Overall Study|Lost to Follow-up|0|||
143423856|NCT02660034|517095783|FG007|Overall Study|Lost to Follow-up|0|||
143423857|NCT02660034|517095784|FG008|Overall Study|Lost to Follow-up|0|||
143423858|NCT02660034|517095785|FG009|Overall Study|Lost to Follow-up|1|||
143423859|NCT02660034|517095786|FG010|Overall Study|Lost to Follow-up|1|||
143423860|NCT02660034|517095787|FG011|Overall Study|Lost to Follow-up|1|||
143423861|NCT02660034|517095788|FG012|Overall Study|Lost to Follow-up|0|||
143423862|NCT02660034|517095789|FG013|Overall Study|Lost to Follow-up|0|||
143423863|NCT02660034|517095776|FG000|Overall Study|Participant moved into special access scheme|1|||
143423864|NCT02660034|517095777|FG001|Overall Study|Participant moved into special access scheme|2|||
143423865|NCT02660034|517095778|FG002|Overall Study|Participant moved into special access scheme|0|||
143423866|NCT02660034|517095779|FG003|Overall Study|Participant moved into special access scheme|0|||
143423867|NCT02660034|517095780|FG004|Overall Study|Participant moved into special access scheme|0|||
143423868|NCT02660034|517095781|FG005|Overall Study|Participant moved into special access scheme|0|||
143423869|NCT02660034|517095782|FG006|Overall Study|Participant moved into special access scheme|0|||
143423870|NCT02660034|517095783|FG007|Overall Study|Participant moved into special access scheme|0|||
143423871|NCT02660034|517095784|FG008|Overall Study|Participant moved into special access scheme|0|||
143423872|NCT02660034|517095785|FG009|Overall Study|Participant moved into special access scheme|0|||
143423873|NCT02660034|517095786|FG010|Overall Study|Participant moved into special access scheme|0|||
143423874|NCT02660034|517095787|FG011|Overall Study|Participant moved into special access scheme|0|||
143423875|NCT02660034|517095788|FG012|Overall Study|Participant moved into special access scheme|0|||
143423876|NCT02660034|517095789|FG013|Overall Study|Participant moved into special access scheme|0|||
143423877|NCT02660034|517095776|FG000|Overall Study|Adverse Event|1|||
143423878|NCT02660034|517095777|FG001|Overall Study|Adverse Event|0|||
143423879|NCT02660034|517095778|FG002|Overall Study|Adverse Event|0|||
143423880|NCT02660034|517095779|FG003|Overall Study|Adverse Event|0|||
143423881|NCT02660034|517095780|FG004|Overall Study|Adverse Event|0|||
143423882|NCT02660034|517095781|FG005|Overall Study|Adverse Event|0|||
143423883|NCT02660034|517095782|FG006|Overall Study|Adverse Event|0|||
143423884|NCT02660034|517095783|FG007|Overall Study|Adverse Event|0|||
143423885|NCT02660034|517095784|FG008|Overall Study|Adverse Event|0|||
143423886|NCT02660034|517095785|FG009|Overall Study|Adverse Event|0|||
143423887|NCT02660034|517095786|FG010|Overall Study|Adverse Event|0|||
143423888|NCT02660034|517095787|FG011|Overall Study|Adverse Event|0|||
143423889|NCT02660034|517095788|FG012|Overall Study|Adverse Event|0|||
143423890|NCT02660034|517095789|FG013|Overall Study|Adverse Event|0|||
143423891|NCT02660034|517095776|FG000|Overall Study|Sponsor Decision|0|||
143423892|NCT02660034|517095777|FG001|Overall Study|Sponsor Decision|1|||
143423893|NCT02660034|517095778|FG002|Overall Study|Sponsor Decision|2|||
143423894|NCT02660034|517095779|FG003|Overall Study|Sponsor Decision|2|||
143423895|NCT02660034|517095780|FG004|Overall Study|Sponsor Decision|3|||
143423896|NCT02660034|517095781|FG005|Overall Study|Sponsor Decision|0|||
143423897|NCT02660034|517095782|FG006|Overall Study|Sponsor Decision|0|||
143423898|NCT02660034|517095783|FG007|Overall Study|Sponsor Decision|0|||
143423899|NCT02660034|517095784|FG008|Overall Study|Sponsor Decision|0|||
143423900|NCT02660034|517095785|FG009|Overall Study|Sponsor Decision|0|||
143423901|NCT02660034|517095786|FG010|Overall Study|Sponsor Decision|0|||
143423902|NCT02660034|517095787|FG011|Overall Study|Sponsor Decision|0|||
143423903|NCT02660034|517095788|FG012|Overall Study|Sponsor Decision|0|||
143423904|NCT02660034|517095789|FG013|Overall Study|Sponsor Decision|1|||
143423905|NCT02660034|517095776|FG000|Overall Study|Withdrawal by Subject|0|||
143423906|NCT02660034|517095777|FG001|Overall Study|Withdrawal by Subject|0|||
143423907|NCT02660034|517095778|FG002|Overall Study|Withdrawal by Subject|0|||
143423908|NCT02660034|517095779|FG003|Overall Study|Withdrawal by Subject|0|||
143423909|NCT02660034|517095780|FG004|Overall Study|Withdrawal by Subject|0|||
143423910|NCT02660034|517095781|FG005|Overall Study|Withdrawal by Subject|0|||
143423911|NCT02660034|517095782|FG006|Overall Study|Withdrawal by Subject|1|||
143423912|NCT02660034|517095783|FG007|Overall Study|Withdrawal by Subject|1|||
143423913|NCT02660034|517095784|FG008|Overall Study|Withdrawal by Subject|1|||
143423914|NCT02660034|517095785|FG009|Overall Study|Withdrawal by Subject|0|||
143423915|NCT02660034|517095786|FG010|Overall Study|Withdrawal by Subject|0|||
143423916|NCT02660034|517095787|FG011|Overall Study|Withdrawal by Subject|1|||
143423917|NCT02660034|517095788|FG012|Overall Study|Withdrawal by Subject|2|||
143423918|NCT02660034|517095789|FG013|Overall Study|Withdrawal by Subject|0|||
143423919|NCT02660034|517095776|FG000|Overall Study|Death|0|||
143423920|NCT02660034|517095777|FG001|Overall Study|Death|0|||
143423921|NCT02660034|517095778|FG002|Overall Study|Death|0|||
143423922|NCT02660034|517095779|FG003|Overall Study|Death|0|||
143423923|NCT02660034|517095780|FG004|Overall Study|Death|0|||
143423924|NCT02660034|517095781|FG005|Overall Study|Death|13|||
143423925|NCT02660034|517095782|FG006|Overall Study|Death|14|||
143423926|NCT02660034|517095783|FG007|Overall Study|Death|10|||
143423927|NCT02660034|517095784|FG008|Overall Study|Death|9|||
143423928|NCT02660034|517095785|FG009|Overall Study|Death|21|||
143423929|NCT02660034|517095786|FG010|Overall Study|Death|17|||
143423930|NCT02660034|517095787|FG011|Overall Study|Death|15|||
143423931|NCT02660034|517095788|FG012|Overall Study|Death|18|||
143423932|NCT02660034|517095789|FG013|Overall Study|Death|7|||
143423933|NCT02660034|517095776|FG000|Overall Study|Physician Decision|0|||
143423934|NCT02660034|517095777|FG001|Overall Study|Physician Decision|0|||
143423935|NCT02660034|517095778|FG002|Overall Study|Physician Decision|0|||
143423936|NCT02660034|517095779|FG003|Overall Study|Physician Decision|0|||
143423937|NCT02660034|517095780|FG004|Overall Study|Physician Decision|0|||
143423938|NCT02660034|517095781|FG005|Overall Study|Physician Decision|0|||
143423939|NCT02660034|517095782|FG006|Overall Study|Physician Decision|0|||
143423940|NCT02660034|517095783|FG007|Overall Study|Physician Decision|0|||
143423941|NCT02660034|517095784|FG008|Overall Study|Physician Decision|0|||
143423942|NCT02660034|517095785|FG009|Overall Study|Physician Decision|0|||
143423943|NCT02660034|517095786|FG010|Overall Study|Physician Decision|0|||
143423944|NCT02660034|517095787|FG011|Overall Study|Physician Decision|0|||
143423945|NCT02660034|517095788|FG012|Overall Study|Physician Decision|0|||
143423946|NCT02660034|517095789|FG013|Overall Study|Physician Decision|1|||
143423947|NCT02660034|517095776|FG000|Overall Study|Participants transferred to LTE|0|||
143423948|NCT02660034|517095777|FG001|Overall Study|Participants transferred to LTE|0|||
143423949|NCT02660034|517095778|FG002|Overall Study|Participants transferred to LTE|0|||
143423950|NCT02660034|517095779|FG003|Overall Study|Participants transferred to LTE|0|||
143423951|NCT02660034|517095780|FG004|Overall Study|Participants transferred to LTE|0|||
143423952|NCT02660034|517095781|FG005|Overall Study|Participants transferred to LTE|10|||
143423953|NCT02660034|517095782|FG006|Overall Study|Participants transferred to LTE|8|||
143423954|NCT02660034|517095783|FG007|Overall Study|Participants transferred to LTE|8|||
143423955|NCT02660034|517095784|FG008|Overall Study|Participants transferred to LTE|10|||
143423956|NCT02660034|517095785|FG009|Overall Study|Participants transferred to LTE|1|||
143423957|NCT02660034|517095786|FG010|Overall Study|Participants transferred to LTE|2|||
143423958|NCT02660034|517095787|FG011|Overall Study|Participants transferred to LTE|4|||
143423959|NCT02660034|517095788|FG012|Overall Study|Participants transferred to LTE|1|||
143423960|NCT02660034|517095789|FG013|Overall Study|Participants transferred to LTE|1|||
143423961|NCT02069366|517095792|FG000|Overall Study|Lost to Follow-up|0|||
143423962|NCT02069366|517095793|FG001|Overall Study|Lost to Follow-up|0|||
143423963|NCT02069366|517095794|FG002|Overall Study|Lost to Follow-up|1|||
143423964|NCT02069366|517095795|FG003|Overall Study|Lost to Follow-up|0|||
143423965|NCT02069366|517095796|FG004|Overall Study|Lost to Follow-up|0|||
143423966|NCT02069366|517095797|FG005|Overall Study|Lost to Follow-up|2|||
143423967|NCT02069366|517095792|FG000|Overall Study|Protocol Violation|0|||
143423968|NCT02069366|517095793|FG001|Overall Study|Protocol Violation|0|||
143423969|NCT02069366|517095794|FG002|Overall Study|Protocol Violation|1|||
143423970|NCT02069366|517095795|FG003|Overall Study|Protocol Violation|0|||
143423971|NCT02069366|517095796|FG004|Overall Study|Protocol Violation|0|||
143423972|NCT02069366|517095797|FG005|Overall Study|Protocol Violation|0|||
143423973|NCT02069366|517095792|FG000|Overall Study|Withdrawal by Subject|1|||
143423974|NCT02069366|517095793|FG001|Overall Study|Withdrawal by Subject|0|||
143423975|NCT02069366|517095794|FG002|Overall Study|Withdrawal by Subject|1|||
143423976|NCT02069366|517095795|FG003|Overall Study|Withdrawal by Subject|2|||
143423977|NCT02069366|517095796|FG004|Overall Study|Withdrawal by Subject|0|||
143423978|NCT02069366|517095797|FG005|Overall Study|Withdrawal by Subject|0|||
143423979|NCT03314233|517095799|FG000|Overall Study|No longer eligible at time of delivery|1|||
143423980|NCT01797705|517095800|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
143423981|NCT01797705|517095800|FG000|Overall Study|Withdrawal by Subject|1|||
143423982|NCT01838447|517095801|FG000|Overall Study|Change in surgical plan|1|||
143423983|NCT01838447|517095802|FG001|Overall Study|Change in surgical plan|2|||
143423984|NCT01838447|517095801|FG000|Overall Study|Withdrawal by Subject|1|||
143423985|NCT01838447|517095802|FG001|Overall Study|Withdrawal by Subject|1|||
143423986|NCT02030847|517095806|FG000|Overall Study|Death|10|||
143423987|NCT02030847|517095806|FG000|Overall Study|Disease Progression|15|||
143423988|NCT02030847|517095806|FG000|Overall Study|New Cancer Therapy|8|||
143423989|NCT02030847|517095806|FG000|Overall Study|Physician Decision|3|||
143423990|NCT02030847|517095806|FG000|Overall Study|Withdrawal by Subject|1|||
143423991|NCT06247488|517095809|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
143423992|NCT06247488|517095810|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
143423993|NCT06247488|517095811|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
143423994|NCT06247488|517095812|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
143423995|NCT06247488|517095813|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
143423996|NCT06247488|517095814|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
143423997|NCT06247488|517095809|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
143423998|NCT06247488|517095810|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
143423999|NCT06247488|517095811|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
143424000|NCT06247488|517095812|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
143424001|NCT06247488|517095813|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
143424002|NCT06247488|517095814|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
143424003|NCT06247488|517095809|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
143424004|NCT06247488|517095810|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
143424005|NCT06247488|517095811|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
143424006|NCT06247488|517095812|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
143424007|NCT06247488|517095813|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
143424008|NCT06247488|517095814|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
143424009|NCT06247488|517095809|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
143424010|NCT06247488|517095810|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
143424011|NCT06247488|517095811|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
143424012|NCT06247488|517095812|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
143424013|NCT06247488|517095813|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
143424014|NCT06247488|517095814|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
143424015|NCT06247488|517095809|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
143424016|NCT06247488|517095810|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
143424017|NCT06247488|517095811|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
143424018|NCT06247488|517095812|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
143424019|NCT06247488|517095813|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
143424020|NCT06247488|517095814|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
143424021|NCT06247488|517095809|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
143424022|NCT06247488|517095810|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
143424023|NCT06247488|517095811|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
143424024|NCT06247488|517095812|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
143424025|NCT06247488|517095813|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
143424026|NCT06247488|517095814|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
143424027|NCT06247488|517095809|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
143424028|NCT06247488|517095810|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
143424029|NCT06247488|517095811|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
143424030|NCT06247488|517095812|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
143424031|NCT06247488|517095813|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
143424032|NCT06247488|517095814|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
143424033|NCT00460434|517095817|FG000|Overall Study|Lost to Follow-up|3|||
143424034|NCT00460434|517095818|FG001|Overall Study|Lost to Follow-up|7|||
143424035|NCT02722278|517095821|FG000|Overall Study|Withdrawal by Subject|5|||
143424036|NCT02722278|517095822|FG001|Overall Study|Withdrawal by Subject|3|||
143424037|NCT02722278|517095821|FG000|Overall Study|Adverse Event|4|||
143424038|NCT02722278|517095822|FG001|Overall Study|Adverse Event|1|||
143424039|NCT02722278|517095821|FG000|Overall Study|Lost to Follow-up|2|||
143424040|NCT02722278|517095822|FG001|Overall Study|Lost to Follow-up|0|||
143424041|NCT02722278|517095821|FG000|Overall Study|Protocol Violation|1|||
143424042|NCT02722278|517095822|FG001|Overall Study|Protocol Violation|0|||
143424043|NCT02722278|517095821|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
143424044|NCT02722278|517095822|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
143424045|NCT02722278|517095821|FG000|Overall Study|Subject declined after tx assignment|0|||
143424046|NCT02722278|517095822|FG001|Overall Study|Subject declined after tx assignment|1|||
143424047|NCT02722278|517095821|FG000|Overall Study|Site closure not study related|0|||
143424048|NCT02722278|517095822|FG001|Overall Study|Site closure not study related|1|||
143424049|NCT00561678|517095823|FG000|Overall Study|Withdrawal by Subject|4|||
143424050|NCT00561678|517095824|FG001|Overall Study|Withdrawal by Subject|3|||
143424051|NCT00561678|517095823|FG000|Overall Study|surgery cancelled|1|||
143424052|NCT00561678|517095824|FG001|Overall Study|surgery cancelled|1|||
143424053|NCT00561678|517095823|FG000|Overall Study|surgery rescheduled to different site|2|||
143424054|NCT00561678|517095824|FG001|Overall Study|surgery rescheduled to different site|2|||
143424055|NCT00561678|517095823|FG000|Overall Study|anesthesia provider refusal|1|||
143424056|NCT00561678|517095824|FG001|Overall Study|anesthesia provider refusal|0|||
143424057|NCT00422162|517095825|FG000|Overall Study|Adverse Event|11|||
143424058|NCT00422162|517095826|FG001|Overall Study|Adverse Event|9|||
143424059|NCT00422162|517095825|FG000|Overall Study|Lack of Efficacy|4|||
143424060|NCT00422162|517095826|FG001|Overall Study|Lack of Efficacy|10|||
143424061|NCT00422162|517095825|FG000|Overall Study|Withdrawal by Subject|7|||
143424062|NCT00422162|517095826|FG001|Overall Study|Withdrawal by Subject|6|||
143424063|NCT00422162|517095825|FG000|Overall Study|Lost to Follow-up|1|||
143424064|NCT00422162|517095826|FG001|Overall Study|Lost to Follow-up|2|||
143424065|NCT00422162|517095825|FG000|Overall Study|Non-Compliant with Protocol|1|||
143424066|NCT00422162|517095826|FG001|Overall Study|Non-Compliant with Protocol|1|||
143424067|NCT00422162|517095825|FG000|Overall Study|Other|0|||
143424068|NCT00422162|517095826|FG001|Overall Study|Other|1|||
143424069|NCT00422162|517095825|FG000|Overall Study|Didn't Receive Treatment|0|||
143424070|NCT00422162|517095826|FG001|Overall Study|Didn't Receive Treatment|1|||
143424071|NCT05274906|517095828|FG000|Overall Study|Withdrawal by Subject|2|||
143424072|NCT05274906|517095829|FG001|Overall Study|Withdrawal by Subject|1|||
143424073|NCT00848198|517095830|FG000|Overall Study|Incomplete Case Report Forms|15|||
143424074|NCT02604199|517095833|FG000|Overall Study|Pregnancy|0|||
143424075|NCT02604199|517095834|FG001|Overall Study|Pregnancy|0|||
143424076|NCT02604199|517095835|FG002|Overall Study|Pregnancy|0|||
143424077|NCT02604199|517095836|FG003|Overall Study|Pregnancy|1|||
143424078|NCT02604199|517095833|FG000|Overall Study|Study terminated by sponsor|0|||
143424079|NCT02604199|517095834|FG001|Overall Study|Study terminated by sponsor|2|||
143424080|NCT02604199|517095835|FG002|Overall Study|Study terminated by sponsor|0|||
143424081|NCT02604199|517095836|FG003|Overall Study|Study terminated by sponsor|2|||
143424082|NCT02604199|517095833|FG000|Overall Study|Withdrawal by Subject|0|||
143424083|NCT02604199|517095834|FG001|Overall Study|Withdrawal by Subject|1|||
143424084|NCT02604199|517095835|FG002|Overall Study|Withdrawal by Subject|0|||
143424085|NCT02604199|517095836|FG003|Overall Study|Withdrawal by Subject|0|||
143424086|NCT00460577|517095841|FG000|Overall Study|Protocol Violation|2|||
143424087|NCT00460577|517095842|FG001|Overall Study|Protocol Violation|6|||
143424088|NCT01622088|517095845|FG000|Overall Study|Adverse Event|20|||
143424089|NCT01622088|517095845|FG000|Overall Study|Lost to Follow-up|1|||
143424090|NCT01622088|517095845|FG000|Overall Study|Withdrawal by Subject|20|||
143424091|NCT01622088|517095845|FG000|Overall Study|Investigator Decision|1|||
143424092|NCT01622088|517095845|FG000|Overall Study|Death|53|||
143424093|NCT01622088|517095845|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
143424094|NCT00134056|517095850|FG000|Randomization|Not eligible for assigned treatment|22|||
143424095|NCT00134056|517095851|FG001|Randomization|Not eligible for assigned treatment|20|||
143424096|NCT00134056|517095850|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
143424097|NCT00134056|517095851|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
143424098|NCT00134056|517095850|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
143424099|NCT00134056|517095851|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
143424100|NCT00134056|517095850|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
143424101|NCT00134056|517095851|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
143424102|NCT00134056|517095850|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
143424103|NCT00134056|517095851|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
143424104|NCT03166215|517095852|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
143424105|NCT03166215|517095853|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
143424106|NCT03166215|517095854|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
143424107|NCT03166215|517095852|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
143424108|NCT03166215|517095853|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
143424109|NCT03166215|517095854|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
143424110|NCT04362176|517095855|FG000|Overall Study|Lost to Follow-up|5|||
143424111|NCT04362176|517095856|FG001|Overall Study|Lost to Follow-up|8|||
143424112|NCT04362176|517095855|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
143424113|NCT04362176|517095856|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
143424114|NCT00742560|517095857|FG000|Overall Study|Adverse Event|0|||
143424115|NCT00742560|517095858|FG001|Overall Study|Adverse Event|0|||
143424116|NCT00742560|517095859|FG002|Overall Study|Adverse Event|1|||
143424117|NCT00742560|517095860|FG003|Overall Study|Adverse Event|1|||
143424118|NCT00742560|517095861|FG004|Overall Study|Adverse Event|1|||
143424119|NCT00742560|517095857|FG000|Overall Study|Death|0|||
143424120|NCT00742560|517095858|FG001|Overall Study|Death|2|||
143424121|NCT00742560|517095859|FG002|Overall Study|Death|0|||
143424122|NCT00742560|517095860|FG003|Overall Study|Death|2|||
143424123|NCT00742560|517095861|FG004|Overall Study|Death|3|||
143424124|NCT00742560|517095857|FG000|Overall Study|Subject's Decision|1|||
143424125|NCT00742560|517095858|FG001|Overall Study|Subject's Decision|0|||
143424126|NCT00742560|517095859|FG002|Overall Study|Subject's Decision|2|||
143424127|NCT00742560|517095860|FG003|Overall Study|Subject's Decision|3|||
143424128|NCT00742560|517095861|FG004|Overall Study|Subject's Decision|3|||
143424129|NCT00742560|517095857|FG000|Overall Study|Investigator's Decision|0|||
143424130|NCT00742560|517095858|FG001|Overall Study|Investigator's Decision|0|||
143424131|NCT00742560|517095859|FG002|Overall Study|Investigator's Decision|4|||
143424132|NCT00742560|517095860|FG003|Overall Study|Investigator's Decision|1|||
143424133|NCT00742560|517095861|FG004|Overall Study|Investigator's Decision|0|||
143424134|NCT00742560|517095857|FG000|Overall Study|Disease Progression|1|||
143424135|NCT00742560|517095858|FG001|Overall Study|Disease Progression|0|||
143424136|NCT00742560|517095859|FG002|Overall Study|Disease Progression|5|||
143424137|NCT00742560|517095860|FG003|Overall Study|Disease Progression|17|||
143424138|NCT00742560|517095861|FG004|Overall Study|Disease Progression|16|||
143424139|NCT00742560|517095857|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
143424140|NCT00742560|517095858|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
143424141|NCT00742560|517095859|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
143424142|NCT00742560|517095860|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
143424143|NCT00742560|517095861|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
143424144|NCT00742560|517095857|FG000|Overall Study|Other|0|||
143424145|NCT00742560|517095858|FG001|Overall Study|Other|1|||
143424146|NCT00742560|517095859|FG002|Overall Study|Other|8|||
143424147|NCT00742560|517095860|FG003|Overall Study|Other|9|||
143424148|NCT00742560|517095861|FG004|Overall Study|Other|9|||
143424149|NCT00742560|517095857|FG000|Overall Study|MIssing|0|||
143424150|NCT00742560|517095858|FG001|Overall Study|MIssing|0|||
143424151|NCT00742560|517095859|FG002|Overall Study|MIssing|0|||
143424152|NCT00742560|517095860|FG003|Overall Study|MIssing|0|||
143424153|NCT00742560|517095861|FG004|Overall Study|MIssing|1|||
143424154|NCT01536795|517095863|FG000|Overall Study|Lost to Follow-up|0|||
143424155|NCT01536795|517095864|FG001|Overall Study|Lost to Follow-up|2|||
143424156|NCT01536795|517095863|FG000|Overall Study|Lack of Efficacy|1|||
143424157|NCT01536795|517095864|FG001|Overall Study|Lack of Efficacy|0|||
143424158|NCT01812837|517095865|FG000|Overall Study|Lost to Follow-up|1|||
143424159|NCT01812837|517095866|FG001|Overall Study|Lost to Follow-up|1|||
143424160|NCT01812837|517095867|FG002|Overall Study|Lost to Follow-up|0|||
143424161|NCT01812837|517095865|FG000|Overall Study|Protocol Violation|1|||
143424162|NCT01812837|517095866|FG001|Overall Study|Protocol Violation|0|||
143424163|NCT01812837|517095867|FG002|Overall Study|Protocol Violation|0|||
143424164|NCT01760876|517095868|FG000|Overall Study|Non-cardiac death (head injury)|1|||
143424165|NCT01760876|517095868|FG000|Overall Study|Carcinoma of prostate|1|||
143424166|NCT01760876|517095868|FG000|Overall Study|Impaired renal function|1|||
143424167|NCT01760876|517095868|FG000|Overall Study|Major depression|1|||
143424168|NCT01760876|517095868|FG000|Overall Study|Very poor baseline OCT quality|2|||
143424169|NCT00732498|517095872|FG000|Overall Study|Ineligible|1|||
143424170|NCT00732498|517095872|FG000|Overall Study|Adverse Event|2|||
143424171|NCT00732498|517095872|FG000|Overall Study|Physician Decision|3|||
143424172|NCT03686176|517095875|FG000|Overall Study|Procedure cancelled|1|||
143424173|NCT03686176|517095876|FG001|Overall Study|Procedure cancelled|0|||
143424174|NCT03686176|517095877|FG002|Overall Study|Procedure cancelled|0|||
143424175|NCT03686176|517095875|FG000|Overall Study|VR Malfunction|1|||
143424176|NCT03686176|517095876|FG001|Overall Study|VR Malfunction|0|||
143424177|NCT03686176|517095877|FG002|Overall Study|VR Malfunction|0|||
143424178|NCT04295499|517095885|FG000|Overall Study|moving out of state|1|||
143424179|NCT04295499|517095886|FG001|Overall Study|moving out of state|0|||
143424180|NCT04295499|517095885|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
143424181|NCT04295499|517095886|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
143424182|NCT03122548|517095889|FG000|Overall Study|Death|2|||
143424183|NCT03122548|517095889|FG000|Overall Study|Progression - subject went into hospice|1|||
143424184|NCT03122548|517095889|FG000|Overall Study|Study Terminated by Sponsor|2|||
143424185|NCT00308113|517095890|FG000|Overall Study|Protocol closure|0|||
143424186|NCT00308113|517095891|FG001|Overall Study|Protocol closure|0|||
143424187|NCT00308113|517095892|FG002|Overall Study|Protocol closure|0|||
143424188|NCT00308113|517095893|FG003|Overall Study|Protocol closure|1|||
143424189|NCT04448561|517095894|FG000|Overall Study|Noncompliance|1|||
143424190|NCT04448561|517095895|FG001|Overall Study|Noncompliance|0|||
143424191|NCT00676195|517097421|FG000|Overall Study|Lost to Follow-up|1|||
143424192|NCT00676195|517097421|FG000|Overall Study|Adverse Event|1|||
143424193|NCT00676195|517097421|FG000|Overall Study|Physician Decision|1|||
143424194|NCT02878590|517097422|FG000|Overall Study|Withdrawal by Subject|2|||
143424195|NCT03050372|517097424|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
143424196|NCT03050372|517097425|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
143424197|NCT03050372|517097424|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
143424198|NCT03050372|517097425|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
143424199|NCT02123797|517097428|FG000|Baseline Intervention|Death|9|||
143424200|NCT02123797|517097429|FG001|Baseline Intervention|Death|16|||
143424201|NCT02123797|517097430|FG002|Baseline Intervention|Death|0|||
143424202|NCT02123797|517097431|FG003|Baseline Intervention|Death|0|||
143424203|NCT02123797|517097432|FG004|Baseline Intervention|Death|0|||
143424204|NCT02123797|517097428|FG000|Baseline Intervention|Withdrawal by Subject|2|||
143424205|NCT02123797|517097429|FG001|Baseline Intervention|Withdrawal by Subject|8|||
143424206|NCT02123797|517097430|FG002|Baseline Intervention|Withdrawal by Subject|0|||
143424207|NCT02123797|517097431|FG003|Baseline Intervention|Withdrawal by Subject|0|||
143424208|NCT02123797|517097432|FG004|Baseline Intervention|Withdrawal by Subject|0|||
143424209|NCT02123797|517097428|FG000|Baseline Intervention|Relocation|2|||
143424210|NCT02123797|517097429|FG001|Baseline Intervention|Relocation|0|||
143424211|NCT02123797|517097430|FG002|Baseline Intervention|Relocation|0|||
143424212|NCT02123797|517097431|FG003|Baseline Intervention|Relocation|0|||
143424213|NCT02123797|517097432|FG004|Baseline Intervention|Relocation|0|||
143424214|NCT02123797|517097428|FG000|Baseline Intervention|Out of window for initial survey|6|||
143424215|NCT02123797|517097429|FG001|Baseline Intervention|Out of window for initial survey|13|||
143424216|NCT02123797|517097430|FG002|Baseline Intervention|Out of window for initial survey|0|||
143424217|NCT02123797|517097431|FG003|Baseline Intervention|Out of window for initial survey|0|||
143424218|NCT02123797|517097432|FG004|Baseline Intervention|Out of window for initial survey|0|||
143424219|NCT02123797|517097428|FG000|Baseline Intervention|Lost to Follow-up|0|||
143424220|NCT02123797|517097429|FG001|Baseline Intervention|Lost to Follow-up|5|||
143424221|NCT02123797|517097430|FG002|Baseline Intervention|Lost to Follow-up|0|||
143424222|NCT02123797|517097431|FG003|Baseline Intervention|Lost to Follow-up|0|||
143424223|NCT02123797|517097432|FG004|Baseline Intervention|Lost to Follow-up|0|||
143424224|NCT02123797|517097428|FG000|Baseline Intervention|Other Disease|3|||
143424225|NCT02123797|517097429|FG001|Baseline Intervention|Other Disease|0|||
143424226|NCT02123797|517097430|FG002|Baseline Intervention|Other Disease|0|||
143424227|NCT02123797|517097431|FG003|Baseline Intervention|Other Disease|0|||
143424228|NCT02123797|517097432|FG004|Baseline Intervention|Other Disease|0|||
143424229|NCT02123797|517097428|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
143424230|NCT02123797|517097429|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
143424231|NCT02123797|517097430|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
143424232|NCT02123797|517097431|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
143424233|NCT02123797|517097432|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
143424234|NCT02123797|517097428|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
143424235|NCT02123797|517097429|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
143424236|NCT02123797|517097430|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
143424237|NCT02123797|517097431|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
143424238|NCT02123797|517097432|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
143424239|NCT02123797|517097428|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
143424240|NCT02123797|517097429|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
143424241|NCT02123797|517097430|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
143424242|NCT02123797|517097431|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
143424243|NCT02123797|517097432|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
143424244|NCT02123797|517097428|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
143424245|NCT02123797|517097429|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
143424246|NCT02123797|517097430|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
143424247|NCT02123797|517097431|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
143424248|NCT02123797|517097432|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
143424249|NCT02123797|517097428|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
143424250|NCT02123797|517097429|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
143424251|NCT02123797|517097430|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
143424252|NCT02123797|517097431|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
143424253|NCT02123797|517097432|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
143424254|NCT02123797|517097428|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
143424255|NCT02123797|517097429|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
143424256|NCT02123797|517097430|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
143424257|NCT02123797|517097431|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
143424258|NCT02123797|517097432|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
143424259|NCT02123797|517097428|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
143424260|NCT02123797|517097429|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
143424261|NCT02123797|517097430|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
143424262|NCT02123797|517097431|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
143424263|NCT02123797|517097432|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
143424264|NCT02123797|517097428|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
143424265|NCT02123797|517097429|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
143424266|NCT02123797|517097430|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
143424267|NCT02123797|517097431|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
143424268|NCT02123797|517097432|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
143424269|NCT02123797|517097428|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
143424270|NCT02123797|517097429|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
143424271|NCT02123797|517097430|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
143424272|NCT02123797|517097431|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
143424273|NCT02123797|517097432|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
143424274|NCT05878990|517097433|FG000|Overall Study|Lost to Follow-up|7|||
143424275|NCT05878990|517097433|FG000|Overall Study|Withdrawal by Subject|1|||
143424276|NCT00396409|517097439|FG000|Period 1 - 2007|Adverse Event|0|||
143424277|NCT00396409|517097440|FG001|Period 1 - 2007|Adverse Event|1|||
143424278|NCT00396409|517097439|FG000|Period 1 - 2007|Lack of Efficacy|0|||
143424279|NCT00396409|517097440|FG001|Period 1 - 2007|Lack of Efficacy|1|||
143424280|NCT00396409|517097439|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
143424281|NCT00396409|517097440|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
143424282|NCT00396409|517097439|FG000|Period 1 - 2007|Lost to Follow-up|2|||
143424283|NCT00396409|517097440|FG001|Period 1 - 2007|Lost to Follow-up|3|||
143424284|NCT00396409|517097439|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
143424285|NCT00396409|517097440|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
143424286|NCT00396409|517097439|FG000|Period 2 - 2008|Protocol Violation|1|||
143424287|NCT00396409|517097440|FG001|Period 2 - 2008|Protocol Violation|0|||
143424288|NCT00396409|517097439|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
143424289|NCT00396409|517097440|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
143424290|NCT00396409|517097439|FG000|Period 2 - 2008|Lost to Follow-up|3|||
143424291|NCT00396409|517097440|FG001|Period 2 - 2008|Lost to Follow-up|1|||
143424292|NCT00331799|517097441|FG000|Overall Study|Withdrawal by Subject|2|||
143424293|NCT00331799|517097441|FG000|Overall Study|Sedation|1|||
143424294|NCT02889809|517097442|FG000|Overall Study|Withdrawal by Subject|30|||
143424295|NCT02889809|517097443|FG001|Overall Study|Withdrawal by Subject|21|||
143424296|NCT02889809|517097442|FG000|Overall Study|Lost to Follow-up|1|||
143424297|NCT02889809|517097443|FG001|Overall Study|Lost to Follow-up|1|||
143424298|NCT02889809|517097442|FG000|Overall Study|Site Closed|12|||
143424299|NCT02889809|517097443|FG001|Overall Study|Site Closed|11|||
143424300|NCT04203199|517097446|FG000|First Intervention Period|Lost to Follow-up|0|||
143424301|NCT04203199|517097447|FG001|First Intervention Period|Lost to Follow-up|1|||
143424302|NCT04203199|517097446|FG000|Second Intervention Period|Medication change|1|||
143424303|NCT04203199|517097447|FG001|Second Intervention Period|Medication change|0|||
143424304|NCT01837719|517097458|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
143424305|NCT01837719|517097458|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
143424306|NCT01703988|517097459|FG000|Overall Study|Investigator Judgment|0|||
143424307|NCT01703988|517097460|FG001|Overall Study|Investigator Judgment|0|||
143424308|NCT01703988|517097461|FG002|Overall Study|Investigator Judgment|0|||
143424309|NCT01703988|517097462|FG003|Overall Study|Investigator Judgment|1|||
143424310|NCT02995733|517097463|FG000|Overall Study|Study site closed|9|||
143424311|NCT02995733|517097464|FG001|Overall Study|Study site closed|10|||
143424312|NCT02995733|517097463|FG000|Overall Study|Death|3|||
143424313|NCT02995733|517097464|FG001|Overall Study|Death|4|||
143424314|NCT02995733|517097463|FG000|Overall Study|Withdrawal by Subject|6|||
143424315|NCT02995733|517097464|FG001|Overall Study|Withdrawal by Subject|2|||
143424316|NCT02995733|517097463|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
143424317|NCT02995733|517097464|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
143424318|NCT02995733|517097463|FG000|Overall Study|Lost to Follow-up|48|||
143424319|NCT02995733|517097464|FG001|Overall Study|Lost to Follow-up|37|||
143424320|NCT02995733|517097463|FG000|Overall Study|Other|0|||
143424321|NCT02995733|517097464|FG001|Overall Study|Other|1|||
143424322|NCT02720198|517097465|FG000|Overall Study|Withdrawal by Subject|0|||
143424323|NCT02720198|517097466|FG001|Overall Study|Withdrawal by Subject|1|||
143424324|NCT01103141|517097469|FG000|Overall Study|Death|0|||
143424325|NCT01103141|517097470|FG001|Overall Study|Death|1|||
143424326|NCT01103141|517097469|FG000|Overall Study|Lost to Follow-up|2|||
143424327|NCT01103141|517097470|FG001|Overall Study|Lost to Follow-up|1|||
143424328|NCT01403805|517097471|FG000|Overall Study|Withdrawal by Subject|0|||
143424329|NCT01403805|517097472|FG001|Overall Study|Withdrawal by Subject|4|||
143424330|NCT01403805|517097471|FG000|Overall Study|Lost to Follow-up|0|||
143424331|NCT01403805|517097472|FG001|Overall Study|Lost to Follow-up|2|||
143424332|NCT01403805|517097471|FG000|Overall Study|Death|0|||
143424333|NCT01403805|517097472|FG001|Overall Study|Death|1|||
143424334|NCT00147745|517097473|FG000|Overall Study|Withdrawal by Subject|1|||
143424335|NCT00147745|517097474|FG001|Overall Study|Withdrawal by Subject|0|||
143424336|NCT00147745|517097475|FG002|Overall Study|Withdrawal by Subject|0|||
143424337|NCT04043806|517097484|FG000|Overall Study|Commercial drug is available for participants|13|||
143424338|NCT04043806|517097484|FG000|Overall Study|Physician Decision|2|||
143424339|NCT04043806|517097484|FG000|Overall Study|Other|12|||
143424340|NCT04043806|517097484|FG000|Overall Study|Adverse Event|2|||
143424341|NCT04043806|517097484|FG000|Overall Study|Lost to Follow-up|6|||
143424342|NCT04043806|517097484|FG000|Overall Study|Other non-compliance|2|||
143424343|NCT04043806|517097484|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
143424344|NCT04043806|517097484|FG000|Overall Study|Never Dosed|1|||
143424345|NCT03045302|517097485|FG000|Overall Study|Pre-treatment adverse event|1|||
143424346|NCT05234632|517097489|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
143424347|NCT05234632|517097490|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
143424348|NCT05234632|517097489|FG000|Overall Study|Withdrawal by Subject|2|||
143424349|NCT05234632|517097490|FG001|Overall Study|Withdrawal by Subject|0|||
143424350|NCT05234632|517097489|FG000|Overall Study|Adverse Event|0|||
143424351|NCT05234632|517097490|FG001|Overall Study|Adverse Event|4|||
143424352|NCT05234632|517097489|FG000|Overall Study|Physician Decision|1|||
143424353|NCT05234632|517097490|FG001|Overall Study|Physician Decision|1|||
143424354|NCT05234632|517097489|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
143424355|NCT05234632|517097490|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
143424356|NCT05234632|517097489|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
143424357|NCT05234632|517097490|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
143424358|NCT04799587|517097491|FG000|Overall Study|Withdrawal by Subject|0|||
143424359|NCT04799587|517097492|FG001|Overall Study|Withdrawal by Subject|1|||
143424360|NCT04985604|517097493|FG000|Overall Study|Death|4|||
143424361|NCT04985604|517097494|FG001|Overall Study|Death|6|||
143424362|NCT04985604|517097493|FG000|Overall Study|Withdrawal by Subject|0|||
143424363|NCT04985604|517097494|FG001|Overall Study|Withdrawal by Subject|1|||
143424364|NCT04598776|517097495|FG000|Overall Study|Protocol Violation|5|||
143424365|NCT04598776|517097495|FG000|Overall Study|Physician Decision|4|||
143424366|NCT00348283|517097496|FG000|Induction|Adverse Event|0|||
143424367|NCT00348283|517097497|FG001|Induction|Adverse Event|2|||
143424368|NCT00348283|517097496|FG000|Induction|Protocol Violation|0|||
143424369|NCT00348283|517097497|FG001|Induction|Protocol Violation|4|||
143424370|NCT00348283|517097496|FG000|Double Blind|Adverse Event|2|||
143424371|NCT00348283|517097497|FG001|Double Blind|Adverse Event|5|||
143424372|NCT00348283|517097496|FG000|Double Blind|Withdrawal by Subject|1|||
143424373|NCT00348283|517097497|FG001|Double Blind|Withdrawal by Subject|1|||
143424374|NCT00348283|517097496|FG000|Double Blind|Protocol Violation|0|||
143424375|NCT00348283|517097497|FG001|Double Blind|Protocol Violation|1|||
143424376|NCT00348283|517097496|FG000|Double Blind|Lack of Efficacy|2|||
143424377|NCT00348283|517097497|FG001|Double Blind|Lack of Efficacy|2|||
143424378|NCT00348283|517097496|FG000|Double Blind|Pregnancy|0|||
143424379|NCT00348283|517097497|FG001|Double Blind|Pregnancy|1|||
143424380|NCT00348283|517097496|FG000|Open Label|Adverse Event|0|||
143424381|NCT00348283|517097497|FG001|Open Label|Adverse Event|8|||
143424382|NCT00348283|517097496|FG000|Open Label|Withdrawal by Subject|0|||
143424383|NCT00348283|517097497|FG001|Open Label|Withdrawal by Subject|4|||
143424384|NCT00348283|517097496|FG000|Open Label|Lost to Follow-up|0|||
143424385|NCT00348283|517097497|FG001|Open Label|Lost to Follow-up|1|||
143424386|NCT00348283|517097496|FG000|Open Label|Lack of Efficacy|0|||
143424387|NCT00348283|517097497|FG001|Open Label|Lack of Efficacy|13|||
143424388|NCT00348283|517097496|FG000|Open Label|Administrative reasons|0|||
143424389|NCT00348283|517097497|FG001|Open Label|Administrative reasons|5|||
143424390|NCT00348283|517097496|FG000|Open Label|Subject moved to the United States|0|||
143424391|NCT00348283|517097497|FG001|Open Label|Subject moved to the United States|1|||
143424392|NCT00348283|517097496|FG000|Open Label|Pregnancy|0|||
143424393|NCT00348283|517097497|FG001|Open Label|Pregnancy|1|||
143424394|NCT00348283|517097496|FG000|Open Label|Sponsor decision|0|||
143424395|NCT00348283|517097497|FG001|Open Label|Sponsor decision|1|||
143424396|NCT02282761|517097500|FG000|Overall Study|Death|0|||
143424397|NCT02282761|517097501|FG001|Overall Study|Death|0|||
143424398|NCT02282761|517097502|FG002|Overall Study|Death|1|||
143424399|NCT02282761|517097500|FG000|Overall Study|Adverse Event|6|||
143424400|NCT02282761|517097501|FG001|Overall Study|Adverse Event|2|||
143424401|NCT02282761|517097502|FG002|Overall Study|Adverse Event|0|||
143424402|NCT02282761|517097500|FG000|Overall Study|Lack of Efficacy|11|||
143424403|NCT02282761|517097501|FG001|Overall Study|Lack of Efficacy|6|||
143424404|NCT02282761|517097502|FG002|Overall Study|Lack of Efficacy|17|||
143424405|NCT02282761|517097500|FG000|Overall Study|Lost to Follow-up|2|||
143424406|NCT02282761|517097501|FG001|Overall Study|Lost to Follow-up|2|||
143424407|NCT02282761|517097502|FG002|Overall Study|Lost to Follow-up|1|||
143424408|NCT02282761|517097500|FG000|Overall Study|Physician Decision|0|||
143424409|NCT02282761|517097501|FG001|Overall Study|Physician Decision|0|||
143424410|NCT02282761|517097502|FG002|Overall Study|Physician Decision|2|||
143424411|NCT02282761|517097500|FG000|Overall Study|Withdrawal by Subject|8|||
143424412|NCT02282761|517097501|FG001|Overall Study|Withdrawal by Subject|10|||
143424413|NCT02282761|517097502|FG002|Overall Study|Withdrawal by Subject|16|||
143424414|NCT02282761|517097500|FG000|Overall Study|Other|3|||
143424415|NCT02282761|517097501|FG001|Overall Study|Other|2|||
143424416|NCT02282761|517097502|FG002|Overall Study|Other|1|||
143424417|NCT00658632|517097505|FG000|Overall Study|Adverse Event|13|||
143424418|NCT00658632|517097506|FG001|Overall Study|Adverse Event|11|||
143424419|NCT00658632|517097505|FG000|Overall Study|Lost to Follow-up|25|||
143424420|NCT00658632|517097506|FG001|Overall Study|Lost to Follow-up|23|||
143424421|NCT00658632|517097505|FG000|Overall Study|Withdrawal by Subject|10|||
143424422|NCT00658632|517097506|FG001|Overall Study|Withdrawal by Subject|7|||
143424423|NCT00658632|517097505|FG000|Overall Study|Lack of Efficacy|0|||
143424424|NCT00658632|517097506|FG001|Overall Study|Lack of Efficacy|1|||
143424425|NCT00658632|517097505|FG000|Overall Study|Withdrawal of consent|8|||
143424426|NCT00658632|517097506|FG001|Overall Study|Withdrawal of consent|14|||
143424427|NCT00658632|517097505|FG000|Overall Study|Pregnancy|1|||
143424428|NCT00658632|517097506|FG001|Overall Study|Pregnancy|1|||
143424429|NCT00658632|517097505|FG000|Overall Study|Other|7|||
143424430|NCT00658632|517097506|FG001|Overall Study|Other|8|||
143424431|NCT06312566|517097511|FG000|Overall Study|Protocol Violation|0|||
143424432|NCT06312566|517097512|FG001|Overall Study|Protocol Violation|1|||
143424433|NCT02632045|517097513|FG000|Overall Study|Withdrawal by Subject|1|||
143424434|NCT02632045|517097514|FG001|Overall Study|Withdrawal by Subject|2|||
143424435|NCT05878522|517097515|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
143424436|NCT05878522|517097516|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
143424437|NCT05878522|517097517|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
143424438|NCT05878522|517097518|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
143424439|NCT05878522|517097519|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
143424440|NCT05878522|517097520|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
143424441|NCT05878522|517097521|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
143424442|NCT05878522|517097522|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
143424443|NCT05878522|517097523|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
143424444|NCT05878522|517097524|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
143424445|NCT05878522|517097525|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
143424446|NCT05878522|517097526|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
143424447|NCT05878522|517097515|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
143424448|NCT05878522|517097516|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
143424449|NCT05878522|517097517|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
143424450|NCT05878522|517097518|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
143424451|NCT05878522|517097519|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
143424452|NCT05878522|517097520|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
143424453|NCT05878522|517097521|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
143424454|NCT05878522|517097522|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
143424455|NCT05878522|517097523|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
143424456|NCT05878522|517097524|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
143424457|NCT05878522|517097525|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
143424458|NCT05878522|517097526|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
143424459|NCT05878522|517097515|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
143424460|NCT05878522|517097516|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
143424461|NCT05878522|517097517|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
143424462|NCT05878522|517097518|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
143424463|NCT05878522|517097519|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
143424464|NCT05878522|517097520|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
143424465|NCT05878522|517097521|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
143424466|NCT05878522|517097522|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
143424467|NCT05878522|517097523|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
143424468|NCT05878522|517097524|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
143424469|NCT05878522|517097525|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
143424470|NCT05878522|517097526|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
143424471|NCT05878522|517097515|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
143424472|NCT05878522|517097516|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
143424473|NCT05878522|517097517|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
143424474|NCT05878522|517097518|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
143424475|NCT05878522|517097519|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
143424476|NCT05878522|517097520|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
143424477|NCT05878522|517097521|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
143424478|NCT05878522|517097522|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
143424479|NCT05878522|517097523|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
143424480|NCT05878522|517097524|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
143424481|NCT05878522|517097525|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
143424482|NCT05878522|517097526|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
143424483|NCT03345420|517097529|FG000|Overall Study|Withdrawal by Subject|1|||
143424484|NCT00617708|517097534|FG000|Overall Study|Adverse Event|0|||
143424485|NCT00617708|517097535|FG001|Overall Study|Adverse Event|6|||
143424486|NCT00617708|517097536|FG002|Overall Study|Adverse Event|9|||
143424487|NCT00617708|517097534|FG000|Overall Study|Withdrawal by Subject|1|||
143424488|NCT00617708|517097535|FG001|Overall Study|Withdrawal by Subject|1|||
143424489|NCT00617708|517097536|FG002|Overall Study|Withdrawal by Subject|7|||
143424490|NCT00617708|517097534|FG000|Overall Study|Death|0|||
143424491|NCT00617708|517097535|FG001|Overall Study|Death|6|||
143424492|NCT00617708|517097536|FG002|Overall Study|Death|5|||
143424493|NCT00617708|517097534|FG000|Overall Study|Progression/Relapse|7|||
143424494|NCT00617708|517097535|FG001|Overall Study|Progression/Relapse|40|||
143424495|NCT00617708|517097536|FG002|Overall Study|Progression/Relapse|36|||
143424496|NCT00617708|517097534|FG000|Overall Study|Not protocol specified|1|||
143424497|NCT00617708|517097535|FG001|Overall Study|Not protocol specified|4|||
143424498|NCT00617708|517097536|FG002|Overall Study|Not protocol specified|2|||
143424499|NCT00617708|517097534|FG000|Overall Study|Not eligible|1|||
143424500|NCT00617708|517097535|FG001|Overall Study|Not eligible|3|||
143424501|NCT00617708|517097536|FG002|Overall Study|Not eligible|5|||
143424502|NCT03747575|517097543|FG000|Overall Study|Withdrawal by Subject|6|||
143424503|NCT03747575|517097544|FG001|Overall Study|Withdrawal by Subject|3|||
143424504|NCT03747575|517097543|FG000|Overall Study|Lost to Follow-up|3|||
143424505|NCT03747575|517097544|FG001|Overall Study|Lost to Follow-up|3|||
143424506|NCT03747575|517097543|FG000|Overall Study|Adverse Event|0|||
143424507|NCT03747575|517097544|FG001|Overall Study|Adverse Event|1|||
143424508|NCT02924051|517097549|FG000|Overall Study|Withdrawal by Subject|1|||
143424509|NCT02924051|517097550|FG001|Overall Study|Withdrawal by Subject|9|||
143424510|NCT03005106|517097551|FG000|Overall Study|Lost to Follow-up|16|||
143424511|NCT03005106|517097551|FG000|Overall Study|Adverse Event|1|||
143424512|NCT03005106|517097551|FG000|Overall Study|Physician Decision|1|||
143424513|NCT03005106|517097551|FG000|Overall Study|Death|2|||
143424514|NCT00936065|517097552|FG000|Overall Study|Adverse Event|1|||
143424515|NCT00936065|517097553|FG001|Overall Study|Adverse Event|0|||
143424516|NCT00936065|517097554|FG002|Overall Study|Adverse Event|1|||
143424517|NCT00936065|517097552|FG000|Overall Study|Lack of Efficacy|1|||
143424518|NCT00936065|517097553|FG001|Overall Study|Lack of Efficacy|0|||
143424519|NCT00936065|517097554|FG002|Overall Study|Lack of Efficacy|1|||
143424520|NCT00936065|517097552|FG000|Overall Study|Lost to Follow-up|1|||
143424521|NCT00936065|517097553|FG001|Overall Study|Lost to Follow-up|0|||
143424522|NCT00936065|517097554|FG002|Overall Study|Lost to Follow-up|0|||
143424523|NCT00936065|517097552|FG000|Overall Study|Protocol Violation|1|||
143424524|NCT00936065|517097553|FG001|Overall Study|Protocol Violation|2|||
143424525|NCT00936065|517097554|FG002|Overall Study|Protocol Violation|1|||
143424526|NCT00936065|517097552|FG000|Overall Study|Withdrawal by Subject|0|||
143424527|NCT00936065|517097553|FG001|Overall Study|Withdrawal by Subject|2|||
143424528|NCT00936065|517097554|FG002|Overall Study|Withdrawal by Subject|4|||
143424529|NCT01429285|517097555|FG000|Overall Study|Protocol Violation|9|||
143424530|NCT01429285|517097556|FG001|Overall Study|Protocol Violation|4|||
143424531|NCT01429285|517097555|FG000|Overall Study|Missing Data|5|||
143424532|NCT01429285|517097556|FG001|Overall Study|Missing Data|3|||
143424533|NCT01429285|517097555|FG000|Overall Study|Erroneously Enrolled Twice|8|||
143424534|NCT01429285|517097556|FG001|Overall Study|Erroneously Enrolled Twice|2|||
143424535|NCT00738400|517097557|FG000|Overall Study|Adverse Event|3|||
143424536|NCT00738400|517097558|FG001|Overall Study|Adverse Event|1|||
143424537|NCT00738400|517097557|FG000|Overall Study|Withdrawal by Subject|0|||
143424538|NCT00738400|517097558|FG001|Overall Study|Withdrawal by Subject|1|||
143424539|NCT00738400|517097557|FG000|Overall Study|Lack of Efficacy|0|||
143424540|NCT00738400|517097558|FG001|Overall Study|Lack of Efficacy|1|||
143424541|NCT00738400|517097557|FG000|Overall Study|Lost to Follow-up|0|||
143424542|NCT00738400|517097558|FG001|Overall Study|Lost to Follow-up|3|||
143424543|NCT00738400|517097557|FG000|Overall Study|Protocol Violation|1|||
143424544|NCT00738400|517097558|FG001|Overall Study|Protocol Violation|0|||
143424545|NCT00738400|517097557|FG000|Overall Study|Non-compliant with study medication|0|||
143424546|NCT00738400|517097558|FG001|Overall Study|Non-compliant with study medication|1|||
143424547|NCT01052714|517097565|FG000|Overall Study|Adverse Event|6|||
143424548|NCT01052714|517097566|FG001|Overall Study|Adverse Event|3|||
143424549|NCT01052714|517097567|FG002|Overall Study|Adverse Event|0|||
143424550|NCT01052714|517097565|FG000|Overall Study|Death|1|||
143424551|NCT01052714|517097566|FG001|Overall Study|Death|2|||
143424552|NCT01052714|517097567|FG002|Overall Study|Death|0|||
143424553|NCT01052714|517097565|FG000|Overall Study|Lost to Follow-up|2|||
143424554|NCT01052714|517097566|FG001|Overall Study|Lost to Follow-up|3|||
143424555|NCT01052714|517097567|FG002|Overall Study|Lost to Follow-up|0|||
143424556|NCT01052714|517097565|FG000|Overall Study|Physician Decision|9|||
143424557|NCT01052714|517097566|FG001|Overall Study|Physician Decision|9|||
143424558|NCT01052714|517097567|FG002|Overall Study|Physician Decision|1|||
143424559|NCT01052714|517097565|FG000|Overall Study|Withdrawal by Subject|7|||
143424560|NCT01052714|517097566|FG001|Overall Study|Withdrawal by Subject|12|||
143424561|NCT01052714|517097567|FG002|Overall Study|Withdrawal by Subject|1|||
143424562|NCT03689452|517097574|FG000|Overall Study|Lost to Follow-up|1|||
143424563|NCT03689452|517097575|FG001|Overall Study|Lost to Follow-up|1|||
143424564|NCT02676778|517097576|FG000|Overall Study|Disease Progression|7|||
143424565|NCT02676778|517097577|FG001|Overall Study|Disease Progression|3|||
143424566|NCT02676778|517097578|FG002|Overall Study|Disease Progression|1|||
143424567|NCT02676778|517097576|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
143424568|NCT02676778|517097577|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
143424569|NCT02676778|517097578|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
143424570|NCT02676778|517097576|FG000|Overall Study|Withdrawal by Subject|3|||
143424571|NCT02676778|517097577|FG001|Overall Study|Withdrawal by Subject|2|||
143424572|NCT02676778|517097578|FG002|Overall Study|Withdrawal by Subject|0|||
143424573|NCT02676778|517097576|FG000|Overall Study|Other|4|||
143424574|NCT02676778|517097577|FG001|Overall Study|Other|3|||
143424575|NCT02676778|517097578|FG002|Overall Study|Other|0|||
143424576|NCT02676778|517097576|FG000|Overall Study|Adverse Event|2|||
143424577|NCT02676778|517097577|FG001|Overall Study|Adverse Event|3|||
143424578|NCT02676778|517097578|FG002|Overall Study|Adverse Event|0|||
143424579|NCT03214198|517097586|FG000|Overall Study|Case Report Forms Uncollected|18|||
143424580|NCT03214198|517097586|FG000|Overall Study|Protocol Deviation|18|||
143424581|NCT00267865|517097587|FG000|Induction Treatment|Died before completing.|2|||
143424582|NCT00267865|517097587|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
143424583|NCT04413149|517099196|FG000|Overall Study|Death|10|||
143424584|NCT04413149|517099197|FG001|Overall Study|Death|5|||
143424585|NCT04413149|517099196|FG000|Overall Study|Lung transplantation|1|||
143424586|NCT04413149|517099197|FG001|Overall Study|Lung transplantation|0|||
143424587|NCT02661490|517099200|FG000|Overall Study|Lost to Follow-up|0|||
143424588|NCT02661490|517099201|FG001|Overall Study|Lost to Follow-up|1|||
143424589|NCT02661490|517099202|FG002|Overall Study|Lost to Follow-up|0|||
143424590|NCT02661490|517099203|FG003|Overall Study|Lost to Follow-up|0|||
143424591|NCT02661490|517099204|FG004|Overall Study|Lost to Follow-up|2|||
143424592|NCT02661490|517099200|FG000|Overall Study|Withdrawal by Subject|2|||
143424593|NCT02661490|517099201|FG001|Overall Study|Withdrawal by Subject|0|||
143424594|NCT02661490|517099202|FG002|Overall Study|Withdrawal by Subject|2|||
143424595|NCT02661490|517099203|FG003|Overall Study|Withdrawal by Subject|0|||
143424596|NCT02661490|517099204|FG004|Overall Study|Withdrawal by Subject|0|||
143424597|NCT02661490|517099200|FG000|Overall Study|Death|1|||
143424598|NCT02661490|517099201|FG001|Overall Study|Death|1|||
143424599|NCT02661490|517099202|FG002|Overall Study|Death|0|||
143424600|NCT02661490|517099203|FG003|Overall Study|Death|1|||
143424601|NCT02661490|517099204|FG004|Overall Study|Death|0|||
143424602|NCT02661490|517099200|FG000|Overall Study|Reason not Specified|0|||
143424603|NCT02661490|517099201|FG001|Overall Study|Reason not Specified|0|||
143424604|NCT02661490|517099202|FG002|Overall Study|Reason not Specified|0|||
143424605|NCT02661490|517099203|FG003|Overall Study|Reason not Specified|0|||
143424606|NCT02661490|517099204|FG004|Overall Study|Reason not Specified|1|||
143424607|NCT03322514|517099205|FG000|Overall Study|Withdrawal by Subject|1|||
143424608|NCT03322514|517099206|FG001|Overall Study|Withdrawal by Subject|1|||
143424609|NCT01184859|517099207|FG000|Period 1: Single Dose|Insufficient urine production|0|||
143424610|NCT01184859|517099208|FG001|Period 1: Single Dose|Insufficient urine production|1|||
143424611|NCT01184859|517099209|FG002|Period 1: Single Dose|Insufficient urine production|0|||
143424612|NCT01184859|517099210|FG003|Period 1: Single Dose|Insufficient urine production|0|||
143424613|NCT01184859|517099211|FG004|Period 1: Single Dose|Insufficient urine production|0|||
143424614|NCT01184859|517099207|FG000|Period 1: Single Dose|Protocol Violation|0|||
143424615|NCT01184859|517099208|FG001|Period 1: Single Dose|Protocol Violation|1|||
143424616|NCT01184859|517099209|FG002|Period 1: Single Dose|Protocol Violation|0|||
143424617|NCT01184859|517099210|FG003|Period 1: Single Dose|Protocol Violation|0|||
143424618|NCT01184859|517099211|FG004|Period 1: Single Dose|Protocol Violation|0|||
143424619|NCT01184859|517099207|FG000|Period 1: Single Dose|Adverse Event|0|||
143424620|NCT01184859|517099208|FG001|Period 1: Single Dose|Adverse Event|0|||
143424621|NCT01184859|517099209|FG002|Period 1: Single Dose|Adverse Event|0|||
143424622|NCT01184859|517099210|FG003|Period 1: Single Dose|Adverse Event|0|||
143424623|NCT01184859|517099211|FG004|Period 1: Single Dose|Adverse Event|1|||
143424624|NCT01184859|517099207|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
143424625|NCT01184859|517099208|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
143424626|NCT01184859|517099209|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
143424627|NCT01184859|517099210|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
143424628|NCT01184859|517099211|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
143424629|NCT01184859|517099207|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
143424630|NCT01184859|517099208|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
143424631|NCT01184859|517099209|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
143424632|NCT01184859|517099210|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
143424633|NCT01184859|517099211|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
143424634|NCT00961298|517099212|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
143424635|NCT00961298|517099212|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
143424636|NCT00961298|517099212|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
143424637|NCT00814632|517099213|FG000|Overall Study|Lack of Efficacy|2|||
143424638|NCT02514577|517099217|FG000|Overall Study|Lost to Follow-up|6|||
143424639|NCT02514577|517099218|FG001|Overall Study|Lost to Follow-up|6|||
143424640|NCT02514577|517099217|FG000|Overall Study|Protocol Violation|1|||
143424641|NCT02514577|517099218|FG001|Overall Study|Protocol Violation|0|||
143424642|NCT02514577|517099217|FG000|Overall Study|Withdrawal by Subject|6|||
143424643|NCT02514577|517099218|FG001|Overall Study|Withdrawal by Subject|6|||
143424644|NCT02514577|517099217|FG000|Overall Study|Adverse Event|1|||
143424645|NCT02514577|517099218|FG001|Overall Study|Adverse Event|1|||
143424646|NCT02388932|517099219|FG000|Overall Study|Death|1|||
143424647|NCT01234675|517099226|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
143424648|NCT01234675|517099227|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
143424649|NCT01234675|517099226|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
143424650|NCT01234675|517099227|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
143424651|NCT02186015|517099239|FG000|Overall Study|Physician Decision|1|||
143424652|NCT02186015|517099240|FG001|Overall Study|Physician Decision|0|||
143424653|NCT01533181|517099241|FG000|Overall Study|Disease progression pre-active treatment|0|||
143424654|NCT01533181|517099242|FG001|Overall Study|Disease progression pre-active treatment|1|||
143424655|NCT01533181|517099241|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
143424656|NCT01533181|517099242|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
143424657|NCT01498445|517099245|FG000|Overall Study|Lack of Efficacy|0|||
143424658|NCT01498445|517099246|FG001|Overall Study|Lack of Efficacy|0|||
143424659|NCT01498445|517099247|FG002|Overall Study|Lack of Efficacy|1|||
143424660|NCT01498445|517099248|FG003|Overall Study|Lack of Efficacy|2|||
143424661|NCT01498445|517099249|FG004|Overall Study|Lack of Efficacy|0|||
143424662|NCT01498445|517099250|FG005|Overall Study|Lack of Efficacy|0|||
143424663|NCT01498445|517099245|FG000|Overall Study|Screen Failure|0|||
143424664|NCT01498445|517099246|FG001|Overall Study|Screen Failure|0|||
143424665|NCT01498445|517099247|FG002|Overall Study|Screen Failure|0|||
143424666|NCT01498445|517099248|FG003|Overall Study|Screen Failure|0|||
143424667|NCT01498445|517099249|FG004|Overall Study|Screen Failure|1|||
143424668|NCT01498445|517099250|FG005|Overall Study|Screen Failure|1|||
143424669|NCT02023099|517099251|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
143424670|NCT02023099|517099252|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
143424671|NCT02023099|517099253|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
143424672|NCT02023099|517099251|FG000|Overall Study|Withdrawn Consent|3|||
143424673|NCT02023099|517099252|FG001|Overall Study|Withdrawn Consent|0|||
143424674|NCT02023099|517099253|FG002|Overall Study|Withdrawn Consent|1|||
143424675|NCT02023099|517099251|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
143424676|NCT02023099|517099252|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
143424677|NCT02023099|517099253|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
143424678|NCT00203502|517099254|FG000|Overall Study|Death|1|||
143424679|NCT00105521|517099277|FG000|Overall Study|Other|1|||
143424680|NCT00105521|517099278|FG001|Overall Study|Other|1|||
143424681|NCT00105521|517099279|FG002|Overall Study|Other|2|||
143424682|NCT00105521|517099280|FG003|Overall Study|Other|0|||
143424683|NCT00105521|517099277|FG000|Overall Study|Adverse Event|10|||
143424684|NCT00105521|517099278|FG001|Overall Study|Adverse Event|4|||
143424685|NCT00105521|517099279|FG002|Overall Study|Adverse Event|10|||
143424686|NCT00105521|517099280|FG003|Overall Study|Adverse Event|8|||
143424687|NCT00105521|517099277|FG000|Overall Study|Withdrawal by Subject|1|||
143424688|NCT00105521|517099278|FG001|Overall Study|Withdrawal by Subject|0|||
143424689|NCT00105521|517099279|FG002|Overall Study|Withdrawal by Subject|1|||
143424690|NCT00105521|517099280|FG003|Overall Study|Withdrawal by Subject|4|||
143424691|NCT00105521|517099277|FG000|Overall Study|Lack of Efficacy|0|||
143424692|NCT00105521|517099278|FG001|Overall Study|Lack of Efficacy|0|||
143424693|NCT00105521|517099279|FG002|Overall Study|Lack of Efficacy|0|||
143424694|NCT00105521|517099280|FG003|Overall Study|Lack of Efficacy|1|||
143424695|NCT00105521|517099277|FG000|Overall Study|Protocol Violation|3|||
143424696|NCT00105521|517099278|FG001|Overall Study|Protocol Violation|5|||
143424697|NCT00105521|517099279|FG002|Overall Study|Protocol Violation|4|||
143424698|NCT00105521|517099280|FG003|Overall Study|Protocol Violation|4|||
143424699|NCT00105521|517099277|FG000|Overall Study|Lost to Follow-up|0|||
143424700|NCT00105521|517099278|FG001|Overall Study|Lost to Follow-up|1|||
143424701|NCT00105521|517099279|FG002|Overall Study|Lost to Follow-up|0|||
143424702|NCT00105521|517099280|FG003|Overall Study|Lost to Follow-up|0|||
143424703|NCT00385697|517099282|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
143424704|NCT00385697|517099283|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
143424705|NCT00385697|517099284|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
143424706|NCT00385697|517099285|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
143424707|NCT00385697|517099286|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
143424708|NCT00385697|517099282|FG000|Open-label Segment 1|Lost to Follow-up|1|||
143424709|NCT00385697|517099283|FG001|Open-label Segment 1|Lost to Follow-up|0|||
143424710|NCT00385697|517099284|FG002|Open-label Segment 1|Lost to Follow-up|0|||
143424711|NCT00385697|517099285|FG003|Open-label Segment 1|Lost to Follow-up|0|||
143424712|NCT00385697|517099286|FG004|Open-label Segment 1|Lost to Follow-up|0|||
143424713|NCT00385697|517099282|FG000|Double-blind Segment 2|Adverse Event|0|||
143424714|NCT00385697|517099283|FG001|Double-blind Segment 2|Adverse Event|3|||
143424715|NCT00385697|517099284|FG002|Double-blind Segment 2|Adverse Event|1|||
143424716|NCT00385697|517099285|FG003|Double-blind Segment 2|Adverse Event|0|||
143424717|NCT00385697|517099286|FG004|Double-blind Segment 2|Adverse Event|0|||
143424718|NCT00385697|517099282|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
143424719|NCT00385697|517099283|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
143424720|NCT00385697|517099284|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
143424721|NCT00385697|517099285|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
143424722|NCT00385697|517099286|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
143424723|NCT00385697|517099282|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
143424724|NCT00385697|517099283|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
143424725|NCT00385697|517099284|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
143424726|NCT00385697|517099285|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
143424727|NCT00385697|517099286|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
143424728|NCT00385697|517099282|FG000|Double-blind Segment 2|Other|0|||
143424729|NCT00385697|517099283|FG001|Double-blind Segment 2|Other|2|||
143424730|NCT00385697|517099284|FG002|Double-blind Segment 2|Other|0|||
143424731|NCT00385697|517099285|FG003|Double-blind Segment 2|Other|0|||
143424732|NCT00385697|517099286|FG004|Double-blind Segment 2|Other|0|||
143424733|NCT00510783|517099290|FG000|Overall Study|Lost to Follow-up|29|||
143424734|NCT00510783|517099291|FG001|Overall Study|Lost to Follow-up|25|||
143424735|NCT00510783|517099290|FG000|Overall Study|Withdrawal by Subject|2|||
143424736|NCT00510783|517099291|FG001|Overall Study|Withdrawal by Subject|3|||
143424737|NCT00510783|517099290|FG000|Overall Study|Protocol Violation|0|||
143424738|NCT00510783|517099291|FG001|Overall Study|Protocol Violation|1|||
143424739|NCT00316121|517099292|FG000|Overall Study|Death|1|||
143424740|NCT00316121|517099293|FG001|Overall Study|Death|0|||
143424741|NCT00316121|517099292|FG000|Overall Study|Lost to Follow-up|14|||
143424742|NCT00316121|517099293|FG001|Overall Study|Lost to Follow-up|8|||
143424743|NCT00316121|517099292|FG000|Overall Study|Withdrawal by Subject|2|||
143424744|NCT00316121|517099293|FG001|Overall Study|Withdrawal by Subject|0|||
143424745|NCT00316121|517099292|FG000|Overall Study|Reason is missing|1|||
143424746|NCT00316121|517099293|FG001|Overall Study|Reason is missing|0|||
143424747|NCT00316121|517099292|FG000|Overall Study|Subject relocated|1|||
143424748|NCT00316121|517099293|FG001|Overall Study|Subject relocated|1|||
143424749|NCT00316121|517099292|FG000|Overall Study|Subject refused to return|1|||
143424750|NCT00316121|517099293|FG001|Overall Study|Subject refused to return|0|||
143424751|NCT00316121|517099292|FG000|Overall Study|Subject no show for visit x 3|1|||
143424752|NCT00316121|517099293|FG001|Overall Study|Subject no show for visit x 3|0|||
143424753|NCT00316121|517099292|FG000|Overall Study|Subject did not have 24 month visit|1|||
143424754|NCT00316121|517099293|FG001|Overall Study|Subject did not have 24 month visit|0|||
143424755|NCT00442559|517099294|FG000|Overall Study|Lost to Follow-up|32|||
143424756|NCT00442559|517099295|FG001|Overall Study|Lost to Follow-up|34|||
143424757|NCT00442559|517099294|FG000|Overall Study|Protocol Violation|1|||
143424758|NCT00442559|517099295|FG001|Overall Study|Protocol Violation|1|||
143424759|NCT00442559|517099294|FG000|Overall Study|Withdrawal by Subject|1|||
143424760|NCT00442559|517099295|FG001|Overall Study|Withdrawal by Subject|0|||
143424761|NCT05287178|517099296|FG000|Overall Study|Lost to Follow-up|2|||
143424762|NCT01426217|517099297|FG000|Overall Study|lost sample|8|||
143424763|NCT01426217|517099298|FG001|Overall Study|lost sample|14|||
143424764|NCT01648699|517099299|FG000|Overall Study|Death|1|||
143424765|NCT01648699|517099299|FG000|Overall Study|Lost to Follow-up|2|||
143424766|NCT01648699|517099299|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
143424767|NCT02267746|517099300|FG000|Overall Study|Adverse Event|0|||
143424768|NCT02267746|517099301|FG001|Overall Study|Adverse Event|2|||
143424769|NCT02267746|517099302|FG002|Overall Study|Adverse Event|1|||
143424770|NCT02267746|517099300|FG000|Overall Study|Protocol Violation|8|||
143424771|NCT02267746|517099301|FG001|Overall Study|Protocol Violation|7|||
143424772|NCT02267746|517099302|FG002|Overall Study|Protocol Violation|3|||
143424773|NCT02267746|517099300|FG000|Overall Study|Lack of Efficacy|11|||
143424774|NCT02267746|517099301|FG001|Overall Study|Lack of Efficacy|11|||
143424775|NCT02267746|517099302|FG002|Overall Study|Lack of Efficacy|15|||
143424776|NCT02267746|517099300|FG000|Overall Study|Protocol Violation|1|||
143424777|NCT02267746|517099301|FG001|Overall Study|Protocol Violation|2|||
143424778|NCT02267746|517099302|FG002|Overall Study|Protocol Violation|1|||
143424779|NCT02267746|517099300|FG000|Overall Study|Miscellaneous|1|||
143424780|NCT02267746|517099301|FG001|Overall Study|Miscellaneous|0|||
143424781|NCT02267746|517099302|FG002|Overall Study|Miscellaneous|1|||
143424782|NCT00288353|517099307|FG000|Overall Study|Lack of Efficacy|2|||
143424783|NCT00288353|517099308|FG001|Overall Study|Lack of Efficacy|2|||
143424784|NCT00288353|517099307|FG000|Overall Study|Withdrawal by Subject|5|||
143424785|NCT00288353|517099308|FG001|Overall Study|Withdrawal by Subject|5|||
143424786|NCT05008224|517099309|FG000|Overall Study|Death|3|||
143424787|NCT05008224|517099309|FG000|Overall Study|Lost to Follow-up|2|||
143424788|NCT05008224|517099309|FG000|Overall Study|Did Not Continue on Extension Study|39|||
143424789|NCT05008224|517099309|FG000|Overall Study|Transferred to Extension Study|100|||
143424790|NCT05008224|517099309|FG000|Overall Study|Withdrawal by Subject|2|||
143424791|NCT00728884|517099310|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
143424792|NCT00728884|517099310|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
143424793|NCT05263492|517099311|FG000|Overall Study|Adverse Event|1|||
143424794|NCT05263492|517099311|FG000|Overall Study|Disease progression during active treatment|3|||
143424795|NCT05216835|517099312|FG000|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
143424796|NCT05216835|517099313|FG001|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
143424797|NCT05216835|517099314|FG002|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
143424798|NCT05216835|517099315|FG003|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
143424799|NCT05216835|517099316|FG004|Overall Study|Ongoing as of DCO (30 Aug 2024)|3|||
143424800|NCT05216835|517099317|FG005|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
143424801|NCT05216835|517099318|FG006|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
143424802|NCT05216835|517099319|FG007|Overall Study|Ongoing as of DCO (30 Aug 2024)|9|||
143424803|NCT05216835|517099312|FG000|Overall Study|Death|0|||
143424804|NCT05216835|517099313|FG001|Overall Study|Death|0|||
143424805|NCT05216835|517099314|FG002|Overall Study|Death|0|||
143424806|NCT05216835|517099315|FG003|Overall Study|Death|1|||
143424807|NCT05216835|517099316|FG004|Overall Study|Death|1|||
143424808|NCT05216835|517099317|FG005|Overall Study|Death|1|||
143424809|NCT05216835|517099318|FG006|Overall Study|Death|1|||
143424810|NCT05216835|517099319|FG007|Overall Study|Death|1|||
143424811|NCT05216835|517099312|FG000|Overall Study|Physician Decision|0|||
143424812|NCT05216835|517099313|FG001|Overall Study|Physician Decision|0|||
143424813|NCT05216835|517099314|FG002|Overall Study|Physician Decision|0|||
143424814|NCT05216835|517099315|FG003|Overall Study|Physician Decision|0|||
143424815|NCT05216835|517099316|FG004|Overall Study|Physician Decision|0|||
143424816|NCT05216835|517099317|FG005|Overall Study|Physician Decision|1|||
143424817|NCT05216835|517099318|FG006|Overall Study|Physician Decision|1|||
143424818|NCT05216835|517099319|FG007|Overall Study|Physician Decision|0|||
143424819|NCT05216835|517099312|FG000|Overall Study|Study terminated by Sponsor|0|||
143424820|NCT05216835|517099313|FG001|Overall Study|Study terminated by Sponsor|0|||
143424821|NCT05216835|517099314|FG002|Overall Study|Study terminated by Sponsor|0|||
143424822|NCT05216835|517099315|FG003|Overall Study|Study terminated by Sponsor|0|||
143424823|NCT05216835|517099316|FG004|Overall Study|Study terminated by Sponsor|0|||
143424824|NCT05216835|517099317|FG005|Overall Study|Study terminated by Sponsor|0|||
143424825|NCT05216835|517099318|FG006|Overall Study|Study terminated by Sponsor|0|||
143424826|NCT05216835|517099319|FG007|Overall Study|Study terminated by Sponsor|1|||
143424827|NCT05216835|517099312|FG000|Overall Study|Withdrawal by Subject|1|||
143424828|NCT05216835|517099313|FG001|Overall Study|Withdrawal by Subject|0|||
143424829|NCT05216835|517099314|FG002|Overall Study|Withdrawal by Subject|1|||
143424830|NCT05216835|517099315|FG003|Overall Study|Withdrawal by Subject|0|||
143424831|NCT05216835|517099316|FG004|Overall Study|Withdrawal by Subject|1|||
143424832|NCT05216835|517099317|FG005|Overall Study|Withdrawal by Subject|0|||
143424833|NCT05216835|517099318|FG006|Overall Study|Withdrawal by Subject|0|||
143424834|NCT05216835|517099319|FG007|Overall Study|Withdrawal by Subject|1|||
143424835|NCT05216835|517099312|FG000|Overall Study|Other|0|||
143424836|NCT05216835|517099313|FG001|Overall Study|Other|1|||
143424837|NCT05216835|517099314|FG002|Overall Study|Other|0|||
143424838|NCT05216835|517099315|FG003|Overall Study|Other|0|||
143424839|NCT05216835|517099316|FG004|Overall Study|Other|0|||
143424840|NCT05216835|517099317|FG005|Overall Study|Other|0|||
143424841|NCT05216835|517099318|FG006|Overall Study|Other|0|||
143424842|NCT05216835|517099319|FG007|Overall Study|Other|0|||
143424843|NCT05179603|517099320|FG000|Overall Study|Unspecified: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
143424844|NCT05179603|517099320|FG000|Overall Study|Withdrawal by Subject|1|||
143424845|NCT05179603|517099320|FG000|Overall Study|Progressive disease|4|||
143424846|NCT05179603|517099320|FG000|Overall Study|Adverse event: Not related to COVID-19|4|||
143424847|NCT04551053|517099321|FG000|Overall Study|Death|10|||
143424848|NCT04551053|517099322|FG001|Overall Study|Death|9|||
143424849|NCT04551053|517099321|FG000|Overall Study|Lost to Follow-up|0|||
143424850|NCT04551053|517099322|FG001|Overall Study|Lost to Follow-up|2|||
143424851|NCT04551053|517099321|FG000|Overall Study|Study Terminated by Sponsor|57|||
143424852|NCT04551053|517099322|FG001|Overall Study|Study Terminated by Sponsor|65|||
143424853|NCT04551053|517099321|FG000|Overall Study|Withdrawal by Subject|12|||
143424854|NCT04551053|517099322|FG001|Overall Study|Withdrawal by Subject|5|||
143424855|NCT04551053|517099321|FG000|Overall Study|Adverse Event|2|||
143424856|NCT04551053|517099322|FG001|Overall Study|Adverse Event|0|||
143424857|NCT04551053|517099321|FG000|Overall Study|Lack of Efficacy|2|||
143424858|NCT04551053|517099322|FG001|Overall Study|Lack of Efficacy|1|||
143424859|NCT04551053|517099321|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
143424860|NCT04551053|517099322|FG001|Overall Study|Transitioned to Rollover per Protocol|4|||
143424861|NCT04551053|517099321|FG000|Overall Study|Splenapendectomi|1|||
143424862|NCT04551053|517099322|FG001|Overall Study|Splenapendectomi|0|||
143424863|NCT04551053|517099321|FG000|Overall Study|Medical Decision|1|||
143424864|NCT04551053|517099322|FG001|Overall Study|Medical Decision|1|||
143424865|NCT03861078|517099323|FG000|Overall Study|COVID-19 shut down|4|||
143424866|NCT03861078|517099323|FG000|Overall Study|Lost to Follow-up|1|||
143424867|NCT03861078|517099323|FG000|Overall Study|Protocol Violation|2|||
143424868|NCT03861078|517099323|FG000|Overall Study|lack of venous access|1|||
143424869|NCT02971683|517099324|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
143424870|NCT02971683|517099325|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
143424871|NCT02971683|517099324|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
143424872|NCT02971683|517099325|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
143424873|NCT02971683|517099324|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
143424874|NCT02971683|517099325|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
143424875|NCT02971683|517099324|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
143424876|NCT02971683|517099325|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
143424877|NCT02971683|517099324|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
143454172|NCT01865747|517206889|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
143454173|NCT01865747|517206888|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
143454174|NCT01865747|517206889|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
143454175|NCT01865747|517206888|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
143454176|NCT01865747|517206889|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
143454177|NCT01865747|517206888|FG000|Primary Intent to Treat (PITT)|Other|0|||
143454178|NCT01865747|517206889|FG001|Primary Intent to Treat (PITT)|Other|1|||
143454179|NCT03973931|517206890|FG000|Overall Study|Lost to Follow-up|47|||
143454180|NCT03973931|517206891|FG001|Overall Study|Lost to Follow-up|63|||
143454181|NCT03973931|517206892|FG002|Overall Study|Lost to Follow-up|51|||
143454182|NCT03973931|517206893|FG003|Overall Study|Lost to Follow-up|54|||
143454183|NCT03973931|517206890|FG000|Overall Study|opted out|6|||
143454184|NCT03973931|517206891|FG001|Overall Study|opted out|5|||
143454185|NCT03973931|517206892|FG002|Overall Study|opted out|5|||
143454186|NCT03973931|517206893|FG003|Overall Study|opted out|1|||
143454187|NCT01022112|517206894|FG000|Overall Study|Adverse Event|1|||
143454188|NCT01022112|517206895|FG001|Overall Study|Adverse Event|2|||
143454189|NCT01022112|517206896|FG002|Overall Study|Adverse Event|0|||
143454190|NCT01022112|517206897|FG003|Overall Study|Adverse Event|1|||
143454191|NCT01022112|517206898|FG004|Overall Study|Adverse Event|0|||
143454192|NCT01022112|517206894|FG000|Overall Study|Lack of Efficacy|1|||
143454193|NCT01022112|517206895|FG001|Overall Study|Lack of Efficacy|0|||
143454194|NCT01022112|517206896|FG002|Overall Study|Lack of Efficacy|0|||
143454195|NCT01022112|517206897|FG003|Overall Study|Lack of Efficacy|0|||
143454196|NCT01022112|517206898|FG004|Overall Study|Lack of Efficacy|1|||
143454197|NCT01022112|517206894|FG000|Overall Study|Physician Decision|0|||
143454198|NCT01022112|517206895|FG001|Overall Study|Physician Decision|0|||
143454199|NCT01022112|517206896|FG002|Overall Study|Physician Decision|1|||
143454200|NCT01022112|517206897|FG003|Overall Study|Physician Decision|0|||
143454201|NCT01022112|517206898|FG004|Overall Study|Physician Decision|1|||
143454202|NCT01022112|517206894|FG000|Overall Study|Withdrawal by Subject|0|||
143454203|NCT01022112|517206895|FG001|Overall Study|Withdrawal by Subject|1|||
143454204|NCT01022112|517206896|FG002|Overall Study|Withdrawal by Subject|2|||
143454205|NCT01022112|517206897|FG003|Overall Study|Withdrawal by Subject|2|||
143454206|NCT01022112|517206898|FG004|Overall Study|Withdrawal by Subject|1|||
143454207|NCT01022112|517206894|FG000|Overall Study|Fasting plasma glucose level increased|1|||
143454208|NCT01022112|517206895|FG001|Overall Study|Fasting plasma glucose level increased|0|||
143454209|NCT01022112|517206896|FG002|Overall Study|Fasting plasma glucose level increased|0|||
143454210|NCT01022112|517206897|FG003|Overall Study|Fasting plasma glucose level increased|0|||
143454211|NCT01022112|517206898|FG004|Overall Study|Fasting plasma glucose level increased|7|||
143454212|NCT01982448|517206899|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
143424878|NCT02971683|517099325|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
143424879|NCT02971683|517099324|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
143424880|NCT02971683|517099325|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
143424881|NCT02971683|517099324|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
143424882|NCT02971683|517099325|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
143424883|NCT02971683|517099324|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
143424884|NCT02971683|517099325|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
143424885|NCT02971683|517099324|FG000|Open-Label|Lost to Follow-up|1|||
143424886|NCT02971683|517099325|FG001|Open-Label|Lost to Follow-up|0|||
143424887|NCT02971683|517099324|FG000|Open-Label|Participants withdrew consent|0|||
143424888|NCT02971683|517099325|FG001|Open-Label|Participants withdrew consent|2|||
143424889|NCT02971683|517099324|FG000|Open-Label|Participant request to discontinue study treatment|1|||
143424890|NCT02971683|517099325|FG001|Open-Label|Participant request to discontinue study treatment|0|||
143424891|NCT02971683|517099324|FG000|Open-Label|Lack of Efficacy|2|||
143424892|NCT02971683|517099325|FG001|Open-Label|Lack of Efficacy|0|||
143424893|NCT02971683|517099324|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
143424894|NCT02971683|517099325|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
143424895|NCT02971683|517099324|FG000|Long-Term Open Label|Participant withdrew consent|1|||
143424896|NCT02971683|517099325|FG001|Long-Term Open Label|Participant withdrew consent|0|||
143424897|NCT02971683|517099324|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
143424898|NCT02971683|517099325|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
143424899|NCT02971683|517099324|FG000|Long-Term Open Label|Adverse Event|1|||
143424900|NCT02971683|517099325|FG001|Long-Term Open Label|Adverse Event|2|||
143424901|NCT02971683|517099324|FG000|Long-Term Open Label|Lack of Efficacy|1|||
143424902|NCT02971683|517099325|FG001|Long-Term Open Label|Lack of Efficacy|1|||
143424903|NCT00512902|517099331|FG000|Overall Study|Adverse Event|7|||
143424904|NCT00512902|517099331|FG000|Overall Study|Lost to Follow-up|1|||
143424905|NCT03019289|517099332|FG000|Overall Study|Adverse Event|1|||
143424906|NCT03019289|517099333|FG001|Overall Study|Adverse Event|0|||
143424907|NCT03019289|517099334|FG002|Overall Study|Adverse Event|0|||
143424908|NCT03019289|517099335|FG003|Overall Study|Adverse Event|0|||
143424909|NCT03019289|517099336|FG004|Overall Study|Adverse Event|0|||
143424910|NCT03019289|517099337|FG005|Overall Study|Adverse Event|0|||
143424911|NCT03019289|517099338|FG006|Overall Study|Adverse Event|0|||
143424912|NCT03019289|517099339|FG007|Overall Study|Adverse Event|0|||
143424913|NCT03019289|517099340|FG008|Overall Study|Adverse Event|1|||
143424914|NCT03019289|517099332|FG000|Overall Study|Other|1|||
143424915|NCT03019289|517099333|FG001|Overall Study|Other|0|||
143424916|NCT03019289|517099334|FG002|Overall Study|Other|0|||
143424917|NCT03019289|517099335|FG003|Overall Study|Other|0|||
143424918|NCT03019289|517099336|FG004|Overall Study|Other|0|||
143424919|NCT03019289|517099337|FG005|Overall Study|Other|0|||
143424920|NCT03019289|517099338|FG006|Overall Study|Other|0|||
143424921|NCT03019289|517099339|FG007|Overall Study|Other|0|||
143424922|NCT03019289|517099340|FG008|Overall Study|Other|0|||
143424923|NCT02389894|517099341|FG000|Overall Study|Death|4|||
143424924|NCT02389894|517099342|FG001|Overall Study|Death|5|||
143424925|NCT02389894|517099343|FG002|Overall Study|Death|3|||
143424926|NCT02389894|517099341|FG000|Overall Study|Withdrawal by Subject|2|||
143424927|NCT02389894|517099342|FG001|Overall Study|Withdrawal by Subject|4|||
143424928|NCT02389894|517099343|FG002|Overall Study|Withdrawal by Subject|5|||
143424929|NCT02389894|517099341|FG000|Overall Study|Lost to Follow-up|2|||
143424930|NCT02389894|517099342|FG001|Overall Study|Lost to Follow-up|1|||
143424931|NCT02389894|517099343|FG002|Overall Study|Lost to Follow-up|1|||
143424932|NCT01549951|517099347|FG000|Overall Study|Adverse Event|15|||
143424933|NCT01549951|517099347|FG000|Overall Study|Withdrawal by Subject|2|||
143424934|NCT01549951|517099347|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
143424935|NCT01549951|517099347|FG000|Overall Study|Progressive disease|29|||
143424936|NCT01549951|517099347|FG000|Overall Study|Symptomatic deterioration|1|||
143424937|NCT01549951|517099347|FG000|Overall Study|Other|2|||
143424938|NCT03138499|517099348|FG000|Overall Study|Lost to Follow-up|1|||
143424939|NCT03138499|517099349|FG001|Overall Study|Lost to Follow-up|0|||
143424940|NCT03138499|517099348|FG000|Overall Study|Participants withdrew consent|1|||
143424941|NCT03138499|517099349|FG001|Overall Study|Participants withdrew consent|0|||
143424942|NCT03138499|517099348|FG000|Overall Study|Participant discontinued study before treatment|0|||
143424943|NCT03138499|517099349|FG001|Overall Study|Participant discontinued study before treatment|1|||
143424944|NCT03138499|517099348|FG000|Overall Study|Disease Progression|2|||
143424945|NCT03138499|517099349|FG001|Overall Study|Disease Progression|6|||
143424946|NCT03138499|517099348|FG000|Overall Study|Study drug toxicity|2|||
143424947|NCT03138499|517099349|FG001|Overall Study|Study drug toxicity|2|||
143424948|NCT03138499|517099348|FG000|Overall Study|Participant request to discontinue study treatment|1|||
143424949|NCT03138499|517099349|FG001|Overall Study|Participant request to discontinue study treatment|1|||
143424950|NCT03138499|517099348|FG000|Overall Study|Other reasons|2|||
143424951|NCT03138499|517099349|FG001|Overall Study|Other reasons|0|||
143424952|NCT01334606|517099350|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
143424953|NCT02312245|517099351|FG000|Overall Study|Death|0|||
143424954|NCT02312245|517099352|FG001|Overall Study|Death|0|||
143424955|NCT02312245|517099353|FG002|Overall Study|Death|0|||
143424956|NCT02312245|517099354|FG003|Overall Study|Death|1|||
143424957|NCT02312245|517099351|FG000|Overall Study|Withdrawal by Subject|1|||
143424958|NCT02312245|517099352|FG001|Overall Study|Withdrawal by Subject|1|||
143424959|NCT02312245|517099353|FG002|Overall Study|Withdrawal by Subject|0|||
143424960|NCT02312245|517099354|FG003|Overall Study|Withdrawal by Subject|2|||
143424961|NCT02312245|517099351|FG000|Overall Study|Alternative Therapy|1|||
143424962|NCT02312245|517099352|FG001|Overall Study|Alternative Therapy|0|||
143424963|NCT02312245|517099353|FG002|Overall Study|Alternative Therapy|0|||
143424964|NCT02312245|517099354|FG003|Overall Study|Alternative Therapy|0|||
143424965|NCT02312245|517099351|FG000|Overall Study|Progression|0|||
143424966|NCT02312245|517099352|FG001|Overall Study|Progression|0|||
143424967|NCT02312245|517099353|FG002|Overall Study|Progression|0|||
143424968|NCT02312245|517099354|FG003|Overall Study|Progression|5|||
143424969|NCT02312245|517099351|FG000|Overall Study|Patient went to hospice|0|||
143424970|NCT02312245|517099352|FG001|Overall Study|Patient went to hospice|0|||
143424971|NCT02312245|517099353|FG002|Overall Study|Patient went to hospice|0|||
143424972|NCT02312245|517099354|FG003|Overall Study|Patient went to hospice|1|||
143424973|NCT02312245|517099351|FG000|Overall Study|Ineligible|1|||
143424974|NCT02312245|517099352|FG001|Overall Study|Ineligible|0|||
143424975|NCT02312245|517099353|FG002|Overall Study|Ineligible|0|||
143424976|NCT02312245|517099354|FG003|Overall Study|Ineligible|0|||
143424977|NCT00448344|517099355|FG000|Overall Study|Lost to Follow-up|20|||
143424978|NCT00448344|517099356|FG001|Overall Study|Lost to Follow-up|22|||
143424979|NCT00448344|517099355|FG000|Overall Study|Withdrawal by Subject|6|||
143424980|NCT00448344|517099356|FG001|Overall Study|Withdrawal by Subject|8|||
143424981|NCT00448344|517099355|FG000|Overall Study|Death|3|||
143424982|NCT00448344|517099356|FG001|Overall Study|Death|4|||
143424983|NCT00448344|517099355|FG000|Overall Study|Physician Decision|1|||
143424984|NCT00448344|517099356|FG001|Overall Study|Physician Decision|2|||
143424985|NCT01123200|517099360|FG000|Overall Study|Withdrawal by Subject|1|||
143424986|NCT00990314|517099361|FG000|Overall Study|Death|2|||
143424987|NCT00990314|517099361|FG000|Overall Study|Adverse Event|2|||
143424988|NCT00990314|517099361|FG000|Overall Study|Withdrawal by Subject|3|||
143424989|NCT00990314|517099361|FG000|Overall Study|Non-Compliance|1|||
143424990|NCT00990314|517099361|FG000|Overall Study|Physician Decision|3|||
143424991|NCT00990314|517099361|FG000|Overall Study|Lack of Efficacy|1|||
143424992|NCT00748098|517099365|FG000|First Treatment Intervention Period|Adverse Event|1|||
143424993|NCT00748098|517099366|FG001|First Treatment Intervention Period|Adverse Event|1|||
143424994|NCT00748098|517099365|FG000|First Treatment Intervention Period|Protocol Violation|1|||
143424995|NCT00748098|517099366|FG001|First Treatment Intervention Period|Protocol Violation|0|||
143424996|NCT00748098|517099365|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
143424997|NCT00748098|517099366|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
143424998|NCT00748098|517099365|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
143424999|NCT00748098|517099366|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
143425000|NCT00748098|517099365|FG000|First Taper Period|Protocol Violation|1|||
143425001|NCT00748098|517099366|FG001|First Taper Period|Protocol Violation|0|||
143425002|NCT00748098|517099365|FG000|First Taper Period|Withdrawal by Subject|2|||
143425003|NCT00748098|517099366|FG001|First Taper Period|Withdrawal by Subject|0|||
143425004|NCT00748098|517099365|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
143425005|NCT00748098|517099366|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
143425006|NCT00748098|517099365|FG000|1-Week Washout Period|Adverse Event|0|||
143425007|NCT00748098|517099366|FG001|1-Week Washout Period|Adverse Event|1|||
143425008|NCT00748098|517099365|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
143425009|NCT00748098|517099366|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
143425010|NCT00748098|517099365|FG000|Second Treatment Intervention Period|Adverse Event|4|||
143425011|NCT00748098|517099366|FG001|Second Treatment Intervention Period|Adverse Event|1|||
143425012|NCT00748098|517099365|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
143425013|NCT00748098|517099366|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
143425014|NCT00748098|517099365|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
143425015|NCT00748098|517099366|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
143425016|NCT01537120|517100975|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
143425017|NCT01537120|517100975|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
143425018|NCT00627523|517100978|FG000|Overall Study|Lack of Efficacy|1|||
143425019|NCT00627523|517100979|FG001|Overall Study|Lack of Efficacy|0|||
143425020|NCT00627523|517100978|FG000|Overall Study|Withdrawal by Subject|0|||
143425021|NCT00627523|517100979|FG001|Overall Study|Withdrawal by Subject|2|||
143425022|NCT00627523|517100978|FG000|Overall Study|Other|1|||
143425023|NCT00627523|517100979|FG001|Overall Study|Other|0|||
143425024|NCT03451292|517100980|FG000|Overall Study|Death|44|||
143425025|NCT03451292|517100981|FG001|Overall Study|Death|59|||
143425026|NCT03451292|517100980|FG000|Overall Study|Withdrawal by Subject|18|||
143425027|NCT03451292|517100981|FG001|Overall Study|Withdrawal by Subject|13|||
143425028|NCT03451292|517100980|FG000|Overall Study|Transplantation|18|||
143425029|NCT03451292|517100981|FG001|Overall Study|Transplantation|12|||
143425030|NCT03451292|517100980|FG000|Overall Study|Lost to Follow-up|4|||
143425031|NCT03451292|517100981|FG001|Overall Study|Lost to Follow-up|12|||
143425032|NCT03451292|517100980|FG000|Overall Study|Physician Decision|4|||
143425033|NCT03451292|517100981|FG001|Overall Study|Physician Decision|3|||
143425034|NCT03451292|517100980|FG000|Overall Study|Adverse Event|3|||
143425035|NCT03451292|517100981|FG001|Overall Study|Adverse Event|3|||
143425036|NCT03451292|517100980|FG000|Overall Study|Non-compliance with Study Drug|2|||
143425037|NCT03451292|517100981|FG001|Overall Study|Non-compliance with Study Drug|0|||
143425038|NCT03602053|517100988|FG000|Overall Study|Withdrawal by Subject|7|||
143425039|NCT03602053|517100989|FG001|Overall Study|Withdrawal by Subject|9|||
143425040|NCT03602053|517100990|FG002|Overall Study|Withdrawal by Subject|7|||
143425041|NCT03602053|517100988|FG000|Overall Study|Lost to Follow-up|5|||
143425042|NCT03602053|517100989|FG001|Overall Study|Lost to Follow-up|6|||
143425043|NCT03602053|517100990|FG002|Overall Study|Lost to Follow-up|0|||
143425044|NCT03602053|517100988|FG000|Overall Study|Protocol Violation|3|||
143425045|NCT03602053|517100989|FG001|Overall Study|Protocol Violation|0|||
143425046|NCT03602053|517100990|FG002|Overall Study|Protocol Violation|4|||
143425047|NCT03602053|517100988|FG000|Overall Study|Physician Decision|1|||
143425048|NCT03602053|517100989|FG001|Overall Study|Physician Decision|0|||
143425049|NCT03602053|517100990|FG002|Overall Study|Physician Decision|0|||
143425050|NCT03602053|517100988|FG000|Overall Study|migration|2|||
143425051|NCT03602053|517100989|FG001|Overall Study|migration|3|||
143425052|NCT03602053|517100990|FG002|Overall Study|migration|0|||
143425053|NCT03602053|517100988|FG000|Overall Study|Other|1|||
143425054|NCT03602053|517100989|FG001|Overall Study|Other|0|||
143425055|NCT03602053|517100990|FG002|Overall Study|Other|0|||
143425056|NCT01038128|517100991|FG000|Overall Study|Lack of Efficacy|1|||
143425057|NCT01038128|517100991|FG000|Overall Study|Lost to Follow-up|1|||
143425058|NCT01038128|517100991|FG000|Overall Study|Withdrawal by Subject|2|||
143425059|NCT01753323|517100996|FG000|Overall Study|Lack of Efficacy|0|||
143425060|NCT01753323|517100997|FG001|Overall Study|Lack of Efficacy|0|||
143425061|NCT01753323|517100998|FG002|Overall Study|Lack of Efficacy|8|||
143425062|NCT01753323|517100996|FG000|Overall Study|Protocol deviation|1|||
143425063|NCT01753323|517100997|FG001|Overall Study|Protocol deviation|0|||
143425064|NCT01753323|517100998|FG002|Overall Study|Protocol deviation|0|||
143425065|NCT01753323|517100996|FG000|Overall Study|Adverse Event|0|||
143425066|NCT01753323|517100997|FG001|Overall Study|Adverse Event|0|||
143425067|NCT01753323|517100998|FG002|Overall Study|Adverse Event|1|||
143425068|NCT01870999|517100999|FG000|Overall Study|Adverse Event|0|||
143425069|NCT01870999|517101000|FG001|Overall Study|Adverse Event|4|||
143425070|NCT01870999|517101001|FG002|Overall Study|Adverse Event|1|||
143425071|NCT01870999|517100999|FG000|Overall Study|Subject met withdrawal criteria|3|||
143425072|NCT01870999|517101000|FG001|Overall Study|Subject met withdrawal criteria|2|||
143425073|NCT01870999|517101001|FG002|Overall Study|Subject met withdrawal criteria|0|||
143425074|NCT01870999|517100999|FG000|Overall Study|Subject withdrawn by Investigator|1|||
143425075|NCT01870999|517101000|FG001|Overall Study|Subject withdrawn by Investigator|0|||
143425076|NCT01870999|517101001|FG002|Overall Study|Subject withdrawn by Investigator|0|||
143425077|NCT01870999|517100999|FG000|Overall Study|Withdrawal by Subject|0|||
143425078|NCT01870999|517101000|FG001|Overall Study|Withdrawal by Subject|2|||
143425079|NCT01870999|517101001|FG002|Overall Study|Withdrawal by Subject|5|||
143425080|NCT01870999|517100999|FG000|Overall Study|Protocol Violation|0|||
143425081|NCT01870999|517101000|FG001|Overall Study|Protocol Violation|0|||
143425082|NCT01870999|517101001|FG002|Overall Study|Protocol Violation|1|||
143425083|NCT01636258|517101002|FG000|Overall Study|Lost to Follow-up|1|||
143425084|NCT01636258|517101003|FG001|Overall Study|Lost to Follow-up|0|||
143425085|NCT00116584|517101004|FG000|Overall Study|Withdrawal by Subject|1|||
143425086|NCT00116584|517101005|FG001|Overall Study|Withdrawal by Subject|0|||
143425087|NCT00116584|517101004|FG000|Overall Study|Protocol Violation|1|||
143425088|NCT00116584|517101005|FG001|Overall Study|Protocol Violation|1|||
143425089|NCT02798861|517101008|FG000|Overall Study|Lost to Follow-up|22|||
143425090|NCT02798861|517101008|FG000|Overall Study|Withdrawal by Subject|1|||
143425091|NCT01695993|517101009|FG000|Overall Study|Lost to Follow-up|2|||
143425092|NCT01695993|517101010|FG001|Overall Study|Lost to Follow-up|1|||
143425093|NCT01695993|517101011|FG002|Overall Study|Lost to Follow-up|3|||
143425094|NCT01695993|517101009|FG000|Overall Study|Withdrawal by Subject|2|||
143425095|NCT01695993|517101010|FG001|Overall Study|Withdrawal by Subject|2|||
143425096|NCT01695993|517101011|FG002|Overall Study|Withdrawal by Subject|2|||
143425097|NCT01695993|517101009|FG000|Overall Study|To ill to continue|1|||
143425098|NCT01695993|517101010|FG001|Overall Study|To ill to continue|2|||
143425099|NCT01695993|517101011|FG002|Overall Study|To ill to continue|0|||
143425100|NCT01695993|517101009|FG000|Overall Study|Changed Medical Facility|0|||
143425101|NCT01695993|517101010|FG001|Overall Study|Changed Medical Facility|0|||
143425102|NCT01695993|517101011|FG002|Overall Study|Changed Medical Facility|1|||
143425103|NCT04057937|517101012|FG000|Placebo-controlled Phase|Adverse Event|3|||
143425104|NCT04057937|517101013|FG001|Placebo-controlled Phase|Adverse Event|0|||
143425105|NCT04057937|517101012|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
143425106|NCT04057937|517101013|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
143425107|NCT04057937|517101012|FG000|Active-treatment Phase|Pregnancy|0|||
143425108|NCT04057937|517101013|FG001|Active-treatment Phase|Pregnancy|1|||
143425109|NCT04057937|517101012|FG000|Active-treatment Phase|Physician Decision|0|||
143425110|NCT04057937|517101013|FG001|Active-treatment Phase|Physician Decision|1|||
143425111|NCT01072396|517101014|FG000|Period One|Adverse Event|1|||
143425112|NCT01072396|517101015|FG001|Period One|Adverse Event|1|||
143425113|NCT01072396|517101014|FG000|Period One|Protocol Violation|2|||
143425114|NCT01072396|517101015|FG001|Period One|Protocol Violation|1|||
143425115|NCT01072396|517101014|FG000|Period One|Withdrawal by Subject|2|||
143425116|NCT01072396|517101015|FG001|Period One|Withdrawal by Subject|0|||
143425117|NCT01072396|517101014|FG000|Washout Period|Missing termination information|0|||
143425118|NCT01072396|517101015|FG001|Washout Period|Missing termination information|1|||
143425119|NCT01072396|517101014|FG000|Period Two|Adverse Event|0|||
143425120|NCT01072396|517101015|FG001|Period Two|Adverse Event|3|||
143425121|NCT01072396|517101014|FG000|Period Two|Lost to Follow-up|1|||
143425122|NCT01072396|517101015|FG001|Period Two|Lost to Follow-up|0|||
143425123|NCT00472199|517101016|FG000|Overall Study|Adverse Event|19|||
143425124|NCT00472199|517101017|FG001|Overall Study|Adverse Event|23|||
143425125|NCT00472199|517101016|FG000|Overall Study|Lack of Efficacy|4|||
143425126|NCT00472199|517101017|FG001|Overall Study|Lack of Efficacy|25|||
143425127|NCT00472199|517101016|FG000|Overall Study|Lost to Follow-up|2|||
143425128|NCT00472199|517101017|FG001|Overall Study|Lost to Follow-up|4|||
143425129|NCT00472199|517101016|FG000|Overall Study|Protocol Violation|3|||
143425130|NCT00472199|517101017|FG001|Overall Study|Protocol Violation|2|||
143425131|NCT00472199|517101016|FG000|Overall Study|Withdrawal by Subject|6|||
143425132|NCT00472199|517101017|FG001|Overall Study|Withdrawal by Subject|5|||
143425133|NCT00472199|517101016|FG000|Overall Study|personal reason|0|||
143425134|NCT00472199|517101017|FG001|Overall Study|personal reason|1|||
143425135|NCT00472199|517101016|FG000|Overall Study|patient was asymptomatic|1|||
143425136|NCT00472199|517101017|FG001|Overall Study|patient was asymptomatic|0|||
143425137|NCT01268488|517101019|FG000|Overall Study|Adverse Event|3|||
143425138|NCT01268488|517101019|FG000|Overall Study|Physician Decision|2|||
143425139|NCT02475733|517101022|FG000|Overall Study|Withdrawal by Subject|1|||
143425140|NCT02475733|517101023|FG001|Overall Study|Withdrawal by Subject|0|||
143425141|NCT02475733|517101022|FG000|Overall Study|Physician Decision|1|||
143425142|NCT02475733|517101023|FG001|Overall Study|Physician Decision|0|||
143425143|NCT00475735|517101027|FG000|Treatment Period 1|Adverse Event|2|||
143425144|NCT00475735|517101028|FG001|Treatment Period 1|Adverse Event|0|||
143425145|NCT00475735|517101029|FG002|Treatment Period 1|Adverse Event|0|||
143425146|NCT00475735|517101030|FG003|Treatment Period 1|Adverse Event|0|||
143425147|NCT00475735|517101031|FG004|Treatment Period 1|Adverse Event|0|||
143425148|NCT00475735|517101032|FG005|Treatment Period 1|Adverse Event|0|||
143425149|NCT00475735|517101027|FG000|Treatment Period 1|Lack of Efficacy|1|||
143425150|NCT00475735|517101028|FG001|Treatment Period 1|Lack of Efficacy|0|||
143425151|NCT00475735|517101029|FG002|Treatment Period 1|Lack of Efficacy|0|||
143425152|NCT00475735|517101030|FG003|Treatment Period 1|Lack of Efficacy|0|||
143425153|NCT00475735|517101031|FG004|Treatment Period 1|Lack of Efficacy|0|||
143425154|NCT00475735|517101032|FG005|Treatment Period 1|Lack of Efficacy|0|||
143425155|NCT00475735|517101027|FG000|Treatment Period 1|Lost to Follow-up|0|||
143425156|NCT00475735|517101028|FG001|Treatment Period 1|Lost to Follow-up|0|||
143425157|NCT00475735|517101029|FG002|Treatment Period 1|Lost to Follow-up|0|||
143425158|NCT00475735|517101030|FG003|Treatment Period 1|Lost to Follow-up|0|||
143425159|NCT00475735|517101031|FG004|Treatment Period 1|Lost to Follow-up|0|||
143425160|NCT00475735|517101032|FG005|Treatment Period 1|Lost to Follow-up|1|||
143425161|NCT00475735|517101027|FG000|Treatment Period 1|Protocol Violation|0|||
143425162|NCT00475735|517101028|FG001|Treatment Period 1|Protocol Violation|0|||
143425163|NCT00475735|517101029|FG002|Treatment Period 1|Protocol Violation|0|||
143425164|NCT00475735|517101030|FG003|Treatment Period 1|Protocol Violation|1|||
143425165|NCT00475735|517101031|FG004|Treatment Period 1|Protocol Violation|0|||
143425166|NCT00475735|517101032|FG005|Treatment Period 1|Protocol Violation|0|||
143425167|NCT00475735|517101027|FG000|Treatment Period 1|Withdrawal by Subject|1|||
143425168|NCT00475735|517101028|FG001|Treatment Period 1|Withdrawal by Subject|1|||
143425169|NCT00475735|517101029|FG002|Treatment Period 1|Withdrawal by Subject|0|||
143425170|NCT00475735|517101030|FG003|Treatment Period 1|Withdrawal by Subject|0|||
143425171|NCT00475735|517101031|FG004|Treatment Period 1|Withdrawal by Subject|0|||
143425172|NCT00475735|517101032|FG005|Treatment Period 1|Withdrawal by Subject|0|||
143425173|NCT00475735|517101027|FG000|Treatment Period 1|DC due to AE but continuing|0|||
143425174|NCT00475735|517101028|FG001|Treatment Period 1|DC due to AE but continuing|0|||
143425175|NCT00475735|517101029|FG002|Treatment Period 1|DC due to AE but continuing|0|||
143425176|NCT00475735|517101030|FG003|Treatment Period 1|DC due to AE but continuing|1|||
143425177|NCT00475735|517101031|FG004|Treatment Period 1|DC due to AE but continuing|2|||
143425178|NCT00475735|517101032|FG005|Treatment Period 1|DC due to AE but continuing|2|||
143425179|NCT00475735|517101027|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
143425180|NCT00475735|517101028|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
143425181|NCT00475735|517101029|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
143425182|NCT00475735|517101030|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
143425183|NCT00475735|517101031|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
143425184|NCT00475735|517101032|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
143425185|NCT00475735|517101027|FG000|Treatment Washout|Lost to Follow-up|0|||
143425186|NCT00475735|517101028|FG001|Treatment Washout|Lost to Follow-up|1|||
143425187|NCT00475735|517101029|FG002|Treatment Washout|Lost to Follow-up|0|||
143425188|NCT00475735|517101030|FG003|Treatment Washout|Lost to Follow-up|0|||
143425189|NCT00475735|517101031|FG004|Treatment Washout|Lost to Follow-up|0|||
143425190|NCT00475735|517101032|FG005|Treatment Washout|Lost to Follow-up|0|||
143425191|NCT00475735|517101027|FG000|Treatment Washout|Protocol Violation|0|||
143425192|NCT00475735|517101028|FG001|Treatment Washout|Protocol Violation|1|||
143425193|NCT00475735|517101029|FG002|Treatment Washout|Protocol Violation|0|||
143425194|NCT00475735|517101030|FG003|Treatment Washout|Protocol Violation|0|||
143425195|NCT00475735|517101031|FG004|Treatment Washout|Protocol Violation|0|||
143425196|NCT00475735|517101032|FG005|Treatment Washout|Protocol Violation|0|||
143425197|NCT00475735|517101027|FG000|Treatment Period 2|Adverse Event|0|||
143425198|NCT00475735|517101028|FG001|Treatment Period 2|Adverse Event|1|||
143425199|NCT00475735|517101029|FG002|Treatment Period 2|Adverse Event|0|||
143425200|NCT00475735|517101030|FG003|Treatment Period 2|Adverse Event|2|||
143425201|NCT00475735|517101031|FG004|Treatment Period 2|Adverse Event|0|||
143425202|NCT00475735|517101032|FG005|Treatment Period 2|Adverse Event|0|||
143425203|NCT00475735|517101027|FG000|Treatment Period 2|Lack of Efficacy|0|||
143425204|NCT00475735|517101028|FG001|Treatment Period 2|Lack of Efficacy|0|||
143425205|NCT00475735|517101029|FG002|Treatment Period 2|Lack of Efficacy|0|||
143425206|NCT00475735|517101030|FG003|Treatment Period 2|Lack of Efficacy|0|||
143425207|NCT00475735|517101031|FG004|Treatment Period 2|Lack of Efficacy|0|||
143425208|NCT00475735|517101032|FG005|Treatment Period 2|Lack of Efficacy|1|||
143425209|NCT00475735|517101027|FG000|Treatment Period 2|Withdrawal by Subject|0|||
143425210|NCT00475735|517101028|FG001|Treatment Period 2|Withdrawal by Subject|0|||
143425211|NCT00475735|517101029|FG002|Treatment Period 2|Withdrawal by Subject|0|||
143425212|NCT00475735|517101030|FG003|Treatment Period 2|Withdrawal by Subject|0|||
143425213|NCT00475735|517101031|FG004|Treatment Period 2|Withdrawal by Subject|1|||
143425214|NCT00475735|517101032|FG005|Treatment Period 2|Withdrawal by Subject|0|||
143425215|NCT01014013|517101033|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
143425216|NCT01014013|517101034|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
143425217|NCT01014013|517101033|FG000|Overall Study|Clinical adverse experience|4|||
143425218|NCT01014013|517101034|FG001|Overall Study|Clinical adverse experience|2|||
143425219|NCT01014013|517101033|FG000|Overall Study|Laboratory adverse experience|1|||
143425220|NCT01014013|517101034|FG001|Overall Study|Laboratory adverse experience|1|||
143425221|NCT01014013|517101033|FG000|Overall Study|Protocol Violation|1|||
143425222|NCT01014013|517101034|FG001|Overall Study|Protocol Violation|3|||
143425223|NCT01014013|517101033|FG000|Overall Study|Withdrawal by Subject|7|||
143425224|NCT01014013|517101034|FG001|Overall Study|Withdrawal by Subject|4|||
143425225|NCT01014013|517101033|FG000|Overall Study|Clinical/microbiologic failure|1|||
143425226|NCT01014013|517101034|FG001|Overall Study|Clinical/microbiologic failure|2|||
143425227|NCT01014013|517101033|FG000|Overall Study|Pathogen culture = no growth|26|||
143425228|NCT01014013|517101034|FG001|Overall Study|Pathogen culture = no growth|34|||
143425229|NCT01014013|517101033|FG000|Overall Study|Negative urine culture|2|||
143425230|NCT01014013|517101034|FG001|Overall Study|Negative urine culture|0|||
143425231|NCT01014013|517101033|FG000|Overall Study|Pathogen resistant|7|||
143425232|NCT01014013|517101034|FG001|Overall Study|Pathogen resistant|4|||
143425233|NCT01014013|517101033|FG000|Overall Study|Physician Decision|0|||
143425234|NCT01014013|517101034|FG001|Overall Study|Physician Decision|1|||
143425235|NCT01014013|517101033|FG000|Overall Study|Another antibiotic therapy required|0|||
143425236|NCT01014013|517101034|FG001|Overall Study|Another antibiotic therapy required|1|||
143425237|NCT01014013|517101033|FG000|Overall Study|Appendectomy|1|||
143425238|NCT01014013|517101034|FG001|Overall Study|Appendectomy|0|||
143425239|NCT01014013|517101033|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
143425240|NCT01014013|517101034|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
143425241|NCT02305797|517101041|FG000|Overall Study|Adverse Event|11|||
143425242|NCT02305797|517101042|FG001|Overall Study|Adverse Event|2|||
143425243|NCT02305797|517101041|FG000|Overall Study|Withdrawal by Subject|9|||
143425244|NCT02305797|517101042|FG001|Overall Study|Withdrawal by Subject|10|||
143425245|NCT02305797|517101041|FG000|Overall Study|Lack of Efficacy|6|||
143425246|NCT02305797|517101042|FG001|Overall Study|Lack of Efficacy|0|||
143425247|NCT02305797|517101041|FG000|Overall Study|Lost to Follow-up|5|||
143425248|NCT02305797|517101042|FG001|Overall Study|Lost to Follow-up|11|||
143425249|NCT02305797|517101041|FG000|Overall Study|Pregnancy|0|||
143425250|NCT02305797|517101042|FG001|Overall Study|Pregnancy|2|||
143425251|NCT02305797|517101041|FG000|Overall Study|Noncompliance|14|||
143425252|NCT02305797|517101042|FG001|Overall Study|Noncompliance|12|||
143425253|NCT02305797|517101041|FG000|Overall Study|Reason not collected|0|||
143425254|NCT02305797|517101042|FG001|Overall Study|Reason not collected|1|||
143425255|NCT03508830|517101043|FG000|Overall Study|Withdrawal by Subject|3|||
143425256|NCT03508830|517101044|FG001|Overall Study|Withdrawal by Subject|4|||
143425257|NCT03508830|517101043|FG000|Overall Study|Physician Decision|2|||
143425258|NCT03508830|517101044|FG001|Overall Study|Physician Decision|2|||
143425259|NCT02097056|517101047|FG000|Overall Study|Protocol Violation|2|||
143425260|NCT02097056|517101047|FG000|Overall Study|Withdrawal by Subject|15|||
143425261|NCT02097056|517101047|FG000|Overall Study|Lost to Follow-up|2|||
143425262|NCT02097056|517101047|FG000|Overall Study|Adverse Event|37|||
143425263|NCT02097056|517101047|FG000|Overall Study|Other|2|||
143425264|NCT01446042|517101048|FG000|Overall Study|Withdrawal by Subject|12|||
143425265|NCT01446042|517101049|FG001|Overall Study|Withdrawal by Subject|2|||
143425266|NCT01446042|517101050|FG002|Overall Study|Withdrawal by Subject|4|||
143425267|NCT01446042|517101048|FG000|Overall Study|Adverse Event|1|||
143425268|NCT01446042|517101049|FG001|Overall Study|Adverse Event|0|||
143425269|NCT01446042|517101050|FG002|Overall Study|Adverse Event|4|||
143425270|NCT01446042|517101048|FG000|Overall Study|Lost to Follow-up|5|||
143425271|NCT01446042|517101049|FG001|Overall Study|Lost to Follow-up|0|||
143425272|NCT01446042|517101050|FG002|Overall Study|Lost to Follow-up|0|||
143425273|NCT01446042|517101048|FG000|Overall Study|Other reasons|2|||
143425274|NCT01446042|517101049|FG001|Overall Study|Other reasons|1|||
143425275|NCT01446042|517101050|FG002|Overall Study|Other reasons|1|||
143425276|NCT03906240|517101051|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
143425277|NCT03906240|517101052|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
143425278|NCT03906240|517101051|FG000|Overall Study|Lost to Follow-up|1|||
143425279|NCT03906240|517101052|FG001|Overall Study|Lost to Follow-up|0|||
143425280|NCT03906240|517101051|FG000|Overall Study|Withdrawal by Subject|0|||
143425281|NCT03906240|517101052|FG001|Overall Study|Withdrawal by Subject|1|||
143425282|NCT01323309|517101064|FG000|Overall Study|Death|9|||
143425283|NCT01323309|517101065|FG001|Overall Study|Death|15|||
143425284|NCT01323309|517101066|FG002|Overall Study|Death|5|||
143425285|NCT01323309|517101064|FG000|Overall Study|Lost to Follow-up|11|||
143425286|NCT01323309|517101065|FG001|Overall Study|Lost to Follow-up|14|||
143425287|NCT01323309|517101066|FG002|Overall Study|Lost to Follow-up|24|||
143425288|NCT01323309|517101064|FG000|Overall Study|Withdrawal by Subject|14|||
143425289|NCT01323309|517101065|FG001|Overall Study|Withdrawal by Subject|14|||
143425290|NCT01323309|517101066|FG002|Overall Study|Withdrawal by Subject|18|||
143425291|NCT01323309|517101064|FG000|Overall Study|Disease progression|5|||
143425292|NCT01323309|517101065|FG001|Overall Study|Disease progression|11|||
143425293|NCT01323309|517101066|FG002|Overall Study|Disease progression|4|||
143425294|NCT01078571|517101067|FG000|Overall Study|Adverse Event|36|||
143425295|NCT01078571|517101067|FG000|Overall Study|Lack of effectiveness|36|||
143425296|NCT01078571|517101067|FG000|Overall Study|Reason not reported|21|||
143425297|NCT01078571|517101067|FG000|Overall Study|Withdrawal by Subject|12|||
143425298|NCT01078571|517101067|FG000|Overall Study|Lost to Follow-up|8|||
143425299|NCT01078571|517101067|FG000|Overall Study|Protocol Violation|2|||
143425300|NCT01047306|517101071|FG000|Overall Study|Withdrawal by Subject|2|||
143425301|NCT01047306|517101072|FG001|Overall Study|Withdrawal by Subject|0|||
143425302|NCT01047306|517101071|FG000|Overall Study|Lost to Follow-up|1|||
143425303|NCT01047306|517101072|FG001|Overall Study|Lost to Follow-up|0|||
143425304|NCT01878253|517101073|FG000|Overall Study|Death|1|||
143425305|NCT01878253|517101073|FG000|Overall Study|SIdus System Removal|3|||
143425306|NCT01878253|517101073|FG000|Overall Study|Withdrawal by Subject|1|||
143425307|NCT01878253|517101073|FG000|Overall Study|Lost to Follow-up|2|||
143425308|NCT01878253|517101073|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
143425309|NCT00596960|517101081|FG000|Overall Study|Death|1|||
143425310|NCT00596960|517101082|FG001|Overall Study|Death|2|||
143425311|NCT00596960|517101081|FG000|Overall Study|Lost to Follow-up|6|||
143425312|NCT00596960|517101082|FG001|Overall Study|Lost to Follow-up|5|||
143425313|NCT00596960|517101081|FG000|Overall Study|Withdrawal by Subject|1|||
143425314|NCT00596960|517101082|FG001|Overall Study|Withdrawal by Subject|0|||
143425315|NCT00596960|517101081|FG000|Overall Study|Incarcerated|2|||
143425316|NCT00596960|517101082|FG001|Overall Study|Incarcerated|0|||
143425317|NCT00596960|517101081|FG000|Overall Study|Physician Decision|1|||
143425318|NCT00596960|517101082|FG001|Overall Study|Physician Decision|0|||
143425319|NCT00596960|517101081|FG000|Overall Study|Protocol Violation|0|||
143425320|NCT00596960|517101082|FG001|Overall Study|Protocol Violation|1|||
143425321|NCT00596960|517101081|FG000|Overall Study|No alcohol use data|0|||
143425322|NCT00596960|517101082|FG001|Overall Study|No alcohol use data|1|||
143425323|NCT01075815|517101083|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
143425324|NCT01075815|517101084|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
143425325|NCT01075815|517101083|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
143425326|NCT01075815|517101084|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
143425327|NCT01075815|517101083|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
143425328|NCT01075815|517101084|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
143425329|NCT02058992|517101085|FG000|Overall Study|Lost to Follow-up|4|||
143425330|NCT02058992|517101085|FG000|Overall Study|Protocol Violation|92|||
143425331|NCT02058992|517101085|FG000|Overall Study|CRF Uncollected|20|||
143425332|NCT02374476|517101088|FG000|VT Induced Ablation|Screening Failures|36|||
143425333|NCT02374476|517101089|FG001|VT Induced Ablation|Screening Failures|0|||
143425334|NCT02374476|517101090|FG002|VT Induced Ablation|Screening Failures|0|||
143425335|NCT02374476|517101088|FG000|Arm Assignment|Withdrawal by Subject|0|||
143425336|NCT02374476|517101089|FG001|Arm Assignment|Withdrawal by Subject|0|||
143425337|NCT02374476|517101090|FG002|Arm Assignment|Withdrawal by Subject|1|||
143425338|NCT05431543|517101091|FG000|Overall Study|Medical History|1|||
143425339|NCT05431543|517101092|FG001|Overall Study|Medical History|0|||
143425340|NCT05431543|517101093|FG002|Overall Study|Medical History|0|||
143425341|NCT00914732|517101095|FG000|Overall Study|Lost to Follow-up|6|||
143425342|NCT00914732|517101096|FG001|Overall Study|Lost to Follow-up|7|||
143425343|NCT00914732|517101097|FG002|Overall Study|Lost to Follow-up|9|||
143425344|NCT00914732|517101095|FG000|Overall Study|Withdrawal by Subject|3|||
143425345|NCT00914732|517101096|FG001|Overall Study|Withdrawal by Subject|0|||
143425346|NCT00914732|517101097|FG002|Overall Study|Withdrawal by Subject|2|||
143425347|NCT00914732|517101095|FG000|Overall Study|Adverse Event|1|||
143425348|NCT00914732|517101096|FG001|Overall Study|Adverse Event|0|||
143425349|NCT00914732|517101097|FG002|Overall Study|Adverse Event|0|||
143425350|NCT02130401|517101098|FG000|Overall Study|Poor enrollment|6|||
143425351|NCT01855399|517101099|FG000|6 Month|Lost to Follow-up|12|||
143425352|NCT01855399|517101100|FG001|6 Month|Lost to Follow-up|9|||
143425353|NCT01855399|517101099|FG000|6 Month|Withdrawal by Subject|8|||
143425354|NCT01855399|517101100|FG001|6 Month|Withdrawal by Subject|6|||
143425355|NCT01855399|517101099|FG000|12 Month|Lost to Follow-up|7|||
143425356|NCT01855399|517101100|FG001|12 Month|Lost to Follow-up|11|||
143425357|NCT00321672|517101101|FG000|Overall Study|Withdrawal by Subject|5|||
143425358|NCT00321672|517101102|FG001|Overall Study|Withdrawal by Subject|1|||
143425359|NCT00321672|517101103|FG002|Overall Study|Withdrawal by Subject|2|||
143425360|NCT00321672|517101104|FG003|Overall Study|Withdrawal by Subject|0|||
143425361|NCT00321672|517101101|FG000|Overall Study|Noncompliance|1|||
143425362|NCT00321672|517101102|FG001|Overall Study|Noncompliance|2|||
143425363|NCT00321672|517101103|FG002|Overall Study|Noncompliance|1|||
143425364|NCT00321672|517101104|FG003|Overall Study|Noncompliance|0|||
143425365|NCT00321672|517101101|FG000|Overall Study|Adverse Event|1|||
143425366|NCT00321672|517101102|FG001|Overall Study|Adverse Event|1|||
143425367|NCT00321672|517101103|FG002|Overall Study|Adverse Event|0|||
143425368|NCT00321672|517101104|FG003|Overall Study|Adverse Event|0|||
143425369|NCT00321672|517101101|FG000|Overall Study|Lack of Efficacy|1|||
143425370|NCT00321672|517101102|FG001|Overall Study|Lack of Efficacy|1|||
143425371|NCT00321672|517101103|FG002|Overall Study|Lack of Efficacy|0|||
143425372|NCT00321672|517101104|FG003|Overall Study|Lack of Efficacy|0|||
143425373|NCT00321672|517101101|FG000|Overall Study|Lost to Follow-up|2|||
143425374|NCT00321672|517101102|FG001|Overall Study|Lost to Follow-up|0|||
143425375|NCT00321672|517101103|FG002|Overall Study|Lost to Follow-up|4|||
143425376|NCT00321672|517101104|FG003|Overall Study|Lost to Follow-up|2|||
143425377|NCT00321672|517101101|FG000|Overall Study|Death|1|||
143425378|NCT00321672|517101102|FG001|Overall Study|Death|0|||
143425379|NCT00321672|517101103|FG002|Overall Study|Death|0|||
143425380|NCT00321672|517101104|FG003|Overall Study|Death|0|||
143425381|NCT00321672|517101101|FG000|Overall Study|Too far to travel for visits|1|||
143425382|NCT00321672|517101102|FG001|Overall Study|Too far to travel for visits|0|||
143425383|NCT00321672|517101103|FG002|Overall Study|Too far to travel for visits|0|||
143425384|NCT00321672|517101104|FG003|Overall Study|Too far to travel for visits|0|||
143425385|NCT00321672|517101101|FG000|Overall Study|Incarcerated|0|||
143425386|NCT00321672|517101102|FG001|Overall Study|Incarcerated|0|||
143425387|NCT00321672|517101103|FG002|Overall Study|Incarcerated|2|||
143425388|NCT00321672|517101104|FG003|Overall Study|Incarcerated|0|||
143425389|NCT00321672|517101101|FG000|Overall Study|Moved out of state|0|||
143425390|NCT00321672|517101102|FG001|Overall Study|Moved out of state|1|||
143425391|NCT00321672|517101103|FG002|Overall Study|Moved out of state|1|||
143425392|NCT00321672|517101104|FG003|Overall Study|Moved out of state|0|||
143425393|NCT00321672|517101101|FG000|Overall Study|Protocol Violation|0|||
143425394|NCT00321672|517101102|FG001|Overall Study|Protocol Violation|0|||
143425395|NCT00321672|517101103|FG002|Overall Study|Protocol Violation|1|||
143425396|NCT00321672|517101104|FG003|Overall Study|Protocol Violation|0|||
143425397|NCT00321672|517101101|FG000|Overall Study|Diagnosis of testicular cancer|0|||
143425398|NCT00321672|517101102|FG001|Overall Study|Diagnosis of testicular cancer|1|||
143425399|NCT00321672|517101103|FG002|Overall Study|Diagnosis of testicular cancer|0|||
143425400|NCT00321672|517101104|FG003|Overall Study|Diagnosis of testicular cancer|0|||
143425401|NCT00321672|517101101|FG000|Overall Study|Extensive travel required for new job|0|||
143425402|NCT00321672|517101102|FG001|Overall Study|Extensive travel required for new job|1|||
143425403|NCT00321672|517101103|FG002|Overall Study|Extensive travel required for new job|0|||
143425404|NCT00321672|517101104|FG003|Overall Study|Extensive travel required for new job|0|||
143425405|NCT00145496|517101109|FG000|Overall Study|Adverse Event|42|||
143425406|NCT00145496|517101110|FG001|Overall Study|Adverse Event|30|||
143425407|NCT00145496|517101109|FG000|Overall Study|Lack of Efficacy|12|||
143425408|NCT00145496|517101110|FG001|Overall Study|Lack of Efficacy|7|||
143425409|NCT00145496|517101109|FG000|Overall Study|Withdrawal by Subject|32|||
143425410|NCT00145496|517101110|FG001|Overall Study|Withdrawal by Subject|26|||
143425411|NCT00145496|517101109|FG000|Overall Study|Lost to Follow-up|12|||
143425412|NCT00145496|517101110|FG001|Overall Study|Lost to Follow-up|5|||
143425413|NCT00145496|517101109|FG000|Overall Study|Other|25|||
143425414|NCT00145496|517101110|FG001|Overall Study|Other|13|||
143425415|NCT01945086|517101113|FG000|Overall Study|Withdrawal by Subject|1|||
143425416|NCT01945086|517101114|FG001|Overall Study|Withdrawal by Subject|0|||
143425417|NCT01945086|517101115|FG002|Overall Study|Withdrawal by Subject|1|||
143425418|NCT01945086|517101113|FG000|Overall Study|Adverse Event|0|||
143425419|NCT01945086|517101114|FG001|Overall Study|Adverse Event|0|||
143425420|NCT01945086|517101115|FG002|Overall Study|Adverse Event|1|||
143425421|NCT04853394|517101119|FG000|Follow-up Interviews|Lost to Follow-up|22|||
143425422|NCT04853394|517101120|FG001|Follow-up Interviews|Lost to Follow-up|15|||
143425423|NCT04212299|517101121|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
143425424|NCT01232569|517102947|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
143425425|NCT01232569|517102948|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
143425426|NCT01232569|517102949|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
143425427|NCT01232569|517102950|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
143425428|NCT01232569|517102947|FG000|Double-blind Treatment Period|Escape|2|||
143425429|NCT01232569|517102948|FG001|Double-blind Treatment Period|Escape|2|||
143425430|NCT01232569|517102949|FG002|Double-blind Treatment Period|Escape|0|||
143425431|NCT01232569|517102950|FG003|Double-blind Treatment Period|Escape|0|||
143425432|NCT01232569|517102947|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
143425433|NCT01232569|517102948|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
143425434|NCT01232569|517102949|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
143425435|NCT01232569|517102950|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
143425436|NCT01232569|517102947|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
143425437|NCT01232569|517102948|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
143425438|NCT01232569|517102949|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
143425439|NCT01232569|517102950|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
143425440|NCT01232569|517102947|FG000|Double-blind Treatment Period|Physician Decision|1|||
143425441|NCT01232569|517102948|FG001|Double-blind Treatment Period|Physician Decision|0|||
143425442|NCT01232569|517102949|FG002|Double-blind Treatment Period|Physician Decision|0|||
143425443|NCT01232569|517102950|FG003|Double-blind Treatment Period|Physician Decision|0|||
143425444|NCT01232569|517102947|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
143425445|NCT01232569|517102948|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
143425446|NCT01232569|517102949|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
143425447|NCT01232569|517102950|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
143425448|NCT01232569|517102947|FG000|Double-blind Treatment Period|Death|2|||
143425449|NCT01232569|517102948|FG001|Double-blind Treatment Period|Death|0|||
143425450|NCT01232569|517102949|FG002|Double-blind Treatment Period|Death|0|||
143425451|NCT01232569|517102950|FG003|Double-blind Treatment Period|Death|0|||
143425452|NCT05335005|517102955|FG000|Overall Study|Lost to Follow-up|1|||
143425453|NCT01503515|517102956|FG000|Overall Study|Adverse Event|4|||
143425454|NCT01503515|517102957|FG001|Overall Study|Adverse Event|5|||
143425455|NCT01503515|517102956|FG000|Overall Study|Death|0|||
143425456|NCT01503515|517102957|FG001|Overall Study|Death|1|||
143425457|NCT01503515|517102956|FG000|Overall Study|Physician Decision|14|||
143425458|NCT01503515|517102957|FG001|Overall Study|Physician Decision|23|||
143425459|NCT01503515|517102956|FG000|Overall Study|Withdrawal by Subject|0|||
143425460|NCT01503515|517102957|FG001|Overall Study|Withdrawal by Subject|1|||
143425461|NCT01503515|517102956|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
143425462|NCT01503515|517102957|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
143425463|NCT01503515|517102956|FG000|Overall Study|Ineligible|1|||
143425464|NCT01503515|517102957|FG001|Overall Study|Ineligible|1|||
143425465|NCT01350102|517102958|FG000|Overall Study|Adverse Event|0|||
143425466|NCT01350102|517102959|FG001|Overall Study|Adverse Event|0|||
143425467|NCT01350102|517102960|FG002|Overall Study|Adverse Event|1|||
143425468|NCT01350102|517102961|FG003|Overall Study|Adverse Event|0|||
143425469|NCT00644332|517102963|FG000|Overall Study|Adverse Event|11|||
143425470|NCT00644332|517102963|FG000|Overall Study|Withdrawal by Subject|6|||
143425471|NCT00644332|517102963|FG000|Overall Study|Completion Status Unknown|2|||
143425472|NCT00644332|517102963|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
143425473|NCT00644332|517102963|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
143425474|NCT03694210|517102964|FG000|Overall Study|Death|1|||
143425475|NCT03694210|517102964|FG000|Overall Study|Screen Failure|7|||
143425476|NCT00443755|517102965|FG000|Overall Study|Withdrawal by Subject|2|||
143425477|NCT00443755|517102966|FG001|Overall Study|Withdrawal by Subject|1|||
143425478|NCT02706834|517102970|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
143425479|NCT02706834|517102971|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
143425480|NCT02706834|517102972|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
143425481|NCT02706834|517102973|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
143425482|NCT02706834|517102974|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
143425483|NCT02706834|517102975|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
143425484|NCT02706834|517102976|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
143425485|NCT02706834|517102977|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
143425486|NCT02706834|517102978|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
143425487|NCT02706834|517102979|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
143425488|NCT02706834|517102980|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
143425489|NCT02706834|517102970|FG000|Overall Study|Lost to Follow-up|0|||
143425490|NCT02706834|517102971|FG001|Overall Study|Lost to Follow-up|0|||
143425491|NCT02706834|517102972|FG002|Overall Study|Lost to Follow-up|1|||
143425492|NCT02706834|517102973|FG003|Overall Study|Lost to Follow-up|0|||
143425493|NCT02706834|517102974|FG004|Overall Study|Lost to Follow-up|0|||
143425494|NCT02706834|517102975|FG005|Overall Study|Lost to Follow-up|0|||
143425495|NCT02706834|517102976|FG006|Overall Study|Lost to Follow-up|0|||
143425496|NCT02706834|517102977|FG007|Overall Study|Lost to Follow-up|0|||
143425497|NCT02706834|517102978|FG008|Overall Study|Lost to Follow-up|0|||
143425498|NCT02706834|517102979|FG009|Overall Study|Lost to Follow-up|0|||
143425499|NCT02706834|517102980|FG010|Overall Study|Lost to Follow-up|0|||
143425500|NCT02706834|517102970|FG000|Overall Study|Voluntary Withdrawal|1|||
143425501|NCT02706834|517102971|FG001|Overall Study|Voluntary Withdrawal|0|||
143425502|NCT02706834|517102972|FG002|Overall Study|Voluntary Withdrawal|0|||
143425503|NCT02706834|517102973|FG003|Overall Study|Voluntary Withdrawal|0|||
143425504|NCT02706834|517102974|FG004|Overall Study|Voluntary Withdrawal|0|||
143425505|NCT02706834|517102975|FG005|Overall Study|Voluntary Withdrawal|0|||
143425506|NCT02706834|517102976|FG006|Overall Study|Voluntary Withdrawal|0|||
143425507|NCT02706834|517102977|FG007|Overall Study|Voluntary Withdrawal|0|||
143425508|NCT02706834|517102978|FG008|Overall Study|Voluntary Withdrawal|0|||
143425509|NCT02706834|517102979|FG009|Overall Study|Voluntary Withdrawal|1|||
143425510|NCT02706834|517102980|FG010|Overall Study|Voluntary Withdrawal|0|||
143425511|NCT02706834|517102970|FG000|Overall Study|Other Reason Not Specified|1|||
143425512|NCT02706834|517102971|FG001|Overall Study|Other Reason Not Specified|0|||
143425513|NCT02706834|517102972|FG002|Overall Study|Other Reason Not Specified|0|||
143425514|NCT02706834|517102973|FG003|Overall Study|Other Reason Not Specified|0|||
143425515|NCT02706834|517102974|FG004|Overall Study|Other Reason Not Specified|1|||
143425516|NCT02706834|517102975|FG005|Overall Study|Other Reason Not Specified|0|||
143425517|NCT02706834|517102976|FG006|Overall Study|Other Reason Not Specified|0|||
143425518|NCT02706834|517102977|FG007|Overall Study|Other Reason Not Specified|0|||
143425519|NCT02706834|517102978|FG008|Overall Study|Other Reason Not Specified|0|||
143425520|NCT02706834|517102979|FG009|Overall Study|Other Reason Not Specified|0|||
143425521|NCT02706834|517102980|FG010|Overall Study|Other Reason Not Specified|0|||
143425522|NCT00678899|517102985|FG000|Overall Study|Adverse Event|1|||
143425523|NCT04385849|517102986|FG000|Overall Study|Lost to Follow-up|1|||
143425524|NCT04385849|517102987|FG001|Overall Study|Lost to Follow-up|0|||
143425525|NCT01375777|517102988|FG000|Overall Study|Withdrawal by Subject|0|||
143425526|NCT01375777|517102989|FG001|Overall Study|Withdrawal by Subject|2|||
143425527|NCT01375777|517102990|FG002|Overall Study|Withdrawal by Subject|1|||
143425528|NCT01375777|517102991|FG003|Overall Study|Withdrawal by Subject|0|||
143425529|NCT01375777|517102992|FG004|Overall Study|Withdrawal by Subject|1|||
143425530|NCT01375777|517102993|FG005|Overall Study|Withdrawal by Subject|1|||
143425531|NCT01375777|517102994|FG006|Overall Study|Withdrawal by Subject|1|||
143425532|NCT01375777|517102995|FG007|Overall Study|Withdrawal by Subject|2|||
143425533|NCT01375777|517102996|FG008|Overall Study|Withdrawal by Subject|1|||
143425534|NCT01375777|517102988|FG000|Overall Study|Lost to Follow-up|1|||
143425535|NCT01375777|517102989|FG001|Overall Study|Lost to Follow-up|0|||
143425536|NCT01375777|517102990|FG002|Overall Study|Lost to Follow-up|0|||
143425537|NCT01375777|517102991|FG003|Overall Study|Lost to Follow-up|0|||
143425538|NCT01375777|517102992|FG004|Overall Study|Lost to Follow-up|0|||
143425539|NCT01375777|517102993|FG005|Overall Study|Lost to Follow-up|0|||
143425540|NCT01375777|517102994|FG006|Overall Study|Lost to Follow-up|1|||
143425541|NCT01375777|517102995|FG007|Overall Study|Lost to Follow-up|0|||
143425542|NCT01375777|517102996|FG008|Overall Study|Lost to Follow-up|0|||
143425543|NCT01375777|517102988|FG000|Overall Study|Other|1|||
143425544|NCT01375777|517102989|FG001|Overall Study|Other|1|||
143425545|NCT01375777|517102990|FG002|Overall Study|Other|0|||
143425546|NCT01375777|517102991|FG003|Overall Study|Other|0|||
143425547|NCT01375777|517102992|FG004|Overall Study|Other|0|||
143425548|NCT01375777|517102993|FG005|Overall Study|Other|0|||
143425549|NCT01375777|517102994|FG006|Overall Study|Other|0|||
143425550|NCT01375777|517102995|FG007|Overall Study|Other|0|||
143425551|NCT01375777|517102996|FG008|Overall Study|Other|1|||
143425552|NCT00355784|517102997|FG000|Overall Study|Withdrawal by Subject|0|||
143425553|NCT00355784|517102998|FG001|Overall Study|Withdrawal by Subject|0|||
143425554|NCT00355784|517102999|FG002|Overall Study|Withdrawal by Subject|2|||
143425555|NCT02543294|517103000|FG000|Overall Study|Lost to Follow-up|3|||
143425556|NCT02543294|517103000|FG000|Overall Study|Physician Decision|2|||
143425557|NCT02543294|517103000|FG000|Overall Study|Withdrawal by Subject|7|||
143425558|NCT02339506|517103001|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
143425559|NCT02339506|517103002|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
143425560|NCT02339506|517103001|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
143425561|NCT02339506|517103002|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
143425562|NCT03997409|517103003|FG000|Overall Study|Protocol Violation|1|||
143425563|NCT03997409|517103004|FG001|Overall Study|Protocol Violation|1|||
143425564|NCT03997409|517103005|FG002|Overall Study|Protocol Violation|0|||
143425565|NCT03997409|517103003|FG000|Overall Study|Withdrawal by Subject|3|||
143425566|NCT03997409|517103004|FG001|Overall Study|Withdrawal by Subject|0|||
143425567|NCT03997409|517103005|FG002|Overall Study|Withdrawal by Subject|0|||
143425568|NCT03997409|517103003|FG000|Overall Study|Lost to Follow-up|0|||
143425569|NCT03997409|517103004|FG001|Overall Study|Lost to Follow-up|0|||
143425570|NCT03997409|517103005|FG002|Overall Study|Lost to Follow-up|1|||
143425571|NCT00907517|517103006|FG000|Overall Study|Progressive Disease|3|||
143425572|NCT00907517|517103007|FG001|Overall Study|Progressive Disease|3|||
143425573|NCT00907517|517103008|FG002|Overall Study|Progressive Disease|4|||
143425574|NCT00907517|517103009|FG003|Overall Study|Progressive Disease|4|||
143425575|NCT00907517|517103010|FG004|Overall Study|Progressive Disease|4|||
143425576|NCT00907517|517103006|FG000|Overall Study|Symptomatic Deterioration|0|||
143425577|NCT00907517|517103007|FG001|Overall Study|Symptomatic Deterioration|0|||
143425578|NCT00907517|517103008|FG002|Overall Study|Symptomatic Deterioration|0|||
143425579|NCT00907517|517103009|FG003|Overall Study|Symptomatic Deterioration|0|||
143425580|NCT00907517|517103010|FG004|Overall Study|Symptomatic Deterioration|1|||
143425581|NCT04879823|517103018|FG000|Overall Study|Physician Decision|3|||
143425582|NCT04879823|517103019|FG001|Overall Study|Physician Decision|1|||
143425583|NCT04879823|517103018|FG000|Overall Study|Protocol Violation|2|||
143425584|NCT04879823|517103019|FG001|Overall Study|Protocol Violation|3|||
143425585|NCT04879823|517103018|FG000|Overall Study|Lost to Follow-up|43|||
143425586|NCT04879823|517103019|FG001|Overall Study|Lost to Follow-up|35|||
143425587|NCT04468633|517103020|FG000|Overall Study|Withdrawal by Subject|4|||
143425588|NCT04468633|517103021|FG001|Overall Study|Withdrawal by Subject|0|||
143425589|NCT02465866|517103022|FG000|Period 3|Withdrawal by Subject|0|||
143425590|NCT02465866|517103023|FG001|Period 3|Withdrawal by Subject|1|||
143425591|NCT02465866|517103024|FG002|Period 3|Withdrawal by Subject|0|||
143425592|NCT02465866|517103025|FG003|Period 3|Withdrawal by Subject|0|||
143425593|NCT02592434|517103026|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
143425594|NCT02592434|517103027|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
143425595|NCT02592434|517103028|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
143425596|NCT02592434|517103026|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
143425597|NCT02592434|517103027|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
143425598|NCT02592434|517103028|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
143425599|NCT02592434|517103026|FG000|Open-Label Phase (18 Weeks)|Other|3|||
143425600|NCT02592434|517103027|FG001|Open-Label Phase (18 Weeks)|Other|0|||
143425601|NCT02592434|517103028|FG002|Open-Label Phase (18 Weeks)|Other|0|||
143425602|NCT02592434|517103026|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
143425603|NCT02592434|517103027|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
143425604|NCT02592434|517103028|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
143425605|NCT02592434|517103026|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
143425606|NCT02592434|517103027|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
143425607|NCT02592434|517103028|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
143425608|NCT02592434|517103026|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
143425609|NCT02592434|517103027|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
143425610|NCT02592434|517103028|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
143425611|NCT02592434|517103026|FG000|Double Blind Phase (26 Weeks)|Other|0|||
143425612|NCT02592434|517103027|FG001|Double Blind Phase (26 Weeks)|Other|1|||
143425613|NCT02592434|517103028|FG002|Double Blind Phase (26 Weeks)|Other|0|||
143425614|NCT02592434|517103026|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
143425615|NCT02592434|517103027|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
143425616|NCT02592434|517103028|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
143425617|NCT02592434|517103026|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
143425618|NCT02592434|517103027|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
143425619|NCT02592434|517103028|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
143425620|NCT02592434|517103026|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
143425621|NCT02592434|517103027|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
143425622|NCT02592434|517103028|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
143425623|NCT01469819|517103029|FG000|Overall Study|Withdrawal by Subject|1|||
143425624|NCT01469819|517103029|FG000|Overall Study|Did not meet inclusionary criteria|2|||
143425625|NCT01469819|517103029|FG000|Overall Study|Could not swallow SmartPill|2|||
143425626|NCT01469819|517103029|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
143425627|NCT02029521|517103032|FG000|Overall Study|Protocol Violation|1|||
143425628|NCT02029521|517103033|FG001|Overall Study|Protocol Violation|0|||
143425629|NCT02029521|517103032|FG000|Overall Study|Withdrawal by Subject|1|||
143425630|NCT02029521|517103033|FG001|Overall Study|Withdrawal by Subject|1|||
143425631|NCT01106586|517103035|FG000|Overall Study|Adverse Event|9|||
143425632|NCT01106586|517103036|FG001|Overall Study|Adverse Event|15|||
143425633|NCT01106586|517103035|FG000|Overall Study|Death|1|||
143425634|NCT01106586|517103036|FG001|Overall Study|Death|3|||
143425635|NCT01106586|517103035|FG000|Overall Study|Pregnancy|2|||
143425636|NCT01106586|517103036|FG001|Overall Study|Pregnancy|2|||
143425637|NCT01106586|517103035|FG000|Overall Study|Lack of Efficacy|1|||
143425638|NCT01106586|517103036|FG001|Overall Study|Lack of Efficacy|0|||
143425639|NCT01106586|517103035|FG000|Overall Study|Investigator's Discretion|5|||
143425640|NCT01106586|517103036|FG001|Overall Study|Investigator's Discretion|8|||
143425641|NCT01106586|517103035|FG000|Overall Study|Withdrew Consent|18|||
143425642|NCT01106586|517103036|FG001|Overall Study|Withdrew Consent|30|||
143425643|NCT01106586|517103035|FG000|Overall Study|Lost to Follow-up|24|||
143425644|NCT01106586|517103036|FG001|Overall Study|Lost to Follow-up|20|||
143425645|NCT01106586|517103035|FG000|Overall Study|Participant Noncompliance|12|||
143425646|NCT01106586|517103036|FG001|Overall Study|Participant Noncompliance|10|||
143425647|NCT01106586|517103035|FG000|Overall Study|Protocol Violation|1|||
143425648|NCT01106586|517103036|FG001|Overall Study|Protocol Violation|0|||
143425649|NCT01106586|517103035|FG000|Overall Study|Participant Transferred to Another Study|212|||
143425650|NCT01106586|517103036|FG001|Overall Study|Participant Transferred to Another Study|197|||
143425651|NCT02131155|517103037|FG000|Overall Study|Adverse Event|1|||
143425652|NCT02131155|517103038|FG001|Overall Study|Adverse Event|0|||
143425653|NCT02131155|517103037|FG000|Overall Study|Treatment completed|1|||
143425654|NCT02131155|517103038|FG001|Overall Study|Treatment completed|0|||
143425655|NCT02131155|517103037|FG000|Overall Study|Primary tumour recurrence|2|||
143425656|NCT02131155|517103038|FG001|Overall Study|Primary tumour recurrence|1|||
143425657|NCT02131155|517103037|FG000|Overall Study|Refused to continue study medication|1|||
143425658|NCT02131155|517103038|FG001|Overall Study|Refused to continue study medication|0|||
143425659|NCT02131155|517103037|FG000|Overall Study|Study early termination|20|||
143425660|NCT02131155|517103038|FG001|Overall Study|Study early termination|10|||
143425661|NCT01887418|517103041|FG000|Overall Study|Travelling difficulties|0|||
143425662|NCT01887418|517103042|FG001|Overall Study|Travelling difficulties|0|||
143425663|NCT01887418|517103043|FG002|Overall Study|Travelling difficulties|1|||
143425664|NCT03132753|517103044|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
143425665|NCT03132753|517103045|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
143425666|NCT03132753|517103044|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
143425667|NCT03132753|517103045|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
143425668|NCT00084747|517103046|FG000|Overall Study|Relapsed|8|||
143425669|NCT00084747|517103046|FG000|Overall Study|Death|3|||
143425670|NCT00084747|517103046|FG000|Overall Study|Withdrawal by Subject|2|||
143425671|NCT02744898|517103048|FG000|Overall Study|Progressive Disease|2|||
143425672|NCT02744898|517103048|FG000|Overall Study|Physician Decision|1|||
143425673|NCT02744898|517103048|FG000|Overall Study|Toxicity|1|||
143425674|NCT03751280|517103049|FG000|Overall Study|Adverse Event|0|||
143425675|NCT03751280|517103050|FG001|Overall Study|Adverse Event|1|||
143425676|NCT03751280|517103049|FG000|Overall Study|Lost to Follow-up|3|||
143425677|NCT03751280|517103050|FG001|Overall Study|Lost to Follow-up|5|||
143425678|NCT03751280|517103049|FG000|Overall Study|Physician Decision|0|||
143425679|NCT03751280|517103050|FG001|Overall Study|Physician Decision|2|||
143425680|NCT03751280|517103049|FG000|Overall Study|Protocol Violation|0|||
143425681|NCT03751280|517103050|FG001|Overall Study|Protocol Violation|2|||
143425682|NCT03751280|517103049|FG000|Overall Study|Withdrawal by Subject|5|||
143425683|NCT03751280|517103050|FG001|Overall Study|Withdrawal by Subject|2|||
143425684|NCT00296504|517103051|FG000|Interim Analysis|Withdrawal by Subject|8|||
143425685|NCT00296504|517103052|FG001|Interim Analysis|Withdrawal by Subject|0|||
143425686|NCT00296504|517103053|FG002|Interim Analysis|Withdrawal by Subject|12|||
143425687|NCT00296504|517103054|FG003|Interim Analysis|Withdrawal by Subject|0|||
143425688|NCT00296504|517103055|FG004|Interim Analysis|Withdrawal by Subject|5|||
143425689|NCT00296504|517103056|FG005|Interim Analysis|Withdrawal by Subject|5|||
143425690|NCT00296504|517103057|FG006|Interim Analysis|Withdrawal by Subject|9|||
143425691|NCT00296504|517103058|FG007|Interim Analysis|Withdrawal by Subject|3|||
143425692|NCT00296504|517103059|FG008|Interim Analysis|Withdrawal by Subject|0|||
143425693|NCT00296504|517103051|FG000|Interim Analysis|Lost to Follow-up|13|||
143425694|NCT00296504|517103052|FG001|Interim Analysis|Lost to Follow-up|3|||
143425695|NCT00296504|517103053|FG002|Interim Analysis|Lost to Follow-up|26|||
143425696|NCT00296504|517103054|FG003|Interim Analysis|Lost to Follow-up|8|||
143425697|NCT00296504|517103055|FG004|Interim Analysis|Lost to Follow-up|14|||
143425698|NCT00296504|517103056|FG005|Interim Analysis|Lost to Follow-up|4|||
143425699|NCT00296504|517103057|FG006|Interim Analysis|Lost to Follow-up|11|||
143425700|NCT00296504|517103058|FG007|Interim Analysis|Lost to Follow-up|4|||
143425701|NCT00296504|517103059|FG008|Interim Analysis|Lost to Follow-up|0|||
143425702|NCT00296504|517103051|FG000|Interim Analysis|Clinical Progression|1|||
143425703|NCT00296504|517103052|FG001|Interim Analysis|Clinical Progression|0|||
143425704|NCT00296504|517103053|FG002|Interim Analysis|Clinical Progression|1|||
143425705|NCT00296504|517103054|FG003|Interim Analysis|Clinical Progression|1|||
143425706|NCT00296504|517103055|FG004|Interim Analysis|Clinical Progression|0|||
143425707|NCT00296504|517103056|FG005|Interim Analysis|Clinical Progression|2|||
143425708|NCT00296504|517103057|FG006|Interim Analysis|Clinical Progression|1|||
143425709|NCT00296504|517103058|FG007|Interim Analysis|Clinical Progression|2|||
143425710|NCT00296504|517103059|FG008|Interim Analysis|Clinical Progression|0|||
143425711|NCT00296504|517103051|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
143425712|NCT00296504|517103052|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
143425713|NCT00296504|517103053|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
143425714|NCT00296504|517103054|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
143425715|NCT00296504|517103055|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
143425716|NCT00296504|517103056|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
143425717|NCT00296504|517103057|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
143425718|NCT00296504|517103058|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
143425719|NCT00296504|517103059|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
143425720|NCT00296504|517103051|FG000|Interim Analysis|Adverse Event|0|||
143425721|NCT00296504|517103052|FG001|Interim Analysis|Adverse Event|0|||
143425722|NCT00296504|517103053|FG002|Interim Analysis|Adverse Event|13|||
143425723|NCT00296504|517103054|FG003|Interim Analysis|Adverse Event|4|||
143425724|NCT00296504|517103055|FG004|Interim Analysis|Adverse Event|6|||
143425725|NCT00296504|517103056|FG005|Interim Analysis|Adverse Event|3|||
143425726|NCT00296504|517103057|FG006|Interim Analysis|Adverse Event|4|||
143425727|NCT00296504|517103058|FG007|Interim Analysis|Adverse Event|5|||
143425728|NCT00296504|517103059|FG008|Interim Analysis|Adverse Event|0|||
143425729|NCT00296504|517103051|FG000|Interim Analysis|Protocol Violation|0|||
143425730|NCT00296504|517103052|FG001|Interim Analysis|Protocol Violation|0|||
143425731|NCT00296504|517103053|FG002|Interim Analysis|Protocol Violation|2|||
143425732|NCT00296504|517103054|FG003|Interim Analysis|Protocol Violation|0|||
143425733|NCT00296504|517103055|FG004|Interim Analysis|Protocol Violation|1|||
143425734|NCT00296504|517103056|FG005|Interim Analysis|Protocol Violation|0|||
143425735|NCT00296504|517103057|FG006|Interim Analysis|Protocol Violation|0|||
143425736|NCT00296504|517103058|FG007|Interim Analysis|Protocol Violation|1|||
143425737|NCT00296504|517103059|FG008|Interim Analysis|Protocol Violation|0|||
143425738|NCT00296504|517103051|FG000|Interim Analysis|Insufficient CD4 Response|0|||
143425739|NCT00296504|517103052|FG001|Interim Analysis|Insufficient CD4 Response|0|||
143425740|NCT00296504|517103053|FG002|Interim Analysis|Insufficient CD4 Response|0|||
143425741|NCT00296504|517103054|FG003|Interim Analysis|Insufficient CD4 Response|0|||
143425742|NCT00296504|517103055|FG004|Interim Analysis|Insufficient CD4 Response|1|||
143425743|NCT00296504|517103056|FG005|Interim Analysis|Insufficient CD4 Response|1|||
143425744|NCT00296504|517103057|FG006|Interim Analysis|Insufficient CD4 Response|0|||
143425745|NCT00296504|517103058|FG007|Interim Analysis|Insufficient CD4 Response|0|||
143425746|NCT00296504|517103059|FG008|Interim Analysis|Insufficient CD4 Response|0|||
143425747|NCT00296504|517103051|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
143425748|NCT00296504|517103052|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
143425749|NCT00296504|517103053|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
143425750|NCT00296504|517103054|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
143425751|NCT00296504|517103055|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
143425752|NCT00296504|517103056|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
143425753|NCT00296504|517103057|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
143425754|NCT00296504|517103058|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
143425755|NCT00296504|517103059|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
143425756|NCT00296504|517103051|FG000|Interim Analysis|Pregnancy|4|||
143425757|NCT00296504|517103052|FG001|Interim Analysis|Pregnancy|1|||
143425758|NCT00296504|517103053|FG002|Interim Analysis|Pregnancy|4|||
143425759|NCT00296504|517103054|FG003|Interim Analysis|Pregnancy|2|||
143425760|NCT00296504|517103055|FG004|Interim Analysis|Pregnancy|0|||
143425761|NCT00296504|517103056|FG005|Interim Analysis|Pregnancy|1|||
143425762|NCT00296504|517103057|FG006|Interim Analysis|Pregnancy|1|||
143425763|NCT00296504|517103058|FG007|Interim Analysis|Pregnancy|1|||
143425764|NCT00296504|517103059|FG008|Interim Analysis|Pregnancy|0|||
143425765|NCT00296504|517103051|FG000|Interim Analysis|Death|1|||
143425766|NCT00296504|517103052|FG001|Interim Analysis|Death|0|||
143425767|NCT00296504|517103053|FG002|Interim Analysis|Death|3|||
143425768|NCT00296504|517103054|FG003|Interim Analysis|Death|0|||
143425769|NCT00296504|517103055|FG004|Interim Analysis|Death|0|||
143425770|NCT00296504|517103056|FG005|Interim Analysis|Death|0|||
143425771|NCT00296504|517103057|FG006|Interim Analysis|Death|0|||
143425772|NCT00296504|517103058|FG007|Interim Analysis|Death|0|||
143425773|NCT00296504|517103059|FG008|Interim Analysis|Death|0|||
143425774|NCT00296504|517103051|FG000|Interim Analysis|Participant Non-compliant|0|||
143425775|NCT00296504|517103052|FG001|Interim Analysis|Participant Non-compliant|1|||
143425776|NCT00296504|517103053|FG002|Interim Analysis|Participant Non-compliant|2|||
143425777|NCT00296504|517103054|FG003|Interim Analysis|Participant Non-compliant|1|||
143425778|NCT00296504|517103055|FG004|Interim Analysis|Participant Non-compliant|1|||
143425779|NCT00296504|517103056|FG005|Interim Analysis|Participant Non-compliant|3|||
143425780|NCT00296504|517103057|FG006|Interim Analysis|Participant Non-compliant|6|||
143425781|NCT00296504|517103058|FG007|Interim Analysis|Participant Non-compliant|2|||
143425782|NCT00296504|517103059|FG008|Interim Analysis|Participant Non-compliant|0|||
143425783|NCT00296504|517103051|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
143425784|NCT00296504|517103052|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
143425785|NCT00296504|517103053|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
143425786|NCT00296504|517103054|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
143425787|NCT00296504|517103055|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
143425788|NCT00296504|517103056|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
143425789|NCT00296504|517103057|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
143425790|NCT00296504|517103058|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
143425791|NCT00296504|517103059|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
143425792|NCT00296504|517103051|FG000|Interim Analysis|To Simplify Treatment|0|||
143425793|NCT00296504|517103052|FG001|Interim Analysis|To Simplify Treatment|0|||
143425794|NCT00296504|517103053|FG002|Interim Analysis|To Simplify Treatment|1|||
143425795|NCT00296504|517103054|FG003|Interim Analysis|To Simplify Treatment|0|||
143425796|NCT00296504|517103055|FG004|Interim Analysis|To Simplify Treatment|0|||
143425797|NCT00296504|517103056|FG005|Interim Analysis|To Simplify Treatment|0|||
143425798|NCT00296504|517103057|FG006|Interim Analysis|To Simplify Treatment|2|||
143425799|NCT00296504|517103058|FG007|Interim Analysis|To Simplify Treatment|0|||
143425800|NCT00296504|517103059|FG008|Interim Analysis|To Simplify Treatment|0|||
143425801|NCT00296504|517103051|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
143425802|NCT00296504|517103052|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
143425803|NCT00296504|517103053|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
143425804|NCT00296504|517103054|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
143425805|NCT00296504|517103055|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
143425806|NCT00296504|517103056|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
143425807|NCT00296504|517103057|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
143425808|NCT00296504|517103058|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
143425809|NCT00296504|517103059|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
143425810|NCT00296504|517103051|FG000|Interim Analysis|Participant Moved|1|||
143425811|NCT00296504|517103052|FG001|Interim Analysis|Participant Moved|0|||
143425812|NCT00296504|517103053|FG002|Interim Analysis|Participant Moved|1|||
143425813|NCT00296504|517103054|FG003|Interim Analysis|Participant Moved|0|||
143425814|NCT00296504|517103055|FG004|Interim Analysis|Participant Moved|0|||
143425815|NCT00296504|517103056|FG005|Interim Analysis|Participant Moved|1|||
143425816|NCT00296504|517103057|FG006|Interim Analysis|Participant Moved|1|||
143425817|NCT00296504|517103058|FG007|Interim Analysis|Participant Moved|0|||
143425818|NCT00296504|517103059|FG008|Interim Analysis|Participant Moved|0|||
143425819|NCT00296504|517103051|FG000|Interim Analysis|Participant Was Incarcerated|2|||
143425820|NCT00296504|517103052|FG001|Interim Analysis|Participant Was Incarcerated|0|||
143425821|NCT00296504|517103053|FG002|Interim Analysis|Participant Was Incarcerated|1|||
143425822|NCT00296504|517103054|FG003|Interim Analysis|Participant Was Incarcerated|0|||
143425823|NCT00296504|517103055|FG004|Interim Analysis|Participant Was Incarcerated|0|||
143425824|NCT00296504|517103056|FG005|Interim Analysis|Participant Was Incarcerated|0|||
143425825|NCT00296504|517103057|FG006|Interim Analysis|Participant Was Incarcerated|0|||
143425826|NCT00296504|517103058|FG007|Interim Analysis|Participant Was Incarcerated|0|||
143425827|NCT00296504|517103059|FG008|Interim Analysis|Participant Was Incarcerated|0|||
143425828|NCT00296504|517103051|FG000|Interim Analysis|Resistance to FPV|0|||
143425829|NCT00296504|517103052|FG001|Interim Analysis|Resistance to FPV|0|||
143425830|NCT00296504|517103053|FG002|Interim Analysis|Resistance to FPV|1|||
143425831|NCT00296504|517103054|FG003|Interim Analysis|Resistance to FPV|0|||
143425832|NCT00296504|517103055|FG004|Interim Analysis|Resistance to FPV|0|||
143425833|NCT00296504|517103056|FG005|Interim Analysis|Resistance to FPV|0|||
143425834|NCT00296504|517103057|FG006|Interim Analysis|Resistance to FPV|0|||
143425835|NCT00296504|517103058|FG007|Interim Analysis|Resistance to FPV|0|||
143425836|NCT00296504|517103059|FG008|Interim Analysis|Resistance to FPV|0|||
143425837|NCT00296504|517103051|FG000|Interim Analysis|Physician Decision|0|||
143425838|NCT00296504|517103052|FG001|Interim Analysis|Physician Decision|0|||
143425839|NCT00296504|517103053|FG002|Interim Analysis|Physician Decision|1|||
143425840|NCT00296504|517103054|FG003|Interim Analysis|Physician Decision|0|||
143425841|NCT00296504|517103055|FG004|Interim Analysis|Physician Decision|0|||
143425842|NCT00296504|517103056|FG005|Interim Analysis|Physician Decision|0|||
143425843|NCT00296504|517103057|FG006|Interim Analysis|Physician Decision|0|||
143425844|NCT00296504|517103058|FG007|Interim Analysis|Physician Decision|0|||
143425845|NCT00296504|517103059|FG008|Interim Analysis|Physician Decision|0|||
143425846|NCT00296504|517103051|FG000|Interim Analysis|Principle Investigator Discretion|2|||
143425847|NCT00296504|517103052|FG001|Interim Analysis|Principle Investigator Discretion|0|||
143425848|NCT00296504|517103053|FG002|Interim Analysis|Principle Investigator Discretion|1|||
143425849|NCT00296504|517103054|FG003|Interim Analysis|Principle Investigator Discretion|1|||
143425850|NCT00296504|517103055|FG004|Interim Analysis|Principle Investigator Discretion|0|||
143425851|NCT00296504|517103056|FG005|Interim Analysis|Principle Investigator Discretion|0|||
143425852|NCT00296504|517103057|FG006|Interim Analysis|Principle Investigator Discretion|0|||
143425853|NCT00296504|517103058|FG007|Interim Analysis|Principle Investigator Discretion|0|||
143425854|NCT00296504|517103059|FG008|Interim Analysis|Principle Investigator Discretion|0|||
143425855|NCT00296504|517103051|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
143425856|NCT00296504|517103052|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
143425857|NCT00296504|517103053|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
143425858|NCT00296504|517103054|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
143425859|NCT00296504|517103055|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
143425860|NCT00296504|517103056|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
143425861|NCT00296504|517103057|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
143425862|NCT00296504|517103058|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
143425863|NCT00296504|517103059|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
143425864|NCT00296504|517103051|FG000|Interim Analysis|Non-adherence|2|||
143425865|NCT00296504|517103052|FG001|Interim Analysis|Non-adherence|0|||
143425866|NCT00296504|517103053|FG002|Interim Analysis|Non-adherence|0|||
143425867|NCT00296504|517103054|FG003|Interim Analysis|Non-adherence|0|||
143425868|NCT00296504|517103055|FG004|Interim Analysis|Non-adherence|1|||
143425869|NCT00296504|517103056|FG005|Interim Analysis|Non-adherence|0|||
143425870|NCT00296504|517103057|FG006|Interim Analysis|Non-adherence|0|||
143425871|NCT00296504|517103058|FG007|Interim Analysis|Non-adherence|1|||
143425872|NCT00296504|517103059|FG008|Interim Analysis|Non-adherence|0|||
143425873|NCT00296504|517103051|FG000|Interim Analysis|Site Closing|1|||
143425874|NCT00296504|517103052|FG001|Interim Analysis|Site Closing|0|||
143425875|NCT00296504|517103053|FG002|Interim Analysis|Site Closing|0|||
143425876|NCT00296504|517103054|FG003|Interim Analysis|Site Closing|0|||
143425877|NCT00296504|517103055|FG004|Interim Analysis|Site Closing|0|||
143425878|NCT00296504|517103056|FG005|Interim Analysis|Site Closing|1|||
143425879|NCT00296504|517103057|FG006|Interim Analysis|Site Closing|2|||
143425880|NCT00296504|517103058|FG007|Interim Analysis|Site Closing|0|||
143425881|NCT00296504|517103059|FG008|Interim Analysis|Site Closing|0|||
143425882|NCT00296504|517103051|FG000|Interim Analysis|Lack of Personnel at Site|1|||
143425883|NCT00296504|517103052|FG001|Interim Analysis|Lack of Personnel at Site|0|||
143425884|NCT00296504|517103053|FG002|Interim Analysis|Lack of Personnel at Site|0|||
143425885|NCT00296504|517103054|FG003|Interim Analysis|Lack of Personnel at Site|0|||
143425886|NCT00296504|517103055|FG004|Interim Analysis|Lack of Personnel at Site|0|||
143425887|NCT00296504|517103056|FG005|Interim Analysis|Lack of Personnel at Site|0|||
143425888|NCT00296504|517103057|FG006|Interim Analysis|Lack of Personnel at Site|0|||
143425889|NCT00296504|517103058|FG007|Interim Analysis|Lack of Personnel at Site|0|||
143425890|NCT00296504|517103059|FG008|Interim Analysis|Lack of Personnel at Site|0|||
143425891|NCT00296504|517103051|FG000|Interim Analysis|Missed Schedule Date|1|||
143425892|NCT00296504|517103052|FG001|Interim Analysis|Missed Schedule Date|0|||
143425893|NCT00296504|517103053|FG002|Interim Analysis|Missed Schedule Date|0|||
143425894|NCT00296504|517103054|FG003|Interim Analysis|Missed Schedule Date|0|||
143425895|NCT00296504|517103055|FG004|Interim Analysis|Missed Schedule Date|0|||
143425896|NCT00296504|517103056|FG005|Interim Analysis|Missed Schedule Date|0|||
143425897|NCT00296504|517103057|FG006|Interim Analysis|Missed Schedule Date|0|||
143425898|NCT00296504|517103058|FG007|Interim Analysis|Missed Schedule Date|0|||
143425899|NCT00296504|517103059|FG008|Interim Analysis|Missed Schedule Date|0|||
143425900|NCT00296504|517103051|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
143425901|NCT00296504|517103052|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
143425902|NCT00296504|517103053|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
143425903|NCT00296504|517103054|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
143425904|NCT00296504|517103055|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
143425905|NCT00296504|517103056|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
143425906|NCT00296504|517103057|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
143425907|NCT00296504|517103058|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
143425908|NCT00296504|517103059|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
143425909|NCT00296504|517103051|FG000|Interim Analysis|Participant Stopped|0|||
143425910|NCT00296504|517103052|FG001|Interim Analysis|Participant Stopped|0|||
143425911|NCT00296504|517103053|FG002|Interim Analysis|Participant Stopped|0|||
143425912|NCT00296504|517103054|FG003|Interim Analysis|Participant Stopped|0|||
143425913|NCT00296504|517103055|FG004|Interim Analysis|Participant Stopped|1|||
143425914|NCT00296504|517103056|FG005|Interim Analysis|Participant Stopped|0|||
143425915|NCT00296504|517103057|FG006|Interim Analysis|Participant Stopped|0|||
143425916|NCT00296504|517103058|FG007|Interim Analysis|Participant Stopped|0|||
143425917|NCT00296504|517103059|FG008|Interim Analysis|Participant Stopped|0|||
143425918|NCT00296504|517103051|FG000|Interim Analysis|Physician and Participant Decision|0|||
143425919|NCT00296504|517103052|FG001|Interim Analysis|Physician and Participant Decision|0|||
143425920|NCT00296504|517103053|FG002|Interim Analysis|Physician and Participant Decision|0|||
143425921|NCT00296504|517103054|FG003|Interim Analysis|Physician and Participant Decision|0|||
143425922|NCT00296504|517103055|FG004|Interim Analysis|Physician and Participant Decision|0|||
143425923|NCT00296504|517103056|FG005|Interim Analysis|Physician and Participant Decision|1|||
143425924|NCT00296504|517103057|FG006|Interim Analysis|Physician and Participant Decision|0|||
143425925|NCT00296504|517103058|FG007|Interim Analysis|Physician and Participant Decision|0|||
143425926|NCT00296504|517103059|FG008|Interim Analysis|Physician and Participant Decision|0|||
143425927|NCT00296504|517103051|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
143425928|NCT00296504|517103052|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
143425929|NCT00296504|517103053|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
143425930|NCT00296504|517103054|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
143425931|NCT00296504|517103055|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
143425932|NCT00296504|517103056|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
143425933|NCT00296504|517103057|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
143425934|NCT00296504|517103058|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
143425935|NCT00296504|517103059|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
143425936|NCT00296504|517103051|FG000|Interim Analysis|Study Ended|0|||
143425937|NCT00296504|517103052|FG001|Interim Analysis|Study Ended|0|||
143425938|NCT00296504|517103053|FG002|Interim Analysis|Study Ended|0|||
143425939|NCT00296504|517103054|FG003|Interim Analysis|Study Ended|0|||
143425940|NCT00296504|517103055|FG004|Interim Analysis|Study Ended|0|||
143425941|NCT00296504|517103056|FG005|Interim Analysis|Study Ended|0|||
143425942|NCT00296504|517103057|FG006|Interim Analysis|Study Ended|1|||
143425943|NCT00296504|517103058|FG007|Interim Analysis|Study Ended|0|||
143425944|NCT00296504|517103059|FG008|Interim Analysis|Study Ended|0|||
143425945|NCT00296504|517103051|FG000|Interim Analysis|Participant Needed Interferon|0|||
143425946|NCT00296504|517103052|FG001|Interim Analysis|Participant Needed Interferon|0|||
143425947|NCT00296504|517103053|FG002|Interim Analysis|Participant Needed Interferon|0|||
143425948|NCT00296504|517103054|FG003|Interim Analysis|Participant Needed Interferon|0|||
143425949|NCT00296504|517103055|FG004|Interim Analysis|Participant Needed Interferon|0|||
143425950|NCT00296504|517103056|FG005|Interim Analysis|Participant Needed Interferon|0|||
143425951|NCT00296504|517103057|FG006|Interim Analysis|Participant Needed Interferon|0|||
143425952|NCT00296504|517103058|FG007|Interim Analysis|Participant Needed Interferon|1|||
143425953|NCT00296504|517103059|FG008|Interim Analysis|Participant Needed Interferon|0|||
143425954|NCT00296504|517103051|FG000|Interim Analysis|Ongoing|32|||
143425955|NCT00296504|517103052|FG001|Interim Analysis|Ongoing|12|||
143425956|NCT00296504|517103053|FG002|Interim Analysis|Ongoing|16|||
143425957|NCT00296504|517103054|FG003|Interim Analysis|Ongoing|22|||
143425958|NCT00296504|517103055|FG004|Interim Analysis|Ongoing|0|||
143425959|NCT00296504|517103056|FG005|Interim Analysis|Ongoing|0|||
143425960|NCT00296504|517103057|FG006|Interim Analysis|Ongoing|30|||
143425961|NCT00296504|517103058|FG007|Interim Analysis|Ongoing|1|||
143425962|NCT00296504|517103059|FG008|Interim Analysis|Ongoing|0|||
143425963|NCT00296504|517103051|FG000|Final Analysis|Withdrawal by Subject|0|||
143425964|NCT00296504|517103052|FG001|Final Analysis|Withdrawal by Subject|0|||
143425965|NCT00296504|517103053|FG002|Final Analysis|Withdrawal by Subject|0|||
143425966|NCT00296504|517103054|FG003|Final Analysis|Withdrawal by Subject|0|||
143425967|NCT00296504|517103055|FG004|Final Analysis|Withdrawal by Subject|0|||
143425968|NCT00296504|517103056|FG005|Final Analysis|Withdrawal by Subject|0|||
143425969|NCT00296504|517103057|FG006|Final Analysis|Withdrawal by Subject|0|||
143425970|NCT00296504|517103058|FG007|Final Analysis|Withdrawal by Subject|0|||
143425971|NCT00296504|517103059|FG008|Final Analysis|Withdrawal by Subject|1|||
143425972|NCT00296504|517103051|FG000|Final Analysis|Lost to Follow-up|0|||
143425973|NCT00296504|517103052|FG001|Final Analysis|Lost to Follow-up|0|||
143425974|NCT00296504|517103053|FG002|Final Analysis|Lost to Follow-up|0|||
143425975|NCT00296504|517103054|FG003|Final Analysis|Lost to Follow-up|0|||
143425976|NCT00296504|517103055|FG004|Final Analysis|Lost to Follow-up|0|||
143425977|NCT00296504|517103056|FG005|Final Analysis|Lost to Follow-up|0|||
143425978|NCT00296504|517103057|FG006|Final Analysis|Lost to Follow-up|0|||
143425979|NCT00296504|517103058|FG007|Final Analysis|Lost to Follow-up|0|||
143425980|NCT00296504|517103059|FG008|Final Analysis|Lost to Follow-up|5|||
143425981|NCT00296504|517103051|FG000|Final Analysis|Insufficient Viral Load Response|0|||
143425982|NCT00296504|517103052|FG001|Final Analysis|Insufficient Viral Load Response|0|||
143425983|NCT00296504|517103053|FG002|Final Analysis|Insufficient Viral Load Response|0|||
143425984|NCT00296504|517103054|FG003|Final Analysis|Insufficient Viral Load Response|0|||
143425985|NCT00296504|517103055|FG004|Final Analysis|Insufficient Viral Load Response|0|||
143425986|NCT00296504|517103056|FG005|Final Analysis|Insufficient Viral Load Response|0|||
143425987|NCT00296504|517103057|FG006|Final Analysis|Insufficient Viral Load Response|0|||
143425988|NCT00296504|517103058|FG007|Final Analysis|Insufficient Viral Load Response|0|||
143425989|NCT00296504|517103059|FG008|Final Analysis|Insufficient Viral Load Response|6|||
143425990|NCT00296504|517103051|FG000|Final Analysis|Adverse Event|0|||
143425991|NCT00296504|517103052|FG001|Final Analysis|Adverse Event|0|||
143425992|NCT00296504|517103053|FG002|Final Analysis|Adverse Event|0|||
143425993|NCT00296504|517103054|FG003|Final Analysis|Adverse Event|0|||
143425994|NCT00296504|517103055|FG004|Final Analysis|Adverse Event|0|||
143425995|NCT00296504|517103056|FG005|Final Analysis|Adverse Event|0|||
143425996|NCT00296504|517103057|FG006|Final Analysis|Adverse Event|0|||
143425997|NCT00296504|517103058|FG007|Final Analysis|Adverse Event|0|||
143425998|NCT00296504|517103059|FG008|Final Analysis|Adverse Event|2|||
143425999|NCT00296504|517103051|FG000|Final Analysis|Pregnancy|0|||
143426000|NCT00296504|517103052|FG001|Final Analysis|Pregnancy|0|||
143426001|NCT00296504|517103053|FG002|Final Analysis|Pregnancy|0|||
143426002|NCT00296504|517103054|FG003|Final Analysis|Pregnancy|0|||
143426003|NCT00296504|517103055|FG004|Final Analysis|Pregnancy|0|||
143426004|NCT00296504|517103056|FG005|Final Analysis|Pregnancy|0|||
143426005|NCT00296504|517103057|FG006|Final Analysis|Pregnancy|0|||
143426006|NCT00296504|517103058|FG007|Final Analysis|Pregnancy|0|||
143426007|NCT00296504|517103059|FG008|Final Analysis|Pregnancy|4|||
143426008|NCT00296504|517103051|FG000|Final Analysis|Tuberculosis|0|||
143426009|NCT00296504|517103052|FG001|Final Analysis|Tuberculosis|0|||
143426010|NCT00296504|517103053|FG002|Final Analysis|Tuberculosis|0|||
143426011|NCT00296504|517103054|FG003|Final Analysis|Tuberculosis|0|||
143426012|NCT00296504|517103055|FG004|Final Analysis|Tuberculosis|0|||
143426013|NCT00296504|517103056|FG005|Final Analysis|Tuberculosis|0|||
143426014|NCT00296504|517103057|FG006|Final Analysis|Tuberculosis|0|||
143426015|NCT00296504|517103058|FG007|Final Analysis|Tuberculosis|0|||
143426016|NCT00296504|517103059|FG008|Final Analysis|Tuberculosis|1|||
143426017|NCT00296504|517103051|FG000|Final Analysis|Participant Moved to Another Country|0|||
143426018|NCT00296504|517103052|FG001|Final Analysis|Participant Moved to Another Country|0|||
143426019|NCT00296504|517103053|FG002|Final Analysis|Participant Moved to Another Country|0|||
143426020|NCT00296504|517103054|FG003|Final Analysis|Participant Moved to Another Country|0|||
143426021|NCT00296504|517103055|FG004|Final Analysis|Participant Moved to Another Country|0|||
143426022|NCT00296504|517103056|FG005|Final Analysis|Participant Moved to Another Country|0|||
143426023|NCT00296504|517103057|FG006|Final Analysis|Participant Moved to Another Country|0|||
143426024|NCT00296504|517103058|FG007|Final Analysis|Participant Moved to Another Country|0|||
143426025|NCT00296504|517103059|FG008|Final Analysis|Participant Moved to Another Country|1|||
143426026|NCT00296504|517103051|FG000|Final Analysis|Poor Adherence|0|||
143426027|NCT00296504|517103052|FG001|Final Analysis|Poor Adherence|0|||
143426028|NCT00296504|517103053|FG002|Final Analysis|Poor Adherence|0|||
143426029|NCT00296504|517103054|FG003|Final Analysis|Poor Adherence|0|||
143426030|NCT00296504|517103055|FG004|Final Analysis|Poor Adherence|0|||
143426031|NCT00296504|517103056|FG005|Final Analysis|Poor Adherence|0|||
143426032|NCT00296504|517103057|FG006|Final Analysis|Poor Adherence|0|||
143426033|NCT00296504|517103058|FG007|Final Analysis|Poor Adherence|0|||
143426034|NCT00296504|517103059|FG008|Final Analysis|Poor Adherence|1|||
143426035|NCT02162771|517103063|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
143426036|NCT02162771|517103064|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
143426037|NCT02162771|517103063|FG000|Core Study Period (Part 2)|Adverse Event|4|||
143426038|NCT02162771|517103064|FG001|Core Study Period (Part 2)|Adverse Event|1|||
143426039|NCT02162771|517103063|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
143426040|NCT02162771|517103064|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
143426041|NCT02162771|517103063|FG000|Core Study Period (Part 2)|Physician Decision|0|||
143426042|NCT02162771|517103064|FG001|Core Study Period (Part 2)|Physician Decision|2|||
143426043|NCT02162771|517103063|FG000|Core Study Period (Part 2)|Death|1|||
143426044|NCT02162771|517103064|FG001|Core Study Period (Part 2)|Death|0|||
143426045|NCT02162771|517103063|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
143426046|NCT02162771|517103064|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
143426047|NCT02162771|517103063|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
143426048|NCT02162771|517103064|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
143426049|NCT02162771|517103063|FG000|Maintenance Study Period (Part 2)|Death|2|||
143426050|NCT02162771|517103064|FG001|Maintenance Study Period (Part 2)|Death|1|||
143426051|NCT02162771|517103063|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
143426052|NCT02162771|517103064|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
143426053|NCT02162771|517103063|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
143426054|NCT02162771|517103064|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
143426055|NCT02162771|517103063|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
143426056|NCT02162771|517103064|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
143426057|NCT00274846|517103070|FG000|Overall Study|Did not receive adequate NK cells|1|||
143426058|NCT01920178|517103073|FG000|Overall Study|Lost to Follow-up|2|||
143426059|NCT01920178|517103074|FG001|Overall Study|Lost to Follow-up|1|||
143426060|NCT03023878|517103075|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
143426061|NCT03023878|517103075|FG000|Pre-Study Run-In Period|Death|1|||
143426062|NCT03023878|517103075|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
143426063|NCT03023878|517103075|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
143426064|NCT03023878|517103075|FG000|Treatment Period|Disease Progression|1|||
143426065|NCT03023878|517103075|FG000|Treatment Period|Withdrawal by Subject|1|||
143426066|NCT03023878|517103075|FG000|Treatment Period|Adverse Event|1|||
143426067|NCT03023878|517103075|FG000|Long Term Follow-Up Period|Death|2|||
143426068|NCT02849509|517103076|FG000|Overall Study|Worsening of disease under study|1|||
143426069|NCT02849509|517103077|FG001|Overall Study|Worsening of disease under study|1|||
143426070|NCT02849509|517103078|FG002|Overall Study|Worsening of disease under study|1|||
143426071|NCT02849509|517103076|FG000|Overall Study|Worsening of other pre-existing disease|0|||
143426072|NCT02849509|517103077|FG001|Overall Study|Worsening of other pre-existing disease|1|||
143426073|NCT02849509|517103078|FG002|Overall Study|Worsening of other pre-existing disease|2|||
143426074|NCT02849509|517103076|FG000|Overall Study|Other adverse event|36|||
143426075|NCT02849509|517103077|FG001|Overall Study|Other adverse event|41|||
143426076|NCT02849509|517103078|FG002|Overall Study|Other adverse event|8|||
143426077|NCT02849509|517103076|FG000|Overall Study|Withdrawal by Subject|6|||
143426078|NCT02849509|517103077|FG001|Overall Study|Withdrawal by Subject|17|||
143426079|NCT02849509|517103078|FG002|Overall Study|Withdrawal by Subject|12|||
143426080|NCT02849509|517103076|FG000|Overall Study|Lost to Follow-up|27|||
143426081|NCT02849509|517103077|FG001|Overall Study|Lost to Follow-up|67|||
143426082|NCT02849509|517103078|FG002|Overall Study|Lost to Follow-up|36|||
143426083|NCT02849509|517103076|FG000|Overall Study|Other, reason not specified|14|||
143426084|NCT02849509|517103077|FG001|Overall Study|Other, reason not specified|29|||
143426085|NCT02849509|517103078|FG002|Overall Study|Other, reason not specified|25|||
143426086|NCT02849509|517103076|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
143426087|NCT02849509|517103077|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
143426088|NCT02849509|517103078|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
143426089|NCT00440037|517103079|FG000|Overall Study|Withdrawal by Subject|6|||
143426090|NCT00440037|517103079|FG000|Overall Study|Administrative decision|3|||
143426091|NCT03928821|517103080|FG000|Overall Study|Death|0|||
143426092|NCT03928821|517103081|FG001|Overall Study|Death|1|||
143426093|NCT03928821|517103082|FG002|Overall Study|Death|0|||
143426094|NCT03928821|517103083|FG003|Overall Study|Death|0|||
143426095|NCT03928821|517103080|FG000|Overall Study|Lost to Follow-up|0|||
143426096|NCT03928821|517103081|FG001|Overall Study|Lost to Follow-up|2|||
143426097|NCT03928821|517103082|FG002|Overall Study|Lost to Follow-up|3|||
143426098|NCT03928821|517103083|FG003|Overall Study|Lost to Follow-up|0|||
143426099|NCT03928821|517103080|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
143426100|NCT03928821|517103081|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
143426101|NCT03928821|517103082|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
143426102|NCT03928821|517103083|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
143426103|NCT01288729|517103087|FG000|Overall Study|Withdrawal by Subject|1|||
143426104|NCT01288729|517103088|FG001|Overall Study|Withdrawal by Subject|0|||
143426105|NCT00417989|517103089|FG000|Overall Study|Withdrawal by Subject|13|||
143426106|NCT00417989|517103090|FG001|Overall Study|Withdrawal by Subject|13|||
143426107|NCT00417989|517103089|FG000|Overall Study|Lost to Follow-up|1|||
143426108|NCT00417989|517103090|FG001|Overall Study|Lost to Follow-up|6|||
143426109|NCT00417989|517103089|FG000|Overall Study|Protocol Violation|1|||
143426110|NCT00417989|517103090|FG001|Overall Study|Protocol Violation|0|||
143426111|NCT00417989|517103089|FG000|Overall Study|Death|0|||
143426112|NCT00417989|517103090|FG001|Overall Study|Death|1|||
143426113|NCT00417989|517103089|FG000|Overall Study|Physician Decision|5|||
143426114|NCT00417989|517103090|FG001|Overall Study|Physician Decision|2|||
143426115|NCT01636778|517103093|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
143426116|NCT01636778|517103094|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
143426117|NCT01636778|517103095|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
143426118|NCT01636778|517103093|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
143426119|NCT01636778|517103094|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
143426120|NCT01636778|517103095|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
143426121|NCT01636778|517103093|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
143426122|NCT01636778|517103094|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
143426123|NCT01636778|517103095|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
143426124|NCT01636778|517103093|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
143426125|NCT01636778|517103094|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
143426126|NCT01636778|517103095|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
143426127|NCT01636778|517103093|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
143426128|NCT01636778|517103094|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
143426129|NCT01636778|517103095|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
143426130|NCT01636778|517103093|FG000|Follow-up Period After Part 2|Other|0|||
143426131|NCT01636778|517103094|FG001|Follow-up Period After Part 2|Other|0|||
143426132|NCT01636778|517103095|FG002|Follow-up Period After Part 2|Other|1|||
143426133|NCT01636778|517103093|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
143426134|NCT01636778|517103094|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
143426135|NCT01636778|517103095|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
143426136|NCT01636778|517103093|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
143426137|NCT01636778|517103094|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
143426138|NCT01636778|517103095|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
143426139|NCT03530345|517103096|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
143426140|NCT03530345|517103097|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
143426141|NCT03530345|517103096|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
143426142|NCT03530345|517103097|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
143426143|NCT03530345|517103096|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
143426144|NCT03530345|517103097|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
143426145|NCT03530345|517103096|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
143426146|NCT03530345|517103097|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
143426147|NCT04150250|517103098|FG000|Overall Study|Lost to Follow-up|0|||
143426148|NCT04150250|517103099|FG001|Overall Study|Lost to Follow-up|2|||
143426149|NCT02176356|517104823|FG000|Overall Study|Screen Failure|14|||
143426150|NCT02176356|517104823|FG000|Overall Study|Lost to Follow-up|4|||
143426151|NCT02176356|517104823|FG000|Overall Study|Personal Reasons|3|||
143426152|NCT02176356|517104823|FG000|Overall Study|Other Miscellaneous Reasons|2|||
143426153|NCT04816708|517104826|FG000|Overall Study|Lost to Follow-up|10|||
143426154|NCT04816708|517104827|FG001|Overall Study|Lost to Follow-up|4|||
143426155|NCT04050722|517104828|FG000|Overall Study|Withdrawal by Subject|1|||
143426156|NCT04050722|517104829|FG001|Overall Study|Withdrawal by Subject|0|||
143426157|NCT03087851|517104833|FG000|Overall Study|Withdraw on medical grounds|0|||
143426158|NCT03087851|517104834|FG001|Overall Study|Withdraw on medical grounds|1|||
143426159|NCT03087851|517104835|FG002|Overall Study|Withdraw on medical grounds|2|||
143426160|NCT00377312|517104838|FG000|Overall Study|Adverse Event|1|||
143426161|NCT00377312|517104839|FG001|Overall Study|Adverse Event|1|||
143426162|NCT01572493|517104844|FG000|Overall Study|Physician Decision|1|||
143426163|NCT01572493|517104845|FG001|Overall Study|Physician Decision|0|||
143426164|NCT01572493|517104846|FG002|Overall Study|Physician Decision|0|||
143426165|NCT01572493|517104847|FG003|Overall Study|Physician Decision|0|||
143426166|NCT01572493|517104848|FG004|Overall Study|Physician Decision|0|||
143426167|NCT01572493|517104849|FG005|Overall Study|Physician Decision|0|||
143426168|NCT01572493|517104850|FG006|Overall Study|Physician Decision|0|||
143426169|NCT01572493|517104851|FG007|Overall Study|Physician Decision|0|||
143426170|NCT01572493|517104852|FG008|Overall Study|Physician Decision|0|||
143426171|NCT01572493|517104844|FG000|Overall Study|Switched to alternative treatment|0|||
143426172|NCT01572493|517104845|FG001|Overall Study|Switched to alternative treatment|1|||
143426173|NCT01572493|517104846|FG002|Overall Study|Switched to alternative treatment|2|||
143426174|NCT01572493|517104847|FG003|Overall Study|Switched to alternative treatment|1|||
143426175|NCT01572493|517104848|FG004|Overall Study|Switched to alternative treatment|2|||
143426176|NCT01572493|517104849|FG005|Overall Study|Switched to alternative treatment|0|||
143426177|NCT01572493|517104850|FG006|Overall Study|Switched to alternative treatment|2|||
143426178|NCT01572493|517104851|FG007|Overall Study|Switched to alternative treatment|0|||
143426179|NCT01572493|517104852|FG008|Overall Study|Switched to alternative treatment|2|||
143426180|NCT01572493|517104844|FG000|Overall Study|Death|0|||
143426181|NCT01572493|517104845|FG001|Overall Study|Death|0|||
143426182|NCT01572493|517104846|FG002|Overall Study|Death|0|||
143426183|NCT01572493|517104847|FG003|Overall Study|Death|1|||
143426184|NCT01572493|517104848|FG004|Overall Study|Death|0|||
143426185|NCT01572493|517104849|FG005|Overall Study|Death|1|||
143426186|NCT01572493|517104850|FG006|Overall Study|Death|0|||
143426187|NCT01572493|517104851|FG007|Overall Study|Death|0|||
143426188|NCT01572493|517104852|FG008|Overall Study|Death|0|||
143426189|NCT01572493|517104844|FG000|Overall Study|Adverse Event|0|||
143426190|NCT01572493|517104845|FG001|Overall Study|Adverse Event|0|||
143426191|NCT01572493|517104846|FG002|Overall Study|Adverse Event|0|||
143426192|NCT01572493|517104847|FG003|Overall Study|Adverse Event|0|||
143426193|NCT01572493|517104848|FG004|Overall Study|Adverse Event|0|||
143426194|NCT01572493|517104849|FG005|Overall Study|Adverse Event|0|||
143426195|NCT01572493|517104850|FG006|Overall Study|Adverse Event|1|||
143426196|NCT01572493|517104851|FG007|Overall Study|Adverse Event|0|||
143426197|NCT01572493|517104852|FG008|Overall Study|Adverse Event|0|||
143426198|NCT03672188|517104853|FG000|Overall Study|Withdrawal by Subject|0|||
143426199|NCT03672188|517104854|FG001|Overall Study|Withdrawal by Subject|0|||
143426200|NCT03672188|517104855|FG002|Overall Study|Withdrawal by Subject|0|||
143426201|NCT03672188|517104856|FG003|Overall Study|Withdrawal by Subject|3|||
143426202|NCT03672188|517104857|FG004|Overall Study|Withdrawal by Subject|0|||
143426203|NCT03672188|517104858|FG005|Overall Study|Withdrawal by Subject|0|||
143426204|NCT03672188|517104859|FG006|Overall Study|Withdrawal by Subject|0|||
143426205|NCT03672188|517104860|FG007|Overall Study|Withdrawal by Subject|0|||
143426206|NCT03672188|517104861|FG008|Overall Study|Withdrawal by Subject|0|||
143426207|NCT03672188|517104862|FG009|Overall Study|Withdrawal by Subject|0|||
143426208|NCT03672188|517104863|FG010|Overall Study|Withdrawal by Subject|0|||
143426209|NCT03672188|517104864|FG011|Overall Study|Withdrawal by Subject|0|||
143426210|NCT03672188|517104865|FG012|Overall Study|Withdrawal by Subject|0|||
143426211|NCT03672188|517104866|FG013|Overall Study|Withdrawal by Subject|0|||
143426212|NCT03672188|517104867|FG014|Overall Study|Withdrawal by Subject|0|||
143426213|NCT03672188|517104853|FG000|Overall Study|Death|0|||
143426214|NCT03672188|517104854|FG001|Overall Study|Death|0|||
143426215|NCT03672188|517104855|FG002|Overall Study|Death|0|||
143426216|NCT03672188|517104856|FG003|Overall Study|Death|0|||
143426217|NCT03672188|517104857|FG004|Overall Study|Death|0|||
143426218|NCT03672188|517104858|FG005|Overall Study|Death|0|||
143426219|NCT03672188|517104859|FG006|Overall Study|Death|0|||
143426220|NCT03672188|517104860|FG007|Overall Study|Death|0|||
143426221|NCT03672188|517104861|FG008|Overall Study|Death|0|||
143426222|NCT03672188|517104862|FG009|Overall Study|Death|0|||
143426223|NCT03672188|517104863|FG010|Overall Study|Death|0|||
143426224|NCT03672188|517104864|FG011|Overall Study|Death|0|||
143426225|NCT03672188|517104865|FG012|Overall Study|Death|1|||
143426226|NCT03672188|517104866|FG013|Overall Study|Death|0|||
143426227|NCT03672188|517104867|FG014|Overall Study|Death|0|||
143426228|NCT03672188|517104853|FG000|Overall Study|Lost to Follow-up|0|||
143426229|NCT03672188|517104854|FG001|Overall Study|Lost to Follow-up|0|||
143426230|NCT03672188|517104855|FG002|Overall Study|Lost to Follow-up|1|||
143426231|NCT03672188|517104856|FG003|Overall Study|Lost to Follow-up|0|||
143426232|NCT03672188|517104857|FG004|Overall Study|Lost to Follow-up|0|||
143426233|NCT03672188|517104858|FG005|Overall Study|Lost to Follow-up|0|||
143426234|NCT03672188|517104859|FG006|Overall Study|Lost to Follow-up|0|||
143426235|NCT03672188|517104860|FG007|Overall Study|Lost to Follow-up|0|||
143426236|NCT03672188|517104861|FG008|Overall Study|Lost to Follow-up|0|||
143426237|NCT03672188|517104862|FG009|Overall Study|Lost to Follow-up|0|||
143426238|NCT03672188|517104863|FG010|Overall Study|Lost to Follow-up|0|||
143426239|NCT03672188|517104864|FG011|Overall Study|Lost to Follow-up|0|||
143426240|NCT03672188|517104865|FG012|Overall Study|Lost to Follow-up|0|||
143426241|NCT03672188|517104866|FG013|Overall Study|Lost to Follow-up|0|||
143426242|NCT03672188|517104867|FG014|Overall Study|Lost to Follow-up|0|||
143426243|NCT00609245|517104868|FG000|Overall Study|Adverse Event|1|||
143426244|NCT01090076|517104869|FG000|Overall Study|Death|1|||
143426245|NCT01090076|517104870|FG001|Overall Study|Death|1|||
143426246|NCT01090076|517104869|FG000|Overall Study|Withdrawal by Subject|0|||
143426247|NCT01090076|517104870|FG001|Overall Study|Withdrawal by Subject|1|||
143426248|NCT01116440|517104871|FG000|Treatment|Withdrawal by Subject|2|||
143426249|NCT01116440|517104872|FG001|Treatment|Withdrawal by Subject|2|||
143426250|NCT01116440|517104871|FG000|Treatment|Lost to Follow-up|1|||
143426251|NCT01116440|517104872|FG001|Treatment|Lost to Follow-up|1|||
143426252|NCT01116440|517104871|FG000|Treatment|Protocol Violation|0|||
143426253|NCT01116440|517104872|FG001|Treatment|Protocol Violation|2|||
143426254|NCT01116440|517104871|FG000|Treatment|Lack of Efficacy|0|||
143426255|NCT01116440|517104872|FG001|Treatment|Lack of Efficacy|1|||
143426256|NCT01116440|517104871|FG000|Treatment|Adverse Event|0|||
143426257|NCT01116440|517104872|FG001|Treatment|Adverse Event|1|||
143426258|NCT01116440|517104871|FG000|Withdrawal|Withdrawal by Subject|0|||
143426259|NCT01116440|517104872|FG001|Withdrawal|Withdrawal by Subject|1|||
143426260|NCT01116440|517104871|FG000|Withdrawal|Lost to Follow-up|0|||
143426261|NCT01116440|517104872|FG001|Withdrawal|Lost to Follow-up|1|||
143426262|NCT01116440|517104871|FG000|Follow-up|Lost to Follow-up|0|||
143426263|NCT01116440|517104872|FG001|Follow-up|Lost to Follow-up|1|||
143426264|NCT01116440|517104871|FG000|Follow-up|Withdrawal by Subject|0|||
143426265|NCT01116440|517104872|FG001|Follow-up|Withdrawal by Subject|1|||
143426266|NCT02446912|517104879|FG000|Overall Study|Adverse Event|3|||
143426267|NCT02446912|517104880|FG001|Overall Study|Adverse Event|13|||
143426268|NCT02446912|517104881|FG002|Overall Study|Adverse Event|5|||
143426269|NCT02446912|517104879|FG000|Overall Study|Condition under investigation worsened|0|||
143426270|NCT02446912|517104880|FG001|Overall Study|Condition under investigation worsened|1|||
143426271|NCT02446912|517104881|FG002|Overall Study|Condition under investigation worsened|1|||
143426272|NCT02446912|517104879|FG000|Overall Study|Study-specific withdrawal criteria|1|||
143426273|NCT02446912|517104880|FG001|Overall Study|Study-specific withdrawal criteria|0|||
143426274|NCT02446912|517104881|FG002|Overall Study|Study-specific withdrawal criteria|0|||
143426275|NCT02446912|517104879|FG000|Overall Study|Lack of Efficacy|1|||
143426276|NCT02446912|517104880|FG001|Overall Study|Lack of Efficacy|4|||
143426277|NCT02446912|517104881|FG002|Overall Study|Lack of Efficacy|7|||
143426278|NCT02446912|517104879|FG000|Overall Study|Lost to Follow-up|0|||
143426279|NCT02446912|517104880|FG001|Overall Study|Lost to Follow-up|0|||
143426280|NCT02446912|517104881|FG002|Overall Study|Lost to Follow-up|2|||
143426281|NCT02446912|517104879|FG000|Overall Study|Severe non-compliance to protocol|1|||
143426282|NCT02446912|517104880|FG001|Overall Study|Severe non-compliance to protocol|0|||
143426283|NCT02446912|517104881|FG002|Overall Study|Severe non-compliance to protocol|1|||
143426284|NCT02446912|517104879|FG000|Overall Study|Withdrawal by Subject|10|||
143426285|NCT02446912|517104880|FG001|Overall Study|Withdrawal by Subject|15|||
143426286|NCT02446912|517104881|FG002|Overall Study|Withdrawal by Subject|15|||
143426287|NCT02446912|517104879|FG000|Overall Study|Miscellaneous|2|||
143426288|NCT02446912|517104880|FG001|Overall Study|Miscellaneous|2|||
143426289|NCT02446912|517104881|FG002|Overall Study|Miscellaneous|4|||
143426290|NCT01379521|517104884|FG000|Overall Study -Treatment Period|Adverse Event|3|||
143426291|NCT01379521|517104885|FG001|Overall Study -Treatment Period|Adverse Event|0|||
143426292|NCT01379521|517104884|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
143426293|NCT01379521|517104885|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
143426294|NCT01379521|517104884|FG000|Overall Study -Treatment Period|Disease Progression|23|||
143426295|NCT01379521|517104885|FG001|Overall Study -Treatment Period|Disease Progression|22|||
143426296|NCT01379521|517104884|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
143426297|NCT01379521|517104885|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
143426298|NCT01379521|517104884|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
143426299|NCT01379521|517104885|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
143426300|NCT01379521|517104884|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
143426301|NCT01379521|517104885|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
143426302|NCT01379521|517104884|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
143426303|NCT01379521|517104885|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
143426304|NCT01379521|517104884|FG000|Overall Study -Treatment Period|Death|2|||
143426305|NCT01379521|517104885|FG001|Overall Study -Treatment Period|Death|1|||
143426306|NCT01379521|517104884|FG000|Post-Treatment Evaluations|Disease Progression|22|||
143426307|NCT01379521|517104885|FG001|Post-Treatment Evaluations|Disease Progression|20|||
143426308|NCT01379521|517104884|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
143426309|NCT01379521|517104885|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
143426310|NCT01379521|517104884|FG000|Post-Treatment Evaluations|Death|1|||
143426311|NCT01379521|517104885|FG001|Post-Treatment Evaluations|Death|0|||
143426312|NCT01757171|517104886|FG000|Overall Study|Adverse Event|5|||
143426313|NCT01757171|517104887|FG001|Overall Study|Adverse Event|1|||
143426314|NCT01757171|517104886|FG000|Overall Study|Disease Progression|1|||
143426315|NCT01757171|517104887|FG001|Overall Study|Disease Progression|0|||
143426316|NCT01757171|517104886|FG000|Overall Study|Hospitalization|1|||
143426317|NCT01757171|517104887|FG001|Overall Study|Hospitalization|0|||
143426318|NCT01757171|517104886|FG000|Overall Study|ECOG decline|1|||
143426319|NCT01757171|517104887|FG001|Overall Study|ECOG decline|0|||
143426320|NCT02504502|517104888|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
143426321|NCT02504502|517104889|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
143426322|NCT02504502|517104888|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
143426323|NCT02504502|517104889|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
143426324|NCT03042559|517104893|FG000|Overall Study|drop out|1|||
143426325|NCT03042559|517104894|FG001|Overall Study|drop out|1|||
143426326|NCT01536535|517104897|FG000|Overall Study|Withdrawal by Subject|10|||
143426327|NCT01536535|517104898|FG001|Overall Study|Withdrawal by Subject|5|||
143426328|NCT01536535|517104897|FG000|Overall Study|Lost to Follow-up|4|||
143426329|NCT01536535|517104898|FG001|Overall Study|Lost to Follow-up|6|||
143426330|NCT01536535|517104897|FG000|Overall Study|Physician Decision|1|||
143426331|NCT01536535|517104898|FG001|Overall Study|Physician Decision|1|||
143426332|NCT01536535|517104897|FG000|Overall Study|Participant moved|0|||
143426333|NCT01536535|517104898|FG001|Overall Study|Participant moved|1|||
143426334|NCT00428441|517104902|FG000|Overall Study|Lost to Follow-up|1|||
143426335|NCT01485991|517104903|FG000|Overall Study|Adverse Event|0|||
143426336|NCT01485991|517104904|FG001|Overall Study|Adverse Event|4|||
143426337|NCT01485991|517104903|FG000|Overall Study|Lost to Follow-up|13|||
143426338|NCT01485991|517104904|FG001|Overall Study|Lost to Follow-up|10|||
143426339|NCT01485991|517104903|FG000|Overall Study|Withdrawal by Subject|13|||
143426340|NCT01485991|517104904|FG001|Overall Study|Withdrawal by Subject|20|||
143426341|NCT01485991|517104903|FG000|Overall Study|randomized but not treated|6|||
143426342|NCT01485991|517104904|FG001|Overall Study|randomized but not treated|2|||
143426343|NCT02538471|517104905|FG000|Overall Study|Progression of disease|2|||
143426344|NCT01475370|517104906|FG000|Overall Study|Exacerbation of primary disease|2|||
143426345|NCT01475370|517104907|FG001|Overall Study|Exacerbation of primary disease|2|||
143426346|NCT01475370|517104908|FG002|Overall Study|Exacerbation of primary disease|2|||
143426347|NCT01475370|517104906|FG000|Overall Study|Study drug administration difficult|0|||
143426348|NCT01475370|517104907|FG001|Overall Study|Study drug administration difficult|1|||
143426349|NCT01475370|517104908|FG002|Overall Study|Study drug administration difficult|1|||
143426350|NCT01475370|517104906|FG000|Overall Study|Other than specified|1|||
143426351|NCT01475370|517104907|FG001|Overall Study|Other than specified|0|||
143426352|NCT01475370|517104908|FG002|Overall Study|Other than specified|0|||
143426353|NCT00125853|517104909|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
143426354|NCT00125853|517104910|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
143426355|NCT02522299|517104911|FG000|Overall Study|Adverse Event|2|||
143426356|NCT02522299|517104912|FG001|Overall Study|Adverse Event|0|||
143426357|NCT02522299|517104911|FG000|Overall Study|Physician Decision|0|||
143426358|NCT02522299|517104912|FG001|Overall Study|Physician Decision|1|||
143426359|NCT02522299|517104911|FG000|Overall Study|Withdrawal by Subject|2|||
143426360|NCT02522299|517104912|FG001|Overall Study|Withdrawal by Subject|0|||
143426361|NCT04908800|517104913|FG000|Overall Study|Adverse Event|0|||
143426362|NCT04908800|517104914|FG001|Overall Study|Adverse Event|0|||
143426363|NCT04908800|517104915|FG002|Overall Study|Adverse Event|0|||
143426364|NCT04908800|517104916|FG003|Overall Study|Adverse Event|0|||
143426365|NCT04908800|517104917|FG004|Overall Study|Adverse Event|0|||
143426366|NCT04908800|517104918|FG005|Overall Study|Adverse Event|0|||
143426367|NCT04908800|517104919|FG006|Overall Study|Adverse Event|0|||
143426368|NCT04908800|517104920|FG007|Overall Study|Adverse Event|0|||
143426369|NCT04908800|517104921|FG008|Overall Study|Adverse Event|0|||
143426370|NCT04908800|517104922|FG009|Overall Study|Adverse Event|0|||
143426371|NCT04908800|517104923|FG010|Overall Study|Adverse Event|1|||
143426372|NCT04908800|517104924|FG011|Overall Study|Adverse Event|0|||
143426373|NCT04908800|517104925|FG012|Overall Study|Adverse Event|0|||
143426374|NCT00157209|517104926|FG000|Overall Study|Ongoing at data cut-off|10|||
143426375|NCT00157209|517104927|FG001|Overall Study|Ongoing at data cut-off|0|||
143426376|NCT04474691|517104928|FG000|Overall Study|Withdrawal by Subject|9|||
143426377|NCT01348763|517104930|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
143426378|NCT01348763|517104930|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
143426379|NCT03647709|517104943|FG000|Overall Study|Lost to Follow-up|5|||
143426380|NCT03647709|517104943|FG000|Overall Study|Physician Decision|6|||
143426381|NCT03647709|517104943|FG000|Overall Study|Withdrawal by Subject|3|||
143426382|NCT00449033|517104948|FG000|Treatment Period|Adverse Event|117|||
143426383|NCT00449033|517104949|FG001|Treatment Period|Adverse Event|83|||
143426384|NCT00449033|517104948|FG000|Treatment Period|Death|21|||
143426385|NCT00449033|517104949|FG001|Treatment Period|Death|12|||
143426386|NCT00449033|517104948|FG000|Treatment Period|Lost to Follow-up|0|||
143426387|NCT00449033|517104949|FG001|Treatment Period|Lost to Follow-up|2|||
143426388|NCT00449033|517104948|FG000|Treatment Period|Physician Decision|4|||
143426389|NCT00449033|517104949|FG001|Treatment Period|Physician Decision|5|||
143426390|NCT00449033|517104948|FG000|Treatment Period|Protocol Violation|8|||
143426391|NCT00449033|517104949|FG001|Treatment Period|Protocol Violation|7|||
143426392|NCT00449033|517104948|FG000|Treatment Period|Disease Progression|231|||
143426393|NCT00449033|517104949|FG001|Treatment Period|Disease Progression|288|||
143426394|NCT00449033|517104948|FG000|Treatment Period|Consent Withdrawn|36|||
143426395|NCT00449033|517104949|FG001|Treatment Period|Consent Withdrawn|20|||
143426396|NCT00449033|517104948|FG000|Treatment Period|Amended Protocol Criteria|22|||
143426397|NCT00449033|517104949|FG001|Treatment Period|Amended Protocol Criteria|18|||
143426398|NCT00449033|517104948|FG000|Treatment Period|Non-compliance|7|||
143426399|NCT00449033|517104949|FG001|Treatment Period|Non-compliance|8|||
143426400|NCT00449033|517104948|FG000|Treatment Period|Second Malignancy|0|||
143426401|NCT00449033|517104949|FG001|Treatment Period|Second Malignancy|1|||
143426402|NCT00449033|517104948|FG000|Treatment Period|Reason Missing|0|||
143426403|NCT00449033|517104949|FG001|Treatment Period|Reason Missing|4|||
143426404|NCT00449033|517104948|FG000|Treatment Period|Treatment Ongoing|6|||
143426405|NCT00449033|517104949|FG001|Treatment Period|Treatment Ongoing|4|||
143426406|NCT00449033|517104948|FG000|Follow-up Period|Death|299|||
143426407|NCT00449033|517104949|FG001|Follow-up Period|Death|311|||
143426408|NCT00449033|517104948|FG000|Follow-up Period|Lost to Follow-up|6|||
143426409|NCT00449033|517104949|FG001|Follow-up Period|Lost to Follow-up|10|||
143426410|NCT00449033|517104948|FG000|Follow-up Period|Reason Missing|120|||
143426411|NCT00449033|517104949|FG001|Follow-up Period|Reason Missing|113|||
143426412|NCT01190228|517104952|FG000|Overall Study|Protocol Violation|4|||
143426413|NCT01190228|517104953|FG001|Overall Study|Protocol Violation|0|||
143426414|NCT01190228|517104954|FG002|Overall Study|Protocol Violation|0|||
143426415|NCT01190228|517104952|FG000|Overall Study|Withdrawal by Subject|1|||
143426416|NCT01190228|517104953|FG001|Overall Study|Withdrawal by Subject|0|||
143426417|NCT01190228|517104954|FG002|Overall Study|Withdrawal by Subject|0|||
143426418|NCT00498797|517104955|FG000|Overall Study|Withdrawal by Subject|4|||
143426419|NCT00498797|517104956|FG001|Overall Study|Withdrawal by Subject|2|||
143426420|NCT00498797|517104955|FG000|Overall Study|Adverse Event|12|||
143426421|NCT00498797|517104956|FG001|Overall Study|Adverse Event|5|||
143426422|NCT00498797|517104955|FG000|Overall Study|Condition under investigation worsened|19|||
143426423|NCT00498797|517104956|FG001|Overall Study|Condition under investigation worsened|21|||
143426424|NCT00498797|517104955|FG000|Overall Study|Other|3|||
143426425|NCT00498797|517104956|FG001|Overall Study|Other|1|||
143426426|NCT00985621|517104959|FG000|Overall Study|Adverse Event|2|||
143426427|NCT00985621|517104960|FG001|Overall Study|Adverse Event|3|||
143426428|NCT00985621|517104961|FG002|Overall Study|Adverse Event|4|||
143426429|NCT00985621|517104962|FG003|Overall Study|Adverse Event|16|||
143426430|NCT00985621|517104959|FG000|Overall Study|Lack of Efficacy|10|||
143426431|NCT00985621|517104960|FG001|Overall Study|Lack of Efficacy|6|||
143426432|NCT00985621|517104961|FG002|Overall Study|Lack of Efficacy|5|||
143426433|NCT00985621|517104962|FG003|Overall Study|Lack of Efficacy|12|||
143426434|NCT00985621|517104959|FG000|Overall Study|Lost to Follow-up|2|||
143426435|NCT00985621|517104960|FG001|Overall Study|Lost to Follow-up|3|||
143426436|NCT00985621|517104961|FG002|Overall Study|Lost to Follow-up|4|||
143426437|NCT00985621|517104962|FG003|Overall Study|Lost to Follow-up|4|||
143426438|NCT00985621|517104959|FG000|Overall Study|Study Terminated by Sponsor|89|||
143426439|NCT00985621|517104960|FG001|Overall Study|Study Terminated by Sponsor|108|||
143426440|NCT00985621|517104961|FG002|Overall Study|Study Terminated by Sponsor|99|||
143426441|NCT00985621|517104962|FG003|Overall Study|Study Terminated by Sponsor|92|||
143426442|NCT00985621|517104959|FG000|Overall Study|Protocol Violation|1|||
143426443|NCT00985621|517104960|FG001|Overall Study|Protocol Violation|1|||
143426444|NCT00985621|517104961|FG002|Overall Study|Protocol Violation|1|||
143426445|NCT00985621|517104962|FG003|Overall Study|Protocol Violation|0|||
143426446|NCT00985621|517104959|FG000|Overall Study|Withdrawal by Subject|8|||
143426447|NCT00985621|517104960|FG001|Overall Study|Withdrawal by Subject|10|||
143426448|NCT00985621|517104961|FG002|Overall Study|Withdrawal by Subject|8|||
143426449|NCT00985621|517104962|FG003|Overall Study|Withdrawal by Subject|12|||
143426450|NCT00985621|517104959|FG000|Overall Study|Other|1|||
143426451|NCT00985621|517104960|FG001|Overall Study|Other|0|||
143426452|NCT00985621|517104961|FG002|Overall Study|Other|0|||
143426453|NCT00985621|517104962|FG003|Overall Study|Other|0|||
143426454|NCT00985621|517104959|FG000|Overall Study|Randomized but not Treated|1|||
143426455|NCT00985621|517104960|FG001|Overall Study|Randomized but not Treated|0|||
143426456|NCT00985621|517104961|FG002|Overall Study|Randomized but not Treated|2|||
143426457|NCT00985621|517104962|FG003|Overall Study|Randomized but not Treated|1|||
143426458|NCT03953079|517104963|FG000|Core Study|Withdrawal by Subject|1|||
143426459|NCT03953079|517104964|FG001|Core Study|Withdrawal by Subject|2|||
143426460|NCT03953079|517104965|FG002|Core Study|Withdrawal by Subject|1|||
143426461|NCT03953079|517104963|FG000|Core Study|COVID-19|0|||
143426462|NCT03953079|517104964|FG001|Core Study|COVID-19|1|||
143426463|NCT03953079|517104965|FG002|Core Study|COVID-19|0|||
143426464|NCT03953079|517104963|FG000|Core Study|Difficulties leaving the house|0|||
143426465|NCT03953079|517104964|FG001|Core Study|Difficulties leaving the house|1|||
143426466|NCT03953079|517104965|FG002|Core Study|Difficulties leaving the house|0|||
143426467|NCT03953079|517104963|FG000|Extension Study|Withdrawal by Subject|1|||
143426468|NCT03953079|517104964|FG001|Extension Study|Withdrawal by Subject|0|||
143426469|NCT03953079|517104965|FG002|Extension Study|Withdrawal by Subject|0|||
143426470|NCT03953079|517104963|FG000|Extension Study|Received Rescue Treatment|5|||
143426471|NCT03953079|517104964|FG001|Extension Study|Received Rescue Treatment|6|||
143426472|NCT03953079|517104965|FG002|Extension Study|Received Rescue Treatment|5|||
143426473|NCT04743999|517104969|FG000|3-month Questionnaire|Death|1|||
143426474|NCT04743999|517104969|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
143426475|NCT04743999|517104969|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
143426476|NCT04743999|517104969|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
143426477|NCT01721759|517104970|FG000|Treatment Period|Disease Progression|85|||
143426478|NCT01721759|517104970|FG000|Treatment Period|Study drug toxicity|14|||
143426479|NCT01721759|517104970|FG000|Treatment Period|Death|1|||
143426480|NCT01721759|517104970|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
143426481|NCT01721759|517104970|FG000|Treatment Period|Participant request to withdraw|3|||
143426482|NCT01721759|517104970|FG000|Treatment Period|Other Reasons|3|||
143426483|NCT01721759|517104970|FG000|End of Study Period|Participant Withdrew Consent|5|||
143426484|NCT01721759|517104970|FG000|End of Study Period|Death|101|||
143426485|NCT01721759|517104970|FG000|End of Study Period|Lost to Follow-up|1|||
143426486|NCT01721759|517104970|FG000|End of Study Period|Other Reasons|10|||
143426487|NCT02577315|517104974|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
143426488|NCT02577315|517104975|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
143426489|NCT00990821|517104981|FG000|Overall Study|Withdrawal by Subject|0|||
143426490|NCT00990821|517104982|FG001|Overall Study|Withdrawal by Subject|2|||
143426491|NCT00990821|517104983|FG002|Overall Study|Withdrawal by Subject|0|||
143426492|NCT00990821|517104984|FG003|Overall Study|Withdrawal by Subject|0|||
143426493|NCT00990821|517104985|FG004|Overall Study|Withdrawal by Subject|3|||
143426494|NCT00990821|517104986|FG005|Overall Study|Withdrawal by Subject|3|||
143426495|NCT00990821|517104987|FG006|Overall Study|Withdrawal by Subject|1|||
143426496|NCT00990821|517104988|FG007|Overall Study|Withdrawal by Subject|0|||
143426497|NCT00990821|517104989|FG008|Overall Study|Withdrawal by Subject|0|||
143426498|NCT00990821|517104990|FG009|Overall Study|Withdrawal by Subject|1|||
143426499|NCT00990821|517104991|FG010|Overall Study|Withdrawal by Subject|3|||
143426500|NCT00990821|517104992|FG011|Overall Study|Withdrawal by Subject|5|||
143426501|NCT00990821|517104993|FG012|Overall Study|Withdrawal by Subject|2|||
143426502|NCT00990821|517104994|FG013|Overall Study|Withdrawal by Subject|1|||
143426503|NCT01786551|517104997|FG000|Overall Study|Participant withdrew consent|2|||
143426504|NCT02442622|517105001|FG000|Overall Study|Withdrawal by Subject|3|||
143426505|NCT02442622|517105002|FG001|Overall Study|Withdrawal by Subject|1|||
143426506|NCT00383500|517105005|FG000|Overall Study|Withdrawal by Subject|8|||
143426507|NCT00383500|517105006|FG001|Overall Study|Withdrawal by Subject|3|||
143426508|NCT00383500|517105007|FG002|Overall Study|Withdrawal by Subject|0|||
143426509|NCT00383500|517105005|FG000|Overall Study|Lost to Follow-up|0|||
143426510|NCT00383500|517105006|FG001|Overall Study|Lost to Follow-up|0|||
143426511|NCT00383500|517105007|FG002|Overall Study|Lost to Follow-up|2|||
143426512|NCT00088452|517106534|FG000|Overall Study|Did not receive intervention|1|||
143426513|NCT00088452|517106535|FG001|Overall Study|Did not receive intervention|0|||
143426514|NCT00088452|517106536|FG002|Overall Study|Did not receive intervention|1|||
143426515|NCT04044352|517106542|FG000|Overall Study|Lost to Follow-up|9|||
143426516|NCT04044352|517106542|FG000|Overall Study|Withdrawal by Subject|2|||
143426517|NCT01904019|517106544|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
143426518|NCT01904019|517106544|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
143426519|NCT01904019|517106544|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
143426520|NCT01904019|517106544|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
143426521|NCT01904019|517106544|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
143426522|NCT01904019|517106544|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
143426523|NCT02775214|517106545|FG000|Overall Study|Withdrawal by Subject|2|||
143426524|NCT02775214|517106546|FG001|Overall Study|Withdrawal by Subject|0|||
143426525|NCT00762723|517106547|FG000|Overall Study|Study Terminated slow enrollement|5|||
143426526|NCT00762723|517106548|FG001|Overall Study|Study Terminated slow enrollement|5|||
143426527|NCT00762723|517106549|FG002|Overall Study|Study Terminated slow enrollement|3|||
143426528|NCT02402465|517106555|FG000|Overall Study|Withdrawal by Subject|0|||
143426529|NCT02402465|517106556|FG001|Overall Study|Withdrawal by Subject|0|||
143426530|NCT02402465|517106557|FG002|Overall Study|Withdrawal by Subject|0|||
143426531|NCT02402465|517106558|FG003|Overall Study|Withdrawal by Subject|0|||
143426532|NCT02402465|517106559|FG004|Overall Study|Withdrawal by Subject|0|||
143426533|NCT02402465|517106560|FG005|Overall Study|Withdrawal by Subject|1|||
143426534|NCT02402465|517106555|FG000|Overall Study|Lost to Follow-up|0|||
143426535|NCT02402465|517106556|FG001|Overall Study|Lost to Follow-up|1|||
143426536|NCT02402465|517106557|FG002|Overall Study|Lost to Follow-up|0|||
143426537|NCT02402465|517106558|FG003|Overall Study|Lost to Follow-up|0|||
143426538|NCT02402465|517106559|FG004|Overall Study|Lost to Follow-up|1|||
143426539|NCT02402465|517106560|FG005|Overall Study|Lost to Follow-up|0|||
143426540|NCT01284634|517106561|FG000|Overall Study|Adverse Event|1|||
143426541|NCT01284634|517106562|FG001|Overall Study|Adverse Event|0|||
143426542|NCT01284634|517106563|FG002|Overall Study|Adverse Event|2|||
143426543|NCT01284634|517106564|FG003|Overall Study|Adverse Event|1|||
143426544|NCT02236598|517106565|FG000|Overall Study|Adverse Event|0|||
143426545|NCT02236598|517106566|FG001|Overall Study|Adverse Event|1|||
143426546|NCT02236598|517106565|FG000|Overall Study|Withdrawal by Subject|0|||
143426547|NCT02236598|517106566|FG001|Overall Study|Withdrawal by Subject|1|||
143426548|NCT00730925|517106572|FG000|Overall Study|Progressive Disease|21|||
143426549|NCT00730925|517106572|FG000|Overall Study|Dose reducing Event|2|||
143426550|NCT00730925|517106572|FG000|Overall Study|Other Averse Event|7|||
143426551|NCT00730925|517106572|FG000|Overall Study|Protocol Violation|1|||
143426552|NCT00730925|517106572|FG000|Overall Study|Withdrawal by Subject|1|||
143426553|NCT00730925|517106572|FG000|Overall Study|Switch to combination therapy|8|||
143426554|NCT00730925|517106572|FG000|Overall Study|Other|1|||
143426555|NCT03334747|517106573|FG000|Treatment Phase|Technical problems|0|||
143426556|NCT03334747|517106574|FG001|Treatment Phase|Technical problems|0|||
143426557|NCT03334747|517106575|FG002|Treatment Phase|Technical problems|0|||
143426558|NCT03334747|517106576|FG003|Treatment Phase|Technical problems|0|||
143426559|NCT03334747|517106577|FG004|Treatment Phase|Technical problems|1|||
143426560|NCT03334747|517106578|FG005|Treatment Phase|Technical problems|0|||
143426561|NCT03334747|517106579|FG006|Treatment Phase|Technical problems|0|||
143426562|NCT03334747|517106580|FG007|Treatment Phase|Technical problems|0|||
143426563|NCT03334747|517106581|FG008|Treatment Phase|Technical problems|0|||
143426564|NCT03334747|517106573|FG000|Treatment Phase|Subject/guardian decision|1|||
143426565|NCT03334747|517106574|FG001|Treatment Phase|Subject/guardian decision|0|||
143426566|NCT03334747|517106575|FG002|Treatment Phase|Subject/guardian decision|0|||
143426567|NCT03334747|517106576|FG003|Treatment Phase|Subject/guardian decision|0|||
143426568|NCT03334747|517106577|FG004|Treatment Phase|Subject/guardian decision|0|||
143426569|NCT03334747|517106578|FG005|Treatment Phase|Subject/guardian decision|1|||
143426570|NCT03334747|517106579|FG006|Treatment Phase|Subject/guardian decision|0|||
143426571|NCT03334747|517106580|FG007|Treatment Phase|Subject/guardian decision|0|||
143426572|NCT03334747|517106581|FG008|Treatment Phase|Subject/guardian decision|0|||
143426573|NCT03334747|517106573|FG000|Follow-Up Phase|Subject/guardian decision|0|||
143426574|NCT03334747|517106574|FG001|Follow-Up Phase|Subject/guardian decision|0|||
143426575|NCT03334747|517106575|FG002|Follow-Up Phase|Subject/guardian decision|0|||
143426576|NCT03334747|517106576|FG003|Follow-Up Phase|Subject/guardian decision|0|||
143426577|NCT03334747|517106577|FG004|Follow-Up Phase|Subject/guardian decision|0|||
143426578|NCT03334747|517106578|FG005|Follow-Up Phase|Subject/guardian decision|0|||
143426579|NCT03334747|517106579|FG006|Follow-Up Phase|Subject/guardian decision|1|||
143426580|NCT03334747|517106580|FG007|Follow-Up Phase|Subject/guardian decision|0|||
143426581|NCT03334747|517106581|FG008|Follow-Up Phase|Subject/guardian decision|1|||
143426582|NCT03303521|517106588|FG000|Overall Study|Withdrawal by Subject|2|||
143426583|NCT03303521|517106589|FG001|Overall Study|Withdrawal by Subject|0|||
143426584|NCT03303521|517106588|FG000|Overall Study|Death|1|||
143426585|NCT03303521|517106589|FG001|Overall Study|Death|0|||
143426586|NCT03303521|517106588|FG000|Overall Study|Kidney transplantation|0|||
143426587|NCT03303521|517106589|FG001|Overall Study|Kidney transplantation|1|||
143426588|NCT03303521|517106588|FG000|Overall Study|Investigational product discontinuation|0|||
143426589|NCT03303521|517106589|FG001|Overall Study|Investigational product discontinuation|1|||
143426590|NCT03303521|517106588|FG000|Overall Study|Transferred to non-study dialysis center|1|||
143426591|NCT03303521|517106589|FG001|Overall Study|Transferred to non-study dialysis center|0|||
143426592|NCT03303521|517106588|FG000|Overall Study|Non-comliance to study protocol|0|||
143426593|NCT03303521|517106589|FG001|Overall Study|Non-comliance to study protocol|1|||
143426594|NCT03303521|517106588|FG000|Overall Study|Adverse Event|1|||
143426595|NCT03303521|517106589|FG001|Overall Study|Adverse Event|0|||
143426596|NCT00191984|517106590|FG000|Overall Study|Disease Progression|21|||
143426597|NCT00191984|517106590|FG000|Overall Study|Adverse Event|4|||
143426598|NCT00191984|517106590|FG000|Overall Study|Death|2|||
143426599|NCT00191984|517106590|FG000|Overall Study|Entry Criteria Exclusion|1|||
143426600|NCT00191984|517106590|FG000|Overall Study|Withdrawal by Subject|7|||
143426601|NCT00191984|517106590|FG000|Overall Study|Physician Decision|4|||
143426602|NCT01654289|517106591|FG000|Overall Study|Withdrawal by Subject|10|||
143426603|NCT01654289|517106592|FG001|Overall Study|Withdrawal by Subject|8|||
143426604|NCT01654289|517106593|FG002|Overall Study|Withdrawal by Subject|5|||
143426605|NCT01654289|517106591|FG000|Overall Study|Withdrew from intervention only|17|||
143426606|NCT01654289|517106592|FG001|Overall Study|Withdrew from intervention only|20|||
143426607|NCT01654289|517106593|FG002|Overall Study|Withdrew from intervention only|0|||
143426608|NCT01732627|517106594|FG000|Overall Study|Withdrawal by Subject|1|||
143426609|NCT01732627|517106595|FG001|Overall Study|Withdrawal by Subject|0|||
143426610|NCT02137239|517106596|FG000|Overall Study|Discontinued Study Treatment|0|||
143426611|NCT02137239|517106597|FG001|Overall Study|Discontinued Study Treatment|3|||
143426612|NCT02137239|517106596|FG000|Overall Study|Withdrew Consent|1|||
143426613|NCT02137239|517106597|FG001|Overall Study|Withdrew Consent|1|||
143426614|NCT02137239|517106596|FG000|Overall Study|Adverse Event|2|||
143426615|NCT02137239|517106597|FG001|Overall Study|Adverse Event|2|||
143426616|NCT00005908|517106598|FG000|Overall Study|Withdrawal by Subject|1|||
143426617|NCT00005908|517106599|FG001|Overall Study|Withdrawal by Subject|0|||
143426618|NCT00938041|517106606|FG000|Overall Study|Lost to Follow-up|6|||
143426619|NCT00938041|517106606|FG000|Overall Study|Received Alternative Therapy|1|||
143426620|NCT00938041|517106606|FG000|Overall Study|Progressive Disease|5|||
143426621|NCT00938041|517106606|FG000|Overall Study|Death|12|||
143426622|NCT00938041|517106606|FG000|Overall Study|Adrenal Insufficiency|3|||
143426623|NCT00404547|517106608|FG000|Overall Study|Adverse Event|39|||
143426624|NCT00404547|517106609|FG001|Overall Study|Adverse Event|6|||
143426625|NCT00404547|517106608|FG000|Overall Study|Withdrawal by Subject|19|||
143426626|NCT00404547|517106609|FG001|Overall Study|Withdrawal by Subject|2|||
143426627|NCT00404547|517106608|FG000|Overall Study|Protocol Violation|0|||
143426628|NCT00404547|517106609|FG001|Overall Study|Protocol Violation|1|||
143426629|NCT00404547|517106608|FG000|Overall Study|Lost to Follow-up|20|||
143426630|NCT00404547|517106609|FG001|Overall Study|Lost to Follow-up|9|||
143426631|NCT00404547|517106608|FG000|Overall Study|Lack of compliance|5|||
143426632|NCT00404547|517106609|FG001|Overall Study|Lack of compliance|1|||
143426633|NCT00404547|517106608|FG000|Overall Study|Other|4|||
143426634|NCT00404547|517106609|FG001|Overall Study|Other|0|||
143426635|NCT00404547|517106608|FG000|Overall Study|Reason not stated|3|||
143426636|NCT00404547|517106609|FG001|Overall Study|Reason not stated|6|||
143426637|NCT02350127|517106615|FG000|4-Month Assessment|Withdrawal by Subject|10|||
143426638|NCT02350127|517106616|FG001|4-Month Assessment|Withdrawal by Subject|9|||
143426639|NCT02350127|517106615|FG000|4-Month Assessment|Death|1|||
143426640|NCT02350127|517106616|FG001|4-Month Assessment|Death|0|||
143426641|NCT02350127|517106615|FG000|8-Month Assessment|Death|1|||
143426642|NCT02350127|517106616|FG001|8-Month Assessment|Death|1|||
143426643|NCT02350127|517106615|FG000|8-Month Assessment|Withdrawal by Subject|5|||
143426644|NCT02350127|517106616|FG001|8-Month Assessment|Withdrawal by Subject|8|||
143426645|NCT03575572|517106619|FG000|Overall Study|Withdrawal by Subject|2|||
143426646|NCT03575572|517106619|FG000|Overall Study|Physician Decision|2|||
143426647|NCT04393779|517106622|FG000|Overall Study|Death|1|||
143426648|NCT04393779|517106622|FG000|Overall Study|Device reintervention or explant|4|||
143426649|NCT03802513|517106623|FG000|Overall Study|Lost to Follow-up|1|||
143426650|NCT01395914|517106627|FG000|Overall Study|Unrelated to study drug AE|6|||
143426651|NCT01395914|517106628|FG001|Overall Study|Unrelated to study drug AE|1|||
143426652|NCT01395914|517106627|FG000|Overall Study|Death|23|||
143426653|NCT01395914|517106628|FG001|Overall Study|Death|17|||
143426654|NCT01395914|517106627|FG000|Overall Study|Other|9|||
143426655|NCT01395914|517106628|FG001|Overall Study|Other|3|||
143426656|NCT01395914|517106627|FG000|Overall Study|Withdrawal by patient|27|||
143426657|NCT01395914|517106628|FG001|Overall Study|Withdrawal by patient|14|||
143426658|NCT01395914|517106627|FG000|Overall Study|Study drug-related AE|1|||
143426659|NCT01395914|517106628|FG001|Overall Study|Study drug-related AE|0|||
143426660|NCT01395914|517106627|FG000|Overall Study|Lost to Follow-up|6|||
143426661|NCT01395914|517106628|FG001|Overall Study|Lost to Follow-up|2|||
143426662|NCT01247922|517106629|FG000|Overall Study|Disease progression|4|||
143426663|NCT02268526|517106631|FG000|Overall Study|Adverse Event|0|||
143426664|NCT02268526|517106632|FG001|Overall Study|Adverse Event|2|||
143426665|NCT02268526|517106633|FG002|Overall Study|Adverse Event|1|||
143426666|NCT02268526|517106631|FG000|Overall Study|Death|1|||
143426667|NCT02268526|517106632|FG001|Overall Study|Death|11|||
143426668|NCT02268526|517106633|FG002|Overall Study|Death|0|||
143426669|NCT02268526|517106631|FG000|Overall Study|protocol deviation|0|||
143426670|NCT02268526|517106632|FG001|Overall Study|protocol deviation|1|||
143426671|NCT02268526|517106633|FG002|Overall Study|protocol deviation|0|||
143426672|NCT02268526|517106631|FG000|Overall Study|Physician Decision|0|||
143426673|NCT02268526|517106632|FG001|Overall Study|Physician Decision|0|||
143426674|NCT02268526|517106633|FG002|Overall Study|Physician Decision|1|||
143426675|NCT02268526|517106631|FG000|Overall Study|Subject/guardian decision|0|||
143426676|NCT02268526|517106632|FG001|Overall Study|Subject/guardian decision|7|||
143426677|NCT02268526|517106633|FG002|Overall Study|Subject/guardian decision|3|||
143426678|NCT00832650|517106636|FG000|Overall Study|Randomized but not treated|0|||
143426679|NCT00832650|517106637|FG001|Overall Study|Randomized but not treated|0|||
143426680|NCT00832650|517106638|FG002|Overall Study|Randomized but not treated|1|||
143426681|NCT03219216|517106639|FG000|Overall Study|Lost to Follow-up|0|||
143426682|NCT03219216|517106640|FG001|Overall Study|Lost to Follow-up|1|||
143426683|NCT03305458|517106641|FG000|Overall Study|Withdrawal by Subject|50|||
143426684|NCT03305458|517106642|FG001|Overall Study|Withdrawal by Subject|46|||
143426685|NCT03305458|517106643|FG002|Overall Study|Withdrawal by Subject|93|||
143426686|NCT03305458|517106641|FG000|Overall Study|Lost to Follow-up|85|||
143426687|NCT03305458|517106642|FG001|Overall Study|Lost to Follow-up|85|||
143426688|NCT03305458|517106643|FG002|Overall Study|Lost to Follow-up|35|||
143426689|NCT02332824|517106645|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
143426690|NCT02332824|517106646|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
143426691|NCT02332824|517106647|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
143426692|NCT02332824|517106648|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
143426693|NCT02332824|517106649|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
143426694|NCT02332824|517106650|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
143426695|NCT02332824|517106645|FG000|Overall Study|Voluntary Withdrawal|1|||
143426696|NCT02332824|517106646|FG001|Overall Study|Voluntary Withdrawal|0|||
143426697|NCT02332824|517106647|FG002|Overall Study|Voluntary Withdrawal|0|||
143426698|NCT02332824|517106648|FG003|Overall Study|Voluntary Withdrawal|0|||
143426699|NCT02332824|517106649|FG004|Overall Study|Voluntary Withdrawal|0|||
143426700|NCT02332824|517106650|FG005|Overall Study|Voluntary Withdrawal|0|||
143426701|NCT02332824|517106645|FG000|Overall Study|Inconvenient schedule|1|||
143426702|NCT02332824|517106646|FG001|Overall Study|Inconvenient schedule|1|||
143426703|NCT02332824|517106647|FG002|Overall Study|Inconvenient schedule|0|||
143426704|NCT02332824|517106648|FG003|Overall Study|Inconvenient schedule|0|||
143426705|NCT02332824|517106649|FG004|Overall Study|Inconvenient schedule|0|||
143426706|NCT02332824|517106650|FG005|Overall Study|Inconvenient schedule|0|||
143426707|NCT02332824|517106645|FG000|Overall Study|Transfer|0|||
143426708|NCT02332824|517106646|FG001|Overall Study|Transfer|0|||
143426709|NCT02332824|517106647|FG002|Overall Study|Transfer|1|||
143426710|NCT02332824|517106648|FG003|Overall Study|Transfer|1|||
143426711|NCT02332824|517106649|FG004|Overall Study|Transfer|0|||
143426712|NCT02332824|517106650|FG005|Overall Study|Transfer|0|||
143426713|NCT02784535|517106657|FG000|Overall Study|Adverse Event|1|||
143426714|NCT02784535|517106658|FG001|Overall Study|Adverse Event|0|||
143426715|NCT02784535|517106657|FG000|Overall Study|Withdrawal by Subject|0|||
143426716|NCT02784535|517106658|FG001|Overall Study|Withdrawal by Subject|1|||
143426717|NCT02784535|517106657|FG000|Overall Study|Physician Decision|0|||
143426718|NCT02784535|517106658|FG001|Overall Study|Physician Decision|1|||
143426719|NCT03740919|517106659|FG000|Lead-in Period|Lost to Follow-up|1|||
143426720|NCT03740919|517106660|FG001|Lead-in Period|Lost to Follow-up|0|||
143426721|NCT03740919|517106661|FG002|Lead-in Period|Lost to Follow-up|0|||
143426722|NCT03740919|517106662|FG003|Lead-in Period|Lost to Follow-up|0|||
143426723|NCT03740919|517106659|FG000|Lead-in Period|Physician Decision|2|||
143426724|NCT03740919|517106660|FG001|Lead-in Period|Physician Decision|0|||
143426725|NCT03740919|517106661|FG002|Lead-in Period|Physician Decision|0|||
143426726|NCT03740919|517106662|FG003|Lead-in Period|Physician Decision|0|||
143426727|NCT03740919|517106659|FG000|Lead-in Period|Protocol Violation|1|||
143426728|NCT03740919|517106660|FG001|Lead-in Period|Protocol Violation|0|||
143426729|NCT03740919|517106661|FG002|Lead-in Period|Protocol Violation|0|||
143426730|NCT03740919|517106662|FG003|Lead-in Period|Protocol Violation|0|||
143426731|NCT03740919|517106659|FG000|Lead-in Period|Withdrawal by Subject|10|||
143426732|NCT03740919|517106660|FG001|Lead-in Period|Withdrawal by Subject|0|||
143426733|NCT03740919|517106661|FG002|Lead-in Period|Withdrawal by Subject|0|||
143426734|NCT03740919|517106662|FG003|Lead-in Period|Withdrawal by Subject|0|||
143426735|NCT03740919|517106659|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
143426736|NCT03740919|517106660|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
143426737|NCT03740919|517106661|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
143426738|NCT03740919|517106662|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
143426739|NCT03740919|517106659|FG000|Lead-in Period|Study Task Too Burdensome|1|||
143426740|NCT03740919|517106660|FG001|Lead-in Period|Study Task Too Burdensome|0|||
143426741|NCT03740919|517106661|FG002|Lead-in Period|Study Task Too Burdensome|0|||
143426742|NCT03740919|517106662|FG003|Lead-in Period|Study Task Too Burdensome|0|||
143426743|NCT03740919|517106659|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
143426744|NCT03740919|517106660|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
143426745|NCT03740919|517106661|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
143426746|NCT03740919|517106662|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
143426747|NCT03740919|517106659|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
143426748|NCT03740919|517106660|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
143426749|NCT03740919|517106661|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
143426750|NCT03740919|517106662|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
143426751|NCT03740919|517106659|FG000|Treatment Period|Adverse Event|0|||
143426752|NCT03740919|517106660|FG001|Treatment Period|Adverse Event|0|||
143426753|NCT03740919|517106661|FG002|Treatment Period|Adverse Event|2|||
143426754|NCT03740919|517106662|FG003|Treatment Period|Adverse Event|0|||
143426755|NCT03740919|517106659|FG000|Treatment Period|Protocol Violation|0|||
143426756|NCT03740919|517106660|FG001|Treatment Period|Protocol Violation|1|||
143426757|NCT03740919|517106661|FG002|Treatment Period|Protocol Violation|0|||
143426758|NCT03740919|517106662|FG003|Treatment Period|Protocol Violation|0|||
143426759|NCT03740919|517106659|FG000|Treatment Period|Withdrawal by Subject|0|||
143426760|NCT03740919|517106660|FG001|Treatment Period|Withdrawal by Subject|7|||
143426761|NCT03740919|517106661|FG002|Treatment Period|Withdrawal by Subject|6|||
143426762|NCT03740919|517106662|FG003|Treatment Period|Withdrawal by Subject|2|||
143426763|NCT03740919|517106659|FG000|Treatment Period|Terminated by Sponsor|0|||
143426764|NCT03740919|517106660|FG001|Treatment Period|Terminated by Sponsor|1|||
143426765|NCT03740919|517106661|FG002|Treatment Period|Terminated by Sponsor|0|||
143426766|NCT03740919|517106662|FG003|Treatment Period|Terminated by Sponsor|0|||
143426767|NCT03740919|517106659|FG000|Treatment Period|Issue with Insulin Pump|0|||
143426768|NCT03740919|517106660|FG001|Treatment Period|Issue with Insulin Pump|1|||
143426769|NCT03740919|517106661|FG002|Treatment Period|Issue with Insulin Pump|0|||
143426770|NCT03740919|517106662|FG003|Treatment Period|Issue with Insulin Pump|0|||
143426771|NCT03740919|517106659|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
143426772|NCT03740919|517106660|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
143426773|NCT03740919|517106661|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
143426774|NCT03740919|517106662|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
143426775|NCT03740919|517106659|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
143426776|NCT03740919|517106660|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
143426777|NCT03740919|517106661|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
143426778|NCT03740919|517106662|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
143426779|NCT03740919|517106659|FG000|Treatment Period|Not Completing Diary|0|||
143426780|NCT03740919|517106660|FG001|Treatment Period|Not Completing Diary|0|||
143426781|NCT03740919|517106661|FG002|Treatment Period|Not Completing Diary|1|||
143426782|NCT03740919|517106662|FG003|Treatment Period|Not Completing Diary|0|||
143426783|NCT03740919|517106659|FG000|Treatment Period|Insulin Painful to Participant|0|||
143426784|NCT03740919|517106660|FG001|Treatment Period|Insulin Painful to Participant|0|||
143426785|NCT03740919|517106661|FG002|Treatment Period|Insulin Painful to Participant|1|||
143426786|NCT03740919|517106662|FG003|Treatment Period|Insulin Painful to Participant|0|||
143426787|NCT04394624|517106663|FG000|Overall Study|Adverse Event|6|||
143426788|NCT04394624|517106664|FG001|Overall Study|Adverse Event|0|||
143426789|NCT04394624|517106663|FG000|Overall Study|Progressive disease|24|||
143426790|NCT04394624|517106664|FG001|Overall Study|Progressive disease|0|||
143426791|NCT04394624|517106663|FG000|Overall Study|Not related to COVID-19|1|||
143426792|NCT04394624|517106664|FG001|Overall Study|Not related to COVID-19|0|||
143426793|NCT02418819|517106667|FG000|Overall Study|Adverse Event|0|||
143426794|NCT02418819|517106668|FG001|Overall Study|Adverse Event|0|||
143426795|NCT02418819|517106669|FG002|Overall Study|Adverse Event|1|||
143426796|NCT02418819|517106670|FG003|Overall Study|Adverse Event|0|||
143426797|NCT02418819|517106667|FG000|Overall Study|Lost to Follow-up|1|||
143426798|NCT02418819|517106668|FG001|Overall Study|Lost to Follow-up|0|||
143426799|NCT02418819|517106669|FG002|Overall Study|Lost to Follow-up|0|||
143426800|NCT02418819|517106670|FG003|Overall Study|Lost to Follow-up|0|||
143426801|NCT02418819|517106667|FG000|Overall Study|No longer meets eligibility criteria|0|||
143426802|NCT02418819|517106668|FG001|Overall Study|No longer meets eligibility criteria|0|||
143426803|NCT02418819|517106669|FG002|Overall Study|No longer meets eligibility criteria|1|||
143426804|NCT02418819|517106670|FG003|Overall Study|No longer meets eligibility criteria|0|||
143426805|NCT02418819|517106667|FG000|Overall Study|No longer willing to participate|0|||
143426806|NCT02418819|517106668|FG001|Overall Study|No longer willing to participate|0|||
143426807|NCT02418819|517106669|FG002|Overall Study|No longer willing to participate|2|||
143426808|NCT02418819|517106670|FG003|Overall Study|No longer willing to participate|1|||
143426809|NCT04374253|517106671|FG000|Overall Study|Adverse Event|0|||
143426810|NCT04374253|517106672|FG001|Overall Study|Adverse Event|26|||
143426811|NCT04374253|517106673|FG002|Overall Study|Adverse Event|2|||
143426812|NCT04374253|517106674|FG003|Overall Study|Adverse Event|12|||
143426813|NCT04374253|517106671|FG000|Overall Study|Study terminated by sponsor|13|||
143426814|NCT04374253|517106672|FG001|Overall Study|Study terminated by sponsor|593|||
143426815|NCT04374253|517106673|FG002|Overall Study|Study terminated by sponsor|21|||
143426816|NCT04374253|517106674|FG003|Overall Study|Study terminated by sponsor|567|||
143426817|NCT04374253|517106671|FG000|Overall Study|Withdrawal by Subject|0|||
143426818|NCT04374253|517106672|FG001|Overall Study|Withdrawal by Subject|55|||
143426819|NCT04374253|517106673|FG002|Overall Study|Withdrawal by Subject|3|||
143426820|NCT04374253|517106674|FG003|Overall Study|Withdrawal by Subject|40|||
143426821|NCT04374253|517106671|FG000|Overall Study|Physician Decision|1|||
143426822|NCT04374253|517106672|FG001|Overall Study|Physician Decision|10|||
143426823|NCT04374253|517106673|FG002|Overall Study|Physician Decision|1|||
143426824|NCT04374253|517106674|FG003|Overall Study|Physician Decision|10|||
143426825|NCT04374253|517106671|FG000|Overall Study|Protocol Violation|0|||
143426826|NCT04374253|517106672|FG001|Overall Study|Protocol Violation|0|||
143426827|NCT04374253|517106673|FG002|Overall Study|Protocol Violation|0|||
143426828|NCT04374253|517106674|FG003|Overall Study|Protocol Violation|2|||
143426829|NCT04374253|517106671|FG000|Overall Study|Death|0|||
143426830|NCT04374253|517106672|FG001|Overall Study|Death|3|||
143426831|NCT04374253|517106673|FG002|Overall Study|Death|1|||
143426832|NCT04374253|517106674|FG003|Overall Study|Death|1|||
143426833|NCT04374253|517106671|FG000|Overall Study|Lack of Efficacy|0|||
143426834|NCT04374253|517106672|FG001|Overall Study|Lack of Efficacy|0|||
143426835|NCT04374253|517106673|FG002|Overall Study|Lack of Efficacy|0|||
143426836|NCT04374253|517106674|FG003|Overall Study|Lack of Efficacy|1|||
143426837|NCT04374253|517106671|FG000|Overall Study|Lost to Follow-up|1|||
143426838|NCT04374253|517106672|FG001|Overall Study|Lost to Follow-up|1|||
143426839|NCT04374253|517106673|FG002|Overall Study|Lost to Follow-up|0|||
143426840|NCT04374253|517106674|FG003|Overall Study|Lost to Follow-up|2|||
143426841|NCT04374253|517106671|FG000|Overall Study|Reason Not Specified|0|||
143426842|NCT04374253|517106672|FG001|Overall Study|Reason Not Specified|8|||
143426843|NCT04374253|517106673|FG002|Overall Study|Reason Not Specified|0|||
143426844|NCT04374253|517106674|FG003|Overall Study|Reason Not Specified|8|||
143426845|NCT04382053|517106680|FG000|Overall Study|Death|6|||
143426846|NCT04382053|517106681|FG001|Overall Study|Death|8|||
143426847|NCT04382053|517106680|FG000|Overall Study|Lost to Follow-up|0|||
143426848|NCT04382053|517106681|FG001|Overall Study|Lost to Follow-up|2|||
143426849|NCT04382053|517106680|FG000|Overall Study|Protocol Deviation|1|||
143426850|NCT04382053|517106681|FG001|Overall Study|Protocol Deviation|2|||
143426851|NCT04382053|517106680|FG000|Overall Study|Withdrawal by Subject|2|||
143426852|NCT04382053|517106681|FG001|Overall Study|Withdrawal by Subject|1|||
143426853|NCT01123642|517106684|FG000|Overall Study|Lost to Follow-up|23|||
143426854|NCT01123642|517106684|FG000|Overall Study|Withdrawal by Subject|9|||
143426855|NCT01123642|517106684|FG000|Overall Study|ineligible at baseline assessment|36|||
143426856|NCT01002547|517108332|FG000|Overall Study|Withdrawal by Subject|4|||
143426857|NCT01002547|517108333|FG001|Overall Study|Withdrawal by Subject|0|||
143426858|NCT01002547|517108334|FG002|Overall Study|Withdrawal by Subject|5|||
143426859|NCT01002547|517108332|FG000|Overall Study|Lost to Follow-up|2|||
143426860|NCT01002547|517108333|FG001|Overall Study|Lost to Follow-up|1|||
143426861|NCT01002547|517108334|FG002|Overall Study|Lost to Follow-up|1|||
143426862|NCT01002547|517108332|FG000|Overall Study|Physician Decision|1|||
143426863|NCT01002547|517108333|FG001|Overall Study|Physician Decision|0|||
143426864|NCT01002547|517108334|FG002|Overall Study|Physician Decision|0|||
143426865|NCT01002547|517108332|FG000|Overall Study|Death|0|||
143426866|NCT01002547|517108333|FG001|Overall Study|Death|2|||
143426867|NCT01002547|517108334|FG002|Overall Study|Death|2|||
143426868|NCT01002547|517108332|FG000|Overall Study|Adverse Event|1|||
143426869|NCT01002547|517108333|FG001|Overall Study|Adverse Event|0|||
143426870|NCT01002547|517108334|FG002|Overall Study|Adverse Event|0|||
143426871|NCT00705614|517108339|FG000|Initial Intervention|Adverse Event|40|||
143426872|NCT00705614|517108340|FG001|Initial Intervention|Adverse Event|21|||
143426873|NCT00705614|517108339|FG000|Initial Intervention|Lost to Follow-up|310|||
143426874|NCT00705614|517108340|FG001|Initial Intervention|Lost to Follow-up|191|||
143426875|NCT00705614|517108339|FG000|Initial Intervention|Withdrawal by Subject|114|||
143426876|NCT00705614|517108340|FG001|Initial Intervention|Withdrawal by Subject|71|||
143426877|NCT00705614|517108339|FG000|Initial Intervention|Administrative Reason|51|||
143426878|NCT00705614|517108340|FG001|Initial Intervention|Administrative Reason|38|||
143426879|NCT00705614|517108339|FG000|Initial Intervention|Status completion unknown|3|||
143426880|NCT00705614|517108340|FG001|Initial Intervention|Status completion unknown|0|||
143426881|NCT00705614|517108339|FG000|Switch to Remicade|Adverse Event|0|||
143426882|NCT00705614|517108340|FG001|Switch to Remicade|Adverse Event|5|||
143426883|NCT00705614|517108339|FG000|Switch to Remicade|Lost to Follow-up|0|||
143426884|NCT00705614|517108340|FG001|Switch to Remicade|Lost to Follow-up|23|||
143426885|NCT00705614|517108339|FG000|Switch to Remicade|Withdrawal by Subject|0|||
143426886|NCT00705614|517108340|FG001|Switch to Remicade|Withdrawal by Subject|12|||
143426887|NCT00705614|517108339|FG000|Switch to Remicade|Administrative Reason|0|||
143426888|NCT00705614|517108340|FG001|Switch to Remicade|Administrative Reason|9|||
143426889|NCT00925288|517108341|FG000|Overall Study|Lost to Follow-up|9|||
143426890|NCT00925288|517108342|FG001|Overall Study|Lost to Follow-up|7|||
143426891|NCT02081196|517108343|FG000|Overall Study|Lost to Follow-up|1|||
143426892|NCT00434577|517108344|FG000|Months 0-3|Serious Adverse Event|0|||
143426893|NCT00434577|517108345|FG001|Months 0-3|Serious Adverse Event|0|||
143426894|NCT00434577|517108346|FG002|Months 0-3|Serious Adverse Event|1|||
143426895|NCT00434577|517108347|FG003|Months 0-3|Serious Adverse Event|0|||
143426896|NCT00434577|517108348|FG004|Months 0-3|Serious Adverse Event|0|||
143426897|NCT00434577|517108344|FG000|Months 0-3|Adverse Event|0|||
143426898|NCT00434577|517108345|FG001|Months 0-3|Adverse Event|1|||
143426899|NCT00434577|517108346|FG002|Months 0-3|Adverse Event|1|||
143426900|NCT00434577|517108347|FG003|Months 0-3|Adverse Event|0|||
143426901|NCT00434577|517108348|FG004|Months 0-3|Adverse Event|0|||
143426902|NCT00434577|517108344|FG000|Months 0-3|Lost to Follow-up|0|||
143426903|NCT00434577|517108345|FG001|Months 0-3|Lost to Follow-up|0|||
143426904|NCT00434577|517108346|FG002|Months 0-3|Lost to Follow-up|0|||
143426905|NCT00434577|517108347|FG003|Months 0-3|Lost to Follow-up|0|||
143426906|NCT00434577|517108348|FG004|Months 0-3|Lost to Follow-up|2|||
143426907|NCT00434577|517108344|FG000|Months 0-3|Protocol Violation|1|||
143426908|NCT00434577|517108345|FG001|Months 0-3|Protocol Violation|0|||
143426909|NCT00434577|517108346|FG002|Months 0-3|Protocol Violation|1|||
143426910|NCT00434577|517108347|FG003|Months 0-3|Protocol Violation|0|||
143426911|NCT00434577|517108348|FG004|Months 0-3|Protocol Violation|0|||
143426912|NCT00434577|517108344|FG000|Months 0-3|Withdrawal by Subject|2|||
143426913|NCT00434577|517108345|FG001|Months 0-3|Withdrawal by Subject|1|||
143426914|NCT00434577|517108346|FG002|Months 0-3|Withdrawal by Subject|1|||
143426915|NCT00434577|517108347|FG003|Months 0-3|Withdrawal by Subject|1|||
143426916|NCT00434577|517108348|FG004|Months 0-3|Withdrawal by Subject|1|||
143426917|NCT00635570|517108349|FG000|Overall Study|Lost to Follow-up|8|||
143426918|NCT00635570|517108350|FG001|Overall Study|Lost to Follow-up|8|||
143426919|NCT00635570|517108349|FG000|Overall Study|Withdrawal by Subject|1|||
143426920|NCT00635570|517108350|FG001|Overall Study|Withdrawal by Subject|1|||
143426921|NCT00635570|517108349|FG000|Overall Study|Adverse Event|2|||
143426922|NCT00635570|517108350|FG001|Overall Study|Adverse Event|0|||
143426923|NCT00635570|517108349|FG000|Overall Study|Physician Decision|1|||
143426924|NCT00635570|517108350|FG001|Overall Study|Physician Decision|0|||
143426925|NCT00635570|517108349|FG000|Overall Study|Did not complete survey|2|||
143426926|NCT00635570|517108350|FG001|Overall Study|Did not complete survey|1|||
143426927|NCT00635570|517108349|FG000|Overall Study|Early termination(No sexual activity)|1|||
143426928|NCT00635570|517108350|FG001|Overall Study|Early termination(No sexual activity)|1|||
143426929|NCT00332488|517108354|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
143426930|NCT00332488|517108355|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
143426931|NCT00332488|517108356|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
143426932|NCT00332488|517108354|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
143426933|NCT00332488|517108355|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
143426934|NCT00332488|517108356|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
143426935|NCT00332488|517108354|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
143426936|NCT00332488|517108355|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
143426937|NCT00332488|517108356|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
143426938|NCT00332488|517108354|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
143426939|NCT00332488|517108355|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
143426940|NCT00332488|517108356|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
143426941|NCT00332488|517108354|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
143426942|NCT00332488|517108355|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
143426943|NCT00332488|517108356|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
143426944|NCT00332488|517108354|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
143426945|NCT00332488|517108355|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
143426946|NCT00332488|517108356|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
143426947|NCT00332488|517108354|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
143426948|NCT00332488|517108355|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
143426949|NCT00332488|517108356|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
143426950|NCT00332488|517108354|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
143426951|NCT00332488|517108355|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
143426952|NCT00332488|517108356|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
143426953|NCT00332488|517108354|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
143426954|NCT00332488|517108355|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
143426955|NCT00332488|517108356|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
143426956|NCT00332488|517108354|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
143426957|NCT00332488|517108355|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
143426958|NCT00332488|517108356|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
143426959|NCT00332488|517108354|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
143426960|NCT00332488|517108355|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
143426961|NCT00332488|517108356|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
143426962|NCT00332488|517108354|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
143426963|NCT00332488|517108355|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
143426964|NCT00332488|517108356|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
143426965|NCT00755716|517108359|FG000|Overall Study|Adverse Event|1|||
143426966|NCT00755716|517108360|FG001|Overall Study|Adverse Event|4|||
143426967|NCT00755716|517108361|FG002|Overall Study|Adverse Event|1|||
143426968|NCT00755716|517108359|FG000|Overall Study|Lack of Efficacy|2|||
143426969|NCT00755716|517108360|FG001|Overall Study|Lack of Efficacy|0|||
143426970|NCT00755716|517108361|FG002|Overall Study|Lack of Efficacy|0|||
143426971|NCT00755716|517108359|FG000|Overall Study|Lost to Follow-up|5|||
143426972|NCT00755716|517108360|FG001|Overall Study|Lost to Follow-up|3|||
143426973|NCT00755716|517108361|FG002|Overall Study|Lost to Follow-up|1|||
143426974|NCT00755716|517108359|FG000|Overall Study|work schedule issues|0|||
143426975|NCT00755716|517108360|FG001|Overall Study|work schedule issues|1|||
143426976|NCT00755716|517108361|FG002|Overall Study|work schedule issues|1|||
143426977|NCT00726388|517108367|FG000|Overall Study|Withdrawal by Subject|5|||
143426978|NCT00726388|517108367|FG000|Overall Study|Adverse Event|3|||
143426979|NCT00726388|517108367|FG000|Overall Study|Lost to Follow-up|10|||
143426980|NCT00726388|517108367|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
143426981|NCT00726388|517108367|FG000|Overall Study|Other|5|||
143426982|NCT00726388|517108367|FG000|Overall Study|Enrolled, Not Treated|79|||
143426983|NCT05372913|517108373|FG000|Overall Study|Withdrawal by Subject|0|||
143426984|NCT05372913|517108374|FG001|Overall Study|Withdrawal by Subject|2|||
143426985|NCT05372913|517108373|FG000|Overall Study|Protocol Violation|2|||
143426986|NCT05372913|517108374|FG001|Overall Study|Protocol Violation|2|||
143426987|NCT05372913|517108373|FG000|Overall Study|Adverse Event|0|||
143426988|NCT05372913|517108374|FG001|Overall Study|Adverse Event|1|||
143426989|NCT03275402|517108375|FG000|Overall Study|Death|17|||
143426990|NCT03275402|517108375|FG000|Overall Study|Study terminated by sponsor|21|||
143426991|NCT03275402|517108375|FG000|Overall Study|Withdrawal by Subject|1|||
143426992|NCT01059526|517108376|FG000|Overall Study|Patient enrolled but not treated|20|||
143426993|NCT01059526|517108377|FG001|Overall Study|Patient enrolled but not treated|17|||
143426994|NCT01059526|517108376|FG000|Overall Study|Adverse Event|2|||
143426995|NCT01059526|517108377|FG001|Overall Study|Adverse Event|2|||
143426996|NCT01059526|517108376|FG000|Overall Study|Protocol Violation|0|||
143426997|NCT01059526|517108377|FG001|Overall Study|Protocol Violation|1|||
143426998|NCT01059526|517108376|FG000|Overall Study|Withdrawal by Subject|3|||
143426999|NCT01059526|517108377|FG001|Overall Study|Withdrawal by Subject|1|||
143427000|NCT01059526|517108376|FG000|Overall Study|Lost to Follow-up|4|||
143427001|NCT01059526|517108377|FG001|Overall Study|Lost to Follow-up|1|||
143427002|NCT01059526|517108376|FG000|Overall Study|Patient found to be dermatographic|1|||
143427003|NCT01059526|517108377|FG001|Overall Study|Patient found to be dermatographic|0|||
143427004|NCT01732588|517108378|FG000|First Intervention (7 Days)|Adverse Event|0|||
143427005|NCT01732588|517108379|FG001|First Intervention (7 Days)|Adverse Event|1|||
143427006|NCT01732588|517108380|FG002|First Intervention (7 Days)|Adverse Event|0|||
143427007|NCT05012397|517108381|FG000|Overall Study|Death|10|||
143427008|NCT05012397|517108381|FG000|Overall Study|Physician Decision|9|||
143427009|NCT05012397|517108381|FG000|Overall Study|Withdrawal by Subject|5|||
143427010|NCT05012397|517108381|FG000|Overall Study|Lost to Follow-up|2|||
143427011|NCT04748445|517108384|FG000|Overall Study|No longer met eligibility criteria|12|||
143427012|NCT04748445|517108384|FG000|Overall Study|Other|36|||
143427013|NCT04748445|517108384|FG000|Overall Study|Withdrawal by Subject|553|||
143427014|NCT04748445|517108384|FG000|Overall Study|Lost to Follow-up|30|||
143427015|NCT04736602|517108385|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
143427016|NCT04736602|517108385|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
143427017|NCT00679549|517108388|FG000|Overall Study|dropout|2|||
143427018|NCT00679549|517108389|FG001|Overall Study|dropout|4|||
143427019|NCT00679549|517108388|FG000|Overall Study|missing outcome echocardiograms|4|||
143427020|NCT00679549|517108389|FG001|Overall Study|missing outcome echocardiograms|5|||
143427021|NCT03048058|517108392|FG000|Overall Study|Lost to Follow-up|4|||
143427022|NCT03048058|517108393|FG001|Overall Study|Lost to Follow-up|0|||
143427023|NCT03048058|517108392|FG000|Overall Study|Withdrawal by Subject|0|||
143427024|NCT03048058|517108393|FG001|Overall Study|Withdrawal by Subject|4|||
143427025|NCT01257698|517108398|FG000|Overall Study|Protocol Violation|4|||
143427026|NCT01257698|517108399|FG001|Overall Study|Protocol Violation|0|||
143427027|NCT00050167|517108421|FG000|Overall Study|not eligible not invasive|1|||
143427028|NCT00050167|517108422|FG001|Overall Study|not eligible not invasive|1|||
143427029|NCT02038803|517108426|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
143427030|NCT02038803|517108426|FG000|Overall Study|Lost to Follow-up|1|||
143427031|NCT04754594|517108427|FG000|Blinded Period|Withdrawal by Subject|4|||
143427032|NCT04754594|517108428|FG001|Blinded Period|Withdrawal by Subject|9|||
143427033|NCT04754594|517108429|FG002|Blinded Period|Withdrawal by Subject|0|||
143427034|NCT04754594|517108430|FG003|Blinded Period|Withdrawal by Subject|0|||
143427035|NCT04754594|517108427|FG000|Blinded Period|Protocol Violation|2|||
143427036|NCT04754594|517108428|FG001|Blinded Period|Protocol Violation|2|||
143427037|NCT04754594|517108429|FG002|Blinded Period|Protocol Violation|0|||
143427038|NCT04754594|517108430|FG003|Blinded Period|Protocol Violation|0|||
143427039|NCT04754594|517108427|FG000|Blinded Period|Lost to Follow-up|1|||
143427040|NCT04754594|517108428|FG001|Blinded Period|Lost to Follow-up|1|||
143427041|NCT04754594|517108429|FG002|Blinded Period|Lost to Follow-up|0|||
143427042|NCT04754594|517108430|FG003|Blinded Period|Lost to Follow-up|0|||
143427043|NCT04754594|517108427|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
143427044|NCT04754594|517108428|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
143427045|NCT04754594|517108429|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
143427046|NCT04754594|517108430|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
143427047|NCT04754594|517108427|FG000|Unblinded Period|Withdrawal by Subject|6|||
143427048|NCT04754594|517108428|FG001|Unblinded Period|Withdrawal by Subject|8|||
143427049|NCT04754594|517108429|FG002|Unblinded Period|Withdrawal by Subject|0|||
143427050|NCT04754594|517108430|FG003|Unblinded Period|Withdrawal by Subject|0|||
143427051|NCT04754594|517108427|FG000|Unblinded Period|Lost to Follow-up|5|||
143427052|NCT04754594|517108428|FG001|Unblinded Period|Lost to Follow-up|3|||
143427053|NCT04754594|517108429|FG002|Unblinded Period|Lost to Follow-up|0|||
143427054|NCT04754594|517108430|FG003|Unblinded Period|Lost to Follow-up|0|||
143427055|NCT04754594|517108427|FG000|Unblinded Period|Protocol Violation|2|||
143427056|NCT04754594|517108428|FG001|Unblinded Period|Protocol Violation|4|||
143427057|NCT04754594|517108429|FG002|Unblinded Period|Protocol Violation|0|||
143427058|NCT04754594|517108430|FG003|Unblinded Period|Protocol Violation|0|||
143427059|NCT04754594|517108427|FG000|Unblinded Period|Other|3|||
143427060|NCT04754594|517108428|FG001|Unblinded Period|Other|0|||
143427061|NCT04754594|517108429|FG002|Unblinded Period|Other|0|||
143427062|NCT04754594|517108430|FG003|Unblinded Period|Other|0|||
143427063|NCT04754594|517108427|FG000|Infant Participants|Withdrawal by Subject|0|||
143427064|NCT04754594|517108428|FG001|Infant Participants|Withdrawal by Subject|0|||
143427065|NCT04754594|517108429|FG002|Infant Participants|Withdrawal by Subject|9|||
143427066|NCT04754594|517108430|FG003|Infant Participants|Withdrawal by Subject|17|||
143427067|NCT04754594|517108427|FG000|Infant Participants|Lost to Follow-up|0|||
143427068|NCT04754594|517108428|FG001|Infant Participants|Lost to Follow-up|0|||
143427069|NCT04754594|517108429|FG002|Infant Participants|Lost to Follow-up|4|||
143427070|NCT04754594|517108430|FG003|Infant Participants|Lost to Follow-up|10|||
143427071|NCT04754594|517108427|FG000|Infant Participants|Death|0|||
143427072|NCT04754594|517108428|FG001|Infant Participants|Death|0|||
143427073|NCT04754594|517108429|FG002|Infant Participants|Death|1|||
143427074|NCT04754594|517108430|FG003|Infant Participants|Death|1|||
143427075|NCT04754594|517108427|FG000|Infant Participants|Other|0|||
143427076|NCT04754594|517108428|FG001|Infant Participants|Other|0|||
143427077|NCT04754594|517108429|FG002|Infant Participants|Other|1|||
143427078|NCT04754594|517108430|FG003|Infant Participants|Other|1|||
143427079|NCT02588027|517108431|FG000|Overall Study|Withdrawal by Subject|1|||
143427080|NCT02588027|517108432|FG001|Overall Study|Withdrawal by Subject|3|||
143427081|NCT02588027|517108431|FG000|Overall Study|Protocol Violation|4|||
143427082|NCT02588027|517108432|FG001|Overall Study|Protocol Violation|1|||
143427083|NCT04372186|517108433|FG000|Overall Study|Death|24|||
143427084|NCT04372186|517108434|FG001|Overall Study|Death|11|||
143427085|NCT04372186|517108433|FG000|Overall Study|Transferred to a different facility for care|0|||
143427086|NCT04372186|517108434|FG001|Overall Study|Transferred to a different facility for care|2|||
143427087|NCT04736472|517108435|FG000|Overall Study|Lost to Follow-up|1|||
143427088|NCT04736472|517108436|FG001|Overall Study|Lost to Follow-up|0|||
143427089|NCT04736472|517108437|FG002|Overall Study|Lost to Follow-up|0|||
143427090|NCT04736472|517108435|FG000|Overall Study|Withdrawal by Subject|2|||
143427091|NCT04736472|517108436|FG001|Overall Study|Withdrawal by Subject|0|||
143427092|NCT04736472|517108437|FG002|Overall Study|Withdrawal by Subject|0|||
143427093|NCT04736472|517108435|FG000|Overall Study|Protocol Violation|48|||
143427094|NCT04736472|517108436|FG001|Overall Study|Protocol Violation|0|||
143427095|NCT04736472|517108437|FG002|Overall Study|Protocol Violation|6|||
143427096|NCT02116582|517108438|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
143427097|NCT02116582|517108438|FG000|Overall Study|Adverse Event|22|||
143427098|NCT02116582|517108438|FG000|Overall Study|Death|9|||
143427099|NCT02116582|517108438|FG000|Overall Study|Progressive Disease|148|||
143427100|NCT02116582|517108438|FG000|Overall Study|Protocol Violation|3|||
143427101|NCT02116582|517108438|FG000|Overall Study|Withdrawal by Subject|8|||
143427102|NCT02116582|517108438|FG000|Overall Study|Other: Miscellaneous|11|||
143427103|NCT02116582|517108438|FG000|Overall Study|Lost to Follow-up|1|||
143427104|NCT02116582|517108438|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
143427105|NCT01876823|517108439|FG000|Overall Study|Withdrawal by Subject|5|||
143427106|NCT01876823|517108439|FG000|Overall Study|Physician Decision|2|||
143427107|NCT01876823|517108439|FG000|Overall Study|Patients moved|2|||
143427108|NCT00577096|517108442|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
143427109|NCT00577096|517108443|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
143427110|NCT00577096|517108442|FG000|Short Term Participation|Withdrawal by Subject|3|||
143427111|NCT00577096|517108443|FG001|Short Term Participation|Withdrawal by Subject|5|||
143427112|NCT00577096|517108442|FG000|Short Term Participation|Death|1|||
143427113|NCT00577096|517108443|FG001|Short Term Participation|Death|1|||
143427114|NCT03562117|517108444|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
143427115|NCT03562117|517108445|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
143427116|NCT03562117|517108446|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
143427117|NCT01911819|517108447|FG000|Overall Study|Adverse Event|0|||
143427118|NCT01911819|517108448|FG001|Overall Study|Adverse Event|1|||
143427119|NCT01911819|517108449|FG002|Overall Study|Adverse Event|0|||
143427120|NCT01911819|517108447|FG000|Overall Study|Withdrawal by Subject|1|||
143427121|NCT01911819|517108448|FG001|Overall Study|Withdrawal by Subject|1|||
143427122|NCT01911819|517108449|FG002|Overall Study|Withdrawal by Subject|0|||
143427123|NCT00603278|517108450|FG000|Overall Study|Lack of Efficacy|35|||
143427124|NCT00603278|517108451|FG001|Overall Study|Lack of Efficacy|10|||
143427125|NCT00603278|517108452|FG002|Overall Study|Lack of Efficacy|11|||
143427126|NCT00603278|517108453|FG003|Overall Study|Lack of Efficacy|8|||
143427127|NCT00603278|517108454|FG004|Overall Study|Lack of Efficacy|7|||
143427128|NCT00603278|517108455|FG005|Overall Study|Lack of Efficacy|14|||
143427129|NCT00603278|517108450|FG000|Overall Study|Adverse Event|0|||
143427130|NCT00603278|517108451|FG001|Overall Study|Adverse Event|3|||
143427131|NCT00603278|517108452|FG002|Overall Study|Adverse Event|1|||
143427132|NCT00603278|517108453|FG003|Overall Study|Adverse Event|0|||
143427133|NCT00603278|517108454|FG004|Overall Study|Adverse Event|2|||
143427134|NCT00603278|517108455|FG005|Overall Study|Adverse Event|1|||
143427135|NCT00603278|517108450|FG000|Overall Study|Withdrawal by Subject|2|||
143427136|NCT00603278|517108451|FG001|Overall Study|Withdrawal by Subject|3|||
143427137|NCT00603278|517108452|FG002|Overall Study|Withdrawal by Subject|1|||
143427138|NCT00603278|517108453|FG003|Overall Study|Withdrawal by Subject|2|||
143427139|NCT00603278|517108454|FG004|Overall Study|Withdrawal by Subject|1|||
143427140|NCT00603278|517108455|FG005|Overall Study|Withdrawal by Subject|2|||
143427141|NCT00603278|517108450|FG000|Overall Study|Protocol Violation|3|||
143427142|NCT00603278|517108451|FG001|Overall Study|Protocol Violation|0|||
143427143|NCT00603278|517108452|FG002|Overall Study|Protocol Violation|1|||
143427144|NCT00603278|517108453|FG003|Overall Study|Protocol Violation|1|||
143427145|NCT00603278|517108454|FG004|Overall Study|Protocol Violation|0|||
143427146|NCT00603278|517108455|FG005|Overall Study|Protocol Violation|1|||
143427147|NCT00603278|517108450|FG000|Overall Study|Physician Decision|0|||
143427148|NCT00603278|517108451|FG001|Overall Study|Physician Decision|1|||
143427149|NCT00603278|517108452|FG002|Overall Study|Physician Decision|0|||
143427150|NCT00603278|517108453|FG003|Overall Study|Physician Decision|0|||
143427151|NCT00603278|517108454|FG004|Overall Study|Physician Decision|2|||
143427152|NCT00603278|517108455|FG005|Overall Study|Physician Decision|1|||
143427153|NCT00603278|517108450|FG000|Overall Study|Lost to Follow-up|1|||
143427154|NCT00603278|517108451|FG001|Overall Study|Lost to Follow-up|0|||
143427155|NCT00603278|517108452|FG002|Overall Study|Lost to Follow-up|0|||
143427156|NCT00603278|517108453|FG003|Overall Study|Lost to Follow-up|0|||
143427157|NCT00603278|517108454|FG004|Overall Study|Lost to Follow-up|1|||
143427158|NCT00603278|517108455|FG005|Overall Study|Lost to Follow-up|0|||
143427159|NCT01207453|517108459|FG000|First Intervention|Adverse Event|2|||
143427160|NCT01207453|517108460|FG001|First Intervention|Adverse Event|1|||
143427161|NCT01207453|517108459|FG000|Washout|Adverse Event|1|||
143427162|NCT01207453|517108460|FG001|Washout|Adverse Event|0|||
143427163|NCT01207453|517108459|FG000|Washout|Lost to Follow-up|1|||
143427164|NCT01207453|517108460|FG001|Washout|Lost to Follow-up|0|||
143427165|NCT01207453|517108459|FG000|2nd Intervention|Adverse Event|1|||
143427166|NCT01207453|517108460|FG001|2nd Intervention|Adverse Event|2|||
143427167|NCT01207453|517108459|FG000|2nd Intervention|Lost to Follow-up|1|||
143427168|NCT01207453|517108460|FG001|2nd Intervention|Lost to Follow-up|0|||
143427169|NCT00676663|517108463|FG000|Overall Study|Death|43|||
143427170|NCT00676663|517108464|FG001|Overall Study|Death|27|||
143427171|NCT00676663|517108463|FG000|Overall Study|Withdrew Consent|1|||
143427172|NCT00676663|517108464|FG001|Overall Study|Withdrew Consent|8|||
143427173|NCT00676663|517108463|FG000|Overall Study|Lost to Follow-up|1|||
143427174|NCT00676663|517108464|FG001|Overall Study|Lost to Follow-up|3|||
143427175|NCT01399905|517108465|FG000|Overall Study|Withdrawal by Subject|1|||
143427176|NCT01399905|517108466|FG001|Overall Study|Withdrawal by Subject|1|||
143427177|NCT00714688|517108472|FG000|Overall Study|Lack of Efficacy|14|||
143427178|NCT00714688|517108473|FG001|Overall Study|Lack of Efficacy|1|||
143427179|NCT00714688|517108474|FG002|Overall Study|Lack of Efficacy|4|||
143427180|NCT00714688|517108472|FG000|Overall Study|Withdrawal by Subject|4|||
143427181|NCT00714688|517108473|FG001|Overall Study|Withdrawal by Subject|3|||
143427182|NCT00714688|517108474|FG002|Overall Study|Withdrawal by Subject|3|||
143427183|NCT00714688|517108472|FG000|Overall Study|Lost to Follow-up|5|||
143427184|NCT00714688|517108473|FG001|Overall Study|Lost to Follow-up|2|||
143427185|NCT00714688|517108474|FG002|Overall Study|Lost to Follow-up|0|||
143427186|NCT00714688|517108472|FG000|Overall Study|Adverse Event|2|||
143427187|NCT00714688|517108473|FG001|Overall Study|Adverse Event|15|||
143427188|NCT00714688|517108474|FG002|Overall Study|Adverse Event|19|||
143427189|NCT00714688|517108472|FG000|Overall Study|Subject Non-compliant|3|||
143427190|NCT00714688|517108473|FG001|Overall Study|Subject Non-compliant|5|||
143427191|NCT00714688|517108474|FG002|Overall Study|Subject Non-compliant|5|||
143427192|NCT00714688|517108472|FG000|Overall Study|Ineligible to Continue the Study|0|||
143427193|NCT00714688|517108473|FG001|Overall Study|Ineligible to Continue the Study|1|||
143427194|NCT00714688|517108474|FG002|Overall Study|Ineligible to Continue the Study|1|||
143427195|NCT00714688|517108472|FG000|Overall Study|Sponsor's Decision|0|||
143427196|NCT00714688|517108473|FG001|Overall Study|Sponsor's Decision|2|||
143427197|NCT00714688|517108474|FG002|Overall Study|Sponsor's Decision|0|||
143427198|NCT00714688|517108472|FG000|Overall Study|Other|1|||
143427199|NCT00714688|517108473|FG001|Overall Study|Other|6|||
143427200|NCT00714688|517108474|FG002|Overall Study|Other|5|||
143427201|NCT00170950|517108475|FG000|Overall Study|Death|236|||
143427202|NCT00170950|517108476|FG001|Overall Study|Death|274|||
143427203|NCT00170950|517108475|FG000|Overall Study|Withdrawal by Subject|496|||
143427204|NCT00170950|517108476|FG001|Overall Study|Withdrawal by Subject|498|||
143427205|NCT00170950|517108475|FG000|Overall Study|Lost to Follow-up|134|||
143427206|NCT00170950|517108476|FG001|Overall Study|Lost to Follow-up|115|||
143427207|NCT00170950|517108475|FG000|Overall Study|Missing|2|||
143427208|NCT00170950|517108476|FG001|Overall Study|Missing|1|||
143427209|NCT00170950|517108475|FG000|Overall Study|Termination Data Not Recorded|17|||
143427210|NCT00170950|517108476|FG001|Overall Study|Termination Data Not Recorded|22|||
143427211|NCT00651937|517110413|FG000|Overall Study|Withdrawal by Subject|4|||
143427212|NCT00651937|517110414|FG001|Overall Study|Withdrawal by Subject|1|||
143427213|NCT00792259|517110420|FG000|Overall Study|Poor Quality Scans|1|||
143427214|NCT00792259|517110421|FG001|Overall Study|Poor Quality Scans|0|||
143427215|NCT00792259|517110422|FG002|Overall Study|Poor Quality Scans|0|||
143427216|NCT03721978|517110423|FG000|Overall Study|Withdrawal by Subject|6|||
143427217|NCT03721978|517110424|FG001|Overall Study|Withdrawal by Subject|1|||
143427218|NCT03721978|517110423|FG000|Overall Study|Adverse Event|1|||
143427219|NCT03721978|517110424|FG001|Overall Study|Adverse Event|1|||
143427220|NCT03721978|517110423|FG000|Overall Study|Progressive Disease|1|||
143427221|NCT03721978|517110424|FG001|Overall Study|Progressive Disease|0|||
143427222|NCT03721978|517110423|FG000|Overall Study|Lost to Follow-up|5|||
143427223|NCT03721978|517110424|FG001|Overall Study|Lost to Follow-up|1|||
143427224|NCT03721978|517110423|FG000|Overall Study|Reason not Specified|0|||
143427225|NCT03721978|517110424|FG001|Overall Study|Reason not Specified|2|||
143427226|NCT02507687|517110427|FG000|Overall Study|Adverse Event|3|||
143427227|NCT02507687|517110428|FG001|Overall Study|Adverse Event|2|||
143427228|NCT02507687|517110429|FG002|Overall Study|Adverse Event|2|||
143427229|NCT02507687|517110430|FG003|Overall Study|Adverse Event|2|||
143427230|NCT02507687|517110427|FG000|Overall Study|Withdrawal by Subject|1|||
143427231|NCT02507687|517110428|FG001|Overall Study|Withdrawal by Subject|4|||
143427232|NCT02507687|517110429|FG002|Overall Study|Withdrawal by Subject|6|||
143427233|NCT02507687|517110430|FG003|Overall Study|Withdrawal by Subject|6|||
143427234|NCT02507687|517110427|FG000|Overall Study|Protocol Violation|1|||
143427235|NCT02507687|517110428|FG001|Overall Study|Protocol Violation|0|||
143427236|NCT02507687|517110429|FG002|Overall Study|Protocol Violation|2|||
143427237|NCT02507687|517110430|FG003|Overall Study|Protocol Violation|0|||
143427238|NCT02507687|517110427|FG000|Overall Study|Lost to Follow-up|0|||
143427239|NCT02507687|517110428|FG001|Overall Study|Lost to Follow-up|0|||
143427240|NCT02507687|517110429|FG002|Overall Study|Lost to Follow-up|2|||
143427241|NCT02507687|517110430|FG003|Overall Study|Lost to Follow-up|1|||
143427242|NCT02507687|517110427|FG000|Overall Study|Screen Failure|0|||
143427243|NCT02507687|517110428|FG001|Overall Study|Screen Failure|0|||
143427244|NCT02507687|517110429|FG002|Overall Study|Screen Failure|1|||
143427245|NCT02507687|517110430|FG003|Overall Study|Screen Failure|0|||
143427246|NCT02507687|517110427|FG000|Overall Study|Other, Not Specified|0|||
143427247|NCT02507687|517110428|FG001|Overall Study|Other, Not Specified|0|||
143427248|NCT02507687|517110429|FG002|Overall Study|Other, Not Specified|2|||
143427249|NCT02507687|517110430|FG003|Overall Study|Other, Not Specified|4|||
143427250|NCT04357964|517110431|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
143427251|NCT04357964|517110432|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
143427252|NCT04357964|517110431|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
143427253|NCT04357964|517110432|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
143427254|NCT04357964|517110431|FG000|Overall Study|Adipose sample was insufficient quality|0|||
143427255|NCT04357964|517110432|FG001|Overall Study|Adipose sample was insufficient quality|1|||
143427256|NCT00733226|517110433|FG000|Overall Study|Withdrawal by Subject|1|||
143427257|NCT00733226|517110434|FG001|Overall Study|Withdrawal by Subject|0|||
143427258|NCT00733226|517110433|FG000|Overall Study|Lost to Follow-up|2|||
143427259|NCT00733226|517110434|FG001|Overall Study|Lost to Follow-up|0|||
143427260|NCT00733226|517110433|FG000|Overall Study|moved to another place|2|||
143427261|NCT00733226|517110434|FG001|Overall Study|moved to another place|0|||
143427262|NCT00848393|517110439|FG000|Overall Study|Protocol Violation|0|||
143427263|NCT00848393|517110440|FG001|Overall Study|Protocol Violation|0|||
143427264|NCT00848393|517110441|FG002|Overall Study|Protocol Violation|1|||
143427265|NCT00848393|517110439|FG000|Overall Study|surgical complications unrelated to stud|0|||
143427266|NCT00848393|517110440|FG001|Overall Study|surgical complications unrelated to stud|0|||
143427267|NCT00848393|517110441|FG002|Overall Study|surgical complications unrelated to stud|2|||
143427268|NCT02561078|517110442|FG000|Overall Study|Adverse Event|5|||
143427269|NCT02561078|517110443|FG001|Overall Study|Adverse Event|2|||
143427270|NCT02561078|517110442|FG000|Overall Study|Death|2|||
143427271|NCT02561078|517110443|FG001|Overall Study|Death|1|||
143427272|NCT02561078|517110442|FG000|Overall Study|Lost to Follow-up|2|||
143427273|NCT02561078|517110443|FG001|Overall Study|Lost to Follow-up|6|||
143427274|NCT02561078|517110442|FG000|Overall Study|Non-Compliance with Study Drug|6|||
143427275|NCT02561078|517110443|FG001|Overall Study|Non-Compliance with Study Drug|3|||
143427276|NCT02561078|517110442|FG000|Overall Study|Physician Decision|2|||
143427277|NCT02561078|517110443|FG001|Overall Study|Physician Decision|3|||
143427278|NCT02561078|517110442|FG000|Overall Study|Withdrawal by Subject|13|||
143427279|NCT02561078|517110443|FG001|Overall Study|Withdrawal by Subject|10|||
143427280|NCT00598871|517110446|FG000|Overall Study|Adverse Event|0|||
143427281|NCT00598871|517110447|FG001|Overall Study|Adverse Event|1|||
143427282|NCT01194271|517110448|FG000|Overall Study|Withdrawal by Subject|1|||
143427283|NCT01194271|517110448|FG000|Overall Study|Ineligible, Screen Failure|1|||
143427284|NCT01194271|517110448|FG000|Overall Study|Death|1|||
143427285|NCT01983462|517110451|FG000|Overall Study|Adverse Event|1|||
143427286|NCT01983462|517110452|FG001|Overall Study|Adverse Event|0|||
143427287|NCT01983462|517110453|FG002|Overall Study|Adverse Event|0|||
143427288|NCT00043186|517110456|FG000|Overall Study|Physician Decision|0|||
143427289|NCT00043186|517110457|FG001|Overall Study|Physician Decision|0|||
143427290|NCT00043186|517110458|FG002|Overall Study|Physician Decision|3|||
143427291|NCT00043186|517110459|FG003|Overall Study|Physician Decision|0|||
143427292|NCT00043186|517110460|FG004|Overall Study|Physician Decision|1|||
143427293|NCT00043186|517110461|FG005|Overall Study|Physician Decision|0|||
143427294|NCT00043186|517110462|FG006|Overall Study|Physician Decision|0|||
143427295|NCT00043186|517110463|FG007|Overall Study|Physician Decision|1|||
143427296|NCT00043186|517110464|FG008|Overall Study|Physician Decision|1|||
143427297|NCT00043186|517110456|FG000|Overall Study|Adverse Event|2|||
143427298|NCT00043186|517110457|FG001|Overall Study|Adverse Event|2|||
143427299|NCT00043186|517110458|FG002|Overall Study|Adverse Event|2|||
143427300|NCT00043186|517110459|FG003|Overall Study|Adverse Event|3|||
143427301|NCT00043186|517110460|FG004|Overall Study|Adverse Event|2|||
143427302|NCT00043186|517110461|FG005|Overall Study|Adverse Event|1|||
143427303|NCT00043186|517110462|FG006|Overall Study|Adverse Event|2|||
143427304|NCT00043186|517110463|FG007|Overall Study|Adverse Event|1|||
143427305|NCT00043186|517110464|FG008|Overall Study|Adverse Event|3|||
143427306|NCT00043186|517110456|FG000|Overall Study|Withdrawal by Subject|11|||
143427307|NCT00043186|517110457|FG001|Overall Study|Withdrawal by Subject|8|||
143427308|NCT00043186|517110458|FG002|Overall Study|Withdrawal by Subject|11|||
143427309|NCT00043186|517110459|FG003|Overall Study|Withdrawal by Subject|13|||
143427310|NCT00043186|517110460|FG004|Overall Study|Withdrawal by Subject|14|||
143427311|NCT00043186|517110461|FG005|Overall Study|Withdrawal by Subject|6|||
143427312|NCT00043186|517110462|FG006|Overall Study|Withdrawal by Subject|12|||
143427313|NCT00043186|517110463|FG007|Overall Study|Withdrawal by Subject|9|||
143427314|NCT00043186|517110464|FG008|Overall Study|Withdrawal by Subject|10|||
143427315|NCT00043186|517110456|FG000|Overall Study|Death|0|||
143427316|NCT00043186|517110457|FG001|Overall Study|Death|0|||
143427317|NCT00043186|517110458|FG002|Overall Study|Death|1|||
143427318|NCT00043186|517110459|FG003|Overall Study|Death|0|||
143427319|NCT00043186|517110460|FG004|Overall Study|Death|0|||
143427320|NCT00043186|517110461|FG005|Overall Study|Death|0|||
143427321|NCT00043186|517110462|FG006|Overall Study|Death|2|||
143427322|NCT00043186|517110463|FG007|Overall Study|Death|0|||
143427323|NCT00043186|517110464|FG008|Overall Study|Death|0|||
143427324|NCT00043186|517110456|FG000|Overall Study|Disease progression|1|||
143427325|NCT00043186|517110457|FG001|Overall Study|Disease progression|0|||
143427326|NCT00043186|517110458|FG002|Overall Study|Disease progression|0|||
143427327|NCT00043186|517110459|FG003|Overall Study|Disease progression|3|||
143427328|NCT00043186|517110460|FG004|Overall Study|Disease progression|0|||
143427329|NCT00043186|517110461|FG005|Overall Study|Disease progression|0|||
143427330|NCT00043186|517110462|FG006|Overall Study|Disease progression|0|||
143427331|NCT00043186|517110463|FG007|Overall Study|Disease progression|4|||
143427332|NCT00043186|517110464|FG008|Overall Study|Disease progression|0|||
143427333|NCT00043186|517110456|FG000|Overall Study|Ineligibility determined|0|||
143427334|NCT00043186|517110457|FG001|Overall Study|Ineligibility determined|0|||
143427335|NCT00043186|517110458|FG002|Overall Study|Ineligibility determined|0|||
143427336|NCT00043186|517110459|FG003|Overall Study|Ineligibility determined|0|||
143427337|NCT00043186|517110460|FG004|Overall Study|Ineligibility determined|0|||
143427338|NCT00043186|517110461|FG005|Overall Study|Ineligibility determined|0|||
143427339|NCT00043186|517110462|FG006|Overall Study|Ineligibility determined|0|||
143427340|NCT00043186|517110463|FG007|Overall Study|Ineligibility determined|0|||
143427341|NCT00043186|517110464|FG008|Overall Study|Ineligibility determined|1|||
143427342|NCT00043186|517110456|FG000|Overall Study|Lost to Follow-up|3|||
143427343|NCT00043186|517110457|FG001|Overall Study|Lost to Follow-up|5|||
143427344|NCT00043186|517110458|FG002|Overall Study|Lost to Follow-up|1|||
143427345|NCT00043186|517110459|FG003|Overall Study|Lost to Follow-up|1|||
143427346|NCT00043186|517110460|FG004|Overall Study|Lost to Follow-up|1|||
143427347|NCT00043186|517110461|FG005|Overall Study|Lost to Follow-up|1|||
143427348|NCT00043186|517110462|FG006|Overall Study|Lost to Follow-up|1|||
143427349|NCT00043186|517110463|FG007|Overall Study|Lost to Follow-up|1|||
143427350|NCT00043186|517110464|FG008|Overall Study|Lost to Follow-up|2|||
143427351|NCT00043186|517110456|FG000|Overall Study|Noncompliance|0|||
143427352|NCT00043186|517110457|FG001|Overall Study|Noncompliance|0|||
143427353|NCT00043186|517110458|FG002|Overall Study|Noncompliance|1|||
143427354|NCT00043186|517110459|FG003|Overall Study|Noncompliance|1|||
143427355|NCT00043186|517110460|FG004|Overall Study|Noncompliance|0|||
143427356|NCT00043186|517110461|FG005|Overall Study|Noncompliance|0|||
143427357|NCT00043186|517110462|FG006|Overall Study|Noncompliance|0|||
143427358|NCT00043186|517110463|FG007|Overall Study|Noncompliance|0|||
143427359|NCT00043186|517110464|FG008|Overall Study|Noncompliance|0|||
143427360|NCT00043186|517110456|FG000|Overall Study|Other|0|||
143427361|NCT00043186|517110457|FG001|Overall Study|Other|0|||
143427362|NCT00043186|517110458|FG002|Overall Study|Other|1|||
143427363|NCT00043186|517110459|FG003|Overall Study|Other|1|||
143427364|NCT00043186|517110460|FG004|Overall Study|Other|0|||
143427365|NCT00043186|517110461|FG005|Overall Study|Other|0|||
143427366|NCT00043186|517110462|FG006|Overall Study|Other|0|||
143427367|NCT00043186|517110463|FG007|Overall Study|Other|0|||
143427368|NCT00043186|517110464|FG008|Overall Study|Other|0|||
143427369|NCT00958711|517110465|FG000|Overall Study|Withdrawal by Subject|0|||
143427370|NCT00958711|517110466|FG001|Overall Study|Withdrawal by Subject|4|||
143427371|NCT00958711|517110465|FG000|Overall Study|Physician Decision|5|||
143427372|NCT00958711|517110466|FG001|Overall Study|Physician Decision|7|||
143427373|NCT00958711|517110465|FG000|Overall Study|Lost to Follow-up|4|||
143427374|NCT00958711|517110466|FG001|Overall Study|Lost to Follow-up|1|||
143427375|NCT00958711|517110465|FG000|Overall Study|Other|2|||
143427376|NCT00958711|517110466|FG001|Overall Study|Other|5|||
143427377|NCT00958711|517110465|FG000|Overall Study|Death|1|||
143427378|NCT00958711|517110466|FG001|Overall Study|Death|2|||
143427379|NCT00958711|517110465|FG000|Overall Study|Adverse Event|1|||
143427380|NCT00958711|517110466|FG001|Overall Study|Adverse Event|2|||
143427381|NCT02151643|517110467|FG000|Overall Study|Adverse Event|2|||
143427382|NCT02151643|517110468|FG001|Overall Study|Adverse Event|0|||
143427383|NCT02151643|517110469|FG002|Overall Study|Adverse Event|1|||
143427384|NCT02151643|517110470|FG003|Overall Study|Adverse Event|4|||
143427385|NCT02151643|517110471|FG004|Overall Study|Adverse Event|0|||
143427386|NCT02151643|517110467|FG000|Overall Study|Withdrawal by Subject|0|||
143427387|NCT02151643|517110468|FG001|Overall Study|Withdrawal by Subject|1|||
143427388|NCT02151643|517110469|FG002|Overall Study|Withdrawal by Subject|1|||
143427389|NCT02151643|517110470|FG003|Overall Study|Withdrawal by Subject|1|||
143427390|NCT02151643|517110471|FG004|Overall Study|Withdrawal by Subject|1|||
143427391|NCT02151643|517110467|FG000|Overall Study|Hyperphosphataemia|1|||
143427392|NCT02151643|517110468|FG001|Overall Study|Hyperphosphataemia|0|||
143427393|NCT02151643|517110469|FG002|Overall Study|Hyperphosphataemia|0|||
143427394|NCT02151643|517110470|FG003|Overall Study|Hyperphosphataemia|0|||
143427395|NCT02151643|517110471|FG004|Overall Study|Hyperphosphataemia|1|||
143427396|NCT02151643|517110467|FG000|Overall Study|High Ferritin levels|3|||
143427397|NCT02151643|517110468|FG001|Overall Study|High Ferritin levels|3|||
143427398|NCT02151643|517110469|FG002|Overall Study|High Ferritin levels|2|||
143427399|NCT02151643|517110470|FG003|Overall Study|High Ferritin levels|2|||
143427400|NCT02151643|517110471|FG004|Overall Study|High Ferritin levels|1|||
143427401|NCT00550771|517110475|FG000|Overall Study|Adverse Event|11|||
143427402|NCT00550771|517110476|FG001|Overall Study|Adverse Event|3|||
143427403|NCT00550771|517110475|FG000|Overall Study|Discontinued for study-related reasons|0|||
143427404|NCT00550771|517110476|FG001|Overall Study|Discontinued for study-related reasons|1|||
143427405|NCT00550771|517110475|FG000|Overall Study|Physician Decision|2|||
143427406|NCT00550771|517110476|FG001|Overall Study|Physician Decision|0|||
143427407|NCT00550771|517110475|FG000|Overall Study|Withdrawal by Subject|0|||
143427408|NCT00550771|517110476|FG001|Overall Study|Withdrawal by Subject|1|||
143427409|NCT00550771|517110475|FG000|Overall Study|Protocol Violation|4|||
143427410|NCT00550771|517110476|FG001|Overall Study|Protocol Violation|5|||
143427411|NCT03022578|517110477|FG000|Overall Study|Adverse Event|1|||
143427412|NCT03022578|517110477|FG000|Overall Study|Lack of Efficacy|2|||
143427413|NCT03022578|517110477|FG000|Overall Study|Withdrawal by Subject|1|||
143427414|NCT03681353|517110478|FG000|Overall Study|Lost to Follow-up|2|||
143427415|NCT03681353|517110478|FG000|Overall Study|Withdrawal by Subject|3|||
143427416|NCT03681353|517110478|FG000|Overall Study|withdrawn by PI|2|||
143427417|NCT01145417|517110479|FG000|Overall Study|Death|1|||
143427418|NCT01145417|517110480|FG001|Overall Study|Death|0|||
143427419|NCT01145417|517110479|FG000|Overall Study|Lost to Follow-up|2|||
143427420|NCT01145417|517110480|FG001|Overall Study|Lost to Follow-up|1|||
143427421|NCT01145417|517110479|FG000|Overall Study|Withdrawal by Subject|1|||
143427422|NCT01145417|517110480|FG001|Overall Study|Withdrawal by Subject|2|||
143427423|NCT01145417|517110479|FG000|Overall Study|Pregnancy|1|||
143427424|NCT01145417|517110480|FG001|Overall Study|Pregnancy|0|||
143427425|NCT01145417|517110479|FG000|Overall Study|Adverse Event|0|||
143427426|NCT01145417|517110480|FG001|Overall Study|Adverse Event|1|||
143427427|NCT01145417|517110479|FG000|Overall Study|Study terminated by sponsor|35|||
143427428|NCT01145417|517110480|FG001|Overall Study|Study terminated by sponsor|43|||
143427429|NCT01145417|517110479|FG000|Overall Study|Other|1|||
143427430|NCT01145417|517110480|FG001|Overall Study|Other|0|||
143427431|NCT01797562|517110481|FG000|Overall Study|Protocol Violation|5|||
143427432|NCT03568708|517110486|FG000|Overall Study|Withdrawal by Subject|1|||
143427433|NCT03568708|517110487|FG001|Overall Study|Withdrawal by Subject|1|||
143427434|NCT03568708|517110486|FG000|Overall Study|Lost to Follow-up|0|||
143427435|NCT03568708|517110487|FG001|Overall Study|Lost to Follow-up|1|||
143427436|NCT00511147|517110488|FG000|Overall Study|Withdrawal by Subject|1|||
143427437|NCT00511147|517110488|FG000|Overall Study|Disease progression|5|||
143427438|NCT00511147|517110488|FG000|Overall Study|Required platelet transfusion|1|||
143427439|NCT03193216|517110495|FG000|Overall Study|Lost to Follow-up|1|||
143427440|NCT03193216|517110496|FG001|Overall Study|Lost to Follow-up|0|||
143427441|NCT03193216|517110495|FG000|Overall Study|Withdrawal by Subject|5|||
143427442|NCT03193216|517110496|FG001|Overall Study|Withdrawal by Subject|0|||
143427443|NCT03193216|517110495|FG000|Overall Study|Physician Decision|4|||
143427444|NCT03193216|517110496|FG001|Overall Study|Physician Decision|0|||
143427445|NCT01514864|517110497|FG000|Overall Study|Disease progression|7|||
143427446|NCT01514864|517110498|FG001|Overall Study|Disease progression|5|||
143427447|NCT01514864|517110497|FG000|Overall Study|Study drug toxicity|2|||
143427448|NCT01514864|517110498|FG001|Overall Study|Study drug toxicity|0|||
143427449|NCT02986659|517110499|FG000|First Intervention Period|Adverse Event|3|||
143427450|NCT02986659|517110500|FG001|First Intervention Period|Adverse Event|1|||
143427451|NCT02986659|517110499|FG000|First Intervention Period|Lost to Follow-up|1|||
143427452|NCT02986659|517110500|FG001|First Intervention Period|Lost to Follow-up|0|||
143427453|NCT02986659|517110499|FG000|First Intervention Period|Withdrawal by Subject|0|||
143427454|NCT02986659|517110500|FG001|First Intervention Period|Withdrawal by Subject|1|||
143427455|NCT02986659|517110499|FG000|Second Intervention Period|Adverse Event|0|||
143427456|NCT02986659|517110500|FG001|Second Intervention Period|Adverse Event|6|||
143427457|NCT02254681|517110508|FG000|Overall Study|Lack of Efficacy|6|||
143427458|NCT02469077|517110509|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
143427459|NCT02469077|517110510|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
143427460|NCT02469077|517110509|FG000|Post Randomization/Intervention Period|Relocated|1|||
143427461|NCT02469077|517110510|FG001|Post Randomization/Intervention Period|Relocated|1|||
143427462|NCT02469077|517110509|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
143427463|NCT02469077|517110510|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
143427464|NCT02469077|517110509|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
143427465|NCT02469077|517110510|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
143427466|NCT02005029|517110511|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
143427467|NCT02005029|517110512|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
143427468|NCT02621047|517110513|FG000|Overall Study|Adverse Event|0|||
143427469|NCT02621047|517110514|FG001|Overall Study|Adverse Event|0|||
143427470|NCT02621047|517110515|FG002|Overall Study|Adverse Event|1|||
143427471|NCT01370018|517110516|FG000|Overall Study|Did not meet criteria for analysis|1|||
143427472|NCT03772041|517110519|FG000|Overall Study|Adverse Event|8|||
143427473|NCT03772041|517110520|FG001|Overall Study|Adverse Event|3|||
143427474|NCT03772041|517110519|FG000|Overall Study|Withdrawal by Subject|0|||
143427475|NCT03772041|517110520|FG001|Overall Study|Withdrawal by Subject|2|||
143427476|NCT03772041|517110519|FG000|Overall Study|Protocol Violation|4|||
143427477|NCT03772041|517110520|FG001|Overall Study|Protocol Violation|2|||
143427478|NCT03772041|517110519|FG000|Overall Study|Physician Decision|2|||
143427479|NCT03772041|517110520|FG001|Overall Study|Physician Decision|3|||
143427480|NCT01525641|517110521|FG000|Overall Study|Case report form not collected|25|||
143427481|NCT01525641|517110521|FG000|Overall Study|No visit since the first visit|16|||
143427482|NCT01525641|517110521|FG000|Overall Study|Adverse Event|73|||
143427483|NCT01525641|517110521|FG000|Overall Study|Lack of Efficacy|24|||
143427484|NCT01525641|517110521|FG000|Overall Study|Improvement|5|||
143427485|NCT01525641|517110521|FG000|Overall Study|Lost to follow-up (relocation)|1|||
143427486|NCT01525641|517110521|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
143427487|NCT01525641|517110521|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
143427488|NCT01525641|517110521|FG000|Overall Study|Other than stated above|7|||
143427489|NCT02204319|517110526|FG000|Overall Study|Pregnancy|1|||
143427490|NCT02204319|517110526|FG000|Overall Study|Withdrawal by Subject|2|||
143427491|NCT03544229|517110527|FG000|Overall Study|Adverse Event|1|||
143427492|NCT03544229|517110528|FG001|Overall Study|Adverse Event|0|||
143427493|NCT03544229|517110529|FG002|Overall Study|Adverse Event|1|||
143427494|NCT03544229|517110530|FG003|Overall Study|Adverse Event|0|||
143427495|NCT03544229|517110527|FG000|Overall Study|Protocol Deviation|0|||
143427496|NCT03544229|517110528|FG001|Overall Study|Protocol Deviation|0|||
143427497|NCT03544229|517110529|FG002|Overall Study|Protocol Deviation|1|||
143427498|NCT03544229|517110530|FG003|Overall Study|Protocol Deviation|0|||
143427499|NCT03544229|517110527|FG000|Overall Study|Lost to Follow-up|3|||
143427500|NCT03544229|517110528|FG001|Overall Study|Lost to Follow-up|0|||
143427501|NCT03544229|517110529|FG002|Overall Study|Lost to Follow-up|0|||
143427502|NCT03544229|517110530|FG003|Overall Study|Lost to Follow-up|2|||
143427503|NCT03544229|517110527|FG000|Overall Study|Voluntary Withdrawal|2|||
143427504|NCT03544229|517110528|FG001|Overall Study|Voluntary Withdrawal|1|||
143427505|NCT03544229|517110529|FG002|Overall Study|Voluntary Withdrawal|3|||
143427506|NCT03544229|517110530|FG003|Overall Study|Voluntary Withdrawal|0|||
143427507|NCT03544229|517110527|FG000|Overall Study|Lack of Efficacy|0|||
143427508|NCT03544229|517110528|FG001|Overall Study|Lack of Efficacy|1|||
143427509|NCT03544229|517110529|FG002|Overall Study|Lack of Efficacy|0|||
143427510|NCT03544229|517110530|FG003|Overall Study|Lack of Efficacy|0|||
143427511|NCT03794609|517110533|FG000|Overall Study|Other|10|||
143427512|NCT03794609|517110533|FG000|Overall Study|Withdrawal by Subject|66|||
143427513|NCT03794609|517110533|FG000|Overall Study|The child is enrolled in an interventional study|70|||
143427514|NCT03794609|517110533|FG000|Overall Study|Inclusion/exclusion criteria|8|||
143427515|NCT03794609|517110533|FG000|Overall Study|At sponsor's request|151|||
143427516|NCT03794609|517110533|FG000|Overall Study|Physician Decision|1|||
143427517|NCT03794609|517110533|FG000|Overall Study|Lost to Follow-up|5|||
143427518|NCT02205476|517110534|FG000|Overall Study|Study termination by Sponsor|7|||
143427519|NCT02205476|517110535|FG001|Overall Study|Study termination by Sponsor|3|||
143427520|NCT00139659|517110540|FG000|Overall Study|Adverse Event|12|||
143427521|NCT00139659|517110541|FG001|Overall Study|Adverse Event|1|||
143427522|NCT00139659|517110540|FG000|Overall Study|Lack of Efficacy|1|||
143427523|NCT00139659|517110541|FG001|Overall Study|Lack of Efficacy|1|||
143427524|NCT00139659|517110540|FG000|Overall Study|Lost to Follow-up|7|||
143427525|NCT00139659|517110541|FG001|Overall Study|Lost to Follow-up|3|||
143427526|NCT00139659|517110540|FG000|Overall Study|Reason not Specified|6|||
143427527|NCT00139659|517110541|FG001|Overall Study|Reason not Specified|3|||
143427528|NCT00139659|517110540|FG000|Overall Study|Withdrawal by Subject|14|||
143427529|NCT00139659|517110541|FG001|Overall Study|Withdrawal by Subject|10|||
143427530|NCT04089332|517110547|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
143427531|NCT04089332|517110547|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
143427532|NCT04089332|517110547|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
143427533|NCT06016127|517110552|FG000|Overall Study|Withdrawal by Subject|4|||
143427534|NCT06016127|517110553|FG001|Overall Study|Withdrawal by Subject|3|||
143427535|NCT02256488|517110556|FG000|Overall Study|Lost to Follow-up|6|||
143427536|NCT02256488|517110557|FG001|Overall Study|Lost to Follow-up|6|||
143427537|NCT02256488|517110558|FG002|Overall Study|Lost to Follow-up|9|||
143427538|NCT02256488|517110559|FG003|Overall Study|Lost to Follow-up|3|||
143427539|NCT02256488|517110556|FG000|Overall Study|OTHER|1|||
143427540|NCT02256488|517110557|FG001|Overall Study|OTHER|0|||
143427541|NCT02256488|517110558|FG002|Overall Study|OTHER|1|||
143427542|NCT02256488|517110559|FG003|Overall Study|OTHER|1|||
143427543|NCT02256488|517110556|FG000|Overall Study|Withdrawal by Subject|1|||
143427544|NCT02256488|517110557|FG001|Overall Study|Withdrawal by Subject|0|||
143427545|NCT02256488|517110558|FG002|Overall Study|Withdrawal by Subject|0|||
143427546|NCT02256488|517110559|FG003|Overall Study|Withdrawal by Subject|2|||
143427547|NCT00975130|517110560|FG000|Study Part 1|Adverse Event|150|||
143427548|NCT00975130|517110561|FG001|Study Part 1|Adverse Event|0|||
143427549|NCT00975130|517110562|FG002|Study Part 1|Adverse Event|0|||
143427550|NCT00975130|517110560|FG000|Study Part 1|Lost to Follow-up|19|||
143427551|NCT00975130|517110561|FG001|Study Part 1|Lost to Follow-up|0|||
143427552|NCT00975130|517110562|FG002|Study Part 1|Lost to Follow-up|0|||
143427553|NCT00975130|517110560|FG000|Study Part 1|Withdrawal by Subject|61|||
143427554|NCT00975130|517110561|FG001|Study Part 1|Withdrawal by Subject|0|||
143427555|NCT00975130|517110562|FG002|Study Part 1|Withdrawal by Subject|0|||
143427556|NCT00975130|517110560|FG000|Study Part 1|Protocol Violation|13|||
143427557|NCT00975130|517110561|FG001|Study Part 1|Protocol Violation|0|||
143427558|NCT00975130|517110562|FG002|Study Part 1|Protocol Violation|0|||
143427559|NCT00975130|517110560|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
143427560|NCT00975130|517110561|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
143427561|NCT00975130|517110562|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
143427562|NCT00975130|517110560|FG000|Study Part 1|Administrative|4|||
143427563|NCT00975130|517110561|FG001|Study Part 1|Administrative|0|||
143427564|NCT00975130|517110562|FG002|Study Part 1|Administrative|0|||
143427565|NCT00975130|517110560|FG000|Study Part 1|Withdrew Consent|24|||
143427566|NCT00975130|517110561|FG001|Study Part 1|Withdrew Consent|0|||
143427567|NCT00975130|517110562|FG002|Study Part 1|Withdrew Consent|0|||
143427568|NCT00975130|517110560|FG000|Study Part 2|Adverse Event|0|||
143427569|NCT00975130|517110561|FG001|Study Part 2|Adverse Event|14|||
143427570|NCT00975130|517110562|FG002|Study Part 2|Adverse Event|7|||
143427571|NCT00975130|517110560|FG000|Study Part 2|Lost to Follow-up|0|||
143427572|NCT00975130|517110561|FG001|Study Part 2|Lost to Follow-up|0|||
143427573|NCT00975130|517110562|FG002|Study Part 2|Lost to Follow-up|1|||
143427574|NCT00975130|517110560|FG000|Study Part 2|Withdrawal by Subject|0|||
143427575|NCT00975130|517110561|FG001|Study Part 2|Withdrawal by Subject|13|||
143427576|NCT00975130|517110562|FG002|Study Part 2|Withdrawal by Subject|5|||
143427577|NCT00975130|517110560|FG000|Study Part 2|Withdrew Consent|0|||
143427578|NCT00975130|517110561|FG001|Study Part 2|Withdrew Consent|6|||
143427579|NCT00975130|517110562|FG002|Study Part 2|Withdrew Consent|2|||
143427580|NCT00975130|517110560|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
143427581|NCT00975130|517110561|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
143427582|NCT00975130|517110562|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
143427583|NCT00975130|517110560|FG000|Study Part 2|Administrative|0|||
143427584|NCT00975130|517110561|FG001|Study Part 2|Administrative|1|||
143427585|NCT00975130|517110562|FG002|Study Part 2|Administrative|0|||
143427586|NCT00975130|517110560|FG000|Study Part 2|Protocol Violation|0|||
143427587|NCT00975130|517110561|FG001|Study Part 2|Protocol Violation|0|||
143427588|NCT00975130|517110562|FG002|Study Part 2|Protocol Violation|1|||
143427589|NCT01261793|517110563|FG000|Overall Study|Lack of Efficacy|44|||
143427590|NCT01261793|517110564|FG001|Overall Study|Lack of Efficacy|37|||
143427591|NCT01261793|517110565|FG002|Overall Study|Lack of Efficacy|32|||
143427592|NCT01261793|517110563|FG000|Overall Study|Protocol Violation|3|||
143427593|NCT01261793|517110564|FG001|Overall Study|Protocol Violation|5|||
143427594|NCT01261793|517110565|FG002|Overall Study|Protocol Violation|6|||
143427595|NCT01261793|517110563|FG000|Overall Study|Lost to Follow-up|10|||
143427596|NCT01261793|517110564|FG001|Overall Study|Lost to Follow-up|3|||
143427597|NCT01261793|517110565|FG002|Overall Study|Lost to Follow-up|7|||
143427598|NCT01261793|517110563|FG000|Overall Study|Withdrawal by Subject|12|||
143427599|NCT01261793|517110564|FG001|Overall Study|Withdrawal by Subject|14|||
143427600|NCT01261793|517110565|FG002|Overall Study|Withdrawal by Subject|14|||
143427601|NCT01261793|517110563|FG000|Overall Study|Death|3|||
143427602|NCT01261793|517110564|FG001|Overall Study|Death|1|||
143427603|NCT01261793|517110565|FG002|Overall Study|Death|0|||
143427604|NCT01261793|517110563|FG000|Overall Study|Adverse Event|9|||
143427605|NCT01261793|517110564|FG001|Overall Study|Adverse Event|24|||
143427606|NCT01261793|517110565|FG002|Overall Study|Adverse Event|19|||
143427607|NCT01261793|517110563|FG000|Overall Study|Patient non-availability|1|||
143427608|NCT01261793|517110564|FG001|Overall Study|Patient non-availability|1|||
143427609|NCT01261793|517110565|FG002|Overall Study|Patient non-availability|1|||
143427610|NCT01261793|517110563|FG000|Overall Study|Suspected pregnancy|1|||
143427611|NCT01261793|517110564|FG001|Overall Study|Suspected pregnancy|1|||
143427612|NCT01261793|517110565|FG002|Overall Study|Suspected pregnancy|0|||
143427613|NCT01261793|517110563|FG000|Overall Study|Patient non-compliance|1|||
143427614|NCT01261793|517110564|FG001|Overall Study|Patient non-compliance|0|||
143427615|NCT01261793|517110565|FG002|Overall Study|Patient non-compliance|1|||
143427616|NCT01261793|517110563|FG000|Overall Study|Patient pregnant|1|||
143427617|NCT01261793|517110564|FG001|Overall Study|Patient pregnant|0|||
143427618|NCT01261793|517110565|FG002|Overall Study|Patient pregnant|0|||
143427619|NCT01261793|517110563|FG000|Overall Study|Outside the study area|0|||
143427620|NCT01261793|517110564|FG001|Overall Study|Outside the study area|2|||
143427621|NCT01261793|517110565|FG002|Overall Study|Outside the study area|1|||
143427622|NCT01261793|517110563|FG000|Overall Study|Lack of efficacy & patient not available|0|||
143427623|NCT01261793|517110564|FG001|Overall Study|Lack of efficacy & patient not available|1|||
143427624|NCT01261793|517110565|FG002|Overall Study|Lack of efficacy & patient not available|0|||
143427625|NCT01261793|517110563|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
143427626|NCT01261793|517110564|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
143427627|NCT01261793|517110565|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
143427628|NCT01261793|517110563|FG000|Overall Study|Randomization error|0|||
143427629|NCT01261793|517110564|FG001|Overall Study|Randomization error|1|||
143427630|NCT01261793|517110565|FG002|Overall Study|Randomization error|0|||
143427631|NCT01261793|517110563|FG000|Overall Study|Patient unable to start IV line|0|||
143427632|NCT01261793|517110564|FG001|Overall Study|Patient unable to start IV line|0|||
143427633|NCT01261793|517110565|FG002|Overall Study|Patient unable to start IV line|1|||
143427634|NCT00734851|517110566|FG000|Overall Study|Withdrawal by Subject|2|||
143427635|NCT00734851|517110566|FG000|Overall Study|Lost to Follow-up|1|||
143427636|NCT00734851|517110566|FG000|Overall Study|Physician Decision|18|||
143427637|NCT01770509|517110567|FG000|Overall Study|Injury|0|||
143427638|NCT01770509|517110568|FG001|Overall Study|Injury|1|||
143427639|NCT01770509|517110567|FG000|Overall Study|Lost to Follow-up|1|||
143427640|NCT01770509|517110568|FG001|Overall Study|Lost to Follow-up|2|||
143427641|NCT03849300|517110571|FG000|Overall Study|move out to different area|1|||
143427642|NCT03849300|517110572|FG001|Overall Study|move out to different area|3|||
143427643|NCT03849300|517110573|FG002|Overall Study|move out to different area|1|||
143427644|NCT03849300|517110574|FG003|Overall Study|move out to different area|4|||
143427645|NCT03849300|517110571|FG000|Overall Study|scheduling/transportation conflict|4|||
143427646|NCT03849300|517110572|FG001|Overall Study|scheduling/transportation conflict|4|||
143427647|NCT03849300|517110573|FG002|Overall Study|scheduling/transportation conflict|3|||
143427648|NCT03849300|517110574|FG003|Overall Study|scheduling/transportation conflict|2|||
143427649|NCT00381888|517112497|FG000|Overall Study|Death|1|||
143427650|NCT00381888|517112497|FG000|Overall Study|Withdrawal by Subject|1|||
143427651|NCT00381888|517112497|FG000|Overall Study|Physician Decision|1|||
143427652|NCT00381888|517112497|FG000|Overall Study|Protocol Violation|9|||
143427653|NCT00381888|517112497|FG000|Overall Study|Had laparoscopic surgery|2|||
143427654|NCT00381888|517112497|FG000|Overall Study|Surgery was cancelled|2|||
143427655|NCT00381888|517112497|FG000|Overall Study|Adverse Event|1|||
143427656|NCT01589523|517112500|FG000|Overall Study|Withdrawal by Subject|1|||
143427657|NCT00961896|517112501|FG000|Overall Study|Abnormal laboratory value|0|||
143427658|NCT00961896|517112502|FG001|Overall Study|Abnormal laboratory value|0|||
143427659|NCT00961896|517112503|FG002|Overall Study|Abnormal laboratory value|1|||
143427660|NCT00506922|517112504|FG000|Overall Study|Physician Decision|0|||
143427661|NCT00506922|517112505|FG001|Overall Study|Physician Decision|0|||
143427662|NCT00506922|517112506|FG002|Overall Study|Physician Decision|0|||
143427663|NCT00506922|517112507|FG003|Overall Study|Physician Decision|2|||
143427664|NCT00506922|517112508|FG004|Overall Study|Physician Decision|0|||
143427665|NCT00506922|517112504|FG000|Overall Study|Withdrawal by Subject|0|||
143427666|NCT00506922|517112505|FG001|Overall Study|Withdrawal by Subject|0|||
143427667|NCT00506922|517112506|FG002|Overall Study|Withdrawal by Subject|0|||
143427668|NCT00506922|517112507|FG003|Overall Study|Withdrawal by Subject|0|||
143427669|NCT00506922|517112508|FG004|Overall Study|Withdrawal by Subject|1|||
143427670|NCT00371462|517112509|FG000|Overall Study|Withdrawal by Subject|1|||
143427671|NCT00371462|517112510|FG001|Overall Study|Withdrawal by Subject|0|||
143427672|NCT00371462|517112509|FG000|Overall Study|Other|7|||
143427673|NCT00371462|517112510|FG001|Overall Study|Other|8|||
143427674|NCT05244226|517112511|FG000|Overall Study|Adverse Event|1|||
143427675|NCT05244226|517112512|FG001|Overall Study|Adverse Event|0|||
143427676|NCT05244226|517112513|FG002|Overall Study|Adverse Event|0|||
143427677|NCT05244226|517112511|FG000|Overall Study|Lost to Follow-up|0|||
143427678|NCT05244226|517112512|FG001|Overall Study|Lost to Follow-up|0|||
143427679|NCT05244226|517112513|FG002|Overall Study|Lost to Follow-up|1|||
143427680|NCT05244226|517112511|FG000|Overall Study|Protocol Violation|0|||
143427681|NCT05244226|517112512|FG001|Overall Study|Protocol Violation|2|||
143427682|NCT05244226|517112513|FG002|Overall Study|Protocol Violation|2|||
143427683|NCT02675998|517112519|FG000|8-Week Treatment Period|Adverse Event|6|||
143427684|NCT02675998|517112520|FG001|8-Week Treatment Period|Adverse Event|5|||
143427685|NCT02675998|517112521|FG002|8-Week Treatment Period|Adverse Event|6|||
143427686|NCT02675998|517112522|FG003|8-Week Treatment Period|Adverse Event|0|||
143427687|NCT02675998|517112519|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
143427688|NCT02675998|517112520|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
143427689|NCT02675998|517112521|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
143427690|NCT02675998|517112522|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
143427691|NCT02675998|517112519|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
143427692|NCT02675998|517112520|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
143427693|NCT02675998|517112521|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
143427694|NCT02675998|517112522|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
143427695|NCT02675998|517112519|FG000|8-Week Treatment Period|Physician Decision|1|||
143427696|NCT02675998|517112520|FG001|8-Week Treatment Period|Physician Decision|0|||
143427697|NCT02675998|517112521|FG002|8-Week Treatment Period|Physician Decision|2|||
143427698|NCT02675998|517112522|FG003|8-Week Treatment Period|Physician Decision|0|||
143427699|NCT02675998|517112519|FG000|8-Week Treatment Period|GI side Effects|1|||
143427700|NCT02675998|517112520|FG001|8-Week Treatment Period|GI side Effects|4|||
143427701|NCT02675998|517112521|FG002|8-Week Treatment Period|GI side Effects|2|||
143427702|NCT02675998|517112522|FG003|8-Week Treatment Period|GI side Effects|0|||
143427703|NCT02675998|517112519|FG000|8-Week Treatment Period|Protocol Violation|1|||
143427704|NCT02675998|517112520|FG001|8-Week Treatment Period|Protocol Violation|1|||
143427705|NCT02675998|517112521|FG002|8-Week Treatment Period|Protocol Violation|1|||
143427706|NCT02675998|517112522|FG003|8-Week Treatment Period|Protocol Violation|0|||
143427707|NCT02675998|517112519|FG000|8-Week Treatment Period|Other|3|||
143427708|NCT02675998|517112520|FG001|8-Week Treatment Period|Other|1|||
143427709|NCT02675998|517112521|FG002|8-Week Treatment Period|Other|2|||
143427710|NCT02675998|517112522|FG003|8-Week Treatment Period|Other|0|||
143427711|NCT02675998|517112519|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
143427712|NCT02675998|517112520|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
143427713|NCT02675998|517112521|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
143427714|NCT02675998|517112522|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
143427715|NCT02675998|517112519|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
143427716|NCT02675998|517112520|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
143427717|NCT02675998|517112521|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
143427718|NCT02675998|517112522|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
143427719|NCT02675998|517112519|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
143427720|NCT02675998|517112520|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
143427721|NCT02675998|517112521|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
143427722|NCT02675998|517112522|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
143427723|NCT02675998|517112519|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
143427724|NCT02675998|517112520|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
143427725|NCT02675998|517112521|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
143427726|NCT02675998|517112522|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
143427727|NCT02675998|517112519|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
143427728|NCT02675998|517112520|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
143427729|NCT02675998|517112521|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
143427730|NCT02675998|517112522|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
143427731|NCT00275301|517112523|FG000|Overall Study|Adverse Event|5|||
143427732|NCT00443898|517112528|FG000|Overall Study|Adverse Event|0|||
143427733|NCT00443898|517112529|FG001|Overall Study|Adverse Event|0|||
143427734|NCT00443898|517112530|FG002|Overall Study|Adverse Event|1|||
143427735|NCT00443898|517112531|FG003|Overall Study|Adverse Event|1|||
143427736|NCT00443898|517112528|FG000|Overall Study|Lack of Efficacy|2|||
143427737|NCT00443898|517112529|FG001|Overall Study|Lack of Efficacy|3|||
143427738|NCT00443898|517112530|FG002|Overall Study|Lack of Efficacy|3|||
143427739|NCT00443898|517112531|FG003|Overall Study|Lack of Efficacy|1|||
143427740|NCT00443898|517112528|FG000|Overall Study|Protocol Violation|1|||
143427741|NCT00443898|517112529|FG001|Overall Study|Protocol Violation|1|||
143427742|NCT00443898|517112530|FG002|Overall Study|Protocol Violation|1|||
143427743|NCT00443898|517112531|FG003|Overall Study|Protocol Violation|0|||
143427744|NCT00443898|517112528|FG000|Overall Study|Withdrawal by Subject|11|||
143427745|NCT00443898|517112529|FG001|Overall Study|Withdrawal by Subject|10|||
143427746|NCT00443898|517112530|FG002|Overall Study|Withdrawal by Subject|10|||
143427747|NCT00443898|517112531|FG003|Overall Study|Withdrawal by Subject|6|||
143427748|NCT00443898|517112528|FG000|Overall Study|Lost to Follow-up|10|||
143427749|NCT00443898|517112529|FG001|Overall Study|Lost to Follow-up|10|||
143427750|NCT00443898|517112530|FG002|Overall Study|Lost to Follow-up|14|||
143427751|NCT00443898|517112531|FG003|Overall Study|Lost to Follow-up|10|||
143427752|NCT00443898|517112528|FG000|Overall Study|Death|0|||
143427753|NCT00443898|517112529|FG001|Overall Study|Death|1|||
143427754|NCT00443898|517112530|FG002|Overall Study|Death|0|||
143427755|NCT00443898|517112531|FG003|Overall Study|Death|0|||
143427756|NCT03722485|517112532|FG000|Overall Study|Withdrawal by Subject|1|||
143427757|NCT03722485|517112533|FG001|Overall Study|Withdrawal by Subject|0|||
143427758|NCT03722485|517112532|FG000|Overall Study|Adverse Event|0|||
143427759|NCT03722485|517112533|FG001|Overall Study|Adverse Event|2|||
143427760|NCT03722485|517112532|FG000|Overall Study|subject discharged prior to study completion|1|||
143427761|NCT03722485|517112533|FG001|Overall Study|subject discharged prior to study completion|5|||
143427762|NCT03722485|517112532|FG000|Overall Study|eligibility criteria not met|2|||
143427763|NCT03722485|517112533|FG001|Overall Study|eligibility criteria not met|0|||
143427764|NCT00197106|517112534|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
143427765|NCT00197106|517112535|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
143427766|NCT00197106|517112536|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
143427767|NCT00197106|517112534|FG000|Overall Treatment Period|Lack of Efficacy|0|||
143427768|NCT00197106|517112535|FG001|Overall Treatment Period|Lack of Efficacy|1|||
143427769|NCT00197106|517112536|FG002|Overall Treatment Period|Lack of Efficacy|0|||
143427770|NCT00197106|517112534|FG000|Overall Treatment Period|Lost to Follow-up|0|||
143427771|NCT00197106|517112535|FG001|Overall Treatment Period|Lost to Follow-up|0|||
143427772|NCT00197106|517112536|FG002|Overall Treatment Period|Lost to Follow-up|2|||
143427773|NCT00197106|517112534|FG000|Overall Treatment Period|Protocol Violation|0|||
143427774|NCT00197106|517112535|FG001|Overall Treatment Period|Protocol Violation|0|||
143427775|NCT00197106|517112536|FG002|Overall Treatment Period|Protocol Violation|2|||
143427776|NCT00197106|517112534|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
143427777|NCT00197106|517112535|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
143427778|NCT00197106|517112536|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
143427779|NCT00382408|517112540|FG000|Overall Study|Did not meet protocol requirement|3|||
143427780|NCT00382408|517112541|FG001|Overall Study|Did not meet protocol requirement|3|||
143427781|NCT00382408|517112540|FG000|Overall Study|Protocol Violation|2|||
143427782|NCT00382408|517112541|FG001|Overall Study|Protocol Violation|2|||
143427783|NCT00382408|517112540|FG000|Overall Study|Physician Decision|1|||
143427784|NCT00382408|517112541|FG001|Overall Study|Physician Decision|0|||
143427785|NCT00382408|517112540|FG000|Overall Study|Withdrawal by Subject|17|||
143427786|NCT00382408|517112541|FG001|Overall Study|Withdrawal by Subject|6|||
143427787|NCT00382408|517112540|FG000|Overall Study|Pregnancy|2|||
143427788|NCT00382408|517112541|FG001|Overall Study|Pregnancy|0|||
143427789|NCT00382408|517112540|FG000|Overall Study|Lost to Follow-up|19|||
143427790|NCT00382408|517112541|FG001|Overall Study|Lost to Follow-up|8|||
143427791|NCT00382408|517112540|FG000|Overall Study|Other|100|||
143427792|NCT00382408|517112541|FG001|Overall Study|Other|35|||
143427793|NCT00520403|517112542|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
143427794|NCT00520403|517112542|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
143427795|NCT00520403|517112542|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
143427796|NCT00520403|517112542|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
143427797|NCT00520403|517112542|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
143427798|NCT00520403|517112542|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
143427799|NCT00520403|517112542|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
143427800|NCT00520403|517112542|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
143427801|NCT00917462|517112543|FG000|Overall Study|Clinical Deterioration|1|||
143427802|NCT03341312|517112544|FG000|Period 1|Withdrawal by Subject|0|||
143427803|NCT03341312|517112545|FG001|Period 1|Withdrawal by Subject|1|||
143427804|NCT03341312|517112546|FG002|Period 1|Withdrawal by Subject|0|||
143427805|NCT03341312|517112547|FG003|Period 1|Withdrawal by Subject|0|||
143427806|NCT01631825|517112548|FG000|Overall Study|Adverse Event|42|||
143427807|NCT01631825|517112548|FG000|Overall Study|Lack of Efficacy|7|||
143427808|NCT01631825|517112548|FG000|Overall Study|Withdrawal by Subject|9|||
143427809|NCT01631825|517112548|FG000|Overall Study|Protocol Violation|4|||
143427810|NCT01631825|517112548|FG000|Overall Study|Discontinuation criteria|1|||
143427811|NCT01631825|517112548|FG000|Overall Study|Physician Decision|2|||
143427812|NCT02110225|517112549|FG000|Overall Study|Lost to Follow-up|0|||
143427813|NCT02110225|517112550|FG001|Overall Study|Lost to Follow-up|1|||
143427814|NCT02110225|517112551|FG002|Overall Study|Lost to Follow-up|0|||
143427815|NCT02176018|517112552|FG000|Overall Study|Adverse Event|0|||
143427816|NCT02176018|517112553|FG001|Overall Study|Adverse Event|2|||
143427817|NCT02176018|517112552|FG000|Overall Study|Lost to Follow-up|3|||
143427818|NCT02176018|517112553|FG001|Overall Study|Lost to Follow-up|1|||
143427819|NCT02176018|517112552|FG000|Overall Study|Protocol Violation|1|||
143427820|NCT02176018|517112553|FG001|Overall Study|Protocol Violation|1|||
143427821|NCT02176018|517112552|FG000|Overall Study|Withdrawal by Subject|1|||
143427822|NCT02176018|517112553|FG001|Overall Study|Withdrawal by Subject|2|||
143427823|NCT00265096|517112554|FG000|Overall Study|Adverse Event|14|||
143427824|NCT00265096|517112555|FG001|Overall Study|Adverse Event|18|||
143427825|NCT00265096|517112556|FG002|Overall Study|Adverse Event|18|||
143427826|NCT00265096|517112554|FG000|Overall Study|Lost to Follow-up|2|||
143427827|NCT00265096|517112555|FG001|Overall Study|Lost to Follow-up|5|||
143427828|NCT00265096|517112556|FG002|Overall Study|Lost to Follow-up|3|||
143427829|NCT00265096|517112554|FG000|Overall Study|Death|0|||
143427830|NCT00265096|517112555|FG001|Overall Study|Death|1|||
143427831|NCT00265096|517112556|FG002|Overall Study|Death|2|||
143427832|NCT00265096|517112554|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
143427833|NCT00265096|517112555|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
143427834|NCT00265096|517112556|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
143427835|NCT00265096|517112554|FG000|Overall Study|Other|11|||
143427836|NCT00265096|517112555|FG001|Overall Study|Other|19|||
143427837|NCT00265096|517112556|FG002|Overall Study|Other|10|||
143427838|NCT00774306|517112557|FG000|Overall Study|Adverse Event|3|||
143427839|NCT00774306|517112558|FG001|Overall Study|Adverse Event|0|||
143427840|NCT00774306|517112559|FG002|Overall Study|Adverse Event|0|||
143427841|NCT00774306|517112560|FG003|Overall Study|Adverse Event|0|||
143427842|NCT00774306|517112557|FG000|Overall Study|Protocol Violation|2|||
143427843|NCT00774306|517112558|FG001|Overall Study|Protocol Violation|0|||
143427844|NCT00774306|517112559|FG002|Overall Study|Protocol Violation|3|||
143427845|NCT00774306|517112560|FG003|Overall Study|Protocol Violation|0|||
143427846|NCT00774306|517112557|FG000|Overall Study|Withdrawal by Subject|6|||
143427847|NCT00774306|517112558|FG001|Overall Study|Withdrawal by Subject|1|||
143427848|NCT00774306|517112559|FG002|Overall Study|Withdrawal by Subject|1|||
143427849|NCT00774306|517112560|FG003|Overall Study|Withdrawal by Subject|0|||
143427850|NCT00774306|517112557|FG000|Overall Study|Lost to Follow-up|6|||
143427851|NCT00774306|517112558|FG001|Overall Study|Lost to Follow-up|0|||
143427852|NCT00774306|517112559|FG002|Overall Study|Lost to Follow-up|4|||
143427853|NCT00774306|517112560|FG003|Overall Study|Lost to Follow-up|5|||
143427854|NCT00774306|517112557|FG000|Overall Study|Death|1|||
143427855|NCT00774306|517112558|FG001|Overall Study|Death|1|||
143427856|NCT00774306|517112559|FG002|Overall Study|Death|0|||
143427857|NCT00774306|517112560|FG003|Overall Study|Death|0|||
143427858|NCT00809783|517112566|FG000|Overall Study|Death|1|||
143427859|NCT00809783|517112567|FG001|Overall Study|Death|0|||
143427860|NCT00809783|517112568|FG002|Overall Study|Death|0|||
143427861|NCT00809783|517112566|FG000|Overall Study|Adverse Event|34|||
143427862|NCT00809783|517112567|FG001|Overall Study|Adverse Event|52|||
143427863|NCT00809783|517112568|FG002|Overall Study|Adverse Event|71|||
143427864|NCT00809783|517112566|FG000|Overall Study|Lack of Efficacy|39|||
143427865|NCT00809783|517112567|FG001|Overall Study|Lack of Efficacy|52|||
143427866|NCT00809783|517112568|FG002|Overall Study|Lack of Efficacy|63|||
143427867|NCT00809783|517112566|FG000|Overall Study|Lost to Follow-up|0|||
143427868|NCT00809783|517112567|FG001|Overall Study|Lost to Follow-up|3|||
143427869|NCT00809783|517112568|FG002|Overall Study|Lost to Follow-up|4|||
143427870|NCT00809783|517112566|FG000|Overall Study|Withdrawal by Subject|47|||
143427871|NCT00809783|517112567|FG001|Overall Study|Withdrawal by Subject|72|||
143427872|NCT00809783|517112568|FG002|Overall Study|Withdrawal by Subject|64|||
143427873|NCT00809783|517112566|FG000|Overall Study|Protocol Violation|2|||
143427874|NCT00809783|517112567|FG001|Overall Study|Protocol Violation|6|||
143427875|NCT00809783|517112568|FG002|Overall Study|Protocol Violation|5|||
143427876|NCT00809783|517112566|FG000|Overall Study|Randomized, but not treated|3|||
143427877|NCT00809783|517112567|FG001|Overall Study|Randomized, but not treated|0|||
143427878|NCT00809783|517112568|FG002|Overall Study|Randomized, but not treated|2|||
143427879|NCT00809783|517112566|FG000|Overall Study|Study Terminated by Sponsor|378|||
143427880|NCT00809783|517112567|FG001|Overall Study|Study Terminated by Sponsor|626|||
143427881|NCT00809783|517112568|FG002|Overall Study|Study Terminated by Sponsor|565|||
143427882|NCT00809783|517112566|FG000|Overall Study|Other|21|||
143427883|NCT00809783|517112567|FG001|Overall Study|Other|21|||
143427884|NCT00809783|517112568|FG002|Overall Study|Other|16|||
143427885|NCT00126555|517112569|FG000|Overall Study|Withdrawal by Subject|1|||
143427886|NCT00126555|517112569|FG000|Overall Study|Adverse Event|2|||
143427887|NCT00126555|517112569|FG000|Overall Study|Progressive Disease|3|||
143427888|NCT01780545|517112573|FG000|Overall Study|Withdrawal by Subject|3|||
143427889|NCT01780545|517112574|FG001|Overall Study|Withdrawal by Subject|1|||
143427890|NCT01780545|517112573|FG000|Overall Study|Lost to Follow-up|1|||
143427891|NCT01780545|517112574|FG001|Overall Study|Lost to Follow-up|1|||
143427892|NCT05135156|517112581|FG000|Overall Study|Lost to Follow-up|0|||
143427893|NCT05135156|517112582|FG001|Overall Study|Lost to Follow-up|0|||
143427894|NCT05135156|517112583|FG002|Overall Study|Lost to Follow-up|2|||
143427895|NCT00396097|517112584|FG000|Overall Study|Withdrawal by Subject|17|||
143427896|NCT00396097|517112585|FG001|Overall Study|Withdrawal by Subject|17|||
143427897|NCT00396097|517112584|FG000|Overall Study|Lost to Follow-up|4|||
143427898|NCT00396097|517112585|FG001|Overall Study|Lost to Follow-up|9|||
143427899|NCT00396097|517112584|FG000|Overall Study|Other|3|||
143427900|NCT00396097|517112585|FG001|Overall Study|Other|5|||
143427901|NCT00396097|517112584|FG000|Overall Study|Protocol Violation|0|||
143427902|NCT00396097|517112585|FG001|Overall Study|Protocol Violation|6|||
143427903|NCT00396097|517112584|FG000|Overall Study|Adverse Event|1|||
143427904|NCT00396097|517112585|FG001|Overall Study|Adverse Event|5|||
143427905|NCT00396097|517112584|FG000|Overall Study|Insufficient Clinical Response|1|||
143427906|NCT00396097|517112585|FG001|Overall Study|Insufficient Clinical Response|4|||
143427907|NCT03461211|517112586|FG000|Overall Study|Adverse Event|1|||
143427908|NCT03461211|517112587|FG001|Overall Study|Adverse Event|1|||
143427909|NCT03461211|517112586|FG000|Overall Study|Lack of Efficacy|0|||
143427910|NCT03461211|517112587|FG001|Overall Study|Lack of Efficacy|1|||
143427911|NCT03807700|517112588|FG000|Overall Study|Withdrawal by Subject|2|||
143427912|NCT03807700|517112589|FG001|Overall Study|Withdrawal by Subject|1|||
143427913|NCT02720081|517112590|FG000|Overall Study|Adverse Event|0|||
143427914|NCT02720081|517112591|FG001|Overall Study|Adverse Event|3|||
143427915|NCT02720081|517112590|FG000|Overall Study|Protocol Violation|4|||
143427916|NCT02720081|517112591|FG001|Overall Study|Protocol Violation|1|||
143427917|NCT03371485|517112595|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
143427918|NCT03371485|517112595|FG000|2-year Follow-up|Death|5|||
143427919|NCT04772313|517112596|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
143427920|NCT04772313|517112596|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
143427921|NCT01836198|517112597|FG000|Part A, Period 2|Protocol Violation|0|||
143427922|NCT01836198|517112598|FG001|Part A, Period 2|Protocol Violation|1|||
143427923|NCT01836198|517112599|FG002|Part A, Period 2|Protocol Violation|0|||
143427924|NCT03187353|517112600|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
143427925|NCT03187353|517112601|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
143427926|NCT03187353|517112600|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
143427927|NCT03187353|517112601|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
143427928|NCT03187353|517112600|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
143427929|NCT03187353|517112601|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
143427930|NCT03187353|517112600|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
143427931|NCT03187353|517112601|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
143427932|NCT03187353|517112600|FG000|Washout (2 Weeks)|Adverse Event|2|||
143427933|NCT03187353|517112601|FG001|Washout (2 Weeks)|Adverse Event|0|||
143427934|NCT03187353|517112600|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
143427935|NCT03187353|517112601|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
143427936|NCT01061775|517112604|FG000|Overall Study|Physician Decision|2|||
143427937|NCT01061775|517112604|FG000|Overall Study|Lost to Follow-up|1|||
143427938|NCT02567227|517112605|FG000|9 Weeks|Adverse Event|5|||
143427939|NCT02567227|517112606|FG001|9 Weeks|Adverse Event|5|||
143427940|NCT02567227|517112605|FG000|9 Weeks|Withdrawal by Subject|18|||
143427941|NCT02567227|517112606|FG001|9 Weeks|Withdrawal by Subject|8|||
143427942|NCT02567227|517112605|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
143427943|NCT02567227|517112606|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
143427944|NCT02567227|517112605|FG000|6 Month|Death|2|||
143427945|NCT02567227|517112606|FG001|6 Month|Death|0|||
143427946|NCT02567227|517112605|FG000|6 Month|Lost to Follow-up|43|||
143427947|NCT02567227|517112606|FG001|6 Month|Lost to Follow-up|40|||
143427948|NCT02567227|517112605|FG000|12 Months|Lost to Follow-up|31|||
143427949|NCT02567227|517112606|FG001|12 Months|Lost to Follow-up|32|||
143427950|NCT02567227|517112605|FG000|12 Months|Death|0|||
143427951|NCT02567227|517112606|FG001|12 Months|Death|2|||
143427952|NCT01026103|517112608|FG000|Overall Study|Physician Decision|1|||
143427953|NCT01026103|517112608|FG000|Overall Study|did not receive study device bc of error|1|||
143427954|NCT02498418|517112609|FG000|Overall Study|Lack of Efficacy|0|||
143427955|NCT02498418|517112610|FG001|Overall Study|Lack of Efficacy|0|||
143427956|NCT02498418|517112611|FG002|Overall Study|Lack of Efficacy|1|||
143427957|NCT02498418|517112609|FG000|Overall Study|Withdrawal by Subject|2|||
143427958|NCT02498418|517112610|FG001|Overall Study|Withdrawal by Subject|0|||
143427959|NCT02498418|517112611|FG002|Overall Study|Withdrawal by Subject|3|||
143427960|NCT02498418|517112609|FG000|Overall Study|Lost to Follow-up|0|||
143427961|NCT02498418|517112610|FG001|Overall Study|Lost to Follow-up|1|||
143427962|NCT02498418|517112611|FG002|Overall Study|Lost to Follow-up|1|||
143427963|NCT02498418|517112609|FG000|Overall Study|Participant taken prohibited medication|0|||
143427964|NCT02498418|517112610|FG001|Overall Study|Participant taken prohibited medication|1|||
143427965|NCT02498418|517112611|FG002|Overall Study|Participant taken prohibited medication|1|||
143427966|NCT00762502|517112612|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
143427967|NCT00762502|517112613|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
143427968|NCT00762502|517112614|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
143427969|NCT00762502|517112612|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
143427970|NCT00762502|517112613|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
143427971|NCT00762502|517112614|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
143427972|NCT00762502|517112612|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
143427973|NCT00762502|517112613|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
143427974|NCT00762502|517112614|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
143427975|NCT02625922|517112616|FG000|Overall Study|Non-availability of IMP|1|||
143427976|NCT02625922|517112617|FG001|Overall Study|Non-availability of IMP|1|||
143427977|NCT02625922|517112616|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
143427978|NCT02625922|517112617|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
143427979|NCT02359552|517112618|FG000|Overall Study|Lost to Follow-up|3|||
143427980|NCT02359552|517112619|FG001|Overall Study|Lost to Follow-up|4|||
143427981|NCT02391116|517112620|FG000|Treatment|Withdrawal by Subject|1|||
143427982|NCT02391116|517112620|FG000|Treatment|Protocol Violation|1|||
143427983|NCT02391116|517112620|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
143427984|NCT02391116|517112620|FG000|Treatment|AE with Clinical PD|3|||
143427985|NCT02391116|517112620|FG000|Safety Follow-up|Adverse Event|1|||
143427986|NCT02391116|517112620|FG000|Safety Follow-up|Withdrawal by Subject|4|||
143427987|NCT02391116|517112620|FG000|Safety Follow-up|Switching to Other Therapy|4|||
143427988|NCT02391116|517112620|FG000|Safety Follow-up|No Follow Up|1|||
143427989|NCT02391116|517112620|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
143427990|NCT02391116|517112620|FG000|Active Follow-up|Withdrawal by Subject|1|||
143427991|NCT02391116|517112620|FG000|Active Follow-up|Switching to Other Therapy|2|||
143427992|NCT02391116|517112620|FG000|Survival Follow-up|Withdrawal by Subject|3|||
143427993|NCT02391116|517112620|FG000|Survival Follow-up|Switching to Other Therapy|1|||
143427994|NCT02282917|517112621|FG000|Overall Study|Withdrawal by Subject|1|||
143427995|NCT02282917|517112621|FG000|Overall Study|Screen Failure/Not Eligible|1|||
143427996|NCT02391545|517112622|FG000|Overall Study|Death|0|||
143427997|NCT02391545|517112623|FG001|Overall Study|Death|2|||
143427998|NCT02391545|517112622|FG000|Overall Study|Lost to Follow-up|0|||
143427999|NCT02391545|517112623|FG001|Overall Study|Lost to Follow-up|1|||
143428000|NCT02391545|517112622|FG000|Overall Study|Termination of study by sponsor|20|||
143428001|NCT02391545|517112623|FG001|Overall Study|Termination of study by sponsor|20|||
143428002|NCT02391545|517112622|FG000|Overall Study|Withdrawal by Subject|0|||
143428003|NCT02391545|517112623|FG001|Overall Study|Withdrawal by Subject|1|||
143428004|NCT02391545|517112622|FG000|Overall Study|Other Reasons|6|||
143428005|NCT02391545|517112623|FG001|Overall Study|Other Reasons|4|||
143428006|NCT00794573|517112624|FG000|Overall Study|Death|3|||
143428007|NCT00794573|517112625|FG001|Overall Study|Death|0|||
143428008|NCT00794573|517112624|FG000|Overall Study|Withdrawal by Subject|9|||
143428009|NCT00794573|517112625|FG001|Overall Study|Withdrawal by Subject|12|||
143428010|NCT00794573|517112624|FG000|Overall Study|Lost to Follow-up|26|||
143428011|NCT00794573|517112625|FG001|Overall Study|Lost to Follow-up|33|||
143428012|NCT01294358|517112626|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
143428013|NCT01294358|517112627|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
143428014|NCT01294358|517112628|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
143428015|NCT01294358|517112629|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
143428016|NCT01294358|517112630|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
143428017|NCT01294358|517112626|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
143428018|NCT01294358|517112627|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
143428019|NCT01294358|517112628|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
143428020|NCT01294358|517112629|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
143428021|NCT01294358|517112630|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
143428022|NCT01294358|517112626|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
143428023|NCT01294358|517112627|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
143428024|NCT01294358|517112628|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
143428025|NCT01294358|517112629|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
143428026|NCT01294358|517112630|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
143428027|NCT01294358|517112626|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
143428028|NCT01294358|517112627|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
143428029|NCT01294358|517112628|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
143428030|NCT01294358|517112629|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
143428031|NCT01294358|517112630|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
143428032|NCT03840148|517112632|FG000|Study Drug Disposition|Adverse Event|13|||
143428033|NCT03840148|517112633|FG001|Study Drug Disposition|Adverse Event|2|||
143428034|NCT03840148|517112632|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
143428035|NCT03840148|517112633|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
143428036|NCT03840148|517112632|FG000|Study Drug Disposition|Lack of Efficacy|3|||
143428037|NCT03840148|517112633|FG001|Study Drug Disposition|Lack of Efficacy|0|||
143428038|NCT03840148|517112632|FG000|Study Drug Disposition|Physician Decision|2|||
143428039|NCT03840148|517112633|FG001|Study Drug Disposition|Physician Decision|0|||
143428040|NCT03840148|517112632|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
143428041|NCT03840148|517112633|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
143428042|NCT03840148|517112632|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
143428043|NCT03840148|517112633|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
143428044|NCT03840148|517112632|FG000|Study Completion Disposition|Physician Decision|2|||
143428045|NCT03840148|517112633|FG001|Study Completion Disposition|Physician Decision|0|||
143428046|NCT03840148|517112632|FG000|Study Completion Disposition|Covid-19 related|2|||
143428047|NCT03840148|517112633|FG001|Study Completion Disposition|Covid-19 related|0|||
143428048|NCT03840148|517112632|FG000|Study Completion Disposition|Lost to Follow-up|1|||
143428049|NCT03840148|517112633|FG001|Study Completion Disposition|Lost to Follow-up|1|||
143428050|NCT03840148|517112632|FG000|Study Completion Disposition|Death|1|||
143428051|NCT03840148|517112633|FG001|Study Completion Disposition|Death|0|||
143428052|NCT03840148|517112632|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
143428053|NCT03840148|517112633|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
143428054|NCT03615404|517112634|FG000|Overall Study|Death|1|||
143428055|NCT03615404|517112634|FG000|Overall Study|vaccine did not pass quality assurance|1|||
143428056|NCT00257556|517112635|FG000|Overall Study|Adverse Event|1|||
143428057|NCT00257556|517112636|FG001|Overall Study|Adverse Event|4|||
143428058|NCT00257556|517112635|FG000|Overall Study|Physician Decision|6|||
143428059|NCT00257556|517112636|FG001|Overall Study|Physician Decision|0|||
143428060|NCT00257556|517112635|FG000|Overall Study|Did not meet hCG criterion|3|||
143428061|NCT00257556|517112636|FG001|Overall Study|Did not meet hCG criterion|0|||
143428062|NCT00257556|517112635|FG000|Overall Study|other reason|4|||
143428063|NCT00257556|517112636|FG001|Overall Study|other reason|6|||
143428064|NCT03873038|517112638|FG000|Part 2|Withdrawal by Subject|0|||
143428065|NCT03873038|517112639|FG001|Part 2|Withdrawal by Subject|0|||
143428066|NCT03873038|517112640|FG002|Part 2|Withdrawal by Subject|0|||
143428067|NCT03873038|517112641|FG003|Part 2|Withdrawal by Subject|0|||
143428068|NCT03873038|517112642|FG004|Part 2|Withdrawal by Subject|0|||
143428069|NCT03873038|517112643|FG005|Part 2|Withdrawal by Subject|1|||
143428070|NCT03873038|517112638|FG000|Part 2|Unknon|0|||
143428071|NCT03873038|517112639|FG001|Part 2|Unknon|0|||
143428072|NCT03873038|517112640|FG002|Part 2|Unknon|0|||
143428073|NCT03873038|517112641|FG003|Part 2|Unknon|0|||
143428074|NCT03873038|517112642|FG004|Part 2|Unknon|1|||
143428075|NCT03873038|517112643|FG005|Part 2|Unknon|0|||
143428076|NCT00905255|517112644|FG000|Overall Study|Adverse Event|7|||
143428077|NCT00905255|517112645|FG001|Overall Study|Adverse Event|5|||
143428078|NCT00905255|517112644|FG000|Overall Study|Withdrawal by Subject|5|||
143428079|NCT00905255|517112645|FG001|Overall Study|Withdrawal by Subject|4|||
143428080|NCT00905255|517112644|FG000|Overall Study|Familial and Personal Reasons|1|||
143428081|NCT00905255|517112645|FG001|Overall Study|Familial and Personal Reasons|0|||
143428082|NCT01774929|517112646|FG000|Overall Study|Adverse Event|3|||
143428083|NCT04839289|517112647|FG000|Overall Study|Withdrawal by Subject|1|||
143428084|NCT04839289|517112648|FG001|Overall Study|Withdrawal by Subject|0|||
143428085|NCT00141271|517112650|FG000|Overall Study|Adverse Event|31|||
143428086|NCT00141271|517112651|FG001|Overall Study|Adverse Event|19|||
143428087|NCT00141271|517112652|FG002|Overall Study|Adverse Event|17|||
143428088|NCT00141271|517112650|FG000|Overall Study|Laboratory Abnormality|2|||
143428089|NCT00141271|517112651|FG001|Overall Study|Laboratory Abnormality|1|||
143428090|NCT00141271|517112652|FG002|Overall Study|Laboratory Abnormality|1|||
143428091|NCT00141271|517112650|FG000|Overall Study|Lack of Efficacy|7|||
143428092|NCT00141271|517112651|FG001|Overall Study|Lack of Efficacy|7|||
143428093|NCT00141271|517112652|FG002|Overall Study|Lack of Efficacy|3|||
143428094|NCT00141271|517112650|FG000|Overall Study|Lost to Follow-up|15|||
143428095|NCT00141271|517112651|FG001|Overall Study|Lost to Follow-up|15|||
143428096|NCT00141271|517112652|FG002|Overall Study|Lost to Follow-up|21|||
143428097|NCT00141271|517112650|FG000|Overall Study|Withdrawal by Subject|14|||
143428098|NCT00141271|517112651|FG001|Overall Study|Withdrawal by Subject|9|||
143428099|NCT00141271|517112652|FG002|Overall Study|Withdrawal by Subject|10|||
143428100|NCT00141271|517112650|FG000|Overall Study|Other|11|||
143428101|NCT00141271|517112651|FG001|Overall Study|Other|12|||
143428102|NCT00141271|517112652|FG002|Overall Study|Other|5|||
143428103|NCT00390806|517112653|FG000|Overall Study|Lost to Follow-up|7|||
143428104|NCT00390806|517112654|FG001|Overall Study|Lost to Follow-up|6|||
143428105|NCT00390806|517112653|FG000|Overall Study|Protocol Violation|2|||
143428106|NCT00390806|517112654|FG001|Overall Study|Protocol Violation|2|||
143428107|NCT00390806|517112653|FG000|Overall Study|Withdrawal by Subject|12|||
143428108|NCT00390806|517112654|FG001|Overall Study|Withdrawal by Subject|15|||
143428109|NCT00390806|517112653|FG000|Overall Study|Investigator Decision|4|||
143428110|NCT00390806|517112654|FG001|Overall Study|Investigator Decision|6|||
143428111|NCT00390806|517112653|FG000|Overall Study|Death|1|||
143428112|NCT00390806|517112654|FG001|Overall Study|Death|0|||
143428113|NCT00390806|517112653|FG000|Overall Study|Physician Decision|0|||
143428114|NCT00390806|517112654|FG001|Overall Study|Physician Decision|1|||
143428115|NCT00390806|517112653|FG000|Overall Study|Ongoing|4|||
143428116|NCT00390806|517112654|FG001|Overall Study|Ongoing|2|||
143428117|NCT00500539|517112655|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
143428118|NCT00500539|517112655|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
143428119|NCT00500539|517112655|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
143428120|NCT00500539|517112655|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
143428121|NCT00500539|517112655|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
143428122|NCT00500539|517112655|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
143428123|NCT00500539|517112655|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
143428124|NCT00500539|517112655|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
143428125|NCT00500539|517112655|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
143428126|NCT00500539|517112655|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
143428127|NCT00500539|517112655|FG000|Follow-up Period (16 Weeks)|Death|1|||
143428128|NCT00500539|517112655|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
143428129|NCT00500539|517112655|FG000|Follow-up Period (16 Weeks)|Missing|3|||
143428130|NCT00663923|517112656|FG000|Overall Study|Lost to Follow-up|2|||
143428131|NCT01524887|517112657|FG000|Overall Study|Withdrawal by Subject|6|||
143428132|NCT01524887|517112658|FG001|Overall Study|Withdrawal by Subject|2|||
143428133|NCT01524887|517112659|FG002|Overall Study|Withdrawal by Subject|3|||
143428134|NCT01524887|517112657|FG000|Overall Study|Adverse Event|5|||
143428135|NCT01524887|517112658|FG001|Overall Study|Adverse Event|1|||
143428136|NCT01524887|517112659|FG002|Overall Study|Adverse Event|1|||
143428137|NCT01524887|517112657|FG000|Overall Study|Protocol Violation|0|||
143428138|NCT01524887|517112658|FG001|Overall Study|Protocol Violation|0|||
143428139|NCT01524887|517112659|FG002|Overall Study|Protocol Violation|1|||
143428140|NCT01524887|517112657|FG000|Overall Study|Study termination|73|||
143428141|NCT01524887|517112658|FG001|Overall Study|Study termination|87|||
143428142|NCT01524887|517112659|FG002|Overall Study|Study termination|79|||
143428143|NCT01524887|517112657|FG000|Overall Study|Withdrawal by Caregiver|0|||
143428144|NCT01524887|517112658|FG001|Overall Study|Withdrawal by Caregiver|0|||
143428145|NCT01524887|517112659|FG002|Overall Study|Withdrawal by Caregiver|2|||
143428146|NCT01524887|517112657|FG000|Overall Study|Use of prohibited medication|1|||
143428147|NCT01524887|517112658|FG001|Overall Study|Use of prohibited medication|0|||
143428148|NCT01524887|517112659|FG002|Overall Study|Use of prohibited medication|0|||
143428149|NCT01808144|517112660|FG000|Overall Study|Death|1|||
143428150|NCT01808144|517112661|FG001|Overall Study|Death|0|||
143428151|NCT01808144|517112660|FG000|Overall Study|Withdrawal by Subject|16|||
143428152|NCT01808144|517112661|FG001|Overall Study|Withdrawal by Subject|23|||
143428153|NCT01808144|517112660|FG000|Overall Study|Lost to Follow-up|6|||
143428154|NCT01808144|517112661|FG001|Overall Study|Lost to Follow-up|3|||
143428155|NCT01808144|517112660|FG000|Overall Study|Protocol Violation|6|||
143428156|NCT01808144|517112661|FG001|Overall Study|Protocol Violation|6|||
143428157|NCT01808144|517112660|FG000|Overall Study|Gout flare|0|||
143428158|NCT01808144|517112661|FG001|Overall Study|Gout flare|1|||
143428159|NCT01808144|517112660|FG000|Overall Study|Adverse Event|11|||
143428160|NCT01808144|517112661|FG001|Overall Study|Adverse Event|15|||
143428161|NCT03993054|517112662|FG000|Overall Study|PI Decision|1|||
143428162|NCT04341584|517112663|FG000|Overall Study|Withdrew consent|0|||
143428163|NCT04341584|517112664|FG001|Overall Study|Withdrew consent|2|||
143428164|NCT04341584|517112665|FG002|Overall Study|Withdrew consent|2|||
143428165|NCT04341584|517112666|FG003|Overall Study|Withdrew consent|1|||
143428166|NCT00497198|517112668|FG000|Overall Study|Adverse Event|4|||
143428167|NCT00497198|517112669|FG001|Overall Study|Adverse Event|2|||
143428168|NCT00497198|517112668|FG000|Overall Study|Physician Decision|1|||
143428169|NCT00497198|517112669|FG001|Overall Study|Physician Decision|2|||
143428170|NCT00497198|517112668|FG000|Overall Study|Withdrawal by Subject|0|||
143428171|NCT00497198|517112669|FG001|Overall Study|Withdrawal by Subject|1|||
143428172|NCT04853238|517112670|FG000|Overall Study|Death|4|||
143428173|NCT04853238|517112671|FG001|Overall Study|Death|0|||
143428174|NCT04853238|517112672|FG002|Overall Study|Death|2|||
143428175|NCT04853238|517112670|FG000|Overall Study|Lost to Follow-up|16|||
143428176|NCT04853238|517112671|FG001|Overall Study|Lost to Follow-up|2|||
143428177|NCT04853238|517112672|FG002|Overall Study|Lost to Follow-up|37|||
143428178|NCT04853238|517112670|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
143428179|NCT04853238|517112671|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
143428180|NCT04853238|517112672|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
143428181|NCT04853238|517112670|FG000|Overall Study|Withdrawal by Subject|6|||
143428182|NCT04853238|517112671|FG001|Overall Study|Withdrawal by Subject|0|||
143428183|NCT04853238|517112672|FG002|Overall Study|Withdrawal by Subject|21|||
143428184|NCT04853238|517112670|FG000|Overall Study|Physician Decision|0|||
143428185|NCT04853238|517112671|FG001|Overall Study|Physician Decision|0|||
143428186|NCT04853238|517112672|FG002|Overall Study|Physician Decision|2|||
143428187|NCT04853238|517112670|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
143428188|NCT04853238|517112671|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
143428189|NCT04853238|517112672|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
143428190|NCT00349622|517114633|FG000|Overall Study|Death|168|||
143428191|NCT00349622|517114634|FG001|Overall Study|Death|86|||
143428192|NCT00349622|517114633|FG000|Overall Study|Lost to Follow-up|5|||
143428193|NCT00349622|517114634|FG001|Overall Study|Lost to Follow-up|1|||
143428194|NCT00349622|517114633|FG000|Overall Study|Withdrawal by Subject|5|||
143428195|NCT00349622|517114634|FG001|Overall Study|Withdrawal by Subject|9|||
143428196|NCT00508274|517114635|FG000|Overall Study|Adverse Event|5|||
143428197|NCT00508274|517114635|FG000|Overall Study|Death|7|||
143428198|NCT00508274|517114635|FG000|Overall Study|Disease progression|32|||
143428199|NCT00508274|517114635|FG000|Overall Study|Withdrawal by Subject|1|||
143428200|NCT00508274|517114635|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
143428201|NCT00508274|517114635|FG000|Overall Study|Missing|3|||
143428202|NCT03296566|517114636|FG000|Overall Study|Lost to Follow-up|19|||
143428203|NCT03296566|517114637|FG001|Overall Study|Lost to Follow-up|46|||
143428204|NCT03296566|517114636|FG000|Overall Study|Withdrawal by Subject|0|||
143428205|NCT03296566|517114637|FG001|Overall Study|Withdrawal by Subject|3|||
143428206|NCT02229396|517114644|FG000|Overall Study|Adverse Event|6|||
143428207|NCT02229396|517114645|FG001|Overall Study|Adverse Event|12|||
143428208|NCT02229396|517114646|FG002|Overall Study|Adverse Event|12|||
143428209|NCT02229396|517114644|FG000|Overall Study|Death|2|||
143428210|NCT02229396|517114645|FG001|Overall Study|Death|3|||
143428211|NCT02229396|517114646|FG002|Overall Study|Death|1|||
143428212|NCT02229396|517114644|FG000|Overall Study|Lost to Follow-up|14|||
143428213|NCT02229396|517114645|FG001|Overall Study|Lost to Follow-up|14|||
143428214|NCT02229396|517114646|FG002|Overall Study|Lost to Follow-up|21|||
143428215|NCT02229396|517114644|FG000|Overall Study|Protocol Violation|2|||
143428216|NCT02229396|517114645|FG001|Overall Study|Protocol Violation|1|||
143428217|NCT02229396|517114646|FG002|Overall Study|Protocol Violation|0|||
143428218|NCT02229396|517114644|FG000|Overall Study|Patient Incorrectly Randomized|0|||
143428219|NCT02229396|517114645|FG001|Overall Study|Patient Incorrectly Randomized|0|||
143428220|NCT02229396|517114646|FG002|Overall Study|Patient Incorrectly Randomized|1|||
143428221|NCT02229396|517114644|FG000|Overall Study|Other|10|||
143428222|NCT02229396|517114645|FG001|Overall Study|Other|18|||
143428223|NCT02229396|517114646|FG002|Overall Study|Other|15|||
143428224|NCT02229396|517114644|FG000|Overall Study|Withdrawal by Subject|42|||
143428225|NCT02229396|517114645|FG001|Overall Study|Withdrawal by Subject|28|||
143428226|NCT02229396|517114646|FG002|Overall Study|Withdrawal by Subject|41|||
143428227|NCT02229396|517114644|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
143428228|NCT02229396|517114645|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
143428229|NCT02229396|517114646|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
143428230|NCT02229396|517114644|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
143428231|NCT02229396|517114645|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
143428232|NCT02229396|517114646|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
143428233|NCT01243411|517114647|FG000|Overall Study|Withdrawal by Subject|18|||
143428234|NCT01243411|517114647|FG000|Overall Study|Lost to Follow-up|10|||
143428235|NCT01243411|517114647|FG000|Overall Study|Adverse Event|5|||
143428236|NCT01243411|517114647|FG000|Overall Study|Other|8|||
143428237|NCT02679079|517114652|FG000|Overall Study|Adverse Event|2|||
143428238|NCT02679079|517114653|FG001|Overall Study|Adverse Event|0|||
143428239|NCT02679079|517114654|FG002|Overall Study|Adverse Event|2|||
143428240|NCT02679079|517114652|FG000|Overall Study|Protocol Violation|0|||
143428241|NCT02679079|517114653|FG001|Overall Study|Protocol Violation|1|||
143428242|NCT02679079|517114654|FG002|Overall Study|Protocol Violation|0|||
143428243|NCT02679079|517114652|FG000|Overall Study|Withdrawal by Subject|2|||
143428244|NCT02679079|517114653|FG001|Overall Study|Withdrawal by Subject|1|||
143428245|NCT02679079|517114654|FG002|Overall Study|Withdrawal by Subject|0|||
143428246|NCT00805285|517114655|FG000|Overall Study|Lack of Efficacy|1|||
143428247|NCT00839306|517114656|FG000|Overall Study|Adverse Event|3|||
143428248|NCT00839306|517114657|FG001|Overall Study|Adverse Event|5|||
143428249|NCT00839306|517114656|FG000|Overall Study|Lost to Follow-up|6|||
143428250|NCT00839306|517114657|FG001|Overall Study|Lost to Follow-up|9|||
143428251|NCT00839306|517114656|FG000|Overall Study|Withdrawal by Subject|5|||
143428252|NCT00839306|517114657|FG001|Overall Study|Withdrawal by Subject|7|||
143428253|NCT00839306|517114656|FG000|Overall Study|Lack of Efficacy|5|||
143428254|NCT00839306|517114657|FG001|Overall Study|Lack of Efficacy|4|||
143428255|NCT00839306|517114656|FG000|Overall Study|Other|6|||
143428256|NCT00839306|517114657|FG001|Overall Study|Other|18|||
143428257|NCT01812707|517114658|FG000|Overall Study|Adverse Event|0|||
143428258|NCT01812707|517114659|FG001|Overall Study|Adverse Event|0|||
143428259|NCT01812707|517114660|FG002|Overall Study|Adverse Event|0|||
143428260|NCT01812707|517114661|FG003|Overall Study|Adverse Event|2|||
143428261|NCT01812707|517114658|FG000|Overall Study|Poor compliance to protocol|1|||
143428262|NCT01812707|517114659|FG001|Overall Study|Poor compliance to protocol|0|||
143428263|NCT01812707|517114660|FG002|Overall Study|Poor compliance to protocol|0|||
143428264|NCT01812707|517114661|FG003|Overall Study|Poor compliance to protocol|0|||
143428265|NCT01812707|517114658|FG000|Overall Study|Consent withdrawn by participant|1|||
143428266|NCT01812707|517114659|FG001|Overall Study|Consent withdrawn by participant|0|||
143428267|NCT01812707|517114660|FG002|Overall Study|Consent withdrawn by participant|0|||
143428268|NCT01812707|517114661|FG003|Overall Study|Consent withdrawn by participant|0|||
143428269|NCT05060237|517114663|FG000|Overall Study|Withdrawal by Subject|4|||
143428270|NCT05060237|517114663|FG000|Overall Study|Screening failure|8|||
143428271|NCT01066897|517114664|FG000|Overall Study|Withdrawal by Subject|1|||
143428272|NCT01066897|517114665|FG001|Overall Study|Withdrawal by Subject|0|||
143428273|NCT01066897|517114664|FG000|Overall Study|stopped study after developing the flu.|1|||
143428274|NCT01066897|517114665|FG001|Overall Study|stopped study after developing the flu.|0|||
143428275|NCT01697592|517114668|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
143428276|NCT01697592|517114669|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
143428277|NCT01697592|517114670|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
143428278|NCT01697592|517114671|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
143428279|NCT01697592|517114672|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
143428280|NCT01697592|517114673|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
143428281|NCT01697592|517114674|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
143428282|NCT01697592|517114675|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
143428283|NCT01697592|517114676|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
143428284|NCT01697592|517114677|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
143428285|NCT01697592|517114668|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
143428286|NCT01697592|517114669|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
143428287|NCT01697592|517114670|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
143428288|NCT01697592|517114671|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
143428289|NCT01697592|517114672|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
143428290|NCT01697592|517114673|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
143428291|NCT01697592|517114674|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
143428292|NCT01697592|517114675|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
143428293|NCT01697592|517114676|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
143428294|NCT01697592|517114677|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
143428295|NCT01697592|517114668|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
143428296|NCT01697592|517114669|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
143428297|NCT01697592|517114670|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
143428298|NCT01697592|517114671|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
143428299|NCT01697592|517114672|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
143428300|NCT01697592|517114673|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
143428301|NCT01697592|517114674|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
143428302|NCT01697592|517114675|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
143428303|NCT01697592|517114676|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
143428304|NCT01697592|517114677|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
143428305|NCT01697592|517114668|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
143428306|NCT01697592|517114669|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
143428307|NCT01697592|517114670|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
143428308|NCT01697592|517114671|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
143428309|NCT01697592|517114672|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
143428310|NCT01697592|517114673|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
143428311|NCT01697592|517114674|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
143428312|NCT01697592|517114675|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
143428313|NCT01697592|517114676|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
143428314|NCT01697592|517114677|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
143428315|NCT01697592|517114668|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
143428316|NCT01697592|517114669|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
143428317|NCT01697592|517114670|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
143428318|NCT01697592|517114671|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
143428319|NCT01697592|517114672|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
143428320|NCT01697592|517114673|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
143428321|NCT01697592|517114674|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
143428322|NCT01697592|517114675|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
143428323|NCT01697592|517114676|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
143428324|NCT01697592|517114677|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
143428325|NCT01697592|517114668|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
143428326|NCT01697592|517114669|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
143428327|NCT01697592|517114670|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
143428328|NCT01697592|517114671|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
143428329|NCT01697592|517114672|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
143428330|NCT01697592|517114673|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
143428331|NCT01697592|517114674|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
143428332|NCT01697592|517114675|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
143428333|NCT01697592|517114676|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
143428334|NCT01697592|517114677|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
143428335|NCT01697592|517114668|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
143428336|NCT01697592|517114669|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
143428337|NCT01697592|517114670|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
143428338|NCT01697592|517114671|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
143428339|NCT01697592|517114672|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
143428340|NCT01697592|517114673|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
143428341|NCT01697592|517114674|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
143428342|NCT01697592|517114675|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
143428343|NCT01697592|517114676|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
143428344|NCT01697592|517114677|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
143428345|NCT01697592|517114668|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
143428346|NCT01697592|517114669|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
143428347|NCT01697592|517114670|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
143428348|NCT01697592|517114671|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
143428349|NCT01697592|517114672|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
143428350|NCT01697592|517114673|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
143428351|NCT01697592|517114674|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
143428352|NCT01697592|517114675|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
143428353|NCT01697592|517114676|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
143428354|NCT01697592|517114677|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
143428355|NCT02396758|517114678|FG000|Overall Study|Withdrawal by Subject|2|||
143428356|NCT02396758|517114679|FG001|Overall Study|Withdrawal by Subject|0|||
143428357|NCT02396758|517114680|FG002|Overall Study|Withdrawal by Subject|0|||
143428358|NCT02396758|517114681|FG003|Overall Study|Withdrawal by Subject|1|||
143428359|NCT02396758|517114678|FG000|Overall Study|Lost to Follow-up|8|||
143428360|NCT02396758|517114679|FG001|Overall Study|Lost to Follow-up|5|||
143428361|NCT02396758|517114680|FG002|Overall Study|Lost to Follow-up|3|||
143428362|NCT02396758|517114681|FG003|Overall Study|Lost to Follow-up|3|||
143428363|NCT02396758|517114678|FG000|Overall Study|Death|1|||
143428364|NCT02396758|517114679|FG001|Overall Study|Death|1|||
143428365|NCT02396758|517114680|FG002|Overall Study|Death|0|||
143428366|NCT02396758|517114681|FG003|Overall Study|Death|1|||
143428367|NCT02396758|517114678|FG000|Overall Study|Randomized but not treated|1|||
143428368|NCT02396758|517114679|FG001|Overall Study|Randomized but not treated|0|||
143428369|NCT02396758|517114680|FG002|Overall Study|Randomized but not treated|1|||
143428370|NCT02396758|517114681|FG003|Overall Study|Randomized but not treated|0|||
143428371|NCT03022045|517114682|FG000|Overall Study|Adverse Event|0|||
143428372|NCT03022045|517114683|FG001|Overall Study|Adverse Event|1|||
143428373|NCT03022045|517114682|FG000|Overall Study|Withdrawal by Subject|1|||
143428374|NCT03022045|517114683|FG001|Overall Study|Withdrawal by Subject|1|||
143428375|NCT01126879|517114684|FG000|Overall Study|Progressive Disease|3|||
143428376|NCT01126879|517114685|FG001|Overall Study|Progressive Disease|1|||
143428377|NCT01126879|517114684|FG000|Overall Study|Withdrawal by Subject|1|||
143428378|NCT01126879|517114685|FG001|Overall Study|Withdrawal by Subject|0|||
143428379|NCT01126879|517114684|FG000|Overall Study|Adverse Event|0|||
143428380|NCT01126879|517114685|FG001|Overall Study|Adverse Event|1|||
143428381|NCT01126879|517114684|FG000|Overall Study|Physician Decision|1|||
143428382|NCT01126879|517114685|FG001|Overall Study|Physician Decision|0|||
143428383|NCT00666835|517114686|FG000|Overall Study|Withdrawal by Subject|5|||
143428384|NCT00666835|517114687|FG001|Overall Study|Withdrawal by Subject|2|||
143428385|NCT00666835|517114686|FG000|Overall Study|Lack of Efficacy|0|||
143428386|NCT00666835|517114687|FG001|Overall Study|Lack of Efficacy|1|||
143428387|NCT00666835|517114686|FG000|Overall Study|Incl./excl. not fulfilled|7|||
143428388|NCT00666835|517114687|FG001|Overall Study|Incl./excl. not fulfilled|2|||
143428389|NCT00666835|517114686|FG000|Overall Study|Adverse Event|7|||
143428390|NCT00666835|517114687|FG001|Overall Study|Adverse Event|6|||
143428391|NCT00666835|517114686|FG000|Overall Study|Protocol Violation|2|||
143428392|NCT00666835|517114687|FG001|Overall Study|Protocol Violation|0|||
143428393|NCT00666835|517114686|FG000|Overall Study|Death|15|||
143428394|NCT00666835|517114687|FG001|Overall Study|Death|4|||
143428395|NCT00666835|517114686|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
143428396|NCT00666835|517114687|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
143428397|NCT00666835|517114686|FG000|Overall Study|Hemoglobulin concentration|4|||
143428398|NCT00666835|517114687|FG001|Overall Study|Hemoglobulin concentration|3|||
143428399|NCT00666835|517114686|FG000|Overall Study|Planned operation|2|||
143428400|NCT00666835|517114687|FG001|Overall Study|Planned operation|0|||
143428401|NCT00666835|517114686|FG000|Overall Study|Physician Decision|1|||
143428402|NCT00666835|517114687|FG001|Overall Study|Physician Decision|2|||
143428403|NCT00899379|517114688|FG000|Overall Study|Adverse Event|2|||
143428404|NCT00899379|517114689|FG001|Overall Study|Adverse Event|2|||
143428405|NCT00899379|517114690|FG002|Overall Study|Adverse Event|1|||
143428406|NCT00899379|517114691|FG003|Overall Study|Adverse Event|1|||
143428407|NCT00899379|517114692|FG004|Overall Study|Adverse Event|2|||
143428408|NCT00899379|517114688|FG000|Overall Study|Lack of Efficacy|0|||
143428409|NCT00899379|517114689|FG001|Overall Study|Lack of Efficacy|4|||
143428410|NCT00899379|517114690|FG002|Overall Study|Lack of Efficacy|3|||
143428411|NCT00899379|517114691|FG003|Overall Study|Lack of Efficacy|0|||
143428412|NCT00899379|517114692|FG004|Overall Study|Lack of Efficacy|1|||
143428413|NCT00899379|517114688|FG000|Overall Study|Lost to Follow-up|9|||
143428414|NCT00899379|517114689|FG001|Overall Study|Lost to Follow-up|3|||
143428415|NCT00899379|517114690|FG002|Overall Study|Lost to Follow-up|0|||
143428416|NCT00899379|517114691|FG003|Overall Study|Lost to Follow-up|6|||
143428417|NCT00899379|517114692|FG004|Overall Study|Lost to Follow-up|2|||
143428418|NCT00899379|517114688|FG000|Overall Study|Protocol Violation|0|||
143428419|NCT00899379|517114689|FG001|Overall Study|Protocol Violation|0|||
143428420|NCT00899379|517114690|FG002|Overall Study|Protocol Violation|1|||
143428421|NCT00899379|517114691|FG003|Overall Study|Protocol Violation|1|||
143428422|NCT00899379|517114692|FG004|Overall Study|Protocol Violation|0|||
143428423|NCT00899379|517114688|FG000|Overall Study|Withdrawal by Subject|2|||
143428424|NCT00899379|517114689|FG001|Overall Study|Withdrawal by Subject|4|||
143428425|NCT00899379|517114690|FG002|Overall Study|Withdrawal by Subject|2|||
143428426|NCT00899379|517114691|FG003|Overall Study|Withdrawal by Subject|3|||
143428427|NCT00899379|517114692|FG004|Overall Study|Withdrawal by Subject|6|||
143428428|NCT00899379|517114688|FG000|Overall Study|Pregnancy|0|||
143428429|NCT00899379|517114689|FG001|Overall Study|Pregnancy|0|||
143428430|NCT00899379|517114690|FG002|Overall Study|Pregnancy|1|||
143428431|NCT00899379|517114691|FG003|Overall Study|Pregnancy|0|||
143428432|NCT00899379|517114692|FG004|Overall Study|Pregnancy|1|||
143428433|NCT00899379|517114688|FG000|Overall Study|Patient Uncooperative|0|||
143428434|NCT00899379|517114689|FG001|Overall Study|Patient Uncooperative|1|||
143428435|NCT00899379|517114690|FG002|Overall Study|Patient Uncooperative|0|||
143428436|NCT00899379|517114691|FG003|Overall Study|Patient Uncooperative|1|||
143428437|NCT00899379|517114692|FG004|Overall Study|Patient Uncooperative|2|||
143428438|NCT00899379|517114688|FG000|Overall Study|Abnormal Baseline ECG|0|||
143428439|NCT00899379|517114689|FG001|Overall Study|Abnormal Baseline ECG|0|||
143428440|NCT00899379|517114690|FG002|Overall Study|Abnormal Baseline ECG|0|||
143428441|NCT00899379|517114691|FG003|Overall Study|Abnormal Baseline ECG|1|||
143428442|NCT00899379|517114692|FG004|Overall Study|Abnormal Baseline ECG|0|||
143428443|NCT00899379|517114688|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
143428444|NCT00899379|517114689|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
143428445|NCT00899379|517114690|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
143428446|NCT00899379|517114691|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
143428447|NCT00899379|517114692|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
143428448|NCT00899379|517114688|FG000|Overall Study|Not Completed/Entered Extn|5|||
143428449|NCT00899379|517114689|FG001|Overall Study|Not Completed/Entered Extn|1|||
143428450|NCT00899379|517114690|FG002|Overall Study|Not Completed/Entered Extn|6|||
143428451|NCT00899379|517114691|FG003|Overall Study|Not Completed/Entered Extn|4|||
143428452|NCT00899379|517114692|FG004|Overall Study|Not Completed/Entered Extn|3|||
143428453|NCT00899379|517114688|FG000|Overall Study|Study Terminated|3|||
143428454|NCT00899379|517114689|FG001|Overall Study|Study Terminated|0|||
143428455|NCT00899379|517114690|FG002|Overall Study|Study Terminated|3|||
143428456|NCT00899379|517114691|FG003|Overall Study|Study Terminated|3|||
143428457|NCT00899379|517114692|FG004|Overall Study|Study Terminated|1|||
143428458|NCT00899379|517114688|FG000|Overall Study|Lost to Follow-up|3|||
143428459|NCT00899379|517114689|FG001|Overall Study|Lost to Follow-up|1|||
143428460|NCT00899379|517114690|FG002|Overall Study|Lost to Follow-up|0|||
143428461|NCT00899379|517114691|FG003|Overall Study|Lost to Follow-up|2|||
143428462|NCT00899379|517114692|FG004|Overall Study|Lost to Follow-up|5|||
143428463|NCT00899379|517114688|FG000|Overall Study|Withdrawal by Subject|4|||
143428464|NCT00899379|517114689|FG001|Overall Study|Withdrawal by Subject|7|||
143428465|NCT00899379|517114690|FG002|Overall Study|Withdrawal by Subject|4|||
143428466|NCT00899379|517114691|FG003|Overall Study|Withdrawal by Subject|7|||
143428467|NCT00899379|517114692|FG004|Overall Study|Withdrawal by Subject|2|||
143428468|NCT00899379|517114688|FG000|Overall Study|Pregnancy|1|||
143428469|NCT00899379|517114689|FG001|Overall Study|Pregnancy|0|||
143428470|NCT00899379|517114690|FG002|Overall Study|Pregnancy|0|||
143428471|NCT00899379|517114691|FG003|Overall Study|Pregnancy|0|||
143428472|NCT00899379|517114692|FG004|Overall Study|Pregnancy|0|||
143428473|NCT00899379|517114688|FG000|Overall Study|Patient Uncooperative|0|||
143428474|NCT00899379|517114689|FG001|Overall Study|Patient Uncooperative|0|||
143428475|NCT00899379|517114690|FG002|Overall Study|Patient Uncooperative|0|||
143428476|NCT00899379|517114691|FG003|Overall Study|Patient Uncooperative|1|||
143428477|NCT00899379|517114692|FG004|Overall Study|Patient Uncooperative|0|||
143428478|NCT00899379|517114688|FG000|Overall Study|Abnormal Prestudy Labs|0|||
143428479|NCT00899379|517114689|FG001|Overall Study|Abnormal Prestudy Labs|0|||
143428480|NCT00899379|517114690|FG002|Overall Study|Abnormal Prestudy Labs|0|||
143428481|NCT00899379|517114691|FG003|Overall Study|Abnormal Prestudy Labs|0|||
143428482|NCT00899379|517114692|FG004|Overall Study|Abnormal Prestudy Labs|2|||
143428483|NCT00899379|517114688|FG000|Overall Study|Abnormal Baseline ECG|0|||
143428484|NCT00899379|517114689|FG001|Overall Study|Abnormal Baseline ECG|0|||
143428485|NCT00899379|517114690|FG002|Overall Study|Abnormal Baseline ECG|1|||
143428486|NCT00899379|517114691|FG003|Overall Study|Abnormal Baseline ECG|1|||
143428487|NCT00899379|517114692|FG004|Overall Study|Abnormal Baseline ECG|0|||
143428488|NCT00899379|517114688|FG000|Overall Study|No Attack Pretreatment|3|||
143428489|NCT00899379|517114689|FG001|Overall Study|No Attack Pretreatment|5|||
143428490|NCT00899379|517114690|FG002|Overall Study|No Attack Pretreatment|5|||
143428491|NCT00899379|517114691|FG003|Overall Study|No Attack Pretreatment|6|||
143428492|NCT00899379|517114692|FG004|Overall Study|No Attack Pretreatment|4|||
143428493|NCT00899379|517114688|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
143428494|NCT00899379|517114689|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
143428495|NCT00899379|517114690|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
143428496|NCT00899379|517114691|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
143428497|NCT00899379|517114692|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
143428498|NCT00899379|517114688|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
143428499|NCT00899379|517114689|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
143428500|NCT00899379|517114690|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
143428501|NCT00899379|517114691|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
143428502|NCT00899379|517114692|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
143428503|NCT00498433|517114697|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
143428504|NCT00498433|517114698|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
143428505|NCT00498433|517114699|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
143428506|NCT00498433|517114697|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
143428507|NCT00498433|517114698|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
143428508|NCT00498433|517114699|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
143428509|NCT00498433|517114697|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
143428510|NCT00498433|517114698|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
143428511|NCT00498433|517114699|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
143428512|NCT00498433|517114697|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
143428513|NCT00498433|517114698|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
143428514|NCT00498433|517114699|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
143428515|NCT02581189|517114700|FG000|Overall Study|Failure to return|36|||
143428516|NCT02581189|517114700|FG000|Overall Study|Withdrew consent|5|||
143428517|NCT02581189|517114700|FG000|Overall Study|Death|3|||
143428518|NCT02581189|517114700|FG000|Overall Study|Insufficient virological response|2|||
143428519|NCT02581189|517114700|FG000|Overall Study|Other, not specified|7|||
143428520|NCT02253147|517114701|FG000|Overall Study|Protocol Violation|30|||
143428521|NCT02253147|517114701|FG000|Overall Study|Did not consent to study extension|9|||
143428522|NCT02253147|517114701|FG000|Overall Study|Conditional re-treatment at W52|5|||
143428523|NCT02253147|517114701|FG000|Overall Study|Lost to Follow-up|2|||
143428524|NCT02253147|517114701|FG000|Overall Study|Withdrawal by Subject|1|||
143428525|NCT02973477|517114703|FG000|First Intervention|Lost to Follow-up|0|||
143428526|NCT02973477|517114704|FG001|First Intervention|Lost to Follow-up|2|||
143428527|NCT02973477|517114703|FG000|Washout|Withdrawal by Subject|1|||
143428528|NCT02973477|517114704|FG001|Washout|Withdrawal by Subject|0|||
143428529|NCT02973477|517114703|FG000|Second Intervention|Lost to Follow-up|1|||
143428530|NCT02973477|517114704|FG001|Second Intervention|Lost to Follow-up|0|||
143428531|NCT02316847|517114705|FG000|Overall Study|Adverse Event|0|||
143428532|NCT02316847|517114706|FG001|Overall Study|Adverse Event|3|||
143428533|NCT02316847|517114705|FG000|Overall Study|Lost to Follow-up|0|||
143428534|NCT02316847|517114706|FG001|Overall Study|Lost to Follow-up|2|||
143428535|NCT02316847|517114705|FG000|Overall Study|Physician Decision|0|||
143428536|NCT02316847|517114706|FG001|Overall Study|Physician Decision|1|||
143428537|NCT02316847|517114705|FG000|Overall Study|Pregnancy|0|||
143428538|NCT02316847|517114706|FG001|Overall Study|Pregnancy|1|||
143428539|NCT02316847|517114705|FG000|Overall Study|Withdrawal by Subject|2|||
143428540|NCT02316847|517114706|FG001|Overall Study|Withdrawal by Subject|9|||
143428541|NCT02316847|517114705|FG000|Overall Study|Noncompliance with study drug|0|||
143428542|NCT02316847|517114706|FG001|Overall Study|Noncompliance with study drug|3|||
143428543|NCT02316847|517114705|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
143428544|NCT02316847|517114706|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
143428545|NCT01264887|517114712|FG000|Overall Study|Adverse Event|5|||
143428546|NCT01264887|517114712|FG000|Overall Study|Death|7|||
143428547|NCT01264887|517114712|FG000|Overall Study|Lack of Efficacy|5|||
143428548|NCT01264887|517114712|FG000|Overall Study|Physician Decision|4|||
143428549|NCT01264887|517114712|FG000|Overall Study|Withdrawal by Subject|6|||
143428550|NCT01264887|517114712|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
143428551|NCT01264887|517114712|FG000|Overall Study|Other|2|||
143428552|NCT02171130|517114715|FG000|Overall Study|Death|1|||
143428553|NCT02171130|517114715|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
143428554|NCT02171130|517114715|FG000|Overall Study|Discontinued; Site Termination|5|||
143428555|NCT02171130|517114715|FG000|Overall Study|Withdrawal by Subject|3|||
143428556|NCT02171130|517114715|FG000|Overall Study|Physician Decision|1|||
143428557|NCT02171130|517114715|FG000|Overall Study|Lost to Follow-up|1|||
143428558|NCT02171130|517114715|FG000|Overall Study|Met Exclusion Criteria|1|||
143428559|NCT00591409|517114716|FG000|Overall Study|Not Treated|0|||
143428560|NCT00591409|517114717|FG001|Overall Study|Not Treated|0|||
143428561|NCT00591409|517114718|FG002|Overall Study|Not Treated|0|||
143428562|NCT00591409|517114719|FG003|Overall Study|Not Treated|0|||
143428563|NCT00591409|517114720|FG004|Overall Study|Not Treated|1|||
143428564|NCT00591409|517114721|FG005|Overall Study|Not Treated|0|||
143428565|NCT00591409|517114722|FG006|Overall Study|Not Treated|0|||
143428566|NCT00591409|517114723|FG007|Overall Study|Not Treated|0|||
143428567|NCT00591409|517114724|FG008|Overall Study|Not Treated|0|||
143428568|NCT00591409|517114725|FG009|Overall Study|Not Treated|1|||
143428569|NCT04531813|517114726|FG000|Overall Study|Protocol Violation|1|||
143428570|NCT04531813|517114726|FG000|Overall Study|Withdrawal by Subject|1|||
143428571|NCT02853305|517114729|FG000|Overall Study|Death|287|||
143428572|NCT02853305|517114730|FG001|Overall Study|Death|249|||
143428573|NCT02853305|517114731|FG002|Overall Study|Death|300|||
143428574|NCT02853305|517114729|FG000|Overall Study|Withdrawal by Subject|2|||
143428575|NCT02853305|517114730|FG001|Overall Study|Withdrawal by Subject|8|||
143428576|NCT02853305|517114731|FG002|Overall Study|Withdrawal by Subject|3|||
143428577|NCT02853305|517114729|FG000|Overall Study|Transferred to Extension Study|46|||
143428578|NCT02853305|517114730|FG001|Overall Study|Transferred to Extension Study|30|||
143428579|NCT02853305|517114731|FG002|Overall Study|Transferred to Extension Study|25|||
143428580|NCT02853305|517114729|FG000|Overall Study|Did Not Continue on Extension Study|16|||
143428581|NCT02853305|517114730|FG001|Overall Study|Did Not Continue on Extension Study|20|||
143428582|NCT02853305|517114731|FG002|Overall Study|Did Not Continue on Extension Study|24|||
143428583|NCT02381652|517114736|FG000|Overall Study|Withdrawal by Subject|0|||
143428584|NCT02381652|517114737|FG001|Overall Study|Withdrawal by Subject|0|||
143428585|NCT02381652|517114738|FG002|Overall Study|Withdrawal by Subject|1|||
143428586|NCT01340300|517114739|FG000|Overall Study|Lost to Follow-up|3|||
143428587|NCT01340300|517114740|FG001|Overall Study|Lost to Follow-up|0|||
143428588|NCT01340300|517114741|FG002|Overall Study|Lost to Follow-up|5|||
143428589|NCT01340300|517114742|FG003|Overall Study|Lost to Follow-up|10|||
143428590|NCT01340300|517114739|FG000|Overall Study|Withdrawal by Subject|5|||
143428591|NCT01340300|517114740|FG001|Overall Study|Withdrawal by Subject|6|||
143428592|NCT01340300|517114741|FG002|Overall Study|Withdrawal by Subject|6|||
143428593|NCT01340300|517114742|FG003|Overall Study|Withdrawal by Subject|3|||
143428594|NCT01340300|517114739|FG000|Overall Study|Adverse Event|1|||
143428595|NCT01340300|517114740|FG001|Overall Study|Adverse Event|0|||
143428596|NCT01340300|517114741|FG002|Overall Study|Adverse Event|4|||
143428597|NCT01340300|517114742|FG003|Overall Study|Adverse Event|0|||
143428598|NCT01340300|517114739|FG000|Overall Study|Physician Decision|0|||
143428599|NCT01340300|517114740|FG001|Overall Study|Physician Decision|1|||
143428600|NCT01340300|517114741|FG002|Overall Study|Physician Decision|0|||
143428601|NCT01340300|517114742|FG003|Overall Study|Physician Decision|0|||
143428602|NCT01340300|517114739|FG000|Overall Study|Unrelated sickness|0|||
143428603|NCT01340300|517114740|FG001|Overall Study|Unrelated sickness|2|||
143428604|NCT01340300|517114741|FG002|Overall Study|Unrelated sickness|0|||
143428605|NCT01340300|517114742|FG003|Overall Study|Unrelated sickness|1|||
143428606|NCT04194541|517114743|FG000|Day 1 Through 13|Lost to Follow-up|3|||
143428607|NCT04194541|517114743|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
143428608|NCT04194541|517114743|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
143428609|NCT02642159|517114744|FG000|Overall Study|Randomized but not treated|1|||
143428610|NCT02642159|517114745|FG001|Overall Study|Randomized but not treated|0|||
143428611|NCT02642159|517114744|FG000|Overall Study|Adverse Event|10|||
143428612|NCT02642159|517114745|FG001|Overall Study|Adverse Event|4|||
143428613|NCT02642159|517114744|FG000|Overall Study|Withdrawal by Subject|9|||
143428614|NCT02642159|517114745|FG001|Overall Study|Withdrawal by Subject|1|||
143428615|NCT02642159|517114744|FG000|Overall Study|Poor compliance to study protocol|1|||
143428616|NCT02642159|517114745|FG001|Overall Study|Poor compliance to study protocol|0|||
143428617|NCT02642159|517114744|FG000|Overall Study|Other than specified above|10|||
143428618|NCT02642159|517114745|FG001|Overall Study|Other than specified above|3|||
143428619|NCT03746483|517114746|FG000|Overall Study|Adverse Event|0|||
143428620|NCT03746483|517114747|FG001|Overall Study|Adverse Event|1|||
143428621|NCT03746483|517114746|FG000|Overall Study|Lack of Efficacy|3|||
143428622|NCT03746483|517114747|FG001|Overall Study|Lack of Efficacy|2|||
143428623|NCT03746483|517114746|FG000|Overall Study|Lost to Follow-up|1|||
143428624|NCT03746483|517114747|FG001|Overall Study|Lost to Follow-up|0|||
143428625|NCT03746483|517114746|FG000|Overall Study|Protocol Violation|2|||
143428626|NCT03746483|517114747|FG001|Overall Study|Protocol Violation|0|||
143428627|NCT01954771|517114748|FG000|Overall Study|Missing HbA1c of end-point|1|||
143428628|NCT01954771|517114749|FG001|Overall Study|Missing HbA1c of end-point|1|||
143428629|NCT01954771|517114750|FG002|Overall Study|Missing HbA1c of end-point|0|||
143428630|NCT01954771|517114748|FG000|Overall Study|Missing CGMS of end-point|1|||
143428631|NCT01954771|517114749|FG001|Overall Study|Missing CGMS of end-point|1|||
143428632|NCT01954771|517114750|FG002|Overall Study|Missing CGMS of end-point|0|||
143428633|NCT01954771|517114748|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
143428634|NCT01954771|517114749|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
143428635|NCT01954771|517114750|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
143428636|NCT01675050|517114754|FG000|Period One Treatment|Withdrawal by Subject|1|||
143428637|NCT01675050|517114755|FG001|Period One Treatment|Withdrawal by Subject|0|||
143428638|NCT02382406|517114756|FG000|Study Treatment|Disease Progression|8|||
143428639|NCT02382406|517114757|FG001|Study Treatment|Disease Progression|0|||
143428640|NCT02382406|517114758|FG002|Study Treatment|Disease Progression|20|||
143428641|NCT02382406|517114756|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
143428642|NCT02382406|517114757|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
143428643|NCT02382406|517114758|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
143428644|NCT02382406|517114756|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
143428645|NCT02382406|517114757|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
143428646|NCT02382406|517114758|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
143428647|NCT02382406|517114756|FG000|Study Treatment|symptomatic deterioration|1|||
143428648|NCT02382406|517114757|FG001|Study Treatment|symptomatic deterioration|0|||
143428649|NCT02382406|517114758|FG002|Study Treatment|symptomatic deterioration|1|||
143428650|NCT02382406|517114756|FG000|Study Treatment|Death|0|||
143428651|NCT02382406|517114757|FG001|Study Treatment|Death|0|||
143428652|NCT02382406|517114758|FG002|Study Treatment|Death|2|||
143428653|NCT02382406|517114756|FG000|Follow up|Death|11|||
143428654|NCT02382406|517114757|FG001|Follow up|Death|0|||
143428655|NCT02382406|517114758|FG002|Follow up|Death|19|||
143428656|NCT02382406|517114756|FG000|Follow up|Symptomatic deterioration|1|||
143428657|NCT02382406|517114757|FG001|Follow up|Symptomatic deterioration|0|||
143428658|NCT02382406|517114758|FG002|Follow up|Symptomatic deterioration|1|||
143428659|NCT02382406|517114756|FG000|Follow up|Patient Refused Follow-up|1|||
143428660|NCT02382406|517114757|FG001|Follow up|Patient Refused Follow-up|0|||
143428661|NCT02382406|517114758|FG002|Follow up|Patient Refused Follow-up|0|||
143428662|NCT02382406|517114756|FG000|Follow up|Study Terminated|1|||
143428663|NCT02382406|517114757|FG001|Follow up|Study Terminated|0|||
143428664|NCT02382406|517114758|FG002|Follow up|Study Terminated|8|||
143428665|NCT02382406|517114756|FG000|Follow up|Withdrawal by Subject|0|||
143428666|NCT02382406|517114757|FG001|Follow up|Withdrawal by Subject|0|||
143428667|NCT02382406|517114758|FG002|Follow up|Withdrawal by Subject|2|||
143428668|NCT04543942|517114759|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
143428669|NCT04543942|517114760|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
143428670|NCT04543942|517114759|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
143428671|NCT04543942|517114760|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
143428672|NCT01747629|517114766|FG000|Overall Study|Adverse Event|1|||
143428673|NCT01747629|517114767|FG001|Overall Study|Adverse Event|2|||
143428674|NCT01747629|517114766|FG000|Overall Study|Withdrawal by Subject|2|||
143428675|NCT01747629|517114767|FG001|Overall Study|Withdrawal by Subject|2|||
143428676|NCT01747629|517114766|FG000|Overall Study|Noncompliance|1|||
143428677|NCT01747629|517114767|FG001|Overall Study|Noncompliance|1|||
143428678|NCT01747629|517114766|FG000|Overall Study|Inclusion criteria not met|1|||
143428679|NCT01747629|517114767|FG001|Overall Study|Inclusion criteria not met|0|||
143428680|NCT01747629|517114766|FG000|Overall Study|Not treated|1|||
143428681|NCT01747629|517114767|FG001|Overall Study|Not treated|0|||
143428682|NCT01747629|517114766|FG000|Overall Study|Other|2|||
143428683|NCT01747629|517114767|FG001|Overall Study|Other|1|||
143428684|NCT02506881|517114768|FG000|First Intervention (Day 1)|Protocol Violation|0|||
143428685|NCT02506881|517114769|FG001|First Intervention (Day 1)|Protocol Violation|0|||
143428686|NCT02506881|517114770|FG002|First Intervention (Day 1)|Protocol Violation|1|||
143428687|NCT02506881|517114771|FG003|First Intervention (Day 1)|Protocol Violation|0|||
143428688|NCT02506881|517114768|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
143428689|NCT02506881|517114769|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
143428690|NCT02506881|517114770|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
143428691|NCT02506881|517114771|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
143428692|NCT02506881|517114768|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
143428693|NCT02506881|517114769|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
143428694|NCT02506881|517114770|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
143428695|NCT02506881|517114771|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
143428696|NCT02016690|517114772|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
143428697|NCT02016690|517114772|FG000|Overall Study|Excluded from SAS: Duplication|2|||
143428698|NCT02016690|517114772|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
143428699|NCT02016690|517114772|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
143428700|NCT02016690|517114772|FG000|Overall Study|Did not meet inclusion criteria|13|||
143428701|NCT02016690|517114772|FG000|Overall Study|Hospitalized for RSV at study start|3|||
143428702|NCT01363297|517114773|FG000|Overall Study|Other|0|||
143428703|NCT01363297|517114774|FG001|Overall Study|Other|0|||
143428704|NCT01363297|517114775|FG002|Overall Study|Other|0|||
143428705|NCT01363297|517114776|FG003|Overall Study|Other|0|||
143428706|NCT01363297|517114777|FG004|Overall Study|Other|1|||
143428707|NCT01363297|517114773|FG000|Overall Study|Death|3|||
143428708|NCT01363297|517114774|FG001|Overall Study|Death|6|||
143428709|NCT01363297|517114775|FG002|Overall Study|Death|6|||
143428710|NCT01363297|517114776|FG003|Overall Study|Death|10|||
143428711|NCT01363297|517114777|FG004|Overall Study|Death|30|||
143428712|NCT00495612|517114778|FG000|Overall Study|Lost to Follow-up|1|||
143428713|NCT00495612|517114779|FG001|Overall Study|Lost to Follow-up|0|||
143428714|NCT00495612|517114778|FG000|Overall Study|Subject's Decision to Withdraw|3|||
143428715|NCT00495612|517114779|FG001|Overall Study|Subject's Decision to Withdraw|0|||
143428716|NCT00818519|517114784|FG000|Overall Study|Adverse Event|2|||
143428717|NCT00818519|517114785|FG001|Overall Study|Adverse Event|2|||
143428718|NCT00818519|517114784|FG000|Overall Study|Lost to Follow-up|4|||
143428719|NCT00818519|517114785|FG001|Overall Study|Lost to Follow-up|6|||
143428720|NCT00818519|517114784|FG000|Overall Study|Protocol Violation|2|||
143428721|NCT00818519|517114785|FG001|Overall Study|Protocol Violation|1|||
143428722|NCT00818519|517114784|FG000|Overall Study|Pregnancy|0|||
143428723|NCT00818519|517114785|FG001|Overall Study|Pregnancy|1|||
143428724|NCT00818519|517114784|FG000|Overall Study|Withdrawal by Subject|4|||
143428725|NCT00818519|517114785|FG001|Overall Study|Withdrawal by Subject|9|||
143428726|NCT00818519|517114784|FG000|Overall Study|participant recovered completely|1|||
143428727|NCT00818519|517114785|FG001|Overall Study|participant recovered completely|0|||
143428728|NCT00818519|517114784|FG000|Overall Study|participant will leave for long tme|1|||
143428729|NCT00818519|517114785|FG001|Overall Study|participant will leave for long tme|0|||
143428730|NCT03356145|517114798|FG000|Overall Study|Withdrawal by Subject|2|||
143428731|NCT03356145|517114799|FG001|Overall Study|Withdrawal by Subject|1|||
143428732|NCT03356145|517114798|FG000|Overall Study|Did not meet inclusion criteria|1|||
143428733|NCT03356145|517114799|FG001|Overall Study|Did not meet inclusion criteria|0|||
143428734|NCT02963922|517114800|FG000|Overall Study|Adverse Event|15|||
143428735|NCT02963922|517114801|FG001|Overall Study|Adverse Event|6|||
143428736|NCT02963922|517114800|FG000|Overall Study|Protocol deviation|6|||
143428737|NCT02963922|517114801|FG001|Overall Study|Protocol deviation|6|||
143428738|NCT02963922|517114800|FG000|Overall Study|Lack of Efficacy|1|||
143428739|NCT02963922|517114801|FG001|Overall Study|Lack of Efficacy|1|||
143428740|NCT02963922|517114800|FG000|Overall Study|Lost to Follow-up|2|||
143428741|NCT02963922|517114801|FG001|Overall Study|Lost to Follow-up|3|||
143428742|NCT02963922|517114800|FG000|Overall Study|Other|8|||
143428743|NCT02963922|517114801|FG001|Overall Study|Other|14|||
143428744|NCT00655668|517114812|FG000|Overall Study|Adverse Event|6|||
143428745|NCT00655668|517114812|FG000|Overall Study|Death|5|||
143428746|NCT00655668|517114812|FG000|Overall Study|Disease Progression|27|||
143428747|NCT00655668|517114812|FG000|Overall Study|Study Terminated|9|||
143428748|NCT00655668|517114812|FG000|Overall Study|Other|1|||
143428749|NCT00655668|517114812|FG000|Overall Study|New Lymphoma Treatment Started|4|||
143428750|NCT00655668|517114812|FG000|Overall Study|Withdrawal by Subject|2|||
143428751|NCT01332318|517114815|FG000|Overall Study|Adverse Event|0|||
143428752|NCT01332318|517114816|FG001|Overall Study|Adverse Event|3|||
143428753|NCT01332318|517114817|FG002|Overall Study|Adverse Event|0|||
143428754|NCT01332318|517114818|FG003|Overall Study|Adverse Event|0|||
143428755|NCT01332318|517114815|FG000|Overall Study|Withdrawal by Subject|1|||
143428756|NCT01332318|517114816|FG001|Overall Study|Withdrawal by Subject|1|||
143428757|NCT01332318|517114817|FG002|Overall Study|Withdrawal by Subject|0|||
143428758|NCT01332318|517114818|FG003|Overall Study|Withdrawal by Subject|1|||
143428759|NCT01332318|517114815|FG000|Overall Study|Protocol Violation|1|||
143428760|NCT01332318|517114816|FG001|Overall Study|Protocol Violation|0|||
143428761|NCT01332318|517114817|FG002|Overall Study|Protocol Violation|1|||
143428762|NCT01332318|517114818|FG003|Overall Study|Protocol Violation|1|||
143428763|NCT02040532|517114819|FG000|Overall Study|Lost to Follow-up|1|||
143428764|NCT02040532|517114819|FG000|Overall Study|Physician Decision|4|||
143428765|NCT02040532|517114819|FG000|Overall Study|Adverse Event|4|||
143428766|NCT02040532|517114819|FG000|Overall Study|Withdrawal by Subject|3|||
143428767|NCT00464737|517114820|FG000|Overall Study|Adverse Event|12|||
143428768|NCT00464737|517114821|FG001|Overall Study|Adverse Event|17|||
143428769|NCT00464737|517114822|FG002|Overall Study|Adverse Event|33|||
143428770|NCT00464737|517114820|FG000|Overall Study|Lack of Efficacy|7|||
143428771|NCT00464737|517114821|FG001|Overall Study|Lack of Efficacy|7|||
143428772|NCT00464737|517114822|FG002|Overall Study|Lack of Efficacy|4|||
143428773|NCT00464737|517114820|FG000|Overall Study|Withdrawal by Subject|5|||
143428774|NCT00464737|517114821|FG001|Overall Study|Withdrawal by Subject|3|||
143428775|NCT00464737|517114822|FG002|Overall Study|Withdrawal by Subject|5|||
143428776|NCT00464737|517114820|FG000|Overall Study|Protocol Violation|1|||
143428777|NCT00464737|517114821|FG001|Overall Study|Protocol Violation|1|||
143428778|NCT00464737|517114822|FG002|Overall Study|Protocol Violation|5|||
143428779|NCT00464737|517114820|FG000|Overall Study|Non-compliance|0|||
143428780|NCT00464737|517114821|FG001|Overall Study|Non-compliance|1|||
143428781|NCT00464737|517114822|FG002|Overall Study|Non-compliance|1|||
143428782|NCT00464737|517114820|FG000|Overall Study|Lost to Follow-up|5|||
143428783|NCT00464737|517114821|FG001|Overall Study|Lost to Follow-up|2|||
143428784|NCT00464737|517114822|FG002|Overall Study|Lost to Follow-up|5|||
143428785|NCT00464737|517114820|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
143428786|NCT00464737|517114821|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
143428787|NCT00464737|517114822|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
143428788|NCT00464737|517114820|FG000|Overall Study|Other: Subject left town; family illness|1|||
143428789|NCT00464737|517114821|FG001|Overall Study|Other: Subject left town; family illness|0|||
143428790|NCT00464737|517114822|FG002|Overall Study|Other: Subject left town; family illness|0|||
143428791|NCT00464737|517114820|FG000|Overall Study|Other: Study demands too great|0|||
143428792|NCT00464737|517114821|FG001|Overall Study|Other: Study demands too great|1|||
143428793|NCT00464737|517114822|FG002|Overall Study|Other: Study demands too great|0|||
143428794|NCT00464737|517114820|FG000|Overall Study|Other: Personal family reasons|0|||
143428795|NCT00464737|517114821|FG001|Overall Study|Other: Personal family reasons|0|||
143428796|NCT00464737|517114822|FG002|Overall Study|Other: Personal family reasons|1|||
143428797|NCT00464737|517114820|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
143428798|NCT00464737|517114821|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
143428799|NCT00464737|517114822|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
143428800|NCT01544153|517114823|FG000|Overall Study|Under 18|0|||
143428801|NCT01544153|517114824|FG001|Overall Study|Under 18|1|||
143428802|NCT01544153|517114825|FG002|Overall Study|Under 18|0|||
143428803|NCT01544153|517114826|FG003|Overall Study|Under 18|0|||
143428804|NCT01544153|517114823|FG000|Overall Study|Non-smoker|0|||
143428805|NCT01544153|517114824|FG001|Overall Study|Non-smoker|0|||
143428806|NCT01544153|517114825|FG002|Overall Study|Non-smoker|1|||
143428807|NCT01544153|517114826|FG003|Overall Study|Non-smoker|0|||
143454213|NCT01982448|517206900|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
143454214|NCT01982448|517206899|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
143454215|NCT01982448|517206900|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
143454216|NCT01982448|517206899|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
143454217|NCT01982448|517206900|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
143454218|NCT01982448|517206899|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
143454219|NCT01982448|517206900|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
143454220|NCT01151410|517208162|FG000|Overall Study|Withdrawal by Subject|3|||
143454221|NCT01151410|517208163|FG001|Overall Study|Withdrawal by Subject|5|||
143454222|NCT01151410|517208162|FG000|Overall Study|Lost to Follow-up|3|||
143454223|NCT01151410|517208163|FG001|Overall Study|Lost to Follow-up|4|||
143454224|NCT01151410|517208162|FG000|Overall Study|Adverse Event|1|||
143454225|NCT01151410|517208163|FG001|Overall Study|Adverse Event|2|||
143454226|NCT01151410|517208162|FG000|Overall Study|Protocol deviation|2|||
143454227|NCT01151410|517208163|FG001|Overall Study|Protocol deviation|1|||
143454228|NCT01151410|517208162|FG000|Overall Study|Administrative problems|1|||
143454229|NCT01151410|517208163|FG001|Overall Study|Administrative problems|1|||
143454230|NCT01151410|517208162|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
143454231|NCT01151410|517208163|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
143454232|NCT01151410|517208162|FG000|Overall Study|Abnormal laboratory value(s)|0|||
143454233|NCT01151410|517208163|FG001|Overall Study|Abnormal laboratory value(s)|1|||
143454234|NCT00735475|517208164|FG000|Overall Study|Adverse Event|0|||
143454235|NCT00735475|517208165|FG001|Overall Study|Adverse Event|1|||
143454236|NCT00735475|517208164|FG000|Overall Study|Death|1|||
143454237|NCT00735475|517208165|FG001|Overall Study|Death|1|||
143428808|NCT02093897|517116551|FG000|Overall Study|Physician Decision|1|||
143428809|NCT02093897|517116551|FG000|Overall Study|Planned age group closure - no's reached|17|||
143428810|NCT02093897|517116551|FG000|Overall Study|Adverse event, non-fatal|1|||
143428811|NCT02972242|517116552|FG000|Overall Study|Withdrawal by Subject|1|||
143428812|NCT02972242|517116553|FG001|Overall Study|Withdrawal by Subject|0|||
143428813|NCT03098797|517116554|FG000|Part 2 Open Label Extension|Adverse Event|2|||
143428814|NCT03098797|517116555|FG001|Part 2 Open Label Extension|Adverse Event|0|||
143428815|NCT01967719|517116556|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
143428816|NCT01967719|517116557|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
143428817|NCT01967719|517116558|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
143428818|NCT01967719|517116559|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
143428819|NCT01967719|517116556|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
143428820|NCT01967719|517116557|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
143428821|NCT01967719|517116558|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
143428822|NCT01967719|517116559|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
143428823|NCT00796614|517116561|FG000|Overall Study|Adverse Event|1|||
143428824|NCT00796614|517116562|FG001|Overall Study|Adverse Event|2|||
143428825|NCT00796614|517116563|FG002|Overall Study|Adverse Event|0|||
143428826|NCT00796614|517116564|FG003|Overall Study|Adverse Event|0|||
143428827|NCT00796614|517116561|FG000|Overall Study|Protocol Violation|0|||
143428828|NCT00796614|517116562|FG001|Overall Study|Protocol Violation|0|||
143428829|NCT00796614|517116563|FG002|Overall Study|Protocol Violation|2|||
143428830|NCT00796614|517116564|FG003|Overall Study|Protocol Violation|0|||
143428831|NCT00796614|517116561|FG000|Overall Study|Lost to Follow-up|2|||
143428832|NCT00796614|517116562|FG001|Overall Study|Lost to Follow-up|2|||
143428833|NCT00796614|517116563|FG002|Overall Study|Lost to Follow-up|1|||
143428834|NCT00796614|517116564|FG003|Overall Study|Lost to Follow-up|0|||
143428835|NCT00796614|517116561|FG000|Overall Study|Withdrawal by Subject|1|||
143428836|NCT00796614|517116562|FG001|Overall Study|Withdrawal by Subject|0|||
143428837|NCT00796614|517116563|FG002|Overall Study|Withdrawal by Subject|0|||
143428838|NCT00796614|517116564|FG003|Overall Study|Withdrawal by Subject|1|||
143428839|NCT00796614|517116561|FG000|Overall Study|Other than stated|1|||
143428840|NCT00796614|517116562|FG001|Overall Study|Other than stated|0|||
143428841|NCT00796614|517116563|FG002|Overall Study|Other than stated|0|||
143428842|NCT00796614|517116564|FG003|Overall Study|Other than stated|0|||
143428843|NCT00509821|517116565|FG000|Study Period 1 (Induction)|Death|0|||
143428844|NCT00509821|517116566|FG001|Study Period 1 (Induction)|Death|1|||
143428845|NCT00509821|517116565|FG000|Study Period 1 (Induction)|Adverse Event|0|||
143428846|NCT00509821|517116566|FG001|Study Period 1 (Induction)|Adverse Event|2|||
143428847|NCT00509821|517116565|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
143428848|NCT00509821|517116566|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
143428849|NCT00740597|517116567|FG000|Overall Study|insurance would not cover treatment|1|||
143428850|NCT00552513|517116573|FG000|Overall Study|Lost to Follow-up|5|||
143428851|NCT00552513|517116574|FG001|Overall Study|Lost to Follow-up|1|||
143428852|NCT01816685|517116575|FG000|Overall Study|Lost to Follow-up|7|||
143428853|NCT01816685|517116576|FG001|Overall Study|Lost to Follow-up|9|||
143428854|NCT01816685|517116575|FG000|Overall Study|Surgery Cancelled|3|||
143428855|NCT01816685|517116576|FG001|Overall Study|Surgery Cancelled|2|||
143428856|NCT02720185|517116577|FG000|Overall Study|Lost to Follow-up|1|||
143428857|NCT00746785|517116578|FG000|Overall Study|Lost to Follow-up|29|||
143428858|NCT00746785|517116579|FG001|Overall Study|Lost to Follow-up|25|||
143428859|NCT00746785|517116580|FG002|Overall Study|Lost to Follow-up|27|||
143428860|NCT01580995|517116583|FG000|Overall Study|Lost to Follow-up|2|||
143428861|NCT01580995|517116584|FG001|Overall Study|Lost to Follow-up|2|||
143428862|NCT02916706|517116585|FG000|Overall Study|Adverse Event|0|||
143428863|NCT02916706|517116586|FG001|Overall Study|Adverse Event|1|||
143428864|NCT02916706|517116585|FG000|Overall Study|Lost to Follow-up|0|||
143428865|NCT02916706|517116586|FG001|Overall Study|Lost to Follow-up|1|||
143428866|NCT02916706|517116585|FG000|Overall Study|Physician Decision|1|||
143428867|NCT02916706|517116586|FG001|Overall Study|Physician Decision|0|||
143428868|NCT02916706|517116585|FG000|Overall Study|Protocol Violation|3|||
143428869|NCT02916706|517116586|FG001|Overall Study|Protocol Violation|1|||
143428870|NCT02916706|517116585|FG000|Overall Study|Withdrawal by Subject|6|||
143428871|NCT02916706|517116586|FG001|Overall Study|Withdrawal by Subject|9|||
143428872|NCT02916706|517116585|FG000|Overall Study|Other|5|||
143428873|NCT02916706|517116586|FG001|Overall Study|Other|19|||
143428874|NCT01902381|517116587|FG000|Overall Study|Withdrawal by Subject|1|||
143428875|NCT02762500|517116588|FG000|Overall Study|Lack of Efficacy|1|||
143428876|NCT02762500|517116589|FG001|Overall Study|Lack of Efficacy|0|||
143428877|NCT02762500|517116588|FG000|Overall Study|Withdrawal by Subject|1|||
143428878|NCT02762500|517116589|FG001|Overall Study|Withdrawal by Subject|1|||
143428879|NCT02762500|517116588|FG000|Overall Study|Adverse Event|0|||
143428880|NCT02762500|517116589|FG001|Overall Study|Adverse Event|2|||
143428881|NCT00730847|517116590|FG000|Overall Study|Adverse Event|1|||
143428882|NCT00730847|517116590|FG000|Overall Study|Protocol Violation|2|||
143428883|NCT00730847|517116590|FG000|Overall Study|Withdrawal by Subject|16|||
143428884|NCT00730847|517116590|FG000|Overall Study|Lost to Follow-up|67|||
143428885|NCT00730847|517116590|FG000|Overall Study|Unknown completion status|21|||
143428886|NCT00730847|517116590|FG000|Overall Study|Other|24|||
143428887|NCT00280683|517116591|FG000|Overall Study|Withdrawal by Subject|1|||
143428888|NCT00280683|517116592|FG001|Overall Study|Withdrawal by Subject|2|||
143428889|NCT00280683|517116591|FG000|Overall Study|Adverse Event|1|||
143428890|NCT00280683|517116592|FG001|Overall Study|Adverse Event|1|||
143428891|NCT00352053|517116603|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
143428892|NCT00352053|517116604|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
143428893|NCT00352053|517116603|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
143428894|NCT00352053|517116604|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
143428895|NCT00352053|517116603|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
143428896|NCT00352053|517116604|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
143428897|NCT00352053|517116603|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
143428898|NCT00352053|517116604|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
143428899|NCT00352053|517116603|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
143428900|NCT00352053|517116604|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
143428901|NCT00352053|517116603|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
143428902|NCT00352053|517116604|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
143428903|NCT00352053|517116603|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
143428904|NCT00352053|517116604|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
143428905|NCT00352053|517116603|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
143428906|NCT00352053|517116604|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
143428907|NCT00352053|517116603|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
143428908|NCT00352053|517116604|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
143428909|NCT00352053|517116603|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
143428910|NCT00352053|517116604|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
143428911|NCT00352053|517116603|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
143428912|NCT00352053|517116604|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
143428913|NCT00352053|517116603|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
143428914|NCT00352053|517116604|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
143428915|NCT00352053|517116603|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
143428916|NCT00352053|517116604|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
143428917|NCT01441583|517116607|FG000|Overall Study|Withdrawal by Subject|1|||
143428918|NCT01441583|517116608|FG001|Overall Study|Withdrawal by Subject|1|||
143428919|NCT01441583|517116609|FG002|Overall Study|Withdrawal by Subject|1|||
143428920|NCT01441583|517116607|FG000|Overall Study|Death|1|||
143428921|NCT01441583|517116608|FG001|Overall Study|Death|0|||
143428922|NCT01441583|517116609|FG002|Overall Study|Death|4|||
143428923|NCT01441583|517116607|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
143428924|NCT01441583|517116608|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
143428925|NCT01441583|517116609|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
143428926|NCT02499835|517116613|FG000|Overall Study|Withdrawal by Subject|1|||
143428927|NCT02499835|517116614|FG001|Overall Study|Withdrawal by Subject|0|||
143428928|NCT02499835|517116615|FG002|Overall Study|Withdrawal by Subject|0|||
143428929|NCT02499835|517116616|FG003|Overall Study|Withdrawal by Subject|1|||
143428930|NCT02499835|517116613|FG000|Overall Study|Physician Decision|0|||
143428931|NCT02499835|517116614|FG001|Overall Study|Physician Decision|3|||
143428932|NCT02499835|517116615|FG002|Overall Study|Physician Decision|18|||
143428933|NCT02499835|517116616|FG003|Overall Study|Physician Decision|7|||
143428934|NCT02499835|517116613|FG000|Overall Study|Adverse Event|0|||
143428935|NCT02499835|517116614|FG001|Overall Study|Adverse Event|0|||
143428936|NCT02499835|517116615|FG002|Overall Study|Adverse Event|0|||
143428937|NCT02499835|517116616|FG003|Overall Study|Adverse Event|1|||
143428938|NCT02499835|517116613|FG000|Overall Study|Disease progression|2|||
143428939|NCT02499835|517116614|FG001|Overall Study|Disease progression|1|||
143428940|NCT02499835|517116615|FG002|Overall Study|Disease progression|0|||
143428941|NCT02499835|517116616|FG003|Overall Study|Disease progression|7|||
143428942|NCT05109117|517116619|FG000|Overall Study|Lost to Follow-up|1|||
143428943|NCT05109117|517116619|FG000|Overall Study|Discontinued for non-compliance|1|||
143428944|NCT03972137|517116623|FG000|Overall Study|Lost to Follow-up|2|||
143428945|NCT03972137|517116623|FG000|Overall Study|Withdrawal by Subject|4|||
143428946|NCT03319719|517116625|FG000|Overall Study|Lost to Follow-up|1|||
143428947|NCT00744796|517116626|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
143428948|NCT01820637|517116627|FG000|Overall Study|Death|2|||
143428949|NCT01820637|517116627|FG000|Overall Study|Withdrawal by Subject|1|||
143428950|NCT00583115|517116628|FG000|Overall Study|Death|1|||
143428951|NCT00264498|517116629|FG000|Randomized Treatment|Death|0|||
143428952|NCT00264498|517116630|FG001|Randomized Treatment|Death|3|||
143428953|NCT00264498|517116629|FG000|Randomized Treatment|Withdrawal by Subject|0|||
143428954|NCT00264498|517116630|FG001|Randomized Treatment|Withdrawal by Subject|1|||
143428955|NCT00264498|517116629|FG000|Randomized Treatment|Objective disease Progression|13|||
143428956|NCT00264498|517116630|FG001|Randomized Treatment|Objective disease Progression|14|||
143428957|NCT00264498|517116629|FG000|Randomized Treatment|Physician Decision|1|||
143428958|NCT00264498|517116630|FG001|Randomized Treatment|Physician Decision|0|||
143428959|NCT00264498|517116629|FG000|Randomized Treatment|Incorrectly randomized|1|||
143428960|NCT00264498|517116630|FG001|Randomized Treatment|Incorrectly randomized|0|||
143428961|NCT00264498|517116629|FG000|Randomized Treatment|Study Closure|1|||
143428962|NCT00264498|517116630|FG001|Randomized Treatment|Study Closure|0|||
143428963|NCT00264498|517116629|FG000|Randomized Treatment|Protocol Violation|1|||
143428964|NCT00264498|517116630|FG001|Randomized Treatment|Protocol Violation|0|||
143428965|NCT00264498|517116629|FG000|Crossover Treatment|Death|1|||
143428966|NCT00264498|517116630|FG001|Crossover Treatment|Death|3|||
143428967|NCT00264498|517116629|FG000|Crossover Treatment|Objective disease progression|4|||
143428968|NCT00264498|517116630|FG001|Crossover Treatment|Objective disease progression|5|||
143428969|NCT00264498|517116629|FG000|Crossover Treatment|Study closure|0|||
143428970|NCT00264498|517116630|FG001|Crossover Treatment|Study closure|1|||
143428971|NCT00264498|517116629|FG000|Crossover Treatment|Withdrawal by Subject|1|||
143428972|NCT00264498|517116630|FG001|Crossover Treatment|Withdrawal by Subject|0|||
143428973|NCT03340766|517116634|FG000|Overall Study|Withdrawal by Subject|2|||
143428974|NCT03340766|517116635|FG001|Overall Study|Withdrawal by Subject|1|||
143428975|NCT03340766|517116636|FG002|Overall Study|Withdrawal by Subject|3|||
143428976|NCT03340766|517116634|FG000|Overall Study|Lost to Follow-up|0|||
143428977|NCT03340766|517116635|FG001|Overall Study|Lost to Follow-up|0|||
143428978|NCT03340766|517116636|FG002|Overall Study|Lost to Follow-up|1|||
143428979|NCT03340766|517116634|FG000|Overall Study|Death|6|||
143428980|NCT03340766|517116635|FG001|Overall Study|Death|7|||
143428981|NCT03340766|517116636|FG002|Overall Study|Death|4|||
143428982|NCT02864147|517116640|FG000|Overall Study|Withdrawal by Subject|3|||
143428983|NCT02864147|517116641|FG001|Overall Study|Withdrawal by Subject|2|||
143428984|NCT02864147|517116642|FG002|Overall Study|Withdrawal by Subject|1|||
143428985|NCT02864147|517116640|FG000|Overall Study|Lost to Follow-up|0|||
143428986|NCT02864147|517116641|FG001|Overall Study|Lost to Follow-up|4|||
143428987|NCT02864147|517116642|FG002|Overall Study|Lost to Follow-up|0|||
143428988|NCT02864147|517116640|FG000|Overall Study|Adverse Event|0|||
143428989|NCT02864147|517116641|FG001|Overall Study|Adverse Event|1|||
143428990|NCT02864147|517116642|FG002|Overall Study|Adverse Event|0|||
143428991|NCT02864147|517116640|FG000|Overall Study|Pregnancy|4|||
143428992|NCT02864147|517116641|FG001|Overall Study|Pregnancy|0|||
143428993|NCT02864147|517116642|FG002|Overall Study|Pregnancy|0|||
143428994|NCT02864147|517116640|FG000|Overall Study|Physician Decision|0|||
143428995|NCT02864147|517116641|FG001|Overall Study|Physician Decision|0|||
143428996|NCT02864147|517116642|FG002|Overall Study|Physician Decision|1|||
143428997|NCT02864147|517116640|FG000|Overall Study|Opted for excisional procedures|0|||
143428998|NCT02864147|517116641|FG001|Overall Study|Opted for excisional procedures|0|||
143428999|NCT02864147|517116642|FG002|Overall Study|Opted for excisional procedures|3|||
143429000|NCT02269917|517116643|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
143429001|NCT02269917|517116644|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
143429002|NCT02269917|517116645|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
143429003|NCT02269917|517116643|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
143429004|NCT02269917|517116644|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
143429005|NCT02269917|517116645|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
143429006|NCT02269917|517116643|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
143429007|NCT02269917|517116644|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
143429008|NCT02269917|517116645|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
143429009|NCT02269917|517116643|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
143429010|NCT02269917|517116644|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
143429011|NCT02269917|517116645|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
143429012|NCT02269917|517116643|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
143429013|NCT02269917|517116644|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
143429014|NCT02269917|517116645|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
143429015|NCT02269917|517116643|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
143429016|NCT02269917|517116644|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
143429017|NCT02269917|517116645|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
143429018|NCT02269917|517116643|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
143429019|NCT02269917|517116644|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
143429020|NCT02269917|517116645|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
143429021|NCT02269917|517116643|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
143429022|NCT02269917|517116644|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
143429023|NCT02269917|517116645|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
143429024|NCT02269917|517116643|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
143429025|NCT02269917|517116644|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
143429026|NCT02269917|517116645|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
143429027|NCT02269917|517116643|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
143429028|NCT02269917|517116644|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
143429029|NCT02269917|517116645|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
143429030|NCT02269917|517116643|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
143429031|NCT02269917|517116644|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
143429032|NCT02269917|517116645|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
143429033|NCT02269917|517116643|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
143429034|NCT02269917|517116644|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
143429035|NCT02269917|517116645|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
143429036|NCT02269917|517116643|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
143429037|NCT02269917|517116644|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
143429038|NCT02269917|517116645|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
143429039|NCT02269917|517116643|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
143429040|NCT02269917|517116644|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
143429041|NCT02269917|517116645|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
143429042|NCT02269917|517116643|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
143429043|NCT02269917|517116644|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
143429044|NCT02269917|517116645|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
143429045|NCT02269917|517116643|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
143429046|NCT02269917|517116644|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
143429047|NCT02269917|517116645|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
143429048|NCT00240097|517116646|FG000|Part I|Adverse Event|1|||
143429049|NCT00240097|517116646|FG000|Part I|Death|1|||
143429050|NCT00240097|517116646|FG000|Part I|histology|1|||
143429051|NCT00240097|517116646|FG000|Part I|unevaluable|1|||
143429052|NCT00240097|517116646|FG000|Part II|did not continue from Part I|23|||
143429053|NCT02335242|517116647|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
143429054|NCT02335242|517116648|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
143429055|NCT02335242|517116647|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
143429056|NCT02335242|517116648|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
143429057|NCT02335242|517116647|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
143429058|NCT02335242|517116648|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
143429059|NCT00595764|517116649|FG000|Overall Study|Protocol Violation|24|||
143429060|NCT00595764|517116650|FG001|Overall Study|Protocol Violation|19|||
143429061|NCT00595764|517116649|FG000|Overall Study|Missed Medication >1 week|10|||
143429062|NCT00595764|517116650|FG001|Overall Study|Missed Medication >1 week|17|||
143429063|NCT00595764|517116649|FG000|Overall Study|Missed 3 PM visits|1|||
143429064|NCT00595764|517116650|FG001|Overall Study|Missed 3 PM visits|7|||
143429065|NCT00595764|517116649|FG000|Overall Study|Withdrawal by Subject|4|||
143429066|NCT00595764|517116650|FG001|Overall Study|Withdrawal by Subject|0|||
143429067|NCT04222088|517116651|FG000|Overall Study|Lost to Follow-up|5|||
143429068|NCT04222088|517116652|FG001|Overall Study|Lost to Follow-up|1|||
143429069|NCT04222088|517116651|FG000|Overall Study|Withdrawal by Subject|4|||
143429070|NCT04222088|517116652|FG001|Overall Study|Withdrawal by Subject|0|||
143429071|NCT00580047|517116659|FG000|Overall Study|Lost to Follow-up|1|||
143429072|NCT00580047|517116660|FG001|Overall Study|Lost to Follow-up|1|||
143429073|NCT00580047|517116661|FG002|Overall Study|Lost to Follow-up|0|||
143429074|NCT00580047|517116659|FG000|Overall Study|Withdrawal by Subject|1|||
143429075|NCT00580047|517116660|FG001|Overall Study|Withdrawal by Subject|1|||
143429076|NCT00580047|517116661|FG002|Overall Study|Withdrawal by Subject|2|||
143429077|NCT00580047|517116659|FG000|Overall Study|Withdrawal by Subject|1|||
143429078|NCT00580047|517116660|FG001|Overall Study|Withdrawal by Subject|0|||
143429079|NCT00580047|517116661|FG002|Overall Study|Withdrawal by Subject|0|||
143429080|NCT02820298|517116662|FG000|Overall Study|Withdrawal by Subject|0|||
143429081|NCT02820298|517116663|FG001|Overall Study|Withdrawal by Subject|1|||
143429082|NCT02820298|517116662|FG000|Overall Study|Physician Decision|1|||
143429083|NCT02820298|517116663|FG001|Overall Study|Physician Decision|0|||
143429084|NCT02820298|517116662|FG000|Overall Study|Protocol Violation|0|||
143429085|NCT02820298|517116663|FG001|Overall Study|Protocol Violation|1|||
143429086|NCT01894256|517116664|FG000|Part A|Adverse Event|0|||
143429087|NCT01894256|517116665|FG001|Part A|Adverse Event|1|||
143429088|NCT01894256|517116666|FG002|Part A|Adverse Event|0|||
143429089|NCT01894256|517116664|FG000|Part B|Death|0|||
143429090|NCT01894256|517116665|FG001|Part B|Death|1|||
143429091|NCT01894256|517116666|FG002|Part B|Death|1|||
143429092|NCT01894256|517116664|FG000|Part B|Withdrawal by Subject|0|||
143429093|NCT01894256|517116665|FG001|Part B|Withdrawal by Subject|1|||
143429094|NCT01894256|517116666|FG002|Part B|Withdrawal by Subject|0|||
143429095|NCT01894256|517116664|FG000|Part B|Lack of Efficacy|15|||
143429096|NCT01894256|517116665|FG001|Part B|Lack of Efficacy|12|||
143429097|NCT01894256|517116666|FG002|Part B|Lack of Efficacy|13|||
143429098|NCT01780584|517116667|FG000|Overall Study|Death|1|||
143429099|NCT01780584|517116668|FG001|Overall Study|Death|0|||
143429100|NCT01780584|517116669|FG002|Overall Study|Death|1|||
143429101|NCT01780584|517116667|FG000|Overall Study|Adverse Event|0|||
143429102|NCT01780584|517116668|FG001|Overall Study|Adverse Event|1|||
143429103|NCT01780584|517116669|FG002|Overall Study|Adverse Event|0|||
143429104|NCT01780584|517116667|FG000|Overall Study|Protocol Violation|0|||
143429105|NCT01780584|517116668|FG001|Overall Study|Protocol Violation|0|||
143429106|NCT01780584|517116669|FG002|Overall Study|Protocol Violation|1|||
143429107|NCT02133131|517116672|FG000|Overall Study|Adverse Event|0|||
143429108|NCT02133131|517116673|FG001|Overall Study|Adverse Event|0|||
143429109|NCT02133131|517116674|FG002|Overall Study|Adverse Event|0|||
143429110|NCT02133131|517116675|FG003|Overall Study|Adverse Event|1|||
143429111|NCT02133131|517116676|FG004|Overall Study|Adverse Event|0|||
143429112|NCT02133131|517116677|FG005|Overall Study|Adverse Event|0|||
143429113|NCT02133131|517116678|FG006|Overall Study|Adverse Event|0|||
143429114|NCT02133131|517116672|FG000|Overall Study|Lost to Follow-up|1|||
143429115|NCT02133131|517116673|FG001|Overall Study|Lost to Follow-up|0|||
143429116|NCT02133131|517116674|FG002|Overall Study|Lost to Follow-up|0|||
143429117|NCT02133131|517116675|FG003|Overall Study|Lost to Follow-up|1|||
143429118|NCT02133131|517116676|FG004|Overall Study|Lost to Follow-up|0|||
143429119|NCT02133131|517116677|FG005|Overall Study|Lost to Follow-up|0|||
143429120|NCT02133131|517116678|FG006|Overall Study|Lost to Follow-up|0|||
143429121|NCT02133131|517116672|FG000|Overall Study|Status not recorded|4|||
143429122|NCT02133131|517116673|FG001|Overall Study|Status not recorded|5|||
143429123|NCT02133131|517116674|FG002|Overall Study|Status not recorded|1|||
143429124|NCT02133131|517116675|FG003|Overall Study|Status not recorded|4|||
143429125|NCT02133131|517116676|FG004|Overall Study|Status not recorded|0|||
143429126|NCT02133131|517116677|FG005|Overall Study|Status not recorded|0|||
143429127|NCT02133131|517116678|FG006|Overall Study|Status not recorded|0|||
143429128|NCT02133131|517116672|FG000|Overall Study|Ongoing in study|0|||
143429129|NCT02133131|517116673|FG001|Overall Study|Ongoing in study|0|||
143429130|NCT02133131|517116674|FG002|Overall Study|Ongoing in study|0|||
143429131|NCT02133131|517116675|FG003|Overall Study|Ongoing in study|0|||
143429132|NCT02133131|517116676|FG004|Overall Study|Ongoing in study|15|||
143429133|NCT02133131|517116677|FG005|Overall Study|Ongoing in study|14|||
143429134|NCT02133131|517116678|FG006|Overall Study|Ongoing in study|11|||
143429135|NCT02133131|517116672|FG000|Overall Study|Protocol Violation|0|||
143429136|NCT02133131|517116673|FG001|Overall Study|Protocol Violation|0|||
143429137|NCT02133131|517116674|FG002|Overall Study|Protocol Violation|0|||
143429138|NCT02133131|517116675|FG003|Overall Study|Protocol Violation|0|||
143429139|NCT02133131|517116676|FG004|Overall Study|Protocol Violation|0|||
143429140|NCT02133131|517116677|FG005|Overall Study|Protocol Violation|0|||
143429141|NCT02133131|517116678|FG006|Overall Study|Protocol Violation|1|||
143429142|NCT04783519|517116685|FG000|Overall Study|Withdrawal by Subject|2|||
143429143|NCT04783519|517116686|FG001|Overall Study|Withdrawal by Subject|7|||
143429144|NCT04783519|517116687|FG002|Overall Study|Withdrawal by Subject|3|||
143429145|NCT04783519|517116685|FG000|Overall Study|Lost to Follow-up|9|||
143429146|NCT04783519|517116686|FG001|Overall Study|Lost to Follow-up|7|||
143429147|NCT04783519|517116687|FG002|Overall Study|Lost to Follow-up|6|||
143429148|NCT00884793|517116688|FG000|Overall Study|Withdrawal by Subject|1|||
143429149|NCT03169530|517116689|FG000|Overall Study|Study ended by NIH|15|||
143429150|NCT03169530|517116690|FG001|Overall Study|Study ended by NIH|17|||
143429151|NCT01032200|517116691|FG000|Overall Study|Death|1|||
143429152|NCT01032200|517116692|FG001|Overall Study|Death|1|||
143429153|NCT01032200|517116691|FG000|Overall Study|Withdrawal by Subject|1|||
143429154|NCT01032200|517116692|FG001|Overall Study|Withdrawal by Subject|3|||
143429155|NCT01032200|517116691|FG000|Overall Study|Toxicity|0|||
143429156|NCT01032200|517116692|FG001|Overall Study|Toxicity|2|||
143429157|NCT01032200|517116691|FG000|Overall Study|Progression|1|||
143429158|NCT01032200|517116692|FG001|Overall Study|Progression|0|||
143429159|NCT01032200|517116691|FG000|Overall Study|Multiple|1|||
143429160|NCT01032200|517116692|FG001|Overall Study|Multiple|1|||
143429161|NCT00727259|517116696|FG000|Overall Study|Not all questionnaires completed|1055|||
143429162|NCT01021683|517116697|FG000|Overall Study|Lack of Efficacy|12|||
143429163|NCT01021683|517116697|FG000|Overall Study|Recovery of neutrophil count|51|||
143429164|NCT01021683|517116697|FG000|Overall Study|Other|8|||
143429165|NCT01804140|517116699|FG000|Overall Study|No sampling or biopsy procedures done|114|||
143429166|NCT02785900|517116700|FG000|Overall Study|Study Termination by Sponsor|64|||
143429167|NCT02785900|517116701|FG001|Overall Study|Study Termination by Sponsor|81|||
143429168|NCT02785900|517116700|FG000|Overall Study|Death|46|||
143429169|NCT02785900|517116701|FG001|Overall Study|Death|32|||
143429170|NCT02785900|517116700|FG000|Overall Study|Withdrawal by Subject|4|||
143429171|NCT02785900|517116701|FG001|Overall Study|Withdrawal by Subject|8|||
143429172|NCT02785900|517116700|FG000|Overall Study|Physician Decision|3|||
143429173|NCT02785900|517116701|FG001|Overall Study|Physician Decision|2|||
143454238|NCT00735475|517208164|FG000|Overall Study|Lost to Follow-up|3|||
143454239|NCT00735475|517208165|FG001|Overall Study|Lost to Follow-up|3|||
143454240|NCT00735475|517208164|FG000|Overall Study|Physician Decision|0|||
143454241|NCT00735475|517208165|FG001|Overall Study|Physician Decision|1|||
143454242|NCT00735475|517208164|FG000|Overall Study|Withdrawal by Subject|4|||
143454243|NCT00735475|517208165|FG001|Overall Study|Withdrawal by Subject|5|||
143454244|NCT01712659|517208168|FG000|Dose Escalation|Physician Decision|0|||
143454245|NCT01712659|517208169|FG001|Dose Escalation|Physician Decision|1|||
143429174|NCT00547300|517116702|FG000|Overall Study|Study was Administratively Terminated|25|||
143429175|NCT00547300|517116703|FG001|Overall Study|Study was Administratively Terminated|24|||
143429176|NCT00547300|517116702|FG000|Overall Study|Did not Meet Entry Criteria|0|||
143429177|NCT00547300|517116703|FG001|Overall Study|Did not Meet Entry Criteria|2|||
143429178|NCT04130061|517116706|FG000|Overall Study|OR team forgot to request membrane|1|||
143429179|NCT04130061|517116707|FG001|Overall Study|OR team forgot to request membrane|0|||
143429180|NCT01772147|517118829|FG000|Overall Study|Adverse Event|13|||
143429181|NCT01772147|517118830|FG001|Overall Study|Adverse Event|10|||
143429182|NCT01772147|517118831|FG002|Overall Study|Adverse Event|6|||
143429183|NCT01772147|517118829|FG000|Overall Study|Withdrew Consent|7|||
143429184|NCT01772147|517118830|FG001|Overall Study|Withdrew Consent|8|||
143429185|NCT01772147|517118831|FG002|Overall Study|Withdrew Consent|4|||
143429186|NCT01772147|517118829|FG000|Overall Study|Lost to Follow-up|1|||
143429187|NCT01772147|517118830|FG001|Overall Study|Lost to Follow-up|0|||
143429188|NCT01772147|517118831|FG002|Overall Study|Lost to Follow-up|1|||
143429189|NCT01772147|517118829|FG000|Overall Study|Protocol Deviation|2|||
143429190|NCT01772147|517118830|FG001|Overall Study|Protocol Deviation|1|||
143429191|NCT01772147|517118831|FG002|Overall Study|Protocol Deviation|1|||
143429192|NCT01772147|517118829|FG000|Overall Study|Lack of Efficacy|8|||
143429193|NCT01772147|517118830|FG001|Overall Study|Lack of Efficacy|6|||
143429194|NCT01772147|517118831|FG002|Overall Study|Lack of Efficacy|6|||
143429195|NCT04572997|517118835|FG000|Overall Study|Adverse Event|1|||
143429196|NCT02956278|517118836|FG000|Overall Study|Withdrawal by Subject|6|||
143429197|NCT02956278|517118837|FG001|Overall Study|Withdrawal by Subject|2|||
143429198|NCT02956278|517118838|FG002|Overall Study|Withdrawal by Subject|0|||
143429199|NCT01157351|517118839|FG000|Overall Study|Adverse Event|5|||
143429200|NCT01157351|517118840|FG001|Overall Study|Adverse Event|4|||
143429201|NCT01157351|517118839|FG000|Overall Study|Death|1|||
143429202|NCT01157351|517118840|FG001|Overall Study|Death|0|||
143429203|NCT01157351|517118839|FG000|Overall Study|Lost to Follow-up|53|||
143429204|NCT01157351|517118840|FG001|Overall Study|Lost to Follow-up|55|||
143429205|NCT01157351|517118839|FG000|Overall Study|Withdrawal by Subject|37|||
143429206|NCT01157351|517118840|FG001|Overall Study|Withdrawal by Subject|27|||
143429207|NCT01157351|517118839|FG000|Overall Study|Physician Decision|5|||
143429208|NCT01157351|517118840|FG001|Overall Study|Physician Decision|4|||
143429209|NCT01157351|517118839|FG000|Overall Study|Protocol Violation|0|||
143429210|NCT01157351|517118840|FG001|Overall Study|Protocol Violation|1|||
143429211|NCT01157351|517118839|FG000|Overall Study|Other|32|||
143429212|NCT01157351|517118840|FG001|Overall Study|Other|36|||
143429213|NCT01157351|517118839|FG000|Overall Study|Noncompliance with Study Drug|0|||
143429214|NCT01157351|517118840|FG001|Overall Study|Noncompliance with Study Drug|3|||
143429215|NCT01157351|517118839|FG000|Overall Study|Randomized but not Treated|4|||
143429216|NCT01157351|517118840|FG001|Overall Study|Randomized but not Treated|2|||
143429217|NCT01231464|517118841|FG000|Overall Study|Adverse Event|0|||
143429218|NCT01231464|517118842|FG001|Overall Study|Adverse Event|1|||
143429219|NCT01231464|517118841|FG000|Overall Study|Protocol Violation|1|||
143429220|NCT01231464|517118842|FG001|Overall Study|Protocol Violation|2|||
143429221|NCT01231464|517118841|FG000|Overall Study|Lost to Follow-up|1|||
143429222|NCT01231464|517118842|FG001|Overall Study|Lost to Follow-up|2|||
143429223|NCT01231464|517118841|FG000|Overall Study|Withdrawal by Subject|3|||
143429224|NCT01231464|517118842|FG001|Overall Study|Withdrawal by Subject|2|||
143429225|NCT03449134|517118843|FG000|52-Week Treatment Period|Death|2|||
143429226|NCT03449134|517118844|FG001|52-Week Treatment Period|Death|1|||
143429227|NCT03449134|517118845|FG002|52-Week Treatment Period|Death|0|||
143429228|NCT03449134|517118843|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
143429229|NCT03449134|517118844|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
143429230|NCT03449134|517118845|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
143429231|NCT03449134|517118843|FG000|52-Week Treatment Period|Physician Decision|2|||
143429232|NCT03449134|517118844|FG001|52-Week Treatment Period|Physician Decision|3|||
143429233|NCT03449134|517118845|FG002|52-Week Treatment Period|Physician Decision|3|||
143429234|NCT03449134|517118843|FG000|52-Week Treatment Period|Screen Failure|1|||
143429235|NCT03449134|517118844|FG001|52-Week Treatment Period|Screen Failure|0|||
143429236|NCT03449134|517118845|FG002|52-Week Treatment Period|Screen Failure|1|||
143429237|NCT03449134|517118843|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
143429238|NCT03449134|517118844|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
143429239|NCT03449134|517118845|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
143429240|NCT03449134|517118843|FG000|52-Week Treatment Period|Site Closure|1|||
143429241|NCT03449134|517118844|FG001|52-Week Treatment Period|Site Closure|0|||
143429242|NCT03449134|517118845|FG002|52-Week Treatment Period|Site Closure|0|||
143429243|NCT00957996|517118851|FG000|Overall Study|Death|4|||
143429244|NCT00957996|517118852|FG001|Overall Study|Death|10|||
143429245|NCT00957996|517118851|FG000|Overall Study|Lost to Follow-up|4|||
143429246|NCT00957996|517118852|FG001|Overall Study|Lost to Follow-up|7|||
143429247|NCT00957996|517118851|FG000|Overall Study|Withdrawal by Subject|9|||
143429248|NCT00957996|517118852|FG001|Overall Study|Withdrawal by Subject|2|||
143429249|NCT00957996|517118851|FG000|Overall Study|Adverse Event|2|||
143429250|NCT00957996|517118852|FG001|Overall Study|Adverse Event|1|||
143429251|NCT00957996|517118851|FG000|Overall Study|Physician Decision|1|||
143429252|NCT00957996|517118852|FG001|Overall Study|Physician Decision|1|||
143429253|NCT00957996|517118851|FG000|Overall Study|Influenza-related complication|0|||
143429254|NCT00957996|517118852|FG001|Overall Study|Influenza-related complication|1|||
143429255|NCT00957996|517118851|FG000|Overall Study|Missing|1|||
143429256|NCT00957996|517118852|FG001|Overall Study|Missing|0|||
143429257|NCT00957996|517118851|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
143429258|NCT00957996|517118852|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
143429259|NCT01960348|517118856|FG000|Overall Study|Adverse event, not serious|2|||
143429260|NCT01960348|517118857|FG001|Overall Study|Adverse event, not serious|2|||
143429261|NCT01960348|517118856|FG000|Overall Study|Adverse event, serious fatal|6|||
143429262|NCT01960348|517118857|FG001|Overall Study|Adverse event, serious fatal|5|||
143429263|NCT01960348|517118856|FG000|Overall Study|Adverse event, serious non-fatal|0|||
143429264|NCT01960348|517118857|FG001|Overall Study|Adverse event, serious non-fatal|3|||
143429265|NCT01960348|517118856|FG000|Overall Study|Withdrawal by Subject|1|||
143429266|NCT01960348|517118857|FG001|Overall Study|Withdrawal by Subject|11|||
143429267|NCT01960348|517118856|FG000|Overall Study|Physician Decision|0|||
143429268|NCT01960348|517118857|FG001|Overall Study|Physician Decision|1|||
143429269|NCT01960348|517118856|FG000|Overall Study|Protocol Violation|1|||
143429270|NCT01960348|517118857|FG001|Overall Study|Protocol Violation|0|||
143429271|NCT01821729|517118858|FG000|Overall Study|Withdrawal by Subject|1|||
143429272|NCT00381797|517118864|FG000|Overall Study|Withdrawal by Subject|1|||
143429273|NCT00381797|517118865|FG001|Overall Study|Withdrawal by Subject|1|||
143429274|NCT00381797|517118866|FG002|Overall Study|Withdrawal by Subject|0|||
143429275|NCT00381797|517118867|FG003|Overall Study|Withdrawal by Subject|0|||
143429276|NCT00381797|517118868|FG004|Overall Study|Withdrawal by Subject|2|||
143429277|NCT00381797|517118864|FG000|Overall Study|Ineligible|0|||
143429278|NCT00381797|517118865|FG001|Overall Study|Ineligible|0|||
143429279|NCT00381797|517118866|FG002|Overall Study|Ineligible|0|||
143429280|NCT00381797|517118867|FG003|Overall Study|Ineligible|1|||
143429281|NCT00381797|517118868|FG004|Overall Study|Ineligible|0|||
143429282|NCT00684203|517118869|FG000|Overall Study|Adverse Event|6|||
143429283|NCT00684203|517118870|FG001|Overall Study|Adverse Event|4|||
143429284|NCT00684203|517118871|FG002|Overall Study|Adverse Event|8|||
143429285|NCT00684203|517118872|FG003|Overall Study|Adverse Event|0|||
143429286|NCT00684203|517118873|FG004|Overall Study|Adverse Event|0|||
143429287|NCT00684203|517118874|FG005|Overall Study|Adverse Event|0|||
143429288|NCT00684203|517118869|FG000|Overall Study|Protocol-defined clinical event|3|||
143429289|NCT00684203|517118870|FG001|Overall Study|Protocol-defined clinical event|1|||
143429290|NCT00684203|517118871|FG002|Overall Study|Protocol-defined clinical event|0|||
143429291|NCT00684203|517118872|FG003|Overall Study|Protocol-defined clinical event|0|||
143429292|NCT00684203|517118873|FG004|Overall Study|Protocol-defined clinical event|0|||
143429293|NCT00684203|517118874|FG005|Overall Study|Protocol-defined clinical event|0|||
143429294|NCT00684203|517118869|FG000|Overall Study|Withdrawal by Subject|0|||
143429295|NCT00684203|517118870|FG001|Overall Study|Withdrawal by Subject|2|||
143429296|NCT00684203|517118871|FG002|Overall Study|Withdrawal by Subject|1|||
143429297|NCT00684203|517118872|FG003|Overall Study|Withdrawal by Subject|0|||
143429298|NCT00684203|517118873|FG004|Overall Study|Withdrawal by Subject|0|||
143429299|NCT00684203|517118874|FG005|Overall Study|Withdrawal by Subject|0|||
143429300|NCT00684203|517118869|FG000|Overall Study|Did not meet protocol eligibility|0|||
143429301|NCT00684203|517118870|FG001|Overall Study|Did not meet protocol eligibility|1|||
143429302|NCT00684203|517118871|FG002|Overall Study|Did not meet protocol eligibility|0|||
143429303|NCT00684203|517118872|FG003|Overall Study|Did not meet protocol eligibility|0|||
143429304|NCT00684203|517118873|FG004|Overall Study|Did not meet protocol eligibility|0|||
143429305|NCT00684203|517118874|FG005|Overall Study|Did not meet protocol eligibility|0|||
143429306|NCT00719212|517118877|FG000|Overall Study|Death|41|||
143429307|NCT00719212|517118877|FG000|Overall Study|Lost to Follow-up|2|||
143429308|NCT00719212|517118877|FG000|Overall Study|Withdrawal by Subject|1|||
143429309|NCT04140266|517118880|FG000|Overall Study|Physician Decision|2|||
143429310|NCT04140266|517118881|FG001|Overall Study|Physician Decision|0|||
143429311|NCT04140266|517118880|FG000|Overall Study|Withdrawal by Subject|4|||
143429312|NCT04140266|517118881|FG001|Overall Study|Withdrawal by Subject|2|||
143429313|NCT03511378|517118884|FG000|Overall Study|Withdrawal by Subject|2|||
143429314|NCT03511378|517118885|FG001|Overall Study|Withdrawal by Subject|2|||
143429315|NCT03511378|517118884|FG000|Overall Study|Patient not coming or schedule visit|1|||
143429316|NCT03511378|517118885|FG001|Overall Study|Patient not coming or schedule visit|0|||
143429317|NCT00837096|517118886|FG000|Overall Study|Physician Decision|1|||
143429318|NCT00837096|517118887|FG001|Overall Study|Physician Decision|1|||
143429319|NCT00837096|517118886|FG000|Overall Study|Not reported|9|||
143429320|NCT00837096|517118887|FG001|Overall Study|Not reported|8|||
143429321|NCT00329550|517118890|FG000|Overall Study|Adverse Event|3|||
143429322|NCT00329550|517118891|FG001|Overall Study|Adverse Event|4|||
143429323|NCT00329550|517118892|FG002|Overall Study|Adverse Event|2|||
143429324|NCT00329550|517118890|FG000|Overall Study|Withdrawal of Consent|1|||
143429325|NCT00329550|517118891|FG001|Overall Study|Withdrawal of Consent|0|||
143429326|NCT00329550|517118892|FG002|Overall Study|Withdrawal of Consent|1|||
143429327|NCT00329550|517118890|FG000|Overall Study|Due to Relocation|0|||
143429328|NCT00329550|517118891|FG001|Overall Study|Due to Relocation|0|||
143429329|NCT00329550|517118892|FG002|Overall Study|Due to Relocation|1|||
143429330|NCT00111839|517118893|FG000|Overall Study|Disease Progression|30|||
143429331|NCT00111839|517118894|FG001|Overall Study|Disease Progression|33|||
143429332|NCT00111839|517118895|FG002|Overall Study|Disease Progression|33|||
143429333|NCT00111839|517118893|FG000|Overall Study|Adverse Event|5|||
143429334|NCT00111839|517118894|FG001|Overall Study|Adverse Event|3|||
143429335|NCT00111839|517118895|FG002|Overall Study|Adverse Event|1|||
143429336|NCT00111839|517118893|FG000|Overall Study|Protocol Violation|2|||
143429337|NCT00111839|517118894|FG001|Overall Study|Protocol Violation|4|||
143429338|NCT00111839|517118895|FG002|Overall Study|Protocol Violation|2|||
143429339|NCT00111839|517118893|FG000|Overall Study|Death|1|||
143429340|NCT00111839|517118894|FG001|Overall Study|Death|1|||
143429341|NCT00111839|517118895|FG002|Overall Study|Death|6|||
143429342|NCT00111839|517118893|FG000|Overall Study|Withdrawal by Subject|2|||
143429343|NCT00111839|517118894|FG001|Overall Study|Withdrawal by Subject|2|||
143429344|NCT00111839|517118895|FG002|Overall Study|Withdrawal by Subject|2|||
143429345|NCT00111839|517118893|FG000|Overall Study|Lost to Follow-up|1|||
143429346|NCT00111839|517118894|FG001|Overall Study|Lost to Follow-up|0|||
143429347|NCT00111839|517118895|FG002|Overall Study|Lost to Follow-up|0|||
143429348|NCT00111839|517118893|FG000|Overall Study|Logistical Constraint|1|||
143429349|NCT00111839|517118894|FG001|Overall Study|Logistical Constraint|0|||
143429350|NCT00111839|517118895|FG002|Overall Study|Logistical Constraint|0|||
143429351|NCT00111839|517118893|FG000|Overall Study|Other|6|||
143429352|NCT00111839|517118894|FG001|Overall Study|Other|3|||
143429353|NCT00111839|517118895|FG002|Overall Study|Other|3|||
143429354|NCT00111839|517118893|FG000|Overall Study|Randomized but Not Treated|0|||
143429355|NCT00111839|517118894|FG001|Overall Study|Randomized but Not Treated|0|||
143429356|NCT00111839|517118895|FG002|Overall Study|Randomized but Not Treated|2|||
143429357|NCT01011049|517118896|FG000|Overall Study|Protocol Violation|0|||
143429358|NCT01011049|517118897|FG001|Overall Study|Protocol Violation|0|||
143429359|NCT01011049|517118898|FG002|Overall Study|Protocol Violation|2|||
143429360|NCT01011049|517118899|FG003|Overall Study|Protocol Violation|0|||
143429361|NCT01011049|517118896|FG000|Overall Study|Lost to Follow-up|1|||
143429362|NCT01011049|517118897|FG001|Overall Study|Lost to Follow-up|2|||
143429363|NCT01011049|517118898|FG002|Overall Study|Lost to Follow-up|1|||
143429364|NCT01011049|517118899|FG003|Overall Study|Lost to Follow-up|0|||
143429365|NCT01011049|517118896|FG000|Overall Study|Withdrawal by Subject|0|||
143429366|NCT01011049|517118897|FG001|Overall Study|Withdrawal by Subject|0|||
143429367|NCT01011049|517118898|FG002|Overall Study|Withdrawal by Subject|1|||
143429368|NCT01011049|517118899|FG003|Overall Study|Withdrawal by Subject|0|||
143429369|NCT03924947|517118902|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
143429370|NCT03924947|517118903|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
143429371|NCT03924947|517118904|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
143429372|NCT03924947|517118905|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
143429373|NCT03924947|517118906|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
143429374|NCT03924947|517118907|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
143429375|NCT02435381|517118908|FG000|Overall Study|Lost to Follow-up|2|||
143429376|NCT02435381|517118909|FG001|Overall Study|Lost to Follow-up|1|||
143429377|NCT04150341|517118910|FG000|Overall Study|Physician Decision|0|||
143429378|NCT04150341|517118911|FG001|Overall Study|Physician Decision|0|||
143429379|NCT04150341|517118912|FG002|Overall Study|Physician Decision|1|||
143429380|NCT04150341|517118913|FG003|Overall Study|Physician Decision|0|||
143429381|NCT04150341|517118914|FG004|Overall Study|Physician Decision|0|||
143429382|NCT04150341|517118915|FG005|Overall Study|Physician Decision|0|||
143429383|NCT04150341|517118910|FG000|Overall Study|Adverse Event|0|||
143429384|NCT04150341|517118911|FG001|Overall Study|Adverse Event|0|||
143429385|NCT04150341|517118912|FG002|Overall Study|Adverse Event|0|||
143429386|NCT04150341|517118913|FG003|Overall Study|Adverse Event|0|||
143429387|NCT04150341|517118914|FG004|Overall Study|Adverse Event|1|||
143429388|NCT04150341|517118915|FG005|Overall Study|Adverse Event|0|||
143429389|NCT00833898|517118921|FG000|Overall Study|Withdrawal by Subject|33|||
143429390|NCT00833898|517118922|FG001|Overall Study|Withdrawal by Subject|27|||
143429391|NCT00833898|517118921|FG000|Overall Study|Lost to Follow-up|7|||
143429392|NCT00833898|517118922|FG001|Overall Study|Lost to Follow-up|7|||
143429393|NCT00833898|517118921|FG000|Overall Study|Patient did not receive transplant|0|||
143429394|NCT00833898|517118922|FG001|Overall Study|Patient did not receive transplant|2|||
143429395|NCT03712449|517118923|FG000|Overall Study|Withdraw Consent|0|||
143429396|NCT03712449|517118924|FG001|Overall Study|Withdraw Consent|1|||
143429397|NCT00666198|517118925|FG000|Overall Study|Protocol Violation|10|||
143429398|NCT00666198|517118925|FG000|Overall Study|No Visit After First Day of Treatment|13|||
143429399|NCT00666198|517118925|FG000|Overall Study|Safety Not Assessable|6|||
143429400|NCT00666198|517118925|FG000|Overall Study|No Drug Administration|4|||
143429401|NCT03220776|517118929|FG000|Overall Study|Claustrophobia|0|||
143429402|NCT03220776|517118930|FG001|Overall Study|Claustrophobia|1|||
143429403|NCT03220776|517118931|FG002|Overall Study|Claustrophobia|1|||
143429404|NCT03220776|517118932|FG003|Overall Study|Claustrophobia|0|||
143429405|NCT03220776|517118933|FG004|Overall Study|Claustrophobia|1|||
143429406|NCT03220776|517118934|FG005|Overall Study|Claustrophobia|0|||
143429407|NCT03220776|517118929|FG000|Overall Study|MRI Equipment Failure|1|||
143429408|NCT03220776|517118930|FG001|Overall Study|MRI Equipment Failure|0|||
143429409|NCT03220776|517118931|FG002|Overall Study|MRI Equipment Failure|0|||
143429410|NCT03220776|517118932|FG003|Overall Study|MRI Equipment Failure|0|||
143429411|NCT03220776|517118933|FG004|Overall Study|MRI Equipment Failure|0|||
143429412|NCT03220776|517118934|FG005|Overall Study|MRI Equipment Failure|0|||
143429413|NCT03220776|517118929|FG000|Overall Study|Inclimate Weather|0|||
143429414|NCT03220776|517118930|FG001|Overall Study|Inclimate Weather|0|||
143429415|NCT03220776|517118931|FG002|Overall Study|Inclimate Weather|0|||
143429416|NCT03220776|517118932|FG003|Overall Study|Inclimate Weather|0|||
143429417|NCT03220776|517118933|FG004|Overall Study|Inclimate Weather|0|||
143429418|NCT03220776|517118934|FG005|Overall Study|Inclimate Weather|1|||
143429419|NCT03220776|517118929|FG000|Overall Study|Physician Decision|0|||
143429420|NCT03220776|517118930|FG001|Overall Study|Physician Decision|0|||
143429421|NCT03220776|517118931|FG002|Overall Study|Physician Decision|0|||
143429422|NCT03220776|517118932|FG003|Overall Study|Physician Decision|1|||
143429423|NCT03220776|517118933|FG004|Overall Study|Physician Decision|0|||
143429424|NCT03220776|517118934|FG005|Overall Study|Physician Decision|0|||
143429425|NCT03220776|517118929|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
143429426|NCT03220776|517118930|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
143429427|NCT03220776|517118931|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
143429428|NCT03220776|517118932|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
143429429|NCT03220776|517118933|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
143429430|NCT03220776|517118934|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
143429431|NCT03220776|517118929|FG000|Overall Study|Protocol Violation|0|||
143429432|NCT03220776|517118930|FG001|Overall Study|Protocol Violation|0|||
143429433|NCT03220776|517118931|FG002|Overall Study|Protocol Violation|0|||
143429434|NCT03220776|517118932|FG003|Overall Study|Protocol Violation|2|||
143429435|NCT03220776|517118933|FG004|Overall Study|Protocol Violation|0|||
143429436|NCT03220776|517118934|FG005|Overall Study|Protocol Violation|1|||
143429437|NCT03220776|517118929|FG000|Overall Study|Withdrawal by Subject|1|||
143429438|NCT03220776|517118930|FG001|Overall Study|Withdrawal by Subject|0|||
143429439|NCT03220776|517118931|FG002|Overall Study|Withdrawal by Subject|0|||
143429440|NCT03220776|517118932|FG003|Overall Study|Withdrawal by Subject|0|||
143429441|NCT03220776|517118933|FG004|Overall Study|Withdrawal by Subject|0|||
143429442|NCT03220776|517118934|FG005|Overall Study|Withdrawal by Subject|0|||
143429443|NCT03226353|517118935|FG000|Overall Study|Withdrawal by Subject|1|||
143429444|NCT03226353|517118935|FG000|Overall Study|Screen Failure|5|||
143429445|NCT03441789|517118936|FG000|Overall Study|Withdrawal by Subject|1|||
143429446|NCT03441789|517118937|FG001|Overall Study|Withdrawal by Subject|1|||
143429447|NCT03441789|517118936|FG000|Overall Study|Adverse Event|0|||
143429448|NCT03441789|517118937|FG001|Overall Study|Adverse Event|1|||
143429449|NCT03441789|517118936|FG000|Overall Study|Protocol Violation|0|||
143429450|NCT03441789|517118937|FG001|Overall Study|Protocol Violation|1|||
143429451|NCT03441789|517118936|FG000|Overall Study|Lost to Follow-up|0|||
143429452|NCT03441789|517118937|FG001|Overall Study|Lost to Follow-up|1|||
143429453|NCT02166047|517118940|FG000|Overall Study|Withdrawal by Participant|0|||
143429454|NCT02166047|517118941|FG001|Overall Study|Withdrawal by Participant|1|||
143429455|NCT02166047|517118942|FG002|Overall Study|Withdrawal by Participant|2|||
143429456|NCT02166047|517118943|FG003|Overall Study|Withdrawal by Participant|0|||
143429457|NCT02166047|517118944|FG004|Overall Study|Withdrawal by Participant|0|||
143429458|NCT02166047|517118945|FG005|Overall Study|Withdrawal by Participant|0|||
143429459|NCT02166047|517118946|FG006|Overall Study|Withdrawal by Participant|1|||
143429460|NCT02166047|517118947|FG007|Overall Study|Withdrawal by Participant|0|||
143429461|NCT02166047|517118948|FG008|Overall Study|Withdrawal by Participant|0|||
143429462|NCT02166047|517118949|FG009|Overall Study|Withdrawal by Participant|0|||
143429463|NCT02166047|517118950|FG010|Overall Study|Withdrawal by Participant|0|||
143429464|NCT02166047|517118951|FG011|Overall Study|Withdrawal by Participant|0|||
143429465|NCT02166047|517118940|FG000|Overall Study|Adverse Event|0|||
143429466|NCT02166047|517118941|FG001|Overall Study|Adverse Event|0|||
143429467|NCT02166047|517118942|FG002|Overall Study|Adverse Event|0|||
143429468|NCT02166047|517118943|FG003|Overall Study|Adverse Event|0|||
143429469|NCT02166047|517118944|FG004|Overall Study|Adverse Event|1|||
143429470|NCT02166047|517118945|FG005|Overall Study|Adverse Event|0|||
143429471|NCT02166047|517118946|FG006|Overall Study|Adverse Event|1|||
143429472|NCT02166047|517118947|FG007|Overall Study|Adverse Event|0|||
143429473|NCT02166047|517118948|FG008|Overall Study|Adverse Event|0|||
143429474|NCT02166047|517118949|FG009|Overall Study|Adverse Event|0|||
143429475|NCT02166047|517118950|FG010|Overall Study|Adverse Event|2|||
143429476|NCT02166047|517118951|FG011|Overall Study|Adverse Event|0|||
143429477|NCT02845375|517118953|FG000|Overall Study|upper airway obstruction|1|||
143429478|NCT02845375|517118954|FG001|Overall Study|upper airway obstruction|2|||
143429479|NCT02845375|517118955|FG002|Overall Study|upper airway obstruction|1|||
143429480|NCT01177137|517118956|FG000|Overall Study|Withdrawal by Subject|10|||
143429481|NCT01177137|517118957|FG001|Overall Study|Withdrawal by Subject|10|||
143429482|NCT01177137|517118958|FG002|Overall Study|Withdrawal by Subject|2|||
143429483|NCT02215954|517118960|FG000|Overall Study|Adverse Event|0|||
143429484|NCT02215954|517118961|FG001|Overall Study|Adverse Event|0|||
143429485|NCT02215954|517118962|FG002|Overall Study|Adverse Event|1|||
143429486|NCT02215954|517118960|FG000|Overall Study|Withdrawal by Subject|0|||
143429487|NCT02215954|517118961|FG001|Overall Study|Withdrawal by Subject|0|||
143429488|NCT02215954|517118962|FG002|Overall Study|Withdrawal by Subject|2|||
143429489|NCT02215954|517118960|FG000|Overall Study|Not exposed|1|||
143429490|NCT02215954|517118961|FG001|Overall Study|Not exposed|1|||
143429491|NCT02215954|517118962|FG002|Overall Study|Not exposed|3|||
143429492|NCT02460562|517118964|FG000|Overall Study|Lost to Follow-up|15|||
143429493|NCT02460562|517118965|FG001|Overall Study|Lost to Follow-up|16|||
143429494|NCT00588341|517118966|FG000|Overall Study|Withdrawal by Subject|3|||
143429495|NCT00588341|517118966|FG000|Overall Study|Not treated due to metastatic disease|1|||
143429496|NCT00588341|517118966|FG000|Overall Study|Patient ineligible|1|||
143429497|NCT01924806|517118969|FG000|Overall Study|Physician Decision|2|||
143429498|NCT01924806|517118970|FG001|Overall Study|Physician Decision|1|||
143429499|NCT03635775|517118971|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
143429500|NCT03635775|517118972|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
143429501|NCT03635775|517118973|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
143429502|NCT03635775|517118974|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
143429503|NCT00297778|517118982|FG000|Overall Study|Adverse Event|16|||
143429504|NCT00297778|517118983|FG001|Overall Study|Adverse Event|10|||
143429505|NCT00297778|517118982|FG000|Overall Study|Withdrawal by Subject|1|||
143429506|NCT00297778|517118983|FG001|Overall Study|Withdrawal by Subject|5|||
143429507|NCT00297778|517118982|FG000|Overall Study|Lack of Efficacy|2|||
143429508|NCT00297778|517118983|FG001|Overall Study|Lack of Efficacy|1|||
143429509|NCT00297778|517118982|FG000|Overall Study|Non-compliant with trial protocol|0|||
143429510|NCT00297778|517118983|FG001|Overall Study|Non-compliant with trial protocol|3|||
143429511|NCT00297778|517118982|FG000|Overall Study|Other|0|||
143429512|NCT00297778|517118983|FG001|Overall Study|Other|1|||
143429513|NCT03280108|517118985|FG000|Overall Study|Lost to Follow-up|2|||
143429514|NCT03280108|517118986|FG001|Overall Study|Lost to Follow-up|0|||
143429515|NCT01187407|517118987|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
143429516|NCT01187407|517118988|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
143429517|NCT01187407|517118989|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
143429518|NCT01187407|517118990|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
143429519|NCT01187407|517118991|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
143429520|NCT01187407|517118987|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
143429521|NCT01187407|517118988|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
143429522|NCT01187407|517118989|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
143429523|NCT01187407|517118990|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
143429524|NCT01187407|517118991|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
143429525|NCT01187407|517118987|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
143429526|NCT01187407|517118988|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
143429527|NCT01187407|517118989|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
143429528|NCT01187407|517118990|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
143429529|NCT01187407|517118991|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
143429530|NCT01187407|517118987|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
143429531|NCT01187407|517118988|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
143429532|NCT01187407|517118989|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
143429533|NCT01187407|517118990|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
143429534|NCT01187407|517118991|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
143429535|NCT01187407|517118987|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
143429536|NCT01187407|517118988|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
143429537|NCT01187407|517118989|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
143429538|NCT01187407|517118990|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
143429539|NCT01187407|517118991|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
143429540|NCT01187407|517118987|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
143429541|NCT01187407|517118988|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
143429542|NCT01187407|517118989|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
143429543|NCT01187407|517118990|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
143429544|NCT01187407|517118991|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
143429545|NCT01187407|517118987|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
143429546|NCT01187407|517118988|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
143429547|NCT01187407|517118989|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
143429548|NCT01187407|517118990|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
143429549|NCT01187407|517118991|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
143429550|NCT01187407|517118987|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
143429551|NCT01187407|517118988|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
143429552|NCT01187407|517118989|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
143429553|NCT01187407|517118990|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
143429554|NCT01187407|517118991|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
143429555|NCT01187407|517118987|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
143429556|NCT01187407|517118988|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
143429557|NCT01187407|517118989|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
143429558|NCT01187407|517118990|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
143429559|NCT01187407|517118991|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
143429560|NCT01187407|517118987|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
143429561|NCT01187407|517118988|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
143429562|NCT01187407|517118989|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
143429563|NCT01187407|517118990|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
143429564|NCT01187407|517118991|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
143429565|NCT01187407|517118987|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
143429566|NCT01187407|517118988|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
143429567|NCT01187407|517118989|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
143429568|NCT01187407|517118990|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
143429569|NCT01187407|517118991|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
143429570|NCT01187407|517118987|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
143429571|NCT01187407|517118988|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
143429572|NCT01187407|517118989|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
143429573|NCT01187407|517118990|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
143429574|NCT01187407|517118991|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
143429575|NCT01187407|517118987|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
143429576|NCT01187407|517118988|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
143429577|NCT01187407|517118989|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
143429578|NCT01187407|517118990|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
143429579|NCT01187407|517118991|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
143429580|NCT01187407|517118987|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
143429581|NCT01187407|517118988|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
143429582|NCT01187407|517118989|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
143429583|NCT01187407|517118990|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
143429584|NCT01187407|517118991|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
143429585|NCT02996097|517118992|FG000|Overall Study|Lost to Follow-up|11|||
143429586|NCT02996097|517118993|FG001|Overall Study|Lost to Follow-up|11|||
143429587|NCT02201771|517118994|FG000|Overall Study|Death|3|||
143429588|NCT02201771|517118995|FG001|Overall Study|Death|2|||
143429589|NCT02201771|517118996|FG002|Overall Study|Death|0|||
143429590|NCT02201771|517118994|FG000|Overall Study|Protocol Violation|10|||
143429591|NCT02201771|517118995|FG001|Overall Study|Protocol Violation|8|||
143429592|NCT02201771|517118996|FG002|Overall Study|Protocol Violation|10|||
143429593|NCT01713998|517118997|FG000|Overall Study|Lost to Follow-up|2|||
143429594|NCT01713998|517118998|FG001|Overall Study|Lost to Follow-up|0|||
143429595|NCT01713998|517118999|FG002|Overall Study|Lost to Follow-up|2|||
143429596|NCT01713998|517118997|FG000|Overall Study|Withdrawal by Subject|1|||
143429597|NCT01713998|517118998|FG001|Overall Study|Withdrawal by Subject|0|||
143429598|NCT01713998|517118999|FG002|Overall Study|Withdrawal by Subject|0|||
143429599|NCT03569475|517119000|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
143429600|NCT03569475|517119001|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
143429601|NCT03569475|517119002|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
143429602|NCT03569475|517119000|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
143429603|NCT03569475|517119001|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
143429604|NCT03569475|517119002|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
143429605|NCT03569475|517119000|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
143429606|NCT03569475|517119001|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
143429607|NCT03569475|517119002|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
143429608|NCT03569475|517119000|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
143429609|NCT03569475|517119001|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
143429610|NCT03569475|517119002|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
143429611|NCT03569475|517119000|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
143429612|NCT03569475|517119001|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
143429613|NCT03569475|517119002|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
143429614|NCT03569475|517119000|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
143429615|NCT03569475|517119001|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
143429616|NCT03569475|517119002|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
143429617|NCT03569475|517119000|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
143429618|NCT03569475|517119001|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
143429619|NCT03569475|517119002|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
143429620|NCT03569475|517119000|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
143429621|NCT03569475|517119001|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
143429622|NCT03569475|517119002|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
143429623|NCT03569475|517119000|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
143429624|NCT03569475|517119001|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
143429625|NCT03569475|517119002|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
143429626|NCT03638258|517119003|FG000|Overall Study|Adverse Event|1|||
143429627|NCT03638258|517119004|FG001|Overall Study|Adverse Event|0|||
143429628|NCT03638258|517119005|FG002|Overall Study|Adverse Event|2|||
143429629|NCT03638258|517119003|FG000|Overall Study|Lost to Follow-up|2|||
143429630|NCT03638258|517119004|FG001|Overall Study|Lost to Follow-up|4|||
143429631|NCT03638258|517119005|FG002|Overall Study|Lost to Follow-up|5|||
143429632|NCT03638258|517119003|FG000|Overall Study|Pregnancy|0|||
143429633|NCT03638258|517119004|FG001|Overall Study|Pregnancy|0|||
143429634|NCT03638258|517119005|FG002|Overall Study|Pregnancy|1|||
143429635|NCT03638258|517119003|FG000|Overall Study|Protocol Violation|0|||
143429636|NCT03638258|517119004|FG001|Overall Study|Protocol Violation|0|||
143429637|NCT03638258|517119005|FG002|Overall Study|Protocol Violation|1|||
143429638|NCT03638258|517119003|FG000|Overall Study|Withdrawal by Subject|4|||
143429639|NCT03638258|517119004|FG001|Overall Study|Withdrawal by Subject|5|||
143429640|NCT03638258|517119005|FG002|Overall Study|Withdrawal by Subject|12|||
143429641|NCT03638258|517119003|FG000|Overall Study|Lack of Efficacy|0|||
143429642|NCT03638258|517119004|FG001|Overall Study|Lack of Efficacy|0|||
143429643|NCT03638258|517119005|FG002|Overall Study|Lack of Efficacy|2|||
143429644|NCT01919398|517119006|FG000|Overall Study|Progressive Disease|0|||
143429645|NCT01919398|517119007|FG001|Overall Study|Progressive Disease|0|||
143429646|NCT01919398|517119008|FG002|Overall Study|Progressive Disease|4|||
143429647|NCT02383927|517119012|FG000|Overall Study|Disease Progression|8|||
143429648|NCT02383927|517119013|FG001|Overall Study|Disease Progression|8|||
143429649|NCT02383927|517119014|FG002|Overall Study|Disease Progression|15|||
143429650|NCT02383927|517119015|FG003|Overall Study|Disease Progression|4|||
143429651|NCT02383927|517119012|FG000|Overall Study|Physician Decision|0|||
143429652|NCT02383927|517119013|FG001|Overall Study|Physician Decision|0|||
143429653|NCT02383927|517119014|FG002|Overall Study|Physician Decision|2|||
143429654|NCT02383927|517119015|FG003|Overall Study|Physician Decision|0|||
143429655|NCT02383927|517119012|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
143429656|NCT02383927|517119013|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
143429657|NCT02383927|517119014|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
143429658|NCT02383927|517119015|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
143429659|NCT02383927|517119012|FG000|Overall Study|Adverse Event|4|||
143429660|NCT02383927|517119013|FG001|Overall Study|Adverse Event|1|||
143429661|NCT02383927|517119014|FG002|Overall Study|Adverse Event|3|||
143429662|NCT02383927|517119015|FG003|Overall Study|Adverse Event|5|||
143429663|NCT02383927|517119012|FG000|Overall Study|Miscellaneous|1|||
143429664|NCT02383927|517119013|FG001|Overall Study|Miscellaneous|0|||
143429665|NCT02383927|517119014|FG002|Overall Study|Miscellaneous|0|||
143429666|NCT02383927|517119015|FG003|Overall Study|Miscellaneous|1|||
143429667|NCT02383927|517119012|FG000|Overall Study|Withdrawal by Subject|0|||
143429668|NCT02383927|517119013|FG001|Overall Study|Withdrawal by Subject|1|||
143429669|NCT02383927|517119014|FG002|Overall Study|Withdrawal by Subject|4|||
143429670|NCT02383927|517119015|FG003|Overall Study|Withdrawal by Subject|0|||
143429671|NCT00981578|517119016|FG000|Overall Study|Death|1|||
143429672|NCT00981578|517119016|FG000|Overall Study|Withdrawal by Subject|2|||
143429673|NCT02865135|517119017|FG000|Overall Study|Death|0|||
143429674|NCT02865135|517119018|FG001|Overall Study|Death|1|||
143429675|NCT02865135|517119019|FG002|Overall Study|Death|0|||
143429676|NCT02865135|517119017|FG000|Overall Study|Progression|6|||
143429677|NCT02865135|517119018|FG001|Overall Study|Progression|2|||
143429678|NCT02865135|517119019|FG002|Overall Study|Progression|2|||
143429679|NCT00645099|517119022|FG000|Overall Study|Lack of Efficacy|15|||
143429680|NCT00645099|517119023|FG001|Overall Study|Lack of Efficacy|6|||
143429681|NCT00645099|517119022|FG000|Overall Study|Withdrawal by Subject|30|||
143429682|NCT00645099|517119023|FG001|Overall Study|Withdrawal by Subject|22|||
143429683|NCT00645099|517119022|FG000|Overall Study|Lost to Follow-up|6|||
143429684|NCT00645099|517119023|FG001|Overall Study|Lost to Follow-up|4|||
143429685|NCT00645099|517119022|FG000|Overall Study|Adverse Event|11|||
143429686|NCT00645099|517119023|FG001|Overall Study|Adverse Event|5|||
143429687|NCT00645099|517119022|FG000|Overall Study|Other|9|||
143429688|NCT00645099|517119023|FG001|Overall Study|Other|5|||
143429689|NCT01201915|517119024|FG000|Overall Study|Adverse Event|2|||
143429690|NCT01201915|517119025|FG001|Overall Study|Adverse Event|1|||
143429691|NCT01201915|517119026|FG002|Overall Study|Adverse Event|1|||
143429692|NCT01201915|517119024|FG000|Overall Study|Lost to Follow-up|0|||
143429693|NCT01201915|517119025|FG001|Overall Study|Lost to Follow-up|4|||
143429694|NCT01201915|517119026|FG002|Overall Study|Lost to Follow-up|0|||
143429695|NCT01201915|517119024|FG000|Overall Study|Physician Decision|3|||
143429696|NCT01201915|517119025|FG001|Overall Study|Physician Decision|0|||
143429697|NCT01201915|517119026|FG002|Overall Study|Physician Decision|0|||
143429698|NCT01201915|517119024|FG000|Overall Study|Subject Decision|3|||
143429699|NCT01201915|517119025|FG001|Overall Study|Subject Decision|3|||
143429700|NCT01201915|517119026|FG002|Overall Study|Subject Decision|5|||
143429701|NCT01201915|517119024|FG000|Overall Study|Target Lesion Progression|0|||
143429702|NCT01201915|517119025|FG001|Overall Study|Target Lesion Progression|3|||
143429703|NCT01201915|517119026|FG002|Overall Study|Target Lesion Progression|0|||
143429704|NCT03406507|517119027|FG000|Extension Period|Lack of Efficacy|0|||
143429705|NCT03406507|517119028|FG001|Extension Period|Lack of Efficacy|1|||
143429706|NCT02316171|517119029|FG000|Overall Study|difficulties with urinary catheter|1|||
143429707|NCT02316171|517119030|FG001|Overall Study|difficulties with urinary catheter|0|||
143429708|NCT02316171|517119031|FG002|Overall Study|difficulties with urinary catheter|0|||
143429709|NCT02316171|517119032|FG003|Overall Study|difficulties with urinary catheter|0|||
143429710|NCT02799745|517119033|FG000|Overall Study|Participant moved out of state|1|||
143429711|NCT02799745|517119034|FG001|Overall Study|Participant moved out of state|0|||
143429712|NCT02799745|517119033|FG000|Overall Study|Discontinued due to planned surgery|1|||
143429713|NCT02799745|517119034|FG001|Overall Study|Discontinued due to planned surgery|0|||
143429714|NCT02799745|517119033|FG000|Overall Study|Withdrawal by Subject|16|||
143429715|NCT02799745|517119034|FG001|Overall Study|Withdrawal by Subject|25|||
143429716|NCT02799745|517119033|FG000|Overall Study|Protocol Deviation|4|||
143429717|NCT02799745|517119034|FG001|Overall Study|Protocol Deviation|5|||
143429718|NCT02799745|517119033|FG000|Overall Study|Progressive Disease|28|||
143429719|NCT02799745|517119034|FG001|Overall Study|Progressive Disease|38|||
143429720|NCT02799745|517119033|FG000|Overall Study|Lost to Follow-up|3|||
143429721|NCT02799745|517119034|FG001|Overall Study|Lost to Follow-up|2|||
143429722|NCT02799745|517119033|FG000|Overall Study|Death|3|||
143429723|NCT02799745|517119034|FG001|Overall Study|Death|0|||
143429724|NCT02799745|517119033|FG000|Overall Study|Adverse Event|0|||
143429725|NCT02799745|517119034|FG001|Overall Study|Adverse Event|1|||
143429726|NCT02329223|517119981|FG000|Overall Study|Withdrawal by Subject|1|||
143429727|NCT02329223|517119982|FG001|Overall Study|Withdrawal by Subject|2|||
143429728|NCT02329223|517119983|FG002|Overall Study|Withdrawal by Subject|5|||
143429729|NCT02329223|517119981|FG000|Overall Study|Physician Decision|0|||
143429730|NCT02329223|517119982|FG001|Overall Study|Physician Decision|0|||
143429731|NCT02329223|517119983|FG002|Overall Study|Physician Decision|1|||
143429732|NCT02329223|517119981|FG000|Overall Study|Adverse Event|0|||
143429733|NCT02329223|517119982|FG001|Overall Study|Adverse Event|1|||
143429734|NCT02329223|517119983|FG002|Overall Study|Adverse Event|0|||
143429735|NCT03168425|517119994|FG000|Overall Study|Lost to Follow-up|5|||
143429736|NCT03168425|517119995|FG001|Overall Study|Lost to Follow-up|8|||
143429737|NCT03168425|517119994|FG000|Overall Study|unable to confirm post op opioids|2|||
143429738|NCT03168425|517119995|FG001|Overall Study|unable to confirm post op opioids|3|||
143429739|NCT04491006|517119996|FG000|Overall Study|Adverse Event|0|||
143429740|NCT04491006|517119997|FG001|Overall Study|Adverse Event|3|||
143429741|NCT04491006|517119998|FG002|Overall Study|Adverse Event|5|||
143429742|NCT04491006|517119996|FG000|Overall Study|Withdrawal by Subject|1|||
143429743|NCT04491006|517119997|FG001|Overall Study|Withdrawal by Subject|0|||
143429744|NCT04491006|517119998|FG002|Overall Study|Withdrawal by Subject|2|||
143429745|NCT01960114|517120003|FG000|Overall Study|Adverse Event|1|||
143429746|NCT01960114|517120004|FG001|Overall Study|Adverse Event|0|||
143429747|NCT01960114|517120003|FG000|Overall Study|Could not swallow study medication|0|||
143429748|NCT01960114|517120004|FG001|Overall Study|Could not swallow study medication|1|||
143429749|NCT02490878|517120008|FG000|Overall Study|deemed ineligible|0|||
143429750|NCT02490878|517120009|FG001|Overall Study|deemed ineligible|1|||
143429751|NCT02490878|517120008|FG000|Overall Study|progression prior to treatment|0|||
143429752|NCT02490878|517120009|FG001|Overall Study|progression prior to treatment|1|||
143429753|NCT02490878|517120008|FG000|Overall Study|only submitted baseline QOL|0|||
143429754|NCT02490878|517120009|FG001|Overall Study|only submitted baseline QOL|1|||
143429755|NCT00451555|517120010|FG000|Overall Study|Protocol Violation|2|||
143429756|NCT00451555|517120011|FG001|Overall Study|Protocol Violation|2|||
143429757|NCT00451555|517120010|FG000|Overall Study|Adverse Event|3|||
143429758|NCT00451555|517120011|FG001|Overall Study|Adverse Event|1|||
143429759|NCT00451555|517120010|FG000|Overall Study|Withdrawal by Subject|6|||
143429760|NCT00451555|517120011|FG001|Overall Study|Withdrawal by Subject|0|||
143429761|NCT00451555|517120010|FG000|Overall Study|Physician Decision|2|||
143429762|NCT00451555|517120011|FG001|Overall Study|Physician Decision|1|||
143429763|NCT00922441|517120012|FG000|Overall Study|Protocol Violation|0|||
143429764|NCT00922441|517120013|FG001|Overall Study|Protocol Violation|0|||
143429765|NCT00922441|517120014|FG002|Overall Study|Protocol Violation|2|||
143429766|NCT00922441|517120012|FG000|Overall Study|Withdrawal by Subject|0|||
143429767|NCT00922441|517120013|FG001|Overall Study|Withdrawal by Subject|0|||
143429768|NCT00922441|517120014|FG002|Overall Study|Withdrawal by Subject|1|||
143429769|NCT02959177|517120015|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
143429770|NCT02959177|517120016|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
143429771|NCT02959177|517120017|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
143429772|NCT02959177|517120015|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
143429773|NCT02959177|517120016|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
143429774|NCT02959177|517120017|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
143429775|NCT02959177|517120015|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
143429776|NCT02959177|517120016|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
143429777|NCT02959177|517120017|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
143429778|NCT02959177|517120015|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
143429779|NCT02959177|517120016|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
143429780|NCT02959177|517120017|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
143429781|NCT02959177|517120015|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
143429782|NCT02959177|517120016|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
143429783|NCT02959177|517120017|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
143429784|NCT02959177|517120015|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
143429785|NCT02959177|517120016|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
143429786|NCT02959177|517120017|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
143429787|NCT02959177|517120015|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
143429788|NCT02959177|517120016|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
143429789|NCT02959177|517120017|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
143429790|NCT00677092|517120019|FG000|Overall Study|Adverse Event|1|||
143429791|NCT00677092|517120019|FG000|Overall Study|Lost to Follow-up|1|||
143429792|NCT00677092|517120019|FG000|Overall Study|Withdrawal by Subject|3|||
143429793|NCT00677092|517120019|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
143429794|NCT00187135|517120020|FG000|Visit One|Withdrawal by Subject|1|||
143429795|NCT00187135|517120021|FG001|Visit One|Withdrawal by Subject|0|||
143429796|NCT00187135|517120022|FG002|Visit One|Withdrawal by Subject|0|||
143429797|NCT00187135|517120023|FG003|Visit One|Withdrawal by Subject|0|||
143429798|NCT00187135|517120024|FG004|Visit One|Withdrawal by Subject|0|||
143429799|NCT00187135|517120025|FG005|Visit One|Withdrawal by Subject|1|||
143429800|NCT00187135|517120020|FG000|Visit One|Physician Decision|3|||
143429801|NCT00187135|517120021|FG001|Visit One|Physician Decision|1|||
143429802|NCT00187135|517120022|FG002|Visit One|Physician Decision|0|||
143429803|NCT00187135|517120023|FG003|Visit One|Physician Decision|0|||
143429804|NCT00187135|517120024|FG004|Visit One|Physician Decision|0|||
143429805|NCT00187135|517120025|FG005|Visit One|Physician Decision|1|||
143429806|NCT00187135|517120020|FG000|Visit Two|Death|0|||
143429807|NCT00187135|517120021|FG001|Visit Two|Death|0|||
143429808|NCT00187135|517120022|FG002|Visit Two|Death|0|||
143429809|NCT00187135|517120023|FG003|Visit Two|Death|1|||
143429810|NCT00187135|517120024|FG004|Visit Two|Death|0|||
143429811|NCT00187135|517120025|FG005|Visit Two|Death|1|||
143429812|NCT00187135|517120020|FG000|Visit Two|Physician Decision|1|||
143429813|NCT00187135|517120021|FG001|Visit Two|Physician Decision|0|||
143429814|NCT00187135|517120022|FG002|Visit Two|Physician Decision|0|||
143429815|NCT00187135|517120023|FG003|Visit Two|Physician Decision|0|||
143429816|NCT00187135|517120024|FG004|Visit Two|Physician Decision|0|||
143429817|NCT00187135|517120025|FG005|Visit Two|Physician Decision|0|||
143429818|NCT00187135|517120020|FG000|Visit Two|Withdrawal by Subject|1|||
143429819|NCT00187135|517120021|FG001|Visit Two|Withdrawal by Subject|1|||
143429820|NCT00187135|517120022|FG002|Visit Two|Withdrawal by Subject|1|||
143429821|NCT00187135|517120023|FG003|Visit Two|Withdrawal by Subject|0|||
143429822|NCT00187135|517120024|FG004|Visit Two|Withdrawal by Subject|1|||
143429823|NCT00187135|517120025|FG005|Visit Two|Withdrawal by Subject|1|||
143429824|NCT00187135|517120020|FG000|Visit Two|Study Discontinued|3|||
143429825|NCT00187135|517120021|FG001|Visit Two|Study Discontinued|2|||
143429826|NCT00187135|517120022|FG002|Visit Two|Study Discontinued|1|||
143429827|NCT00187135|517120023|FG003|Visit Two|Study Discontinued|7|||
143429828|NCT00187135|517120024|FG004|Visit Two|Study Discontinued|5|||
143429829|NCT00187135|517120025|FG005|Visit Two|Study Discontinued|6|||
143429830|NCT00187135|517120020|FG000|Visit Three|Death|0|||
143429831|NCT00187135|517120021|FG001|Visit Three|Death|0|||
143429832|NCT00187135|517120022|FG002|Visit Three|Death|1|||
143429833|NCT00187135|517120023|FG003|Visit Three|Death|0|||
143429834|NCT00187135|517120024|FG004|Visit Three|Death|1|||
143429835|NCT00187135|517120025|FG005|Visit Three|Death|0|||
143429836|NCT00187135|517120020|FG000|Visit Three|Withdrawal by Subject|0|||
143429837|NCT00187135|517120021|FG001|Visit Three|Withdrawal by Subject|1|||
143429838|NCT00187135|517120022|FG002|Visit Three|Withdrawal by Subject|1|||
143429839|NCT00187135|517120023|FG003|Visit Three|Withdrawal by Subject|2|||
143429840|NCT00187135|517120024|FG004|Visit Three|Withdrawal by Subject|0|||
143429841|NCT00187135|517120025|FG005|Visit Three|Withdrawal by Subject|0|||
143429842|NCT00187135|517120020|FG000|Visit Three|Study Discontinued|7|||
143429843|NCT00187135|517120021|FG001|Visit Three|Study Discontinued|6|||
143429844|NCT00187135|517120022|FG002|Visit Three|Study Discontinued|7|||
143429845|NCT00187135|517120023|FG003|Visit Three|Study Discontinued|7|||
143429846|NCT00187135|517120024|FG004|Visit Three|Study Discontinued|7|||
143429847|NCT00187135|517120025|FG005|Visit Three|Study Discontinued|6|||
143429848|NCT01951261|517120026|FG000|Overall Study|Death|1|||
143429849|NCT01951261|517120027|FG001|Overall Study|Death|0|||
143429850|NCT01951261|517120026|FG000|Overall Study|Lost to Follow-up|4|||
143429851|NCT01951261|517120027|FG001|Overall Study|Lost to Follow-up|3|||
143429852|NCT01951261|517120026|FG000|Overall Study|Protocol Violation|4|||
143429853|NCT01951261|517120027|FG001|Overall Study|Protocol Violation|3|||
143429854|NCT01287416|517120028|FG000|Pre-post Training|Withdrawal by Subject|17|||
143429855|NCT01287416|517120029|FG001|Pre-post Training|Withdrawal by Subject|24|||
143429856|NCT01287416|517120028|FG000|Pre-post Training|Lost to Follow-up|5|||
143429857|NCT01287416|517120029|FG001|Pre-post Training|Lost to Follow-up|1|||
143429858|NCT01287416|517120028|FG000|6 Month Follow-up|Lost to Follow-up|3|||
143429859|NCT01287416|517120029|FG001|6 Month Follow-up|Lost to Follow-up|2|||
143429860|NCT02109107|517120032|FG000|Overall Study|Lost to Follow-up|2|||
143429861|NCT03078751|517120034|FG000|Overall Study|Adverse Event|4|||
143429862|NCT03078751|517120035|FG001|Overall Study|Adverse Event|0|||
143429863|NCT03078751|517120034|FG000|Overall Study|Physician Decision|1|||
143429864|NCT03078751|517120035|FG001|Overall Study|Physician Decision|0|||
143429865|NCT03078751|517120034|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
143429866|NCT03078751|517120035|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
143429867|NCT03078751|517120034|FG000|Overall Study|Subject/guardian decision|8|||
143429868|NCT03078751|517120035|FG001|Overall Study|Subject/guardian decision|1|||
143429869|NCT03078751|517120034|FG000|Overall Study|Untreated|0|||
143429870|NCT03078751|517120035|FG001|Overall Study|Untreated|4|||
143429871|NCT00607789|517120040|FG000|Overall Study|Adverse Event|3|||
143429872|NCT00607789|517120041|FG001|Overall Study|Adverse Event|0|||
143429873|NCT00607789|517120040|FG000|Overall Study|Lack of Efficacy|0|||
143429874|NCT00607789|517120041|FG001|Overall Study|Lack of Efficacy|1|||
143429875|NCT00607789|517120040|FG000|Overall Study|Inadequate adherence|3|||
143429876|NCT00607789|517120041|FG001|Overall Study|Inadequate adherence|0|||
143429877|NCT00607789|517120040|FG000|Overall Study|Lost to Follow-up|0|||
143429878|NCT00607789|517120041|FG001|Overall Study|Lost to Follow-up|5|||
143429879|NCT00607789|517120040|FG000|Overall Study|Withdrawal by Subject|1|||
143429880|NCT00607789|517120041|FG001|Overall Study|Withdrawal by Subject|0|||
143429881|NCT04414397|517120042|FG000|Control Period|Withdrawal by Subject|2|||
143429882|NCT04414397|517120043|FG001|Control Period|Withdrawal by Subject|2|||
143429883|NCT04414397|517120042|FG000|Control Period|Lost to Follow-up|0|||
143429884|NCT04414397|517120043|FG001|Control Period|Lost to Follow-up|4|||
143429885|NCT04414397|517120042|FG000|Control Period|Protocol deviation|0|||
143429886|NCT04414397|517120043|FG001|Control Period|Protocol deviation|1|||
143429887|NCT04414397|517120042|FG000|Post-Control Period|Withdrawal by Subject|3|||
143429888|NCT04414397|517120043|FG001|Post-Control Period|Withdrawal by Subject|6|||
143429889|NCT04414397|517120042|FG000|Post-Control Period|Lost to Follow-up|4|||
143429890|NCT04414397|517120043|FG001|Post-Control Period|Lost to Follow-up|9|||
143429891|NCT04414397|517120042|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
143429892|NCT04414397|517120043|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
143429893|NCT04414397|517120042|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
143429894|NCT04414397|517120043|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
143429895|NCT01313299|517120044|FG000|Overall Study|Adverse Event|3|||
143429896|NCT01313299|517120045|FG001|Overall Study|Adverse Event|1|||
143429897|NCT01313299|517120046|FG002|Overall Study|Adverse Event|1|||
143429898|NCT01313299|517120044|FG000|Overall Study|Lost to Follow-up|1|||
143429899|NCT01313299|517120045|FG001|Overall Study|Lost to Follow-up|0|||
143429900|NCT01313299|517120046|FG002|Overall Study|Lost to Follow-up|0|||
143429901|NCT01313299|517120044|FG000|Overall Study|Protocol Violation|2|||
143429902|NCT01313299|517120045|FG001|Overall Study|Protocol Violation|0|||
143429903|NCT01313299|517120046|FG002|Overall Study|Protocol Violation|0|||
143429904|NCT01313299|517120044|FG000|Overall Study|Withdrawal by Subject|1|||
143429905|NCT01313299|517120045|FG001|Overall Study|Withdrawal by Subject|0|||
143429906|NCT01313299|517120046|FG002|Overall Study|Withdrawal by Subject|2|||
143429907|NCT01313299|517120044|FG000|Overall Study|Family reason and moved out of state|0|||
143429908|NCT01313299|517120045|FG001|Overall Study|Family reason and moved out of state|2|||
143429909|NCT01313299|517120046|FG002|Overall Study|Family reason and moved out of state|0|||
143429910|NCT01313299|517120044|FG000|Overall Study|Lack of subject compliance|0|||
143429911|NCT01313299|517120045|FG001|Overall Study|Lack of subject compliance|0|||
143429912|NCT01313299|517120046|FG002|Overall Study|Lack of subject compliance|1|||
143429913|NCT01222078|517120048|FG000|Overall Study|Early termination of the study|1|||
143429914|NCT02515097|517120049|FG000|Overall Study|Lost to Follow-up|4|||
143429915|NCT02515097|517120050|FG001|Overall Study|Lost to Follow-up|2|||
143429916|NCT02515097|517120049|FG000|Overall Study|Withdrawal by Subject|1|||
143429917|NCT02515097|517120050|FG001|Overall Study|Withdrawal by Subject|3|||
143429918|NCT02515097|517120049|FG000|Overall Study|Adverse Event|2|||
143429919|NCT02515097|517120050|FG001|Overall Study|Adverse Event|1|||
143429920|NCT00853021|517120051|FG000|Overall Study|Adverse Event|2|||
143429921|NCT00853021|517120051|FG000|Overall Study|Withdrawal by Subject|2|||
143429922|NCT00853021|517120051|FG000|Overall Study|Death|1|||
143429923|NCT03613454|517120052|FG000|Overall Study|Protocol Violation|1|||
143429924|NCT03613454|517120053|FG001|Overall Study|Protocol Violation|0|||
143429925|NCT03613454|517120052|FG000|Overall Study|Protocol Violation|0|||
143429926|NCT03613454|517120053|FG001|Overall Study|Protocol Violation|1|||
143429927|NCT01180790|517120054|FG000|Overall Study|Adverse Event|1|||
143429928|NCT01180790|517120055|FG001|Overall Study|Adverse Event|1|||
143429929|NCT01180790|517120056|FG002|Overall Study|Adverse Event|2|||
143429930|NCT01180790|517120057|FG003|Overall Study|Adverse Event|0|||
143429931|NCT01180790|517120058|FG004|Overall Study|Adverse Event|1|||
143429932|NCT01180790|517120059|FG005|Overall Study|Adverse Event|3|||
143429933|NCT01180790|517120060|FG006|Overall Study|Adverse Event|0|||
143429934|NCT01180790|517120054|FG000|Overall Study|Withdrawal by Subject|3|||
143429935|NCT01180790|517120055|FG001|Overall Study|Withdrawal by Subject|0|||
143429936|NCT01180790|517120056|FG002|Overall Study|Withdrawal by Subject|5|||
143429937|NCT01180790|517120057|FG003|Overall Study|Withdrawal by Subject|0|||
143429938|NCT01180790|517120058|FG004|Overall Study|Withdrawal by Subject|2|||
143429939|NCT01180790|517120059|FG005|Overall Study|Withdrawal by Subject|1|||
143429940|NCT01180790|517120060|FG006|Overall Study|Withdrawal by Subject|0|||
143429941|NCT01180790|517120054|FG000|Overall Study|Lost to Follow-up|3|||
143429942|NCT01180790|517120055|FG001|Overall Study|Lost to Follow-up|1|||
143429943|NCT01180790|517120056|FG002|Overall Study|Lost to Follow-up|0|||
143429944|NCT01180790|517120057|FG003|Overall Study|Lost to Follow-up|2|||
143429945|NCT01180790|517120058|FG004|Overall Study|Lost to Follow-up|1|||
143429946|NCT01180790|517120059|FG005|Overall Study|Lost to Follow-up|0|||
143429947|NCT01180790|517120060|FG006|Overall Study|Lost to Follow-up|1|||
143429948|NCT01180790|517120054|FG000|Overall Study|Physician Decision|1|||
143429949|NCT01180790|517120055|FG001|Overall Study|Physician Decision|0|||
143429950|NCT01180790|517120056|FG002|Overall Study|Physician Decision|0|||
143429951|NCT01180790|517120057|FG003|Overall Study|Physician Decision|1|||
143429952|NCT01180790|517120058|FG004|Overall Study|Physician Decision|0|||
143429953|NCT01180790|517120059|FG005|Overall Study|Physician Decision|0|||
143429954|NCT01180790|517120060|FG006|Overall Study|Physician Decision|0|||
143429955|NCT01180790|517120054|FG000|Overall Study|Lack of Efficacy|1|||
143429956|NCT01180790|517120055|FG001|Overall Study|Lack of Efficacy|2|||
143429957|NCT01180790|517120056|FG002|Overall Study|Lack of Efficacy|5|||
143429958|NCT01180790|517120057|FG003|Overall Study|Lack of Efficacy|6|||
143429959|NCT01180790|517120058|FG004|Overall Study|Lack of Efficacy|1|||
143429960|NCT01180790|517120059|FG005|Overall Study|Lack of Efficacy|3|||
143429961|NCT01180790|517120060|FG006|Overall Study|Lack of Efficacy|0|||
143429962|NCT01180790|517120054|FG000|Overall Study|compliance|0|||
143429963|NCT01180790|517120055|FG001|Overall Study|compliance|1|||
143429964|NCT01180790|517120056|FG002|Overall Study|compliance|0|||
143429965|NCT01180790|517120057|FG003|Overall Study|compliance|0|||
143429966|NCT01180790|517120058|FG004|Overall Study|compliance|0|||
143429967|NCT01180790|517120059|FG005|Overall Study|compliance|0|||
143429968|NCT01180790|517120060|FG006|Overall Study|compliance|0|||
143429969|NCT01180790|517120054|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
143429970|NCT01180790|517120055|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
143429971|NCT01180790|517120056|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
143429972|NCT01180790|517120057|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
143429973|NCT01180790|517120058|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
143429974|NCT01180790|517120059|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
143429975|NCT01180790|517120060|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
143429976|NCT01064856|517120064|FG000|Double-blind (DB) Period|Adverse Event|1|||
143429977|NCT01064856|517120065|FG001|Double-blind (DB) Period|Adverse Event|0|||
143429978|NCT01064856|517120066|FG002|Double-blind (DB) Period|Adverse Event|0|||
143429979|NCT01064856|517120067|FG003|Double-blind (DB) Period|Adverse Event|0|||
143429980|NCT01064856|517120064|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
143429981|NCT01064856|517120065|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
143429982|NCT01064856|517120066|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
143429983|NCT01064856|517120067|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
143429984|NCT01064856|517120064|FG000|Open-label (OL) Period|Adverse Event|0|||
143429985|NCT01064856|517120065|FG001|Open-label (OL) Period|Adverse Event|0|||
143429986|NCT01064856|517120066|FG002|Open-label (OL) Period|Adverse Event|12|||
143429987|NCT01064856|517120067|FG003|Open-label (OL) Period|Adverse Event|6|||
143429988|NCT01064856|517120064|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
143429989|NCT01064856|517120065|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
143429990|NCT01064856|517120066|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
143429991|NCT01064856|517120067|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
143429992|NCT01064856|517120064|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
143429993|NCT01064856|517120065|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
143429994|NCT01064856|517120066|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
143429995|NCT01064856|517120067|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
143429996|NCT01064856|517120064|FG000|Open-label (OL) Period|Other|0|||
143429997|NCT01064856|517120065|FG001|Open-label (OL) Period|Other|0|||
143429998|NCT01064856|517120066|FG002|Open-label (OL) Period|Other|7|||
143429999|NCT01064856|517120067|FG003|Open-label (OL) Period|Other|7|||
143430000|NCT02273180|517120071|FG000|Overall Study|Adverse Event|2|||
143430001|NCT02273180|517120072|FG001|Overall Study|Adverse Event|2|||
143430002|NCT02273180|517120071|FG000|Overall Study|Lack of Efficacy|1|||
143430003|NCT02273180|517120072|FG001|Overall Study|Lack of Efficacy|0|||
143430004|NCT02273180|517120071|FG000|Overall Study|Protocol Violation|1|||
143430005|NCT02273180|517120072|FG001|Overall Study|Protocol Violation|7|||
143430006|NCT02273180|517120071|FG000|Overall Study|Randomized but not treated|1|||
143430007|NCT02273180|517120072|FG001|Overall Study|Randomized but not treated|0|||
143430008|NCT02273180|517120071|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
143430009|NCT02273180|517120072|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
143430010|NCT02273180|517120071|FG000|Overall Study|Other than specified above|21|||
143430011|NCT02273180|517120072|FG001|Overall Study|Other than specified above|10|||
143430012|NCT02154516|517120073|FG000|Overall Study|Withdrawal by Subject|0|||
143430013|NCT02154516|517120074|FG001|Overall Study|Withdrawal by Subject|1|||
143430014|NCT02154516|517120073|FG000|Overall Study|Lost to Follow-up|1|||
143430015|NCT02154516|517120074|FG001|Overall Study|Lost to Follow-up|0|||
143430016|NCT02154516|517120073|FG000|Overall Study|Removal/revision of device|1|||
143430017|NCT02154516|517120074|FG001|Overall Study|Removal/revision of device|0|||
143430018|NCT02154516|517120073|FG000|Overall Study|Death|2|||
143430019|NCT02154516|517120074|FG001|Overall Study|Death|1|||
143430020|NCT02965599|517120078|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
143430021|NCT02965599|517120079|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
143430022|NCT04435522|517120083|FG000|Overall Study|Withdrawal by Subject|2|||
143430023|NCT02517528|517121526|FG000|Overall Study|Withdrawal by Subject|1|||
143430024|NCT01093599|517121529|FG000|Overall Study|Lost to Follow-up|32|||
143430025|NCT01093599|517121530|FG001|Overall Study|Lost to Follow-up|46|||
143430026|NCT01703845|517121531|FG000|Overall Study|Adverse Event|1|||
143430027|NCT01703845|517121532|FG001|Overall Study|Adverse Event|0|||
143430028|NCT01703845|517121531|FG000|Overall Study|Protocol Violation|1|||
143430029|NCT01703845|517121532|FG001|Overall Study|Protocol Violation|0|||
143430030|NCT01703845|517121531|FG000|Overall Study|other than stated above|1|||
143430031|NCT01703845|517121532|FG001|Overall Study|other than stated above|0|||
143430032|NCT01644188|517121533|FG000|Overall Study|Adverse Event|44|||
143430033|NCT01644188|517121534|FG001|Overall Study|Adverse Event|20|||
143430034|NCT01644188|517121533|FG000|Overall Study|Poor compliance to protocol|26|||
143430035|NCT01644188|517121534|FG001|Overall Study|Poor compliance to protocol|14|||
143430036|NCT01644188|517121533|FG000|Overall Study|Physician Decision|1|||
143430037|NCT01644188|517121534|FG001|Overall Study|Physician Decision|3|||
143430038|NCT01644188|517121533|FG000|Overall Study|Participant moved|7|||
143430039|NCT01644188|517121534|FG001|Overall Study|Participant moved|2|||
143430040|NCT01644188|517121533|FG000|Overall Study|Related to auto-injector administration|2|||
143430041|NCT01644188|517121534|FG001|Overall Study|Related to auto-injector administration|2|||
143430042|NCT01644188|517121533|FG000|Overall Study|Consent withdrawn by participant|14|||
143430043|NCT01644188|517121534|FG001|Overall Study|Consent withdrawn by participant|7|||
143430044|NCT01644188|517121533|FG000|Overall Study|Selection criteria finally not met|2|||
143430045|NCT01644188|517121534|FG001|Overall Study|Selection criteria finally not met|0|||
143430046|NCT01644188|517121533|FG000|Overall Study|Lost to Follow-up|1|||
143430047|NCT01644188|517121534|FG001|Overall Study|Lost to Follow-up|0|||
143430048|NCT01644188|517121533|FG000|Overall Study|Death|4|||
143430049|NCT01644188|517121534|FG001|Overall Study|Death|3|||
143430050|NCT01644188|517121533|FG000|Overall Study|Last visit outside protocol visit window|14|||
143430051|NCT01644188|517121534|FG001|Overall Study|Last visit outside protocol visit window|16|||
143430052|NCT01644188|517121533|FG000|Overall Study|Site closure|1|||
143430053|NCT01644188|517121534|FG001|Overall Study|Site closure|1|||
143430054|NCT01644188|517121533|FG000|Overall Study|Other than specified above|6|||
143430055|NCT01644188|517121534|FG001|Overall Study|Other than specified above|7|||
143430056|NCT03991988|517121537|FG000|Overall Study|Withdrawal by Subject|2|||
143430057|NCT03991988|517121538|FG001|Overall Study|Withdrawal by Subject|2|||
143430058|NCT00966979|517121539|FG000|Overall Study|Death|1|||
143430059|NCT00966979|517121539|FG000|Overall Study|Lost to Follow-up|6|||
143430060|NCT00966979|517121539|FG000|Overall Study|Withdrawal by Subject|14|||
143430061|NCT00966979|517121539|FG000|Overall Study|Adverse Event|5|||
143430062|NCT00966979|517121539|FG000|Overall Study|Sponsor terminated early|49|||
143430063|NCT00966979|517121539|FG000|Overall Study|Censored because surgery not done|2|||
143430064|NCT00966979|517121539|FG000|Overall Study|Censored because study device was not implanted|14|||
143430065|NCT00966979|517121539|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
143430066|NCT00630552|517121543|FG000|Overall Study|Adverse Event|0|||
143430067|NCT00630552|517121544|FG001|Overall Study|Adverse Event|1|||
143430068|NCT00630552|517121545|FG002|Overall Study|Adverse Event|5|||
143430069|NCT00630552|517121546|FG003|Overall Study|Adverse Event|4|||
143430070|NCT00630552|517121547|FG004|Overall Study|Adverse Event|2|||
143430071|NCT00630552|517121543|FG000|Overall Study|Disease progression|5|||
143430072|NCT00630552|517121544|FG001|Overall Study|Disease progression|6|||
143430073|NCT00630552|517121545|FG002|Overall Study|Disease progression|27|||
143430074|NCT00630552|517121546|FG003|Overall Study|Disease progression|22|||
143430075|NCT00630552|517121547|FG004|Overall Study|Disease progression|31|||
143430076|NCT00630552|517121543|FG000|Overall Study|Never received IP|0|||
143430077|NCT00630552|517121544|FG001|Overall Study|Never received IP|0|||
143430078|NCT00630552|517121545|FG002|Overall Study|Never received IP|0|||
143430079|NCT00630552|517121546|FG003|Overall Study|Never received IP|2|||
143430080|NCT00630552|517121547|FG004|Overall Study|Never received IP|2|||
143430081|NCT00630552|517121543|FG000|Overall Study|Ineligibility determined|0|||
143430082|NCT00630552|517121544|FG001|Overall Study|Ineligibility determined|0|||
143430083|NCT00630552|517121545|FG002|Overall Study|Ineligibility determined|0|||
143430084|NCT00630552|517121546|FG003|Overall Study|Ineligibility determined|0|||
143430085|NCT00630552|517121547|FG004|Overall Study|Ineligibility determined|1|||
143430086|NCT00630552|517121543|FG000|Overall Study|Protocol Violation|0|||
143430087|NCT00630552|517121544|FG001|Overall Study|Protocol Violation|0|||
143430088|NCT00630552|517121545|FG002|Overall Study|Protocol Violation|0|||
143430089|NCT00630552|517121546|FG003|Overall Study|Protocol Violation|1|||
143430090|NCT00630552|517121547|FG004|Overall Study|Protocol Violation|0|||
143430091|NCT00630552|517121543|FG000|Overall Study|Physician Decision|0|||
143430092|NCT00630552|517121544|FG001|Overall Study|Physician Decision|0|||
143430093|NCT00630552|517121545|FG002|Overall Study|Physician Decision|0|||
143430094|NCT00630552|517121546|FG003|Overall Study|Physician Decision|0|||
143430095|NCT00630552|517121547|FG004|Overall Study|Physician Decision|1|||
143430096|NCT00630552|517121543|FG000|Overall Study|Death|0|||
143430097|NCT00630552|517121544|FG001|Overall Study|Death|0|||
143430098|NCT00630552|517121545|FG002|Overall Study|Death|1|||
143430099|NCT00630552|517121546|FG003|Overall Study|Death|2|||
143430100|NCT00630552|517121547|FG004|Overall Study|Death|2|||
143430101|NCT00630552|517121543|FG000|Overall Study|Withdrawal by Subject|0|||
143430102|NCT00630552|517121544|FG001|Overall Study|Withdrawal by Subject|0|||
143430103|NCT00630552|517121545|FG002|Overall Study|Withdrawal by Subject|0|||
143430104|NCT00630552|517121546|FG003|Overall Study|Withdrawal by Subject|1|||
143430105|NCT00630552|517121547|FG004|Overall Study|Withdrawal by Subject|0|||
143430106|NCT00630552|517121543|FG000|Overall Study|Other|0|||
143430107|NCT00630552|517121544|FG001|Overall Study|Other|0|||
143430108|NCT00630552|517121545|FG002|Overall Study|Other|4|||
143430109|NCT00630552|517121546|FG003|Overall Study|Other|2|||
143430110|NCT00630552|517121547|FG004|Overall Study|Other|0|||
143430111|NCT03226106|517121548|FG000|Overall Study|Withdrawal by Subject|2|||
143430112|NCT03226106|517121549|FG001|Overall Study|Withdrawal by Subject|0|||
143430113|NCT03226106|517121548|FG000|Overall Study|Adverse Event|1|||
143430114|NCT03226106|517121549|FG001|Overall Study|Adverse Event|0|||
143430115|NCT03226106|517121548|FG000|Overall Study|Lost to Follow-up|2|||
143430116|NCT03226106|517121549|FG001|Overall Study|Lost to Follow-up|0|||
143430117|NCT01084239|517121550|FG000|28-Day Follow-up|Lost to Follow-up|4|||
143430118|NCT01084239|517121551|FG001|28-Day Follow-up|Lost to Follow-up|9|||
143430119|NCT00721214|517121553|FG000|Overall Study|Chose another center for transplant|1|||
143430120|NCT00721214|517121553|FG000|Overall Study|Death|3|||
143430121|NCT00983905|517121554|FG000|Theophylline Alone|Adverse Event|1|||
143430122|NCT00983905|517121554|FG000|Colchicine Alone|Adverse Event|2|||
143430123|NCT02396953|517121555|FG000|Overall Study|Withdrawal by Subject|0|||
143430124|NCT02396953|517121556|FG001|Overall Study|Withdrawal by Subject|0|||
143430125|NCT02396953|517121557|FG002|Overall Study|Withdrawal by Subject|1|||
143430126|NCT02396953|517121555|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
143430127|NCT02396953|517121556|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
143430128|NCT02396953|517121557|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
143430129|NCT02396953|517121555|FG000|Overall Study|Personal Reasons|1|||
143430130|NCT02396953|517121556|FG001|Overall Study|Personal Reasons|1|||
143430131|NCT02396953|517121557|FG002|Overall Study|Personal Reasons|0|||
143430132|NCT00488319|517121558|FG000|Overall Study|Adverse Event|1|||
143430133|NCT00488319|517121559|FG001|Overall Study|Adverse Event|2|||
143430134|NCT00488319|517121560|FG002|Overall Study|Adverse Event|23|||
143430135|NCT00488319|517121558|FG000|Overall Study|Lack of Efficacy|6|||
143430136|NCT00488319|517121559|FG001|Overall Study|Lack of Efficacy|12|||
143430137|NCT00488319|517121560|FG002|Overall Study|Lack of Efficacy|27|||
143430138|NCT00488319|517121558|FG000|Overall Study|Lost to Follow-up|3|||
143430139|NCT00488319|517121559|FG001|Overall Study|Lost to Follow-up|5|||
143430140|NCT00488319|517121560|FG002|Overall Study|Lost to Follow-up|16|||
143430141|NCT00488319|517121558|FG000|Overall Study|Withdrawal by Subject|5|||
143430142|NCT00488319|517121559|FG001|Overall Study|Withdrawal by Subject|20|||
143430143|NCT00488319|517121560|FG002|Overall Study|Withdrawal by Subject|44|||
143430144|NCT00488319|517121558|FG000|Overall Study|Other reasons for withdrawal|0|||
143430145|NCT00488319|517121559|FG001|Overall Study|Other reasons for withdrawal|4|||
143430146|NCT00488319|517121560|FG002|Overall Study|Other reasons for withdrawal|12|||
143430147|NCT00875615|517121565|FG000|Overall Study|Withdrawal by Subject|1|||
143430148|NCT00405912|517121567|FG000|Overall Study|Withdrawal by Subject|12|||
143430149|NCT00405912|517121568|FG001|Overall Study|Withdrawal by Subject|11|||
143430150|NCT00405912|517121569|FG002|Overall Study|Withdrawal by Subject|12|||
143430151|NCT00405912|517121567|FG000|Overall Study|Lost to Follow-up|4|||
143430152|NCT00405912|517121568|FG001|Overall Study|Lost to Follow-up|8|||
143430153|NCT00405912|517121569|FG002|Overall Study|Lost to Follow-up|4|||
143430154|NCT03730662|517121570|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
143430155|NCT03730662|517121571|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
143430156|NCT03730662|517121572|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
143430157|NCT03730662|517121573|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
143430158|NCT03730662|517121570|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
143430159|NCT03730662|517121571|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
143430160|NCT03730662|517121572|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
143430161|NCT03730662|517121573|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
143430162|NCT03730662|517121570|FG000|Treatment Period (52 Weeks)|Death|6|||
143430163|NCT03730662|517121571|FG001|Treatment Period (52 Weeks)|Death|2|||
143430164|NCT03730662|517121572|FG002|Treatment Period (52 Weeks)|Death|2|||
143430165|NCT03730662|517121573|FG003|Treatment Period (52 Weeks)|Death|9|||
143430166|NCT03730662|517121570|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
143430167|NCT03730662|517121571|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
143430168|NCT03730662|517121572|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
143430169|NCT03730662|517121573|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
143430170|NCT03730662|517121570|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
143430171|NCT03730662|517121571|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
143430172|NCT03730662|517121572|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
143430173|NCT03730662|517121573|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
143430174|NCT03730662|517121570|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
143430175|NCT03730662|517121571|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
143430176|NCT03730662|517121572|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
143430177|NCT03730662|517121573|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
143430178|NCT03730662|517121570|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
143430179|NCT03730662|517121571|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
143430180|NCT03730662|517121572|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
143430181|NCT03730662|517121573|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
143430182|NCT03730662|517121570|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
143430183|NCT03730662|517121571|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
143430184|NCT03730662|517121572|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
143430185|NCT03730662|517121573|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
143430186|NCT03730662|517121570|FG000|Variable Treatment Period|Adverse Event|1|||
143430187|NCT03730662|517121571|FG001|Variable Treatment Period|Adverse Event|2|||
143430188|NCT03730662|517121572|FG002|Variable Treatment Period|Adverse Event|0|||
143430189|NCT03730662|517121573|FG003|Variable Treatment Period|Adverse Event|7|||
143430190|NCT03730662|517121570|FG000|Variable Treatment Period|Death|9|||
143430191|NCT03730662|517121571|FG001|Variable Treatment Period|Death|0|||
143430192|NCT03730662|517121572|FG002|Variable Treatment Period|Death|6|||
143430193|NCT03730662|517121573|FG003|Variable Treatment Period|Death|26|||
143430194|NCT03730662|517121570|FG000|Variable Treatment Period|Lost to Follow-up|2|||
143430195|NCT03730662|517121571|FG001|Variable Treatment Period|Lost to Follow-up|1|||
143430196|NCT03730662|517121572|FG002|Variable Treatment Period|Lost to Follow-up|4|||
143430197|NCT03730662|517121573|FG003|Variable Treatment Period|Lost to Follow-up|11|||
143430198|NCT03730662|517121570|FG000|Variable Treatment Period|Personal Reason|0|||
143430199|NCT03730662|517121571|FG001|Variable Treatment Period|Personal Reason|2|||
143430200|NCT03730662|517121572|FG002|Variable Treatment Period|Personal Reason|1|||
143430201|NCT03730662|517121573|FG003|Variable Treatment Period|Personal Reason|6|||
143430202|NCT03730662|517121570|FG000|Variable Treatment Period|Physician Decision|0|||
143430203|NCT03730662|517121571|FG001|Variable Treatment Period|Physician Decision|0|||
143430204|NCT03730662|517121572|FG002|Variable Treatment Period|Physician Decision|0|||
143430205|NCT03730662|517121573|FG003|Variable Treatment Period|Physician Decision|3|||
143430206|NCT03730662|517121570|FG000|Variable Treatment Period|Protocol Violation|0|||
143430207|NCT03730662|517121571|FG001|Variable Treatment Period|Protocol Violation|1|||
143430208|NCT03730662|517121572|FG002|Variable Treatment Period|Protocol Violation|1|||
143430209|NCT03730662|517121573|FG003|Variable Treatment Period|Protocol Violation|1|||
143430210|NCT03730662|517121570|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
143430211|NCT03730662|517121571|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
143430212|NCT03730662|517121572|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
143430213|NCT03730662|517121573|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
143430214|NCT01309243|517121574|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
143430215|NCT01309243|517121575|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
143430216|NCT01309243|517121574|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
143430217|NCT01309243|517121575|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
143430218|NCT01309243|517121574|FG000|Randomized Phase Through Week 96|Death|0|||
143430219|NCT01309243|517121575|FG001|Randomized Phase Through Week 96|Death|1|||
143430220|NCT01309243|517121574|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
143430221|NCT01309243|517121575|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
143430222|NCT01309243|517121574|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
143430223|NCT01309243|517121575|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
143430224|NCT01309243|517121574|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
143430225|NCT01309243|517121575|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
143430226|NCT01309243|517121574|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
143430227|NCT01309243|517121575|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
143430228|NCT01309243|517121574|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
143430229|NCT01309243|517121575|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
143430230|NCT01309243|517121574|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
143430231|NCT01309243|517121575|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
143430232|NCT01309243|517121574|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
143430233|NCT01309243|517121575|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
143430234|NCT01309243|517121574|FG000|Extension Phase|Lost to Follow-up|6|||
143430235|NCT01309243|517121575|FG001|Extension Phase|Lost to Follow-up|0|||
143430236|NCT00632931|517121576|FG000|Part 1, Period 1|Protocol Violation|1|||
143430237|NCT00632931|517121577|FG001|Part 1, Period 1|Protocol Violation|0|||
143430238|NCT00632931|517121578|FG002|Part 1, Period 1|Protocol Violation|0|||
143430239|NCT00632931|517121576|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
143430240|NCT00632931|517121577|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
143430241|NCT00632931|517121578|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
143430242|NCT00632931|517121576|FG000|Part 2|Adverse Event|0|||
143430243|NCT00632931|517121577|FG001|Part 2|Adverse Event|0|||
143430244|NCT00632931|517121578|FG002|Part 2|Adverse Event|3|||
143430245|NCT00632931|517121576|FG000|Part 2|Death|0|||
143430246|NCT00632931|517121577|FG001|Part 2|Death|0|||
143430247|NCT00632931|517121578|FG002|Part 2|Death|1|||
143430248|NCT00632931|517121576|FG000|Part 2|Lack of Efficacy|0|||
143430249|NCT00632931|517121577|FG001|Part 2|Lack of Efficacy|0|||
143430250|NCT00632931|517121578|FG002|Part 2|Lack of Efficacy|17|||
143430251|NCT00632931|517121576|FG000|Part 2|Withdrawal by Subject|0|||
143430252|NCT00632931|517121577|FG001|Part 2|Withdrawal by Subject|0|||
143430253|NCT00632931|517121578|FG002|Part 2|Withdrawal by Subject|3|||
143430254|NCT01402063|517121581|FG000|Overall Study|Withdrawal by Subject|3|||
143430255|NCT01402063|517121582|FG001|Overall Study|Withdrawal by Subject|3|||
143430256|NCT05153499|517121588|FG000|Overall Study|Withdrawal by Subject|1|||
143430257|NCT05153499|517121589|FG001|Overall Study|Withdrawal by Subject|0|||
143430258|NCT05153499|517121588|FG000|Overall Study|Clinical Hold|1|||
143430259|NCT05153499|517121589|FG001|Overall Study|Clinical Hold|0|||
143430260|NCT05153499|517121588|FG000|Overall Study|Study Termination|6|||
143430261|NCT05153499|517121589|FG001|Overall Study|Study Termination|5|||
143430262|NCT00468858|517121597|FG000|Overall Study|Adverse Event|0|||
143430263|NCT00468858|517121598|FG001|Overall Study|Adverse Event|1|||
143430264|NCT00468858|517121599|FG002|Overall Study|Adverse Event|0|||
143430265|NCT00468858|517121597|FG000|Overall Study|Withdrawal by Subject|7|||
143430266|NCT00468858|517121598|FG001|Overall Study|Withdrawal by Subject|4|||
143430267|NCT00468858|517121599|FG002|Overall Study|Withdrawal by Subject|5|||
143430268|NCT00468858|517121597|FG000|Overall Study|Relocation|1|||
143430269|NCT00468858|517121598|FG001|Overall Study|Relocation|3|||
143430270|NCT00468858|517121599|FG002|Overall Study|Relocation|3|||
143430271|NCT00468858|517121597|FG000|Overall Study|Lost to Follow-up|1|||
143430272|NCT00468858|517121598|FG001|Overall Study|Lost to Follow-up|2|||
143430273|NCT00468858|517121599|FG002|Overall Study|Lost to Follow-up|5|||
143430274|NCT00468858|517121597|FG000|Overall Study|Other|0|||
143430275|NCT00468858|517121598|FG001|Overall Study|Other|0|||
143430276|NCT00468858|517121599|FG002|Overall Study|Other|1|||
143430277|NCT01885936|517121602|FG000|Overall Study|Withdrawal by Subject|1|||
143430278|NCT01885936|517121603|FG001|Overall Study|Withdrawal by Subject|0|||
143430279|NCT00317603|517121606|FG000|Overall Study|Progressive Disease|3|||
143430280|NCT00523549|517121607|FG000|Overall Study|Adverse Event|6|||
143430281|NCT00523549|517121608|FG001|Overall Study|Adverse Event|3|||
143430282|NCT00523549|517121607|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
143430283|NCT00523549|517121608|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
143430284|NCT00523549|517121607|FG000|Overall Study|Protocol Deviation|3|||
143430285|NCT00523549|517121608|FG001|Overall Study|Protocol Deviation|1|||
143430286|NCT00523549|517121607|FG000|Overall Study|Patient withdrew consent|7|||
143430287|NCT00523549|517121608|FG001|Overall Study|Patient withdrew consent|6|||
143430288|NCT00523549|517121607|FG000|Overall Study|Lost to Follow-up|3|||
143430289|NCT00523549|517121608|FG001|Overall Study|Lost to Follow-up|5|||
143430290|NCT00427778|517121613|FG000|First Intervention (4 Weeks)|no longer interested|1|||
143430291|NCT00427778|517121614|FG001|First Intervention (4 Weeks)|no longer interested|0|||
143430292|NCT00427778|517121613|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
143430293|NCT00427778|517121614|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
143430294|NCT00427778|517121613|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
143430295|NCT00427778|517121614|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
143430296|NCT00427778|517121613|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
143430297|NCT00427778|517121614|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
143430298|NCT00439647|517121615|FG000|Overall Study|Withdrawal by Subject|25|||
143430299|NCT00439647|517121616|FG001|Overall Study|Withdrawal by Subject|22|||
143430300|NCT00439647|517121615|FG000|Overall Study|Death|15|||
143430301|NCT00439647|517121616|FG001|Overall Study|Death|18|||
143430302|NCT00439647|517121615|FG000|Overall Study|Adverse Event|11|||
143430303|NCT00439647|517121616|FG001|Overall Study|Adverse Event|11|||
143430304|NCT00439647|517121615|FG000|Overall Study|Lost to Follow-up|4|||
143430305|NCT00439647|517121616|FG001|Overall Study|Lost to Follow-up|12|||
143430306|NCT00439647|517121615|FG000|Overall Study|Protocol Violation|3|||
143430307|NCT00439647|517121616|FG001|Overall Study|Protocol Violation|4|||
143430308|NCT00439647|517121615|FG000|Overall Study|Lack of Efficacy|0|||
143430309|NCT00439647|517121616|FG001|Overall Study|Lack of Efficacy|4|||
143430310|NCT00053352|517121618|FG000|Overall Study|Lost to Follow-up|0|||
143430311|NCT00053352|517121619|FG001|Overall Study|Lost to Follow-up|1|||
143430312|NCT00053352|517121618|FG000|Overall Study|Physician Decision|11|||
143430313|NCT00053352|517121619|FG001|Overall Study|Physician Decision|1|||
143430314|NCT00053352|517121618|FG000|Overall Study|Withdrawal by Subject|1|||
143430315|NCT00053352|517121619|FG001|Overall Study|Withdrawal by Subject|0|||
143430316|NCT00053352|517121618|FG000|Overall Study|Ineligible|8|||
143430317|NCT00053352|517121619|FG001|Overall Study|Ineligible|8|||
143430318|NCT00053352|517121618|FG000|Overall Study|Disease at new site|1|||
143430319|NCT00053352|517121619|FG001|Overall Study|Disease at new site|0|||
143430320|NCT00843115|517121620|FG000|Overall Study|Death|4|||
143430321|NCT00843115|517121620|FG000|Overall Study|Adverse Event|30|||
143430322|NCT00843115|517121620|FG000|Overall Study|Lost to Follow-up|4|||
143430323|NCT00843115|517121620|FG000|Overall Study|Withdrawal by Subject|17|||
143430324|NCT00843115|517121620|FG000|Overall Study|Family wanted meds stopped|1|||
143430325|NCT00843115|517121620|FG000|Overall Study|Family does not want continuation|1|||
143430326|NCT00843115|517121620|FG000|Overall Study|Patient forgot to take meds|1|||
143430327|NCT00843115|517121620|FG000|Overall Study|Does not meet entrance criteria|1|||
143430328|NCT00843115|517121620|FG000|Overall Study|Physician Decision|1|||
143430329|NCT00843115|517121620|FG000|Overall Study|Family discontinued meds|1|||
143430330|NCT00843115|517121620|FG000|Overall Study|patient took for 2 days then stopped|1|||
143430331|NCT00843115|517121620|FG000|Overall Study|patient never took the medication|1|||
143430332|NCT00843115|517121620|FG000|Overall Study|hospitalized due to deterioration|1|||
143430333|NCT00843115|517121620|FG000|Overall Study|week 12 not done|1|||
143430334|NCT00843115|517121620|FG000|Overall Study|Syndrome De Glissement|1|||
143430335|NCT01388478|517121621|FG000|Overall Study|Adverse Event|4|||
143430336|NCT01388478|517121621|FG000|Overall Study|Withdrawal by Subject|1|||
143430337|NCT01990664|517121622|FG000|Overall Study|Lost to Follow-up|2|||
143430338|NCT01990664|517121623|FG001|Overall Study|Lost to Follow-up|6|||
143430339|NCT01990664|517121622|FG000|Overall Study|Withdrawal by Subject|2|||
143430340|NCT01990664|517121623|FG001|Overall Study|Withdrawal by Subject|3|||
143430341|NCT01990664|517121622|FG000|Overall Study|Protocol Violation|1|||
143430342|NCT01990664|517121623|FG001|Overall Study|Protocol Violation|0|||
143430343|NCT01990664|517121622|FG000|Overall Study|Lens Discomfort|1|||
143430344|NCT01990664|517121623|FG001|Overall Study|Lens Discomfort|1|||
143430345|NCT01990664|517121622|FG000|Overall Study|Lens Handling Difficulties|1|||
143430346|NCT01990664|517121623|FG001|Overall Study|Lens Handling Difficulties|0|||
143430347|NCT01990664|517121622|FG000|Overall Study|Unsatisfactory Visual Response|0|||
143430348|NCT01990664|517121623|FG001|Overall Study|Unsatisfactory Visual Response|1|||
143430349|NCT01037413|517121624|FG000|Part A: Skin Testing|Adverse Event|1|||
143430350|NCT01037413|517121625|FG001|Part A: Skin Testing|Adverse Event|0|||
143430351|NCT01037413|517121624|FG000|Part A: Skin Testing|Protocol Violation|1|||
143430352|NCT01037413|517121625|FG001|Part A: Skin Testing|Protocol Violation|0|||
143430353|NCT01037413|517121624|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
143430354|NCT01037413|517121625|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
143430355|NCT01037413|517121624|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
143430356|NCT01037413|517121625|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
143430357|NCT00809341|517121629|FG000|Overall Study|Physician Decision|0|||
143430358|NCT00809341|517121630|FG001|Overall Study|Physician Decision|1|||
143430359|NCT00225277|517121631|FG000|Overall Study|Adverse Event|30|||
143430360|NCT00225277|517121632|FG001|Overall Study|Adverse Event|34|||
143430361|NCT00225277|517121631|FG000|Overall Study|Lack of Efficacy|4|||
143430362|NCT00225277|517121632|FG001|Overall Study|Lack of Efficacy|1|||
143430363|NCT00225277|517121631|FG000|Overall Study|Lost to Follow-up|4|||
143430364|NCT00225277|517121632|FG001|Overall Study|Lost to Follow-up|6|||
143430365|NCT00225277|517121631|FG000|Overall Study|Physician Decision|6|||
143430366|NCT00225277|517121632|FG001|Overall Study|Physician Decision|8|||
143430367|NCT00225277|517121631|FG000|Overall Study|Protocol Violation|6|||
143430368|NCT00225277|517121632|FG001|Overall Study|Protocol Violation|3|||
143430369|NCT00225277|517121631|FG000|Overall Study|Withdrawal by Subject|40|||
143430370|NCT00225277|517121632|FG001|Overall Study|Withdrawal by Subject|34|||
143430371|NCT00225277|517121631|FG000|Overall Study|Other|7|||
143430372|NCT00225277|517121632|FG001|Overall Study|Other|9|||
143430373|NCT03891641|517121637|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
143430374|NCT03891641|517121638|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
143430375|NCT00784277|517121639|FG000|IR Treatment|Adverse Event|4|||
143430376|NCT00784277|517121640|FG001|IR Treatment|Adverse Event|8|||
143430377|NCT00784277|517121641|FG002|IR Treatment|Adverse Event|19|||
143430378|NCT00784277|517121642|FG003|IR Treatment|Adverse Event|35|||
143430379|NCT00784277|517121643|FG004|IR Treatment|Adverse Event|0|||
143430380|NCT00784277|517121644|FG005|IR Treatment|Adverse Event|0|||
143430381|NCT00784277|517121645|FG006|IR Treatment|Adverse Event|0|||
143430382|NCT00784277|517121639|FG000|IR Treatment|Lack of Efficacy|4|||
143430383|NCT00784277|517121640|FG001|IR Treatment|Lack of Efficacy|4|||
143430384|NCT00784277|517121641|FG002|IR Treatment|Lack of Efficacy|1|||
143430385|NCT00784277|517121642|FG003|IR Treatment|Lack of Efficacy|0|||
143430386|NCT00784277|517121643|FG004|IR Treatment|Lack of Efficacy|0|||
143430387|NCT00784277|517121644|FG005|IR Treatment|Lack of Efficacy|0|||
143430388|NCT00784277|517121645|FG006|IR Treatment|Lack of Efficacy|0|||
143430389|NCT00784277|517121639|FG000|IR Treatment|Lost to Follow-up|1|||
143430390|NCT00784277|517121640|FG001|IR Treatment|Lost to Follow-up|0|||
143430391|NCT00784277|517121641|FG002|IR Treatment|Lost to Follow-up|1|||
143430392|NCT00784277|517121642|FG003|IR Treatment|Lost to Follow-up|0|||
143430393|NCT00784277|517121643|FG004|IR Treatment|Lost to Follow-up|0|||
143430394|NCT00784277|517121644|FG005|IR Treatment|Lost to Follow-up|0|||
143430395|NCT00784277|517121645|FG006|IR Treatment|Lost to Follow-up|0|||
143430396|NCT00784277|517121639|FG000|IR Treatment|Withdrawal by Subject|5|||
143430397|NCT00784277|517121640|FG001|IR Treatment|Withdrawal by Subject|1|||
143430398|NCT00784277|517121641|FG002|IR Treatment|Withdrawal by Subject|4|||
143430399|NCT00784277|517121642|FG003|IR Treatment|Withdrawal by Subject|6|||
143430400|NCT00784277|517121643|FG004|IR Treatment|Withdrawal by Subject|0|||
143430401|NCT00784277|517121644|FG005|IR Treatment|Withdrawal by Subject|0|||
143430402|NCT00784277|517121645|FG006|IR Treatment|Withdrawal by Subject|0|||
143430403|NCT00784277|517121639|FG000|IR Treatment|Resolution Of Pain|0|||
143430404|NCT00784277|517121640|FG001|IR Treatment|Resolution Of Pain|1|||
143430405|NCT00784277|517121641|FG002|IR Treatment|Resolution Of Pain|0|||
143430406|NCT00784277|517121642|FG003|IR Treatment|Resolution Of Pain|0|||
143430407|NCT00784277|517121643|FG004|IR Treatment|Resolution Of Pain|0|||
143430408|NCT00784277|517121644|FG005|IR Treatment|Resolution Of Pain|0|||
143430409|NCT00784277|517121645|FG006|IR Treatment|Resolution Of Pain|0|||
143430410|NCT00784277|517121639|FG000|IR Treatment|Other|2|||
143430411|NCT00784277|517121640|FG001|IR Treatment|Other|3|||
143430412|NCT00784277|517121641|FG002|IR Treatment|Other|3|||
143430413|NCT00784277|517121642|FG003|IR Treatment|Other|2|||
143430414|NCT00784277|517121643|FG004|IR Treatment|Other|0|||
143430415|NCT00784277|517121644|FG005|IR Treatment|Other|0|||
143430416|NCT00784277|517121645|FG006|IR Treatment|Other|0|||
143430417|NCT00784277|517121639|FG000|ER Treatment|Adverse Event|0|||
143430418|NCT00784277|517121640|FG001|ER Treatment|Adverse Event|0|||
143430419|NCT00784277|517121641|FG002|ER Treatment|Adverse Event|0|||
143430420|NCT00784277|517121642|FG003|ER Treatment|Adverse Event|0|||
143430421|NCT00784277|517121643|FG004|ER Treatment|Adverse Event|1|||
143430422|NCT00784277|517121644|FG005|ER Treatment|Adverse Event|7|||
143430423|NCT00784277|517121645|FG006|ER Treatment|Adverse Event|7|||
143430424|NCT00784277|517121639|FG000|ER Treatment|Lack of Efficacy|0|||
143430425|NCT00784277|517121640|FG001|ER Treatment|Lack of Efficacy|0|||
143430426|NCT00784277|517121641|FG002|ER Treatment|Lack of Efficacy|0|||
143430427|NCT00784277|517121642|FG003|ER Treatment|Lack of Efficacy|0|||
143430428|NCT00784277|517121643|FG004|ER Treatment|Lack of Efficacy|3|||
143430429|NCT00784277|517121644|FG005|ER Treatment|Lack of Efficacy|4|||
143430430|NCT00784277|517121645|FG006|ER Treatment|Lack of Efficacy|0|||
143430431|NCT00784277|517121639|FG000|ER Treatment|Lost to Follow-up|0|||
143430432|NCT00784277|517121640|FG001|ER Treatment|Lost to Follow-up|0|||
143430433|NCT00784277|517121641|FG002|ER Treatment|Lost to Follow-up|0|||
143430434|NCT00784277|517121642|FG003|ER Treatment|Lost to Follow-up|0|||
143430435|NCT00784277|517121643|FG004|ER Treatment|Lost to Follow-up|0|||
143430436|NCT00784277|517121644|FG005|ER Treatment|Lost to Follow-up|2|||
143430437|NCT00784277|517121645|FG006|ER Treatment|Lost to Follow-up|0|||
143430438|NCT00784277|517121639|FG000|ER Treatment|Withdrawal by Subject|0|||
143430439|NCT00784277|517121640|FG001|ER Treatment|Withdrawal by Subject|0|||
143430440|NCT00784277|517121641|FG002|ER Treatment|Withdrawal by Subject|0|||
143430441|NCT00784277|517121642|FG003|ER Treatment|Withdrawal by Subject|0|||
143430442|NCT00784277|517121643|FG004|ER Treatment|Withdrawal by Subject|2|||
143430443|NCT00784277|517121644|FG005|ER Treatment|Withdrawal by Subject|5|||
143430444|NCT00784277|517121645|FG006|ER Treatment|Withdrawal by Subject|3|||
143430445|NCT00784277|517121639|FG000|ER Treatment|Study Medication Non-Compliant|0|||
143430446|NCT00784277|517121640|FG001|ER Treatment|Study Medication Non-Compliant|0|||
143430447|NCT00784277|517121641|FG002|ER Treatment|Study Medication Non-Compliant|0|||
143430448|NCT00784277|517121642|FG003|ER Treatment|Study Medication Non-Compliant|0|||
143430449|NCT00784277|517121643|FG004|ER Treatment|Study Medication Non-Compliant|2|||
143430450|NCT00784277|517121644|FG005|ER Treatment|Study Medication Non-Compliant|3|||
143430451|NCT00784277|517121645|FG006|ER Treatment|Study Medication Non-Compliant|3|||
143430452|NCT00784277|517121639|FG000|ER Treatment|Other|0|||
143430453|NCT00784277|517121640|FG001|ER Treatment|Other|0|||
143430454|NCT00784277|517121641|FG002|ER Treatment|Other|0|||
143430455|NCT00784277|517121642|FG003|ER Treatment|Other|0|||
143430456|NCT00784277|517121643|FG004|ER Treatment|Other|1|||
143430457|NCT00784277|517121644|FG005|ER Treatment|Other|3|||
143430458|NCT00784277|517121645|FG006|ER Treatment|Other|2|||
143430459|NCT01093222|517121646|FG000|Overall Study|Ineligible|6|||
143430460|NCT01093222|517121646|FG000|Overall Study|Adverse Event|7|||
143430461|NCT01093222|517121646|FG000|Overall Study|Progression/relapse|24|||
143430462|NCT01093222|517121646|FG000|Overall Study|Death|2|||
143430463|NCT01093222|517121646|FG000|Overall Study|Not protocol specified|1|||
143430464|NCT03927222|517121652|FG000|Overall Study|Progression|3|||
143430465|NCT03927222|517121652|FG000|Overall Study|CMV testing results inconclusive|1|||
143430466|NCT03927222|517121652|FG000|Overall Study|Unable to generate enough vaccines|1|||
143430467|NCT03927222|517121652|FG000|Overall Study|Early study termination|1|||
143430468|NCT01592383|517121653|FG000|Overall Study|Adverse Event|1|||
143430469|NCT04167085|517121654|FG000|Baseline|Withdrawal by Subject|2|||
143430470|NCT04167085|517121655|FG001|Baseline|Withdrawal by Subject|1|||
143430471|NCT04167085|517121654|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
143430472|NCT04167085|517121655|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
143430473|NCT01204775|517121656|FG000|Overall Study|Poor/non-compliance|0|||
143430474|NCT01204775|517121657|FG001|Overall Study|Poor/non-compliance|1|||
143430475|NCT01204775|517121656|FG000|Overall Study|Withdrawal by Subject|1|||
143430476|NCT01204775|517121657|FG001|Overall Study|Withdrawal by Subject|0|||
143430477|NCT01679613|517121658|FG000|Overall Study|other than stated above|0|||
143430478|NCT01679613|517121659|FG001|Overall Study|other than stated above|1|||
143430479|NCT01679613|517121660|FG002|Overall Study|other than stated above|2|||
143430480|NCT01679613|517121661|FG003|Overall Study|other than stated above|2|||
143430481|NCT01374971|517121662|FG000|Overall Study|Withdrawal by Subject|1|||
143430482|NCT00509925|517121664|FG000|Overall Study|Personal reasons|0|||
143430483|NCT00509925|517121665|FG001|Overall Study|Personal reasons|1|||
143430484|NCT00919061|517121666|FG000|Overall Study|Adverse Event|1|||
143430485|NCT00919061|517121666|FG000|Overall Study|Withdrawal by Subject|1|||
143430486|NCT00560313|517123155|FG000|Overall Study|Adverse Events or Death|2|||
143430487|NCT00560313|517123155|FG000|Overall Study|Withdrawal by Subject|2|||
143430488|NCT00560313|517123155|FG000|Overall Study|Lost to Follow-up|1|||
143430489|NCT00560313|517123155|FG000|Overall Study|Protocol Violation|1|||
143430490|NCT00113269|517123156|FG000|Overall Study|Not transplanted, donor issues|4|||
143430491|NCT00113269|517123157|FG001|Overall Study|Not transplanted, donor issues|0|||
143430492|NCT00113269|517123158|FG002|Overall Study|Not transplanted, donor issues|2|||
143430493|NCT00113269|517123159|FG003|Overall Study|Not transplanted, donor issues|2|||
143430494|NCT00113269|517123156|FG000|Overall Study|Not transplanted, recipient issues|2|||
143430495|NCT00113269|517123157|FG001|Overall Study|Not transplanted, recipient issues|1|||
143430496|NCT00113269|517123158|FG002|Overall Study|Not transplanted, recipient issues|7|||
143430497|NCT00113269|517123159|FG003|Overall Study|Not transplanted, recipient issues|4|||
143430498|NCT00113269|517123156|FG000|Overall Study|Early graft loss, technical|0|||
143430499|NCT00113269|517123157|FG001|Overall Study|Early graft loss, technical|0|||
143430500|NCT00113269|517123158|FG002|Overall Study|Early graft loss, technical|2|||
143430501|NCT00113269|517123159|FG003|Overall Study|Early graft loss, technical|0|||
143430502|NCT00113269|517123156|FG000|Overall Study|Death in operating room|0|||
143430503|NCT00113269|517123157|FG001|Overall Study|Death in operating room|0|||
143430504|NCT00113269|517123158|FG002|Overall Study|Death in operating room|0|||
143430505|NCT00113269|517123159|FG003|Overall Study|Death in operating room|1|||
143430506|NCT00113269|517123156|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
143430507|NCT00113269|517123157|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
143430508|NCT00113269|517123158|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
143430509|NCT00113269|517123159|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
143430510|NCT00113269|517123156|FG000|Overall Study|Adverse Event|2|||
143430511|NCT00113269|517123157|FG001|Overall Study|Adverse Event|7|||
143430512|NCT00113269|517123158|FG002|Overall Study|Adverse Event|11|||
143430513|NCT00113269|517123159|FG003|Overall Study|Adverse Event|7|||
143430514|NCT00113269|517123156|FG000|Overall Study|Withdrawal by Subject|4|||
143430515|NCT00113269|517123157|FG001|Overall Study|Withdrawal by Subject|3|||
143430516|NCT00113269|517123158|FG002|Overall Study|Withdrawal by Subject|4|||
143430517|NCT00113269|517123159|FG003|Overall Study|Withdrawal by Subject|2|||
143430518|NCT00113269|517123156|FG000|Overall Study|Graft loss|6|||
143430519|NCT00113269|517123157|FG001|Overall Study|Graft loss|6|||
143430520|NCT00113269|517123158|FG002|Overall Study|Graft loss|4|||
143430521|NCT00113269|517123159|FG003|Overall Study|Graft loss|9|||
143430522|NCT00113269|517123156|FG000|Overall Study|Protocol Violation|1|||
143430523|NCT00113269|517123157|FG001|Overall Study|Protocol Violation|0|||
143430524|NCT00113269|517123158|FG002|Overall Study|Protocol Violation|4|||
143430525|NCT00113269|517123159|FG003|Overall Study|Protocol Violation|2|||
143430526|NCT00113269|517123156|FG000|Overall Study|Lost to Follow-up|2|||
143430527|NCT00113269|517123157|FG001|Overall Study|Lost to Follow-up|3|||
143430528|NCT00113269|517123158|FG002|Overall Study|Lost to Follow-up|6|||
143430529|NCT00113269|517123159|FG003|Overall Study|Lost to Follow-up|3|||
143430530|NCT00113269|517123156|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
143430531|NCT00113269|517123157|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
143430532|NCT00113269|517123158|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
143430533|NCT00113269|517123159|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
143430534|NCT00113269|517123156|FG000|Overall Study|Discontinued due to rejection|0|||
143430535|NCT00113269|517123157|FG001|Overall Study|Discontinued due to rejection|0|||
143430536|NCT00113269|517123158|FG002|Overall Study|Discontinued due to rejection|1|||
143430537|NCT00113269|517123159|FG003|Overall Study|Discontinued due to rejection|0|||
143430538|NCT00113269|517123156|FG000|Overall Study|Moved|0|||
143430539|NCT00113269|517123157|FG001|Overall Study|Moved|1|||
143430540|NCT00113269|517123158|FG002|Overall Study|Moved|0|||
143430541|NCT00113269|517123159|FG003|Overall Study|Moved|3|||
143430542|NCT00113269|517123156|FG000|Overall Study|Received pancreas transplant|0|||
143430543|NCT00113269|517123157|FG001|Overall Study|Received pancreas transplant|0|||
143430544|NCT00113269|517123158|FG002|Overall Study|Received pancreas transplant|0|||
143430545|NCT00113269|517123159|FG003|Overall Study|Received pancreas transplant|2|||
143430546|NCT00113269|517123156|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
143430547|NCT00113269|517123157|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
143430548|NCT00113269|517123158|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
143430549|NCT00113269|517123159|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
143430550|NCT00113269|517123156|FG000|Overall Study|Did not meet eligibility criteria|1|||
143430551|NCT00113269|517123157|FG001|Overall Study|Did not meet eligibility criteria|0|||
143430552|NCT00113269|517123158|FG002|Overall Study|Did not meet eligibility criteria|0|||
143430553|NCT00113269|517123159|FG003|Overall Study|Did not meet eligibility criteria|1|||
143430554|NCT00113269|517123156|FG000|Overall Study|Unable to return for follow up|2|||
143430555|NCT00113269|517123157|FG001|Overall Study|Unable to return for follow up|1|||
143430556|NCT00113269|517123158|FG002|Overall Study|Unable to return for follow up|0|||
143430557|NCT00113269|517123159|FG003|Overall Study|Unable to return for follow up|0|||
143430558|NCT00853372|517123164|FG000|Overall Study|Death|30|||
143430559|NCT00853372|517123165|FG001|Overall Study|Death|26|||
143430560|NCT00853372|517123164|FG000|Overall Study|Lost to Follow-up|1|||
143430561|NCT00853372|517123165|FG001|Overall Study|Lost to Follow-up|2|||
143430562|NCT00853372|517123164|FG000|Overall Study|Full Consent Withdrawn|1|||
143430563|NCT00853372|517123165|FG001|Overall Study|Full Consent Withdrawn|1|||
143430564|NCT01268098|517123168|FG000|Overall Study|Adverse Event|1|||
143430565|NCT01268098|517123169|FG001|Overall Study|Adverse Event|0|||
143430566|NCT01845649|517123172|FG000|Overall Study|Adverse Event|7|||
143430567|NCT01845649|517123173|FG001|Overall Study|Adverse Event|10|||
143430568|NCT01845649|517123172|FG000|Overall Study|Lack of Efficacy|1|||
143430569|NCT01845649|517123173|FG001|Overall Study|Lack of Efficacy|1|||
143430570|NCT01845649|517123172|FG000|Overall Study|Lost to Follow-up|2|||
143430571|NCT01845649|517123173|FG001|Overall Study|Lost to Follow-up|2|||
143430572|NCT01845649|517123172|FG000|Overall Study|Withdrew Consent|12|||
143430573|NCT01845649|517123173|FG001|Overall Study|Withdrew Consent|4|||
143430574|NCT01845649|517123172|FG000|Overall Study|Protocol Deviation|7|||
143430575|NCT01845649|517123173|FG001|Overall Study|Protocol Deviation|4|||
143430576|NCT01845649|517123172|FG000|Overall Study|Reason not Specified|2|||
143430577|NCT01845649|517123173|FG001|Overall Study|Reason not Specified|1|||
143430578|NCT01222533|517123175|FG000|Overall Study|Adverse Event|5|||
143430579|NCT01222533|517123175|FG000|Overall Study|Withdrawal by Subject|5|||
143430580|NCT01222533|517123175|FG000|Overall Study|Other|4|||
143430581|NCT01947517|517123176|FG000|Overall Study|Withdrawal by Subject|1|||
143430582|NCT01947517|517123177|FG001|Overall Study|Withdrawal by Subject|1|||
143430583|NCT03418493|517123178|FG000|Overall Study|Adverse Event|1|||
143430584|NCT03418493|517123179|FG001|Overall Study|Adverse Event|0|||
143430585|NCT03418493|517123180|FG002|Overall Study|Adverse Event|0|||
143430586|NCT03418493|517123181|FG003|Overall Study|Adverse Event|0|||
143430587|NCT03418493|517123182|FG004|Overall Study|Adverse Event|0|||
143430588|NCT03418493|517123183|FG005|Overall Study|Adverse Event|0|||
143430589|NCT03418493|517123184|FG006|Overall Study|Adverse Event|0|||
143430590|NCT03418493|517123185|FG007|Overall Study|Adverse Event|0|||
143430591|NCT03418493|517123186|FG008|Overall Study|Adverse Event|0|||
143430592|NCT03418493|517123187|FG009|Overall Study|Adverse Event|0|||
143430593|NCT03418493|517123188|FG010|Overall Study|Adverse Event|0|||
143430594|NCT03418493|517123178|FG000|Overall Study|Protocol Violation|0|||
143430595|NCT03418493|517123179|FG001|Overall Study|Protocol Violation|0|||
143430596|NCT03418493|517123180|FG002|Overall Study|Protocol Violation|0|||
143430597|NCT03418493|517123181|FG003|Overall Study|Protocol Violation|0|||
143430598|NCT03418493|517123182|FG004|Overall Study|Protocol Violation|0|||
143430599|NCT03418493|517123183|FG005|Overall Study|Protocol Violation|0|||
143430600|NCT03418493|517123184|FG006|Overall Study|Protocol Violation|0|||
143430601|NCT03418493|517123185|FG007|Overall Study|Protocol Violation|0|||
143430602|NCT03418493|517123186|FG008|Overall Study|Protocol Violation|0|||
143430603|NCT03418493|517123187|FG009|Overall Study|Protocol Violation|1|||
143430604|NCT03418493|517123188|FG010|Overall Study|Protocol Violation|0|||
143430605|NCT05446714|517123192|FG000|Overall Study|Lost to Follow-up|1|||
143430606|NCT05446714|517123193|FG001|Overall Study|Lost to Follow-up|3|||
143430607|NCT05446714|517123194|FG002|Overall Study|Lost to Follow-up|2|||
143430608|NCT05446714|517123192|FG000|Overall Study|Protocol Violation|2|||
143430609|NCT05446714|517123193|FG001|Overall Study|Protocol Violation|0|||
143430610|NCT05446714|517123194|FG002|Overall Study|Protocol Violation|0|||
143430611|NCT00943618|517123200|FG000|Overall Study|Lost to Follow-up|38|||
143430612|NCT00943618|517123201|FG001|Overall Study|Lost to Follow-up|48|||
143430613|NCT00943618|517123202|FG002|Overall Study|Lost to Follow-up|20|||
143430614|NCT00943618|517123200|FG000|Overall Study|Discontinued Medication|17|||
143430615|NCT00943618|517123201|FG001|Overall Study|Discontinued Medication|29|||
143430616|NCT00943618|517123202|FG002|Overall Study|Discontinued Medication|11|||
143430617|NCT00494026|517123203|FG000|Overall Study|Sponsor Decision|4|||
143430618|NCT00931918|517123204|FG000|Overall Study|Adverse Event|4|||
143430619|NCT00931918|517123205|FG001|Overall Study|Adverse Event|6|||
143430620|NCT00931918|517123204|FG000|Overall Study|Progressive Disease|2|||
143430621|NCT00931918|517123205|FG001|Overall Study|Progressive Disease|1|||
143430622|NCT00931918|517123204|FG000|Overall Study|Symptomatic Deterioration|1|||
143430623|NCT00931918|517123205|FG001|Overall Study|Symptomatic Deterioration|0|||
143430624|NCT00931918|517123204|FG000|Overall Study|Withdrawal by Patient|3|||
143430625|NCT00931918|517123205|FG001|Overall Study|Withdrawal by Patient|4|||
143430626|NCT00931918|517123204|FG000|Overall Study|Other Reason not Specified|4|||
143430627|NCT00931918|517123205|FG001|Overall Study|Other Reason not Specified|4|||
143430628|NCT00931918|517123204|FG000|Overall Study|Did not receive study drug|3|||
143430629|NCT00931918|517123205|FG001|Overall Study|Did not receive study drug|2|||
143430630|NCT00745121|517123218|FG000|Overall Study|Death|3|||
143430631|NCT00745121|517123219|FG001|Overall Study|Death|0|||
143430632|NCT00745121|517123218|FG000|Overall Study|Adverse Event|1|||
143430633|NCT00745121|517123219|FG001|Overall Study|Adverse Event|0|||
143430634|NCT00745121|517123218|FG000|Overall Study|Lost to Follow-up|1|||
143430635|NCT00745121|517123219|FG001|Overall Study|Lost to Follow-up|0|||
143430636|NCT00745121|517123218|FG000|Overall Study|Withdrawal by Subject|4|||
143430637|NCT00745121|517123219|FG001|Overall Study|Withdrawal by Subject|2|||
143430638|NCT03723915|517123221|FG000|Screening|Failed to meet screening requirements.|2|||
143430639|NCT03723915|517123221|FG000|On Treatment|Failed to meet treatment requirements|2|||
143430640|NCT01281917|517123232|FG000|Overall Study|Withdrawal by Subject|1|||
143430641|NCT04016805|517123234|FG000|Overall Study|Sponsor's Discretion|30|||
143430642|NCT04016805|517123235|FG001|Overall Study|Sponsor's Discretion|6|||
143430643|NCT04016805|517123236|FG002|Overall Study|Sponsor's Discretion|5|||
143430644|NCT02101268|517123239|FG000|Randomized Treatment Phase|Subject Decision|8|||
143430645|NCT02101268|517123240|FG001|Randomized Treatment Phase|Subject Decision|4|||
143430646|NCT02101268|517123241|FG002|Randomized Treatment Phase|Subject Decision|0|||
143430647|NCT02101268|517123242|FG003|Randomized Treatment Phase|Subject Decision|0|||
143430648|NCT02101268|517123239|FG000|Randomized Treatment Phase|Physician Decision|4|||
143430649|NCT02101268|517123240|FG001|Randomized Treatment Phase|Physician Decision|1|||
143430650|NCT02101268|517123241|FG002|Randomized Treatment Phase|Physician Decision|0|||
143430651|NCT02101268|517123242|FG003|Randomized Treatment Phase|Physician Decision|0|||
143430652|NCT02101268|517123239|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
143430653|NCT02101268|517123240|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
143430654|NCT02101268|517123241|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
143430655|NCT02101268|517123242|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
143430656|NCT02101268|517123239|FG000|Randomized Treatment Phase|Adverse Event|6|||
143430657|NCT02101268|517123240|FG001|Randomized Treatment Phase|Adverse Event|0|||
143430658|NCT02101268|517123241|FG002|Randomized Treatment Phase|Adverse Event|0|||
143430659|NCT02101268|517123242|FG003|Randomized Treatment Phase|Adverse Event|0|||
143430660|NCT02101268|517123239|FG000|Randomized Treatment Phase|Death|5|||
143430661|NCT02101268|517123240|FG001|Randomized Treatment Phase|Death|4|||
143430662|NCT02101268|517123241|FG002|Randomized Treatment Phase|Death|0|||
143430663|NCT02101268|517123242|FG003|Randomized Treatment Phase|Death|0|||
143430664|NCT02101268|517123239|FG000|Randomized Treatment Phase|Disease Progression|4|||
143430665|NCT02101268|517123240|FG001|Randomized Treatment Phase|Disease Progression|1|||
143430666|NCT02101268|517123241|FG002|Randomized Treatment Phase|Disease Progression|0|||
143430667|NCT02101268|517123242|FG003|Randomized Treatment Phase|Disease Progression|0|||
143430668|NCT02101268|517123239|FG000|Extended Treatment Phase|Subject Decision|0|||
143430669|NCT02101268|517123240|FG001|Extended Treatment Phase|Subject Decision|0|||
143430670|NCT02101268|517123241|FG002|Extended Treatment Phase|Subject Decision|3|||
143430671|NCT02101268|517123242|FG003|Extended Treatment Phase|Subject Decision|2|||
143430672|NCT02101268|517123239|FG000|Extended Treatment Phase|Physician Decision|0|||
143430673|NCT02101268|517123240|FG001|Extended Treatment Phase|Physician Decision|0|||
143430674|NCT02101268|517123241|FG002|Extended Treatment Phase|Physician Decision|5|||
143430675|NCT02101268|517123242|FG003|Extended Treatment Phase|Physician Decision|2|||
143430676|NCT02101268|517123239|FG000|Extended Treatment Phase|Adverse Event|0|||
143430677|NCT02101268|517123240|FG001|Extended Treatment Phase|Adverse Event|0|||
143430678|NCT02101268|517123241|FG002|Extended Treatment Phase|Adverse Event|14|||
143430679|NCT02101268|517123242|FG003|Extended Treatment Phase|Adverse Event|18|||
143430680|NCT02101268|517123239|FG000|Extended Treatment Phase|Death|0|||
143430681|NCT02101268|517123240|FG001|Extended Treatment Phase|Death|0|||
143430682|NCT02101268|517123241|FG002|Extended Treatment Phase|Death|5|||
143430683|NCT02101268|517123242|FG003|Extended Treatment Phase|Death|1|||
143430684|NCT02101268|517123239|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
143430685|NCT02101268|517123240|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
143430686|NCT02101268|517123241|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
143430687|NCT02101268|517123242|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
143430688|NCT02101268|517123239|FG000|Extended Treatment Phase|Disease Progression|0|||
143430689|NCT02101268|517123240|FG001|Extended Treatment Phase|Disease Progression|0|||
143430690|NCT02101268|517123241|FG002|Extended Treatment Phase|Disease Progression|13|||
143430691|NCT02101268|517123242|FG003|Extended Treatment Phase|Disease Progression|6|||
143430692|NCT02101268|517123239|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
143430693|NCT02101268|517123240|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
143430694|NCT02101268|517123241|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
143430695|NCT02101268|517123242|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
143430696|NCT00740870|517123243|FG000|Overall Study|Not Catheterized|4|||
143430697|NCT00740870|517123243|FG000|Overall Study|Further testing contraindicated implant|17|||
143430698|NCT00819013|517123245|FG000|Overall Study|Not meeting continuing study eligibility|2|||
143430699|NCT00819013|517123246|FG001|Overall Study|Not meeting continuing study eligibility|1|||
143430700|NCT00819013|517123247|FG002|Overall Study|Not meeting continuing study eligibility|2|||
143430701|NCT00819013|517123248|FG003|Overall Study|Not meeting continuing study eligibility|1|||
143430702|NCT00819013|517123245|FG000|Overall Study|Adverse Event|0|||
143430703|NCT00819013|517123246|FG001|Overall Study|Adverse Event|0|||
143430704|NCT00819013|517123247|FG002|Overall Study|Adverse Event|1|||
143430705|NCT00819013|517123248|FG003|Overall Study|Adverse Event|0|||
143430706|NCT00819013|517123245|FG000|Overall Study|Withdrawal by Subject|1|||
143430707|NCT00819013|517123246|FG001|Overall Study|Withdrawal by Subject|0|||
143430708|NCT00819013|517123247|FG002|Overall Study|Withdrawal by Subject|1|||
143430709|NCT00819013|517123248|FG003|Overall Study|Withdrawal by Subject|0|||
143430710|NCT00819013|517123245|FG000|Overall Study|Lost to Follow-up|0|||
143430711|NCT00819013|517123246|FG001|Overall Study|Lost to Follow-up|0|||
143430712|NCT00819013|517123247|FG002|Overall Study|Lost to Follow-up|1|||
143430713|NCT00819013|517123248|FG003|Overall Study|Lost to Follow-up|2|||
143430714|NCT00819013|517123245|FG000|Overall Study|Death|0|||
143430715|NCT00819013|517123246|FG001|Overall Study|Death|0|||
143430716|NCT00819013|517123247|FG002|Overall Study|Death|0|||
143430717|NCT00819013|517123248|FG003|Overall Study|Death|1|||
143430718|NCT00607997|517123249|FG000|Overall Study|Lack of Efficacy|6|||
143430719|NCT00607997|517123250|FG001|Overall Study|Lack of Efficacy|20|||
143430720|NCT00607997|517123251|FG002|Overall Study|Lack of Efficacy|14|||
143430721|NCT00607997|517123252|FG003|Overall Study|Lack of Efficacy|10|||
143430722|NCT00607997|517123249|FG000|Overall Study|Death|8|||
143430723|NCT00607997|517123250|FG001|Overall Study|Death|5|||
143430724|NCT00607997|517123251|FG002|Overall Study|Death|2|||
143430725|NCT00607997|517123252|FG003|Overall Study|Death|5|||
143430726|NCT00607997|517123249|FG000|Overall Study|Adverse Event|3|||
143430727|NCT00607997|517123250|FG001|Overall Study|Adverse Event|1|||
143430728|NCT00607997|517123251|FG002|Overall Study|Adverse Event|2|||
143430729|NCT00607997|517123252|FG003|Overall Study|Adverse Event|0|||
143430730|NCT00607997|517123249|FG000|Overall Study|Physician Decision|4|||
143430731|NCT00607997|517123250|FG001|Overall Study|Physician Decision|1|||
143430732|NCT00607997|517123251|FG002|Overall Study|Physician Decision|0|||
143430733|NCT00607997|517123252|FG003|Overall Study|Physician Decision|0|||
143430734|NCT00607997|517123249|FG000|Overall Study|Relapse, recurrent illness|4|||
143430735|NCT00607997|517123250|FG001|Overall Study|Relapse, recurrent illness|0|||
143430736|NCT00607997|517123251|FG002|Overall Study|Relapse, recurrent illness|2|||
143430737|NCT00607997|517123252|FG003|Overall Study|Relapse, recurrent illness|0|||
143430738|NCT00607997|517123249|FG000|Overall Study|Other without explanation|2|||
143430739|NCT00607997|517123250|FG001|Overall Study|Other without explanation|0|||
143430740|NCT00607997|517123251|FG002|Overall Study|Other without explanation|4|||
143430741|NCT00607997|517123252|FG003|Overall Study|Other without explanation|1|||
143430742|NCT00839332|517123256|FG000|Phase 1|Disease Progression|38|||
143430743|NCT00839332|517123257|FG001|Phase 1|Disease Progression|0|||
143430744|NCT00839332|517123258|FG002|Phase 1|Disease Progression|0|||
143430745|NCT00839332|517123256|FG000|Phase 1|Adverse Event|6|||
143430746|NCT00839332|517123257|FG001|Phase 1|Adverse Event|0|||
143430747|NCT00839332|517123258|FG002|Phase 1|Adverse Event|0|||
143430748|NCT00839332|517123256|FG000|Phase 1|Withdrawal by Subject|4|||
143430749|NCT00839332|517123257|FG001|Phase 1|Withdrawal by Subject|0|||
143430750|NCT00839332|517123258|FG002|Phase 1|Withdrawal by Subject|0|||
143430751|NCT00839332|517123256|FG000|Phase 1|Physician Decision|2|||
143430752|NCT00839332|517123257|FG001|Phase 1|Physician Decision|0|||
143430753|NCT00839332|517123258|FG002|Phase 1|Physician Decision|0|||
143430754|NCT00839332|517123256|FG000|Phase 2|Protocol Violation|0|||
143430755|NCT00839332|517123257|FG001|Phase 2|Protocol Violation|1|||
143430756|NCT00839332|517123258|FG002|Phase 2|Protocol Violation|0|||
143430757|NCT00839332|517123256|FG000|Phase 2|Disease Progression|0|||
143430758|NCT00839332|517123257|FG001|Phase 2|Disease Progression|46|||
143430759|NCT00839332|517123258|FG002|Phase 2|Disease Progression|21|||
143430760|NCT00839332|517123256|FG000|Phase 2|Adverse Event|0|||
143430761|NCT00839332|517123257|FG001|Phase 2|Adverse Event|8|||
143430762|NCT00839332|517123258|FG002|Phase 2|Adverse Event|6|||
143430763|NCT00839332|517123256|FG000|Phase 2|Death|0|||
143430764|NCT00839332|517123257|FG001|Phase 2|Death|4|||
143430765|NCT00839332|517123258|FG002|Phase 2|Death|2|||
143430766|NCT00839332|517123256|FG000|Phase 2|Withdrawal by Subject|0|||
143430767|NCT00839332|517123257|FG001|Phase 2|Withdrawal by Subject|5|||
143430768|NCT00839332|517123258|FG002|Phase 2|Withdrawal by Subject|8|||
143430769|NCT00839332|517123256|FG000|Phase 2|Physician Decision|0|||
143430770|NCT00839332|517123257|FG001|Phase 2|Physician Decision|4|||
143430771|NCT00839332|517123258|FG002|Phase 2|Physician Decision|1|||
143430772|NCT00839332|517123256|FG000|Phase 2|Lost to Follow-up|0|||
143430773|NCT00839332|517123257|FG001|Phase 2|Lost to Follow-up|0|||
143430774|NCT00839332|517123258|FG002|Phase 2|Lost to Follow-up|1|||
143430775|NCT01200485|517123259|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
143430776|NCT01200485|517123260|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
143430777|NCT01200485|517123261|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
143430778|NCT01200485|517123259|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
143430779|NCT01200485|517123260|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
143430780|NCT01200485|517123261|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
143430781|NCT06080438|517123263|FG000|Overall Study|Lost to Follow-up|2|||
143430782|NCT03589300|517123265|FG000|Overall Study|Adverse Event|2|||
143430783|NCT03589300|517123265|FG000|Overall Study|Death|4|||
143430784|NCT03589300|517123265|FG000|Overall Study|Lost to Follow-up|12|||
143430785|NCT03589300|517123265|FG000|Overall Study|Withdrawal by Subject|5|||
143430786|NCT01678898|517123270|FG000|PB-102-F01|Adverse Event|0|||
143430787|NCT01678898|517123271|FG001|PB-102-F01|Adverse Event|1|||
143430788|NCT01678898|517123272|FG002|PB-102-F01|Adverse Event|0|||
143430789|NCT01678898|517123270|FG000|PB-102-F01|Physician Decision|0|||
143430790|NCT01678898|517123271|FG001|PB-102-F01|Physician Decision|1|||
143430791|NCT01678898|517123272|FG002|PB-102-F01|Physician Decision|0|||
143430792|NCT00640042|517123273|FG000|Enrollment|Did not receive study drug|83|||
143430793|NCT03640754|517123287|FG000|Overall Study|Withdrawal by Subject|1|||
143430794|NCT03640754|517123288|FG001|Overall Study|Withdrawal by Subject|0|||
143430795|NCT03640754|517123287|FG000|Overall Study|Lost to Follow-up|0|||
143430796|NCT03640754|517123288|FG001|Overall Study|Lost to Follow-up|1|||
143430797|NCT00276016|517123293|FG000|Intervention 1|Withdrawal by Subject|0|||
143430798|NCT00276016|517123294|FG001|Intervention 1|Withdrawal by Subject|1|||
143430799|NCT00276016|517123295|FG002|Intervention 1|Withdrawal by Subject|0|||
143430800|NCT00276016|517123296|FG003|Intervention 1|Withdrawal by Subject|0|||
143430801|NCT00276016|517123297|FG004|Intervention 1|Withdrawal by Subject|0|||
143430802|NCT00276016|517123298|FG005|Intervention 1|Withdrawal by Subject|0|||
143430803|NCT00230971|517123299|FG000|Randomization|No study drug administered|3|||
143430804|NCT00230971|517123300|FG001|Randomization|No study drug administered|3|||
143430805|NCT00230971|517123299|FG000|Baseline Participants|Lost to Follow-up|5|||
143430806|NCT00230971|517123300|FG001|Baseline Participants|Lost to Follow-up|12|||
143430807|NCT00230971|517123299|FG000|Baseline Participants|Death|6|||
143430808|NCT00230971|517123300|FG001|Baseline Participants|Death|5|||
143430809|NCT00230971|517123299|FG000|Baseline Participants|Withdrawal by Subject|7|||
143430810|NCT00230971|517123300|FG001|Baseline Participants|Withdrawal by Subject|1|||
143430811|NCT00230971|517123299|FG000|Baseline Participants|Adverse Event|1|||
143430812|NCT00230971|517123300|FG001|Baseline Participants|Adverse Event|0|||
143430813|NCT00230971|517123299|FG000|Baseline Participants|No bacteria observed|1|||
143430814|NCT00230971|517123300|FG001|Baseline Participants|No bacteria observed|0|||
143430815|NCT00230971|517123299|FG000|Baseline Participants|Failure to return|1|||
143430816|NCT00230971|517123300|FG001|Baseline Participants|Failure to return|1|||
143430817|NCT00230971|517123299|FG000|Baseline Participants|Reintervention|1|||
143430818|NCT00230971|517123300|FG001|Baseline Participants|Reintervention|0|||
143430819|NCT04380688|517123302|FG000|Overall Study|Death|2|||
143430820|NCT04380688|517123303|FG001|Overall Study|Death|2|||
143430821|NCT04380688|517123302|FG000|Overall Study|Lost to Follow-up|2|||
143430822|NCT04380688|517123303|FG001|Overall Study|Lost to Follow-up|4|||
143430823|NCT04380688|517123302|FG000|Overall Study|Withdrawal by Subject|3|||
143430824|NCT04380688|517123303|FG001|Overall Study|Withdrawal by Subject|3|||
143430825|NCT00951171|517123307|FG000|Overall Study|Adverse Event|2|||
143430826|NCT00951171|517123308|FG001|Overall Study|Adverse Event|0|||
143430827|NCT05294328|517123309|FG000|Overall Study|Adverse Event|1|||
143430828|NCT05294328|517123310|FG001|Overall Study|Adverse Event|0|||
143430829|NCT05294328|517123311|FG002|Overall Study|Adverse Event|0|||
143430830|NCT05294328|517123309|FG000|Overall Study|Physician Decision|1|||
143430831|NCT05294328|517123310|FG001|Overall Study|Physician Decision|1|||
143430832|NCT05294328|517123311|FG002|Overall Study|Physician Decision|0|||
143430833|NCT05294328|517123309|FG000|Overall Study|Withdrawal by Subject|0|||
143430834|NCT05294328|517123310|FG001|Overall Study|Withdrawal by Subject|2|||
143430835|NCT05294328|517123311|FG002|Overall Study|Withdrawal by Subject|1|||
143430836|NCT05294328|517123309|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
143430837|NCT05294328|517123310|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
143430838|NCT05294328|517123311|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
143430839|NCT04267393|517123312|FG000|Randomization|Adverse Event|1|||
143430840|NCT04267393|517123313|FG001|Randomization|Adverse Event|0|||
143430841|NCT04267393|517123314|FG002|Randomization|Adverse Event|0|||
143430842|NCT04267393|517123312|FG000|Randomization|Administrative Reasons by Sponsor|0|||
143430843|NCT04267393|517123313|FG001|Randomization|Administrative Reasons by Sponsor|1|||
143430844|NCT04267393|517123314|FG002|Randomization|Administrative Reasons by Sponsor|0|||
143430845|NCT04267393|517123312|FG000|Treatment Period|Adverse Event|0|||
143430846|NCT04267393|517123313|FG001|Treatment Period|Adverse Event|2|||
143430847|NCT04267393|517123314|FG002|Treatment Period|Adverse Event|3|||
143430848|NCT04267393|517123312|FG000|Treatment Period|Participant Withdrew Consent|0|||
143430849|NCT04267393|517123313|FG001|Treatment Period|Participant Withdrew Consent|0|||
143430850|NCT04267393|517123314|FG002|Treatment Period|Participant Withdrew Consent|1|||
143430851|NCT04267393|517123312|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
143430852|NCT04267393|517123313|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
143430853|NCT04267393|517123314|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
143430854|NCT02056873|517123315|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
143430855|NCT01929876|517125493|FG000|Period 2|Non-Compliance|1|||
143430856|NCT00526097|517125496|FG000|Overall Study|Adverse Event|6|||
143430857|NCT00526097|517125497|FG001|Overall Study|Adverse Event|44|||
143430858|NCT00526097|517125496|FG000|Overall Study|Protocol Violation|4|||
143430859|NCT00526097|517125497|FG001|Overall Study|Protocol Violation|10|||
143430860|NCT00526097|517125496|FG000|Overall Study|Withdrawal by Subject|3|||
143430861|NCT00526097|517125497|FG001|Overall Study|Withdrawal by Subject|1|||
143430862|NCT00526097|517125496|FG000|Overall Study|Other|2|||
143430863|NCT00526097|517125497|FG001|Overall Study|Other|1|||
143430864|NCT03713281|517125502|FG000|Overall Study|Lens handling difficuluties|2|||
143430865|NCT03713281|517125502|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
143430866|NCT02412111|517125504|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
143430867|NCT02412111|517125505|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
143430868|NCT02412111|517125506|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
143430869|NCT02412111|517125504|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
143430870|NCT02412111|517125505|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
143430871|NCT02412111|517125506|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
143430872|NCT02412111|517125504|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
143430873|NCT02412111|517125505|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
143430874|NCT02412111|517125506|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
143430875|NCT02412111|517125504|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
143430876|NCT02412111|517125505|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
143430877|NCT02412111|517125506|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
143430878|NCT02412111|517125504|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
143430879|NCT02412111|517125505|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
143430880|NCT02412111|517125506|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
143430881|NCT02412111|517125504|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
143430882|NCT02412111|517125505|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
143430883|NCT02412111|517125506|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
143430884|NCT02412111|517125504|FG000|Active Comparator Period (8 Weeks)|Other|0|||
143430885|NCT02412111|517125505|FG001|Active Comparator Period (8 Weeks)|Other|0|||
143430886|NCT02412111|517125506|FG002|Active Comparator Period (8 Weeks)|Other|2|||
143430887|NCT00487552|517125507|FG000|Overall Study|Unsuccessful magnet placements|3|||
143430888|NCT00487552|517125507|FG000|Overall Study|Death due to progressive malignancy|2|||
143430889|NCT00487552|517125507|FG000|Overall Study|Stent not placed|1|||
143430890|NCT04349644|517125509|FG000|Allocation/Pretest|Lost to pretest|0|||
143430891|NCT04349644|517125510|FG001|Allocation/Pretest|Lost to pretest|3|||
143430892|NCT04349644|517125509|FG000|Posttest|Lost to posttest|0|||
143430893|NCT04349644|517125510|FG001|Posttest|Lost to posttest|8|||
143430894|NCT04349644|517125509|FG000|Posttest|Discontinued intervention|6|||
143430895|NCT04349644|517125510|FG001|Posttest|Discontinued intervention|0|||
143430896|NCT04349644|517125509|FG000|Follow-up|Lost to Follow-up|0|||
143430897|NCT04349644|517125510|FG001|Follow-up|Lost to Follow-up|2|||
143430898|NCT05006417|517125511|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
143430899|NCT01169636|517125512|FG000|Overall Study|Adverse Event|0|||
143430900|NCT01169636|517125513|FG001|Overall Study|Adverse Event|0|||
143430901|NCT01169636|517125514|FG002|Overall Study|Adverse Event|1|||
143430902|NCT01169636|517125515|FG003|Overall Study|Adverse Event|1|||
143430903|NCT01169636|517125516|FG004|Overall Study|Adverse Event|0|||
143430904|NCT01169636|517125512|FG000|Overall Study|Screen failure|0|||
143430905|NCT01169636|517125513|FG001|Overall Study|Screen failure|0|||
143430906|NCT01169636|517125514|FG002|Overall Study|Screen failure|2|||
143430907|NCT01169636|517125515|FG003|Overall Study|Screen failure|0|||
143430908|NCT01169636|517125516|FG004|Overall Study|Screen failure|0|||
143430909|NCT01169636|517125512|FG000|Overall Study|Withdrawal by Subject|0|||
143430910|NCT01169636|517125513|FG001|Overall Study|Withdrawal by Subject|0|||
143430911|NCT01169636|517125514|FG002|Overall Study|Withdrawal by Subject|0|||
143430912|NCT01169636|517125515|FG003|Overall Study|Withdrawal by Subject|0|||
143430913|NCT01169636|517125516|FG004|Overall Study|Withdrawal by Subject|3|||
143430914|NCT00510198|517125517|FG000|Overall Study|Withdrawal by Subject|5|||
143430915|NCT00510198|517125518|FG001|Overall Study|Withdrawal by Subject|4|||
143430916|NCT02994784|517125519|FG000|6 Months Follow-up|Lost to Follow-up|3|||
143430917|NCT02466243|517125520|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
143430918|NCT02466243|517125521|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
143430919|NCT02466243|517125520|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
143430920|NCT02466243|517125521|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
143430921|NCT02466243|517125520|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
143430922|NCT02466243|517125521|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
143430923|NCT02466243|517125520|FG000|Part B Open-label Treatment Period|Missing|2|||
143430924|NCT02466243|517125521|FG001|Part B Open-label Treatment Period|Missing|2|||
143430925|NCT01649557|517125525|FG000|Overall Study|Lost to Follow-up|5|||
143430926|NCT01649557|517125526|FG001|Overall Study|Lost to Follow-up|0|||
143430927|NCT01649557|517125527|FG002|Overall Study|Lost to Follow-up|3|||
143430928|NCT01649557|517125525|FG000|Overall Study|Adverse Event|7|||
143430929|NCT01649557|517125526|FG001|Overall Study|Adverse Event|5|||
143430930|NCT01649557|517125527|FG002|Overall Study|Adverse Event|1|||
143430931|NCT01649557|517125525|FG000|Overall Study|Met withdrawal criteria|4|||
143430932|NCT01649557|517125526|FG001|Overall Study|Met withdrawal criteria|0|||
143430933|NCT01649557|517125527|FG002|Overall Study|Met withdrawal criteria|0|||
143430934|NCT01649557|517125525|FG000|Overall Study|Physician Decision|8|||
143430935|NCT01649557|517125526|FG001|Overall Study|Physician Decision|2|||
143430936|NCT01649557|517125527|FG002|Overall Study|Physician Decision|1|||
143430937|NCT01649557|517125525|FG000|Overall Study|Withdrawal by Subject|15|||
143430938|NCT01649557|517125526|FG001|Overall Study|Withdrawal by Subject|5|||
143430939|NCT01649557|517125527|FG002|Overall Study|Withdrawal by Subject|4|||
143430940|NCT01649557|517125525|FG000|Overall Study|Protocol deviation|0|||
143430941|NCT01649557|517125526|FG001|Overall Study|Protocol deviation|2|||
143430942|NCT01649557|517125527|FG002|Overall Study|Protocol deviation|0|||
143430943|NCT01649557|517125525|FG000|Overall Study|Lack of Efficacy|5|||
143430944|NCT01649557|517125526|FG001|Overall Study|Lack of Efficacy|0|||
143430945|NCT01649557|517125527|FG002|Overall Study|Lack of Efficacy|0|||
143430946|NCT03029234|517125528|FG000|Overall Study|Sponsor Decision|1|||
143430947|NCT03029234|517125528|FG000|Overall Study|Withdrawal by Subject|5|||
143430948|NCT03029234|517125528|FG000|Overall Study|Death|91|||
143430949|NCT03029234|517125528|FG000|Overall Study|Lost to Follow-up|2|||
143430950|NCT02544113|517125531|FG000|Overall Study|Death|3|||
143430951|NCT02544113|517125532|FG001|Overall Study|Death|4|||
143430952|NCT02847637|517125534|FG000|Overall Study|Withdrawal by Subject|0|||
143430953|NCT02847637|517125535|FG001|Overall Study|Withdrawal by Subject|1|||
143430954|NCT02847637|517125536|FG002|Overall Study|Withdrawal by Subject|1|||
143430955|NCT02847637|517125537|FG003|Overall Study|Withdrawal by Subject|0|||
143430956|NCT02847637|517125534|FG000|Overall Study|Lost to Follow-up|1|||
143430957|NCT02847637|517125535|FG001|Overall Study|Lost to Follow-up|1|||
143430958|NCT02847637|517125536|FG002|Overall Study|Lost to Follow-up|0|||
143430959|NCT02847637|517125537|FG003|Overall Study|Lost to Follow-up|0|||
143430960|NCT01746108|517125540|FG000|Overall Study|Migrated /moved from study area|0|||
143430961|NCT01746108|517125541|FG001|Overall Study|Migrated /moved from study area|1|||
143430962|NCT01746108|517125542|FG002|Overall Study|Migrated /moved from study area|0|||
143430963|NCT01746108|517125540|FG000|Overall Study|Adverse event, non-fatal|0|||
143430964|NCT01746108|517125541|FG001|Overall Study|Adverse event, non-fatal|1|||
143430965|NCT01746108|517125542|FG002|Overall Study|Adverse event, non-fatal|0|||
143430966|NCT01746108|517125540|FG000|Overall Study|Withdrawal by Subject|0|||
143430967|NCT01746108|517125541|FG001|Overall Study|Withdrawal by Subject|1|||
143430968|NCT01746108|517125542|FG002|Overall Study|Withdrawal by Subject|0|||
143430969|NCT01746108|517125540|FG000|Overall Study|Lost to Follow-up|0|||
143430970|NCT01746108|517125541|FG001|Overall Study|Lost to Follow-up|1|||
143430971|NCT01746108|517125542|FG002|Overall Study|Lost to Follow-up|0|||
143430972|NCT01040403|517125546|FG000|Overall Study|Adverse Event|10|||
143430973|NCT01040403|517125546|FG000|Overall Study|Protocol Violation|2|||
143430974|NCT01040403|517125546|FG000|Overall Study|Lost to Follow-up|1|||
143430975|NCT01040403|517125546|FG000|Overall Study|Not treated|1|||
143430976|NCT01040403|517125546|FG000|Overall Study|Other reason not defined above|6|||
143430977|NCT00797511|517125547|FG000|Overall Study|Withdrawal by Subject|1|||
143430978|NCT03036150|517125548|FG000|Overall Study|Withdrawal by Subject|8|||
143430979|NCT03036150|517125549|FG001|Overall Study|Withdrawal by Subject|3|||
143430980|NCT03036150|517125548|FG000|Overall Study|Lost to Follow-up|2|||
143430981|NCT03036150|517125549|FG001|Overall Study|Lost to Follow-up|2|||
143430982|NCT02741713|517125555|FG000|Overall Study|Surgery type changed intra-operatively|2|||
143430983|NCT02741713|517125556|FG001|Overall Study|Surgery type changed intra-operatively|1|||
143430984|NCT00619983|517125559|FG000|Test Drug Alone|Withdrawal by Subject|1|||
143430985|NCT00619983|517125560|FG001|Test Drug Alone|Withdrawal by Subject|0|||
143430986|NCT00619983|517125561|FG002|Test Drug Alone|Withdrawal by Subject|0|||
143430987|NCT00619983|517125562|FG003|Test Drug Alone|Withdrawal by Subject|1|||
143430988|NCT00619983|517125559|FG000|Test Drug Alone|Failure of daily diary device|1|||
143430989|NCT00619983|517125560|FG001|Test Drug Alone|Failure of daily diary device|1|||
143430990|NCT00619983|517125561|FG002|Test Drug Alone|Failure of daily diary device|2|||
143430991|NCT00619983|517125562|FG003|Test Drug Alone|Failure of daily diary device|2|||
143430992|NCT00570921|517125564|FG000|Overall Study|Protocol Violation|1|||
143430993|NCT00570921|517125564|FG000|Overall Study|Physician Decision|1|||
143430994|NCT03201900|517125565|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
143430995|NCT03201900|517125565|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
143430996|NCT03201900|517125565|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
143430997|NCT03201900|517125565|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
143430998|NCT03201900|517125565|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
143430999|NCT03201900|517125565|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
143431000|NCT03201900|517125565|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
143431001|NCT03201900|517125565|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
143431002|NCT03201900|517125565|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
143431003|NCT03201900|517125565|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
143431004|NCT03201900|517125565|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
143431005|NCT03201900|517125565|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
143431006|NCT03201900|517125565|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
143431007|NCT02971228|517125566|FG000|Overall Study|Withdrawal by Subject|1|||
143431008|NCT02971228|517125567|FG001|Overall Study|Withdrawal by Subject|1|||
143431009|NCT02971228|517125568|FG002|Overall Study|Withdrawal by Subject|0|||
143431010|NCT02971228|517125569|FG003|Overall Study|Withdrawal by Subject|0|||
143431011|NCT02971228|517125570|FG004|Overall Study|Withdrawal by Subject|0|||
143431012|NCT02971228|517125566|FG000|Overall Study|Logistical challenges|0|||
143431013|NCT02971228|517125567|FG001|Overall Study|Logistical challenges|1|||
143431014|NCT02971228|517125568|FG002|Overall Study|Logistical challenges|0|||
143431015|NCT02971228|517125569|FG003|Overall Study|Logistical challenges|0|||
143431016|NCT02971228|517125570|FG004|Overall Study|Logistical challenges|0|||
143431017|NCT02560389|517125571|FG000|Overall Study|Lost to Follow-up|1|||
143431018|NCT02560389|517125572|FG001|Overall Study|Lost to Follow-up|2|||
143431019|NCT02560389|517125573|FG002|Overall Study|Lost to Follow-up|2|||
143431020|NCT02560389|517125571|FG000|Overall Study|Tested positive for illicit substance|0|||
143431021|NCT02560389|517125572|FG001|Overall Study|Tested positive for illicit substance|1|||
143431022|NCT02560389|517125573|FG002|Overall Study|Tested positive for illicit substance|0|||
143431023|NCT02716298|517125574|FG000|First Intervention (1 Month)|Lens discomfort|1|||
143431024|NCT02716298|517125575|FG001|First Intervention (1 Month)|Lens discomfort|1|||
143431025|NCT00550446|517125576|FG000|Up To Week 12|Adverse Event|2|||
143431026|NCT00550446|517125577|FG001|Up To Week 12|Adverse Event|2|||
143431027|NCT00550446|517125578|FG002|Up To Week 12|Adverse Event|0|||
143431028|NCT00550446|517125579|FG003|Up To Week 12|Adverse Event|0|||
143431029|NCT00550446|517125580|FG004|Up To Week 12|Adverse Event|2|||
143431030|NCT00550446|517125581|FG005|Up To Week 12|Adverse Event|2|||
143431031|NCT00550446|517125582|FG006|Up To Week 12|Adverse Event|1|||
143431032|NCT00550446|517125583|FG007|Up To Week 12|Adverse Event|0|||
143431033|NCT00550446|517125584|FG008|Up To Week 12|Adverse Event|0|||
143431034|NCT00550446|517125585|FG009|Up To Week 12|Adverse Event|0|||
143431035|NCT00550446|517125586|FG010|Up To Week 12|Adverse Event|0|||
143431036|NCT00550446|517125576|FG000|Up To Week 12|Lack of Efficacy|3|||
143431037|NCT00550446|517125577|FG001|Up To Week 12|Lack of Efficacy|1|||
143431038|NCT00550446|517125578|FG002|Up To Week 12|Lack of Efficacy|0|||
143431039|NCT00550446|517125579|FG003|Up To Week 12|Lack of Efficacy|1|||
143431040|NCT00550446|517125580|FG004|Up To Week 12|Lack of Efficacy|0|||
143431041|NCT00550446|517125581|FG005|Up To Week 12|Lack of Efficacy|3|||
143431042|NCT00550446|517125582|FG006|Up To Week 12|Lack of Efficacy|3|||
143431043|NCT00550446|517125583|FG007|Up To Week 12|Lack of Efficacy|0|||
143431044|NCT00550446|517125584|FG008|Up To Week 12|Lack of Efficacy|0|||
143431045|NCT00550446|517125585|FG009|Up To Week 12|Lack of Efficacy|0|||
143431046|NCT00550446|517125586|FG010|Up To Week 12|Lack of Efficacy|0|||
143431047|NCT00550446|517125576|FG000|Up To Week 12|Lost to Follow-up|0|||
143431048|NCT00550446|517125577|FG001|Up To Week 12|Lost to Follow-up|1|||
143431049|NCT00550446|517125578|FG002|Up To Week 12|Lost to Follow-up|0|||
143431050|NCT00550446|517125579|FG003|Up To Week 12|Lost to Follow-up|0|||
143431051|NCT00550446|517125580|FG004|Up To Week 12|Lost to Follow-up|1|||
143431052|NCT00550446|517125581|FG005|Up To Week 12|Lost to Follow-up|1|||
143431053|NCT00550446|517125582|FG006|Up To Week 12|Lost to Follow-up|2|||
143431054|NCT00550446|517125583|FG007|Up To Week 12|Lost to Follow-up|0|||
143431055|NCT00550446|517125584|FG008|Up To Week 12|Lost to Follow-up|0|||
143431056|NCT00550446|517125585|FG009|Up To Week 12|Lost to Follow-up|0|||
143431057|NCT00550446|517125586|FG010|Up To Week 12|Lost to Follow-up|0|||
143431058|NCT00550446|517125576|FG000|Up To Week 12|Withdrawal by Subject|2|||
143431059|NCT00550446|517125577|FG001|Up To Week 12|Withdrawal by Subject|0|||
143431060|NCT00550446|517125578|FG002|Up To Week 12|Withdrawal by Subject|3|||
143431061|NCT00550446|517125579|FG003|Up To Week 12|Withdrawal by Subject|2|||
143431062|NCT00550446|517125580|FG004|Up To Week 12|Withdrawal by Subject|0|||
143431063|NCT00550446|517125581|FG005|Up To Week 12|Withdrawal by Subject|1|||
143431064|NCT00550446|517125582|FG006|Up To Week 12|Withdrawal by Subject|3|||
143431065|NCT00550446|517125583|FG007|Up To Week 12|Withdrawal by Subject|0|||
143431066|NCT00550446|517125584|FG008|Up To Week 12|Withdrawal by Subject|0|||
143431067|NCT00550446|517125585|FG009|Up To Week 12|Withdrawal by Subject|0|||
143431068|NCT00550446|517125586|FG010|Up To Week 12|Withdrawal by Subject|0|||
143431069|NCT00550446|517125576|FG000|Up To Week 12|Other|3|||
143431070|NCT00550446|517125577|FG001|Up To Week 12|Other|0|||
143431071|NCT00550446|517125578|FG002|Up To Week 12|Other|0|||
143431072|NCT00550446|517125579|FG003|Up To Week 12|Other|0|||
143431073|NCT00550446|517125580|FG004|Up To Week 12|Other|0|||
143431074|NCT00550446|517125581|FG005|Up To Week 12|Other|1|||
143431075|NCT00550446|517125582|FG006|Up To Week 12|Other|4|||
143431076|NCT00550446|517125583|FG007|Up To Week 12|Other|0|||
143431077|NCT00550446|517125584|FG008|Up To Week 12|Other|0|||
143431078|NCT00550446|517125585|FG009|Up To Week 12|Other|0|||
143431079|NCT00550446|517125586|FG010|Up To Week 12|Other|0|||
143431080|NCT00550446|517125576|FG000|Up To Week 12|Randomized not treated|0|||
143431081|NCT00550446|517125577|FG001|Up To Week 12|Randomized not treated|1|||
143431082|NCT00550446|517125578|FG002|Up To Week 12|Randomized not treated|1|||
143431083|NCT00550446|517125579|FG003|Up To Week 12|Randomized not treated|0|||
143431084|NCT00550446|517125580|FG004|Up To Week 12|Randomized not treated|0|||
143431085|NCT00550446|517125581|FG005|Up To Week 12|Randomized not treated|0|||
143431086|NCT00550446|517125582|FG006|Up To Week 12|Randomized not treated|0|||
143431087|NCT00550446|517125583|FG007|Up To Week 12|Randomized not treated|0|||
143431088|NCT00550446|517125584|FG008|Up To Week 12|Randomized not treated|0|||
143431089|NCT00550446|517125585|FG009|Up To Week 12|Randomized not treated|0|||
143431090|NCT00550446|517125586|FG010|Up To Week 12|Randomized not treated|0|||
143431091|NCT00550446|517125576|FG000|Post Week 12|Adverse Event|2|||
143431092|NCT00550446|517125577|FG001|Post Week 12|Adverse Event|1|||
143431093|NCT00550446|517125578|FG002|Post Week 12|Adverse Event|1|||
143431094|NCT00550446|517125579|FG003|Post Week 12|Adverse Event|1|||
143431095|NCT00550446|517125580|FG004|Post Week 12|Adverse Event|1|||
143431096|NCT00550446|517125581|FG005|Post Week 12|Adverse Event|1|||
143431097|NCT00550446|517125582|FG006|Post Week 12|Adverse Event|0|||
143431098|NCT00550446|517125583|FG007|Post Week 12|Adverse Event|0|||
143431099|NCT00550446|517125584|FG008|Post Week 12|Adverse Event|0|||
143431100|NCT00550446|517125585|FG009|Post Week 12|Adverse Event|4|||
143431101|NCT00550446|517125586|FG010|Post Week 12|Adverse Event|0|||
143431102|NCT00550446|517125576|FG000|Post Week 12|Lack of Efficacy|0|||
143431103|NCT00550446|517125577|FG001|Post Week 12|Lack of Efficacy|0|||
143431104|NCT00550446|517125578|FG002|Post Week 12|Lack of Efficacy|1|||
143431105|NCT00550446|517125579|FG003|Post Week 12|Lack of Efficacy|0|||
143431106|NCT00550446|517125580|FG004|Post Week 12|Lack of Efficacy|0|||
143431107|NCT00550446|517125581|FG005|Post Week 12|Lack of Efficacy|0|||
143431108|NCT00550446|517125582|FG006|Post Week 12|Lack of Efficacy|0|||
143431109|NCT00550446|517125583|FG007|Post Week 12|Lack of Efficacy|1|||
143431110|NCT00550446|517125584|FG008|Post Week 12|Lack of Efficacy|1|||
143431111|NCT00550446|517125585|FG009|Post Week 12|Lack of Efficacy|2|||
143431112|NCT00550446|517125586|FG010|Post Week 12|Lack of Efficacy|1|||
143431113|NCT00550446|517125576|FG000|Post Week 12|Lost to Follow-up|0|||
143431114|NCT00550446|517125577|FG001|Post Week 12|Lost to Follow-up|0|||
143431115|NCT00550446|517125578|FG002|Post Week 12|Lost to Follow-up|1|||
143431116|NCT00550446|517125579|FG003|Post Week 12|Lost to Follow-up|1|||
143431117|NCT00550446|517125580|FG004|Post Week 12|Lost to Follow-up|0|||
143431118|NCT00550446|517125581|FG005|Post Week 12|Lost to Follow-up|0|||
143431119|NCT00550446|517125582|FG006|Post Week 12|Lost to Follow-up|1|||
143431120|NCT00550446|517125583|FG007|Post Week 12|Lost to Follow-up|0|||
143431121|NCT00550446|517125584|FG008|Post Week 12|Lost to Follow-up|0|||
143431122|NCT00550446|517125585|FG009|Post Week 12|Lost to Follow-up|0|||
143431123|NCT00550446|517125586|FG010|Post Week 12|Lost to Follow-up|0|||
143431124|NCT00550446|517125576|FG000|Post Week 12|Withdrawal by Subject|0|||
143431125|NCT00550446|517125577|FG001|Post Week 12|Withdrawal by Subject|0|||
143431126|NCT00550446|517125578|FG002|Post Week 12|Withdrawal by Subject|0|||
143431127|NCT00550446|517125579|FG003|Post Week 12|Withdrawal by Subject|0|||
143431128|NCT00550446|517125580|FG004|Post Week 12|Withdrawal by Subject|1|||
143431129|NCT00550446|517125581|FG005|Post Week 12|Withdrawal by Subject|0|||
143431130|NCT00550446|517125582|FG006|Post Week 12|Withdrawal by Subject|0|||
143431131|NCT00550446|517125583|FG007|Post Week 12|Withdrawal by Subject|0|||
143431132|NCT00550446|517125584|FG008|Post Week 12|Withdrawal by Subject|0|||
143431133|NCT00550446|517125585|FG009|Post Week 12|Withdrawal by Subject|0|||
143431134|NCT00550446|517125586|FG010|Post Week 12|Withdrawal by Subject|0|||
143431135|NCT00550446|517125576|FG000|Post Week 12|Other|1|||
143431136|NCT00550446|517125577|FG001|Post Week 12|Other|1|||
143431137|NCT00550446|517125578|FG002|Post Week 12|Other|0|||
143431138|NCT00550446|517125579|FG003|Post Week 12|Other|1|||
143431139|NCT00550446|517125580|FG004|Post Week 12|Other|0|||
143431140|NCT00550446|517125581|FG005|Post Week 12|Other|0|||
143431141|NCT00550446|517125582|FG006|Post Week 12|Other|1|||
143431142|NCT00550446|517125583|FG007|Post Week 12|Other|0|||
143431143|NCT00550446|517125584|FG008|Post Week 12|Other|1|||
143431144|NCT00550446|517125585|FG009|Post Week 12|Other|1|||
143431145|NCT00550446|517125586|FG010|Post Week 12|Other|0|||
143431146|NCT02246218|517125587|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
143431147|NCT02246218|517125588|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
143431148|NCT02246218|517125587|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
143431149|NCT02246218|517125588|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
143431150|NCT02246218|517125587|FG000|Overall Study|Adverse Event|1|||
143431151|NCT02246218|517125588|FG001|Overall Study|Adverse Event|1|||
143431152|NCT02246218|517125587|FG000|Overall Study|Lost to Follow-up|1|||
143431153|NCT02246218|517125588|FG001|Overall Study|Lost to Follow-up|0|||
143431154|NCT01321723|517125589|FG000|Overall Study|Adverse Event|3|||
143431155|NCT01321723|517125590|FG001|Overall Study|Adverse Event|5|||
143431156|NCT01321723|517125591|FG002|Overall Study|Adverse Event|2|||
143431157|NCT01321723|517125589|FG000|Overall Study|Withdrawal by Subject|2|||
143431158|NCT01321723|517125590|FG001|Overall Study|Withdrawal by Subject|0|||
143431159|NCT01321723|517125591|FG002|Overall Study|Withdrawal by Subject|2|||
143431160|NCT04952701|517125592|FG000|Control Lens|Physician Decision|4|||
143431161|NCT04952701|517125592|FG000|Test Lens|Physician Decision|1|||
143431162|NCT04081389|517125594|FG000|Overall Study|Withdrawal by Subject|0|||
143431163|NCT04081389|517125595|FG001|Overall Study|Withdrawal by Subject|0|||
143431164|NCT04081389|517125596|FG002|Overall Study|Withdrawal by Subject|1|||
143431165|NCT04081389|517125597|FG003|Overall Study|Withdrawal by Subject|0|||
143431166|NCT01670188|517125606|FG000|Overall Study|Death|0|||
143431167|NCT01670188|517125607|FG001|Overall Study|Death|1|||
143431168|NCT00866918|517125610|FG000|Overall Study|Death|1|||
143431169|NCT00866918|517125611|FG001|Overall Study|Death|5|||
143431170|NCT00866918|517125610|FG000|Overall Study|Lack of Efficacy|1|||
143431171|NCT00866918|517125611|FG001|Overall Study|Lack of Efficacy|1|||
143431172|NCT00866918|517125610|FG000|Overall Study|Physician Decision|10|||
143431173|NCT00866918|517125611|FG001|Overall Study|Physician Decision|2|||
143431174|NCT00866918|517125610|FG000|Overall Study|Ineligible|2|||
143431175|NCT00866918|517125611|FG001|Overall Study|Ineligible|4|||
143431176|NCT00866918|517125610|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
143431177|NCT00866918|517125611|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
143431178|NCT00866918|517125610|FG000|Overall Study|Secondary malignancy|1|||
143431179|NCT00866918|517125611|FG001|Overall Study|Secondary malignancy|0|||
143431180|NCT00802438|517125612|FG000|Overall Study|Screen Failure|20|||
143431181|NCT00802438|517125612|FG000|Overall Study|Withdrawal by Subject|7|||
143431182|NCT00802438|517125612|FG000|Overall Study|Physician Decision|1|||
143431183|NCT03175198|517125613|FG000|Overall Study|Adverse Event|480|||
143431184|NCT03175198|517125613|FG000|Overall Study|No actual visit|120|||
143431185|NCT03175198|517125613|FG000|Overall Study|Registration rule not followed|4|||
143431186|NCT03175198|517125613|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
143431187|NCT03175198|517125613|FG000|Overall Study|Other personal reason|509|||
143431188|NCT03175198|517125613|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
143431189|NCT03175198|517125613|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
143431190|NCT03175198|517125613|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
143431191|NCT03175198|517125613|FG000|Overall Study|To conduct invasive treatment of operation|53|||
143431192|NCT03175198|517125613|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
143431193|NCT02630706|517125615|FG000|Overall Study|Adverse Event|2|||
143431194|NCT02630706|517125616|FG001|Overall Study|Adverse Event|1|||
143431195|NCT02630706|517125617|FG002|Overall Study|Adverse Event|1|||
143431196|NCT02630706|517125615|FG000|Overall Study|Lost to Follow-up|0|||
143431197|NCT02630706|517125616|FG001|Overall Study|Lost to Follow-up|1|||
143431198|NCT02630706|517125617|FG002|Overall Study|Lost to Follow-up|2|||
143431199|NCT02630706|517125615|FG000|Overall Study|Physician Decision|1|||
143431200|NCT02630706|517125616|FG001|Overall Study|Physician Decision|1|||
143431201|NCT02630706|517125617|FG002|Overall Study|Physician Decision|0|||
143431202|NCT02630706|517125615|FG000|Overall Study|Pregnancy|0|||
143431203|NCT02630706|517125616|FG001|Overall Study|Pregnancy|1|||
143431204|NCT02630706|517125617|FG002|Overall Study|Pregnancy|0|||
143431205|NCT02630706|517125615|FG000|Overall Study|Withdrawal by Subject|4|||
143431206|NCT02630706|517125616|FG001|Overall Study|Withdrawal by Subject|5|||
143431207|NCT02630706|517125617|FG002|Overall Study|Withdrawal by Subject|7|||
143431208|NCT01544309|517125622|FG000|Overall Study|Withdrawal by Subject|12|||
143431209|NCT01544309|517125623|FG001|Overall Study|Withdrawal by Subject|7|||
143431210|NCT01544309|517125622|FG000|Overall Study|Protocol Violation|2|||
143431211|NCT01544309|517125623|FG001|Overall Study|Protocol Violation|1|||
143431212|NCT01544309|517125622|FG000|Overall Study|Physician Decision|4|||
143431213|NCT01544309|517125623|FG001|Overall Study|Physician Decision|1|||
143431214|NCT01544309|517125622|FG000|Overall Study|Not performed pre-dose examination|1|||
143431215|NCT01544309|517125623|FG001|Overall Study|Not performed pre-dose examination|2|||
143431216|NCT01544309|517125622|FG000|Overall Study|Administered prohibit prior medication|1|||
143431217|NCT01544309|517125623|FG001|Overall Study|Administered prohibit prior medication|0|||
143431218|NCT02551692|517125628|FG000|Overall Study|Lost to Follow-up|0|||
143431219|NCT02551692|517125629|FG001|Overall Study|Lost to Follow-up|1|||
143431220|NCT02551692|517125630|FG002|Overall Study|Lost to Follow-up|4|||
143431221|NCT02551692|517125628|FG000|Overall Study|Withdrawal by Subject|1|||
143431222|NCT02551692|517125629|FG001|Overall Study|Withdrawal by Subject|0|||
143431223|NCT02551692|517125630|FG002|Overall Study|Withdrawal by Subject|1|||
143431224|NCT01091519|517125631|FG000|Overall Study|Adverse Event|12|||
143431225|NCT01091519|517125632|FG001|Overall Study|Adverse Event|16|||
143431226|NCT01091519|517125631|FG000|Overall Study|Death|1|||
143431227|NCT01091519|517125632|FG001|Overall Study|Death|0|||
143431228|NCT01091519|517125631|FG000|Overall Study|Lack of Efficacy|16|||
143431229|NCT01091519|517125632|FG001|Overall Study|Lack of Efficacy|19|||
143431230|NCT01091519|517125631|FG000|Overall Study|Lost to Follow-up|14|||
143431231|NCT01091519|517125632|FG001|Overall Study|Lost to Follow-up|24|||
143431232|NCT01091519|517125631|FG000|Overall Study|Withdrawal by Subject|2|||
143431233|NCT01091519|517125632|FG001|Overall Study|Withdrawal by Subject|2|||
143431234|NCT01091519|517125631|FG000|Overall Study|Other|6|||
143431235|NCT01091519|517125632|FG001|Overall Study|Other|8|||
143431236|NCT01091519|517125631|FG000|Overall Study|Randomized not treated|4|||
143431237|NCT01091519|517125632|FG001|Overall Study|Randomized not treated|4|||
143431238|NCT01196741|517125635|FG000|Overall Study|Disease progression|34|||
143431239|NCT01196741|517125636|FG001|Overall Study|Disease progression|14|||
143431240|NCT01196741|517125635|FG000|Overall Study|Adverse Event|10|||
143431241|NCT01196741|517125636|FG001|Overall Study|Adverse Event|6|||
143431242|NCT01196741|517125635|FG000|Overall Study|Serious Adverse Event|3|||
143431243|NCT01196741|517125636|FG001|Overall Study|Serious Adverse Event|1|||
143431244|NCT01196741|517125635|FG000|Overall Study|Dose limiting Adverse Event|2|||
143431245|NCT01196741|517125636|FG001|Overall Study|Dose limiting Adverse Event|1|||
143431246|NCT01196741|517125635|FG000|Overall Study|Withdrawal by Subject|3|||
143431247|NCT01196741|517125636|FG001|Overall Study|Withdrawal by Subject|0|||
143431248|NCT01196741|517125635|FG000|Overall Study|Other reason|3|||
143431249|NCT01196741|517125636|FG001|Overall Study|Other reason|3|||
143431250|NCT01196741|517125635|FG000|Overall Study|Other|3|||
143431251|NCT01196741|517125636|FG001|Overall Study|Other|2|||
143431252|NCT01196741|517125635|FG000|Overall Study|Protocol Violation|2|||
143431253|NCT01196741|517125636|FG001|Overall Study|Protocol Violation|1|||
143431254|NCT01227928|517125637|FG000|Overall Study|Lost to Follow-up|4|||
143431255|NCT01227928|517125638|FG001|Overall Study|Lost to Follow-up|2|||
143431256|NCT01227928|517125637|FG000|Overall Study|Withdrawal by Subject|4|||
143431257|NCT01227928|517125638|FG001|Overall Study|Withdrawal by Subject|3|||
143431258|NCT01227928|517125637|FG000|Overall Study|Death|14|||
143431259|NCT01227928|517125638|FG001|Overall Study|Death|12|||
143431260|NCT03030599|517125639|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
143431261|NCT03030599|517125640|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
143431262|NCT03030599|517125641|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
143431263|NCT03030599|517125639|FG000|Open Label Treatment and Titration|Other|1|||
143431264|NCT03030599|517125640|FG001|Open Label Treatment and Titration|Other|0|||
143431265|NCT03030599|517125641|FG002|Open Label Treatment and Titration|Other|0|||
143431266|NCT03030599|517125639|FG000|Open Label Treatment and Titration|Physician Decision|3|||
143431267|NCT03030599|517125640|FG001|Open Label Treatment and Titration|Physician Decision|0|||
143431268|NCT03030599|517125641|FG002|Open Label Treatment and Titration|Physician Decision|0|||
143431269|NCT03030599|517125639|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
143431270|NCT03030599|517125640|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
143431271|NCT03030599|517125641|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
143431272|NCT03030599|517125639|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
143431273|NCT03030599|517125640|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
143431274|NCT03030599|517125641|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
143431275|NCT03030599|517125639|FG000|Open Label Treatment and Titration|Adverse Event|18|||
143431276|NCT03030599|517125640|FG001|Open Label Treatment and Titration|Adverse Event|0|||
143431277|NCT03030599|517125641|FG002|Open Label Treatment and Titration|Adverse Event|0|||
143431278|NCT03030599|517125639|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
143431279|NCT03030599|517125640|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
143431280|NCT03030599|517125641|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
143431281|NCT03030599|517125639|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
143431282|NCT03030599|517125640|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
143431283|NCT03030599|517125641|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
143431284|NCT03030599|517125639|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
143431285|NCT03030599|517125640|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
143431286|NCT03030599|517125641|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
143431287|NCT03030599|517125639|FG000|Stable Dose|Protocol deviation|3|||
143431288|NCT03030599|517125640|FG001|Stable Dose|Protocol deviation|0|||
143431289|NCT03030599|517125641|FG002|Stable Dose|Protocol deviation|0|||
143431290|NCT03030599|517125639|FG000|Stable Dose|Adverse Event|1|||
143431291|NCT03030599|517125640|FG001|Stable Dose|Adverse Event|0|||
143431292|NCT03030599|517125641|FG002|Stable Dose|Adverse Event|0|||
143431293|NCT03030599|517125639|FG000|Stable Dose|Lost to Follow-up|1|||
143431294|NCT03030599|517125640|FG001|Stable Dose|Lost to Follow-up|0|||
143431295|NCT03030599|517125641|FG002|Stable Dose|Lost to Follow-up|0|||
143431296|NCT03030599|517125639|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
143431297|NCT03030599|517125640|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
143431298|NCT03030599|517125641|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
143431299|NCT03030599|517125639|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
143431300|NCT03030599|517125640|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
143431301|NCT03030599|517125641|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
143431302|NCT03030599|517125639|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
143431303|NCT03030599|517125640|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
143431304|NCT03030599|517125641|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
143431305|NCT03030599|517125639|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
143431306|NCT03030599|517125640|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
143431307|NCT03030599|517125641|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
143431308|NCT03030599|517125639|FG000|Open-label Extension|Adverse Event|3|||
143431309|NCT03030599|517125640|FG001|Open-label Extension|Adverse Event|0|||
143431310|NCT03030599|517125641|FG002|Open-label Extension|Adverse Event|0|||
143431311|NCT03030599|517125639|FG000|Open-label Extension|Lost to Follow-up|2|||
143431312|NCT03030599|517125640|FG001|Open-label Extension|Lost to Follow-up|0|||
143431313|NCT03030599|517125641|FG002|Open-label Extension|Lost to Follow-up|0|||
143431314|NCT03030599|517125639|FG000|Open-label Extension|Lack of Efficacy|1|||
143431315|NCT03030599|517125640|FG001|Open-label Extension|Lack of Efficacy|0|||
143431316|NCT03030599|517125641|FG002|Open-label Extension|Lack of Efficacy|0|||
143431317|NCT03030599|517125639|FG000|Open-label Extension|Other Reason|1|||
143431318|NCT03030599|517125640|FG001|Open-label Extension|Other Reason|0|||
143431319|NCT03030599|517125641|FG002|Open-label Extension|Other Reason|0|||
143431320|NCT02930837|517125642|FG000|Overall Study|Adverse Event|6|||
143431321|NCT02930837|517125642|FG000|Overall Study|Lost to Follow-up|5|||
143431322|NCT02930837|517125642|FG000|Overall Study|Withdrawal by Subject|1|||
143431323|NCT04582864|517125643|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
143431324|NCT04582864|517125643|FG000|Overall Study|Death|1|||
143431325|NCT00006436|517125644|FG000|Overall Study|Refused further treatment|2|||
143431326|NCT00006436|517125644|FG000|Overall Study|Declined to participate (before treatment started)|1|||
143431327|NCT01071317|517125645|FG000|Overall Study|Lost to Follow-up|2|||
143431328|NCT01071317|517125646|FG001|Overall Study|Lost to Follow-up|2|||
143431329|NCT00092521|517127382|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
143431330|NCT00092521|517127383|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
143431331|NCT00092521|517127384|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
143431332|NCT00092521|517127385|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
143431333|NCT00092521|517127382|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
143431334|NCT00092521|517127383|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
143431335|NCT00092521|517127384|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
143431336|NCT00092521|517127385|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
143431337|NCT00092521|517127382|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
143431338|NCT00092521|517127383|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
143431339|NCT00092521|517127384|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
143431340|NCT00092521|517127385|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
143431341|NCT00092521|517127382|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
143431342|NCT00092521|517127383|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
143431343|NCT00092521|517127384|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
143431344|NCT00092521|517127385|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
143431345|NCT00092521|517127382|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
143431346|NCT00092521|517127383|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
143431347|NCT00092521|517127384|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
143431348|NCT00092521|517127385|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
143431349|NCT00092521|517127382|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
143431350|NCT00092521|517127383|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
143431351|NCT00092521|517127384|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
143431352|NCT00092521|517127385|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
143431353|NCT00092521|517127382|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
143431354|NCT00092521|517127383|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
143431355|NCT00092521|517127384|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
143431356|NCT00092521|517127385|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
143431357|NCT00092521|517127382|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
143431358|NCT00092521|517127383|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
143431359|NCT00092521|517127384|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
143431360|NCT00092521|517127385|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
143431361|NCT00092521|517127382|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
143431362|NCT00092521|517127383|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
143431363|NCT00092521|517127384|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
143431364|NCT00092521|517127385|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
143431365|NCT00092521|517127382|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
143431366|NCT00092521|517127383|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
143431367|NCT00092521|517127384|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
143431368|NCT00092521|517127385|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
143431369|NCT00092521|517127382|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
143431370|NCT00092521|517127383|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
143431371|NCT00092521|517127384|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
143431372|NCT00092521|517127385|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
143431373|NCT00092521|517127382|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
143431374|NCT00092521|517127383|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
143431375|NCT00092521|517127384|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
143431376|NCT00092521|517127385|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
143431377|NCT00092521|517127382|FG000|Follow-Up (After Month 7)|Death|2|||
143431378|NCT00092521|517127383|FG001|Follow-Up (After Month 7)|Death|0|||
143431379|NCT00092521|517127384|FG002|Follow-Up (After Month 7)|Death|1|||
143431380|NCT00092521|517127385|FG003|Follow-Up (After Month 7)|Death|0|||
143431381|NCT00092521|517127382|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
143431382|NCT00092521|517127383|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
143431383|NCT00092521|517127384|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
143431384|NCT00092521|517127385|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
143431385|NCT00092521|517127382|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
143431386|NCT00092521|517127383|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
143431387|NCT00092521|517127384|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
143431388|NCT00092521|517127385|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
143431389|NCT00092521|517127382|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
143431390|NCT00092521|517127383|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
143431391|NCT00092521|517127384|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
143431392|NCT00092521|517127385|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
143431393|NCT00092521|517127382|FG000|Follow-Up (After Month 7)|Moved|32|||
143431394|NCT00092521|517127383|FG001|Follow-Up (After Month 7)|Moved|2|||
143431395|NCT00092521|517127384|FG002|Follow-Up (After Month 7)|Moved|28|||
143431396|NCT00092521|517127385|FG003|Follow-Up (After Month 7)|Moved|0|||
143431397|NCT00092521|517127382|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
143431398|NCT00092521|517127383|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
143431399|NCT00092521|517127384|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
143431400|NCT00092521|517127385|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
143431401|NCT00092521|517127382|FG000|Follow-Up (After Month 7)|Travel|2|||
143431402|NCT00092521|517127383|FG001|Follow-Up (After Month 7)|Travel|0|||
143431403|NCT00092521|517127384|FG002|Follow-Up (After Month 7)|Travel|0|||
143431404|NCT00092521|517127385|FG003|Follow-Up (After Month 7)|Travel|0|||
143431405|NCT00092521|517127382|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
143431406|NCT00092521|517127383|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
143431407|NCT00092521|517127384|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
143431408|NCT00092521|517127385|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
143431409|NCT00092521|517127382|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
143431410|NCT00092521|517127383|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
143431411|NCT00092521|517127384|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
143431412|NCT00092521|517127385|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
143431413|NCT00092521|517127382|FG000|Extension Study (Group 4)|Adverse Event|0|||
143431414|NCT00092521|517127383|FG001|Extension Study (Group 4)|Adverse Event|0|||
143431415|NCT00092521|517127384|FG002|Extension Study (Group 4)|Adverse Event|0|||
143431416|NCT00092521|517127385|FG003|Extension Study (Group 4)|Adverse Event|2|||
143431417|NCT00092521|517127382|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
143431418|NCT00092521|517127383|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
143431419|NCT00092521|517127384|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
143431420|NCT00092521|517127385|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
143431421|NCT00092521|517127382|FG000|Extension Study (Group 4)|Pregnancy|0|||
143431422|NCT00092521|517127383|FG001|Extension Study (Group 4)|Pregnancy|0|||
143431423|NCT00092521|517127384|FG002|Extension Study (Group 4)|Pregnancy|0|||
143431424|NCT00092521|517127385|FG003|Extension Study (Group 4)|Pregnancy|4|||
143431425|NCT00092521|517127382|FG000|Extension Study (Group 4)|Protocol Violation|0|||
143431426|NCT00092521|517127383|FG001|Extension Study (Group 4)|Protocol Violation|0|||
143431427|NCT00092521|517127384|FG002|Extension Study (Group 4)|Protocol Violation|0|||
143431428|NCT00092521|517127385|FG003|Extension Study (Group 4)|Protocol Violation|2|||
143431429|NCT00092521|517127382|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
143431430|NCT00092521|517127383|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
143431431|NCT00092521|517127384|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
143431432|NCT00092521|517127385|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
143431433|NCT00092521|517127382|FG000|Extension Study (Group 4)|Moved|0|||
143431434|NCT00092521|517127383|FG001|Extension Study (Group 4)|Moved|0|||
143431435|NCT00092521|517127384|FG002|Extension Study (Group 4)|Moved|0|||
143431436|NCT00092521|517127385|FG003|Extension Study (Group 4)|Moved|16|||
143431437|NCT00092521|517127382|FG000|Extension Study (Group 4)|Site Terminated|0|||
143431438|NCT00092521|517127383|FG001|Extension Study (Group 4)|Site Terminated|0|||
143431439|NCT00092521|517127384|FG002|Extension Study (Group 4)|Site Terminated|0|||
143431440|NCT00092521|517127385|FG003|Extension Study (Group 4)|Site Terminated|4|||
143431441|NCT00092521|517127382|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
143431442|NCT00092521|517127383|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
143431443|NCT00092521|517127384|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
143431444|NCT00092521|517127385|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
143431445|NCT01878383|517127386|FG000|Overall Study|Lost to Follow-up|0|||
143431446|NCT01878383|517127387|FG001|Overall Study|Lost to Follow-up|1499|||
143431447|NCT03464383|517127388|FG000|Overall Study|Lost to Follow-up|1|||
143431448|NCT03464383|517127389|FG001|Overall Study|Lost to Follow-up|0|||
143431449|NCT03464383|517127390|FG002|Overall Study|Lost to Follow-up|0|||
143431450|NCT03464383|517127388|FG000|Overall Study|Withdrawal by Subject|0|||
143431451|NCT03464383|517127389|FG001|Overall Study|Withdrawal by Subject|1|||
143431452|NCT03464383|517127390|FG002|Overall Study|Withdrawal by Subject|0|||
143431453|NCT03475056|517127391|FG000|Overall Study|Lost to Follow-up|0|||
143431454|NCT03475056|517127392|FG001|Overall Study|Lost to Follow-up|1|||
143431455|NCT03475056|517127391|FG000|Overall Study|Moved from Area|0|||
143431456|NCT03475056|517127392|FG001|Overall Study|Moved from Area|2|||
143431457|NCT01904136|517127396|FG000|Overall Study|Physician Decision|0|||
143431458|NCT01904136|517127397|FG001|Overall Study|Physician Decision|0|||
143431459|NCT01904136|517127398|FG002|Overall Study|Physician Decision|0|||
143431460|NCT01904136|517127399|FG003|Overall Study|Physician Decision|0|||
143431461|NCT01904136|517127400|FG004|Overall Study|Physician Decision|0|||
143431462|NCT01904136|517127401|FG005|Overall Study|Physician Decision|1|||
143431463|NCT01904136|517127402|FG006|Overall Study|Physician Decision|0|||
143431464|NCT01904136|517127403|FG007|Overall Study|Physician Decision|0|||
143431465|NCT01904136|517127404|FG008|Overall Study|Physician Decision|0|||
143431466|NCT02418845|517127407|FG000|Overall Study|Lost to Follow-up|7|||
143431467|NCT02418845|517127408|FG001|Overall Study|Lost to Follow-up|2|||
143431468|NCT02418845|517127407|FG000|Overall Study|Lack of Efficacy|0|||
143431469|NCT02418845|517127408|FG001|Overall Study|Lack of Efficacy|3|||
143431470|NCT02418845|517127407|FG000|Overall Study|Physician Decision|5|||
143431471|NCT02418845|517127408|FG001|Overall Study|Physician Decision|5|||
143431472|NCT02418845|517127407|FG000|Overall Study|Protocol Violation|1|||
143431473|NCT02418845|517127408|FG001|Overall Study|Protocol Violation|0|||
143431474|NCT02418845|517127407|FG000|Overall Study|Withdrawal by Subject|3|||
143431475|NCT02418845|517127408|FG001|Overall Study|Withdrawal by Subject|2|||
143431476|NCT00460564|517127409|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
143431477|NCT00460564|517127410|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
143431478|NCT00460564|517127411|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
143431479|NCT00460564|517127412|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
143431480|NCT00460564|517127413|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
143431481|NCT00460564|517127414|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
143431482|NCT00460564|517127415|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
143431483|NCT00460564|517127416|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
143431484|NCT00460564|517127409|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
143431485|NCT00460564|517127410|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
143431486|NCT00460564|517127411|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
143431487|NCT00460564|517127412|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
143431488|NCT00460564|517127413|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
143431489|NCT00460564|517127414|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
143431490|NCT00460564|517127415|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
143431491|NCT00460564|517127416|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
143431492|NCT00460564|517127409|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
143431493|NCT00460564|517127410|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
143431494|NCT00460564|517127411|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
143431495|NCT00460564|517127412|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
143431496|NCT00460564|517127413|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
143431497|NCT00460564|517127414|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
143431498|NCT00460564|517127415|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
143431499|NCT00460564|517127416|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
143431500|NCT00460564|517127409|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
143431501|NCT00460564|517127410|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
143431502|NCT00460564|517127411|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
143431503|NCT00460564|517127412|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
143431504|NCT00460564|517127413|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
143431505|NCT00460564|517127414|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
143431506|NCT00460564|517127415|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
143431507|NCT00460564|517127416|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
143431508|NCT00460564|517127409|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
143431509|NCT00460564|517127410|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
143431510|NCT00460564|517127411|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
143431511|NCT00460564|517127412|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
143431512|NCT00460564|517127413|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
143431513|NCT00460564|517127414|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
143431514|NCT00460564|517127415|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
143431515|NCT00460564|517127416|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
143431516|NCT01990313|517127431|FG000|Overall Study|Lost to Follow-up|1|||
143431517|NCT03119688|517127432|FG000|Overall Study|Adverse Event|4|||
143431518|NCT00320398|517127433|FG000|Overall Study|Adverse Event|1|||
143431519|NCT00320398|517127434|FG001|Overall Study|Adverse Event|4|||
143431520|NCT00320398|517127433|FG000|Overall Study|Other|1|||
143431521|NCT00320398|517127434|FG001|Overall Study|Other|0|||
143431522|NCT04190225|517127435|FG000|Overall Study|Lost to Follow-up|2|||
143431523|NCT04190225|517127436|FG001|Overall Study|Lost to Follow-up|3|||
143431524|NCT04190225|517127435|FG000|Overall Study|Withdrawal by Subject|3|||
143431525|NCT04190225|517127436|FG001|Overall Study|Withdrawal by Subject|2|||
143431526|NCT04190225|517127435|FG000|Overall Study|Unrelated health condition|2|||
143431527|NCT04190225|517127436|FG001|Overall Study|Unrelated health condition|0|||
143431528|NCT02624869|517127437|FG000|Overall Study|Lost to Follow-up|0|||
143431529|NCT02624869|517127438|FG001|Overall Study|Lost to Follow-up|0|||
143431530|NCT02624869|517127439|FG002|Overall Study|Lost to Follow-up|1|||
143431531|NCT02624869|517127437|FG000|Overall Study|Withdrawal by Subject|1|||
143431532|NCT02624869|517127438|FG001|Overall Study|Withdrawal by Subject|3|||
143431533|NCT02624869|517127439|FG002|Overall Study|Withdrawal by Subject|1|||
143431534|NCT02705625|517127440|FG000|Overall Study|Protocol Violation|1|||
143431535|NCT02705625|517127441|FG001|Overall Study|Protocol Violation|0|||
143431536|NCT02705625|517127442|FG002|Overall Study|Protocol Violation|0|||
143431537|NCT02705625|517127440|FG000|Overall Study|Adverse Event|6|||
143431538|NCT02705625|517127441|FG001|Overall Study|Adverse Event|5|||
143431539|NCT02705625|517127442|FG002|Overall Study|Adverse Event|2|||
143431540|NCT02705625|517127440|FG000|Overall Study|Death|0|||
143431541|NCT02705625|517127441|FG001|Overall Study|Death|0|||
143431542|NCT02705625|517127442|FG002|Overall Study|Death|1|||
143431543|NCT02705625|517127440|FG000|Overall Study|Withdrawal by Subject|1|||
143431544|NCT02705625|517127441|FG001|Overall Study|Withdrawal by Subject|4|||
143431545|NCT02705625|517127442|FG002|Overall Study|Withdrawal by Subject|5|||
143431546|NCT02705625|517127440|FG000|Overall Study|Lost to Follow-up|0|||
143431547|NCT02705625|517127441|FG001|Overall Study|Lost to Follow-up|0|||
143431548|NCT02705625|517127442|FG002|Overall Study|Lost to Follow-up|1|||
143431549|NCT02705625|517127440|FG000|Overall Study|Non-compliance|0|||
143431550|NCT02705625|517127441|FG001|Overall Study|Non-compliance|1|||
143431551|NCT02705625|517127442|FG002|Overall Study|Non-compliance|1|||
143431552|NCT02705625|517127440|FG000|Overall Study|Overdosing|0|||
143431553|NCT02705625|517127441|FG001|Overall Study|Overdosing|0|||
143431554|NCT02705625|517127442|FG002|Overall Study|Overdosing|1|||
143431555|NCT00863798|517127443|FG000|Overall Study|Adverse Event|5|||
143431556|NCT00863798|517127444|FG001|Overall Study|Adverse Event|2|||
143431557|NCT00863798|517127445|FG002|Overall Study|Adverse Event|4|||
143431558|NCT00863798|517127443|FG000|Overall Study|Participant failed to return|2|||
143431559|NCT00863798|517127444|FG001|Overall Study|Participant failed to return|1|||
143431560|NCT00863798|517127445|FG002|Overall Study|Participant failed to return|0|||
143431561|NCT00863798|517127443|FG000|Overall Study|Investigator request|1|||
143431562|NCT00863798|517127444|FG001|Overall Study|Investigator request|2|||
143431563|NCT00863798|517127445|FG002|Overall Study|Investigator request|1|||
143431564|NCT00863798|517127443|FG000|Overall Study|Lack of Efficacy|4|||
143431565|NCT00863798|517127444|FG001|Overall Study|Lack of Efficacy|3|||
143431566|NCT00863798|517127445|FG002|Overall Study|Lack of Efficacy|6|||
143431567|NCT00863798|517127443|FG000|Overall Study|Lost to Follow-up|6|||
143431568|NCT00863798|517127444|FG001|Overall Study|Lost to Follow-up|9|||
143431569|NCT00863798|517127445|FG002|Overall Study|Lost to Follow-up|5|||
143431570|NCT00863798|517127443|FG000|Overall Study|Other|2|||
143431571|NCT00863798|517127444|FG001|Overall Study|Other|3|||
143431572|NCT00863798|517127445|FG002|Overall Study|Other|1|||
143431573|NCT00863798|517127443|FG000|Overall Study|Protocol Violation|0|||
143431574|NCT00863798|517127444|FG001|Overall Study|Protocol Violation|1|||
143431575|NCT00863798|517127445|FG002|Overall Study|Protocol Violation|1|||
143431576|NCT00863798|517127443|FG000|Overall Study|Withdrawal by Subject|8|||
143431577|NCT00863798|517127444|FG001|Overall Study|Withdrawal by Subject|7|||
143431578|NCT00863798|517127445|FG002|Overall Study|Withdrawal by Subject|4|||
143431579|NCT00863798|517127443|FG000|Overall Study|Randomized not treated|4|||
143431580|NCT00863798|517127444|FG001|Overall Study|Randomized not treated|2|||
143431581|NCT00863798|517127445|FG002|Overall Study|Randomized not treated|3|||
143431582|NCT04238520|517127447|FG000|Overall Study|Withdrawal by Subject|1|||
143431583|NCT04238520|517127448|FG001|Overall Study|Withdrawal by Subject|1|||
143431584|NCT04238520|517127447|FG000|Overall Study|Lost to Follow-up|1|||
143431585|NCT04238520|517127448|FG001|Overall Study|Lost to Follow-up|2|||
143431586|NCT04238520|517127447|FG000|Overall Study|Death|0|||
143431587|NCT04238520|517127448|FG001|Overall Study|Death|2|||
143431588|NCT04238520|517127447|FG000|Overall Study|Unsafe home environment for research staff|0|||
143431589|NCT04238520|517127448|FG001|Overall Study|Unsafe home environment for research staff|1|||
143431590|NCT01470599|517127449|FG000|Overall Study|Did not meet entrance criteria|1|||
143431591|NCT01470599|517127450|FG001|Overall Study|Did not meet entrance criteria|0|||
143431592|NCT01470599|517127449|FG000|Overall Study|Lost to Follow-up|2|||
143431593|NCT01470599|517127450|FG001|Overall Study|Lost to Follow-up|1|||
143431594|NCT01470599|517127449|FG000|Overall Study|Withdrawal by Subject|3|||
143431595|NCT01470599|517127450|FG001|Overall Study|Withdrawal by Subject|4|||
143431596|NCT01470599|517127449|FG000|Overall Study|Other|1|||
143431597|NCT01470599|517127450|FG001|Overall Study|Other|0|||
143431598|NCT01470599|517127449|FG000|Overall Study|Protocol Violation|3|||
143431599|NCT01470599|517127450|FG001|Overall Study|Protocol Violation|1|||
143431600|NCT01470599|517127449|FG000|Overall Study|Adverse event related to study drug|2|||
143431601|NCT01470599|517127450|FG001|Overall Study|Adverse event related to study drug|5|||
143431602|NCT01470599|517127449|FG000|Overall Study|Insufficient clinical response|6|||
143431603|NCT01470599|517127450|FG001|Overall Study|Insufficient clinical response|27|||
143431604|NCT01470599|517127449|FG000|Overall Study|Adverse event not related to study drug|1|||
143431605|NCT01470599|517127450|FG001|Overall Study|Adverse event not related to study drug|5|||
143431606|NCT00195442|517127451|FG000|Overall Study|Less than expected therapeutic effect|38|||
143431607|NCT00195442|517127451|FG000|Overall Study|Lost to Follow-up|27|||
143431608|NCT00195442|517127451|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
143431609|NCT00195442|517127451|FG000|Overall Study|Intermittent product shortage|21|||
143431610|NCT00195442|517127451|FG000|Overall Study|Death|7|||
143431611|NCT00195442|517127451|FG000|Overall Study|No reason specified|4|||
143431612|NCT00195442|517127451|FG000|Overall Study|Poor cooperation|2|||
143431613|NCT00195442|517127451|FG000|Overall Study|Other|14|||
143431614|NCT01917006|517127452|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
143431615|NCT01917006|517127453|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
143431616|NCT01917006|517127454|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
143431617|NCT01917006|517127455|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
143431618|NCT01917006|517127456|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
143431619|NCT01917006|517127457|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
143431620|NCT01917006|517127458|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
143431621|NCT01917006|517127459|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
143431622|NCT01917006|517127452|FG000|Randomized-treatment Period|Personal Reasons|0|||
143431623|NCT01917006|517127453|FG001|Randomized-treatment Period|Personal Reasons|0|||
143431624|NCT01917006|517127454|FG002|Randomized-treatment Period|Personal Reasons|0|||
143431625|NCT01917006|517127455|FG003|Randomized-treatment Period|Personal Reasons|0|||
143431626|NCT01917006|517127456|FG004|Randomized-treatment Period|Personal Reasons|0|||
143431627|NCT01917006|517127457|FG005|Randomized-treatment Period|Personal Reasons|1|||
143431628|NCT01917006|517127458|FG006|Randomized-treatment Period|Personal Reasons|0|||
143431629|NCT01917006|517127459|FG007|Randomized-treatment Period|Personal Reasons|0|||
143431630|NCT01917006|517127452|FG000|Randomized-treatment Period|Protocol Violation|1|||
143431631|NCT01917006|517127453|FG001|Randomized-treatment Period|Protocol Violation|0|||
143431632|NCT01917006|517127454|FG002|Randomized-treatment Period|Protocol Violation|0|||
143431633|NCT01917006|517127455|FG003|Randomized-treatment Period|Protocol Violation|0|||
143431634|NCT01917006|517127456|FG004|Randomized-treatment Period|Protocol Violation|0|||
143431635|NCT01917006|517127457|FG005|Randomized-treatment Period|Protocol Violation|0|||
143431636|NCT01917006|517127458|FG006|Randomized-treatment Period|Protocol Violation|0|||
143431637|NCT01917006|517127459|FG007|Randomized-treatment Period|Protocol Violation|0|||
143431638|NCT01917006|517127452|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
143431639|NCT01917006|517127453|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
143431640|NCT01917006|517127454|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
143431641|NCT01917006|517127455|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
143431642|NCT01917006|517127456|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
143431643|NCT01917006|517127457|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
143431644|NCT01917006|517127458|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
143431645|NCT01917006|517127459|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
143431646|NCT01917006|517127452|FG000|Open-label Period|Adverse Event|0|||
143431647|NCT01917006|517127453|FG001|Open-label Period|Adverse Event|0|||
143431648|NCT01917006|517127454|FG002|Open-label Period|Adverse Event|0|||
143431649|NCT01917006|517127455|FG003|Open-label Period|Adverse Event|0|||
143431650|NCT01917006|517127456|FG004|Open-label Period|Adverse Event|0|||
143431651|NCT01917006|517127457|FG005|Open-label Period|Adverse Event|0|||
143431652|NCT01917006|517127458|FG006|Open-label Period|Adverse Event|0|||
143431653|NCT01917006|517127459|FG007|Open-label Period|Adverse Event|1|||
143431654|NCT01917006|517127452|FG000|Open-label Period|Lost to Follow-up|0|||
143431655|NCT01917006|517127453|FG001|Open-label Period|Lost to Follow-up|0|||
143431656|NCT01917006|517127454|FG002|Open-label Period|Lost to Follow-up|0|||
143431657|NCT01917006|517127455|FG003|Open-label Period|Lost to Follow-up|0|||
143431658|NCT01917006|517127456|FG004|Open-label Period|Lost to Follow-up|0|||
143431659|NCT01917006|517127457|FG005|Open-label Period|Lost to Follow-up|0|||
143431660|NCT01917006|517127458|FG006|Open-label Period|Lost to Follow-up|0|||
143431661|NCT01917006|517127459|FG007|Open-label Period|Lost to Follow-up|1|||
143431662|NCT02158247|517127460|FG000|Overall Study|Invisible vocal cords|5|||
143431663|NCT02637856|517127468|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
143431664|NCT02637856|517127469|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
143431665|NCT02637856|517127468|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
143431666|NCT02637856|517127469|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
143431667|NCT02637856|517127468|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
143431668|NCT02637856|517127469|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
143431669|NCT02637856|517127468|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
143431670|NCT02637856|517127469|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
143431671|NCT02637856|517127468|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
143431672|NCT02637856|517127469|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
143431673|NCT02637856|517127468|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
143431674|NCT02637856|517127469|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
143431675|NCT02637856|517127468|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
143431676|NCT02637856|517127469|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
143431677|NCT02637856|517127468|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
143431678|NCT02637856|517127469|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
143431679|NCT02637856|517127468|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
143431680|NCT02637856|517127469|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
143431681|NCT02637856|517127468|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
143431682|NCT02637856|517127469|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
143431683|NCT02637856|517127468|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
143431684|NCT02637856|517127469|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
143431685|NCT02637856|517127468|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
143431686|NCT02637856|517127469|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
143431687|NCT02637856|517127468|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
143431688|NCT02637856|517127469|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
143431689|NCT02509312|517127470|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
143431690|NCT02509312|517127471|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
143431691|NCT02509312|517127470|FG000|Overall Study|Obstetrician refusal|0|||
143431692|NCT02509312|517127471|FG001|Overall Study|Obstetrician refusal|1|||
143431693|NCT02509312|517127470|FG000|Overall Study|Patient elected for TOLAC|1|||
143431694|NCT02509312|517127471|FG001|Overall Study|Patient elected for TOLAC|0|||
143431695|NCT02509312|517127470|FG000|Overall Study|Cesarean deemed stat|1|||
143431696|NCT02509312|517127471|FG001|Overall Study|Cesarean deemed stat|0|||
143431697|NCT02509312|517127470|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
143431698|NCT02509312|517127471|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
143431699|NCT02815735|517127474|FG000|First Intervention (4 Weeks)|Discomfort|1|||
143431700|NCT02815735|517127475|FG001|First Intervention (4 Weeks)|Discomfort|0|||
143431701|NCT02815735|517127474|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
143431702|NCT02815735|517127475|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
143431703|NCT02815735|517127474|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
143431704|NCT02815735|517127475|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
143431705|NCT02815735|517127474|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
143431706|NCT02815735|517127475|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
143431707|NCT02973802|517127476|FG000|Overall Study|Lost to Follow-up|1|||
143431708|NCT02973802|517127476|FG000|Overall Study|Withdrawal by Subject|1|||
143431709|NCT00702650|517127478|FG000|Overall Study|Withdrawal by Subject|9|||
143431710|NCT00702650|517127478|FG000|Overall Study|Non-Compliance of Study Drug|3|||
143431711|NCT00702650|517127478|FG000|Overall Study|Lost to Follow-up|2|||
143431712|NCT00702650|517127478|FG000|Overall Study|Non-Compliance with Site Directives|1|||
143431713|NCT00702650|517127478|FG000|Overall Study|Sponsor Request|1|||
143431714|NCT00702650|517127478|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
143431715|NCT00702650|517127478|FG000|Overall Study|Adverse Event|3|||
143431716|NCT00988533|517127479|FG000|Overall Study|Lost to Follow-up|3|||
143431717|NCT00943722|517127481|FG000|Base Study|Adverse Event|0|||
143431718|NCT00943722|517127482|FG001|Base Study|Adverse Event|0|||
143431719|NCT00943722|517127483|FG002|Base Study|Adverse Event|0|||
143431720|NCT00943722|517127484|FG003|Base Study|Adverse Event|1|||
143431721|NCT00943722|517127485|FG004|Base Study|Adverse Event|0|||
143431722|NCT00943722|517127486|FG005|Base Study|Adverse Event|0|||
143431723|NCT00943722|517127487|FG006|Base Study|Adverse Event|0|||
143431724|NCT00943722|517127481|FG000|Base Study|Lost to Follow-up|12|||
143431725|NCT00943722|517127482|FG001|Base Study|Lost to Follow-up|8|||
143431726|NCT00943722|517127483|FG002|Base Study|Lost to Follow-up|10|||
143431727|NCT00943722|517127484|FG003|Base Study|Lost to Follow-up|8|||
143431728|NCT00943722|517127485|FG004|Base Study|Lost to Follow-up|11|||
143431729|NCT00943722|517127486|FG005|Base Study|Lost to Follow-up|0|||
143431730|NCT00943722|517127487|FG006|Base Study|Lost to Follow-up|0|||
143431731|NCT00943722|517127481|FG000|Base Study|Physician Decision|1|||
143431732|NCT00943722|517127482|FG001|Base Study|Physician Decision|0|||
143431733|NCT00943722|517127483|FG002|Base Study|Physician Decision|0|||
143431734|NCT00943722|517127484|FG003|Base Study|Physician Decision|0|||
143431735|NCT00943722|517127485|FG004|Base Study|Physician Decision|1|||
143431736|NCT00943722|517127486|FG005|Base Study|Physician Decision|0|||
143431737|NCT00943722|517127487|FG006|Base Study|Physician Decision|0|||
143431738|NCT00943722|517127481|FG000|Base Study|Pregnancy|0|||
143431739|NCT00943722|517127482|FG001|Base Study|Pregnancy|0|||
143431740|NCT00943722|517127483|FG002|Base Study|Pregnancy|1|||
143431741|NCT00943722|517127484|FG003|Base Study|Pregnancy|0|||
143431742|NCT00943722|517127485|FG004|Base Study|Pregnancy|2|||
143431743|NCT00943722|517127486|FG005|Base Study|Pregnancy|0|||
143431744|NCT00943722|517127487|FG006|Base Study|Pregnancy|0|||
143431745|NCT00943722|517127481|FG000|Base Study|Protocol Violation|0|||
143431746|NCT00943722|517127482|FG001|Base Study|Protocol Violation|1|||
143431747|NCT00943722|517127483|FG002|Base Study|Protocol Violation|0|||
143431748|NCT00943722|517127484|FG003|Base Study|Protocol Violation|0|||
143431749|NCT00943722|517127485|FG004|Base Study|Protocol Violation|2|||
143431750|NCT00943722|517127486|FG005|Base Study|Protocol Violation|0|||
143431751|NCT00943722|517127487|FG006|Base Study|Protocol Violation|0|||
143431752|NCT00943722|517127481|FG000|Base Study|Withdrawal by Subject|12|||
143431753|NCT00943722|517127482|FG001|Base Study|Withdrawal by Subject|13|||
143431754|NCT00943722|517127483|FG002|Base Study|Withdrawal by Subject|2|||
143431755|NCT00943722|517127484|FG003|Base Study|Withdrawal by Subject|13|||
143431756|NCT00943722|517127485|FG004|Base Study|Withdrawal by Subject|8|||
143431757|NCT00943722|517127486|FG005|Base Study|Withdrawal by Subject|0|||
143431758|NCT00943722|517127487|FG006|Base Study|Withdrawal by Subject|0|||
143431759|NCT00943722|517127481|FG000|Base Study|Month 12 visit not completed|0|||
143431760|NCT00943722|517127482|FG001|Base Study|Month 12 visit not completed|0|||
143431761|NCT00943722|517127483|FG002|Base Study|Month 12 visit not completed|0|||
143431762|NCT00943722|517127484|FG003|Base Study|Month 12 visit not completed|0|||
143431763|NCT00943722|517127485|FG004|Base Study|Month 12 visit not completed|2|||
143431764|NCT00943722|517127486|FG005|Base Study|Month 12 visit not completed|0|||
143431765|NCT00943722|517127487|FG006|Base Study|Month 12 visit not completed|0|||
143431766|NCT00943722|517127481|FG000|First Extension Study: EXT 1|Adverse Event|0|||
143431767|NCT00943722|517127482|FG001|First Extension Study: EXT 1|Adverse Event|0|||
143431768|NCT00943722|517127483|FG002|First Extension Study: EXT 1|Adverse Event|0|||
143431769|NCT00943722|517127484|FG003|First Extension Study: EXT 1|Adverse Event|0|||
143431770|NCT00943722|517127485|FG004|First Extension Study: EXT 1|Adverse Event|0|||
143431771|NCT00943722|517127486|FG005|First Extension Study: EXT 1|Adverse Event|1|||
143431772|NCT00943722|517127487|FG006|First Extension Study: EXT 1|Adverse Event|0|||
143431773|NCT00943722|517127481|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
143431774|NCT00943722|517127482|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
143431775|NCT00943722|517127483|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
143431776|NCT00943722|517127484|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
143431777|NCT00943722|517127485|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
143431778|NCT00943722|517127486|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
143431779|NCT00943722|517127487|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
143431780|NCT00943722|517127481|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
143431781|NCT00943722|517127482|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
143431782|NCT00943722|517127483|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
143431783|NCT00943722|517127484|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
143431784|NCT00943722|517127485|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
143431785|NCT00943722|517127486|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
143431786|NCT00943722|517127487|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
143431787|NCT00943722|517127481|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
143431788|NCT00943722|517127482|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
143431789|NCT00943722|517127483|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
143431790|NCT00943722|517127484|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
143431791|NCT00943722|517127485|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
143431792|NCT00943722|517127486|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
143431793|NCT00943722|517127487|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
143431794|NCT00943722|517127481|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
143431795|NCT00943722|517127482|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
143431796|NCT00943722|517127483|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
143431797|NCT00943722|517127484|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
143431798|NCT00943722|517127485|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
143431799|NCT00943722|517127486|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
143431800|NCT00943722|517127487|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
143431801|NCT00943722|517127481|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
143431802|NCT00943722|517127482|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
143431803|NCT00943722|517127483|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
143431804|NCT00943722|517127484|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
143431805|NCT00943722|517127485|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
143431806|NCT00943722|517127486|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
143431807|NCT00943722|517127487|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
143431808|NCT00943722|517127481|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
143431809|NCT00943722|517127482|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
143431810|NCT00943722|517127483|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
143431811|NCT00943722|517127484|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
143431812|NCT00943722|517127485|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
143431813|NCT00943722|517127486|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
143431814|NCT00943722|517127487|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
143431815|NCT00943722|517127481|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
143431816|NCT00943722|517127482|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
143431817|NCT00943722|517127483|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
143431818|NCT00943722|517127484|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
143431819|NCT00943722|517127485|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
143431820|NCT00943722|517127486|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
143431821|NCT00943722|517127487|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
143431822|NCT00943722|517127481|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
143431823|NCT00943722|517127482|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
143431824|NCT00943722|517127483|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
143431825|NCT00943722|517127484|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
143431826|NCT00943722|517127485|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
143431827|NCT00943722|517127486|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
143431828|NCT00943722|517127487|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
143431829|NCT01772823|517127488|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
143431830|NCT01772823|517127489|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
143431831|NCT01772823|517127488|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
143431832|NCT01772823|517127489|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
143431833|NCT01772823|517127488|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
143431834|NCT01772823|517127489|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
143431835|NCT01772823|517127488|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
143431836|NCT01772823|517127489|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
143431837|NCT01772823|517127488|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
143431838|NCT01772823|517127489|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
143431839|NCT01772823|517127488|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
143431840|NCT01772823|517127489|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
143431841|NCT01772823|517127488|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
143431842|NCT01772823|517127489|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
143431843|NCT01772823|517127488|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
143431844|NCT01772823|517127489|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
143431845|NCT01772823|517127488|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
143431846|NCT01772823|517127489|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
143431847|NCT01772823|517127488|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
143431848|NCT01772823|517127489|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
143431849|NCT01772823|517127488|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
143431850|NCT01772823|517127489|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
143431851|NCT01772823|517127488|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
143431852|NCT01772823|517127489|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
143431853|NCT01772823|517127488|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
143431854|NCT01772823|517127489|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
143431855|NCT01772823|517127488|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
143431856|NCT01772823|517127489|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
143431857|NCT01772823|517127488|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
143431858|NCT01772823|517127489|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
143431859|NCT01772823|517127488|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
143431860|NCT01772823|517127489|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
143431861|NCT01036165|517127490|FG000|Overall Study|Adverse Event|6|||
143431862|NCT01036165|517127490|FG000|Overall Study|Lost to Follow-up|2|||
143431863|NCT01036165|517127490|FG000|Overall Study|Withdrawal by Subject|3|||
143431864|NCT01036165|517127490|FG000|Overall Study|Device Related Issues|3|||
143431865|NCT01036165|517127490|FG000|Overall Study|Problems finding proper area to inject|1|||
143431866|NCT00307164|517127495|FG000|Overall Study|Death|1|||
143431867|NCT00307164|517127496|FG001|Overall Study|Death|0|||
143431868|NCT00307164|517127495|FG000|Overall Study|Severe debilitation, unable to continue|1|||
143431869|NCT00307164|517127496|FG001|Overall Study|Severe debilitation, unable to continue|0|||
143431870|NCT00307164|517127495|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
143431871|NCT00307164|517127496|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
143431872|NCT00307164|517127495|FG000|Overall Study|Withdrawal by Subject|1|||
143431873|NCT00307164|517127496|FG001|Overall Study|Withdrawal by Subject|8|||
143431874|NCT00307164|517127495|FG000|Overall Study|Not compliant with requirements|4|||
143431875|NCT00307164|517127496|FG001|Overall Study|Not compliant with requirements|4|||
143431876|NCT00307164|517127495|FG000|Overall Study|Lost to Follow-up|6|||
143431877|NCT00307164|517127496|FG001|Overall Study|Lost to Follow-up|1|||
143431878|NCT01649297|517127498|FG000|Overall Study|Adverse Event|5|||
143431879|NCT01649297|517127499|FG001|Overall Study|Adverse Event|5|||
143431880|NCT01649297|517127500|FG002|Overall Study|Adverse Event|4|||
143431881|NCT01649297|517127501|FG003|Overall Study|Adverse Event|13|||
143431882|NCT01649297|517127502|FG004|Overall Study|Adverse Event|1|||
143431883|NCT01649297|517127498|FG000|Overall Study|Lack of Efficacy|0|||
143431884|NCT01649297|517127499|FG001|Overall Study|Lack of Efficacy|0|||
143431885|NCT01649297|517127500|FG002|Overall Study|Lack of Efficacy|0|||
143431886|NCT01649297|517127501|FG003|Overall Study|Lack of Efficacy|0|||
143431887|NCT01649297|517127502|FG004|Overall Study|Lack of Efficacy|1|||
143431888|NCT01649297|517127498|FG000|Overall Study|Non compliant with Protocol|1|||
143431889|NCT01649297|517127499|FG001|Overall Study|Non compliant with Protocol|0|||
143431890|NCT01649297|517127500|FG002|Overall Study|Non compliant with Protocol|3|||
143431891|NCT01649297|517127501|FG003|Overall Study|Non compliant with Protocol|2|||
143431892|NCT01649297|517127502|FG004|Overall Study|Non compliant with Protocol|1|||
143431893|NCT01649297|517127498|FG000|Overall Study|Lost to Follow-up|1|||
143431894|NCT01649297|517127499|FG001|Overall Study|Lost to Follow-up|1|||
143431895|NCT01649297|517127500|FG002|Overall Study|Lost to Follow-up|4|||
143431896|NCT01649297|517127501|FG003|Overall Study|Lost to Follow-up|3|||
143431897|NCT01649297|517127502|FG004|Overall Study|Lost to Follow-up|0|||
143431898|NCT01649297|517127498|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
143431899|NCT01649297|517127499|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
143431900|NCT01649297|517127500|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
143431901|NCT01649297|517127501|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
143431902|NCT01649297|517127502|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
143431903|NCT01649297|517127498|FG000|Overall Study|For other reason|4|||
143431904|NCT01649297|517127499|FG001|Overall Study|For other reason|1|||
143431905|NCT01649297|517127500|FG002|Overall Study|For other reason|2|||
143431906|NCT01649297|517127501|FG003|Overall Study|For other reason|0|||
143431907|NCT01649297|517127502|FG004|Overall Study|For other reason|0|||
143431908|NCT01685047|517127503|FG000|Overall Study|Withdrawal by Subject|20|||
143431909|NCT01685047|517127503|FG000|Overall Study|Death|26|||
143431910|NCT01685047|517127503|FG000|Overall Study|Lost to Follow-up|8|||
143431911|NCT01685047|517127503|FG000|Overall Study|Physician Decision|25|||
143431912|NCT01685047|517127503|FG000|Overall Study|Adverse Event|5|||
143431913|NCT01685047|517127503|FG000|Overall Study|patient withdrawn by sponsor|1|||
143431914|NCT01049984|517127504|FG000|Overall Study|Withdrawal by Subject|1|||
143431915|NCT01049984|517127505|FG001|Overall Study|Withdrawal by Subject|5|||
143431916|NCT01049984|517127504|FG000|Overall Study|Protocol Violation|3|||
143431917|NCT01049984|517127505|FG001|Overall Study|Protocol Violation|4|||
143431918|NCT01049984|517127504|FG000|Overall Study|Lost to Follow-up|2|||
143431919|NCT01049984|517127505|FG001|Overall Study|Lost to Follow-up|1|||
143431920|NCT01049984|517127504|FG000|Overall Study|Adverse Event|13|||
143431921|NCT01049984|517127505|FG001|Overall Study|Adverse Event|7|||
143431922|NCT01049984|517127504|FG000|Overall Study|Treatment failure|0|||
143431923|NCT01049984|517127505|FG001|Overall Study|Treatment failure|2|||
143431924|NCT01233999|517127510|FG000|Overall Study|Withdrawal by Subject|1|||
143431925|NCT01233999|517127510|FG000|Overall Study|Lost to Follow-up|1|||
143431926|NCT00827775|517127511|FG000|Overall Study|Withdrawal by Subject|0|||
143431927|NCT00827775|517127512|FG001|Overall Study|Withdrawal by Subject|5|||
143431928|NCT02212301|517127513|FG000|Period 1|Lost to Follow-up|0|||
143431929|NCT02212301|517127514|FG001|Period 1|Lost to Follow-up|1|||
143431930|NCT00578318|517127517|FG000|Overall Study|Lost to Follow-up|2|||
143431931|NCT00578318|517127518|FG001|Overall Study|Lost to Follow-up|0|||
143431932|NCT00578318|517127517|FG000|Overall Study|Physician Decision|1|||
143431933|NCT00578318|517127518|FG001|Overall Study|Physician Decision|0|||
143431934|NCT02025985|517127519|FG000|Overall Study|Consent withdrawn|0|||
143431935|NCT02025985|517127520|FG001|Overall Study|Consent withdrawn|0|||
143431936|NCT02025985|517127521|FG002|Overall Study|Consent withdrawn|1|||
143431937|NCT02025985|517127522|FG003|Overall Study|Consent withdrawn|0|||
143431938|NCT02025985|517127523|FG004|Overall Study|Consent withdrawn|0|||
143431939|NCT02025985|517127519|FG000|Overall Study|Termination of study by Sponsor|4|||
143431940|NCT02025985|517127520|FG001|Overall Study|Termination of study by Sponsor|3|||
143431941|NCT02025985|517127521|FG002|Overall Study|Termination of study by Sponsor|1|||
143431942|NCT02025985|517127522|FG003|Overall Study|Termination of study by Sponsor|1|||
143431943|NCT02025985|517127523|FG004|Overall Study|Termination of study by Sponsor|3|||
143431944|NCT02025985|517127519|FG000|Overall Study|Death|21|||
143431945|NCT02025985|517127520|FG001|Overall Study|Death|20|||
143431946|NCT02025985|517127521|FG002|Overall Study|Death|23|||
143431947|NCT02025985|517127522|FG003|Overall Study|Death|20|||
143431948|NCT02025985|517127523|FG004|Overall Study|Death|17|||
143431949|NCT00527514|517127524|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
143431950|NCT00527514|517127524|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
143431951|NCT00527514|517127524|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
143431952|NCT00527514|517127524|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
143431953|NCT00527514|517127524|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
143431954|NCT00527514|517127524|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
143431955|NCT00527514|517127524|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
143431956|NCT03041701|517127525|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
143431957|NCT03041701|517127526|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
143431958|NCT03041701|517127527|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
143431959|NCT03041701|517127525|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
143431960|NCT03041701|517127526|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
143431961|NCT03041701|517127527|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
143431962|NCT00920699|517127530|FG000|Overall Study|Withdrawal by Subject|2|||
143431963|NCT00920699|517127531|FG001|Overall Study|Withdrawal by Subject|0|||
143431964|NCT00920699|517127532|FG002|Overall Study|Withdrawal by Subject|2|||
143431965|NCT00920699|517127530|FG000|Overall Study|no longer met eligibility|0|||
143431966|NCT00920699|517127531|FG001|Overall Study|no longer met eligibility|1|||
143431967|NCT00920699|517127532|FG002|Overall Study|no longer met eligibility|0|||
143431968|NCT00920699|517127530|FG000|Overall Study|Lost to Follow-up|0|||
143431969|NCT00920699|517127531|FG001|Overall Study|Lost to Follow-up|0|||
143431970|NCT00920699|517127532|FG002|Overall Study|Lost to Follow-up|2|||
143431971|NCT00001941|517127533|FG000|Overall Study|not treated- rapidly progressing disease|0|||
143431972|NCT00001941|517127534|FG001|Overall Study|not treated- rapidly progressing disease|0|||
143431973|NCT00001941|517127535|FG002|Overall Study|not treated- rapidly progressing disease|0|||
143431974|NCT00001941|517127536|FG003|Overall Study|not treated- rapidly progressing disease|0|||
143431975|NCT00001941|517127537|FG004|Overall Study|not treated- rapidly progressing disease|1|||
143431976|NCT01527500|517127539|FG000|Part A|Administrative|11|||
143431977|NCT01527500|517127540|FG001|Part A|Administrative|7|||
143431978|NCT01527500|517127539|FG000|Part A|Adverse Event|4|||
143431979|NCT01527500|517127540|FG001|Part A|Adverse Event|2|||
143431980|NCT01527500|517127539|FG000|Part A|Death|4|||
143431981|NCT01527500|517127540|FG001|Part A|Death|1|||
143431982|NCT01527500|517127539|FG000|Part A|Lost to Follow-up|0|||
143431983|NCT01527500|517127540|FG001|Part A|Lost to Follow-up|1|||
143431984|NCT01527500|517127539|FG000|Part A|Protocol Deviation|9|||
143431985|NCT01527500|517127540|FG001|Part A|Protocol Deviation|2|||
143431986|NCT01527500|517127539|FG000|Part A|Withdrawal by Subject|2|||
143431987|NCT01527500|517127540|FG001|Part A|Withdrawal by Subject|0|||
143431988|NCT01527500|517127539|FG000|Part B|Adverse Event|1|||
143431989|NCT01527500|517127540|FG001|Part B|Adverse Event|0|||
143431990|NCT00776984|517127541|FG000|Overall Study|Adverse Event|8|||
143431991|NCT00776984|517127542|FG001|Overall Study|Adverse Event|2|||
143431992|NCT00776984|517127541|FG000|Overall Study|Protocol Violation|4|||
143431993|NCT00776984|517127542|FG001|Overall Study|Protocol Violation|2|||
143431994|NCT00776984|517127541|FG000|Overall Study|Lost to Follow-up|2|||
143431995|NCT00776984|517127542|FG001|Overall Study|Lost to Follow-up|0|||
143431996|NCT00776984|517127541|FG000|Overall Study|Withdrawal by Subject|12|||
143431997|NCT00776984|517127542|FG001|Overall Study|Withdrawal by Subject|7|||
143431998|NCT00776984|517127541|FG000|Overall Study|Lack of Efficacy|0|||
143431999|NCT00776984|517127542|FG001|Overall Study|Lack of Efficacy|1|||
143432000|NCT00776984|517127541|FG000|Overall Study|Other|5|||
143432001|NCT00776984|517127542|FG001|Overall Study|Other|9|||
143432002|NCT02864342|517127543|FG000|Overall Study|Eligibility Criteria Deviation|2|||
143432003|NCT02864342|517127544|FG001|Overall Study|Eligibility Criteria Deviation|3|||
143432004|NCT02864342|517127543|FG000|Overall Study|Withdrawal by Subject|4|||
143432005|NCT02864342|517127544|FG001|Overall Study|Withdrawal by Subject|2|||
143432006|NCT02864342|517127543|FG000|Overall Study|Device Technology Issue|6|||
143432007|NCT02864342|517127544|FG001|Overall Study|Device Technology Issue|7|||
143432008|NCT02864342|517127543|FG000|Overall Study|Death|0|||
143432009|NCT02864342|517127544|FG001|Overall Study|Death|1|||
143432010|NCT02864342|517127543|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
143432011|NCT02864342|517127544|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
143432012|NCT02864342|517127543|FG000|Overall Study|Lost to Follow-up|1|||
143432013|NCT02864342|517127544|FG001|Overall Study|Lost to Follow-up|5|||
143432014|NCT02864342|517127543|FG000|Overall Study|Lost Device|1|||
143432015|NCT02864342|517127544|FG001|Overall Study|Lost Device|0|||
143432016|NCT02864342|517127543|FG000|Overall Study|Adverse Event|1|||
143432017|NCT02864342|517127544|FG001|Overall Study|Adverse Event|0|||
143432018|NCT02573883|517127545|FG000|Six Month Follow Up|Lost to Follow-up|1|||
143432019|NCT02573883|517127546|FG001|Six Month Follow Up|Lost to Follow-up|0|||
143432020|NCT02573883|517127547|FG002|Six Month Follow Up|Lost to Follow-up|0|||
143432021|NCT02573883|517127548|FG003|Six Month Follow Up|Lost to Follow-up|0|||
143432022|NCT02573883|517127545|FG000|One Year Follow Up|Lost to Follow-up|2|||
143432023|NCT02573883|517127546|FG001|One Year Follow Up|Lost to Follow-up|1|||
143432024|NCT02573883|517127547|FG002|One Year Follow Up|Lost to Follow-up|0|||
143432025|NCT02573883|517127548|FG003|One Year Follow Up|Lost to Follow-up|0|||
143432026|NCT01560585|517127554|FG000|Overall Study|Physician Decision|3|||
143432027|NCT00519285|517127555|FG000|Overall Study|Adverse Event|127|||
143432028|NCT00519285|517127556|FG001|Overall Study|Adverse Event|266|||
143432029|NCT00519285|517127555|FG000|Overall Study|Disease progression|334|||
143432030|NCT00519285|517127556|FG001|Overall Study|Disease progression|186|||
143432031|NCT00519285|517127555|FG000|Overall Study|Physician Decision|75|||
143432032|NCT00519285|517127556|FG001|Overall Study|Physician Decision|47|||
143432033|NCT00519285|517127555|FG000|Overall Study|Participant's request|53|||
143432034|NCT00519285|517127556|FG001|Overall Study|Participant's request|84|||
143432035|NCT00519285|517127555|FG000|Overall Study|Consent withdrawn|4|||
143432036|NCT00519285|517127556|FG001|Overall Study|Consent withdrawn|5|||
143432037|NCT00519285|517127555|FG000|Overall Study|Poor compliance to protocol|5|||
143432038|NCT00519285|517127556|FG001|Overall Study|Poor compliance to protocol|7|||
143432039|NCT00519285|517127555|FG000|Overall Study|Reason unspecified|5|||
143432040|NCT00519285|517127556|FG001|Overall Study|Reason unspecified|8|||
143432041|NCT00519285|517127555|FG000|Overall Study|Not treated|8|||
143432042|NCT00519285|517127556|FG001|Overall Study|Not treated|7|||
143432043|NCT00519285|517127555|FG000|Overall Study|Treatment ongoing|1|||
143432044|NCT00519285|517127556|FG001|Overall Study|Treatment ongoing|2|||
143432045|NCT00988117|517127557|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
143432046|NCT00988117|517127557|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
143432047|NCT04088500|517127558|FG000|Overall Study|Reason unknown|1|||
143432048|NCT04088500|517127558|FG000|Overall Study|Participant withdrew consent|1|||
143432049|NCT04088500|517127558|FG000|Overall Study|Disease progression|3|||
143432050|NCT04544865|517129400|FG000|Overall Study|Death|0|||
143432051|NCT04544865|517129401|FG001|Overall Study|Death|2|||
143432052|NCT04544865|517129400|FG000|Overall Study|Lost to Follow-up|11|||
143432053|NCT04544865|517129401|FG001|Overall Study|Lost to Follow-up|7|||
143432054|NCT04544865|517129400|FG000|Overall Study|Withdrawal by Subject|0|||
143432055|NCT04544865|517129401|FG001|Overall Study|Withdrawal by Subject|1|||
143432056|NCT04544865|517129400|FG000|Overall Study|Other|0|||
143432057|NCT04544865|517129401|FG001|Overall Study|Other|1|||
143432058|NCT02895360|517129406|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
143432059|NCT02895360|517129407|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
143432060|NCT02895360|517129408|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
143432061|NCT02895360|517129409|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
143432062|NCT02895360|517129410|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
143432063|NCT02895360|517129411|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
143432064|NCT02895360|517129406|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
143432065|NCT02895360|517129407|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
143432066|NCT02895360|517129408|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
143432067|NCT02895360|517129409|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
143432068|NCT02895360|517129410|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
143432069|NCT02895360|517129411|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
143432070|NCT02895360|517129406|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
143432071|NCT02895360|517129407|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
143432072|NCT02895360|517129408|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
143432073|NCT02895360|517129409|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
143432074|NCT02895360|517129410|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
143432075|NCT02895360|517129411|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
143432076|NCT02895360|517129406|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
143432077|NCT02895360|517129407|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
143432078|NCT02895360|517129408|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
143432079|NCT02895360|517129409|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
143432080|NCT02895360|517129410|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
143432081|NCT02895360|517129411|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
143432082|NCT02895360|517129406|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
143432083|NCT02895360|517129407|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
143432084|NCT02895360|517129408|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
143432085|NCT02895360|517129409|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
143432086|NCT02895360|517129410|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
143432087|NCT02895360|517129411|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
143432088|NCT02895360|517129406|FG000|Phase 2a|Adverse Event|0|||
143432089|NCT02895360|517129407|FG001|Phase 2a|Adverse Event|0|||
143432090|NCT02895360|517129408|FG002|Phase 2a|Adverse Event|0|||
143432091|NCT02895360|517129409|FG003|Phase 2a|Adverse Event|0|||
143432092|NCT02895360|517129410|FG004|Phase 2a|Adverse Event|0|||
143432093|NCT02895360|517129411|FG005|Phase 2a|Adverse Event|1|||
143432094|NCT02895360|517129406|FG000|Phase 2a|Progressive disease|0|||
143432095|NCT02895360|517129407|FG001|Phase 2a|Progressive disease|0|||
143432096|NCT02895360|517129408|FG002|Phase 2a|Progressive disease|0|||
143432097|NCT02895360|517129409|FG003|Phase 2a|Progressive disease|0|||
143432098|NCT02895360|517129410|FG004|Phase 2a|Progressive disease|11|||
143432099|NCT02895360|517129411|FG005|Phase 2a|Progressive disease|11|||
143432100|NCT01732926|517129412|FG000|Overall Study|Study Terminated by Sponsor|168|||
143432101|NCT01732926|517129413|FG001|Overall Study|Study Terminated by Sponsor|80|||
143432102|NCT01732926|517129412|FG000|Overall Study|Withdrawal by Subject|46|||
143432103|NCT01732926|517129413|FG001|Overall Study|Withdrawal by Subject|8|||
143432104|NCT01732926|517129412|FG000|Overall Study|Physician Decision|24|||
143432105|NCT01732926|517129413|FG001|Overall Study|Physician Decision|11|||
143432106|NCT01732926|517129412|FG000|Overall Study|Other Reason|21|||
143432107|NCT01732926|517129413|FG001|Overall Study|Other Reason|4|||
143432108|NCT01732926|517129412|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
143432109|NCT01732926|517129413|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
143432110|NCT01732926|517129412|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
143432111|NCT01732926|517129413|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
143432112|NCT02262364|517129416|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
143432113|NCT00337285|517129417|FG000|Overall Study|Withdrawal by Subject|42|||
143432114|NCT00337285|517129417|FG000|Overall Study|Lost to Follow-up|41|||
143432115|NCT00337285|517129417|FG000|Overall Study|Adverse Event|28|||
143432116|NCT00337285|517129417|FG000|Overall Study|Protocol Violation|27|||
143432117|NCT00337285|517129417|FG000|Overall Study|Lack of Efficacy|11|||
143432118|NCT00337285|517129417|FG000|Overall Study|Death|1|||
143432119|NCT00337285|517129417|FG000|Overall Study|Physician Decision|1|||
143432120|NCT00337285|517129417|FG000|Overall Study|Lack of protocol compliance|7|||
143432121|NCT03214250|517129419|FG000|Overall Study|Death|5|||
143432122|NCT03214250|517129420|FG001|Overall Study|Death|5|||
143432123|NCT03214250|517129421|FG002|Overall Study|Death|7|||
143432124|NCT03214250|517129422|FG003|Overall Study|Death|4|||
143432125|NCT03214250|517129423|FG004|Overall Study|Death|23|||
143432126|NCT03214250|517129424|FG005|Overall Study|Death|23|||
143432127|NCT03214250|517129425|FG006|Overall Study|Death|24|||
143432128|NCT03214250|517129419|FG000|Overall Study|Lost to Follow-up|0|||
143432129|NCT03214250|517129420|FG001|Overall Study|Lost to Follow-up|0|||
143432130|NCT03214250|517129421|FG002|Overall Study|Lost to Follow-up|0|||
143432131|NCT03214250|517129422|FG003|Overall Study|Lost to Follow-up|1|||
143432132|NCT03214250|517129423|FG004|Overall Study|Lost to Follow-up|1|||
143432133|NCT03214250|517129424|FG005|Overall Study|Lost to Follow-up|2|||
143432134|NCT03214250|517129425|FG006|Overall Study|Lost to Follow-up|0|||
143432135|NCT03214250|517129419|FG000|Overall Study|Other|0|||
143432136|NCT03214250|517129420|FG001|Overall Study|Other|0|||
143432137|NCT03214250|517129421|FG002|Overall Study|Other|0|||
143432138|NCT03214250|517129422|FG003|Overall Study|Other|0|||
143432139|NCT03214250|517129423|FG004|Overall Study|Other|1|||
143432140|NCT03214250|517129424|FG005|Overall Study|Other|1|||
143432141|NCT03214250|517129425|FG006|Overall Study|Other|2|||
143432142|NCT03214250|517129419|FG000|Overall Study|Remains on Study|2|||
143432143|NCT03214250|517129420|FG001|Overall Study|Remains on Study|2|||
143432144|NCT03214250|517129421|FG002|Overall Study|Remains on Study|0|||
143432145|NCT03214250|517129422|FG003|Overall Study|Remains on Study|1|||
143432146|NCT03214250|517129423|FG004|Overall Study|Remains on Study|7|||
143432147|NCT03214250|517129424|FG005|Overall Study|Remains on Study|5|||
143432148|NCT03214250|517129425|FG006|Overall Study|Remains on Study|3|||
143432149|NCT03214250|517129419|FG000|Overall Study|Withdrawal by Subject|0|||
143432150|NCT03214250|517129420|FG001|Overall Study|Withdrawal by Subject|0|||
143432151|NCT03214250|517129421|FG002|Overall Study|Withdrawal by Subject|1|||
143432152|NCT03214250|517129422|FG003|Overall Study|Withdrawal by Subject|2|||
143432153|NCT03214250|517129423|FG004|Overall Study|Withdrawal by Subject|5|||
143432154|NCT03214250|517129424|FG005|Overall Study|Withdrawal by Subject|0|||
143432155|NCT03214250|517129425|FG006|Overall Study|Withdrawal by Subject|2|||
143432156|NCT00292981|517129430|FG000|Overall Study|Adverse Event|1|||
143432157|NCT00292981|517129430|FG000|Overall Study|Lost to Follow-up|13|||
143432158|NCT00292981|517129430|FG000|Overall Study|Withdrawal by Subject|22|||
143432159|NCT00292981|517129430|FG000|Overall Study|Other|3|||
143432160|NCT01085812|517129431|FG000|Open-Label Period|Adverse Event|0|||
143432161|NCT01085812|517129432|FG001|Open-Label Period|Adverse Event|80|||
143432162|NCT01085812|517129431|FG000|Open-Label Period|Lack of Efficacy|0|||
143432163|NCT01085812|517129432|FG001|Open-Label Period|Lack of Efficacy|26|||
143432164|NCT01085812|517129431|FG000|Open-Label Period|Protocol Violation|0|||
143432165|NCT01085812|517129432|FG001|Open-Label Period|Protocol Violation|39|||
143432166|NCT01085812|517129431|FG000|Open-Label Period|Withdrawal by Subject|0|||
143432167|NCT01085812|517129432|FG001|Open-Label Period|Withdrawal by Subject|53|||
143432168|NCT01085812|517129431|FG000|Open-Label Period|Lost to Follow-up|0|||
143432169|NCT01085812|517129432|FG001|Open-Label Period|Lost to Follow-up|42|||
143432170|NCT01085812|517129431|FG000|Double-Blind Period|Adverse Event|3|||
143432171|NCT01085812|517129432|FG001|Double-Blind Period|Adverse Event|8|||
143432172|NCT01085812|517129431|FG000|Double-Blind Period|Protocol Violation|2|||
143432173|NCT01085812|517129432|FG001|Double-Blind Period|Protocol Violation|7|||
143432174|NCT01085812|517129431|FG000|Double-Blind Period|Withdrawal by Subject|11|||
143432175|NCT01085812|517129432|FG001|Double-Blind Period|Withdrawal by Subject|24|||
143432176|NCT01085812|517129431|FG000|Double-Blind Period|Lost to Follow-up|5|||
143432177|NCT01085812|517129432|FG001|Double-Blind Period|Lost to Follow-up|17|||
143432178|NCT01085812|517129431|FG000|Double-Blind Period|Other Reasons|0|||
143432179|NCT01085812|517129432|FG001|Double-Blind Period|Other Reasons|2|||
143432180|NCT01085812|517129431|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
143432181|NCT01085812|517129432|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
143432182|NCT01085812|517129431|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
143432183|NCT01085812|517129432|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
143432184|NCT01085812|517129431|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
143432185|NCT01085812|517129432|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
143432186|NCT01085812|517129431|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
143432187|NCT01085812|517129432|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
143432188|NCT01085812|517129431|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
143432189|NCT01085812|517129432|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
143432190|NCT04582669|517129438|FG000|Overall Study|Subject missed appointment(s).|1|||
143432191|NCT04582669|517129439|FG001|Overall Study|Subject missed appointment(s).|0|||
143432192|NCT04582669|517129440|FG002|Overall Study|Subject missed appointment(s).|1|||
143432193|NCT04582669|517129441|FG003|Overall Study|Subject missed appointment(s).|2|||
143432194|NCT04582669|517129438|FG000|Overall Study|Protocol Violation|0|||
143432195|NCT04582669|517129439|FG001|Overall Study|Protocol Violation|1|||
143432196|NCT04582669|517129440|FG002|Overall Study|Protocol Violation|1|||
143432197|NCT04582669|517129441|FG003|Overall Study|Protocol Violation|0|||
143432198|NCT01274559|517129444|FG000|Overall Study|Adverse Event|57|||
143432199|NCT01274559|517129445|FG001|Overall Study|Adverse Event|13|||
143432200|NCT01274559|517129444|FG000|Overall Study|Death|1|||
143432201|NCT01274559|517129445|FG001|Overall Study|Death|1|||
143432202|NCT01274559|517129444|FG000|Overall Study|Lost to Follow-up|3|||
143432203|NCT01274559|517129445|FG001|Overall Study|Lost to Follow-up|3|||
143432204|NCT01274559|517129444|FG000|Overall Study|Non-compliance with Study Drug|2|||
143432205|NCT01274559|517129445|FG001|Overall Study|Non-compliance with Study Drug|4|||
143432206|NCT01274559|517129444|FG000|Overall Study|Physician Decision|2|||
143432207|NCT01274559|517129445|FG001|Overall Study|Physician Decision|1|||
143432208|NCT01274559|517129444|FG000|Overall Study|Protocol Violation|28|||
143432209|NCT01274559|517129445|FG001|Overall Study|Protocol Violation|23|||
143432210|NCT01274559|517129444|FG000|Overall Study|Study Terminated by Sponsor|79|||
143432211|NCT01274559|517129445|FG001|Overall Study|Study Terminated by Sponsor|87|||
143432212|NCT01274559|517129444|FG000|Overall Study|Withdrawal by Subject|25|||
143432213|NCT01274559|517129445|FG001|Overall Study|Withdrawal by Subject|13|||
143432214|NCT03245619|517129447|FG000|Part A (Up to Day 22)|Physician Decision|4|||
143432215|NCT03245619|517129448|FG001|Part A (Up to Day 22)|Physician Decision|6|||
143432216|NCT03245619|517129449|FG002|Part A (Up to Day 22)|Physician Decision|6|||
143432217|NCT03245619|517129450|FG003|Part A (Up to Day 22)|Physician Decision|0|||
143432218|NCT03245619|517129451|FG004|Part A (Up to Day 22)|Physician Decision|0|||
143432219|NCT03245619|517129452|FG005|Part A (Up to Day 22)|Physician Decision|0|||
143432220|NCT03245619|517129453|FG006|Part A (Up to Day 22)|Physician Decision|0|||
143432221|NCT03245619|517129454|FG007|Part A (Up to Day 22)|Physician Decision|0|||
143432222|NCT03245619|517129455|FG008|Part A (Up to Day 22)|Physician Decision|0|||
143432223|NCT03245619|517129456|FG009|Part A (Up to Day 22)|Physician Decision|0|||
143432224|NCT03245619|517129457|FG010|Part A (Up to Day 22)|Physician Decision|0|||
143432225|NCT03245619|517129458|FG011|Part A (Up to Day 22)|Physician Decision|0|||
143432226|NCT03245619|517129459|FG012|Part A (Up to Day 22)|Physician Decision|0|||
143432227|NCT03245619|517129460|FG013|Part A (Up to Day 22)|Physician Decision|0|||
143432228|NCT03245619|517129461|FG014|Part A (Up to Day 22)|Physician Decision|0|||
143432229|NCT03245619|517129462|FG015|Part A (Up to Day 22)|Physician Decision|0|||
143432230|NCT03245619|517129463|FG016|Part A (Up to Day 22)|Physician Decision|0|||
143432231|NCT00776659|517129479|FG000|Overall Study|Lost to Follow-up|15|||
143432232|NCT00776659|517129479|FG000|Overall Study|Withdrawal by Subject|10|||
143432233|NCT00776659|517129479|FG000|Overall Study|Study Terminated by Sponsor|1|||
143432234|NCT01167192|517129482|FG000|Overall Study|Adverse Event|1|||
143432235|NCT01167192|517129482|FG000|Overall Study|Death|1|||
143432236|NCT01167192|517129482|FG000|Overall Study|Withdrawal by Subject|1|||
143432237|NCT01167192|517129482|FG000|Overall Study|Insurance denial|1|||
143432238|NCT01336205|517129487|FG000|Overall Study|Other|22|||
143432239|NCT01336205|517129488|FG001|Overall Study|Other|9|||
143432240|NCT01336205|517129487|FG000|Overall Study|Lost to Follow-up|40|||
143432241|NCT01336205|517129488|FG001|Overall Study|Lost to Follow-up|20|||
143432242|NCT01336205|517129487|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
143432243|NCT01336205|517129488|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
143432244|NCT01336205|517129487|FG000|Overall Study|Lack of Efficacy|4|||
143432245|NCT01336205|517129488|FG001|Overall Study|Lack of Efficacy|0|||
143432246|NCT01336205|517129487|FG000|Overall Study|Severe noncompliance with protocol|9|||
143432247|NCT01336205|517129488|FG001|Overall Study|Severe noncompliance with protocol|2|||
143432248|NCT01336205|517129487|FG000|Overall Study|Adverse Event|56|||
143432249|NCT01336205|517129488|FG001|Overall Study|Adverse Event|6|||
143432250|NCT01336205|517129487|FG000|Overall Study|Death|1|||
143432251|NCT01336205|517129488|FG001|Overall Study|Death|1|||
143432252|NCT01336205|517129487|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
143432253|NCT01336205|517129488|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
143432254|NCT01336205|517129487|FG000|Overall Study|Withdrawal by Subject|72|||
143432255|NCT01336205|517129488|FG001|Overall Study|Withdrawal by Subject|38|||
143432256|NCT01336205|517129487|FG000|Overall Study|Did not receive treatment|4|||
143432257|NCT01336205|517129488|FG001|Overall Study|Did not receive treatment|0|||
143432258|NCT00129649|517129497|FG000|Overall Study|Withdrawal by Subject|76|||
143432259|NCT00129649|517129498|FG001|Overall Study|Withdrawal by Subject|65|||
143432260|NCT02482935|517129502|FG000|Period 1|Withdrawal by Subject|1|||
143432261|NCT02482935|517129503|FG001|Period 1|Withdrawal by Subject|0|||
143432262|NCT03503162|517129504|FG000|Overall Study|did not meet eligibility|1|||
143432263|NCT02835092|517129505|FG000|Overall Study|Withdrawal by Subject|3|||
143432264|NCT02835092|517129506|FG001|Overall Study|Withdrawal by Subject|6|||
143432265|NCT02835092|517129507|FG002|Overall Study|Withdrawal by Subject|3|||
143432266|NCT02835092|517129505|FG000|Overall Study|Lost to Follow-up|0|||
143432267|NCT02835092|517129506|FG001|Overall Study|Lost to Follow-up|2|||
143432268|NCT02835092|517129507|FG002|Overall Study|Lost to Follow-up|0|||
143432269|NCT00025506|517129508|FG000|Overall Study|Ineligible: clerical error|1|||
143432270|NCT00025506|517129508|FG000|Overall Study|Ineligible: wrong cell type|5|||
143432271|NCT00025506|517129508|FG000|Overall Study|Ineligible: inadequate pathology|2|||
143432272|NCT00025506|517129508|FG000|Overall Study|Never Treated|2|||
143432273|NCT00713206|517129509|FG000|Overall Study|Lost to Follow-up|4|||
143432274|NCT00713206|517129510|FG001|Overall Study|Lost to Follow-up|4|||
143432275|NCT00713206|517129509|FG000|Overall Study|Death|1|||
143432276|NCT00713206|517129510|FG001|Overall Study|Death|0|||
143432277|NCT02561806|517129511|FG000|Induction Period|Adverse Event|0|||
143432278|NCT02561806|517129512|FG001|Induction Period|Adverse Event|2|||
143432279|NCT02561806|517129511|FG000|Induction Period|Lack of Efficacy|1|||
143432280|NCT02561806|517129512|FG001|Induction Period|Lack of Efficacy|0|||
143432281|NCT02561806|517129511|FG000|Induction Period|Withdrawal by Subject|0|||
143432282|NCT02561806|517129512|FG001|Induction Period|Withdrawal by Subject|2|||
143432283|NCT02561806|517129511|FG000|Induction Period|Site staff became unblinded|1|||
143432284|NCT02561806|517129512|FG001|Induction Period|Site staff became unblinded|0|||
143432285|NCT02561806|517129511|FG000|Induction Period|Randomized but not treated|0|||
143432286|NCT02561806|517129512|FG001|Induction Period|Randomized but not treated|1|||
143432287|NCT02561806|517129511|FG000|Maintenance Period|Adverse Event|2|||
143432288|NCT02561806|517129512|FG001|Maintenance Period|Adverse Event|1|||
143432289|NCT02561806|517129511|FG000|Maintenance Period|Lack of Efficacy|3|||
143432290|NCT02561806|517129512|FG001|Maintenance Period|Lack of Efficacy|1|||
143432291|NCT02561806|517129511|FG000|Maintenance Period|Lost to Follow-up|2|||
143432292|NCT02561806|517129512|FG001|Maintenance Period|Lost to Follow-up|2|||
143432293|NCT02561806|517129511|FG000|Maintenance Period|Protocol Violation|1|||
143432294|NCT02561806|517129512|FG001|Maintenance Period|Protocol Violation|0|||
143432295|NCT02561806|517129511|FG000|Maintenance Period|Withdrawal by Subject|5|||
143432296|NCT02561806|517129512|FG001|Maintenance Period|Withdrawal by Subject|3|||
143432297|NCT02561806|517129511|FG000|Maintenance Period|Site staff became unblinded|0|||
143432298|NCT02561806|517129512|FG001|Maintenance Period|Site staff became unblinded|1|||
143432299|NCT02561806|517129511|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
143432300|NCT02561806|517129512|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
143432301|NCT02561806|517129511|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
143432302|NCT02561806|517129512|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
143432303|NCT02547441|517129513|FG000|Double-Blind Study Period|Adverse Event|4|||
143432304|NCT02547441|517129514|FG001|Double-Blind Study Period|Adverse Event|9|||
143432305|NCT02547441|517129513|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
143432306|NCT02547441|517129514|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
143432307|NCT02547441|517129513|FG000|Double-Blind Study Period|Physician Decision|1|||
143432308|NCT02547441|517129514|FG001|Double-Blind Study Period|Physician Decision|0|||
143432309|NCT02547441|517129513|FG000|Double-Blind Study Period|Protocol Violation|1|||
143432310|NCT02547441|517129514|FG001|Double-Blind Study Period|Protocol Violation|2|||
143432311|NCT02547441|517129513|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
143432312|NCT02547441|517129514|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
143432313|NCT02547441|517129513|FG000|Double-Blind Study Period|Sponsor Decision|1|||
143432314|NCT02547441|517129514|FG001|Double-Blind Study Period|Sponsor Decision|0|||
143432315|NCT02547441|517129513|FG000|Open-Label Study Period|Adverse Event|10|||
143432316|NCT02547441|517129514|FG001|Open-Label Study Period|Adverse Event|11|||
143432317|NCT02547441|517129513|FG000|Open-Label Study Period|Lack of Efficacy|3|||
143432318|NCT02547441|517129514|FG001|Open-Label Study Period|Lack of Efficacy|2|||
143432319|NCT02547441|517129513|FG000|Open-Label Study Period|Lost to Follow-up|7|||
143432320|NCT02547441|517129514|FG001|Open-Label Study Period|Lost to Follow-up|8|||
143432321|NCT02547441|517129513|FG000|Open-Label Study Period|Physician Decision|1|||
143432322|NCT02547441|517129514|FG001|Open-Label Study Period|Physician Decision|0|||
143432323|NCT02547441|517129513|FG000|Open-Label Study Period|Protocol Violation|2|||
143432324|NCT02547441|517129514|FG001|Open-Label Study Period|Protocol Violation|0|||
143432325|NCT02547441|517129513|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
143432326|NCT02547441|517129514|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
143432327|NCT02547441|517129513|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
143432328|NCT02547441|517129514|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
143432329|NCT01322009|517129515|FG000|Overall Study|Death|0|||
143432330|NCT01322009|517129516|FG001|Overall Study|Death|1|||
143432331|NCT01322009|517129515|FG000|Overall Study|Adverse Event|0|||
143432332|NCT01322009|517129516|FG001|Overall Study|Adverse Event|1|||
143432333|NCT01322009|517129515|FG000|Overall Study|ng tube discontinued|0|||
143432334|NCT01322009|517129516|FG001|Overall Study|ng tube discontinued|1|||
143432335|NCT01657877|517129517|FG000|Overall Study|Withdrawal by Subject|4|||
143432336|NCT01657877|517129517|FG000|Overall Study|Protocol Violation|6|||
143432337|NCT01657877|517129517|FG000|Overall Study|Adverse Event|2|||
143432338|NCT01657877|517129517|FG000|Overall Study|Other Reason|2|||
143432339|NCT00394589|517129519|FG000|Overall Study|Adverse Event|2|||
143432340|NCT00394589|517129520|FG001|Overall Study|Adverse Event|1|||
143432341|NCT00394589|517129521|FG002|Overall Study|Adverse Event|2|||
143432342|NCT00394589|517129519|FG000|Overall Study|Lack of Efficacy|2|||
143432343|NCT00394589|517129520|FG001|Overall Study|Lack of Efficacy|2|||
143432344|NCT00394589|517129521|FG002|Overall Study|Lack of Efficacy|3|||
143432345|NCT00394589|517129519|FG000|Overall Study|Protocol Violation|4|||
143432346|NCT00394589|517129520|FG001|Overall Study|Protocol Violation|0|||
143432347|NCT00394589|517129521|FG002|Overall Study|Protocol Violation|2|||
143432348|NCT03409731|517129522|FG000|Overall Study|Withdrawal by Subject|17|||
143432349|NCT03409731|517129522|FG000|Overall Study|Death|4|||
143432350|NCT01710800|517129523|FG000|Overall Study|Withdrawal by Subject|21|||
143432351|NCT01710800|517129523|FG000|Overall Study|Protocol Violation|1|||
143432352|NCT02427958|517129524|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
143432353|NCT02427958|517129524|FG000|Overall Study|Lost to Follow-up|6|||
143432354|NCT02427958|517129524|FG000|Overall Study|Withdrawal by Subject|14|||
143432355|NCT02427958|517129524|FG000|Overall Study|Lack of Efficacy|1|||
143432356|NCT02287883|517129530|FG000|Overall Study|Death|8|||
143432357|NCT02287883|517129531|FG001|Overall Study|Death|7|||
143432358|NCT02287883|517129530|FG000|Overall Study|No longer eligible|222|||
143432359|NCT02287883|517129531|FG001|Overall Study|No longer eligible|182|||
143432360|NCT02287883|517129530|FG000|Overall Study|Non-response to survey|229|||
143432361|NCT02287883|517129531|FG001|Overall Study|Non-response to survey|237|||
143432362|NCT00545571|517129535|FG000|Overall Study|Administrative Reasons|1|||
143432363|NCT00545571|517129535|FG000|Overall Study|Adverse Event|2|||
143432364|NCT00545571|517129535|FG000|Overall Study|Death|5|||
143432365|NCT00545571|517129535|FG000|Overall Study|Lack of Efficacy|1|||
143432366|NCT00545571|517129535|FG000|Overall Study|Protocol Violation|2|||
143432367|NCT00545571|517129535|FG000|Overall Study|Refused Treatment|1|||
143432368|NCT00545571|517129535|FG000|Overall Study|Screen Failure|16|||
143432369|NCT00545571|517129535|FG000|Overall Study|Transfusion|12|||
143432370|NCT00545571|517129535|FG000|Overall Study|Early Termination of Study|24|||
143432371|NCT00545571|517129535|FG000|Overall Study|Kidney Transplantation|3|||
143432372|NCT01978236|517129536|FG000|Overall Study|Discontinued due to study close|2|||
143432373|NCT00634920|517129538|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
143432374|NCT00634920|517129539|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
143432375|NCT00634920|517129540|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
143432376|NCT00634920|517129538|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
143432377|NCT00634920|517129539|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
143432378|NCT00634920|517129540|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
143432379|NCT00634920|517129538|FG000|Period 1 - Pre-Randomization|Rejections|0|||
143432380|NCT00634920|517129539|FG001|Period 1 - Pre-Randomization|Rejections|0|||
143432381|NCT00634920|517129540|FG002|Period 1 - Pre-Randomization|Rejections|55|||
143432382|NCT00634920|517129538|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
143432383|NCT00634920|517129539|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
143432384|NCT00634920|517129540|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
143432385|NCT00634920|517129538|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
143432386|NCT00634920|517129539|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
143432387|NCT00634920|517129540|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
143432388|NCT00634920|517129538|FG000|Period 1 - Pre-Randomization|Other issues|0|||
143432389|NCT00634920|517129539|FG001|Period 1 - Pre-Randomization|Other issues|0|||
143432390|NCT00634920|517129540|FG002|Period 1 - Pre-Randomization|Other issues|6|||
143432391|NCT00634920|517129538|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
143432392|NCT00634920|517129539|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
143432393|NCT00634920|517129540|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
143432394|NCT00634920|517129538|FG000|Period 2 - Post-Randomization|Rejection|11|||
143432395|NCT00634920|517129539|FG001|Period 2 - Post-Randomization|Rejection|5|||
143432396|NCT00634920|517129540|FG002|Period 2 - Post-Randomization|Rejection|0|||
143432397|NCT00634920|517129538|FG000|Period 2 - Post-Randomization|Death|2|||
143432398|NCT00634920|517129539|FG001|Period 2 - Post-Randomization|Death|5|||
143432399|NCT00634920|517129540|FG002|Period 2 - Post-Randomization|Death|0|||
143432400|NCT00634920|517129538|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
143432401|NCT00634920|517129539|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
143432402|NCT00634920|517129540|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
143432403|NCT00634920|517129538|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
143432404|NCT00634920|517129539|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
143432405|NCT00634920|517129540|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
143432406|NCT01193218|517129541|FG000|0-12 Weeks|Adverse Event|6|||
143432407|NCT01193218|517129542|FG001|0-12 Weeks|Adverse Event|0|||
143432408|NCT01193218|517129543|FG002|0-12 Weeks|Adverse Event|1|||
143432409|NCT01193218|517129544|FG003|0-12 Weeks|Adverse Event|0|||
143432410|NCT01193218|517129545|FG004|0-12 Weeks|Adverse Event|0|||
143432411|NCT01193218|517129546|FG005|0-12 Weeks|Adverse Event|2|||
143432412|NCT01193218|517129547|FG006|0-12 Weeks|Adverse Event|2|||
143432413|NCT01193218|517129548|FG007|0-12 Weeks|Adverse Event|0|||
143432414|NCT01193218|517129541|FG000|0-12 Weeks|Protocol Violation|0|||
143432415|NCT01193218|517129542|FG001|0-12 Weeks|Protocol Violation|0|||
143432416|NCT01193218|517129543|FG002|0-12 Weeks|Protocol Violation|0|||
143432417|NCT01193218|517129544|FG003|0-12 Weeks|Protocol Violation|0|||
143432418|NCT01193218|517129545|FG004|0-12 Weeks|Protocol Violation|1|||
143432419|NCT01193218|517129546|FG005|0-12 Weeks|Protocol Violation|1|||
143432420|NCT01193218|517129547|FG006|0-12 Weeks|Protocol Violation|0|||
143432421|NCT01193218|517129548|FG007|0-12 Weeks|Protocol Violation|0|||
143432422|NCT01193218|517129541|FG000|0-12 Weeks|Withdrawal by Subject|3|||
143432423|NCT01193218|517129542|FG001|0-12 Weeks|Withdrawal by Subject|0|||
143432424|NCT01193218|517129543|FG002|0-12 Weeks|Withdrawal by Subject|2|||
143432425|NCT01193218|517129544|FG003|0-12 Weeks|Withdrawal by Subject|0|||
143432426|NCT01193218|517129545|FG004|0-12 Weeks|Withdrawal by Subject|0|||
143432427|NCT01193218|517129546|FG005|0-12 Weeks|Withdrawal by Subject|0|||
143432428|NCT01193218|517129547|FG006|0-12 Weeks|Withdrawal by Subject|1|||
143432429|NCT01193218|517129548|FG007|0-12 Weeks|Withdrawal by Subject|0|||
143432430|NCT01193218|517129541|FG000|12-52 Weeks|Adverse Event|1|||
143432431|NCT01193218|517129542|FG001|12-52 Weeks|Adverse Event|0|||
143432432|NCT01193218|517129543|FG002|12-52 Weeks|Adverse Event|1|||
143432433|NCT01193218|517129544|FG003|12-52 Weeks|Adverse Event|2|||
143432434|NCT01193218|517129545|FG004|12-52 Weeks|Adverse Event|3|||
143432435|NCT01193218|517129546|FG005|12-52 Weeks|Adverse Event|3|||
143432436|NCT01193218|517129547|FG006|12-52 Weeks|Adverse Event|1|||
143432437|NCT01193218|517129548|FG007|12-52 Weeks|Adverse Event|2|||
143432438|NCT01193218|517129541|FG000|12-52 Weeks|Lack of Efficacy|0|||
143432439|NCT01193218|517129542|FG001|12-52 Weeks|Lack of Efficacy|0|||
143432440|NCT01193218|517129543|FG002|12-52 Weeks|Lack of Efficacy|0|||
143432441|NCT01193218|517129544|FG003|12-52 Weeks|Lack of Efficacy|0|||
143432442|NCT01193218|517129545|FG004|12-52 Weeks|Lack of Efficacy|0|||
143432443|NCT01193218|517129546|FG005|12-52 Weeks|Lack of Efficacy|0|||
143432444|NCT01193218|517129547|FG006|12-52 Weeks|Lack of Efficacy|1|||
143432445|NCT01193218|517129548|FG007|12-52 Weeks|Lack of Efficacy|0|||
143432446|NCT01193218|517129541|FG000|12-52 Weeks|Withdrawal by Subject|3|||
143432447|NCT01193218|517129542|FG001|12-52 Weeks|Withdrawal by Subject|0|||
143432448|NCT01193218|517129543|FG002|12-52 Weeks|Withdrawal by Subject|3|||
143432449|NCT01193218|517129544|FG003|12-52 Weeks|Withdrawal by Subject|0|||
143432450|NCT01193218|517129545|FG004|12-52 Weeks|Withdrawal by Subject|0|||
143432451|NCT01193218|517129546|FG005|12-52 Weeks|Withdrawal by Subject|2|||
143432452|NCT01193218|517129547|FG006|12-52 Weeks|Withdrawal by Subject|1|||
143432453|NCT01193218|517129548|FG007|12-52 Weeks|Withdrawal by Subject|2|||
143432454|NCT01193218|517129541|FG000|12-52 Weeks|Other reason than above|1|||
143432455|NCT01193218|517129542|FG001|12-52 Weeks|Other reason than above|0|||
143432456|NCT01193218|517129543|FG002|12-52 Weeks|Other reason than above|0|||
143432457|NCT01193218|517129544|FG003|12-52 Weeks|Other reason than above|1|||
143432458|NCT01193218|517129545|FG004|12-52 Weeks|Other reason than above|1|||
143432459|NCT01193218|517129546|FG005|12-52 Weeks|Other reason than above|0|||
143432460|NCT01193218|517129547|FG006|12-52 Weeks|Other reason than above|0|||
143432461|NCT01193218|517129548|FG007|12-52 Weeks|Other reason than above|0|||
143432462|NCT00363649|517129549|FG000|Overall Study|Withdrawal by Subject|1|||
143432463|NCT00363649|517129550|FG001|Overall Study|Withdrawal by Subject|1|||
143432464|NCT00363649|517129549|FG000|Overall Study|Adverse Event|6|||
143432465|NCT00363649|517129550|FG001|Overall Study|Adverse Event|0|||
143432466|NCT01013740|517129551|FG000|Overall Study|Lost to Follow-up|3|||
143432467|NCT01013740|517129552|FG001|Overall Study|Lost to Follow-up|5|||
143432468|NCT01013740|517129551|FG000|Overall Study|Physician Decision|2|||
143432469|NCT01013740|517129552|FG001|Overall Study|Physician Decision|0|||
143432470|NCT01013740|517129551|FG000|Overall Study|Withdrawal by Subject|2|||
143432471|NCT01013740|517129552|FG001|Overall Study|Withdrawal by Subject|10|||
143432472|NCT01013740|517129551|FG000|Overall Study|study close / terminated : done in error|2|||
143432473|NCT01013740|517129552|FG001|Overall Study|study close / terminated : done in error|1|||
143432474|NCT01013740|517129551|FG000|Overall Study|Missing|2|||
143432475|NCT01013740|517129552|FG001|Overall Study|Missing|1|||
143432476|NCT01013740|517129551|FG000|Overall Study|Ongoing: Study records not completed|0|||
143432477|NCT01013740|517129552|FG001|Overall Study|Ongoing: Study records not completed|2|||
143432478|NCT02970305|517129555|FG000|Overall Study|Adverse Event|10|||
143432479|NCT02970305|517129556|FG001|Overall Study|Adverse Event|6|||
143432480|NCT02970305|517129555|FG000|Overall Study|Lack of Efficacy|1|||
143432481|NCT02970305|517129556|FG001|Overall Study|Lack of Efficacy|1|||
143432482|NCT02970305|517129555|FG000|Overall Study|Noncompliance with study drug|2|||
143432483|NCT02970305|517129556|FG001|Overall Study|Noncompliance with study drug|4|||
143432484|NCT02970305|517129555|FG000|Overall Study|Protocol Violation|2|||
143432485|NCT02970305|517129556|FG001|Overall Study|Protocol Violation|2|||
143432486|NCT02970305|517129555|FG000|Overall Study|Withdrawal by Subject|12|||
143432487|NCT02970305|517129556|FG001|Overall Study|Withdrawal by Subject|11|||
143432488|NCT02970305|517129555|FG000|Overall Study|Not further specified|1|||
143432489|NCT02970305|517129556|FG001|Overall Study|Not further specified|2|||
143432490|NCT02970305|517129555|FG000|Overall Study|Lost to Follow-up|1|||
143432491|NCT02970305|517129556|FG001|Overall Study|Lost to Follow-up|2|||
143432492|NCT01813305|517129558|FG000|Overall Study|Withdrawal by Subject|12|||
143432493|NCT01813305|517129559|FG001|Overall Study|Withdrawal by Subject|5|||
143432494|NCT01813305|517129558|FG000|Overall Study|Safety Concern|4|||
143432495|NCT01813305|517129559|FG001|Overall Study|Safety Concern|0|||
143432496|NCT01813305|517129558|FG000|Overall Study|Ulcer became worse|4|||
143432497|NCT01813305|517129559|FG001|Overall Study|Ulcer became worse|0|||
143432498|NCT01813305|517129558|FG000|Overall Study|Physician Decision|4|||
143432499|NCT01813305|517129559|FG001|Overall Study|Physician Decision|0|||
143432500|NCT01813305|517129558|FG000|Overall Study|Lost to Follow-up|3|||
143432501|NCT01813305|517129559|FG001|Overall Study|Lost to Follow-up|1|||
143432502|NCT01813305|517129558|FG000|Overall Study|Protocol Violation|1|||
143432503|NCT01813305|517129559|FG001|Overall Study|Protocol Violation|0|||
143432504|NCT01813305|517129558|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
143432505|NCT01813305|517129559|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
143432506|NCT01078584|517129564|FG000|Overall Study|Final Status Unknown|1073|||
143432507|NCT01078584|517129564|FG000|Overall Study|Lost to Follow-up|670|||
143432508|NCT01078584|517129564|FG000|Overall Study|Non-serious Adverse Event|577|||
143432509|NCT01078584|517129564|FG000|Overall Study|Withdrawal of Consent|244|||
143432510|NCT01078584|517129564|FG000|Overall Study|Physician Withdrew from Study|90|||
143432511|NCT01078584|517129564|FG000|Overall Study|Non-compliance|67|||
143432512|NCT01078584|517129564|FG000|Overall Study|Blood Pressure Controlled|49|||
143432513|NCT01078584|517129564|FG000|Overall Study|Physician Switched Medication|26|||
143432514|NCT01078584|517129564|FG000|Overall Study|Physician Discontinued Patient|12|||
143432515|NCT01078584|517129564|FG000|Overall Study|Lack of Efficacy|98|||
143432516|NCT01078584|517129564|FG000|Overall Study|Protocol Violation|75|||
143432517|NCT01078584|517129564|FG000|Overall Study|Serious Adverse Event|27|||
143432518|NCT01078584|517129564|FG000|Overall Study|Multiple Reasons|2|||
143432519|NCT01121185|517129565|FG000|Overall Study|Not infused|0|||
143432520|NCT01121185|517129566|FG001|Overall Study|Not infused|1|||
143432521|NCT01121185|517129565|FG000|Overall Study|Not transplanted|1|||
143432522|NCT01121185|517129566|FG001|Overall Study|Not transplanted|0|||
143432523|NCT00316589|517129567|FG000|Overall Study|Withdrawal by Subject|0|||
143432524|NCT00316589|517129568|FG001|Overall Study|Withdrawal by Subject|5|||
143432525|NCT00316589|517129569|FG002|Overall Study|Withdrawal by Subject|0|||
143432526|NCT00316589|517129570|FG003|Overall Study|Withdrawal by Subject|1|||
143432527|NCT00316589|517129567|FG000|Overall Study|Subject unwilling/unable to comply|0|||
143432528|NCT00316589|517129568|FG001|Overall Study|Subject unwilling/unable to comply|6|||
143432529|NCT00316589|517129569|FG002|Overall Study|Subject unwilling/unable to comply|0|||
143432530|NCT00316589|517129570|FG003|Overall Study|Subject unwilling/unable to comply|2|||
143432531|NCT00316589|517129567|FG000|Overall Study|Adverse Event|1|||
143432532|NCT00316589|517129568|FG001|Overall Study|Adverse Event|0|||
143432533|NCT00316589|517129569|FG002|Overall Study|Adverse Event|0|||
143432534|NCT00316589|517129570|FG003|Overall Study|Adverse Event|1|||
143432535|NCT00316589|517129567|FG000|Overall Study|Physician Decision|0|||
143432536|NCT00316589|517129568|FG001|Overall Study|Physician Decision|1|||
143432537|NCT00316589|517129569|FG002|Overall Study|Physician Decision|0|||
143432538|NCT00316589|517129570|FG003|Overall Study|Physician Decision|0|||
143432539|NCT00316589|517129567|FG000|Overall Study|Other reason|0|||
143432540|NCT00316589|517129568|FG001|Overall Study|Other reason|12|||
143432541|NCT00316589|517129569|FG002|Overall Study|Other reason|1|||
143432542|NCT00316589|517129570|FG003|Overall Study|Other reason|1|||
143432543|NCT01283971|517129575|FG000|Overall Study|Adverse Event|3|||
143432544|NCT01283971|517129576|FG001|Overall Study|Adverse Event|5|||
143432545|NCT01283971|517129575|FG000|Overall Study|Insufficient therapeutic responses|3|||
143432546|NCT01283971|517129576|FG001|Overall Study|Insufficient therapeutic responses|3|||
143432547|NCT01283971|517129575|FG000|Overall Study|Protocol Violation|5|||
143432548|NCT01283971|517129576|FG001|Overall Study|Protocol Violation|1|||
143432549|NCT01283971|517129575|FG000|Overall Study|Refused treatment|3|||
143432550|NCT01283971|517129576|FG001|Overall Study|Refused treatment|1|||
143432551|NCT01283971|517129575|FG000|Overall Study|Failure to return|0|||
143432552|NCT01283971|517129576|FG001|Overall Study|Failure to return|1|||
143432553|NCT01283971|517129575|FG000|Overall Study|Administrative reasons|1|||
143432554|NCT01283971|517129576|FG001|Overall Study|Administrative reasons|1|||
143432555|NCT01502371|517129581|FG000|Overall Study|Withdrawal by Subject|1|||
143432556|NCT01502371|517129582|FG001|Overall Study|Withdrawal by Subject|2|||
143432557|NCT01502371|517129583|FG002|Overall Study|Withdrawal by Subject|1|||
143432558|NCT01502371|517129584|FG003|Overall Study|Withdrawal by Subject|1|||
143432559|NCT01502371|517129585|FG004|Overall Study|Withdrawal by Subject|1|||
143432560|NCT01502371|517129581|FG000|Overall Study|Adverse Event|2|||
143432561|NCT01502371|517129582|FG001|Overall Study|Adverse Event|1|||
143432562|NCT01502371|517129583|FG002|Overall Study|Adverse Event|0|||
143432563|NCT01502371|517129584|FG003|Overall Study|Adverse Event|4|||
143432564|NCT01502371|517129585|FG004|Overall Study|Adverse Event|3|||
143432565|NCT01502371|517129581|FG000|Overall Study|Treatment Failure|22|||
143432566|NCT01502371|517129582|FG001|Overall Study|Treatment Failure|20|||
143432567|NCT01502371|517129583|FG002|Overall Study|Treatment Failure|12|||
143432568|NCT01502371|517129584|FG003|Overall Study|Treatment Failure|19|||
143432569|NCT01502371|517129585|FG004|Overall Study|Treatment Failure|30|||
143432570|NCT01502371|517129581|FG000|Overall Study|Lack of Efficacy|3|||
143432571|NCT01502371|517129582|FG001|Overall Study|Lack of Efficacy|3|||
143432572|NCT01502371|517129583|FG002|Overall Study|Lack of Efficacy|2|||
143432573|NCT01502371|517129584|FG003|Overall Study|Lack of Efficacy|2|||
143432574|NCT01502371|517129585|FG004|Overall Study|Lack of Efficacy|4|||
143432575|NCT01502371|517129581|FG000|Overall Study|Physician Decision|3|||
143432576|NCT01502371|517129582|FG001|Overall Study|Physician Decision|0|||
143432577|NCT01502371|517129583|FG002|Overall Study|Physician Decision|0|||
143432578|NCT01502371|517129584|FG003|Overall Study|Physician Decision|0|||
143432579|NCT01502371|517129585|FG004|Overall Study|Physician Decision|1|||
143432580|NCT01502371|517129581|FG000|Overall Study|Noncompliance with Study Drug|0|||
143432581|NCT01502371|517129582|FG001|Overall Study|Noncompliance with Study Drug|0|||
143432582|NCT01502371|517129583|FG002|Overall Study|Noncompliance with Study Drug|1|||
143432583|NCT01502371|517129584|FG003|Overall Study|Noncompliance with Study Drug|2|||
143432584|NCT01502371|517129585|FG004|Overall Study|Noncompliance with Study Drug|1|||
143432585|NCT01502371|517129581|FG000|Overall Study|Technical Problems|1|||
143432586|NCT01502371|517129582|FG001|Overall Study|Technical Problems|0|||
143432587|NCT01502371|517129583|FG002|Overall Study|Technical Problems|2|||
143432588|NCT01502371|517129584|FG003|Overall Study|Technical Problems|4|||
143432589|NCT01502371|517129585|FG004|Overall Study|Technical Problems|1|||
143432590|NCT01502371|517129581|FG000|Overall Study|Protocol Violation|9|||
143432591|NCT01502371|517129582|FG001|Overall Study|Protocol Violation|5|||
143432592|NCT01502371|517129583|FG002|Overall Study|Protocol Violation|6|||
143432593|NCT01502371|517129584|FG003|Overall Study|Protocol Violation|5|||
143432594|NCT01502371|517129585|FG004|Overall Study|Protocol Violation|10|||
143432595|NCT01502371|517129581|FG000|Overall Study|Excluded Medication|0|||
143432596|NCT01502371|517129582|FG001|Overall Study|Excluded Medication|1|||
143432597|NCT01502371|517129583|FG002|Overall Study|Excluded Medication|1|||
143432598|NCT01502371|517129584|FG003|Overall Study|Excluded Medication|0|||
143432599|NCT01502371|517129585|FG004|Overall Study|Excluded Medication|1|||
143432600|NCT02598934|517129591|FG000|Overall Study|Adverse Event|11|||
143432601|NCT02598934|517129592|FG001|Overall Study|Adverse Event|13|||
143432602|NCT02598934|517129591|FG000|Overall Study|Failure to Return|3|||
143432603|NCT02598934|517129592|FG001|Overall Study|Failure to Return|3|||
143432604|NCT02598934|517129591|FG000|Overall Study|Withdrawal by Subject|2|||
143432605|NCT02598934|517129592|FG001|Overall Study|Withdrawal by Subject|3|||
143432606|NCT02598934|517129591|FG000|Overall Study|Administrative|2|||
143432607|NCT02598934|517129592|FG001|Overall Study|Administrative|1|||
143432608|NCT02598934|517129591|FG000|Overall Study|Protocol Violation|1|||
143432609|NCT02598934|517129592|FG001|Overall Study|Protocol Violation|2|||
143432610|NCT02481934|517129593|FG000|Overall Study|Death|2|||
143432611|NCT03749616|517129594|FG000|Overall Study|Lost to Follow-up|4|||
143432612|NCT03749616|517129595|FG001|Overall Study|Lost to Follow-up|7|||
143432613|NCT03749616|517129594|FG000|Overall Study|Screen Failure|1|||
143432614|NCT03749616|517129595|FG001|Overall Study|Screen Failure|1|||
143432615|NCT03749616|517129594|FG000|Overall Study|Withdrawal by Subject|2|||
143432616|NCT03749616|517129595|FG001|Overall Study|Withdrawal by Subject|0|||
143432617|NCT03302559|517129598|FG000|Overall Study|Adverse Event|2|||
143432618|NCT03302559|517129598|FG000|Overall Study|Lost to Follow-up|1|||
143432619|NCT03302559|517129598|FG000|Overall Study|Withdrew Consent|3|||
143432620|NCT00847132|517131216|FG000|Overall Study|Death|1|||
143432621|NCT00847132|517131217|FG001|Overall Study|Death|1|||
143432622|NCT01057251|517131218|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
143432623|NCT01057251|517131219|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
143432624|NCT01057251|517131218|FG000|Overall Study|Adverse Event|4|||
143432625|NCT01057251|517131219|FG001|Overall Study|Adverse Event|2|||
143432626|NCT01057251|517131218|FG000|Overall Study|Lack of Efficacy|2|||
143432627|NCT01057251|517131219|FG001|Overall Study|Lack of Efficacy|11|||
143432628|NCT01057251|517131218|FG000|Overall Study|Protocol Violation|6|||
143432629|NCT01057251|517131219|FG001|Overall Study|Protocol Violation|2|||
143432630|NCT01057251|517131218|FG000|Overall Study|Withdrawal by Subject|4|||
143432631|NCT01057251|517131219|FG001|Overall Study|Withdrawal by Subject|5|||
143432632|NCT01057251|517131218|FG000|Overall Study|Lost to Follow-up|7|||
143432633|NCT01057251|517131219|FG001|Overall Study|Lost to Follow-up|6|||
143432634|NCT01057251|517131218|FG000|Overall Study|Other Reason|1|||
143432635|NCT01057251|517131219|FG001|Overall Study|Other Reason|1|||
143432636|NCT01850823|517131223|FG000|Overall Study|Early Visit Window|0|||
143432637|NCT01850823|517131224|FG001|Overall Study|Early Visit Window|1|||
143432638|NCT01850823|517131225|FG002|Overall Study|Early Visit Window|4|||
143432639|NCT01850823|517131223|FG000|Overall Study|Enrolled in Error|0|||
143432640|NCT01850823|517131224|FG001|Overall Study|Enrolled in Error|1|||
143432641|NCT01850823|517131225|FG002|Overall Study|Enrolled in Error|2|||
143432642|NCT01850823|517131223|FG000|Overall Study|Lack of Efficacy|1|||
143432643|NCT01850823|517131224|FG001|Overall Study|Lack of Efficacy|0|||
143432644|NCT01850823|517131225|FG002|Overall Study|Lack of Efficacy|0|||
143432645|NCT01850823|517131223|FG000|Overall Study|Lost to Follow-up|0|||
143432646|NCT01850823|517131224|FG001|Overall Study|Lost to Follow-up|0|||
143432647|NCT01850823|517131225|FG002|Overall Study|Lost to Follow-up|1|||
143432648|NCT01850823|517131223|FG000|Overall Study|Restricted Medication|0|||
143432649|NCT01850823|517131224|FG001|Overall Study|Restricted Medication|0|||
143432650|NCT01850823|517131225|FG002|Overall Study|Restricted Medication|2|||
143432651|NCT01850823|517131223|FG000|Overall Study|Significant worstening of SAR|0|||
143432652|NCT01850823|517131224|FG001|Overall Study|Significant worstening of SAR|1|||
143432653|NCT01850823|517131225|FG002|Overall Study|Significant worstening of SAR|0|||
143432654|NCT01850823|517131223|FG000|Overall Study|Withdrawal by Subject|2|||
143432655|NCT01850823|517131224|FG001|Overall Study|Withdrawal by Subject|0|||
143432656|NCT01850823|517131225|FG002|Overall Study|Withdrawal by Subject|1|||
143432657|NCT01751165|517131226|FG000|Overall Study|Adverse event, serious fatal|1|||
143432658|NCT01751165|517131227|FG001|Overall Study|Adverse event, serious fatal|0|||
143432659|NCT01751165|517131228|FG002|Overall Study|Adverse event, serious fatal|1|||
143432660|NCT01751165|517131226|FG000|Overall Study|Withdrawal by Subject|0|||
143432661|NCT01751165|517131227|FG001|Overall Study|Withdrawal by Subject|0|||
143432662|NCT01751165|517131228|FG002|Overall Study|Withdrawal by Subject|1|||
143432663|NCT01751165|517131226|FG000|Overall Study|Serious adverse event|0|||
143432664|NCT01751165|517131227|FG001|Overall Study|Serious adverse event|2|||
143432665|NCT01751165|517131228|FG002|Overall Study|Serious adverse event|0|||
143432666|NCT01751165|517131226|FG000|Overall Study|Lost to Follow-up|1|||
143432667|NCT01751165|517131227|FG001|Overall Study|Lost to Follow-up|1|||
143432668|NCT01751165|517131228|FG002|Overall Study|Lost to Follow-up|1|||
143432669|NCT00913523|517131232|FG000|Overall Study|Withdrawal by Subject|3|||
143432670|NCT00913523|517131233|FG001|Overall Study|Withdrawal by Subject|2|||
143432671|NCT00913523|517131234|FG002|Overall Study|Withdrawal by Subject|2|||
143432672|NCT00913523|517131232|FG000|Overall Study|Lost to Follow-up|1|||
143432673|NCT00913523|517131233|FG001|Overall Study|Lost to Follow-up|1|||
143432674|NCT00913523|517131234|FG002|Overall Study|Lost to Follow-up|1|||
143432675|NCT00913523|517131232|FG000|Overall Study|Adverse Event|1|||
143432676|NCT00913523|517131233|FG001|Overall Study|Adverse Event|0|||
143432677|NCT00913523|517131234|FG002|Overall Study|Adverse Event|0|||
143432678|NCT00913523|517131232|FG000|Overall Study|Protocol Violation|5|||
143432679|NCT00913523|517131233|FG001|Overall Study|Protocol Violation|8|||
143432680|NCT00913523|517131234|FG002|Overall Study|Protocol Violation|8|||
143432681|NCT00913523|517131232|FG000|Overall Study|Pregnancy|1|||
143432682|NCT00913523|517131233|FG001|Overall Study|Pregnancy|3|||
143432683|NCT00913523|517131234|FG002|Overall Study|Pregnancy|0|||
143432684|NCT00913523|517131232|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
143432685|NCT00913523|517131233|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
143432686|NCT00913523|517131234|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
143432687|NCT01202409|517131236|FG000|Overall Study|Adverse Event|1|||
143432688|NCT01202409|517131236|FG000|Overall Study|Ineligible - KRAS mutants|7|||
143432689|NCT01774019|517131239|FG000|Overall Study|No longer meets protocol criteria|2|||
143432690|NCT01774019|517131240|FG001|Overall Study|No longer meets protocol criteria|0|||
143432691|NCT01774019|517131239|FG000|Overall Study|Withdrawal by Subject|1|||
143432692|NCT01774019|517131240|FG001|Overall Study|Withdrawal by Subject|0|||
143432693|NCT01774019|517131239|FG000|Overall Study|Surgery delayed > 120 days|1|||
143432694|NCT01774019|517131240|FG001|Overall Study|Surgery delayed > 120 days|0|||
143432695|NCT01774019|517131239|FG000|Overall Study|Patient refused surgery|1|||
143432696|NCT01774019|517131240|FG001|Overall Study|Patient refused surgery|1|||
143432697|NCT01774019|517131239|FG000|Overall Study|Unable to implant study device|1|||
143432698|NCT01774019|517131240|FG001|Overall Study|Unable to implant study device|0|||
143432699|NCT01774019|517131239|FG000|Overall Study|Lost to Follow-up|0|||
143432700|NCT01774019|517131240|FG001|Overall Study|Lost to Follow-up|3|||
143432701|NCT00553605|517131241|FG000|Overall Study|Did not meet entrance criteria|1|||
143432702|NCT00553605|517131242|FG001|Overall Study|Did not meet entrance criteria|3|||
143432703|NCT00553605|517131241|FG000|Overall Study|Did not receive full dose|1|||
143432704|NCT00553605|517131242|FG001|Overall Study|Did not receive full dose|0|||
143432705|NCT00553605|517131241|FG000|Overall Study|Randomized but not treated|2|||
143432706|NCT00553605|517131242|FG001|Overall Study|Randomized but not treated|0|||
143432707|NCT01004185|517131245|FG000|Overall Study|Adverse Event|1|||
143432708|NCT01004185|517131246|FG001|Overall Study|Adverse Event|1|||
143432709|NCT01004185|517131245|FG000|Overall Study|Lost to Follow-up|0|||
143432710|NCT01004185|517131246|FG001|Overall Study|Lost to Follow-up|1|||
143432711|NCT01004185|517131245|FG000|Overall Study|Lack of Efficacy|2|||
143432712|NCT01004185|517131246|FG001|Overall Study|Lack of Efficacy|1|||
143432713|NCT01004185|517131245|FG000|Overall Study|Sponsor Terminated Study|4|||
143432714|NCT01004185|517131246|FG001|Overall Study|Sponsor Terminated Study|5|||
143432715|NCT01004185|517131245|FG000|Overall Study|Withdrawal by Subject|2|||
143432716|NCT01004185|517131246|FG001|Overall Study|Withdrawal by Subject|1|||
143432717|NCT00594178|517131253|FG000|Overall Study|Physician Decision|5|||
143432718|NCT00496626|517131254|FG000|Overall Study|Lost to Follow-up|0|||
143432719|NCT00496626|517131255|FG001|Overall Study|Lost to Follow-up|1|||
143432720|NCT00496626|517131254|FG000|Overall Study|Protocol Violation|1|||
143432721|NCT00496626|517131255|FG001|Overall Study|Protocol Violation|0|||
143432722|NCT00496626|517131254|FG000|Overall Study|Withdrawal by Subject|5|||
143432723|NCT00496626|517131255|FG001|Overall Study|Withdrawal by Subject|4|||
143432724|NCT00496626|517131254|FG000|Overall Study|Relocated|0|||
143432725|NCT00496626|517131255|FG001|Overall Study|Relocated|1|||
143432726|NCT04191148|517131256|FG000|Overall Study|Withdrawal by Subject|1|||
143432727|NCT04191148|517131257|FG001|Overall Study|Withdrawal by Subject|0|||
143432728|NCT04191148|517131256|FG000|Overall Study|Adverse Event|1|||
143432729|NCT04191148|517131257|FG001|Overall Study|Adverse Event|0|||
143432730|NCT01874665|517131258|FG000|Overall Study|Adverse Event|6|||
143432731|NCT01874665|517131259|FG001|Overall Study|Adverse Event|2|||
143432732|NCT01874665|517131258|FG000|Overall Study|Withdrawal by Subject|4|||
143432733|NCT01874665|517131259|FG001|Overall Study|Withdrawal by Subject|1|||
143432734|NCT01874665|517131258|FG000|Overall Study|Physician Decision|3|||
143432735|NCT01874665|517131259|FG001|Overall Study|Physician Decision|0|||
143432736|NCT01874665|517131258|FG000|Overall Study|Clinical Progressive Disease|4|||
143432737|NCT01874665|517131259|FG001|Overall Study|Clinical Progressive Disease|3|||
143432738|NCT01874665|517131258|FG000|Overall Study|Study Terminated by Sponsor|0|||
143432739|NCT01874665|517131259|FG001|Overall Study|Study Terminated by Sponsor|2|||
143432740|NCT01874665|517131258|FG000|Overall Study|Documented Progressive Disease|11|||
143432741|NCT01874665|517131259|FG001|Overall Study|Documented Progressive Disease|7|||
143432742|NCT01874665|517131258|FG000|Overall Study|Other|2|||
143432743|NCT01874665|517131259|FG001|Overall Study|Other|0|||
143432744|NCT02647788|517131260|FG000|Overall Study|Lost to Follow-up|13|||
143432745|NCT02647788|517131261|FG001|Overall Study|Lost to Follow-up|11|||
143432746|NCT02647788|517131260|FG000|Overall Study|Did not want opiate|0|||
143432747|NCT02647788|517131261|FG001|Overall Study|Did not want opiate|1|||
143432748|NCT02647788|517131260|FG000|Overall Study|Withdrawal by Subject|1|||
143432749|NCT02647788|517131261|FG001|Overall Study|Withdrawal by Subject|0|||
143432750|NCT02647788|517131260|FG000|Overall Study|Felt itchy with assigned medication|1|||
143432751|NCT02647788|517131261|FG001|Overall Study|Felt itchy with assigned medication|0|||
143432752|NCT02647788|517131260|FG000|Overall Study|Felt nauseous with assigned medication|1|||
143432753|NCT02647788|517131261|FG001|Overall Study|Felt nauseous with assigned medication|1|||
143432754|NCT00905034|517131265|FG000|Overall Study|Withdrawal by Subject|1|||
143432755|NCT01114672|517131266|FG000|Overall Study|Death|0|||
143432756|NCT01114672|517131267|FG001|Overall Study|Death|1|||
143432757|NCT01114672|517131266|FG000|Overall Study|Withdrawal by Subject|2|||
143432758|NCT01114672|517131267|FG001|Overall Study|Withdrawal by Subject|1|||
143432759|NCT01114672|517131266|FG000|Overall Study|Lost to Follow-up|1|||
143432760|NCT01114672|517131267|FG001|Overall Study|Lost to Follow-up|0|||
143432761|NCT01114672|517131266|FG000|Overall Study|transplanted|1|||
143432762|NCT01114672|517131267|FG001|Overall Study|transplanted|0|||
143432763|NCT03811834|517131270|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
143432764|NCT00576823|517131271|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
143432765|NCT00576823|517131272|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
143432766|NCT00576823|517131273|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
143432767|NCT00576823|517131271|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
143432768|NCT00576823|517131272|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
143432769|NCT00576823|517131273|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
143432770|NCT01242371|517131274|FG000|Overall Study|Withdrawal by Subject|2|||
143432771|NCT01242371|517131275|FG001|Overall Study|Withdrawal by Subject|2|||
143432772|NCT01242371|517131274|FG000|Overall Study|Protocol Violation|0|||
143432773|NCT01242371|517131275|FG001|Overall Study|Protocol Violation|3|||
143432774|NCT00510146|517131278|FG000|Double-Blind Treatment|Adverse Event|30|||
143432775|NCT00510146|517131279|FG001|Double-Blind Treatment|Adverse Event|13|||
143432776|NCT00510146|517131278|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
143432777|NCT00510146|517131279|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
143432778|NCT00510146|517131278|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
143432779|NCT00510146|517131279|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
143432780|NCT00510146|517131278|FG000|Double-Blind Treatment|Physician Decision|6|||
143432781|NCT00510146|517131279|FG001|Double-Blind Treatment|Physician Decision|0|||
143432782|NCT00510146|517131278|FG000|Double-Blind Treatment|Protocol Violation|1|||
143432783|NCT00510146|517131279|FG001|Double-Blind Treatment|Protocol Violation|2|||
143432784|NCT00510146|517131278|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
143432785|NCT00510146|517131279|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
143432786|NCT00510146|517131278|FG000|Double-Blind Treatment|Clinical Relapse|0|||
143432787|NCT00510146|517131279|FG001|Double-Blind Treatment|Clinical Relapse|1|||
143432788|NCT00510146|517131278|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
143432789|NCT00510146|517131279|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
143432790|NCT00510146|517131278|FG000|Open-Label Treatment|Adverse Event|22|||
143432791|NCT00510146|517131279|FG001|Open-Label Treatment|Adverse Event|8|||
143432792|NCT00510146|517131278|FG000|Open-Label Treatment|Death|1|||
143432793|NCT00510146|517131279|FG001|Open-Label Treatment|Death|1|||
143432794|NCT00510146|517131278|FG000|Open-Label Treatment|Lack of Efficacy|4|||
143432795|NCT00510146|517131279|FG001|Open-Label Treatment|Lack of Efficacy|0|||
143432796|NCT00510146|517131278|FG000|Open-Label Treatment|Lost to Follow-up|10|||
143432797|NCT00510146|517131279|FG001|Open-Label Treatment|Lost to Follow-up|1|||
143432798|NCT00510146|517131278|FG000|Open-Label Treatment|Physician Decision|3|||
143432799|NCT00510146|517131279|FG001|Open-Label Treatment|Physician Decision|1|||
143432800|NCT00510146|517131278|FG000|Open-Label Treatment|Protocol Violation|4|||
143432801|NCT00510146|517131279|FG001|Open-Label Treatment|Protocol Violation|2|||
143432802|NCT00510146|517131278|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
143432803|NCT00510146|517131279|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
143432804|NCT00510146|517131278|FG000|Open-Label Treatment|Clinical Relapse|1|||
143432805|NCT00510146|517131279|FG001|Open-Label Treatment|Clinical Relapse|1|||
143432806|NCT00510146|517131278|FG000|Open-Label Treatment|Sponsor Decision|2|||
143432807|NCT00510146|517131279|FG001|Open-Label Treatment|Sponsor Decision|0|||
143432808|NCT03188536|517131280|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
143432809|NCT03188536|517131280|FG000|Overall Study|Not participated/met inclusion criteria|1|||
143432810|NCT01930214|517131281|FG000|Overall Study|Death|4|||
143432811|NCT01930214|517131282|FG001|Overall Study|Death|4|||
143432812|NCT01930214|517131283|FG002|Overall Study|Death|11|||
143432813|NCT01930214|517131281|FG000|Overall Study|Lost to Follow-up|12|||
143432814|NCT01930214|517131282|FG001|Overall Study|Lost to Follow-up|13|||
143432815|NCT01930214|517131283|FG002|Overall Study|Lost to Follow-up|12|||
143432816|NCT01930214|517131281|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
143432817|NCT01930214|517131282|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
143432818|NCT01930214|517131283|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
143432819|NCT01930214|517131281|FG000|Overall Study|Physician Decision|2|||
143432820|NCT01930214|517131282|FG001|Overall Study|Physician Decision|0|||
143432821|NCT01930214|517131283|FG002|Overall Study|Physician Decision|0|||
143432822|NCT00025662|517131284|FG000|Overall Study|Withdrawal by Subject|2|||
143432823|NCT00025662|517131284|FG000|Overall Study|Technical failure of manipulation|1|||
143432824|NCT02132117|517131287|FG000|Overall Study|Adverse Event|6|||
143432825|NCT02132117|517131288|FG001|Overall Study|Adverse Event|1|||
143432826|NCT02132117|517131287|FG000|Overall Study|Lost to Follow-up|2|||
143432827|NCT02132117|517131288|FG001|Overall Study|Lost to Follow-up|2|||
143432828|NCT02132117|517131287|FG000|Overall Study|Personal Reasons|1|||
143432829|NCT02132117|517131288|FG001|Overall Study|Personal Reasons|2|||
143432830|NCT02132117|517131287|FG000|Overall Study|Other Miscellaneous Reasons|2|||
143432831|NCT02132117|517131288|FG001|Overall Study|Other Miscellaneous Reasons|0|||
143432832|NCT04947436|517131289|FG000|Overall Study|Lost to Follow-up|3|||
143432833|NCT04947436|517131290|FG001|Overall Study|Lost to Follow-up|7|||
143432834|NCT04947436|517131291|FG002|Overall Study|Lost to Follow-up|5|||
143432835|NCT04947436|517131289|FG000|Overall Study|Death|1|||
143432836|NCT04947436|517131290|FG001|Overall Study|Death|1|||
143432837|NCT04947436|517131291|FG002|Overall Study|Death|1|||
143432838|NCT02161185|517131295|FG000|Treatment Phase|Administrative/Other|7|||
143432839|NCT00372255|517131296|FG000|Overall Study|Withdrawn for other reasons|2|||
143432840|NCT00372255|517131297|FG001|Overall Study|Withdrawn for other reasons|1|||
143432841|NCT00582114|517131301|FG000|Overall Study|Death|4|||
143432842|NCT00582114|517131302|FG001|Overall Study|Death|4|||
143432843|NCT00582114|517131301|FG000|Overall Study|Kidney Transplant|3|||
143432844|NCT00582114|517131302|FG001|Overall Study|Kidney Transplant|1|||
143432845|NCT00582114|517131301|FG000|Overall Study|Lost to Follow-up|7|||
143432846|NCT00582114|517131302|FG001|Overall Study|Lost to Follow-up|6|||
143432847|NCT00582114|517131301|FG000|Overall Study|Withdrawal by Subject|8|||
143432848|NCT00582114|517131302|FG001|Overall Study|Withdrawal by Subject|16|||
143432849|NCT00582114|517131301|FG000|Overall Study|Adverse Event|1|||
143432850|NCT00582114|517131302|FG001|Overall Study|Adverse Event|1|||
143432851|NCT00582114|517131301|FG000|Overall Study|Physician Decision|0|||
143432852|NCT00582114|517131302|FG001|Overall Study|Physician Decision|6|||
143432853|NCT00582114|517131301|FG000|Overall Study|Stopped by data safety monitoring board|19|||
143432854|NCT00582114|517131302|FG001|Overall Study|Stopped by data safety monitoring board|20|||
143432855|NCT00118703|517131303|FG000|Overall Study|Protocol Violation|1|||
143432856|NCT00118703|517131304|FG001|Overall Study|Protocol Violation|0|||
143432857|NCT00118703|517131303|FG000|Overall Study|Adverse Event|1|||
143432858|NCT00118703|517131304|FG001|Overall Study|Adverse Event|1|||
143432859|NCT00118703|517131303|FG000|Overall Study|Participant took two different treatment|0|||
143432860|NCT00118703|517131304|FG001|Overall Study|Participant took two different treatment|1|||
143432861|NCT00118703|517131303|FG000|Overall Study|Withdrawal by Subject|2|||
143432862|NCT00118703|517131304|FG001|Overall Study|Withdrawal by Subject|5|||
143432863|NCT00118703|517131303|FG000|Overall Study|Lost to Follow-up|1|||
143432864|NCT00118703|517131304|FG001|Overall Study|Lost to Follow-up|2|||
143432865|NCT00130728|517131309|FG000|Overall Study|Death|258|||
143432866|NCT00130728|517131310|FG001|Overall Study|Death|258|||
143432867|NCT00130728|517131309|FG000|Overall Study|Lost to Follow-up|4|||
143432868|NCT00130728|517131310|FG001|Overall Study|Lost to Follow-up|0|||
143432869|NCT00130728|517131309|FG000|Overall Study|Withdrawal by Subject|0|||
143432870|NCT00130728|517131310|FG001|Overall Study|Withdrawal by Subject|2|||
143432871|NCT01209286|517131313|FG000|Overall Study|Adverse Event|4|||
143432872|NCT01209286|517131314|FG001|Overall Study|Adverse Event|3|||
143432873|NCT01209286|517131315|FG002|Overall Study|Adverse Event|1|||
143432874|NCT01209286|517131313|FG000|Overall Study|Hematological Relapse After Remission|0|||
143432875|NCT01209286|517131314|FG001|Overall Study|Hematological Relapse After Remission|1|||
143432876|NCT01209286|517131315|FG002|Overall Study|Hematological Relapse After Remission|1|||
143432877|NCT01209286|517131313|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
143432878|NCT01209286|517131314|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
143432879|NCT01209286|517131315|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
143432880|NCT01209286|517131313|FG000|Overall Study|Physician Decision|0|||
143432881|NCT01209286|517131314|FG001|Overall Study|Physician Decision|2|||
143432882|NCT01209286|517131315|FG002|Overall Study|Physician Decision|0|||
143432883|NCT01209286|517131313|FG000|Overall Study|Other|0|||
143432884|NCT01209286|517131314|FG001|Overall Study|Other|1|||
143432885|NCT01209286|517131315|FG002|Overall Study|Other|0|||
143432886|NCT01349036|517131316|FG000|Overall Study|Disease progression|13|||
143432887|NCT01349036|517131317|FG001|Overall Study|Disease progression|22|||
143432888|NCT01349036|517131316|FG000|Overall Study|Other|1|||
143432889|NCT01349036|517131317|FG001|Overall Study|Other|0|||
143432890|NCT01349036|517131316|FG000|Overall Study|Withdrawal by Subject|0|||
143432891|NCT01349036|517131317|FG001|Overall Study|Withdrawal by Subject|2|||
143432892|NCT03796208|517131318|FG000|Overall Study|Withdrawal by Subject|3|||
143432893|NCT03796208|517131319|FG001|Overall Study|Withdrawal by Subject|0|||
143432894|NCT03796208|517131318|FG000|Overall Study|Loss of pregnancy|1|||
143432895|NCT03796208|517131319|FG001|Overall Study|Loss of pregnancy|1|||
143432896|NCT03796208|517131318|FG000|Overall Study|Changed prenatal clinics|0|||
143432897|NCT03796208|517131319|FG001|Overall Study|Changed prenatal clinics|5|||
143432898|NCT03796208|517131318|FG000|Overall Study|Lost to Follow-up|20|||
143432899|NCT03796208|517131319|FG001|Overall Study|Lost to Follow-up|16|||
143432900|NCT01215032|517131321|FG000|Overall Study|Adverse Event|3|||
143432901|NCT01215032|517131321|FG000|Overall Study|Lack of Efficacy|17|||
143432902|NCT01125566|517131322|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
143432903|NCT01125566|517131323|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
143432904|NCT01125566|517131324|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
143432905|NCT01125566|517131322|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
143432906|NCT01125566|517131323|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
143432907|NCT01125566|517131324|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
143432908|NCT01125566|517131322|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
143432909|NCT01125566|517131323|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
143432910|NCT01125566|517131324|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
143432911|NCT01125566|517131322|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
143432912|NCT01125566|517131323|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
143432913|NCT01125566|517131324|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
143432914|NCT01125566|517131322|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
143432915|NCT01125566|517131323|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
143432916|NCT01125566|517131324|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
143432917|NCT01125566|517131322|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
143432918|NCT01125566|517131323|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
143432919|NCT01125566|517131324|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
143432920|NCT01125566|517131322|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
143432921|NCT01125566|517131323|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
143432922|NCT01125566|517131324|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
143432923|NCT01125566|517131322|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
143432924|NCT01125566|517131323|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
143432925|NCT01125566|517131324|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
143432926|NCT01125566|517131322|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
143432927|NCT01125566|517131323|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
143432928|NCT01125566|517131324|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
143432929|NCT01125566|517131322|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
143432930|NCT01125566|517131323|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
143432931|NCT01125566|517131324|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
143432932|NCT01125566|517131322|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
143432933|NCT01125566|517131323|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
143432934|NCT01125566|517131324|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
143432935|NCT01125566|517131322|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
143432936|NCT01125566|517131323|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
143432937|NCT01125566|517131324|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
143432938|NCT02725008|517131327|FG000|Overall Study|Lost to Follow-up|7|||
143432939|NCT02725008|517131328|FG001|Overall Study|Lost to Follow-up|9|||
143432940|NCT02725008|517131327|FG000|Overall Study|Withdrawal by Subject|2|||
143432941|NCT02725008|517131328|FG001|Overall Study|Withdrawal by Subject|2|||
143432942|NCT02725008|517131327|FG000|Overall Study|Admitted to hospital|0|||
143432943|NCT02725008|517131328|FG001|Overall Study|Admitted to hospital|1|||
143432944|NCT04688086|517131329|FG000|Overall Study|Lost to Follow-up|164|||
143432945|NCT04688086|517131329|FG000|Overall Study|Imaging error;|64|||
143432946|NCT01329419|517131332|FG000|Overall Study|Protocol Violation|235|||
143432947|NCT00069277|517131333|FG000|Overall Study|Adverse Event|3|||
143432948|NCT00069277|517131333|FG000|Overall Study|Withdrawal by Subject|1|||
143432949|NCT00069277|517131333|FG000|Overall Study|Progressive Disease|15|||
143432950|NCT00069277|517131333|FG000|Overall Study|Physician Decision|2|||
143432951|NCT03512288|517131335|FG000|Overall Study|Adverse Event|1|||
143432952|NCT03512288|517131336|FG001|Overall Study|Adverse Event|0|||
143432953|NCT03512288|517131335|FG000|Overall Study|Lost to Follow-up|12|||
143432954|NCT03512288|517131336|FG001|Overall Study|Lost to Follow-up|15|||
143432955|NCT03512288|517131335|FG000|Overall Study|Physician Decision|0|||
143432956|NCT03512288|517131336|FG001|Overall Study|Physician Decision|2|||
143432957|NCT03512288|517131335|FG000|Overall Study|Protocol Violation|6|||
143432958|NCT03512288|517131336|FG001|Overall Study|Protocol Violation|4|||
143432959|NCT03512288|517131335|FG000|Overall Study|Medication error without associated adverse event|1|||
143432960|NCT03512288|517131336|FG001|Overall Study|Medication error without associated adverse event|0|||
143432961|NCT03512288|517131335|FG000|Overall Study|No longer met eligibility criteria|5|||
143432962|NCT03512288|517131336|FG001|Overall Study|No longer met eligibility criteria|2|||
143432963|NCT03512288|517131335|FG000|Overall Study|Withdrawal by parent/guardian|14|||
143432964|NCT03512288|517131336|FG001|Overall Study|Withdrawal by parent/guardian|18|||
143432965|NCT03512288|517131335|FG000|Overall Study|Other|1|||
143432966|NCT03512288|517131336|FG001|Overall Study|Other|1|||
143432967|NCT03512288|517131335|FG000|Overall Study|Randomized but not treated|1|||
143432968|NCT03512288|517131336|FG001|Overall Study|Randomized but not treated|1|||
143432969|NCT01208870|517131337|FG000|Overall Study|Lost to Follow-up|2|||
143432970|NCT01208870|517131338|FG001|Overall Study|Lost to Follow-up|8|||
143432971|NCT00424177|517131339|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
143432972|NCT00424177|517131339|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
143432973|NCT00424177|517131339|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
143432974|NCT00424177|517131339|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
143432975|NCT00424177|517131339|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
143432976|NCT00424177|517131339|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
143432977|NCT00424177|517131339|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
143432978|NCT00424177|517131339|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
143432979|NCT00424177|517131339|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
143432980|NCT00424177|517131339|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
143432981|NCT00605566|517132777|FG000|Overall Study|Adverse Event|1|||
143432982|NCT00605566|517132777|FG000|Overall Study|Clinical deterioration|1|||
143432983|NCT00605566|517132777|FG000|Overall Study|Poor compliance in run-in period|1|||
143432984|NCT03864341|517132780|FG000|Overall Study|Withdrawal by Subject|1|||
143432985|NCT01066936|517132781|FG000|Overall Study|Death|2|||
143432986|NCT01066936|517132781|FG000|Overall Study|Device revised/removed|1|||
143432987|NCT01066936|517132781|FG000|Overall Study|Lost to Follow-up|3|||
143432988|NCT01066936|517132781|FG000|Overall Study|Withdrawal by Subject|4|||
143432989|NCT00695136|517132782|FG000|Overall Study|Withdrawal by Subject|1|||
143432990|NCT00695136|517132782|FG000|Overall Study|unrelated adverse event|1|||
143432991|NCT01726049|517132784|FG000|Overall Study|Death|1|||
143432992|NCT01726049|517132785|FG001|Overall Study|Death|1|||
143432993|NCT01726049|517132784|FG000|Overall Study|Adverse Event|4|||
143432994|NCT01726049|517132785|FG001|Overall Study|Adverse Event|1|||
143432995|NCT01726049|517132784|FG000|Overall Study|refused second HC|0|||
143432996|NCT01726049|517132785|FG001|Overall Study|refused second HC|2|||
143432997|NCT02202109|517132788|FG000|Overall Study|Lost to Follow-up|88|||
143432998|NCT02202109|517132789|FG001|Overall Study|Lost to Follow-up|87|||
143432999|NCT02202109|517132788|FG000|Overall Study|Withdrawal by Subject|2|||
143433000|NCT02202109|517132789|FG001|Overall Study|Withdrawal by Subject|0|||
143433001|NCT04156399|517132796|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
143433002|NCT04156399|517132796|FG000|Overall Study|study suspension due to COVID pandemic|3|||
143433003|NCT01333111|517132799|FG000|Overall Study|patient undergoing major surgery|0|||
143433004|NCT01333111|517132800|FG001|Overall Study|patient undergoing major surgery|2|||
143433005|NCT01333111|517132801|FG002|Overall Study|patient undergoing major surgery|0|||
143433006|NCT01333111|517132799|FG000|Overall Study|personal reasons|0|||
143433007|NCT01333111|517132800|FG001|Overall Study|personal reasons|0|||
143433008|NCT01333111|517132801|FG002|Overall Study|personal reasons|1|||
143433009|NCT01333111|517132799|FG000|Overall Study|unclassified|1|||
143433010|NCT01333111|517132800|FG001|Overall Study|unclassified|0|||
143433011|NCT01333111|517132801|FG002|Overall Study|unclassified|0|||
143433012|NCT01333111|517132799|FG000|Overall Study|withdrawal criteria|0|||
143433013|NCT01333111|517132800|FG001|Overall Study|withdrawal criteria|1|||
143433014|NCT01333111|517132801|FG002|Overall Study|withdrawal criteria|0|||
143433015|NCT01333111|517132799|FG000|Overall Study|Non-compliance|1|||
143433016|NCT01333111|517132800|FG001|Overall Study|Non-compliance|0|||
143433017|NCT01333111|517132801|FG002|Overall Study|Non-compliance|0|||
143433018|NCT01333111|517132799|FG000|Overall Study|Ineffective therapy|0|||
143433019|NCT01333111|517132800|FG001|Overall Study|Ineffective therapy|0|||
143433020|NCT01333111|517132801|FG002|Overall Study|Ineffective therapy|1|||
143433021|NCT00664105|517132802|FG000|Overall Study|Death|3|||
143433022|NCT00664105|517132802|FG000|Overall Study|Withdrawal by Subject|5|||
143433023|NCT00664105|517132802|FG000|Overall Study|Adverse Event|9|||
143433024|NCT00664105|517132802|FG000|Overall Study|Disease progression|7|||
143433025|NCT03834623|517132803|FG000|Overall Study|Progression|0|||
143433026|NCT03834623|517132804|FG001|Overall Study|Progression|1|||
143433027|NCT00478647|517132805|FG000|Overall Study|Adverse Event|1|||
143433028|NCT00478647|517132805|FG000|Overall Study|Withdrawal by Subject|1|||
143433029|NCT00477464|517132809|FG000|Overall Study|Lost to Follow-up|1|||
143433030|NCT00477464|517132809|FG000|Overall Study|Death|36|||
143433031|NCT00477464|517132809|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
143433032|NCT00639769|517132810|FG000|Overall Study|Death|2|||
143433033|NCT00639769|517132810|FG000|Overall Study|Adverse Event|7|||
143433034|NCT00639769|517132810|FG000|Overall Study|Lack of Efficacy|1|||
143433035|NCT00639769|517132810|FG000|Overall Study|Disease progression|26|||
143433036|NCT00639769|517132810|FG000|Overall Study|Withdrawal by Subject|4|||
143433037|NCT00784147|517132811|FG000|Overall Study|Lost to Follow-up|2|||
143433038|NCT00784147|517132812|FG001|Overall Study|Lost to Follow-up|4|||
143433039|NCT00784147|517132811|FG000|Overall Study|Withdrawal by Subject|1|||
143433040|NCT00784147|517132812|FG001|Overall Study|Withdrawal by Subject|3|||
143433041|NCT00784147|517132811|FG000|Overall Study|Physician Decision|2|||
143433042|NCT00784147|517132812|FG001|Overall Study|Physician Decision|1|||
143433043|NCT00784147|517132811|FG000|Overall Study|Protocol Violation|1|||
143433044|NCT00784147|517132812|FG001|Overall Study|Protocol Violation|1|||
143433045|NCT00784147|517132811|FG000|Overall Study|Death|2|||
143433046|NCT00784147|517132812|FG001|Overall Study|Death|0|||
143433047|NCT01475461|517132814|FG000|Run-in Period|Not meet eligibility criteria|16|||
143433048|NCT01475461|517132815|FG001|Run-in Period|Not meet eligibility criteria|0|||
143433049|NCT01475461|517132816|FG002|Run-in Period|Not meet eligibility criteria|0|||
143433050|NCT01475461|517132817|FG003|Run-in Period|Not meet eligibility criteria|0|||
143433051|NCT01475461|517132818|FG004|Run-in Period|Not meet eligibility criteria|0|||
143433052|NCT01475461|517132819|FG005|Run-in Period|Not meet eligibility criteria|0|||
143433053|NCT01475461|517132820|FG006|Run-in Period|Not meet eligibility criteria|0|||
143433054|NCT01475461|517132814|FG000|Run-in Period|Lost to Follow-up|7|||
143433055|NCT01475461|517132815|FG001|Run-in Period|Lost to Follow-up|0|||
143433056|NCT01475461|517132816|FG002|Run-in Period|Lost to Follow-up|0|||
143433057|NCT01475461|517132817|FG003|Run-in Period|Lost to Follow-up|0|||
143433058|NCT01475461|517132818|FG004|Run-in Period|Lost to Follow-up|0|||
143433059|NCT01475461|517132819|FG005|Run-in Period|Lost to Follow-up|0|||
143433060|NCT01475461|517132820|FG006|Run-in Period|Lost to Follow-up|0|||
143433061|NCT01475461|517132814|FG000|Run-in Period|Withdrawal by Subject|11|||
143433062|NCT01475461|517132815|FG001|Run-in Period|Withdrawal by Subject|0|||
143433063|NCT01475461|517132816|FG002|Run-in Period|Withdrawal by Subject|0|||
143433064|NCT01475461|517132817|FG003|Run-in Period|Withdrawal by Subject|0|||
143433065|NCT01475461|517132818|FG004|Run-in Period|Withdrawal by Subject|0|||
143433066|NCT01475461|517132819|FG005|Run-in Period|Withdrawal by Subject|0|||
143433067|NCT01475461|517132820|FG006|Run-in Period|Withdrawal by Subject|0|||
143433068|NCT01475461|517132814|FG000|Run-in Period|Other|3|||
143433069|NCT01475461|517132815|FG001|Run-in Period|Other|0|||
143433070|NCT01475461|517132816|FG002|Run-in Period|Other|0|||
143433071|NCT01475461|517132817|FG003|Run-in Period|Other|0|||
143433072|NCT01475461|517132818|FG004|Run-in Period|Other|0|||
143433073|NCT01475461|517132819|FG005|Run-in Period|Other|0|||
143433074|NCT01475461|517132820|FG006|Run-in Period|Other|0|||
143433075|NCT01475461|517132814|FG000|Run-in Period|Protocol Violation|4|||
143433076|NCT01475461|517132815|FG001|Run-in Period|Protocol Violation|0|||
143433077|NCT01475461|517132816|FG002|Run-in Period|Protocol Violation|0|||
143433078|NCT01475461|517132817|FG003|Run-in Period|Protocol Violation|0|||
143433079|NCT01475461|517132818|FG004|Run-in Period|Protocol Violation|0|||
143433080|NCT01475461|517132819|FG005|Run-in Period|Protocol Violation|0|||
143433081|NCT01475461|517132820|FG006|Run-in Period|Protocol Violation|0|||
143433082|NCT01475461|517132814|FG000|Treatment Period|Death|0|||
143433083|NCT01475461|517132815|FG001|Treatment Period|Death|0|||
143433084|NCT01475461|517132816|FG002|Treatment Period|Death|0|||
143433085|NCT01475461|517132817|FG003|Treatment Period|Death|1|||
143433086|NCT01475461|517132818|FG004|Treatment Period|Death|0|||
143433087|NCT01475461|517132819|FG005|Treatment Period|Death|0|||
143433088|NCT01475461|517132820|FG006|Treatment Period|Death|0|||
143433089|NCT01475461|517132814|FG000|Treatment Period|Lost to Follow-up|0|||
143433090|NCT01475461|517132815|FG001|Treatment Period|Lost to Follow-up|3|||
143433091|NCT01475461|517132816|FG002|Treatment Period|Lost to Follow-up|2|||
143433092|NCT01475461|517132817|FG003|Treatment Period|Lost to Follow-up|3|||
143433093|NCT01475461|517132818|FG004|Treatment Period|Lost to Follow-up|1|||
143433094|NCT01475461|517132819|FG005|Treatment Period|Lost to Follow-up|2|||
143433095|NCT01475461|517132820|FG006|Treatment Period|Lost to Follow-up|1|||
143433096|NCT01475461|517132814|FG000|Treatment Period|Withdrawal by Subject|0|||
143433097|NCT01475461|517132815|FG001|Treatment Period|Withdrawal by Subject|2|||
143433098|NCT01475461|517132816|FG002|Treatment Period|Withdrawal by Subject|2|||
143433099|NCT01475461|517132817|FG003|Treatment Period|Withdrawal by Subject|0|||
143433100|NCT01475461|517132818|FG004|Treatment Period|Withdrawal by Subject|2|||
143433101|NCT01475461|517132819|FG005|Treatment Period|Withdrawal by Subject|2|||
143433102|NCT01475461|517132820|FG006|Treatment Period|Withdrawal by Subject|0|||
143433103|NCT01475461|517132814|FG000|Treatment Period|Other|0|||
143433104|NCT01475461|517132815|FG001|Treatment Period|Other|1|||
143433105|NCT01475461|517132816|FG002|Treatment Period|Other|0|||
143433106|NCT01475461|517132817|FG003|Treatment Period|Other|0|||
143433107|NCT01475461|517132818|FG004|Treatment Period|Other|0|||
143433108|NCT01475461|517132819|FG005|Treatment Period|Other|0|||
143433109|NCT01475461|517132820|FG006|Treatment Period|Other|0|||
143433110|NCT01475461|517132814|FG000|Treatment Period|Protocol Violation|0|||
143433111|NCT01475461|517132815|FG001|Treatment Period|Protocol Violation|1|||
143433112|NCT01475461|517132816|FG002|Treatment Period|Protocol Violation|0|||
143433113|NCT01475461|517132817|FG003|Treatment Period|Protocol Violation|0|||
143433114|NCT01475461|517132818|FG004|Treatment Period|Protocol Violation|0|||
143433115|NCT01475461|517132819|FG005|Treatment Period|Protocol Violation|0|||
143433116|NCT01475461|517132820|FG006|Treatment Period|Protocol Violation|1|||
143433117|NCT01475461|517132814|FG000|Treatment Period|Lack of Efficacy|0|||
143433118|NCT01475461|517132815|FG001|Treatment Period|Lack of Efficacy|2|||
143433119|NCT01475461|517132816|FG002|Treatment Period|Lack of Efficacy|0|||
143433120|NCT01475461|517132817|FG003|Treatment Period|Lack of Efficacy|2|||
143433121|NCT01475461|517132818|FG004|Treatment Period|Lack of Efficacy|1|||
143433122|NCT01475461|517132819|FG005|Treatment Period|Lack of Efficacy|1|||
143433123|NCT01475461|517132820|FG006|Treatment Period|Lack of Efficacy|0|||
143433124|NCT01475461|517132814|FG000|Treatment Period|Medication Error|0|||
143433125|NCT01475461|517132815|FG001|Treatment Period|Medication Error|0|||
143433126|NCT01475461|517132816|FG002|Treatment Period|Medication Error|0|||
143433127|NCT01475461|517132817|FG003|Treatment Period|Medication Error|1|||
143433128|NCT01475461|517132818|FG004|Treatment Period|Medication Error|0|||
143433129|NCT01475461|517132819|FG005|Treatment Period|Medication Error|0|||
143433130|NCT01475461|517132820|FG006|Treatment Period|Medication Error|0|||
143433131|NCT01475461|517132814|FG000|Treatment Period|Adverse Event|0|||
143433132|NCT01475461|517132815|FG001|Treatment Period|Adverse Event|0|||
143433133|NCT01475461|517132816|FG002|Treatment Period|Adverse Event|0|||
143433134|NCT01475461|517132817|FG003|Treatment Period|Adverse Event|1|||
143433135|NCT01475461|517132818|FG004|Treatment Period|Adverse Event|0|||
143433136|NCT01475461|517132819|FG005|Treatment Period|Adverse Event|0|||
143433137|NCT01475461|517132820|FG006|Treatment Period|Adverse Event|0|||
143433138|NCT04051242|517132823|FG000|Overall Study|Withdrawal by Subject|1|||
143433139|NCT04051242|517132823|FG000|Overall Study|Physician Decision|1|||
143433140|NCT03029819|517132824|FG000|Overall Study|Lost to Follow-up|3|||
143433141|NCT03029819|517132825|FG001|Overall Study|Lost to Follow-up|5|||
143433142|NCT03029819|517132824|FG000|Overall Study|Removed due to disruptive behavior|0|||
143433143|NCT03029819|517132825|FG001|Overall Study|Removed due to disruptive behavior|1|||
143433144|NCT01020747|517132828|FG000|Overall Study|Withdrawal by Subject|1|||
143433145|NCT02175745|517132833|FG000|Overall Study|Not Eligible|1|||
143433146|NCT00983892|517132834|FG000|Overall Study|Withdrawal by Subject|10|||
143433147|NCT00983892|517132835|FG001|Overall Study|Withdrawal by Subject|12|||
143433148|NCT00808899|517132836|FG000|Overall Study|Death|1|||
143433149|NCT00808899|517132836|FG000|Overall Study|Physician Decision|3|||
143433150|NCT03028012|517132837|FG000|Overall Study|Lost to Follow-up|2|||
143433151|NCT03028012|517132838|FG001|Overall Study|Lost to Follow-up|3|||
143433152|NCT03028012|517132839|FG002|Overall Study|Lost to Follow-up|3|||
143433153|NCT02484547|517132848|FG000|Placebo-Controlled Period|Adverse Event|10|||
143433154|NCT02484547|517132849|FG001|Placebo-Controlled Period|Adverse Event|13|||
143433155|NCT02484547|517132850|FG002|Placebo-Controlled Period|Adverse Event|20|||
143433156|NCT02484547|517132851|FG003|Placebo-Controlled Period|Adverse Event|0|||
143433157|NCT02484547|517132852|FG004|Placebo-Controlled Period|Adverse Event|0|||
143433158|NCT02484547|517132853|FG005|Placebo-Controlled Period|Adverse Event|0|||
143433159|NCT02484547|517132854|FG006|Placebo-Controlled Period|Adverse Event|0|||
143433160|NCT02484547|517132848|FG000|Placebo-Controlled Period|Change of Treatment|0|||
143433161|NCT02484547|517132849|FG001|Placebo-Controlled Period|Change of Treatment|0|||
143433162|NCT02484547|517132850|FG002|Placebo-Controlled Period|Change of Treatment|1|||
143433163|NCT02484547|517132851|FG003|Placebo-Controlled Period|Change of Treatment|0|||
143433164|NCT02484547|517132852|FG004|Placebo-Controlled Period|Change of Treatment|0|||
143433165|NCT02484547|517132853|FG005|Placebo-Controlled Period|Change of Treatment|0|||
143433166|NCT02484547|517132854|FG006|Placebo-Controlled Period|Change of Treatment|0|||
143433167|NCT02484547|517132848|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
143433168|NCT02484547|517132849|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
143433169|NCT02484547|517132850|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
143433170|NCT02484547|517132851|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
143433171|NCT02484547|517132852|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
143433172|NCT02484547|517132853|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
143433173|NCT02484547|517132854|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
143433174|NCT02484547|517132848|FG000|Placebo-Controlled Period|Death|5|||
143433175|NCT02484547|517132849|FG001|Placebo-Controlled Period|Death|0|||
143433176|NCT02484547|517132850|FG002|Placebo-Controlled Period|Death|6|||
143433177|NCT02484547|517132851|FG003|Placebo-Controlled Period|Death|0|||
143433178|NCT02484547|517132852|FG004|Placebo-Controlled Period|Death|0|||
143433179|NCT02484547|517132853|FG005|Placebo-Controlled Period|Death|0|||
143433180|NCT02484547|517132854|FG006|Placebo-Controlled Period|Death|0|||
143433181|NCT02484547|517132848|FG000|Placebo-Controlled Period|Disease Progression|2|||
143433182|NCT02484547|517132849|FG001|Placebo-Controlled Period|Disease Progression|0|||
143433183|NCT02484547|517132850|FG002|Placebo-Controlled Period|Disease Progression|1|||
143433184|NCT02484547|517132851|FG003|Placebo-Controlled Period|Disease Progression|0|||
143433185|NCT02484547|517132852|FG004|Placebo-Controlled Period|Disease Progression|0|||
143433186|NCT02484547|517132853|FG005|Placebo-Controlled Period|Disease Progression|0|||
143433187|NCT02484547|517132854|FG006|Placebo-Controlled Period|Disease Progression|0|||
143433188|NCT02484547|517132848|FG000|Placebo-Controlled Period|Investigator Decision|2|||
143433189|NCT02484547|517132849|FG001|Placebo-Controlled Period|Investigator Decision|2|||
143433190|NCT02484547|517132850|FG002|Placebo-Controlled Period|Investigator Decision|5|||
143433191|NCT02484547|517132851|FG003|Placebo-Controlled Period|Investigator Decision|0|||
143433192|NCT02484547|517132852|FG004|Placebo-Controlled Period|Investigator Decision|0|||
143433193|NCT02484547|517132853|FG005|Placebo-Controlled Period|Investigator Decision|0|||
143433194|NCT02484547|517132854|FG006|Placebo-Controlled Period|Investigator Decision|0|||
143433195|NCT02484547|517132848|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
143433196|NCT02484547|517132849|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
143433197|NCT02484547|517132850|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
143433198|NCT02484547|517132851|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
143433199|NCT02484547|517132852|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
143433200|NCT02484547|517132853|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
143433201|NCT02484547|517132854|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
143433202|NCT02484547|517132848|FG000|Placebo-Controlled Period|Relocation|1|||
143433203|NCT02484547|517132849|FG001|Placebo-Controlled Period|Relocation|1|||
143433204|NCT02484547|517132850|FG002|Placebo-Controlled Period|Relocation|1|||
143433205|NCT02484547|517132851|FG003|Placebo-Controlled Period|Relocation|0|||
143433206|NCT02484547|517132852|FG004|Placebo-Controlled Period|Relocation|0|||
143433207|NCT02484547|517132853|FG005|Placebo-Controlled Period|Relocation|0|||
143433208|NCT02484547|517132854|FG006|Placebo-Controlled Period|Relocation|0|||
143433209|NCT02484547|517132848|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
143433210|NCT02484547|517132849|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
143433211|NCT02484547|517132850|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
143433212|NCT02484547|517132851|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
143433213|NCT02484547|517132852|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
143433214|NCT02484547|517132853|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
143433215|NCT02484547|517132854|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
143433216|NCT02484547|517132848|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
143433217|NCT02484547|517132849|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
143433218|NCT02484547|517132850|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
143433219|NCT02484547|517132851|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
143433220|NCT02484547|517132852|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
143433221|NCT02484547|517132853|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
143433222|NCT02484547|517132854|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
143433223|NCT02484547|517132848|FG000|Placebo-Controlled Period|Reason not Specified|216|||
143433224|NCT02484547|517132849|FG001|Placebo-Controlled Period|Reason not Specified|194|||
143433225|NCT02484547|517132850|FG002|Placebo-Controlled Period|Reason not Specified|183|||
143433226|NCT02484547|517132851|FG003|Placebo-Controlled Period|Reason not Specified|0|||
143433227|NCT02484547|517132852|FG004|Placebo-Controlled Period|Reason not Specified|0|||
143433228|NCT02484547|517132853|FG005|Placebo-Controlled Period|Reason not Specified|0|||
143433229|NCT02484547|517132854|FG006|Placebo-Controlled Period|Reason not Specified|0|||
143433230|NCT02484547|517132848|FG000|Long-Term Extension Period|Adverse Event|0|||
143433231|NCT02484547|517132849|FG001|Long-Term Extension Period|Adverse Event|0|||
143433232|NCT02484547|517132850|FG002|Long-Term Extension Period|Adverse Event|0|||
143433233|NCT02484547|517132851|FG003|Long-Term Extension Period|Adverse Event|0|||
143433234|NCT02484547|517132852|FG004|Long-Term Extension Period|Adverse Event|1|||
143433235|NCT02484547|517132853|FG005|Long-Term Extension Period|Adverse Event|3|||
143433236|NCT02484547|517132854|FG006|Long-Term Extension Period|Adverse Event|2|||
143433237|NCT02484547|517132848|FG000|Long-Term Extension Period|Death|0|||
143433238|NCT02484547|517132849|FG001|Long-Term Extension Period|Death|0|||
143433239|NCT02484547|517132850|FG002|Long-Term Extension Period|Death|0|||
143433240|NCT02484547|517132851|FG003|Long-Term Extension Period|Death|0|||
143433241|NCT02484547|517132852|FG004|Long-Term Extension Period|Death|0|||
143433242|NCT02484547|517132853|FG005|Long-Term Extension Period|Death|3|||
143433243|NCT02484547|517132854|FG006|Long-Term Extension Period|Death|0|||
143433244|NCT02484547|517132848|FG000|Long-Term Extension Period|Disease Progression|0|||
143433245|NCT02484547|517132849|FG001|Long-Term Extension Period|Disease Progression|0|||
143433246|NCT02484547|517132850|FG002|Long-Term Extension Period|Disease Progression|0|||
143433247|NCT02484547|517132851|FG003|Long-Term Extension Period|Disease Progression|0|||
143433248|NCT02484547|517132852|FG004|Long-Term Extension Period|Disease Progression|2|||
143433249|NCT02484547|517132853|FG005|Long-Term Extension Period|Disease Progression|4|||
143433250|NCT02484547|517132854|FG006|Long-Term Extension Period|Disease Progression|0|||
143433251|NCT02484547|517132848|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
143433252|NCT02484547|517132849|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
143433253|NCT02484547|517132850|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
143433254|NCT02484547|517132851|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
143433255|NCT02484547|517132852|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
143433256|NCT02484547|517132853|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
143433257|NCT02484547|517132854|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
143433258|NCT02484547|517132848|FG000|Long-Term Extension Period|Loss of Capacity|0|||
143433259|NCT02484547|517132849|FG001|Long-Term Extension Period|Loss of Capacity|0|||
143433260|NCT02484547|517132850|FG002|Long-Term Extension Period|Loss of Capacity|0|||
143433261|NCT02484547|517132851|FG003|Long-Term Extension Period|Loss of Capacity|0|||
143433262|NCT02484547|517132852|FG004|Long-Term Extension Period|Loss of Capacity|1|||
143433263|NCT02484547|517132853|FG005|Long-Term Extension Period|Loss of Capacity|0|||
143433264|NCT02484547|517132854|FG006|Long-Term Extension Period|Loss of Capacity|0|||
143433265|NCT02484547|517132848|FG000|Long-Term Extension Period|Change of Treatment|0|||
143433266|NCT02484547|517132849|FG001|Long-Term Extension Period|Change of Treatment|0|||
143433267|NCT02484547|517132850|FG002|Long-Term Extension Period|Change of Treatment|0|||
143433268|NCT02484547|517132851|FG003|Long-Term Extension Period|Change of Treatment|0|||
143433269|NCT02484547|517132852|FG004|Long-Term Extension Period|Change of Treatment|0|||
143433270|NCT02484547|517132853|FG005|Long-Term Extension Period|Change of Treatment|0|||
143433271|NCT02484547|517132854|FG006|Long-Term Extension Period|Change of Treatment|1|||
143433272|NCT02484547|517132848|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
143433273|NCT02484547|517132849|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
143433274|NCT02484547|517132850|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
143433275|NCT02484547|517132851|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
143433276|NCT02484547|517132852|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
143433277|NCT02484547|517132853|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
143433278|NCT02484547|517132854|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
143433279|NCT02484547|517132848|FG000|Long-Term Extension Period|Investigator Decision|0|||
143433280|NCT02484547|517132849|FG001|Long-Term Extension Period|Investigator Decision|0|||
143433281|NCT02484547|517132850|FG002|Long-Term Extension Period|Investigator Decision|0|||
143433282|NCT02484547|517132851|FG003|Long-Term Extension Period|Investigator Decision|2|||
143433283|NCT02484547|517132852|FG004|Long-Term Extension Period|Investigator Decision|1|||
143433284|NCT02484547|517132853|FG005|Long-Term Extension Period|Investigator Decision|0|||
143433285|NCT02484547|517132854|FG006|Long-Term Extension Period|Investigator Decision|1|||
143433286|NCT02484547|517132848|FG000|Long-Term Extension Period|Relocation|0|||
143433287|NCT02484547|517132849|FG001|Long-Term Extension Period|Relocation|0|||
143433288|NCT02484547|517132850|FG002|Long-Term Extension Period|Relocation|0|||
143433289|NCT02484547|517132851|FG003|Long-Term Extension Period|Relocation|1|||
143433290|NCT02484547|517132852|FG004|Long-Term Extension Period|Relocation|1|||
143433291|NCT02484547|517132853|FG005|Long-Term Extension Period|Relocation|0|||
143433292|NCT02484547|517132854|FG006|Long-Term Extension Period|Relocation|0|||
143433293|NCT02484547|517132848|FG000|Long-Term Extension Period|Study Visit Burden|0|||
143433294|NCT02484547|517132849|FG001|Long-Term Extension Period|Study Visit Burden|0|||
143433295|NCT02484547|517132850|FG002|Long-Term Extension Period|Study Visit Burden|0|||
143433296|NCT02484547|517132851|FG003|Long-Term Extension Period|Study Visit Burden|2|||
143433297|NCT02484547|517132852|FG004|Long-Term Extension Period|Study Visit Burden|0|||
143433298|NCT02484547|517132853|FG005|Long-Term Extension Period|Study Visit Burden|0|||
143433299|NCT02484547|517132854|FG006|Long-Term Extension Period|Study Visit Burden|3|||
143433300|NCT02484547|517132848|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
143433301|NCT02484547|517132849|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
143433302|NCT02484547|517132850|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
143433303|NCT02484547|517132851|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
143433304|NCT02484547|517132852|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
143433305|NCT02484547|517132853|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
143433306|NCT02484547|517132854|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
143433307|NCT02484547|517132848|FG000|Long-Term Extension Period|Reason not Specified|0|||
143433308|NCT02484547|517132849|FG001|Long-Term Extension Period|Reason not Specified|0|||
143433309|NCT02484547|517132850|FG002|Long-Term Extension Period|Reason not Specified|0|||
143433310|NCT02484547|517132851|FG003|Long-Term Extension Period|Reason not Specified|119|||
143433311|NCT02484547|517132852|FG004|Long-Term Extension Period|Reason not Specified|117|||
143433312|NCT02484547|517132853|FG005|Long-Term Extension Period|Reason not Specified|223|||
143433313|NCT02484547|517132854|FG006|Long-Term Extension Period|Reason not Specified|231|||
143433314|NCT01424189|517132855|FG000|Overall Study|Adverse Event|1|||
143433315|NCT01424189|517132856|FG001|Overall Study|Adverse Event|0|||
143433316|NCT01424189|517132855|FG000|Overall Study|Lost to Follow-up|4|||
143433317|NCT01424189|517132856|FG001|Overall Study|Lost to Follow-up|1|||
143433318|NCT01424189|517132855|FG000|Overall Study|Withdrawal by Subject|4|||
143433319|NCT01424189|517132856|FG001|Overall Study|Withdrawal by Subject|4|||
143433320|NCT01424189|517132855|FG000|Overall Study|Subject moved|1|||
143433321|NCT01424189|517132856|FG001|Overall Study|Subject moved|0|||
143433322|NCT01424189|517132855|FG000|Overall Study|Death|3|||
143433323|NCT01424189|517132856|FG001|Overall Study|Death|1|||
143433324|NCT03120949|517132857|FG000|Overall Study|randomized in error|1|||
143433325|NCT03120949|517132858|FG001|Overall Study|randomized in error|0|||
143433326|NCT03120949|517132857|FG000|Overall Study|Death|13|||
143433327|NCT03120949|517132858|FG001|Overall Study|Death|13|||
143433328|NCT03120949|517132857|FG000|Overall Study|Lost to Follow-up|23|||
143433329|NCT03120949|517132858|FG001|Overall Study|Lost to Follow-up|13|||
143433330|NCT03120949|517132857|FG000|Overall Study|Withdrawal by Subject|139|||
143433331|NCT03120949|517132858|FG001|Overall Study|Withdrawal by Subject|124|||
143433332|NCT03120949|517132857|FG000|Overall Study|Covid-19|43|||
143433333|NCT03120949|517132858|FG001|Overall Study|Covid-19|34|||
143433334|NCT03120949|517132857|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
143433335|NCT03120949|517132858|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
143433336|NCT03120949|517132857|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
143433337|NCT03120949|517132858|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
143433338|NCT03120949|517132857|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
143433339|NCT03120949|517132858|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
143433340|NCT03120949|517132857|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
143433341|NCT03120949|517132858|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
143433342|NCT03120949|517132857|FG000|Overall Study|Site was closed|2|||
143433343|NCT03120949|517132858|FG001|Overall Study|Site was closed|3|||
143433344|NCT03120949|517132857|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
143433345|NCT03120949|517132858|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
143433346|NCT03120949|517132857|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
143433347|NCT03120949|517132858|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
143433348|NCT03120949|517132857|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
143433349|NCT03120949|517132858|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
143433350|NCT03120949|517132857|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
143433351|NCT03120949|517132858|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
143433352|NCT03120949|517132857|FG000|Overall Study|Other: Adverse Event|0|||
143433353|NCT03120949|517132858|FG001|Overall Study|Other: Adverse Event|1|||
143433354|NCT03120949|517132857|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
143433355|NCT03120949|517132858|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
143433356|NCT03120949|517132857|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
143433357|NCT03120949|517132858|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
143433358|NCT03120949|517132857|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
143433359|NCT03120949|517132858|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
143433360|NCT03120949|517132857|FG000|Overall Study|Personal Reasons|0|||
143433361|NCT03120949|517132858|FG001|Overall Study|Personal Reasons|1|||
143433362|NCT03120949|517132857|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
143433363|NCT03120949|517132858|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
143433364|NCT03120949|517132857|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
143433365|NCT03120949|517132858|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
143433366|NCT03120949|517132857|FG000|Overall Study|Compliance With Medication|0|||
143433367|NCT03120949|517132858|FG001|Overall Study|Compliance With Medication|1|||
143433368|NCT03120949|517132857|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
143433369|NCT03120949|517132858|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
143433370|NCT03120949|517132857|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
143433371|NCT03120949|517132858|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
143433372|NCT03120949|517132857|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
143433373|NCT03120949|517132858|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
143433374|NCT01705145|517132859|FG000|Part B|Adverse Event|1|||
143433375|NCT01203956|517132862|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
143433376|NCT01203956|517132863|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
143433377|NCT04522778|517132864|FG000|Overall Study|Patient did not want to wear the device|1|||
143433378|NCT04522778|517132865|FG001|Overall Study|Patient did not want to wear the device|0|||
143433379|NCT04522778|517132864|FG000|Overall Study|Lost to Follow-up|0|||
143433380|NCT04522778|517132865|FG001|Overall Study|Lost to Follow-up|1|||
143433381|NCT02230306|517132868|FG000|Overall Study|Did not receive study treatment|1|||
143433382|NCT00312845|517132871|FG000|Overall Study|Adverse Event|19|||
143433383|NCT00312845|517132872|FG001|Overall Study|Adverse Event|5|||
143433384|NCT00312845|517132871|FG000|Overall Study|Death|2|||
143433385|NCT00312845|517132872|FG001|Overall Study|Death|2|||
143433386|NCT00312845|517132871|FG000|Overall Study|Withdrawal by Subject|14|||
143433387|NCT00312845|517132872|FG001|Overall Study|Withdrawal by Subject|6|||
143433388|NCT00312845|517132871|FG000|Overall Study|Disease Progression|56|||
143433389|NCT00312845|517132872|FG001|Overall Study|Disease Progression|77|||
143433390|NCT00312845|517132871|FG000|Overall Study|Lost to Follow-up|2|||
143433391|NCT00312845|517132872|FG001|Overall Study|Lost to Follow-up|0|||
143433392|NCT00312845|517132871|FG000|Overall Study|Other|6|||
143433393|NCT00312845|517132872|FG001|Overall Study|Other|5|||
143433394|NCT01220856|517132875|FG000|Overall Study|graft loss|3|||
143433395|NCT01220856|517132876|FG001|Overall Study|graft loss|3|||
143433396|NCT01220856|517132875|FG000|Overall Study|Lost to Follow-up|1|||
143433397|NCT01220856|517132876|FG001|Overall Study|Lost to Follow-up|0|||
143433398|NCT00361842|517132877|FG000|Overall Study|Withdrawal by Subject|2|||
143433399|NCT00361842|517132878|FG001|Overall Study|Withdrawal by Subject|3|||
143433400|NCT00361842|517132877|FG000|Overall Study|Death|2|||
143433401|NCT00361842|517132878|FG001|Overall Study|Death|1|||
143433402|NCT00361842|517132877|FG000|Overall Study|Disease progression|19|||
143433403|NCT00361842|517132878|FG001|Overall Study|Disease progression|20|||
143433404|NCT00361842|517132877|FG000|Overall Study|Adverse Event|2|||
143433405|NCT00361842|517132878|FG001|Overall Study|Adverse Event|3|||
143433406|NCT00361842|517132877|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
143433407|NCT00361842|517132878|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
143433408|NCT00361842|517132877|FG000|Overall Study|Other|1|||
143433409|NCT00361842|517132878|FG001|Overall Study|Other|0|||
143433410|NCT00361842|517132877|FG000|Overall Study|Other|0|||
143433411|NCT00361842|517132878|FG001|Overall Study|Other|2|||
143433412|NCT04206384|517132879|FG000|Overall Study|Withdrawal by Subject|8|||
143433413|NCT04206384|517132879|FG000|Overall Study|Adverse Event|2|||
143433414|NCT02212197|517132880|FG000|Overall Study|Need for radiotherapy|1|||
143433415|NCT02212197|517132881|FG001|Overall Study|Need for radiotherapy|0|||
143433416|NCT02212197|517132882|FG002|Overall Study|Need for radiotherapy|0|||
143433417|NCT03015181|517132883|FG000|Overall Study|Enrolled, but product never administered|1|||
143433418|NCT03015181|517132884|FG001|Overall Study|Enrolled, but product never administered|0|||
143433419|NCT03015181|517132885|FG002|Overall Study|Enrolled, but product never administered|0|||
143433420|NCT03015181|517132886|FG003|Overall Study|Enrolled, but product never administered|0|||
143433421|NCT03015181|517132887|FG004|Overall Study|Enrolled, but product never administered|0|||
143433422|NCT03015181|517132888|FG005|Overall Study|Enrolled, but product never administered|0|||
143433423|NCT03015181|517132889|FG006|Overall Study|Enrolled, but product never administered|0|||
143433424|NCT03015181|517132883|FG000|Overall Study|Withdrawal by Subject|0|||
143433425|NCT03015181|517132884|FG001|Overall Study|Withdrawal by Subject|0|||
143433426|NCT03015181|517132885|FG002|Overall Study|Withdrawal by Subject|0|||
143433427|NCT03015181|517132886|FG003|Overall Study|Withdrawal by Subject|0|||
143433428|NCT03015181|517132887|FG004|Overall Study|Withdrawal by Subject|0|||
143433429|NCT03015181|517132888|FG005|Overall Study|Withdrawal by Subject|1|||
143433430|NCT03015181|517132889|FG006|Overall Study|Withdrawal by Subject|0|||
143433431|NCT03015181|517132883|FG000|Overall Study|Physician Decision|0|||
143433432|NCT03015181|517132884|FG001|Overall Study|Physician Decision|0|||
143433433|NCT03015181|517132885|FG002|Overall Study|Physician Decision|0|||
143433434|NCT03015181|517132886|FG003|Overall Study|Physician Decision|0|||
143433435|NCT03015181|517132887|FG004|Overall Study|Physician Decision|0|||
143433436|NCT03015181|517132888|FG005|Overall Study|Physician Decision|0|||
143433437|NCT03015181|517132889|FG006|Overall Study|Physician Decision|1|||
143433438|NCT01077622|517132891|FG000|Overall Study|Physician Decision|2|||
143433439|NCT01077622|517132891|FG000|Overall Study|Withdrawal by Subject|1|||
143433440|NCT01260142|517132892|FG000|Treatment Period 1|Study on hold|1|||
143433441|NCT01260142|517132893|FG001|Treatment Period 1|Study on hold|1|||
143433442|NCT01260142|517132894|FG002|Treatment Period 1|Study on hold|0|||
143433443|NCT01260142|517132895|FG003|Treatment Period 1|Study on hold|0|||
143433444|NCT01260142|517132896|FG004|Treatment Period 1|Study on hold|1|||
143433445|NCT01260142|517132897|FG005|Treatment Period 1|Study on hold|2|||
143433446|NCT01260142|517132892|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
143433447|NCT01260142|517132893|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
143433448|NCT01260142|517132894|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
143433449|NCT01260142|517132895|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
143433450|NCT01260142|517132896|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
143433451|NCT01260142|517132897|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
143433452|NCT01260142|517132892|FG000|Treatment Period 1|Withdrawal by Subject|0|||
143433453|NCT01260142|517132893|FG001|Treatment Period 1|Withdrawal by Subject|0|||
143433454|NCT01260142|517132894|FG002|Treatment Period 1|Withdrawal by Subject|0|||
143433455|NCT01260142|517132895|FG003|Treatment Period 1|Withdrawal by Subject|0|||
143433456|NCT01260142|517132896|FG004|Treatment Period 1|Withdrawal by Subject|0|||
143433457|NCT01260142|517132897|FG005|Treatment Period 1|Withdrawal by Subject|1|||
143433458|NCT00496834|517132906|FG000|Overall Study|Withdrawal by Subject|4|||
143433459|NCT00496834|517132907|FG001|Overall Study|Withdrawal by Subject|6|||
143433460|NCT00496834|517132906|FG000|Overall Study|Contraindicated medication administered|0|||
143433461|NCT00496834|517132907|FG001|Overall Study|Contraindicated medication administered|1|||
143433462|NCT00496834|517132906|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
143433463|NCT00496834|517132907|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
143433464|NCT00496834|517132906|FG000|Overall Study|Adverse Event|5|||
143433465|NCT00496834|517132907|FG001|Overall Study|Adverse Event|3|||
143433466|NCT00496834|517132906|FG000|Overall Study|IP administration violation|2|||
143433467|NCT00496834|517132907|FG001|Overall Study|IP administration violation|0|||
143433468|NCT00496834|517132906|FG000|Overall Study|Lost to Follow-up|2|||
143433469|NCT00496834|517132907|FG001|Overall Study|Lost to Follow-up|0|||
143433470|NCT00496834|517132906|FG000|Overall Study|Blood Pressure control failure|2|||
143433471|NCT00496834|517132907|FG001|Overall Study|Blood Pressure control failure|1|||
143433472|NCT01503164|517132908|FG000|Overall Study|Withdrawal by Subject|2|||
143433473|NCT01503164|517132909|FG001|Overall Study|Withdrawal by Subject|1|||
143433474|NCT00474383|517132913|FG000|Main Study|Adverse Event|11|||
143433475|NCT00474383|517132914|FG001|Main Study|Adverse Event|0|||
143433476|NCT00474383|517132913|FG000|Main Study|Symptomatic Deterioration|1|||
143433477|NCT00474383|517132914|FG001|Main Study|Symptomatic Deterioration|0|||
143433478|NCT00474383|517132913|FG000|Main Study|Progressive Disease|23|||
143433479|NCT00474383|517132914|FG001|Main Study|Progressive Disease|0|||
143433480|NCT00474383|517132913|FG000|Main Study|Other|1|||
143433481|NCT00474383|517132914|FG001|Main Study|Other|0|||
143433482|NCT00474383|517132913|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
143433483|NCT00474383|517132914|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
143433484|NCT00474383|517132913|FG000|Extension|Progressive Disease|0|||
143433485|NCT00474383|517132914|FG001|Extension|Progressive Disease|5|||
143433486|NCT01482819|517132918|FG000|Overall Study|Lost to Follow-up|2|||
143433487|NCT00562484|517132921|FG000|Overall Study|Adverse Event|6|||
143433488|NCT00562484|517132922|FG001|Overall Study|Adverse Event|1|||
143433489|NCT00562484|517132921|FG000|Overall Study|Protocol Violation|11|||
143433490|NCT00562484|517132922|FG001|Overall Study|Protocol Violation|2|||
143433491|NCT00562484|517132921|FG000|Overall Study|Withdrawal by Subject|12|||
143433492|NCT00562484|517132922|FG001|Overall Study|Withdrawal by Subject|9|||
143433493|NCT00562484|517132921|FG000|Overall Study|Moved away from the study area|20|||
143433494|NCT00562484|517132922|FG001|Overall Study|Moved away from the study area|9|||
143433495|NCT00562484|517132921|FG000|Overall Study|Lost to Follow-up|132|||
143433496|NCT00562484|517132922|FG001|Overall Study|Lost to Follow-up|71|||
143433497|NCT00562484|517132921|FG000|Overall Study|Reason not provided or not specified|25|||
143433498|NCT00562484|517132922|FG001|Overall Study|Reason not provided or not specified|12|||
143433499|NCT03325608|517132923|FG000|Overall Study|Lost to Follow-up|23|||
143433500|NCT03325608|517132924|FG001|Overall Study|Lost to Follow-up|23|||
143433501|NCT03325608|517132925|FG002|Overall Study|Lost to Follow-up|30|||
143433502|NCT03325608|517132926|FG003|Overall Study|Lost to Follow-up|30|||
143433503|NCT03325608|517132923|FG000|Overall Study|Death of Caregiver|0|||
143433504|NCT03325608|517132924|FG001|Overall Study|Death of Caregiver|0|||
143433505|NCT03325608|517132925|FG002|Overall Study|Death of Caregiver|2|||
143433506|NCT03325608|517132926|FG003|Overall Study|Death of Caregiver|2|||
143433507|NCT03325608|517132923|FG000|Overall Study|Death of Care Recipient|34|||
143433508|NCT03325608|517132924|FG001|Overall Study|Death of Care Recipient|34|||
143433509|NCT03325608|517132925|FG002|Overall Study|Death of Care Recipient|28|||
143433510|NCT03325608|517132926|FG003|Overall Study|Death of Care Recipient|28|||
143433511|NCT03325608|517132923|FG000|Overall Study|Withdrawal by Subject|49|||
143433512|NCT03325608|517132924|FG001|Overall Study|Withdrawal by Subject|49|||
143433513|NCT03325608|517132925|FG002|Overall Study|Withdrawal by Subject|35|||
143433514|NCT03325608|517132926|FG003|Overall Study|Withdrawal by Subject|35|||
143433515|NCT03325608|517132923|FG000|Overall Study|Ineligible|7|||
143433516|NCT03325608|517132924|FG001|Overall Study|Ineligible|7|||
143433517|NCT03325608|517132925|FG002|Overall Study|Ineligible|5|||
143433518|NCT03325608|517132926|FG003|Overall Study|Ineligible|5|||
143433519|NCT02154347|517132927|FG000|Double-blind Period|Adverse Event|1|||
143433520|NCT02154347|517132928|FG001|Double-blind Period|Adverse Event|2|||
143433521|NCT02154347|517132927|FG000|Double-blind Period|Lack of Efficacy|1|||
143433522|NCT02154347|517132928|FG001|Double-blind Period|Lack of Efficacy|0|||
143433523|NCT02154347|517132927|FG000|Double-blind Period|Physician Decision|0|||
143433524|NCT02154347|517132928|FG001|Double-blind Period|Physician Decision|1|||
143433525|NCT02154347|517132927|FG000|Double-blind Period|Withdrawal by Subject|1|||
143433526|NCT02154347|517132928|FG001|Double-blind Period|Withdrawal by Subject|1|||
143433527|NCT02154347|517132927|FG000|Open-label Period|Adverse Event|3|||
143433528|NCT02154347|517132928|FG001|Open-label Period|Adverse Event|4|||
143433529|NCT02154347|517132927|FG000|Open-label Period|Lack of Efficacy|4|||
143433530|NCT02154347|517132928|FG001|Open-label Period|Lack of Efficacy|19|||
143433531|NCT02154347|517132927|FG000|Open-label Period|Protocol Violation|0|||
143433532|NCT02154347|517132928|FG001|Open-label Period|Protocol Violation|1|||
143433533|NCT02154347|517132927|FG000|Open-label Period|Withdrawal by Subject|0|||
143433534|NCT02154347|517132928|FG001|Open-label Period|Withdrawal by Subject|1|||
143433535|NCT02188784|517132929|FG000|Overall Study|Death|3|||
143433536|NCT02188784|517132930|FG001|Overall Study|Death|1|||
143433537|NCT02188784|517132929|FG000|Overall Study|Lost to Follow-up|1|||
143433538|NCT02188784|517132930|FG001|Overall Study|Lost to Follow-up|0|||
143433539|NCT02188784|517132929|FG000|Overall Study|Withdrawal by Subject|3|||
143433540|NCT02188784|517132930|FG001|Overall Study|Withdrawal by Subject|9|||
143433541|NCT02188784|517132929|FG000|Overall Study|Physician Decision|2|||
143433542|NCT02188784|517132930|FG001|Overall Study|Physician Decision|3|||
143433543|NCT05041439|517132931|FG000|Overall Study|Withdrawal by Subject|1|||
143433544|NCT05041439|517132932|FG001|Overall Study|Withdrawal by Subject|1|||
143433545|NCT05041439|517132931|FG000|Overall Study|Death|1|||
143433546|NCT05041439|517132932|FG001|Overall Study|Death|0|||
143433547|NCT02250183|517132933|FG000|Overall Study|Withdrawal by Subject|2|||
143433548|NCT02250183|517132933|FG000|Overall Study|Adverse Event|5|||
143433549|NCT02250183|517132933|FG000|Overall Study|Lost to Follow-up|1|||
143433550|NCT03282799|517132934|FG000|Overall Study|Pregnancy|1|||
143433551|NCT03282799|517132935|FG001|Overall Study|Pregnancy|0|||
143433552|NCT03282799|517132934|FG000|Overall Study|Physician Decision|1|||
143433553|NCT03282799|517132935|FG001|Overall Study|Physician Decision|0|||
143433554|NCT01932762|517134453|FG000|Overall Study|Withdrawal by Subject|1|||
143433555|NCT01932762|517134454|FG001|Overall Study|Withdrawal by Subject|2|||
143433556|NCT01932762|517134455|FG002|Overall Study|Withdrawal by Subject|0|||
143433557|NCT01932762|517134456|FG003|Overall Study|Withdrawal by Subject|0|||
143433558|NCT01932762|517134453|FG000|Overall Study|Lost to Follow-up|4|||
143433559|NCT01932762|517134454|FG001|Overall Study|Lost to Follow-up|0|||
143433560|NCT01932762|517134455|FG002|Overall Study|Lost to Follow-up|0|||
143433561|NCT01932762|517134456|FG003|Overall Study|Lost to Follow-up|1|||
143433562|NCT01932762|517134453|FG000|Overall Study|Physician Decision|1|||
143433563|NCT01932762|517134454|FG001|Overall Study|Physician Decision|0|||
143433564|NCT01932762|517134455|FG002|Overall Study|Physician Decision|0|||
143433565|NCT01932762|517134456|FG003|Overall Study|Physician Decision|0|||
143433566|NCT01468077|517134463|FG000|Overall Study|Adverse Event|2|||
143433567|NCT01468077|517134464|FG001|Overall Study|Adverse Event|2|||
143433568|NCT01468077|517134463|FG000|Overall Study|Lack of Efficacy|1|||
143433569|NCT01468077|517134464|FG001|Overall Study|Lack of Efficacy|1|||
143433570|NCT01468077|517134463|FG000|Overall Study|Physician Decision|1|||
143433571|NCT01468077|517134464|FG001|Overall Study|Physician Decision|0|||
143433572|NCT04843579|517134465|FG000|Overall Study|Adverse Event|1|||
143433573|NCT04843579|517134465|FG000|Overall Study|Disease Progression|1|||
143433574|NCT03024996|517134467|FG000|Overall Study|Death|57|||
143433575|NCT03024996|517134468|FG001|Overall Study|Death|55|||
143433576|NCT03024996|517134467|FG000|Overall Study|Disease relapse|1|||
143433577|NCT03024996|517134468|FG001|Overall Study|Disease relapse|0|||
143433578|NCT03024996|517134467|FG000|Overall Study|Lost to Follow-up|5|||
143433579|NCT03024996|517134468|FG001|Overall Study|Lost to Follow-up|10|||
143433580|NCT03024996|517134467|FG000|Overall Study|Other|3|||
143433581|NCT03024996|517134468|FG001|Overall Study|Other|3|||
143433582|NCT03024996|517134467|FG000|Overall Study|Physician Decision|0|||
143433583|NCT03024996|517134468|FG001|Overall Study|Physician Decision|1|||
143433584|NCT03024996|517134467|FG000|Overall Study|Study terminated by sponsor|303|||
143433585|NCT03024996|517134468|FG001|Overall Study|Study terminated by sponsor|283|||
143433586|NCT03024996|517134467|FG000|Overall Study|Withdrawal by Subject|21|||
143433587|NCT03024996|517134468|FG001|Overall Study|Withdrawal by Subject|36|||
143433588|NCT04606199|517134469|FG000|Overall Study|Withdrawal by Subject|2|||
143433589|NCT03596242|517134470|FG000|Overall Study|Lost to Follow-up|2|||
143433590|NCT03596242|517134471|FG001|Overall Study|Lost to Follow-up|2|||
143433591|NCT03357471|517134472|FG000|Overall Study|Adverse Event|1|||
143433592|NCT03357471|517134473|FG001|Overall Study|Adverse Event|0|||
143433593|NCT03357471|517134472|FG000|Overall Study|Lost to Follow-up|1|||
143433594|NCT03357471|517134473|FG001|Overall Study|Lost to Follow-up|0|||
143433595|NCT03294941|517134474|FG000|Overall Study|Withdrawal by Subject|0|||
143433596|NCT03294941|517134475|FG001|Overall Study|Withdrawal by Subject|2|||
143433597|NCT00916305|517134476|FG000|Overall Study|Lost to Follow-up|21|||
143433598|NCT00916305|517134477|FG001|Overall Study|Lost to Follow-up|27|||
143433599|NCT00916305|517134476|FG000|Overall Study|Withdrawal by Subject|0|||
143433600|NCT00916305|517134477|FG001|Overall Study|Withdrawal by Subject|1|||
143433601|NCT02512861|517134480|FG000|Overall Study|Protocol Violation|3|||
143433602|NCT02512861|517134481|FG001|Overall Study|Protocol Violation|7|||
143433603|NCT02512861|517134480|FG000|Overall Study|Physician Decision|3|||
143433604|NCT02512861|517134481|FG001|Overall Study|Physician Decision|1|||
143433605|NCT02512861|517134480|FG000|Overall Study|Withdrawal by Subject|0|||
143433606|NCT02512861|517134481|FG001|Overall Study|Withdrawal by Subject|1|||
143433607|NCT01585298|517134484|FG000|Overall Study|Study completion was not documented.|1|||
143433608|NCT01585298|517134484|FG000|Overall Study|Protocol deviation|1|||
143433609|NCT01585298|517134484|FG000|Overall Study|Administrative problems|4|||
143433610|NCT01585298|517134484|FG000|Overall Study|Lost to Follow-up|2|||
143433611|NCT01585298|517134484|FG000|Overall Study|Withdrawal by Subject|4|||
143433612|NCT01585298|517134484|FG000|Overall Study|Abnormal test procedure results|1|||
143433613|NCT01585298|517134484|FG000|Overall Study|Adverse Event|24|||
143433614|NCT04545476|517134485|FG000|Overall Study|Lost to Follow-up|1|||
143433615|NCT04545476|517134486|FG001|Overall Study|Lost to Follow-up|1|||
143433616|NCT04545476|517134487|FG002|Overall Study|Lost to Follow-up|0|||
143433617|NCT04545476|517134488|FG003|Overall Study|Lost to Follow-up|0|||
143433618|NCT04035577|517134502|FG000|Overall Study|Lost to Follow-up|1|||
143433619|NCT04035577|517134502|FG000|Overall Study|Withdrawal by Subject|1|||
143433620|NCT00505414|517134504|FG000|Titration Phase|Adverse Event|0|||
143433621|NCT00505414|517134505|FG001|Titration Phase|Adverse Event|0|||
143433622|NCT00505414|517134506|FG002|Titration Phase|Adverse Event|0|||
143433623|NCT00505414|517134507|FG003|Titration Phase|Adverse Event|8|||
143433624|NCT00505414|517134508|FG004|Titration Phase|Adverse Event|3|||
143433625|NCT00505414|517134504|FG000|Titration Phase|Death|0|||
143433626|NCT00505414|517134505|FG001|Titration Phase|Death|0|||
143433627|NCT00505414|517134506|FG002|Titration Phase|Death|0|||
143433628|NCT00505414|517134507|FG003|Titration Phase|Death|2|||
143433629|NCT00505414|517134508|FG004|Titration Phase|Death|0|||
143433630|NCT00505414|517134504|FG000|Titration Phase|Lack of Efficacy|0|||
143433631|NCT00505414|517134505|FG001|Titration Phase|Lack of Efficacy|0|||
143433632|NCT00505414|517134506|FG002|Titration Phase|Lack of Efficacy|0|||
143433633|NCT00505414|517134507|FG003|Titration Phase|Lack of Efficacy|10|||
143433634|NCT00505414|517134508|FG004|Titration Phase|Lack of Efficacy|1|||
143433635|NCT00505414|517134504|FG000|Titration Phase|Protocol Violation|0|||
143433636|NCT00505414|517134505|FG001|Titration Phase|Protocol Violation|0|||
143433637|NCT00505414|517134506|FG002|Titration Phase|Protocol Violation|0|||
143433638|NCT00505414|517134507|FG003|Titration Phase|Protocol Violation|0|||
143433639|NCT00505414|517134508|FG004|Titration Phase|Protocol Violation|1|||
143433640|NCT00505414|517134504|FG000|Titration Phase|Withdrawal by Subject|0|||
143433641|NCT00505414|517134505|FG001|Titration Phase|Withdrawal by Subject|0|||
143433642|NCT00505414|517134506|FG002|Titration Phase|Withdrawal by Subject|0|||
143433643|NCT00505414|517134507|FG003|Titration Phase|Withdrawal by Subject|3|||
143433644|NCT00505414|517134508|FG004|Titration Phase|Withdrawal by Subject|4|||
143433645|NCT00505414|517134504|FG000|Titration Phase|Underlying disease and therapy required|0|||
143433646|NCT00505414|517134505|FG001|Titration Phase|Underlying disease and therapy required|0|||
143433647|NCT00505414|517134506|FG002|Titration Phase|Underlying disease and therapy required|0|||
143433648|NCT00505414|517134507|FG003|Titration Phase|Underlying disease and therapy required|7|||
143433649|NCT00505414|517134508|FG004|Titration Phase|Underlying disease and therapy required|3|||
143433650|NCT00505414|517134504|FG000|Maintenance Phase|Adverse Event|2|||
143433651|NCT00505414|517134505|FG001|Maintenance Phase|Adverse Event|2|||
143433652|NCT00505414|517134506|FG002|Maintenance Phase|Adverse Event|3|||
143433653|NCT00505414|517134507|FG003|Maintenance Phase|Adverse Event|0|||
143433654|NCT00505414|517134508|FG004|Maintenance Phase|Adverse Event|0|||
143433655|NCT00505414|517134504|FG000|Maintenance Phase|Death|2|||
143433656|NCT00505414|517134505|FG001|Maintenance Phase|Death|0|||
143433657|NCT00505414|517134506|FG002|Maintenance Phase|Death|1|||
143433658|NCT00505414|517134507|FG003|Maintenance Phase|Death|0|||
143433659|NCT00505414|517134508|FG004|Maintenance Phase|Death|0|||
143433660|NCT00505414|517134504|FG000|Maintenance Phase|Lack of Efficacy|2|||
143433661|NCT00505414|517134505|FG001|Maintenance Phase|Lack of Efficacy|1|||
143433662|NCT00505414|517134506|FG002|Maintenance Phase|Lack of Efficacy|1|||
143433663|NCT00505414|517134507|FG003|Maintenance Phase|Lack of Efficacy|0|||
143433664|NCT00505414|517134508|FG004|Maintenance Phase|Lack of Efficacy|0|||
143433665|NCT00505414|517134504|FG000|Maintenance Phase|Withdrawal by Subject|0|||
143433666|NCT00505414|517134505|FG001|Maintenance Phase|Withdrawal by Subject|0|||
143433667|NCT00505414|517134506|FG002|Maintenance Phase|Withdrawal by Subject|1|||
143433668|NCT00505414|517134507|FG003|Maintenance Phase|Withdrawal by Subject|0|||
143433669|NCT00505414|517134508|FG004|Maintenance Phase|Withdrawal by Subject|0|||
143433670|NCT00505414|517134504|FG000|Maintenance Phase|underlying disease and therapy required|0|||
143433671|NCT00505414|517134505|FG001|Maintenance Phase|underlying disease and therapy required|2|||
143433672|NCT00505414|517134506|FG002|Maintenance Phase|underlying disease and therapy required|2|||
143433673|NCT00505414|517134507|FG003|Maintenance Phase|underlying disease and therapy required|0|||
143433674|NCT00505414|517134508|FG004|Maintenance Phase|underlying disease and therapy required|0|||
143433675|NCT00846768|517134509|FG000|Overall Study|Adverse Event|0|||
143433676|NCT00846768|517134510|FG001|Overall Study|Adverse Event|1|||
143433677|NCT00846768|517134511|FG002|Overall Study|Adverse Event|0|||
143433678|NCT00846768|517134512|FG003|Overall Study|Adverse Event|0|||
143433679|NCT00644878|517134513|FG000|Overall Study|Adverse Event|2|||
143433680|NCT00644878|517134513|FG000|Overall Study|Abnormal laboratory value|3|||
143433681|NCT00644878|517134513|FG000|Overall Study|Protocol deviation|2|||
143433682|NCT00644878|517134513|FG000|Overall Study|Treatment duration completed as per protocol|11|||
143433683|NCT04353817|517134514|FG000|Overall Study|Adverse Event|0|||
143433684|NCT04353817|517134515|FG001|Overall Study|Adverse Event|1|||
143433685|NCT04358068|517134516|FG000|Overall Study|Did not initiate study treatment|2|||
143433686|NCT04358068|517134517|FG001|Overall Study|Did not initiate study treatment|2|||
143433687|NCT00770588|517134518|FG000|Overall Study|Adverse Event|9|||
143433688|NCT00770588|517134519|FG001|Overall Study|Adverse Event|2|||
143433689|NCT00770588|517134518|FG000|Overall Study|Death caused by progression of disease|70|||
143433690|NCT00770588|517134519|FG001|Overall Study|Death caused by progression of disease|91|||
143433691|NCT00770588|517134518|FG000|Overall Study|Lost to Follow-up|1|||
143433692|NCT00770588|517134519|FG001|Overall Study|Lost to Follow-up|1|||
143433693|NCT00770588|517134518|FG000|Overall Study|Withdrawal by Subject|1|||
143433694|NCT00770588|517134519|FG001|Overall Study|Withdrawal by Subject|1|||
143433695|NCT00338949|517134520|FG000|Subject Screening|Screen failures|11|||
143433696|NCT00338949|517134521|FG001|Subject Screening|Screen failures|11|||
143433697|NCT00338949|517134520|FG000|Randomization|Withdrawal by Subject|1|||
143433698|NCT00338949|517134521|FG001|Randomization|Withdrawal by Subject|0|||
143433699|NCT00338949|517134520|FG000|Randomization|Adverse Event|0|||
143433700|NCT00338949|517134521|FG001|Randomization|Adverse Event|5|||
143433701|NCT01841112|517134523|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
143433702|NCT01841112|517134524|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
143433703|NCT01841112|517134525|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
143433704|NCT01841112|517134526|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
143433705|NCT01841112|517134527|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
143433706|NCT00878553|517134530|FG000|Sleep Study|Withdrawal by Subject|2|||
143433707|NCT00878553|517134531|FG001|Sleep Study|Withdrawal by Subject|0|||
143433708|NCT00878553|517134532|FG002|Sleep Study|Withdrawal by Subject|0|||
143433709|NCT00878553|517134533|FG003|Sleep Study|Withdrawal by Subject|0|||
143433710|NCT00878553|517134534|FG004|Sleep Study|Withdrawal by Subject|0|||
143433711|NCT00878553|517134530|FG000|Sleep Study|Lost to Follow-up|1|||
143433712|NCT00878553|517134531|FG001|Sleep Study|Lost to Follow-up|0|||
143433713|NCT00878553|517134532|FG002|Sleep Study|Lost to Follow-up|0|||
143433714|NCT00878553|517134533|FG003|Sleep Study|Lost to Follow-up|0|||
143433715|NCT00878553|517134534|FG004|Sleep Study|Lost to Follow-up|0|||
143433716|NCT00878553|517134530|FG000|Sleep Study|car accident|1|||
143433717|NCT00878553|517134531|FG001|Sleep Study|car accident|0|||
143433718|NCT00878553|517134532|FG002|Sleep Study|car accident|0|||
143433719|NCT00878553|517134533|FG003|Sleep Study|car accident|0|||
143433720|NCT00878553|517134534|FG004|Sleep Study|car accident|0|||
143433721|NCT00878553|517134530|FG000|Sleep Study|family emergency|1|||
143433722|NCT00878553|517134531|FG001|Sleep Study|family emergency|0|||
143433723|NCT00878553|517134532|FG002|Sleep Study|family emergency|0|||
143433724|NCT00878553|517134533|FG003|Sleep Study|family emergency|0|||
143433725|NCT00878553|517134534|FG004|Sleep Study|family emergency|0|||
143433726|NCT00878553|517134530|FG000|PK Study|Withdrawal by Subject|0|||
143433727|NCT00878553|517134531|FG001|PK Study|Withdrawal by Subject|0|||
143433728|NCT00878553|517134532|FG002|PK Study|Withdrawal by Subject|0|||
143433729|NCT00878553|517134533|FG003|PK Study|Withdrawal by Subject|1|||
143433730|NCT00878553|517134534|FG004|PK Study|Withdrawal by Subject|0|||
143433731|NCT02143063|517134535|FG000|Overall Study|Lost to Follow-up|16|||
143433732|NCT02143063|517134536|FG001|Overall Study|Lost to Follow-up|28|||
143433733|NCT02143063|517134537|FG002|Overall Study|Lost to Follow-up|29|||
143433734|NCT02143063|517134535|FG000|Overall Study|Withdrawal by Subject|0|||
143433735|NCT02143063|517134536|FG001|Overall Study|Withdrawal by Subject|1|||
143433736|NCT02143063|517134537|FG002|Overall Study|Withdrawal by Subject|0|||
143433737|NCT02143063|517134535|FG000|Overall Study|Death|0|||
143433738|NCT02143063|517134536|FG001|Overall Study|Death|1|||
143433739|NCT02143063|517134537|FG002|Overall Study|Death|1|||
143433740|NCT00912223|517134538|FG000|Overall Study|Withdrawal by Subject|1|||
143433741|NCT00912223|517134538|FG000|Overall Study|Not transplanted|1|||
143433742|NCT00912223|517134538|FG000|Overall Study|Transformed disease|1|||
143433743|NCT00461123|517134539|FG000|Overall Study|Adverse Event|1|||
143433744|NCT00461123|517134540|FG001|Overall Study|Adverse Event|0|||
143433745|NCT00461123|517134539|FG000|Overall Study|Lost to Follow-up|1|||
143433746|NCT00461123|517134540|FG001|Overall Study|Lost to Follow-up|1|||
143433747|NCT00461123|517134539|FG000|Overall Study|Protocol Violation|3|||
143433748|NCT00461123|517134540|FG001|Overall Study|Protocol Violation|2|||
143433749|NCT00461123|517134539|FG000|Overall Study|Withdrawal by Subject|1|||
143433750|NCT00461123|517134540|FG001|Overall Study|Withdrawal by Subject|3|||
143433751|NCT02604342|517134541|FG000|Overall Study|Death|32|||
143433752|NCT02604342|517134542|FG001|Overall Study|Death|16|||
143433753|NCT02604342|517134541|FG000|Overall Study|Progression of disease|1|||
143433754|NCT02604342|517134542|FG001|Overall Study|Progression of disease|0|||
143433755|NCT02604342|517134541|FG000|Overall Study|Withdrawal by Subject|5|||
143433756|NCT02604342|517134542|FG001|Overall Study|Withdrawal by Subject|6|||
143433757|NCT02604342|517134541|FG000|Overall Study|Other|1|||
143433758|NCT02604342|517134542|FG001|Overall Study|Other|0|||
143433759|NCT02604342|517134541|FG000|Overall Study|Study Termination by Sponsor|1|||
143433760|NCT02604342|517134542|FG001|Overall Study|Study Termination by Sponsor|0|||
143433761|NCT02604342|517134541|FG000|Overall Study|Lost to Follow-up|1|||
143433762|NCT02604342|517134542|FG001|Overall Study|Lost to Follow-up|1|||
143433763|NCT02604342|517134541|FG000|Overall Study|Physician Decision|2|||
143433764|NCT02604342|517134542|FG001|Overall Study|Physician Decision|0|||
143433765|NCT02024750|517134543|FG000|Overall Study|Withdrawal by Subject|2|||
143433766|NCT02024750|517134544|FG001|Overall Study|Withdrawal by Subject|1|||
143433767|NCT02261285|517134545|FG000|Overall Study|Disease progression|0|||
143433768|NCT02261285|517134546|FG001|Overall Study|Disease progression|0|||
143433769|NCT02261285|517134547|FG002|Overall Study|Disease progression|1|||
143433770|NCT01702519|517134548|FG000|Washout Period|Lost to Follow-up|1|||
143433771|NCT01702519|517134549|FG001|Washout Period|Lost to Follow-up|0|||
143433772|NCT01702519|517134548|FG000|Washout Period|Withdrawal by Subject|0|||
143433773|NCT01702519|517134549|FG001|Washout Period|Withdrawal by Subject|2|||
143433774|NCT00746356|517134556|FG000|Overall Study|Withdrawal by Subject|2|||
143433775|NCT00746356|517134557|FG001|Overall Study|Withdrawal by Subject|3|||
143433776|NCT00746356|517134556|FG000|Overall Study|Death|7|||
143433777|NCT00746356|517134557|FG001|Overall Study|Death|3|||
143433778|NCT00746356|517134556|FG000|Overall Study|Lost to Follow-up|1|||
143433779|NCT00746356|517134557|FG001|Overall Study|Lost to Follow-up|0|||
143433780|NCT00746356|517134556|FG000|Overall Study|Removal of Device|0|||
143433781|NCT00746356|517134557|FG001|Overall Study|Removal of Device|1|||
143433782|NCT00746356|517134556|FG000|Overall Study|Patient relocated|1|||
143433783|NCT00746356|517134557|FG001|Overall Study|Patient relocated|0|||
143433784|NCT01263925|517134558|FG000|Overall Study|Protocol Violation|1|||
143433785|NCT01263925|517134559|FG001|Overall Study|Protocol Violation|0|||
143433786|NCT01263925|517134558|FG000|Overall Study|Lack of Efficacy|0|||
143433787|NCT01263925|517134559|FG001|Overall Study|Lack of Efficacy|1|||
143433788|NCT01263925|517134558|FG000|Overall Study|Adverse Event|23|||
143433789|NCT01263925|517134559|FG001|Overall Study|Adverse Event|22|||
143433790|NCT01263925|517134558|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
143433791|NCT01263925|517134559|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
143433792|NCT01263925|517134558|FG000|Overall Study|Withdrawal by Subject|6|||
143433793|NCT01263925|517134559|FG001|Overall Study|Withdrawal by Subject|8|||
143433794|NCT01263925|517134558|FG000|Overall Study|Other|4|||
143433795|NCT01263925|517134559|FG001|Overall Study|Other|4|||
143433796|NCT01263925|517134558|FG000|Overall Study|Lost to Follow-up|3|||
143433797|NCT01263925|517134559|FG001|Overall Study|Lost to Follow-up|1|||
143433798|NCT01263925|517134558|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
143433799|NCT01263925|517134559|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
143433800|NCT01263925|517134558|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
143433801|NCT01263925|517134559|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
143433802|NCT01263925|517134558|FG000|Overall Study|AE/ Withdrawal|1|||
143433803|NCT01263925|517134559|FG001|Overall Study|AE/ Withdrawal|4|||
143433804|NCT01263925|517134558|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
143433805|NCT01263925|517134559|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
143433806|NCT01263925|517134558|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
143433807|NCT01263925|517134559|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
143433808|NCT01263925|517134558|FG000|Overall Study|Withdrawal/ Not specified|0|||
143433809|NCT01263925|517134559|FG001|Overall Study|Withdrawal/ Not specified|1|||
143433810|NCT01665599|517134560|FG000|Overall Study|Adverse Event|1|||
143433811|NCT01665599|517134560|FG000|Overall Study|Consent Withdrawn|1|||
143433812|NCT01665599|517134560|FG000|Overall Study|Investigator/Sponsor decision|1|||
143433813|NCT01665599|517134560|FG000|Overall Study|Death|1|||
143433814|NCT01665599|517134560|FG000|Overall Study|Lost to Follow-up|2|||
143433815|NCT01665599|517134560|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
143433816|NCT01665599|517134560|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
143433817|NCT01225159|517134561|FG000|Overall Study|Change operation|1|||
143433818|NCT01225159|517134562|FG001|Overall Study|Change operation|0|||
143433819|NCT04088136|517134563|FG000|Overall Study|Withdrawal by Subject|5|||
143433820|NCT04088136|517134564|FG001|Overall Study|Withdrawal by Subject|0|||
143433821|NCT04088136|517134563|FG000|Overall Study|Lack of Efficacy|0|||
143433822|NCT04088136|517134564|FG001|Overall Study|Lack of Efficacy|1|||
143433823|NCT01177228|517134565|FG000|Overall Study|Positive tuberculosis test|0|||
143433824|NCT01177228|517134566|FG001|Overall Study|Positive tuberculosis test|1|||
143433825|NCT01177228|517134567|FG002|Overall Study|Positive tuberculosis test|0|||
143433826|NCT01177228|517134568|FG003|Overall Study|Positive tuberculosis test|0|||
143433827|NCT01177228|517134565|FG000|Overall Study|Worsening disease activity|1|||
143433828|NCT01177228|517134566|FG001|Overall Study|Worsening disease activity|0|||
143433829|NCT01177228|517134567|FG002|Overall Study|Worsening disease activity|0|||
143433830|NCT01177228|517134568|FG003|Overall Study|Worsening disease activity|0|||
143433831|NCT01177228|517134565|FG000|Overall Study|Withdrawal by Subject|0|||
143433832|NCT01177228|517134566|FG001|Overall Study|Withdrawal by Subject|1|||
143433833|NCT01177228|517134567|FG002|Overall Study|Withdrawal by Subject|0|||
143433834|NCT01177228|517134568|FG003|Overall Study|Withdrawal by Subject|0|||
143433835|NCT00356759|517134569|FG000|Overall Study|Death|5|||
143433836|NCT00356759|517134570|FG001|Overall Study|Death|2|||
143433837|NCT00356759|517134569|FG000|Overall Study|Withdrawal by Subject|2|||
143433838|NCT00356759|517134570|FG001|Overall Study|Withdrawal by Subject|2|||
143433839|NCT00356759|517134569|FG000|Overall Study|Adverse Event|1|||
143433840|NCT00356759|517134570|FG001|Overall Study|Adverse Event|3|||
143433841|NCT00356759|517134569|FG000|Overall Study|Lost to Follow-up|1|||
143433842|NCT00356759|517134570|FG001|Overall Study|Lost to Follow-up|1|||
143433843|NCT00356759|517134569|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
143433844|NCT00356759|517134570|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
143433845|NCT01494298|517134571|FG000|Overall Study|Protocol Violation|2|||
143433846|NCT01494298|517134572|FG001|Overall Study|Protocol Violation|8|||
143433847|NCT04159805|517134573|FG000|Overall Study|Withdrawal by Subject|0|||
143433848|NCT04159805|517134574|FG001|Overall Study|Withdrawal by Subject|2|||
143433849|NCT04159805|517134575|FG002|Overall Study|Withdrawal by Subject|2|||
143433850|NCT01393613|517134576|FG000|Overall Study|Adverse Event|11|||
143433851|NCT01393613|517134577|FG001|Overall Study|Adverse Event|11|||
143433852|NCT01393613|517134578|FG002|Overall Study|Adverse Event|13|||
143433853|NCT01393613|517134579|FG003|Overall Study|Adverse Event|22|||
143433854|NCT01393613|517134576|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
143433855|NCT01393613|517134577|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
143433856|NCT01393613|517134578|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
143433857|NCT01393613|517134579|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
143433858|NCT01393613|517134576|FG000|Overall Study|Physician Decision|2|||
143433859|NCT01393613|517134577|FG001|Overall Study|Physician Decision|0|||
143433860|NCT01393613|517134578|FG002|Overall Study|Physician Decision|0|||
143433861|NCT01393613|517134579|FG003|Overall Study|Physician Decision|1|||
143433862|NCT01393613|517134576|FG000|Overall Study|Withdrawal by Subject|15|||
143433863|NCT01393613|517134577|FG001|Overall Study|Withdrawal by Subject|25|||
143433864|NCT01393613|517134578|FG002|Overall Study|Withdrawal by Subject|23|||
143433865|NCT01393613|517134579|FG003|Overall Study|Withdrawal by Subject|21|||
143433866|NCT01393613|517134576|FG000|Overall Study|Protocol Deviation|2|||
143433867|NCT01393613|517134577|FG001|Overall Study|Protocol Deviation|1|||
143433868|NCT01393613|517134578|FG002|Overall Study|Protocol Deviation|0|||
143433869|NCT01393613|517134579|FG003|Overall Study|Protocol Deviation|0|||
143433870|NCT01393613|517134576|FG000|Overall Study|Lack of Efficacy|9|||
143433871|NCT01393613|517134577|FG001|Overall Study|Lack of Efficacy|20|||
143433872|NCT01393613|517134578|FG002|Overall Study|Lack of Efficacy|16|||
143433873|NCT01393613|517134579|FG003|Overall Study|Lack of Efficacy|21|||
143433874|NCT03821064|517134580|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
143433875|NCT02998918|517134583|FG000|Overall Study|Withdrawal by Subject|1|||
143433876|NCT02998918|517134584|FG001|Overall Study|Withdrawal by Subject|0|||
143433877|NCT00702520|517134587|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
143433878|NCT00702520|517134588|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
143433879|NCT00702520|517134589|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
143433880|NCT00702520|517134590|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
143433881|NCT00702520|517134587|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
143433882|NCT00702520|517134588|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
143433883|NCT00702520|517134589|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
143433884|NCT00702520|517134590|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
143433885|NCT00702520|517134587|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
143433886|NCT00702520|517134588|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
143433887|NCT00702520|517134589|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
143433888|NCT00702520|517134590|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
143433889|NCT00942188|517134591|FG000|Overall Study|Adverse Event|0|||
143433890|NCT00942188|517134592|FG001|Overall Study|Adverse Event|3|||
143433891|NCT00942188|517134593|FG002|Overall Study|Adverse Event|2|||
143433892|NCT00942188|517134594|FG003|Overall Study|Adverse Event|0|||
143433893|NCT00942188|517134591|FG000|Overall Study|Lack of Efficacy|0|||
143433894|NCT00942188|517134592|FG001|Overall Study|Lack of Efficacy|0|||
143433895|NCT00942188|517134593|FG002|Overall Study|Lack of Efficacy|0|||
143433896|NCT00942188|517134594|FG003|Overall Study|Lack of Efficacy|1|||
143433897|NCT00942188|517134591|FG000|Overall Study|Protocol Violation|1|||
143433898|NCT00942188|517134592|FG001|Overall Study|Protocol Violation|1|||
143433899|NCT00942188|517134593|FG002|Overall Study|Protocol Violation|0|||
143433900|NCT00942188|517134594|FG003|Overall Study|Protocol Violation|0|||
143433901|NCT00942188|517134591|FG000|Overall Study|Lost to Follow-up|2|||
143433902|NCT00942188|517134592|FG001|Overall Study|Lost to Follow-up|1|||
143433903|NCT00942188|517134593|FG002|Overall Study|Lost to Follow-up|2|||
143433904|NCT00942188|517134594|FG003|Overall Study|Lost to Follow-up|0|||
143433905|NCT00942188|517134591|FG000|Overall Study|Withdrawal by Subject|1|||
143433906|NCT00942188|517134592|FG001|Overall Study|Withdrawal by Subject|3|||
143433907|NCT00942188|517134593|FG002|Overall Study|Withdrawal by Subject|4|||
143433908|NCT00942188|517134594|FG003|Overall Study|Withdrawal by Subject|2|||
143433909|NCT00942188|517134591|FG000|Overall Study|Physician Decision|0|||
143433910|NCT00942188|517134592|FG001|Overall Study|Physician Decision|0|||
143433911|NCT00942188|517134593|FG002|Overall Study|Physician Decision|1|||
143433912|NCT00942188|517134594|FG003|Overall Study|Physician Decision|0|||
143433913|NCT00942188|517134591|FG000|Overall Study|Sponsor Decision|0|||
143433914|NCT00942188|517134592|FG001|Overall Study|Sponsor Decision|2|||
143433915|NCT00942188|517134593|FG002|Overall Study|Sponsor Decision|0|||
143433916|NCT00942188|517134594|FG003|Overall Study|Sponsor Decision|1|||
143433917|NCT02473913|517134596|FG000|Overall Study|Lost to Follow-up|3|||
143433918|NCT02473913|517134597|FG001|Overall Study|Lost to Follow-up|3|||
143433919|NCT04944784|517134606|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
143433920|NCT04944784|517134607|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
143433921|NCT04944784|517134608|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
143433922|NCT04944784|517134609|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
143433923|NCT04944784|517134606|FG000|Double-blind Period|Adverse Event|20|||
143433924|NCT04944784|517134607|FG001|Double-blind Period|Adverse Event|4|||
143433925|NCT04944784|517134608|FG002|Double-blind Period|Adverse Event|0|||
143433926|NCT04944784|517134609|FG003|Double-blind Period|Adverse Event|0|||
143433927|NCT04944784|517134606|FG000|Double-blind Period|Withdrawal by Subject|15|||
143433928|NCT04944784|517134607|FG001|Double-blind Period|Withdrawal by Subject|4|||
143433929|NCT04944784|517134608|FG002|Double-blind Period|Withdrawal by Subject|0|||
143433930|NCT04944784|517134609|FG003|Double-blind Period|Withdrawal by Subject|0|||
143433931|NCT04944784|517134606|FG000|Double-blind Period|Death|7|||
143433932|NCT04944784|517134607|FG001|Double-blind Period|Death|2|||
143433933|NCT04944784|517134608|FG002|Double-blind Period|Death|0|||
143433934|NCT04944784|517134609|FG003|Double-blind Period|Death|0|||
143433935|NCT04944784|517134606|FG000|Double-blind Period|Physician Decision|2|||
143433936|NCT04944784|517134607|FG001|Double-blind Period|Physician Decision|1|||
143433937|NCT04944784|517134608|FG002|Double-blind Period|Physician Decision|0|||
143433938|NCT04944784|517134609|FG003|Double-blind Period|Physician Decision|0|||
143433939|NCT04944784|517134606|FG000|Double-blind Period|Lack of Efficacy|0|||
143433940|NCT04944784|517134607|FG001|Double-blind Period|Lack of Efficacy|1|||
143433941|NCT04944784|517134608|FG002|Double-blind Period|Lack of Efficacy|0|||
143433942|NCT04944784|517134609|FG003|Double-blind Period|Lack of Efficacy|0|||
143433943|NCT04944784|517134606|FG000|Double-blind Period|Sponsor Request|2|||
143433944|NCT04944784|517134607|FG001|Double-blind Period|Sponsor Request|1|||
143433945|NCT04944784|517134608|FG002|Double-blind Period|Sponsor Request|0|||
143433946|NCT04944784|517134609|FG003|Double-blind Period|Sponsor Request|0|||
143433947|NCT04944784|517134606|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
143433948|NCT04944784|517134607|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
143433949|NCT04944784|517134608|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
143433950|NCT04944784|517134609|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
143433951|NCT04944784|517134606|FG000|Double-blind Period|Participant Choice|1|||
143433952|NCT04944784|517134607|FG001|Double-blind Period|Participant Choice|1|||
143433953|NCT04944784|517134608|FG002|Double-blind Period|Participant Choice|0|||
143433954|NCT04944784|517134609|FG003|Double-blind Period|Participant Choice|0|||
143433955|NCT04944784|517134606|FG000|Double-blind Period|Progressive Disease|2|||
143433956|NCT04944784|517134607|FG001|Double-blind Period|Progressive Disease|2|||
143433957|NCT04944784|517134608|FG002|Double-blind Period|Progressive Disease|0|||
143433958|NCT04944784|517134609|FG003|Double-blind Period|Progressive Disease|0|||
143433959|NCT04944784|517134606|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
143433960|NCT04944784|517134607|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
143433961|NCT04944784|517134608|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
143433962|NCT04944784|517134609|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
143433963|NCT04944784|517134606|FG000|Active Drug Period|Adverse Event|0|||
143433964|NCT04944784|517134607|FG001|Active Drug Period|Adverse Event|0|||
143433965|NCT04944784|517134608|FG002|Active Drug Period|Adverse Event|3|||
143433966|NCT04944784|517134609|FG003|Active Drug Period|Adverse Event|6|||
143433967|NCT04944784|517134606|FG000|Active Drug Period|Withdrawal by Subject|0|||
143433968|NCT04944784|517134607|FG001|Active Drug Period|Withdrawal by Subject|0|||
143433969|NCT04944784|517134608|FG002|Active Drug Period|Withdrawal by Subject|4|||
143433970|NCT04944784|517134609|FG003|Active Drug Period|Withdrawal by Subject|7|||
143433971|NCT04944784|517134606|FG000|Active Drug Period|Death|0|||
143433972|NCT04944784|517134607|FG001|Active Drug Period|Death|0|||
143433973|NCT04944784|517134608|FG002|Active Drug Period|Death|3|||
143433974|NCT04944784|517134609|FG003|Active Drug Period|Death|4|||
143433975|NCT04944784|517134606|FG000|Active Drug Period|Lack of Efficacy|0|||
143433976|NCT04944784|517134607|FG001|Active Drug Period|Lack of Efficacy|0|||
143433977|NCT04944784|517134608|FG002|Active Drug Period|Lack of Efficacy|2|||
143433978|NCT04944784|517134609|FG003|Active Drug Period|Lack of Efficacy|2|||
143433979|NCT04944784|517134606|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
143433980|NCT04944784|517134607|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
143433981|NCT04944784|517134608|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
143433982|NCT04944784|517134609|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
143433983|NCT04944784|517134606|FG000|Active Drug Period|Participant Choice|0|||
143433984|NCT04944784|517134607|FG001|Active Drug Period|Participant Choice|0|||
143433985|NCT04944784|517134608|FG002|Active Drug Period|Participant Choice|0|||
143433986|NCT04944784|517134609|FG003|Active Drug Period|Participant Choice|1|||
143433987|NCT04944784|517134606|FG000|Active Drug Period|Progressive Disease|0|||
143433988|NCT04944784|517134607|FG001|Active Drug Period|Progressive Disease|0|||
143433989|NCT04944784|517134608|FG002|Active Drug Period|Progressive Disease|4|||
143433990|NCT04944784|517134609|FG003|Active Drug Period|Progressive Disease|4|||
143433991|NCT04944784|517134606|FG000|Active Drug Period|Lost to Follow-up|0|||
143433992|NCT04944784|517134607|FG001|Active Drug Period|Lost to Follow-up|0|||
143433993|NCT04944784|517134608|FG002|Active Drug Period|Lost to Follow-up|0|||
143433994|NCT04944784|517134609|FG003|Active Drug Period|Lost to Follow-up|1|||
143433995|NCT03614676|517136451|FG000|Overall Study|Delivery before planned visit|2|||
143433996|NCT03614676|517136452|FG001|Overall Study|Delivery before planned visit|0|||
143433997|NCT03614676|517136451|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
143433998|NCT03614676|517136452|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
143433999|NCT03614676|517136451|FG000|Overall Study|Migrated / moved from the study area|30|||
143434000|NCT03614676|517136452|FG001|Overall Study|Migrated / moved from the study area|22|||
143434001|NCT03614676|517136451|FG000|Overall Study|Lost to Follow-up|17|||
143434002|NCT03614676|517136452|FG001|Overall Study|Lost to Follow-up|42|||
143434003|NCT03614676|517136451|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
143434004|NCT03614676|517136452|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
143434005|NCT03614676|517136451|FG000|Overall Study|Other|16|||
143434006|NCT03614676|517136452|FG001|Overall Study|Other|47|||
143434007|NCT03614676|517136451|FG000|Overall Study|Protocol Violation|0|||
143434008|NCT03614676|517136452|FG001|Overall Study|Protocol Violation|2|||
143434009|NCT03614676|517136451|FG000|Overall Study|Neonatal event of interest|0|||
143434010|NCT03614676|517136452|FG001|Overall Study|Neonatal event of interest|6|||
143434011|NCT03614676|517136451|FG000|Overall Study|Death in infant greater than 28 days old|0|||
143434012|NCT03614676|517136452|FG001|Overall Study|Death in infant greater than 28 days old|12|||
143434013|NCT03614676|517136451|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
143434014|NCT03614676|517136452|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
143434015|NCT02080403|517136453|FG000|Overall Study|Adverse Event|5|||
143434016|NCT02080403|517136454|FG001|Overall Study|Adverse Event|1|||
143434017|NCT02080403|517136453|FG000|Overall Study|Death|0|||
143434018|NCT02080403|517136454|FG001|Overall Study|Death|2|||
143434019|NCT02080403|517136453|FG000|Overall Study|Lost to Follow-up|2|||
143434020|NCT02080403|517136454|FG001|Overall Study|Lost to Follow-up|0|||
143434021|NCT02080403|517136453|FG000|Overall Study|Pregnancy|0|||
143434022|NCT02080403|517136454|FG001|Overall Study|Pregnancy|1|||
143434023|NCT02080403|517136453|FG000|Overall Study|Protocol Violation|3|||
143434024|NCT02080403|517136454|FG001|Overall Study|Protocol Violation|7|||
143434025|NCT02080403|517136453|FG000|Overall Study|Withdrawal by Subject|5|||
143434026|NCT02080403|517136454|FG001|Overall Study|Withdrawal by Subject|1|||
143434027|NCT01999972|517136455|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
143434028|NCT01999972|517136456|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
143434029|NCT01999972|517136457|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
143434030|NCT01999972|517136458|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
143434031|NCT01999972|517136459|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
143434032|NCT01999972|517136460|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
143434033|NCT01999972|517136455|FG000|Dose Escalation Part|Death|0|||
143434034|NCT01999972|517136456|FG001|Dose Escalation Part|Death|1|||
143434035|NCT01999972|517136457|FG002|Dose Escalation Part|Death|0|||
143434036|NCT01999972|517136458|FG003|Dose Escalation Part|Death|0|||
143434037|NCT01999972|517136459|FG004|Dose Escalation Part|Death|0|||
143434038|NCT01999972|517136460|FG005|Dose Escalation Part|Death|0|||
143434039|NCT01999972|517136455|FG000|Dose Escalation Part|Enrolled but not treated|0|||
143434040|NCT01999972|517136456|FG001|Dose Escalation Part|Enrolled but not treated|0|||
143434041|NCT01999972|517136457|FG002|Dose Escalation Part|Enrolled but not treated|1|||
143434042|NCT01999972|517136458|FG003|Dose Escalation Part|Enrolled but not treated|1|||
143434043|NCT01999972|517136459|FG004|Dose Escalation Part|Enrolled but not treated|0|||
143434044|NCT01999972|517136460|FG005|Dose Escalation Part|Enrolled but not treated|0|||
143434045|NCT01999972|517136455|FG000|Dose Escalation Part|Disease progression|3|||
143434046|NCT01999972|517136456|FG001|Dose Escalation Part|Disease progression|2|||
143434047|NCT01999972|517136457|FG002|Dose Escalation Part|Disease progression|3|||
143434048|NCT01999972|517136458|FG003|Dose Escalation Part|Disease progression|6|||
143434049|NCT01999972|517136459|FG004|Dose Escalation Part|Disease progression|0|||
143434050|NCT01999972|517136460|FG005|Dose Escalation Part|Disease progression|0|||
143434051|NCT01999972|517136455|FG000|Dose Escalation Part|Adverse Event|0|||
143434052|NCT01999972|517136456|FG001|Dose Escalation Part|Adverse Event|0|||
143434053|NCT01999972|517136457|FG002|Dose Escalation Part|Adverse Event|0|||
143434054|NCT01999972|517136458|FG003|Dose Escalation Part|Adverse Event|2|||
143434055|NCT01999972|517136459|FG004|Dose Escalation Part|Adverse Event|0|||
143434056|NCT01999972|517136460|FG005|Dose Escalation Part|Adverse Event|0|||
143434057|NCT01999972|517136455|FG000|Dose Escalation Part|Global deterioration of health status|1|||
143434058|NCT01999972|517136456|FG001|Dose Escalation Part|Global deterioration of health status|0|||
143434059|NCT01999972|517136457|FG002|Dose Escalation Part|Global deterioration of health status|0|||
143434060|NCT01999972|517136458|FG003|Dose Escalation Part|Global deterioration of health status|1|||
143434061|NCT01999972|517136459|FG004|Dose Escalation Part|Global deterioration of health status|0|||
143434062|NCT01999972|517136460|FG005|Dose Escalation Part|Global deterioration of health status|0|||
143434063|NCT01999972|517136455|FG000|Dose Expansion Part|Death|0|||
143434064|NCT01999972|517136456|FG001|Dose Expansion Part|Death|0|||
143434065|NCT01999972|517136457|FG002|Dose Expansion Part|Death|0|||
143434066|NCT01999972|517136458|FG003|Dose Expansion Part|Death|0|||
143434067|NCT01999972|517136459|FG004|Dose Expansion Part|Death|2|||
143434068|NCT01999972|517136460|FG005|Dose Expansion Part|Death|1|||
143434069|NCT01999972|517136455|FG000|Dose Expansion Part|Disease progression|0|||
143434070|NCT01999972|517136456|FG001|Dose Expansion Part|Disease progression|0|||
143434071|NCT01999972|517136457|FG002|Dose Expansion Part|Disease progression|0|||
143434072|NCT01999972|517136458|FG003|Dose Expansion Part|Disease progression|0|||
143434073|NCT01999972|517136459|FG004|Dose Expansion Part|Disease progression|9|||
143434074|NCT01999972|517136460|FG005|Dose Expansion Part|Disease progression|3|||
143434075|NCT01999972|517136455|FG000|Dose Expansion Part|Sponsor decision|0|||
143434076|NCT01999972|517136456|FG001|Dose Expansion Part|Sponsor decision|0|||
143434077|NCT01999972|517136457|FG002|Dose Expansion Part|Sponsor decision|0|||
143434078|NCT01999972|517136458|FG003|Dose Expansion Part|Sponsor decision|0|||
143434079|NCT01999972|517136459|FG004|Dose Expansion Part|Sponsor decision|1|||
143434080|NCT01999972|517136460|FG005|Dose Expansion Part|Sponsor decision|0|||
143434081|NCT01999972|517136455|FG000|Dose Expansion Part|Adverse Event|0|||
143434082|NCT01999972|517136456|FG001|Dose Expansion Part|Adverse Event|0|||
143434083|NCT01999972|517136457|FG002|Dose Expansion Part|Adverse Event|0|||
143434084|NCT01999972|517136458|FG003|Dose Expansion Part|Adverse Event|0|||
143434085|NCT01999972|517136459|FG004|Dose Expansion Part|Adverse Event|4|||
143434086|NCT01999972|517136460|FG005|Dose Expansion Part|Adverse Event|2|||
143434087|NCT01999972|517136455|FG000|Dose Expansion Part|Participant's non-compliance|0|||
143434088|NCT01999972|517136456|FG001|Dose Expansion Part|Participant's non-compliance|0|||
143434089|NCT01999972|517136457|FG002|Dose Expansion Part|Participant's non-compliance|0|||
143434090|NCT01999972|517136458|FG003|Dose Expansion Part|Participant's non-compliance|0|||
143434091|NCT01999972|517136459|FG004|Dose Expansion Part|Participant's non-compliance|0|||
143434092|NCT01999972|517136460|FG005|Dose Expansion Part|Participant's non-compliance|1|||
143434093|NCT01999972|517136455|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
143434094|NCT01999972|517136456|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
143434095|NCT01999972|517136457|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
143434096|NCT01999972|517136458|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
143434097|NCT01999972|517136459|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
143434098|NCT01999972|517136460|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
143434099|NCT01999972|517136455|FG000|Dose Expansion Part|Changed to standard of care|0|||
143434100|NCT01999972|517136456|FG001|Dose Expansion Part|Changed to standard of care|0|||
143434101|NCT01999972|517136457|FG002|Dose Expansion Part|Changed to standard of care|0|||
143434102|NCT01999972|517136458|FG003|Dose Expansion Part|Changed to standard of care|0|||
143434103|NCT01999972|517136459|FG004|Dose Expansion Part|Changed to standard of care|1|||
143434104|NCT01999972|517136460|FG005|Dose Expansion Part|Changed to standard of care|0|||
143434105|NCT02210208|517136461|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
143434106|NCT02210208|517136461|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
143434107|NCT02210208|517136461|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
143434108|NCT01171183|517136462|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
143434109|NCT01171183|517136463|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
143434110|NCT01171183|517136462|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
143434111|NCT01171183|517136463|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
143434112|NCT01171183|517136462|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
143434113|NCT01171183|517136463|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
143434114|NCT01171183|517136462|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
143434115|NCT01171183|517136463|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
143434116|NCT01171183|517136462|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
143434117|NCT01171183|517136463|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
143434118|NCT01171183|517136462|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
143434119|NCT01171183|517136463|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
143434120|NCT01101334|517136464|FG000|Overall Study|Adverse Event|9|||
143434121|NCT01101334|517136465|FG001|Overall Study|Adverse Event|4|||
143434122|NCT01101334|517136464|FG000|Overall Study|Death|7|||
143434123|NCT01101334|517136465|FG001|Overall Study|Death|1|||
143434124|NCT01101334|517136464|FG000|Overall Study|Withdrawal by Subject|4|||
143434125|NCT01101334|517136465|FG001|Overall Study|Withdrawal by Subject|3|||
143434126|NCT01101334|517136464|FG000|Overall Study|Withdrawal by Sponsor|1|||
143434127|NCT01101334|517136465|FG001|Overall Study|Withdrawal by Sponsor|1|||
143434128|NCT01101334|517136464|FG000|Overall Study|Progressive Disease|22|||
143434129|NCT01101334|517136465|FG001|Overall Study|Progressive Disease|35|||
143434130|NCT01101334|517136464|FG000|Overall Study|Other|2|||
143434131|NCT01101334|517136465|FG001|Overall Study|Other|1|||
143434132|NCT02826798|517136472|FG000|Overall Study|Withdrawal by Subject|0|||
143434133|NCT02826798|517136473|FG001|Overall Study|Withdrawal by Subject|1|||
143434134|NCT02826798|517136474|FG002|Overall Study|Withdrawal by Subject|0|||
143434135|NCT02826798|517136475|FG003|Overall Study|Withdrawal by Subject|1|||
143434136|NCT02826798|517136476|FG004|Overall Study|Withdrawal by Subject|0|||
143434137|NCT02806505|517136477|FG000|Overall Study|Adverse event/intercurrent illness|1|||
143434138|NCT02806505|517136478|FG001|Overall Study|Adverse event/intercurrent illness|3|||
143434139|NCT02806505|517136477|FG000|Overall Study|Death|4|||
143434140|NCT02806505|517136478|FG001|Overall Study|Death|0|||
143434141|NCT02806505|517136477|FG000|Overall Study|Did not cooperate/refused treatment|3|||
143434142|NCT02806505|517136478|FG001|Overall Study|Did not cooperate/refused treatment|3|||
143434143|NCT02806505|517136477|FG000|Overall Study|Failure to return|0|||
143434144|NCT02806505|517136478|FG001|Overall Study|Failure to return|1|||
143434145|NCT02806505|517136477|FG000|Overall Study|Insufficient therapeutic response|2|||
143434146|NCT02806505|517136478|FG001|Overall Study|Insufficient therapeutic response|4|||
143434147|NCT03440047|517136480|FG000|Overall Study|Withdrawal by Subject|2|||
143434148|NCT01181609|517136481|FG000|Overall Study|Adverse Event|1|||
143434149|NCT01181609|517136481|FG000|Overall Study|Withdrawal by Subject|1|||
143434150|NCT01181609|517136481|FG000|Overall Study|Lost to Follow-up|1|||
143434151|NCT01181609|517136481|FG000|Overall Study|Death|50|||
143434152|NCT01722045|517136482|FG000|Overall Study|Adverse Event|8|||
143434153|NCT01722045|517136482|FG000|Overall Study|Death|3|||
143434154|NCT01722045|517136482|FG000|Overall Study|Withdrawal by Subject|8|||
143434155|NCT01722045|517136482|FG000|Overall Study|Lost to Follow-up|4|||
143434156|NCT01722045|517136482|FG000|Overall Study|Protocol Deviation|1|||
143434157|NCT01722045|517136482|FG000|Overall Study|Physician Decision|3|||
143434158|NCT01722045|517136482|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
143434159|NCT00612352|517136483|FG000|Overall Study|Adverse Event|1|||
143434160|NCT00612352|517136484|FG001|Overall Study|Adverse Event|0|||
143434161|NCT00612352|517136483|FG000|Overall Study|Withdrawal by Subject|3|||
143434162|NCT00612352|517136484|FG001|Overall Study|Withdrawal by Subject|5|||
143434163|NCT00612352|517136483|FG000|Overall Study|moved out of state|1|||
143434164|NCT00612352|517136484|FG001|Overall Study|moved out of state|0|||
143434165|NCT00612352|517136483|FG000|Overall Study|didn't return calls/show up on test date|4|||
143434166|NCT00612352|517136484|FG001|Overall Study|didn't return calls/show up on test date|1|||
143434167|NCT02161406|517136485|FG000|Overall Study|Death|2|||
143434168|NCT02161406|517136486|FG001|Overall Study|Death|1|||
143434169|NCT02161406|517136485|FG000|Overall Study|Lost to Follow-up|2|||
143434170|NCT02161406|517136486|FG001|Overall Study|Lost to Follow-up|1|||
143434171|NCT02161406|517136485|FG000|Overall Study|Withdrawal by Subject|2|||
143434172|NCT02161406|517136486|FG001|Overall Study|Withdrawal by Subject|4|||
143434173|NCT02161406|517136485|FG000|Overall Study|investigator withdrew subject|3|||
143434174|NCT02161406|517136486|FG001|Overall Study|investigator withdrew subject|1|||
143434175|NCT02161406|517136485|FG000|Overall Study|Lack of Efficacy|1|||
143434176|NCT02161406|517136486|FG001|Overall Study|Lack of Efficacy|1|||
143434177|NCT02161406|517136485|FG000|Overall Study|relocation|0|||
143434178|NCT02161406|517136486|FG001|Overall Study|relocation|1|||
143434179|NCT04732871|517136489|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
143434180|NCT04732871|517136490|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
143434181|NCT04732871|517136491|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
143434182|NCT04732871|517136489|FG000|Overall Study|Lost to Follow-up|7|||
143434183|NCT04732871|517136490|FG001|Overall Study|Lost to Follow-up|4|||
143434184|NCT04732871|517136491|FG002|Overall Study|Lost to Follow-up|3|||
143434185|NCT04732871|517136489|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
143434186|NCT04732871|517136490|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
143434187|NCT04732871|517136491|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
143434188|NCT04732871|517136489|FG000|Overall Study|Migrated / moved from the study area|5|||
143434189|NCT04732871|517136490|FG001|Overall Study|Migrated / moved from the study area|0|||
143434190|NCT04732871|517136491|FG002|Overall Study|Migrated / moved from the study area|0|||
143434191|NCT04732871|517136489|FG000|Overall Study|Other|1|||
143434192|NCT04732871|517136490|FG001|Overall Study|Other|0|||
143434193|NCT04732871|517136491|FG002|Overall Study|Other|1|||
143434194|NCT04732871|517136489|FG000|Overall Study|Ongoing|6|||
143434195|NCT04732871|517136490|FG001|Overall Study|Ongoing|0|||
143434196|NCT04732871|517136491|FG002|Overall Study|Ongoing|1|||
143434197|NCT04732871|517136489|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
143434198|NCT04732871|517136490|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
143434199|NCT04732871|517136491|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
143434200|NCT00263211|517136492|FG000|Overall Study|Death|1|||
143434201|NCT00263211|517136493|FG001|Overall Study|Death|0|||
143434202|NCT00263211|517136492|FG000|Overall Study|Withdrawal by Subject|3|||
143434203|NCT00263211|517136493|FG001|Overall Study|Withdrawal by Subject|0|||
143434204|NCT00263211|517136492|FG000|Overall Study|Protocol Violation|1|||
143434205|NCT00263211|517136493|FG001|Overall Study|Protocol Violation|0|||
143434206|NCT00263211|517136492|FG000|Overall Study|Disease Progression|0|||
143434207|NCT00263211|517136493|FG001|Overall Study|Disease Progression|1|||
143434208|NCT02034162|517136494|FG000|Double-blind|Lost to Follow-up|3|||
143434209|NCT02034162|517136495|FG001|Double-blind|Lost to Follow-up|0|||
143434210|NCT02034162|517136496|FG002|Double-blind|Lost to Follow-up|0|||
143434211|NCT02034162|517136494|FG000|Double-blind|Physician Decision|1|||
143434212|NCT02034162|517136495|FG001|Double-blind|Physician Decision|0|||
143434213|NCT02034162|517136496|FG002|Double-blind|Physician Decision|0|||
143434214|NCT02034162|517136494|FG000|Double-blind|Protocol Violation|0|||
143434215|NCT02034162|517136495|FG001|Double-blind|Protocol Violation|1|||
143434216|NCT02034162|517136496|FG002|Double-blind|Protocol Violation|0|||
143434217|NCT02034162|517136494|FG000|Double-blind|Withdrawal by Subject|5|||
143434218|NCT02034162|517136495|FG001|Double-blind|Withdrawal by Subject|7|||
143434219|NCT02034162|517136496|FG002|Double-blind|Withdrawal by Subject|0|||
143434220|NCT00760513|517136497|FG000|Overall Study|Withdrawal by Subject|5|||
143434221|NCT00760513|517136498|FG001|Overall Study|Withdrawal by Subject|7|||
143434222|NCT03458728|517136504|FG000|Overall Study|Adverse Event|1|||
143434223|NCT03458728|517136505|FG001|Overall Study|Adverse Event|0|||
143434224|NCT03458728|517136504|FG000|Overall Study|Physician Decision|1|||
143434225|NCT03458728|517136505|FG001|Overall Study|Physician Decision|0|||
143434226|NCT03458728|517136504|FG000|Overall Study|Progressive disease - clinical assessment|1|||
143434227|NCT03458728|517136505|FG001|Overall Study|Progressive disease - clinical assessment|0|||
143434228|NCT03458728|517136504|FG000|Overall Study|Progressive disease - radiological progression|21|||
143434229|NCT03458728|517136505|FG001|Overall Study|Progressive disease - radiological progression|6|||
143434230|NCT03458728|517136504|FG000|Overall Study|Withdrawal by Subject|0|||
143434231|NCT03458728|517136505|FG001|Overall Study|Withdrawal by Subject|1|||
143434232|NCT00908349|517136511|FG000|Overall Study|Adverse Event|10|||
143434233|NCT00908349|517136511|FG000|Overall Study|Withdrawal by Subject|9|||
143434234|NCT00908349|517136511|FG000|Overall Study|Physician Decision|5|||
143434235|NCT00908349|517136511|FG000|Overall Study|Lost to Follow-up|5|||
143434236|NCT00908349|517136511|FG000|Overall Study|Various|6|||
143434237|NCT03602586|517136513|FG000|Overall Study|Withdrawal by Subject|3|||
143434238|NCT00511836|517136516|FG000|Double-blind Period|Lost to Follow-up|1|||
143434239|NCT00511836|517136517|FG001|Double-blind Period|Lost to Follow-up|0|||
143434240|NCT01755546|517136521|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
143434241|NCT01755546|517136521|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
143434242|NCT01755546|517136521|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
143434243|NCT01755546|517136521|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
143434244|NCT01755546|517136521|FG000|Titration Phase|Adverse Event|11|||
143434245|NCT01755546|517136521|FG000|Titration Phase|Lack of Efficacy|18|||
143434246|NCT01755546|517136521|FG000|Titration Phase|Protocol Violation|9|||
143434247|NCT01755546|517136521|FG000|Titration Phase|Lost to Follow-up|2|||
143434248|NCT01755546|517136521|FG000|Titration Phase|Other and Continuing|22|||
143434249|NCT01755546|517136521|FG000|Titration Phase|Withdrawal by Subject|8|||
143434250|NCT01755546|517136521|FG000|Long Term Treatment|Adverse Event|12|||
143434251|NCT01755546|517136521|FG000|Long Term Treatment|Lack of Efficacy|6|||
143434252|NCT01755546|517136521|FG000|Long Term Treatment|Protocol Violation|10|||
143434253|NCT01755546|517136521|FG000|Long Term Treatment|Withdrawal by Subject|35|||
143434254|NCT01755546|517136521|FG000|Long Term Treatment|Lost to Follow-up|17|||
143434255|NCT01755546|517136521|FG000|Long Term Treatment|other and ongoing|41|||
143434256|NCT00891046|517136526|FG000|Overall Study|Protocol Violation|1|||
143434257|NCT00891046|517136527|FG001|Overall Study|Protocol Violation|1|||
143434258|NCT00891046|517136528|FG002|Overall Study|Protocol Violation|0|||
143434259|NCT00891046|517136529|FG003|Overall Study|Protocol Violation|0|||
143434260|NCT00891046|517136530|FG004|Overall Study|Protocol Violation|1|||
143434261|NCT00891046|517136526|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
143434262|NCT00891046|517136527|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
143434263|NCT00891046|517136528|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
143434264|NCT00891046|517136529|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
143434265|NCT00891046|517136530|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
143434266|NCT00891046|517136526|FG000|Overall Study|Administrative problems|0|||
143434267|NCT00891046|517136527|FG001|Overall Study|Administrative problems|0|||
143434268|NCT00891046|517136528|FG002|Overall Study|Administrative problems|0|||
143434269|NCT00891046|517136529|FG003|Overall Study|Administrative problems|0|||
143434270|NCT00891046|517136530|FG004|Overall Study|Administrative problems|1|||
143434271|NCT00891046|517136526|FG000|Overall Study|Participant no longer required drug|0|||
143434272|NCT00891046|517136527|FG001|Overall Study|Participant no longer required drug|2|||
143434273|NCT00891046|517136528|FG002|Overall Study|Participant no longer required drug|0|||
143434274|NCT00891046|517136529|FG003|Overall Study|Participant no longer required drug|0|||
143434275|NCT00891046|517136530|FG004|Overall Study|Participant no longer required drug|1|||
143434276|NCT00891046|517136526|FG000|Overall Study|Adverse Event|4|||
143434277|NCT00891046|517136527|FG001|Overall Study|Adverse Event|3|||
143434278|NCT00891046|517136528|FG002|Overall Study|Adverse Event|2|||
143434279|NCT00891046|517136529|FG003|Overall Study|Adverse Event|0|||
143434280|NCT00891046|517136530|FG004|Overall Study|Adverse Event|14|||
143434281|NCT00891046|517136526|FG000|Overall Study|Withdrawal by Subject|2|||
143434282|NCT00891046|517136527|FG001|Overall Study|Withdrawal by Subject|1|||
143434283|NCT00891046|517136528|FG002|Overall Study|Withdrawal by Subject|2|||
143434284|NCT00891046|517136529|FG003|Overall Study|Withdrawal by Subject|1|||
143434285|NCT00891046|517136530|FG004|Overall Study|Withdrawal by Subject|1|||
143434286|NCT00891046|517136526|FG000|Overall Study|Lost to Follow-up|0|||
143434287|NCT00891046|517136527|FG001|Overall Study|Lost to Follow-up|0|||
143434288|NCT00891046|517136528|FG002|Overall Study|Lost to Follow-up|0|||
143434289|NCT00891046|517136529|FG003|Overall Study|Lost to Follow-up|0|||
143434290|NCT00891046|517136530|FG004|Overall Study|Lost to Follow-up|1|||
143434291|NCT04333147|517136531|FG000|Overall Study|Adverse Event|43|||
143434292|NCT04333147|517136532|FG001|Overall Study|Adverse Event|40|||
143434293|NCT04333147|517136531|FG000|Overall Study|Lack of Efficacy|49|||
143434294|NCT04333147|517136532|FG001|Overall Study|Lack of Efficacy|48|||
143434295|NCT04333147|517136531|FG000|Overall Study|Lost to Follow-up|19|||
143434296|NCT04333147|517136532|FG001|Overall Study|Lost to Follow-up|16|||
143434297|NCT04333147|517136531|FG000|Overall Study|Physician Decision|17|||
143434298|NCT04333147|517136532|FG001|Overall Study|Physician Decision|20|||
143434299|NCT04333147|517136531|FG000|Overall Study|Withdrawal by Subject|65|||
143434300|NCT04333147|517136532|FG001|Overall Study|Withdrawal by Subject|68|||
143434301|NCT04333147|517136531|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
143434302|NCT04333147|517136532|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
143434303|NCT04333147|517136531|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
143434304|NCT04333147|517136532|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
143434305|NCT04333147|517136531|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
143434306|NCT04333147|517136532|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
143434307|NCT00362375|517136533|FG000|Overall Study|Lost to Follow-up|40|||
143434308|NCT00362375|517136534|FG001|Overall Study|Lost to Follow-up|35|||
143434309|NCT02106195|517136535|FG000|Overall Study|Adverse Event|2|||
143434310|NCT02106195|517136535|FG000|Overall Study|Protocol Violation|1|||
143434311|NCT04984239|517136536|FG000|Overall Study|Lost to Follow-up|1|||
143434312|NCT01114139|517136539|FG000|Overall Study|Adverse Event|3|||
143434313|NCT01114139|517136540|FG001|Overall Study|Adverse Event|2|||
143434314|NCT01114139|517136539|FG000|Overall Study|Lost to Follow-up|15|||
143434315|NCT01114139|517136540|FG001|Overall Study|Lost to Follow-up|3|||
143434316|NCT01114139|517136539|FG000|Overall Study|Withdrawal by Subject|17|||
143434317|NCT01114139|517136540|FG001|Overall Study|Withdrawal by Subject|6|||
143434318|NCT01114139|517136539|FG000|Overall Study|Other-Missed 1 visit|1|||
143434319|NCT01114139|517136540|FG001|Overall Study|Other-Missed 1 visit|0|||
143434320|NCT01114139|517136539|FG000|Overall Study|Other-Protocol Violation|1|||
143434321|NCT01114139|517136540|FG001|Overall Study|Other-Protocol Violation|0|||
143434322|NCT01114139|517136539|FG000|Overall Study|Other-Out of window for study drug dose|1|||
143434323|NCT01114139|517136540|FG001|Overall Study|Other-Out of window for study drug dose|0|||
143434324|NCT01114139|517136539|FG000|Overall Study|Other-Participant falsified records|0|||
143434325|NCT01114139|517136540|FG001|Overall Study|Other-Participant falsified records|1|||
143434326|NCT01114139|517136539|FG000|Overall Study|Other-Participant went on hospice|0|||
143434327|NCT01114139|517136540|FG001|Overall Study|Other-Participant went on hospice|1|||
143434328|NCT01114139|517136539|FG000|Overall Study|Other-Physician changed treatment|1|||
143434329|NCT01114139|517136540|FG001|Overall Study|Other-Physician changed treatment|0|||
143434330|NCT01114139|517136539|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
143434331|NCT01114139|517136540|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
143434332|NCT02536742|517136542|FG000|Overall Study|Did not start protocol therapy|1|||
143434333|NCT02536742|517136542|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
143434334|NCT00706914|517136543|FG000|Overall Study|Lack of Efficacy|0|||
143434335|NCT00706914|517136544|FG001|Overall Study|Lack of Efficacy|1|||
143434336|NCT00706914|517136545|FG002|Overall Study|Lack of Efficacy|0|||
143434337|NCT00706914|517136543|FG000|Overall Study|Lost to Follow-up|1|||
143434338|NCT00706914|517136544|FG001|Overall Study|Lost to Follow-up|0|||
143434339|NCT00706914|517136545|FG002|Overall Study|Lost to Follow-up|0|||
143434340|NCT00706914|517136543|FG000|Overall Study|Adverse Event|2|||
143434341|NCT00706914|517136544|FG001|Overall Study|Adverse Event|2|||
143434342|NCT00706914|517136545|FG002|Overall Study|Adverse Event|0|||
143434343|NCT00706914|517136543|FG000|Overall Study|Protocol Violation|3|||
143434344|NCT00706914|517136544|FG001|Overall Study|Protocol Violation|1|||
143434345|NCT00706914|517136545|FG002|Overall Study|Protocol Violation|1|||
143434346|NCT04629443|517136546|FG000|Overall Study|Adverse Event|2|||
143434347|NCT04629443|517136547|FG001|Overall Study|Adverse Event|1|||
143434348|NCT04629443|517136548|FG002|Overall Study|Adverse Event|2|||
143434349|NCT04629443|517136546|FG000|Overall Study|Progressive Disease|2|||
143434350|NCT04629443|517136547|FG001|Overall Study|Progressive Disease|3|||
143434351|NCT04629443|517136548|FG002|Overall Study|Progressive Disease|3|||
143434352|NCT04629443|517136546|FG000|Overall Study|Physician Decision|1|||
143434353|NCT04629443|517136547|FG001|Overall Study|Physician Decision|3|||
143434354|NCT04629443|517136548|FG002|Overall Study|Physician Decision|0|||
143434355|NCT00858247|517136555|FG000|Baseline Assessment|Withdrawal by Subject|1|||
143434356|NCT00858247|517136556|FG001|Baseline Assessment|Withdrawal by Subject|1|||
143434357|NCT00858247|517136555|FG000|Baseline Assessment|Poor IV access|1|||
143434358|NCT00858247|517136556|FG001|Baseline Assessment|Poor IV access|0|||
143434359|NCT00858247|517136555|FG000|Baseline Assessment|Protocol Violation|0|||
143434360|NCT00858247|517136556|FG001|Baseline Assessment|Protocol Violation|1|||
143434361|NCT00858247|517136555|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
143434362|NCT00858247|517136556|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
143434363|NCT01172639|517136557|FG000|Overall Study|Death|1|||
143434364|NCT01172639|517136558|FG001|Overall Study|Death|1|||
143434365|NCT01172639|517136559|FG002|Overall Study|Death|0|||
143434366|NCT01172639|517136560|FG003|Overall Study|Death|0|||
143434367|NCT01172639|517136561|FG004|Overall Study|Death|0|||
143434368|NCT01172639|517136557|FG000|Overall Study|Lost to Follow-up|9|||
143434369|NCT01172639|517136558|FG001|Overall Study|Lost to Follow-up|7|||
143434370|NCT01172639|517136559|FG002|Overall Study|Lost to Follow-up|11|||
143434371|NCT01172639|517136560|FG003|Overall Study|Lost to Follow-up|6|||
143434372|NCT01172639|517136561|FG004|Overall Study|Lost to Follow-up|6|||
143434373|NCT01172639|517136557|FG000|Overall Study|Withdrawal by Subject|3|||
143434374|NCT01172639|517136558|FG001|Overall Study|Withdrawal by Subject|3|||
143434375|NCT01172639|517136559|FG002|Overall Study|Withdrawal by Subject|5|||
143434376|NCT01172639|517136560|FG003|Overall Study|Withdrawal by Subject|5|||
143434377|NCT01172639|517136561|FG004|Overall Study|Withdrawal by Subject|0|||
143434378|NCT02447432|517136562|FG000|Epoch 001|Adverse Event|1|||
143434379|NCT02447432|517136563|FG001|Epoch 001|Adverse Event|1|||
143434380|NCT02447432|517136562|FG000|Epoch 001|Withdrawal by Subject|0|||
143434381|NCT02447432|517136563|FG001|Epoch 001|Withdrawal by Subject|4|||
143434382|NCT02447432|517136562|FG000|Epoch 001|Migrated/moved from study area|3|||
143434383|NCT02447432|517136563|FG001|Epoch 001|Migrated/moved from study area|5|||
143434384|NCT02447432|517136562|FG000|Epoch 001|Lost to Follow-up|1|||
143434385|NCT02447432|517136563|FG001|Epoch 001|Lost to Follow-up|3|||
143434386|NCT00002597|517136564|FG000|Overall Study|Protocol Violation|19|||
143434387|NCT00002597|517136565|FG001|Overall Study|Protocol Violation|17|||
143434388|NCT00002597|517136564|FG000|Overall Study|Withdrawal by Subject|7|||
143434389|NCT00002597|517136565|FG001|Overall Study|Withdrawal by Subject|6|||
143434390|NCT01891890|517136569|FG000|Overall Study|Lost to Follow-up|0|||
143434391|NCT01891890|517136570|FG001|Overall Study|Lost to Follow-up|0|||
143434392|NCT01891890|517136571|FG002|Overall Study|Lost to Follow-up|1|||
143434393|NCT01891890|517136569|FG000|Overall Study|Study ended before endpoint reached|7|||
143434394|NCT01891890|517136570|FG001|Overall Study|Study ended before endpoint reached|3|||
143434395|NCT01891890|517136571|FG002|Overall Study|Study ended before endpoint reached|6|||
143434396|NCT01161628|517136572|FG000|Overall Study|Death|6|||
143434397|NCT01161628|517136572|FG000|Overall Study|Lack of Efficacy|2|||
143434398|NCT03605368|517136578|FG000|Overall Study|Lost to Follow-up|2|||
143434399|NCT03605368|517136579|FG001|Overall Study|Lost to Follow-up|1|||
143434400|NCT03605368|517136580|FG002|Overall Study|Lost to Follow-up|3|||
143434401|NCT03605368|517136581|FG003|Overall Study|Lost to Follow-up|2|||
143434402|NCT03605368|517136578|FG000|Overall Study|Withdrawal by Subject|0|||
143434403|NCT03605368|517136579|FG001|Overall Study|Withdrawal by Subject|0|||
143434404|NCT03605368|517136580|FG002|Overall Study|Withdrawal by Subject|4|||
143434405|NCT03605368|517136581|FG003|Overall Study|Withdrawal by Subject|3|||
143434406|NCT01726517|517136582|FG000|Overall Study|Withdrawal by Subject|0|||
143434407|NCT01726517|517136583|FG001|Overall Study|Withdrawal by Subject|0|||
143434408|NCT01726517|517136584|FG002|Overall Study|Withdrawal by Subject|1|||
143434409|NCT01726517|517136585|FG003|Overall Study|Withdrawal by Subject|0|||
143434410|NCT01726517|517136586|FG004|Overall Study|Withdrawal by Subject|0|||
143434411|NCT03765164|517136587|FG000|Pre-intervention|Withdrawal by Subject|5|||
143434412|NCT03765164|517136588|FG001|Pre-intervention|Withdrawal by Subject|6|||
143434413|NCT03448536|517136589|FG000|Overall Study|Protocol Violation|2|||
143434414|NCT03448536|517136590|FG001|Overall Study|Protocol Violation|0|||
143434415|NCT03448536|517136589|FG000|Overall Study|Pregnancy|1|||
143434416|NCT03448536|517136590|FG001|Overall Study|Pregnancy|0|||
143434417|NCT03448536|517136589|FG000|Overall Study|Withdrawal by Subject|1|||
143434418|NCT03448536|517136590|FG001|Overall Study|Withdrawal by Subject|2|||
143434419|NCT03448536|517136589|FG000|Overall Study|Lost to Follow-up|3|||
143434420|NCT03448536|517136590|FG001|Overall Study|Lost to Follow-up|2|||
143434421|NCT03448536|517136589|FG000|Overall Study|Inadequate pain reporter|1|||
143434422|NCT03448536|517136590|FG001|Overall Study|Inadequate pain reporter|0|||
143434423|NCT03448536|517136589|FG000|Overall Study|Other|3|||
143434424|NCT03448536|517136590|FG001|Overall Study|Other|0|||
143434425|NCT03448536|517136589|FG000|Overall Study|Physician Decision|1|||
143434426|NCT03448536|517136590|FG001|Overall Study|Physician Decision|0|||
143434427|NCT04814992|517136594|FG000|Overall Study|Withdrawal by Subject|6|||
143434428|NCT04814992|517136595|FG001|Overall Study|Withdrawal by Subject|3|||
143434429|NCT04814992|517136594|FG000|Overall Study|Lost to Follow-up|1|||
143434430|NCT04814992|517136595|FG001|Overall Study|Lost to Follow-up|4|||
143434431|NCT01831726|517136598|FG000|Overall Study|Adverse Event|16|||
143434432|NCT01831726|517136598|FG000|Overall Study|Death|7|||
143434433|NCT01831726|517136598|FG000|Overall Study|Disease Progression|49|||
143434434|NCT01831726|517136598|FG000|Overall Study|Physician Decision|1|||
143434435|NCT01831726|517136598|FG000|Overall Study|Subject/guardian decision|7|||
143434436|NCT01568112|517136601|FG000|Overall Study|Randomized But Not Treated|0|||
143434437|NCT01568112|517136602|FG001|Overall Study|Randomized But Not Treated|1|||
143434438|NCT01568112|517136603|FG002|Overall Study|Randomized But Not Treated|0|||
143434439|NCT01568112|517136604|FG003|Overall Study|Randomized But Not Treated|0|||
143434440|NCT01568112|517136601|FG000|Overall Study|Withdrew due to Adverse Event|2|||
143434441|NCT01568112|517136602|FG001|Overall Study|Withdrew due to Adverse Event|4|||
143434442|NCT01568112|517136603|FG002|Overall Study|Withdrew due to Adverse Event|6|||
143434443|NCT01568112|517136604|FG003|Overall Study|Withdrew due to Adverse Event|3|||
143434444|NCT01568112|517136601|FG000|Overall Study|Lost to Follow-up|0|||
143434445|NCT01568112|517136602|FG001|Overall Study|Lost to Follow-up|0|||
143434446|NCT01568112|517136603|FG002|Overall Study|Lost to Follow-up|0|||
143434447|NCT01568112|517136604|FG003|Overall Study|Lost to Follow-up|1|||
143434448|NCT01568112|517136601|FG000|Overall Study|Withdrawal by Subject|2|||
143434449|NCT01568112|517136602|FG001|Overall Study|Withdrawal by Subject|3|||
143434450|NCT01568112|517136603|FG002|Overall Study|Withdrawal by Subject|0|||
143434451|NCT01568112|517136604|FG003|Overall Study|Withdrawal by Subject|7|||
143434452|NCT01568112|517136601|FG000|Overall Study|Withdrawal by Physician|1|||
143434453|NCT01568112|517136602|FG001|Overall Study|Withdrawal by Physician|0|||
143434454|NCT01568112|517136603|FG002|Overall Study|Withdrawal by Physician|1|||
143434455|NCT01568112|517136604|FG003|Overall Study|Withdrawal by Physician|1|||
143434456|NCT00497874|517138236|FG000|Overall Study|Withdrawal by Subject|48|||
143434457|NCT00497874|517138237|FG001|Overall Study|Withdrawal by Subject|17|||
143434458|NCT00497874|517138236|FG000|Overall Study|Illness|8|||
143434459|NCT00497874|517138237|FG001|Overall Study|Illness|4|||
143434460|NCT00497874|517138236|FG000|Overall Study|Death|2|||
143434461|NCT00497874|517138237|FG001|Overall Study|Death|4|||
143434462|NCT00497874|517138236|FG000|Overall Study|Unable to contact|52|||
143434463|NCT00497874|517138237|FG001|Overall Study|Unable to contact|67|||
143434464|NCT00497874|517138236|FG000|Overall Study|Unable to schedule|37|||
143434465|NCT00497874|517138237|FG001|Overall Study|Unable to schedule|24|||
143434466|NCT04009629|517138240|FG000|Overall Study|Withdrawal by Subject|2|||
143434467|NCT04009629|517138241|FG001|Overall Study|Withdrawal by Subject|0|||
143434468|NCT00761956|517138245|FG000|Overall Study|Lost to Follow-up|6|||
143434469|NCT00761956|517138246|FG001|Overall Study|Lost to Follow-up|11|||
143434470|NCT00761956|517138245|FG000|Overall Study|Withdrawal by Subject|3|||
143434471|NCT00761956|517138246|FG001|Overall Study|Withdrawal by Subject|8|||
143434472|NCT00761956|517138245|FG000|Overall Study|Death|0|||
143434473|NCT00761956|517138246|FG001|Overall Study|Death|1|||
143434474|NCT00761956|517138245|FG000|Overall Study|Adverse Event|26|||
143434475|NCT00761956|517138246|FG001|Overall Study|Adverse Event|34|||
143434476|NCT02808975|517138247|FG000|Overall Study|Adverse Event|3|||
143434477|NCT02808975|517138248|FG001|Overall Study|Adverse Event|4|||
143434478|NCT02808975|517138247|FG000|Overall Study|Withdrew consent|9|||
143434479|NCT02808975|517138248|FG001|Overall Study|Withdrew consent|8|||
143434480|NCT02808975|517138247|FG000|Overall Study|Lost to Follow-up|4|||
143434481|NCT02808975|517138248|FG001|Overall Study|Lost to Follow-up|6|||
143434482|NCT02808975|517138247|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
143434483|NCT02808975|517138248|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
143434484|NCT02808975|517138247|FG000|Overall Study|Other, not specified|5|||
143434485|NCT02808975|517138248|FG001|Overall Study|Other, not specified|1|||
143434486|NCT00030823|517138249|FG000|Overall Study|Withdrawal by Subject|1|||
143434487|NCT01951378|517138250|FG000|Overall Study|Study Terminated-Not completed|23|||
143434488|NCT01951378|517138251|FG001|Overall Study|Study Terminated-Not completed|17|||
143434489|NCT00543062|517138252|FG000|Overall Study|Withdrawal by Subject|1|||
143434490|NCT00543062|517138253|FG001|Overall Study|Withdrawal by Subject|0|||
143434491|NCT00543062|517138254|FG002|Overall Study|Withdrawal by Subject|2|||
143434492|NCT00543062|517138255|FG003|Overall Study|Withdrawal by Subject|0|||
143434493|NCT00543062|517138252|FG000|Overall Study|Adverse Event|0|||
143434494|NCT00543062|517138253|FG001|Overall Study|Adverse Event|1|||
143434495|NCT00543062|517138254|FG002|Overall Study|Adverse Event|1|||
143434496|NCT00543062|517138255|FG003|Overall Study|Adverse Event|1|||
143434497|NCT00543062|517138252|FG000|Overall Study|Protocol Violation|1|||
143434498|NCT00543062|517138253|FG001|Overall Study|Protocol Violation|0|||
143434499|NCT00543062|517138254|FG002|Overall Study|Protocol Violation|0|||
143434500|NCT00543062|517138255|FG003|Overall Study|Protocol Violation|0|||
143434501|NCT03927690|517138258|FG000|Overall Study|Withdrawal by Subject|3|||
143434502|NCT03927690|517138259|FG001|Overall Study|Withdrawal by Subject|1|||
143434503|NCT03927690|517138260|FG002|Overall Study|Withdrawal by Subject|1|||
143434504|NCT03927690|517138258|FG000|Overall Study|Adverse Event|1|||
143434505|NCT03927690|517138259|FG001|Overall Study|Adverse Event|0|||
143434506|NCT03927690|517138260|FG002|Overall Study|Adverse Event|0|||
143434507|NCT03927690|517138258|FG000|Overall Study|Death|1|||
143434508|NCT03927690|517138259|FG001|Overall Study|Death|0|||
143434509|NCT03927690|517138260|FG002|Overall Study|Death|0|||
143434510|NCT03927690|517138258|FG000|Overall Study|Lost to Follow-up|2|||
143434511|NCT03927690|517138259|FG001|Overall Study|Lost to Follow-up|2|||
143434512|NCT03927690|517138260|FG002|Overall Study|Lost to Follow-up|1|||
143434513|NCT01844726|517138267|FG000|Overall Study|Withdrawal by Subject|0|||
143434514|NCT01844726|517138268|FG001|Overall Study|Withdrawal by Subject|1|||
143434515|NCT01844726|517138267|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
143434516|NCT01844726|517138268|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
143434517|NCT03898960|517138271|FG000|Overall Study|Death|10|||
143434518|NCT04799418|517138272|FG000|Overall Study|Death|1|||
143434519|NCT04799418|517138273|FG001|Overall Study|Death|1|||
143434520|NCT04799418|517138272|FG000|Overall Study|Lack of Efficacy|14|||
143434521|NCT04799418|517138273|FG001|Overall Study|Lack of Efficacy|14|||
143434522|NCT04799418|517138272|FG000|Overall Study|Withdrawal by Subject|10|||
143434523|NCT04799418|517138273|FG001|Overall Study|Withdrawal by Subject|7|||
143434524|NCT04799418|517138272|FG000|Overall Study|Adverse Event|3|||
143434525|NCT04799418|517138273|FG001|Overall Study|Adverse Event|2|||
143434526|NCT00548847|517138274|FG000|Overall Study|Disease progression|7|||
143434527|NCT00853229|517138283|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
143434528|NCT00853229|517138284|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
143434529|NCT01664923|517138285|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
143434530|NCT01664923|517138286|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
143434531|NCT01664923|517138285|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
143434532|NCT01664923|517138286|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
143434533|NCT01664923|517138285|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
143434534|NCT01664923|517138286|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
143434535|NCT01664923|517138285|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
143434536|NCT01664923|517138286|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
143434537|NCT01664923|517138285|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
143434538|NCT01664923|517138286|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
143434539|NCT01664923|517138285|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
143434540|NCT01664923|517138286|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
143434541|NCT01664923|517138285|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
143434542|NCT01664923|517138286|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
143434543|NCT01664923|517138285|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
143434544|NCT01664923|517138286|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
143434545|NCT01664923|517138285|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
143434546|NCT01664923|517138286|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
143434547|NCT01664923|517138285|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
143434548|NCT01664923|517138286|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
143434549|NCT01664923|517138285|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
143434550|NCT01664923|517138286|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
143434551|NCT01664923|517138285|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
143434552|NCT01664923|517138286|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
143434553|NCT01664923|517138285|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
143434554|NCT01664923|517138286|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
143434555|NCT01664923|517138285|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
143434556|NCT01664923|517138286|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
143434557|NCT02586415|517138293|FG000|Overall Study|Death|13|||
143434558|NCT02586415|517138294|FG001|Overall Study|Death|23|||
143434559|NCT02586415|517138293|FG000|Overall Study|Lost to Follow-up|1|||
143434560|NCT02586415|517138294|FG001|Overall Study|Lost to Follow-up|2|||
143434561|NCT01898442|517138295|FG000|Overall Study|Hemolysis/technical problems|1|||
143434562|NCT01898442|517138296|FG001|Overall Study|Hemolysis/technical problems|2|||
143434563|NCT01898442|517138297|FG002|Overall Study|Hemolysis/technical problems|2|||
143434564|NCT01898442|517138295|FG000|Overall Study|Patient vomited pills|0|||
143434565|NCT01898442|517138296|FG001|Overall Study|Patient vomited pills|0|||
143434566|NCT01898442|517138297|FG002|Overall Study|Patient vomited pills|1|||
143434567|NCT03974100|517138298|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
143434568|NCT03974100|517138299|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
143434569|NCT03974100|517138300|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
143434570|NCT03974100|517138301|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
143434571|NCT03974100|517138302|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
143434572|NCT03974100|517138298|FG000|TP1 - Day 1 to Week 52|Death|1|||
143434573|NCT03974100|517138299|FG001|TP1 - Day 1 to Week 52|Death|0|||
143434574|NCT03974100|517138300|FG002|TP1 - Day 1 to Week 52|Death|0|||
143434575|NCT03974100|517138301|FG003|TP1 - Day 1 to Week 52|Death|0|||
143434576|NCT03974100|517138302|FG004|TP1 - Day 1 to Week 52|Death|0|||
143434577|NCT03974100|517138298|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
143434578|NCT03974100|517138299|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
143434579|NCT03974100|517138300|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
143434580|NCT03974100|517138301|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
143434581|NCT03974100|517138302|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
143434582|NCT03974100|517138298|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
143434583|NCT03974100|517138299|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
143434584|NCT03974100|517138300|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
143434585|NCT03974100|517138301|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
143434586|NCT03974100|517138302|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
143434587|NCT03974100|517138298|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
143434588|NCT03974100|517138299|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
143434589|NCT03974100|517138300|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
143434590|NCT03974100|517138301|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
143434591|NCT03974100|517138302|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
143434592|NCT03974100|517138298|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
143434593|NCT03974100|517138299|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
143434594|NCT03974100|517138300|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
143434595|NCT03974100|517138301|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
143434596|NCT03974100|517138302|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
143434597|NCT03974100|517138298|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
143434598|NCT03974100|517138299|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
143434599|NCT03974100|517138300|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
143434600|NCT03974100|517138301|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
143434601|NCT03974100|517138302|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
143434602|NCT00874497|517138303|FG000|Overall Study|Lost to Follow-up|2|||
143434603|NCT00874497|517138304|FG001|Overall Study|Lost to Follow-up|4|||
143434604|NCT00874497|517138303|FG000|Overall Study|Adverse Event|9|||
143434605|NCT00874497|517138304|FG001|Overall Study|Adverse Event|4|||
143434606|NCT00874497|517138303|FG000|Overall Study|Sponsor Discontinued Trial|7|||
143434607|NCT00874497|517138304|FG001|Overall Study|Sponsor Discontinued Trial|3|||
143434608|NCT00874497|517138303|FG000|Overall Study|Met Withdrawal Criteria|4|||
143434609|NCT00874497|517138304|FG001|Overall Study|Met Withdrawal Criteria|2|||
143434610|NCT00874497|517138303|FG000|Overall Study|Physician Decision|1|||
143434611|NCT00874497|517138304|FG001|Overall Study|Physician Decision|1|||
143434612|NCT00874497|517138303|FG000|Overall Study|Withdrawal by Subject|5|||
143434613|NCT00874497|517138304|FG001|Overall Study|Withdrawal by Subject|4|||
143434614|NCT01721746|517138305|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
143434615|NCT01721746|517138306|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
143434616|NCT01721746|517138305|FG000|Pre-Treatment|Withdrawal by Subject|1|||
143434617|NCT01721746|517138306|FG001|Pre-Treatment|Withdrawal by Subject|16|||
143434618|NCT01721746|517138305|FG000|Pre-Treatment|Poor/Non-compliance|1|||
143434619|NCT01721746|517138306|FG001|Pre-Treatment|Poor/Non-compliance|0|||
143434620|NCT01721746|517138305|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
143434621|NCT01721746|517138306|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
143434622|NCT01721746|517138305|FG000|Treatment|Disease Progression|192|||
143434623|NCT01721746|517138306|FG001|Treatment|Disease Progression|74|||
143434624|NCT01721746|517138305|FG000|Treatment|Study Drug Toxicity|19|||
143434625|NCT01721746|517138306|FG001|Treatment|Study Drug Toxicity|11|||
143434626|NCT01721746|517138305|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
143434627|NCT01721746|517138306|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
143434628|NCT01721746|517138305|FG000|Treatment|Participant request to discontinue Study treatment|26|||
143434629|NCT01721746|517138306|FG001|Treatment|Participant request to discontinue Study treatment|7|||
143434630|NCT01721746|517138305|FG000|Treatment|Participant withdrew consent|4|||
143434631|NCT01721746|517138306|FG001|Treatment|Participant withdrew consent|2|||
143434632|NCT01721746|517138305|FG000|Treatment|Maximum Clinical Benefit|9|||
143434633|NCT01721746|517138306|FG001|Treatment|Maximum Clinical Benefit|3|||
143434634|NCT01721746|517138305|FG000|Treatment|Poor/Non-compliance|2|||
143434635|NCT01721746|517138306|FG001|Treatment|Poor/Non-compliance|0|||
143434636|NCT01721746|517138305|FG000|Treatment|Participant no longer met Study criteria|4|||
143434637|NCT01721746|517138306|FG001|Treatment|Participant no longer met Study criteria|0|||
143434638|NCT01721746|517138305|FG000|Treatment|Other reasons|6|||
143434639|NCT01721746|517138306|FG001|Treatment|Other reasons|2|||
143434640|NCT00665223|517138309|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
143434641|NCT00665223|517138310|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
143434642|NCT00665223|517138311|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
143434643|NCT00665223|517138309|FG000|Randomized Phase (26 Weeks)|Death|0|||
143434644|NCT00665223|517138310|FG001|Randomized Phase (26 Weeks)|Death|0|||
143434645|NCT00665223|517138311|FG002|Randomized Phase (26 Weeks)|Death|1|||
143434646|NCT00665223|517138309|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
143434647|NCT00665223|517138310|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
143434648|NCT00665223|517138311|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
143434649|NCT00665223|517138309|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
143434650|NCT00665223|517138310|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
143434651|NCT00665223|517138311|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
143434652|NCT00665223|517138309|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
143434653|NCT00665223|517138310|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
143434654|NCT00665223|517138311|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
143434655|NCT00665223|517138309|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
143434656|NCT00665223|517138310|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
143434657|NCT00665223|517138311|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
143434658|NCT00665223|517138309|FG000|Open-Label Period (26 Weeks)|Death|0|||
143434659|NCT00665223|517138310|FG001|Open-Label Period (26 Weeks)|Death|1|||
143434660|NCT00665223|517138311|FG002|Open-Label Period (26 Weeks)|Death|0|||
143434661|NCT00665223|517138309|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
143434662|NCT00665223|517138310|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
143434663|NCT00665223|517138311|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
143434664|NCT00665223|517138309|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
143434665|NCT00665223|517138310|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
143434666|NCT00665223|517138311|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
143434667|NCT00665223|517138309|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
143434668|NCT00665223|517138310|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
143434669|NCT00665223|517138311|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
143434670|NCT00665223|517138309|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
143434671|NCT00665223|517138310|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
143434672|NCT00665223|517138311|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
143434673|NCT00591591|517138312|FG000|Overall Study|Withdrawal by Subject|1|||
143434674|NCT00591591|517138313|FG001|Overall Study|Withdrawal by Subject|37|||
143434675|NCT00591591|517138312|FG000|Overall Study|Lack of Efficacy|10|||
143434676|NCT00591591|517138313|FG001|Overall Study|Lack of Efficacy|2|||
143434677|NCT01426113|517138316|FG000|Overall Study|Study Discontinued|1|||
143434678|NCT01426113|517138317|FG001|Overall Study|Study Discontinued|1|||
143434679|NCT01426113|517138316|FG000|Overall Study|Adverse Event|0|||
143434680|NCT01426113|517138317|FG001|Overall Study|Adverse Event|1|||
143434681|NCT00468130|517138319|FG000|Overall Study|Adverse Event|2|||
143434682|NCT00468130|517138320|FG001|Overall Study|Adverse Event|1|||
143434683|NCT00468130|517138319|FG000|Overall Study|Withdrawal by Subject|0|||
143434684|NCT00468130|517138320|FG001|Overall Study|Withdrawal by Subject|1|||
143434685|NCT02485899|517138321|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
143434686|NCT02485899|517138322|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
143434687|NCT02485899|517138321|FG000|Overall Study|Withdrawal by Subject|1|||
143434688|NCT02485899|517138322|FG001|Overall Study|Withdrawal by Subject|0|||
143434689|NCT02485899|517138321|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
143434690|NCT02485899|517138322|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
143434691|NCT00436956|517138323|FG000|Overall Study|Not evaluable|1|||
143434692|NCT00436956|517138324|FG001|Overall Study|Not evaluable|0|||
143434693|NCT03517111|517138325|FG000|Enrolled|Withdrawal by Subject|0|||
143434694|NCT03517111|517138326|FG001|Enrolled|Withdrawal by Subject|1|||
143434695|NCT03517111|517138327|FG002|Enrolled|Withdrawal by Subject|0|||
143434696|NCT03517111|517138325|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
143434697|NCT03517111|517138326|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
143434698|NCT03517111|517138327|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
143434699|NCT03517111|517138325|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
143434700|NCT03517111|517138326|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
143434701|NCT03517111|517138327|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
143434702|NCT03517111|517138325|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
143434703|NCT03517111|517138326|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
143434704|NCT03517111|517138327|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
143434705|NCT03517111|517138325|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
143434706|NCT03517111|517138326|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
143434707|NCT03517111|517138327|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
143434708|NCT00623363|517138328|FG000|Overall Study|Adverse Event|2|||
143434709|NCT00623363|517138329|FG001|Overall Study|Adverse Event|2|||
143434710|NCT01209598|517138330|FG000|Overall Study|Withdrawal by Subject|1|||
143434711|NCT01209598|517138331|FG001|Overall Study|Withdrawal by Subject|0|||
143434712|NCT02719743|517138332|FG000|Overall Study|Consent withdrawal|0|||
143434713|NCT02719743|517138333|FG001|Overall Study|Consent withdrawal|2|||
143434714|NCT02719743|517138334|FG002|Overall Study|Consent withdrawal|0|||
143434715|NCT02719743|517138335|FG003|Overall Study|Consent withdrawal|1|||
143434716|NCT02719743|517138336|FG004|Overall Study|Consent withdrawal|0|||
143434717|NCT02719743|517138332|FG000|Overall Study|Migrated/moved from study area|0|||
143434718|NCT02719743|517138333|FG001|Overall Study|Migrated/moved from study area|0|||
143434719|NCT02719743|517138334|FG002|Overall Study|Migrated/moved from study area|0|||
143434720|NCT02719743|517138335|FG003|Overall Study|Migrated/moved from study area|0|||
143434721|NCT02719743|517138336|FG004|Overall Study|Migrated/moved from study area|2|||
143434722|NCT02719743|517138332|FG000|Overall Study|Lost to Follow-up|1|||
143434723|NCT02719743|517138333|FG001|Overall Study|Lost to Follow-up|1|||
143434724|NCT02719743|517138334|FG002|Overall Study|Lost to Follow-up|0|||
143434725|NCT02719743|517138335|FG003|Overall Study|Lost to Follow-up|0|||
143434726|NCT02719743|517138336|FG004|Overall Study|Lost to Follow-up|0|||
143434727|NCT01438840|517138337|FG000|Core Study|Adverse Event|0|||
143434728|NCT01438840|517138338|FG001|Core Study|Adverse Event|3|||
143434729|NCT01438840|517138339|FG002|Core Study|Adverse Event|0|||
143434730|NCT01438840|517138337|FG000|Core Study|Lack of Efficacy|15|||
143434731|NCT01438840|517138338|FG001|Core Study|Lack of Efficacy|7|||
143434732|NCT01438840|517138339|FG002|Core Study|Lack of Efficacy|0|||
143434733|NCT01438840|517138337|FG000|Core Study|Withdrawal of consent|1|||
143434734|NCT01438840|517138338|FG001|Core Study|Withdrawal of consent|0|||
143434735|NCT01438840|517138339|FG002|Core Study|Withdrawal of consent|0|||
143434736|NCT01438840|517138337|FG000|Extension Phase|Adverse Event|0|||
143434737|NCT01438840|517138338|FG001|Extension Phase|Adverse Event|0|||
143434738|NCT01438840|517138339|FG002|Extension Phase|Adverse Event|3|||
143434739|NCT01438840|517138337|FG000|Extension Phase|Lost to Follow-up|0|||
143434740|NCT01438840|517138338|FG001|Extension Phase|Lost to Follow-up|0|||
143434741|NCT01438840|517138339|FG002|Extension Phase|Lost to Follow-up|1|||
143434742|NCT01438840|517138337|FG000|Extension Phase|Withdrawal by Subject|0|||
143434743|NCT01438840|517138338|FG001|Extension Phase|Withdrawal by Subject|0|||
143434744|NCT01438840|517138339|FG002|Extension Phase|Withdrawal by Subject|3|||
143434745|NCT01438840|517138337|FG000|Extension Phase|Lack of Efficacy|0|||
143434746|NCT01438840|517138338|FG001|Extension Phase|Lack of Efficacy|0|||
143434747|NCT01438840|517138339|FG002|Extension Phase|Lack of Efficacy|2|||
143434748|NCT01438840|517138337|FG000|Extension Phase|Other|0|||
143434749|NCT01438840|517138338|FG001|Extension Phase|Other|0|||
143434750|NCT01438840|517138339|FG002|Extension Phase|Other|1|||
143434751|NCT02062645|517138345|FG000|Overall Study|Adverse Event|2|||
143434752|NCT02062645|517138345|FG000|Overall Study|Protocol Violation|8|||
143434753|NCT02062645|517138345|FG000|Overall Study|Lost to Follow-up|5|||
143434754|NCT00927901|517138348|FG000|Treatment Period 1|Subject withdrew consent|0|||
143434755|NCT00927901|517138349|FG001|Treatment Period 1|Subject withdrew consent|0|||
143434756|NCT00927901|517138350|FG002|Treatment Period 1|Subject withdrew consent|1|||
143434757|NCT00927901|517138351|FG003|Treatment Period 1|Subject withdrew consent|0|||
143434758|NCT00927901|517138348|FG000|Treatment Period 4|Adverse Event|0|||
143434759|NCT00927901|517138349|FG001|Treatment Period 4|Adverse Event|0|||
143434760|NCT00927901|517138350|FG002|Treatment Period 4|Adverse Event|0|||
143434761|NCT00927901|517138351|FG003|Treatment Period 4|Adverse Event|1|||
143434762|NCT00927901|517138348|FG000|Treatment Period 4|Subject withdrew consent|0|||
143434763|NCT00927901|517138349|FG001|Treatment Period 4|Subject withdrew consent|0|||
143434764|NCT00927901|517138350|FG002|Treatment Period 4|Subject withdrew consent|1|||
143434765|NCT00927901|517138351|FG003|Treatment Period 4|Subject withdrew consent|0|||
143434766|NCT02344173|517138352|FG000|Procedure|Ablation Procedure Not Performed|7|||
143434767|NCT02344173|517138352|FG000|12-month Visit|Death|8|||
143434768|NCT02344173|517138352|FG000|12-month Visit|Withdrawal by Subject|30|||
143434769|NCT02344173|517138352|FG000|12-month Visit|Lost to Follow-up|58|||
143434770|NCT03738397|517138353|FG000|Overall Study|Adverse Event|3|||
143434771|NCT03738397|517138354|FG001|Overall Study|Adverse Event|7|||
143434772|NCT03738397|517138353|FG000|Overall Study|Withdrawal by Subject|8|||
143434773|NCT03738397|517138354|FG001|Overall Study|Withdrawal by Subject|11|||
143434774|NCT03738397|517138353|FG000|Overall Study|Lost to Follow-up|7|||
143434775|NCT03738397|517138354|FG001|Overall Study|Lost to Follow-up|5|||
143434776|NCT03738397|517138353|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
143434777|NCT03738397|517138354|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
143434778|NCT03738397|517138353|FG000|Overall Study|Other|4|||
143434779|NCT03738397|517138354|FG001|Overall Study|Other|6|||
143434780|NCT01185171|517138355|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
143434781|NCT01185171|517138355|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
143434782|NCT01185171|517138355|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
143434783|NCT01185171|517138355|FG000|Maintenance|Elevated liver transaminases|3|||
143434784|NCT01185171|517138355|FG000|Maintenance|Rush|2|||
143434785|NCT01185171|517138355|FG000|Maintenance|Diarrhea|1|||
143434786|NCT01185171|517138355|FG000|Maintenance|Xerostomia|1|||
143434787|NCT01185171|517138355|FG000|Maintenance|Nausea|1|||
143434788|NCT01185171|517138355|FG000|Maintenance|Comorbid Illness|2|||
143434789|NCT01185171|517138355|FG000|Maintenance|Withdrawal by Subject|1|||
143434790|NCT01185171|517138355|FG000|Maintenance|Disease Recurrence|1|||
143434791|NCT02881047|517138356|FG000|Overall Study|Adverse Event|1|||
143434792|NCT02881047|517138356|FG000|Overall Study|Withdrawal by Subject|1|||
143434793|NCT00573651|517138360|FG000|Overall Study|Lost to Follow-up|3|||
143434794|NCT00573651|517138360|FG000|Overall Study|Withdrawal by Subject|1|||
143434795|NCT01837797|517138363|FG000|Period 1|Adverse Event|9|||
143434796|NCT01837797|517138364|FG001|Period 1|Adverse Event|0|||
143434797|NCT01837797|517138365|FG002|Period 1|Adverse Event|0|||
143434798|NCT01837797|517138366|FG003|Period 1|Adverse Event|0|||
143434799|NCT01837797|517138367|FG004|Period 1|Adverse Event|0|||
143434800|NCT01837797|517138363|FG000|Period 1|Withdrawal by Subject|6|||
143434801|NCT01837797|517138364|FG001|Period 1|Withdrawal by Subject|0|||
143434802|NCT01837797|517138365|FG002|Period 1|Withdrawal by Subject|0|||
143434803|NCT01837797|517138366|FG003|Period 1|Withdrawal by Subject|0|||
143434804|NCT01837797|517138367|FG004|Period 1|Withdrawal by Subject|0|||
143434805|NCT01837797|517138363|FG000|Period 1|Administrative reasons|76|||
143434806|NCT01837797|517138364|FG001|Period 1|Administrative reasons|0|||
143434807|NCT01837797|517138365|FG002|Period 1|Administrative reasons|0|||
143434808|NCT01837797|517138366|FG003|Period 1|Administrative reasons|0|||
143434809|NCT01837797|517138367|FG004|Period 1|Administrative reasons|0|||
143434810|NCT01837797|517138363|FG000|Period 1|Withdrawal of consent before treatment|1|||
143434811|NCT01837797|517138364|FG001|Period 1|Withdrawal of consent before treatment|0|||
143434812|NCT01837797|517138365|FG002|Period 1|Withdrawal of consent before treatment|0|||
143434813|NCT01837797|517138366|FG003|Period 1|Withdrawal of consent before treatment|0|||
143434814|NCT01837797|517138367|FG004|Period 1|Withdrawal of consent before treatment|0|||
143434815|NCT01837797|517138363|FG000|Period 1|Other|10|||
143434816|NCT01837797|517138364|FG001|Period 1|Other|0|||
143434817|NCT01837797|517138365|FG002|Period 1|Other|0|||
143434818|NCT01837797|517138366|FG003|Period 1|Other|0|||
143434819|NCT01837797|517138367|FG004|Period 1|Other|0|||
143434820|NCT01837797|517138363|FG000|Period 2|Administrative or other reasons|0|||
143434821|NCT01837797|517138364|FG001|Period 2|Administrative or other reasons|5|||
143434822|NCT01837797|517138365|FG002|Period 2|Administrative or other reasons|2|||
143434823|NCT01837797|517138366|FG003|Period 2|Administrative or other reasons|4|||
143434824|NCT01837797|517138367|FG004|Period 2|Administrative or other reasons|0|||
143434825|NCT01837797|517138363|FG000|Period 2|Adverse Event|0|||
143434826|NCT01837797|517138364|FG001|Period 2|Adverse Event|0|||
143434827|NCT01837797|517138365|FG002|Period 2|Adverse Event|0|||
143434828|NCT01837797|517138366|FG003|Period 2|Adverse Event|1|||
143434829|NCT01837797|517138367|FG004|Period 2|Adverse Event|0|||
143434830|NCT01837797|517138363|FG000|Period 3|Adverse Event|0|||
143434831|NCT01837797|517138364|FG001|Period 3|Adverse Event|0|||
143434832|NCT01837797|517138365|FG002|Period 3|Adverse Event|0|||
143434833|NCT01837797|517138366|FG003|Period 3|Adverse Event|0|||
143434834|NCT01837797|517138367|FG004|Period 3|Adverse Event|1|||
143434835|NCT01837797|517138363|FG000|Period 3|Administrative reasons|0|||
143434836|NCT01837797|517138364|FG001|Period 3|Administrative reasons|0|||
143434837|NCT01837797|517138365|FG002|Period 3|Administrative reasons|0|||
143434838|NCT01837797|517138366|FG003|Period 3|Administrative reasons|0|||
143434839|NCT01837797|517138367|FG004|Period 3|Administrative reasons|20|||
143434840|NCT01837797|517138363|FG000|Period 3|Other|0|||
143434841|NCT01837797|517138364|FG001|Period 3|Other|0|||
143434842|NCT01837797|517138365|FG002|Period 3|Other|0|||
143434843|NCT01837797|517138366|FG003|Period 3|Other|0|||
143434844|NCT01837797|517138367|FG004|Period 3|Other|2|||
143434845|NCT03797989|517138368|FG000|VAC069A|Withdrawal by Subject|0|||
143434846|NCT03797989|517138369|FG001|VAC069A|Withdrawal by Subject|0|||
143434847|NCT03797989|517138370|FG002|VAC069A|Withdrawal by Subject|1|||
143434848|NCT03797989|517138371|FG003|VAC069A|Withdrawal by Subject|0|||
143434849|NCT03797989|517138372|FG004|VAC069A|Withdrawal by Subject|0|||
143434850|NCT03797989|517138373|FG005|VAC069A|Withdrawal by Subject|0|||
143434851|NCT03797989|517138374|FG006|VAC069A|Withdrawal by Subject|0|||
143434852|NCT03797989|517138375|FG007|VAC069A|Withdrawal by Subject|0|||
143434853|NCT03797989|517138376|FG008|VAC069A|Withdrawal by Subject|0|||
143434854|NCT03797989|517138377|FG009|VAC069A|Withdrawal by Subject|0|||
143434855|NCT03797989|517138378|FG010|VAC069A|Withdrawal by Subject|0|||
143434856|NCT03797989|517138379|FG011|VAC069A|Withdrawal by Subject|0|||
143434857|NCT04052997|517138380|FG000|Overall Study|Withdrawal by Subject|17|||
143434858|NCT04052997|517138380|FG000|Overall Study|Physician Decision|50|||
143434859|NCT04052997|517138380|FG000|Overall Study|Death|43|||
143434860|NCT04052997|517138380|FG000|Overall Study|Lost to Follow-up|5|||
143434861|NCT04052997|517138380|FG000|Overall Study|Progression of Disease|1|||
143434862|NCT00514813|517138391|FG000|Overall Study|Study terminated|14|||
143434863|NCT00514813|517138392|FG001|Overall Study|Study terminated|74|||
143434864|NCT00514813|517138393|FG002|Overall Study|Study terminated|40|||
143434865|NCT00514813|517138394|FG003|Overall Study|Study terminated|2|||
143434866|NCT00514813|517138391|FG000|Overall Study|Adverse Event|0|||
143434867|NCT00514813|517138392|FG001|Overall Study|Adverse Event|2|||
143434868|NCT00514813|517138393|FG002|Overall Study|Adverse Event|2|||
143434869|NCT00514813|517138394|FG003|Overall Study|Adverse Event|0|||
143434870|NCT00514813|517138391|FG000|Overall Study|Protocol Violation|1|||
143434871|NCT00514813|517138392|FG001|Overall Study|Protocol Violation|0|||
143434872|NCT00514813|517138393|FG002|Overall Study|Protocol Violation|0|||
143434873|NCT00514813|517138394|FG003|Overall Study|Protocol Violation|0|||
143434874|NCT00514813|517138391|FG000|Overall Study|Withdrawal by Subject|0|||
143434875|NCT00514813|517138392|FG001|Overall Study|Withdrawal by Subject|1|||
143434876|NCT00514813|517138393|FG002|Overall Study|Withdrawal by Subject|0|||
143434877|NCT00514813|517138394|FG003|Overall Study|Withdrawal by Subject|0|||
143434878|NCT00514813|517138391|FG000|Overall Study|Lack of Efficacy|0|||
143434879|NCT00514813|517138392|FG001|Overall Study|Lack of Efficacy|1|||
143434880|NCT00514813|517138393|FG002|Overall Study|Lack of Efficacy|0|||
143434881|NCT00514813|517138394|FG003|Overall Study|Lack of Efficacy|0|||
143434882|NCT00514813|517138391|FG000|Overall Study|Kidney transplant|0|||
143434883|NCT00514813|517138392|FG001|Overall Study|Kidney transplant|6|||
143434884|NCT00514813|517138393|FG002|Overall Study|Kidney transplant|2|||
143434885|NCT00514813|517138394|FG003|Overall Study|Kidney transplant|0|||
143434886|NCT00514813|517138391|FG000|Overall Study|Death|0|||
143434887|NCT00514813|517138392|FG001|Overall Study|Death|2|||
143434888|NCT00514813|517138393|FG002|Overall Study|Death|3|||
143434889|NCT00514813|517138394|FG003|Overall Study|Death|2|||
143434890|NCT02979613|517138395|FG000|Double-Blind Phase|Withdrew Consent|2|||
143434891|NCT02979613|517138396|FG001|Double-Blind Phase|Withdrew Consent|4|||
143434892|NCT02979613|517138395|FG000|Double-Blind Phase|Pregnancy|2|||
143434893|NCT02979613|517138396|FG001|Double-Blind Phase|Pregnancy|2|||
143434894|NCT02979613|517138395|FG000|Double-Blind Phase|Adverse Event|2|||
143434895|NCT02979613|517138396|FG001|Double-Blind Phase|Adverse Event|0|||
143434896|NCT02979613|517138395|FG000|Double-Blind Phase|Lost to Follow-up|1|||
143434897|NCT02979613|517138396|FG001|Double-Blind Phase|Lost to Follow-up|1|||
143434898|NCT02979613|517138395|FG000|Double-Blind Phase|Protocol Violation|1|||
143434899|NCT02979613|517138396|FG001|Double-Blind Phase|Protocol Violation|1|||
143434900|NCT02979613|517138395|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
143434901|NCT02979613|517138396|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
143434902|NCT02979613|517138395|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
143434903|NCT02979613|517138396|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
143434904|NCT02979613|517138395|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
143434905|NCT02979613|517138396|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
143434906|NCT02979613|517138395|FG000|Open-Label Extension (OLE) Phase|Death|0|||
143434907|NCT02979613|517138396|FG001|Open-Label Extension (OLE) Phase|Death|1|||
143434908|NCT02979613|517138395|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
143434909|NCT02979613|517138396|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
143434910|NCT01075100|517138399|FG000|Overall Study|Adverse Event|15|||
143434911|NCT01075100|517138400|FG001|Overall Study|Adverse Event|18|||
143434912|NCT01075100|517138399|FG000|Overall Study|Patient Request|4|||
143434913|NCT01075100|517138400|FG001|Overall Study|Patient Request|4|||
143434914|NCT01075100|517138399|FG000|Overall Study|Investigator Request|2|||
143434915|NCT01075100|517138400|FG001|Overall Study|Investigator Request|1|||
143434916|NCT01075100|517138399|FG000|Overall Study|Disease Progression|25|||
143434917|NCT01075100|517138400|FG001|Overall Study|Disease Progression|29|||
143434918|NCT01075100|517138399|FG000|Overall Study|Other|3|||
143434919|NCT01075100|517138400|FG001|Overall Study|Other|1|||
143434920|NCT02820597|517140505|FG000|Overall Study|Lost to Follow-up|12|||
143434921|NCT01053247|517140506|FG000|Overall Study|Withdrawal by Subject|9|||
143434922|NCT01053247|517140507|FG001|Overall Study|Withdrawal by Subject|4|||
143434923|NCT01053247|517140508|FG002|Overall Study|Withdrawal by Subject|15|||
143434924|NCT01053247|517140506|FG000|Overall Study|Lack of Efficacy|1|||
143434925|NCT01053247|517140507|FG001|Overall Study|Lack of Efficacy|0|||
143434926|NCT01053247|517140508|FG002|Overall Study|Lack of Efficacy|1|||
143434927|NCT01053247|517140506|FG000|Overall Study|Protocol Violation|2|||
143434928|NCT01053247|517140507|FG001|Overall Study|Protocol Violation|1|||
143434929|NCT01053247|517140508|FG002|Overall Study|Protocol Violation|2|||
143434930|NCT01053247|517140506|FG000|Overall Study|Lost to Follow-up|8|||
143434931|NCT01053247|517140507|FG001|Overall Study|Lost to Follow-up|5|||
143434932|NCT01053247|517140508|FG002|Overall Study|Lost to Follow-up|7|||
143434933|NCT01053247|517140506|FG000|Overall Study|Adverse Event|0|||
143434934|NCT01053247|517140507|FG001|Overall Study|Adverse Event|9|||
143434935|NCT01053247|517140508|FG002|Overall Study|Adverse Event|3|||
143434936|NCT03898700|517140509|FG000|Overall Study|Withdrawal by Subject|2|||
143434937|NCT00701909|517140510|FG000|Overall Study|Withdrawal by Subject|0|||
143434938|NCT00701909|517140511|FG001|Overall Study|Withdrawal by Subject|1|||
143434939|NCT00971997|517140512|FG000|Overall Study|Adverse Event|2|||
143434940|NCT00971997|517140512|FG000|Overall Study|Death|1|||
143434941|NCT00971997|517140512|FG000|Overall Study|Protocol Violation|4|||
143434942|NCT00971997|517140512|FG000|Overall Study|Withdrawal by Subject|5|||
143434943|NCT00971997|517140512|FG000|Overall Study|Physician Decision|7|||
143434944|NCT04523207|517140515|FG000|Overall Study|Adverse Event|5|||
143434945|NCT04523207|517140516|FG001|Overall Study|Adverse Event|1|||
143434946|NCT04523207|517140515|FG000|Overall Study|Lost to Follow-up|2|||
143434947|NCT04523207|517140516|FG001|Overall Study|Lost to Follow-up|0|||
143434948|NCT04523207|517140515|FG000|Overall Study|Withdrawal by Subject|2|||
143434949|NCT04523207|517140516|FG001|Overall Study|Withdrawal by Subject|0|||
143434950|NCT04523207|517140515|FG000|Overall Study|Progressive Disease|2|||
143434951|NCT04523207|517140516|FG001|Overall Study|Progressive Disease|1|||
143434952|NCT04523207|517140515|FG000|Overall Study|Other|7|||
143434953|NCT04523207|517140516|FG001|Overall Study|Other|1|||
143434954|NCT03113383|517140517|FG000|Overall Study|Death|4|||
143434955|NCT03113383|517140518|FG001|Overall Study|Death|0|||
143434956|NCT03062449|517140519|FG000|Overall Study|Withdrawal by Subject|7|||
143434957|NCT03062449|517140520|FG001|Overall Study|Withdrawal by Subject|1|||
143434958|NCT04702893|517140522|FG000|Overall Study|Other reasons than listed|11|||
143434959|NCT04702893|517140522|FG000|Overall Study|Withdrawal by Subject|3|||
143434960|NCT04702893|517140522|FG000|Overall Study|Lost to Follow-up|7|||
143434961|NCT04702893|517140522|FG000|Overall Study|Death|10|||
143434962|NCT04702893|517140522|FG000|Overall Study|Not treated|6|||
143434963|NCT00408928|517140523|FG000|Overall Study|Withdrawal by Subject|1|||
143434964|NCT00408928|517140523|FG000|Overall Study|Death|1|||
143434965|NCT00408928|517140523|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
143434966|NCT03568812|517140525|FG000|Overall Study|Physician Decision|0|||
143434967|NCT03568812|517140526|FG001|Overall Study|Physician Decision|1|||
143434968|NCT03194867|517140530|FG000|Overall Study|Incorrect completion of end of study form|0|||
143434969|NCT03194867|517140531|FG001|Overall Study|Incorrect completion of end of study form|0|||
143434970|NCT03194867|517140532|FG002|Overall Study|Incorrect completion of end of study form|1|||
143434971|NCT03194867|517140533|FG003|Overall Study|Incorrect completion of end of study form|0|||
143434972|NCT00464945|517140534|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
143434973|NCT00464945|517140535|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
143434974|NCT00464945|517140534|FG000|Infant Series|Protocol Violation|1|||
143434975|NCT00464945|517140535|FG001|Infant Series|Protocol Violation|0|||
143434976|NCT00464945|517140534|FG000|Infant Series|Lost to Follow-up|1|||
143434977|NCT00464945|517140535|FG001|Infant Series|Lost to Follow-up|0|||
143434978|NCT00464945|517140534|FG000|After Infant Series|Withdrawal by Subject|0|||
143434979|NCT00464945|517140535|FG001|After Infant Series|Withdrawal by Subject|2|||
143434980|NCT00464945|517140534|FG000|Toddler Dose|Lost to Follow-up|0|||
143434981|NCT00464945|517140535|FG001|Toddler Dose|Lost to Follow-up|1|||
143434982|NCT03546816|517140536|FG000|Overall Study|Adverse Event|5|||
143434983|NCT03546816|517140537|FG001|Overall Study|Adverse Event|3|||
143434984|NCT03546816|517140536|FG000|Overall Study|Lack of Efficacy|2|||
143434985|NCT03546816|517140537|FG001|Overall Study|Lack of Efficacy|4|||
143434986|NCT03546816|517140536|FG000|Overall Study|Pregnancy|1|||
143434987|NCT03546816|517140537|FG001|Overall Study|Pregnancy|0|||
143434988|NCT03546816|517140536|FG000|Overall Study|Physician Decision|2|||
143434989|NCT03546816|517140537|FG001|Overall Study|Physician Decision|0|||
143434990|NCT03546816|517140536|FG000|Overall Study|Withdrawal by Subject|8|||
143434991|NCT03546816|517140537|FG001|Overall Study|Withdrawal by Subject|10|||
143434992|NCT03546816|517140536|FG000|Overall Study|Lost to Follow-up|3|||
143434993|NCT03546816|517140537|FG001|Overall Study|Lost to Follow-up|2|||
143434994|NCT02438371|517140538|FG000|Overall Study|Lost to Follow-up|3|||
143434995|NCT02438371|517140539|FG001|Overall Study|Lost to Follow-up|2|||
143434996|NCT02438371|517140538|FG000|Overall Study|Withdrawal by Subject|1|||
143434997|NCT02438371|517140539|FG001|Overall Study|Withdrawal by Subject|1|||
143434998|NCT03065933|517140542|FG000|Overall Study|study terminated|5|||
143434999|NCT01010204|517140543|FG000|Overall Study|Lost to Follow-up|2|||
143435000|NCT01010204|517140544|FG001|Overall Study|Lost to Follow-up|2|||
143435001|NCT01010204|517140543|FG000|Overall Study|Adverse Event|1|||
143435002|NCT01010204|517140544|FG001|Overall Study|Adverse Event|3|||
143435003|NCT01010204|517140543|FG000|Overall Study|Withdrawal by Subject|2|||
143435004|NCT01010204|517140544|FG001|Overall Study|Withdrawal by Subject|3|||
143435005|NCT01010204|517140543|FG000|Overall Study|psychiatric hospitalization|2|||
143435006|NCT01010204|517140544|FG001|Overall Study|psychiatric hospitalization|1|||
143435007|NCT01513330|517140545|FG000|SenSura Mio First,|Adverse Event|2|||
143435008|NCT01513330|517140546|FG001|SenSura Mio First,|Adverse Event|0|||
143435009|NCT01513330|517140545|FG000|SenSura Mio First,|Lack of Efficacy|0|||
143435010|NCT01513330|517140546|FG001|SenSura Mio First,|Lack of Efficacy|1|||
143435011|NCT01513330|517140545|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
143435012|NCT01513330|517140546|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
143435013|NCT01513330|517140545|FG000|SenSura Mio First,|Other|1|||
143435014|NCT01513330|517140546|FG001|SenSura Mio First,|Other|0|||
143435015|NCT01513330|517140545|FG000|Standard Care First,|Lack of Efficacy|2|||
143435016|NCT01513330|517140546|FG001|Standard Care First,|Lack of Efficacy|2|||
143435017|NCT01513330|517140545|FG000|Standard Care First,|Withdrawal by Subject|1|||
143435018|NCT01513330|517140546|FG001|Standard Care First,|Withdrawal by Subject|2|||
143435019|NCT01513330|517140545|FG000|Standard Care First,|Other|1|||
143435020|NCT01513330|517140546|FG001|Standard Care First,|Other|0|||
143435021|NCT01519778|517140547|FG000|Overall Study|Withdrawal by Subject|3|||
143435022|NCT01519778|517140547|FG000|Overall Study|Lost to Follow-up|10|||
143435023|NCT01519778|517140547|FG000|Overall Study|Physician Decision|1|||
143435024|NCT01547117|517140549|FG000|Overall Study|Physician Decision|0|||
143435025|NCT01547117|517140550|FG001|Overall Study|Physician Decision|1|||
143435026|NCT01547117|517140551|FG002|Overall Study|Physician Decision|1|||
143435027|NCT01547117|517140552|FG003|Overall Study|Physician Decision|3|||
143435028|NCT01547117|517140549|FG000|Overall Study|Withdrawal by Subject|1|||
143435029|NCT01547117|517140550|FG001|Overall Study|Withdrawal by Subject|2|||
143435030|NCT01547117|517140551|FG002|Overall Study|Withdrawal by Subject|1|||
143435031|NCT01547117|517140552|FG003|Overall Study|Withdrawal by Subject|2|||
143435032|NCT03021551|517140555|FG000|Overall Study|Equipment Issues|2|||
143435033|NCT03021551|517140555|FG000|Overall Study|Protocol Violation|1|||
143435034|NCT00551135|517140564|FG000|Overall Study|Adverse Event|1|||
143435035|NCT00551135|517140565|FG001|Overall Study|Adverse Event|0|||
143435036|NCT00551135|517140566|FG002|Overall Study|Adverse Event|1|||
143435037|NCT00551135|517140567|FG003|Overall Study|Adverse Event|1|||
143435038|NCT00551135|517140564|FG000|Overall Study|Lost to Follow-up|0|||
143435039|NCT00551135|517140565|FG001|Overall Study|Lost to Follow-up|0|||
143435040|NCT00551135|517140566|FG002|Overall Study|Lost to Follow-up|0|||
143435041|NCT00551135|517140567|FG003|Overall Study|Lost to Follow-up|1|||
143435042|NCT00551135|517140564|FG000|Overall Study|Other|3|||
143435043|NCT00551135|517140565|FG001|Overall Study|Other|2|||
143435044|NCT00551135|517140566|FG002|Overall Study|Other|1|||
143435045|NCT00551135|517140567|FG003|Overall Study|Other|2|||
143435046|NCT00551135|517140564|FG000|Overall Study|Withdrawal by Subject|1|||
143435047|NCT00551135|517140565|FG001|Overall Study|Withdrawal by Subject|0|||
143435048|NCT00551135|517140566|FG002|Overall Study|Withdrawal by Subject|3|||
143435049|NCT00551135|517140567|FG003|Overall Study|Withdrawal by Subject|1|||
143435050|NCT01379703|517140568|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
143435051|NCT01379703|517140569|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
143435052|NCT01379703|517140570|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
143435053|NCT01379703|517140568|FG000|Study Start Through 9 Months|Adverse Event|0|||
143435054|NCT01379703|517140569|FG001|Study Start Through 9 Months|Adverse Event|14|||
143435055|NCT01379703|517140570|FG002|Study Start Through 9 Months|Adverse Event|10|||
143435056|NCT01379703|517140568|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
143435057|NCT01379703|517140569|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
143435058|NCT01379703|517140570|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
143435059|NCT01379703|517140568|FG000|Study Start Through 9 Months|Treatment Failure|0|||
143435060|NCT01379703|517140569|FG001|Study Start Through 9 Months|Treatment Failure|2|||
143435061|NCT01379703|517140570|FG002|Study Start Through 9 Months|Treatment Failure|2|||
143435062|NCT01379703|517140568|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
143435063|NCT01379703|517140569|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
143435064|NCT01379703|517140570|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
143435065|NCT01379703|517140568|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
143435066|NCT01379703|517140569|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
143435067|NCT01379703|517140570|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
143435068|NCT01379703|517140568|FG000|Study Start Through 9 Months|Medication not available|0|||
143435069|NCT01379703|517140569|FG001|Study Start Through 9 Months|Medication not available|2|||
143435070|NCT01379703|517140570|FG002|Study Start Through 9 Months|Medication not available|1|||
143435071|NCT01379703|517140568|FG000|Study Start Through 9 Months|Poor general condition|0|||
143435072|NCT01379703|517140569|FG001|Study Start Through 9 Months|Poor general condition|1|||
143435073|NCT01379703|517140570|FG002|Study Start Through 9 Months|Poor general condition|0|||
143435074|NCT01379703|517140568|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
143435075|NCT01379703|517140569|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
143435076|NCT01379703|517140570|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
143435077|NCT01379703|517140568|FG000|Study Start Through 9 Months|Reason unknown|2|||
143435078|NCT01379703|517140569|FG001|Study Start Through 9 Months|Reason unknown|31|||
143435079|NCT01379703|517140570|FG002|Study Start Through 9 Months|Reason unknown|24|||
143435080|NCT01379703|517140568|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
143435081|NCT01379703|517140569|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
143435082|NCT01379703|517140570|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
143435083|NCT01379703|517140568|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
143435084|NCT01379703|517140569|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
143435085|NCT01379703|517140570|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
143435086|NCT01379703|517140568|FG000|9 Months Through 18 Months|Adverse Event|0|||
143435087|NCT01379703|517140569|FG001|9 Months Through 18 Months|Adverse Event|6|||
143435088|NCT01379703|517140570|FG002|9 Months Through 18 Months|Adverse Event|0|||
143435089|NCT01379703|517140568|FG000|9 Months Through 18 Months|Treatment failure|0|||
143435090|NCT01379703|517140569|FG001|9 Months Through 18 Months|Treatment failure|5|||
143435091|NCT01379703|517140570|FG002|9 Months Through 18 Months|Treatment failure|0|||
143435092|NCT01379703|517140568|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
143435093|NCT01379703|517140569|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
143435094|NCT01379703|517140570|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
143435095|NCT01379703|517140568|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
143435096|NCT01379703|517140569|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
143435097|NCT01379703|517140570|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
143435098|NCT01379703|517140568|FG000|9 Months Through 18 Months|Fatigue|0|||
143435099|NCT01379703|517140569|FG001|9 Months Through 18 Months|Fatigue|1|||
143435100|NCT01379703|517140570|FG002|9 Months Through 18 Months|Fatigue|0|||
143435101|NCT01379703|517140568|FG000|9 Months Through 18 Months|Reason Unknown|0|||
143435102|NCT01379703|517140569|FG001|9 Months Through 18 Months|Reason Unknown|23|||
143435103|NCT01379703|517140570|FG002|9 Months Through 18 Months|Reason Unknown|0|||
143435104|NCT03463577|517140571|FG000|Overall Study|Lost to Follow-up|238|||
143435105|NCT03463577|517140572|FG001|Overall Study|Lost to Follow-up|435|||
143435106|NCT03463577|517140573|FG002|Overall Study|Lost to Follow-up|0|||
143435107|NCT03463577|517140574|FG003|Overall Study|Lost to Follow-up|0|||
143435108|NCT03463577|517140575|FG004|Overall Study|Lost to Follow-up|0|||
143435109|NCT03463577|517140576|FG005|Overall Study|Lost to Follow-up|0|||
143435110|NCT03463577|517140571|FG000|Overall Study|With unknown pregnancy outcome|0|||
143435111|NCT03463577|517140572|FG001|Overall Study|With unknown pregnancy outcome|5|||
143435112|NCT03463577|517140573|FG002|Overall Study|With unknown pregnancy outcome|0|||
143435113|NCT03463577|517140574|FG003|Overall Study|With unknown pregnancy outcome|0|||
143435114|NCT03463577|517140575|FG004|Overall Study|With unknown pregnancy outcome|0|||
143435115|NCT03463577|517140576|FG005|Overall Study|With unknown pregnancy outcome|0|||
143435116|NCT03463577|517140571|FG000|Overall Study|Maternal death|2|||
143435117|NCT03463577|517140572|FG001|Overall Study|Maternal death|0|||
143435118|NCT03463577|517140573|FG002|Overall Study|Maternal death|0|||
143435119|NCT03463577|517140574|FG003|Overall Study|Maternal death|0|||
143435120|NCT03463577|517140575|FG004|Overall Study|Maternal death|0|||
143435121|NCT03463577|517140576|FG005|Overall Study|Maternal death|0|||
143435122|NCT03463577|517140571|FG000|Overall Study|Neonatal death|0|||
143435123|NCT03463577|517140572|FG001|Overall Study|Neonatal death|0|||
143435124|NCT03463577|517140573|FG002|Overall Study|Neonatal death|0|||
143435125|NCT03463577|517140574|FG003|Overall Study|Neonatal death|15|||
143435126|NCT03463577|517140575|FG004|Overall Study|Neonatal death|17|||
143435127|NCT03463577|517140576|FG005|Overall Study|Neonatal death|0|||
143435128|NCT00236184|517140577|FG000|Overall Study|Adverse Event|5|||
143435129|NCT00236184|517140578|FG001|Overall Study|Adverse Event|2|||
143435130|NCT00236184|517140577|FG000|Overall Study|Lack of Efficacy|0|||
143435131|NCT00236184|517140578|FG001|Overall Study|Lack of Efficacy|1|||
143435132|NCT00236184|517140577|FG000|Overall Study|Lost to Follow-up|3|||
143435133|NCT00236184|517140578|FG001|Overall Study|Lost to Follow-up|4|||
143435134|NCT00236184|517140577|FG000|Overall Study|Physician Decision|1|||
143435135|NCT00236184|517140578|FG001|Overall Study|Physician Decision|1|||
143435136|NCT00236184|517140577|FG000|Overall Study|Withdrawal by Subject|3|||
143435137|NCT00236184|517140578|FG001|Overall Study|Withdrawal by Subject|0|||
143435138|NCT00236184|517140577|FG000|Overall Study|Protocol Violation|3|||
143435139|NCT00236184|517140578|FG001|Overall Study|Protocol Violation|0|||
143435140|NCT00236184|517140577|FG000|Overall Study|non-compliance with study drug|2|||
143435141|NCT00236184|517140578|FG001|Overall Study|non-compliance with study drug|1|||
143435142|NCT00236184|517140577|FG000|Overall Study|other|1|||
143435143|NCT00236184|517140578|FG001|Overall Study|other|2|||
143435144|NCT02669407|517140581|FG000|Overall Study|Physician Decision|3|||
143435145|NCT00704171|517140582|FG000|Overall Study|Withdrawal by Subject|1|||
143435146|NCT00704171|517140583|FG001|Overall Study|Withdrawal by Subject|0|||
143435147|NCT03634839|517140586|FG000|First Intervention (2 Hours)|Adverse Event|0|||
143435148|NCT03634839|517140587|FG001|First Intervention (2 Hours)|Adverse Event|2|||
143435149|NCT00233389|517140588|FG000|Overall Study|Adverse Event|5|||
143435150|NCT00233389|517140589|FG001|Overall Study|Adverse Event|5|||
143435151|NCT00233389|517140588|FG000|Overall Study|Lack of Efficacy|11|||
143435152|NCT00233389|517140589|FG001|Overall Study|Lack of Efficacy|8|||
143435153|NCT00233389|517140588|FG000|Overall Study|Lost to Follow-up|1|||
143435154|NCT00233389|517140589|FG001|Overall Study|Lost to Follow-up|1|||
143435155|NCT00233389|517140588|FG000|Overall Study|Physician Decision|1|||
143435156|NCT00233389|517140589|FG001|Overall Study|Physician Decision|0|||
143435157|NCT00233389|517140588|FG000|Overall Study|Protocol Violation|0|||
143435158|NCT00233389|517140589|FG001|Overall Study|Protocol Violation|1|||
143435159|NCT00233389|517140588|FG000|Overall Study|Withdrawal by Subject|0|||
143435160|NCT00233389|517140589|FG001|Overall Study|Withdrawal by Subject|1|||
143435161|NCT01588366|517140595|FG000|Overall Study|Adverse Event|0|||
143435162|NCT01588366|517140596|FG001|Overall Study|Adverse Event|1|||
143435163|NCT01588366|517140597|FG002|Overall Study|Adverse Event|0|||
143435164|NCT01588366|517140598|FG003|Overall Study|Adverse Event|1|||
143435165|NCT01588366|517140599|FG004|Overall Study|Adverse Event|0|||
143435166|NCT01588366|517140600|FG005|Overall Study|Adverse Event|2|||
143435167|NCT00719043|517140601|FG000|Overall Study|Adverse Event|5|||
143435168|NCT00719043|517140602|FG001|Overall Study|Adverse Event|1|||
143435169|NCT00719043|517140603|FG002|Overall Study|Adverse Event|2|||
143435170|NCT00719043|517140604|FG003|Overall Study|Adverse Event|2|||
143435171|NCT00719043|517140605|FG004|Overall Study|Adverse Event|1|||
143435172|NCT00719043|517140606|FG005|Overall Study|Adverse Event|4|||
143435173|NCT00719043|517140607|FG006|Overall Study|Adverse Event|4|||
143435174|NCT00719043|517140601|FG000|Overall Study|Lost to Follow-up|14|||
143435175|NCT00719043|517140602|FG001|Overall Study|Lost to Follow-up|10|||
143435176|NCT00719043|517140603|FG002|Overall Study|Lost to Follow-up|8|||
143435177|NCT00719043|517140604|FG003|Overall Study|Lost to Follow-up|9|||
143435178|NCT00719043|517140605|FG004|Overall Study|Lost to Follow-up|10|||
143435179|NCT00719043|517140606|FG005|Overall Study|Lost to Follow-up|9|||
143435180|NCT00719043|517140607|FG006|Overall Study|Lost to Follow-up|9|||
143435181|NCT00719043|517140601|FG000|Overall Study|Protocol Violation|0|||
143435182|NCT00719043|517140602|FG001|Overall Study|Protocol Violation|0|||
143435183|NCT00719043|517140603|FG002|Overall Study|Protocol Violation|0|||
143435184|NCT00719043|517140604|FG003|Overall Study|Protocol Violation|0|||
143435185|NCT00719043|517140605|FG004|Overall Study|Protocol Violation|0|||
143435186|NCT00719043|517140606|FG005|Overall Study|Protocol Violation|1|||
143435187|NCT00719043|517140607|FG006|Overall Study|Protocol Violation|0|||
143435188|NCT00719043|517140601|FG000|Overall Study|Other|1|||
143435189|NCT00719043|517140602|FG001|Overall Study|Other|0|||
143435190|NCT00719043|517140603|FG002|Overall Study|Other|1|||
143435191|NCT00719043|517140604|FG003|Overall Study|Other|2|||
143435192|NCT00719043|517140605|FG004|Overall Study|Other|0|||
143435193|NCT00719043|517140606|FG005|Overall Study|Other|2|||
143435194|NCT00719043|517140607|FG006|Overall Study|Other|1|||
143435195|NCT00719043|517140601|FG000|Overall Study|Withdrawal by Subject|12|||
143435196|NCT00719043|517140602|FG001|Overall Study|Withdrawal by Subject|14|||
143435197|NCT00719043|517140603|FG002|Overall Study|Withdrawal by Subject|9|||
143435198|NCT00719043|517140604|FG003|Overall Study|Withdrawal by Subject|10|||
143435199|NCT00719043|517140605|FG004|Overall Study|Withdrawal by Subject|16|||
143435200|NCT00719043|517140606|FG005|Overall Study|Withdrawal by Subject|18|||
143435201|NCT00719043|517140607|FG006|Overall Study|Withdrawal by Subject|14|||
143435202|NCT00302159|517140608|FG000|Overall Study|pt declined before treatment started|1|||
143435203|NCT00302159|517140608|FG000|Overall Study|pt started Avastin|1|||
143435204|NCT00813098|517140609|FG000|Overall Study|Adverse Event|2|||
143435205|NCT00813098|517140610|FG001|Overall Study|Adverse Event|4|||
143435206|NCT00813098|517140611|FG002|Overall Study|Adverse Event|1|||
143435207|NCT00813098|517140609|FG000|Overall Study|Withdrawal by Subject|0|||
143435208|NCT00813098|517140610|FG001|Overall Study|Withdrawal by Subject|1|||
143435209|NCT00813098|517140611|FG002|Overall Study|Withdrawal by Subject|0|||
143435210|NCT00813098|517140609|FG000|Overall Study|Inability to complete study procedures|1|||
143435211|NCT00813098|517140610|FG001|Overall Study|Inability to complete study procedures|0|||
143435212|NCT00813098|517140611|FG002|Overall Study|Inability to complete study procedures|0|||
143435213|NCT00813098|517140609|FG000|Overall Study|Lost to Follow-up|0|||
143435214|NCT00813098|517140610|FG001|Overall Study|Lost to Follow-up|1|||
143435215|NCT00813098|517140611|FG002|Overall Study|Lost to Follow-up|0|||
143435216|NCT00813098|517140609|FG000|Overall Study|Protocol Violation|0|||
143435217|NCT00813098|517140610|FG001|Overall Study|Protocol Violation|0|||
143435218|NCT00813098|517140611|FG002|Overall Study|Protocol Violation|1|||
143435219|NCT00813098|517140609|FG000|Overall Study|Principal Investigator decision|0|||
143435220|NCT00813098|517140610|FG001|Overall Study|Principal Investigator decision|1|||
143435221|NCT00813098|517140611|FG002|Overall Study|Principal Investigator decision|0|||
143435222|NCT00813098|517140609|FG000|Overall Study|Withdrew Consent|0|||
143435223|NCT00813098|517140610|FG001|Overall Study|Withdrew Consent|1|||
143435224|NCT00813098|517140611|FG002|Overall Study|Withdrew Consent|0|||
143435225|NCT04962698|517140612|FG000|Motor Imagery|Technical difficulty|1|||
143435226|NCT04962698|517140613|FG001|Motor Imagery|Technical difficulty|0|||
143435227|NCT04962698|517140612|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
143435228|NCT04962698|517140613|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
143435229|NCT04962698|517140612|FG000|Kinesthetic MI|Technical difficulty|1|||
143435230|NCT04962698|517140613|FG001|Kinesthetic MI|Technical difficulty|0|||
143435231|NCT04962698|517140612|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
143435232|NCT04962698|517140613|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
143435233|NCT04962698|517140612|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
143435234|NCT04962698|517140613|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
143435235|NCT04962698|517140612|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
143435236|NCT04962698|517140613|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
143435237|NCT04962698|517140612|FG000|Virtual-hand Interaction|Technical difficulty|1|||
143435238|NCT04962698|517140613|FG001|Virtual-hand Interaction|Technical difficulty|0|||
143435239|NCT04962698|517140612|FG000|Robotic Action Observation|Technical difficulty|1|||
143435240|NCT04962698|517140613|FG001|Robotic Action Observation|Technical difficulty|0|||
143435241|NCT04962698|517140612|FG000|Rest|Technical difficulty|1|||
143435242|NCT04962698|517140613|FG001|Rest|Technical difficulty|0|||
143435243|NCT04962698|517140612|FG000|Rest|Exclusion criteria met after enrollment|0|||
143435244|NCT04962698|517140613|FG001|Rest|Exclusion criteria met after enrollment|2|||
143435245|NCT03470545|517140614|FG000|Overall Study|Death|0|||
143435246|NCT03470545|517140615|FG001|Overall Study|Death|1|||
143435247|NCT03470545|517140614|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
143435248|NCT03470545|517140615|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
143435249|NCT03470545|517140614|FG000|Overall Study|Adverse Event|2|||
143435250|NCT03470545|517140615|FG001|Overall Study|Adverse Event|0|||
143435251|NCT03470545|517140614|FG000|Overall Study|Withdrawal by Subject|1|||
143435252|NCT03470545|517140615|FG001|Overall Study|Withdrawal by Subject|1|||
143435253|NCT03470545|517140614|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
143435254|NCT03470545|517140615|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
143435255|NCT03672175|517140623|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
143435256|NCT03672175|517140624|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
143435257|NCT03672175|517140625|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
143435258|NCT03672175|517140623|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
143435259|NCT03672175|517140624|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
143435260|NCT03672175|517140625|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
143435261|NCT03672175|517140623|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
143435262|NCT03672175|517140624|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
143435263|NCT03672175|517140625|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
143435264|NCT03672175|517140623|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
143435265|NCT03672175|517140624|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
143435266|NCT03672175|517140625|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
143435267|NCT03672175|517140623|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
143435268|NCT03672175|517140624|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
143435269|NCT03672175|517140625|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
143435270|NCT03672175|517140623|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
143435271|NCT03672175|517140624|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
143435272|NCT03672175|517140625|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
143435273|NCT03672175|517140623|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
143435274|NCT03672175|517140624|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
143435275|NCT03672175|517140625|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
143435276|NCT03672175|517140623|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
143435277|NCT03672175|517140624|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
143435278|NCT03672175|517140625|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
143435279|NCT03672175|517140623|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
143435280|NCT03672175|517140624|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
143435281|NCT03672175|517140625|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
143435282|NCT03672175|517140623|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
143435283|NCT03672175|517140624|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
143435284|NCT03672175|517140625|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
143435285|NCT03672175|517140623|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
143435286|NCT03672175|517140624|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
143435287|NCT03672175|517140625|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
143435288|NCT03672175|517140623|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
143435289|NCT03672175|517140624|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
143435290|NCT03672175|517140625|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
143435291|NCT01772563|517140627|FG000|Cycle 1|Dose limiting toxicity|2|||
143435292|NCT01772563|517140627|FG000|Cycle 1|Progressive disease|2|||
143435293|NCT01772563|517140627|FG000|Cycle 2 and Beyond|Progressive disease|17|||
143435294|NCT01772563|517140627|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
143435295|NCT01772563|517140627|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
143435296|NCT01192776|517140629|FG000|Overall Study|Death|8|||
143435297|NCT01192776|517140630|FG001|Overall Study|Death|15|||
143435298|NCT01192776|517140631|FG002|Overall Study|Death|18|||
143435299|NCT01192776|517140632|FG003|Overall Study|Death|15|||
143435300|NCT01192776|517140629|FG000|Overall Study|Lost to Follow-up|3|||
143435301|NCT01192776|517140630|FG001|Overall Study|Lost to Follow-up|6|||
143435302|NCT01192776|517140631|FG002|Overall Study|Lost to Follow-up|3|||
143435303|NCT01192776|517140632|FG003|Overall Study|Lost to Follow-up|5|||
143435304|NCT01086384|517140633|FG000|2-week Run-in Period|Adverse Event|1|||
143435305|NCT01086384|517140634|FG001|2-week Run-in Period|Adverse Event|0|||
143435306|NCT01086384|517140635|FG002|2-week Run-in Period|Adverse Event|0|||
143435307|NCT01086384|517140633|FG000|2-week Run-in Period|Protocol Violation|1|||
143435308|NCT01086384|517140634|FG001|2-week Run-in Period|Protocol Violation|0|||
143435309|NCT01086384|517140635|FG002|2-week Run-in Period|Protocol Violation|0|||
143435310|NCT01086384|517140633|FG000|2-week Run-in Period|Lost to Follow-up|1|||
143435311|NCT01086384|517140634|FG001|2-week Run-in Period|Lost to Follow-up|0|||
143435312|NCT01086384|517140635|FG002|2-week Run-in Period|Lost to Follow-up|0|||
143435313|NCT01086384|517140633|FG000|2-week Run-in Period|Physician Decision|6|||
143435314|NCT01086384|517140634|FG001|2-week Run-in Period|Physician Decision|0|||
143435315|NCT01086384|517140635|FG002|2-week Run-in Period|Physician Decision|0|||
143435316|NCT01086384|517140633|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
143435317|NCT01086384|517140634|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
143435318|NCT01086384|517140635|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
143435319|NCT01086384|517140633|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
143435320|NCT01086384|517140634|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
143435321|NCT01086384|517140635|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
143435322|NCT01086384|517140633|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
143435323|NCT01086384|517140634|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
143435324|NCT01086384|517140635|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
143435325|NCT01086384|517140633|FG000|2-week Run-in Period|Randomized in Error|1|||
143435326|NCT01086384|517140634|FG001|2-week Run-in Period|Randomized in Error|0|||
143435327|NCT01086384|517140635|FG002|2-week Run-in Period|Randomized in Error|0|||
143435328|NCT01086384|517140633|FG000|Treatment Period|Withdrawal by Subject|0|||
143435329|NCT01086384|517140634|FG001|Treatment Period|Withdrawal by Subject|53|||
143435330|NCT01086384|517140635|FG002|Treatment Period|Withdrawal by Subject|55|||
143435331|NCT01086384|517140633|FG000|Treatment Period|Protocol Violation|0|||
143435332|NCT01086384|517140634|FG001|Treatment Period|Protocol Violation|26|||
143435333|NCT01086384|517140635|FG002|Treatment Period|Protocol Violation|17|||
143435334|NCT01086384|517140633|FG000|Treatment Period|Lack of Efficacy|0|||
143435335|NCT01086384|517140634|FG001|Treatment Period|Lack of Efficacy|22|||
143435336|NCT01086384|517140635|FG002|Treatment Period|Lack of Efficacy|13|||
143435337|NCT01086384|517140633|FG000|Treatment Period|Adverse Event|0|||
143435338|NCT01086384|517140634|FG001|Treatment Period|Adverse Event|19|||
143435339|NCT01086384|517140635|FG002|Treatment Period|Adverse Event|15|||
143435340|NCT01086384|517140633|FG000|Treatment Period|Lost to Follow-up|0|||
143435341|NCT01086384|517140634|FG001|Treatment Period|Lost to Follow-up|11|||
143435342|NCT01086384|517140635|FG002|Treatment Period|Lost to Follow-up|9|||
143435343|NCT01086384|517140633|FG000|Treatment Period|Physician Decision|0|||
143435344|NCT01086384|517140634|FG001|Treatment Period|Physician Decision|9|||
143435345|NCT01086384|517140635|FG002|Treatment Period|Physician Decision|6|||
143435346|NCT01086384|517140633|FG000|Treatment Period|Study Closed/Terminated|0|||
143435347|NCT01086384|517140634|FG001|Treatment Period|Study Closed/Terminated|7|||
143435348|NCT01086384|517140635|FG002|Treatment Period|Study Closed/Terminated|8|||
143435349|NCT01086384|517140633|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
143435350|NCT01086384|517140634|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
143435351|NCT01086384|517140635|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
143435352|NCT01086384|517140633|FG000|Treatment Period|Received Treatment in Error|0|||
143435353|NCT01086384|517140634|FG001|Treatment Period|Received Treatment in Error|1|||
143435354|NCT01086384|517140635|FG002|Treatment Period|Received Treatment in Error|0|||
143435355|NCT02872311|517140636|FG000|Overall Study|Death|2|||
143435356|NCT02872311|517140637|FG001|Overall Study|Death|0|||
143435357|NCT02872311|517140638|FG002|Overall Study|Death|0|||
143435358|NCT02872311|517140639|FG003|Overall Study|Death|0|||
143435359|NCT02872311|517140640|FG004|Overall Study|Death|0|||
143435360|NCT02872311|517140636|FG000|Overall Study|Lost to Follow-up|2|||
143435361|NCT02872311|517140637|FG001|Overall Study|Lost to Follow-up|0|||
143435362|NCT02872311|517140638|FG002|Overall Study|Lost to Follow-up|0|||
143435363|NCT02872311|517140639|FG003|Overall Study|Lost to Follow-up|0|||
143435364|NCT02872311|517140640|FG004|Overall Study|Lost to Follow-up|0|||
143435365|NCT02872311|517140636|FG000|Overall Study|Protocol Violation|0|||
143435366|NCT02872311|517140637|FG001|Overall Study|Protocol Violation|2|||
143435367|NCT02872311|517140638|FG002|Overall Study|Protocol Violation|1|||
143435368|NCT02872311|517140639|FG003|Overall Study|Protocol Violation|0|||
143435369|NCT02872311|517140640|FG004|Overall Study|Protocol Violation|0|||
143435370|NCT00832000|517140641|FG000|Overall Study|Adverse Event|2|||
143435371|NCT00832000|517140642|FG001|Overall Study|Adverse Event|0|||
143435372|NCT00832000|517140641|FG000|Overall Study|Withdrawal by Subject|1|||
143435373|NCT00832000|517140642|FG001|Overall Study|Withdrawal by Subject|0|||
143435374|NCT00832000|517140641|FG000|Overall Study|No calls to IVR in either period|1|||
143435375|NCT00832000|517140642|FG001|Overall Study|No calls to IVR in either period|1|||
143435376|NCT00832000|517140641|FG000|Overall Study|No calls to IVR in period 2|2|||
143435377|NCT00832000|517140642|FG001|Overall Study|No calls to IVR in period 2|0|||
143435378|NCT02725567|517140644|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
143435379|NCT02725567|517140645|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
143435380|NCT02725567|517140644|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
143435381|NCT02725567|517140645|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
143435382|NCT02725567|517140644|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
143435383|NCT02725567|517140645|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
143435384|NCT02777242|517140646|FG000|Overall Study|Other|2|||
143435385|NCT02777242|517140646|FG000|Overall Study|Lost to Follow-up|1|||
143435386|NCT02777242|517140646|FG000|Overall Study|Multiple|1|||
143435387|NCT02777242|517140646|FG000|Overall Study|Sponsor's request|1|||
143435388|NCT02777242|517140646|FG000|Overall Study|Withdrawal by Subject|1|||
143435389|NCT05178979|517140647|FG000|Overall Study|Death|0|||
143435390|NCT05178979|517140648|FG001|Overall Study|Death|5|||
143435391|NCT05178979|517140649|FG002|Overall Study|Death|0|||
143435392|NCT05178979|517140650|FG003|Overall Study|Death|3|||
143435393|NCT05178979|517140647|FG000|Overall Study|Adverse Event|0|||
143435394|NCT05178979|517140648|FG001|Overall Study|Adverse Event|1|||
143435395|NCT05178979|517140649|FG002|Overall Study|Adverse Event|0|||
143435396|NCT05178979|517140650|FG003|Overall Study|Adverse Event|0|||
143435397|NCT05178979|517140647|FG000|Overall Study|Lost to Follow-up|1|||
143435398|NCT05178979|517140648|FG001|Overall Study|Lost to Follow-up|8|||
143435399|NCT05178979|517140649|FG002|Overall Study|Lost to Follow-up|3|||
143435400|NCT05178979|517140650|FG003|Overall Study|Lost to Follow-up|8|||
143435401|NCT00255944|517140651|FG000|Overall Study|Lost to Follow-up|797|||
143435402|NCT00255944|517140652|FG001|Overall Study|Lost to Follow-up|834|||
143435403|NCT01129115|517140654|FG000|Overall Study|Adverse Event|1|||
143435404|NCT01129115|517140655|FG001|Overall Study|Adverse Event|2|||
143435405|NCT01129115|517140656|FG002|Overall Study|Adverse Event|3|||
143435406|NCT01129115|517140657|FG003|Overall Study|Adverse Event|3|||
143435407|NCT01129115|517140654|FG000|Overall Study|Withdrawal by Subject|1|||
143435408|NCT01129115|517140655|FG001|Overall Study|Withdrawal by Subject|3|||
143435409|NCT01129115|517140656|FG002|Overall Study|Withdrawal by Subject|1|||
143435410|NCT01129115|517140657|FG003|Overall Study|Withdrawal by Subject|4|||
143435411|NCT01129115|517140654|FG000|Overall Study|Protocol Violation|0|||
143435412|NCT01129115|517140655|FG001|Overall Study|Protocol Violation|2|||
143435413|NCT01129115|517140656|FG002|Overall Study|Protocol Violation|2|||
143435414|NCT01129115|517140657|FG003|Overall Study|Protocol Violation|2|||
143435415|NCT01747837|517140659|FG000|Overall Study|Lost to Follow-up|5|||
143435416|NCT01747837|517140660|FG001|Overall Study|Lost to Follow-up|2|||
143435417|NCT01747837|517140659|FG000|Overall Study|Death|4|||
143435418|NCT01747837|517140660|FG001|Overall Study|Death|4|||
143435419|NCT01435798|517140662|FG000|Overall Study|Withdrawal by Subject|1|||
143435420|NCT00817336|517140663|FG000|Overall Study|Withdrawal by Subject|1|||
143435421|NCT00817336|517140664|FG001|Overall Study|Withdrawal by Subject|1|||
143435422|NCT00690378|517140671|FG000|Overall Study|Adverse Event|1|||
143435423|NCT00690378|517140672|FG001|Overall Study|Adverse Event|0|||
143435424|NCT00690378|517140671|FG000|Overall Study|Withdrawal by Subject|2|||
143435425|NCT00690378|517140672|FG001|Overall Study|Withdrawal by Subject|0|||
143435426|NCT00690378|517140671|FG000|Overall Study|Protocol Violation|1|||
143435427|NCT00690378|517140672|FG001|Overall Study|Protocol Violation|0|||
143435428|NCT00690378|517140671|FG000|Overall Study|Lost to Follow-up|2|||
143435429|NCT00690378|517140672|FG001|Overall Study|Lost to Follow-up|3|||
143435430|NCT00690378|517140671|FG000|Overall Study|Did not meet inc/exc criteria|13|||
143435431|NCT00690378|517140672|FG001|Overall Study|Did not meet inc/exc criteria|11|||
143435432|NCT00690378|517140671|FG000|Overall Study|Social problem|1|||
143435433|NCT00690378|517140672|FG001|Overall Study|Social problem|0|||
143435434|NCT00935259|517140673|FG000|Period 1|Administrative (scheduling conflict)|1|||
143435435|NCT00935259|517140674|FG001|Period 1|Administrative (scheduling conflict)|1|||
143435436|NCT02019641|517140675|FG000|10-Week Follow up|Withdrawal by investigator|2|||
143435437|NCT02019641|517140676|FG001|10-Week Follow up|Withdrawal by investigator|0|||
143435438|NCT02019641|517140677|FG002|10-Week Follow up|Withdrawal by investigator|0|||
143435439|NCT02019641|517140675|FG000|10-Week Follow up|Withdrawal by Subject|1|||
143435440|NCT02019641|517140676|FG001|10-Week Follow up|Withdrawal by Subject|1|||
143435441|NCT02019641|517140677|FG002|10-Week Follow up|Withdrawal by Subject|0|||
143435442|NCT02019641|517140675|FG000|20-Week Follow up|Withdrawal by investigator|0|||
143435443|NCT02019641|517140676|FG001|20-Week Follow up|Withdrawal by investigator|0|||
143435444|NCT02019641|517140677|FG002|20-Week Follow up|Withdrawal by investigator|1|||
143435445|NCT03318783|517140678|FG000|Overall Study|Withdrawal by Subject|0|||
143435446|NCT03318783|517140679|FG001|Overall Study|Withdrawal by Subject|1|||
143435447|NCT03318783|517140678|FG000|Overall Study|Death|0|||
143435448|NCT03318783|517140679|FG001|Overall Study|Death|1|||
143435449|NCT03410108|517140682|FG000|Overall Study|Ongoing|41|||
143435450|NCT03410108|517140682|FG000|Overall Study|Adverse Event|4|||
143435451|NCT03410108|517140682|FG000|Overall Study|Progressive Disease|58|||
143435452|NCT03410108|517140682|FG000|Overall Study|Withdrawal by Subject|1|||
143435453|NCT03856047|517140683|FG000|Overall Study|Withdrawal by Subject|0|||
143435454|NCT03856047|517140684|FG001|Overall Study|Withdrawal by Subject|1|||
143435455|NCT03856047|517140685|FG002|Overall Study|Withdrawal by Subject|1|||
143435456|NCT03856047|517140686|FG003|Overall Study|Withdrawal by Subject|0|||
143435457|NCT03856047|517140687|FG004|Overall Study|Withdrawal by Subject|3|||
143435458|NCT03856047|517140688|FG005|Overall Study|Withdrawal by Subject|0|||
143435459|NCT03856047|517140689|FG006|Overall Study|Withdrawal by Subject|2|||
143435460|NCT03856047|517140683|FG000|Overall Study|Lost to Follow-up|4|||
143435461|NCT03856047|517140684|FG001|Overall Study|Lost to Follow-up|2|||
143435462|NCT03856047|517140685|FG002|Overall Study|Lost to Follow-up|3|||
143435463|NCT03856047|517140686|FG003|Overall Study|Lost to Follow-up|1|||
143435464|NCT03856047|517140687|FG004|Overall Study|Lost to Follow-up|4|||
143435465|NCT03856047|517140688|FG005|Overall Study|Lost to Follow-up|4|||
143435466|NCT03856047|517140689|FG006|Overall Study|Lost to Follow-up|4|||
143435467|NCT00934700|517140697|FG000|Overall Study|missing scan|5|||
143435468|NCT00934700|517140698|FG001|Overall Study|missing scan|9|||
143435469|NCT00934700|517140697|FG000|Overall Study|Death|8|||
143435470|NCT00934700|517140698|FG001|Overall Study|Death|3|||
143435471|NCT03049306|517140701|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
143435472|NCT03049306|517140702|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
143435473|NCT03151551|517140703|FG000|Open-Label Treatment Period|Adverse Event|0|||
143435474|NCT03151551|517140704|FG001|Open-Label Treatment Period|Adverse Event|2|||
143435475|NCT03151551|517140703|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
143435476|NCT03151551|517140704|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
143435477|NCT03151551|517140703|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
143435478|NCT03151551|517140704|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
143435479|NCT03151551|517140703|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
143435480|NCT03151551|517140704|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
143435481|NCT03151551|517140703|FG000|Open-Label Treatment Period|Physician Decision|3|||
143435482|NCT03151551|517140704|FG001|Open-Label Treatment Period|Physician Decision|0|||
143435483|NCT03151551|517140703|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
143435484|NCT03151551|517140704|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
143435485|NCT03151551|517140703|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
143435486|NCT03151551|517140704|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
143435487|NCT03151551|517140703|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
143435488|NCT03151551|517140704|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
143435489|NCT03151551|517140703|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
143435490|NCT03151551|517140704|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
143435491|NCT03151551|517140703|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
143435492|NCT03151551|517140704|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
143435493|NCT05896696|517140705|FG000|Overall Study|Screening Failure|7|||
143435494|NCT05896696|517140705|FG000|Overall Study|Withdrawal by Subject|2|||
143435495|NCT00143598|517140706|FG000|Overall Study|Lost to Follow-up|23|||
143435496|NCT00143598|517140707|FG001|Overall Study|Lost to Follow-up|21|||
143435497|NCT00143598|517140706|FG000|Overall Study|Withdrawal by Subject|33|||
143435498|NCT00143598|517140707|FG001|Overall Study|Withdrawal by Subject|37|||
143435499|NCT00143598|517140706|FG000|Overall Study|Death|36|||
143435500|NCT00143598|517140707|FG001|Overall Study|Death|36|||
143435501|NCT03900715|517140708|FG000|Overall Study|Protocol Deviation|1|||
143435502|NCT03900715|517140708|FG000|Overall Study|Lack of Efficacy|1|||
143435503|NCT03900715|517140708|FG000|Overall Study|Progressive Disease|6|||
143435504|NCT03900715|517140708|FG000|Overall Study|Adverse Event|2|||
143435505|NCT03900715|517140708|FG000|Overall Study|Other reasons|11|||
143435506|NCT00634842|517142572|FG000|Overall Study|Adverse Event|2|||
143435507|NCT00634842|517142573|FG001|Overall Study|Adverse Event|3|||
143435508|NCT00634842|517142572|FG000|Overall Study|Protocol Violation|8|||
143435509|NCT00634842|517142573|FG001|Overall Study|Protocol Violation|4|||
143435510|NCT00634842|517142572|FG000|Overall Study|Move to another state|1|||
143435511|NCT00634842|517142573|FG001|Overall Study|Move to another state|0|||
143435512|NCT00634842|517142572|FG000|Overall Study|Inclusion criteria were not met|1|||
143435513|NCT00634842|517142573|FG001|Overall Study|Inclusion criteria were not met|0|||
143435514|NCT00634842|517142572|FG000|Overall Study|Lost to Follow-up|1|||
143435515|NCT00634842|517142573|FG001|Overall Study|Lost to Follow-up|2|||
143435516|NCT00634842|517142572|FG000|Overall Study|Physician Decision|1|||
143435517|NCT00634842|517142573|FG001|Overall Study|Physician Decision|0|||
143435518|NCT00634842|517142572|FG000|Overall Study|Withdrawal by Subject|1|||
143435519|NCT00634842|517142573|FG001|Overall Study|Withdrawal by Subject|3|||
143435520|NCT00634842|517142572|FG000|Overall Study|Lack of time and intolerance to drug|0|||
143435521|NCT00634842|517142573|FG001|Overall Study|Lack of time and intolerance to drug|1|||
143435522|NCT00634842|517142572|FG000|Overall Study|Discontinued due to injection|0|||
143435523|NCT00634842|517142573|FG001|Overall Study|Discontinued due to injection|2|||
143435524|NCT00634842|517142572|FG000|Overall Study|No need of study drug to treat diabetes|0|||
143435525|NCT00634842|517142573|FG001|Overall Study|No need of study drug to treat diabetes|1|||
143435526|NCT00634842|517142572|FG000|Overall Study|No wish to keep taking Avandia|0|||
143435527|NCT00634842|517142573|FG001|Overall Study|No wish to keep taking Avandia|1|||
143435528|NCT00634842|517142572|FG000|Overall Study|Subject off study drug for too long|0|||
143435529|NCT00634842|517142573|FG001|Overall Study|Subject off study drug for too long|1|||
143435530|NCT00328562|517142576|FG000|Overall Study|Disease progression|1|||
143435531|NCT03305809|517142577|FG000|Overall Study|Adverse Event|2|||
143435532|NCT03305809|517142578|FG001|Overall Study|Adverse Event|2|||
143435533|NCT03305809|517142579|FG002|Overall Study|Adverse Event|6|||
143435534|NCT03305809|517142580|FG003|Overall Study|Adverse Event|6|||
143435535|NCT03305809|517142577|FG000|Overall Study|Death|0|||
143435536|NCT03305809|517142578|FG001|Overall Study|Death|0|||
143435537|NCT03305809|517142579|FG002|Overall Study|Death|1|||
143435538|NCT03305809|517142580|FG003|Overall Study|Death|1|||
143435539|NCT03305809|517142577|FG000|Overall Study|Lost to Follow-up|1|||
143435540|NCT03305809|517142578|FG001|Overall Study|Lost to Follow-up|2|||
143435541|NCT03305809|517142579|FG002|Overall Study|Lost to Follow-up|0|||
143435542|NCT03305809|517142580|FG003|Overall Study|Lost to Follow-up|0|||
143435543|NCT03305809|517142577|FG000|Overall Study|Sponsor Decision|1|||
143435544|NCT03305809|517142578|FG001|Overall Study|Sponsor Decision|0|||
143435545|NCT03305809|517142579|FG002|Overall Study|Sponsor Decision|1|||
143435546|NCT03305809|517142580|FG003|Overall Study|Sponsor Decision|8|||
143435547|NCT03305809|517142577|FG000|Overall Study|Physician Decision|0|||
143435548|NCT03305809|517142578|FG001|Overall Study|Physician Decision|0|||
143435549|NCT03305809|517142579|FG002|Overall Study|Physician Decision|2|||
143435550|NCT03305809|517142580|FG003|Overall Study|Physician Decision|4|||
143435551|NCT03305809|517142577|FG000|Overall Study|Progressive Disease|0|||
143435552|NCT03305809|517142578|FG001|Overall Study|Progressive Disease|0|||
143435553|NCT03305809|517142579|FG002|Overall Study|Progressive Disease|1|||
143435554|NCT03305809|517142580|FG003|Overall Study|Progressive Disease|0|||
143435555|NCT03305809|517142577|FG000|Overall Study|Protocol Violation|1|||
143435556|NCT03305809|517142578|FG001|Overall Study|Protocol Violation|0|||
143435557|NCT03305809|517142579|FG002|Overall Study|Protocol Violation|2|||
143435558|NCT03305809|517142580|FG003|Overall Study|Protocol Violation|3|||
143435559|NCT03305809|517142577|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
143435560|NCT03305809|517142578|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
143435561|NCT03305809|517142579|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
143435562|NCT03305809|517142580|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
143435563|NCT03305809|517142577|FG000|Overall Study|Withdrawal by Subject|2|||
143435564|NCT03305809|517142578|FG001|Overall Study|Withdrawal by Subject|4|||
143435565|NCT03305809|517142579|FG002|Overall Study|Withdrawal by Subject|5|||
143435566|NCT03305809|517142580|FG003|Overall Study|Withdrawal by Subject|2|||
143435567|NCT03305809|517142577|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
143435568|NCT03305809|517142578|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
143435569|NCT03305809|517142579|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
143435570|NCT03305809|517142580|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
143435571|NCT04014790|517142581|FG000|Overall Study|Death|4|||
143435572|NCT04014790|517142581|FG000|Overall Study|Adverse Event|1|||
143435573|NCT04014790|517142581|FG000|Overall Study|Withdrawal by Subject|1|||
143435574|NCT00816556|517142582|FG000|Overall Study|Adverse Event|1|||
143435575|NCT00816556|517142583|FG001|Overall Study|Adverse Event|1|||
143435576|NCT00816556|517142584|FG002|Overall Study|Adverse Event|1|||
143435577|NCT00816556|517142582|FG000|Overall Study|Withdrawal by Subject|1|||
143435578|NCT00816556|517142583|FG001|Overall Study|Withdrawal by Subject|1|||
143435579|NCT00816556|517142584|FG002|Overall Study|Withdrawal by Subject|1|||
143435580|NCT00816556|517142582|FG000|Overall Study|Lost to Follow-up|0|||
143435581|NCT00816556|517142583|FG001|Overall Study|Lost to Follow-up|0|||
143435582|NCT00816556|517142584|FG002|Overall Study|Lost to Follow-up|1|||
143435583|NCT01161446|517142585|FG000|Overall Study|Lost to Follow-up|18|||
143435584|NCT01161446|517142586|FG001|Overall Study|Lost to Follow-up|14|||
143435585|NCT01161446|517142585|FG000|Overall Study|Withdrawal by Subject|0|||
143435586|NCT01161446|517142586|FG001|Overall Study|Withdrawal by Subject|1|||
143435587|NCT02330562|517142591|FG000|Overall Study|Adverse Event|0|||
143435588|NCT02330562|517142592|FG001|Overall Study|Adverse Event|0|||
143435589|NCT02330562|517142593|FG002|Overall Study|Adverse Event|3|||
143435590|NCT02330562|517142594|FG003|Overall Study|Adverse Event|0|||
143435591|NCT02330562|517142595|FG004|Overall Study|Adverse Event|3|||
143435592|NCT02330562|517142596|FG005|Overall Study|Adverse Event|1|||
143435593|NCT02330562|517142597|FG006|Overall Study|Adverse Event|0|||
143435594|NCT02330562|517142598|FG007|Overall Study|Adverse Event|0|||
143435595|NCT02330562|517142599|FG008|Overall Study|Adverse Event|0|||
143435596|NCT02330562|517142600|FG009|Overall Study|Adverse Event|1|||
143435597|NCT02330562|517142601|FG010|Overall Study|Adverse Event|1|||
143435598|NCT02330562|517142591|FG000|Overall Study|Participant decision|1|||
143435599|NCT02330562|517142592|FG001|Overall Study|Participant decision|0|||
143435600|NCT02330562|517142593|FG002|Overall Study|Participant decision|4|||
143435601|NCT02330562|517142594|FG003|Overall Study|Participant decision|1|||
143435602|NCT02330562|517142595|FG004|Overall Study|Participant decision|5|||
143435603|NCT02330562|517142596|FG005|Overall Study|Participant decision|2|||
143435604|NCT02330562|517142597|FG006|Overall Study|Participant decision|0|||
143435605|NCT02330562|517142598|FG007|Overall Study|Participant decision|0|||
143435606|NCT02330562|517142599|FG008|Overall Study|Participant decision|0|||
143435607|NCT02330562|517142600|FG009|Overall Study|Participant decision|3|||
143435608|NCT02330562|517142601|FG010|Overall Study|Participant decision|0|||
143435609|NCT02330562|517142591|FG000|Overall Study|Disease progression|5|||
143435610|NCT02330562|517142592|FG001|Overall Study|Disease progression|3|||
143435611|NCT02330562|517142593|FG002|Overall Study|Disease progression|20|||
143435612|NCT02330562|517142594|FG003|Overall Study|Disease progression|28|||
143435613|NCT02330562|517142595|FG004|Overall Study|Disease progression|23|||
143435614|NCT02330562|517142596|FG005|Overall Study|Disease progression|7|||
143435615|NCT02330562|517142597|FG006|Overall Study|Disease progression|1|||
143435616|NCT02330562|517142598|FG007|Overall Study|Disease progression|1|||
143435617|NCT02330562|517142599|FG008|Overall Study|Disease progression|1|||
143435618|NCT02330562|517142600|FG009|Overall Study|Disease progression|0|||
143435619|NCT02330562|517142601|FG010|Overall Study|Disease progression|5|||
143435620|NCT02330562|517142591|FG000|Overall Study|Other reasons|0|||
143435621|NCT02330562|517142592|FG001|Overall Study|Other reasons|0|||
143435622|NCT02330562|517142593|FG002|Overall Study|Other reasons|0|||
143435623|NCT02330562|517142594|FG003|Overall Study|Other reasons|1|||
143435624|NCT02330562|517142595|FG004|Overall Study|Other reasons|0|||
143435625|NCT02330562|517142596|FG005|Overall Study|Other reasons|0|||
143435626|NCT02330562|517142597|FG006|Overall Study|Other reasons|0|||
143435627|NCT02330562|517142598|FG007|Overall Study|Other reasons|0|||
143435628|NCT02330562|517142599|FG008|Overall Study|Other reasons|0|||
143435629|NCT02330562|517142600|FG009|Overall Study|Other reasons|0|||
143435630|NCT02330562|517142601|FG010|Overall Study|Other reasons|0|||
143435631|NCT02330562|517142591|FG000|Overall Study|Withdrawal by Subject|0|||
143435632|NCT02330562|517142592|FG001|Overall Study|Withdrawal by Subject|0|||
143435633|NCT02330562|517142593|FG002|Overall Study|Withdrawal by Subject|0|||
143435634|NCT02330562|517142594|FG003|Overall Study|Withdrawal by Subject|0|||
143435635|NCT02330562|517142595|FG004|Overall Study|Withdrawal by Subject|0|||
143435636|NCT02330562|517142596|FG005|Overall Study|Withdrawal by Subject|0|||
143435637|NCT02330562|517142597|FG006|Overall Study|Withdrawal by Subject|0|||
143435638|NCT02330562|517142598|FG007|Overall Study|Withdrawal by Subject|0|||
143435639|NCT02330562|517142599|FG008|Overall Study|Withdrawal by Subject|0|||
143435640|NCT02330562|517142600|FG009|Overall Study|Withdrawal by Subject|1|||
143435641|NCT02330562|517142601|FG010|Overall Study|Withdrawal by Subject|0|||
143435642|NCT00412880|517142602|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
143435643|NCT00412880|517142602|FG000|Overall Study|Consent withdrawn|1|||
143435644|NCT00412880|517142602|FG000|Overall Study|Adverse Event|1|||
143435645|NCT00412880|517142602|FG000|Overall Study|Progressive disease|20|||
143435646|NCT02232399|517142604|FG000|Overall Study|Adverse Event|1|||
143435647|NCT02232399|517142605|FG001|Overall Study|Adverse Event|0|||
143435648|NCT02232399|517142604|FG000|Overall Study|Withdrawal by Subject|0|||
143435649|NCT02232399|517142605|FG001|Overall Study|Withdrawal by Subject|1|||
143435650|NCT02706951|517142606|FG000|Period 1|Adverse Event|1|||
143435651|NCT02706951|517142607|FG001|Period 1|Adverse Event|5|||
143435652|NCT02706951|517142608|FG002|Period 1|Adverse Event|3|||
143435653|NCT02706951|517142609|FG003|Period 1|Adverse Event|0|||
143435654|NCT02706951|517142610|FG004|Period 1|Adverse Event|0|||
143435655|NCT02706951|517142606|FG000|Period 1|Withdrawal by Subject|10|||
143435656|NCT02706951|517142607|FG001|Period 1|Withdrawal by Subject|6|||
143435657|NCT02706951|517142608|FG002|Period 1|Withdrawal by Subject|6|||
143435658|NCT02706951|517142609|FG003|Period 1|Withdrawal by Subject|0|||
143435659|NCT02706951|517142610|FG004|Period 1|Withdrawal by Subject|0|||
143435660|NCT02706951|517142606|FG000|Period 1|Lost to Follow-up|0|||
143435661|NCT02706951|517142607|FG001|Period 1|Lost to Follow-up|4|||
143435662|NCT02706951|517142608|FG002|Period 1|Lost to Follow-up|1|||
143435663|NCT02706951|517142609|FG003|Period 1|Lost to Follow-up|0|||
143435664|NCT02706951|517142610|FG004|Period 1|Lost to Follow-up|0|||
143435665|NCT02706951|517142606|FG000|Period 1|Other|2|||
143435666|NCT02706951|517142607|FG001|Period 1|Other|1|||
143435667|NCT02706951|517142608|FG002|Period 1|Other|0|||
143435668|NCT02706951|517142609|FG003|Period 1|Other|0|||
143435669|NCT02706951|517142610|FG004|Period 1|Other|0|||
143435670|NCT02706951|517142606|FG000|Period 2|Adverse Event|0|||
143435671|NCT02706951|517142607|FG001|Period 2|Adverse Event|0|||
143435672|NCT02706951|517142608|FG002|Period 2|Adverse Event|0|||
143435673|NCT02706951|517142609|FG003|Period 2|Adverse Event|25|||
143435674|NCT02706951|517142610|FG004|Period 2|Adverse Event|34|||
143435675|NCT02706951|517142606|FG000|Period 2|Withdrawal by Subject|0|||
143435676|NCT02706951|517142607|FG001|Period 2|Withdrawal by Subject|0|||
143435677|NCT02706951|517142608|FG002|Period 2|Withdrawal by Subject|0|||
143435678|NCT02706951|517142609|FG003|Period 2|Withdrawal by Subject|38|||
143435679|NCT02706951|517142610|FG004|Period 2|Withdrawal by Subject|44|||
143435680|NCT02706951|517142606|FG000|Period 2|Lost to Follow-up|0|||
143435681|NCT02706951|517142607|FG001|Period 2|Lost to Follow-up|0|||
143435682|NCT02706951|517142608|FG002|Period 2|Lost to Follow-up|0|||
143435683|NCT02706951|517142609|FG003|Period 2|Lost to Follow-up|17|||
143435684|NCT02706951|517142610|FG004|Period 2|Lost to Follow-up|9|||
143435685|NCT02706951|517142606|FG000|Period 2|COVID-19 Related|0|||
143435686|NCT02706951|517142607|FG001|Period 2|COVID-19 Related|0|||
143435687|NCT02706951|517142608|FG002|Period 2|COVID-19 Related|0|||
143435688|NCT02706951|517142609|FG003|Period 2|COVID-19 Related|1|||
143435689|NCT02706951|517142610|FG004|Period 2|COVID-19 Related|2|||
143435690|NCT02706951|517142606|FG000|Period 2|Other|0|||
143435691|NCT02706951|517142607|FG001|Period 2|Other|0|||
143435692|NCT02706951|517142608|FG002|Period 2|Other|0|||
143435693|NCT02706951|517142609|FG003|Period 2|Other|37|||
143435694|NCT02706951|517142610|FG004|Period 2|Other|31|||
143435695|NCT03491215|517142611|FG000|Overall Study|Death|6|||
143435696|NCT03491215|517142612|FG001|Overall Study|Death|2|||
143435697|NCT03491215|517142613|FG002|Overall Study|Death|1|||
143435698|NCT03491215|517142614|FG003|Overall Study|Death|0|||
143435699|NCT03491215|517142611|FG000|Overall Study|Physician Decision|1|||
143435700|NCT03491215|517142612|FG001|Overall Study|Physician Decision|0|||
143435701|NCT03491215|517142613|FG002|Overall Study|Physician Decision|0|||
143435702|NCT03491215|517142614|FG003|Overall Study|Physician Decision|0|||
143435703|NCT02165397|517142615|FG000|Overall Study|Death|7|||
143435704|NCT02165397|517142616|FG001|Overall Study|Death|10|||
143435705|NCT02165397|517142617|FG002|Overall Study|Death|8|||
143435706|NCT02165397|517142615|FG000|Overall Study|Lost to Follow-up|1|||
143435707|NCT02165397|517142616|FG001|Overall Study|Lost to Follow-up|3|||
143435708|NCT02165397|517142617|FG002|Overall Study|Lost to Follow-up|0|||
143435709|NCT02165397|517142615|FG000|Overall Study|Withdrawal by Subject|6|||
143435710|NCT02165397|517142616|FG001|Overall Study|Withdrawal by Subject|6|||
143435711|NCT02165397|517142617|FG002|Overall Study|Withdrawal by Subject|1|||
143435712|NCT02165397|517142615|FG000|Overall Study|Other, Not Specified|0|||
143435713|NCT02165397|517142616|FG001|Overall Study|Other, Not Specified|0|||
143435714|NCT02165397|517142617|FG002|Overall Study|Other, Not Specified|1|||
143435715|NCT03297398|517142618|FG000|Overall Study|Sponsor's decision|6|||
143435716|NCT03297398|517142619|FG001|Overall Study|Sponsor's decision|9|||
143435717|NCT03297398|517142620|FG002|Overall Study|Sponsor's decision|7|||
143435718|NCT03297398|517142618|FG000|Overall Study|Adverse Event|1|||
143435719|NCT03297398|517142619|FG001|Overall Study|Adverse Event|4|||
143435720|NCT03297398|517142620|FG002|Overall Study|Adverse Event|4|||
143435721|NCT03297398|517142618|FG000|Overall Study|Withdrawal by Subject|1|||
143435722|NCT03297398|517142619|FG001|Overall Study|Withdrawal by Subject|2|||
143435723|NCT03297398|517142620|FG002|Overall Study|Withdrawal by Subject|2|||
143435724|NCT03297398|517142618|FG000|Overall Study|Protocol Violation|0|||
143435725|NCT03297398|517142619|FG001|Overall Study|Protocol Violation|2|||
143435726|NCT03297398|517142620|FG002|Overall Study|Protocol Violation|0|||
143435727|NCT03297398|517142618|FG000|Overall Study|Physician Decision|0|||
143435728|NCT03297398|517142619|FG001|Overall Study|Physician Decision|0|||
143435729|NCT03297398|517142620|FG002|Overall Study|Physician Decision|1|||
143435730|NCT03297398|517142618|FG000|Overall Study|Lost to Follow-up|0|||
143435731|NCT03297398|517142619|FG001|Overall Study|Lost to Follow-up|0|||
143435732|NCT03297398|517142620|FG002|Overall Study|Lost to Follow-up|1|||
143435733|NCT03481556|517142623|FG000|Overall Study|Adverse Event|1|||
143435734|NCT03481556|517142624|FG001|Overall Study|Adverse Event|0|||
143435735|NCT03481556|517142625|FG002|Overall Study|Adverse Event|0|||
143435736|NCT03481556|517142626|FG003|Overall Study|Adverse Event|0|||
143435737|NCT03481556|517142623|FG000|Overall Study|Death|4|||
143435738|NCT03481556|517142624|FG001|Overall Study|Death|2|||
143435739|NCT03481556|517142625|FG002|Overall Study|Death|3|||
143435740|NCT03481556|517142626|FG003|Overall Study|Death|16|||
143435741|NCT03481556|517142623|FG000|Overall Study|Study Terminated by Sponsor|10|||
143435742|NCT03481556|517142624|FG001|Overall Study|Study Terminated by Sponsor|5|||
143435743|NCT03481556|517142625|FG002|Overall Study|Study Terminated by Sponsor|2|||
143435744|NCT03481556|517142626|FG003|Overall Study|Study Terminated by Sponsor|9|||
143435745|NCT01101997|517142627|FG000|Overall Study|Withdrawal by Subject|2|||
143435746|NCT00469456|517142628|FG000|Overall Study|Adverse Event|4|||
143435747|NCT00469456|517142629|FG001|Overall Study|Adverse Event|3|||
143435748|NCT00469456|517142628|FG000|Overall Study|Protocol Violation|1|||
143435749|NCT00469456|517142629|FG001|Overall Study|Protocol Violation|0|||
143435750|NCT00469456|517142628|FG000|Overall Study|Withdrawal by Subject|4|||
143435751|NCT00469456|517142629|FG001|Overall Study|Withdrawal by Subject|1|||
143435752|NCT00611715|517142630|FG000|Overall Study|Disease Progression|24|||
143435753|NCT00611715|517142631|FG001|Overall Study|Disease Progression|4|||
143435754|NCT00611715|517142630|FG000|Overall Study|Withdrawal by Subject|5|||
143435755|NCT00611715|517142631|FG001|Overall Study|Withdrawal by Subject|1|||
143435756|NCT00611715|517142630|FG000|Overall Study|Adverse Event|9|||
143435757|NCT00611715|517142631|FG001|Overall Study|Adverse Event|1|||
143435758|NCT00611715|517142630|FG000|Overall Study|Death|1|||
143435759|NCT00611715|517142631|FG001|Overall Study|Death|0|||
143435760|NCT00611715|517142630|FG000|Overall Study|two patients are still on treatment|2|||
143435761|NCT00611715|517142631|FG001|Overall Study|two patients are still on treatment|0|||
143435762|NCT00107978|517142632|FG000|Overall Study|Adverse Event|1|||
143435763|NCT00107978|517142633|FG001|Overall Study|Adverse Event|5|||
143435764|NCT00107978|517142632|FG000|Overall Study|Death|3|||
143435765|NCT00107978|517142633|FG001|Overall Study|Death|3|||
143435766|NCT00107978|517142632|FG000|Overall Study|Lost to Follow-up|20|||
143435767|NCT00107978|517142633|FG001|Overall Study|Lost to Follow-up|28|||
143435768|NCT00107978|517142632|FG000|Overall Study|Withdrawal by Subject|4|||
143435769|NCT00107978|517142633|FG001|Overall Study|Withdrawal by Subject|9|||
143435770|NCT00107978|517142632|FG000|Overall Study|Protocol Violation|0|||
143435771|NCT00107978|517142633|FG001|Overall Study|Protocol Violation|1|||
143435772|NCT00107978|517142632|FG000|Overall Study|Other|5|||
143435773|NCT00107978|517142633|FG001|Overall Study|Other|4|||
143435774|NCT00350298|517142636|FG000|Overall Study|Death|7|||
143435775|NCT00350298|517142637|FG001|Overall Study|Death|8|||
143435776|NCT00350298|517142636|FG000|Overall Study|Lost to Follow-up|1|||
143435777|NCT00350298|517142637|FG001|Overall Study|Lost to Follow-up|2|||
143435778|NCT00350298|517142636|FG000|Overall Study|Withdrawal by Subject|1|||
143435779|NCT00350298|517142637|FG001|Overall Study|Withdrawal by Subject|3|||
143435780|NCT02312206|517142645|FG000|Overall Study|Adverse Event|3|||
143435781|NCT02312206|517142646|FG001|Overall Study|Adverse Event|6|||
143435782|NCT02312206|517142645|FG000|Overall Study|Withdrawal by Subject|6|||
143435783|NCT02312206|517142646|FG001|Overall Study|Withdrawal by Subject|6|||
143435784|NCT02312206|517142645|FG000|Overall Study|Physician Decision|7|||
143435785|NCT02312206|517142646|FG001|Overall Study|Physician Decision|6|||
143435786|NCT02312206|517142645|FG000|Overall Study|Death|31|||
143435787|NCT02312206|517142646|FG001|Overall Study|Death|36|||
143435788|NCT02312206|517142645|FG000|Overall Study|Study Terminated by Sponsor|81|||
143435789|NCT02312206|517142646|FG001|Overall Study|Study Terminated by Sponsor|74|||
143435790|NCT02312206|517142645|FG000|Overall Study|Patient transferred to hospice|0|||
143435791|NCT02312206|517142646|FG001|Overall Study|Patient transferred to hospice|1|||
143435792|NCT02312206|517142645|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
143435793|NCT02312206|517142646|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
143435794|NCT02312206|517142645|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
143435795|NCT02312206|517142646|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
143435796|NCT02312206|517142645|FG000|Overall Study|Disease Progression|1|||
143435797|NCT02312206|517142646|FG001|Overall Study|Disease Progression|0|||
143435798|NCT03082612|517142647|FG000|Overall Study|Lost to Follow-up|2|||
143435799|NCT03082612|517142648|FG001|Overall Study|Lost to Follow-up|0|||
143435800|NCT01006616|517142649|FG000|Period 1 (6 Months)|Adverse Event|10|||
143435801|NCT01006616|517142650|FG001|Period 1 (6 Months)|Adverse Event|31|||
143435802|NCT01006616|517142651|FG002|Period 1 (6 Months)|Adverse Event|37|||
143435803|NCT01006616|517142652|FG003|Period 1 (6 Months)|Adverse Event|9|||
143435804|NCT01006616|517142649|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
143435805|NCT01006616|517142650|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
143435806|NCT01006616|517142651|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
143435807|NCT01006616|517142652|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
143435808|NCT01006616|517142649|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
143435809|NCT01006616|517142650|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
143435810|NCT01006616|517142651|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
143435811|NCT01006616|517142652|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
143435812|NCT01006616|517142649|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
143435813|NCT01006616|517142650|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
143435814|NCT01006616|517142651|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
143435815|NCT01006616|517142652|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
143435816|NCT01006616|517142649|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
143435817|NCT01006616|517142650|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
143435818|NCT01006616|517142651|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
143435819|NCT01006616|517142652|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
143435820|NCT01006616|517142649|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
143435821|NCT01006616|517142650|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
143435822|NCT01006616|517142651|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
143435823|NCT01006616|517142652|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
143435824|NCT01006616|517142649|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
143435825|NCT01006616|517142650|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
143435826|NCT01006616|517142651|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
143435827|NCT01006616|517142652|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
143435828|NCT01006616|517142649|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
143435829|NCT01006616|517142650|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
143435830|NCT01006616|517142651|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
143435831|NCT01006616|517142652|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
143435832|NCT01006616|517142649|FG000|Period 1 (6 Months)|Not Treated|0|||
143435833|NCT01006616|517142650|FG001|Period 1 (6 Months)|Not Treated|0|||
143435834|NCT01006616|517142651|FG002|Period 1 (6 Months)|Not Treated|1|||
143435835|NCT01006616|517142652|FG003|Period 1 (6 Months)|Not Treated|1|||
143435836|NCT01006616|517142649|FG000|Period 2 (18 Months)|Adverse Event|6|||
143435837|NCT01006616|517142650|FG001|Period 2 (18 Months)|Adverse Event|6|||
143435838|NCT01006616|517142651|FG002|Period 2 (18 Months)|Adverse Event|6|||
143435839|NCT01006616|517142652|FG003|Period 2 (18 Months)|Adverse Event|4|||
143435840|NCT01006616|517142649|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
143435841|NCT01006616|517142650|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
143435842|NCT01006616|517142651|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
143435843|NCT01006616|517142652|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
143435844|NCT01006616|517142649|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
143435845|NCT01006616|517142650|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
143435846|NCT01006616|517142651|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
143435847|NCT01006616|517142652|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
143435848|NCT01006616|517142649|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
143435849|NCT01006616|517142650|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
143435850|NCT01006616|517142651|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
143435851|NCT01006616|517142652|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
143435852|NCT01006616|517142649|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
143435853|NCT01006616|517142650|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
143435854|NCT01006616|517142651|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
143435855|NCT01006616|517142652|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
143435856|NCT01006616|517142649|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
143435857|NCT01006616|517142650|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
143435858|NCT01006616|517142651|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
143435859|NCT01006616|517142652|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
143435860|NCT01006616|517142649|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
143435861|NCT01006616|517142650|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
143435862|NCT01006616|517142651|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
143435863|NCT01006616|517142652|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
143435864|NCT01006616|517142649|FG000|Period 2 (18 Months)|Study Terminated|63|||
143435865|NCT01006616|517142650|FG001|Period 2 (18 Months)|Study Terminated|46|||
143435866|NCT01006616|517142651|FG002|Period 2 (18 Months)|Study Terminated|44|||
143435867|NCT01006616|517142652|FG003|Period 2 (18 Months)|Study Terminated|70|||
143435868|NCT00952848|517142657|FG000|Overall Study|Withdrawal by Subject|4|||
143435869|NCT02250534|517142658|FG000|Overall Study|Lost to Follow-up|18|||
143435870|NCT02250534|517142659|FG001|Overall Study|Lost to Follow-up|28|||
143435871|NCT02250534|517142660|FG002|Overall Study|Lost to Follow-up|33|||
143435872|NCT02250534|517142658|FG000|Overall Study|Personal reasons|7|||
143435873|NCT02250534|517142659|FG001|Overall Study|Personal reasons|8|||
143435874|NCT02250534|517142660|FG002|Overall Study|Personal reasons|14|||
143435875|NCT02250534|517142658|FG000|Overall Study|Adverse Event|6|||
143435876|NCT02250534|517142659|FG001|Overall Study|Adverse Event|3|||
143435877|NCT02250534|517142660|FG002|Overall Study|Adverse Event|8|||
143435878|NCT02250534|517142658|FG000|Overall Study|incarcerated|2|||
143435879|NCT02250534|517142659|FG001|Overall Study|incarcerated|1|||
143435880|NCT02250534|517142660|FG002|Overall Study|incarcerated|2|||
143435881|NCT02250534|517142658|FG000|Overall Study|Withdrawal by Subject|0|||
143435882|NCT02250534|517142659|FG001|Overall Study|Withdrawal by Subject|1|||
143435883|NCT02250534|517142660|FG002|Overall Study|Withdrawal by Subject|2|||
143435884|NCT02250534|517142658|FG000|Overall Study|Death|0|||
143435885|NCT02250534|517142659|FG001|Overall Study|Death|1|||
143435886|NCT02250534|517142660|FG002|Overall Study|Death|1|||
143435887|NCT02250534|517142658|FG000|Overall Study|Physician Decision|1|||
143435888|NCT02250534|517142659|FG001|Overall Study|Physician Decision|3|||
143435889|NCT02250534|517142660|FG002|Overall Study|Physician Decision|1|||
143435890|NCT02250534|517142658|FG000|Overall Study|Protocol Violation|1|||
143435891|NCT02250534|517142659|FG001|Overall Study|Protocol Violation|0|||
143435892|NCT02250534|517142660|FG002|Overall Study|Protocol Violation|1|||
143435893|NCT02250534|517142658|FG000|Overall Study|Reason unknown|1|||
143435894|NCT02250534|517142659|FG001|Overall Study|Reason unknown|0|||
143435895|NCT02250534|517142660|FG002|Overall Study|Reason unknown|0|||
143435896|NCT00458393|517142661|FG000|Overall Study|Withdrawal by Subject|67|||
143435897|NCT00458393|517142662|FG001|Overall Study|Withdrawal by Subject|80|||
143435898|NCT00458393|517142661|FG000|Overall Study|Physician Decision|31|||
143435899|NCT00458393|517142662|FG001|Overall Study|Physician Decision|22|||
143435900|NCT00458393|517142661|FG000|Overall Study|Relocated|77|||
143435901|NCT00458393|517142662|FG001|Overall Study|Relocated|81|||
143435902|NCT00458393|517142661|FG000|Overall Study|Lost to Follow-up|115|||
143435903|NCT00458393|517142662|FG001|Overall Study|Lost to Follow-up|92|||
143435904|NCT00458393|517142661|FG000|Overall Study|Sites marked other on the form.|19|||
143435905|NCT00458393|517142662|FG001|Overall Study|Sites marked other on the form.|20|||
143435906|NCT01253447|517142664|FG000|Overall Study|Adverse Event|2|||
143435907|NCT02299427|517142665|FG000|Overall Study|Withdrawal by Subject|1|||
143435908|NCT02299427|517142666|FG001|Overall Study|Withdrawal by Subject|0|||
143435909|NCT02299427|517142665|FG000|Overall Study|Lost to Follow-up|1|||
143435910|NCT02299427|517142666|FG001|Overall Study|Lost to Follow-up|3|||
143435911|NCT02299427|517142665|FG000|Overall Study|not adherent to dog website use|21|||
143435912|NCT02299427|517142666|FG001|Overall Study|not adherent to dog website use|0|||
143435913|NCT01121913|517142669|FG000|First Intervention Period|Adverse Event|0|||
143435914|NCT01121913|517142670|FG001|First Intervention Period|Adverse Event|0|||
143435915|NCT01121913|517142671|FG002|First Intervention Period|Adverse Event|1|||
143435916|NCT01121913|517142672|FG003|First Intervention Period|Adverse Event|0|||
143435917|NCT01121913|517142669|FG000|First Washout Period|Withdrawal by Subject|1|||
143435918|NCT01121913|517142670|FG001|First Washout Period|Withdrawal by Subject|0|||
143435919|NCT01121913|517142671|FG002|First Washout Period|Withdrawal by Subject|0|||
143435920|NCT01121913|517142672|FG003|First Washout Period|Withdrawal by Subject|0|||
143435921|NCT01121913|517142669|FG000|Second Intervention Period|Adverse Event|0|||
143435922|NCT01121913|517142670|FG001|Second Intervention Period|Adverse Event|0|||
143435923|NCT01121913|517142671|FG002|Second Intervention Period|Adverse Event|1|||
143435924|NCT01121913|517142672|FG003|Second Intervention Period|Adverse Event|0|||
143435925|NCT01121913|517142669|FG000|Second Washout Period|Withdrawal by Subject|0|||
143435926|NCT01121913|517142670|FG001|Second Washout Period|Withdrawal by Subject|0|||
143435927|NCT01121913|517142671|FG002|Second Washout Period|Withdrawal by Subject|1|||
143435928|NCT01121913|517142672|FG003|Second Washout Period|Withdrawal by Subject|0|||
143435929|NCT01121913|517142669|FG000|Third Washout Period|Adverse Event|1|||
143435930|NCT01121913|517142670|FG001|Third Washout Period|Adverse Event|0|||
143435931|NCT01121913|517142671|FG002|Third Washout Period|Adverse Event|0|||
143435932|NCT01121913|517142672|FG003|Third Washout Period|Adverse Event|0|||
143435933|NCT00937521|517142673|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
143435934|NCT00937521|517142674|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
143435935|NCT00937521|517142675|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
143435936|NCT00937521|517142676|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
143435937|NCT00937521|517142677|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
143435938|NCT00937521|517142678|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
143435939|NCT00937521|517142679|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
143435940|NCT00937521|517142680|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
143435941|NCT00937521|517142673|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
143435942|NCT00937521|517142674|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
143435943|NCT00937521|517142675|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
143435944|NCT00937521|517142676|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
143435945|NCT00937521|517142677|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
143435946|NCT00937521|517142678|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
143435947|NCT00937521|517142679|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
143435948|NCT00937521|517142680|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
143435949|NCT00937521|517142673|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
143435950|NCT00937521|517142674|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
143435951|NCT00937521|517142675|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
143435952|NCT00937521|517142676|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
143435953|NCT00937521|517142677|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
143435954|NCT00937521|517142678|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
143435955|NCT00937521|517142679|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
143435956|NCT00937521|517142680|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
143435957|NCT00937521|517142673|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
143435958|NCT00937521|517142674|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
143435959|NCT00937521|517142675|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
143435960|NCT00937521|517142676|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
143435961|NCT00937521|517142677|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
143435962|NCT00937521|517142678|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
143435963|NCT00937521|517142679|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
143435964|NCT00937521|517142680|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
143435965|NCT00937521|517142673|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
143435966|NCT00937521|517142674|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
143435967|NCT00937521|517142675|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
143435968|NCT00937521|517142676|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
143435969|NCT00937521|517142677|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
143435970|NCT00937521|517142678|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
143435971|NCT00937521|517142679|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
143435972|NCT00937521|517142680|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
143435973|NCT00937521|517142673|FG000|Booster Phase|Adverse Event|0|||
143435974|NCT00937521|517142674|FG001|Booster Phase|Adverse Event|0|||
143435975|NCT00937521|517142675|FG002|Booster Phase|Adverse Event|0|||
143435976|NCT00937521|517142676|FG003|Booster Phase|Adverse Event|0|||
143435977|NCT00937521|517142677|FG004|Booster Phase|Adverse Event|0|||
143435978|NCT00937521|517142678|FG005|Booster Phase|Adverse Event|0|||
143435979|NCT00937521|517142679|FG006|Booster Phase|Adverse Event|1|||
143435980|NCT00937521|517142680|FG007|Booster Phase|Adverse Event|0|||
143435981|NCT00937521|517142673|FG000|Booster Phase|Withdrawal by Subject|1|||
143435982|NCT00937521|517142674|FG001|Booster Phase|Withdrawal by Subject|0|||
143435983|NCT00937521|517142675|FG002|Booster Phase|Withdrawal by Subject|0|||
143435984|NCT00937521|517142676|FG003|Booster Phase|Withdrawal by Subject|1|||
143435985|NCT00937521|517142677|FG004|Booster Phase|Withdrawal by Subject|0|||
143435986|NCT00937521|517142678|FG005|Booster Phase|Withdrawal by Subject|0|||
143435987|NCT00937521|517142679|FG006|Booster Phase|Withdrawal by Subject|0|||
143435988|NCT00937521|517142680|FG007|Booster Phase|Withdrawal by Subject|2|||
143435989|NCT00937521|517142673|FG000|Booster Phase|Lost to Follow-up|2|||
143435990|NCT00937521|517142674|FG001|Booster Phase|Lost to Follow-up|2|||
143435991|NCT00937521|517142675|FG002|Booster Phase|Lost to Follow-up|4|||
143435992|NCT00937521|517142676|FG003|Booster Phase|Lost to Follow-up|2|||
143435993|NCT00937521|517142677|FG004|Booster Phase|Lost to Follow-up|4|||
143435994|NCT00937521|517142678|FG005|Booster Phase|Lost to Follow-up|4|||
143435995|NCT00937521|517142679|FG006|Booster Phase|Lost to Follow-up|3|||
143435996|NCT00937521|517142680|FG007|Booster Phase|Lost to Follow-up|0|||
143435997|NCT00937521|517142673|FG000|Booster Phase|Administrative Reason|0|||
143435998|NCT00937521|517142674|FG001|Booster Phase|Administrative Reason|0|||
143435999|NCT00937521|517142675|FG002|Booster Phase|Administrative Reason|1|||
143436000|NCT00937521|517142676|FG003|Booster Phase|Administrative Reason|0|||
143436001|NCT00937521|517142677|FG004|Booster Phase|Administrative Reason|1|||
143436002|NCT00937521|517142678|FG005|Booster Phase|Administrative Reason|1|||
143436003|NCT00937521|517142679|FG006|Booster Phase|Administrative Reason|0|||
143436004|NCT00937521|517142680|FG007|Booster Phase|Administrative Reason|0|||
143436005|NCT00937521|517142673|FG000|Booster Phase|Protocol Deviation|0|||
143436006|NCT00937521|517142674|FG001|Booster Phase|Protocol Deviation|0|||
143436007|NCT00937521|517142675|FG002|Booster Phase|Protocol Deviation|0|||
143436008|NCT00937521|517142676|FG003|Booster Phase|Protocol Deviation|0|||
143436009|NCT00937521|517142677|FG004|Booster Phase|Protocol Deviation|0|||
143436010|NCT00937521|517142678|FG005|Booster Phase|Protocol Deviation|0|||
143436011|NCT00937521|517142679|FG006|Booster Phase|Protocol Deviation|1|||
143436012|NCT00937521|517142680|FG007|Booster Phase|Protocol Deviation|0|||
143436013|NCT03269695|517142686|FG000|Overall Study|Adverse Event|2|||
143436014|NCT03269695|517142687|FG001|Overall Study|Adverse Event|1|||
143436015|NCT03269695|517142686|FG000|Overall Study|Lack of Efficacy|0|||
143436016|NCT03269695|517142687|FG001|Overall Study|Lack of Efficacy|1|||
143436017|NCT03269695|517142686|FG000|Overall Study|Withdrawal by Subject|0|||
143436018|NCT03269695|517142687|FG001|Overall Study|Withdrawal by Subject|1|||
143436019|NCT01313624|517142688|FG000|Double-Blind Phase|Adverse Event|27|||
143436020|NCT01313624|517142689|FG001|Double-Blind Phase|Adverse Event|4|||
143436021|NCT01313624|517142688|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
143436022|NCT01313624|517142689|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
143436023|NCT01313624|517142688|FG000|Double-Blind Phase|Lost to Follow-up|0|||
143436024|NCT01313624|517142689|FG001|Double-Blind Phase|Lost to Follow-up|2|||
143436025|NCT01313624|517142688|FG000|Double-Blind Phase|Physician Decision|1|||
143436026|NCT01313624|517142689|FG001|Double-Blind Phase|Physician Decision|0|||
143436027|NCT01313624|517142688|FG000|Double-Blind Phase|Lack of Efficacy|1|||
143436028|NCT01313624|517142689|FG001|Double-Blind Phase|Lack of Efficacy|0|||
143436029|NCT01313624|517142688|FG000|Open-Label Phase|Adverse Event|1|||
143436030|NCT01313624|517142689|FG001|Open-Label Phase|Adverse Event|10|||
143436031|NCT01313624|517142688|FG000|Open-Label Phase|Withdrawal by Subject|2|||
143436032|NCT01313624|517142689|FG001|Open-Label Phase|Withdrawal by Subject|2|||
143436033|NCT01313624|517142688|FG000|Open-Label Phase|Lost to Follow-up|1|||
143436034|NCT01313624|517142689|FG001|Open-Label Phase|Lost to Follow-up|1|||
143436035|NCT00104637|517142690|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
143436036|NCT00104637|517142691|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
143436037|NCT00239681|517142694|FG000|Overall Study|Adverse Event|100|||
143436038|NCT00239681|517142695|FG001|Overall Study|Adverse Event|99|||
143436039|NCT00239681|517142694|FG000|Overall Study|Withdrawal by Subject|458|||
143436040|NCT00239681|517142695|FG001|Overall Study|Withdrawal by Subject|489|||
143436041|NCT00239681|517142694|FG000|Overall Study|Lost to Follow-up|28|||
143436042|NCT00239681|517142695|FG001|Overall Study|Lost to Follow-up|22|||
143436043|NCT00239681|517142694|FG000|Overall Study|Protocol Violation|4|||
143436044|NCT00239681|517142695|FG001|Overall Study|Protocol Violation|4|||
143436045|NCT00239681|517142694|FG000|Overall Study|Physician Decision|13|||
143436046|NCT00239681|517142695|FG001|Overall Study|Physician Decision|17|||
143436047|NCT00239681|517142694|FG000|Overall Study|No information chacked on CaseReportForm|90|||
143436048|NCT00239681|517142695|FG001|Overall Study|No information chacked on CaseReportForm|84|||
143436049|NCT02447718|517142696|FG000|Overall Study|Lost to Follow-up|8|||
143436050|NCT02447718|517142697|FG001|Overall Study|Lost to Follow-up|0|||
143436051|NCT02447718|517142696|FG000|Overall Study|Withdrawal by Subject|3|||
143436052|NCT02447718|517142697|FG001|Overall Study|Withdrawal by Subject|0|||
143436053|NCT02447718|517142696|FG000|Overall Study|Screen Failure|1|||
143436054|NCT02447718|517142697|FG001|Overall Study|Screen Failure|0|||
143436055|NCT02654132|517142698|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
143436056|NCT02654132|517142699|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
143436057|NCT02654132|517142698|FG000|Treatment Period|Disease progression|43|||
143436058|NCT02654132|517142699|FG001|Treatment Period|Disease progression|38|||
143436059|NCT02654132|517142698|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
143436060|NCT02654132|517142699|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
143436061|NCT02654132|517142698|FG000|Treatment Period|Other reasons|4|||
143436062|NCT02654132|517142699|FG001|Treatment Period|Other reasons|2|||
143436063|NCT02654132|517142698|FG000|Treatment Period|Study drug toxicity|2|||
143436064|NCT02654132|517142699|FG001|Treatment Period|Study drug toxicity|2|||
143436065|NCT02654132|517142698|FG000|Treatment Period|Withdrawal by Subject|2|||
143436066|NCT02654132|517142699|FG001|Treatment Period|Withdrawal by Subject|1|||
143436067|NCT02654132|517142698|FG000|Treatment Period|Maximum Clinical Benefit|0|||
143436068|NCT02654132|517142699|FG001|Treatment Period|Maximum Clinical Benefit|2|||
143436069|NCT02654132|517142698|FG000|Treatment Period|Participant request to discontinue|2|||
143436070|NCT02654132|517142699|FG001|Treatment Period|Participant request to discontinue|0|||
143436071|NCT02654132|517142698|FG000|Treatment Period|Administrative reasons by sponsor|0|||
143436072|NCT02654132|517142699|FG001|Treatment Period|Administrative reasons by sponsor|1|||
143436073|NCT02654132|517142698|FG000|Treatment Period|Death|1|||
143436074|NCT02654132|517142699|FG001|Treatment Period|Death|0|||
143436075|NCT03713320|517142702|FG000|Randomized Period|Adverse Event|1|||
143436076|NCT03713320|517142703|FG001|Randomized Period|Adverse Event|5|||
143436077|NCT03713320|517142704|FG002|Randomized Period|Adverse Event|0|||
143436078|NCT03713320|517142702|FG000|Randomized Period|Physician Decision|1|||
143436079|NCT03713320|517142703|FG001|Randomized Period|Physician Decision|1|||
143436080|NCT03713320|517142704|FG002|Randomized Period|Physician Decision|0|||
143436081|NCT03713320|517142702|FG000|Randomized Period|Withdrawal by Subject|4|||
143436082|NCT03713320|517142703|FG001|Randomized Period|Withdrawal by Subject|0|||
143436083|NCT03713320|517142704|FG002|Randomized Period|Withdrawal by Subject|0|||
143436084|NCT03713320|517142702|FG000|Randomized Period|Participant decision|3|||
143436085|NCT03713320|517142703|FG001|Randomized Period|Participant decision|1|||
143436086|NCT03713320|517142704|FG002|Randomized Period|Participant decision|0|||
143436087|NCT03713320|517142702|FG000|Randomized Period|Study terminated by sponsor|6|||
143436088|NCT03713320|517142703|FG001|Randomized Period|Study terminated by sponsor|3|||
143436089|NCT03713320|517142704|FG002|Randomized Period|Study terminated by sponsor|0|||
143436090|NCT03713320|517142702|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
143436091|NCT03713320|517142703|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
143436092|NCT03713320|517142704|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
143436093|NCT03713320|517142702|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
143436094|NCT03713320|517142703|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
143436095|NCT03713320|517142704|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
143436096|NCT01880437|517142705|FG000|Overall Study|Death|12|||
143436097|NCT01880437|517142706|FG001|Overall Study|Death|4|||
143436098|NCT01880437|517142707|FG002|Overall Study|Death|17|||
143436099|NCT01880437|517142705|FG000|Overall Study|Study terminated by Sponsor|3|||
143436100|NCT01880437|517142706|FG001|Overall Study|Study terminated by Sponsor|0|||
143436101|NCT01880437|517142707|FG002|Overall Study|Study terminated by Sponsor|2|||
143436102|NCT00909532|517142708|FG000|Overall Study|Adverse Event|4|||
143436103|NCT00909532|517142709|FG001|Overall Study|Adverse Event|1|||
143436104|NCT00909532|517142708|FG000|Overall Study|Pregnancy|0|||
143436105|NCT00909532|517142709|FG001|Overall Study|Pregnancy|1|||
143436106|NCT00909532|517142708|FG000|Overall Study|Prohibited Medication|2|||
143436107|NCT00909532|517142709|FG001|Overall Study|Prohibited Medication|1|||
143436108|NCT00909532|517142708|FG000|Overall Study|Withdrawal of Consent|1|||
143436109|NCT00909532|517142709|FG001|Overall Study|Withdrawal of Consent|1|||
143436110|NCT00909532|517142708|FG000|Overall Study|Noncompliance with Study Requirements|0|||
143436111|NCT00909532|517142709|FG001|Overall Study|Noncompliance with Study Requirements|2|||
143436112|NCT00909532|517142708|FG000|Overall Study|Physician Decision|1|||
143436113|NCT00909532|517142709|FG001|Overall Study|Physician Decision|0|||
143436114|NCT00909532|517142708|FG000|Overall Study|Wrong Genotype|1|||
143436115|NCT00909532|517142709|FG001|Overall Study|Wrong Genotype|0|||
143436116|NCT00909532|517142708|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
143436117|NCT00909532|517142709|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
143436118|NCT02287233|517142710|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
143436119|NCT02287233|517142711|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
143436120|NCT02287233|517142712|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
143436121|NCT02287233|517142710|FG000|Overall Study|Adverse Event Related to Progression|0|||
143436122|NCT02287233|517142711|FG001|Overall Study|Adverse Event Related to Progression|2|||
143436123|NCT02287233|517142712|FG002|Overall Study|Adverse Event Related to Progression|8|||
143436124|NCT02287233|517142710|FG000|Overall Study|Physician Decision|1|||
143436125|NCT02287233|517142711|FG001|Overall Study|Physician Decision|2|||
143436126|NCT02287233|517142712|FG002|Overall Study|Physician Decision|4|||
143436127|NCT02287233|517142710|FG000|Overall Study|Progressive Disease with Death|0|||
143436128|NCT02287233|517142711|FG001|Overall Study|Progressive Disease with Death|0|||
143436129|NCT02287233|517142712|FG002|Overall Study|Progressive Disease with Death|10|||
143436130|NCT02287233|517142710|FG000|Overall Study|Progressive Disease Without Death|2|||
143436131|NCT02287233|517142711|FG001|Overall Study|Progressive Disease Without Death|3|||
143436132|NCT02287233|517142712|FG002|Overall Study|Progressive Disease Without Death|20|||
143436133|NCT02287233|517142710|FG000|Overall Study|Withdrawal by Subject|1|||
143436134|NCT02287233|517142711|FG001|Overall Study|Withdrawal by Subject|1|||
143436135|NCT02287233|517142712|FG002|Overall Study|Withdrawal by Subject|7|||
143436136|NCT02287233|517142710|FG000|Overall Study|Other|3|||
143436137|NCT02287233|517142711|FG001|Overall Study|Other|0|||
143436138|NCT02287233|517142712|FG002|Overall Study|Other|15|||
143436139|NCT02287233|517142710|FG000|Overall Study|Did Not Receive Treatment|0|||
143436140|NCT02287233|517142711|FG001|Overall Study|Did Not Receive Treatment|0|||
143436141|NCT02287233|517142712|FG002|Overall Study|Did Not Receive Treatment|2|||
143436142|NCT00085566|517142713|FG000|Overall Study|Adverse Event|0|||
143436143|NCT00085566|517142714|FG001|Overall Study|Adverse Event|0|||
143436144|NCT00085566|517142715|FG002|Overall Study|Adverse Event|10|||
143436145|NCT00085566|517142713|FG000|Overall Study|Patient Not treated|0|||
143436146|NCT00085566|517142714|FG001|Overall Study|Patient Not treated|0|||
143436147|NCT00085566|517142715|FG002|Overall Study|Patient Not treated|3|||
143436148|NCT00085566|517142713|FG000|Overall Study|Clinical progression|0|||
143436149|NCT00085566|517142714|FG001|Overall Study|Clinical progression|0|||
143436150|NCT00085566|517142715|FG002|Overall Study|Clinical progression|1|||
143436151|NCT02601209|517142716|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
143436152|NCT02601209|517142717|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
143436153|NCT02601209|517142718|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
143436154|NCT02601209|517142719|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
143436155|NCT02601209|517142720|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
143436156|NCT02601209|517142721|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
143436157|NCT02601209|517142722|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
143436158|NCT02601209|517142723|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
143436159|NCT02601209|517142724|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
143436160|NCT02601209|517142716|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
143436161|NCT02601209|517142717|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
143436162|NCT02601209|517142718|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
143436163|NCT02601209|517142719|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
143436164|NCT02601209|517142720|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
143436165|NCT02601209|517142721|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
143436166|NCT02601209|517142722|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
143436167|NCT02601209|517142723|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
143436168|NCT02601209|517142724|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
143436169|NCT02804399|517142725|FG000|Period 2|Adverse Event|0|||
143436170|NCT02804399|517142726|FG001|Period 2|Adverse Event|1|||
143436171|NCT01174264|517142727|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
143436172|NCT01174264|517142728|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
143436173|NCT01174264|517142729|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
143436174|NCT01174264|517142727|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
143436175|NCT01174264|517142728|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
143436176|NCT01174264|517142729|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
143436177|NCT01174264|517142727|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
143436178|NCT01174264|517142728|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
143436179|NCT01174264|517142729|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
143436180|NCT01774305|517142731|FG000|Overall Study|Physician Decision|1|||
143436181|NCT01774305|517142732|FG001|Overall Study|Physician Decision|0|||
143436182|NCT01157377|517142734|FG000|Overall Study|Lost to Follow-up|0|||
143436183|NCT01157377|517142735|FG001|Overall Study|Lost to Follow-up|0|||
143436184|NCT01157377|517142736|FG002|Overall Study|Lost to Follow-up|1|||
143436185|NCT01157377|517142737|FG003|Overall Study|Lost to Follow-up|0|||
143436186|NCT01157377|517142738|FG004|Overall Study|Lost to Follow-up|1|||
143436187|NCT01157377|517142739|FG005|Overall Study|Lost to Follow-up|1|||
143436188|NCT01157377|517142740|FG006|Overall Study|Lost to Follow-up|0|||
143436189|NCT01157377|517142734|FG000|Overall Study|Personal Reasons|2|||
143436190|NCT01157377|517142735|FG001|Overall Study|Personal Reasons|1|||
143436191|NCT01157377|517142736|FG002|Overall Study|Personal Reasons|0|||
143436192|NCT01157377|517142737|FG003|Overall Study|Personal Reasons|1|||
143436193|NCT01157377|517142738|FG004|Overall Study|Personal Reasons|0|||
143436194|NCT01157377|517142739|FG005|Overall Study|Personal Reasons|0|||
143436195|NCT01157377|517142740|FG006|Overall Study|Personal Reasons|0|||
143436196|NCT01157377|517142734|FG000|Overall Study|Protocol Violation|0|||
143436197|NCT01157377|517142735|FG001|Overall Study|Protocol Violation|0|||
143436198|NCT01157377|517142736|FG002|Overall Study|Protocol Violation|0|||
143436199|NCT01157377|517142737|FG003|Overall Study|Protocol Violation|0|||
143436200|NCT01157377|517142738|FG004|Overall Study|Protocol Violation|0|||
143436201|NCT01157377|517142739|FG005|Overall Study|Protocol Violation|1|||
143436202|NCT01157377|517142740|FG006|Overall Study|Protocol Violation|0|||
143436203|NCT01157377|517142734|FG000|Overall Study|Lack of Efficacy|0|||
143436204|NCT01157377|517142735|FG001|Overall Study|Lack of Efficacy|0|||
143436205|NCT01157377|517142736|FG002|Overall Study|Lack of Efficacy|0|||
143436206|NCT01157377|517142737|FG003|Overall Study|Lack of Efficacy|0|||
143436207|NCT01157377|517142738|FG004|Overall Study|Lack of Efficacy|0|||
143436208|NCT01157377|517142739|FG005|Overall Study|Lack of Efficacy|0|||
143436209|NCT01157377|517142740|FG006|Overall Study|Lack of Efficacy|1|||
143436210|NCT01157377|517142734|FG000|Overall Study|Other Miscellaneous Reasons|0|||
143436211|NCT01157377|517142735|FG001|Overall Study|Other Miscellaneous Reasons|2|||
143436212|NCT01157377|517142736|FG002|Overall Study|Other Miscellaneous Reasons|0|||
143436213|NCT01157377|517142737|FG003|Overall Study|Other Miscellaneous Reasons|0|||
143436214|NCT01157377|517142738|FG004|Overall Study|Other Miscellaneous Reasons|1|||
143436215|NCT01157377|517142739|FG005|Overall Study|Other Miscellaneous Reasons|1|||
143436216|NCT01157377|517142740|FG006|Overall Study|Other Miscellaneous Reasons|1|||
143436217|NCT00087555|517142741|FG000|Overall Study|Adverse Event|3|||
143436218|NCT00087555|517142742|FG001|Overall Study|Adverse Event|6|||
143436219|NCT00087555|517142743|FG002|Overall Study|Adverse Event|14|||
143436220|NCT00087555|517142741|FG000|Overall Study|Lost to Follow-up|0|||
143436221|NCT00087555|517142742|FG001|Overall Study|Lost to Follow-up|1|||
143436222|NCT00087555|517142743|FG002|Overall Study|Lost to Follow-up|1|||
143436223|NCT00087555|517142741|FG000|Overall Study|Non - Compliance|1|||
143436224|NCT00087555|517142742|FG001|Overall Study|Non - Compliance|0|||
143436225|NCT00087555|517142743|FG002|Overall Study|Non - Compliance|0|||
143436226|NCT00087555|517142741|FG000|Overall Study|Protocol Violation|0|||
143436227|NCT00087555|517142742|FG001|Overall Study|Protocol Violation|0|||
143436228|NCT00087555|517142743|FG002|Overall Study|Protocol Violation|2|||
143436229|NCT00087555|517142741|FG000|Overall Study|Screen Failure|1|||
143436230|NCT00087555|517142742|FG001|Overall Study|Screen Failure|1|||
143436231|NCT00087555|517142743|FG002|Overall Study|Screen Failure|0|||
143436232|NCT00087555|517142741|FG000|Overall Study|Pregnancy|0|||
143436233|NCT00087555|517142742|FG001|Overall Study|Pregnancy|1|||
143436234|NCT00087555|517142743|FG002|Overall Study|Pregnancy|1|||
143436235|NCT00087555|517142741|FG000|Overall Study|Withdrawal by Subject|3|||
143436236|NCT00087555|517142742|FG001|Overall Study|Withdrawal by Subject|2|||
143436237|NCT00087555|517142743|FG002|Overall Study|Withdrawal by Subject|1|||
143436238|NCT00087555|517142741|FG000|Overall Study|Lack of Efficacy|2|||
143436239|NCT00087555|517142742|FG001|Overall Study|Lack of Efficacy|0|||
143436240|NCT00087555|517142743|FG002|Overall Study|Lack of Efficacy|1|||
143436241|NCT00087555|517142741|FG000|Overall Study|Non Compliance|0|||
143436242|NCT00087555|517142742|FG001|Overall Study|Non Compliance|0|||
143436243|NCT00087555|517142743|FG002|Overall Study|Non Compliance|1|||
143436244|NCT00087555|517142741|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
143436245|NCT00087555|517142742|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
143436246|NCT00087555|517142743|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
143436247|NCT00087555|517142741|FG000|Overall Study|Patient wanted to go back on Med|1|||
143436248|NCT00087555|517142742|FG001|Overall Study|Patient wanted to go back on Med|0|||
143436249|NCT00087555|517142743|FG002|Overall Study|Patient wanted to go back on Med|0|||
143436250|NCT05523219|517142744|FG000|Overall Study|Wrong inclusion|1|||
143436251|NCT05523219|517142744|FG000|Overall Study|Lost to Follow-up|7|||
143436252|NCT03772613|517142747|FG000|Overall Study|Lost to Follow-up|0|||
143436253|NCT03772613|517142748|FG001|Overall Study|Lost to Follow-up|1|||
143436254|NCT03772613|517142749|FG002|Overall Study|Lost to Follow-up|1|||
143436255|NCT00661713|517142750|FG000|Overall Study|Death|1|||
143436256|NCT00661713|517142751|FG001|Overall Study|Death|0|||
143436257|NCT00661713|517142752|FG002|Overall Study|Death|0|||
143436258|NCT00661713|517142753|FG003|Overall Study|Death|0|||
143436259|NCT00661713|517142754|FG004|Overall Study|Death|1|||
143436260|NCT00661713|517142755|FG005|Overall Study|Death|0|||
143436261|NCT00661713|517142756|FG006|Overall Study|Death|0|||
143436262|NCT00661713|517142757|FG007|Overall Study|Death|0|||
143436263|NCT00661713|517142750|FG000|Overall Study|Unable to Classify|1|||
143436264|NCT00661713|517142751|FG001|Overall Study|Unable to Classify|0|||
143436265|NCT00661713|517142752|FG002|Overall Study|Unable to Classify|0|||
143436266|NCT00661713|517142753|FG003|Overall Study|Unable to Classify|0|||
143436267|NCT00661713|517142754|FG004|Overall Study|Unable to Classify|0|||
143436268|NCT00661713|517142755|FG005|Overall Study|Unable to Classify|0|||
143436269|NCT00661713|517142756|FG006|Overall Study|Unable to Classify|0|||
143436270|NCT00661713|517142757|FG007|Overall Study|Unable to Classify|0|||
143436271|NCT00661713|517142750|FG000|Overall Study|Protocol Violation|1|||
143436272|NCT00661713|517142751|FG001|Overall Study|Protocol Violation|6|||
143436273|NCT00661713|517142752|FG002|Overall Study|Protocol Violation|3|||
143436274|NCT00661713|517142753|FG003|Overall Study|Protocol Violation|3|||
143436275|NCT00661713|517142754|FG004|Overall Study|Protocol Violation|0|||
143436276|NCT00661713|517142755|FG005|Overall Study|Protocol Violation|2|||
143436277|NCT00661713|517142756|FG006|Overall Study|Protocol Violation|2|||
143436278|NCT00661713|517142757|FG007|Overall Study|Protocol Violation|1|||
143436279|NCT00661713|517142750|FG000|Overall Study|Withdrawal by Subject|11|||
143436280|NCT00661713|517142751|FG001|Overall Study|Withdrawal by Subject|25|||
143436281|NCT00661713|517142752|FG002|Overall Study|Withdrawal by Subject|12|||
143436282|NCT00661713|517142753|FG003|Overall Study|Withdrawal by Subject|21|||
143436283|NCT00661713|517142754|FG004|Overall Study|Withdrawal by Subject|12|||
143436284|NCT00661713|517142755|FG005|Overall Study|Withdrawal by Subject|26|||
143436285|NCT00661713|517142756|FG006|Overall Study|Withdrawal by Subject|45|||
143436286|NCT00661713|517142757|FG007|Overall Study|Withdrawal by Subject|9|||
143436287|NCT00661713|517142750|FG000|Overall Study|Lost to Follow-up|2|||
143436288|NCT00661713|517142751|FG001|Overall Study|Lost to Follow-up|7|||
143436289|NCT00661713|517142752|FG002|Overall Study|Lost to Follow-up|2|||
143436290|NCT00661713|517142753|FG003|Overall Study|Lost to Follow-up|2|||
143436291|NCT00661713|517142754|FG004|Overall Study|Lost to Follow-up|5|||
143436292|NCT00661713|517142755|FG005|Overall Study|Lost to Follow-up|7|||
143436293|NCT00661713|517142756|FG006|Overall Study|Lost to Follow-up|14|||
143436294|NCT00661713|517142757|FG007|Overall Study|Lost to Follow-up|1|||
143436295|NCT00661713|517142750|FG000|Overall Study|Administrative Reason|0|||
143436296|NCT00661713|517142751|FG001|Overall Study|Administrative Reason|1|||
143436297|NCT00661713|517142752|FG002|Overall Study|Administrative Reason|0|||
143436298|NCT00661713|517142753|FG003|Overall Study|Administrative Reason|2|||
143436299|NCT00661713|517142754|FG004|Overall Study|Administrative Reason|2|||
143436300|NCT00661713|517142755|FG005|Overall Study|Administrative Reason|2|||
143436301|NCT00661713|517142756|FG006|Overall Study|Administrative Reason|1|||
143436302|NCT00661713|517142757|FG007|Overall Study|Administrative Reason|0|||
143436303|NCT00661713|517142750|FG000|Overall Study|Adverse Event|0|||
143436304|NCT00661713|517142751|FG001|Overall Study|Adverse Event|0|||
143436305|NCT00661713|517142752|FG002|Overall Study|Adverse Event|0|||
143436306|NCT00661713|517142753|FG003|Overall Study|Adverse Event|0|||
143436307|NCT00661713|517142754|FG004|Overall Study|Adverse Event|0|||
143436308|NCT00661713|517142755|FG005|Overall Study|Adverse Event|0|||
143436309|NCT00661713|517142756|FG006|Overall Study|Adverse Event|1|||
143436310|NCT00661713|517142757|FG007|Overall Study|Adverse Event|0|||
143436311|NCT00661713|517142750|FG000|Overall Study|Inappropriate Enrollment|0|||
143436312|NCT00661713|517142751|FG001|Overall Study|Inappropriate Enrollment|0|||
143436313|NCT00661713|517142752|FG002|Overall Study|Inappropriate Enrollment|0|||
143436314|NCT00661713|517142753|FG003|Overall Study|Inappropriate Enrollment|0|||
143436315|NCT00661713|517142754|FG004|Overall Study|Inappropriate Enrollment|0|||
143436316|NCT00661713|517142755|FG005|Overall Study|Inappropriate Enrollment|0|||
143436317|NCT00661713|517142756|FG006|Overall Study|Inappropriate Enrollment|1|||
143436318|NCT00661713|517142757|FG007|Overall Study|Inappropriate Enrollment|0|||
143436319|NCT01190449|517142758|FG000|Overall Study|Ineligible|0|||
143436320|NCT01190449|517142759|FG001|Overall Study|Ineligible|4|||
143436321|NCT04811339|517142760|FG000|Overall Study|lack of transportation not wanting to return|4|||
143436322|NCT04811339|517142761|FG001|Overall Study|lack of transportation not wanting to return|8|||
143436323|NCT04811339|517142762|FG002|Overall Study|lack of transportation not wanting to return|0|||
143436324|NCT04811339|517142760|FG000|Overall Study|Adverse Event|3|||
143436325|NCT04811339|517142761|FG001|Overall Study|Adverse Event|0|||
143436326|NCT04811339|517142762|FG002|Overall Study|Adverse Event|0|||
143436327|NCT04811339|517142760|FG000|Overall Study|Lost to Follow-up|1|||
143436328|NCT04811339|517142761|FG001|Overall Study|Lost to Follow-up|0|||
143436329|NCT04811339|517142762|FG002|Overall Study|Lost to Follow-up|0|||
143436330|NCT04811339|517142760|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
143436331|NCT04811339|517142761|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
143436332|NCT04811339|517142762|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
143436333|NCT04811339|517142760|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
143436334|NCT04811339|517142761|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
143436335|NCT04811339|517142762|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
143436336|NCT04811339|517142760|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
143436337|NCT04811339|517142761|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
143436338|NCT04811339|517142762|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
143436339|NCT04811339|517142760|FG000|Overall Study|Withdrawal by Subject|0|||
143436340|NCT04811339|517142761|FG001|Overall Study|Withdrawal by Subject|3|||
143436341|NCT04811339|517142762|FG002|Overall Study|Withdrawal by Subject|0|||
143436342|NCT04811339|517142760|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
143436343|NCT04811339|517142761|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
143436344|NCT04811339|517142762|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
143436345|NCT04811339|517142760|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
143436346|NCT04811339|517142761|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
143436347|NCT04811339|517142762|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
143436348|NCT02388347|517145337|FG000|Overall Study|Withdrawal by Subject|0|||
143436349|NCT02388347|517145338|FG001|Overall Study|Withdrawal by Subject|0|||
143436350|NCT02388347|517145339|FG002|Overall Study|Withdrawal by Subject|1|||
143436351|NCT02388347|517145340|FG003|Overall Study|Withdrawal by Subject|0|||
143436352|NCT02388347|517145341|FG004|Overall Study|Withdrawal by Subject|0|||
143436353|NCT01639742|517145342|FG000|Overall Study|Study Ongoing|17|||
143436354|NCT01639742|517145342|FG000|Overall Study|Lost to Follow-up|1|||
143436355|NCT04398368|517145345|FG000|Overall Study|Withdrawal by Subject|2|||
143436356|NCT02370251|517145347|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
143436357|NCT02370251|517145347|FG000|Overall Study|Death|4|||
143436358|NCT04469465|517145348|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
143436359|NCT04469465|517145349|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
143436360|NCT04469465|517145348|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
143436361|NCT04469465|517145349|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
143436362|NCT04469465|517145348|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
143436363|NCT04469465|517145349|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
143436364|NCT04469465|517145348|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
143436365|NCT04469465|517145349|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
143436366|NCT04469465|517145348|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
143436367|NCT04469465|517145349|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
143436368|NCT04469465|517145348|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
143436369|NCT04469465|517145349|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
143436370|NCT04469465|517145348|FG000|Long-Term Extension (LTE)|Death|0|||
143436371|NCT04469465|517145349|FG001|Long-Term Extension (LTE)|Death|1|||
143436372|NCT04469465|517145348|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
143436373|NCT04469465|517145349|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
143436374|NCT04120376|517145350|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
143436375|NCT04120376|517145351|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
143436376|NCT02053610|517145352|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
143436377|NCT02053610|517145353|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
143436378|NCT02053610|517145352|FG000|Overall Study|Withdrew Consent|2|||
143436379|NCT02053610|517145353|FG001|Overall Study|Withdrew Consent|9|||
143436380|NCT02053610|517145352|FG000|Overall Study|Death|5|||
143436381|NCT02053610|517145353|FG001|Overall Study|Death|5|||
143436382|NCT02053610|517145352|FG000|Overall Study|Administrative/Other|1|||
143436383|NCT02053610|517145353|FG001|Overall Study|Administrative/Other|1|||
143436384|NCT02053610|517145352|FG000|Overall Study|Disease Progression|2|||
143436385|NCT02053610|517145353|FG001|Overall Study|Disease Progression|3|||
143436386|NCT02053610|517145352|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
143436387|NCT02053610|517145353|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
143436388|NCT02053610|517145352|FG000|Overall Study|Did not Receive Treatment|4|||
143436389|NCT02053610|517145353|FG001|Overall Study|Did not Receive Treatment|2|||
143436390|NCT02053610|517145352|FG000|Overall Study|Insufficient Therapeutic Response|1|||
143436391|NCT02053610|517145353|FG001|Overall Study|Insufficient Therapeutic Response|1|||
143436392|NCT02053610|517145352|FG000|Overall Study|Violation of Selection Criteria|1|||
143436393|NCT02053610|517145353|FG001|Overall Study|Violation of Selection Criteria|0|||
143436394|NCT02641587|517145354|FG000|Confinement Period|Adverse Event|1|||
143436395|NCT02641587|517145355|FG001|Confinement Period|Adverse Event|0|||
143436396|NCT02641587|517145354|FG000|Confinement Period|Withdrawal by Subject|2|||
143436397|NCT02641587|517145355|FG001|Confinement Period|Withdrawal by Subject|1|||
143436398|NCT02641587|517145354|FG000|Ambulatory Period|Withdrawal by Subject|1|||
143436399|NCT02641587|517145355|FG001|Ambulatory Period|Withdrawal by Subject|0|||
143436400|NCT01165177|517145356|FG000|Overall Study|Serious Adverse Event|227|||
143436401|NCT01165177|517145357|FG001|Overall Study|Serious Adverse Event|235|||
143436402|NCT01165177|517145356|FG000|Overall Study|Withdrawal by Subject|368|||
143436403|NCT01165177|517145357|FG001|Overall Study|Withdrawal by Subject|354|||
143436404|NCT01165177|517145356|FG000|Overall Study|Protocol Violation|19|||
143436405|NCT01165177|517145357|FG001|Overall Study|Protocol Violation|21|||
143436406|NCT01165177|517145356|FG000|Overall Study|Non-serious adverse event|30|||
143436407|NCT01165177|517145357|FG001|Overall Study|Non-serious adverse event|18|||
143436408|NCT01165177|517145356|FG000|Overall Study|Other unspecified reasons|47|||
143436409|NCT01165177|517145357|FG001|Overall Study|Other unspecified reasons|35|||
143436410|NCT01165177|517145356|FG000|Overall Study|Suspected HZ episode|0|||
143436411|NCT01165177|517145357|FG001|Overall Study|Suspected HZ episode|2|||
143436412|NCT01165177|517145356|FG000|Overall Study|Lost to Follow-up|183|||
143436413|NCT01165177|517145357|FG001|Overall Study|Lost to Follow-up|194|||
143436414|NCT01165177|517145356|FG000|Overall Study|Migrated/ moved from study area|48|||
143436415|NCT01165177|517145357|FG001|Overall Study|Migrated/ moved from study area|43|||
143436416|NCT00781937|517145363|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
143436417|NCT00781937|517145364|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
143436418|NCT00781937|517145363|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
143436419|NCT00781937|517145364|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
143436420|NCT00781937|517145363|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
143436421|NCT00781937|517145364|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
143436422|NCT00781937|517145363|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
143436423|NCT00781937|517145364|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
143436424|NCT00781937|517145363|FG000|Main Trial Period Through Week 56|Unclassified|10|||
143436425|NCT00781937|517145364|FG001|Main Trial Period Through Week 56|Unclassified|15|||
143436426|NCT00781937|517145363|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
143436427|NCT00781937|517145364|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
143436428|NCT00781937|517145363|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
143436429|NCT00781937|517145364|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
143436430|NCT01150045|517145365|FG000|Overall Study|Protocol Violation|0|||
143436431|NCT01150045|517145366|FG001|Overall Study|Protocol Violation|1|||
143436432|NCT01150045|517145367|FG002|Overall Study|Protocol Violation|0|||
143436433|NCT01150045|517145368|FG003|Overall Study|Protocol Violation|1|||
143436434|NCT01663506|517145370|FG000|Overall Study|Lack of Efficacy|3|||
143436435|NCT01663506|517145370|FG000|Overall Study|Consent Withdrawal by Subject|1|||
143436436|NCT01663506|517145370|FG000|Overall Study|Lost to Follow-up|1|||
143436437|NCT01663506|517145370|FG000|Overall Study|Adverse Event|1|||
143436438|NCT01663506|517145370|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
143436439|NCT02094898|517145376|FG000|Overall Study|Clinical Worsening|2|||
143436440|NCT02094898|517145376|FG000|Overall Study|Adverse Event|2|||
143436441|NCT02094898|517145376|FG000|Overall Study|Lack of Efficacy|1|||
143436442|NCT03520075|517145377|FG000|Phase 1 (Dose Escalation)|Death|2|||
143436443|NCT03520075|517145378|FG001|Phase 1 (Dose Escalation)|Death|2|||
143436444|NCT03520075|517145379|FG002|Phase 1 (Dose Escalation)|Death|3|||
143436445|NCT03520075|517145380|FG003|Phase 1 (Dose Escalation)|Death|2|||
143436446|NCT03520075|517145381|FG004|Phase 1 (Dose Escalation)|Death|6|||
143436447|NCT03520075|517145382|FG005|Phase 1 (Dose Escalation)|Death|5|||
143436448|NCT03520075|517145383|FG006|Phase 1 (Dose Escalation)|Death|3|||
143436449|NCT03520075|517145384|FG007|Phase 1 (Dose Escalation)|Death|2|||
143436450|NCT03520075|517145385|FG008|Phase 1 (Dose Escalation)|Death|3|||
143436451|NCT03520075|517145386|FG009|Phase 1 (Dose Escalation)|Death|1|||
143436452|NCT03520075|517145387|FG010|Phase 1 (Dose Escalation)|Death|5|||
143436453|NCT03520075|517145388|FG011|Phase 1 (Dose Escalation)|Death|7|||
143436454|NCT03520075|517145389|FG012|Phase 1 (Dose Escalation)|Death|11|||
143436455|NCT03520075|517145390|FG013|Phase 1 (Dose Escalation)|Death|0|||
143436456|NCT03520075|517145391|FG014|Phase 1 (Dose Escalation)|Death|0|||
143436457|NCT03520075|517145392|FG015|Phase 1 (Dose Escalation)|Death|0|||
143436458|NCT03520075|517145393|FG016|Phase 1 (Dose Escalation)|Death|0|||
143436459|NCT03520075|517145394|FG017|Phase 1 (Dose Escalation)|Death|0|||
143436460|NCT03520075|517145395|FG018|Phase 1 (Dose Escalation)|Death|0|||
143436461|NCT03520075|517145377|FG000|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
143436462|NCT03520075|517145378|FG001|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
143436463|NCT03520075|517145379|FG002|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
143436464|NCT03520075|517145380|FG003|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
143436465|NCT03520075|517145381|FG004|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|3|||
143436466|NCT03520075|517145382|FG005|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
143436467|NCT03520075|517145383|FG006|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
143436468|NCT03520075|517145384|FG007|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
143436469|NCT03520075|517145385|FG008|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
143436470|NCT03520075|517145386|FG009|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
143436471|NCT03520075|517145387|FG010|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
143436472|NCT03520075|517145388|FG011|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
143436473|NCT03520075|517145389|FG012|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|4|||
143436474|NCT03520075|517145390|FG013|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
143436475|NCT03520075|517145391|FG014|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
143436476|NCT03520075|517145392|FG015|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
143436477|NCT03520075|517145393|FG016|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
143436478|NCT03520075|517145394|FG017|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
143436479|NCT03520075|517145395|FG018|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
143436480|NCT03520075|517145377|FG000|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
143436481|NCT03520075|517145378|FG001|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
143436482|NCT03520075|517145379|FG002|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
143436483|NCT03520075|517145380|FG003|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
143436484|NCT03520075|517145381|FG004|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
143436485|NCT03520075|517145382|FG005|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
143436486|NCT03520075|517145383|FG006|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
143436487|NCT03520075|517145384|FG007|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
143436488|NCT03520075|517145385|FG008|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
143436489|NCT03520075|517145386|FG009|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
143436490|NCT03520075|517145387|FG010|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
143436491|NCT03520075|517145388|FG011|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
143436492|NCT03520075|517145389|FG012|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
143436493|NCT03520075|517145390|FG013|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
143436494|NCT03520075|517145391|FG014|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
143436495|NCT03520075|517145392|FG015|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
143436496|NCT03520075|517145393|FG016|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
143436497|NCT03520075|517145394|FG017|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
143436498|NCT03520075|517145395|FG018|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
143436499|NCT03520075|517145377|FG000|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
143436500|NCT03520075|517145378|FG001|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
143436501|NCT03520075|517145379|FG002|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
143436502|NCT03520075|517145380|FG003|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
143436503|NCT03520075|517145381|FG004|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
143436504|NCT03520075|517145382|FG005|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
143436505|NCT03520075|517145383|FG006|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
143436506|NCT03520075|517145384|FG007|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
143436507|NCT03520075|517145385|FG008|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
143436508|NCT03520075|517145386|FG009|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|1|||
143436509|NCT03520075|517145387|FG010|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
143436510|NCT03520075|517145388|FG011|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
143436511|NCT03520075|517145389|FG012|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|3|||
143436512|NCT03520075|517145390|FG013|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
143436513|NCT03520075|517145391|FG014|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
143436514|NCT03520075|517145392|FG015|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
143436515|NCT03520075|517145393|FG016|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
143436516|NCT03520075|517145394|FG017|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
143436517|NCT03520075|517145395|FG018|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
143436518|NCT03520075|517145377|FG000|Phase 2 (Dose Expansion)|Death|0|||
143436519|NCT03520075|517145378|FG001|Phase 2 (Dose Expansion)|Death|0|||
143436520|NCT03520075|517145379|FG002|Phase 2 (Dose Expansion)|Death|0|||
143436521|NCT03520075|517145380|FG003|Phase 2 (Dose Expansion)|Death|0|||
143436522|NCT03520075|517145381|FG004|Phase 2 (Dose Expansion)|Death|0|||
143436523|NCT03520075|517145382|FG005|Phase 2 (Dose Expansion)|Death|0|||
143436524|NCT03520075|517145383|FG006|Phase 2 (Dose Expansion)|Death|0|||
143436525|NCT03520075|517145384|FG007|Phase 2 (Dose Expansion)|Death|0|||
143436526|NCT03520075|517145385|FG008|Phase 2 (Dose Expansion)|Death|0|||
143436527|NCT03520075|517145386|FG009|Phase 2 (Dose Expansion)|Death|0|||
143436528|NCT03520075|517145387|FG010|Phase 2 (Dose Expansion)|Death|0|||
143436529|NCT03520075|517145388|FG011|Phase 2 (Dose Expansion)|Death|0|||
143436530|NCT03520075|517145389|FG012|Phase 2 (Dose Expansion)|Death|0|||
143436531|NCT03520075|517145390|FG013|Phase 2 (Dose Expansion)|Death|20|||
143436532|NCT03520075|517145391|FG014|Phase 2 (Dose Expansion)|Death|13|||
143436533|NCT03520075|517145392|FG015|Phase 2 (Dose Expansion)|Death|9|||
143436534|NCT03520075|517145393|FG016|Phase 2 (Dose Expansion)|Death|5|||
143436535|NCT03520075|517145394|FG017|Phase 2 (Dose Expansion)|Death|14|||
143436536|NCT03520075|517145395|FG018|Phase 2 (Dose Expansion)|Death|12|||
143436537|NCT03520075|517145377|FG000|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
143436538|NCT03520075|517145378|FG001|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
143436539|NCT03520075|517145379|FG002|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
143436540|NCT03520075|517145380|FG003|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
143436541|NCT03520075|517145381|FG004|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
143436542|NCT03520075|517145382|FG005|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
143436543|NCT03520075|517145383|FG006|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
143436544|NCT03520075|517145384|FG007|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
143436545|NCT03520075|517145385|FG008|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
143436546|NCT03520075|517145386|FG009|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
143436547|NCT03520075|517145387|FG010|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
143436548|NCT03520075|517145388|FG011|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
143436549|NCT03520075|517145389|FG012|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
143436550|NCT03520075|517145390|FG013|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
143436551|NCT03520075|517145391|FG014|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
143436552|NCT03520075|517145392|FG015|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
143436553|NCT03520075|517145393|FG016|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
143436554|NCT03520075|517145394|FG017|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|3|||
143436555|NCT03520075|517145395|FG018|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
143436556|NCT03520075|517145377|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
143436557|NCT03520075|517145378|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
143436558|NCT03520075|517145379|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
143436559|NCT03520075|517145380|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
143436560|NCT03520075|517145381|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
143436561|NCT03520075|517145382|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
143436562|NCT03520075|517145383|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
143436563|NCT03520075|517145384|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
143436564|NCT03520075|517145385|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
143436565|NCT03520075|517145386|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
143436566|NCT03520075|517145387|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
143436567|NCT03520075|517145388|FG011|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
143436568|NCT03520075|517145389|FG012|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
143436569|NCT03520075|517145390|FG013|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
143436570|NCT03520075|517145391|FG014|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
143436571|NCT03520075|517145392|FG015|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
143436572|NCT03520075|517145393|FG016|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
143436573|NCT03520075|517145394|FG017|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
143436574|NCT03520075|517145395|FG018|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
143436575|NCT03520075|517145377|FG000|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
143436576|NCT03520075|517145378|FG001|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
143436577|NCT03520075|517145379|FG002|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
143436578|NCT03520075|517145380|FG003|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
143436579|NCT03520075|517145381|FG004|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
143436580|NCT03520075|517145382|FG005|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
143436581|NCT03520075|517145383|FG006|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
143436582|NCT03520075|517145384|FG007|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
143436583|NCT03520075|517145385|FG008|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
143436584|NCT03520075|517145386|FG009|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
143436585|NCT03520075|517145387|FG010|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
143436586|NCT03520075|517145388|FG011|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
143436587|NCT03520075|517145389|FG012|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
143436588|NCT03520075|517145390|FG013|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|6|||
143436589|NCT03520075|517145391|FG014|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
143436590|NCT03520075|517145392|FG015|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
143436591|NCT03520075|517145393|FG016|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|3|||
143436592|NCT03520075|517145394|FG017|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|10|||
143436593|NCT03520075|517145395|FG018|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
143436594|NCT00810342|517145396|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
143436595|NCT00810342|517145397|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
143436596|NCT00810342|517145396|FG000|Month 1 Follow-up|Pregnancy|1|||
143436597|NCT00810342|517145397|FG001|Month 1 Follow-up|Pregnancy|0|||
143436598|NCT00810342|517145396|FG000|6-month Follow-up|Lost to Follow-up|18|||
143436599|NCT00810342|517145397|FG001|6-month Follow-up|Lost to Follow-up|6|||
143436600|NCT00810342|517145396|FG000|6-month Follow-up|Pregnancy|6|||
143436601|NCT00810342|517145397|FG001|6-month Follow-up|Pregnancy|2|||
143436602|NCT00810342|517145396|FG000|12-month Followup|Pregnancy|9|||
143436603|NCT00810342|517145397|FG001|12-month Followup|Pregnancy|10|||
143436604|NCT00810342|517145396|FG000|12-month Followup|Lost to Follow-up|3|||
143436605|NCT00810342|517145397|FG001|12-month Followup|Lost to Follow-up|1|||
143436606|NCT01496365|517145398|FG000|Overall Study|Adverse Event|2|||
143436607|NCT01496365|517145399|FG001|Overall Study|Adverse Event|3|||
143436608|NCT01496365|517145400|FG002|Overall Study|Adverse Event|3|||
143436609|NCT01496365|517145401|FG003|Overall Study|Adverse Event|2|||
143436610|NCT01496365|517145402|FG004|Overall Study|Adverse Event|5|||
143436611|NCT01496365|517145403|FG005|Overall Study|Adverse Event|6|||
143436612|NCT01496365|517145404|FG006|Overall Study|Adverse Event|4|||
143436613|NCT01496365|517145398|FG000|Overall Study|Withdrawal by Subject|6|||
143436614|NCT01496365|517145399|FG001|Overall Study|Withdrawal by Subject|6|||
143436615|NCT01496365|517145400|FG002|Overall Study|Withdrawal by Subject|0|||
143436616|NCT01496365|517145401|FG003|Overall Study|Withdrawal by Subject|1|||
143436617|NCT01496365|517145402|FG004|Overall Study|Withdrawal by Subject|3|||
143436618|NCT01496365|517145403|FG005|Overall Study|Withdrawal by Subject|2|||
143436619|NCT01496365|517145404|FG006|Overall Study|Withdrawal by Subject|1|||
143436620|NCT01496365|517145398|FG000|Overall Study|Protocol Violation|2|||
143436621|NCT01496365|517145399|FG001|Overall Study|Protocol Violation|1|||
143436622|NCT01496365|517145400|FG002|Overall Study|Protocol Violation|1|||
143436623|NCT01496365|517145401|FG003|Overall Study|Protocol Violation|0|||
143436624|NCT01496365|517145402|FG004|Overall Study|Protocol Violation|0|||
143436625|NCT01496365|517145403|FG005|Overall Study|Protocol Violation|1|||
143436626|NCT01496365|517145404|FG006|Overall Study|Protocol Violation|0|||
143436627|NCT01496365|517145398|FG000|Overall Study|Lack of Efficacy|1|||
143436628|NCT01496365|517145399|FG001|Overall Study|Lack of Efficacy|0|||
143436629|NCT01496365|517145400|FG002|Overall Study|Lack of Efficacy|0|||
143436630|NCT01496365|517145401|FG003|Overall Study|Lack of Efficacy|0|||
143436631|NCT01496365|517145402|FG004|Overall Study|Lack of Efficacy|0|||
143436632|NCT01496365|517145403|FG005|Overall Study|Lack of Efficacy|1|||
143436633|NCT01496365|517145404|FG006|Overall Study|Lack of Efficacy|0|||
143436634|NCT01496365|517145398|FG000|Overall Study|Lost to Follow-up|0|||
143436635|NCT01496365|517145399|FG001|Overall Study|Lost to Follow-up|1|||
143436636|NCT01496365|517145400|FG002|Overall Study|Lost to Follow-up|0|||
143436637|NCT01496365|517145401|FG003|Overall Study|Lost to Follow-up|0|||
143436638|NCT01496365|517145402|FG004|Overall Study|Lost to Follow-up|2|||
143436639|NCT01496365|517145403|FG005|Overall Study|Lost to Follow-up|0|||
143436640|NCT01496365|517145404|FG006|Overall Study|Lost to Follow-up|0|||
143436641|NCT01496365|517145398|FG000|Overall Study|Other|4|||
143436642|NCT01496365|517145399|FG001|Overall Study|Other|4|||
143436643|NCT01496365|517145400|FG002|Overall Study|Other|2|||
143436644|NCT01496365|517145401|FG003|Overall Study|Other|1|||
143436645|NCT01496365|517145402|FG004|Overall Study|Other|3|||
143436646|NCT01496365|517145403|FG005|Overall Study|Other|0|||
143436647|NCT01496365|517145404|FG006|Overall Study|Other|1|||
143436648|NCT01288209|517145405|FG000|Overall Study|Withdrawal by Subject|1|||
143436649|NCT01288209|517145406|FG001|Overall Study|Withdrawal by Subject|3|||
143436650|NCT01288209|517145405|FG000|Overall Study|Other|1|||
143436651|NCT01288209|517145406|FG001|Overall Study|Other|0|||
143436652|NCT01015677|517145407|FG000|Overall Study|Adverse Event|0|||
143436653|NCT01015677|517145408|FG001|Overall Study|Adverse Event|1|||
143436654|NCT01015677|517145409|FG002|Overall Study|Adverse Event|0|||
143436655|NCT01015677|517145407|FG000|Overall Study|Lack of Efficacy|0|||
143436656|NCT01015677|517145408|FG001|Overall Study|Lack of Efficacy|1|||
143436657|NCT01015677|517145409|FG002|Overall Study|Lack of Efficacy|0|||
143436658|NCT01015677|517145407|FG000|Overall Study|Protocol Violation|0|||
143436659|NCT01015677|517145408|FG001|Overall Study|Protocol Violation|1|||
143436660|NCT01015677|517145409|FG002|Overall Study|Protocol Violation|0|||
143436661|NCT01015677|517145407|FG000|Overall Study|Withdrawal by Subject|1|||
143436662|NCT01015677|517145408|FG001|Overall Study|Withdrawal by Subject|1|||
143436663|NCT01015677|517145409|FG002|Overall Study|Withdrawal by Subject|0|||
143436664|NCT04599855|517145410|FG000|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
143436665|NCT04599855|517145411|FG001|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|2|||
143436666|NCT04599855|517145412|FG002|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
143436667|NCT04599855|517145410|FG000|Double Blind Period (Day 1 to Day 28)|Adverse Event|2|||
143436668|NCT04599855|517145411|FG001|Double Blind Period (Day 1 to Day 28)|Adverse Event|1|||
143436669|NCT04599855|517145412|FG002|Double Blind Period (Day 1 to Day 28)|Adverse Event|5|||
143436670|NCT04599855|517145410|FG000|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
143436671|NCT04599855|517145411|FG001|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|0|||
143436672|NCT04599855|517145412|FG002|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
143436673|NCT04599855|517145410|FG000|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
143436674|NCT04599855|517145411|FG001|Double Blind Period (Day 1 to Day 28)|Protocol Violation|0|||
143436675|NCT04599855|517145412|FG002|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
143436676|NCT04599855|517145410|FG000|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
143436677|NCT04599855|517145411|FG001|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|1|||
143436678|NCT04599855|517145412|FG002|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
143436679|NCT04599855|517145410|FG000|Double Blind Period (Day 1 to Day 28)|Pregnancy|1|||
143436680|NCT04599855|517145411|FG001|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
143436681|NCT04599855|517145412|FG002|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
143436682|NCT04599855|517145410|FG000|Double Blind Period (Day 1 to Day 28)|Other|1|||
143436683|NCT04599855|517145411|FG001|Double Blind Period (Day 1 to Day 28)|Other|0|||
143436684|NCT04599855|517145412|FG002|Double Blind Period (Day 1 to Day 28)|Other|1|||
143436685|NCT04599855|517145410|FG000|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
143436686|NCT04599855|517145411|FG001|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|1|||
143436687|NCT04599855|517145412|FG002|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
143436688|NCT04599855|517145410|FG000|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|8|||
143436689|NCT04599855|517145411|FG001|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|5|||
143436690|NCT04599855|517145412|FG002|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|6|||
143436691|NCT04599855|517145410|FG000|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|10|||
143436692|NCT04599855|517145411|FG001|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|3|||
143436693|NCT04599855|517145412|FG002|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|2|||
143436694|NCT04599855|517145410|FG000|Period Title: OL Period (Week 5 to 16)|Adverse Event|4|||
143436695|NCT04599855|517145411|FG001|Period Title: OL Period (Week 5 to 16)|Adverse Event|2|||
143436696|NCT04599855|517145412|FG002|Period Title: OL Period (Week 5 to 16)|Adverse Event|1|||
143436697|NCT04599855|517145410|FG000|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|4|||
143436698|NCT04599855|517145411|FG001|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|1|||
143436699|NCT04599855|517145412|FG002|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|2|||
143436700|NCT04599855|517145410|FG000|Period Title: OL Period (Week 5 to 16)|Protocol Violation|2|||
143436701|NCT04599855|517145411|FG001|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
143436702|NCT04599855|517145412|FG002|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
143436703|NCT04599855|517145410|FG000|Period Title: OL Period (Week 5 to 16)|Other|5|||
143436704|NCT04599855|517145411|FG001|Period Title: OL Period (Week 5 to 16)|Other|1|||
143436705|NCT04599855|517145412|FG002|Period Title: OL Period (Week 5 to 16)|Other|0|||
143436706|NCT04294667|517145413|FG000|Overall Study|Lack of Efficacy|4|||
143436707|NCT04294667|517145414|FG001|Overall Study|Lack of Efficacy|4|||
143436708|NCT04294667|517145413|FG000|Overall Study|Consent Withdrawal by Study Participant|9|||
143436709|NCT04294667|517145414|FG001|Overall Study|Consent Withdrawal by Study Participant|7|||
143436710|NCT04294667|517145413|FG000|Overall Study|Patient has a Renal Flare|1|||
143436711|NCT04294667|517145414|FG001|Overall Study|Patient has a Renal Flare|0|||
143436712|NCT04294667|517145413|FG000|Overall Study|SLE Worsening|0|||
143436713|NCT04294667|517145414|FG001|Overall Study|SLE Worsening|1|||
143436714|NCT04294667|517145413|FG000|Overall Study|Subject Decision due to Personal Reason|0|||
143436715|NCT04294667|517145414|FG001|Overall Study|Subject Decision due to Personal Reason|1|||
143436716|NCT04294667|517145413|FG000|Overall Study|PI closed Site - Subject Early Withdrawal|0|||
143436717|NCT04294667|517145414|FG001|Overall Study|PI closed Site - Subject Early Withdrawal|1|||
143436718|NCT04294667|517145413|FG000|Overall Study|Subject Withdrew due to Personal Reason|0|||
143436719|NCT04294667|517145414|FG001|Overall Study|Subject Withdrew due to Personal Reason|1|||
143436720|NCT04294667|517145413|FG000|Overall Study|Subject Moved to Another State|0|||
143436721|NCT04294667|517145414|FG001|Overall Study|Subject Moved to Another State|1|||
143436722|NCT04294667|517145413|FG000|Overall Study|Adverse event, serious fatal|0|||
143436723|NCT04294667|517145414|FG001|Overall Study|Adverse event, serious fatal|1|||
143436724|NCT04294667|517145413|FG000|Overall Study|Adverse event, non-fatal|3|||
143436725|NCT04294667|517145414|FG001|Overall Study|Adverse event, non-fatal|4|||
143436726|NCT00992992|517145417|FG000|Overall Study|Lost to Follow-up|3|||
143436727|NCT00992992|517145417|FG000|Overall Study|Death|16|||
143436728|NCT00992992|517145417|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
143436729|NCT00992992|517145417|FG000|Overall Study|Sponsor Closed the Study|4|||
143436730|NCT00217022|517145419|FG000|Overall Study|Withdrawal by Subject|1|||
143436731|NCT00217022|517145420|FG001|Overall Study|Withdrawal by Subject|1|||
143436732|NCT02108652|517145421|FG000|Overall Study|Death|253|||
143436733|NCT02108652|517145421|FG000|Overall Study|Lost to Follow-up|2|||
143436734|NCT02108652|517145421|FG000|Overall Study|Withdrawal by Subject|16|||
143436735|NCT02108652|517145421|FG000|Overall Study|Study Terminated By Sponsor|31|||
143436736|NCT02108652|517145421|FG000|Overall Study|Non-Compliance|1|||
143436737|NCT02108652|517145421|FG000|Overall Study|Physician Decision|6|||
143436738|NCT02108652|517145421|FG000|Overall Study|Progression Of Disease|1|||
143436739|NCT01017263|517145422|FG000|Overall Study|not eligible|12|||
143436740|NCT01560871|517145423|FG000|Overall Study|transportation issues|2|||
143436741|NCT01560871|517145424|FG001|Overall Study|transportation issues|1|||
143436742|NCT01560871|517145423|FG000|Overall Study|relocation|1|||
143436743|NCT01560871|517145424|FG001|Overall Study|relocation|0|||
143436744|NCT01560871|517145423|FG000|Overall Study|readmission to a hospital|2|||
143436745|NCT01560871|517145424|FG001|Overall Study|readmission to a hospital|1|||
143436746|NCT01560871|517145423|FG000|Overall Study|Lost to Follow-up|1|||
143436747|NCT01560871|517145424|FG001|Overall Study|Lost to Follow-up|0|||
143436748|NCT05043883|517145425|FG000|Overall Study|Minimum required measurements could not be taken|4|||
143436749|NCT02980705|517145426|FG000|Overall Study|Adverse Event|0|||
143436750|NCT02980705|517145427|FG001|Overall Study|Adverse Event|1|||
143436751|NCT02980705|517145426|FG000|Overall Study|Withdrawal by Subject|6|||
143436752|NCT02980705|517145427|FG001|Overall Study|Withdrawal by Subject|9|||
143436753|NCT02980705|517145426|FG000|Overall Study|withdrew participation|0|||
143436754|NCT02980705|517145427|FG001|Overall Study|withdrew participation|1|||
143436755|NCT02980705|517145426|FG000|Overall Study|Lost to Follow-up|2|||
143436756|NCT02980705|517145427|FG001|Overall Study|Lost to Follow-up|0|||
143436757|NCT00263575|517145428|FG000|Titration Period|Adverse Event|14|||
143436758|NCT00263575|517145428|FG000|Titration Period|Withdrawal by Subject|10|||
143436759|NCT00263575|517145428|FG000|Titration Period|Protocol Violation|9|||
143436760|NCT00263575|517145428|FG000|Titration Period|Sponsor Decision|2|||
143436761|NCT00263575|517145428|FG000|Titration Period|Other|2|||
143436762|NCT00263575|517145428|FG000|Titration Period|Lack of Efficacy|6|||
143436763|NCT00263575|517145428|FG000|Maintence Period|Adverse Event|23|||
143436764|NCT00263575|517145428|FG000|Maintence Period|Withdrawal by Subject|8|||
143436765|NCT00263575|517145428|FG000|Maintence Period|Protocol Violation|4|||
143436766|NCT00263575|517145428|FG000|Maintence Period|Lack of Efficacy|4|||
143436767|NCT00263575|517145428|FG000|Maintence Period|Physician Decision|6|||
143436768|NCT00263575|517145428|FG000|Maintence Period|Lost to Follow-up|1|||
143436769|NCT00263575|517145428|FG000|Maintence Period|Sponsor Decision|24|||
143436770|NCT00263575|517145428|FG000|Maintence Period|Other|7|||
143436771|NCT00537329|517145429|FG000|Overall Study|Death|10|||
143436772|NCT00537329|517145429|FG000|Overall Study|Adverse Event|3|||
143436773|NCT00537329|517145429|FG000|Overall Study|Lack of Efficacy|2|||
143436774|NCT00537329|517145429|FG000|Overall Study|Lost to Follow-up|6|||
143436775|NCT00537329|517145429|FG000|Overall Study|Withdrawal by Subject|4|||
143436776|NCT00537329|517145429|FG000|Overall Study|Other|1|||
143436777|NCT01278615|517145430|FG000|Overall Study|Withdrawal by Subject|2|||
143436778|NCT00905359|517145431|FG000|Overall Study|Lost to Follow-up|17|||
143436779|NCT00905359|517145432|FG001|Overall Study|Lost to Follow-up|10|||
143436780|NCT00905359|517145431|FG000|Overall Study|Death|2|||
143436781|NCT00905359|517145432|FG001|Overall Study|Death|0|||
143436782|NCT00905359|517145431|FG000|Overall Study|Withdrawal consent|5|||
143436783|NCT00905359|517145432|FG001|Overall Study|Withdrawal consent|6|||
143436784|NCT02138253|517145433|FG000|Overall Study|Adverse Event|3|||
143436785|NCT02138253|517145434|FG001|Overall Study|Adverse Event|3|||
143436786|NCT02138253|517145433|FG000|Overall Study|Lost to Follow-up|2|||
143436787|NCT02138253|517145434|FG001|Overall Study|Lost to Follow-up|1|||
143436788|NCT02138253|517145433|FG000|Overall Study|Physician Decision|2|||
143436789|NCT02138253|517145434|FG001|Overall Study|Physician Decision|0|||
143436790|NCT02138253|517145433|FG000|Overall Study|Non compliance|1|||
143436791|NCT02138253|517145434|FG001|Overall Study|Non compliance|0|||
143436792|NCT02138253|517145433|FG000|Overall Study|Withdrawal by Subject|1|||
143436793|NCT02138253|517145434|FG001|Overall Study|Withdrawal by Subject|0|||
143436794|NCT01006889|517145435|FG000|Overall Study|Withdrawal by Subject|3|||
143436795|NCT00243022|517145436|FG000|Overall Study|Withdrawal by Subject|1|||
143436796|NCT00243022|517145437|FG001|Overall Study|Withdrawal by Subject|0|||
143436797|NCT00243022|517145436|FG000|Overall Study|Death|1|||
143436798|NCT00243022|517145437|FG001|Overall Study|Death|0|||
143436799|NCT00243022|517145436|FG000|Overall Study|Difficult Travel Distance|0|||
143436800|NCT00243022|517145437|FG001|Overall Study|Difficult Travel Distance|1|||
143436801|NCT01390441|517145442|FG000|Treatment Period|Protocol Violation|0|||
143436802|NCT01390441|517145443|FG001|Treatment Period|Protocol Violation|1|||
143436803|NCT01390441|517145444|FG002|Treatment Period|Protocol Violation|0|||
143436804|NCT01390441|517145445|FG003|Treatment Period|Protocol Violation|0|||
143436805|NCT01390441|517145446|FG004|Treatment Period|Protocol Violation|0|||
143436806|NCT01390441|517145442|FG000|Treatment Period|Physician Decision|0|||
143436807|NCT01390441|517145443|FG001|Treatment Period|Physician Decision|0|||
143436808|NCT01390441|517145444|FG002|Treatment Period|Physician Decision|0|||
143436809|NCT01390441|517145445|FG003|Treatment Period|Physician Decision|1|||
143436810|NCT01390441|517145446|FG004|Treatment Period|Physician Decision|0|||
143436811|NCT01390441|517145442|FG000|Treatment Period|Lack of Efficacy|0|||
143436812|NCT01390441|517145443|FG001|Treatment Period|Lack of Efficacy|0|||
143436813|NCT01390441|517145444|FG002|Treatment Period|Lack of Efficacy|0|||
143436814|NCT01390441|517145445|FG003|Treatment Period|Lack of Efficacy|0|||
143436815|NCT01390441|517145446|FG004|Treatment Period|Lack of Efficacy|1|||
143436816|NCT01390441|517145442|FG000|Treatment Period|Unknown due to early stopping of study|0|||
143436817|NCT01390441|517145443|FG001|Treatment Period|Unknown due to early stopping of study|0|||
143436818|NCT01390441|517145444|FG002|Treatment Period|Unknown due to early stopping of study|8|||
143436819|NCT01390441|517145445|FG003|Treatment Period|Unknown due to early stopping of study|11|||
143436820|NCT01390441|517145446|FG004|Treatment Period|Unknown due to early stopping of study|7|||
143436821|NCT01390441|517145442|FG000|Treatment Period|Adverse Event|0|||
143436822|NCT01390441|517145443|FG001|Treatment Period|Adverse Event|0|||
143436823|NCT01390441|517145444|FG002|Treatment Period|Adverse Event|1|||
143436824|NCT01390441|517145445|FG003|Treatment Period|Adverse Event|1|||
143436825|NCT01390441|517145446|FG004|Treatment Period|Adverse Event|2|||
143436826|NCT01390441|517145442|FG000|Treatment Period|Withdrawal by Subject|0|||
143436827|NCT01390441|517145443|FG001|Treatment Period|Withdrawal by Subject|0|||
143436828|NCT01390441|517145444|FG002|Treatment Period|Withdrawal by Subject|1|||
143436829|NCT01390441|517145445|FG003|Treatment Period|Withdrawal by Subject|0|||
143436830|NCT01390441|517145446|FG004|Treatment Period|Withdrawal by Subject|1|||
143436831|NCT01390441|517145442|FG000|Treatment Period|Lost to Follow-up|1|||
143436832|NCT01390441|517145443|FG001|Treatment Period|Lost to Follow-up|0|||
143436833|NCT01390441|517145444|FG002|Treatment Period|Lost to Follow-up|0|||
143436834|NCT01390441|517145445|FG003|Treatment Period|Lost to Follow-up|0|||
143436835|NCT01390441|517145446|FG004|Treatment Period|Lost to Follow-up|0|||
143436836|NCT01390441|517145442|FG000|Extension Period|Protocol Violation|3|||
143436837|NCT01390441|517145443|FG001|Extension Period|Protocol Violation|1|||
143436838|NCT01390441|517145444|FG002|Extension Period|Protocol Violation|0|||
143436839|NCT01390441|517145445|FG003|Extension Period|Protocol Violation|1|||
143436840|NCT01390441|517145446|FG004|Extension Period|Protocol Violation|0|||
143436841|NCT00621192|517145447|FG000|Overall Study|Withdrawal by Subject|0|||
143436842|NCT00621192|517145448|FG001|Overall Study|Withdrawal by Subject|0|||
143436843|NCT00621192|517145449|FG002|Overall Study|Withdrawal by Subject|2|||
143436844|NCT00621192|517145450|FG003|Overall Study|Withdrawal by Subject|0|||
143436845|NCT00621192|517145447|FG000|Overall Study|Physician Decision|1|||
143436846|NCT00621192|517145448|FG001|Overall Study|Physician Decision|3|||
143436847|NCT00621192|517145449|FG002|Overall Study|Physician Decision|0|||
143436848|NCT00621192|517145450|FG003|Overall Study|Physician Decision|0|||
143436849|NCT00621192|517145447|FG000|Overall Study|Protocol Violation|1|||
143436850|NCT00621192|517145448|FG001|Overall Study|Protocol Violation|0|||
143436851|NCT00621192|517145449|FG002|Overall Study|Protocol Violation|0|||
143436852|NCT00621192|517145450|FG003|Overall Study|Protocol Violation|1|||
143436853|NCT00621192|517145447|FG000|Overall Study|Adverse Event|0|||
143436854|NCT00621192|517145448|FG001|Overall Study|Adverse Event|1|||
143436855|NCT00621192|517145449|FG002|Overall Study|Adverse Event|0|||
143436856|NCT00621192|517145450|FG003|Overall Study|Adverse Event|1|||
143436857|NCT00621192|517145447|FG000|Overall Study|Death|2|||
143436858|NCT00621192|517145448|FG001|Overall Study|Death|5|||
143436859|NCT00621192|517145449|FG002|Overall Study|Death|0|||
143436860|NCT00621192|517145450|FG003|Overall Study|Death|0|||
143436861|NCT00621192|517145447|FG000|Overall Study|Final Assessments not Completed|0|||
143436862|NCT00621192|517145448|FG001|Overall Study|Final Assessments not Completed|0|||
143436863|NCT00621192|517145449|FG002|Overall Study|Final Assessments not Completed|3|||
143436864|NCT00621192|517145450|FG003|Overall Study|Final Assessments not Completed|1|||
143436865|NCT00823836|517145451|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
143436866|NCT00823836|517145452|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
143436867|NCT00823836|517145451|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
143436868|NCT00823836|517145452|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
143436869|NCT00823836|517145451|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
143436870|NCT00823836|517145452|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
143436871|NCT00823836|517145451|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
143436872|NCT00823836|517145452|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
143436873|NCT00823836|517145451|FG000|Long-term Phase|Adverse Event|3|||
143436874|NCT00823836|517145452|FG001|Long-term Phase|Adverse Event|2|||
143436875|NCT00823836|517145451|FG000|Long-term Phase|Physician Decision|1|||
143436876|NCT00823836|517145452|FG001|Long-term Phase|Physician Decision|2|||
143436877|NCT00823836|517145451|FG000|Long-term Phase|Withdrawal by Subject|1|||
143436878|NCT00823836|517145452|FG001|Long-term Phase|Withdrawal by Subject|1|||
143436879|NCT01099579|517145453|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
143436880|NCT01099579|517145454|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
143436881|NCT01099579|517145455|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
143436882|NCT01099579|517145453|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
143436883|NCT01099579|517145454|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
143436884|NCT01099579|517145455|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
143436885|NCT01099579|517145453|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
143436886|NCT01099579|517145454|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
143436887|NCT01099579|517145455|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
143436888|NCT01099579|517145453|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
143436889|NCT01099579|517145454|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
143436890|NCT01099579|517145455|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
143436891|NCT01099579|517145453|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
143436892|NCT01099579|517145454|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
143436893|NCT01099579|517145455|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
143436894|NCT01099579|517145453|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
143436895|NCT01099579|517145454|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
143436896|NCT01099579|517145455|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
143436897|NCT01099579|517145453|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
143436898|NCT01099579|517145454|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
143436899|NCT01099579|517145455|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
143436900|NCT01099579|517145453|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
143436901|NCT01099579|517145454|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
143436902|NCT01099579|517145455|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
143436903|NCT01099579|517145453|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
143436904|NCT01099579|517145454|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
143436905|NCT01099579|517145455|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
143436906|NCT01099579|517145453|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
143436907|NCT01099579|517145454|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
143436908|NCT01099579|517145455|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
143436909|NCT02725528|517145456|FG000|Overall Study|Lost to Follow-up|1|||
143436910|NCT02725528|517145457|FG001|Overall Study|Lost to Follow-up|4|||
143436911|NCT02725528|517145456|FG000|Overall Study|Withdrawal by Subject|0|||
143436912|NCT02725528|517145457|FG001|Overall Study|Withdrawal by Subject|1|||
143436913|NCT00904722|517145458|FG000|Overall Study|Physician Decision|1|||
143436914|NCT00727506|517145462|FG000|Overall Study|Adverse Event|0|||
143436915|NCT00727506|517145463|FG001|Overall Study|Adverse Event|0|||
143436916|NCT00727506|517145464|FG002|Overall Study|Adverse Event|4|||
143436917|NCT00727506|517145465|FG003|Overall Study|Adverse Event|4|||
143436918|NCT00727506|517145466|FG004|Overall Study|Adverse Event|1|||
143436919|NCT00727506|517145467|FG005|Overall Study|Adverse Event|8|||
143436920|NCT00727506|517145462|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
143436921|NCT00727506|517145463|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
143436922|NCT00727506|517145464|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
143436923|NCT00727506|517145465|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
143436924|NCT00727506|517145466|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
143436925|NCT00727506|517145467|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
143436926|NCT00727506|517145462|FG000|Overall Study|Progressive disease|4|||
143436927|NCT00727506|517145463|FG001|Overall Study|Progressive disease|7|||
143436928|NCT00727506|517145464|FG002|Overall Study|Progressive disease|9|||
143436929|NCT00727506|517145465|FG003|Overall Study|Progressive disease|28|||
143436930|NCT00727506|517145466|FG004|Overall Study|Progressive disease|38|||
143436931|NCT00727506|517145467|FG005|Overall Study|Progressive disease|28|||
143436932|NCT00727506|517145462|FG000|Overall Study|Refused to continue medication|0|||
143436933|NCT00727506|517145463|FG001|Overall Study|Refused to continue medication|1|||
143436934|NCT00727506|517145464|FG002|Overall Study|Refused to continue medication|2|||
143436935|NCT00727506|517145465|FG003|Overall Study|Refused to continue medication|3|||
143436936|NCT00727506|517145466|FG004|Overall Study|Refused to continue medication|1|||
143436937|NCT00727506|517145467|FG005|Overall Study|Refused to continue medication|2|||
143436938|NCT00727506|517145462|FG000|Overall Study|Other reason not described above|0|||
143436939|NCT00727506|517145463|FG001|Overall Study|Other reason not described above|0|||
143436940|NCT00727506|517145464|FG002|Overall Study|Other reason not described above|1|||
143436941|NCT00727506|517145465|FG003|Overall Study|Other reason not described above|4|||
143436942|NCT00727506|517145466|FG004|Overall Study|Other reason not described above|1|||
143436943|NCT00727506|517145467|FG005|Overall Study|Other reason not described above|1|||
143436944|NCT02650466|517145468|FG000|Overall Study|Physician Decision|1|||
143436945|NCT02650466|517145468|FG000|Overall Study|Withdrawal by Subject|5|||
143436946|NCT02650466|517145468|FG000|Overall Study|Lost to Follow-up|1|||
143436947|NCT03561597|517145469|FG000|Overall Study|Lost to Follow-up|20|||
143436948|NCT04887506|517145470|FG000|Overall Study|Death|1|||
143436949|NCT04887506|517145471|FG001|Overall Study|Death|1|||
143436950|NCT04887506|517145470|FG000|Overall Study|Withdrawal by Subject|0|||
143436951|NCT04887506|517145471|FG001|Overall Study|Withdrawal by Subject|3|||
143436952|NCT04887506|517145470|FG000|Overall Study|Adverse Event|4|||
143436953|NCT04887506|517145471|FG001|Overall Study|Adverse Event|3|||
143436954|NCT04887506|517145470|FG000|Overall Study|Other - Not Reported|1|||
143436955|NCT04887506|517145471|FG001|Overall Study|Other - Not Reported|1|||
143436956|NCT02636608|517145472|FG000|Overall Study|Failure to Return|4|||
143436957|NCT02636608|517145472|FG000|Overall Study|Insufficient Virological Response|1|||
143436958|NCT02636608|517145472|FG000|Overall Study|Death|3|||
143436959|NCT02636608|517145472|FG000|Overall Study|Other|2|||
143436960|NCT02636608|517145472|FG000|Overall Study|Did Not Receive Treatment|1|||
143436961|NCT04594733|517145496|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
143436962|NCT04594733|517145497|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
143436963|NCT04594733|517145496|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
143436964|NCT04594733|517145497|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
143436965|NCT04594733|517145496|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
143436966|NCT04594733|517145497|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
143436967|NCT01024036|517145500|FG000|Blinded Treatment|Adverse Event|1|||
143436968|NCT01024036|517145501|FG001|Blinded Treatment|Adverse Event|1|||
143436969|NCT01024036|517145500|FG000|Blinded Treatment|Lack of Efficacy|16|||
143436970|NCT01024036|517145501|FG001|Blinded Treatment|Lack of Efficacy|14|||
143436971|NCT01024036|517145500|FG000|Blinded Treatment|Physician Decision|1|||
143436972|NCT01024036|517145501|FG001|Blinded Treatment|Physician Decision|0|||
143436973|NCT01024036|517145500|FG000|Blinded Treatment|Death|0|||
143436974|NCT01024036|517145501|FG001|Blinded Treatment|Death|2|||
143436975|NCT01024036|517145500|FG000|Blinded Treatment|Withdrawal by Subject|4|||
143436976|NCT01024036|517145501|FG001|Blinded Treatment|Withdrawal by Subject|3|||
143436977|NCT01024036|517145500|FG000|Unblinded Treatment|Adverse Event|0|||
143436978|NCT01024036|517145501|FG001|Unblinded Treatment|Adverse Event|1|||
143436979|NCT01024036|517145500|FG000|Unblinded Treatment|Lack of Efficacy|0|||
143436980|NCT01024036|517145501|FG001|Unblinded Treatment|Lack of Efficacy|2|||
143436981|NCT01024036|517145500|FG000|Follow-Up Period|Lost to Follow-up|1|||
143436982|NCT01024036|517145501|FG001|Follow-Up Period|Lost to Follow-up|1|||
143436983|NCT01024036|517145500|FG000|Follow-Up Period|Withdrawal by Subject|0|||
143436984|NCT01024036|517145501|FG001|Follow-Up Period|Withdrawal by Subject|1|||
143436985|NCT01024036|517145500|FG000|Follow-Up Period|Adverse Event|4|||
143436986|NCT01024036|517145501|FG001|Follow-Up Period|Adverse Event|1|||
143436987|NCT04680637|517145507|FG000|Overall Study|Lost to Follow-up|0|||
143436988|NCT04680637|517145508|FG001|Overall Study|Lost to Follow-up|1|||
143436989|NCT04680637|517145509|FG002|Overall Study|Lost to Follow-up|0|||
143436990|NCT04680637|517145510|FG003|Overall Study|Lost to Follow-up|1|||
143436991|NCT04680637|517145507|FG000|Overall Study|Death|1|||
143436992|NCT04680637|517145508|FG001|Overall Study|Death|0|||
143436993|NCT04680637|517145509|FG002|Overall Study|Death|0|||
143436994|NCT04680637|517145510|FG003|Overall Study|Death|0|||
143436995|NCT04680637|517145507|FG000|Overall Study|Withdrawal by Subject|7|||
143436996|NCT04680637|517145508|FG001|Overall Study|Withdrawal by Subject|10|||
143436997|NCT04680637|517145509|FG002|Overall Study|Withdrawal by Subject|17|||
143436998|NCT04680637|517145510|FG003|Overall Study|Withdrawal by Subject|15|||
143436999|NCT04680637|517145507|FG000|Overall Study|Decision by Sponsor|21|||
143437000|NCT04680637|517145508|FG001|Overall Study|Decision by Sponsor|15|||
143437001|NCT04680637|517145509|FG002|Overall Study|Decision by Sponsor|7|||
143437002|NCT04680637|517145510|FG003|Overall Study|Decision by Sponsor|32|||
143437003|NCT00691678|517145511|FG000|Overall Study|Adverse Event|5|||
143437004|NCT00691678|517145511|FG000|Overall Study|life events, pain|11|||
143437005|NCT00903760|517147102|FG000|Overall Study|Disease Progression/Death|8|||
143437006|NCT00903760|517147103|FG001|Overall Study|Disease Progression/Death|6|||
143437007|NCT00903760|517147102|FG000|Overall Study|Stem Cell Transplant|8|||
143437008|NCT00903760|517147103|FG001|Overall Study|Stem Cell Transplant|4|||
143437009|NCT00903760|517147102|FG000|Overall Study|Physician Decision|1|||
143437010|NCT00903760|517147103|FG001|Overall Study|Physician Decision|2|||
143437011|NCT00903760|517147102|FG000|Overall Study|Death|0|||
143437012|NCT00903760|517147103|FG001|Overall Study|Death|1|||
143437013|NCT00903760|517147102|FG000|Overall Study|Lost to Follow-up|1|||
143437014|NCT00903760|517147103|FG001|Overall Study|Lost to Follow-up|0|||
143437015|NCT00903760|517147102|FG000|Overall Study|Withdrawal by Subject|1|||
143437016|NCT00903760|517147103|FG001|Overall Study|Withdrawal by Subject|2|||
143437017|NCT00903760|517147102|FG000|Overall Study|Off treatment for long period|0|||
143437018|NCT00903760|517147103|FG001|Overall Study|Off treatment for long period|1|||
143437019|NCT01256671|517147109|FG000|Overall Study|Adverse Event|29|||
143437020|NCT01256671|517147109|FG000|Overall Study|Lost to Follow-up|16|||
143437021|NCT01256671|517147109|FG000|Overall Study|Withdrawal by Subject|31|||
143437022|NCT01256671|517147109|FG000|Overall Study|Physician Decision|3|||
143437023|NCT01256671|517147109|FG000|Overall Study|Lack of Efficacy|4|||
143437024|NCT01256671|517147109|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
143437025|NCT04411186|517147110|FG000|Overall Study|Withdrawn due to protocol violation|0|||
143437026|NCT04411186|517147111|FG001|Overall Study|Withdrawn due to protocol violation|1|||
143437027|NCT02166476|517147118|FG000|Overall Study|Withdrawal by Subject|5|||
143437028|NCT02166476|517147119|FG001|Overall Study|Withdrawal by Subject|7|||
143437029|NCT02166476|517147118|FG000|Overall Study|Adverse Event|3|||
143437030|NCT02166476|517147119|FG001|Overall Study|Adverse Event|3|||
143437031|NCT02166476|517147118|FG000|Overall Study|Lost to Follow-up|5|||
143437032|NCT02166476|517147119|FG001|Overall Study|Lost to Follow-up|10|||
143437033|NCT02166476|517147118|FG000|Overall Study|Physician Decision|1|||
143437034|NCT02166476|517147119|FG001|Overall Study|Physician Decision|0|||
143437035|NCT02166476|517147118|FG000|Overall Study|Unable to Come for Visit|0|||
143437036|NCT02166476|517147119|FG001|Overall Study|Unable to Come for Visit|3|||
143437037|NCT04367480|517147122|FG000|Overall Study|Adverse Event|1|||
143437038|NCT04367480|517147123|FG001|Overall Study|Adverse Event|1|||
143437039|NCT04367480|517147122|FG000|Overall Study|Death|1|||
143437040|NCT04367480|517147123|FG001|Overall Study|Death|0|||
143437041|NCT04367480|517147122|FG000|Overall Study|Lost to Follow-up|1|||
143437042|NCT04367480|517147123|FG001|Overall Study|Lost to Follow-up|1|||
143437043|NCT04367480|517147122|FG000|Overall Study|Withdrawal by Subject|0|||
143437044|NCT04367480|517147123|FG001|Overall Study|Withdrawal by Subject|3|||
143437045|NCT04367480|517147122|FG000|Overall Study|App glitch during the study|1|||
143437046|NCT04367480|517147123|FG001|Overall Study|App glitch during the study|0|||
143437047|NCT04367480|517147122|FG000|Overall Study|Device Distribution Error|0|||
143437048|NCT04367480|517147123|FG001|Overall Study|Device Distribution Error|2|||
143437049|NCT04367480|517147122|FG000|Overall Study|Ineligible after Randomization|0|||
143437050|NCT04367480|517147123|FG001|Overall Study|Ineligible after Randomization|1|||
143437051|NCT04367480|517147122|FG000|Overall Study|Other Medical Reasons|0|||
143437052|NCT04367480|517147123|FG001|Overall Study|Other Medical Reasons|2|||
143437053|NCT01432626|517147125|FG000|Overall Study|LV function recovered|2|||
143437054|NCT01432626|517147125|FG000|Overall Study|Withdrawal by Subject|2|||
143437055|NCT01432626|517147125|FG000|Overall Study|Only 1 image competed|2|||
143437056|NCT01432626|517147125|FG000|Overall Study|Imaging agent not available|1|||
143437057|NCT05382039|517147126|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
143437058|NCT05382039|517147127|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
143437059|NCT05382039|517147128|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
143437060|NCT05382039|517147126|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
143437061|NCT05382039|517147127|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
143437062|NCT05382039|517147128|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
143437063|NCT05382039|517147126|FG000|Overall Study|waiting for confirmation|0|||
143437064|NCT05382039|517147127|FG001|Overall Study|waiting for confirmation|0|||
143437065|NCT05382039|517147128|FG002|Overall Study|waiting for confirmation|1|||
143437066|NCT04504630|517147134|FG000|Assigned to Treatment|Withdrawal by Subject|2|||
143437067|NCT04504630|517147135|FG001|Assigned to Treatment|Withdrawal by Subject|0|||
143437068|NCT04504630|517147134|FG000|Follow-Up at 3 Months|Lost to Follow-up|3|||
143437069|NCT04504630|517147135|FG001|Follow-Up at 3 Months|Lost to Follow-up|1|||
143437070|NCT01660256|517147137|FG000|Overall Study|Adverse Event|4|||
143437071|NCT01660256|517147138|FG001|Overall Study|Adverse Event|0|||
143437072|NCT01660256|517147139|FG002|Overall Study|Adverse Event|2|||
143437073|NCT01660256|517147137|FG000|Overall Study|Withdrawal by Subject|1|||
143437074|NCT01660256|517147138|FG001|Overall Study|Withdrawal by Subject|0|||
143437075|NCT01660256|517147139|FG002|Overall Study|Withdrawal by Subject|2|||
143437076|NCT01777334|517147143|FG000|Overall Study|Adverse Event|18|||
143437077|NCT01777334|517147144|FG001|Overall Study|Adverse Event|14|||
143437078|NCT01777334|517147143|FG000|Overall Study|Lack of Efficacy|15|||
143437079|NCT01777334|517147144|FG001|Overall Study|Lack of Efficacy|29|||
143437080|NCT01777334|517147143|FG000|Overall Study|Protocol Violation|3|||
143437081|NCT01777334|517147144|FG001|Overall Study|Protocol Violation|7|||
143437082|NCT01777334|517147143|FG000|Overall Study|Lost to Follow-up|3|||
143437083|NCT01777334|517147144|FG001|Overall Study|Lost to Follow-up|2|||
143437084|NCT01777334|517147143|FG000|Overall Study|Withdrawal by Subject|14|||
143437085|NCT01777334|517147144|FG001|Overall Study|Withdrawal by Subject|11|||
143437086|NCT01316887|517147152|FG000|Overall Study|Adverse Event|13|||
143437087|NCT01316887|517147153|FG001|Overall Study|Adverse Event|21|||
143437088|NCT01316887|517147154|FG002|Overall Study|Adverse Event|17|||
143437089|NCT01316887|517147152|FG000|Overall Study|Lack of Efficacy|9|||
143437090|NCT01316887|517147153|FG001|Overall Study|Lack of Efficacy|3|||
143437091|NCT01316887|517147154|FG002|Overall Study|Lack of Efficacy|1|||
143437092|NCT01316887|517147152|FG000|Overall Study|Protocol Violation|2|||
143437093|NCT01316887|517147153|FG001|Overall Study|Protocol Violation|6|||
143437094|NCT01316887|517147154|FG002|Overall Study|Protocol Violation|6|||
143437095|NCT01316887|517147152|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
143437096|NCT01316887|517147153|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
143437097|NCT01316887|517147154|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
143437098|NCT01316887|517147152|FG000|Overall Study|Study Closed/Terminated|2|||
143437099|NCT01316887|517147153|FG001|Overall Study|Study Closed/Terminated|4|||
143437100|NCT01316887|517147154|FG002|Overall Study|Study Closed/Terminated|3|||
143437101|NCT01316887|517147152|FG000|Overall Study|Lost to Follow-up|1|||
143437102|NCT01316887|517147153|FG001|Overall Study|Lost to Follow-up|7|||
143437103|NCT01316887|517147154|FG002|Overall Study|Lost to Follow-up|5|||
143437104|NCT01316887|517147152|FG000|Overall Study|Withdrawal by Subject|8|||
143437105|NCT01316887|517147153|FG001|Overall Study|Withdrawal by Subject|16|||
143437106|NCT01316887|517147154|FG002|Overall Study|Withdrawal by Subject|15|||
143437107|NCT02172950|517147155|FG000|Overall Study|Physician Decision|3|||
143437108|NCT02172950|517147156|FG001|Overall Study|Physician Decision|3|||
143437109|NCT02172950|517147155|FG000|Overall Study|Lack of Efficacy|1|||
143437110|NCT02172950|517147156|FG001|Overall Study|Lack of Efficacy|0|||
143437111|NCT02172950|517147155|FG000|Overall Study|Adverse Event|4|||
143437112|NCT02172950|517147156|FG001|Overall Study|Adverse Event|1|||
143437113|NCT02172950|517147155|FG000|Overall Study|Withdrawal by Subject|10|||
143437114|NCT02172950|517147156|FG001|Overall Study|Withdrawal by Subject|0|||
143437115|NCT02172950|517147155|FG000|Overall Study|Protocol Violation|1|||
143437116|NCT02172950|517147156|FG001|Overall Study|Protocol Violation|0|||
143437117|NCT02172950|517147155|FG000|Overall Study|Lost to Follow-up|1|||
143437118|NCT02172950|517147156|FG001|Overall Study|Lost to Follow-up|0|||
143437119|NCT02172950|517147155|FG000|Overall Study|Death|1|||
143437120|NCT02172950|517147156|FG001|Overall Study|Death|0|||
143437121|NCT02172950|517147155|FG000|Overall Study|Patient traveling|1|||
143437122|NCT02172950|517147156|FG001|Overall Study|Patient traveling|0|||
143437123|NCT02172950|517147155|FG000|Overall Study|Patient went to other country|1|||
143437124|NCT02172950|517147156|FG001|Overall Study|Patient went to other country|0|||
143437125|NCT02172950|517147155|FG000|Overall Study|Patient relocated overseas|1|||
143437126|NCT02172950|517147156|FG001|Overall Study|Patient relocated overseas|1|||
143437127|NCT02172950|517147155|FG000|Overall Study|Patient moving|1|||
143437128|NCT02172950|517147156|FG001|Overall Study|Patient moving|0|||
143437129|NCT00585975|517147160|FG000|Overall Study|Withdrawal by Subject|3|||
143437130|NCT00585975|517147161|FG001|Overall Study|Withdrawal by Subject|3|||
143437131|NCT00585975|517147160|FG000|Overall Study|Lost to Follow-up|2|||
143437132|NCT00585975|517147161|FG001|Overall Study|Lost to Follow-up|1|||
143437133|NCT00585975|517147160|FG000|Overall Study|Enrollment met/over-enrolled|10|||
143437134|NCT00585975|517147161|FG001|Overall Study|Enrollment met/over-enrolled|9|||
143437135|NCT03414047|517147162|FG000|Overall Study|Adverse Event|0|||
143437136|NCT03414047|517147163|FG001|Overall Study|Adverse Event|0|||
143437137|NCT03414047|517147164|FG002|Overall Study|Adverse Event|1|||
143437138|NCT03414047|517147165|FG003|Overall Study|Adverse Event|1|||
143437139|NCT03414047|517147162|FG000|Overall Study|Physician Decision|1|||
143437140|NCT03414047|517147163|FG001|Overall Study|Physician Decision|0|||
143437141|NCT03414047|517147164|FG002|Overall Study|Physician Decision|0|||
143437142|NCT03414047|517147165|FG003|Overall Study|Physician Decision|1|||
143437143|NCT03414047|517147162|FG000|Overall Study|Withdrawal by Subject|1|||
143437144|NCT03414047|517147163|FG001|Overall Study|Withdrawal by Subject|0|||
143437145|NCT03414047|517147164|FG002|Overall Study|Withdrawal by Subject|2|||
143437146|NCT03414047|517147165|FG003|Overall Study|Withdrawal by Subject|0|||
143437147|NCT00511797|517147174|FG000|Overall Study|Adverse Event|1|||
143437148|NCT00511797|517147175|FG001|Overall Study|Adverse Event|2|||
143437149|NCT00511797|517147176|FG002|Overall Study|Adverse Event|2|||
143437150|NCT00511797|517147177|FG003|Overall Study|Adverse Event|2|||
143437151|NCT00511797|517147174|FG000|Overall Study|Lost to Follow-up|1|||
143437152|NCT00511797|517147175|FG001|Overall Study|Lost to Follow-up|0|||
143437153|NCT00511797|517147176|FG002|Overall Study|Lost to Follow-up|0|||
143437154|NCT00511797|517147177|FG003|Overall Study|Lost to Follow-up|1|||
143437155|NCT00511797|517147174|FG000|Overall Study|Pregnancy|0|||
143437156|NCT00511797|517147175|FG001|Overall Study|Pregnancy|0|||
143437157|NCT00511797|517147176|FG002|Overall Study|Pregnancy|0|||
143437158|NCT00511797|517147177|FG003|Overall Study|Pregnancy|1|||
143437159|NCT00511797|517147174|FG000|Overall Study|Protocol Violation|0|||
143437160|NCT00511797|517147175|FG001|Overall Study|Protocol Violation|2|||
143437161|NCT00511797|517147176|FG002|Overall Study|Protocol Violation|2|||
143437162|NCT00511797|517147177|FG003|Overall Study|Protocol Violation|3|||
143437163|NCT00511797|517147174|FG000|Overall Study|Withdrawal by Subject|3|||
143437164|NCT00511797|517147175|FG001|Overall Study|Withdrawal by Subject|3|||
143437165|NCT00511797|517147176|FG002|Overall Study|Withdrawal by Subject|4|||
143437166|NCT00511797|517147177|FG003|Overall Study|Withdrawal by Subject|2|||
143437167|NCT00511797|517147174|FG000|Overall Study|Never dispensed|1|||
143437168|NCT00511797|517147175|FG001|Overall Study|Never dispensed|0|||
143437169|NCT00511797|517147176|FG002|Overall Study|Never dispensed|1|||
143437170|NCT00511797|517147177|FG003|Overall Study|Never dispensed|3|||
143437171|NCT00511797|517147174|FG000|Overall Study|Study drug not taken|0|||
143437172|NCT00511797|517147175|FG001|Overall Study|Study drug not taken|1|||
143437173|NCT00511797|517147176|FG002|Overall Study|Study drug not taken|0|||
143437174|NCT00511797|517147177|FG003|Overall Study|Study drug not taken|1|||
143437175|NCT00511797|517147174|FG000|Overall Study|Partially missing diary|0|||
143437176|NCT00511797|517147175|FG001|Overall Study|Partially missing diary|0|||
143437177|NCT00511797|517147176|FG002|Overall Study|Partially missing diary|1|||
143437178|NCT00511797|517147177|FG003|Overall Study|Partially missing diary|0|||
143437179|NCT00511797|517147174|FG000|Overall Study|Other (moving etc)|1|||
143437180|NCT00511797|517147175|FG001|Overall Study|Other (moving etc)|0|||
143437181|NCT00511797|517147176|FG002|Overall Study|Other (moving etc)|1|||
143437182|NCT00511797|517147177|FG003|Overall Study|Other (moving etc)|2|||
143437183|NCT01704547|517147178|FG000|Overall Study|Physician Decision|4|||
143437184|NCT01704547|517147178|FG000|Overall Study|Withdrawal by Subject|1|||
143437185|NCT02564718|517147179|FG000|Overall Study|Withdrew from treatment|0|||
143437186|NCT02564718|517147180|FG001|Overall Study|Withdrew from treatment|1|||
143437187|NCT03845075|517147181|FG000|Part 1 - DB|Withdrawal by Subject|1|||
143437188|NCT03845075|517147182|FG001|Part 1 - DB|Withdrawal by Subject|1|||
143437189|NCT03845075|517147183|FG002|Part 1 - DB|Withdrawal by Subject|0|||
143437190|NCT03845075|517147184|FG003|Part 1 - DB|Withdrawal by Subject|0|||
143437191|NCT03845075|517147181|FG000|Part 1 - DB|Adverse Event|0|||
143437192|NCT03845075|517147182|FG001|Part 1 - DB|Adverse Event|1|||
143437193|NCT03845075|517147183|FG002|Part 1 - DB|Adverse Event|0|||
143437194|NCT03845075|517147184|FG003|Part 1 - DB|Adverse Event|0|||
143437195|NCT03845075|517147181|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
143437196|NCT03845075|517147182|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
143437197|NCT03845075|517147183|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
143437198|NCT03845075|517147184|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
143437199|NCT03599622|517147187|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
143437200|NCT03599622|517147188|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
143437201|NCT03599622|517147189|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
143437202|NCT03599622|517147190|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
143437203|NCT03599622|517147187|FG000|Pre-Treatment Period|Other reasons|1|||
143437204|NCT03599622|517147188|FG001|Pre-Treatment Period|Other reasons|1|||
143437205|NCT03599622|517147189|FG002|Pre-Treatment Period|Other reasons|1|||
143437206|NCT03599622|517147190|FG003|Pre-Treatment Period|Other reasons|0|||
143437207|NCT03599622|517147187|FG000|Treatment Period|Adverse Event|11|||
143437208|NCT03599622|517147188|FG001|Treatment Period|Adverse Event|20|||
143437209|NCT03599622|517147189|FG002|Treatment Period|Adverse Event|18|||
143437210|NCT03599622|517147190|FG003|Treatment Period|Adverse Event|2|||
143437211|NCT03599622|517147187|FG000|Treatment Period|Lack of Efficacy|18|||
143437212|NCT03599622|517147188|FG001|Treatment Period|Lack of Efficacy|12|||
143437213|NCT03599622|517147189|FG002|Treatment Period|Lack of Efficacy|13|||
143437214|NCT03599622|517147190|FG003|Treatment Period|Lack of Efficacy|2|||
143437215|NCT03599622|517147187|FG000|Treatment Period|Withdrawal by Subject|5|||
143437216|NCT03599622|517147188|FG001|Treatment Period|Withdrawal by Subject|11|||
143437217|NCT03599622|517147189|FG002|Treatment Period|Withdrawal by Subject|16|||
143437218|NCT03599622|517147190|FG003|Treatment Period|Withdrawal by Subject|1|||
143437219|NCT03599622|517147187|FG000|Treatment Period|Other reasons|4|||
143437220|NCT03599622|517147188|FG001|Treatment Period|Other reasons|6|||
143437221|NCT03599622|517147189|FG002|Treatment Period|Other reasons|7|||
143437222|NCT03599622|517147190|FG003|Treatment Period|Other reasons|0|||
143437223|NCT03599622|517147187|FG000|Treatment Period|Lost to Follow-up|1|||
143437224|NCT03599622|517147188|FG001|Treatment Period|Lost to Follow-up|0|||
143437225|NCT03599622|517147189|FG002|Treatment Period|Lost to Follow-up|0|||
143437226|NCT03599622|517147190|FG003|Treatment Period|Lost to Follow-up|0|||
143437227|NCT03599622|517147187|FG000|Treatment Period|Study terminated by sponsor|7|||
143437228|NCT03599622|517147188|FG001|Treatment Period|Study terminated by sponsor|20|||
143437229|NCT03599622|517147189|FG002|Treatment Period|Study terminated by sponsor|15|||
143437230|NCT03599622|517147190|FG003|Treatment Period|Study terminated by sponsor|0|||
143437231|NCT03599622|517147187|FG000|Treatment Period|Site terminated by sponsor|0|||
143437232|NCT03599622|517147188|FG001|Treatment Period|Site terminated by sponsor|1|||
143437233|NCT03599622|517147189|FG002|Treatment Period|Site terminated by sponsor|0|||
143437234|NCT03599622|517147190|FG003|Treatment Period|Site terminated by sponsor|0|||
143437235|NCT01918371|517147193|FG000|Overall Study|Missing Data|1|||
143437236|NCT01918371|517147194|FG001|Overall Study|Missing Data|1|||
143437237|NCT04706793|517147195|FG000|Treatment|Disease worsening|10|||
143437238|NCT04706793|517147196|FG001|Treatment|Disease worsening|10|||
143437239|NCT04706793|517147195|FG000|Follow-up|Lack of Efficacy|1|||
143437240|NCT04706793|517147196|FG001|Follow-up|Lack of Efficacy|0|||
143437241|NCT04706793|517147195|FG000|Follow-up|Disease worsening|8|||
143437242|NCT04706793|517147196|FG001|Follow-up|Disease worsening|10|||
143437243|NCT04706793|517147195|FG000|Follow-up|Adverse Event|1|||
143437244|NCT04706793|517147196|FG001|Follow-up|Adverse Event|0|||
143437245|NCT01130168|517147204|FG000|Period 1|Withdrawal by Subject|0|||
143437246|NCT01130168|517147205|FG001|Period 1|Withdrawal by Subject|1|||
143437247|NCT01130168|517147206|FG002|Period 1|Withdrawal by Subject|0|||
143437248|NCT01130168|517147207|FG003|Period 1|Withdrawal by Subject|1|||
143437249|NCT01130168|517147208|FG004|Period 1|Withdrawal by Subject|0|||
143437250|NCT01130168|517147209|FG005|Period 1|Withdrawal by Subject|0|||
143437251|NCT01130168|517147204|FG000|Period 1|Discontinued For Other Reason|0|||
143437252|NCT01130168|517147205|FG001|Period 1|Discontinued For Other Reason|0|||
143437253|NCT01130168|517147206|FG002|Period 1|Discontinued For Other Reason|1|||
143437254|NCT01130168|517147207|FG003|Period 1|Discontinued For Other Reason|1|||
143437255|NCT01130168|517147208|FG004|Period 1|Discontinued For Other Reason|0|||
143437256|NCT01130168|517147209|FG005|Period 1|Discontinued For Other Reason|0|||
143437257|NCT01130168|517147204|FG000|Period 1|Adverse Event|0|||
143437258|NCT01130168|517147205|FG001|Period 1|Adverse Event|0|||
143437259|NCT01130168|517147206|FG002|Period 1|Adverse Event|0|||
143437260|NCT01130168|517147207|FG003|Period 1|Adverse Event|1|||
143437261|NCT01130168|517147208|FG004|Period 1|Adverse Event|0|||
143437262|NCT01130168|517147209|FG005|Period 1|Adverse Event|0|||
143437263|NCT02569957|517147211|FG000|Overall Study|Withdrawal by Subject|0|||
143437264|NCT02569957|517147212|FG001|Overall Study|Withdrawal by Subject|1|||
143437265|NCT02635386|517147214|FG000|Overall Study|Pregnancy|2|||
143437266|NCT02635386|517147215|FG001|Overall Study|Pregnancy|0|||
143437267|NCT02635386|517147216|FG002|Overall Study|Pregnancy|0|||
143437268|NCT02635386|517147217|FG003|Overall Study|Pregnancy|0|||
143437269|NCT02635386|517147218|FG004|Overall Study|Pregnancy|2|||
143437270|NCT02635386|517147214|FG000|Overall Study|Withdrawal by Subject|1|||
143437271|NCT02635386|517147215|FG001|Overall Study|Withdrawal by Subject|1|||
143437272|NCT02635386|517147216|FG002|Overall Study|Withdrawal by Subject|0|||
143437273|NCT02635386|517147217|FG003|Overall Study|Withdrawal by Subject|1|||
143437274|NCT02635386|517147218|FG004|Overall Study|Withdrawal by Subject|0|||
143437275|NCT02635386|517147214|FG000|Overall Study|Physician Decision|0|||
143437276|NCT02635386|517147215|FG001|Overall Study|Physician Decision|1|||
143437277|NCT02635386|517147216|FG002|Overall Study|Physician Decision|0|||
143437278|NCT02635386|517147217|FG003|Overall Study|Physician Decision|0|||
143437279|NCT02635386|517147218|FG004|Overall Study|Physician Decision|0|||
143437280|NCT02635386|517147214|FG000|Overall Study|Moved Out of State|0|||
143437281|NCT02635386|517147215|FG001|Overall Study|Moved Out of State|1|||
143437282|NCT02635386|517147216|FG002|Overall Study|Moved Out of State|0|||
143437283|NCT02635386|517147217|FG003|Overall Study|Moved Out of State|0|||
143437284|NCT02635386|517147218|FG004|Overall Study|Moved Out of State|0|||
143437285|NCT02635386|517147214|FG000|Overall Study|Noncompliant|0|||
143437286|NCT02635386|517147215|FG001|Overall Study|Noncompliant|2|||
143437287|NCT02635386|517147216|FG002|Overall Study|Noncompliant|1|||
143437288|NCT02635386|517147217|FG003|Overall Study|Noncompliant|1|||
143437289|NCT02635386|517147218|FG004|Overall Study|Noncompliant|1|||
143437290|NCT02635386|517147214|FG000|Overall Study|side effects|0|||
143437291|NCT02635386|517147215|FG001|Overall Study|side effects|0|||
143437292|NCT02635386|517147216|FG002|Overall Study|side effects|1|||
143437293|NCT02635386|517147217|FG003|Overall Study|side effects|4|||
143437294|NCT02635386|517147218|FG004|Overall Study|side effects|6|||
143437295|NCT02635386|517147214|FG000|Overall Study|needed other major surgery|0|||
143437296|NCT02635386|517147215|FG001|Overall Study|needed other major surgery|1|||
143437297|NCT02635386|517147216|FG002|Overall Study|needed other major surgery|0|||
143437298|NCT02635386|517147217|FG003|Overall Study|needed other major surgery|0|||
143437299|NCT02635386|517147218|FG004|Overall Study|needed other major surgery|0|||
143437300|NCT02635386|517147214|FG000|Overall Study|Other medical problems not drug related|0|||
143437301|NCT02635386|517147215|FG001|Overall Study|Other medical problems not drug related|0|||
143437302|NCT02635386|517147216|FG002|Overall Study|Other medical problems not drug related|0|||
143437303|NCT02635386|517147217|FG003|Overall Study|Other medical problems not drug related|1|||
143437304|NCT02635386|517147218|FG004|Overall Study|Other medical problems not drug related|0|||
143437305|NCT04354168|517147219|FG000|Overall Study|Lost to Follow-up|22|||
143437306|NCT01781832|517147220|FG000|Overall Study|Withdrawal by Subject|1|||
143437307|NCT02706847|517147225|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
143437308|NCT02706847|517147226|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
143437309|NCT02706847|517147227|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
143437310|NCT02706847|517147228|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
143437311|NCT02706847|517147225|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
143437312|NCT02706847|517147226|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
143437313|NCT02706847|517147227|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
143437314|NCT02706847|517147228|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
143437315|NCT02706847|517147225|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
143437316|NCT02706847|517147226|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
143437317|NCT02706847|517147227|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
143437318|NCT02706847|517147228|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
143437319|NCT02706847|517147225|FG000|Period 1: Day 1 to Week 12|Other|4|||
143437320|NCT02706847|517147226|FG001|Period 1: Day 1 to Week 12|Other|4|||
143437321|NCT02706847|517147227|FG002|Period 1: Day 1 to Week 12|Other|2|||
143437322|NCT02706847|517147228|FG003|Period 1: Day 1 to Week 12|Other|2|||
143437323|NCT02706847|517147225|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
143437324|NCT02706847|517147226|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
143437325|NCT02706847|517147227|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
143437326|NCT02706847|517147228|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
143437327|NCT02706847|517147225|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
143437328|NCT02706847|517147226|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
143437329|NCT02706847|517147227|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
143437330|NCT02706847|517147228|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
143437331|NCT02706847|517147225|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
143437332|NCT02706847|517147226|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
143437333|NCT02706847|517147227|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
143437334|NCT02706847|517147228|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
143437335|NCT02706847|517147225|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
143437336|NCT02706847|517147226|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
143437337|NCT02706847|517147227|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
143437338|NCT02706847|517147228|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
143437339|NCT02706847|517147225|FG000|Period 1: Week 12 to Week 24|Other|1|||
143437340|NCT02706847|517147226|FG001|Period 1: Week 12 to Week 24|Other|0|||
143437341|NCT02706847|517147227|FG002|Period 1: Week 12 to Week 24|Other|1|||
143437342|NCT02706847|517147228|FG003|Period 1: Week 12 to Week 24|Other|4|||
143437343|NCT02706847|517147225|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
143437344|NCT02706847|517147226|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
143437345|NCT02706847|517147227|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
143437346|NCT02706847|517147228|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
143437347|NCT02706847|517147225|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
143437348|NCT02706847|517147226|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
143437349|NCT02706847|517147227|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
143437350|NCT02706847|517147228|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
143437351|NCT02706847|517147225|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
143437352|NCT02706847|517147226|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
143437353|NCT02706847|517147227|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
143437354|NCT02706847|517147228|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
143437355|NCT02706847|517147225|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
143437356|NCT02706847|517147226|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
143437357|NCT02706847|517147227|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
143437358|NCT02706847|517147228|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
143437359|NCT02706847|517147225|FG000|Period 2: Week 24 to Week 260|Other|8|||
143437360|NCT02706847|517147226|FG001|Period 2: Week 24 to Week 260|Other|5|||
143437361|NCT02706847|517147227|FG002|Period 2: Week 24 to Week 260|Other|15|||
143437362|NCT02706847|517147228|FG003|Period 2: Week 24 to Week 260|Other|15|||
143437363|NCT03432390|517147229|FG000|Apnea Period|Protocol Violation|2|||
143437364|NCT03432390|517147230|FG001|Apnea Period|Protocol Violation|2|||
143437365|NCT02058836|517147231|FG000|Overall Study|Withdrawal by Subject|1|||
143437366|NCT02058836|517147232|FG001|Overall Study|Withdrawal by Subject|1|||
143437367|NCT00725543|517147236|FG000|Overall Study|Adverse Event|10|||
143437368|NCT00725543|517147236|FG000|Overall Study|Lack of Efficacy|3|||
143437369|NCT00725543|517147236|FG000|Overall Study|Withdrawal by Subject|10|||
143437370|NCT00725543|517147236|FG000|Overall Study|Physician Decision|5|||
143437371|NCT00725543|517147236|FG000|Overall Study|Lost to Follow-up|4|||
143437372|NCT00725543|517147236|FG000|Overall Study|Non-compliance|2|||
143437373|NCT00725543|517147236|FG000|Overall Study|Other|119|||
143437374|NCT01062971|517147238|FG000|Overall Study|Protocol Violation|1|||
143437375|NCT01062971|517147239|FG001|Overall Study|Protocol Violation|3|||
143437376|NCT01062971|517147238|FG000|Overall Study|Lost to Follow-up|3|||
143437377|NCT01062971|517147239|FG001|Overall Study|Lost to Follow-up|4|||
143437378|NCT05314374|517147240|FG000|Overall Study|Adverse Event|2|||
143437379|NCT05314374|517147241|FG001|Overall Study|Adverse Event|2|||
143437380|NCT02658175|517147242|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
143437381|NCT02658175|517147243|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
143437382|NCT02658175|517147244|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
143437383|NCT02658175|517147242|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
143437384|NCT02658175|517147243|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
143437385|NCT02658175|517147244|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
143437386|NCT02658175|517147242|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
143437387|NCT02658175|517147243|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
143437388|NCT02658175|517147244|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
143437389|NCT02658175|517147242|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
143437390|NCT02658175|517147243|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
143437391|NCT02658175|517147244|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
143437392|NCT02658175|517147242|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
143437393|NCT02658175|517147243|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
143437394|NCT02658175|517147244|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
143437395|NCT02658175|517147242|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
143437396|NCT02658175|517147243|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
143437397|NCT02658175|517147244|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
143437398|NCT02658175|517147242|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
143437399|NCT02658175|517147243|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
143437400|NCT02658175|517147244|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
143437401|NCT02658175|517147242|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
143437402|NCT02658175|517147243|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
143437403|NCT02658175|517147244|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
143437404|NCT02658175|517147242|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
143437405|NCT02658175|517147243|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
143437406|NCT02658175|517147244|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
143437407|NCT02658175|517147242|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
143437408|NCT02658175|517147243|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
143437409|NCT02658175|517147244|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
143437410|NCT01801982|517147247|FG000|Overall Study|Lost to Follow-up|1|||
143437411|NCT02918292|517147248|FG000|Study Enrollment Prior to Transplant|Death|1|||
143437412|NCT02918292|517147248|FG000|Study Follow up After Transplant|Death|6|||
143437413|NCT01482429|517147249|FG000|Care Usual|Protocol Violation|0|||
143437414|NCT01482429|517147250|FG001|Care Usual|Protocol Violation|172|||
143437415|NCT01482429|517147249|FG000|Care Usual|Lost to Follow-up|0|||
143437416|NCT01482429|517147250|FG001|Care Usual|Lost to Follow-up|1|||
143437417|NCT01482429|517147249|FG000|Protocol|Protocol Violation|275|||
143437418|NCT01482429|517147250|FG001|Protocol|Protocol Violation|0|||
143437419|NCT01214421|517147251|FG000|Overall Study|Lost to Follow-up|7|||
143437420|NCT01214421|517147252|FG001|Overall Study|Lost to Follow-up|3|||
143437421|NCT01214421|517147253|FG002|Overall Study|Lost to Follow-up|7|||
143437422|NCT01214421|517147254|FG003|Overall Study|Lost to Follow-up|3|||
143437423|NCT01214421|517147251|FG000|Overall Study|Adverse Event|16|||
143437424|NCT01214421|517147252|FG001|Overall Study|Adverse Event|35|||
143437425|NCT01214421|517147253|FG002|Overall Study|Adverse Event|14|||
143437426|NCT01214421|517147254|FG003|Overall Study|Adverse Event|3|||
143437427|NCT01214421|517147251|FG000|Overall Study|Sponsor Discontinued Site|1|||
143437428|NCT01214421|517147252|FG001|Overall Study|Sponsor Discontinued Site|2|||
143437429|NCT01214421|517147253|FG002|Overall Study|Sponsor Discontinued Site|0|||
143437430|NCT01214421|517147254|FG003|Overall Study|Sponsor Discontinued Site|0|||
143437431|NCT01214421|517147251|FG000|Overall Study|Withdrawal Criteria Met|3|||
143437432|NCT01214421|517147252|FG001|Overall Study|Withdrawal Criteria Met|0|||
143437433|NCT01214421|517147253|FG002|Overall Study|Withdrawal Criteria Met|2|||
143437434|NCT01214421|517147254|FG003|Overall Study|Withdrawal Criteria Met|1|||
143437435|NCT01214421|517147251|FG000|Overall Study|Physician Decision|2|||
143437436|NCT01214421|517147252|FG001|Overall Study|Physician Decision|0|||
143437437|NCT01214421|517147253|FG002|Overall Study|Physician Decision|4|||
143437438|NCT01214421|517147254|FG003|Overall Study|Physician Decision|0|||
143437439|NCT01214421|517147251|FG000|Overall Study|Withdrawal by Subject|21|||
143437440|NCT01214421|517147252|FG001|Overall Study|Withdrawal by Subject|18|||
143437441|NCT01214421|517147253|FG002|Overall Study|Withdrawal by Subject|11|||
143437442|NCT01214421|517147254|FG003|Overall Study|Withdrawal by Subject|2|||
143437443|NCT03783689|517147258|FG000|Overall Study|Adverse Event|2|||
143437444|NCT03783689|517147259|FG001|Overall Study|Adverse Event|0|||
143437445|NCT03783689|517147258|FG000|Overall Study|Lost to Follow-up|2|||
143437446|NCT03783689|517147259|FG001|Overall Study|Lost to Follow-up|1|||
143437447|NCT03783689|517147258|FG000|Overall Study|Physician Decision|2|||
143437448|NCT03783689|517147259|FG001|Overall Study|Physician Decision|1|||
143437449|NCT03783689|517147258|FG000|Overall Study|Withdrawal by Subject|3|||
143437450|NCT03783689|517147259|FG001|Overall Study|Withdrawal by Subject|3|||
143437451|NCT01266018|517149005|FG000|Overall Study|Physician Decision|1|||
143437452|NCT01266018|517149006|FG001|Overall Study|Physician Decision|0|||
143437453|NCT01266018|517149005|FG000|Overall Study|Progressive disease|0|||
143437454|NCT01266018|517149006|FG001|Overall Study|Progressive disease|1|||
143437455|NCT03167151|517149007|FG000|Overall Study|Withdrawal by Subject|1|||
143437456|NCT03167151|517149008|FG001|Overall Study|Withdrawal by Subject|0|||
143437457|NCT03167151|517149009|FG002|Overall Study|Withdrawal by Subject|0|||
143437458|NCT03167151|517149007|FG000|Overall Study|No evidence of tumour at surgery|0|||
143437459|NCT03167151|517149008|FG001|Overall Study|No evidence of tumour at surgery|1|||
143437460|NCT03167151|517149009|FG002|Overall Study|No evidence of tumour at surgery|1|||
143437461|NCT01458522|517149010|FG000|Overall Study|Withdrawal by Subject|2|||
143437462|NCT01458522|517149011|FG001|Overall Study|Withdrawal by Subject|2|||
143437463|NCT01458522|517149010|FG000|Overall Study|Physician Decision|1|||
143437464|NCT01458522|517149011|FG001|Overall Study|Physician Decision|9|||
143437465|NCT00516139|517149012|FG000|Overall Study|Adverse Event|27|||
143437466|NCT00516139|517149012|FG000|Overall Study|Lost to Follow-up|1|||
143437467|NCT00516139|517149012|FG000|Overall Study|Protocol Violation|1|||
143437468|NCT00516139|517149012|FG000|Overall Study|Withdrawal by Subject|8|||
143437469|NCT00516139|517149012|FG000|Overall Study|Lack of Efficacy|1|||
143437470|NCT00416598|517149013|FG000|Induction & Intensification|Adverse Event|38|||
143437471|NCT00416598|517149013|FG000|Induction & Intensification|Death|32|||
143437472|NCT00416598|517149013|FG000|Induction & Intensification|Withdrawal by Subject|46|||
143437473|NCT00416598|517149013|FG000|Induction & Intensification|Alternative Treatment|135|||
143437474|NCT00416598|517149013|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
143437475|NCT00416598|517149013|FG000|Induction & Intensification|Relapse/progression|29|||
143437476|NCT00416598|517149013|FG000|Induction & Intensification|Failed induction|87|||
143437477|NCT00416598|517149013|FG000|Decitabine Maintenance|Adverse Event|5|||
143437478|NCT00416598|517149013|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
143437479|NCT00416598|517149013|FG000|Decitabine Maintenance|Progression/relapse|38|||
143437480|NCT00416598|517149013|FG000|Decitabine Maintenance|Alternative treatment|2|||
143437481|NCT00416598|517149013|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
143437482|NCT03382561|517149018|FG000|Overall Study|Disease progression|47|||
143437483|NCT03382561|517149019|FG001|Overall Study|Disease progression|6|||
143437484|NCT03382561|517149018|FG000|Overall Study|Adverse Event|10|||
143437485|NCT03382561|517149019|FG001|Overall Study|Adverse Event|2|||
143437486|NCT03382561|517149018|FG000|Overall Study|Death|8|||
143437487|NCT03382561|517149019|FG001|Overall Study|Death|3|||
143437488|NCT03382561|517149018|FG000|Overall Study|Withdrawal by Subject|6|||
143437489|NCT03382561|517149019|FG001|Overall Study|Withdrawal by Subject|5|||
143437490|NCT03382561|517149018|FG000|Overall Study|Alternative therapy|2|||
143437491|NCT03382561|517149019|FG001|Overall Study|Alternative therapy|8|||
143437492|NCT03382561|517149018|FG000|Overall Study|Never started treatment|3|||
143437493|NCT03382561|517149019|FG001|Overall Study|Never started treatment|6|||
143437494|NCT03382561|517149018|FG000|Overall Study|Lack of Efficacy|0|||
143437495|NCT03382561|517149019|FG001|Overall Study|Lack of Efficacy|1|||
143437496|NCT03382561|517149018|FG000|Overall Study|Physician Decision|0|||
143437497|NCT03382561|517149019|FG001|Overall Study|Physician Decision|1|||
143437498|NCT03382561|517149018|FG000|Overall Study|Other complicating disease|0|||
143437499|NCT03382561|517149019|FG001|Overall Study|Other complicating disease|1|||
143437500|NCT01131104|517149020|FG000|Overall Study|Withdrawal by Subject|3|||
143437501|NCT01131104|517149020|FG000|Overall Study|Physician Decision|4|||
143437502|NCT01131104|517149020|FG000|Overall Study|Information Not Available|5|||
143437503|NCT01131104|517149020|FG000|Overall Study|No Information on Index Date of Onset|1|||
143437504|NCT04836559|517149021|FG000|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
143437505|NCT04836559|517149022|FG001|Double Blind Period (Day 1 to Day 85)|Adverse Event|4|||
143437506|NCT04836559|517149023|FG002|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
143437507|NCT04836559|517149024|FG003|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
143437508|NCT04836559|517149025|FG004|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
143437509|NCT04836559|517149026|FG005|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
143437510|NCT04836559|517149027|FG006|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
143437511|NCT04836559|517149028|FG007|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
143437512|NCT04836559|517149021|FG000|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
143437513|NCT04836559|517149022|FG001|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
143437514|NCT04836559|517149023|FG002|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
143437515|NCT04836559|517149024|FG003|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|3|||
143437516|NCT04836559|517149025|FG004|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
143437517|NCT04836559|517149026|FG005|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
143437518|NCT04836559|517149027|FG006|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
143437519|NCT04836559|517149028|FG007|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
143437520|NCT04836559|517149021|FG000|Double Blind Period (Day 1 to Day 85)|Protocol Violation|1|||
143437521|NCT04836559|517149022|FG001|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
143437522|NCT04836559|517149023|FG002|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
143437523|NCT04836559|517149024|FG003|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
143437524|NCT04836559|517149025|FG004|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
143437525|NCT04836559|517149026|FG005|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
143437526|NCT04836559|517149027|FG006|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
143437527|NCT04836559|517149028|FG007|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
143437528|NCT04836559|517149021|FG000|Double Blind Period (Day 1 to Day 85)|Other|1|||
143437529|NCT04836559|517149022|FG001|Double Blind Period (Day 1 to Day 85)|Other|0|||
143437530|NCT04836559|517149023|FG002|Double Blind Period (Day 1 to Day 85)|Other|0|||
143437531|NCT04836559|517149024|FG003|Double Blind Period (Day 1 to Day 85)|Other|0|||
143437532|NCT04836559|517149025|FG004|Double Blind Period (Day 1 to Day 85)|Other|0|||
143437533|NCT04836559|517149026|FG005|Double Blind Period (Day 1 to Day 85)|Other|0|||
143437534|NCT04836559|517149027|FG006|Double Blind Period (Day 1 to Day 85)|Other|0|||
143437535|NCT04836559|517149028|FG007|Double Blind Period (Day 1 to Day 85)|Other|0|||
143437536|NCT04836559|517149021|FG000|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
143437537|NCT04836559|517149022|FG001|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
143437538|NCT04836559|517149023|FG002|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
143437539|NCT04836559|517149024|FG003|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|1|||
143437540|NCT04836559|517149025|FG004|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
143437541|NCT04836559|517149026|FG005|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
143437542|NCT04836559|517149027|FG006|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
143437543|NCT04836559|517149028|FG007|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
143437544|NCT04836559|517149021|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
143437545|NCT04836559|517149022|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
143437546|NCT04836559|517149023|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
143437547|NCT04836559|517149024|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
143437548|NCT04836559|517149025|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|7|||
143437549|NCT04836559|517149026|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|14|||
143437550|NCT04836559|517149027|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|4|||
143437551|NCT04836559|517149028|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|24|||
143437552|NCT04836559|517149021|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
143437553|NCT04836559|517149022|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
143437554|NCT04836559|517149023|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
143437555|NCT04836559|517149024|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
143437556|NCT04836559|517149025|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|1|||
143437557|NCT04836559|517149026|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|7|||
143437558|NCT04836559|517149027|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|3|||
143437559|NCT04836559|517149028|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|4|||
143437560|NCT04836559|517149021|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
143437561|NCT04836559|517149022|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
143437562|NCT04836559|517149023|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
143437563|NCT04836559|517149024|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
143437564|NCT04836559|517149025|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|4|||
143437565|NCT04836559|517149026|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
143437566|NCT04836559|517149027|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
143437567|NCT04836559|517149028|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
143437568|NCT04836559|517149021|FG000|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
143437569|NCT04836559|517149022|FG001|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
143437570|NCT04836559|517149023|FG002|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
143437571|NCT04836559|517149024|FG003|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
143437572|NCT04836559|517149025|FG004|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
143437573|NCT04836559|517149026|FG005|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
143437574|NCT04836559|517149027|FG006|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
143437575|NCT04836559|517149028|FG007|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|1|||
143437576|NCT00730015|517149029|FG000|Overall Study|Adverse Event|11|||
143437577|NCT00730015|517149030|FG001|Overall Study|Adverse Event|10|||
143437578|NCT00730015|517149031|FG002|Overall Study|Adverse Event|8|||
143437579|NCT00730015|517149029|FG000|Overall Study|Protocol Violation|2|||
143437580|NCT00730015|517149030|FG001|Overall Study|Protocol Violation|6|||
143437581|NCT00730015|517149031|FG002|Overall Study|Protocol Violation|4|||
143437582|NCT00730015|517149029|FG000|Overall Study|Withdrawal by Subject|12|||
143437583|NCT00730015|517149030|FG001|Overall Study|Withdrawal by Subject|12|||
143437584|NCT00730015|517149031|FG002|Overall Study|Withdrawal by Subject|8|||
143437585|NCT00730015|517149029|FG000|Overall Study|Lost to Follow-up|4|||
143437586|NCT00730015|517149030|FG001|Overall Study|Lost to Follow-up|10|||
143437587|NCT00730015|517149031|FG002|Overall Study|Lost to Follow-up|3|||
143437588|NCT00730015|517149029|FG000|Overall Study|Lack of Efficacy|1|||
143437589|NCT00730015|517149030|FG001|Overall Study|Lack of Efficacy|2|||
143437590|NCT00730015|517149031|FG002|Overall Study|Lack of Efficacy|8|||
143437591|NCT00730015|517149029|FG000|Overall Study|Other Reason|1|||
143437592|NCT00730015|517149030|FG001|Overall Study|Other Reason|0|||
143437593|NCT00730015|517149031|FG002|Overall Study|Other Reason|1|||
143437594|NCT04978350|517149032|FG000|Overall Study|Lost to Follow-up|6|||
143437595|NCT02577003|517149033|FG000|Overall Study|Adverse Event|2|||
143437596|NCT02577003|517149034|FG001|Overall Study|Adverse Event|4|||
143437597|NCT02577003|517149033|FG000|Overall Study|Withdrawal by Subject|0|||
143437598|NCT02577003|517149034|FG001|Overall Study|Withdrawal by Subject|1|||
143437599|NCT03210519|517149035|FG000|Overall Study|Adverse Event|2|||
143437600|NCT03210519|517149036|FG001|Overall Study|Adverse Event|0|||
143437601|NCT02270671|517149037|FG000|Overall Study|Withdrawal by Subject|1|||
143437602|NCT02270671|517149038|FG001|Overall Study|Withdrawal by Subject|1|||
143437603|NCT02270671|517149037|FG000|Overall Study|Protocol Violation|0|||
143437604|NCT02270671|517149038|FG001|Overall Study|Protocol Violation|1|||
143437605|NCT02270671|517149037|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
143437606|NCT02270671|517149038|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
143437607|NCT02270671|517149037|FG000|Overall Study|Lost to Follow-up|2|||
143437608|NCT02270671|517149038|FG001|Overall Study|Lost to Follow-up|1|||
143437609|NCT01657799|517149041|FG000|Overall Study|Adverse Event Related to progression|6|||
143437610|NCT01657799|517149042|FG001|Overall Study|Adverse Event Related to progression|8|||
143437611|NCT01657799|517149043|FG002|Overall Study|Adverse Event Related to progression|12|||
143437612|NCT01657799|517149041|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
143437613|NCT01657799|517149042|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
143437614|NCT01657799|517149043|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
143437615|NCT01657799|517149041|FG000|Overall Study|Withdrawal by Subject|13|||
143437616|NCT01657799|517149042|FG001|Overall Study|Withdrawal by Subject|10|||
143437617|NCT01657799|517149043|FG002|Overall Study|Withdrawal by Subject|10|||
143437618|NCT01657799|517149041|FG000|Overall Study|Lost to Follow-up|1|||
143437619|NCT01657799|517149042|FG001|Overall Study|Lost to Follow-up|0|||
143437620|NCT01657799|517149043|FG002|Overall Study|Lost to Follow-up|1|||
143437621|NCT01657799|517149041|FG000|Overall Study|Disease Progression|2|||
143437622|NCT01657799|517149042|FG001|Overall Study|Disease Progression|4|||
143437623|NCT01657799|517149043|FG002|Overall Study|Disease Progression|4|||
143437624|NCT01657799|517149041|FG000|Overall Study|Progressive Disease Clinical|7|||
143437625|NCT01657799|517149042|FG001|Overall Study|Progressive Disease Clinical|4|||
143437626|NCT01657799|517149043|FG002|Overall Study|Progressive Disease Clinical|7|||
143437627|NCT01657799|517149041|FG000|Overall Study|Radiographic & Clinical Progression|16|||
143437628|NCT01657799|517149042|FG001|Overall Study|Radiographic & Clinical Progression|11|||
143437629|NCT01657799|517149043|FG002|Overall Study|Radiographic & Clinical Progression|15|||
143437630|NCT01657799|517149041|FG000|Overall Study|Other|52|||
143437631|NCT01657799|517149042|FG001|Overall Study|Other|62|||
143437632|NCT01657799|517149043|FG002|Overall Study|Other|49|||
143437633|NCT01271504|517149050|FG000|Overall Study|Death|7|||
143437634|NCT01271504|517149051|FG001|Overall Study|Death|6|||
143437635|NCT01271504|517149052|FG002|Overall Study|Death|32|||
143437636|NCT01271504|517149053|FG003|Overall Study|Death|32|||
143437637|NCT01271504|517149050|FG000|Overall Study|Lost to Follow-up|0|||
143437638|NCT01271504|517149051|FG001|Overall Study|Lost to Follow-up|1|||
143437639|NCT01271504|517149052|FG002|Overall Study|Lost to Follow-up|3|||
143437640|NCT01271504|517149053|FG003|Overall Study|Lost to Follow-up|1|||
143437641|NCT01271504|517149050|FG000|Overall Study|Protocol Violation|0|||
143437642|NCT01271504|517149051|FG001|Overall Study|Protocol Violation|0|||
143437643|NCT01271504|517149052|FG002|Overall Study|Protocol Violation|0|||
143437644|NCT01271504|517149053|FG003|Overall Study|Protocol Violation|2|||
143437645|NCT01271504|517149050|FG000|Overall Study|Administrative Reasons|0|||
143437646|NCT01271504|517149051|FG001|Overall Study|Administrative Reasons|0|||
143437647|NCT01271504|517149052|FG002|Overall Study|Administrative Reasons|6|||
143437648|NCT01271504|517149053|FG003|Overall Study|Administrative Reasons|5|||
143437649|NCT01271504|517149050|FG000|Overall Study|Withdrawal by Subject|0|||
143437650|NCT01271504|517149051|FG001|Overall Study|Withdrawal by Subject|0|||
143437651|NCT01271504|517149052|FG002|Overall Study|Withdrawal by Subject|1|||
143437652|NCT01271504|517149053|FG003|Overall Study|Withdrawal by Subject|3|||
143437653|NCT01271504|517149050|FG000|Overall Study|Other|0|||
143437654|NCT01271504|517149051|FG001|Overall Study|Other|1|||
143437655|NCT01271504|517149052|FG002|Overall Study|Other|2|||
143437656|NCT01271504|517149053|FG003|Overall Study|Other|0|||
143437657|NCT03865953|517149054|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
143437658|NCT03865953|517149055|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
143437659|NCT03865953|517149054|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
143437660|NCT03865953|517149055|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
143437661|NCT03865953|517149054|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
143437662|NCT03865953|517149055|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
143437663|NCT00882115|517149056|FG000|Overall Study|Withdrawal by Subject|3|||
143437664|NCT00882115|517149056|FG000|Overall Study|did not respond to DEP challe|6|||
143437665|NCT00940875|517149071|FG000|Treatment Phase|Adverse Event|9|||
143437666|NCT00940875|517149072|FG001|Treatment Phase|Adverse Event|3|||
143437667|NCT00940875|517149071|FG000|Treatment Phase|Death|3|||
143437668|NCT00940875|517149072|FG001|Treatment Phase|Death|5|||
143437669|NCT00940875|517149071|FG000|Treatment Phase|Lack of Efficacy|1|||
143437670|NCT00940875|517149072|FG001|Treatment Phase|Lack of Efficacy|0|||
143437671|NCT00940875|517149071|FG000|Treatment Phase|Withdrawal by Subject|3|||
143437672|NCT00940875|517149072|FG001|Treatment Phase|Withdrawal by Subject|0|||
143437673|NCT00940875|517149071|FG000|Treatment Phase|Disease progression|9|||
143437674|NCT00940875|517149072|FG001|Treatment Phase|Disease progression|11|||
143437675|NCT00940875|517149071|FG000|Treatment Phase|Physician Decision|1|||
143437676|NCT00940875|517149072|FG001|Treatment Phase|Physician Decision|0|||
143437677|NCT00940875|517149071|FG000|Post-Study Treatment|Death|0|||
143437678|NCT00940875|517149072|FG001|Post-Study Treatment|Death|1|||
143437679|NCT00940875|517149071|FG000|Post-Study Treatment|Disease Progression|0|||
143437680|NCT00940875|517149072|FG001|Post-Study Treatment|Disease Progression|2|||
143437681|NCT00490945|517149073|FG000|Overall Study|Adverse Event|0|||
143437682|NCT00490945|517149074|FG001|Overall Study|Adverse Event|1|||
143437683|NCT00490945|517149075|FG002|Overall Study|Adverse Event|0|||
143437684|NCT00490945|517149076|FG003|Overall Study|Adverse Event|0|||
143437685|NCT00490945|517149077|FG004|Overall Study|Adverse Event|0|||
143437686|NCT01646385|517149080|FG000|Overall Study|Death|202|||
143437687|NCT01646385|517149081|FG001|Overall Study|Death|222|||
143437688|NCT01646385|517149080|FG000|Overall Study|Switched to alternate biologic|636|||
143437689|NCT01646385|517149081|FG001|Overall Study|Switched to alternate biologic|649|||
143437690|NCT01841697|517149082|FG000|Overall Study|Death|0|||
143437691|NCT01841697|517149083|FG001|Overall Study|Death|1|||
143437692|NCT01841697|517149082|FG000|Overall Study|Lost to Follow-up|4|||
143437693|NCT01841697|517149083|FG001|Overall Study|Lost to Follow-up|1|||
143437694|NCT01841697|517149082|FG000|Overall Study|Withdrawal by Subject|16|||
143437695|NCT01841697|517149083|FG001|Overall Study|Withdrawal by Subject|16|||
143437696|NCT00727415|517149084|FG000|Phase I|Dose Limiting Toxicity|2|||
143437697|NCT00756457|517149085|FG000|Overall Study|Lost to Follow-up|1|||
143437698|NCT00756457|517149086|FG001|Overall Study|Lost to Follow-up|2|||
143437699|NCT01777490|517149088|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
143437700|NCT01777490|517149089|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
143437701|NCT01777490|517149090|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
143437702|NCT01777490|517149091|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
143437703|NCT02947100|517149094|FG000|Overall Study|study terminated early|3|||
143437704|NCT02947100|517149094|FG000|Overall Study|did not meet inclusion criteria|1|||
143437705|NCT00822770|517149095|FG000|Overall Study|Not treated|1|||
143437706|NCT00822770|517149096|FG001|Overall Study|Not treated|0|||
143437707|NCT00822770|517149095|FG000|Overall Study|Complication/Incomplete treatment|1|||
143437708|NCT00822770|517149096|FG001|Overall Study|Complication/Incomplete treatment|0|||
143437709|NCT00822770|517149095|FG000|Overall Study|Death|1|||
143437710|NCT00822770|517149096|FG001|Overall Study|Death|1|||
143437711|NCT02402322|517149097|FG000|Pretreatment|Withdrawal by Subject|3|||
143437712|NCT02402322|517149098|FG001|Pretreatment|Withdrawal by Subject|1|||
143437713|NCT02402322|517149099|FG002|Pretreatment|Withdrawal by Subject|1|||
143437714|NCT02402322|517149097|FG000|Follow-up|Withdrawal by Subject|6|||
143437715|NCT02402322|517149098|FG001|Follow-up|Withdrawal by Subject|3|||
143437716|NCT02402322|517149099|FG002|Follow-up|Withdrawal by Subject|24|||
143437717|NCT04593823|517149103|FG000|Overall Study|Withdrawal by Subject|1|||
143437718|NCT04593823|517149104|FG001|Overall Study|Withdrawal by Subject|1|||
143437719|NCT04593823|517149103|FG000|Overall Study|Lost to Follow-up|0|||
143437720|NCT04593823|517149104|FG001|Overall Study|Lost to Follow-up|1|||
143437721|NCT01080326|517149105|FG000|Overall Study|Patient deterioration prior to procedure|3|||
143437722|NCT01080326|517149105|FG000|Overall Study|Surgeon decision|1|||
143437723|NCT00267098|517149106|FG000|Overall Study|Death|0|||
143437724|NCT00267098|517149107|FG001|Overall Study|Death|0|||
143437725|NCT00267098|517149108|FG002|Overall Study|Death|57|||
143437726|NCT00267098|517149109|FG003|Overall Study|Death|66|||
143437727|NCT00267098|517149110|FG004|Overall Study|Death|14|||
143437728|NCT00267098|517149111|FG005|Overall Study|Death|23|||
143437729|NCT00267098|517149112|FG006|Overall Study|Death|28|||
143437730|NCT00267098|517149113|FG007|Overall Study|Death|9|||
143437731|NCT00267098|517149106|FG000|Overall Study|Lost to Follow-up|0|||
143437732|NCT00267098|517149107|FG001|Overall Study|Lost to Follow-up|0|||
143437733|NCT00267098|517149108|FG002|Overall Study|Lost to Follow-up|6|||
143437734|NCT00267098|517149109|FG003|Overall Study|Lost to Follow-up|5|||
143437735|NCT00267098|517149110|FG004|Overall Study|Lost to Follow-up|2|||
143437736|NCT00267098|517149111|FG005|Overall Study|Lost to Follow-up|3|||
143437737|NCT00267098|517149112|FG006|Overall Study|Lost to Follow-up|1|||
143437738|NCT00267098|517149113|FG007|Overall Study|Lost to Follow-up|1|||
143437739|NCT00267098|517149106|FG000|Overall Study|Withdrawal by Subject|8|||
143437740|NCT00267098|517149107|FG001|Overall Study|Withdrawal by Subject|0|||
143437741|NCT00267098|517149108|FG002|Overall Study|Withdrawal by Subject|24|||
143437742|NCT00267098|517149109|FG003|Overall Study|Withdrawal by Subject|21|||
143437743|NCT00267098|517149110|FG004|Overall Study|Withdrawal by Subject|12|||
143437744|NCT00267098|517149111|FG005|Overall Study|Withdrawal by Subject|9|||
143437745|NCT00267098|517149112|FG006|Overall Study|Withdrawal by Subject|12|||
143437746|NCT00267098|517149113|FG007|Overall Study|Withdrawal by Subject|5|||
143437747|NCT00267098|517149106|FG000|Overall Study|Physician Decision|5|||
143437748|NCT00267098|517149107|FG001|Overall Study|Physician Decision|0|||
143437749|NCT00267098|517149108|FG002|Overall Study|Physician Decision|7|||
143437750|NCT00267098|517149109|FG003|Overall Study|Physician Decision|11|||
143437751|NCT00267098|517149110|FG004|Overall Study|Physician Decision|5|||
143437752|NCT00267098|517149111|FG005|Overall Study|Physician Decision|4|||
143437753|NCT00267098|517149112|FG006|Overall Study|Physician Decision|3|||
143437754|NCT00267098|517149113|FG007|Overall Study|Physician Decision|0|||
143437755|NCT00267098|517149106|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
143437756|NCT00267098|517149107|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
143437757|NCT00267098|517149108|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
143437758|NCT00267098|517149109|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
143437759|NCT00267098|517149110|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
143437760|NCT00267098|517149111|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
143437761|NCT00267098|517149112|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
143437762|NCT00267098|517149113|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
143437763|NCT00267098|517149106|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
143437764|NCT00267098|517149107|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
143437765|NCT00267098|517149108|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
143437766|NCT00267098|517149109|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
143437767|NCT00267098|517149110|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
143437768|NCT00267098|517149111|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
143437769|NCT00267098|517149112|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
143437770|NCT00267098|517149113|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
143437771|NCT00267098|517149106|FG000|Overall Study|Site closure|0|||
143437772|NCT00267098|517149107|FG001|Overall Study|Site closure|0|||
143437773|NCT00267098|517149108|FG002|Overall Study|Site closure|0|||
143437774|NCT00267098|517149109|FG003|Overall Study|Site closure|1|||
143437775|NCT00267098|517149110|FG004|Overall Study|Site closure|0|||
143437776|NCT00267098|517149111|FG005|Overall Study|Site closure|1|||
143437777|NCT00267098|517149112|FG006|Overall Study|Site closure|1|||
143437778|NCT00267098|517149113|FG007|Overall Study|Site closure|0|||
143437779|NCT00267098|517149106|FG000|Overall Study|Explanted Medtronic device|0|||
143437780|NCT00267098|517149107|FG001|Overall Study|Explanted Medtronic device|0|||
143437781|NCT00267098|517149108|FG002|Overall Study|Explanted Medtronic device|0|||
143437782|NCT00267098|517149109|FG003|Overall Study|Explanted Medtronic device|1|||
143437783|NCT00267098|517149110|FG004|Overall Study|Explanted Medtronic device|0|||
143437784|NCT00267098|517149111|FG005|Overall Study|Explanted Medtronic device|0|||
143437785|NCT00267098|517149112|FG006|Overall Study|Explanted Medtronic device|0|||
143437786|NCT00267098|517149113|FG007|Overall Study|Explanted Medtronic device|0|||
143437787|NCT00267098|517149106|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
143437788|NCT00267098|517149107|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
143437789|NCT00267098|517149108|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
143437790|NCT00267098|517149109|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
143437791|NCT00267098|517149110|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
143437792|NCT00267098|517149111|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
143437793|NCT00267098|517149112|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
143437794|NCT00267098|517149113|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
143437795|NCT00267098|517149106|FG000|Overall Study|Subject listed for heart transplant|0|||
143437796|NCT00267098|517149107|FG001|Overall Study|Subject listed for heart transplant|0|||
143437797|NCT00267098|517149108|FG002|Overall Study|Subject listed for heart transplant|0|||
143437798|NCT00267098|517149109|FG003|Overall Study|Subject listed for heart transplant|0|||
143437799|NCT00267098|517149110|FG004|Overall Study|Subject listed for heart transplant|0|||
143437800|NCT00267098|517149111|FG005|Overall Study|Subject listed for heart transplant|0|||
143437801|NCT00267098|517149112|FG006|Overall Study|Subject listed for heart transplant|1|||
143437802|NCT00267098|517149113|FG007|Overall Study|Subject listed for heart transplant|0|||
143437803|NCT00267098|517149106|FG000|Overall Study|Sponsor withdrew subject|0|||
143437804|NCT00267098|517149107|FG001|Overall Study|Sponsor withdrew subject|0|||
143437805|NCT00267098|517149108|FG002|Overall Study|Sponsor withdrew subject|0|||
143437806|NCT00267098|517149109|FG003|Overall Study|Sponsor withdrew subject|1|||
143437807|NCT00267098|517149110|FG004|Overall Study|Sponsor withdrew subject|0|||
143437808|NCT00267098|517149111|FG005|Overall Study|Sponsor withdrew subject|0|||
143437809|NCT00267098|517149112|FG006|Overall Study|Sponsor withdrew subject|0|||
143437810|NCT00267098|517149113|FG007|Overall Study|Sponsor withdrew subject|0|||
143437811|NCT00798304|517149117|FG000|Overall Study|Adverse Event|0|||
143437812|NCT00798304|517149118|FG001|Overall Study|Adverse Event|1|||
143437813|NCT00798304|517149119|FG002|Overall Study|Adverse Event|1|||
143437814|NCT00798304|517149117|FG000|Overall Study|Discontinuation by Sponsor|14|||
143437815|NCT00798304|517149118|FG001|Overall Study|Discontinuation by Sponsor|21|||
143437816|NCT00798304|517149119|FG002|Overall Study|Discontinuation by Sponsor|9|||
143437817|NCT00547534|517149120|FG000|Overall Study|Adverse Event|7|||
143437818|NCT00547534|517149120|FG000|Overall Study|Disease Progression|4|||
143437819|NCT00763451|517149127|FG000|Overall Study|Adverse Event|4|||
143437820|NCT00763451|517149128|FG001|Overall Study|Adverse Event|6|||
143437821|NCT00763451|517149129|FG002|Overall Study|Adverse Event|19|||
143437822|NCT00763451|517149130|FG003|Overall Study|Adverse Event|14|||
143437823|NCT00763451|517149127|FG000|Overall Study|Lack of Efficacy|1|||
143437824|NCT00763451|517149128|FG001|Overall Study|Lack of Efficacy|4|||
143437825|NCT00763451|517149129|FG002|Overall Study|Lack of Efficacy|3|||
143437826|NCT00763451|517149130|FG003|Overall Study|Lack of Efficacy|2|||
143437827|NCT00763451|517149127|FG000|Overall Study|Withdrawal by Subject|1|||
143437828|NCT00763451|517149128|FG001|Overall Study|Withdrawal by Subject|6|||
143437829|NCT00763451|517149129|FG002|Overall Study|Withdrawal by Subject|9|||
143437830|NCT00763451|517149130|FG003|Overall Study|Withdrawal by Subject|7|||
143437831|NCT00763451|517149127|FG000|Overall Study|Protocol Violation|0|||
143437832|NCT00763451|517149128|FG001|Overall Study|Protocol Violation|0|||
143437833|NCT00763451|517149129|FG002|Overall Study|Protocol Violation|1|||
143437834|NCT00763451|517149130|FG003|Overall Study|Protocol Violation|0|||
143437835|NCT00763451|517149127|FG000|Overall Study|Poor Compliance to Protocol|1|||
143437836|NCT00763451|517149128|FG001|Overall Study|Poor Compliance to Protocol|1|||
143437837|NCT00763451|517149129|FG002|Overall Study|Poor Compliance to Protocol|2|||
143437838|NCT00763451|517149130|FG003|Overall Study|Poor Compliance to Protocol|2|||
143437839|NCT00763451|517149127|FG000|Overall Study|Familial and Personal Reasons|5|||
143437840|NCT00763451|517149128|FG001|Overall Study|Familial and Personal Reasons|3|||
143437841|NCT00763451|517149129|FG002|Overall Study|Familial and Personal Reasons|5|||
143437842|NCT00763451|517149130|FG003|Overall Study|Familial and Personal Reasons|4|||
143437843|NCT00763451|517149127|FG000|Overall Study|Randomized but not Treated|1|||
143437844|NCT00763451|517149128|FG001|Overall Study|Randomized but not Treated|1|||
143437845|NCT00763451|517149129|FG002|Overall Study|Randomized but not Treated|0|||
143437846|NCT00763451|517149130|FG003|Overall Study|Randomized but not Treated|0|||
143437847|NCT00763451|517149127|FG000|Overall Study|Study Site Reason|0|||
143437848|NCT00763451|517149128|FG001|Overall Study|Study Site Reason|1|||
143437849|NCT00763451|517149129|FG002|Overall Study|Study Site Reason|1|||
143437850|NCT00763451|517149130|FG003|Overall Study|Study Site Reason|1|||
143437851|NCT01182207|517149131|FG000|First Intervention|Positive Hepatitis Results|0|||
143437852|NCT01182207|517149132|FG001|First Intervention|Positive Hepatitis Results|1|||
143437853|NCT01182207|517149131|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
143437854|NCT01182207|517149132|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
143437855|NCT01087814|517149133|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
143437856|NCT01087814|517149134|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
143437857|NCT01087814|517149133|FG000|Second Intervention (5 Days)|Physician Decision|1|||
143437858|NCT01087814|517149134|FG001|Second Intervention (5 Days)|Physician Decision|0|||
143437859|NCT01427738|517149135|FG000|Overall Study|Death|12|||
143437860|NCT01427738|517149136|FG001|Overall Study|Death|9|||
143437861|NCT01427738|517149135|FG000|Overall Study|Severe debilitation, unable to continue|0|||
143437862|NCT01427738|517149136|FG001|Overall Study|Severe debilitation, unable to continue|1|||
143437863|NCT01427738|517149135|FG000|Overall Study|Subject unable to get to clinic|5|||
143437864|NCT01427738|517149136|FG001|Overall Study|Subject unable to get to clinic|2|||
143437865|NCT01427738|517149135|FG000|Overall Study|Withdrawal by Subject|0|||
143437866|NCT01427738|517149136|FG001|Overall Study|Withdrawal by Subject|2|||
143437867|NCT01427738|517149135|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
143437868|NCT01427738|517149136|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
143437869|NCT01427738|517149135|FG000|Overall Study|Lost to Follow-up|1|||
143437870|NCT01427738|517149136|FG001|Overall Study|Lost to Follow-up|5|||
143437871|NCT02581059|517149141|FG000|Study Treatment|Disease Progression|1|||
143437872|NCT02581059|517149142|FG001|Study Treatment|Disease Progression|1|||
143437873|NCT02581059|517149141|FG000|Study Treatment|Adverse Event|2|||
143437874|NCT02581059|517149142|FG001|Study Treatment|Adverse Event|1|||
143437875|NCT02581059|517149141|FG000|Study Treatment|Death|1|||
143437876|NCT02581059|517149142|FG001|Study Treatment|Death|1|||
143437877|NCT02581059|517149141|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
143437878|NCT02581059|517149142|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
143437879|NCT02581059|517149141|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
143437880|NCT02581059|517149142|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
143437881|NCT02581059|517149141|FG000|Follow up|Death|1|||
143437882|NCT02581059|517149142|FG001|Follow up|Death|3|||
143437883|NCT02581059|517149141|FG000|Follow up|study terminated|1|||
143437884|NCT02581059|517149142|FG001|Follow up|study terminated|1|||
143437885|NCT02581059|517149141|FG000|Follow up|screen failure|0|||
143437886|NCT02581059|517149142|FG001|Follow up|screen failure|1|||
143437887|NCT02581059|517149141|FG000|Follow up|Patient started new clinical trial|1|||
143437888|NCT02581059|517149142|FG001|Follow up|Patient started new clinical trial|0|||
143437889|NCT02392104|517149143|FG000|Overall Study|discontinuation of warfarin|3|||
143437890|NCT02392104|517149143|FG000|Overall Study|bleeding event|1|||
143437891|NCT02392104|517149143|FG000|Overall Study|transferred care to another doctor|2|||
143437892|NCT02392104|517149143|FG000|Overall Study|INR goal range changed|1|||
143437893|NCT02392104|517149143|FG000|Overall Study|admitted to skilled nursing facility|3|||
143437894|NCT02392104|517149143|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
143437895|NCT03912532|517149147|FG000|Overall Study|Adverse Event|3|||
143437896|NCT03912532|517149148|FG001|Overall Study|Adverse Event|3|||
143437897|NCT03912532|517149149|FG002|Overall Study|Adverse Event|2|||
143437898|NCT03912532|517149150|FG003|Overall Study|Adverse Event|2|||
143437899|NCT03912532|517149147|FG000|Overall Study|Lost to Follow-up|3|||
143437900|NCT03912532|517149148|FG001|Overall Study|Lost to Follow-up|2|||
143437901|NCT03912532|517149149|FG002|Overall Study|Lost to Follow-up|1|||
143437902|NCT03912532|517149150|FG003|Overall Study|Lost to Follow-up|2|||
143437903|NCT03912532|517149147|FG000|Overall Study|Withdrawal by Subject|1|||
143437904|NCT03912532|517149148|FG001|Overall Study|Withdrawal by Subject|1|||
143437905|NCT03912532|517149149|FG002|Overall Study|Withdrawal by Subject|2|||
143437906|NCT03912532|517149150|FG003|Overall Study|Withdrawal by Subject|0|||
143437907|NCT03912532|517149147|FG000|Overall Study|Physician Decision|1|||
143437908|NCT03912532|517149148|FG001|Overall Study|Physician Decision|0|||
143437909|NCT03912532|517149149|FG002|Overall Study|Physician Decision|0|||
143437910|NCT03912532|517149150|FG003|Overall Study|Physician Decision|3|||
143437911|NCT03912532|517149147|FG000|Overall Study|Other|0|||
143437912|NCT03912532|517149148|FG001|Overall Study|Other|1|||
143437913|NCT03912532|517149149|FG002|Overall Study|Other|1|||
143437914|NCT03912532|517149150|FG003|Overall Study|Other|0|||
143437915|NCT04913948|517149151|FG000|Overall Study|Withdrawal by Subject|2|||
143437916|NCT04913948|517149151|FG000|Overall Study|Sample processing issues|1|||
143437917|NCT04913948|517149151|FG000|Overall Study|Suspected to have COVID-19 at the time of delivery but was found to be negative upon RT-PCR testing|1|||
143437918|NCT03783871|517149154|FG000|Overall Study|Withdrawal by Subject|15|||
143437919|NCT03783871|517149154|FG000|Overall Study|Death|13|||
143437920|NCT03783871|517149154|FG000|Overall Study|Lost to Follow-up|2|||
143437921|NCT03569891|517149156|FG000|Lead-in|Ineligible during lead-in|8|||
143437922|NCT03569891|517149156|FG000|Lead-in|Withdrawal by Subject|3|||
143437923|NCT03569891|517149156|FG000|Lead-in|Risks related to COVID-19|2|||
143437924|NCT03569891|517149156|FG000|AMT-061|Adverse Event|1|||
143437925|NCT05990387|517149157|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|3|||
143437926|NCT05990387|517149158|FG001|Informed Consent/Screening Visit|Withdrawal by Subject|2|||
143437927|NCT00815919|517149159|FG000|Overall Study|Unrelated Fungal Infection|1|||
143437928|NCT00815919|517149159|FG000|Overall Study|AML Relapse|1|||
143437929|NCT00815919|517149159|FG000|Overall Study|Lack of Efficacy|2|||
143437930|NCT03522389|517149160|FG000|Overall Study|Lost to Follow-up|1|||
143437931|NCT03522389|517149161|FG001|Overall Study|Lost to Follow-up|1|||
143437932|NCT03522389|517149162|FG002|Overall Study|Lost to Follow-up|2|||
143437933|NCT03522389|517149160|FG000|Overall Study|had herniated nucleus pulposus|0|||
143437934|NCT03522389|517149161|FG001|Overall Study|had herniated nucleus pulposus|1|||
143437935|NCT03522389|517149162|FG002|Overall Study|had herniated nucleus pulposus|0|||
143437936|NCT03522389|517149160|FG000|Overall Study|go to work in other province|1|||
143437937|NCT03522389|517149161|FG001|Overall Study|go to work in other province|0|||
143437938|NCT03522389|517149162|FG002|Overall Study|go to work in other province|0|||
143437939|NCT04750577|517149163|FG000|Overall Study|Adverse Event|2|||
143437940|NCT04750577|517149164|FG001|Overall Study|Adverse Event|10|||
143437941|NCT04750577|517149165|FG002|Overall Study|Adverse Event|8|||
143437942|NCT04750577|517149166|FG003|Overall Study|Adverse Event|1|||
143437943|NCT04750577|517149163|FG000|Overall Study|Change of residence|0|||
143437944|NCT04750577|517149164|FG001|Overall Study|Change of residence|0|||
143437945|NCT04750577|517149165|FG002|Overall Study|Change of residence|1|||
143437946|NCT04750577|517149166|FG003|Overall Study|Change of residence|0|||
143437947|NCT04750577|517149163|FG000|Overall Study|Burden of study procedures|0|||
143437948|NCT04750577|517149164|FG001|Overall Study|Burden of study procedures|2|||
143437949|NCT04750577|517149165|FG002|Overall Study|Burden of study procedures|2|||
143437950|NCT04750577|517149166|FG003|Overall Study|Burden of study procedures|0|||
143437951|NCT04750577|517149163|FG000|Overall Study|Prematurely discontinued|0|||
143437952|NCT04750577|517149164|FG001|Overall Study|Prematurely discontinued|0|||
143437953|NCT04750577|517149165|FG002|Overall Study|Prematurely discontinued|0|||
143437954|NCT04750577|517149166|FG003|Overall Study|Prematurely discontinued|2|||
143437955|NCT04750577|517149163|FG000|Overall Study|Protocol deviation|1|||
143437956|NCT04750577|517149164|FG001|Overall Study|Protocol deviation|1|||
143437957|NCT04750577|517149165|FG002|Overall Study|Protocol deviation|1|||
143437958|NCT04750577|517149166|FG003|Overall Study|Protocol deviation|1|||
143437959|NCT04750577|517149163|FG000|Overall Study|Other than listed|3|||
143437960|NCT04750577|517149164|FG001|Overall Study|Other than listed|2|||
143437961|NCT04750577|517149165|FG002|Overall Study|Other than listed|2|||
143437962|NCT04750577|517149166|FG003|Overall Study|Other than listed|1|||
143437963|NCT04750577|517149163|FG000|Overall Study|Not treated|0|||
143437964|NCT04750577|517149164|FG001|Overall Study|Not treated|0|||
143437965|NCT04750577|517149165|FG002|Overall Study|Not treated|0|||
143437966|NCT04750577|517149166|FG003|Overall Study|Not treated|2|||
143437967|NCT00604188|517149171|FG000|Overall Study|Adverse Event|1|||
143437968|NCT00604188|517149172|FG001|Overall Study|Adverse Event|4|||
143437969|NCT00604188|517149171|FG000|Overall Study|Lost to Follow-up|17|||
143437970|NCT00604188|517149172|FG001|Overall Study|Lost to Follow-up|15|||
143437971|NCT00604188|517149171|FG000|Overall Study|Withdrawal by Subject|5|||
143437972|NCT00604188|517149172|FG001|Overall Study|Withdrawal by Subject|1|||
143437973|NCT00604188|517149171|FG000|Overall Study|Non-compliance with protocol|4|||
143437974|NCT00604188|517149172|FG001|Overall Study|Non-compliance with protocol|4|||
143437975|NCT00604188|517149171|FG000|Overall Study|Did not receive study drug|0|||
143437976|NCT00604188|517149172|FG001|Overall Study|Did not receive study drug|1|||
143437977|NCT01251887|517149174|FG000|Overall Study|Scheduling conflict|1|||
143437978|NCT01251887|517149175|FG001|Overall Study|Scheduling conflict|2|||
143437979|NCT01251887|517149176|FG002|Overall Study|Scheduling conflict|2|||
143437980|NCT01251887|517149174|FG000|Overall Study|Physician Decision|0|||
143437981|NCT01251887|517149175|FG001|Overall Study|Physician Decision|1|||
143437982|NCT01251887|517149176|FG002|Overall Study|Physician Decision|0|||
143437983|NCT03668223|517149177|FG000|Overall Study|Death|10|||
143437984|NCT03668223|517149178|FG001|Overall Study|Death|5|||
143437985|NCT03668223|517149177|FG000|Overall Study|Lost to Follow-up|12|||
143437986|NCT03668223|517149178|FG001|Overall Study|Lost to Follow-up|12|||
143437987|NCT03668223|517149177|FG000|Overall Study|Withdrawal by Subject|8|||
143437988|NCT03668223|517149178|FG001|Overall Study|Withdrawal by Subject|3|||
143437989|NCT00443599|517149182|FG000|Overall Study|Physician Decision|2|||
143437990|NCT00443599|517149183|FG001|Overall Study|Physician Decision|1|||
143437991|NCT00443599|517149182|FG000|Overall Study|Death|1|||
143437992|NCT00443599|517149183|FG001|Overall Study|Death|1|||
143437993|NCT00443599|517149182|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
143437994|NCT00443599|517149183|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
143437995|NCT03733899|517149184|FG000|Period 1|Protocol Violation|0|||
143437996|NCT03733899|517149185|FG001|Period 1|Protocol Violation|0|||
143437997|NCT03733899|517149186|FG002|Period 1|Protocol Violation|0|||
143437998|NCT03733899|517149187|FG003|Period 1|Protocol Violation|0|||
143437999|NCT03733899|517149188|FG004|Period 1|Protocol Violation|0|||
143438000|NCT03733899|517149189|FG005|Period 1|Protocol Violation|1|||
143438001|NCT03733899|517149184|FG000|Period 2|Unscuccessful Treatment|0|||
143438002|NCT03733899|517149185|FG001|Period 2|Unscuccessful Treatment|1|||
143438003|NCT03733899|517149186|FG002|Period 2|Unscuccessful Treatment|0|||
143438004|NCT03733899|517149187|FG003|Period 2|Unscuccessful Treatment|0|||
143438005|NCT03733899|517149188|FG004|Period 2|Unscuccessful Treatment|0|||
143438006|NCT03733899|517149189|FG005|Period 2|Unscuccessful Treatment|0|||
143438007|NCT03733899|517149184|FG000|Period 3|Withdrawal by Subject|1|||
143438008|NCT03733899|517149185|FG001|Period 3|Withdrawal by Subject|0|||
143438009|NCT03733899|517149186|FG002|Period 3|Withdrawal by Subject|0|||
143438010|NCT03733899|517149187|FG003|Period 3|Withdrawal by Subject|0|||
143438011|NCT03733899|517149188|FG004|Period 3|Withdrawal by Subject|0|||
143438012|NCT03733899|517149189|FG005|Period 3|Withdrawal by Subject|0|||
143438013|NCT00826228|517150736|FG000|Overall Study|Withdrawal by Subject|1|||
143438014|NCT00487825|517150738|FG000|Overall Study|Adverse Event|2|||
143438015|NCT00487825|517150739|FG001|Overall Study|Adverse Event|2|||
143438016|NCT00487825|517150738|FG000|Overall Study|Lack of Efficacy|1|||
143438017|NCT00487825|517150739|FG001|Overall Study|Lack of Efficacy|1|||
143438018|NCT00487825|517150738|FG000|Overall Study|Other|3|||
143438019|NCT00487825|517150739|FG001|Overall Study|Other|2|||
143438020|NCT00575042|517150740|FG000|Overall Study|Adverse Event|2|||
143438021|NCT00575042|517150740|FG000|Overall Study|Lost to Follow-up|1|||
143438022|NCT04486313|517150741|FG000|Overall Study|Lost to Follow-up|7|||
143438023|NCT04486313|517150742|FG001|Overall Study|Lost to Follow-up|9|||
143438024|NCT04486313|517150741|FG000|Overall Study|Withdrawal by Subject|8|||
143438025|NCT04486313|517150742|FG001|Overall Study|Withdrawal by Subject|6|||
143438026|NCT04486313|517150741|FG000|Overall Study|Physician Decision|1|||
143438027|NCT04486313|517150742|FG001|Overall Study|Physician Decision|1|||
143438028|NCT04486313|517150741|FG000|Overall Study|Death|2|||
143438029|NCT04486313|517150742|FG001|Overall Study|Death|0|||
143438030|NCT04486313|517150741|FG000|Overall Study|Protocol Violation|1|||
143438031|NCT04486313|517150742|FG001|Overall Study|Protocol Violation|1|||
143438032|NCT00126659|517150743|FG000|Overall Study|Adverse Event|0|||
143438033|NCT00126659|517150744|FG001|Overall Study|Adverse Event|0|||
143438034|NCT00126659|517150745|FG002|Overall Study|Adverse Event|2|||
143438035|NCT00174447|517150746|FG000|Overall Study|Adverse Event|19|||
143438036|NCT00174447|517150746|FG000|Overall Study|Withdrawal by Subject|15|||
143438037|NCT00174447|517150746|FG000|Overall Study|Protocol Violation|1|||
143438038|NCT00174447|517150746|FG000|Overall Study|Lack of Efficacy|1|||
143438039|NCT00174447|517150746|FG000|Overall Study|Administrative reason/Other|2|||
143438040|NCT02229578|517150749|FG000|Overall Study|Withdrawal by Subject|1|||
143438041|NCT02229578|517150750|FG001|Overall Study|Withdrawal by Subject|3|||
143438042|NCT02229578|517150749|FG000|Overall Study|Protocol Violation|2|||
143438043|NCT02229578|517150750|FG001|Overall Study|Protocol Violation|0|||
143438044|NCT00943787|517150752|FG000|Overall Study|Physician Decision|4|||
143438045|NCT00943787|517150752|FG000|Overall Study|Withdrawal by Subject|3|||
143438046|NCT04071301|517150753|FG000|Overall Study|Withdrawal by Subject|6|||
143438047|NCT04071301|517150753|FG000|Overall Study|Death|1|||
143438048|NCT01850589|517150759|FG000|Overall Study|Withdrawal by Subject|8|||
143438049|NCT01850589|517150760|FG001|Overall Study|Withdrawal by Subject|0|||
143438050|NCT03721705|517150764|FG000|Overall Study|Adverse Event|2|||
143438051|NCT03721705|517150765|FG001|Overall Study|Adverse Event|0|||
143438052|NCT03721705|517150764|FG000|Overall Study|Withdrawal by Subject|4|||
143438053|NCT03721705|517150765|FG001|Overall Study|Withdrawal by Subject|10|||
143438054|NCT03721705|517150764|FG000|Overall Study|No Suitable Study Partner|1|||
143438055|NCT03721705|517150765|FG001|Overall Study|No Suitable Study Partner|0|||
143438056|NCT03721705|517150764|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
143438057|NCT03721705|517150765|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
143438058|NCT03721705|517150764|FG000|Overall Study|Death|0|||
143438059|NCT03721705|517150765|FG001|Overall Study|Death|1|||
143438060|NCT01843777|517150766|FG000|Overall Study|Withdrawal by Subject|1|||
143438061|NCT01843777|517150767|FG001|Overall Study|Withdrawal by Subject|0|||
143438062|NCT03721172|517150769|FG000|Placebo-controlled Phase|Adverse Event|7|||
143438063|NCT03721172|517150770|FG001|Placebo-controlled Phase|Adverse Event|7|||
143438064|NCT03721172|517150771|FG002|Placebo-controlled Phase|Adverse Event|0|||
143438065|NCT03721172|517150769|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
143438066|NCT03721172|517150770|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
143438067|NCT03721172|517150771|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
143438068|NCT03721172|517150769|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
143438069|NCT03721172|517150770|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
143438070|NCT03721172|517150771|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
143438071|NCT03721172|517150769|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
143438072|NCT03721172|517150770|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
143438073|NCT03721172|517150771|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
143438074|NCT03721172|517150769|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
143438075|NCT03721172|517150770|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
143438076|NCT03721172|517150771|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
143438077|NCT03721172|517150769|FG000|Placebo-controlled Phase|Other|3|||
143438078|NCT03721172|517150770|FG001|Placebo-controlled Phase|Other|0|||
143438079|NCT03721172|517150771|FG002|Placebo-controlled Phase|Other|0|||
143438080|NCT03721172|517150769|FG000|Apremilast Extension Phase|Adverse Event|0|||
143438081|NCT03721172|517150770|FG001|Apremilast Extension Phase|Adverse Event|0|||
143438082|NCT03721172|517150771|FG002|Apremilast Extension Phase|Adverse Event|10|||
143438083|NCT03721172|517150769|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
143438084|NCT03721172|517150770|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
143438085|NCT03721172|517150771|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
143438086|NCT03721172|517150769|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
143438087|NCT03721172|517150770|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
143438088|NCT03721172|517150771|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
143438089|NCT03721172|517150769|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
143438090|NCT03721172|517150770|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
143438091|NCT03721172|517150771|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
143438092|NCT03721172|517150769|FG000|Apremilast Extension Phase|Protocol Violation|0|||
143438093|NCT03721172|517150770|FG001|Apremilast Extension Phase|Protocol Violation|0|||
143438094|NCT03721172|517150771|FG002|Apremilast Extension Phase|Protocol Violation|1|||
143438095|NCT03721172|517150769|FG000|Apremilast Extension Phase|Physician Decision|0|||
143438096|NCT03721172|517150770|FG001|Apremilast Extension Phase|Physician Decision|0|||
143438097|NCT03721172|517150771|FG002|Apremilast Extension Phase|Physician Decision|1|||
143438098|NCT03721172|517150769|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
143438099|NCT03721172|517150770|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
143438100|NCT03721172|517150771|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
143438101|NCT03721172|517150769|FG000|Apremilast Extension Phase|Other|0|||
143438102|NCT03721172|517150770|FG001|Apremilast Extension Phase|Other|0|||
143438103|NCT03721172|517150771|FG002|Apremilast Extension Phase|Other|3|||
143438104|NCT03721172|517150769|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
143438105|NCT03721172|517150770|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
143438106|NCT03721172|517150771|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
143438107|NCT01162135|517150773|FG000|Overall Study|Withdrawal by Subject|1|||
143438108|NCT01162135|517150773|FG000|Overall Study|Severe back pain|1|||
143438109|NCT01162135|517150773|FG000|Overall Study|Ineligible|1|||
143438110|NCT03603639|517150774|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
143438111|NCT03603639|517150775|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
143438112|NCT03603639|517150776|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
143438113|NCT03603639|517150777|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
143438114|NCT03603639|517150778|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
143438115|NCT03603639|517150779|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
143438116|NCT03603639|517150774|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
143438117|NCT03603639|517150775|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
143438118|NCT03603639|517150776|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
143438119|NCT03603639|517150777|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
143438120|NCT03603639|517150778|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
143438121|NCT03603639|517150779|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
142941520|NCT00064701|515324680|FG000|One Year Post-transplant|Non-compliance|4|||
143438122|NCT01216072|517150782|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
143438123|NCT01216072|517150783|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
143438124|NCT01216072|517150782|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
143438125|NCT01216072|517150783|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
143438126|NCT01216072|517150782|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
143438127|NCT01216072|517150783|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
143438128|NCT01216072|517150782|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
143438129|NCT01216072|517150783|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
143438130|NCT01216072|517150782|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
143438131|NCT01216072|517150783|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
143438132|NCT01216072|517150782|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
143438133|NCT01216072|517150783|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
143438134|NCT01216072|517150782|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
143438135|NCT01216072|517150783|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
143438136|NCT01216072|517150782|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
143438137|NCT01216072|517150783|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
143438138|NCT01216072|517150782|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
143438139|NCT01216072|517150783|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
143438140|NCT01216072|517150782|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
143438141|NCT01216072|517150783|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
143438142|NCT02818998|517150790|FG000|Overall Study|Adverse Event|3|||
143438143|NCT02818998|517150791|FG001|Overall Study|Adverse Event|2|||
143438144|NCT02818998|517150792|FG002|Overall Study|Adverse Event|1|||
143438145|NCT02818998|517150790|FG000|Overall Study|Lost to Follow-up|4|||
143438146|NCT02818998|517150791|FG001|Overall Study|Lost to Follow-up|1|||
143438147|NCT02818998|517150792|FG002|Overall Study|Lost to Follow-up|2|||
143438148|NCT02818998|517150790|FG000|Overall Study|Withdrawal by sponsor|0|||
143438149|NCT02818998|517150791|FG001|Overall Study|Withdrawal by sponsor|1|||
143438150|NCT02818998|517150792|FG002|Overall Study|Withdrawal by sponsor|1|||
143438151|NCT02818998|517150790|FG000|Overall Study|Death|3|||
143438152|NCT02818998|517150791|FG001|Overall Study|Death|6|||
143438153|NCT02818998|517150792|FG002|Overall Study|Death|8|||
143438154|NCT02818998|517150790|FG000|Overall Study|Withdrawal by Subject|7|||
143438155|NCT02818998|517150791|FG001|Overall Study|Withdrawal by Subject|6|||
143438156|NCT02818998|517150792|FG002|Overall Study|Withdrawal by Subject|6|||
143438157|NCT02818998|517150790|FG000|Overall Study|Physician Decision|1|||
143438158|NCT02818998|517150791|FG001|Overall Study|Physician Decision|0|||
143438159|NCT02818998|517150792|FG002|Overall Study|Physician Decision|0|||
143438160|NCT02472145|517150793|FG000|Overall Study|Death|10|||
143438161|NCT02472145|517150794|FG001|Overall Study|Death|101|||
143438162|NCT02472145|517150795|FG002|Overall Study|Death|99|||
143438163|NCT02472145|517150793|FG000|Overall Study|Lost to Follow-up|0|||
143438164|NCT02472145|517150794|FG001|Overall Study|Lost to Follow-up|1|||
143438165|NCT02472145|517150795|FG002|Overall Study|Lost to Follow-up|0|||
143438166|NCT02472145|517150793|FG000|Overall Study|Withdrawal by Subject|0|||
143438167|NCT02472145|517150794|FG001|Overall Study|Withdrawal by Subject|9|||
143438168|NCT02472145|517150795|FG002|Overall Study|Withdrawal by Subject|13|||
143438169|NCT02472145|517150793|FG000|Overall Study|Sponsor decision|0|||
143438170|NCT02472145|517150794|FG001|Overall Study|Sponsor decision|3|||
143438171|NCT02472145|517150795|FG002|Overall Study|Sponsor decision|2|||
143438172|NCT02472145|517150793|FG000|Overall Study|Other|0|||
143438173|NCT02472145|517150794|FG001|Overall Study|Other|45|||
143438174|NCT02472145|517150795|FG002|Overall Study|Other|43|||
143438175|NCT01296555|517150796|FG000|Overall Study|Adverse Event|0|||
143438176|NCT01296555|517150797|FG001|Overall Study|Adverse Event|0|||
143438177|NCT01296555|517150798|FG002|Overall Study|Adverse Event|1|||
143438178|NCT01296555|517150799|FG003|Overall Study|Adverse Event|1|||
143438179|NCT01296555|517150800|FG004|Overall Study|Adverse Event|2|||
143438180|NCT01296555|517150801|FG005|Overall Study|Adverse Event|4|||
143438181|NCT01296555|517150802|FG006|Overall Study|Adverse Event|1|||
143438182|NCT01296555|517150803|FG007|Overall Study|Adverse Event|4|||
143438183|NCT01296555|517150804|FG008|Overall Study|Adverse Event|3|||
143438184|NCT01296555|517150805|FG009|Overall Study|Adverse Event|1|||
143438185|NCT01296555|517150806|FG010|Overall Study|Adverse Event|0|||
143438186|NCT01296555|517150807|FG011|Overall Study|Adverse Event|4|||
143438187|NCT01296555|517150808|FG012|Overall Study|Adverse Event|1|||
143438188|NCT01296555|517150809|FG013|Overall Study|Adverse Event|4|||
143438189|NCT01296555|517150810|FG014|Overall Study|Adverse Event|0|||
143438190|NCT01296555|517150811|FG015|Overall Study|Adverse Event|0|||
143438191|NCT01296555|517150812|FG016|Overall Study|Adverse Event|0|||
143438192|NCT01296555|517150813|FG017|Overall Study|Adverse Event|0|||
143438193|NCT01296555|517150814|FG018|Overall Study|Adverse Event|0|||
143438194|NCT01296555|517150815|FG019|Overall Study|Adverse Event|1|||
143438195|NCT01296555|517150816|FG020|Overall Study|Adverse Event|0|||
143438196|NCT01296555|517150817|FG021|Overall Study|Adverse Event|0|||
143438197|NCT01296555|517150818|FG022|Overall Study|Adverse Event|0|||
143438198|NCT01296555|517150819|FG023|Overall Study|Adverse Event|0|||
143438199|NCT01296555|517150820|FG024|Overall Study|Adverse Event|0|||
143438200|NCT01296555|517150821|FG025|Overall Study|Adverse Event|0|||
143438201|NCT01296555|517150822|FG026|Overall Study|Adverse Event|0|||
143438202|NCT01296555|517150823|FG027|Overall Study|Adverse Event|0|||
143438203|NCT01296555|517150824|FG028|Overall Study|Adverse Event|0|||
143438204|NCT01296555|517150796|FG000|Overall Study|Reason Not Specified|0|||
143438205|NCT01296555|517150797|FG001|Overall Study|Reason Not Specified|0|||
143438206|NCT01296555|517150798|FG002|Overall Study|Reason Not Specified|0|||
143438207|NCT01296555|517150799|FG003|Overall Study|Reason Not Specified|0|||
143438208|NCT01296555|517150800|FG004|Overall Study|Reason Not Specified|0|||
143438209|NCT01296555|517150801|FG005|Overall Study|Reason Not Specified|0|||
143438210|NCT01296555|517150802|FG006|Overall Study|Reason Not Specified|0|||
143438211|NCT01296555|517150803|FG007|Overall Study|Reason Not Specified|0|||
143438212|NCT01296555|517150804|FG008|Overall Study|Reason Not Specified|0|||
143438213|NCT01296555|517150805|FG009|Overall Study|Reason Not Specified|0|||
143438214|NCT01296555|517150806|FG010|Overall Study|Reason Not Specified|0|||
143438215|NCT01296555|517150807|FG011|Overall Study|Reason Not Specified|0|||
143438216|NCT01296555|517150808|FG012|Overall Study|Reason Not Specified|0|||
143438217|NCT01296555|517150809|FG013|Overall Study|Reason Not Specified|1|||
143438218|NCT01296555|517150810|FG014|Overall Study|Reason Not Specified|2|||
143438219|NCT01296555|517150811|FG015|Overall Study|Reason Not Specified|3|||
143438220|NCT01296555|517150812|FG016|Overall Study|Reason Not Specified|7|||
143438221|NCT01296555|517150813|FG017|Overall Study|Reason Not Specified|4|||
143438222|NCT01296555|517150814|FG018|Overall Study|Reason Not Specified|3|||
143438223|NCT01296555|517150815|FG019|Overall Study|Reason Not Specified|7|||
143438224|NCT01296555|517150816|FG020|Overall Study|Reason Not Specified|11|||
143438225|NCT01296555|517150817|FG021|Overall Study|Reason Not Specified|5|||
143438226|NCT01296555|517150818|FG022|Overall Study|Reason Not Specified|5|||
143438227|NCT01296555|517150819|FG023|Overall Study|Reason Not Specified|7|||
143438228|NCT01296555|517150820|FG024|Overall Study|Reason Not Specified|2|||
143438229|NCT01296555|517150821|FG025|Overall Study|Reason Not Specified|2|||
143438230|NCT01296555|517150822|FG026|Overall Study|Reason Not Specified|19|||
143438231|NCT01296555|517150823|FG027|Overall Study|Reason Not Specified|11|||
143438232|NCT01296555|517150824|FG028|Overall Study|Reason Not Specified|9|||
143438233|NCT01296555|517150796|FG000|Overall Study|Physician Decision|0|||
143438234|NCT01296555|517150797|FG001|Overall Study|Physician Decision|0|||
143438235|NCT01296555|517150798|FG002|Overall Study|Physician Decision|0|||
143438236|NCT01296555|517150799|FG003|Overall Study|Physician Decision|0|||
143438237|NCT01296555|517150800|FG004|Overall Study|Physician Decision|1|||
143438238|NCT01296555|517150801|FG005|Overall Study|Physician Decision|0|||
143438239|NCT01296555|517150802|FG006|Overall Study|Physician Decision|0|||
143438240|NCT01296555|517150803|FG007|Overall Study|Physician Decision|0|||
143438241|NCT01296555|517150804|FG008|Overall Study|Physician Decision|0|||
143438242|NCT01296555|517150805|FG009|Overall Study|Physician Decision|0|||
143438243|NCT01296555|517150806|FG010|Overall Study|Physician Decision|0|||
143438244|NCT01296555|517150807|FG011|Overall Study|Physician Decision|0|||
143438245|NCT01296555|517150808|FG012|Overall Study|Physician Decision|0|||
143438246|NCT01296555|517150809|FG013|Overall Study|Physician Decision|1|||
143438247|NCT01296555|517150810|FG014|Overall Study|Physician Decision|0|||
143438248|NCT01296555|517150811|FG015|Overall Study|Physician Decision|0|||
143438249|NCT01296555|517150812|FG016|Overall Study|Physician Decision|0|||
143438250|NCT01296555|517150813|FG017|Overall Study|Physician Decision|0|||
143438251|NCT01296555|517150814|FG018|Overall Study|Physician Decision|0|||
143438252|NCT01296555|517150815|FG019|Overall Study|Physician Decision|1|||
143438253|NCT01296555|517150816|FG020|Overall Study|Physician Decision|0|||
143438254|NCT01296555|517150817|FG021|Overall Study|Physician Decision|0|||
143438255|NCT01296555|517150818|FG022|Overall Study|Physician Decision|0|||
143438256|NCT01296555|517150819|FG023|Overall Study|Physician Decision|0|||
143438257|NCT01296555|517150820|FG024|Overall Study|Physician Decision|0|||
143438258|NCT01296555|517150821|FG025|Overall Study|Physician Decision|0|||
143438259|NCT01296555|517150822|FG026|Overall Study|Physician Decision|0|||
143438260|NCT01296555|517150823|FG027|Overall Study|Physician Decision|0|||
143438261|NCT01296555|517150824|FG028|Overall Study|Physician Decision|0|||
143438262|NCT01296555|517150796|FG000|Overall Study|Progressive Disease|6|||
143438263|NCT01296555|517150797|FG001|Overall Study|Progressive Disease|3|||
143438264|NCT01296555|517150798|FG002|Overall Study|Progressive Disease|3|||
143438265|NCT01296555|517150799|FG003|Overall Study|Progressive Disease|7|||
143438266|NCT01296555|517150800|FG004|Overall Study|Progressive Disease|6|||
143438267|NCT01296555|517150801|FG005|Overall Study|Progressive Disease|16|||
143438268|NCT01296555|517150802|FG006|Overall Study|Progressive Disease|16|||
143438269|NCT01296555|517150803|FG007|Overall Study|Progressive Disease|8|||
143438270|NCT01296555|517150804|FG008|Overall Study|Progressive Disease|7|||
143438271|NCT01296555|517150805|FG009|Overall Study|Progressive Disease|18|||
143438272|NCT01296555|517150806|FG010|Overall Study|Progressive Disease|7|||
143438273|NCT01296555|517150807|FG011|Overall Study|Progressive Disease|14|||
143438274|NCT01296555|517150808|FG012|Overall Study|Progressive Disease|5|||
143438275|NCT01296555|517150809|FG013|Overall Study|Progressive Disease|12|||
143438276|NCT01296555|517150810|FG014|Overall Study|Progressive Disease|1|||
143438277|NCT01296555|517150811|FG015|Overall Study|Progressive Disease|1|||
143438278|NCT01296555|517150812|FG016|Overall Study|Progressive Disease|0|||
143438279|NCT01296555|517150813|FG017|Overall Study|Progressive Disease|0|||
143438280|NCT01296555|517150814|FG018|Overall Study|Progressive Disease|0|||
143438281|NCT01296555|517150815|FG019|Overall Study|Progressive Disease|1|||
143438282|NCT01296555|517150816|FG020|Overall Study|Progressive Disease|0|||
143438283|NCT01296555|517150817|FG021|Overall Study|Progressive Disease|0|||
143438284|NCT01296555|517150818|FG022|Overall Study|Progressive Disease|0|||
143438285|NCT01296555|517150819|FG023|Overall Study|Progressive Disease|0|||
143438286|NCT01296555|517150820|FG024|Overall Study|Progressive Disease|1|||
143438287|NCT01296555|517150821|FG025|Overall Study|Progressive Disease|0|||
143438288|NCT01296555|517150822|FG026|Overall Study|Progressive Disease|5|||
143438289|NCT01296555|517150823|FG027|Overall Study|Progressive Disease|1|||
143438290|NCT01296555|517150824|FG028|Overall Study|Progressive Disease|0|||
143438291|NCT01296555|517150796|FG000|Overall Study|Protocol Violation|0|||
143438292|NCT01296555|517150797|FG001|Overall Study|Protocol Violation|0|||
143438293|NCT01296555|517150798|FG002|Overall Study|Protocol Violation|0|||
143438294|NCT01296555|517150799|FG003|Overall Study|Protocol Violation|0|||
143438295|NCT01296555|517150800|FG004|Overall Study|Protocol Violation|0|||
143438296|NCT01296555|517150801|FG005|Overall Study|Protocol Violation|0|||
143438297|NCT01296555|517150802|FG006|Overall Study|Protocol Violation|0|||
143438298|NCT01296555|517150803|FG007|Overall Study|Protocol Violation|0|||
143438299|NCT01296555|517150804|FG008|Overall Study|Protocol Violation|0|||
143438300|NCT01296555|517150805|FG009|Overall Study|Protocol Violation|0|||
143438301|NCT01296555|517150806|FG010|Overall Study|Protocol Violation|0|||
143438302|NCT01296555|517150807|FG011|Overall Study|Protocol Violation|0|||
143438303|NCT01296555|517150808|FG012|Overall Study|Protocol Violation|0|||
143438304|NCT01296555|517150809|FG013|Overall Study|Protocol Violation|1|||
143438305|NCT01296555|517150810|FG014|Overall Study|Protocol Violation|0|||
143438306|NCT01296555|517150811|FG015|Overall Study|Protocol Violation|0|||
143438307|NCT01296555|517150812|FG016|Overall Study|Protocol Violation|0|||
143438308|NCT01296555|517150813|FG017|Overall Study|Protocol Violation|0|||
143438309|NCT01296555|517150814|FG018|Overall Study|Protocol Violation|0|||
143438310|NCT01296555|517150815|FG019|Overall Study|Protocol Violation|0|||
143438311|NCT01296555|517150816|FG020|Overall Study|Protocol Violation|0|||
143438312|NCT01296555|517150817|FG021|Overall Study|Protocol Violation|0|||
143438313|NCT01296555|517150818|FG022|Overall Study|Protocol Violation|0|||
143438314|NCT01296555|517150819|FG023|Overall Study|Protocol Violation|0|||
143438315|NCT01296555|517150820|FG024|Overall Study|Protocol Violation|0|||
143438316|NCT01296555|517150821|FG025|Overall Study|Protocol Violation|0|||
143438317|NCT01296555|517150822|FG026|Overall Study|Protocol Violation|0|||
143438318|NCT01296555|517150823|FG027|Overall Study|Protocol Violation|0|||
143438319|NCT01296555|517150824|FG028|Overall Study|Protocol Violation|0|||
143438320|NCT01296555|517150796|FG000|Overall Study|Study Terminated By Sponsor|0|||
143438321|NCT01296555|517150797|FG001|Overall Study|Study Terminated By Sponsor|0|||
143438322|NCT01296555|517150798|FG002|Overall Study|Study Terminated By Sponsor|0|||
143438323|NCT01296555|517150799|FG003|Overall Study|Study Terminated By Sponsor|0|||
143438324|NCT01296555|517150800|FG004|Overall Study|Study Terminated By Sponsor|0|||
143438325|NCT01296555|517150801|FG005|Overall Study|Study Terminated By Sponsor|0|||
143438326|NCT01296555|517150802|FG006|Overall Study|Study Terminated By Sponsor|0|||
143438327|NCT01296555|517150803|FG007|Overall Study|Study Terminated By Sponsor|0|||
143438328|NCT01296555|517150804|FG008|Overall Study|Study Terminated By Sponsor|0|||
143438329|NCT01296555|517150805|FG009|Overall Study|Study Terminated By Sponsor|0|||
143438330|NCT01296555|517150806|FG010|Overall Study|Study Terminated By Sponsor|0|||
143438331|NCT01296555|517150807|FG011|Overall Study|Study Terminated By Sponsor|0|||
143438332|NCT01296555|517150808|FG012|Overall Study|Study Terminated By Sponsor|0|||
143438333|NCT01296555|517150809|FG013|Overall Study|Study Terminated By Sponsor|0|||
143438334|NCT01296555|517150810|FG014|Overall Study|Study Terminated By Sponsor|0|||
143438335|NCT01296555|517150811|FG015|Overall Study|Study Terminated By Sponsor|0|||
143438336|NCT01296555|517150812|FG016|Overall Study|Study Terminated By Sponsor|0|||
143438337|NCT01296555|517150813|FG017|Overall Study|Study Terminated By Sponsor|0|||
143438338|NCT01296555|517150814|FG018|Overall Study|Study Terminated By Sponsor|0|||
143438339|NCT01296555|517150815|FG019|Overall Study|Study Terminated By Sponsor|0|||
143438340|NCT01296555|517150816|FG020|Overall Study|Study Terminated By Sponsor|0|||
143438341|NCT01296555|517150817|FG021|Overall Study|Study Terminated By Sponsor|0|||
143438342|NCT01296555|517150818|FG022|Overall Study|Study Terminated By Sponsor|0|||
143438343|NCT01296555|517150819|FG023|Overall Study|Study Terminated By Sponsor|0|||
143438344|NCT01296555|517150820|FG024|Overall Study|Study Terminated By Sponsor|0|||
143438345|NCT01296555|517150821|FG025|Overall Study|Study Terminated By Sponsor|1|||
143438346|NCT01296555|517150822|FG026|Overall Study|Study Terminated By Sponsor|0|||
143438347|NCT01296555|517150823|FG027|Overall Study|Study Terminated By Sponsor|0|||
143438348|NCT01296555|517150824|FG028|Overall Study|Study Terminated By Sponsor|0|||
143438349|NCT01296555|517150796|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
143438350|NCT01296555|517150797|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
143438351|NCT01296555|517150798|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
143438352|NCT01296555|517150799|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
143438353|NCT01296555|517150800|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
143438354|NCT01296555|517150801|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
143438355|NCT01296555|517150802|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
143438356|NCT01296555|517150803|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
143438357|NCT01296555|517150804|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
143438358|NCT01296555|517150805|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
143438359|NCT01296555|517150806|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
143438360|NCT01296555|517150807|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
143438361|NCT01296555|517150808|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
143438362|NCT01296555|517150809|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
143438363|NCT01296555|517150810|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
143438364|NCT01296555|517150811|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
143438365|NCT01296555|517150812|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
143438366|NCT01296555|517150813|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
143438367|NCT01296555|517150814|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
143438368|NCT01296555|517150815|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
143438369|NCT01296555|517150816|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
143438370|NCT01296555|517150817|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
143438371|NCT01296555|517150818|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
143438372|NCT01296555|517150819|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
143438373|NCT01296555|517150820|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
143438374|NCT01296555|517150821|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
143438375|NCT01296555|517150822|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
143438376|NCT01296555|517150823|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
143438377|NCT01296555|517150824|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
143438378|NCT01296555|517150796|FG000|Overall Study|Death|0|||
143438379|NCT01296555|517150797|FG001|Overall Study|Death|0|||
143438380|NCT01296555|517150798|FG002|Overall Study|Death|0|||
143438381|NCT01296555|517150799|FG003|Overall Study|Death|2|||
143438382|NCT01296555|517150800|FG004|Overall Study|Death|1|||
143438383|NCT01296555|517150801|FG005|Overall Study|Death|0|||
143438384|NCT01296555|517150802|FG006|Overall Study|Death|2|||
143438385|NCT01296555|517150803|FG007|Overall Study|Death|0|||
143438386|NCT01296555|517150804|FG008|Overall Study|Death|0|||
143438387|NCT01296555|517150805|FG009|Overall Study|Death|1|||
143438388|NCT01296555|517150806|FG010|Overall Study|Death|0|||
143438389|NCT01296555|517150807|FG011|Overall Study|Death|1|||
143438390|NCT01296555|517150808|FG012|Overall Study|Death|0|||
143438391|NCT01296555|517150809|FG013|Overall Study|Death|2|||
143438392|NCT01296555|517150810|FG014|Overall Study|Death|27|||
143438393|NCT01296555|517150811|FG015|Overall Study|Death|15|||
143438394|NCT01296555|517150812|FG016|Overall Study|Death|11|||
143438395|NCT01296555|517150813|FG017|Overall Study|Death|11|||
143438396|NCT01296555|517150814|FG018|Overall Study|Death|17|||
143438397|NCT01296555|517150815|FG019|Overall Study|Death|12|||
143438398|NCT01296555|517150816|FG020|Overall Study|Death|13|||
143438399|NCT01296555|517150817|FG021|Overall Study|Death|12|||
143438400|NCT01296555|517150818|FG022|Overall Study|Death|12|||
143438401|NCT01296555|517150819|FG023|Overall Study|Death|13|||
143438402|NCT01296555|517150820|FG024|Overall Study|Death|7|||
143438403|NCT01296555|517150821|FG025|Overall Study|Death|7|||
143438404|NCT01296555|517150822|FG026|Overall Study|Death|35|||
143438405|NCT01296555|517150823|FG027|Overall Study|Death|92|||
143438406|NCT01296555|517150824|FG028|Overall Study|Death|44|||
143438407|NCT01296555|517150796|FG000|Overall Study|Lost to Follow-up|0|||
143438408|NCT01296555|517150797|FG001|Overall Study|Lost to Follow-up|0|||
143438409|NCT01296555|517150798|FG002|Overall Study|Lost to Follow-up|0|||
143438410|NCT01296555|517150799|FG003|Overall Study|Lost to Follow-up|0|||
143438411|NCT01296555|517150800|FG004|Overall Study|Lost to Follow-up|0|||
143438412|NCT01296555|517150801|FG005|Overall Study|Lost to Follow-up|0|||
143438413|NCT01296555|517150802|FG006|Overall Study|Lost to Follow-up|0|||
143438414|NCT01296555|517150803|FG007|Overall Study|Lost to Follow-up|0|||
143438415|NCT01296555|517150804|FG008|Overall Study|Lost to Follow-up|0|||
143438416|NCT01296555|517150805|FG009|Overall Study|Lost to Follow-up|0|||
143438417|NCT01296555|517150806|FG010|Overall Study|Lost to Follow-up|0|||
143438418|NCT01296555|517150807|FG011|Overall Study|Lost to Follow-up|0|||
143438419|NCT01296555|517150808|FG012|Overall Study|Lost to Follow-up|0|||
143438420|NCT01296555|517150809|FG013|Overall Study|Lost to Follow-up|0|||
143438421|NCT01296555|517150810|FG014|Overall Study|Lost to Follow-up|2|||
143438422|NCT01296555|517150811|FG015|Overall Study|Lost to Follow-up|1|||
143438423|NCT01296555|517150812|FG016|Overall Study|Lost to Follow-up|0|||
143438424|NCT01296555|517150813|FG017|Overall Study|Lost to Follow-up|2|||
143438425|NCT01296555|517150814|FG018|Overall Study|Lost to Follow-up|0|||
143438426|NCT01296555|517150815|FG019|Overall Study|Lost to Follow-up|2|||
143438427|NCT01296555|517150816|FG020|Overall Study|Lost to Follow-up|3|||
143438428|NCT01296555|517150817|FG021|Overall Study|Lost to Follow-up|2|||
143438429|NCT01296555|517150818|FG022|Overall Study|Lost to Follow-up|0|||
143438430|NCT01296555|517150819|FG023|Overall Study|Lost to Follow-up|0|||
143438431|NCT01296555|517150820|FG024|Overall Study|Lost to Follow-up|0|||
143438432|NCT01296555|517150821|FG025|Overall Study|Lost to Follow-up|0|||
143438433|NCT01296555|517150822|FG026|Overall Study|Lost to Follow-up|3|||
143438434|NCT01296555|517150823|FG027|Overall Study|Lost to Follow-up|13|||
143438435|NCT01296555|517150824|FG028|Overall Study|Lost to Follow-up|5|||
143438436|NCT01296555|517150796|FG000|Overall Study|Non-Compliance With Study Drug|0|||
143438437|NCT01296555|517150797|FG001|Overall Study|Non-Compliance With Study Drug|0|||
143438438|NCT01296555|517150798|FG002|Overall Study|Non-Compliance With Study Drug|0|||
143438439|NCT01296555|517150799|FG003|Overall Study|Non-Compliance With Study Drug|0|||
143438440|NCT01296555|517150800|FG004|Overall Study|Non-Compliance With Study Drug|0|||
143438441|NCT01296555|517150801|FG005|Overall Study|Non-Compliance With Study Drug|0|||
143438442|NCT01296555|517150802|FG006|Overall Study|Non-Compliance With Study Drug|0|||
143438443|NCT01296555|517150803|FG007|Overall Study|Non-Compliance With Study Drug|1|||
143438444|NCT01296555|517150804|FG008|Overall Study|Non-Compliance With Study Drug|0|||
143438445|NCT01296555|517150805|FG009|Overall Study|Non-Compliance With Study Drug|0|||
143438446|NCT01296555|517150806|FG010|Overall Study|Non-Compliance With Study Drug|0|||
143438447|NCT01296555|517150807|FG011|Overall Study|Non-Compliance With Study Drug|0|||
143438448|NCT01296555|517150808|FG012|Overall Study|Non-Compliance With Study Drug|0|||
143438449|NCT01296555|517150809|FG013|Overall Study|Non-Compliance With Study Drug|0|||
143438450|NCT01296555|517150810|FG014|Overall Study|Non-Compliance With Study Drug|0|||
143438451|NCT01296555|517150811|FG015|Overall Study|Non-Compliance With Study Drug|0|||
143438452|NCT01296555|517150812|FG016|Overall Study|Non-Compliance With Study Drug|0|||
143438453|NCT01296555|517150813|FG017|Overall Study|Non-Compliance With Study Drug|0|||
143438454|NCT01296555|517150814|FG018|Overall Study|Non-Compliance With Study Drug|0|||
143438455|NCT01296555|517150815|FG019|Overall Study|Non-Compliance With Study Drug|0|||
143438456|NCT01296555|517150816|FG020|Overall Study|Non-Compliance With Study Drug|0|||
143438457|NCT01296555|517150817|FG021|Overall Study|Non-Compliance With Study Drug|0|||
143438458|NCT01296555|517150818|FG022|Overall Study|Non-Compliance With Study Drug|0|||
143438459|NCT01296555|517150819|FG023|Overall Study|Non-Compliance With Study Drug|0|||
143438460|NCT01296555|517150820|FG024|Overall Study|Non-Compliance With Study Drug|0|||
143438461|NCT01296555|517150821|FG025|Overall Study|Non-Compliance With Study Drug|0|||
143438462|NCT01296555|517150822|FG026|Overall Study|Non-Compliance With Study Drug|0|||
143438463|NCT01296555|517150823|FG027|Overall Study|Non-Compliance With Study Drug|0|||
143438464|NCT01296555|517150824|FG028|Overall Study|Non-Compliance With Study Drug|0|||
143438465|NCT01296555|517150796|FG000|Overall Study|Withdrawal by Subject|0|||
143438466|NCT01296555|517150797|FG001|Overall Study|Withdrawal by Subject|0|||
143438467|NCT01296555|517150798|FG002|Overall Study|Withdrawal by Subject|0|||
143438468|NCT01296555|517150799|FG003|Overall Study|Withdrawal by Subject|0|||
143438469|NCT01296555|517150800|FG004|Overall Study|Withdrawal by Subject|1|||
143438470|NCT01296555|517150801|FG005|Overall Study|Withdrawal by Subject|0|||
143438471|NCT01296555|517150802|FG006|Overall Study|Withdrawal by Subject|1|||
143438472|NCT01296555|517150803|FG007|Overall Study|Withdrawal by Subject|0|||
143438473|NCT01296555|517150804|FG008|Overall Study|Withdrawal by Subject|0|||
143438474|NCT01296555|517150805|FG009|Overall Study|Withdrawal by Subject|0|||
143438475|NCT01296555|517150806|FG010|Overall Study|Withdrawal by Subject|1|||
143438476|NCT01296555|517150807|FG011|Overall Study|Withdrawal by Subject|1|||
143438477|NCT01296555|517150808|FG012|Overall Study|Withdrawal by Subject|0|||
143438478|NCT01296555|517150809|FG013|Overall Study|Withdrawal by Subject|0|||
143438479|NCT01296555|517150810|FG014|Overall Study|Withdrawal by Subject|3|||
143438480|NCT01296555|517150811|FG015|Overall Study|Withdrawal by Subject|0|||
143438481|NCT01296555|517150812|FG016|Overall Study|Withdrawal by Subject|2|||
143438482|NCT01296555|517150813|FG017|Overall Study|Withdrawal by Subject|1|||
143438483|NCT01296555|517150814|FG018|Overall Study|Withdrawal by Subject|0|||
143438484|NCT01296555|517150815|FG019|Overall Study|Withdrawal by Subject|1|||
143438485|NCT01296555|517150816|FG020|Overall Study|Withdrawal by Subject|1|||
143438486|NCT01296555|517150817|FG021|Overall Study|Withdrawal by Subject|1|||
143438487|NCT01296555|517150818|FG022|Overall Study|Withdrawal by Subject|3|||
143438488|NCT01296555|517150819|FG023|Overall Study|Withdrawal by Subject|0|||
143438489|NCT01296555|517150820|FG024|Overall Study|Withdrawal by Subject|0|||
143438490|NCT01296555|517150821|FG025|Overall Study|Withdrawal by Subject|0|||
143438491|NCT01296555|517150822|FG026|Overall Study|Withdrawal by Subject|8|||
143438492|NCT01296555|517150823|FG027|Overall Study|Withdrawal by Subject|4|||
143438493|NCT01296555|517150824|FG028|Overall Study|Withdrawal by Subject|2|||
143438494|NCT01182181|517150825|FG000|First Intervention|Adverse Event|1|||
143438495|NCT01182181|517150826|FG001|First Intervention|Adverse Event|0|||
143438496|NCT01182181|517150825|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
143438497|NCT01182181|517150826|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
143438498|NCT02413593|517150829|FG000|Overall Study|Lost to Follow-up|3|||
143438499|NCT02413593|517150829|FG000|Overall Study|Adverse Event|1|||
143438500|NCT01101061|517150830|FG000|Overall Study|Adverse Event|0|||
143438501|NCT01101061|517150831|FG001|Overall Study|Adverse Event|0|||
143438502|NCT01101061|517150832|FG002|Overall Study|Adverse Event|1|||
143438503|NCT01101061|517150833|FG003|Overall Study|Adverse Event|0|||
143438504|NCT01101061|517150834|FG004|Overall Study|Adverse Event|0|||
143438505|NCT01101061|517150835|FG005|Overall Study|Adverse Event|0|||
143438506|NCT00857233|517150836|FG000|Overall Study|Adverse Event|24|||
143438507|NCT00857233|517150836|FG000|Overall Study|Lack of Efficacy|1|||
143438508|NCT00857233|517150836|FG000|Overall Study|Non-compliance|1|||
143438509|NCT00857233|517150836|FG000|Overall Study|Withdrawal of Consent|9|||
143438510|NCT00857233|517150836|FG000|Overall Study|Lost to Follow-up|4|||
143438511|NCT00857233|517150836|FG000|Overall Study|Nursing Home Placement|14|||
143438512|NCT00857233|517150836|FG000|Overall Study|Other Reasons|2|||
143438513|NCT01587118|517150837|FG000|Overall Study|Adverse Event|3|||
143438514|NCT01587118|517150837|FG000|Overall Study|Lost to Follow-up|2|||
143438515|NCT01587118|517150837|FG000|Overall Study|Relocation|1|||
143438516|NCT01587118|517150837|FG000|Overall Study|nonresponse|1|||
143438517|NCT00409409|517150838|FG000|Overall Study|Adverse Event|7|||
143438518|NCT00409409|517150839|FG001|Overall Study|Adverse Event|2|||
143438519|NCT00409409|517150838|FG000|Overall Study|Withdrawal by Subject|1|||
143438520|NCT00409409|517150839|FG001|Overall Study|Withdrawal by Subject|1|||
143438521|NCT00409409|517150838|FG000|Overall Study|Any other reason not above-mentioned|0|||
143438522|NCT00409409|517150839|FG001|Overall Study|Any other reason not above-mentioned|1|||
143438523|NCT02872012|517150840|FG000|Overall Study|Withdrawal by Subject|1|||
143438524|NCT02872012|517150841|FG001|Overall Study|Withdrawal by Subject|0|||
143438525|NCT02872012|517150842|FG002|Overall Study|Withdrawal by Subject|0|||
143438526|NCT02872012|517150843|FG003|Overall Study|Withdrawal by Subject|0|||
143438527|NCT02872012|517150844|FG004|Overall Study|Withdrawal by Subject|0|||
143438528|NCT01728623|517150845|FG000|Overall Study|Disease progression|26|||
143438529|NCT01728623|517150845|FG000|Overall Study|Adverse Event|1|||
143438530|NCT01728623|517150845|FG000|Overall Study|Withdrawal by Subject|1|||
143438531|NCT03000348|517150846|FG000|Overall Study|Adverse Event|1|||
143438532|NCT03000348|517150847|FG001|Overall Study|Adverse Event|1|||
143438533|NCT03000348|517150848|FG002|Overall Study|Adverse Event|1|||
143438534|NCT03000348|517150849|FG003|Overall Study|Adverse Event|1|||
143438535|NCT03000348|517150850|FG004|Overall Study|Adverse Event|1|||
143438536|NCT03000348|517150851|FG005|Overall Study|Adverse Event|1|||
143438537|NCT03000348|517150846|FG000|Overall Study|Lost to Follow-up|0|||
143438538|NCT03000348|517150847|FG001|Overall Study|Lost to Follow-up|0|||
143438539|NCT03000348|517150848|FG002|Overall Study|Lost to Follow-up|1|||
143438540|NCT03000348|517150849|FG003|Overall Study|Lost to Follow-up|0|||
143438541|NCT03000348|517150850|FG004|Overall Study|Lost to Follow-up|0|||
143438542|NCT03000348|517150851|FG005|Overall Study|Lost to Follow-up|0|||
143438543|NCT03000348|517150846|FG000|Overall Study|Withdrawal by Subject|0|||
143438544|NCT03000348|517150847|FG001|Overall Study|Withdrawal by Subject|1|||
143438545|NCT03000348|517150848|FG002|Overall Study|Withdrawal by Subject|0|||
143438546|NCT03000348|517150849|FG003|Overall Study|Withdrawal by Subject|0|||
143438547|NCT03000348|517150850|FG004|Overall Study|Withdrawal by Subject|0|||
143438548|NCT03000348|517150851|FG005|Overall Study|Withdrawal by Subject|0|||
143438549|NCT03000348|517150846|FG000|Overall Study|Consent|0|||
143438550|NCT03000348|517150847|FG001|Overall Study|Consent|0|||
143438551|NCT03000348|517150848|FG002|Overall Study|Consent|0|||
143438552|NCT03000348|517150849|FG003|Overall Study|Consent|0|||
143438553|NCT03000348|517150850|FG004|Overall Study|Consent|1|||
143438554|NCT03000348|517150851|FG005|Overall Study|Consent|0|||
143438555|NCT03000348|517150846|FG000|Overall Study|Failure to expectorate sputum|1|||
143438556|NCT03000348|517150847|FG001|Overall Study|Failure to expectorate sputum|0|||
143438557|NCT03000348|517150848|FG002|Overall Study|Failure to expectorate sputum|1|||
143438558|NCT03000348|517150849|FG003|Overall Study|Failure to expectorate sputum|0|||
143438559|NCT03000348|517150850|FG004|Overall Study|Failure to expectorate sputum|1|||
143438560|NCT03000348|517150851|FG005|Overall Study|Failure to expectorate sputum|0|||
143438561|NCT03000348|517150846|FG000|Overall Study|No gram negative|1|||
143438562|NCT03000348|517150847|FG001|Overall Study|No gram negative|2|||
143438563|NCT03000348|517150848|FG002|Overall Study|No gram negative|1|||
143438564|NCT03000348|517150849|FG003|Overall Study|No gram negative|1|||
143438565|NCT03000348|517150850|FG004|Overall Study|No gram negative|1|||
143438566|NCT03000348|517150851|FG005|Overall Study|No gram negative|1|||
143438567|NCT03000348|517150846|FG000|Overall Study|Patient had no transport|0|||
143438568|NCT03000348|517150847|FG001|Overall Study|Patient had no transport|0|||
143438569|NCT03000348|517150848|FG002|Overall Study|Patient had no transport|0|||
143438570|NCT03000348|517150849|FG003|Overall Study|Patient had no transport|1|||
143438571|NCT03000348|517150850|FG004|Overall Study|Patient had no transport|0|||
143438572|NCT03000348|517150851|FG005|Overall Study|Patient had no transport|0|||
143438573|NCT03000348|517150846|FG000|Overall Study|Dosing|0|||
143438574|NCT03000348|517150847|FG001|Overall Study|Dosing|0|||
143438575|NCT03000348|517150848|FG002|Overall Study|Dosing|0|||
143438576|NCT03000348|517150849|FG003|Overall Study|Dosing|0|||
143438577|NCT03000348|517150850|FG004|Overall Study|Dosing|1|||
143438578|NCT03000348|517150851|FG005|Overall Study|Dosing|0|||
143438579|NCT00745498|517150853|FG000|Overall Study|Lost to Follow-up|1|||
143438580|NCT00745498|517150854|FG001|Overall Study|Lost to Follow-up|1|||
143438581|NCT00745498|517150855|FG002|Overall Study|Lost to Follow-up|3|||
143438582|NCT00745498|517150853|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
143438583|NCT00745498|517150854|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
143438584|NCT00745498|517150855|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
143438585|NCT00745498|517150853|FG000|Overall Study|Non-PDR related VH|0|||
143438586|NCT00745498|517150854|FG001|Overall Study|Non-PDR related VH|1|||
143438587|NCT00745498|517150855|FG002|Overall Study|Non-PDR related VH|1|||
143438588|NCT00745498|517150853|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
143438589|NCT00745498|517150854|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
143438590|NCT00745498|517150855|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
143438591|NCT03174782|517150856|FG000|Overall Study|Protocol Violation|1|||
143438592|NCT03174782|517150857|FG001|Overall Study|Protocol Violation|0|||
143438593|NCT03174782|517150856|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
143438594|NCT03174782|517150857|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
143438595|NCT03636373|517150858|FG000|Overall Study|Study closure due to Covid-19|1|||
143438596|NCT03636373|517150859|FG001|Overall Study|Study closure due to Covid-19|0|||
143438597|NCT00572533|517150862|FG000|Overall Study|Death|4|||
143438598|NCT00572533|517150863|FG001|Overall Study|Death|1|||
143438599|NCT00572533|517150862|FG000|Overall Study|Received Kidney Transplant|2|||
143438600|NCT00572533|517150863|FG001|Overall Study|Received Kidney Transplant|1|||
143438601|NCT00572533|517150862|FG000|Overall Study|Social Issues|1|||
143438602|NCT00572533|517150863|FG001|Overall Study|Social Issues|0|||
143438603|NCT00572533|517150862|FG000|Overall Study|Transfer out of Facility|0|||
143438604|NCT00572533|517150863|FG001|Overall Study|Transfer out of Facility|1|||
143438605|NCT04211389|517150864|FG000|Overall Study|Adverse Event|1|||
143438606|NCT04211389|517150865|FG001|Overall Study|Adverse Event|2|||
143438607|NCT04211389|517150864|FG000|Overall Study|Lost to Follow-up|15|||
143438608|NCT04211389|517150865|FG001|Overall Study|Lost to Follow-up|7|||
143438609|NCT04211389|517150864|FG000|Overall Study|Protocol Violation|0|||
143438610|NCT04211389|517150865|FG001|Overall Study|Protocol Violation|1|||
143438611|NCT04211389|517150864|FG000|Overall Study|Withdrawal by Subject|10|||
143438612|NCT04211389|517150865|FG001|Overall Study|Withdrawal by Subject|11|||
143438613|NCT02688530|517150870|FG000|Overall Study|Withdrawal by Subject|0|||
143438614|NCT02688530|517150871|FG001|Overall Study|Withdrawal by Subject|1|||
143438615|NCT02688530|517150872|FG002|Overall Study|Withdrawal by Subject|0|||
143438616|NCT02688530|517150873|FG003|Overall Study|Withdrawal by Subject|0|||
143438617|NCT02688530|517150870|FG000|Overall Study|Lost to Follow-up|0|||
143438618|NCT02688530|517150871|FG001|Overall Study|Lost to Follow-up|0|||
143438619|NCT02688530|517150872|FG002|Overall Study|Lost to Follow-up|2|||
143438620|NCT02688530|517150873|FG003|Overall Study|Lost to Follow-up|0|||
143438621|NCT01658020|517150874|FG000|Overall Study|Adverse Event|3|||
143438622|NCT01658020|517150875|FG001|Overall Study|Adverse Event|3|||
143438623|NCT01658020|517150874|FG000|Overall Study|Lost to Follow-up|1|||
143438624|NCT01658020|517150875|FG001|Overall Study|Lost to Follow-up|0|||
143438625|NCT01658020|517150874|FG000|Overall Study|Withdrawal by Subject|4|||
143438626|NCT01658020|517150875|FG001|Overall Study|Withdrawal by Subject|5|||
143438627|NCT01658020|517150874|FG000|Overall Study|Protocol Violation|0|||
143438628|NCT01658020|517150875|FG001|Overall Study|Protocol Violation|1|||
143438629|NCT04206085|517150876|FG000|Overall Study|Lost to Follow-up|0|||
143438630|NCT04206085|517150877|FG001|Overall Study|Lost to Follow-up|1|||
143438631|NCT04206085|517150878|FG002|Overall Study|Lost to Follow-up|0|||
143438632|NCT04206085|517150876|FG000|Overall Study|Lost to Follow-up|0|||
143438633|NCT04206085|517150877|FG001|Overall Study|Lost to Follow-up|0|||
143438634|NCT04206085|517150878|FG002|Overall Study|Lost to Follow-up|1|||
143438635|NCT05594589|517150881|FG000|Overall Study|Other|0|||
143438636|NCT05594589|517150882|FG001|Overall Study|Other|1|||
143438637|NCT05594589|517150883|FG002|Overall Study|Other|0|||
143438638|NCT02168478|517150890|FG000|Overall Study|Withdrawal by Subject|1|||
143438639|NCT02168478|517150890|FG000|Overall Study|Did Not Consent to Participation|2|||
143438640|NCT02168478|517150890|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
143438641|NCT01530087|517150891|FG000|Overall Study|Physician Decision|2|||
143438642|NCT02760485|517150900|FG000|Phase 1|Death|3|||
143438643|NCT02760485|517150901|FG001|Phase 1|Death|6|||
143438644|NCT02760485|517150902|FG002|Phase 1|Death|0|||
143438645|NCT02760485|517150900|FG000|Phase 1|Withdrawal by Subject|2|||
143438646|NCT02760485|517150901|FG001|Phase 1|Withdrawal by Subject|0|||
143438647|NCT02760485|517150902|FG002|Phase 1|Withdrawal by Subject|0|||
143438648|NCT02760485|517150900|FG000|Phase 1|Progressive Disease|1|||
143438649|NCT02760485|517150901|FG001|Phase 1|Progressive Disease|0|||
143438650|NCT02760485|517150902|FG002|Phase 1|Progressive Disease|0|||
143438651|NCT02760485|517150900|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
143438652|NCT02760485|517150901|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
143438653|NCT02760485|517150902|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
143438654|NCT02760485|517150900|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
143438655|NCT02760485|517150901|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
143438656|NCT02760485|517150902|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
143438657|NCT02760485|517150900|FG000|Phase 2|Death|0|||
143438658|NCT02760485|517150901|FG001|Phase 2|Death|0|||
143438659|NCT02760485|517150902|FG002|Phase 2|Death|12|||
143438660|NCT02760485|517150900|FG000|Phase 2|Withdrawal by Subject|0|||
143438661|NCT02760485|517150901|FG001|Phase 2|Withdrawal by Subject|0|||
143438662|NCT02760485|517150902|FG002|Phase 2|Withdrawal by Subject|3|||
143438663|NCT02760485|517150900|FG000|Phase 2|Progressive Disease|0|||
143438664|NCT02760485|517150901|FG001|Phase 2|Progressive Disease|0|||
143438665|NCT02760485|517150902|FG002|Phase 2|Progressive Disease|1|||
143438666|NCT02760485|517150900|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
143438667|NCT02760485|517150901|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
143438668|NCT02760485|517150902|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
143438669|NCT03845023|517150903|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
143438670|NCT03845023|517150904|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
143438671|NCT03845023|517150905|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
143438672|NCT03845023|517150906|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
143438673|NCT03845023|517150903|FG000|Follow-Up (14 Days)|Adverse Event|0|||
143438674|NCT03845023|517150904|FG001|Follow-Up (14 Days)|Adverse Event|0|||
143438675|NCT03845023|517150905|FG002|Follow-Up (14 Days)|Adverse Event|1|||
143438676|NCT03845023|517150906|FG003|Follow-Up (14 Days)|Adverse Event|1|||
143438677|NCT02353871|517150907|FG000|Overall Study|Protocol deviation|0|||
143438678|NCT02353871|517150908|FG001|Overall Study|Protocol deviation|1|||
143438679|NCT02353871|517150907|FG000|Overall Study|Consent withdrawn|1|||
143438680|NCT02353871|517150908|FG001|Overall Study|Consent withdrawn|8|||
143438681|NCT02353871|517150907|FG000|Overall Study|Lost to Follow-up|2|||
143438682|NCT02353871|517150908|FG001|Overall Study|Lost to Follow-up|0|||
143438683|NCT00115336|517150909|FG000|Overall Study|Hospital discharge before study drug|0|||
143438684|NCT00115336|517150910|FG001|Overall Study|Hospital discharge before study drug|1|||
143438685|NCT02554383|517150913|FG000|Overall Study|Ineligible|3|||
143438686|NCT02554383|517150914|FG001|Overall Study|Ineligible|2|||
143438687|NCT02554383|517150913|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
143438688|NCT02554383|517150914|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
143438689|NCT02554383|517150913|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
143438690|NCT02554383|517150914|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
143438691|NCT02554383|517150913|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
143438692|NCT02554383|517150914|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
143438693|NCT02394665|517150917|FG000|Overall Study|Physician Decision|1|||
143438694|NCT02394665|517150918|FG001|Overall Study|Physician Decision|0|||
143438695|NCT02394665|517150919|FG002|Overall Study|Physician Decision|0|||
143438696|NCT02647645|517150920|FG000|Overall Study|Lost to Follow-up|2|||
143438697|NCT02647645|517150921|FG001|Overall Study|Lost to Follow-up|1|||
143438698|NCT02037256|517150922|FG000|Overall Study|Protocol Violation|0|||
143438699|NCT02037256|517150923|FG001|Overall Study|Protocol Violation|1|||
143438700|NCT02037256|517150922|FG000|Overall Study|Withdrawn prior to Velcade|0|||
143438701|NCT02037256|517150923|FG001|Overall Study|Withdrawn prior to Velcade|2|||
143438702|NCT04599907|517150928|FG000|Overall Study|Withdrawal by Subject|1|||
143438703|NCT04599907|517150929|FG001|Overall Study|Withdrawal by Subject|7|||
143438704|NCT04599907|517150930|FG002|Overall Study|Withdrawal by Subject|6|||
143438705|NCT04599907|517150928|FG000|Overall Study|Lost to Follow-up|0|||
143438706|NCT04599907|517150929|FG001|Overall Study|Lost to Follow-up|1|||
143438707|NCT04599907|517150930|FG002|Overall Study|Lost to Follow-up|0|||
143438708|NCT01466790|517150934|FG000|Overall Study|Adverse Event|1|||
143438709|NCT01466790|517150935|FG001|Overall Study|Adverse Event|0|||
143438710|NCT01466790|517150936|FG002|Overall Study|Adverse Event|0|||
143438711|NCT01466790|517150937|FG003|Overall Study|Adverse Event|0|||
143438712|NCT01466790|517150938|FG004|Overall Study|Adverse Event|2|||
143438713|NCT01466790|517150939|FG005|Overall Study|Adverse Event|0|||
143438714|NCT01466790|517150940|FG006|Overall Study|Adverse Event|0|||
143438715|NCT01466790|517150941|FG007|Overall Study|Adverse Event|0|||
143438716|NCT01466790|517150934|FG000|Overall Study|Lost to Follow-up|2|||
143438717|NCT01466790|517150935|FG001|Overall Study|Lost to Follow-up|0|||
143438718|NCT01466790|517150936|FG002|Overall Study|Lost to Follow-up|0|||
143438719|NCT01466790|517150937|FG003|Overall Study|Lost to Follow-up|0|||
143438720|NCT01466790|517150938|FG004|Overall Study|Lost to Follow-up|0|||
143438721|NCT01466790|517150939|FG005|Overall Study|Lost to Follow-up|0|||
143438722|NCT01466790|517150940|FG006|Overall Study|Lost to Follow-up|0|||
143438723|NCT01466790|517150941|FG007|Overall Study|Lost to Follow-up|0|||
143438724|NCT01466790|517150934|FG000|Overall Study|Withdrawal by Subject|1|||
143438725|NCT01466790|517150935|FG001|Overall Study|Withdrawal by Subject|1|||
143438726|NCT01466790|517150936|FG002|Overall Study|Withdrawal by Subject|0|||
143438727|NCT01466790|517150937|FG003|Overall Study|Withdrawal by Subject|0|||
143438728|NCT01466790|517150938|FG004|Overall Study|Withdrawal by Subject|1|||
143438729|NCT01466790|517150939|FG005|Overall Study|Withdrawal by Subject|0|||
143438730|NCT01466790|517150940|FG006|Overall Study|Withdrawal by Subject|1|||
143438731|NCT01466790|517150941|FG007|Overall Study|Withdrawal by Subject|1|||
143438732|NCT00356811|517150942|FG000|Overall Study|Death|35|||
143438733|NCT00356811|517150942|FG000|Overall Study|Lost to Follow-up|2|||
143438734|NCT00356811|517150942|FG000|Overall Study|Withdrawal by Subject|6|||
143438735|NCT00356811|517150942|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
143438736|NCT00356811|517150942|FG000|Overall Study|Study Is Terminating|3|||
143438737|NCT00356811|517150942|FG000|Overall Study|Site Closed during Follow-up|2|||
143438738|NCT02386839|517150943|FG000|Overall Study|Death|1|||
143438739|NCT02386839|517150944|FG001|Overall Study|Death|0|||
143438740|NCT02386839|517150943|FG000|Overall Study|Withdrawal by Subject|9|||
143438741|NCT02386839|517150944|FG001|Overall Study|Withdrawal by Subject|10|||
143438742|NCT02386839|517150943|FG000|Overall Study|Lost to Follow-up|4|||
143438743|NCT02386839|517150944|FG001|Overall Study|Lost to Follow-up|4|||
143438744|NCT02386839|517150943|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
143438745|NCT02386839|517150944|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
143438746|NCT02386839|517150943|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
143438747|NCT02386839|517150944|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
143438748|NCT02386839|517150943|FG000|Overall Study|Other (unspecified)|1|||
143438749|NCT02386839|517150944|FG001|Overall Study|Other (unspecified)|0|||
143438750|NCT02242643|517150947|FG000|Overall Study|Protocol Violation|1|||
143438751|NCT02242643|517150948|FG001|Overall Study|Protocol Violation|2|||
143438752|NCT02242643|517150947|FG000|Overall Study|Withdrawal by Subject|15|||
143438753|NCT02242643|517150948|FG001|Overall Study|Withdrawal by Subject|10|||
143438754|NCT02242643|517150947|FG000|Overall Study|Migrated/moved from study area|1|||
143438755|NCT02242643|517150948|FG001|Overall Study|Migrated/moved from study area|3|||
143438756|NCT02242643|517150947|FG000|Overall Study|Lost to Follow-up|54|||
143438757|NCT02242643|517150948|FG001|Overall Study|Lost to Follow-up|61|||
143438758|NCT02242643|517150947|FG000|Overall Study|Child placed in foster care by family|0|||
143438759|NCT02242643|517150948|FG001|Overall Study|Child placed in foster care by family|1|||
143438760|NCT02242643|517150947|FG000|Overall Study|Non-compliance|1|||
143438761|NCT02242643|517150948|FG001|Overall Study|Non-compliance|0|||
143438762|NCT02242643|517150947|FG000|Overall Study|Consent withdrawal by parent|1|||
143438763|NCT02242643|517150948|FG001|Overall Study|Consent withdrawal by parent|0|||
143438764|NCT02242643|517150947|FG000|Overall Study|Protocol requirements not followed|1|||
143438765|NCT02242643|517150948|FG001|Overall Study|Protocol requirements not followed|0|||
143438766|NCT02242643|517150947|FG000|Overall Study|Language barrier|1|||
143438767|NCT02242643|517150948|FG001|Overall Study|Language barrier|0|||
143438768|NCT02242643|517150947|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
143438769|NCT02242643|517150948|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
143438770|NCT02101983|517150949|FG000|Overall Study|Physician Decision|1|||
143438771|NCT02101983|517150950|FG001|Overall Study|Physician Decision|0|||
143438772|NCT01103232|517150954|FG000|Overall Study|Withdrawal by Subject|1|||
143438773|NCT01103232|517150955|FG001|Overall Study|Withdrawal by Subject|1|||
143438774|NCT01103232|517150954|FG000|Overall Study|Protocol Violation|0|||
143438775|NCT01103232|517150955|FG001|Overall Study|Protocol Violation|1|||
143438776|NCT02035696|517153061|FG000|Overall Study|Lost to Follow-up|0|||
143438777|NCT02035696|517153062|FG001|Overall Study|Lost to Follow-up|3|||
143438778|NCT02035696|517153063|FG002|Overall Study|Lost to Follow-up|1|||
143438779|NCT02035696|517153064|FG003|Overall Study|Lost to Follow-up|2|||
143438780|NCT02035696|517153061|FG000|Overall Study|Withdrawal by Subject|3|||
143438781|NCT02035696|517153062|FG001|Overall Study|Withdrawal by Subject|0|||
143438782|NCT02035696|517153063|FG002|Overall Study|Withdrawal by Subject|2|||
143438783|NCT02035696|517153064|FG003|Overall Study|Withdrawal by Subject|1|||
143438784|NCT00966264|517153066|FG000|Overall Study|Lost to Follow-up|4|||
143438785|NCT00966264|517153067|FG001|Overall Study|Lost to Follow-up|3|||
143438786|NCT01246999|517153068|FG000|Overall Study|Lost to Follow-up|0|||
143438787|NCT01246999|517153069|FG001|Overall Study|Lost to Follow-up|1|||
143438788|NCT01246999|517153070|FG002|Overall Study|Lost to Follow-up|0|||
143438789|NCT01246999|517153071|FG003|Overall Study|Lost to Follow-up|0|||
143438790|NCT01246999|517153068|FG000|Overall Study|Withdrawal by Subject|0|||
143438791|NCT01246999|517153069|FG001|Overall Study|Withdrawal by Subject|0|||
143438792|NCT01246999|517153070|FG002|Overall Study|Withdrawal by Subject|0|||
143438793|NCT01246999|517153071|FG003|Overall Study|Withdrawal by Subject|2|||
143438794|NCT01867047|517153072|FG000|Overall Study|Lost to Follow-up|3|||
143438795|NCT01867047|517153073|FG001|Overall Study|Lost to Follow-up|3|||
143438796|NCT01867047|517153072|FG000|Overall Study|Withdrawal by Subject|2|||
143438797|NCT01867047|517153073|FG001|Overall Study|Withdrawal by Subject|0|||
143438798|NCT01867047|517153072|FG000|Overall Study|Physician Decision|2|||
143438799|NCT01867047|517153073|FG001|Overall Study|Physician Decision|0|||
143438800|NCT01867047|517153072|FG000|Overall Study|surgery not indicated in protocol|1|||
143438801|NCT01867047|517153073|FG001|Overall Study|surgery not indicated in protocol|2|||
143438802|NCT04650698|517153074|FG000|Overall Study|Protocol Violation|2|||
143438803|NCT04650698|517153075|FG001|Overall Study|Protocol Violation|1|||
143438804|NCT04650698|517153074|FG000|Overall Study|Withdrawal by Subject|0|||
143438805|NCT04650698|517153075|FG001|Overall Study|Withdrawal by Subject|1|||
143438806|NCT01090011|517153076|FG000|Overall Study|Progressive disease|128|||
143438807|NCT01090011|517153076|FG000|Overall Study|Adverse Event|32|||
143438808|NCT01090011|517153076|FG000|Overall Study|Protocol Violation|1|||
143438809|NCT01090011|517153076|FG000|Overall Study|Refusal to start/continue medication|5|||
143438810|NCT01090011|517153076|FG000|Overall Study|Other reason not defined above|5|||
143438811|NCT00307047|517153077|FG000|Overall Study|Lost to Follow-up|35|||
143438812|NCT00307047|517153078|FG001|Overall Study|Lost to Follow-up|24|||
143438813|NCT00307047|517153077|FG000|Overall Study|Withdrawal by Subject|6|||
143438814|NCT00307047|517153078|FG001|Overall Study|Withdrawal by Subject|6|||
143438815|NCT00307047|517153077|FG000|Overall Study|Physician Decision|1|||
143438816|NCT00307047|517153078|FG001|Overall Study|Physician Decision|2|||
143438817|NCT00307047|517153077|FG000|Overall Study|Lost to follow-up for other reasons|0|||
143438818|NCT00307047|517153078|FG001|Overall Study|Lost to follow-up for other reasons|1|||
143438819|NCT00307047|517153077|FG000|Overall Study|All death, all MI, all Revascularization|27|||
143438820|NCT00307047|517153078|FG001|Overall Study|All death, all MI, all Revascularization|16|||
143438821|NCT00379769|517153079|FG000|Main Study|Death|57|||
143438822|NCT00379769|517153080|FG001|Main Study|Death|67|||
143438823|NCT00379769|517153081|FG002|Main Study|Death|54|||
143438824|NCT00379769|517153082|FG003|Main Study|Death|72|||
143438825|NCT00379769|517153083|FG004|Main Study|Death|0|||
143438826|NCT00379769|517153084|FG005|Main Study|Death|0|||
143438827|NCT00379769|517153079|FG000|Main Study|Adverse Event|5|||
143438828|NCT00379769|517153080|FG001|Main Study|Adverse Event|8|||
143438829|NCT00379769|517153081|FG002|Main Study|Adverse Event|10|||
143438830|NCT00379769|517153082|FG003|Main Study|Adverse Event|11|||
143438831|NCT00379769|517153083|FG004|Main Study|Adverse Event|0|||
143438832|NCT00379769|517153084|FG005|Main Study|Adverse Event|0|||
143438833|NCT00379769|517153079|FG000|Main Study|Lost to Follow-up|29|||
143438834|NCT00379769|517153080|FG001|Main Study|Lost to Follow-up|29|||
143438835|NCT00379769|517153081|FG002|Main Study|Lost to Follow-up|25|||
143438836|NCT00379769|517153082|FG003|Main Study|Lost to Follow-up|26|||
143438837|NCT00379769|517153083|FG004|Main Study|Lost to Follow-up|0|||
143438838|NCT00379769|517153084|FG005|Main Study|Lost to Follow-up|0|||
143438839|NCT00379769|517153079|FG000|Main Study|Withdrawal by Subject|46|||
143438840|NCT00379769|517153080|FG001|Main Study|Withdrawal by Subject|56|||
143438841|NCT00379769|517153081|FG002|Main Study|Withdrawal by Subject|72|||
143438842|NCT00379769|517153082|FG003|Main Study|Withdrawal by Subject|70|||
143438843|NCT00379769|517153083|FG004|Main Study|Withdrawal by Subject|0|||
143438844|NCT00379769|517153084|FG005|Main Study|Withdrawal by Subject|0|||
143438845|NCT00379769|517153079|FG000|Main Study|Moved to survival status follow-up only|27|||
143438846|NCT00379769|517153080|FG001|Main Study|Moved to survival status follow-up only|25|||
143438847|NCT00379769|517153081|FG002|Main Study|Moved to survival status follow-up only|32|||
143438848|NCT00379769|517153082|FG003|Main Study|Moved to survival status follow-up only|36|||
143438849|NCT00379769|517153083|FG004|Main Study|Moved to survival status follow-up only|0|||
143438850|NCT00379769|517153084|FG005|Main Study|Moved to survival status follow-up only|0|||
143438851|NCT00379769|517153079|FG000|Main Study|Participant moved|3|||
143438852|NCT00379769|517153080|FG001|Main Study|Participant moved|2|||
143438853|NCT00379769|517153081|FG002|Main Study|Participant moved|3|||
143438854|NCT00379769|517153082|FG003|Main Study|Participant moved|3|||
143438855|NCT00379769|517153083|FG004|Main Study|Participant moved|0|||
143438856|NCT00379769|517153084|FG005|Main Study|Participant moved|0|||
143438857|NCT00379769|517153079|FG000|Main Study|Poor compliance|3|||
143438858|NCT00379769|517153080|FG001|Main Study|Poor compliance|2|||
143438859|NCT00379769|517153081|FG002|Main Study|Poor compliance|2|||
143438860|NCT00379769|517153082|FG003|Main Study|Poor compliance|1|||
143438861|NCT00379769|517153083|FG004|Main Study|Poor compliance|0|||
143438862|NCT00379769|517153084|FG005|Main Study|Poor compliance|0|||
143438863|NCT00379769|517153079|FG000|Main Study|Prohibited glucose lowering medication|0|||
143438864|NCT00379769|517153080|FG001|Main Study|Prohibited glucose lowering medication|3|||
143438865|NCT00379769|517153081|FG002|Main Study|Prohibited glucose lowering medication|0|||
143438866|NCT00379769|517153082|FG003|Main Study|Prohibited glucose lowering medication|1|||
143438867|NCT00379769|517153083|FG004|Main Study|Prohibited glucose lowering medication|0|||
143438868|NCT00379769|517153084|FG005|Main Study|Prohibited glucose lowering medication|0|||
143438869|NCT00379769|517153079|FG000|Main Study|Site closed|4|||
143438870|NCT00379769|517153080|FG001|Main Study|Site closed|4|||
143438871|NCT00379769|517153081|FG002|Main Study|Site closed|4|||
143438872|NCT00379769|517153082|FG003|Main Study|Site closed|8|||
143438873|NCT00379769|517153083|FG004|Main Study|Site closed|0|||
143438874|NCT00379769|517153084|FG005|Main Study|Site closed|0|||
143438875|NCT00379769|517153079|FG000|Main Study|Entry criteria violation|0|||
143438876|NCT00379769|517153080|FG001|Main Study|Entry criteria violation|0|||
143438877|NCT00379769|517153081|FG002|Main Study|Entry criteria violation|1|||
143438878|NCT00379769|517153082|FG003|Main Study|Entry criteria violation|1|||
143438879|NCT00379769|517153083|FG004|Main Study|Entry criteria violation|0|||
143438880|NCT00379769|517153084|FG005|Main Study|Entry criteria violation|0|||
143438881|NCT00379769|517153079|FG000|Main Study|Participant did not take study drug|0|||
143438882|NCT00379769|517153080|FG001|Main Study|Participant did not take study drug|0|||
143438883|NCT00379769|517153081|FG002|Main Study|Participant did not take study drug|1|||
143438884|NCT00379769|517153082|FG003|Main Study|Participant did not take study drug|0|||
143438885|NCT00379769|517153083|FG004|Main Study|Participant did not take study drug|0|||
143438886|NCT00379769|517153084|FG005|Main Study|Participant did not take study drug|0|||
143438887|NCT00379769|517153079|FG000|Main Study|Physician Decision|2|||
143438888|NCT00379769|517153080|FG001|Main Study|Physician Decision|2|||
143438889|NCT00379769|517153081|FG002|Main Study|Physician Decision|1|||
143438890|NCT00379769|517153082|FG003|Main Study|Physician Decision|1|||
143438891|NCT00379769|517153083|FG004|Main Study|Physician Decision|0|||
143438892|NCT00379769|517153084|FG005|Main Study|Physician Decision|0|||
143438893|NCT00379769|517153079|FG000|Main Study|Participant completed study at visit 27|1|||
143438894|NCT00379769|517153080|FG001|Main Study|Participant completed study at visit 27|0|||
143438895|NCT00379769|517153081|FG002|Main Study|Participant completed study at visit 27|0|||
143438896|NCT00379769|517153082|FG003|Main Study|Participant completed study at visit 27|0|||
143438897|NCT00379769|517153083|FG004|Main Study|Participant completed study at visit 27|0|||
143438898|NCT00379769|517153084|FG005|Main Study|Participant completed study at visit 27|0|||
143438899|NCT00379769|517153079|FG000|Main Study|Personal reasons|1|||
143438900|NCT00379769|517153080|FG001|Main Study|Personal reasons|0|||
143438901|NCT00379769|517153081|FG002|Main Study|Personal reasons|0|||
143438902|NCT00379769|517153082|FG003|Main Study|Personal reasons|0|||
143438903|NCT00379769|517153083|FG004|Main Study|Personal reasons|0|||
143438904|NCT00379769|517153084|FG005|Main Study|Personal reasons|0|||
143438905|NCT00379769|517153079|FG000|Main Study|Risk of heart failure|0|||
143438906|NCT00379769|517153080|FG001|Main Study|Risk of heart failure|1|||
143438907|NCT00379769|517153081|FG002|Main Study|Risk of heart failure|0|||
143438908|NCT00379769|517153082|FG003|Main Study|Risk of heart failure|0|||
143438909|NCT00379769|517153083|FG004|Main Study|Risk of heart failure|0|||
143438910|NCT00379769|517153084|FG005|Main Study|Risk of heart failure|0|||
143438911|NCT00379769|517153079|FG000|Main Study|Investigator refused to log temperature|0|||
143438912|NCT00379769|517153080|FG001|Main Study|Investigator refused to log temperature|0|||
143438913|NCT00379769|517153081|FG002|Main Study|Investigator refused to log temperature|1|||
143438914|NCT00379769|517153082|FG003|Main Study|Investigator refused to log temperature|0|||
143438915|NCT00379769|517153083|FG004|Main Study|Investigator refused to log temperature|0|||
143438916|NCT00379769|517153084|FG005|Main Study|Investigator refused to log temperature|0|||
143438917|NCT00379769|517153079|FG000|Main Study|Reason unspecified|0|||
143438918|NCT00379769|517153080|FG001|Main Study|Reason unspecified|0|||
143438919|NCT00379769|517153081|FG002|Main Study|Reason unspecified|1|||
143438920|NCT00379769|517153082|FG003|Main Study|Reason unspecified|0|||
143438921|NCT00379769|517153083|FG004|Main Study|Reason unspecified|0|||
143438922|NCT00379769|517153084|FG005|Main Study|Reason unspecified|0|||
143438923|NCT00379769|517153079|FG000|Observational Follow-up|Death|0|||
143438924|NCT00379769|517153080|FG001|Observational Follow-up|Death|0|||
143438925|NCT00379769|517153081|FG002|Observational Follow-up|Death|0|||
143438926|NCT00379769|517153082|FG003|Observational Follow-up|Death|0|||
143438927|NCT00379769|517153083|FG004|Observational Follow-up|Death|78|||
143438928|NCT00379769|517153084|FG005|Observational Follow-up|Death|70|||
143438929|NCT00379769|517153079|FG000|Observational Follow-up|Adverse Event|0|||
143438930|NCT00379769|517153080|FG001|Observational Follow-up|Adverse Event|0|||
143438931|NCT00379769|517153081|FG002|Observational Follow-up|Adverse Event|0|||
143438932|NCT00379769|517153082|FG003|Observational Follow-up|Adverse Event|0|||
143438933|NCT00379769|517153083|FG004|Observational Follow-up|Adverse Event|1|||
143438934|NCT00379769|517153084|FG005|Observational Follow-up|Adverse Event|0|||
143438935|NCT00379769|517153079|FG000|Observational Follow-up|Lost to Follow-up|0|||
143438936|NCT00379769|517153080|FG001|Observational Follow-up|Lost to Follow-up|0|||
143438937|NCT00379769|517153081|FG002|Observational Follow-up|Lost to Follow-up|0|||
143438938|NCT00379769|517153082|FG003|Observational Follow-up|Lost to Follow-up|0|||
143438939|NCT00379769|517153083|FG004|Observational Follow-up|Lost to Follow-up|25|||
143438940|NCT00379769|517153084|FG005|Observational Follow-up|Lost to Follow-up|27|||
143438941|NCT00379769|517153079|FG000|Observational Follow-up|Withdrawal by Subject|0|||
143438942|NCT00379769|517153080|FG001|Observational Follow-up|Withdrawal by Subject|0|||
143438943|NCT00379769|517153081|FG002|Observational Follow-up|Withdrawal by Subject|0|||
143438944|NCT00379769|517153082|FG003|Observational Follow-up|Withdrawal by Subject|0|||
143438945|NCT00379769|517153083|FG004|Observational Follow-up|Withdrawal by Subject|12|||
143438946|NCT00379769|517153084|FG005|Observational Follow-up|Withdrawal by Subject|12|||
143438947|NCT00379769|517153079|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
143438948|NCT00379769|517153080|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
143438949|NCT00379769|517153081|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
143438950|NCT00379769|517153082|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
143438951|NCT00379769|517153083|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
143438952|NCT00379769|517153084|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
143438953|NCT00379769|517153079|FG000|Observational Follow-up|Physician Decision|0|||
143438954|NCT00379769|517153080|FG001|Observational Follow-up|Physician Decision|0|||
143438955|NCT00379769|517153081|FG002|Observational Follow-up|Physician Decision|0|||
143438956|NCT00379769|517153082|FG003|Observational Follow-up|Physician Decision|0|||
143438957|NCT00379769|517153083|FG004|Observational Follow-up|Physician Decision|8|||
143438958|NCT00379769|517153084|FG005|Observational Follow-up|Physician Decision|8|||
143438959|NCT00379769|517153079|FG000|Observational Follow-up|Site Closed Early|0|||
143438960|NCT00379769|517153080|FG001|Observational Follow-up|Site Closed Early|0|||
143438961|NCT00379769|517153081|FG002|Observational Follow-up|Site Closed Early|0|||
143438962|NCT00379769|517153082|FG003|Observational Follow-up|Site Closed Early|0|||
143438963|NCT00379769|517153083|FG004|Observational Follow-up|Site Closed Early|6|||
143438964|NCT00379769|517153084|FG005|Observational Follow-up|Site Closed Early|7|||
143438965|NCT00379769|517153079|FG000|Observational Follow-up|Participant Moved|0|||
143438966|NCT00379769|517153080|FG001|Observational Follow-up|Participant Moved|0|||
143438967|NCT00379769|517153081|FG002|Observational Follow-up|Participant Moved|0|||
143438968|NCT00379769|517153082|FG003|Observational Follow-up|Participant Moved|0|||
143438969|NCT00379769|517153083|FG004|Observational Follow-up|Participant Moved|0|||
143438970|NCT00379769|517153084|FG005|Observational Follow-up|Participant Moved|1|||
143438971|NCT00379769|517153079|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
143438972|NCT00379769|517153080|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
143438973|NCT00379769|517153081|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
143438974|NCT00379769|517153082|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
143438975|NCT00379769|517153083|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
143438976|NCT00379769|517153084|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
143438977|NCT03778294|517153085|FG000|Overall Study|Death|1|||
143438978|NCT03778294|517153085|FG000|Overall Study|Issues with insurance|1|||
143438979|NCT03778294|517153085|FG000|Overall Study|disease progression before treatment|2|||
143438980|NCT02825251|517153088|FG000|Overall Study|Adverse Event|0|||
143438981|NCT02825251|517153089|FG001|Overall Study|Adverse Event|1|||
143438982|NCT02825251|517153088|FG000|Overall Study|Lost to Follow-up|0|||
143438983|NCT02825251|517153089|FG001|Overall Study|Lost to Follow-up|1|||
143438984|NCT02825251|517153088|FG000|Overall Study|Withdrawal by Subject|1|||
143438985|NCT02825251|517153089|FG001|Overall Study|Withdrawal by Subject|4|||
143438986|NCT02825251|517153088|FG000|Overall Study|Unclassified|2|||
143438987|NCT02825251|517153089|FG001|Overall Study|Unclassified|0|||
143438988|NCT01689363|517153096|FG000|Overall Study|Protocol Violation|0|||
143438989|NCT01689363|517153097|FG001|Overall Study|Protocol Violation|1|||
143438990|NCT01689363|517153098|FG002|Overall Study|Protocol Violation|0|||
143438991|NCT01689363|517153099|FG003|Overall Study|Protocol Violation|0|||
143438992|NCT01689363|517153100|FG004|Overall Study|Protocol Violation|0|||
143438993|NCT01689363|517153101|FG005|Overall Study|Protocol Violation|0|||
143438994|NCT01689363|517153102|FG006|Overall Study|Protocol Violation|0|||
143438995|NCT01689363|517153103|FG007|Overall Study|Protocol Violation|0|||
143438996|NCT02104505|517153104|FG000|First Intervention (14 Days)|Adverse Event|2|||
143438997|NCT02104505|517153105|FG001|First Intervention (14 Days)|Adverse Event|0|||
143438998|NCT02104505|517153104|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
143438999|NCT02104505|517153105|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
143439000|NCT02104505|517153104|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
143439001|NCT02104505|517153105|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
143439002|NCT02104505|517153104|FG000|First Intervention (14 Days)|exclusionary condition|0|||
143439003|NCT02104505|517153105|FG001|First Intervention (14 Days)|exclusionary condition|1|||
143439004|NCT02104505|517153104|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
143439005|NCT02104505|517153105|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
143439006|NCT02104505|517153104|FG000|Second Intervention (14 Days)|Adverse Event|2|||
143439007|NCT02104505|517153105|FG001|Second Intervention (14 Days)|Adverse Event|0|||
143439008|NCT01845805|517153106|FG000|Overall Study|Withdrawal by Subject|1|||
143439009|NCT01845805|517153107|FG001|Overall Study|Withdrawal by Subject|2|||
143439010|NCT01845805|517153106|FG000|Overall Study|Disease Progression|13|||
143439011|NCT01845805|517153107|FG001|Overall Study|Disease Progression|14|||
143439012|NCT01845805|517153106|FG000|Overall Study|Drug-related Toxicity|4|||
143439013|NCT01845805|517153107|FG001|Overall Study|Drug-related Toxicity|0|||
143439014|NCT00321685|517153110|FG000|Overall Study|Adverse Event|18|||
143439015|NCT00321685|517153110|FG000|Overall Study|Death|2|||
143439016|NCT00321685|517153110|FG000|Overall Study|Withdrawal by Subject|8|||
143439017|NCT00321685|517153110|FG000|Overall Study|Alternative therapy|1|||
143439018|NCT00321685|517153110|FG000|Overall Study|Complicating disese|1|||
143439019|NCT00321685|517153110|FG000|Overall Study|Other|5|||
143439020|NCT00321685|517153110|FG000|Overall Study|Not start protocol therapy|2|||
143439021|NCT00321685|517153110|FG000|Overall Study|Ineligible|2|||
143439022|NCT01986114|517153114|FG000|Overall Study|Adverse Event|59|||
143439023|NCT01986114|517153114|FG000|Overall Study|Lack of Efficacy|23|||
143439024|NCT01986114|517153114|FG000|Overall Study|Withdrawal by Subject|58|||
143439025|NCT01986114|517153114|FG000|Overall Study|Noncompliance|3|||
143439026|NCT01986114|517153114|FG000|Overall Study|Protocol Violation|1|||
143439027|NCT01986114|517153114|FG000|Overall Study|Lost to Follow-up|5|||
143439028|NCT01986114|517153114|FG000|Overall Study|Other reason|7|||
143439029|NCT01190644|517153115|FG000|Overall Study|Death|2|||
143439030|NCT01190644|517153115|FG000|Overall Study|Disease progression|1|||
143439031|NCT02366143|517153116|FG000|Overall Study|Death|307|||
143439032|NCT02366143|517153117|FG001|Overall Study|Death|278|||
143439033|NCT02366143|517153118|FG002|Overall Study|Death|280|||
143439034|NCT02366143|517153116|FG000|Overall Study|Lost to Follow-up|2|||
143439035|NCT02366143|517153117|FG001|Overall Study|Lost to Follow-up|4|||
143439036|NCT02366143|517153118|FG002|Overall Study|Lost to Follow-up|2|||
143439037|NCT02366143|517153116|FG000|Overall Study|Physician Decision|1|||
143439038|NCT02366143|517153117|FG001|Overall Study|Physician Decision|2|||
143439039|NCT02366143|517153118|FG002|Overall Study|Physician Decision|1|||
143439040|NCT02366143|517153116|FG000|Overall Study|Protocol Violation|0|||
143439041|NCT02366143|517153117|FG001|Overall Study|Protocol Violation|0|||
143439042|NCT02366143|517153118|FG002|Overall Study|Protocol Violation|2|||
143439043|NCT02366143|517153116|FG000|Overall Study|Withdrawal by Subject|16|||
143439044|NCT02366143|517153117|FG001|Overall Study|Withdrawal by Subject|17|||
143439045|NCT02366143|517153118|FG002|Overall Study|Withdrawal by Subject|22|||
143439046|NCT02366143|517153116|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
143439047|NCT02366143|517153117|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
143439048|NCT02366143|517153118|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
143439049|NCT02366143|517153116|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
143439050|NCT02366143|517153117|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
143439051|NCT02366143|517153118|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
143439052|NCT02366143|517153116|FG000|Overall Study|Randomization Error|1|||
143439053|NCT02366143|517153117|FG001|Overall Study|Randomization Error|0|||
143439054|NCT02366143|517153118|FG002|Overall Study|Randomization Error|0|||
143439055|NCT02366143|517153116|FG000|Overall Study|PI Move and Site Closure|1|||
143439056|NCT02366143|517153117|FG001|Overall Study|PI Move and Site Closure|0|||
143439057|NCT02366143|517153118|FG002|Overall Study|PI Move and Site Closure|1|||
143439058|NCT02366143|517153116|FG000|Overall Study|Study Terminated By Sponsor|0|||
143439059|NCT02366143|517153117|FG001|Overall Study|Study Terminated By Sponsor|0|||
143439060|NCT02366143|517153118|FG002|Overall Study|Study Terminated By Sponsor|2|||
143439061|NCT02366143|517153116|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
143439062|NCT02366143|517153117|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
143439063|NCT02366143|517153118|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
143439064|NCT02366143|517153116|FG000|Overall Study|Patient moved to roll-over study|1|||
143439065|NCT02366143|517153117|FG001|Overall Study|Patient moved to roll-over study|19|||
143439066|NCT02366143|517153118|FG002|Overall Study|Patient moved to roll-over study|28|||
143439067|NCT02366143|517153116|FG000|Overall Study|Patient moved to commercial stock|0|||
143439068|NCT02366143|517153117|FG001|Overall Study|Patient moved to commercial stock|0|||
143439069|NCT02366143|517153118|FG002|Overall Study|Patient moved to commercial stock|1|||
143439070|NCT02366143|517153116|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
143439071|NCT02366143|517153117|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
143439072|NCT02366143|517153118|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
143439073|NCT02366143|517153116|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
143439074|NCT02366143|517153117|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
143439075|NCT02366143|517153118|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
143439076|NCT02366143|517153116|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
143439077|NCT02366143|517153117|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
143439078|NCT02366143|517153118|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
143439079|NCT02366143|517153116|FG000|Overall Study|Requester's instructions|1|||
143439080|NCT02366143|517153117|FG001|Overall Study|Requester's instructions|1|||
143439081|NCT02366143|517153118|FG002|Overall Study|Requester's instructions|1|||
143439082|NCT02366143|517153116|FG000|Overall Study|Uneligible|0|||
143439083|NCT02366143|517153117|FG001|Overall Study|Uneligible|1|||
143439084|NCT02366143|517153118|FG002|Overall Study|Uneligible|0|||
143439085|NCT02366143|517153116|FG000|Overall Study|Post Trial Migration|0|||
143439086|NCT02366143|517153117|FG001|Overall Study|Post Trial Migration|1|||
143439087|NCT02366143|517153118|FG002|Overall Study|Post Trial Migration|0|||
143439088|NCT02366143|517153116|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
143439089|NCT02366143|517153117|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
143439090|NCT02366143|517153118|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
143439091|NCT02366143|517153116|FG000|Overall Study|Patient switched to PTAP|0|||
143439092|NCT02366143|517153117|FG001|Overall Study|Patient switched to PTAP|1|||
143439093|NCT02366143|517153118|FG002|Overall Study|Patient switched to PTAP|0|||
143439094|NCT02366143|517153116|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
143439095|NCT02366143|517153117|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
143439096|NCT02366143|517153118|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
143439097|NCT02172911|517153119|FG000|Overall Study|Serious Adverse Event|0|||
143439098|NCT02172911|517153120|FG001|Overall Study|Serious Adverse Event|1|||
143439099|NCT02172911|517153119|FG000|Overall Study|Progression of Disease|0|||
143439100|NCT02172911|517153120|FG001|Overall Study|Progression of Disease|1|||
143439101|NCT02172911|517153119|FG000|Overall Study|Loss of insurance coverage|1|||
143439102|NCT02172911|517153120|FG001|Overall Study|Loss of insurance coverage|0|||
143439103|NCT04795336|517153123|FG000|Overall Study|Withdrawal by Subject|3|||
143439104|NCT04795336|517153124|FG001|Overall Study|Withdrawal by Subject|4|||
143439105|NCT04795336|517153125|FG002|Overall Study|Withdrawal by Subject|3|||
143439106|NCT04795336|517153126|FG003|Overall Study|Withdrawal by Subject|12|||
143439107|NCT04795336|517153123|FG000|Overall Study|Lost study logs|0|||
143439108|NCT04795336|517153124|FG001|Overall Study|Lost study logs|1|||
143439109|NCT04795336|517153125|FG002|Overall Study|Lost study logs|0|||
143439110|NCT04795336|517153126|FG003|Overall Study|Lost study logs|2|||
143439111|NCT04795336|517153123|FG000|Overall Study|Did not take study medication|2|||
143439112|NCT04795336|517153124|FG001|Overall Study|Did not take study medication|0|||
143439113|NCT04795336|517153125|FG002|Overall Study|Did not take study medication|0|||
143439114|NCT04795336|517153126|FG003|Overall Study|Did not take study medication|0|||
143439115|NCT01638390|517153127|FG000|Overall Study|screening failures|21|||
143439116|NCT01536587|517153134|FG000|Overall Study|Adverse Event|2|||
143439117|NCT03023722|517153135|FG000|Overall Study|No follow-up assessment|4|||
143439118|NCT02666664|517153136|FG000|Overall Study|Physician Decision|0|||
143439119|NCT02666664|517153137|FG001|Overall Study|Physician Decision|1|||
143439120|NCT02666664|517153136|FG000|Overall Study|Protocol Violation|0|||
143439121|NCT02666664|517153137|FG001|Overall Study|Protocol Violation|2|||
143439122|NCT02666664|517153136|FG000|Overall Study|Other|0|||
143439123|NCT02666664|517153137|FG001|Overall Study|Other|1|||
143439124|NCT02666664|517153136|FG000|Overall Study|Adverse Event|12|||
143439125|NCT02666664|517153137|FG001|Overall Study|Adverse Event|37|||
143439126|NCT02666664|517153136|FG000|Overall Study|Withdrawal by participant|23|||
143439127|NCT02666664|517153137|FG001|Overall Study|Withdrawal by participant|40|||
143439128|NCT02666664|517153136|FG000|Overall Study|Sponsor decision|0|||
143439129|NCT02666664|517153137|FG001|Overall Study|Sponsor decision|1|||
143439130|NCT02666664|517153136|FG000|Overall Study|Lost to Follow-up|1|||
143439131|NCT02666664|517153137|FG001|Overall Study|Lost to Follow-up|2|||
143439132|NCT03616964|517153138|FG000|Overall Study|Adverse Event|15|||
143439133|NCT03616964|517153139|FG001|Overall Study|Adverse Event|10|||
143439134|NCT03616964|517153140|FG002|Overall Study|Adverse Event|16|||
143439135|NCT03616964|517153138|FG000|Overall Study|Death|3|||
143439136|NCT03616964|517153139|FG001|Overall Study|Death|0|||
143439137|NCT03616964|517153140|FG002|Overall Study|Death|4|||
143439138|NCT03616964|517153138|FG000|Overall Study|Lack of Efficacy|4|||
143439139|NCT03616964|517153139|FG001|Overall Study|Lack of Efficacy|8|||
143439140|NCT03616964|517153140|FG002|Overall Study|Lack of Efficacy|8|||
143439141|NCT03616964|517153138|FG000|Overall Study|Lost to Follow-up|2|||
143439142|NCT03616964|517153139|FG001|Overall Study|Lost to Follow-up|1|||
143439143|NCT03616964|517153140|FG002|Overall Study|Lost to Follow-up|3|||
143439144|NCT03616964|517153138|FG000|Overall Study|Withdrawal by Subject|18|||
143439145|NCT03616964|517153139|FG001|Overall Study|Withdrawal by Subject|14|||
143439146|NCT03616964|517153140|FG002|Overall Study|Withdrawal by Subject|21|||
143439147|NCT03616964|517153138|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
143439148|NCT03616964|517153139|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
143439149|NCT03616964|517153140|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
143439150|NCT03616964|517153138|FG000|Overall Study|Sponsor's Decision|1|||
143439151|NCT03616964|517153139|FG001|Overall Study|Sponsor's Decision|0|||
143439152|NCT03616964|517153140|FG002|Overall Study|Sponsor's Decision|0|||
143439153|NCT03616964|517153138|FG000|Overall Study|Physician Decision|0|||
143439154|NCT03616964|517153139|FG001|Overall Study|Physician Decision|2|||
143439155|NCT03616964|517153140|FG002|Overall Study|Physician Decision|0|||
143439156|NCT03616964|517153138|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
143439157|NCT03616964|517153139|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
143439158|NCT03616964|517153140|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
143439159|NCT03616964|517153138|FG000|Overall Study|Protocol Violation|0|||
143439160|NCT03616964|517153139|FG001|Overall Study|Protocol Violation|1|||
143439161|NCT03616964|517153140|FG002|Overall Study|Protocol Violation|0|||
143439162|NCT03616964|517153138|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
143439163|NCT03616964|517153139|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
143439164|NCT03616964|517153140|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
143439165|NCT03616964|517153138|FG000|Overall Study|Randomized but Never Treated|1|||
143439166|NCT03616964|517153139|FG001|Overall Study|Randomized but Never Treated|1|||
143439167|NCT03616964|517153140|FG002|Overall Study|Randomized but Never Treated|1|||
143439168|NCT04596995|517153141|FG000|Overall Study|Lack of Efficacy|8|||
143439169|NCT04596995|517153141|FG000|Overall Study|Lost to Follow-up|3|||
143439170|NCT04596995|517153141|FG000|Overall Study|Withdrawal by Subject|12|||
143439171|NCT04596995|517153141|FG000|Overall Study|Sponsor decision|3|||
143439172|NCT04596995|517153141|FG000|Overall Study|Enrolled in managed access program|3|||
143439173|NCT00129935|517153142|FG000|Overall Study|Adverse Event|18|||
143439174|NCT00129935|517153143|FG001|Overall Study|Adverse Event|56|||
143439175|NCT00129935|517153142|FG000|Overall Study|Death|1|||
143439176|NCT00129935|517153143|FG001|Overall Study|Death|1|||
143439177|NCT00129935|517153142|FG000|Overall Study|Withdrawal by Subject|7|||
143439178|NCT00129935|517153143|FG001|Overall Study|Withdrawal by Subject|20|||
143439179|NCT00129935|517153142|FG000|Overall Study|Protocol Violation|0|||
143439180|NCT00129935|517153143|FG001|Overall Study|Protocol Violation|4|||
143439181|NCT00129935|517153142|FG000|Overall Study|Physician Decision|3|||
143439182|NCT00129935|517153143|FG001|Overall Study|Physician Decision|4|||
143439183|NCT00129935|517153142|FG000|Overall Study|Recurrence|1|||
143439184|NCT00129935|517153143|FG001|Overall Study|Recurrence|3|||
143439185|NCT00129935|517153142|FG000|Overall Study|Second primary|0|||
143439186|NCT00129935|517153143|FG001|Overall Study|Second primary|1|||
143439187|NCT00129935|517153142|FG000|Overall Study|Other|3|||
143439188|NCT00129935|517153143|FG001|Overall Study|Other|2|||
143439189|NCT00129935|517153142|FG000|Overall Study|Crossed to the other arm|2|||
143439190|NCT00129935|517153143|FG001|Overall Study|Crossed to the other arm|1|||
143439191|NCT00129935|517153142|FG000|Overall Study|Incorrect study treatment|1|||
143439192|NCT00129935|517153143|FG001|Overall Study|Incorrect study treatment|0|||
143439193|NCT01385748|517153144|FG000|Overall Study|Withdrawal by Subject|7|||
143439194|NCT01385748|517153145|FG001|Overall Study|Withdrawal by Subject|4|||
143439195|NCT01385748|517153146|FG002|Overall Study|Withdrawal by Subject|5|||
143439196|NCT01385748|517153144|FG000|Overall Study|Noncompliance|3|||
143439197|NCT01385748|517153145|FG001|Overall Study|Noncompliance|1|||
143439198|NCT01385748|517153146|FG002|Overall Study|Noncompliance|6|||
143439199|NCT01385748|517153144|FG000|Overall Study|Other|1|||
143439200|NCT01385748|517153145|FG001|Overall Study|Other|7|||
143439201|NCT01385748|517153146|FG002|Overall Study|Other|1|||
143439202|NCT01385748|517153144|FG000|Overall Study|Adverse Event|4|||
143439203|NCT01385748|517153145|FG001|Overall Study|Adverse Event|2|||
143439204|NCT01385748|517153146|FG002|Overall Study|Adverse Event|1|||
143439205|NCT02354651|517153147|FG000|Overall Study|Withdrawal by Subject|2|||
143439206|NCT02354651|517153147|FG000|Overall Study|Physician Decision|1|||
143439207|NCT02783573|517153149|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
143439208|NCT02783573|517153150|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
143439209|NCT02783573|517153151|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
143439210|NCT02783573|517153149|FG000|Placebo-Controlled Treatment Period|Death|4|||
143439211|NCT02783573|517153150|FG001|Placebo-Controlled Treatment Period|Death|2|||
143439212|NCT02783573|517153151|FG002|Placebo-Controlled Treatment Period|Death|3|||
143439213|NCT02783573|517153149|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
143439214|NCT02783573|517153150|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
143439215|NCT02783573|517153151|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
143439216|NCT02783573|517153149|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
143439217|NCT02783573|517153150|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
143439218|NCT02783573|517153151|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
143439219|NCT02783573|517153149|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
143439220|NCT02783573|517153150|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
143439221|NCT02783573|517153151|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
143439222|NCT02783573|517153149|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
143439223|NCT02783573|517153150|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
143439224|NCT02783573|517153151|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
143439225|NCT02783573|517153149|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
143439226|NCT02783573|517153150|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
143439227|NCT02783573|517153151|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
143439228|NCT02783573|517153149|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
143439229|NCT02783573|517153150|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
143439230|NCT02783573|517153151|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
143439231|NCT02783573|517153149|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
143439232|NCT02783573|517153150|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
143439233|NCT02783573|517153151|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
143439234|NCT02783573|517153149|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
143439235|NCT02783573|517153150|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
143439236|NCT02783573|517153151|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
143439237|NCT02783573|517153149|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
143439238|NCT02783573|517153150|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
143439239|NCT02783573|517153151|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
143439240|NCT02783573|517153149|FG000|Delayed-Start Period|Sponsor Decision|0|||
143439241|NCT02783573|517153150|FG001|Delayed-Start Period|Sponsor Decision|17|||
143439242|NCT02783573|517153151|FG002|Delayed-Start Period|Sponsor Decision|12|||
143439243|NCT01434680|517153158|FG000|Overall Study|Withdrawal by Subject|1|||
143439244|NCT01434680|517153159|FG001|Overall Study|Withdrawal by Subject|0|||
143439245|NCT01434680|517153160|FG002|Overall Study|Withdrawal by Subject|2|||
143439246|NCT01434680|517153161|FG003|Overall Study|Withdrawal by Subject|0|||
143439247|NCT01434680|517153158|FG000|Overall Study|Lost to Follow-up|1|||
143439248|NCT01434680|517153159|FG001|Overall Study|Lost to Follow-up|1|||
143439249|NCT01434680|517153160|FG002|Overall Study|Lost to Follow-up|0|||
143439250|NCT01434680|517153161|FG003|Overall Study|Lost to Follow-up|0|||
143439251|NCT01434680|517153158|FG000|Overall Study|Protocol Violation|1|||
143439252|NCT01434680|517153159|FG001|Overall Study|Protocol Violation|1|||
143439253|NCT01434680|517153160|FG002|Overall Study|Protocol Violation|0|||
143439254|NCT01434680|517153161|FG003|Overall Study|Protocol Violation|0|||
143439255|NCT00725712|517153162|FG000|Overall Study|Withdrawal by Subject|2|||
143439256|NCT00725712|517153163|FG001|Overall Study|Withdrawal by Subject|1|||
143439257|NCT00725712|517153162|FG000|Overall Study|Protocol Violation|1|||
143439258|NCT00725712|517153163|FG001|Overall Study|Protocol Violation|0|||
143439259|NCT00725712|517153162|FG000|Overall Study|Progressive disease|37|||
143439260|NCT00725712|517153163|FG001|Overall Study|Progressive disease|16|||
143439261|NCT00725712|517153162|FG000|Overall Study|Clinical progression not based on RECIST|0|||
143439262|NCT00725712|517153163|FG001|Overall Study|Clinical progression not based on RECIST|3|||
143439263|NCT00725712|517153162|FG000|Overall Study|Adverse Event|5|||
143439264|NCT00725712|517153163|FG001|Overall Study|Adverse Event|5|||
143439265|NCT00725712|517153162|FG000|Overall Study|Death|2|||
143439266|NCT00725712|517153163|FG001|Overall Study|Death|0|||
143439267|NCT00725712|517153162|FG000|Overall Study|Other: Death|1|||
143439268|NCT00725712|517153163|FG001|Overall Study|Other: Death|0|||
143439269|NCT00725712|517153162|FG000|Overall Study|Hospitalized, unable to continue|0|||
143439270|NCT00725712|517153163|FG001|Overall Study|Hospitalized, unable to continue|1|||
143439271|NCT03020069|517153167|FG000|Overall Study|Lost to Follow-up|0|||
143439272|NCT03020069|517153168|FG001|Overall Study|Lost to Follow-up|1|||
143439273|NCT00589303|517153169|FG000|Overall Study|Withdrawal by Subject|2|||
143439274|NCT00589303|517153170|FG001|Overall Study|Withdrawal by Subject|1|||
143439275|NCT02056626|517153171|FG000|Overall Study|patient did not follow directions|3|||
143439276|NCT02056626|517153172|FG001|Overall Study|patient did not follow directions|1|||
143439277|NCT02056626|517153173|FG002|Overall Study|patient did not follow directions|0|||
143439278|NCT02056626|517153174|FG003|Overall Study|patient did not follow directions|0|||
143439279|NCT05765435|517153177|FG000|Overall Study|Lost to Follow-up|0|||
143439280|NCT05765435|517153178|FG001|Overall Study|Lost to Follow-up|1|||
143439281|NCT05765435|517153179|FG002|Overall Study|Lost to Follow-up|0|||
143439282|NCT05765435|517153177|FG000|Overall Study|Withdrawal by Subject|0|||
143439283|NCT05765435|517153178|FG001|Overall Study|Withdrawal by Subject|0|||
143439284|NCT05765435|517153179|FG002|Overall Study|Withdrawal by Subject|1|||
143439285|NCT01952847|517153180|FG000|Overall Study|Ineligible|1|||
143439286|NCT01952847|517153181|FG001|Overall Study|Ineligible|0|||
143439287|NCT01952847|517153182|FG002|Overall Study|Ineligible|0|||
143439288|NCT01952847|517153183|FG003|Overall Study|Ineligible|0|||
143439289|NCT01952847|517153180|FG000|Overall Study|Lack of Insurance Coverage|0|||
143439290|NCT01952847|517153181|FG001|Overall Study|Lack of Insurance Coverage|1|||
143439291|NCT01952847|517153182|FG002|Overall Study|Lack of Insurance Coverage|0|||
143439292|NCT01952847|517153183|FG003|Overall Study|Lack of Insurance Coverage|0|||
143439293|NCT01952847|517153180|FG000|Overall Study|Withdrawal by Subject|1|||
143439294|NCT01952847|517153181|FG001|Overall Study|Withdrawal by Subject|1|||
143439295|NCT01952847|517153182|FG002|Overall Study|Withdrawal by Subject|0|||
143439296|NCT01952847|517153183|FG003|Overall Study|Withdrawal by Subject|1|||
143439297|NCT00013611|517153184|FG000|Overall Study|Lost to Follow-up|91|||
143439298|NCT00013611|517153185|FG001|Overall Study|Lost to Follow-up|100|||
143439299|NCT02786004|517153186|FG000|Overall Study|Withdrawal by Subject|0|||
143439300|NCT02786004|517153187|FG001|Overall Study|Withdrawal by Subject|1|||
143439301|NCT01234883|517153188|FG000|Overall Study|Early treatment release|8|||
143439302|NCT01234883|517153189|FG001|Overall Study|Early treatment release|10|||
143439303|NCT01234883|517153188|FG000|Overall Study|Parent/guardian withdrew consent|1|||
143439304|NCT01234883|517153189|FG001|Overall Study|Parent/guardian withdrew consent|2|||
143439305|NCT01234883|517153188|FG000|Overall Study|Technical difficulties with IV infusion|0|||
143439306|NCT01234883|517153189|FG001|Overall Study|Technical difficulties with IV infusion|1|||
143439307|NCT01234883|517153188|FG000|Overall Study|Inclusion/exclusion failure|1|||
143439308|NCT01234883|517153189|FG001|Overall Study|Inclusion/exclusion failure|0|||
143439309|NCT04351269|517153190|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
143439310|NCT04351269|517153191|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
143439311|NCT04351269|517153192|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
143439312|NCT04351269|517153190|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
143439313|NCT04351269|517153191|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
143439314|NCT04351269|517153192|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
143439315|NCT04351269|517153190|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
143439316|NCT04351269|517153191|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
143439317|NCT04351269|517153192|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
143439318|NCT04351269|517153190|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
143439319|NCT04351269|517153191|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
143439320|NCT04351269|517153192|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
143439321|NCT04351269|517153190|FG000|Overall Study|Lost to Follow-up|1|||
143439322|NCT04351269|517153191|FG001|Overall Study|Lost to Follow-up|3|||
143439323|NCT04351269|517153192|FG002|Overall Study|Lost to Follow-up|0|||
143439324|NCT01628692|517153197|FG000|Overall Study|Lack of Efficacy|4|||
143439325|NCT01628692|517153198|FG001|Overall Study|Lack of Efficacy|4|||
143439326|NCT01628692|517153199|FG002|Overall Study|Lack of Efficacy|5|||
143439327|NCT01628692|517153200|FG003|Overall Study|Lack of Efficacy|1|||
143439328|NCT01628692|517153201|FG004|Overall Study|Lack of Efficacy|4|||
143439329|NCT01628692|517153202|FG005|Overall Study|Lack of Efficacy|7|||
143439330|NCT01628692|517153197|FG000|Overall Study|Adverse Event|2|||
143439331|NCT01628692|517153198|FG001|Overall Study|Adverse Event|0|||
143439332|NCT01628692|517153199|FG002|Overall Study|Adverse Event|2|||
143439333|NCT01628692|517153200|FG003|Overall Study|Adverse Event|0|||
143439334|NCT01628692|517153201|FG004|Overall Study|Adverse Event|0|||
143439335|NCT01628692|517153202|FG005|Overall Study|Adverse Event|0|||
143439336|NCT01628692|517153197|FG000|Overall Study|Withdrawal by Subject|0|||
143439337|NCT01628692|517153198|FG001|Overall Study|Withdrawal by Subject|1|||
143439338|NCT01628692|517153199|FG002|Overall Study|Withdrawal by Subject|1|||
143439339|NCT01628692|517153200|FG003|Overall Study|Withdrawal by Subject|0|||
143439340|NCT01628692|517153201|FG004|Overall Study|Withdrawal by Subject|0|||
143439341|NCT01628692|517153202|FG005|Overall Study|Withdrawal by Subject|0|||
143439342|NCT01628692|517153197|FG000|Overall Study|Death|0|||
143439343|NCT01628692|517153198|FG001|Overall Study|Death|1|||
143439344|NCT01628692|517153199|FG002|Overall Study|Death|0|||
143439345|NCT01628692|517153200|FG003|Overall Study|Death|0|||
143439346|NCT01628692|517153201|FG004|Overall Study|Death|0|||
143439347|NCT01628692|517153202|FG005|Overall Study|Death|0|||
143439348|NCT01628692|517153197|FG000|Overall Study|Poor compliance/noncompliance|1|||
143439349|NCT01628692|517153198|FG001|Overall Study|Poor compliance/noncompliance|0|||
143439350|NCT01628692|517153199|FG002|Overall Study|Poor compliance/noncompliance|0|||
143439351|NCT01628692|517153200|FG003|Overall Study|Poor compliance/noncompliance|0|||
143439352|NCT01628692|517153201|FG004|Overall Study|Poor compliance/noncompliance|0|||
143439353|NCT01628692|517153202|FG005|Overall Study|Poor compliance/noncompliance|0|||
143439354|NCT01628692|517153197|FG000|Overall Study|Administrative reason by sponsor|0|||
143439355|NCT01628692|517153198|FG001|Overall Study|Administrative reason by sponsor|0|||
143439356|NCT01628692|517153199|FG002|Overall Study|Administrative reason by sponsor|0|||
143439357|NCT01628692|517153200|FG003|Overall Study|Administrative reason by sponsor|0|||
143439358|NCT01628692|517153201|FG004|Overall Study|Administrative reason by sponsor|0|||
143439359|NCT01628692|517153202|FG005|Overall Study|Administrative reason by sponsor|1|||
143439360|NCT01628692|517153197|FG000|Overall Study|Completed 12 Week only|0|||
143439361|NCT01628692|517153198|FG001|Overall Study|Completed 12 Week only|0|||
143439362|NCT01628692|517153199|FG002|Overall Study|Completed 12 Week only|0|||
143439363|NCT01628692|517153200|FG003|Overall Study|Completed 12 Week only|0|||
143439364|NCT01628692|517153201|FG004|Overall Study|Completed 12 Week only|0|||
143439365|NCT01628692|517153202|FG005|Overall Study|Completed 12 Week only|1|||
143439366|NCT02049515|517153203|FG000|Overall Study|Adverse Event|46|||
143439367|NCT02049515|517153204|FG001|Overall Study|Adverse Event|2|||
143439368|NCT02049515|517153203|FG000|Overall Study|Protocol-specified Disease Progression|23|||
143439369|NCT02049515|517153204|FG001|Overall Study|Protocol-specified Disease Progression|2|||
143439370|NCT02049515|517153203|FG000|Overall Study|Death|6|||
143439371|NCT02049515|517153204|FG001|Overall Study|Death|0|||
143439372|NCT02049515|517153203|FG000|Overall Study|Physician Decision|5|||
143439373|NCT02049515|517153204|FG001|Overall Study|Physician Decision|1|||
143439374|NCT02049515|517153203|FG000|Overall Study|Withdrawal by Subject|3|||
143439375|NCT02049515|517153204|FG001|Overall Study|Withdrawal by Subject|0|||
143439376|NCT02049515|517153203|FG000|Overall Study|Termination of the Study by Sponsor|2|||
143439377|NCT02049515|517153204|FG001|Overall Study|Termination of the Study by Sponsor|0|||
143439378|NCT02049515|517153203|FG000|Overall Study|Protocol Violation|1|||
143439379|NCT02049515|517153204|FG001|Overall Study|Protocol Violation|1|||
143439380|NCT02049515|517153203|FG000|Overall Study|Clinical Deterioration|1|||
143439381|NCT02049515|517153204|FG001|Overall Study|Clinical Deterioration|0|||
143439382|NCT02049515|517153203|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
143439383|NCT02049515|517153204|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
143439384|NCT02049515|517153203|FG000|Overall Study|Treatment Interruption >42 Days|1|||
143439385|NCT02049515|517153204|FG001|Overall Study|Treatment Interruption >42 Days|0|||
143439386|NCT02049515|517153203|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
143439387|NCT02049515|517153204|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
143439388|NCT00224029|517153211|FG000|Overall Study|Lost to Follow-up|1|||
143439389|NCT00224029|517153211|FG000|Overall Study|Withdrawal by Subject|4|||
143439390|NCT00224029|517153211|FG000|Overall Study|Other|1|||
143439391|NCT00778921|517153212|FG000|Overall Study|Adverse Event|9|||
143439392|NCT00778921|517153213|FG001|Overall Study|Adverse Event|10|||
143439393|NCT00778921|517153214|FG002|Overall Study|Adverse Event|14|||
143439394|NCT00778921|517153212|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
143439395|NCT00778921|517153213|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
143439396|NCT00778921|517153214|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
143439397|NCT00778921|517153212|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
143439398|NCT00778921|517153213|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
143439399|NCT00778921|517153214|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
143439400|NCT00778921|517153212|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
143439401|NCT00778921|517153213|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
143439402|NCT00778921|517153214|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
143439403|NCT00778921|517153212|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
143439404|NCT00778921|517153213|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
143439405|NCT00778921|517153214|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
143439406|NCT00778921|517153212|FG000|Overall Study|Patient withdrew request|3|||
143439407|NCT00778921|517153213|FG001|Overall Study|Patient withdrew request|1|||
143439408|NCT00778921|517153214|FG002|Overall Study|Patient withdrew request|6|||
143439409|NCT00778921|517153212|FG000|Overall Study|Lost to Follow-up|0|||
143439410|NCT00778921|517153213|FG001|Overall Study|Lost to Follow-up|2|||
143439411|NCT00778921|517153214|FG002|Overall Study|Lost to Follow-up|1|||
143439412|NCT00778921|517153212|FG000|Overall Study|Administrative Problems|1|||
143439413|NCT00778921|517153213|FG001|Overall Study|Administrative Problems|2|||
143439414|NCT00778921|517153214|FG002|Overall Study|Administrative Problems|0|||
143439415|NCT00778921|517153212|FG000|Overall Study|Protocol Violation|3|||
143439416|NCT00778921|517153213|FG001|Overall Study|Protocol Violation|0|||
143439417|NCT00778921|517153214|FG002|Overall Study|Protocol Violation|2|||
143439418|NCT00778921|517153212|FG000|Overall Study|Not treated|0|||
143439419|NCT00778921|517153213|FG001|Overall Study|Not treated|2|||
143439420|NCT00778921|517153214|FG002|Overall Study|Not treated|2|||
143439421|NCT01575873|517153218|FG000|Overall Study|Withdrawal by Subject|15|||
143439422|NCT01575873|517153219|FG001|Overall Study|Withdrawal by Subject|20|||
143439423|NCT01575873|517153220|FG002|Overall Study|Withdrawal by Subject|34|||
143439424|NCT01575873|517153221|FG003|Overall Study|Withdrawal by Subject|34|||
143439425|NCT01575873|517153218|FG000|Overall Study|Adverse Event|7|||
143439426|NCT01575873|517153219|FG001|Overall Study|Adverse Event|7|||
143439427|NCT01575873|517153220|FG002|Overall Study|Adverse Event|9|||
143439428|NCT01575873|517153221|FG003|Overall Study|Adverse Event|12|||
143439429|NCT01575873|517153218|FG000|Overall Study|Lost to Follow-up|1|||
143439430|NCT01575873|517153219|FG001|Overall Study|Lost to Follow-up|3|||
143439431|NCT01575873|517153220|FG002|Overall Study|Lost to Follow-up|13|||
143439432|NCT01575873|517153221|FG003|Overall Study|Lost to Follow-up|5|||
143439433|NCT01575873|517153218|FG000|Overall Study|Death|3|||
143439434|NCT01575873|517153219|FG001|Overall Study|Death|2|||
143439435|NCT01575873|517153220|FG002|Overall Study|Death|8|||
143439436|NCT01575873|517153221|FG003|Overall Study|Death|9|||
143439437|NCT01575873|517153218|FG000|Overall Study|Noncompliance|1|||
143439438|NCT01575873|517153219|FG001|Overall Study|Noncompliance|2|||
143439439|NCT01575873|517153220|FG002|Overall Study|Noncompliance|4|||
143439440|NCT01575873|517153221|FG003|Overall Study|Noncompliance|3|||
143439441|NCT01575873|517153218|FG000|Overall Study|Administrative decision|1|||
143439442|NCT01575873|517153219|FG001|Overall Study|Administrative decision|1|||
143439443|NCT01575873|517153220|FG002|Overall Study|Administrative decision|1|||
143439444|NCT01575873|517153221|FG003|Overall Study|Administrative decision|0|||
143439445|NCT01575873|517153218|FG000|Overall Study|Protocol deviation|0|||
143439446|NCT01575873|517153219|FG001|Overall Study|Protocol deviation|1|||
143439447|NCT01575873|517153220|FG002|Overall Study|Protocol deviation|0|||
143439448|NCT01575873|517153221|FG003|Overall Study|Protocol deviation|1|||
143439449|NCT01575873|517153218|FG000|Overall Study|Requirement for Alternative Therapy|0|||
143439450|NCT01575873|517153219|FG001|Overall Study|Requirement for Alternative Therapy|0|||
143439451|NCT01575873|517153220|FG002|Overall Study|Requirement for Alternative Therapy|1|||
143439452|NCT01575873|517153221|FG003|Overall Study|Requirement for Alternative Therapy|1|||
143439453|NCT01575873|517153218|FG000|Overall Study|Other|0|||
143439454|NCT01575873|517153219|FG001|Overall Study|Other|0|||
143439455|NCT01575873|517153220|FG002|Overall Study|Other|4|||
143439456|NCT01575873|517153221|FG003|Overall Study|Other|2|||
143439457|NCT02031536|517153222|FG000|Overall Study|ineligible|1|||
143439458|NCT02031536|517153223|FG001|Overall Study|ineligible|0|||
143439459|NCT05093504|517153225|FG000|Overall Study|Death|0|||
143439460|NCT05093504|517153226|FG001|Overall Study|Death|1|||
143439461|NCT02859064|517154848|FG000|Overall Study|Progressive Disease|3|||
143439462|NCT02859064|517154848|FG000|Overall Study|Physician Decision|1|||
143439463|NCT02859064|517154848|FG000|Overall Study|Withdrawal by Subject|1|||
143439464|NCT02859064|517154848|FG000|Overall Study|Death|1|||
143439465|NCT00127842|517154849|FG000|Overall Study|Adverse Event|15|||
143439466|NCT00127842|517154849|FG000|Overall Study|Withdrawal by Subject|3|||
143439467|NCT00127842|517154849|FG000|Overall Study|Lost to Follow-up|1|||
143439468|NCT00127842|517154849|FG000|Overall Study|Lack of Efficacy|12|||
143439469|NCT00127842|517154849|FG000|Overall Study|Noncompliance|2|||
143439470|NCT00127842|517154849|FG000|Overall Study|Protocol Violation|1|||
143439471|NCT00127842|517154849|FG000|Overall Study|Other|5|||
143439472|NCT00581893|517154852|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
143439473|NCT00581893|517154853|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
143439474|NCT00590564|517154854|FG000|Overall Study|Withdrawal by Subject|4|||
143439475|NCT00590564|517154854|FG000|Overall Study|Lost to Follow-up|6|||
143439476|NCT00590564|517154854|FG000|Overall Study|Protocol Violation|1|||
143439477|NCT00590564|517154854|FG000|Overall Study|Patient Found to be Ineligible|1|||
143439478|NCT00590564|517154854|FG000|Overall Study|Patient Non-compliance|6|||
143439479|NCT01377389|517154857|FG000|Overall Study|Withdrawal by Subject|1|||
143439480|NCT01377389|517154857|FG000|Overall Study|Screen failure|2|||
143439481|NCT02037477|517154859|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
143439482|NCT02037477|517154860|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
143439483|NCT02037477|517154861|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
143439484|NCT02037477|517154862|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
143439485|NCT00983749|517154865|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
143439486|NCT00983749|517154866|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
143439487|NCT02367352|517154874|FG000|Overall Study|Progressive disease|7|||
143439488|NCT02367352|517154875|FG001|Overall Study|Progressive disease|0|||
143439489|NCT02367352|517154876|FG002|Overall Study|Progressive disease|0|||
143439490|NCT02367352|517154874|FG000|Overall Study|Participant Received Alternative Therapy|1|||
143439491|NCT02367352|517154875|FG001|Overall Study|Participant Received Alternative Therapy|0|||
143439492|NCT02367352|517154876|FG002|Overall Study|Participant Received Alternative Therapy|0|||
143439493|NCT02367352|517154874|FG000|Overall Study|Adverse Event|1|||
143439494|NCT02367352|517154875|FG001|Overall Study|Adverse Event|0|||
143439495|NCT02367352|517154876|FG002|Overall Study|Adverse Event|0|||
143439496|NCT01013961|517154877|FG000|Overall Study|Adverse Event|2|||
143439497|NCT01013961|517154878|FG001|Overall Study|Adverse Event|2|||
143439498|NCT01013961|517154877|FG000|Overall Study|Withdrawal by Subject|1|||
143439499|NCT01013961|517154878|FG001|Overall Study|Withdrawal by Subject|0|||
143439500|NCT01013961|517154877|FG000|Overall Study|Physician Decision|0|||
143439501|NCT01013961|517154878|FG001|Overall Study|Physician Decision|1|||
143439502|NCT01437423|517154883|FG000|Overall Study|Lost to Follow-up|12|||
143439503|NCT01437423|517154883|FG000|Overall Study|Off label usage|3|||
143439504|NCT01375751|517154884|FG000|Overall Study|Other|0|||
143439505|NCT01375751|517154885|FG001|Overall Study|Other|1|||
143439506|NCT01375751|517154886|FG002|Overall Study|Other|0|||
143439507|NCT05878873|517154887|FG000|Overall Study|Lost to Follow-up|2|||
143439508|NCT05878873|517154888|FG001|Overall Study|Lost to Follow-up|0|||
143439509|NCT02980523|517154889|FG000|Overall Study|Lost to Follow-up|1|||
143439510|NCT02980523|517154890|FG001|Overall Study|Lost to Follow-up|4|||
143439511|NCT02980523|517154891|FG002|Overall Study|Lost to Follow-up|1|||
143439512|NCT02980523|517154892|FG003|Overall Study|Lost to Follow-up|2|||
143439513|NCT02980523|517154893|FG004|Overall Study|Lost to Follow-up|1|||
143439514|NCT02980523|517154889|FG000|Overall Study|Excluded from analysis|1|||
143439515|NCT02980523|517154890|FG001|Overall Study|Excluded from analysis|3|||
143439516|NCT02980523|517154891|FG002|Overall Study|Excluded from analysis|1|||
143439517|NCT02980523|517154892|FG003|Overall Study|Excluded from analysis|1|||
143439518|NCT02980523|517154893|FG004|Overall Study|Excluded from analysis|1|||
143439519|NCT02980523|517154889|FG000|Overall Study|Lack of Efficacy|1|||
143439520|NCT02980523|517154890|FG001|Overall Study|Lack of Efficacy|4|||
143439521|NCT02980523|517154891|FG002|Overall Study|Lack of Efficacy|4|||
143439522|NCT02980523|517154892|FG003|Overall Study|Lack of Efficacy|5|||
143439523|NCT02980523|517154893|FG004|Overall Study|Lack of Efficacy|8|||
143439524|NCT02980523|517154889|FG000|Overall Study|Did not receive intervention|0|||
143439525|NCT02980523|517154890|FG001|Overall Study|Did not receive intervention|0|||
143439526|NCT02980523|517154891|FG002|Overall Study|Did not receive intervention|0|||
143439527|NCT02980523|517154892|FG003|Overall Study|Did not receive intervention|1|||
143439528|NCT02980523|517154893|FG004|Overall Study|Did not receive intervention|0|||
143439529|NCT00633945|517154894|FG000|Overall Study|Physician Decision|2|||
143439530|NCT02552147|517154895|FG000|First Intervention (7 Days)|Protocol Violation|1|||
143439531|NCT02552147|517154896|FG001|First Intervention (7 Days)|Protocol Violation|0|||
143439532|NCT02552147|517154895|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
143439533|NCT02552147|517154896|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
143439534|NCT00559377|517154897|FG000|Overall Study|Withdrawal by Subject|9|||
143439535|NCT00872001|517154905|FG000|Overall Study|Adverse Event|34|||
143439536|NCT00872001|517154906|FG001|Overall Study|Adverse Event|23|||
143439537|NCT00872001|517154905|FG000|Overall Study|Protocol Defined Clinical Event|5|||
143439538|NCT00872001|517154906|FG001|Overall Study|Protocol Defined Clinical Event|7|||
143439539|NCT00872001|517154905|FG000|Overall Study|Lost to Follow-up|13|||
143439540|NCT00872001|517154906|FG001|Overall Study|Lost to Follow-up|12|||
143439541|NCT00872001|517154905|FG000|Overall Study|Withdrawal by Subject|18|||
143439542|NCT00872001|517154906|FG001|Overall Study|Withdrawal by Subject|30|||
143439543|NCT00872001|517154905|FG000|Overall Study|Protocol Violation|5|||
143439544|NCT00872001|517154906|FG001|Overall Study|Protocol Violation|8|||
143439545|NCT00872001|517154905|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
143439546|NCT00872001|517154906|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
143439547|NCT00872001|517154905|FG000|Overall Study|Administrative|23|||
143439548|NCT00872001|517154906|FG001|Overall Study|Administrative|15|||
143439549|NCT01453023|517154907|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
143439550|NCT01453023|517154908|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
143439551|NCT01453023|517154907|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
143439552|NCT01453023|517154908|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
143439553|NCT01453023|517154907|FG000|Treatment Period 2|Protocol Violation|0|||
143439554|NCT01453023|517154908|FG001|Treatment Period 2|Protocol Violation|1|||
143439555|NCT04468230|517154912|FG000|Overall Study|Adverse Event|2|||
143439556|NCT01790295|517154913|FG000|Overall Study|Adverse Event|1|||
143439557|NCT01790295|517154913|FG000|Overall Study|Death|4|||
143439558|NCT01790295|517154913|FG000|Overall Study|Lack of Efficacy|2|||
143439559|NCT01790295|517154913|FG000|Overall Study|Study closure|4|||
143439560|NCT00420784|517154916|FG000|Overall Study|Adverse Event|11|||
143439561|NCT00420784|517154917|FG001|Overall Study|Adverse Event|29|||
143439562|NCT00420784|517154918|FG002|Overall Study|Adverse Event|10|||
143439563|NCT00420784|517154919|FG003|Overall Study|Adverse Event|5|||
143439564|NCT00420784|517154916|FG000|Overall Study|Withdrawal by Subject|0|||
143439565|NCT00420784|517154917|FG001|Overall Study|Withdrawal by Subject|1|||
143439566|NCT00420784|517154918|FG002|Overall Study|Withdrawal by Subject|0|||
143439567|NCT00420784|517154919|FG003|Overall Study|Withdrawal by Subject|0|||
143439568|NCT00420784|517154916|FG000|Overall Study|Lost to Follow-up|0|||
143439569|NCT00420784|517154917|FG001|Overall Study|Lost to Follow-up|0|||
143439570|NCT00420784|517154918|FG002|Overall Study|Lost to Follow-up|2|||
143439571|NCT00420784|517154919|FG003|Overall Study|Lost to Follow-up|1|||
143439572|NCT00420784|517154916|FG000|Overall Study|Virologic Stopping Rule|17|||
143439573|NCT00420784|517154917|FG001|Overall Study|Virologic Stopping Rule|26|||
143439574|NCT00420784|517154918|FG002|Overall Study|Virologic Stopping Rule|41|||
143439575|NCT00420784|517154919|FG003|Overall Study|Virologic Stopping Rule|67|||
143439576|NCT00420784|517154916|FG000|Overall Study|Other|1|||
143439577|NCT00420784|517154917|FG001|Overall Study|Other|2|||
143439578|NCT00420784|517154918|FG002|Overall Study|Other|0|||
143439579|NCT00420784|517154919|FG003|Overall Study|Other|5|||
143439580|NCT02417441|517154922|FG000|Overall Study|Inconclusive due to missing data|52|||
143439581|NCT02417441|517154923|FG001|Overall Study|Inconclusive due to missing data|19|||
143439582|NCT00983853|517154924|FG000|Overall Study|Lost to Follow-up|1|||
143439583|NCT00983853|517154925|FG001|Overall Study|Lost to Follow-up|1|||
143439584|NCT00983853|517154926|FG002|Overall Study|Lost to Follow-up|2|||
143439585|NCT00983853|517154927|FG003|Overall Study|Lost to Follow-up|2|||
143439586|NCT00983853|517154928|FG004|Overall Study|Lost to Follow-up|2|||
143439587|NCT00983853|517154929|FG005|Overall Study|Lost to Follow-up|1|||
143439588|NCT00983853|517154924|FG000|Overall Study|Withdrawal by Subject|0|||
143439589|NCT00983853|517154925|FG001|Overall Study|Withdrawal by Subject|0|||
143439590|NCT00983853|517154926|FG002|Overall Study|Withdrawal by Subject|1|||
143439591|NCT00983853|517154927|FG003|Overall Study|Withdrawal by Subject|0|||
143439592|NCT00983853|517154928|FG004|Overall Study|Withdrawal by Subject|1|||
143439593|NCT00983853|517154929|FG005|Overall Study|Withdrawal by Subject|0|||
143439594|NCT00983853|517154924|FG000|Overall Study|Unable to come to study follow-up visits|0|||
143439595|NCT00983853|517154925|FG001|Overall Study|Unable to come to study follow-up visits|1|||
143439596|NCT00983853|517154926|FG002|Overall Study|Unable to come to study follow-up visits|0|||
143439597|NCT00983853|517154927|FG003|Overall Study|Unable to come to study follow-up visits|0|||
143439598|NCT00983853|517154928|FG004|Overall Study|Unable to come to study follow-up visits|0|||
143439599|NCT00983853|517154929|FG005|Overall Study|Unable to come to study follow-up visits|0|||
143439600|NCT03016598|517154934|FG000|Overall Study|Lost to Follow-up|0|||
143439601|NCT03016598|517154935|FG001|Overall Study|Lost to Follow-up|2|||
143439602|NCT00632021|517154939|FG000|Overall Study|Withdrawal/death|4|||
143439603|NCT00632021|517154940|FG001|Overall Study|Withdrawal/death|7|||
143439604|NCT00443209|517154941|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
143439605|NCT00443209|517154942|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
143439606|NCT00443209|517154941|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
143439607|NCT00443209|517154942|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
143439608|NCT00443209|517154941|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
143439609|NCT00443209|517154942|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
143439610|NCT00443209|517154941|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
143439611|NCT00443209|517154942|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
143439612|NCT00443209|517154941|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
143439613|NCT00443209|517154942|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
143439614|NCT00443209|517154941|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
143439615|NCT00443209|517154942|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
143439616|NCT00443209|517154941|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
143439617|NCT00443209|517154942|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
143439618|NCT00443209|517154941|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
143439619|NCT00443209|517154942|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
143439620|NCT00443209|517154941|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
143439621|NCT00443209|517154942|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
143439622|NCT00443209|517154941|FG000|Months 1 to 12 Treatment Period|Missing|2|||
143439623|NCT00443209|517154942|FG001|Months 1 to 12 Treatment Period|Missing|1|||
143439624|NCT00443209|517154941|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
143439625|NCT00443209|517154942|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
143439626|NCT00443209|517154941|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
143439627|NCT00443209|517154942|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
143439628|NCT00443209|517154941|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
143439629|NCT00443209|517154942|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
143439630|NCT00443209|517154941|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
143439631|NCT00443209|517154942|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
143439632|NCT00443209|517154941|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
143439633|NCT00443209|517154942|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
143439634|NCT00443209|517154941|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
143439635|NCT00443209|517154942|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
143439636|NCT00443209|517154941|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
143439637|NCT00443209|517154942|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
143439638|NCT01318876|517154943|FG000|Day 8 Survey|email address invalid|96|||
143439639|NCT01318876|517154943|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
143439640|NCT01318876|517154943|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
143439641|NCT01807182|517154944|FG000|Overall Study|Death|1|||
143439642|NCT01807182|517154944|FG000|Overall Study|New therapy|1|||
143439643|NCT01807182|517154944|FG000|Overall Study|Moved to hospice care|1|||
143439644|NCT03513068|517154945|FG000|Overall Study|Death|1|||
143439645|NCT03513068|517154946|FG001|Overall Study|Death|0|||
143439646|NCT03513068|517154945|FG000|Overall Study|Withdrawal by Subject|4|||
143439647|NCT03513068|517154946|FG001|Overall Study|Withdrawal by Subject|6|||
143439648|NCT01791413|517154947|FG000|Overall Study|Lost to Follow-up|5|||
143439649|NCT01791413|517154948|FG001|Overall Study|Lost to Follow-up|1|||
143439650|NCT03178045|517154949|FG000|Overall Study|Withdrawal by Subject|5|||
143439651|NCT03178045|517154950|FG001|Overall Study|Withdrawal by Subject|7|||
143439652|NCT03178045|517154949|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
143439653|NCT03178045|517154950|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
143439654|NCT03178045|517154949|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
143439655|NCT03178045|517154950|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
143439656|NCT01078922|517154961|FG000|Overall Study|Adverse Event|1|||
143439657|NCT00003477|517154962|FG000|Overall Study|Not evalauable|4|||
143439658|NCT01236352|517154963|FG000|Overall Study|Death|0|||
143439659|NCT01236352|517154964|FG001|Overall Study|Death|0|||
143439660|NCT01236352|517154965|FG002|Overall Study|Death|0|||
143439661|NCT01236352|517154966|FG003|Overall Study|Death|0|||
143439662|NCT01236352|517154967|FG004|Overall Study|Death|0|||
143439663|NCT01236352|517154968|FG005|Overall Study|Death|0|||
143439664|NCT01236352|517154969|FG006|Overall Study|Death|0|||
143439665|NCT01236352|517154970|FG007|Overall Study|Death|1|||
143439666|NCT01236352|517154971|FG008|Overall Study|Death|0|||
143439667|NCT01236352|517154972|FG009|Overall Study|Death|0|||
143439668|NCT01236352|517154973|FG010|Overall Study|Death|0|||
143439669|NCT01236352|517154963|FG000|Overall Study|Withdrawal by Subject|0|||
143439670|NCT01236352|517154964|FG001|Overall Study|Withdrawal by Subject|0|||
143439671|NCT01236352|517154965|FG002|Overall Study|Withdrawal by Subject|0|||
143439672|NCT01236352|517154966|FG003|Overall Study|Withdrawal by Subject|0|||
143439673|NCT01236352|517154967|FG004|Overall Study|Withdrawal by Subject|0|||
143439674|NCT01236352|517154968|FG005|Overall Study|Withdrawal by Subject|0|||
143439675|NCT01236352|517154969|FG006|Overall Study|Withdrawal by Subject|0|||
143439676|NCT01236352|517154970|FG007|Overall Study|Withdrawal by Subject|0|||
143439677|NCT01236352|517154971|FG008|Overall Study|Withdrawal by Subject|0|||
143439678|NCT01236352|517154972|FG009|Overall Study|Withdrawal by Subject|2|||
143439679|NCT01236352|517154973|FG010|Overall Study|Withdrawal by Subject|1|||
143439680|NCT01236352|517154963|FG000|Overall Study|Adverse Event|0|||
143439681|NCT01236352|517154964|FG001|Overall Study|Adverse Event|0|||
143439682|NCT01236352|517154965|FG002|Overall Study|Adverse Event|0|||
143439683|NCT01236352|517154966|FG003|Overall Study|Adverse Event|0|||
143439684|NCT01236352|517154967|FG004|Overall Study|Adverse Event|0|||
143439685|NCT01236352|517154968|FG005|Overall Study|Adverse Event|0|||
143439686|NCT01236352|517154969|FG006|Overall Study|Adverse Event|2|||
143439687|NCT01236352|517154970|FG007|Overall Study|Adverse Event|0|||
143439688|NCT01236352|517154971|FG008|Overall Study|Adverse Event|0|||
143439689|NCT01236352|517154972|FG009|Overall Study|Adverse Event|4|||
143439690|NCT01236352|517154973|FG010|Overall Study|Adverse Event|1|||
143439691|NCT01236352|517154963|FG000|Overall Study|Study drug toxicity|0|||
143439692|NCT01236352|517154964|FG001|Overall Study|Study drug toxicity|0|||
143439693|NCT01236352|517154965|FG002|Overall Study|Study drug toxicity|0|||
143439694|NCT01236352|517154966|FG003|Overall Study|Study drug toxicity|0|||
143439695|NCT01236352|517154967|FG004|Overall Study|Study drug toxicity|0|||
143439696|NCT01236352|517154968|FG005|Overall Study|Study drug toxicity|1|||
143439697|NCT01236352|517154969|FG006|Overall Study|Study drug toxicity|1|||
143439698|NCT01236352|517154970|FG007|Overall Study|Study drug toxicity|0|||
143439699|NCT01236352|517154971|FG008|Overall Study|Study drug toxicity|0|||
143439700|NCT01236352|517154972|FG009|Overall Study|Study drug toxicity|2|||
143439701|NCT01236352|517154973|FG010|Overall Study|Study drug toxicity|2|||
143439702|NCT01236352|517154963|FG000|Overall Study|Disease progression|1|||
143439703|NCT01236352|517154964|FG001|Overall Study|Disease progression|2|||
143439704|NCT01236352|517154965|FG002|Overall Study|Disease progression|1|||
143439705|NCT01236352|517154966|FG003|Overall Study|Disease progression|2|||
143439706|NCT01236352|517154967|FG004|Overall Study|Disease progression|2|||
143439707|NCT01236352|517154968|FG005|Overall Study|Disease progression|2|||
143439708|NCT01236352|517154969|FG006|Overall Study|Disease progression|1|||
143439709|NCT01236352|517154970|FG007|Overall Study|Disease progression|3|||
143439710|NCT01236352|517154971|FG008|Overall Study|Disease progression|2|||
143439711|NCT01236352|517154972|FG009|Overall Study|Disease progression|2|||
143439712|NCT01236352|517154973|FG010|Overall Study|Disease progression|2|||
143439713|NCT01236352|517154963|FG000|Overall Study|Poor/Non-compliance|1|||
143439714|NCT01236352|517154964|FG001|Overall Study|Poor/Non-compliance|0|||
143439715|NCT01236352|517154965|FG002|Overall Study|Poor/Non-compliance|0|||
143439716|NCT01236352|517154966|FG003|Overall Study|Poor/Non-compliance|0|||
143439717|NCT01236352|517154967|FG004|Overall Study|Poor/Non-compliance|0|||
143439718|NCT01236352|517154968|FG005|Overall Study|Poor/Non-compliance|0|||
143439719|NCT01236352|517154969|FG006|Overall Study|Poor/Non-compliance|0|||
143439720|NCT01236352|517154970|FG007|Overall Study|Poor/Non-compliance|0|||
143439721|NCT01236352|517154971|FG008|Overall Study|Poor/Non-compliance|0|||
143439722|NCT01236352|517154972|FG009|Overall Study|Poor/Non-compliance|0|||
143439723|NCT01236352|517154973|FG010|Overall Study|Poor/Non-compliance|0|||
143439724|NCT01236352|517154963|FG000|Overall Study|Maximum clinical benefit|1|||
143439725|NCT01236352|517154964|FG001|Overall Study|Maximum clinical benefit|1|||
143439726|NCT01236352|517154965|FG002|Overall Study|Maximum clinical benefit|1|||
143439727|NCT01236352|517154966|FG003|Overall Study|Maximum clinical benefit|0|||
143439728|NCT01236352|517154967|FG004|Overall Study|Maximum clinical benefit|2|||
143439729|NCT01236352|517154968|FG005|Overall Study|Maximum clinical benefit|0|||
143439730|NCT01236352|517154969|FG006|Overall Study|Maximum clinical benefit|3|||
143439731|NCT01236352|517154970|FG007|Overall Study|Maximum clinical benefit|1|||
143439732|NCT01236352|517154971|FG008|Overall Study|Maximum clinical benefit|1|||
143439733|NCT01236352|517154972|FG009|Overall Study|Maximum clinical benefit|4|||
143439734|NCT01236352|517154973|FG010|Overall Study|Maximum clinical benefit|2|||
143439735|NCT01236352|517154963|FG000|Overall Study|Subject request to discontinue treatment|0|||
143439736|NCT01236352|517154964|FG001|Overall Study|Subject request to discontinue treatment|0|||
143439737|NCT01236352|517154965|FG002|Overall Study|Subject request to discontinue treatment|1|||
143439738|NCT01236352|517154966|FG003|Overall Study|Subject request to discontinue treatment|1|||
143439739|NCT01236352|517154967|FG004|Overall Study|Subject request to discontinue treatment|0|||
143439740|NCT01236352|517154968|FG005|Overall Study|Subject request to discontinue treatment|1|||
143439741|NCT01236352|517154969|FG006|Overall Study|Subject request to discontinue treatment|0|||
143439742|NCT01236352|517154970|FG007|Overall Study|Subject request to discontinue treatment|0|||
143439743|NCT01236352|517154971|FG008|Overall Study|Subject request to discontinue treatment|0|||
143439744|NCT01236352|517154972|FG009|Overall Study|Subject request to discontinue treatment|1|||
143439745|NCT01236352|517154973|FG010|Overall Study|Subject request to discontinue treatment|4|||
143439746|NCT01236352|517154963|FG000|Overall Study|Subject to receive drug via EAP|1|||
143439747|NCT01236352|517154964|FG001|Overall Study|Subject to receive drug via EAP|1|||
143439748|NCT01236352|517154965|FG002|Overall Study|Subject to receive drug via EAP|1|||
143439749|NCT01236352|517154966|FG003|Overall Study|Subject to receive drug via EAP|0|||
143439750|NCT01236352|517154967|FG004|Overall Study|Subject to receive drug via EAP|0|||
143439751|NCT01236352|517154968|FG005|Overall Study|Subject to receive drug via EAP|0|||
143439752|NCT01236352|517154969|FG006|Overall Study|Subject to receive drug via EAP|0|||
143439753|NCT01236352|517154970|FG007|Overall Study|Subject to receive drug via EAP|2|||
143439754|NCT01236352|517154971|FG008|Overall Study|Subject to receive drug via EAP|0|||
143439755|NCT01236352|517154972|FG009|Overall Study|Subject to receive drug via EAP|4|||
143439756|NCT01236352|517154973|FG010|Overall Study|Subject to receive drug via EAP|0|||
143439757|NCT01236352|517154963|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
143439758|NCT01236352|517154964|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
143439759|NCT01236352|517154965|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
143439760|NCT01236352|517154966|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
143439761|NCT01236352|517154967|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
143439762|NCT01236352|517154968|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
143439763|NCT01236352|517154969|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
143439764|NCT01236352|517154970|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
143439765|NCT01236352|517154971|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
143439766|NCT01236352|517154972|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
143439767|NCT01236352|517154973|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
143439768|NCT01236352|517154963|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
143439769|NCT01236352|517154964|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
143439770|NCT01236352|517154965|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
143439771|NCT01236352|517154966|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
143439772|NCT01236352|517154967|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
143439773|NCT01236352|517154968|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
143439774|NCT01236352|517154969|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
143439775|NCT01236352|517154970|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
143439776|NCT01236352|517154971|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
143439777|NCT01236352|517154972|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
143439778|NCT01236352|517154973|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
143439779|NCT01236352|517154963|FG000|Overall Study|Lack of response to drug|0|||
143439780|NCT01236352|517154964|FG001|Overall Study|Lack of response to drug|0|||
143439781|NCT01236352|517154965|FG002|Overall Study|Lack of response to drug|0|||
143439782|NCT01236352|517154966|FG003|Overall Study|Lack of response to drug|0|||
143439783|NCT01236352|517154967|FG004|Overall Study|Lack of response to drug|0|||
143439784|NCT01236352|517154968|FG005|Overall Study|Lack of response to drug|0|||
143439785|NCT01236352|517154969|FG006|Overall Study|Lack of response to drug|0|||
143439786|NCT01236352|517154970|FG007|Overall Study|Lack of response to drug|0|||
143439787|NCT01236352|517154971|FG008|Overall Study|Lack of response to drug|0|||
143439788|NCT01236352|517154972|FG009|Overall Study|Lack of response to drug|1|||
143439789|NCT01236352|517154973|FG010|Overall Study|Lack of response to drug|1|||
143439790|NCT01236352|517154963|FG000|Overall Study|Patient transferred to IST|0|||
143439791|NCT01236352|517154964|FG001|Overall Study|Patient transferred to IST|0|||
143439792|NCT01236352|517154965|FG002|Overall Study|Patient transferred to IST|0|||
143439793|NCT01236352|517154966|FG003|Overall Study|Patient transferred to IST|0|||
143439794|NCT01236352|517154967|FG004|Overall Study|Patient transferred to IST|0|||
143439795|NCT01236352|517154968|FG005|Overall Study|Patient transferred to IST|0|||
143439796|NCT01236352|517154969|FG006|Overall Study|Patient transferred to IST|0|||
143439797|NCT01236352|517154970|FG007|Overall Study|Patient transferred to IST|0|||
143439798|NCT01236352|517154971|FG008|Overall Study|Patient transferred to IST|0|||
143439799|NCT01236352|517154972|FG009|Overall Study|Patient transferred to IST|2|||
143439800|NCT01236352|517154973|FG010|Overall Study|Patient transferred to IST|6|||
143439801|NCT01850030|517154974|FG000|Overall Study|Adverse Event|64|||
143439802|NCT01850030|517154975|FG001|Overall Study|Adverse Event|82|||
143439803|NCT01850030|517154974|FG000|Overall Study|Lack of Efficacy|3|||
143439804|NCT01850030|517154975|FG001|Overall Study|Lack of Efficacy|1|||
143439805|NCT01850030|517154974|FG000|Overall Study|Lost to Follow-up|5|||
143439806|NCT01850030|517154975|FG001|Overall Study|Lost to Follow-up|5|||
143439807|NCT01850030|517154974|FG000|Overall Study|Withdrawal by Subject|3|||
143439808|NCT01850030|517154975|FG001|Overall Study|Withdrawal by Subject|4|||
143439809|NCT01850030|517154974|FG000|Overall Study|Protocol Violation|24|||
143439810|NCT01850030|517154975|FG001|Overall Study|Protocol Violation|28|||
143439811|NCT01850030|517154974|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
143439812|NCT01850030|517154975|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
143439813|NCT00246090|517154976|FG000|Overall Study|Adverse Event|25|||
143439814|NCT00246090|517154976|FG000|Overall Study|Withdrawal by Subject|7|||
143439815|NCT00246090|517154976|FG000|Overall Study|Progressive Disease|212|||
143439816|NCT00246090|517154976|FG000|Overall Study|Clinical Progression|30|||
143439817|NCT00246090|517154976|FG000|Overall Study|Physician Decision|11|||
143439818|NCT00246090|517154976|FG000|Overall Study|Not Otherwise Specified|10|||
143439819|NCT00715117|517154983|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
143439820|NCT00715117|517154984|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
143439821|NCT01191008|517154988|FG000|Overall Study|Protocol Violation|7|||
143439822|NCT01191008|517154988|FG000|Overall Study|Lost to Follow-up|8|||
143439823|NCT00978562|517154989|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
143439824|NCT00838929|517154994|FG000|Overall Study|Protocol Violation|0|||
143439825|NCT00838929|517154995|FG001|Overall Study|Protocol Violation|1|||
143439826|NCT00838929|517154996|FG002|Overall Study|Protocol Violation|0|||
143439827|NCT00838929|517154994|FG000|Overall Study|Disease progression|0|||
143439828|NCT00838929|517154995|FG001|Overall Study|Disease progression|2|||
143439829|NCT00838929|517154996|FG002|Overall Study|Disease progression|1|||
143439830|NCT03371823|517154997|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
143439831|NCT03371823|517154998|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
143439832|NCT01310699|517154999|FG000|Overall Study|Patients did not complete tandem.|4|||
143439833|NCT01310699|517155000|FG001|Overall Study|Patients did not complete tandem.|6|||
143439834|NCT00926575|517155001|FG000|Overall Study|Adverse Event|1|||
143439835|NCT00926575|517155002|FG001|Overall Study|Adverse Event|1|||
143439836|NCT00926575|517155001|FG000|Overall Study|Death|4|||
143439837|NCT00926575|517155002|FG001|Overall Study|Death|4|||
143439838|NCT00926575|517155001|FG000|Overall Study|Lost to Follow-up|1|||
143439839|NCT00926575|517155002|FG001|Overall Study|Lost to Follow-up|1|||
143439840|NCT00926575|517155001|FG000|Overall Study|Physician Decision|1|||
143439841|NCT00926575|517155002|FG001|Overall Study|Physician Decision|2|||
143439842|NCT00926575|517155001|FG000|Overall Study|Protocol Violation|1|||
143439843|NCT00926575|517155002|FG001|Overall Study|Protocol Violation|0|||
143439844|NCT00926575|517155001|FG000|Overall Study|Withdrawal by Subject|8|||
143439845|NCT00926575|517155002|FG001|Overall Study|Withdrawal by Subject|9|||
143439846|NCT00738283|517155006|FG000|Overall Study|Death|1|||
143439847|NCT00738283|517155006|FG000|Overall Study|Transfer to another facility|2|||
143439848|NCT00738283|517155006|FG000|Overall Study|Discharge home prior to end of study|1|||
143439849|NCT02559310|517155009|FG000|Overall Study|Death|4|||
143439850|NCT02559310|517155010|FG001|Overall Study|Death|3|||
143439851|NCT02559310|517155009|FG000|Overall Study|Lost to Follow-up|5|||
143439852|NCT02559310|517155010|FG001|Overall Study|Lost to Follow-up|3|||
143439853|NCT02559310|517155009|FG000|Overall Study|Physician Decision|2|||
143439854|NCT02559310|517155010|FG001|Overall Study|Physician Decision|1|||
143439855|NCT02559310|517155009|FG000|Overall Study|Withdrawal by Subject|13|||
143439856|NCT02559310|517155010|FG001|Overall Study|Withdrawal by Subject|9|||
143439857|NCT02559310|517155009|FG000|Overall Study|Sponsor Decision|0|||
143439858|NCT02559310|517155010|FG001|Overall Study|Sponsor Decision|1|||
143439859|NCT02559310|517155009|FG000|Overall Study|Randomized but not treated|3|||
143439860|NCT02559310|517155010|FG001|Overall Study|Randomized but not treated|2|||
143439861|NCT03595878|517155012|FG000|Overall Study|Death|2|||
143439862|NCT03595878|517155013|FG001|Overall Study|Death|1|||
143439863|NCT03595878|517155014|FG002|Overall Study|Death|0|||
143439864|NCT03595878|517155012|FG000|Overall Study|Disease progression|2|||
143439865|NCT03595878|517155013|FG001|Overall Study|Disease progression|1|||
143439866|NCT03595878|517155014|FG002|Overall Study|Disease progression|2|||
143439867|NCT03494985|517155015|FG000|Overall Study|Adverse Event|3|||
143439868|NCT03494985|517155016|FG001|Overall Study|Adverse Event|2|||
143439869|NCT03494985|517155017|FG002|Overall Study|Adverse Event|3|||
143439870|NCT03494985|517155018|FG003|Overall Study|Adverse Event|0|||
143439871|NCT03494985|517155015|FG000|Overall Study|Other (Withdrawal of consent)|2|||
143439872|NCT03494985|517155016|FG001|Overall Study|Other (Withdrawal of consent)|3|||
143439873|NCT03494985|517155017|FG002|Overall Study|Other (Withdrawal of consent)|2|||
143439874|NCT03494985|517155018|FG003|Overall Study|Other (Withdrawal of consent)|5|||
143439875|NCT03494985|517155015|FG000|Overall Study|Other (Not specified)|0|||
143439876|NCT03494985|517155016|FG001|Overall Study|Other (Not specified)|1|||
143439877|NCT03494985|517155017|FG002|Overall Study|Other (Not specified)|1|||
143439878|NCT03494985|517155018|FG003|Overall Study|Other (Not specified)|0|||
143439879|NCT04124471|517155019|FG000|Overall Study|screen failure|1|||
143439880|NCT03036124|517155020|FG000|Overall Study|Lost to Follow-up|0|||
143439881|NCT03036124|517155021|FG001|Overall Study|Lost to Follow-up|2|||
143439882|NCT03036124|517155020|FG000|Overall Study|Withdrawal by Subject|5|||
143439883|NCT03036124|517155021|FG001|Overall Study|Withdrawal by Subject|4|||
143439884|NCT02282059|517155022|FG000|Overall Study|Other|15|||
143439885|NCT02282059|517155023|FG001|Overall Study|Other|3|||
143439886|NCT02282059|517155022|FG000|Overall Study|Participant refused further follow-up|8|||
143439887|NCT02282059|517155023|FG001|Overall Study|Participant refused further follow-up|4|||
143439888|NCT02282059|517155022|FG000|Overall Study|Lost to Follow-up|19|||
143439889|NCT02282059|517155023|FG001|Overall Study|Lost to Follow-up|3|||
143439890|NCT02282059|517155022|FG000|Overall Study|Death|40|||
143439891|NCT02282059|517155023|FG001|Overall Study|Death|8|||
143439892|NCT02394925|517155024|FG000|Overall Study|Adverse Event|1|||
143439893|NCT02394925|517155024|FG000|Overall Study|Lens Discomfort|3|||
143439894|NCT02394925|517155024|FG000|Overall Study|Lens handling difficulities|5|||
143439895|NCT02394925|517155024|FG000|Overall Study|Lost to Follow-up|9|||
143439896|NCT02394925|517155024|FG000|Overall Study|Protocol Violation|5|||
143439897|NCT02394925|517155024|FG000|Overall Study|No longer meet eligibility criteria|1|||
143439898|NCT02394925|517155024|FG000|Overall Study|Unsatisfactory Visual Response|5|||
143439899|NCT05347485|517155030|FG000|Overall Study|Death|14|||
143439900|NCT05347485|517155030|FG000|Overall Study|Lost to Follow-up|2|||
143439901|NCT05347485|517155030|FG000|Overall Study|Withdrawal by Subject|13|||
143439902|NCT05347485|517155030|FG000|Overall Study|Progressive Disease|1|||
143439903|NCT05347485|517155030|FG000|Overall Study|Study Terminated by Sponsor|49|||
143439904|NCT05347485|517155030|FG000|Overall Study|Other|1|||
143439905|NCT05347485|517155030|FG000|Overall Study|Enrolled (consented) but not treated|4|||
143439906|NCT05347485|517155030|FG000|Overall Study|Disease Relapse|2|||
143439907|NCT04886518|517155031|FG000|Overall Study|Noncompliance with study drug|1|||
143439908|NCT04886518|517155032|FG001|Overall Study|Noncompliance with study drug|0|||
143439909|NCT04886518|517155033|FG002|Overall Study|Noncompliance with study drug|0|||
143439910|NCT04886518|517155031|FG000|Overall Study|Adverse Event|0|||
143439911|NCT04886518|517155032|FG001|Overall Study|Adverse Event|1|||
143439912|NCT04886518|517155033|FG002|Overall Study|Adverse Event|0|||
143439913|NCT04886518|517155031|FG000|Overall Study|Withdrawal by Subject|1|||
143439914|NCT04886518|517155032|FG001|Overall Study|Withdrawal by Subject|0|||
143439915|NCT04886518|517155033|FG002|Overall Study|Withdrawal by Subject|0|||
143439916|NCT01730950|517156685|FG000|Overall Study|Protocol Violation|6|||
143439917|NCT01730950|517156686|FG001|Overall Study|Protocol Violation|6|||
143439918|NCT00667459|517156687|FG000|Overall Study|Death|0|||
143439919|NCT00667459|517156688|FG001|Overall Study|Death|2|||
143439920|NCT00667459|517156687|FG000|Overall Study|Lost to Follow-up|8|||
143439921|NCT00667459|517156688|FG001|Overall Study|Lost to Follow-up|43|||
143439922|NCT02568397|517156689|FG000|Period 2|Withdrawal by Subject|0|||
143439923|NCT02568397|517156690|FG001|Period 2|Withdrawal by Subject|1|||
143439924|NCT02568397|517156689|FG000|Period 2|Physician Decision|0|||
143439925|NCT02568397|517156690|FG001|Period 2|Physician Decision|1|||
143439926|NCT02684123|517156691|FG000|Phase 1|Lack of Efficacy|5|||
143439927|NCT02684123|517156692|FG001|Phase 1|Lack of Efficacy|0|||
143439928|NCT02684123|517156691|FG000|Phase 1|Adverse Event|3|||
143439929|NCT02684123|517156692|FG001|Phase 1|Adverse Event|0|||
143439930|NCT02684123|517156691|FG000|Phase 1|Lost to Follow-up|0|||
143439931|NCT02684123|517156692|FG001|Phase 1|Lost to Follow-up|1|||
143439932|NCT02684123|517156691|FG000|Phase 2|Lack of Efficacy|1|||
143439933|NCT02684123|517156692|FG001|Phase 2|Lack of Efficacy|8|||
143439934|NCT01245140|517156700|FG000|Overall Study|Adverse Event|1|||
143439935|NCT01245140|517156701|FG001|Overall Study|Adverse Event|3|||
143439936|NCT01245140|517156700|FG000|Overall Study|Lack of Efficacy|2|||
143439937|NCT01245140|517156701|FG001|Overall Study|Lack of Efficacy|4|||
143439938|NCT01245140|517156700|FG000|Overall Study|Protocol Violation|0|||
143439939|NCT01245140|517156701|FG001|Overall Study|Protocol Violation|1|||
143439940|NCT01245140|517156700|FG000|Overall Study|Withdrawal by Subject|0|||
143439941|NCT01245140|517156701|FG001|Overall Study|Withdrawal by Subject|1|||
143439942|NCT01245140|517156700|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
143439943|NCT01245140|517156701|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
143439944|NCT02635360|517156702|FG000|Overall Study|Adverse Event|0|||
143439945|NCT02635360|517156703|FG001|Overall Study|Adverse Event|3|||
143439946|NCT02635360|517156702|FG000|Overall Study|Withdrawal by Subject|2|||
143439947|NCT02635360|517156703|FG001|Overall Study|Withdrawal by Subject|0|||
143439948|NCT02635360|517156702|FG000|Overall Study|Non-Compliance|3|||
143439949|NCT02635360|517156703|FG001|Overall Study|Non-Compliance|1|||
143439950|NCT02635360|517156702|FG000|Overall Study|Disease Progression|0|||
143439951|NCT02635360|517156703|FG001|Overall Study|Disease Progression|2|||
143439952|NCT02635360|517156702|FG000|Overall Study|Lost to Follow-up|1|||
143439953|NCT02635360|517156703|FG001|Overall Study|Lost to Follow-up|1|||
143439954|NCT00334542|517156704|FG000|Overall Study|Adverse Event|3|||
143439955|NCT00334542|517156704|FG000|Overall Study|Withdrawal by Subject|1|||
143439956|NCT00334542|517156704|FG000|Overall Study|New cancer diagnosis|1|||
143439957|NCT01454739|517156707|FG000|Overall Study|Protocol Violation|2|||
143439958|NCT01454739|517156708|FG001|Overall Study|Protocol Violation|3|||
143439959|NCT01454739|517156707|FG000|Overall Study|Withdrawal by Subject|2|||
143439960|NCT01454739|517156708|FG001|Overall Study|Withdrawal by Subject|6|||
143439961|NCT01454739|517156707|FG000|Overall Study|Other|3|||
143439962|NCT01454739|517156708|FG001|Overall Study|Other|5|||
143439963|NCT01454739|517156707|FG000|Overall Study|Physician Decision|0|||
143439964|NCT01454739|517156708|FG001|Overall Study|Physician Decision|5|||
143439965|NCT01454739|517156707|FG000|Overall Study|Lost to Follow-up|0|||
143439966|NCT01454739|517156708|FG001|Overall Study|Lost to Follow-up|1|||
143439967|NCT01454739|517156707|FG000|Overall Study|Adverse Event|0|||
143439968|NCT01454739|517156708|FG001|Overall Study|Adverse Event|1|||
143439969|NCT02375347|517156723|FG000|Overall Study|Protocol Violation|1|||
143439970|NCT00193479|517156724|FG000|Induction Chemotherapy|Adverse Event|2|||
143439971|NCT00193479|517156724|FG000|Induction Chemotherapy|Disease Progression|1|||
143439972|NCT00193479|517156724|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
143439973|NCT00193479|517156724|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
143439974|NCT01547598|517156725|FG000|Overall Study|Withdrew consent|1|||
143439975|NCT01547598|517156726|FG001|Overall Study|Withdrew consent|1|||
143439976|NCT01547598|517156725|FG000|Overall Study|Lost to Follow-up|1|||
143439977|NCT01547598|517156726|FG001|Overall Study|Lost to Follow-up|1|||
143439978|NCT01547598|517156725|FG000|Overall Study|Adverse Event|1|||
143439979|NCT01547598|517156726|FG001|Overall Study|Adverse Event|1|||
143439980|NCT01547598|517156725|FG000|Overall Study|Protocol Violation|1|||
143439981|NCT01547598|517156726|FG001|Overall Study|Protocol Violation|1|||
143439982|NCT01547598|517156725|FG000|Overall Study|Other Miscellaneous Reasons|2|||
143439983|NCT01547598|517156726|FG001|Overall Study|Other Miscellaneous Reasons|1|||
143439984|NCT02229227|517156731|FG000|Overall Study|Adverse Event|14|||
143439985|NCT02229227|517156732|FG001|Overall Study|Adverse Event|9|||
143439986|NCT02229227|517156731|FG000|Overall Study|Lack of Efficacy|3|||
143439987|NCT02229227|517156732|FG001|Overall Study|Lack of Efficacy|3|||
143439988|NCT02229227|517156731|FG000|Overall Study|Protocol Violation|6|||
143439989|NCT02229227|517156732|FG001|Overall Study|Protocol Violation|8|||
143439990|NCT02229227|517156731|FG000|Overall Study|Protocol defined stopping criteria|1|||
143439991|NCT02229227|517156732|FG001|Overall Study|Protocol defined stopping criteria|3|||
143439992|NCT02229227|517156731|FG000|Overall Study|Lost to Follow-up|3|||
143439993|NCT02229227|517156732|FG001|Overall Study|Lost to Follow-up|3|||
143439994|NCT02229227|517156731|FG000|Overall Study|Study terminated by sponsor|11|||
143439995|NCT02229227|517156732|FG001|Overall Study|Study terminated by sponsor|11|||
143439996|NCT02229227|517156731|FG000|Overall Study|Withdrawal by Subject|8|||
143439997|NCT02229227|517156732|FG001|Overall Study|Withdrawal by Subject|12|||
143439998|NCT02229227|517156731|FG000|Overall Study|Other|0|||
143439999|NCT02229227|517156732|FG001|Overall Study|Other|1|||
143440000|NCT02229227|517156731|FG000|Overall Study|Physician Decision|5|||
143440001|NCT02229227|517156732|FG001|Overall Study|Physician Decision|12|||
143440002|NCT00340704|517156733|FG000|PK Study|Adverse Event|0|||
143440003|NCT00340704|517156734|FG001|PK Study|Adverse Event|1|||
143440004|NCT00340704|517156735|FG002|PK Study|Adverse Event|0|||
143440005|NCT00340704|517156736|FG003|PK Study|Adverse Event|0|||
143440006|NCT00340704|517156737|FG004|PK Study|Adverse Event|0|||
143440007|NCT00340704|517156738|FG005|PK Study|Adverse Event|0|||
143440008|NCT00340704|517156739|FG006|PK Study|Adverse Event|0|||
143440009|NCT00340704|517156740|FG007|PK Study|Adverse Event|0|||
143440010|NCT00340704|517156741|FG008|PK Study|Adverse Event|0|||
143440011|NCT00340704|517156733|FG000|PK Study|Not treated|0|||
143440012|NCT00340704|517156734|FG001|PK Study|Not treated|0|||
143440013|NCT00340704|517156735|FG002|PK Study|Not treated|1|||
143440014|NCT00340704|517156736|FG003|PK Study|Not treated|0|||
143440015|NCT00340704|517156737|FG004|PK Study|Not treated|0|||
143440016|NCT00340704|517156738|FG005|PK Study|Not treated|0|||
143440017|NCT00340704|517156739|FG006|PK Study|Not treated|0|||
143440018|NCT00340704|517156740|FG007|PK Study|Not treated|0|||
143440019|NCT00340704|517156741|FG008|PK Study|Not treated|0|||
143440020|NCT00340704|517156733|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
143440021|NCT00340704|517156734|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
143440022|NCT00340704|517156735|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
143440023|NCT00340704|517156736|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
143440024|NCT00340704|517156737|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
143440025|NCT00340704|517156738|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
143440026|NCT00340704|517156739|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
143440027|NCT00340704|517156740|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
143440028|NCT00340704|517156741|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
143440029|NCT00340704|517156733|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
143440030|NCT00340704|517156734|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
143440031|NCT00340704|517156735|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
143440032|NCT00340704|517156736|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
143440033|NCT00340704|517156737|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
143440034|NCT00340704|517156738|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
143440035|NCT00340704|517156739|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
143440036|NCT00340704|517156740|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
143440037|NCT00340704|517156741|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
143440038|NCT00340704|517156733|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
143440039|NCT00340704|517156734|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
143440040|NCT00340704|517156735|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
143440041|NCT00340704|517156736|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
143440042|NCT00340704|517156737|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
143440043|NCT00340704|517156738|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
143440044|NCT00340704|517156739|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
143440045|NCT00340704|517156740|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
143440046|NCT00340704|517156741|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
143440047|NCT00340704|517156733|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
143440048|NCT00340704|517156734|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
143440049|NCT00340704|517156735|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
143440050|NCT00340704|517156736|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
143440051|NCT00340704|517156737|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
143440052|NCT00340704|517156738|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
143440053|NCT00340704|517156739|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
143440054|NCT00340704|517156740|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
143440055|NCT00340704|517156741|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
143440056|NCT00121667|517156742|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
143440057|NCT00121667|517156743|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
143440058|NCT00121667|517156744|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
143440059|NCT00121667|517156745|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
143440060|NCT00121667|517156742|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
143440061|NCT00121667|517156743|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
143440062|NCT00121667|517156744|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
143440063|NCT00121667|517156745|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
143440064|NCT00121667|517156742|FG000|Short Term (ST) Period|Adverse Event|5|||
143440065|NCT00121667|517156743|FG001|Short Term (ST) Period|Adverse Event|6|||
143440066|NCT00121667|517156744|FG002|Short Term (ST) Period|Adverse Event|5|||
143440067|NCT00121667|517156745|FG003|Short Term (ST) Period|Adverse Event|3|||
143440068|NCT00121667|517156742|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
143440069|NCT00121667|517156743|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
143440070|NCT00121667|517156744|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
143440071|NCT00121667|517156745|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
143440072|NCT00121667|517156742|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
143440073|NCT00121667|517156743|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
143440074|NCT00121667|517156744|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
143440075|NCT00121667|517156745|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
143440076|NCT00121667|517156742|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
143440077|NCT00121667|517156743|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
143440078|NCT00121667|517156744|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
143440079|NCT00121667|517156745|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
143440080|NCT00121667|517156742|FG000|Short Term (ST) Period|Other Reason|3|||
143440081|NCT00121667|517156743|FG001|Short Term (ST) Period|Other Reason|0|||
143440082|NCT00121667|517156744|FG002|Short Term (ST) Period|Other Reason|0|||
143440083|NCT00121667|517156745|FG003|Short Term (ST) Period|Other Reason|0|||
143440084|NCT00121667|517156742|FG000|Short Term (ST) Period|Death|0|||
143440085|NCT00121667|517156743|FG001|Short Term (ST) Period|Death|0|||
143440086|NCT00121667|517156744|FG002|Short Term (ST) Period|Death|0|||
143440087|NCT00121667|517156745|FG003|Short Term (ST) Period|Death|1|||
143440088|NCT00121667|517156742|FG000|Short Term (ST) Period|Pregnancy|0|||
143440089|NCT00121667|517156743|FG001|Short Term (ST) Period|Pregnancy|0|||
143440090|NCT00121667|517156744|FG002|Short Term (ST) Period|Pregnancy|0|||
143440091|NCT00121667|517156745|FG003|Short Term (ST) Period|Pregnancy|1|||
143440092|NCT00121667|517156742|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
143440093|NCT00121667|517156743|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
143440094|NCT00121667|517156744|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
143440095|NCT00121667|517156745|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
143440096|NCT00121667|517156742|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
143440097|NCT00121667|517156743|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
143440098|NCT00121667|517156744|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
143440099|NCT00121667|517156745|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
143440100|NCT00121667|517156742|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
143440101|NCT00121667|517156743|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
143440102|NCT00121667|517156744|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
143440103|NCT00121667|517156745|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
143440104|NCT00121667|517156742|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
143440105|NCT00121667|517156743|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
143440106|NCT00121667|517156744|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
143440107|NCT00121667|517156745|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
143440108|NCT00121667|517156742|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
143440109|NCT00121667|517156743|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
143440110|NCT00121667|517156744|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
143440111|NCT00121667|517156745|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
143440112|NCT00121667|517156742|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
143440113|NCT00121667|517156743|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
143440114|NCT00121667|517156744|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
143440115|NCT00121667|517156745|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
143440116|NCT00121667|517156742|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
143440117|NCT00121667|517156743|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
143440118|NCT00121667|517156744|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
143440119|NCT00121667|517156745|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
143440120|NCT00121667|517156742|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
143440121|NCT00121667|517156743|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
143440122|NCT00121667|517156744|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
143440123|NCT00121667|517156745|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
143440124|NCT00121667|517156742|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
143440125|NCT00121667|517156743|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
143440126|NCT00121667|517156744|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
143440127|NCT00121667|517156745|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
143440128|NCT02879383|517156746|FG000|First 24 Weeks|Physician Decision|0|||
143440129|NCT02879383|517156747|FG001|First 24 Weeks|Physician Decision|1|||
143440130|NCT02879383|517156748|FG002|First 24 Weeks|Physician Decision|0|||
143440131|NCT02879383|517156749|FG003|First 24 Weeks|Physician Decision|0|||
143440132|NCT05186311|517156750|FG000|Part A: Serum|Withdrawal by Subject|1|||
143440133|NCT02125279|517156751|FG000|Overall Study|Lack of Efficacy|2|||
143440134|NCT02125279|517156751|FG000|Overall Study|Withdrawal by Subject|6|||
143440135|NCT02125279|517156751|FG000|Overall Study|Protocol Violation|1|||
143440136|NCT02125279|517156751|FG000|Overall Study|Lost to Follow-up|4|||
143440137|NCT01407276|517156757|FG000|Overall Study|Withdrawal by Subject|0|||
143440138|NCT01407276|517156758|FG001|Overall Study|Withdrawal by Subject|0|||
143440139|NCT01407276|517156759|FG002|Overall Study|Withdrawal by Subject|0|||
143440140|NCT01407276|517156760|FG003|Overall Study|Withdrawal by Subject|0|||
143440141|NCT01407276|517156761|FG004|Overall Study|Withdrawal by Subject|0|||
143440142|NCT01407276|517156762|FG005|Overall Study|Withdrawal by Subject|0|||
143440143|NCT01407276|517156763|FG006|Overall Study|Withdrawal by Subject|0|||
143440144|NCT01407276|517156764|FG007|Overall Study|Withdrawal by Subject|1|||
143440145|NCT01080300|517156765|FG000|Overall Study|Adverse Event|49|||
143440146|NCT01080300|517156766|FG001|Overall Study|Adverse Event|35|||
143440147|NCT01080300|517156765|FG000|Overall Study|Lack of Efficacy|12|||
143440148|NCT01080300|517156766|FG001|Overall Study|Lack of Efficacy|15|||
143440149|NCT01080300|517156765|FG000|Overall Study|Protocol Violation|7|||
143440150|NCT01080300|517156766|FG001|Overall Study|Protocol Violation|13|||
143440151|NCT01080300|517156765|FG000|Overall Study|Lost to Follow-up|10|||
143440152|NCT01080300|517156766|FG001|Overall Study|Lost to Follow-up|6|||
143440153|NCT01080300|517156765|FG000|Overall Study|Death|0|||
143440154|NCT01080300|517156766|FG001|Overall Study|Death|1|||
143440155|NCT01080300|517156765|FG000|Overall Study|Withdrawal by Subject|12|||
143440156|NCT01080300|517156766|FG001|Overall Study|Withdrawal by Subject|28|||
143440157|NCT01080300|517156765|FG000|Overall Study|Reasons not specified|4|||
143440158|NCT01080300|517156766|FG001|Overall Study|Reasons not specified|6|||
143440159|NCT00478205|517156768|FG000|Overall Study|Adverse Event|182|||
143440160|NCT00478205|517156769|FG001|Overall Study|Adverse Event|39|||
143440161|NCT00478205|517156768|FG000|Overall Study|Medication Non-compliance|9|||
143440162|NCT00478205|517156769|FG001|Overall Study|Medication Non-compliance|4|||
143440163|NCT00478205|517156768|FG000|Overall Study|Protocol Violation|15|||
143440164|NCT00478205|517156769|FG001|Overall Study|Protocol Violation|5|||
143440165|NCT00478205|517156768|FG000|Overall Study|Request of Investigator or Sponsor|4|||
143440166|NCT00478205|517156769|FG001|Overall Study|Request of Investigator or Sponsor|5|||
143440167|NCT00478205|517156768|FG000|Overall Study|Withdrawal by Subject|61|||
143440168|NCT00478205|517156769|FG001|Overall Study|Withdrawal by Subject|22|||
143440169|NCT00478205|517156768|FG000|Overall Study|Lack of Efficacy|1|||
143440170|NCT00478205|517156769|FG001|Overall Study|Lack of Efficacy|0|||
143440171|NCT00478205|517156768|FG000|Overall Study|Other|24|||
143440172|NCT00478205|517156769|FG001|Overall Study|Other|12|||
143440173|NCT00825305|517156771|FG000|Overall Study|Adverse Event|1|||
143440174|NCT00825305|517156772|FG001|Overall Study|Adverse Event|1|||
143440175|NCT00825305|517156771|FG000|Overall Study|Withdrawal by Subject|6|||
143440176|NCT00825305|517156772|FG001|Overall Study|Withdrawal by Subject|12|||
143440177|NCT00825305|517156771|FG000|Overall Study|Inappropriate inclusion|1|||
143440178|NCT00825305|517156772|FG001|Overall Study|Inappropriate inclusion|0|||
143440179|NCT00825305|517156771|FG000|Overall Study|Protocol Violation|9|||
143440180|NCT00825305|517156772|FG001|Overall Study|Protocol Violation|9|||
143440181|NCT00825305|517156771|FG000|Overall Study|Can not be classified|0|||
143440182|NCT00825305|517156772|FG001|Overall Study|Can not be classified|1|||
143440183|NCT04016272|517156773|FG000|Overall Study|Withdrawal by Subject|1|||
143440184|NCT04016272|517156774|FG001|Overall Study|Withdrawal by Subject|2|||
143440185|NCT02353468|517156777|FG000|Overall Study|Study terminated|3|||
143440186|NCT02689453|517156780|FG000|Overall Study|Progressive disease|0|||
143440187|NCT02689453|517156781|FG001|Overall Study|Progressive disease|1|||
143440188|NCT02689453|517156782|FG002|Overall Study|Progressive disease|1|||
143440189|NCT01018732|517156787|FG000|Overall Study|Lost to Follow-up|0|||
143440190|NCT01018732|517156788|FG001|Overall Study|Lost to Follow-up|0|||
143440191|NCT01018732|517156789|FG002|Overall Study|Lost to Follow-up|3|||
143440192|NCT01018732|517156787|FG000|Overall Study|Protocol Violation|1|||
143440193|NCT01018732|517156788|FG001|Overall Study|Protocol Violation|1|||
143440194|NCT01018732|517156789|FG002|Overall Study|Protocol Violation|0|||
143440195|NCT01018732|517156787|FG000|Overall Study|Inappropriate Enrollment|0|||
143440196|NCT01018732|517156788|FG001|Overall Study|Inappropriate Enrollment|1|||
143440197|NCT01018732|517156789|FG002|Overall Study|Inappropriate Enrollment|0|||
143440198|NCT01018732|517156787|FG000|Overall Study|Unable to Classify|0|||
143440199|NCT01018732|517156788|FG001|Overall Study|Unable to Classify|0|||
143440200|NCT01018732|517156789|FG002|Overall Study|Unable to Classify|1|||
143440201|NCT00585078|517156790|FG000|Overall Study|Withdrawal by Subject|4|||
143440202|NCT00585078|517156790|FG000|Overall Study|Poor performance status|1|||
143440203|NCT00585078|517156790|FG000|Overall Study|Disease Progression|24|||
143440204|NCT00585078|517156790|FG000|Overall Study|Adverse Event|10|||
143440205|NCT00585078|517156790|FG000|Overall Study|Death|1|||
143440206|NCT01536171|517156791|FG000|Overall Study|Withdrawal by Subject|1|||
143440207|NCT02781311|517156794|FG000|Overall Study|Adverse Event|2|||
143440208|NCT02781311|517156795|FG001|Overall Study|Adverse Event|6|||
143440209|NCT02781311|517156796|FG002|Overall Study|Adverse Event|1|||
143440210|NCT02781311|517156794|FG000|Overall Study|Withdrawal of Consent|11|||
143440211|NCT02781311|517156795|FG001|Overall Study|Withdrawal of Consent|12|||
143440212|NCT02781311|517156796|FG002|Overall Study|Withdrawal of Consent|2|||
143440213|NCT02781311|517156794|FG000|Overall Study|Lost to Follow-up|11|||
143440214|NCT02781311|517156795|FG001|Overall Study|Lost to Follow-up|8|||
143440215|NCT02781311|517156796|FG002|Overall Study|Lost to Follow-up|1|||
143440216|NCT02781311|517156794|FG000|Overall Study|Non-Compliance with Study Drug|2|||
143440217|NCT02781311|517156795|FG001|Overall Study|Non-Compliance with Study Drug|0|||
143440218|NCT02781311|517156796|FG002|Overall Study|Non-Compliance with Study Drug|0|||
143440219|NCT02165826|517156798|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
143440220|NCT02165826|517156799|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
143440221|NCT02165826|517156800|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
143440222|NCT02165826|517156798|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
143440223|NCT02165826|517156799|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
143440224|NCT02165826|517156800|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
143440225|NCT02165826|517156798|FG000|Main Treatment Period|Lost to Follow-up|4|||
143440226|NCT02165826|517156799|FG001|Main Treatment Period|Lost to Follow-up|2|||
143440227|NCT02165826|517156800|FG002|Main Treatment Period|Lost to Follow-up|1|||
143440228|NCT02165826|517156798|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
143440229|NCT02165826|517156799|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
143440230|NCT02165826|517156800|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
143440231|NCT02165826|517156798|FG000|Main Treatment Period|Lack of Efficacy|2|||
143440232|NCT02165826|517156799|FG001|Main Treatment Period|Lack of Efficacy|0|||
143440233|NCT02165826|517156800|FG002|Main Treatment Period|Lack of Efficacy|0|||
143440234|NCT02165826|517156798|FG000|Main Treatment Period|Reason Not Specified|8|||
143440235|NCT02165826|517156799|FG001|Main Treatment Period|Reason Not Specified|5|||
143440236|NCT02165826|517156800|FG002|Main Treatment Period|Reason Not Specified|16|||
143440237|NCT02165826|517156798|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
143440238|NCT02165826|517156799|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
143440239|NCT02165826|517156800|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
143440240|NCT02165826|517156798|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
143440241|NCT02165826|517156799|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
143440242|NCT02165826|517156800|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
143440243|NCT02165826|517156798|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
143440244|NCT02165826|517156799|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
143440245|NCT02165826|517156800|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
143440246|NCT02165826|517156798|FG000|Down-Titration Period|Reason Not Specified|1|||
143440247|NCT02165826|517156799|FG001|Down-Titration Period|Reason Not Specified|0|||
143440248|NCT02165826|517156800|FG002|Down-Titration Period|Reason Not Specified|2|||
143440249|NCT00250432|517156805|FG000|Overall Study|Adverse Event|25|||
143440250|NCT00250432|517156806|FG001|Overall Study|Adverse Event|29|||
143440251|NCT00250432|517156805|FG000|Overall Study|Lack of Efficacy|2|||
143440252|NCT00250432|517156806|FG001|Overall Study|Lack of Efficacy|1|||
143440253|NCT00250432|517156805|FG000|Overall Study|Lost to Follow-up|6|||
143440254|NCT00250432|517156806|FG001|Overall Study|Lost to Follow-up|5|||
143440255|NCT00250432|517156805|FG000|Overall Study|Patient Moved|0|||
143440256|NCT00250432|517156806|FG001|Overall Study|Patient Moved|1|||
143440257|NCT00250432|517156805|FG000|Overall Study|Protocol Violation|0|||
143440258|NCT00250432|517156806|FG001|Overall Study|Protocol Violation|3|||
143440259|NCT00250432|517156805|FG000|Overall Study|Withdrawal by Subject|6|||
143440260|NCT00250432|517156806|FG001|Overall Study|Withdrawal by Subject|2|||
143440261|NCT00250432|517156805|FG000|Overall Study|Pt died out of posttherapy report period|6|||
143440262|NCT00250432|517156806|FG001|Overall Study|Pt died out of posttherapy report period|5|||
143440263|NCT00250432|517156805|FG000|Overall Study|Pt was considered untreatable|0|||
143440264|NCT00250432|517156806|FG001|Overall Study|Pt was considered untreatable|1|||
143440265|NCT01056263|517156807|FG000|Overall Study|Adverse Event|12|||
143440266|NCT01056263|517156807|FG000|Overall Study|Death|1|||
143440267|NCT01056263|517156807|FG000|Overall Study|Withdrawal by Subject|1|||
143440268|NCT01056263|517156807|FG000|Overall Study|Lack of Efficacy|29|||
143440269|NCT01056263|517156807|FG000|Overall Study|Progressive disease|2|||
143440270|NCT01056263|517156807|FG000|Overall Study|Neoplasm progression|1|||
143440271|NCT01056263|517156807|FG000|Overall Study|Objective progression or relapse|1|||
143440272|NCT01056263|517156807|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
143440273|NCT00658606|517156810|FG000|Overall Study|Adverse Event|2|||
143440274|NCT00658606|517156811|FG001|Overall Study|Adverse Event|1|||
143440275|NCT00658606|517156810|FG000|Overall Study|Lack of Efficacy|6|||
143440276|NCT00658606|517156811|FG001|Overall Study|Lack of Efficacy|3|||
143440277|NCT00658606|517156810|FG000|Overall Study|Lost to Follow-up|1|||
143440278|NCT00658606|517156811|FG001|Overall Study|Lost to Follow-up|0|||
143440279|NCT00658606|517156810|FG000|Overall Study|Withdrawal by Subject|7|||
143440280|NCT00658606|517156811|FG001|Overall Study|Withdrawal by Subject|16|||
143440281|NCT00658606|517156810|FG000|Overall Study|Lack of Compliance|0|||
143440282|NCT00658606|517156811|FG001|Overall Study|Lack of Compliance|3|||
143440283|NCT04905849|517156812|FG000|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|6|||
143440284|NCT04905849|517156813|FG001|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|0|||
143440285|NCT01068210|517156820|FG000|Overall Study|Lost to Follow-up|1|||
143440286|NCT01068210|517156821|FG001|Overall Study|Lost to Follow-up|2|||
143440287|NCT01068210|517156822|FG002|Overall Study|Lost to Follow-up|2|||
143440288|NCT01068210|517156823|FG003|Overall Study|Lost to Follow-up|1|||
143440289|NCT01068210|517156820|FG000|Overall Study|Second cancer|0|||
143440290|NCT01068210|517156821|FG001|Overall Study|Second cancer|1|||
143440291|NCT01068210|517156822|FG002|Overall Study|Second cancer|0|||
143440292|NCT01068210|517156823|FG003|Overall Study|Second cancer|0|||
143440293|NCT01068210|517156820|FG000|Overall Study|Disease progression|0|||
143440294|NCT01068210|517156821|FG001|Overall Study|Disease progression|0|||
143440295|NCT01068210|517156822|FG002|Overall Study|Disease progression|0|||
143440296|NCT01068210|517156823|FG003|Overall Study|Disease progression|2|||
143440297|NCT00699842|517156824|FG000|Overall Study|Death|0|||
143440298|NCT00699842|517156825|FG001|Overall Study|Death|1|||
143440299|NCT00699842|517156826|FG002|Overall Study|Death|0|||
143440300|NCT01806389|517156831|FG000|Overall Study|Withdrawal by Subject|4|||
143440301|NCT00490698|517156835|FG000|Overall Study|Withdrawal by Subject|1|||
143440302|NCT00490698|517156835|FG000|Overall Study|Disease Progression|7|||
143440303|NCT00490698|517156835|FG000|Overall Study|Physician Decision|2|||
143440304|NCT02201901|517156838|FG000|Overall Study|Randomized but never treated|0|||
143440305|NCT02201901|517156839|FG001|Overall Study|Randomized but never treated|1|||
143440306|NCT02201901|517156840|FG002|Overall Study|Randomized but never treated|0|||
143440307|NCT02201901|517156838|FG000|Overall Study|Lack of Efficacy|7|||
143440308|NCT02201901|517156839|FG001|Overall Study|Lack of Efficacy|1|||
143440309|NCT02201901|517156840|FG002|Overall Study|Lack of Efficacy|6|||
143440310|NCT02201901|517156838|FG000|Overall Study|Death|3|||
143440311|NCT02201901|517156839|FG001|Overall Study|Death|3|||
143440312|NCT02201901|517156840|FG002|Overall Study|Death|3|||
143440313|NCT02201901|517156838|FG000|Overall Study|Lost to Follow-up|2|||
143440314|NCT02201901|517156839|FG001|Overall Study|Lost to Follow-up|3|||
143440315|NCT02201901|517156840|FG002|Overall Study|Lost to Follow-up|2|||
143440316|NCT02201901|517156838|FG000|Overall Study|Withdrew Consent|2|||
143440317|NCT02201901|517156839|FG001|Overall Study|Withdrew Consent|0|||
143440318|NCT02201901|517156840|FG002|Overall Study|Withdrew Consent|2|||
143440319|NCT02201901|517156838|FG000|Overall Study|Adverse Event|1|||
143440320|NCT02201901|517156839|FG001|Overall Study|Adverse Event|1|||
143440321|NCT02201901|517156840|FG002|Overall Study|Adverse Event|0|||
143440322|NCT02633397|517156841|FG000|Overall Study|Adverse Event|8|||
143440323|NCT02633397|517156842|FG001|Overall Study|Adverse Event|8|||
143440324|NCT02633397|517156841|FG000|Overall Study|Study Burden|4|||
143440325|NCT02633397|517156842|FG001|Overall Study|Study Burden|1|||
143440326|NCT02633397|517156841|FG000|Overall Study|Treatment interruption|2|||
143440327|NCT02633397|517156842|FG001|Overall Study|Treatment interruption|5|||
143440328|NCT02633397|517156841|FG000|Overall Study|Death|2|||
143440329|NCT02633397|517156842|FG001|Overall Study|Death|2|||
143440330|NCT02633397|517156841|FG000|Overall Study|Physician Decision|0|||
143440331|NCT02633397|517156842|FG001|Overall Study|Physician Decision|1|||
143440332|NCT00469859|517156843|FG000|Overall Study|Inevaluable|0|||
143440333|NCT00469859|517156844|FG001|Overall Study|Inevaluable|2|||
143440334|NCT01240551|517158456|FG000|Overall Study|Refused further treatment|3|||
143440335|NCT01240551|517158457|FG001|Overall Study|Refused further treatment|2|||
143440336|NCT01240551|517158456|FG000|Overall Study|Lost to Follow-up|1|||
143440337|NCT01240551|517158457|FG001|Overall Study|Lost to Follow-up|1|||
143440338|NCT02737826|517158460|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
143440339|NCT02737826|517158461|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
143440340|NCT02737826|517158462|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
143440341|NCT00078377|517158463|FG000|Overall Study|Adverse Event|2|||
143440342|NCT00078377|517158464|FG001|Overall Study|Adverse Event|5|||
143440343|NCT00078377|517158465|FG002|Overall Study|Adverse Event|1|||
143440344|NCT00078377|517158463|FG000|Overall Study|Lack of Efficacy|2|||
143440345|NCT00078377|517158464|FG001|Overall Study|Lack of Efficacy|0|||
143440346|NCT00078377|517158465|FG002|Overall Study|Lack of Efficacy|2|||
143440347|NCT00078377|517158463|FG000|Overall Study|Lost to Follow-up|0|||
143440348|NCT00078377|517158464|FG001|Overall Study|Lost to Follow-up|1|||
143440349|NCT00078377|517158465|FG002|Overall Study|Lost to Follow-up|1|||
143440350|NCT00078377|517158463|FG000|Overall Study|Physician Decision|2|||
143440351|NCT00078377|517158464|FG001|Overall Study|Physician Decision|0|||
143440352|NCT00078377|517158465|FG002|Overall Study|Physician Decision|0|||
143440353|NCT00078377|517158463|FG000|Overall Study|Withdrawal by Subject|3|||
143440354|NCT00078377|517158464|FG001|Overall Study|Withdrawal by Subject|4|||
143440355|NCT00078377|517158465|FG002|Overall Study|Withdrawal by Subject|4|||
143440356|NCT00078377|517158463|FG000|Overall Study|Miscellaneous|2|||
143440357|NCT00078377|517158464|FG001|Overall Study|Miscellaneous|6|||
143440358|NCT00078377|517158465|FG002|Overall Study|Miscellaneous|1|||
143440359|NCT04546217|517158466|FG000|Overall Study|Withdrawal by Subject|2|||
143440360|NCT04546217|517158467|FG001|Overall Study|Withdrawal by Subject|0|||
143440361|NCT04546217|517158466|FG000|Overall Study|Uncontrolled hypertension|1|||
143440362|NCT04546217|517158467|FG001|Overall Study|Uncontrolled hypertension|0|||
143440363|NCT00863512|517158468|FG000|Overall Study|Adverse Event|2|||
143440364|NCT00863512|517158469|FG001|Overall Study|Adverse Event|0|||
143440365|NCT00863512|517158468|FG000|Overall Study|Withdrawal by Subject|11|||
143440366|NCT00863512|517158469|FG001|Overall Study|Withdrawal by Subject|0|||
143440367|NCT00863512|517158468|FG000|Overall Study|Physician Decision|1|||
143440368|NCT00863512|517158469|FG001|Overall Study|Physician Decision|0|||
143440369|NCT04292470|517158472|FG000|Overall Study|Withdrawal by Subject|0|||
143440370|NCT04292470|517158473|FG001|Overall Study|Withdrawal by Subject|1|||
143440371|NCT02906020|517158474|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
143440372|NCT02906020|517158475|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
143440373|NCT02906020|517158476|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
143440374|NCT02906020|517158477|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
143440375|NCT02906020|517158478|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
143440376|NCT02906020|517158479|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
143440377|NCT02906020|517158480|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
143440378|NCT02906020|517158481|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
143440379|NCT02906020|517158482|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
143440380|NCT02906020|517158483|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
143440381|NCT02906020|517158484|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
143440382|NCT02906020|517158485|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
143440383|NCT02906020|517158486|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
143440384|NCT02906020|517158487|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
143440385|NCT02906020|517158488|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
143440386|NCT02906020|517158489|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
143440387|NCT02906020|517158474|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
143440388|NCT02906020|517158475|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
143440389|NCT02906020|517158476|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
143440390|NCT02906020|517158477|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
143440391|NCT02906020|517158478|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
143440392|NCT02906020|517158479|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
143440393|NCT02906020|517158480|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
143440394|NCT02906020|517158481|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
143440395|NCT02906020|517158482|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
143440396|NCT02906020|517158483|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
143440397|NCT02906020|517158484|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
143440398|NCT02906020|517158485|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
143440399|NCT02906020|517158486|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
143440400|NCT02906020|517158487|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
143440401|NCT02906020|517158488|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
143440402|NCT02906020|517158489|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
143440403|NCT02906020|517158474|FG000|Part 2: Double-blind Treatment Period|Other|0|||
143440404|NCT02906020|517158475|FG001|Part 2: Double-blind Treatment Period|Other|0|||
143440405|NCT02906020|517158476|FG002|Part 2: Double-blind Treatment Period|Other|0|||
143440406|NCT02906020|517158477|FG003|Part 2: Double-blind Treatment Period|Other|0|||
143440407|NCT02906020|517158478|FG004|Part 2: Double-blind Treatment Period|Other|0|||
143440408|NCT02906020|517158479|FG005|Part 2: Double-blind Treatment Period|Other|0|||
143440409|NCT02906020|517158480|FG006|Part 2: Double-blind Treatment Period|Other|0|||
143440410|NCT02906020|517158481|FG007|Part 2: Double-blind Treatment Period|Other|0|||
143440411|NCT02906020|517158482|FG008|Part 2: Double-blind Treatment Period|Other|6|||
143440412|NCT02906020|517158483|FG009|Part 2: Double-blind Treatment Period|Other|10|||
143440413|NCT02906020|517158484|FG010|Part 2: Double-blind Treatment Period|Other|0|||
143440414|NCT02906020|517158485|FG011|Part 2: Double-blind Treatment Period|Other|0|||
143440415|NCT02906020|517158486|FG012|Part 2: Double-blind Treatment Period|Other|0|||
143440416|NCT02906020|517158487|FG013|Part 2: Double-blind Treatment Period|Other|0|||
143440417|NCT02906020|517158488|FG014|Part 2: Double-blind Treatment Period|Other|0|||
143440418|NCT02906020|517158489|FG015|Part 2: Double-blind Treatment Period|Other|0|||
143440419|NCT02906020|517158474|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
143440420|NCT02906020|517158475|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
143440421|NCT02906020|517158476|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
143440422|NCT02906020|517158477|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
143440423|NCT02906020|517158478|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
143440424|NCT02906020|517158479|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
143440425|NCT02906020|517158480|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
143440426|NCT02906020|517158481|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
143440427|NCT02906020|517158482|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
143440428|NCT02906020|517158483|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
143440429|NCT02906020|517158484|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
143440430|NCT02906020|517158485|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
143440431|NCT02906020|517158486|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
143440432|NCT02906020|517158487|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
143440433|NCT02906020|517158488|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
143440434|NCT02906020|517158489|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
143440435|NCT02906020|517158474|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
143440436|NCT02906020|517158475|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
143440437|NCT02906020|517158476|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
143440438|NCT02906020|517158477|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
143440439|NCT02906020|517158478|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
143440440|NCT02906020|517158479|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
143440441|NCT02906020|517158480|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
143440442|NCT02906020|517158481|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
143440443|NCT02906020|517158482|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
143440444|NCT02906020|517158483|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
143440445|NCT02906020|517158484|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
143440446|NCT02906020|517158485|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
143440447|NCT02906020|517158486|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
143440448|NCT02906020|517158487|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
143440449|NCT02906020|517158488|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
143440450|NCT02906020|517158489|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
143440451|NCT02906020|517158474|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
143440452|NCT02906020|517158475|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
143440453|NCT02906020|517158476|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
143440454|NCT02906020|517158477|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
143440455|NCT02906020|517158478|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
143440456|NCT02906020|517158479|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
143440457|NCT02906020|517158480|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
143440458|NCT02906020|517158481|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
143440459|NCT02906020|517158482|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
143440460|NCT02906020|517158483|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
143440461|NCT02906020|517158484|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
143440462|NCT02906020|517158485|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
143440463|NCT02906020|517158486|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
143440464|NCT02906020|517158487|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
143440465|NCT02906020|517158488|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
143440466|NCT02906020|517158489|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
143440467|NCT02906020|517158474|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
143440468|NCT02906020|517158475|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
143440469|NCT02906020|517158476|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
143440470|NCT02906020|517158477|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
143440471|NCT02906020|517158478|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
143440472|NCT02906020|517158479|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
143440473|NCT02906020|517158480|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
143440474|NCT02906020|517158481|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
143440475|NCT02906020|517158482|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
143440476|NCT02906020|517158483|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
143440477|NCT02906020|517158484|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
143440478|NCT02906020|517158485|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
143440479|NCT02906020|517158486|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
143440480|NCT02906020|517158487|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
143440481|NCT02906020|517158488|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
143440482|NCT02906020|517158489|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
143440483|NCT02906020|517158474|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
143440484|NCT02906020|517158475|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
143440485|NCT02906020|517158476|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
143440486|NCT02906020|517158477|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
143440487|NCT02906020|517158478|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
143440488|NCT02906020|517158479|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
143440489|NCT02906020|517158480|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
143440490|NCT02906020|517158481|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
143440491|NCT02906020|517158482|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
143440492|NCT02906020|517158483|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
143440493|NCT02906020|517158484|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
143440494|NCT02906020|517158485|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
143440495|NCT02906020|517158486|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
143440496|NCT02906020|517158487|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
143440497|NCT02906020|517158488|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
143440498|NCT02906020|517158489|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
143440499|NCT02906020|517158474|FG000|Part 2: Long-term Follow-up Period|Other|0|||
143440500|NCT02906020|517158475|FG001|Part 2: Long-term Follow-up Period|Other|0|||
143440501|NCT02906020|517158476|FG002|Part 2: Long-term Follow-up Period|Other|0|||
143440502|NCT02906020|517158477|FG003|Part 2: Long-term Follow-up Period|Other|0|||
143440503|NCT02906020|517158478|FG004|Part 2: Long-term Follow-up Period|Other|0|||
143440504|NCT02906020|517158479|FG005|Part 2: Long-term Follow-up Period|Other|0|||
143440505|NCT02906020|517158480|FG006|Part 2: Long-term Follow-up Period|Other|0|||
143440506|NCT02906020|517158481|FG007|Part 2: Long-term Follow-up Period|Other|0|||
143440507|NCT02906020|517158482|FG008|Part 2: Long-term Follow-up Period|Other|0|||
143440508|NCT02906020|517158483|FG009|Part 2: Long-term Follow-up Period|Other|0|||
143440509|NCT02906020|517158484|FG010|Part 2: Long-term Follow-up Period|Other|0|||
143440510|NCT02906020|517158485|FG011|Part 2: Long-term Follow-up Period|Other|0|||
143440511|NCT02906020|517158486|FG012|Part 2: Long-term Follow-up Period|Other|13|||
143440512|NCT02906020|517158487|FG013|Part 2: Long-term Follow-up Period|Other|8|||
143440513|NCT02906020|517158488|FG014|Part 2: Long-term Follow-up Period|Other|3|||
143440514|NCT02906020|517158489|FG015|Part 2: Long-term Follow-up Period|Other|2|||
143440515|NCT04698915|517158490|FG000|Overall Study|Adverse Event|2|||
143440516|NCT04698915|517158491|FG001|Overall Study|Adverse Event|0|||
143440517|NCT04698915|517158490|FG000|Overall Study|Death|23|||
143440518|NCT04698915|517158491|FG001|Overall Study|Death|20|||
143440519|NCT04698915|517158490|FG000|Overall Study|Physician Decision|1|||
143440520|NCT04698915|517158491|FG001|Overall Study|Physician Decision|1|||
143440521|NCT04698915|517158490|FG000|Overall Study|Lost to Follow-up|1|||
143440522|NCT04698915|517158491|FG001|Overall Study|Lost to Follow-up|0|||
143440523|NCT04698915|517158490|FG000|Overall Study|Study Terminated by Sponsor|55|||
143440524|NCT04698915|517158491|FG001|Overall Study|Study Terminated by Sponsor|60|||
143440525|NCT04698915|517158490|FG000|Overall Study|Withdrawal by Subject|2|||
143440526|NCT04698915|517158491|FG001|Overall Study|Withdrawal by Subject|3|||
143440527|NCT00979953|517158492|FG000|Overall Study|Adverse Event|5|||
143440528|NCT00979953|517158493|FG001|Overall Study|Adverse Event|2|||
143440529|NCT00979953|517158494|FG002|Overall Study|Adverse Event|17|||
143440530|NCT00979953|517158495|FG003|Overall Study|Adverse Event|4|||
143440531|NCT00979953|517158492|FG000|Overall Study|Lack of Efficacy|1|||
143440532|NCT00979953|517158493|FG001|Overall Study|Lack of Efficacy|2|||
143440533|NCT00979953|517158494|FG002|Overall Study|Lack of Efficacy|0|||
143440534|NCT00979953|517158495|FG003|Overall Study|Lack of Efficacy|0|||
143440535|NCT00979953|517158492|FG000|Overall Study|Lost to Follow-up|1|||
143440536|NCT00979953|517158493|FG001|Overall Study|Lost to Follow-up|1|||
143440537|NCT00979953|517158494|FG002|Overall Study|Lost to Follow-up|1|||
143440538|NCT00979953|517158495|FG003|Overall Study|Lost to Follow-up|0|||
143440539|NCT00979953|517158492|FG000|Overall Study|Withdrawal by Subject|0|||
143440540|NCT00979953|517158493|FG001|Overall Study|Withdrawal by Subject|0|||
143440541|NCT00979953|517158494|FG002|Overall Study|Withdrawal by Subject|2|||
143440542|NCT00979953|517158495|FG003|Overall Study|Withdrawal by Subject|1|||
143440543|NCT00979953|517158492|FG000|Overall Study|Protocol Violation|1|||
143440544|NCT00979953|517158493|FG001|Overall Study|Protocol Violation|0|||
143440545|NCT00979953|517158494|FG002|Overall Study|Protocol Violation|2|||
143440546|NCT00979953|517158495|FG003|Overall Study|Protocol Violation|2|||
143440547|NCT01124097|517158496|FG000|Overall Study|Withdrawal by Subject|4|||
143440548|NCT01124097|517158497|FG001|Overall Study|Withdrawal by Subject|3|||
143440549|NCT01124097|517158498|FG002|Overall Study|Withdrawal by Subject|2|||
143440550|NCT01124097|517158499|FG003|Overall Study|Withdrawal by Subject|3|||
143440551|NCT01124097|517158496|FG000|Overall Study|Lack of Efficacy|2|||
143440552|NCT01124097|517158497|FG001|Overall Study|Lack of Efficacy|3|||
143440553|NCT01124097|517158498|FG002|Overall Study|Lack of Efficacy|1|||
143440554|NCT01124097|517158499|FG003|Overall Study|Lack of Efficacy|3|||
143440555|NCT01124097|517158496|FG000|Overall Study|Adverse Event|24|||
143440556|NCT01124097|517158497|FG001|Overall Study|Adverse Event|15|||
143440557|NCT01124097|517158498|FG002|Overall Study|Adverse Event|15|||
143440558|NCT01124097|517158499|FG003|Overall Study|Adverse Event|7|||
143440559|NCT01124097|517158496|FG000|Overall Study|Protocol Violation|2|||
143440560|NCT01124097|517158497|FG001|Overall Study|Protocol Violation|0|||
143440561|NCT01124097|517158498|FG002|Overall Study|Protocol Violation|2|||
143440562|NCT01124097|517158499|FG003|Overall Study|Protocol Violation|1|||
143440563|NCT01124097|517158496|FG000|Overall Study|Physician Decision|2|||
143440564|NCT01124097|517158497|FG001|Overall Study|Physician Decision|1|||
143440565|NCT01124097|517158498|FG002|Overall Study|Physician Decision|0|||
143440566|NCT01124097|517158499|FG003|Overall Study|Physician Decision|0|||
143440567|NCT00079339|517158504|FG000|Overall Study|Adverse Event|1|||
143440568|NCT00079339|517158505|FG001|Overall Study|Adverse Event|7|||
143440569|NCT00079339|517158506|FG002|Overall Study|Adverse Event|2|||
143440570|NCT00079339|517158504|FG000|Overall Study|Death|1|||
143440571|NCT00079339|517158505|FG001|Overall Study|Death|0|||
143440572|NCT00079339|517158506|FG002|Overall Study|Death|0|||
143440573|NCT00079339|517158504|FG000|Overall Study|Non-compliance|0|||
143440574|NCT00079339|517158505|FG001|Overall Study|Non-compliance|0|||
143440575|NCT00079339|517158506|FG002|Overall Study|Non-compliance|1|||
143440576|NCT00079339|517158504|FG000|Overall Study|Withdrawal by Subject|0|||
143440577|NCT00079339|517158505|FG001|Overall Study|Withdrawal by Subject|4|||
143440578|NCT00079339|517158506|FG002|Overall Study|Withdrawal by Subject|1|||
143440579|NCT00079339|517158504|FG000|Overall Study|Disease progression|3|||
143440580|NCT00079339|517158505|FG001|Overall Study|Disease progression|28|||
143440581|NCT00079339|517158506|FG002|Overall Study|Disease progression|2|||
143440582|NCT01592045|517158511|FG000|Overall Study|Disease Progression|1|||
143440583|NCT01592045|517158512|FG001|Overall Study|Disease Progression|1|||
143440584|NCT01592045|517158511|FG000|Overall Study|Adverse Event|1|||
143440585|NCT01592045|517158512|FG001|Overall Study|Adverse Event|1|||
143440586|NCT01592045|517158511|FG000|Overall Study|Withdrawal by Subject|1|||
143440587|NCT01592045|517158512|FG001|Overall Study|Withdrawal by Subject|0|||
143440588|NCT01592045|517158511|FG000|Overall Study|Moved out of country|2|||
143440589|NCT01592045|517158512|FG001|Overall Study|Moved out of country|0|||
143440590|NCT02599688|517158527|FG000|Overall Study|Lack of Efficacy|1|||
143440591|NCT02599688|517158527|FG000|Overall Study|Withdrawal by Subject|1|||
143440592|NCT02599688|517158527|FG000|Overall Study|Termination by Sponsor|2|||
143440593|NCT00742326|517158529|FG000|Overall Study|Physician Decision|0|||
143440594|NCT00742326|517158530|FG001|Overall Study|Physician Decision|1|||
143440595|NCT03635086|517158542|FG000|Overall Study|Withdrawal of consent|0|||
143440596|NCT03635086|517158543|FG001|Overall Study|Withdrawal of consent|0|||
143440597|NCT03635086|517158544|FG002|Overall Study|Withdrawal of consent|1|||
143440598|NCT03635086|517158545|FG003|Overall Study|Withdrawal of consent|0|||
143440599|NCT03635086|517158546|FG004|Overall Study|Withdrawal of consent|0|||
143440600|NCT03635086|517158542|FG000|Overall Study|Adverse Event|0|||
143440601|NCT03635086|517158543|FG001|Overall Study|Adverse Event|1|||
143440602|NCT03635086|517158544|FG002|Overall Study|Adverse Event|0|||
143440603|NCT03635086|517158545|FG003|Overall Study|Adverse Event|0|||
143440604|NCT03635086|517158546|FG004|Overall Study|Adverse Event|0|||
143440605|NCT03635086|517158542|FG000|Overall Study|Lost to Follow-up|1|||
143440606|NCT03635086|517158543|FG001|Overall Study|Lost to Follow-up|0|||
143440607|NCT03635086|517158544|FG002|Overall Study|Lost to Follow-up|0|||
143440608|NCT03635086|517158545|FG003|Overall Study|Lost to Follow-up|0|||
143440609|NCT03635086|517158546|FG004|Overall Study|Lost to Follow-up|0|||
143440610|NCT00723125|517158547|FG000|Overall Study|Met Dx|1|||
143440611|NCT00723125|517158548|FG001|Overall Study|Met Dx|0|||
143440612|NCT00723125|517158547|FG000|Overall Study|Withdrawal by Subject|15|||
143440613|NCT00723125|517158548|FG001|Overall Study|Withdrawal by Subject|6|||
143440614|NCT00723125|517158547|FG000|Overall Study|Adverse Event|2|||
143440615|NCT00723125|517158548|FG001|Overall Study|Adverse Event|0|||
143440616|NCT02196077|517158549|FG000|Overall Study|Adverse Event|4|||
143440617|NCT02196077|517158549|FG000|Overall Study|Lack of Efficacy|1|||
143440618|NCT02196077|517158549|FG000|Overall Study|Withdrawal by Subject|14|||
143440619|NCT02196077|517158549|FG000|Overall Study|Physician Decision|1|||
143440620|NCT02196077|517158549|FG000|Overall Study|Lost to Follow-up|3|||
143440621|NCT02196077|517158549|FG000|Overall Study|Protocol Violation|24|||
143440622|NCT04042077|517158552|FG000|Overall Study|Adverse Event|0|||
143440623|NCT04042077|517158553|FG001|Overall Study|Adverse Event|1|||
143440624|NCT04042077|517158552|FG000|Overall Study|Death|2|||
143440625|NCT04042077|517158553|FG001|Overall Study|Death|1|||
143440626|NCT04042077|517158552|FG000|Overall Study|Physician Decision|2|||
143440627|NCT04042077|517158553|FG001|Overall Study|Physician Decision|0|||
143440628|NCT04042077|517158552|FG000|Overall Study|Withdrawal by Subject|3|||
143440629|NCT04042077|517158553|FG001|Overall Study|Withdrawal by Subject|2|||
143440630|NCT04042077|517158552|FG000|Overall Study|Lack of Efficacy|0|||
143440631|NCT04042077|517158553|FG001|Overall Study|Lack of Efficacy|1|||
143440632|NCT01667549|517158554|FG000|Overall Study|Withdrawal by Subject|3|||
143440633|NCT01667549|517158555|FG001|Overall Study|Withdrawal by Subject|5|||
143440634|NCT01667549|517158556|FG002|Overall Study|Withdrawal by Subject|7|||
143440635|NCT01667549|517158557|FG003|Overall Study|Withdrawal by Subject|6|||
143440636|NCT01667549|517158558|FG004|Overall Study|Withdrawal by Subject|1|||
143440637|NCT03482752|517158561|FG000|Overall Study|Withdrawal by Subject|2|||
143440638|NCT03482752|517158561|FG000|Overall Study|Lost to Follow-up|1|||
143440639|NCT03482752|517158561|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
143440640|NCT02844777|517158563|FG000|Overall Study|Withdrawal by Subject|2|||
143440641|NCT02844777|517158564|FG001|Overall Study|Withdrawal by Subject|0|||
143440642|NCT02844777|517158565|FG002|Overall Study|Withdrawal by Subject|0|||
143440643|NCT01776008|517158566|FG000|Overall Study|ineligible|2|||
143440644|NCT00150618|517158568|FG000|Overall Study|Adverse Event|2|||
143440645|NCT00150618|517158569|FG001|Overall Study|Adverse Event|2|||
143440646|NCT00150618|517158570|FG002|Overall Study|Adverse Event|6|||
143440647|NCT00150618|517158571|FG003|Overall Study|Adverse Event|9|||
143440648|NCT00150618|517158572|FG004|Overall Study|Adverse Event|5|||
143440649|NCT00150618|517158568|FG000|Overall Study|Withdrawal by Subject|6|||
143440650|NCT00150618|517158569|FG001|Overall Study|Withdrawal by Subject|8|||
143440651|NCT00150618|517158570|FG002|Overall Study|Withdrawal by Subject|8|||
143440652|NCT00150618|517158571|FG003|Overall Study|Withdrawal by Subject|4|||
143440653|NCT00150618|517158572|FG004|Overall Study|Withdrawal by Subject|5|||
143440654|NCT00150618|517158568|FG000|Overall Study|Lost to Follow-up|4|||
143440655|NCT00150618|517158569|FG001|Overall Study|Lost to Follow-up|1|||
143440656|NCT00150618|517158570|FG002|Overall Study|Lost to Follow-up|5|||
143440657|NCT00150618|517158571|FG003|Overall Study|Lost to Follow-up|8|||
143440658|NCT00150618|517158572|FG004|Overall Study|Lost to Follow-up|4|||
143440659|NCT00150618|517158568|FG000|Overall Study|Protocol Violation|1|||
143440660|NCT00150618|517158569|FG001|Overall Study|Protocol Violation|0|||
143440661|NCT00150618|517158570|FG002|Overall Study|Protocol Violation|0|||
143440662|NCT00150618|517158571|FG003|Overall Study|Protocol Violation|0|||
143440663|NCT00150618|517158572|FG004|Overall Study|Protocol Violation|1|||
143440664|NCT00150618|517158568|FG000|Overall Study|Lack of Efficacy|1|||
143440665|NCT00150618|517158569|FG001|Overall Study|Lack of Efficacy|4|||
143440666|NCT00150618|517158570|FG002|Overall Study|Lack of Efficacy|7|||
143440667|NCT00150618|517158571|FG003|Overall Study|Lack of Efficacy|4|||
143440668|NCT00150618|517158572|FG004|Overall Study|Lack of Efficacy|6|||
143440669|NCT00150618|517158568|FG000|Overall Study|No study meds|0|||
143440670|NCT00150618|517158569|FG001|Overall Study|No study meds|0|||
143440671|NCT00150618|517158570|FG002|Overall Study|No study meds|0|||
143440672|NCT00150618|517158571|FG003|Overall Study|No study meds|0|||
143440673|NCT00150618|517158572|FG004|Overall Study|No study meds|2|||
143440674|NCT00150618|517158568|FG000|Overall Study|Physician Decision|0|||
143440675|NCT00150618|517158569|FG001|Overall Study|Physician Decision|2|||
143440676|NCT00150618|517158570|FG002|Overall Study|Physician Decision|0|||
143440677|NCT00150618|517158571|FG003|Overall Study|Physician Decision|0|||
143440678|NCT00150618|517158572|FG004|Overall Study|Physician Decision|1|||
143440679|NCT00150618|517158568|FG000|Overall Study|Lack of compliance|2|||
143440680|NCT00150618|517158569|FG001|Overall Study|Lack of compliance|1|||
143440681|NCT00150618|517158570|FG002|Overall Study|Lack of compliance|1|||
143440682|NCT00150618|517158571|FG003|Overall Study|Lack of compliance|0|||
143440683|NCT00150618|517158572|FG004|Overall Study|Lack of compliance|1|||
143440684|NCT00150618|517158568|FG000|Overall Study|Abnormal ECG|1|||
143440685|NCT00150618|517158569|FG001|Overall Study|Abnormal ECG|0|||
143440686|NCT00150618|517158570|FG002|Overall Study|Abnormal ECG|0|||
143440687|NCT00150618|517158571|FG003|Overall Study|Abnormal ECG|0|||
143440688|NCT00150618|517158572|FG004|Overall Study|Abnormal ECG|0|||
143440689|NCT00150618|517158568|FG000|Overall Study|Sponsor's decision|0|||
143440690|NCT00150618|517158569|FG001|Overall Study|Sponsor's decision|0|||
143440691|NCT00150618|517158570|FG002|Overall Study|Sponsor's decision|0|||
143440692|NCT00150618|517158571|FG003|Overall Study|Sponsor's decision|1|||
143440693|NCT00150618|517158572|FG004|Overall Study|Sponsor's decision|0|||
143440694|NCT04092452|517158573|FG000|Overall Study|Adverse Event|1|||
143440695|NCT04092452|517158574|FG001|Overall Study|Adverse Event|3|||
143440696|NCT04092452|517158575|FG002|Overall Study|Adverse Event|3|||
143440697|NCT04092452|517158576|FG003|Overall Study|Adverse Event|7|||
143440698|NCT04092452|517158573|FG000|Overall Study|Lack of Efficacy|1|||
143440699|NCT04092452|517158574|FG001|Overall Study|Lack of Efficacy|1|||
143440700|NCT04092452|517158575|FG002|Overall Study|Lack of Efficacy|1|||
143440701|NCT04092452|517158576|FG003|Overall Study|Lack of Efficacy|0|||
143440702|NCT04092452|517158573|FG000|Overall Study|Lost to Follow-up|4|||
143440703|NCT04092452|517158574|FG001|Overall Study|Lost to Follow-up|3|||
143440704|NCT04092452|517158575|FG002|Overall Study|Lost to Follow-up|5|||
143440705|NCT04092452|517158576|FG003|Overall Study|Lost to Follow-up|1|||
143440706|NCT04092452|517158573|FG000|Overall Study|Non-Compliance With Study Drug|0|||
143440707|NCT04092452|517158574|FG001|Overall Study|Non-Compliance With Study Drug|0|||
143440708|NCT04092452|517158575|FG002|Overall Study|Non-Compliance With Study Drug|1|||
143440709|NCT04092452|517158576|FG003|Overall Study|Non-Compliance With Study Drug|1|||
143440710|NCT04092452|517158573|FG000|Overall Study|Physician Decision|1|||
143440711|NCT04092452|517158574|FG001|Overall Study|Physician Decision|0|||
143440712|NCT04092452|517158575|FG002|Overall Study|Physician Decision|1|||
143440713|NCT04092452|517158576|FG003|Overall Study|Physician Decision|0|||
143440714|NCT04092452|517158573|FG000|Overall Study|Pregnancy|2|||
143440715|NCT04092452|517158574|FG001|Overall Study|Pregnancy|0|||
143440716|NCT04092452|517158575|FG002|Overall Study|Pregnancy|0|||
143440717|NCT04092452|517158576|FG003|Overall Study|Pregnancy|0|||
143440718|NCT04092452|517158573|FG000|Overall Study|Protocol Deviation|1|||
143440719|NCT04092452|517158574|FG001|Overall Study|Protocol Deviation|0|||
143440720|NCT04092452|517158575|FG002|Overall Study|Protocol Deviation|0|||
143440721|NCT04092452|517158576|FG003|Overall Study|Protocol Deviation|0|||
143440722|NCT04092452|517158573|FG000|Overall Study|Withdrawal by Subject|3|||
143440723|NCT04092452|517158574|FG001|Overall Study|Withdrawal by Subject|10|||
143440724|NCT04092452|517158575|FG002|Overall Study|Withdrawal by Subject|3|||
143440725|NCT04092452|517158576|FG003|Overall Study|Withdrawal by Subject|5|||
143440726|NCT04092452|517158573|FG000|Overall Study|Other|0|||
143440727|NCT04092452|517158574|FG001|Overall Study|Other|0|||
143440728|NCT04092452|517158575|FG002|Overall Study|Other|1|||
143440729|NCT04092452|517158576|FG003|Overall Study|Other|2|||
143440730|NCT01012947|517158584|FG000|Overall Study|Lost to Follow-up|131|||
143440731|NCT01012947|517158585|FG001|Overall Study|Lost to Follow-up|135|||
143440732|NCT01012947|517158586|FG002|Overall Study|Lost to Follow-up|130|||
143440733|NCT01012947|517158587|FG003|Overall Study|Lost to Follow-up|118|||
143440734|NCT01012947|517158588|FG004|Overall Study|Lost to Follow-up|142|||
143440735|NCT02127125|517158589|FG000|Overall Study|Lost to Follow-up|0|||
143440736|NCT02127125|517158590|FG001|Overall Study|Lost to Follow-up|0|||
143440737|NCT02127125|517158591|FG002|Overall Study|Lost to Follow-up|0|||
143440738|NCT02127125|517158592|FG003|Overall Study|Lost to Follow-up|0|||
143440739|NCT02127125|517158593|FG004|Overall Study|Lost to Follow-up|2|||
143440740|NCT02127125|517158594|FG005|Overall Study|Lost to Follow-up|1|||
143440741|NCT02127125|517158595|FG006|Overall Study|Lost to Follow-up|0|||
143440742|NCT02127125|517158596|FG007|Overall Study|Lost to Follow-up|0|||
143440743|NCT02127125|517158597|FG008|Overall Study|Lost to Follow-up|0|||
143440744|NCT02127125|517158589|FG000|Overall Study|Withdrawal by Subject|0|||
143440745|NCT02127125|517158590|FG001|Overall Study|Withdrawal by Subject|0|||
143440746|NCT02127125|517158591|FG002|Overall Study|Withdrawal by Subject|0|||
143440747|NCT02127125|517158592|FG003|Overall Study|Withdrawal by Subject|1|||
143440748|NCT02127125|517158593|FG004|Overall Study|Withdrawal by Subject|0|||
143440749|NCT02127125|517158594|FG005|Overall Study|Withdrawal by Subject|0|||
143440750|NCT02127125|517158595|FG006|Overall Study|Withdrawal by Subject|0|||
143440751|NCT02127125|517158596|FG007|Overall Study|Withdrawal by Subject|0|||
143440752|NCT02127125|517158597|FG008|Overall Study|Withdrawal by Subject|0|||
143440753|NCT02127125|517158589|FG000|Overall Study|Physician Decision|0|||
143440754|NCT02127125|517158590|FG001|Overall Study|Physician Decision|0|||
143440755|NCT02127125|517158591|FG002|Overall Study|Physician Decision|1|||
143440756|NCT02127125|517158592|FG003|Overall Study|Physician Decision|0|||
143440757|NCT02127125|517158593|FG004|Overall Study|Physician Decision|1|||
143440758|NCT02127125|517158594|FG005|Overall Study|Physician Decision|2|||
143440759|NCT02127125|517158595|FG006|Overall Study|Physician Decision|0|||
143440760|NCT02127125|517158596|FG007|Overall Study|Physician Decision|0|||
143440761|NCT02127125|517158597|FG008|Overall Study|Physician Decision|0|||
143440762|NCT01163474|517158598|FG000|Overall Study|Withdrawal by Subject|1|||
143440763|NCT01163474|517158598|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
143440764|NCT01163474|517158598|FG000|Overall Study|Lost to Follow-up|3|||
143440765|NCT02493946|517158602|FG000|DB Period|Withdrawal by Subject|8|||
143440766|NCT02493946|517158603|FG001|DB Period|Withdrawal by Subject|5|||
143440767|NCT02493946|517158604|FG002|DB Period|Withdrawal by Subject|0|||
143440768|NCT02493946|517158602|FG000|Open Label Period|Withdrawal by Subject|0|||
143440769|NCT02493946|517158603|FG001|Open Label Period|Withdrawal by Subject|0|||
143440770|NCT02493946|517158604|FG002|Open Label Period|Withdrawal by Subject|74|||
143440771|NCT02493946|517158602|FG000|Open Label Period|Adverse Event|0|||
143440772|NCT02493946|517158603|FG001|Open Label Period|Adverse Event|0|||
143440773|NCT02493946|517158604|FG002|Open Label Period|Adverse Event|4|||
143440774|NCT02493946|517158602|FG000|Open Label Period|Lost to Follow-up|0|||
143440775|NCT02493946|517158603|FG001|Open Label Period|Lost to Follow-up|0|||
143440776|NCT02493946|517158604|FG002|Open Label Period|Lost to Follow-up|1|||
143440777|NCT02493946|517158602|FG000|Open Label Period|Investigator decision, non-compliance|0|||
143440778|NCT02493946|517158603|FG001|Open Label Period|Investigator decision, non-compliance|0|||
143440779|NCT02493946|517158604|FG002|Open Label Period|Investigator decision, non-compliance|2|||
143440780|NCT02493946|517158602|FG000|Open Label Period|Investigator decision, non-availability|0|||
143440781|NCT02493946|517158603|FG001|Open Label Period|Investigator decision, non-availability|0|||
143440782|NCT02493946|517158604|FG002|Open Label Period|Investigator decision, non-availability|1|||
143440783|NCT02493946|517158602|FG000|Open Label Period|Pregnancy|0|||
143440784|NCT02493946|517158603|FG001|Open Label Period|Pregnancy|0|||
143440785|NCT02493946|517158604|FG002|Open Label Period|Pregnancy|3|||
143440786|NCT02493946|517158602|FG000|Open Label Period|Site error|0|||
143440787|NCT02493946|517158603|FG001|Open Label Period|Site error|0|||
143440788|NCT02493946|517158604|FG002|Open Label Period|Site error|1|||
143440789|NCT00965497|517158608|FG000|Overall Study|Physician Decision|1|||
143440790|NCT02638103|517158610|FG000|Overall Study|Adverse Event|13|||
143440791|NCT02638103|517158611|FG001|Overall Study|Adverse Event|12|||
143440792|NCT02638103|517158612|FG002|Overall Study|Adverse Event|19|||
143440793|NCT02638103|517158613|FG003|Overall Study|Adverse Event|12|||
143440794|NCT02638103|517158610|FG000|Overall Study|Withdrawal by Subject|43|||
143440795|NCT02638103|517158611|FG001|Overall Study|Withdrawal by Subject|53|||
143440796|NCT02638103|517158612|FG002|Overall Study|Withdrawal by Subject|30|||
143440797|NCT02638103|517158613|FG003|Overall Study|Withdrawal by Subject|61|||
143440798|NCT02638103|517158610|FG000|Overall Study|Protocol Violation|1|||
143440799|NCT02638103|517158611|FG001|Overall Study|Protocol Violation|2|||
143440800|NCT02638103|517158612|FG002|Overall Study|Protocol Violation|1|||
143440801|NCT02638103|517158613|FG003|Overall Study|Protocol Violation|4|||
143440802|NCT02638103|517158610|FG000|Overall Study|Pregnancy|2|||
143440803|NCT02638103|517158611|FG001|Overall Study|Pregnancy|3|||
143440804|NCT02638103|517158612|FG002|Overall Study|Pregnancy|0|||
143440805|NCT02638103|517158613|FG003|Overall Study|Pregnancy|1|||
143440806|NCT02638103|517158610|FG000|Overall Study|Non-compliance to Study Procedures|2|||
143440807|NCT02638103|517158611|FG001|Overall Study|Non-compliance to Study Procedures|1|||
143440808|NCT02638103|517158612|FG002|Overall Study|Non-compliance to Study Procedures|1|||
143440809|NCT02638103|517158613|FG003|Overall Study|Non-compliance to Study Procedures|1|||
143440810|NCT02638103|517158610|FG000|Overall Study|Lost to Follow-up|26|||
143440811|NCT02638103|517158611|FG001|Overall Study|Lost to Follow-up|33|||
143440812|NCT02638103|517158612|FG002|Overall Study|Lost to Follow-up|20|||
143440813|NCT02638103|517158613|FG003|Overall Study|Lost to Follow-up|37|||
143440814|NCT02638103|517158610|FG000|Overall Study|Lack of Efficacy|14|||
143440815|NCT02638103|517158611|FG001|Overall Study|Lack of Efficacy|10|||
143440816|NCT02638103|517158612|FG002|Overall Study|Lack of Efficacy|12|||
143440817|NCT02638103|517158613|FG003|Overall Study|Lack of Efficacy|22|||
143440818|NCT02638103|517158610|FG000|Overall Study|Other than specified|5|||
143440819|NCT02638103|517158611|FG001|Overall Study|Other than specified|4|||
143440820|NCT02638103|517158612|FG002|Overall Study|Other than specified|2|||
143440821|NCT02638103|517158613|FG003|Overall Study|Other than specified|4|||
143440822|NCT00794924|517158622|FG000|Overall Study|Lost to Follow-up|6|||
143440823|NCT00794924|517158623|FG001|Overall Study|Lost to Follow-up|8|||
143440824|NCT00794924|517158622|FG000|Overall Study|Withdrawal by Subject|48|||
143440825|NCT00794924|517158623|FG001|Overall Study|Withdrawal by Subject|60|||
143440826|NCT00794924|517158622|FG000|Overall Study|Adverse Event|6|||
143440827|NCT00794924|517158623|FG001|Overall Study|Adverse Event|2|||
143440828|NCT00953615|517158624|FG000|Overall Study|Adverse Event|1|||
143440829|NCT01827046|517158627|FG000|Overall Study|Lost to Follow-up|1|||
143440830|NCT01827046|517158628|FG001|Overall Study|Lost to Follow-up|5|||
143440831|NCT01827046|517158627|FG000|Overall Study|Withdrawal by Subject|0|||
143440832|NCT01827046|517158628|FG001|Overall Study|Withdrawal by Subject|4|||
143440833|NCT01294436|517158630|FG000|Overall Study|Adverse Event|10|||
143440834|NCT01294436|517158631|FG001|Overall Study|Adverse Event|17|||
143440835|NCT01294436|517158630|FG000|Overall Study|Withdrawal by Subject|11|||
143440836|NCT01294436|517158631|FG001|Overall Study|Withdrawal by Subject|28|||
143440837|NCT01294436|517158630|FG000|Overall Study|subject no longer meets study criteria|5|||
143440838|NCT01294436|517158631|FG001|Overall Study|subject no longer meets study criteria|20|||
143440839|NCT01294436|517158630|FG000|Overall Study|poor/non-compliance|2|||
143440840|NCT01294436|517158631|FG001|Overall Study|poor/non-compliance|5|||
143440841|NCT02389764|517158632|FG000|Overall Study|Lack of Efficacy|9|||
143440842|NCT01255761|517158638|FG000|Overall Study|Adverse Event|29|||
143440843|NCT01255761|517158639|FG001|Overall Study|Adverse Event|43|||
143440844|NCT01255761|517158638|FG000|Overall Study|Lack of Efficacy|86|||
143440845|NCT01255761|517158639|FG001|Overall Study|Lack of Efficacy|74|||
143440846|NCT01255761|517158638|FG000|Overall Study|Protocol Violation|9|||
143440847|NCT01255761|517158639|FG001|Overall Study|Protocol Violation|5|||
143440848|NCT01255761|517158638|FG000|Overall Study|Lost to Follow-up|10|||
143440849|NCT01255761|517158639|FG001|Overall Study|Lost to Follow-up|8|||
143440850|NCT01255761|517158638|FG000|Overall Study|Withdrawal by Subject|11|||
143440851|NCT01255761|517158639|FG001|Overall Study|Withdrawal by Subject|27|||
143440852|NCT01255761|517158638|FG000|Overall Study|Other Reasons|37|||
143440853|NCT01255761|517158639|FG001|Overall Study|Other Reasons|18|||
143440854|NCT03170518|517158643|FG000|Overall Study|Lost to Follow-up|4|||
143440855|NCT03170518|517158644|FG001|Overall Study|Lost to Follow-up|1|||
143440856|NCT03170518|517158645|FG002|Overall Study|Lost to Follow-up|0|||
143440857|NCT03170518|517158643|FG000|Overall Study|Physician Decision|1|||
143440858|NCT03170518|517158644|FG001|Overall Study|Physician Decision|0|||
143440859|NCT03170518|517158645|FG002|Overall Study|Physician Decision|0|||
143440860|NCT03170518|517158643|FG000|Overall Study|Withdrawal by Subject|4|||
143440861|NCT03170518|517158644|FG001|Overall Study|Withdrawal by Subject|5|||
143440862|NCT03170518|517158645|FG002|Overall Study|Withdrawal by Subject|2|||
143440863|NCT03170518|517158643|FG000|Overall Study|Site terminated by sponsor|0|||
143440864|NCT03170518|517158644|FG001|Overall Study|Site terminated by sponsor|1|||
143440865|NCT03170518|517158645|FG002|Overall Study|Site terminated by sponsor|0|||
143440866|NCT03170518|517158643|FG000|Overall Study|Non-compliance with study drug|1|||
143440867|NCT03170518|517158644|FG001|Overall Study|Non-compliance with study drug|0|||
143440868|NCT03170518|517158645|FG002|Overall Study|Non-compliance with study drug|1|||
143440869|NCT03170518|517158643|FG000|Overall Study|Withdrawal by parent/guardian|2|||
143440870|NCT03170518|517158644|FG001|Overall Study|Withdrawal by parent/guardian|0|||
143440871|NCT03170518|517158645|FG002|Overall Study|Withdrawal by parent/guardian|0|||
143440872|NCT03842436|517158646|FG000|Overall Study|Lost to Follow-up|1|||
143440873|NCT01263054|517158649|FG000|Overall Study|Death|1|||
143440874|NCT01263054|517158650|FG001|Overall Study|Death|0|||
143440875|NCT01263054|517158649|FG000|Overall Study|Lost to Follow-up|2|||
143440876|NCT01263054|517158650|FG001|Overall Study|Lost to Follow-up|2|||
143440877|NCT01263054|517158649|FG000|Overall Study|Withdrawal by Subject|1|||
143440878|NCT01263054|517158650|FG001|Overall Study|Withdrawal by Subject|3|||
143440879|NCT01263054|517158649|FG000|Overall Study|Qualification Violation|1|||
143440880|NCT01263054|517158650|FG001|Overall Study|Qualification Violation|0|||
143440881|NCT01263054|517158649|FG000|Overall Study|Other|0|||
143440882|NCT01263054|517158650|FG001|Overall Study|Other|1|||
143440883|NCT00936598|517158651|FG000|Overall Study|Withdrawal by Subject|1|||
143440884|NCT00936598|517158652|FG001|Overall Study|Withdrawal by Subject|0|||
143440885|NCT00936598|517158651|FG000|Overall Study|Ineligible after consent|1|||
143440886|NCT00936598|517158652|FG001|Overall Study|Ineligible after consent|0|||
143440887|NCT03358238|517158653|FG000|Overall Study|Withdrawal by Subject|0|||
143440888|NCT03358238|517158654|FG001|Overall Study|Withdrawal by Subject|1|||
143440889|NCT02358668|517160866|FG000|Overall Study|Adverse Event|2|||
143440890|NCT02358668|517160867|FG001|Overall Study|Adverse Event|0|||
143440891|NCT02358668|517160868|FG002|Overall Study|Adverse Event|0|||
143440892|NCT02358668|517160866|FG000|Overall Study|Withdrawal by Subject|0|||
143440893|NCT02358668|517160867|FG001|Overall Study|Withdrawal by Subject|1|||
143440894|NCT02358668|517160868|FG002|Overall Study|Withdrawal by Subject|0|||
143440895|NCT01317875|517160874|FG000|Overall Study|Other|0|||
143440896|NCT01317875|517160875|FG001|Overall Study|Other|0|||
143440897|NCT01317875|517160876|FG002|Overall Study|Other|1|||
143440898|NCT01317875|517160877|FG003|Overall Study|Other|0|||
143440899|NCT01317875|517160878|FG004|Overall Study|Other|0|||
143440900|NCT01317875|517160879|FG005|Overall Study|Other|0|||
143440901|NCT01317875|517160880|FG006|Overall Study|Other|0|||
143440902|NCT01317875|517160881|FG007|Overall Study|Other|0|||
143440903|NCT01317875|517160882|FG008|Overall Study|Other|0|||
143440904|NCT01317875|517160883|FG009|Overall Study|Other|0|||
143440905|NCT01317875|517160874|FG000|Overall Study|Noncompliance with study drug|0|||
143440906|NCT01317875|517160875|FG001|Overall Study|Noncompliance with study drug|0|||
143440907|NCT01317875|517160876|FG002|Overall Study|Noncompliance with study drug|1|||
143440908|NCT01317875|517160877|FG003|Overall Study|Noncompliance with study drug|0|||
143440909|NCT01317875|517160878|FG004|Overall Study|Noncompliance with study drug|0|||
143440910|NCT01317875|517160879|FG005|Overall Study|Noncompliance with study drug|0|||
143440911|NCT01317875|517160880|FG006|Overall Study|Noncompliance with study drug|0|||
143440912|NCT01317875|517160881|FG007|Overall Study|Noncompliance with study drug|0|||
143440913|NCT01317875|517160882|FG008|Overall Study|Noncompliance with study drug|0|||
143440914|NCT01317875|517160883|FG009|Overall Study|Noncompliance with study drug|0|||
143440915|NCT01317875|517160874|FG000|Overall Study|Progressive Disease|1|||
143440916|NCT01317875|517160875|FG001|Overall Study|Progressive Disease|0|||
143440917|NCT01317875|517160876|FG002|Overall Study|Progressive Disease|2|||
143440918|NCT01317875|517160877|FG003|Overall Study|Progressive Disease|0|||
143440919|NCT01317875|517160878|FG004|Overall Study|Progressive Disease|1|||
143440920|NCT01317875|517160879|FG005|Overall Study|Progressive Disease|0|||
143440921|NCT01317875|517160880|FG006|Overall Study|Progressive Disease|0|||
143440922|NCT01317875|517160881|FG007|Overall Study|Progressive Disease|1|||
143440923|NCT01317875|517160882|FG008|Overall Study|Progressive Disease|0|||
143440924|NCT01317875|517160883|FG009|Overall Study|Progressive Disease|0|||
143440925|NCT01317875|517160874|FG000|Overall Study|Withdrawal by Subject|0|||
143440926|NCT01317875|517160875|FG001|Overall Study|Withdrawal by Subject|0|||
143440927|NCT01317875|517160876|FG002|Overall Study|Withdrawal by Subject|0|||
143440928|NCT01317875|517160877|FG003|Overall Study|Withdrawal by Subject|0|||
143440929|NCT01317875|517160878|FG004|Overall Study|Withdrawal by Subject|1|||
143440930|NCT01317875|517160879|FG005|Overall Study|Withdrawal by Subject|0|||
143440931|NCT01317875|517160880|FG006|Overall Study|Withdrawal by Subject|0|||
143440932|NCT01317875|517160881|FG007|Overall Study|Withdrawal by Subject|3|||
143440933|NCT01317875|517160882|FG008|Overall Study|Withdrawal by Subject|0|||
143440934|NCT01317875|517160883|FG009|Overall Study|Withdrawal by Subject|0|||
143440935|NCT01317875|517160874|FG000|Overall Study|Physician Decision|0|||
143440936|NCT01317875|517160875|FG001|Overall Study|Physician Decision|1|||
143440937|NCT01317875|517160876|FG002|Overall Study|Physician Decision|1|||
143440938|NCT01317875|517160877|FG003|Overall Study|Physician Decision|0|||
143440939|NCT01317875|517160878|FG004|Overall Study|Physician Decision|2|||
143440940|NCT01317875|517160879|FG005|Overall Study|Physician Decision|0|||
143440941|NCT01317875|517160880|FG006|Overall Study|Physician Decision|0|||
143440942|NCT01317875|517160881|FG007|Overall Study|Physician Decision|2|||
143440943|NCT01317875|517160882|FG008|Overall Study|Physician Decision|0|||
143440944|NCT01317875|517160883|FG009|Overall Study|Physician Decision|0|||
143440945|NCT01317875|517160874|FG000|Overall Study|Death|0|||
143440946|NCT01317875|517160875|FG001|Overall Study|Death|0|||
143440947|NCT01317875|517160876|FG002|Overall Study|Death|2|||
143440948|NCT01317875|517160877|FG003|Overall Study|Death|1|||
143440949|NCT01317875|517160878|FG004|Overall Study|Death|0|||
143440950|NCT01317875|517160879|FG005|Overall Study|Death|1|||
143440951|NCT01317875|517160880|FG006|Overall Study|Death|0|||
143440952|NCT01317875|517160881|FG007|Overall Study|Death|4|||
143440953|NCT01317875|517160882|FG008|Overall Study|Death|0|||
143440954|NCT01317875|517160883|FG009|Overall Study|Death|0|||
143440955|NCT01317875|517160874|FG000|Overall Study|Adverse Event|2|||
143440956|NCT01317875|517160875|FG001|Overall Study|Adverse Event|1|||
143440957|NCT01317875|517160876|FG002|Overall Study|Adverse Event|2|||
143440958|NCT01317875|517160877|FG003|Overall Study|Adverse Event|1|||
143440959|NCT01317875|517160878|FG004|Overall Study|Adverse Event|5|||
143440960|NCT01317875|517160879|FG005|Overall Study|Adverse Event|1|||
143440961|NCT01317875|517160880|FG006|Overall Study|Adverse Event|2|||
143440962|NCT01317875|517160881|FG007|Overall Study|Adverse Event|5|||
143440963|NCT01317875|517160882|FG008|Overall Study|Adverse Event|0|||
143440964|NCT01317875|517160883|FG009|Overall Study|Adverse Event|0|||
143440965|NCT00233480|517160884|FG000|Overall Study|Underwent status II heart transplant|0|||
143440966|NCT00233480|517160885|FG001|Overall Study|Underwent status II heart transplant|1|||
143440967|NCT00592293|517160890|FG000|Overall Study|Withdrawal by Subject|1|||
143440968|NCT01606319|517160891|FG000|Overall Study|Lost to Follow-up|17|||
143440969|NCT01606319|517160892|FG001|Overall Study|Lost to Follow-up|14|||
143440970|NCT01606319|517160891|FG000|Overall Study|Withdrawal by Subject|9|||
143440971|NCT01606319|517160892|FG001|Overall Study|Withdrawal by Subject|12|||
143440972|NCT01606319|517160891|FG000|Overall Study|Physician Decision|1|||
143440973|NCT01606319|517160892|FG001|Overall Study|Physician Decision|2|||
143440974|NCT01606319|517160891|FG000|Overall Study|Lack of Efficacy|6|||
143440975|NCT01606319|517160892|FG001|Overall Study|Lack of Efficacy|8|||
143440976|NCT01606319|517160891|FG000|Overall Study|Adverse Event|1|||
143440977|NCT01606319|517160892|FG001|Overall Study|Adverse Event|4|||
143440978|NCT00022659|517160897|FG000|Overall Study|Ineligible: wrong primary|1|||
143440979|NCT00022659|517160897|FG000|Overall Study|Never treated|1|||
143440980|NCT01821937|517160906|FG000|Overall Study|Adverse Event|0|||
143440981|NCT01821937|517160907|FG001|Overall Study|Adverse Event|3|||
143440982|NCT04829747|517160910|FG000|Overall Study|Protocol Violation|1|||
143440983|NCT02153905|517160915|FG000|Overall Study|Death|1|||
143440984|NCT02153905|517160916|FG001|Overall Study|Death|0|||
143440985|NCT00425607|517160921|FG000|Overall Study|Death|1|||
143440986|NCT00425607|517160921|FG000|Overall Study|Withdrawal by Subject|1|||
143440987|NCT02563548|517160922|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
143440988|NCT02563548|517160923|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
143440989|NCT02563548|517160924|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
143440990|NCT02563548|517160925|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
143440991|NCT02563548|517160926|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
143440992|NCT02563548|517160927|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
143440993|NCT02563548|517160922|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
143440994|NCT02563548|517160923|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
143440995|NCT02563548|517160924|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
143440996|NCT02563548|517160925|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
143440997|NCT02563548|517160926|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
143440998|NCT02563548|517160927|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
143440999|NCT02563548|517160922|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
143441000|NCT02563548|517160923|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
143441001|NCT02563548|517160924|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
143441002|NCT02563548|517160925|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
143441003|NCT02563548|517160926|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
143441004|NCT02563548|517160927|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
143441005|NCT02563548|517160922|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
143441006|NCT02563548|517160923|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
143441007|NCT02563548|517160924|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
143441008|NCT02563548|517160925|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
143441009|NCT02563548|517160926|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
143441010|NCT02563548|517160927|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
143441011|NCT02563548|517160922|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
143441012|NCT02563548|517160923|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
143441013|NCT02563548|517160924|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
143441014|NCT02563548|517160925|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
143441015|NCT02563548|517160926|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
143441016|NCT02563548|517160927|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
143441017|NCT02563548|517160922|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
143441018|NCT02563548|517160923|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
143441019|NCT02563548|517160924|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
143441020|NCT02563548|517160925|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
143441021|NCT02563548|517160926|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
143441022|NCT02563548|517160927|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
143441023|NCT02563548|517160922|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
143441024|NCT02563548|517160923|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
143441025|NCT02563548|517160924|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
143441026|NCT02563548|517160925|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
143441027|NCT02563548|517160926|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
143441028|NCT02563548|517160927|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
143441029|NCT02563548|517160922|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
143441030|NCT02563548|517160923|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
143441031|NCT02563548|517160924|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
143441032|NCT02563548|517160925|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
143441033|NCT02563548|517160926|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
143441034|NCT02563548|517160927|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
143441035|NCT02563548|517160922|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
143441036|NCT02563548|517160923|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
143441037|NCT02563548|517160924|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
143441038|NCT02563548|517160925|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
143441039|NCT02563548|517160926|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
143441040|NCT02563548|517160927|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
143441041|NCT02563548|517160922|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
143441042|NCT02563548|517160923|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
143441043|NCT02563548|517160924|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
143441044|NCT02563548|517160925|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
143441045|NCT02563548|517160926|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
143441046|NCT02563548|517160927|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
143441047|NCT02563548|517160922|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
143441048|NCT02563548|517160923|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
143441049|NCT02563548|517160924|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
143441050|NCT02563548|517160925|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
143441051|NCT02563548|517160926|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
143441052|NCT02563548|517160927|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
143441053|NCT02563548|517160922|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
143441054|NCT02563548|517160923|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
143441055|NCT02563548|517160924|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
143441056|NCT02563548|517160925|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
143441057|NCT02563548|517160926|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
143441058|NCT02563548|517160927|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
143441059|NCT00203047|517160928|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
143441060|NCT00203047|517160929|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
143441061|NCT00203047|517160928|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
143441062|NCT00203047|517160929|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
143441063|NCT00203047|517160928|FG000|Overall Study|Withdrawal by Subject|13|||
143441064|NCT00203047|517160929|FG001|Overall Study|Withdrawal by Subject|47|||
143441065|NCT00203047|517160928|FG000|Overall Study|Teva requested participant withdrawal|1|||
143441066|NCT00203047|517160929|FG001|Overall Study|Teva requested participant withdrawal|1|||
143441067|NCT00203047|517160928|FG000|Overall Study|Physician Decision|8|||
143441068|NCT00203047|517160929|FG001|Overall Study|Physician Decision|7|||
143441069|NCT00203047|517160928|FG000|Overall Study|Non-compliance|4|||
143441070|NCT00203047|517160929|FG001|Overall Study|Non-compliance|8|||
143441071|NCT00203047|517160928|FG000|Overall Study|Protocol Violation|1|||
143441072|NCT00203047|517160929|FG001|Overall Study|Protocol Violation|0|||
143441073|NCT00203047|517160928|FG000|Overall Study|Lost to Follow-up|11|||
143441074|NCT00203047|517160929|FG001|Overall Study|Lost to Follow-up|5|||
143441075|NCT00203047|517160928|FG000|Overall Study|Adverse Event|8|||
143441076|NCT00203047|517160929|FG001|Overall Study|Adverse Event|18|||
143441077|NCT00203047|517160928|FG000|Overall Study|Death|1|||
143441078|NCT00203047|517160929|FG001|Overall Study|Death|2|||
143441079|NCT00203047|517160928|FG000|Overall Study|Pregnancy|3|||
143441080|NCT00203047|517160929|FG001|Overall Study|Pregnancy|0|||
143441081|NCT00203047|517160928|FG000|Overall Study|Other|5|||
143441082|NCT00203047|517160929|FG001|Overall Study|Other|5|||
143441083|NCT00351377|517160930|FG000|Overall Study|Adverse Event|5|||
143441084|NCT00351377|517160930|FG000|Overall Study|Death|1|||
143441085|NCT00351377|517160930|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
143441086|NCT01607879|517160933|FG000|Overall Study|Death|1|||
143441087|NCT01607879|517160934|FG001|Overall Study|Death|0|||
143441088|NCT03845140|517160935|FG000|Overall Study|Participant travelled outside study area|0|||
143441089|NCT03845140|517160936|FG001|Overall Study|Participant travelled outside study area|1|||
143441090|NCT03845140|517160937|FG002|Overall Study|Participant travelled outside study area|0|||
143441091|NCT03845140|517160938|FG003|Overall Study|Participant travelled outside study area|0|||
143441092|NCT03845140|517160939|FG004|Overall Study|Participant travelled outside study area|0|||
143441093|NCT03845140|517160940|FG005|Overall Study|Participant travelled outside study area|0|||
143441094|NCT00762476|517160947|FG000|Overall Study|Adverse Event|7|||
143441095|NCT00762476|517160948|FG001|Overall Study|Adverse Event|1|||
143441096|NCT00762476|517160947|FG000|Overall Study|Lost to Follow-up|2|||
143441097|NCT00762476|517160948|FG001|Overall Study|Lost to Follow-up|0|||
143441098|NCT00762476|517160947|FG000|Overall Study|Protocol Violation|5|||
143441099|NCT00762476|517160948|FG001|Overall Study|Protocol Violation|6|||
143441100|NCT00762476|517160947|FG000|Overall Study|Physician Decision|2|||
143441101|NCT00762476|517160948|FG001|Overall Study|Physician Decision|14|||
143441102|NCT00762476|517160947|FG000|Overall Study|Withdrawal by Subject|6|||
143441103|NCT00762476|517160948|FG001|Overall Study|Withdrawal by Subject|12|||
143441104|NCT00762476|517160947|FG000|Overall Study|antibiotic use|0|||
143441105|NCT00762476|517160948|FG001|Overall Study|antibiotic use|1|||
143441106|NCT00762476|517160947|FG000|Overall Study|non-compliance with study visits|0|||
143441107|NCT00762476|517160948|FG001|Overall Study|non-compliance with study visits|2|||
143441108|NCT00762476|517160947|FG000|Overall Study|Seasonal allergies|1|||
143441109|NCT00762476|517160948|FG001|Overall Study|Seasonal allergies|0|||
143441110|NCT02878603|517160949|FG000|Overall Study|Lost to Follow-up|4|||
143441111|NCT02878603|517160950|FG001|Overall Study|Lost to Follow-up|1|||
143441112|NCT02878603|517160949|FG000|Overall Study|Withdrawal by Subject|1|||
143441113|NCT02878603|517160950|FG001|Overall Study|Withdrawal by Subject|1|||
143441114|NCT02878603|517160949|FG000|Overall Study|Death|1|||
143441115|NCT02878603|517160950|FG001|Overall Study|Death|0|||
143441116|NCT02878603|517160949|FG000|Overall Study|Physician Decision|0|||
143441117|NCT02878603|517160950|FG001|Overall Study|Physician Decision|3|||
143441118|NCT01358331|517160951|FG000|Overall Study|Lost to Follow-up|0|||
143441119|NCT01358331|517160952|FG001|Overall Study|Lost to Follow-up|0|||
143441120|NCT01358331|517160953|FG002|Overall Study|Lost to Follow-up|0|||
143441121|NCT01358331|517160954|FG003|Overall Study|Lost to Follow-up|1|||
143441122|NCT01358331|517160955|FG004|Overall Study|Lost to Follow-up|0|||
143441123|NCT01358331|517160956|FG005|Overall Study|Lost to Follow-up|0|||
143441124|NCT01358331|517160951|FG000|Overall Study|Withdrawal by Subject|0|||
143441125|NCT01358331|517160952|FG001|Overall Study|Withdrawal by Subject|0|||
143441126|NCT01358331|517160953|FG002|Overall Study|Withdrawal by Subject|0|||
143441127|NCT01358331|517160954|FG003|Overall Study|Withdrawal by Subject|1|||
143441128|NCT01358331|517160955|FG004|Overall Study|Withdrawal by Subject|1|||
143441129|NCT01358331|517160956|FG005|Overall Study|Withdrawal by Subject|1|||
143441130|NCT01358331|517160951|FG000|Overall Study|Adverse Events|1|||
143441131|NCT01358331|517160952|FG001|Overall Study|Adverse Events|1|||
143441132|NCT01358331|517160953|FG002|Overall Study|Adverse Events|1|||
143441133|NCT01358331|517160954|FG003|Overall Study|Adverse Events|0|||
143441134|NCT01358331|517160955|FG004|Overall Study|Adverse Events|1|||
143441135|NCT01358331|517160956|FG005|Overall Study|Adverse Events|5|||
143441136|NCT01358331|517160951|FG000|Overall Study|Symptomatic Deterioration|0|||
143441137|NCT01358331|517160952|FG001|Overall Study|Symptomatic Deterioration|0|||
143441138|NCT01358331|517160953|FG002|Overall Study|Symptomatic Deterioration|0|||
143441139|NCT01358331|517160954|FG003|Overall Study|Symptomatic Deterioration|0|||
143441140|NCT01358331|517160955|FG004|Overall Study|Symptomatic Deterioration|1|||
143441141|NCT01358331|517160956|FG005|Overall Study|Symptomatic Deterioration|0|||
143441142|NCT01358331|517160951|FG000|Overall Study|Participants did not wish to continue|0|||
143441143|NCT01358331|517160952|FG001|Overall Study|Participants did not wish to continue|0|||
143441144|NCT01358331|517160953|FG002|Overall Study|Participants did not wish to continue|0|||
143441145|NCT01358331|517160954|FG003|Overall Study|Participants did not wish to continue|0|||
143441146|NCT01358331|517160955|FG004|Overall Study|Participants did not wish to continue|1|||
143441147|NCT01358331|517160956|FG005|Overall Study|Participants did not wish to continue|0|||
143441148|NCT01358331|517160951|FG000|Overall Study|Progress of disease under investigation|1|||
143441149|NCT01358331|517160952|FG001|Overall Study|Progress of disease under investigation|2|||
143441150|NCT01358331|517160953|FG002|Overall Study|Progress of disease under investigation|3|||
143441151|NCT01358331|517160954|FG003|Overall Study|Progress of disease under investigation|1|||
143441152|NCT01358331|517160955|FG004|Overall Study|Progress of disease under investigation|3|||
143441153|NCT01358331|517160956|FG005|Overall Study|Progress of disease under investigation|0|||
143441154|NCT04674189|517160957|FG000|Overall Study|Adverse Event|0|||
143441155|NCT04674189|517160958|FG001|Overall Study|Adverse Event|0|||
143441156|NCT04674189|517160959|FG002|Overall Study|Adverse Event|1|||
143441157|NCT04674189|517160957|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
143441158|NCT04674189|517160958|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
143441159|NCT04674189|517160959|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
143441160|NCT04674189|517160957|FG000|Overall Study|Physician Decision|1|||
143441161|NCT04674189|517160958|FG001|Overall Study|Physician Decision|0|||
143441162|NCT04674189|517160959|FG002|Overall Study|Physician Decision|0|||
143441163|NCT04674189|517160957|FG000|Overall Study|Withdrawal by Participant|83|||
143441164|NCT04674189|517160958|FG001|Overall Study|Withdrawal by Participant|71|||
143441165|NCT04674189|517160959|FG002|Overall Study|Withdrawal by Participant|142|||
143441166|NCT04674189|517160957|FG000|Overall Study|Lost to Follow-up|55|||
143441167|NCT04674189|517160958|FG001|Overall Study|Lost to Follow-up|53|||
143441168|NCT04674189|517160959|FG002|Overall Study|Lost to Follow-up|44|||
143441169|NCT04674189|517160957|FG000|Overall Study|Miscellaneous|27|||
143441170|NCT04674189|517160958|FG001|Overall Study|Miscellaneous|23|||
143441171|NCT04674189|517160959|FG002|Overall Study|Miscellaneous|207|||
143441172|NCT04674189|517160957|FG000|Overall Study|Did Not Receive Treatment|3|||
143441173|NCT04674189|517160958|FG001|Overall Study|Did Not Receive Treatment|1|||
143441174|NCT04674189|517160959|FG002|Overall Study|Did Not Receive Treatment|2|||
143441175|NCT02838134|517160960|FG000|Overall Study|Lost to Follow-up|1|||
143441176|NCT02838134|517160961|FG001|Overall Study|Lost to Follow-up|2|||
143441177|NCT02838134|517160960|FG000|Overall Study|logistic problems|1|||
143441178|NCT02838134|517160961|FG001|Overall Study|logistic problems|1|||
143441179|NCT01637077|517160962|FG000|Overall Study|Cancel|1|||
143441180|NCT01637077|517160963|FG001|Overall Study|Cancel|1|||
143441181|NCT01637077|517160962|FG000|Overall Study|Withdrawal by Subject|1|||
143441182|NCT01637077|517160963|FG001|Overall Study|Withdrawal by Subject|0|||
143441183|NCT01637077|517160962|FG000|Overall Study|No cycle 1 questionnaire data|2|||
143441184|NCT01637077|517160963|FG001|Overall Study|No cycle 1 questionnaire data|0|||
143441185|NCT01969851|517160969|FG000|Overall Study|Adverse Event|0|||
143441186|NCT01969851|517160970|FG001|Overall Study|Adverse Event|0|||
143441187|NCT01969851|517160971|FG002|Overall Study|Adverse Event|3|||
143441188|NCT01969851|517160969|FG000|Overall Study|Lack of Efficacy|0|||
143441189|NCT01969851|517160970|FG001|Overall Study|Lack of Efficacy|3|||
143441190|NCT01969851|517160971|FG002|Overall Study|Lack of Efficacy|1|||
143441191|NCT01969851|517160969|FG000|Overall Study|Withdrawal by Subject|1|||
143441192|NCT01969851|517160970|FG001|Overall Study|Withdrawal by Subject|0|||
143441193|NCT01969851|517160971|FG002|Overall Study|Withdrawal by Subject|1|||
143441194|NCT01969851|517160969|FG000|Overall Study|No effective dose in Titration period|0|||
143441195|NCT01969851|517160970|FG001|Overall Study|No effective dose in Titration period|0|||
143441196|NCT01969851|517160971|FG002|Overall Study|No effective dose in Titration period|1|||
143441197|NCT01969851|517160969|FG000|Overall Study|Sponsor decision|0|||
143441198|NCT01969851|517160970|FG001|Overall Study|Sponsor decision|0|||
143441199|NCT01969851|517160971|FG002|Overall Study|Sponsor decision|1|||
143441200|NCT02734004|517160976|FG000|Overall Study|Death|36|||
143441201|NCT02734004|517160977|FG001|Overall Study|Death|24|||
143441202|NCT02734004|517160978|FG002|Overall Study|Death|26|||
143441203|NCT02734004|517160979|FG003|Overall Study|Death|35|||
143441204|NCT02734004|517160980|FG004|Overall Study|Death|13|||
143441205|NCT02734004|517160981|FG005|Overall Study|Death|17|||
143441206|NCT02734004|517160982|FG006|Overall Study|Death|20|||
143441207|NCT02734004|517160976|FG000|Overall Study|Lost to Follow-up|1|||
143441208|NCT02734004|517160977|FG001|Overall Study|Lost to Follow-up|1|||
143441209|NCT02734004|517160978|FG002|Overall Study|Lost to Follow-up|0|||
143441210|NCT02734004|517160979|FG003|Overall Study|Lost to Follow-up|0|||
143441211|NCT02734004|517160980|FG004|Overall Study|Lost to Follow-up|1|||
143441212|NCT02734004|517160981|FG005|Overall Study|Lost to Follow-up|0|||
143441213|NCT02734004|517160982|FG006|Overall Study|Lost to Follow-up|0|||
143441214|NCT02734004|517160976|FG000|Overall Study|Withdrawal by Subject|3|||
143441215|NCT02734004|517160977|FG001|Overall Study|Withdrawal by Subject|1|||
143441216|NCT02734004|517160978|FG002|Overall Study|Withdrawal by Subject|1|||
143441217|NCT02734004|517160979|FG003|Overall Study|Withdrawal by Subject|1|||
143441218|NCT02734004|517160980|FG004|Overall Study|Withdrawal by Subject|3|||
143441219|NCT02734004|517160981|FG005|Overall Study|Withdrawal by Subject|0|||
143441220|NCT02734004|517160982|FG006|Overall Study|Withdrawal by Subject|2|||
143441221|NCT02734004|517160976|FG000|Overall Study|Other|0|||
143441222|NCT02734004|517160977|FG001|Overall Study|Other|8|||
143441223|NCT02734004|517160978|FG002|Overall Study|Other|7|||
143441224|NCT02734004|517160979|FG003|Overall Study|Other|4|||
143441225|NCT02734004|517160980|FG004|Overall Study|Other|34|||
143441226|NCT02734004|517160981|FG005|Overall Study|Other|14|||
143441227|NCT02734004|517160982|FG006|Overall Study|Other|10|||
143441228|NCT01011868|517160983|FG000|After Week 18 Follow-up|Adverse Event|8|||
143441229|NCT01011868|517160984|FG001|After Week 18 Follow-up|Adverse Event|6|||
143441230|NCT01011868|517160985|FG002|After Week 18 Follow-up|Adverse Event|13|||
143441231|NCT01011868|517160983|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
143441232|NCT01011868|517160984|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
143441233|NCT01011868|517160985|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
143441234|NCT01011868|517160983|FG000|After Week 18 Follow-up|Protocol Violation|1|||
143441235|NCT01011868|517160984|FG001|After Week 18 Follow-up|Protocol Violation|1|||
143441236|NCT01011868|517160985|FG002|After Week 18 Follow-up|Protocol Violation|1|||
143441237|NCT01011868|517160983|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
143441238|NCT01011868|517160984|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
143441239|NCT01011868|517160985|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
143441240|NCT01011868|517160983|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
143441241|NCT01011868|517160984|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
143441242|NCT01011868|517160985|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
143441243|NCT01011868|517160983|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
143441244|NCT01011868|517160984|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
143441245|NCT01011868|517160985|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
143441246|NCT01011868|517160983|FG000|After Week 78 Follow-up|Adverse Event|14|||
143441247|NCT01011868|517160984|FG001|After Week 78 Follow-up|Adverse Event|18|||
143441248|NCT01011868|517160985|FG002|After Week 78 Follow-up|Adverse Event|21|||
143441249|NCT01011868|517160983|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
143441250|NCT01011868|517160984|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
143441251|NCT01011868|517160985|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
143441252|NCT01011868|517160983|FG000|After Week 78 Follow-up|Protocol Violation|9|||
143441253|NCT01011868|517160984|FG001|After Week 78 Follow-up|Protocol Violation|1|||
143441254|NCT01011868|517160985|FG002|After Week 78 Follow-up|Protocol Violation|2|||
143441255|NCT01011868|517160983|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
143441256|NCT01011868|517160984|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
143441257|NCT01011868|517160985|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
143441258|NCT01011868|517160983|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
143441259|NCT01011868|517160984|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
143441260|NCT01011868|517160985|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
143441261|NCT01011868|517160983|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
143441262|NCT01011868|517160984|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
143441263|NCT01011868|517160985|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
143441264|NCT01262092|517160986|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
143441265|NCT01262092|517160987|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
143441266|NCT01262092|517160986|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
143441267|NCT01262092|517160987|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
143441268|NCT01262092|517160986|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
143441269|NCT01262092|517160987|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
143441270|NCT01262092|517160986|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
143441271|NCT01262092|517160987|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
143441272|NCT03784820|517160988|FG000|Overall Study|Lost to Follow-up|5|||
143441273|NCT03784820|517160989|FG001|Overall Study|Lost to Follow-up|5|||
143441274|NCT03784820|517160990|FG002|Overall Study|Lost to Follow-up|3|||
143441275|NCT03784820|517160991|FG003|Overall Study|Lost to Follow-up|3|||
143441276|NCT04147858|517160993|FG000|Overall Study|Adverse Event|6|||
143441277|NCT04147858|517160994|FG001|Overall Study|Adverse Event|6|||
143441278|NCT04147858|517160995|FG002|Overall Study|Adverse Event|6|||
143441279|NCT04147858|517160993|FG000|Overall Study|Lack of Efficacy|3|||
143441280|NCT04147858|517160994|FG001|Overall Study|Lack of Efficacy|3|||
143441281|NCT04147858|517160995|FG002|Overall Study|Lack of Efficacy|1|||
143441282|NCT04147858|517160993|FG000|Overall Study|Lost to Follow-up|1|||
143441283|NCT04147858|517160994|FG001|Overall Study|Lost to Follow-up|6|||
143441284|NCT04147858|517160995|FG002|Overall Study|Lost to Follow-up|2|||
143441285|NCT04147858|517160993|FG000|Overall Study|Withdrawal by Subject|3|||
143441286|NCT04147858|517160994|FG001|Overall Study|Withdrawal by Subject|4|||
143441287|NCT04147858|517160995|FG002|Overall Study|Withdrawal by Subject|10|||
143441288|NCT04147858|517160993|FG000|Overall Study|Subject Noncompliance, Other|4|||
143441289|NCT04147858|517160994|FG001|Overall Study|Subject Noncompliance, Other|3|||
143441290|NCT04147858|517160995|FG002|Overall Study|Subject Noncompliance, Other|1|||
143441291|NCT02336425|517160996|FG000|Overall Study|Study terminated.|2|||
143441292|NCT02336425|517160997|FG001|Overall Study|Study terminated.|2|||
143441293|NCT02336425|517160998|FG002|Overall Study|Study terminated.|3|||
143441294|NCT02336425|517160999|FG003|Overall Study|Study terminated.|3|||
143441295|NCT04907357|517161003|FG000|Overall Study|Death|0|||
143441296|NCT04907357|517161004|FG001|Overall Study|Death|1|||
143441297|NCT04907357|517161003|FG000|Overall Study|Lost to Follow-up|9|||
143441298|NCT04907357|517161004|FG001|Overall Study|Lost to Follow-up|18|||
143441299|NCT04907357|517161003|FG000|Overall Study|Physician Decision|1|||
143441300|NCT04907357|517161004|FG001|Overall Study|Physician Decision|0|||
143441301|NCT04907357|517161003|FG000|Overall Study|Withdrawal by Subject|0|||
143441302|NCT04907357|517161004|FG001|Overall Study|Withdrawal by Subject|1|||
143441303|NCT04907357|517161003|FG000|Overall Study|Unable to attend visits|1|||
143441304|NCT04907357|517161004|FG001|Overall Study|Unable to attend visits|0|||
143441305|NCT04907357|517161003|FG000|Overall Study|Incarcerated|1|||
143441306|NCT04907357|517161004|FG001|Overall Study|Incarcerated|1|||
143441307|NCT00365547|517161005|FG000|Overall Study|Insurance did not cover Avastin|1|||
143441308|NCT00365547|517161005|FG000|Overall Study|Screen failure|1|||
143441309|NCT00365547|517161005|FG000|Overall Study|Withdrawal by Subject|1|||
143441310|NCT00546078|517161006|FG000|Overall Study|Lost to Follow-up|1|||
143441311|NCT00546078|517161007|FG001|Overall Study|Lost to Follow-up|3|||
143441312|NCT00546078|517161006|FG000|Overall Study|Withdrawal by Subject|2|||
143441313|NCT00546078|517161007|FG001|Overall Study|Withdrawal by Subject|3|||
143441314|NCT00546078|517161006|FG000|Overall Study|Other reason|1|||
143441315|NCT00546078|517161007|FG001|Overall Study|Other reason|1|||
143441316|NCT02257918|517161008|FG000|Overall Study|Lost to Follow-up|4|||
143441317|NCT02257918|517161009|FG001|Overall Study|Lost to Follow-up|1|||
143441318|NCT02257918|517161010|FG002|Overall Study|Lost to Follow-up|0|||
143441319|NCT02257918|517161008|FG000|Overall Study|Withdrawal by Subject|0|||
143441320|NCT02257918|517161009|FG001|Overall Study|Withdrawal by Subject|0|||
143441321|NCT02257918|517161010|FG002|Overall Study|Withdrawal by Subject|1|||
143441322|NCT02257918|517161008|FG000|Overall Study|Pregnancy|0|||
143441323|NCT02257918|517161009|FG001|Overall Study|Pregnancy|0|||
143441324|NCT02257918|517161010|FG002|Overall Study|Pregnancy|1|||
143441325|NCT03023423|517161011|FG000|Overall Study|Death|5|||
143441326|NCT03023423|517161012|FG001|Overall Study|Death|12|||
143441327|NCT03023423|517161013|FG002|Overall Study|Death|20|||
143441328|NCT03023423|517161011|FG000|Overall Study|Other|0|||
143441329|NCT03023423|517161012|FG001|Overall Study|Other|2|||
143441330|NCT03023423|517161013|FG002|Overall Study|Other|2|||
143441331|NCT03023423|517161011|FG000|Overall Study|Ongoing|2|||
143441332|NCT03023423|517161012|FG001|Overall Study|Ongoing|32|||
143441333|NCT03023423|517161013|FG002|Overall Study|Ongoing|24|||
143441334|NCT03512197|517161014|FG000|Overall Study|Guardian decision|1|||
143441335|NCT03512197|517161015|FG001|Overall Study|Guardian decision|1|||
143441336|NCT03512197|517161014|FG000|Overall Study|Lack of Efficacy|19|||
143441337|NCT03512197|517161015|FG001|Overall Study|Lack of Efficacy|11|||
143441338|NCT03512197|517161014|FG000|Overall Study|New Therapy for Study Indication|16|||
143441339|NCT03512197|517161015|FG001|Overall Study|New Therapy for Study Indication|16|||
143441340|NCT03512197|517161014|FG000|Overall Study|Physician Decision|60|||
143441341|NCT03512197|517161015|FG001|Overall Study|Physician Decision|60|||
143441342|NCT03512197|517161014|FG000|Overall Study|Protocol Violation|0|||
143441343|NCT03512197|517161015|FG001|Overall Study|Protocol Violation|2|||
143441344|NCT03512197|517161014|FG000|Overall Study|Terminated by Sponsored|46|||
143441345|NCT03512197|517161015|FG001|Overall Study|Terminated by Sponsored|50|||
143441346|NCT03512197|517161014|FG000|Overall Study|Subject Decision|15|||
143441347|NCT03512197|517161015|FG001|Overall Study|Subject Decision|12|||
143441348|NCT03512197|517161014|FG000|Overall Study|Withdrawal of informed consent|20|||
143441349|NCT03512197|517161015|FG001|Overall Study|Withdrawal of informed consent|14|||
143441350|NCT03512197|517161014|FG000|Overall Study|Adverse Event|30|||
143441351|NCT03512197|517161015|FG001|Overall Study|Adverse Event|34|||
143441352|NCT03512197|517161014|FG000|Overall Study|Death|14|||
143441353|NCT03512197|517161015|FG001|Overall Study|Death|9|||
143441354|NCT03512197|517161014|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
143441355|NCT03512197|517161015|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
143441356|NCT03512197|517161014|FG000|Overall Study|Missing|3|||
143441357|NCT03512197|517161015|FG001|Overall Study|Missing|13|||
143441358|NCT04277507|517161017|FG000|Overall Study|Lost to Follow-up|17|||
143441359|NCT04277507|517161017|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
143441360|NCT04277507|517161017|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
143441361|NCT04277507|517161017|FG000|Overall Study|Withdrawal by Subject|3|||
143441362|NCT04277507|517161017|FG000|Overall Study|Death due to COVID-19|1|||
143441363|NCT04277507|517161017|FG000|Overall Study|Data missing for full evaluation|5|||
143441364|NCT01431950|517161018|FG000|Overall Study|Study Site Closed/Terminated|7|||
143441365|NCT01431950|517161019|FG001|Overall Study|Study Site Closed/Terminated|3|||
143441366|NCT01431950|517161018|FG000|Overall Study|Withdrawal by Subject|4|||
143441367|NCT01431950|517161019|FG001|Overall Study|Withdrawal by Subject|3|||
143441368|NCT01431950|517161018|FG000|Overall Study|Protocol Violation|2|||
143441369|NCT01431950|517161019|FG001|Overall Study|Protocol Violation|3|||
143441370|NCT01431950|517161018|FG000|Overall Study|Adverse Event|2|||
143441371|NCT01431950|517161019|FG001|Overall Study|Adverse Event|2|||
143441372|NCT01431950|517161018|FG000|Overall Study|Physician Decision|2|||
143441373|NCT01431950|517161019|FG001|Overall Study|Physician Decision|1|||
143441374|NCT01431950|517161018|FG000|Overall Study|Lack of Efficacy|2|||
143441375|NCT01431950|517161019|FG001|Overall Study|Lack of Efficacy|1|||
143441376|NCT01431950|517161018|FG000|Overall Study|Lost to Follow-up|0|||
143441377|NCT01431950|517161019|FG001|Overall Study|Lost to Follow-up|1|||
143441378|NCT01431950|517161018|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
143441379|NCT01431950|517161019|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
143441380|NCT01261247|517161020|FG000|Overall Study|Ineligible|2|||
143441381|NCT01210651|517161021|FG000|Overall Study|Lost to Follow-up|1|||
143441382|NCT01210651|517161022|FG001|Overall Study|Lost to Follow-up|1|||
143441383|NCT01210651|517161021|FG000|Overall Study|schedule conflicts|1|||
143441384|NCT01210651|517161022|FG001|Overall Study|schedule conflicts|5|||
143441385|NCT01210651|517161021|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
143441386|NCT01210651|517161022|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
143441387|NCT01210651|517161021|FG000|Overall Study|Withdrawal by Subject|1|||
143441388|NCT01210651|517161022|FG001|Overall Study|Withdrawal by Subject|1|||
143441389|NCT01210651|517161021|FG000|Overall Study|Injury outside study|2|||
143441390|NCT01210651|517161022|FG001|Overall Study|Injury outside study|0|||
143441391|NCT01740154|517161023|FG000|Overall Study|Adverse Event|1|||
143441392|NCT05226130|517161024|FG000|Overall Study|Lost to Follow-up|0|||
143441393|NCT05226130|517161025|FG001|Overall Study|Lost to Follow-up|1|||
143441394|NCT05226130|517161024|FG000|Overall Study|Not treatment adherent|0|||
143441395|NCT05226130|517161025|FG001|Overall Study|Not treatment adherent|2|||
143441396|NCT04013971|517161026|FG000|Overall Study|Treadmill speed less than 0.50 miles per hour|2|||
143441397|NCT04013971|517161027|FG001|Overall Study|Treadmill speed less than 0.50 miles per hour|0|||
143441398|NCT04013971|517161026|FG000|Overall Study|Missing biomechanical data|0|||
143441399|NCT04013971|517161027|FG001|Overall Study|Missing biomechanical data|1|||
143441400|NCT01340014|517161030|FG000|Period 1, First 7 Days|Adverse Event|1|||
143441401|NCT01340014|517161031|FG001|Period 1, First 7 Days|Adverse Event|0|||
143441402|NCT01340014|517161030|FG000|Period 1, First 7 Days|Personal Reasons|1|||
143441403|NCT01340014|517161031|FG001|Period 1, First 7 Days|Personal Reasons|0|||
143441404|NCT01340014|517161030|FG000|Period 2, Second 7 Days|Adverse Event|0|||
143441405|NCT01340014|517161031|FG001|Period 2, Second 7 Days|Adverse Event|1|||
143441406|NCT05101993|517161032|FG000|Overall Study|Withdrawal by Subject|1|||
143441407|NCT04577573|517161033|FG000|Overall Study|Technical - invalid protocol|0|||
143441408|NCT04577573|517161034|FG001|Overall Study|Technical - invalid protocol|2|||
143441409|NCT04577573|517161035|FG002|Overall Study|Technical - invalid protocol|0|||
143441410|NCT01124838|517161036|FG000|Overall Study|Miscellaneous|4|||
143441411|NCT01124838|517161037|FG001|Overall Study|Miscellaneous|2|||
143441412|NCT01124838|517161036|FG000|Overall Study|Adverse Event|7|||
143441413|NCT01124838|517161037|FG001|Overall Study|Adverse Event|11|||
143441414|NCT01124838|517161036|FG000|Overall Study|Lack of Efficacy|2|||
143441415|NCT01124838|517161037|FG001|Overall Study|Lack of Efficacy|0|||
143441416|NCT01124838|517161036|FG000|Overall Study|Withdrawal by Subject|3|||
143441417|NCT01124838|517161037|FG001|Overall Study|Withdrawal by Subject|2|||
143441418|NCT01124838|517161036|FG000|Overall Study|Lost to Follow-up|2|||
143441419|NCT01124838|517161037|FG001|Overall Study|Lost to Follow-up|0|||
143441420|NCT04297618|517161038|FG000|Overall Study|Adverse Event|1|||
143441421|NCT04297618|517161038|FG000|Overall Study|Withdrawal by Subject|1|||
143441422|NCT02065882|517161039|FG000|Part I: PK/PD|Screening failure|5|||
143441423|NCT02065882|517161039|FG000|Part I: PK/PD|Withdrawal by Subject|2|||
143441424|NCT02065882|517161039|FG000|Part I: PK/PD|Adverse Event|1|||
143441425|NCT02065882|517161039|FG000|Part II: Clinical Efficacy|Screening failure|7|||
143441426|NCT02065882|517161039|FG000|Part II: Clinical Efficacy|Withdrawal by Subject|2|||
143441427|NCT02065882|517161039|FG000|Part II: Clinical Efficacy|Adverse Event|5|||
143441428|NCT02065882|517161039|FG000|Part II: Clinical Efficacy|Regulatory Authority Decision|3|||
143441429|NCT02065882|517161039|FG000|Part II: Clinical Efficacy|No Bleeding Event|11|||
143441430|NCT02065882|517161039|FG000|Part II: Clinical Efficacy|Protocol Violation|3|||
143441431|NCT05992922|517161040|FG000|Overall Study|Adverse Event|6|||
143441432|NCT05992922|517161041|FG001|Overall Study|Adverse Event|0|||
143441433|NCT05992922|517161040|FG000|Overall Study|Sponsor Termination of Study|14|||
143441434|NCT05992922|517161041|FG001|Overall Study|Sponsor Termination of Study|20|||
143441435|NCT04949802|517163312|FG000|Overall Study|Lost to Follow-up|3|||
143441436|NCT02419417|517163313|FG000|Overall Study|Disease progression|5|||
143441437|NCT02419417|517163314|FG001|Overall Study|Disease progression|4|||
143441438|NCT02419417|517163315|FG002|Overall Study|Disease progression|13|||
143441439|NCT02419417|517163316|FG003|Overall Study|Disease progression|10|||
143441440|NCT02419417|517163317|FG004|Overall Study|Disease progression|10|||
143441441|NCT02419417|517163318|FG005|Overall Study|Disease progression|3|||
143441442|NCT02419417|517163319|FG006|Overall Study|Disease progression|4|||
143441443|NCT02419417|517163320|FG007|Overall Study|Disease progression|5|||
143441444|NCT02419417|517163321|FG008|Overall Study|Disease progression|13|||
143441445|NCT02419417|517163322|FG009|Overall Study|Disease progression|9|||
143441446|NCT02419417|517163323|FG010|Overall Study|Disease progression|0|||
143441447|NCT02419417|517163313|FG000|Overall Study|Study drug toxicity|0|||
143441448|NCT02419417|517163314|FG001|Overall Study|Study drug toxicity|0|||
143441449|NCT02419417|517163315|FG002|Overall Study|Study drug toxicity|0|||
143441450|NCT02419417|517163316|FG003|Overall Study|Study drug toxicity|0|||
143441451|NCT02419417|517163317|FG004|Overall Study|Study drug toxicity|1|||
143441452|NCT02419417|517163318|FG005|Overall Study|Study drug toxicity|0|||
143441453|NCT02419417|517163319|FG006|Overall Study|Study drug toxicity|0|||
143441454|NCT02419417|517163320|FG007|Overall Study|Study drug toxicity|0|||
143441455|NCT02419417|517163321|FG008|Overall Study|Study drug toxicity|0|||
143441456|NCT02419417|517163322|FG009|Overall Study|Study drug toxicity|0|||
143441457|NCT02419417|517163323|FG010|Overall Study|Study drug toxicity|0|||
143441458|NCT02419417|517163313|FG000|Overall Study|Adverse event unrelated to study drug|0|||
143441459|NCT02419417|517163314|FG001|Overall Study|Adverse event unrelated to study drug|0|||
143441460|NCT02419417|517163315|FG002|Overall Study|Adverse event unrelated to study drug|0|||
143441461|NCT02419417|517163316|FG003|Overall Study|Adverse event unrelated to study drug|0|||
143441462|NCT02419417|517163317|FG004|Overall Study|Adverse event unrelated to study drug|2|||
143441463|NCT02419417|517163318|FG005|Overall Study|Adverse event unrelated to study drug|1|||
143441464|NCT02419417|517163319|FG006|Overall Study|Adverse event unrelated to study drug|0|||
143441465|NCT02419417|517163320|FG007|Overall Study|Adverse event unrelated to study drug|1|||
143441466|NCT02419417|517163321|FG008|Overall Study|Adverse event unrelated to study drug|0|||
143441467|NCT02419417|517163322|FG009|Overall Study|Adverse event unrelated to study drug|0|||
143441468|NCT02419417|517163323|FG010|Overall Study|Adverse event unrelated to study drug|0|||
143441469|NCT02419417|517163313|FG000|Overall Study|Participant request to discontinue|0|||
143441470|NCT02419417|517163314|FG001|Overall Study|Participant request to discontinue|0|||
143441471|NCT02419417|517163315|FG002|Overall Study|Participant request to discontinue|0|||
143441472|NCT02419417|517163316|FG003|Overall Study|Participant request to discontinue|0|||
143441473|NCT02419417|517163317|FG004|Overall Study|Participant request to discontinue|0|||
143441474|NCT02419417|517163318|FG005|Overall Study|Participant request to discontinue|0|||
143441475|NCT02419417|517163319|FG006|Overall Study|Participant request to discontinue|0|||
143441476|NCT02419417|517163320|FG007|Overall Study|Participant request to discontinue|0|||
143441477|NCT02419417|517163321|FG008|Overall Study|Participant request to discontinue|0|||
143441478|NCT02419417|517163322|FG009|Overall Study|Participant request to discontinue|1|||
143441479|NCT02419417|517163323|FG010|Overall Study|Participant request to discontinue|0|||
143441480|NCT02419417|517163313|FG000|Overall Study|Withdrawal by Subject|0|||
143441481|NCT02419417|517163314|FG001|Overall Study|Withdrawal by Subject|0|||
143441482|NCT02419417|517163315|FG002|Overall Study|Withdrawal by Subject|0|||
143441483|NCT02419417|517163316|FG003|Overall Study|Withdrawal by Subject|0|||
143441484|NCT02419417|517163317|FG004|Overall Study|Withdrawal by Subject|0|||
143441485|NCT02419417|517163318|FG005|Overall Study|Withdrawal by Subject|0|||
143441486|NCT02419417|517163319|FG006|Overall Study|Withdrawal by Subject|0|||
143441487|NCT02419417|517163320|FG007|Overall Study|Withdrawal by Subject|0|||
143441488|NCT02419417|517163321|FG008|Overall Study|Withdrawal by Subject|0|||
143441489|NCT02419417|517163322|FG009|Overall Study|Withdrawal by Subject|0|||
143441490|NCT02419417|517163323|FG010|Overall Study|Withdrawal by Subject|1|||
143441491|NCT01381575|517163324|FG000|Overall Study|Serious Adverse Event|1|||
143441492|NCT01381575|517163325|FG001|Overall Study|Serious Adverse Event|0|||
143441493|NCT01381575|517163326|FG002|Overall Study|Serious Adverse Event|0|||
143441494|NCT01381575|517163324|FG000|Overall Study|Non-Serious Adverse Event|0|||
143441495|NCT01381575|517163325|FG001|Overall Study|Non-Serious Adverse Event|0|||
143441496|NCT01381575|517163326|FG002|Overall Study|Non-Serious Adverse Event|1|||
143441497|NCT01381575|517163324|FG000|Overall Study|Protocol Violation|0|||
143441498|NCT01381575|517163325|FG001|Overall Study|Protocol Violation|1|||
143441499|NCT01381575|517163326|FG002|Overall Study|Protocol Violation|1|||
143441500|NCT01381575|517163324|FG000|Overall Study|Withdrawal by Subject|15|||
143441501|NCT01381575|517163325|FG001|Overall Study|Withdrawal by Subject|9|||
143441502|NCT01381575|517163326|FG002|Overall Study|Withdrawal by Subject|7|||
143441503|NCT01381575|517163324|FG000|Overall Study|Migrated/moved from study area|2|||
143441504|NCT01381575|517163325|FG001|Overall Study|Migrated/moved from study area|12|||
143441505|NCT01381575|517163326|FG002|Overall Study|Migrated/moved from study area|2|||
143441506|NCT01381575|517163324|FG000|Overall Study|Lost to Follow-up|8|||
143441507|NCT01381575|517163325|FG001|Overall Study|Lost to Follow-up|17|||
143441508|NCT01381575|517163326|FG002|Overall Study|Lost to Follow-up|9|||
143441509|NCT01200342|517163327|FG000|Overall Study|Disease Progression|1|||
143441510|NCT02550938|517163328|FG000|Overall Study|Lost to Follow-up|8|||
143441511|NCT02550938|517163329|FG001|Overall Study|Lost to Follow-up|7|||
143441512|NCT02550938|517163330|FG002|Overall Study|Lost to Follow-up|12|||
143441513|NCT02550938|517163331|FG003|Overall Study|Lost to Follow-up|11|||
143441514|NCT01367847|517163332|FG000|Overall Study|Withdrawal by Subject|2|||
143441515|NCT01367847|517163333|FG001|Overall Study|Withdrawal by Subject|2|||
143441516|NCT01439867|517163334|FG000|Overall Study|Non-compliance|0|||
143441517|NCT01439867|517163335|FG001|Overall Study|Non-compliance|1|||
143441518|NCT01439867|517163334|FG000|Overall Study|Withdrawal by Subject|1|||
143441519|NCT01439867|517163335|FG001|Overall Study|Withdrawal by Subject|2|||
143441520|NCT01439867|517163334|FG000|Overall Study|Administrative Decision|4|||
143441521|NCT01439867|517163335|FG001|Overall Study|Administrative Decision|5|||
143441522|NCT01439867|517163334|FG000|Overall Study|Protocol-specified Criteria|1|||
143441523|NCT01439867|517163335|FG001|Overall Study|Protocol-specified Criteria|0|||
143441524|NCT02763215|517163336|FG000|Overall Study|Participants withdrew from study|3|||
143441525|NCT02763215|517163336|FG000|Overall Study|Missed visit|1|||
143441526|NCT02763215|517163336|FG000|Overall Study|Visit outside visit-window|1|||
143441527|NCT02763215|517163336|FG000|Overall Study|Death|1|||
143441528|NCT02763215|517163336|FG000|Overall Study|Lost to Follow-up|1|||
143441529|NCT03258723|517163337|FG000|Overall Study|COVID Interruption of study|54|||
143441530|NCT03258723|517163337|FG000|Overall Study|Lost to Follow-up|8|||
143441531|NCT01107899|517163338|FG000|Overall Study|Physician Decision|5|||
143441532|NCT01107899|517163339|FG001|Overall Study|Physician Decision|0|||
143441533|NCT01107899|517163340|FG002|Overall Study|Physician Decision|3|||
143441534|NCT01107899|517163338|FG000|Overall Study|Withdrawal by Subject|0|||
143441535|NCT01107899|517163339|FG001|Overall Study|Withdrawal by Subject|0|||
143441536|NCT01107899|517163340|FG002|Overall Study|Withdrawal by Subject|1|||
143441537|NCT00953771|517163341|FG000|Overall Study|Death|1|||
143441538|NCT00953771|517163342|FG001|Overall Study|Death|0|||
143441539|NCT00974259|517163343|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
143441540|NCT00974259|517163344|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
143441541|NCT01375673|517163351|FG000|Overall Study|Withdrawal by Subject|0|||
143441542|NCT01375673|517163352|FG001|Overall Study|Withdrawal by Subject|1|||
143441543|NCT01784523|517163355|FG000|Overall Study|Study closed early|7|||
143441544|NCT01784523|517163356|FG001|Overall Study|Study closed early|4|||
143441545|NCT04340947|517163359|FG000|7-day Washout Period|Lost to Follow-up|5|||
143441546|NCT04340947|517163360|FG001|7-day Washout Period|Lost to Follow-up|4|||
143441547|NCT01907906|517163361|FG000|Overall Study|Withdrawal by Subject|1|||
143441548|NCT01907906|517163362|FG001|Overall Study|Withdrawal by Subject|0|||
143441549|NCT01907906|517163361|FG000|Overall Study|Physician Decision|3|||
143441550|NCT01907906|517163362|FG001|Overall Study|Physician Decision|1|||
143441551|NCT00884650|517163363|FG000|Overall Study|Did not return complete pain diaries|7|||
143441552|NCT00884650|517163364|FG001|Overall Study|Did not return complete pain diaries|7|||
143441553|NCT00884650|517163363|FG000|Overall Study|Admitted Post-Op|1|||
143441554|NCT00884650|517163364|FG001|Overall Study|Admitted Post-Op|0|||
143441555|NCT00884650|517163363|FG000|Overall Study|Femoral Stress Fracture|1|||
143441556|NCT00884650|517163364|FG001|Overall Study|Femoral Stress Fracture|0|||
143441557|NCT00884650|517163363|FG000|Overall Study|Pain Pump Complication|0|||
143441558|NCT00884650|517163364|FG001|Overall Study|Pain Pump Complication|1|||
143441559|NCT04334278|517163367|FG000|Overall Study|Lost to Follow-up|0|||
143441560|NCT04334278|517163368|FG001|Overall Study|Lost to Follow-up|3|||
143441561|NCT04334278|517163367|FG000|Overall Study|Withdrawal by Subject|4|||
143441562|NCT04334278|517163368|FG001|Overall Study|Withdrawal by Subject|2|||
143441563|NCT02030002|517163369|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
143441564|NCT02030002|517163369|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
143441565|NCT02030002|517163369|FG000|Follow-up|Lost to Follow-up|2|||
143441566|NCT03994731|517163370|FG000|Pegloticase + IMM Period|Death|2|||
143441567|NCT03994731|517163371|FG001|Pegloticase + IMM Period|Death|0|||
143441568|NCT03994731|517163370|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
143441569|NCT03994731|517163371|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
143441570|NCT03994731|517163370|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
143441571|NCT03994731|517163371|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
143441572|NCT02406248|517163372|FG000|Overall Study|Death|7|||
143441573|NCT02406248|517163372|FG000|Overall Study|Withdrawal by Subject|2|||
143441574|NCT00790205|517163377|FG000|Overall Study|Lost to Follow-up|61|||
143441575|NCT00790205|517163378|FG001|Overall Study|Lost to Follow-up|71|||
143441576|NCT00790205|517163377|FG000|Overall Study|Withdrawal by Subject|299|||
143441577|NCT00790205|517163378|FG001|Overall Study|Withdrawal by Subject|363|||
143441578|NCT04805073|517163383|FG000|Overall Study|study personnel not available|2|||
143441579|NCT04805073|517163384|FG001|Overall Study|study personnel not available|0|||
143441580|NCT04805073|517163383|FG000|Overall Study|spinal anesthesia failure|0|||
143441581|NCT04805073|517163384|FG001|Overall Study|spinal anesthesia failure|1|||
143441582|NCT04805073|517163383|FG000|Overall Study|Lost to Follow-up|0|||
143441583|NCT04805073|517163384|FG001|Overall Study|Lost to Follow-up|2|||
143441584|NCT02975102|517163387|FG000|Overall Study|Adverse Event|2|||
143441585|NCT02975102|517163388|FG001|Overall Study|Adverse Event|1|||
143441586|NCT01162486|517163389|FG000|Overall Study|low ANC|1|||
143441587|NCT01162486|517163390|FG001|Overall Study|low ANC|0|||
143441588|NCT01162486|517163391|FG002|Overall Study|low ANC|0|||
143441589|NCT01162486|517163392|FG003|Overall Study|low ANC|0|||
143441590|NCT01162486|517163393|FG004|Overall Study|low ANC|0|||
143441591|NCT01162486|517163389|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
143441592|NCT01162486|517163390|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
143441593|NCT01162486|517163391|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
143441594|NCT01162486|517163392|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
143441595|NCT01162486|517163393|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
143441596|NCT01162486|517163389|FG000|Overall Study|elevated LFTs|0|||
143441597|NCT01162486|517163390|FG001|Overall Study|elevated LFTs|0|||
143441598|NCT01162486|517163391|FG002|Overall Study|elevated LFTs|1|||
143441599|NCT01162486|517163392|FG003|Overall Study|elevated LFTs|0|||
143441600|NCT01162486|517163393|FG004|Overall Study|elevated LFTs|0|||
143441601|NCT01162486|517163389|FG000|Overall Study|Pregnancy|0|||
143441602|NCT01162486|517163390|FG001|Overall Study|Pregnancy|0|||
143441603|NCT01162486|517163391|FG002|Overall Study|Pregnancy|0|||
143441604|NCT01162486|517163392|FG003|Overall Study|Pregnancy|1|||
143441605|NCT01162486|517163393|FG004|Overall Study|Pregnancy|0|||
143441606|NCT03274895|517163394|FG000|Overall Study|Lack of Efficacy|1|||
143441607|NCT03274895|517163395|FG001|Overall Study|Lack of Efficacy|0|||
143441608|NCT03274895|517163394|FG000|Overall Study|Adverse Event|8|||
143441609|NCT03274895|517163395|FG001|Overall Study|Adverse Event|7|||
143441610|NCT03274895|517163394|FG000|Overall Study|Lost to Follow-up|1|||
143441611|NCT03274895|517163395|FG001|Overall Study|Lost to Follow-up|0|||
143441612|NCT03274895|517163394|FG000|Overall Study|Diagnosis not confirmed|3|||
143441613|NCT03274895|517163395|FG001|Overall Study|Diagnosis not confirmed|4|||
143441614|NCT03332784|517163396|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
143441615|NCT03332784|517163397|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
143441616|NCT03332784|517163398|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
143441617|NCT03332784|517163399|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
143441618|NCT03332784|517163400|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
143441619|NCT03332784|517163401|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
143441620|NCT03332784|517163402|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
143441621|NCT03332784|517163403|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
143441622|NCT03332784|517163404|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
143441623|NCT03332784|517163405|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
143441624|NCT03332784|517163406|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
143441625|NCT03332784|517163407|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
143441626|NCT03332784|517163408|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
143441627|NCT03332784|517163409|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
143441628|NCT03332784|517163410|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
143441629|NCT03332784|517163411|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
143441630|NCT03332784|517163412|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
143441631|NCT03332784|517163413|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
143441632|NCT03332784|517163414|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
143441633|NCT03332784|517163415|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
143441634|NCT02498236|517163416|FG000|Overall Study|Did not show for testing|1|||
143441635|NCT02498236|517163417|FG001|Overall Study|Did not show for testing|0|||
143441636|NCT02498236|517163418|FG002|Overall Study|Did not show for testing|0|||
143441637|NCT02498236|517163419|FG003|Overall Study|Did not show for testing|0|||
143441638|NCT02498236|517163420|FG004|Overall Study|Did not show for testing|0|||
143441639|NCT02498236|517163421|FG005|Overall Study|Did not show for testing|0|||
143441640|NCT02498236|517163422|FG006|Overall Study|Did not show for testing|0|||
143441641|NCT02498236|517163423|FG007|Overall Study|Did not show for testing|1|||
143441642|NCT02498236|517163416|FG000|Overall Study|Equipment failure|0|||
143441643|NCT02498236|517163417|FG001|Overall Study|Equipment failure|0|||
143441644|NCT02498236|517163418|FG002|Overall Study|Equipment failure|0|||
143441645|NCT02498236|517163419|FG003|Overall Study|Equipment failure|0|||
143441646|NCT02498236|517163420|FG004|Overall Study|Equipment failure|0|||
143441647|NCT02498236|517163421|FG005|Overall Study|Equipment failure|0|||
143441648|NCT02498236|517163422|FG006|Overall Study|Equipment failure|1|||
143441649|NCT02498236|517163423|FG007|Overall Study|Equipment failure|0|||
143441650|NCT02498236|517163416|FG000|Overall Study|Withdrawal by Subject|0|||
143441651|NCT02498236|517163417|FG001|Overall Study|Withdrawal by Subject|0|||
143441652|NCT02498236|517163418|FG002|Overall Study|Withdrawal by Subject|0|||
143441653|NCT02498236|517163419|FG003|Overall Study|Withdrawal by Subject|0|||
143441654|NCT02498236|517163420|FG004|Overall Study|Withdrawal by Subject|1|||
143441655|NCT02498236|517163421|FG005|Overall Study|Withdrawal by Subject|0|||
143441656|NCT02498236|517163422|FG006|Overall Study|Withdrawal by Subject|0|||
143441657|NCT02498236|517163423|FG007|Overall Study|Withdrawal by Subject|0|||
143441658|NCT02296892|517163424|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
143441659|NCT02296892|517163425|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
143441660|NCT02296892|517163426|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
143441661|NCT02296892|517163424|FG000|Overall Study|Lost to Follow-up|5|||
143441662|NCT02296892|517163425|FG001|Overall Study|Lost to Follow-up|0|||
143441663|NCT02296892|517163426|FG002|Overall Study|Lost to Follow-up|1|||
143441664|NCT00383123|517163429|FG000|Overall Study|Adverse Event|1|||
143441665|NCT00383123|517163430|FG001|Overall Study|Adverse Event|0|||
143441666|NCT00383123|517163429|FG000|Overall Study|Lost to Follow-up|68|||
143441667|NCT00383123|517163430|FG001|Overall Study|Lost to Follow-up|61|||
143441668|NCT00383123|517163429|FG000|Overall Study|Protocol Violation|5|||
143441669|NCT00383123|517163430|FG001|Overall Study|Protocol Violation|1|||
143441670|NCT00383123|517163429|FG000|Overall Study|Withdrawal by Subject|27|||
143441671|NCT00383123|517163430|FG001|Overall Study|Withdrawal by Subject|18|||
143441672|NCT00383123|517163429|FG000|Overall Study|Other reason|10|||
143441673|NCT00383123|517163430|FG001|Overall Study|Other reason|6|||
143441674|NCT01814072|517163431|FG000|Overall Study|Lost to Follow-up|2|||
143441675|NCT01814072|517163432|FG001|Overall Study|Lost to Follow-up|2|||
143441676|NCT01814072|517163433|FG002|Overall Study|Lost to Follow-up|2|||
143441677|NCT01814072|517163434|FG003|Overall Study|Lost to Follow-up|0|||
143441678|NCT01814072|517163435|FG004|Overall Study|Lost to Follow-up|2|||
143441679|NCT01814072|517163436|FG005|Overall Study|Lost to Follow-up|3|||
143441680|NCT01814072|517163437|FG006|Overall Study|Lost to Follow-up|3|||
143441681|NCT01814072|517163438|FG007|Overall Study|Lost to Follow-up|1|||
143441682|NCT01814072|517163439|FG008|Overall Study|Lost to Follow-up|2|||
143441683|NCT01814072|517163440|FG009|Overall Study|Lost to Follow-up|3|||
143441684|NCT01814072|517163441|FG010|Overall Study|Lost to Follow-up|1|||
143441685|NCT01814072|517163442|FG011|Overall Study|Lost to Follow-up|2|||
143441686|NCT01814072|517163443|FG012|Overall Study|Lost to Follow-up|2|||
143441687|NCT01814072|517163444|FG013|Overall Study|Lost to Follow-up|1|||
143441688|NCT01814072|517163445|FG014|Overall Study|Lost to Follow-up|2|||
143441689|NCT01814072|517163446|FG015|Overall Study|Lost to Follow-up|1|||
143441690|NCT01814072|517163447|FG016|Overall Study|Lost to Follow-up|3|||
143441691|NCT01814072|517163448|FG017|Overall Study|Lost to Follow-up|1|||
143441692|NCT01814072|517163449|FG018|Overall Study|Lost to Follow-up|3|||
143441693|NCT01814072|517163450|FG019|Overall Study|Lost to Follow-up|3|||
143441694|NCT01814072|517163451|FG020|Overall Study|Lost to Follow-up|2|||
143441695|NCT01814072|517163452|FG021|Overall Study|Lost to Follow-up|1|||
143441696|NCT01814072|517163453|FG022|Overall Study|Lost to Follow-up|3|||
143441697|NCT01814072|517163454|FG023|Overall Study|Lost to Follow-up|1|||
143441698|NCT01814072|517163455|FG024|Overall Study|Lost to Follow-up|4|||
143441699|NCT01814072|517163456|FG025|Overall Study|Lost to Follow-up|1|||
143441700|NCT01814072|517163457|FG026|Overall Study|Lost to Follow-up|1|||
143441701|NCT01814072|517163458|FG027|Overall Study|Lost to Follow-up|2|||
143441702|NCT01814072|517163459|FG028|Overall Study|Lost to Follow-up|3|||
143441703|NCT01814072|517163460|FG029|Overall Study|Lost to Follow-up|3|||
143441704|NCT01814072|517163461|FG030|Overall Study|Lost to Follow-up|2|||
143441705|NCT01814072|517163462|FG031|Overall Study|Lost to Follow-up|0|||
143441706|NCT01814072|517163431|FG000|Overall Study|Withdrawal by Subject|2|||
143441707|NCT01814072|517163432|FG001|Overall Study|Withdrawal by Subject|0|||
143441708|NCT01814072|517163433|FG002|Overall Study|Withdrawal by Subject|1|||
143441709|NCT01814072|517163434|FG003|Overall Study|Withdrawal by Subject|0|||
143441710|NCT01814072|517163435|FG004|Overall Study|Withdrawal by Subject|2|||
143441711|NCT01814072|517163436|FG005|Overall Study|Withdrawal by Subject|3|||
143441712|NCT01814072|517163437|FG006|Overall Study|Withdrawal by Subject|1|||
143441713|NCT01814072|517163438|FG007|Overall Study|Withdrawal by Subject|0|||
143441714|NCT01814072|517163439|FG008|Overall Study|Withdrawal by Subject|1|||
143441715|NCT01814072|517163440|FG009|Overall Study|Withdrawal by Subject|2|||
143441716|NCT01814072|517163441|FG010|Overall Study|Withdrawal by Subject|0|||
143441717|NCT01814072|517163442|FG011|Overall Study|Withdrawal by Subject|0|||
143441718|NCT01814072|517163443|FG012|Overall Study|Withdrawal by Subject|1|||
143441719|NCT01814072|517163444|FG013|Overall Study|Withdrawal by Subject|1|||
143441720|NCT01814072|517163445|FG014|Overall Study|Withdrawal by Subject|1|||
143441721|NCT01814072|517163446|FG015|Overall Study|Withdrawal by Subject|1|||
143441722|NCT01814072|517163447|FG016|Overall Study|Withdrawal by Subject|0|||
143441723|NCT01814072|517163448|FG017|Overall Study|Withdrawal by Subject|0|||
143441724|NCT01814072|517163449|FG018|Overall Study|Withdrawal by Subject|0|||
143441725|NCT01814072|517163450|FG019|Overall Study|Withdrawal by Subject|2|||
143441726|NCT01814072|517163451|FG020|Overall Study|Withdrawal by Subject|0|||
143441727|NCT01814072|517163452|FG021|Overall Study|Withdrawal by Subject|0|||
143441728|NCT01814072|517163453|FG022|Overall Study|Withdrawal by Subject|1|||
143441729|NCT01814072|517163454|FG023|Overall Study|Withdrawal by Subject|0|||
143441730|NCT01814072|517163455|FG024|Overall Study|Withdrawal by Subject|2|||
143441731|NCT01814072|517163456|FG025|Overall Study|Withdrawal by Subject|1|||
143441732|NCT01814072|517163457|FG026|Overall Study|Withdrawal by Subject|1|||
143441733|NCT01814072|517163458|FG027|Overall Study|Withdrawal by Subject|2|||
143441734|NCT01814072|517163459|FG028|Overall Study|Withdrawal by Subject|1|||
143441735|NCT01814072|517163460|FG029|Overall Study|Withdrawal by Subject|0|||
143441736|NCT01814072|517163461|FG030|Overall Study|Withdrawal by Subject|0|||
143441737|NCT01814072|517163462|FG031|Overall Study|Withdrawal by Subject|0|||
143441738|NCT03566979|517163463|FG000|Overall Study|Withdrawal by Subject|2|||
143441739|NCT03566979|517163464|FG001|Overall Study|Withdrawal by Subject|0|||
143441740|NCT03566979|517163465|FG002|Overall Study|Withdrawal by Subject|1|||
143441741|NCT03566979|517163466|FG003|Overall Study|Withdrawal by Subject|1|||
143441742|NCT03566979|517163463|FG000|Overall Study|Lost to Follow-up|2|||
143441743|NCT03566979|517163464|FG001|Overall Study|Lost to Follow-up|7|||
143441744|NCT03566979|517163465|FG002|Overall Study|Lost to Follow-up|9|||
143441745|NCT03566979|517163466|FG003|Overall Study|Lost to Follow-up|5|||
143441746|NCT03566979|517163463|FG000|Overall Study|Adverse Event|1|||
143441747|NCT03566979|517163464|FG001|Overall Study|Adverse Event|0|||
143441748|NCT03566979|517163465|FG002|Overall Study|Adverse Event|0|||
143441749|NCT03566979|517163466|FG003|Overall Study|Adverse Event|0|||
143441750|NCT04547023|517163471|FG000|Overall Study|Did Not Receive Intervention|3|||
143441751|NCT04547023|517163472|FG001|Overall Study|Did Not Receive Intervention|2|||
143441752|NCT04547023|517163471|FG000|Overall Study|Lost to Follow-up|1|||
143441753|NCT04547023|517163472|FG001|Overall Study|Lost to Follow-up|1|||
143441754|NCT04946942|517163473|FG000|Overall Study|Lost to Follow-up|6|||
143441755|NCT04946942|517163474|FG001|Overall Study|Lost to Follow-up|2|||
143441756|NCT04946942|517163475|FG002|Overall Study|Lost to Follow-up|0|||
143441757|NCT00583947|517163479|FG000|Cross-over Period|Adverse Event|2|||
143441758|NCT00583947|517163480|FG001|Cross-over Period|Adverse Event|0|||
143441759|NCT00583947|517163479|FG000|Cross-over Period|Withdrawal by Subject|2|||
143441760|NCT00583947|517163480|FG001|Cross-over Period|Withdrawal by Subject|0|||
143441761|NCT00583947|517163479|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
143441762|NCT00583947|517163480|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
143441763|NCT00583947|517163479|FG000|Cross-over Period|Other|1|||
143441764|NCT00583947|517163480|FG001|Cross-over Period|Other|1|||
143441765|NCT00486252|517163481|FG000|Overall Study|Adverse Event|7|||
143441766|NCT00486252|517163481|FG000|Overall Study|Lack of Efficacy|9|||
143441767|NCT00486252|517163481|FG000|Overall Study|Lost to Follow-up|24|||
143441768|NCT00486252|517163481|FG000|Overall Study|Other|18|||
143441769|NCT02520310|517163482|FG000|At 6 Months Clinical Follow-up|Death|1|||
143441770|NCT02520310|517163482|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
143441771|NCT02520310|517163482|FG000|AT 3 Year Clinical Follow-up|Death|2|||
143441772|NCT02520310|517163482|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
143441773|NCT02520310|517163482|FG000|AT 4 Year Clinical Follow-up|Death|1|||
143441774|NCT02520310|517163482|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
143441775|NCT06719986|517163485|FG000|Washout (up to 72 Hours)|Adverse Event|0|||
143441776|NCT06719986|517163486|FG001|Washout (up to 72 Hours)|Adverse Event|0|||
143441777|NCT06719986|517163487|FG002|Washout (up to 72 Hours)|Adverse Event|1|||
143441778|NCT06719986|517163485|FG000|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
143441779|NCT06719986|517163486|FG001|Washout (up to 72 Hours)|Withdrawal by Subject|1|||
143441780|NCT06719986|517163487|FG002|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
143441781|NCT02600897|517163488|FG000|Overall Study|Death|1|||
143441782|NCT02600897|517163489|FG001|Overall Study|Death|2|||
143441783|NCT02600897|517163490|FG002|Overall Study|Death|1|||
143441784|NCT02600897|517163491|FG003|Overall Study|Death|2|||
143441785|NCT02600897|517163492|FG004|Overall Study|Death|3|||
143441786|NCT02600897|517163493|FG005|Overall Study|Death|2|||
143441787|NCT02600897|517163494|FG006|Overall Study|Death|10|||
143441788|NCT02600897|517163495|FG007|Overall Study|Death|7|||
143441789|NCT02600897|517163496|FG008|Overall Study|Death|20|||
143441790|NCT02600897|517163488|FG000|Overall Study|Lost to Follow-up|1|||
143441791|NCT02600897|517163489|FG001|Overall Study|Lost to Follow-up|0|||
143441792|NCT02600897|517163490|FG002|Overall Study|Lost to Follow-up|0|||
143441793|NCT02600897|517163491|FG003|Overall Study|Lost to Follow-up|0|||
143441794|NCT02600897|517163492|FG004|Overall Study|Lost to Follow-up|0|||
143441795|NCT02600897|517163493|FG005|Overall Study|Lost to Follow-up|0|||
143441796|NCT02600897|517163494|FG006|Overall Study|Lost to Follow-up|0|||
143441797|NCT02600897|517163495|FG007|Overall Study|Lost to Follow-up|1|||
143441798|NCT02600897|517163496|FG008|Overall Study|Lost to Follow-up|0|||
143441799|NCT02600897|517163488|FG000|Overall Study|Withdrawal by Subject|0|||
143441800|NCT02600897|517163489|FG001|Overall Study|Withdrawal by Subject|0|||
143441801|NCT02600897|517163490|FG002|Overall Study|Withdrawal by Subject|0|||
143441802|NCT02600897|517163491|FG003|Overall Study|Withdrawal by Subject|0|||
143441803|NCT02600897|517163492|FG004|Overall Study|Withdrawal by Subject|0|||
143441804|NCT02600897|517163493|FG005|Overall Study|Withdrawal by Subject|0|||
143441805|NCT02600897|517163494|FG006|Overall Study|Withdrawal by Subject|0|||
143441806|NCT02600897|517163495|FG007|Overall Study|Withdrawal by Subject|4|||
143441807|NCT02600897|517163496|FG008|Overall Study|Withdrawal by Subject|2|||
143441808|NCT02600897|517163488|FG000|Overall Study|Reason Not Specified|0|||
143441809|NCT02600897|517163489|FG001|Overall Study|Reason Not Specified|0|||
143441810|NCT02600897|517163490|FG002|Overall Study|Reason Not Specified|0|||
143441811|NCT02600897|517163491|FG003|Overall Study|Reason Not Specified|0|||
143441812|NCT02600897|517163492|FG004|Overall Study|Reason Not Specified|0|||
143441813|NCT02600897|517163493|FG005|Overall Study|Reason Not Specified|0|||
143441814|NCT02600897|517163494|FG006|Overall Study|Reason Not Specified|0|||
143441815|NCT02600897|517163495|FG007|Overall Study|Reason Not Specified|0|||
143441816|NCT02600897|517163496|FG008|Overall Study|Reason Not Specified|1|||
143441817|NCT03816761|517165610|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
143441818|NCT03816761|517165611|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
143441819|NCT03816761|517165612|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
143441820|NCT03816761|517165613|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
143441821|NCT03816761|517165614|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
143441822|NCT03816761|517165615|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
143441823|NCT03816761|517165610|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
143441824|NCT03816761|517165611|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
143441825|NCT03816761|517165612|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
143441826|NCT03816761|517165613|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
143441827|NCT03816761|517165614|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
143441828|NCT03816761|517165615|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
143441829|NCT01443403|517165616|FG000|Overall Study|Adverse Event|1|||
143441830|NCT01443403|517165617|FG001|Overall Study|Adverse Event|1|||
143441831|NCT01443403|517165618|FG002|Overall Study|Adverse Event|4|||
143441832|NCT01443403|517165619|FG003|Overall Study|Adverse Event|5|||
143441833|NCT01443403|517165616|FG000|Overall Study|Withdrawal by Subject|0|||
143441834|NCT01443403|517165617|FG001|Overall Study|Withdrawal by Subject|1|||
143441835|NCT01443403|517165618|FG002|Overall Study|Withdrawal by Subject|2|||
143441836|NCT01443403|517165619|FG003|Overall Study|Withdrawal by Subject|1|||
143441837|NCT01443403|517165616|FG000|Overall Study|Lost to Follow-up|0|||
143441838|NCT01443403|517165617|FG001|Overall Study|Lost to Follow-up|0|||
143441839|NCT01443403|517165618|FG002|Overall Study|Lost to Follow-up|0|||
143441840|NCT01443403|517165619|FG003|Overall Study|Lost to Follow-up|1|||
143441841|NCT01443403|517165616|FG000|Overall Study|Protocol Violation|2|||
143441842|NCT01443403|517165617|FG001|Overall Study|Protocol Violation|1|||
143441843|NCT01443403|517165618|FG002|Overall Study|Protocol Violation|1|||
143441844|NCT01443403|517165619|FG003|Overall Study|Protocol Violation|1|||
143441845|NCT01443403|517165616|FG000|Overall Study|Use of Prohibited Treatment|2|||
143441846|NCT01443403|517165617|FG001|Overall Study|Use of Prohibited Treatment|3|||
143441847|NCT01443403|517165618|FG002|Overall Study|Use of Prohibited Treatment|0|||
143441848|NCT01443403|517165619|FG003|Overall Study|Use of Prohibited Treatment|0|||
143441849|NCT01443403|517165616|FG000|Overall Study|Other - Miscellaneous|1|||
143441850|NCT01443403|517165617|FG001|Overall Study|Other - Miscellaneous|0|||
143441851|NCT01443403|517165618|FG002|Overall Study|Other - Miscellaneous|0|||
143441852|NCT01443403|517165619|FG003|Overall Study|Other - Miscellaneous|1|||
143441853|NCT00474526|517165620|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
143441854|NCT00474526|517165621|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
143441855|NCT00474526|517165622|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
143441856|NCT00474526|517165623|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
143441857|NCT00474526|517165624|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
143441858|NCT00474526|517165625|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
143441859|NCT00474526|517165626|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
143441860|NCT00474526|517165627|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
143441861|NCT00474526|517165628|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
143441862|NCT00474526|517165629|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
143441863|NCT00474526|517165630|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
143441864|NCT00474526|517165631|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
143441865|NCT00474526|517165632|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
143441866|NCT00474526|517165633|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
143441867|NCT00474526|517165634|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
143441868|NCT00474526|517165635|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
143441869|NCT00474526|517165636|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
143441870|NCT00474526|517165620|FG000|Overall Study|Adverse Event|2|||
143441871|NCT00474526|517165621|FG001|Overall Study|Adverse Event|0|||
143441872|NCT00474526|517165622|FG002|Overall Study|Adverse Event|2|||
143441873|NCT00474526|517165623|FG003|Overall Study|Adverse Event|4|||
143441874|NCT00474526|517165624|FG004|Overall Study|Adverse Event|2|||
143441875|NCT00474526|517165625|FG005|Overall Study|Adverse Event|1|||
143441876|NCT00474526|517165626|FG006|Overall Study|Adverse Event|1|||
143441877|NCT00474526|517165627|FG007|Overall Study|Adverse Event|0|||
143441878|NCT00474526|517165628|FG008|Overall Study|Adverse Event|0|||
143441879|NCT00474526|517165629|FG009|Overall Study|Adverse Event|0|||
143441880|NCT00474526|517165630|FG010|Overall Study|Adverse Event|0|||
143441881|NCT00474526|517165631|FG011|Overall Study|Adverse Event|0|||
143441882|NCT00474526|517165632|FG012|Overall Study|Adverse Event|0|||
143441883|NCT00474526|517165633|FG013|Overall Study|Adverse Event|0|||
143441884|NCT00474526|517165634|FG014|Overall Study|Adverse Event|1|||
143441885|NCT00474526|517165635|FG015|Overall Study|Adverse Event|1|||
143441886|NCT00474526|517165636|FG016|Overall Study|Adverse Event|0|||
143441887|NCT00474526|517165620|FG000|Overall Study|Death|0|||
143441888|NCT00474526|517165621|FG001|Overall Study|Death|0|||
143441889|NCT00474526|517165622|FG002|Overall Study|Death|0|||
143441890|NCT00474526|517165623|FG003|Overall Study|Death|0|||
143441891|NCT00474526|517165624|FG004|Overall Study|Death|0|||
143441892|NCT00474526|517165625|FG005|Overall Study|Death|0|||
143441893|NCT00474526|517165626|FG006|Overall Study|Death|0|||
143441894|NCT00474526|517165627|FG007|Overall Study|Death|0|||
143441895|NCT00474526|517165628|FG008|Overall Study|Death|0|||
143441896|NCT00474526|517165629|FG009|Overall Study|Death|0|||
143441897|NCT00474526|517165630|FG010|Overall Study|Death|0|||
143441898|NCT00474526|517165631|FG011|Overall Study|Death|0|||
143441899|NCT00474526|517165632|FG012|Overall Study|Death|0|||
143441900|NCT00474526|517165633|FG013|Overall Study|Death|3|||
143441901|NCT00474526|517165634|FG014|Overall Study|Death|0|||
143441902|NCT00474526|517165635|FG015|Overall Study|Death|0|||
143441903|NCT00474526|517165636|FG016|Overall Study|Death|0|||
143441904|NCT00474526|517165620|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
143441905|NCT00474526|517165621|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
143441906|NCT00474526|517165622|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
143441907|NCT00474526|517165623|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
143441908|NCT00474526|517165624|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
143441909|NCT00474526|517165625|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
143441910|NCT00474526|517165626|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
143441911|NCT00474526|517165627|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
143441912|NCT00474526|517165628|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
143441913|NCT00474526|517165629|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
143441914|NCT00474526|517165630|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
143441915|NCT00474526|517165631|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
143441916|NCT00474526|517165632|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
143441917|NCT00474526|517165633|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
143441918|NCT00474526|517165634|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
143441919|NCT00474526|517165635|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
143441920|NCT00474526|517165636|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
143441921|NCT00474526|517165620|FG000|Overall Study|Lost to Follow-up|8|||
143441922|NCT00474526|517165621|FG001|Overall Study|Lost to Follow-up|6|||
143441923|NCT00474526|517165622|FG002|Overall Study|Lost to Follow-up|13|||
143441924|NCT00474526|517165623|FG003|Overall Study|Lost to Follow-up|29|||
143441925|NCT00474526|517165624|FG004|Overall Study|Lost to Follow-up|11|||
143441926|NCT00474526|517165625|FG005|Overall Study|Lost to Follow-up|5|||
143441927|NCT00474526|517165626|FG006|Overall Study|Lost to Follow-up|8|||
143441928|NCT00474526|517165627|FG007|Overall Study|Lost to Follow-up|1|||
143441929|NCT00474526|517165628|FG008|Overall Study|Lost to Follow-up|0|||
143441930|NCT00474526|517165629|FG009|Overall Study|Lost to Follow-up|6|||
143441931|NCT00474526|517165630|FG010|Overall Study|Lost to Follow-up|2|||
143441932|NCT00474526|517165631|FG011|Overall Study|Lost to Follow-up|4|||
143441933|NCT00474526|517165632|FG012|Overall Study|Lost to Follow-up|6|||
143441934|NCT00474526|517165633|FG013|Overall Study|Lost to Follow-up|74|||
143441935|NCT00474526|517165634|FG014|Overall Study|Lost to Follow-up|29|||
143441936|NCT00474526|517165635|FG015|Overall Study|Lost to Follow-up|4|||
143441937|NCT00474526|517165636|FG016|Overall Study|Lost to Follow-up|5|||
143441938|NCT00474526|517165620|FG000|Overall Study|Protocol Violation|2|||
143441939|NCT00474526|517165621|FG001|Overall Study|Protocol Violation|6|||
143441940|NCT00474526|517165622|FG002|Overall Study|Protocol Violation|4|||
143441941|NCT00474526|517165623|FG003|Overall Study|Protocol Violation|12|||
143441942|NCT00474526|517165624|FG004|Overall Study|Protocol Violation|3|||
143441943|NCT00474526|517165625|FG005|Overall Study|Protocol Violation|1|||
143441944|NCT00474526|517165626|FG006|Overall Study|Protocol Violation|3|||
143441945|NCT00474526|517165627|FG007|Overall Study|Protocol Violation|0|||
143441946|NCT00474526|517165628|FG008|Overall Study|Protocol Violation|0|||
143441947|NCT00474526|517165629|FG009|Overall Study|Protocol Violation|4|||
143441948|NCT00474526|517165630|FG010|Overall Study|Protocol Violation|2|||
143441949|NCT00474526|517165631|FG011|Overall Study|Protocol Violation|2|||
143441950|NCT00474526|517165632|FG012|Overall Study|Protocol Violation|4|||
143441951|NCT00474526|517165633|FG013|Overall Study|Protocol Violation|19|||
143441952|NCT00474526|517165634|FG014|Overall Study|Protocol Violation|9|||
143441953|NCT00474526|517165635|FG015|Overall Study|Protocol Violation|6|||
143441954|NCT00474526|517165636|FG016|Overall Study|Protocol Violation|2|||
143441955|NCT00474526|517165620|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
143441956|NCT00474526|517165621|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
143441957|NCT00474526|517165622|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
143441958|NCT00474526|517165623|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
143441959|NCT00474526|517165624|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
143441960|NCT00474526|517165625|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
143441961|NCT00474526|517165626|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
143441962|NCT00474526|517165627|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
143441963|NCT00474526|517165628|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
143441964|NCT00474526|517165629|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
143441965|NCT00474526|517165630|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
143441966|NCT00474526|517165631|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
143441967|NCT00474526|517165632|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
143441968|NCT00474526|517165633|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
143441969|NCT00474526|517165634|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
143441970|NCT00474526|517165635|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
143441971|NCT00474526|517165636|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
143441972|NCT00474526|517165620|FG000|Overall Study|Withdrawal by Subject|9|||
143441973|NCT00474526|517165621|FG001|Overall Study|Withdrawal by Subject|24|||
143441974|NCT00474526|517165622|FG002|Overall Study|Withdrawal by Subject|21|||
143441975|NCT00474526|517165623|FG003|Overall Study|Withdrawal by Subject|52|||
143441976|NCT00474526|517165624|FG004|Overall Study|Withdrawal by Subject|38|||
143441977|NCT00474526|517165625|FG005|Overall Study|Withdrawal by Subject|6|||
143441978|NCT00474526|517165626|FG006|Overall Study|Withdrawal by Subject|12|||
143441979|NCT00474526|517165627|FG007|Overall Study|Withdrawal by Subject|4|||
143441980|NCT00474526|517165628|FG008|Overall Study|Withdrawal by Subject|4|||
143441981|NCT00474526|517165629|FG009|Overall Study|Withdrawal by Subject|13|||
143441982|NCT00474526|517165630|FG010|Overall Study|Withdrawal by Subject|5|||
143441983|NCT00474526|517165631|FG011|Overall Study|Withdrawal by Subject|4|||
143441984|NCT00474526|517165632|FG012|Overall Study|Withdrawal by Subject|4|||
143441985|NCT00474526|517165633|FG013|Overall Study|Withdrawal by Subject|37|||
143441986|NCT00474526|517165634|FG014|Overall Study|Withdrawal by Subject|22|||
143441987|NCT00474526|517165635|FG015|Overall Study|Withdrawal by Subject|1|||
143441988|NCT00474526|517165636|FG016|Overall Study|Withdrawal by Subject|1|||
143441989|NCT02797522|517165637|FG000|Overall Study|Study Terminated by Sponsor|0|||
143441990|NCT02797522|517165638|FG001|Overall Study|Study Terminated by Sponsor|0|||
143441991|NCT02797522|517165639|FG002|Overall Study|Study Terminated by Sponsor|0|||
143441992|NCT02797522|517165640|FG003|Overall Study|Study Terminated by Sponsor|0|||
143441993|NCT02797522|517165641|FG004|Overall Study|Study Terminated by Sponsor|0|||
143441994|NCT02797522|517165642|FG005|Overall Study|Study Terminated by Sponsor|0|||
143441995|NCT02797522|517165643|FG006|Overall Study|Study Terminated by Sponsor|0|||
143441996|NCT02797522|517165644|FG007|Overall Study|Study Terminated by Sponsor|4|||
143441997|NCT02797522|517165645|FG008|Overall Study|Study Terminated by Sponsor|2|||
143441998|NCT02797522|517165646|FG009|Overall Study|Study Terminated by Sponsor|4|||
143441999|NCT02797522|517165647|FG010|Overall Study|Study Terminated by Sponsor|1|||
143442000|NCT00132678|517165650|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
143442001|NCT00132678|517165651|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
143442002|NCT00132678|517165652|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
143442003|NCT00132678|517165650|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
143442004|NCT00132678|517165651|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
143442005|NCT00132678|517165652|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
143442006|NCT00132678|517165650|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
143442007|NCT00132678|517165651|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
143442008|NCT00132678|517165652|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
143442009|NCT00132678|517165650|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
143442010|NCT00132678|517165651|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
143442011|NCT00132678|517165652|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
143442012|NCT00132678|517165650|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
143442013|NCT00132678|517165651|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
143442014|NCT00132678|517165652|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
143442015|NCT00132678|517165650|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
143442016|NCT00132678|517165651|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
143442017|NCT00132678|517165652|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
143442018|NCT00132678|517165650|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
143442019|NCT00132678|517165651|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
143442020|NCT00132678|517165652|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
143442021|NCT00132678|517165650|FG000|Period III (Open-Label Stabilization)|Death|2|||
143442022|NCT00132678|517165651|FG001|Period III (Open-Label Stabilization)|Death|0|||
143442023|NCT00132678|517165652|FG002|Period III (Open-Label Stabilization)|Death|0|||
143442024|NCT00132678|517165650|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
143442025|NCT00132678|517165651|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
143442026|NCT00132678|517165652|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
143442027|NCT00132678|517165650|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
143442028|NCT00132678|517165651|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
143442029|NCT00132678|517165652|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
143442030|NCT00132678|517165650|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
143442031|NCT00132678|517165651|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
143442032|NCT00132678|517165652|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
143442033|NCT00132678|517165650|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
143442034|NCT00132678|517165651|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
143442035|NCT00132678|517165652|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
143442036|NCT00132678|517165650|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
143442037|NCT00132678|517165651|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
143442038|NCT00132678|517165652|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
143442039|NCT00132678|517165650|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
143442040|NCT00132678|517165651|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
143442041|NCT00132678|517165652|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
143442042|NCT00132678|517165650|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
143442043|NCT00132678|517165651|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
143442044|NCT00132678|517165652|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
143442045|NCT00132678|517165650|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
143442046|NCT00132678|517165651|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
143442047|NCT00132678|517165652|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
143442048|NCT00132678|517165650|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
143442049|NCT00132678|517165651|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
143442050|NCT00132678|517165652|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
143442051|NCT00132678|517165650|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
143442052|NCT00132678|517165651|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
143442053|NCT00132678|517165652|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
143442054|NCT00132678|517165650|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
143442055|NCT00132678|517165651|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
143442056|NCT00132678|517165652|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
143442057|NCT00132678|517165650|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
143442058|NCT00132678|517165651|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
143442059|NCT00132678|517165652|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
143442060|NCT00132678|517165650|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
143442061|NCT00132678|517165651|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
143442062|NCT00132678|517165652|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
143442063|NCT00132678|517165650|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
143442064|NCT00132678|517165651|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
143442065|NCT00132678|517165652|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
143442066|NCT00132678|517165650|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
143442067|NCT00132678|517165651|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
143442068|NCT00132678|517165652|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
143442069|NCT00953147|517165655|FG000|Overall Study|Adverse Event|8|||
143442070|NCT00953147|517165656|FG001|Overall Study|Adverse Event|16|||
143442071|NCT00953147|517165657|FG002|Overall Study|Adverse Event|6|||
143442072|NCT00953147|517165655|FG000|Overall Study|Protocol Violation|2|||
143442073|NCT00953147|517165656|FG001|Overall Study|Protocol Violation|8|||
143442074|NCT00953147|517165657|FG002|Overall Study|Protocol Violation|4|||
143442075|NCT00953147|517165655|FG000|Overall Study|Withdrawal by Subject|13|||
143442076|NCT00953147|517165656|FG001|Overall Study|Withdrawal by Subject|15|||
143442077|NCT00953147|517165657|FG002|Overall Study|Withdrawal by Subject|12|||
143442078|NCT00953147|517165655|FG000|Overall Study|Lost to Follow-up|8|||
143442079|NCT00953147|517165656|FG001|Overall Study|Lost to Follow-up|9|||
143442080|NCT00953147|517165657|FG002|Overall Study|Lost to Follow-up|4|||
143442081|NCT00953147|517165655|FG000|Overall Study|Physician Decision|2|||
143442082|NCT00953147|517165656|FG001|Overall Study|Physician Decision|7|||
143442083|NCT00953147|517165657|FG002|Overall Study|Physician Decision|3|||
143442084|NCT00953147|517165655|FG000|Overall Study|Other|4|||
143442085|NCT00953147|517165656|FG001|Overall Study|Other|11|||
143442086|NCT00953147|517165657|FG002|Overall Study|Other|13|||
143442087|NCT01484431|517165658|FG000|Period 1: High Dose|Physician Decision|0|||
143442088|NCT01484431|517165659|FG001|Period 1: High Dose|Physician Decision|1|||
143442089|NCT01484431|517165660|FG002|Period 1: High Dose|Physician Decision|0|||
143442090|NCT01484431|517165658|FG000|Period 2|Death|0|||
143442091|NCT01484431|517165659|FG001|Period 2|Death|1|||
143442092|NCT01484431|517165660|FG002|Period 2|Death|1|||
143442093|NCT01484431|517165658|FG000|Period 2|Physician Decision|0|||
143442094|NCT01484431|517165659|FG001|Period 2|Physician Decision|0|||
143442095|NCT01484431|517165660|FG002|Period 2|Physician Decision|1|||
143442096|NCT01484431|517165658|FG000|Period 2|Non-Compliance with Study Drug|1|||
143442097|NCT01484431|517165659|FG001|Period 2|Non-Compliance with Study Drug|0|||
143442098|NCT01484431|517165660|FG002|Period 2|Non-Compliance with Study Drug|0|||
143442099|NCT01251770|517165661|FG000|Overall Study|Protocol Violation|13|||
143442100|NCT01251770|517165662|FG001|Overall Study|Protocol Violation|7|||
143442101|NCT02514239|517165663|FG000|Overall Study|Refused to continue trial medication|0|||
143442102|NCT02514239|517165664|FG001|Overall Study|Refused to continue trial medication|0|||
143442103|NCT02514239|517165665|FG002|Overall Study|Refused to continue trial medication|0|||
143442104|NCT02514239|517165666|FG003|Overall Study|Refused to continue trial medication|0|||
143442105|NCT02514239|517165667|FG004|Overall Study|Refused to continue trial medication|0|||
143442106|NCT02514239|517165668|FG005|Overall Study|Refused to continue trial medication|0|||
143442107|NCT02514239|517165669|FG006|Overall Study|Refused to continue trial medication|0|||
143442108|NCT02514239|517165670|FG007|Overall Study|Refused to continue trial medication|0|||
143442109|NCT02514239|517165671|FG008|Overall Study|Refused to continue trial medication|0|||
143442110|NCT02514239|517165672|FG009|Overall Study|Refused to continue trial medication|1|||
143442111|NCT02514239|517165663|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
143442112|NCT02514239|517165664|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
143442113|NCT02514239|517165665|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
143442114|NCT02514239|517165666|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
143442115|NCT02514239|517165667|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
143442116|NCT02514239|517165668|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
143442117|NCT02514239|517165669|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
143442118|NCT02514239|517165670|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
143442119|NCT02514239|517165671|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
143442120|NCT02514239|517165672|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
143442121|NCT02514239|517165663|FG000|Overall Study|Not treated|0|||
143442122|NCT02514239|517165664|FG001|Overall Study|Not treated|1|||
143442123|NCT02514239|517165665|FG002|Overall Study|Not treated|0|||
143442124|NCT02514239|517165666|FG003|Overall Study|Not treated|0|||
143442125|NCT02514239|517165667|FG004|Overall Study|Not treated|0|||
143442126|NCT02514239|517165668|FG005|Overall Study|Not treated|0|||
143442127|NCT02514239|517165669|FG006|Overall Study|Not treated|0|||
143442128|NCT02514239|517165670|FG007|Overall Study|Not treated|0|||
143442129|NCT02514239|517165671|FG008|Overall Study|Not treated|0|||
143442130|NCT02514239|517165672|FG009|Overall Study|Not treated|0|||
143442131|NCT02514239|517165663|FG000|Overall Study|Other Adverse Events|2|||
143442132|NCT02514239|517165664|FG001|Overall Study|Other Adverse Events|0|||
143442133|NCT02514239|517165665|FG002|Overall Study|Other Adverse Events|0|||
143442134|NCT02514239|517165666|FG003|Overall Study|Other Adverse Events|1|||
143442135|NCT02514239|517165667|FG004|Overall Study|Other Adverse Events|0|||
143442136|NCT02514239|517165668|FG005|Overall Study|Other Adverse Events|1|||
143442137|NCT02514239|517165669|FG006|Overall Study|Other Adverse Events|0|||
143442138|NCT02514239|517165670|FG007|Overall Study|Other Adverse Events|1|||
143442139|NCT02514239|517165671|FG008|Overall Study|Other Adverse Events|2|||
143442140|NCT02514239|517165672|FG009|Overall Study|Other Adverse Events|0|||
143442141|NCT02514239|517165663|FG000|Overall Study|Progressive disease|3|||
143442142|NCT02514239|517165664|FG001|Overall Study|Progressive disease|3|||
143442143|NCT02514239|517165665|FG002|Overall Study|Progressive disease|2|||
143442144|NCT02514239|517165666|FG003|Overall Study|Progressive disease|2|||
143442145|NCT02514239|517165667|FG004|Overall Study|Progressive disease|3|||
143442146|NCT02514239|517165668|FG005|Overall Study|Progressive disease|3|||
143442147|NCT02514239|517165669|FG006|Overall Study|Progressive disease|4|||
143442148|NCT02514239|517165670|FG007|Overall Study|Progressive disease|2|||
143442149|NCT02514239|517165671|FG008|Overall Study|Progressive disease|5|||
143442150|NCT02514239|517165672|FG009|Overall Study|Progressive disease|0|||
143442151|NCT01888874|517165673|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
143442152|NCT01888874|517165674|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
143442153|NCT01888874|517165675|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
143442154|NCT01888874|517165676|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
143442155|NCT01888874|517165677|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
143442156|NCT01888874|517165678|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
143442157|NCT01888874|517165679|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
143442158|NCT01888874|517165673|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
143442159|NCT01888874|517165674|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
143442160|NCT01888874|517165675|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
143442161|NCT01888874|517165676|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
143442162|NCT01888874|517165677|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
143442163|NCT01888874|517165678|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
143442164|NCT01888874|517165679|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
143442165|NCT01888874|517165673|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
143442166|NCT01888874|517165674|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
143442167|NCT01888874|517165675|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
143442168|NCT01888874|517165676|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
143442169|NCT01888874|517165677|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
143442170|NCT01888874|517165678|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
143442171|NCT01888874|517165679|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
143442172|NCT01888874|517165673|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
143442173|NCT01888874|517165674|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
143442174|NCT01888874|517165675|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
143442175|NCT01888874|517165676|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
143442176|NCT01888874|517165677|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
143442177|NCT01888874|517165678|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
143442178|NCT01888874|517165679|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
143442179|NCT01888874|517165673|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
143442180|NCT01888874|517165674|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
143442181|NCT01888874|517165675|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
143442182|NCT01888874|517165676|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
143442183|NCT01888874|517165677|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
143442184|NCT01888874|517165678|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
143442185|NCT01888874|517165679|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
143442186|NCT01888874|517165673|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
143442187|NCT01888874|517165674|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
143442188|NCT01888874|517165675|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
143442189|NCT01888874|517165676|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
143442190|NCT01888874|517165677|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
143442191|NCT01888874|517165678|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
143442192|NCT01888874|517165679|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
143442193|NCT01888874|517165673|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
143442194|NCT01888874|517165674|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
143442195|NCT01888874|517165675|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
143442196|NCT01888874|517165676|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
143442197|NCT01888874|517165677|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
143442198|NCT01888874|517165678|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
143442199|NCT01888874|517165679|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
143442200|NCT01888874|517165673|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
143442201|NCT01888874|517165674|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
143442202|NCT01888874|517165675|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
143442203|NCT01888874|517165676|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
143442204|NCT01888874|517165677|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
143442205|NCT01888874|517165678|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
143442206|NCT01888874|517165679|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
143442207|NCT01888874|517165673|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
143442208|NCT01888874|517165674|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
143442209|NCT01888874|517165675|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
143442210|NCT01888874|517165676|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
143442211|NCT01888874|517165677|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
143442212|NCT01888874|517165678|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
143442213|NCT01888874|517165679|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
143442214|NCT01888874|517165673|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
143442215|NCT01888874|517165674|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
143442216|NCT01888874|517165675|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
143442217|NCT01888874|517165676|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
143442218|NCT01888874|517165677|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
143442219|NCT01888874|517165678|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
143442220|NCT01888874|517165679|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
143442221|NCT01888874|517165673|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
143442222|NCT01888874|517165674|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
143442223|NCT01888874|517165675|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
143442224|NCT01888874|517165676|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
143442225|NCT01888874|517165677|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
143442226|NCT01888874|517165678|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
143442227|NCT01888874|517165679|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
143442228|NCT01888874|517165673|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
143442229|NCT01888874|517165674|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
143442230|NCT01888874|517165675|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
143442231|NCT01888874|517165676|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
143442232|NCT01888874|517165677|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
143442233|NCT01888874|517165678|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
143442234|NCT01888874|517165679|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
143442235|NCT01888874|517165673|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
143442236|NCT01888874|517165674|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
143442237|NCT01888874|517165675|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
143442238|NCT01888874|517165676|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
143442239|NCT01888874|517165677|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
143442240|NCT01888874|517165678|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
143442241|NCT01888874|517165679|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
143442242|NCT02980042|517165682|FG000|Overall Study|Lost to Follow-up|5|||
143442243|NCT02980042|517165683|FG001|Overall Study|Lost to Follow-up|0|||
143442244|NCT02980042|517165682|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
143442245|NCT02980042|517165683|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
143442246|NCT01020877|517165691|FG000|Second Intervention|Withdrawal by Subject|1|||
143442247|NCT01020877|517165692|FG001|Second Intervention|Withdrawal by Subject|0|||
143442248|NCT01483144|517165693|FG000|Overall Study|Adverse Event|9|||
143442249|NCT01483144|517165694|FG001|Overall Study|Adverse Event|4|||
143442250|NCT01483144|517165695|FG002|Overall Study|Adverse Event|6|||
143442251|NCT01483144|517165693|FG000|Overall Study|Withdrawal by Subject|0|||
143442252|NCT01483144|517165694|FG001|Overall Study|Withdrawal by Subject|2|||
143442253|NCT01483144|517165695|FG002|Overall Study|Withdrawal by Subject|5|||
143442254|NCT01483144|517165693|FG000|Overall Study|Physician Decision|1|||
143442255|NCT01483144|517165694|FG001|Overall Study|Physician Decision|0|||
143442256|NCT01483144|517165695|FG002|Overall Study|Physician Decision|0|||
143442257|NCT01483144|517165693|FG000|Overall Study|Lost to Follow-up|2|||
143442258|NCT01483144|517165694|FG001|Overall Study|Lost to Follow-up|4|||
143442259|NCT01483144|517165695|FG002|Overall Study|Lost to Follow-up|1|||
143442260|NCT01483144|517165693|FG000|Overall Study|Protocol Violation|3|||
143442261|NCT01483144|517165694|FG001|Overall Study|Protocol Violation|3|||
143442262|NCT01483144|517165695|FG002|Overall Study|Protocol Violation|3|||
143442263|NCT00944229|517165696|FG000|Overall Study|Withdrawal by Subject|11|||
143442264|NCT00944229|517165696|FG000|Overall Study|Physician Decision|14|||
143442265|NCT02179177|517165697|FG000|Overall Study|Lost to Follow-up|1|||
143442266|NCT02179177|517165698|FG001|Overall Study|Lost to Follow-up|1|||
143442267|NCT02179177|517165697|FG000|Overall Study|Withdrawal by Subject|1|||
143442268|NCT02179177|517165698|FG001|Overall Study|Withdrawal by Subject|1|||
143442269|NCT04400487|517165699|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
143442270|NCT04400487|517165699|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
143442271|NCT04400487|517165699|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
143442272|NCT04052425|517165700|FG000|24-Week Double-blind Period|Adverse Event|0|||
143442273|NCT04052425|517165701|FG001|24-Week Double-blind Period|Adverse Event|1|||
143442274|NCT04052425|517165702|FG002|24-Week Double-blind Period|Adverse Event|0|||
143442275|NCT04052425|517165703|FG003|24-Week Double-blind Period|Adverse Event|0|||
143442276|NCT04052425|517165700|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
143442277|NCT04052425|517165701|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
143442278|NCT04052425|517165702|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
143442279|NCT04052425|517165703|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
143442280|NCT04052425|517165700|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
143442281|NCT04052425|517165701|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
143442282|NCT04052425|517165702|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
143442283|NCT04052425|517165703|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
143442284|NCT04052425|517165700|FG000|24-Week Double-blind Period|Physician Decision|1|||
143442285|NCT04052425|517165701|FG001|24-Week Double-blind Period|Physician Decision|0|||
143442286|NCT04052425|517165702|FG002|24-Week Double-blind Period|Physician Decision|0|||
143442287|NCT04052425|517165703|FG003|24-Week Double-blind Period|Physician Decision|0|||
143442288|NCT04052425|517165700|FG000|24-Week Double-blind Period|Protocol Violation|1|||
143442289|NCT04052425|517165701|FG001|24-Week Double-blind Period|Protocol Violation|0|||
143442290|NCT04052425|517165702|FG002|24-Week Double-blind Period|Protocol Violation|0|||
143442291|NCT04052425|517165703|FG003|24-Week Double-blind Period|Protocol Violation|0|||
143442292|NCT04052425|517165700|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
143442293|NCT04052425|517165701|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
143442294|NCT04052425|517165702|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
143442295|NCT04052425|517165703|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
143442296|NCT04052425|517165700|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
143442297|NCT04052425|517165701|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
143442298|NCT04052425|517165702|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
143442299|NCT04052425|517165703|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
143442300|NCT04052425|517165700|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
143442301|NCT04052425|517165701|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
143442302|NCT04052425|517165702|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
143442303|NCT04052425|517165703|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
143442304|NCT04052425|517165700|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
143442305|NCT04052425|517165701|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
143442306|NCT04052425|517165702|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
143442307|NCT04052425|517165703|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
143442308|NCT04052425|517165700|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
143442309|NCT04052425|517165701|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
143442310|NCT04052425|517165702|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
143442311|NCT04052425|517165703|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
143442312|NCT04052425|517165700|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
143442313|NCT04052425|517165701|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
143442314|NCT04052425|517165702|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
143442315|NCT04052425|517165703|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
143442316|NCT04052425|517165700|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
143442317|NCT04052425|517165701|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
143442318|NCT04052425|517165702|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
143442319|NCT04052425|517165703|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
143442320|NCT04052425|517165700|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
143442321|NCT04052425|517165701|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
143442322|NCT04052425|517165702|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
143442323|NCT04052425|517165703|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
143442324|NCT04052425|517165700|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
143442325|NCT04052425|517165701|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
143442326|NCT04052425|517165702|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
143442327|NCT04052425|517165703|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
143442328|NCT01677299|517165704|FG000|Overall Study|Adverse Event|0|||
143442329|NCT01677299|517165705|FG001|Overall Study|Adverse Event|2|||
143442330|NCT01677299|517165706|FG002|Overall Study|Adverse Event|1|||
143442331|NCT01677299|517165707|FG003|Overall Study|Adverse Event|0|||
143442332|NCT01677299|517165704|FG000|Overall Study|Withdrawal by Subject|0|||
143442333|NCT01677299|517165705|FG001|Overall Study|Withdrawal by Subject|1|||
143442334|NCT01677299|517165706|FG002|Overall Study|Withdrawal by Subject|0|||
143442335|NCT01677299|517165707|FG003|Overall Study|Withdrawal by Subject|1|||
143442336|NCT00520845|517165708|FG000|Overall Study|Death|3|||
143442337|NCT00520845|517165708|FG000|Overall Study|Adverse Event|4|||
143442338|NCT00520845|517165708|FG000|Overall Study|Disease Progression, relapse|13|||
143442339|NCT00520845|517165708|FG000|Overall Study|Withdrawal by Subject|1|||
143442340|NCT00520845|517165708|FG000|Overall Study|Alternative Therapy|1|||
143442341|NCT03334253|517165711|FG000|Overall Study|Withdrawal by Subject|1|||
143442342|NCT03334253|517165712|FG001|Overall Study|Withdrawal by Subject|0|||
143442343|NCT03334253|517165711|FG000|Overall Study|Lost to Follow-up|4|||
143442344|NCT03334253|517165712|FG001|Overall Study|Lost to Follow-up|3|||
143442345|NCT03334253|517165711|FG000|Overall Study|Moved residence|2|||
143442346|NCT03334253|517165712|FG001|Overall Study|Moved residence|2|||
143442347|NCT01516749|517165713|FG000|Active Therapy|Lost to Follow-up|1|||
143442348|NCT01516749|517165713|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
143442349|NCT01732549|517165714|FG000|Overall Study|Adverse Event|13|||
143442350|NCT01732549|517165715|FG001|Overall Study|Adverse Event|3|||
143442351|NCT01732549|517165714|FG000|Overall Study|Consent withdrawn|13|||
143442352|NCT01732549|517165715|FG001|Overall Study|Consent withdrawn|6|||
143442353|NCT01732549|517165714|FG000|Overall Study|Disease progression|37|||
143442354|NCT01732549|517165715|FG001|Overall Study|Disease progression|50|||
143442355|NCT01732549|517165714|FG000|Overall Study|Other|8|||
143442356|NCT01732549|517165715|FG001|Overall Study|Other|14|||
143442357|NCT00945672|517165717|FG000|Overall Study|Withdrawal by Subject|0|||
143442358|NCT00945672|517165718|FG001|Overall Study|Withdrawal by Subject|0|||
143442359|NCT00945672|517165719|FG002|Overall Study|Withdrawal by Subject|0|||
143442360|NCT00945672|517165720|FG003|Overall Study|Withdrawal by Subject|1|||
143442361|NCT01681992|517165727|FG000|Overall Study|Adverse Event|3|||
143442362|NCT01681992|517165728|FG001|Overall Study|Adverse Event|2|||
143442363|NCT01681992|517165729|FG002|Overall Study|Adverse Event|3|||
143442364|NCT01681992|517165727|FG000|Overall Study|Lost to Follow-up|36|||
143442365|NCT01681992|517165728|FG001|Overall Study|Lost to Follow-up|38|||
143442366|NCT01681992|517165729|FG002|Overall Study|Lost to Follow-up|53|||
143442367|NCT01681992|517165727|FG000|Overall Study|As Per Sponsor Decision|0|||
143442368|NCT01681992|517165728|FG001|Overall Study|As Per Sponsor Decision|0|||
143442369|NCT01681992|517165729|FG002|Overall Study|As Per Sponsor Decision|1|||
143442370|NCT01681992|517165727|FG000|Overall Study|Protocol Violation|0|||
143442371|NCT01681992|517165728|FG001|Overall Study|Protocol Violation|0|||
143442372|NCT01681992|517165729|FG002|Overall Study|Protocol Violation|1|||
143442373|NCT01681992|517165727|FG000|Overall Study|Withdrawal by Subject|27|||
143442374|NCT01681992|517165728|FG001|Overall Study|Withdrawal by Subject|30|||
143442375|NCT01681992|517165729|FG002|Overall Study|Withdrawal by Subject|25|||
143442376|NCT00447590|517165734|FG000|Overall Study|Withdrawal by Subject|26|||
143442377|NCT00447590|517165734|FG000|Overall Study|Lost to Follow-up|24|||
143442378|NCT00447590|517165734|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
143442379|NCT00609947|517165737|FG000|Overall Study|Death|1|||
143442380|NCT05569421|517165738|FG000|Overall Study|Withdrawal by Subject|1|||
143442381|NCT05569421|517165739|FG001|Overall Study|Withdrawal by Subject|0|||
143442382|NCT05569421|517165740|FG002|Overall Study|Withdrawal by Subject|0|||
143442383|NCT00504075|517165741|FG000|Overall Study|Adverse Event|1|||
143442384|NCT00504075|517165741|FG000|Overall Study|Lost to Follow-up|5|||
143442385|NCT00504075|517165741|FG000|Overall Study|Withdrawal by Subject|1|||
143442386|NCT00504075|517165741|FG000|Overall Study|Required other therapeutic intervention|1|||
143442387|NCT03812029|517165744|FG000|Overall Study|Protocol Violation|1|||
143442388|NCT03812029|517165745|FG001|Overall Study|Protocol Violation|0|||
143442389|NCT03812029|517165746|FG002|Overall Study|Protocol Violation|0|||
143442390|NCT03812029|517165747|FG003|Overall Study|Protocol Violation|1|||
143442391|NCT03812029|517165748|FG004|Overall Study|Protocol Violation|0|||
143442392|NCT03812029|517165744|FG000|Overall Study|Withdrawal by Subject|1|||
143442393|NCT03812029|517165745|FG001|Overall Study|Withdrawal by Subject|0|||
143442394|NCT03812029|517165746|FG002|Overall Study|Withdrawal by Subject|0|||
143442395|NCT03812029|517165747|FG003|Overall Study|Withdrawal by Subject|2|||
143442396|NCT03812029|517165748|FG004|Overall Study|Withdrawal by Subject|2|||
143442397|NCT03812029|517165744|FG000|Overall Study|Stopping rules|0|||
143442398|NCT03812029|517165745|FG001|Overall Study|Stopping rules|1|||
143442399|NCT03812029|517165746|FG002|Overall Study|Stopping rules|0|||
143442400|NCT03812029|517165747|FG003|Overall Study|Stopping rules|0|||
143442401|NCT03812029|517165748|FG004|Overall Study|Stopping rules|0|||
143442402|NCT03812029|517165744|FG000|Overall Study|Adverse Event|0|||
143442403|NCT03812029|517165745|FG001|Overall Study|Adverse Event|9|||
143442404|NCT03812029|517165746|FG002|Overall Study|Adverse Event|0|||
143442405|NCT03812029|517165747|FG003|Overall Study|Adverse Event|3|||
143442406|NCT03812029|517165748|FG004|Overall Study|Adverse Event|5|||
143442407|NCT03812029|517165744|FG000|Overall Study|Lost to Follow-up|0|||
143442408|NCT03812029|517165745|FG001|Overall Study|Lost to Follow-up|0|||
143442409|NCT03812029|517165746|FG002|Overall Study|Lost to Follow-up|0|||
143442410|NCT03812029|517165747|FG003|Overall Study|Lost to Follow-up|0|||
143442411|NCT03812029|517165748|FG004|Overall Study|Lost to Follow-up|3|||
143442412|NCT03149042|517165749|FG000|Overall Study|Invasive FFR not performed|21|||
143442413|NCT03149042|517165749|FG000|Overall Study|Poor CT Image Quality|1|||
143442414|NCT03149042|517165749|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
143442415|NCT02643628|517165750|FG000|Overall Study|Lost to Follow-up|1|||
143442416|NCT02643628|517165751|FG001|Overall Study|Lost to Follow-up|4|||
143442417|NCT02643628|517165750|FG000|Overall Study|Withdrawal by Subject|0|||
143442418|NCT02643628|517165751|FG001|Overall Study|Withdrawal by Subject|1|||
143442419|NCT02643628|517165750|FG000|Overall Study|Relocated out of state|0|||
143442420|NCT02643628|517165751|FG001|Overall Study|Relocated out of state|1|||
143442421|NCT00732992|517165752|FG000|Overall Study|Adverse Event|1|||
143442422|NCT00732992|517165753|FG001|Overall Study|Adverse Event|1|||
143442423|NCT00732992|517165752|FG000|Overall Study|Objective Progression or Relapse|3|||
143442424|NCT00732992|517165753|FG001|Overall Study|Objective Progression or Relapse|5|||
143442425|NCT00732992|517165752|FG000|Overall Study|Global Deterioration of Health Status|1|||
143442426|NCT00732992|517165753|FG001|Overall Study|Global Deterioration of Health Status|0|||
143442427|NCT00732992|517165752|FG000|Overall Study|Withdrawal by Subject|1|||
143442428|NCT00732992|517165753|FG001|Overall Study|Withdrawal by Subject|0|||
143442429|NCT03017742|517165758|FG000|Overall Study|Protocol Violation|36|||
143442430|NCT03017742|517165758|FG000|Overall Study|Withdrawal by Subject|37|||
143442431|NCT01441635|517165762|FG000|Overall Study|Adverse Event|4|||
143442432|NCT01441635|517165763|FG001|Overall Study|Adverse Event|3|||
143442433|NCT01441635|517165764|FG002|Overall Study|Adverse Event|1|||
143442434|NCT01441635|517165765|FG003|Overall Study|Adverse Event|5|||
143442435|NCT01441635|517165766|FG004|Overall Study|Adverse Event|1|||
143442436|NCT01441635|517165767|FG005|Overall Study|Adverse Event|2|||
143442437|NCT01441635|517165768|FG006|Overall Study|Adverse Event|2|||
143442438|NCT01441635|517165769|FG007|Overall Study|Adverse Event|2|||
143442439|NCT01441635|517165770|FG008|Overall Study|Adverse Event|1|||
143442440|NCT01441635|517165771|FG009|Overall Study|Adverse Event|0|||
143442441|NCT01441635|517165762|FG000|Overall Study|Withdrawal by Subject|1|||
143442442|NCT01441635|517165763|FG001|Overall Study|Withdrawal by Subject|1|||
143442443|NCT01441635|517165764|FG002|Overall Study|Withdrawal by Subject|0|||
143442444|NCT01441635|517165765|FG003|Overall Study|Withdrawal by Subject|1|||
143442445|NCT01441635|517165766|FG004|Overall Study|Withdrawal by Subject|0|||
143442446|NCT01441635|517165767|FG005|Overall Study|Withdrawal by Subject|0|||
143442447|NCT01441635|517165768|FG006|Overall Study|Withdrawal by Subject|2|||
143442448|NCT01441635|517165769|FG007|Overall Study|Withdrawal by Subject|0|||
143442449|NCT01441635|517165770|FG008|Overall Study|Withdrawal by Subject|1|||
143442450|NCT01441635|517165771|FG009|Overall Study|Withdrawal by Subject|1|||
143442451|NCT01441635|517165762|FG000|Overall Study|Lost to Follow-up|0|||
143442452|NCT01441635|517165763|FG001|Overall Study|Lost to Follow-up|1|||
143442453|NCT01441635|517165764|FG002|Overall Study|Lost to Follow-up|1|||
143442454|NCT01441635|517165765|FG003|Overall Study|Lost to Follow-up|1|||
143442455|NCT01441635|517165766|FG004|Overall Study|Lost to Follow-up|1|||
143442456|NCT01441635|517165767|FG005|Overall Study|Lost to Follow-up|3|||
143442457|NCT01441635|517165768|FG006|Overall Study|Lost to Follow-up|1|||
143442458|NCT01441635|517165769|FG007|Overall Study|Lost to Follow-up|1|||
143442459|NCT01441635|517165770|FG008|Overall Study|Lost to Follow-up|0|||
143442460|NCT01441635|517165771|FG009|Overall Study|Lost to Follow-up|1|||
143442461|NCT01441635|517165762|FG000|Overall Study|Noncompliance|0|||
143442462|NCT01441635|517165763|FG001|Overall Study|Noncompliance|1|||
143442463|NCT01441635|517165764|FG002|Overall Study|Noncompliance|0|||
143442464|NCT01441635|517165765|FG003|Overall Study|Noncompliance|0|||
143442465|NCT01441635|517165766|FG004|Overall Study|Noncompliance|0|||
143442466|NCT01441635|517165767|FG005|Overall Study|Noncompliance|0|||
143442467|NCT01441635|517165768|FG006|Overall Study|Noncompliance|1|||
143442468|NCT01441635|517165769|FG007|Overall Study|Noncompliance|0|||
143442469|NCT01441635|517165770|FG008|Overall Study|Noncompliance|0|||
143442470|NCT01441635|517165771|FG009|Overall Study|Noncompliance|0|||
143442471|NCT01441635|517165762|FG000|Overall Study|Surgery or Invasive Intervention|0|||
143442472|NCT01441635|517165763|FG001|Overall Study|Surgery or Invasive Intervention|0|||
143442473|NCT01441635|517165764|FG002|Overall Study|Surgery or Invasive Intervention|1|||
143442474|NCT01441635|517165765|FG003|Overall Study|Surgery or Invasive Intervention|0|||
143442475|NCT01441635|517165766|FG004|Overall Study|Surgery or Invasive Intervention|0|||
143442476|NCT01441635|517165767|FG005|Overall Study|Surgery or Invasive Intervention|0|||
143442477|NCT01441635|517165768|FG006|Overall Study|Surgery or Invasive Intervention|0|||
143442478|NCT01441635|517165769|FG007|Overall Study|Surgery or Invasive Intervention|0|||
143442479|NCT01441635|517165770|FG008|Overall Study|Surgery or Invasive Intervention|0|||
143442480|NCT01441635|517165771|FG009|Overall Study|Surgery or Invasive Intervention|0|||
143442481|NCT01441635|517165762|FG000|Overall Study|Received Exclusionary Medication|1|||
143442482|NCT01441635|517165763|FG001|Overall Study|Received Exclusionary Medication|0|||
143442483|NCT01441635|517165764|FG002|Overall Study|Received Exclusionary Medication|0|||
143442484|NCT01441635|517165765|FG003|Overall Study|Received Exclusionary Medication|0|||
143442485|NCT01441635|517165766|FG004|Overall Study|Received Exclusionary Medication|0|||
143442486|NCT01441635|517165767|FG005|Overall Study|Received Exclusionary Medication|0|||
143442487|NCT01441635|517165768|FG006|Overall Study|Received Exclusionary Medication|0|||
143442488|NCT01441635|517165769|FG007|Overall Study|Received Exclusionary Medication|0|||
143442489|NCT01441635|517165770|FG008|Overall Study|Received Exclusionary Medication|0|||
143442490|NCT01441635|517165771|FG009|Overall Study|Received Exclusionary Medication|0|||
143442491|NCT01441635|517165762|FG000|Overall Study|Other|0|||
143442492|NCT01441635|517165763|FG001|Overall Study|Other|0|||
143442493|NCT01441635|517165764|FG002|Overall Study|Other|0|||
143442494|NCT01441635|517165765|FG003|Overall Study|Other|0|||
143442495|NCT01441635|517165766|FG004|Overall Study|Other|0|||
143442496|NCT01441635|517165767|FG005|Overall Study|Other|0|||
143442497|NCT01441635|517165768|FG006|Overall Study|Other|0|||
143442498|NCT01441635|517165769|FG007|Overall Study|Other|1|||
143442499|NCT01441635|517165770|FG008|Overall Study|Other|0|||
143442500|NCT01441635|517165771|FG009|Overall Study|Other|0|||
143442501|NCT01825577|517165772|FG000|Overall Study|Physician Decision|2|||
143442502|NCT01825577|517165772|FG000|Overall Study|Withdrawal by Subject|1|||
143442503|NCT01825577|517165772|FG000|Overall Study|Withdrawn by family members|2|||
143442504|NCT01825577|517165772|FG000|Overall Study|Lack of Efficacy|3|||
143442505|NCT00358644|517165773|FG000|Overall Study|Progressive Disease|21|||
143442506|NCT00358644|517165773|FG000|Overall Study|Adverse Event|7|||
143442507|NCT00358644|517165773|FG000|Overall Study|Death|11|||
143442508|NCT00358644|517165773|FG000|Overall Study|Withdrawal by Subject|4|||
143442509|NCT00358644|517165773|FG000|Overall Study|Physician Decision|6|||
143442510|NCT00358644|517165773|FG000|Overall Study|Patient not eligible for study|1|||
143442511|NCT00513708|517165774|FG000|Overall Study|Lost to Follow-up|4|||
143442512|NCT00513708|517165775|FG001|Overall Study|Lost to Follow-up|4|||
143442513|NCT00513708|517165776|FG002|Overall Study|Lost to Follow-up|4|||
143442514|NCT00368875|517165777|FG000|Overall Study|Adverse Event|0|||
143442515|NCT00368875|517165778|FG001|Overall Study|Adverse Event|12|||
143442516|NCT00368875|517165777|FG000|Overall Study|Progressive disease|3|||
143442517|NCT00368875|517165778|FG001|Overall Study|Progressive disease|27|||
143442518|NCT00368875|517165777|FG000|Overall Study|Withdrawal by Subject|2|||
143442519|NCT00368875|517165778|FG001|Overall Study|Withdrawal by Subject|6|||
143442520|NCT00368875|517165777|FG000|Overall Study|Other Reason|0|||
143442521|NCT00368875|517165778|FG001|Overall Study|Other Reason|2|||
143442522|NCT00368875|517165777|FG000|Overall Study|Alternative Therapy|1|||
143442523|NCT00368875|517165778|FG001|Overall Study|Alternative Therapy|1|||
143442524|NCT03327831|517165779|FG000|Overall Study|Lost to Follow-up|2|||
143442525|NCT01564277|517165780|FG000|Overall Study|Protocol Violation|0|||
143442526|NCT01564277|517165781|FG001|Overall Study|Protocol Violation|1|||
143442527|NCT01564277|517165780|FG000|Overall Study|Physician Decision|1|||
143442528|NCT01564277|517165781|FG001|Overall Study|Physician Decision|0|||
143442529|NCT02595372|517165782|FG000|Overall Study|Adverse Event|6|||
143442530|NCT02595372|517165782|FG000|Overall Study|Physician Decision|2|||
143442531|NCT02595372|517165782|FG000|Overall Study|Disease Progression|1|||
143442532|NCT02473965|517167309|FG000|Overall Study|Adverse Event|6|||
143442533|NCT02473965|517167310|FG001|Overall Study|Adverse Event|4|||
143442534|NCT02473965|517167309|FG000|Overall Study|MG worsening|4|||
143442535|NCT02473965|517167310|FG001|Overall Study|MG worsening|1|||
143442536|NCT02473965|517167309|FG000|Overall Study|Withdrawal by Subject|2|||
143442537|NCT02473965|517167310|FG001|Overall Study|Withdrawal by Subject|3|||
143442538|NCT02473965|517167309|FG000|Overall Study|Physician Decision|0|||
143442539|NCT02473965|517167310|FG001|Overall Study|Physician Decision|2|||
143442540|NCT01183390|517167311|FG000|First Intervention|Adverse Event|0|||
143442541|NCT01183390|517167312|FG001|First Intervention|Adverse Event|1|||
143442542|NCT04057573|517167313|FG000|24-Week Double-Blind Period|Adverse Event|2|||
143442543|NCT04057573|517167314|FG001|24-Week Double-Blind Period|Adverse Event|0|||
143442544|NCT04057573|517167315|FG002|24-Week Double-Blind Period|Adverse Event|0|||
143442545|NCT04057573|517167316|FG003|24-Week Double-Blind Period|Adverse Event|0|||
143442546|NCT04057573|517167313|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
143442547|NCT04057573|517167314|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
143442548|NCT04057573|517167315|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
143442549|NCT04057573|517167316|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
143442550|NCT04057573|517167313|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
143442551|NCT04057573|517167314|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
143442552|NCT04057573|517167315|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
143442553|NCT04057573|517167316|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
143442554|NCT04057573|517167313|FG000|24-Week Double-Blind Period|Physician Decision|1|||
143442555|NCT04057573|517167314|FG001|24-Week Double-Blind Period|Physician Decision|0|||
143442556|NCT04057573|517167315|FG002|24-Week Double-Blind Period|Physician Decision|0|||
143442557|NCT04057573|517167316|FG003|24-Week Double-Blind Period|Physician Decision|0|||
143442558|NCT04057573|517167313|FG000|24-Week Double-Blind Period|Pregnancy|1|||
143442559|NCT04057573|517167314|FG001|24-Week Double-Blind Period|Pregnancy|0|||
143442560|NCT04057573|517167315|FG002|24-Week Double-Blind Period|Pregnancy|0|||
143442561|NCT04057573|517167316|FG003|24-Week Double-Blind Period|Pregnancy|0|||
143442562|NCT04057573|517167313|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
143442563|NCT04057573|517167314|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
143442564|NCT04057573|517167315|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
143442565|NCT04057573|517167316|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
143442566|NCT04057573|517167313|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
143442567|NCT04057573|517167314|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
143442568|NCT04057573|517167315|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
143442569|NCT04057573|517167316|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
143442570|NCT04057573|517167313|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
143442571|NCT04057573|517167314|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
143442572|NCT04057573|517167315|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
143442573|NCT04057573|517167316|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
143442574|NCT04057573|517167313|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
143442575|NCT04057573|517167314|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
143442576|NCT04057573|517167315|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
143442577|NCT04057573|517167316|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
143442578|NCT04057573|517167313|FG000|24-Week Double-Blind Period|Not Treated|1|||
143442579|NCT04057573|517167314|FG001|24-Week Double-Blind Period|Not Treated|0|||
143442580|NCT04057573|517167315|FG002|24-Week Double-Blind Period|Not Treated|0|||
143442581|NCT04057573|517167316|FG003|24-Week Double-Blind Period|Not Treated|0|||
143442582|NCT04057573|517167313|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
143442583|NCT04057573|517167314|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
143442584|NCT04057573|517167315|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
143442585|NCT04057573|517167316|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
143442586|NCT04057573|517167313|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
143442587|NCT04057573|517167314|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
143442588|NCT04057573|517167315|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
143442589|NCT04057573|517167316|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
143442590|NCT04057573|517167313|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
143442591|NCT04057573|517167314|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
143442592|NCT04057573|517167315|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
143442593|NCT04057573|517167316|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
143442594|NCT04057573|517167313|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
143442595|NCT04057573|517167314|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
143442596|NCT04057573|517167315|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
143442597|NCT04057573|517167316|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
143442598|NCT04057573|517167313|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
143442599|NCT04057573|517167314|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
143442600|NCT04057573|517167315|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
143442601|NCT04057573|517167316|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
143442602|NCT03299049|517167323|FG000|Overall Study|On-going|486|||
143442603|NCT03299049|517167324|FG001|Overall Study|On-going|481|||
143442604|NCT03299049|517167323|FG000|Overall Study|Withdrawal by Subject|6|||
143442605|NCT03299049|517167324|FG001|Overall Study|Withdrawal by Subject|21|||
143442606|NCT03299049|517167323|FG000|Overall Study|Physician Decision|5|||
143442607|NCT03299049|517167324|FG001|Overall Study|Physician Decision|1|||
143442608|NCT03299049|517167323|FG000|Overall Study|Lost to Follow-up|2|||
143442609|NCT03299049|517167324|FG001|Overall Study|Lost to Follow-up|0|||
143442610|NCT03299049|517167323|FG000|Overall Study|Pregnancy|1|||
143442611|NCT03299049|517167324|FG001|Overall Study|Pregnancy|3|||
143442612|NCT03299049|517167323|FG000|Overall Study|Protocol Violation|1|||
143442613|NCT03299049|517167324|FG001|Overall Study|Protocol Violation|1|||
143442614|NCT03299049|517167323|FG000|Overall Study|Lack of Efficacy|9|||
143442615|NCT03299049|517167324|FG001|Overall Study|Lack of Efficacy|3|||
143442616|NCT03299049|517167323|FG000|Overall Study|Adverse Event|12|||
143442617|NCT03299049|517167324|FG001|Overall Study|Adverse Event|13|||
143442618|NCT00475644|517167326|FG000|Overall Study|Protocol Violation|13|||
143442619|NCT01411241|517167327|FG000|Overall Study|Protocol Violation|0|||
143442620|NCT01411241|517167328|FG001|Overall Study|Protocol Violation|5|||
143442621|NCT01411241|517167327|FG000|Overall Study|Withdrawal by Subject|9|||
143442622|NCT01411241|517167328|FG001|Overall Study|Withdrawal by Subject|10|||
143442623|NCT01411241|517167327|FG000|Overall Study|Serious Adverse Event|0|||
143442624|NCT01411241|517167328|FG001|Overall Study|Serious Adverse Event|3|||
143442625|NCT01411241|517167327|FG000|Overall Study|Lost to Follow-up|2|||
143442626|NCT01411241|517167328|FG001|Overall Study|Lost to Follow-up|4|||
143442627|NCT00790400|517167332|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
143442628|NCT00790400|517167333|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
143442629|NCT00790400|517167332|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
143442630|NCT00790400|517167333|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
143442631|NCT00790400|517167332|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
143442632|NCT00790400|517167333|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
143442633|NCT00790400|517167332|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
143442634|NCT00790400|517167333|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
143442635|NCT00790400|517167332|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
143442636|NCT00790400|517167333|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
143442637|NCT00790400|517167332|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
143442638|NCT00790400|517167333|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
143442639|NCT00790400|517167332|FG000|Double-blind Period (Core Phase)|Death|1|||
143442640|NCT00790400|517167333|FG001|Double-blind Period (Core Phase)|Death|0|||
143442641|NCT00790400|517167332|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
143442642|NCT00790400|517167333|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
143442643|NCT00790400|517167332|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
143442644|NCT00790400|517167333|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
143442645|NCT00790400|517167332|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
143442646|NCT00790400|517167333|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
143442647|NCT00790400|517167332|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
143442648|NCT00790400|517167333|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
143442649|NCT00790400|517167332|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
143442650|NCT00790400|517167333|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
143442651|NCT00790400|517167332|FG000|Everolimus Period (Core or Extension)|Death|1|||
143442652|NCT00790400|517167333|FG001|Everolimus Period (Core or Extension)|Death|0|||
143442653|NCT00790400|517167332|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
143442654|NCT00790400|517167333|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
143442655|NCT00790400|517167332|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
143442656|NCT00790400|517167333|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
143442657|NCT00790400|517167332|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
143442658|NCT00790400|517167333|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
143442659|NCT00078338|517167335|FG000|Overall Study|Adverse Event|31|||
143442660|NCT00078338|517167336|FG001|Overall Study|Adverse Event|24|||
143442661|NCT00078338|517167335|FG000|Overall Study|Lost to Follow-up|17|||
143442662|NCT00078338|517167336|FG001|Overall Study|Lost to Follow-up|2|||
143442663|NCT00078338|517167335|FG000|Overall Study|Protocol Violation|2|||
143442664|NCT00078338|517167336|FG001|Overall Study|Protocol Violation|2|||
143442665|NCT00078338|517167335|FG000|Overall Study|Disease Progression|4|||
143442666|NCT00078338|517167336|FG001|Overall Study|Disease Progression|7|||
143442667|NCT00078338|517167335|FG000|Overall Study|Other|28|||
143442668|NCT00078338|517167336|FG001|Overall Study|Other|16|||
143442669|NCT00078338|517167335|FG000|Overall Study|Subjects randomized, but not treated|3|||
143442670|NCT00078338|517167336|FG001|Overall Study|Subjects randomized, but not treated|3|||
143442671|NCT02460575|517167337|FG000|Overall Study|Lost to Follow-up|1|||
143442672|NCT02460575|517167338|FG001|Overall Study|Lost to Follow-up|0|||
143442673|NCT04307940|517167339|FG000|Overall Study|Adverse Event|1|||
143442674|NCT04307940|517167340|FG001|Overall Study|Adverse Event|0|||
143442675|NCT04307940|517167341|FG002|Overall Study|Adverse Event|0|||
143442676|NCT04307940|517167339|FG000|Overall Study|Withdrawal by Subject|2|||
143442677|NCT04307940|517167340|FG001|Overall Study|Withdrawal by Subject|3|||
143442678|NCT04307940|517167341|FG002|Overall Study|Withdrawal by Subject|1|||
143442679|NCT04307940|517167339|FG000|Overall Study|Lost to Follow-up|2|||
143442680|NCT04307940|517167340|FG001|Overall Study|Lost to Follow-up|0|||
143442681|NCT04307940|517167341|FG002|Overall Study|Lost to Follow-up|1|||
143442682|NCT02521363|517167342|FG000|Overall Study|Withdrawal by Subject|1|||
143442683|NCT02521363|517167343|FG001|Overall Study|Withdrawal by Subject|2|||
143442684|NCT05543174|517167344|FG000|Overall Study|Ongoing|7|||
143442685|NCT03104075|517167347|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
143442686|NCT03104075|517167348|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
143442687|NCT04024462|517167349|FG000|Overall Study|Withdrawal by Subject|6|||
143442688|NCT04024462|517167350|FG001|Overall Study|Withdrawal by Subject|7|||
143442689|NCT04024462|517167349|FG000|Overall Study|Progressive Disease|0|||
143442690|NCT04024462|517167350|FG001|Overall Study|Progressive Disease|1|||
143442691|NCT04024462|517167349|FG000|Overall Study|Adverse Event|0|||
143442692|NCT04024462|517167350|FG001|Overall Study|Adverse Event|1|||
143442693|NCT04024462|517167349|FG000|Overall Study|Death|0|||
143442694|NCT04024462|517167350|FG001|Overall Study|Death|1|||
143442695|NCT04024462|517167349|FG000|Overall Study|Lost to Follow-up|1|||
143442696|NCT04024462|517167350|FG001|Overall Study|Lost to Follow-up|0|||
143442697|NCT04024462|517167349|FG000|Overall Study|Ongoing in the Study|94|||
143442698|NCT04024462|517167350|FG001|Overall Study|Ongoing in the Study|89|||
143442699|NCT04896008|517167351|FG000|Overall Study|Ongoing|70|||
143442700|NCT04896008|517167352|FG001|Overall Study|Ongoing|38|||
143442701|NCT04896008|517167351|FG000|Overall Study|Adverse Event|0|||
143442702|NCT04896008|517167352|FG001|Overall Study|Adverse Event|2|||
143442703|NCT04896008|517167351|FG000|Overall Study|Death|5|||
143442704|NCT04896008|517167352|FG001|Overall Study|Death|10|||
143442705|NCT04896008|517167351|FG000|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|1|||
143442706|NCT04896008|517167352|FG001|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|0|||
143442707|NCT04896008|517167351|FG000|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|0|||
143442708|NCT04896008|517167352|FG001|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|1|||
143442709|NCT04896008|517167351|FG000|Overall Study|Unwillingness Or Inability To Comply With Protocol|1|||
143442710|NCT04896008|517167352|FG001|Overall Study|Unwillingness Or Inability To Comply With Protocol|0|||
143442711|NCT04896008|517167351|FG000|Overall Study|Withdrawal by Subject|1|||
143442712|NCT04896008|517167352|FG001|Overall Study|Withdrawal by Subject|4|||
143442713|NCT04896008|517167351|FG000|Overall Study|Investigator Decision|2|||
143442714|NCT04896008|517167352|FG001|Overall Study|Investigator Decision|0|||
143442715|NCT04896008|517167351|FG000|Overall Study|Transitioned to Commercial Sotatercept|2|||
143442716|NCT04896008|517167352|FG001|Overall Study|Transitioned to Commercial Sotatercept|1|||
143442717|NCT01270828|517167357|FG000|Pregabalin CR SB|Reason Unspecified|0|||
143442718|NCT01270828|517167358|FG001|Pregabalin CR SB|Reason Unspecified|0|||
143442719|NCT01270828|517167359|FG002|Pregabalin CR SB|Reason Unspecified|8|||
143442720|NCT01270828|517167357|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
143442721|NCT01270828|517167358|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
143442722|NCT01270828|517167359|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
143442723|NCT01270828|517167357|FG000|Pregabalin CR SB|Related adverse event|0|||
143442724|NCT01270828|517167358|FG001|Pregabalin CR SB|Related adverse event|0|||
143442725|NCT01270828|517167359|FG002|Pregabalin CR SB|Related adverse event|46|||
143442726|NCT01270828|517167357|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
143442727|NCT01270828|517167358|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
143442728|NCT01270828|517167359|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
143442729|NCT01270828|517167357|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
143442730|NCT01270828|517167358|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
143442731|NCT01270828|517167359|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
143442732|NCT01270828|517167357|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
143442733|NCT01270828|517167358|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
143442734|NCT01270828|517167359|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
143442735|NCT01270828|517167357|FG000|Pregabalin CR SB|Unrelated AE|0|||
143442736|NCT01270828|517167358|FG001|Pregabalin CR SB|Unrelated AE|0|||
143442737|NCT01270828|517167359|FG002|Pregabalin CR SB|Unrelated AE|8|||
143442738|NCT01270828|517167357|FG000|Pregabalin CR SB|Protocol Violation|0|||
143442739|NCT01270828|517167358|FG001|Pregabalin CR SB|Protocol Violation|0|||
143442740|NCT01270828|517167359|FG002|Pregabalin CR SB|Protocol Violation|8|||
143442741|NCT01270828|517167357|FG000|Double Blind Phase|Death|0|||
143442742|NCT01270828|517167358|FG001|Double Blind Phase|Death|1|||
143442743|NCT01270828|517167359|FG002|Double Blind Phase|Death|0|||
143442744|NCT01270828|517167357|FG000|Double Blind Phase|Protocol Violation|0|||
143442745|NCT01270828|517167358|FG001|Double Blind Phase|Protocol Violation|1|||
143442746|NCT01270828|517167359|FG002|Double Blind Phase|Protocol Violation|0|||
143442747|NCT01270828|517167357|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
143442748|NCT01270828|517167358|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
143442749|NCT01270828|517167359|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
143442750|NCT01270828|517167357|FG000|Double Blind Phase|Reason Unspecified|7|||
143442751|NCT01270828|517167358|FG001|Double Blind Phase|Reason Unspecified|4|||
143442752|NCT01270828|517167359|FG002|Double Blind Phase|Reason Unspecified|0|||
143442753|NCT01270828|517167357|FG000|Double Blind Phase|Withdrawal by Subject|6|||
143442754|NCT01270828|517167358|FG001|Double Blind Phase|Withdrawal by Subject|15|||
143442755|NCT01270828|517167359|FG002|Double Blind Phase|Withdrawal by Subject|0|||
143442756|NCT01270828|517167357|FG000|Double Blind Phase|Lost to Follow-up|1|||
143442757|NCT01270828|517167358|FG001|Double Blind Phase|Lost to Follow-up|2|||
143442758|NCT01270828|517167359|FG002|Double Blind Phase|Lost to Follow-up|0|||
143442759|NCT01270828|517167357|FG000|Double Blind Phase|Lack of Efficacy|2|||
143442760|NCT01270828|517167358|FG001|Double Blind Phase|Lack of Efficacy|11|||
143442761|NCT01270828|517167359|FG002|Double Blind Phase|Lack of Efficacy|0|||
143442762|NCT01270828|517167357|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
143442763|NCT01270828|517167358|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
143442764|NCT01270828|517167359|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
143442765|NCT01270828|517167357|FG000|Double Blind Phase|Adverse event related to study drug|5|||
143442766|NCT01270828|517167358|FG001|Double Blind Phase|Adverse event related to study drug|7|||
143442767|NCT01270828|517167359|FG002|Double Blind Phase|Adverse event related to study drug|0|||
143442768|NCT01810939|517167360|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
143442769|NCT01810939|517167361|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
143442770|NCT01810939|517167362|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
143442771|NCT01810939|517167360|FG000|Part A Treatment Period|Protocol Violation|2|||
143442772|NCT01810939|517167361|FG001|Part A Treatment Period|Protocol Violation|0|||
143442773|NCT01810939|517167362|FG002|Part A Treatment Period|Protocol Violation|0|||
143442774|NCT01810939|517167360|FG000|Part A Treatment Period|Adverse Event|10|||
143442775|NCT01810939|517167361|FG001|Part A Treatment Period|Adverse Event|0|||
143442776|NCT01810939|517167362|FG002|Part A Treatment Period|Adverse Event|0|||
143442777|NCT01810939|517167360|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
143442778|NCT01810939|517167361|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
143442779|NCT01810939|517167362|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
143442780|NCT01810939|517167360|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
143442781|NCT01810939|517167361|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
143442782|NCT01810939|517167362|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
143442783|NCT01810939|517167360|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
143442784|NCT01810939|517167361|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
143442785|NCT01810939|517167362|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
143442786|NCT01810939|517167360|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
143442787|NCT01810939|517167361|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
143442788|NCT01810939|517167362|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
143442789|NCT01810939|517167360|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
143442790|NCT01810939|517167361|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
143442791|NCT01810939|517167362|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
143442792|NCT01810939|517167360|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
143442793|NCT01810939|517167361|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
143442794|NCT01810939|517167362|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
143442795|NCT01810939|517167360|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
143442796|NCT01810939|517167361|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
143442797|NCT01810939|517167362|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
143442798|NCT01810939|517167360|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
143442799|NCT01810939|517167361|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
143442800|NCT01810939|517167362|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
143442801|NCT01810939|517167360|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
143442802|NCT01810939|517167361|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
143442803|NCT01810939|517167362|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
143442804|NCT01810939|517167360|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
143442805|NCT01810939|517167361|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
143442806|NCT01810939|517167362|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
143442807|NCT01810939|517167360|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
143442808|NCT01810939|517167361|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
143442809|NCT01810939|517167362|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
143442810|NCT01810939|517167360|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
143442811|NCT01810939|517167361|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
143442812|NCT01810939|517167362|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
143442813|NCT01810939|517167360|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
143442814|NCT01810939|517167361|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
143442815|NCT01810939|517167362|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
143442816|NCT01810939|517167360|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
143442817|NCT01810939|517167361|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
143442818|NCT01810939|517167362|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
143442819|NCT00709228|517167363|FG000|Overall Study|Not treated|14|||
143442820|NCT00709228|517167363|FG000|Overall Study|Eligibility criteria not met|281|||
143442821|NCT00709228|517167363|FG000|Overall Study|Adverse events|2|||
143442822|NCT00709228|517167363|FG000|Overall Study|Discontinued treatment|14|||
143442823|NCT00709228|517167363|FG000|Overall Study|Did not enter follow-up|4|||
143442824|NCT00709228|517167363|FG000|Overall Study|Discontinued follow-up|5|||
143442825|NCT00709228|517167363|FG000|Overall Study|Disease progression|1|||
143442826|NCT00709228|517167363|FG000|Overall Study|Lost to Follow-up|6|||
143442827|NCT00709228|517167363|FG000|Overall Study|Non-compliance|5|||
143442828|NCT01594827|517167365|FG000|Overall Study|Adverse Event|1|||
143442829|NCT01594827|517167366|FG001|Overall Study|Adverse Event|0|||
143442830|NCT01594827|517167365|FG000|Overall Study|Physician Decision|3|||
143442831|NCT01594827|517167366|FG001|Overall Study|Physician Decision|0|||
143442832|NCT04148651|517167371|FG000|Overall Study|Lost to Follow-up|2|||
143442833|NCT03690427|517167374|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
143442834|NCT03690427|517167375|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
143442835|NCT02609672|517167381|FG000|Overall Study|Lost to Follow-up|3|||
143442836|NCT02609672|517167382|FG001|Overall Study|Lost to Follow-up|1|||
143442837|NCT03519204|517167383|FG000|Overall Study|Lost to Follow-up|3|||
143442838|NCT03519204|517167384|FG001|Overall Study|Lost to Follow-up|8|||
143442839|NCT03519204|517167383|FG000|Overall Study|Withdrawal by Subject|9|||
143442840|NCT03519204|517167384|FG001|Overall Study|Withdrawal by Subject|7|||
143442841|NCT03519204|517167383|FG000|Overall Study|Other Miscellaneous Reasons|1|||
143442842|NCT03519204|517167384|FG001|Overall Study|Other Miscellaneous Reasons|0|||
143442843|NCT01721954|517167385|FG000|Overall Study|Death|58|||
143442844|NCT01721954|517167386|FG001|Overall Study|Death|64|||
143442845|NCT01721954|517167385|FG000|Overall Study|Withdrawal by Subject|8|||
143442846|NCT01721954|517167386|FG001|Overall Study|Withdrawal by Subject|4|||
143442847|NCT01721954|517167385|FG000|Overall Study|Adverse Event|2|||
143442848|NCT01721954|517167386|FG001|Overall Study|Adverse Event|0|||
143442849|NCT01721954|517167385|FG000|Overall Study|Lost to Follow-up|2|||
143442850|NCT01721954|517167386|FG001|Overall Study|Lost to Follow-up|1|||
143442851|NCT02956837|517167388|FG000|Overall Study|Serious Adverse Events|0|||
143442852|NCT02956837|517167389|FG001|Overall Study|Serious Adverse Events|1|||
143442853|NCT02956837|517167390|FG002|Overall Study|Serious Adverse Events|0|||
143442854|NCT02956837|517167391|FG003|Overall Study|Serious Adverse Events|0|||
143442855|NCT02956837|517167388|FG000|Overall Study|Withdrawal by Subject|0|||
143442856|NCT02956837|517167389|FG001|Overall Study|Withdrawal by Subject|1|||
143442857|NCT02956837|517167390|FG002|Overall Study|Withdrawal by Subject|0|||
143442858|NCT02956837|517167391|FG003|Overall Study|Withdrawal by Subject|3|||
143442859|NCT02956837|517167388|FG000|Overall Study|Lost to Follow-up|0|||
143442860|NCT02956837|517167389|FG001|Overall Study|Lost to Follow-up|1|||
143442861|NCT02956837|517167390|FG002|Overall Study|Lost to Follow-up|2|||
143442862|NCT02956837|517167391|FG003|Overall Study|Lost to Follow-up|0|||
143442863|NCT02597712|517167392|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
143442864|NCT02597712|517167393|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
143442865|NCT02597712|517167392|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
143442866|NCT02597712|517167393|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
143442867|NCT02597712|517167392|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
143442868|NCT02597712|517167393|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
143442869|NCT02637323|517167398|FG000|Overall Study|Lost to Follow-up|2|||
143442870|NCT02637323|517167399|FG001|Overall Study|Lost to Follow-up|0|||
143442871|NCT02637323|517167398|FG000|Overall Study|Protocol Violation|0|||
143442872|NCT02637323|517167399|FG001|Overall Study|Protocol Violation|1|||
143442873|NCT01594970|517167400|FG000|Overall Study|Non-Adverse Event Related|4|||
143442874|NCT01594970|517167401|FG001|Overall Study|Non-Adverse Event Related|5|||
143442875|NCT01594970|517167402|FG002|Overall Study|Non-Adverse Event Related|6|||
143442876|NCT01594970|517167400|FG000|Overall Study|Adverse Event|17|||
143442877|NCT01594970|517167401|FG001|Overall Study|Adverse Event|23|||
143442878|NCT01594970|517167402|FG002|Overall Study|Adverse Event|23|||
143442879|NCT01594970|517167400|FG000|Overall Study|Lost to Follow-up|54|||
143442880|NCT01594970|517167401|FG001|Overall Study|Lost to Follow-up|54|||
143442881|NCT01594970|517167402|FG002|Overall Study|Lost to Follow-up|37|||
143442882|NCT00401258|517167403|FG000|Overall Study|Adverse Event|7|||
143442883|NCT01305239|517167405|FG000|Overall Study|Adverse Event|22|||
143442884|NCT01305239|517167405|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
143442885|NCT01245374|517167410|FG000|Overall Study|Protocol Violation|1|||
143442886|NCT01245374|517167410|FG000|Overall Study|Withdrawal by Subject|3|||
143442887|NCT01782690|517167412|FG000|Overall Study|Not reported|7|||
143442888|NCT01782690|517167412|FG000|Overall Study|Toxicity of gemcitabine|1|||
143442889|NCT01782690|517167412|FG000|Overall Study|Toxicity of erlotinib|1|||
143442890|NCT01782690|517167412|FG000|Overall Study|Lost to Follow-up|31|||
143442891|NCT01782690|517167412|FG000|Overall Study|Withdrawal of informed consent|2|||
143442892|NCT01782690|517167412|FG000|Overall Study|Absent rash|9|||
143442893|NCT01782690|517167412|FG000|Overall Study|Physician Decision|13|||
143442894|NCT01782690|517167412|FG000|Overall Study|Patient's wish|21|||
143442895|NCT01782690|517167412|FG000|Overall Study|Tumor progression|74|||
143442896|NCT01782690|517167412|FG000|Overall Study|Death|133|||
143442897|NCT01782690|517167412|FG000|Overall Study|Study completion unknown|7|||
143442898|NCT04199052|517167415|FG000|Overall Study|Lost to Follow-up|11|||
143442899|NCT04199052|517167416|FG001|Overall Study|Lost to Follow-up|18|||
143442900|NCT01948076|517167417|FG000|Overall Study|Withdrawal by Subject|0|||
143442901|NCT01948076|517167418|FG001|Overall Study|Withdrawal by Subject|1|||
143442902|NCT01151423|517167419|FG000|Overall Study|Study terminated by Sponsor|9|||
143442903|NCT01151423|517167420|FG001|Overall Study|Study terminated by Sponsor|10|||
143442904|NCT01151423|517167419|FG000|Overall Study|Protocol Violation|0|||
143442905|NCT01151423|517167420|FG001|Overall Study|Protocol Violation|1|||
143442906|NCT01151423|517167419|FG000|Overall Study|Physician Decision|1|||
143442907|NCT01151423|517167420|FG001|Overall Study|Physician Decision|1|||
143442908|NCT01151423|517167419|FG000|Overall Study|Pregnancy|0|||
143442909|NCT01151423|517167420|FG001|Overall Study|Pregnancy|1|||
143442910|NCT01151423|517167419|FG000|Overall Study|Death|0|||
143442911|NCT01151423|517167420|FG001|Overall Study|Death|1|||
143442912|NCT01151423|517167419|FG000|Overall Study|Adverse Event|3|||
143442913|NCT01151423|517167420|FG001|Overall Study|Adverse Event|0|||
143442914|NCT01151423|517167419|FG000|Overall Study|Withdrawal by Subject|1|||
143442915|NCT01151423|517167420|FG001|Overall Study|Withdrawal by Subject|3|||
143442916|NCT01151423|517167419|FG000|Overall Study|Lost to Follow-up|1|||
143442917|NCT01151423|517167420|FG001|Overall Study|Lost to Follow-up|0|||
143442918|NCT01151423|517167419|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
143442919|NCT01151423|517167420|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
143442920|NCT01151423|517167419|FG000|Overall Study|Participated in other clinical trial|1|||
143442921|NCT01151423|517167420|FG001|Overall Study|Participated in other clinical trial|0|||
143442922|NCT00681668|517167421|FG000|Overall Study|Protocol Violation|1|||
143442923|NCT00681668|517167421|FG000|Overall Study|Withdrawal by Subject|1|||
143442924|NCT06840769|517167436|FG000|Overall Study|Withdrawal by Subject|1|||
143442925|NCT06840769|517167437|FG001|Overall Study|Withdrawal by Subject|0|||
143442926|NCT06840769|517167438|FG002|Overall Study|Withdrawal by Subject|0|||
143442927|NCT06840769|517167439|FG003|Overall Study|Withdrawal by Subject|0|||
143442928|NCT06840769|517167440|FG004|Overall Study|Withdrawal by Subject|0|||
143442929|NCT01006980|517169656|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
143442930|NCT01006980|517169657|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
143442931|NCT01006980|517169656|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
143442932|NCT01006980|517169657|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
143442933|NCT01006980|517169656|FG000|Vemurafenib and Dacarbazine|Death|13|||
143442934|NCT01006980|517169657|FG001|Vemurafenib and Dacarbazine|Death|12|||
143442935|NCT01006980|517169656|FG000|Vemurafenib and Dacarbazine|Progression|257|||
143442936|NCT01006980|517169657|FG001|Vemurafenib and Dacarbazine|Progression|218|||
143442937|NCT01006980|517169656|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
143442938|NCT01006980|517169657|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
143442939|NCT01006980|517169656|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
143442940|NCT01006980|517169657|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
143442941|NCT01006980|517169656|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
143442942|NCT01006980|517169657|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
143442943|NCT01006980|517169656|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
143442944|NCT01006980|517169657|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
143442945|NCT01006980|517169656|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
143442946|NCT01006980|517169657|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
143442947|NCT01006980|517169656|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
143442948|NCT01006980|517169657|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
143442949|NCT01006980|517169656|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
143442950|NCT01006980|517169657|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
143442951|NCT01006980|517169656|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
143442952|NCT01006980|517169657|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
143442953|NCT01006980|517169656|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
143442954|NCT01006980|517169657|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
143442955|NCT02963090|517169660|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
143442956|NCT02963090|517169661|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
143442957|NCT02870972|517169665|FG000|Overall Study|Adverse Event|1|||
143442958|NCT02870972|517169666|FG001|Overall Study|Adverse Event|0|||
143442959|NCT02870972|517169667|FG002|Overall Study|Adverse Event|0|||
143442960|NCT02870972|517169668|FG003|Overall Study|Adverse Event|0|||
143442961|NCT02870972|517169669|FG004|Overall Study|Adverse Event|0|||
143442962|NCT03559062|517169670|FG000|Overall Study|Other|0|||
143442963|NCT03559062|517169671|FG001|Overall Study|Other|1|||
143442964|NCT03559062|517169672|FG002|Overall Study|Other|0|||
143442965|NCT03054337|517169675|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
143442966|NCT03054337|517169676|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
143442967|NCT03054337|517169677|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
143442968|NCT03054337|517169678|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
143442969|NCT03054337|517169679|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
143442970|NCT03054337|517169680|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
143442971|NCT01967069|517169682|FG000|Overall Study|Adverse Event|2|||
143442972|NCT01967069|517169683|FG001|Overall Study|Adverse Event|2|||
143442973|NCT01967069|517169682|FG000|Overall Study|Lost to Follow-up|5|||
143442974|NCT01967069|517169683|FG001|Overall Study|Lost to Follow-up|2|||
143442975|NCT01967069|517169682|FG000|Overall Study|Withdrawal by Subject|1|||
143442976|NCT01967069|517169683|FG001|Overall Study|Withdrawal by Subject|3|||
143442977|NCT01967069|517169682|FG000|Overall Study|Lack of Efficacy|0|||
143442978|NCT01967069|517169683|FG001|Overall Study|Lack of Efficacy|1|||
143442979|NCT00874731|517169685|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
143442980|NCT00874731|517169686|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
143442981|NCT00874731|517169687|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
143442982|NCT00874731|517169685|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
143442983|NCT00874731|517169686|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
143442984|NCT00874731|517169687|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
143442985|NCT00874731|517169685|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
143442986|NCT00874731|517169686|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
143442987|NCT00874731|517169687|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
143442988|NCT01016262|517169688|FG000|Double-blind Phase|Adverse Event|0|||
143442989|NCT01016262|517169689|FG001|Double-blind Phase|Adverse Event|0|||
143442990|NCT01016262|517169690|FG002|Double-blind Phase|Adverse Event|1|||
143442991|NCT01016262|517169691|FG003|Double-blind Phase|Adverse Event|0|||
143442992|NCT01016262|517169692|FG004|Double-blind Phase|Adverse Event|0|||
143442993|NCT01016262|517169693|FG005|Double-blind Phase|Adverse Event|0|||
143442994|NCT01016262|517169688|FG000|Double-blind Phase|Lack of Efficacy|1|||
143442995|NCT01016262|517169689|FG001|Double-blind Phase|Lack of Efficacy|0|||
143442996|NCT01016262|517169690|FG002|Double-blind Phase|Lack of Efficacy|5|||
143442997|NCT01016262|517169691|FG003|Double-blind Phase|Lack of Efficacy|0|||
143442998|NCT01016262|517169692|FG004|Double-blind Phase|Lack of Efficacy|0|||
143442999|NCT01016262|517169693|FG005|Double-blind Phase|Lack of Efficacy|0|||
143443000|NCT01016262|517169688|FG000|Double-blind Phase|Disease Progression|0|||
143443001|NCT01016262|517169689|FG001|Double-blind Phase|Disease Progression|1|||
143443002|NCT01016262|517169690|FG002|Double-blind Phase|Disease Progression|2|||
143443003|NCT01016262|517169691|FG003|Double-blind Phase|Disease Progression|0|||
143443004|NCT01016262|517169692|FG004|Double-blind Phase|Disease Progression|0|||
143443005|NCT01016262|517169693|FG005|Double-blind Phase|Disease Progression|0|||
143443006|NCT01016262|517169688|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
143443007|NCT01016262|517169689|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
143443008|NCT01016262|517169690|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
143443009|NCT01016262|517169691|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
143443010|NCT01016262|517169692|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
143443011|NCT01016262|517169693|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
143443012|NCT01016262|517169688|FG000|Open-Label Phase|Adverse Event|0|||
143443013|NCT01016262|517169689|FG001|Open-Label Phase|Adverse Event|0|||
143443014|NCT01016262|517169690|FG002|Open-Label Phase|Adverse Event|0|||
143443015|NCT01016262|517169691|FG003|Open-Label Phase|Adverse Event|1|||
143443016|NCT01016262|517169692|FG004|Open-Label Phase|Adverse Event|0|||
143443017|NCT01016262|517169693|FG005|Open-Label Phase|Adverse Event|0|||
143443018|NCT01016262|517169688|FG000|Open-Label Phase|Lost to Follow-up|0|||
143443019|NCT01016262|517169689|FG001|Open-Label Phase|Lost to Follow-up|0|||
143443020|NCT01016262|517169690|FG002|Open-Label Phase|Lost to Follow-up|0|||
143443021|NCT01016262|517169691|FG003|Open-Label Phase|Lost to Follow-up|0|||
143443022|NCT01016262|517169692|FG004|Open-Label Phase|Lost to Follow-up|1|||
143443023|NCT01016262|517169693|FG005|Open-Label Phase|Lost to Follow-up|0|||
143443024|NCT01016262|517169688|FG000|Open-Label Phase|Lack of Efficacy|0|||
143443025|NCT01016262|517169689|FG001|Open-Label Phase|Lack of Efficacy|0|||
143443026|NCT01016262|517169690|FG002|Open-Label Phase|Lack of Efficacy|0|||
143443027|NCT01016262|517169691|FG003|Open-Label Phase|Lack of Efficacy|1|||
143443028|NCT01016262|517169692|FG004|Open-Label Phase|Lack of Efficacy|0|||
143443029|NCT01016262|517169693|FG005|Open-Label Phase|Lack of Efficacy|0|||
143443030|NCT01016262|517169688|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
143443031|NCT01016262|517169689|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
143443032|NCT01016262|517169690|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
143443033|NCT01016262|517169691|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
143443034|NCT01016262|517169692|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
143443035|NCT01016262|517169693|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
143443036|NCT01736540|517169694|FG000|Overall Study|Did not complete scan within 45 days|2|||
143443037|NCT01736540|517169694|FG000|Overall Study|Death|1|||
143443038|NCT01736540|517169694|FG000|Overall Study|Abnormal test procedure|1|||
143443039|NCT01736540|517169694|FG000|Overall Study|Withdrawal by Subject|5|||
143443040|NCT01736540|517169694|FG000|Overall Study|Protocol Violation|1|||
143443041|NCT01736540|517169694|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
143443042|NCT01736540|517169694|FG000|Overall Study|No show for MRI appointment|1|||
143443043|NCT01736540|517169694|FG000|Overall Study|Unable to make MRI appointment|3|||
143443044|NCT00581477|517169695|FG000|Overall Study|Physician Decision|2|||
143443045|NCT03106753|517169696|FG000|Overall Study|Withdrawal by Subject|0|||
143443046|NCT03106753|517169697|FG001|Overall Study|Withdrawal by Subject|1|||
143443047|NCT01643044|517169701|FG000|Overall Study|Lost to Follow-up|1|||
143443048|NCT01643044|517169702|FG001|Overall Study|Lost to Follow-up|1|||
143443049|NCT01643044|517169701|FG000|Overall Study|Miscarried baby|2|||
143443050|NCT01643044|517169702|FG001|Overall Study|Miscarried baby|2|||
143443051|NCT01643044|517169701|FG000|Overall Study|Delivered outside of hospital|1|||
143443052|NCT01643044|517169702|FG001|Overall Study|Delivered outside of hospital|2|||
143443053|NCT01031628|517169708|FG000|Overall Study|Study terminated early|0|||
143443054|NCT01031628|517169709|FG001|Overall Study|Study terminated early|1|||
143443055|NCT01031628|517169710|FG002|Overall Study|Study terminated early|3|||
143443056|NCT01031628|517169711|FG003|Overall Study|Study terminated early|0|||
143443057|NCT02362503|517169713|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
143443058|NCT02362503|517169714|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
143443059|NCT02362503|517169715|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
143443060|NCT02362503|517169713|FG000|Double-blind Period-Up to 8 Days|Death|1|||
143443061|NCT02362503|517169714|FG001|Double-blind Period-Up to 8 Days|Death|0|||
143443062|NCT02362503|517169715|FG002|Double-blind Period-Up to 8 Days|Death|0|||
143443063|NCT02362503|517169713|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
143443064|NCT02362503|517169714|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
143443065|NCT02362503|517169715|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
143443066|NCT02362503|517169713|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
143443067|NCT02362503|517169714|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
143443068|NCT02362503|517169715|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
143443069|NCT02362503|517169713|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
143443070|NCT02362503|517169714|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
143443071|NCT02362503|517169715|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
143443072|NCT02362503|517169713|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
143443073|NCT02362503|517169714|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
143443074|NCT02362503|517169715|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
143443075|NCT02362503|517169713|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
143443076|NCT02362503|517169714|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
143443077|NCT02362503|517169715|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
143443078|NCT02362503|517169713|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
143443079|NCT02362503|517169714|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
143443080|NCT02362503|517169715|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
143443081|NCT02362503|517169713|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
143443082|NCT02362503|517169714|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
143443083|NCT02362503|517169715|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
143443084|NCT02362503|517169713|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
143443085|NCT02362503|517169714|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
143443086|NCT02362503|517169715|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
143443087|NCT02362503|517169713|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
143443088|NCT02362503|517169714|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
143443089|NCT02362503|517169715|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
143443090|NCT02362503|517169713|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
143443091|NCT02362503|517169714|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
143443092|NCT02362503|517169715|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
143443093|NCT02362503|517169713|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
143443094|NCT02362503|517169714|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
143443095|NCT02362503|517169715|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
143443096|NCT02362503|517169713|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
143443097|NCT02362503|517169714|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
143443098|NCT02362503|517169715|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
143443099|NCT02803593|517169716|FG000|Overall Study|Lost to Follow-up|17|||
143443100|NCT02803593|517169717|FG001|Overall Study|Lost to Follow-up|35|||
143443101|NCT05143138|517169718|FG000|Overall Study|Death|5|||
143443102|NCT05143138|517169719|FG001|Overall Study|Death|35|||
143443103|NCT05143138|517169720|FG002|Overall Study|Death|1|||
143443104|NCT05143138|517169718|FG000|Overall Study|Lost to Follow-up|2|||
143443105|NCT05143138|517169719|FG001|Overall Study|Lost to Follow-up|4|||
143443106|NCT05143138|517169720|FG002|Overall Study|Lost to Follow-up|0|||
143443107|NCT05143138|517169718|FG000|Overall Study|withdrawal|1|||
143443108|NCT05143138|517169719|FG001|Overall Study|withdrawal|1|||
143443109|NCT05143138|517169720|FG002|Overall Study|withdrawal|0|||
143443110|NCT04245345|517169731|FG000|Overall Study|Death|1|||
143443111|NCT04245345|517169731|FG000|Overall Study|Exited prior to implant|5|||
143443112|NCT04245345|517169731|FG000|Overall Study|Exited prior to 1-month|9|||
143443113|NCT04245345|517169731|FG000|Overall Study|Missed 1-month visit|3|||
143443114|NCT04245345|517169731|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
143443115|NCT04245345|517169731|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
143443116|NCT01834586|517169732|FG000|Overall Study|Adverse Event|1|||
143443117|NCT03325777|517169735|FG000|Overall Study|Lost to Follow-up|9|||
143443118|NCT03325777|517169736|FG001|Overall Study|Lost to Follow-up|12|||
143443119|NCT03004404|517169738|FG000|Period 2|Adverse Event|0|||
143443120|NCT03004404|517169739|FG001|Period 2|Adverse Event|0|||
143443121|NCT03004404|517169740|FG002|Period 2|Adverse Event|0|||
143443122|NCT03004404|517169741|FG003|Period 2|Adverse Event|0|||
143443123|NCT03004404|517169742|FG004|Period 2|Adverse Event|0|||
143443124|NCT03004404|517169743|FG005|Period 2|Adverse Event|0|||
143443125|NCT03004404|517169744|FG006|Period 2|Adverse Event|0|||
143443126|NCT03004404|517169745|FG007|Period 2|Adverse Event|0|||
143443127|NCT03004404|517169746|FG008|Period 2|Adverse Event|1|||
143443128|NCT03004404|517169747|FG009|Period 2|Adverse Event|0|||
143443129|NCT03004404|517169748|FG010|Period 2|Adverse Event|0|||
143443130|NCT03004404|517169749|FG011|Period 2|Adverse Event|0|||
143443131|NCT03004404|517169750|FG012|Period 2|Adverse Event|0|||
143443132|NCT03004404|517169751|FG013|Period 2|Adverse Event|0|||
143443133|NCT03004404|517169752|FG014|Period 2|Adverse Event|0|||
143443134|NCT03004404|517169753|FG015|Period 2|Adverse Event|1|||
143443135|NCT03933462|517169756|FG000|Overall Study|Adverse Event|2|||
143443136|NCT03933462|517169757|FG001|Overall Study|Adverse Event|0|||
143443137|NCT02522728|517169761|FG000|Overall Study|Withdrawal by Subject|6|||
143443138|NCT02522728|517169762|FG001|Overall Study|Withdrawal by Subject|6|||
143443139|NCT02522728|517169761|FG000|Overall Study|Death|4|||
143443140|NCT02522728|517169762|FG001|Overall Study|Death|3|||
143443141|NCT02522728|517169761|FG000|Overall Study|Adverse Event|2|||
143443142|NCT02522728|517169762|FG001|Overall Study|Adverse Event|1|||
143443143|NCT02522728|517169761|FG000|Overall Study|Did not receive randomized study device|0|||
143443144|NCT02522728|517169762|FG001|Overall Study|Did not receive randomized study device|1|||
143443145|NCT04210843|517169764|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
143443146|NCT04210843|517169765|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
143443147|NCT04210843|517169764|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
143443148|NCT04210843|517169765|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
143443149|NCT04210843|517169764|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
143443150|NCT04210843|517169765|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
143443151|NCT04210843|517169764|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
143443152|NCT04210843|517169765|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
143443153|NCT04210843|517169764|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
143443154|NCT04210843|517169765|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
143443155|NCT04210843|517169764|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
143443156|NCT04210843|517169765|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
143443157|NCT04210843|517169764|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
143443158|NCT04210843|517169765|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
143443159|NCT04210843|517169764|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
143443160|NCT04210843|517169765|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
143443161|NCT04210843|517169764|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
143443162|NCT04210843|517169765|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
143443163|NCT04210843|517169764|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
143443164|NCT04210843|517169765|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
143443165|NCT04210843|517169764|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
143443166|NCT04210843|517169765|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
143443167|NCT04210843|517169764|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
143443168|NCT04210843|517169765|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
143443169|NCT04210843|517169764|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
143443170|NCT04210843|517169765|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
143443171|NCT04210843|517169764|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
143443172|NCT04210843|517169765|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
143443173|NCT04210843|517169764|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
143443174|NCT04210843|517169765|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
143443175|NCT04210843|517169764|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
143443176|NCT04210843|517169765|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
143443177|NCT04210843|517169764|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
143443178|NCT04210843|517169765|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
143443179|NCT04210843|517169764|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
143443180|NCT04210843|517169765|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
143443181|NCT04210843|517169764|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
143443182|NCT04210843|517169765|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
143443183|NCT04210843|517169764|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
143443184|NCT04210843|517169765|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
143443185|NCT04210843|517169764|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
143443186|NCT04210843|517169765|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
143443187|NCT04210843|517169764|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
143443188|NCT04210843|517169765|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
143443189|NCT04210843|517169764|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
143443190|NCT04210843|517169765|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
143443191|NCT04210843|517169764|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
143443192|NCT04210843|517169765|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
143443193|NCT01099917|517169766|FG000|Overall Study|Adverse Event|3|||
143443194|NCT01099917|517169766|FG000|Overall Study|Not Treated|24|||
143443195|NCT01266161|517169773|FG000|Overall Study|Ineligible|1|||
143443196|NCT01266161|517169774|FG001|Overall Study|Ineligible|0|||
143443197|NCT01266161|517169773|FG000|Overall Study|Lack of Efficacy|0|||
143443198|NCT01266161|517169774|FG001|Overall Study|Lack of Efficacy|1|||
143443199|NCT01266161|517169773|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
143443200|NCT01266161|517169774|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
143443201|NCT02990468|517169775|FG000|Phase 2: MTD|Change in treatment|0|||
143443202|NCT02990468|517169776|FG001|Phase 2: MTD|Change in treatment|0|||
143443203|NCT02990468|517169777|FG002|Phase 2: MTD|Change in treatment|1|||
143443204|NCT01436305|517169779|FG000|Overall Study|Death|1|||
143443205|NCT01436305|517169780|FG001|Overall Study|Death|0|||
143443206|NCT01436305|517169781|FG002|Overall Study|Death|0|||
143443207|NCT01436305|517169779|FG000|Overall Study|Lost to Follow-up|0|||
143443208|NCT01436305|517169780|FG001|Overall Study|Lost to Follow-up|1|||
143443209|NCT01436305|517169781|FG002|Overall Study|Lost to Follow-up|0|||
143443210|NCT01436305|517169779|FG000|Overall Study|Withdrawal by Subject|1|||
143443211|NCT01436305|517169780|FG001|Overall Study|Withdrawal by Subject|3|||
143443212|NCT01436305|517169781|FG002|Overall Study|Withdrawal by Subject|0|||
143443213|NCT03392168|517169790|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
143443214|NCT03392168|517169791|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
143443215|NCT03392168|517169792|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
143443216|NCT03392168|517169793|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
143443217|NCT03392168|517169790|FG000|Period 2: Cohort 2|Other|0|||
143443218|NCT03392168|517169791|FG001|Period 2: Cohort 2|Other|1|||
143443219|NCT03392168|517169792|FG002|Period 2: Cohort 2|Other|0|||
143443220|NCT03392168|517169793|FG003|Period 2: Cohort 2|Other|0|||
143443221|NCT01727505|517169794|FG000|First 24 Hours|Adverse Event|0|||
143443222|NCT01727505|517169795|FG001|First 24 Hours|Adverse Event|1|||
143443223|NCT01727505|517169794|FG000|Second 24 Hours|Missing data|0|||
143443224|NCT01727505|517169795|FG001|Second 24 Hours|Missing data|1|||
143443225|NCT01299480|517169796|FG000|Overall Study|No longer willing to participate|19|||
143443226|NCT01299480|517169797|FG001|Overall Study|No longer willing to participate|17|||
143443227|NCT01299480|517169798|FG002|Overall Study|No longer willing to participate|14|||
143443228|NCT01299480|517169799|FG003|Overall Study|No longer willing to participate|13|||
143443229|NCT01299480|517169800|FG004|Overall Study|No longer willing to participate|10|||
143443230|NCT01299480|517169796|FG000|Overall Study|Protocol Violation|7|||
143443231|NCT01299480|517169797|FG001|Overall Study|Protocol Violation|5|||
143443232|NCT01299480|517169798|FG002|Overall Study|Protocol Violation|8|||
143443233|NCT01299480|517169799|FG003|Overall Study|Protocol Violation|1|||
143443234|NCT01299480|517169800|FG004|Overall Study|Protocol Violation|1|||
143443235|NCT01299480|517169796|FG000|Overall Study|Withdrawal by Subject|3|||
143443236|NCT01299480|517169797|FG001|Overall Study|Withdrawal by Subject|4|||
143443237|NCT01299480|517169798|FG002|Overall Study|Withdrawal by Subject|7|||
143443238|NCT01299480|517169799|FG003|Overall Study|Withdrawal by Subject|3|||
143443239|NCT01299480|517169800|FG004|Overall Study|Withdrawal by Subject|4|||
143443240|NCT01299480|517169796|FG000|Overall Study|Adverse Event|6|||
143443241|NCT01299480|517169797|FG001|Overall Study|Adverse Event|4|||
143443242|NCT01299480|517169798|FG002|Overall Study|Adverse Event|5|||
143443243|NCT01299480|517169799|FG003|Overall Study|Adverse Event|4|||
143443244|NCT01299480|517169800|FG004|Overall Study|Adverse Event|0|||
143443245|NCT01299480|517169796|FG000|Overall Study|Withdrawal due to pregnancy|0|||
143443246|NCT01299480|517169797|FG001|Overall Study|Withdrawal due to pregnancy|1|||
143443247|NCT01299480|517169798|FG002|Overall Study|Withdrawal due to pregnancy|1|||
143443248|NCT01299480|517169799|FG003|Overall Study|Withdrawal due to pregnancy|0|||
143443249|NCT01299480|517169800|FG004|Overall Study|Withdrawal due to pregnancy|0|||
143443250|NCT01299480|517169796|FG000|Overall Study|Physician Decision|1|||
143443251|NCT01299480|517169797|FG001|Overall Study|Physician Decision|1|||
143443252|NCT01299480|517169798|FG002|Overall Study|Physician Decision|0|||
143443253|NCT01299480|517169799|FG003|Overall Study|Physician Decision|2|||
143443254|NCT01299480|517169800|FG004|Overall Study|Physician Decision|0|||
143443255|NCT01299480|517169796|FG000|Overall Study|Lost to Follow-up|3|||
143443256|NCT01299480|517169797|FG001|Overall Study|Lost to Follow-up|1|||
143443257|NCT01299480|517169798|FG002|Overall Study|Lost to Follow-up|2|||
143443258|NCT01299480|517169799|FG003|Overall Study|Lost to Follow-up|1|||
143443259|NCT01299480|517169800|FG004|Overall Study|Lost to Follow-up|2|||
143443260|NCT01299480|517169796|FG000|Overall Study|Other|3|||
143443261|NCT01299480|517169797|FG001|Overall Study|Other|2|||
143443262|NCT01299480|517169798|FG002|Overall Study|Other|3|||
143443263|NCT01299480|517169799|FG003|Overall Study|Other|0|||
143443264|NCT01299480|517169800|FG004|Overall Study|Other|3|||
143443265|NCT01299480|517169796|FG000|Overall Study|Started, but not vaccinated|0|||
143443266|NCT01299480|517169797|FG001|Overall Study|Started, but not vaccinated|0|||
143443267|NCT01299480|517169798|FG002|Overall Study|Started, but not vaccinated|1|||
143443268|NCT01299480|517169799|FG003|Overall Study|Started, but not vaccinated|1|||
143443269|NCT01299480|517169800|FG004|Overall Study|Started, but not vaccinated|0|||
143443270|NCT01430468|517169807|FG000|Overall Study|Physician Decision|2|||
143443271|NCT01430468|517169808|FG001|Overall Study|Physician Decision|1|||
143443272|NCT01430468|517169807|FG000|Overall Study|Withdrawal by Subject|5|||
143443273|NCT01430468|517169808|FG001|Overall Study|Withdrawal by Subject|5|||
143443274|NCT03229486|517169809|FG000|Overall Study|Protocol Violation|0|||
143443275|NCT03229486|517169810|FG001|Overall Study|Protocol Violation|1|||
143443276|NCT01426347|517169814|FG000|Overall Study|Lost to Follow-up|0|||
143443277|NCT01426347|517169815|FG001|Overall Study|Lost to Follow-up|3|||
143443278|NCT01426347|517169814|FG000|Overall Study|Protocol Violation|2|||
143443279|NCT01426347|517169815|FG001|Overall Study|Protocol Violation|0|||
143443280|NCT01426347|517169814|FG000|Overall Study|Withdrawal by Subject|5|||
143443281|NCT01426347|517169815|FG001|Overall Study|Withdrawal by Subject|0|||
143443282|NCT00455741|517169816|FG000|Overall Study|Physician Decision|0|||
143443283|NCT00455741|517169817|FG001|Overall Study|Physician Decision|1|||
143443284|NCT02592707|517169822|FG000|Overall Study|Consent Withdrawn|0|||
143443285|NCT02592707|517169823|FG001|Overall Study|Consent Withdrawn|1|||
143443286|NCT02592707|517169824|FG002|Overall Study|Consent Withdrawn|2|||
143443287|NCT02592707|517169825|FG003|Overall Study|Consent Withdrawn|0|||
143443288|NCT02592707|517169822|FG000|Overall Study|Death|1|||
143443289|NCT02592707|517169823|FG001|Overall Study|Death|0|||
143443290|NCT02592707|517169824|FG002|Overall Study|Death|0|||
143443291|NCT02592707|517169825|FG003|Overall Study|Death|0|||
143443292|NCT02592707|517169822|FG000|Overall Study|Progressive Disease|4|||
143443293|NCT02592707|517169823|FG001|Overall Study|Progressive Disease|4|||
143443294|NCT02592707|517169824|FG002|Overall Study|Progressive Disease|3|||
143443295|NCT02592707|517169825|FG003|Overall Study|Progressive Disease|3|||
143443296|NCT02592707|517169822|FG000|Overall Study|Other|0|||
143443297|NCT02592707|517169823|FG001|Overall Study|Other|0|||
143443298|NCT02592707|517169824|FG002|Overall Study|Other|1|||
143443299|NCT02592707|517169825|FG003|Overall Study|Other|2|||
143443300|NCT02592707|517169822|FG000|Overall Study|Never entered LTFU period|1|||
143443301|NCT02592707|517169823|FG001|Overall Study|Never entered LTFU period|0|||
143443302|NCT02592707|517169824|FG002|Overall Study|Never entered LTFU period|0|||
143443303|NCT02592707|517169825|FG003|Overall Study|Never entered LTFU period|2|||
143443304|NCT04855734|517169826|FG000|Overall Study|Lost to Follow-up|2|||
143443305|NCT04855734|517169827|FG001|Overall Study|Lost to Follow-up|2|||
143443306|NCT03358472|517169828|FG000|Overall Study|Death|6|||
143443307|NCT03358472|517169829|FG001|Overall Study|Death|3|||
143443308|NCT03358472|517169830|FG002|Overall Study|Death|10|||
143443309|NCT03358472|517169828|FG000|Overall Study|Physician Decision|0|||
143443310|NCT03358472|517169829|FG001|Overall Study|Physician Decision|1|||
143443311|NCT03358472|517169830|FG002|Overall Study|Physician Decision|0|||
143443312|NCT03358472|517169828|FG000|Overall Study|Withdrawal by Subject|0|||
143443313|NCT03358472|517169829|FG001|Overall Study|Withdrawal by Subject|0|||
143443314|NCT03358472|517169830|FG002|Overall Study|Withdrawal by Subject|1|||
143443315|NCT03358472|517169828|FG000|Overall Study|On-going at clinical cut off date|9|||
143443316|NCT03358472|517169829|FG001|Overall Study|On-going at clinical cut off date|6|||
143443317|NCT03358472|517169830|FG002|Overall Study|On-going at clinical cut off date|5|||
143443318|NCT04535544|517169833|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
143443319|NCT04535544|517169834|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
143443320|NCT04535544|517169835|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
143443321|NCT04535544|517169836|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
143443322|NCT04535544|517169833|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
143443323|NCT04535544|517169834|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
143443324|NCT04535544|517169835|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
143443325|NCT04535544|517169836|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
143443326|NCT04535544|517169833|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
143443327|NCT04535544|517169834|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
143443328|NCT04535544|517169835|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
143443329|NCT04535544|517169836|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
143443330|NCT04535544|517169833|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
143443331|NCT04535544|517169834|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
143443332|NCT04535544|517169835|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
143443333|NCT04535544|517169836|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
143443334|NCT04535544|517169833|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
143443335|NCT04535544|517169834|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
143443336|NCT04535544|517169835|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
143443337|NCT04535544|517169836|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
143443338|NCT04535544|517169833|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
143443339|NCT04535544|517169834|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
143443340|NCT04535544|517169835|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
143443341|NCT04535544|517169836|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
143443342|NCT04535544|517169833|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
143443343|NCT04535544|517169834|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
143443344|NCT04535544|517169835|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
143443345|NCT04535544|517169836|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
143443346|NCT04535544|517169833|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
143443347|NCT04535544|517169834|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
143443348|NCT04535544|517169835|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
143443349|NCT04535544|517169836|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
143443350|NCT00344032|517169839|FG000|Overall Study|Adverse Event|0|||
143443351|NCT00344032|517169840|FG001|Overall Study|Adverse Event|1|||
143443352|NCT00344032|517169839|FG000|Overall Study|Withdrawal by Subject|6|||
143443353|NCT00344032|517169840|FG001|Overall Study|Withdrawal by Subject|2|||
143443354|NCT00344032|517169839|FG000|Overall Study|Lost to Follow-up|4|||
143443355|NCT00344032|517169840|FG001|Overall Study|Lost to Follow-up|6|||
143443356|NCT00344032|517169839|FG000|Overall Study|Physician Decision|4|||
143443357|NCT00344032|517169840|FG001|Overall Study|Physician Decision|1|||
143443358|NCT05131477|517169847|FG000|PART 1|Withdrawal by Subject|2|||
143443359|NCT05131477|517169848|FG001|PART 1|Withdrawal by Subject|9|||
143443360|NCT05131477|517169849|FG002|PART 1|Withdrawal by Subject|6|||
143443361|NCT05131477|517169850|FG003|PART 1|Withdrawal by Subject|2|||
143443362|NCT05131477|517169851|FG004|PART 1|Withdrawal by Subject|8|||
143443363|NCT05131477|517169852|FG005|PART 1|Withdrawal by Subject|0|||
143443364|NCT05131477|517169853|FG006|PART 1|Withdrawal by Subject|0|||
143443365|NCT05131477|517169854|FG007|PART 1|Withdrawal by Subject|0|||
143443366|NCT05131477|517169855|FG008|PART 1|Withdrawal by Subject|0|||
143443367|NCT05131477|517169856|FG009|PART 1|Withdrawal by Subject|0|||
143443368|NCT05131477|517169857|FG010|PART 1|Withdrawal by Subject|0|||
143443369|NCT05131477|517169858|FG011|PART 1|Withdrawal by Subject|0|||
143443370|NCT05131477|517169859|FG012|PART 1|Withdrawal by Subject|0|||
143443371|NCT05131477|517169860|FG013|PART 1|Withdrawal by Subject|0|||
143443372|NCT05131477|517169847|FG000|PART 1|Physician Decision|1|||
143443373|NCT05131477|517169848|FG001|PART 1|Physician Decision|0|||
143443374|NCT05131477|517169849|FG002|PART 1|Physician Decision|0|||
143443375|NCT05131477|517169850|FG003|PART 1|Physician Decision|0|||
143443376|NCT05131477|517169851|FG004|PART 1|Physician Decision|0|||
143443377|NCT05131477|517169852|FG005|PART 1|Physician Decision|0|||
143443378|NCT05131477|517169853|FG006|PART 1|Physician Decision|0|||
143443379|NCT05131477|517169854|FG007|PART 1|Physician Decision|0|||
143443380|NCT05131477|517169855|FG008|PART 1|Physician Decision|0|||
143443381|NCT05131477|517169856|FG009|PART 1|Physician Decision|0|||
143443382|NCT05131477|517169857|FG010|PART 1|Physician Decision|0|||
143443383|NCT05131477|517169858|FG011|PART 1|Physician Decision|0|||
143443384|NCT05131477|517169859|FG012|PART 1|Physician Decision|0|||
143443385|NCT05131477|517169860|FG013|PART 1|Physician Decision|0|||
143443386|NCT05131477|517169847|FG000|PART 1|Adverse Event|3|||
143443387|NCT05131477|517169848|FG001|PART 1|Adverse Event|5|||
143443388|NCT05131477|517169849|FG002|PART 1|Adverse Event|1|||
143443389|NCT05131477|517169850|FG003|PART 1|Adverse Event|6|||
143443390|NCT05131477|517169851|FG004|PART 1|Adverse Event|4|||
143443391|NCT05131477|517169852|FG005|PART 1|Adverse Event|0|||
143443392|NCT05131477|517169853|FG006|PART 1|Adverse Event|0|||
143443393|NCT05131477|517169854|FG007|PART 1|Adverse Event|0|||
143443394|NCT05131477|517169855|FG008|PART 1|Adverse Event|0|||
143443395|NCT05131477|517169856|FG009|PART 1|Adverse Event|0|||
143443396|NCT05131477|517169857|FG010|PART 1|Adverse Event|0|||
143443397|NCT05131477|517169858|FG011|PART 1|Adverse Event|0|||
143443398|NCT05131477|517169859|FG012|PART 1|Adverse Event|0|||
143443399|NCT05131477|517169860|FG013|PART 1|Adverse Event|0|||
143443400|NCT05131477|517169847|FG000|PART 1|unclassified|1|||
143443401|NCT05131477|517169848|FG001|PART 1|unclassified|1|||
143443402|NCT05131477|517169849|FG002|PART 1|unclassified|0|||
143443403|NCT05131477|517169850|FG003|PART 1|unclassified|0|||
143443404|NCT05131477|517169851|FG004|PART 1|unclassified|4|||
143443405|NCT05131477|517169852|FG005|PART 1|unclassified|0|||
143443406|NCT05131477|517169853|FG006|PART 1|unclassified|0|||
143443407|NCT05131477|517169854|FG007|PART 1|unclassified|0|||
143443408|NCT05131477|517169855|FG008|PART 1|unclassified|0|||
143443409|NCT05131477|517169856|FG009|PART 1|unclassified|0|||
143443410|NCT05131477|517169857|FG010|PART 1|unclassified|0|||
143443411|NCT05131477|517169858|FG011|PART 1|unclassified|0|||
143443412|NCT05131477|517169859|FG012|PART 1|unclassified|0|||
143443413|NCT05131477|517169860|FG013|PART 1|unclassified|0|||
143443414|NCT05131477|517169847|FG000|PART 1|Randomized and not treated|0|||
143443415|NCT05131477|517169848|FG001|PART 1|Randomized and not treated|0|||
143443416|NCT05131477|517169849|FG002|PART 1|Randomized and not treated|0|||
143443417|NCT05131477|517169850|FG003|PART 1|Randomized and not treated|1|||
143443418|NCT05131477|517169851|FG004|PART 1|Randomized and not treated|1|||
143443419|NCT05131477|517169852|FG005|PART 1|Randomized and not treated|0|||
143443420|NCT05131477|517169853|FG006|PART 1|Randomized and not treated|0|||
143443421|NCT05131477|517169854|FG007|PART 1|Randomized and not treated|0|||
143443422|NCT05131477|517169855|FG008|PART 1|Randomized and not treated|0|||
143443423|NCT05131477|517169856|FG009|PART 1|Randomized and not treated|0|||
143443424|NCT05131477|517169857|FG010|PART 1|Randomized and not treated|0|||
143443425|NCT05131477|517169858|FG011|PART 1|Randomized and not treated|0|||
143443426|NCT05131477|517169859|FG012|PART 1|Randomized and not treated|0|||
143443427|NCT05131477|517169860|FG013|PART 1|Randomized and not treated|0|||
143443428|NCT05131477|517169847|FG000|PART 1|Protocol Violation|2|||
143443429|NCT05131477|517169848|FG001|PART 1|Protocol Violation|0|||
143443430|NCT05131477|517169849|FG002|PART 1|Protocol Violation|0|||
143443431|NCT05131477|517169850|FG003|PART 1|Protocol Violation|1|||
143443432|NCT05131477|517169851|FG004|PART 1|Protocol Violation|0|||
143443433|NCT05131477|517169852|FG005|PART 1|Protocol Violation|0|||
143443434|NCT05131477|517169853|FG006|PART 1|Protocol Violation|0|||
143443435|NCT05131477|517169854|FG007|PART 1|Protocol Violation|0|||
143443436|NCT05131477|517169855|FG008|PART 1|Protocol Violation|0|||
143443437|NCT05131477|517169856|FG009|PART 1|Protocol Violation|0|||
143443438|NCT05131477|517169857|FG010|PART 1|Protocol Violation|0|||
143443439|NCT05131477|517169858|FG011|PART 1|Protocol Violation|0|||
143443440|NCT05131477|517169859|FG012|PART 1|Protocol Violation|0|||
143443441|NCT05131477|517169860|FG013|PART 1|Protocol Violation|0|||
143443442|NCT05131477|517169847|FG000|PART 1|Lack of Efficacy|0|||
143443443|NCT05131477|517169848|FG001|PART 1|Lack of Efficacy|1|||
143443444|NCT05131477|517169849|FG002|PART 1|Lack of Efficacy|1|||
143443445|NCT05131477|517169850|FG003|PART 1|Lack of Efficacy|2|||
143443446|NCT05131477|517169851|FG004|PART 1|Lack of Efficacy|5|||
143443447|NCT05131477|517169852|FG005|PART 1|Lack of Efficacy|0|||
143443448|NCT05131477|517169853|FG006|PART 1|Lack of Efficacy|0|||
143443449|NCT05131477|517169854|FG007|PART 1|Lack of Efficacy|0|||
143443450|NCT05131477|517169855|FG008|PART 1|Lack of Efficacy|0|||
143443451|NCT05131477|517169856|FG009|PART 1|Lack of Efficacy|0|||
143443452|NCT05131477|517169857|FG010|PART 1|Lack of Efficacy|0|||
143443453|NCT05131477|517169858|FG011|PART 1|Lack of Efficacy|0|||
143443454|NCT05131477|517169859|FG012|PART 1|Lack of Efficacy|0|||
143443455|NCT05131477|517169860|FG013|PART 1|Lack of Efficacy|0|||
143443456|NCT05131477|517169847|FG000|PART 2|Withdrawal by Subject|0|||
143443457|NCT05131477|517169848|FG001|PART 2|Withdrawal by Subject|0|||
143443458|NCT05131477|517169849|FG002|PART 2|Withdrawal by Subject|0|||
143443459|NCT05131477|517169850|FG003|PART 2|Withdrawal by Subject|0|||
143443460|NCT05131477|517169851|FG004|PART 2|Withdrawal by Subject|0|||
143443461|NCT05131477|517169852|FG005|PART 2|Withdrawal by Subject|0|||
143443462|NCT05131477|517169853|FG006|PART 2|Withdrawal by Subject|2|||
143443463|NCT05131477|517169854|FG007|PART 2|Withdrawal by Subject|0|||
143443464|NCT05131477|517169855|FG008|PART 2|Withdrawal by Subject|0|||
143443465|NCT05131477|517169856|FG009|PART 2|Withdrawal by Subject|0|||
143443466|NCT05131477|517169857|FG010|PART 2|Withdrawal by Subject|2|||
143443467|NCT05131477|517169858|FG011|PART 2|Withdrawal by Subject|0|||
143443468|NCT05131477|517169859|FG012|PART 2|Withdrawal by Subject|2|||
143443469|NCT05131477|517169860|FG013|PART 2|Withdrawal by Subject|2|||
143443470|NCT05131477|517169847|FG000|PART 2|Other|0|||
143443471|NCT05131477|517169848|FG001|PART 2|Other|0|||
143443472|NCT05131477|517169849|FG002|PART 2|Other|0|||
143443473|NCT05131477|517169850|FG003|PART 2|Other|0|||
143443474|NCT05131477|517169851|FG004|PART 2|Other|0|||
143443475|NCT05131477|517169852|FG005|PART 2|Other|0|||
143443476|NCT05131477|517169853|FG006|PART 2|Other|0|||
143443477|NCT05131477|517169854|FG007|PART 2|Other|0|||
143443478|NCT05131477|517169855|FG008|PART 2|Other|1|||
143443479|NCT05131477|517169856|FG009|PART 2|Other|1|||
143443480|NCT05131477|517169857|FG010|PART 2|Other|0|||
143443481|NCT05131477|517169858|FG011|PART 2|Other|0|||
143443482|NCT05131477|517169859|FG012|PART 2|Other|1|||
143443483|NCT05131477|517169860|FG013|PART 2|Other|0|||
143443484|NCT05131477|517169847|FG000|PART 2|Lack of Efficacy|0|||
143443485|NCT05131477|517169848|FG001|PART 2|Lack of Efficacy|0|||
143443486|NCT05131477|517169849|FG002|PART 2|Lack of Efficacy|0|||
143443487|NCT05131477|517169850|FG003|PART 2|Lack of Efficacy|0|||
143443488|NCT05131477|517169851|FG004|PART 2|Lack of Efficacy|0|||
143443489|NCT05131477|517169852|FG005|PART 2|Lack of Efficacy|1|||
143443490|NCT05131477|517169853|FG006|PART 2|Lack of Efficacy|1|||
143443491|NCT05131477|517169854|FG007|PART 2|Lack of Efficacy|0|||
143443492|NCT05131477|517169855|FG008|PART 2|Lack of Efficacy|3|||
143443493|NCT05131477|517169856|FG009|PART 2|Lack of Efficacy|0|||
143443494|NCT05131477|517169857|FG010|PART 2|Lack of Efficacy|1|||
143443495|NCT05131477|517169858|FG011|PART 2|Lack of Efficacy|0|||
143443496|NCT05131477|517169859|FG012|PART 2|Lack of Efficacy|2|||
143443497|NCT05131477|517169860|FG013|PART 2|Lack of Efficacy|0|||
143443498|NCT05131477|517169847|FG000|PART 2|Unclassified|0|||
143443499|NCT05131477|517169848|FG001|PART 2|Unclassified|0|||
143443500|NCT05131477|517169849|FG002|PART 2|Unclassified|0|||
143443501|NCT05131477|517169850|FG003|PART 2|Unclassified|0|||
143443502|NCT05131477|517169851|FG004|PART 2|Unclassified|0|||
143443503|NCT05131477|517169852|FG005|PART 2|Unclassified|0|||
143443504|NCT05131477|517169853|FG006|PART 2|Unclassified|0|||
143443505|NCT05131477|517169854|FG007|PART 2|Unclassified|0|||
143443506|NCT05131477|517169855|FG008|PART 2|Unclassified|0|||
143443507|NCT05131477|517169856|FG009|PART 2|Unclassified|0|||
143443508|NCT05131477|517169857|FG010|PART 2|Unclassified|1|||
143443509|NCT05131477|517169858|FG011|PART 2|Unclassified|0|||
143443510|NCT05131477|517169859|FG012|PART 2|Unclassified|0|||
143443511|NCT05131477|517169860|FG013|PART 2|Unclassified|0|||
143443512|NCT05131477|517169847|FG000|PART 2|Re-randomized and not treated|0|||
143443513|NCT05131477|517169848|FG001|PART 2|Re-randomized and not treated|0|||
143443514|NCT05131477|517169849|FG002|PART 2|Re-randomized and not treated|0|||
143443515|NCT05131477|517169850|FG003|PART 2|Re-randomized and not treated|0|||
143443516|NCT05131477|517169851|FG004|PART 2|Re-randomized and not treated|0|||
143443517|NCT05131477|517169852|FG005|PART 2|Re-randomized and not treated|0|||
143443518|NCT05131477|517169853|FG006|PART 2|Re-randomized and not treated|0|||
143443519|NCT05131477|517169854|FG007|PART 2|Re-randomized and not treated|1|||
143443520|NCT05131477|517169855|FG008|PART 2|Re-randomized and not treated|0|||
143443521|NCT05131477|517169856|FG009|PART 2|Re-randomized and not treated|0|||
143443522|NCT05131477|517169857|FG010|PART 2|Re-randomized and not treated|1|||
143443523|NCT05131477|517169858|FG011|PART 2|Re-randomized and not treated|0|||
143443524|NCT05131477|517169859|FG012|PART 2|Re-randomized and not treated|1|||
143443525|NCT05131477|517169860|FG013|PART 2|Re-randomized and not treated|1|||
143443526|NCT02194829|517169861|FG000|Overall Study|Adverse Event|2|||
143443527|NCT02194829|517169862|FG001|Overall Study|Adverse Event|2|||
143443528|NCT02194829|517169861|FG000|Overall Study|Death|0|||
143443529|NCT02194829|517169862|FG001|Overall Study|Death|1|||
143443530|NCT02194829|517169861|FG000|Overall Study|Disease progression|0|||
143443531|NCT02194829|517169862|FG001|Overall Study|Disease progression|1|||
143443532|NCT02194829|517169861|FG000|Overall Study|Withdrawal by Subject|0|||
143443533|NCT02194829|517169862|FG001|Overall Study|Withdrawal by Subject|1|||
143443534|NCT02194829|517169861|FG000|Overall Study|Never started protocol therapy|0|||
143443535|NCT02194829|517169862|FG001|Overall Study|Never started protocol therapy|1|||
143443536|NCT02614183|517169865|FG000|Double Blind Treatment Phase|Adverse Event|10|||
143443537|NCT02614183|517169866|FG001|Double Blind Treatment Phase|Adverse Event|9|||
143443538|NCT02614183|517169867|FG002|Double Blind Treatment Phase|Adverse Event|7|||
143443539|NCT02614183|517169865|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
143443540|NCT02614183|517169866|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
143443541|NCT02614183|517169867|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
143443542|NCT02614183|517169865|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
143443543|NCT02614183|517169866|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
143443544|NCT02614183|517169867|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
143443545|NCT02614183|517169865|FG000|Double Blind Treatment Phase|Physician Decision|7|||
143443546|NCT02614183|517169866|FG001|Double Blind Treatment Phase|Physician Decision|3|||
143443547|NCT02614183|517169867|FG002|Double Blind Treatment Phase|Physician Decision|2|||
143443548|NCT02614183|517169865|FG000|Double Blind Treatment Phase|Pregnancy|2|||
143443549|NCT02614183|517169866|FG001|Double Blind Treatment Phase|Pregnancy|1|||
143443550|NCT02614183|517169867|FG002|Double Blind Treatment Phase|Pregnancy|3|||
143443551|NCT02614183|517169865|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
143443552|NCT02614183|517169866|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
143443553|NCT02614183|517169867|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
143443554|NCT02614183|517169865|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
143443555|NCT02614183|517169866|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
143443556|NCT02614183|517169867|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
143443557|NCT02614183|517169865|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
143443558|NCT02614183|517169866|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
143443559|NCT02614183|517169867|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
143443560|NCT02614183|517169865|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
143443561|NCT02614183|517169866|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
143443562|NCT02614183|517169867|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
143443563|NCT02614183|517169865|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
143443564|NCT02614183|517169866|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
143443565|NCT02614183|517169867|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
143443566|NCT02614183|517169865|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
143443567|NCT02614183|517169866|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
143443568|NCT02614183|517169867|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
143443569|NCT02614183|517169865|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
143443570|NCT02614183|517169866|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
143443571|NCT02614183|517169867|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
143443572|NCT02726945|517169868|FG000|Overall Study|Withdrawal by Subject|0|||
143443573|NCT02726945|517169869|FG001|Overall Study|Withdrawal by Subject|0|||
143443574|NCT02726945|517169870|FG002|Overall Study|Withdrawal by Subject|1|||
143443575|NCT02726945|517169868|FG000|Overall Study|Elected to have total knee replacement|0|||
143443576|NCT02726945|517169869|FG001|Overall Study|Elected to have total knee replacement|1|||
143443577|NCT02726945|517169870|FG002|Overall Study|Elected to have total knee replacement|0|||
143443578|NCT04991753|517171998|FG000|Overall Study|Withdrawal by Subject|0|||
143443579|NCT04991753|517171999|FG001|Overall Study|Withdrawal by Subject|1|||
143443580|NCT02113124|517172000|FG000|Overall Study|Unable to retrieve blood sample|1|||
143443581|NCT02113124|517172001|FG001|Overall Study|Unable to retrieve blood sample|1|||
143443582|NCT01901419|517172002|FG000|Overall Study|Protocol Violation|2|||
143443583|NCT01901419|517172003|FG001|Overall Study|Protocol Violation|6|||
143443584|NCT01901419|517172002|FG000|Overall Study|unavailable researchers|6|||
143443585|NCT01901419|517172003|FG001|Overall Study|unavailable researchers|3|||
143443586|NCT00699153|517172004|FG000|Overall Study|Lost to Follow-up|1|||
143443587|NCT00699153|517172005|FG001|Overall Study|Lost to Follow-up|0|||
143443588|NCT00699153|517172004|FG000|Overall Study|Adverse Event|0|||
143443589|NCT00699153|517172005|FG001|Overall Study|Adverse Event|2|||
143443590|NCT00699153|517172004|FG000|Overall Study|Protocol Violation|1|||
143443591|NCT00699153|517172005|FG001|Overall Study|Protocol Violation|0|||
143443592|NCT00699153|517172004|FG000|Overall Study|Travel Problem|1|||
143443593|NCT00699153|517172005|FG001|Overall Study|Travel Problem|0|||
143443594|NCT02412735|517172008|FG000|Overall Study|Adverse Event|0|||
143443595|NCT02412735|517172009|FG001|Overall Study|Adverse Event|1|||
143443596|NCT02412735|517172010|FG002|Overall Study|Adverse Event|2|||
143443597|NCT02412735|517172008|FG000|Overall Study|Withdrawal by Subject|23|||
143443598|NCT02412735|517172009|FG001|Overall Study|Withdrawal by Subject|27|||
143443599|NCT02412735|517172010|FG002|Overall Study|Withdrawal by Subject|22|||
143443600|NCT02412735|517172008|FG000|Overall Study|Investigator Decision|3|||
143443601|NCT02412735|517172009|FG001|Overall Study|Investigator Decision|3|||
143443602|NCT02412735|517172010|FG002|Overall Study|Investigator Decision|2|||
143443603|NCT02412735|517172008|FG000|Overall Study|Lost to Follow-up|17|||
143443604|NCT02412735|517172009|FG001|Overall Study|Lost to Follow-up|11|||
143443605|NCT02412735|517172010|FG002|Overall Study|Lost to Follow-up|18|||
143443606|NCT02412735|517172008|FG000|Overall Study|Reason not Specified|3|||
143443607|NCT02412735|517172009|FG001|Overall Study|Reason not Specified|2|||
143443608|NCT02412735|517172010|FG002|Overall Study|Reason not Specified|2|||
143443609|NCT00603525|517172012|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
143443610|NCT00603525|517172013|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
143443611|NCT00603525|517172014|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
143443612|NCT00603525|517172012|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
143443613|NCT00603525|517172013|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
143443614|NCT00603525|517172014|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
143443615|NCT00603525|517172012|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
143443616|NCT00603525|517172013|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
143443617|NCT00603525|517172014|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
143443618|NCT00603525|517172012|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
143443619|NCT00603525|517172013|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
143443620|NCT00603525|517172014|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
143443621|NCT00603525|517172012|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
143443622|NCT00603525|517172013|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
143443623|NCT00603525|517172014|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
143443624|NCT00603525|517172012|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
143443625|NCT00603525|517172013|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
143443626|NCT00603525|517172014|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
143443627|NCT00603525|517172012|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
143443628|NCT00603525|517172013|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
143443629|NCT00603525|517172014|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
143443630|NCT00603525|517172012|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
143443631|NCT00603525|517172013|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
143443632|NCT00603525|517172014|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
143443633|NCT00603525|517172012|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
143443634|NCT00603525|517172013|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
143443635|NCT00603525|517172014|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
143443636|NCT00603525|517172012|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
143443637|NCT00603525|517172013|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
143443638|NCT00603525|517172014|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
143443639|NCT00603525|517172012|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
143443640|NCT00603525|517172013|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
143443641|NCT00603525|517172014|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
143443642|NCT00603525|517172012|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
143443643|NCT00603525|517172013|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
143443644|NCT00603525|517172014|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
143443645|NCT00603525|517172012|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
143443646|NCT00603525|517172013|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
143443647|NCT00603525|517172014|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
143443648|NCT00603525|517172012|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
143443649|NCT00603525|517172013|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
143443650|NCT00603525|517172014|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
143443651|NCT00603525|517172012|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
143443652|NCT00603525|517172013|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
143443653|NCT00603525|517172014|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
143443654|NCT04043143|517172015|FG000|Overall Study|Lost to Follow-up|5|||
143443655|NCT04043143|517172016|FG001|Overall Study|Lost to Follow-up|5|||
143443656|NCT04043143|517172015|FG000|Overall Study|screen failure|1|||
143443657|NCT04043143|517172016|FG001|Overall Study|screen failure|0|||
143443658|NCT03480932|517172017|FG000|Overall Study|Death|1|||
143443659|NCT03480932|517172018|FG001|Overall Study|Death|1|||
143443660|NCT03480932|517172019|FG002|Overall Study|Death|0|||
143443661|NCT03480932|517172017|FG000|Overall Study|Lost to Follow-up|0|||
143443662|NCT03480932|517172018|FG001|Overall Study|Lost to Follow-up|2|||
143443663|NCT03480932|517172019|FG002|Overall Study|Lost to Follow-up|3|||
143443664|NCT03480932|517172017|FG000|Overall Study|Incarcerated|2|||
143443665|NCT03480932|517172018|FG001|Overall Study|Incarcerated|2|||
143443666|NCT03480932|517172019|FG002|Overall Study|Incarcerated|2|||
143443667|NCT03374488|517172029|FG000|Overall Study|Death|13|||
143443668|NCT03374488|517172030|FG001|Overall Study|Death|13|||
143443669|NCT03374488|517172029|FG000|Overall Study|Withdrawal by Subject|3|||
143443670|NCT03374488|517172030|FG001|Overall Study|Withdrawal by Subject|1|||
143443671|NCT03374488|517172029|FG000|Overall Study|Physician Decision|3|||
143443672|NCT03374488|517172030|FG001|Overall Study|Physician Decision|0|||
143443673|NCT04201288|517172033|FG000|Overall Study|Death|1|||
143443674|NCT04201288|517172034|FG001|Overall Study|Death|1|||
143443675|NCT04201288|517172033|FG000|Overall Study|Lost to Follow-up|5|||
143443676|NCT04201288|517172034|FG001|Overall Study|Lost to Follow-up|3|||
143443677|NCT04201288|517172033|FG000|Overall Study|Withdrawal by Subject|1|||
143443678|NCT04201288|517172034|FG001|Overall Study|Withdrawal by Subject|0|||
143443679|NCT04497389|517172037|FG000|Overall Study|Withdrawal by Subject|1|||
143443680|NCT04497389|517172038|FG001|Overall Study|Withdrawal by Subject|0|||
143443681|NCT00789360|517172041|FG000|Overall Study|Protocol Violation|3|||
143443682|NCT00789360|517172042|FG001|Overall Study|Protocol Violation|1|||
143443683|NCT03322540|517172047|FG000|Overall Study|Death|21|||
143443684|NCT03322540|517172048|FG001|Overall Study|Death|28|||
143443685|NCT03322540|517172047|FG000|Overall Study|Lost to Follow-up|0|||
143443686|NCT03322540|517172048|FG001|Overall Study|Lost to Follow-up|1|||
143443687|NCT03322540|517172047|FG000|Overall Study|Physician Decision|7|||
143443688|NCT03322540|517172048|FG001|Overall Study|Physician Decision|6|||
143443689|NCT03322540|517172047|FG000|Overall Study|Withdrawal by Subject|3|||
143443690|NCT03322540|517172048|FG001|Overall Study|Withdrawal by Subject|1|||
143443691|NCT03322540|517172047|FG000|Overall Study|Study terminated by sponsor|0|||
143443692|NCT03322540|517172048|FG001|Overall Study|Study terminated by sponsor|1|||
143443693|NCT03445533|517172049|FG000|Overall Study|Progressive Disease|48|||
143443694|NCT03445533|517172050|FG001|Overall Study|Progressive Disease|81|||
143443695|NCT03445533|517172049|FG000|Overall Study|Adverse Event|60|||
143443696|NCT03445533|517172050|FG001|Overall Study|Adverse Event|64|||
143443697|NCT03445533|517172049|FG000|Overall Study|Death|9|||
143443698|NCT03445533|517172050|FG001|Overall Study|Death|19|||
143443699|NCT03445533|517172049|FG000|Overall Study|Miscellaneous|0|||
143443700|NCT03445533|517172050|FG001|Overall Study|Miscellaneous|16|||
143443701|NCT03445533|517172049|FG000|Overall Study|Withdrawal by Subject|3|||
143443702|NCT03445533|517172050|FG001|Overall Study|Withdrawal by Subject|4|||
143443703|NCT03445533|517172049|FG000|Overall Study|Physician Decision|1|||
143443704|NCT03445533|517172050|FG001|Overall Study|Physician Decision|3|||
143443705|NCT03445533|517172049|FG000|Overall Study|Sponsor Decision|0|||
143443706|NCT03445533|517172050|FG001|Overall Study|Sponsor Decision|1|||
143443707|NCT03445533|517172049|FG000|Overall Study|Lost to Follow-up|0|||
143443708|NCT03445533|517172050|FG001|Overall Study|Lost to Follow-up|1|||
143443709|NCT03445533|517172049|FG000|Overall Study|Never Received any Study Treatment|7|||
143443710|NCT03445533|517172050|FG001|Overall Study|Never Received any Study Treatment|4|||
143443711|NCT02615509|517172051|FG000|Overall Study|Lost to Follow-up|134|||
143443712|NCT02615509|517172051|FG000|Overall Study|Death|4|||
143443713|NCT02615509|517172051|FG000|Overall Study|Withdrawal by Subject|8|||
143443714|NCT03274453|517172052|FG000|Overall Study|Lost to Follow-up|2|||
143443715|NCT03274453|517172053|FG001|Overall Study|Lost to Follow-up|5|||
143443716|NCT03274453|517172054|FG002|Overall Study|Lost to Follow-up|4|||
143443717|NCT03274453|517172055|FG003|Overall Study|Lost to Follow-up|1|||
143443718|NCT03274453|517172052|FG000|Overall Study|Physician Decision|2|||
143443719|NCT03274453|517172053|FG001|Overall Study|Physician Decision|0|||
143443720|NCT03274453|517172054|FG002|Overall Study|Physician Decision|0|||
143443721|NCT03274453|517172055|FG003|Overall Study|Physician Decision|3|||
143443722|NCT03274453|517172052|FG000|Overall Study|Surgery Cancelled|0|||
143443723|NCT03274453|517172053|FG001|Overall Study|Surgery Cancelled|1|||
143443724|NCT03274453|517172054|FG002|Overall Study|Surgery Cancelled|0|||
143443725|NCT03274453|517172055|FG003|Overall Study|Surgery Cancelled|0|||
143443726|NCT00968526|517172057|FG000|Overall Study|Adverse Event|2|||
143443727|NCT00968526|517172058|FG001|Overall Study|Adverse Event|0|||
143443728|NCT00968526|517172057|FG000|Overall Study|Migrated/moved from study area|1|||
143443729|NCT00968526|517172058|FG001|Overall Study|Migrated/moved from study area|0|||
143443730|NCT04703192|517172062|FG000|Overall Study|Withdrawal by Subject|2|||
143443731|NCT04703192|517172063|FG001|Overall Study|Withdrawal by Subject|0|||
143443732|NCT04703192|517172062|FG000|Overall Study|Death|3|||
143443733|NCT04703192|517172063|FG001|Overall Study|Death|1|||
143443734|NCT04703192|517172062|FG000|Overall Study|Adverse Event|13|||
143443735|NCT04703192|517172063|FG001|Overall Study|Adverse Event|2|||
143443736|NCT04703192|517172062|FG000|Overall Study|Progressive or Relapsed Disease|46|||
143443737|NCT04703192|517172063|FG001|Overall Study|Progressive or Relapsed Disease|7|||
143443738|NCT04703192|517172062|FG000|Overall Study|Clinical Progression|19|||
143443739|NCT04703192|517172063|FG001|Overall Study|Clinical Progression|8|||
143443740|NCT04703192|517172062|FG000|Overall Study|Lost to Follow-up|1|||
143443741|NCT04703192|517172063|FG001|Overall Study|Lost to Follow-up|0|||
143443742|NCT04703192|517172062|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
143443743|NCT04703192|517172063|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
143443744|NCT04703192|517172062|FG000|Overall Study|Other|5|||
143443745|NCT04703192|517172063|FG001|Overall Study|Other|1|||
143443746|NCT02493062|517172064|FG000|Overall Study|Physician Decision|12|||
143443747|NCT03926195|517172065|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
143443748|NCT03926195|517172066|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
143443749|NCT03926195|517172065|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
143443750|NCT03926195|517172066|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
143443751|NCT03926195|517172065|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
143443752|NCT03926195|517172066|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
143443753|NCT03926195|517172065|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
143443754|NCT03926195|517172066|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
143443755|NCT03926195|517172065|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
143443756|NCT03926195|517172066|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
143443757|NCT03926195|517172065|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
143443758|NCT03926195|517172066|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
143443759|NCT01327612|517172067|FG000|Overall Study|Withdrawal by Subject|0|||
143443760|NCT01327612|517172068|FG001|Overall Study|Withdrawal by Subject|0|||
143443761|NCT01327612|517172069|FG002|Overall Study|Withdrawal by Subject|0|||
143443762|NCT01327612|517172070|FG003|Overall Study|Withdrawal by Subject|0|||
143443763|NCT01327612|517172071|FG004|Overall Study|Withdrawal by Subject|0|||
143443764|NCT01327612|517172072|FG005|Overall Study|Withdrawal by Subject|1|||
143443765|NCT01327612|517172073|FG006|Overall Study|Withdrawal by Subject|0|||
143443766|NCT01327612|517172067|FG000|Overall Study|Disease Progression|1|||
143443767|NCT01327612|517172068|FG001|Overall Study|Disease Progression|1|||
143443768|NCT01327612|517172069|FG002|Overall Study|Disease Progression|1|||
143443769|NCT01327612|517172070|FG003|Overall Study|Disease Progression|0|||
143443770|NCT01327612|517172071|FG004|Overall Study|Disease Progression|1|||
143443771|NCT01327612|517172072|FG005|Overall Study|Disease Progression|2|||
143443772|NCT01327612|517172073|FG006|Overall Study|Disease Progression|2|||
143443773|NCT01327612|517172067|FG000|Overall Study|Administrative Decision|0|||
143443774|NCT01327612|517172068|FG001|Overall Study|Administrative Decision|0|||
143443775|NCT01327612|517172069|FG002|Overall Study|Administrative Decision|0|||
143443776|NCT01327612|517172070|FG003|Overall Study|Administrative Decision|1|||
143443777|NCT01327612|517172071|FG004|Overall Study|Administrative Decision|0|||
143443778|NCT01327612|517172072|FG005|Overall Study|Administrative Decision|0|||
143443779|NCT01327612|517172073|FG006|Overall Study|Administrative Decision|0|||
143443780|NCT01327612|517172067|FG000|Overall Study|Death|0|||
143443781|NCT01327612|517172068|FG001|Overall Study|Death|0|||
143443782|NCT01327612|517172069|FG002|Overall Study|Death|0|||
143443783|NCT01327612|517172070|FG003|Overall Study|Death|0|||
143443784|NCT01327612|517172071|FG004|Overall Study|Death|1|||
143443785|NCT01327612|517172072|FG005|Overall Study|Death|0|||
143443786|NCT01327612|517172073|FG006|Overall Study|Death|0|||
143443787|NCT01661205|517172074|FG000|Overall Study|Physician Decision|2|||
143443788|NCT00426127|517172075|FG000|Overall Study|Adverse Event|1|||
143443789|NCT00426127|517172075|FG000|Overall Study|Removed due to disease progression|1|||
143443790|NCT03111095|517172079|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
143443791|NCT03111095|517172080|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
143443792|NCT03111095|517172079|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
143443793|NCT03111095|517172080|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
143443794|NCT01689857|517172082|FG000|Overall Study|Lost to Follow-up|5|||
143443795|NCT01689857|517172083|FG001|Overall Study|Lost to Follow-up|2|||
143443796|NCT01730378|517172084|FG000|Overall Study|Lost to Follow-up|1|||
143443797|NCT01730378|517172085|FG001|Overall Study|Lost to Follow-up|0|||
143443798|NCT00955708|517172088|FG000|Overall Study|Death|269|||
143443799|NCT00955708|517172088|FG000|Overall Study|Lost to Follow-up|72|||
143443800|NCT00955708|517172088|FG000|Overall Study|Physician Decision|36|||
143443801|NCT00955708|517172088|FG000|Overall Study|Protocol Violation|134|||
143443802|NCT00955708|517172088|FG000|Overall Study|Registry Conclusion|186|||
143443803|NCT00955708|517172088|FG000|Overall Study|Product removed from service|94|||
143443804|NCT00955708|517172088|FG000|Overall Study|Patient Refused to participate further|116|||
143443805|NCT00955708|517172088|FG000|Overall Study|Closure of study location|60|||
143443806|NCT00955708|517172088|FG000|Overall Study|Patient changed care provider/moved|91|||
143443807|NCT05105087|517172089|FG000|Overall Study|Withdrawal by Subject|2|||
143443808|NCT05105087|517172089|FG000|Overall Study|Ineligible for surgery due to advanced disease|2|||
143443809|NCT00479882|517172092|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
143443810|NCT00479882|517172093|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
143443811|NCT00479882|517172094|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
143443812|NCT00479882|517172095|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
143443813|NCT00479882|517172092|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
143443814|NCT00479882|517172093|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
143443815|NCT00479882|517172094|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
143443816|NCT00479882|517172095|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
143443817|NCT00479882|517172092|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
143443818|NCT00479882|517172093|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
143443819|NCT00479882|517172094|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
143443820|NCT00479882|517172095|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
143443821|NCT00479882|517172092|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
143443822|NCT00479882|517172093|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
143443823|NCT00479882|517172094|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
143443824|NCT00479882|517172095|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
143443825|NCT00479882|517172092|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
143443826|NCT00479882|517172093|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
143443827|NCT00479882|517172094|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
143443828|NCT00479882|517172095|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
143443829|NCT00479882|517172092|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
143443830|NCT00479882|517172093|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
143443831|NCT00479882|517172094|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
143443832|NCT00479882|517172095|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
143443833|NCT00479882|517172092|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
143443834|NCT00479882|517172093|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
143443835|NCT00479882|517172094|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
143443836|NCT00479882|517172095|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
143443837|NCT00479882|517172092|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
143443838|NCT00479882|517172093|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
143443839|NCT00479882|517172094|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
143443840|NCT00479882|517172095|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
143443841|NCT00479882|517172092|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
143443842|NCT00479882|517172093|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
143443843|NCT00479882|517172094|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
143443844|NCT00479882|517172095|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
143443845|NCT00479882|517172092|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
143443846|NCT00479882|517172093|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
143443847|NCT00479882|517172094|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
143443848|NCT00479882|517172095|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
143443849|NCT00479882|517172092|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
143443850|NCT00479882|517172093|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
143443851|NCT00479882|517172094|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
143443852|NCT00479882|517172095|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
143443853|NCT00479882|517172092|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
143443854|NCT00479882|517172093|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
143443855|NCT00479882|517172094|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
143443856|NCT00479882|517172095|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
143443857|NCT00479882|517172092|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
143443858|NCT00479882|517172093|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
143443859|NCT00479882|517172094|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
143443860|NCT00479882|517172095|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
143443861|NCT00479882|517172092|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
143443862|NCT00479882|517172093|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
143443863|NCT00479882|517172094|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
143443864|NCT00479882|517172095|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
143443865|NCT03738475|517172096|FG000|Overall Study|Participant Non-Compliance|1|||
143443866|NCT03738475|517172097|FG001|Overall Study|Participant Non-Compliance|0|||
143443867|NCT00737477|517172098|FG000|Overall Study|Adverse Event|9|||
143443868|NCT00737477|517172098|FG000|Overall Study|Death|9|||
143443869|NCT00737477|517172098|FG000|Overall Study|Treatment Refusal|1|||
143443870|NCT00737477|517172098|FG000|Overall Study|Withdrawal by Subject|1|||
143443871|NCT00737477|517172098|FG000|Overall Study|Renal Transplantation|10|||
143443872|NCT00737477|517172098|FG000|Overall Study|Other|4|||
143443873|NCT01132820|517172099|FG000|Overall Study|Ineligible: wrong cell type|1|||
143443874|NCT01132820|517172099|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
143443875|NCT01132820|517172099|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
143443876|NCT01132820|517172099|FG000|Overall Study|Never treated|1|||
143443877|NCT01132820|517172099|FG000|Overall Study|Inadequate data|1|||
143443878|NCT01370655|517172102|FG000|Period 1|Adverse Event|2|||
143443879|NCT01370655|517172103|FG001|Period 1|Adverse Event|0|||
143443880|NCT01370655|517172104|FG002|Period 1|Adverse Event|0|||
143443881|NCT01370655|517172105|FG003|Period 1|Adverse Event|0|||
143443882|NCT01370655|517172106|FG004|Period 1|Adverse Event|0|||
143443883|NCT01370655|517172107|FG005|Period 1|Adverse Event|0|||
143443884|NCT01370655|517172108|FG006|Period 1|Adverse Event|1|||
143443885|NCT01370655|517172109|FG007|Period 1|Adverse Event|0|||
143443886|NCT01370655|517172110|FG008|Period 1|Adverse Event|0|||
143443887|NCT01370655|517172111|FG009|Period 1|Adverse Event|0|||
143443888|NCT01370655|517172112|FG010|Period 1|Adverse Event|0|||
143443889|NCT01370655|517172113|FG011|Period 1|Adverse Event|0|||
143443890|NCT01370655|517172102|FG000|Period 2|Adverse Event|0|||
143443891|NCT01370655|517172103|FG001|Period 2|Adverse Event|0|||
143443892|NCT01370655|517172104|FG002|Period 2|Adverse Event|1|||
143443893|NCT01370655|517172105|FG003|Period 2|Adverse Event|0|||
143443894|NCT01370655|517172106|FG004|Period 2|Adverse Event|1|||
143443895|NCT01370655|517172107|FG005|Period 2|Adverse Event|0|||
143443896|NCT01370655|517172108|FG006|Period 2|Adverse Event|0|||
143443897|NCT01370655|517172109|FG007|Period 2|Adverse Event|1|||
143443898|NCT01370655|517172110|FG008|Period 2|Adverse Event|0|||
143443899|NCT01370655|517172111|FG009|Period 2|Adverse Event|0|||
143443900|NCT01370655|517172112|FG010|Period 2|Adverse Event|0|||
143443901|NCT01370655|517172113|FG011|Period 2|Adverse Event|0|||
143443902|NCT01370655|517172102|FG000|Period 2|met protocol specified stopping criteria|0|||
143443903|NCT01370655|517172103|FG001|Period 2|met protocol specified stopping criteria|0|||
143443904|NCT01370655|517172104|FG002|Period 2|met protocol specified stopping criteria|1|||
143443905|NCT01370655|517172105|FG003|Period 2|met protocol specified stopping criteria|0|||
143443906|NCT01370655|517172106|FG004|Period 2|met protocol specified stopping criteria|0|||
143443907|NCT01370655|517172107|FG005|Period 2|met protocol specified stopping criteria|0|||
143443908|NCT01370655|517172108|FG006|Period 2|met protocol specified stopping criteria|1|||
143443909|NCT01370655|517172109|FG007|Period 2|met protocol specified stopping criteria|0|||
143443910|NCT01370655|517172110|FG008|Period 2|met protocol specified stopping criteria|1|||
143443911|NCT01370655|517172111|FG009|Period 2|met protocol specified stopping criteria|0|||
143443912|NCT01370655|517172112|FG010|Period 2|met protocol specified stopping criteria|1|||
143443913|NCT01370655|517172113|FG011|Period 2|met protocol specified stopping criteria|0|||
143443914|NCT01370655|517172102|FG000|Period 2|Withdrawal by Subject|0|||
143443915|NCT01370655|517172103|FG001|Period 2|Withdrawal by Subject|0|||
143443916|NCT01370655|517172104|FG002|Period 2|Withdrawal by Subject|0|||
143443917|NCT01370655|517172105|FG003|Period 2|Withdrawal by Subject|0|||
143443918|NCT01370655|517172106|FG004|Period 2|Withdrawal by Subject|0|||
143443919|NCT01370655|517172107|FG005|Period 2|Withdrawal by Subject|0|||
143443920|NCT01370655|517172108|FG006|Period 2|Withdrawal by Subject|0|||
143443921|NCT01370655|517172109|FG007|Period 2|Withdrawal by Subject|0|||
143443922|NCT01370655|517172110|FG008|Period 2|Withdrawal by Subject|1|||
143443923|NCT01370655|517172111|FG009|Period 2|Withdrawal by Subject|0|||
143443924|NCT01370655|517172112|FG010|Period 2|Withdrawal by Subject|0|||
143443925|NCT01370655|517172113|FG011|Period 2|Withdrawal by Subject|0|||
143443926|NCT00659880|517172118|FG000|Overall Study|Lost to Follow-up|5|||
143443927|NCT01853475|517172119|FG000|Overall Study|Withdrawal by Subject|0|||
143443928|NCT01853475|517172120|FG001|Overall Study|Withdrawal by Subject|1|||
143443929|NCT01853475|517172121|FG002|Overall Study|Withdrawal by Subject|0|||
143443930|NCT01023958|517172126|FG000|Overall Study|Progressive disease|48|||
143443931|NCT01023958|517172126|FG000|Overall Study|Other adverse event|1|||
143443932|NCT01023958|517172126|FG000|Overall Study|Refused to continue medication|1|||
143443933|NCT02159040|517172127|FG000|Overall Study|Death|1|||
143443934|NCT03080493|517172128|FG000|Overall Study|Did not provide NRS pain results|1|||
143443935|NCT03080493|517172129|FG001|Overall Study|Did not provide NRS pain results|0|||
143443936|NCT03080493|517172128|FG000|Overall Study|Adverse Event|0|||
143443937|NCT03080493|517172129|FG001|Overall Study|Adverse Event|1|||
143443938|NCT03080493|517172128|FG000|Overall Study|Randomization error (parity group)|0|||
143443939|NCT03080493|517172129|FG001|Overall Study|Randomization error (parity group)|1|||
143443940|NCT01304498|517172130|FG000|Overall Study|Adverse Event|1|||
143443941|NCT01304498|517172131|FG001|Overall Study|Adverse Event|1|||
143443942|NCT01304498|517172130|FG000|Overall Study|Withdrawal by Subject|2|||
143443943|NCT01304498|517172131|FG001|Overall Study|Withdrawal by Subject|3|||
143443944|NCT01304498|517172130|FG000|Overall Study|Protocol Violation|1|||
143443945|NCT01304498|517172131|FG001|Overall Study|Protocol Violation|0|||
143443946|NCT01304498|517172130|FG000|Overall Study|Lost to Follow-up|2|||
143443947|NCT01304498|517172131|FG001|Overall Study|Lost to Follow-up|1|||
143443948|NCT00755417|517172132|FG000|Overall Study|Adverse Event|28|||
143443949|NCT00755417|517172133|FG001|Overall Study|Adverse Event|20|||
143443950|NCT00755417|517172134|FG002|Overall Study|Adverse Event|7|||
143443951|NCT00755417|517172132|FG000|Overall Study|Lack of Efficacy|8|||
143443952|NCT00755417|517172133|FG001|Overall Study|Lack of Efficacy|4|||
143443953|NCT00755417|517172134|FG002|Overall Study|Lack of Efficacy|9|||
143443954|NCT00755417|517172132|FG000|Overall Study|Protocol Violation|2|||
143443955|NCT00755417|517172133|FG001|Overall Study|Protocol Violation|1|||
143443956|NCT00755417|517172134|FG002|Overall Study|Protocol Violation|1|||
143443957|NCT00755417|517172132|FG000|Overall Study|Lost to Follow-up|3|||
143443958|NCT00755417|517172133|FG001|Overall Study|Lost to Follow-up|0|||
143443959|NCT00755417|517172134|FG002|Overall Study|Lost to Follow-up|1|||
143443960|NCT00755417|517172132|FG000|Overall Study|Withdrawal by Subject|12|||
143443961|NCT00755417|517172133|FG001|Overall Study|Withdrawal by Subject|12|||
143443962|NCT00755417|517172134|FG002|Overall Study|Withdrawal by Subject|12|||
143443963|NCT00755417|517172132|FG000|Overall Study|Not specified or missing data|9|||
143443964|NCT00755417|517172133|FG001|Overall Study|Not specified or missing data|18|||
143443965|NCT00755417|517172134|FG002|Overall Study|Not specified or missing data|12|||
143443966|NCT01485120|517172136|FG000|Overall Study|Withdrawal by Subject|2|||
143443967|NCT00422734|517172137|FG000|Overall Study|Physician Decision|1|||
143443968|NCT00422734|517172138|FG001|Overall Study|Physician Decision|1|||
143443969|NCT00422734|517172137|FG000|Overall Study|Protocol Violation|1|||
143443970|NCT00422734|517172138|FG001|Overall Study|Protocol Violation|6|||
143443971|NCT00422734|517172137|FG000|Overall Study|Withdrawal by Subject|12|||
143443972|NCT00422734|517172138|FG001|Overall Study|Withdrawal by Subject|8|||
143443973|NCT00422734|517172137|FG000|Overall Study|Adverse Event|0|||
143443974|NCT00422734|517172138|FG001|Overall Study|Adverse Event|3|||
143443975|NCT00422734|517172137|FG000|Overall Study|Partner Decision|0|||
143443976|NCT00422734|517172138|FG001|Overall Study|Partner Decision|3|||
143443977|NCT02344342|517172139|FG000|Overall Study|Industry partner dropped out|11|||
143443978|NCT02344342|517172140|FG001|Overall Study|Industry partner dropped out|9|||
143443979|NCT02344342|517172141|FG002|Overall Study|Industry partner dropped out|14|||
143443980|NCT02344342|517172142|FG003|Overall Study|Industry partner dropped out|10|||
143443981|NCT00848484|517172143|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
143443982|NCT00848484|517172144|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
143443983|NCT00848484|517172143|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
143443984|NCT00848484|517172144|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
143443985|NCT00848484|517172143|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
143443986|NCT00848484|517172144|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
143443987|NCT00848484|517172143|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
143443988|NCT00848484|517172144|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
143443989|NCT00848484|517172143|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
143443990|NCT00848484|517172144|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
143443991|NCT03355209|517172148|FG000|Part 1: Double-Blind Period|Adverse Event|0|||
143443992|NCT03355209|517172149|FG001|Part 1: Double-Blind Period|Adverse Event|4|||
143443993|NCT03355209|517172150|FG002|Part 1: Double-Blind Period|Adverse Event|4|||
143443994|NCT03355209|517172151|FG003|Part 1: Double-Blind Period|Adverse Event|0|||
143443995|NCT03355209|517172152|FG004|Part 1: Double-Blind Period|Adverse Event|1|||
143443996|NCT03355209|517172153|FG005|Part 1: Double-Blind Period|Adverse Event|0|||
143443997|NCT03355209|517172148|FG000|Part 1: Double-Blind Period|Death|0|||
143443998|NCT03355209|517172149|FG001|Part 1: Double-Blind Period|Death|0|||
143443999|NCT03355209|517172150|FG002|Part 1: Double-Blind Period|Death|1|||
143444000|NCT03355209|517172151|FG003|Part 1: Double-Blind Period|Death|0|||
143444001|NCT03355209|517172152|FG004|Part 1: Double-Blind Period|Death|0|||
143444002|NCT03355209|517172153|FG005|Part 1: Double-Blind Period|Death|0|||
143444003|NCT03355209|517172148|FG000|Part 1: Double-Blind Period|Physician Decision|0|||
143444004|NCT03355209|517172149|FG001|Part 1: Double-Blind Period|Physician Decision|1|||
143444005|NCT03355209|517172150|FG002|Part 1: Double-Blind Period|Physician Decision|0|||
143444006|NCT03355209|517172151|FG003|Part 1: Double-Blind Period|Physician Decision|0|||
143444007|NCT03355209|517172152|FG004|Part 1: Double-Blind Period|Physician Decision|0|||
143444008|NCT03355209|517172153|FG005|Part 1: Double-Blind Period|Physician Decision|0|||
143444009|NCT03355209|517172148|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
143444010|NCT03355209|517172149|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
143444011|NCT03355209|517172150|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
143444012|NCT03355209|517172151|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
143444013|NCT03355209|517172152|FG004|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
143444014|NCT03355209|517172153|FG005|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
143444015|NCT03355209|517172148|FG000|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
143444016|NCT03355209|517172149|FG001|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
143444017|NCT03355209|517172150|FG002|Part 2:Open-Label Extension (OLE) Period|Adverse Event|3|||
143444018|NCT03355209|517172151|FG003|Part 2:Open-Label Extension (OLE) Period|Adverse Event|0|||
143444019|NCT03355209|517172152|FG004|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
143444020|NCT03355209|517172153|FG005|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
143444021|NCT03355209|517172148|FG000|Part 2:Open-Label Extension (OLE) Period|Death|0|||
143444022|NCT03355209|517172149|FG001|Part 2:Open-Label Extension (OLE) Period|Death|1|||
143444023|NCT03355209|517172150|FG002|Part 2:Open-Label Extension (OLE) Period|Death|0|||
143444024|NCT03355209|517172151|FG003|Part 2:Open-Label Extension (OLE) Period|Death|0|||
143444025|NCT03355209|517172152|FG004|Part 2:Open-Label Extension (OLE) Period|Death|0|||
143444026|NCT03355209|517172153|FG005|Part 2:Open-Label Extension (OLE) Period|Death|0|||
143444027|NCT03355209|517172148|FG000|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|13|||
143444028|NCT03355209|517172149|FG001|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|21|||
143444029|NCT03355209|517172150|FG002|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|23|||
143444030|NCT03355209|517172151|FG003|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
143444031|NCT03355209|517172152|FG004|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
143444032|NCT03355209|517172153|FG005|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|1|||
143444033|NCT03355209|517172148|FG000|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
143444034|NCT03355209|517172149|FG001|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
143444035|NCT03355209|517172150|FG002|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
143444036|NCT03355209|517172151|FG003|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|5|||
143444037|NCT03355209|517172152|FG004|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|6|||
143444038|NCT03355209|517172153|FG005|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|3|||
143444039|NCT03355209|517172148|FG000|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|6|||
143444040|NCT03355209|517172149|FG001|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
143444041|NCT03355209|517172150|FG002|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|4|||
143444042|NCT03355209|517172151|FG003|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
143444043|NCT03355209|517172152|FG004|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
143444044|NCT03355209|517172153|FG005|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
143444045|NCT03355209|517172148|FG000|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
143444046|NCT03355209|517172149|FG001|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
143444047|NCT03355209|517172150|FG002|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
143444048|NCT03355209|517172151|FG003|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
143444049|NCT03355209|517172152|FG004|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
143444050|NCT03355209|517172153|FG005|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
143444051|NCT03355209|517172148|FG000|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|1|||
143444052|NCT03355209|517172149|FG001|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
143444053|NCT03355209|517172150|FG002|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|2|||
143444054|NCT03355209|517172151|FG003|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
143444055|NCT03355209|517172152|FG004|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
143444056|NCT03355209|517172153|FG005|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
143444057|NCT01081886|517172154|FG000|Overall Study|Study termination|11|||
143444058|NCT01081886|517172155|FG001|Overall Study|Study termination|13|||
143444059|NCT02567708|517172156|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
143444060|NCT02567708|517172157|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
143444061|NCT02567708|517172156|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
143444062|NCT02567708|517172157|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
143444063|NCT02567708|517172156|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
143444064|NCT02567708|517172157|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
143444065|NCT02567708|517172156|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
143444066|NCT02567708|517172157|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
143444067|NCT00706654|517172158|FG000|Conversion Phase|Lost to Follow-up|4|||
143444068|NCT00706654|517172159|FG001|Conversion Phase|Lost to Follow-up|0|||
143444069|NCT00706654|517172160|FG002|Conversion Phase|Lost to Follow-up|0|||
143444070|NCT00706654|517172161|FG003|Conversion Phase|Lost to Follow-up|0|||
143444071|NCT00706654|517172158|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
143444072|NCT00706654|517172159|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
143444073|NCT00706654|517172160|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
143444074|NCT00706654|517172161|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
143444075|NCT00706654|517172158|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
143444076|NCT00706654|517172159|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
143444077|NCT00706654|517172160|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
143444078|NCT00706654|517172161|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
143444079|NCT00706654|517172158|FG000|Conversion Phase|Withdrawn by Investigator|14|||
143444080|NCT00706654|517172159|FG001|Conversion Phase|Withdrawn by Investigator|0|||
143444081|NCT00706654|517172160|FG002|Conversion Phase|Withdrawn by Investigator|0|||
143444082|NCT00706654|517172161|FG003|Conversion Phase|Withdrawn by Investigator|0|||
143444083|NCT00706654|517172158|FG000|Conversion Phase|Withdrew Consent|38|||
143444084|NCT00706654|517172159|FG001|Conversion Phase|Withdrew Consent|0|||
143444085|NCT00706654|517172160|FG002|Conversion Phase|Withdrew Consent|0|||
143444086|NCT00706654|517172161|FG003|Conversion Phase|Withdrew Consent|0|||
143444087|NCT00706654|517172158|FG000|Conversion Phase|Adverse Event|18|||
143444088|NCT00706654|517172159|FG001|Conversion Phase|Adverse Event|0|||
143444089|NCT00706654|517172160|FG002|Conversion Phase|Adverse Event|0|||
143444090|NCT00706654|517172161|FG003|Conversion Phase|Adverse Event|0|||
143444091|NCT00706654|517172158|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
143444092|NCT00706654|517172159|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
143444093|NCT00706654|517172160|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
143444094|NCT00706654|517172161|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
143444095|NCT00706654|517172158|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
143444096|NCT00706654|517172159|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
143444097|NCT00706654|517172160|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
143444098|NCT00706654|517172161|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
143444099|NCT00706654|517172158|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
143444100|NCT00706654|517172159|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
143444101|NCT00706654|517172160|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
143444102|NCT00706654|517172161|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
143444103|NCT00706654|517172158|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
143444104|NCT00706654|517172159|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
143444105|NCT00706654|517172160|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
143444106|NCT00706654|517172161|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
143444107|NCT00706654|517172158|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
143444108|NCT00706654|517172159|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
143444109|NCT00706654|517172160|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
143444110|NCT00706654|517172161|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
143444111|NCT00706654|517172158|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
143444112|NCT00706654|517172159|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
143444113|NCT00706654|517172160|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
143444114|NCT00706654|517172161|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
143444115|NCT00706654|517172158|FG000|Oral Stabilization Phase|Withdrew consent|55|||
143444116|NCT00706654|517172159|FG001|Oral Stabilization Phase|Withdrew consent|0|||
143444117|NCT00706654|517172160|FG002|Oral Stabilization Phase|Withdrew consent|0|||
143444118|NCT00706654|517172161|FG003|Oral Stabilization Phase|Withdrew consent|0|||
143444119|NCT00706654|517172158|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
143444120|NCT00706654|517172159|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
143444121|NCT00706654|517172160|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
143444122|NCT00706654|517172161|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
143444123|NCT00706654|517172158|FG000|Oral Stabilization Phase|Adverse Event|21|||
143444124|NCT00706654|517172159|FG001|Oral Stabilization Phase|Adverse Event|0|||
143444125|NCT00706654|517172160|FG002|Oral Stabilization Phase|Adverse Event|0|||
143444126|NCT00706654|517172161|FG003|Oral Stabilization Phase|Adverse Event|0|||
143444127|NCT00706654|517172158|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
143444128|NCT00706654|517172159|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
143444129|NCT00706654|517172160|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
143444130|NCT00706654|517172161|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
143444131|NCT00706654|517172158|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
143444132|NCT00706654|517172159|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
143444133|NCT00706654|517172160|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
143444134|NCT00706654|517172161|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
143444135|NCT00706654|517172158|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
143444136|NCT00706654|517172159|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
143444137|NCT00706654|517172160|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
143444138|NCT00706654|517172161|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
143444139|NCT00706654|517172158|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
143444140|NCT00706654|517172159|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
143444141|NCT00706654|517172160|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
143444142|NCT00706654|517172161|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
143444143|NCT00706654|517172158|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
143444144|NCT00706654|517172159|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
143444145|NCT00706654|517172160|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
143444146|NCT00706654|517172161|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
143444147|NCT00706654|517172158|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
143444148|NCT00706654|517172159|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
143444149|NCT00706654|517172160|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
143444150|NCT00706654|517172161|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
143444151|NCT00706654|517172158|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
143444152|NCT00706654|517172159|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
143444153|NCT00706654|517172160|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
143444154|NCT00706654|517172161|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
143444155|NCT00706654|517172158|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
143444156|NCT00706654|517172159|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
143444157|NCT00706654|517172160|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
143444158|NCT00706654|517172161|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
143444159|NCT00706654|517172158|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
143444160|NCT00706654|517172159|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
143444161|NCT00706654|517172160|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
143444162|NCT00706654|517172161|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
143444163|NCT00706654|517172158|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
143444164|NCT00706654|517172159|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
143444165|NCT00706654|517172160|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
143444166|NCT00706654|517172161|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
143444167|NCT05262751|517172162|FG000|Washout Period 2|Adverse Event|1|||
143444168|NCT05262751|517172163|FG001|Washout Period 2|Adverse Event|0|||
143444169|NCT05262751|517172164|FG002|Washout Period 2|Adverse Event|0|||
143444170|NCT05262751|517172165|FG003|Washout Period 2|Adverse Event|0|||
143444171|NCT05262751|517172166|FG004|Washout Period 2|Adverse Event|0|||
143444172|NCT05262751|517172167|FG005|Washout Period 2|Adverse Event|0|||
143444173|NCT05262751|517172162|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
143444174|NCT05262751|517172163|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
143444175|NCT05262751|517172164|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
143444176|NCT05262751|517172165|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
143444177|NCT05262751|517172166|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
143444178|NCT05262751|517172167|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
143444179|NCT01151215|517172168|FG000|Overall Study|Worsening of condition under study|1|||
143444180|NCT01151215|517172169|FG001|Overall Study|Worsening of condition under study|1|||
143444181|NCT01151215|517172170|FG002|Overall Study|Worsening of condition under study|1|||
143444182|NCT01151215|517172168|FG000|Overall Study|Death|16|||
143444183|NCT01151215|517172169|FG001|Overall Study|Death|20|||
143444184|NCT01151215|517172170|FG002|Overall Study|Death|11|||
143444185|NCT01151215|517172168|FG000|Overall Study|Lost to Follow-up|0|||
143444186|NCT01151215|517172169|FG001|Overall Study|Lost to Follow-up|0|||
143444187|NCT01151215|517172170|FG002|Overall Study|Lost to Follow-up|3|||
143444188|NCT01151215|517172168|FG000|Overall Study|Withdrawal by Subject|3|||
143444189|NCT01151215|517172169|FG001|Overall Study|Withdrawal by Subject|1|||
143444190|NCT01151215|517172170|FG002|Overall Study|Withdrawal by Subject|2|||
143444191|NCT01151215|517172168|FG000|Overall Study|Disease progression|0|||
143444192|NCT01151215|517172169|FG001|Overall Study|Disease progression|1|||
143444193|NCT01151215|517172170|FG002|Overall Study|Disease progression|1|||
143444194|NCT01151215|517172168|FG000|Overall Study|Safety as judged by the investigator|0|||
143444195|NCT01151215|517172169|FG001|Overall Study|Safety as judged by the investigator|0|||
143444196|NCT01151215|517172170|FG002|Overall Study|Safety as judged by the investigator|1|||
143444197|NCT01427725|517172171|FG000|Overall Study|Lost to Follow-up|17|||
143444198|NCT01427725|517172171|FG000|Overall Study|Protocol Violation|1|||
143444199|NCT01427725|517172171|FG000|Overall Study|Drug not administered|1|||
143444200|NCT01427725|517172171|FG000|Overall Study|Failure to visit|7|||
143444201|NCT01427725|517172171|FG000|Overall Study|Adverse Event|46|||
143444202|NCT01427725|517172171|FG000|Overall Study|Failure to visit after administration|40|||
143444203|NCT01427725|517172171|FG000|Overall Study|Patient's rejection|27|||
143444204|NCT01427725|517172171|FG000|Overall Study|Transfer to a different hospital|17|||
143444205|NCT01427725|517172171|FG000|Overall Study|Lack of Efficacy|8|||
143444206|NCT01427725|517172171|FG000|Overall Study|Death|7|||
143444207|NCT01427725|517172171|FG000|Overall Study|Symptom improvement|6|||
143444208|NCT01427725|517172171|FG000|Overall Study|AE and Patient's rejection|5|||
143444209|NCT01427725|517172171|FG000|Overall Study|Physician Decision|5|||
143444210|NCT01427725|517172171|FG000|Overall Study|Exacerbation of underlying disease|5|||
143444211|NCT01427725|517172171|FG000|Overall Study|Oral feeding difficulty|5|||
143444212|NCT01427725|517172171|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
143444213|NCT01427725|517172171|FG000|Overall Study|Forgetting prescription|1|||
143444214|NCT01427725|517172171|FG000|Overall Study|Other|2|||
143444215|NCT01281839|517172172|FG000|Overall Study|Lost to Follow-up|6|||
143444216|NCT01281839|517172173|FG001|Overall Study|Lost to Follow-up|3|||
143444217|NCT01281839|517172172|FG000|Overall Study|Withdrawal by Subject|4|||
143444218|NCT01281839|517172173|FG001|Overall Study|Withdrawal by Subject|10|||
143444219|NCT01281839|517172172|FG000|Overall Study|Reason not specified|0|||
143444220|NCT01281839|517172173|FG001|Overall Study|Reason not specified|1|||
143444221|NCT01754753|517172174|FG000|Overall Study|Study close|43|||
143444222|NCT01754753|517172175|FG001|Overall Study|Study close|44|||
143444223|NCT01754753|517172174|FG000|Overall Study|Lost to Follow-up|9|||
143444224|NCT01754753|517172175|FG001|Overall Study|Lost to Follow-up|5|||
143444225|NCT00617929|517172176|FG000|Overall Study|Physician Decision|1|||
143444226|NCT00760747|517172181|FG000|Study Period II|Adverse Event|3|||
143444227|NCT00760747|517172182|FG001|Study Period II|Adverse Event|4|||
143444228|NCT00760747|517172181|FG000|Study Period II|Lack of Efficacy|0|||
143444229|NCT00760747|517172182|FG001|Study Period II|Lack of Efficacy|6|||
143444230|NCT00760747|517172181|FG000|Study Period II|Parent/Caregiver Decision|3|||
143444231|NCT00760747|517172182|FG001|Study Period II|Parent/Caregiver Decision|0|||
143444232|NCT00760747|517172181|FG000|Study Period II|Protocol Violation|6|||
143444233|NCT00760747|517172182|FG001|Study Period II|Protocol Violation|3|||
143444234|NCT00760747|517172181|FG000|Study Period II|Withdrawal by Subject|1|||
143444235|NCT00760747|517172182|FG001|Study Period II|Withdrawal by Subject|0|||
143444236|NCT00760747|517172181|FG000|Study Period II|No drug administered|0|||
143444237|NCT00760747|517172182|FG001|Study Period II|No drug administered|1|||
143444238|NCT00760747|517172181|FG000|Study Period III|Adverse Event|1|||
143444239|NCT00760747|517172182|FG001|Study Period III|Adverse Event|0|||
143444240|NCT00760747|517172181|FG000|Study Period III|Lack of Efficacy|1|||
143444241|NCT00760747|517172182|FG001|Study Period III|Lack of Efficacy|0|||
143444242|NCT00760747|517172181|FG000|Study Period III|Parent/Caregiver Decision|0|||
143444243|NCT00760747|517172182|FG001|Study Period III|Parent/Caregiver Decision|1|||
143444244|NCT00760747|517172181|FG000|Study Period III|Protocol Violation|1|||
143444245|NCT00760747|517172182|FG001|Study Period III|Protocol Violation|1|||
143444246|NCT00760747|517172181|FG000|Study Period III|Physician Decision|0|||
143444247|NCT00760747|517172182|FG001|Study Period III|Physician Decision|1|||
143444248|NCT00844597|517172183|FG000|Overall Study|Adverse Event|0|||
143444249|NCT00844597|517172184|FG001|Overall Study|Adverse Event|0|||
143444250|NCT00844597|517172185|FG002|Overall Study|Adverse Event|0|||
143444251|NCT00844597|517172186|FG003|Overall Study|Adverse Event|1|||
143444252|NCT00844597|517172187|FG004|Overall Study|Adverse Event|0|||
143444253|NCT00844597|517172188|FG005|Overall Study|Adverse Event|0|||
143444254|NCT04160988|517172189|FG000|Overall Study|poor image quality|28|||
143444255|NCT02124811|517174525|FG000|Overall Study|Early termination|2|||
143444256|NCT02124811|517174526|FG001|Overall Study|Early termination|2|||
143444257|NCT02124811|517174525|FG000|Overall Study|Withdrawal by Subject|1|||
143444258|NCT02124811|517174526|FG001|Overall Study|Withdrawal by Subject|0|||
143444259|NCT04624243|517174527|FG000|Overall Study|Death|0|||
143444260|NCT04624243|517174528|FG001|Overall Study|Death|1|||
143444261|NCT04624243|517174529|FG002|Overall Study|Death|0|||
143444262|NCT04624243|517174530|FG003|Overall Study|Death|0|||
143444263|NCT04624243|517174531|FG004|Overall Study|Death|0|||
143444264|NCT04624243|517174527|FG000|Overall Study|Lost to Follow-up|2|||
143444265|NCT04624243|517174528|FG001|Overall Study|Lost to Follow-up|3|||
143444266|NCT04624243|517174529|FG002|Overall Study|Lost to Follow-up|7|||
143444267|NCT04624243|517174530|FG003|Overall Study|Lost to Follow-up|1|||
143444268|NCT04624243|517174531|FG004|Overall Study|Lost to Follow-up|3|||
143444269|NCT04624243|517174527|FG000|Overall Study|Physician Decision|3|||
143444270|NCT04624243|517174528|FG001|Overall Study|Physician Decision|8|||
143444271|NCT04624243|517174529|FG002|Overall Study|Physician Decision|15|||
143444272|NCT04624243|517174530|FG003|Overall Study|Physician Decision|2|||
143444273|NCT04624243|517174531|FG004|Overall Study|Physician Decision|11|||
143444274|NCT04624243|517174527|FG000|Overall Study|Withdrawal by Subject|19|||
143444275|NCT04624243|517174528|FG001|Overall Study|Withdrawal by Subject|44|||
143444276|NCT04624243|517174529|FG002|Overall Study|Withdrawal by Subject|40|||
143444277|NCT04624243|517174530|FG003|Overall Study|Withdrawal by Subject|21|||
143444278|NCT04624243|517174531|FG004|Overall Study|Withdrawal by Subject|39|||
143444279|NCT04624243|517174527|FG000|Overall Study|Miscellaneous|3|||
143444280|NCT04624243|517174528|FG001|Overall Study|Miscellaneous|12|||
143444281|NCT04624243|517174529|FG002|Overall Study|Miscellaneous|9|||
143444282|NCT04624243|517174530|FG003|Overall Study|Miscellaneous|4|||
143444283|NCT04624243|517174531|FG004|Overall Study|Miscellaneous|6|||
143444284|NCT04079868|517174532|FG000|Overall Study|Lost to Follow-up|100|||
143444285|NCT04079868|517174533|FG001|Overall Study|Lost to Follow-up|200|||
143444286|NCT04079868|517174532|FG000|Overall Study|Physician Decision|100|||
143444287|NCT04079868|517174533|FG001|Overall Study|Physician Decision|0|||
143444288|NCT01294397|517174534|FG000|Overall Study|Withdrawal by Subject|1|||
143444289|NCT01294397|517174534|FG000|Overall Study|Administrative Decision|1|||
143444290|NCT05000216|517174540|FG000|Stage 1|Lost to Follow-up|0|||
143444291|NCT05000216|517174541|FG001|Stage 1|Lost to Follow-up|0|||
143444292|NCT05000216|517174542|FG002|Stage 1|Lost to Follow-up|0|||
143444293|NCT05000216|517174543|FG003|Stage 1|Lost to Follow-up|0|||
143444294|NCT05000216|517174544|FG004|Stage 1|Lost to Follow-up|0|||
143444295|NCT05000216|517174545|FG005|Stage 1|Lost to Follow-up|0|||
143444296|NCT05000216|517174546|FG006|Stage 1|Lost to Follow-up|1|||
143444297|NCT05000216|517174547|FG007|Stage 1|Lost to Follow-up|1|||
143444298|NCT05000216|517174548|FG008|Stage 1|Lost to Follow-up|0|||
143444299|NCT05000216|517174549|FG009|Stage 1|Lost to Follow-up|2|||
143444300|NCT05000216|517174550|FG010|Stage 1|Lost to Follow-up|3|||
143444301|NCT05000216|517174551|FG011|Stage 1|Lost to Follow-up|0|||
143444302|NCT05000216|517174552|FG012|Stage 1|Lost to Follow-up|0|||
143444303|NCT05000216|517174553|FG013|Stage 1|Lost to Follow-up|0|||
143444304|NCT05000216|517174554|FG014|Stage 1|Lost to Follow-up|0|||
143444305|NCT05000216|517174555|FG015|Stage 1|Lost to Follow-up|0|||
143444306|NCT05000216|517174556|FG016|Stage 1|Lost to Follow-up|0|||
143444307|NCT05000216|517174557|FG017|Stage 1|Lost to Follow-up|0|||
143444308|NCT05000216|517174558|FG018|Stage 1|Lost to Follow-up|0|||
143444309|NCT05000216|517174559|FG019|Stage 1|Lost to Follow-up|0|||
143444310|NCT05000216|517174560|FG020|Stage 1|Lost to Follow-up|0|||
143444311|NCT05000216|517174561|FG021|Stage 1|Lost to Follow-up|0|||
143444312|NCT05000216|517174540|FG000|Stage 1|Physician Decision|0|||
143444313|NCT05000216|517174541|FG001|Stage 1|Physician Decision|0|||
143444314|NCT05000216|517174542|FG002|Stage 1|Physician Decision|0|||
143444315|NCT05000216|517174543|FG003|Stage 1|Physician Decision|0|||
143444316|NCT05000216|517174544|FG004|Stage 1|Physician Decision|0|||
143444317|NCT05000216|517174545|FG005|Stage 1|Physician Decision|0|||
143444318|NCT05000216|517174546|FG006|Stage 1|Physician Decision|0|||
143444319|NCT05000216|517174547|FG007|Stage 1|Physician Decision|1|||
143444320|NCT05000216|517174548|FG008|Stage 1|Physician Decision|1|||
143444321|NCT05000216|517174549|FG009|Stage 1|Physician Decision|0|||
143444322|NCT05000216|517174550|FG010|Stage 1|Physician Decision|0|||
143444323|NCT05000216|517174551|FG011|Stage 1|Physician Decision|0|||
143444324|NCT05000216|517174552|FG012|Stage 1|Physician Decision|0|||
143444325|NCT05000216|517174553|FG013|Stage 1|Physician Decision|0|||
143444326|NCT05000216|517174554|FG014|Stage 1|Physician Decision|0|||
143444327|NCT05000216|517174555|FG015|Stage 1|Physician Decision|0|||
143444328|NCT05000216|517174556|FG016|Stage 1|Physician Decision|0|||
143444329|NCT05000216|517174557|FG017|Stage 1|Physician Decision|0|||
143444330|NCT05000216|517174558|FG018|Stage 1|Physician Decision|0|||
143444331|NCT05000216|517174559|FG019|Stage 1|Physician Decision|0|||
143444332|NCT05000216|517174560|FG020|Stage 1|Physician Decision|0|||
143444333|NCT05000216|517174561|FG021|Stage 1|Physician Decision|0|||
143444334|NCT05000216|517174540|FG000|Stage 1|Withdrawal by Subject|0|||
143444335|NCT05000216|517174541|FG001|Stage 1|Withdrawal by Subject|1|||
143444336|NCT05000216|517174542|FG002|Stage 1|Withdrawal by Subject|0|||
143444337|NCT05000216|517174543|FG003|Stage 1|Withdrawal by Subject|0|||
143444338|NCT05000216|517174544|FG004|Stage 1|Withdrawal by Subject|0|||
143444339|NCT05000216|517174545|FG005|Stage 1|Withdrawal by Subject|0|||
143444340|NCT05000216|517174546|FG006|Stage 1|Withdrawal by Subject|0|||
143444341|NCT05000216|517174547|FG007|Stage 1|Withdrawal by Subject|0|||
143444342|NCT05000216|517174548|FG008|Stage 1|Withdrawal by Subject|0|||
143444343|NCT05000216|517174549|FG009|Stage 1|Withdrawal by Subject|3|||
143444344|NCT05000216|517174550|FG010|Stage 1|Withdrawal by Subject|10|||
143444345|NCT05000216|517174551|FG011|Stage 1|Withdrawal by Subject|0|||
143444346|NCT05000216|517174552|FG012|Stage 1|Withdrawal by Subject|0|||
143444347|NCT05000216|517174553|FG013|Stage 1|Withdrawal by Subject|0|||
143444348|NCT05000216|517174554|FG014|Stage 1|Withdrawal by Subject|0|||
143444349|NCT05000216|517174555|FG015|Stage 1|Withdrawal by Subject|0|||
143444350|NCT05000216|517174556|FG016|Stage 1|Withdrawal by Subject|0|||
143444351|NCT05000216|517174557|FG017|Stage 1|Withdrawal by Subject|0|||
143444352|NCT05000216|517174558|FG018|Stage 1|Withdrawal by Subject|0|||
143444353|NCT05000216|517174559|FG019|Stage 1|Withdrawal by Subject|0|||
143444354|NCT05000216|517174560|FG020|Stage 1|Withdrawal by Subject|0|||
143444355|NCT05000216|517174561|FG021|Stage 1|Withdrawal by Subject|0|||
143444356|NCT05000216|517174540|FG000|Stage 1|Did not receive vaccine at Week 0|0|||
143444357|NCT05000216|517174541|FG001|Stage 1|Did not receive vaccine at Week 0|0|||
143444358|NCT05000216|517174542|FG002|Stage 1|Did not receive vaccine at Week 0|1|||
143444359|NCT05000216|517174543|FG003|Stage 1|Did not receive vaccine at Week 0|1|||
143444360|NCT05000216|517174544|FG004|Stage 1|Did not receive vaccine at Week 0|0|||
143444361|NCT05000216|517174545|FG005|Stage 1|Did not receive vaccine at Week 0|0|||
143444362|NCT05000216|517174546|FG006|Stage 1|Did not receive vaccine at Week 0|0|||
143444363|NCT05000216|517174547|FG007|Stage 1|Did not receive vaccine at Week 0|0|||
143444364|NCT05000216|517174548|FG008|Stage 1|Did not receive vaccine at Week 0|0|||
143444365|NCT05000216|517174549|FG009|Stage 1|Did not receive vaccine at Week 0|1|||
143444366|NCT05000216|517174550|FG010|Stage 1|Did not receive vaccine at Week 0|0|||
143444367|NCT05000216|517174551|FG011|Stage 1|Did not receive vaccine at Week 0|0|||
143444368|NCT05000216|517174552|FG012|Stage 1|Did not receive vaccine at Week 0|0|||
143444369|NCT05000216|517174553|FG013|Stage 1|Did not receive vaccine at Week 0|0|||
143444370|NCT05000216|517174554|FG014|Stage 1|Did not receive vaccine at Week 0|0|||
143444371|NCT05000216|517174555|FG015|Stage 1|Did not receive vaccine at Week 0|0|||
143444372|NCT05000216|517174556|FG016|Stage 1|Did not receive vaccine at Week 0|0|||
143444373|NCT05000216|517174557|FG017|Stage 1|Did not receive vaccine at Week 0|0|||
143444374|NCT05000216|517174558|FG018|Stage 1|Did not receive vaccine at Week 0|0|||
143444375|NCT05000216|517174559|FG019|Stage 1|Did not receive vaccine at Week 0|0|||
143444376|NCT05000216|517174560|FG020|Stage 1|Did not receive vaccine at Week 0|0|||
143444377|NCT05000216|517174561|FG021|Stage 1|Did not receive vaccine at Week 0|0|||
143444378|NCT05000216|517174540|FG000|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
143444379|NCT05000216|517174541|FG001|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
143444380|NCT05000216|517174542|FG002|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
143444381|NCT05000216|517174543|FG003|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
143444382|NCT05000216|517174544|FG004|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
143444383|NCT05000216|517174545|FG005|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
143444384|NCT05000216|517174546|FG006|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
143444385|NCT05000216|517174547|FG007|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
143444386|NCT05000216|517174548|FG008|Stage 1|Received a SARS-CoV-2 vaccine off study|1|||
143444387|NCT05000216|517174549|FG009|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
143444388|NCT05000216|517174550|FG010|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
143444389|NCT05000216|517174551|FG011|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
143444390|NCT05000216|517174552|FG012|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
143444391|NCT05000216|517174553|FG013|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
143444392|NCT05000216|517174554|FG014|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
143444393|NCT05000216|517174555|FG015|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
143444394|NCT05000216|517174556|FG016|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
143444395|NCT05000216|517174557|FG017|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
143444396|NCT05000216|517174558|FG018|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
143444397|NCT05000216|517174559|FG019|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
143444398|NCT05000216|517174560|FG020|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
143444399|NCT05000216|517174561|FG021|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
143444400|NCT05000216|517174540|FG000|Stage 1|Other|0|||
143444401|NCT05000216|517174541|FG001|Stage 1|Other|0|||
143444402|NCT05000216|517174542|FG002|Stage 1|Other|0|||
143444403|NCT05000216|517174543|FG003|Stage 1|Other|0|||
143444404|NCT05000216|517174544|FG004|Stage 1|Other|1|||
143444405|NCT05000216|517174545|FG005|Stage 1|Other|0|||
143444406|NCT05000216|517174546|FG006|Stage 1|Other|0|||
143444407|NCT05000216|517174547|FG007|Stage 1|Other|2|||
143444408|NCT05000216|517174548|FG008|Stage 1|Other|0|||
143444409|NCT05000216|517174549|FG009|Stage 1|Other|0|||
143444410|NCT05000216|517174550|FG010|Stage 1|Other|1|||
143444411|NCT05000216|517174551|FG011|Stage 1|Other|1|||
143444412|NCT05000216|517174552|FG012|Stage 1|Other|0|||
143444413|NCT05000216|517174553|FG013|Stage 1|Other|0|||
143444414|NCT05000216|517174554|FG014|Stage 1|Other|0|||
143444415|NCT05000216|517174555|FG015|Stage 1|Other|0|||
143444416|NCT05000216|517174556|FG016|Stage 1|Other|0|||
143444417|NCT05000216|517174557|FG017|Stage 1|Other|0|||
143444418|NCT05000216|517174558|FG018|Stage 1|Other|0|||
143444419|NCT05000216|517174559|FG019|Stage 1|Other|0|||
143444420|NCT05000216|517174560|FG020|Stage 1|Other|0|||
143444421|NCT05000216|517174561|FG021|Stage 1|Other|0|||
143444422|NCT05000216|517174540|FG000|Stage 1|Rolled over to Stage 2 of the study|1|||
143444423|NCT05000216|517174541|FG001|Stage 1|Rolled over to Stage 2 of the study|0|||
143444424|NCT05000216|517174542|FG002|Stage 1|Rolled over to Stage 2 of the study|3|||
143444425|NCT05000216|517174543|FG003|Stage 1|Rolled over to Stage 2 of the study|3|||
143444426|NCT05000216|517174544|FG004|Stage 1|Rolled over to Stage 2 of the study|0|||
143444427|NCT05000216|517174545|FG005|Stage 1|Rolled over to Stage 2 of the study|1|||
143444428|NCT05000216|517174546|FG006|Stage 1|Rolled over to Stage 2 of the study|0|||
143444429|NCT05000216|517174547|FG007|Stage 1|Rolled over to Stage 2 of the study|2|||
143444430|NCT05000216|517174548|FG008|Stage 1|Rolled over to Stage 2 of the study|0|||
143444431|NCT05000216|517174549|FG009|Stage 1|Rolled over to Stage 2 of the study|13|||
143444432|NCT05000216|517174550|FG010|Stage 1|Rolled over to Stage 2 of the study|18|||
143444433|NCT05000216|517174551|FG011|Stage 1|Rolled over to Stage 2 of the study|2|||
143444434|NCT05000216|517174552|FG012|Stage 1|Rolled over to Stage 2 of the study|0|||
143444435|NCT05000216|517174553|FG013|Stage 1|Rolled over to Stage 2 of the study|0|||
143444436|NCT05000216|517174554|FG014|Stage 1|Rolled over to Stage 2 of the study|0|||
143444437|NCT05000216|517174555|FG015|Stage 1|Rolled over to Stage 2 of the study|0|||
143444438|NCT05000216|517174556|FG016|Stage 1|Rolled over to Stage 2 of the study|0|||
143444439|NCT05000216|517174557|FG017|Stage 1|Rolled over to Stage 2 of the study|0|||
143444440|NCT05000216|517174558|FG018|Stage 1|Rolled over to Stage 2 of the study|0|||
143444441|NCT05000216|517174559|FG019|Stage 1|Rolled over to Stage 2 of the study|0|||
143444442|NCT05000216|517174560|FG020|Stage 1|Rolled over to Stage 2 of the study|0|||
143444443|NCT05000216|517174561|FG021|Stage 1|Rolled over to Stage 2 of the study|0|||
143444444|NCT05000216|517174540|FG000|Stage 2|Lost to Follow-up|0|||
143444445|NCT05000216|517174541|FG001|Stage 2|Lost to Follow-up|0|||
143444446|NCT05000216|517174542|FG002|Stage 2|Lost to Follow-up|0|||
143444447|NCT05000216|517174543|FG003|Stage 2|Lost to Follow-up|0|||
143444448|NCT05000216|517174544|FG004|Stage 2|Lost to Follow-up|0|||
143444449|NCT05000216|517174545|FG005|Stage 2|Lost to Follow-up|0|||
143444450|NCT05000216|517174546|FG006|Stage 2|Lost to Follow-up|0|||
143444451|NCT05000216|517174547|FG007|Stage 2|Lost to Follow-up|0|||
143444452|NCT05000216|517174548|FG008|Stage 2|Lost to Follow-up|0|||
143444453|NCT05000216|517174549|FG009|Stage 2|Lost to Follow-up|0|||
143444454|NCT05000216|517174550|FG010|Stage 2|Lost to Follow-up|0|||
143444455|NCT05000216|517174551|FG011|Stage 2|Lost to Follow-up|0|||
143444456|NCT05000216|517174552|FG012|Stage 2|Lost to Follow-up|0|||
143444457|NCT05000216|517174553|FG013|Stage 2|Lost to Follow-up|0|||
143444458|NCT05000216|517174554|FG014|Stage 2|Lost to Follow-up|0|||
143444459|NCT05000216|517174555|FG015|Stage 2|Lost to Follow-up|0|||
143444460|NCT05000216|517174556|FG016|Stage 2|Lost to Follow-up|4|||
143444461|NCT05000216|517174557|FG017|Stage 2|Lost to Follow-up|0|||
143444462|NCT05000216|517174558|FG018|Stage 2|Lost to Follow-up|0|||
143444463|NCT05000216|517174559|FG019|Stage 2|Lost to Follow-up|0|||
143444464|NCT05000216|517174560|FG020|Stage 2|Lost to Follow-up|0|||
143444465|NCT05000216|517174561|FG021|Stage 2|Lost to Follow-up|0|||
143444466|NCT05000216|517174540|FG000|Stage 2|Physician Decision|0|||
143444467|NCT05000216|517174541|FG001|Stage 2|Physician Decision|0|||
143444468|NCT05000216|517174542|FG002|Stage 2|Physician Decision|0|||
143444469|NCT05000216|517174543|FG003|Stage 2|Physician Decision|0|||
143444470|NCT05000216|517174544|FG004|Stage 2|Physician Decision|0|||
143444471|NCT05000216|517174545|FG005|Stage 2|Physician Decision|0|||
143444472|NCT05000216|517174546|FG006|Stage 2|Physician Decision|0|||
143444473|NCT05000216|517174547|FG007|Stage 2|Physician Decision|0|||
143444474|NCT05000216|517174548|FG008|Stage 2|Physician Decision|0|||
143444475|NCT05000216|517174549|FG009|Stage 2|Physician Decision|0|||
143444476|NCT05000216|517174550|FG010|Stage 2|Physician Decision|0|||
143444477|NCT05000216|517174551|FG011|Stage 2|Physician Decision|0|||
143444478|NCT05000216|517174552|FG012|Stage 2|Physician Decision|1|||
143444479|NCT05000216|517174553|FG013|Stage 2|Physician Decision|0|||
143444480|NCT05000216|517174554|FG014|Stage 2|Physician Decision|0|||
143444481|NCT05000216|517174555|FG015|Stage 2|Physician Decision|0|||
143444482|NCT05000216|517174556|FG016|Stage 2|Physician Decision|0|||
143444483|NCT05000216|517174557|FG017|Stage 2|Physician Decision|0|||
143444484|NCT05000216|517174558|FG018|Stage 2|Physician Decision|0|||
143444485|NCT05000216|517174559|FG019|Stage 2|Physician Decision|0|||
143444486|NCT05000216|517174560|FG020|Stage 2|Physician Decision|0|||
143444487|NCT05000216|517174561|FG021|Stage 2|Physician Decision|0|||
143444488|NCT05000216|517174540|FG000|Stage 2|Withdrawal by Subject|0|||
143444489|NCT05000216|517174541|FG001|Stage 2|Withdrawal by Subject|0|||
143444490|NCT05000216|517174542|FG002|Stage 2|Withdrawal by Subject|0|||
143444491|NCT05000216|517174543|FG003|Stage 2|Withdrawal by Subject|0|||
143444492|NCT05000216|517174544|FG004|Stage 2|Withdrawal by Subject|0|||
143444493|NCT05000216|517174545|FG005|Stage 2|Withdrawal by Subject|0|||
143444494|NCT05000216|517174546|FG006|Stage 2|Withdrawal by Subject|0|||
143444495|NCT05000216|517174547|FG007|Stage 2|Withdrawal by Subject|0|||
143444496|NCT05000216|517174548|FG008|Stage 2|Withdrawal by Subject|0|||
143444497|NCT05000216|517174549|FG009|Stage 2|Withdrawal by Subject|0|||
143444498|NCT05000216|517174550|FG010|Stage 2|Withdrawal by Subject|0|||
143444499|NCT05000216|517174551|FG011|Stage 2|Withdrawal by Subject|0|||
143444500|NCT05000216|517174552|FG012|Stage 2|Withdrawal by Subject|0|||
143444501|NCT05000216|517174553|FG013|Stage 2|Withdrawal by Subject|0|||
143444502|NCT05000216|517174554|FG014|Stage 2|Withdrawal by Subject|2|||
143444503|NCT05000216|517174555|FG015|Stage 2|Withdrawal by Subject|0|||
143444504|NCT05000216|517174556|FG016|Stage 2|Withdrawal by Subject|9|||
143444505|NCT05000216|517174557|FG017|Stage 2|Withdrawal by Subject|0|||
143444506|NCT05000216|517174558|FG018|Stage 2|Withdrawal by Subject|0|||
143444507|NCT05000216|517174559|FG019|Stage 2|Withdrawal by Subject|0|||
143444508|NCT05000216|517174560|FG020|Stage 2|Withdrawal by Subject|0|||
143444509|NCT05000216|517174561|FG021|Stage 2|Withdrawal by Subject|0|||
143444510|NCT05000216|517174540|FG000|Stage 2|Did not receive vaccine at Week 0|0|||
143444511|NCT05000216|517174541|FG001|Stage 2|Did not receive vaccine at Week 0|0|||
143444512|NCT05000216|517174542|FG002|Stage 2|Did not receive vaccine at Week 0|0|||
143444513|NCT05000216|517174543|FG003|Stage 2|Did not receive vaccine at Week 0|0|||
143444514|NCT05000216|517174544|FG004|Stage 2|Did not receive vaccine at Week 0|0|||
143444515|NCT05000216|517174545|FG005|Stage 2|Did not receive vaccine at Week 0|0|||
143444516|NCT05000216|517174546|FG006|Stage 2|Did not receive vaccine at Week 0|0|||
143444517|NCT05000216|517174547|FG007|Stage 2|Did not receive vaccine at Week 0|0|||
143444518|NCT05000216|517174548|FG008|Stage 2|Did not receive vaccine at Week 0|0|||
143444519|NCT05000216|517174549|FG009|Stage 2|Did not receive vaccine at Week 0|0|||
143444520|NCT05000216|517174550|FG010|Stage 2|Did not receive vaccine at Week 0|0|||
143444521|NCT05000216|517174551|FG011|Stage 2|Did not receive vaccine at Week 0|0|||
143444522|NCT05000216|517174552|FG012|Stage 2|Did not receive vaccine at Week 0|0|||
143444523|NCT05000216|517174553|FG013|Stage 2|Did not receive vaccine at Week 0|0|||
143444524|NCT05000216|517174554|FG014|Stage 2|Did not receive vaccine at Week 0|0|||
143444525|NCT05000216|517174555|FG015|Stage 2|Did not receive vaccine at Week 0|0|||
143444526|NCT05000216|517174556|FG016|Stage 2|Did not receive vaccine at Week 0|4|||
143444527|NCT05000216|517174557|FG017|Stage 2|Did not receive vaccine at Week 0|0|||
143444528|NCT05000216|517174558|FG018|Stage 2|Did not receive vaccine at Week 0|0|||
143444529|NCT05000216|517174559|FG019|Stage 2|Did not receive vaccine at Week 0|1|||
143444530|NCT05000216|517174560|FG020|Stage 2|Did not receive vaccine at Week 0|0|||
143444531|NCT05000216|517174561|FG021|Stage 2|Did not receive vaccine at Week 0|0|||
143444532|NCT05000216|517174540|FG000|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
143444533|NCT05000216|517174541|FG001|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
143444534|NCT05000216|517174542|FG002|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
143444535|NCT05000216|517174543|FG003|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
143444536|NCT05000216|517174544|FG004|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
143444537|NCT05000216|517174545|FG005|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
143444538|NCT05000216|517174546|FG006|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
143444539|NCT05000216|517174547|FG007|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
143444540|NCT05000216|517174548|FG008|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
143444541|NCT05000216|517174549|FG009|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
143444542|NCT05000216|517174550|FG010|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
143444543|NCT05000216|517174551|FG011|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
143444544|NCT05000216|517174552|FG012|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
143444545|NCT05000216|517174553|FG013|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
143444546|NCT05000216|517174554|FG014|Stage 2|Received a SARS-CoV-2 vaccine off study|1|||
143444547|NCT05000216|517174555|FG015|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
143444548|NCT05000216|517174556|FG016|Stage 2|Received a SARS-CoV-2 vaccine off study|6|||
143444549|NCT05000216|517174557|FG017|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
143444550|NCT05000216|517174558|FG018|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
143444551|NCT05000216|517174559|FG019|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
143444552|NCT05000216|517174560|FG020|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
143444553|NCT05000216|517174561|FG021|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
143444554|NCT05000216|517174540|FG000|Stage 2|Other reason|0|||
143444555|NCT05000216|517174541|FG001|Stage 2|Other reason|0|||
143444556|NCT05000216|517174542|FG002|Stage 2|Other reason|0|||
143444557|NCT05000216|517174543|FG003|Stage 2|Other reason|0|||
143444558|NCT05000216|517174544|FG004|Stage 2|Other reason|0|||
143444559|NCT05000216|517174545|FG005|Stage 2|Other reason|0|||
143444560|NCT05000216|517174546|FG006|Stage 2|Other reason|0|||
143444561|NCT05000216|517174547|FG007|Stage 2|Other reason|0|||
143444562|NCT05000216|517174548|FG008|Stage 2|Other reason|0|||
143444563|NCT05000216|517174549|FG009|Stage 2|Other reason|0|||
143444564|NCT05000216|517174550|FG010|Stage 2|Other reason|0|||
143444565|NCT05000216|517174551|FG011|Stage 2|Other reason|0|||
143444566|NCT05000216|517174552|FG012|Stage 2|Other reason|0|||
143444567|NCT05000216|517174553|FG013|Stage 2|Other reason|0|||
143444568|NCT05000216|517174554|FG014|Stage 2|Other reason|0|||
143444569|NCT05000216|517174555|FG015|Stage 2|Other reason|0|||
143444570|NCT05000216|517174556|FG016|Stage 2|Other reason|1|||
143444571|NCT05000216|517174557|FG017|Stage 2|Other reason|0|||
143444572|NCT05000216|517174558|FG018|Stage 2|Other reason|0|||
143444573|NCT05000216|517174559|FG019|Stage 2|Other reason|0|||
143444574|NCT05000216|517174560|FG020|Stage 2|Other reason|0|||
143444575|NCT05000216|517174561|FG021|Stage 2|Other reason|0|||
143444576|NCT05000216|517174540|FG000|Stage 2 Sanofi|Lost to Follow-up|0|||
143444577|NCT05000216|517174541|FG001|Stage 2 Sanofi|Lost to Follow-up|0|||
143444578|NCT05000216|517174542|FG002|Stage 2 Sanofi|Lost to Follow-up|0|||
143444579|NCT05000216|517174543|FG003|Stage 2 Sanofi|Lost to Follow-up|0|||
143444580|NCT05000216|517174544|FG004|Stage 2 Sanofi|Lost to Follow-up|0|||
143444581|NCT05000216|517174545|FG005|Stage 2 Sanofi|Lost to Follow-up|0|||
143444582|NCT05000216|517174546|FG006|Stage 2 Sanofi|Lost to Follow-up|0|||
143444583|NCT05000216|517174547|FG007|Stage 2 Sanofi|Lost to Follow-up|0|||
143444584|NCT05000216|517174548|FG008|Stage 2 Sanofi|Lost to Follow-up|0|||
143444585|NCT05000216|517174549|FG009|Stage 2 Sanofi|Lost to Follow-up|0|||
143444586|NCT05000216|517174550|FG010|Stage 2 Sanofi|Lost to Follow-up|0|||
143444587|NCT05000216|517174551|FG011|Stage 2 Sanofi|Lost to Follow-up|0|||
143444588|NCT05000216|517174552|FG012|Stage 2 Sanofi|Lost to Follow-up|0|||
143444589|NCT05000216|517174553|FG013|Stage 2 Sanofi|Lost to Follow-up|0|||
143444590|NCT05000216|517174554|FG014|Stage 2 Sanofi|Lost to Follow-up|0|||
143444591|NCT05000216|517174555|FG015|Stage 2 Sanofi|Lost to Follow-up|0|||
143444592|NCT05000216|517174556|FG016|Stage 2 Sanofi|Lost to Follow-up|0|||
143444593|NCT05000216|517174557|FG017|Stage 2 Sanofi|Lost to Follow-up|0|||
143444594|NCT05000216|517174558|FG018|Stage 2 Sanofi|Lost to Follow-up|1|||
143444595|NCT05000216|517174559|FG019|Stage 2 Sanofi|Lost to Follow-up|0|||
143444596|NCT05000216|517174560|FG020|Stage 2 Sanofi|Lost to Follow-up|0|||
143444597|NCT05000216|517174561|FG021|Stage 2 Sanofi|Lost to Follow-up|0|||
143444598|NCT05000216|517174540|FG000|Stage 2 Sanofi|Withdrawal by Subject|0|||
143444599|NCT05000216|517174541|FG001|Stage 2 Sanofi|Withdrawal by Subject|0|||
143444600|NCT05000216|517174542|FG002|Stage 2 Sanofi|Withdrawal by Subject|0|||
143444601|NCT05000216|517174543|FG003|Stage 2 Sanofi|Withdrawal by Subject|0|||
143444602|NCT05000216|517174544|FG004|Stage 2 Sanofi|Withdrawal by Subject|0|||
143444603|NCT05000216|517174545|FG005|Stage 2 Sanofi|Withdrawal by Subject|0|||
143444604|NCT05000216|517174546|FG006|Stage 2 Sanofi|Withdrawal by Subject|0|||
143444605|NCT05000216|517174547|FG007|Stage 2 Sanofi|Withdrawal by Subject|0|||
143444606|NCT05000216|517174548|FG008|Stage 2 Sanofi|Withdrawal by Subject|0|||
143444607|NCT05000216|517174549|FG009|Stage 2 Sanofi|Withdrawal by Subject|0|||
143444608|NCT05000216|517174550|FG010|Stage 2 Sanofi|Withdrawal by Subject|0|||
143444609|NCT05000216|517174551|FG011|Stage 2 Sanofi|Withdrawal by Subject|0|||
143444610|NCT05000216|517174552|FG012|Stage 2 Sanofi|Withdrawal by Subject|0|||
143444611|NCT05000216|517174553|FG013|Stage 2 Sanofi|Withdrawal by Subject|0|||
143444612|NCT05000216|517174554|FG014|Stage 2 Sanofi|Withdrawal by Subject|0|||
143444613|NCT05000216|517174555|FG015|Stage 2 Sanofi|Withdrawal by Subject|1|||
143444614|NCT05000216|517174556|FG016|Stage 2 Sanofi|Withdrawal by Subject|0|||
143444615|NCT05000216|517174557|FG017|Stage 2 Sanofi|Withdrawal by Subject|0|||
143444616|NCT05000216|517174558|FG018|Stage 2 Sanofi|Withdrawal by Subject|0|||
143444617|NCT05000216|517174559|FG019|Stage 2 Sanofi|Withdrawal by Subject|0|||
143444618|NCT05000216|517174560|FG020|Stage 2 Sanofi|Withdrawal by Subject|0|||
143444619|NCT05000216|517174561|FG021|Stage 2 Sanofi|Withdrawal by Subject|0|||
143444620|NCT05000216|517174540|FG000|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
143444621|NCT05000216|517174541|FG001|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
143444622|NCT05000216|517174542|FG002|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
143444623|NCT05000216|517174543|FG003|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
143444624|NCT05000216|517174544|FG004|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
143444625|NCT05000216|517174545|FG005|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
143444626|NCT05000216|517174546|FG006|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
143444627|NCT05000216|517174547|FG007|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
143444628|NCT05000216|517174548|FG008|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
143444629|NCT05000216|517174549|FG009|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
143444630|NCT05000216|517174550|FG010|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
143444631|NCT05000216|517174551|FG011|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
143444632|NCT05000216|517174552|FG012|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
143444633|NCT05000216|517174553|FG013|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|1|||
143444634|NCT05000216|517174554|FG014|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
143444635|NCT05000216|517174555|FG015|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
143444636|NCT05000216|517174556|FG016|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
143444637|NCT05000216|517174557|FG017|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
143444638|NCT05000216|517174558|FG018|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
143444639|NCT05000216|517174559|FG019|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
143444640|NCT05000216|517174560|FG020|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
143444641|NCT05000216|517174561|FG021|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
143444642|NCT02057575|517174563|FG000|Overall Study|Adverse Event|0|||
143444643|NCT02057575|517174564|FG001|Overall Study|Adverse Event|2|||
143444644|NCT02057575|517174565|FG002|Overall Study|Adverse Event|0|||
143444645|NCT02057575|517174566|FG003|Overall Study|Adverse Event|1|||
143444646|NCT02057575|517174563|FG000|Overall Study|Withdrawal by Subject|1|||
143444647|NCT02057575|517174564|FG001|Overall Study|Withdrawal by Subject|0|||
143444648|NCT02057575|517174565|FG002|Overall Study|Withdrawal by Subject|0|||
143444649|NCT02057575|517174566|FG003|Overall Study|Withdrawal by Subject|0|||
143444650|NCT02057575|517174563|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
143444651|NCT02057575|517174564|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
143444652|NCT02057575|517174565|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
143444653|NCT02057575|517174566|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
143444654|NCT02057575|517174563|FG000|Overall Study|Protocol Violation|0|||
143444655|NCT02057575|517174564|FG001|Overall Study|Protocol Violation|1|||
143444656|NCT02057575|517174565|FG002|Overall Study|Protocol Violation|0|||
143444657|NCT02057575|517174566|FG003|Overall Study|Protocol Violation|0|||
143444658|NCT00332462|517174567|FG000|Overall Study|Adverse Event|5|||
143444659|NCT00332462|517174567|FG000|Overall Study|Abnormal Lab Value|1|||
143444660|NCT00332462|517174567|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
143444661|NCT00332462|517174567|FG000|Overall Study|no longer requires study drug|1|||
143444662|NCT00332462|517174567|FG000|Overall Study|Death|3|||
143444663|NCT00332462|517174567|FG000|Overall Study|Graft Loss|2|||
143444664|NCT00863681|517174568|FG000|Overall Study|Other|2|||
143444665|NCT00863681|517174569|FG001|Overall Study|Other|0|||
143444666|NCT00863681|517174570|FG002|Overall Study|Other|0|||
143444667|NCT00863681|517174568|FG000|Overall Study|Missing|1|||
143444668|NCT00863681|517174569|FG001|Overall Study|Missing|0|||
143444669|NCT00863681|517174570|FG002|Overall Study|Missing|0|||
143444670|NCT00863681|517174568|FG000|Overall Study|Death|40|||
143444671|NCT00863681|517174569|FG001|Overall Study|Death|23|||
143444672|NCT00863681|517174570|FG002|Overall Study|Death|6|||
143444673|NCT00863681|517174568|FG000|Overall Study|Withdrawal by Subject|12|||
143444674|NCT00863681|517174569|FG001|Overall Study|Withdrawal by Subject|5|||
143444675|NCT00863681|517174570|FG002|Overall Study|Withdrawal by Subject|2|||
143444676|NCT00863681|517174568|FG000|Overall Study|Protocol Violation|2|||
143444677|NCT00863681|517174569|FG001|Overall Study|Protocol Violation|0|||
143444678|NCT00863681|517174570|FG002|Overall Study|Protocol Violation|0|||
143444679|NCT00863681|517174568|FG000|Overall Study|Lost to Follow-up|3|||
143444680|NCT00863681|517174569|FG001|Overall Study|Lost to Follow-up|0|||
143444681|NCT00863681|517174570|FG002|Overall Study|Lost to Follow-up|3|||
143444682|NCT00863681|517174568|FG000|Overall Study|Adverse Event|28|||
143444683|NCT00863681|517174569|FG001|Overall Study|Adverse Event|10|||
143444684|NCT00863681|517174570|FG002|Overall Study|Adverse Event|6|||
143444685|NCT00863681|517174568|FG000|Overall Study|Lack of Efficacy|2|||
143444686|NCT00863681|517174569|FG001|Overall Study|Lack of Efficacy|2|||
143444687|NCT00863681|517174570|FG002|Overall Study|Lack of Efficacy|1|||
143444688|NCT00863681|517174568|FG000|Overall Study|Non-compliance with study drug|1|||
143444689|NCT00863681|517174569|FG001|Overall Study|Non-compliance with study drug|3|||
143444690|NCT00863681|517174570|FG002|Overall Study|Non-compliance with study drug|0|||
143444691|NCT02922023|517174571|FG000|Overall Study|Lost to Follow-up|2|||
143444692|NCT02922023|517174572|FG001|Overall Study|Lost to Follow-up|0|||
143444693|NCT01735175|517174573|FG000|Overall Study|Withdrawal by Subject|9|||
143444694|NCT01735175|517174574|FG001|Overall Study|Withdrawal by Subject|2|||
143444695|NCT01735175|517174573|FG000|Overall Study|Lost to Follow-up|4|||
143444696|NCT01735175|517174574|FG001|Overall Study|Lost to Follow-up|2|||
143444697|NCT01735175|517174573|FG000|Overall Study|Death|3|||
143444698|NCT01735175|517174574|FG001|Overall Study|Death|2|||
143444699|NCT01735175|517174573|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
143444700|NCT01735175|517174574|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
143444701|NCT03199469|517174575|FG000|Overall Study|Randomized, not treated|0|||
143444702|NCT03199469|517174576|FG001|Overall Study|Randomized, not treated|3|||
143444703|NCT03199469|517174575|FG000|Overall Study|Withdrawal by Subject|1|||
143444704|NCT03199469|517174576|FG001|Overall Study|Withdrawal by Subject|0|||
143444705|NCT03199469|517174575|FG000|Overall Study|Death|1|||
143444706|NCT03199469|517174576|FG001|Overall Study|Death|3|||
143444707|NCT03199469|517174575|FG000|Overall Study|Ongoing|5|||
143444708|NCT03199469|517174576|FG001|Overall Study|Ongoing|14|||
143444709|NCT03443414|517174577|FG000|Overall Study|Adverse Event|6|||
143444710|NCT03443414|517174578|FG001|Overall Study|Adverse Event|0|||
143444711|NCT03443414|517174579|FG002|Overall Study|Adverse Event|4|||
143444712|NCT03443414|517174580|FG003|Overall Study|Adverse Event|2|||
143444713|NCT03443414|517174581|FG004|Overall Study|Adverse Event|3|||
143444714|NCT03443414|517174577|FG000|Overall Study|Withdrawal by Subject|3|||
143444715|NCT03443414|517174578|FG001|Overall Study|Withdrawal by Subject|2|||
143444716|NCT03443414|517174579|FG002|Overall Study|Withdrawal by Subject|2|||
143444717|NCT03443414|517174580|FG003|Overall Study|Withdrawal by Subject|2|||
143444718|NCT03443414|517174581|FG004|Overall Study|Withdrawal by Subject|1|||
143444719|NCT03443414|517174577|FG000|Overall Study|Death|0|||
143444720|NCT03443414|517174578|FG001|Overall Study|Death|1|||
143444721|NCT03443414|517174579|FG002|Overall Study|Death|0|||
143444722|NCT03443414|517174580|FG003|Overall Study|Death|1|||
143444723|NCT03443414|517174581|FG004|Overall Study|Death|0|||
143444724|NCT03443414|517174577|FG000|Overall Study|Reason not specified|2|||
143444725|NCT03443414|517174578|FG001|Overall Study|Reason not specified|0|||
143444726|NCT03443414|517174579|FG002|Overall Study|Reason not specified|0|||
143444727|NCT03443414|517174580|FG003|Overall Study|Reason not specified|0|||
143444728|NCT03443414|517174581|FG004|Overall Study|Reason not specified|1|||
143444729|NCT01263509|517174582|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
143444730|NCT01263509|517174583|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
143444731|NCT01263509|517174584|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
143444732|NCT01263509|517174585|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
143444733|NCT01263509|517174582|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
143444734|NCT01263509|517174583|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
143444735|NCT01263509|517174584|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
143444736|NCT01263509|517174585|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
143444737|NCT01263509|517174582|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
143444738|NCT01263509|517174583|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
143444739|NCT01263509|517174584|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
143444740|NCT01263509|517174585|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
143444741|NCT01263509|517174582|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
143444742|NCT01263509|517174583|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
143444743|NCT01263509|517174584|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
143444744|NCT01263509|517174585|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
143444745|NCT01263509|517174582|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
143444746|NCT01263509|517174583|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
143444747|NCT01263509|517174584|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
143444748|NCT01263509|517174585|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
143444749|NCT04276051|517174589|FG000|Overall Study|Lost to Follow-up|0|||
143444750|NCT04276051|517174590|FG001|Overall Study|Lost to Follow-up|1|||
143444751|NCT04276051|517174589|FG000|Overall Study|Physician Decision|0|||
143444752|NCT04276051|517174590|FG001|Overall Study|Physician Decision|1|||
143444753|NCT04276051|517174589|FG000|Overall Study|Withdrawal by Subject|1|||
143444754|NCT04276051|517174590|FG001|Overall Study|Withdrawal by Subject|1|||
143444755|NCT01912404|517174591|FG000|Overall Study|Due to personal reasons|1|||
143444756|NCT01912404|517174592|FG001|Overall Study|Due to personal reasons|0|||
143444757|NCT02269423|517174596|FG000|Overall Study|Discontinued due to change in residence|0|||
143444758|NCT02269423|517174597|FG001|Overall Study|Discontinued due to change in residence|1|||
143444759|NCT02269423|517174598|FG002|Overall Study|Discontinued due to change in residence|0|||
143444760|NCT02269423|517174599|FG003|Overall Study|Discontinued due to change in residence|1|||
143444761|NCT00856245|517174602|FG000|Overall Study|Was not transplanted|5|||
143444762|NCT02670122|517174603|FG000|Overall Study|Lost to Follow-up|4|||
143444763|NCT02762903|517174606|FG000|Overall Study|Lost to Follow-up|0|||
143444764|NCT02762903|517174607|FG001|Overall Study|Lost to Follow-up|1|||
143444765|NCT00108745|517174608|FG000|Overall Study|Withdrawal by Subject|19|||
143444766|NCT00108745|517174609|FG001|Overall Study|Withdrawal by Subject|12|||
143444767|NCT00108745|517174610|FG002|Overall Study|Withdrawal by Subject|12|||
143444768|NCT00108745|517174608|FG000|Overall Study|Never Treated|8|||
143444769|NCT00108745|517174609|FG001|Overall Study|Never Treated|10|||
143444770|NCT00108745|517174610|FG002|Overall Study|Never Treated|12|||
143444771|NCT00108745|517174608|FG000|Overall Study|Ineligible|7|||
143444772|NCT00108745|517174609|FG001|Overall Study|Ineligible|13|||
143444773|NCT00108745|517174610|FG002|Overall Study|Ineligible|13|||
143444774|NCT01889069|517174611|FG000|Overall Study|Death|18|||
143444775|NCT01889069|517174611|FG000|Overall Study|Progression of Disease|14|||
143444776|NCT01889069|517174611|FG000|Overall Study|Lost to Follow-up|6|||
143444777|NCT01889069|517174611|FG000|Overall Study|Other|4|||
143444778|NCT01889069|517174611|FG000|Overall Study|Consent Withdrawal|3|||
143444779|NCT00243074|517174615|FG000|Overall Study|Ineligible|6|||
143444780|NCT00243074|517174615|FG000|Overall Study|Adverse Event|6|||
143444781|NCT00243074|517174615|FG000|Overall Study|Withdrawal by Subject|2|||
143444782|NCT00243074|517174615|FG000|Overall Study|Lack of Efficacy|36|||
143444783|NCT00243074|517174615|FG000|Overall Study|Death|2|||
143444784|NCT00243074|517174615|FG000|Overall Study|not protocol specified|1|||
143444785|NCT00243074|517174615|FG000|Overall Study|Did not receive any treatment|1|||
143444786|NCT01371708|517174622|FG000|Overall Study|Insufficient clinical response|3|||
143444787|NCT01371708|517174623|FG001|Overall Study|Insufficient clinical response|2|||
143444788|NCT01371708|517174624|FG002|Overall Study|Insufficient clinical response|0|||
143444789|NCT01371708|517174622|FG000|Overall Study|Lost to Follow-up|5|||
143444790|NCT01371708|517174623|FG001|Overall Study|Lost to Follow-up|9|||
143444791|NCT01371708|517174624|FG002|Overall Study|Lost to Follow-up|7|||
143444792|NCT01371708|517174622|FG000|Overall Study|Protocol Violation|2|||
143444793|NCT01371708|517174623|FG001|Overall Study|Protocol Violation|1|||
143444794|NCT01371708|517174624|FG002|Overall Study|Protocol Violation|2|||
143444795|NCT01371708|517174622|FG000|Overall Study|No longer willing to participate|7|||
143444796|NCT01371708|517174623|FG001|Overall Study|No longer willing to participate|7|||
143444797|NCT01371708|517174624|FG002|Overall Study|No longer willing to participate|13|||
143444798|NCT01371708|517174622|FG000|Overall Study|Medication error/not related to AE|0|||
143444799|NCT01371708|517174623|FG001|Overall Study|Medication error/not related to AE|1|||
143444800|NCT01371708|517174624|FG002|Overall Study|Medication error/not related to AE|0|||
143444801|NCT01371708|517174622|FG000|Overall Study|Other|3|||
143444802|NCT01371708|517174623|FG001|Overall Study|Other|2|||
143444803|NCT01371708|517174624|FG002|Overall Study|Other|4|||
143444804|NCT01371708|517174622|FG000|Overall Study|Adverse Event|5|||
143444805|NCT01371708|517174623|FG001|Overall Study|Adverse Event|8|||
143444806|NCT01371708|517174624|FG002|Overall Study|Adverse Event|12|||
143444807|NCT01371708|517174622|FG000|Overall Study|Started but did not receive treatment|1|||
143444808|NCT01371708|517174623|FG001|Overall Study|Started but did not receive treatment|0|||
143444809|NCT01371708|517174624|FG002|Overall Study|Started but did not receive treatment|1|||
143444810|NCT02514551|517174625|FG000|Overall Study|Lost to Follow-up|0|||
143444811|NCT02514551|517174626|FG001|Overall Study|Lost to Follow-up|1|||
143444812|NCT02514551|517174625|FG000|Overall Study|Participant Never Treated|0|||
143444813|NCT02514551|517174626|FG001|Overall Study|Participant Never Treated|2|||
143444814|NCT00996606|517174637|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
143444815|NCT00996606|517174637|FG000|Overall Study|Insufficient Therapeutic Response|2|||
143444816|NCT00996606|517174637|FG000|Overall Study|Protocol Violation|1|||
143444817|NCT00996606|517174637|FG000|Overall Study|Withdrawal by Subject|3|||
143444818|NCT00632502|517174639|FG000|Overall Study|Adverse Event|0|||
143444819|NCT00632502|517174640|FG001|Overall Study|Adverse Event|1|||
143444820|NCT00632502|517174639|FG000|Overall Study|Randomized not treated|3|||
143444821|NCT00632502|517174640|FG001|Overall Study|Randomized not treated|0|||
143444822|NCT04954326|517174641|FG000|Overall Study|Protocol Violation|0|||
143444823|NCT04954326|517174642|FG001|Overall Study|Protocol Violation|1|||
143444824|NCT04954326|517174641|FG000|Overall Study|Death|0|||
143444825|NCT04954326|517174642|FG001|Overall Study|Death|2|||
143444826|NCT04954326|517174641|FG000|Overall Study|Physician Decision|0|||
143444827|NCT04954326|517174642|FG001|Overall Study|Physician Decision|1|||
143444828|NCT01213524|517174643|FG000|Baseline|Withdrawal by Subject|5|||
143444829|NCT01213524|517174643|FG000|Baseline|high breath alcohol levels|1|||
143444830|NCT01213524|517174643|FG000|Baseline|Physician Decision|1|||
143444831|NCT01213524|517174643|FG000|Session 2|Withdrawal by Subject|5|||
143444832|NCT01213524|517174643|FG000|Session 3|Withdrawal by Subject|4|||
143444833|NCT01213524|517174643|FG000|Session 4|Physician Decision|1|||
143444834|NCT01213524|517174643|FG000|Session 4|Withdrawal by Subject|2|||
143444835|NCT02519348|517174647|FG000|Overall Study|Death|31|||
143444836|NCT02519348|517174648|FG001|Overall Study|Death|74|||
143444837|NCT02519348|517174649|FG002|Overall Study|Death|47|||
143444838|NCT02519348|517174650|FG003|Overall Study|Death|54|||
143444839|NCT02519348|517174651|FG004|Overall Study|Death|63|||
143444840|NCT02519348|517174652|FG005|Overall Study|Death|18|||
143444841|NCT02519348|517174653|FG006|Overall Study|Death|2|||
143444842|NCT02519348|517174654|FG007|Overall Study|Death|5|||
143444843|NCT02519348|517174655|FG008|Overall Study|Death|5|||
143444844|NCT02519348|517174647|FG000|Overall Study|Withdrawal by Subject|4|||
143444845|NCT02519348|517174648|FG001|Overall Study|Withdrawal by Subject|7|||
143444846|NCT02519348|517174649|FG002|Overall Study|Withdrawal by Subject|4|||
143444847|NCT02519348|517174650|FG003|Overall Study|Withdrawal by Subject|3|||
143444848|NCT02519348|517174651|FG004|Overall Study|Withdrawal by Subject|3|||
143444849|NCT02519348|517174652|FG005|Overall Study|Withdrawal by Subject|2|||
143444850|NCT02519348|517174653|FG006|Overall Study|Withdrawal by Subject|0|||
143444851|NCT02519348|517174654|FG007|Overall Study|Withdrawal by Subject|0|||
143444852|NCT02519348|517174655|FG008|Overall Study|Withdrawal by Subject|1|||
143444853|NCT02519348|517174647|FG000|Overall Study|Lost to Follow-up|0|||
143444854|NCT02519348|517174648|FG001|Overall Study|Lost to Follow-up|0|||
143444855|NCT02519348|517174649|FG002|Overall Study|Lost to Follow-up|1|||
143444856|NCT02519348|517174650|FG003|Overall Study|Lost to Follow-up|0|||
143444857|NCT02519348|517174651|FG004|Overall Study|Lost to Follow-up|2|||
143444858|NCT02519348|517174652|FG005|Overall Study|Lost to Follow-up|1|||
143444859|NCT02519348|517174653|FG006|Overall Study|Lost to Follow-up|1|||
143444860|NCT02519348|517174654|FG007|Overall Study|Lost to Follow-up|0|||
143444861|NCT02519348|517174655|FG008|Overall Study|Lost to Follow-up|0|||
143444862|NCT02519348|517174647|FG000|Overall Study|Other|0|||
143444863|NCT02519348|517174648|FG001|Overall Study|Other|3|||
143444864|NCT02519348|517174649|FG002|Overall Study|Other|0|||
143444865|NCT02519348|517174650|FG003|Overall Study|Other|0|||
143444866|NCT02519348|517174651|FG004|Overall Study|Other|1|||
143444867|NCT02519348|517174652|FG005|Overall Study|Other|0|||
143444868|NCT02519348|517174653|FG006|Overall Study|Other|0|||
143444869|NCT02519348|517174654|FG007|Overall Study|Other|0|||
143444870|NCT02519348|517174655|FG008|Overall Study|Other|0|||
143444871|NCT02519348|517174647|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
143444872|NCT02519348|517174648|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
143444873|NCT02519348|517174649|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
143444874|NCT02519348|517174650|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
143444875|NCT02519348|517174651|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
143444876|NCT02519348|517174652|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
143444877|NCT02519348|517174653|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
143444878|NCT02519348|517174654|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
143444879|NCT02519348|517174655|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
143444880|NCT05415748|517174659|FG000|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
143444881|NCT05415748|517174660|FG001|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
143444882|NCT05415748|517174661|FG002|Wash-out #1 (1 Week)|Withdrawal by Subject|2|||
143444883|NCT05415748|517174662|FG003|Wash-out #1 (1 Week)|Withdrawal by Subject|0|||
143444884|NCT05415748|517174659|FG000|Intervention #2 (2 Weeks)|Withdrawal by Subject|1|||
143444885|NCT05415748|517174660|FG001|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
143444886|NCT05415748|517174661|FG002|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
143444887|NCT05415748|517174662|FG003|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
143444888|NCT03075527|517174663|FG000|Overall Study|Death|1|||
143444889|NCT03075527|517174663|FG000|Overall Study|Withdrawal by Subject|1|||
143444890|NCT03075527|517174663|FG000|Overall Study|Physician Decision|3|||
143444891|NCT03075527|517174663|FG000|Overall Study|Progression/Relapse|14|||
143444892|NCT00792948|517174666|FG000|Overall Study|Adverse Event|6|||
143444893|NCT00792948|517174666|FG000|Overall Study|Death|4|||
143444894|NCT00792948|517174666|FG000|Overall Study|Withdrawal by Subject|3|||
143444895|NCT00792948|517174666|FG000|Overall Study|Ineligible|2|||
143444896|NCT00792948|517174666|FG000|Overall Study|Insurance denial - not treated|1|||
143444897|NCT00792948|517174666|FG000|Overall Study|Physician Decision|11|||
143444898|NCT00792948|517174666|FG000|Overall Study|Protocol Violation|1|||
143444899|NCT00281320|517174667|FG000|Overall Study|Adverse Event|12|||
143444900|NCT00281320|517174668|FG001|Overall Study|Adverse Event|9|||
143444901|NCT00281320|517174667|FG000|Overall Study|Lack of Efficacy|4|||
143444902|NCT00281320|517174668|FG001|Overall Study|Lack of Efficacy|3|||
143444903|NCT00281320|517174667|FG000|Overall Study|Withdrawal by Subject|5|||
143444904|NCT00281320|517174668|FG001|Overall Study|Withdrawal by Subject|6|||
143444905|NCT00281320|517174667|FG000|Overall Study|Lost to Follow-up|1|||
143444906|NCT00281320|517174668|FG001|Overall Study|Lost to Follow-up|2|||
143444907|NCT00281320|517174667|FG000|Overall Study|Other|3|||
143444908|NCT00281320|517174668|FG001|Overall Study|Other|1|||
143444909|NCT00475228|517174671|FG000|Overall Study|Lost to Follow-up|17|||
143444910|NCT00475228|517174672|FG001|Overall Study|Lost to Follow-up|17|||
143444911|NCT00975676|517174674|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
143444912|NCT00975676|517174675|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
143444913|NCT02209181|517174676|FG000|Overall Study|Adverse Event|1|||
143444914|NCT02209181|517174677|FG001|Overall Study|Adverse Event|0|||
143444915|NCT02209181|517174678|FG002|Overall Study|Adverse Event|1|||
142941521|NCT00064701|515324681|FG001|One Year Post-transplant|Non-compliance|2|||
142941522|NCT00064701|515324682|FG002|One Year Post-transplant|Non-compliance|5|||
142941523|NCT00064701|515324680|FG000|One Year Post-transplant|Graft Failure|3|||
142941524|NCT00064701|515324681|FG001|One Year Post-transplant|Graft Failure|2|||
142941525|NCT00064701|515324682|FG002|One Year Post-transplant|Graft Failure|1|||
142941526|NCT00064701|515324680|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
142941527|NCT00064701|515324681|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
142941528|NCT00064701|515324682|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
142941529|NCT00064701|515324680|FG000|One Year Post-transplant|Lost to Follow-up|1|||
142941530|NCT00064701|515324681|FG001|One Year Post-transplant|Lost to Follow-up|0|||
142941531|NCT00064701|515324682|FG002|One Year Post-transplant|Lost to Follow-up|0|||
142941532|NCT00064701|515324680|FG000|One Year Post-transplant|Converted to rapamycin|1|||
142941533|NCT00064701|515324681|FG001|One Year Post-transplant|Converted to rapamycin|0|||
142941534|NCT00064701|515324682|FG002|One Year Post-transplant|Converted to rapamycin|0|||
142941535|NCT00064701|515324680|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
142941536|NCT00064701|515324681|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
142941537|NCT00064701|515324682|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
142941538|NCT00064701|515324680|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
142941539|NCT00064701|515324681|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
142941540|NCT00064701|515324682|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
142941541|NCT00064701|515324680|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
142941542|NCT00064701|515324681|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
142941543|NCT00064701|515324682|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
142941544|NCT00064701|515324680|FG000|One Year Post-transplant|Poor absorption|0|||
142941545|NCT00064701|515324681|FG001|One Year Post-transplant|Poor absorption|1|||
142941546|NCT00064701|515324682|FG002|One Year Post-transplant|Poor absorption|0|||
142941547|NCT00064701|515324680|FG000|One Year Post-transplant|Pancreas transplant|0|||
142941548|NCT00064701|515324681|FG001|One Year Post-transplant|Pancreas transplant|0|||
142941549|NCT00064701|515324682|FG002|One Year Post-transplant|Pancreas transplant|1|||
142941550|NCT00064701|515324680|FG000|Clinical Continuation Phase|Adverse Event|12|||
142941551|NCT00064701|515324681|FG001|Clinical Continuation Phase|Adverse Event|21|||
142941552|NCT00064701|515324682|FG002|Clinical Continuation Phase|Adverse Event|14|||
142941553|NCT00064701|515324680|FG000|Clinical Continuation Phase|Non-compliance|8|||
142941554|NCT00064701|515324681|FG001|Clinical Continuation Phase|Non-compliance|6|||
142941555|NCT00064701|515324682|FG002|Clinical Continuation Phase|Non-compliance|7|||
142941556|NCT00064701|515324680|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
142941557|NCT00064701|515324681|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
142941558|NCT00064701|515324682|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
142941559|NCT00064701|515324680|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
142941560|NCT00064701|515324681|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
143444916|NCT02209181|517174679|FG003|Overall Study|Adverse Event|0|||
143444917|NCT02209181|517174676|FG000|Overall Study|Withdrawal by Subject|0|||
143444918|NCT02209181|517174677|FG001|Overall Study|Withdrawal by Subject|1|||
143444919|NCT02209181|517174678|FG002|Overall Study|Withdrawal by Subject|0|||
143444920|NCT02209181|517174679|FG003|Overall Study|Withdrawal by Subject|0|||
143444921|NCT02548078|517174680|FG000|Overall Study|Serious adverse event/Adverse event|1|||
143444922|NCT02548078|517174681|FG001|Overall Study|Serious adverse event/Adverse event|0|||
143444923|NCT02548078|517174680|FG000|Overall Study|Moved from study area|3|||
143444924|NCT02548078|517174681|FG001|Overall Study|Moved from study area|3|||
143444925|NCT02548078|517174680|FG000|Overall Study|Lost to Follow-up|1|||
143444926|NCT02548078|517174681|FG001|Overall Study|Lost to Follow-up|3|||
143444927|NCT02579772|517174682|FG000|Overall Study|Withdrawal by Subject|0|||
143444928|NCT02579772|517174683|FG001|Overall Study|Withdrawal by Subject|1|||
143444929|NCT02579772|517174682|FG000|Overall Study|Usage of additional antioxidants|1|||
143444930|NCT02579772|517174683|FG001|Overall Study|Usage of additional antioxidants|0|||
143444931|NCT02579772|517174682|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
143444932|NCT02579772|517174683|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
143444933|NCT03128671|517174684|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
143444934|NCT03128671|517174685|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
143444935|NCT03128671|517174684|FG000|Allocation|Death|1|||
143444936|NCT03128671|517174685|FG001|Allocation|Death|0|||
143444937|NCT03128671|517174684|FG000|Allocation|Withdrawal by Subject|4|||
143444938|NCT03128671|517174685|FG001|Allocation|Withdrawal by Subject|0|||
143444939|NCT03128671|517174684|FG000|Intervention|Withdrawal by Subject|11|||
143444940|NCT03128671|517174685|FG001|Intervention|Withdrawal by Subject|10|||
143444941|NCT03128671|517174684|FG000|Intervention|Palliative/hospice care initiated|9|||
143444942|NCT03128671|517174685|FG001|Intervention|Palliative/hospice care initiated|10|||
143444943|NCT03128671|517174684|FG000|Intervention|Death|13|||
143444944|NCT03128671|517174685|FG001|Intervention|Death|11|||
143444945|NCT03128671|517174684|FG000|Intervention|Interrupted by hurricane|1|||
143444946|NCT03128671|517174685|FG001|Intervention|Interrupted by hurricane|0|||
143444947|NCT03128671|517174684|FG000|Intervention|Physician Decision|2|||
143444948|NCT03128671|517174685|FG001|Intervention|Physician Decision|3|||
143444949|NCT04641962|517174687|FG000|DBT Period: Up to 52 Weeks|Miscellaneous|5|||
143444950|NCT04641962|517174688|FG001|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
143444951|NCT04641962|517174689|FG002|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
143444952|NCT04641962|517174690|FG003|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
143444953|NCT04641962|517174691|FG004|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
143444954|NCT04641962|517174687|FG000|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
143444955|NCT04641962|517174688|FG001|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
143444956|NCT04641962|517174689|FG002|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
143444957|NCT04641962|517174690|FG003|DBT Period: Up to 52 Weeks|Withdrawal by Subject|1|||
143444958|NCT04641962|517174691|FG004|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
143444959|NCT04641962|517174687|FG000|DBT Period: Up to 52 Weeks|Protocol deviation|1|||
143444960|NCT04641962|517174688|FG001|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
143444961|NCT04641962|517174689|FG002|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
143444962|NCT04641962|517174690|FG003|DBT Period: Up to 52 Weeks|Protocol deviation|2|||
143444963|NCT04641962|517174691|FG004|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
143444964|NCT04641962|517174687|FG000|DBT Period: Up to 52 Weeks|Death|1|||
143444965|NCT04641962|517174688|FG001|DBT Period: Up to 52 Weeks|Death|0|||
143444966|NCT04641962|517174689|FG002|DBT Period: Up to 52 Weeks|Death|0|||
143444967|NCT04641962|517174690|FG003|DBT Period: Up to 52 Weeks|Death|0|||
143444968|NCT04641962|517174691|FG004|DBT Period: Up to 52 Weeks|Death|0|||
143444969|NCT04641962|517174687|FG000|DBT Period: Up to 52 Weeks|Adverse Event|0|||
143444970|NCT04641962|517174688|FG001|DBT Period: Up to 52 Weeks|Adverse Event|3|||
143444971|NCT04641962|517174689|FG002|DBT Period: Up to 52 Weeks|Adverse Event|0|||
143444972|NCT04641962|517174690|FG003|DBT Period: Up to 52 Weeks|Adverse Event|2|||
143444973|NCT04641962|517174691|FG004|DBT Period: Up to 52 Weeks|Adverse Event|0|||
143444974|NCT04641962|517174687|FG000|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
143444975|NCT04641962|517174688|FG001|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
143444976|NCT04641962|517174689|FG002|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|4|||
143444977|NCT04641962|517174690|FG003|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
143444978|NCT04641962|517174691|FG004|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|1|||
143444979|NCT04641962|517174687|FG000|OLE Treatment Period: Up to 76 Weeks|Death|0|||
143444980|NCT04641962|517174688|FG001|OLE Treatment Period: Up to 76 Weeks|Death|0|||
143444981|NCT04641962|517174689|FG002|OLE Treatment Period: Up to 76 Weeks|Death|1|||
143444982|NCT04641962|517174690|FG003|OLE Treatment Period: Up to 76 Weeks|Death|0|||
143444983|NCT04641962|517174691|FG004|OLE Treatment Period: Up to 76 Weeks|Death|0|||
143444984|NCT00862836|517174693|FG000|Overall Study|Withdrawal by Subject|1|||
143444985|NCT04463680|517174694|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
143444986|NCT04463680|517174694|FG000|Overall Study|Not eligible due to implant duration of use|1|||
143444987|NCT04463680|517174694|FG000|Overall Study|Withdrawal by Subject|3|||
143444988|NCT03832595|517174701|FG000|Overall Study|Death|142|||
143444989|NCT03832595|517174702|FG001|Overall Study|Death|130|||
143444990|NCT03832595|517174701|FG000|Overall Study|Medical management without dialysis|37|||
143444991|NCT03832595|517174702|FG001|Overall Study|Medical management without dialysis|1|||
143444992|NCT03277352|517174703|FG000|Overall Study|Study Terminated By Sponsor|2|||
143444993|NCT03277352|517174703|FG000|Overall Study|Withdrawal by Subject|4|||
143444994|NCT03277352|517174703|FG000|Overall Study|Death|4|||
143444995|NCT04147195|517174704|FG000|Overall Study|Adverse Event|0|||
143444996|NCT04147195|517174705|FG001|Overall Study|Adverse Event|3|||
143444997|NCT04147195|517174704|FG000|Overall Study|Study Terminated by Sponsor|4|||
143444998|NCT04147195|517174705|FG001|Overall Study|Study Terminated by Sponsor|2|||
143444999|NCT04147195|517174704|FG000|Overall Study|Withdrawal by Subject|0|||
143445000|NCT04147195|517174705|FG001|Overall Study|Withdrawal by Subject|1|||
143445001|NCT04427280|517176534|FG000|Overall Study|Withdrawal by Subject|0|||
143445002|NCT04427280|517176535|FG001|Overall Study|Withdrawal by Subject|2|||
143445003|NCT01667926|517176544|FG000|Overall Study|Withdrawal by Subject|1|||
143445004|NCT01667926|517176545|FG001|Overall Study|Withdrawal by Subject|2|||
143445005|NCT01667926|517176546|FG002|Overall Study|Withdrawal by Subject|2|||
143445006|NCT01667926|517176544|FG000|Overall Study|Physician Decision|0|||
143445007|NCT01667926|517176545|FG001|Overall Study|Physician Decision|0|||
143445008|NCT01667926|517176546|FG002|Overall Study|Physician Decision|1|||
143445009|NCT01667926|517176544|FG000|Overall Study|Time committment|0|||
143445010|NCT01667926|517176545|FG001|Overall Study|Time committment|0|||
143445011|NCT01667926|517176546|FG002|Overall Study|Time committment|2|||
143445012|NCT01667926|517176544|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
143445013|NCT01667926|517176545|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
143445014|NCT01667926|517176546|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
143445015|NCT01667926|517176544|FG000|Overall Study|Lost to Follow-up|1|||
143445016|NCT01667926|517176545|FG001|Overall Study|Lost to Follow-up|2|||
143445017|NCT01667926|517176546|FG002|Overall Study|Lost to Follow-up|1|||
143445018|NCT01667926|517176544|FG000|Overall Study|Side effects|3|||
143445019|NCT01667926|517176545|FG001|Overall Study|Side effects|0|||
143445020|NCT01667926|517176546|FG002|Overall Study|Side effects|0|||
143445021|NCT02271984|517176547|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
143445022|NCT02271984|517176548|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
143445023|NCT02271984|517176549|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
143445024|NCT02271984|517176550|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
143445025|NCT02271984|517176551|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
143445026|NCT02271984|517176552|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
143445027|NCT02271984|517176553|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
143445028|NCT02271984|517176554|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
143445029|NCT02271984|517176555|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
143445030|NCT02271984|517176556|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
143445031|NCT02271984|517176557|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
143445032|NCT02271984|517176558|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
143445033|NCT01088984|517176559|FG000|Phase 1|Death|2|||
143445034|NCT01088984|517176560|FG001|Phase 1|Death|1|||
143445035|NCT01088984|517176559|FG000|Phase 1|Disease Progression|2|||
143445036|NCT01088984|517176560|FG001|Phase 1|Disease Progression|4|||
143445037|NCT01088984|517176559|FG000|Phase 1|Other|1|||
143445038|NCT01088984|517176560|FG001|Phase 1|Other|1|||
143445039|NCT01088984|517176559|FG000|Phase 2|Death|0|||
143445040|NCT01088984|517176560|FG001|Phase 2|Death|5|||
143445041|NCT01088984|517176559|FG000|Phase 2|Withdrawal by Subject|0|||
143445042|NCT01088984|517176560|FG001|Phase 2|Withdrawal by Subject|1|||
143445043|NCT01088984|517176559|FG000|Phase 2|DIsease Progression|0|||
143445044|NCT01088984|517176560|FG001|Phase 2|DIsease Progression|25|||
143445045|NCT01088984|517176559|FG000|Phase 2|Other|0|||
143445046|NCT01088984|517176560|FG001|Phase 2|Other|1|||
143445047|NCT01228318|517176565|FG000|Overall Study|Clinic no show to receive intervention|1|||
143445048|NCT01228318|517176566|FG001|Overall Study|Clinic no show to receive intervention|0|||
143445049|NCT01228318|517176565|FG000|Overall Study|Unable to contact|2|||
143445050|NCT01228318|517176566|FG001|Overall Study|Unable to contact|5|||
143445051|NCT01228318|517176565|FG000|Overall Study|Moved|0|||
143445052|NCT01228318|517176566|FG001|Overall Study|Moved|2|||
143445053|NCT01228318|517176565|FG000|Overall Study|Incarcerated|1|||
143445054|NCT01228318|517176566|FG001|Overall Study|Incarcerated|0|||
143445055|NCT00770029|517176571|FG000|Overall Study|Lost to Follow-up|2|||
143445056|NCT00770029|517176572|FG001|Overall Study|Lost to Follow-up|0|||
143445057|NCT00770029|517176571|FG000|Overall Study|Withdrawal by Subject|3|||
143445058|NCT00770029|517176572|FG001|Overall Study|Withdrawal by Subject|3|||
143445059|NCT00770029|517176571|FG000|Overall Study|Adverse Event|1|||
143445060|NCT00770029|517176572|FG001|Overall Study|Adverse Event|0|||
143445061|NCT02088957|517176573|FG000|Overall Study|Lack of Efficacy|1|||
143445062|NCT02088957|517176574|FG001|Overall Study|Lack of Efficacy|0|||
143445063|NCT01923662|517176575|FG000|Overall Study|Withdrawal by Subject|1|||
143445064|NCT01199068|517176576|FG000|Overall Study|Unacceptable toxicity|0|||
143445065|NCT01199068|517176577|FG001|Overall Study|Unacceptable toxicity|0|||
143445066|NCT01199068|517176578|FG002|Overall Study|Unacceptable toxicity|2|||
143445067|NCT01199068|517176576|FG000|Overall Study|Progressive disease|3|||
143445068|NCT01199068|517176577|FG001|Overall Study|Progressive disease|3|||
143445069|NCT01199068|517176578|FG002|Overall Study|Progressive disease|6|||
143445070|NCT01199068|517176576|FG000|Overall Study|Withdrawal by Subject|0|||
143445071|NCT01199068|517176577|FG001|Overall Study|Withdrawal by Subject|0|||
143445072|NCT01199068|517176578|FG002|Overall Study|Withdrawal by Subject|1|||
143445073|NCT03842228|517176579|FG000|Overall Study|Adverse Event|1|||
143445074|NCT03842228|517176580|FG001|Overall Study|Adverse Event|1|||
143445075|NCT03842228|517176581|FG002|Overall Study|Adverse Event|1|||
143445076|NCT03842228|517176582|FG003|Overall Study|Adverse Event|0|||
143445077|NCT03842228|517176583|FG004|Overall Study|Adverse Event|0|||
143445078|NCT03842228|517176584|FG005|Overall Study|Adverse Event|0|||
143445079|NCT03842228|517176585|FG006|Overall Study|Adverse Event|0|||
143445080|NCT03842228|517176579|FG000|Overall Study|Death|0|||
143445081|NCT03842228|517176580|FG001|Overall Study|Death|1|||
143445082|NCT03842228|517176581|FG002|Overall Study|Death|0|||
143445083|NCT03842228|517176582|FG003|Overall Study|Death|0|||
143445084|NCT03842228|517176583|FG004|Overall Study|Death|0|||
143445085|NCT03842228|517176584|FG005|Overall Study|Death|0|||
143445086|NCT03842228|517176585|FG006|Overall Study|Death|0|||
143445087|NCT03842228|517176579|FG000|Overall Study|Withdrawal by Subject|0|||
143445088|NCT03842228|517176580|FG001|Overall Study|Withdrawal by Subject|0|||
143445089|NCT03842228|517176581|FG002|Overall Study|Withdrawal by Subject|2|||
143445090|NCT03842228|517176582|FG003|Overall Study|Withdrawal by Subject|1|||
143445091|NCT03842228|517176583|FG004|Overall Study|Withdrawal by Subject|0|||
143445092|NCT03842228|517176584|FG005|Overall Study|Withdrawal by Subject|0|||
143445093|NCT03842228|517176585|FG006|Overall Study|Withdrawal by Subject|2|||
143445094|NCT03842228|517176579|FG000|Overall Study|Progression|8|||
143445095|NCT03842228|517176580|FG001|Overall Study|Progression|1|||
143445096|NCT03842228|517176581|FG002|Overall Study|Progression|7|||
143445097|NCT03842228|517176582|FG003|Overall Study|Progression|5|||
143445098|NCT03842228|517176583|FG004|Overall Study|Progression|4|||
143445099|NCT03842228|517176584|FG005|Overall Study|Progression|2|||
143445100|NCT03842228|517176585|FG006|Overall Study|Progression|3|||
143445101|NCT01261000|517176586|FG000|Overall Study|Screen failure|1|||
143445102|NCT01154140|517176587|FG000|Overall Study|Death|71|||
143445103|NCT01154140|517176588|FG001|Overall Study|Death|81|||
143445104|NCT01154140|517176587|FG000|Overall Study|Lost to Follow-up|4|||
143445105|NCT01154140|517176588|FG001|Overall Study|Lost to Follow-up|5|||
143445106|NCT01154140|517176587|FG000|Overall Study|Withdrawal by Subject|12|||
143445107|NCT01154140|517176588|FG001|Overall Study|Withdrawal by Subject|13|||
143445108|NCT01154140|517176587|FG000|Overall Study|Other|3|||
143445109|NCT01154140|517176588|FG001|Overall Study|Other|1|||
143445110|NCT01154140|517176587|FG000|Overall Study|Randomized but not treated|1|||
143445111|NCT01154140|517176588|FG001|Overall Study|Randomized but not treated|2|||
143445112|NCT01374568|517176595|FG000|Overall Study|Lab unable to analyze BTM|0|||
143445113|NCT01374568|517176596|FG001|Overall Study|Lab unable to analyze BTM|2|||
143445114|NCT04916730|517176597|FG000|Overall Study|Withdrawal by Subject|4|||
143445115|NCT04916730|517176598|FG001|Overall Study|Withdrawal by Subject|2|||
143445116|NCT04916730|517176597|FG000|Overall Study|Lost to Follow-up|0|||
143445117|NCT04916730|517176598|FG001|Overall Study|Lost to Follow-up|2|||
143445118|NCT04916730|517176597|FG000|Overall Study|Physician Decision|1|||
143445119|NCT04916730|517176598|FG001|Overall Study|Physician Decision|0|||
143445120|NCT03945825|517176601|FG000|Overall Study|Enrolled but treatment not administered|0|||
143445121|NCT03945825|517176602|FG001|Overall Study|Enrolled but treatment not administered|0|||
143445122|NCT03945825|517176603|FG002|Overall Study|Enrolled but treatment not administered|0|||
143445123|NCT03945825|517176604|FG003|Overall Study|Enrolled but treatment not administered|0|||
143445124|NCT03945825|517176605|FG004|Overall Study|Enrolled but treatment not administered|1|||
143445125|NCT03945825|517176606|FG005|Overall Study|Enrolled but treatment not administered|0|||
143445126|NCT03945825|517176601|FG000|Overall Study|Lost to Follow-up|1|||
143445127|NCT03945825|517176602|FG001|Overall Study|Lost to Follow-up|5|||
143445128|NCT03945825|517176603|FG002|Overall Study|Lost to Follow-up|0|||
143445129|NCT03945825|517176604|FG003|Overall Study|Lost to Follow-up|1|||
143445130|NCT03945825|517176605|FG004|Overall Study|Lost to Follow-up|2|||
143445131|NCT03945825|517176606|FG005|Overall Study|Lost to Follow-up|2|||
143445132|NCT03945825|517176601|FG000|Overall Study|Withdrawal by Subject|1|||
143445133|NCT03945825|517176602|FG001|Overall Study|Withdrawal by Subject|0|||
143445134|NCT03945825|517176603|FG002|Overall Study|Withdrawal by Subject|1|||
143445135|NCT03945825|517176604|FG003|Overall Study|Withdrawal by Subject|1|||
143445136|NCT03945825|517176605|FG004|Overall Study|Withdrawal by Subject|0|||
143445137|NCT03945825|517176606|FG005|Overall Study|Withdrawal by Subject|1|||
143445138|NCT01461005|517176610|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
143445139|NCT01443923|517176611|FG000|Overall Study|Adverse Event|1|||
143445140|NCT01443923|517176612|FG001|Overall Study|Adverse Event|0|||
143445141|NCT01250509|517176615|FG000|Overall Study|Lost to Follow-up|5|||
143445142|NCT01250509|517176616|FG001|Overall Study|Lost to Follow-up|2|||
143445143|NCT01228175|517176617|FG000|Overall Study|Lost to Follow-up|64|||
143445144|NCT01228175|517176618|FG001|Overall Study|Lost to Follow-up|50|||
143445145|NCT01228175|517176617|FG000|Overall Study|Withdrawal by Subject|1|||
143445146|NCT01228175|517176618|FG001|Overall Study|Withdrawal by Subject|2|||
143445147|NCT01228175|517176617|FG000|Overall Study|Physician Decision|1|||
143445148|NCT01228175|517176618|FG001|Overall Study|Physician Decision|1|||
143445149|NCT00600613|517176621|FG000|Overall Study|Protocol Deviation|1|||
143445150|NCT00664534|517176622|FG000|Overall Study|Adverse Event|2|||
143445151|NCT00664534|517176623|FG001|Overall Study|Adverse Event|3|||
143445152|NCT00664534|517176622|FG000|Overall Study|Lost to Follow-up|6|||
143445153|NCT00664534|517176623|FG001|Overall Study|Lost to Follow-up|10|||
143445154|NCT00664534|517176622|FG000|Overall Study|Protocol Violation|10|||
143445155|NCT00664534|517176623|FG001|Overall Study|Protocol Violation|8|||
143445156|NCT00664534|517176622|FG000|Overall Study|Withdrawal by Subject|7|||
143445157|NCT00664534|517176623|FG001|Overall Study|Withdrawal by Subject|6|||
143445158|NCT00664534|517176622|FG000|Overall Study|Physician Decision|8|||
143445159|NCT00664534|517176623|FG001|Overall Study|Physician Decision|0|||
143445160|NCT00664534|517176622|FG000|Overall Study|Sponsor decision|8|||
143445161|NCT00664534|517176623|FG001|Overall Study|Sponsor decision|6|||
143445162|NCT03041792|517176624|FG000|Overall Study|Adverse Event|4|||
143445163|NCT03041792|517176625|FG001|Overall Study|Adverse Event|0|||
143445164|NCT03041792|517176624|FG000|Overall Study|Death in the family|0|||
143445165|NCT03041792|517176625|FG001|Overall Study|Death in the family|2|||
143445166|NCT03041792|517176624|FG000|Overall Study|Randomized but not treated|0|||
143445167|NCT03041792|517176625|FG001|Overall Study|Randomized but not treated|1|||
143445168|NCT04978090|517176626|FG000|Overall Study|unable to adequately fit device|2|||
143445169|NCT02227992|517176629|FG000|Overall Study|Lost to Follow-up|1|||
143445170|NCT02227992|517176630|FG001|Overall Study|Lost to Follow-up|1|||
143445171|NCT01509547|517176631|FG000|Overall Study|Lost to Follow-up|24|||
143445172|NCT01509547|517176632|FG001|Overall Study|Lost to Follow-up|14|||
143445173|NCT01509547|517176631|FG000|Overall Study|Withdrawal by Subject|11|||
143445174|NCT01509547|517176632|FG001|Overall Study|Withdrawal by Subject|24|||
143445175|NCT01509547|517176631|FG000|Overall Study|Physician Decision|0|||
143445176|NCT01509547|517176632|FG001|Overall Study|Physician Decision|1|||
143445177|NCT00935532|517176633|FG000|Overall Study|Adverse Event|11|||
143445178|NCT00935532|517176634|FG001|Overall Study|Adverse Event|6|||
143445179|NCT00935532|517176633|FG000|Overall Study|Death|1|||
143445180|NCT00935532|517176634|FG001|Overall Study|Death|0|||
143445181|NCT00935532|517176633|FG000|Overall Study|Lost to Follow-up|1|||
143445182|NCT00935532|517176634|FG001|Overall Study|Lost to Follow-up|0|||
143445183|NCT00935532|517176633|FG000|Overall Study|Physician Decision|1|||
143445184|NCT00935532|517176634|FG001|Overall Study|Physician Decision|2|||
143445185|NCT00935532|517176633|FG000|Overall Study|Protocol Violation|2|||
143445186|NCT00935532|517176634|FG001|Overall Study|Protocol Violation|1|||
143445187|NCT00935532|517176633|FG000|Overall Study|Subject Decision|2|||
143445188|NCT00935532|517176634|FG001|Overall Study|Subject Decision|1|||
143445189|NCT00935532|517176633|FG000|Overall Study|Sponsor Decision|0|||
143445190|NCT00935532|517176634|FG001|Overall Study|Sponsor Decision|1|||
143445191|NCT00935532|517176633|FG000|Overall Study|Loss Glucose Control|4|||
143445192|NCT00935532|517176634|FG001|Overall Study|Loss Glucose Control|0|||
143445193|NCT00402051|517176639|FG000|Overall Study|Progressive Disease|13|||
143445194|NCT00402051|517176640|FG001|Overall Study|Progressive Disease|20|||
143445195|NCT00402051|517176639|FG000|Overall Study|Adverse Event|11|||
143445196|NCT00402051|517176640|FG001|Overall Study|Adverse Event|4|||
143445197|NCT00402051|517176639|FG000|Overall Study|Physician Decision|7|||
143445198|NCT00402051|517176640|FG001|Overall Study|Physician Decision|3|||
143445199|NCT00402051|517176639|FG000|Overall Study|Withdrawal by Subject|3|||
143445200|NCT00402051|517176640|FG001|Overall Study|Withdrawal by Subject|3|||
143445201|NCT00402051|517176639|FG000|Overall Study|Death - Related to Study Drug|1|||
143445202|NCT00402051|517176640|FG001|Overall Study|Death - Related to Study Drug|2|||
143445203|NCT00402051|517176639|FG000|Overall Study|Death Due to Study Disease|2|||
143445204|NCT00402051|517176640|FG001|Overall Study|Death Due to Study Disease|1|||
143445205|NCT00402051|517176639|FG000|Overall Study|Death Due to Adverse Event|0|||
143445206|NCT00402051|517176640|FG001|Overall Study|Death Due to Adverse Event|2|||
143445207|NCT00402051|517176639|FG000|Overall Study|Lost to Follow-up|1|||
143445208|NCT00402051|517176640|FG001|Overall Study|Lost to Follow-up|0|||
143445209|NCT00570908|517176644|FG000|Overall Study|Adverse Event|5|||
143445210|NCT00570908|517176644|FG000|Overall Study|Withdrawal by Subject|2|||
143445211|NCT00277095|517176645|FG000|Overall Study|Death|2|||
143445212|NCT00277095|517176645|FG000|Overall Study|Explanted|7|||
143445213|NCT00277095|517176645|FG000|Overall Study|Lost to Follow-up|2|||
143445214|NCT00277095|517176645|FG000|Overall Study|Missed Follow-up|9|||
143445215|NCT00277095|517176645|FG000|Overall Study|Physician Decision|1|||
143445216|NCT01447576|517176651|FG000|Overall Study|Lost to Follow-up|52|||
143445217|NCT01447576|517176651|FG000|Overall Study|Adverse Event|127|||
143445218|NCT01447576|517176651|FG000|Overall Study|Participant met withdrawal criteria|40|||
143445219|NCT01447576|517176651|FG000|Overall Study|Withdrawal by Subject|100|||
143445220|NCT01447576|517176651|FG000|Overall Study|Protocol deviation|83|||
143445221|NCT01447576|517176651|FG000|Overall Study|Lack of Efficacy|68|||
143445222|NCT01447576|517176651|FG000|Overall Study|Physician Decision|6|||
143445223|NCT05239598|517176652|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
143445224|NCT05239598|517176653|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
143445225|NCT05239598|517176652|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
143445226|NCT05239598|517176653|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
143445227|NCT02998476|517176656|FG000|Overall Study|Lost to Follow-up|1|||
143445228|NCT02998476|517176657|FG001|Overall Study|Lost to Follow-up|0|||
143445229|NCT02998476|517176656|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
143445230|NCT02998476|517176657|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
143445231|NCT02998476|517176656|FG000|Overall Study|Withdrawal by Subject|1|||
143445232|NCT02998476|517176657|FG001|Overall Study|Withdrawal by Subject|2|||
143445233|NCT02998476|517176656|FG000|Overall Study|Death|45|||
143445234|NCT02998476|517176657|FG001|Overall Study|Death|2|||
143445235|NCT02998476|517176656|FG000|Overall Study|Other|6|||
143445236|NCT02998476|517176657|FG001|Overall Study|Other|1|||
143445237|NCT05855967|517176658|FG000|Overall Study|Withdrawal by Subject|7|||
143445238|NCT05855967|517176659|FG001|Overall Study|Withdrawal by Subject|5|||
143445239|NCT05855967|517176658|FG000|Overall Study|Lost to Follow-up|2|||
143445240|NCT05855967|517176659|FG001|Overall Study|Lost to Follow-up|1|||
143445241|NCT01435772|517176661|FG000|Overall Study|Adverse Event|1|||
143445242|NCT01435772|517176662|FG001|Overall Study|Adverse Event|0|||
143445243|NCT01435772|517176663|FG002|Overall Study|Adverse Event|2|||
143445244|NCT01435772|517176661|FG000|Overall Study|Withdrawal by Subject|0|||
143445245|NCT01435772|517176662|FG001|Overall Study|Withdrawal by Subject|1|||
143445246|NCT01435772|517176663|FG002|Overall Study|Withdrawal by Subject|3|||
143445247|NCT01435772|517176661|FG000|Overall Study|Other - study termination|2|||
143445248|NCT01435772|517176662|FG001|Overall Study|Other - study termination|2|||
143445249|NCT01435772|517176663|FG002|Overall Study|Other - study termination|10|||
143445250|NCT03238963|517176664|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
143445251|NCT03238963|517176665|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
143445252|NCT03238963|517176664|FG000|Overall Study|Withdrawal by Subject|1|||
143445253|NCT03238963|517176665|FG001|Overall Study|Withdrawal by Subject|1|||
143445254|NCT03238963|517176664|FG000|Overall Study|Lost to Follow-up|1|||
143445255|NCT03238963|517176665|FG001|Overall Study|Lost to Follow-up|0|||
143445256|NCT03238963|517176664|FG000|Overall Study|Protocol Violation|1|||
143445257|NCT03238963|517176665|FG001|Overall Study|Protocol Violation|1|||
143445258|NCT03238963|517176664|FG000|Overall Study|Adverse Event|1|||
143445259|NCT03238963|517176665|FG001|Overall Study|Adverse Event|0|||
143445260|NCT06926673|517176666|FG000|Overall Study|Lost to Follow-up|0|||
143445261|NCT06926673|517176667|FG001|Overall Study|Lost to Follow-up|0|||
143445262|NCT06926673|517176668|FG002|Overall Study|Lost to Follow-up|0|||
143445263|NCT06926673|517176669|FG003|Overall Study|Lost to Follow-up|1|||
143445264|NCT06926673|517176670|FG004|Overall Study|Lost to Follow-up|0|||
143445265|NCT06926673|517176671|FG005|Overall Study|Lost to Follow-up|0|||
143445266|NCT06926673|517176672|FG006|Overall Study|Lost to Follow-up|0|||
143445267|NCT06926673|517176666|FG000|Overall Study|Physician Decision|0|||
143445268|NCT06926673|517176667|FG001|Overall Study|Physician Decision|0|||
143445269|NCT06926673|517176668|FG002|Overall Study|Physician Decision|0|||
143445270|NCT06926673|517176669|FG003|Overall Study|Physician Decision|0|||
143445271|NCT06926673|517176670|FG004|Overall Study|Physician Decision|0|||
143445272|NCT06926673|517176671|FG005|Overall Study|Physician Decision|0|||
143445273|NCT06926673|517176672|FG006|Overall Study|Physician Decision|1|||
143445274|NCT06926673|517176666|FG000|Overall Study|Withdrawal by Subject|0|||
143445275|NCT06926673|517176667|FG001|Overall Study|Withdrawal by Subject|3|||
143445276|NCT06926673|517176668|FG002|Overall Study|Withdrawal by Subject|2|||
143445277|NCT06926673|517176669|FG003|Overall Study|Withdrawal by Subject|1|||
143445278|NCT06926673|517176670|FG004|Overall Study|Withdrawal by Subject|0|||
143445279|NCT06926673|517176671|FG005|Overall Study|Withdrawal by Subject|2|||
143445280|NCT06926673|517176672|FG006|Overall Study|Withdrawal by Subject|0|||
143445281|NCT01424813|517176673|FG000|Overall Study|Withdrawal by Subject|3|||
143445282|NCT01424813|517176674|FG001|Overall Study|Withdrawal by Subject|0|||
143445283|NCT01424813|517176673|FG000|Overall Study|Protocol Violation|1|||
143445284|NCT01424813|517176674|FG001|Overall Study|Protocol Violation|0|||
143445285|NCT01424813|517176673|FG000|Overall Study|Other|1|||
143445286|NCT01424813|517176674|FG001|Overall Study|Other|2|||
143445287|NCT03939689|517178500|FG000|Overall Study|Radiographic progression|14|||
143445288|NCT03939689|517178501|FG001|Overall Study|Radiographic progression|17|||
143445289|NCT03939689|517178500|FG000|Overall Study|Treatment is no longer benefiting participant|5|||
143445290|NCT03939689|517178501|FG001|Overall Study|Treatment is no longer benefiting participant|6|||
143445291|NCT03939689|517178500|FG000|Overall Study|Adverse Event|1|||
143445292|NCT03939689|517178501|FG001|Overall Study|Adverse Event|8|||
143445293|NCT03939689|517178500|FG000|Overall Study|Unequivocal clinical progression|2|||
143445294|NCT03939689|517178501|FG001|Overall Study|Unequivocal clinical progression|5|||
143445295|NCT03939689|517178500|FG000|Overall Study|Other|1|||
143445296|NCT03939689|517178501|FG001|Overall Study|Other|4|||
143445297|NCT03939689|517178500|FG000|Overall Study|Death|0|||
143445298|NCT03939689|517178501|FG001|Overall Study|Death|3|||
143445299|NCT03939689|517178500|FG000|Overall Study|Participant decision|0|||
143445300|NCT03939689|517178501|FG001|Overall Study|Participant decision|3|||
143445301|NCT03939689|517178500|FG000|Overall Study|Withdrawal of consent|2|||
143445302|NCT03939689|517178501|FG001|Overall Study|Withdrawal of consent|1|||
143445303|NCT03939689|517178500|FG000|Overall Study|Investigator decision|1|||
143445304|NCT03939689|517178501|FG001|Overall Study|Investigator decision|0|||
143445305|NCT01920477|517178504|FG000|Overall Study|Adverse Event|0|||
143445306|NCT01920477|517178505|FG001|Overall Study|Adverse Event|1|||
143445307|NCT01920477|517178504|FG000|Overall Study|Lack of Efficacy|1|||
143445308|NCT01920477|517178505|FG001|Overall Study|Lack of Efficacy|0|||
143445309|NCT01920477|517178504|FG000|Overall Study|Study closed/terminated|14|||
143445310|NCT01920477|517178505|FG001|Overall Study|Study closed/terminated|15|||
143445311|NCT01920477|517178504|FG000|Overall Study|Withdrawal by Subject|0|||
143445312|NCT01920477|517178505|FG001|Overall Study|Withdrawal by Subject|1|||
143445313|NCT01681277|517178506|FG000|Overall Study|Adverse Event|1|||
143445314|NCT01681277|517178507|FG001|Overall Study|Adverse Event|0|||
143445315|NCT01681277|517178508|FG002|Overall Study|Adverse Event|0|||
143445316|NCT01681277|517178509|FG003|Overall Study|Adverse Event|0|||
143445317|NCT01681277|517178510|FG004|Overall Study|Adverse Event|0|||
143445318|NCT03838731|517178511|FG000|Overall Study|Pregnancy|0|||
143445319|NCT03838731|517178512|FG001|Overall Study|Pregnancy|1|||
143445320|NCT03838731|517178511|FG000|Overall Study|Withdrawal of consent|1|||
143445321|NCT03838731|517178512|FG001|Overall Study|Withdrawal of consent|0|||
143445322|NCT04707664|517178513|FG000|Overall Study|Adverse Event|2|||
143445323|NCT04707664|517178514|FG001|Overall Study|Adverse Event|0|||
143445324|NCT04707664|517178513|FG000|Overall Study|Death|1|||
143445325|NCT04707664|517178514|FG001|Overall Study|Death|2|||
143445326|NCT04707664|517178513|FG000|Overall Study|Withdrawal by Subject|13|||
143445327|NCT04707664|517178514|FG001|Overall Study|Withdrawal by Subject|21|||
143445328|NCT04707664|517178513|FG000|Overall Study|Lost to Follow-up|11|||
143445329|NCT04707664|517178514|FG001|Overall Study|Lost to Follow-up|13|||
143445330|NCT04707664|517178513|FG000|Overall Study|Not treated|2|||
143445331|NCT04707664|517178514|FG001|Overall Study|Not treated|0|||
143445332|NCT01182441|517178515|FG000|Overall Study|Patient Still in Follow-up|152|||
143445333|NCT01182441|517178516|FG001|Overall Study|Patient Still in Follow-up|72|||
143445334|NCT01182441|517178515|FG000|Overall Study|Death|37|||
143445335|NCT01182441|517178516|FG001|Overall Study|Death|25|||
143445336|NCT01182441|517178515|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
143445337|NCT01182441|517178516|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
143445338|NCT01182441|517178515|FG000|Overall Study|Lost to Follow-up|5|||
143445339|NCT01182441|517178516|FG001|Overall Study|Lost to Follow-up|8|||
143445340|NCT01182441|517178515|FG000|Overall Study|Withdrawal by Subject|6|||
143445341|NCT01182441|517178516|FG001|Overall Study|Withdrawal by Subject|13|||
143445342|NCT01182441|517178515|FG000|Overall Study|Implant Not Attempted|4|||
143445343|NCT01182441|517178516|FG001|Overall Study|Implant Not Attempted|0|||
143445344|NCT01182441|517178515|FG000|Overall Study|Adverse Event|2|||
143445345|NCT01182441|517178516|FG001|Overall Study|Adverse Event|0|||
143445346|NCT01182441|517178515|FG000|Overall Study|Physician Decision|1|||
143445347|NCT01182441|517178516|FG001|Overall Study|Physician Decision|1|||
143445348|NCT02304705|517178517|FG000|Overall Study|Withdrawal by Subject|2|||
143445349|NCT02304705|517178518|FG001|Overall Study|Withdrawal by Subject|0|||
143445350|NCT02304705|517178517|FG000|Overall Study|Physician Decision|2|||
143445351|NCT02304705|517178518|FG001|Overall Study|Physician Decision|4|||
143445352|NCT02304705|517178517|FG000|Overall Study|Death|0|||
143445353|NCT02304705|517178518|FG001|Overall Study|Death|1|||
143445354|NCT02304705|517178517|FG000|Overall Study|Lost to Follow-up|0|||
143445355|NCT02304705|517178518|FG001|Overall Study|Lost to Follow-up|2|||
143445356|NCT01195948|517178519|FG000|Overall Study|Lost to Follow-up|0|||
143445357|NCT01195948|517178520|FG001|Overall Study|Lost to Follow-up|1|||
143445358|NCT01195948|517178521|FG002|Overall Study|Lost to Follow-up|2|||
143445359|NCT04996004|517178522|FG000|Phase I|Death|1|||
143445360|NCT04996004|517178523|FG001|Phase I|Death|2|||
143445361|NCT04996004|517178524|FG002|Phase I|Death|1|||
143445362|NCT04996004|517178525|FG003|Phase I|Death|0|||
143445363|NCT04996004|517178526|FG004|Phase I|Death|0|||
143445364|NCT04996004|517178527|FG005|Phase I|Death|0|||
143445365|NCT04996004|517178522|FG000|Phase I|Study terminated by sponsor|2|||
143445366|NCT04996004|517178523|FG001|Phase I|Study terminated by sponsor|1|||
143445367|NCT04996004|517178524|FG002|Phase I|Study terminated by sponsor|2|||
143445368|NCT04996004|517178525|FG003|Phase I|Study terminated by sponsor|0|||
143445369|NCT04996004|517178526|FG004|Phase I|Study terminated by sponsor|0|||
143445370|NCT04996004|517178527|FG005|Phase I|Study terminated by sponsor|0|||
143445371|NCT04996004|517178522|FG000|Phase II|Study terminated by sponsor|0|||
143445372|NCT04996004|517178523|FG001|Phase II|Study terminated by sponsor|0|||
143445373|NCT04996004|517178524|FG002|Phase II|Study terminated by sponsor|0|||
143445374|NCT04996004|517178525|FG003|Phase II|Study terminated by sponsor|20|||
143445375|NCT04996004|517178526|FG004|Phase II|Study terminated by sponsor|10|||
143445376|NCT04996004|517178527|FG005|Phase II|Study terminated by sponsor|10|||
143445377|NCT04996004|517178522|FG000|Phase II|Withdrawal by Subject|0|||
143445378|NCT04996004|517178523|FG001|Phase II|Withdrawal by Subject|0|||
143445379|NCT04996004|517178524|FG002|Phase II|Withdrawal by Subject|0|||
143445380|NCT04996004|517178525|FG003|Phase II|Withdrawal by Subject|0|||
143445381|NCT04996004|517178526|FG004|Phase II|Withdrawal by Subject|1|||
143445382|NCT04996004|517178527|FG005|Phase II|Withdrawal by Subject|2|||
143445383|NCT04996004|517178522|FG000|Phase II|Death|0|||
143445384|NCT04996004|517178523|FG001|Phase II|Death|0|||
143445385|NCT04996004|517178524|FG002|Phase II|Death|0|||
143445386|NCT04996004|517178525|FG003|Phase II|Death|12|||
143445387|NCT04996004|517178526|FG004|Phase II|Death|2|||
143445388|NCT04996004|517178527|FG005|Phase II|Death|9|||
143445389|NCT04996004|517178522|FG000|Phase II|Other|0|||
143445390|NCT04996004|517178523|FG001|Phase II|Other|0|||
143445391|NCT04996004|517178524|FG002|Phase II|Other|0|||
143445392|NCT04996004|517178525|FG003|Phase II|Other|0|||
143445393|NCT04996004|517178526|FG004|Phase II|Other|0|||
143445394|NCT04996004|517178527|FG005|Phase II|Other|1|||
143445395|NCT05620108|517178528|FG000|Overall Study|Physician Decision|1|||
143445396|NCT05620108|517178529|FG001|Overall Study|Physician Decision|2|||
143445397|NCT02038842|517178530|FG000|Overall Study|Withdrawal by Subject|2|||
143445398|NCT02038842|517178531|FG001|Overall Study|Withdrawal by Subject|2|||
143445399|NCT02038842|517178532|FG002|Overall Study|Withdrawal by Subject|0|||
143445400|NCT02038842|517178533|FG003|Overall Study|Withdrawal by Subject|0|||
143445401|NCT02038842|517178530|FG000|Overall Study|Participant decision|0|||
143445402|NCT02038842|517178531|FG001|Overall Study|Participant decision|0|||
143445403|NCT02038842|517178532|FG002|Overall Study|Participant decision|2|||
143445404|NCT02038842|517178533|FG003|Overall Study|Participant decision|1|||
143445405|NCT02038842|517178530|FG000|Overall Study|Adverse Event|0|||
143445406|NCT02038842|517178531|FG001|Overall Study|Adverse Event|0|||
143445407|NCT02038842|517178532|FG002|Overall Study|Adverse Event|3|||
143445408|NCT02038842|517178533|FG003|Overall Study|Adverse Event|1|||
143445409|NCT02038842|517178530|FG000|Overall Study|Other (professional impossibility, etc.)|0|||
143445410|NCT02038842|517178531|FG001|Overall Study|Other (professional impossibility, etc.)|0|||
143445411|NCT02038842|517178532|FG002|Overall Study|Other (professional impossibility, etc.)|0|||
143445412|NCT02038842|517178533|FG003|Overall Study|Other (professional impossibility, etc.)|2|||
143445413|NCT01757197|517178536|FG000|Overall Study|Death|2|||
143445414|NCT05332912|517178537|FG000|Overall Study|Withdrawal by Subject|0|||
143445415|NCT05332912|517178538|FG001|Overall Study|Withdrawal by Subject|1|||
143445416|NCT05332912|517178539|FG002|Overall Study|Withdrawal by Subject|2|||
143445417|NCT05332912|517178540|FG003|Overall Study|Withdrawal by Subject|0|||
143445418|NCT05332912|517178537|FG000|Overall Study|Lost to Follow-up|0|||
143445419|NCT05332912|517178538|FG001|Overall Study|Lost to Follow-up|0|||
143445420|NCT05332912|517178539|FG002|Overall Study|Lost to Follow-up|1|||
143445421|NCT05332912|517178540|FG003|Overall Study|Lost to Follow-up|0|||
143445422|NCT01174446|517178541|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
143445423|NCT01174446|517178542|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
143445424|NCT01174446|517178543|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
143445425|NCT01174446|517178544|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
143445426|NCT01174446|517178541|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
143445427|NCT01174446|517178542|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
143445428|NCT01174446|517178543|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
143445429|NCT01174446|517178544|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
143445430|NCT01174446|517178541|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
143445431|NCT01174446|517178542|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
143445432|NCT01174446|517178543|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
143445433|NCT01174446|517178544|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
143445434|NCT01174446|517178541|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
143445435|NCT01174446|517178542|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
143445436|NCT01174446|517178543|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
143445437|NCT01174446|517178544|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
143445438|NCT03057847|517178545|FG000|Overall Study|Lost to Follow-up|16|||
143445439|NCT02942004|517178547|FG000|Overall Study|Withdrawal by Subject|0|||
143445440|NCT02942004|517178548|FG001|Overall Study|Withdrawal by Subject|2|||
143445441|NCT02942004|517178549|FG002|Overall Study|Withdrawal by Subject|3|||
143445442|NCT02942004|517178547|FG000|Overall Study|Lost to Follow-up|1|||
143445443|NCT02942004|517178548|FG001|Overall Study|Lost to Follow-up|1|||
143445444|NCT02942004|517178549|FG002|Overall Study|Lost to Follow-up|2|||
143445445|NCT02942004|517178547|FG000|Overall Study|Randomized but not dosed|3|||
143445446|NCT02942004|517178548|FG001|Overall Study|Randomized but not dosed|9|||
143445447|NCT02942004|517178549|FG002|Overall Study|Randomized but not dosed|4|||
143445448|NCT04517669|517178550|FG000|Overall Study|Lost to Follow-up|2|||
143445449|NCT04517669|517178550|FG000|Overall Study|Withdrawal by Subject|3|||
143445450|NCT04517669|517178550|FG000|Overall Study|Drug withdrawn|44|||
143445451|NCT04517669|517178550|FG000|Overall Study|Other|1|||
143445452|NCT04517669|517178550|FG000|Overall Study|Eligibility criteria not met|4|||
143445453|NCT04517669|517178550|FG000|Overall Study|Did not receive treatment|3|||
143445454|NCT02138786|517178551|FG000|Overall Study|Adverse Event|0|||
143445455|NCT02138786|517178552|FG001|Overall Study|Adverse Event|2|||
143445456|NCT02138786|517178553|FG002|Overall Study|Adverse Event|1|||
143445457|NCT02138786|517178551|FG000|Overall Study|Death|1|||
143445458|NCT02138786|517178552|FG001|Overall Study|Death|7|||
143445459|NCT02138786|517178553|FG002|Overall Study|Death|2|||
143445460|NCT02138786|517178551|FG000|Overall Study|Disease Progression|1|||
143445461|NCT02138786|517178552|FG001|Overall Study|Disease Progression|1|||
143445462|NCT02138786|517178553|FG002|Overall Study|Disease Progression|3|||
143445463|NCT02138786|517178551|FG000|Overall Study|Withdrawal by Subject|1|||
143445464|NCT02138786|517178552|FG001|Overall Study|Withdrawal by Subject|2|||
143445465|NCT02138786|517178553|FG002|Overall Study|Withdrawal by Subject|0|||
143445466|NCT02138786|517178551|FG000|Overall Study|Patient's Wish|0|||
143445467|NCT02138786|517178552|FG001|Overall Study|Patient's Wish|2|||
143445468|NCT02138786|517178553|FG002|Overall Study|Patient's Wish|0|||
143445469|NCT02138786|517178551|FG000|Overall Study|Sponsor Terminated Study|0|||
143445470|NCT02138786|517178552|FG001|Overall Study|Sponsor Terminated Study|1|||
143445471|NCT02138786|517178553|FG002|Overall Study|Sponsor Terminated Study|1|||
143445472|NCT02138786|517178551|FG000|Overall Study|Non-Compliance|0|||
143445473|NCT02138786|517178552|FG001|Overall Study|Non-Compliance|0|||
143445474|NCT02138786|517178553|FG002|Overall Study|Non-Compliance|1|||
143445475|NCT01250925|517178554|FG000|Overall Study|Lost to Follow-up|1|||
143445476|NCT01250925|517178555|FG001|Overall Study|Lost to Follow-up|1|||
143445477|NCT01250925|517178556|FG002|Overall Study|Lost to Follow-up|0|||
143445478|NCT01250925|517178554|FG000|Overall Study|Withdrawal by Subject|2|||
143445479|NCT01250925|517178555|FG001|Overall Study|Withdrawal by Subject|0|||
143445480|NCT01250925|517178556|FG002|Overall Study|Withdrawal by Subject|0|||
143445481|NCT01250925|517178554|FG000|Overall Study|Protocol Violation|2|||
143445482|NCT01250925|517178555|FG001|Overall Study|Protocol Violation|0|||
143445483|NCT01250925|517178556|FG002|Overall Study|Protocol Violation|0|||
143445484|NCT01250925|517178554|FG000|Overall Study|Physician Decision|0|||
143445485|NCT01250925|517178555|FG001|Overall Study|Physician Decision|2|||
143445486|NCT01250925|517178556|FG002|Overall Study|Physician Decision|1|||
143445487|NCT01250925|517178554|FG000|Overall Study|Adverse Event|0|||
143445488|NCT01250925|517178555|FG001|Overall Study|Adverse Event|0|||
143445489|NCT01250925|517178556|FG002|Overall Study|Adverse Event|1|||
143445490|NCT00677534|517178561|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
143445491|NCT00677534|517178561|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
143445492|NCT00677534|517178561|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
143445493|NCT02687035|517178562|FG000|Overall Study|Withdrawal by Subject|1|||
143445494|NCT02687035|517178562|FG000|Overall Study|Death|87|||
143445495|NCT02687035|517178562|FG000|Overall Study|Lost to Follow-up|1|||
143445496|NCT02687035|517178562|FG000|Overall Study|Missed Visit|87|||
143445497|NCT02687035|517178562|FG000|Overall Study|Did not receive Study Device|8|||
143445498|NCT00667394|517178565|FG000|Overall Study|Adverse Event|3|||
143445499|NCT00667394|517178566|FG001|Overall Study|Adverse Event|0|||
143445500|NCT00667394|517178565|FG000|Overall Study|Progressive disease|1|||
143445501|NCT00667394|517178566|FG001|Overall Study|Progressive disease|0|||
143445502|NCT04638660|517178568|FG000|Overall Study|Withdrawal by Subject|2|||
143445503|NCT04638660|517178569|FG001|Overall Study|Withdrawal by Subject|0|||
143445504|NCT04638660|517178568|FG000|Overall Study|Lost to Follow-up|1|||
143445505|NCT04638660|517178569|FG001|Overall Study|Lost to Follow-up|0|||
143445506|NCT04481373|517178574|FG000|Overall Study|Protocol Violation|1|||
143445507|NCT04481373|517178575|FG001|Overall Study|Protocol Violation|0|||
143445508|NCT04481373|517178574|FG000|Overall Study|Viral load in hospital not over 1000|2|||
143445509|NCT04481373|517178575|FG001|Overall Study|Viral load in hospital not over 1000|1|||
143445510|NCT04481373|517178574|FG000|Overall Study|Death before hospital discharge|1|||
143445511|NCT04481373|517178575|FG001|Overall Study|Death before hospital discharge|0|||
143445512|NCT02224703|517178577|FG000|Overall Study|Adverse Event|0|||
143445513|NCT02224703|517178578|FG001|Overall Study|Adverse Event|5|||
143445514|NCT02224703|517178579|FG002|Overall Study|Adverse Event|0|||
143445515|NCT02224703|517178577|FG000|Overall Study|Withdrawn by investigator|1|||
143445516|NCT02224703|517178578|FG001|Overall Study|Withdrawn by investigator|0|||
143445517|NCT02224703|517178579|FG002|Overall Study|Withdrawn by investigator|0|||
143445518|NCT02224703|517178577|FG000|Overall Study|Advised by medical monitor|1|||
143445519|NCT02224703|517178578|FG001|Overall Study|Advised by medical monitor|0|||
143445520|NCT02224703|517178579|FG002|Overall Study|Advised by medical monitor|0|||
143445521|NCT02224703|517178577|FG000|Overall Study|Withdrawn by parent/guardian|0|||
143445522|NCT02224703|517178578|FG001|Overall Study|Withdrawn by parent/guardian|1|||
143445523|NCT02224703|517178579|FG002|Overall Study|Withdrawn by parent/guardian|0|||
143445524|NCT02224703|517178577|FG000|Overall Study|Lack of Efficacy|1|||
143445525|NCT02224703|517178578|FG001|Overall Study|Lack of Efficacy|0|||
143445526|NCT02224703|517178579|FG002|Overall Study|Lack of Efficacy|0|||
143445527|NCT01886287|517178589|FG000|Overall Study|Radiographic disease progression|1|||
143445528|NCT01886287|517178589|FG000|Overall Study|Clinical progression due to disease|1|||
143445529|NCT03596762|517178590|FG000|Overall Study|Protocol Violation|0|||
143445530|NCT03596762|517178591|FG001|Overall Study|Protocol Violation|0|||
143445531|NCT03596762|517178592|FG002|Overall Study|Protocol Violation|0|||
143445532|NCT03596762|517178593|FG003|Overall Study|Protocol Violation|0|||
143445533|NCT03596762|517178594|FG004|Overall Study|Protocol Violation|1|||
143445534|NCT03596762|517178590|FG000|Overall Study|Adverse Event|2|||
143445535|NCT03596762|517178591|FG001|Overall Study|Adverse Event|0|||
143445536|NCT03596762|517178592|FG002|Overall Study|Adverse Event|1|||
143445537|NCT03596762|517178593|FG003|Overall Study|Adverse Event|0|||
143445538|NCT03596762|517178594|FG004|Overall Study|Adverse Event|5|||
143445539|NCT03596762|517178590|FG000|Overall Study|Withdrawal by Subject|2|||
143445540|NCT03596762|517178591|FG001|Overall Study|Withdrawal by Subject|1|||
143445541|NCT03596762|517178592|FG002|Overall Study|Withdrawal by Subject|0|||
143445542|NCT03596762|517178593|FG003|Overall Study|Withdrawal by Subject|1|||
143445543|NCT03596762|517178594|FG004|Overall Study|Withdrawal by Subject|1|||
143445544|NCT02195479|517178595|FG000|Overall Study|Lost to Follow-up|18|||
143445545|NCT02195479|517178596|FG001|Overall Study|Lost to Follow-up|15|||
143445546|NCT02195479|517178595|FG000|Overall Study|Death|217|||
143445547|NCT02195479|517178596|FG001|Overall Study|Death|171|||
143445548|NCT02195479|517178595|FG000|Overall Study|Physician Decision|1|||
143445549|NCT02195479|517178596|FG001|Overall Study|Physician Decision|0|||
143445550|NCT02195479|517178595|FG000|Overall Study|Withdrawal by Subject|30|||
143445551|NCT02195479|517178596|FG001|Overall Study|Withdrawal by Subject|30|||
143445552|NCT02195479|517178595|FG000|Overall Study|Other|3|||
143445553|NCT02195479|517178596|FG001|Overall Study|Other|4|||
143445554|NCT02195479|517178595|FG000|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|87|||
143445555|NCT02195479|517178596|FG001|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|130|||
143445556|NCT05071053|517178597|FG000|Overall Study|Progressive disease|30|||
143445557|NCT05071053|517178597|FG000|Overall Study|Adverse Event|5|||
143445558|NCT02593123|517178598|FG000|Overall Study|Physician Decision|2|||
143445559|NCT02593123|517178599|FG001|Overall Study|Physician Decision|1|||
143445560|NCT02593123|517178598|FG000|Overall Study|Relapse|1|||
143445561|NCT02593123|517178599|FG001|Overall Study|Relapse|1|||
143445562|NCT01602510|517178607|FG000|Open Label Phase|Adverse Event|46|||
143445563|NCT01602510|517178608|FG001|Open Label Phase|Adverse Event|0|||
143445564|NCT01602510|517178609|FG002|Open Label Phase|Adverse Event|0|||
143445565|NCT01602510|517178607|FG000|Open Label Phase|Lack of Efficacy|22|||
143445566|NCT01602510|517178608|FG001|Open Label Phase|Lack of Efficacy|0|||
143445567|NCT01602510|517178609|FG002|Open Label Phase|Lack of Efficacy|0|||
143445568|NCT01602510|517178607|FG000|Open Label Phase|Protocol Violation|15|||
143445569|NCT01602510|517178608|FG001|Open Label Phase|Protocol Violation|0|||
143445570|NCT01602510|517178609|FG002|Open Label Phase|Protocol Violation|0|||
143445571|NCT01602510|517178607|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
143445572|NCT01602510|517178608|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
143445573|NCT01602510|517178609|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
143445574|NCT01602510|517178607|FG000|Open Label Phase|Lost to Follow-up|22|||
143445575|NCT01602510|517178608|FG001|Open Label Phase|Lost to Follow-up|0|||
143445576|NCT01602510|517178609|FG002|Open Label Phase|Lost to Follow-up|0|||
143445577|NCT01602510|517178607|FG000|Open Label Phase|Physician Decision|19|||
143445578|NCT01602510|517178608|FG001|Open Label Phase|Physician Decision|0|||
143445579|NCT01602510|517178609|FG002|Open Label Phase|Physician Decision|0|||
143445580|NCT01602510|517178607|FG000|Open Label Phase|Withdrawal by Subject|57|||
143445581|NCT01602510|517178608|FG001|Open Label Phase|Withdrawal by Subject|0|||
143445582|NCT01602510|517178609|FG002|Open Label Phase|Withdrawal by Subject|0|||
143445583|NCT01602510|517178607|FG000|Randomized Phase|Adverse Event|0|||
143445584|NCT01602510|517178608|FG001|Randomized Phase|Adverse Event|2|||
143445585|NCT01602510|517178609|FG002|Randomized Phase|Adverse Event|6|||
143445586|NCT01602510|517178607|FG000|Randomized Phase|Lack of Efficacy|0|||
143445587|NCT01602510|517178608|FG001|Randomized Phase|Lack of Efficacy|4|||
143445588|NCT01602510|517178609|FG002|Randomized Phase|Lack of Efficacy|4|||
143445589|NCT01602510|517178607|FG000|Randomized Phase|Protocol Violation|0|||
143445590|NCT01602510|517178608|FG001|Randomized Phase|Protocol Violation|3|||
143445591|NCT01602510|517178609|FG002|Randomized Phase|Protocol Violation|3|||
143445592|NCT01602510|517178607|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
143445593|NCT01602510|517178608|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
143445594|NCT01602510|517178609|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
143445595|NCT01602510|517178607|FG000|Randomized Phase|Lost to Follow-up|0|||
143445596|NCT01602510|517178608|FG001|Randomized Phase|Lost to Follow-up|1|||
143445597|NCT01602510|517178609|FG002|Randomized Phase|Lost to Follow-up|3|||
143445598|NCT01602510|517178607|FG000|Randomized Phase|Physician Decision|0|||
143445599|NCT01602510|517178608|FG001|Randomized Phase|Physician Decision|0|||
143445600|NCT01602510|517178609|FG002|Randomized Phase|Physician Decision|2|||
143445601|NCT01602510|517178607|FG000|Randomized Phase|Withdrawal by Subject|0|||
143445602|NCT01602510|517178608|FG001|Randomized Phase|Withdrawal by Subject|6|||
143445603|NCT01602510|517178609|FG002|Randomized Phase|Withdrawal by Subject|7|||
143445604|NCT01001390|517178610|FG000|Overall Study|Failure to wear AFO device|2|||
143445605|NCT01001390|517178611|FG001|Overall Study|Failure to wear AFO device|0|||
143445606|NCT00504777|517178612|FG000|Overall Study|Adverse Event|1|||
143445607|NCT01195623|517178613|FG000|Overall Study|Lost to Follow-up|35|||
143445608|NCT01195623|517178614|FG001|Overall Study|Lost to Follow-up|37|||
143445609|NCT00477490|517178618|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
143445610|NCT00477490|517178619|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
143445611|NCT00477490|517178620|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
143445612|NCT00477490|517178621|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
143445613|NCT00477490|517178622|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
143445614|NCT00477490|517178623|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
143445615|NCT00477490|517178624|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
143445616|NCT00477490|517178625|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
143445617|NCT00477490|517178626|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
143445618|NCT00477490|517178618|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
143445619|NCT00477490|517178619|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
143445620|NCT00477490|517178620|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
143445621|NCT00477490|517178621|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
143445622|NCT00477490|517178622|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
143445623|NCT00477490|517178623|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
143445624|NCT00477490|517178624|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
143445625|NCT00477490|517178625|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
143445626|NCT00477490|517178626|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
143445627|NCT00477490|517178618|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
143445628|NCT00477490|517178619|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
143445629|NCT00477490|517178620|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
143445630|NCT00477490|517178621|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
143445631|NCT00477490|517178622|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
143445632|NCT00477490|517178623|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
143445633|NCT00477490|517178624|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
143445634|NCT00477490|517178625|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
143445635|NCT00477490|517178626|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
143445636|NCT00477490|517178618|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
143445637|NCT00477490|517178619|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
143445638|NCT00477490|517178620|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
143445639|NCT00477490|517178621|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
143445640|NCT00477490|517178622|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
143445641|NCT00477490|517178623|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
143445642|NCT00477490|517178624|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
143445643|NCT00477490|517178625|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
143445644|NCT00477490|517178626|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
143445645|NCT00477490|517178618|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
143445646|NCT00477490|517178619|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
143445647|NCT00477490|517178620|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
143445648|NCT00477490|517178621|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
143445649|NCT00477490|517178622|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
143445650|NCT00477490|517178623|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
143445651|NCT00477490|517178624|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
143445652|NCT00477490|517178625|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
143445653|NCT00477490|517178626|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
143445654|NCT00477490|517178618|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
143445655|NCT00477490|517178619|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
143445656|NCT00477490|517178620|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
143445657|NCT00477490|517178621|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
143445658|NCT00477490|517178622|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
143445659|NCT00477490|517178623|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
143445660|NCT00477490|517178624|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
143445661|NCT00477490|517178625|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
143445662|NCT00477490|517178626|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
143445663|NCT00477490|517178618|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
143445664|NCT00477490|517178619|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
143445665|NCT00477490|517178620|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
143445666|NCT00477490|517178621|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
143445667|NCT00477490|517178622|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
143445668|NCT00477490|517178623|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
143445669|NCT00477490|517178624|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
143445670|NCT00477490|517178625|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
143445671|NCT00477490|517178626|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
143445672|NCT00477490|517178618|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
143445673|NCT00477490|517178619|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
143445674|NCT00477490|517178620|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
143445675|NCT00477490|517178621|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
143445676|NCT00477490|517178622|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
143445677|NCT00477490|517178623|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
143445678|NCT00477490|517178624|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
143445679|NCT00477490|517178625|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
143445680|NCT00477490|517178626|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
143445681|NCT00477490|517178618|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
143445682|NCT00477490|517178619|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
143445683|NCT00477490|517178620|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
143445684|NCT00477490|517178621|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
143445685|NCT00477490|517178622|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
143445686|NCT00477490|517178623|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
143445687|NCT00477490|517178624|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
143445688|NCT00477490|517178625|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
143445689|NCT00477490|517178626|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
143445690|NCT00477490|517178618|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
143445691|NCT00477490|517178619|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
143445692|NCT00477490|517178620|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
143445693|NCT00477490|517178621|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
143445694|NCT00477490|517178622|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
143445695|NCT00477490|517178623|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
143445696|NCT00477490|517178624|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
143445697|NCT00477490|517178625|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
143445698|NCT00477490|517178626|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
143445699|NCT00477490|517178618|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
143445700|NCT00477490|517178619|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
143445701|NCT00477490|517178620|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
143445702|NCT00477490|517178621|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
143445703|NCT00477490|517178622|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
143445704|NCT00477490|517178623|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
143445705|NCT00477490|517178624|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
143445706|NCT00477490|517178625|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
143445707|NCT00477490|517178626|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
143445708|NCT00477490|517178618|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
143445709|NCT00477490|517178619|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
143445710|NCT00477490|517178620|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
143445711|NCT00477490|517178621|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
143445712|NCT00477490|517178622|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
143445713|NCT00477490|517178623|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
143445714|NCT00477490|517178624|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
143445715|NCT00477490|517178625|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
143445716|NCT00477490|517178626|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
143445717|NCT00477490|517178618|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
143445718|NCT00477490|517178619|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
143445719|NCT00477490|517178620|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
143445720|NCT00477490|517178621|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
143445721|NCT00477490|517178622|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
143445722|NCT00477490|517178623|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
143445723|NCT00477490|517178624|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
143445724|NCT00477490|517178625|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
143445725|NCT00477490|517178626|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
143445726|NCT00477490|517178618|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
143445727|NCT00477490|517178619|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
143445728|NCT00477490|517178620|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
143445729|NCT00477490|517178621|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
143445730|NCT00477490|517178622|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
143445731|NCT00477490|517178623|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
143445732|NCT00477490|517178624|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
143445733|NCT00477490|517178625|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
143445734|NCT00477490|517178626|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
143445735|NCT01110408|517178629|FG000|Overall Study|Protocol Violation|1|||
143445736|NCT01110408|517178630|FG001|Overall Study|Protocol Violation|0|||
143445737|NCT00669877|517178631|FG000|Overall Study|Disease Progression/Death|4|||
143445738|NCT01646177|517178632|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
143445739|NCT01646177|517178633|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
143445740|NCT01646177|517178634|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
143445741|NCT01646177|517178635|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
143445742|NCT01646177|517178636|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
143445743|NCT01646177|517178637|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
143445744|NCT01646177|517178638|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
143445745|NCT01646177|517178639|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
143445746|NCT01646177|517178640|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
143445747|NCT01646177|517178641|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
143445748|NCT01646177|517178642|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
143445749|NCT01646177|517178643|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
143445750|NCT01646177|517178632|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
143445751|NCT01646177|517178633|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
143445752|NCT01646177|517178634|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
143445753|NCT01646177|517178635|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
143445754|NCT01646177|517178636|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
143445755|NCT01646177|517178637|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
143445756|NCT01646177|517178638|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
143445757|NCT01646177|517178639|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
143445758|NCT01646177|517178640|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
143445759|NCT01646177|517178641|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
143445760|NCT01646177|517178642|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
143445761|NCT01646177|517178643|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
143445762|NCT01646177|517178632|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
143445763|NCT01646177|517178633|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
143445764|NCT01646177|517178634|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
143445765|NCT01646177|517178635|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
143445766|NCT01646177|517178636|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
143445767|NCT01646177|517178637|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
143445768|NCT01646177|517178638|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
143445769|NCT01646177|517178639|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
143445770|NCT01646177|517178640|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
143445771|NCT01646177|517178641|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
143445772|NCT01646177|517178642|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
143445773|NCT01646177|517178643|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
143445774|NCT01646177|517178632|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
143445775|NCT01646177|517178633|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
143445776|NCT01646177|517178634|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
143445777|NCT01646177|517178635|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
143445778|NCT01646177|517178636|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
143445779|NCT01646177|517178637|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
143445780|NCT01646177|517178638|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
143445781|NCT01646177|517178639|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
143445782|NCT01646177|517178640|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
143445783|NCT01646177|517178641|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
143445784|NCT01646177|517178642|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
143445785|NCT01646177|517178643|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
143445786|NCT01646177|517178632|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
143445787|NCT01646177|517178633|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
143445788|NCT01646177|517178634|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
143445789|NCT01646177|517178635|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
143445790|NCT01646177|517178636|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
143445791|NCT01646177|517178637|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
143445792|NCT01646177|517178638|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
143445793|NCT01646177|517178639|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
143445794|NCT01646177|517178640|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
143445795|NCT01646177|517178641|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
143445796|NCT01646177|517178642|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
143445797|NCT01646177|517178643|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
143445798|NCT01646177|517178632|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
143445799|NCT01646177|517178633|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
143445800|NCT01646177|517178634|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
143445801|NCT01646177|517178635|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
143445802|NCT01646177|517178636|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
143445803|NCT01646177|517178637|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
143445804|NCT01646177|517178638|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
143445805|NCT01646177|517178639|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
143445806|NCT01646177|517178640|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
143445807|NCT01646177|517178641|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
143445808|NCT01646177|517178642|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
143445809|NCT01646177|517178643|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
143445810|NCT01646177|517178632|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
143445811|NCT01646177|517178633|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
143445812|NCT01646177|517178634|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
143445813|NCT01646177|517178635|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
143445814|NCT01646177|517178636|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
143445815|NCT01646177|517178637|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
143445816|NCT01646177|517178638|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
143445817|NCT01646177|517178639|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
143445818|NCT01646177|517178640|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
143445819|NCT01646177|517178641|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
143445820|NCT01646177|517178642|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
143445821|NCT01646177|517178643|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
143445822|NCT01646177|517178632|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
143445823|NCT01646177|517178633|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
143445824|NCT01646177|517178634|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
143445825|NCT01646177|517178635|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
143445826|NCT01646177|517178636|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
143445827|NCT01646177|517178637|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
143445828|NCT01646177|517178638|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
143445829|NCT01646177|517178639|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
143445830|NCT01646177|517178640|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
143445831|NCT01646177|517178641|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
143445832|NCT01646177|517178642|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
143445833|NCT01646177|517178643|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
143445834|NCT01646177|517178632|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
143445835|NCT01646177|517178633|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
143445836|NCT01646177|517178634|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
143445837|NCT01646177|517178635|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
143445838|NCT01646177|517178636|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
143445839|NCT01646177|517178637|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
143445840|NCT01646177|517178638|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
143445841|NCT01646177|517178639|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
143445842|NCT01646177|517178640|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
143445843|NCT01646177|517178641|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
143445844|NCT01646177|517178642|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
143445845|NCT01646177|517178643|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
143445846|NCT01646177|517178632|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
143445847|NCT01646177|517178633|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
143445848|NCT01646177|517178634|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
143445849|NCT01646177|517178635|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
143445850|NCT01646177|517178636|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
143445851|NCT01646177|517178637|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
143445852|NCT01646177|517178638|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
143445853|NCT01646177|517178639|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
143445854|NCT01646177|517178640|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
143445855|NCT01646177|517178641|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
143445856|NCT01646177|517178642|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
143445857|NCT01646177|517178643|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
143445858|NCT01646177|517178632|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
143445859|NCT01646177|517178633|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
143445860|NCT01646177|517178634|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
143445861|NCT01646177|517178635|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
143445862|NCT01646177|517178636|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
143445863|NCT01646177|517178637|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
143445864|NCT01646177|517178638|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
143445865|NCT01646177|517178639|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
143445866|NCT01646177|517178640|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
143445867|NCT01646177|517178641|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
143445868|NCT01646177|517178642|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
143445869|NCT01646177|517178643|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
143445870|NCT01646177|517178632|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
143445871|NCT01646177|517178633|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
143445872|NCT01646177|517178634|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
143445873|NCT01646177|517178635|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
143445874|NCT01646177|517178636|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
143445875|NCT01646177|517178637|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
143445876|NCT01646177|517178638|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
143445877|NCT01646177|517178639|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
143445878|NCT01646177|517178640|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
143445879|NCT01646177|517178641|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
143445880|NCT01646177|517178642|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
143445881|NCT01646177|517178643|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
143445882|NCT01646177|517178632|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
143445883|NCT01646177|517178633|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
143445884|NCT01646177|517178634|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
143445885|NCT01646177|517178635|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
143445886|NCT01646177|517178636|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
143445887|NCT01646177|517178637|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
143445888|NCT01646177|517178638|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
143445889|NCT01646177|517178639|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
143445890|NCT01646177|517178640|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
143445891|NCT01646177|517178641|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
143445892|NCT01646177|517178642|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
143445893|NCT01646177|517178643|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
143445894|NCT01646177|517178632|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
143445895|NCT01646177|517178633|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
143445896|NCT01646177|517178634|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
143445897|NCT01646177|517178635|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
143445898|NCT01646177|517178636|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
143445899|NCT01646177|517178637|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
143445900|NCT01646177|517178638|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
143445901|NCT01646177|517178639|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
143445902|NCT01646177|517178640|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
143445903|NCT01646177|517178641|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
143445904|NCT01646177|517178642|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
143445905|NCT01646177|517178643|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
143445906|NCT01646177|517178632|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
143445907|NCT01646177|517178633|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
143445908|NCT01646177|517178634|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
143445909|NCT01646177|517178635|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
143445910|NCT01646177|517178636|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
143445911|NCT01646177|517178637|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
143445912|NCT01646177|517178638|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
143445913|NCT01646177|517178639|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
143445914|NCT01646177|517178640|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
143445915|NCT01646177|517178641|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
143445916|NCT01646177|517178642|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
143445917|NCT01646177|517178643|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
143445918|NCT01646177|517178632|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
143445919|NCT01646177|517178633|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
143445920|NCT01646177|517178634|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
143445921|NCT01646177|517178635|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
143445922|NCT01646177|517178636|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
143445923|NCT01646177|517178637|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
143445924|NCT01646177|517178638|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
143445925|NCT01646177|517178639|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
143445926|NCT01646177|517178640|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
143445927|NCT01646177|517178641|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
143445928|NCT01646177|517178642|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
143445929|NCT01646177|517178643|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
143445930|NCT01646177|517178632|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
143445931|NCT01646177|517178633|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
143445932|NCT01646177|517178634|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
143445933|NCT01646177|517178635|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
143445934|NCT01646177|517178636|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
143445935|NCT01646177|517178637|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
143445936|NCT01646177|517178638|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
143445937|NCT01646177|517178639|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
143445938|NCT01646177|517178640|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
143445939|NCT01646177|517178641|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
143445940|NCT01646177|517178642|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
143445941|NCT01646177|517178643|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
143445942|NCT01646177|517178632|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
143445943|NCT01646177|517178633|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
143445944|NCT01646177|517178634|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
143445945|NCT01646177|517178635|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
143445946|NCT01646177|517178636|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
143445947|NCT01646177|517178637|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
143445948|NCT01646177|517178638|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
143445949|NCT01646177|517178639|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
143445950|NCT01646177|517178640|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
143445951|NCT01646177|517178641|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
143445952|NCT01646177|517178642|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
143445953|NCT01646177|517178643|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
143445954|NCT01646177|517178632|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
143445955|NCT01646177|517178633|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
143445956|NCT01646177|517178634|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
143445957|NCT01646177|517178635|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
143445958|NCT01646177|517178636|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
143445959|NCT01646177|517178637|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
143445960|NCT01646177|517178638|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
143445961|NCT01646177|517178639|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
143445962|NCT01646177|517178640|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
143445963|NCT01646177|517178641|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
143445964|NCT01646177|517178642|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
143445965|NCT01646177|517178643|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
143445966|NCT01646177|517178632|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
143445967|NCT01646177|517178633|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
143445968|NCT01646177|517178634|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
143445969|NCT01646177|517178635|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
143445970|NCT01646177|517178636|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
143445971|NCT01646177|517178637|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
143445972|NCT01646177|517178638|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
143445973|NCT01646177|517178639|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
143445974|NCT01646177|517178640|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
143445975|NCT01646177|517178641|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
143445976|NCT01646177|517178642|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
143445977|NCT01646177|517178643|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
143445978|NCT01646177|517178632|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
143445979|NCT01646177|517178633|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
143445980|NCT01646177|517178634|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
143445981|NCT01646177|517178635|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
143445982|NCT01646177|517178636|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
143445983|NCT01646177|517178637|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
143445984|NCT01646177|517178638|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
143445985|NCT01646177|517178639|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
143445986|NCT01646177|517178640|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
143445987|NCT01646177|517178641|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
143445988|NCT01646177|517178642|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
143445989|NCT01646177|517178643|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
143445990|NCT01646177|517178632|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
143445991|NCT01646177|517178633|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
143445992|NCT01646177|517178634|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
143445993|NCT01646177|517178635|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
143445994|NCT01646177|517178636|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
143445995|NCT01646177|517178637|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
143445996|NCT01646177|517178638|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
143445997|NCT01646177|517178639|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
143445998|NCT01646177|517178640|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
143445999|NCT01646177|517178641|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
143446000|NCT01646177|517178642|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
143446001|NCT01646177|517178643|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
143446002|NCT01646177|517178632|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
143446003|NCT01646177|517178633|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
143446004|NCT01646177|517178634|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
143446005|NCT01646177|517178635|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
143446006|NCT01646177|517178636|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
143446007|NCT01646177|517178637|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
143446008|NCT01646177|517178638|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
143446009|NCT01646177|517178639|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
143446010|NCT01646177|517178640|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
143446011|NCT01646177|517178641|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
143446012|NCT01646177|517178642|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
143446013|NCT01646177|517178643|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
143446014|NCT01646177|517178632|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
143446015|NCT01646177|517178633|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
143446016|NCT01646177|517178634|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
143446017|NCT01646177|517178635|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
143446018|NCT01646177|517178636|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
143446019|NCT01646177|517178637|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
143446020|NCT01646177|517178638|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
143446021|NCT01646177|517178639|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
143446022|NCT01646177|517178640|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
143446023|NCT01646177|517178641|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
143446024|NCT01646177|517178642|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
143446025|NCT01646177|517178643|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
143446026|NCT01646177|517178632|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
143446027|NCT01646177|517178633|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
143446028|NCT01646177|517178634|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
143446029|NCT01646177|517178635|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
143446030|NCT01646177|517178636|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
143446031|NCT01646177|517178637|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
143446032|NCT01646177|517178638|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
143446033|NCT01646177|517178639|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
143446034|NCT01646177|517178640|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
143446035|NCT01646177|517178641|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
143446036|NCT01646177|517178642|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
143446037|NCT01646177|517178643|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
143446038|NCT01646177|517178632|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
143446039|NCT01646177|517178633|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
143446040|NCT01646177|517178634|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
143446041|NCT01646177|517178635|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
143446042|NCT01646177|517178636|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
143446043|NCT01646177|517178637|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
143446044|NCT01646177|517178638|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
143446045|NCT01646177|517178639|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
143446046|NCT01646177|517178640|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
143446047|NCT01646177|517178641|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
143446048|NCT01646177|517178642|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
143446049|NCT01646177|517178643|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
143446050|NCT01646177|517178632|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
143446051|NCT01646177|517178633|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
143446052|NCT01646177|517178634|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
143446053|NCT01646177|517178635|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
143446054|NCT01646177|517178636|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
143446055|NCT01646177|517178637|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
143446056|NCT01646177|517178638|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
143446057|NCT01646177|517178639|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
143446058|NCT01646177|517178640|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
143446059|NCT01646177|517178641|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
143446060|NCT01646177|517178642|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
143446061|NCT01646177|517178643|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
143446062|NCT02920970|517178644|FG000|First Intervention|Protocol Violation|0|||
143446063|NCT02920970|517178645|FG001|First Intervention|Protocol Violation|1|||
143446064|NCT02920970|517178644|FG000|First Intervention|Adverse Event|0|||
143446065|NCT02920970|517178645|FG001|First Intervention|Adverse Event|1|||
143446066|NCT02920970|517178644|FG000|Second Intervention|Poor Lens Fit|1|||
143446067|NCT02920970|517178645|FG001|Second Intervention|Poor Lens Fit|0|||
143446068|NCT01711853|517178646|FG000|Overall Study|Not treated|3|||
143446069|NCT07149155|517178650|FG000|Overall Study|Lost to Follow-up|10|||
143446070|NCT03345576|517178651|FG000|Overall Study|Withdrawal by Subject|2|||
143446071|NCT03345576|517178652|FG001|Overall Study|Withdrawal by Subject|2|||
143446072|NCT03345576|517178651|FG000|Overall Study|Adverse Event|1|||
143446073|NCT03345576|517178652|FG001|Overall Study|Adverse Event|0|||
143446074|NCT04942366|517180551|FG000|Overall Study|Withdrawal by Subject|5|||
143446075|NCT04942366|517180552|FG001|Overall Study|Withdrawal by Subject|5|||
143446076|NCT02706405|517180558|FG000|Overall Study|Death|3|||
143446077|NCT02706405|517180559|FG001|Overall Study|Death|2|||
143446078|NCT02706405|517180560|FG002|Overall Study|Death|0|||
143446079|NCT02706405|517180561|FG003|Overall Study|Death|1|||
143446080|NCT02706405|517180562|FG004|Overall Study|Death|0|||
143446081|NCT02706405|517180563|FG005|Overall Study|Death|0|||
143446082|NCT02706405|517180564|FG006|Overall Study|Death|3|||
143446083|NCT02706405|517180565|FG007|Overall Study|Death|4|||
143446084|NCT02706405|517180558|FG000|Overall Study|Disease progression|0|||
143446085|NCT02706405|517180559|FG001|Overall Study|Disease progression|0|||
143446086|NCT02706405|517180560|FG002|Overall Study|Disease progression|0|||
143446087|NCT02706405|517180561|FG003|Overall Study|Disease progression|0|||
143446088|NCT02706405|517180562|FG004|Overall Study|Disease progression|0|||
143446089|NCT02706405|517180563|FG005|Overall Study|Disease progression|0|||
143446090|NCT02706405|517180564|FG006|Overall Study|Disease progression|0|||
143446091|NCT02706405|517180565|FG007|Overall Study|Disease progression|1|||
143446092|NCT02706405|517180558|FG000|Overall Study|Pt moved to new therapy|0|||
143446093|NCT02706405|517180559|FG001|Overall Study|Pt moved to new therapy|0|||
143446094|NCT02706405|517180560|FG002|Overall Study|Pt moved to new therapy|0|||
143446095|NCT02706405|517180561|FG003|Overall Study|Pt moved to new therapy|0|||
143446096|NCT02706405|517180562|FG004|Overall Study|Pt moved to new therapy|0|||
143446097|NCT02706405|517180563|FG005|Overall Study|Pt moved to new therapy|1|||
143446098|NCT02706405|517180564|FG006|Overall Study|Pt moved to new therapy|0|||
143446099|NCT02706405|517180565|FG007|Overall Study|Pt moved to new therapy|1|||
143446100|NCT02706405|517180558|FG000|Overall Study|Physician Decision|1|||
143446101|NCT02706405|517180559|FG001|Overall Study|Physician Decision|0|||
143446102|NCT02706405|517180560|FG002|Overall Study|Physician Decision|0|||
143446103|NCT02706405|517180561|FG003|Overall Study|Physician Decision|0|||
143446104|NCT02706405|517180562|FG004|Overall Study|Physician Decision|0|||
143446105|NCT02706405|517180563|FG005|Overall Study|Physician Decision|0|||
143446106|NCT02706405|517180564|FG006|Overall Study|Physician Decision|0|||
143446107|NCT02706405|517180565|FG007|Overall Study|Physician Decision|0|||
143446108|NCT03140280|517180566|FG000|Overall Study|Physician Decision|5|||
143446109|NCT05577715|517180575|FG000|Overall Study|Withdrawal by Subject|1|||
143446110|NCT05577715|517180575|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|16|||
143446111|NCT05577715|517180575|FG000|Overall Study|Lost to Follow-up|1|||
143446112|NCT05577715|517180575|FG000|Overall Study|Death|6|||
143446113|NCT03412773|517180576|FG000|Overall Study|Lost to Follow-up|0|||
143446114|NCT03412773|517180577|FG001|Overall Study|Lost to Follow-up|7|||
143446115|NCT03412773|517180578|FG002|Overall Study|Lost to Follow-up|6|||
143446116|NCT03412773|517180576|FG000|Overall Study|Withdrawal by Subject|0|||
143446117|NCT03412773|517180577|FG001|Overall Study|Withdrawal by Subject|15|||
143446118|NCT03412773|517180578|FG002|Overall Study|Withdrawal by Subject|19|||
143446119|NCT03412773|517180576|FG000|Overall Study|Study Closed By Sponsor|3|||
143446120|NCT03412773|517180577|FG001|Overall Study|Study Closed By Sponsor|46|||
143446121|NCT03412773|517180578|FG002|Overall Study|Study Closed By Sponsor|33|||
143446122|NCT03412773|517180576|FG000|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
143446123|NCT03412773|517180577|FG001|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|15|||
143446124|NCT03412773|517180578|FG002|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
143446125|NCT03412773|517180576|FG000|Overall Study|Death|7|||
143446126|NCT03412773|517180577|FG001|Overall Study|Death|259|||
143446127|NCT03412773|517180578|FG002|Overall Study|Death|273|||
143446128|NCT03412773|517180576|FG000|Overall Study|Physician Decision|0|||
143446129|NCT03412773|517180577|FG001|Overall Study|Physician Decision|0|||
143446130|NCT03412773|517180578|FG002|Overall Study|Physician Decision|1|||
143446131|NCT01706705|517180587|FG000|Overall Study|Death|1|||
143446132|NCT01706705|517180587|FG000|Overall Study|Lack of Efficacy|13|||
143446133|NCT01706705|517180587|FG000|Overall Study|Non-clinical|6|||
143446134|NCT03510455|517180588|FG000|Overall Study|Physician Decision|1|||
143446135|NCT00384189|517180589|FG000|Overall Study|Reason Not Specified|50|||
143446136|NCT00384189|517180590|FG001|Overall Study|Reason Not Specified|57|||
143446137|NCT00384189|517180591|FG002|Overall Study|Reason Not Specified|58|||
143446138|NCT00384189|517180592|FG003|Overall Study|Reason Not Specified|40|||
143446139|NCT04958642|517180593|FG000|Overall Study|Transferred to OLEX program|3|||
143446140|NCT04958642|517180594|FG001|Overall Study|Transferred to OLEX program|0|||
143446141|NCT04958642|517180595|FG002|Overall Study|Transferred to OLEX program|5|||
143446142|NCT04958642|517180593|FG000|Overall Study|Death|0|||
143446143|NCT04958642|517180594|FG001|Overall Study|Death|0|||
143446144|NCT04958642|517180595|FG002|Overall Study|Death|1|||
143446145|NCT04958642|517180593|FG000|Overall Study|Withdrawal by Subject|4|||
143446146|NCT04958642|517180594|FG001|Overall Study|Withdrawal by Subject|9|||
143446147|NCT04958642|517180595|FG002|Overall Study|Withdrawal by Subject|13|||
143446148|NCT04958642|517180593|FG000|Overall Study|Investigator's Decision|0|||
143446149|NCT04958642|517180594|FG001|Overall Study|Investigator's Decision|0|||
143446150|NCT04958642|517180595|FG002|Overall Study|Investigator's Decision|1|||
143446151|NCT04958642|517180593|FG000|Overall Study|Adverse Event|1|||
143446152|NCT04958642|517180594|FG001|Overall Study|Adverse Event|0|||
143446153|NCT04958642|517180595|FG002|Overall Study|Adverse Event|1|||
143446154|NCT04958642|517180593|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
143446155|NCT04958642|517180594|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
143446156|NCT04958642|517180595|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
143446157|NCT04958642|517180593|FG000|Overall Study|Lost to Follow-up|1|||
143446158|NCT04958642|517180594|FG001|Overall Study|Lost to Follow-up|0|||
143446159|NCT04958642|517180595|FG002|Overall Study|Lost to Follow-up|0|||
143446160|NCT04958642|517180593|FG000|Overall Study|Transferred to EAP following study termination|0|||
143446161|NCT04958642|517180594|FG001|Overall Study|Transferred to EAP following study termination|0|||
143446162|NCT04958642|517180595|FG002|Overall Study|Transferred to EAP following study termination|1|||
143446163|NCT04958642|517180593|FG000|Overall Study|Transferred to Expanded Access Program|1|||
143446164|NCT04958642|517180594|FG001|Overall Study|Transferred to Expanded Access Program|0|||
143446165|NCT04958642|517180595|FG002|Overall Study|Transferred to Expanded Access Program|0|||
143446166|NCT05627258|517180596|FG000|Overall Study|Lost to Follow-up|1|||
143446167|NCT05627258|517180597|FG001|Overall Study|Lost to Follow-up|0|||
143446168|NCT05627258|517180598|FG002|Overall Study|Lost to Follow-up|0|||
143446169|NCT05627258|517180599|FG003|Overall Study|Lost to Follow-up|0|||
143446170|NCT05627258|517180600|FG004|Overall Study|Lost to Follow-up|0|||
143446171|NCT05627258|517180601|FG005|Overall Study|Lost to Follow-up|0|||
143446172|NCT05627258|517180596|FG000|Overall Study|Withdrawal by Subject|0|||
143446173|NCT05627258|517180597|FG001|Overall Study|Withdrawal by Subject|0|||
143446174|NCT05627258|517180598|FG002|Overall Study|Withdrawal by Subject|0|||
143446175|NCT05627258|517180599|FG003|Overall Study|Withdrawal by Subject|0|||
143446176|NCT05627258|517180600|FG004|Overall Study|Withdrawal by Subject|2|||
143446177|NCT05627258|517180601|FG005|Overall Study|Withdrawal by Subject|0|||
143446178|NCT05627258|517180596|FG000|Overall Study|Enrolled, but product not administered|1|||
143446179|NCT05627258|517180597|FG001|Overall Study|Enrolled, but product not administered|0|||
143446180|NCT05627258|517180598|FG002|Overall Study|Enrolled, but product not administered|0|||
143446181|NCT05627258|517180599|FG003|Overall Study|Enrolled, but product not administered|0|||
143446182|NCT05627258|517180600|FG004|Overall Study|Enrolled, but product not administered|0|||
143446183|NCT05627258|517180601|FG005|Overall Study|Enrolled, but product not administered|0|||
143446184|NCT05627258|517180596|FG000|Overall Study|Other subject illness/injury|1|||
143446185|NCT05627258|517180597|FG001|Overall Study|Other subject illness/injury|0|||
143446186|NCT05627258|517180598|FG002|Overall Study|Other subject illness/injury|0|||
143446187|NCT05627258|517180599|FG003|Overall Study|Other subject illness/injury|0|||
143446188|NCT05627258|517180600|FG004|Overall Study|Other subject illness/injury|0|||
143446189|NCT05627258|517180601|FG005|Overall Study|Other subject illness/injury|0|||
143446190|NCT05627258|517180596|FG000|Overall Study|Subject moved from area|0|||
143446191|NCT05627258|517180597|FG001|Overall Study|Subject moved from area|0|||
143446192|NCT05627258|517180598|FG002|Overall Study|Subject moved from area|1|||
143446193|NCT05627258|517180599|FG003|Overall Study|Subject moved from area|0|||
143446194|NCT05627258|517180600|FG004|Overall Study|Subject moved from area|0|||
143446195|NCT05627258|517180601|FG005|Overall Study|Subject moved from area|0|||
143446196|NCT00678301|517180605|FG000|Overall Study|Non-compliance with study procedures|0|||
143446197|NCT00678301|517180606|FG001|Overall Study|Non-compliance with study procedures|1|||
143446198|NCT00678301|517180605|FG000|Overall Study|Adverse Event|1|||
143446199|NCT00678301|517180606|FG001|Overall Study|Adverse Event|0|||
143446200|NCT00678301|517180605|FG000|Overall Study|Withdrawal by Subject|4|||
143446201|NCT00678301|517180606|FG001|Overall Study|Withdrawal by Subject|0|||
143446202|NCT00678301|517180605|FG000|Overall Study|Lost to Follow-up|3|||
143446203|NCT00678301|517180606|FG001|Overall Study|Lost to Follow-up|1|||
143446204|NCT03338296|517180607|FG000|Overall Study|Adverse Event|0|||
143446205|NCT03338296|517180608|FG001|Overall Study|Adverse Event|1|||
143446206|NCT03338296|517180607|FG000|Overall Study|Withdrawal by Subject|14|||
143446207|NCT03338296|517180608|FG001|Overall Study|Withdrawal by Subject|13|||
143446208|NCT03338296|517180607|FG000|Overall Study|Lost to Follow-up|10|||
143446209|NCT03338296|517180608|FG001|Overall Study|Lost to Follow-up|10|||
143446210|NCT03338296|517180607|FG000|Overall Study|Study Terminated by Sponsor|77|||
143446211|NCT03338296|517180608|FG001|Overall Study|Study Terminated by Sponsor|76|||
143446212|NCT03338296|517180607|FG000|Overall Study|Other|2|||
143446213|NCT03338296|517180608|FG001|Overall Study|Other|7|||
143446214|NCT03338296|517180607|FG000|Overall Study|Missing|0|||
143446215|NCT03338296|517180608|FG001|Overall Study|Missing|1|||
143446216|NCT01939353|517180609|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
143446217|NCT01939353|517180609|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
143446218|NCT01939353|517180609|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
143446219|NCT01939353|517180609|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
143446220|NCT01939353|517180609|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
143446221|NCT05048238|517180613|FG000|Overall Study|Withdrawal by Subject|1|||
143446222|NCT04076943|517180616|FG000|Overall Study|Withdrawal by Subject|12|||
143446223|NCT04076943|517180616|FG000|Overall Study|Adverse Event|1|||
143446224|NCT04076943|517180616|FG000|Overall Study|Progressive Disease|2|||
143446225|NCT04076943|517180616|FG000|Overall Study|Death|13|||
143446226|NCT04076943|517180616|FG000|Overall Study|Other than specified|6|||
143446227|NCT02964325|517180627|FG000|Overall Study|Lost to Follow-up|3|||
143446228|NCT02964325|517180628|FG001|Overall Study|Lost to Follow-up|3|||
143446229|NCT02964325|517180627|FG000|Overall Study|Physician Decision|5|||
143446230|NCT02964325|517180628|FG001|Overall Study|Physician Decision|4|||
143446231|NCT02964325|517180627|FG000|Overall Study|Death|1|||
143446232|NCT02964325|517180628|FG001|Overall Study|Death|3|||
143446233|NCT02964325|517180627|FG000|Overall Study|Withdrawal by Subject|2|||
143446234|NCT02964325|517180628|FG001|Overall Study|Withdrawal by Subject|1|||
143446235|NCT02964325|517180627|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
143446236|NCT02964325|517180628|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
143446237|NCT01371825|517180633|FG000|Overall Study|Death|4|||
143446238|NCT00895895|517180634|FG000|Period 1|Adverse Event|7|||
143446239|NCT00895895|517180635|FG001|Period 1|Adverse Event|6|||
143446240|NCT00895895|517180636|FG002|Period 1|Adverse Event|4|||
143446241|NCT00895895|517180637|FG003|Period 1|Adverse Event|6|||
143446242|NCT00895895|517180638|FG004|Period 1|Adverse Event|7|||
143446243|NCT00895895|517180634|FG000|Period 1|Death|0|||
143446244|NCT00895895|517180635|FG001|Period 1|Death|0|||
143446245|NCT00895895|517180636|FG002|Period 1|Death|0|||
143446246|NCT00895895|517180637|FG003|Period 1|Death|0|||
143446247|NCT00895895|517180638|FG004|Period 1|Death|1|||
143446248|NCT00895895|517180634|FG000|Period 1|discontinued by sponsor|2|||
143446249|NCT00895895|517180635|FG001|Period 1|discontinued by sponsor|1|||
143446250|NCT00895895|517180636|FG002|Period 1|discontinued by sponsor|2|||
143446251|NCT00895895|517180637|FG003|Period 1|discontinued by sponsor|1|||
143446252|NCT00895895|517180638|FG004|Period 1|discontinued by sponsor|1|||
143446253|NCT00895895|517180634|FG000|Period 1|failed to return|0|||
143446254|NCT00895895|517180635|FG001|Period 1|failed to return|0|||
143446255|NCT00895895|517180636|FG002|Period 1|failed to return|1|||
143446256|NCT00895895|517180637|FG003|Period 1|failed to return|0|||
143446257|NCT00895895|517180638|FG004|Period 1|failed to return|1|||
143446258|NCT00895895|517180634|FG000|Period 1|investigator request|0|||
143446259|NCT00895895|517180635|FG001|Period 1|investigator request|1|||
143446260|NCT00895895|517180636|FG002|Period 1|investigator request|0|||
143446261|NCT00895895|517180637|FG003|Period 1|investigator request|0|||
143446262|NCT00895895|517180638|FG004|Period 1|investigator request|0|||
143446263|NCT00895895|517180634|FG000|Period 1|Lost to Follow-up|2|||
143446264|NCT00895895|517180635|FG001|Period 1|Lost to Follow-up|1|||
143446265|NCT00895895|517180636|FG002|Period 1|Lost to Follow-up|3|||
143446266|NCT00895895|517180637|FG003|Period 1|Lost to Follow-up|2|||
143446267|NCT00895895|517180638|FG004|Period 1|Lost to Follow-up|3|||
143446268|NCT00895895|517180634|FG000|Period 1|Other|1|||
143446269|NCT00895895|517180635|FG001|Period 1|Other|2|||
143446270|NCT00895895|517180636|FG002|Period 1|Other|1|||
143446271|NCT00895895|517180637|FG003|Period 1|Other|1|||
143446272|NCT00895895|517180638|FG004|Period 1|Other|1|||
143446273|NCT00895895|517180634|FG000|Period 1|Protocol Violation|0|||
143446274|NCT00895895|517180635|FG001|Period 1|Protocol Violation|1|||
143446275|NCT00895895|517180636|FG002|Period 1|Protocol Violation|0|||
143446276|NCT00895895|517180637|FG003|Period 1|Protocol Violation|0|||
143446277|NCT00895895|517180638|FG004|Period 1|Protocol Violation|0|||
143446278|NCT00895895|517180634|FG000|Period 1|Withdrawal by Subject|6|||
143446279|NCT00895895|517180635|FG001|Period 1|Withdrawal by Subject|6|||
143446280|NCT00895895|517180636|FG002|Period 1|Withdrawal by Subject|8|||
143446281|NCT00895895|517180637|FG003|Period 1|Withdrawal by Subject|2|||
143446282|NCT00895895|517180638|FG004|Period 1|Withdrawal by Subject|4|||
143446283|NCT00895895|517180634|FG000|Period 1|unsatisfactory response-efficacy|2|||
143446284|NCT00895895|517180635|FG001|Period 1|unsatisfactory response-efficacy|0|||
143446285|NCT00895895|517180636|FG002|Period 1|unsatisfactory response-efficacy|0|||
143446286|NCT00895895|517180637|FG003|Period 1|unsatisfactory response-efficacy|0|||
143446287|NCT00895895|517180638|FG004|Period 1|unsatisfactory response-efficacy|0|||
143446288|NCT00895895|517180634|FG000|Period 1|randomized and not treated|1|||
143446289|NCT00895895|517180635|FG001|Period 1|randomized and not treated|3|||
143446290|NCT00895895|517180636|FG002|Period 1|randomized and not treated|1|||
143446291|NCT00895895|517180637|FG003|Period 1|randomized and not treated|1|||
143446292|NCT00895895|517180638|FG004|Period 1|randomized and not treated|2|||
143446293|NCT00895895|517180634|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
143446294|NCT00895895|517180635|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
143446295|NCT00895895|517180636|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
143446296|NCT00895895|517180637|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
143446297|NCT00895895|517180638|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
143446298|NCT00895895|517180634|FG000|After Period 1, Prior to Period 2|Other|0|||
143446299|NCT00895895|517180635|FG001|After Period 1, Prior to Period 2|Other|0|||
143446300|NCT00895895|517180636|FG002|After Period 1, Prior to Period 2|Other|1|||
143446301|NCT00895895|517180637|FG003|After Period 1, Prior to Period 2|Other|0|||
143446302|NCT00895895|517180638|FG004|After Period 1, Prior to Period 2|Other|0|||
143446303|NCT00895895|517180634|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
143446304|NCT00895895|517180635|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
143446305|NCT00895895|517180636|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
143446306|NCT00895895|517180637|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
143446307|NCT00895895|517180638|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
143446308|NCT00895895|517180634|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
143446309|NCT00895895|517180635|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
143446310|NCT00895895|517180636|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
143446311|NCT00895895|517180637|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
143446312|NCT00895895|517180638|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
143446313|NCT00895895|517180634|FG000|Period 2|Adverse Event|3|||
143446314|NCT00895895|517180635|FG001|Period 2|Adverse Event|3|||
143446315|NCT00895895|517180636|FG002|Period 2|Adverse Event|5|||
143446316|NCT00895895|517180637|FG003|Period 2|Adverse Event|2|||
143446317|NCT00895895|517180638|FG004|Period 2|Adverse Event|5|||
143446318|NCT00895895|517180634|FG000|Period 2|Death|0|||
143446319|NCT00895895|517180635|FG001|Period 2|Death|0|||
143446320|NCT00895895|517180636|FG002|Period 2|Death|1|||
143446321|NCT00895895|517180637|FG003|Period 2|Death|0|||
143446322|NCT00895895|517180638|FG004|Period 2|Death|0|||
143446323|NCT00895895|517180634|FG000|Period 2|discontinued by sponsor|44|||
143446324|NCT00895895|517180635|FG001|Period 2|discontinued by sponsor|44|||
143446325|NCT00895895|517180636|FG002|Period 2|discontinued by sponsor|38|||
143446326|NCT00895895|517180637|FG003|Period 2|discontinued by sponsor|46|||
143446327|NCT00895895|517180638|FG004|Period 2|discontinued by sponsor|37|||
143446328|NCT00895895|517180634|FG000|Period 2|failed to return|2|||
143446329|NCT00895895|517180635|FG001|Period 2|failed to return|0|||
143446330|NCT00895895|517180636|FG002|Period 2|failed to return|0|||
143446331|NCT00895895|517180637|FG003|Period 2|failed to return|0|||
143446332|NCT00895895|517180638|FG004|Period 2|failed to return|0|||
143446333|NCT00895895|517180634|FG000|Period 2|investigator request|2|||
143446334|NCT00895895|517180635|FG001|Period 2|investigator request|0|||
143446335|NCT00895895|517180636|FG002|Period 2|investigator request|0|||
143446336|NCT00895895|517180637|FG003|Period 2|investigator request|0|||
143446337|NCT00895895|517180638|FG004|Period 2|investigator request|0|||
143446338|NCT00895895|517180634|FG000|Period 2|Lost to Follow-up|1|||
143446339|NCT00895895|517180635|FG001|Period 2|Lost to Follow-up|2|||
143446340|NCT00895895|517180636|FG002|Period 2|Lost to Follow-up|1|||
143446341|NCT00895895|517180637|FG003|Period 2|Lost to Follow-up|1|||
143446342|NCT00895895|517180638|FG004|Period 2|Lost to Follow-up|0|||
143446343|NCT00895895|517180634|FG000|Period 2|Other|1|||
143446344|NCT00895895|517180635|FG001|Period 2|Other|1|||
143446345|NCT00895895|517180636|FG002|Period 2|Other|3|||
143446346|NCT00895895|517180637|FG003|Period 2|Other|1|||
143446347|NCT00895895|517180638|FG004|Period 2|Other|1|||
143446348|NCT00895895|517180634|FG000|Period 2|Protocol Violation|1|||
143446349|NCT00895895|517180635|FG001|Period 2|Protocol Violation|0|||
143446350|NCT00895895|517180636|FG002|Period 2|Protocol Violation|1|||
143446351|NCT00895895|517180637|FG003|Period 2|Protocol Violation|1|||
143446352|NCT00895895|517180638|FG004|Period 2|Protocol Violation|1|||
143446353|NCT00895895|517180634|FG000|Period 2|Withdrawal by Subject|0|||
143446354|NCT00895895|517180635|FG001|Period 2|Withdrawal by Subject|2|||
143446355|NCT00895895|517180636|FG002|Period 2|Withdrawal by Subject|0|||
143446356|NCT00895895|517180637|FG003|Period 2|Withdrawal by Subject|3|||
143446357|NCT00895895|517180638|FG004|Period 2|Withdrawal by Subject|5|||
143446358|NCT00895895|517180634|FG000|Period 2|unsatisfactory response-efficacy|2|||
143446359|NCT00895895|517180635|FG001|Period 2|unsatisfactory response-efficacy|1|||
143446360|NCT00895895|517180636|FG002|Period 2|unsatisfactory response-efficacy|0|||
143446361|NCT00895895|517180637|FG003|Period 2|unsatisfactory response-efficacy|0|||
143446362|NCT00895895|517180638|FG004|Period 2|unsatisfactory response-efficacy|0|||
143446363|NCT03019640|517180639|FG000|Overall Study|Screen Failures|4|||
143446364|NCT03019640|517180639|FG000|Overall Study|Adverse Event|3|||
143446365|NCT03019640|517180639|FG000|Overall Study|Participant Relapsed|1|||
143446366|NCT01277887|517180644|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
143446367|NCT01277887|517180645|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
143446368|NCT01277887|517180644|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
143446369|NCT01277887|517180645|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
143446370|NCT01277887|517180644|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
143446371|NCT01277887|517180645|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
143446372|NCT03651700|517180646|FG000|Overall Study|Withdrawal by Subject|1|||
143446373|NCT03651700|517180647|FG001|Overall Study|Withdrawal by Subject|0|||
143446374|NCT04844879|517180650|FG000|Overall Study|Death|1|||
143446375|NCT04844879|517180650|FG000|Overall Study|Withdrawal by Subject|1|||
143446376|NCT04844879|517180650|FG000|Overall Study|Adverse Event|1|||
143446377|NCT04520659|517180651|FG000|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
143446378|NCT04520659|517180652|FG001|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
143446379|NCT04520659|517180653|FG002|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
143446380|NCT04520659|517180654|FG003|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
143446381|NCT04879849|517180655|FG000|Overall Study|Lost to Follow-up|0|||
143446382|NCT04879849|517180656|FG001|Overall Study|Lost to Follow-up|0|||
143446383|NCT04879849|517180657|FG002|Overall Study|Lost to Follow-up|0|||
143446384|NCT04879849|517180658|FG003|Overall Study|Lost to Follow-up|1|||
143446385|NCT04879849|517180659|FG004|Overall Study|Lost to Follow-up|0|||
143446386|NCT04879849|517180660|FG005|Overall Study|Lost to Follow-up|0|||
143446387|NCT04879849|517180661|FG006|Overall Study|Lost to Follow-up|0|||
143446388|NCT04879849|517180662|FG007|Overall Study|Lost to Follow-up|0|||
143446389|NCT04879849|517180655|FG000|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
143446390|NCT04879849|517180656|FG001|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
143446391|NCT04879849|517180657|FG002|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
143446392|NCT04879849|517180658|FG003|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
143446393|NCT04879849|517180659|FG004|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
143446394|NCT04879849|517180660|FG005|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
143446395|NCT04879849|517180661|FG006|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
143446396|NCT04879849|517180662|FG007|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
143446397|NCT04879849|517180655|FG000|Overall Study|Withdrawal by Subject|0|||
143446398|NCT04879849|517180656|FG001|Overall Study|Withdrawal by Subject|0|||
143446399|NCT04879849|517180657|FG002|Overall Study|Withdrawal by Subject|0|||
143446400|NCT04879849|517180658|FG003|Overall Study|Withdrawal by Subject|0|||
143446401|NCT04879849|517180659|FG004|Overall Study|Withdrawal by Subject|2|||
143446402|NCT04879849|517180660|FG005|Overall Study|Withdrawal by Subject|0|||
143446403|NCT04879849|517180661|FG006|Overall Study|Withdrawal by Subject|1|||
143446404|NCT04879849|517180662|FG007|Overall Study|Withdrawal by Subject|0|||
143446405|NCT04879849|517180655|FG000|Overall Study|Progressive Disease|0|||
143446406|NCT04879849|517180656|FG001|Overall Study|Progressive Disease|0|||
143446407|NCT04879849|517180657|FG002|Overall Study|Progressive Disease|1|||
143446408|NCT04879849|517180658|FG003|Overall Study|Progressive Disease|0|||
143446409|NCT04879849|517180659|FG004|Overall Study|Progressive Disease|0|||
143446410|NCT04879849|517180660|FG005|Overall Study|Progressive Disease|0|||
143446411|NCT04879849|517180661|FG006|Overall Study|Progressive Disease|0|||
143446412|NCT04879849|517180662|FG007|Overall Study|Progressive Disease|0|||
143446413|NCT04879849|517180655|FG000|Overall Study|Death|0|||
143446414|NCT04879849|517180656|FG001|Overall Study|Death|0|||
143446415|NCT04879849|517180657|FG002|Overall Study|Death|1|||
143446416|NCT04879849|517180658|FG003|Overall Study|Death|1|||
143446417|NCT04879849|517180659|FG004|Overall Study|Death|1|||
143446418|NCT04879849|517180660|FG005|Overall Study|Death|2|||
143446419|NCT04879849|517180661|FG006|Overall Study|Death|1|||
143446420|NCT04879849|517180662|FG007|Overall Study|Death|2|||
143446421|NCT04879849|517180655|FG000|Overall Study|Completion of Follow-up Period and Assessments|0|||
143446422|NCT04879849|517180656|FG001|Overall Study|Completion of Follow-up Period and Assessments|1|||
143446423|NCT04879849|517180657|FG002|Overall Study|Completion of Follow-up Period and Assessments|0|||
143446424|NCT04879849|517180658|FG003|Overall Study|Completion of Follow-up Period and Assessments|1|||
143446425|NCT04879849|517180659|FG004|Overall Study|Completion of Follow-up Period and Assessments|3|||
143446426|NCT04879849|517180660|FG005|Overall Study|Completion of Follow-up Period and Assessments|2|||
143446427|NCT04879849|517180661|FG006|Overall Study|Completion of Follow-up Period and Assessments|0|||
143446428|NCT04879849|517180662|FG007|Overall Study|Completion of Follow-up Period and Assessments|0|||
143446429|NCT04879849|517180655|FG000|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
143446430|NCT04879849|517180656|FG001|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
143446431|NCT04879849|517180657|FG002|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
143446432|NCT04879849|517180658|FG003|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
143446433|NCT04879849|517180659|FG004|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
143446434|NCT04879849|517180660|FG005|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
143446435|NCT04879849|517180661|FG006|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|1|||
143446436|NCT04879849|517180662|FG007|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
143446437|NCT04879849|517180655|FG000|Overall Study|Reason Not Specified|1|||
143446438|NCT04879849|517180656|FG001|Overall Study|Reason Not Specified|0|||
143446439|NCT04879849|517180657|FG002|Overall Study|Reason Not Specified|0|||
143446440|NCT04879849|517180658|FG003|Overall Study|Reason Not Specified|0|||
143446441|NCT04879849|517180659|FG004|Overall Study|Reason Not Specified|0|||
143446442|NCT04879849|517180660|FG005|Overall Study|Reason Not Specified|0|||
143446443|NCT04879849|517180661|FG006|Overall Study|Reason Not Specified|0|||
143446444|NCT04879849|517180662|FG007|Overall Study|Reason Not Specified|0|||
143446445|NCT03361865|517180663|FG000|Overall Study|Death|17|||
143446446|NCT03361865|517180664|FG001|Overall Study|Death|18|||
143446447|NCT03361865|517180663|FG000|Overall Study|Physician Decision|1|||
143446448|NCT03361865|517180664|FG001|Overall Study|Physician Decision|9|||
143446449|NCT03361865|517180663|FG000|Overall Study|Withdrawal by Subject|1|||
143446450|NCT03361865|517180664|FG001|Overall Study|Withdrawal by Subject|0|||
143446451|NCT04201262|517180666|FG000|Primary Treatment Period|Adverse Event|1|||
143446452|NCT04201262|517180667|FG001|Primary Treatment Period|Adverse Event|2|||
143446453|NCT04201262|517180666|FG000|Primary Treatment Period|Physician Decision|1|||
143446454|NCT04201262|517180667|FG001|Primary Treatment Period|Physician Decision|1|||
143446455|NCT04201262|517180666|FG000|Long-term Extension Period|Death|1|||
143446456|NCT04201262|517180667|FG001|Long-term Extension Period|Death|0|||
143446457|NCT03307785|517180669|FG000|Part A: Up to 28.5 Months|Disease progression|2|||
143446458|NCT03307785|517180670|FG001|Part A: Up to 28.5 Months|Disease progression|0|||
143446459|NCT03307785|517180671|FG002|Part A: Up to 28.5 Months|Disease progression|0|||
143446460|NCT03307785|517180672|FG003|Part A: Up to 28.5 Months|Disease progression|0|||
143446461|NCT03307785|517180673|FG004|Part A: Up to 28.5 Months|Disease progression|0|||
143446462|NCT03307785|517180674|FG005|Part A: Up to 28.5 Months|Disease progression|0|||
143446463|NCT03307785|517180675|FG006|Part A: Up to 28.5 Months|Disease progression|0|||
143446464|NCT03307785|517180676|FG007|Part A: Up to 28.5 Months|Disease progression|0|||
143446465|NCT03307785|517180677|FG008|Part A: Up to 28.5 Months|Disease progression|0|||
143446466|NCT03307785|517180678|FG009|Part A: Up to 28.5 Months|Disease progression|0|||
143446467|NCT03307785|517180679|FG010|Part A: Up to 28.5 Months|Disease progression|0|||
143446468|NCT03307785|517180669|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
143446469|NCT03307785|517180670|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
143446470|NCT03307785|517180671|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
143446471|NCT03307785|517180672|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
143446472|NCT03307785|517180673|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
143446473|NCT03307785|517180674|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
143446474|NCT03307785|517180675|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
143446475|NCT03307785|517180676|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
143446476|NCT03307785|517180677|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
143446477|NCT03307785|517180678|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
143446478|NCT03307785|517180679|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
143446479|NCT03307785|517180669|FG000|Part A: Up to 28.5 Months|Death|4|||
143446480|NCT03307785|517180670|FG001|Part A: Up to 28.5 Months|Death|4|||
143446481|NCT03307785|517180671|FG002|Part A: Up to 28.5 Months|Death|0|||
143446482|NCT03307785|517180672|FG003|Part A: Up to 28.5 Months|Death|0|||
143446483|NCT03307785|517180673|FG004|Part A: Up to 28.5 Months|Death|0|||
143446484|NCT03307785|517180674|FG005|Part A: Up to 28.5 Months|Death|0|||
143446485|NCT03307785|517180675|FG006|Part A: Up to 28.5 Months|Death|0|||
143446486|NCT03307785|517180676|FG007|Part A: Up to 28.5 Months|Death|0|||
143446487|NCT03307785|517180677|FG008|Part A: Up to 28.5 Months|Death|0|||
143446488|NCT03307785|517180678|FG009|Part A: Up to 28.5 Months|Death|0|||
143446489|NCT03307785|517180679|FG010|Part A: Up to 28.5 Months|Death|0|||
143446490|NCT03307785|517180669|FG000|Part A: Up to 28.5 Months|Physician Decision|3|||
143446491|NCT03307785|517180670|FG001|Part A: Up to 28.5 Months|Physician Decision|1|||
143446492|NCT03307785|517180671|FG002|Part A: Up to 28.5 Months|Physician Decision|0|||
143446493|NCT03307785|517180672|FG003|Part A: Up to 28.5 Months|Physician Decision|0|||
143446494|NCT03307785|517180673|FG004|Part A: Up to 28.5 Months|Physician Decision|0|||
143446495|NCT03307785|517180674|FG005|Part A: Up to 28.5 Months|Physician Decision|0|||
143446496|NCT03307785|517180675|FG006|Part A: Up to 28.5 Months|Physician Decision|0|||
143446497|NCT03307785|517180676|FG007|Part A: Up to 28.5 Months|Physician Decision|0|||
143446498|NCT03307785|517180677|FG008|Part A: Up to 28.5 Months|Physician Decision|0|||
143446499|NCT03307785|517180678|FG009|Part A: Up to 28.5 Months|Physician Decision|0|||
143446500|NCT03307785|517180679|FG010|Part A: Up to 28.5 Months|Physician Decision|0|||
143446501|NCT03307785|517180669|FG000|Part B: Up to Approx. 66 Months|Disease progression|0|||
143446502|NCT03307785|517180670|FG001|Part B: Up to Approx. 66 Months|Disease progression|0|||
143446503|NCT03307785|517180671|FG002|Part B: Up to Approx. 66 Months|Disease progression|2|||
143446504|NCT03307785|517180672|FG003|Part B: Up to Approx. 66 Months|Disease progression|0|||
143446505|NCT03307785|517180673|FG004|Part B: Up to Approx. 66 Months|Disease progression|0|||
143446506|NCT03307785|517180674|FG005|Part B: Up to Approx. 66 Months|Disease progression|0|||
143446507|NCT03307785|517180675|FG006|Part B: Up to Approx. 66 Months|Disease progression|0|||
143446508|NCT03307785|517180676|FG007|Part B: Up to Approx. 66 Months|Disease progression|0|||
143446509|NCT03307785|517180677|FG008|Part B: Up to Approx. 66 Months|Disease progression|0|||
143446510|NCT03307785|517180678|FG009|Part B: Up to Approx. 66 Months|Disease progression|0|||
143446511|NCT03307785|517180679|FG010|Part B: Up to Approx. 66 Months|Disease progression|0|||
143446512|NCT03307785|517180669|FG000|Part B: Up to Approx. 66 Months|Death|0|||
143446513|NCT03307785|517180670|FG001|Part B: Up to Approx. 66 Months|Death|0|||
143446514|NCT03307785|517180671|FG002|Part B: Up to Approx. 66 Months|Death|7|||
143446515|NCT03307785|517180672|FG003|Part B: Up to Approx. 66 Months|Death|0|||
143446516|NCT03307785|517180673|FG004|Part B: Up to Approx. 66 Months|Death|0|||
143446517|NCT03307785|517180674|FG005|Part B: Up to Approx. 66 Months|Death|0|||
143446518|NCT03307785|517180675|FG006|Part B: Up to Approx. 66 Months|Death|0|||
143446519|NCT03307785|517180676|FG007|Part B: Up to Approx. 66 Months|Death|0|||
143446520|NCT03307785|517180677|FG008|Part B: Up to Approx. 66 Months|Death|0|||
143446521|NCT03307785|517180678|FG009|Part B: Up to Approx. 66 Months|Death|0|||
143446522|NCT03307785|517180679|FG010|Part B: Up to Approx. 66 Months|Death|0|||
143446523|NCT03307785|517180669|FG000|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
143446524|NCT03307785|517180670|FG001|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
143446525|NCT03307785|517180671|FG002|Part B: Up to Approx. 66 Months|Withdrawal by Subject|2|||
143446526|NCT03307785|517180672|FG003|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
143446527|NCT03307785|517180673|FG004|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
143446528|NCT03307785|517180674|FG005|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
143446529|NCT03307785|517180675|FG006|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
143446530|NCT03307785|517180676|FG007|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
143446531|NCT03307785|517180677|FG008|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
143446532|NCT03307785|517180678|FG009|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
143446533|NCT03307785|517180679|FG010|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
143446534|NCT03307785|517180669|FG000|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
143446535|NCT03307785|517180670|FG001|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
143446536|NCT03307785|517180671|FG002|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|2|||
143446537|NCT03307785|517180672|FG003|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
143446538|NCT03307785|517180673|FG004|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
143446539|NCT03307785|517180674|FG005|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
143446540|NCT03307785|517180675|FG006|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
143446541|NCT03307785|517180676|FG007|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
143446542|NCT03307785|517180677|FG008|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
143446543|NCT03307785|517180678|FG009|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
143446544|NCT03307785|517180679|FG010|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
143446545|NCT03307785|517180669|FG000|Part B: Up to Approx. 66 Months|Physician Decision|0|||
143446546|NCT03307785|517180670|FG001|Part B: Up to Approx. 66 Months|Physician Decision|0|||
143446547|NCT03307785|517180671|FG002|Part B: Up to Approx. 66 Months|Physician Decision|1|||
143446548|NCT03307785|517180672|FG003|Part B: Up to Approx. 66 Months|Physician Decision|0|||
143446549|NCT03307785|517180673|FG004|Part B: Up to Approx. 66 Months|Physician Decision|0|||
143446550|NCT03307785|517180674|FG005|Part B: Up to Approx. 66 Months|Physician Decision|0|||
143446551|NCT03307785|517180675|FG006|Part B: Up to Approx. 66 Months|Physician Decision|0|||
143446552|NCT03307785|517180676|FG007|Part B: Up to Approx. 66 Months|Physician Decision|0|||
143446553|NCT03307785|517180677|FG008|Part B: Up to Approx. 66 Months|Physician Decision|0|||
143446554|NCT03307785|517180678|FG009|Part B: Up to Approx. 66 Months|Physician Decision|0|||
143446555|NCT03307785|517180679|FG010|Part B: Up to Approx. 66 Months|Physician Decision|0|||
143446556|NCT03307785|517180669|FG000|Part C: Up to Approx. 60 Months|Physician Decision|0|||
143446557|NCT03307785|517180670|FG001|Part C: Up to Approx. 60 Months|Physician Decision|0|||
143446558|NCT03307785|517180671|FG002|Part C: Up to Approx. 60 Months|Physician Decision|0|||
143446559|NCT03307785|517180672|FG003|Part C: Up to Approx. 60 Months|Physician Decision|3|||
143446560|NCT03307785|517180673|FG004|Part C: Up to Approx. 60 Months|Physician Decision|1|||
143446561|NCT03307785|517180674|FG005|Part C: Up to Approx. 60 Months|Physician Decision|0|||
143446562|NCT03307785|517180675|FG006|Part C: Up to Approx. 60 Months|Physician Decision|0|||
143446563|NCT03307785|517180676|FG007|Part C: Up to Approx. 60 Months|Physician Decision|0|||
143446564|NCT03307785|517180677|FG008|Part C: Up to Approx. 60 Months|Physician Decision|0|||
143446565|NCT03307785|517180678|FG009|Part C: Up to Approx. 60 Months|Physician Decision|0|||
143446566|NCT03307785|517180679|FG010|Part C: Up to Approx. 60 Months|Physician Decision|0|||
143446567|NCT03307785|517180669|FG000|Part C: Up to Approx. 60 Months|Death|0|||
143446568|NCT03307785|517180670|FG001|Part C: Up to Approx. 60 Months|Death|0|||
143446569|NCT03307785|517180671|FG002|Part C: Up to Approx. 60 Months|Death|0|||
143446570|NCT03307785|517180672|FG003|Part C: Up to Approx. 60 Months|Death|2|||
143446571|NCT03307785|517180673|FG004|Part C: Up to Approx. 60 Months|Death|5|||
143446572|NCT03307785|517180674|FG005|Part C: Up to Approx. 60 Months|Death|0|||
143446573|NCT03307785|517180675|FG006|Part C: Up to Approx. 60 Months|Death|0|||
143446574|NCT03307785|517180676|FG007|Part C: Up to Approx. 60 Months|Death|0|||
143446575|NCT03307785|517180677|FG008|Part C: Up to Approx. 60 Months|Death|0|||
143446576|NCT03307785|517180678|FG009|Part C: Up to Approx. 60 Months|Death|0|||
143446577|NCT03307785|517180679|FG010|Part C: Up to Approx. 60 Months|Death|0|||
143446578|NCT03307785|517180669|FG000|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
143446579|NCT03307785|517180670|FG001|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
143446580|NCT03307785|517180671|FG002|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
143446581|NCT03307785|517180672|FG003|Part C: Up to Approx. 60 Months|Withdrawal by Subject|1|||
143446582|NCT03307785|517180673|FG004|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
143446583|NCT03307785|517180674|FG005|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
143446584|NCT03307785|517180675|FG006|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
143446585|NCT03307785|517180676|FG007|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
143446586|NCT03307785|517180677|FG008|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
143446587|NCT03307785|517180678|FG009|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
143446588|NCT03307785|517180679|FG010|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
143446589|NCT03307785|517180669|FG000|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
143446590|NCT03307785|517180670|FG001|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
143446591|NCT03307785|517180671|FG002|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
143446592|NCT03307785|517180672|FG003|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
143446593|NCT03307785|517180673|FG004|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|1|||
143446594|NCT03307785|517180674|FG005|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
143446595|NCT03307785|517180675|FG006|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
143446596|NCT03307785|517180676|FG007|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
143446597|NCT03307785|517180677|FG008|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
143446598|NCT03307785|517180678|FG009|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
143446599|NCT03307785|517180679|FG010|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
143446600|NCT03307785|517180669|FG000|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
143446601|NCT03307785|517180670|FG001|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
143446602|NCT03307785|517180671|FG002|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
143446603|NCT03307785|517180672|FG003|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
143446604|NCT03307785|517180673|FG004|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
143446605|NCT03307785|517180674|FG005|Part D: Up to Approx. 62.5 Months|Physician Decision|2|||
143446606|NCT03307785|517180675|FG006|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
143446607|NCT03307785|517180676|FG007|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
143446608|NCT03307785|517180677|FG008|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
143446609|NCT03307785|517180678|FG009|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
143446610|NCT03307785|517180679|FG010|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
143446611|NCT03307785|517180669|FG000|Part D: Up to Approx. 62.5 Months|Death|0|||
143446612|NCT03307785|517180670|FG001|Part D: Up to Approx. 62.5 Months|Death|0|||
143446613|NCT03307785|517180671|FG002|Part D: Up to Approx. 62.5 Months|Death|0|||
143446614|NCT03307785|517180672|FG003|Part D: Up to Approx. 62.5 Months|Death|0|||
143446615|NCT03307785|517180673|FG004|Part D: Up to Approx. 62.5 Months|Death|0|||
143446616|NCT03307785|517180674|FG005|Part D: Up to Approx. 62.5 Months|Death|1|||
143446617|NCT03307785|517180675|FG006|Part D: Up to Approx. 62.5 Months|Death|0|||
143446618|NCT03307785|517180676|FG007|Part D: Up to Approx. 62.5 Months|Death|0|||
143446619|NCT03307785|517180677|FG008|Part D: Up to Approx. 62.5 Months|Death|0|||
143446620|NCT03307785|517180678|FG009|Part D: Up to Approx. 62.5 Months|Death|0|||
143446621|NCT03307785|517180679|FG010|Part D: Up to Approx. 62.5 Months|Death|0|||
143446622|NCT03307785|517180669|FG000|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
143446623|NCT03307785|517180670|FG001|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
143446624|NCT03307785|517180671|FG002|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
143446625|NCT03307785|517180672|FG003|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
143446626|NCT03307785|517180673|FG004|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
143446627|NCT03307785|517180674|FG005|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|1|||
143446628|NCT03307785|517180675|FG006|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
143446629|NCT03307785|517180676|FG007|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
143446630|NCT03307785|517180677|FG008|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
143446631|NCT03307785|517180678|FG009|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
143446632|NCT03307785|517180679|FG010|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
143446633|NCT03307785|517180669|FG000|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
143446634|NCT03307785|517180670|FG001|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
143446635|NCT03307785|517180671|FG002|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
143446636|NCT03307785|517180672|FG003|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
143446637|NCT03307785|517180673|FG004|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
143446638|NCT03307785|517180674|FG005|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|1|||
143446639|NCT03307785|517180675|FG006|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
143446640|NCT03307785|517180676|FG007|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
143446641|NCT03307785|517180677|FG008|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
143446642|NCT03307785|517180678|FG009|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
143446643|NCT03307785|517180679|FG010|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
143446644|NCT03307785|517180669|FG000|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
143446645|NCT03307785|517180670|FG001|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
143446646|NCT03307785|517180671|FG002|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
143446647|NCT03307785|517180672|FG003|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
143446648|NCT03307785|517180673|FG004|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
143446649|NCT03307785|517180674|FG005|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|1|||
143446650|NCT03307785|517180675|FG006|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
143446651|NCT03307785|517180676|FG007|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
143446652|NCT03307785|517180677|FG008|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
143446653|NCT03307785|517180678|FG009|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
143446654|NCT03307785|517180679|FG010|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
143446655|NCT03307785|517180669|FG000|Part E: Up to 4.4 Months|Death|0|||
143446656|NCT03307785|517180670|FG001|Part E: Up to 4.4 Months|Death|0|||
143446657|NCT03307785|517180671|FG002|Part E: Up to 4.4 Months|Death|0|||
143446658|NCT03307785|517180672|FG003|Part E: Up to 4.4 Months|Death|0|||
143446659|NCT03307785|517180673|FG004|Part E: Up to 4.4 Months|Death|0|||
143446660|NCT03307785|517180674|FG005|Part E: Up to 4.4 Months|Death|0|||
143446661|NCT03307785|517180675|FG006|Part E: Up to 4.4 Months|Death|1|||
143446662|NCT03307785|517180676|FG007|Part E: Up to 4.4 Months|Death|0|||
143446663|NCT03307785|517180677|FG008|Part E: Up to 4.4 Months|Death|0|||
143446664|NCT03307785|517180678|FG009|Part E: Up to 4.4 Months|Death|0|||
143446665|NCT03307785|517180679|FG010|Part E: Up to 4.4 Months|Death|0|||
143446666|NCT03307785|517180669|FG000|Part E: Up to 4.4 Months|Physician Decision|0|||
143446667|NCT03307785|517180670|FG001|Part E: Up to 4.4 Months|Physician Decision|0|||
143446668|NCT03307785|517180671|FG002|Part E: Up to 4.4 Months|Physician Decision|0|||
143446669|NCT03307785|517180672|FG003|Part E: Up to 4.4 Months|Physician Decision|0|||
143446670|NCT03307785|517180673|FG004|Part E: Up to 4.4 Months|Physician Decision|0|||
143446671|NCT03307785|517180674|FG005|Part E: Up to 4.4 Months|Physician Decision|0|||
143446672|NCT03307785|517180675|FG006|Part E: Up to 4.4 Months|Physician Decision|1|||
143446673|NCT03307785|517180676|FG007|Part E: Up to 4.4 Months|Physician Decision|0|||
143446674|NCT03307785|517180677|FG008|Part E: Up to 4.4 Months|Physician Decision|0|||
143446675|NCT03307785|517180678|FG009|Part E: Up to 4.4 Months|Physician Decision|0|||
143446676|NCT03307785|517180679|FG010|Part E: Up to 4.4 Months|Physician Decision|0|||
143446677|NCT03307785|517180669|FG000|Part F: Up to 3.5 Months|Physician Decision|0|||
143446678|NCT03307785|517180670|FG001|Part F: Up to 3.5 Months|Physician Decision|0|||
143446679|NCT03307785|517180671|FG002|Part F: Up to 3.5 Months|Physician Decision|0|||
143446680|NCT03307785|517180672|FG003|Part F: Up to 3.5 Months|Physician Decision|0|||
143446681|NCT03307785|517180673|FG004|Part F: Up to 3.5 Months|Physician Decision|0|||
143446682|NCT03307785|517180674|FG005|Part F: Up to 3.5 Months|Physician Decision|0|||
143446683|NCT03307785|517180675|FG006|Part F: Up to 3.5 Months|Physician Decision|0|||
143446684|NCT03307785|517180676|FG007|Part F: Up to 3.5 Months|Physician Decision|1|||
143446685|NCT03307785|517180677|FG008|Part F: Up to 3.5 Months|Physician Decision|0|||
143446686|NCT03307785|517180678|FG009|Part F: Up to 3.5 Months|Physician Decision|0|||
143446687|NCT03307785|517180679|FG010|Part F: Up to 3.5 Months|Physician Decision|0|||
143446688|NCT04103892|517180680|FG000|Overall Study|Adverse Event|0|||
143446689|NCT04103892|517180681|FG001|Overall Study|Adverse Event|0|||
143446690|NCT04103892|517180682|FG002|Overall Study|Adverse Event|0|||
143446691|NCT04103892|517180683|FG003|Overall Study|Adverse Event|3|||
143446692|NCT04103892|517180680|FG000|Overall Study|Lost to Follow-up|0|||
143446693|NCT04103892|517180681|FG001|Overall Study|Lost to Follow-up|0|||
143446694|NCT04103892|517180682|FG002|Overall Study|Lost to Follow-up|2|||
143446695|NCT04103892|517180683|FG003|Overall Study|Lost to Follow-up|0|||
143446696|NCT04103892|517180680|FG000|Overall Study|Protocol Violation|0|||
143446697|NCT04103892|517180681|FG001|Overall Study|Protocol Violation|0|||
143446698|NCT04103892|517180682|FG002|Overall Study|Protocol Violation|1|||
143446699|NCT04103892|517180683|FG003|Overall Study|Protocol Violation|1|||
143446700|NCT04103892|517180680|FG000|Overall Study|Withdrawal by Subject|1|||
143446701|NCT04103892|517180681|FG001|Overall Study|Withdrawal by Subject|0|||
143446702|NCT04103892|517180682|FG002|Overall Study|Withdrawal by Subject|2|||
143446703|NCT04103892|517180683|FG003|Overall Study|Withdrawal by Subject|5|||
143446704|NCT04103892|517180680|FG000|Overall Study|Requirement of prohibited concomitant medication|0|||
143446705|NCT04103892|517180681|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
143446706|NCT04103892|517180682|FG002|Overall Study|Requirement of prohibited concomitant medication|1|||
143446707|NCT04103892|517180683|FG003|Overall Study|Requirement of prohibited concomitant medication|1|||
143446708|NCT02819024|517180684|FG000|Overall Study|Withdrawal by Subject|1|||
143446709|NCT05576662|517180685|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
143446710|NCT05576662|517180686|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
143446711|NCT05576662|517180685|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
143446712|NCT05576662|517180686|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
143446713|NCT05576662|517180685|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
143446714|NCT05576662|517180686|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
143446715|NCT05576662|517180685|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
143446716|NCT05576662|517180686|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
143446717|NCT03008005|517180694|FG000|Overall Study|Physician Decision|1|||
143446718|NCT03008005|517180695|FG001|Overall Study|Physician Decision|0|||
143446719|NCT03008005|517180696|FG002|Overall Study|Physician Decision|0|||
143446720|NCT03008005|517180694|FG000|Overall Study|Withdrawal by Subject|1|||
143446721|NCT03008005|517180695|FG001|Overall Study|Withdrawal by Subject|0|||
143446722|NCT03008005|517180696|FG002|Overall Study|Withdrawal by Subject|0|||
143446723|NCT03008005|517180694|FG000|Overall Study|Ineligible|0|||
143446724|NCT03008005|517180695|FG001|Overall Study|Ineligible|1|||
143446725|NCT03008005|517180696|FG002|Overall Study|Ineligible|0|||
143446726|NCT05217641|517180697|FG000|Overall Study|Lost to Follow-up|1|||
143446727|NCT05217641|517180698|FG001|Overall Study|Lost to Follow-up|1|||
143446728|NCT05217641|517180699|FG002|Overall Study|Lost to Follow-up|0|||
143446729|NCT05217641|517180700|FG003|Overall Study|Lost to Follow-up|1|||
143446730|NCT05217641|517180701|FG004|Overall Study|Lost to Follow-up|1|||
143446731|NCT05217641|517180702|FG005|Overall Study|Lost to Follow-up|0|||
143446732|NCT05217641|517180697|FG000|Overall Study|Withdrawal by Subject|0|||
143446733|NCT05217641|517180698|FG001|Overall Study|Withdrawal by Subject|0|||
143446734|NCT05217641|517180699|FG002|Overall Study|Withdrawal by Subject|0|||
143446735|NCT05217641|517180700|FG003|Overall Study|Withdrawal by Subject|3|||
143446736|NCT05217641|517180701|FG004|Overall Study|Withdrawal by Subject|1|||
143446737|NCT05217641|517180702|FG005|Overall Study|Withdrawal by Subject|0|||
143446738|NCT05217641|517180697|FG000|Overall Study|Other: participant did not specify reason|0|||
143446739|NCT05217641|517180698|FG001|Overall Study|Other: participant did not specify reason|0|||
143446740|NCT05217641|517180699|FG002|Overall Study|Other: participant did not specify reason|0|||
143446741|NCT05217641|517180700|FG003|Overall Study|Other: participant did not specify reason|0|||
143446742|NCT05217641|517180701|FG004|Overall Study|Other: participant did not specify reason|1|||
143446743|NCT05217641|517180702|FG005|Overall Study|Other: participant did not specify reason|0|||
143446744|NCT05217641|517180697|FG000|Overall Study|Extended Follow up|1|||
143446745|NCT05217641|517180698|FG001|Overall Study|Extended Follow up|1|||
143446746|NCT05217641|517180699|FG002|Overall Study|Extended Follow up|0|||
143446747|NCT05217641|517180700|FG003|Overall Study|Extended Follow up|0|||
143446748|NCT05217641|517180701|FG004|Overall Study|Extended Follow up|1|||
143446749|NCT05217641|517180702|FG005|Overall Study|Extended Follow up|0|||
143446750|NCT03007420|517180708|FG000|Overall Study|Withdrawal by Subject|0|||
143446751|NCT03007420|517180709|FG001|Overall Study|Withdrawal by Subject|2|||
143446752|NCT03007420|517180708|FG000|Overall Study|Physician Decision|0|||
143446753|NCT03007420|517180709|FG001|Overall Study|Physician Decision|1|||
143446754|NCT05823012|517180710|FG000|Titration Period|Adverse Event|1|||
143446755|NCT05823012|517180710|FG000|Titration Period|Inability to Achieve a tolerable replacement dosage|3|||
143446756|NCT05823012|517180710|FG000|Maintenance Period|Adverse Event|1|||
143446757|NCT05823012|517180710|FG000|Maintenance Period|Inability to achieve a tolerable replacement dosage|1|||
143446758|NCT05823012|517180710|FG000|Maintenance Period|Inability to achieve an adequate replacement dosage|1|||
143446759|NCT03301155|517182150|FG000|Overall Study|Сompliance with exclusion criteria|8|||
143446760|NCT03301155|517182151|FG001|Overall Study|Сompliance with exclusion criteria|7|||
143446761|NCT04421950|517182154|FG000|Overall Study|Dropped or lost to follow up|4|||
143446762|NCT04421950|517182155|FG001|Overall Study|Dropped or lost to follow up|2|||
143446763|NCT00335140|517182158|FG000|Overall Study|Ineligible|1|||
143446764|NCT04546425|517182159|FG000|Overall Study|Protocol Violation|1|||
143446765|NCT04546425|517182160|FG001|Overall Study|Protocol Violation|1|||
143446766|NCT04546425|517182161|FG002|Overall Study|Protocol Violation|0|||
143446767|NCT04546425|517182162|FG003|Overall Study|Protocol Violation|0|||
143446768|NCT04546425|517182159|FG000|Overall Study|Adverse Event|3|||
143446769|NCT04546425|517182160|FG001|Overall Study|Adverse Event|0|||
143446770|NCT04546425|517182161|FG002|Overall Study|Adverse Event|0|||
143446771|NCT04546425|517182162|FG003|Overall Study|Adverse Event|0|||
143446772|NCT04546425|517182159|FG000|Overall Study|Lost to Follow-up|5|||
143446773|NCT04546425|517182160|FG001|Overall Study|Lost to Follow-up|4|||
143446774|NCT04546425|517182161|FG002|Overall Study|Lost to Follow-up|0|||
143446775|NCT04546425|517182162|FG003|Overall Study|Lost to Follow-up|0|||
143446776|NCT04546425|517182159|FG000|Overall Study|No Longer met eligibility criteria|3|||
143446777|NCT04546425|517182160|FG001|Overall Study|No Longer met eligibility criteria|3|||
143446778|NCT04546425|517182161|FG002|Overall Study|No Longer met eligibility criteria|1|||
143446779|NCT04546425|517182162|FG003|Overall Study|No Longer met eligibility criteria|1|||
143446780|NCT04546425|517182159|FG000|Overall Study|Withdrawal by parent/guardian|6|||
143446781|NCT04546425|517182160|FG001|Overall Study|Withdrawal by parent/guardian|5|||
143446782|NCT04546425|517182161|FG002|Overall Study|Withdrawal by parent/guardian|1|||
143446783|NCT04546425|517182162|FG003|Overall Study|Withdrawal by parent/guardian|1|||
143446784|NCT01125046|517182170|FG000|First 6 Months of Treatment|Death|1|||
143446785|NCT01125046|517182170|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
143446786|NCT01125046|517182170|FG000|First 6 Months of Treatment|Non-compliance|1|||
143446787|NCT01125046|517182170|FG000|First 6 Months of Treatment|Surgery|1|||
143446788|NCT01125046|517182170|FG000|First 6 Months of Treatment|Progressive Disease|7|||
143446789|NCT01125046|517182170|FG000|First 6 Months of Treatment|Adverse Event|2|||
143446790|NCT01125046|517182170|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
143446791|NCT01125046|517182170|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
143446792|NCT01125046|517182170|FG000|Follow-up/Data Cut Off Point|Death|29|||
143446793|NCT01125046|517182170|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
143446794|NCT01685229|517182171|FG000|Overall Study|Subjects missing Study Exit form|3|||
143446795|NCT01685229|517182172|FG001|Overall Study|Subjects missing Study Exit form|1|||
143446796|NCT01685229|517182171|FG000|Overall Study|Lost to Follow-up|16|||
143446797|NCT01685229|517182172|FG001|Overall Study|Lost to Follow-up|10|||
143446798|NCT01685229|517182171|FG000|Overall Study|Withdrawal by Subject|6|||
143446799|NCT01685229|517182172|FG001|Overall Study|Withdrawal by Subject|5|||
143446800|NCT01685229|517182171|FG000|Overall Study|Death|1|||
143446801|NCT01685229|517182172|FG001|Overall Study|Death|0|||
143446802|NCT02766777|517182173|FG000|Overall Study|Adverse Event|12|||
143446803|NCT02766777|517182173|FG000|Overall Study|Lost to Follow-up|16|||
143446804|NCT02766777|517182173|FG000|Overall Study|Non-Compliance With Study Drug|1|||
143446805|NCT02766777|517182173|FG000|Overall Study|Protocol Violation|1|||
143446806|NCT02766777|517182173|FG000|Overall Study|Withdrawal by Subject|4|||
143446807|NCT00534495|517182176|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
143446808|NCT00534495|517182177|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
143446809|NCT00534495|517182178|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
143446810|NCT00534495|517182176|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
143446811|NCT00534495|517182177|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
143446812|NCT00534495|517182178|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
143446813|NCT00534495|517182176|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
143446814|NCT00534495|517182177|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
143446815|NCT00534495|517182178|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
143446816|NCT00534495|517182176|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
143446817|NCT00534495|517182177|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
143446818|NCT00534495|517182178|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
143446819|NCT00534495|517182176|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
143446820|NCT00534495|517182177|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
143446821|NCT00534495|517182178|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
143446822|NCT00534495|517182176|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
143446823|NCT00534495|517182177|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
143446824|NCT00534495|517182178|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
143446825|NCT00534495|517182176|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
143446826|NCT00534495|517182177|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
143446827|NCT00534495|517182178|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
143446828|NCT00534495|517182176|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
143446829|NCT00534495|517182177|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
143446830|NCT00534495|517182178|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
143446831|NCT00534495|517182176|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
143446832|NCT00534495|517182177|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
143446833|NCT00534495|517182178|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
143446834|NCT04868539|517182179|FG000|Overall Study|Unable to complete study due to poor IV access|1|||
143446835|NCT04868539|517182180|FG001|Overall Study|Unable to complete study due to poor IV access|1|||
143446836|NCT01572740|517182181|FG000|Overall Study|Adverse Event|1|||
143446837|NCT01572740|517182182|FG001|Overall Study|Adverse Event|1|||
143446838|NCT01572740|517182181|FG000|Overall Study|Withdrawal by Subject|1|||
143446839|NCT01572740|517182182|FG001|Overall Study|Withdrawal by Subject|1|||
143446840|NCT01572740|517182181|FG000|Overall Study|unclassified|4|||
143446841|NCT01572740|517182182|FG001|Overall Study|unclassified|3|||
143446842|NCT01289210|517182185|FG000|Overall Study|Adverse Event|1|||
143446843|NCT01401153|517182186|FG000|First Test Day|Learning disabilities; illness|1|||
143446844|NCT01401153|517182187|FG001|First Test Day|Learning disabilities; illness|10|||
143446845|NCT01401153|517182186|FG000|Second Test Day|illness|0|||
143446846|NCT01401153|517182187|FG001|Second Test Day|illness|5|||
143446847|NCT01818531|517182190|FG000|Overall Study|Withdrawn for case delay after block|1|||
143446848|NCT01818531|517182191|FG001|Overall Study|Withdrawn for case delay after block|0|||
143446849|NCT01818531|517182190|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
143446850|NCT01818531|517182191|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
143446851|NCT01818531|517182190|FG000|Overall Study|Withdrawn for failure to place block|0|||
143446852|NCT01818531|517182191|FG001|Overall Study|Withdrawn for failure to place block|1|||
143446853|NCT00214019|517182192|FG000|Overall Study|Lost to Follow-up|11|||
143446854|NCT00214019|517182192|FG000|Overall Study|Withdrawal by Subject|2|||
143446855|NCT00214019|517182192|FG000|Overall Study|Screen Failed prior to randomization|17|||
143446856|NCT01465763|517182195|FG000|Overall Study|Withdrawal by Subject|4|||
143446857|NCT01465763|517182196|FG001|Overall Study|Withdrawal by Subject|0|||
143446858|NCT01465763|517182197|FG002|Overall Study|Withdrawal by Subject|1|||
143446859|NCT01465763|517182195|FG000|Overall Study|Insufficient Clinical Response|11|||
143446860|NCT01465763|517182196|FG001|Overall Study|Insufficient Clinical Response|0|||
143446861|NCT01465763|517182197|FG002|Overall Study|Insufficient Clinical Response|1|||
143446862|NCT01465763|517182195|FG000|Overall Study|Adverse Event|9|||
143446863|NCT01465763|517182196|FG001|Overall Study|Adverse Event|0|||
143446864|NCT01465763|517182197|FG002|Overall Study|Adverse Event|1|||
143446865|NCT01465763|517182195|FG000|Overall Study|Other|2|||
143446866|NCT01465763|517182196|FG001|Overall Study|Other|0|||
143446867|NCT01465763|517182197|FG002|Overall Study|Other|0|||
143446868|NCT01465763|517182195|FG000|Overall Study|Protocol Violation|4|||
143446869|NCT01465763|517182196|FG001|Overall Study|Protocol Violation|1|||
143446870|NCT01465763|517182197|FG002|Overall Study|Protocol Violation|1|||
143446871|NCT01465763|517182195|FG000|Overall Study|Death|1|||
143446872|NCT01465763|517182196|FG001|Overall Study|Death|0|||
143446873|NCT01465763|517182197|FG002|Overall Study|Death|0|||
143446874|NCT03635099|517182198|FG000|Period 1|Adverse Event|1|||
143446875|NCT03635099|517182199|FG001|Period 1|Adverse Event|0|||
143446876|NCT03635099|517182200|FG002|Period 1|Adverse Event|0|||
143446877|NCT03635099|517182201|FG003|Period 1|Adverse Event|1|||
143446878|NCT03635099|517182202|FG004|Period 1|Adverse Event|0|||
143446879|NCT03635099|517182203|FG005|Period 1|Adverse Event|0|||
143446880|NCT03635099|517182204|FG006|Period 1|Adverse Event|0|||
143446881|NCT03635099|517182205|FG007|Period 1|Adverse Event|0|||
143446882|NCT03635099|517182198|FG000|Period 1|Protocol Violation|0|||
143446883|NCT03635099|517182199|FG001|Period 1|Protocol Violation|0|||
143446884|NCT03635099|517182200|FG002|Period 1|Protocol Violation|1|||
143446885|NCT03635099|517182201|FG003|Period 1|Protocol Violation|0|||
143446886|NCT03635099|517182202|FG004|Period 1|Protocol Violation|0|||
143446887|NCT03635099|517182203|FG005|Period 1|Protocol Violation|0|||
143446888|NCT03635099|517182204|FG006|Period 1|Protocol Violation|0|||
143446889|NCT03635099|517182205|FG007|Period 1|Protocol Violation|0|||
143446890|NCT03635099|517182198|FG000|Period 1|Lost to Follow-up|0|||
143446891|NCT03635099|517182199|FG001|Period 1|Lost to Follow-up|0|||
143446892|NCT03635099|517182200|FG002|Period 1|Lost to Follow-up|1|||
143446893|NCT03635099|517182201|FG003|Period 1|Lost to Follow-up|2|||
143446894|NCT03635099|517182202|FG004|Period 1|Lost to Follow-up|1|||
143446895|NCT03635099|517182203|FG005|Period 1|Lost to Follow-up|0|||
143446896|NCT03635099|517182204|FG006|Period 1|Lost to Follow-up|1|||
143446897|NCT03635099|517182205|FG007|Period 1|Lost to Follow-up|2|||
143446898|NCT03635099|517182198|FG000|Period 1|Withdrawal by Subject|3|||
143446899|NCT03635099|517182199|FG001|Period 1|Withdrawal by Subject|3|||
143446900|NCT03635099|517182200|FG002|Period 1|Withdrawal by Subject|5|||
143446901|NCT03635099|517182201|FG003|Period 1|Withdrawal by Subject|2|||
143446902|NCT03635099|517182202|FG004|Period 1|Withdrawal by Subject|2|||
143446903|NCT03635099|517182203|FG005|Period 1|Withdrawal by Subject|0|||
143446904|NCT03635099|517182204|FG006|Period 1|Withdrawal by Subject|3|||
143446905|NCT03635099|517182205|FG007|Period 1|Withdrawal by Subject|0|||
143446906|NCT03635099|517182198|FG000|Period 1|History of suicidal ideation|0|||
143446907|NCT03635099|517182199|FG001|Period 1|History of suicidal ideation|0|||
143446908|NCT03635099|517182200|FG002|Period 1|History of suicidal ideation|1|||
143446909|NCT03635099|517182201|FG003|Period 1|History of suicidal ideation|0|||
143446910|NCT03635099|517182202|FG004|Period 1|History of suicidal ideation|0|||
143446911|NCT03635099|517182203|FG005|Period 1|History of suicidal ideation|0|||
143446912|NCT03635099|517182204|FG006|Period 1|History of suicidal ideation|0|||
143446913|NCT03635099|517182205|FG007|Period 1|History of suicidal ideation|0|||
143446914|NCT03635099|517182198|FG000|Period 1|pursue other treatment options|0|||
143446915|NCT03635099|517182199|FG001|Period 1|pursue other treatment options|0|||
143446916|NCT03635099|517182200|FG002|Period 1|pursue other treatment options|0|||
143446917|NCT03635099|517182201|FG003|Period 1|pursue other treatment options|0|||
143446918|NCT03635099|517182202|FG004|Period 1|pursue other treatment options|0|||
143446919|NCT03635099|517182203|FG005|Period 1|pursue other treatment options|1|||
143446920|NCT03635099|517182204|FG006|Period 1|pursue other treatment options|0|||
143446921|NCT03635099|517182205|FG007|Period 1|pursue other treatment options|0|||
143446922|NCT03635099|517182198|FG000|Not Eligible for Period 2|Pregnancy|0|||
143446923|NCT03635099|517182199|FG001|Not Eligible for Period 2|Pregnancy|0|||
143446924|NCT03635099|517182200|FG002|Not Eligible for Period 2|Pregnancy|0|||
143446925|NCT03635099|517182201|FG003|Not Eligible for Period 2|Pregnancy|1|||
143446926|NCT03635099|517182202|FG004|Not Eligible for Period 2|Pregnancy|0|||
143446927|NCT03635099|517182203|FG005|Not Eligible for Period 2|Pregnancy|0|||
143446928|NCT03635099|517182204|FG006|Not Eligible for Period 2|Pregnancy|0|||
143446929|NCT03635099|517182205|FG007|Not Eligible for Period 2|Pregnancy|0|||
143446930|NCT03635099|517182198|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
143446931|NCT03635099|517182199|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
143446932|NCT03635099|517182200|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
143446933|NCT03635099|517182201|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
143446934|NCT03635099|517182202|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
143446935|NCT03635099|517182203|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
143446936|NCT03635099|517182204|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
143446937|NCT03635099|517182205|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
143446938|NCT03635099|517182198|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
143446939|NCT03635099|517182199|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
143446940|NCT03635099|517182200|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
143446941|NCT03635099|517182201|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
143446942|NCT03635099|517182202|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
143446943|NCT03635099|517182203|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
143446944|NCT03635099|517182204|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
143446945|NCT03635099|517182205|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
143446946|NCT03635099|517182198|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
143446947|NCT03635099|517182199|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
143446948|NCT03635099|517182200|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
143446949|NCT03635099|517182201|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
143446950|NCT03635099|517182202|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
143446951|NCT03635099|517182203|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
143446952|NCT03635099|517182204|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
143446953|NCT03635099|517182205|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
143446954|NCT03635099|517182198|FG000|Period 2|Adverse Event|0|||
143446955|NCT03635099|517182199|FG001|Period 2|Adverse Event|0|||
143446956|NCT03635099|517182200|FG002|Period 2|Adverse Event|1|||
143446957|NCT03635099|517182201|FG003|Period 2|Adverse Event|0|||
143446958|NCT03635099|517182202|FG004|Period 2|Adverse Event|1|||
143446959|NCT03635099|517182203|FG005|Period 2|Adverse Event|0|||
143446960|NCT03635099|517182204|FG006|Period 2|Adverse Event|0|||
143446961|NCT03635099|517182205|FG007|Period 2|Adverse Event|0|||
143446962|NCT03635099|517182198|FG000|Period 2|Lost to Follow-up|0|||
143446963|NCT03635099|517182199|FG001|Period 2|Lost to Follow-up|0|||
143446964|NCT03635099|517182200|FG002|Period 2|Lost to Follow-up|1|||
143446965|NCT03635099|517182201|FG003|Period 2|Lost to Follow-up|0|||
143446966|NCT03635099|517182202|FG004|Period 2|Lost to Follow-up|4|||
143446967|NCT03635099|517182203|FG005|Period 2|Lost to Follow-up|0|||
143446968|NCT03635099|517182204|FG006|Period 2|Lost to Follow-up|0|||
143446969|NCT03635099|517182205|FG007|Period 2|Lost to Follow-up|0|||
143446970|NCT03635099|517182198|FG000|Period 2|Withdrawal by Subject|0|||
143446971|NCT03635099|517182199|FG001|Period 2|Withdrawal by Subject|0|||
143446972|NCT03635099|517182200|FG002|Period 2|Withdrawal by Subject|7|||
143446973|NCT03635099|517182201|FG003|Period 2|Withdrawal by Subject|4|||
143446974|NCT03635099|517182202|FG004|Period 2|Withdrawal by Subject|7|||
143446975|NCT03635099|517182203|FG005|Period 2|Withdrawal by Subject|0|||
143446976|NCT03635099|517182204|FG006|Period 2|Withdrawal by Subject|0|||
143446977|NCT03635099|517182205|FG007|Period 2|Withdrawal by Subject|0|||
143446978|NCT01068665|517182206|FG000|Overall Study|Adverse Event|5|||
143446979|NCT01068665|517182207|FG001|Overall Study|Adverse Event|4|||
143446980|NCT01068665|517182206|FG000|Overall Study|Lack of Efficacy|0|||
143446981|NCT01068665|517182207|FG001|Overall Study|Lack of Efficacy|2|||
143446982|NCT01068665|517182206|FG000|Overall Study|Protocol Violation|5|||
143446983|NCT01068665|517182207|FG001|Overall Study|Protocol Violation|2|||
143446984|NCT01068665|517182206|FG000|Overall Study|Withdrawal Criteria|3|||
143446985|NCT01068665|517182207|FG001|Overall Study|Withdrawal Criteria|9|||
143446986|NCT01068665|517182206|FG000|Overall Study|Other|17|||
143446987|NCT01068665|517182207|FG001|Overall Study|Other|12|||
143446988|NCT02807272|517182211|FG000|Overall Study|Death|9|||
143446989|NCT02807272|517182212|FG001|Overall Study|Death|5|||
143446990|NCT02807272|517182213|FG002|Overall Study|Death|2|||
143446991|NCT02807272|517182214|FG003|Overall Study|Death|0|||
143446992|NCT02807272|517182215|FG004|Overall Study|Death|1|||
143446993|NCT02807272|517182211|FG000|Overall Study|Lost to Follow-up|1|||
143446994|NCT02807272|517182212|FG001|Overall Study|Lost to Follow-up|0|||
143446995|NCT02807272|517182213|FG002|Overall Study|Lost to Follow-up|0|||
143446996|NCT02807272|517182214|FG003|Overall Study|Lost to Follow-up|0|||
143446997|NCT02807272|517182215|FG004|Overall Study|Lost to Follow-up|0|||
143446998|NCT02807272|517182211|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
143446999|NCT02807272|517182212|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
143447000|NCT02807272|517182213|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
143447001|NCT02807272|517182214|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
143447002|NCT02807272|517182215|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
143447003|NCT02807272|517182211|FG000|Overall Study|Protocol-defined Disease Progression|0|||
143447004|NCT02807272|517182212|FG001|Overall Study|Protocol-defined Disease Progression|1|||
143447005|NCT02807272|517182213|FG002|Overall Study|Protocol-defined Disease Progression|0|||
143447006|NCT02807272|517182214|FG003|Overall Study|Protocol-defined Disease Progression|0|||
143447007|NCT02807272|517182215|FG004|Overall Study|Protocol-defined Disease Progression|1|||
143447008|NCT02807272|517182211|FG000|Overall Study|Study Terminated by Sponsor|1|||
143447009|NCT02807272|517182212|FG001|Overall Study|Study Terminated by Sponsor|0|||
143447010|NCT02807272|517182213|FG002|Overall Study|Study Terminated by Sponsor|0|||
143447011|NCT02807272|517182214|FG003|Overall Study|Study Terminated by Sponsor|1|||
143447012|NCT02807272|517182215|FG004|Overall Study|Study Terminated by Sponsor|0|||
143447013|NCT02807272|517182211|FG000|Overall Study|Other|1|||
143447014|NCT02807272|517182212|FG001|Overall Study|Other|0|||
143447015|NCT02807272|517182213|FG002|Overall Study|Other|0|||
143447016|NCT02807272|517182214|FG003|Overall Study|Other|0|||
143447017|NCT02807272|517182215|FG004|Overall Study|Other|1|||
143447018|NCT04191616|517182217|FG000|Pre-assignment Period|Did not receive study treatment|2|||
143447019|NCT04191616|517182217|FG000|Treatment Period|Death|37|||
143447020|NCT04191616|517182217|FG000|Treatment Period|Sponsor decision|11|||
143447021|NCT04191616|517182217|FG000|Treatment Period|Withdrawal by Subject|4|||
143447022|NCT01038427|517182218|FG000|Overall Study|Lost to follow up|1|||
143447023|NCT01038427|517182219|FG001|Overall Study|Lost to follow up|1|||
143447024|NCT01038427|517182220|FG002|Overall Study|Lost to follow up|0|||
143447025|NCT01038427|517182218|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
143447026|NCT01038427|517182219|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
143447027|NCT01038427|517182220|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
143447028|NCT01038427|517182218|FG000|Overall Study|Withdrew consent|0|||
143447029|NCT01038427|517182219|FG001|Overall Study|Withdrew consent|0|||
143447030|NCT01038427|517182220|FG002|Overall Study|Withdrew consent|1|||
143447031|NCT01038427|517182218|FG000|Overall Study|Adverse Event|2|||
143447032|NCT01038427|517182219|FG001|Overall Study|Adverse Event|2|||
143447033|NCT01038427|517182220|FG002|Overall Study|Adverse Event|1|||
143447034|NCT01038427|517182218|FG000|Overall Study|Enrolled in error|0|||
143447035|NCT01038427|517182219|FG001|Overall Study|Enrolled in error|1|||
143447036|NCT01038427|517182220|FG002|Overall Study|Enrolled in error|1|||
143447037|NCT01038427|517182218|FG000|Overall Study|Other|0|||
143447038|NCT01038427|517182219|FG001|Overall Study|Other|2|||
143447039|NCT01038427|517182220|FG002|Overall Study|Other|0|||
143447040|NCT01162863|517182221|FG000|Overall Study|Lack of Efficacy|1|||
143447041|NCT01162863|517182222|FG001|Overall Study|Lack of Efficacy|0|||
143447042|NCT01162863|517182223|FG002|Overall Study|Lack of Efficacy|0|||
143447043|NCT01162863|517182221|FG000|Overall Study|Adverse Event|0|||
143447044|NCT01162863|517182222|FG001|Overall Study|Adverse Event|1|||
143447045|NCT01162863|517182223|FG002|Overall Study|Adverse Event|0|||
143447046|NCT02992691|517182224|FG000|Overall Study|Adverse Event|2|||
143447047|NCT02992691|517182224|FG000|Overall Study|Withdrawal by Subject|1|||
143447048|NCT00588692|517182225|FG000|Overall Study|Withdrawal by Subject|4|||
143447049|NCT00588692|517182226|FG001|Overall Study|Withdrawal by Subject|2|||
143447050|NCT00588692|517182225|FG000|Overall Study|Hip Surgery|0|||
143447051|NCT00588692|517182226|FG001|Overall Study|Hip Surgery|1|||
143447052|NCT00588692|517182225|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
143447053|NCT00588692|517182226|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
143447054|NCT00588692|517182225|FG000|Overall Study|Cancer|1|||
143447055|NCT00588692|517182226|FG001|Overall Study|Cancer|0|||
143447056|NCT00588692|517182225|FG000|Overall Study|Death|1|||
143447057|NCT00588692|517182226|FG001|Overall Study|Death|0|||
143447058|NCT00392925|517182228|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
143447059|NCT00392925|517182229|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
143447060|NCT00392925|517182230|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
143447061|NCT00392925|517182231|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
143447062|NCT00392925|517182228|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
143447063|NCT00392925|517182229|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
143447064|NCT00392925|517182230|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
143447065|NCT00392925|517182231|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
143447066|NCT00392925|517182228|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
143447067|NCT00392925|517182229|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
143447068|NCT00392925|517182230|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
143447069|NCT00392925|517182231|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
143447070|NCT00392925|517182228|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
143447071|NCT00392925|517182229|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
143447072|NCT00392925|517182230|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
143447073|NCT00392925|517182231|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
143447074|NCT00392925|517182228|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
143447075|NCT00392925|517182229|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
143447076|NCT00392925|517182230|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
143447077|NCT00392925|517182231|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
143447078|NCT00392925|517182228|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
143447079|NCT00392925|517182229|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
143447080|NCT00392925|517182230|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
143447081|NCT00392925|517182231|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
143447082|NCT00392925|517182228|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
143447083|NCT00392925|517182229|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
143447084|NCT00392925|517182230|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
143447085|NCT00392925|517182231|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
143447086|NCT00392925|517182228|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
143447087|NCT00392925|517182229|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
143447088|NCT00392925|517182230|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
143447089|NCT00392925|517182231|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
143447090|NCT00392925|517182228|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
143447091|NCT00392925|517182229|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
143447092|NCT00392925|517182230|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
143447093|NCT00392925|517182231|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
143447094|NCT04230122|517182232|FG000|Overall Study|Lost to Follow-up|1|||
143447095|NCT04230122|517182233|FG001|Overall Study|Lost to Follow-up|0|||
143447096|NCT00820170|517182235|FG000|Overall Study|Adverse Event|0|||
143447097|NCT00820170|517182236|FG001|Overall Study|Adverse Event|0|||
143447098|NCT00820170|517182237|FG002|Overall Study|Adverse Event|0|||
143447099|NCT00820170|517182238|FG003|Overall Study|Adverse Event|0|||
143447100|NCT00820170|517182239|FG004|Overall Study|Adverse Event|2|||
143447101|NCT00820170|517182235|FG000|Overall Study|Progressive Disease|0|||
143447102|NCT00820170|517182236|FG001|Overall Study|Progressive Disease|0|||
143447103|NCT00820170|517182237|FG002|Overall Study|Progressive Disease|0|||
143447104|NCT00820170|517182238|FG003|Overall Study|Progressive Disease|0|||
143447105|NCT00820170|517182239|FG004|Overall Study|Progressive Disease|2|||
143447106|NCT03538938|517182242|FG000|Overall Study|Death|0|||
143447107|NCT03538938|517182243|FG001|Overall Study|Death|0|||
143447108|NCT03538938|517182244|FG002|Overall Study|Death|2|||
143447109|NCT03538938|517182245|FG003|Overall Study|Death|0|||
143447110|NCT03538938|517182246|FG004|Overall Study|Death|0|||
143447111|NCT03538938|517182247|FG005|Overall Study|Death|1|||
143447112|NCT03538938|517182248|FG006|Overall Study|Death|0|||
143447113|NCT03538938|517182249|FG007|Overall Study|Death|1|||
143447114|NCT03538938|517182250|FG008|Overall Study|Death|1|||
143447115|NCT03538938|517182251|FG009|Overall Study|Death|1|||
143447116|NCT03538938|517182252|FG010|Overall Study|Death|0|||
143447117|NCT03538938|517182253|FG011|Overall Study|Death|0|||
143447118|NCT03538938|517182254|FG012|Overall Study|Death|1|||
143447119|NCT03538938|517182255|FG013|Overall Study|Death|1|||
143447120|NCT03538938|517182256|FG014|Overall Study|Death|0|||
143447121|NCT03538938|517182257|FG015|Overall Study|Death|1|||
143447122|NCT03538938|517182242|FG000|Overall Study|Withdrawal by Subject|4|||
143447123|NCT03538938|517182243|FG001|Overall Study|Withdrawal by Subject|6|||
143447124|NCT03538938|517182244|FG002|Overall Study|Withdrawal by Subject|5|||
143447125|NCT03538938|517182245|FG003|Overall Study|Withdrawal by Subject|3|||
143447126|NCT03538938|517182246|FG004|Overall Study|Withdrawal by Subject|0|||
143447127|NCT03538938|517182247|FG005|Overall Study|Withdrawal by Subject|0|||
143447128|NCT03538938|517182248|FG006|Overall Study|Withdrawal by Subject|3|||
143447129|NCT03538938|517182249|FG007|Overall Study|Withdrawal by Subject|1|||
143447130|NCT03538938|517182250|FG008|Overall Study|Withdrawal by Subject|5|||
143447131|NCT03538938|517182251|FG009|Overall Study|Withdrawal by Subject|1|||
143447132|NCT03538938|517182252|FG010|Overall Study|Withdrawal by Subject|2|||
143447133|NCT03538938|517182253|FG011|Overall Study|Withdrawal by Subject|1|||
143447134|NCT03538938|517182254|FG012|Overall Study|Withdrawal by Subject|3|||
143447135|NCT03538938|517182255|FG013|Overall Study|Withdrawal by Subject|0|||
143447136|NCT03538938|517182256|FG014|Overall Study|Withdrawal by Subject|2|||
143447137|NCT03538938|517182257|FG015|Overall Study|Withdrawal by Subject|4|||
143447138|NCT03538938|517182242|FG000|Overall Study|Incarcerated|0|||
143447139|NCT03538938|517182243|FG001|Overall Study|Incarcerated|0|||
143447140|NCT03538938|517182244|FG002|Overall Study|Incarcerated|0|||
143447141|NCT03538938|517182245|FG003|Overall Study|Incarcerated|0|||
143447142|NCT03538938|517182246|FG004|Overall Study|Incarcerated|0|||
143447143|NCT03538938|517182247|FG005|Overall Study|Incarcerated|0|||
143447144|NCT03538938|517182248|FG006|Overall Study|Incarcerated|0|||
143447145|NCT03538938|517182249|FG007|Overall Study|Incarcerated|0|||
143447146|NCT03538938|517182250|FG008|Overall Study|Incarcerated|0|||
143447147|NCT03538938|517182251|FG009|Overall Study|Incarcerated|0|||
143447148|NCT03538938|517182252|FG010|Overall Study|Incarcerated|0|||
143447149|NCT03538938|517182253|FG011|Overall Study|Incarcerated|1|||
143447150|NCT03538938|517182254|FG012|Overall Study|Incarcerated|0|||
143447151|NCT03538938|517182255|FG013|Overall Study|Incarcerated|0|||
143447152|NCT03538938|517182256|FG014|Overall Study|Incarcerated|0|||
143447153|NCT03538938|517182257|FG015|Overall Study|Incarcerated|0|||
143447154|NCT03995316|517182259|FG000|Overall Study|Lost to Follow-up|10|||
143447155|NCT03995316|517182260|FG001|Overall Study|Lost to Follow-up|3|||
143447156|NCT01137578|517182261|FG000|Overall Study|Participant requested to Discontinue|3|||
143447157|NCT01137578|517182262|FG001|Overall Study|Participant requested to Discontinue|0|||
143447158|NCT01137578|517182263|FG002|Overall Study|Participant requested to Discontinue|0|||
143447159|NCT01137578|517182261|FG000|Overall Study|Withdrawal by Subject|1|||
143447160|NCT01137578|517182262|FG001|Overall Study|Withdrawal by Subject|0|||
143447161|NCT01137578|517182263|FG002|Overall Study|Withdrawal by Subject|0|||
143447162|NCT01137578|517182261|FG000|Overall Study|Other|12|||
143447163|NCT01137578|517182262|FG001|Overall Study|Other|2|||
143447164|NCT01137578|517182263|FG002|Overall Study|Other|6|||
143447165|NCT01361594|517182264|FG000|Overall Study|Withdrawal by Subject|1|||
143447166|NCT01361594|517182265|FG001|Overall Study|Withdrawal by Subject|2|||
143447167|NCT00415051|517182267|FG000|Overall Study|Protocol Violation|1|||
143447168|NCT01518153|517182270|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
143447169|NCT01518153|517182271|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
143447170|NCT01518153|517182272|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
143447171|NCT01518153|517182270|FG000|Stem Cell Transplant|Death|2|||
143447172|NCT01518153|517182271|FG001|Stem Cell Transplant|Death|0|||
143447173|NCT01518153|517182272|FG002|Stem Cell Transplant|Death|0|||
143447174|NCT01518153|517182270|FG000|Stem Cell Transplant|Secondary graft failure|1|||
143447175|NCT01518153|517182271|FG001|Stem Cell Transplant|Secondary graft failure|0|||
143447176|NCT01518153|517182272|FG002|Stem Cell Transplant|Secondary graft failure|0|||
143447177|NCT01518153|517182270|FG000|Stem Cell Transplant|Adverse Event|1|||
143447178|NCT01518153|517182271|FG001|Stem Cell Transplant|Adverse Event|0|||
143447179|NCT01518153|517182272|FG002|Stem Cell Transplant|Adverse Event|0|||
143447180|NCT01518153|517182270|FG000|Donor Lymphocyte Infusion|Death|0|||
143447181|NCT01518153|517182271|FG001|Donor Lymphocyte Infusion|Death|2|||
143447182|NCT01518153|517182272|FG002|Donor Lymphocyte Infusion|Death|1|||
143447183|NCT05479734|517182275|FG000|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|1|||
143447184|NCT05479734|517182276|FG001|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
143447185|NCT05479734|517182275|FG000|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
143447186|NCT05479734|517182276|FG001|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|3|||
143447187|NCT05479734|517182275|FG000|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
143447188|NCT05479734|517182276|FG001|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|5|||
143447189|NCT05479734|517182275|FG000|Post-Intervention Assessment|Lost to Follow-up|0|||
143447190|NCT05479734|517182276|FG001|Post-Intervention Assessment|Lost to Follow-up|1|||
143447191|NCT01399918|517182277|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
143447192|NCT03197766|517182278|FG000|Overall Study|Withdrawal by Subject|2|||
143447193|NCT03197766|517182279|FG001|Overall Study|Withdrawal by Subject|0|||
143447194|NCT01436253|517182280|FG000|Overall Study|Lost to Follow-up|182|||
143447195|NCT01436253|517182280|FG000|Overall Study|Not meeting all eligibility criteria|117|||
143447196|NCT03083665|517182282|FG000|Double-Blind Period|Adverse Event|5|||
143447197|NCT03083665|517182283|FG001|Double-Blind Period|Adverse Event|4|||
143447198|NCT03083665|517182284|FG002|Double-Blind Period|Adverse Event|5|||
143447199|NCT03083665|517182285|FG003|Double-Blind Period|Adverse Event|0|||
143447200|NCT03083665|517182286|FG004|Double-Blind Period|Adverse Event|0|||
143447201|NCT03083665|517182287|FG005|Double-Blind Period|Adverse Event|0|||
143447202|NCT03083665|517182282|FG000|Double-Blind Period|Lack of Efficacy|0|||
143447203|NCT03083665|517182283|FG001|Double-Blind Period|Lack of Efficacy|0|||
143447204|NCT03083665|517182284|FG002|Double-Blind Period|Lack of Efficacy|1|||
143447205|NCT03083665|517182285|FG003|Double-Blind Period|Lack of Efficacy|0|||
143447206|NCT03083665|517182286|FG004|Double-Blind Period|Lack of Efficacy|0|||
143447207|NCT03083665|517182287|FG005|Double-Blind Period|Lack of Efficacy|0|||
143447208|NCT03083665|517182282|FG000|Double-Blind Period|Protocol Violation|1|||
143447209|NCT03083665|517182283|FG001|Double-Blind Period|Protocol Violation|0|||
143447210|NCT03083665|517182284|FG002|Double-Blind Period|Protocol Violation|1|||
143447211|NCT03083665|517182285|FG003|Double-Blind Period|Protocol Violation|0|||
143447212|NCT03083665|517182286|FG004|Double-Blind Period|Protocol Violation|0|||
143447213|NCT03083665|517182287|FG005|Double-Blind Period|Protocol Violation|0|||
143447214|NCT03083665|517182282|FG000|Double-Blind Period|Lost to Follow-up|1|||
143447215|NCT03083665|517182283|FG001|Double-Blind Period|Lost to Follow-up|0|||
143447216|NCT03083665|517182284|FG002|Double-Blind Period|Lost to Follow-up|1|||
143447217|NCT03083665|517182285|FG003|Double-Blind Period|Lost to Follow-up|0|||
143447218|NCT03083665|517182286|FG004|Double-Blind Period|Lost to Follow-up|0|||
143447219|NCT03083665|517182287|FG005|Double-Blind Period|Lost to Follow-up|0|||
143447220|NCT03083665|517182282|FG000|Double-Blind Period|Withdrawal by Subject|3|||
143447221|NCT03083665|517182283|FG001|Double-Blind Period|Withdrawal by Subject|0|||
143447222|NCT03083665|517182284|FG002|Double-Blind Period|Withdrawal by Subject|0|||
143447223|NCT03083665|517182285|FG003|Double-Blind Period|Withdrawal by Subject|0|||
143447224|NCT03083665|517182286|FG004|Double-Blind Period|Withdrawal by Subject|0|||
143447225|NCT03083665|517182287|FG005|Double-Blind Period|Withdrawal by Subject|0|||
143447226|NCT03083665|517182282|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
143447227|NCT03083665|517182283|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
143447228|NCT03083665|517182284|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
143447229|NCT03083665|517182285|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
143447230|NCT03083665|517182286|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
143447231|NCT03083665|517182287|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
143447232|NCT03083665|517182282|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
143447233|NCT03083665|517182283|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
143447234|NCT03083665|517182284|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
143447235|NCT03083665|517182285|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
143447236|NCT03083665|517182286|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
143447237|NCT03083665|517182287|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
143447238|NCT03083665|517182282|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
143447239|NCT03083665|517182283|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
143447240|NCT03083665|517182284|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
143447241|NCT03083665|517182285|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
143447242|NCT03083665|517182286|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
143447243|NCT03083665|517182287|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
143447244|NCT03083665|517182282|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
143447245|NCT03083665|517182283|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
143447246|NCT03083665|517182284|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
143447247|NCT03083665|517182285|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
143447248|NCT03083665|517182286|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
143447249|NCT03083665|517182287|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
143447250|NCT03083665|517182282|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
143447251|NCT03083665|517182283|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
143447252|NCT03083665|517182284|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
143447253|NCT03083665|517182285|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
143447254|NCT03083665|517182286|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
143447255|NCT03083665|517182287|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
143447256|NCT03083665|517182282|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
143447257|NCT03083665|517182283|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
143447258|NCT03083665|517182284|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
143447259|NCT03083665|517182285|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
143447260|NCT03083665|517182286|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
143447261|NCT03083665|517182287|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
143447262|NCT03083665|517182282|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
143447263|NCT03083665|517182283|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
143447264|NCT03083665|517182284|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
143447265|NCT03083665|517182285|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
143447266|NCT03083665|517182286|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
143447267|NCT03083665|517182287|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
143447268|NCT03083665|517182282|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
143447269|NCT03083665|517182283|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
143447270|NCT03083665|517182284|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
143454246|NCT01712659|517208170|FG002|Dose Escalation|Physician Decision|0|||
143447271|NCT03083665|517182285|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
143447272|NCT03083665|517182286|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
143447273|NCT03083665|517182287|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
143447274|NCT03083665|517182282|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
143447275|NCT03083665|517182283|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
143447276|NCT03083665|517182284|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
143447277|NCT03083665|517182285|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
143447278|NCT03083665|517182286|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
143447279|NCT03083665|517182287|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
143447280|NCT06285240|517182288|FG000|Overall Study|Withdrawal by Subject|2|||
143447281|NCT06285240|517182289|FG001|Overall Study|Withdrawal by Subject|0|||
143447282|NCT06285240|517182290|FG002|Overall Study|Withdrawal by Subject|0|||
143447283|NCT06285240|517182291|FG003|Overall Study|Withdrawal by Subject|0|||
143447284|NCT06285240|517182288|FG000|Overall Study|Serious Adverse Event|0|||
143447285|NCT06285240|517182289|FG001|Overall Study|Serious Adverse Event|0|||
143447286|NCT06285240|517182290|FG002|Overall Study|Serious Adverse Event|1|||
143447287|NCT06285240|517182291|FG003|Overall Study|Serious Adverse Event|0|||
143447288|NCT05140915|517182292|FG000|Overall Study|Lost to Follow-up|2|||
143447289|NCT05140915|517182293|FG001|Overall Study|Lost to Follow-up|1|||
143447290|NCT04485611|517182298|FG000|Prehabilitation|Physician Decision|1|||
143447291|NCT00350727|517182299|FG000|Phase I: Dose Escalation|Adverse Event|4|||
143447292|NCT00350727|517182300|FG001|Phase I: Dose Escalation|Adverse Event|0|||
143447293|NCT00350727|517182301|FG002|Phase I: Dose Escalation|Adverse Event|0|||
143447294|NCT00350727|517182299|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
143447295|NCT00350727|517182300|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
143447296|NCT00350727|517182301|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
143447297|NCT00350727|517182299|FG000|Phase I: Dose Escalation|Death|1|||
143447298|NCT00350727|517182300|FG001|Phase I: Dose Escalation|Death|0|||
143447299|NCT00350727|517182301|FG002|Phase I: Dose Escalation|Death|0|||
143447300|NCT00350727|517182299|FG000|Phase I: Dose Escalation|Physician Decision|1|||
143447301|NCT00350727|517182300|FG001|Phase I: Dose Escalation|Physician Decision|0|||
143447302|NCT00350727|517182301|FG002|Phase I: Dose Escalation|Physician Decision|0|||
143447303|NCT00350727|517182299|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
143447304|NCT00350727|517182300|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
143447305|NCT00350727|517182301|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
143447306|NCT00350727|517182299|FG000|Phase II|Disease Progression|0|||
143447307|NCT00350727|517182300|FG001|Phase II|Disease Progression|15|||
143447308|NCT00350727|517182301|FG002|Phase II|Disease Progression|16|||
143447309|NCT00350727|517182299|FG000|Phase II|Clinical Deterioration|0|||
143447310|NCT00350727|517182300|FG001|Phase II|Clinical Deterioration|1|||
143447311|NCT00350727|517182301|FG002|Phase II|Clinical Deterioration|0|||
143447312|NCT00350727|517182299|FG000|Phase II|Withdrawal by Subject|0|||
143447313|NCT00350727|517182300|FG001|Phase II|Withdrawal by Subject|2|||
143447314|NCT00350727|517182301|FG002|Phase II|Withdrawal by Subject|1|||
143447315|NCT00350727|517182299|FG000|Phase II|Adverse Event|0|||
143447316|NCT00350727|517182300|FG001|Phase II|Adverse Event|1|||
143447317|NCT00350727|517182301|FG002|Phase II|Adverse Event|1|||
143447318|NCT00350727|517182299|FG000|Phase II|Death|0|||
143447319|NCT00350727|517182300|FG001|Phase II|Death|0|||
143447320|NCT00350727|517182301|FG002|Phase II|Death|2|||
143447321|NCT00350727|517182299|FG000|Phase II|Sponsor Terminated Study|0|||
143447322|NCT00350727|517182300|FG001|Phase II|Sponsor Terminated Study|0|||
143447323|NCT00350727|517182301|FG002|Phase II|Sponsor Terminated Study|1|||
143447324|NCT00350727|517182299|FG000|Phase II|Enrolled in Rollover Study|0|||
143447325|NCT00350727|517182300|FG001|Phase II|Enrolled in Rollover Study|0|||
143447326|NCT00350727|517182301|FG002|Phase II|Enrolled in Rollover Study|1|||
143447327|NCT03633799|517182306|FG000|Overall Study|Adverse Event|349|||
143447328|NCT03633799|517182306|FG000|Overall Study|Withdrawal by Subject|288|||
143447329|NCT03633799|517182306|FG000|Overall Study|Lost to Follow-up|97|||
143447330|NCT03633799|517182306|FG000|Overall Study|Physician Decision|9|||
143447331|NCT03633799|517182306|FG000|Overall Study|Protocol Violation|4|||
143447332|NCT03633799|517182306|FG000|Overall Study|Pregnancy|20|||
143447333|NCT03633799|517182306|FG000|Overall Study|other|39|||
143447334|NCT03633799|517182306|FG000|Overall Study|ongoing within third year of study|106|||
143447335|NCT03633799|517182306|FG000|Overall Study|unsuccessful study drug placement|19|||
143447336|NCT01876082|517184662|FG000|Overall Study|Withdrawal by Subject|0|||
143447337|NCT01876082|517184663|FG001|Overall Study|Withdrawal by Subject|2|||
143447338|NCT01876082|517184662|FG000|Overall Study|Protocol Violation|1|||
143447339|NCT01876082|517184663|FG001|Overall Study|Protocol Violation|0|||
143447340|NCT01876082|517184662|FG000|Overall Study|Adverse Event|1|||
143447341|NCT01876082|517184663|FG001|Overall Study|Adverse Event|1|||
143447342|NCT01876082|517184662|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
143447343|NCT01876082|517184663|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
143447344|NCT03829501|517184674|FG000|Overall Study|Withdrawal of Consent|2|||
143447345|NCT03829501|517184675|FG001|Overall Study|Withdrawal of Consent|0|||
143447346|NCT03829501|517184676|FG002|Overall Study|Withdrawal of Consent|3|||
143447347|NCT03829501|517184677|FG003|Overall Study|Withdrawal of Consent|0|||
143447348|NCT03829501|517184678|FG004|Overall Study|Withdrawal of Consent|1|||
143447349|NCT03829501|517184679|FG005|Overall Study|Withdrawal of Consent|1|||
143447350|NCT03829501|517184680|FG006|Overall Study|Withdrawal of Consent|0|||
143447351|NCT03829501|517184681|FG007|Overall Study|Withdrawal of Consent|10|||
143447352|NCT03829501|517184682|FG008|Overall Study|Withdrawal of Consent|10|||
143447353|NCT03829501|517184683|FG009|Overall Study|Withdrawal of Consent|3|||
143447354|NCT03829501|517184684|FG010|Overall Study|Withdrawal of Consent|4|||
143447355|NCT03829501|517184685|FG011|Overall Study|Withdrawal of Consent|4|||
143447356|NCT03829501|517184686|FG012|Overall Study|Withdrawal of Consent|4|||
143447357|NCT03829501|517184687|FG013|Overall Study|Withdrawal of Consent|0|||
143447358|NCT03829501|517184688|FG014|Overall Study|Withdrawal of Consent|3|||
143447359|NCT03829501|517184689|FG015|Overall Study|Withdrawal of Consent|0|||
143447360|NCT03829501|517184690|FG016|Overall Study|Withdrawal of Consent|1|||
143447361|NCT03829501|517184691|FG017|Overall Study|Withdrawal of Consent|1|||
143447362|NCT03829501|517184692|FG018|Overall Study|Withdrawal of Consent|0|||
143447363|NCT03829501|517184693|FG019|Overall Study|Withdrawal of Consent|0|||
143447364|NCT03829501|517184694|FG020|Overall Study|Withdrawal of Consent|3|||
143447365|NCT03829501|517184695|FG021|Overall Study|Withdrawal of Consent|0|||
143447366|NCT03829501|517184696|FG022|Overall Study|Withdrawal of Consent|1|||
143447367|NCT03829501|517184674|FG000|Overall Study|PD|0|||
143447368|NCT03829501|517184675|FG001|Overall Study|PD|0|||
143447369|NCT03829501|517184676|FG002|Overall Study|PD|0|||
143447370|NCT03829501|517184677|FG003|Overall Study|PD|2|||
143447371|NCT03829501|517184678|FG004|Overall Study|PD|0|||
143447372|NCT03829501|517184679|FG005|Overall Study|PD|0|||
143447373|NCT03829501|517184680|FG006|Overall Study|PD|0|||
143447374|NCT03829501|517184681|FG007|Overall Study|PD|0|||
143447375|NCT03829501|517184682|FG008|Overall Study|PD|0|||
143447376|NCT03829501|517184683|FG009|Overall Study|PD|0|||
143447377|NCT03829501|517184684|FG010|Overall Study|PD|0|||
143447378|NCT03829501|517184685|FG011|Overall Study|PD|0|||
143447379|NCT03829501|517184686|FG012|Overall Study|PD|0|||
143447380|NCT03829501|517184687|FG013|Overall Study|PD|0|||
143447381|NCT03829501|517184688|FG014|Overall Study|PD|0|||
143447382|NCT03829501|517184689|FG015|Overall Study|PD|1|||
143447383|NCT03829501|517184690|FG016|Overall Study|PD|0|||
143447384|NCT03829501|517184691|FG017|Overall Study|PD|0|||
143447385|NCT03829501|517184692|FG018|Overall Study|PD|0|||
143447386|NCT03829501|517184693|FG019|Overall Study|PD|0|||
143447387|NCT03829501|517184694|FG020|Overall Study|PD|1|||
143447388|NCT03829501|517184695|FG021|Overall Study|PD|0|||
143447389|NCT03829501|517184696|FG022|Overall Study|PD|0|||
143447390|NCT03829501|517184674|FG000|Overall Study|Study Terminated by Sponsor|0|||
143447391|NCT03829501|517184675|FG001|Overall Study|Study Terminated by Sponsor|0|||
143447392|NCT03829501|517184676|FG002|Overall Study|Study Terminated by Sponsor|0|||
143447393|NCT03829501|517184677|FG003|Overall Study|Study Terminated by Sponsor|0|||
143447394|NCT03829501|517184678|FG004|Overall Study|Study Terminated by Sponsor|0|||
143447395|NCT03829501|517184679|FG005|Overall Study|Study Terminated by Sponsor|0|||
143447396|NCT03829501|517184680|FG006|Overall Study|Study Terminated by Sponsor|0|||
143447397|NCT03829501|517184681|FG007|Overall Study|Study Terminated by Sponsor|3|||
143447398|NCT03829501|517184682|FG008|Overall Study|Study Terminated by Sponsor|1|||
143447399|NCT03829501|517184683|FG009|Overall Study|Study Terminated by Sponsor|0|||
143447400|NCT03829501|517184684|FG010|Overall Study|Study Terminated by Sponsor|0|||
143447401|NCT03829501|517184685|FG011|Overall Study|Study Terminated by Sponsor|0|||
143447402|NCT03829501|517184686|FG012|Overall Study|Study Terminated by Sponsor|0|||
143447403|NCT03829501|517184687|FG013|Overall Study|Study Terminated by Sponsor|0|||
143447404|NCT03829501|517184688|FG014|Overall Study|Study Terminated by Sponsor|3|||
143447405|NCT03829501|517184689|FG015|Overall Study|Study Terminated by Sponsor|2|||
143447406|NCT03829501|517184690|FG016|Overall Study|Study Terminated by Sponsor|2|||
143447407|NCT03829501|517184691|FG017|Overall Study|Study Terminated by Sponsor|0|||
143447408|NCT03829501|517184692|FG018|Overall Study|Study Terminated by Sponsor|0|||
143447409|NCT03829501|517184693|FG019|Overall Study|Study Terminated by Sponsor|0|||
143447410|NCT03829501|517184694|FG020|Overall Study|Study Terminated by Sponsor|1|||
143447411|NCT03829501|517184695|FG021|Overall Study|Study Terminated by Sponsor|0|||
143447412|NCT03829501|517184696|FG022|Overall Study|Study Terminated by Sponsor|3|||
143447413|NCT03829501|517184674|FG000|Overall Study|Lost to Follow Up|0|||
143447414|NCT03829501|517184675|FG001|Overall Study|Lost to Follow Up|0|||
143447415|NCT03829501|517184676|FG002|Overall Study|Lost to Follow Up|0|||
143447416|NCT03829501|517184677|FG003|Overall Study|Lost to Follow Up|0|||
143447417|NCT03829501|517184678|FG004|Overall Study|Lost to Follow Up|1|||
143447418|NCT03829501|517184679|FG005|Overall Study|Lost to Follow Up|0|||
143447419|NCT03829501|517184680|FG006|Overall Study|Lost to Follow Up|0|||
143447420|NCT03829501|517184681|FG007|Overall Study|Lost to Follow Up|2|||
143447421|NCT03829501|517184682|FG008|Overall Study|Lost to Follow Up|2|||
143447422|NCT03829501|517184683|FG009|Overall Study|Lost to Follow Up|0|||
143447423|NCT03829501|517184684|FG010|Overall Study|Lost to Follow Up|2|||
143447424|NCT03829501|517184685|FG011|Overall Study|Lost to Follow Up|1|||
143447425|NCT03829501|517184686|FG012|Overall Study|Lost to Follow Up|0|||
143447426|NCT03829501|517184687|FG013|Overall Study|Lost to Follow Up|1|||
143447427|NCT03829501|517184688|FG014|Overall Study|Lost to Follow Up|1|||
143447428|NCT03829501|517184689|FG015|Overall Study|Lost to Follow Up|0|||
143447429|NCT03829501|517184690|FG016|Overall Study|Lost to Follow Up|0|||
143447430|NCT03829501|517184691|FG017|Overall Study|Lost to Follow Up|0|||
143447431|NCT03829501|517184692|FG018|Overall Study|Lost to Follow Up|0|||
143447432|NCT03829501|517184693|FG019|Overall Study|Lost to Follow Up|0|||
143447433|NCT03829501|517184694|FG020|Overall Study|Lost to Follow Up|0|||
143447434|NCT03829501|517184695|FG021|Overall Study|Lost to Follow Up|0|||
143447435|NCT03829501|517184696|FG022|Overall Study|Lost to Follow Up|1|||
143447436|NCT03829501|517184674|FG000|Overall Study|Death|2|||
143447437|NCT03829501|517184675|FG001|Overall Study|Death|4|||
143447438|NCT03829501|517184676|FG002|Overall Study|Death|5|||
143447439|NCT03829501|517184677|FG003|Overall Study|Death|6|||
143447440|NCT03829501|517184678|FG004|Overall Study|Death|5|||
143447441|NCT03829501|517184679|FG005|Overall Study|Death|4|||
143447442|NCT03829501|517184680|FG006|Overall Study|Death|5|||
143447443|NCT03829501|517184681|FG007|Overall Study|Death|24|||
143447444|NCT03829501|517184682|FG008|Overall Study|Death|22|||
143447445|NCT03829501|517184683|FG009|Overall Study|Death|6|||
143447446|NCT03829501|517184684|FG010|Overall Study|Death|3|||
143447447|NCT03829501|517184685|FG011|Overall Study|Death|10|||
143447448|NCT03829501|517184686|FG012|Overall Study|Death|10|||
143447449|NCT03829501|517184687|FG013|Overall Study|Death|5|||
143447450|NCT03829501|517184688|FG014|Overall Study|Death|7|||
143447451|NCT03829501|517184689|FG015|Overall Study|Death|2|||
143447452|NCT03829501|517184690|FG016|Overall Study|Death|2|||
143447453|NCT03829501|517184691|FG017|Overall Study|Death|1|||
143447454|NCT03829501|517184692|FG018|Overall Study|Death|1|||
143447455|NCT03829501|517184693|FG019|Overall Study|Death|1|||
143447456|NCT03829501|517184694|FG020|Overall Study|Death|1|||
143447457|NCT03829501|517184695|FG021|Overall Study|Death|2|||
143447458|NCT03829501|517184696|FG022|Overall Study|Death|3|||
143447459|NCT03829501|517184674|FG000|Overall Study|Miscellaneous|0|||
143447460|NCT03829501|517184675|FG001|Overall Study|Miscellaneous|0|||
143447461|NCT03829501|517184676|FG002|Overall Study|Miscellaneous|1|||
143447462|NCT03829501|517184677|FG003|Overall Study|Miscellaneous|0|||
143447463|NCT03829501|517184678|FG004|Overall Study|Miscellaneous|0|||
143447464|NCT03829501|517184679|FG005|Overall Study|Miscellaneous|0|||
143447465|NCT03829501|517184680|FG006|Overall Study|Miscellaneous|0|||
143447466|NCT03829501|517184681|FG007|Overall Study|Miscellaneous|1|||
143447467|NCT03829501|517184682|FG008|Overall Study|Miscellaneous|0|||
143447468|NCT03829501|517184683|FG009|Overall Study|Miscellaneous|0|||
143447469|NCT03829501|517184684|FG010|Overall Study|Miscellaneous|0|||
143447470|NCT03829501|517184685|FG011|Overall Study|Miscellaneous|0|||
143447471|NCT03829501|517184686|FG012|Overall Study|Miscellaneous|0|||
143447472|NCT03829501|517184687|FG013|Overall Study|Miscellaneous|0|||
143447473|NCT03829501|517184688|FG014|Overall Study|Miscellaneous|0|||
143447474|NCT03829501|517184689|FG015|Overall Study|Miscellaneous|0|||
143447475|NCT03829501|517184690|FG016|Overall Study|Miscellaneous|0|||
143447476|NCT03829501|517184691|FG017|Overall Study|Miscellaneous|0|||
143447477|NCT03829501|517184692|FG018|Overall Study|Miscellaneous|0|||
143447478|NCT03829501|517184693|FG019|Overall Study|Miscellaneous|0|||
143447479|NCT03829501|517184694|FG020|Overall Study|Miscellaneous|0|||
143447480|NCT03829501|517184695|FG021|Overall Study|Miscellaneous|0|||
143447481|NCT03829501|517184696|FG022|Overall Study|Miscellaneous|1|||
143447482|NCT02964013|517184697|FG000|Overall Study|Death|58|||
143447483|NCT02964013|517184698|FG001|Overall Study|Death|239|||
143447484|NCT02964013|517184699|FG002|Overall Study|Death|38|||
143447485|NCT02964013|517184700|FG003|Overall Study|Death|10|||
143447486|NCT02964013|517184701|FG004|Overall Study|Death|33|||
143447487|NCT02964013|517184697|FG000|Overall Study|Lost to Follow-up|1|||
143447488|NCT02964013|517184698|FG001|Overall Study|Lost to Follow-up|4|||
143447489|NCT02964013|517184699|FG002|Overall Study|Lost to Follow-up|2|||
143447490|NCT02964013|517184700|FG003|Overall Study|Lost to Follow-up|0|||
143447491|NCT02964013|517184701|FG004|Overall Study|Lost to Follow-up|0|||
143447492|NCT02964013|517184697|FG000|Overall Study|Physician Decision|0|||
143447493|NCT02964013|517184698|FG001|Overall Study|Physician Decision|1|||
143447494|NCT02964013|517184699|FG002|Overall Study|Physician Decision|0|||
143447495|NCT02964013|517184700|FG003|Overall Study|Physician Decision|0|||
143447496|NCT02964013|517184701|FG004|Overall Study|Physician Decision|0|||
143447497|NCT02964013|517184697|FG000|Overall Study|Sponsor Decision|3|||
143447498|NCT02964013|517184698|FG001|Overall Study|Sponsor Decision|22|||
143447499|NCT02964013|517184699|FG002|Overall Study|Sponsor Decision|11|||
143447500|NCT02964013|517184700|FG003|Overall Study|Sponsor Decision|0|||
143447501|NCT02964013|517184701|FG004|Overall Study|Sponsor Decision|7|||
143447502|NCT02964013|517184697|FG000|Overall Study|Withdrawal by Subject|6|||
143447503|NCT02964013|517184698|FG001|Overall Study|Withdrawal by Subject|27|||
143447504|NCT02964013|517184699|FG002|Overall Study|Withdrawal by Subject|9|||
143447505|NCT02964013|517184700|FG003|Overall Study|Withdrawal by Subject|0|||
143447506|NCT02964013|517184701|FG004|Overall Study|Withdrawal by Subject|0|||
143447507|NCT02964013|517184697|FG000|Overall Study|Not Treated|0|||
143447508|NCT02964013|517184698|FG001|Overall Study|Not Treated|2|||
143447509|NCT02964013|517184699|FG002|Overall Study|Not Treated|0|||
143447510|NCT02964013|517184700|FG003|Overall Study|Not Treated|1|||
143447511|NCT02964013|517184701|FG004|Overall Study|Not Treated|0|||
143447512|NCT00747227|517184708|FG000|Overall Study|Death|3|||
143447513|NCT00747227|517184709|FG001|Overall Study|Death|1|||
143447514|NCT00747227|517184708|FG000|Overall Study|Withdrawal by Subject|1|||
143447515|NCT00747227|517184709|FG001|Overall Study|Withdrawal by Subject|0|||
143447516|NCT00747227|517184708|FG000|Overall Study|Lost to Follow-up|1|||
143447517|NCT00747227|517184709|FG001|Overall Study|Lost to Follow-up|2|||
143447518|NCT00747227|517184708|FG000|Overall Study|Illness|1|||
143447519|NCT00747227|517184709|FG001|Overall Study|Illness|1|||
143447520|NCT03284229|517184710|FG000|Overall Study|Lost to Follow-up|3|||
143447521|NCT00663702|517184713|FG000|Overall Study|Adverse Event|8|||
143447522|NCT00663702|517184714|FG001|Overall Study|Adverse Event|4|||
143447523|NCT00663702|517184713|FG000|Overall Study|Withdrawal by Subject|3|||
143447524|NCT00663702|517184714|FG001|Overall Study|Withdrawal by Subject|1|||
143447525|NCT00663702|517184713|FG000|Overall Study|Pregnancy|0|||
143447526|NCT00663702|517184714|FG001|Overall Study|Pregnancy|1|||
143447527|NCT00663702|517184713|FG000|Overall Study|Lost to Follow-up|3|||
143447528|NCT00663702|517184714|FG001|Overall Study|Lost to Follow-up|0|||
143447529|NCT00663702|517184713|FG000|Overall Study|Death|1|||
143447530|NCT00663702|517184714|FG001|Overall Study|Death|1|||
143447531|NCT00663702|517184713|FG000|Overall Study|Lack of Efficacy|3|||
143447532|NCT00663702|517184714|FG001|Overall Study|Lack of Efficacy|3|||
143447533|NCT02993406|517184721|FG000|Overall Study|Withdrawal by Subject|170|||
143447534|NCT02993406|517184722|FG001|Overall Study|Withdrawal by Subject|196|||
143447535|NCT02993406|517184721|FG000|Overall Study|Physician Decision|3|||
143447536|NCT02993406|517184722|FG001|Overall Study|Physician Decision|5|||
143447537|NCT02993406|517184721|FG000|Overall Study|Lost to Follow-up|12|||
143447538|NCT02993406|517184722|FG001|Overall Study|Lost to Follow-up|13|||
143447539|NCT02993406|517184721|FG000|Overall Study|Unclassifiable Response|105|||
143447540|NCT02993406|517184722|FG001|Overall Study|Unclassifiable Response|139|||
143447541|NCT02993406|517184721|FG000|Overall Study|Administrative decision|1|||
143447542|NCT02993406|517184722|FG001|Overall Study|Administrative decision|0|||
143447543|NCT02993406|517184721|FG000|Overall Study|Sponsor decision|4|||
143447544|NCT02993406|517184722|FG001|Overall Study|Sponsor decision|5|||
143447545|NCT02248818|517184723|FG000|Screening|Protocol Violation|0|||
143447546|NCT02248818|517184724|FG001|Screening|Protocol Violation|0|||
143447547|NCT02248818|517184725|FG002|Screening|Protocol Violation|0|||
143447548|NCT02248818|517184726|FG003|Screening|Protocol Violation|0|||
143447549|NCT02248818|517184727|FG004|Screening|Protocol Violation|0|||
143447550|NCT02248818|517184728|FG005|Screening|Protocol Violation|0|||
143447551|NCT02248818|517184729|FG006|Screening|Protocol Violation|0|||
143447552|NCT02248818|517184730|FG007|Screening|Protocol Violation|0|||
143447553|NCT02248818|517184731|FG008|Screening|Protocol Violation|7|||
143447554|NCT02248818|517184723|FG000|Screening|Study fully enrolled|0|||
143447555|NCT02248818|517184724|FG001|Screening|Study fully enrolled|0|||
143447556|NCT02248818|517184725|FG002|Screening|Study fully enrolled|0|||
143447557|NCT02248818|517184726|FG003|Screening|Study fully enrolled|0|||
143447558|NCT02248818|517184727|FG004|Screening|Study fully enrolled|0|||
143447559|NCT02248818|517184728|FG005|Screening|Study fully enrolled|0|||
143447560|NCT02248818|517184729|FG006|Screening|Study fully enrolled|0|||
143447561|NCT02248818|517184730|FG007|Screening|Study fully enrolled|0|||
143447562|NCT02248818|517184731|FG008|Screening|Study fully enrolled|14|||
143447563|NCT02248818|517184723|FG000|Screening|Physician Decision|0|||
143447564|NCT02248818|517184724|FG001|Screening|Physician Decision|0|||
143447565|NCT02248818|517184725|FG002|Screening|Physician Decision|0|||
143447566|NCT02248818|517184726|FG003|Screening|Physician Decision|0|||
143447567|NCT02248818|517184727|FG004|Screening|Physician Decision|0|||
143447568|NCT02248818|517184728|FG005|Screening|Physician Decision|0|||
143447569|NCT02248818|517184729|FG006|Screening|Physician Decision|0|||
143447570|NCT02248818|517184730|FG007|Screening|Physician Decision|0|||
143447571|NCT02248818|517184731|FG008|Screening|Physician Decision|73|||
143447572|NCT02248818|517184723|FG000|Screening|Withdrawal by Subject|0|||
143447573|NCT02248818|517184724|FG001|Screening|Withdrawal by Subject|0|||
143447574|NCT02248818|517184725|FG002|Screening|Withdrawal by Subject|0|||
143447575|NCT02248818|517184726|FG003|Screening|Withdrawal by Subject|0|||
143447576|NCT02248818|517184727|FG004|Screening|Withdrawal by Subject|0|||
143447577|NCT02248818|517184728|FG005|Screening|Withdrawal by Subject|0|||
143447578|NCT02248818|517184729|FG006|Screening|Withdrawal by Subject|0|||
143447579|NCT02248818|517184730|FG007|Screening|Withdrawal by Subject|0|||
143447580|NCT02248818|517184731|FG008|Screening|Withdrawal by Subject|6|||
143447581|NCT02248818|517184723|FG000|Screening|Lost to Follow-up|0|||
143447582|NCT02248818|517184724|FG001|Screening|Lost to Follow-up|0|||
143447583|NCT02248818|517184725|FG002|Screening|Lost to Follow-up|0|||
143447584|NCT02248818|517184726|FG003|Screening|Lost to Follow-up|0|||
143447585|NCT02248818|517184727|FG004|Screening|Lost to Follow-up|0|||
143447586|NCT02248818|517184728|FG005|Screening|Lost to Follow-up|0|||
143447587|NCT02248818|517184729|FG006|Screening|Lost to Follow-up|0|||
143447588|NCT02248818|517184730|FG007|Screening|Lost to Follow-up|0|||
143447589|NCT02248818|517184731|FG008|Screening|Lost to Follow-up|7|||
143447590|NCT02248818|517184723|FG000|Randomised Study|Administrative - randomization error|0|||
143447591|NCT02248818|517184724|FG001|Randomised Study|Administrative - randomization error|0|||
143447592|NCT02248818|517184725|FG002|Randomised Study|Administrative - randomization error|0|||
143447593|NCT02248818|517184726|FG003|Randomised Study|Administrative - randomization error|0|||
143447594|NCT02248818|517184727|FG004|Randomised Study|Administrative - randomization error|0|||
143447595|NCT02248818|517184728|FG005|Randomised Study|Administrative - randomization error|8|||
143447596|NCT02248818|517184729|FG006|Randomised Study|Administrative - randomization error|0|||
143447597|NCT02248818|517184730|FG007|Randomised Study|Administrative - randomization error|0|||
143447598|NCT02248818|517184731|FG008|Randomised Study|Administrative - randomization error|0|||
143447599|NCT01283152|517184732|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
143447600|NCT01283152|517184733|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
143447601|NCT01283152|517184732|FG000|Overall Study|Refused HESA|1|||
143447602|NCT01283152|517184733|FG001|Overall Study|Refused HESA|0|||
143447603|NCT00626197|517184737|FG000|Overall Study|Did not cooperate|2|||
143447604|NCT00626197|517184738|FG001|Overall Study|Did not cooperate|6|||
143447605|NCT00626197|517184739|FG002|Overall Study|Did not cooperate|1|||
143447606|NCT00626197|517184737|FG000|Overall Study|Failure to return|6|||
143447607|NCT00626197|517184738|FG001|Overall Study|Failure to return|5|||
143447608|NCT00626197|517184739|FG002|Overall Study|Failure to return|6|||
143447609|NCT00626197|517184737|FG000|Overall Study|Adverse event, serious fatal|3|||
143447610|NCT00626197|517184738|FG001|Overall Study|Adverse event, serious fatal|6|||
143447611|NCT00626197|517184739|FG002|Overall Study|Adverse event, serious fatal|6|||
143447612|NCT00626197|517184737|FG000|Overall Study|Adverse Event|1|||
143447613|NCT00626197|517184738|FG001|Overall Study|Adverse Event|1|||
143447614|NCT00626197|517184739|FG002|Overall Study|Adverse Event|2|||
143447615|NCT00626197|517184737|FG000|Overall Study|Withdrawal by Subject|17|||
143447616|NCT00626197|517184738|FG001|Overall Study|Withdrawal by Subject|17|||
143447617|NCT00626197|517184739|FG002|Overall Study|Withdrawal by Subject|7|||
143447618|NCT00626197|517184737|FG000|Overall Study|Administrative reasons|15|||
143447619|NCT00626197|517184738|FG001|Overall Study|Administrative reasons|19|||
143447620|NCT00626197|517184739|FG002|Overall Study|Administrative reasons|55|||
143447621|NCT00461981|517184746|FG000|Overall Study|Lost to Follow-up|9|||
143447622|NCT00461981|517184747|FG001|Overall Study|Lost to Follow-up|6|||
143447623|NCT00461981|517184746|FG000|Overall Study|Withdrawal by Subject|2|||
143447624|NCT00461981|517184747|FG001|Overall Study|Withdrawal by Subject|3|||
143447625|NCT01077128|517184753|FG000|Overall Study|Adverse Event|8|||
143447626|NCT01077128|517184753|FG000|Overall Study|Lack of Efficacy|1|||
143447627|NCT01077128|517184753|FG000|Overall Study|Disease exacerbation|1|||
143447628|NCT01077128|517184753|FG000|Overall Study|Adverse event and consent withdrawal|1|||
143447629|NCT01077128|517184753|FG000|Overall Study|Adverse event and disease exacerbation|1|||
143447630|NCT01077128|517184753|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
143447631|NCT01077128|517184753|FG000|Overall Study|Other|54|||
143447632|NCT00847626|517184754|FG000|Overall Study|Adverse Event|10|||
143447633|NCT00847626|517184755|FG001|Overall Study|Adverse Event|10|||
143447634|NCT00847626|517184756|FG002|Overall Study|Adverse Event|6|||
143447635|NCT00847626|517184757|FG003|Overall Study|Adverse Event|19|||
143447636|NCT00847626|517184758|FG004|Overall Study|Adverse Event|11|||
143447637|NCT00847626|517184759|FG005|Overall Study|Adverse Event|22|||
143447638|NCT00847626|517184760|FG006|Overall Study|Adverse Event|4|||
143447639|NCT00847626|517184761|FG007|Overall Study|Adverse Event|6|||
143447640|NCT00847626|517184762|FG008|Overall Study|Adverse Event|3|||
143447641|NCT00847626|517184763|FG009|Overall Study|Adverse Event|6|||
143447642|NCT00847626|517184764|FG010|Overall Study|Adverse Event|6|||
143447643|NCT00847626|517184754|FG000|Overall Study|Protocol Violation|2|||
143447644|NCT00847626|517184755|FG001|Overall Study|Protocol Violation|1|||
143447645|NCT00847626|517184756|FG002|Overall Study|Protocol Violation|2|||
143447646|NCT00847626|517184757|FG003|Overall Study|Protocol Violation|1|||
143447647|NCT00847626|517184758|FG004|Overall Study|Protocol Violation|1|||
143447648|NCT00847626|517184759|FG005|Overall Study|Protocol Violation|1|||
143447649|NCT00847626|517184760|FG006|Overall Study|Protocol Violation|1|||
143447650|NCT00847626|517184761|FG007|Overall Study|Protocol Violation|1|||
143447651|NCT00847626|517184762|FG008|Overall Study|Protocol Violation|0|||
143447652|NCT00847626|517184763|FG009|Overall Study|Protocol Violation|1|||
143447653|NCT00847626|517184764|FG010|Overall Study|Protocol Violation|1|||
143447654|NCT00847626|517184754|FG000|Overall Study|Lost to Follow-up|0|||
143447655|NCT00847626|517184755|FG001|Overall Study|Lost to Follow-up|1|||
143447656|NCT00847626|517184756|FG002|Overall Study|Lost to Follow-up|1|||
143447657|NCT00847626|517184757|FG003|Overall Study|Lost to Follow-up|1|||
143447658|NCT00847626|517184758|FG004|Overall Study|Lost to Follow-up|0|||
143447659|NCT00847626|517184759|FG005|Overall Study|Lost to Follow-up|3|||
143447660|NCT00847626|517184760|FG006|Overall Study|Lost to Follow-up|1|||
143447661|NCT00847626|517184761|FG007|Overall Study|Lost to Follow-up|3|||
143447662|NCT00847626|517184762|FG008|Overall Study|Lost to Follow-up|1|||
143447663|NCT00847626|517184763|FG009|Overall Study|Lost to Follow-up|0|||
143447664|NCT00847626|517184764|FG010|Overall Study|Lost to Follow-up|1|||
143447665|NCT00847626|517184754|FG000|Overall Study|Withdrawal by Subject|5|||
143447666|NCT00847626|517184755|FG001|Overall Study|Withdrawal by Subject|5|||
143447667|NCT00847626|517184756|FG002|Overall Study|Withdrawal by Subject|3|||
143447668|NCT00847626|517184757|FG003|Overall Study|Withdrawal by Subject|8|||
143447669|NCT00847626|517184758|FG004|Overall Study|Withdrawal by Subject|12|||
143447670|NCT00847626|517184759|FG005|Overall Study|Withdrawal by Subject|9|||
143447671|NCT00847626|517184760|FG006|Overall Study|Withdrawal by Subject|8|||
143447672|NCT00847626|517184761|FG007|Overall Study|Withdrawal by Subject|4|||
143447673|NCT00847626|517184762|FG008|Overall Study|Withdrawal by Subject|4|||
143447674|NCT00847626|517184763|FG009|Overall Study|Withdrawal by Subject|5|||
143447675|NCT00847626|517184764|FG010|Overall Study|Withdrawal by Subject|2|||
143447676|NCT00847626|517184754|FG000|Overall Study|Lack of Efficacy|3|||
143447677|NCT00847626|517184755|FG001|Overall Study|Lack of Efficacy|1|||
143447678|NCT00847626|517184756|FG002|Overall Study|Lack of Efficacy|0|||
143447679|NCT00847626|517184757|FG003|Overall Study|Lack of Efficacy|1|||
143447680|NCT00847626|517184758|FG004|Overall Study|Lack of Efficacy|2|||
143447681|NCT00847626|517184759|FG005|Overall Study|Lack of Efficacy|0|||
143447682|NCT00847626|517184760|FG006|Overall Study|Lack of Efficacy|6|||
143447683|NCT00847626|517184761|FG007|Overall Study|Lack of Efficacy|2|||
143447684|NCT00847626|517184762|FG008|Overall Study|Lack of Efficacy|5|||
143447685|NCT00847626|517184763|FG009|Overall Study|Lack of Efficacy|1|||
143447686|NCT00847626|517184764|FG010|Overall Study|Lack of Efficacy|7|||
143447687|NCT00847626|517184754|FG000|Overall Study|Other|1|||
143447688|NCT00847626|517184755|FG001|Overall Study|Other|5|||
143447689|NCT00847626|517184756|FG002|Overall Study|Other|4|||
143447690|NCT00847626|517184757|FG003|Overall Study|Other|1|||
143447691|NCT00847626|517184758|FG004|Overall Study|Other|2|||
143447692|NCT00847626|517184759|FG005|Overall Study|Other|2|||
143447693|NCT00847626|517184760|FG006|Overall Study|Other|2|||
143447694|NCT00847626|517184761|FG007|Overall Study|Other|3|||
143447695|NCT00847626|517184762|FG008|Overall Study|Other|1|||
143447696|NCT00847626|517184763|FG009|Overall Study|Other|1|||
143447697|NCT00847626|517184764|FG010|Overall Study|Other|3|||
143447698|NCT03809039|517184765|FG000|Part 1|Withdrawal by Subject|1|||
143447699|NCT03809039|517184766|FG001|Part 1|Withdrawal by Subject|0|||
143447700|NCT03809039|517184767|FG002|Part 1|Withdrawal by Subject|0|||
143447701|NCT03809039|517184768|FG003|Part 1|Withdrawal by Subject|1|||
143447702|NCT03809039|517184769|FG004|Part 1|Withdrawal by Subject|0|||
143447703|NCT03809039|517184770|FG005|Part 1|Withdrawal by Subject|0|||
143447704|NCT03809039|517184771|FG006|Part 1|Withdrawal by Subject|0|||
143447705|NCT03809039|517184772|FG007|Part 1|Withdrawal by Subject|0|||
143447706|NCT03809039|517184773|FG008|Part 1|Withdrawal by Subject|0|||
143447707|NCT03809039|517184765|FG000|Part 3|Withdrawn by study termination|0|||
143447708|NCT03809039|517184766|FG001|Part 3|Withdrawn by study termination|0|||
143447709|NCT03809039|517184767|FG002|Part 3|Withdrawn by study termination|0|||
143447710|NCT03809039|517184768|FG003|Part 3|Withdrawn by study termination|0|||
143447711|NCT03809039|517184769|FG004|Part 3|Withdrawn by study termination|0|||
143447712|NCT03809039|517184770|FG005|Part 3|Withdrawn by study termination|0|||
143447713|NCT03809039|517184771|FG006|Part 3|Withdrawn by study termination|0|||
143447714|NCT03809039|517184772|FG007|Part 3|Withdrawn by study termination|2|||
143447715|NCT03809039|517184773|FG008|Part 3|Withdrawn by study termination|6|||
143447716|NCT02476175|517184778|FG000|Overall Study|Adverse Event|2|||
143447717|NCT03031496|517184779|FG000|Period 1|Adverse Event|2|||
143447718|NCT03031496|517184780|FG001|Period 1|Adverse Event|0|||
143447719|NCT03031496|517184779|FG000|Period 1|Withdrawal by Subject|0|||
143447720|NCT03031496|517184780|FG001|Period 1|Withdrawal by Subject|2|||
143447721|NCT02979249|517184782|FG000|Overall Study|Lost to Follow-up|2|||
143447722|NCT02979249|517184782|FG000|Overall Study|Withdrawal by Subject|4|||
143447723|NCT03868787|517184783|FG000|Overall Study|Withdrawal by Subject|2|||
143447724|NCT03868787|517184784|FG001|Overall Study|Withdrawal by Subject|1|||
143447725|NCT01399697|517184785|FG000|Overall Study|Adverse Event|13|||
143447726|NCT01399697|517184786|FG001|Overall Study|Adverse Event|3|||
143447727|NCT01399697|517184787|FG002|Overall Study|Adverse Event|1|||
143447728|NCT01399697|517184785|FG000|Overall Study|Lost to Follow-up|2|||
143447729|NCT01399697|517184786|FG001|Overall Study|Lost to Follow-up|0|||
143447730|NCT01399697|517184787|FG002|Overall Study|Lost to Follow-up|0|||
143447731|NCT01399697|517184785|FG000|Overall Study|Withdrawal by Subject|8|||
143447732|NCT01399697|517184786|FG001|Overall Study|Withdrawal by Subject|0|||
143447733|NCT01399697|517184787|FG002|Overall Study|Withdrawal by Subject|0|||
143447734|NCT01399697|517184785|FG000|Overall Study|Investigator Decisión|1|||
143447735|NCT01399697|517184786|FG001|Overall Study|Investigator Decisión|0|||
143447736|NCT01399697|517184787|FG002|Overall Study|Investigator Decisión|2|||
143447737|NCT01399697|517184785|FG000|Overall Study|Lack of Efficacy|9|||
143447738|NCT01399697|517184786|FG001|Overall Study|Lack of Efficacy|0|||
143447739|NCT01399697|517184787|FG002|Overall Study|Lack of Efficacy|1|||
143447740|NCT01399697|517184785|FG000|Overall Study|Protocol Violation|2|||
143447741|NCT01399697|517184786|FG001|Overall Study|Protocol Violation|0|||
143447742|NCT01399697|517184787|FG002|Overall Study|Protocol Violation|0|||
143447743|NCT01399697|517184785|FG000|Overall Study|Non-Compliant|1|||
143447744|NCT01399697|517184786|FG001|Overall Study|Non-Compliant|0|||
143447745|NCT01399697|517184787|FG002|Overall Study|Non-Compliant|0|||
143447746|NCT01399697|517184785|FG000|Overall Study|Inclusion Error|2|||
143447747|NCT01399697|517184786|FG001|Overall Study|Inclusion Error|0|||
143447748|NCT01399697|517184787|FG002|Overall Study|Inclusion Error|0|||
143447749|NCT01399697|517184785|FG000|Overall Study|Positive result for hepatitis B|1|||
143447750|NCT01399697|517184786|FG001|Overall Study|Positive result for hepatitis B|0|||
143447751|NCT01399697|517184787|FG002|Overall Study|Positive result for hepatitis B|0|||
143447752|NCT01399697|517184785|FG000|Overall Study|Clinical RA remission|1|||
143447753|NCT01399697|517184786|FG001|Overall Study|Clinical RA remission|0|||
143447754|NCT01399697|517184787|FG002|Overall Study|Clinical RA remission|0|||
143447755|NCT01399697|517184785|FG000|Overall Study|Sponsor Decision|1|||
143447756|NCT01399697|517184786|FG001|Overall Study|Sponsor Decision|0|||
143447757|NCT01399697|517184787|FG002|Overall Study|Sponsor Decision|0|||
143447758|NCT02510040|517184788|FG000|Overall Study|Deemed no longer eligible|18|||
143447759|NCT02510040|517184789|FG001|Overall Study|Deemed no longer eligible|3|||
143447760|NCT02510040|517184790|FG002|Overall Study|Deemed no longer eligible|1|||
143447761|NCT00967005|517184794|FG000|Overall Study|Lost to Follow-up|7|||
143447762|NCT00967005|517184795|FG001|Overall Study|Lost to Follow-up|10|||
143447763|NCT03552523|517184796|FG000|Overall Study|Withdrawal by Subject|1|||
143447764|NCT03552523|517184797|FG001|Overall Study|Withdrawal by Subject|1|||
143447765|NCT00604708|517184798|FG000|Overall Study|Withdrawal by Subject|9|||
143447766|NCT00604708|517184799|FG001|Overall Study|Withdrawal by Subject|10|||
143447767|NCT00604708|517184798|FG000|Overall Study|Protocol Violation|2|||
143447768|NCT00604708|517184799|FG001|Overall Study|Protocol Violation|8|||
143447769|NCT00604708|517184798|FG000|Overall Study|Lost to Follow-up|5|||
143447770|NCT00604708|517184799|FG001|Overall Study|Lost to Follow-up|5|||
143447771|NCT00604708|517184798|FG000|Overall Study|administrative reasons|9|||
143447772|NCT00604708|517184799|FG001|Overall Study|administrative reasons|11|||
143447773|NCT00604708|517184798|FG000|Overall Study|Adverse Event|6|||
143447774|NCT00604708|517184799|FG001|Overall Study|Adverse Event|6|||
143447775|NCT02202785|517184800|FG000|Overall Study|Study Terminated by Sponsor|1|||
143447776|NCT02202785|517184801|FG001|Overall Study|Study Terminated by Sponsor|6|||
143447777|NCT02202785|517184802|FG002|Overall Study|Study Terminated by Sponsor|4|||
143447778|NCT02202785|517184800|FG000|Overall Study|Withdrawal by Subject|0|||
143447779|NCT02202785|517184801|FG001|Overall Study|Withdrawal by Subject|1|||
143447780|NCT02202785|517184802|FG002|Overall Study|Withdrawal by Subject|0|||
143447781|NCT02202785|517184800|FG000|Overall Study|Lost to Follow-up|0|||
143447782|NCT02202785|517184801|FG001|Overall Study|Lost to Follow-up|1|||
143447783|NCT02202785|517184802|FG002|Overall Study|Lost to Follow-up|0|||
143447784|NCT02202785|517184800|FG000|Overall Study|Reason not Specified|10|||
143447785|NCT02202785|517184801|FG001|Overall Study|Reason not Specified|7|||
143447786|NCT02202785|517184802|FG002|Overall Study|Reason not Specified|13|||
143447787|NCT02180243|517184803|FG000|Overall Study|Withdrawal by Subject|12|||
143447788|NCT02180243|517184804|FG001|Overall Study|Withdrawal by Subject|12|||
143447789|NCT02180243|517184803|FG000|Overall Study|Lost to Follow-up|12|||
143447790|NCT02180243|517184804|FG001|Overall Study|Lost to Follow-up|2|||
143447791|NCT01647542|517184805|FG000|Overall Study|Major Protocol Deviation|1|||
143447792|NCT01647542|517184806|FG001|Overall Study|Major Protocol Deviation|0|||
143447793|NCT01647542|517184807|FG002|Overall Study|Major Protocol Deviation|0|||
143447794|NCT01647542|517184805|FG000|Overall Study|Adverse Event|4|||
143447795|NCT01647542|517184806|FG001|Overall Study|Adverse Event|5|||
143447796|NCT01647542|517184807|FG002|Overall Study|Adverse Event|4|||
143447797|NCT01647542|517184805|FG000|Overall Study|Lost to Follow-up|0|||
143447798|NCT01647542|517184806|FG001|Overall Study|Lost to Follow-up|2|||
143447799|NCT01647542|517184807|FG002|Overall Study|Lost to Follow-up|2|||
143447800|NCT01647542|517184805|FG000|Overall Study|Withdrawal by Subject|6|||
143447801|NCT01647542|517184806|FG001|Overall Study|Withdrawal by Subject|4|||
143447802|NCT01647542|517184807|FG002|Overall Study|Withdrawal by Subject|0|||
143447803|NCT01647542|517184805|FG000|Overall Study|Study Termination|64|||
143447804|NCT01647542|517184806|FG001|Overall Study|Study Termination|61|||
143447805|NCT01647542|517184807|FG002|Overall Study|Study Termination|65|||
143447806|NCT01647542|517184805|FG000|Overall Study|Lack of Efficacy|1|||
143447807|NCT01647542|517184806|FG001|Overall Study|Lack of Efficacy|1|||
143447808|NCT01647542|517184807|FG002|Overall Study|Lack of Efficacy|0|||
143447809|NCT01647542|517184805|FG000|Overall Study|Death|0|||
143447810|NCT01647542|517184806|FG001|Overall Study|Death|0|||
143447811|NCT01647542|517184807|FG002|Overall Study|Death|1|||
143447812|NCT05292586|517184808|FG000|Overall Study|Withdrawal by Subject|3|||
143447813|NCT05292586|517184809|FG001|Overall Study|Withdrawal by Subject|10|||
143447814|NCT05292586|517184808|FG000|Overall Study|Randomization error|3|||
143447815|NCT05292586|517184809|FG001|Overall Study|Randomization error|7|||
143447816|NCT05292586|517184808|FG000|Overall Study|Adverse Event|3|||
143447817|NCT05292586|517184809|FG001|Overall Study|Adverse Event|0|||
143447818|NCT05292586|517184808|FG000|Overall Study|Lost to Follow-up|0|||
143447819|NCT05292586|517184809|FG001|Overall Study|Lost to Follow-up|1|||
143447820|NCT05292586|517184808|FG000|Overall Study|Patient refused treatment|1|||
143447821|NCT05292586|517184809|FG001|Overall Study|Patient refused treatment|0|||
143447822|NCT05292586|517184808|FG000|Overall Study|Patient could not travel to the study site|1|||
143447823|NCT05292586|517184809|FG001|Overall Study|Patient could not travel to the study site|0|||
143447824|NCT05292586|517184808|FG000|Overall Study|Technical issues with the masterscope|0|||
143447825|NCT05292586|517184809|FG001|Overall Study|Technical issues with the masterscope|3|||
143447826|NCT05292586|517184808|FG000|Overall Study|Patient moved to a different state|0|||
143447827|NCT05292586|517184809|FG001|Overall Study|Patient moved to a different state|1|||
143447828|NCT01040169|517184823|FG000|Overall Study|Lost to Follow-up|3|||
143447829|NCT01040169|517184824|FG001|Overall Study|Lost to Follow-up|8|||
143447830|NCT03551691|517184825|FG000|Overall Study|Withdrawal by Subject|3|||
143447831|NCT03551691|517184826|FG001|Overall Study|Withdrawal by Subject|3|||
143447832|NCT02367040|517184827|FG000|Overall Study|Lost to Follow-up|1|||
143447833|NCT02367040|517184828|FG001|Overall Study|Lost to Follow-up|1|||
143447834|NCT02367040|517184827|FG000|Overall Study|Lack of Efficacy|1|||
143447835|NCT02367040|517184828|FG001|Overall Study|Lack of Efficacy|0|||
143447836|NCT02367040|517184827|FG000|Overall Study|Additional primary malignancy|1|||
143447837|NCT02367040|517184828|FG001|Overall Study|Additional primary malignancy|1|||
143447838|NCT02367040|517184827|FG000|Overall Study|AE not associated with clinical disease progression|117|||
143447839|NCT02367040|517184828|FG001|Overall Study|AE not associated with clinical disease progression|12|||
143447840|NCT02367040|517184827|FG000|Overall Study|AE associated with clinical disease progression|1|||
143447841|NCT02367040|517184828|FG001|Overall Study|AE associated with clinical disease progression|4|||
143447842|NCT02367040|517184827|FG000|Overall Study|Physician Decision|2|||
143447843|NCT02367040|517184828|FG001|Overall Study|Physician Decision|8|||
143447844|NCT02367040|517184827|FG000|Overall Study|Non-compliance to study drug|1|||
143447845|NCT02367040|517184828|FG001|Overall Study|Non-compliance to study drug|0|||
143447846|NCT02367040|517184827|FG000|Overall Study|Failure to meet continuation criteria|1|||
143447847|NCT02367040|517184828|FG001|Overall Study|Failure to meet continuation criteria|0|||
143447848|NCT02367040|517184827|FG000|Overall Study|Switching to other therapy|2|||
143447849|NCT02367040|517184828|FG001|Overall Study|Switching to other therapy|0|||
143447850|NCT02367040|517184827|FG000|Overall Study|Withdrawal by Subject|51|||
143447851|NCT02367040|517184828|FG001|Overall Study|Withdrawal by Subject|16|||
143447852|NCT02367040|517184827|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
143447853|NCT02367040|517184828|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
143447854|NCT02367040|517184827|FG000|Overall Study|Patient decision|40|||
143447855|NCT02367040|517184828|FG001|Overall Study|Patient decision|14|||
143447856|NCT02367040|517184827|FG000|Overall Study|Required procedure failed|1|||
143447857|NCT02367040|517184828|FG001|Overall Study|Required procedure failed|0|||
143447858|NCT02367040|517184827|FG000|Overall Study|Randomized by mistake with study treatment|1|||
143447859|NCT02367040|517184828|FG001|Overall Study|Randomized by mistake with study treatment|0|||
143447860|NCT02367040|517184827|FG000|Overall Study|Protocol Violation|1|||
143447861|NCT02367040|517184828|FG001|Overall Study|Protocol Violation|0|||
143447862|NCT02367040|517184827|FG000|Overall Study|Progressive disease - radiological progression|54|||
143447863|NCT02367040|517184828|FG001|Overall Study|Progressive disease - radiological progression|80|||
143447864|NCT02367040|517184827|FG000|Overall Study|Progressive disease - clinical progression|6|||
143447865|NCT02367040|517184828|FG001|Overall Study|Progressive disease - clinical progression|6|||
143447866|NCT02367040|517184827|FG000|Overall Study|Drug not administered|3|||
143447867|NCT02367040|517184828|FG001|Overall Study|Drug not administered|2|||
143447868|NCT02367040|517184827|FG000|Overall Study|Progressive disease|0|||
143447869|NCT02367040|517184828|FG001|Overall Study|Progressive disease|1|||
143447870|NCT02367040|517184827|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
143447871|NCT02367040|517184828|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
143447872|NCT02367040|517184827|FG000|Overall Study|Death|2|||
143447873|NCT02367040|517184828|FG001|Overall Study|Death|0|||
143447874|NCT02367040|517184827|FG000|Overall Study|Study terminated by sponsor|19|||
143447875|NCT02367040|517184828|FG001|Overall Study|Study terminated by sponsor|2|||
143447876|NCT02477618|517184829|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
143447877|NCT02477618|517184830|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
143447878|NCT02477618|517184829|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
143447879|NCT02477618|517184830|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
143447880|NCT02477618|517184829|FG000|Overall Study|Adverse Event|1|||
143447881|NCT02477618|517184830|FG001|Overall Study|Adverse Event|1|||
143447882|NCT02477618|517184829|FG000|Overall Study|Transferred Away from Study Site|1|||
143447883|NCT02477618|517184830|FG001|Overall Study|Transferred Away from Study Site|0|||
143447884|NCT02477618|517184829|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
143447885|NCT02477618|517184830|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
143447886|NCT02446821|517184831|FG000|Overall Study|Adverse Event|28|||
143447887|NCT02446821|517184831|FG000|Overall Study|Withdrawal by Subject|6|||
143447888|NCT02446821|517184831|FG000|Overall Study|Lost to Follow-up|22|||
143447889|NCT02446821|517184831|FG000|Overall Study|other|9|||
143447890|NCT02446821|517184831|FG000|Overall Study|insertion failure|3|||
143447891|NCT02284009|517184835|FG000|Overall Study|Adverse Event|3|||
143447892|NCT02284009|517184836|FG001|Overall Study|Adverse Event|0|||
143447893|NCT02284009|517184835|FG000|Overall Study|Lost to Follow-up|1|||
143447894|NCT02284009|517184836|FG001|Overall Study|Lost to Follow-up|3|||
143447895|NCT02284009|517184835|FG000|Overall Study|Physician Decision|0|||
143447896|NCT02284009|517184836|FG001|Overall Study|Physician Decision|2|||
143447897|NCT02284009|517184835|FG000|Overall Study|Withdrawal by Subject|2|||
143447898|NCT02284009|517184836|FG001|Overall Study|Withdrawal by Subject|5|||
143447899|NCT02397447|517184837|FG000|Overall Study|Lost to Follow-up|2|||
143447900|NCT02397447|517184838|FG001|Overall Study|Lost to Follow-up|2|||
143447901|NCT03524092|517184839|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
143447902|NCT03524092|517184840|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
143447903|NCT03524092|517184841|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
143447904|NCT03524092|517184842|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
143447905|NCT03524092|517184843|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
143447906|NCT03524092|517184844|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
143447907|NCT03524092|517184839|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
143447908|NCT03524092|517184840|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
143447909|NCT03524092|517184841|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
143447910|NCT03524092|517184842|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
143447911|NCT03524092|517184843|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
143447912|NCT03524092|517184844|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
143447913|NCT03524092|517184839|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
143447914|NCT03524092|517184840|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
143447915|NCT03524092|517184841|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
143447916|NCT03524092|517184842|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
143447917|NCT03524092|517184843|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
143447918|NCT03524092|517184844|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
143447919|NCT03524092|517184839|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
143447920|NCT03524092|517184840|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
143447921|NCT03524092|517184841|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
143447922|NCT03524092|517184842|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
143447923|NCT03524092|517184843|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
143447924|NCT03524092|517184844|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
143447925|NCT03524092|517184839|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
143447926|NCT03524092|517184840|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
143447927|NCT03524092|517184841|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
143447928|NCT03524092|517184842|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
143447929|NCT03524092|517184843|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
143447930|NCT03524092|517184844|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
143447931|NCT03524092|517184839|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
143447932|NCT03524092|517184840|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
143447933|NCT03524092|517184841|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
143447934|NCT03524092|517184842|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
143447935|NCT03524092|517184843|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
143447936|NCT03524092|517184844|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
143447937|NCT03524092|517184839|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
143447938|NCT03524092|517184840|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
143447939|NCT03524092|517184841|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
143447940|NCT03524092|517184842|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
143447941|NCT03524092|517184843|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
143447942|NCT03524092|517184844|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
143447943|NCT03524092|517184839|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
143447944|NCT03524092|517184840|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
143447945|NCT03524092|517184841|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
143447946|NCT03524092|517184842|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
143447947|NCT03524092|517184843|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
143447948|NCT03524092|517184844|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
143447949|NCT03524092|517184839|FG000|Loss of Response Rescue Period|Adverse Event|0|||
143447950|NCT03524092|517184840|FG001|Loss of Response Rescue Period|Adverse Event|0|||
143447951|NCT03524092|517184841|FG002|Loss of Response Rescue Period|Adverse Event|0|||
143447952|NCT03524092|517184842|FG003|Loss of Response Rescue Period|Adverse Event|2|||
143447953|NCT03524092|517184843|FG004|Loss of Response Rescue Period|Adverse Event|0|||
143447954|NCT03524092|517184844|FG005|Loss of Response Rescue Period|Adverse Event|0|||
143447955|NCT03524092|517184839|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
143447956|NCT03524092|517184840|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
143447957|NCT03524092|517184841|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
143447958|NCT03524092|517184842|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
143447959|NCT03524092|517184843|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
143447960|NCT03524092|517184844|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
143447961|NCT03524092|517184839|FG000|Loss of Response Rescue Period|Pregnancy|0|||
143447962|NCT03524092|517184840|FG001|Loss of Response Rescue Period|Pregnancy|0|||
143447963|NCT03524092|517184841|FG002|Loss of Response Rescue Period|Pregnancy|0|||
143447964|NCT03524092|517184842|FG003|Loss of Response Rescue Period|Pregnancy|1|||
143447965|NCT03524092|517184843|FG004|Loss of Response Rescue Period|Pregnancy|0|||
143447966|NCT03524092|517184844|FG005|Loss of Response Rescue Period|Pregnancy|0|||
143447967|NCT03524092|517184839|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
143447968|NCT03524092|517184840|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
143447969|NCT03524092|517184841|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
143447970|NCT03524092|517184842|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
143447971|NCT03524092|517184843|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
143447972|NCT03524092|517184844|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
143447973|NCT03524092|517184839|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
143447974|NCT03524092|517184840|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
143447975|NCT03524092|517184841|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
143447976|NCT03524092|517184842|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
143447977|NCT03524092|517184843|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
143447978|NCT03524092|517184844|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
143447979|NCT03524092|517184839|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
143447980|NCT03524092|517184840|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
143447981|NCT03524092|517184841|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
143447982|NCT03524092|517184842|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
143447983|NCT03524092|517184843|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
143447984|NCT03524092|517184844|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
143447985|NCT03524092|517184839|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
143447986|NCT03524092|517184840|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
143447987|NCT03524092|517184841|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
143447988|NCT03524092|517184842|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
143447989|NCT03524092|517184843|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
143447990|NCT03524092|517184844|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
143447991|NCT03524092|517184839|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
143447992|NCT03524092|517184840|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
143447993|NCT03524092|517184841|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
143447994|NCT03524092|517184842|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
143447995|NCT03524092|517184843|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
143447996|NCT03524092|517184844|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
143447997|NCT03524092|517184839|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
143447998|NCT03524092|517184840|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
143447999|NCT03524092|517184841|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
143448000|NCT03524092|517184842|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
143448001|NCT03524092|517184843|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
143448002|NCT03524092|517184844|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
143448003|NCT03524092|517184839|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
143448004|NCT03524092|517184840|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
143448005|NCT03524092|517184841|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
143448006|NCT03524092|517184842|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
143448007|NCT03524092|517184843|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
143448008|NCT03524092|517184844|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
143448009|NCT03524092|517184839|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
143448010|NCT03524092|517184840|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
143448011|NCT03524092|517184841|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
143448012|NCT03524092|517184842|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
143448013|NCT03524092|517184843|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
143448014|NCT03524092|517184844|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
143448015|NCT03524092|517184839|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
143448016|NCT03524092|517184840|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
143448017|NCT03524092|517184841|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
143448018|NCT03524092|517184842|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
143448019|NCT03524092|517184843|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
143448020|NCT03524092|517184844|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
143448021|NCT03524092|517184839|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
143448022|NCT03524092|517184840|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
143448023|NCT03524092|517184841|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
143448024|NCT03524092|517184842|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
143448025|NCT03524092|517184843|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
143448026|NCT03524092|517184844|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
143448027|NCT03524092|517184839|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
143448028|NCT03524092|517184840|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
143448029|NCT03524092|517184841|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
143448030|NCT03524092|517184842|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
143448031|NCT03524092|517184843|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
143448032|NCT03524092|517184844|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
143448033|NCT03524092|517184839|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
143448034|NCT03524092|517184840|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
143448035|NCT03524092|517184841|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
143448036|NCT03524092|517184842|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
143448037|NCT03524092|517184843|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
143448038|NCT03524092|517184844|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
143448039|NCT01123070|517185909|FG000|Part B Double Blind Period|Protocol Violation|0|||
143448040|NCT01123070|517185910|FG001|Part B Double Blind Period|Protocol Violation|0|||
143448041|NCT01123070|517185911|FG002|Part B Double Blind Period|Protocol Violation|0|||
143448042|NCT01123070|517185912|FG003|Part B Double Blind Period|Protocol Violation|1|||
143448043|NCT01123070|517185909|FG000|Part B Double Blind Period|Adverse Event|0|||
143448044|NCT01123070|517185910|FG001|Part B Double Blind Period|Adverse Event|0|||
143448045|NCT01123070|517185911|FG002|Part B Double Blind Period|Adverse Event|2|||
143448046|NCT01123070|517185912|FG003|Part B Double Blind Period|Adverse Event|0|||
143448047|NCT01123070|517185909|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
143448048|NCT01123070|517185910|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
143448049|NCT01123070|517185911|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
143448050|NCT01123070|517185912|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
143448051|NCT03554629|517185913|FG000|Overall Study|Inadequate data|6|||
143448052|NCT00667225|517185916|FG000|Overall Study|Subject had no more lesions to treat.|1|||
143448053|NCT00667225|517185917|FG001|Overall Study|Subject had no more lesions to treat.|0|||
143448054|NCT00667225|517185916|FG000|Overall Study|Lost to Follow-up|0|||
143448055|NCT00667225|517185917|FG001|Overall Study|Lost to Follow-up|1|||
143448056|NCT03563157|517185918|FG000|Overall Study|Progressive Disease|2|||
143448057|NCT05262517|517185919|FG000|Overall Study|Randomized but not treated|5|||
143448058|NCT05262517|517185920|FG001|Overall Study|Randomized but not treated|11|||
143448059|NCT02942277|517185921|FG000|Year 1|Withdrawal by Subject|0|||
143448060|NCT02942277|517185922|FG001|Year 1|Withdrawal by Subject|0|||
143448061|NCT02942277|517185923|FG002|Year 1|Withdrawal by Subject|0|||
143448062|NCT02942277|517185924|FG003|Year 1|Withdrawal by Subject|0|||
143448063|NCT02942277|517185925|FG004|Year 1|Withdrawal by Subject|1|||
143448064|NCT02942277|517185926|FG005|Year 1|Withdrawal by Subject|3|||
143448065|NCT02942277|517185927|FG006|Year 1|Withdrawal by Subject|0|||
143448066|NCT02942277|517185928|FG007|Year 1|Withdrawal by Subject|1|||
143448067|NCT02942277|517185929|FG008|Year 1|Withdrawal by Subject|0|||
143448068|NCT02942277|517185930|FG009|Year 1|Withdrawal by Subject|0|||
143448069|NCT02942277|517185931|FG010|Year 1|Withdrawal by Subject|3|||
143448070|NCT02942277|517185921|FG000|Year 1|Travel|0|||
143448071|NCT02942277|517185922|FG001|Year 1|Travel|1|||
143448072|NCT02942277|517185923|FG002|Year 1|Travel|0|||
143448073|NCT02942277|517185924|FG003|Year 1|Travel|0|||
143448074|NCT02942277|517185925|FG004|Year 1|Travel|4|||
143448075|NCT02942277|517185926|FG005|Year 1|Travel|5|||
143448076|NCT02942277|517185927|FG006|Year 1|Travel|0|||
143448077|NCT02942277|517185928|FG007|Year 1|Travel|0|||
143448078|NCT02942277|517185929|FG008|Year 1|Travel|0|||
143448079|NCT02942277|517185930|FG009|Year 1|Travel|0|||
143448080|NCT02942277|517185931|FG010|Year 1|Travel|8|||
143448081|NCT02942277|517185921|FG000|Year 1|Joined Army|0|||
143448082|NCT02942277|517185922|FG001|Year 1|Joined Army|1|||
143448083|NCT02942277|517185923|FG002|Year 1|Joined Army|0|||
143448084|NCT02942277|517185924|FG003|Year 1|Joined Army|0|||
143448085|NCT02942277|517185925|FG004|Year 1|Joined Army|0|||
143448086|NCT02942277|517185926|FG005|Year 1|Joined Army|0|||
143448087|NCT02942277|517185927|FG006|Year 1|Joined Army|0|||
143448088|NCT02942277|517185928|FG007|Year 1|Joined Army|0|||
143448089|NCT02942277|517185929|FG008|Year 1|Joined Army|0|||
143448090|NCT02942277|517185930|FG009|Year 1|Joined Army|0|||
143448091|NCT02942277|517185931|FG010|Year 1|Joined Army|0|||
143448092|NCT02942277|517185921|FG000|Year 1|Subject met withdrawal criteria|0|||
143448093|NCT02942277|517185922|FG001|Year 1|Subject met withdrawal criteria|0|||
143448094|NCT02942277|517185923|FG002|Year 1|Subject met withdrawal criteria|0|||
143448095|NCT02942277|517185924|FG003|Year 1|Subject met withdrawal criteria|1|||
143448096|NCT02942277|517185925|FG004|Year 1|Subject met withdrawal criteria|0|||
143448097|NCT02942277|517185926|FG005|Year 1|Subject met withdrawal criteria|0|||
143448098|NCT02942277|517185927|FG006|Year 1|Subject met withdrawal criteria|0|||
143448099|NCT02942277|517185928|FG007|Year 1|Subject met withdrawal criteria|0|||
143448100|NCT02942277|517185929|FG008|Year 1|Subject met withdrawal criteria|0|||
143448101|NCT02942277|517185930|FG009|Year 1|Subject met withdrawal criteria|0|||
143448102|NCT02942277|517185931|FG010|Year 1|Subject met withdrawal criteria|0|||
143448103|NCT02942277|517185921|FG000|Year 1|Lost to Follow-up|0|||
143448104|NCT02942277|517185922|FG001|Year 1|Lost to Follow-up|0|||
143448105|NCT02942277|517185923|FG002|Year 1|Lost to Follow-up|0|||
143448106|NCT02942277|517185924|FG003|Year 1|Lost to Follow-up|0|||
143448107|NCT02942277|517185925|FG004|Year 1|Lost to Follow-up|1|||
143448108|NCT02942277|517185926|FG005|Year 1|Lost to Follow-up|0|||
143448109|NCT02942277|517185927|FG006|Year 1|Lost to Follow-up|0|||
143448110|NCT02942277|517185928|FG007|Year 1|Lost to Follow-up|0|||
143448111|NCT02942277|517185929|FG008|Year 1|Lost to Follow-up|0|||
143448112|NCT02942277|517185930|FG009|Year 1|Lost to Follow-up|0|||
143448113|NCT02942277|517185931|FG010|Year 1|Lost to Follow-up|2|||
143448114|NCT02942277|517185921|FG000|Year 1|Protocol Violation|0|||
143448115|NCT02942277|517185922|FG001|Year 1|Protocol Violation|0|||
143448116|NCT02942277|517185923|FG002|Year 1|Protocol Violation|0|||
143448117|NCT02942277|517185924|FG003|Year 1|Protocol Violation|0|||
143448118|NCT02942277|517185925|FG004|Year 1|Protocol Violation|1|||
143448119|NCT02942277|517185926|FG005|Year 1|Protocol Violation|1|||
143448120|NCT02942277|517185927|FG006|Year 1|Protocol Violation|0|||
143448121|NCT02942277|517185928|FG007|Year 1|Protocol Violation|0|||
143448122|NCT02942277|517185929|FG008|Year 1|Protocol Violation|0|||
143448123|NCT02942277|517185930|FG009|Year 1|Protocol Violation|0|||
143448124|NCT02942277|517185931|FG010|Year 1|Protocol Violation|2|||
143448125|NCT02942277|517185921|FG000|Year 1|Pregnancy|0|||
143448126|NCT02942277|517185922|FG001|Year 1|Pregnancy|0|||
143448127|NCT02942277|517185923|FG002|Year 1|Pregnancy|0|||
143448128|NCT02942277|517185924|FG003|Year 1|Pregnancy|0|||
143448129|NCT02942277|517185925|FG004|Year 1|Pregnancy|0|||
143448130|NCT02942277|517185926|FG005|Year 1|Pregnancy|1|||
143448131|NCT02942277|517185927|FG006|Year 1|Pregnancy|0|||
143448132|NCT02942277|517185928|FG007|Year 1|Pregnancy|0|||
143448133|NCT02942277|517185929|FG008|Year 1|Pregnancy|0|||
143448134|NCT02942277|517185930|FG009|Year 1|Pregnancy|0|||
143448135|NCT02942277|517185931|FG010|Year 1|Pregnancy|0|||
143448136|NCT02942277|517185921|FG000|Year 2|Lost to Follow-up|0|||
143448137|NCT02942277|517185922|FG001|Year 2|Lost to Follow-up|0|||
143448138|NCT02942277|517185923|FG002|Year 2|Lost to Follow-up|0|||
143448139|NCT02942277|517185924|FG003|Year 2|Lost to Follow-up|0|||
143448140|NCT02942277|517185925|FG004|Year 2|Lost to Follow-up|2|||
143448141|NCT02942277|517185926|FG005|Year 2|Lost to Follow-up|1|||
143448142|NCT02942277|517185927|FG006|Year 2|Lost to Follow-up|0|||
143448143|NCT02942277|517185928|FG007|Year 2|Lost to Follow-up|0|||
143448144|NCT02942277|517185929|FG008|Year 2|Lost to Follow-up|0|||
143448145|NCT02942277|517185930|FG009|Year 2|Lost to Follow-up|0|||
143448146|NCT02942277|517185931|FG010|Year 2|Lost to Follow-up|0|||
143448147|NCT02942277|517185921|FG000|Year 2|Did not rescreen|0|||
143448148|NCT02942277|517185922|FG001|Year 2|Did not rescreen|0|||
143448149|NCT02942277|517185923|FG002|Year 2|Did not rescreen|1|||
143448150|NCT02942277|517185924|FG003|Year 2|Did not rescreen|1|||
143448151|NCT02942277|517185925|FG004|Year 2|Did not rescreen|9|||
143448152|NCT02942277|517185926|FG005|Year 2|Did not rescreen|6|||
143448153|NCT02942277|517185927|FG006|Year 2|Did not rescreen|0|||
143448154|NCT02942277|517185928|FG007|Year 2|Did not rescreen|1|||
143448155|NCT02942277|517185929|FG008|Year 2|Did not rescreen|0|||
143448156|NCT02942277|517185930|FG009|Year 2|Did not rescreen|0|||
143448157|NCT02942277|517185931|FG010|Year 2|Did not rescreen|21|||
143448158|NCT02942277|517185921|FG000|Year 2|Met withdrawal criteria|0|||
143448159|NCT02942277|517185922|FG001|Year 2|Met withdrawal criteria|0|||
143448160|NCT02942277|517185923|FG002|Year 2|Met withdrawal criteria|0|||
143448161|NCT02942277|517185924|FG003|Year 2|Met withdrawal criteria|0|||
143448162|NCT02942277|517185925|FG004|Year 2|Met withdrawal criteria|1|||
143448163|NCT02942277|517185926|FG005|Year 2|Met withdrawal criteria|2|||
143448164|NCT02942277|517185927|FG006|Year 2|Met withdrawal criteria|0|||
143448165|NCT02942277|517185928|FG007|Year 2|Met withdrawal criteria|0|||
143448166|NCT02942277|517185929|FG008|Year 2|Met withdrawal criteria|0|||
143448167|NCT02942277|517185930|FG009|Year 2|Met withdrawal criteria|0|||
143448168|NCT02942277|517185931|FG010|Year 2|Met withdrawal criteria|1|||
143448169|NCT02942277|517185921|FG000|Year 2|Travel|0|||
143448170|NCT02942277|517185922|FG001|Year 2|Travel|1|||
143448171|NCT02942277|517185923|FG002|Year 2|Travel|0|||
143448172|NCT02942277|517185924|FG003|Year 2|Travel|0|||
143448173|NCT02942277|517185925|FG004|Year 2|Travel|0|||
143448174|NCT02942277|517185926|FG005|Year 2|Travel|1|||
143448175|NCT02942277|517185927|FG006|Year 2|Travel|0|||
143448176|NCT02942277|517185928|FG007|Year 2|Travel|0|||
143448177|NCT02942277|517185929|FG008|Year 2|Travel|0|||
143448178|NCT02942277|517185930|FG009|Year 2|Travel|1|||
143448179|NCT02942277|517185931|FG010|Year 2|Travel|3|||
143448180|NCT02942277|517185921|FG000|Year 2|Non-compliant|0|||
143448181|NCT02942277|517185922|FG001|Year 2|Non-compliant|0|||
143448182|NCT02942277|517185923|FG002|Year 2|Non-compliant|0|||
143448183|NCT02942277|517185924|FG003|Year 2|Non-compliant|0|||
143448184|NCT02942277|517185925|FG004|Year 2|Non-compliant|1|||
143448185|NCT02942277|517185926|FG005|Year 2|Non-compliant|1|||
143448186|NCT02942277|517185927|FG006|Year 2|Non-compliant|0|||
143448187|NCT02942277|517185928|FG007|Year 2|Non-compliant|0|||
143448188|NCT02942277|517185929|FG008|Year 2|Non-compliant|0|||
143448189|NCT02942277|517185930|FG009|Year 2|Non-compliant|0|||
143448190|NCT02942277|517185931|FG010|Year 2|Non-compliant|0|||
143448191|NCT02942277|517185921|FG000|Year 2|Withdrawal by Subject|0|||
143448192|NCT02942277|517185922|FG001|Year 2|Withdrawal by Subject|0|||
143448193|NCT02942277|517185923|FG002|Year 2|Withdrawal by Subject|0|||
143448194|NCT02942277|517185924|FG003|Year 2|Withdrawal by Subject|0|||
143448195|NCT02942277|517185925|FG004|Year 2|Withdrawal by Subject|0|||
143448196|NCT02942277|517185926|FG005|Year 2|Withdrawal by Subject|0|||
143448197|NCT02942277|517185927|FG006|Year 2|Withdrawal by Subject|1|||
143448198|NCT02942277|517185928|FG007|Year 2|Withdrawal by Subject|0|||
143448199|NCT02942277|517185929|FG008|Year 2|Withdrawal by Subject|0|||
143448200|NCT02942277|517185930|FG009|Year 2|Withdrawal by Subject|0|||
143448201|NCT02942277|517185931|FG010|Year 2|Withdrawal by Subject|0|||
143448202|NCT02187159|517185932|FG000|Overall Study|Protocol Violation|4|||
143448203|NCT02187159|517185933|FG001|Overall Study|Protocol Violation|6|||
143448204|NCT02187159|517185934|FG002|Overall Study|Protocol Violation|3|||
143448205|NCT02187159|517185935|FG003|Overall Study|Protocol Violation|4|||
143448206|NCT02187159|517185932|FG000|Overall Study|Lack of Efficacy|10|||
143448207|NCT02187159|517185933|FG001|Overall Study|Lack of Efficacy|5|||
143448208|NCT02187159|517185934|FG002|Overall Study|Lack of Efficacy|4|||
143448209|NCT02187159|517185935|FG003|Overall Study|Lack of Efficacy|7|||
143448210|NCT02187159|517185932|FG000|Overall Study|Adverse Event|28|||
143448211|NCT02187159|517185933|FG001|Overall Study|Adverse Event|33|||
143448212|NCT02187159|517185934|FG002|Overall Study|Adverse Event|42|||
143448213|NCT02187159|517185935|FG003|Overall Study|Adverse Event|50|||
143448214|NCT02187159|517185932|FG000|Overall Study|Withdrawal by Subject|24|||
143448215|NCT02187159|517185933|FG001|Overall Study|Withdrawal by Subject|28|||
143448216|NCT02187159|517185934|FG002|Overall Study|Withdrawal by Subject|25|||
143448217|NCT02187159|517185935|FG003|Overall Study|Withdrawal by Subject|26|||
143448218|NCT02187159|517185932|FG000|Overall Study|Other|3|||
143448219|NCT02187159|517185933|FG001|Overall Study|Other|7|||
143448220|NCT02187159|517185934|FG002|Overall Study|Other|3|||
143448221|NCT02187159|517185935|FG003|Overall Study|Other|9|||
143448222|NCT04325282|517185936|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
143448223|NCT04325282|517185937|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
143448224|NCT04325282|517185936|FG000|Second Intervention (1 Day)|Withdrawal by Subject|0|||
143448225|NCT04325282|517185937|FG001|Second Intervention (1 Day)|Withdrawal by Subject|1|||
143448226|NCT05282121|517185943|FG000|Overall Study|Adverse Event|1|||
143448227|NCT05282121|517185944|FG001|Overall Study|Adverse Event|1|||
143448228|NCT05282121|517185945|FG002|Overall Study|Adverse Event|4|||
143448229|NCT05282121|517185946|FG003|Overall Study|Adverse Event|1|||
143448230|NCT05282121|517185943|FG000|Overall Study|Study Terminated by Sponsor|1|||
143448231|NCT05282121|517185944|FG001|Overall Study|Study Terminated by Sponsor|2|||
143448232|NCT05282121|517185945|FG002|Overall Study|Study Terminated by Sponsor|2|||
143448233|NCT05282121|517185946|FG003|Overall Study|Study Terminated by Sponsor|2|||
143448234|NCT05282121|517185943|FG000|Overall Study|Other than listed|0|||
143448235|NCT05282121|517185944|FG001|Overall Study|Other than listed|0|||
143448236|NCT05282121|517185945|FG002|Overall Study|Other than listed|1|||
143448237|NCT05282121|517185946|FG003|Overall Study|Other than listed|0|||
143448238|NCT05282121|517185943|FG000|Overall Study|No reason available|0|||
143448239|NCT05282121|517185944|FG001|Overall Study|No reason available|0|||
143448240|NCT05282121|517185945|FG002|Overall Study|No reason available|1|||
143448241|NCT05282121|517185946|FG003|Overall Study|No reason available|0|||
143448242|NCT01736189|517185949|FG000|Overall Study|Violation of registration criteria|41|||
143448243|NCT01736189|517185949|FG000|Overall Study|Protocol Violation|4|||
143448244|NCT01736189|517185949|FG000|Overall Study|Criteria and protocol violations|1|||
143448245|NCT00608868|517185952|FG000|Overall Study|Withdrawal by Subject|7|||
143448246|NCT00608868|517185952|FG000|Overall Study|Protocol Violation|3|||
143448247|NCT00608868|517185952|FG000|Overall Study|Lost to Follow-up|2|||
143448248|NCT00608868|517185952|FG000|Overall Study|Adverse Event|1|||
143448249|NCT00608868|517185952|FG000|Overall Study|Physician Decision|2|||
143448250|NCT01712061|517185953|FG000|Overall Study|Adverse Event|4|||
143448251|NCT01712061|517185954|FG001|Overall Study|Adverse Event|9|||
143448252|NCT01712061|517185955|FG002|Overall Study|Adverse Event|5|||
143448253|NCT01712061|517185953|FG000|Overall Study|Death|0|||
143448254|NCT01712061|517185954|FG001|Overall Study|Death|0|||
143448255|NCT01712061|517185955|FG002|Overall Study|Death|1|||
143448256|NCT01712061|517185953|FG000|Overall Study|Lost to Follow-up|1|||
143448257|NCT01712061|517185954|FG001|Overall Study|Lost to Follow-up|0|||
143448258|NCT01712061|517185955|FG002|Overall Study|Lost to Follow-up|1|||
143448259|NCT01712061|517185953|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
143448260|NCT01712061|517185954|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
143448261|NCT01712061|517185955|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
143448262|NCT01712061|517185953|FG000|Overall Study|Medication Error Without Associated AE|0|||
143448263|NCT01712061|517185954|FG001|Overall Study|Medication Error Without Associated AE|1|||
143448264|NCT01712061|517185955|FG002|Overall Study|Medication Error Without Associated AE|0|||
143448265|NCT01712061|517185953|FG000|Overall Study|Withdrawal by Subject|1|||
143448266|NCT01712061|517185954|FG001|Overall Study|Withdrawal by Subject|7|||
143448267|NCT01712061|517185955|FG002|Overall Study|Withdrawal by Subject|1|||
143448268|NCT01712061|517185953|FG000|Overall Study|Other|0|||
143448269|NCT01712061|517185954|FG001|Overall Study|Other|3|||
143448270|NCT01712061|517185955|FG002|Overall Study|Other|0|||
143448271|NCT00879775|517185958|FG000|Overall Study|Lost to Follow-up|2|||
143448272|NCT00879775|517185959|FG001|Overall Study|Lost to Follow-up|1|||
143448273|NCT01677767|517185960|FG000|Overall Study|Adverse Event|1|||
143448274|NCT01677767|517185960|FG000|Overall Study|Death|4|||
143448275|NCT01677767|517185960|FG000|Overall Study|Protocol Violation|4|||
143448276|NCT01677767|517185960|FG000|Overall Study|Withdrawal by Subject|10|||
143448277|NCT01677767|517185960|FG000|Overall Study|Non-compliance by the participants|3|||
143448278|NCT00755105|517185961|FG000|Overall Study|Withdrawal by Subject|9|||
143448279|NCT00755105|517185962|FG001|Overall Study|Withdrawal by Subject|11|||
143448280|NCT00755105|517185963|FG002|Overall Study|Withdrawal by Subject|4|||
143448281|NCT00818779|517185966|FG000|Overall Study|Protocol Violation|1|||
143448282|NCT00818779|517185967|FG001|Overall Study|Protocol Violation|0|||
143448283|NCT00818779|517185966|FG000|Overall Study|Lost to Follow-up|1|||
143448284|NCT00818779|517185967|FG001|Overall Study|Lost to Follow-up|0|||
143448285|NCT00818779|517185966|FG000|Overall Study|Adverse Event|4|||
143448286|NCT00818779|517185967|FG001|Overall Study|Adverse Event|1|||
143448287|NCT01840410|517185970|FG000|Overall Study|Physician Decision|1|||
143448288|NCT01840410|517185971|FG001|Overall Study|Physician Decision|2|||
143448289|NCT01840410|517185970|FG000|Overall Study|Pregnancy|1|||
143448290|NCT01840410|517185971|FG001|Overall Study|Pregnancy|0|||
143448291|NCT01840410|517185970|FG000|Overall Study|Protocol deviation|1|||
143448292|NCT01840410|517185971|FG001|Overall Study|Protocol deviation|0|||
143448293|NCT01840410|517185970|FG000|Overall Study|Lost to Follow-up|1|||
143448294|NCT01840410|517185971|FG001|Overall Study|Lost to Follow-up|0|||
143448295|NCT01840410|517185970|FG000|Overall Study|Withdrawal by Subject|2|||
143448296|NCT01840410|517185971|FG001|Overall Study|Withdrawal by Subject|1|||
143448297|NCT01840410|517185970|FG000|Overall Study|Adverse Event|1|||
143448298|NCT01840410|517185971|FG001|Overall Study|Adverse Event|1|||
143448299|NCT00839956|517185972|FG000|Overall Study|Adverse Event|2|||
143448300|NCT00839956|517185972|FG000|Overall Study|Lack of Efficacy|6|||
143448301|NCT00839956|517185972|FG000|Overall Study|Physician Decision|1|||
143448302|NCT00839956|517185972|FG000|Overall Study|Withdrawal by Subject|3|||
143448303|NCT04343976|517185973|FG000|Overall Study|Withdrawal by Subject|0|||
143448304|NCT04343976|517185974|FG001|Overall Study|Withdrawal by Subject|1|||
143448305|NCT02807883|517185975|FG000|Overall Study|Withdrawal by Subject|2|||
143448306|NCT00594880|517185976|FG000|Overall Study|Withdrawal by Subject|1|||
143448307|NCT00594880|517185977|FG001|Overall Study|Withdrawal by Subject|1|||
143448308|NCT00594880|517185976|FG000|Overall Study|Lost to Follow-up|1|||
143448309|NCT00594880|517185977|FG001|Overall Study|Lost to Follow-up|0|||
143448310|NCT00694109|517185978|FG000|Overall Study|Physician Decision|3|||
143448311|NCT00694109|517185978|FG000|Overall Study|Adverse Event|74|||
143448312|NCT00694109|517185978|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
143448313|NCT00694109|517185978|FG000|Overall Study|Lack of Efficacy|2|||
143448314|NCT00694109|517185978|FG000|Overall Study|Withdrawal by Subject|13|||
143448315|NCT00694109|517185978|FG000|Overall Study|Pregnancy|1|||
143448316|NCT00694109|517185978|FG000|Overall Study|Enrolled but not treated|1|||
143448317|NCT00694109|517185978|FG000|Overall Study|Other|2|||
143448318|NCT00694109|517185978|FG000|Overall Study|Consented but no additional treatment|3|||
143448319|NCT01077518|517185983|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
143448320|NCT01077518|517185984|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
143448321|NCT01077518|517185985|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
143448322|NCT01077518|517185983|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
143448323|NCT01077518|517185984|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
143448324|NCT01077518|517185985|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
143448325|NCT01077518|517185983|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
143448326|NCT01077518|517185984|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
143448327|NCT01077518|517185985|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
143448328|NCT01077518|517185983|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
143448329|NCT01077518|517185984|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
143448330|NCT01077518|517185985|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
143448331|NCT01077518|517185983|FG000|Optional Ofa Phase|Physician Decision|0|||
143448332|NCT01077518|517185984|FG001|Optional Ofa Phase|Physician Decision|0|||
143448333|NCT01077518|517185985|FG002|Optional Ofa Phase|Physician Decision|1|||
143448334|NCT01077518|517185983|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
143448335|NCT01077518|517185984|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
143448336|NCT01077518|517185985|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
143448337|NCT01077518|517185983|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
143448338|NCT01077518|517185984|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
143448339|NCT01077518|517185985|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
143448340|NCT04958200|517185986|FG000|Overall Study|Withdrawal by Subject|0|||
143448341|NCT04958200|517185987|FG001|Overall Study|Withdrawal by Subject|2|||
143448342|NCT04958200|517185986|FG000|Overall Study|Lost to Follow-up|3|||
143448343|NCT04958200|517185987|FG001|Overall Study|Lost to Follow-up|2|||
143448344|NCT02387970|517185988|FG000|Overall Study|Did not complete 1-year follow up|1|||
143448345|NCT02387970|517185989|FG001|Overall Study|Did not complete 1-year follow up|2|||
143448346|NCT01495598|517185990|FG000|Overall Study|Death during follow up period|2|||
143448347|NCT01495598|517185990|FG000|Overall Study|Death on study|1|||
143448348|NCT01495598|517185990|FG000|Overall Study|Lost to Follow-up|3|||
143448349|NCT01495598|517185990|FG000|Overall Study|Physician Decision|8|||
143448350|NCT05511038|517185991|FG000|Overall|Withdrawal by Subject|5|||
143448351|NCT05511038|517185992|FG001|Overall|Withdrawal by Subject|3|||
143448352|NCT05511038|517185991|FG000|Overall|Screen Failure|20|||
143448353|NCT05511038|517185992|FG001|Overall|Screen Failure|1|||
143448354|NCT05511038|517185991|FG000|Overall|Physician Decision|3|||
143448355|NCT05511038|517185992|FG001|Overall|Physician Decision|0|||
143448356|NCT05511038|517185991|FG000|Overall|Lost to Follow-up|3|||
143448357|NCT05511038|517185992|FG001|Overall|Lost to Follow-up|0|||
143448358|NCT05511038|517185991|FG000|Overall|Death|1|||
143448359|NCT05511038|517185992|FG001|Overall|Death|0|||
143448360|NCT05511038|517185991|FG000|Screening|Withdrawal by Subject|1|||
143448361|NCT05511038|517185992|FG001|Screening|Withdrawal by Subject|0|||
143448362|NCT05511038|517185991|FG000|Screening|Lost to Follow Up (1 participant)|1|||
143448363|NCT05511038|517185992|FG001|Screening|Lost to Follow Up (1 participant)|0|||
143448364|NCT05511038|517185991|FG000|Screening|Screen Failure|3|||
143448365|NCT05511038|517185992|FG001|Screening|Screen Failure|0|||
143448366|NCT05511038|517185991|FG000|Screening|Screen Failure that was identified after screening (1 participant)|1|||
143448367|NCT05511038|517185992|FG001|Screening|Screen Failure that was identified after screening (1 participant)|0|||
143448368|NCT05511038|517185991|FG000|Treatment|Withdrawal by Subject|5|||
143448369|NCT05511038|517185992|FG001|Treatment|Withdrawal by Subject|3|||
143448370|NCT05511038|517185991|FG000|Treatment|Physician Decision|4|||
143448371|NCT05511038|517185992|FG001|Treatment|Physician Decision|0|||
143448372|NCT05511038|517185991|FG000|Treatment|Lost to Follow-up|2|||
143448373|NCT05511038|517185992|FG001|Treatment|Lost to Follow-up|0|||
143448374|NCT05511038|517185991|FG000|Treatment|Death|1|||
143448375|NCT05511038|517185992|FG001|Treatment|Death|0|||
143448376|NCT05511038|517185991|FG000|Treatment|Subject did nod visit the site despite multiple follow-up|3|||
143448377|NCT05511038|517185992|FG001|Treatment|Subject did nod visit the site despite multiple follow-up|1|||
143448378|NCT05511038|517185991|FG000|Treatment|Refuse by subject|1|||
143448379|NCT05511038|517185992|FG001|Treatment|Refuse by subject|0|||
143448380|NCT05511038|517185991|FG000|Treatment|Subject did not go to the site for visit|1|||
143448381|NCT05511038|517185992|FG001|Treatment|Subject did not go to the site for visit|0|||
143448382|NCT03852719|517185993|FG000|Overall Study|Withdrawal of consent|8|||
143448383|NCT03852719|517185994|FG001|Overall Study|Withdrawal of consent|8|||
143448384|NCT03852719|517185995|FG002|Overall Study|Withdrawal of consent|9|||
143448385|NCT03852719|517185993|FG000|Overall Study|Physician Decision|5|||
143448386|NCT03852719|517185994|FG001|Overall Study|Physician Decision|4|||
143448387|NCT03852719|517185995|FG002|Overall Study|Physician Decision|1|||
143448388|NCT03852719|517185993|FG000|Overall Study|Pregnancy|2|||
143448389|NCT03852719|517185994|FG001|Overall Study|Pregnancy|1|||
143448390|NCT03852719|517185995|FG002|Overall Study|Pregnancy|0|||
143448391|NCT03852719|517185993|FG000|Overall Study|Death|1|||
143448392|NCT03852719|517185994|FG001|Overall Study|Death|0|||
143448393|NCT03852719|517185995|FG002|Overall Study|Death|0|||
143448394|NCT03852719|517185993|FG000|Overall Study|Reason not Specified|3|||
143448395|NCT03852719|517185994|FG001|Overall Study|Reason not Specified|3|||
143448396|NCT03852719|517185995|FG002|Overall Study|Reason not Specified|5|||
143448397|NCT03852719|517185993|FG000|Overall Study|Adverse Event|2|||
143448398|NCT03852719|517185994|FG001|Overall Study|Adverse Event|1|||
143448399|NCT03852719|517185995|FG002|Overall Study|Adverse Event|4|||
143448400|NCT03852719|517185993|FG000|Overall Study|Progressive disease|1|||
143448401|NCT03852719|517185994|FG001|Overall Study|Progressive disease|4|||
143448402|NCT03852719|517185995|FG002|Overall Study|Progressive disease|1|||
143448403|NCT03852719|517185993|FG000|Overall Study|Lost to Follow-up|1|||
143448404|NCT03852719|517185994|FG001|Overall Study|Lost to Follow-up|0|||
143448405|NCT03852719|517185995|FG002|Overall Study|Lost to Follow-up|0|||
143448406|NCT05543187|517185998|FG000|Overall Study|Ongoing|3|||
143448407|NCT05543187|517185999|FG001|Overall Study|Ongoing|2|||
143448408|NCT03810235|517186000|FG000|Overall Study|Withdrawal by Subject|2|||
143448409|NCT03810235|517186001|FG001|Overall Study|Withdrawal by Subject|0|||
143448410|NCT04777864|517186002|FG000|Overall Study|Lost to Follow-up|8|||
143448411|NCT04777864|517186003|FG001|Overall Study|Lost to Follow-up|19|||
143448412|NCT03086655|517186006|FG000|3 Month Follow-up Assessment|Lost to Follow-up|5|||
143448413|NCT03086655|517186007|FG001|3 Month Follow-up Assessment|Lost to Follow-up|4|||
143448414|NCT03086655|517186006|FG000|3 Month Follow-up Assessment|Withdrawal by Subject|2|||
143448415|NCT03086655|517186007|FG001|3 Month Follow-up Assessment|Withdrawal by Subject|0|||
143448416|NCT03086655|517186006|FG000|6 Month Follow-up Assessment|Lost to Follow-up|7|||
143448417|NCT03086655|517186007|FG001|6 Month Follow-up Assessment|Lost to Follow-up|6|||
143448418|NCT03086655|517186006|FG000|6 Month Follow-up Assessment|Withdrawal by Subject|2|||
143448419|NCT03086655|517186007|FG001|6 Month Follow-up Assessment|Withdrawal by Subject|1|||
143448420|NCT03086655|517186006|FG000|9 Month Follow-up Assessment|Lost to Follow-up|9|||
143448421|NCT03086655|517186007|FG001|9 Month Follow-up Assessment|Lost to Follow-up|4|||
143448422|NCT03086655|517186006|FG000|12 Month Follow-up = Final Assessment|Lost to Follow-up|7|||
143448423|NCT03086655|517186007|FG001|12 Month Follow-up = Final Assessment|Lost to Follow-up|3|||
143448424|NCT03086655|517186006|FG000|12 Month Follow-up = Final Assessment|Death|0|||
143448425|NCT03086655|517186007|FG001|12 Month Follow-up = Final Assessment|Death|1|||
143448426|NCT03841526|517186009|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
143448427|NCT03841526|517186010|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
143448428|NCT03841526|517186011|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
143448429|NCT03841526|517186012|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
143448430|NCT03841526|517186013|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
143448431|NCT03841526|517186014|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
143448432|NCT03841526|517186009|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
143448433|NCT03841526|517186010|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
143448434|NCT03841526|517186011|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
143448435|NCT03841526|517186012|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
143448436|NCT03841526|517186013|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
143448437|NCT03841526|517186014|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
143448438|NCT03841526|517186009|FG000|Outpatient Phase Treatment|Physician Decision|0|||
143448439|NCT03841526|517186010|FG001|Outpatient Phase Treatment|Physician Decision|1|||
143448440|NCT03841526|517186011|FG002|Outpatient Phase Treatment|Physician Decision|0|||
143448441|NCT03841526|517186012|FG003|Outpatient Phase Treatment|Physician Decision|0|||
143448442|NCT03841526|517186013|FG004|Outpatient Phase Treatment|Physician Decision|0|||
143448443|NCT03841526|517186014|FG005|Outpatient Phase Treatment|Physician Decision|0|||
143448444|NCT03841526|517186009|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
143448445|NCT03841526|517186010|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
143448446|NCT03841526|517186011|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
143448447|NCT03841526|517186012|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
143448448|NCT03841526|517186013|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
143448449|NCT03841526|517186014|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
143448450|NCT02994069|517186015|FG000|Overall Study|Death|7|||
143448451|NCT02994069|517186016|FG001|Overall Study|Death|13|||
143448452|NCT02994069|517186015|FG000|Overall Study|Adverse Event|1|||
143448453|NCT02994069|517186016|FG001|Overall Study|Adverse Event|0|||
143448454|NCT02994069|517186015|FG000|Overall Study|Other|2|||
143448455|NCT02994069|517186016|FG001|Overall Study|Other|0|||
143448456|NCT02994069|517186015|FG000|Overall Study|still on follow up/treatment|5|||
143448457|NCT02994069|517186016|FG001|Overall Study|still on follow up/treatment|6|||
143448458|NCT04303780|517186022|FG000|Overall Study|Death|104|||
143448459|NCT04303780|517186023|FG001|Overall Study|Death|85|||
143448460|NCT04303780|517186022|FG000|Overall Study|Lost to Follow-up|5|||
143448461|NCT04303780|517186023|FG001|Overall Study|Lost to Follow-up|2|||
143448462|NCT04303780|517186022|FG000|Overall Study|Withdrawal by Subject|12|||
143448463|NCT04303780|517186023|FG001|Overall Study|Withdrawal by Subject|39|||
143448464|NCT04303780|517186022|FG000|Overall Study|Ongoing in study|50|||
143448465|NCT04303780|517186023|FG001|Overall Study|Ongoing in study|45|||
143448466|NCT04893460|517186024|FG000|Overall Study|Lost to Follow-up|18|||
143448467|NCT01977677|517187604|FG000|Overall Study|Unrelated Adverse Event|0|||
143448468|NCT01977677|517187605|FG001|Overall Study|Unrelated Adverse Event|0|||
143448469|NCT01977677|517187606|FG002|Overall Study|Unrelated Adverse Event|1|||
143448470|NCT01498887|517187607|FG000|Overall Study|Administrative problems|1|||
143448471|NCT01498887|517187608|FG001|Overall Study|Administrative problems|0|||
143448472|NCT01498887|517187607|FG000|Overall Study|Lost to Follow-up|1|||
143448473|NCT01498887|517187608|FG001|Overall Study|Lost to Follow-up|1|||
143448474|NCT01498887|517187607|FG000|Overall Study|Withdrawal by Subject|1|||
143448475|NCT01498887|517187608|FG001|Overall Study|Withdrawal by Subject|0|||
143448476|NCT01498887|517187607|FG000|Overall Study|Protocol Violation|1|||
143448477|NCT01498887|517187608|FG001|Overall Study|Protocol Violation|3|||
143448478|NCT01498887|517187607|FG000|Overall Study|Lack of Efficacy|5|||
143448479|NCT01498887|517187608|FG001|Overall Study|Lack of Efficacy|3|||
143448480|NCT01498887|517187607|FG000|Overall Study|Abnormal result from test procedure|1|||
143448481|NCT01498887|517187608|FG001|Overall Study|Abnormal result from test procedure|1|||
143448482|NCT01498887|517187607|FG000|Overall Study|Abnormal laboratory value|2|||
143448483|NCT01498887|517187608|FG001|Overall Study|Abnormal laboratory value|2|||
143448484|NCT01498887|517187607|FG000|Overall Study|Adverse Event|4|||
143448485|NCT01498887|517187608|FG001|Overall Study|Adverse Event|1|||
143448486|NCT03056300|517187611|FG000|Overall Study|Surgical reason per study protocol|3|||
143448487|NCT04020185|517187612|FG000|Overall Study|Death|0|||
143448488|NCT04020185|517187613|FG001|Overall Study|Death|0|||
143448489|NCT04020185|517187614|FG002|Overall Study|Death|1|||
143448490|NCT04020185|517187615|FG003|Overall Study|Death|2|||
143448491|NCT04020185|517187616|FG004|Overall Study|Death|1|||
143448492|NCT04020185|517187617|FG005|Overall Study|Death|0|||
143448493|NCT04020185|517187618|FG006|Overall Study|Death|1|||
143448494|NCT04020185|517187619|FG007|Overall Study|Death|0|||
143448495|NCT04020185|517187612|FG000|Overall Study|Consent withdrawn|1|||
143448496|NCT04020185|517187613|FG001|Overall Study|Consent withdrawn|0|||
143448497|NCT04020185|517187614|FG002|Overall Study|Consent withdrawn|0|||
143448498|NCT04020185|517187615|FG003|Overall Study|Consent withdrawn|0|||
143448499|NCT04020185|517187616|FG004|Overall Study|Consent withdrawn|2|||
143448500|NCT04020185|517187617|FG005|Overall Study|Consent withdrawn|0|||
143448501|NCT04020185|517187618|FG006|Overall Study|Consent withdrawn|1|||
143448502|NCT04020185|517187619|FG007|Overall Study|Consent withdrawn|1|||
143448503|NCT04020185|517187612|FG000|Overall Study|Patient in hospice|0|||
143448504|NCT04020185|517187613|FG001|Overall Study|Patient in hospice|1|||
143448505|NCT04020185|517187614|FG002|Overall Study|Patient in hospice|0|||
143448506|NCT04020185|517187615|FG003|Overall Study|Patient in hospice|0|||
143448507|NCT04020185|517187616|FG004|Overall Study|Patient in hospice|0|||
143448508|NCT04020185|517187617|FG005|Overall Study|Patient in hospice|0|||
143448509|NCT04020185|517187618|FG006|Overall Study|Patient in hospice|0|||
143448510|NCT04020185|517187619|FG007|Overall Study|Patient in hospice|0|||
143448511|NCT04020185|517187612|FG000|Overall Study|Continuing on expanded access|0|||
143448512|NCT04020185|517187613|FG001|Overall Study|Continuing on expanded access|0|||
143448513|NCT04020185|517187614|FG002|Overall Study|Continuing on expanded access|0|||
143448514|NCT04020185|517187615|FG003|Overall Study|Continuing on expanded access|0|||
143448515|NCT04020185|517187616|FG004|Overall Study|Continuing on expanded access|0|||
143448516|NCT04020185|517187617|FG005|Overall Study|Continuing on expanded access|0|||
143448517|NCT04020185|517187618|FG006|Overall Study|Continuing on expanded access|1|||
143448518|NCT04020185|517187619|FG007|Overall Study|Continuing on expanded access|1|||
143448519|NCT00527787|517187622|FG000|Overall Study|Adverse Event|14|||
143448520|NCT00527787|517187623|FG001|Overall Study|Adverse Event|24|||
143448521|NCT00527787|517187622|FG000|Overall Study|Withdrawal by Subject|13|||
143448522|NCT00527787|517187623|FG001|Overall Study|Withdrawal by Subject|25|||
143448523|NCT00527787|517187622|FG000|Overall Study|Lost to Follow-up|5|||
143448524|NCT00527787|517187623|FG001|Overall Study|Lost to Follow-up|2|||
143448525|NCT00527787|517187622|FG000|Overall Study|Duodenal Ulcer|1|||
143448526|NCT00527787|517187623|FG001|Overall Study|Duodenal Ulcer|10|||
143448527|NCT00527787|517187622|FG000|Overall Study|misc|5|||
143448528|NCT00527787|517187623|FG001|Overall Study|misc|2|||
143448529|NCT04833127|517187624|FG000|Overall Study|Lost to Follow-up|1|||
143448530|NCT04833127|517187625|FG001|Overall Study|Lost to Follow-up|1|||
143448531|NCT01499303|517187626|FG000|Overall Study|Ongoing|2|||
143448532|NCT01499303|517187627|FG001|Overall Study|Ongoing|1|||
143448533|NCT01499303|517187626|FG000|Overall Study|Withdrawal by Subject|0|||
143448534|NCT01499303|517187627|FG001|Overall Study|Withdrawal by Subject|1|||
143448535|NCT01499303|517187626|FG000|Overall Study|Adverse Event|1|||
143448536|NCT01499303|517187627|FG001|Overall Study|Adverse Event|4|||
143448537|NCT01499303|517187626|FG000|Overall Study|Other|0|||
143448538|NCT01499303|517187627|FG001|Overall Study|Other|1|||
143448539|NCT03435692|517187629|FG000|Overall Study|Lack of Efficacy|2|||
143448540|NCT03435692|517187630|FG001|Overall Study|Lack of Efficacy|2|||
143448541|NCT03435692|517187631|FG002|Overall Study|Lack of Efficacy|0|||
143448542|NCT04313608|517187632|FG000|Overall Study|Death|12|||
143448543|NCT04313608|517187633|FG001|Overall Study|Death|3|||
143448544|NCT01145898|517187634|FG000|3-year Treatment|medication change by treating physician|3|||
143448545|NCT01145898|517187635|FG001|3-year Treatment|medication change by treating physician|16|||
143448546|NCT02440425|517187636|FG000|Overall Study|Death likely due to disease progression|1|||
143448547|NCT02440425|517187636|FG000|Overall Study|Withdrawal by Subject|2|||
143448548|NCT02440425|517187636|FG000|Overall Study|Adverse Event|1|||
143448549|NCT02440425|517187636|FG000|Overall Study|Adverse Event/Ineligible|1|||
143448550|NCT00842244|517187637|FG000|Overall Study|Death|3|||
143448551|NCT00842244|517187637|FG000|Overall Study|Withdrawal by Subject|1|||
143448552|NCT00842244|517187637|FG000|Overall Study|Other|17|||
143448553|NCT04145700|517187638|FG000|Overall Study|Withdrawal by Subject|8|||
143448554|NCT04145700|517187639|FG001|Overall Study|Withdrawal by Subject|3|||
143448555|NCT00780559|517187640|FG000|Overall Study|Lost to Follow-up|2|||
143448556|NCT00780559|517187641|FG001|Overall Study|Lost to Follow-up|7|||
143448557|NCT00780559|517187640|FG000|Overall Study|Death|1|||
143448558|NCT00780559|517187641|FG001|Overall Study|Death|0|||
143448559|NCT01327846|517187643|FG000|Core Phase|Subject decision (vital status: missing)|1|||
143448560|NCT01327846|517187644|FG001|Core Phase|Subject decision (vital status: missing)|2|||
143448561|NCT01327846|517187645|FG002|Core Phase|Subject decision (vital status: missing)|2|||
143448562|NCT01327846|517187646|FG003|Core Phase|Subject decision (vital status: missing)|1|||
143448563|NCT01327846|517187643|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
143448564|NCT01327846|517187644|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
143448565|NCT01327846|517187645|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
143448566|NCT01327846|517187646|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
143448567|NCT01327846|517187643|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
143448568|NCT01327846|517187644|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
143448569|NCT01327846|517187645|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
143448570|NCT01327846|517187646|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
143448571|NCT01327846|517187643|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
143448572|NCT01327846|517187644|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
143448573|NCT01327846|517187645|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
143448574|NCT01327846|517187646|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
143448575|NCT01327846|517187643|FG000|Core Phase|Lost to Follow-up|3|||
143448576|NCT01327846|517187644|FG001|Core Phase|Lost to Follow-up|3|||
143448577|NCT01327846|517187645|FG002|Core Phase|Lost to Follow-up|4|||
143448578|NCT01327846|517187646|FG003|Core Phase|Lost to Follow-up|5|||
143448579|NCT01327846|517187643|FG000|Extension Phase|Study terminated by sponsor|1073|||
143448580|NCT01327846|517187644|FG001|Extension Phase|Study terminated by sponsor|1124|||
143448581|NCT01327846|517187645|FG002|Extension Phase|Study terminated by sponsor|1067|||
143448582|NCT01327846|517187646|FG003|Extension Phase|Study terminated by sponsor|1660|||
143448583|NCT01327846|517187643|FG000|Extension Phase|Withdrawal by Subject|20|||
143448584|NCT01327846|517187644|FG001|Extension Phase|Withdrawal by Subject|13|||
143448585|NCT01327846|517187645|FG002|Extension Phase|Withdrawal by Subject|19|||
143448586|NCT01327846|517187646|FG003|Extension Phase|Withdrawal by Subject|37|||
143448587|NCT01327846|517187643|FG000|Extension Phase|Lost to Follow-up|4|||
143448588|NCT01327846|517187644|FG001|Extension Phase|Lost to Follow-up|3|||
143448589|NCT01327846|517187645|FG002|Extension Phase|Lost to Follow-up|4|||
143448590|NCT01327846|517187646|FG003|Extension Phase|Lost to Follow-up|7|||
143448591|NCT01327846|517187643|FG000|Extension Phase|Technical Problems|2|||
143448592|NCT01327846|517187644|FG001|Extension Phase|Technical Problems|4|||
143448593|NCT01327846|517187645|FG002|Extension Phase|Technical Problems|2|||
143448594|NCT01327846|517187646|FG003|Extension Phase|Technical Problems|2|||
143448595|NCT00203268|517187652|FG000|Early Treatment|only treated one headache|2|||
143448596|NCT00203268|517187652|FG000|Early Treatment|Lost to Follow-up|1|||
143448597|NCT00203268|517187652|FG000|Early Treatment|Withdrawal by Subject|1|||
143448598|NCT01254747|517187654|FG000|Overall Study|Unacceptable subjective vision|0|||
143448599|NCT01254747|517187655|FG001|Overall Study|Unacceptable subjective vision|0|||
143448600|NCT01254747|517187656|FG002|Overall Study|Unacceptable subjective vision|0|||
143448601|NCT01254747|517187657|FG003|Overall Study|Unacceptable subjective vision|2|||
143448602|NCT01254747|517187654|FG000|Overall Study|Difficult removal handling|0|||
143448603|NCT01254747|517187655|FG001|Overall Study|Difficult removal handling|0|||
143448604|NCT01254747|517187656|FG002|Overall Study|Difficult removal handling|1|||
143448605|NCT01254747|517187657|FG003|Overall Study|Difficult removal handling|0|||
143448606|NCT01254747|517187654|FG000|Overall Study|Symptoms and problems|0|||
143448607|NCT01254747|517187655|FG001|Overall Study|Symptoms and problems|2|||
143448608|NCT01254747|517187656|FG002|Overall Study|Symptoms and problems|1|||
143448609|NCT01254747|517187657|FG003|Overall Study|Symptoms and problems|0|||
143448610|NCT01254747|517187654|FG000|Overall Study|Lost to Follow-up|0|||
143448611|NCT01254747|517187655|FG001|Overall Study|Lost to Follow-up|0|||
143448612|NCT01254747|517187656|FG002|Overall Study|Lost to Follow-up|1|||
143448613|NCT01254747|517187657|FG003|Overall Study|Lost to Follow-up|0|||
143448614|NCT01254747|517187654|FG000|Overall Study|Biomicroscopy|0|||
143448615|NCT01254747|517187655|FG001|Overall Study|Biomicroscopy|0|||
143448616|NCT01254747|517187656|FG002|Overall Study|Biomicroscopy|1|||
143448617|NCT01254747|517187657|FG003|Overall Study|Biomicroscopy|0|||
143448618|NCT01254747|517187654|FG000|Overall Study|Discomfort|0|||
143448619|NCT01254747|517187655|FG001|Overall Study|Discomfort|4|||
143448620|NCT01254747|517187656|FG002|Overall Study|Discomfort|0|||
143448621|NCT01254747|517187657|FG003|Overall Study|Discomfort|0|||
143448622|NCT00846807|517187659|FG000|Overall Study|Adverse Event|270|||
143448623|NCT00846807|517187659|FG000|Overall Study|Lost to Follow-up|94|||
143448624|NCT00846807|517187659|FG000|Overall Study|Withdrawal by Subject|56|||
143448625|NCT00846807|517187659|FG000|Overall Study|Non compliant with European label|7|||
143448626|NCT00846807|517187659|FG000|Overall Study|Switch to other anticoagulants|89|||
143448627|NCT00846807|517187659|FG000|Overall Study|No prescription after hospital discharge|56|||
143448628|NCT00846807|517187659|FG000|Overall Study|Other|60|||
143448629|NCT00245960|517187660|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
143448630|NCT00245960|517187661|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
143448631|NCT00245960|517187660|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
143448632|NCT00245960|517187661|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
143448633|NCT00245960|517187660|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
143448634|NCT00245960|517187661|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
143448635|NCT00245960|517187660|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
143448636|NCT00245960|517187661|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
143448637|NCT00245960|517187660|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
143448638|NCT00245960|517187661|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
143448639|NCT00245960|517187660|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
143448640|NCT00245960|517187661|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
143448641|NCT00245960|517187660|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
143448642|NCT00245960|517187661|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
143448643|NCT00245960|517187660|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
143448644|NCT00245960|517187661|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
143448645|NCT00245960|517187660|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
143448646|NCT00245960|517187661|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
143448647|NCT00245960|517187660|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
143448648|NCT00245960|517187661|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
143448649|NCT00245960|517187660|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
143448650|NCT00245960|517187661|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
143448651|NCT00245960|517187660|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
143448652|NCT00245960|517187661|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
143448653|NCT00737698|517187662|FG000|Overall Study|Withdrawal by Subject|6|||
143448654|NCT00737698|517187663|FG001|Overall Study|Withdrawal by Subject|5|||
143448655|NCT00737698|517187664|FG002|Overall Study|Withdrawal by Subject|3|||
143448656|NCT00737698|517187662|FG000|Overall Study|Death|0|||
143448657|NCT00737698|517187663|FG001|Overall Study|Death|0|||
143448658|NCT00737698|517187664|FG002|Overall Study|Death|1|||
143448659|NCT01067846|517187665|FG000|Overall Study|Lost to Follow-up|17|||
143448660|NCT01067846|517187666|FG001|Overall Study|Lost to Follow-up|19|||
143448661|NCT01067846|517187665|FG000|Overall Study|Withdrawal by Subject|1|||
143448662|NCT01067846|517187666|FG001|Overall Study|Withdrawal by Subject|0|||
143448663|NCT01067846|517187665|FG000|Overall Study|participation in other tx study|1|||
143448664|NCT01067846|517187666|FG001|Overall Study|participation in other tx study|0|||
143448665|NCT02817906|517187667|FG000|Overall Study|Adverse Event|3|||
143448666|NCT02817906|517187668|FG001|Overall Study|Adverse Event|0|||
143448667|NCT02817906|517187667|FG000|Overall Study|Lack of Efficacy|1|||
143448668|NCT02817906|517187668|FG001|Overall Study|Lack of Efficacy|0|||
143448669|NCT02817906|517187667|FG000|Overall Study|Protocol Violation|1|||
143448670|NCT02817906|517187668|FG001|Overall Study|Protocol Violation|1|||
143448671|NCT02817906|517187667|FG000|Overall Study|Study Terminated by Sponsor|2|||
143448672|NCT02817906|517187668|FG001|Overall Study|Study Terminated by Sponsor|2|||
143448673|NCT02817906|517187667|FG000|Overall Study|Withdrawal by Subject|7|||
143448674|NCT02817906|517187668|FG001|Overall Study|Withdrawal by Subject|0|||
143448675|NCT02817906|517187667|FG000|Overall Study|Other|2|||
143448676|NCT02817906|517187668|FG001|Overall Study|Other|2|||
143448677|NCT04608773|517187674|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
143448678|NCT04608773|517187675|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
143448679|NCT04608773|517187674|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
143448680|NCT04608773|517187675|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
143448681|NCT04608773|517187674|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
143448682|NCT04608773|517187675|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
143448683|NCT04608773|517187674|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
143448684|NCT04608773|517187675|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
143448685|NCT04608773|517187674|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
143448686|NCT04608773|517187675|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
143448687|NCT00972322|517187676|FG000|Overall Study|Adverse Event|2|||
143448688|NCT00972322|517187677|FG001|Overall Study|Adverse Event|1|||
143448689|NCT00972322|517187676|FG000|Overall Study|Positive drug screen|0|||
143448690|NCT00972322|517187677|FG001|Overall Study|Positive drug screen|1|||
143448691|NCT00972322|517187676|FG000|Overall Study|Lost to Follow-up|0|||
143448692|NCT00972322|517187677|FG001|Overall Study|Lost to Follow-up|1|||
143448693|NCT00972322|517187676|FG000|Overall Study|Consistently high glucose values|1|||
143448694|NCT00972322|517187677|FG001|Overall Study|Consistently high glucose values|0|||
143448695|NCT00316017|517187682|FG000|Overall Study|Protocol Violation|11|||
143448696|NCT00316017|517187683|FG001|Overall Study|Protocol Violation|13|||
143448697|NCT00316017|517187684|FG002|Overall Study|Protocol Violation|19|||
143448698|NCT05235269|517187702|FG000|Overall Study|Adverse Event|1|||
143448699|NCT05235269|517187702|FG000|Overall Study|Participant elected to drop out (i.e., not undergo second scan) but did not withdraw consent|1|||
143448700|NCT05235269|517187702|FG000|Overall Study|Protocol-specified withdrawal criterion met|5|||
143448701|NCT00798434|517187703|FG000|Double-Blind|Adverse Event|22|||
143448702|NCT00798434|517187704|FG001|Double-Blind|Adverse Event|46|||
143448703|NCT00798434|517187703|FG000|Double-Blind|Death|0|||
143448704|NCT00798434|517187704|FG001|Double-Blind|Death|1|||
143448705|NCT00798434|517187703|FG000|Double-Blind|Lost to Follow-up|1|||
143448706|NCT00798434|517187704|FG001|Double-Blind|Lost to Follow-up|0|||
143448707|NCT00798434|517187703|FG000|Double-Blind|Lack of Efficacy|8|||
143448708|NCT00798434|517187704|FG001|Double-Blind|Lack of Efficacy|12|||
143448709|NCT00798434|517187703|FG000|Double-Blind|Withdrawal by Subject|17|||
143448710|NCT00798434|517187704|FG001|Double-Blind|Withdrawal by Subject|14|||
143448711|NCT00798434|517187703|FG000|Double-Blind|Protocol Violation|1|||
143448712|NCT00798434|517187704|FG001|Double-Blind|Protocol Violation|4|||
143448713|NCT00798434|517187703|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
143448714|NCT00798434|517187704|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
143448715|NCT00798434|517187703|FG000|Double-Blind|Other|1|||
143448716|NCT00798434|517187704|FG001|Double-Blind|Other|0|||
143448717|NCT00798434|517187703|FG000|Double-Blind|Not Treated|3|||
143448718|NCT00798434|517187704|FG001|Double-Blind|Not Treated|6|||
143448719|NCT00798434|517187703|FG000|Open-Label|Adverse Event|33|||
143448720|NCT00798434|517187704|FG001|Open-Label|Adverse Event|11|||
143448721|NCT00798434|517187703|FG000|Open-Label|Lack of Efficacy|5|||
143448722|NCT00798434|517187704|FG001|Open-Label|Lack of Efficacy|11|||
143448723|NCT00798434|517187703|FG000|Open-Label|Withdrawal by Subject|2|||
143448724|NCT00798434|517187704|FG001|Open-Label|Withdrawal by Subject|7|||
143448725|NCT00798434|517187703|FG000|Open-Label|Protocol Violation|1|||
143448726|NCT00798434|517187704|FG001|Open-Label|Protocol Violation|0|||
143448727|NCT00798434|517187703|FG000|Open-Label|Other|1|||
143448728|NCT00798434|517187704|FG001|Open-Label|Other|2|||
143448729|NCT00798434|517187703|FG000|Open-Label|Not Treated|0|||
143448730|NCT00798434|517187704|FG001|Open-Label|Not Treated|1|||
143448731|NCT03682185|517187708|FG000|Overall Study|Lost to Follow-up|4|||
143448732|NCT03682185|517187709|FG001|Overall Study|Lost to Follow-up|7|||
143448733|NCT03682185|517187710|FG002|Overall Study|Lost to Follow-up|4|||
143448734|NCT03682185|517187711|FG003|Overall Study|Lost to Follow-up|7|||
143448735|NCT03682185|517187712|FG004|Overall Study|Lost to Follow-up|1|||
143448736|NCT03682185|517187708|FG000|Overall Study|Withdrawal by Subject|7|||
143448737|NCT03682185|517187709|FG001|Overall Study|Withdrawal by Subject|3|||
143448738|NCT03682185|517187710|FG002|Overall Study|Withdrawal by Subject|7|||
143448739|NCT03682185|517187711|FG003|Overall Study|Withdrawal by Subject|3|||
143448740|NCT03682185|517187712|FG004|Overall Study|Withdrawal by Subject|0|||
143448741|NCT04908631|517187713|FG000|Overall Study|Lost to Follow-up|1|||
143448742|NCT04908631|517187713|FG000|Overall Study|Physician Decision|1|||
143448743|NCT04908631|517187713|FG000|Overall Study|Received a second implant after the 1 month visit|1|||
143448744|NCT02336451|517187717|FG000|Overall Study|Adverse Event|1|||
143448745|NCT02336451|517187718|FG001|Overall Study|Adverse Event|2|||
143448746|NCT02336451|517187719|FG002|Overall Study|Adverse Event|0|||
143448747|NCT02336451|517187720|FG003|Overall Study|Adverse Event|6|||
143448748|NCT02336451|517187721|FG004|Overall Study|Adverse Event|4|||
143448749|NCT02336451|517187717|FG000|Overall Study|Death|6|||
143448750|NCT02336451|517187718|FG001|Overall Study|Death|2|||
143448751|NCT02336451|517187719|FG002|Overall Study|Death|3|||
143448752|NCT02336451|517187720|FG003|Overall Study|Death|6|||
143448753|NCT02336451|517187721|FG004|Overall Study|Death|6|||
143448754|NCT02336451|517187717|FG000|Overall Study|Physician Decision|9|||
143448755|NCT02336451|517187718|FG001|Overall Study|Physician Decision|6|||
143448756|NCT02336451|517187719|FG002|Overall Study|Physician Decision|7|||
143448757|NCT02336451|517187720|FG003|Overall Study|Physician Decision|16|||
143448758|NCT02336451|517187721|FG004|Overall Study|Physician Decision|3|||
143448759|NCT02336451|517187717|FG000|Overall Study|Progressive disease|23|||
143448760|NCT02336451|517187718|FG001|Overall Study|Progressive disease|26|||
143448761|NCT02336451|517187719|FG002|Overall Study|Progressive disease|2|||
143448762|NCT02336451|517187720|FG003|Overall Study|Progressive disease|14|||
143448763|NCT02336451|517187721|FG004|Overall Study|Progressive disease|4|||
143448764|NCT02336451|517187717|FG000|Overall Study|Protocol Violation|1|||
143448765|NCT02336451|517187718|FG001|Overall Study|Protocol Violation|0|||
143448766|NCT02336451|517187719|FG002|Overall Study|Protocol Violation|0|||
143448767|NCT02336451|517187720|FG003|Overall Study|Protocol Violation|0|||
143448768|NCT02336451|517187721|FG004|Overall Study|Protocol Violation|0|||
143448769|NCT02336451|517187717|FG000|Overall Study|Patient/guardian decision|2|||
143448770|NCT02336451|517187718|FG001|Overall Study|Patient/guardian decision|4|||
143448771|NCT02336451|517187719|FG002|Overall Study|Patient/guardian decision|0|||
143448772|NCT02336451|517187720|FG003|Overall Study|Patient/guardian decision|2|||
143448773|NCT02336451|517187721|FG004|Overall Study|Patient/guardian decision|1|||
143448774|NCT03520712|517187723|FG000|Overall Study|Early termination of the study by Sponsor|2|||
143448775|NCT02344290|517187731|FG000|Overall Study|Withdrawal by Subject|315|||
143448776|NCT02344290|517187732|FG001|Overall Study|Withdrawal by Subject|324|||
143448777|NCT02344290|517187731|FG000|Overall Study|Lost to Follow-up|258|||
143448778|NCT02344290|517187732|FG001|Overall Study|Lost to Follow-up|249|||
143448779|NCT02344290|517187731|FG000|Overall Study|Unable to get to clinic|69|||
143448780|NCT02344290|517187732|FG001|Overall Study|Unable to get to clinic|60|||
143448781|NCT02344290|517187731|FG000|Overall Study|Physician Decision|25|||
143448782|NCT02344290|517187732|FG001|Overall Study|Physician Decision|25|||
143448783|NCT02344290|517187731|FG000|Overall Study|Site Closure|15|||
143448784|NCT02344290|517187732|FG001|Overall Study|Site Closure|19|||
143448785|NCT02344290|517187731|FG000|Overall Study|Other|5|||
143448786|NCT02344290|517187732|FG001|Overall Study|Other|3|||
143448787|NCT04047862|517187736|FG000|Overall Study|Death|0|||
143448788|NCT04047862|517187737|FG001|Overall Study|Death|0|||
143448789|NCT04047862|517187738|FG002|Overall Study|Death|4|||
143448790|NCT04047862|517187739|FG003|Overall Study|Death|7|||
143448791|NCT04047862|517187740|FG004|Overall Study|Death|2|||
143448792|NCT04047862|517187741|FG005|Overall Study|Death|4|||
143448793|NCT04047862|517187742|FG006|Overall Study|Death|3|||
143448794|NCT04047862|517187743|FG007|Overall Study|Death|24|||
143448795|NCT04047862|517187744|FG008|Overall Study|Death|24|||
143448796|NCT04047862|517187745|FG009|Overall Study|Death|22|||
143448797|NCT04047862|517187746|FG010|Overall Study|Death|35|||
143448798|NCT04047862|517187747|FG011|Overall Study|Death|18|||
143448799|NCT04047862|517187748|FG012|Overall Study|Death|14|||
143448800|NCT04047862|517187749|FG013|Overall Study|Death|6|||
143448801|NCT04047862|517187750|FG014|Overall Study|Death|19|||
143448802|NCT04047862|517187751|FG015|Overall Study|Death|42|||
143448803|NCT04047862|517187752|FG016|Overall Study|Death|9|||
143448804|NCT04047862|517187753|FG017|Overall Study|Death|8|||
143448805|NCT04047862|517187754|FG018|Overall Study|Death|10|||
143448806|NCT04047862|517187736|FG000|Overall Study|Withdrawal by Subject|0|||
143448807|NCT04047862|517187737|FG001|Overall Study|Withdrawal by Subject|0|||
143448808|NCT04047862|517187738|FG002|Overall Study|Withdrawal by Subject|0|||
143448809|NCT04047862|517187739|FG003|Overall Study|Withdrawal by Subject|5|||
143448810|NCT04047862|517187740|FG004|Overall Study|Withdrawal by Subject|2|||
143448811|NCT04047862|517187741|FG005|Overall Study|Withdrawal by Subject|0|||
143448812|NCT04047862|517187742|FG006|Overall Study|Withdrawal by Subject|1|||
143448813|NCT04047862|517187743|FG007|Overall Study|Withdrawal by Subject|0|||
143448814|NCT04047862|517187744|FG008|Overall Study|Withdrawal by Subject|4|||
143448815|NCT04047862|517187745|FG009|Overall Study|Withdrawal by Subject|4|||
143448816|NCT04047862|517187746|FG010|Overall Study|Withdrawal by Subject|4|||
143448817|NCT04047862|517187747|FG011|Overall Study|Withdrawal by Subject|2|||
143448818|NCT04047862|517187748|FG012|Overall Study|Withdrawal by Subject|3|||
143448819|NCT04047862|517187749|FG013|Overall Study|Withdrawal by Subject|0|||
143448820|NCT04047862|517187750|FG014|Overall Study|Withdrawal by Subject|9|||
143448821|NCT04047862|517187751|FG015|Overall Study|Withdrawal by Subject|5|||
143448822|NCT04047862|517187752|FG016|Overall Study|Withdrawal by Subject|1|||
143448823|NCT04047862|517187753|FG017|Overall Study|Withdrawal by Subject|3|||
143448824|NCT04047862|517187754|FG018|Overall Study|Withdrawal by Subject|1|||
143448825|NCT04047862|517187736|FG000|Overall Study|Lost to Follow-up|0|||
143448826|NCT04047862|517187737|FG001|Overall Study|Lost to Follow-up|0|||
143448827|NCT04047862|517187738|FG002|Overall Study|Lost to Follow-up|1|||
143448828|NCT04047862|517187739|FG003|Overall Study|Lost to Follow-up|0|||
143448829|NCT04047862|517187740|FG004|Overall Study|Lost to Follow-up|0|||
143448830|NCT04047862|517187741|FG005|Overall Study|Lost to Follow-up|0|||
143448831|NCT04047862|517187742|FG006|Overall Study|Lost to Follow-up|0|||
143448832|NCT04047862|517187743|FG007|Overall Study|Lost to Follow-up|1|||
143448833|NCT04047862|517187744|FG008|Overall Study|Lost to Follow-up|0|||
143448834|NCT04047862|517187745|FG009|Overall Study|Lost to Follow-up|1|||
143448835|NCT04047862|517187746|FG010|Overall Study|Lost to Follow-up|0|||
143448836|NCT04047862|517187747|FG011|Overall Study|Lost to Follow-up|3|||
143448837|NCT04047862|517187748|FG012|Overall Study|Lost to Follow-up|0|||
143448838|NCT04047862|517187749|FG013|Overall Study|Lost to Follow-up|0|||
143448839|NCT04047862|517187750|FG014|Overall Study|Lost to Follow-up|2|||
143448840|NCT04047862|517187751|FG015|Overall Study|Lost to Follow-up|2|||
143448841|NCT04047862|517187752|FG016|Overall Study|Lost to Follow-up|1|||
143448842|NCT04047862|517187753|FG017|Overall Study|Lost to Follow-up|0|||
143448843|NCT04047862|517187754|FG018|Overall Study|Lost to Follow-up|0|||
143448844|NCT04047862|517187736|FG000|Overall Study|Physician Decision|0|||
143448845|NCT04047862|517187737|FG001|Overall Study|Physician Decision|0|||
143448846|NCT04047862|517187738|FG002|Overall Study|Physician Decision|0|||
143448847|NCT04047862|517187739|FG003|Overall Study|Physician Decision|1|||
143448848|NCT04047862|517187740|FG004|Overall Study|Physician Decision|0|||
143448849|NCT04047862|517187741|FG005|Overall Study|Physician Decision|0|||
143448850|NCT04047862|517187742|FG006|Overall Study|Physician Decision|0|||
143448851|NCT04047862|517187743|FG007|Overall Study|Physician Decision|0|||
143448852|NCT04047862|517187744|FG008|Overall Study|Physician Decision|0|||
143448853|NCT04047862|517187745|FG009|Overall Study|Physician Decision|0|||
143448854|NCT04047862|517187746|FG010|Overall Study|Physician Decision|0|||
143448855|NCT04047862|517187747|FG011|Overall Study|Physician Decision|0|||
143448856|NCT04047862|517187748|FG012|Overall Study|Physician Decision|0|||
143448857|NCT04047862|517187749|FG013|Overall Study|Physician Decision|0|||
143448858|NCT04047862|517187750|FG014|Overall Study|Physician Decision|1|||
143448859|NCT04047862|517187751|FG015|Overall Study|Physician Decision|0|||
143448860|NCT04047862|517187752|FG016|Overall Study|Physician Decision|1|||
143448861|NCT04047862|517187753|FG017|Overall Study|Physician Decision|0|||
143448862|NCT04047862|517187754|FG018|Overall Study|Physician Decision|0|||
143448863|NCT04047862|517187736|FG000|Overall Study|Completed all Assessments|1|||
143448864|NCT04047862|517187737|FG001|Overall Study|Completed all Assessments|3|||
143448865|NCT04047862|517187738|FG002|Overall Study|Completed all Assessments|1|||
143448866|NCT04047862|517187739|FG003|Overall Study|Completed all Assessments|3|||
143448867|NCT04047862|517187740|FG004|Overall Study|Completed all Assessments|2|||
143448868|NCT04047862|517187741|FG005|Overall Study|Completed all Assessments|5|||
143448869|NCT04047862|517187742|FG006|Overall Study|Completed all Assessments|7|||
143448870|NCT04047862|517187743|FG007|Overall Study|Completed all Assessments|0|||
143448871|NCT04047862|517187744|FG008|Overall Study|Completed all Assessments|0|||
143448872|NCT04047862|517187745|FG009|Overall Study|Completed all Assessments|0|||
143448873|NCT04047862|517187746|FG010|Overall Study|Completed all Assessments|0|||
143448874|NCT04047862|517187747|FG011|Overall Study|Completed all Assessments|0|||
143448875|NCT04047862|517187748|FG012|Overall Study|Completed all Assessments|0|||
143448876|NCT04047862|517187749|FG013|Overall Study|Completed all Assessments|0|||
143448877|NCT04047862|517187750|FG014|Overall Study|Completed all Assessments|0|||
143448878|NCT04047862|517187751|FG015|Overall Study|Completed all Assessments|0|||
143448879|NCT04047862|517187752|FG016|Overall Study|Completed all Assessments|0|||
143448880|NCT04047862|517187753|FG017|Overall Study|Completed all Assessments|0|||
143448881|NCT04047862|517187754|FG018|Overall Study|Completed all Assessments|0|||
143448882|NCT04047862|517187736|FG000|Overall Study|Sponsor Decision|0|||
143448883|NCT04047862|517187737|FG001|Overall Study|Sponsor Decision|0|||
143448884|NCT04047862|517187738|FG002|Overall Study|Sponsor Decision|0|||
143448885|NCT04047862|517187739|FG003|Overall Study|Sponsor Decision|0|||
143448886|NCT04047862|517187740|FG004|Overall Study|Sponsor Decision|0|||
143448887|NCT04047862|517187741|FG005|Overall Study|Sponsor Decision|0|||
143448888|NCT04047862|517187742|FG006|Overall Study|Sponsor Decision|0|||
143448889|NCT04047862|517187743|FG007|Overall Study|Sponsor Decision|13|||
143448890|NCT04047862|517187744|FG008|Overall Study|Sponsor Decision|10|||
143448891|NCT04047862|517187745|FG009|Overall Study|Sponsor Decision|18|||
143448892|NCT04047862|517187746|FG010|Overall Study|Sponsor Decision|3|||
143448893|NCT04047862|517187747|FG011|Overall Study|Sponsor Decision|3|||
143448894|NCT04047862|517187748|FG012|Overall Study|Sponsor Decision|4|||
143448895|NCT04047862|517187749|FG013|Overall Study|Sponsor Decision|0|||
143448896|NCT04047862|517187750|FG014|Overall Study|Sponsor Decision|7|||
143448897|NCT04047862|517187751|FG015|Overall Study|Sponsor Decision|8|||
143448898|NCT04047862|517187752|FG016|Overall Study|Sponsor Decision|9|||
143448899|NCT04047862|517187753|FG017|Overall Study|Sponsor Decision|7|||
143448900|NCT04047862|517187754|FG018|Overall Study|Sponsor Decision|8|||
143448901|NCT04047862|517187736|FG000|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
143448902|NCT04047862|517187737|FG001|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
143448903|NCT04047862|517187738|FG002|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
143448904|NCT04047862|517187739|FG003|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
143448905|NCT04047862|517187740|FG004|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
143448906|NCT04047862|517187741|FG005|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
143448907|NCT04047862|517187742|FG006|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
143448908|NCT04047862|517187743|FG007|Overall Study|Transfer to a Company Sponsored Clinical Trial|3|||
143448909|NCT04047862|517187744|FG008|Overall Study|Transfer to a Company Sponsored Clinical Trial|5|||
143448910|NCT04047862|517187745|FG009|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
143448911|NCT04047862|517187746|FG010|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
143448912|NCT04047862|517187747|FG011|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
143448913|NCT04047862|517187748|FG012|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
143448914|NCT04047862|517187749|FG013|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
143448915|NCT04047862|517187750|FG014|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
143448916|NCT04047862|517187751|FG015|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
143448917|NCT04047862|517187752|FG016|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
143448918|NCT04047862|517187753|FG017|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
143448919|NCT04047862|517187754|FG018|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
143448920|NCT04047862|517187736|FG000|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
143448921|NCT04047862|517187737|FG001|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
143448922|NCT04047862|517187738|FG002|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
143448923|NCT04047862|517187739|FG003|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
143448924|NCT04047862|517187740|FG004|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
143448925|NCT04047862|517187741|FG005|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
143448926|NCT04047862|517187742|FG006|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
143448927|NCT04047862|517187743|FG007|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
143448928|NCT04047862|517187744|FG008|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
143448929|NCT04047862|517187745|FG009|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
143448930|NCT04047862|517187746|FG010|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
143448931|NCT04047862|517187747|FG011|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
143448932|NCT04047862|517187748|FG012|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
143448933|NCT04047862|517187749|FG013|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
143448934|NCT04047862|517187750|FG014|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
143448935|NCT04047862|517187751|FG015|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|1|||
143448936|NCT04047862|517187752|FG016|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
143448937|NCT04047862|517187753|FG017|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
143448938|NCT04047862|517187754|FG018|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|2|||
143448939|NCT04047862|517187736|FG000|Overall Study|Other|0|||
143448940|NCT04047862|517187737|FG001|Overall Study|Other|0|||
143448941|NCT04047862|517187738|FG002|Overall Study|Other|0|||
143448942|NCT04047862|517187739|FG003|Overall Study|Other|0|||
143448943|NCT04047862|517187740|FG004|Overall Study|Other|0|||
143448944|NCT04047862|517187741|FG005|Overall Study|Other|0|||
143448945|NCT04047862|517187742|FG006|Overall Study|Other|0|||
143448946|NCT04047862|517187743|FG007|Overall Study|Other|0|||
143448947|NCT04047862|517187744|FG008|Overall Study|Other|0|||
143448948|NCT04047862|517187745|FG009|Overall Study|Other|0|||
143448949|NCT04047862|517187746|FG010|Overall Study|Other|0|||
143448950|NCT04047862|517187747|FG011|Overall Study|Other|0|||
143448951|NCT04047862|517187748|FG012|Overall Study|Other|0|||
143448952|NCT04047862|517187749|FG013|Overall Study|Other|0|||
143448953|NCT04047862|517187750|FG014|Overall Study|Other|2|||
143448954|NCT04047862|517187751|FG015|Overall Study|Other|1|||
143448955|NCT04047862|517187752|FG016|Overall Study|Other|1|||
143448956|NCT04047862|517187753|FG017|Overall Study|Other|1|||
143448957|NCT04047862|517187754|FG018|Overall Study|Other|0|||
143448958|NCT01901432|517189140|FG000|Overall Study|Adverse Event|0|||
143448959|NCT01901432|517189141|FG001|Overall Study|Adverse Event|1|||
143448960|NCT01901432|517189142|FG002|Overall Study|Adverse Event|1|||
143448961|NCT01901432|517189143|FG003|Overall Study|Adverse Event|0|||
143448962|NCT01901432|517189144|FG004|Overall Study|Adverse Event|1|||
143448963|NCT01901432|517189140|FG000|Overall Study|Withdrawal by Subject|0|||
143448964|NCT01901432|517189141|FG001|Overall Study|Withdrawal by Subject|0|||
143448965|NCT01901432|517189142|FG002|Overall Study|Withdrawal by Subject|1|||
143448966|NCT01901432|517189143|FG003|Overall Study|Withdrawal by Subject|0|||
143448967|NCT01901432|517189144|FG004|Overall Study|Withdrawal by Subject|5|||
143448968|NCT01901432|517189140|FG000|Overall Study|Physician Decision|0|||
143448969|NCT01901432|517189141|FG001|Overall Study|Physician Decision|0|||
143448970|NCT01901432|517189142|FG002|Overall Study|Physician Decision|0|||
143448971|NCT01901432|517189143|FG003|Overall Study|Physician Decision|0|||
143448972|NCT01901432|517189144|FG004|Overall Study|Physician Decision|2|||
143448973|NCT01901432|517189140|FG000|Overall Study|Patient decision to stop study drug|0|||
143448974|NCT01901432|517189141|FG001|Overall Study|Patient decision to stop study drug|0|||
143448975|NCT01901432|517189142|FG002|Overall Study|Patient decision to stop study drug|0|||
143448976|NCT01901432|517189143|FG003|Overall Study|Patient decision to stop study drug|0|||
143448977|NCT01901432|517189144|FG004|Overall Study|Patient decision to stop study drug|1|||
143448978|NCT00379288|517189145|FG000|Overall Study|Adverse Event|5|||
143448979|NCT00379288|517189146|FG001|Overall Study|Adverse Event|6|||
143448980|NCT00379288|517189147|FG002|Overall Study|Adverse Event|2|||
143448981|NCT00379288|517189148|FG003|Overall Study|Adverse Event|0|||
143448982|NCT00379288|517189145|FG000|Overall Study|Treatment Failure|0|||
143448983|NCT00379288|517189146|FG001|Overall Study|Treatment Failure|1|||
143448984|NCT00379288|517189147|FG002|Overall Study|Treatment Failure|0|||
143448985|NCT00379288|517189148|FG003|Overall Study|Treatment Failure|1|||
143448986|NCT00379288|517189145|FG000|Overall Study|Lost to Follow-up|3|||
143448987|NCT00379288|517189146|FG001|Overall Study|Lost to Follow-up|3|||
143448988|NCT00379288|517189147|FG002|Overall Study|Lost to Follow-up|2|||
143448989|NCT00379288|517189148|FG003|Overall Study|Lost to Follow-up|0|||
143448990|NCT00379288|517189145|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
143448991|NCT00379288|517189146|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
143448992|NCT00379288|517189147|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
143448993|NCT00379288|517189148|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
143448994|NCT00379288|517189145|FG000|Overall Study|Subject withdrew-related to study drug|1|||
143448995|NCT00379288|517189146|FG001|Overall Study|Subject withdrew-related to study drug|0|||
143448996|NCT00379288|517189147|FG002|Overall Study|Subject withdrew-related to study drug|0|||
143448997|NCT00379288|517189148|FG003|Overall Study|Subject withdrew-related to study drug|1|||
143448998|NCT00379288|517189145|FG000|Overall Study|Noncompliance with protocol|8|||
143448999|NCT00379288|517189146|FG001|Overall Study|Noncompliance with protocol|6|||
143449000|NCT00379288|517189147|FG002|Overall Study|Noncompliance with protocol|2|||
143449001|NCT00379288|517189148|FG003|Overall Study|Noncompliance with protocol|1|||
143449002|NCT00379288|517189145|FG000|Overall Study|Did not meet protocol eligibility|0|||
143449003|NCT00379288|517189146|FG001|Overall Study|Did not meet protocol eligibility|1|||
143449004|NCT00379288|517189147|FG002|Overall Study|Did not meet protocol eligibility|0|||
143449005|NCT00379288|517189148|FG003|Overall Study|Did not meet protocol eligibility|2|||
143449006|NCT00379288|517189145|FG000|Overall Study|Administrative|2|||
143449007|NCT00379288|517189146|FG001|Overall Study|Administrative|2|||
143449008|NCT00379288|517189147|FG002|Overall Study|Administrative|0|||
143449009|NCT00379288|517189148|FG003|Overall Study|Administrative|1|||
142941561|NCT00064701|515324682|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
143449010|NCT00918879|517189149|FG000|Overall Study|Withdrawal by Subject|4|||
143449011|NCT00918879|517189150|FG001|Overall Study|Withdrawal by Subject|4|||
143449012|NCT00918879|517189149|FG000|Overall Study|Lost to Follow-up|1|||
143449013|NCT00918879|517189150|FG001|Overall Study|Lost to Follow-up|1|||
143449014|NCT00918879|517189149|FG000|Overall Study|Severe non-compliance to protocol|1|||
143449015|NCT00918879|517189150|FG001|Overall Study|Severe non-compliance to protocol|1|||
143449016|NCT00357110|517189153|FG000|Overall Study|Early study termination|5|||
143449017|NCT00357110|517189154|FG001|Overall Study|Early study termination|5|||
143449018|NCT00515671|517189156|FG000|Overall Study|Lost to Follow-up|13|||
143449019|NCT00515671|517189157|FG001|Overall Study|Lost to Follow-up|10|||
143449020|NCT00515671|517189156|FG000|Overall Study|Withdrawal by Subject|3|||
143449021|NCT00515671|517189157|FG001|Overall Study|Withdrawal by Subject|5|||
143449022|NCT00515671|517189156|FG000|Overall Study|incarcerated|1|||
143449023|NCT00515671|517189157|FG001|Overall Study|incarcerated|2|||
143449024|NCT01014208|517189161|FG000|Overall Study|Lost to Follow-up|2|||
143449025|NCT01014208|517189162|FG001|Overall Study|Lost to Follow-up|5|||
143449026|NCT01014208|517189161|FG000|Overall Study|Participant Withdrew Consent|12|||
143449027|NCT01014208|517189162|FG001|Overall Study|Participant Withdrew Consent|12|||
143449028|NCT01014208|517189161|FG000|Overall Study|Did Not Receive Study Drug|2|||
143449029|NCT01014208|517189162|FG001|Overall Study|Did Not Receive Study Drug|0|||
143449030|NCT01014208|517189161|FG000|Overall Study|Study Closed/terminated|78|||
143449031|NCT01014208|517189162|FG001|Overall Study|Study Closed/terminated|83|||
143449032|NCT00414908|517189165|FG000|Overall Study|Protocol Violation|1|||
143449033|NCT00414908|517189166|FG001|Overall Study|Protocol Violation|1|||
143449034|NCT01076153|517189167|FG000|Overall Study|Symptoms improved/resolved|10|||
143449035|NCT01076153|517189167|FG000|Overall Study|Adverse Event|1|||
143449036|NCT04165031|517189168|FG000|Overall Study|Adverse Event|1|||
143449037|NCT04165031|517189169|FG001|Overall Study|Adverse Event|1|||
143449038|NCT04165031|517189170|FG002|Overall Study|Adverse Event|0|||
143449039|NCT04165031|517189171|FG003|Overall Study|Adverse Event|0|||
143449040|NCT04165031|517189172|FG004|Overall Study|Adverse Event|0|||
143449041|NCT04165031|517189173|FG005|Overall Study|Adverse Event|0|||
143449042|NCT04165031|517189168|FG000|Overall Study|Withdrawal by Subject|0|||
143449043|NCT04165031|517189169|FG001|Overall Study|Withdrawal by Subject|0|||
143449044|NCT04165031|517189170|FG002|Overall Study|Withdrawal by Subject|1|||
143449045|NCT04165031|517189171|FG003|Overall Study|Withdrawal by Subject|0|||
143449046|NCT04165031|517189172|FG004|Overall Study|Withdrawal by Subject|0|||
143449047|NCT04165031|517189173|FG005|Overall Study|Withdrawal by Subject|0|||
143449048|NCT01332630|517189174|FG000|Overall Study|Withdrawal by Subject|3|||
143449049|NCT05602727|517189180|FG000|Overall Study|Physician Decision|0|||
143449050|NCT05602727|517189181|FG001|Overall Study|Physician Decision|1|||
143449051|NCT05602727|517189182|FG002|Overall Study|Physician Decision|0|||
143449052|NCT05602727|517189180|FG000|Overall Study|Randomized by mistake without study medication|1|||
143449053|NCT05602727|517189181|FG001|Overall Study|Randomized by mistake without study medication|0|||
143449054|NCT05602727|517189182|FG002|Overall Study|Randomized by mistake without study medication|0|||
143449055|NCT05602727|517189180|FG000|Overall Study|Study termination by Sponsor|18|||
143449056|NCT05602727|517189181|FG001|Overall Study|Study termination by Sponsor|15|||
143449057|NCT05602727|517189182|FG002|Overall Study|Study termination by Sponsor|19|||
143449058|NCT05602727|517189180|FG000|Overall Study|Withdrawal by Subject|2|||
143449059|NCT05602727|517189181|FG001|Overall Study|Withdrawal by Subject|1|||
143449060|NCT05602727|517189182|FG002|Overall Study|Withdrawal by Subject|1|||
143449061|NCT05602727|517189180|FG000|Overall Study|Various reasons|1|||
143449062|NCT05602727|517189181|FG001|Overall Study|Various reasons|6|||
143449063|NCT05602727|517189182|FG002|Overall Study|Various reasons|1|||
143449064|NCT00567567|517189183|FG000|Overall Study|Adverse Event|0|||
143449065|NCT00567567|517189184|FG001|Overall Study|Adverse Event|2|||
143449066|NCT00567567|517189185|FG002|Overall Study|Adverse Event|5|||
143449067|NCT00567567|517189183|FG000|Overall Study|Death|8|||
143449068|NCT00567567|517189184|FG001|Overall Study|Death|1|||
143449069|NCT00567567|517189185|FG002|Overall Study|Death|5|||
143449070|NCT00567567|517189183|FG000|Overall Study|Lack of Efficacy|16|||
143449071|NCT00567567|517189184|FG001|Overall Study|Lack of Efficacy|17|||
143449072|NCT00567567|517189185|FG002|Overall Study|Lack of Efficacy|48|||
143449073|NCT00567567|517189183|FG000|Overall Study|Lost to Follow-up|0|||
143449074|NCT00567567|517189184|FG001|Overall Study|Lost to Follow-up|0|||
143449075|NCT00567567|517189185|FG002|Overall Study|Lost to Follow-up|1|||
143449076|NCT00567567|517189183|FG000|Overall Study|Physician Decision|16|||
143449077|NCT00567567|517189184|FG001|Overall Study|Physician Decision|18|||
143449078|NCT00567567|517189185|FG002|Overall Study|Physician Decision|84|||
143449079|NCT00567567|517189183|FG000|Overall Study|Withdrawal by Subject|0|||
143449080|NCT00567567|517189184|FG001|Overall Study|Withdrawal by Subject|0|||
143449081|NCT00567567|517189185|FG002|Overall Study|Withdrawal by Subject|2|||
143449082|NCT00567567|517189183|FG000|Overall Study|Ineligible|4|||
143449083|NCT00567567|517189184|FG001|Overall Study|Ineligible|0|||
143449084|NCT00567567|517189185|FG002|Overall Study|Ineligible|9|||
143449085|NCT00567567|517189183|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
143449086|NCT00567567|517189184|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
143449087|NCT00567567|517189185|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
143449088|NCT00567567|517189183|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
143449089|NCT00567567|517189184|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
143449090|NCT00567567|517189185|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
143449091|NCT00567567|517189183|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
143449092|NCT00567567|517189184|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
143449093|NCT00567567|517189185|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
143449094|NCT03330405|517189186|FG000|Overall Study|Other|1|||
143449095|NCT03330405|517189187|FG001|Overall Study|Other|3|||
143449096|NCT03330405|517189188|FG002|Overall Study|Other|1|||
143449097|NCT03330405|517189189|FG003|Overall Study|Other|0|||
143449098|NCT03330405|517189190|FG004|Overall Study|Other|2|||
143449099|NCT03330405|517189191|FG005|Overall Study|Other|0|||
143449100|NCT03330405|517189192|FG006|Overall Study|Other|1|||
143449101|NCT03330405|517189193|FG007|Overall Study|Other|0|||
143449102|NCT03330405|517189194|FG008|Overall Study|Other|0|||
143449103|NCT03330405|517189195|FG009|Overall Study|Other|0|||
143449104|NCT03330405|517189196|FG010|Overall Study|Other|0|||
143449105|NCT03330405|517189186|FG000|Overall Study|Progressive disease|8|||
143449106|NCT03330405|517189187|FG001|Overall Study|Progressive disease|27|||
143449107|NCT03330405|517189188|FG002|Overall Study|Progressive disease|4|||
143449108|NCT03330405|517189189|FG003|Overall Study|Progressive disease|18|||
143449109|NCT03330405|517189190|FG004|Overall Study|Progressive disease|16|||
143449110|NCT03330405|517189191|FG005|Overall Study|Progressive disease|14|||
143449111|NCT03330405|517189192|FG006|Overall Study|Progressive disease|7|||
143449112|NCT03330405|517189193|FG007|Overall Study|Progressive disease|29|||
143449113|NCT03330405|517189194|FG008|Overall Study|Progressive disease|9|||
143449114|NCT03330405|517189195|FG009|Overall Study|Progressive disease|11|||
143449115|NCT03330405|517189196|FG010|Overall Study|Progressive disease|5|||
143449116|NCT03330405|517189186|FG000|Overall Study|Withdrawal by Subject|1|||
143449117|NCT03330405|517189187|FG001|Overall Study|Withdrawal by Subject|4|||
143449118|NCT03330405|517189188|FG002|Overall Study|Withdrawal by Subject|0|||
143449119|NCT03330405|517189189|FG003|Overall Study|Withdrawal by Subject|1|||
143449120|NCT03330405|517189190|FG004|Overall Study|Withdrawal by Subject|1|||
143449121|NCT03330405|517189191|FG005|Overall Study|Withdrawal by Subject|1|||
143449122|NCT03330405|517189192|FG006|Overall Study|Withdrawal by Subject|0|||
143449123|NCT03330405|517189193|FG007|Overall Study|Withdrawal by Subject|2|||
143449124|NCT03330405|517189194|FG008|Overall Study|Withdrawal by Subject|2|||
143449125|NCT03330405|517189195|FG009|Overall Study|Withdrawal by Subject|1|||
143449126|NCT03330405|517189196|FG010|Overall Study|Withdrawal by Subject|1|||
143449127|NCT03330405|517189186|FG000|Overall Study|Global deterioration of health status|2|||
143449128|NCT03330405|517189187|FG001|Overall Study|Global deterioration of health status|3|||
143449129|NCT03330405|517189188|FG002|Overall Study|Global deterioration of health status|0|||
143449130|NCT03330405|517189189|FG003|Overall Study|Global deterioration of health status|2|||
143449131|NCT03330405|517189190|FG004|Overall Study|Global deterioration of health status|3|||
143449132|NCT03330405|517189191|FG005|Overall Study|Global deterioration of health status|3|||
143449133|NCT03330405|517189192|FG006|Overall Study|Global deterioration of health status|0|||
143449134|NCT03330405|517189193|FG007|Overall Study|Global deterioration of health status|2|||
143449135|NCT03330405|517189194|FG008|Overall Study|Global deterioration of health status|8|||
143449136|NCT03330405|517189195|FG009|Overall Study|Global deterioration of health status|4|||
143449137|NCT03330405|517189196|FG010|Overall Study|Global deterioration of health status|1|||
143449138|NCT03330405|517189186|FG000|Overall Study|Adverse Event|0|||
143449139|NCT03330405|517189187|FG001|Overall Study|Adverse Event|1|||
143449140|NCT03330405|517189188|FG002|Overall Study|Adverse Event|0|||
143449141|NCT03330405|517189189|FG003|Overall Study|Adverse Event|1|||
143449142|NCT03330405|517189190|FG004|Overall Study|Adverse Event|1|||
143449143|NCT03330405|517189191|FG005|Overall Study|Adverse Event|1|||
143449144|NCT03330405|517189192|FG006|Overall Study|Adverse Event|3|||
143449145|NCT03330405|517189193|FG007|Overall Study|Adverse Event|4|||
143449146|NCT03330405|517189194|FG008|Overall Study|Adverse Event|2|||
143449147|NCT03330405|517189195|FG009|Overall Study|Adverse Event|2|||
143449148|NCT03330405|517189196|FG010|Overall Study|Adverse Event|2|||
143449149|NCT03330405|517189186|FG000|Overall Study|Death|0|||
143449150|NCT03330405|517189187|FG001|Overall Study|Death|4|||
143449151|NCT03330405|517189188|FG002|Overall Study|Death|0|||
143449152|NCT03330405|517189189|FG003|Overall Study|Death|0|||
143449153|NCT03330405|517189190|FG004|Overall Study|Death|0|||
143449154|NCT03330405|517189191|FG005|Overall Study|Death|1|||
143449155|NCT03330405|517189192|FG006|Overall Study|Death|0|||
143449156|NCT03330405|517189193|FG007|Overall Study|Death|2|||
143449157|NCT03330405|517189194|FG008|Overall Study|Death|0|||
143449158|NCT03330405|517189195|FG009|Overall Study|Death|0|||
143449159|NCT03330405|517189196|FG010|Overall Study|Death|0|||
143449160|NCT03330405|517189186|FG000|Overall Study|Physician Decision|0|||
143449161|NCT03330405|517189187|FG001|Overall Study|Physician Decision|0|||
143449162|NCT03330405|517189188|FG002|Overall Study|Physician Decision|0|||
143449163|NCT03330405|517189189|FG003|Overall Study|Physician Decision|0|||
143449164|NCT03330405|517189190|FG004|Overall Study|Physician Decision|0|||
143449165|NCT03330405|517189191|FG005|Overall Study|Physician Decision|0|||
143449166|NCT03330405|517189192|FG006|Overall Study|Physician Decision|0|||
143449167|NCT03330405|517189193|FG007|Overall Study|Physician Decision|1|||
143449168|NCT03330405|517189194|FG008|Overall Study|Physician Decision|0|||
143449169|NCT03330405|517189195|FG009|Overall Study|Physician Decision|0|||
143449170|NCT03330405|517189196|FG010|Overall Study|Physician Decision|0|||
143449171|NCT02643303|517189197|FG000|Overall Study|Progressive Disease|4|||
143449172|NCT02643303|517189198|FG001|Overall Study|Progressive Disease|4|||
143449173|NCT02643303|517189199|FG002|Overall Study|Progressive Disease|1|||
143449174|NCT02643303|517189200|FG003|Overall Study|Progressive Disease|12|||
143449175|NCT02643303|517189201|FG004|Overall Study|Progressive Disease|6|||
143449176|NCT02643303|517189202|FG005|Overall Study|Progressive Disease|4|||
143449177|NCT02643303|517189203|FG006|Overall Study|Progressive Disease|8|||
143449178|NCT02643303|517189204|FG007|Overall Study|Progressive Disease|2|||
143449179|NCT02643303|517189205|FG008|Overall Study|Progressive Disease|6|||
143449180|NCT02643303|517189197|FG000|Overall Study|Adverse Event|0|||
143449181|NCT02643303|517189198|FG001|Overall Study|Adverse Event|1|||
143449182|NCT02643303|517189199|FG002|Overall Study|Adverse Event|0|||
143449183|NCT02643303|517189200|FG003|Overall Study|Adverse Event|0|||
143449184|NCT02643303|517189201|FG004|Overall Study|Adverse Event|1|||
143449185|NCT02643303|517189202|FG005|Overall Study|Adverse Event|0|||
143449186|NCT02643303|517189203|FG006|Overall Study|Adverse Event|0|||
143449187|NCT02643303|517189204|FG007|Overall Study|Adverse Event|0|||
143449188|NCT02643303|517189205|FG008|Overall Study|Adverse Event|0|||
143449189|NCT02643303|517189197|FG000|Overall Study|Withdrawal by Subject|0|||
143449190|NCT02643303|517189198|FG001|Overall Study|Withdrawal by Subject|0|||
143449191|NCT02643303|517189199|FG002|Overall Study|Withdrawal by Subject|0|||
143449192|NCT02643303|517189200|FG003|Overall Study|Withdrawal by Subject|1|||
143449193|NCT02643303|517189201|FG004|Overall Study|Withdrawal by Subject|0|||
143449194|NCT02643303|517189202|FG005|Overall Study|Withdrawal by Subject|0|||
143449195|NCT02643303|517189203|FG006|Overall Study|Withdrawal by Subject|1|||
143449196|NCT02643303|517189204|FG007|Overall Study|Withdrawal by Subject|1|||
143449197|NCT02643303|517189205|FG008|Overall Study|Withdrawal by Subject|1|||
143449198|NCT04335591|517189210|FG000|Overall Study|Adverse Event|5|||
143449199|NCT04335591|517189211|FG001|Overall Study|Adverse Event|2|||
143449200|NCT04335591|517189212|FG002|Overall Study|Adverse Event|3|||
143449201|NCT04335591|517189213|FG003|Overall Study|Adverse Event|2|||
143449202|NCT04335591|517189210|FG000|Overall Study|Protocol Violation|1|||
143449203|NCT04335591|517189211|FG001|Overall Study|Protocol Violation|0|||
143449204|NCT04335591|517189212|FG002|Overall Study|Protocol Violation|0|||
143449205|NCT04335591|517189213|FG003|Overall Study|Protocol Violation|0|||
143449206|NCT04335591|517189210|FG000|Overall Study|Withdrawal by Subject|8|||
143449207|NCT04335591|517189211|FG001|Overall Study|Withdrawal by Subject|4|||
143449208|NCT04335591|517189212|FG002|Overall Study|Withdrawal by Subject|4|||
143449209|NCT04335591|517189213|FG003|Overall Study|Withdrawal by Subject|5|||
143449210|NCT04335591|517189210|FG000|Overall Study|Subject planning pregnancy|0|||
143449211|NCT04335591|517189211|FG001|Overall Study|Subject planning pregnancy|1|||
143449212|NCT04335591|517189212|FG002|Overall Study|Subject planning pregnancy|0|||
143449213|NCT04335591|517189213|FG003|Overall Study|Subject planning pregnancy|0|||
143449214|NCT04335591|517189210|FG000|Overall Study|Ukrainian Russian war conflict|4|||
143449215|NCT04335591|517189211|FG001|Overall Study|Ukrainian Russian war conflict|5|||
143449216|NCT04335591|517189212|FG002|Overall Study|Ukrainian Russian war conflict|2|||
143449217|NCT04335591|517189213|FG003|Overall Study|Ukrainian Russian war conflict|0|||
143449218|NCT00731133|517189216|FG000|Overall Study|Withdrawal by Subject|10|||
143449219|NCT03853551|517189220|FG000|Overall Study|Death|2|||
143449220|NCT03853551|517189220|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
143449221|NCT01252355|517189221|FG000|Overall Study|Adverse Event|9|||
143449222|NCT01252355|517189222|FG001|Overall Study|Adverse Event|17|||
143449223|NCT01252355|517189223|FG002|Overall Study|Adverse Event|22|||
143449224|NCT01252355|517189221|FG000|Overall Study|Lack of Efficacy|6|||
143449225|NCT01252355|517189222|FG001|Overall Study|Lack of Efficacy|4|||
143449226|NCT01252355|517189223|FG002|Overall Study|Lack of Efficacy|2|||
143449227|NCT01252355|517189221|FG000|Overall Study|Lost to Follow-up|0|||
143449228|NCT01252355|517189222|FG001|Overall Study|Lost to Follow-up|0|||
143449229|NCT01252355|517189223|FG002|Overall Study|Lost to Follow-up|1|||
143449230|NCT01252355|517189221|FG000|Overall Study|Poor Compliance to Protocol|1|||
143449231|NCT01252355|517189222|FG001|Overall Study|Poor Compliance to Protocol|1|||
143449232|NCT01252355|517189223|FG002|Overall Study|Poor Compliance to Protocol|1|||
143449233|NCT01252355|517189221|FG000|Overall Study|Progressive Disease|2|||
143449234|NCT01252355|517189222|FG001|Overall Study|Progressive Disease|0|||
143449235|NCT01252355|517189223|FG002|Overall Study|Progressive Disease|0|||
143449236|NCT01252355|517189221|FG000|Overall Study|Sponsor Early Termination of Study|149|||
143449237|NCT01252355|517189222|FG001|Overall Study|Sponsor Early Termination of Study|149|||
143449238|NCT01252355|517189223|FG002|Overall Study|Sponsor Early Termination of Study|146|||
143449239|NCT01252355|517189221|FG000|Overall Study|Randomized but not Treated|2|||
143449240|NCT01252355|517189222|FG001|Overall Study|Randomized but not Treated|0|||
143449241|NCT01252355|517189223|FG002|Overall Study|Randomized but not Treated|0|||
143449242|NCT01252355|517189221|FG000|Overall Study|Other Than Above|8|||
143449243|NCT01252355|517189222|FG001|Overall Study|Other Than Above|7|||
143449244|NCT01252355|517189223|FG002|Overall Study|Other Than Above|7|||
143449245|NCT01725126|517189224|FG000|Overall Study|Protocol Violation|0|||
143449246|NCT01725126|517189225|FG001|Overall Study|Protocol Violation|1|||
143449247|NCT01725126|517189226|FG002|Overall Study|Protocol Violation|0|||
143449248|NCT01725126|517189227|FG003|Overall Study|Protocol Violation|0|||
143449249|NCT01725126|517189228|FG004|Overall Study|Protocol Violation|0|||
143449250|NCT01725126|517189229|FG005|Overall Study|Protocol Violation|0|||
143449251|NCT01725126|517189224|FG000|Overall Study|Withdrawal by Subject|0|||
143449252|NCT01725126|517189225|FG001|Overall Study|Withdrawal by Subject|0|||
143449253|NCT01725126|517189226|FG002|Overall Study|Withdrawal by Subject|0|||
143449254|NCT01725126|517189227|FG003|Overall Study|Withdrawal by Subject|1|||
143449255|NCT01725126|517189228|FG004|Overall Study|Withdrawal by Subject|0|||
143449256|NCT01725126|517189229|FG005|Overall Study|Withdrawal by Subject|0|||
143449257|NCT01876901|517189232|FG000|Overall Study|Protocol Violation|10|||
143449258|NCT01876901|517189233|FG001|Overall Study|Protocol Violation|2|||
143449259|NCT01876901|517189232|FG000|Overall Study|No or other surgical intervention|7|||
143449260|NCT01876901|517189233|FG001|Overall Study|No or other surgical intervention|5|||
143449261|NCT02242097|517189236|FG000|Ibrutinib Treatment|Adverse Event|16|||
143449262|NCT02242097|517189236|FG000|Ibrutinib Treatment|Physician Decision|1|||
143449263|NCT02242097|517189236|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
143449264|NCT02242097|517189236|FG000|Ibrutinib Treatment|Death|1|||
143449265|NCT02242097|517189236|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
143449266|NCT02242097|517189236|FG000|Post Therapy Follow Up|Death|3|||
143449267|NCT02242097|517189236|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
143449268|NCT02781090|517189238|FG000|3-Month Follow-Up|Missed Visit|20|||
143449269|NCT02781090|517189239|FG001|3-Month Follow-Up|Missed Visit|20|||
143449270|NCT02781090|517189238|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
143449271|NCT02781090|517189239|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
143449272|NCT02781090|517189238|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
143449273|NCT02781090|517189239|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
143449274|NCT02781090|517189238|FG000|3-Month Follow-Up|Death|1|||
143449275|NCT02781090|517189239|FG001|3-Month Follow-Up|Death|0|||
143449276|NCT02781090|517189238|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
143449277|NCT02781090|517189239|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
143449278|NCT02781090|517189238|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
143449279|NCT02781090|517189239|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
143449280|NCT02781090|517189238|FG000|6-Month Follow-Up|Death|0|||
143449281|NCT02781090|517189239|FG001|6-Month Follow-Up|Death|1|||
143449282|NCT01867333|517189240|FG000|Overall Study|Withdrawal by Subject|1|||
143449283|NCT01867333|517189241|FG001|Overall Study|Withdrawal by Subject|0|||
143449284|NCT01867333|517189240|FG000|Overall Study|Adverse Event|1|||
143449285|NCT01867333|517189241|FG001|Overall Study|Adverse Event|0|||
143449286|NCT01867333|517189240|FG000|Overall Study|Participant choice|1|||
143449287|NCT01867333|517189241|FG001|Overall Study|Participant choice|2|||
143449288|NCT01867333|517189240|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
143449289|NCT01867333|517189241|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
143449290|NCT01867333|517189240|FG000|Overall Study|Death|0|||
143449291|NCT01867333|517189241|FG001|Overall Study|Death|1|||
143449292|NCT01867333|517189240|FG000|Overall Study|Physician Decision|3|||
143449293|NCT01867333|517189241|FG001|Overall Study|Physician Decision|2|||
143449294|NCT01867333|517189240|FG000|Overall Study|Switched to alternative treatment|1|||
143449295|NCT01867333|517189241|FG001|Overall Study|Switched to alternative treatment|0|||
143449296|NCT02683785|517189242|FG000|Overall Study|Withdrawal by Subject|1|||
143449297|NCT02683785|517189243|FG001|Overall Study|Withdrawal by Subject|1|||
143449298|NCT02683785|517189242|FG000|Overall Study|Lost to Follow-up|0|||
143449299|NCT02683785|517189243|FG001|Overall Study|Lost to Follow-up|1|||
143449300|NCT02683785|517189242|FG000|Overall Study|Adverse Event|0|||
143449301|NCT02683785|517189243|FG001|Overall Study|Adverse Event|2|||
143449302|NCT04462289|517189250|FG000|Overall Study|Lost to Follow-up|4|||
143449303|NCT04462289|517189251|FG001|Overall Study|Lost to Follow-up|5|||
143449304|NCT04462289|517189250|FG000|Overall Study|Death|0|||
143449305|NCT04462289|517189251|FG001|Overall Study|Death|3|||
143449306|NCT04462289|517189250|FG000|Overall Study|Withdrawal by Subject|1|||
143449307|NCT04462289|517189251|FG001|Overall Study|Withdrawal by Subject|3|||
143449308|NCT02206061|517189252|FG000|Overall Study|Withdrawal by Subject|4|||
143449309|NCT02206061|517189253|FG001|Overall Study|Withdrawal by Subject|7|||
143449310|NCT02206061|517189254|FG002|Overall Study|Withdrawal by Subject|1|||
143449311|NCT02206061|517189252|FG000|Overall Study|Lost to Follow-up|14|||
143449312|NCT02206061|517189253|FG001|Overall Study|Lost to Follow-up|7|||
143449313|NCT02206061|517189254|FG002|Overall Study|Lost to Follow-up|20|||
143449314|NCT04187326|517189255|FG000|Overall Study|Lost to Follow-up|2|||
143449315|NCT04187326|517189256|FG001|Overall Study|Lost to Follow-up|1|||
143449316|NCT04187326|517189255|FG000|Overall Study|Computer error- task was only partially completed.|0|||
143449317|NCT04187326|517189256|FG001|Overall Study|Computer error- task was only partially completed.|1|||
143449318|NCT03686423|517189262|FG000|Overall Study|Withdrawal by Subject|9|||
143449319|NCT03686423|517189262|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
143449320|NCT02833077|517189263|FG000|Overall Study|Adverse Event|1|||
143449321|NCT02833077|517189264|FG001|Overall Study|Adverse Event|2|||
143449322|NCT02833077|517189263|FG000|Overall Study|Lost to Follow-up|10|||
143449323|NCT02833077|517189264|FG001|Overall Study|Lost to Follow-up|1|||
143449324|NCT02833077|517189263|FG000|Overall Study|Personal Reasons|6|||
143449325|NCT02833077|517189264|FG001|Overall Study|Personal Reasons|4|||
143449326|NCT02833077|517189263|FG000|Overall Study|Protocol Deviation|0|||
143449327|NCT02833077|517189264|FG001|Overall Study|Protocol Deviation|1|||
143449328|NCT05718466|517190664|FG000|Overall Study|Withdrawal by Subject|1|||
143449329|NCT05718466|517190665|FG001|Overall Study|Withdrawal by Subject|2|||
143449330|NCT05718466|517190664|FG000|Overall Study|Death|0|||
143449331|NCT05718466|517190665|FG001|Overall Study|Death|1|||
143449332|NCT00387426|517190666|FG000|Overall Study|Lack of Response|7|||
143449333|NCT00387426|517190666|FG000|Overall Study|Toxicities|4|||
143449334|NCT00387426|517190666|FG000|Overall Study|Disease Progression|3|||
143449335|NCT01253135|517190667|FG000|Original Protocol|Protocol Amendment|15|||
143449336|NCT01253135|517190667|FG000|Amended Protocol|Non-compliance|1|||
143449337|NCT01015560|517190668|FG000|Overall Study|Adverse Event|1|||
143449338|NCT01015560|517190668|FG000|Overall Study|Not protocol specified|1|||
143449339|NCT01015560|517190668|FG000|Overall Study|Withdrawal by Subject|1|||
143449340|NCT00288639|517190678|FG000|Overall Study|Adverse Event|5|||
143449341|NCT00288639|517190678|FG000|Overall Study|Lack of Efficacy|4|||
143449342|NCT00288639|517190678|FG000|Overall Study|Withdrawal by Subject|2|||
143449343|NCT00288639|517190678|FG000|Overall Study|Other|1|||
143449344|NCT02815579|517190684|FG000|Overall Study|Non-payment of loan down-payment|16|||
143449345|NCT02815579|517190685|FG001|Overall Study|Non-payment of loan down-payment|0|||
143449346|NCT02815579|517190684|FG000|Overall Study|Withdrawal by Subject|7|||
143449347|NCT02815579|517190685|FG001|Overall Study|Withdrawal by Subject|1|||
143449348|NCT02815579|517190684|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
143449349|NCT02815579|517190685|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
143449350|NCT02815579|517190684|FG000|Overall Study|Lost to Follow-up|7|||
143449351|NCT02815579|517190685|FG001|Overall Study|Lost to Follow-up|4|||
143449352|NCT02815579|517190684|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
143449353|NCT02815579|517190685|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
143449354|NCT02815579|517190684|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
143449355|NCT02815579|517190685|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
143449356|NCT02815579|517190684|FG000|Overall Study|Death|5|||
143449357|NCT02815579|517190685|FG001|Overall Study|Death|4|||
143449358|NCT02815579|517190684|FG000|Overall Study|Imprisoned|0|||
143449359|NCT02815579|517190685|FG001|Overall Study|Imprisoned|2|||
143449360|NCT02815579|517190684|FG000|Overall Study|Did not meet enrollment criteria|0|||
143449361|NCT02815579|517190685|FG001|Overall Study|Did not meet enrollment criteria|1|||
143449362|NCT02311673|517190686|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
143449363|NCT02311673|517190687|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
143449364|NCT02311673|517190688|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
143449365|NCT02311673|517190689|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
143449366|NCT02787044|517190692|FG000|Overall Study|Lost to Follow-up|15|||
143449367|NCT02787044|517190693|FG001|Overall Study|Lost to Follow-up|19|||
143449368|NCT04552899|517190694|FG000|Overall Study|Adverse Event|4|||
143449369|NCT04552899|517190695|FG001|Overall Study|Adverse Event|3|||
143449370|NCT04552899|517190694|FG000|Overall Study|Death|4|||
143449371|NCT04552899|517190695|FG001|Overall Study|Death|4|||
143449372|NCT04552899|517190694|FG000|Overall Study|Lost to Follow-up|8|||
143449373|NCT04552899|517190695|FG001|Overall Study|Lost to Follow-up|13|||
143449374|NCT04552899|517190694|FG000|Overall Study|Lung Transplant|4|||
143449375|NCT04552899|517190695|FG001|Overall Study|Lung Transplant|3|||
143449376|NCT04552899|517190694|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
143449377|NCT04552899|517190695|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
143449378|NCT04552899|517190694|FG000|Overall Study|Physician Decision|3|||
143449379|NCT04552899|517190695|FG001|Overall Study|Physician Decision|4|||
143449380|NCT04552899|517190694|FG000|Overall Study|Study Terminated By Sponsor|237|||
143449381|NCT04552899|517190695|FG001|Overall Study|Study Terminated By Sponsor|239|||
143449382|NCT04552899|517190694|FG000|Overall Study|Withdrawal by Subject|15|||
143449383|NCT04552899|517190695|FG001|Overall Study|Withdrawal by Subject|17|||
143449384|NCT01517295|517190696|FG000|Overall Study|Physician Decision|1|||
143449385|NCT01517295|517190697|FG001|Overall Study|Physician Decision|0|||
143449386|NCT03248882|517190698|FG000|Overall Study|Adverse Event|3|||
143449387|NCT03248882|517190699|FG001|Overall Study|Adverse Event|3|||
143449388|NCT03248882|517190700|FG002|Overall Study|Adverse Event|2|||
143449389|NCT03248882|517190701|FG003|Overall Study|Adverse Event|6|||
143449390|NCT03248882|517190702|FG004|Overall Study|Adverse Event|9|||
143449391|NCT03248882|517190698|FG000|Overall Study|Lost to Follow-up|0|||
143449392|NCT03248882|517190699|FG001|Overall Study|Lost to Follow-up|0|||
143449393|NCT03248882|517190700|FG002|Overall Study|Lost to Follow-up|0|||
143449394|NCT03248882|517190701|FG003|Overall Study|Lost to Follow-up|0|||
143449395|NCT03248882|517190702|FG004|Overall Study|Lost to Follow-up|1|||
143449396|NCT03248882|517190698|FG000|Overall Study|Protocol Violation|2|||
143449397|NCT03248882|517190699|FG001|Overall Study|Protocol Violation|0|||
143449398|NCT03248882|517190700|FG002|Overall Study|Protocol Violation|2|||
143449399|NCT03248882|517190701|FG003|Overall Study|Protocol Violation|0|||
143449400|NCT03248882|517190702|FG004|Overall Study|Protocol Violation|1|||
143449401|NCT03248882|517190698|FG000|Overall Study|Withdrawal by Subject|2|||
143449402|NCT03248882|517190699|FG001|Overall Study|Withdrawal by Subject|2|||
143449403|NCT03248882|517190700|FG002|Overall Study|Withdrawal by Subject|3|||
143449404|NCT03248882|517190701|FG003|Overall Study|Withdrawal by Subject|4|||
143449405|NCT03248882|517190702|FG004|Overall Study|Withdrawal by Subject|2|||
143449406|NCT05487586|517190703|FG000|Overall Study|Death|22|||
143449407|NCT05487586|517190703|FG000|Overall Study|Physician Decision|1|||
143449408|NCT05487586|517190703|FG000|Overall Study|Transfer to another hospital|4|||
143449409|NCT05487586|517190703|FG000|Overall Study|Other|1|||
143449410|NCT01493427|517190704|FG000|Overall Study|Adverse Event|10|||
143449411|NCT01493427|517190704|FG000|Overall Study|Personal Reasons|4|||
143449412|NCT01493427|517190704|FG000|Overall Study|Lost to Follow-up|2|||
143449413|NCT01493427|517190704|FG000|Overall Study|Inability to Follow Instructions|2|||
143449414|NCT01493427|517190704|FG000|Overall Study|Other|2|||
143449415|NCT02574845|517190705|FG000|Overall Study|Consent withdrawn further participation|0|||
143449416|NCT02574845|517190706|FG001|Overall Study|Consent withdrawn further participation|0|||
143449417|NCT02574845|517190707|FG002|Overall Study|Consent withdrawn further participation|0|||
143449418|NCT02574845|517190708|FG003|Overall Study|Consent withdrawn further participation|0|||
143449419|NCT02574845|517190709|FG004|Overall Study|Consent withdrawn further participation|1|||
143449420|NCT02574845|517190710|FG005|Overall Study|Consent withdrawn further participation|0|||
143449421|NCT02574845|517190705|FG000|Overall Study|Adverse Event|0|||
143449422|NCT02574845|517190706|FG001|Overall Study|Adverse Event|1|||
143449423|NCT02574845|517190707|FG002|Overall Study|Adverse Event|0|||
143449424|NCT02574845|517190708|FG003|Overall Study|Adverse Event|0|||
143449425|NCT02574845|517190709|FG004|Overall Study|Adverse Event|0|||
143449426|NCT02574845|517190710|FG005|Overall Study|Adverse Event|1|||
143449427|NCT02233803|517190716|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
143449428|NCT02233803|517190717|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
143449429|NCT02233803|517190716|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
143449430|NCT02233803|517190717|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
143449431|NCT02233803|517190716|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
143449432|NCT02233803|517190717|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
143449433|NCT02233803|517190716|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
143449434|NCT02233803|517190717|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
143449435|NCT02233803|517190716|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
143449436|NCT02233803|517190717|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
143449437|NCT02233803|517190716|FG000|Washout Period (4-Wks)|Physician Decision|1|||
143449438|NCT02233803|517190717|FG001|Washout Period (4-Wks)|Physician Decision|0|||
143449439|NCT02233803|517190716|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
143449440|NCT02233803|517190717|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
143449441|NCT02233803|517190716|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
143449442|NCT02233803|517190717|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
143449443|NCT02233803|517190716|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
143449444|NCT02233803|517190717|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
143449445|NCT01559129|517190722|FG000|Treatment Phase|Adverse Event|0|||
143449446|NCT01559129|517190723|FG001|Treatment Phase|Adverse Event|2|||
143449447|NCT01559129|517190722|FG000|Treatment Phase|Progressive Disease|1|||
143449448|NCT01559129|517190723|FG001|Treatment Phase|Progressive Disease|1|||
143449449|NCT01559129|517190722|FG000|Treatment Phase|Lack of Efficacy|0|||
143449450|NCT01559129|517190723|FG001|Treatment Phase|Lack of Efficacy|1|||
143449451|NCT01559129|517190722|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
143449452|NCT01559129|517190723|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
143449453|NCT01559129|517190722|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
143449454|NCT01559129|517190723|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
143449455|NCT01559129|517190722|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
143449456|NCT01559129|517190723|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
143449457|NCT01559129|517190722|FG000|Open-label Extension Period|Adverse Event|1|||
143449458|NCT01559129|517190723|FG001|Open-label Extension Period|Adverse Event|0|||
143449459|NCT01559129|517190722|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
143449460|NCT01559129|517190723|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
143449461|NCT00368927|517190724|FG000|Overall Study|Lost to Follow-up|2|||
143449462|NCT00368927|517190725|FG001|Overall Study|Lost to Follow-up|0|||
143449463|NCT00368927|517190724|FG000|Overall Study|Adverse Event|1|||
143449464|NCT00368927|517190725|FG001|Overall Study|Adverse Event|1|||
143449465|NCT00368927|517190724|FG000|Overall Study|Withdrawal by Subject|1|||
143449466|NCT00368927|517190725|FG001|Overall Study|Withdrawal by Subject|2|||
143449467|NCT00368927|517190724|FG000|Overall Study|Physician Decision|1|||
143449468|NCT00368927|517190725|FG001|Overall Study|Physician Decision|0|||
143449469|NCT03525392|517190726|FG000|Overall Study|Adverse Event|1|||
143449470|NCT03525392|517190727|FG001|Overall Study|Adverse Event|0|||
143449471|NCT03525392|517190728|FG002|Overall Study|Adverse Event|2|||
143449472|NCT03525392|517190729|FG003|Overall Study|Adverse Event|0|||
143449473|NCT03525392|517190730|FG004|Overall Study|Adverse Event|0|||
143449474|NCT03525392|517190726|FG000|Overall Study|Progressive disease|0|||
143449475|NCT03525392|517190727|FG001|Overall Study|Progressive disease|1|||
143449476|NCT03525392|517190728|FG002|Overall Study|Progressive disease|1|||
143449477|NCT03525392|517190729|FG003|Overall Study|Progressive disease|3|||
143449478|NCT03525392|517190730|FG004|Overall Study|Progressive disease|1|||
143449479|NCT03284203|517190733|FG000|Overall Study|Lost to Follow-up|3|||
143449480|NCT03309813|517190734|FG000|Main Randomized Study|Withdrawal by Subject|1|||
143449481|NCT03309813|517190735|FG001|Main Randomized Study|Withdrawal by Subject|0|||
143449482|NCT04978493|517190736|FG000|Overall Study|No reason available|0|||
143449483|NCT04978493|517190737|FG001|Overall Study|No reason available|1|||
143449484|NCT04978493|517190736|FG000|Overall Study|Adverse Event|1|||
143449485|NCT04978493|517190737|FG001|Overall Study|Adverse Event|0|||
143449486|NCT01128114|517190738|FG000|Overall Study|Treatment Withdrawn|6|||
143449487|NCT01128114|517190738|FG000|Overall Study|Screening Failed|2|||
143449488|NCT00208325|517190739|FG000|Overall Study|Death|18|||
143449489|NCT00208325|517190740|FG001|Overall Study|Death|19|||
143449490|NCT00208325|517190741|FG002|Overall Study|Death|7|||
143449491|NCT00208325|517190742|FG003|Overall Study|Death|5|||
143449492|NCT00208325|517190739|FG000|Overall Study|Withdrawal by Subject|0|||
143449493|NCT00208325|517190740|FG001|Overall Study|Withdrawal by Subject|1|||
143449494|NCT00208325|517190741|FG002|Overall Study|Withdrawal by Subject|0|||
143449495|NCT00208325|517190742|FG003|Overall Study|Withdrawal by Subject|0|||
143449496|NCT00208325|517190739|FG000|Overall Study|Revision|4|||
143449497|NCT00208325|517190740|FG001|Overall Study|Revision|1|||
143449498|NCT00208325|517190741|FG002|Overall Study|Revision|0|||
143449499|NCT00208325|517190742|FG003|Overall Study|Revision|4|||
143449500|NCT00208325|517190739|FG000|Overall Study|Lost to Follow-up|1|||
143449501|NCT00208325|517190740|FG001|Overall Study|Lost to Follow-up|0|||
143449502|NCT00208325|517190741|FG002|Overall Study|Lost to Follow-up|2|||
143449503|NCT00208325|517190742|FG003|Overall Study|Lost to Follow-up|0|||
143449504|NCT00208325|517190739|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
143449505|NCT00208325|517190740|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
143449506|NCT00208325|517190741|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
143449507|NCT00208325|517190742|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
143449508|NCT00208325|517190739|FG000|Overall Study|Does not wish to Continue in Study|5|||
143449509|NCT00208325|517190740|FG001|Overall Study|Does not wish to Continue in Study|8|||
143449510|NCT00208325|517190741|FG002|Overall Study|Does not wish to Continue in Study|3|||
143449511|NCT00208325|517190742|FG003|Overall Study|Does not wish to Continue in Study|2|||
143449512|NCT00208325|517190739|FG000|Overall Study|Other|2|||
143449513|NCT00208325|517190740|FG001|Overall Study|Other|1|||
143449514|NCT00208325|517190741|FG002|Overall Study|Other|1|||
143449515|NCT00208325|517190742|FG003|Overall Study|Other|0|||
143449516|NCT00208325|517190739|FG000|Overall Study|Mis-Randomized|17|||
143449517|NCT00208325|517190740|FG001|Overall Study|Mis-Randomized|20|||
143449518|NCT00208325|517190741|FG002|Overall Study|Mis-Randomized|0|||
143449519|NCT00208325|517190742|FG003|Overall Study|Mis-Randomized|0|||
143449520|NCT00586612|517190743|FG000|Primary Phase|Protocol Violation|1|||
143449521|NCT00586612|517190744|FG001|Primary Phase|Protocol Violation|0|||
143449522|NCT00586612|517190743|FG000|Primary Phase|Lost to Follow-up|0|||
143449523|NCT00586612|517190744|FG001|Primary Phase|Lost to Follow-up|1|||
143449524|NCT00586612|517190743|FG000|Primary Phase|Withdrawal by Subject|0|||
143449525|NCT00586612|517190744|FG001|Primary Phase|Withdrawal by Subject|2|||
143449526|NCT00586612|517190743|FG000|Booster Phase|Lost to Follow-up|3|||
143449527|NCT00586612|517190744|FG001|Booster Phase|Lost to Follow-up|1|||
143449528|NCT02738853|517190745|FG000|Enrollment|Inclusion/Exclusion not met|21|||
143449529|NCT02738853|517190745|FG000|Enrollment|Withdrawal by Subject|3|||
143449530|NCT02738853|517190745|FG000|Enrollment|Subject treated with commercially available device|6|||
143449531|NCT02738853|517190745|FG000|Enrollment|Study Enrollment Closed|3|||
143449532|NCT02738853|517190745|FG000|Procedure|Death|1|||
143449533|NCT02738853|517190745|FG000|1 Month|Death|2|||
143449534|NCT02738853|517190745|FG000|6 Month|Death|4|||
143449535|NCT02738853|517190745|FG000|6 Month|Withdrawal by Subject|2|||
143449536|NCT02738853|517190745|FG000|1 Year|Death|6|||
143449537|NCT02738853|517190745|FG000|1 Year|Withdrawal by Subject|1|||
143449538|NCT02738853|517190745|FG000|2 Year|Death|2|||
143449539|NCT02738853|517190745|FG000|2 Year|Lost to Follow-up|1|||
143449540|NCT02738853|517190745|FG000|3 Year|Death|2|||
143449541|NCT02738853|517190745|FG000|3 Year|Withdrawal by Subject|1|||
143449542|NCT02738853|517190745|FG000|4 Year|Death|9|||
143449543|NCT02738853|517190745|FG000|5 Year|Lost to Follow-up|4|||
143449544|NCT04157400|517190747|FG000|Overall Study|Withdrawal by Subject|1|||
143449545|NCT04157400|517190747|FG000|Overall Study|Lost to Follow-up|3|||
143449546|NCT00623805|517190748|FG000|Overall Study|Adverse Event|9|||
143449547|NCT00623805|517190749|FG001|Overall Study|Adverse Event|6|||
143449548|NCT00623805|517190748|FG000|Overall Study|Death|2|||
143449549|NCT00623805|517190749|FG001|Overall Study|Death|0|||
143449550|NCT00623805|517190748|FG000|Overall Study|Lack of Efficacy|3|||
143449551|NCT00623805|517190749|FG001|Overall Study|Lack of Efficacy|7|||
143449552|NCT00623805|517190748|FG000|Overall Study|Lost to Follow-up|2|||
143449553|NCT00623805|517190749|FG001|Overall Study|Lost to Follow-up|2|||
143449554|NCT00623805|517190748|FG000|Overall Study|Protocol Violation|1|||
143449555|NCT00623805|517190749|FG001|Overall Study|Protocol Violation|1|||
143449556|NCT00623805|517190748|FG000|Overall Study|Reason not Specified|3|||
143449557|NCT00623805|517190749|FG001|Overall Study|Reason not Specified|6|||
143449558|NCT01803282|517190753|FG000|Overall Study|Progressive Disease|4|||
143449559|NCT01803282|517190754|FG001|Overall Study|Progressive Disease|3|||
143449560|NCT01803282|517190755|FG002|Overall Study|Progressive Disease|6|||
143449561|NCT01803282|517190756|FG003|Overall Study|Progressive Disease|22|||
143449562|NCT01803282|517190757|FG004|Overall Study|Progressive Disease|5|||
143449563|NCT01803282|517190758|FG005|Overall Study|Progressive Disease|8|||
143449564|NCT01803282|517190759|FG006|Overall Study|Progressive Disease|23|||
143449565|NCT01803282|517190760|FG007|Overall Study|Progressive Disease|24|||
143449566|NCT01803282|517190761|FG008|Overall Study|Progressive Disease|3|||
143449567|NCT01803282|517190762|FG009|Overall Study|Progressive Disease|29|||
143449568|NCT01803282|517190763|FG010|Overall Study|Progressive Disease|6|||
143449569|NCT01803282|517190764|FG011|Overall Study|Progressive Disease|11|||
143449570|NCT01803282|517190753|FG000|Overall Study|Death|0|||
143449571|NCT01803282|517190754|FG001|Overall Study|Death|0|||
143449572|NCT01803282|517190755|FG002|Overall Study|Death|0|||
143449573|NCT01803282|517190756|FG003|Overall Study|Death|0|||
143449574|NCT01803282|517190757|FG004|Overall Study|Death|2|||
143449575|NCT01803282|517190758|FG005|Overall Study|Death|1|||
143449576|NCT01803282|517190759|FG006|Overall Study|Death|1|||
143449577|NCT01803282|517190760|FG007|Overall Study|Death|5|||
143449578|NCT01803282|517190761|FG008|Overall Study|Death|1|||
143449579|NCT01803282|517190762|FG009|Overall Study|Death|1|||
143449580|NCT01803282|517190763|FG010|Overall Study|Death|0|||
143449581|NCT01803282|517190764|FG011|Overall Study|Death|0|||
143449582|NCT01803282|517190753|FG000|Overall Study|Withdrew Consent|0|||
143449583|NCT01803282|517190754|FG001|Overall Study|Withdrew Consent|0|||
143449584|NCT01803282|517190755|FG002|Overall Study|Withdrew Consent|0|||
143449585|NCT01803282|517190756|FG003|Overall Study|Withdrew Consent|6|||
143449586|NCT01803282|517190757|FG004|Overall Study|Withdrew Consent|1|||
143449587|NCT01803282|517190758|FG005|Overall Study|Withdrew Consent|0|||
143449588|NCT01803282|517190759|FG006|Overall Study|Withdrew Consent|8|||
143449589|NCT01803282|517190760|FG007|Overall Study|Withdrew Consent|3|||
143449590|NCT01803282|517190761|FG008|Overall Study|Withdrew Consent|1|||
143449591|NCT01803282|517190762|FG009|Overall Study|Withdrew Consent|5|||
143449592|NCT01803282|517190763|FG010|Overall Study|Withdrew Consent|0|||
143449593|NCT01803282|517190764|FG011|Overall Study|Withdrew Consent|1|||
143449594|NCT01803282|517190753|FG000|Overall Study|Investigator's Discretion|0|||
143449595|NCT01803282|517190754|FG001|Overall Study|Investigator's Discretion|0|||
143449596|NCT01803282|517190755|FG002|Overall Study|Investigator's Discretion|0|||
143449597|NCT01803282|517190756|FG003|Overall Study|Investigator's Discretion|7|||
143449598|NCT01803282|517190757|FG004|Overall Study|Investigator's Discretion|2|||
143449599|NCT01803282|517190758|FG005|Overall Study|Investigator's Discretion|1|||
143449600|NCT01803282|517190759|FG006|Overall Study|Investigator's Discretion|7|||
143449601|NCT01803282|517190760|FG007|Overall Study|Investigator's Discretion|10|||
143449602|NCT01803282|517190761|FG008|Overall Study|Investigator's Discretion|6|||
143449603|NCT01803282|517190762|FG009|Overall Study|Investigator's Discretion|7|||
143449604|NCT01803282|517190763|FG010|Overall Study|Investigator's Discretion|1|||
143449605|NCT01803282|517190764|FG011|Overall Study|Investigator's Discretion|0|||
143449606|NCT01803282|517190753|FG000|Overall Study|Adverse Event|0|||
143449607|NCT01803282|517190754|FG001|Overall Study|Adverse Event|0|||
143449608|NCT01803282|517190755|FG002|Overall Study|Adverse Event|0|||
143449609|NCT01803282|517190756|FG003|Overall Study|Adverse Event|0|||
143449610|NCT01803282|517190757|FG004|Overall Study|Adverse Event|0|||
143449611|NCT01803282|517190758|FG005|Overall Study|Adverse Event|0|||
143449612|NCT01803282|517190759|FG006|Overall Study|Adverse Event|1|||
143449613|NCT01803282|517190760|FG007|Overall Study|Adverse Event|2|||
143449614|NCT01803282|517190761|FG008|Overall Study|Adverse Event|0|||
143449615|NCT01803282|517190762|FG009|Overall Study|Adverse Event|1|||
143449616|NCT01803282|517190763|FG010|Overall Study|Adverse Event|0|||
143449617|NCT01803282|517190764|FG011|Overall Study|Adverse Event|3|||
143449618|NCT01803282|517190753|FG000|Overall Study|Non-Compliance with Study Drug|0|||
143449619|NCT01803282|517190754|FG001|Overall Study|Non-Compliance with Study Drug|0|||
143449620|NCT01803282|517190755|FG002|Overall Study|Non-Compliance with Study Drug|0|||
143449621|NCT01803282|517190756|FG003|Overall Study|Non-Compliance with Study Drug|1|||
143449622|NCT01803282|517190757|FG004|Overall Study|Non-Compliance with Study Drug|0|||
143449623|NCT01803282|517190758|FG005|Overall Study|Non-Compliance with Study Drug|0|||
143449624|NCT01803282|517190759|FG006|Overall Study|Non-Compliance with Study Drug|0|||
143449625|NCT01803282|517190760|FG007|Overall Study|Non-Compliance with Study Drug|0|||
143449626|NCT01803282|517190761|FG008|Overall Study|Non-Compliance with Study Drug|0|||
143449627|NCT01803282|517190762|FG009|Overall Study|Non-Compliance with Study Drug|0|||
143449628|NCT01803282|517190763|FG010|Overall Study|Non-Compliance with Study Drug|0|||
143449629|NCT01803282|517190764|FG011|Overall Study|Non-Compliance with Study Drug|0|||
143449630|NCT01803282|517190753|FG000|Overall Study|Unknown Reason|0|||
143449631|NCT01803282|517190754|FG001|Overall Study|Unknown Reason|0|||
143449632|NCT01803282|517190755|FG002|Overall Study|Unknown Reason|0|||
143449633|NCT01803282|517190756|FG003|Overall Study|Unknown Reason|0|||
143449634|NCT01803282|517190757|FG004|Overall Study|Unknown Reason|0|||
143449635|NCT01803282|517190758|FG005|Overall Study|Unknown Reason|0|||
143449636|NCT01803282|517190759|FG006|Overall Study|Unknown Reason|0|||
143449637|NCT01803282|517190760|FG007|Overall Study|Unknown Reason|1|||
143449638|NCT01803282|517190761|FG008|Overall Study|Unknown Reason|0|||
143449639|NCT01803282|517190762|FG009|Overall Study|Unknown Reason|0|||
143449640|NCT01803282|517190763|FG010|Overall Study|Unknown Reason|0|||
143449641|NCT01803282|517190764|FG011|Overall Study|Unknown Reason|0|||
143449642|NCT01803282|517190753|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
143449643|NCT01803282|517190754|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
143449644|NCT01803282|517190755|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
143449645|NCT01803282|517190756|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
143449646|NCT01803282|517190757|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
143449647|NCT01803282|517190758|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
143449648|NCT01803282|517190759|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
143449649|NCT01803282|517190760|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
143449650|NCT01803282|517190761|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
143449651|NCT01803282|517190762|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
143449652|NCT01803282|517190763|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
143449653|NCT01803282|517190764|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
143449654|NCT01803282|517190753|FG000|Overall Study|Enrolled but Never Treated|0|||
143449655|NCT01803282|517190754|FG001|Overall Study|Enrolled but Never Treated|0|||
143449656|NCT01803282|517190755|FG002|Overall Study|Enrolled but Never Treated|0|||
143449657|NCT01803282|517190756|FG003|Overall Study|Enrolled but Never Treated|0|||
143449658|NCT01803282|517190757|FG004|Overall Study|Enrolled but Never Treated|1|||
143449659|NCT01803282|517190758|FG005|Overall Study|Enrolled but Never Treated|0|||
143449660|NCT01803282|517190759|FG006|Overall Study|Enrolled but Never Treated|1|||
143449661|NCT01803282|517190760|FG007|Overall Study|Enrolled but Never Treated|1|||
143449662|NCT01803282|517190761|FG008|Overall Study|Enrolled but Never Treated|0|||
143449663|NCT01803282|517190762|FG009|Overall Study|Enrolled but Never Treated|1|||
143449664|NCT01803282|517190763|FG010|Overall Study|Enrolled but Never Treated|0|||
143449665|NCT01803282|517190764|FG011|Overall Study|Enrolled but Never Treated|0|||
143449666|NCT02671500|517190765|FG000|Overall Study|Lack of Efficacy|12|||
143449667|NCT02671500|517190765|FG000|Overall Study|Lost to Follow-up|2|||
143449668|NCT01217437|517190768|FG000|Overall Study|Adverse Event|0|||
143449669|NCT01217437|517190769|FG001|Overall Study|Adverse Event|8|||
143449670|NCT01217437|517190768|FG000|Overall Study|Death|5|||
143449671|NCT01217437|517190769|FG001|Overall Study|Death|0|||
143449672|NCT01217437|517190768|FG000|Overall Study|Lack of Efficacy|29|||
143449673|NCT01217437|517190769|FG001|Overall Study|Lack of Efficacy|25|||
143449674|NCT01217437|517190768|FG000|Overall Study|Physician Decision|8|||
143449675|NCT01217437|517190769|FG001|Overall Study|Physician Decision|5|||
143449676|NCT01217437|517190768|FG000|Overall Study|Withdrawal by Subject|0|||
143449677|NCT01217437|517190769|FG001|Overall Study|Withdrawal by Subject|2|||
143449678|NCT01217437|517190768|FG000|Overall Study|Ineligible|1|||
143449679|NCT01217437|517190769|FG001|Overall Study|Ineligible|1|||
143449680|NCT03548220|517190770|FG000|Overall Study|Lost to Follow-up|1|||
143449681|NCT03548220|517190771|FG001|Overall Study|Lost to Follow-up|0|||
143449682|NCT03548220|517190772|FG002|Overall Study|Lost to Follow-up|0|||
143449683|NCT03548220|517190773|FG003|Overall Study|Lost to Follow-up|0|||
143449684|NCT02906007|517190774|FG000|Overall Study|Physician Decision|0|||
143449685|NCT02906007|517190775|FG001|Overall Study|Physician Decision|0|||
143449686|NCT02906007|517190776|FG002|Overall Study|Physician Decision|1|||
143449687|NCT02906007|517190774|FG000|Overall Study|Died|1|||
143449688|NCT02906007|517190775|FG001|Overall Study|Died|0|||
143449689|NCT02906007|517190776|FG002|Overall Study|Died|0|||
143449690|NCT04531982|517190777|FG000|Overall Study|Withdrawal by Subject|10|||
143449691|NCT04531982|517190778|FG001|Overall Study|Withdrawal by Subject|11|||
143449692|NCT04531982|517190777|FG000|Overall Study|Adverse Event|6|||
143449693|NCT04531982|517190778|FG001|Overall Study|Adverse Event|14|||
143449694|NCT04531982|517190777|FG000|Overall Study|Protocol Violation|6|||
143449695|NCT04531982|517190778|FG001|Overall Study|Protocol Violation|9|||
143449696|NCT04531982|517190777|FG000|Overall Study|Non-compliance with study drug|3|||
143449697|NCT04531982|517190778|FG001|Overall Study|Non-compliance with study drug|2|||
143449698|NCT04531982|517190777|FG000|Overall Study|Use of prohibited medication|2|||
143449699|NCT04531982|517190778|FG001|Overall Study|Use of prohibited medication|0|||
143449700|NCT04531982|517190777|FG000|Overall Study|Lost to Follow-up|0|||
143449701|NCT04531982|517190778|FG001|Overall Study|Lost to Follow-up|1|||
143449702|NCT04531982|517190777|FG000|Overall Study|Geopolitical conflict|2|||
143449703|NCT04531982|517190778|FG001|Overall Study|Geopolitical conflict|0|||
143449704|NCT04531982|517190777|FG000|Overall Study|Lack of Efficacy|3|||
143449705|NCT04531982|517190778|FG001|Overall Study|Lack of Efficacy|1|||
143449706|NCT06655558|517190779|FG000|Overall Study|Protocol Violation|1|||
143449707|NCT04998812|517190783|FG000|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|1|||
143449708|NCT04998812|517190784|FG001|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|0|||
143449709|NCT04998812|517190783|FG000|Pregnancy and Early Post-Partum Period|Lost to Follow-up|1|||
143449710|NCT04998812|517190784|FG001|Pregnancy and Early Post-Partum Period|Lost to Follow-up|0|||
143449711|NCT04998812|517190783|FG000|Pregnancy and Early Post-Partum Period|Other|0|||
143449712|NCT04998812|517190784|FG001|Pregnancy and Early Post-Partum Period|Other|1|||
143449713|NCT04998812|517190783|FG000|Vaccination Period|Ongoing in study|23|||
143449714|NCT04998812|517190784|FG001|Vaccination Period|Ongoing in study|23|||
143449715|NCT06748729|517190787|FG000|Overall Study|Withdrawal by Subject|1|||
143449716|NCT00833261|517192615|FG000|Overall Study|Withdrawal by Subject|4|||
143449717|NCT03439254|517192616|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
143449718|NCT03439254|517192617|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
143449719|NCT03439254|517192618|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
143449720|NCT03439254|517192619|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
143449721|NCT03439254|517192620|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
143449722|NCT03439254|517192621|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
143449723|NCT03439254|517192616|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
143449724|NCT03439254|517192617|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
143449725|NCT03439254|517192618|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
143449726|NCT03439254|517192619|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
143449727|NCT03439254|517192620|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
143449728|NCT03439254|517192621|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
143449729|NCT03439254|517192616|FG000|Double-blind Phase (18 Months)|Death|1|||
143449730|NCT03439254|517192617|FG001|Double-blind Phase (18 Months)|Death|2|||
143449731|NCT03439254|517192618|FG002|Double-blind Phase (18 Months)|Death|2|||
143449732|NCT03439254|517192619|FG003|Double-blind Phase (18 Months)|Death|0|||
143449733|NCT03439254|517192620|FG004|Double-blind Phase (18 Months)|Death|0|||
143449734|NCT03439254|517192621|FG005|Double-blind Phase (18 Months)|Death|0|||
143449735|NCT03439254|517192616|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
143449736|NCT03439254|517192617|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
143449737|NCT03439254|517192618|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
143449738|NCT03439254|517192619|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
143449739|NCT03439254|517192620|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
143449740|NCT03439254|517192621|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
143449741|NCT03439254|517192616|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
143449742|NCT03439254|517192617|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
143449743|NCT03439254|517192618|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
143449744|NCT03439254|517192619|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
143449745|NCT03439254|517192620|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
143449746|NCT03439254|517192621|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
143449747|NCT03439254|517192616|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
143449748|NCT03439254|517192617|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
143449749|NCT03439254|517192618|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
143449750|NCT03439254|517192619|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
143449751|NCT03439254|517192620|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
143449752|NCT03439254|517192621|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
143449753|NCT03439254|517192616|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
143449754|NCT03439254|517192617|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
143449755|NCT03439254|517192618|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
143449756|NCT03439254|517192619|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
143449757|NCT03439254|517192620|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
143449758|NCT03439254|517192621|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
143449759|NCT03439254|517192616|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
143449760|NCT03439254|517192617|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
143449761|NCT03439254|517192618|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
143449762|NCT03439254|517192619|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
143449763|NCT03439254|517192620|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
143449764|NCT03439254|517192621|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
143449765|NCT03439254|517192616|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
143449766|NCT03439254|517192617|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
143449767|NCT03439254|517192618|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
143449768|NCT03439254|517192619|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
143449769|NCT03439254|517192620|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
143449770|NCT03439254|517192621|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
143449771|NCT03439254|517192616|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
143449772|NCT03439254|517192617|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
143449773|NCT03439254|517192618|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
143449774|NCT03439254|517192619|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
143449775|NCT03439254|517192620|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
143449776|NCT03439254|517192621|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
143449777|NCT03439254|517192616|FG000|Double-blind Phase (18 Months)|Site closure|0|||
143449778|NCT03439254|517192617|FG001|Double-blind Phase (18 Months)|Site closure|0|||
143449779|NCT03439254|517192618|FG002|Double-blind Phase (18 Months)|Site closure|1|||
143449780|NCT03439254|517192619|FG003|Double-blind Phase (18 Months)|Site closure|0|||
143449781|NCT03439254|517192620|FG004|Double-blind Phase (18 Months)|Site closure|0|||
143449782|NCT03439254|517192621|FG005|Double-blind Phase (18 Months)|Site closure|0|||
143449783|NCT03439254|517192616|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
143449784|NCT03439254|517192617|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
143449785|NCT03439254|517192618|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
143449786|NCT03439254|517192619|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
143449787|NCT03439254|517192620|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
143449788|NCT03439254|517192621|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
143449789|NCT03439254|517192616|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
143449790|NCT03439254|517192617|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
143449791|NCT03439254|517192618|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
143449792|NCT03439254|517192619|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
143449793|NCT03439254|517192620|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
143449794|NCT03439254|517192621|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
143449795|NCT03439254|517192616|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
143449796|NCT03439254|517192617|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
143449797|NCT03439254|517192618|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
143449798|NCT03439254|517192619|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
143449799|NCT03439254|517192620|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
143449800|NCT03439254|517192621|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
143449801|NCT03439254|517192616|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
143449802|NCT03439254|517192617|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
143449803|NCT03439254|517192618|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
143449804|NCT03439254|517192619|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
143449805|NCT03439254|517192620|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
143449806|NCT03439254|517192621|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
143449807|NCT03439254|517192616|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
143449808|NCT03439254|517192617|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
143449809|NCT03439254|517192618|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
143449810|NCT03439254|517192619|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
143449811|NCT03439254|517192620|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
143449812|NCT03439254|517192621|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
143449813|NCT03439254|517192616|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
143449814|NCT03439254|517192617|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
143449815|NCT03439254|517192618|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
143449816|NCT03439254|517192619|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
143449817|NCT03439254|517192620|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
143449818|NCT03439254|517192621|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
143449819|NCT03439254|517192616|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
143449820|NCT03439254|517192617|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
143449821|NCT03439254|517192618|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
143449822|NCT03439254|517192619|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
143449823|NCT03439254|517192620|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
143449824|NCT03439254|517192621|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
143449825|NCT03439254|517192616|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
143449826|NCT03439254|517192617|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
143449827|NCT03439254|517192618|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
143449828|NCT03439254|517192619|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
143449829|NCT03439254|517192620|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
143449830|NCT03439254|517192621|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
143449831|NCT03439254|517192616|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
143449832|NCT03439254|517192617|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
143449833|NCT03439254|517192618|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
143449834|NCT03439254|517192619|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
143449835|NCT03439254|517192620|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
143449836|NCT03439254|517192621|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
143449837|NCT03439254|517192616|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
143449838|NCT03439254|517192617|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
143449839|NCT03439254|517192618|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
143449840|NCT03439254|517192619|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
143449841|NCT03439254|517192620|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
143449842|NCT03439254|517192621|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
143449843|NCT03439254|517192616|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
143449844|NCT03439254|517192617|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
143449845|NCT03439254|517192618|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
143449846|NCT03439254|517192619|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
143449847|NCT03439254|517192620|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
143449848|NCT03439254|517192621|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
143449849|NCT03439254|517192616|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
143449850|NCT03439254|517192617|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
143449851|NCT03439254|517192618|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
143449852|NCT03439254|517192619|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
143449853|NCT03439254|517192620|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
143449854|NCT03439254|517192621|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
143449855|NCT01255631|517192622|FG000|Overall Study|poor enrollment, no data analyzed|9|||
143449856|NCT01255631|517192623|FG001|Overall Study|poor enrollment, no data analyzed|6|||
143449857|NCT03339245|517192626|FG000|Overall Study|Adverse Event|1|||
143449858|NCT03339245|517192627|FG001|Overall Study|Adverse Event|1|||
143449859|NCT03339245|517192626|FG000|Overall Study|Withdrawal by Subject|1|||
143449860|NCT03339245|517192627|FG001|Overall Study|Withdrawal by Subject|0|||
143449861|NCT01531673|517192635|FG000|Overall Study|Non-Compliance|0|||
143449862|NCT01531673|517192636|FG001|Overall Study|Non-Compliance|0|||
143449863|NCT01531673|517192637|FG002|Overall Study|Non-Compliance|0|||
143449864|NCT01531673|517192638|FG003|Overall Study|Non-Compliance|0|||
143449865|NCT01531673|517192639|FG004|Overall Study|Non-Compliance|0|||
143449866|NCT01531673|517192640|FG005|Overall Study|Non-Compliance|1|||
143449867|NCT01531673|517192641|FG006|Overall Study|Non-Compliance|0|||
143449868|NCT01531673|517192642|FG007|Overall Study|Non-Compliance|0|||
143449869|NCT01531673|517192643|FG008|Overall Study|Non-Compliance|0|||
143449870|NCT01531673|517192644|FG009|Overall Study|Non-Compliance|0|||
143449871|NCT01531673|517192645|FG010|Overall Study|Non-Compliance|0|||
143449872|NCT01531673|517192646|FG011|Overall Study|Non-Compliance|0|||
143449873|NCT01531673|517192647|FG012|Overall Study|Non-Compliance|0|||
143449874|NCT01531673|517192635|FG000|Overall Study|Adverse Event|0|||
143449875|NCT01531673|517192636|FG001|Overall Study|Adverse Event|1|||
143449876|NCT01531673|517192637|FG002|Overall Study|Adverse Event|0|||
143449877|NCT01531673|517192638|FG003|Overall Study|Adverse Event|0|||
143449878|NCT01531673|517192639|FG004|Overall Study|Adverse Event|0|||
143449879|NCT01531673|517192640|FG005|Overall Study|Adverse Event|0|||
143449880|NCT01531673|517192641|FG006|Overall Study|Adverse Event|0|||
143449881|NCT01531673|517192642|FG007|Overall Study|Adverse Event|0|||
143449882|NCT01531673|517192643|FG008|Overall Study|Adverse Event|0|||
143449883|NCT01531673|517192644|FG009|Overall Study|Adverse Event|0|||
143449884|NCT01531673|517192645|FG010|Overall Study|Adverse Event|0|||
143449885|NCT01531673|517192646|FG011|Overall Study|Adverse Event|0|||
143449886|NCT01531673|517192647|FG012|Overall Study|Adverse Event|0|||
143449887|NCT01531673|517192635|FG000|Overall Study|Lost to Follow-up|0|||
143449888|NCT01531673|517192636|FG001|Overall Study|Lost to Follow-up|0|||
143449889|NCT01531673|517192637|FG002|Overall Study|Lost to Follow-up|0|||
143449890|NCT01531673|517192638|FG003|Overall Study|Lost to Follow-up|0|||
143449891|NCT01531673|517192639|FG004|Overall Study|Lost to Follow-up|1|||
143449892|NCT01531673|517192640|FG005|Overall Study|Lost to Follow-up|0|||
143449893|NCT01531673|517192641|FG006|Overall Study|Lost to Follow-up|0|||
143449894|NCT01531673|517192642|FG007|Overall Study|Lost to Follow-up|0|||
143449895|NCT01531673|517192643|FG008|Overall Study|Lost to Follow-up|0|||
143449896|NCT01531673|517192644|FG009|Overall Study|Lost to Follow-up|0|||
143449897|NCT01531673|517192645|FG010|Overall Study|Lost to Follow-up|0|||
143449898|NCT01531673|517192646|FG011|Overall Study|Lost to Follow-up|0|||
143449899|NCT01531673|517192647|FG012|Overall Study|Lost to Follow-up|0|||
143449900|NCT01531673|517192635|FG000|Overall Study|Other|0|||
143449901|NCT01531673|517192636|FG001|Overall Study|Other|0|||
143449902|NCT01531673|517192637|FG002|Overall Study|Other|0|||
143449903|NCT01531673|517192638|FG003|Overall Study|Other|1|||
143449904|NCT01531673|517192639|FG004|Overall Study|Other|0|||
143449905|NCT01531673|517192640|FG005|Overall Study|Other|0|||
143449906|NCT01531673|517192641|FG006|Overall Study|Other|0|||
143449907|NCT01531673|517192642|FG007|Overall Study|Other|0|||
143449908|NCT01531673|517192643|FG008|Overall Study|Other|0|||
143449909|NCT01531673|517192644|FG009|Overall Study|Other|1|||
143449910|NCT01531673|517192645|FG010|Overall Study|Other|0|||
143449911|NCT01531673|517192646|FG011|Overall Study|Other|0|||
143449912|NCT01531673|517192647|FG012|Overall Study|Other|0|||
143449913|NCT00568178|517192648|FG000|Double Blind Base Study|Adverse Event|0|||
143449914|NCT00568178|517192649|FG001|Double Blind Base Study|Adverse Event|2|||
143449915|NCT00568178|517192650|FG002|Double Blind Base Study|Adverse Event|1|||
143449916|NCT00568178|517192651|FG003|Double Blind Base Study|Adverse Event|2|||
143449917|NCT00568178|517192652|FG004|Double Blind Base Study|Adverse Event|0|||
143449918|NCT00568178|517192653|FG005|Double Blind Base Study|Adverse Event|0|||
143449919|NCT00568178|517192648|FG000|Double Blind Base Study|Lost to Follow-up|1|||
143449920|NCT00568178|517192649|FG001|Double Blind Base Study|Lost to Follow-up|0|||
143449921|NCT00568178|517192650|FG002|Double Blind Base Study|Lost to Follow-up|0|||
143449922|NCT00568178|517192651|FG003|Double Blind Base Study|Lost to Follow-up|1|||
143449923|NCT00568178|517192652|FG004|Double Blind Base Study|Lost to Follow-up|0|||
143449924|NCT00568178|517192653|FG005|Double Blind Base Study|Lost to Follow-up|0|||
143449925|NCT00568178|517192648|FG000|Double Blind Base Study|Physician Decision|1|||
143449926|NCT00568178|517192649|FG001|Double Blind Base Study|Physician Decision|1|||
143449927|NCT00568178|517192650|FG002|Double Blind Base Study|Physician Decision|0|||
143449928|NCT00568178|517192651|FG003|Double Blind Base Study|Physician Decision|1|||
143449929|NCT00568178|517192652|FG004|Double Blind Base Study|Physician Decision|0|||
143449930|NCT00568178|517192653|FG005|Double Blind Base Study|Physician Decision|0|||
143449931|NCT00568178|517192648|FG000|Double Blind Base Study|Protocol Violation|3|||
143449932|NCT00568178|517192649|FG001|Double Blind Base Study|Protocol Violation|2|||
143449933|NCT00568178|517192650|FG002|Double Blind Base Study|Protocol Violation|0|||
143449934|NCT00568178|517192651|FG003|Double Blind Base Study|Protocol Violation|0|||
143449935|NCT00568178|517192652|FG004|Double Blind Base Study|Protocol Violation|0|||
143449936|NCT00568178|517192653|FG005|Double Blind Base Study|Protocol Violation|0|||
143449937|NCT00568178|517192648|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
143449938|NCT00568178|517192649|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
143449939|NCT00568178|517192650|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
143449940|NCT00568178|517192651|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
143449941|NCT00568178|517192652|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
143449942|NCT00568178|517192653|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
143449943|NCT00568178|517192648|FG000|Double Blind Base Study|Progressive Disease|0|||
143449944|NCT00568178|517192649|FG001|Double Blind Base Study|Progressive Disease|0|||
143449945|NCT00568178|517192650|FG002|Double Blind Base Study|Progressive Disease|0|||
143449946|NCT00568178|517192651|FG003|Double Blind Base Study|Progressive Disease|1|||
143449947|NCT00568178|517192652|FG004|Double Blind Base Study|Progressive Disease|0|||
143449948|NCT00568178|517192653|FG005|Double Blind Base Study|Progressive Disease|0|||
143449949|NCT00568178|517192648|FG000|Open Label Extension|Adverse Event|0|||
143449950|NCT00568178|517192649|FG001|Open Label Extension|Adverse Event|0|||
143449951|NCT00568178|517192650|FG002|Open Label Extension|Adverse Event|0|||
143449952|NCT00568178|517192651|FG003|Open Label Extension|Adverse Event|0|||
143449953|NCT00568178|517192652|FG004|Open Label Extension|Adverse Event|11|||
143449954|NCT00568178|517192653|FG005|Open Label Extension|Adverse Event|8|||
143449955|NCT00568178|517192648|FG000|Open Label Extension|Protocol Violation|0|||
143449956|NCT00568178|517192649|FG001|Open Label Extension|Protocol Violation|0|||
143449957|NCT00568178|517192650|FG002|Open Label Extension|Protocol Violation|0|||
143449958|NCT00568178|517192651|FG003|Open Label Extension|Protocol Violation|0|||
143449959|NCT00568178|517192652|FG004|Open Label Extension|Protocol Violation|1|||
143449960|NCT00568178|517192653|FG005|Open Label Extension|Protocol Violation|0|||
143449961|NCT00568178|517192648|FG000|Open Label Extension|Lost to Follow-up|0|||
143449962|NCT00568178|517192649|FG001|Open Label Extension|Lost to Follow-up|0|||
143449963|NCT00568178|517192650|FG002|Open Label Extension|Lost to Follow-up|0|||
143449964|NCT00568178|517192651|FG003|Open Label Extension|Lost to Follow-up|0|||
143449965|NCT00568178|517192652|FG004|Open Label Extension|Lost to Follow-up|6|||
143449966|NCT00568178|517192653|FG005|Open Label Extension|Lost to Follow-up|11|||
143449967|NCT00568178|517192648|FG000|Open Label Extension|Physician Decision|0|||
143449968|NCT00568178|517192649|FG001|Open Label Extension|Physician Decision|0|||
143449969|NCT00568178|517192650|FG002|Open Label Extension|Physician Decision|0|||
143449970|NCT00568178|517192651|FG003|Open Label Extension|Physician Decision|0|||
143449971|NCT00568178|517192652|FG004|Open Label Extension|Physician Decision|9|||
143449972|NCT00568178|517192653|FG005|Open Label Extension|Physician Decision|8|||
143449973|NCT00568178|517192648|FG000|Open Label Extension|Pregnancy|0|||
143449974|NCT00568178|517192649|FG001|Open Label Extension|Pregnancy|0|||
143449975|NCT00568178|517192650|FG002|Open Label Extension|Pregnancy|0|||
143449976|NCT00568178|517192651|FG003|Open Label Extension|Pregnancy|0|||
143449977|NCT00568178|517192652|FG004|Open Label Extension|Pregnancy|0|||
143449978|NCT00568178|517192653|FG005|Open Label Extension|Pregnancy|1|||
143449979|NCT00568178|517192648|FG000|Open Label Extension|Progressive Disease|0|||
143449980|NCT00568178|517192649|FG001|Open Label Extension|Progressive Disease|0|||
143449981|NCT00568178|517192650|FG002|Open Label Extension|Progressive Disease|0|||
143449982|NCT00568178|517192651|FG003|Open Label Extension|Progressive Disease|0|||
143449983|NCT00568178|517192652|FG004|Open Label Extension|Progressive Disease|3|||
143449984|NCT00568178|517192653|FG005|Open Label Extension|Progressive Disease|1|||
143449985|NCT00568178|517192648|FG000|Open Label Extension|Termination of Trial|0|||
143449986|NCT00568178|517192649|FG001|Open Label Extension|Termination of Trial|0|||
143449987|NCT00568178|517192650|FG002|Open Label Extension|Termination of Trial|0|||
143449988|NCT00568178|517192651|FG003|Open Label Extension|Termination of Trial|0|||
143449989|NCT00568178|517192652|FG004|Open Label Extension|Termination of Trial|45|||
143449990|NCT00568178|517192653|FG005|Open Label Extension|Termination of Trial|47|||
143449991|NCT00568178|517192648|FG000|Open Label Extension|Withdrawal by Subject|0|||
143449992|NCT00568178|517192649|FG001|Open Label Extension|Withdrawal by Subject|0|||
143449993|NCT00568178|517192650|FG002|Open Label Extension|Withdrawal by Subject|0|||
143449994|NCT00568178|517192651|FG003|Open Label Extension|Withdrawal by Subject|0|||
143449995|NCT00568178|517192652|FG004|Open Label Extension|Withdrawal by Subject|4|||
143449996|NCT00568178|517192653|FG005|Open Label Extension|Withdrawal by Subject|4|||
143449997|NCT00264303|517192654|FG000|Overall Study|Adverse Event|4|||
143449998|NCT00264303|517192655|FG001|Overall Study|Adverse Event|3|||
143449999|NCT00264303|517192654|FG000|Overall Study|Lack of Efficacy|10|||
143450000|NCT00264303|517192655|FG001|Overall Study|Lack of Efficacy|13|||
143450001|NCT00264303|517192654|FG000|Overall Study|Lost to Follow-up|3|||
143450002|NCT00264303|517192655|FG001|Overall Study|Lost to Follow-up|3|||
143450003|NCT00264303|517192654|FG000|Overall Study|Withdrawal by Subject|2|||
143450004|NCT00264303|517192655|FG001|Overall Study|Withdrawal by Subject|3|||
143450005|NCT00264303|517192654|FG000|Overall Study|Various reasons listed in study report|6|||
143450006|NCT00264303|517192655|FG001|Overall Study|Various reasons listed in study report|7|||
143450007|NCT02389452|517192656|FG000|Overall Study|Lost to Follow-up|13|||
143450008|NCT02389452|517192656|FG000|Overall Study|Adverse Event|1|||
143450009|NCT02389452|517192656|FG000|Overall Study|Withdrawal by Subject|5|||
143450010|NCT02389452|517192656|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
143450011|NCT00837694|517192659|FG000|Overall Study|Lost to Follow-up|2|||
143450012|NCT00837694|517192660|FG001|Overall Study|Lost to Follow-up|0|||
143450013|NCT00837694|517192661|FG002|Overall Study|Lost to Follow-up|2|||
143450014|NCT00837694|517192662|FG003|Overall Study|Lost to Follow-up|1|||
143450015|NCT00837694|517192663|FG004|Overall Study|Lost to Follow-up|1|||
143450016|NCT00837694|517192664|FG005|Overall Study|Lost to Follow-up|1|||
143450017|NCT00818168|517192674|FG000|Overall Study|Lack of Efficacy|18|||
143450018|NCT00818168|517192674|FG000|Overall Study|Pregnancy|2|||
143450019|NCT00818168|517192674|FG000|Overall Study|Withdrawal by Subject|16|||
143450020|NCT00818168|517192674|FG000|Overall Study|Lost to Follow-up|7|||
143450021|NCT00818168|517192674|FG000|Overall Study|Adverse Event|19|||
143450022|NCT00818168|517192674|FG000|Overall Study|Reason for Non-completion Not reported|6|||
143450023|NCT00818168|517192674|FG000|Overall Study|Participant Moved|2|||
143450024|NCT01008553|517192675|FG000|Period 1 (Titration Period)|Physician Decision|2|||
143450025|NCT01008553|517192676|FG001|Period 1 (Titration Period)|Physician Decision|0|||
143450026|NCT01008553|517192677|FG002|Period 1 (Titration Period)|Physician Decision|0|||
143450027|NCT01008553|517192675|FG000|Period 1 (Titration Period)|Adverse Event|33|||
143450028|NCT01008553|517192676|FG001|Period 1 (Titration Period)|Adverse Event|0|||
143450029|NCT01008553|517192677|FG002|Period 1 (Titration Period)|Adverse Event|0|||
143450030|NCT01008553|517192675|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
143450031|NCT01008553|517192676|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
143450032|NCT01008553|517192677|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
143450033|NCT01008553|517192675|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
143450034|NCT01008553|517192676|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
143450035|NCT01008553|517192677|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
143450036|NCT01008553|517192675|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
143450037|NCT01008553|517192676|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
143450038|NCT01008553|517192677|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
143450039|NCT01008553|517192675|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
143450040|NCT01008553|517192676|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
143450041|NCT01008553|517192677|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
143450042|NCT01008553|517192675|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
143450043|NCT01008553|517192676|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
143450044|NCT01008553|517192677|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
143450045|NCT01008553|517192675|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
143450046|NCT01008553|517192676|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
143450047|NCT01008553|517192677|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
143450048|NCT01008553|517192675|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
143450049|NCT01008553|517192676|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
143450050|NCT01008553|517192677|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
143450051|NCT01008553|517192675|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
143450052|NCT01008553|517192676|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
143450053|NCT01008553|517192677|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
143450054|NCT01008553|517192675|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
143450055|NCT01008553|517192676|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
143450056|NCT01008553|517192677|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
143450057|NCT01008553|517192675|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
143450058|NCT01008553|517192676|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
143450059|NCT01008553|517192677|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
143450060|NCT01008553|517192675|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
143450061|NCT01008553|517192676|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
143450062|NCT01008553|517192677|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
143450063|NCT01008553|517192675|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
143450064|NCT01008553|517192676|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
143450065|NCT01008553|517192677|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
143450066|NCT01008410|517192678|FG000|Overall Study|Adverse Event|13|||
143450067|NCT01008410|517192679|FG001|Overall Study|Adverse Event|7|||
143450068|NCT01008410|517192678|FG000|Overall Study|Withdrawal by Subject|6|||
143450069|NCT01008410|517192679|FG001|Overall Study|Withdrawal by Subject|2|||
143450070|NCT01008410|517192678|FG000|Overall Study|Lost to Follow-up|1|||
143450071|NCT01008410|517192679|FG001|Overall Study|Lost to Follow-up|0|||
143450072|NCT01008410|517192678|FG000|Overall Study|Noncompliance|1|||
143450073|NCT01008410|517192679|FG001|Overall Study|Noncompliance|0|||
143450074|NCT01008410|517192678|FG000|Overall Study|Low Cortisol|2|||
143450075|NCT01008410|517192679|FG001|Overall Study|Low Cortisol|0|||
143450076|NCT01008410|517192678|FG000|Overall Study|Lack of Efficacy|2|||
143450077|NCT01008410|517192679|FG001|Overall Study|Lack of Efficacy|6|||
143450078|NCT01008410|517192678|FG000|Overall Study|Met Exclusion Criterion|0|||
143450079|NCT01008410|517192679|FG001|Overall Study|Met Exclusion Criterion|1|||
143450080|NCT03433677|517192682|FG000|Period 1|Protocol Violation|1|||
143450081|NCT03433677|517192683|FG001|Period 1|Protocol Violation|0|||
143450082|NCT03433677|517192682|FG000|Period 2|Withdrawal by Subject|1|||
143450083|NCT03433677|517192683|FG001|Period 2|Withdrawal by Subject|1|||
143450084|NCT03889704|517192685|FG000|Overall Study|Study terminated due to pandemic|1|||
143450085|NCT03482466|517192686|FG000|Overall Study|Protocol Violation|2|||
143450086|NCT03268603|517192687|FG000|Overall Study|Withdrawal by Subject|6|||
143450087|NCT03268603|517192687|FG000|Overall Study|Physician Decision|1|||
143450088|NCT03268603|517192687|FG000|Overall Study|Withdrawn due to disease progression|2|||
143450089|NCT02591953|517192688|FG000|Overall Study|Lost to Follow-up|6|||
143450090|NCT02591953|517192689|FG001|Overall Study|Lost to Follow-up|6|||
143450091|NCT02060370|517192690|FG000|Overall Study|Physician Decision|1|||
143450092|NCT04939701|517192691|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
143450093|NCT04939701|517192692|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
143450094|NCT04939701|517192693|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
143450095|NCT04939701|517192691|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
143450096|NCT04939701|517192692|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
143450097|NCT04939701|517192693|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
143450098|NCT04939701|517192691|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
143450099|NCT04939701|517192692|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
143450100|NCT04939701|517192693|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
143450101|NCT04939701|517192691|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
143450102|NCT04939701|517192692|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
143450103|NCT04939701|517192693|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
143450104|NCT04939701|517192691|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
143450105|NCT04939701|517192692|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
143450106|NCT04939701|517192693|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
143450107|NCT04939701|517192691|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
143450108|NCT04939701|517192692|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
143450109|NCT04939701|517192693|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
143450110|NCT04939701|517192691|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
143450111|NCT04939701|517192692|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
143450112|NCT04939701|517192693|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
143450113|NCT02383940|517192698|FG000|Overall Study|Adverse Event|1|||
143450114|NCT02383940|517192699|FG001|Overall Study|Adverse Event|0|||
143450115|NCT02383940|517192698|FG000|Overall Study|Lost to Follow-up|2|||
143450116|NCT02383940|517192699|FG001|Overall Study|Lost to Follow-up|2|||
143450117|NCT02383940|517192698|FG000|Overall Study|Physician Decision|2|||
143450118|NCT02383940|517192699|FG001|Overall Study|Physician Decision|0|||
143450119|NCT02383940|517192698|FG000|Overall Study|Withdrawal by Subject|1|||
143450120|NCT02383940|517192699|FG001|Overall Study|Withdrawal by Subject|1|||
143450121|NCT02383940|517192698|FG000|Overall Study|Randomized but not treated|2|||
143450122|NCT02383940|517192699|FG001|Overall Study|Randomized but not treated|0|||
143450123|NCT02383940|517192698|FG000|Overall Study|Other than specified above|1|||
143450124|NCT02383940|517192699|FG001|Overall Study|Other than specified above|0|||
143450125|NCT02672852|517192701|FG000|Part A1|Disease Worsening|1|||
143450126|NCT02672852|517192702|FG001|Part A1|Disease Worsening|0|||
143450127|NCT02672852|517192703|FG002|Part A1|Disease Worsening|0|||
143450128|NCT02672852|517192704|FG003|Part A1|Disease Worsening|0|||
143450129|NCT02672852|517192705|FG004|Part A1|Disease Worsening|0|||
143450130|NCT02672852|517192706|FG005|Part A1|Disease Worsening|0|||
143450131|NCT02672852|517192707|FG006|Part A1|Disease Worsening|0|||
143450132|NCT02672852|517192701|FG000|Part A1|Adverse Event|0|||
143450133|NCT02672852|517192702|FG001|Part A1|Adverse Event|1|||
143450134|NCT02672852|517192703|FG002|Part A1|Adverse Event|0|||
143450135|NCT02672852|517192704|FG003|Part A1|Adverse Event|0|||
143450136|NCT02672852|517192705|FG004|Part A1|Adverse Event|0|||
143450137|NCT02672852|517192706|FG005|Part A1|Adverse Event|0|||
143450138|NCT02672852|517192707|FG006|Part A1|Adverse Event|0|||
143450139|NCT02672852|517192701|FG000|Part A1|Lost to Follow-up|1|||
143450140|NCT02672852|517192702|FG001|Part A1|Lost to Follow-up|2|||
143450141|NCT02672852|517192703|FG002|Part A1|Lost to Follow-up|0|||
143450142|NCT02672852|517192704|FG003|Part A1|Lost to Follow-up|0|||
143450143|NCT02672852|517192705|FG004|Part A1|Lost to Follow-up|0|||
143450144|NCT02672852|517192706|FG005|Part A1|Lost to Follow-up|0|||
143450145|NCT02672852|517192707|FG006|Part A1|Lost to Follow-up|0|||
143450146|NCT02672852|517192701|FG000|Part A1|Withdrawal by Subject|1|||
143450147|NCT02672852|517192702|FG001|Part A1|Withdrawal by Subject|1|||
143450148|NCT02672852|517192703|FG002|Part A1|Withdrawal by Subject|0|||
143450149|NCT02672852|517192704|FG003|Part A1|Withdrawal by Subject|0|||
143450150|NCT02672852|517192705|FG004|Part A1|Withdrawal by Subject|0|||
143450151|NCT02672852|517192706|FG005|Part A1|Withdrawal by Subject|0|||
143450152|NCT02672852|517192707|FG006|Part A1|Withdrawal by Subject|0|||
143450153|NCT02672852|517192701|FG000|Part A2|Disease worsening|0|||
143450154|NCT02672852|517192702|FG001|Part A2|Disease worsening|0|||
143450155|NCT02672852|517192703|FG002|Part A2|Disease worsening|1|||
143450156|NCT02672852|517192704|FG003|Part A2|Disease worsening|0|||
143450157|NCT02672852|517192705|FG004|Part A2|Disease worsening|0|||
143450158|NCT02672852|517192706|FG005|Part A2|Disease worsening|0|||
143450159|NCT02672852|517192707|FG006|Part A2|Disease worsening|0|||
143450160|NCT02672852|517192701|FG000|Part A2|Adverse Event|0|||
143450161|NCT02672852|517192702|FG001|Part A2|Adverse Event|0|||
143450162|NCT02672852|517192703|FG002|Part A2|Adverse Event|3|||
143450163|NCT02672852|517192704|FG003|Part A2|Adverse Event|0|||
143450164|NCT02672852|517192705|FG004|Part A2|Adverse Event|0|||
143450165|NCT02672852|517192706|FG005|Part A2|Adverse Event|0|||
143450166|NCT02672852|517192707|FG006|Part A2|Adverse Event|0|||
143450167|NCT02672852|517192701|FG000|Part A2|Lost to Follow-up|0|||
143450168|NCT02672852|517192702|FG001|Part A2|Lost to Follow-up|0|||
143450169|NCT02672852|517192703|FG002|Part A2|Lost to Follow-up|2|||
143450170|NCT02672852|517192704|FG003|Part A2|Lost to Follow-up|0|||
143450171|NCT02672852|517192705|FG004|Part A2|Lost to Follow-up|0|||
143450172|NCT02672852|517192706|FG005|Part A2|Lost to Follow-up|0|||
143450173|NCT02672852|517192707|FG006|Part A2|Lost to Follow-up|0|||
143450174|NCT02672852|517192701|FG000|Part A2|Withdrawal by Subject|0|||
143450175|NCT02672852|517192702|FG001|Part A2|Withdrawal by Subject|0|||
143450176|NCT02672852|517192703|FG002|Part A2|Withdrawal by Subject|1|||
143450177|NCT02672852|517192704|FG003|Part A2|Withdrawal by Subject|0|||
143450178|NCT02672852|517192705|FG004|Part A2|Withdrawal by Subject|0|||
143450179|NCT02672852|517192706|FG005|Part A2|Withdrawal by Subject|0|||
143450180|NCT02672852|517192707|FG006|Part A2|Withdrawal by Subject|0|||
143450181|NCT02672852|517192701|FG000|Part A2|Other|0|||
143450182|NCT02672852|517192702|FG001|Part A2|Other|0|||
143450183|NCT02672852|517192703|FG002|Part A2|Other|3|||
143450184|NCT02672852|517192704|FG003|Part A2|Other|0|||
143450185|NCT02672852|517192705|FG004|Part A2|Other|0|||
143450186|NCT02672852|517192706|FG005|Part A2|Other|0|||
143450187|NCT02672852|517192707|FG006|Part A2|Other|0|||
143450188|NCT02672852|517192701|FG000|Part A2|Not entered in Part B|0|||
143450189|NCT02672852|517192702|FG001|Part A2|Not entered in Part B|0|||
143450190|NCT02672852|517192703|FG002|Part A2|Not entered in Part B|0|||
143450191|NCT02672852|517192704|FG003|Part A2|Not entered in Part B|4|||
143450192|NCT02672852|517192705|FG004|Part A2|Not entered in Part B|0|||
143450193|NCT02672852|517192706|FG005|Part A2|Not entered in Part B|0|||
143450194|NCT02672852|517192707|FG006|Part A2|Not entered in Part B|0|||
143450195|NCT02672852|517192701|FG000|Part B|Disease worsening|0|||
143450196|NCT02672852|517192702|FG001|Part B|Disease worsening|0|||
143450197|NCT02672852|517192703|FG002|Part B|Disease worsening|0|||
143450198|NCT02672852|517192704|FG003|Part B|Disease worsening|0|||
143450199|NCT02672852|517192705|FG004|Part B|Disease worsening|1|||
143450200|NCT02672852|517192706|FG005|Part B|Disease worsening|0|||
143450201|NCT02672852|517192707|FG006|Part B|Disease worsening|1|||
143450202|NCT02672852|517192701|FG000|Part B|Worsening pre-existing condition|0|||
143450203|NCT02672852|517192702|FG001|Part B|Worsening pre-existing condition|0|||
143450204|NCT02672852|517192703|FG002|Part B|Worsening pre-existing condition|0|||
143450205|NCT02672852|517192704|FG003|Part B|Worsening pre-existing condition|0|||
143450206|NCT02672852|517192705|FG004|Part B|Worsening pre-existing condition|0|||
143450207|NCT02672852|517192706|FG005|Part B|Worsening pre-existing condition|1|||
143450208|NCT02672852|517192707|FG006|Part B|Worsening pre-existing condition|0|||
143450209|NCT02672852|517192701|FG000|Part B|Other adverse event|0|||
143450210|NCT02672852|517192702|FG001|Part B|Other adverse event|0|||
143450211|NCT02672852|517192703|FG002|Part B|Other adverse event|0|||
143450212|NCT02672852|517192704|FG003|Part B|Other adverse event|0|||
143450213|NCT02672852|517192705|FG004|Part B|Other adverse event|3|||
143450214|NCT02672852|517192706|FG005|Part B|Other adverse event|5|||
143450215|NCT02672852|517192707|FG006|Part B|Other adverse event|1|||
143450216|NCT02672852|517192701|FG000|Part B|Lost to Follow-up|0|||
143450217|NCT02672852|517192702|FG001|Part B|Lost to Follow-up|0|||
143450218|NCT02672852|517192703|FG002|Part B|Lost to Follow-up|0|||
143450219|NCT02672852|517192704|FG003|Part B|Lost to Follow-up|0|||
143450220|NCT02672852|517192705|FG004|Part B|Lost to Follow-up|3|||
143450221|NCT02672852|517192706|FG005|Part B|Lost to Follow-up|4|||
143450222|NCT02672852|517192707|FG006|Part B|Lost to Follow-up|1|||
143450223|NCT02672852|517192701|FG000|Part B|Withdrawal by Subject|0|||
143450224|NCT02672852|517192702|FG001|Part B|Withdrawal by Subject|0|||
143450225|NCT02672852|517192703|FG002|Part B|Withdrawal by Subject|0|||
143450226|NCT02672852|517192704|FG003|Part B|Withdrawal by Subject|0|||
143450227|NCT02672852|517192705|FG004|Part B|Withdrawal by Subject|5|||
143450228|NCT02672852|517192706|FG005|Part B|Withdrawal by Subject|0|||
143450229|NCT02672852|517192707|FG006|Part B|Withdrawal by Subject|7|||
143450230|NCT02672852|517192701|FG000|Part B|Other|0|||
143450231|NCT02672852|517192702|FG001|Part B|Other|0|||
143450232|NCT02672852|517192703|FG002|Part B|Other|0|||
143450233|NCT02672852|517192704|FG003|Part B|Other|0|||
143450234|NCT02672852|517192705|FG004|Part B|Other|4|||
143450235|NCT02672852|517192706|FG005|Part B|Other|1|||
143450236|NCT02672852|517192707|FG006|Part B|Other|2|||
143450237|NCT04308590|517192708|FG000|Overall Study|Adverse Event|12|||
143450238|NCT04308590|517192709|FG001|Overall Study|Adverse Event|2|||
143450239|NCT04308590|517192708|FG000|Overall Study|Withdrawal by Subject|10|||
143450240|NCT04308590|517192709|FG001|Overall Study|Withdrawal by Subject|4|||
143450241|NCT04308590|517192708|FG000|Overall Study|Death|1|||
143450242|NCT04308590|517192709|FG001|Overall Study|Death|0|||
143450243|NCT04308590|517192708|FG000|Overall Study|Lost to Follow-up|1|||
143450244|NCT04308590|517192709|FG001|Overall Study|Lost to Follow-up|1|||
143450245|NCT04308590|517192708|FG000|Overall Study|Physician Decision|1|||
143450246|NCT04308590|517192709|FG001|Overall Study|Physician Decision|0|||
143450247|NCT04308590|517192708|FG000|Overall Study|Subject does not want to continue with Pi|0|||
143450248|NCT04308590|517192709|FG001|Overall Study|Subject does not want to continue with Pi|1|||
143450249|NCT00356408|517192710|FG000|Overall Study|Adverse Event|9|||
143450250|NCT00356408|517192710|FG000|Overall Study|Lack of Efficacy|36|||
143450251|NCT00356408|517192710|FG000|Overall Study|Lost to Follow-up|2|||
143450252|NCT00356408|517192710|FG000|Overall Study|Withdrawal by Subject|6|||
143450253|NCT00356408|517192710|FG000|Overall Study|Other: Principal investigator discretion|3|||
143450254|NCT00356408|517192710|FG000|Overall Study|Other: Sponsor request|1|||
143450255|NCT00356408|517192710|FG000|Overall Study|Other: Azathioprine stopped|1|||
143450256|NCT00356408|517192710|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
143450257|NCT00356408|517192710|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
143450258|NCT01156376|517192712|FG000|Overall Study|Adverse Event|1|||
143450259|NCT01156376|517192713|FG001|Overall Study|Adverse Event|0|||
143450260|NCT01156376|517192714|FG002|Overall Study|Adverse Event|1|||
143450261|NCT01156376|517192712|FG000|Overall Study|Withdrawal by Subject|0|||
143450262|NCT01156376|517192713|FG001|Overall Study|Withdrawal by Subject|0|||
143450263|NCT01156376|517192714|FG002|Overall Study|Withdrawal by Subject|3|||
143450264|NCT00565773|517192715|FG000|Overall Study|Withdrawal by Subject|1|||
143450265|NCT00565773|517192715|FG000|Overall Study|Physician Decision|1|||
143450266|NCT05775991|517192716|FG000|Overall Study|Withdrawal by Subject|0|||
143450267|NCT05775991|517192717|FG001|Overall Study|Withdrawal by Subject|0|||
143450268|NCT05775991|517192718|FG002|Overall Study|Withdrawal by Subject|2|||
143450269|NCT00702962|517192719|FG000|Overall Study|Progressive disease|0|||
143450270|NCT00702962|517192720|FG001|Overall Study|Progressive disease|1|||
143450271|NCT00702962|517192719|FG000|Overall Study|Hospitalized for other health disorder|1|||
143450272|NCT00702962|517192720|FG001|Overall Study|Hospitalized for other health disorder|0|||
143450273|NCT02175641|517192723|FG000|Overall Study|Death|3|||
143450274|NCT02175641|517192724|FG001|Overall Study|Death|4|||
143450275|NCT02175641|517192723|FG000|Overall Study|Lost to Follow-up|4|||
143450276|NCT02175641|517192724|FG001|Overall Study|Lost to Follow-up|4|||
143450277|NCT02175641|517192723|FG000|Overall Study|Withdrawal by Subject|7|||
143450278|NCT02175641|517192724|FG001|Overall Study|Withdrawal by Subject|4|||
143450279|NCT02175641|517192723|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
143450280|NCT02175641|517192724|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
143450281|NCT02175641|517192723|FG000|Overall Study|Developed Contraindicated Condition|8|||
143450282|NCT02175641|517192724|FG001|Overall Study|Developed Contraindicated Condition|0|||
143450283|NCT01923467|517192727|FG000|Overall Study|Lost to Follow-up|62|||
143450284|NCT01923467|517192727|FG000|Overall Study|Subject non-interest|479|||
143450285|NCT01075958|517192728|FG000|Overall Study|Blood sample could not be obtained|44|||
143450286|NCT01240915|517192729|FG000|Overall Study|Adverse Event|0|||
143450287|NCT01240915|517192730|FG001|Overall Study|Adverse Event|0|||
143450288|NCT01240915|517192731|FG002|Overall Study|Adverse Event|0|||
143450289|NCT01240915|517192732|FG003|Overall Study|Adverse Event|1|||
143450290|NCT01240915|517192733|FG004|Overall Study|Adverse Event|0|||
143450291|NCT01240915|517192734|FG005|Overall Study|Adverse Event|2|||
143450292|NCT01240915|517192735|FG006|Overall Study|Adverse Event|0|||
143450293|NCT01240915|517192736|FG007|Overall Study|Adverse Event|0|||
143450294|NCT01240915|517192737|FG008|Overall Study|Adverse Event|1|||
143450295|NCT01240915|517192729|FG000|Overall Study|Lost to Follow-up|0|||
143450296|NCT01240915|517192730|FG001|Overall Study|Lost to Follow-up|0|||
143450297|NCT01240915|517192731|FG002|Overall Study|Lost to Follow-up|0|||
143450298|NCT01240915|517192732|FG003|Overall Study|Lost to Follow-up|0|||
143450299|NCT01240915|517192733|FG004|Overall Study|Lost to Follow-up|1|||
143450300|NCT01240915|517192734|FG005|Overall Study|Lost to Follow-up|1|||
143450301|NCT01240915|517192735|FG006|Overall Study|Lost to Follow-up|0|||
143450302|NCT01240915|517192736|FG007|Overall Study|Lost to Follow-up|1|||
143450303|NCT01240915|517192737|FG008|Overall Study|Lost to Follow-up|1|||
143450304|NCT01240915|517192729|FG000|Overall Study|Withdrawal by Subject|2|||
143450305|NCT01240915|517192730|FG001|Overall Study|Withdrawal by Subject|1|||
143450306|NCT01240915|517192731|FG002|Overall Study|Withdrawal by Subject|0|||
143450307|NCT01240915|517192732|FG003|Overall Study|Withdrawal by Subject|2|||
143450308|NCT01240915|517192733|FG004|Overall Study|Withdrawal by Subject|0|||
143450309|NCT01240915|517192734|FG005|Overall Study|Withdrawal by Subject|4|||
143450310|NCT01240915|517192735|FG006|Overall Study|Withdrawal by Subject|2|||
143450311|NCT01240915|517192736|FG007|Overall Study|Withdrawal by Subject|3|||
143450312|NCT01240915|517192737|FG008|Overall Study|Withdrawal by Subject|3|||
143450313|NCT01240915|517192729|FG000|Overall Study|Other|0|||
143450314|NCT01240915|517192730|FG001|Overall Study|Other|0|||
143450315|NCT01240915|517192731|FG002|Overall Study|Other|0|||
143450316|NCT01240915|517192732|FG003|Overall Study|Other|0|||
143450317|NCT01240915|517192733|FG004|Overall Study|Other|2|||
143450318|NCT01240915|517192734|FG005|Overall Study|Other|0|||
143450319|NCT01240915|517192735|FG006|Overall Study|Other|0|||
143450320|NCT01240915|517192736|FG007|Overall Study|Other|0|||
143450321|NCT01240915|517192737|FG008|Overall Study|Other|0|||
143450322|NCT01240915|517192729|FG000|Overall Study|Insufficient Clinical Response|0|||
143450323|NCT01240915|517192730|FG001|Overall Study|Insufficient Clinical Response|0|||
143450324|NCT01240915|517192731|FG002|Overall Study|Insufficient Clinical Response|0|||
143450325|NCT01240915|517192732|FG003|Overall Study|Insufficient Clinical Response|0|||
143450326|NCT01240915|517192733|FG004|Overall Study|Insufficient Clinical Response|1|||
143450327|NCT01240915|517192734|FG005|Overall Study|Insufficient Clinical Response|3|||
143450328|NCT01240915|517192735|FG006|Overall Study|Insufficient Clinical Response|6|||
143450329|NCT01240915|517192736|FG007|Overall Study|Insufficient Clinical Response|0|||
143450330|NCT01240915|517192737|FG008|Overall Study|Insufficient Clinical Response|3|||
143450331|NCT01598662|517192739|FG000|Overall Study|Lost to Follow-up|10|||
143450332|NCT01598662|517192740|FG001|Overall Study|Lost to Follow-up|17|||
143450333|NCT01598662|517192739|FG000|Overall Study|Physician Decision|1|||
143450334|NCT01598662|517192740|FG001|Overall Study|Physician Decision|2|||
143450335|NCT01598662|517192739|FG000|Overall Study|IUD expelled before month 6|0|||
143450336|NCT01598662|517192740|FG001|Overall Study|IUD expelled before month 6|2|||
143450337|NCT00643617|517192741|FG000|Overall Study|Death|6|||
143450338|NCT00643617|517192742|FG001|Overall Study|Death|9|||
143450339|NCT00643617|517192741|FG000|Overall Study|Lost to Follow-up|42|||
143450340|NCT00643617|517192742|FG001|Overall Study|Lost to Follow-up|51|||
143450341|NCT02075073|517192743|FG000|Overall Study|Withdrawal by Subject|0|||
143450342|NCT02075073|517192744|FG001|Overall Study|Withdrawal by Subject|1|||
143450343|NCT02075073|517192745|FG002|Overall Study|Withdrawal by Subject|0|||
143450344|NCT00416195|517192761|FG000|Overall Study|Adverse Event|1|||
143450345|NCT00416195|517192762|FG001|Overall Study|Adverse Event|2|||
143450346|NCT00416195|517192761|FG000|Overall Study|Protocol Violation|1|||
143450347|NCT00416195|517192762|FG001|Overall Study|Protocol Violation|1|||
143450348|NCT00416195|517192761|FG000|Overall Study|Other|0|||
143450349|NCT00416195|517192762|FG001|Overall Study|Other|1|||
143450350|NCT03361605|517192767|FG000|Overall Study|Analyzable data not available|3|||
143450351|NCT00831129|517192770|FG000|Overall Study|Adverse Event|0|||
143450352|NCT00831129|517192771|FG001|Overall Study|Adverse Event|1|||
143450353|NCT00831129|517192770|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
143450354|NCT00831129|517192771|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
143450355|NCT01877239|517192773|FG000|Overall Study|Adverse Event|4|||
143450356|NCT01877239|517192773|FG000|Overall Study|Disease Remission|1|||
143450357|NCT01877239|517192773|FG000|Overall Study|Withdrawal by Subject|4|||
143450358|NCT01877239|517192773|FG000|Overall Study|Other|2|||
143450359|NCT01877239|517192773|FG000|Overall Study|Lack of Efficacy|4|||
143450360|NCT01877239|517192773|FG000|Overall Study|Data not available|35|||
143450361|NCT01283516|517192774|FG000|Overall Study|Adverse Event|0|||
143450362|NCT01283516|517192775|FG001|Overall Study|Adverse Event|0|||
143450363|NCT01283516|517192776|FG002|Overall Study|Adverse Event|0|||
143450364|NCT01283516|517192777|FG003|Overall Study|Adverse Event|0|||
143450365|NCT01283516|517192778|FG004|Overall Study|Adverse Event|0|||
143450366|NCT01283516|517192779|FG005|Overall Study|Adverse Event|0|||
143450367|NCT01283516|517192780|FG006|Overall Study|Adverse Event|2|||
143450368|NCT01283516|517192781|FG007|Overall Study|Adverse Event|0|||
143450369|NCT01283516|517192782|FG008|Overall Study|Adverse Event|28|||
143450370|NCT01283516|517192774|FG000|Overall Study|Death|0|||
143450371|NCT01283516|517192775|FG001|Overall Study|Death|0|||
143450372|NCT01283516|517192776|FG002|Overall Study|Death|0|||
143450373|NCT01283516|517192777|FG003|Overall Study|Death|0|||
143450374|NCT01283516|517192778|FG004|Overall Study|Death|0|||
143450375|NCT01283516|517192779|FG005|Overall Study|Death|1|||
143450376|NCT01283516|517192780|FG006|Overall Study|Death|0|||
143450377|NCT01283516|517192781|FG007|Overall Study|Death|1|||
143450378|NCT01283516|517192782|FG008|Overall Study|Death|12|||
143450379|NCT01283516|517192774|FG000|Overall Study|Disease Progression|2|||
143450380|NCT01283516|517192775|FG001|Overall Study|Disease Progression|2|||
143450381|NCT01283516|517192776|FG002|Overall Study|Disease Progression|3|||
143450382|NCT01283516|517192777|FG003|Overall Study|Disease Progression|3|||
143450383|NCT01283516|517192778|FG004|Overall Study|Disease Progression|13|||
143450384|NCT01283516|517192779|FG005|Overall Study|Disease Progression|8|||
143450385|NCT01283516|517192780|FG006|Overall Study|Disease Progression|6|||
143450386|NCT01283516|517192781|FG007|Overall Study|Disease Progression|3|||
143450387|NCT01283516|517192782|FG008|Overall Study|Disease Progression|139|||
143450388|NCT01283516|517192774|FG000|Overall Study|Withdrawal by Subject|0|||
143450389|NCT01283516|517192775|FG001|Overall Study|Withdrawal by Subject|0|||
143450390|NCT01283516|517192776|FG002|Overall Study|Withdrawal by Subject|0|||
143450391|NCT01283516|517192777|FG003|Overall Study|Withdrawal by Subject|0|||
143450392|NCT01283516|517192778|FG004|Overall Study|Withdrawal by Subject|1|||
143450393|NCT01283516|517192779|FG005|Overall Study|Withdrawal by Subject|0|||
143450394|NCT01283516|517192780|FG006|Overall Study|Withdrawal by Subject|1|||
143450395|NCT01283516|517192781|FG007|Overall Study|Withdrawal by Subject|0|||
143450396|NCT01283516|517192782|FG008|Overall Study|Withdrawal by Subject|36|||
143450397|NCT01283516|517192774|FG000|Overall Study|Administrative problems|0|||
143450398|NCT01283516|517192775|FG001|Overall Study|Administrative problems|0|||
143450399|NCT01283516|517192776|FG002|Overall Study|Administrative problems|0|||
143450400|NCT01283516|517192777|FG003|Overall Study|Administrative problems|0|||
143450401|NCT01283516|517192778|FG004|Overall Study|Administrative problems|0|||
143450402|NCT01283516|517192779|FG005|Overall Study|Administrative problems|1|||
143450403|NCT01283516|517192780|FG006|Overall Study|Administrative problems|1|||
143450404|NCT01283516|517192781|FG007|Overall Study|Administrative problems|1|||
143450405|NCT01283516|517192782|FG008|Overall Study|Administrative problems|39|||
143450406|NCT01283516|517192774|FG000|Overall Study|Lost to Follow-up|0|||
143450407|NCT01283516|517192775|FG001|Overall Study|Lost to Follow-up|0|||
143450408|NCT01283516|517192776|FG002|Overall Study|Lost to Follow-up|0|||
143450409|NCT01283516|517192777|FG003|Overall Study|Lost to Follow-up|0|||
143450410|NCT01283516|517192778|FG004|Overall Study|Lost to Follow-up|0|||
143450411|NCT01283516|517192779|FG005|Overall Study|Lost to Follow-up|0|||
143450412|NCT01283516|517192780|FG006|Overall Study|Lost to Follow-up|0|||
143450413|NCT01283516|517192781|FG007|Overall Study|Lost to Follow-up|0|||
143450414|NCT01283516|517192782|FG008|Overall Study|Lost to Follow-up|1|||
143450415|NCT00132873|517192785|FG000|Overall Study|Adverse Event|3|||
143450416|NCT00132873|517192785|FG000|Overall Study|Lost to Follow-up|1|||
143450417|NCT00132873|517192785|FG000|Overall Study|Lack of Efficacy|1|||
143450418|NCT00132873|517192785|FG000|Overall Study|Withdrawal by Subject|3|||
143450419|NCT00132873|517192785|FG000|Overall Study|Planned Pregnancy|1|||
143450420|NCT04531904|517192789|FG000|Overall Study|Lost to Follow-up|1|||
143450421|NCT04531904|517192789|FG000|Overall Study|Death|14|||
143450422|NCT04372121|517192790|FG000|Overall Study|Lost to Follow-up|0|||
143450423|NCT04372121|517192791|FG001|Overall Study|Lost to Follow-up|0|||
143450424|NCT04372121|517192792|FG002|Overall Study|Lost to Follow-up|0|||
143450425|NCT04372121|517192793|FG003|Overall Study|Lost to Follow-up|1|||
143450426|NCT04372121|517192790|FG000|Overall Study|Protocol Violation|0|||
143450427|NCT04372121|517192791|FG001|Overall Study|Protocol Violation|0|||
143450428|NCT04372121|517192792|FG002|Overall Study|Protocol Violation|1|||
143450429|NCT04372121|517192793|FG003|Overall Study|Protocol Violation|0|||
143450430|NCT04372121|517192790|FG000|Overall Study|Withdrawal by Subject|3|||
143450431|NCT04372121|517192791|FG001|Overall Study|Withdrawal by Subject|1|||
143450432|NCT04372121|517192792|FG002|Overall Study|Withdrawal by Subject|0|||
143450433|NCT04372121|517192793|FG003|Overall Study|Withdrawal by Subject|0|||
143450434|NCT04372121|517192790|FG000|Overall Study|Study termination|6|||
143450435|NCT04372121|517192791|FG001|Overall Study|Study termination|5|||
143450436|NCT04372121|517192792|FG002|Overall Study|Study termination|1|||
143450437|NCT04372121|517192793|FG003|Overall Study|Study termination|1|||
143450438|NCT04372121|517192790|FG000|Overall Study|Hysterectomy planned|1|||
143450439|NCT04372121|517192791|FG001|Overall Study|Hysterectomy planned|0|||
143450440|NCT04372121|517192792|FG002|Overall Study|Hysterectomy planned|0|||
143450441|NCT04372121|517192793|FG003|Overall Study|Hysterectomy planned|0|||
143450442|NCT01967147|517194243|FG000|Overall Study|Adverse Event|5|||
143450443|NCT01967147|517194244|FG001|Overall Study|Adverse Event|2|||
143450444|NCT01967147|517194243|FG000|Overall Study|Lack of Efficacy|1|||
143450445|NCT01967147|517194244|FG001|Overall Study|Lack of Efficacy|4|||
143450446|NCT01967147|517194243|FG000|Overall Study|Lost to Follow-up|1|||
143450447|NCT01967147|517194244|FG001|Overall Study|Lost to Follow-up|2|||
143450448|NCT01967147|517194243|FG000|Overall Study|Withdrawal by Subject|2|||
143450449|NCT01967147|517194244|FG001|Overall Study|Withdrawal by Subject|4|||
143450450|NCT01967147|517194243|FG000|Overall Study|Non-compliance with Study Drug|0|||
143450451|NCT01967147|517194244|FG001|Overall Study|Non-compliance with Study Drug|3|||
143450452|NCT01967147|517194243|FG000|Overall Study|Other|4|||
143450453|NCT01967147|517194244|FG001|Overall Study|Other|5|||
143450454|NCT00890695|517194247|FG000|Overall Study|Protocol Violation|1|||
143450455|NCT00890695|517194248|FG001|Overall Study|Protocol Violation|0|||
143450456|NCT03986944|517194255|FG000|Overall Study|Adverse Event|1|||
143450457|NCT03986944|517194256|FG001|Overall Study|Adverse Event|2|||
143450458|NCT03986944|517194257|FG002|Overall Study|Adverse Event|3|||
143450459|NCT03986944|517194255|FG000|Overall Study|Protocol Violation|0|||
143450460|NCT03986944|517194256|FG001|Overall Study|Protocol Violation|1|||
143450461|NCT03986944|517194257|FG002|Overall Study|Protocol Violation|1|||
143450462|NCT03986944|517194255|FG000|Overall Study|Withdrawal by Subject|3|||
143450463|NCT03986944|517194256|FG001|Overall Study|Withdrawal by Subject|5|||
143450464|NCT03986944|517194257|FG002|Overall Study|Withdrawal by Subject|5|||
143450465|NCT03986944|517194255|FG000|Overall Study|Study termination|10|||
143450466|NCT03986944|517194256|FG001|Overall Study|Study termination|10|||
143450467|NCT03986944|517194257|FG002|Overall Study|Study termination|10|||
143450468|NCT03986944|517194255|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
143450469|NCT03986944|517194256|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
143450470|NCT03986944|517194257|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
143450471|NCT03986944|517194255|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
143450472|NCT03986944|517194256|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
143450473|NCT03986944|517194257|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
143450474|NCT01302080|517194263|FG000|Overall Study|Withdrew Consent|92|||
143450475|NCT01302080|517194264|FG001|Overall Study|Withdrew Consent|39|||
143450476|NCT01302080|517194263|FG000|Overall Study|Patient/Family Moved|28|||
143450477|NCT01302080|517194264|FG001|Overall Study|Patient/Family Moved|3|||
143450478|NCT01302080|517194263|FG000|Overall Study|Lost to Follow-up|192|||
143450479|NCT01302080|517194264|FG001|Overall Study|Lost to Follow-up|93|||
143450480|NCT01302080|517194263|FG000|Overall Study|Death|1|||
143450481|NCT01302080|517194264|FG001|Overall Study|Death|0|||
143450482|NCT01302080|517194263|FG000|Overall Study|Other|52|||
143450483|NCT01302080|517194264|FG001|Overall Study|Other|8|||
143450484|NCT01302080|517194263|FG000|Overall Study|Reason Missing For Discontinuation|1|||
143450485|NCT01302080|517194264|FG001|Overall Study|Reason Missing For Discontinuation|0|||
143450486|NCT02530970|517194267|FG000|Overall Study|Adverse Event|8|||
143450487|NCT02530970|517194267|FG000|Overall Study|Lost to Follow-up|88|||
143450488|NCT02530970|517194267|FG000|Overall Study|Physician Decision|5|||
143450489|NCT02530970|517194267|FG000|Overall Study|Withdrawal by Subject|14|||
143450490|NCT02530970|517194267|FG000|Overall Study|Death|6|||
143450491|NCT02530970|517194267|FG000|Overall Study|Hospitalization|1|||
143450492|NCT02530970|517194267|FG000|Overall Study|Insurance|2|||
143450493|NCT02530970|517194267|FG000|Overall Study|Explant|2|||
143450494|NCT02530970|517194267|FG000|Overall Study|Change in Provider|5|||
143450495|NCT02530970|517194267|FG000|Overall Study|Relocation|3|||
143450496|NCT02770612|517194268|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
143450497|NCT01204710|517194272|FG000|Randomization Treatment|Lost to Follow-up|1|||
143450498|NCT01204710|517194273|FG001|Randomization Treatment|Lost to Follow-up|0|||
143450499|NCT01204710|517194272|FG000|Randomization Treatment|Withdrawal by Subject|6|||
143450500|NCT01204710|517194273|FG001|Randomization Treatment|Withdrawal by Subject|5|||
143450501|NCT01204710|517194272|FG000|Randomization Treatment|Physician Decision|3|||
143450502|NCT01204710|517194273|FG001|Randomization Treatment|Physician Decision|2|||
143450503|NCT01204710|517194272|FG000|Randomization Treatment|Entry criteria not met|0|||
143450504|NCT01204710|517194273|FG001|Randomization Treatment|Entry criteria not met|1|||
143450505|NCT01204710|517194272|FG000|Randomization Treatment|Adverse Event|4|||
143450506|NCT01204710|517194273|FG001|Randomization Treatment|Adverse Event|2|||
143450507|NCT01204710|517194272|FG000|Randomization Treatment|Sponsor Decision|0|||
143450508|NCT01204710|517194273|FG001|Randomization Treatment|Sponsor Decision|1|||
143450509|NCT01204710|517194272|FG000|Randomization Treatment|Worsening of General condition|0|||
143450510|NCT01204710|517194273|FG001|Randomization Treatment|Worsening of General condition|1|||
143450511|NCT01204710|517194272|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
143450512|NCT01204710|517194273|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
143450513|NCT01204710|517194272|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
143450514|NCT01204710|517194273|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
143450515|NCT01204710|517194272|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
143450516|NCT01204710|517194273|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
143450517|NCT01204710|517194272|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
143450518|NCT01204710|517194273|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
143450519|NCT00743431|517194274|FG000|Overall Study|Toxicity|6|||
143450520|NCT00743431|517194274|FG000|Overall Study|Tumor progression|56|||
143450521|NCT00743431|517194274|FG000|Overall Study|Withdrawal by Subject|13|||
143450522|NCT00743431|517194274|FG000|Overall Study|Death|9|||
143450523|NCT00743431|517194274|FG000|Overall Study|Reason for discontinuation not specified|29|||
143450524|NCT00743431|517194274|FG000|Overall Study|No documentation available|13|||
143450525|NCT03291288|517194275|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
143450526|NCT03291288|517194276|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
143450527|NCT03291288|517194275|FG000|Drug-drug Interaction Phase|Disease progression|1|||
143450528|NCT03291288|517194276|FG001|Drug-drug Interaction Phase|Disease progression|0|||
143450529|NCT03291288|517194275|FG000|Drug-drug Interaction Phase|Other|3|||
143450530|NCT03291288|517194276|FG001|Drug-drug Interaction Phase|Other|0|||
143450531|NCT03291288|517194275|FG000|Pexidartinib Only|Ongoing|0|||
143450532|NCT03291288|517194276|FG001|Pexidartinib Only|Ongoing|2|||
143450533|NCT04276415|517194277|FG000|Overall Study|Adverse Event|0|||
143450534|NCT04276415|517194278|FG001|Overall Study|Adverse Event|0|||
143450535|NCT04276415|517194279|FG002|Overall Study|Adverse Event|0|||
143450536|NCT04276415|517194280|FG003|Overall Study|Adverse Event|3|||
143450537|NCT04276415|517194281|FG004|Overall Study|Adverse Event|0|||
143450538|NCT04276415|517194282|FG005|Overall Study|Adverse Event|0|||
143450539|NCT04276415|517194277|FG000|Overall Study|Clinical progression|1|||
143450540|NCT04276415|517194278|FG001|Overall Study|Clinical progression|1|||
143450541|NCT04276415|517194279|FG002|Overall Study|Clinical progression|0|||
143450542|NCT04276415|517194280|FG003|Overall Study|Clinical progression|0|||
143450543|NCT04276415|517194281|FG004|Overall Study|Clinical progression|1|||
143450544|NCT04276415|517194282|FG005|Overall Study|Clinical progression|0|||
143450545|NCT04276415|517194277|FG000|Overall Study|Other|0|||
143450546|NCT04276415|517194278|FG001|Overall Study|Other|0|||
143450547|NCT04276415|517194279|FG002|Overall Study|Other|0|||
143450548|NCT04276415|517194280|FG003|Overall Study|Other|1|||
143450549|NCT04276415|517194281|FG004|Overall Study|Other|0|||
143450550|NCT04276415|517194282|FG005|Overall Study|Other|0|||
143450551|NCT04276415|517194277|FG000|Overall Study|Physician Decision|0|||
143450552|NCT04276415|517194278|FG001|Overall Study|Physician Decision|0|||
143450553|NCT04276415|517194279|FG002|Overall Study|Physician Decision|1|||
143450554|NCT04276415|517194280|FG003|Overall Study|Physician Decision|3|||
143450555|NCT04276415|517194281|FG004|Overall Study|Physician Decision|2|||
143450556|NCT04276415|517194282|FG005|Overall Study|Physician Decision|0|||
143450557|NCT04276415|517194277|FG000|Overall Study|Progressive disease|3|||
143450558|NCT04276415|517194278|FG001|Overall Study|Progressive disease|3|||
143450559|NCT04276415|517194279|FG002|Overall Study|Progressive disease|4|||
143450560|NCT04276415|517194280|FG003|Overall Study|Progressive disease|5|||
143450561|NCT04276415|517194281|FG004|Overall Study|Progressive disease|1|||
143450562|NCT04276415|517194282|FG005|Overall Study|Progressive disease|2|||
143450563|NCT04276415|517194277|FG000|Overall Study|Withdrawal by patient|0|||
143450564|NCT04276415|517194278|FG001|Overall Study|Withdrawal by patient|0|||
143450565|NCT04276415|517194279|FG002|Overall Study|Withdrawal by patient|0|||
143450566|NCT04276415|517194280|FG003|Overall Study|Withdrawal by patient|1|||
143450567|NCT04276415|517194281|FG004|Overall Study|Withdrawal by patient|2|||
143450568|NCT04276415|517194282|FG005|Overall Study|Withdrawal by patient|0|||
143450569|NCT01896726|517194283|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
143450570|NCT01896726|517194283|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
143450571|NCT02406677|517194284|FG000|Overall Study|Death|16|||
143450572|NCT02406677|517194285|FG001|Overall Study|Death|8|||
143450573|NCT02406677|517194284|FG000|Overall Study|Discharged without P2Y12|1|||
143450574|NCT02406677|517194285|FG001|Overall Study|Discharged without P2Y12|3|||
143450575|NCT02406677|517194284|FG000|Overall Study|Discharged on prasugrel|283|||
143450576|NCT02406677|517194285|FG001|Overall Study|Discharged on prasugrel|587|||
143450577|NCT02406677|517194284|FG000|Overall Study|Withdrawal by Subject|1|||
143450578|NCT02406677|517194285|FG001|Overall Study|Withdrawal by Subject|0|||
143450579|NCT01114880|517194286|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
143450580|NCT01114880|517194287|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
143450581|NCT01114880|517194286|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
143450582|NCT01114880|517194287|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
143450583|NCT01114880|517194286|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
143450584|NCT01114880|517194287|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
143450585|NCT01114880|517194286|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
143450586|NCT01114880|517194287|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
143450587|NCT01114880|517194286|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
143450588|NCT01114880|517194287|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
143450589|NCT01114880|517194286|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
143450590|NCT01114880|517194287|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
143450591|NCT04531098|517194291|FG000|Stage I|Adverse Event|0|||
143450592|NCT04531098|517194292|FG001|Stage I|Adverse Event|0|||
143450593|NCT04531098|517194293|FG002|Stage I|Adverse Event|3|||
143450594|NCT04531098|517194291|FG000|Stage I|Protocol Violation|0|||
143450595|NCT04531098|517194292|FG001|Stage I|Protocol Violation|0|||
143450596|NCT04531098|517194293|FG002|Stage I|Protocol Violation|5|||
143450597|NCT04531098|517194291|FG000|Stage I|Withdrawal by Subject|0|||
143450598|NCT04531098|517194292|FG001|Stage I|Withdrawal by Subject|5|||
143450599|NCT04531098|517194293|FG002|Stage I|Withdrawal by Subject|10|||
143450600|NCT04531098|517194291|FG000|Stage II|Adverse Event|1|||
143450601|NCT04531098|517194292|FG001|Stage II|Adverse Event|2|||
143450602|NCT04531098|517194293|FG002|Stage II|Adverse Event|0|||
143450603|NCT04531098|517194291|FG000|Stage II|Protocol Violation|1|||
143450604|NCT04531098|517194292|FG001|Stage II|Protocol Violation|2|||
143450605|NCT04531098|517194293|FG002|Stage II|Protocol Violation|0|||
143450606|NCT04531098|517194291|FG000|Stage II|Withdrawal by Subject|3|||
143450607|NCT04531098|517194292|FG001|Stage II|Withdrawal by Subject|1|||
143450608|NCT04531098|517194293|FG002|Stage II|Withdrawal by Subject|0|||
143450609|NCT04531098|517194291|FG000|Stage II|Moved from study area|8|||
143450610|NCT04531098|517194292|FG001|Stage II|Moved from study area|5|||
143450611|NCT04531098|517194293|FG002|Stage II|Moved from study area|0|||
143450612|NCT00283244|517194294|FG000|Overall Study|Adverse Event|0|||
143450613|NCT00283244|517194295|FG001|Overall Study|Adverse Event|8|||
143450614|NCT00283244|517194296|FG002|Overall Study|Adverse Event|11|||
143450615|NCT00283244|517194294|FG000|Overall Study|Death|4|||
143450616|NCT00283244|517194295|FG001|Overall Study|Death|3|||
143450617|NCT00283244|517194296|FG002|Overall Study|Death|2|||
143450618|NCT00283244|517194294|FG000|Overall Study|Lack of Efficacy|8|||
143450619|NCT00283244|517194295|FG001|Overall Study|Lack of Efficacy|32|||
143450620|NCT00283244|517194296|FG002|Overall Study|Lack of Efficacy|26|||
143450621|NCT00283244|517194294|FG000|Overall Study|Withdrawal by Subject|1|||
143450622|NCT00283244|517194295|FG001|Overall Study|Withdrawal by Subject|2|||
143450623|NCT00283244|517194296|FG002|Overall Study|Withdrawal by Subject|2|||
143450624|NCT00283244|517194294|FG000|Overall Study|Physician Decision|0|||
143450625|NCT00283244|517194295|FG001|Overall Study|Physician Decision|0|||
143450626|NCT00283244|517194296|FG002|Overall Study|Physician Decision|1|||
143450627|NCT00283244|517194294|FG000|Overall Study|Medical illness (other complicating dz)|4|||
143450628|NCT00283244|517194295|FG001|Overall Study|Medical illness (other complicating dz)|3|||
143450629|NCT00283244|517194296|FG002|Overall Study|Medical illness (other complicating dz)|6|||
143450630|NCT00283244|517194294|FG000|Overall Study|Clinical deterioration|1|||
143450631|NCT00283244|517194295|FG001|Overall Study|Clinical deterioration|3|||
143450632|NCT00283244|517194296|FG002|Overall Study|Clinical deterioration|3|||
143450633|NCT02628028|517194297|FG000|Dosing Period|Withdrawal by Subject|0|||
143450634|NCT02628028|517194298|FG001|Dosing Period|Withdrawal by Subject|0|||
143450635|NCT02628028|517194299|FG002|Dosing Period|Withdrawal by Subject|1|||
143450636|NCT02628028|517194300|FG003|Dosing Period|Withdrawal by Subject|0|||
143450637|NCT02628028|517194301|FG004|Dosing Period|Withdrawal by Subject|2|||
143450638|NCT02628028|517194302|FG005|Dosing Period|Withdrawal by Subject|4|||
143450639|NCT02628028|517194303|FG006|Dosing Period|Withdrawal by Subject|1|||
143450640|NCT02628028|517194304|FG007|Dosing Period|Withdrawal by Subject|1|||
143450641|NCT02628028|517194297|FG000|Dosing Period|Adverse Event|0|||
143450642|NCT02628028|517194298|FG001|Dosing Period|Adverse Event|0|||
143450643|NCT02628028|517194299|FG002|Dosing Period|Adverse Event|0|||
143450644|NCT02628028|517194300|FG003|Dosing Period|Adverse Event|0|||
143450645|NCT02628028|517194301|FG004|Dosing Period|Adverse Event|2|||
143450646|NCT02628028|517194302|FG005|Dosing Period|Adverse Event|1|||
143450647|NCT02628028|517194303|FG006|Dosing Period|Adverse Event|3|||
143450648|NCT02628028|517194304|FG007|Dosing Period|Adverse Event|2|||
143450649|NCT02628028|517194297|FG000|Dosing Period|Death|0|||
143450650|NCT02628028|517194298|FG001|Dosing Period|Death|0|||
143450651|NCT02628028|517194299|FG002|Dosing Period|Death|0|||
143450652|NCT02628028|517194300|FG003|Dosing Period|Death|0|||
143450653|NCT02628028|517194301|FG004|Dosing Period|Death|0|||
143450654|NCT02628028|517194302|FG005|Dosing Period|Death|0|||
143450655|NCT02628028|517194303|FG006|Dosing Period|Death|0|||
143450656|NCT02628028|517194304|FG007|Dosing Period|Death|1|||
143450657|NCT02628028|517194297|FG000|Dosing Period|Lack of Efficacy|0|||
143450658|NCT02628028|517194298|FG001|Dosing Period|Lack of Efficacy|0|||
143450659|NCT02628028|517194299|FG002|Dosing Period|Lack of Efficacy|0|||
143450660|NCT02628028|517194300|FG003|Dosing Period|Lack of Efficacy|0|||
143450661|NCT02628028|517194301|FG004|Dosing Period|Lack of Efficacy|3|||
143450662|NCT02628028|517194302|FG005|Dosing Period|Lack of Efficacy|0|||
143450663|NCT02628028|517194303|FG006|Dosing Period|Lack of Efficacy|1|||
143450664|NCT02628028|517194304|FG007|Dosing Period|Lack of Efficacy|0|||
143450665|NCT02628028|517194297|FG000|Dosing Period|Study Terminated by Sponsor|0|||
143450666|NCT02628028|517194298|FG001|Dosing Period|Study Terminated by Sponsor|0|||
143450667|NCT02628028|517194299|FG002|Dosing Period|Study Terminated by Sponsor|0|||
143450668|NCT02628028|517194300|FG003|Dosing Period|Study Terminated by Sponsor|0|||
143450669|NCT02628028|517194301|FG004|Dosing Period|Study Terminated by Sponsor|7|||
143450670|NCT02628028|517194302|FG005|Dosing Period|Study Terminated by Sponsor|6|||
143450671|NCT02628028|517194303|FG006|Dosing Period|Study Terminated by Sponsor|7|||
143450672|NCT02628028|517194304|FG007|Dosing Period|Study Terminated by Sponsor|7|||
143450673|NCT02628028|517194297|FG000|Dosing Period|Physician Decision|0|||
143450674|NCT02628028|517194298|FG001|Dosing Period|Physician Decision|0|||
143450675|NCT02628028|517194299|FG002|Dosing Period|Physician Decision|0|||
143450676|NCT02628028|517194300|FG003|Dosing Period|Physician Decision|0|||
143450677|NCT02628028|517194301|FG004|Dosing Period|Physician Decision|0|||
143450678|NCT02628028|517194302|FG005|Dosing Period|Physician Decision|1|||
143450679|NCT02628028|517194303|FG006|Dosing Period|Physician Decision|0|||
143450680|NCT02628028|517194304|FG007|Dosing Period|Physician Decision|0|||
143450681|NCT02628028|517194297|FG000|Dosing Period|Site Terminated by Sponsor|0|||
143450682|NCT02628028|517194298|FG001|Dosing Period|Site Terminated by Sponsor|0|||
143450683|NCT02628028|517194299|FG002|Dosing Period|Site Terminated by Sponsor|0|||
143450684|NCT02628028|517194300|FG003|Dosing Period|Site Terminated by Sponsor|0|||
143450685|NCT02628028|517194301|FG004|Dosing Period|Site Terminated by Sponsor|0|||
143450686|NCT02628028|517194302|FG005|Dosing Period|Site Terminated by Sponsor|1|||
143450687|NCT02628028|517194303|FG006|Dosing Period|Site Terminated by Sponsor|1|||
143450688|NCT02628028|517194304|FG007|Dosing Period|Site Terminated by Sponsor|0|||
143450689|NCT02628028|517194297|FG000|Dosing Period|Lost to Follow-up|0|||
143450690|NCT02628028|517194298|FG001|Dosing Period|Lost to Follow-up|0|||
143450691|NCT02628028|517194299|FG002|Dosing Period|Lost to Follow-up|0|||
143450692|NCT02628028|517194300|FG003|Dosing Period|Lost to Follow-up|0|||
143450693|NCT02628028|517194301|FG004|Dosing Period|Lost to Follow-up|0|||
143450694|NCT02628028|517194302|FG005|Dosing Period|Lost to Follow-up|0|||
143450695|NCT02628028|517194303|FG006|Dosing Period|Lost to Follow-up|1|||
143450696|NCT02628028|517194304|FG007|Dosing Period|Lost to Follow-up|0|||
143450697|NCT02628028|517194297|FG000|Dosing Period|Other|0|||
143450698|NCT02628028|517194298|FG001|Dosing Period|Other|0|||
143450699|NCT02628028|517194299|FG002|Dosing Period|Other|0|||
143450700|NCT02628028|517194300|FG003|Dosing Period|Other|0|||
143450701|NCT02628028|517194301|FG004|Dosing Period|Other|2|||
143450702|NCT02628028|517194302|FG005|Dosing Period|Other|1|||
143450703|NCT02628028|517194303|FG006|Dosing Period|Other|2|||
143450704|NCT02628028|517194304|FG007|Dosing Period|Other|4|||
143450705|NCT02628028|517194297|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
143450706|NCT02628028|517194298|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
143450707|NCT02628028|517194299|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
143450708|NCT02628028|517194300|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
143450709|NCT02628028|517194301|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
143450710|NCT02628028|517194302|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
143450711|NCT02628028|517194303|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
143450712|NCT02628028|517194304|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
143450713|NCT02628028|517194297|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
143450714|NCT02628028|517194298|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
143450715|NCT02628028|517194299|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
143450716|NCT02628028|517194300|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
143450717|NCT02628028|517194301|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
143450718|NCT02628028|517194302|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
143450719|NCT02628028|517194303|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
143450720|NCT02628028|517194304|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
143450721|NCT02628028|517194297|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
143450722|NCT02628028|517194298|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
143450723|NCT02628028|517194299|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
143450724|NCT02628028|517194300|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
143450725|NCT02628028|517194301|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
143450726|NCT02628028|517194302|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
143450727|NCT02628028|517194303|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
143450728|NCT02628028|517194304|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
143450729|NCT02628028|517194297|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
143450730|NCT02628028|517194298|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
143450731|NCT02628028|517194299|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
143450732|NCT02628028|517194300|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
143450733|NCT02628028|517194301|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
143450734|NCT02628028|517194302|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
143450735|NCT02628028|517194303|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
143450736|NCT02628028|517194304|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
143450737|NCT02628028|517194297|FG000|Long-term Extension (LTE) Period|Other|0|||
143450738|NCT02628028|517194298|FG001|Long-term Extension (LTE) Period|Other|0|||
143450739|NCT02628028|517194299|FG002|Long-term Extension (LTE) Period|Other|0|||
143450740|NCT02628028|517194300|FG003|Long-term Extension (LTE) Period|Other|0|||
143450741|NCT02628028|517194301|FG004|Long-term Extension (LTE) Period|Other|0|||
143450742|NCT02628028|517194302|FG005|Long-term Extension (LTE) Period|Other|3|||
143450743|NCT02628028|517194303|FG006|Long-term Extension (LTE) Period|Other|4|||
143450744|NCT02628028|517194304|FG007|Long-term Extension (LTE) Period|Other|3|||
143450745|NCT02145468|517194305|FG000|Overall Study|Withdrawal by Subject|5|||
143450746|NCT02145468|517194306|FG001|Overall Study|Withdrawal by Subject|8|||
143450747|NCT02235311|517194313|FG000|Overall Study|Lost to Follow-up|0|||
143450748|NCT02235311|517194314|FG001|Overall Study|Lost to Follow-up|1|||
143450749|NCT02235311|517194313|FG000|Overall Study|Protocol Violation|0|||
143450750|NCT02235311|517194314|FG001|Overall Study|Protocol Violation|1|||
143450751|NCT00658788|517194315|FG000|Overall Study|Adverse Event|11|||
143450752|NCT00658788|517194315|FG000|Overall Study|Withdrawal by Subject|13|||
143450753|NCT00658788|517194315|FG000|Overall Study|Lost to Follow-up|18|||
143450754|NCT00658788|517194315|FG000|Overall Study|Treatment Discontinuation|32|||
143450755|NCT03519997|517194316|FG000|Overall Study|Adverse Event|4|||
143450756|NCT03519997|517194316|FG000|Overall Study|Withdrawal by Subject|2|||
143450757|NCT03519997|517194316|FG000|Overall Study|Protocol Violation|1|||
143450758|NCT03898167|517194317|FG000|Overall Study|Terminated phone call early|7|||
143450759|NCT03898167|517194318|FG001|Overall Study|Terminated phone call early|0|||
143450760|NCT03898167|517194319|FG002|Overall Study|Terminated phone call early|0|||
143450761|NCT03898167|517194317|FG000|Overall Study|Terminated phone call early or requested to not receive a kit|0|||
143450762|NCT03898167|517194318|FG001|Overall Study|Terminated phone call early or requested to not receive a kit|91|||
143450763|NCT03898167|517194319|FG002|Overall Study|Terminated phone call early or requested to not receive a kit|103|||
143450764|NCT00384397|517194321|FG000|Overall Study|Adverse Event|0|||
143450765|NCT00384397|517194322|FG001|Overall Study|Adverse Event|1|||
143450766|NCT00384397|517194323|FG002|Overall Study|Adverse Event|2|||
143450767|NCT00384397|517194321|FG000|Overall Study|Protocol Violation|7|||
143450768|NCT00384397|517194322|FG001|Overall Study|Protocol Violation|15|||
143450769|NCT00384397|517194323|FG002|Overall Study|Protocol Violation|13|||
143450770|NCT00384397|517194321|FG000|Overall Study|Lost to Follow-up|11|||
143450771|NCT00384397|517194322|FG001|Overall Study|Lost to Follow-up|13|||
143450772|NCT00384397|517194323|FG002|Overall Study|Lost to Follow-up|3|||
143450773|NCT00384397|517194321|FG000|Overall Study|Withdrawal by Subject|14|||
143450774|NCT00384397|517194322|FG001|Overall Study|Withdrawal by Subject|17|||
143450775|NCT00384397|517194323|FG002|Overall Study|Withdrawal by Subject|15|||
143450776|NCT01214642|517194324|FG000|Overall Study|Progressive Disease|3|||
143450777|NCT01214642|517194325|FG001|Overall Study|Progressive Disease|2|||
143450778|NCT01214642|517194326|FG002|Overall Study|Progressive Disease|3|||
143450779|NCT01214642|517194327|FG003|Overall Study|Progressive Disease|5|||
143450780|NCT01214642|517194328|FG004|Overall Study|Progressive Disease|5|||
143450781|NCT01214642|517194329|FG005|Overall Study|Progressive Disease|3|||
143450782|NCT01214642|517194330|FG006|Overall Study|Progressive Disease|5|||
143450783|NCT01214642|517194331|FG007|Overall Study|Progressive Disease|3|||
143450784|NCT01214642|517194332|FG008|Overall Study|Progressive Disease|10|||
143450785|NCT01214642|517194333|FG009|Overall Study|Progressive Disease|2|||
143450786|NCT01214642|517194334|FG010|Overall Study|Progressive Disease|1|||
143450787|NCT01214642|517194335|FG011|Overall Study|Progressive Disease|4|||
143450788|NCT01214642|517194324|FG000|Overall Study|Adverse Event|0|||
143450789|NCT01214642|517194325|FG001|Overall Study|Adverse Event|1|||
143450790|NCT01214642|517194326|FG002|Overall Study|Adverse Event|0|||
143450791|NCT01214642|517194327|FG003|Overall Study|Adverse Event|0|||
143450792|NCT01214642|517194328|FG004|Overall Study|Adverse Event|0|||
143450793|NCT01214642|517194329|FG005|Overall Study|Adverse Event|0|||
143450794|NCT01214642|517194330|FG006|Overall Study|Adverse Event|1|||
143450795|NCT01214642|517194331|FG007|Overall Study|Adverse Event|0|||
143450796|NCT01214642|517194332|FG008|Overall Study|Adverse Event|0|||
143450797|NCT01214642|517194333|FG009|Overall Study|Adverse Event|1|||
143450798|NCT01214642|517194334|FG010|Overall Study|Adverse Event|1|||
143450799|NCT01214642|517194335|FG011|Overall Study|Adverse Event|0|||
143450800|NCT01214642|517194324|FG000|Overall Study|Death|0|||
143450801|NCT01214642|517194325|FG001|Overall Study|Death|0|||
143450802|NCT01214642|517194326|FG002|Overall Study|Death|1|||
143450803|NCT01214642|517194327|FG003|Overall Study|Death|0|||
143450804|NCT01214642|517194328|FG004|Overall Study|Death|0|||
143450805|NCT01214642|517194329|FG005|Overall Study|Death|0|||
143450806|NCT01214642|517194330|FG006|Overall Study|Death|0|||
143450807|NCT01214642|517194331|FG007|Overall Study|Death|0|||
143450808|NCT01214642|517194332|FG008|Overall Study|Death|0|||
143450809|NCT01214642|517194333|FG009|Overall Study|Death|0|||
143450810|NCT01214642|517194334|FG010|Overall Study|Death|1|||
143450811|NCT01214642|517194335|FG011|Overall Study|Death|0|||
143450812|NCT01214642|517194324|FG000|Overall Study|Withdrawal by Subject|0|||
143450813|NCT01214642|517194325|FG001|Overall Study|Withdrawal by Subject|0|||
143450814|NCT01214642|517194326|FG002|Overall Study|Withdrawal by Subject|1|||
143450815|NCT01214642|517194327|FG003|Overall Study|Withdrawal by Subject|0|||
143450816|NCT01214642|517194328|FG004|Overall Study|Withdrawal by Subject|0|||
143450817|NCT01214642|517194329|FG005|Overall Study|Withdrawal by Subject|0|||
143450818|NCT01214642|517194330|FG006|Overall Study|Withdrawal by Subject|0|||
143450819|NCT01214642|517194331|FG007|Overall Study|Withdrawal by Subject|0|||
143450820|NCT01214642|517194332|FG008|Overall Study|Withdrawal by Subject|3|||
143450821|NCT01214642|517194333|FG009|Overall Study|Withdrawal by Subject|1|||
143450822|NCT01214642|517194334|FG010|Overall Study|Withdrawal by Subject|1|||
143450823|NCT01214642|517194335|FG011|Overall Study|Withdrawal by Subject|0|||
143450824|NCT01214642|517194324|FG000|Overall Study|Physician Decision|0|||
143450825|NCT01214642|517194325|FG001|Overall Study|Physician Decision|0|||
143450826|NCT01214642|517194326|FG002|Overall Study|Physician Decision|1|||
143450827|NCT01214642|517194327|FG003|Overall Study|Physician Decision|1|||
143450828|NCT01214642|517194328|FG004|Overall Study|Physician Decision|1|||
143450829|NCT01214642|517194329|FG005|Overall Study|Physician Decision|0|||
143450830|NCT01214642|517194330|FG006|Overall Study|Physician Decision|0|||
143450831|NCT01214642|517194331|FG007|Overall Study|Physician Decision|0|||
143450832|NCT01214642|517194332|FG008|Overall Study|Physician Decision|0|||
143450833|NCT01214642|517194333|FG009|Overall Study|Physician Decision|0|||
143450834|NCT01214642|517194334|FG010|Overall Study|Physician Decision|0|||
143450835|NCT01214642|517194335|FG011|Overall Study|Physician Decision|2|||
143450836|NCT01946529|517194338|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
143450837|NCT01946529|517194339|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
143450838|NCT01946529|517194340|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
143450839|NCT01946529|517194338|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
143450840|NCT01946529|517194339|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
143450841|NCT01946529|517194340|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
143450842|NCT03826030|517194345|FG000|Overall Study|Withdrawal by Subject|2|||
143450843|NCT03826030|517194346|FG001|Overall Study|Withdrawal by Subject|0|||
143450844|NCT03826030|517194347|FG002|Overall Study|Withdrawal by Subject|1|||
143450845|NCT03826030|517194345|FG000|Overall Study|Lost to Follow-up|1|||
143450846|NCT03826030|517194346|FG001|Overall Study|Lost to Follow-up|1|||
143450847|NCT03826030|517194347|FG002|Overall Study|Lost to Follow-up|1|||
143450848|NCT03826030|517194345|FG000|Overall Study|Too busy to return for visits|1|||
143450849|NCT03826030|517194346|FG001|Overall Study|Too busy to return for visits|0|||
143450850|NCT03826030|517194347|FG002|Overall Study|Too busy to return for visits|0|||
143450851|NCT03820947|517194350|FG000|Overall Study|Physician Decision|0|||
143450852|NCT03820947|517194351|FG001|Overall Study|Physician Decision|1|||
143450853|NCT03820947|517194352|FG002|Overall Study|Physician Decision|1|||
143450854|NCT03820947|517194353|FG003|Overall Study|Physician Decision|0|||
143450855|NCT03820947|517194354|FG004|Overall Study|Physician Decision|3|||
143450856|NCT03820947|517194350|FG000|Overall Study|Withdrawal by Subject|6|||
143450857|NCT03820947|517194351|FG001|Overall Study|Withdrawal by Subject|10|||
143450858|NCT03820947|517194352|FG002|Overall Study|Withdrawal by Subject|3|||
143450859|NCT03820947|517194353|FG003|Overall Study|Withdrawal by Subject|8|||
143450860|NCT03820947|517194354|FG004|Overall Study|Withdrawal by Subject|5|||
143450861|NCT03820947|517194350|FG000|Overall Study|Procedure Not Attempted|0|||
143450862|NCT03820947|517194351|FG001|Overall Study|Procedure Not Attempted|2|||
143450863|NCT03820947|517194352|FG002|Overall Study|Procedure Not Attempted|1|||
143450864|NCT03820947|517194353|FG003|Overall Study|Procedure Not Attempted|0|||
143450865|NCT03820947|517194354|FG004|Overall Study|Procedure Not Attempted|0|||
143450866|NCT03820947|517194350|FG000|Overall Study|Other Exit|1|||
143450867|NCT03820947|517194351|FG001|Overall Study|Other Exit|3|||
143450868|NCT03820947|517194352|FG002|Overall Study|Other Exit|3|||
143450869|NCT03820947|517194353|FG003|Overall Study|Other Exit|3|||
143450870|NCT03820947|517194354|FG004|Overall Study|Other Exit|0|||
143450871|NCT03820947|517194350|FG000|Overall Study|Follow-up Not Done|10|||
143450872|NCT03820947|517194351|FG001|Overall Study|Follow-up Not Done|13|||
143450873|NCT03820947|517194352|FG002|Overall Study|Follow-up Not Done|2|||
143450874|NCT03820947|517194353|FG003|Overall Study|Follow-up Not Done|3|||
143450875|NCT03820947|517194354|FG004|Overall Study|Follow-up Not Done|12|||
143450876|NCT03820947|517194350|FG000|Overall Study|Death|0|||
143450877|NCT03820947|517194351|FG001|Overall Study|Death|0|||
143450878|NCT03820947|517194352|FG002|Overall Study|Death|0|||
143450879|NCT03820947|517194353|FG003|Overall Study|Death|0|||
143450880|NCT03820947|517194354|FG004|Overall Study|Death|9|||
143450881|NCT03820947|517194350|FG000|Overall Study|Lost to Follow-up|4|||
143450882|NCT03820947|517194351|FG001|Overall Study|Lost to Follow-up|6|||
143450883|NCT03820947|517194352|FG002|Overall Study|Lost to Follow-up|0|||
143450884|NCT03820947|517194353|FG003|Overall Study|Lost to Follow-up|0|||
143450885|NCT03820947|517194354|FG004|Overall Study|Lost to Follow-up|9|||
143450886|NCT03578887|517194355|FG000|Overall Study|Withdrawal by Subject|7|||
143450887|NCT03578887|517194356|FG001|Overall Study|Withdrawal by Subject|2|||
143450888|NCT03578887|517194357|FG002|Overall Study|Withdrawal by Subject|1|||
143450889|NCT03578887|517194355|FG000|Overall Study|Lost to Follow-up|13|||
143450890|NCT03578887|517194356|FG001|Overall Study|Lost to Follow-up|1|||
143450891|NCT03578887|517194357|FG002|Overall Study|Lost to Follow-up|4|||
143450892|NCT03578887|517194355|FG000|Overall Study|Physician Decision|0|||
143450893|NCT03578887|517194356|FG001|Overall Study|Physician Decision|1|||
143450894|NCT03578887|517194357|FG002|Overall Study|Physician Decision|1|||
143450895|NCT03002220|517196245|FG000|Overall Study|Lack of Efficacy|2|||
143450896|NCT03002220|517196245|FG000|Overall Study|Withdrawal by Subject|3|||
143450897|NCT03002220|517196245|FG000|Overall Study|Adverse Event|2|||
143450898|NCT03002220|517196245|FG000|Overall Study|Disease progression|13|||
143450899|NCT03002220|517196245|FG000|Overall Study|Physician Decision|1|||
143450900|NCT00640133|517196246|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
143450901|NCT00640133|517196247|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
143450902|NCT00640133|517196246|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
143450903|NCT00640133|517196247|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
143450904|NCT00640133|517196246|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
143450905|NCT00640133|517196247|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
143450906|NCT01183260|517196248|FG000|Overall Study|Intraop screen failure|2|||
143450907|NCT01183260|517196249|FG001|Overall Study|Intraop screen failure|0|||
143450908|NCT01183260|517196248|FG000|Overall Study|Withdrawal by Subject|1|||
143450909|NCT01183260|517196249|FG001|Overall Study|Withdrawal by Subject|1|||
143450910|NCT01183260|517196248|FG000|Overall Study|Revised within 30 days|0|||
143450911|NCT01183260|517196249|FG001|Overall Study|Revised within 30 days|1|||
143450912|NCT01183260|517196248|FG000|Overall Study|Death|1|||
143450913|NCT01183260|517196249|FG001|Overall Study|Death|0|||
143450914|NCT00128102|517196250|FG000|Overall Study|Site Discontinued|3|||
143450915|NCT00128102|517196251|FG001|Overall Study|Site Discontinued|6|||
143450916|NCT00128102|517196250|FG000|Overall Study|Other|0|||
143450917|NCT00128102|517196251|FG001|Overall Study|Other|1|||
143450918|NCT00128102|517196250|FG000|Overall Study|Progressive Disease|255|||
143450919|NCT00128102|517196251|FG001|Overall Study|Progressive Disease|285|||
143450920|NCT00128102|517196250|FG000|Overall Study|Adverse Event|34|||
143450921|NCT00128102|517196251|FG001|Overall Study|Adverse Event|11|||
143450922|NCT00128102|517196250|FG000|Overall Study|Death|12|||
143450923|NCT00128102|517196251|FG001|Overall Study|Death|13|||
143450924|NCT00128102|517196250|FG000|Overall Study|Physician Decision|3|||
143450925|NCT00128102|517196251|FG001|Overall Study|Physician Decision|3|||
143450926|NCT00128102|517196250|FG000|Overall Study|Withdrawal by Subject|19|||
143450927|NCT00128102|517196251|FG001|Overall Study|Withdrawal by Subject|11|||
143450928|NCT00128102|517196250|FG000|Overall Study|Protocol Violation|2|||
143450929|NCT00128102|517196251|FG001|Overall Study|Protocol Violation|2|||
143450930|NCT01202903|517196252|FG000|Overall Study|Administrative Probelms|1|||
143450931|NCT01202903|517196253|FG001|Overall Study|Administrative Probelms|4|||
143450932|NCT01202903|517196252|FG000|Overall Study|Protocol Violation|0|||
143450933|NCT01202903|517196253|FG001|Overall Study|Protocol Violation|1|||
143450934|NCT01202903|517196252|FG000|Overall Study|Death|1|||
143450935|NCT01202903|517196253|FG001|Overall Study|Death|0|||
143450936|NCT01202903|517196252|FG000|Overall Study|Lost to Follow-up|1|||
143450937|NCT01202903|517196253|FG001|Overall Study|Lost to Follow-up|1|||
143450938|NCT01202903|517196252|FG000|Overall Study|Lack of Efficacy|1|||
143450939|NCT01202903|517196253|FG001|Overall Study|Lack of Efficacy|3|||
143450940|NCT01202903|517196252|FG000|Overall Study|Adverse Event|3|||
143450941|NCT01202903|517196253|FG001|Overall Study|Adverse Event|3|||
143450942|NCT01202903|517196252|FG000|Overall Study|Withdrawal by Subject|4|||
143450943|NCT01202903|517196253|FG001|Overall Study|Withdrawal by Subject|4|||
143450944|NCT00996476|517196254|FG000|Overall Study|Withdrawal by Subject|1|||
143450945|NCT00996476|517196255|FG001|Overall Study|Withdrawal by Subject|2|||
143450946|NCT00996476|517196256|FG002|Overall Study|Withdrawal by Subject|1|||
143450947|NCT00996476|517196257|FG003|Overall Study|Withdrawal by Subject|0|||
143450948|NCT00996476|517196258|FG004|Overall Study|Withdrawal by Subject|1|||
143450949|NCT00996476|517196254|FG000|Overall Study|Adverse Event|0|||
143450950|NCT00996476|517196255|FG001|Overall Study|Adverse Event|1|||
143450951|NCT00996476|517196256|FG002|Overall Study|Adverse Event|0|||
143450952|NCT00996476|517196257|FG003|Overall Study|Adverse Event|0|||
143450953|NCT00996476|517196258|FG004|Overall Study|Adverse Event|1|||
143450954|NCT01896557|517196259|FG000|Clopidogrel Alone|Adverse Event|1|||
143450955|NCT01896557|517196260|FG001|Clopidogrel Alone|Adverse Event|0|||
143450956|NCT01896557|517196259|FG000|Clopidogrel + GI Protector|low adherence|1|||
143450957|NCT01896557|517196260|FG001|Clopidogrel + GI Protector|low adherence|1|||
143450958|NCT01896557|517196259|FG000|Clopidogrel + GI Protector|Reading error|1|||
143450959|NCT01896557|517196260|FG001|Clopidogrel + GI Protector|Reading error|3|||
143450960|NCT00734591|517196261|FG000|Screening for Prospective Period|Site did not participate|1604|||
143450961|NCT00734591|517196262|FG001|Screening for Prospective Period|Site did not participate|1488|||
143450962|NCT00734591|517196261|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
143450963|NCT00734591|517196262|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
143450964|NCT00734591|517196261|FG000|Prospective Period|Withdrawal by Subject|11|||
143450965|NCT00734591|517196262|FG001|Prospective Period|Withdrawal by Subject|9|||
143450966|NCT00734591|517196261|FG000|Prospective Period|Lost to Follow-up|37|||
143450967|NCT00734591|517196262|FG001|Prospective Period|Lost to Follow-up|33|||
143450968|NCT00734591|517196261|FG000|Prospective Period|Study Terminated|1|||
143450969|NCT00734591|517196262|FG001|Prospective Period|Study Terminated|0|||
143450970|NCT00734591|517196261|FG000|Prospective Period|Other|2|||
143450971|NCT00734591|517196262|FG001|Prospective Period|Other|2|||
143450972|NCT01656200|517196263|FG000|Overall Study|Withdrawal by Subject|1|||
143450973|NCT02236988|517196264|FG000|Overall Study|Lost to Follow-up|0|||
143450974|NCT02236988|517196265|FG001|Overall Study|Lost to Follow-up|0|||
143450975|NCT02236988|517196266|FG002|Overall Study|Lost to Follow-up|0|||
143450976|NCT02236988|517196267|FG003|Overall Study|Lost to Follow-up|1|||
143450977|NCT02236988|517196264|FG000|Overall Study|Unable to Comply with Study Visits|0|||
143450978|NCT02236988|517196265|FG001|Overall Study|Unable to Comply with Study Visits|0|||
143450979|NCT02236988|517196266|FG002|Overall Study|Unable to Comply with Study Visits|0|||
143450980|NCT02236988|517196267|FG003|Overall Study|Unable to Comply with Study Visits|2|||
143450981|NCT03015129|517196271|FG000|Overall Study|Death|2|||
143450982|NCT03015129|517196272|FG001|Overall Study|Death|2|||
143450983|NCT03015129|517196271|FG000|Overall Study|Lost to Follow-up|0|||
143450984|NCT03015129|517196272|FG001|Overall Study|Lost to Follow-up|1|||
143450985|NCT03015129|517196271|FG000|Overall Study|Progression of disease|38|||
143450986|NCT03015129|517196272|FG001|Overall Study|Progression of disease|33|||
143450987|NCT03015129|517196271|FG000|Overall Study|Adverse Event|0|||
143450988|NCT03015129|517196272|FG001|Overall Study|Adverse Event|4|||
143450989|NCT01072630|517196280|FG000|Overall Study|Adverse Event|11|||
143450990|NCT01072630|517196281|FG001|Overall Study|Adverse Event|19|||
143450991|NCT01072630|517196282|FG002|Overall Study|Adverse Event|2|||
143450992|NCT01072630|517196280|FG000|Overall Study|Lack of Efficacy|10|||
143450993|NCT01072630|517196281|FG001|Overall Study|Lack of Efficacy|10|||
143450994|NCT01072630|517196282|FG002|Overall Study|Lack of Efficacy|1|||
143450995|NCT01072630|517196280|FG000|Overall Study|Withdrawal by Subject|8|||
143450996|NCT01072630|517196281|FG001|Overall Study|Withdrawal by Subject|7|||
143450997|NCT01072630|517196282|FG002|Overall Study|Withdrawal by Subject|2|||
143450998|NCT01072630|517196280|FG000|Overall Study|Protocol Violation|10|||
143450999|NCT01072630|517196281|FG001|Overall Study|Protocol Violation|8|||
143451000|NCT01072630|517196282|FG002|Overall Study|Protocol Violation|4|||
143451001|NCT01072630|517196280|FG000|Overall Study|Lost to Follow-up|11|||
143451002|NCT01072630|517196281|FG001|Overall Study|Lost to Follow-up|11|||
143451003|NCT01072630|517196282|FG002|Overall Study|Lost to Follow-up|1|||
143451004|NCT01072630|517196280|FG000|Overall Study|Noncompliance with study medication|1|||
143451005|NCT01072630|517196281|FG001|Overall Study|Noncompliance with study medication|1|||
143451006|NCT01072630|517196282|FG002|Overall Study|Noncompliance with study medication|1|||
143451007|NCT01072630|517196280|FG000|Overall Study|Noncompliance with study procedures|1|||
143451008|NCT01072630|517196281|FG001|Overall Study|Noncompliance with study procedures|2|||
143451009|NCT01072630|517196282|FG002|Overall Study|Noncompliance with study procedures|1|||
143451010|NCT01072630|517196280|FG000|Overall Study|Other|3|||
143451011|NCT01072630|517196281|FG001|Overall Study|Other|2|||
143451012|NCT01072630|517196282|FG002|Overall Study|Other|1|||
143451013|NCT03046121|517196283|FG000|Overall Study|Death|32|||
143451014|NCT03046121|517196284|FG001|Overall Study|Death|60|||
143451015|NCT03046121|517196283|FG000|Overall Study|Withdrawal by Subject|14|||
143451016|NCT03046121|517196284|FG001|Overall Study|Withdrawal by Subject|12|||
143451017|NCT04514510|517196287|FG000|Overall Study|Lost to Follow-up|0|||
143451018|NCT04514510|517196288|FG001|Overall Study|Lost to Follow-up|1|||
143451019|NCT04514510|517196287|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
143451020|NCT04514510|517196288|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
143451021|NCT00821587|517196293|FG000|Overall Study|Physician Decision|0|||
143451022|NCT00821587|517196294|FG001|Overall Study|Physician Decision|1|||
143451023|NCT04488770|517196297|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
143451024|NCT04488770|517196298|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
143451025|NCT04488770|517196299|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
143451026|NCT04488770|517196300|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
143451027|NCT04488770|517196301|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
143451028|NCT04488770|517196302|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
143451029|NCT04488770|517196303|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
143451030|NCT04488770|517196304|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
143451031|NCT04488770|517196305|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
143451032|NCT04488770|517196306|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
143451033|NCT04488770|517196307|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
143451034|NCT04488770|517196308|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
143451035|NCT04488770|517196309|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
143451036|NCT04488770|517196297|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
143451037|NCT04488770|517196298|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
143451038|NCT04488770|517196299|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
143451039|NCT04488770|517196300|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
143451040|NCT04488770|517196301|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
143451041|NCT04488770|517196302|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
143451042|NCT04488770|517196303|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
143451043|NCT04488770|517196304|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
143451044|NCT04488770|517196305|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
143451045|NCT04488770|517196306|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
143451046|NCT04488770|517196307|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
143451047|NCT04488770|517196308|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
143451048|NCT04488770|517196309|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
143451049|NCT04488770|517196297|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
143451050|NCT04488770|517196298|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
143451051|NCT04488770|517196299|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
143451052|NCT04488770|517196300|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
143451053|NCT04488770|517196301|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
143451054|NCT04488770|517196302|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
143451055|NCT04488770|517196303|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
143451056|NCT04488770|517196304|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
143451057|NCT04488770|517196305|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
143451058|NCT04488770|517196306|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
143451059|NCT04488770|517196307|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
143451060|NCT04488770|517196308|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
143451061|NCT04488770|517196309|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
143451062|NCT04488770|517196297|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
143451063|NCT04488770|517196298|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
143451064|NCT04488770|517196299|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
143451065|NCT04488770|517196300|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
143451066|NCT04488770|517196301|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
143451067|NCT04488770|517196302|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
143451068|NCT04488770|517196303|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
143451069|NCT04488770|517196304|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
143451070|NCT04488770|517196305|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
143451071|NCT04488770|517196306|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
143451072|NCT04488770|517196307|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
143451073|NCT04488770|517196308|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
143451074|NCT04488770|517196309|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
143451075|NCT01208103|517196310|FG000|Overall Study|Adverse Event|1|||
143451076|NCT01208103|517196310|FG000|Overall Study|Withdrawal by Subject|1|||
143451077|NCT01305408|517196311|FG000|Overall Study|Adverse Event|10|||
143451078|NCT01305408|517196312|FG001|Overall Study|Adverse Event|7|||
143451079|NCT01305408|517196311|FG000|Overall Study|Lack of Efficacy|3|||
143451080|NCT01305408|517196312|FG001|Overall Study|Lack of Efficacy|4|||
143451081|NCT01305408|517196311|FG000|Overall Study|Withdrawal by Subject|9|||
143451082|NCT01305408|517196312|FG001|Overall Study|Withdrawal by Subject|9|||
143451083|NCT01305408|517196311|FG000|Overall Study|Protocol Violation|4|||
143451084|NCT01305408|517196312|FG001|Overall Study|Protocol Violation|6|||
143451085|NCT01305408|517196311|FG000|Overall Study|Lost to Follow-up|5|||
143451086|NCT01305408|517196312|FG001|Overall Study|Lost to Follow-up|3|||
143451087|NCT01305408|517196311|FG000|Overall Study|Noncompliance with study medication|0|||
143451088|NCT01305408|517196312|FG001|Overall Study|Noncompliance with study medication|1|||
143451089|NCT01305408|517196311|FG000|Overall Study|Noncompliance with study procedures|0|||
143451090|NCT01305408|517196312|FG001|Overall Study|Noncompliance with study procedures|1|||
143451091|NCT01305408|517196311|FG000|Overall Study|Other|1|||
143451092|NCT01305408|517196312|FG001|Overall Study|Other|0|||
143451093|NCT03101462|517196313|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
143451094|NCT03101462|517196314|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
143451095|NCT03846453|517196316|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
143451096|NCT03846453|517196317|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
143451097|NCT03846453|517196318|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
143451098|NCT03846453|517196316|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
143451099|NCT03846453|517196317|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
143451100|NCT03846453|517196318|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
143451101|NCT03846453|517196316|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
143451102|NCT03846453|517196317|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
143451103|NCT03846453|517196318|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
143451104|NCT03846453|517196316|FG000|Placebo Run-in (14 Days)|Other|2|||
143451105|NCT03846453|517196317|FG001|Placebo Run-in (14 Days)|Other|0|||
143451106|NCT03846453|517196318|FG002|Placebo Run-in (14 Days)|Other|0|||
143451107|NCT03846453|517196316|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
143451108|NCT03846453|517196317|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
143451109|NCT03846453|517196318|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
143451110|NCT03846453|517196316|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
143451111|NCT03846453|517196317|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
143451112|NCT03846453|517196318|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
143451113|NCT03846453|517196316|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
143451114|NCT03846453|517196317|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
143451115|NCT03846453|517196318|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
143451116|NCT03846453|517196316|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
143451117|NCT03846453|517196317|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
143451118|NCT03846453|517196318|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
143451119|NCT03846453|517196316|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
143451120|NCT03846453|517196317|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
143451121|NCT03846453|517196318|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
143451122|NCT00468143|517196319|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
143451123|NCT00468143|517196320|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
143451124|NCT00468143|517196319|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
143451125|NCT00468143|517196320|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
143451126|NCT01606670|517196321|FG000|Overall Study|Adverse Event|6|||
143451127|NCT01606670|517196321|FG000|Overall Study|Lack of Efficacy|2|||
143451128|NCT01606670|517196321|FG000|Overall Study|Lost to Follow-up|3|||
143451129|NCT01606670|517196321|FG000|Overall Study|Withdrawal by Subject|3|||
143451130|NCT01606670|517196321|FG000|Overall Study|Other Reason|2|||
143451131|NCT02636725|517196322|FG000|Overall Study|Adverse Event|1|||
143451132|NCT03653208|517196325|FG000|Overall Study|Withdrawal by Subject|0|||
143451133|NCT03653208|517196326|FG001|Overall Study|Withdrawal by Subject|0|||
143451134|NCT03653208|517196327|FG002|Overall Study|Withdrawal by Subject|0|||
143451135|NCT03653208|517196328|FG003|Overall Study|Withdrawal by Subject|0|||
143451136|NCT03653208|517196329|FG004|Overall Study|Withdrawal by Subject|1|||
143451137|NCT03653208|517196330|FG005|Overall Study|Withdrawal by Subject|0|||
143451138|NCT03653208|517196331|FG006|Overall Study|Withdrawal by Subject|0|||
143451139|NCT03653208|517196332|FG007|Overall Study|Withdrawal by Subject|1|||
143451140|NCT03653208|517196333|FG008|Overall Study|Withdrawal by Subject|1|||
143451141|NCT01696045|517196335|FG000|Overall Study|Study drug toxicity|1|||
143451142|NCT01696045|517196336|FG001|Overall Study|Study drug toxicity|5|||
143451143|NCT01696045|517196335|FG000|Overall Study|Disease progression|2|||
143451144|NCT01696045|517196336|FG001|Overall Study|Disease progression|2|||
143451145|NCT01152814|517196338|FG000|Overall Study|Lost to Follow-up|2|||
143451146|NCT00886795|517196339|FG000|Overall Study|Lack of Efficacy|1|||
143451147|NCT01669577|517196343|FG000|Overall Study|Death|22|||
143451148|NCT01669577|517196343|FG000|Overall Study|Lost to Follow-up|78|||
143451149|NCT01669577|517196343|FG000|Overall Study|Physician Decision|34|||
143451150|NCT03466073|517196344|FG000|Overall Study|Death|1|||
143451151|NCT03466073|517196345|FG001|Overall Study|Death|0|||
143451152|NCT03466073|517196346|FG002|Overall Study|Death|0|||
143451153|NCT03466073|517196347|FG003|Overall Study|Death|0|||
143451154|NCT03466073|517196348|FG004|Overall Study|Death|0|||
143451155|NCT03466073|517196349|FG005|Overall Study|Death|1|||
143451156|NCT02045875|517196353|FG000|Overall Study|Lost to Follow-up|3|||
143451157|NCT02045875|517196354|FG001|Overall Study|Lost to Follow-up|0|||
143451158|NCT02045875|517196353|FG000|Overall Study|Withdrawal by Subject|4|||
143451159|NCT02045875|517196354|FG001|Overall Study|Withdrawal by Subject|3|||
143451160|NCT00444275|517196355|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
143451161|NCT00444275|517196356|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
143451162|NCT00444275|517196357|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
143451163|NCT00444275|517196358|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
143451164|NCT00444275|517196359|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
143451165|NCT00444275|517196355|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
143451166|NCT00444275|517196356|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
143451167|NCT00444275|517196357|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
143451168|NCT00444275|517196358|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
143451169|NCT00444275|517196359|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
143451170|NCT00444275|517196355|FG000|Maintenance Treatment Phase|Adverse Event|0|||
143451171|NCT00444275|517196356|FG001|Maintenance Treatment Phase|Adverse Event|0|||
143451172|NCT00444275|517196357|FG002|Maintenance Treatment Phase|Adverse Event|3|||
143451173|NCT00444275|517196358|FG003|Maintenance Treatment Phase|Adverse Event|2|||
143451174|NCT00444275|517196359|FG004|Maintenance Treatment Phase|Adverse Event|13|||
143451175|NCT00444275|517196355|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
143451176|NCT00444275|517196356|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
143451177|NCT00444275|517196357|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
143451178|NCT00444275|517196358|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
143451179|NCT00444275|517196359|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
143451180|NCT00444275|517196355|FG000|Maintenance Treatment Phase|Patient's wish|0|||
143451181|NCT00444275|517196356|FG001|Maintenance Treatment Phase|Patient's wish|0|||
143451182|NCT00444275|517196357|FG002|Maintenance Treatment Phase|Patient's wish|19|||
143451183|NCT00444275|517196358|FG003|Maintenance Treatment Phase|Patient's wish|9|||
143451184|NCT00444275|517196359|FG004|Maintenance Treatment Phase|Patient's wish|20|||
143451185|NCT00444275|517196355|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
143451186|NCT00444275|517196356|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
143451187|NCT00444275|517196357|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
143451188|NCT00444275|517196358|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
143451189|NCT00444275|517196359|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
143451190|NCT00444275|517196355|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
143451191|NCT00444275|517196356|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
143451192|NCT00444275|517196357|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
143451193|NCT00444275|517196358|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
143451194|NCT00444275|517196359|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
143451195|NCT01276379|517196360|FG000|Overall Study|Screening failure|40|||
143451196|NCT00864253|517196361|FG000|Overall Study|Adverse Event|56|||
143451197|NCT00864253|517196362|FG001|Overall Study|Adverse Event|11|||
143451198|NCT00864253|517196361|FG000|Overall Study|Unrelated Adverse Event|3|||
143451199|NCT00864253|517196362|FG001|Overall Study|Unrelated Adverse Event|1|||
143451200|NCT00864253|517196361|FG000|Overall Study|Physician Decision|11|||
143451201|NCT00864253|517196362|FG001|Overall Study|Physician Decision|15|||
143451202|NCT00864253|517196361|FG000|Overall Study|Protocol Violation|0|||
143451203|NCT00864253|517196362|FG001|Overall Study|Protocol Violation|2|||
143451204|NCT00864253|517196361|FG000|Overall Study|Lost to Follow-up|1|||
143451205|NCT00864253|517196362|FG001|Overall Study|Lost to Follow-up|1|||
143451206|NCT00864253|517196361|FG000|Overall Study|Withdrawal by Subject|18|||
143451207|NCT00864253|517196362|FG001|Overall Study|Withdrawal by Subject|18|||
143451208|NCT00864253|517196361|FG000|Overall Study|Death|1|||
143451209|NCT00864253|517196362|FG001|Overall Study|Death|0|||
143451210|NCT00864253|517196361|FG000|Overall Study|Ongoing|2|||
143451211|NCT00864253|517196362|FG001|Overall Study|Ongoing|3|||
143451212|NCT00864253|517196361|FG000|Overall Study|Untreated|7|||
143451213|NCT00864253|517196362|FG001|Overall Study|Untreated|7|||
143451214|NCT01111240|517196365|FG000|Overall Study|Adverse Event|190|||
143451215|NCT01111240|517196365|FG000|Overall Study|Lack of Efficacy|545|||
143451216|NCT01111240|517196365|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
143451217|NCT01111240|517196365|FG000|Overall Study|Other|312|||
143451218|NCT04662931|517196366|FG000|Overall Study|Withdrawal by Subject|17|||
143451219|NCT04662931|517196366|FG000|Overall Study|Death|3|||
143451220|NCT04662931|517196366|FG000|Overall Study|Lost to Follow-up|3|||
143451221|NCT04662931|517196366|FG000|Overall Study|Guardian Decision|1|||
143451222|NCT01989169|517196367|FG000|Period 2|Adverse Event|0|||
143451223|NCT01989169|517196368|FG001|Period 2|Adverse Event|1|||
143451224|NCT01585155|517196369|FG000|Overall Study|Adverse Event|1|||
143451225|NCT01585155|517196369|FG000|Overall Study|Lack of Efficacy|2|||
143451226|NCT01585155|517196369|FG000|Overall Study|Worsening ulcerative colitis|2|||
143451227|NCT01743989|517196370|FG000|Treatment Phase|Unstable MR4.0|0|||
143451228|NCT01743989|517196371|FG001|Treatment Phase|Unstable MR4.0|6|||
143451229|NCT01743989|517196372|FG002|Treatment Phase|Unstable MR4.0|263|||
143451230|NCT01743989|517196370|FG000|Treatment Phase|Adverse Event|0|||
143451231|NCT01743989|517196371|FG001|Treatment Phase|Adverse Event|4|||
143451232|NCT01743989|517196372|FG002|Treatment Phase|Adverse Event|67|||
143451233|NCT01743989|517196370|FG000|Treatment Phase|Withdrawal by Subject|1|||
143451234|NCT01743989|517196371|FG001|Treatment Phase|Withdrawal by Subject|3|||
143451235|NCT01743989|517196372|FG002|Treatment Phase|Withdrawal by Subject|28|||
143451236|NCT01743989|517196370|FG000|Treatment Phase|Death|0|||
143451237|NCT01743989|517196371|FG001|Treatment Phase|Death|1|||
143451238|NCT01743989|517196372|FG002|Treatment Phase|Death|3|||
143451239|NCT01743989|517196370|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
143451240|NCT01743989|517196371|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
143451241|NCT01743989|517196372|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
143451242|NCT01743989|517196370|FG000|Treatment Phase|Protocol deviation|0|||
143451243|NCT01743989|517196371|FG001|Treatment Phase|Protocol deviation|0|||
143451244|NCT01743989|517196372|FG002|Treatment Phase|Protocol deviation|3|||
143451245|NCT01743989|517196370|FG000|Treatment Phase|Pregnancy|0|||
143451246|NCT01743989|517196371|FG001|Treatment Phase|Pregnancy|0|||
143451247|NCT01743989|517196372|FG002|Treatment Phase|Pregnancy|2|||
143451248|NCT01743989|517196370|FG000|Treatment Phase|Lost to Follow-up|0|||
143451249|NCT01743989|517196371|FG001|Treatment Phase|Lost to Follow-up|0|||
143451250|NCT01743989|517196372|FG002|Treatment Phase|Lost to Follow-up|2|||
143451251|NCT01743989|517196370|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
143451252|NCT01743989|517196371|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
143451253|NCT01743989|517196372|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
143451254|NCT01743989|517196370|FG000|Treatment Phase|Administrative problems|0|||
143451255|NCT01743989|517196371|FG001|Treatment Phase|Administrative problems|0|||
143451256|NCT01743989|517196372|FG002|Treatment Phase|Administrative problems|1|||
143451257|NCT01743989|517196370|FG000|Treatment Phase|New cancer (CML) therapy|0|||
143451258|NCT01743989|517196371|FG001|Treatment Phase|New cancer (CML) therapy|1|||
143451259|NCT01743989|517196372|FG002|Treatment Phase|New cancer (CML) therapy|0|||
143451260|NCT01743989|517196370|FG000|Treatment Phase|Physician Decision|0|||
143451261|NCT01743989|517196371|FG001|Treatment Phase|Physician Decision|0|||
143451262|NCT01743989|517196372|FG002|Treatment Phase|Physician Decision|3|||
143451263|NCT01743989|517196370|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
143451264|NCT01743989|517196371|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
143451265|NCT01743989|517196372|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
143451266|NCT01743989|517196370|FG000|Treatment Phase|Not randomized by mistake|0|||
143451267|NCT01743989|517196371|FG001|Treatment Phase|Not randomized by mistake|0|||
143451268|NCT01743989|517196372|FG002|Treatment Phase|Not randomized by mistake|1|||
143451269|NCT01743989|517196370|FG000|Treatment Phase|Included by mistake|0|||
143451270|NCT01743989|517196371|FG001|Treatment Phase|Included by mistake|0|||
143451271|NCT01743989|517196372|FG002|Treatment Phase|Included by mistake|1|||
143451272|NCT01743989|517196370|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
143451273|NCT01743989|517196371|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
143451274|NCT01743989|517196372|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
143451275|NCT01743989|517196370|FG000|TFR Phase|Adverse Event|0|||
143451276|NCT01743989|517196371|FG001|TFR Phase|Adverse Event|1|||
143451277|NCT01743989|517196372|FG002|TFR Phase|Adverse Event|0|||
143451278|NCT01743989|517196370|FG000|TFR Phase|Lost to Follow-up|0|||
143451279|NCT01743989|517196371|FG001|TFR Phase|Lost to Follow-up|2|||
143451280|NCT01743989|517196372|FG002|TFR Phase|Lost to Follow-up|0|||
143451281|NCT01743989|517196370|FG000|TFR Phase|Physician Decision|0|||
143451282|NCT01743989|517196371|FG001|TFR Phase|Physician Decision|1|||
143451283|NCT01743989|517196372|FG002|TFR Phase|Physician Decision|0|||
143451284|NCT01743989|517196370|FG000|TFR Phase|Logistical problems|0|||
143451285|NCT01743989|517196371|FG001|TFR Phase|Logistical problems|2|||
143451286|NCT01743989|517196372|FG002|TFR Phase|Logistical problems|0|||
143451287|NCT01743989|517196370|FG000|TFR Phase|Protocol deviation|0|||
143451288|NCT01743989|517196371|FG001|TFR Phase|Protocol deviation|1|||
143451289|NCT01743989|517196372|FG002|TFR Phase|Protocol deviation|0|||
143451290|NCT01743989|517196370|FG000|TFR Phase|Withdrawal by Subject|0|||
143451291|NCT01743989|517196371|FG001|TFR Phase|Withdrawal by Subject|2|||
143451292|NCT01743989|517196372|FG002|TFR Phase|Withdrawal by Subject|0|||
143451293|NCT01743989|517196370|FG000|Re-treatment Phase|Adverse Event|8|||
143451294|NCT01743989|517196371|FG001|Re-treatment Phase|Adverse Event|4|||
143451295|NCT01743989|517196372|FG002|Re-treatment Phase|Adverse Event|0|||
143451296|NCT01743989|517196370|FG000|Re-treatment Phase|Death|1|||
143451297|NCT01743989|517196371|FG001|Re-treatment Phase|Death|1|||
143451298|NCT01743989|517196372|FG002|Re-treatment Phase|Death|0|||
143451299|NCT01743989|517196370|FG000|Re-treatment Phase|Administrative problems|1|||
143451300|NCT01743989|517196371|FG001|Re-treatment Phase|Administrative problems|1|||
143451301|NCT01743989|517196372|FG002|Re-treatment Phase|Administrative problems|0|||
143451302|NCT01743989|517196370|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
143451303|NCT01743989|517196371|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
143451304|NCT01743989|517196372|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
143451305|NCT01743989|517196370|FG000|Re-treatment Phase|Unstable MR|1|||
143451306|NCT01743989|517196371|FG001|Re-treatment Phase|Unstable MR|0|||
143451307|NCT01743989|517196372|FG002|Re-treatment Phase|Unstable MR|0|||
143451308|NCT01743989|517196370|FG000|Re-treatment Phase|Physician Decision|0|||
143451309|NCT01743989|517196371|FG001|Re-treatment Phase|Physician Decision|1|||
143451310|NCT01743989|517196372|FG002|Re-treatment Phase|Physician Decision|0|||
143451311|NCT01743989|517196370|FG000|Re-treatment Phase|Lost to Follow-up|0|||
143451312|NCT01743989|517196371|FG001|Re-treatment Phase|Lost to Follow-up|1|||
143451313|NCT01743989|517196372|FG002|Re-treatment Phase|Lost to Follow-up|0|||
143451314|NCT04655027|517196379|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
143451315|NCT04655027|517196380|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
143451316|NCT00653523|517196381|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
143451317|NCT00653523|517196381|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
143451318|NCT00653523|517196381|FG000|Overall Study|Adverse Event|7|||
143451319|NCT00653523|517196381|FG000|Overall Study|Withdrawal by Subject|6|||
143451320|NCT00653523|517196381|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
143451321|NCT00653523|517196381|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
143451322|NCT05543707|517196384|FG000|Overall Study|Study drug non-compliance/|5|||
143451323|NCT05543707|517196385|FG001|Overall Study|Study drug non-compliance/|0|||
143451324|NCT05543707|517196384|FG000|Overall Study|Withdrawal by Subject|1|||
143451325|NCT05543707|517196385|FG001|Overall Study|Withdrawal by Subject|1|||
143451326|NCT05543707|517196384|FG000|Overall Study|Adverse Event|1|||
143451327|NCT05543707|517196385|FG001|Overall Study|Adverse Event|0|||
143451328|NCT05543707|517196384|FG000|Overall Study|concurrent illness|0|||
143451329|NCT05543707|517196385|FG001|Overall Study|concurrent illness|1|||
143451330|NCT05543707|517196384|FG000|Overall Study|Pregnancy|1|||
143451331|NCT05543707|517196385|FG001|Overall Study|Pregnancy|1|||
143451332|NCT00186888|517196386|FG000|Overall Study|Toxicity|0|||
143451333|NCT00186888|517196387|FG001|Overall Study|Toxicity|1|||
143451334|NCT00186888|517196388|FG002|Overall Study|Toxicity|0|||
143451335|NCT00186888|517196386|FG000|Overall Study|Relapse or progression of disease|4|||
143451336|NCT00186888|517196387|FG001|Overall Study|Relapse or progression of disease|2|||
143451337|NCT00186888|517196388|FG002|Overall Study|Relapse or progression of disease|0|||
143451338|NCT02425904|517196389|FG000|Overall Study|Lost to Follow-up|1|||
143451339|NCT02425904|517196390|FG001|Overall Study|Lost to Follow-up|0|||
143451340|NCT02425904|517196389|FG000|Overall Study|Withdrawal by Subject|2|||
143451341|NCT02425904|517196390|FG001|Overall Study|Withdrawal by Subject|0|||
143451342|NCT02425904|517196389|FG000|Overall Study|Death|0|||
143451343|NCT02425904|517196390|FG001|Overall Study|Death|3|||
143451344|NCT02108964|517196391|FG000|Overall Study|Progressive disease|15|||
143451345|NCT02108964|517196392|FG001|Overall Study|Progressive disease|31|||
143451346|NCT02108964|517196393|FG002|Overall Study|Progressive disease|54|||
143451347|NCT02108964|517196394|FG003|Overall Study|Progressive disease|7|||
143451348|NCT02108964|517196395|FG004|Overall Study|Progressive disease|20|||
143451349|NCT02108964|517196396|FG005|Overall Study|Progressive disease|4|||
143451350|NCT02108964|517196397|FG006|Overall Study|Progressive disease|6|||
143451351|NCT02108964|517196398|FG007|Overall Study|Progressive disease|33|||
143451352|NCT02108964|517196391|FG000|Overall Study|Physician Decision|1|||
143451353|NCT02108964|517196392|FG001|Overall Study|Physician Decision|5|||
143451354|NCT02108964|517196393|FG002|Overall Study|Physician Decision|7|||
143451355|NCT02108964|517196394|FG003|Overall Study|Physician Decision|1|||
143451356|NCT02108964|517196395|FG004|Overall Study|Physician Decision|2|||
143451357|NCT02108964|517196396|FG005|Overall Study|Physician Decision|1|||
143451358|NCT02108964|517196397|FG006|Overall Study|Physician Decision|1|||
143451359|NCT02108964|517196398|FG007|Overall Study|Physician Decision|3|||
143451360|NCT02108964|517196391|FG000|Overall Study|Adverse Event|0|||
143451361|NCT02108964|517196392|FG001|Overall Study|Adverse Event|0|||
143451362|NCT02108964|517196393|FG002|Overall Study|Adverse Event|4|||
143451363|NCT02108964|517196394|FG003|Overall Study|Adverse Event|0|||
143451364|NCT02108964|517196395|FG004|Overall Study|Adverse Event|1|||
143451365|NCT02108964|517196396|FG005|Overall Study|Adverse Event|0|||
143451366|NCT02108964|517196397|FG006|Overall Study|Adverse Event|3|||
143451367|NCT02108964|517196398|FG007|Overall Study|Adverse Event|2|||
143451368|NCT02108964|517196391|FG000|Overall Study|Death|1|||
143451369|NCT02108964|517196392|FG001|Overall Study|Death|1|||
143451370|NCT02108964|517196393|FG002|Overall Study|Death|4|||
143451371|NCT02108964|517196394|FG003|Overall Study|Death|0|||
143451372|NCT02108964|517196395|FG004|Overall Study|Death|3|||
143451373|NCT02108964|517196396|FG005|Overall Study|Death|0|||
143451374|NCT02108964|517196397|FG006|Overall Study|Death|0|||
143451375|NCT02108964|517196398|FG007|Overall Study|Death|2|||
143451376|NCT02108964|517196391|FG000|Overall Study|Subject/Guardian decision|0|||
143451377|NCT02108964|517196392|FG001|Overall Study|Subject/Guardian decision|1|||
143451378|NCT02108964|517196393|FG002|Overall Study|Subject/Guardian decision|4|||
143451379|NCT02108964|517196394|FG003|Overall Study|Subject/Guardian decision|0|||
143451380|NCT02108964|517196395|FG004|Overall Study|Subject/Guardian decision|2|||
143451381|NCT02108964|517196396|FG005|Overall Study|Subject/Guardian decision|0|||
143451382|NCT02108964|517196397|FG006|Overall Study|Subject/Guardian decision|1|||
143451383|NCT02108964|517196398|FG007|Overall Study|Subject/Guardian decision|2|||
143451384|NCT02108964|517196391|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
143451385|NCT02108964|517196392|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
143451386|NCT02108964|517196393|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
143451387|NCT02108964|517196394|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
143451388|NCT02108964|517196395|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
143451389|NCT02108964|517196396|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
143451390|NCT02108964|517196397|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
143451391|NCT02108964|517196398|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
143451392|NCT03006848|517196399|FG000|Overall Study|Adverse Event|1|||
143451393|NCT03006848|517196399|FG000|Overall Study|Physician Decision|1|||
143451394|NCT03006848|517196399|FG000|Overall Study|Lack of Efficacy|16|||
143451395|NCT05384938|517196400|FG000|Overall Study|Withdrawal by Subject|8|||
143451396|NCT05384938|517196400|FG000|Overall Study|Lost to Follow-up|6|||
143451397|NCT05384938|517196400|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
143451398|NCT04696653|517196401|FG000|Overall Study|left organization|18|||
143451399|NCT04696653|517196401|FG000|Overall Study|Lost to Follow-up|3|||
143451400|NCT04500769|517198803|FG000|Overall Study|Withdrawal by Subject|5|||
143451401|NCT03843554|517198804|FG000|Overall Study|Physician Decision|0|||
143451402|NCT03843554|517198805|FG001|Overall Study|Physician Decision|2|||
143451403|NCT01099215|517198806|FG000|Overall Study|Withdrawal by Subject|1|||
143451404|NCT01099215|517198807|FG001|Overall Study|Withdrawal by Subject|0|||
143451405|NCT01099215|517198806|FG000|Overall Study|Adverse Event|0|||
143451406|NCT01099215|517198807|FG001|Overall Study|Adverse Event|1|||
143451407|NCT02218606|517198808|FG000|Overall Study|Adverse Event|1|||
143451408|NCT02218606|517198809|FG001|Overall Study|Adverse Event|1|||
143451409|NCT02218606|517198808|FG000|Overall Study|Death|15|||
143451410|NCT02218606|517198809|FG001|Overall Study|Death|28|||
143451411|NCT02218606|517198808|FG000|Overall Study|Physician Decision|0|||
143451412|NCT02218606|517198809|FG001|Overall Study|Physician Decision|1|||
143451413|NCT02218606|517198808|FG000|Overall Study|Withdrawal by Subject|4|||
143451414|NCT02218606|517198809|FG001|Overall Study|Withdrawal by Subject|0|||
143451415|NCT02218606|517198808|FG000|Overall Study|Noncompliance|1|||
143451416|NCT02218606|517198809|FG001|Overall Study|Noncompliance|0|||
143451417|NCT02218606|517198808|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
143451418|NCT02218606|517198809|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
143451419|NCT02218606|517198808|FG000|Overall Study|Other|2|||
143451420|NCT02218606|517198809|FG001|Overall Study|Other|1|||
143451421|NCT02218606|517198808|FG000|Overall Study|Never started treatment|0|||
143451422|NCT02218606|517198809|FG001|Overall Study|Never started treatment|1|||
143451423|NCT03203473|517198810|FG000|Induction Phase|Never started primary treatment|2|||
143451424|NCT03203473|517198811|FG001|Induction Phase|Never started primary treatment|0|||
143451425|NCT03203473|517198812|FG002|Induction Phase|Never started primary treatment|0|||
143451426|NCT03203473|517198810|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
143451427|NCT03203473|517198811|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
143451428|NCT03203473|517198812|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
143451429|NCT03203473|517198810|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
143451430|NCT03203473|517198811|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
143451431|NCT03203473|517198812|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
143451432|NCT03203473|517198810|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
143451433|NCT03203473|517198811|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
143451434|NCT03203473|517198812|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
143451435|NCT03203473|517198810|FG000|Arm Allocation Phase|started salvage therapy|0|||
143451436|NCT03203473|517198811|FG001|Arm Allocation Phase|started salvage therapy|5|||
143451437|NCT03203473|517198812|FG002|Arm Allocation Phase|started salvage therapy|0|||
143451438|NCT03203473|517198810|FG000|Arm Allocation Phase|Disease progression|0|||
143451439|NCT03203473|517198811|FG001|Arm Allocation Phase|Disease progression|0|||
143451440|NCT03203473|517198812|FG002|Arm Allocation Phase|Disease progression|37|||
143451441|NCT03203473|517198810|FG000|Arm Allocation Phase|Adverse Event|0|||
143451442|NCT03203473|517198811|FG001|Arm Allocation Phase|Adverse Event|0|||
143451443|NCT03203473|517198812|FG002|Arm Allocation Phase|Adverse Event|11|||
143451444|NCT03203473|517198810|FG000|Arm Allocation Phase|Physician Decision|0|||
143451445|NCT03203473|517198811|FG001|Arm Allocation Phase|Physician Decision|0|||
143451446|NCT03203473|517198812|FG002|Arm Allocation Phase|Physician Decision|3|||
143451447|NCT03203473|517198810|FG000|Arm Allocation Phase|Death|0|||
143451448|NCT03203473|517198811|FG001|Arm Allocation Phase|Death|0|||
143451449|NCT03203473|517198812|FG002|Arm Allocation Phase|Death|1|||
143451450|NCT03203473|517198810|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
143451451|NCT03203473|517198811|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
143451452|NCT03203473|517198812|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
143451453|NCT03203473|517198810|FG000|Arm Allocation Phase|Intercurrent illness|0|||
143451454|NCT03203473|517198811|FG001|Arm Allocation Phase|Intercurrent illness|0|||
143451455|NCT03203473|517198812|FG002|Arm Allocation Phase|Intercurrent illness|1|||
143451456|NCT03203473|517198810|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
143451457|NCT03203473|517198811|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
143451458|NCT03203473|517198812|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
143451459|NCT02314780|517198819|FG000|Overall Study|organizational reasons|0|||
143451460|NCT02314780|517198820|FG001|Overall Study|organizational reasons|2|||
143451461|NCT02314780|517198821|FG002|Overall Study|organizational reasons|0|||
143451462|NCT02314780|517198819|FG000|Overall Study|Adverse Event|0|||
143451463|NCT02314780|517198820|FG001|Overall Study|Adverse Event|1|||
143451464|NCT02314780|517198821|FG002|Overall Study|Adverse Event|0|||
143451465|NCT01077271|517198822|FG000|Overall Study|Parental desire|8|||
143451466|NCT01077271|517198822|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
143451467|NCT01077271|517198822|FG000|Overall Study|Noncompliance|2|||
143451468|NCT01077271|517198822|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
143451469|NCT01077271|517198822|FG000|Overall Study|Changed doctors|2|||
143451470|NCT01077271|517198822|FG000|Overall Study|Parents thought too many injections|2|||
143451471|NCT01077271|517198822|FG000|Overall Study|End of RSV season nearly reached|1|||
143451472|NCT01077271|517198822|FG000|Overall Study|Mother unconvinced of the necessity|1|||
143451473|NCT00215137|517198823|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
143451474|NCT00215137|517198824|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
143451475|NCT00215137|517198825|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
143451476|NCT00215137|517198823|FG000|Randomization Period|Lost to Follow-up|0|||
143451477|NCT00215137|517198824|FG001|Randomization Period|Lost to Follow-up|1|||
143451478|NCT00215137|517198825|FG002|Randomization Period|Lost to Follow-up|0|||
143451479|NCT00215137|517198823|FG000|Randomization Period|Withdrawal by Subject|0|||
143451480|NCT00215137|517198824|FG001|Randomization Period|Withdrawal by Subject|1|||
143451481|NCT00215137|517198825|FG002|Randomization Period|Withdrawal by Subject|0|||
143451482|NCT03333876|517198826|FG000|Screening Period|Screen Failure|4|||
143451483|NCT03333876|517198826|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
143451484|NCT03333876|517198826|FG000|Mandibular Advancement|Adverse Event|2|||
143451485|NCT03333876|517198826|FG000|Mandibular Advancement|Product Damage|2|||
143451486|NCT00095498|517198830|FG000|Overall Study|Physician Decision|9|||
143451487|NCT00095498|517198831|FG001|Overall Study|Physician Decision|10|||
143451488|NCT00095498|517198832|FG002|Overall Study|Physician Decision|8|||
143451489|NCT00095498|517198830|FG000|Overall Study|Adverse Event|1|||
143451490|NCT00095498|517198831|FG001|Overall Study|Adverse Event|0|||
143451491|NCT00095498|517198832|FG002|Overall Study|Adverse Event|1|||
143451492|NCT00095498|517198830|FG000|Overall Study|Withdrawal by Subject|15|||
143451493|NCT00095498|517198831|FG001|Overall Study|Withdrawal by Subject|16|||
143451494|NCT00095498|517198832|FG002|Overall Study|Withdrawal by Subject|15|||
143451495|NCT00095498|517198830|FG000|Overall Study|Disease progression|0|||
143451496|NCT00095498|517198831|FG001|Overall Study|Disease progression|1|||
143451497|NCT00095498|517198832|FG002|Overall Study|Disease progression|1|||
143451498|NCT00095498|517198830|FG000|Overall Study|Ineligibility determined|3|||
143451499|NCT00095498|517198831|FG001|Overall Study|Ineligibility determined|0|||
143451500|NCT00095498|517198832|FG002|Overall Study|Ineligibility determined|2|||
143451501|NCT00095498|517198830|FG000|Overall Study|Lost to Follow-up|1|||
143451502|NCT00095498|517198831|FG001|Overall Study|Lost to Follow-up|1|||
143451503|NCT00095498|517198832|FG002|Overall Study|Lost to Follow-up|2|||
143451504|NCT00095498|517198830|FG000|Overall Study|Noncompliance|1|||
143451505|NCT00095498|517198831|FG001|Overall Study|Noncompliance|0|||
143451506|NCT00095498|517198832|FG002|Overall Study|Noncompliance|1|||
143451507|NCT00095498|517198830|FG000|Overall Study|Other|6|||
143451508|NCT00095498|517198831|FG001|Overall Study|Other|7|||
143451509|NCT00095498|517198832|FG002|Overall Study|Other|6|||
143451510|NCT00095498|517198830|FG000|Overall Study|Protocol Violation|0|||
143451511|NCT00095498|517198831|FG001|Overall Study|Protocol Violation|0|||
143451512|NCT00095498|517198832|FG002|Overall Study|Protocol Violation|1|||
143451513|NCT00095498|517198830|FG000|Overall Study|Requirement for alternative therapy|1|||
143451514|NCT00095498|517198831|FG001|Overall Study|Requirement for alternative therapy|0|||
143451515|NCT00095498|517198832|FG002|Overall Study|Requirement for alternative therapy|2|||
143451516|NCT04396366|517198833|FG000|Overall Study|Adverse Event|1|||
143451517|NCT04396366|517198834|FG001|Overall Study|Adverse Event|0|||
143451518|NCT00166712|517198836|FG000|Overall Study|Death|0|||
143451519|NCT00166712|517198837|FG001|Overall Study|Death|1|||
143451520|NCT00166712|517198836|FG000|Overall Study|Adverse Event|1|||
143451521|NCT00166712|517198837|FG001|Overall Study|Adverse Event|0|||
143451522|NCT00166712|517198836|FG000|Overall Study|Withdrawal by Subject|1|||
143451523|NCT00166712|517198837|FG001|Overall Study|Withdrawal by Subject|2|||
143451524|NCT00166712|517198836|FG000|Overall Study|Physician Decision|0|||
143451525|NCT00166712|517198837|FG001|Overall Study|Physician Decision|2|||
143451526|NCT04684394|517198838|FG000|Overall Study|Death|1|||
143451527|NCT04684394|517198839|FG001|Overall Study|Death|2|||
143451528|NCT04684394|517198838|FG000|Overall Study|Lost to Follow-up|1|||
143451529|NCT04684394|517198839|FG001|Overall Study|Lost to Follow-up|0|||
143451530|NCT04684394|517198838|FG000|Overall Study|Withdrawal by Subject|2|||
143451531|NCT04684394|517198839|FG001|Overall Study|Withdrawal by Subject|0|||
143451532|NCT04684394|517198838|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
143451533|NCT04684394|517198839|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
143451534|NCT00306670|517198841|FG000|Overall Study|patients recruited; Genentech, the st|0|||
143451535|NCT00306670|517198842|FG001|Overall Study|patients recruited; Genentech, the st|2|||
143451536|NCT04476251|517198846|FG000|Overall Study|Not treated|1|||
143451537|NCT00297427|517198854|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
143451538|NCT00297427|517198855|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
143451539|NCT00297427|517198854|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
143451540|NCT00297427|517198855|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
143451541|NCT00297427|517198854|FG000|Phase 1: Initial Intervention|Death|0|||
143451542|NCT00297427|517198855|FG001|Phase 1: Initial Intervention|Death|1|||
143451543|NCT00297427|517198854|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
143451544|NCT00297427|517198855|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
143451545|NCT00297427|517198854|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
143451546|NCT00297427|517198855|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
143451547|NCT00297427|517198854|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
143451548|NCT00297427|517198855|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
143451549|NCT00297427|517198854|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
143451550|NCT00297427|517198855|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
143451551|NCT00297427|517198854|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
143451552|NCT00297427|517198855|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
143451553|NCT01127893|517198856|FG000|Overall Study|Study Termination by the Sponsor|1|||
143451554|NCT01470001|517198857|FG000|Overall Study|Lost to Follow-up|1|||
143451555|NCT01470001|517198858|FG001|Overall Study|Lost to Follow-up|1|||
143451556|NCT01470001|517198857|FG000|Overall Study|Physician Decision|2|||
143451557|NCT01470001|517198858|FG001|Overall Study|Physician Decision|0|||
143451558|NCT01470001|517198857|FG000|Overall Study|Withdrawal by Subject|2|||
143451559|NCT01470001|517198858|FG001|Overall Study|Withdrawal by Subject|1|||
143451560|NCT01895101|517198859|FG000|Overall Study|OPCAB procedure|1|||
143451561|NCT01895101|517198860|FG001|Overall Study|OPCAB procedure|1|||
143451562|NCT01895101|517198861|FG002|Overall Study|OPCAB procedure|3|||
143451563|NCT01895101|517198859|FG000|Overall Study|Withdrawal by Subject|0|||
143451564|NCT01895101|517198860|FG001|Overall Study|Withdrawal by Subject|1|||
143451565|NCT01895101|517198861|FG002|Overall Study|Withdrawal by Subject|2|||
143451566|NCT01895101|517198859|FG000|Overall Study|another study, enrolled in other study|0|||
143451567|NCT01895101|517198860|FG001|Overall Study|another study, enrolled in other study|1|||
143451568|NCT01895101|517198861|FG002|Overall Study|another study, enrolled in other study|0|||
143451569|NCT01895101|517198859|FG000|Overall Study|Death|0|||
143451570|NCT01895101|517198860|FG001|Overall Study|Death|1|||
143451571|NCT01895101|517198861|FG002|Overall Study|Death|0|||
143451572|NCT01895101|517198859|FG000|Overall Study|coagulation disorder|0|||
143451573|NCT01895101|517198860|FG001|Overall Study|coagulation disorder|1|||
143451574|NCT01895101|517198861|FG002|Overall Study|coagulation disorder|0|||
143451575|NCT03339583|517198864|FG000|First Intervention (14 Days)|Adverse Event|1|||
143451576|NCT03339583|517198865|FG001|First Intervention (14 Days)|Adverse Event|0|||
143451577|NCT03339583|517198864|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
143451578|NCT03339583|517198865|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
143451579|NCT03339583|517198864|FG000|Second Intervention (14 Days)|Adverse Event|0|||
143451580|NCT03339583|517198865|FG001|Second Intervention (14 Days)|Adverse Event|1|||
143451581|NCT03339583|517198864|FG000|Follow-up (14 Days)|Physician Decision|6|||
143451582|NCT03339583|517198865|FG001|Follow-up (14 Days)|Physician Decision|3|||
143451583|NCT02182947|517198866|FG000|Overall Study|Withdrawal by Subject|7|||
143451584|NCT02182947|517198866|FG000|Overall Study|Lost to Follow-up|3|||
143451585|NCT02182947|517198866|FG000|Overall Study|Failed screening activities|8|||
143451586|NCT00730275|517198867|FG000|Overall Study|Withdrawal by Subject|0|||
143451587|NCT00730275|517198868|FG001|Overall Study|Withdrawal by Subject|0|||
143451588|NCT00730275|517198869|FG002|Overall Study|Withdrawal by Subject|0|||
143451589|NCT00730275|517198870|FG003|Overall Study|Withdrawal by Subject|1|||
143451590|NCT03921723|517198871|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
143451591|NCT03921723|517198871|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
143451592|NCT01461811|517198872|FG000|Overall Study|Adverse Event|2|||
143451593|NCT01461811|517198873|FG001|Overall Study|Adverse Event|1|||
143451594|NCT01461811|517198872|FG000|Overall Study|Subject decision unrelated to an AE|1|||
143451595|NCT01461811|517198873|FG001|Overall Study|Subject decision unrelated to an AE|1|||
143451596|NCT01461811|517198872|FG000|Overall Study|Noncompliance|1|||
143451597|NCT01461811|517198873|FG001|Overall Study|Noncompliance|1|||
143451598|NCT00338962|517198874|FG000|Overall Study|Lost to Follow-up|3|||
143451599|NCT00338962|517198875|FG001|Overall Study|Lost to Follow-up|3|||
143451600|NCT00338962|517198876|FG002|Overall Study|Lost to Follow-up|2|||
143451601|NCT00338962|517198877|FG003|Overall Study|Lost to Follow-up|3|||
143451602|NCT00338962|517198874|FG000|Overall Study|Withdrawal by Subject|1|||
143451603|NCT00338962|517198875|FG001|Overall Study|Withdrawal by Subject|0|||
143451604|NCT00338962|517198876|FG002|Overall Study|Withdrawal by Subject|0|||
143451605|NCT00338962|517198877|FG003|Overall Study|Withdrawal by Subject|0|||
143451606|NCT00338962|517198874|FG000|Overall Study|No Transportation|2|||
143451607|NCT00338962|517198875|FG001|Overall Study|No Transportation|0|||
143451608|NCT00338962|517198876|FG002|Overall Study|No Transportation|0|||
143451609|NCT00338962|517198877|FG003|Overall Study|No Transportation|0|||
143451610|NCT00338962|517198874|FG000|Overall Study|Time Constraint|2|||
143451611|NCT00338962|517198875|FG001|Overall Study|Time Constraint|0|||
143451612|NCT00338962|517198876|FG002|Overall Study|Time Constraint|0|||
143451613|NCT00338962|517198877|FG003|Overall Study|Time Constraint|0|||
143451614|NCT00338962|517198874|FG000|Overall Study|Moved|0|||
143451615|NCT00338962|517198875|FG001|Overall Study|Moved|1|||
143451616|NCT00338962|517198876|FG002|Overall Study|Moved|0|||
143451617|NCT00338962|517198877|FG003|Overall Study|Moved|0|||
143451618|NCT00338962|517198874|FG000|Overall Study|Adverse Event|0|||
143451619|NCT00338962|517198875|FG001|Overall Study|Adverse Event|0|||
143451620|NCT00338962|517198876|FG002|Overall Study|Adverse Event|2|||
143451621|NCT00338962|517198877|FG003|Overall Study|Adverse Event|0|||
143451622|NCT00338962|517198874|FG000|Overall Study|Poor Compliance|0|||
143451623|NCT00338962|517198875|FG001|Overall Study|Poor Compliance|0|||
143451624|NCT00338962|517198876|FG002|Overall Study|Poor Compliance|2|||
143451625|NCT00338962|517198877|FG003|Overall Study|Poor Compliance|0|||
143451626|NCT03733314|517198878|FG000|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|2|||
143451627|NCT03733314|517198879|FG001|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|0|||
143451628|NCT03733314|517198878|FG000|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|1|||
143451629|NCT03733314|517198879|FG001|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|2|||
143451630|NCT03733314|517198878|FG000|Rescue Period: (Weeks 12 to 24)|Progressive disease|0|||
143451631|NCT03733314|517198879|FG001|Rescue Period: (Weeks 12 to 24)|Progressive disease|2|||
143451632|NCT03733314|517198878|FG000|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
143451633|NCT03733314|517198879|FG001|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
143451634|NCT03733314|517198878|FG000|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|1|||
143451635|NCT03733314|517198879|FG001|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|0|||
143451636|NCT03733314|517198878|FG000|Extension Period:(Week 12-52/Week 24-64)|Other|3|||
143451637|NCT03733314|517198879|FG001|Extension Period:(Week 12-52/Week 24-64)|Other|2|||
143451638|NCT03214640|517198880|FG000|Overall Study|Protocol Violation|1|||
143451639|NCT03214640|517198881|FG001|Overall Study|Protocol Violation|2|||
143451640|NCT03214640|517198882|FG002|Overall Study|Protocol Violation|1|||
143451641|NCT03214640|517198883|FG003|Overall Study|Protocol Violation|4|||
143451642|NCT00406692|517198884|FG000|Overall Study|Withdrawal by Subject|4|||
143451643|NCT00406692|517198884|FG000|Overall Study|Physician Decision|1|||
143451644|NCT00406692|517198884|FG000|Overall Study|Adverse Event|1|||
143451645|NCT00406692|517198884|FG000|Overall Study|Lack of Efficacy|1|||
143451646|NCT00635661|517198896|FG000|Overall Study|Withdrawal by Subject|4|||
143451647|NCT01641159|517198904|FG000|Overall Study|Lost to Follow-up|2|||
143451648|NCT01641159|517198905|FG001|Overall Study|Lost to Follow-up|1|||
143451649|NCT01641159|517198904|FG000|Overall Study|Withdrawal by Subject|0|||
143451650|NCT01641159|517198905|FG001|Overall Study|Withdrawal by Subject|1|||
143451651|NCT05330676|517198908|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
143451652|NCT05330676|517198909|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
143451653|NCT02229851|517198912|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
143451654|NCT02229851|517198913|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
143451655|NCT02229851|517198914|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
143451656|NCT02229851|517198915|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
143451657|NCT02229851|517198916|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
143451658|NCT02229851|517198917|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
143451659|NCT02229851|517198918|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
143451660|NCT02229851|517198912|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
143451661|NCT02229851|517198913|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
143451662|NCT02229851|517198914|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
143451663|NCT02229851|517198915|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
143451664|NCT02229851|517198916|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
143451665|NCT02229851|517198917|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
143451666|NCT02229851|517198918|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
143451667|NCT02229851|517198912|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
143451668|NCT02229851|517198913|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
143451669|NCT02229851|517198914|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
143451670|NCT02229851|517198915|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
143451671|NCT02229851|517198916|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
143451672|NCT02229851|517198917|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
143451673|NCT02229851|517198918|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
143451674|NCT02229851|517198912|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
143451675|NCT02229851|517198913|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
143451676|NCT02229851|517198914|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
143451677|NCT02229851|517198915|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
143451678|NCT02229851|517198916|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
143451679|NCT02229851|517198917|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
143451680|NCT02229851|517198918|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
143451681|NCT02229851|517198912|FG000|Main Phase (Double-blind Phase)|Death|1|||
143451682|NCT02229851|517198913|FG001|Main Phase (Double-blind Phase)|Death|1|||
143451683|NCT02229851|517198914|FG002|Main Phase (Double-blind Phase)|Death|0|||
143451684|NCT02229851|517198915|FG003|Main Phase (Double-blind Phase)|Death|0|||
143451685|NCT02229851|517198916|FG004|Main Phase (Double-blind Phase)|Death|0|||
143451686|NCT02229851|517198917|FG005|Main Phase (Double-blind Phase)|Death|0|||
143451687|NCT02229851|517198918|FG006|Main Phase (Double-blind Phase)|Death|0|||
143451688|NCT02229851|517198912|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
143451689|NCT02229851|517198913|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
143451690|NCT02229851|517198914|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
143451691|NCT02229851|517198915|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
143451692|NCT02229851|517198916|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
143451693|NCT02229851|517198917|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
143451694|NCT02229851|517198918|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
143451695|NCT02229851|517198912|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
143451696|NCT02229851|517198913|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
143451697|NCT02229851|517198914|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
143451698|NCT02229851|517198915|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
143451699|NCT02229851|517198916|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
143451700|NCT02229851|517198917|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
143451701|NCT02229851|517198918|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
143451702|NCT02229851|517198912|FG000|Extension Phase (Open-label Phase)|Death|0|||
143451703|NCT02229851|517198913|FG001|Extension Phase (Open-label Phase)|Death|0|||
143451704|NCT02229851|517198914|FG002|Extension Phase (Open-label Phase)|Death|0|||
143451705|NCT02229851|517198915|FG003|Extension Phase (Open-label Phase)|Death|1|||
143451706|NCT02229851|517198916|FG004|Extension Phase (Open-label Phase)|Death|0|||
143451707|NCT02229851|517198917|FG005|Extension Phase (Open-label Phase)|Death|1|||
143451708|NCT02229851|517198918|FG006|Extension Phase (Open-label Phase)|Death|1|||
143451709|NCT03541200|517198919|FG000|Overall Study|Adverse Event|19|||
143451710|NCT03541200|517198919|FG000|Overall Study|Death|1|||
143451711|NCT03541200|517198919|FG000|Overall Study|Lost to Follow-up|10|||
143451712|NCT03541200|517198919|FG000|Overall Study|Physician Decision|1|||
143451713|NCT03541200|517198919|FG000|Overall Study|Protocol Violation|51|||
143451714|NCT03541200|517198919|FG000|Overall Study|Withdrawal by Subject|23|||
143451715|NCT03541200|517198919|FG000|Overall Study|other|8|||
143451716|NCT01607476|517198922|FG000|Overall Study|Withdrawal by Subject|1|||
143451717|NCT01607476|517198923|FG001|Overall Study|Withdrawal by Subject|0|||
143451718|NCT01607476|517198924|FG002|Overall Study|Withdrawal by Subject|1|||
143451719|NCT01607476|517198922|FG000|Overall Study|Lost to Follow-up|0|||
143451720|NCT01607476|517198923|FG001|Overall Study|Lost to Follow-up|0|||
143451721|NCT01607476|517198924|FG002|Overall Study|Lost to Follow-up|2|||
143451722|NCT04445987|517198925|FG000|Overall Study|Adverse Event|0|||
143451723|NCT04445987|517198926|FG001|Overall Study|Adverse Event|0|||
143451724|NCT04445987|517198927|FG002|Overall Study|Adverse Event|1|||
143451725|NCT04445987|517198928|FG003|Overall Study|Adverse Event|0|||
143451726|NCT04445987|517198929|FG004|Overall Study|Adverse Event|4|||
143451727|NCT04445987|517198930|FG005|Overall Study|Adverse Event|0|||
143451728|NCT04445987|517198925|FG000|Overall Study|Lost to Follow-up|4|||
143451729|NCT04445987|517198926|FG001|Overall Study|Lost to Follow-up|3|||
143451730|NCT04445987|517198927|FG002|Overall Study|Lost to Follow-up|1|||
143451731|NCT04445987|517198928|FG003|Overall Study|Lost to Follow-up|1|||
143451732|NCT04445987|517198929|FG004|Overall Study|Lost to Follow-up|29|||
143451733|NCT04445987|517198930|FG005|Overall Study|Lost to Follow-up|0|||
143451734|NCT04445987|517198925|FG000|Overall Study|Physician Decision|0|||
143451735|NCT04445987|517198926|FG001|Overall Study|Physician Decision|0|||
143451736|NCT04445987|517198927|FG002|Overall Study|Physician Decision|0|||
143451737|NCT04445987|517198928|FG003|Overall Study|Physician Decision|0|||
143451738|NCT04445987|517198929|FG004|Overall Study|Physician Decision|1|||
143451739|NCT04445987|517198930|FG005|Overall Study|Physician Decision|0|||
143451740|NCT04445987|517198925|FG000|Overall Study|Protocol Violation|1|||
143451741|NCT04445987|517198926|FG001|Overall Study|Protocol Violation|0|||
143451742|NCT04445987|517198927|FG002|Overall Study|Protocol Violation|0|||
143451743|NCT04445987|517198928|FG003|Overall Study|Protocol Violation|0|||
143451744|NCT04445987|517198929|FG004|Overall Study|Protocol Violation|2|||
143451745|NCT04445987|517198930|FG005|Overall Study|Protocol Violation|0|||
143451746|NCT04445987|517198925|FG000|Overall Study|Withdrawal by Subject|4|||
143451747|NCT04445987|517198926|FG001|Overall Study|Withdrawal by Subject|0|||
143451748|NCT04445987|517198927|FG002|Overall Study|Withdrawal by Subject|1|||
143451749|NCT04445987|517198928|FG003|Overall Study|Withdrawal by Subject|0|||
143451750|NCT04445987|517198929|FG004|Overall Study|Withdrawal by Subject|18|||
143451751|NCT04445987|517198930|FG005|Overall Study|Withdrawal by Subject|1|||
143451752|NCT04445987|517198925|FG000|Overall Study|Other reason|0|||
143451753|NCT04445987|517198926|FG001|Overall Study|Other reason|0|||
143451754|NCT04445987|517198927|FG002|Overall Study|Other reason|1|||
143451755|NCT04445987|517198928|FG003|Overall Study|Other reason|0|||
143451756|NCT04445987|517198929|FG004|Overall Study|Other reason|2|||
143451757|NCT04445987|517198930|FG005|Overall Study|Other reason|0|||
143451758|NCT02001064|517198933|FG000|Overall Study|Withdrawal by Subject|2|||
143451759|NCT02001064|517198934|FG001|Overall Study|Withdrawal by Subject|1|||
143451760|NCT05148962|517198935|FG000|Overall Study|Withdrawal by Subject|1|||
143451761|NCT05148962|517198936|FG001|Overall Study|Withdrawal by Subject|1|||
143451762|NCT05148962|517198937|FG002|Overall Study|Withdrawal by Subject|0|||
143451763|NCT05148962|517198938|FG003|Overall Study|Withdrawal by Subject|1|||
143451764|NCT05148962|517198939|FG004|Overall Study|Withdrawal by Subject|0|||
143451765|NCT05148962|517198935|FG000|Overall Study|Participant was early terminated per protocol|0|||
143451766|NCT05148962|517198936|FG001|Overall Study|Participant was early terminated per protocol|0|||
143451767|NCT05148962|517198937|FG002|Overall Study|Participant was early terminated per protocol|3|||
143451768|NCT05148962|517198938|FG003|Overall Study|Participant was early terminated per protocol|5|||
143451769|NCT05148962|517198939|FG004|Overall Study|Participant was early terminated per protocol|2|||
143451770|NCT05148962|517198935|FG000|Overall Study|Miscellaneous|0|||
143451771|NCT05148962|517198936|FG001|Overall Study|Miscellaneous|0|||
143451772|NCT05148962|517198937|FG002|Overall Study|Miscellaneous|0|||
143451773|NCT05148962|517198938|FG003|Overall Study|Miscellaneous|1|||
143451774|NCT05148962|517198939|FG004|Overall Study|Miscellaneous|0|||
143451775|NCT01525238|517198941|FG000|Overall Study|Withdrawal by Subject|1|||
143451776|NCT01525238|517198942|FG001|Overall Study|Withdrawal by Subject|0|||
143451777|NCT01525238|517198943|FG002|Overall Study|Withdrawal by Subject|0|||
143451778|NCT01732822|517200799|FG000|Overall Study|Withdrawal by Subject|123|||
143451779|NCT01732822|517200800|FG001|Overall Study|Withdrawal by Subject|113|||
143451780|NCT05020327|517200804|FG000|Overall Study|Physician Decision|3|||
143451781|NCT05020327|517200805|FG001|Overall Study|Physician Decision|0|||
143451782|NCT05020327|517200806|FG002|Overall Study|Physician Decision|0|||
143451783|NCT05020327|517200804|FG000|Overall Study|Withdrawal by Subject|1|||
143451784|NCT05020327|517200805|FG001|Overall Study|Withdrawal by Subject|1|||
143451785|NCT05020327|517200806|FG002|Overall Study|Withdrawal by Subject|0|||
143451786|NCT05020327|517200804|FG000|Overall Study|personal/cultural, ineligible|12|||
143451787|NCT05020327|517200805|FG001|Overall Study|personal/cultural, ineligible|0|||
143451788|NCT05020327|517200806|FG002|Overall Study|personal/cultural, ineligible|0|||
143451789|NCT00503139|517200810|FG000|Overall Study|Case Report Forms were not collected|4|||
143451790|NCT00503139|517200810|FG000|Overall Study|Protocol Violation|4|||
143451791|NCT00833833|517200811|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
143451792|NCT00833833|517200812|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
143451793|NCT00833833|517200813|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
143451794|NCT00833833|517200814|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
143451795|NCT00833833|517200815|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
143451796|NCT00833833|517200816|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
143451797|NCT00833833|517200811|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
143451798|NCT00833833|517200812|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
143451799|NCT00833833|517200813|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
143451800|NCT00833833|517200814|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
143451801|NCT00833833|517200815|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
143451802|NCT00833833|517200816|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
143451803|NCT00833833|517200811|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
143451804|NCT00833833|517200812|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
143451805|NCT00833833|517200813|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
143451806|NCT00833833|517200814|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
143451807|NCT00833833|517200815|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
143451808|NCT00833833|517200816|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
143451809|NCT00833833|517200811|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
143451810|NCT00833833|517200812|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
143451811|NCT00833833|517200813|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
143451812|NCT00833833|517200814|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
143451813|NCT00833833|517200815|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
143451814|NCT00833833|517200816|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
143451815|NCT00833833|517200811|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
143451816|NCT00833833|517200812|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
143451817|NCT00833833|517200813|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
143451818|NCT00833833|517200814|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
143451819|NCT00833833|517200815|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
143451820|NCT00833833|517200816|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
143451821|NCT00833833|517200811|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
143451822|NCT00833833|517200812|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
143451823|NCT00833833|517200813|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
143451824|NCT00833833|517200814|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
143451825|NCT00833833|517200815|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
143451826|NCT00833833|517200816|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
143451827|NCT00833833|517200811|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
143451828|NCT00833833|517200812|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
143451829|NCT00833833|517200813|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
143451830|NCT00833833|517200814|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
143451831|NCT00833833|517200815|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
143451832|NCT00833833|517200816|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
143451833|NCT00833833|517200811|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
143451834|NCT00833833|517200812|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
143451835|NCT00833833|517200813|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
143451836|NCT00833833|517200814|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
143451837|NCT00833833|517200815|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
143451838|NCT00833833|517200816|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
143451839|NCT00833833|517200811|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
143451840|NCT00833833|517200812|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
143451841|NCT00833833|517200813|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
143451842|NCT00833833|517200814|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
143451843|NCT00833833|517200815|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
143451844|NCT00833833|517200816|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
143451845|NCT00833833|517200811|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
143451846|NCT00833833|517200812|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
143451847|NCT00833833|517200813|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
143451848|NCT00833833|517200814|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
143451849|NCT00833833|517200815|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
143451850|NCT00833833|517200816|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
143451851|NCT00833833|517200811|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
143451852|NCT00833833|517200812|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
143451853|NCT00833833|517200813|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
143451854|NCT00833833|517200814|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
143451855|NCT00833833|517200815|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
143451856|NCT00833833|517200816|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
143451857|NCT00833833|517200811|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
143451858|NCT00833833|517200812|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
143451859|NCT00833833|517200813|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
143451860|NCT00833833|517200814|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
143451861|NCT00833833|517200815|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
143451862|NCT00833833|517200816|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
143451863|NCT00833833|517200811|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
143451864|NCT00833833|517200812|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
143451865|NCT00833833|517200813|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
143451866|NCT00833833|517200814|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
143451867|NCT00833833|517200815|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
143451868|NCT00833833|517200816|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
143451869|NCT02040259|517200819|FG000|Overall Study|Death|280|||
143451870|NCT02040259|517200819|FG000|Overall Study|Lost to Follow-up|76|||
143451871|NCT02040259|517200819|FG000|Overall Study|Assessment not completed|3|||
143451872|NCT02040259|517200819|FG000|Overall Study|Withdrawal by Subject|4|||
143451873|NCT00316602|517200823|FG000|Overall Study|Withdrawal by Subject|3|||
143451874|NCT00316602|517200824|FG001|Overall Study|Withdrawal by Subject|2|||
143451875|NCT00316602|517200823|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
143451876|NCT00316602|517200824|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
143451877|NCT00316602|517200823|FG000|Overall Study|Adverse Event|1|||
143451878|NCT00316602|517200824|FG001|Overall Study|Adverse Event|0|||
143451879|NCT00316602|517200823|FG000|Overall Study|Other|3|||
143451880|NCT00316602|517200824|FG001|Overall Study|Other|6|||
143451881|NCT01142232|517200825|FG000|Overall Study|Adverse Event|1|||
143451882|NCT01142232|517200826|FG001|Overall Study|Adverse Event|2|||
143451883|NCT01142232|517200827|FG002|Overall Study|Adverse Event|1|||
143451884|NCT01142232|517200828|FG003|Overall Study|Adverse Event|0|||
143451885|NCT01142232|517200829|FG004|Overall Study|Adverse Event|4|||
143451886|NCT01142232|517200825|FG000|Overall Study|Death|0|||
143451887|NCT01142232|517200826|FG001|Overall Study|Death|0|||
143451888|NCT01142232|517200827|FG002|Overall Study|Death|0|||
143451889|NCT01142232|517200828|FG003|Overall Study|Death|0|||
143451890|NCT01142232|517200829|FG004|Overall Study|Death|1|||
143451891|NCT01142232|517200825|FG000|Overall Study|Disease Progression|2|||
143451892|NCT01142232|517200826|FG001|Overall Study|Disease Progression|0|||
143451893|NCT01142232|517200827|FG002|Overall Study|Disease Progression|1|||
143451894|NCT01142232|517200828|FG003|Overall Study|Disease Progression|2|||
143451895|NCT01142232|517200829|FG004|Overall Study|Disease Progression|12|||
143451896|NCT01142232|517200825|FG000|Overall Study|Withdrawal by Subject|0|||
143451897|NCT01142232|517200826|FG001|Overall Study|Withdrawal by Subject|0|||
143451898|NCT01142232|517200827|FG002|Overall Study|Withdrawal by Subject|0|||
143451899|NCT01142232|517200828|FG003|Overall Study|Withdrawal by Subject|1|||
143451900|NCT01142232|517200829|FG004|Overall Study|Withdrawal by Subject|3|||
143451901|NCT01142232|517200825|FG000|Overall Study|Physician Decision|0|||
143451902|NCT01142232|517200826|FG001|Overall Study|Physician Decision|1|||
143451903|NCT01142232|517200827|FG002|Overall Study|Physician Decision|0|||
143451904|NCT01142232|517200828|FG003|Overall Study|Physician Decision|2|||
143451905|NCT01142232|517200829|FG004|Overall Study|Physician Decision|10|||
143451906|NCT01142232|517200825|FG000|Overall Study|Alternative Therapy|0|||
143451907|NCT01142232|517200826|FG001|Overall Study|Alternative Therapy|1|||
143451908|NCT01142232|517200827|FG002|Overall Study|Alternative Therapy|1|||
143451909|NCT01142232|517200828|FG003|Overall Study|Alternative Therapy|0|||
143451910|NCT01142232|517200829|FG004|Overall Study|Alternative Therapy|1|||
143451911|NCT01142232|517200825|FG000|Overall Study|Off Trt for other complicating disease|0|||
143451912|NCT01142232|517200826|FG001|Overall Study|Off Trt for other complicating disease|0|||
143451913|NCT01142232|517200827|FG002|Overall Study|Off Trt for other complicating disease|0|||
143451914|NCT01142232|517200828|FG003|Overall Study|Off Trt for other complicating disease|0|||
143451915|NCT01142232|517200829|FG004|Overall Study|Off Trt for other complicating disease|1|||
143451916|NCT01142232|517200825|FG000|Overall Study|Noncompliance|0|||
143451917|NCT01142232|517200826|FG001|Overall Study|Noncompliance|0|||
143451918|NCT01142232|517200827|FG002|Overall Study|Noncompliance|0|||
143451919|NCT01142232|517200828|FG003|Overall Study|Noncompliance|0|||
143451920|NCT01142232|517200829|FG004|Overall Study|Noncompliance|2|||
143451921|NCT00626990|517200830|FG000|Overall Study|Lack of Efficacy|6|||
143451922|NCT00626990|517200831|FG001|Overall Study|Lack of Efficacy|7|||
143451923|NCT00626990|517200832|FG002|Overall Study|Lack of Efficacy|49|||
143451924|NCT00626990|517200833|FG003|Overall Study|Lack of Efficacy|40|||
143451925|NCT00626990|517200830|FG000|Overall Study|Adverse Event|1|||
143451926|NCT00626990|517200831|FG001|Overall Study|Adverse Event|7|||
143451927|NCT00626990|517200832|FG002|Overall Study|Adverse Event|14|||
143451928|NCT00626990|517200833|FG003|Overall Study|Adverse Event|28|||
143451929|NCT00626990|517200830|FG000|Overall Study|Death|0|||
143451930|NCT00626990|517200831|FG001|Overall Study|Death|1|||
143451931|NCT00626990|517200832|FG002|Overall Study|Death|0|||
143451932|NCT00626990|517200833|FG003|Overall Study|Death|0|||
143451933|NCT00626990|517200830|FG000|Overall Study|Withdrawal by Subject|3|||
143451934|NCT00626990|517200831|FG001|Overall Study|Withdrawal by Subject|1|||
143451935|NCT00626990|517200832|FG002|Overall Study|Withdrawal by Subject|5|||
143451936|NCT00626990|517200833|FG003|Overall Study|Withdrawal by Subject|11|||
143451937|NCT00626990|517200830|FG000|Overall Study|Protocol Violation|0|||
143451938|NCT00626990|517200831|FG001|Overall Study|Protocol Violation|1|||
143451939|NCT00626990|517200832|FG002|Overall Study|Protocol Violation|1|||
143451940|NCT00626990|517200833|FG003|Overall Study|Protocol Violation|0|||
143451941|NCT00626990|517200830|FG000|Overall Study|Various different reasons/missing|4|||
143451942|NCT00626990|517200831|FG001|Overall Study|Various different reasons/missing|8|||
143451943|NCT00626990|517200832|FG002|Overall Study|Various different reasons/missing|8|||
143451944|NCT00626990|517200833|FG003|Overall Study|Various different reasons/missing|16|||
143451945|NCT04138576|517200838|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
143451946|NCT01994837|517200839|FG000|Overall Study|Progressive disease per protocol|23|||
143451947|NCT01994837|517200839|FG000|Overall Study|Adv event related to progressive disease|3|||
143451948|NCT01994837|517200839|FG000|Overall Study|Fatal progressive disease|2|||
143451949|NCT01994837|517200839|FG000|Overall Study|Adverse event not related to progression|1|||
143451950|NCT01994837|517200839|FG000|Overall Study|Chose palliative care|1|||
143451951|NCT01994837|517200839|FG000|Overall Study|Proceeded to transplant|1|||
143451952|NCT01994837|517200839|FG000|Overall Study|Removed from study due to no response|1|||
143451953|NCT01262677|517200841|FG000|Overall Study|Does not meet entrance criteria|0|||
143451954|NCT01262677|517200842|FG001|Overall Study|Does not meet entrance criteria|2|||
143451955|NCT01262677|517200843|FG002|Overall Study|Does not meet entrance criteria|0|||
143451956|NCT01262677|517200841|FG000|Overall Study|Insufficient clinical response|0|||
143451957|NCT01262677|517200842|FG001|Overall Study|Insufficient clinical response|0|||
143451958|NCT01262677|517200843|FG002|Overall Study|Insufficient clinical response|1|||
143451959|NCT01262677|517200841|FG000|Overall Study|Lost to Follow-up|1|||
143451960|NCT01262677|517200842|FG001|Overall Study|Lost to Follow-up|0|||
143451961|NCT01262677|517200843|FG002|Overall Study|Lost to Follow-up|2|||
143451962|NCT01262677|517200841|FG000|Overall Study|No longer willing to participate|3|||
143451963|NCT01262677|517200842|FG001|Overall Study|No longer willing to participate|3|||
143451964|NCT01262677|517200843|FG002|Overall Study|No longer willing to participate|2|||
143451965|NCT01262677|517200841|FG000|Overall Study|Reason not provided|2|||
143451966|NCT01262677|517200842|FG001|Overall Study|Reason not provided|1|||
143451967|NCT01262677|517200843|FG002|Overall Study|Reason not provided|3|||
143451968|NCT01262677|517200841|FG000|Overall Study|Protocol Violation|0|||
143451969|NCT01262677|517200842|FG001|Overall Study|Protocol Violation|1|||
143451970|NCT01262677|517200843|FG002|Overall Study|Protocol Violation|1|||
143451971|NCT01262677|517200841|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
143451972|NCT01262677|517200842|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
143451973|NCT01262677|517200843|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
143451974|NCT00581555|517200847|FG000|Overall Study|Adverse Event|4|||
143451975|NCT00581555|517200848|FG001|Overall Study|Adverse Event|3|||
143451976|NCT00581555|517200847|FG000|Overall Study|Physician Decision|3|||
143451977|NCT00581555|517200848|FG001|Overall Study|Physician Decision|2|||
143451978|NCT00581555|517200847|FG000|Overall Study|Withdrawal by Subject|18|||
143451979|NCT00581555|517200848|FG001|Overall Study|Withdrawal by Subject|9|||
143451980|NCT00581555|517200847|FG000|Overall Study|Lost to Follow-up|2|||
143451981|NCT00581555|517200848|FG001|Overall Study|Lost to Follow-up|2|||
143451982|NCT00581555|517200847|FG000|Overall Study|Other reasons|16|||
143451983|NCT00581555|517200848|FG001|Overall Study|Other reasons|4|||
143451984|NCT05816330|517200854|FG000|Overall Study|Withdrawal by Subject|4|||
143451985|NCT05816330|517200855|FG001|Overall Study|Withdrawal by Subject|1|||
143451986|NCT03446781|517200858|FG000|Overall Study|Lost to Follow-up|11|||
143451987|NCT03446781|517200859|FG001|Overall Study|Lost to Follow-up|5|||
143451988|NCT03446781|517200858|FG000|Overall Study|Withdrawal by Subject|9|||
143451989|NCT03446781|517200859|FG001|Overall Study|Withdrawal by Subject|7|||
143451990|NCT03446781|517200858|FG000|Overall Study|Adverse Event|8|||
143451991|NCT03446781|517200859|FG001|Overall Study|Adverse Event|2|||
143451992|NCT03446781|517200858|FG000|Overall Study|Protocol Violation|0|||
143451993|NCT03446781|517200859|FG001|Overall Study|Protocol Violation|3|||
143451994|NCT03568318|517200866|FG000|Overall Study|Adverse Event|3|||
143451995|NCT03568318|517200867|FG001|Overall Study|Adverse Event|1|||
143451996|NCT03568318|517200868|FG002|Overall Study|Adverse Event|1|||
143451997|NCT03568318|517200869|FG003|Overall Study|Adverse Event|0|||
143451998|NCT03568318|517200870|FG004|Overall Study|Adverse Event|1|||
143451999|NCT03568318|517200871|FG005|Overall Study|Adverse Event|0|||
143452000|NCT03568318|517200866|FG000|Overall Study|Withdrawal by Subject|6|||
143452001|NCT03568318|517200867|FG001|Overall Study|Withdrawal by Subject|5|||
143452002|NCT03568318|517200868|FG002|Overall Study|Withdrawal by Subject|2|||
143452003|NCT03568318|517200869|FG003|Overall Study|Withdrawal by Subject|1|||
143452004|NCT03568318|517200870|FG004|Overall Study|Withdrawal by Subject|0|||
143452005|NCT03568318|517200871|FG005|Overall Study|Withdrawal by Subject|0|||
143452006|NCT03568318|517200866|FG000|Overall Study|Lost to Follow-up|3|||
143452007|NCT03568318|517200867|FG001|Overall Study|Lost to Follow-up|2|||
143452008|NCT03568318|517200868|FG002|Overall Study|Lost to Follow-up|2|||
143452009|NCT03568318|517200869|FG003|Overall Study|Lost to Follow-up|2|||
143452010|NCT03568318|517200870|FG004|Overall Study|Lost to Follow-up|1|||
143452011|NCT03568318|517200871|FG005|Overall Study|Lost to Follow-up|0|||
143452012|NCT03568318|517200866|FG000|Overall Study|Other|3|||
143452013|NCT03568318|517200867|FG001|Overall Study|Other|1|||
143452014|NCT03568318|517200868|FG002|Overall Study|Other|3|||
143452015|NCT03568318|517200869|FG003|Overall Study|Other|0|||
143452016|NCT03568318|517200870|FG004|Overall Study|Other|0|||
143452017|NCT03568318|517200871|FG005|Overall Study|Other|0|||
143452018|NCT03568318|517200866|FG000|Overall Study|Ongoing at Time of Analysis|5|||
143452019|NCT03568318|517200867|FG001|Overall Study|Ongoing at Time of Analysis|3|||
143452020|NCT03568318|517200868|FG002|Overall Study|Ongoing at Time of Analysis|2|||
143452021|NCT03568318|517200869|FG003|Overall Study|Ongoing at Time of Analysis|1|||
143452022|NCT03568318|517200870|FG004|Overall Study|Ongoing at Time of Analysis|0|||
143452023|NCT03568318|517200871|FG005|Overall Study|Ongoing at Time of Analysis|0|||
143452024|NCT02898077|517200872|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
143452025|NCT02898077|517200873|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
143452026|NCT02898077|517200872|FG000|Overall Study|Lost to Follow-up|4|||
143452027|NCT02898077|517200873|FG001|Overall Study|Lost to Follow-up|3|||
143452028|NCT02898077|517200872|FG000|Overall Study|Physician Decision|0|||
143452029|NCT02898077|517200873|FG001|Overall Study|Physician Decision|2|||
143452030|NCT02898077|517200872|FG000|Overall Study|Sponsor Decision|32|||
143452031|NCT02898077|517200873|FG001|Overall Study|Sponsor Decision|13|||
143452032|NCT02898077|517200872|FG000|Overall Study|Withdrawal by Subject|6|||
143452033|NCT02898077|517200873|FG001|Overall Study|Withdrawal by Subject|3|||
143452034|NCT02898077|517200872|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
143452035|NCT02898077|517200873|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
143452036|NCT02898077|517200872|FG000|Overall Study|Ended extension period|3|||
143452037|NCT02898077|517200873|FG001|Overall Study|Ended extension period|0|||
143452038|NCT04410523|517200874|FG000|Overall Study|Study terminated by sponsor|1|||
143452039|NCT04410523|517200875|FG001|Overall Study|Study terminated by sponsor|3|||
143452040|NCT04410523|517200876|FG002|Overall Study|Study terminated by sponsor|2|||
143452041|NCT04410523|517200877|FG003|Overall Study|Study terminated by sponsor|6|||
143452042|NCT04410523|517200878|FG004|Overall Study|Study terminated by sponsor|3|||
143452043|NCT04410523|517200879|FG005|Overall Study|Study terminated by sponsor|4|||
143452044|NCT04410523|517200874|FG000|Overall Study|Adverse Event|1|||
143452045|NCT04410523|517200875|FG001|Overall Study|Adverse Event|0|||
143452046|NCT04410523|517200876|FG002|Overall Study|Adverse Event|0|||
143452047|NCT04410523|517200877|FG003|Overall Study|Adverse Event|0|||
143452048|NCT04410523|517200878|FG004|Overall Study|Adverse Event|0|||
143452049|NCT04410523|517200879|FG005|Overall Study|Adverse Event|2|||
143452050|NCT04410523|517200874|FG000|Overall Study|Lost to Follow-up|0|||
143452051|NCT04410523|517200875|FG001|Overall Study|Lost to Follow-up|1|||
143452052|NCT04410523|517200876|FG002|Overall Study|Lost to Follow-up|0|||
143452053|NCT04410523|517200877|FG003|Overall Study|Lost to Follow-up|0|||
143452054|NCT04410523|517200878|FG004|Overall Study|Lost to Follow-up|0|||
143452055|NCT04410523|517200879|FG005|Overall Study|Lost to Follow-up|0|||
143452056|NCT04410523|517200874|FG000|Overall Study|Physician Decision|0|||
143452057|NCT04410523|517200875|FG001|Overall Study|Physician Decision|1|||
143452058|NCT04410523|517200876|FG002|Overall Study|Physician Decision|0|||
143452059|NCT04410523|517200877|FG003|Overall Study|Physician Decision|0|||
143452060|NCT04410523|517200878|FG004|Overall Study|Physician Decision|0|||
143452061|NCT04410523|517200879|FG005|Overall Study|Physician Decision|0|||
143452062|NCT04410523|517200874|FG000|Overall Study|Pregnancy|0|||
143452063|NCT04410523|517200875|FG001|Overall Study|Pregnancy|0|||
143452064|NCT04410523|517200876|FG002|Overall Study|Pregnancy|0|||
143452065|NCT04410523|517200877|FG003|Overall Study|Pregnancy|0|||
143452066|NCT04410523|517200878|FG004|Overall Study|Pregnancy|0|||
143452067|NCT04410523|517200879|FG005|Overall Study|Pregnancy|1|||
143452068|NCT04410523|517200874|FG000|Overall Study|Protocol deviation|0|||
143452069|NCT04410523|517200875|FG001|Overall Study|Protocol deviation|0|||
143452070|NCT04410523|517200876|FG002|Overall Study|Protocol deviation|0|||
143452071|NCT04410523|517200877|FG003|Overall Study|Protocol deviation|0|||
143452072|NCT04410523|517200878|FG004|Overall Study|Protocol deviation|0|||
143452073|NCT04410523|517200879|FG005|Overall Study|Protocol deviation|2|||
143452074|NCT04410523|517200874|FG000|Overall Study|Subject decision|2|||
143452075|NCT04410523|517200875|FG001|Overall Study|Subject decision|0|||
143452076|NCT04410523|517200876|FG002|Overall Study|Subject decision|0|||
143452077|NCT04410523|517200877|FG003|Overall Study|Subject decision|1|||
143452078|NCT04410523|517200878|FG004|Overall Study|Subject decision|0|||
143452079|NCT04410523|517200879|FG005|Overall Study|Subject decision|1|||
143452080|NCT01638429|517200882|FG000|Overall Study|Withdrawal by Subject|1|||
143452081|NCT03207451|517200883|FG000|Overall Study|scheduling conflict|1|||
143452082|NCT03207451|517200884|FG001|Overall Study|scheduling conflict|0|||
143452083|NCT03207451|517200885|FG002|Overall Study|scheduling conflict|2|||
143452084|NCT03207451|517200886|FG003|Overall Study|scheduling conflict|2|||
143452085|NCT03207451|517200883|FG000|Overall Study|Adverse Event|0|||
143452086|NCT03207451|517200884|FG001|Overall Study|Adverse Event|0|||
143452087|NCT03207451|517200885|FG002|Overall Study|Adverse Event|0|||
143452088|NCT03207451|517200886|FG003|Overall Study|Adverse Event|1|||
143452089|NCT02040584|517200888|FG000|Overall Study|Adverse Event|13|||
143452090|NCT02040584|517200889|FG001|Overall Study|Adverse Event|6|||
143452091|NCT02040584|517200888|FG000|Overall Study|Protocol Violation|9|||
143452092|NCT02040584|517200889|FG001|Overall Study|Protocol Violation|11|||
143452093|NCT02040584|517200888|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
143452094|NCT02040584|517200889|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
143452095|NCT02040584|517200888|FG000|Overall Study|Death|6|||
143452096|NCT02040584|517200889|FG001|Overall Study|Death|3|||
143452097|NCT02040584|517200888|FG000|Overall Study|Transplant rejection/retransplant|0|||
143452098|NCT02040584|517200889|FG001|Overall Study|Transplant rejection/retransplant|1|||
143452099|NCT02040584|517200888|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
143452100|NCT02040584|517200889|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
143452101|NCT01802567|517200890|FG000|Overall Study|Withdrawal by Subject|2|||
143452102|NCT01802567|517200890|FG000|Overall Study|Physician Decision|1|||
143452103|NCT01802567|517200890|FG000|Overall Study|Lack of Efficacy|7|||
143452104|NCT01802567|517200890|FG000|Overall Study|Consented but did not start therapy|7|||
143452105|NCT01802567|517200890|FG000|Overall Study|Protocol Violation|1|||
143452106|NCT01940939|517200891|FG000|Overall Study|Withdrawal by Subject|2|||
143452107|NCT01940939|517200892|FG001|Overall Study|Withdrawal by Subject|8|||
143452108|NCT00436852|517200896|FG000|Overall Study|Death|23|||
143452109|NCT00436852|517200897|FG001|Overall Study|Death|34|||
143452110|NCT00436852|517200896|FG000|Overall Study|Lack of Efficacy|9|||
143452111|NCT00436852|517200897|FG001|Overall Study|Lack of Efficacy|7|||
143452112|NCT00436852|517200896|FG000|Overall Study|Withdrawal by Subject|2|||
143452113|NCT00436852|517200897|FG001|Overall Study|Withdrawal by Subject|4|||
143452114|NCT00436852|517200896|FG000|Overall Study|Ineligible|1|||
143452115|NCT00436852|517200897|FG001|Overall Study|Ineligible|0|||
143452116|NCT00127205|517200898|FG000|Overall Study|Adverse Event|228|||
143452117|NCT00127205|517200899|FG001|Overall Study|Adverse Event|387|||
143452118|NCT00127205|517200900|FG002|Overall Study|Adverse Event|273|||
143452119|NCT00127205|517200898|FG000|Overall Study|Death|8|||
143452120|NCT00127205|517200899|FG001|Overall Study|Death|6|||
143452121|NCT00127205|517200900|FG002|Overall Study|Death|5|||
143452122|NCT00127205|517200898|FG000|Overall Study|Withdrawal by Subject|318|||
143452123|NCT00127205|517200899|FG001|Overall Study|Withdrawal by Subject|310|||
143452124|NCT00127205|517200900|FG002|Overall Study|Withdrawal by Subject|172|||
143452125|NCT00127205|517200898|FG000|Overall Study|Other-non protocol specified|142|||
143452126|NCT00127205|517200899|FG001|Overall Study|Other-non protocol specified|129|||
143452127|NCT00127205|517200900|FG002|Overall Study|Other-non protocol specified|77|||
143452128|NCT00127205|517200898|FG000|Overall Study|Data not reported|6|||
143452129|NCT00127205|517200899|FG001|Overall Study|Data not reported|10|||
143452130|NCT00127205|517200900|FG002|Overall Study|Data not reported|1|||
143452131|NCT00127205|517200898|FG000|Overall Study|Progression|127|||
143452132|NCT00127205|517200899|FG001|Overall Study|Progression|131|||
143452133|NCT00127205|517200900|FG002|Overall Study|Progression|84|||
143452134|NCT05032872|517200903|FG000|Overall Study|Adverse Event|1|||
143452135|NCT05032872|517200904|FG001|Overall Study|Adverse Event|0|||
143452136|NCT05032872|517200903|FG000|Overall Study|Lost to Follow-up|2|||
143452137|NCT05032872|517200904|FG001|Overall Study|Lost to Follow-up|4|||
143452138|NCT05032872|517200903|FG000|Overall Study|Withdrawal by Subject|4|||
143452139|NCT05032872|517200904|FG001|Overall Study|Withdrawal by Subject|3|||
143452140|NCT00910039|517200905|FG000|Overall Study|Physician Decision|1|||
143452141|NCT04155047|517200906|FG000|Overall Study|Adverse Event|1|||
143452142|NCT04155047|517200907|FG001|Overall Study|Adverse Event|0|||
143452143|NCT04155047|517200906|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
143452144|NCT04155047|517200907|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
143452145|NCT03192475|517200923|FG000|Overall Study|Death|0|||
143452146|NCT03192475|517200924|FG001|Overall Study|Death|1|||
143452147|NCT03192475|517200923|FG000|Overall Study|Lost to Follow-up|13|||
143452148|NCT03192475|517200924|FG001|Overall Study|Lost to Follow-up|8|||
143452149|NCT00798590|517200925|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
143452150|NCT00798590|517200926|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
143452151|NCT00436605|517200930|FG000|Overall Study|Protocol Violation|3|||
143452152|NCT03014011|517200931|FG000|First Intervention|Withdrawal by Subject|1|||
143452153|NCT03014011|517200932|FG001|First Intervention|Withdrawal by Subject|0|||
143452154|NCT03014011|517200931|FG000|Washout|Withdrawal by Subject|1|||
143452155|NCT03014011|517200932|FG001|Washout|Withdrawal by Subject|0|||
143452156|NCT00573859|517200933|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
143452157|NCT00573859|517200933|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
143452158|NCT00688870|517200940|FG000|Infant Series|Parent or legal guardian request|4|||
143452159|NCT00688870|517200941|FG001|Infant Series|Parent or legal guardian request|0|||
143452160|NCT03449901|517200944|FG000|Overall Study|Progression|57|||
143452161|NCT03449901|517200945|FG001|Overall Study|Progression|12|||
143452162|NCT03449901|517200944|FG000|Overall Study|Adverse Event|3|||
143452163|NCT03449901|517200945|FG001|Overall Study|Adverse Event|0|||
143452164|NCT03449901|517200944|FG000|Overall Study|Death|6|||
143452165|NCT03449901|517200945|FG001|Overall Study|Death|2|||
143452166|NCT03449901|517200944|FG000|Overall Study|Withdrawal by Subject|12|||
143452167|NCT03449901|517200945|FG001|Overall Study|Withdrawal by Subject|1|||
143452168|NCT03449901|517200944|FG000|Overall Study|Physician Decision|1|||
143452169|NCT03449901|517200945|FG001|Overall Study|Physician Decision|0|||
143452170|NCT03449901|517200944|FG000|Overall Study|Patient elected for surgical intervention|1|||
143452171|NCT03449901|517200945|FG001|Overall Study|Patient elected for surgical intervention|0|||
143452172|NCT03449901|517200944|FG000|Overall Study|Patient off for other complicating disease|1|||
143452173|NCT03449901|517200945|FG001|Overall Study|Patient off for other complicating disease|0|||
143452174|NCT03682302|517200946|FG000|Overall Study|Lost to Follow-up|1|||
143452175|NCT03682302|517200947|FG001|Overall Study|Lost to Follow-up|2|||
143452176|NCT03682302|517200948|FG002|Overall Study|Lost to Follow-up|0|||
143452177|NCT03682302|517200949|FG003|Overall Study|Lost to Follow-up|1|||
143452178|NCT03682302|517200946|FG000|Overall Study|Study drug was not administered|0|||
143452179|NCT03682302|517200947|FG001|Overall Study|Study drug was not administered|0|||
143452180|NCT03682302|517200948|FG002|Overall Study|Study drug was not administered|1|||
143452181|NCT03682302|517200949|FG003|Overall Study|Study drug was not administered|1|||
143452182|NCT00293059|517200951|FG000|Overall Study|Adverse Event|12|||
143452183|NCT00293059|517200952|FG001|Overall Study|Adverse Event|4|||
143452184|NCT00293059|517200951|FG000|Overall Study|Lack of Efficacy|2|||
143452185|NCT00293059|517200952|FG001|Overall Study|Lack of Efficacy|0|||
143452186|NCT00293059|517200951|FG000|Overall Study|Lost to Follow-up|2|||
143452187|NCT00293059|517200952|FG001|Overall Study|Lost to Follow-up|3|||
143452188|NCT00293059|517200951|FG000|Overall Study|Pregnancy|1|||
143452189|NCT00293059|517200952|FG001|Overall Study|Pregnancy|1|||
143452190|NCT00293059|517200951|FG000|Overall Study|Protocol Violation|2|||
143452191|NCT00293059|517200952|FG001|Overall Study|Protocol Violation|0|||
143452192|NCT00293059|517200951|FG000|Overall Study|Withdrawal by Subject|11|||
143452193|NCT00293059|517200952|FG001|Overall Study|Withdrawal by Subject|5|||
143452194|NCT00293059|517200951|FG000|Overall Study|Participant moved out of state|1|||
143452195|NCT00293059|517200952|FG001|Overall Study|Participant moved out of state|0|||
143452196|NCT00293059|517200951|FG000|Overall Study|Participant stopped study drug|1|||
143452197|NCT00293059|517200952|FG001|Overall Study|Participant stopped study drug|0|||
143452198|NCT00293059|517200951|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
143452199|NCT00293059|517200952|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
143452200|NCT00293059|517200951|FG000|Overall Study|missing|3|||
143452201|NCT00293059|517200952|FG001|Overall Study|missing|5|||
143452202|NCT01609062|517200953|FG000|Extension Phase|Terminated by Sponsor|14|||
143452203|NCT01609062|517200954|FG001|Extension Phase|Terminated by Sponsor|9|||
143452204|NCT01609062|517200953|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
143452205|NCT01609062|517200954|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
143452206|NCT01609062|517200953|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
143452207|NCT01609062|517200954|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
143452208|NCT00680992|517200955|FG000|Overall Study|Complete Resection (as per protocol)|25|||
143452209|NCT00680992|517200956|FG001|Overall Study|Complete Resection (as per protocol)|121|||
143452210|NCT00680992|517200957|FG002|Overall Study|Complete Resection (as per protocol)|0|||
143452211|NCT00680992|517200955|FG000|Overall Study|Administrative Decision|83|||
143452212|NCT00680992|517200956|FG001|Overall Study|Administrative Decision|42|||
143452213|NCT00680992|517200957|FG002|Overall Study|Administrative Decision|5|||
143452214|NCT00680992|517200955|FG000|Overall Study|End of Trial|32|||
143452215|NCT00680992|517200956|FG001|Overall Study|End of Trial|12|||
143452216|NCT00680992|517200957|FG002|Overall Study|End of Trial|3|||
143452217|NCT00680992|517200955|FG000|Overall Study|Withdrawal by Subject|33|||
143452218|NCT00680992|517200956|FG001|Overall Study|Withdrawal by Subject|11|||
143452219|NCT00680992|517200957|FG002|Overall Study|Withdrawal by Subject|1|||
143452220|NCT00680992|517200955|FG000|Overall Study|Adverse Event|21|||
143452221|NCT00680992|517200956|FG001|Overall Study|Adverse Event|19|||
143452222|NCT00680992|517200957|FG002|Overall Study|Adverse Event|1|||
143452223|NCT00680992|517200955|FG000|Overall Study|Other|19|||
143452224|NCT00680992|517200956|FG001|Overall Study|Other|14|||
143452225|NCT00680992|517200957|FG002|Overall Study|Other|1|||
143452226|NCT00680992|517200955|FG000|Overall Study|Disease Progression|21|||
143452227|NCT00680992|517200956|FG001|Overall Study|Disease Progression|9|||
143452228|NCT00680992|517200957|FG002|Overall Study|Disease Progression|0|||
143452229|NCT00680992|517200955|FG000|Overall Study|Lost to Follow-up|12|||
143452230|NCT00680992|517200956|FG001|Overall Study|Lost to Follow-up|14|||
143452231|NCT00680992|517200957|FG002|Overall Study|Lost to Follow-up|0|||
143452232|NCT00680992|517200955|FG000|Overall Study|Noncompliance|4|||
143452233|NCT00680992|517200956|FG001|Overall Study|Noncompliance|6|||
143452234|NCT00680992|517200957|FG002|Overall Study|Noncompliance|0|||
143452235|NCT00680992|517200955|FG000|Overall Study|Requirement for Alternative Therapy|8|||
143452236|NCT00680992|517200956|FG001|Overall Study|Requirement for Alternative Therapy|2|||
143452237|NCT00680992|517200957|FG002|Overall Study|Requirement for Alternative Therapy|0|||
143452238|NCT00680992|517200955|FG000|Overall Study|Pregnancy|5|||
143452239|NCT00680992|517200956|FG001|Overall Study|Pregnancy|0|||
143452240|NCT00680992|517200957|FG002|Overall Study|Pregnancy|1|||
143452241|NCT00680992|517200955|FG000|Overall Study|Death|5|||
143452242|NCT00680992|517200956|FG001|Overall Study|Death|1|||
143452243|NCT00680992|517200957|FG002|Overall Study|Death|0|||
143452244|NCT00680992|517200955|FG000|Overall Study|Ineligibility Determined|0|||
143452245|NCT00680992|517200956|FG001|Overall Study|Ineligibility Determined|1|||
143452246|NCT00680992|517200957|FG002|Overall Study|Ineligibility Determined|0|||
143452247|NCT03772587|517200958|FG000|Overall Study|COVID-19|0|||
143452248|NCT03772587|517200959|FG001|Overall Study|COVID-19|0|||
143452249|NCT03772587|517200960|FG002|Overall Study|COVID-19|1|||
143452250|NCT03772587|517200961|FG003|Overall Study|COVID-19|1|||
143452251|NCT03772587|517200962|FG004|Overall Study|COVID-19|0|||
143452252|NCT03772587|517200958|FG000|Overall Study|Withdrawal by Subject|1|||
143452253|NCT03772587|517200959|FG001|Overall Study|Withdrawal by Subject|0|||
143452254|NCT03772587|517200960|FG002|Overall Study|Withdrawal by Subject|0|||
143452255|NCT03772587|517200961|FG003|Overall Study|Withdrawal by Subject|0|||
143452256|NCT03772587|517200962|FG004|Overall Study|Withdrawal by Subject|0|||
143452257|NCT00591370|517202636|FG000|Overall Study|Not Treated|2|||
143452258|NCT00095056|517202637|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
143452259|NCT00095056|517202638|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
143452260|NCT00095056|517202637|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
143452261|NCT00095056|517202638|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
143452262|NCT00095056|517202637|FG000|Phase A (Weeks 0-12)|Death|1|||
143452263|NCT00095056|517202638|FG001|Phase A (Weeks 0-12)|Death|0|||
143452264|NCT00095056|517202637|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
143452265|NCT00095056|517202638|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
143452266|NCT00095056|517202637|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
143452267|NCT00095056|517202638|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
143452268|NCT00095056|517202637|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
143452269|NCT00095056|517202638|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
143452270|NCT00095056|517202637|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
143452271|NCT00095056|517202638|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
143452272|NCT00095056|517202637|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
143452273|NCT00095056|517202638|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
143452274|NCT00095056|517202637|FG000|Phase B (Weeks 12-54)|Death|3|||
143452275|NCT00095056|517202638|FG001|Phase B (Weeks 12-54)|Death|1|||
143452276|NCT00095056|517202637|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
143452277|NCT00095056|517202638|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
143452278|NCT00095056|517202637|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
143452279|NCT00095056|517202638|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
143452280|NCT00574873|517202640|FG000|Overall Study|Withdrawal by Subject|18|||
143452281|NCT00574873|517202641|FG001|Overall Study|Withdrawal by Subject|19|||
143452282|NCT00574873|517202640|FG000|Overall Study|Investigator request|18|||
143452283|NCT00574873|517202641|FG001|Overall Study|Investigator request|8|||
143452284|NCT00574873|517202640|FG000|Overall Study|Death|15|||
143452285|NCT00574873|517202641|FG001|Overall Study|Death|14|||
143452286|NCT00574873|517202640|FG000|Overall Study|Lost to Follow-up|14|||
143452287|NCT00574873|517202641|FG001|Overall Study|Lost to Follow-up|5|||
143452288|NCT00574873|517202640|FG000|Overall Study|Other|40|||
143452289|NCT00574873|517202641|FG001|Overall Study|Other|4|||
143452290|NCT00574873|517202640|FG000|Overall Study|Discontinuation of study by sponsor|5|||
143452291|NCT00574873|517202641|FG001|Overall Study|Discontinuation of study by sponsor|199|||
143452292|NCT00574873|517202640|FG000|Overall Study|Blank, site closed per local regulations|2|||
143452293|NCT00574873|517202641|FG001|Overall Study|Blank, site closed per local regulations|2|||
143452294|NCT00574873|517202640|FG000|Overall Study|Extension Study|126|||
143452295|NCT00574873|517202641|FG001|Overall Study|Extension Study|0|||
143452296|NCT00201643|517202642|FG000|Overall Study|Withdrawal by Subject|5|||
143452297|NCT00201643|517202643|FG001|Overall Study|Withdrawal by Subject|4|||
143452298|NCT03896152|517202644|FG000|Overall Study|Patient/guardian decision|1|||
143452299|NCT03896152|517202645|FG001|Overall Study|Patient/guardian decision|1|||
143452300|NCT03896152|517202644|FG000|Overall Study|Adverse Event|0|||
143452301|NCT03896152|517202645|FG001|Overall Study|Adverse Event|1|||
143452302|NCT03896152|517202644|FG000|Overall Study|Physician Decision|1|||
143452303|NCT03896152|517202645|FG001|Overall Study|Physician Decision|0|||
143452304|NCT03896152|517202644|FG000|Overall Study|Technical problems|1|||
143452305|NCT03896152|517202645|FG001|Overall Study|Technical problems|0|||
143452306|NCT00370682|517202646|FG000|Overall Study|Moved from area|0|||
143452307|NCT00370682|517202647|FG001|Overall Study|Moved from area|2|||
143452308|NCT00370682|517202648|FG002|Overall Study|Moved from area|0|||
143452309|NCT00370682|517202646|FG000|Overall Study|Lost to Follow-up|0|||
143452310|NCT00370682|517202647|FG001|Overall Study|Lost to Follow-up|1|||
143452311|NCT00370682|517202648|FG002|Overall Study|Lost to Follow-up|1|||
143452312|NCT03167359|517202649|FG000|Overall Study|Physician Decision|1|||
143452313|NCT03167359|517202649|FG000|Overall Study|Lost to Follow-up|1|||
143452314|NCT00943852|517202650|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
143452315|NCT00943852|517202651|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
143452316|NCT00943852|517202652|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
143452317|NCT00943852|517202653|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
143452318|NCT00943852|517202654|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
143452319|NCT00943852|517202655|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
143452320|NCT00943852|517202656|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
143452321|NCT00943852|517202657|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
143452322|NCT00943852|517202658|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
143452323|NCT00943852|517202659|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
143452324|NCT00943852|517202650|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
143452325|NCT00943852|517202651|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
143452326|NCT00943852|517202652|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
143452327|NCT00943852|517202653|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
143452328|NCT00943852|517202654|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
143452329|NCT00943852|517202655|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
143452330|NCT00943852|517202656|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
143452331|NCT00943852|517202657|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
143452332|NCT00943852|517202658|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
143452333|NCT00943852|517202659|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
143452334|NCT00943852|517202650|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
143452335|NCT00943852|517202651|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
143452336|NCT00943852|517202652|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
143452337|NCT00943852|517202653|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
143452338|NCT00943852|517202654|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
143452339|NCT00943852|517202655|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
143452340|NCT00943852|517202656|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
143452341|NCT00943852|517202657|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
143452342|NCT00943852|517202658|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
143452343|NCT00943852|517202659|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
143452344|NCT00943852|517202650|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
143452345|NCT00943852|517202651|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
143452346|NCT00943852|517202652|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
143452347|NCT00943852|517202653|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
143452348|NCT00943852|517202654|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
143452349|NCT00943852|517202655|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
143452350|NCT00943852|517202656|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
143452351|NCT00943852|517202657|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
143452352|NCT00943852|517202658|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
143452353|NCT00943852|517202659|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
143452354|NCT00943852|517202650|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
143452355|NCT00943852|517202651|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
143452356|NCT00943852|517202652|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
143452357|NCT00943852|517202653|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
143452358|NCT00943852|517202654|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
143452359|NCT00943852|517202655|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
143452360|NCT00943852|517202656|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
143452361|NCT00943852|517202657|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
143452362|NCT00943852|517202658|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
143452363|NCT00943852|517202659|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
143452364|NCT00772330|517202660|FG000|Overall Study|Lost to Follow-up|3|||
143452365|NCT01519089|517202661|FG000|Overall Study|Adverse Event|4|||
143452366|NCT01519089|517202662|FG001|Overall Study|Adverse Event|4|||
143452367|NCT01519089|517202661|FG000|Overall Study|Lack of Efficacy|0|||
143452368|NCT01519089|517202662|FG001|Overall Study|Lack of Efficacy|2|||
143452369|NCT01519089|517202661|FG000|Overall Study|Lost to Follow-up|1|||
143452370|NCT01519089|517202662|FG001|Overall Study|Lost to Follow-up|0|||
143452371|NCT01519089|517202661|FG000|Overall Study|Withdrawal by Subject|0|||
143452372|NCT01519089|517202662|FG001|Overall Study|Withdrawal by Subject|2|||
143452373|NCT01519089|517202661|FG000|Overall Study|Other|2|||
143452374|NCT01519089|517202662|FG001|Overall Study|Other|6|||
143452375|NCT01519089|517202661|FG000|Overall Study|Not received study drug|0|||
143452376|NCT01519089|517202662|FG001|Overall Study|Not received study drug|1|||
143452377|NCT03582943|517202665|FG000|Allocated to Groups|Withdrawal by Subject|1|||
143452378|NCT03582943|517202666|FG001|Allocated to Groups|Withdrawal by Subject|1|||
143452379|NCT03582943|517202665|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
143452380|NCT03582943|517202666|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
143452381|NCT03582943|517202665|FG000|Analyzed|Protocol Violation|4|||
143452382|NCT03582943|517202666|FG001|Analyzed|Protocol Violation|1|||
143452383|NCT00488475|517202670|FG000|Overall Study|Other|1754|||
143452384|NCT00400725|517202671|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
143452385|NCT00400725|517202672|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
143452386|NCT00400725|517202673|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
143452387|NCT00400725|517202671|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
143452388|NCT00400725|517202672|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
143452389|NCT00400725|517202673|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
143452390|NCT00400725|517202671|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
143452391|NCT00400725|517202672|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
143452392|NCT00400725|517202673|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
143452393|NCT00400725|517202671|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
143452394|NCT00400725|517202672|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
143452395|NCT00400725|517202673|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
143452396|NCT00400725|517202671|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
143452397|NCT00400725|517202672|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
143452398|NCT00400725|517202673|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
143452399|NCT00400725|517202671|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
143452400|NCT00400725|517202672|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
143452401|NCT00400725|517202673|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
143452402|NCT00400725|517202671|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
143452403|NCT00400725|517202672|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
143452404|NCT00400725|517202673|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
143452405|NCT00400725|517202671|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
143452406|NCT00400725|517202672|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
143452407|NCT00400725|517202673|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
143452408|NCT00400725|517202671|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
143452409|NCT00400725|517202672|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
143452410|NCT00400725|517202673|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
143452411|NCT03547739|517202674|FG000|Overall Study|Death|0|||
143452412|NCT03547739|517202675|FG001|Overall Study|Death|1|||
143452413|NCT03547739|517202676|FG002|Overall Study|Death|5|||
143452414|NCT03547739|517202674|FG000|Overall Study|Adverse Event|24|||
143452415|NCT03547739|517202675|FG001|Overall Study|Adverse Event|11|||
143452416|NCT03547739|517202676|FG002|Overall Study|Adverse Event|13|||
143452417|NCT03547739|517202674|FG000|Overall Study|Partner discontinued due to the death of the female participant or adverse event|24|||
143452418|NCT03547739|517202675|FG001|Overall Study|Partner discontinued due to the death of the female participant or adverse event|12|||
143452419|NCT03547739|517202676|FG002|Overall Study|Partner discontinued due to the death of the female participant or adverse event|18|||
143452420|NCT03547739|517202674|FG000|Overall Study|Lost to Follow-up|80|||
143452421|NCT03547739|517202675|FG001|Overall Study|Lost to Follow-up|84|||
143452422|NCT03547739|517202676|FG002|Overall Study|Lost to Follow-up|116|||
143452423|NCT01744392|517202678|FG000|Overall Study|Physician Decision|1|||
143452424|NCT01365481|517202679|FG000|Overall Study|Adverse Event|6|||
143452425|NCT01365481|517202680|FG001|Overall Study|Adverse Event|9|||
143452426|NCT01365481|517202681|FG002|Overall Study|Adverse Event|0|||
143452427|NCT01365481|517202682|FG003|Overall Study|Adverse Event|2|||
143452428|NCT01365481|517202679|FG000|Overall Study|Withdrawal by Subject|0|||
143452429|NCT01365481|517202680|FG001|Overall Study|Withdrawal by Subject|2|||
143452430|NCT01365481|517202681|FG002|Overall Study|Withdrawal by Subject|1|||
143452431|NCT01365481|517202682|FG003|Overall Study|Withdrawal by Subject|1|||
143452432|NCT01365481|517202679|FG000|Overall Study|Lost to Follow-up|1|||
143452433|NCT01365481|517202680|FG001|Overall Study|Lost to Follow-up|1|||
143452434|NCT01365481|517202681|FG002|Overall Study|Lost to Follow-up|2|||
143452435|NCT01365481|517202682|FG003|Overall Study|Lost to Follow-up|3|||
143452436|NCT01365481|517202679|FG000|Overall Study|Abnormal laboratory value(s)|0|||
143452437|NCT01365481|517202680|FG001|Overall Study|Abnormal laboratory value(s)|1|||
143452438|NCT01365481|517202681|FG002|Overall Study|Abnormal laboratory value(s)|0|||
143452439|NCT01365481|517202682|FG003|Overall Study|Abnormal laboratory value(s)|0|||
143452440|NCT01365481|517202679|FG000|Overall Study|Administrative problems|0|||
143452441|NCT01365481|517202680|FG001|Overall Study|Administrative problems|1|||
143452442|NCT01365481|517202681|FG002|Overall Study|Administrative problems|0|||
143452443|NCT01365481|517202682|FG003|Overall Study|Administrative problems|0|||
143452444|NCT01365481|517202679|FG000|Overall Study|Protocol deviation|0|||
143452445|NCT01365481|517202680|FG001|Overall Study|Protocol deviation|1|||
143452446|NCT01365481|517202681|FG002|Overall Study|Protocol deviation|0|||
143452447|NCT01365481|517202682|FG003|Overall Study|Protocol deviation|1|||
143452448|NCT01365481|517202679|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
143452449|NCT01365481|517202680|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
143452450|NCT01365481|517202681|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
143452451|NCT01365481|517202682|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
143452452|NCT00757627|517202683|FG000|Overall Study|Adverse Event|15|||
143452453|NCT00757627|517202683|FG000|Overall Study|Lack of Efficacy|10|||
143452454|NCT00757627|517202683|FG000|Overall Study|Lost to Follow-up|28|||
143452455|NCT00757627|517202683|FG000|Overall Study|Withdrawal by Subject|27|||
143452456|NCT00757627|517202683|FG000|Overall Study|Other|1|||
143452457|NCT00403767|517202686|FG000|Overall Study|Adverse Event|993|||
143452458|NCT00403767|517202687|FG001|Overall Study|Adverse Event|919|||
143452459|NCT00403767|517202686|FG000|Overall Study|Non-compliant with study medication|134|||
143452460|NCT00403767|517202687|FG001|Overall Study|Non-compliant with study medication|164|||
143452461|NCT00403767|517202686|FG000|Overall Study|Consent withdrawn|671|||
143452462|NCT00403767|517202687|FG001|Overall Study|Consent withdrawn|673|||
143452463|NCT00403767|517202686|FG000|Overall Study|Investigator dec./not protocol-related|191|||
143452464|NCT00403767|517202687|FG001|Overall Study|Investigator dec./not protocol-related|178|||
143452465|NCT00403767|517202686|FG000|Overall Study|Lost to Follow-up|6|||
143452466|NCT00403767|517202687|FG001|Overall Study|Lost to Follow-up|8|||
143452467|NCT00403767|517202686|FG000|Overall Study|Protocol Violation|142|||
143452468|NCT00403767|517202687|FG001|Overall Study|Protocol Violation|124|||
143452469|NCT00403767|517202686|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
143452470|NCT00403767|517202687|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
143452471|NCT00403767|517202686|FG000|Overall Study|Study terminated by sponsor|82|||
143452472|NCT00403767|517202687|FG001|Overall Study|Study terminated by sponsor|69|||
143452473|NCT00403767|517202686|FG000|Overall Study|Missing/incomplete data|1|||
143452474|NCT00403767|517202687|FG001|Overall Study|Missing/incomplete data|1|||
143452475|NCT01696955|517202688|FG000|Main Study|Protocol Violation|1|||
143452476|NCT01696955|517202689|FG001|Main Study|Protocol Violation|0|||
143452477|NCT01696955|517202688|FG000|Main Study|Withdrawal by Subject|1|||
143452478|NCT01696955|517202689|FG001|Main Study|Withdrawal by Subject|1|||
143452479|NCT02416453|517202690|FG000|Overall Study|Adverse Event|0|||
143452480|NCT02416453|517202691|FG001|Overall Study|Adverse Event|0|||
143452481|NCT02416453|517202692|FG002|Overall Study|Adverse Event|0|||
143452482|NCT02416453|517202693|FG003|Overall Study|Adverse Event|2|||
143452483|NCT02416453|517202694|FG004|Overall Study|Adverse Event|0|||
143452484|NCT02416453|517202695|FG005|Overall Study|Adverse Event|1|||
143452485|NCT02416453|517202696|FG006|Overall Study|Adverse Event|0|||
143452486|NCT02416453|517202697|FG007|Overall Study|Adverse Event|0|||
143452487|NCT02416453|517202698|FG008|Overall Study|Adverse Event|0|||
143452488|NCT02416453|517202699|FG009|Overall Study|Adverse Event|0|||
143452489|NCT02416453|517202700|FG010|Overall Study|Adverse Event|0|||
143452490|NCT02416453|517202690|FG000|Overall Study|Lost to Follow-up|1|||
143452491|NCT02416453|517202691|FG001|Overall Study|Lost to Follow-up|3|||
143452492|NCT02416453|517202692|FG002|Overall Study|Lost to Follow-up|0|||
143452493|NCT02416453|517202693|FG003|Overall Study|Lost to Follow-up|8|||
143452494|NCT02416453|517202694|FG004|Overall Study|Lost to Follow-up|0|||
143452495|NCT02416453|517202695|FG005|Overall Study|Lost to Follow-up|5|||
143452496|NCT02416453|517202696|FG006|Overall Study|Lost to Follow-up|1|||
143452497|NCT02416453|517202697|FG007|Overall Study|Lost to Follow-up|3|||
143452498|NCT02416453|517202698|FG008|Overall Study|Lost to Follow-up|1|||
143452499|NCT02416453|517202699|FG009|Overall Study|Lost to Follow-up|0|||
143452500|NCT02416453|517202700|FG010|Overall Study|Lost to Follow-up|0|||
143452501|NCT02416453|517202690|FG000|Overall Study|Physician Decision|0|||
143452502|NCT02416453|517202691|FG001|Overall Study|Physician Decision|0|||
143452503|NCT02416453|517202692|FG002|Overall Study|Physician Decision|0|||
143452504|NCT02416453|517202693|FG003|Overall Study|Physician Decision|0|||
143452505|NCT02416453|517202694|FG004|Overall Study|Physician Decision|0|||
143452506|NCT02416453|517202695|FG005|Overall Study|Physician Decision|1|||
143452507|NCT02416453|517202696|FG006|Overall Study|Physician Decision|1|||
143452508|NCT02416453|517202697|FG007|Overall Study|Physician Decision|1|||
143452509|NCT02416453|517202698|FG008|Overall Study|Physician Decision|0|||
143452510|NCT02416453|517202699|FG009|Overall Study|Physician Decision|0|||
143452511|NCT02416453|517202700|FG010|Overall Study|Physician Decision|0|||
143452512|NCT02416453|517202690|FG000|Overall Study|Withdrawal by Subject|2|||
143452513|NCT02416453|517202691|FG001|Overall Study|Withdrawal by Subject|0|||
143452514|NCT02416453|517202692|FG002|Overall Study|Withdrawal by Subject|0|||
143452515|NCT02416453|517202693|FG003|Overall Study|Withdrawal by Subject|5|||
143452516|NCT02416453|517202694|FG004|Overall Study|Withdrawal by Subject|1|||
143452517|NCT02416453|517202695|FG005|Overall Study|Withdrawal by Subject|8|||
143452518|NCT02416453|517202696|FG006|Overall Study|Withdrawal by Subject|0|||
143452519|NCT02416453|517202697|FG007|Overall Study|Withdrawal by Subject|8|||
143452520|NCT02416453|517202698|FG008|Overall Study|Withdrawal by Subject|4|||
143452521|NCT02416453|517202699|FG009|Overall Study|Withdrawal by Subject|0|||
143452522|NCT02416453|517202700|FG010|Overall Study|Withdrawal by Subject|0|||
143452523|NCT02416453|517202690|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
143452524|NCT02416453|517202691|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
143452525|NCT02416453|517202692|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
143452526|NCT02416453|517202693|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
143452527|NCT02416453|517202694|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
143452528|NCT02416453|517202695|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
143452529|NCT02416453|517202696|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
143452530|NCT02416453|517202697|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
143452531|NCT02416453|517202698|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
143452532|NCT02416453|517202699|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
143452533|NCT02416453|517202700|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
143452534|NCT02416453|517202690|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
143452535|NCT02416453|517202691|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
143452536|NCT02416453|517202692|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
143452537|NCT02416453|517202693|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
143452538|NCT02416453|517202694|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
143452539|NCT02416453|517202695|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
143452540|NCT02416453|517202696|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
143452541|NCT02416453|517202697|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
143452542|NCT02416453|517202698|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
143452543|NCT02416453|517202699|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
143452544|NCT02416453|517202700|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
143452545|NCT01259089|517202712|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
143452546|NCT01259089|517202713|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
143452547|NCT01259089|517202714|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
143452548|NCT01259089|517202715|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
143452549|NCT01259089|517202716|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
143452550|NCT01259089|517202717|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
143452551|NCT01259089|517202712|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
143452552|NCT01259089|517202713|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
143452553|NCT01259089|517202714|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
143452554|NCT01259089|517202715|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
143452555|NCT01259089|517202716|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
143452556|NCT01259089|517202717|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
143452557|NCT01259089|517202712|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
143452558|NCT01259089|517202713|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
143452559|NCT01259089|517202714|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
143452560|NCT01259089|517202715|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
143452561|NCT01259089|517202716|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
143452562|NCT01259089|517202717|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
143452563|NCT01259089|517202712|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
143452564|NCT01259089|517202713|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
143452565|NCT01259089|517202714|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
143452566|NCT01259089|517202715|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
143452567|NCT01259089|517202716|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
143452568|NCT01259089|517202717|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
143452569|NCT01259089|517202712|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
143452570|NCT01259089|517202713|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
143452571|NCT01259089|517202714|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
143452572|NCT01259089|517202715|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
143452573|NCT01259089|517202716|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
143452574|NCT01259089|517202717|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
143452575|NCT01259089|517202712|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
143452576|NCT01259089|517202713|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
143452577|NCT01259089|517202714|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
143452578|NCT01259089|517202715|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
143452579|NCT01259089|517202716|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
143452580|NCT01259089|517202717|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
143452581|NCT01259089|517202712|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
143452582|NCT01259089|517202713|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
143452583|NCT01259089|517202714|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
143452584|NCT01259089|517202715|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
143452585|NCT01259089|517202716|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
143452586|NCT01259089|517202717|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
143452587|NCT01259089|517202712|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
143452588|NCT01259089|517202713|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
143452589|NCT01259089|517202714|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
143452590|NCT01259089|517202715|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
143452591|NCT01259089|517202716|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
143452592|NCT01259089|517202717|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
143452593|NCT01259089|517202712|FG000|Survival Follow up for Two Years|Death|3|||
143452594|NCT01259089|517202713|FG001|Survival Follow up for Two Years|Death|2|||
143452595|NCT01259089|517202714|FG002|Survival Follow up for Two Years|Death|2|||
143452596|NCT01259089|517202715|FG003|Survival Follow up for Two Years|Death|3|||
143452597|NCT01259089|517202716|FG004|Survival Follow up for Two Years|Death|6|||
143452598|NCT01259089|517202717|FG005|Survival Follow up for Two Years|Death|13|||
143452599|NCT01259089|517202712|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
143452600|NCT01259089|517202713|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
143452601|NCT01259089|517202714|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
143452602|NCT01259089|517202715|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
143452603|NCT01259089|517202716|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
143452604|NCT01259089|517202717|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
143452605|NCT01259089|517202712|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
143452606|NCT01259089|517202713|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
143452607|NCT01259089|517202714|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
143452608|NCT01259089|517202715|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
143452609|NCT01259089|517202716|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
143452610|NCT01259089|517202717|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
143452611|NCT02310100|517202718|FG000|Overall Study|Physician Decision|3|||
143452612|NCT02310100|517202718|FG000|Overall Study|Withdrawal by Subject|10|||
143452613|NCT02310100|517202718|FG000|Overall Study|Enrollment closure|1|||
143452614|NCT02310100|517202718|FG000|Overall Study|Unapproved ablation operator|1|||
143452615|NCT02310100|517202718|FG000|Overall Study|Visit compliance|1|||
143452616|NCT02310100|517202718|FG000|Overall Study|Lost to Follow-up|2|||
143452617|NCT01253018|517202722|FG000|Overall Study|Lost to Follow-up|1|||
143452618|NCT01253018|517202723|FG001|Overall Study|Lost to Follow-up|1|||
143452619|NCT01253018|517202722|FG000|Overall Study|Robot Repair Issues|2|||
143452620|NCT01253018|517202723|FG001|Overall Study|Robot Repair Issues|0|||
143452621|NCT01253018|517202722|FG000|Overall Study|Withdrawal by Subject|1|||
143452622|NCT01253018|517202723|FG001|Overall Study|Withdrawal by Subject|1|||
143452623|NCT00744757|517202724|FG000|Overall Study|Objective disease progression|7|||
143452624|NCT00744757|517202724|FG000|Overall Study|Physician Decision|5|||
143452625|NCT00744757|517202724|FG000|Overall Study|Withdrawal by Subject|1|||
143452626|NCT00744757|517202724|FG000|Overall Study|Death|6|||
143452627|NCT00744757|517202724|FG000|Overall Study|Adverse Event|2|||
143452628|NCT00532493|517202725|FG000|Overall Study|Death|1|||
143452629|NCT00532493|517202726|FG001|Overall Study|Death|1|||
143452630|NCT00532493|517202725|FG000|Overall Study|Lost to Follow-up|10|||
143452631|NCT00532493|517202726|FG001|Overall Study|Lost to Follow-up|7|||
143452632|NCT00532493|517202725|FG000|Overall Study|Withdrawal by Subject|7|||
143452633|NCT00532493|517202726|FG001|Overall Study|Withdrawal by Subject|9|||
143452634|NCT00532493|517202725|FG000|Overall Study|Physician Decision|1|||
143452635|NCT00532493|517202726|FG001|Overall Study|Physician Decision|6|||
143452636|NCT00532493|517202725|FG000|Overall Study|Adverse Event|6|||
143452637|NCT00532493|517202726|FG001|Overall Study|Adverse Event|5|||
143452638|NCT00532493|517202725|FG000|Overall Study|Protocol Deviation|1|||
143452639|NCT00532493|517202726|FG001|Overall Study|Protocol Deviation|0|||
143452640|NCT00532493|517202725|FG000|Overall Study|Subject Moved Away|3|||
143452641|NCT00532493|517202726|FG001|Overall Study|Subject Moved Away|1|||
143452642|NCT00532493|517202725|FG000|Overall Study|Contraindicative Medication|1|||
143452643|NCT00532493|517202726|FG001|Overall Study|Contraindicative Medication|0|||
143452644|NCT01769326|517202732|FG000|Overall Study|Lost to Follow-up|1|||
143452645|NCT01769326|517202733|FG001|Overall Study|Lost to Follow-up|2|||
143452646|NCT01769326|517202734|FG002|Overall Study|Lost to Follow-up|0|||
143452647|NCT01769326|517202735|FG003|Overall Study|Lost to Follow-up|0|||
143452648|NCT01769326|517202732|FG000|Overall Study|unrelated injry|1|||
143452649|NCT01769326|517202733|FG001|Overall Study|unrelated injry|1|||
143452650|NCT01769326|517202734|FG002|Overall Study|unrelated injry|0|||
143452651|NCT01769326|517202735|FG003|Overall Study|unrelated injry|0|||
143452652|NCT01769326|517202732|FG000|Overall Study|got a job|0|||
143452653|NCT01769326|517202733|FG001|Overall Study|got a job|1|||
143452654|NCT01769326|517202734|FG002|Overall Study|got a job|0|||
143452655|NCT01769326|517202735|FG003|Overall Study|got a job|0|||
143452656|NCT01769326|517202732|FG000|Overall Study|Got sick and could not complete study|0|||
143452657|NCT01769326|517202733|FG001|Overall Study|Got sick and could not complete study|0|||
143452658|NCT01769326|517202734|FG002|Overall Study|Got sick and could not complete study|1|||
143452659|NCT01769326|517202735|FG003|Overall Study|Got sick and could not complete study|0|||
143452660|NCT00888927|517202736|FG000|Overall Study|Adverse Event|0|||
143452661|NCT00888927|517202737|FG001|Overall Study|Adverse Event|0|||
143452662|NCT00888927|517202738|FG002|Overall Study|Adverse Event|0|||
143452663|NCT00888927|517202739|FG003|Overall Study|Adverse Event|1|||
143452664|NCT00888927|517202736|FG000|Overall Study|Withdrawal of consent|0|||
143452665|NCT00888927|517202737|FG001|Overall Study|Withdrawal of consent|0|||
143452666|NCT00888927|517202738|FG002|Overall Study|Withdrawal of consent|0|||
143452667|NCT00888927|517202739|FG003|Overall Study|Withdrawal of consent|1|||
143452668|NCT03459443|517202740|FG000|Overall Study|Lack of Efficacy|3|||
143452669|NCT03459443|517202740|FG000|Overall Study|Adverse Event|1|||
143452670|NCT03459443|517202740|FG000|Overall Study|Sponsor's decision to close the study|18|||
143452671|NCT02153073|517202741|FG000|Overall Study|Case Report Forms Uncollected|230|||
143452672|NCT02153073|517202741|FG000|Overall Study|Protocol Deviation|68|||
143452673|NCT03702231|517202742|FG000|Overall Study|Withdrawal by Subject|1|||
143452674|NCT03702231|517202743|FG001|Overall Study|Withdrawal by Subject|0|||
143452675|NCT03702231|517202744|FG002|Overall Study|Withdrawal by Subject|0|||
143452676|NCT03702231|517202742|FG000|Overall Study|Protocol Violation|0|||
143452677|NCT03702231|517202743|FG001|Overall Study|Protocol Violation|0|||
143452678|NCT03702231|517202744|FG002|Overall Study|Protocol Violation|1|||
143452679|NCT03702231|517202742|FG000|Overall Study|Change in CLL Treatment|0|||
143452680|NCT03702231|517202743|FG001|Overall Study|Change in CLL Treatment|0|||
143452681|NCT03702231|517202744|FG002|Overall Study|Change in CLL Treatment|1|||
143452682|NCT03702231|517202742|FG000|Overall Study|COVID Pandemic|1|||
143452683|NCT03702231|517202743|FG001|Overall Study|COVID Pandemic|4|||
143452684|NCT03702231|517202744|FG002|Overall Study|COVID Pandemic|1|||
143452685|NCT03702231|517202742|FG000|Overall Study|Non-compliance|0|||
143452686|NCT03702231|517202743|FG001|Overall Study|Non-compliance|0|||
143452687|NCT03702231|517202744|FG002|Overall Study|Non-compliance|1|||
143452688|NCT05051462|517202748|FG000|Overall Study|Lost to Follow-up|1|||
143452689|NCT05051462|517202749|FG001|Overall Study|Lost to Follow-up|8|||
143452690|NCT05051462|517202748|FG000|Overall Study|Withdrawal by Subject|1|||
143452691|NCT05051462|517202749|FG001|Overall Study|Withdrawal by Subject|0|||
143452692|NCT05051462|517202748|FG000|Overall Study|Protocol Violation|0|||
143452693|NCT05051462|517202749|FG001|Overall Study|Protocol Violation|2|||
143452694|NCT03842358|517202754|FG000|Overall Study|Poor DOT probe contact with breast|2|||
143452695|NCT03842358|517202754|FG000|Overall Study|DOT system problem|1|||
143452696|NCT03842358|517202754|FG000|Overall Study|Switched to x-ray guided biopsy|3|||
143452697|NCT03842358|517202754|FG000|Overall Study|No biopsy after physician review|4|||
143452698|NCT03842358|517202754|FG000|Overall Study|Patient withdrew|2|||
143452699|NCT02626455|517202755|FG000|Overall Study|Other|1|||
143452700|NCT02626455|517202756|FG001|Overall Study|Other|1|||
143452701|NCT02626455|517202757|FG002|Overall Study|Other|0|||
143452702|NCT02626455|517202758|FG003|Overall Study|Other|0|||
143452703|NCT02626455|517202759|FG004|Overall Study|Other|0|||
143452704|NCT02626455|517202760|FG005|Overall Study|Other|17|||
143452705|NCT02626455|517202761|FG006|Overall Study|Other|23|||
143452706|NCT02626455|517202755|FG000|Overall Study|Withdrawal by Subject|1|||
143452707|NCT02626455|517202756|FG001|Overall Study|Withdrawal by Subject|0|||
143452708|NCT02626455|517202757|FG002|Overall Study|Withdrawal by Subject|0|||
143452709|NCT02626455|517202758|FG003|Overall Study|Withdrawal by Subject|0|||
143452710|NCT02626455|517202759|FG004|Overall Study|Withdrawal by Subject|0|||
143452711|NCT02626455|517202760|FG005|Overall Study|Withdrawal by Subject|10|||
143452712|NCT02626455|517202761|FG006|Overall Study|Withdrawal by Subject|6|||
143452713|NCT02626455|517202755|FG000|Overall Study|Physician Decision|0|||
143452714|NCT02626455|517202756|FG001|Overall Study|Physician Decision|2|||
143452715|NCT02626455|517202757|FG002|Overall Study|Physician Decision|2|||
143452716|NCT02626455|517202758|FG003|Overall Study|Physician Decision|2|||
143452717|NCT02626455|517202759|FG004|Overall Study|Physician Decision|1|||
143452718|NCT02626455|517202760|FG005|Overall Study|Physician Decision|10|||
143452719|NCT02626455|517202761|FG006|Overall Study|Physician Decision|3|||
143452720|NCT02626455|517202755|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
143452721|NCT02626455|517202756|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
143452722|NCT02626455|517202757|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
143452723|NCT02626455|517202758|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
143452724|NCT02626455|517202759|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
143452725|NCT02626455|517202760|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
143452726|NCT02626455|517202761|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
143452727|NCT02626455|517202755|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
143452728|NCT02626455|517202756|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
143452729|NCT02626455|517202757|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
143452730|NCT02626455|517202758|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
143452731|NCT02626455|517202759|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
143452732|NCT02626455|517202760|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
143452733|NCT02626455|517202761|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
143452734|NCT02626455|517202755|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
143452735|NCT02626455|517202756|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
143452736|NCT02626455|517202757|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
143452737|NCT02626455|517202758|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
143452738|NCT02626455|517202759|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
143452739|NCT02626455|517202760|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
143452740|NCT02626455|517202761|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
143452741|NCT02626455|517202755|FG000|Overall Study|Patient decision|0|||
143452742|NCT02626455|517202756|FG001|Overall Study|Patient decision|1|||
143452743|NCT02626455|517202757|FG002|Overall Study|Patient decision|0|||
143452744|NCT02626455|517202758|FG003|Overall Study|Patient decision|0|||
143452745|NCT02626455|517202759|FG004|Overall Study|Patient decision|1|||
143452746|NCT02626455|517202760|FG005|Overall Study|Patient decision|36|||
143452747|NCT02626455|517202761|FG006|Overall Study|Patient decision|22|||
143452748|NCT02626455|517202755|FG000|Overall Study|Protocol Violation|0|||
143452749|NCT02626455|517202756|FG001|Overall Study|Protocol Violation|0|||
143452750|NCT02626455|517202757|FG002|Overall Study|Protocol Violation|0|||
143452751|NCT02626455|517202758|FG003|Overall Study|Protocol Violation|0|||
143452752|NCT02626455|517202759|FG004|Overall Study|Protocol Violation|0|||
143452753|NCT02626455|517202760|FG005|Overall Study|Protocol Violation|0|||
143452754|NCT02626455|517202761|FG006|Overall Study|Protocol Violation|1|||
143452755|NCT02626455|517202755|FG000|Overall Study|Progressive disease - radiological progression|0|||
143452756|NCT02626455|517202756|FG001|Overall Study|Progressive disease - radiological progression|0|||
143452757|NCT02626455|517202757|FG002|Overall Study|Progressive disease - radiological progression|0|||
143452758|NCT02626455|517202758|FG003|Overall Study|Progressive disease - radiological progression|0|||
143452759|NCT02626455|517202759|FG004|Overall Study|Progressive disease - radiological progression|0|||
143452760|NCT02626455|517202760|FG005|Overall Study|Progressive disease - radiological progression|11|||
143452761|NCT02626455|517202761|FG006|Overall Study|Progressive disease - radiological progression|22|||
143452762|NCT02626455|517202755|FG000|Overall Study|Progressive disease - clinical progression|0|||
143452763|NCT02626455|517202756|FG001|Overall Study|Progressive disease - clinical progression|0|||
143452764|NCT02626455|517202757|FG002|Overall Study|Progressive disease - clinical progression|0|||
143452765|NCT02626455|517202758|FG003|Overall Study|Progressive disease - clinical progression|0|||
143452766|NCT02626455|517202759|FG004|Overall Study|Progressive disease - clinical progression|0|||
143452767|NCT02626455|517202760|FG005|Overall Study|Progressive disease - clinical progression|1|||
143452768|NCT02626455|517202761|FG006|Overall Study|Progressive disease - clinical progression|2|||
143452769|NCT02626455|517202755|FG000|Overall Study|Lost to Follow-up|0|||
143452770|NCT02626455|517202756|FG001|Overall Study|Lost to Follow-up|0|||
143452771|NCT02626455|517202757|FG002|Overall Study|Lost to Follow-up|0|||
143452772|NCT02626455|517202758|FG003|Overall Study|Lost to Follow-up|0|||
143452773|NCT02626455|517202759|FG004|Overall Study|Lost to Follow-up|0|||
143452774|NCT02626455|517202760|FG005|Overall Study|Lost to Follow-up|1|||
143452775|NCT02626455|517202761|FG006|Overall Study|Lost to Follow-up|0|||
143452776|NCT02626455|517202755|FG000|Overall Study|AE not associated with clinical disease progression|1|||
143452777|NCT02626455|517202756|FG001|Overall Study|AE not associated with clinical disease progression|1|||
143452778|NCT02626455|517202757|FG002|Overall Study|AE not associated with clinical disease progression|0|||
143452779|NCT02626455|517202758|FG003|Overall Study|AE not associated with clinical disease progression|2|||
143452780|NCT02626455|517202759|FG004|Overall Study|AE not associated with clinical disease progression|1|||
143452781|NCT02626455|517202760|FG005|Overall Study|AE not associated with clinical disease progression|65|||
143452782|NCT02626455|517202761|FG006|Overall Study|AE not associated with clinical disease progression|21|||
143452783|NCT02626455|517202755|FG000|Overall Study|AE associated with clinical disease progression|0|||
143452784|NCT02626455|517202756|FG001|Overall Study|AE associated with clinical disease progression|0|||
143452785|NCT02626455|517202757|FG002|Overall Study|AE associated with clinical disease progression|0|||
143452786|NCT02626455|517202758|FG003|Overall Study|AE associated with clinical disease progression|0|||
143452787|NCT02626455|517202759|FG004|Overall Study|AE associated with clinical disease progression|0|||
143452788|NCT02626455|517202760|FG005|Overall Study|AE associated with clinical disease progression|1|||
143452789|NCT02626455|517202761|FG006|Overall Study|AE associated with clinical disease progression|2|||
143452790|NCT02626455|517202755|FG000|Overall Study|Study intervention never administered|0|||
143452791|NCT02626455|517202756|FG001|Overall Study|Study intervention never administered|0|||
143452792|NCT02626455|517202757|FG002|Overall Study|Study intervention never administered|0|||
143452793|NCT02626455|517202758|FG003|Overall Study|Study intervention never administered|0|||
143452794|NCT02626455|517202759|FG004|Overall Study|Study intervention never administered|0|||
143452795|NCT02626455|517202760|FG005|Overall Study|Study intervention never administered|1|||
143452796|NCT02626455|517202761|FG006|Overall Study|Study intervention never administered|3|||
143452797|NCT06665919|517202762|FG000|Overall Study|Withdrawal by Subject|4|||
143452798|NCT06665919|517202763|FG001|Overall Study|Withdrawal by Subject|4|||
143452799|NCT06665919|517202764|FG002|Overall Study|Withdrawal by Subject|4|||
143452800|NCT06665919|517202762|FG000|Overall Study|Non-compliance to Treatment|4|||
143452801|NCT06665919|517202763|FG001|Overall Study|Non-compliance to Treatment|1|||
143452802|NCT06665919|517202764|FG002|Overall Study|Non-compliance to Treatment|6|||
143452803|NCT06665919|517202762|FG000|Overall Study|Lost to Follow-up|3|||
143452804|NCT06665919|517202763|FG001|Overall Study|Lost to Follow-up|0|||
143452805|NCT06665919|517202764|FG002|Overall Study|Lost to Follow-up|2|||
143452806|NCT06665919|517202762|FG000|Overall Study|Physician Decision|4|||
143452807|NCT06665919|517202763|FG001|Overall Study|Physician Decision|0|||
143452808|NCT06665919|517202764|FG002|Overall Study|Physician Decision|1|||
143452809|NCT01200290|517202765|FG000|Treatment Period|Adverse Event|1|||
143452810|NCT01200290|517202765|FG000|Post-Treatment Follow-Up Period|Death|2|||
143452811|NCT01144377|517202766|FG000|52 Week Treatment Period|Adverse Event|0|||
143452812|NCT01144377|517202767|FG001|52 Week Treatment Period|Adverse Event|0|||
143452813|NCT01144377|517202768|FG002|52 Week Treatment Period|Adverse Event|3|||
143452814|NCT01144377|517202769|FG003|52 Week Treatment Period|Adverse Event|2|||
143452815|NCT01144377|517202770|FG004|52 Week Treatment Period|Adverse Event|1|||
143452816|NCT01144377|517202766|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
143452817|NCT01144377|517202767|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
143452818|NCT01144377|517202768|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
143452819|NCT01144377|517202769|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
143452820|NCT01144377|517202770|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
143452821|NCT01144377|517202766|FG000|52 Week Treatment Period|Protocol Violation|0|||
143452822|NCT01144377|517202767|FG001|52 Week Treatment Period|Protocol Violation|0|||
143452823|NCT01144377|517202768|FG002|52 Week Treatment Period|Protocol Violation|0|||
143452824|NCT01144377|517202769|FG003|52 Week Treatment Period|Protocol Violation|0|||
143452825|NCT01144377|517202770|FG004|52 Week Treatment Period|Protocol Violation|1|||
143452826|NCT01144377|517202766|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
143452827|NCT01144377|517202767|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
143452828|NCT01144377|517202768|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
143452829|NCT01144377|517202769|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
143452830|NCT01144377|517202770|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
143452831|NCT01144377|517202766|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
143452832|NCT01144377|517202767|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
143452833|NCT01144377|517202768|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
143452834|NCT01144377|517202769|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
143452835|NCT01144377|517202770|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
143452836|NCT01144377|517202766|FG000|52 Week Treatment Period|Sponsor Decision|0|||
143452837|NCT01144377|517202767|FG001|52 Week Treatment Period|Sponsor Decision|0|||
143452838|NCT01144377|517202768|FG002|52 Week Treatment Period|Sponsor Decision|0|||
143452839|NCT01144377|517202769|FG003|52 Week Treatment Period|Sponsor Decision|0|||
143452840|NCT01144377|517202770|FG004|52 Week Treatment Period|Sponsor Decision|1|||
143452841|NCT01144377|517202766|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
143452842|NCT01144377|517202767|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
143452843|NCT01144377|517202768|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
143452844|NCT01144377|517202769|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
143452845|NCT01144377|517202770|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
143452846|NCT01144377|517202766|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
143452847|NCT01144377|517202767|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
143452848|NCT01144377|517202768|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
143452849|NCT01144377|517202769|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
143452850|NCT01144377|517202770|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
143452851|NCT01144377|517202766|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
143452852|NCT01144377|517202767|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
143452853|NCT01144377|517202768|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
143452854|NCT01144377|517202769|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
143452855|NCT01144377|517202770|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
143452856|NCT00607724|517202771|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
143452857|NCT00607724|517202772|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
143452858|NCT00607724|517202773|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
143452859|NCT00607724|517202774|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
143452860|NCT00607724|517202775|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
143452861|NCT00607724|517202776|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
143452862|NCT00607724|517202777|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
143452863|NCT00607724|517202771|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
143452864|NCT00607724|517202772|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
143452865|NCT00607724|517202773|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
143452866|NCT00607724|517202774|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
143452867|NCT00607724|517202775|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
143452868|NCT00607724|517202776|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
143452869|NCT00607724|517202777|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
143452870|NCT00607724|517202771|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
143452871|NCT00607724|517202772|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
143452872|NCT00607724|517202773|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
143452873|NCT00607724|517202774|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
143452874|NCT00607724|517202775|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
143452875|NCT00607724|517202776|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
143452876|NCT00607724|517202777|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
143452877|NCT00607724|517202771|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
143452878|NCT00607724|517202772|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
143452879|NCT00607724|517202773|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
143452880|NCT00607724|517202774|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
143452881|NCT00607724|517202775|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
143452882|NCT00607724|517202776|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
143452883|NCT00607724|517202777|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
143452884|NCT00607724|517202771|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
143452885|NCT00607724|517202772|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
143452886|NCT00607724|517202773|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
143452887|NCT00607724|517202774|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
143452888|NCT00607724|517202775|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
143452889|NCT00607724|517202776|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
143452890|NCT00607724|517202777|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
143452891|NCT00151281|517202778|FG000|Overall Study|Not evaluable|3|||
143452892|NCT01133418|517202781|FG000|Overall Study|Lost to Follow-up|5|||
143452893|NCT01133418|517202782|FG001|Overall Study|Lost to Follow-up|6|||
143452894|NCT04150068|517202783|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
143452895|NCT04150068|517202784|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
143452896|NCT04150068|517202785|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
143452897|NCT04150068|517202783|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
143452898|NCT04150068|517202784|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
143452899|NCT04150068|517202785|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
143452900|NCT05316701|517202786|FG000|Overall Study|Adverse Event|0|||
143452901|NCT05316701|517202787|FG001|Overall Study|Adverse Event|1|||
143452902|NCT05316701|517202786|FG000|Overall Study|Death|3|||
143452903|NCT05316701|517202787|FG001|Overall Study|Death|9|||
143452904|NCT05316701|517202786|FG000|Overall Study|Lost to Follow-up|1|||
143452905|NCT05316701|517202787|FG001|Overall Study|Lost to Follow-up|0|||
143452906|NCT05316701|517202786|FG000|Overall Study|Physician Decision|1|||
143452907|NCT05316701|517202787|FG001|Overall Study|Physician Decision|4|||
143452908|NCT05316701|517202786|FG000|Overall Study|Withdrawal by Subject|3|||
143452909|NCT05316701|517202787|FG001|Overall Study|Withdrawal by Subject|5|||
143452910|NCT05316701|517202786|FG000|Overall Study|Progression/Relapse|14|||
143452911|NCT05316701|517202787|FG001|Overall Study|Progression/Relapse|9|||
143452912|NCT05316701|517202786|FG000|Overall Study|Received Standard of Care|1|||
143452913|NCT05316701|517202787|FG001|Overall Study|Received Standard of Care|0|||
143452914|NCT05316701|517202786|FG000|Overall Study|Ongoing|70|||
143452915|NCT05316701|517202787|FG001|Overall Study|Ongoing|64|||
143452916|NCT04679935|517202788|FG000|Overall Study|Death|0|||
143452917|NCT04679935|517202789|FG001|Overall Study|Death|1|||
143452918|NCT04362189|517202790|FG000|Overall Study|Lost to Follow-up|0|||
143452919|NCT04362189|517202791|FG001|Overall Study|Lost to Follow-up|1|||
143452920|NCT04362189|517202790|FG000|Overall Study|Withdrawal by Subject|1|||
143452921|NCT04362189|517202791|FG001|Overall Study|Withdrawal by Subject|0|||
143452922|NCT04362189|517202790|FG000|Overall Study|FDA Clinical Hold|7|||
143452923|NCT04362189|517202791|FG001|Overall Study|FDA Clinical Hold|2|||
143452924|NCT04362189|517202790|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
143452925|NCT04362189|517202791|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
143452926|NCT04362189|517202790|FG000|Overall Study|Adverse Event|0|||
143452927|NCT04362189|517202791|FG001|Overall Study|Adverse Event|2|||
143452928|NCT04362189|517202790|FG000|Overall Study|Death|4|||
143452929|NCT04362189|517202791|FG001|Overall Study|Death|1|||
143452930|NCT02111681|517202792|FG000|Overall Study|Death|5|||
143452931|NCT02111681|517202792|FG000|Overall Study|Lack of Efficacy|2|||
143452932|NCT02111681|517202792|FG000|Overall Study|Progression of disease|4|||
143452933|NCT02731690|517204212|FG000|Overall Study|Adverse Event|1|||
143452934|NCT02731690|517204212|FG000|Overall Study|Withdrawal by Subject|3|||
143452935|NCT02731690|517204212|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
143452936|NCT02735577|517204213|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
143452937|NCT02735577|517204213|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
143452938|NCT03828747|517204220|FG000|Double-Blind Treatment Period|Adverse Event|6|||
143452939|NCT03828747|517204221|FG001|Double-Blind Treatment Period|Adverse Event|6|||
143452940|NCT03828747|517204220|FG000|Double-Blind Treatment Period|Death|1|||
143452941|NCT03828747|517204221|FG001|Double-Blind Treatment Period|Death|1|||
143452942|NCT03828747|517204220|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
143452943|NCT03828747|517204221|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
143452944|NCT03828747|517204220|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
143452945|NCT03828747|517204221|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
143452946|NCT03828747|517204220|FG000|Double-Blind Treatment Period|Physician Decision|1|||
143452947|NCT03828747|517204221|FG001|Double-Blind Treatment Period|Physician Decision|4|||
143452948|NCT03828747|517204220|FG000|Double-Blind Treatment Period|Various reasons|5|||
143452949|NCT03828747|517204221|FG001|Double-Blind Treatment Period|Various reasons|3|||
143452950|NCT03828747|517204220|FG000|Open-Label Extension|Adverse Event|9|||
143452951|NCT03828747|517204221|FG001|Open-Label Extension|Adverse Event|7|||
143452952|NCT03828747|517204220|FG000|Open-Label Extension|Death|0|||
143452953|NCT03828747|517204221|FG001|Open-Label Extension|Death|2|||
143452954|NCT03828747|517204220|FG000|Open-Label Extension|Lost to Follow-up|4|||
143452955|NCT03828747|517204221|FG001|Open-Label Extension|Lost to Follow-up|0|||
143452956|NCT03828747|517204220|FG000|Open-Label Extension|Withdrawal by Subject|31|||
143452957|NCT03828747|517204221|FG001|Open-Label Extension|Withdrawal by Subject|30|||
143452958|NCT03828747|517204220|FG000|Open-Label Extension|Various reasons|4|||
143452959|NCT03828747|517204221|FG001|Open-Label Extension|Various reasons|4|||
143452960|NCT03828747|517204220|FG000|Open-Label Extension|Physician Decision|6|||
143452961|NCT03828747|517204221|FG001|Open-Label Extension|Physician Decision|2|||
143452962|NCT00836745|517204229|FG000|Overall Study|Death|2|||
143452963|NCT00836745|517204229|FG000|Overall Study|Lost to Follow-up|10|||
143452964|NCT00836745|517204229|FG000|Overall Study|Adverse Event|3|||
143452965|NCT00836745|517204229|FG000|Overall Study|Objective progression or relapse|4|||
143452966|NCT00836745|517204229|FG000|Overall Study|Other|2|||
143452967|NCT02366468|517204230|FG000|Overall Study|Adverse Event|2|||
143452968|NCT02366468|517204231|FG001|Overall Study|Adverse Event|0|||
143452969|NCT02366468|517204230|FG000|Overall Study|Withdrawal by Subject|1|||
143452970|NCT02366468|517204231|FG001|Overall Study|Withdrawal by Subject|5|||
143452971|NCT02366468|517204230|FG000|Overall Study|Lost to Follow-up|2|||
143452972|NCT02366468|517204231|FG001|Overall Study|Lost to Follow-up|0|||
143452973|NCT02366468|517204230|FG000|Overall Study|Death|1|||
143452974|NCT02366468|517204231|FG001|Overall Study|Death|2|||
143452975|NCT02366468|517204230|FG000|Overall Study|Other|0|||
143452976|NCT02366468|517204231|FG001|Overall Study|Other|2|||
143452977|NCT00490490|517204232|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
143452978|NCT00490490|517204232|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
143452979|NCT05540717|517204233|FG000|Overall Study|Lost to Follow-up|2|||
143452980|NCT05540717|517204234|FG001|Overall Study|Lost to Follow-up|5|||
143452981|NCT05540717|517204233|FG000|Overall Study|Withdrawal by Subject|6|||
143452982|NCT05540717|517204234|FG001|Overall Study|Withdrawal by Subject|6|||
143452983|NCT05540717|517204233|FG000|Overall Study|Sponsor request|1|||
143452984|NCT05540717|517204234|FG001|Overall Study|Sponsor request|0|||
143452985|NCT05540717|517204233|FG000|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
143452986|NCT05540717|517204234|FG001|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
143452987|NCT05540717|517204233|FG000|Overall Study|Other|0|||
143452988|NCT05540717|517204234|FG001|Overall Study|Other|1|||
143452989|NCT02141620|517204235|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
143452990|NCT02141620|517204236|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
143452991|NCT03651622|517204237|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
143452992|NCT03651622|517204238|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
143452993|NCT03651622|517204239|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
143452994|NCT03651622|517204237|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
143452995|NCT03651622|517204238|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
143452996|NCT03651622|517204239|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
143452997|NCT03651622|517204237|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
143452998|NCT03651622|517204238|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
143452999|NCT03651622|517204239|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
143453000|NCT03651622|517204237|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
143453001|NCT03651622|517204238|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
143453002|NCT03651622|517204239|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
143453003|NCT03651622|517204237|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
143453004|NCT03651622|517204238|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
143453005|NCT03651622|517204239|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
143453006|NCT00307684|517204240|FG000|Open Label Phase|Lack of Efficacy|0|||
143453007|NCT00307684|517204241|FG001|Open Label Phase|Lack of Efficacy|0|||
143453008|NCT00307684|517204242|FG002|Open Label Phase|Lack of Efficacy|3|||
143453009|NCT00307684|517204240|FG000|Open Label Phase|Adverse Event|0|||
143453010|NCT00307684|517204241|FG001|Open Label Phase|Adverse Event|0|||
143453011|NCT00307684|517204242|FG002|Open Label Phase|Adverse Event|16|||
143453012|NCT00307684|517204240|FG000|Open Label Phase|Withdrawal by Subject|0|||
143453013|NCT00307684|517204241|FG001|Open Label Phase|Withdrawal by Subject|0|||
143453014|NCT00307684|517204242|FG002|Open Label Phase|Withdrawal by Subject|15|||
143453015|NCT00307684|517204240|FG000|Open Label Phase|Lost to Follow-up|0|||
143453016|NCT00307684|517204241|FG001|Open Label Phase|Lost to Follow-up|0|||
143453017|NCT00307684|517204242|FG002|Open Label Phase|Lost to Follow-up|11|||
143453018|NCT00307684|517204240|FG000|Open Label Phase|non compliance|0|||
143453019|NCT00307684|517204241|FG001|Open Label Phase|non compliance|0|||
143453020|NCT00307684|517204242|FG002|Open Label Phase|non compliance|5|||
143453021|NCT00307684|517204240|FG000|Open Label Phase|other|0|||
143453022|NCT00307684|517204241|FG001|Open Label Phase|other|0|||
143453023|NCT00307684|517204242|FG002|Open Label Phase|other|6|||
143453024|NCT00307684|517204240|FG000|Double Blind Phase|Lack of Efficacy|2|||
143453025|NCT00307684|517204241|FG001|Double Blind Phase|Lack of Efficacy|5|||
143453026|NCT00307684|517204242|FG002|Double Blind Phase|Lack of Efficacy|0|||
143453027|NCT02580305|517204243|FG000|Overall Study|Adverse Event|15|||
143453028|NCT02580305|517204244|FG001|Overall Study|Adverse Event|19|||
143453029|NCT02580305|517204245|FG002|Overall Study|Adverse Event|10|||
143453030|NCT02580305|517204243|FG000|Overall Study|Lack of Efficacy|5|||
143453031|NCT02580305|517204244|FG001|Overall Study|Lack of Efficacy|0|||
143453032|NCT02580305|517204245|FG002|Overall Study|Lack of Efficacy|2|||
143453033|NCT02580305|517204243|FG000|Overall Study|Protocol Violation|4|||
143453034|NCT02580305|517204244|FG001|Overall Study|Protocol Violation|9|||
143453035|NCT02580305|517204245|FG002|Overall Study|Protocol Violation|6|||
143453036|NCT02580305|517204243|FG000|Overall Study|Lost to Follow-up|4|||
143453037|NCT02580305|517204244|FG001|Overall Study|Lost to Follow-up|4|||
143453038|NCT02580305|517204245|FG002|Overall Study|Lost to Follow-up|2|||
143453039|NCT02580305|517204243|FG000|Overall Study|Withdrawal by Subject|11|||
143453040|NCT02580305|517204244|FG001|Overall Study|Withdrawal by Subject|9|||
143453041|NCT02580305|517204245|FG002|Overall Study|Withdrawal by Subject|7|||
143453042|NCT02580305|517204243|FG000|Overall Study|Randomized in error and never treated|4|||
143453043|NCT02580305|517204244|FG001|Overall Study|Randomized in error and never treated|8|||
143453044|NCT02580305|517204245|FG002|Overall Study|Randomized in error and never treated|5|||
143453045|NCT00224887|517204246|FG000|Overall Study|Pregnancy|6|||
143453046|NCT00224887|517204247|FG001|Overall Study|Pregnancy|6|||
143453047|NCT01353859|517204248|FG000|Overall Study|Adverse Event|3|||
143453048|NCT01353859|517204248|FG000|Overall Study|Lack of Efficacy|1|||
143453049|NCT03527550|517204253|FG000|Overall Study|Lost to Follow-up|4|||
143453050|NCT03527550|517204254|FG001|Overall Study|Lost to Follow-up|2|||
143453051|NCT03527550|517204253|FG000|Overall Study|Withdrawal by Subject|4|||
143453052|NCT03527550|517204254|FG001|Overall Study|Withdrawal by Subject|1|||
143453053|NCT03527550|517204253|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
143453054|NCT03527550|517204254|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
143453055|NCT04032613|517204255|FG000|Overall Study|Did not complete post-program assessment|5|||
143453056|NCT04032613|517204256|FG001|Overall Study|Did not complete post-program assessment|2|||
143453057|NCT01659853|517204257|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
143453058|NCT01659853|517204258|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
143453059|NCT01659853|517204257|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
143453060|NCT01659853|517204258|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
143453061|NCT03053518|517204261|FG000|Overall Study|Withdrawal by Subject|3|||
143453062|NCT03053518|517204261|FG000|Overall Study|Lost to Follow-up|2|||
143453063|NCT03053518|517204261|FG000|Overall Study|Ineligible|5|||
143453064|NCT02683876|517204262|FG000|Overall Study|samples damaged during shipping|2|||
143453065|NCT02683876|517204263|FG001|Overall Study|samples damaged during shipping|0|||
143453066|NCT02071290|517204264|FG000|Overall Study|Death|1|||
143453067|NCT02071290|517204265|FG001|Overall Study|Death|0|||
143453068|NCT02071290|517204264|FG000|Overall Study|Withdrawal by Subject|0|||
143453069|NCT02071290|517204265|FG001|Overall Study|Withdrawal by Subject|1|||
143453070|NCT02071290|517204264|FG000|Overall Study|Protocol Violation|3|||
143453071|NCT02071290|517204265|FG001|Overall Study|Protocol Violation|5|||
143453072|NCT02071290|517204264|FG000|Overall Study|Physician Decision|0|||
143453073|NCT02071290|517204265|FG001|Overall Study|Physician Decision|1|||
143453074|NCT00939822|517204270|FG000|Overall Study|Lost to Follow-up|1|||
143453075|NCT00939822|517204271|FG001|Overall Study|Lost to Follow-up|0|||
143453076|NCT00939822|517204270|FG000|Overall Study|withdrew from study due to busy schedule|1|||
143453077|NCT00939822|517204271|FG001|Overall Study|withdrew from study due to busy schedule|1|||
143453078|NCT00939822|517204270|FG000|Overall Study|Mental health issues|0|||
143453079|NCT00939822|517204271|FG001|Overall Study|Mental health issues|2|||
143453080|NCT01232738|517204272|FG000|Overall Study|Death|3|||
143453081|NCT01232738|517204272|FG000|Overall Study|Physician Decision|2|||
143453082|NCT01232738|517204272|FG000|Overall Study|Lost to Follow-up|1|||
143453083|NCT01232738|517204272|FG000|Overall Study|Withdrawal by Subject|2|||
143453084|NCT01232738|517204272|FG000|Overall Study|Adverse Event|5|||
143453085|NCT00859222|517204273|FG000|Overall Study|Adverse Event|2|||
143453086|NCT00859222|517204274|FG001|Overall Study|Adverse Event|3|||
143453087|NCT00859222|517204275|FG002|Overall Study|Adverse Event|6|||
143453088|NCT00859222|517204276|FG003|Overall Study|Adverse Event|24|||
143453089|NCT00859222|517204277|FG004|Overall Study|Adverse Event|15|||
143453090|NCT00859222|517204273|FG000|Overall Study|DLT|1|||
143453091|NCT00859222|517204274|FG001|Overall Study|DLT|0|||
143453092|NCT00859222|517204275|FG002|Overall Study|DLT|0|||
143453093|NCT00859222|517204276|FG003|Overall Study|DLT|0|||
143453094|NCT00859222|517204277|FG004|Overall Study|DLT|0|||
143453095|NCT00941070|517204278|FG000|Overall Study|Patient non-compliant|1|||
143453096|NCT02797080|517204279|FG000|Overall Study|Lost to Follow-up|1|||
143453097|NCT02797080|517204279|FG000|Overall Study|Withdrawal by Subject|1|||
143453098|NCT00951015|517204280|FG000|Randomization Phase 96 Week|Adverse Event|1|||
143453099|NCT00951015|517204281|FG001|Randomization Phase 96 Week|Adverse Event|1|||
143453100|NCT00951015|517204282|FG002|Randomization Phase 96 Week|Adverse Event|2|||
143453101|NCT00951015|517204283|FG003|Randomization Phase 96 Week|Adverse Event|5|||
143453102|NCT00951015|517204284|FG004|Randomization Phase 96 Week|Adverse Event|0|||
143453103|NCT00951015|517204280|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
143453104|NCT00951015|517204281|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
143453105|NCT00951015|517204282|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
143453106|NCT00951015|517204283|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
143453107|NCT00951015|517204284|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
143453108|NCT00951015|517204280|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
143453109|NCT00951015|517204281|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
143453110|NCT00951015|517204282|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
143453111|NCT00951015|517204283|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
143453112|NCT00951015|517204284|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
143453113|NCT00951015|517204280|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
143453114|NCT00951015|517204281|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
143453115|NCT00951015|517204282|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
143453116|NCT00951015|517204283|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
143453117|NCT00951015|517204284|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
143453118|NCT00951015|517204280|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
143453119|NCT00951015|517204281|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
143453120|NCT00951015|517204282|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
143453121|NCT00951015|517204283|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
143453122|NCT00951015|517204284|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
143453123|NCT00951015|517204280|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
143453124|NCT00951015|517204281|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
143453125|NCT00951015|517204282|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
143453126|NCT00951015|517204283|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
143453127|NCT00951015|517204284|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
143453128|NCT00951015|517204280|FG000|Open-label Phase|Adverse Event|0|||
143453129|NCT00951015|517204281|FG001|Open-label Phase|Adverse Event|0|||
143453130|NCT00951015|517204282|FG002|Open-label Phase|Adverse Event|0|||
143453131|NCT00951015|517204283|FG003|Open-label Phase|Adverse Event|0|||
143453132|NCT00951015|517204284|FG004|Open-label Phase|Adverse Event|3|||
143453133|NCT00951015|517204280|FG000|Open-label Phase|Lack of Efficacy|0|||
143453134|NCT00951015|517204281|FG001|Open-label Phase|Lack of Efficacy|0|||
143453135|NCT00951015|517204282|FG002|Open-label Phase|Lack of Efficacy|0|||
143453136|NCT00951015|517204283|FG003|Open-label Phase|Lack of Efficacy|0|||
143453137|NCT00951015|517204284|FG004|Open-label Phase|Lack of Efficacy|1|||
143453138|NCT00951015|517204280|FG000|Open-label Phase|Protocol Violation|0|||
143453139|NCT00951015|517204281|FG001|Open-label Phase|Protocol Violation|0|||
143453140|NCT00951015|517204282|FG002|Open-label Phase|Protocol Violation|0|||
143453141|NCT00951015|517204283|FG003|Open-label Phase|Protocol Violation|0|||
143453142|NCT00951015|517204284|FG004|Open-label Phase|Protocol Violation|12|||
143453143|NCT00951015|517204280|FG000|Open-label Phase|Lost to Follow-up|0|||
143453144|NCT00951015|517204281|FG001|Open-label Phase|Lost to Follow-up|0|||
143453145|NCT00951015|517204282|FG002|Open-label Phase|Lost to Follow-up|0|||
143453146|NCT00951015|517204283|FG003|Open-label Phase|Lost to Follow-up|0|||
143453147|NCT00951015|517204284|FG004|Open-label Phase|Lost to Follow-up|12|||
143453148|NCT00951015|517204280|FG000|Open-label Phase|Withdrawal by Subject|0|||
143453149|NCT00951015|517204281|FG001|Open-label Phase|Withdrawal by Subject|0|||
143453150|NCT00951015|517204282|FG002|Open-label Phase|Withdrawal by Subject|0|||
143453151|NCT00951015|517204283|FG003|Open-label Phase|Withdrawal by Subject|0|||
143453152|NCT00951015|517204284|FG004|Open-label Phase|Withdrawal by Subject|14|||
143453153|NCT00951015|517204280|FG000|Open-label Phase|Physician Decision|0|||
143453154|NCT00951015|517204281|FG001|Open-label Phase|Physician Decision|0|||
143453155|NCT00951015|517204282|FG002|Open-label Phase|Physician Decision|0|||
143453156|NCT00951015|517204283|FG003|Open-label Phase|Physician Decision|0|||
143453157|NCT00951015|517204284|FG004|Open-label Phase|Physician Decision|8|||
143453158|NCT00299494|517204285|FG000|Overall Study|Withdrawal by Subject|0|||
143453159|NCT00299494|517204286|FG001|Overall Study|Withdrawal by Subject|0|||
143453160|NCT00299494|517204287|FG002|Overall Study|Withdrawal by Subject|0|||
143453161|NCT00299494|517204288|FG003|Overall Study|Withdrawal by Subject|3|||
143453162|NCT00299494|517204289|FG004|Overall Study|Withdrawal by Subject|1|||
143453163|NCT00299494|517204290|FG005|Overall Study|Withdrawal by Subject|4|||
143453164|NCT00299494|517204285|FG000|Overall Study|Physician Decision|0|||
143453165|NCT00299494|517204286|FG001|Overall Study|Physician Decision|0|||
143453166|NCT00299494|517204287|FG002|Overall Study|Physician Decision|0|||
143453167|NCT00299494|517204288|FG003|Overall Study|Physician Decision|0|||
143453168|NCT00299494|517204289|FG004|Overall Study|Physician Decision|1|||
143453169|NCT00299494|517204290|FG005|Overall Study|Physician Decision|0|||
143453170|NCT00299494|517204285|FG000|Overall Study|Death|3|||
143453171|NCT00299494|517204286|FG001|Overall Study|Death|1|||
143453172|NCT00299494|517204287|FG002|Overall Study|Death|4|||
143453173|NCT00299494|517204288|FG003|Overall Study|Death|6|||
143453174|NCT00299494|517204289|FG004|Overall Study|Death|18|||
143453175|NCT00299494|517204290|FG005|Overall Study|Death|19|||
143453176|NCT00299494|517204285|FG000|Overall Study|Lost to Follow-up|0|||
143453177|NCT00299494|517204286|FG001|Overall Study|Lost to Follow-up|0|||
143453178|NCT00299494|517204287|FG002|Overall Study|Lost to Follow-up|0|||
143453179|NCT00299494|517204288|FG003|Overall Study|Lost to Follow-up|0|||
143453180|NCT00299494|517204289|FG004|Overall Study|Lost to Follow-up|3|||
143453181|NCT00299494|517204290|FG005|Overall Study|Lost to Follow-up|1|||
143453182|NCT00299494|517204285|FG000|Overall Study|Other - Unspecified|0|||
143453183|NCT00299494|517204286|FG001|Overall Study|Other - Unspecified|0|||
143453184|NCT00299494|517204287|FG002|Overall Study|Other - Unspecified|0|||
143453185|NCT00299494|517204288|FG003|Overall Study|Other - Unspecified|0|||
143453186|NCT00299494|517204289|FG004|Overall Study|Other - Unspecified|3|||
143453187|NCT00299494|517204290|FG005|Overall Study|Other - Unspecified|1|||
143453188|NCT00299494|517204285|FG000|Overall Study|Other - site closure|0|||
143453189|NCT00299494|517204286|FG001|Overall Study|Other - site closure|0|||
143453190|NCT00299494|517204287|FG002|Overall Study|Other - site closure|0|||
143453191|NCT00299494|517204288|FG003|Overall Study|Other - site closure|1|||
143453192|NCT00299494|517204289|FG004|Overall Study|Other - site closure|1|||
143453193|NCT00299494|517204290|FG005|Overall Study|Other - site closure|1|||
143453194|NCT00958841|517204291|FG000|Overall Study|Abnormal laboratory value(s)|1|||
143453195|NCT00958841|517204291|FG000|Overall Study|Abnormal test procedure result(s)|3|||
143453196|NCT00958841|517204291|FG000|Overall Study|Administrative problems|1|||
143453197|NCT00958841|517204291|FG000|Overall Study|Adverse Event|8|||
143453198|NCT00958841|517204291|FG000|Overall Study|New cancer therapy|5|||
143453199|NCT00958841|517204291|FG000|Overall Study|Withdrawal by Subject|1|||
143453200|NCT00958841|517204291|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
143453201|NCT00958841|517204291|FG000|Overall Study|Completed M6/did not enter extension|27|||
143453202|NCT00958841|517204291|FG000|Overall Study|Discontinued prior to M*|28|||
143453203|NCT02755818|517204293|FG000|Overall Study|Withdrawal by Subject|0|||
143453204|NCT02755818|517204294|FG001|Overall Study|Withdrawal by Subject|0|||
143453205|NCT02755818|517204295|FG002|Overall Study|Withdrawal by Subject|0|||
143453206|NCT02755818|517204296|FG003|Overall Study|Withdrawal by Subject|2|||
143453207|NCT02755818|517204293|FG000|Overall Study|withdrawal by PI|0|||
143453208|NCT02755818|517204294|FG001|Overall Study|withdrawal by PI|0|||
143453209|NCT02755818|517204295|FG002|Overall Study|withdrawal by PI|1|||
143453210|NCT02755818|517204296|FG003|Overall Study|withdrawal by PI|1|||
143453211|NCT01280357|517204299|FG000|Overall Study|Excluded no internal monitoring|14|||
143453212|NCT01280357|517204299|FG000|Overall Study|IInsufficient data/No data supplied|12|||
143453213|NCT00992225|517204300|FG000|Overall Study|Entry Criteria Not Met|8|||
143453214|NCT00992225|517204300|FG000|Overall Study|Adverse Event|2|||
143453215|NCT01036438|517204304|FG000|Overall Study|Adverse Event|7|||
143453216|NCT01036438|517204305|FG001|Overall Study|Adverse Event|8|||
143453217|NCT01036438|517204304|FG000|Overall Study|Death|0|||
143453218|NCT01036438|517204305|FG001|Overall Study|Death|1|||
143453219|NCT01036438|517204304|FG000|Overall Study|No effect of study treatment|3|||
143453220|NCT01036438|517204305|FG001|Overall Study|No effect of study treatment|1|||
143453221|NCT02729831|517204306|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
143453222|NCT02729831|517204307|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
143453223|NCT02729831|517204308|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
143453224|NCT02729831|517204309|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
143453225|NCT02729831|517204306|FG000|1 Week Post-visit|Lost to Follow-up|43|||
143453226|NCT02729831|517204307|FG001|1 Week Post-visit|Lost to Follow-up|40|||
143453227|NCT02729831|517204308|FG002|1 Week Post-visit|Lost to Follow-up|38|||
143453228|NCT02729831|517204309|FG003|1 Week Post-visit|Lost to Follow-up|36|||
143453229|NCT02729831|517204306|FG000|6 Month Follow-up|Lost to Follow-up|54|||
143453230|NCT02729831|517204307|FG001|6 Month Follow-up|Lost to Follow-up|51|||
143453231|NCT02729831|517204308|FG002|6 Month Follow-up|Lost to Follow-up|48|||
143453232|NCT02729831|517204309|FG003|6 Month Follow-up|Lost to Follow-up|42|||
143453233|NCT02729831|517204306|FG000|6 Month Follow-up|Death|1|||
143453234|NCT02729831|517204307|FG001|6 Month Follow-up|Death|3|||
143453235|NCT02729831|517204308|FG002|6 Month Follow-up|Death|0|||
143453236|NCT02729831|517204309|FG003|6 Month Follow-up|Death|1|||
143453237|NCT05260021|517204316|FG000|Double-blind Period (30 Weeks)|Adverse Event|2|||
143453238|NCT05260021|517204317|FG001|Double-blind Period (30 Weeks)|Adverse Event|0|||
143453239|NCT05260021|517204318|FG002|Double-blind Period (30 Weeks)|Adverse Event|0|||
143453240|NCT05260021|517204316|FG000|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
143453241|NCT05260021|517204317|FG001|Double-blind Period (30 Weeks)|Withdrawal by Subject|2|||
143453242|NCT05260021|517204318|FG002|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
143453243|NCT05260021|517204316|FG000|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
143453244|NCT05260021|517204317|FG001|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
143453245|NCT05260021|517204318|FG002|Double-blind Period (30 Weeks)|Lost to Follow-up|1|||
143453246|NCT05260021|517204316|FG000|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
143453247|NCT05260021|517204317|FG001|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|1|||
143453248|NCT05260021|517204318|FG002|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
143453249|NCT05260021|517204316|FG000|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
143453250|NCT05260021|517204317|FG001|Double-blind Period (30 Weeks)|Incorrectly Enrolled|1|||
143453251|NCT05260021|517204318|FG002|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
143453252|NCT05597787|517204320|FG000|Overall Study|Withdrawal by Subject|0|||
143453253|NCT05597787|517204321|FG001|Overall Study|Withdrawal by Subject|0|||
143453254|NCT05597787|517204322|FG002|Overall Study|Withdrawal by Subject|1|||
143453255|NCT04349631|517204323|FG000|Overall Study|Lost to Follow-up|3|||
143453256|NCT04349631|517204323|FG000|Overall Study|Withdrawal by Subject|7|||
143453257|NCT05560243|517205371|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
143453258|NCT05870228|517205372|FG000|Overall Study|Lost to Follow-up|2|||
143453259|NCT05870228|517205373|FG001|Overall Study|Lost to Follow-up|0|||
143453260|NCT05870228|517205372|FG000|Overall Study|Withdrawal by Subject|1|||
143453261|NCT05870228|517205373|FG001|Overall Study|Withdrawal by Subject|0|||
143453262|NCT03231800|517205375|FG000|Overall Study|Lost to Follow-up|0|||
143453263|NCT03231800|517205376|FG001|Overall Study|Lost to Follow-up|2|||
143453264|NCT03231800|517205375|FG000|Overall Study|Protocol Violation|1|||
143453265|NCT03231800|517205376|FG001|Overall Study|Protocol Violation|1|||
143453266|NCT03231800|517205375|FG000|Overall Study|reason not provided|2|||
143453267|NCT03231800|517205376|FG001|Overall Study|reason not provided|0|||
143453268|NCT03174431|517205387|FG000|Overall Study|Withdrawal by Subject|14|||
143453269|NCT03174431|517205388|FG001|Overall Study|Withdrawal by Subject|11|||
143453270|NCT03174431|517205387|FG000|Overall Study|alternative treatment|2|||
143453271|NCT03174431|517205388|FG001|Overall Study|alternative treatment|0|||
143453272|NCT03174431|517205387|FG000|Overall Study|Lost to Follow-up|1|||
143453273|NCT03174431|517205388|FG001|Overall Study|Lost to Follow-up|5|||
143453274|NCT04075994|517205389|FG000|Overall Study|Withdrawal by Subject|8|||
143453275|NCT04075994|517205390|FG001|Overall Study|Withdrawal by Subject|9|||
143453276|NCT04075994|517205389|FG000|Overall Study|Adverse Event|2|||
143453277|NCT04075994|517205390|FG001|Overall Study|Adverse Event|2|||
143453278|NCT04075994|517205389|FG000|Overall Study|Investigator withdrew|3|||
143453279|NCT04075994|517205390|FG001|Overall Study|Investigator withdrew|1|||
143453280|NCT01941719|517205398|FG000|Overall Study|Lost to Follow-up|20|||
143453281|NCT01941719|517205399|FG001|Overall Study|Lost to Follow-up|19|||
143453282|NCT00252577|517205400|FG000|Overall Study|Lost to Follow-up|20|||
143453283|NCT04035499|517205405|FG000|Overall Study|Death|2|||
143453284|NCT04035499|517205405|FG000|Overall Study|Withdrawal by Subject|1|||
143453285|NCT03819634|517205407|FG000|Overall Study|Physician Decision|2|||
143453286|NCT01417104|517205411|FG000|Overall Study|Withdrawal by Subject|5|||
143453287|NCT01417104|517205412|FG001|Overall Study|Withdrawal by Subject|1|||
143453288|NCT01417104|517205411|FG000|Overall Study|Failure to make contact|0|||
143453289|NCT01417104|517205412|FG001|Overall Study|Failure to make contact|1|||
143453290|NCT01417104|517205411|FG000|Overall Study|Adverse Event|1|||
143453291|NCT01417104|517205412|FG001|Overall Study|Adverse Event|0|||
143453292|NCT01416389|517205413|FG000|Overall Study|Lost to Follow-up|1|||
143453293|NCT01416389|517205414|FG001|Overall Study|Lost to Follow-up|0|||
143453294|NCT01416389|517205413|FG000|Overall Study|Started New Therapy|2|||
143453295|NCT01416389|517205414|FG001|Overall Study|Started New Therapy|0|||
143453296|NCT00858364|517205417|FG000|Overall Study|Administrative Decision|3|||
143453297|NCT00858364|517205418|FG001|Overall Study|Administrative Decision|2|||
143453298|NCT00858364|517205417|FG000|Overall Study|Adverse Event|5|||
143453299|NCT00858364|517205418|FG001|Overall Study|Adverse Event|2|||
143453300|NCT00858364|517205417|FG000|Overall Study|Withdrawal by Subject|44|||
143453301|NCT00858364|517205418|FG001|Overall Study|Withdrawal by Subject|118|||
143453302|NCT00858364|517205417|FG000|Overall Study|Ineligibility Determined|1|||
143453303|NCT00858364|517205418|FG001|Overall Study|Ineligibility Determined|10|||
143453304|NCT00858364|517205417|FG000|Overall Study|Lost to Follow-up|24|||
143453305|NCT00858364|517205418|FG001|Overall Study|Lost to Follow-up|54|||
143453306|NCT00858364|517205417|FG000|Overall Study|Noncompliance|3|||
143453307|NCT00858364|517205418|FG001|Overall Study|Noncompliance|4|||
143453308|NCT00858364|517205417|FG000|Overall Study|Protocol Deviation|0|||
143453309|NCT00858364|517205418|FG001|Overall Study|Protocol Deviation|2|||
143453310|NCT00858364|517205417|FG000|Overall Study|Other|9|||
143453311|NCT00858364|517205418|FG001|Overall Study|Other|17|||
143453312|NCT00858364|517205417|FG000|Overall Study|Missing|1|||
143453313|NCT00858364|517205418|FG001|Overall Study|Missing|1|||
143453314|NCT00858364|517205417|FG000|Overall Study|Still on-study|114|||
143453315|NCT00858364|517205418|FG001|Overall Study|Still on-study|247|||
143453316|NCT00929110|517205419|FG000|Overall Study|Adverse Event|40|||
143453317|NCT00929110|517205420|FG001|Overall Study|Adverse Event|29|||
143453318|NCT00929110|517205421|FG002|Overall Study|Adverse Event|18|||
143453319|NCT00929110|517205419|FG000|Overall Study|Subject withdrew consent|40|||
143453320|NCT00929110|517205420|FG001|Overall Study|Subject withdrew consent|23|||
143453321|NCT00929110|517205421|FG002|Overall Study|Subject withdrew consent|26|||
143453322|NCT00929110|517205419|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
143453323|NCT00929110|517205420|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
143453324|NCT00929110|517205421|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
143453325|NCT00929110|517205419|FG000|Overall Study|Lost to Follow-up|7|||
143453326|NCT00929110|517205420|FG001|Overall Study|Lost to Follow-up|7|||
143453327|NCT00929110|517205421|FG002|Overall Study|Lost to Follow-up|3|||
143453328|NCT00929110|517205419|FG000|Overall Study|Protocol deviation|5|||
143453329|NCT00929110|517205420|FG001|Overall Study|Protocol deviation|2|||
143453330|NCT00929110|517205421|FG002|Overall Study|Protocol deviation|4|||
143453331|NCT00929110|517205419|FG000|Overall Study|Administrative problems|4|||
143453332|NCT00929110|517205420|FG001|Overall Study|Administrative problems|1|||
143453333|NCT00929110|517205421|FG002|Overall Study|Administrative problems|2|||
143453334|NCT00929110|517205419|FG000|Overall Study|Death|2|||
143453335|NCT00929110|517205420|FG001|Overall Study|Death|2|||
143453336|NCT00929110|517205421|FG002|Overall Study|Death|2|||
143453337|NCT00929110|517205419|FG000|Overall Study|Abnormal laboratory value(s)|0|||
143453338|NCT00929110|517205420|FG001|Overall Study|Abnormal laboratory value(s)|1|||
143453339|NCT00929110|517205421|FG002|Overall Study|Abnormal laboratory value(s)|0|||
143453340|NCT00929110|517205419|FG000|Overall Study|Abnormal test procedure result(s)|0|||
143453341|NCT00929110|517205420|FG001|Overall Study|Abnormal test procedure result(s)|1|||
143453342|NCT00929110|517205421|FG002|Overall Study|Abnormal test procedure result(s)|1|||
143453343|NCT00929110|517205419|FG000|Overall Study|Patient inability to use the device|0|||
143453344|NCT00929110|517205420|FG001|Overall Study|Patient inability to use the device|1|||
143453345|NCT00929110|517205421|FG002|Overall Study|Patient inability to use the device|0|||
143453346|NCT01163292|517205424|FG000|Overall Study|Lack of Efficacy|9|||
143453347|NCT01163292|517205425|FG001|Overall Study|Lack of Efficacy|0|||
143453348|NCT01163292|517205424|FG000|Overall Study|Adverse Event|6|||
143453349|NCT01163292|517205425|FG001|Overall Study|Adverse Event|0|||
143453350|NCT01163292|517205424|FG000|Overall Study|Initiation of biological therapy|0|||
143453351|NCT01163292|517205425|FG001|Overall Study|Initiation of biological therapy|15|||
143453352|NCT01163292|517205424|FG000|Overall Study|Sufficient response to adalimumab|8|||
143453353|NCT01163292|517205425|FG001|Overall Study|Sufficient response to adalimumab|0|||
143453354|NCT01163292|517205424|FG000|Overall Study|Refusal to receive adalimumab|7|||
143453355|NCT01163292|517205425|FG001|Overall Study|Refusal to receive adalimumab|0|||
143453356|NCT01163292|517205424|FG000|Overall Study|Economic reasons|6|||
143453357|NCT01163292|517205425|FG001|Overall Study|Economic reasons|0|||
143453358|NCT01163292|517205424|FG000|Overall Study|No further visits|5|||
143453359|NCT01163292|517205425|FG001|Overall Study|No further visits|7|||
143453360|NCT01258595|517205426|FG000|Overall Study|Lost to Follow-up|1|||
143453361|NCT01258595|517205427|FG001|Overall Study|Lost to Follow-up|0|||
143453362|NCT01258595|517205426|FG000|Overall Study|Withdrawal by Subject|0|||
143453363|NCT01258595|517205427|FG001|Overall Study|Withdrawal by Subject|1|||
143453364|NCT01012414|517205428|FG000|Overall Study|Withdrawal by Subject|2|||
143453365|NCT01012414|517205428|FG000|Overall Study|Lost to Follow-up|1|||
143453366|NCT01012414|517205428|FG000|Overall Study|Trial was stopped before completed|7|||
143453367|NCT01215188|517205429|FG000|Overall Study|Lost to Follow-up|22|||
143453368|NCT01215188|517205430|FG001|Overall Study|Lost to Follow-up|22|||
143453369|NCT01215188|517205431|FG002|Overall Study|Lost to Follow-up|16|||
143453370|NCT01215188|517205429|FG000|Overall Study|Adverse Event|1|||
143453371|NCT01215188|517205430|FG001|Overall Study|Adverse Event|1|||
143453372|NCT01215188|517205431|FG002|Overall Study|Adverse Event|3|||
143453373|NCT01215188|517205429|FG000|Overall Study|Physician Decision|2|||
143453374|NCT01215188|517205430|FG001|Overall Study|Physician Decision|1|||
143453375|NCT01215188|517205431|FG002|Overall Study|Physician Decision|0|||
143453376|NCT01215188|517205429|FG000|Overall Study|Lack of Efficacy|0|||
143453377|NCT01215188|517205430|FG001|Overall Study|Lack of Efficacy|0|||
143453378|NCT01215188|517205431|FG002|Overall Study|Lack of Efficacy|1|||
143453379|NCT01215188|517205429|FG000|Overall Study|Protocol Violation|1|||
143453380|NCT01215188|517205430|FG001|Overall Study|Protocol Violation|1|||
143453381|NCT01215188|517205431|FG002|Overall Study|Protocol Violation|1|||
143453382|NCT01215188|517205429|FG000|Overall Study|Withdrawal by Subject|32|||
143453383|NCT01215188|517205430|FG001|Overall Study|Withdrawal by Subject|34|||
143453384|NCT01215188|517205431|FG002|Overall Study|Withdrawal by Subject|31|||
143453385|NCT02601300|517205432|FG000|Induction Phase|Lack of Efficacy|2|||
143453386|NCT02601300|517205432|FG000|Induction Phase|Protocol Violation|1|||
143453387|NCT02601300|517205432|FG000|Extension Phase|Withdrawal by Subject|3|||
143453388|NCT02601300|517205432|FG000|Extension Phase|Adverse Event|4|||
143453389|NCT02601300|517205432|FG000|Extension Phase|Lack of Efficacy|10|||
143453390|NCT01127763|517205433|FG000|Overall Study|Adverse Event|2|||
143453391|NCT01127763|517205433|FG000|Overall Study|Withdrawal by Subject|1|||
143453392|NCT01127763|517205433|FG000|Overall Study|Physician Decision|2|||
143453393|NCT00528931|517205434|FG000|Overall Study|Lost to Follow-up|1|||
143453394|NCT02285153|517205435|FG000|Overall Study|Adverse Event|1|||
143453395|NCT02285153|517205436|FG001|Overall Study|Adverse Event|0|||
143453396|NCT01489891|517205439|FG000|Overall Study|Endoscopy failure|1|||
143453397|NCT01489891|517205440|FG001|Overall Study|Endoscopy failure|0|||
143453398|NCT02576587|517205441|FG000|Baseline|Equipment failure|0|||
143453399|NCT02576587|517205442|FG001|Baseline|Equipment failure|1|||
143453400|NCT02576587|517205441|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
143453401|NCT02576587|517205442|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
143453402|NCT02576587|517205441|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
143453403|NCT02576587|517205442|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
143453404|NCT02576587|517205441|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
143453405|NCT02576587|517205442|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
143453406|NCT00777088|517205443|FG000|Overall Study|PED Treatment not attempted|1|||
143453407|NCT01278173|517205444|FG000|Overall Study|Lack of Efficacy|13|||
143453408|NCT01278173|517205444|FG000|Overall Study|Adverse Event|8|||
143453409|NCT01278173|517205444|FG000|Overall Study|Administrative or other reason|4|||
143453410|NCT01278173|517205444|FG000|Overall Study|Protocol Violation|1|||
143453411|NCT01278173|517205444|FG000|Overall Study|Withdrawal by Subject|1|||
143453412|NCT03592745|517205445|FG000|Overall Study|Adverse Event|0|||
143453413|NCT03592745|517205446|FG001|Overall Study|Adverse Event|2|||
143453414|NCT03592745|517205445|FG000|Overall Study|Lost to Follow-up|2|||
143453415|NCT03592745|517205446|FG001|Overall Study|Lost to Follow-up|0|||
143453416|NCT03592745|517205445|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
143453417|NCT03592745|517205446|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
143453418|NCT01413503|517205448|FG000|Overall Study|Lost to Follow-up|1|||
143453419|NCT02546921|517205449|FG000|Overall Study|Adverse Event|0|||
143453420|NCT02546921|517205450|FG001|Overall Study|Adverse Event|5|||
143453421|NCT02546921|517205451|FG002|Overall Study|Adverse Event|2|||
143453422|NCT02546921|517205452|FG003|Overall Study|Adverse Event|0|||
143453423|NCT02546921|517205453|FG004|Overall Study|Adverse Event|0|||
143453424|NCT02546921|517205454|FG005|Overall Study|Adverse Event|0|||
143453425|NCT02546921|517205455|FG006|Overall Study|Adverse Event|0|||
143453426|NCT02546921|517205449|FG000|Overall Study|Evidence of Disease Progression|1|||
143453427|NCT02546921|517205450|FG001|Overall Study|Evidence of Disease Progression|0|||
143453428|NCT02546921|517205451|FG002|Overall Study|Evidence of Disease Progression|0|||
143453429|NCT02546921|517205452|FG003|Overall Study|Evidence of Disease Progression|0|||
143453430|NCT02546921|517205453|FG004|Overall Study|Evidence of Disease Progression|1|||
143453431|NCT02546921|517205454|FG005|Overall Study|Evidence of Disease Progression|0|||
143453432|NCT02546921|517205455|FG006|Overall Study|Evidence of Disease Progression|0|||
143453433|NCT02546921|517205449|FG000|Overall Study|Patient Choice|0|||
143453434|NCT02546921|517205450|FG001|Overall Study|Patient Choice|1|||
143453435|NCT02546921|517205451|FG002|Overall Study|Patient Choice|0|||
143453436|NCT02546921|517205452|FG003|Overall Study|Patient Choice|0|||
143453437|NCT02546921|517205453|FG004|Overall Study|Patient Choice|0|||
143453438|NCT02546921|517205454|FG005|Overall Study|Patient Choice|1|||
143453439|NCT02546921|517205455|FG006|Overall Study|Patient Choice|0|||
143453440|NCT01373151|517205456|FG000|Period 1|Lack of Efficacy|3|||
143453441|NCT01373151|517205457|FG001|Period 1|Lack of Efficacy|0|||
143453442|NCT01373151|517205458|FG002|Period 1|Lack of Efficacy|0|||
143453443|NCT01373151|517205459|FG003|Period 1|Lack of Efficacy|0|||
143453444|NCT01373151|517205460|FG004|Period 1|Lack of Efficacy|1|||
143453445|NCT01373151|517205461|FG005|Period 1|Lack of Efficacy|0|||
143453446|NCT01373151|517205462|FG006|Period 1|Lack of Efficacy|0|||
143453447|NCT01373151|517205456|FG000|Period 1|Adverse Event|0|||
143453448|NCT01373151|517205457|FG001|Period 1|Adverse Event|0|||
143453449|NCT01373151|517205458|FG002|Period 1|Adverse Event|1|||
143453450|NCT01373151|517205459|FG003|Period 1|Adverse Event|0|||
143453451|NCT01373151|517205460|FG004|Period 1|Adverse Event|4|||
143453452|NCT01373151|517205461|FG005|Period 1|Adverse Event|3|||
143453453|NCT01373151|517205462|FG006|Period 1|Adverse Event|0|||
143453454|NCT01373151|517205456|FG000|Period 1|Withdrawal by Subject|2|||
143453455|NCT01373151|517205457|FG001|Period 1|Withdrawal by Subject|0|||
143453456|NCT01373151|517205458|FG002|Period 1|Withdrawal by Subject|3|||
143453457|NCT01373151|517205459|FG003|Period 1|Withdrawal by Subject|1|||
143453458|NCT01373151|517205460|FG004|Period 1|Withdrawal by Subject|0|||
143453459|NCT01373151|517205461|FG005|Period 1|Withdrawal by Subject|1|||
143453460|NCT01373151|517205462|FG006|Period 1|Withdrawal by Subject|0|||
143453461|NCT01373151|517205456|FG000|Period 2|Lack of Efficacy|9|||
143453462|NCT01373151|517205457|FG001|Period 2|Lack of Efficacy|0|||
143453463|NCT01373151|517205458|FG002|Period 2|Lack of Efficacy|0|||
143453464|NCT01373151|517205459|FG003|Period 2|Lack of Efficacy|1|||
143453465|NCT01373151|517205460|FG004|Period 2|Lack of Efficacy|2|||
143453466|NCT01373151|517205461|FG005|Period 2|Lack of Efficacy|0|||
143453467|NCT01373151|517205462|FG006|Period 2|Lack of Efficacy|3|||
143453468|NCT01373151|517205456|FG000|Period 2|Adverse Event|0|||
143453469|NCT01373151|517205457|FG001|Period 2|Adverse Event|0|||
143453470|NCT01373151|517205458|FG002|Period 2|Adverse Event|3|||
143453471|NCT01373151|517205459|FG003|Period 2|Adverse Event|3|||
143453472|NCT01373151|517205460|FG004|Period 2|Adverse Event|0|||
143453473|NCT01373151|517205461|FG005|Period 2|Adverse Event|0|||
143453474|NCT01373151|517205462|FG006|Period 2|Adverse Event|1|||
143453475|NCT01373151|517205456|FG000|Period 2|subject request to discontinue|0|||
143453476|NCT01373151|517205457|FG001|Period 2|subject request to discontinue|1|||
143453477|NCT01373151|517205458|FG002|Period 2|subject request to discontinue|0|||
143453478|NCT01373151|517205459|FG003|Period 2|subject request to discontinue|0|||
143453479|NCT01373151|517205460|FG004|Period 2|subject request to discontinue|0|||
143453480|NCT01373151|517205461|FG005|Period 2|subject request to discontinue|0|||
143453481|NCT01373151|517205462|FG006|Period 2|subject request to discontinue|0|||
143453482|NCT01373151|517205456|FG000|Period 2|Withdrawal by Subject|0|||
143453483|NCT01373151|517205457|FG001|Period 2|Withdrawal by Subject|0|||
143453484|NCT01373151|517205458|FG002|Period 2|Withdrawal by Subject|0|||
143453485|NCT01373151|517205459|FG003|Period 2|Withdrawal by Subject|1|||
143453486|NCT01373151|517205460|FG004|Period 2|Withdrawal by Subject|0|||
143453487|NCT01373151|517205461|FG005|Period 2|Withdrawal by Subject|0|||
143453488|NCT01373151|517205462|FG006|Period 2|Withdrawal by Subject|0|||
143453489|NCT01373151|517205456|FG000|Period 2|Other|0|||
143453490|NCT01373151|517205457|FG001|Period 2|Other|0|||
143453491|NCT01373151|517205458|FG002|Period 2|Other|1|||
143453492|NCT01373151|517205459|FG003|Period 2|Other|0|||
143453493|NCT01373151|517205460|FG004|Period 2|Other|0|||
143453494|NCT01373151|517205461|FG005|Period 2|Other|0|||
143453495|NCT01373151|517205462|FG006|Period 2|Other|1|||
143453496|NCT03026075|517205464|FG000|Overall Study|Physician Decision|1|||
143453497|NCT04927247|517205468|FG000|Overall Study|Other|2|||
143453498|NCT04927247|517205469|FG001|Overall Study|Other|1|||
143453499|NCT04927247|517205468|FG000|Overall Study|Physician Decision|0|||
143453500|NCT04927247|517205469|FG001|Overall Study|Physician Decision|1|||
143453501|NCT04927247|517205468|FG000|Overall Study|Adverse Event|1|||
143453502|NCT04927247|517205469|FG001|Overall Study|Adverse Event|0|||
143453503|NCT04828837|517205471|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
143453504|NCT04828837|517205472|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
143453505|NCT04828837|517205471|FG000|Overall Study|Lost to Follow-up|2|||
143453506|NCT04828837|517205472|FG001|Overall Study|Lost to Follow-up|6|||
143453507|NCT04828837|517205471|FG000|Overall Study|Lack of Efficacy|1|||
143453508|NCT04828837|517205472|FG001|Overall Study|Lack of Efficacy|0|||
143453509|NCT04828837|517205471|FG000|Overall Study|Admitted due to pneumothorax.|1|||
143453510|NCT04828837|517205472|FG001|Overall Study|Admitted due to pneumothorax.|0|||
143453511|NCT04828837|517205471|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
143453512|NCT04828837|517205472|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
143453513|NCT01397422|517205473|FG000|Overall Study|Adverse Event|0|||
143453514|NCT01397422|517205474|FG001|Overall Study|Adverse Event|3|||
143453515|NCT01397422|517205475|FG002|Overall Study|Adverse Event|3|||
143453516|NCT01397422|517205476|FG003|Overall Study|Adverse Event|8|||
143453517|NCT01397422|517205473|FG000|Overall Study|Withdrawal by Subject|1|||
143453518|NCT01397422|517205474|FG001|Overall Study|Withdrawal by Subject|0|||
143453519|NCT01397422|517205475|FG002|Overall Study|Withdrawal by Subject|0|||
143453520|NCT01397422|517205476|FG003|Overall Study|Withdrawal by Subject|0|||
143453521|NCT01397422|517205473|FG000|Overall Study|Increased bradykinesia related to PD|1|||
143453522|NCT01397422|517205474|FG001|Overall Study|Increased bradykinesia related to PD|0|||
143453523|NCT01397422|517205475|FG002|Overall Study|Increased bradykinesia related to PD|0|||
143453524|NCT01397422|517205476|FG003|Overall Study|Increased bradykinesia related to PD|0|||
143453525|NCT00545753|517205477|FG000|Overall Study|Withdrawal by Subject|0|||
143453526|NCT00545753|517205478|FG001|Overall Study|Withdrawal by Subject|1|||
143453527|NCT00545753|517205479|FG002|Overall Study|Withdrawal by Subject|10|||
143453528|NCT00545753|517205477|FG000|Overall Study|Lost to Follow-up|13|||
143453529|NCT00545753|517205478|FG001|Overall Study|Lost to Follow-up|3|||
143453530|NCT00545753|517205479|FG002|Overall Study|Lost to Follow-up|12|||
143453531|NCT00545753|517205477|FG000|Overall Study|Protocol Violation|3|||
143453532|NCT00545753|517205478|FG001|Overall Study|Protocol Violation|1|||
143453533|NCT00545753|517205479|FG002|Overall Study|Protocol Violation|4|||
143453534|NCT02489968|517205488|FG000|Open-label Treatment Period|Adverse Event|14|||
143453535|NCT02489968|517205489|FG001|Open-label Treatment Period|Adverse Event|7|||
143453536|NCT02489968|517205490|FG002|Open-label Treatment Period|Adverse Event|0|||
143453537|NCT02489968|517205491|FG003|Open-label Treatment Period|Adverse Event|0|||
143453538|NCT02489968|517205492|FG004|Open-label Treatment Period|Adverse Event|0|||
143453539|NCT02489968|517205493|FG005|Open-label Treatment Period|Adverse Event|0|||
143453540|NCT02489968|517205488|FG000|Open-label Treatment Period|Protocol Violation|2|||
143453541|NCT02489968|517205489|FG001|Open-label Treatment Period|Protocol Violation|2|||
143453542|NCT02489968|517205490|FG002|Open-label Treatment Period|Protocol Violation|0|||
143453543|NCT02489968|517205491|FG003|Open-label Treatment Period|Protocol Violation|0|||
143453544|NCT02489968|517205492|FG004|Open-label Treatment Period|Protocol Violation|0|||
143453545|NCT02489968|517205493|FG005|Open-label Treatment Period|Protocol Violation|0|||
143453546|NCT02489968|517205488|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
143453547|NCT02489968|517205489|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
143453548|NCT02489968|517205490|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
143453549|NCT02489968|517205491|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
143453550|NCT02489968|517205492|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
143453551|NCT02489968|517205493|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
143453552|NCT02489968|517205488|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
143453553|NCT02489968|517205489|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
143453554|NCT02489968|517205490|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
143453555|NCT02489968|517205491|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
143453556|NCT02489968|517205492|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
143453557|NCT02489968|517205493|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
143453558|NCT02489968|517205488|FG000|Open-label Treatment Period|Other than specified above|204|||
143453559|NCT02489968|517205489|FG001|Open-label Treatment Period|Other than specified above|189|||
143453560|NCT02489968|517205490|FG002|Open-label Treatment Period|Other than specified above|0|||
143453561|NCT02489968|517205491|FG003|Open-label Treatment Period|Other than specified above|0|||
143453562|NCT02489968|517205492|FG004|Open-label Treatment Period|Other than specified above|0|||
143453563|NCT02489968|517205493|FG005|Open-label Treatment Period|Other than specified above|0|||
143453564|NCT02489968|517205488|FG000|Double-blind Treatment Period|Adverse Event|0|||
143453565|NCT02489968|517205489|FG001|Double-blind Treatment Period|Adverse Event|0|||
143453566|NCT02489968|517205490|FG002|Double-blind Treatment Period|Adverse Event|2|||
143453567|NCT02489968|517205491|FG003|Double-blind Treatment Period|Adverse Event|6|||
143453568|NCT02489968|517205492|FG004|Double-blind Treatment Period|Adverse Event|4|||
143453569|NCT02489968|517205493|FG005|Double-blind Treatment Period|Adverse Event|5|||
143453570|NCT02489968|517205488|FG000|Double-blind Treatment Period|Protocol Violation|0|||
143453571|NCT02489968|517205489|FG001|Double-blind Treatment Period|Protocol Violation|0|||
143453572|NCT02489968|517205490|FG002|Double-blind Treatment Period|Protocol Violation|0|||
143453573|NCT02489968|517205491|FG003|Double-blind Treatment Period|Protocol Violation|0|||
143453574|NCT02489968|517205492|FG004|Double-blind Treatment Period|Protocol Violation|1|||
143453575|NCT02489968|517205493|FG005|Double-blind Treatment Period|Protocol Violation|1|||
143453576|NCT02489968|517205488|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
143453577|NCT02489968|517205489|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
143453578|NCT02489968|517205490|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
143453579|NCT02489968|517205491|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
143453580|NCT02489968|517205492|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
143453581|NCT02489968|517205493|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
143453582|NCT02489968|517205488|FG000|Double-blind Treatment Period|Other than specified above|0|||
143453583|NCT02489968|517205489|FG001|Double-blind Treatment Period|Other than specified above|0|||
143453584|NCT02489968|517205490|FG002|Double-blind Treatment Period|Other than specified above|0|||
143453585|NCT02489968|517205491|FG003|Double-blind Treatment Period|Other than specified above|0|||
143453586|NCT02489968|517205492|FG004|Double-blind Treatment Period|Other than specified above|1|||
143453587|NCT02489968|517205493|FG005|Double-blind Treatment Period|Other than specified above|0|||
143453588|NCT04577001|517205494|FG000|Overall Study|Subject became ineligible|0|||
143453589|NCT04577001|517205495|FG001|Overall Study|Subject became ineligible|1|||
143453590|NCT01241604|517205496|FG000|Screening Period|Screen Failure|3|||
143453591|NCT01241604|517205497|FG001|Screening Period|Screen Failure|0|||
143453592|NCT01241604|517205498|FG002|Screening Period|Screen Failure|0|||
143453593|NCT00775463|517206777|FG000|Overall Study|Withdrawal by Subject|0|||
143453594|NCT00775463|517206778|FG001|Overall Study|Withdrawal by Subject|1|||
143453595|NCT00775463|517206777|FG000|Overall Study|Adverse Event|7|||
143453596|NCT00775463|517206778|FG001|Overall Study|Adverse Event|9|||
143453597|NCT00775463|517206777|FG000|Overall Study|Protocol Violation|2|||
143453598|NCT00775463|517206778|FG001|Overall Study|Protocol Violation|2|||
143453599|NCT00775463|517206777|FG000|Overall Study|Lost to Follow-up|1|||
143453600|NCT00775463|517206778|FG001|Overall Study|Lost to Follow-up|0|||
143453601|NCT00775463|517206777|FG000|Overall Study|Lack of Efficacy|1|||
143453602|NCT00775463|517206778|FG001|Overall Study|Lack of Efficacy|1|||
143453603|NCT00969709|517206779|FG000|Overall Study|Adverse Event|3|||
143453604|NCT00969709|517206780|FG001|Overall Study|Adverse Event|13|||
143453605|NCT00969709|517206781|FG002|Overall Study|Adverse Event|26|||
143453606|NCT00969709|517206782|FG003|Overall Study|Adverse Event|12|||
143453607|NCT00969709|517206779|FG000|Overall Study|Lack of Efficacy|7|||
143453608|NCT00969709|517206780|FG001|Overall Study|Lack of Efficacy|4|||
143453609|NCT00969709|517206781|FG002|Overall Study|Lack of Efficacy|1|||
143453610|NCT00969709|517206782|FG003|Overall Study|Lack of Efficacy|3|||
143453611|NCT00969709|517206779|FG000|Overall Study|Protocol Violation|9|||
143453612|NCT00969709|517206780|FG001|Overall Study|Protocol Violation|5|||
143453613|NCT00969709|517206781|FG002|Overall Study|Protocol Violation|9|||
143453614|NCT00969709|517206782|FG003|Overall Study|Protocol Violation|10|||
143453615|NCT00969709|517206779|FG000|Overall Study|Withdrawal by Subject|9|||
143453616|NCT00969709|517206780|FG001|Overall Study|Withdrawal by Subject|12|||
143453617|NCT00969709|517206781|FG002|Overall Study|Withdrawal by Subject|11|||
143453618|NCT00969709|517206782|FG003|Overall Study|Withdrawal by Subject|23|||
143453619|NCT00969709|517206779|FG000|Overall Study|Lost to Follow-up|10|||
143453620|NCT00969709|517206780|FG001|Overall Study|Lost to Follow-up|14|||
143453621|NCT00969709|517206781|FG002|Overall Study|Lost to Follow-up|8|||
143453622|NCT00969709|517206782|FG003|Overall Study|Lost to Follow-up|15|||
143453623|NCT00969709|517206779|FG000|Overall Study|Other reasons|0|||
143453624|NCT00969709|517206780|FG001|Overall Study|Other reasons|0|||
143453625|NCT00969709|517206781|FG002|Overall Study|Other reasons|3|||
143453626|NCT00969709|517206782|FG003|Overall Study|Other reasons|0|||
143453627|NCT02980731|517206783|FG000|Overall Study|Death|63|||
143453628|NCT02980731|517206783|FG000|Overall Study|Withdrawal by Subject|6|||
143453629|NCT02980731|517206783|FG000|Overall Study|Lost to Follow-up|5|||
143453630|NCT02980731|517206783|FG000|Overall Study|Study terminated by Sponsor|4|||
143453631|NCT02980731|517206783|FG000|Overall Study|Completed survival follow-up period|65|||
143453632|NCT02980731|517206783|FG000|Overall Study|COVID-19 infection|1|||
143453633|NCT02980731|517206783|FG000|Overall Study|Other, not specified|66|||
143453634|NCT03037931|517206784|FG000|Overall Study|Death|354|||
143453635|NCT03037931|517206785|FG001|Overall Study|Death|367|||
143453636|NCT03037931|517206784|FG000|Overall Study|Lost to Follow-up|7|||
143453637|NCT03037931|517206785|FG001|Overall Study|Lost to Follow-up|4|||
143453638|NCT03037931|517206784|FG000|Overall Study|Withdrawal by Subject|48|||
143453639|NCT03037931|517206785|FG001|Overall Study|Withdrawal by Subject|41|||
143453640|NCT02075476|517206786|FG000|Overall Study|Death|2|||
143453641|NCT02075476|517206787|FG001|Overall Study|Death|2|||
143453642|NCT02075476|517206786|FG000|Overall Study|Lost to Follow-up|1|||
143453643|NCT02075476|517206787|FG001|Overall Study|Lost to Follow-up|3|||
143453644|NCT00091169|517206790|FG000|Overall Study|Disease progression|3|||
143453645|NCT00091169|517206791|FG001|Overall Study|Disease progression|1|||
143453646|NCT00091169|517206790|FG000|Overall Study|Adverse Event|11|||
143453647|NCT00091169|517206791|FG001|Overall Study|Adverse Event|17|||
143453648|NCT00091169|517206790|FG000|Overall Study|Death|4|||
143453649|NCT00091169|517206791|FG001|Overall Study|Death|1|||
143453650|NCT00091169|517206790|FG000|Overall Study|Withdrawal by Subject|10|||
143453651|NCT00091169|517206791|FG001|Overall Study|Withdrawal by Subject|13|||
143453652|NCT00091169|517206790|FG000|Overall Study|Other|3|||
143453653|NCT00091169|517206791|FG001|Overall Study|Other|4|||
143453654|NCT00091169|517206790|FG000|Overall Study|Not start protocol therapy|26|||
143453655|NCT00091169|517206791|FG001|Overall Study|Not start protocol therapy|17|||
143453656|NCT03809429|517206792|FG000|Overall Study|Withdrawal by Subject|7|||
143453657|NCT03809429|517206793|FG001|Overall Study|Withdrawal by Subject|3|||
143453658|NCT03809429|517206792|FG000|Overall Study|Adverse Event|6|||
143453659|NCT03809429|517206793|FG001|Overall Study|Adverse Event|9|||
143453660|NCT03809429|517206792|FG000|Overall Study|COVID-19|3|||
143453661|NCT03809429|517206793|FG001|Overall Study|COVID-19|1|||
143453662|NCT03809429|517206792|FG000|Overall Study|Participant was discontinued by investigator|12|||
143453663|NCT03809429|517206793|FG001|Overall Study|Participant was discontinued by investigator|7|||
143453664|NCT00901186|517206794|FG000|Overall Study|Lack of Efficacy|0|||
143453665|NCT00901186|517206795|FG001|Overall Study|Lack of Efficacy|1|||
143453666|NCT00901186|517206794|FG000|Overall Study|Abnormal laboratory values|0|||
143453667|NCT00901186|517206795|FG001|Overall Study|Abnormal laboratory values|1|||
143453668|NCT00901186|517206794|FG000|Overall Study|Lost to Follow-up|2|||
143453669|NCT00901186|517206795|FG001|Overall Study|Lost to Follow-up|0|||
143453670|NCT00901186|517206794|FG000|Overall Study|Adverse Event|2|||
143453671|NCT00901186|517206795|FG001|Overall Study|Adverse Event|4|||
143453672|NCT00901186|517206794|FG000|Overall Study|Administration problems|0|||
143453673|NCT00901186|517206795|FG001|Overall Study|Administration problems|1|||
143453674|NCT00901186|517206794|FG000|Overall Study|Protocol deviations|5|||
143453675|NCT00901186|517206795|FG001|Overall Study|Protocol deviations|4|||
143453676|NCT03377699|517206803|FG000|Overall Study|Withdrawal by Subject|2|||
143453677|NCT03377699|517206804|FG001|Overall Study|Withdrawal by Subject|9|||
143453678|NCT03377699|517206803|FG000|Overall Study|Lost to Follow-up|1|||
143453679|NCT03377699|517206804|FG001|Overall Study|Lost to Follow-up|1|||
143453680|NCT03377699|517206803|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
143453681|NCT03377699|517206804|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
143453682|NCT03377699|517206803|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
143453683|NCT03377699|517206804|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
143453684|NCT03377699|517206803|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
143453685|NCT03377699|517206804|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
143453686|NCT03377699|517206803|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
143453687|NCT03377699|517206804|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
143453688|NCT00774930|517206808|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
143453689|NCT00774930|517206809|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
143453690|NCT00774930|517206808|FG000|DB Phase|Adverse Event|1|||
143453691|NCT00774930|517206809|FG001|DB Phase|Adverse Event|2|||
143453692|NCT00774930|517206808|FG000|DB Phase|Subject Decision|1|||
143453693|NCT00774930|517206809|FG001|DB Phase|Subject Decision|5|||
143453694|NCT00774930|517206808|FG000|DB Phase|Sponsor Decision|0|||
143453695|NCT00774930|517206809|FG001|DB Phase|Sponsor Decision|1|||
143453696|NCT00774930|517206808|FG000|DB Phase|Disease Progression|1|||
143453697|NCT00774930|517206809|FG001|DB Phase|Disease Progression|1|||
143453698|NCT00774930|517206808|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
143453699|NCT00774930|517206809|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
143453700|NCT00774930|517206808|FG000|IOL Phase|Adverse Event|1|||
143453701|NCT00774930|517206809|FG001|IOL Phase|Adverse Event|1|||
143453702|NCT00774930|517206808|FG000|IOL Phase|Subject Decision|4|||
143453703|NCT00774930|517206809|FG001|IOL Phase|Subject Decision|3|||
143453704|NCT00774930|517206808|FG000|IOL Phase|Physician Decision|3|||
143453705|NCT00774930|517206809|FG001|IOL Phase|Physician Decision|2|||
143453706|NCT00774930|517206808|FG000|IOL Phase|Sponsor Decision|1|||
143453707|NCT00774930|517206809|FG001|IOL Phase|Sponsor Decision|0|||
143453708|NCT00774930|517206808|FG000|IOL Phase|Disease Progression|2|||
143453709|NCT00774930|517206809|FG001|IOL Phase|Disease Progression|1|||
143453710|NCT00774930|517206808|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
143453711|NCT00774930|517206809|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
143453712|NCT00774930|517206808|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
143453713|NCT00774930|517206809|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
143453714|NCT00774930|517206808|FG000|IOL Phase|Other|1|||
143453715|NCT00774930|517206809|FG001|IOL Phase|Other|0|||
143453716|NCT00774930|517206808|FG000|IOL Phase|Brain radiation|0|||
143453717|NCT00774930|517206809|FG001|IOL Phase|Brain radiation|1|||
143453718|NCT00774930|517206808|FG000|LTOLE Phase|Adverse Event|7|||
143453719|NCT00774930|517206809|FG001|LTOLE Phase|Adverse Event|3|||
143453720|NCT00774930|517206808|FG000|LTOLE Phase|Subject decision|0|||
143453721|NCT00774930|517206809|FG001|LTOLE Phase|Subject decision|5|||
143453722|NCT00774930|517206808|FG000|LTOLE Phase|Physician Decision|4|||
143453723|NCT00774930|517206809|FG001|LTOLE Phase|Physician Decision|1|||
143453724|NCT00774930|517206808|FG000|LTOLE Phase|Sponsor decision|2|||
143453725|NCT00774930|517206809|FG001|LTOLE Phase|Sponsor decision|1|||
143453726|NCT00774930|517206808|FG000|LTOLE Phase|Disease Progression|2|||
143453727|NCT00774930|517206809|FG001|LTOLE Phase|Disease Progression|5|||
143453728|NCT00774930|517206808|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
143453729|NCT00774930|517206809|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
143453730|NCT00774930|517206808|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
143453731|NCT00774930|517206809|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
143453732|NCT01153321|517206810|FG000|Overall Study|Development of study withdrawal criteria|0|||
143453733|NCT01153321|517206811|FG001|Overall Study|Development of study withdrawal criteria|1|||
143453734|NCT01153321|517206810|FG000|Overall Study|Withdrawal by Subject|0|||
143453735|NCT01153321|517206811|FG001|Overall Study|Withdrawal by Subject|1|||
143453736|NCT01153321|517206810|FG000|Overall Study|Adverse Event|1|||
143453737|NCT01153321|517206811|FG001|Overall Study|Adverse Event|1|||
143453738|NCT01177800|517206812|FG000|Overall Study|Adverse Event|9|||
143453739|NCT01177800|517206813|FG001|Overall Study|Adverse Event|3|||
143453740|NCT01177800|517206812|FG000|Overall Study|Protocol Violation|0|||
143453741|NCT01177800|517206813|FG001|Overall Study|Protocol Violation|1|||
143453742|NCT01177800|517206812|FG000|Overall Study|Physician Decision|1|||
143453743|NCT01177800|517206813|FG001|Overall Study|Physician Decision|0|||
143453744|NCT01177800|517206812|FG000|Overall Study|Withdrawal of informed consent|0|||
143453745|NCT01177800|517206813|FG001|Overall Study|Withdrawal of informed consent|1|||
143453746|NCT00700427|517206815|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
143453747|NCT00700427|517206816|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
143453748|NCT00700427|517206817|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
143453749|NCT00700427|517206818|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
143453750|NCT00700427|517206819|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
143453751|NCT00700427|517206815|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
143453752|NCT00700427|517206816|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
143453753|NCT00700427|517206817|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
143453754|NCT00700427|517206818|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
143453755|NCT00700427|517206819|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
143453756|NCT00700427|517206815|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
143453757|NCT00700427|517206816|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
143453758|NCT00700427|517206817|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
143453759|NCT00700427|517206818|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
143453760|NCT00700427|517206819|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
143453761|NCT00700427|517206815|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
143453762|NCT00700427|517206816|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
143453763|NCT00700427|517206817|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
143453764|NCT00700427|517206818|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
143453765|NCT00700427|517206819|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
143453766|NCT00700427|517206815|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
143453767|NCT00700427|517206816|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
143453768|NCT00700427|517206817|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
143453769|NCT00700427|517206818|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
143453770|NCT00700427|517206819|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
143453771|NCT00700427|517206815|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
143453772|NCT00700427|517206816|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
143453773|NCT00700427|517206817|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
143453774|NCT00700427|517206818|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
143453775|NCT00700427|517206819|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
143453776|NCT00700427|517206815|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
143453777|NCT00700427|517206816|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
143453778|NCT00700427|517206817|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
143453779|NCT00700427|517206818|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
143453780|NCT00700427|517206819|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
143453781|NCT00700427|517206815|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
143453782|NCT00700427|517206816|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
143453783|NCT00700427|517206817|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
143453784|NCT00700427|517206818|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
143453785|NCT00700427|517206819|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
143453786|NCT00700427|517206815|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
143453787|NCT00700427|517206816|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
143453788|NCT00700427|517206817|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
143453789|NCT00700427|517206818|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
143453790|NCT00700427|517206819|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
143453791|NCT00700427|517206815|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
143453792|NCT00700427|517206816|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
143453793|NCT00700427|517206817|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
143453794|NCT00700427|517206818|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
143453795|NCT00700427|517206819|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
143453796|NCT00700427|517206815|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
143453797|NCT00700427|517206816|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
143453798|NCT00700427|517206817|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
143453799|NCT00700427|517206818|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
143453800|NCT00700427|517206819|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
143453801|NCT00700427|517206815|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
143453802|NCT00700427|517206816|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
143453803|NCT00700427|517206817|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
143453804|NCT00700427|517206818|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
143453805|NCT00700427|517206819|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
143453806|NCT00700427|517206815|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
143453807|NCT00700427|517206816|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
143453808|NCT00700427|517206817|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
143453809|NCT00700427|517206818|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
143453810|NCT00700427|517206819|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
143453811|NCT00700427|517206815|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
143453812|NCT00700427|517206816|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
143453813|NCT00700427|517206817|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
143453814|NCT00700427|517206818|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
143453815|NCT00700427|517206819|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
143453816|NCT00700427|517206815|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
143453817|NCT00700427|517206816|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
143453818|NCT00700427|517206817|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
143453819|NCT00700427|517206818|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
143453820|NCT00700427|517206819|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
143453821|NCT00700427|517206815|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
143453822|NCT00700427|517206816|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
143453823|NCT00700427|517206817|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
143453824|NCT00700427|517206818|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
143453825|NCT00700427|517206819|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
143453826|NCT00700427|517206815|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
143453827|NCT00700427|517206816|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
143453828|NCT00700427|517206817|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
143453829|NCT00700427|517206818|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
143453830|NCT00700427|517206819|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
143453831|NCT00700427|517206815|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
143453832|NCT00700427|517206816|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
143453833|NCT00700427|517206817|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
143453834|NCT00700427|517206818|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
143453835|NCT00700427|517206819|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
143453836|NCT00700427|517206815|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
143453837|NCT00700427|517206816|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
143453838|NCT00700427|517206817|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
143453839|NCT00700427|517206818|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
143453840|NCT00700427|517206819|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
143453841|NCT00700427|517206815|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
143453842|NCT00700427|517206816|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
143453843|NCT00700427|517206817|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
143453844|NCT00700427|517206818|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
143453845|NCT00700427|517206819|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
143453846|NCT00700427|517206815|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
143453847|NCT00700427|517206816|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
143453848|NCT00700427|517206817|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
143453849|NCT00700427|517206818|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
143453850|NCT00700427|517206819|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
143453851|NCT00700427|517206815|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
143453852|NCT00700427|517206816|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
143453853|NCT00700427|517206817|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
143453854|NCT00700427|517206818|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
143453855|NCT00700427|517206819|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
143453856|NCT00700427|517206815|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
143453857|NCT00700427|517206816|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
143453858|NCT00700427|517206817|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
143453859|NCT00700427|517206818|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
143453860|NCT00700427|517206819|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
143453861|NCT00700427|517206815|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
143453862|NCT00700427|517206816|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
143453863|NCT00700427|517206817|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
143453864|NCT00700427|517206818|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
143453865|NCT00700427|517206819|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
143453866|NCT00700427|517206815|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
143453867|NCT00700427|517206816|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
143453868|NCT00700427|517206817|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
143453869|NCT00700427|517206818|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
143453870|NCT00700427|517206819|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
143453871|NCT00700427|517206815|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
143453872|NCT00700427|517206816|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
143453873|NCT00700427|517206817|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
143453874|NCT00700427|517206818|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
143453875|NCT00700427|517206819|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
143453876|NCT00700427|517206815|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
143453877|NCT00700427|517206816|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
143453878|NCT00700427|517206817|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
143453879|NCT00700427|517206818|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
143453880|NCT00700427|517206819|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
143453881|NCT00700427|517206815|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
143453882|NCT00700427|517206816|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
143453883|NCT00700427|517206817|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
143453884|NCT00700427|517206818|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
143453885|NCT00700427|517206819|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
143453886|NCT00700427|517206815|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
143453887|NCT00700427|517206816|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
143453888|NCT00700427|517206817|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
143453889|NCT00700427|517206818|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
143453890|NCT00700427|517206819|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
143453891|NCT00700427|517206815|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
143453892|NCT00700427|517206816|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
143453893|NCT00700427|517206817|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
143453894|NCT00700427|517206818|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
143453895|NCT00700427|517206819|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
143453896|NCT00700427|517206815|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
143453897|NCT00700427|517206816|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
143453898|NCT00700427|517206817|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
143453899|NCT00700427|517206818|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
143453900|NCT00700427|517206819|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
143453901|NCT00700427|517206815|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
143453902|NCT00700427|517206816|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
143453903|NCT00700427|517206817|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
143453904|NCT00700427|517206818|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
143453905|NCT00700427|517206819|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
143453906|NCT00700427|517206815|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
143453907|NCT00700427|517206816|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
143453908|NCT00700427|517206817|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
143453909|NCT00700427|517206818|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
143453910|NCT00700427|517206819|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
143453911|NCT00700427|517206815|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
143453912|NCT00700427|517206816|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
143453913|NCT00700427|517206817|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
143453914|NCT00700427|517206818|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
143453915|NCT00700427|517206819|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
143453916|NCT00700427|517206815|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
143453917|NCT00700427|517206816|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
143453918|NCT00700427|517206817|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
143453919|NCT00700427|517206818|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
143453920|NCT00700427|517206819|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
143453921|NCT00700427|517206815|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
143453922|NCT00700427|517206816|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
143453923|NCT00700427|517206817|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
143453924|NCT00700427|517206818|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
143453925|NCT00700427|517206819|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
143453926|NCT00700427|517206815|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
143453927|NCT00700427|517206816|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
143453928|NCT00700427|517206817|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
143453929|NCT00700427|517206818|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
143453930|NCT00700427|517206819|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
143453931|NCT00700427|517206815|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
143453932|NCT00700427|517206816|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
143453933|NCT00700427|517206817|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
143453934|NCT00700427|517206818|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
143453935|NCT00700427|517206819|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
143453936|NCT00424385|517206820|FG000|Cohort 0|Withdrawal by Subject|5|||
143453937|NCT00424385|517206820|FG000|Cohort 0|Physician Decision|1|||
143453938|NCT00424385|517206820|FG000|Cohort 1|Withdrawal by Subject|1|||
143453939|NCT01125514|517206829|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
143453940|NCT01125514|517206829|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
143453941|NCT01125514|517206829|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
143453942|NCT01125514|517206829|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
143453943|NCT01125514|517206829|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
143453944|NCT01125514|517206829|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
143453945|NCT03980808|517206830|FG000|Overall Study|Lost to Follow-up|2|||
143453946|NCT03980808|517206831|FG001|Overall Study|Lost to Follow-up|2|||
143453947|NCT01655693|517206832|FG000|Overall Study|Progression of Disease|92|||
143453948|NCT01655693|517206833|FG001|Overall Study|Progression of Disease|76|||
143453949|NCT01655693|517206834|FG002|Overall Study|Progression of Disease|58|||
143453950|NCT01655693|517206832|FG000|Overall Study|Death|8|||
143453951|NCT01655693|517206833|FG001|Overall Study|Death|9|||
143453952|NCT01655693|517206834|FG002|Overall Study|Death|12|||
143453953|NCT01655693|517206832|FG000|Overall Study|Serious Adverse Event|3|||
143453954|NCT01655693|517206833|FG001|Overall Study|Serious Adverse Event|15|||
143453955|NCT01655693|517206834|FG002|Overall Study|Serious Adverse Event|11|||
143453956|NCT01655693|517206832|FG000|Overall Study|Withdrawal by Subject|3|||
143453957|NCT01655693|517206833|FG001|Overall Study|Withdrawal by Subject|2|||
143453958|NCT01655693|517206834|FG002|Overall Study|Withdrawal by Subject|20|||
143453959|NCT01655693|517206832|FG000|Overall Study|Adverse Event|3|||
143453960|NCT01655693|517206833|FG001|Overall Study|Adverse Event|11|||
143453961|NCT01655693|517206834|FG002|Overall Study|Adverse Event|3|||
143453962|NCT01655693|517206832|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
143453963|NCT01655693|517206833|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
143453964|NCT01655693|517206834|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
143453965|NCT01655693|517206832|FG000|Overall Study|Non-Compliance|0|||
143453966|NCT01655693|517206833|FG001|Overall Study|Non-Compliance|0|||
143453967|NCT01655693|517206834|FG002|Overall Study|Non-Compliance|7|||
143453968|NCT01655693|517206832|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
143453969|NCT01655693|517206833|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
143453970|NCT01655693|517206834|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
143453971|NCT01655693|517206832|FG000|Overall Study|Protocol Violation|1|||
143453972|NCT01655693|517206833|FG001|Overall Study|Protocol Violation|0|||
143453973|NCT01655693|517206834|FG002|Overall Study|Protocol Violation|3|||
143453974|NCT01655693|517206832|FG000|Overall Study|Lost to Follow-up|1|||
143453975|NCT01655693|517206833|FG001|Overall Study|Lost to Follow-up|0|||
142940378|NCT02185521|515322172|FG000|Overall Study|Withdrawal by Subject|1|||
142940379|NCT02185521|515322172|FG000|Overall Study|Protocol Violation|1|||
142940380|NCT00398112|515322173|FG000|Overall Study|Adverse Event|4|||
142940381|NCT00398112|515322173|FG000|Overall Study|Disease progression|9|||
142940382|NCT00398112|515322173|FG000|Overall Study|Alternative treatment|1|||
142940383|NCT00398112|515322173|FG000|Overall Study|Withdrawal by Subject|3|||
142940384|NCT00398112|515322173|FG000|Overall Study|Death|1|||
142940385|NCT00450580|515322174|FG000|Overall Study|Adverse Event|5|||
142940386|NCT00450580|515322175|FG001|Overall Study|Adverse Event|7|||
142940387|NCT00450580|515322174|FG000|Overall Study|Lost to Follow-up|4|||
142940388|NCT00450580|515322175|FG001|Overall Study|Lost to Follow-up|5|||
142940389|NCT00450580|515322174|FG000|Overall Study|Withdrawal by Subject|2|||
142940390|NCT00450580|515322175|FG001|Overall Study|Withdrawal by Subject|2|||
142940391|NCT00450580|515322174|FG000|Overall Study|Protocol Violation|1|||
142940392|NCT00450580|515322175|FG001|Overall Study|Protocol Violation|1|||
142940393|NCT00450580|515322174|FG000|Overall Study|Protocol-defined virologic failure|1|||
142940394|NCT00450580|515322175|FG001|Overall Study|Protocol-defined virologic failure|0|||
142940395|NCT00450580|515322174|FG000|Overall Study|Could not comply with scheduled visits|1|||
142940396|NCT00450580|515322175|FG001|Overall Study|Could not comply with scheduled visits|0|||
142940397|NCT00450580|515322174|FG000|Overall Study|Patient went to Brazil|1|||
142940398|NCT00450580|515322175|FG001|Overall Study|Patient went to Brazil|0|||
142940399|NCT00450580|515322174|FG000|Overall Study|Patient could not swallow Norvir|1|||
142940400|NCT00450580|515322175|FG001|Overall Study|Patient could not swallow Norvir|0|||
142940401|NCT00450580|515322174|FG000|Overall Study|Withdrawal due to pregnancy|0|||
142940402|NCT00450580|515322175|FG001|Overall Study|Withdrawal due to pregnancy|1|||
142940421|NCT00603239|515322187|FG000|Overall Study|Adverse Event|4|||
142940422|NCT00603239|515322188|FG001|Overall Study|Adverse Event|1|||
142940423|NCT00603239|515322187|FG000|Overall Study|Entry criteria not met|0|||
142940424|NCT00603239|515322188|FG001|Overall Study|Entry criteria not met|1|||
142940425|NCT00603239|515322187|FG000|Overall Study|Loss of glucose control|3|||
142940426|NCT00603239|515322188|FG001|Overall Study|Loss of glucose control|0|||
142940427|NCT00603239|515322187|FG000|Overall Study|Lost to Follow-up|2|||
142940428|NCT00603239|515322188|FG001|Overall Study|Lost to Follow-up|1|||
142940429|NCT00603239|515322187|FG000|Overall Study|Physician Decision|2|||
142940430|NCT00603239|515322188|FG001|Overall Study|Physician Decision|0|||
142940431|NCT00603239|515322187|FG000|Overall Study|Protocol Violation|2|||
142940432|NCT00603239|515322188|FG001|Overall Study|Protocol Violation|0|||
142940433|NCT00603239|515322187|FG000|Overall Study|Subject decision|2|||
142940434|NCT00603239|515322188|FG001|Overall Study|Subject decision|1|||
142940435|NCT01562028|515322189|FG000|Overall Study|Withdrawal by Subject|1|||
142940436|NCT01562028|515322190|FG001|Overall Study|Withdrawal by Subject|1|||
142940437|NCT01562028|515322189|FG000|Overall Study|Lost to Follow-up|2|||
142940438|NCT01562028|515322190|FG001|Overall Study|Lost to Follow-up|1|||
142940443|NCT00391976|515322200|FG000|Overall Study|Adverse Event|0|||
142940444|NCT00391976|515322201|FG001|Overall Study|Adverse Event|0|||
142940445|NCT00391976|515322202|FG002|Overall Study|Adverse Event|1|||
142940446|NCT00391976|515322200|FG000|Overall Study|Withdrawal of consent|0|||
142940447|NCT00391976|515322201|FG001|Overall Study|Withdrawal of consent|1|||
142940448|NCT00391976|515322202|FG002|Overall Study|Withdrawal of consent|1|||
142940449|NCT00391976|515322200|FG000|Overall Study|Lost to Follow-up|1|||
142940450|NCT00391976|515322201|FG001|Overall Study|Lost to Follow-up|2|||
142940451|NCT00391976|515322202|FG002|Overall Study|Lost to Follow-up|0|||
142940452|NCT00391976|515322200|FG000|Overall Study|Inappropriate enrollment|1|||
142940453|NCT00391976|515322201|FG001|Overall Study|Inappropriate enrollment|1|||
142940454|NCT00391976|515322202|FG002|Overall Study|Inappropriate enrollment|0|||
142940455|NCT00391976|515322200|FG000|Overall Study|Protocol deviation/violation|4|||
142940456|NCT00391976|515322201|FG001|Overall Study|Protocol deviation/violation|2|||
142940457|NCT00391976|515322202|FG002|Overall Study|Protocol deviation/violation|1|||
142940458|NCT00391976|515322200|FG000|Overall Study|Recurrence/no eradication of infection|21|||
142940459|NCT00391976|515322201|FG001|Overall Study|Recurrence/no eradication of infection|19|||
142940460|NCT00391976|515322202|FG002|Overall Study|Recurrence/no eradication of infection|0|||
142940461|NCT00391976|515322200|FG000|Overall Study|Unable to classify|0|||
142940462|NCT00391976|515322201|FG001|Overall Study|Unable to classify|0|||
142940463|NCT00391976|515322202|FG002|Overall Study|Unable to classify|1|||
142940464|NCT00391976|515322200|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
143453976|NCT01655693|517206834|FG002|Overall Study|Lost to Follow-up|1|||
143453977|NCT01655693|517206832|FG000|Overall Study|Screening Failure|1|||
143453978|NCT01655693|517206833|FG001|Overall Study|Screening Failure|0|||
142940465|NCT00391976|515322201|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
142940466|NCT00391976|515322202|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
142940468|NCT01701258|515322208|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
142940469|NCT01701258|515322209|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
142940470|NCT01701258|515322210|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
142940471|NCT01701258|515322211|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
142940472|NCT01701258|515322212|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
142940473|NCT01701258|515322213|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
142940474|NCT01701258|515322214|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
142940475|NCT01701258|515322215|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
143453979|NCT01655693|517206834|FG002|Overall Study|Screening Failure|0|||
143453980|NCT01655693|517206832|FG000|Overall Study|Other|8|||
143453981|NCT01655693|517206833|FG001|Overall Study|Other|6|||
143453982|NCT01655693|517206834|FG002|Overall Study|Other|15|||
143453983|NCT02535091|517206838|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
143453984|NCT02535091|517206839|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
143453985|NCT02535091|517206840|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
143453986|NCT02535091|517206838|FG000|Overall Study|Withdrawal by Subject|14|||
143453987|NCT02535091|517206839|FG001|Overall Study|Withdrawal by Subject|5|||
142940476|NCT01701258|515322216|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
142940477|NCT01701258|515322217|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
142940478|NCT01701258|515322218|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
142940479|NCT01701258|515322219|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
142940480|NCT01701258|515322220|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
142940481|NCT01701258|515322208|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
142940482|NCT01701258|515322209|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
142940483|NCT01701258|515322210|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
142940484|NCT01701258|515322211|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
142940485|NCT01701258|515322212|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
142940486|NCT01701258|515322213|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
142940487|NCT01701258|515322214|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
142940488|NCT01701258|515322215|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
142940489|NCT01701258|515322216|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
142940490|NCT01701258|515322217|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
142940491|NCT01701258|515322218|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
142940492|NCT01701258|515322219|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
142940493|NCT01701258|515322220|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
142940494|NCT01701258|515322208|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
142940495|NCT01701258|515322209|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
142940496|NCT01701258|515322210|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
142940497|NCT01701258|515322211|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
142940498|NCT01701258|515322212|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
142940499|NCT01701258|515322213|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
142940500|NCT01701258|515322214|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
142940501|NCT01701258|515322215|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
142940502|NCT01701258|515322216|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
142940503|NCT01701258|515322217|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
142940504|NCT01701258|515322218|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
142940505|NCT01701258|515322219|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
142940506|NCT01701258|515322220|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
142940507|NCT01701258|515322208|FG000|Assessment and Scheduling|Investigator Terminated|2|||
142940508|NCT01701258|515322209|FG001|Assessment and Scheduling|Investigator Terminated|0|||
142940509|NCT01701258|515322210|FG002|Assessment and Scheduling|Investigator Terminated|0|||
142940510|NCT01701258|515322211|FG003|Assessment and Scheduling|Investigator Terminated|0|||
142940511|NCT01701258|515322212|FG004|Assessment and Scheduling|Investigator Terminated|0|||
142940512|NCT01701258|515322213|FG005|Assessment and Scheduling|Investigator Terminated|0|||
142940513|NCT01701258|515322214|FG006|Assessment and Scheduling|Investigator Terminated|0|||
142940514|NCT01701258|515322215|FG007|Assessment and Scheduling|Investigator Terminated|0|||
142940515|NCT01701258|515322216|FG008|Assessment and Scheduling|Investigator Terminated|0|||
142940516|NCT01701258|515322217|FG009|Assessment and Scheduling|Investigator Terminated|0|||
142940517|NCT01701258|515322218|FG010|Assessment and Scheduling|Investigator Terminated|0|||
142940518|NCT01701258|515322219|FG011|Assessment and Scheduling|Investigator Terminated|0|||
142940519|NCT01701258|515322220|FG012|Assessment and Scheduling|Investigator Terminated|0|||
142940532|NCT01670994|515322226|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
142940533|NCT01670994|515322227|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
142940534|NCT01670994|515322226|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
142940535|NCT01670994|515322227|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
142940536|NCT01670994|515322226|FG000|Overall Study|Patient experienced DLT|0|||
142940537|NCT01670994|515322227|FG001|Overall Study|Patient experienced DLT|1|||
142940538|NCT02013544|515322228|FG000|Overall Study|Adverse Event|5|||
142940539|NCT02013544|515322229|FG001|Overall Study|Adverse Event|5|||
142940540|NCT02013544|515322228|FG000|Overall Study|Lost to Follow-up|2|||
142940541|NCT02013544|515322229|FG001|Overall Study|Lost to Follow-up|3|||
142940542|NCT02013544|515322228|FG000|Overall Study|Withdrawal by Subject|2|||
142940543|NCT02013544|515322229|FG001|Overall Study|Withdrawal by Subject|8|||
142940544|NCT02013544|515322228|FG000|Overall Study|Physician Decision|0|||
142940545|NCT02013544|515322229|FG001|Overall Study|Physician Decision|1|||
142940546|NCT02013544|515322228|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
142940547|NCT02013544|515322229|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
142940548|NCT03514914|515322230|FG000|Overall Study|Death|3|||
142940549|NCT03514914|515322231|FG001|Overall Study|Death|3|||
142940550|NCT03514914|515322230|FG000|Overall Study|Lost to Follow-up|117|||
142940551|NCT03514914|515322231|FG001|Overall Study|Lost to Follow-up|89|||
142940552|NCT00891735|515322232|FG000|Overall Study|Adverse Event|2|||
142940553|NCT00891735|515322233|FG001|Overall Study|Adverse Event|0|||
142940554|NCT00891735|515322234|FG002|Overall Study|Adverse Event|2|||
142940555|NCT00891735|515322235|FG003|Overall Study|Adverse Event|0|||
142940556|NCT00891735|515322232|FG000|Overall Study|Death|8|||
142940557|NCT00891735|515322233|FG001|Overall Study|Death|5|||
142940558|NCT00891735|515322234|FG002|Overall Study|Death|4|||
142940559|NCT00891735|515322235|FG003|Overall Study|Death|5|||
142940560|NCT00891735|515322232|FG000|Overall Study|Lost to Follow-up|2|||
142940561|NCT00891735|515322233|FG001|Overall Study|Lost to Follow-up|2|||
142940562|NCT00891735|515322234|FG002|Overall Study|Lost to Follow-up|2|||
142940563|NCT00891735|515322235|FG003|Overall Study|Lost to Follow-up|2|||
142940564|NCT00891735|515322232|FG000|Overall Study|Physician's decision to withdraw patient|1|||
142940565|NCT00891735|515322233|FG001|Overall Study|Physician's decision to withdraw patient|0|||
142940566|NCT00891735|515322234|FG002|Overall Study|Physician's decision to withdraw patient|0|||
142940567|NCT00891735|515322235|FG003|Overall Study|Physician's decision to withdraw patient|0|||
142940568|NCT00891735|515322232|FG000|Overall Study|Patient's decision to withdraw|4|||
142940569|NCT00891735|515322233|FG001|Overall Study|Patient's decision to withdraw|9|||
142940570|NCT00891735|515322234|FG002|Overall Study|Patient's decision to withdraw|4|||
142940571|NCT00891735|515322235|FG003|Overall Study|Patient's decision to withdraw|8|||
142940633|NCT01147809|515322273|FG000|Phase I (168 Days)|Adverse Event|0|||
142940634|NCT01147809|515322274|FG001|Phase I (168 Days)|Adverse Event|0|||
142940635|NCT01147809|515322275|FG002|Phase I (168 Days)|Adverse Event|0|||
142940636|NCT01147809|515322276|FG003|Phase I (168 Days)|Adverse Event|1|||
142940637|NCT01147809|515322277|FG004|Phase I (168 Days)|Adverse Event|0|||
142940638|NCT01147809|515322278|FG005|Phase I (168 Days)|Adverse Event|0|||
142940639|NCT01147809|515322273|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
142940640|NCT01147809|515322274|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
142940641|NCT01147809|515322275|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
142940642|NCT01147809|515322276|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
142940643|NCT01147809|515322277|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
142940644|NCT01147809|515322278|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
142940645|NCT01147809|515322273|FG000|Phase I (168 Days)|Physician Decision|0|||
142940646|NCT01147809|515322274|FG001|Phase I (168 Days)|Physician Decision|1|||
142940647|NCT01147809|515322275|FG002|Phase I (168 Days)|Physician Decision|2|||
142940648|NCT01147809|515322276|FG003|Phase I (168 Days)|Physician Decision|0|||
142940649|NCT01147809|515322277|FG004|Phase I (168 Days)|Physician Decision|0|||
142940650|NCT01147809|515322278|FG005|Phase I (168 Days)|Physician Decision|0|||
142940651|NCT01147809|515322273|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
142940652|NCT01147809|515322274|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
142940653|NCT01147809|515322275|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
142940654|NCT01147809|515322276|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
142940655|NCT01147809|515322277|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
142940656|NCT01147809|515322278|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
142940657|NCT01147809|515322273|FG000|Phase II (168 Days)|Adverse Event|0|||
142940658|NCT01147809|515322274|FG001|Phase II (168 Days)|Adverse Event|0|||
142940659|NCT01147809|515322275|FG002|Phase II (168 Days)|Adverse Event|0|||
142940660|NCT01147809|515322276|FG003|Phase II (168 Days)|Adverse Event|0|||
142940661|NCT01147809|515322277|FG004|Phase II (168 Days)|Adverse Event|3|||
142940662|NCT01147809|515322278|FG005|Phase II (168 Days)|Adverse Event|6|||
142940663|NCT01147809|515322273|FG000|Phase II (168 Days)|Protocol Violation|0|||
142940664|NCT01147809|515322274|FG001|Phase II (168 Days)|Protocol Violation|0|||
142940665|NCT01147809|515322275|FG002|Phase II (168 Days)|Protocol Violation|0|||
142940666|NCT01147809|515322276|FG003|Phase II (168 Days)|Protocol Violation|0|||
142940667|NCT01147809|515322277|FG004|Phase II (168 Days)|Protocol Violation|0|||
142940668|NCT01147809|515322278|FG005|Phase II (168 Days)|Protocol Violation|1|||
142940669|NCT01147809|515322273|FG000|Phase II (168 Days)|Physician Decision|0|||
142940670|NCT01147809|515322274|FG001|Phase II (168 Days)|Physician Decision|0|||
142940671|NCT01147809|515322275|FG002|Phase II (168 Days)|Physician Decision|0|||
142940672|NCT01147809|515322276|FG003|Phase II (168 Days)|Physician Decision|0|||
142940673|NCT01147809|515322277|FG004|Phase II (168 Days)|Physician Decision|5|||
142940674|NCT01147809|515322278|FG005|Phase II (168 Days)|Physician Decision|11|||
142940675|NCT01147809|515322273|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
142940676|NCT01147809|515322274|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
142940677|NCT01147809|515322275|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
142940678|NCT01147809|515322276|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
142940679|NCT01147809|515322277|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
142940680|NCT01147809|515322278|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
142940681|NCT01147809|515322273|FG000|Phase II (168 Days)|Ongoing|0|||
142940682|NCT01147809|515322274|FG001|Phase II (168 Days)|Ongoing|0|||
142940683|NCT01147809|515322275|FG002|Phase II (168 Days)|Ongoing|0|||
142940684|NCT01147809|515322276|FG003|Phase II (168 Days)|Ongoing|0|||
142940685|NCT01147809|515322277|FG004|Phase II (168 Days)|Ongoing|1|||
142940686|NCT01147809|515322278|FG005|Phase II (168 Days)|Ongoing|0|||
142940687|NCT01307423|515322279|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
142940688|NCT01307423|515322280|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
142940689|NCT01307423|515322281|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
142940690|NCT01307423|515322282|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
142940691|NCT01307423|515322283|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
142940692|NCT01307423|515322284|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
142940693|NCT01307423|515322285|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
142940694|NCT01307423|515322286|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
142940695|NCT01307423|515322287|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
142940696|NCT01307423|515322279|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
142940697|NCT01307423|515322280|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
142940698|NCT01307423|515322281|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
142940699|NCT01307423|515322282|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
142940700|NCT01307423|515322283|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
142940701|NCT01307423|515322284|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
142940702|NCT01307423|515322285|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
142940703|NCT01307423|515322286|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
142940704|NCT01307423|515322287|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
142940705|NCT01307423|515322279|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
142940706|NCT01307423|515322280|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
142940707|NCT01307423|515322281|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
142940708|NCT01307423|515322282|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
142940709|NCT01307423|515322283|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
142940710|NCT01307423|515322284|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
142940711|NCT01307423|515322285|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
142940712|NCT01307423|515322286|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
142940713|NCT01307423|515322287|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
142940714|NCT01307423|515322279|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
142940715|NCT01307423|515322280|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
142940716|NCT01307423|515322281|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
142940717|NCT01307423|515322282|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
142940718|NCT01307423|515322283|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
142940719|NCT01307423|515322284|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
142940720|NCT01307423|515322285|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
142940721|NCT01307423|515322286|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
142940722|NCT01307423|515322287|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
142940723|NCT01307423|515322279|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
142940724|NCT01307423|515322280|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
142940725|NCT01307423|515322281|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
142940726|NCT01307423|515322282|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
142940727|NCT01307423|515322283|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
142940728|NCT01307423|515322284|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
142940729|NCT01307423|515322285|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
142940730|NCT01307423|515322286|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
142940731|NCT01307423|515322287|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
142940732|NCT01307423|515322279|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
142940733|NCT01307423|515322280|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
142940734|NCT01307423|515322281|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
142940735|NCT01307423|515322282|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
142940736|NCT01307423|515322283|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
143453988|NCT02535091|517206840|FG002|Overall Study|Withdrawal by Subject|121|||
142940737|NCT01307423|515322284|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
142940738|NCT01307423|515322285|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
142940739|NCT01307423|515322286|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
142940740|NCT01307423|515322287|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
142940741|NCT01307423|515322279|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
142940742|NCT01307423|515322280|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
142940743|NCT01307423|515322281|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
142940744|NCT01307423|515322282|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
142940745|NCT01307423|515322283|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
142940746|NCT01307423|515322284|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
142940747|NCT01307423|515322285|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
142940748|NCT01307423|515322286|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
142940749|NCT01307423|515322287|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
142940750|NCT01307423|515322279|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
142940751|NCT01307423|515322280|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
142940752|NCT01307423|515322281|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
142940753|NCT01307423|515322282|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
142940754|NCT01307423|515322283|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
142940755|NCT01307423|515322284|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
142940756|NCT01307423|515322285|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
142940757|NCT01307423|515322286|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
142940758|NCT01307423|515322287|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
142940759|NCT01307423|515322279|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
142940760|NCT01307423|515322280|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
142940761|NCT01307423|515322281|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
142940762|NCT01307423|515322282|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
142940763|NCT01307423|515322283|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
142940764|NCT01307423|515322284|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
142940765|NCT01307423|515322285|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
142940766|NCT01307423|515322286|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
142940767|NCT01307423|515322287|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
142940768|NCT01307423|515322279|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
142940769|NCT01307423|515322280|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
142940770|NCT01307423|515322281|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
142940771|NCT01307423|515322282|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
142940772|NCT01307423|515322283|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
142940773|NCT01307423|515322284|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
142940774|NCT01307423|515322285|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
142940775|NCT01307423|515322286|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
142940776|NCT01307423|515322287|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
142940777|NCT01307423|515322279|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
142940778|NCT01307423|515322280|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
142940779|NCT01307423|515322281|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
142940780|NCT01307423|515322282|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
142940781|NCT01307423|515322283|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
142940782|NCT01307423|515322284|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
142940783|NCT01307423|515322285|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
142940784|NCT01307423|515322286|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
142940785|NCT01307423|515322287|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
142940786|NCT01307423|515322279|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
142940787|NCT01307423|515322280|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
142940788|NCT01307423|515322281|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
142940789|NCT01307423|515322282|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
142940790|NCT01307423|515322283|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
142940791|NCT01307423|515322284|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
142940792|NCT01307423|515322285|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
142940793|NCT01307423|515322286|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
142940794|NCT01307423|515322287|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
142940795|NCT01307423|515322279|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
142940796|NCT01307423|515322280|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
142940797|NCT01307423|515322281|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
142940798|NCT01307423|515322282|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
142940799|NCT01307423|515322283|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
142940800|NCT01307423|515322284|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
142940801|NCT01307423|515322285|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
142940802|NCT01307423|515322286|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
142940803|NCT01307423|515322287|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
142940804|NCT01307423|515322279|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
142940805|NCT01307423|515322280|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
142940806|NCT01307423|515322281|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
143453989|NCT02535091|517206838|FG000|Overall Study|Adverse Event|9|||
143453990|NCT02535091|517206839|FG001|Overall Study|Adverse Event|4|||
142940807|NCT01307423|515322282|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
142940808|NCT01307423|515322283|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
142940809|NCT01307423|515322284|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
142940810|NCT01307423|515322285|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
142940811|NCT01307423|515322286|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
142940812|NCT01307423|515322287|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
142940813|NCT01307423|515322279|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
142940814|NCT01307423|515322280|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
142940815|NCT01307423|515322281|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
142940816|NCT01307423|515322282|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
142940817|NCT01307423|515322283|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
142940818|NCT01307423|515322284|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
142940819|NCT01307423|515322285|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
142940820|NCT01307423|515322286|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
142940821|NCT01307423|515322287|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
143453991|NCT02535091|517206840|FG002|Overall Study|Adverse Event|170|||
142940822|NCT01307423|515322279|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
142940823|NCT01307423|515322280|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
142940824|NCT01307423|515322281|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
142940825|NCT01307423|515322282|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
143453992|NCT02535091|517206838|FG000|Overall Study|Other|4|||
143453993|NCT02535091|517206839|FG001|Overall Study|Other|3|||
142940826|NCT01307423|515322283|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
142940827|NCT01307423|515322284|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
142940828|NCT01307423|515322285|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
142940829|NCT01307423|515322286|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
142940830|NCT01307423|515322287|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
142940831|NCT01307423|515322279|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
142940832|NCT01307423|515322280|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
142940833|NCT01307423|515322281|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
142940834|NCT01307423|515322282|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
142940835|NCT01307423|515322283|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
142940836|NCT01307423|515322284|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
142940837|NCT01307423|515322285|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
142940838|NCT01307423|515322286|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
142940839|NCT01307423|515322287|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
142940840|NCT01307423|515322279|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
142940841|NCT01307423|515322280|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
142940842|NCT01307423|515322281|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
142940843|NCT01307423|515322282|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
142940844|NCT01307423|515322283|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
142940845|NCT01307423|515322284|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
142940846|NCT01307423|515322285|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
142940847|NCT01307423|515322286|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
142940848|NCT01307423|515322287|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
142940849|NCT01307423|515322279|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
142940850|NCT01307423|515322280|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
142940851|NCT01307423|515322281|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
142940852|NCT01307423|515322282|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
142940853|NCT01307423|515322283|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
142940854|NCT01307423|515322284|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
142940855|NCT01307423|515322285|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
142940856|NCT01307423|515322286|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
142940857|NCT01307423|515322287|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
142940858|NCT01307423|515322279|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
142940859|NCT01307423|515322280|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
142940860|NCT01307423|515322281|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
142940861|NCT01307423|515322282|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
142940862|NCT01307423|515322283|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
142940863|NCT01307423|515322284|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
142940864|NCT01307423|515322285|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
142940865|NCT01307423|515322286|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
142940866|NCT01307423|515322287|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
142940867|NCT01307423|515322279|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
142940868|NCT01307423|515322280|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
142940869|NCT01307423|515322281|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
142940870|NCT01307423|515322282|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
142940871|NCT01307423|515322283|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
142940872|NCT01307423|515322284|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
142940873|NCT01307423|515322285|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
142940874|NCT01307423|515322286|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
142940875|NCT01307423|515322287|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
142940876|NCT01307423|515322279|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
142940877|NCT01307423|515322280|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
142940878|NCT01307423|515322281|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
142940879|NCT01307423|515322282|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
142940880|NCT01307423|515322283|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
142940881|NCT01307423|515322284|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
142940882|NCT01307423|515322285|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
142940883|NCT01307423|515322286|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
142940884|NCT01307423|515322287|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
142940885|NCT01307423|515322279|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
142940886|NCT01307423|515322280|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
142940887|NCT01307423|515322281|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
142940888|NCT01307423|515322282|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
142940889|NCT01307423|515322283|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
142940890|NCT01307423|515322284|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
142940891|NCT01307423|515322285|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
142940892|NCT01307423|515322286|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
142940893|NCT01307423|515322287|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
142940894|NCT01307423|515322279|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
142940895|NCT01307423|515322280|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
142940896|NCT01307423|515322281|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
142940897|NCT01307423|515322282|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
142940898|NCT01307423|515322283|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
142940899|NCT01307423|515322284|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
142940900|NCT01307423|515322285|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
142940901|NCT01307423|515322286|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
142940902|NCT01307423|515322287|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
142940903|NCT01307423|515322279|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
142940904|NCT01307423|515322280|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
142940905|NCT01307423|515322281|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
142940906|NCT01307423|515322282|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
142940907|NCT01307423|515322283|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
142940908|NCT01307423|515322284|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
142940909|NCT01307423|515322285|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
142940910|NCT01307423|515322286|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
142940911|NCT01307423|515322287|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
142940912|NCT01307423|515322279|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
142940913|NCT01307423|515322280|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
142940914|NCT01307423|515322281|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
142940915|NCT01307423|515322282|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
142940916|NCT01307423|515322283|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
142940917|NCT01307423|515322284|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
142940918|NCT01307423|515322285|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
142940919|NCT01307423|515322286|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
142940920|NCT01307423|515322287|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
142940921|NCT01307423|515322279|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
142940922|NCT01307423|515322280|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
142940923|NCT01307423|515322281|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
142940924|NCT01307423|515322282|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
142940925|NCT01307423|515322283|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
142940926|NCT01307423|515322284|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
142940927|NCT01307423|515322285|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
142940928|NCT01307423|515322286|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
142940929|NCT01307423|515322287|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
142940930|NCT01307423|515322279|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
142940931|NCT01307423|515322280|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
142940932|NCT01307423|515322281|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
142940933|NCT01307423|515322282|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
142940934|NCT01307423|515322283|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
142940935|NCT01307423|515322284|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
142940936|NCT01307423|515322285|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
142940937|NCT01307423|515322286|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
142940938|NCT01307423|515322287|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
142940939|NCT01307423|515322279|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
142940940|NCT01307423|515322280|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
142940941|NCT01307423|515322281|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
142940942|NCT01307423|515322282|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
142940943|NCT01307423|515322283|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
142940944|NCT01307423|515322284|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
142940945|NCT01307423|515322285|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
142940946|NCT01307423|515322286|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
142940947|NCT01307423|515322287|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
142940948|NCT01307423|515322279|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
142940949|NCT01307423|515322280|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
142940950|NCT01307423|515322281|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
142940951|NCT01307423|515322282|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
142940952|NCT01307423|515322283|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
142940953|NCT01307423|515322284|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
142940954|NCT01307423|515322285|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
142940955|NCT01307423|515322286|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
142940956|NCT01307423|515322287|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
142940957|NCT01307423|515322279|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
142940958|NCT01307423|515322280|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
142940959|NCT01307423|515322281|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
142940960|NCT01307423|515322282|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
142940961|NCT01307423|515322283|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
142940962|NCT01307423|515322284|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
143453994|NCT02535091|517206840|FG002|Overall Study|Other|81|||
142940963|NCT01307423|515322285|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
142940964|NCT01307423|515322286|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
142940965|NCT01307423|515322287|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
142940966|NCT01307423|515322279|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
142940967|NCT01307423|515322280|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
142940968|NCT01307423|515322281|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
142940969|NCT01307423|515322282|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
142940970|NCT01307423|515322283|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
142940971|NCT01307423|515322284|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
142940972|NCT01307423|515322285|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
142940973|NCT01307423|515322286|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
142940974|NCT01307423|515322287|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
142940975|NCT01307423|515322279|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
142940976|NCT01307423|515322280|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
142940977|NCT01307423|515322281|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
142940978|NCT01307423|515322282|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
142940979|NCT01307423|515322283|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
142940980|NCT01307423|515322284|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
142940981|NCT01307423|515322285|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
142940982|NCT01307423|515322286|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
142940983|NCT01307423|515322287|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
142940984|NCT01307423|515322279|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
142940985|NCT01307423|515322280|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
142940986|NCT01307423|515322281|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
142940987|NCT01307423|515322282|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
142940988|NCT01307423|515322283|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
142940989|NCT01307423|515322284|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
142940990|NCT01307423|515322285|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
142940991|NCT01307423|515322286|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
142940992|NCT01307423|515322287|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
142940993|NCT01307423|515322279|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
142940994|NCT01307423|515322280|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
142940995|NCT01307423|515322281|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
142940996|NCT01307423|515322282|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
142940997|NCT01307423|515322283|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
142940998|NCT01307423|515322284|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
142940999|NCT01307423|515322285|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
142941000|NCT01307423|515322286|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
142941001|NCT01307423|515322287|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
142941002|NCT01307423|515322279|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
142941003|NCT01307423|515322280|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
142941004|NCT01307423|515322281|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
142941005|NCT01307423|515322282|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
142941006|NCT01307423|515322283|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
142941007|NCT01307423|515322284|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
142941008|NCT01307423|515322285|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
142941009|NCT01307423|515322286|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
142941010|NCT01307423|515322287|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
142941011|NCT03406962|515322288|FG000|Overall Study|Death|2|||
142941012|NCT03406962|515322288|FG000|Overall Study|Adverse Event|1|||
143453995|NCT02535091|517206838|FG000|Overall Study|Lost to Follow-up|0|||
142941039|NCT00700804|515322295|FG000|Overall Study|Withdrawal by Subject|1|||
142941040|NCT00700804|515322296|FG001|Overall Study|Withdrawal by Subject|2|||
142941041|NCT00700804|515322295|FG000|Overall Study|Protocol Violation|1|||
142941042|NCT00700804|515322296|FG001|Overall Study|Protocol Violation|1|||
142941043|NCT00700804|515322295|FG000|Overall Study|Loose Stools|1|||
142941044|NCT00700804|515322296|FG001|Overall Study|Loose Stools|1|||
142941045|NCT00151892|515322297|FG000|Overall Study|Lack of Efficacy|50|||
142941046|NCT00151892|515322298|FG001|Overall Study|Lack of Efficacy|57|||
142941047|NCT00151892|515322297|FG000|Overall Study|Patient request|10|||
142941048|NCT00151892|515322298|FG001|Overall Study|Patient request|7|||
142941049|NCT00151892|515322297|FG000|Overall Study|Lost to Follow-up|5|||
142941050|NCT00151892|515322298|FG001|Overall Study|Lost to Follow-up|10|||
142941051|NCT00151892|515322297|FG000|Overall Study|Adverse Event|6|||
142941052|NCT00151892|515322298|FG001|Overall Study|Adverse Event|3|||
142941053|NCT00151892|515322297|FG000|Overall Study|Protocol Violation|3|||
142941054|NCT00151892|515322298|FG001|Overall Study|Protocol Violation|3|||
142941055|NCT00151892|515322297|FG000|Overall Study|Non-compliance|0|||
142941056|NCT00151892|515322298|FG001|Overall Study|Non-compliance|1|||
142941057|NCT00151892|515322297|FG000|Overall Study|Pregnancy|0|||
142941058|NCT00151892|515322298|FG001|Overall Study|Pregnancy|1|||
142941059|NCT00151892|515322297|FG000|Overall Study|Did not return for a visit|1|||
142941060|NCT00151892|515322298|FG001|Overall Study|Did not return for a visit|0|||
142941061|NCT00151892|515322297|FG000|Overall Study|Used prohibited corticosteroids|1|||
142941062|NCT00151892|515322298|FG001|Overall Study|Used prohibited corticosteroids|0|||
142941063|NCT00151892|515322297|FG000|Overall Study|Lack of study medication at center|0|||
142941064|NCT00151892|515322298|FG001|Overall Study|Lack of study medication at center|1|||
142941092|NCT02500537|515322309|FG000|Overall Study|Death|2|||
142941093|NCT02500537|515322310|FG001|Overall Study|Death|0|||
142941094|NCT02500537|515322309|FG000|Overall Study|Lost to Follow-up|0|||
142941095|NCT02500537|515322310|FG001|Overall Study|Lost to Follow-up|1|||
142941096|NCT02500537|515322309|FG000|Overall Study|Withdrawal by Subject|1|||
142941097|NCT02500537|515322310|FG001|Overall Study|Withdrawal by Subject|0|||
142941098|NCT04672083|515322311|FG000|Overall Study|Lost to Follow-up|1|||
142941099|NCT04672083|515322312|FG001|Overall Study|Lost to Follow-up|0|||
142941100|NCT04672083|515322313|FG002|Overall Study|Lost to Follow-up|0|||
142941101|NCT04672083|515322314|FG003|Overall Study|Lost to Follow-up|0|||
142941102|NCT04672083|515322315|FG004|Overall Study|Lost to Follow-up|0|||
142941103|NCT00355121|515322318|FG000|Overall Study|Did not receive study vaccine|1|||
142941104|NCT00355121|515322319|FG001|Overall Study|Did not receive study vaccine|0|||
142941105|NCT00355121|515322320|FG002|Overall Study|Did not receive study vaccine|1|||
142941106|NCT00355121|515322318|FG000|Overall Study|Adverse Event|0|||
142941107|NCT00355121|515322319|FG001|Overall Study|Adverse Event|1|||
142941108|NCT00355121|515322320|FG002|Overall Study|Adverse Event|0|||
142941109|NCT00355121|515322318|FG000|Overall Study|Protocol Violation|7|||
142941110|NCT00355121|515322319|FG001|Overall Study|Protocol Violation|9|||
142941111|NCT00355121|515322320|FG002|Overall Study|Protocol Violation|1|||
142941112|NCT00355121|515322318|FG000|Overall Study|Lost to Follow-up|4|||
142941113|NCT00355121|515322319|FG001|Overall Study|Lost to Follow-up|7|||
142941114|NCT00355121|515322320|FG002|Overall Study|Lost to Follow-up|1|||
142941115|NCT00355121|515322318|FG000|Overall Study|Withdrawal by Subject|9|||
142941116|NCT00355121|515322319|FG001|Overall Study|Withdrawal by Subject|10|||
142941117|NCT00355121|515322320|FG002|Overall Study|Withdrawal by Subject|2|||
142941118|NCT00355121|515322318|FG000|Overall Study|Serious adverse events|0|||
142941119|NCT00355121|515322319|FG001|Overall Study|Serious adverse events|2|||
142941120|NCT00355121|515322320|FG002|Overall Study|Serious adverse events|0|||
142941293|NCT03896581|515324570|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
142941294|NCT03896581|515324571|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
142941295|NCT03896581|515324570|FG000|Overall Study|Withdrawal by Subject|4|||
142941296|NCT03896581|515324571|FG001|Overall Study|Withdrawal by Subject|1|||
142941297|NCT03896581|515324570|FG000|Overall Study|Lost to Follow-up|1|||
142941298|NCT03896581|515324571|FG001|Overall Study|Lost to Follow-up|0|||
142941299|NCT03896581|515324570|FG000|Overall Study|Lack of Efficacy|2|||
142941300|NCT03896581|515324571|FG001|Overall Study|Lack of Efficacy|1|||
142941301|NCT03896581|515324570|FG000|Overall Study|Adverse event, non-fatal|0|||
142941302|NCT03896581|515324571|FG001|Overall Study|Adverse event, non-fatal|2|||
142941303|NCT05556616|515324572|FG000|Overall Study|Withdrawal by Subject|1|||
142941304|NCT05556616|515324573|FG001|Overall Study|Withdrawal by Subject|0|||
142941305|NCT05556616|515324574|FG002|Overall Study|Withdrawal by Subject|0|||
142941306|NCT05556616|515324575|FG003|Overall Study|Withdrawal by Subject|0|||
142941307|NCT05556616|515324576|FG004|Overall Study|Withdrawal by Subject|0|||
142941308|NCT05556616|515324577|FG005|Overall Study|Withdrawal by Subject|0|||
142941309|NCT05556616|515324578|FG006|Overall Study|Withdrawal by Subject|0|||
142941310|NCT05556616|515324572|FG000|Overall Study|Death|0|||
142941311|NCT05556616|515324573|FG001|Overall Study|Death|0|||
142941312|NCT05556616|515324574|FG002|Overall Study|Death|2|||
142941313|NCT05556616|515324575|FG003|Overall Study|Death|1|||
142941314|NCT05556616|515324576|FG004|Overall Study|Death|0|||
142941315|NCT05556616|515324577|FG005|Overall Study|Death|0|||
142941316|NCT05556616|515324578|FG006|Overall Study|Death|0|||
142941317|NCT05556616|515324572|FG000|Overall Study|Study Terminated by Sponsor|0|||
142941318|NCT05556616|515324573|FG001|Overall Study|Study Terminated by Sponsor|3|||
142941319|NCT05556616|515324574|FG002|Overall Study|Study Terminated by Sponsor|0|||
142941320|NCT05556616|515324575|FG003|Overall Study|Study Terminated by Sponsor|0|||
142941321|NCT05556616|515324576|FG004|Overall Study|Study Terminated by Sponsor|0|||
142941322|NCT05556616|515324577|FG005|Overall Study|Study Terminated by Sponsor|0|||
142941323|NCT05556616|515324578|FG006|Overall Study|Study Terminated by Sponsor|0|||
142941324|NCT01445171|515324580|FG000|Overall Study|Lost to Follow-up|11|||
142941325|NCT01445171|515324580|FG000|Overall Study|Withdrawal by Subject|16|||
142941326|NCT01445171|515324580|FG000|Overall Study|Death|51|||
142941327|NCT01445171|515324580|FG000|Overall Study|Subjects declined to return for followup|9|||
142941328|NCT01445171|515324580|FG000|Overall Study|Consented but did not receive device|8|||
142941329|NCT00215150|515324583|FG000|Open Label Phase|Lost to Follow-up|7|||
142941330|NCT00215150|515324583|FG000|Open Label Phase|Withdrawal by Subject|1|||
142941331|NCT00215150|515324583|FG000|Open Label Phase|Did not complete a post base visit|13|||
142941332|NCT00215150|515324583|FG000|Open Label Phase|Did not meet randomization criteria|9|||
142941333|NCT00215150|515324583|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
143453996|NCT02535091|517206839|FG001|Overall Study|Lost to Follow-up|1|||
142941334|NCT00215150|515324583|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
142941335|NCT00215150|515324583|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
142941336|NCT01903876|515324589|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
142941337|NCT01903876|515324590|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
142941338|NCT01903876|515324589|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
142941339|NCT01903876|515324590|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
142941340|NCT02612909|515324591|FG000|Phase 2|Withdrawal by Subject|2|||
142941341|NCT02612909|515324592|FG001|Phase 2|Withdrawal by Subject|5|||
143453997|NCT02535091|517206840|FG002|Overall Study|Lost to Follow-up|19|||
142941342|NCT02612909|515324593|FG002|Phase 2|Withdrawal by Subject|0|||
142941343|NCT02612909|515324594|FG003|Phase 2|Withdrawal by Subject|0|||
142941344|NCT02612909|515324595|FG004|Phase 2|Withdrawal by Subject|0|||
142941345|NCT02612909|515324591|FG000|Phase 2|Pregnancy|0|||
142941346|NCT02612909|515324592|FG001|Phase 2|Pregnancy|0|||
142941347|NCT02612909|515324593|FG002|Phase 2|Pregnancy|1|||
142941348|NCT02612909|515324594|FG003|Phase 2|Pregnancy|0|||
142941349|NCT02612909|515324595|FG004|Phase 2|Pregnancy|0|||
142941350|NCT02612909|515324591|FG000|Phase 3|Withdrawal by Subject|0|||
142941351|NCT02612909|515324592|FG001|Phase 3|Withdrawal by Subject|0|||
142941352|NCT02612909|515324593|FG002|Phase 3|Withdrawal by Subject|0|||
142941353|NCT02612909|515324594|FG003|Phase 3|Withdrawal by Subject|1|||
142941354|NCT02612909|515324595|FG004|Phase 3|Withdrawal by Subject|0|||
142941355|NCT00826748|515324598|FG000|Overall Study|Withdrawal by Subject|0|||
142941356|NCT00826748|515324599|FG001|Overall Study|Withdrawal by Subject|0|||
142941357|NCT00826748|515324600|FG002|Overall Study|Withdrawal by Subject|2|||
142941358|NCT00826748|515324598|FG000|Overall Study|Physician Decision|0|||
142941359|NCT00826748|515324599|FG001|Overall Study|Physician Decision|0|||
142941360|NCT00826748|515324600|FG002|Overall Study|Physician Decision|1|||
142941361|NCT00826748|515324598|FG000|Overall Study|Samples Did Not pass QC|0|||
142941362|NCT00826748|515324599|FG001|Overall Study|Samples Did Not pass QC|0|||
143453998|NCT02535091|517206838|FG000|Overall Study|Protocol Violation|0|||
143453999|NCT02535091|517206839|FG001|Overall Study|Protocol Violation|1|||
142941363|NCT00826748|515324600|FG002|Overall Study|Samples Did Not pass QC|1|||
142941364|NCT01887912|515324604|FG000|Overall Study|Serious adverse event|400|||
142941365|NCT01887912|515324605|FG001|Overall Study|Serious adverse event|198|||
142941366|NCT01887912|515324604|FG000|Overall Study|Other Adverse Event|34|||
142941367|NCT01887912|515324605|FG001|Overall Study|Other Adverse Event|15|||
142941368|NCT01887912|515324604|FG000|Overall Study|Protocol Violation|67|||
142941369|NCT01887912|515324605|FG001|Overall Study|Protocol Violation|37|||
142941370|NCT01887912|515324604|FG000|Overall Study|Lost to Follow-up|163|||
142941371|NCT01887912|515324605|FG001|Overall Study|Lost to Follow-up|74|||
142941372|NCT01887912|515324604|FG000|Overall Study|Withdrawal by Subject|606|||
142941373|NCT01887912|515324605|FG001|Overall Study|Withdrawal by Subject|349|||
142941374|NCT01887912|515324604|FG000|Overall Study|Other|122|||
142941375|NCT01887912|515324605|FG001|Overall Study|Other|58|||
142941376|NCT05113940|515324611|FG000|Part A (18 Days)|Adverse Event|0|||
142941377|NCT05113940|515324612|FG001|Part A (18 Days)|Adverse Event|0|||
142941378|NCT05113940|515324613|FG002|Part A (18 Days)|Adverse Event|1|||
142941379|NCT05113940|515324614|FG003|Part A (18 Days)|Adverse Event|1|||
142941380|NCT05113940|515324615|FG004|Part A (18 Days)|Adverse Event|1|||
142941381|NCT05113940|515324616|FG005|Part A (18 Days)|Adverse Event|0|||
142941382|NCT05113940|515324617|FG006|Part A (18 Days)|Adverse Event|0|||
142941383|NCT05113940|515324618|FG007|Part A (18 Days)|Adverse Event|0|||
142941384|NCT05113940|515324619|FG008|Part A (18 Days)|Adverse Event|0|||
142941385|NCT05113940|515324620|FG009|Part A (18 Days)|Adverse Event|0|||
142941386|NCT05113940|515324621|FG010|Part A (18 Days)|Adverse Event|0|||
142941387|NCT05113940|515324622|FG011|Part A (18 Days)|Adverse Event|2|||
142941388|NCT05113940|515324623|FG012|Part A (18 Days)|Adverse Event|0|||
142941389|NCT05113940|515324624|FG013|Part A (18 Days)|Adverse Event|0|||
142941390|NCT05113940|515324625|FG014|Part A (18 Days)|Adverse Event|0|||
142941391|NCT05113940|515324611|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
142941392|NCT05113940|515324612|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
142941393|NCT05113940|515324613|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
142941394|NCT05113940|515324614|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
142941395|NCT05113940|515324615|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
142941396|NCT05113940|515324616|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
142941397|NCT05113940|515324617|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
142941398|NCT05113940|515324618|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
142941399|NCT05113940|515324619|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
142941400|NCT05113940|515324620|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
142941401|NCT05113940|515324621|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
142941402|NCT05113940|515324622|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
142941403|NCT05113940|515324623|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
142941404|NCT05113940|515324624|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
142941405|NCT05113940|515324625|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
142941406|NCT00382967|515324626|FG000|Overall Study|Protocol Violation|1|||
142941407|NCT00382967|515324627|FG001|Overall Study|Protocol Violation|1|||
143454000|NCT02535091|517206840|FG002|Overall Study|Protocol Violation|11|||
143454001|NCT02535091|517206838|FG000|Overall Study|Pregnancy|0|||
143454002|NCT02535091|517206839|FG001|Overall Study|Pregnancy|0|||
143454003|NCT02535091|517206840|FG002|Overall Study|Pregnancy|7|||
143454004|NCT03223662|517206841|FG000|Overall Study|Physician Decision|1|||
142941408|NCT03417440|515324628|FG000|Overall Study|Lost to Follow-up|0|||
142941409|NCT03417440|515324629|FG001|Overall Study|Lost to Follow-up|1|||
142941410|NCT03417440|515324630|FG002|Overall Study|Lost to Follow-up|0|||
142941411|NCT03417440|515324631|FG003|Overall Study|Lost to Follow-up|0|||
142941412|NCT03417440|515324632|FG004|Overall Study|Lost to Follow-up|1|||
142941413|NCT03417440|515324633|FG005|Overall Study|Lost to Follow-up|0|||
142941414|NCT03417440|515324634|FG006|Overall Study|Lost to Follow-up|0|||
142941415|NCT03417440|515324635|FG007|Overall Study|Lost to Follow-up|0|||
142941416|NCT03417440|515324628|FG000|Overall Study|Withdrawal by Subject|2|||
142941417|NCT03417440|515324629|FG001|Overall Study|Withdrawal by Subject|0|||
143454005|NCT03223662|517206841|FG000|Overall Study|Study closure|1|||
142941418|NCT03417440|515324630|FG002|Overall Study|Withdrawal by Subject|2|||
142941419|NCT03417440|515324631|FG003|Overall Study|Withdrawal by Subject|1|||
142941420|NCT03417440|515324632|FG004|Overall Study|Withdrawal by Subject|1|||
142941421|NCT03417440|515324633|FG005|Overall Study|Withdrawal by Subject|0|||
142941422|NCT03417440|515324634|FG006|Overall Study|Withdrawal by Subject|0|||
142941423|NCT03417440|515324635|FG007|Overall Study|Withdrawal by Subject|1|||
142941424|NCT04336163|515324637|FG000|Overall Study|Lost to Follow-up|55|||
142941425|NCT04336163|515324638|FG001|Overall Study|Lost to Follow-up|0|||
142941426|NCT00826514|515324639|FG000|Overall Study|Adverse Event|1|||
142941427|NCT00826514|515324640|FG001|Overall Study|Adverse Event|1|||
142941428|NCT00826514|515324639|FG000|Overall Study|Lack of Efficacy|0|||
142941429|NCT00826514|515324640|FG001|Overall Study|Lack of Efficacy|1|||
142941430|NCT00826514|515324639|FG000|Overall Study|Withdrawal by Subject|2|||
142941431|NCT00826514|515324640|FG001|Overall Study|Withdrawal by Subject|3|||
142941432|NCT01773473|515324641|FG000|Overall Study|Adverse Event|3|||
143454006|NCT02643472|517206842|FG000|Overall Study|Death|2|||
143454007|NCT02643472|517206843|FG001|Overall Study|Death|5|||
143454008|NCT02643472|517206842|FG000|Overall Study|Withdrawal by Subject|3|||
143454009|NCT02643472|517206843|FG001|Overall Study|Withdrawal by Subject|2|||
143454010|NCT02643472|517206842|FG000|Overall Study|Protocol Violation|0|||
143454011|NCT02643472|517206843|FG001|Overall Study|Protocol Violation|1|||
143454012|NCT02643472|517206842|FG000|Overall Study|Lost to Follow-up|22|||
143454013|NCT02643472|517206843|FG001|Overall Study|Lost to Follow-up|26|||
143454014|NCT00506441|517206844|FG000|Period 1; Open-label Period|Adverse Event|21|||
143454015|NCT00506441|517206845|FG001|Period 1; Open-label Period|Adverse Event|0|||
143454016|NCT00506441|517206844|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
143454017|NCT00506441|517206845|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
143454018|NCT00506441|517206844|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
143454019|NCT00506441|517206845|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
143454020|NCT00506441|517206844|FG000|Period 1; Open-label Period|Physician Decision|5|||
143454021|NCT00506441|517206845|FG001|Period 1; Open-label Period|Physician Decision|0|||
143454022|NCT00506441|517206844|FG000|Period 1; Open-label Period|Protocol Violation|9|||
143454023|NCT00506441|517206845|FG001|Period 1; Open-label Period|Protocol Violation|0|||
143454024|NCT00506441|517206844|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
143454025|NCT00506441|517206845|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
143454026|NCT00506441|517206844|FG000|Period 1; Open-label Period|Other Reasons|13|||
143454027|NCT00506441|517206845|FG001|Period 1; Open-label Period|Other Reasons|0|||
143454028|NCT00506441|517206844|FG000|Period 2; Double-blind Period|Adverse Event|0|||
143454029|NCT00506441|517206845|FG001|Period 2; Double-blind Period|Adverse Event|1|||
143454030|NCT00506441|517206844|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
143454031|NCT00506441|517206845|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
143454032|NCT00506441|517206844|FG000|Period 2; Double-blind Period|Physician Decision|1|||
143454033|NCT00506441|517206845|FG001|Period 2; Double-blind Period|Physician Decision|1|||
143454034|NCT00506441|517206844|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
143454035|NCT00506441|517206845|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
143454036|NCT00506441|517206844|FG000|Period 2; Double-blind Period|Other Reason|1|||
143454037|NCT00506441|517206845|FG001|Period 2; Double-blind Period|Other Reason|1|||
143454038|NCT03122223|517206852|FG000|Overall Study|Withdrawal by Subject|2|||
143454039|NCT03122223|517206853|FG001|Overall Study|Withdrawal by Subject|2|||
143454040|NCT03122223|517206854|FG002|Overall Study|Withdrawal by Subject|1|||
143454041|NCT03122223|517206855|FG003|Overall Study|Withdrawal by Subject|0|||
143454042|NCT03122223|517206852|FG000|Overall Study|Lost to Follow-up|0|||
143454043|NCT03122223|517206853|FG001|Overall Study|Lost to Follow-up|2|||
143454044|NCT03122223|517206854|FG002|Overall Study|Lost to Follow-up|2|||
143454045|NCT03122223|517206855|FG003|Overall Study|Lost to Follow-up|0|||
143454046|NCT03122223|517206852|FG000|Overall Study|Participant unable to adhere|1|||
143454047|NCT03122223|517206853|FG001|Overall Study|Participant unable to adhere|1|||
143454048|NCT03122223|517206854|FG002|Overall Study|Participant unable to adhere|1|||
143454049|NCT03122223|517206855|FG003|Overall Study|Participant unable to adhere|0|||
143454050|NCT00291642|517206859|FG000|Overall Study|Adverse Event|1|||
143454051|NCT00291642|517206860|FG001|Overall Study|Adverse Event|0|||
143454052|NCT00291642|517206861|FG002|Overall Study|Adverse Event|1|||
143454053|NCT00291642|517206862|FG003|Overall Study|Adverse Event|0|||
142941433|NCT01773473|515324642|FG001|Overall Study|Adverse Event|2|||
142941434|NCT01773473|515324641|FG000|Overall Study|Protocol Violation|0|||
143454054|NCT00291642|517206863|FG004|Overall Study|Adverse Event|1|||
143454055|NCT00291642|517206859|FG000|Overall Study|Patient missed visit|0|||
143454056|NCT00291642|517206860|FG001|Overall Study|Patient missed visit|0|||
143454057|NCT00291642|517206861|FG002|Overall Study|Patient missed visit|1|||
143454058|NCT00291642|517206862|FG003|Overall Study|Patient missed visit|0|||
143454059|NCT00291642|517206863|FG004|Overall Study|Patient missed visit|0|||
142941435|NCT01773473|515324642|FG001|Overall Study|Protocol Violation|4|||
142941436|NCT01773473|515324641|FG000|Overall Study|Physician Decision|3|||
142941437|NCT01773473|515324642|FG001|Overall Study|Physician Decision|5|||
142941438|NCT01773473|515324641|FG000|Overall Study|Sponsor Decision|2|||
142941439|NCT01773473|515324642|FG001|Overall Study|Sponsor Decision|0|||
142941440|NCT01773473|515324641|FG000|Overall Study|Lack of Efficacy|0|||
142941441|NCT01773473|515324642|FG001|Overall Study|Lack of Efficacy|1|||
142941442|NCT01773473|515324641|FG000|Overall Study|Non-Compliance with study drug|1|||
142941443|NCT01773473|515324642|FG001|Overall Study|Non-Compliance with study drug|4|||
142941444|NCT01773473|515324641|FG000|Overall Study|Withdrawal by Subject|5|||
142941445|NCT01773473|515324642|FG001|Overall Study|Withdrawal by Subject|3|||
142941446|NCT01773473|515324641|FG000|Overall Study|Lost to Follow-up|2|||
142941447|NCT01773473|515324642|FG001|Overall Study|Lost to Follow-up|0|||
142941448|NCT01085682|515324643|FG000|Overall Study|Withdrawal by Subject|25|||
142941449|NCT01085682|515324644|FG001|Overall Study|Withdrawal by Subject|25|||
142941450|NCT01451645|515324645|FG000|Overall Study|Protocol Violation|1|||
142941451|NCT01451645|515324646|FG001|Overall Study|Protocol Violation|0|||
142941452|NCT01451645|515324645|FG000|Overall Study|Adverse Event|0|||
142941453|NCT01451645|515324646|FG001|Overall Study|Adverse Event|3|||
142941454|NCT01451645|515324645|FG000|Overall Study|Withdrawal by Subject|4|||
142941455|NCT01451645|515324646|FG001|Overall Study|Withdrawal by Subject|2|||
142941456|NCT01451645|515324645|FG000|Overall Study|Lost to Follow-up|4|||
142941457|NCT01451645|515324646|FG001|Overall Study|Lost to Follow-up|3|||
142941458|NCT03545282|515324653|FG000|Overall Study|Lost to Follow-up|15|||
142941459|NCT03545282|515324654|FG001|Overall Study|Lost to Follow-up|10|||
142941460|NCT03545282|515324653|FG000|Overall Study|Withdrawal by Subject|2|||
142941461|NCT03545282|515324654|FG001|Overall Study|Withdrawal by Subject|2|||
142941462|NCT01276288|515324657|FG000|Overall Study|Adverse Event|1|||
142941463|NCT01276288|515324658|FG001|Overall Study|Adverse Event|1|||
142941464|NCT01276288|515324659|FG002|Overall Study|Adverse Event|0|||
142941465|NCT01276288|515324660|FG003|Overall Study|Adverse Event|0|||
142941466|NCT01276288|515324657|FG000|Overall Study|not treated|1|||
142941467|NCT01276288|515324658|FG001|Overall Study|not treated|0|||
142941468|NCT01276288|515324659|FG002|Overall Study|not treated|0|||
142941469|NCT01276288|515324660|FG003|Overall Study|not treated|0|||
142941470|NCT01193686|515324665|FG000|Overall Study|Withdrawal by Subject|4|||
142941471|NCT01193686|515324666|FG001|Overall Study|Withdrawal by Subject|1|||
142941472|NCT01193686|515324665|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
142941473|NCT01193686|515324666|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
142941474|NCT01499290|515324669|FG000|Overall Study|Withdrawal by Subject|22|||
142941475|NCT01499290|515324670|FG001|Overall Study|Withdrawal by Subject|15|||
142941476|NCT01499290|515324669|FG000|Overall Study|Not specified in study report|11|||
142941477|NCT01499290|515324670|FG001|Overall Study|Not specified in study report|5|||
142941478|NCT01499290|515324669|FG000|Overall Study|Condition improved/subject recovered|1|||
142941479|NCT01499290|515324670|FG001|Overall Study|Condition improved/subject recovered|0|||
142941480|NCT01499290|515324669|FG000|Overall Study|Lack of Efficacy|7|||
142941481|NCT01499290|515324670|FG001|Overall Study|Lack of Efficacy|8|||
142941482|NCT01499290|515324669|FG000|Overall Study|Adverse Event|14|||
142941483|NCT01499290|515324670|FG001|Overall Study|Adverse Event|7|||
142941484|NCT00805207|515324671|FG000|Overall Study|Protocol Violation|0|||
142941485|NCT00805207|515324672|FG001|Overall Study|Protocol Violation|0|||
142941486|NCT00805207|515324673|FG002|Overall Study|Protocol Violation|1|||
142941487|NCT00805207|515324674|FG003|Overall Study|Protocol Violation|0|||
142941488|NCT00805207|515324675|FG004|Overall Study|Protocol Violation|0|||
142941489|NCT00805207|515324676|FG005|Overall Study|Protocol Violation|0|||
142941490|NCT00805207|515324677|FG006|Overall Study|Protocol Violation|0|||
142941491|NCT00805207|515324678|FG007|Overall Study|Protocol Violation|0|||
142941492|NCT00805207|515324679|FG008|Overall Study|Protocol Violation|0|||
142941493|NCT00805207|515324671|FG000|Overall Study|Physician Decision|0|||
142941494|NCT00805207|515324672|FG001|Overall Study|Physician Decision|1|||
142941495|NCT00805207|515324673|FG002|Overall Study|Physician Decision|0|||
142941496|NCT00805207|515324674|FG003|Overall Study|Physician Decision|0|||
142941497|NCT00805207|515324675|FG004|Overall Study|Physician Decision|0|||
142941498|NCT00805207|515324676|FG005|Overall Study|Physician Decision|1|||
142941499|NCT00805207|515324677|FG006|Overall Study|Physician Decision|0|||
142941500|NCT00805207|515324678|FG007|Overall Study|Physician Decision|0|||
142941501|NCT00805207|515324679|FG008|Overall Study|Physician Decision|0|||
142941502|NCT00805207|515324671|FG000|Overall Study|Withdrawal by Subject|0|||
142941503|NCT00805207|515324672|FG001|Overall Study|Withdrawal by Subject|1|||
142941504|NCT00805207|515324673|FG002|Overall Study|Withdrawal by Subject|0|||
142941505|NCT00805207|515324674|FG003|Overall Study|Withdrawal by Subject|0|||
142941506|NCT00805207|515324675|FG004|Overall Study|Withdrawal by Subject|1|||
142941507|NCT00805207|515324676|FG005|Overall Study|Withdrawal by Subject|2|||
142941508|NCT00805207|515324677|FG006|Overall Study|Withdrawal by Subject|0|||
142941509|NCT00805207|515324678|FG007|Overall Study|Withdrawal by Subject|0|||
142941510|NCT00805207|515324679|FG008|Overall Study|Withdrawal by Subject|0|||
142941511|NCT00064701|515324680|FG000|One Year Post-transplant|Did not receive study drug|7|||
142941512|NCT00064701|515324681|FG001|One Year Post-transplant|Did not receive study drug|12|||
142941513|NCT00064701|515324682|FG002|One Year Post-transplant|Did not receive study drug|11|||
142941514|NCT00064701|515324680|FG000|One Year Post-transplant|Adverse Event|23|||
142941515|NCT00064701|515324681|FG001|One Year Post-transplant|Adverse Event|19|||
142941562|NCT00064701|515324680|FG000|Clinical Continuation Phase|Graft Failure|5|||
142941563|NCT00064701|515324681|FG001|Clinical Continuation Phase|Graft Failure|5|||
142941564|NCT00064701|515324682|FG002|Clinical Continuation Phase|Graft Failure|2|||
142941565|NCT00064701|515324680|FG000|Clinical Continuation Phase|Rejection|1|||
142941566|NCT00064701|515324681|FG001|Clinical Continuation Phase|Rejection|2|||
142941567|NCT00064701|515324682|FG002|Clinical Continuation Phase|Rejection|2|||
142941568|NCT00064701|515324680|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
142941569|NCT00064701|515324681|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
142941570|NCT00064701|515324682|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
142941571|NCT00064701|515324680|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
142941572|NCT00064701|515324681|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
142941573|NCT00064701|515324682|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
142941574|NCT00064701|515324680|FG000|Clinical Continuation Phase|Physician Decision|1|||
142941575|NCT00064701|515324681|FG001|Clinical Continuation Phase|Physician Decision|3|||
142941576|NCT00064701|515324682|FG002|Clinical Continuation Phase|Physician Decision|0|||
142941577|NCT00064701|515324680|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
142941578|NCT00064701|515324681|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
142941579|NCT00064701|515324682|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
142941580|NCT00064701|515324680|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
142941581|NCT00064701|515324681|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
142941582|NCT00064701|515324682|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
142941583|NCT00064701|515324680|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
142941584|NCT00064701|515324681|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
142941585|NCT00064701|515324682|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
142941586|NCT00064701|515324680|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
142941587|NCT00064701|515324681|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
142941588|NCT00064701|515324682|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
142941589|NCT00064701|515324680|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
142941590|NCT00064701|515324681|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
142941591|NCT00064701|515324682|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
142941592|NCT00064701|515324680|FG000|Clinical Continuation Phase|Patient opted out|0|||
142941593|NCT00064701|515324681|FG001|Clinical Continuation Phase|Patient opted out|0|||
142941594|NCT00064701|515324682|FG002|Clinical Continuation Phase|Patient opted out|1|||
142941595|NCT04373460|515324684|FG000|Overall Study|Did not receive tranfusion|18|||
142941596|NCT04373460|515324685|FG001|Overall Study|Did not receive tranfusion|26|||
142941597|NCT00454207|515324686|FG000|Overall Study|Adverse Event|3|||
142941598|NCT00454207|515324687|FG001|Overall Study|Adverse Event|1|||
142941599|NCT00454207|515324686|FG000|Overall Study|Lack of Efficacy|1|||
142941600|NCT00454207|515324687|FG001|Overall Study|Lack of Efficacy|0|||
142941601|NCT00454207|515324686|FG000|Overall Study|Protocol Violation|0|||
142941602|NCT00454207|515324687|FG001|Overall Study|Protocol Violation|1|||
142941603|NCT01672957|515324688|FG000|Overall Study|Protocol Violation|48|||
142941604|NCT01672957|515324688|FG000|Overall Study|Death|2|||
142941605|NCT01672957|515324688|FG000|Overall Study|ICF Signed After Transplantation|5|||
142941606|NCT02901431|515324691|FG000|PK Part|Adverse Event|0|||
142941607|NCT02901431|515324692|FG001|PK Part|Adverse Event|1|||
142941608|NCT02901431|515324693|FG002|PK Part|Adverse Event|0|||
142941609|NCT02901431|515324694|FG003|PK Part|Adverse Event|0|||
142941610|NCT02901431|515324695|FG004|PK Part|Adverse Event|0|||
142941611|NCT02901431|515324696|FG005|PK Part|Adverse Event|0|||
142941612|NCT02901431|515324697|FG006|PK Part|Adverse Event|0|||
142941613|NCT02901431|515324698|FG007|PK Part|Adverse Event|0|||
142941614|NCT02901431|515324699|FG008|PK Part|Adverse Event|0|||
142941615|NCT02901431|515324700|FG009|PK Part|Adverse Event|0|||
142941616|NCT02901431|515324701|FG010|PK Part|Adverse Event|0|||
142941617|NCT02901431|515324702|FG011|PK Part|Adverse Event|0|||
142941618|NCT02901431|515324703|FG012|PK Part|Adverse Event|0|||
142941619|NCT02901431|515324691|FG000|PK Part|Lost to Follow-up|0|||
142941620|NCT02901431|515324692|FG001|PK Part|Lost to Follow-up|0|||
142941621|NCT02901431|515324693|FG002|PK Part|Lost to Follow-up|1|||
142941622|NCT02901431|515324694|FG003|PK Part|Lost to Follow-up|0|||
143454357|NCT03117998|517208215|FG005|Overall Study|Withdrawal by Subject|0|||
143454358|NCT03117998|517208210|FG000|Overall Study|Physician Decision|0|||
142941623|NCT02901431|515324695|FG004|PK Part|Lost to Follow-up|0|||
142941624|NCT02901431|515324696|FG005|PK Part|Lost to Follow-up|0|||
142941625|NCT02901431|515324697|FG006|PK Part|Lost to Follow-up|0|||
142941626|NCT02901431|515324698|FG007|PK Part|Lost to Follow-up|0|||
142941627|NCT02901431|515324699|FG008|PK Part|Lost to Follow-up|0|||
142941628|NCT02901431|515324700|FG009|PK Part|Lost to Follow-up|0|||
142941629|NCT02901431|515324701|FG010|PK Part|Lost to Follow-up|0|||
142941630|NCT02901431|515324702|FG011|PK Part|Lost to Follow-up|0|||
142941631|NCT02901431|515324703|FG012|PK Part|Lost to Follow-up|0|||
142941632|NCT02901431|515324691|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
142941633|NCT02901431|515324692|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
143454359|NCT03117998|517208211|FG001|Overall Study|Physician Decision|1|||
143454360|NCT03117998|517208212|FG002|Overall Study|Physician Decision|1|||
143454361|NCT03117998|517208213|FG003|Overall Study|Physician Decision|0|||
143454362|NCT03117998|517208214|FG004|Overall Study|Physician Decision|0|||
143454363|NCT03117998|517208215|FG005|Overall Study|Physician Decision|0|||
143454364|NCT03117998|517208210|FG000|Overall Study|Lost to Follow-up|0|||
143454365|NCT03117998|517208211|FG001|Overall Study|Lost to Follow-up|0|||
143454366|NCT03117998|517208212|FG002|Overall Study|Lost to Follow-up|0|||
142941634|NCT02901431|515324693|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
142941635|NCT02901431|515324694|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
142941636|NCT02901431|515324695|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
142941637|NCT02901431|515324696|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
142941638|NCT02901431|515324697|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
142941639|NCT02901431|515324698|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
142941640|NCT02901431|515324699|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
142941641|NCT02901431|515324700|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
142941642|NCT02901431|515324701|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
142941643|NCT02901431|515324702|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
142941644|NCT02901431|515324703|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
142941645|NCT02901431|515324691|FG000|PK Part|Pending dose confirmation|0|||
142941646|NCT02901431|515324692|FG001|PK Part|Pending dose confirmation|1|||
142941647|NCT02901431|515324693|FG002|PK Part|Pending dose confirmation|0|||
142941648|NCT02901431|515324694|FG003|PK Part|Pending dose confirmation|0|||
142941649|NCT02901431|515324695|FG004|PK Part|Pending dose confirmation|0|||
142941650|NCT02901431|515324696|FG005|PK Part|Pending dose confirmation|0|||
142941651|NCT02901431|515324697|FG006|PK Part|Pending dose confirmation|0|||
142941652|NCT02901431|515324698|FG007|PK Part|Pending dose confirmation|0|||
142941653|NCT02901431|515324699|FG008|PK Part|Pending dose confirmation|0|||
142941654|NCT02901431|515324700|FG009|PK Part|Pending dose confirmation|0|||
142941655|NCT02901431|515324701|FG010|PK Part|Pending dose confirmation|0|||
142941656|NCT02901431|515324702|FG011|PK Part|Pending dose confirmation|0|||
142941657|NCT02901431|515324703|FG012|PK Part|Pending dose confirmation|0|||
142941658|NCT02901431|515324691|FG000|PK Part|8 weeks of treatment ran out|2|||
142941659|NCT02901431|515324692|FG001|PK Part|8 weeks of treatment ran out|0|||
142941660|NCT02901431|515324693|FG002|PK Part|8 weeks of treatment ran out|0|||
142941661|NCT02901431|515324694|FG003|PK Part|8 weeks of treatment ran out|0|||
142941662|NCT02901431|515324695|FG004|PK Part|8 weeks of treatment ran out|0|||
142941663|NCT02901431|515324696|FG005|PK Part|8 weeks of treatment ran out|0|||
142941664|NCT02901431|515324697|FG006|PK Part|8 weeks of treatment ran out|0|||
142941665|NCT02901431|515324698|FG007|PK Part|8 weeks of treatment ran out|0|||
142941666|NCT02901431|515324699|FG008|PK Part|8 weeks of treatment ran out|0|||
142941667|NCT02901431|515324700|FG009|PK Part|8 weeks of treatment ran out|0|||
142941668|NCT02901431|515324701|FG010|PK Part|8 weeks of treatment ran out|0|||
142941669|NCT02901431|515324702|FG011|PK Part|8 weeks of treatment ran out|0|||
142941670|NCT02901431|515324703|FG012|PK Part|8 weeks of treatment ran out|0|||
142941671|NCT02901431|515324691|FG000|PK Part|Stopped treatment after 8 weeks|1|||
142941672|NCT02901431|515324692|FG001|PK Part|Stopped treatment after 8 weeks|0|||
142941673|NCT02901431|515324693|FG002|PK Part|Stopped treatment after 8 weeks|1|||
142941674|NCT02901431|515324694|FG003|PK Part|Stopped treatment after 8 weeks|0|||
142941675|NCT02901431|515324695|FG004|PK Part|Stopped treatment after 8 weeks|0|||
142941676|NCT02901431|515324696|FG005|PK Part|Stopped treatment after 8 weeks|0|||
142941677|NCT02901431|515324697|FG006|PK Part|Stopped treatment after 8 weeks|0|||
142941678|NCT02901431|515324698|FG007|PK Part|Stopped treatment after 8 weeks|0|||
142941679|NCT02901431|515324699|FG008|PK Part|Stopped treatment after 8 weeks|0|||
142941680|NCT02901431|515324700|FG009|PK Part|Stopped treatment after 8 weeks|0|||
142941681|NCT02901431|515324701|FG010|PK Part|Stopped treatment after 8 weeks|0|||
142941682|NCT02901431|515324702|FG011|PK Part|Stopped treatment after 8 weeks|0|||
142941683|NCT02901431|515324703|FG012|PK Part|Stopped treatment after 8 weeks|0|||
142941684|NCT02901431|515324691|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
142941685|NCT02901431|515324692|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
142941686|NCT02901431|515324693|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
142941687|NCT02901431|515324694|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
142941688|NCT02901431|515324695|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
142941689|NCT02901431|515324696|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
142941690|NCT02901431|515324697|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
142941691|NCT02901431|515324698|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
142941692|NCT02901431|515324699|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
142941693|NCT02901431|515324700|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
142941694|NCT02901431|515324701|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
142941695|NCT02901431|515324702|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
142941696|NCT02901431|515324703|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
142941697|NCT02901431|515324691|FG000|PK Part|Discontinued per Sponsor|0|||
142941698|NCT02901431|515324692|FG001|PK Part|Discontinued per Sponsor|3|||
142941699|NCT02901431|515324693|FG002|PK Part|Discontinued per Sponsor|0|||
143117111|NCT02470403|515970028|FG003|Overall Study|Subject/guardian decision|4|||
142941700|NCT02901431|515324694|FG003|PK Part|Discontinued per Sponsor|0|||
142941701|NCT02901431|515324695|FG004|PK Part|Discontinued per Sponsor|0|||
142941702|NCT02901431|515324696|FG005|PK Part|Discontinued per Sponsor|0|||
142941703|NCT02901431|515324697|FG006|PK Part|Discontinued per Sponsor|0|||
142941704|NCT02901431|515324698|FG007|PK Part|Discontinued per Sponsor|0|||
142941705|NCT02901431|515324699|FG008|PK Part|Discontinued per Sponsor|0|||
142941706|NCT02901431|515324700|FG009|PK Part|Discontinued per Sponsor|0|||
142941707|NCT02901431|515324701|FG010|PK Part|Discontinued per Sponsor|0|||
142941708|NCT02901431|515324702|FG011|PK Part|Discontinued per Sponsor|0|||
142941709|NCT02901431|515324703|FG012|PK Part|Discontinued per Sponsor|0|||
142941710|NCT02901431|515324691|FG000|PK Part|Withdrawal by Subject|1|||
142941711|NCT02901431|515324692|FG001|PK Part|Withdrawal by Subject|1|||
142941712|NCT02901431|515324693|FG002|PK Part|Withdrawal by Subject|3|||
142941713|NCT02901431|515324694|FG003|PK Part|Withdrawal by Subject|0|||
142941714|NCT02901431|515324695|FG004|PK Part|Withdrawal by Subject|0|||
142941715|NCT02901431|515324696|FG005|PK Part|Withdrawal by Subject|0|||
142941716|NCT02901431|515324697|FG006|PK Part|Withdrawal by Subject|0|||
142941717|NCT02901431|515324698|FG007|PK Part|Withdrawal by Subject|0|||
142941718|NCT02901431|515324699|FG008|PK Part|Withdrawal by Subject|0|||
142941719|NCT02901431|515324700|FG009|PK Part|Withdrawal by Subject|0|||
142941720|NCT02901431|515324701|FG010|PK Part|Withdrawal by Subject|0|||
142941721|NCT02901431|515324702|FG011|PK Part|Withdrawal by Subject|0|||
142941722|NCT02901431|515324703|FG012|PK Part|Withdrawal by Subject|0|||
142941723|NCT02901431|515324691|FG000|Main Treatment Part|Adverse Event|0|||
142941724|NCT02901431|515324692|FG001|Main Treatment Part|Adverse Event|0|||
142941725|NCT02901431|515324693|FG002|Main Treatment Part|Adverse Event|0|||
142941726|NCT02901431|515324694|FG003|Main Treatment Part|Adverse Event|3|||
142941727|NCT02901431|515324695|FG004|Main Treatment Part|Adverse Event|3|||
142941728|NCT02901431|515324696|FG005|Main Treatment Part|Adverse Event|4|||
142941729|NCT02901431|515324697|FG006|Main Treatment Part|Adverse Event|1|||
142941730|NCT02901431|515324698|FG007|Main Treatment Part|Adverse Event|0|||
142941731|NCT02901431|515324699|FG008|Main Treatment Part|Adverse Event|0|||
142941732|NCT02901431|515324700|FG009|Main Treatment Part|Adverse Event|0|||
142941733|NCT02901431|515324701|FG010|Main Treatment Part|Adverse Event|0|||
142941734|NCT02901431|515324702|FG011|Main Treatment Part|Adverse Event|0|||
142941735|NCT02901431|515324703|FG012|Main Treatment Part|Adverse Event|0|||
142941736|NCT02901431|515324691|FG000|Main Treatment Part|Lack of Efficacy|0|||
142941737|NCT02901431|515324692|FG001|Main Treatment Part|Lack of Efficacy|0|||
142941738|NCT02901431|515324693|FG002|Main Treatment Part|Lack of Efficacy|0|||
142941739|NCT02901431|515324694|FG003|Main Treatment Part|Lack of Efficacy|1|||
142941740|NCT02901431|515324695|FG004|Main Treatment Part|Lack of Efficacy|0|||
142941741|NCT02901431|515324696|FG005|Main Treatment Part|Lack of Efficacy|0|||
142941742|NCT02901431|515324697|FG006|Main Treatment Part|Lack of Efficacy|0|||
142941743|NCT02901431|515324698|FG007|Main Treatment Part|Lack of Efficacy|0|||
142941744|NCT02901431|515324699|FG008|Main Treatment Part|Lack of Efficacy|0|||
142941745|NCT02901431|515324700|FG009|Main Treatment Part|Lack of Efficacy|0|||
142941746|NCT02901431|515324701|FG010|Main Treatment Part|Lack of Efficacy|0|||
142941747|NCT02901431|515324702|FG011|Main Treatment Part|Lack of Efficacy|0|||
142941748|NCT02901431|515324703|FG012|Main Treatment Part|Lack of Efficacy|0|||
142941749|NCT02901431|515324691|FG000|Main Treatment Part|Lost to Follow-up|0|||
142941750|NCT02901431|515324692|FG001|Main Treatment Part|Lost to Follow-up|0|||
142941751|NCT02901431|515324693|FG002|Main Treatment Part|Lost to Follow-up|0|||
142941752|NCT02901431|515324694|FG003|Main Treatment Part|Lost to Follow-up|3|||
142941753|NCT02901431|515324695|FG004|Main Treatment Part|Lost to Follow-up|1|||
142941754|NCT02901431|515324696|FG005|Main Treatment Part|Lost to Follow-up|2|||
142941755|NCT02901431|515324697|FG006|Main Treatment Part|Lost to Follow-up|3|||
142941756|NCT02901431|515324698|FG007|Main Treatment Part|Lost to Follow-up|0|||
142941757|NCT02901431|515324699|FG008|Main Treatment Part|Lost to Follow-up|0|||
142941758|NCT02901431|515324700|FG009|Main Treatment Part|Lost to Follow-up|0|||
142941759|NCT02901431|515324701|FG010|Main Treatment Part|Lost to Follow-up|0|||
142941760|NCT02901431|515324702|FG011|Main Treatment Part|Lost to Follow-up|0|||
142941761|NCT02901431|515324703|FG012|Main Treatment Part|Lost to Follow-up|0|||
142941762|NCT02901431|515324691|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
142941763|NCT02901431|515324692|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
142941764|NCT02901431|515324693|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
142941765|NCT02901431|515324694|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
142941766|NCT02901431|515324695|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
142941767|NCT02901431|515324696|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
142941768|NCT02901431|515324697|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
142941769|NCT02901431|515324698|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
142941770|NCT02901431|515324699|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
142941771|NCT02901431|515324700|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
142941772|NCT02901431|515324701|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
142941773|NCT02901431|515324702|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
142941774|NCT02901431|515324703|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
142941775|NCT02901431|515324691|FG000|Main Treatment Part|Physician Decision|0|||
142941776|NCT02901431|515324692|FG001|Main Treatment Part|Physician Decision|0|||
142941777|NCT02901431|515324693|FG002|Main Treatment Part|Physician Decision|0|||
142941778|NCT02901431|515324694|FG003|Main Treatment Part|Physician Decision|1|||
142941779|NCT02901431|515324695|FG004|Main Treatment Part|Physician Decision|0|||
142941780|NCT02901431|515324696|FG005|Main Treatment Part|Physician Decision|0|||
142941781|NCT02901431|515324697|FG006|Main Treatment Part|Physician Decision|1|||
142941782|NCT02901431|515324698|FG007|Main Treatment Part|Physician Decision|0|||
142941783|NCT02901431|515324699|FG008|Main Treatment Part|Physician Decision|0|||
142941784|NCT02901431|515324700|FG009|Main Treatment Part|Physician Decision|0|||
142941785|NCT02901431|515324701|FG010|Main Treatment Part|Physician Decision|0|||
142941786|NCT02901431|515324702|FG011|Main Treatment Part|Physician Decision|0|||
142941787|NCT02901431|515324703|FG012|Main Treatment Part|Physician Decision|0|||
142941788|NCT02901431|515324691|FG000|Main Treatment Part|Withdrawal by Subject|0|||
142941789|NCT02901431|515324692|FG001|Main Treatment Part|Withdrawal by Subject|0|||
142941790|NCT02901431|515324693|FG002|Main Treatment Part|Withdrawal by Subject|0|||
142941791|NCT02901431|515324694|FG003|Main Treatment Part|Withdrawal by Subject|18|||
142941792|NCT02901431|515324695|FG004|Main Treatment Part|Withdrawal by Subject|3|||
142941793|NCT02901431|515324696|FG005|Main Treatment Part|Withdrawal by Subject|5|||
142941794|NCT02901431|515324697|FG006|Main Treatment Part|Withdrawal by Subject|6|||
142941795|NCT02901431|515324698|FG007|Main Treatment Part|Withdrawal by Subject|0|||
142941796|NCT02901431|515324699|FG008|Main Treatment Part|Withdrawal by Subject|0|||
142941797|NCT02901431|515324700|FG009|Main Treatment Part|Withdrawal by Subject|0|||
142941798|NCT02901431|515324701|FG010|Main Treatment Part|Withdrawal by Subject|0|||
142941799|NCT02901431|515324702|FG011|Main Treatment Part|Withdrawal by Subject|0|||
143454367|NCT03117998|517208213|FG003|Overall Study|Lost to Follow-up|1|||
143454368|NCT03117998|517208214|FG004|Overall Study|Lost to Follow-up|4|||
143454369|NCT03117998|517208215|FG005|Overall Study|Lost to Follow-up|0|||
143454370|NCT03117998|517208210|FG000|Overall Study|Subject noncompliance|0|||
143454371|NCT03117998|517208211|FG001|Overall Study|Subject noncompliance|0|||
143454372|NCT03117998|517208212|FG002|Overall Study|Subject noncompliance|1|||
143454373|NCT03117998|517208213|FG003|Overall Study|Subject noncompliance|0|||
143454374|NCT03117998|517208214|FG004|Overall Study|Subject noncompliance|0|||
143454375|NCT03117998|517208215|FG005|Overall Study|Subject noncompliance|2|||
143454376|NCT03117998|517208210|FG000|Overall Study|Protocol Violation|0|||
143454377|NCT03117998|517208211|FG001|Overall Study|Protocol Violation|0|||
143454378|NCT03117998|517208212|FG002|Overall Study|Protocol Violation|0|||
143454379|NCT03117998|517208213|FG003|Overall Study|Protocol Violation|0|||
143454380|NCT03117998|517208214|FG004|Overall Study|Protocol Violation|0|||
143454381|NCT03117998|517208215|FG005|Overall Study|Protocol Violation|1|||
143454382|NCT04664400|517208216|FG000|Overall Study|Withdrawal by Subject|2|||
143454383|NCT01011153|517208219|FG000|Overall Study|Less than 78 cases completed|8|||
143454384|NCT01011153|517208220|FG001|Overall Study|Less than 78 cases completed|11|||
143454385|NCT01011153|517208221|FG002|Overall Study|Less than 78 cases completed|9|||
143454386|NCT01081132|517208222|FG000|Overall Study|Lack of Efficacy|25|||
143454387|NCT01081132|517208223|FG001|Overall Study|Lack of Efficacy|9|||
143454388|NCT01081132|517208222|FG000|Overall Study|Withdrawal by Subject|13|||
143454389|NCT01081132|517208223|FG001|Overall Study|Withdrawal by Subject|16|||
143454390|NCT01081132|517208222|FG000|Overall Study|Lost to Follow-up|4|||
143454391|NCT01081132|517208223|FG001|Overall Study|Lost to Follow-up|11|||
143454392|NCT01081132|517208222|FG000|Overall Study|Adverse Event|3|||
143454393|NCT01081132|517208223|FG001|Overall Study|Adverse Event|9|||
143454394|NCT01081132|517208222|FG000|Overall Study|Non Compliance|4|||
143454395|NCT01081132|517208223|FG001|Overall Study|Non Compliance|2|||
143454396|NCT01081132|517208222|FG000|Overall Study|Lack Of Compliance|0|||
143454397|NCT01081132|517208223|FG001|Overall Study|Lack Of Compliance|1|||
143454398|NCT01081132|517208222|FG000|Overall Study|Missed Visits|1|||
143454399|NCT01081132|517208223|FG001|Overall Study|Missed Visits|1|||
143454400|NCT01081132|517208222|FG000|Overall Study|Stopped Taking Meds|2|||
143454401|NCT01081132|517208223|FG001|Overall Study|Stopped Taking Meds|0|||
143454402|NCT01081132|517208222|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
143454403|NCT01081132|517208223|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
143454404|NCT01081132|517208222|FG000|Overall Study|Declined Taper Phase|0|||
143454405|NCT01081132|517208223|FG001|Overall Study|Declined Taper Phase|1|||
143454406|NCT01081132|517208222|FG000|Overall Study|Protocol Violation|3|||
143454407|NCT01081132|517208223|FG001|Overall Study|Protocol Violation|1|||
143454408|NCT02297139|517208224|FG000|Overall Study|Disease progression|0|||
143454409|NCT02297139|517208225|FG001|Overall Study|Disease progression|1|||
143454410|NCT02297139|517208224|FG000|Overall Study|Study drug toxicity|0|||
143454411|NCT02297139|517208225|FG001|Overall Study|Study drug toxicity|4|||
143454412|NCT02297139|517208224|FG000|Overall Study|Participant request to discontinue study treatment|0|||
143454413|NCT02297139|517208225|FG001|Overall Study|Participant request to discontinue study treatment|1|||
143454414|NCT02297139|517208224|FG000|Overall Study|Maximum clinical benefit|1|||
143454415|NCT02297139|517208225|FG001|Overall Study|Maximum clinical benefit|0|||
143454416|NCT02297139|517208224|FG000|Overall Study|Administrative reason by sponsor|0|||
143454417|NCT02297139|517208225|FG001|Overall Study|Administrative reason by sponsor|2|||
143454418|NCT02297139|517208224|FG000|Overall Study|Other reasons|0|||
143454419|NCT02297139|517208225|FG001|Overall Study|Other reasons|8|||
143454420|NCT02101385|517208228|FG000|Study Treatment|Disease Progression|9|||
143454421|NCT02101385|517208229|FG001|Study Treatment|Disease Progression|3|||
143454422|NCT02101385|517208228|FG000|Study Treatment|Alternative therapy|0|||
143454423|NCT02101385|517208229|FG001|Study Treatment|Alternative therapy|1|||
143454424|NCT02101385|517208228|FG000|Study Treatment|No treatment, per protocol criteria|0|||
143454425|NCT02101385|517208229|FG001|Study Treatment|No treatment, per protocol criteria|4|||
143454426|NCT02101385|517208228|FG000|Study Treatment|Patient Non compliance|0|||
143454427|NCT02101385|517208229|FG001|Study Treatment|Patient Non compliance|2|||
143454428|NCT02101385|517208228|FG000|Study Treatment|Withdrawal by Subject|5|||
143454429|NCT02101385|517208229|FG001|Study Treatment|Withdrawal by Subject|2|||
143454430|NCT02101385|517208228|FG000|Study Treatment|screen failure|1|||
143454431|NCT02101385|517208229|FG001|Study Treatment|screen failure|0|||
143454432|NCT02101385|517208228|FG000|Study Treatment|AE/Side Effects/Complications|8|||
143454433|NCT02101385|517208229|FG001|Study Treatment|AE/Side Effects/Complications|0|||
143454434|NCT02101385|517208228|FG000|Study Treatment|Lost to Follow-up|1|||
143454435|NCT02101385|517208229|FG001|Study Treatment|Lost to Follow-up|0|||
143454436|NCT02101385|517208228|FG000|Study Treatment|Disease Progression before treatment|1|||
143454437|NCT02101385|517208229|FG001|Study Treatment|Disease Progression before treatment|0|||
143454438|NCT02101385|517208228|FG000|Study Treatment|Death|1|||
143454439|NCT02101385|517208229|FG001|Study Treatment|Death|0|||
143454440|NCT02101385|517208228|FG000|Follow up|Lost to Follow-up|4|||
143454441|NCT02101385|517208229|FG001|Follow up|Lost to Follow-up|9|||
143454442|NCT02101385|517208228|FG000|Follow up|Refused to follow up|5|||
143454443|NCT02101385|517208229|FG001|Follow up|Refused to follow up|4|||
143454444|NCT02101385|517208228|FG000|Follow up|Death|21|||
143454445|NCT02101385|517208229|FG001|Follow up|Death|39|||
143454446|NCT02101385|517208228|FG000|Follow up|study completed|33|||
143454447|NCT02101385|517208229|FG001|Follow up|study completed|52|||
143454448|NCT02101385|517208228|FG000|Follow up|screen failure|2|||
143454449|NCT02101385|517208229|FG001|Follow up|screen failure|0|||
143454450|NCT02101385|517208228|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
143454451|NCT02101385|517208229|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
143454452|NCT02101385|517208228|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
143454453|NCT02101385|517208229|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
143454454|NCT02101385|517208228|FG000|Follow up|Withdrawal by Subject|2|||
143454455|NCT02101385|517208229|FG001|Follow up|Withdrawal by Subject|2|||
143454456|NCT02101385|517208228|FG000|Follow up|PI requested closure of site|0|||
143454457|NCT02101385|517208229|FG001|Follow up|PI requested closure of site|5|||
143454458|NCT01905150|517208231|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
143454459|NCT01905150|517208232|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
143454460|NCT03738423|517208237|FG000|Overall Study|Withdrawal by Subject|9|||
143454461|NCT03738423|517208238|FG001|Overall Study|Withdrawal by Subject|12|||
143454462|NCT03738423|517208239|FG002|Overall Study|Withdrawal by Subject|9|||
143454463|NCT03738423|517208240|FG003|Overall Study|Withdrawal by Subject|12|||
143454464|NCT03738423|517208241|FG004|Overall Study|Withdrawal by Subject|10|||
143454465|NCT03738423|517208237|FG000|Overall Study|Lack of Efficacy|3|||
143454466|NCT03738423|517208238|FG001|Overall Study|Lack of Efficacy|1|||
143454467|NCT03738423|517208239|FG002|Overall Study|Lack of Efficacy|1|||
143454468|NCT03738423|517208240|FG003|Overall Study|Lack of Efficacy|1|||
143454469|NCT03738423|517208241|FG004|Overall Study|Lack of Efficacy|2|||
143454470|NCT03738423|517208237|FG000|Overall Study|Lost to Follow-up|1|||
143454471|NCT03738423|517208238|FG001|Overall Study|Lost to Follow-up|0|||
143454472|NCT03738423|517208239|FG002|Overall Study|Lost to Follow-up|1|||
143454473|NCT03738423|517208240|FG003|Overall Study|Lost to Follow-up|1|||
143454474|NCT03738423|517208241|FG004|Overall Study|Lost to Follow-up|0|||
143454475|NCT03738423|517208237|FG000|Overall Study|Protocol Violation|1|||
143454476|NCT03738423|517208238|FG001|Overall Study|Protocol Violation|0|||
143454477|NCT03738423|517208239|FG002|Overall Study|Protocol Violation|0|||
143454478|NCT03738423|517208240|FG003|Overall Study|Protocol Violation|0|||
143454479|NCT03738423|517208241|FG004|Overall Study|Protocol Violation|1|||
143454480|NCT03738423|517208237|FG000|Overall Study|Physician Decision|0|||
143454481|NCT03738423|517208238|FG001|Overall Study|Physician Decision|0|||
143454482|NCT03738423|517208239|FG002|Overall Study|Physician Decision|1|||
143454483|NCT03738423|517208240|FG003|Overall Study|Physician Decision|0|||
143454484|NCT03738423|517208241|FG004|Overall Study|Physician Decision|1|||
143454485|NCT03738423|517208237|FG000|Overall Study|Death|0|||
143454486|NCT03738423|517208238|FG001|Overall Study|Death|0|||
143454487|NCT03738423|517208239|FG002|Overall Study|Death|0|||
143454488|NCT03738423|517208240|FG003|Overall Study|Death|0|||
143454489|NCT03738423|517208241|FG004|Overall Study|Death|1|||
143454490|NCT03738423|517208237|FG000|Overall Study|Randomized but never treated|0|||
143454491|NCT03738423|517208238|FG001|Overall Study|Randomized but never treated|0|||
143454492|NCT03738423|517208239|FG002|Overall Study|Randomized but never treated|1|||
143454493|NCT03738423|517208240|FG003|Overall Study|Randomized but never treated|1|||
142941800|NCT02901431|515324703|FG012|Main Treatment Part|Withdrawal by Subject|0|||
142941801|NCT02901431|515324691|FG000|Open Label Part|Adverse Event|0|||
142941802|NCT02901431|515324692|FG001|Open Label Part|Adverse Event|0|||
142941803|NCT02901431|515324693|FG002|Open Label Part|Adverse Event|0|||
142941804|NCT02901431|515324694|FG003|Open Label Part|Adverse Event|0|||
142941805|NCT02901431|515324695|FG004|Open Label Part|Adverse Event|0|||
142941806|NCT02901431|515324696|FG005|Open Label Part|Adverse Event|0|||
142941807|NCT02901431|515324697|FG006|Open Label Part|Adverse Event|0|||
142941808|NCT02901431|515324698|FG007|Open Label Part|Adverse Event|0|||
142941809|NCT02901431|515324699|FG008|Open Label Part|Adverse Event|4|||
142941810|NCT02901431|515324700|FG009|Open Label Part|Adverse Event|4|||
142941811|NCT02901431|515324701|FG010|Open Label Part|Adverse Event|0|||
142941812|NCT02901431|515324702|FG011|Open Label Part|Adverse Event|4|||
142941813|NCT02901431|515324703|FG012|Open Label Part|Adverse Event|1|||
142941814|NCT02901431|515324691|FG000|Open Label Part|Lost to Follow-up|0|||
142941815|NCT02901431|515324692|FG001|Open Label Part|Lost to Follow-up|0|||
142941816|NCT02901431|515324693|FG002|Open Label Part|Lost to Follow-up|0|||
142941817|NCT02901431|515324694|FG003|Open Label Part|Lost to Follow-up|0|||
142941818|NCT02901431|515324695|FG004|Open Label Part|Lost to Follow-up|0|||
142941819|NCT02901431|515324696|FG005|Open Label Part|Lost to Follow-up|0|||
142941820|NCT02901431|515324697|FG006|Open Label Part|Lost to Follow-up|0|||
142941821|NCT02901431|515324698|FG007|Open Label Part|Lost to Follow-up|0|||
142941822|NCT02901431|515324699|FG008|Open Label Part|Lost to Follow-up|2|||
142941823|NCT02901431|515324700|FG009|Open Label Part|Lost to Follow-up|2|||
142941824|NCT02901431|515324701|FG010|Open Label Part|Lost to Follow-up|1|||
142941825|NCT02901431|515324702|FG011|Open Label Part|Lost to Follow-up|1|||
142941826|NCT02901431|515324703|FG012|Open Label Part|Lost to Follow-up|1|||
142941827|NCT02901431|515324691|FG000|Open Label Part|Physician Decision|0|||
142941828|NCT02901431|515324692|FG001|Open Label Part|Physician Decision|0|||
142941829|NCT02901431|515324693|FG002|Open Label Part|Physician Decision|0|||
142941830|NCT02901431|515324694|FG003|Open Label Part|Physician Decision|0|||
142941831|NCT02901431|515324695|FG004|Open Label Part|Physician Decision|0|||
142941832|NCT02901431|515324696|FG005|Open Label Part|Physician Decision|0|||
142941833|NCT02901431|515324697|FG006|Open Label Part|Physician Decision|0|||
142941834|NCT02901431|515324698|FG007|Open Label Part|Physician Decision|0|||
142941835|NCT02901431|515324699|FG008|Open Label Part|Physician Decision|1|||
142941836|NCT02901431|515324700|FG009|Open Label Part|Physician Decision|1|||
142941837|NCT02901431|515324701|FG010|Open Label Part|Physician Decision|0|||
142941838|NCT02901431|515324702|FG011|Open Label Part|Physician Decision|0|||
142941839|NCT02901431|515324703|FG012|Open Label Part|Physician Decision|0|||
142941840|NCT02901431|515324691|FG000|Open Label Part|Study Terminated By Sponsor|0|||
142941841|NCT02901431|515324692|FG001|Open Label Part|Study Terminated By Sponsor|0|||
142941842|NCT02901431|515324693|FG002|Open Label Part|Study Terminated By Sponsor|0|||
142941843|NCT02901431|515324694|FG003|Open Label Part|Study Terminated By Sponsor|0|||
142941844|NCT02901431|515324695|FG004|Open Label Part|Study Terminated By Sponsor|0|||
142941845|NCT02901431|515324696|FG005|Open Label Part|Study Terminated By Sponsor|0|||
142941846|NCT02901431|515324697|FG006|Open Label Part|Study Terminated By Sponsor|0|||
142941847|NCT02901431|515324698|FG007|Open Label Part|Study Terminated By Sponsor|0|||
142941848|NCT02901431|515324699|FG008|Open Label Part|Study Terminated By Sponsor|35|||
142941849|NCT02901431|515324700|FG009|Open Label Part|Study Terminated By Sponsor|12|||
142941850|NCT02901431|515324701|FG010|Open Label Part|Study Terminated By Sponsor|21|||
142941851|NCT02901431|515324702|FG011|Open Label Part|Study Terminated By Sponsor|31|||
142941852|NCT02901431|515324703|FG012|Open Label Part|Study Terminated By Sponsor|0|||
142941853|NCT02901431|515324691|FG000|Open Label Part|Withdrawal by Subject|0|||
142941854|NCT02901431|515324692|FG001|Open Label Part|Withdrawal by Subject|0|||
142941855|NCT02901431|515324693|FG002|Open Label Part|Withdrawal by Subject|0|||
142941856|NCT02901431|515324694|FG003|Open Label Part|Withdrawal by Subject|0|||
142941857|NCT02901431|515324695|FG004|Open Label Part|Withdrawal by Subject|0|||
142941858|NCT02901431|515324696|FG005|Open Label Part|Withdrawal by Subject|0|||
142941859|NCT02901431|515324697|FG006|Open Label Part|Withdrawal by Subject|0|||
142941860|NCT02901431|515324698|FG007|Open Label Part|Withdrawal by Subject|0|||
142941861|NCT02901431|515324699|FG008|Open Label Part|Withdrawal by Subject|6|||
142941862|NCT02901431|515324700|FG009|Open Label Part|Withdrawal by Subject|5|||
142941863|NCT02901431|515324701|FG010|Open Label Part|Withdrawal by Subject|7|||
142941864|NCT02901431|515324702|FG011|Open Label Part|Withdrawal by Subject|3|||
142941865|NCT02901431|515324703|FG012|Open Label Part|Withdrawal by Subject|1|||
142941866|NCT04223609|515324704|FG000|Overall Study|Adverse Event|0|||
142941867|NCT04223609|515324705|FG001|Overall Study|Adverse Event|1|||
142941868|NCT04223609|515324704|FG000|Overall Study|Missed last visit|0|||
142941869|NCT04223609|515324705|FG001|Overall Study|Missed last visit|1|||
142941870|NCT03440944|515324706|FG000|Overall Study|Physician Decision|1|||
142941871|NCT03440944|515324707|FG001|Overall Study|Physician Decision|0|||
142941872|NCT03440944|515324706|FG000|Overall Study|No Acceptable Vasculature|0|||
142941873|NCT03440944|515324707|FG001|Overall Study|No Acceptable Vasculature|1|||
142941874|NCT00591734|515324708|FG000|Overall Study|Lack of Efficacy|35|||
142941875|NCT00591734|515324708|FG000|Overall Study|Adverse Event|5|||
142941876|NCT00591734|515324708|FG000|Overall Study|Physician Decision|5|||
142941877|NCT00591734|515324708|FG000|Overall Study|Intercurrent Illness|8|||
142941878|NCT01661790|515324709|FG000|Overall Study|Lost to Follow-up|0|||
143454494|NCT03738423|517208241|FG004|Overall Study|Randomized but never treated|0|||
143454495|NCT01593787|517208242|FG000|Overall Study|Adverse Event|1|||
143454496|NCT01593787|517208243|FG001|Overall Study|Adverse Event|0|||
143454497|NCT01593787|517208244|FG002|Overall Study|Adverse Event|0|||
143454498|NCT02592876|517208251|FG000|Overall Study|Withdrawal by Subject|3|||
143454499|NCT02592876|517208252|FG001|Overall Study|Withdrawal by Subject|3|||
143454500|NCT02592876|517208251|FG000|Overall Study|Study Termination by Sponsor|32|||
143454501|NCT02592876|517208252|FG001|Overall Study|Study Termination by Sponsor|27|||
143454502|NCT02592876|517208251|FG000|Overall Study|Lost to Follow-up|0|||
143454503|NCT02592876|517208252|FG001|Overall Study|Lost to Follow-up|1|||
143454504|NCT02592876|517208251|FG000|Overall Study|Death|6|||
143454505|NCT02592876|517208252|FG001|Overall Study|Death|9|||
143454506|NCT00611975|517208255|FG000|Overall Study|Withdrawal by Subject|3|||
143454507|NCT00611975|517208256|FG001|Overall Study|Withdrawal by Subject|7|||
143454508|NCT00611975|517208255|FG000|Overall Study|Pregnancy|2|||
143454509|NCT00611975|517208256|FG001|Overall Study|Pregnancy|1|||
142941879|NCT01661790|515324710|FG001|Overall Study|Lost to Follow-up|2|||
142941880|NCT04696861|515324714|FG000|Overall Study|Death|1|||
142941881|NCT04696861|515324715|FG001|Overall Study|Death|0|||
142941882|NCT04696861|515324714|FG000|Overall Study|Lost to Follow-up|3|||
142941883|NCT04696861|515324715|FG001|Overall Study|Lost to Follow-up|0|||
142941884|NCT01813890|515324718|FG000|Overall Study|Adverse Event|0|||
142941885|NCT01813890|515324719|FG001|Overall Study|Adverse Event|3|||
142941886|NCT01813890|515324720|FG002|Overall Study|Adverse Event|4|||
142941887|NCT01813890|515324718|FG000|Overall Study|Lack of Efficacy|9|||
142941888|NCT01813890|515324719|FG001|Overall Study|Lack of Efficacy|1|||
142941889|NCT01813890|515324720|FG002|Overall Study|Lack of Efficacy|2|||
142941890|NCT01827384|515324721|FG000|Overall Study|Switched to alternative treatment|0|||
142941891|NCT01827384|515324722|FG001|Overall Study|Switched to alternative treatment|0|||
142941892|NCT01827384|515324723|FG002|Overall Study|Switched to alternative treatment|0|||
142941893|NCT01827384|515324724|FG003|Overall Study|Switched to alternative treatment|0|||
142941894|NCT01827384|515324725|FG004|Overall Study|Switched to alternative treatment|0|||
142941895|NCT01827384|515324726|FG005|Overall Study|Switched to alternative treatment|0|||
142941896|NCT01827384|515324727|FG006|Overall Study|Switched to alternative treatment|0|||
142941897|NCT01827384|515324728|FG007|Overall Study|Switched to alternative treatment|0|||
142941898|NCT01827384|515324729|FG008|Overall Study|Switched to alternative treatment|0|||
142941899|NCT01827384|515324730|FG009|Overall Study|Switched to alternative treatment|0|||
142941900|NCT01827384|515324731|FG010|Overall Study|Switched to alternative treatment|0|||
142941901|NCT01827384|515324732|FG011|Overall Study|Switched to alternative treatment|0|||
142941902|NCT01827384|515324733|FG012|Overall Study|Switched to alternative treatment|0|||
142941903|NCT01827384|515324734|FG013|Overall Study|Switched to alternative treatment|2|||
142941904|NCT01827384|515324721|FG000|Overall Study|Disease progression before treatment|0|||
142941905|NCT01827384|515324722|FG001|Overall Study|Disease progression before treatment|0|||
142941906|NCT01827384|515324723|FG002|Overall Study|Disease progression before treatment|0|||
142941907|NCT01827384|515324724|FG003|Overall Study|Disease progression before treatment|0|||
142941908|NCT01827384|515324725|FG004|Overall Study|Disease progression before treatment|0|||
142941909|NCT01827384|515324726|FG005|Overall Study|Disease progression before treatment|0|||
142941910|NCT01827384|515324727|FG006|Overall Study|Disease progression before treatment|0|||
142941911|NCT01827384|515324728|FG007|Overall Study|Disease progression before treatment|0|||
142941912|NCT01827384|515324729|FG008|Overall Study|Disease progression before treatment|0|||
142941913|NCT01827384|515324730|FG009|Overall Study|Disease progression before treatment|0|||
142941914|NCT01827384|515324731|FG010|Overall Study|Disease progression before treatment|0|||
142941915|NCT01827384|515324732|FG011|Overall Study|Disease progression before treatment|0|||
142941916|NCT01827384|515324733|FG012|Overall Study|Disease progression before treatment|0|||
142941917|NCT01827384|515324734|FG013|Overall Study|Disease progression before treatment|4|||
142941918|NCT01827384|515324721|FG000|Overall Study|Ineligible|0|||
142941919|NCT01827384|515324722|FG001|Overall Study|Ineligible|0|||
143454510|NCT03465904|517208257|FG000|Overall Study|Withdrawal by Subject|9|||
142941920|NCT01827384|515324723|FG002|Overall Study|Ineligible|0|||
142941921|NCT01827384|515324724|FG003|Overall Study|Ineligible|0|||
142941922|NCT01827384|515324725|FG004|Overall Study|Ineligible|0|||
142941923|NCT01827384|515324726|FG005|Overall Study|Ineligible|0|||
142941924|NCT01827384|515324727|FG006|Overall Study|Ineligible|0|||
142941925|NCT01827384|515324728|FG007|Overall Study|Ineligible|0|||
142941926|NCT01827384|515324729|FG008|Overall Study|Ineligible|0|||
142941927|NCT01827384|515324730|FG009|Overall Study|Ineligible|0|||
142941928|NCT01827384|515324731|FG010|Overall Study|Ineligible|0|||
142941929|NCT01827384|515324732|FG011|Overall Study|Ineligible|0|||
142941930|NCT01827384|515324733|FG012|Overall Study|Ineligible|0|||
143454511|NCT03465904|517208258|FG001|Overall Study|Withdrawal by Subject|5|||
143454512|NCT03465904|517208257|FG000|Overall Study|Lost to Follow-up|11|||
143454513|NCT03465904|517208258|FG001|Overall Study|Lost to Follow-up|9|||
143454514|NCT03465904|517208257|FG000|Overall Study|Protocol Violation|20|||
143454515|NCT03465904|517208258|FG001|Overall Study|Protocol Violation|15|||
143454516|NCT04625413|517208259|FG000|Overall Study|Hospice|2|||
143454517|NCT04625413|517208259|FG000|Overall Study|Distress|1|||
143454518|NCT04625413|517208259|FG000|Overall Study|Not feeling well|1|||
143454519|NCT01305200|517208260|FG000|Overall Study|Physician Decision|4|||
143454520|NCT01305200|517208261|FG001|Overall Study|Physician Decision|6|||
143454521|NCT01305200|517208262|FG002|Overall Study|Physician Decision|1|||
143454522|NCT01305200|517208260|FG000|Overall Study|Withdrawal by Subject|24|||
143454523|NCT01305200|517208261|FG001|Overall Study|Withdrawal by Subject|21|||
143454524|NCT01305200|517208262|FG002|Overall Study|Withdrawal by Subject|1|||
143454525|NCT01305200|517208260|FG000|Overall Study|Ineligible|1|||
143454526|NCT01305200|517208261|FG001|Overall Study|Ineligible|2|||
143454527|NCT01305200|517208262|FG002|Overall Study|Ineligible|1|||
143454528|NCT01305200|517208260|FG000|Overall Study|Death|0|||
143454529|NCT01305200|517208261|FG001|Overall Study|Death|2|||
143454530|NCT01305200|517208262|FG002|Overall Study|Death|0|||
143454531|NCT03981861|517208263|FG000|Overall Study|Withdrawal by Subject|3|||
143454532|NCT05618912|517208264|FG000|Overall Study|Lost to Follow-up|14|||
143454533|NCT05618912|517208265|FG001|Overall Study|Lost to Follow-up|19|||
143454534|NCT00925353|517208266|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
143454535|NCT02516332|517210659|FG000|Overall Study|Withdrawal by Subject|2|||
143454536|NCT02516332|517210660|FG001|Overall Study|Withdrawal by Subject|1|||
143454537|NCT02516332|517210661|FG002|Overall Study|Withdrawal by Subject|2|||
143454538|NCT03695237|517210662|FG000|Overall Study|Withdrawal by Subject|1|||
143454539|NCT03695237|517210663|FG001|Overall Study|Withdrawal by Subject|3|||
143454540|NCT03695237|517210662|FG000|Overall Study|Lost to Follow-up|1|||
143454541|NCT03695237|517210663|FG001|Overall Study|Lost to Follow-up|2|||
143454542|NCT03695237|517210662|FG000|Overall Study|Other, Not Specified|8|||
143454543|NCT03695237|517210663|FG001|Overall Study|Other, Not Specified|2|||
143454544|NCT00605215|517210666|FG000|Overall Study|Death|0|||
143454545|NCT00605215|517210667|FG001|Overall Study|Death|0|||
143454546|NCT00605215|517210668|FG002|Overall Study|Death|1|||
143454547|NCT00605215|517210666|FG000|Overall Study|Adverse Event|19|||
143454548|NCT00605215|517210667|FG001|Overall Study|Adverse Event|21|||
143454549|NCT00605215|517210668|FG002|Overall Study|Adverse Event|26|||
143454550|NCT00605215|517210666|FG000|Overall Study|Refusal to sign the re-consent form|8|||
143454551|NCT00605215|517210667|FG001|Overall Study|Refusal to sign the re-consent form|3|||
143454552|NCT00605215|517210668|FG002|Overall Study|Refusal to sign the re-consent form|3|||
143454553|NCT00605215|517210666|FG000|Overall Study|Withdrawal by Subject|39|||
143454554|NCT00605215|517210667|FG001|Overall Study|Withdrawal by Subject|37|||
143454555|NCT00605215|517210668|FG002|Overall Study|Withdrawal by Subject|27|||
143454556|NCT00605215|517210666|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
143454557|NCT00605215|517210667|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
143454558|NCT00605215|517210668|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
143454559|NCT00605215|517210666|FG000|Overall Study|Protocol Violation|3|||
143454560|NCT00605215|517210667|FG001|Overall Study|Protocol Violation|4|||
143454561|NCT00605215|517210668|FG002|Overall Study|Protocol Violation|1|||
143454562|NCT00605215|517210666|FG000|Overall Study|Pregnancy|8|||
143454563|NCT00605215|517210667|FG001|Overall Study|Pregnancy|5|||
143454564|NCT00605215|517210668|FG002|Overall Study|Pregnancy|4|||
143454565|NCT00605215|517210666|FG000|Overall Study|Lost to Follow-up|8|||
143454566|NCT00605215|517210667|FG001|Overall Study|Lost to Follow-up|5|||
143454567|NCT00605215|517210668|FG002|Overall Study|Lost to Follow-up|2|||
143454568|NCT00605215|517210666|FG000|Overall Study|Other than specified|0|||
143454569|NCT00605215|517210667|FG001|Overall Study|Other than specified|2|||
143454570|NCT00605215|517210668|FG002|Overall Study|Other than specified|1|||
143454571|NCT01789567|517210669|FG000|Overall Study|Death|6|||
142941931|NCT01827384|515324734|FG013|Overall Study|Ineligible|19|||
142941932|NCT01827384|515324721|FG000|Overall Study|Participant died before treatment|0|||
142941933|NCT01827384|515324722|FG001|Overall Study|Participant died before treatment|0|||
142941934|NCT01827384|515324723|FG002|Overall Study|Participant died before treatment|0|||
142941935|NCT01827384|515324724|FG003|Overall Study|Participant died before treatment|0|||
143454572|NCT00872989|517210670|FG000|Overall Study|Adverse Event|7|||
142941936|NCT01827384|515324725|FG004|Overall Study|Participant died before treatment|0|||
142941937|NCT01827384|515324726|FG005|Overall Study|Participant died before treatment|0|||
143454573|NCT00872989|517210671|FG001|Overall Study|Adverse Event|15|||
143454574|NCT00872989|517210670|FG000|Overall Study|Withdrawal by Subject|8|||
143454575|NCT00872989|517210671|FG001|Overall Study|Withdrawal by Subject|5|||
143454576|NCT00872989|517210670|FG000|Overall Study|Progression/relapse|47|||
143454577|NCT00872989|517210671|FG001|Overall Study|Progression/relapse|35|||
143454578|NCT00872989|517210670|FG000|Overall Study|Not protocol specified|3|||
143454579|NCT00872989|517210671|FG001|Overall Study|Not protocol specified|8|||
143454580|NCT02407990|517210672|FG000|Overall Study|Death|2|||
143454581|NCT02407990|517210673|FG001|Overall Study|Death|22|||
143454582|NCT02407990|517210674|FG002|Overall Study|Death|23|||
143454583|NCT02407990|517210675|FG003|Overall Study|Death|7|||
143454584|NCT02407990|517210676|FG004|Overall Study|Death|17|||
143454585|NCT02407990|517210677|FG005|Overall Study|Death|16|||
143454586|NCT02407990|517210678|FG006|Overall Study|Death|10|||
143454587|NCT02407990|517210679|FG007|Overall Study|Death|248|||
143454588|NCT02407990|517210672|FG000|Overall Study|Lost to Follow-up|0|||
143454589|NCT02407990|517210673|FG001|Overall Study|Lost to Follow-up|1|||
143454590|NCT02407990|517210674|FG002|Overall Study|Lost to Follow-up|0|||
143454591|NCT02407990|517210675|FG003|Overall Study|Lost to Follow-up|0|||
143454592|NCT02407990|517210676|FG004|Overall Study|Lost to Follow-up|0|||
143454593|NCT02407990|517210677|FG005|Overall Study|Lost to Follow-up|0|||
143454594|NCT02407990|517210678|FG006|Overall Study|Lost to Follow-up|0|||
143454595|NCT02407990|517210679|FG007|Overall Study|Lost to Follow-up|17|||
143454596|NCT02407990|517210672|FG000|Overall Study|Progressive Disease|0|||
143454597|NCT02407990|517210673|FG001|Overall Study|Progressive Disease|0|||
143454598|NCT02407990|517210674|FG002|Overall Study|Progressive Disease|0|||
143454599|NCT02407990|517210675|FG003|Overall Study|Progressive Disease|0|||
143454600|NCT02407990|517210676|FG004|Overall Study|Progressive Disease|0|||
143454601|NCT02407990|517210677|FG005|Overall Study|Progressive Disease|0|||
143454602|NCT02407990|517210678|FG006|Overall Study|Progressive Disease|0|||
143454603|NCT02407990|517210679|FG007|Overall Study|Progressive Disease|1|||
143454604|NCT02407990|517210672|FG000|Overall Study|Withdrawal by Subject|0|||
143454605|NCT02407990|517210673|FG001|Overall Study|Withdrawal by Subject|0|||
143454606|NCT02407990|517210674|FG002|Overall Study|Withdrawal by Subject|0|||
143454607|NCT02407990|517210675|FG003|Overall Study|Withdrawal by Subject|0|||
143454608|NCT02407990|517210676|FG004|Overall Study|Withdrawal by Subject|1|||
143454609|NCT02407990|517210677|FG005|Overall Study|Withdrawal by Subject|0|||
143454610|NCT02407990|517210678|FG006|Overall Study|Withdrawal by Subject|0|||
143454611|NCT02407990|517210679|FG007|Overall Study|Withdrawal by Subject|30|||
143454612|NCT02407990|517210672|FG000|Overall Study|Study Terminated by Sponsor|1|||
143454613|NCT02407990|517210673|FG001|Overall Study|Study Terminated by Sponsor|3|||
143454614|NCT02407990|517210674|FG002|Overall Study|Study Terminated by Sponsor|3|||
143454615|NCT02407990|517210675|FG003|Overall Study|Study Terminated by Sponsor|0|||
143454616|NCT02407990|517210676|FG004|Overall Study|Study Terminated by Sponsor|3|||
143454617|NCT02407990|517210677|FG005|Overall Study|Study Terminated by Sponsor|4|||
143454618|NCT02407990|517210678|FG006|Overall Study|Study Terminated by Sponsor|3|||
143454619|NCT02407990|517210679|FG007|Overall Study|Study Terminated by Sponsor|37|||
143454620|NCT02407990|517210672|FG000|Overall Study|Logistics|0|||
143454621|NCT02407990|517210673|FG001|Overall Study|Logistics|0|||
143454622|NCT02407990|517210674|FG002|Overall Study|Logistics|0|||
143454623|NCT02407990|517210675|FG003|Overall Study|Logistics|0|||
143454624|NCT02407990|517210676|FG004|Overall Study|Logistics|0|||
143454625|NCT02407990|517210677|FG005|Overall Study|Logistics|0|||
143454626|NCT02407990|517210678|FG006|Overall Study|Logistics|0|||
143454627|NCT02407990|517210679|FG007|Overall Study|Logistics|1|||
143454628|NCT02407990|517210672|FG000|Overall Study|Rolled into long-term extension study|0|||
143454629|NCT02407990|517210673|FG001|Overall Study|Rolled into long-term extension study|0|||
143454630|NCT02407990|517210674|FG002|Overall Study|Rolled into long-term extension study|0|||
143454631|NCT02407990|517210675|FG003|Overall Study|Rolled into long-term extension study|0|||
143454632|NCT02407990|517210676|FG004|Overall Study|Rolled into long-term extension study|0|||
143454633|NCT02407990|517210677|FG005|Overall Study|Rolled into long-term extension study|0|||
143454634|NCT02407990|517210678|FG006|Overall Study|Rolled into long-term extension study|0|||
143454635|NCT02407990|517210679|FG007|Overall Study|Rolled into long-term extension study|1|||
143454636|NCT00923260|517210680|FG000|Overall Study|Lost to Follow-up|1|||
143454637|NCT00923260|517210681|FG001|Overall Study|Lost to Follow-up|1|||
143454638|NCT01302067|517210684|FG000|Overall Study|Death|0|||
143454639|NCT01302067|517210685|FG001|Overall Study|Death|0|||
143454640|NCT01302067|517210686|FG002|Overall Study|Death|1|||
143454641|NCT01302067|517210684|FG000|Overall Study|Physician Decision|9|||
143454642|NCT01302067|517210685|FG001|Overall Study|Physician Decision|5|||
143454643|NCT01302067|517210686|FG002|Overall Study|Physician Decision|14|||
143454644|NCT01302067|517210684|FG000|Overall Study|Lack of Efficacy|8|||
143454645|NCT01302067|517210685|FG001|Overall Study|Lack of Efficacy|4|||
143454646|NCT01302067|517210686|FG002|Overall Study|Lack of Efficacy|2|||
143454647|NCT01302067|517210684|FG000|Overall Study|Lost to Follow-up|9|||
143454648|NCT01302067|517210685|FG001|Overall Study|Lost to Follow-up|4|||
143454649|NCT01302067|517210686|FG002|Overall Study|Lost to Follow-up|15|||
143454650|NCT01302067|517210684|FG000|Overall Study|Withdrawal by Subject|13|||
143454651|NCT01302067|517210685|FG001|Overall Study|Withdrawal by Subject|6|||
143454652|NCT01302067|517210686|FG002|Overall Study|Withdrawal by Subject|10|||
143454653|NCT01302067|517210684|FG000|Overall Study|Other|1|||
143454654|NCT01302067|517210685|FG001|Overall Study|Other|1|||
143454655|NCT01302067|517210686|FG002|Overall Study|Other|3|||
143454656|NCT01302067|517210684|FG000|Overall Study|Protocol Violation|11|||
143454657|NCT01302067|517210685|FG001|Overall Study|Protocol Violation|0|||
143454658|NCT01302067|517210686|FG002|Overall Study|Protocol Violation|8|||
143454659|NCT01302067|517210684|FG000|Overall Study|Adverse Event|27|||
143454660|NCT01302067|517210685|FG001|Overall Study|Adverse Event|14|||
143454661|NCT01302067|517210686|FG002|Overall Study|Adverse Event|45|||
143454662|NCT02738203|517210688|FG000|Overall Study|Failed IUD Insertion|2|||
143454663|NCT02738203|517210689|FG001|Overall Study|Failed IUD Insertion|2|||
143454664|NCT02738203|517210688|FG000|Overall Study|Protocol Violation|0|||
143454665|NCT02738203|517210689|FG001|Overall Study|Protocol Violation|1|||
143454666|NCT00266227|517210690|FG000|Initial Treatment|Adverse Event|0|||
142941938|NCT01827384|515324727|FG006|Overall Study|Participant died before treatment|0|||
142941939|NCT01827384|515324728|FG007|Overall Study|Participant died before treatment|0|||
142941940|NCT01827384|515324729|FG008|Overall Study|Participant died before treatment|0|||
142941941|NCT01827384|515324730|FG009|Overall Study|Participant died before treatment|0|||
142941942|NCT01827384|515324731|FG010|Overall Study|Participant died before treatment|0|||
142941943|NCT01827384|515324732|FG011|Overall Study|Participant died before treatment|0|||
142941944|NCT01827384|515324733|FG012|Overall Study|Participant died before treatment|0|||
142941945|NCT01827384|515324734|FG013|Overall Study|Participant died before treatment|5|||
142941946|NCT01827384|515324721|FG000|Overall Study|Insufficient tumor cells|0|||
142941947|NCT01827384|515324722|FG001|Overall Study|Insufficient tumor cells|0|||
142941948|NCT01827384|515324723|FG002|Overall Study|Insufficient tumor cells|0|||
142941949|NCT01827384|515324724|FG003|Overall Study|Insufficient tumor cells|0|||
142941950|NCT01827384|515324725|FG004|Overall Study|Insufficient tumor cells|0|||
142941951|NCT01827384|515324726|FG005|Overall Study|Insufficient tumor cells|0|||
142941952|NCT01827384|515324727|FG006|Overall Study|Insufficient tumor cells|0|||
142941953|NCT01827384|515324728|FG007|Overall Study|Insufficient tumor cells|0|||
142941954|NCT01827384|515324729|FG008|Overall Study|Insufficient tumor cells|0|||
142941955|NCT01827384|515324730|FG009|Overall Study|Insufficient tumor cells|0|||
142941956|NCT01827384|515324731|FG010|Overall Study|Insufficient tumor cells|0|||
142941957|NCT01827384|515324732|FG011|Overall Study|Insufficient tumor cells|0|||
142941958|NCT01827384|515324733|FG012|Overall Study|Insufficient tumor cells|0|||
142941959|NCT01827384|515324734|FG013|Overall Study|Insufficient tumor cells|13|||
142941960|NCT01827384|515324721|FG000|Overall Study|No actionable mutation|0|||
142941961|NCT01827384|515324722|FG001|Overall Study|No actionable mutation|0|||
142941962|NCT01827384|515324723|FG002|Overall Study|No actionable mutation|0|||
142941963|NCT01827384|515324724|FG003|Overall Study|No actionable mutation|0|||
142941964|NCT01827384|515324725|FG004|Overall Study|No actionable mutation|0|||
142941965|NCT01827384|515324726|FG005|Overall Study|No actionable mutation|0|||
142941966|NCT01827384|515324727|FG006|Overall Study|No actionable mutation|0|||
142941967|NCT01827384|515324728|FG007|Overall Study|No actionable mutation|0|||
142941968|NCT01827384|515324729|FG008|Overall Study|No actionable mutation|0|||
142941969|NCT01827384|515324730|FG009|Overall Study|No actionable mutation|0|||
142941970|NCT01827384|515324731|FG010|Overall Study|No actionable mutation|0|||
142941971|NCT01827384|515324732|FG011|Overall Study|No actionable mutation|0|||
142941972|NCT01827384|515324733|FG012|Overall Study|No actionable mutation|0|||
142941973|NCT01827384|515324734|FG013|Overall Study|No actionable mutation|73|||
142941974|NCT01827384|515324721|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
142941975|NCT01827384|515324722|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
142941976|NCT01827384|515324723|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
142941977|NCT01827384|515324724|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
142941978|NCT01827384|515324725|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
142941979|NCT01827384|515324726|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
142941980|NCT01827384|515324727|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
142941981|NCT01827384|515324728|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
142941982|NCT01827384|515324729|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
142941983|NCT01827384|515324730|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
142941984|NCT01827384|515324731|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
142941985|NCT01827384|515324732|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
142941986|NCT01827384|515324733|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
142941987|NCT01827384|515324734|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
142941988|NCT01707992|515324738|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
142941989|NCT01707992|515324739|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
142941990|NCT01707992|515324740|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
142941991|NCT01707992|515324741|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
142941992|NCT01707992|515324742|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
142941993|NCT01707992|515324743|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
142941994|NCT01707992|515324738|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
142941995|NCT01707992|515324739|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
142941996|NCT01707992|515324740|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
142941997|NCT01707992|515324741|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
142941998|NCT01707992|515324742|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
142941999|NCT01707992|515324743|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
142942000|NCT01707992|515324738|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
142942001|NCT01707992|515324739|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
142942002|NCT01707992|515324740|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
142942003|NCT01707992|515324741|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
143003052|NCT01049360|515548744|FG000|Period 1|Adverse Event|0|||
142942004|NCT01707992|515324742|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
142942005|NCT01707992|515324743|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
142942006|NCT01707992|515324738|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
142942007|NCT01707992|515324739|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
142942008|NCT01707992|515324740|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
142942009|NCT01707992|515324741|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
142942010|NCT01707992|515324742|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
142942011|NCT01707992|515324743|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
142942012|NCT01707992|515324738|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
142942013|NCT01707992|515324739|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
142942014|NCT01707992|515324740|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
142942015|NCT01707992|515324741|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
142942016|NCT01707992|515324742|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
142942017|NCT01707992|515324743|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
142942018|NCT01707992|515324738|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
142942019|NCT01707992|515324739|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
142942020|NCT01707992|515324740|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
142942021|NCT01707992|515324741|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
142942022|NCT01707992|515324742|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
142942023|NCT01707992|515324743|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
142942024|NCT01707992|515324738|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
142942025|NCT01707992|515324739|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
142942026|NCT01707992|515324740|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
142942027|NCT01707992|515324741|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
142942028|NCT01707992|515324742|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
142942029|NCT01707992|515324743|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
142942030|NCT01707992|515324738|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
142942031|NCT01707992|515324739|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
142942032|NCT01707992|515324740|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
142942033|NCT01707992|515324741|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
142942034|NCT01707992|515324742|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
142942035|NCT01707992|515324743|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
142942036|NCT01707992|515324738|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
142942037|NCT01707992|515324739|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
142942038|NCT01707992|515324740|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
142942039|NCT01707992|515324741|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
142942040|NCT01707992|515324742|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
142942041|NCT01707992|515324743|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
142942042|NCT01707992|515324738|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
142942043|NCT01707992|515324739|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
142942044|NCT01707992|515324740|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
142942045|NCT01707992|515324741|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
142942046|NCT01707992|515324742|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
142942047|NCT01707992|515324743|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
142942048|NCT01707992|515324738|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
142942049|NCT01707992|515324739|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
142942050|NCT01707992|515324740|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
142942051|NCT01707992|515324741|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
142942052|NCT01707992|515324742|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
142942053|NCT01707992|515324743|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
142942054|NCT01707992|515324738|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
142942055|NCT01707992|515324739|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
142942056|NCT01707992|515324740|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
142942057|NCT01707992|515324741|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
142942058|NCT01707992|515324742|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
142942059|NCT01707992|515324743|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
142942060|NCT01707992|515324738|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
142942061|NCT01707992|515324739|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
142942062|NCT01707992|515324740|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
142942063|NCT01707992|515324741|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
142942064|NCT01707992|515324742|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
142942065|NCT01707992|515324743|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
142942066|NCT01707992|515324738|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
142942067|NCT01707992|515324739|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
142942068|NCT01707992|515324740|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
142942069|NCT01707992|515324741|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
142942070|NCT01707992|515324742|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
142942071|NCT01707992|515324743|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
142942072|NCT01707992|515324738|FG000|Active Treatment Phase (24 Months)|Death|0|||
142942073|NCT01707992|515324739|FG001|Active Treatment Phase (24 Months)|Death|0|||
142942074|NCT01707992|515324740|FG002|Active Treatment Phase (24 Months)|Death|0|||
142942075|NCT01707992|515324741|FG003|Active Treatment Phase (24 Months)|Death|2|||
142942076|NCT01707992|515324742|FG004|Active Treatment Phase (24 Months)|Death|0|||
142942077|NCT01707992|515324743|FG005|Active Treatment Phase (24 Months)|Death|0|||
142942078|NCT01707992|515324738|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
142942079|NCT01707992|515324739|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
142942080|NCT01707992|515324740|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
142942081|NCT01707992|515324741|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
142942082|NCT01707992|515324742|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
142942083|NCT01707992|515324743|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
142942084|NCT01707992|515324738|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
142942085|NCT01707992|515324739|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
142942086|NCT01707992|515324740|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
142942087|NCT01707992|515324741|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
142942088|NCT01707992|515324742|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
142942089|NCT01707992|515324743|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
142942090|NCT01707992|515324738|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
142942091|NCT01707992|515324739|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
142942092|NCT01707992|515324740|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
142942093|NCT01707992|515324741|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
142942094|NCT01707992|515324742|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
142942095|NCT01707992|515324743|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
142942096|NCT01707992|515324738|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
142942097|NCT01707992|515324739|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
142942098|NCT01707992|515324740|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
142942099|NCT01707992|515324741|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
142942100|NCT01707992|515324742|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
142942101|NCT01707992|515324743|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
142942102|NCT00998738|515324745|FG000|Overall Study|Uknown|1|||
142942103|NCT03313050|515324747|FG000|Stage 2: 12 Months|Adverse Event|0|||
142942104|NCT03313050|515324748|FG001|Stage 2: 12 Months|Adverse Event|0|||
142942105|NCT03313050|515324749|FG002|Stage 2: 12 Months|Adverse Event|0|||
142942106|NCT03313050|515324750|FG003|Stage 2: 12 Months|Adverse Event|1|||
142942107|NCT03313050|515324747|FG000|Stage 2: 12 Months|Death|0|||
142942108|NCT03313050|515324748|FG001|Stage 2: 12 Months|Death|0|||
142942109|NCT03313050|515324749|FG002|Stage 2: 12 Months|Death|3|||
142942110|NCT03313050|515324750|FG003|Stage 2: 12 Months|Death|0|||
142942111|NCT03313050|515324747|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
142942112|NCT03313050|515324748|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
142942113|NCT03313050|515324749|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
142942114|NCT03313050|515324750|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
142942115|NCT03313050|515324747|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
142942116|NCT03313050|515324748|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
142942117|NCT03313050|515324749|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
142942118|NCT03313050|515324750|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
142942119|NCT03313050|515324747|FG000|Stage 2: 12 Months|Protocol deviation|0|||
142942120|NCT03313050|515324748|FG001|Stage 2: 12 Months|Protocol deviation|0|||
143454667|NCT00266227|517210691|FG001|Initial Treatment|Adverse Event|0|||
142942121|NCT03313050|515324749|FG002|Stage 2: 12 Months|Protocol deviation|7|||
142942122|NCT03313050|515324750|FG003|Stage 2: 12 Months|Protocol deviation|7|||
142942123|NCT03313050|515324747|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
142942124|NCT03313050|515324748|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
143454668|NCT00266227|517210692|FG002|Initial Treatment|Adverse Event|13|||
142942125|NCT03313050|515324749|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
143454669|NCT00266227|517210690|FG000|Initial Treatment|Lost to Follow-up|0|||
143454670|NCT00266227|517210691|FG001|Initial Treatment|Lost to Follow-up|0|||
143454671|NCT00266227|517210692|FG002|Initial Treatment|Lost to Follow-up|6|||
143454672|NCT00266227|517210690|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
143454673|NCT00266227|517210691|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
143454674|NCT00266227|517210692|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
143454675|NCT00266227|517210690|FG000|Initial Treatment|Physician decision to withdraw|0|||
143454676|NCT00266227|517210691|FG001|Initial Treatment|Physician decision to withdraw|0|||
143454677|NCT00266227|517210692|FG002|Initial Treatment|Physician decision to withdraw|12|||
143454678|NCT00266227|517210690|FG000|Initial Treatment|Pregnancy|0|||
143454679|NCT00266227|517210691|FG001|Initial Treatment|Pregnancy|0|||
143454680|NCT00266227|517210692|FG002|Initial Treatment|Pregnancy|1|||
142942126|NCT03313050|515324750|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
142942127|NCT03313050|515324747|FG000|Stage 2: 12 Months|Other|0|||
142942128|NCT03313050|515324748|FG001|Stage 2: 12 Months|Other|0|||
142942129|NCT03313050|515324749|FG002|Stage 2: 12 Months|Other|0|||
142942130|NCT03313050|515324750|FG003|Stage 2: 12 Months|Other|1|||
142942131|NCT04211337|515324751|FG000|Overall Study|On Treatment|175|||
142942132|NCT04211337|515324752|FG001|Overall Study|On Treatment|40|||
142942133|NCT04211337|515324751|FG000|Overall Study|Withdrawal by Subject|0|||
142942134|NCT04211337|515324752|FG001|Overall Study|Withdrawal by Subject|2|||
142942135|NCT02847598|515324761|FG000|Overall Study|Adverse Event|0|||
142942136|NCT02847598|515324762|FG001|Overall Study|Adverse Event|0|||
142942137|NCT02847598|515324763|FG002|Overall Study|Adverse Event|0|||
142942138|NCT02847598|515324764|FG003|Overall Study|Adverse Event|0|||
142942139|NCT02847598|515324765|FG004|Overall Study|Adverse Event|0|||
142942140|NCT02847598|515324766|FG005|Overall Study|Adverse Event|0|||
142942141|NCT02847598|515324767|FG006|Overall Study|Adverse Event|0|||
142942142|NCT02847598|515324768|FG007|Overall Study|Adverse Event|1|||
142942143|NCT02847598|515324761|FG000|Overall Study|Consent withdrawn|2|||
142942144|NCT02847598|515324762|FG001|Overall Study|Consent withdrawn|0|||
142942145|NCT02847598|515324763|FG002|Overall Study|Consent withdrawn|0|||
142942146|NCT02847598|515324764|FG003|Overall Study|Consent withdrawn|4|||
142942147|NCT02847598|515324765|FG004|Overall Study|Consent withdrawn|3|||
142942148|NCT02847598|515324766|FG005|Overall Study|Consent withdrawn|2|||
142942149|NCT02847598|515324767|FG006|Overall Study|Consent withdrawn|1|||
142942150|NCT02847598|515324768|FG007|Overall Study|Consent withdrawn|3|||
142942151|NCT02847598|515324761|FG000|Overall Study|Death|3|||
142942152|NCT02847598|515324762|FG001|Overall Study|Death|0|||
142942153|NCT02847598|515324763|FG002|Overall Study|Death|0|||
142942154|NCT02847598|515324764|FG003|Overall Study|Death|0|||
142942155|NCT02847598|515324765|FG004|Overall Study|Death|0|||
142942156|NCT02847598|515324766|FG005|Overall Study|Death|0|||
142942157|NCT02847598|515324767|FG006|Overall Study|Death|0|||
142942158|NCT02847598|515324768|FG007|Overall Study|Death|0|||
142942159|NCT02847598|515324761|FG000|Overall Study|Lost to Follow-up|0|||
142942160|NCT02847598|515324762|FG001|Overall Study|Lost to Follow-up|0|||
142942161|NCT02847598|515324763|FG002|Overall Study|Lost to Follow-up|0|||
142942162|NCT02847598|515324764|FG003|Overall Study|Lost to Follow-up|0|||
142942163|NCT02847598|515324765|FG004|Overall Study|Lost to Follow-up|0|||
142942164|NCT02847598|515324766|FG005|Overall Study|Lost to Follow-up|1|||
142942165|NCT02847598|515324767|FG006|Overall Study|Lost to Follow-up|1|||
142942166|NCT02847598|515324768|FG007|Overall Study|Lost to Follow-up|0|||
142942167|NCT02848833|515324769|FG000|Overall Study|subject who are duplicated|1|||
142942168|NCT02848833|515324769|FG000|Overall Study|have not taken the study drug|11|||
142942169|NCT02848833|515324769|FG000|Overall Study|follow-up failure|6|||
142942170|NCT02848833|515324769|FG000|Overall Study|Protocol Violation|119|||
142942171|NCT04980391|515324770|FG000|Overall Study|Death|0|||
142942172|NCT04980391|515324771|FG001|Overall Study|Death|0|||
142942173|NCT04980391|515324772|FG002|Overall Study|Death|1|||
142942174|NCT04980391|515324773|FG003|Overall Study|Death|1|||
142942175|NCT04980391|515324770|FG000|Overall Study|Lost to Follow-up|3|||
142942176|NCT04980391|515324771|FG001|Overall Study|Lost to Follow-up|3|||
142942177|NCT04980391|515324772|FG002|Overall Study|Lost to Follow-up|2|||
142942178|NCT04980391|515324773|FG003|Overall Study|Lost to Follow-up|3|||
142942179|NCT04980391|515324770|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
142942180|NCT04980391|515324771|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
142942181|NCT04980391|515324772|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
142942182|NCT04980391|515324773|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
142942183|NCT04980391|515324770|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
142942184|NCT04980391|515324771|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
142942185|NCT04980391|515324772|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
142942186|NCT04980391|515324773|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
142942187|NCT04980391|515324770|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
142942188|NCT04980391|515324771|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
142942189|NCT04980391|515324772|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
142942190|NCT04980391|515324773|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
142942191|NCT02029976|515326972|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
142942192|NCT02029976|515326973|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
142942193|NCT02029976|515326972|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
142942194|NCT02029976|515326973|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
142942195|NCT02029976|515326972|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
142942196|NCT02029976|515326973|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
142942197|NCT02029976|515326972|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
142942198|NCT02029976|515326973|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
142942199|NCT00075881|515326974|FG000|Overall Study|Lack of Efficacy|18|||
142942200|NCT00075881|515326974|FG000|Overall Study|Adverse Event|7|||
142942201|NCT00075881|515326974|FG000|Overall Study|Death|1|||
142942202|NCT00075881|515326974|FG000|Overall Study|Withdrawal by Subject|2|||
142942203|NCT00075881|515326974|FG000|Overall Study|Protocol Violation|4|||
142942204|NCT00075881|515326974|FG000|Overall Study|other complicating disease|3|||
142942205|NCT00075881|515326974|FG000|Overall Study|other|4|||
142942206|NCT00075881|515326974|FG000|Overall Study|missing data|2|||
142942207|NCT00075881|515326974|FG000|Overall Study|Ineligible|1|||
143454681|NCT00266227|517210690|FG000|Retreatment: Up to Week 48|Death|1|||
143454682|NCT00266227|517210691|FG001|Retreatment: Up to Week 48|Death|0|||
143454683|NCT00266227|517210692|FG002|Retreatment: Up to Week 48|Death|0|||
143454684|NCT00266227|517210690|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
143454685|NCT00266227|517210691|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
143454686|NCT00266227|517210692|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
143454687|NCT00266227|517210690|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
143454688|NCT00266227|517210691|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
143454689|NCT00266227|517210692|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
143454690|NCT00266227|517210690|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
143454691|NCT00266227|517210691|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
143454692|NCT00266227|517210692|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
143454693|NCT00266227|517210690|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
143454694|NCT00266227|517210691|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
143454695|NCT00266227|517210692|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
143454696|NCT00266227|517210690|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
143454697|NCT00266227|517210691|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
143454698|NCT00266227|517210692|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
143454699|NCT00266227|517210690|FG000|Retreatment: Week 48 to Week 72|Death|1|||
143454700|NCT00266227|517210691|FG001|Retreatment: Week 48 to Week 72|Death|1|||
143454701|NCT00266227|517210692|FG002|Retreatment: Week 48 to Week 72|Death|0|||
143454702|NCT00266227|517210690|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
143454703|NCT00266227|517210691|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
143454704|NCT00266227|517210692|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
143454705|NCT00266227|517210690|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
143454706|NCT00266227|517210691|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
143454707|NCT00266227|517210692|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
143454708|NCT00266227|517210690|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
143454709|NCT00266227|517210691|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
143454710|NCT00266227|517210692|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
143454711|NCT00266227|517210690|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
143454712|NCT00266227|517210691|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
143454713|NCT00266227|517210692|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
143454714|NCT03241927|517210693|FG000|Overall Study|study terminated|1|||
143454715|NCT03241927|517210694|FG001|Overall Study|study terminated|0|||
143454716|NCT01198756|517210695|FG000|Overall Study|Adverse Event|0|||
143454717|NCT01198756|517210696|FG001|Overall Study|Adverse Event|0|||
143454718|NCT01198756|517210697|FG002|Overall Study|Adverse Event|0|||
143454719|NCT01198756|517210698|FG003|Overall Study|Adverse Event|1|||
143454720|NCT01198756|517210695|FG000|Overall Study|Protocol Violation|0|||
143454721|NCT01198756|517210696|FG001|Overall Study|Protocol Violation|0|||
143454722|NCT01198756|517210697|FG002|Overall Study|Protocol Violation|0|||
143454723|NCT01198756|517210698|FG003|Overall Study|Protocol Violation|2|||
143454724|NCT01198756|517210695|FG000|Overall Study|Withdrawal by Subject|9|||
143454725|NCT01198756|517210696|FG001|Overall Study|Withdrawal by Subject|4|||
143454726|NCT01198756|517210697|FG002|Overall Study|Withdrawal by Subject|7|||
143454727|NCT01198756|517210698|FG003|Overall Study|Withdrawal by Subject|5|||
143454728|NCT01198756|517210695|FG000|Overall Study|Lost to Follow-up|29|||
143454729|NCT01198756|517210696|FG001|Overall Study|Lost to Follow-up|36|||
143454730|NCT01198756|517210697|FG002|Overall Study|Lost to Follow-up|23|||
143454731|NCT01198756|517210698|FG003|Overall Study|Lost to Follow-up|18|||
143454732|NCT02915302|517210701|FG000|Overall Study|Adverse Event|3|||
143454733|NCT02915302|517210702|FG001|Overall Study|Adverse Event|0|||
143454734|NCT02915302|517210701|FG000|Overall Study|Protocol Violation|20|||
143454735|NCT02915302|517210702|FG001|Overall Study|Protocol Violation|27|||
143454736|NCT02915302|517210701|FG000|Overall Study|Lost to Follow-up|19|||
143454737|NCT02915302|517210702|FG001|Overall Study|Lost to Follow-up|22|||
143454738|NCT02915302|517210701|FG000|Overall Study|Withdrawal by Subject|22|||
143454739|NCT02915302|517210702|FG001|Overall Study|Withdrawal by Subject|29|||
143454740|NCT02915302|517210701|FG000|Overall Study|Other|1|||
143454741|NCT02915302|517210702|FG001|Overall Study|Other|0|||
142942208|NCT00075881|515326974|FG000|Overall Study|never start protocol therapy|1|||
143454742|NCT04343872|517210706|FG000|Overall Study|Lost to Follow-up|6|||
143454743|NCT04343872|517210707|FG001|Overall Study|Lost to Follow-up|3|||
142942209|NCT02224664|515326975|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
142942210|NCT02224664|515326976|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
142942211|NCT02224664|515326977|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
143454744|NCT01850446|517210708|FG000|Overall Study|Lack of Efficacy|1|||
143454745|NCT01850446|517210709|FG001|Overall Study|Lack of Efficacy|0|||
142942212|NCT02224664|515326978|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
142942213|NCT02224664|515326979|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
142942214|NCT02224664|515326975|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
142942215|NCT02224664|515326976|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
142942216|NCT02224664|515326977|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
142942217|NCT02224664|515326978|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
142942218|NCT02224664|515326979|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
142942219|NCT02224664|515326975|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
142942220|NCT02224664|515326976|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
142942221|NCT02224664|515326977|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
142942222|NCT02224664|515326978|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
142942223|NCT02224664|515326979|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
142942224|NCT03019549|515326980|FG000|Washout|DId not meet genotype criteria|11|||
142942225|NCT03019549|515326980|FG000|Period 2|Adverse Event|2|||
142942226|NCT03019549|515326980|FG000|Period 2|Physician Decision|2|||
142942227|NCT03019549|515326980|FG000|Period 2|Withdrawal by Subject|1|||
142942228|NCT01412879|515326983|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
142942229|NCT01412879|515326984|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
142942230|NCT01412879|515326985|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
142942231|NCT01412879|515326983|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
142942232|NCT01412879|515326984|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
142942233|NCT01412879|515326985|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
142942234|NCT01412879|515326983|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
142942235|NCT01412879|515326984|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
142942236|NCT01412879|515326985|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
142942237|NCT01412879|515326983|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
142942238|NCT01412879|515326984|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
142942239|NCT01412879|515326985|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
142942240|NCT01412879|515326983|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
142942241|NCT01412879|515326984|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
142942242|NCT01412879|515326985|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
142942243|NCT03195894|515326986|FG000|Overall Study|"An example is Started other treatment."|4|||
142942244|NCT03195894|515326987|FG001|Overall Study|"An example is Started other treatment."|5|||
142942245|NCT03195894|515326986|FG000|Overall Study|Withdrawal by Subject|15|||
142942246|NCT03195894|515326987|FG001|Overall Study|Withdrawal by Subject|4|||
142942247|NCT03195894|515326986|FG000|Overall Study|Lost to Follow-up|14|||
142942248|NCT03195894|515326987|FG001|Overall Study|Lost to Follow-up|19|||
142942249|NCT02251743|515326991|FG000|Overall Study|Withdrawal by Subject|1|||
142942250|NCT02251743|515326992|FG001|Overall Study|Withdrawal by Subject|1|||
142942251|NCT03124459|515326995|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
142942252|NCT03124459|515326996|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
142942253|NCT03124459|515326997|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
142942254|NCT03124459|515326998|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
142942255|NCT03124459|515326999|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
142942256|NCT03124459|515327000|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
142942257|NCT03124459|515326995|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
142942258|NCT03124459|515326996|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
142942259|NCT03124459|515326997|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
142942260|NCT03124459|515326998|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
142942261|NCT03124459|515326999|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
142942262|NCT03124459|515327000|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
142942263|NCT03124459|515326995|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
142942264|NCT03124459|515326996|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
142942265|NCT03124459|515326997|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
142942266|NCT03124459|515326998|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
142942267|NCT03124459|515326999|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
142942268|NCT03124459|515327000|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
142942269|NCT03124459|515326995|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
142942270|NCT03124459|515326996|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
142942271|NCT03124459|515326997|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
142942272|NCT03124459|515326998|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
142942273|NCT03124459|515326999|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
142942274|NCT03124459|515327000|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
142942275|NCT03124459|515326995|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
142942276|NCT03124459|515326996|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
142942277|NCT03124459|515326997|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
142942278|NCT03124459|515326998|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
142942279|NCT03124459|515326999|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
142942280|NCT03124459|515327000|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
142942281|NCT03124459|515326995|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
142942282|NCT03124459|515326996|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
142942283|NCT03124459|515326997|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
142942284|NCT03124459|515326998|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
142942285|NCT03124459|515326999|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
142942286|NCT03124459|515327000|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
142942287|NCT01028352|515327001|FG000|Overall Study|Ineligible due to baseline average pain|5|||
142942288|NCT01028352|515327001|FG000|Overall Study|Withdrawal by Subject|1|||
142942289|NCT00278629|515327002|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
142942290|NCT05224258|515327003|FG000|Overall Study|Withdrawal by Subject|1|||
142942291|NCT05224258|515327004|FG001|Overall Study|Withdrawal by Subject|1|||
142942292|NCT05224258|515327003|FG000|Overall Study|Physician Decision|1|||
142942293|NCT05224258|515327004|FG001|Overall Study|Physician Decision|1|||
142942294|NCT05224258|515327003|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
142942295|NCT05224258|515327004|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
142942296|NCT05224258|515327003|FG000|Overall Study|Study Product No Longer in Use|1|||
142942297|NCT05224258|515327004|FG001|Overall Study|Study Product No Longer in Use|0|||
142942298|NCT05224258|515327003|FG000|Overall Study|Adverse Event|0|||
142942299|NCT05224258|515327004|FG001|Overall Study|Adverse Event|1|||
142942300|NCT05224258|515327003|FG000|Overall Study|Protocol Deviation|0|||
142942301|NCT05224258|515327004|FG001|Overall Study|Protocol Deviation|1|||
142942302|NCT05067127|515327005|FG000|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
142942303|NCT05067127|515327006|FG001|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|1|||
142942304|NCT05067127|515327007|FG002|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
142942305|NCT05067127|515327008|FG003|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
142942306|NCT05067127|515327005|FG000|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
142942307|NCT05067127|515327006|FG001|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
142942308|NCT05067127|515327007|FG002|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
142942309|NCT05067127|515327008|FG003|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
142942310|NCT05067127|515327005|FG000|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
142942311|NCT05067127|515327006|FG001|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
142942312|NCT05067127|515327007|FG002|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
142942313|NCT05067127|515327008|FG003|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
142942314|NCT05067127|515327005|FG000|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
142942315|NCT05067127|515327006|FG001|Randomized Controlled Period (26 Weeks)|Pregnancy|1|||
142942316|NCT05067127|515327007|FG002|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
142942317|NCT05067127|515327008|FG003|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
142942318|NCT05067127|515327005|FG000|Randomized Controlled Period (26 Weeks)|Death|1|||
142942319|NCT05067127|515327006|FG001|Randomized Controlled Period (26 Weeks)|Death|0|||
142942320|NCT05067127|515327007|FG002|Randomized Controlled Period (26 Weeks)|Death|0|||
142942321|NCT05067127|515327008|FG003|Randomized Controlled Period (26 Weeks)|Death|0|||
142942322|NCT05067127|515327005|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
142942323|NCT05067127|515327006|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
142942324|NCT05067127|515327007|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
142942325|NCT05067127|515327008|FG003|Open-Label Period (26 Weeks)|Withdrawal by Subject|1|||
142942326|NCT05067127|515327005|FG000|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
142942327|NCT05067127|515327006|FG001|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
142942328|NCT05067127|515327007|FG002|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|2|||
142942329|NCT05067127|515327008|FG003|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
142942330|NCT04462536|515327009|FG000|Overall Study|Withdrawal by Subject|3|||
142942331|NCT04462536|515327010|FG001|Overall Study|Withdrawal by Subject|9|||
142942332|NCT04462536|515327009|FG000|Overall Study|Lost to Follow-up|2|||
142942333|NCT04462536|515327010|FG001|Overall Study|Lost to Follow-up|4|||
142942334|NCT00824564|515327015|FG000|Overall Study|Lost to Follow-up|5|||
142942335|NCT00824564|515327016|FG001|Overall Study|Lost to Follow-up|7|||
142942336|NCT00824564|515327015|FG000|Overall Study|Withdrawal by Subject|1|||
142942337|NCT00824564|515327016|FG001|Overall Study|Withdrawal by Subject|1|||
142942338|NCT00824564|515327015|FG000|Overall Study|Other|1|||
142942339|NCT00824564|515327016|FG001|Overall Study|Other|2|||
142942340|NCT00824564|515327015|FG000|Overall Study|Randomized, but not treated|1|||
142942341|NCT00824564|515327016|FG001|Overall Study|Randomized, but not treated|0|||
142942342|NCT04125680|515327023|FG000|Overall Study|Lost to Follow-up|15|||
142942343|NCT04938648|515327024|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
142942344|NCT04938648|515327025|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
142942345|NCT04938648|515327024|FG000|Overall Study|Patient too ill|0|||
143117112|NCT02470403|515970029|FG004|Overall Study|Subject/guardian decision|0|||
142942346|NCT04938648|515327025|FG001|Overall Study|Patient too ill|1|||
142942347|NCT04938648|515327024|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
142942348|NCT04938648|515327025|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
142942349|NCT04938648|515327024|FG000|Overall Study|Patient did not have memory problems|1|||
142942350|NCT04938648|515327025|FG001|Overall Study|Patient did not have memory problems|1|||
142942351|NCT04938648|515327024|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
142942352|NCT04938648|515327025|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
142942353|NCT04938648|515327024|FG000|Overall Study|Care partner could not be reached|0|||
142942354|NCT04938648|515327025|FG001|Overall Study|Care partner could not be reached|1|||
142942355|NCT04938648|515327024|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
142942356|NCT04938648|515327025|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
142942357|NCT04938648|515327024|FG000|Overall Study|Withdrawal by Subject|2|||
142942358|NCT04938648|515327025|FG001|Overall Study|Withdrawal by Subject|1|||
142942359|NCT01287754|515327028|FG000|Overall Study|Death|2|||
142942360|NCT01287754|515327029|FG001|Overall Study|Death|12|||
142942361|NCT01287754|515327028|FG000|Overall Study|Lost to Follow-up|1|||
142942362|NCT01287754|515327029|FG001|Overall Study|Lost to Follow-up|6|||
142942363|NCT01287754|515327028|FG000|Overall Study|Protocol Violation|0|||
142942364|NCT01287754|515327029|FG001|Overall Study|Protocol Violation|3|||
142942365|NCT02601950|515327040|FG000|Overall Study|Participant enrolled in rollover study|0|||
142942366|NCT02601950|515327041|FG001|Overall Study|Participant enrolled in rollover study|0|||
142942367|NCT02601950|515327042|FG002|Overall Study|Participant enrolled in rollover study|1|||
142942368|NCT02601950|515327043|FG003|Overall Study|Participant enrolled in rollover study|0|||
142942369|NCT02601950|515327044|FG004|Overall Study|Participant enrolled in rollover study|1|||
142942370|NCT02601950|515327045|FG005|Overall Study|Participant enrolled in rollover study|1|||
142942371|NCT02601950|515327046|FG006|Overall Study|Participant enrolled in rollover study|1|||
142942372|NCT02601950|515327047|FG007|Overall Study|Participant enrolled in rollover study|0|||
142942373|NCT02601950|515327040|FG000|Overall Study|Disease progression - radiological|21|||
142942374|NCT02601950|515327041|FG001|Overall Study|Disease progression - radiological|26|||
142942375|NCT02601950|515327042|FG002|Overall Study|Disease progression - radiological|22|||
142942376|NCT02601950|515327043|FG003|Overall Study|Disease progression - radiological|11|||
142942377|NCT02601950|515327044|FG004|Overall Study|Disease progression - radiological|46|||
142942378|NCT02601950|515327045|FG005|Overall Study|Disease progression - radiological|52|||
142942379|NCT02601950|515327046|FG006|Overall Study|Disease progression - radiological|7|||
142942380|NCT02601950|515327047|FG007|Overall Study|Disease progression - radiological|5|||
142942381|NCT02601950|515327040|FG000|Overall Study|Disease progression - clinical|3|||
142942382|NCT02601950|515327041|FG001|Overall Study|Disease progression - clinical|5|||
142942383|NCT02601950|515327042|FG002|Overall Study|Disease progression - clinical|4|||
142942384|NCT02601950|515327043|FG003|Overall Study|Disease progression - clinical|2|||
142942385|NCT02601950|515327044|FG004|Overall Study|Disease progression - clinical|6|||
142942386|NCT02601950|515327045|FG005|Overall Study|Disease progression - clinical|6|||
142942387|NCT02601950|515327046|FG006|Overall Study|Disease progression - clinical|5|||
142942388|NCT02601950|515327047|FG007|Overall Study|Disease progression - clinical|1|||
142942389|NCT02601950|515327040|FG000|Overall Study|Death|6|||
142942390|NCT02601950|515327041|FG001|Overall Study|Death|0|||
142942391|NCT02601950|515327042|FG002|Overall Study|Death|3|||
142942392|NCT02601950|515327043|FG003|Overall Study|Death|1|||
142942393|NCT02601950|515327044|FG004|Overall Study|Death|4|||
142942394|NCT02601950|515327045|FG005|Overall Study|Death|1|||
142942395|NCT02601950|515327046|FG006|Overall Study|Death|0|||
142942396|NCT02601950|515327047|FG007|Overall Study|Death|0|||
142942397|NCT02601950|515327040|FG000|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
142942398|NCT02601950|515327041|FG001|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
142942399|NCT02601950|515327042|FG002|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
142942400|NCT02601950|515327043|FG003|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
142942401|NCT02601950|515327044|FG004|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
142942402|NCT02601950|515327045|FG005|Overall Study|Unacceptable toxicity (related to study treatment)|1|||
142942403|NCT02601950|515327046|FG006|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
142942404|NCT02601950|515327047|FG007|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
142942405|NCT02601950|515327040|FG000|Overall Study|Adverse event (not related to study treatment)|1|||
142942406|NCT02601950|515327041|FG001|Overall Study|Adverse event (not related to study treatment)|0|||
142942407|NCT02601950|515327042|FG002|Overall Study|Adverse event (not related to study treatment)|0|||
142942408|NCT02601950|515327043|FG003|Overall Study|Adverse event (not related to study treatment)|0|||
142942409|NCT02601950|515327044|FG004|Overall Study|Adverse event (not related to study treatment)|0|||
142942410|NCT02601950|515327045|FG005|Overall Study|Adverse event (not related to study treatment)|2|||
142942411|NCT02601950|515327046|FG006|Overall Study|Adverse event (not related to study treatment)|0|||
142942412|NCT02601950|515327047|FG007|Overall Study|Adverse event (not related to study treatment)|0|||
142942413|NCT02601950|515327040|FG000|Overall Study|Non-compliance|0|||
143454746|NCT01850446|517210708|FG000|Overall Study|Withdrawal by Subject|4|||
142942414|NCT02601950|515327041|FG001|Overall Study|Non-compliance|1|||
142942415|NCT02601950|515327042|FG002|Overall Study|Non-compliance|0|||
142942416|NCT02601950|515327043|FG003|Overall Study|Non-compliance|0|||
142942417|NCT02601950|515327044|FG004|Overall Study|Non-compliance|0|||
142942418|NCT02601950|515327045|FG005|Overall Study|Non-compliance|1|||
142942419|NCT02601950|515327046|FG006|Overall Study|Non-compliance|1|||
142942420|NCT02601950|515327047|FG007|Overall Study|Non-compliance|0|||
142942421|NCT02601950|515327040|FG000|Overall Study|Participant refused further study treatment|0|||
142942422|NCT02601950|515327041|FG001|Overall Study|Participant refused further study treatment|1|||
142942423|NCT02601950|515327042|FG002|Overall Study|Participant refused further study treatment|1|||
142942424|NCT02601950|515327043|FG003|Overall Study|Participant refused further study treatment|0|||
142942425|NCT02601950|515327044|FG004|Overall Study|Participant refused further study treatment|2|||
142942426|NCT02601950|515327045|FG005|Overall Study|Participant refused further study treatment|2|||
142942427|NCT02601950|515327046|FG006|Overall Study|Participant refused further study treatment|2|||
142942428|NCT02601950|515327047|FG007|Overall Study|Participant refused further study treatment|1|||
142942429|NCT02601950|515327040|FG000|Overall Study|Investigator discretion|1|||
142942430|NCT02601950|515327041|FG001|Overall Study|Investigator discretion|0|||
142942431|NCT02601950|515327042|FG002|Overall Study|Investigator discretion|1|||
142942432|NCT02601950|515327043|FG003|Overall Study|Investigator discretion|0|||
142942433|NCT02601950|515327044|FG004|Overall Study|Investigator discretion|1|||
142942434|NCT02601950|515327045|FG005|Overall Study|Investigator discretion|1|||
142942435|NCT02601950|515327046|FG006|Overall Study|Investigator discretion|1|||
142942436|NCT02601950|515327047|FG007|Overall Study|Investigator discretion|0|||
142942437|NCT02601950|515327040|FG000|Overall Study|Other|0|||
142942438|NCT02601950|515327041|FG001|Overall Study|Other|0|||
142942439|NCT02601950|515327042|FG002|Overall Study|Other|0|||
142942440|NCT02601950|515327043|FG003|Overall Study|Other|0|||
142942441|NCT02601950|515327044|FG004|Overall Study|Other|2|||
142942442|NCT02601950|515327045|FG005|Overall Study|Other|2|||
142942443|NCT02601950|515327046|FG006|Overall Study|Other|1|||
142942444|NCT02601950|515327047|FG007|Overall Study|Other|0|||
142942445|NCT05817045|515327052|FG000|Overall Study|Protocol Violation|0|||
142942446|NCT05817045|515327053|FG001|Overall Study|Protocol Violation|3|||
142942447|NCT05817045|515327052|FG000|Overall Study|Withdrawal by Subject|10|||
142942448|NCT05817045|515327053|FG001|Overall Study|Withdrawal by Subject|7|||
142942449|NCT05817045|515327052|FG000|Overall Study|Physician Decision|3|||
142942450|NCT05817045|515327053|FG001|Overall Study|Physician Decision|0|||
142942451|NCT05817045|515327052|FG000|Overall Study|Lost to Follow-up|0|||
142942452|NCT05817045|515327053|FG001|Overall Study|Lost to Follow-up|1|||
142942453|NCT05817045|515327052|FG000|Overall Study|Device Deficiency|1|||
142942454|NCT05817045|515327053|FG001|Overall Study|Device Deficiency|0|||
142942455|NCT05817045|515327052|FG000|Overall Study|System Error|1|||
142942456|NCT05817045|515327053|FG001|Overall Study|System Error|0|||
142942457|NCT02542267|515327057|FG000|Overall Study|Withdrawal by Subject|10|||
142942458|NCT02542267|515327057|FG000|Overall Study|Physician Decision|6|||
142942459|NCT02542267|515327057|FG000|Overall Study|Lost to Follow-up|4|||
142942460|NCT02542267|515327057|FG000|Overall Study|Death|13|||
142942461|NCT02542267|515327057|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
142942462|NCT02542267|515327057|FG000|Overall Study|Other|9|||
142942463|NCT03049449|515327058|FG000|Overall Study|Did not receive treatment.|0|||
142942464|NCT03049449|515327059|FG001|Overall Study|Did not receive treatment.|0|||
142942465|NCT03049449|515327060|FG002|Overall Study|Did not receive treatment.|0|||
142942466|NCT03049449|515327061|FG003|Overall Study|Did not receive treatment.|0|||
142942467|NCT03049449|515327062|FG004|Overall Study|Did not receive treatment.|0|||
142942468|NCT03049449|515327063|FG005|Overall Study|Did not receive treatment.|0|||
143454747|NCT01850446|517210709|FG001|Overall Study|Withdrawal by Subject|0|||
143454748|NCT01850446|517210708|FG000|Overall Study|Protocol Violation|0|||
143454749|NCT01850446|517210709|FG001|Overall Study|Protocol Violation|2|||
143454750|NCT01290315|517210710|FG000|Overall Study|Adverse Event|0|||
142942469|NCT03049449|515327064|FG006|Overall Study|Did not receive treatment.|0|||
142942470|NCT03049449|515327065|FG007|Overall Study|Did not receive treatment.|0|||
142942471|NCT03049449|515327066|FG008|Overall Study|Did not receive treatment.|1|||
142942472|NCT03049449|515327067|FG009|Overall Study|Did not receive treatment.|0|||
142942473|NCT03049449|515327058|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
142942474|NCT03049449|515327059|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
143454751|NCT01290315|517210711|FG001|Overall Study|Adverse Event|0|||
143454752|NCT01290315|517210712|FG002|Overall Study|Adverse Event|0|||
142942475|NCT03049449|515327060|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
142942476|NCT03049449|515327061|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
142942477|NCT03049449|515327062|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
142942478|NCT03049449|515327063|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
142942479|NCT03049449|515327064|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
142942480|NCT03049449|515327065|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
142942481|NCT03049449|515327066|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
143003053|NCT01049360|515548745|FG001|Period 1|Adverse Event|1|||
142942482|NCT03049449|515327067|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
142942483|NCT03049449|515327058|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
142942484|NCT03049449|515327059|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
142942485|NCT03049449|515327060|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
142942486|NCT03049449|515327061|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
142942487|NCT03049449|515327062|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
142942488|NCT03049449|515327063|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
142942489|NCT03049449|515327064|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
142942490|NCT03049449|515327065|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
142942491|NCT03049449|515327066|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
142942492|NCT03049449|515327067|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
142942493|NCT00442598|515327068|FG000|Overall Study|Adverse Event|1|||
142942494|NCT00442598|515327069|FG001|Overall Study|Adverse Event|0|||
142942495|NCT00442598|515327070|FG002|Overall Study|Adverse Event|0|||
142942496|NCT00442598|515327068|FG000|Overall Study|Tumor progression|3|||
142942497|NCT00442598|515327069|FG001|Overall Study|Tumor progression|4|||
142942498|NCT00442598|515327070|FG002|Overall Study|Tumor progression|0|||
142942499|NCT00442598|515327068|FG000|Overall Study|Clinical deterioration|1|||
142942500|NCT00442598|515327069|FG001|Overall Study|Clinical deterioration|2|||
142942501|NCT00442598|515327070|FG002|Overall Study|Clinical deterioration|0|||
142942502|NCT00442598|515327068|FG000|Overall Study|CA125 progression|0|||
142942503|NCT00442598|515327069|FG001|Overall Study|CA125 progression|1|||
142942504|NCT00442598|515327070|FG002|Overall Study|CA125 progression|0|||
143454753|NCT01290315|517210713|FG003|Overall Study|Adverse Event|3|||
143454754|NCT01290315|517210710|FG000|Overall Study|Selection criteria/compliance|2|||
143454755|NCT01290315|517210711|FG001|Overall Study|Selection criteria/compliance|1|||
143454756|NCT01290315|517210712|FG002|Overall Study|Selection criteria/compliance|0|||
143454757|NCT01290315|517210713|FG003|Overall Study|Selection criteria/compliance|2|||
143454758|NCT01290315|517210710|FG000|Overall Study|Lost to Follow-up|0|||
143454759|NCT01290315|517210711|FG001|Overall Study|Lost to Follow-up|1|||
143454760|NCT01290315|517210712|FG002|Overall Study|Lost to Follow-up|0|||
143454761|NCT01290315|517210713|FG003|Overall Study|Lost to Follow-up|0|||
143454762|NCT01290315|517210710|FG000|Overall Study|Withdrawal by Subject|1|||
143454763|NCT01290315|517210711|FG001|Overall Study|Withdrawal by Subject|1|||
143454764|NCT01290315|517210712|FG002|Overall Study|Withdrawal by Subject|0|||
143454765|NCT01290315|517210713|FG003|Overall Study|Withdrawal by Subject|0|||
143454766|NCT00591721|517210714|FG000|Overall Study|Withdrawal by Subject|10|||
143454767|NCT00591721|517210715|FG001|Overall Study|Withdrawal by Subject|10|||
143454768|NCT00591721|517210714|FG000|Overall Study|Lost to Follow-up|1|||
143454769|NCT00591721|517210715|FG001|Overall Study|Lost to Follow-up|4|||
143454770|NCT00591721|517210714|FG000|Overall Study|Intervention not received|10|||
143454771|NCT00591721|517210715|FG001|Overall Study|Intervention not received|8|||
143454772|NCT03725085|517210716|FG000|Overall Study|Lost to Follow-up|2|||
143454773|NCT02704754|517210717|FG000|Overall Study|Lost to Follow-up|1|||
143454774|NCT02704754|517210718|FG001|Overall Study|Lost to Follow-up|1|||
143454775|NCT02704754|517210717|FG000|Overall Study|Lack of Efficacy|1|||
143454776|NCT02704754|517210718|FG001|Overall Study|Lack of Efficacy|0|||
143454777|NCT02704754|517210717|FG000|Overall Study|Withdrawal by Subject|1|||
143454778|NCT02704754|517210718|FG001|Overall Study|Withdrawal by Subject|0|||
142942505|NCT00442598|515327068|FG000|Overall Study|Reduced creatinine clearance|1|||
142942506|NCT00442598|515327069|FG001|Overall Study|Reduced creatinine clearance|0|||
142942507|NCT00442598|515327070|FG002|Overall Study|Reduced creatinine clearance|0|||
142942508|NCT00442598|515327068|FG000|Overall Study|Death|0|||
142942509|NCT00442598|515327069|FG001|Overall Study|Death|1|||
142942510|NCT00442598|515327070|FG002|Overall Study|Death|0|||
142942511|NCT01147926|515327071|FG000|Overall Study|Subject Withdrew Consent|9|||
142942512|NCT01147926|515327072|FG001|Overall Study|Subject Withdrew Consent|10|||
142942513|NCT01147926|515327071|FG000|Overall Study|Adverse Event|7|||
142942514|NCT01147926|515327072|FG001|Overall Study|Adverse Event|6|||
142942515|NCT01147926|515327071|FG000|Overall Study|Subject Non-Compliant|5|||
142942516|NCT01147926|515327072|FG001|Overall Study|Subject Non-Compliant|4|||
142942517|NCT01147926|515327071|FG000|Overall Study|Principal investigator left hospital|1|||
142942518|NCT01147926|515327072|FG001|Overall Study|Principal investigator left hospital|3|||
142942519|NCT01147926|515327071|FG000|Overall Study|Selection criteria not met|3|||
143454779|NCT00423943|517210719|FG000|Overall Study|Withdrawal by Subject|3|||
143454780|NCT00423943|517210720|FG001|Overall Study|Withdrawal by Subject|1|||
143454781|NCT02134977|517210721|FG000|Overall Study|Protocol Deviation|102|||
143454782|NCT02383056|517210730|FG000|Overall Study|Adverse Event|1|||
143454783|NCT02383056|517210731|FG001|Overall Study|Adverse Event|0|||
143454784|NCT02383056|517210730|FG000|Overall Study|Lost to Follow-up|0|||
142942520|NCT01147926|515327072|FG001|Overall Study|Selection criteria not met|1|||
142942521|NCT01147926|515327071|FG000|Overall Study|Lost to Follow-up|0|||
142942522|NCT01147926|515327072|FG001|Overall Study|Lost to Follow-up|2|||
142942523|NCT01147926|515327071|FG000|Overall Study|Sponsor's Decision|0|||
142942524|NCT01147926|515327072|FG001|Overall Study|Sponsor's Decision|1|||
142942525|NCT01147926|515327071|FG000|Overall Study|Lack of Efficacy|1|||
142942526|NCT01147926|515327072|FG001|Overall Study|Lack of Efficacy|0|||
142942527|NCT01147926|515327071|FG000|Overall Study|Too busy, no time for study|1|||
142942528|NCT01147926|515327072|FG001|Overall Study|Too busy, no time for study|0|||
142942529|NCT01147926|515327071|FG000|Overall Study|Went on holiday|0|||
142942530|NCT01147926|515327072|FG001|Overall Study|Went on holiday|1|||
142942531|NCT01147926|515327071|FG000|Overall Study|Colonoscopy result|0|||
142942532|NCT01147926|515327072|FG001|Overall Study|Colonoscopy result|1|||
142942533|NCT00607048|515327073|FG000|Overall Study|Adverse Event|0|||
142942534|NCT00607048|515327074|FG001|Overall Study|Adverse Event|1|||
142942535|NCT00607048|515327075|FG002|Overall Study|Adverse Event|0|||
142942536|NCT00607048|515327076|FG003|Overall Study|Adverse Event|0|||
142942537|NCT00607048|515327077|FG004|Overall Study|Adverse Event|4|||
142942538|NCT00607048|515327078|FG005|Overall Study|Adverse Event|0|||
142942539|NCT00607048|515327073|FG000|Overall Study|Global deterioration of health|1|||
142942540|NCT00607048|515327074|FG001|Overall Study|Global deterioration of health|0|||
142942541|NCT00607048|515327075|FG002|Overall Study|Global deterioration of health|0|||
142942542|NCT00607048|515327076|FG003|Overall Study|Global deterioration of health|0|||
142942543|NCT00607048|515327077|FG004|Overall Study|Global deterioration of health|0|||
142942544|NCT00607048|515327078|FG005|Overall Study|Global deterioration of health|0|||
142942545|NCT00607048|515327073|FG000|Overall Study|Objective disease progression - relapse|1|||
142942546|NCT00607048|515327074|FG001|Overall Study|Objective disease progression - relapse|2|||
142942547|NCT00607048|515327075|FG002|Overall Study|Objective disease progression - relapse|4|||
142942548|NCT00607048|515327076|FG003|Overall Study|Objective disease progression - relapse|2|||
142942549|NCT00607048|515327077|FG004|Overall Study|Objective disease progression - relapse|2|||
142942550|NCT00607048|515327078|FG005|Overall Study|Objective disease progression - relapse|2|||
142942551|NCT00607048|515327073|FG000|Overall Study|Withdrawal by Subject|0|||
142942552|NCT00607048|515327074|FG001|Overall Study|Withdrawal by Subject|0|||
142942553|NCT00607048|515327075|FG002|Overall Study|Withdrawal by Subject|0|||
142942554|NCT00607048|515327076|FG003|Overall Study|Withdrawal by Subject|1|||
142942555|NCT00607048|515327077|FG004|Overall Study|Withdrawal by Subject|0|||
142942556|NCT00607048|515327078|FG005|Overall Study|Withdrawal by Subject|2|||
142942557|NCT00607048|515327073|FG000|Overall Study|Other|1|||
142942558|NCT00607048|515327074|FG001|Overall Study|Other|1|||
142942559|NCT00607048|515327075|FG002|Overall Study|Other|0|||
142942560|NCT00607048|515327076|FG003|Overall Study|Other|0|||
142942561|NCT00607048|515327077|FG004|Overall Study|Other|0|||
142942562|NCT00607048|515327078|FG005|Overall Study|Other|1|||
142942563|NCT00316264|515327079|FG000|Overall Study|Lost to Follow-up|0|||
142942564|NCT00316264|515327080|FG001|Overall Study|Lost to Follow-up|1|||
142942565|NCT00316264|515327081|FG002|Overall Study|Lost to Follow-up|0|||
142942566|NCT00316264|515327079|FG000|Overall Study|Withdrawal of Consent|3|||
142942567|NCT00316264|515327080|FG001|Overall Study|Withdrawal of Consent|5|||
142942568|NCT00316264|515327081|FG002|Overall Study|Withdrawal of Consent|6|||
142942569|NCT00316264|515327079|FG000|Overall Study|Death|2|||
142942570|NCT00316264|515327080|FG001|Overall Study|Death|0|||
142942571|NCT00316264|515327081|FG002|Overall Study|Death|0|||
142942572|NCT00316264|515327079|FG000|Overall Study|Other|1|||
142942573|NCT00316264|515327080|FG001|Overall Study|Other|1|||
142942574|NCT00316264|515327081|FG002|Overall Study|Other|0|||
142942575|NCT03926143|515327083|FG000|Overall Study|Physician Decision|3|||
142942576|NCT03926143|515327083|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
142942577|NCT03926143|515327083|FG000|Overall Study|Adverse Event|2|||
142942578|NCT03926143|515327083|FG000|Overall Study|Progressive disease|3|||
142942579|NCT02207907|515327091|FG000|Overall Study|Lost to Follow-up|3|||
142942580|NCT02207907|515327092|FG001|Overall Study|Lost to Follow-up|1|||
142942581|NCT02207907|515327091|FG000|Overall Study|Withdrawal by Subject|5|||
142942582|NCT02207907|515327092|FG001|Overall Study|Withdrawal by Subject|6|||
142942583|NCT02207907|515327091|FG000|Overall Study|Did not meet study criteria|3|||
142942584|NCT02207907|515327092|FG001|Overall Study|Did not meet study criteria|0|||
142942585|NCT02207907|515327091|FG000|Overall Study|Pregnancy|0|||
142942586|NCT02207907|515327092|FG001|Overall Study|Pregnancy|1|||
142942587|NCT00158184|515327093|FG000|Overall Study|personal issues|3|||
142942588|NCT00158184|515327094|FG001|Overall Study|personal issues|1|||
142942589|NCT00158184|515327093|FG000|Overall Study|failed for follow unit/study rules|2|||
142942590|NCT00158184|515327094|FG001|Overall Study|failed for follow unit/study rules|0|||
142942591|NCT00158184|515327093|FG000|Overall Study|Adverse Event|1|||
142942592|NCT00158184|515327094|FG001|Overall Study|Adverse Event|1|||
142942593|NCT02620020|515327105|FG000|Overall Study|Adverse Event|8|||
142942594|NCT02620020|515327106|FG001|Overall Study|Adverse Event|4|||
142942595|NCT02620020|515327107|FG002|Overall Study|Adverse Event|3|||
142942596|NCT02620020|515327108|FG003|Overall Study|Adverse Event|5|||
142942597|NCT02620020|515327105|FG000|Overall Study|Lost to Follow-up|4|||
142942598|NCT02620020|515327106|FG001|Overall Study|Lost to Follow-up|8|||
142942599|NCT02620020|515327107|FG002|Overall Study|Lost to Follow-up|1|||
142942600|NCT02620020|515327108|FG003|Overall Study|Lost to Follow-up|4|||
142942601|NCT02620020|515327105|FG000|Overall Study|Physician Decision|7|||
142942602|NCT02620020|515327106|FG001|Overall Study|Physician Decision|4|||
142942603|NCT02620020|515327107|FG002|Overall Study|Physician Decision|3|||
142942604|NCT02620020|515327108|FG003|Overall Study|Physician Decision|4|||
142942605|NCT02620020|515327105|FG000|Overall Study|Protocol Violation|5|||
142942606|NCT02620020|515327106|FG001|Overall Study|Protocol Violation|2|||
142942607|NCT02620020|515327107|FG002|Overall Study|Protocol Violation|1|||
142942608|NCT02620020|515327108|FG003|Overall Study|Protocol Violation|1|||
142942609|NCT02620020|515327105|FG000|Overall Study|Withdrawal by Subject|20|||
142942610|NCT02620020|515327106|FG001|Overall Study|Withdrawal by Subject|16|||
142942611|NCT02620020|515327107|FG002|Overall Study|Withdrawal by Subject|17|||
142942612|NCT02620020|515327108|FG003|Overall Study|Withdrawal by Subject|12|||
142942613|NCT02620020|515327105|FG000|Overall Study|Death|0|||
142942614|NCT02620020|515327106|FG001|Overall Study|Death|1|||
142942615|NCT02620020|515327107|FG002|Overall Study|Death|0|||
142942616|NCT02620020|515327108|FG003|Overall Study|Death|0|||
142942617|NCT02393209|515327111|FG000|Overall Study|Study Terminated by Sponsor|1|||
142942618|NCT02393209|515327112|FG001|Overall Study|Study Terminated by Sponsor|1|||
142942619|NCT02393209|515327113|FG002|Overall Study|Study Terminated by Sponsor|0|||
142942620|NCT02393209|515327114|FG003|Overall Study|Study Terminated by Sponsor|0|||
142942621|NCT02393209|515327111|FG000|Overall Study|Withdrawal by Patient|1|||
142942622|NCT02393209|515327112|FG001|Overall Study|Withdrawal by Patient|0|||
142942623|NCT02393209|515327113|FG002|Overall Study|Withdrawal by Patient|0|||
142942624|NCT02393209|515327114|FG003|Overall Study|Withdrawal by Patient|0|||
142942625|NCT02393209|515327111|FG000|Overall Study|Death|2|||
142942626|NCT02393209|515327112|FG001|Overall Study|Death|2|||
142942627|NCT02393209|515327113|FG002|Overall Study|Death|0|||
142942628|NCT02393209|515327114|FG003|Overall Study|Death|0|||
142942629|NCT02393209|515327111|FG000|Overall Study|Death due to Disease Progression|2|||
142942630|NCT02393209|515327112|FG001|Overall Study|Death due to Disease Progression|2|||
142942631|NCT02393209|515327113|FG002|Overall Study|Death due to Disease Progression|0|||
142942632|NCT02393209|515327114|FG003|Overall Study|Death due to Disease Progression|0|||
142942633|NCT02393209|515327111|FG000|Overall Study|Death from Legionella Infection|0|||
142942634|NCT02393209|515327112|FG001|Overall Study|Death from Legionella Infection|1|||
142942635|NCT02393209|515327113|FG002|Overall Study|Death from Legionella Infection|0|||
142942636|NCT02393209|515327114|FG003|Overall Study|Death from Legionella Infection|0|||
142942637|NCT02393209|515327111|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
142942638|NCT02393209|515327112|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
142942639|NCT02393209|515327113|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
142942640|NCT02393209|515327114|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
142942641|NCT02393209|515327111|FG000|Overall Study|Lost to Follow-up|0|||
142942642|NCT02393209|515327112|FG001|Overall Study|Lost to Follow-up|1|||
142942643|NCT02393209|515327113|FG002|Overall Study|Lost to Follow-up|0|||
142942644|NCT02393209|515327114|FG003|Overall Study|Lost to Follow-up|0|||
142942645|NCT02537678|515327115|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
142942646|NCT02537678|515327116|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
142942647|NCT02537678|515327115|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
142942648|NCT02537678|515327116|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
142942649|NCT02537678|515327115|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
142942650|NCT02537678|515327116|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
142942651|NCT02537678|515327115|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
142942652|NCT02537678|515327116|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
142942653|NCT02537678|515327115|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
142942654|NCT02537678|515327116|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
142942655|NCT02537678|515327115|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
142942656|NCT02537678|515327116|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
142942657|NCT02537678|515327115|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
142942658|NCT02537678|515327116|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
142942659|NCT00629083|515327117|FG000|Overall Study|Adverse Event|0|||
142942660|NCT00629083|515327118|FG001|Overall Study|Adverse Event|2|||
142942661|NCT00629083|515327117|FG000|Overall Study|Lack of Efficacy|3|||
142942662|NCT00629083|515327118|FG001|Overall Study|Lack of Efficacy|1|||
142942663|NCT00629083|515327117|FG000|Overall Study|Withdrawal by Subject|10|||
142942664|NCT00629083|515327118|FG001|Overall Study|Withdrawal by Subject|2|||
142942665|NCT00629083|515327117|FG000|Overall Study|Lost to Follow-up|12|||
142942666|NCT00629083|515327118|FG001|Overall Study|Lost to Follow-up|8|||
142942667|NCT00629083|515327117|FG000|Overall Study|Moved out of country/state|2|||
142942668|NCT00629083|515327118|FG001|Overall Study|Moved out of country/state|1|||
142942669|NCT00629083|515327117|FG000|Overall Study|Refused to return for 12 month visit|1|||
142942670|NCT00629083|515327118|FG001|Overall Study|Refused to return for 12 month visit|0|||
142942671|NCT01478958|515327119|FG000|Overall Study|Withdrawal by Subject|1|||
142942672|NCT01478958|515327120|FG001|Overall Study|Withdrawal by Subject|1|||
142942673|NCT01478958|515327121|FG002|Overall Study|Withdrawal by Subject|1|||
142942674|NCT01478958|515327119|FG000|Overall Study|Weight loss|1|||
142942675|NCT01478958|515327120|FG001|Overall Study|Weight loss|0|||
142942676|NCT01478958|515327121|FG002|Overall Study|Weight loss|0|||
142942677|NCT01478958|515327119|FG000|Overall Study|Re-located|0|||
142942678|NCT01478958|515327120|FG001|Overall Study|Re-located|1|||
142942679|NCT01478958|515327121|FG002|Overall Study|Re-located|0|||
142942680|NCT01478958|515327119|FG000|Overall Study|Unable to comply|0|||
142942681|NCT01478958|515327120|FG001|Overall Study|Unable to comply|0|||
142942682|NCT01478958|515327121|FG002|Overall Study|Unable to comply|2|||
142942683|NCT03401749|515327122|FG000|Overall Study|Lost to Follow-up|20|||
142942684|NCT03401749|515327123|FG001|Overall Study|Lost to Follow-up|16|||
142942685|NCT03401749|515327124|FG002|Overall Study|Lost to Follow-up|26|||
142942686|NCT04052139|515327125|FG000|Overall Study|Lost to Follow-up|2|||
142942687|NCT04052139|515327126|FG001|Overall Study|Lost to Follow-up|0|||
142942688|NCT04052139|515327127|FG002|Overall Study|Lost to Follow-up|0|||
142942689|NCT04052139|515327125|FG000|Overall Study|Withdrawal by Subject|1|||
142942690|NCT04052139|515327126|FG001|Overall Study|Withdrawal by Subject|0|||
142942691|NCT04052139|515327127|FG002|Overall Study|Withdrawal by Subject|0|||
142942692|NCT00707577|515327128|FG000|Overall Study|Withdrawal by Subject|3|||
142942693|NCT00707577|515327129|FG001|Overall Study|Withdrawal by Subject|2|||
142942694|NCT00707577|515327128|FG000|Overall Study|Lost to Follow-up|34|||
142942695|NCT00707577|515327129|FG001|Overall Study|Lost to Follow-up|25|||
142942696|NCT00707577|515327128|FG000|Overall Study|Left employment|13|||
142942697|NCT00707577|515327129|FG001|Overall Study|Left employment|10|||
142942698|NCT00707577|515327128|FG000|Overall Study|Pregnancy|4|||
142942699|NCT00707577|515327129|FG001|Overall Study|Pregnancy|1|||
142942700|NCT00327444|515327130|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
142942701|NCT00327444|515327131|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
142942702|NCT00327444|515327130|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
142942703|NCT00327444|515327131|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
142942704|NCT00327444|515327130|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
142942705|NCT00327444|515327131|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
142942706|NCT00327444|515327130|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
142942707|NCT00327444|515327131|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
142942708|NCT00327444|515327130|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
142942709|NCT00327444|515327131|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
142942710|NCT00327444|515327130|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
142942711|NCT00327444|515327131|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
142942712|NCT00327444|515327130|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
142942713|NCT00327444|515327131|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
142942714|NCT00327444|515327130|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
142942715|NCT00327444|515327131|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
142942716|NCT00481065|515327133|FG000|Overall Study|Adverse event or death|1|||
142942717|NCT00481065|515327134|FG001|Overall Study|Adverse event or death|1|||
142942718|NCT00481065|515327135|FG002|Overall Study|Adverse event or death|3|||
142942719|NCT00481065|515327136|FG003|Overall Study|Adverse event or death|0|||
142942720|NCT00481065|515327137|FG004|Overall Study|Adverse event or death|2|||
142942721|NCT00481065|515327138|FG005|Overall Study|Adverse event or death|0|||
142942722|NCT00481065|515327139|FG006|Overall Study|Adverse event or death|1|||
142942723|NCT00481065|515327140|FG007|Overall Study|Adverse event or death|1|||
142942724|NCT00481065|515327133|FG000|Overall Study|Withdrawal by Subject|11|||
142942725|NCT00481065|515327134|FG001|Overall Study|Withdrawal by Subject|12|||
142942726|NCT00481065|515327135|FG002|Overall Study|Withdrawal by Subject|7|||
142942727|NCT00481065|515327136|FG003|Overall Study|Withdrawal by Subject|11|||
142942728|NCT00481065|515327137|FG004|Overall Study|Withdrawal by Subject|13|||
142942729|NCT00481065|515327138|FG005|Overall Study|Withdrawal by Subject|12|||
142942730|NCT00481065|515327139|FG006|Overall Study|Withdrawal by Subject|9|||
142942731|NCT00481065|515327140|FG007|Overall Study|Withdrawal by Subject|10|||
142942732|NCT00481065|515327133|FG000|Overall Study|Lost to Follow-up|4|||
142942733|NCT00481065|515327134|FG001|Overall Study|Lost to Follow-up|2|||
142942734|NCT00481065|515327135|FG002|Overall Study|Lost to Follow-up|4|||
142942735|NCT00481065|515327136|FG003|Overall Study|Lost to Follow-up|3|||
142942736|NCT00481065|515327137|FG004|Overall Study|Lost to Follow-up|3|||
142942737|NCT00481065|515327138|FG005|Overall Study|Lost to Follow-up|3|||
142942738|NCT00481065|515327139|FG006|Overall Study|Lost to Follow-up|2|||
142942739|NCT00481065|515327140|FG007|Overall Study|Lost to Follow-up|5|||
142942740|NCT00481065|515327133|FG000|Overall Study|Inappropriate enrollment|4|||
142942741|NCT00481065|515327134|FG001|Overall Study|Inappropriate enrollment|0|||
142942742|NCT00481065|515327135|FG002|Overall Study|Inappropriate enrollment|2|||
142942743|NCT00481065|515327136|FG003|Overall Study|Inappropriate enrollment|0|||
142942744|NCT00481065|515327137|FG004|Overall Study|Inappropriate enrollment|2|||
142942745|NCT00481065|515327138|FG005|Overall Study|Inappropriate enrollment|1|||
142942746|NCT00481065|515327139|FG006|Overall Study|Inappropriate enrollment|0|||
142942747|NCT00481065|515327140|FG007|Overall Study|Inappropriate enrollment|1|||
142942748|NCT00481065|515327133|FG000|Overall Study|Administrative reason|0|||
142942749|NCT00481065|515327134|FG001|Overall Study|Administrative reason|0|||
142942750|NCT00481065|515327135|FG002|Overall Study|Administrative reason|0|||
142942751|NCT00481065|515327136|FG003|Overall Study|Administrative reason|0|||
142942752|NCT00481065|515327137|FG004|Overall Study|Administrative reason|0|||
142942753|NCT00481065|515327138|FG005|Overall Study|Administrative reason|2|||
142942754|NCT00481065|515327139|FG006|Overall Study|Administrative reason|1|||
142942755|NCT00481065|515327140|FG007|Overall Study|Administrative reason|0|||
142942756|NCT00481065|515327133|FG000|Overall Study|Protocol Violation|2|||
142942757|NCT00481065|515327134|FG001|Overall Study|Protocol Violation|1|||
142942758|NCT00481065|515327135|FG002|Overall Study|Protocol Violation|1|||
142942759|NCT00481065|515327136|FG003|Overall Study|Protocol Violation|1|||
142942760|NCT00481065|515327137|FG004|Overall Study|Protocol Violation|2|||
142942761|NCT00481065|515327138|FG005|Overall Study|Protocol Violation|6|||
142942762|NCT00481065|515327139|FG006|Overall Study|Protocol Violation|3|||
142942763|NCT00481065|515327140|FG007|Overall Study|Protocol Violation|2|||
142942764|NCT00481065|515327133|FG000|Overall Study|Unable to classify|0|||
142942765|NCT00481065|515327134|FG001|Overall Study|Unable to classify|1|||
142942766|NCT00481065|515327135|FG002|Overall Study|Unable to classify|2|||
142942767|NCT00481065|515327136|FG003|Overall Study|Unable to classify|0|||
142942768|NCT00481065|515327137|FG004|Overall Study|Unable to classify|1|||
142942769|NCT00481065|515327138|FG005|Overall Study|Unable to classify|0|||
142942770|NCT00481065|515327139|FG006|Overall Study|Unable to classify|0|||
142942771|NCT00481065|515327140|FG007|Overall Study|Unable to classify|0|||
142942772|NCT03770403|515327141|FG000|Overall Study|Adverse Event|8|||
142942773|NCT03770403|515327141|FG000|Overall Study|Death|5|||
142942774|NCT03770403|515327141|FG000|Overall Study|Physician Decision|1|||
142942775|NCT03770403|515327141|FG000|Overall Study|Sponsor decision|1|||
142942776|NCT03770403|515327141|FG000|Overall Study|Study terminated by Sponsor|1|||
142942777|NCT03770403|515327141|FG000|Overall Study|Withdrawal by Subject|13|||
142942778|NCT03770403|515327141|FG000|Overall Study|Other|88|||
142942779|NCT03896295|515327142|FG000|Overall Study|Adverse Event|0|||
142942780|NCT03896295|515327143|FG001|Overall Study|Adverse Event|1|||
142942781|NCT03896295|515327142|FG000|Overall Study|COVID-19|7|||
142942782|NCT03896295|515327143|FG001|Overall Study|COVID-19|29|||
142942783|NCT00552110|515327144|FG000|Overall Study|Serious or Life-Threatening AE|0|||
142942784|NCT00552110|515327145|FG001|Overall Study|Serious or Life-Threatening AE|0|||
142942785|NCT00552110|515327146|FG002|Overall Study|Serious or Life-Threatening AE|1|||
142942786|NCT00552110|515327147|FG003|Overall Study|Serious or Life-Threatening AE|0|||
142942787|NCT00552110|515327148|FG004|Overall Study|Serious or Life-Threatening AE|0|||
142942788|NCT00552110|515327144|FG000|Overall Study|Lack of Efficacy|1|||
142942789|NCT00552110|515327145|FG001|Overall Study|Lack of Efficacy|0|||
142942790|NCT00552110|515327146|FG002|Overall Study|Lack of Efficacy|0|||
142942791|NCT00552110|515327147|FG003|Overall Study|Lack of Efficacy|1|||
142942792|NCT00552110|515327148|FG004|Overall Study|Lack of Efficacy|4|||
142942793|NCT00552110|515327144|FG000|Overall Study|Withdrawal by Subject|0|||
142942794|NCT00552110|515327145|FG001|Overall Study|Withdrawal by Subject|2|||
142942795|NCT00552110|515327146|FG002|Overall Study|Withdrawal by Subject|0|||
142942796|NCT00552110|515327147|FG003|Overall Study|Withdrawal by Subject|3|||
142942797|NCT00552110|515327148|FG004|Overall Study|Withdrawal by Subject|2|||
142942798|NCT00552110|515327144|FG000|Overall Study|Lost to Follow-up|0|||
142942799|NCT00552110|515327145|FG001|Overall Study|Lost to Follow-up|0|||
142942800|NCT00552110|515327146|FG002|Overall Study|Lost to Follow-up|0|||
142942801|NCT00552110|515327147|FG003|Overall Study|Lost to Follow-up|1|||
142942802|NCT00552110|515327148|FG004|Overall Study|Lost to Follow-up|1|||
142942803|NCT00552110|515327144|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
142942804|NCT00552110|515327145|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
142942805|NCT00552110|515327146|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
142942806|NCT00552110|515327147|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
142942807|NCT00552110|515327148|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
142942808|NCT00552110|515327144|FG000|Overall Study|Withdrawn per Sponsor|0|||
142942809|NCT00552110|515327145|FG001|Overall Study|Withdrawn per Sponsor|1|||
142942810|NCT00552110|515327146|FG002|Overall Study|Withdrawn per Sponsor|0|||
142942811|NCT00552110|515327147|FG003|Overall Study|Withdrawn per Sponsor|0|||
142942812|NCT00552110|515327148|FG004|Overall Study|Withdrawn per Sponsor|1|||
142942813|NCT00552110|515327144|FG000|Overall Study|Use of Prohibited Medication|1|||
142942814|NCT00552110|515327145|FG001|Overall Study|Use of Prohibited Medication|1|||
142942815|NCT00552110|515327146|FG002|Overall Study|Use of Prohibited Medication|0|||
142942816|NCT00552110|515327147|FG003|Overall Study|Use of Prohibited Medication|0|||
142942817|NCT00552110|515327148|FG004|Overall Study|Use of Prohibited Medication|0|||
142942818|NCT00552110|515327144|FG000|Overall Study|Delay of Study due to Relabeling|0|||
142942819|NCT00552110|515327145|FG001|Overall Study|Delay of Study due to Relabeling|0|||
142942820|NCT00552110|515327146|FG002|Overall Study|Delay of Study due to Relabeling|0|||
142942821|NCT00552110|515327147|FG003|Overall Study|Delay of Study due to Relabeling|1|||
142942822|NCT00552110|515327148|FG004|Overall Study|Delay of Study due to Relabeling|0|||
142942823|NCT00552110|515327144|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
142942824|NCT00552110|515327145|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
142942825|NCT00552110|515327146|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
142942826|NCT00552110|515327147|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
142942827|NCT00552110|515327148|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
142942828|NCT00552110|515327144|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
142942829|NCT00552110|515327145|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
142942830|NCT00552110|515327146|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
142942831|NCT00552110|515327147|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
142942832|NCT00552110|515327148|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
142942833|NCT03029832|515327149|FG000|Overall Study|Safety Follow-Up Completed|2|||
142942834|NCT03029832|515327150|FG001|Overall Study|Safety Follow-Up Completed|0|||
142942835|NCT03029832|515327149|FG000|Overall Study|Death due to Disease Progression|1|||
142942836|NCT03029832|515327150|FG001|Overall Study|Death due to Disease Progression|0|||
142942837|NCT03029832|515327149|FG000|Overall Study|Study Terminated By Sponsor|1|||
142942838|NCT03029832|515327150|FG001|Overall Study|Study Terminated By Sponsor|1|||
142942839|NCT01412229|515327151|FG000|Overall Study|Physician Decision|1|||
142942840|NCT01275222|515327152|FG000|Phase l by Treatment|Adverse Event|1|||
142942841|NCT01275222|515327153|FG001|Phase l by Treatment|Adverse Event|4|||
142942842|NCT01275222|515327154|FG002|Phase l by Treatment|Adverse Event|2|||
142942843|NCT01275222|515327155|FG003|Phase l by Treatment|Adverse Event|3|||
142942844|NCT01275222|515327156|FG004|Phase l by Treatment|Adverse Event|0|||
142942845|NCT01275222|515327157|FG005|Phase l by Treatment|Adverse Event|0|||
142942846|NCT01275222|515327152|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
142942847|NCT01275222|515327153|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
142942848|NCT01275222|515327154|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
142942849|NCT01275222|515327155|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
142942850|NCT01275222|515327156|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
142942851|NCT01275222|515327157|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
142942852|NCT01275222|515327152|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
142942853|NCT01275222|515327153|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
142942854|NCT01275222|515327154|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
142942855|NCT01275222|515327155|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
142942856|NCT01275222|515327156|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
142942857|NCT01275222|515327157|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
142942858|NCT01275222|515327152|FG000|Phase l by Treatment|Disease progression|12|||
142942859|NCT01275222|515327153|FG001|Phase l by Treatment|Disease progression|8|||
142942860|NCT01275222|515327154|FG002|Phase l by Treatment|Disease progression|2|||
142942861|NCT01275222|515327155|FG003|Phase l by Treatment|Disease progression|5|||
142942862|NCT01275222|515327156|FG004|Phase l by Treatment|Disease progression|0|||
142942863|NCT01275222|515327157|FG005|Phase l by Treatment|Disease progression|0|||
142942864|NCT01275222|515327152|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
142942865|NCT01275222|515327153|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
142942866|NCT01275222|515327154|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
142942867|NCT01275222|515327155|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
142942868|NCT01275222|515327156|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
142942869|NCT01275222|515327157|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
142942870|NCT01275222|515327152|FG000|Phase l by Treatment|Death|0|||
142942871|NCT01275222|515327153|FG001|Phase l by Treatment|Death|1|||
142942872|NCT01275222|515327154|FG002|Phase l by Treatment|Death|0|||
142942873|NCT01275222|515327155|FG003|Phase l by Treatment|Death|1|||
142942874|NCT01275222|515327156|FG004|Phase l by Treatment|Death|0|||
142942875|NCT01275222|515327157|FG005|Phase l by Treatment|Death|0|||
142942876|NCT01275222|515327152|FG000|Phase ll by Stratum|Adverse Event|0|||
142942877|NCT01275222|515327153|FG001|Phase ll by Stratum|Adverse Event|0|||
142942878|NCT01275222|515327154|FG002|Phase ll by Stratum|Adverse Event|0|||
142942879|NCT01275222|515327155|FG003|Phase ll by Stratum|Adverse Event|0|||
142942880|NCT01275222|515327156|FG004|Phase ll by Stratum|Adverse Event|2|||
142942881|NCT01275222|515327157|FG005|Phase ll by Stratum|Adverse Event|10|||
142942882|NCT01275222|515327152|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
142942883|NCT01275222|515327153|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
142942884|NCT01275222|515327154|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
142942885|NCT01275222|515327155|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
142942886|NCT01275222|515327156|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
142942887|NCT01275222|515327157|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
142942888|NCT01275222|515327152|FG000|Phase ll by Stratum|Disease progression|0|||
142942889|NCT01275222|515327153|FG001|Phase ll by Stratum|Disease progression|0|||
142942890|NCT01275222|515327154|FG002|Phase ll by Stratum|Disease progression|0|||
142942891|NCT01275222|515327155|FG003|Phase ll by Stratum|Disease progression|0|||
142942892|NCT01275222|515327156|FG004|Phase ll by Stratum|Disease progression|23|||
142942893|NCT01275222|515327157|FG005|Phase ll by Stratum|Disease progression|31|||
142942894|NCT01275222|515327152|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
142942895|NCT01275222|515327153|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
142942896|NCT01275222|515327154|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
142942897|NCT01275222|515327155|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
142942898|NCT01275222|515327156|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
142942899|NCT01275222|515327157|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
142942900|NCT01275222|515327152|FG000|Phase ll by Stratum|Death|0|||
142942901|NCT01275222|515327153|FG001|Phase ll by Stratum|Death|0|||
142942902|NCT01275222|515327154|FG002|Phase ll by Stratum|Death|0|||
142942903|NCT01275222|515327155|FG003|Phase ll by Stratum|Death|0|||
142942904|NCT01275222|515327156|FG004|Phase ll by Stratum|Death|1|||
142942905|NCT01275222|515327157|FG005|Phase ll by Stratum|Death|1|||
142942906|NCT02048904|515327158|FG000|Overall Study|Withdrawal by Subject|7|||
142942907|NCT02048904|515327158|FG000|Overall Study|Physician Decision|70|||
142942908|NCT03832387|515327159|FG000|Overall Study|Protocol Violation|2|||
142942909|NCT03832387|515327160|FG001|Overall Study|Protocol Violation|6|||
142942910|NCT03832387|515327159|FG000|Overall Study|EXCLUSION CRITERIA|3|||
142942911|NCT03832387|515327160|FG001|Overall Study|EXCLUSION CRITERIA|1|||
142942912|NCT01856114|515327161|FG000|Overall Study|Withdrawal by Subject|1|||
142942913|NCT01856114|515327162|FG001|Overall Study|Withdrawal by Subject|0|||
142942914|NCT01856114|515327161|FG000|Overall Study|Adverse Event|1|||
142942915|NCT01856114|515327162|FG001|Overall Study|Adverse Event|0|||
142942916|NCT00490542|515327163|FG000|Overall Study|Lost to Follow-up|3|||
142942917|NCT00490542|515327164|FG001|Overall Study|Lost to Follow-up|0|||
142942918|NCT00490542|515327163|FG000|Overall Study|Adverse Event|3|||
142942919|NCT00490542|515327164|FG001|Overall Study|Adverse Event|3|||
142942920|NCT00490542|515327163|FG000|Overall Study|Lack of Efficacy|1|||
142942921|NCT00490542|515327164|FG001|Overall Study|Lack of Efficacy|1|||
142942922|NCT04640766|515327165|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
142942923|NCT00655928|515327166|FG000|Overall Study|Withdrawal by Subject|2|||
142942924|NCT00655928|515327167|FG001|Overall Study|Withdrawal by Subject|1|||
142942925|NCT00655928|515327166|FG000|Overall Study|Physician Decision|1|||
142942926|NCT00655928|515327167|FG001|Overall Study|Physician Decision|1|||
142942927|NCT01587989|515327169|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
142942928|NCT01587989|515327170|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
143454785|NCT02383056|517210731|FG001|Overall Study|Lost to Follow-up|2|||
143454786|NCT04187989|517210732|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
143454787|NCT04187989|517210733|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
143454788|NCT04187989|517210732|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
143454789|NCT04187989|517210733|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
143454790|NCT03646656|517210734|FG000|Overall Study|Lost to Follow-up|1|||
143454791|NCT03646656|517210735|FG001|Overall Study|Lost to Follow-up|0|||
143454792|NCT03646656|517210734|FG000|Overall Study|Withdrawal by Subject|2|||
143454793|NCT03646656|517210735|FG001|Overall Study|Withdrawal by Subject|0|||
143454794|NCT03900416|517210736|FG000|Six Week Follow-up|Lost to Follow-up|1|||
143454795|NCT03900416|517210737|FG001|Six Week Follow-up|Lost to Follow-up|0|||
143454796|NCT03900416|517210736|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
143454797|NCT03900416|517210737|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
143454798|NCT03900416|517210736|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
143454799|NCT03900416|517210737|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
143454800|NCT03900416|517210736|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
143454801|NCT03900416|517210737|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
143454802|NCT03900416|517210736|FG000|Twelve Week Follow-up|Adverse Event|1|||
143454803|NCT03900416|517210737|FG001|Twelve Week Follow-up|Adverse Event|1|||
143454804|NCT03900416|517210736|FG000|Six Month Follow-up|Lost to Follow-up|4|||
143454805|NCT03900416|517210737|FG001|Six Month Follow-up|Lost to Follow-up|3|||
143454806|NCT03900416|517210736|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
143454807|NCT03900416|517210737|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
143454808|NCT03507777|517210738|FG000|Overall Study|Lost to Follow-up|5|||
143454809|NCT03507777|517210739|FG001|Overall Study|Lost to Follow-up|7|||
143454810|NCT03507777|517210738|FG000|Overall Study|Withdrawal by Subject|6|||
143454811|NCT03507777|517210739|FG001|Overall Study|Withdrawal by Subject|11|||
143454812|NCT03507777|517210738|FG000|Overall Study|Death|30|||
143454813|NCT03507777|517210739|FG001|Overall Study|Death|44|||
143454814|NCT03507777|517210738|FG000|Overall Study|Other Reasons|3|||
143454815|NCT03507777|517210739|FG001|Overall Study|Other Reasons|8|||
143454816|NCT02245737|517210740|FG000|Overall Study|Adverse Event|23|||
143454817|NCT02245737|517210741|FG001|Overall Study|Adverse Event|26|||
143454818|NCT02245737|517210742|FG002|Overall Study|Adverse Event|33|||
143454819|NCT02245737|517210740|FG000|Overall Study|Condition Worsened|9|||
142942929|NCT01587989|515327171|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
142942930|NCT01587989|515327169|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
142942931|NCT01587989|515327170|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
142942932|NCT01587989|515327171|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
142942933|NCT01587989|515327169|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
143454820|NCT02245737|517210741|FG001|Overall Study|Condition Worsened|10|||
143454821|NCT02245737|517210742|FG002|Overall Study|Condition Worsened|9|||
143454822|NCT02245737|517210740|FG000|Overall Study|Death|2|||
142942934|NCT01587989|515327170|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
142942935|NCT01587989|515327171|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
142942936|NCT01587989|515327169|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
142942937|NCT01587989|515327170|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
142942938|NCT01587989|515327171|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
142942939|NCT01587989|515327169|FG000|Randomized Study Treatment|Screening failure|0|||
142942940|NCT01587989|515327170|FG001|Randomized Study Treatment|Screening failure|1|||
142942941|NCT01587989|515327171|FG002|Randomized Study Treatment|Screening failure|0|||
142942942|NCT01587989|515327169|FG000|Randomized Study Treatment|Physician Decision|0|||
142942943|NCT01587989|515327170|FG001|Randomized Study Treatment|Physician Decision|0|||
142942944|NCT01587989|515327171|FG002|Randomized Study Treatment|Physician Decision|1|||
142942945|NCT04375761|515329452|FG000|Overall Study|Death|1|||
142942946|NCT04375761|515329453|FG001|Overall Study|Death|2|||
142942947|NCT04375761|515329452|FG000|Overall Study|Lost to Follow-up|203|||
142942948|NCT04375761|515329453|FG001|Overall Study|Lost to Follow-up|380|||
142942949|NCT04375761|515329452|FG000|Overall Study|Withdrawal by Subject|47|||
142942950|NCT04375761|515329453|FG001|Overall Study|Withdrawal by Subject|98|||
142942951|NCT04375761|515329452|FG000|Overall Study|Noncompliance with study procedure|121|||
142942952|NCT04375761|515329453|FG001|Overall Study|Noncompliance with study procedure|251|||
142942953|NCT04375761|515329452|FG000|Overall Study|Reimbursement not enough|1|||
142942954|NCT04375761|515329453|FG001|Overall Study|Reimbursement not enough|2|||
142942955|NCT04375761|515329452|FG000|Overall Study|Unforeseen family circumstances|1|||
142942956|NCT04375761|515329453|FG001|Overall Study|Unforeseen family circumstances|3|||
142942957|NCT04375761|515329452|FG000|Overall Study|Test too painful|1|||
142942958|NCT04375761|515329453|FG001|Overall Study|Test too painful|1|||
142942959|NCT04375761|515329452|FG000|Overall Study|Moved|0|||
142942960|NCT04375761|515329453|FG001|Overall Study|Moved|2|||
142942961|NCT04375761|515329452|FG000|Overall Study|Nonresponsive|0|||
142942962|NCT04375761|515329453|FG001|Overall Study|Nonresponsive|5|||
142942963|NCT03797001|515329454|FG000|Overall Study|Withdrawn due to COVID19|4|||
142942964|NCT03797001|515329455|FG001|Overall Study|Withdrawn due to COVID19|0|||
142942965|NCT03797001|515329454|FG000|Overall Study|Withdrawal by Subject|7|||
142942966|NCT03797001|515329455|FG001|Overall Study|Withdrawal by Subject|6|||
142942967|NCT03797001|515329454|FG000|Overall Study|Adverse Event|0|||
142942968|NCT03797001|515329455|FG001|Overall Study|Adverse Event|1|||
142942969|NCT05630846|515329458|FG000|Overall Study|Death|1|||
142942970|NCT05630846|515329459|FG001|Overall Study|Death|0|||
142942971|NCT05630846|515329460|FG002|Overall Study|Death|0|||
142942972|NCT05630846|515329461|FG003|Overall Study|Death|0|||
142942973|NCT05630846|515329458|FG000|Overall Study|Withdrawal by Subject|3|||
142942974|NCT05630846|515329459|FG001|Overall Study|Withdrawal by Subject|3|||
142942975|NCT05630846|515329460|FG002|Overall Study|Withdrawal by Subject|4|||
142942976|NCT05630846|515329461|FG003|Overall Study|Withdrawal by Subject|1|||
142942977|NCT05630846|515329458|FG000|Overall Study|Lost to Follow-up|6|||
142942978|NCT05630846|515329459|FG001|Overall Study|Lost to Follow-up|5|||
142942979|NCT05630846|515329460|FG002|Overall Study|Lost to Follow-up|2|||
142942980|NCT05630846|515329461|FG003|Overall Study|Lost to Follow-up|5|||
142942981|NCT05630846|515329458|FG000|Overall Study|Other|1|||
142942982|NCT05630846|515329459|FG001|Overall Study|Other|0|||
142942983|NCT05630846|515329460|FG002|Overall Study|Other|0|||
142942984|NCT05630846|515329461|FG003|Overall Study|Other|0|||
142942985|NCT00960076|515329472|FG000|Overall Study|Adverse Event|1|||
142942986|NCT00960076|515329473|FG001|Overall Study|Adverse Event|7|||
142942987|NCT00960076|515329472|FG000|Overall Study|No longer met study criteria|1|||
142942988|NCT00960076|515329473|FG001|Overall Study|No longer met study criteria|5|||
142942989|NCT00960076|515329472|FG000|Overall Study|Withdrawal by Subject|1|||
142942990|NCT00960076|515329473|FG001|Overall Study|Withdrawal by Subject|2|||
142942991|NCT00960076|515329472|FG000|Overall Study|Lost to Follow-up|3|||
142942992|NCT00960076|515329473|FG001|Overall Study|Lost to Follow-up|3|||
142942993|NCT00960076|515329472|FG000|Overall Study|Severe non-compliance to protocol|1|||
142942994|NCT00960076|515329473|FG001|Overall Study|Severe non-compliance to protocol|2|||
142942995|NCT00960076|515329472|FG000|Overall Study|Hyperglycemia|1|||
142942996|NCT00960076|515329473|FG001|Overall Study|Hyperglycemia|5|||
142942997|NCT00960076|515329472|FG000|Overall Study|Did not attend the termination visit|0|||
142942998|NCT00960076|515329473|FG001|Overall Study|Did not attend the termination visit|1|||
142942999|NCT00500266|515329474|FG000|Overall Study|Death|3|||
142943000|NCT00500266|515329474|FG000|Overall Study|Lost to Follow-up|3|||
142943001|NCT00500266|515329474|FG000|Overall Study|Withdrawal by Subject|3|||
142943002|NCT00500266|515329474|FG000|Overall Study|Assigned, not treated|4|||
142943003|NCT01431287|515329475|FG000|Overall Study|not treated|0|||
142943004|NCT01431287|515329476|FG001|Overall Study|not treated|0|||
142943005|NCT01431287|515329477|FG002|Overall Study|not treated|1|||
142943006|NCT01431287|515329478|FG003|Overall Study|not treated|0|||
142943007|NCT01431287|515329479|FG004|Overall Study|not treated|0|||
142943008|NCT01431287|515329475|FG000|Overall Study|Adverse Event|59|||
142943009|NCT01431287|515329476|FG001|Overall Study|Adverse Event|57|||
142943010|NCT01431287|515329477|FG002|Overall Study|Adverse Event|53|||
142943011|NCT01431287|515329478|FG003|Overall Study|Adverse Event|33|||
142943012|NCT01431287|515329479|FG004|Overall Study|Adverse Event|41|||
142943013|NCT01431287|515329475|FG000|Overall Study|Non compliant with protocol|6|||
142943014|NCT01431287|515329476|FG001|Overall Study|Non compliant with protocol|6|||
142943015|NCT01431287|515329477|FG002|Overall Study|Non compliant with protocol|5|||
142943016|NCT01431287|515329478|FG003|Overall Study|Non compliant with protocol|6|||
142943017|NCT01431287|515329479|FG004|Overall Study|Non compliant with protocol|5|||
142943018|NCT01431287|515329475|FG000|Overall Study|Lost to Follow-up|0|||
142943019|NCT01431287|515329476|FG001|Overall Study|Lost to Follow-up|3|||
142943020|NCT01431287|515329477|FG002|Overall Study|Lost to Follow-up|2|||
142943021|NCT01431287|515329478|FG003|Overall Study|Lost to Follow-up|3|||
142943022|NCT01431287|515329479|FG004|Overall Study|Lost to Follow-up|1|||
142943023|NCT01431287|515329475|FG000|Overall Study|Consent withdrawn not due to AE|29|||
142943024|NCT01431287|515329476|FG001|Overall Study|Consent withdrawn not due to AE|30|||
142943025|NCT01431287|515329477|FG002|Overall Study|Consent withdrawn not due to AE|34|||
142943026|NCT01431287|515329478|FG003|Overall Study|Consent withdrawn not due to AE|19|||
142943027|NCT01431287|515329479|FG004|Overall Study|Consent withdrawn not due to AE|29|||
142943028|NCT01431287|515329475|FG000|Overall Study|not stated above|4|||
142943029|NCT01431287|515329476|FG001|Overall Study|not stated above|2|||
142943030|NCT01431287|515329477|FG002|Overall Study|not stated above|2|||
142943031|NCT01431287|515329478|FG003|Overall Study|not stated above|2|||
142943032|NCT01431287|515329479|FG004|Overall Study|not stated above|1|||
142943033|NCT02660580|515329480|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
142943034|NCT02660580|515329481|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
142943035|NCT02660580|515329482|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
142943036|NCT02660580|515329483|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
142943037|NCT02660580|515329484|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
142943038|NCT02660580|515329480|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
142943039|NCT02660580|515329481|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
142943040|NCT02660580|515329482|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
142943041|NCT02660580|515329483|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
142943042|NCT02660580|515329484|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
142943043|NCT02660580|515329480|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
142943044|NCT02660580|515329481|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
142943045|NCT02660580|515329482|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
142943046|NCT02660580|515329483|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
142943047|NCT02660580|515329484|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
142943048|NCT02660580|515329480|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
142943049|NCT02660580|515329481|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
142943050|NCT02660580|515329482|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
142943051|NCT02660580|515329483|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
142943052|NCT02660580|515329484|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
142943053|NCT02660580|515329480|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
142943054|NCT02660580|515329481|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
142943055|NCT02660580|515329482|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
142943056|NCT02660580|515329483|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
142943057|NCT02660580|515329484|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
142943058|NCT02660580|515329480|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
142943059|NCT02660580|515329481|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
142943060|NCT02660580|515329482|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
142943061|NCT02660580|515329483|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
142943062|NCT02660580|515329484|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
142943063|NCT02660580|515329480|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
142943064|NCT02660580|515329481|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
142943065|NCT02660580|515329482|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
142943066|NCT02660580|515329483|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
142943067|NCT02660580|515329484|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
142943068|NCT02660580|515329480|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
142943069|NCT02660580|515329481|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
142943070|NCT02660580|515329482|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
142943071|NCT02660580|515329483|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
142943072|NCT02660580|515329484|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
142943073|NCT02660580|515329480|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
142943074|NCT02660580|515329481|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
142943075|NCT02660580|515329482|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
142943076|NCT02660580|515329483|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
142943077|NCT02660580|515329484|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
142943078|NCT02660580|515329480|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
142943079|NCT02660580|515329481|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
142943080|NCT02660580|515329482|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
142943081|NCT02660580|515329483|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
142943082|NCT02660580|515329484|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
142943083|NCT02660580|515329480|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
142943084|NCT02660580|515329481|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
142943085|NCT02660580|515329482|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
142943086|NCT02660580|515329483|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
142943087|NCT02660580|515329484|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
142943088|NCT02660580|515329480|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
142943089|NCT02660580|515329481|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
142943090|NCT02660580|515329482|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
142943091|NCT02660580|515329483|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
142943092|NCT02660580|515329484|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
142943093|NCT02660580|515329480|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
142943094|NCT02660580|515329481|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
142943095|NCT02660580|515329482|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
142943096|NCT02660580|515329483|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
142943097|NCT02660580|515329484|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
142943098|NCT00496366|515329485|FG000|Overall Study|Death|1|||
142943099|NCT03095703|515329496|FG000|Overall Study|Withdrawal by Subject|1|||
142943100|NCT03539432|515329497|FG000|Overall Study|Lost to Follow-up|0|||
142943101|NCT03539432|515329498|FG001|Overall Study|Lost to Follow-up|1|||
142943102|NCT03615222|515329510|FG000|Overall Study|Ineligible|26|||
142943103|NCT03615222|515329510|FG000|Overall Study|Withdrawal by Subject|7|||
142943104|NCT03615222|515329510|FG000|Overall Study|Death|1|||
142943105|NCT00476086|515329511|FG000|Overall Study|Alternative therapy|1|||
142943106|NCT00476086|515329511|FG000|Overall Study|Progressive Disease|4|||
142943107|NCT03895203|515329512|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
142943108|NCT03895203|515329513|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
142943109|NCT03895203|515329514|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
142943110|NCT03895203|515329515|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
142943111|NCT03895203|515329516|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
142943112|NCT03895203|515329517|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
142943113|NCT03895203|515329512|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
142943114|NCT03895203|515329513|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
142943115|NCT03895203|515329514|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
142943116|NCT03895203|515329515|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
142943117|NCT03895203|515329516|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
142943118|NCT03895203|515329517|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
142943119|NCT03895203|515329512|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
142943120|NCT03895203|515329513|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
142943121|NCT03895203|515329514|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
142943122|NCT03895203|515329515|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
142943123|NCT03895203|515329516|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
142943124|NCT03895203|515329517|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
142943125|NCT03895203|515329512|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
142943126|NCT03895203|515329513|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
142943127|NCT03895203|515329514|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
142943128|NCT03895203|515329515|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
142943129|NCT03895203|515329516|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
142943130|NCT03895203|515329517|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
142943131|NCT03895203|515329512|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
142943132|NCT03895203|515329513|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
142943133|NCT03895203|515329514|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
142943134|NCT03895203|515329515|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
142943135|NCT03895203|515329516|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
142943136|NCT03895203|515329517|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
142943137|NCT03895203|515329512|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
143454823|NCT02245737|517210741|FG001|Overall Study|Death|4|||
143454824|NCT02245737|517210742|FG002|Overall Study|Death|4|||
143454825|NCT02245737|517210740|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
143454826|NCT02245737|517210741|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
142943138|NCT03895203|515329513|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
142943139|NCT03895203|515329514|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
142943140|NCT03895203|515329515|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
142943141|NCT03895203|515329516|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
142943142|NCT03895203|515329517|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
142943143|NCT03895203|515329512|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
142943144|NCT03895203|515329513|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
142943145|NCT03895203|515329514|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
142943146|NCT03895203|515329515|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
142943147|NCT03895203|515329516|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
142943148|NCT03895203|515329517|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
142943149|NCT03895203|515329512|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
142943150|NCT03895203|515329513|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
142943151|NCT03895203|515329514|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
142943152|NCT03895203|515329515|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
142943153|NCT03895203|515329516|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
142943154|NCT03895203|515329517|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
142943155|NCT03895203|515329512|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
142943156|NCT03895203|515329513|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
142943157|NCT03895203|515329514|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
142943158|NCT03895203|515329515|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
142943159|NCT03895203|515329516|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
142943160|NCT03895203|515329517|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
142943161|NCT03895203|515329512|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
142943162|NCT03895203|515329513|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
142943163|NCT03895203|515329514|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
142943164|NCT03895203|515329515|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
142943165|NCT03895203|515329516|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
142943166|NCT03895203|515329517|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
142943167|NCT03895203|515329512|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
142943168|NCT03895203|515329513|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
142943169|NCT03895203|515329514|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
142943170|NCT03895203|515329515|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
142943171|NCT03895203|515329516|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
142943172|NCT03895203|515329517|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
142943173|NCT03895203|515329512|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
142943174|NCT03895203|515329513|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
142943175|NCT03895203|515329514|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
142943176|NCT03895203|515329515|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
142943177|NCT03895203|515329516|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
142943178|NCT03895203|515329517|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
142943179|NCT03895203|515329512|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
142943180|NCT03895203|515329513|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
142943181|NCT03895203|515329514|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
142943182|NCT03895203|515329515|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
142943183|NCT03895203|515329516|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
142943184|NCT03895203|515329517|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
142943185|NCT03895203|515329512|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
142943186|NCT03895203|515329513|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
142943187|NCT03895203|515329514|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
142943188|NCT03895203|515329515|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
142943189|NCT03895203|515329516|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
142943190|NCT03895203|515329517|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
142943191|NCT00364793|515329518|FG000|Overall Study|Adverse Event|2|||
142943192|NCT00364793|515329519|FG001|Overall Study|Adverse Event|0|||
142943193|NCT00364793|515329520|FG002|Overall Study|Adverse Event|0|||
142943194|NCT00364793|515329521|FG003|Overall Study|Adverse Event|0|||
142943195|NCT00364793|515329518|FG000|Overall Study|Death|1|||
142943196|NCT00364793|515329519|FG001|Overall Study|Death|0|||
142943197|NCT00364793|515329520|FG002|Overall Study|Death|1|||
142943198|NCT00364793|515329521|FG003|Overall Study|Death|0|||
142943199|NCT00364793|515329518|FG000|Overall Study|Lack of Efficacy|3|||
142943200|NCT00364793|515329519|FG001|Overall Study|Lack of Efficacy|3|||
142943201|NCT00364793|515329520|FG002|Overall Study|Lack of Efficacy|1|||
142943202|NCT00364793|515329521|FG003|Overall Study|Lack of Efficacy|1|||
142943203|NCT00364793|515329518|FG000|Overall Study|Lost to Follow-up|1|||
142943204|NCT00364793|515329519|FG001|Overall Study|Lost to Follow-up|0|||
142943205|NCT00364793|515329520|FG002|Overall Study|Lost to Follow-up|2|||
142943206|NCT00364793|515329521|FG003|Overall Study|Lost to Follow-up|0|||
142943207|NCT00364793|515329518|FG000|Overall Study|Poor or non-compliance|1|||
142943208|NCT00364793|515329519|FG001|Overall Study|Poor or non-compliance|1|||
142943209|NCT00364793|515329520|FG002|Overall Study|Poor or non-compliance|0|||
142943210|NCT00364793|515329521|FG003|Overall Study|Poor or non-compliance|1|||
142943211|NCT00364793|515329518|FG000|Overall Study|No longer meets criteria|0|||
142943212|NCT00364793|515329519|FG001|Overall Study|No longer meets criteria|0|||
142943213|NCT00364793|515329520|FG002|Overall Study|No longer meets criteria|0|||
142943214|NCT00364793|515329521|FG003|Overall Study|No longer meets criteria|1|||
142943215|NCT00364793|515329518|FG000|Overall Study|Withdrawal by Subject|0|||
142943216|NCT00364793|515329519|FG001|Overall Study|Withdrawal by Subject|1|||
142943217|NCT00364793|515329520|FG002|Overall Study|Withdrawal by Subject|0|||
142943218|NCT00364793|515329521|FG003|Overall Study|Withdrawal by Subject|0|||
142943219|NCT00049127|515329522|FG000|Overall Study|Withdrawal by Subject|0|||
142943220|NCT00049127|515329523|FG001|Overall Study|Withdrawal by Subject|0|||
142943221|NCT00049127|515329524|FG002|Overall Study|Withdrawal by Subject|1|||
142943222|NCT00049127|515329525|FG003|Overall Study|Withdrawal by Subject|0|||
142943223|NCT00049127|515329526|FG004|Overall Study|Withdrawal by Subject|0|||
142943224|NCT00001337|515329528|FG000|Overall Study|Switched to alternate treatment|2|||
142943225|NCT00001337|515329529|FG001|Overall Study|Switched to alternate treatment|2|||
142943226|NCT00001337|515329530|FG002|Overall Study|Switched to alternate treatment|0|||
142943227|NCT00001337|515329528|FG000|Overall Study|Refused further treatment|2|||
142943228|NCT00001337|515329529|FG001|Overall Study|Refused further treatment|1|||
142943229|NCT00001337|515329530|FG002|Overall Study|Refused further treatment|0|||
142943230|NCT00001337|515329528|FG000|Overall Study|Began other Tx|1|||
142943231|NCT00001337|515329529|FG001|Overall Study|Began other Tx|0|||
142943232|NCT00001337|515329530|FG002|Overall Study|Began other Tx|0|||
142943233|NCT00001337|515329528|FG000|Overall Study|Physician Decision|3|||
142943234|NCT00001337|515329529|FG001|Overall Study|Physician Decision|1|||
142943235|NCT00001337|515329530|FG002|Overall Study|Physician Decision|0|||
142943236|NCT00001337|515329528|FG000|Overall Study|Doesn't have NHL|0|||
142943237|NCT00001337|515329529|FG001|Overall Study|Doesn't have NHL|1|||
142943238|NCT00001337|515329530|FG002|Overall Study|Doesn't have NHL|0|||
142943239|NCT00001337|515329528|FG000|Overall Study|Non protocol tx needed|3|||
142943240|NCT00001337|515329529|FG001|Overall Study|Non protocol tx needed|1|||
142943241|NCT00001337|515329530|FG002|Overall Study|Non protocol tx needed|0|||
142943242|NCT00001337|515329528|FG000|Overall Study|Protocol change|1|||
142943243|NCT00001337|515329529|FG001|Overall Study|Protocol change|0|||
142943244|NCT00001337|515329530|FG002|Overall Study|Protocol change|0|||
142943245|NCT00001337|515329528|FG000|Overall Study|2nd primary disease|0|||
142943246|NCT00001337|515329529|FG001|Overall Study|2nd primary disease|0|||
142943247|NCT00001337|515329530|FG002|Overall Study|2nd primary disease|1|||
142943248|NCT00001337|515329528|FG000|Overall Study|Death during follow up period|9|||
142943249|NCT00001337|515329529|FG001|Overall Study|Death during follow up period|4|||
142943250|NCT00001337|515329530|FG002|Overall Study|Death during follow up period|0|||
142943251|NCT00001337|515329528|FG000|Overall Study|Death on study|19|||
142943252|NCT00001337|515329529|FG001|Overall Study|Death on study|9|||
142943253|NCT00001337|515329530|FG002|Overall Study|Death on study|0|||
142943254|NCT00001337|515329528|FG000|Overall Study|Disease progression during follow-up period|3|||
142943255|NCT00001337|515329529|FG001|Overall Study|Disease progression during follow-up period|1|||
142943256|NCT00001337|515329530|FG002|Overall Study|Disease progression during follow-up period|0|||
142943257|NCT00001337|515329528|FG000|Overall Study|Disease progression on study|33|||
142943258|NCT00001337|515329529|FG001|Overall Study|Disease progression on study|41|||
142943259|NCT00001337|515329530|FG002|Overall Study|Disease progression on study|0|||
143454827|NCT02245737|517210742|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
143454828|NCT02245737|517210740|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
143454829|NCT02245737|517210741|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
143454830|NCT02245737|517210742|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
143454831|NCT02245737|517210740|FG000|Overall Study|Lost to Follow-up|2|||
143454832|NCT02245737|517210741|FG001|Overall Study|Lost to Follow-up|5|||
143454833|NCT02245737|517210742|FG002|Overall Study|Lost to Follow-up|4|||
143454834|NCT02245737|517210740|FG000|Overall Study|Other-determined by Investigator|9|||
143454835|NCT02245737|517210741|FG001|Overall Study|Other-determined by Investigator|10|||
143454836|NCT02245737|517210742|FG002|Overall Study|Other-determined by Investigator|10|||
143454837|NCT02245737|517210740|FG000|Overall Study|Physician Decision|6|||
143454838|NCT02245737|517210741|FG001|Overall Study|Physician Decision|3|||
143454839|NCT02245737|517210742|FG002|Overall Study|Physician Decision|6|||
143454840|NCT02245737|517210740|FG000|Overall Study|Protocol Violation|3|||
143454841|NCT02245737|517210741|FG001|Overall Study|Protocol Violation|2|||
142943260|NCT00001337|515329528|FG000|Overall Study|Lost to further follow-up|10|||
142943261|NCT00001337|515329529|FG001|Overall Study|Lost to further follow-up|6|||
142943262|NCT00001337|515329530|FG002|Overall Study|Lost to further follow-up|0|||
142943263|NCT00001337|515329528|FG000|Overall Study|2nd malignancy|1|||
142943264|NCT00001337|515329529|FG001|Overall Study|2nd malignancy|0|||
142943265|NCT00001337|515329530|FG002|Overall Study|2nd malignancy|0|||
142943266|NCT00001337|515329528|FG000|Overall Study|Treatment for second lymphoma|0|||
142943267|NCT00001337|515329529|FG001|Overall Study|Treatment for second lymphoma|1|||
142943268|NCT00001337|515329530|FG002|Overall Study|Treatment for second lymphoma|0|||
142943269|NCT00001337|515329528|FG000|Overall Study|Transfer to transplant|0|||
142943270|NCT00001337|515329529|FG001|Overall Study|Transfer to transplant|1|||
142943271|NCT00001337|515329530|FG002|Overall Study|Transfer to transplant|0|||
142943272|NCT01725165|515329533|FG000|Overall Study|Death|11|||
142943273|NCT01725165|515329534|FG001|Overall Study|Death|18|||
142943274|NCT03619213|515329535|FG000|Overall Study|Lost to Follow-up|2|||
142943275|NCT03619213|515329536|FG001|Overall Study|Lost to Follow-up|1|||
142943276|NCT03619213|515329535|FG000|Overall Study|Withdrawal by Subject|8|||
142943277|NCT03619213|515329536|FG001|Overall Study|Withdrawal by Subject|10|||
142943278|NCT03093402|515329537|FG000|Overall Study|Lost to Follow-up|1|||
142943279|NCT03093402|515329538|FG001|Overall Study|Lost to Follow-up|0|||
142943280|NCT03093402|515329539|FG002|Overall Study|Lost to Follow-up|0|||
142943281|NCT03093402|515329540|FG003|Overall Study|Lost to Follow-up|0|||
142943282|NCT03093402|515329537|FG000|Overall Study|Withdrawal by Subject|3|||
142943283|NCT03093402|515329538|FG001|Overall Study|Withdrawal by Subject|3|||
142943284|NCT03093402|515329539|FG002|Overall Study|Withdrawal by Subject|0|||
142943285|NCT03093402|515329540|FG003|Overall Study|Withdrawal by Subject|1|||
142943286|NCT03093402|515329537|FG000|Overall Study|Withdrew prior to dosing|2|||
142943287|NCT03093402|515329538|FG001|Overall Study|Withdrew prior to dosing|1|||
142943288|NCT03093402|515329539|FG002|Overall Study|Withdrew prior to dosing|2|||
142943289|NCT03093402|515329540|FG003|Overall Study|Withdrew prior to dosing|3|||
142943290|NCT03093402|515329537|FG000|Overall Study|Ineligible for study|1|||
142943291|NCT03093402|515329538|FG001|Overall Study|Ineligible for study|0|||
142943292|NCT03093402|515329539|FG002|Overall Study|Ineligible for study|0|||
142943293|NCT03093402|515329540|FG003|Overall Study|Ineligible for study|0|||
142943294|NCT03093402|515329537|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
142943295|NCT03093402|515329538|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
142943296|NCT03093402|515329539|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
142943297|NCT03093402|515329540|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
142943298|NCT02886702|515329541|FG000|Overall Study|Other|4|||
142943299|NCT02886702|515329542|FG001|Overall Study|Other|3|||
142943300|NCT02886702|515329543|FG002|Overall Study|Other|9|||
142943301|NCT02886702|515329541|FG000|Overall Study|Withdrawal by Subject|24|||
142943302|NCT02886702|515329542|FG001|Overall Study|Withdrawal by Subject|18|||
142943303|NCT02886702|515329543|FG002|Overall Study|Withdrawal by Subject|22|||
142943304|NCT02886702|515329541|FG000|Overall Study|Significant Worsening of Condition|0|||
142943305|NCT02886702|515329542|FG001|Overall Study|Significant Worsening of Condition|1|||
142943306|NCT02886702|515329543|FG002|Overall Study|Significant Worsening of Condition|0|||
142943307|NCT02886702|515329541|FG000|Overall Study|Protocol Violation|2|||
142943308|NCT02886702|515329542|FG001|Overall Study|Protocol Violation|2|||
142943309|NCT02886702|515329543|FG002|Overall Study|Protocol Violation|1|||
142943310|NCT02886702|515329541|FG000|Overall Study|Non-Compliance With Study Drug|0|||
142943311|NCT02886702|515329542|FG001|Overall Study|Non-Compliance With Study Drug|1|||
142943312|NCT02886702|515329543|FG002|Overall Study|Non-Compliance With Study Drug|4|||
142943313|NCT02886702|515329541|FG000|Overall Study|Lost to Follow-up|11|||
142943314|NCT02886702|515329542|FG001|Overall Study|Lost to Follow-up|13|||
142943315|NCT02886702|515329543|FG002|Overall Study|Lost to Follow-up|8|||
142943316|NCT02886702|515329541|FG000|Overall Study|Lack of Efficacy|3|||
142943317|NCT02886702|515329542|FG001|Overall Study|Lack of Efficacy|4|||
142943318|NCT02886702|515329543|FG002|Overall Study|Lack of Efficacy|5|||
142943319|NCT02886702|515329541|FG000|Overall Study|Adverse Event|4|||
142943320|NCT02886702|515329542|FG001|Overall Study|Adverse Event|9|||
142943321|NCT02886702|515329543|FG002|Overall Study|Adverse Event|3|||
142943322|NCT02886702|515329541|FG000|Overall Study|Administrative Reasons|0|||
142943323|NCT02886702|515329542|FG001|Overall Study|Administrative Reasons|0|||
142943324|NCT02886702|515329543|FG002|Overall Study|Administrative Reasons|1|||
142943325|NCT02731742|515329548|FG000|Overall Study|Death|1|||
142943326|NCT02731742|515329549|FG001|Overall Study|Death|2|||
142943327|NCT02731742|515329550|FG002|Overall Study|Death|5|||
142943328|NCT02731742|515329551|FG003|Overall Study|Death|0|||
142943329|NCT02731742|515329548|FG000|Overall Study|Physician Decision|0|||
142943330|NCT02731742|515329549|FG001|Overall Study|Physician Decision|0|||
142943331|NCT02731742|515329550|FG002|Overall Study|Physician Decision|0|||
142943332|NCT02731742|515329551|FG003|Overall Study|Physician Decision|1|||
142943333|NCT02731742|515329548|FG000|Overall Study|Study Terminated by Sponsor|2|||
142943334|NCT02731742|515329549|FG001|Overall Study|Study Terminated by Sponsor|1|||
142943335|NCT02731742|515329550|FG002|Overall Study|Study Terminated by Sponsor|1|||
142943336|NCT02731742|515329551|FG003|Overall Study|Study Terminated by Sponsor|1|||
142943337|NCT00331760|515329552|FG000|Overall Study|Ineligible / no protocol treatment|15|||
142943338|NCT00331760|515329553|FG001|Overall Study|Ineligible / no protocol treatment|8|||
142943339|NCT00461175|515329554|FG000|Overall Study|Protocol Violation|522|||
142943340|NCT00461175|515329555|FG001|Overall Study|Protocol Violation|365|||
142943341|NCT03093155|515329557|FG000|Overall Study|Not Eligible|1|||
142943342|NCT03093155|515329558|FG001|Overall Study|Not Eligible|0|||
142943343|NCT03093155|515329557|FG000|Overall Study|Withdrawal by Subject|0|||
143454842|NCT02245737|517210742|FG002|Overall Study|Protocol Violation|3|||
143454843|NCT02245737|517210740|FG000|Overall Study|Withdrawal by Subject|40|||
143454844|NCT02245737|517210741|FG001|Overall Study|Withdrawal by Subject|41|||
143454845|NCT02245737|517210742|FG002|Overall Study|Withdrawal by Subject|44|||
143454846|NCT02245737|517210740|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
143454847|NCT02245737|517210741|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
143454848|NCT02245737|517210742|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
143454849|NCT02245737|517210740|FG000|Overall Study|Sponsor Decision|445|||
143454850|NCT02245737|517210741|FG001|Overall Study|Sponsor Decision|430|||
143454851|NCT02245737|517210742|FG002|Overall Study|Sponsor Decision|432|||
143454852|NCT00621777|517210745|FG000|Open Phase|Adverse Event|20|||
143454853|NCT00621777|517210746|FG001|Open Phase|Adverse Event|0|||
143454854|NCT00621777|517210745|FG000|Open Phase|Did not abstain during open phase|56|||
143454855|NCT00621777|517210746|FG001|Open Phase|Did not abstain during open phase|0|||
143454856|NCT00621777|517210745|FG000|Open Phase|Withdrawal by Subject|17|||
143454857|NCT00621777|517210746|FG001|Open Phase|Withdrawal by Subject|0|||
143454858|NCT00621777|517210745|FG000|Open Phase|administrative|13|||
143454859|NCT00621777|517210746|FG001|Open Phase|administrative|0|||
143454860|NCT00621777|517210745|FG000|Open Phase|Lost to Follow-up|10|||
143454861|NCT00621777|517210746|FG001|Open Phase|Lost to Follow-up|0|||
143454862|NCT00621777|517210745|FG000|Randomized Phase|Adverse Event|3|||
143454863|NCT00621777|517210746|FG001|Randomized Phase|Adverse Event|3|||
143454864|NCT00621777|517210745|FG000|Randomized Phase|Lost to Follow-up|3|||
143454865|NCT00621777|517210746|FG001|Randomized Phase|Lost to Follow-up|3|||
143454866|NCT00621777|517210745|FG000|Randomized Phase|Withdrawal by Subject|1|||
143454867|NCT00621777|517210746|FG001|Randomized Phase|Withdrawal by Subject|9|||
143454868|NCT00621777|517210745|FG000|Randomized Phase|administrative|0|||
143454869|NCT00621777|517210746|FG001|Randomized Phase|administrative|3|||
143454870|NCT00621777|517210745|FG000|Randomized Phase|Death|0|||
143454871|NCT00621777|517210746|FG001|Randomized Phase|Death|1|||
143454872|NCT00446043|517210747|FG000|Overall Study|Adverse Event|9|||
143454873|NCT00446043|517210747|FG000|Overall Study|Withdrawal by Subject|70|||
143454874|NCT00446043|517210747|FG000|Overall Study|Protocol Violation|2|||
143454875|NCT00446043|517210747|FG000|Overall Study|Lost to Follow-up|42|||
143454876|NCT00446043|517210747|FG000|Overall Study|Pregnancy|2|||
143454877|NCT01239043|517210748|FG000|Overall Study|Protocol Violation|2|||
143454878|NCT01239043|517210749|FG001|Overall Study|Protocol Violation|1|||
143454879|NCT02929329|517210752|FG000|Overall Study|Withdrawal by Subject|24|||
143454880|NCT02929329|517210753|FG001|Overall Study|Withdrawal by Subject|21|||
142943344|NCT03093155|515329558|FG001|Overall Study|Withdrawal by Subject|1|||
142943345|NCT02786901|515329559|FG000|Overall Study|Adverse Event|1|||
142943346|NCT02786901|515329560|FG001|Overall Study|Adverse Event|1|||
142943347|NCT02786901|515329561|FG002|Overall Study|Adverse Event|2|||
142943348|NCT02786901|515329559|FG000|Overall Study|Physician Decision|1|||
142943349|NCT02786901|515329560|FG001|Overall Study|Physician Decision|0|||
142943350|NCT02786901|515329561|FG002|Overall Study|Physician Decision|0|||
142943351|NCT02786901|515329559|FG000|Overall Study|Rescue Therapy Use|71|||
142943352|NCT02786901|515329560|FG001|Overall Study|Rescue Therapy Use|49|||
142943353|NCT02786901|515329561|FG002|Overall Study|Rescue Therapy Use|33|||
142943354|NCT02786901|515329559|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
142943355|NCT02786901|515329560|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
142943356|NCT02786901|515329561|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
142943357|NCT02786901|515329559|FG000|Overall Study|Disallowed medication|1|||
142943358|NCT02786901|515329560|FG001|Overall Study|Disallowed medication|1|||
142943359|NCT02786901|515329561|FG002|Overall Study|Disallowed medication|0|||
142943360|NCT02786901|515329559|FG000|Overall Study|Randomized in error|2|||
142943361|NCT02786901|515329560|FG001|Overall Study|Randomized in error|0|||
142943362|NCT02786901|515329561|FG002|Overall Study|Randomized in error|1|||
142943363|NCT02561156|515329566|FG000|Part 2|Adverse Event|0|||
142943364|NCT02561156|515329567|FG001|Part 2|Adverse Event|0|||
142943365|NCT02561156|515329568|FG002|Part 2|Adverse Event|0|||
142943366|NCT02561156|515329569|FG003|Part 2|Adverse Event|0|||
142943367|NCT02561156|515329570|FG004|Part 2|Adverse Event|0|||
142943368|NCT02561156|515329571|FG005|Part 2|Adverse Event|0|||
142943369|NCT02561156|515329572|FG006|Part 2|Adverse Event|0|||
142943370|NCT02561156|515329573|FG007|Part 2|Adverse Event|0|||
142943371|NCT02561156|515329574|FG008|Part 2|Adverse Event|0|||
142943372|NCT02561156|515329575|FG009|Part 2|Adverse Event|0|||
142943373|NCT02561156|515329576|FG010|Part 2|Adverse Event|0|||
142943374|NCT02561156|515329577|FG011|Part 2|Adverse Event|1|||
142943375|NCT02561156|515329578|FG012|Part 2|Adverse Event|0|||
142943376|NCT01071070|515329583|FG000|Overall Study|Adverse Event|0|||
142943377|NCT01071070|515329584|FG001|Overall Study|Adverse Event|3|||
142943378|NCT01071070|515329583|FG000|Overall Study|Withdrawal by Subject|1|||
142943379|NCT01071070|515329584|FG001|Overall Study|Withdrawal by Subject|0|||
142943380|NCT01071070|515329583|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
143454881|NCT02929329|517210752|FG000|Overall Study|Lost to Follow-up|26|||
143454882|NCT02929329|517210753|FG001|Overall Study|Lost to Follow-up|20|||
143454883|NCT02929329|517210752|FG000|Overall Study|Death|1054|||
143454884|NCT02929329|517210753|FG001|Overall Study|Death|1051|||
142943381|NCT01071070|515329584|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
142943382|NCT01071070|515329583|FG000|Overall Study|Hypercalcemia|1|||
142943383|NCT01071070|515329584|FG001|Overall Study|Hypercalcemia|0|||
142943384|NCT01025635|515329589|FG000|Overall Study|Withdrawal by Subject|6|||
142943385|NCT01025635|515329590|FG001|Overall Study|Withdrawal by Subject|7|||
142943386|NCT01025635|515329589|FG000|Overall Study|Protocol Violation|4|||
142943387|NCT01025635|515329590|FG001|Overall Study|Protocol Violation|2|||
142943388|NCT01025635|515329589|FG000|Overall Study|Lack of Efficacy|0|||
142943389|NCT01025635|515329590|FG001|Overall Study|Lack of Efficacy|1|||
142943390|NCT01025635|515329589|FG000|Overall Study|Lost to Follow-up|9|||
142943391|NCT01025635|515329590|FG001|Overall Study|Lost to Follow-up|13|||
142943392|NCT01025635|515329589|FG000|Overall Study|Reason not known|4|||
142943393|NCT01025635|515329590|FG001|Overall Study|Reason not known|2|||
142943394|NCT02209506|515329591|FG000|Overall Study|Withdrawal by Subject|0|||
142943395|NCT02209506|515329592|FG001|Overall Study|Withdrawal by Subject|0|||
142943396|NCT02209506|515329593|FG002|Overall Study|Withdrawal by Subject|0|||
142943397|NCT02209506|515329594|FG003|Overall Study|Withdrawal by Subject|0|||
142943398|NCT02209506|515329595|FG004|Overall Study|Withdrawal by Subject|1|||
142943399|NCT02582671|515329596|FG000|Overall Study|Failure to return|1|||
142943400|NCT02582671|515329596|FG000|Overall Study|Other, not specified|1|||
142943401|NCT03853694|515329597|FG000|Overall Study|Protocol Violation|3|||
142943402|NCT03853694|515329598|FG001|Overall Study|Protocol Violation|5|||
142943403|NCT03853694|515329599|FG002|Overall Study|Protocol Violation|3|||
142943404|NCT03853694|515329597|FG000|Overall Study|Delivered early|0|||
142943405|NCT03853694|515329598|FG001|Overall Study|Delivered early|1|||
142943406|NCT03853694|515329599|FG002|Overall Study|Delivered early|0|||
142943407|NCT03853694|515329597|FG000|Overall Study|not suitable to proceed|0|||
142943408|NCT03853694|515329598|FG001|Overall Study|not suitable to proceed|1|||
142943409|NCT03853694|515329599|FG002|Overall Study|not suitable to proceed|0|||
142943410|NCT03853694|515329597|FG000|Overall Study|difficult surgery|0|||
142943411|NCT03853694|515329598|FG001|Overall Study|difficult surgery|0|||
142943412|NCT03853694|515329599|FG002|Overall Study|difficult surgery|1|||
142943413|NCT03853694|515329597|FG000|Overall Study|Lost to Follow-up|0|||
142943414|NCT03853694|515329598|FG001|Overall Study|Lost to Follow-up|1|||
142943415|NCT03853694|515329599|FG002|Overall Study|Lost to Follow-up|0|||
142943416|NCT03853694|515329597|FG000|Overall Study|Withdrawal by Subject|0|||
142943417|NCT03853694|515329598|FG001|Overall Study|Withdrawal by Subject|1|||
142943418|NCT03853694|515329599|FG002|Overall Study|Withdrawal by Subject|0|||
142943419|NCT00519077|515329600|FG000|Overall Study|Death|6|||
142943420|NCT00519077|515329600|FG000|Overall Study|Other|2|||
142943421|NCT01967225|515329602|FG000|Overall Study|Adverse Event|3|||
142943422|NCT01967225|515329603|FG001|Overall Study|Adverse Event|1|||
142943423|NCT01967225|515329602|FG000|Overall Study|Withdrawal by Subject|2|||
142943424|NCT01967225|515329603|FG001|Overall Study|Withdrawal by Subject|1|||
142943425|NCT01967225|515329602|FG000|Overall Study|Lack of Efficacy|1|||
142943426|NCT01967225|515329603|FG001|Overall Study|Lack of Efficacy|1|||
142943427|NCT01967225|515329602|FG000|Overall Study|Switching to other therapy|2|||
142943428|NCT01967225|515329603|FG001|Overall Study|Switching to other therapy|0|||
142943429|NCT01967225|515329602|FG000|Overall Study|Protocol driven decision point|1|||
143454885|NCT02121301|517210754|FG000|Overall Study|Protocol Violation|1|||
143454886|NCT02121301|517210755|FG001|Overall Study|Protocol Violation|4|||
143454887|NCT02121301|517210756|FG002|Overall Study|Protocol Violation|1|||
143454888|NCT02663518|517210759|FG000|Part 1: Phase 1a Escalation|Death|0|||
143454889|NCT02663518|517210760|FG001|Part 1: Phase 1a Escalation|Death|0|||
143454890|NCT02663518|517210761|FG002|Part 1: Phase 1a Escalation|Death|1|||
142943430|NCT01967225|515329603|FG001|Overall Study|Protocol driven decision point|0|||
142943431|NCT01967225|515329602|FG000|Overall Study|Logistical difficulties|1|||
142943432|NCT01967225|515329603|FG001|Overall Study|Logistical difficulties|0|||
142943433|NCT01967225|515329602|FG000|Overall Study|Protocol Violation|2|||
142943434|NCT01967225|515329603|FG001|Overall Study|Protocol Violation|0|||
142943435|NCT02209766|515329604|FG000|Overall Study|Withdrawal by Subject|0|||
142943436|NCT02209766|515329605|FG001|Overall Study|Withdrawal by Subject|0|||
142943437|NCT02209766|515329606|FG002|Overall Study|Withdrawal by Subject|0|||
142943438|NCT02209766|515329607|FG003|Overall Study|Withdrawal by Subject|1|||
142943439|NCT02209766|515329608|FG004|Overall Study|Withdrawal by Subject|0|||
142943440|NCT00818259|515329619|FG000|Part I|Withdrawal by Subject|1|||
142943441|NCT00818259|515329620|FG001|Part I|Withdrawal by Subject|0|||
143454891|NCT02663518|517210762|FG003|Part 1: Phase 1a Escalation|Death|0|||
143454892|NCT02663518|517210763|FG004|Part 1: Phase 1a Escalation|Death|0|||
142943442|NCT00818259|515329621|FG002|Part I|Withdrawal by Subject|0|||
142943443|NCT00818259|515329622|FG003|Part I|Withdrawal by Subject|0|||
142943444|NCT00818259|515329623|FG004|Part I|Withdrawal by Subject|0|||
142943445|NCT00818259|515329624|FG005|Part I|Withdrawal by Subject|0|||
142943446|NCT00818259|515329625|FG006|Part I|Withdrawal by Subject|0|||
142943447|NCT00818259|515329626|FG007|Part I|Withdrawal by Subject|0|||
142943448|NCT00818259|515329627|FG008|Part I|Withdrawal by Subject|0|||
142943449|NCT00818259|515329619|FG000|Part II|Physician Decision|0|||
142943450|NCT00818259|515329620|FG001|Part II|Physician Decision|0|||
143454893|NCT02663518|517210764|FG005|Part 1: Phase 1a Escalation|Death|0|||
142943451|NCT00818259|515329621|FG002|Part II|Physician Decision|1|||
142943452|NCT00818259|515329622|FG003|Part II|Physician Decision|0|||
142943453|NCT00818259|515329623|FG004|Part II|Physician Decision|0|||
142943454|NCT00818259|515329624|FG005|Part II|Physician Decision|0|||
142943455|NCT00818259|515329625|FG006|Part II|Physician Decision|0|||
142943456|NCT00818259|515329626|FG007|Part II|Physician Decision|0|||
142943457|NCT00818259|515329627|FG008|Part II|Physician Decision|0|||
142943458|NCT00818259|515329619|FG000|Part II|Lack of Efficacy|0|||
142943459|NCT00818259|515329620|FG001|Part II|Lack of Efficacy|0|||
142943460|NCT00818259|515329621|FG002|Part II|Lack of Efficacy|0|||
142943461|NCT00818259|515329622|FG003|Part II|Lack of Efficacy|1|||
142943462|NCT00818259|515329623|FG004|Part II|Lack of Efficacy|0|||
142943463|NCT00818259|515329624|FG005|Part II|Lack of Efficacy|0|||
142943464|NCT00818259|515329625|FG006|Part II|Lack of Efficacy|0|||
142943465|NCT00818259|515329626|FG007|Part II|Lack of Efficacy|0|||
142943466|NCT00818259|515329627|FG008|Part II|Lack of Efficacy|0|||
142943467|NCT00818259|515329619|FG000|Part II|Not Treated|0|||
142943468|NCT00818259|515329620|FG001|Part II|Not Treated|0|||
142943469|NCT00818259|515329621|FG002|Part II|Not Treated|0|||
142943470|NCT00818259|515329622|FG003|Part II|Not Treated|1|||
142943471|NCT00818259|515329623|FG004|Part II|Not Treated|0|||
142943472|NCT00818259|515329624|FG005|Part II|Not Treated|0|||
142943473|NCT00818259|515329625|FG006|Part II|Not Treated|0|||
142943474|NCT00818259|515329626|FG007|Part II|Not Treated|0|||
142943475|NCT00818259|515329627|FG008|Part II|Not Treated|0|||
142943476|NCT00818259|515329619|FG000|Part IV|Physician Decision|0|||
142943477|NCT00818259|515329620|FG001|Part IV|Physician Decision|0|||
142943478|NCT00818259|515329621|FG002|Part IV|Physician Decision|0|||
142943479|NCT00818259|515329622|FG003|Part IV|Physician Decision|0|||
142943480|NCT00818259|515329623|FG004|Part IV|Physician Decision|0|||
142943481|NCT00818259|515329624|FG005|Part IV|Physician Decision|1|||
142943482|NCT00818259|515329625|FG006|Part IV|Physician Decision|0|||
142943483|NCT00818259|515329626|FG007|Part IV|Physician Decision|0|||
142943484|NCT00818259|515329627|FG008|Part IV|Physician Decision|0|||
142943485|NCT00818259|515329619|FG000|Part V|Adverse Event|0|||
142943486|NCT00818259|515329620|FG001|Part V|Adverse Event|0|||
142943487|NCT00818259|515329621|FG002|Part V|Adverse Event|0|||
142943488|NCT00818259|515329622|FG003|Part V|Adverse Event|0|||
142943489|NCT00818259|515329623|FG004|Part V|Adverse Event|0|||
142943490|NCT00818259|515329624|FG005|Part V|Adverse Event|0|||
142943491|NCT00818259|515329625|FG006|Part V|Adverse Event|0|||
142943492|NCT00818259|515329626|FG007|Part V|Adverse Event|1|||
142943493|NCT00818259|515329627|FG008|Part V|Adverse Event|0|||
142943494|NCT00666562|515329628|FG000|Overall Study|Withdrawal by Subject|0|||
142943495|NCT00666562|515329629|FG001|Overall Study|Withdrawal by Subject|1|||
142943496|NCT00666562|515329630|FG002|Overall Study|Withdrawal by Subject|0|||
142943497|NCT00666562|515329628|FG000|Overall Study|Concomitant Medication|0|||
142943498|NCT00666562|515329629|FG001|Overall Study|Concomitant Medication|1|||
142943499|NCT00666562|515329630|FG002|Overall Study|Concomitant Medication|0|||
142943500|NCT04906707|515329631|FG000|Overall Study|Withdrawal by Subject|2|||
142943501|NCT04906707|515329632|FG001|Overall Study|Withdrawal by Subject|0|||
142943502|NCT04906707|515329631|FG000|Overall Study|Withdrawal due to PI decision|1|||
142943503|NCT04906707|515329632|FG001|Overall Study|Withdrawal due to PI decision|0|||
142943504|NCT04906707|515329631|FG000|Overall Study|Lost to Follow-up|0|||
142943505|NCT04906707|515329632|FG001|Overall Study|Lost to Follow-up|1|||
142943506|NCT01976806|515329633|FG000|Overall Study|Lost to Follow-up|1|||
142943507|NCT01976806|515329634|FG001|Overall Study|Lost to Follow-up|4|||
142943508|NCT01976806|515329633|FG000|Overall Study|Adverse Event|1|||
142943509|NCT01976806|515329634|FG001|Overall Study|Adverse Event|1|||
142943510|NCT01976806|515329633|FG000|Overall Study|Withdrawal by Subject|1|||
142943511|NCT01976806|515329634|FG001|Overall Study|Withdrawal by Subject|1|||
142943512|NCT02654002|515329638|FG000|Overall Study|Adverse Event|0|||
142943513|NCT02654002|515329639|FG001|Overall Study|Adverse Event|0|||
142943514|NCT02654002|515329640|FG002|Overall Study|Adverse Event|0|||
142943515|NCT02654002|515329641|FG003|Overall Study|Adverse Event|0|||
142943516|NCT02654002|515329642|FG004|Overall Study|Adverse Event|0|||
142943517|NCT02654002|515329643|FG005|Overall Study|Adverse Event|0|||
142943518|NCT02654002|515329644|FG006|Overall Study|Adverse Event|1|||
142943519|NCT02654002|515329645|FG007|Overall Study|Adverse Event|0|||
142943520|NCT02654002|515329646|FG008|Overall Study|Adverse Event|0|||
142943521|NCT02654002|515329638|FG000|Overall Study|Withdrew Consent|0|||
142943522|NCT02654002|515329639|FG001|Overall Study|Withdrew Consent|0|||
142943523|NCT02654002|515329640|FG002|Overall Study|Withdrew Consent|0|||
142943524|NCT02654002|515329641|FG003|Overall Study|Withdrew Consent|0|||
142943525|NCT02654002|515329642|FG004|Overall Study|Withdrew Consent|0|||
142943526|NCT02654002|515329643|FG005|Overall Study|Withdrew Consent|1|||
142943527|NCT02654002|515329644|FG006|Overall Study|Withdrew Consent|0|||
142943528|NCT02654002|515329645|FG007|Overall Study|Withdrew Consent|1|||
142943529|NCT02654002|515329646|FG008|Overall Study|Withdrew Consent|0|||
142943530|NCT01769105|515329648|FG000|First Intervention|Protocol Violation|2|||
142943531|NCT01769105|515329649|FG001|First Intervention|Protocol Violation|2|||
142943532|NCT01769105|515329648|FG000|Cross-over|Lost to Follow-up|5|||
142943533|NCT01769105|515329649|FG001|Cross-over|Lost to Follow-up|0|||
142943534|NCT00963807|515329650|FG000|Overall Study|Physician Decision|2|||
142943535|NCT00963807|515329650|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
142943536|NCT00963807|515329650|FG000|Overall Study|Disease progression|15|||
142943537|NCT00684177|515329651|FG000|Overall Study|Adverse Event|4|||
142943538|NCT00684177|515329652|FG001|Overall Study|Adverse Event|3|||
142943539|NCT00684177|515329651|FG000|Overall Study|Lack of Efficacy|10|||
142943540|NCT00684177|515329652|FG001|Overall Study|Lack of Efficacy|15|||
142943541|NCT00684177|515329651|FG000|Overall Study|Protocol Violation|1|||
142943542|NCT00684177|515329652|FG001|Overall Study|Protocol Violation|0|||
142943543|NCT00684177|515329651|FG000|Overall Study|Lost to Follow-up|2|||
142943544|NCT00684177|515329652|FG001|Overall Study|Lost to Follow-up|1|||
142943545|NCT00684177|515329651|FG000|Overall Study|Physician Decision|2|||
142943546|NCT00684177|515329652|FG001|Overall Study|Physician Decision|0|||
142943547|NCT00684177|515329651|FG000|Overall Study|Withdrawal by Subject|1|||
142943548|NCT00684177|515329652|FG001|Overall Study|Withdrawal by Subject|2|||
142943549|NCT00684177|515329651|FG000|Overall Study|Other|1|||
142943550|NCT00684177|515329652|FG001|Overall Study|Other|2|||
142943551|NCT01291017|515329653|FG000|Overall Study|Lost to Follow-up|2|||
142943552|NCT01291017|515329653|FG000|Overall Study|Withdrawal by Subject|3|||
142943553|NCT06119191|515329654|FG000|Overall Study|Adverse Event|0|||
142943554|NCT06119191|515329655|FG001|Overall Study|Adverse Event|1|||
142943555|NCT06119191|515329654|FG000|Overall Study|Protocol Violation|1|||
142943556|NCT06119191|515329655|FG001|Overall Study|Protocol Violation|0|||
142943557|NCT00162773|515332276|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
142943558|NCT00260208|515332279|FG000|Overall Study|Subject withdrew consent|11|||
142943559|NCT00260208|515332280|FG001|Overall Study|Subject withdrew consent|7|||
142943560|NCT00260208|515332279|FG000|Overall Study|Lost to Follow-up|6|||
142943561|NCT00260208|515332280|FG001|Overall Study|Lost to Follow-up|1|||
142943562|NCT00260208|515332279|FG000|Overall Study|Death|12|||
142943563|NCT00260208|515332280|FG001|Overall Study|Death|10|||
142943564|NCT00260208|515332279|FG000|Overall Study|Missing|18|||
142943565|NCT00260208|515332280|FG001|Overall Study|Missing|16|||
142943566|NCT02091440|515332281|FG000|Overall Study|Death|2|||
142943567|NCT00768222|515332282|FG000|Overall Study|Lost to Follow-up|1|||
142943568|NCT00768222|515332283|FG001|Overall Study|Lost to Follow-up|1|||
142943569|NCT00768222|515332282|FG000|Overall Study|Withdrawal by Subject|3|||
142943570|NCT00768222|515332283|FG001|Overall Study|Withdrawal by Subject|1|||
142943571|NCT00768222|515332282|FG000|Overall Study|Protocol Violation|0|||
142943572|NCT00768222|515332283|FG001|Overall Study|Protocol Violation|2|||
142943573|NCT03323749|515332284|FG000|Double-blind Period|Lost to Follow-up|4|||
142943574|NCT03323749|515332285|FG001|Double-blind Period|Lost to Follow-up|5|||
142943575|NCT03323749|515332284|FG000|Double-blind Period|Adverse Event|3|||
142943576|NCT03323749|515332285|FG001|Double-blind Period|Adverse Event|1|||
142943577|NCT03323749|515332284|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
142943578|NCT03323749|515332285|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
142943579|NCT03323749|515332284|FG000|Open-Label Period|Adverse Event|3|||
142943580|NCT03323749|515332285|FG001|Open-Label Period|Adverse Event|10|||
142943581|NCT03323749|515332284|FG000|Open-Label Period|Withdrawal by Subject|7|||
142943582|NCT03323749|515332285|FG001|Open-Label Period|Withdrawal by Subject|5|||
142943583|NCT00506389|515332289|FG000|In-treatment Period|Other|3|||
142943584|NCT00506389|515332290|FG001|In-treatment Period|Other|3|||
143454894|NCT02663518|517210765|FG006|Part 1: Phase 1a Escalation|Death|0|||
143454895|NCT02663518|517210766|FG007|Part 1: Phase 1a Escalation|Death|0|||
143454896|NCT02663518|517210767|FG008|Part 1: Phase 1a Escalation|Death|0|||
143454897|NCT02663518|517210768|FG009|Part 1: Phase 1a Escalation|Death|0|||
143454898|NCT02663518|517210769|FG010|Part 1: Phase 1a Escalation|Death|0|||
143454899|NCT02663518|517210770|FG011|Part 1: Phase 1a Escalation|Death|0|||
143454900|NCT02663518|517210771|FG012|Part 1: Phase 1a Escalation|Death|0|||
143454901|NCT02663518|517210772|FG013|Part 1: Phase 1a Escalation|Death|0|||
143454902|NCT02663518|517210759|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
143454903|NCT02663518|517210760|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
143454904|NCT02663518|517210761|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
143454905|NCT02663518|517210762|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
143454906|NCT02663518|517210763|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
143454907|NCT02663518|517210764|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
142943585|NCT00506389|515332291|FG002|In-treatment Period|Other|4|||
142943586|NCT00506389|515332289|FG000|In-treatment Period|Lost to Follow-up|0|||
142943587|NCT00506389|515332290|FG001|In-treatment Period|Lost to Follow-up|0|||
142943588|NCT00506389|515332291|FG002|In-treatment Period|Lost to Follow-up|1|||
142943589|NCT00506389|515332289|FG000|In-treatment Period|Lack of compliance|1|||
142943590|NCT00506389|515332290|FG001|In-treatment Period|Lack of compliance|0|||
142943591|NCT00506389|515332291|FG002|In-treatment Period|Lack of compliance|0|||
142943592|NCT00506389|515332289|FG000|In-treatment Period|Reasons not related to trial|4|||
142943593|NCT00506389|515332290|FG001|In-treatment Period|Reasons not related to trial|1|||
142943594|NCT00506389|515332291|FG002|In-treatment Period|Reasons not related to trial|0|||
143454908|NCT02663518|517210765|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
142943595|NCT00506389|515332289|FG000|In-treatment Period|Withdrawal by Subject|3|||
142943596|NCT00506389|515332290|FG001|In-treatment Period|Withdrawal by Subject|3|||
142943597|NCT00506389|515332291|FG002|In-treatment Period|Withdrawal by Subject|4|||
142943598|NCT00506389|515332289|FG000|In-treatment Period|Lack of Efficacy|0|||
142943599|NCT00506389|515332290|FG001|In-treatment Period|Lack of Efficacy|2|||
142943600|NCT00506389|515332291|FG002|In-treatment Period|Lack of Efficacy|0|||
142943601|NCT00506389|515332289|FG000|In-treatment Period|Adverse Event|11|||
142943602|NCT00506389|515332290|FG001|In-treatment Period|Adverse Event|5|||
142943603|NCT00506389|515332291|FG002|In-treatment Period|Adverse Event|2|||
142943604|NCT00506389|515332289|FG000|In-treatment Period|Randomized but not treated|4|||
142943605|NCT00506389|515332290|FG001|In-treatment Period|Randomized but not treated|1|||
142943606|NCT00506389|515332291|FG002|In-treatment Period|Randomized but not treated|1|||
142943607|NCT02443402|515332296|FG000|Overall Study|Withdrawal by Subject|3|||
142943608|NCT02443402|515332297|FG001|Overall Study|Withdrawal by Subject|1|||
142943609|NCT02443402|515332296|FG000|Overall Study|Screen Failure|1|||
142943610|NCT02443402|515332297|FG001|Overall Study|Screen Failure|2|||
142943611|NCT01934504|515332298|FG000|Overall Study|Protocol Deviation|0|||
142943612|NCT01934504|515332299|FG001|Overall Study|Protocol Deviation|0|||
142943613|NCT01934504|515332300|FG002|Overall Study|Protocol Deviation|0|||
142943614|NCT01934504|515332301|FG003|Overall Study|Protocol Deviation|2|||
142943615|NCT01934504|515332298|FG000|Overall Study|Study Terminated by Sponsor|1|||
142943616|NCT01934504|515332299|FG001|Overall Study|Study Terminated by Sponsor|0|||
142943617|NCT01934504|515332300|FG002|Overall Study|Study Terminated by Sponsor|5|||
142943618|NCT01934504|515332301|FG003|Overall Study|Study Terminated by Sponsor|5|||
142943619|NCT02665689|515332302|FG000|Overall Study|Adverse Event|1|||
142943620|NCT02665689|515332303|FG001|Overall Study|Adverse Event|0|||
142943621|NCT02665689|515332302|FG000|Overall Study|Trial termination|1|||
142943622|NCT02665689|515332303|FG001|Overall Study|Trial termination|1|||
142943623|NCT02665689|515332302|FG000|Overall Study|Lost to Follow-up|0|||
142943624|NCT02665689|515332303|FG001|Overall Study|Lost to Follow-up|1|||
142943625|NCT00486902|515332304|FG000|Overall Study|Withdrawal by Subject|1|||
142943626|NCT00486902|515332305|FG001|Overall Study|Withdrawal by Subject|2|||
142943627|NCT00486902|515332304|FG000|Overall Study|decision for postpartum tubal ligation|3|||
142943628|NCT00486902|515332305|FG001|Overall Study|decision for postpartum tubal ligation|1|||
142943629|NCT00486902|515332304|FG000|Overall Study|spinal anesthetic protocal violation|1|||
142943630|NCT00486902|515332305|FG001|Overall Study|spinal anesthetic protocal violation|1|||
142943631|NCT00486902|515332304|FG000|Overall Study|Did not meet inclusion criteria|1|||
142943632|NCT00486902|515332305|FG001|Overall Study|Did not meet inclusion criteria|0|||
142943633|NCT00486902|515332304|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
142943634|NCT00486902|515332305|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
142943635|NCT02900092|515332306|FG000|Overall Study|Adverse Event|1|||
142943636|NCT04178590|515332307|FG000|Overall Study|Pregnancy|1|||
142943637|NCT04178590|515332307|FG000|Overall Study|Lost to Follow-up|1|||
142943638|NCT04889209|515332308|FG000|All Cohorts Except 15E|Adverse Event|0|||
142943639|NCT04889209|515332309|FG001|All Cohorts Except 15E|Adverse Event|0|||
142943640|NCT04889209|515332310|FG002|All Cohorts Except 15E|Adverse Event|0|||
142943641|NCT04889209|515332311|FG003|All Cohorts Except 15E|Adverse Event|0|||
142943642|NCT04889209|515332312|FG004|All Cohorts Except 15E|Adverse Event|0|||
142943643|NCT04889209|515332313|FG005|All Cohorts Except 15E|Adverse Event|0|||
142943644|NCT04889209|515332314|FG006|All Cohorts Except 15E|Adverse Event|1|||
142943645|NCT04889209|515332315|FG007|All Cohorts Except 15E|Adverse Event|0|||
142943646|NCT04889209|515332316|FG008|All Cohorts Except 15E|Adverse Event|0|||
142943647|NCT04889209|515332317|FG009|All Cohorts Except 15E|Adverse Event|0|||
142943648|NCT04889209|515332318|FG010|All Cohorts Except 15E|Adverse Event|0|||
142943649|NCT04889209|515332319|FG011|All Cohorts Except 15E|Adverse Event|0|||
142943650|NCT04889209|515332320|FG012|All Cohorts Except 15E|Adverse Event|0|||
142943651|NCT04889209|515332321|FG013|All Cohorts Except 15E|Adverse Event|0|||
142943652|NCT04889209|515332322|FG014|All Cohorts Except 15E|Adverse Event|0|||
142943653|NCT04889209|515332323|FG015|All Cohorts Except 15E|Adverse Event|0|||
142943654|NCT04889209|515332324|FG016|All Cohorts Except 15E|Adverse Event|0|||
142943655|NCT04889209|515332325|FG017|All Cohorts Except 15E|Adverse Event|0|||
143454909|NCT02663518|517210766|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
142943656|NCT04889209|515332308|FG000|All Cohorts Except 15E|Death|0|||
142943657|NCT04889209|515332309|FG001|All Cohorts Except 15E|Death|1|||
142943658|NCT04889209|515332310|FG002|All Cohorts Except 15E|Death|0|||
142943659|NCT04889209|515332311|FG003|All Cohorts Except 15E|Death|0|||
142943660|NCT04889209|515332312|FG004|All Cohorts Except 15E|Death|0|||
142943661|NCT04889209|515332313|FG005|All Cohorts Except 15E|Death|0|||
142943662|NCT04889209|515332314|FG006|All Cohorts Except 15E|Death|0|||
142943663|NCT04889209|515332315|FG007|All Cohorts Except 15E|Death|0|||
142943664|NCT04889209|515332316|FG008|All Cohorts Except 15E|Death|0|||
142943665|NCT04889209|515332317|FG009|All Cohorts Except 15E|Death|0|||
142943666|NCT04889209|515332318|FG010|All Cohorts Except 15E|Death|0|||
142943667|NCT04889209|515332319|FG011|All Cohorts Except 15E|Death|0|||
142943668|NCT04889209|515332320|FG012|All Cohorts Except 15E|Death|0|||
142943669|NCT04889209|515332321|FG013|All Cohorts Except 15E|Death|0|||
142943670|NCT04889209|515332322|FG014|All Cohorts Except 15E|Death|0|||
142943671|NCT04889209|515332323|FG015|All Cohorts Except 15E|Death|0|||
142943672|NCT04889209|515332324|FG016|All Cohorts Except 15E|Death|0|||
142943673|NCT04889209|515332325|FG017|All Cohorts Except 15E|Death|0|||
142943674|NCT04889209|515332308|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
142943675|NCT04889209|515332309|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
142943676|NCT04889209|515332310|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
142943677|NCT04889209|515332311|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
142943678|NCT04889209|515332312|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
142943679|NCT04889209|515332313|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
142943680|NCT04889209|515332314|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
142943681|NCT04889209|515332315|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
142943682|NCT04889209|515332316|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
142943683|NCT04889209|515332317|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
142943684|NCT04889209|515332318|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
142943685|NCT04889209|515332319|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
142943686|NCT04889209|515332320|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
142943687|NCT04889209|515332321|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
142943688|NCT04889209|515332322|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
142943689|NCT04889209|515332323|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
142943690|NCT04889209|515332324|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
142943691|NCT04889209|515332325|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
142943692|NCT04889209|515332308|FG000|All Cohorts Except 15E|Physician Decision|0|||
142943693|NCT04889209|515332309|FG001|All Cohorts Except 15E|Physician Decision|0|||
142943694|NCT04889209|515332310|FG002|All Cohorts Except 15E|Physician Decision|0|||
142943695|NCT04889209|515332311|FG003|All Cohorts Except 15E|Physician Decision|0|||
142943696|NCT04889209|515332312|FG004|All Cohorts Except 15E|Physician Decision|1|||
142943697|NCT04889209|515332313|FG005|All Cohorts Except 15E|Physician Decision|0|||
142943698|NCT04889209|515332314|FG006|All Cohorts Except 15E|Physician Decision|0|||
142943699|NCT04889209|515332315|FG007|All Cohorts Except 15E|Physician Decision|1|||
142943700|NCT04889209|515332316|FG008|All Cohorts Except 15E|Physician Decision|0|||
142943701|NCT04889209|515332317|FG009|All Cohorts Except 15E|Physician Decision|1|||
142943702|NCT04889209|515332318|FG010|All Cohorts Except 15E|Physician Decision|0|||
142943703|NCT04889209|515332319|FG011|All Cohorts Except 15E|Physician Decision|1|||
142943704|NCT04889209|515332320|FG012|All Cohorts Except 15E|Physician Decision|1|||
142943705|NCT04889209|515332321|FG013|All Cohorts Except 15E|Physician Decision|0|||
142943706|NCT04889209|515332322|FG014|All Cohorts Except 15E|Physician Decision|0|||
142943707|NCT04889209|515332323|FG015|All Cohorts Except 15E|Physician Decision|0|||
142943708|NCT04889209|515332324|FG016|All Cohorts Except 15E|Physician Decision|0|||
142943709|NCT04889209|515332325|FG017|All Cohorts Except 15E|Physician Decision|0|||
142943710|NCT04889209|515332308|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
142943711|NCT04889209|515332309|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
142943712|NCT04889209|515332310|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
142943713|NCT04889209|515332311|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
142943714|NCT04889209|515332312|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
142943715|NCT04889209|515332313|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
142943716|NCT04889209|515332314|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
142943717|NCT04889209|515332315|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
142943718|NCT04889209|515332316|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
142943719|NCT04889209|515332317|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
142943720|NCT04889209|515332318|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
142943721|NCT04889209|515332319|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
142943722|NCT04889209|515332320|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
142943723|NCT04889209|515332321|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
142943724|NCT04889209|515332322|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
142943725|NCT04889209|515332323|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
142943726|NCT04889209|515332324|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
142943727|NCT04889209|515332325|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
142943728|NCT04889209|515332308|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
142943729|NCT04889209|515332309|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
142943730|NCT04889209|515332310|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
142943731|NCT04889209|515332311|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
142943732|NCT04889209|515332312|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
142943733|NCT04889209|515332313|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
142943734|NCT04889209|515332314|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
142943735|NCT04889209|515332315|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
142943736|NCT04889209|515332316|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
142943737|NCT04889209|515332317|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
142943738|NCT04889209|515332318|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
142943739|NCT04889209|515332319|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
143003054|NCT01049360|515548746|FG002|Period 1|Adverse Event|0|||
142943740|NCT04889209|515332320|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
142943741|NCT04889209|515332321|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
142943742|NCT04889209|515332322|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
142943743|NCT04889209|515332323|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
142943744|NCT04889209|515332324|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
142943745|NCT04889209|515332325|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
142943746|NCT04889209|515332308|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
142943747|NCT04889209|515332309|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
142943748|NCT04889209|515332310|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
142943749|NCT04889209|515332311|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
142943750|NCT04889209|515332312|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
142943751|NCT04889209|515332313|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
142943752|NCT04889209|515332314|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
142943753|NCT04889209|515332315|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
142943754|NCT04889209|515332316|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
142943755|NCT04889209|515332317|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
142943756|NCT04889209|515332318|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
142943757|NCT04889209|515332319|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
142943758|NCT04889209|515332320|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
142943759|NCT04889209|515332321|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
142943760|NCT04889209|515332322|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
142943761|NCT04889209|515332323|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
142943762|NCT04889209|515332324|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
142943763|NCT04889209|515332325|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
142943764|NCT04889209|515332308|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
142943765|NCT04889209|515332309|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
142943766|NCT04889209|515332310|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
142943767|NCT04889209|515332311|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
142943768|NCT04889209|515332312|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
142943769|NCT04889209|515332313|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
142943770|NCT04889209|515332314|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
142943771|NCT04889209|515332315|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
142943772|NCT04889209|515332316|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
142943773|NCT04889209|515332317|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
142943774|NCT04889209|515332318|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
142943775|NCT04889209|515332319|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
142943776|NCT04889209|515332320|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
142943777|NCT04889209|515332321|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
142943778|NCT04889209|515332322|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
142943779|NCT04889209|515332323|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
142943780|NCT04889209|515332324|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
142943781|NCT04889209|515332325|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
142943782|NCT04889209|515332308|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
142943783|NCT04889209|515332309|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
142943784|NCT04889209|515332310|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
142943785|NCT04889209|515332311|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
142943786|NCT04889209|515332312|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
142943787|NCT04889209|515332313|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
142943788|NCT04889209|515332314|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
142943789|NCT04889209|515332315|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
142943790|NCT04889209|515332316|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
142943791|NCT04889209|515332317|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
142943792|NCT04889209|515332318|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
142943793|NCT04889209|515332319|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
142943794|NCT04889209|515332320|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
142943795|NCT04889209|515332321|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
142943796|NCT04889209|515332322|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
142943797|NCT04889209|515332323|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
142943798|NCT04889209|515332324|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
142943799|NCT04889209|515332325|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
142943800|NCT04889209|515332308|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
142943801|NCT04889209|515332309|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
142943802|NCT04889209|515332310|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
142943803|NCT04889209|515332311|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
142943804|NCT04889209|515332312|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
142943805|NCT04889209|515332313|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
142943806|NCT04889209|515332314|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
142943807|NCT04889209|515332315|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
142943808|NCT04889209|515332316|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
142943809|NCT04889209|515332317|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
142943810|NCT04889209|515332318|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
142943811|NCT04889209|515332319|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
142943812|NCT04889209|515332320|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
142943813|NCT04889209|515332321|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
142943814|NCT04889209|515332322|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
142943815|NCT04889209|515332323|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
142943816|NCT04889209|515332324|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
142943817|NCT04889209|515332325|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
142943818|NCT04889209|515332308|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
142943819|NCT04889209|515332309|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
142943820|NCT04889209|515332310|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
142943821|NCT04889209|515332311|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
142943822|NCT04889209|515332312|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
142943823|NCT04889209|515332313|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
142943824|NCT04889209|515332314|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
142943825|NCT04889209|515332315|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
142943826|NCT04889209|515332316|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
142943827|NCT04889209|515332317|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
142943828|NCT04889209|515332318|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
142943829|NCT04889209|515332319|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
142943830|NCT04889209|515332320|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
142943831|NCT04889209|515332321|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
142943832|NCT04889209|515332322|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
142943833|NCT04889209|515332323|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
142943834|NCT04889209|515332324|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
142943835|NCT04889209|515332325|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
142943836|NCT04607408|515332326|FG000|Overall Study|Lost to Follow-up|0|||
142943837|NCT04607408|515332327|FG001|Overall Study|Lost to Follow-up|0|||
142943838|NCT04607408|515332328|FG002|Overall Study|Lost to Follow-up|0|||
142943839|NCT04607408|515332329|FG003|Overall Study|Lost to Follow-up|1|||
142943840|NCT04607408|515332330|FG004|Overall Study|Lost to Follow-up|0|||
142943841|NCT04607408|515332326|FG000|Overall Study|Withdrawal by Subject|0|||
142943842|NCT04607408|515332327|FG001|Overall Study|Withdrawal by Subject|1|||
142943843|NCT04607408|515332328|FG002|Overall Study|Withdrawal by Subject|0|||
142943844|NCT04607408|515332329|FG003|Overall Study|Withdrawal by Subject|1|||
142943845|NCT04607408|515332330|FG004|Overall Study|Withdrawal by Subject|0|||
142943846|NCT01147497|515332333|FG000|Overall Study|failed insertion|2|||
142943847|NCT01147497|515332334|FG001|Overall Study|failed insertion|0|||
142943848|NCT04026568|515332335|FG000|Overall Study|study terminated|0|||
142943849|NCT04026568|515332336|FG001|Overall Study|study terminated|1|||
142943850|NCT02197377|515332339|FG000|Overall Study|Insertion Failure|0|||
142943851|NCT02197377|515332340|FG001|Overall Study|Insertion Failure|3|||
142943852|NCT00502840|515332341|FG000|Overall Study|Adverse Event|5|||
142943853|NCT00502840|515332341|FG000|Overall Study|Additional or changed therapy|48|||
142943854|NCT00502840|515332341|FG000|Overall Study|Lack of Efficacy|11|||
142943855|NCT00502840|515332341|FG000|Overall Study|Protocol Violation|4|||
142943856|NCT00502840|515332341|FG000|Overall Study|Withdrawal by Subject|5|||
142943857|NCT00502840|515332341|FG000|Overall Study|Lost to Follow-up|6|||
142943858|NCT00502840|515332341|FG000|Overall Study|Administrative problems|1|||
142943859|NCT00502840|515332341|FG000|Overall Study|Other|20|||
142943860|NCT01974323|515332342|FG000|Overall Study|Other Reasons|25|||
142943861|NCT01974323|515332343|FG001|Overall Study|Other Reasons|28|||
142943862|NCT01974323|515332342|FG000|Overall Study|Protocol Violation|2|||
142943863|NCT01974323|515332343|FG001|Overall Study|Protocol Violation|2|||
142943864|NCT01974323|515332342|FG000|Overall Study|Personal Reasons|15|||
142943865|NCT01974323|515332343|FG001|Overall Study|Personal Reasons|19|||
142943866|NCT01974323|515332342|FG000|Overall Study|Lost to Follow-up|45|||
142943867|NCT01974323|515332343|FG001|Overall Study|Lost to Follow-up|40|||
142943868|NCT01974323|515332342|FG000|Overall Study|Pregnancy|2|||
142943869|NCT01974323|515332343|FG001|Overall Study|Pregnancy|1|||
142943870|NCT01974323|515332342|FG000|Overall Study|Lack of Efficacy|1|||
142943871|NCT01974323|515332343|FG001|Overall Study|Lack of Efficacy|1|||
142943872|NCT01974323|515332342|FG000|Overall Study|Adverse Event|2|||
142943873|NCT01974323|515332343|FG001|Overall Study|Adverse Event|2|||
142943874|NCT00809133|515332344|FG000|Overall Study|Progressive disease|2|||
142943875|NCT00809133|515332345|FG001|Overall Study|Progressive disease|5|||
142943876|NCT00809133|515332346|FG002|Overall Study|Progressive disease|5|||
142943877|NCT00809133|515332347|FG003|Overall Study|Progressive disease|3|||
142943878|NCT00809133|515332348|FG004|Overall Study|Progressive disease|4|||
142943879|NCT00809133|515332349|FG005|Overall Study|Progressive disease|1|||
142943880|NCT00809133|515332350|FG006|Overall Study|Progressive disease|3|||
142943881|NCT00809133|515332351|FG007|Overall Study|Progressive disease|3|||
142943882|NCT00809133|515332352|FG008|Overall Study|Progressive disease|3|||
142943883|NCT00809133|515332353|FG009|Overall Study|Progressive disease|9|||
142943884|NCT00809133|515332354|FG010|Overall Study|Progressive disease|5|||
142943885|NCT00809133|515332355|FG011|Overall Study|Progressive disease|7|||
142943886|NCT00809133|515332356|FG012|Overall Study|Progressive disease|5|||
142943887|NCT00809133|515332357|FG013|Overall Study|Progressive disease|4|||
142943888|NCT00809133|515332344|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
142943889|NCT00809133|515332345|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
142943890|NCT00809133|515332346|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
142943891|NCT00809133|515332347|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
142943892|NCT00809133|515332348|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
142943893|NCT00809133|515332349|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
142943894|NCT00809133|515332350|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
142943895|NCT00809133|515332351|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
142943896|NCT00809133|515332352|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
142943897|NCT00809133|515332353|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
142943898|NCT00809133|515332354|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
142943899|NCT00809133|515332355|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
142943900|NCT00809133|515332356|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
142943901|NCT00809133|515332357|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
142943902|NCT00809133|515332344|FG000|Overall Study|Other adverse event|1|||
142943903|NCT00809133|515332345|FG001|Overall Study|Other adverse event|1|||
142943904|NCT00809133|515332346|FG002|Overall Study|Other adverse event|1|||
142943905|NCT00809133|515332347|FG003|Overall Study|Other adverse event|0|||
142943906|NCT00809133|515332348|FG004|Overall Study|Other adverse event|0|||
142943907|NCT00809133|515332349|FG005|Overall Study|Other adverse event|3|||
142943908|NCT00809133|515332350|FG006|Overall Study|Other adverse event|2|||
142943909|NCT00809133|515332351|FG007|Overall Study|Other adverse event|4|||
142943910|NCT00809133|515332352|FG008|Overall Study|Other adverse event|0|||
142943911|NCT00809133|515332353|FG009|Overall Study|Other adverse event|0|||
142943912|NCT00809133|515332354|FG010|Overall Study|Other adverse event|1|||
142943913|NCT00809133|515332355|FG011|Overall Study|Other adverse event|1|||
142943914|NCT00809133|515332356|FG012|Overall Study|Other adverse event|0|||
142943915|NCT00809133|515332357|FG013|Overall Study|Other adverse event|1|||
142943916|NCT00809133|515332344|FG000|Overall Study|Lost to Follow-up|0|||
142943917|NCT00809133|515332345|FG001|Overall Study|Lost to Follow-up|0|||
142943918|NCT00809133|515332346|FG002|Overall Study|Lost to Follow-up|0|||
142943919|NCT00809133|515332347|FG003|Overall Study|Lost to Follow-up|0|||
142943920|NCT00809133|515332348|FG004|Overall Study|Lost to Follow-up|0|||
142943921|NCT00809133|515332349|FG005|Overall Study|Lost to Follow-up|1|||
142943922|NCT00809133|515332350|FG006|Overall Study|Lost to Follow-up|0|||
142943923|NCT00809133|515332351|FG007|Overall Study|Lost to Follow-up|0|||
142943924|NCT00809133|515332352|FG008|Overall Study|Lost to Follow-up|0|||
142943925|NCT00809133|515332353|FG009|Overall Study|Lost to Follow-up|0|||
142943926|NCT00809133|515332354|FG010|Overall Study|Lost to Follow-up|0|||
142943927|NCT00809133|515332355|FG011|Overall Study|Lost to Follow-up|0|||
142943928|NCT00809133|515332356|FG012|Overall Study|Lost to Follow-up|0|||
142943929|NCT00809133|515332357|FG013|Overall Study|Lost to Follow-up|0|||
142943930|NCT00809133|515332344|FG000|Overall Study|Consent withdrawn|0|||
142943931|NCT00809133|515332345|FG001|Overall Study|Consent withdrawn|0|||
142943932|NCT00809133|515332346|FG002|Overall Study|Consent withdrawn|0|||
142943933|NCT00809133|515332347|FG003|Overall Study|Consent withdrawn|0|||
142943934|NCT00809133|515332348|FG004|Overall Study|Consent withdrawn|1|||
142943935|NCT00809133|515332349|FG005|Overall Study|Consent withdrawn|0|||
142943936|NCT00809133|515332350|FG006|Overall Study|Consent withdrawn|0|||
142943937|NCT00809133|515332351|FG007|Overall Study|Consent withdrawn|0|||
142943938|NCT00809133|515332352|FG008|Overall Study|Consent withdrawn|0|||
143454910|NCT02663518|517210767|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
142943939|NCT00809133|515332353|FG009|Overall Study|Consent withdrawn|0|||
142943940|NCT00809133|515332354|FG010|Overall Study|Consent withdrawn|0|||
142943941|NCT00809133|515332355|FG011|Overall Study|Consent withdrawn|0|||
142943942|NCT00809133|515332356|FG012|Overall Study|Consent withdrawn|0|||
142943943|NCT00809133|515332357|FG013|Overall Study|Consent withdrawn|0|||
142943944|NCT00809133|515332344|FG000|Overall Study|Other not mentioned above|0|||
142943945|NCT00809133|515332345|FG001|Overall Study|Other not mentioned above|1|||
142943946|NCT00809133|515332346|FG002|Overall Study|Other not mentioned above|0|||
142943947|NCT00809133|515332347|FG003|Overall Study|Other not mentioned above|0|||
142943948|NCT00809133|515332348|FG004|Overall Study|Other not mentioned above|0|||
142943949|NCT00809133|515332349|FG005|Overall Study|Other not mentioned above|1|||
142943950|NCT00809133|515332350|FG006|Overall Study|Other not mentioned above|0|||
142943951|NCT00809133|515332351|FG007|Overall Study|Other not mentioned above|0|||
142943952|NCT00809133|515332352|FG008|Overall Study|Other not mentioned above|0|||
142943953|NCT00809133|515332353|FG009|Overall Study|Other not mentioned above|0|||
142943954|NCT00809133|515332354|FG010|Overall Study|Other not mentioned above|0|||
142943955|NCT00809133|515332355|FG011|Overall Study|Other not mentioned above|0|||
142943956|NCT00809133|515332356|FG012|Overall Study|Other not mentioned above|0|||
142943957|NCT00809133|515332357|FG013|Overall Study|Other not mentioned above|0|||
142943958|NCT00619229|515332358|FG000|Overall Study|Withdrawal by Subject|1|||
142943959|NCT00619229|515332359|FG001|Overall Study|Withdrawal by Subject|1|||
142943960|NCT00619229|515332358|FG000|Overall Study|Lost to Follow-up|1|||
142943961|NCT00619229|515332359|FG001|Overall Study|Lost to Follow-up|0|||
142943962|NCT00619229|515332358|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
142943963|NCT00619229|515332359|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
142943964|NCT00619229|515332358|FG000|Overall Study|Investigator planned Cataract Operation|1|||
142943965|NCT00619229|515332359|FG001|Overall Study|Investigator planned Cataract Operation|0|||
142943966|NCT01700829|515332360|FG000|Overall Study|Withdrawal by Subject|1|||
142943967|NCT01700829|515332361|FG001|Overall Study|Withdrawal by Subject|1|||
142943968|NCT01075178|515332362|FG000|Subject Matching|eligible but not matched|130|||
142943969|NCT01075178|515332363|FG001|Subject Matching|eligible but not matched|403|||
142943970|NCT01075178|515332362|FG000|Subject Chart Review|died before chart review period|0|||
142943971|NCT01075178|515332363|FG001|Subject Chart Review|died before chart review period|2|||
142943972|NCT01075178|515332362|FG000|Subject Chart Review|no data collected due to site closure|3|||
142943973|NCT01075178|515332363|FG001|Subject Chart Review|no data collected due to site closure|4|||
142943974|NCT01075178|515332362|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
142943975|NCT01075178|515332363|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
142943976|NCT00727402|515332371|FG000|Overall Study|Physician Decision|116|||
142943977|NCT01287104|515332376|FG000|Overall Study|Patient developed progressive disease|1|||
142943978|NCT01287104|515332377|FG001|Overall Study|Patient developed progressive disease|1|||
142943979|NCT01287104|515332378|FG002|Overall Study|Patient developed progressive disease|3|||
142943980|NCT01287104|515332379|FG003|Overall Study|Patient developed progressive disease|2|||
142943981|NCT01287104|515332376|FG000|Overall Study|Donor anaphylaxis|0|||
142943982|NCT01287104|515332377|FG001|Overall Study|Donor anaphylaxis|1|||
142943983|NCT01287104|515332378|FG002|Overall Study|Donor anaphylaxis|0|||
142943984|NCT01287104|515332379|FG003|Overall Study|Donor anaphylaxis|1|||
142943985|NCT01287104|515332376|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
142943986|NCT01287104|515332377|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
142943987|NCT01287104|515332378|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
142943988|NCT01287104|515332379|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
142943989|NCT01287104|515332376|FG000|Overall Study|Low donor chimerism|0|||
142943990|NCT01287104|515332377|FG001|Overall Study|Low donor chimerism|1|||
142943991|NCT01287104|515332378|FG002|Overall Study|Low donor chimerism|0|||
142943992|NCT01287104|515332379|FG003|Overall Study|Low donor chimerism|0|||
142943993|NCT01287104|515332376|FG000|Overall Study|NK cells did not meet release criteria|0|||
142943994|NCT01287104|515332377|FG001|Overall Study|NK cells did not meet release criteria|1|||
142943995|NCT01287104|515332378|FG002|Overall Study|NK cells did not meet release criteria|0|||
142943996|NCT01287104|515332379|FG003|Overall Study|NK cells did not meet release criteria|0|||
142943997|NCT03068715|515332380|FG000|Overall Study|No longer met inclusion criteria|1|||
142943998|NCT03068715|515332381|FG001|Overall Study|No longer met inclusion criteria|0|||
142943999|NCT00098787|515332382|FG000|Overall Study|Never started treatment|3|||
142944000|NCT00098787|515332383|FG001|Overall Study|Never started treatment|2|||
142944001|NCT00098787|515332384|FG002|Overall Study|Never started treatment|1|||
142944002|NCT00098787|515332382|FG000|Overall Study|Ineligible|9|||
142944003|NCT00098787|515332383|FG001|Overall Study|Ineligible|7|||
142944004|NCT00098787|515332384|FG002|Overall Study|Ineligible|3|||
142944005|NCT00098787|515332382|FG000|Overall Study|Disease progression|28|||
142944006|NCT00098787|515332383|FG001|Overall Study|Disease progression|17|||
142944007|NCT00098787|515332384|FG002|Overall Study|Disease progression|23|||
142944008|NCT00098787|515332382|FG000|Overall Study|Adverse Event|8|||
142944009|NCT00098787|515332383|FG001|Overall Study|Adverse Event|17|||
142944010|NCT00098787|515332384|FG002|Overall Study|Adverse Event|8|||
142944011|NCT00098787|515332382|FG000|Overall Study|Death|6|||
142944012|NCT00098787|515332383|FG001|Overall Study|Death|1|||
142944013|NCT00098787|515332384|FG002|Overall Study|Death|0|||
142944014|NCT00098787|515332382|FG000|Overall Study|Withdrawal by Subject|4|||
142944015|NCT00098787|515332383|FG001|Overall Study|Withdrawal by Subject|12|||
142944016|NCT00098787|515332384|FG002|Overall Study|Withdrawal by Subject|6|||
142944017|NCT00098787|515332382|FG000|Overall Study|Alternative therapy|8|||
142944018|NCT00098787|515332383|FG001|Overall Study|Alternative therapy|13|||
142944019|NCT00098787|515332384|FG002|Overall Study|Alternative therapy|13|||
142944020|NCT00098787|515332382|FG000|Overall Study|Other|7|||
142944021|NCT00098787|515332383|FG001|Overall Study|Other|6|||
142944022|NCT00098787|515332384|FG002|Overall Study|Other|9|||
142944023|NCT00684814|515332385|FG000|Washout Period of 7 Days|Adverse Event|1|||
142944024|NCT00684814|515332386|FG001|Washout Period of 7 Days|Adverse Event|2|||
142944025|NCT00684814|515332385|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
142944026|NCT00684814|515332386|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
142944027|NCT00684814|515332385|FG000|Second Intervention|Adverse Event|1|||
142944028|NCT00684814|515332386|FG001|Second Intervention|Adverse Event|0|||
142944029|NCT03168867|515332387|FG000|Overall Study|Withdrawal by Subject|1|||
142944030|NCT03168867|515332388|FG001|Overall Study|Withdrawal by Subject|5|||
142944031|NCT04348851|515332389|FG000|Post-Test 1|Withdrawal by Subject|0|||
142944032|NCT04348851|515332390|FG001|Post-Test 1|Withdrawal by Subject|1|||
142944033|NCT04348851|515332391|FG002|Post-Test 1|Withdrawal by Subject|0|||
142944034|NCT04348851|515332392|FG003|Post-Test 1|Withdrawal by Subject|0|||
142944035|NCT04348851|515332389|FG000|Post-Test 1|Lost to Follow-up|0|||
142944036|NCT04348851|515332390|FG001|Post-Test 1|Lost to Follow-up|1|||
142944037|NCT04348851|515332391|FG002|Post-Test 1|Lost to Follow-up|0|||
142944038|NCT04348851|515332392|FG003|Post-Test 1|Lost to Follow-up|0|||
142944039|NCT04348851|515332389|FG000|Post-Test 2|Stroke survivor death|0|||
142944040|NCT04348851|515332390|FG001|Post-Test 2|Stroke survivor death|1|||
142944041|NCT04348851|515332391|FG002|Post-Test 2|Stroke survivor death|0|||
142944042|NCT04348851|515332392|FG003|Post-Test 2|Stroke survivor death|1|||
142944043|NCT00195650|515332393|FG000|Overall Study|Adverse Event|194|||
142944044|NCT00195650|515332393|FG000|Overall Study|Lack of Efficacy|99|||
142944045|NCT00195650|515332393|FG000|Overall Study|Withdrawal by Subject|67|||
142944046|NCT00195650|515332393|FG000|Overall Study|Lost to Follow-up|44|||
142944047|NCT00195650|515332393|FG000|Overall Study|Death|23|||
142944048|NCT00195650|515332393|FG000|Overall Study|Protocol Violation|15|||
142944049|NCT00195650|515332393|FG000|Overall Study|Administrative reasons|83|||
142944050|NCT05292755|515332394|FG000|Overall Study|Lost to Follow-up|5|||
142944051|NCT05292755|515332395|FG001|Overall Study|Lost to Follow-up|9|||
142944052|NCT00432809|515332396|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
142944053|NCT00432809|515332397|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
142944054|NCT00432809|515332398|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
142944055|NCT00432809|515332396|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
142944056|NCT00432809|515332397|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
142944057|NCT00432809|515332398|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
142944058|NCT03075839|515332399|FG000|Overall Study|Lost to Follow-up|4|||
142944059|NCT00190775|515332400|FG000|Overall Study|Adverse Event|57|||
142944060|NCT00190775|515332401|FG001|Overall Study|Adverse Event|22|||
142944061|NCT00190775|515332400|FG000|Overall Study|Satisfactory Response|1|||
142944062|NCT00190775|515332401|FG001|Overall Study|Satisfactory Response|0|||
142944063|NCT00190775|515332400|FG000|Overall Study|Lack of Efficacy|28|||
142944064|NCT00190775|515332401|FG001|Overall Study|Lack of Efficacy|32|||
142944065|NCT00190775|515332400|FG000|Overall Study|Lost to Follow-up|31|||
142944066|NCT00190775|515332401|FG001|Overall Study|Lost to Follow-up|23|||
142944067|NCT00190775|515332400|FG000|Overall Study|Participant Moved|0|||
142944068|NCT00190775|515332401|FG001|Overall Study|Participant Moved|1|||
142944069|NCT00190775|515332400|FG000|Overall Study|Withdrawal by Subject|24|||
142944070|NCT00190775|515332401|FG001|Overall Study|Withdrawal by Subject|13|||
142944071|NCT00190775|515332400|FG000|Overall Study|Sponsor Decision|1|||
142944072|NCT00190775|515332401|FG001|Overall Study|Sponsor Decision|0|||
142944073|NCT00190775|515332400|FG000|Overall Study|Physician Decision|3|||
142944074|NCT00190775|515332401|FG001|Overall Study|Physician Decision|0|||
142944075|NCT00190775|515332400|FG000|Overall Study|Noncompliance|3|||
142944076|NCT00190775|515332401|FG001|Overall Study|Noncompliance|5|||
142944077|NCT00190775|515332400|FG000|Overall Study|Protocol Violation|0|||
142944078|NCT00190775|515332401|FG001|Overall Study|Protocol Violation|1|||
142944079|NCT00190775|515332400|FG000|Overall Study|Exclusion Criteria Met|1|||
142944080|NCT00190775|515332401|FG001|Overall Study|Exclusion Criteria Met|3|||
142944081|NCT01491945|515332402|FG000|Overall Study|Death|30|||
142944082|NCT01491945|515332402|FG000|Overall Study|Withdrwan/LTF|16|||
142944083|NCT01491945|515332402|FG000|Overall Study|Conversion|4|||
142944084|NCT01491945|515332402|FG000|Overall Study|Missed Visit|1|||
142944085|NCT01709331|515332405|FG000|Overall Study|Adverse Event|1|||
142944086|NCT02305563|515332407|FG000|Treatment Period|Disease progression|0|||
142944087|NCT02305563|515332408|FG001|Treatment Period|Disease progression|0|||
142944088|NCT02305563|515332409|FG002|Treatment Period|Disease progression|15|||
142944089|NCT02305563|515332410|FG003|Treatment Period|Disease progression|6|||
142944090|NCT02305563|515332411|FG004|Treatment Period|Disease progression|6|||
142944091|NCT02305563|515332407|FG000|Treatment Period|Study drug toxicity|0|||
142944092|NCT02305563|515332408|FG001|Treatment Period|Study drug toxicity|0|||
142944093|NCT02305563|515332409|FG002|Treatment Period|Study drug toxicity|0|||
142944094|NCT02305563|515332410|FG003|Treatment Period|Study drug toxicity|1|||
142944095|NCT02305563|515332411|FG004|Treatment Period|Study drug toxicity|2|||
142944096|NCT02305563|515332407|FG000|Treatment Period|Death|0|||
142944097|NCT02305563|515332408|FG001|Treatment Period|Death|0|||
142944098|NCT02305563|515332409|FG002|Treatment Period|Death|1|||
142944099|NCT02305563|515332410|FG003|Treatment Period|Death|2|||
142944100|NCT02305563|515332411|FG004|Treatment Period|Death|1|||
142944101|NCT02305563|515332407|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
142944102|NCT02305563|515332408|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
142944103|NCT02305563|515332409|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
142944104|NCT02305563|515332410|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
142944105|NCT02305563|515332411|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
142944106|NCT02305563|515332407|FG000|Treatment Period|Participant request to stop therapy|0|||
142944107|NCT02305563|515332408|FG001|Treatment Period|Participant request to stop therapy|2|||
142944108|NCT02305563|515332409|FG002|Treatment Period|Participant request to stop therapy|0|||
142944109|NCT02305563|515332410|FG003|Treatment Period|Participant request to stop therapy|1|||
142944110|NCT02305563|515332411|FG004|Treatment Period|Participant request to stop therapy|0|||
142944111|NCT02305563|515332407|FG000|Treatment Period|Participant withdrew consent|0|||
142944112|NCT02305563|515332408|FG001|Treatment Period|Participant withdrew consent|0|||
142944113|NCT02305563|515332409|FG002|Treatment Period|Participant withdrew consent|1|||
142944114|NCT02305563|515332410|FG003|Treatment Period|Participant withdrew consent|1|||
142944115|NCT02305563|515332411|FG004|Treatment Period|Participant withdrew consent|1|||
142944116|NCT02305563|515332407|FG000|Treatment Period|Maximum clinical benefit|0|||
142944117|NCT02305563|515332408|FG001|Treatment Period|Maximum clinical benefit|0|||
142944118|NCT02305563|515332409|FG002|Treatment Period|Maximum clinical benefit|0|||
142944119|NCT02305563|515332410|FG003|Treatment Period|Maximum clinical benefit|0|||
142944120|NCT02305563|515332411|FG004|Treatment Period|Maximum clinical benefit|1|||
142944121|NCT02305563|515332407|FG000|Treatment Period|Poor/non-compliance|0|||
142944122|NCT02305563|515332408|FG001|Treatment Period|Poor/non-compliance|0|||
142944123|NCT02305563|515332409|FG002|Treatment Period|Poor/non-compliance|0|||
142944124|NCT02305563|515332410|FG003|Treatment Period|Poor/non-compliance|0|||
142944125|NCT02305563|515332411|FG004|Treatment Period|Poor/non-compliance|1|||
142944126|NCT02305563|515332407|FG000|Treatment Period|Administrative reason by Sponsor|0|||
142944127|NCT02305563|515332408|FG001|Treatment Period|Administrative reason by Sponsor|0|||
142944128|NCT02305563|515332409|FG002|Treatment Period|Administrative reason by Sponsor|0|||
142944129|NCT02305563|515332410|FG003|Treatment Period|Administrative reason by Sponsor|0|||
142944130|NCT02305563|515332411|FG004|Treatment Period|Administrative reason by Sponsor|1|||
142944131|NCT02305563|515332407|FG000|Treatment Period|other reason|2|||
142944132|NCT02305563|515332408|FG001|Treatment Period|other reason|0|||
142944133|NCT02305563|515332409|FG002|Treatment Period|other reason|2|||
142944134|NCT02305563|515332410|FG003|Treatment Period|other reason|2|||
142944135|NCT02305563|515332411|FG004|Treatment Period|other reason|1|||
142944136|NCT02305563|515332407|FG000|Treatment Period|Randomized but not treated|0|||
142944137|NCT02305563|515332408|FG001|Treatment Period|Randomized but not treated|0|||
142944138|NCT02305563|515332409|FG002|Treatment Period|Randomized but not treated|0|||
142944139|NCT02305563|515332410|FG003|Treatment Period|Randomized but not treated|0|||
142944140|NCT02305563|515332411|FG004|Treatment Period|Randomized but not treated|2|||
142944141|NCT02305563|515332407|FG000|Treatment Period|added ULO, then disease progression|0|||
142944142|NCT02305563|515332408|FG001|Treatment Period|added ULO, then disease progression|0|||
142944143|NCT02305563|515332409|FG002|Treatment Period|added ULO, then disease progression|0|||
142944144|NCT02305563|515332410|FG003|Treatment Period|added ULO, then disease progression|0|||
142944145|NCT02305563|515332411|FG004|Treatment Period|added ULO, then disease progression|4|||
142944146|NCT02305563|515332407|FG000|Treatment Period|added ULO; then other reason|0|||
142944147|NCT02305563|515332408|FG001|Treatment Period|added ULO; then other reason|0|||
142944148|NCT02305563|515332409|FG002|Treatment Period|added ULO; then other reason|0|||
142944149|NCT02305563|515332410|FG003|Treatment Period|added ULO; then other reason|0|||
142944150|NCT02305563|515332411|FG004|Treatment Period|added ULO; then other reason|1|||
142944151|NCT02305563|515332407|FG000|Treatment Period|added ULO, then request to stop|0|||
142944152|NCT02305563|515332408|FG001|Treatment Period|added ULO, then request to stop|0|||
142944153|NCT02305563|515332409|FG002|Treatment Period|added ULO, then request to stop|0|||
142944154|NCT02305563|515332410|FG003|Treatment Period|added ULO, then request to stop|0|||
142944155|NCT02305563|515332411|FG004|Treatment Period|added ULO, then request to stop|1|||
142944156|NCT02305563|515332407|FG000|Follow-up Period|Death|0|||
142944157|NCT02305563|515332408|FG001|Follow-up Period|Death|0|||
142944158|NCT02305563|515332409|FG002|Follow-up Period|Death|5|||
142944159|NCT02305563|515332410|FG003|Follow-up Period|Death|4|||
142944160|NCT02305563|515332411|FG004|Follow-up Period|Death|7|||
142944161|NCT02305563|515332407|FG000|Follow-up Period|Participant withdrew consent|0|||
142944162|NCT02305563|515332408|FG001|Follow-up Period|Participant withdrew consent|0|||
142944163|NCT02305563|515332409|FG002|Follow-up Period|Participant withdrew consent|2|||
142944164|NCT02305563|515332410|FG003|Follow-up Period|Participant withdrew consent|1|||
142944165|NCT02305563|515332411|FG004|Follow-up Period|Participant withdrew consent|0|||
142944166|NCT02305563|515332407|FG000|Follow-up Period|other reason|0|||
142944167|NCT02305563|515332408|FG001|Follow-up Period|other reason|0|||
142944168|NCT02305563|515332409|FG002|Follow-up Period|other reason|0|||
142944169|NCT02305563|515332410|FG003|Follow-up Period|other reason|0|||
142944170|NCT02305563|515332411|FG004|Follow-up Period|other reason|1|||
142944171|NCT02305563|515332407|FG000|Follow-up Period|Followup no longer required per protocol|3|||
142944172|NCT02305563|515332408|FG001|Follow-up Period|Followup no longer required per protocol|3|||
142944173|NCT02305563|515332409|FG002|Follow-up Period|Followup no longer required per protocol|4|||
142944174|NCT02305563|515332410|FG003|Follow-up Period|Followup no longer required per protocol|1|||
142944175|NCT02305563|515332411|FG004|Follow-up Period|Followup no longer required per protocol|4|||
142944176|NCT00642642|515332416|FG000|Treatment & Follow Up|Adverse Event|2|||
142944177|NCT00642642|515332416|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
142944178|NCT00642642|515332416|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
142944179|NCT00144170|515332417|FG000|Overall Study|Adverse Event|84|||
142944180|NCT00144170|515332418|FG001|Overall Study|Adverse Event|41|||
142944181|NCT00144170|515332417|FG000|Overall Study|Protocol Violation|23|||
142944182|NCT00144170|515332418|FG001|Overall Study|Protocol Violation|16|||
142944183|NCT00144170|515332417|FG000|Overall Study|Lost to Follow-up|5|||
142944184|NCT00144170|515332418|FG001|Overall Study|Lost to Follow-up|10|||
142944185|NCT00144170|515332417|FG000|Overall Study|Withdrawal by Subject|29|||
142944186|NCT00144170|515332418|FG001|Overall Study|Withdrawal by Subject|13|||
142944187|NCT00144170|515332417|FG000|Overall Study|Other reason not defined above|211|||
142944188|NCT00144170|515332418|FG001|Overall Study|Other reason not defined above|316|||
142944189|NCT01523873|515332423|FG000|Overall Study|Protocol Violation|422|||
142944190|NCT04030195|515334384|FG000|Overall Study|Withdrawal by Subject|2|||
142944191|NCT04030195|515334385|FG001|Overall Study|Withdrawal by Subject|0|||
142944192|NCT04030195|515334386|FG002|Overall Study|Withdrawal by Subject|0|||
142944193|NCT02109029|515334387|FG000|Part B|Adverse Event|0|||
142944194|NCT02109029|515334388|FG001|Part B|Adverse Event|0|||
142944195|NCT02109029|515334389|FG002|Part B|Adverse Event|0|||
142944196|NCT02109029|515334390|FG003|Part B|Adverse Event|0|||
142944197|NCT02109029|515334391|FG004|Part B|Adverse Event|1|||
142944198|NCT02109029|515334392|FG005|Part B|Adverse Event|1|||
142944199|NCT03263091|515334396|FG000|OL Component|Withdrawal by Subject|1|||
142944200|NCT03263091|515334397|FG001|OL Component|Withdrawal by Subject|1|||
142944201|NCT03263091|515334398|FG002|OL Component|Withdrawal by Subject|0|||
142944202|NCT03263091|515334399|FG003|OL Component|Withdrawal by Subject|0|||
142944203|NCT03263091|515334400|FG004|OL Component|Withdrawal by Subject|0|||
142944204|NCT03263091|515334401|FG005|OL Component|Withdrawal by Subject|0|||
142944205|NCT03263091|515334396|FG000|OL Component|Physician Decision|0|||
142944206|NCT03263091|515334397|FG001|OL Component|Physician Decision|1|||
142944207|NCT03263091|515334398|FG002|OL Component|Physician Decision|2|||
142944208|NCT03263091|515334399|FG003|OL Component|Physician Decision|0|||
142944209|NCT03263091|515334400|FG004|OL Component|Physician Decision|0|||
142944210|NCT03263091|515334401|FG005|OL Component|Physician Decision|0|||
142944211|NCT03263091|515334396|FG000|OL Component|Death|1|||
142944212|NCT03263091|515334397|FG001|OL Component|Death|0|||
142944213|NCT03263091|515334398|FG002|OL Component|Death|0|||
142944214|NCT03263091|515334399|FG003|OL Component|Death|0|||
142944215|NCT03263091|515334400|FG004|OL Component|Death|0|||
142944216|NCT03263091|515334401|FG005|OL Component|Death|0|||
142944217|NCT03263091|515334396|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
142944218|NCT03263091|515334397|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
142944219|NCT03263091|515334398|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
142944220|NCT03263091|515334399|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
142944221|NCT03263091|515334400|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
142944222|NCT03263091|515334401|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
142944223|NCT03263091|515334396|FG000|OL High-EPO Component|Physician Decision|0|||
142944224|NCT03263091|515334397|FG001|OL High-EPO Component|Physician Decision|0|||
142944225|NCT03263091|515334398|FG002|OL High-EPO Component|Physician Decision|0|||
142944226|NCT03263091|515334399|FG003|OL High-EPO Component|Physician Decision|1|||
142944227|NCT03263091|515334400|FG004|OL High-EPO Component|Physician Decision|0|||
142944228|NCT03263091|515334401|FG005|OL High-EPO Component|Physician Decision|0|||
142944229|NCT03263091|515334396|FG000|OL High-EPO Component|Death|0|||
142944230|NCT03263091|515334397|FG001|OL High-EPO Component|Death|0|||
142944231|NCT03263091|515334398|FG002|OL High-EPO Component|Death|0|||
142944232|NCT03263091|515334399|FG003|OL High-EPO Component|Death|3|||
142944233|NCT03263091|515334400|FG004|OL High-EPO Component|Death|0|||
142944234|NCT03263091|515334401|FG005|OL High-EPO Component|Death|0|||
142944235|NCT03263091|515334396|FG000|DB Component|Withdrawal by Subject|0|||
142944236|NCT03263091|515334397|FG001|DB Component|Withdrawal by Subject|0|||
142944237|NCT03263091|515334398|FG002|DB Component|Withdrawal by Subject|0|||
142944238|NCT03263091|515334399|FG003|DB Component|Withdrawal by Subject|0|||
142944239|NCT03263091|515334400|FG004|DB Component|Withdrawal by Subject|22|||
142944240|NCT03263091|515334401|FG005|DB Component|Withdrawal by Subject|8|||
142944241|NCT03263091|515334396|FG000|DB Component|Physician Decision|0|||
142944242|NCT03263091|515334397|FG001|DB Component|Physician Decision|0|||
142944243|NCT03263091|515334398|FG002|DB Component|Physician Decision|0|||
142944244|NCT03263091|515334399|FG003|DB Component|Physician Decision|0|||
142944245|NCT03263091|515334400|FG004|DB Component|Physician Decision|3|||
142944246|NCT03263091|515334401|FG005|DB Component|Physician Decision|1|||
142944247|NCT03263091|515334396|FG000|DB Component|Adverse Event|0|||
142944248|NCT03263091|515334397|FG001|DB Component|Adverse Event|0|||
142944249|NCT03263091|515334398|FG002|DB Component|Adverse Event|0|||
142944250|NCT03263091|515334399|FG003|DB Component|Adverse Event|0|||
142944251|NCT03263091|515334400|FG004|DB Component|Adverse Event|2|||
142944252|NCT03263091|515334401|FG005|DB Component|Adverse Event|1|||
142944253|NCT03263091|515334396|FG000|DB Component|Lost to Follow-up|0|||
142944254|NCT03263091|515334397|FG001|DB Component|Lost to Follow-up|0|||
142944255|NCT03263091|515334398|FG002|DB Component|Lost to Follow-up|0|||
142944256|NCT03263091|515334399|FG003|DB Component|Lost to Follow-up|0|||
142944257|NCT03263091|515334400|FG004|DB Component|Lost to Follow-up|2|||
142944258|NCT03263091|515334401|FG005|DB Component|Lost to Follow-up|1|||
142944259|NCT03263091|515334396|FG000|DB Component|Death|0|||
142944260|NCT03263091|515334397|FG001|DB Component|Death|0|||
142944261|NCT03263091|515334398|FG002|DB Component|Death|0|||
142944262|NCT03263091|515334399|FG003|DB Component|Death|0|||
142944263|NCT03263091|515334400|FG004|DB Component|Death|7|||
142944264|NCT03263091|515334401|FG005|DB Component|Death|4|||
142944265|NCT03263091|515334396|FG000|DB Component|Other than specified|0|||
142944266|NCT03263091|515334397|FG001|DB Component|Other than specified|0|||
142944267|NCT03263091|515334398|FG002|DB Component|Other than specified|0|||
142944268|NCT03263091|515334399|FG003|DB Component|Other than specified|0|||
142944269|NCT03263091|515334400|FG004|DB Component|Other than specified|8|||
142944270|NCT03263091|515334401|FG005|DB Component|Other than specified|6|||
142944271|NCT01381094|515334402|FG000|Overall Study|Adverse Event|1|||
142944272|NCT01381094|515334403|FG001|Overall Study|Adverse Event|2|||
142944273|NCT01381094|515334404|FG002|Overall Study|Adverse Event|0|||
142944274|NCT01381094|515334405|FG003|Overall Study|Adverse Event|1|||
142944275|NCT01381094|515334406|FG004|Overall Study|Adverse Event|0|||
142944276|NCT01381094|515334402|FG000|Overall Study|Lost to Follow-up|0|||
142944277|NCT01381094|515334403|FG001|Overall Study|Lost to Follow-up|0|||
142944278|NCT01381094|515334404|FG002|Overall Study|Lost to Follow-up|0|||
142944279|NCT01381094|515334405|FG003|Overall Study|Lost to Follow-up|0|||
142944280|NCT01381094|515334406|FG004|Overall Study|Lost to Follow-up|1|||
142944281|NCT01381094|515334402|FG000|Overall Study|Withdrawal of informed consent|0|||
142944282|NCT01381094|515334403|FG001|Overall Study|Withdrawal of informed consent|1|||
142944283|NCT01381094|515334404|FG002|Overall Study|Withdrawal of informed consent|0|||
142944284|NCT01381094|515334405|FG003|Overall Study|Withdrawal of informed consent|0|||
142944285|NCT01381094|515334406|FG004|Overall Study|Withdrawal of informed consent|0|||
142944286|NCT01381094|515334402|FG000|Overall Study|Participant given Aranesp injection|1|||
142944287|NCT01381094|515334403|FG001|Overall Study|Participant given Aranesp injection|0|||
142944288|NCT01381094|515334404|FG002|Overall Study|Participant given Aranesp injection|0|||
142944289|NCT01381094|515334405|FG003|Overall Study|Participant given Aranesp injection|0|||
142944290|NCT01381094|515334406|FG004|Overall Study|Participant given Aranesp injection|0|||
142944291|NCT01552057|515334410|FG000|Overall Study|Adverse Event|14|||
142944292|NCT01552057|515334411|FG001|Overall Study|Adverse Event|15|||
142944293|NCT01552057|515334410|FG000|Overall Study|Lack of Efficacy|8|||
142944294|NCT01552057|515334411|FG001|Overall Study|Lack of Efficacy|23|||
142944295|NCT01552057|515334410|FG000|Overall Study|Withdrawal by Subject|5|||
142944296|NCT01552057|515334411|FG001|Overall Study|Withdrawal by Subject|8|||
142944297|NCT01552057|515334410|FG000|Overall Study|Entry Criteria Not Met|2|||
142944298|NCT01552057|515334411|FG001|Overall Study|Entry Criteria Not Met|2|||
142944299|NCT01552057|515334410|FG000|Overall Study|Physician Decision|1|||
142944300|NCT01552057|515334411|FG001|Overall Study|Physician Decision|0|||
142944301|NCT00996840|515334412|FG000|Overall Study|Adverse Event|0|||
142944302|NCT00996840|515334413|FG001|Overall Study|Adverse Event|1|||
142944303|NCT00996840|515334414|FG002|Overall Study|Adverse Event|0|||
142944304|NCT00996840|515334415|FG003|Overall Study|Adverse Event|0|||
142944305|NCT00996840|515334416|FG004|Overall Study|Adverse Event|0|||
142944306|NCT00996840|515334412|FG000|Overall Study|Physician Decision|0|||
142944307|NCT00996840|515334413|FG001|Overall Study|Physician Decision|0|||
142944308|NCT00996840|515334414|FG002|Overall Study|Physician Decision|1|||
142944309|NCT00996840|515334415|FG003|Overall Study|Physician Decision|1|||
142944310|NCT00996840|515334416|FG004|Overall Study|Physician Decision|2|||
142944311|NCT00996840|515334412|FG000|Overall Study|Withdrawal by Subject|1|||
142944312|NCT00996840|515334413|FG001|Overall Study|Withdrawal by Subject|1|||
142944313|NCT00996840|515334414|FG002|Overall Study|Withdrawal by Subject|0|||
142944314|NCT00996840|515334415|FG003|Overall Study|Withdrawal by Subject|0|||
142944315|NCT00996840|515334416|FG004|Overall Study|Withdrawal by Subject|0|||
142944316|NCT01389245|515334417|FG000|Overall Study|Protocol Violation|10|||
142944317|NCT01389245|515334417|FG000|Overall Study|Lost to Follow-up|3|||
142944318|NCT01389245|515334417|FG000|Overall Study|Withdrawal by Subject|2|||
142944319|NCT05127486|515334418|FG000|Overall Study|Adverse Event|2|||
142944320|NCT05127486|515334419|FG001|Overall Study|Adverse Event|4|||
142944321|NCT05127486|515334418|FG000|Overall Study|Lack of Efficacy|1|||
142944322|NCT05127486|515334419|FG001|Overall Study|Lack of Efficacy|0|||
142944323|NCT05127486|515334418|FG000|Overall Study|Pregnancy|0|||
142944324|NCT05127486|515334419|FG001|Overall Study|Pregnancy|1|||
142944325|NCT05127486|515334418|FG000|Overall Study|Physician Decision|4|||
142944326|NCT05127486|515334419|FG001|Overall Study|Physician Decision|1|||
142944327|NCT05127486|515334418|FG000|Overall Study|Withdrawal by Subject|14|||
142944328|NCT05127486|515334419|FG001|Overall Study|Withdrawal by Subject|13|||
142944329|NCT05127486|515334418|FG000|Overall Study|Lost to Follow-up|5|||
142944330|NCT05127486|515334419|FG001|Overall Study|Lost to Follow-up|8|||
142944331|NCT02582515|515334420|FG000|Overall Study|Withdrawal by Subject|0|||
142944332|NCT02582515|515334421|FG001|Overall Study|Withdrawal by Subject|1|||
142944333|NCT00775021|515334422|FG000|First Intervention|Lost to Follow-up|1|||
142944334|NCT00775021|515334423|FG001|First Intervention|Lost to Follow-up|0|||
142944335|NCT00775021|515334422|FG000|Second Intervention|Adverse Event|0|||
142944336|NCT00775021|515334423|FG001|Second Intervention|Adverse Event|1|||
142944337|NCT00363415|515334424|FG000|Overall Study|Progressive Disease|196|||
142944338|NCT00363415|515334425|FG001|Overall Study|Progressive Disease|107|||
142944339|NCT00363415|515334424|FG000|Overall Study|Sponsor Decision|67|||
142944340|NCT00363415|515334425|FG001|Overall Study|Sponsor Decision|31|||
142944341|NCT00363415|515334424|FG000|Overall Study|Death|32|||
142944342|NCT00363415|515334425|FG001|Overall Study|Death|29|||
142944343|NCT00363415|515334424|FG000|Overall Study|Adverse Event|24|||
142944344|NCT00363415|515334425|FG001|Overall Study|Adverse Event|15|||
142944345|NCT00363415|515334424|FG000|Overall Study|Physician Decision|18|||
142944346|NCT00363415|515334425|FG001|Overall Study|Physician Decision|35|||
142944347|NCT00363415|515334424|FG000|Overall Study|Entry Criteria Not Met|11|||
142944348|NCT00363415|515334425|FG001|Overall Study|Entry Criteria Not Met|10|||
142944349|NCT00363415|515334424|FG000|Overall Study|Withdrawal by Subject|9|||
142944350|NCT00363415|515334425|FG001|Overall Study|Withdrawal by Subject|15|||
142944351|NCT00363415|515334424|FG000|Overall Study|Lost to Follow-up|3|||
142944352|NCT00363415|515334425|FG001|Overall Study|Lost to Follow-up|3|||
142944353|NCT00363415|515334424|FG000|Overall Study|Protocol Violation|1|||
142944354|NCT00363415|515334425|FG001|Overall Study|Protocol Violation|4|||
142944355|NCT05027802|515334428|FG000|Overall Study|Adverse Event|2|||
142944356|NCT05027802|515334428|FG000|Overall Study|Withdrawal by Subject|18|||
142944357|NCT05027802|515334428|FG000|Overall Study|Death|2|||
142944358|NCT05027802|515334428|FG000|Overall Study|Other|1|||
142944359|NCT01506141|515334435|FG000|Overall Study|Adverse Event|0|||
142944360|NCT01506141|515334436|FG001|Overall Study|Adverse Event|2|||
142944361|NCT01506141|515334435|FG000|Overall Study|Participation Terminated by Investigator|1|||
142944362|NCT01506141|515334436|FG001|Overall Study|Participation Terminated by Investigator|1|||
142944363|NCT01506141|515334435|FG000|Overall Study|Site Terminated by Sponsor|2|||
142944364|NCT01506141|515334436|FG001|Overall Study|Site Terminated by Sponsor|0|||
142944365|NCT01506141|515334435|FG000|Overall Study|Reason Not Specified|4|||
142944366|NCT01506141|515334436|FG001|Overall Study|Reason Not Specified|2|||
142944367|NCT02725788|515334447|FG000|Overall Study|Lost to Follow-up|1|||
142944368|NCT02725788|515334448|FG001|Overall Study|Lost to Follow-up|1|||
142944369|NCT02725788|515334447|FG000|Overall Study|Protocol Violation|0|||
142944370|NCT02725788|515334448|FG001|Overall Study|Protocol Violation|1|||
142944371|NCT05590377|515334449|FG000|Overall Study|Death|1|||
142944372|NCT05590377|515334450|FG001|Overall Study|Death|1|||
142944373|NCT05590377|515334451|FG002|Overall Study|Death|2|||
142944374|NCT05590377|515334452|FG003|Overall Study|Death|0|||
142944375|NCT05590377|515334453|FG004|Overall Study|Death|0|||
142944376|NCT05590377|515334449|FG000|Overall Study|Study Terminated by Sponsor|1|||
142944377|NCT05590377|515334450|FG001|Overall Study|Study Terminated by Sponsor|5|||
142944378|NCT05590377|515334451|FG002|Overall Study|Study Terminated by Sponsor|4|||
142944379|NCT05590377|515334452|FG003|Overall Study|Study Terminated by Sponsor|0|||
142944380|NCT05590377|515334453|FG004|Overall Study|Study Terminated by Sponsor|0|||
142944381|NCT05590377|515334449|FG000|Overall Study|Withdrawal by Subject|1|||
142944382|NCT05590377|515334450|FG001|Overall Study|Withdrawal by Subject|0|||
142944383|NCT05590377|515334451|FG002|Overall Study|Withdrawal by Subject|0|||
142944384|NCT05590377|515334452|FG003|Overall Study|Withdrawal by Subject|0|||
142944385|NCT05590377|515334453|FG004|Overall Study|Withdrawal by Subject|0|||
142944386|NCT02688647|515334454|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
142944387|NCT02688647|515334455|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
142944388|NCT02688647|515334454|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
143454911|NCT02663518|517210768|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
143454912|NCT02663518|517210769|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
143454913|NCT02663518|517210770|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
142944389|NCT02688647|515334455|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
143454914|NCT02663518|517210771|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
143454915|NCT02663518|517210772|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
142944390|NCT02688647|515334454|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
142944391|NCT02688647|515334455|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
142944392|NCT02688647|515334454|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
142944393|NCT02688647|515334455|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
142944394|NCT02688647|515334454|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
142944395|NCT02688647|515334455|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
142944396|NCT02688647|515334454|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
143454916|NCT02663518|517210759|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
142944397|NCT02688647|515334455|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
142944398|NCT02688647|515334454|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
142944399|NCT02688647|515334455|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
142944400|NCT00828464|515334456|FG000|Overall Study|Withdrawal by Subject|1|||
142944401|NCT00833092|515334462|FG000|Overall Study|Withdrawal by Subject|2|||
142944402|NCT00833092|515334463|FG001|Overall Study|Withdrawal by Subject|3|||
142944403|NCT00833092|515334462|FG000|Overall Study|Protocol Violation|2|||
142944404|NCT00833092|515334463|FG001|Overall Study|Protocol Violation|1|||
142944405|NCT00833092|515334462|FG000|Overall Study|Diarrhea|0|||
142944406|NCT00833092|515334463|FG001|Overall Study|Diarrhea|2|||
142944407|NCT00833092|515334462|FG000|Overall Study|constipation|0|||
142944408|NCT00833092|515334463|FG001|Overall Study|constipation|1|||
142944409|NCT03367871|515334464|FG000|Overall Study|Lost to Follow-up|1|||
142944410|NCT02983604|515334465|FG000|Overall Study|Enrolled but not Treated|0|||
142944411|NCT02983604|515334466|FG001|Overall Study|Enrolled but not Treated|0|||
142944412|NCT02983604|515334467|FG002|Overall Study|Enrolled but not Treated|1|||
142944413|NCT02983604|515334468|FG003|Overall Study|Enrolled but not Treated|0|||
142944414|NCT00355264|515334469|FG000|Extension (Variable Duration)|Adverse Event|1|||
142944415|NCT00355264|515334469|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
142944416|NCT00699192|515334470|FG000|Overall Study|Missing|1|||
142944417|NCT00699192|515334471|FG001|Overall Study|Missing|1|||
142944418|NCT00699192|515334472|FG002|Overall Study|Missing|1|||
142944419|NCT00699192|515334470|FG000|Overall Study|Adverse Event|9|||
142944420|NCT00699192|515334471|FG001|Overall Study|Adverse Event|4|||
142944421|NCT00699192|515334472|FG002|Overall Study|Adverse Event|3|||
142944422|NCT00699192|515334470|FG000|Overall Study|Abnormal test procedure result(s)|0|||
142944423|NCT00699192|515334471|FG001|Overall Study|Abnormal test procedure result(s)|0|||
142944424|NCT00699192|515334472|FG002|Overall Study|Abnormal test procedure result(s)|1|||
142944425|NCT00699192|515334470|FG000|Overall Study|Lack of Efficacy|0|||
142944426|NCT00699192|515334471|FG001|Overall Study|Lack of Efficacy|0|||
142944427|NCT00699192|515334472|FG002|Overall Study|Lack of Efficacy|1|||
142944428|NCT00699192|515334470|FG000|Overall Study|Withdrawal by Subject|3|||
142944429|NCT00699192|515334471|FG001|Overall Study|Withdrawal by Subject|2|||
142944430|NCT00699192|515334472|FG002|Overall Study|Withdrawal by Subject|4|||
142944431|NCT00699192|515334470|FG000|Overall Study|Administrative problems|1|||
142944432|NCT00699192|515334471|FG001|Overall Study|Administrative problems|3|||
142944433|NCT00699192|515334472|FG002|Overall Study|Administrative problems|1|||
142944434|NCT00699192|515334470|FG000|Overall Study|Protocol Violation|2|||
142944435|NCT00699192|515334471|FG001|Overall Study|Protocol Violation|2|||
142944436|NCT00699192|515334472|FG002|Overall Study|Protocol Violation|0|||
142944437|NCT03663166|515334473|FG000|Overall Study|Withdrawal by Subject|1|||
142944438|NCT04433117|515334476|FG000|Overall Study|Withdrawal by Subject|1|||
142944439|NCT04433117|515334477|FG001|Overall Study|Withdrawal by Subject|0|||
142944440|NCT05089708|515334478|FG000|Overall Study|Lost to Follow-up|9|||
142944441|NCT05089708|515334479|FG001|Overall Study|Lost to Follow-up|7|||
142944442|NCT05089708|515334478|FG000|Overall Study|Withdrawal by Subject|3|||
142944443|NCT05089708|515334479|FG001|Overall Study|Withdrawal by Subject|1|||
142944444|NCT05089708|515334478|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
142944445|NCT05089708|515334479|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
142944446|NCT05089708|515334478|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
142944447|NCT05089708|515334479|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
142944448|NCT01440101|515334480|FG000|Overall Study|Adverse Event|2|||
142944449|NCT01440101|515334481|FG001|Overall Study|Adverse Event|0|||
142944450|NCT01440101|515334482|FG002|Overall Study|Adverse Event|0|||
142944451|NCT01440101|515334480|FG000|Overall Study|Withdrawal by Subject|0|||
142944452|NCT01440101|515334481|FG001|Overall Study|Withdrawal by Subject|3|||
142944453|NCT01440101|515334482|FG002|Overall Study|Withdrawal by Subject|1|||
142944454|NCT01440101|515334480|FG000|Overall Study|Other|0|||
142944455|NCT01440101|515334481|FG001|Overall Study|Other|1|||
142944456|NCT01440101|515334482|FG002|Overall Study|Other|0|||
142944457|NCT00074958|515334483|FG000|Overall Study|Adverse Event|1|||
142944458|NCT00404092|515334486|FG000|Overall Study|Death|1|||
142944459|NCT00404092|515334487|FG001|Overall Study|Death|0|||
142944460|NCT00404092|515334488|FG002|Overall Study|Death|0|||
142944461|NCT00404092|515334489|FG003|Overall Study|Death|0|||
142944462|NCT00404092|515334486|FG000|Overall Study|Adverse Event|0|||
142944463|NCT00404092|515334487|FG001|Overall Study|Adverse Event|0|||
142944464|NCT00404092|515334488|FG002|Overall Study|Adverse Event|1|||
142944465|NCT00404092|515334489|FG003|Overall Study|Adverse Event|0|||
142944466|NCT01658514|515334492|FG000|Overall Study|Protocol Violation|1|||
142944467|NCT01658514|515334493|FG001|Overall Study|Protocol Violation|0|||
142944468|NCT01658514|515334494|FG002|Overall Study|Protocol Violation|2|||
142944469|NCT01511445|515334495|FG000|Overall Study|Lost to Follow-up|3|||
142944470|NCT01511445|515334496|FG001|Overall Study|Lost to Follow-up|1|||
142944471|NCT01511445|515334495|FG000|Overall Study|Protocol Violation|1|||
142944472|NCT01511445|515334496|FG001|Overall Study|Protocol Violation|3|||
142944473|NCT01511445|515334495|FG000|Overall Study|Protocol Violation|1|||
142944474|NCT01511445|515334496|FG001|Overall Study|Protocol Violation|0|||
142944475|NCT04325503|515334511|FG000|Overall Study|Withdrawal by Subject|1|||
142944476|NCT04325503|515334511|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
142944477|NCT01642212|515334512|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
142944478|NCT01642212|515334513|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
142944479|NCT01642212|515334514|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
142944480|NCT01642212|515334515|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
142944481|NCT01642212|515334516|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
142944482|NCT01642212|515334512|FG000|Double-blind Treatment|Other|0|||
142944483|NCT01642212|515334513|FG001|Double-blind Treatment|Other|2|||
142944484|NCT01642212|515334514|FG002|Double-blind Treatment|Other|1|||
142944485|NCT01642212|515334515|FG003|Double-blind Treatment|Other|0|||
142944486|NCT01642212|515334516|FG004|Double-blind Treatment|Other|0|||
142944487|NCT01642212|515334512|FG000|Double-blind Treatment|Non-compliance|0|||
142944488|NCT01642212|515334513|FG001|Double-blind Treatment|Non-compliance|1|||
142944489|NCT01642212|515334514|FG002|Double-blind Treatment|Non-compliance|0|||
142944490|NCT01642212|515334515|FG003|Double-blind Treatment|Non-compliance|0|||
142944491|NCT01642212|515334516|FG004|Double-blind Treatment|Non-compliance|0|||
142944492|NCT01642212|515334512|FG000|Double-blind Treatment|Adverse Event|0|||
142944493|NCT01642212|515334513|FG001|Double-blind Treatment|Adverse Event|0|||
142944494|NCT01642212|515334514|FG002|Double-blind Treatment|Adverse Event|1|||
142944495|NCT01642212|515334515|FG003|Double-blind Treatment|Adverse Event|0|||
142944496|NCT01642212|515334516|FG004|Double-blind Treatment|Adverse Event|0|||
142944497|NCT01642212|515334512|FG000|Open-label Extension|Adverse Event|0|||
142944498|NCT01642212|515334513|FG001|Open-label Extension|Adverse Event|0|||
142944499|NCT01642212|515334514|FG002|Open-label Extension|Adverse Event|0|||
142944500|NCT01642212|515334515|FG003|Open-label Extension|Adverse Event|3|||
142944501|NCT01642212|515334516|FG004|Open-label Extension|Adverse Event|0|||
142944502|NCT01642212|515334512|FG000|Open-label Extension|Sponsor Decision|0|||
142944503|NCT01642212|515334513|FG001|Open-label Extension|Sponsor Decision|0|||
142944504|NCT01642212|515334514|FG002|Open-label Extension|Sponsor Decision|0|||
142944505|NCT01642212|515334515|FG003|Open-label Extension|Sponsor Decision|7|||
142944506|NCT01642212|515334516|FG004|Open-label Extension|Sponsor Decision|4|||
142944507|NCT01642212|515334512|FG000|Open-label Extension|Consent Withdrawn|0|||
142944508|NCT01642212|515334513|FG001|Open-label Extension|Consent Withdrawn|0|||
142944509|NCT01642212|515334514|FG002|Open-label Extension|Consent Withdrawn|0|||
142944510|NCT01642212|515334515|FG003|Open-label Extension|Consent Withdrawn|0|||
142944511|NCT01642212|515334516|FG004|Open-label Extension|Consent Withdrawn|2|||
142944512|NCT01642212|515334512|FG000|Open-label Extension|Lost to Follow-up|0|||
142944513|NCT01642212|515334513|FG001|Open-label Extension|Lost to Follow-up|0|||
142944514|NCT01642212|515334514|FG002|Open-label Extension|Lost to Follow-up|0|||
142944515|NCT01642212|515334515|FG003|Open-label Extension|Lost to Follow-up|0|||
142944516|NCT01642212|515334516|FG004|Open-label Extension|Lost to Follow-up|1|||
142944517|NCT01642212|515334512|FG000|Open-label Extension|Other|0|||
142944518|NCT01642212|515334513|FG001|Open-label Extension|Other|0|||
142944519|NCT01642212|515334514|FG002|Open-label Extension|Other|0|||
142944520|NCT01642212|515334515|FG003|Open-label Extension|Other|0|||
142944521|NCT01642212|515334516|FG004|Open-label Extension|Other|1|||
142944522|NCT00981526|515334517|FG000|Overall Study|Withdrawal by Subject|0|||
142944523|NCT00981526|515334518|FG001|Overall Study|Withdrawal by Subject|2|||
142944524|NCT00981526|515334517|FG000|Overall Study|Physician Decision|4|||
142944525|NCT00981526|515334518|FG001|Overall Study|Physician Decision|4|||
142944526|NCT01243268|515334519|FG000|Overall Study|Lost to Follow-up|4|||
142944527|NCT01243268|515334519|FG000|Overall Study|Protocol Violation|51|||
142944528|NCT01243268|515334519|FG000|Overall Study|Deviation with contract date|7|||
142944529|NCT01243268|515334519|FG000|Overall Study|Duplicate subject|2|||
142944530|NCT01564784|515334520|FG000|Overall Study|Other|1|||
142944531|NCT01564784|515334521|FG001|Overall Study|Other|0|||
142944532|NCT01564784|515334520|FG000|Overall Study|Subject refused further follow-up|1|||
142944533|NCT01564784|515334521|FG001|Overall Study|Subject refused further follow-up|6|||
142944534|NCT01564784|515334520|FG000|Overall Study|Lost to Follow-up|1|||
142944535|NCT01564784|515334521|FG001|Overall Study|Lost to Follow-up|1|||
142944536|NCT01564784|515334520|FG000|Overall Study|Death|131|||
142944537|NCT01564784|515334521|FG001|Overall Study|Death|126|||
142944538|NCT02272790|515334522|FG000|Overall Study|Physician Decision|0|||
142944539|NCT02272790|515334523|FG001|Overall Study|Physician Decision|1|||
142944540|NCT02272790|515334524|FG002|Overall Study|Physician Decision|0|||
142944541|NCT02272790|515334525|FG003|Overall Study|Physician Decision|0|||
142944542|NCT02272790|515334526|FG004|Overall Study|Physician Decision|0|||
142944543|NCT02272790|515334527|FG005|Overall Study|Physician Decision|0|||
142944544|NCT00332202|515334528|FG000|Overall Study|Adverse Event|72|||
142944545|NCT00332202|515334529|FG001|Overall Study|Adverse Event|28|||
142944546|NCT00332202|515334528|FG000|Overall Study|Lost to Follow-up|2|||
142944547|NCT00332202|515334529|FG001|Overall Study|Lost to Follow-up|1|||
142944548|NCT00332202|515334528|FG000|Overall Study|Physician Decision|6|||
142944549|NCT00332202|515334529|FG001|Overall Study|Physician Decision|8|||
142944550|NCT00332202|515334528|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
143454917|NCT02663518|517210760|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
143454918|NCT02663518|517210761|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
143454919|NCT02663518|517210762|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
143454920|NCT02663518|517210763|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
143454921|NCT02663518|517210764|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
143454922|NCT02663518|517210765|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
143454923|NCT02663518|517210766|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
143454924|NCT02663518|517210767|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
143454925|NCT02663518|517210768|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
143454926|NCT02663518|517210769|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
143454927|NCT02663518|517210770|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
143454928|NCT02663518|517210771|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
143454929|NCT02663518|517210772|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
143454930|NCT02663518|517210759|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
143454931|NCT02663518|517210760|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
143454932|NCT02663518|517210761|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
143454933|NCT02663518|517210762|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
143454934|NCT02663518|517210763|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
143454935|NCT02663518|517210764|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
143454936|NCT02663518|517210765|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
143454937|NCT02663518|517210766|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
143454938|NCT02663518|517210767|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
143454939|NCT02663518|517210768|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
143454940|NCT02663518|517210769|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
143454941|NCT02663518|517210770|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
143454942|NCT02663518|517210771|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
143454943|NCT02663518|517210772|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
143454944|NCT02663518|517210759|FG000|Part 1: Phase 1a Escalation|Other|0|||
143454945|NCT02663518|517210760|FG001|Part 1: Phase 1a Escalation|Other|0|||
143454946|NCT02663518|517210761|FG002|Part 1: Phase 1a Escalation|Other|2|||
143454947|NCT02663518|517210762|FG003|Part 1: Phase 1a Escalation|Other|0|||
143454948|NCT02663518|517210763|FG004|Part 1: Phase 1a Escalation|Other|0|||
143454949|NCT02663518|517210764|FG005|Part 1: Phase 1a Escalation|Other|0|||
143454950|NCT02663518|517210765|FG006|Part 1: Phase 1a Escalation|Other|0|||
143454951|NCT02663518|517210766|FG007|Part 1: Phase 1a Escalation|Other|0|||
143454952|NCT02663518|517210767|FG008|Part 1: Phase 1a Escalation|Other|0|||
143454953|NCT02663518|517210768|FG009|Part 1: Phase 1a Escalation|Other|0|||
143454954|NCT02663518|517210769|FG010|Part 1: Phase 1a Escalation|Other|0|||
143454955|NCT02663518|517210770|FG011|Part 1: Phase 1a Escalation|Other|0|||
143454956|NCT02663518|517210771|FG012|Part 1: Phase 1a Escalation|Other|0|||
143454957|NCT02663518|517210772|FG013|Part 1: Phase 1a Escalation|Other|0|||
143454958|NCT02663518|517210759|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
143454959|NCT02663518|517210760|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
143454960|NCT02663518|517210761|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
143454961|NCT02663518|517210762|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
143454962|NCT02663518|517210763|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
143454963|NCT02663518|517210764|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
143454964|NCT02663518|517210765|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
143454965|NCT02663518|517210766|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
143454966|NCT02663518|517210767|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
143454967|NCT02663518|517210768|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
143454968|NCT02663518|517210769|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
143454969|NCT02663518|517210770|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
143454970|NCT02663518|517210771|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
143454971|NCT02663518|517210772|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
142944551|NCT00332202|515334529|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
142944552|NCT00332202|515334528|FG000|Overall Study|Protocol Violation|7|||
142944553|NCT00332202|515334529|FG001|Overall Study|Protocol Violation|2|||
142944554|NCT00332202|515334528|FG000|Overall Study|Sponsor Decision|1|||
142944555|NCT00332202|515334529|FG001|Overall Study|Sponsor Decision|2|||
142944556|NCT00332202|515334528|FG000|Overall Study|Withdrawal by Subject|36|||
142944557|NCT00332202|515334529|FG001|Overall Study|Withdrawal by Subject|17|||
142944558|NCT00332202|515334528|FG000|Overall Study|Progressive Disease|106|||
142944559|NCT00332202|515334529|FG001|Overall Study|Progressive Disease|60|||
142944560|NCT00332202|515334528|FG000|Overall Study|Death|5|||
142944561|NCT00332202|515334529|FG001|Overall Study|Death|2|||
142944562|NCT01444300|515334539|FG000|Overall Study|Adverse Event|4|||
142944563|NCT01444300|515334540|FG001|Overall Study|Adverse Event|0|||
142944564|NCT00752986|515334541|FG000|Overall Study|Withdrawal by Subject|2|||
142944565|NCT00752986|515334542|FG001|Overall Study|Withdrawal by Subject|1|||
142944566|NCT00752986|515334543|FG002|Overall Study|Withdrawal by Subject|2|||
142944567|NCT00752986|515334541|FG000|Overall Study|Protocol Violation|3|||
143454972|NCT02663518|517210759|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
143454973|NCT02663518|517210760|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
142944568|NCT00752986|515334542|FG001|Overall Study|Protocol Violation|0|||
142944569|NCT00752986|515334543|FG002|Overall Study|Protocol Violation|0|||
142944570|NCT00924703|515334545|FG000|Overall Study|Withdrawal by Subject|11|||
142944571|NCT00924703|515334545|FG000|Overall Study|Physician Decision|5|||
142944572|NCT00924703|515334545|FG000|Overall Study|Lost to Follow-up|3|||
142944573|NCT00924703|515334545|FG000|Overall Study|Adverse Event|2|||
142944574|NCT00924703|515334545|FG000|Overall Study|Withdrawal by Sponsor|1|||
142944575|NCT02382133|515334546|FG000|Overall Study|Death|22|||
142944576|NCT02382133|515334546|FG000|Overall Study|transfer out of ICU|4|||
142944577|NCT02382133|515334546|FG000|Overall Study|Physician Decision|2|||
142944578|NCT02382133|515334546|FG000|Overall Study|arterial catheter loss|4|||
142944579|NCT02382133|515334546|FG000|Overall Study|pressure injury both sites|1|||
142944580|NCT02370121|515334551|FG000|Overall Study|Lost to Follow-up|1|||
142944581|NCT02370121|515334552|FG001|Overall Study|Lost to Follow-up|1|||
142944582|NCT04429022|515334555|FG000|Overall Study|Protocol Violation|18|||
142944583|NCT04429022|515334556|FG001|Overall Study|Protocol Violation|1|||
142944584|NCT00275561|515334557|FG000|Overall Study|Withdrawal by Subject|0|||
142944585|NCT00275561|515334558|FG001|Overall Study|Withdrawal by Subject|1|||
142944586|NCT00275561|515334557|FG000|Overall Study|Travel|1|||
142944587|NCT00275561|515334558|FG001|Overall Study|Travel|1|||
142944588|NCT00275561|515334557|FG000|Overall Study|Scheduling|1|||
142944589|NCT00275561|515334558|FG001|Overall Study|Scheduling|2|||
142944590|NCT00275561|515334557|FG000|Overall Study|Family Issues|0|||
142944591|NCT00275561|515334558|FG001|Overall Study|Family Issues|2|||
142944592|NCT00045032|515334559|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
142944593|NCT00045032|515334560|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
142944594|NCT00045032|515334561|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
142944595|NCT00045032|515334559|FG000|Overall Study|Death|22|||
142944596|NCT00045032|515334560|FG001|Overall Study|Death|24|||
142944597|NCT00045032|515334561|FG002|Overall Study|Death|17|||
142944598|NCT00045032|515334559|FG000|Overall Study|Insufficient Therapeutic Response|542|||
142944599|NCT00045032|515334560|FG001|Overall Study|Insufficient Therapeutic Response|437|||
142944600|NCT00045032|515334561|FG002|Overall Study|Insufficient Therapeutic Response|445|||
142944601|NCT00045032|515334559|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
142944602|NCT00045032|515334560|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
142944603|NCT00045032|515334561|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
142944604|NCT00045032|515334559|FG000|Overall Study|Other Protocol Violation|2|||
142944605|NCT00045032|515334560|FG001|Overall Study|Other Protocol Violation|0|||
142944606|NCT00045032|515334561|FG002|Overall Study|Other Protocol Violation|1|||
142944607|NCT00045032|515334559|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
142944608|NCT00045032|515334560|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
142944609|NCT00045032|515334561|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
142944610|NCT00045032|515334559|FG000|Overall Study|Failure to Return|57|||
142944611|NCT00045032|515334560|FG001|Overall Study|Failure to Return|62|||
142944612|NCT00045032|515334561|FG002|Overall Study|Failure to Return|61|||
142944613|NCT00045032|515334559|FG000|Overall Study|Other|93|||
142944614|NCT00045032|515334560|FG001|Overall Study|Other|84|||
142944615|NCT00045032|515334561|FG002|Overall Study|Other|105|||
142944616|NCT02582658|515334562|FG000|Overall Study|Failure to Return|10|||
142944617|NCT02582658|515334562|FG000|Overall Study|Insufficient Virological Response|2|||
142944618|NCT02582658|515334562|FG000|Overall Study|Withdrawn Consent|1|||
142944619|NCT02582658|515334562|FG000|Overall Study|Death|1|||
142944620|NCT02582658|515334562|FG000|Overall Study|Not further specified|11|||
142944621|NCT01056107|515335761|FG000|Overall Study|Withdrawal by Subject|0|||
142944622|NCT01056107|515335762|FG001|Overall Study|Withdrawal by Subject|1|||
142944623|NCT01056107|515335763|FG002|Overall Study|Withdrawal by Subject|3|||
142944624|NCT01056107|515335764|FG003|Overall Study|Withdrawal by Subject|0|||
142944625|NCT00377962|515335765|FG000|Core Study: 0-12 Months|Adverse Event|18|||
142944626|NCT00377962|515335766|FG001|Core Study: 0-12 Months|Adverse Event|2|||
142944627|NCT00377962|515335765|FG000|Core Study: 0-12 Months|Death|3|||
142944628|NCT00377962|515335766|FG001|Core Study: 0-12 Months|Death|0|||
142944629|NCT00377962|515335765|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
142944630|NCT00377962|515335766|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
142944631|NCT00377962|515335765|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
142944632|NCT00377962|515335766|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
142944633|NCT00377962|515335765|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
142944634|NCT00377962|515335766|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
142944635|NCT00377962|515335765|FG000|Extension Study: 12-24 Months|Death|1|||
142944636|NCT00377962|515335766|FG001|Extension Study: 12-24 Months|Death|1|||
142944637|NCT00377962|515335765|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
142944638|NCT00377962|515335766|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
142944639|NCT00377962|515335765|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
142944640|NCT00377962|515335766|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
142944641|NCT00377962|515335765|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
142944642|NCT00377962|515335766|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
142944643|NCT00374556|515335769|FG000|Overall Study|Lost to Follow-up|1|||
142944644|NCT00374556|515335770|FG001|Overall Study|Lost to Follow-up|0|||
142944645|NCT00374556|515335769|FG000|Overall Study|Removed at baseline due to medical cond|0|||
142944646|NCT00374556|515335770|FG001|Overall Study|Removed at baseline due to medical cond|1|||
142944647|NCT01821963|515335785|FG000|Overall Study|Adverse Event|1|||
142944648|NCT00783289|515335786|FG000|Overall Study|Protocol Violation|0|||
142944649|NCT00783289|515335787|FG001|Overall Study|Protocol Violation|1|||
142944650|NCT00783289|515335788|FG002|Overall Study|Protocol Violation|0|||
142944651|NCT00783289|515335789|FG003|Overall Study|Protocol Violation|0|||
142944652|NCT01217606|515335792|FG000|Initial Treatment Phase|Other Reasons|0|||
142944653|NCT01217606|515335793|FG001|Initial Treatment Phase|Other Reasons|2|||
142944654|NCT01217606|515335792|FG000|Initial Treatment Phase|Protocol Violation|3|||
142944655|NCT01217606|515335793|FG001|Initial Treatment Phase|Protocol Violation|2|||
142944656|NCT01217606|515335792|FG000|Initial Treatment Phase|Personal Reasons|0|||
142944657|NCT01217606|515335793|FG001|Initial Treatment Phase|Personal Reasons|2|||
142944658|NCT01217606|515335792|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
142944659|NCT01217606|515335793|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
142944660|NCT01217606|515335792|FG000|Initial Treatment Phase|Adverse Event|10|||
142944661|NCT01217606|515335793|FG001|Initial Treatment Phase|Adverse Event|6|||
142944662|NCT01217606|515335792|FG000|9-Month Masked Extension|Adverse Event|3|||
142944663|NCT01217606|515335793|FG001|9-Month Masked Extension|Adverse Event|6|||
142944664|NCT01217606|515335792|FG000|9-Month Masked Extension|Other Reasons|4|||
142944665|NCT01217606|515335793|FG001|9-Month Masked Extension|Other Reasons|4|||
142944666|NCT01217606|515335792|FG000|9-Month Masked Extension|Personal Reasons|2|||
142944667|NCT01217606|515335793|FG001|9-Month Masked Extension|Personal Reasons|1|||
142944668|NCT01217606|515335792|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
142944669|NCT01217606|515335793|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
142944670|NCT01217606|515335792|FG000|9-Month Masked Extension|Pregnancy|1|||
142944671|NCT01217606|515335793|FG001|9-Month Masked Extension|Pregnancy|0|||
142944672|NCT01217606|515335792|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
142944673|NCT01217606|515335793|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
142944674|NCT02292849|515335799|FG000|Overall Study|Lost to Follow-up|0|||
142944675|NCT02292849|515335800|FG001|Overall Study|Lost to Follow-up|2|||
142944676|NCT02292849|515335801|FG002|Overall Study|Lost to Follow-up|2|||
142944677|NCT02292849|515335799|FG000|Overall Study|Physician Decision|4|||
142944678|NCT02292849|515335800|FG001|Overall Study|Physician Decision|0|||
142944679|NCT02292849|515335801|FG002|Overall Study|Physician Decision|0|||
142944680|NCT00097539|515335802|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
142944681|NCT00097539|515335803|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
142944682|NCT00097539|515335804|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
142944683|NCT00097539|515335805|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
142944684|NCT00097539|515335806|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
142944685|NCT00097539|515335807|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
142944686|NCT00097539|515335808|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
142944687|NCT00097539|515335802|FG000|Overall Study|Withdrawal by Subject|925|||
142944688|NCT00097539|515335803|FG001|Overall Study|Withdrawal by Subject|323|||
142944689|NCT00097539|515335804|FG002|Overall Study|Withdrawal by Subject|346|||
142944690|NCT00097539|515335805|FG003|Overall Study|Withdrawal by Subject|217|||
142944691|NCT00097539|515335806|FG004|Overall Study|Withdrawal by Subject|68|||
142944692|NCT00097539|515335807|FG005|Overall Study|Withdrawal by Subject|229|||
142944693|NCT00097539|515335808|FG006|Overall Study|Withdrawal by Subject|3|||
142944694|NCT00097539|515335802|FG000|Overall Study|Participant Non-compliant|2140|||
142944695|NCT00097539|515335803|FG001|Overall Study|Participant Non-compliant|567|||
142944696|NCT00097539|515335804|FG002|Overall Study|Participant Non-compliant|1067|||
142944697|NCT00097539|515335805|FG003|Overall Study|Participant Non-compliant|353|||
142944698|NCT00097539|515335806|FG004|Overall Study|Participant Non-compliant|136|||
142944699|NCT00097539|515335807|FG005|Overall Study|Participant Non-compliant|543|||
142944700|NCT00097539|515335808|FG006|Overall Study|Participant Non-compliant|18|||
142944701|NCT00097539|515335802|FG000|Overall Study|Lack of Efficacy|249|||
142944702|NCT00097539|515335803|FG001|Overall Study|Lack of Efficacy|122|||
142944703|NCT00097539|515335804|FG002|Overall Study|Lack of Efficacy|202|||
142944704|NCT00097539|515335805|FG003|Overall Study|Lack of Efficacy|105|||
142944705|NCT00097539|515335806|FG004|Overall Study|Lack of Efficacy|45|||
142944706|NCT00097539|515335807|FG005|Overall Study|Lack of Efficacy|228|||
142944707|NCT00097539|515335808|FG006|Overall Study|Lack of Efficacy|5|||
142944708|NCT00097539|515335802|FG000|Overall Study|Adverse Event|78|||
142944709|NCT00097539|515335803|FG001|Overall Study|Adverse Event|133|||
142944710|NCT00097539|515335804|FG002|Overall Study|Adverse Event|37|||
142944711|NCT00097539|515335805|FG003|Overall Study|Adverse Event|27|||
142944712|NCT00097539|515335806|FG004|Overall Study|Adverse Event|30|||
142944713|NCT00097539|515335807|FG005|Overall Study|Adverse Event|59|||
142944714|NCT00097539|515335808|FG006|Overall Study|Adverse Event|1|||
142944715|NCT00097539|515335802|FG000|Overall Study|Death|2|||
142944716|NCT00097539|515335803|FG001|Overall Study|Death|7|||
142944717|NCT00097539|515335804|FG002|Overall Study|Death|0|||
142944718|NCT00097539|515335805|FG003|Overall Study|Death|0|||
142944719|NCT00097539|515335806|FG004|Overall Study|Death|1|||
142944720|NCT00097539|515335807|FG005|Overall Study|Death|3|||
142944721|NCT00097539|515335808|FG006|Overall Study|Death|0|||
142944722|NCT00097539|515335802|FG000|Overall Study|Reasons Other Than Above|3602|||
142944723|NCT00097539|515335803|FG001|Overall Study|Reasons Other Than Above|1382|||
142944724|NCT00097539|515335804|FG002|Overall Study|Reasons Other Than Above|1757|||
142944725|NCT00097539|515335805|FG003|Overall Study|Reasons Other Than Above|692|||
142944726|NCT00097539|515335806|FG004|Overall Study|Reasons Other Than Above|361|||
142944727|NCT00097539|515335807|FG005|Overall Study|Reasons Other Than Above|1244|||
142944728|NCT00097539|515335808|FG006|Overall Study|Reasons Other Than Above|34|||
142944729|NCT00097539|515335802|FG000|Overall Study|Reason not Specified|111|||
142944730|NCT00097539|515335803|FG001|Overall Study|Reason not Specified|49|||
142944731|NCT00097539|515335804|FG002|Overall Study|Reason not Specified|53|||
142944732|NCT00097539|515335805|FG003|Overall Study|Reason not Specified|21|||
142944733|NCT00097539|515335806|FG004|Overall Study|Reason not Specified|11|||
142944734|NCT00097539|515335807|FG005|Overall Study|Reason not Specified|40|||
142944735|NCT00097539|515335808|FG006|Overall Study|Reason not Specified|2|||
142944736|NCT00474240|515335809|FG000|Overall Study|Withdrawal by Subject|1|||
142944737|NCT00474240|515335810|FG001|Overall Study|Withdrawal by Subject|1|||
142944738|NCT00474240|515335811|FG002|Overall Study|Withdrawal by Subject|0|||
142944739|NCT00474240|515335812|FG003|Overall Study|Withdrawal by Subject|2|||
142944740|NCT00474240|515335813|FG004|Overall Study|Withdrawal by Subject|3|||
142944741|NCT00474240|515335814|FG005|Overall Study|Withdrawal by Subject|1|||
142944742|NCT00474240|515335809|FG000|Overall Study|Adverse Event|0|||
142944743|NCT00474240|515335810|FG001|Overall Study|Adverse Event|0|||
142944744|NCT00474240|515335811|FG002|Overall Study|Adverse Event|9|||
142944745|NCT00474240|515335812|FG003|Overall Study|Adverse Event|14|||
142944746|NCT00474240|515335813|FG004|Overall Study|Adverse Event|5|||
142944747|NCT00474240|515335814|FG005|Overall Study|Adverse Event|16|||
142944748|NCT00474240|515335809|FG000|Overall Study|Removed due to lab value|0|||
142944749|NCT00474240|515335810|FG001|Overall Study|Removed due to lab value|0|||
142944750|NCT00474240|515335811|FG002|Overall Study|Removed due to lab value|0|||
142944751|NCT00474240|515335812|FG003|Overall Study|Removed due to lab value|0|||
142944752|NCT00474240|515335813|FG004|Overall Study|Removed due to lab value|0|||
142944753|NCT00474240|515335814|FG005|Overall Study|Removed due to lab value|1|||
142944754|NCT04927312|515335815|FG000|Overall Study|Adverse Event|1|||
142944755|NCT04927312|515335815|FG000|Overall Study|Death|1|||
142944756|NCT04927312|515335815|FG000|Overall Study|Withdrawal by Subject|1|||
142944757|NCT04927312|515335815|FG000|Overall Study|Other|1|||
142944758|NCT04919564|515335816|FG000|Overall Study|Lost to Follow-up|1|||
142944759|NCT04919564|515335817|FG001|Overall Study|Lost to Follow-up|0|||
142944760|NCT04919564|515335816|FG000|Overall Study|Physician Decision|1|||
142944761|NCT04919564|515335817|FG001|Overall Study|Physician Decision|1|||
142944762|NCT01241786|515335818|FG000|Overall Study|Lack of Efficacy|5|||
142944763|NCT05340504|515335823|FG000|Overall Study|Withdrawal by Subject|1|||
142944764|NCT05340504|515335824|FG001|Overall Study|Withdrawal by Subject|0|||
142944765|NCT00929240|515335827|FG000|Initial Treatment Phase|Adverse Event|31|||
142944766|NCT00929240|515335828|FG001|Initial Treatment Phase|Adverse Event|0|||
142944767|NCT00929240|515335829|FG002|Initial Treatment Phase|Adverse Event|0|||
142944768|NCT00929240|515335827|FG000|Initial Treatment Phase|Disease progression|41|||
142944769|NCT00929240|515335828|FG001|Initial Treatment Phase|Disease progression|0|||
142944770|NCT00929240|515335829|FG002|Initial Treatment Phase|Disease progression|0|||
142944771|NCT00929240|515335827|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
142944772|NCT00929240|515335828|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
142944773|NCT00929240|515335829|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
142944774|NCT00929240|515335827|FG000|Initial Treatment Phase|Protocol Violation|5|||
142944775|NCT00929240|515335828|FG001|Initial Treatment Phase|Protocol Violation|0|||
142944776|NCT00929240|515335829|FG002|Initial Treatment Phase|Protocol Violation|0|||
142944777|NCT00929240|515335827|FG000|Initial Treatment Phase|Death|2|||
142944778|NCT00929240|515335828|FG001|Initial Treatment Phase|Death|0|||
142944779|NCT00929240|515335829|FG002|Initial Treatment Phase|Death|0|||
142944780|NCT00929240|515335827|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
142944781|NCT00929240|515335828|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
142944782|NCT00929240|515335829|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
142944783|NCT00929240|515335827|FG000|Initial Treatment Phase|Physician Decision|4|||
142944784|NCT00929240|515335828|FG001|Initial Treatment Phase|Physician Decision|0|||
142944785|NCT00929240|515335829|FG002|Initial Treatment Phase|Physician Decision|0|||
142944786|NCT00929240|515335827|FG000|Maintenance Phase|Disease progression|0|||
142944787|NCT00929240|515335828|FG001|Maintenance Phase|Disease progression|73|||
142944788|NCT00929240|515335829|FG002|Maintenance Phase|Disease progression|60|||
142944789|NCT00929240|515335827|FG000|Maintenance Phase|Adverse Event|0|||
142944790|NCT00929240|515335828|FG001|Maintenance Phase|Adverse Event|9|||
142944791|NCT00929240|515335829|FG002|Maintenance Phase|Adverse Event|12|||
142944792|NCT00929240|515335827|FG000|Maintenance Phase|Withdrawal by Subject|0|||
142944793|NCT00929240|515335828|FG001|Maintenance Phase|Withdrawal by Subject|2|||
142944794|NCT00929240|515335829|FG002|Maintenance Phase|Withdrawal by Subject|6|||
142944795|NCT00929240|515335827|FG000|Maintenance Phase|Protocol Violation|0|||
142944796|NCT00929240|515335828|FG001|Maintenance Phase|Protocol Violation|1|||
142944797|NCT00929240|515335829|FG002|Maintenance Phase|Protocol Violation|0|||
142944798|NCT00929240|515335827|FG000|Maintenance Phase|Health authority/Study termination|0|||
142944799|NCT00929240|515335828|FG001|Maintenance Phase|Health authority/Study termination|1|||
142944800|NCT00929240|515335829|FG002|Maintenance Phase|Health authority/Study termination|2|||
142944801|NCT00929240|515335827|FG000|Maintenance Phase|Physician Decision|0|||
142944802|NCT00929240|515335828|FG001|Maintenance Phase|Physician Decision|2|||
142944803|NCT00929240|515335829|FG002|Maintenance Phase|Physician Decision|1|||
142944804|NCT00929240|515335827|FG000|Maintenance Phase|Change of treatment|0|||
142944805|NCT00929240|515335828|FG001|Maintenance Phase|Change of treatment|4|||
142944806|NCT00929240|515335829|FG002|Maintenance Phase|Change of treatment|0|||
142944807|NCT00929240|515335827|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
142944808|NCT00929240|515335828|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
142944809|NCT00929240|515335829|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
142944810|NCT00929240|515335827|FG000|Maintenance Phase|Participant not treated|0|||
142944811|NCT00929240|515335828|FG001|Maintenance Phase|Participant not treated|2|||
142944812|NCT00929240|515335829|FG002|Maintenance Phase|Participant not treated|0|||
142944813|NCT02203149|515335834|FG000|Part 1|Adverse Event|0|||
142944814|NCT02203149|515335835|FG001|Part 1|Adverse Event|1|||
142944815|NCT02203149|515335836|FG002|Part 1|Adverse Event|0|||
142944816|NCT02203149|515335837|FG003|Part 1|Adverse Event|0|||
142944817|NCT02203149|515335838|FG004|Part 1|Adverse Event|0|||
142944818|NCT02203149|515335834|FG000|Part 2|Death|0|||
142944819|NCT02203149|515335835|FG001|Part 2|Death|0|||
142944820|NCT02203149|515335836|FG002|Part 2|Death|1|||
142944821|NCT02203149|515335837|FG003|Part 2|Death|1|||
142944822|NCT02203149|515335838|FG004|Part 2|Death|0|||
142944823|NCT02203149|515335834|FG000|Part 2|Withdrawal by Subject|0|||
142944824|NCT02203149|515335835|FG001|Part 2|Withdrawal by Subject|0|||
142944825|NCT02203149|515335836|FG002|Part 2|Withdrawal by Subject|0|||
142944826|NCT02203149|515335837|FG003|Part 2|Withdrawal by Subject|1|||
142944827|NCT02203149|515335838|FG004|Part 2|Withdrawal by Subject|0|||
142944828|NCT02203149|515335834|FG000|Part 2|Adverse Event|0|||
142944829|NCT02203149|515335835|FG001|Part 2|Adverse Event|0|||
142944830|NCT02203149|515335836|FG002|Part 2|Adverse Event|0|||
142944831|NCT02203149|515335837|FG003|Part 2|Adverse Event|1|||
142944832|NCT02203149|515335838|FG004|Part 2|Adverse Event|1|||
142944833|NCT00446030|515335839|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
142944834|NCT00446030|515335840|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
142944835|NCT00446030|515335839|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
142944836|NCT00446030|515335840|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
142944837|NCT00446030|515335839|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
142944838|NCT00446030|515335840|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
142944839|NCT00446030|515335839|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
142944840|NCT00446030|515335840|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
142944841|NCT00446030|515335839|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
142944842|NCT00446030|515335840|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
142944843|NCT00446030|515335839|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
142944844|NCT00446030|515335840|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
142944845|NCT00446030|515335839|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
142944846|NCT00446030|515335840|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
142944847|NCT00446030|515335839|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
142944848|NCT00446030|515335840|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
142944849|NCT00446030|515335839|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
142944850|NCT00446030|515335840|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
142944851|NCT00446030|515335839|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
142944852|NCT00446030|515335840|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
143454974|NCT02663518|517210761|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
143454975|NCT02663518|517210762|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
143454976|NCT02663518|517210763|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
143454977|NCT02663518|517210764|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
143454978|NCT02663518|517210765|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
142944853|NCT00446030|515335839|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
142944854|NCT00446030|515335840|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
142944855|NCT00446030|515335839|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
142944856|NCT00446030|515335840|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
142944857|NCT00446030|515335839|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
142944858|NCT00446030|515335840|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
142944859|NCT00446030|515335839|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
142944860|NCT00446030|515335840|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
142944861|NCT00446030|515335839|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
142944862|NCT00446030|515335840|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
143003055|NCT01049360|515548747|FG003|Period 1|Adverse Event|1|||
142944863|NCT00446030|515335839|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
142944864|NCT00446030|515335840|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
142944865|NCT00446030|515335839|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
142944866|NCT00446030|515335840|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
142944867|NCT00446030|515335839|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
142944868|NCT00446030|515335840|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
142944869|NCT00446030|515335839|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
142944870|NCT00446030|515335840|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
142944871|NCT02886715|515335843|FG000|Overall Study|Non-Compliance With Study Drug|0|||
142944872|NCT02886715|515335844|FG001|Overall Study|Non-Compliance With Study Drug|2|||
142944873|NCT02886715|515335845|FG002|Overall Study|Non-Compliance With Study Drug|0|||
142944874|NCT02886715|515335843|FG000|Overall Study|Adverse Event|4|||
142944875|NCT02886715|515335844|FG001|Overall Study|Adverse Event|2|||
142944876|NCT02886715|515335845|FG002|Overall Study|Adverse Event|0|||
142944877|NCT02886715|515335843|FG000|Overall Study|Lack of Efficacy|0|||
142944878|NCT02886715|515335844|FG001|Overall Study|Lack of Efficacy|2|||
142944879|NCT02886715|515335845|FG002|Overall Study|Lack of Efficacy|1|||
142944880|NCT02886715|515335843|FG000|Overall Study|Lost to Follow-up|29|||
142944881|NCT02886715|515335844|FG001|Overall Study|Lost to Follow-up|26|||
142944882|NCT02886715|515335845|FG002|Overall Study|Lost to Follow-up|10|||
142944883|NCT02886715|515335843|FG000|Overall Study|Pregnancy|1|||
142944884|NCT02886715|515335844|FG001|Overall Study|Pregnancy|1|||
142944885|NCT02886715|515335845|FG002|Overall Study|Pregnancy|1|||
142944886|NCT02886715|515335843|FG000|Overall Study|Protocol Violation|3|||
142944887|NCT02886715|515335844|FG001|Overall Study|Protocol Violation|2|||
142944888|NCT02886715|515335845|FG002|Overall Study|Protocol Violation|1|||
142944889|NCT02886715|515335843|FG000|Overall Study|Withdrawal by Subject|20|||
142944890|NCT02886715|515335844|FG001|Overall Study|Withdrawal by Subject|18|||
142944891|NCT02886715|515335845|FG002|Overall Study|Withdrawal by Subject|5|||
142944892|NCT02886715|515335843|FG000|Overall Study|missing|7|||
142944893|NCT02886715|515335844|FG001|Overall Study|missing|2|||
142944894|NCT02886715|515335845|FG002|Overall Study|missing|2|||
142944895|NCT00503399|515335846|FG000|Overall Study|Death|2|||
142944896|NCT00503399|515335847|FG001|Overall Study|Death|1|||
142944897|NCT00503399|515335846|FG000|Overall Study|Protocol Violation|1|||
142944898|NCT00503399|515335847|FG001|Overall Study|Protocol Violation|0|||
142944899|NCT00503399|515335846|FG000|Overall Study|Withdrawal by Subject|4|||
142944900|NCT00503399|515335847|FG001|Overall Study|Withdrawal by Subject|2|||
142944901|NCT00503399|515335846|FG000|Overall Study|Adverse Event|0|||
142944902|NCT00503399|515335847|FG001|Overall Study|Adverse Event|3|||
142944903|NCT00503399|515335846|FG000|Overall Study|Lost to Follow-up|0|||
142944904|NCT00503399|515335847|FG001|Overall Study|Lost to Follow-up|2|||
142944905|NCT01676961|515335848|FG000|Overall Study|Death|3|||
142944906|NCT01676961|515335848|FG000|Overall Study|Lost to Follow-up|1|||
142944907|NCT01676961|515335848|FG000|Overall Study|Withdrawal by Subject|1|||
142944908|NCT00858832|515335851|FG000|Overall Study|became ineligible: delivered vaginally|1|||
142944909|NCT00858832|515335852|FG001|Overall Study|became ineligible: delivered vaginally|0|||
142944910|NCT00858832|515335851|FG000|Overall Study|Adverse Event|0|||
142944911|NCT00858832|515335852|FG001|Overall Study|Adverse Event|1|||
142944912|NCT01794780|515335857|FG000|Overall Study|Adverse Event|0|||
142944913|NCT01794780|515335858|FG001|Overall Study|Adverse Event|1|||
142944914|NCT01794780|515335859|FG002|Overall Study|Adverse Event|2|||
142944915|NCT01794780|515335860|FG003|Overall Study|Adverse Event|0|||
142944916|NCT01794780|515335861|FG004|Overall Study|Adverse Event|0|||
142944917|NCT01794780|515335862|FG005|Overall Study|Adverse Event|0|||
142944918|NCT01794780|515335863|FG006|Overall Study|Adverse Event|0|||
142944919|NCT01794780|515335864|FG007|Overall Study|Adverse Event|0|||
142944920|NCT01794780|515335857|FG000|Overall Study|Death|0|||
142944921|NCT01794780|515335858|FG001|Overall Study|Death|2|||
142944922|NCT01794780|515335859|FG002|Overall Study|Death|14|||
142944923|NCT01794780|515335860|FG003|Overall Study|Death|1|||
142944924|NCT01794780|515335861|FG004|Overall Study|Death|0|||
142944925|NCT01794780|515335862|FG005|Overall Study|Death|9|||
142944926|NCT01794780|515335863|FG006|Overall Study|Death|4|||
142944927|NCT01794780|515335864|FG007|Overall Study|Death|0|||
142944928|NCT01794780|515335857|FG000|Overall Study|Lost to Follow-up|10|||
142944929|NCT01794780|515335858|FG001|Overall Study|Lost to Follow-up|64|||
142944930|NCT01794780|515335859|FG002|Overall Study|Lost to Follow-up|165|||
142944931|NCT01794780|515335860|FG003|Overall Study|Lost to Follow-up|53|||
142944932|NCT01794780|515335861|FG004|Overall Study|Lost to Follow-up|2|||
142944933|NCT01794780|515335862|FG005|Overall Study|Lost to Follow-up|99|||
142944934|NCT01794780|515335863|FG006|Overall Study|Lost to Follow-up|30|||
142944935|NCT01794780|515335864|FG007|Overall Study|Lost to Follow-up|5|||
142944936|NCT01794780|515335857|FG000|Overall Study|Withdrew informed consent|7|||
142944937|NCT01794780|515335858|FG001|Overall Study|Withdrew informed consent|17|||
142944938|NCT01794780|515335859|FG002|Overall Study|Withdrew informed consent|36|||
142944939|NCT01794780|515335860|FG003|Overall Study|Withdrew informed consent|9|||
142944940|NCT01794780|515335861|FG004|Overall Study|Withdrew informed consent|0|||
142944941|NCT01794780|515335862|FG005|Overall Study|Withdrew informed consent|48|||
142944942|NCT01794780|515335863|FG006|Overall Study|Withdrew informed consent|4|||
142944943|NCT01794780|515335864|FG007|Overall Study|Withdrew informed consent|3|||
142944944|NCT01794780|515335857|FG000|Overall Study|Other|0|||
142944945|NCT01794780|515335858|FG001|Overall Study|Other|12|||
142944946|NCT01794780|515335859|FG002|Overall Study|Other|25|||
142944947|NCT01794780|515335860|FG003|Overall Study|Other|20|||
142944948|NCT01794780|515335861|FG004|Overall Study|Other|1|||
142944949|NCT01794780|515335862|FG005|Overall Study|Other|24|||
142944950|NCT01794780|515335863|FG006|Overall Study|Other|4|||
142944951|NCT01794780|515335864|FG007|Overall Study|Other|1|||
142944952|NCT02499952|515335865|FG000|Overall Study|Lost to Follow-up|1|||
142944953|NCT02499952|515335865|FG000|Overall Study|Death|9|||
142944954|NCT02337387|515335867|FG000|Overall Study|Adverse Event|0|||
142944955|NCT02337387|515335868|FG001|Overall Study|Adverse Event|1|||
142944956|NCT02337387|515335869|FG002|Overall Study|Adverse Event|0|||
142944957|NCT02337387|515335870|FG003|Overall Study|Adverse Event|0|||
142944958|NCT02337387|515335867|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
142944959|NCT02337387|515335868|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
142944960|NCT02337387|515335869|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
142944961|NCT02337387|515335870|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
142944962|NCT02853760|515335871|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
142944963|NCT02853760|515335872|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
142944964|NCT02853760|515335873|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
142944965|NCT02853760|515335874|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
142944966|NCT02853760|515335875|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
142944967|NCT02853760|515335876|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
142944968|NCT02747004|515335877|FG000|Overall Study|Withdrawal by Subject|8|||
142944969|NCT02747004|515335878|FG001|Overall Study|Withdrawal by Subject|5|||
142944970|NCT02747004|515335879|FG002|Overall Study|Withdrawal by Subject|4|||
142944971|NCT02747004|515335877|FG000|Overall Study|Lost to Follow-up|1|||
142944972|NCT02747004|515335878|FG001|Overall Study|Lost to Follow-up|2|||
142944973|NCT02747004|515335879|FG002|Overall Study|Lost to Follow-up|2|||
142944974|NCT02747004|515335877|FG000|Overall Study|on study treatment/follow-up|48|||
142944975|NCT02747004|515335878|FG001|Overall Study|on study treatment/follow-up|42|||
142944976|NCT02747004|515335879|FG002|Overall Study|on study treatment/follow-up|41|||
142944977|NCT06218251|515335880|FG000|Overall Study|Lost to Follow-up|4|||
142944978|NCT05087030|515335881|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
142944979|NCT05087030|515335882|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
142944980|NCT05087030|515335883|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
142944981|NCT05087030|515335884|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
142944982|NCT05087030|515335885|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
142944983|NCT05087030|515335881|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
142944984|NCT05087030|515335882|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
142944985|NCT05087030|515335883|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
142944986|NCT05087030|515335884|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
142944987|NCT05087030|515335885|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
142944988|NCT05087030|515335881|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
142944989|NCT05087030|515335882|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
142944990|NCT05087030|515335883|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
142944991|NCT05087030|515335884|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
142944992|NCT05087030|515335885|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
142944993|NCT05087030|515335881|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
142944994|NCT05087030|515335882|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
142944995|NCT05087030|515335883|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
142944996|NCT05087030|515335884|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
142944997|NCT05087030|515335885|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
142944998|NCT05087030|515335881|FG000|Main Period (Week 0 to Week 52)|Death|0|||
142944999|NCT05087030|515335882|FG001|Main Period (Week 0 to Week 52)|Death|1|||
142945000|NCT05087030|515335883|FG002|Main Period (Week 0 to Week 52)|Death|0|||
142945001|NCT05087030|515335884|FG003|Main Period (Week 0 to Week 52)|Death|0|||
142945002|NCT05087030|515335885|FG004|Main Period (Week 0 to Week 52)|Death|0|||
142945003|NCT05087030|515335881|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
142945004|NCT05087030|515335882|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
142945005|NCT05087030|515335883|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
142945006|NCT05087030|515335884|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
142945007|NCT05087030|515335885|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
142945008|NCT05087030|515335881|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
142945009|NCT05087030|515335882|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
142945010|NCT05087030|515335883|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
142945011|NCT05087030|515335884|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
142945012|NCT05087030|515335885|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
142945013|NCT05087030|515335881|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
142945014|NCT05087030|515335882|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
142945015|NCT05087030|515335883|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
142945016|NCT05087030|515335884|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
142945017|NCT05087030|515335885|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
142945018|NCT05087030|515335881|FG000|Main Period (Week 0 to Week 52)|Other|1|||
142945019|NCT05087030|515335882|FG001|Main Period (Week 0 to Week 52)|Other|2|||
142945020|NCT05087030|515335883|FG002|Main Period (Week 0 to Week 52)|Other|0|||
142945021|NCT05087030|515335884|FG003|Main Period (Week 0 to Week 52)|Other|0|||
142945022|NCT05087030|515335885|FG004|Main Period (Week 0 to Week 52)|Other|0|||
142945023|NCT05087030|515335881|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
142945024|NCT05087030|515335882|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
142945025|NCT05087030|515335883|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
142945026|NCT05087030|515335884|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
142945027|NCT05087030|515335885|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
142945028|NCT04826900|515335886|FG000|Overall Study|Family factor|1|||
142945029|NCT04826900|515335887|FG001|Overall Study|Family factor|1|||
142945030|NCT02597062|515335891|FG000|Overall Study|Ineligible|1|||
142945031|NCT03372941|515335892|FG000|Overall Study|Lost to Follow-up|2|||
142945032|NCT03372941|515335893|FG001|Overall Study|Lost to Follow-up|4|||
142945033|NCT00609622|515335894|FG000|Overall Study|Adverse Event|14|||
142945034|NCT00609622|515335895|FG001|Overall Study|Adverse Event|10|||
142945035|NCT00609622|515335894|FG000|Overall Study|Withdrawal by Subject|4|||
142945036|NCT00609622|515335895|FG001|Overall Study|Withdrawal by Subject|20|||
142945037|NCT00609622|515335894|FG000|Overall Study|Death|1|||
142945038|NCT00609622|515335895|FG001|Overall Study|Death|4|||
142945039|NCT00609622|515335894|FG000|Overall Study|Protocol Violation|1|||
142945040|NCT00609622|515335895|FG001|Overall Study|Protocol Violation|1|||
142945041|NCT00609622|515335894|FG000|Overall Study|Objective progression or relapse|47|||
142945042|NCT00609622|515335895|FG001|Overall Study|Objective progression or relapse|41|||
142945043|NCT00609622|515335894|FG000|Overall Study|Study terminated by sponsor|16|||
142945044|NCT00609622|515335895|FG001|Overall Study|Study terminated by sponsor|3|||
142945045|NCT00609622|515335894|FG000|Overall Study|Other|7|||
142945046|NCT00609622|515335895|FG001|Overall Study|Other|14|||
142945047|NCT00609622|515335894|FG000|Overall Study|Global deterioration of health status|6|||
142945048|NCT00609622|515335895|FG001|Overall Study|Global deterioration of health status|2|||
142945049|NCT00686543|515335896|FG000|Overall Study|Adverse Event|9|||
142945050|NCT00686543|515335897|FG001|Overall Study|Adverse Event|1|||
142945051|NCT00686543|515335898|FG002|Overall Study|Adverse Event|3|||
142945052|NCT00686543|515335899|FG003|Overall Study|Adverse Event|2|||
142945053|NCT00686543|515335896|FG000|Overall Study|Withdrawal by Subject|2|||
142945054|NCT00686543|515335897|FG001|Overall Study|Withdrawal by Subject|0|||
142945055|NCT00686543|515335898|FG002|Overall Study|Withdrawal by Subject|0|||
142945056|NCT00686543|515335899|FG003|Overall Study|Withdrawal by Subject|0|||
142945057|NCT00686543|515335896|FG000|Overall Study|Protocol Violation|3|||
142945058|NCT00686543|515335897|FG001|Overall Study|Protocol Violation|0|||
142945059|NCT00686543|515335898|FG002|Overall Study|Protocol Violation|2|||
142945060|NCT00686543|515335899|FG003|Overall Study|Protocol Violation|1|||
142945061|NCT01053429|515335902|FG000|Overall Study|Adverse Event|64|||
142945062|NCT01053429|515335902|FG000|Overall Study|Other|309|||
142945063|NCT01237951|515335903|FG000|Overall Study|Death|1|||
142945064|NCT01708057|515335904|FG000|Overall Study|Withdrawal due to study termination.|1|||
142945065|NCT01708057|515335905|FG001|Overall Study|Withdrawal due to study termination.|1|||
142945066|NCT01708057|515335906|FG002|Overall Study|Withdrawal due to study termination.|1|||
142945067|NCT01697345|515335909|FG000|Overall Study|Withdrawal by Subject|1|||
142945068|NCT02970929|515335910|FG000|Overall Study|Adverse Event|18|||
142945069|NCT02970929|515335910|FG000|Overall Study|Lack of Efficacy|8|||
142945070|NCT02970929|515335910|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
142945071|NCT02970929|515335910|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
142945072|NCT02970929|515335910|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
142945073|NCT02970929|515335910|FG000|Overall Study|LOST TO FOLLOWUP|6|||
142945074|NCT02970929|515335910|FG000|Overall Study|MOVED OUT OF STATE|1|||
142945075|NCT02970929|515335910|FG000|Overall Study|Withdrawal by Subject|16|||
142945076|NCT01024244|515337639|FG000|Overall Study|Adverse Event|1|||
142945077|NCT01024244|515337640|FG001|Overall Study|Adverse Event|2|||
142945078|NCT01024244|515337641|FG002|Overall Study|Adverse Event|0|||
142945079|NCT01024244|515337642|FG003|Overall Study|Adverse Event|1|||
142945080|NCT01024244|515337643|FG004|Overall Study|Adverse Event|2|||
142945081|NCT01024244|515337639|FG000|Overall Study|Entry Criteria Not Met|0|||
142945082|NCT01024244|515337640|FG001|Overall Study|Entry Criteria Not Met|1|||
142945083|NCT01024244|515337641|FG002|Overall Study|Entry Criteria Not Met|0|||
142945084|NCT01024244|515337642|FG003|Overall Study|Entry Criteria Not Met|0|||
143003056|NCT01049360|515548748|FG004|Period 1|Adverse Event|0|||
142945085|NCT01024244|515337643|FG004|Overall Study|Entry Criteria Not Met|0|||
142945086|NCT01024244|515337639|FG000|Overall Study|Lack of Efficacy|1|||
142945087|NCT01024244|515337640|FG001|Overall Study|Lack of Efficacy|0|||
142945088|NCT01024244|515337641|FG002|Overall Study|Lack of Efficacy|0|||
142945089|NCT01024244|515337642|FG003|Overall Study|Lack of Efficacy|0|||
142945090|NCT01024244|515337643|FG004|Overall Study|Lack of Efficacy|0|||
142945091|NCT01024244|515337639|FG000|Overall Study|Protocol Violation|1|||
142945092|NCT01024244|515337640|FG001|Overall Study|Protocol Violation|0|||
142945093|NCT01024244|515337641|FG002|Overall Study|Protocol Violation|0|||
142945094|NCT01024244|515337642|FG003|Overall Study|Protocol Violation|0|||
142945095|NCT01024244|515337643|FG004|Overall Study|Protocol Violation|2|||
142945096|NCT01024244|515337639|FG000|Overall Study|Sponsor Decision|14|||
142945097|NCT01024244|515337640|FG001|Overall Study|Sponsor Decision|7|||
142945098|NCT01024244|515337641|FG002|Overall Study|Sponsor Decision|14|||
142945099|NCT01024244|515337642|FG003|Overall Study|Sponsor Decision|12|||
142945100|NCT01024244|515337643|FG004|Overall Study|Sponsor Decision|10|||
142945101|NCT01024244|515337639|FG000|Overall Study|Withdrawal by Subject|0|||
142945102|NCT01024244|515337640|FG001|Overall Study|Withdrawal by Subject|1|||
142945103|NCT01024244|515337641|FG002|Overall Study|Withdrawal by Subject|0|||
142945104|NCT01024244|515337642|FG003|Overall Study|Withdrawal by Subject|0|||
142945105|NCT01024244|515337643|FG004|Overall Study|Withdrawal by Subject|0|||
142945106|NCT02468193|515337647|FG000|Overall Study|Adverse Event|4|||
142945107|NCT02468193|515337647|FG000|Overall Study|Subject/ Guardian decision|2|||
142945108|NCT00742781|515337648|FG000|Overall Study|Withdrawal by Subject|3|||
142945109|NCT03874234|515337649|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
142945110|NCT03874234|515337650|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
142945111|NCT03874234|515337651|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
142945112|NCT03874234|515337652|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
142945113|NCT03874234|515337653|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
142945114|NCT03874234|515337654|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
142945115|NCT03874234|515337655|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
142945116|NCT03874234|515337656|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
142945117|NCT03874234|515337657|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
142945118|NCT03874234|515337658|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
142945119|NCT03874234|515337659|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
142945120|NCT03874234|515337660|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
142945121|NCT03874234|515337661|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
142945122|NCT03874234|515337649|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
142945123|NCT03874234|515337650|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
142945124|NCT03874234|515337651|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
142945125|NCT03874234|515337652|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
142945126|NCT03874234|515337653|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
142945127|NCT03874234|515337654|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
142945128|NCT03874234|515337655|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
142945129|NCT03874234|515337656|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
142945130|NCT03874234|515337657|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
142945131|NCT03874234|515337658|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
142945132|NCT03874234|515337659|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
142945133|NCT03874234|515337660|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
142945134|NCT03874234|515337661|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
142945135|NCT03874234|515337649|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
142945136|NCT03874234|515337650|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
142945137|NCT03874234|515337651|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
142945138|NCT03874234|515337652|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
142945139|NCT03874234|515337653|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
142945140|NCT03874234|515337654|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
142945141|NCT03874234|515337655|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
142945142|NCT03874234|515337656|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
142945143|NCT03874234|515337657|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
142945144|NCT03874234|515337658|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
142945145|NCT03874234|515337659|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
142945146|NCT03874234|515337660|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
142945147|NCT03874234|515337661|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
142945148|NCT03874234|515337649|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
142945149|NCT03874234|515337650|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
142945150|NCT03874234|515337651|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
143454979|NCT02663518|517210766|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
143454980|NCT02663518|517210767|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
142945151|NCT03874234|515337652|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
142945152|NCT03874234|515337653|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
142945153|NCT03874234|515337654|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
142945154|NCT03874234|515337655|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
142945155|NCT03874234|515337656|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
142945156|NCT03874234|515337657|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
142945157|NCT03874234|515337658|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
142945158|NCT03874234|515337659|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
142945159|NCT03874234|515337660|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
142945160|NCT03874234|515337661|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
142945161|NCT03874234|515337649|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
142945162|NCT03874234|515337650|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
142945163|NCT03874234|515337651|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
142945164|NCT03874234|515337652|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
142945165|NCT03874234|515337653|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
142945166|NCT03874234|515337654|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
142945167|NCT03874234|515337655|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
142945168|NCT03874234|515337656|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
142945169|NCT03874234|515337657|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
142945170|NCT03874234|515337658|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
142945171|NCT03874234|515337659|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
142945172|NCT03874234|515337660|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
142945173|NCT03874234|515337661|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
142945174|NCT03874234|515337649|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
142945175|NCT03874234|515337650|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
142945176|NCT03874234|515337651|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
142945177|NCT03874234|515337652|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
142945178|NCT03874234|515337653|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
142945179|NCT03874234|515337654|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
142945180|NCT03874234|515337655|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
142945181|NCT03874234|515337656|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
142945182|NCT03874234|515337657|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
142945183|NCT03874234|515337658|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
142945184|NCT03874234|515337659|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
142945185|NCT03874234|515337660|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
142945186|NCT03874234|515337661|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
142945187|NCT03874234|515337649|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
142945188|NCT03874234|515337650|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
142945189|NCT03874234|515337651|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
142945190|NCT03874234|515337652|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
142945191|NCT03874234|515337653|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
142945192|NCT03874234|515337654|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
142945193|NCT03874234|515337655|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
142945194|NCT03874234|515337656|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
142945195|NCT03874234|515337657|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
142945196|NCT03874234|515337658|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
142945197|NCT03874234|515337659|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
142945198|NCT03874234|515337660|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
142945199|NCT03874234|515337661|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
142945200|NCT03874234|515337649|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
142945201|NCT03874234|515337650|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
142945202|NCT03874234|515337651|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
142945203|NCT03874234|515337652|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
142945204|NCT03874234|515337653|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
142945205|NCT03874234|515337654|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
142945206|NCT03874234|515337655|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
142945207|NCT03874234|515337656|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
142945208|NCT03874234|515337657|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
142945209|NCT03874234|515337658|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
142945210|NCT03874234|515337659|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
142945211|NCT03874234|515337660|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
142945212|NCT03874234|515337661|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
142945213|NCT01896232|515337664|FG000|Overall Study|Death|6|||
142945214|NCT01896232|515337665|FG001|Overall Study|Death|10|||
143003057|NCT01049360|515548749|FG005|Period 1|Adverse Event|0|||
143454981|NCT02663518|517210768|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
143454982|NCT02663518|517210769|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
143454983|NCT02663518|517210770|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
142945215|NCT01896232|515337664|FG000|Overall Study|Withdrawal by Subject|32|||
142945216|NCT01896232|515337665|FG001|Overall Study|Withdrawal by Subject|31|||
142945217|NCT01896232|515337664|FG000|Overall Study|Sponsor Decision|2|||
142945218|NCT01896232|515337665|FG001|Overall Study|Sponsor Decision|0|||
142945219|NCT01896232|515337664|FG000|Overall Study|Lost to Follow-up|9|||
142945220|NCT01896232|515337665|FG001|Overall Study|Lost to Follow-up|12|||
142945221|NCT00686205|515337666|FG000|Overall Study|Protocol Violation|127|||
142945222|NCT00686205|515337667|FG001|Overall Study|Protocol Violation|0|||
142945223|NCT00686205|515337666|FG000|Overall Study|Withdrawal by Subject|2|||
142945224|NCT00686205|515337667|FG001|Overall Study|Withdrawal by Subject|0|||
142945225|NCT00686205|515337666|FG000|Overall Study|Specimen handling procedure altered|5878|||
142945226|NCT00686205|515337667|FG001|Overall Study|Specimen handling procedure altered|0|||
142945227|NCT00686205|515337666|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
142945228|NCT00686205|515337667|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
142945229|NCT00265941|515337668|FG000|Overall Study|Protocol Violation|22|||
142945230|NCT00265941|515337669|FG001|Overall Study|Protocol Violation|25|||
142945231|NCT00265941|515337668|FG000|Overall Study|Lost to Follow-up|1|||
142945232|NCT00265941|515337669|FG001|Overall Study|Lost to Follow-up|1|||
142945233|NCT03812510|515337675|FG000|Overall Study|Lost to Follow-up|39|||
142945234|NCT03812510|515337675|FG000|Overall Study|Withdrawal by Subject|42|||
142945235|NCT03812510|515337675|FG000|Overall Study|Physician Decision|2|||
142945236|NCT03812510|515337675|FG000|Overall Study|Study Terminated by Sponsor|9|||
142945237|NCT03812510|515337675|FG000|Overall Study|Did Not Start Study Medication|55|||
142945238|NCT03812510|515337675|FG000|Overall Study|Adverse Event|5|||
142945239|NCT00768560|515337676|FG000|Intervention Set 1|Adverse Event|0|||
142945240|NCT00768560|515337677|FG001|Intervention Set 1|Adverse Event|1|||
142945241|NCT00768560|515337678|FG002|Intervention Set 1|Adverse Event|0|||
142945242|NCT00768560|515337679|FG003|Intervention Set 1|Adverse Event|0|||
142945243|NCT00768560|515337680|FG004|Intervention Set 1|Adverse Event|0|||
142945244|NCT00768560|515337681|FG005|Intervention Set 1|Adverse Event|0|||
142945245|NCT00117312|515337682|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
142945246|NCT00117312|515337683|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
142945247|NCT00117312|515337684|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
142945248|NCT00117312|515337685|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
142945249|NCT00117312|515337682|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
142945250|NCT00117312|515337683|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
142945251|NCT00117312|515337684|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
142945252|NCT00117312|515337685|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
142945253|NCT00117312|515337682|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
142945254|NCT00117312|515337683|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
142945255|NCT00117312|515337684|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
142945256|NCT00117312|515337685|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
142945257|NCT00117312|515337682|FG000|Overall Study|Other|0|||
142945258|NCT00117312|515337683|FG001|Overall Study|Other|1|||
142945259|NCT00117312|515337684|FG002|Overall Study|Other|3|||
142945260|NCT00117312|515337685|FG003|Overall Study|Other|1|||
142945261|NCT00117312|515337682|FG000|Overall Study|Patient choice|0|||
142945262|NCT00117312|515337683|FG001|Overall Study|Patient choice|0|||
142945263|NCT00117312|515337684|FG002|Overall Study|Patient choice|2|||
142945264|NCT00117312|515337685|FG003|Overall Study|Patient choice|1|||
142945265|NCT00117312|515337682|FG000|Overall Study|Adverse Event|0|||
142945266|NCT00117312|515337683|FG001|Overall Study|Adverse Event|2|||
142945267|NCT00117312|515337684|FG002|Overall Study|Adverse Event|0|||
142945268|NCT00117312|515337685|FG003|Overall Study|Adverse Event|0|||
142945269|NCT00117312|515337682|FG000|Overall Study|Protocol Violation|0|||
142945270|NCT00117312|515337683|FG001|Overall Study|Protocol Violation|1|||
142945271|NCT00117312|515337684|FG002|Overall Study|Protocol Violation|3|||
142945272|NCT00117312|515337685|FG003|Overall Study|Protocol Violation|0|||
142945273|NCT00117312|515337682|FG000|Overall Study|PSA decrease <=50%|0|||
142945274|NCT00117312|515337683|FG001|Overall Study|PSA decrease <=50%|2|||
142945275|NCT00117312|515337684|FG002|Overall Study|PSA decrease <=50%|2|||
142945276|NCT00117312|515337685|FG003|Overall Study|PSA decrease <=50%|4|||
142945277|NCT00117312|515337682|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
142945278|NCT00117312|515337683|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
142945279|NCT00117312|515337684|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
143454984|NCT02663518|517210771|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
142945280|NCT00117312|515337685|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
142945281|NCT00117312|515337682|FG000|Overall Study|Hepatic abnormality|0|||
142945282|NCT00117312|515337683|FG001|Overall Study|Hepatic abnormality|1|||
142945283|NCT00117312|515337684|FG002|Overall Study|Hepatic abnormality|0|||
142945284|NCT00117312|515337685|FG003|Overall Study|Hepatic abnormality|1|||
142945285|NCT00117312|515337682|FG000|Overall Study|Withdrawal by Subject|0|||
142945286|NCT00117312|515337683|FG001|Overall Study|Withdrawal by Subject|2|||
142945287|NCT00117312|515337684|FG002|Overall Study|Withdrawal by Subject|0|||
142945288|NCT00117312|515337685|FG003|Overall Study|Withdrawal by Subject|0|||
142945289|NCT01128387|515337686|FG000|Overall Study|Physician Decision|0|||
142945290|NCT01128387|515337687|FG001|Overall Study|Physician Decision|1|||
142945291|NCT01535235|515337688|FG000|Overall Study|Adverse Event|1|||
142945292|NCT01535235|515337689|FG001|Overall Study|Adverse Event|0|||
142945293|NCT00389207|515337691|FG000|Overall Study|Adverse Event|26|||
142945294|NCT00389207|515337692|FG001|Overall Study|Adverse Event|32|||
142945295|NCT00389207|515337693|FG002|Overall Study|Adverse Event|10|||
142945296|NCT00389207|515337691|FG000|Overall Study|Protocol Violation|3|||
142945297|NCT00389207|515337692|FG001|Overall Study|Protocol Violation|1|||
142945298|NCT00389207|515337693|FG002|Overall Study|Protocol Violation|4|||
142945299|NCT00389207|515337691|FG000|Overall Study|Lost to Follow-up|12|||
142945300|NCT00389207|515337692|FG001|Overall Study|Lost to Follow-up|9|||
142945301|NCT00389207|515337693|FG002|Overall Study|Lost to Follow-up|7|||
142945302|NCT00389207|515337691|FG000|Overall Study|Withdrawal by Subject|5|||
142945303|NCT00389207|515337692|FG001|Overall Study|Withdrawal by Subject|7|||
142945304|NCT00389207|515337693|FG002|Overall Study|Withdrawal by Subject|11|||
142945305|NCT00389207|515337691|FG000|Overall Study|Other|17|||
142945306|NCT00389207|515337692|FG001|Overall Study|Other|23|||
142945307|NCT00389207|515337693|FG002|Overall Study|Other|9|||
142945308|NCT02371629|515337702|FG000|Overall Study|Patient decision|14|||
142945309|NCT02371629|515337703|FG001|Overall Study|Patient decision|10|||
142945310|NCT02371629|515337702|FG000|Overall Study|Adverse Event|8|||
142945311|NCT02371629|515337703|FG001|Overall Study|Adverse Event|8|||
142945312|NCT02371629|515337702|FG000|Overall Study|Physician Decision|2|||
142945313|NCT02371629|515337703|FG001|Overall Study|Physician Decision|3|||
142945314|NCT02371629|515337702|FG000|Overall Study|Death|1|||
142945315|NCT02371629|515337703|FG001|Overall Study|Death|1|||
142945316|NCT02371629|515337702|FG000|Overall Study|Noncompliance with study treatment|1|||
142945317|NCT02371629|515337703|FG001|Overall Study|Noncompliance with study treatment|0|||
142945318|NCT02371629|515337702|FG000|Overall Study|Lack of Efficacy|0|||
142945319|NCT02371629|515337703|FG001|Overall Study|Lack of Efficacy|2|||
142945320|NCT02371629|515337702|FG000|Overall Study|Protocol deviation|0|||
142945321|NCT02371629|515337703|FG001|Overall Study|Protocol deviation|1|||
142945322|NCT01073943|515337706|FG000|Overall Study|Withdrawal by Subject|8|||
142945323|NCT01073943|515337707|FG001|Overall Study|Withdrawal by Subject|2|||
142945324|NCT01073943|515337706|FG000|Overall Study|Protocol Violation|2|||
142945325|NCT01073943|515337707|FG001|Overall Study|Protocol Violation|1|||
142945326|NCT01073943|515337706|FG000|Overall Study|Adverse Event|1|||
142945327|NCT01073943|515337707|FG001|Overall Study|Adverse Event|1|||
142945328|NCT01073943|515337706|FG000|Overall Study|Lost to Follow-up|0|||
142945329|NCT01073943|515337707|FG001|Overall Study|Lost to Follow-up|2|||
142945330|NCT01073943|515337706|FG000|Overall Study|Power outage; colonoscopy not done|1|||
142945331|NCT01073943|515337707|FG001|Overall Study|Power outage; colonoscopy not done|0|||
142945332|NCT01073943|515337706|FG000|Overall Study|Subject forgot|0|||
142945333|NCT01073943|515337707|FG001|Overall Study|Subject forgot|1|||
142945334|NCT01073943|515337706|FG000|Overall Study|Unable to return for follow-up|0|||
142945335|NCT01073943|515337707|FG001|Overall Study|Unable to return for follow-up|1|||
142945336|NCT01073943|515337706|FG000|Overall Study|Could not tolerate prep|1|||
142945337|NCT01073943|515337707|FG001|Overall Study|Could not tolerate prep|0|||
142945338|NCT01051739|515337708|FG000|Overall Study|Death|3|||
142945339|NCT01051739|515337709|FG001|Overall Study|Death|3|||
142945340|NCT01051739|515337708|FG000|Overall Study|Withdrawal by Subject|25|||
142945341|NCT01051739|515337709|FG001|Overall Study|Withdrawal by Subject|10|||
142945342|NCT02120417|515337712|FG000|Overall Study|Death|5|||
142945343|NCT02120417|515337713|FG001|Overall Study|Death|1|||
142945344|NCT02120417|515337712|FG000|Overall Study|Adverse Event|3|||
142945345|NCT02120417|515337713|FG001|Overall Study|Adverse Event|9|||
142945346|NCT02120417|515337712|FG000|Overall Study|Participant decision|4|||
142945347|NCT02120417|515337713|FG001|Overall Study|Participant decision|4|||
142945348|NCT02120417|515337712|FG000|Overall Study|Disease progression|41|||
142945349|NCT02120417|515337713|FG001|Overall Study|Disease progression|45|||
142945350|NCT02120417|515337712|FG000|Overall Study|Noncompliance with study treatment|0|||
142945351|NCT02120417|515337713|FG001|Overall Study|Noncompliance with study treatment|2|||
142945352|NCT02120417|515337712|FG000|Overall Study|Physician Decision|2|||
142945353|NCT02120417|515337713|FG001|Overall Study|Physician Decision|3|||
142945354|NCT02120417|515337712|FG000|Overall Study|Other unspecified|5|||
142945355|NCT02120417|515337713|FG001|Overall Study|Other unspecified|4|||
142945356|NCT02286102|515337714|FG000|Overall Study|Screen Failure|1|||
142945357|NCT02286102|515337715|FG001|Overall Study|Screen Failure|1|||
142945358|NCT00927485|515337716|FG000|Overall Study|Adverse Event|4|||
142945359|NCT00927485|515337717|FG001|Overall Study|Adverse Event|2|||
142945360|NCT00927485|515337716|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
142945361|NCT00927485|515337717|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
142945362|NCT00201851|515337718|FG000|Overall Study|Lost to Follow-up|2|||
142945363|NCT00201851|515337719|FG001|Overall Study|Lost to Follow-up|1|||
142945364|NCT00201851|515337720|FG002|Overall Study|Lost to Follow-up|0|||
142945365|NCT00201851|515337718|FG000|Overall Study|Ineligible post enrollment|6|||
142945366|NCT00201851|515337719|FG001|Overall Study|Ineligible post enrollment|1|||
142945367|NCT00201851|515337720|FG002|Overall Study|Ineligible post enrollment|1|||
142945368|NCT00636818|515337724|FG000|Overall Study|Adverse Event|1|||
142945369|NCT00636818|515337724|FG000|Overall Study|Lost to Follow-up|2|||
142945370|NCT00636818|515337724|FG000|Overall Study|Entry Criteria Exclusion|3|||
142945371|NCT00636818|515337724|FG000|Overall Study|Protocol Violation|1|||
142945372|NCT00636818|515337724|FG000|Overall Study|Withdrawal by Subject|4|||
142945373|NCT02700451|515337727|FG000|Overall Study|Protocol Violation|2|||
142945374|NCT02700451|515337728|FG001|Overall Study|Protocol Violation|2|||
142945375|NCT02700451|515337729|FG002|Overall Study|Protocol Violation|3|||
142945376|NCT02700451|515337727|FG000|Overall Study|Discontinued intervention|14|||
142945377|NCT02700451|515337728|FG001|Overall Study|Discontinued intervention|15|||
142945378|NCT02700451|515337729|FG002|Overall Study|Discontinued intervention|14|||
142945379|NCT02690701|515337730|FG000|Treatment Period 1|Adverse Event|2|||
142945380|NCT02690701|515337731|FG001|Treatment Period 1|Adverse Event|2|||
142945381|NCT02690701|515337730|FG000|Treatment Period 1|Withdrawal by Subject|0|||
142945382|NCT02690701|515337731|FG001|Treatment Period 1|Withdrawal by Subject|1|||
142945383|NCT02690701|515337730|FG000|Treatment Period 2|Adverse Event|2|||
142945384|NCT02690701|515337731|FG001|Treatment Period 2|Adverse Event|0|||
142945385|NCT02690701|515337730|FG000|Treatment Period 2|Lack of Efficacy|1|||
142945386|NCT02690701|515337731|FG001|Treatment Period 2|Lack of Efficacy|0|||
142945387|NCT02690701|515337730|FG000|Treatment Period 2|Lost to Follow-up|0|||
142945388|NCT02690701|515337731|FG001|Treatment Period 2|Lost to Follow-up|2|||
142945389|NCT02690701|515337730|FG000|Treatment Period 2|Withdrawal by Subject|0|||
142945390|NCT02690701|515337731|FG001|Treatment Period 2|Withdrawal by Subject|2|||
142945391|NCT02690701|515337730|FG000|Treatment Period 2|Protocol Violation|0|||
142945392|NCT02690701|515337731|FG001|Treatment Period 2|Protocol Violation|1|||
142945393|NCT02115308|515337736|FG000|Overall Study|Safety Screening|2|||
142945394|NCT02115308|515337737|FG001|Overall Study|Safety Screening|2|||
142945395|NCT00749203|515337739|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
142945396|NCT00749203|515337740|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
142945397|NCT00749203|515337739|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
142945398|NCT00749203|515337740|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
142945399|NCT00749203|515337739|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
142945400|NCT00749203|515337740|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
142945401|NCT00749203|515337739|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
142945402|NCT00749203|515337740|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
142945403|NCT00749203|515337739|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
142945404|NCT00749203|515337740|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
142945405|NCT00749203|515337739|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
142945406|NCT00749203|515337740|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
142945407|NCT00957853|515337741|FG000|Overall Study|Withdrawal by Subject|1|||
142945408|NCT00957853|515337742|FG001|Overall Study|Withdrawal by Subject|0|||
142945409|NCT00957853|515337743|FG002|Overall Study|Withdrawal by Subject|0|||
142945410|NCT00702143|515337744|FG000|Overall Study|Lost to Follow-up|0|||
142945411|NCT00702143|515337745|FG001|Overall Study|Lost to Follow-up|0|||
142945412|NCT00702143|515337746|FG002|Overall Study|Lost to Follow-up|1|||
142945413|NCT05202808|515337747|FG000|Overall Study|Lost to Follow-up|3|||
142945414|NCT05202808|515337748|FG001|Overall Study|Lost to Follow-up|1|||
142945415|NCT04996797|515337749|FG000|Overall Study|Adverse Event|0|||
142945416|NCT04996797|515337750|FG001|Overall Study|Adverse Event|2|||
142945417|NCT04996797|515337751|FG002|Overall Study|Adverse Event|0|||
142945418|NCT04996797|515337752|FG003|Overall Study|Adverse Event|1|||
142945419|NCT04996797|515337749|FG000|Overall Study|Lack of Efficacy|0|||
142945420|NCT04996797|515337750|FG001|Overall Study|Lack of Efficacy|2|||
142945421|NCT04996797|515337751|FG002|Overall Study|Lack of Efficacy|0|||
142945422|NCT04996797|515337752|FG003|Overall Study|Lack of Efficacy|0|||
142945423|NCT04996797|515337749|FG000|Overall Study|Prohibited Medication|0|||
142945424|NCT04996797|515337750|FG001|Overall Study|Prohibited Medication|1|||
142945425|NCT04996797|515337751|FG002|Overall Study|Prohibited Medication|0|||
142945426|NCT04996797|515337752|FG003|Overall Study|Prohibited Medication|0|||
143117113|NCT01832818|515970032|FG000|Overall Study|Lost to Follow-up|6|||
143454985|NCT02663518|517210772|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
143454986|NCT02663518|517210759|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
143454987|NCT02663518|517210760|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
143454988|NCT02663518|517210761|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
142945427|NCT04996797|515337749|FG000|Overall Study|Ongoing|68|||
142945428|NCT04996797|515337750|FG001|Overall Study|Ongoing|60|||
142945429|NCT04996797|515337751|FG002|Overall Study|Ongoing|22|||
142945430|NCT04996797|515337752|FG003|Overall Study|Ongoing|20|||
142945431|NCT04996797|515337749|FG000|Overall Study|Withdrawal by Subject|0|||
142945432|NCT04996797|515337750|FG001|Overall Study|Withdrawal by Subject|2|||
142945433|NCT04996797|515337751|FG002|Overall Study|Withdrawal by Subject|0|||
142945434|NCT04996797|515337752|FG003|Overall Study|Withdrawal by Subject|0|||
142945435|NCT02793544|515337753|FG000|Overall Study|Death|10|||
142945436|NCT02793544|515337754|FG001|Overall Study|Death|8|||
142945437|NCT02793544|515337753|FG000|Overall Study|Lost to Follow-up|2|||
142945438|NCT02793544|515337754|FG001|Overall Study|Lost to Follow-up|0|||
143454989|NCT02663518|517210762|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
143454990|NCT02663518|517210763|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
142945439|NCT02793544|515337753|FG000|Overall Study|Withdrawal by Subject|1|||
142945440|NCT02793544|515337754|FG001|Overall Study|Withdrawal by Subject|0|||
142945441|NCT02495948|515337755|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
142945442|NCT02495948|515337756|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
142945443|NCT02495948|515337755|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
142945444|NCT02495948|515337756|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
142945445|NCT00100048|515337758|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
142945446|NCT00100048|515337759|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
142945447|NCT00100048|515337760|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
142945448|NCT00100048|515337761|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
142945449|NCT00100048|515337762|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
142945450|NCT00100048|515337763|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
142945451|NCT00100048|515337758|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
142945452|NCT00100048|515337759|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
142945453|NCT00100048|515337760|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
142945454|NCT00100048|515337761|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
142945455|NCT00100048|515337762|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
142945456|NCT00100048|515337763|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
142945457|NCT00100048|515337758|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
143454991|NCT02663518|517210764|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
142945458|NCT00100048|515337759|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
142945459|NCT00100048|515337760|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
142945460|NCT00100048|515337761|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
142945461|NCT00100048|515337762|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
142945462|NCT00100048|515337763|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
142945463|NCT00100048|515337758|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
142945464|NCT00100048|515337759|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
142945465|NCT00100048|515337760|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
142945466|NCT00100048|515337761|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
142945467|NCT00100048|515337762|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
142945468|NCT00100048|515337763|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
142945469|NCT00100048|515337758|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
142945470|NCT00100048|515337759|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
142945471|NCT00100048|515337760|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
142945472|NCT00100048|515337761|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
142945473|NCT00100048|515337762|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
142945474|NCT00100048|515337763|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
142945475|NCT00100048|515337758|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
142945476|NCT00100048|515337759|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
142945477|NCT00100048|515337760|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
142945478|NCT00100048|515337761|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
142945479|NCT00100048|515337762|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
142945480|NCT00100048|515337763|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
142945481|NCT00100048|515337758|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
142945482|NCT00100048|515337759|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
142945483|NCT00100048|515337760|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
142945484|NCT00100048|515337761|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
142945485|NCT00100048|515337762|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
142945486|NCT00100048|515337763|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
142945487|NCT00100048|515337758|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
142945488|NCT00100048|515337759|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
142945489|NCT00100048|515337760|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
142945490|NCT00100048|515337761|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
142945491|NCT00100048|515337762|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
142945492|NCT00100048|515337763|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
142945493|NCT01624142|515337764|FG000|Overall Study|Withdrawal by Subject|14|||
142945494|NCT01624142|515337765|FG001|Overall Study|Withdrawal by Subject|4|||
142945495|NCT01624142|515337764|FG000|Overall Study|Death|3|||
142945496|NCT01624142|515337765|FG001|Overall Study|Death|6|||
142945497|NCT01624142|515337764|FG000|Overall Study|Study Closure|12|||
142945498|NCT01624142|515337765|FG001|Overall Study|Study Closure|6|||
142945499|NCT01624142|515337764|FG000|Overall Study|Lost to Follow-up|2|||
143454992|NCT02663518|517210765|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
143454993|NCT02663518|517210766|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
143454994|NCT02663518|517210767|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
142945500|NCT01624142|515337765|FG001|Overall Study|Lost to Follow-up|0|||
142945501|NCT01624142|515337764|FG000|Overall Study|Other|1|||
142945502|NCT01624142|515337765|FG001|Overall Study|Other|0|||
142945503|NCT01822561|515337766|FG000|Overall Study|Withdrawal by Subject|2|||
142945504|NCT03929250|515337769|FG000|Overall Study|Blood draws could not be successfully obtained|0|||
142945505|NCT03929250|515337770|FG001|Overall Study|Blood draws could not be successfully obtained|1|||
142945506|NCT02770807|515337776|FG000|Overall Study|Adverse Event|3|||
142945507|NCT02770807|515337777|FG001|Overall Study|Adverse Event|3|||
142945508|NCT02770807|515337778|FG002|Overall Study|Adverse Event|1|||
142945509|NCT02770807|515337776|FG000|Overall Study|Withdrawal by Subject|7|||
142945510|NCT02770807|515337777|FG001|Overall Study|Withdrawal by Subject|3|||
142945511|NCT02770807|515337778|FG002|Overall Study|Withdrawal by Subject|4|||
142945512|NCT02770807|515337776|FG000|Overall Study|Other|0|||
142945513|NCT02770807|515337777|FG001|Overall Study|Other|1|||
142945514|NCT02770807|515337778|FG002|Overall Study|Other|0|||
142945515|NCT02770807|515337776|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
142945516|NCT02770807|515337777|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
142945517|NCT02770807|515337778|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
142945518|NCT02770807|515337776|FG000|Overall Study|Physician Decision|0|||
142945519|NCT02770807|515337777|FG001|Overall Study|Physician Decision|0|||
142945520|NCT02770807|515337778|FG002|Overall Study|Physician Decision|1|||
142945521|NCT00222105|515337781|FG000|Overall Study|Removed due to wrong diagnosis|1|||
142945522|NCT00222105|515337781|FG000|Overall Study|Withdrawal by Subject|1|||
142945523|NCT00222105|515337781|FG000|Overall Study|Adverse Event|8|||
142945524|NCT00222105|515337781|FG000|Overall Study|Treatment delays|2|||
142945525|NCT00222105|515337781|FG000|Overall Study|Death|2|||
142945526|NCT03277196|515337782|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
142945527|NCT03277196|515337782|FG000|Overall Study|Lost to Follow-up|3|||
142945528|NCT03277196|515337782|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
142945529|NCT03277196|515337782|FG000|Overall Study|Other|2|||
142945530|NCT00473694|515339068|FG000|Overall Study|Adverse Event|0|||
142945531|NCT00473694|515339069|FG001|Overall Study|Adverse Event|1|||
142945532|NCT00473694|515339070|FG002|Overall Study|Adverse Event|0|||
142945533|NCT00473694|515339071|FG003|Overall Study|Adverse Event|0|||
142945534|NCT00473694|515339068|FG000|Overall Study|Participants did not receive treatment|11|||
142945535|NCT00473694|515339069|FG001|Overall Study|Participants did not receive treatment|3|||
142945536|NCT00473694|515339070|FG002|Overall Study|Participants did not receive treatment|5|||
142945537|NCT00473694|515339071|FG003|Overall Study|Participants did not receive treatment|6|||
142945538|NCT00473694|515339068|FG000|Overall Study|Lost to Follow-up|0|||
142945539|NCT00473694|515339069|FG001|Overall Study|Lost to Follow-up|0|||
142945540|NCT00473694|515339070|FG002|Overall Study|Lost to Follow-up|0|||
142945541|NCT00473694|515339071|FG003|Overall Study|Lost to Follow-up|1|||
142945542|NCT03816995|515339078|FG000|Overall Study|Withdrawal by Subject|3|||
142945543|NCT03816995|515339079|FG001|Overall Study|Withdrawal by Subject|1|||
142945544|NCT03816995|515339078|FG000|Overall Study|Cancelled Surgery|8|||
142945545|NCT03816995|515339079|FG001|Overall Study|Cancelled Surgery|12|||
142945546|NCT03816995|515339078|FG000|Overall Study|No wound protector used|11|||
142945547|NCT03816995|515339079|FG001|Overall Study|No wound protector used|17|||
142945548|NCT03816995|515339078|FG000|Overall Study|Protocol Violation|2|||
142945549|NCT03816995|515339079|FG001|Overall Study|Protocol Violation|3|||
142945550|NCT04645797|515339080|FG000|Overall Study|Disease Progression|3|||
142945551|NCT04645797|515339081|FG001|Overall Study|Disease Progression|3|||
142945552|NCT04645797|515339082|FG002|Overall Study|Disease Progression|1|||
142945553|NCT04645797|515339083|FG003|Overall Study|Disease Progression|0|||
142945554|NCT04645797|515339084|FG004|Overall Study|Disease Progression|0|||
142945555|NCT04645797|515339085|FG005|Overall Study|Disease Progression|0|||
142945556|NCT04645797|515339086|FG006|Overall Study|Disease Progression|0|||
142945557|NCT04645797|515339080|FG000|Overall Study|Death|3|||
142945558|NCT04645797|515339081|FG001|Overall Study|Death|1|||
142945559|NCT04645797|515339082|FG002|Overall Study|Death|0|||
142945560|NCT04645797|515339083|FG003|Overall Study|Death|0|||
142945561|NCT04645797|515339084|FG004|Overall Study|Death|0|||
142945562|NCT04645797|515339085|FG005|Overall Study|Death|0|||
142945563|NCT04645797|515339086|FG006|Overall Study|Death|0|||
142945564|NCT00283387|515339092|FG000|First Intervention|Subject non-compliant|1|||
142945565|NCT00283387|515339093|FG001|First Intervention|Subject non-compliant|1|||
142945566|NCT00283387|515339092|FG000|First Intervention|Withdrawal by Subject|0|||
142945567|NCT00283387|515339093|FG001|First Intervention|Withdrawal by Subject|1|||
142945568|NCT01122927|515339095|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
142945569|NCT01122927|515339096|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
142945570|NCT01122927|515339095|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
142945571|NCT01122927|515339096|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
142945572|NCT01122927|515339095|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
142945573|NCT01122927|515339096|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
142945574|NCT01122927|515339095|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
142945575|NCT01122927|515339096|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
142945576|NCT01122927|515339095|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
142945577|NCT01122927|515339096|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
142945578|NCT01122927|515339095|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
142945579|NCT01122927|515339096|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
142945580|NCT01122927|515339095|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
142945581|NCT01122927|515339096|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
142945582|NCT01122927|515339095|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
142945583|NCT01122927|515339096|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
142945584|NCT01122927|515339095|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
142945585|NCT01122927|515339096|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
142945586|NCT01122927|515339095|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
142945587|NCT01122927|515339096|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
142945588|NCT01122927|515339095|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
142945589|NCT01122927|515339096|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
142945590|NCT01122927|515339095|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
142945591|NCT01122927|515339096|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
142945592|NCT03182738|515339097|FG000|Overall Study|Lost to Follow-up|9|||
142945593|NCT03182738|515339098|FG001|Overall Study|Lost to Follow-up|3|||
142945594|NCT03182738|515339097|FG000|Overall Study|Pregnancy|0|||
142945595|NCT03182738|515339098|FG001|Overall Study|Pregnancy|1|||
142945596|NCT03182738|515339097|FG000|Overall Study|Withdrawal by Subject|0|||
142945597|NCT03182738|515339098|FG001|Overall Study|Withdrawal by Subject|1|||
142945598|NCT00728416|515339099|FG000|Overall Study|Adverse Event|1|||
142945599|NCT00728416|515339100|FG001|Overall Study|Adverse Event|1|||
142945600|NCT00728416|515339099|FG000|Overall Study|Treatment Failure|0|||
142945601|NCT00728416|515339100|FG001|Overall Study|Treatment Failure|1|||
142945602|NCT00728416|515339099|FG000|Overall Study|Withdrawal by Subject|1|||
142945603|NCT00728416|515339100|FG001|Overall Study|Withdrawal by Subject|0|||
142945604|NCT03584009|515339101|FG000|Overall Study|Death|25|||
142945605|NCT03584009|515339102|FG001|Overall Study|Death|18|||
142945606|NCT03584009|515339101|FG000|Overall Study|Lost to Follow-up|0|||
142945607|NCT03584009|515339102|FG001|Overall Study|Lost to Follow-up|1|||
142945608|NCT03584009|515339101|FG000|Overall Study|Physician Decision|1|||
142945609|NCT03584009|515339102|FG001|Overall Study|Physician Decision|1|||
142945610|NCT03584009|515339101|FG000|Overall Study|Study Terminated by Sponsor|22|||
142945611|NCT03584009|515339102|FG001|Overall Study|Study Terminated by Sponsor|30|||
142945612|NCT03584009|515339101|FG000|Overall Study|Withdrawal by Subject|3|||
142945613|NCT03584009|515339102|FG001|Overall Study|Withdrawal by Subject|2|||
142945614|NCT02635204|515339103|FG000|Overall Study|Adverse Event|1|||
142945615|NCT02635204|515339104|FG001|Overall Study|Adverse Event|0|||
142945616|NCT02635204|515339103|FG000|Overall Study|Lost to Follow-up|1|||
142945617|NCT02635204|515339104|FG001|Overall Study|Lost to Follow-up|1|||
142945618|NCT00509106|515339106|FG000|Overall Study|Adverse Event|3|||
142945619|NCT00509106|515339107|FG001|Overall Study|Adverse Event|2|||
142945620|NCT00509106|515339106|FG000|Overall Study|Noncompliance|0|||
142945621|NCT00509106|515339107|FG001|Overall Study|Noncompliance|1|||
142945622|NCT00509106|515339106|FG000|Overall Study|At the request of sponsor/investigator|1|||
142945623|NCT00509106|515339107|FG001|Overall Study|At the request of sponsor/investigator|2|||
142945624|NCT00509106|515339106|FG000|Overall Study|Withdrew consent|4|||
142945625|NCT00509106|515339107|FG001|Overall Study|Withdrew consent|8|||
142945626|NCT00509106|515339106|FG000|Overall Study|Lost to Follow-up|16|||
142945627|NCT00509106|515339107|FG001|Overall Study|Lost to Follow-up|10|||
142945628|NCT00509106|515339106|FG000|Overall Study|Other|1|||
142945629|NCT00509106|515339107|FG001|Overall Study|Other|0|||
142945630|NCT00509106|515339106|FG000|Overall Study|Death|6|||
142945631|NCT00509106|515339107|FG001|Overall Study|Death|6|||
142945632|NCT00824421|515339110|FG000|Overall Study|Adverse Event|6|||
142945633|NCT00824421|515339111|FG001|Overall Study|Adverse Event|6|||
142945634|NCT00824421|515339112|FG002|Overall Study|Adverse Event|6|||
142945635|NCT00824421|515339110|FG000|Overall Study|Death|0|||
142945636|NCT00824421|515339111|FG001|Overall Study|Death|1|||
142945637|NCT00824421|515339112|FG002|Overall Study|Death|0|||
142945638|NCT00824421|515339110|FG000|Overall Study|Lack of Efficacy|5|||
142945639|NCT00824421|515339111|FG001|Overall Study|Lack of Efficacy|7|||
142945640|NCT00824421|515339112|FG002|Overall Study|Lack of Efficacy|4|||
142945641|NCT00824421|515339110|FG000|Overall Study|Lost to Follow-up|2|||
142945642|NCT00824421|515339111|FG001|Overall Study|Lost to Follow-up|3|||
142945643|NCT00824421|515339112|FG002|Overall Study|Lost to Follow-up|0|||
142945644|NCT00824421|515339110|FG000|Overall Study|Pregnancy|1|||
142945645|NCT00824421|515339111|FG001|Overall Study|Pregnancy|0|||
142945646|NCT00824421|515339112|FG002|Overall Study|Pregnancy|1|||
142945647|NCT00824421|515339110|FG000|Overall Study|Withdrawal by Subject|2|||
142945648|NCT00824421|515339111|FG001|Overall Study|Withdrawal by Subject|3|||
142945649|NCT00824421|515339112|FG002|Overall Study|Withdrawal by Subject|3|||
142945650|NCT00824421|515339110|FG000|Overall Study|Randomized but not Treated|1|||
142945651|NCT00824421|515339111|FG001|Overall Study|Randomized but not Treated|1|||
142945652|NCT00824421|515339112|FG002|Overall Study|Randomized but not Treated|0|||
142945653|NCT00824421|515339110|FG000|Overall Study|Other|0|||
142945654|NCT00824421|515339111|FG001|Overall Study|Other|1|||
142945655|NCT00824421|515339112|FG002|Overall Study|Other|0|||
142945656|NCT03527043|515339113|FG000|Overall Study|Withdrawal by Subject|1|||
142945657|NCT03527043|515339114|FG001|Overall Study|Withdrawal by Subject|0|||
142945658|NCT00659438|515339115|FG000|Overall Study|Withdrawal by Subject|2|||
142945659|NCT00659438|515339116|FG001|Overall Study|Withdrawal by Subject|2|||
142945660|NCT00659438|515339115|FG000|Overall Study|Death|11|||
142945661|NCT00659438|515339116|FG001|Overall Study|Death|6|||
142945662|NCT00659438|515339115|FG000|Overall Study|Lost to Follow-up|1|||
142945663|NCT00659438|515339116|FG001|Overall Study|Lost to Follow-up|0|||
142945664|NCT02469246|515339117|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
142945665|NCT02469246|515339118|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
142945666|NCT02469246|515339117|FG000|Double-Blind Phase|Adverse Event|12|||
142945667|NCT02469246|515339118|FG001|Double-Blind Phase|Adverse Event|9|||
142945668|NCT02469246|515339117|FG000|Double-Blind Phase|Death|2|||
142945669|NCT02469246|515339118|FG001|Double-Blind Phase|Death|0|||
142945670|NCT02469246|515339117|FG000|Double-Blind Phase|Lack of Efficacy|2|||
142945671|NCT02469246|515339118|FG001|Double-Blind Phase|Lack of Efficacy|1|||
142945672|NCT02469246|515339117|FG000|Double-Blind Phase|Investigator's Discretion|8|||
142945673|NCT02469246|515339118|FG001|Double-Blind Phase|Investigator's Discretion|8|||
142945674|NCT02469246|515339117|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
142945675|NCT02469246|515339118|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
142945676|NCT02469246|515339117|FG000|Double-Blind Phase|Protocol Violation|1|||
142945677|NCT02469246|515339118|FG001|Double-Blind Phase|Protocol Violation|1|||
142945678|NCT02469246|515339117|FG000|Double-Blind Phase|Withdrew Consent|25|||
142945679|NCT02469246|515339118|FG001|Double-Blind Phase|Withdrew Consent|25|||
142945680|NCT02469246|515339117|FG000|Double-Blind Phase|Lost to Follow-up|9|||
142945681|NCT02469246|515339118|FG001|Double-Blind Phase|Lost to Follow-up|5|||
142945682|NCT02344576|515339131|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
142945683|NCT02344576|515339132|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
142945684|NCT02344576|515339133|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
142945685|NCT02344576|515339134|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
142945686|NCT02344576|515339131|FG000|1-Month Follow-Up|Death|13|||
142945687|NCT02344576|515339132|FG001|1-Month Follow-Up|Death|8|||
142945688|NCT02344576|515339133|FG002|1-Month Follow-Up|Death|0|||
142945689|NCT02344576|515339134|FG003|1-Month Follow-Up|Death|0|||
142945690|NCT02344576|515339131|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
142945691|NCT02344576|515339132|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
142945692|NCT02344576|515339133|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
142945693|NCT02344576|515339134|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
142945694|NCT02344576|515339131|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
142945695|NCT02344576|515339132|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
142945696|NCT02344576|515339133|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
142945697|NCT02344576|515339134|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
142945698|NCT02344576|515339131|FG000|6-Month Follow-Up|Death|14|||
142945699|NCT02344576|515339132|FG001|6-Month Follow-Up|Death|14|||
142945700|NCT02344576|515339133|FG002|6-Month Follow-Up|Death|0|||
142945701|NCT02344576|515339134|FG003|6-Month Follow-Up|Death|0|||
142945702|NCT02344576|515339131|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
142945703|NCT02344576|515339132|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
142945704|NCT02344576|515339133|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
142945705|NCT02344576|515339134|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
142945706|NCT02344576|515339131|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
142945707|NCT02344576|515339132|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
142945708|NCT02344576|515339133|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
142945709|NCT02344576|515339134|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
142945710|NCT02698189|515339136|FG000|Overall Study|Physician Decision|3|||
142945711|NCT02698189|515339137|FG001|Overall Study|Physician Decision|0|||
142945712|NCT02698189|515339136|FG000|Overall Study|Progressive disease|0|||
142945713|NCT02698189|515339137|FG001|Overall Study|Progressive disease|5|||
142945714|NCT02698189|515339136|FG000|Overall Study|Study terminated by sponsor|0|||
142945715|NCT02698189|515339137|FG001|Overall Study|Study terminated by sponsor|1|||
142945716|NCT03871491|515339143|FG000|Overall Study|Withdrawal by Subject|14|||
142945717|NCT03871491|515339144|FG001|Overall Study|Withdrawal by Subject|14|||
142945718|NCT03871491|515339145|FG002|Overall Study|Withdrawal by Subject|14|||
142945719|NCT03871491|515339146|FG003|Overall Study|Withdrawal by Subject|14|||
142945720|NCT03871491|515339143|FG000|Overall Study|Physician Decision|0|||
142945721|NCT03871491|515339144|FG001|Overall Study|Physician Decision|0|||
142945722|NCT03871491|515339145|FG002|Overall Study|Physician Decision|1|||
142945723|NCT03871491|515339146|FG003|Overall Study|Physician Decision|1|||
142945724|NCT03871491|515339143|FG000|Overall Study|Lost to Follow-up|50|||
142945725|NCT03871491|515339144|FG001|Overall Study|Lost to Follow-up|15|||
142945726|NCT03871491|515339145|FG002|Overall Study|Lost to Follow-up|36|||
142945727|NCT03871491|515339146|FG003|Overall Study|Lost to Follow-up|11|||
142945728|NCT04091217|515339149|FG000|Overall Study|Lost to Follow-up|2|||
142945729|NCT02722044|515339152|FG000|Overall Study|Adverse Event|2|||
142945730|NCT02722044|515339152|FG000|Overall Study|Physician Decision|1|||
142945731|NCT02722044|515339152|FG000|Overall Study|Withdrawal by Subject|1|||
142945732|NCT02722044|515339152|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
142945733|NCT04885257|515339153|FG000|Overall Study|Withdrawal by Subject|1|||
142945734|NCT04885257|515339154|FG001|Overall Study|Withdrawal by Subject|0|||
142945735|NCT00741819|515339155|FG000|Overall Study|Adverse Event|3|||
142945736|NCT00741819|515339155|FG000|Overall Study|Withdrawal by Subject|3|||
142945737|NCT00741819|515339155|FG000|Overall Study|Death|1|||
142945738|NCT00741819|515339155|FG000|Overall Study|Disease progression|1|||
142945739|NCT01126580|515339156|FG000|Overall Study|Adverse Event|14|||
142945740|NCT01126580|515339157|FG001|Overall Study|Adverse Event|8|||
142945741|NCT01126580|515339158|FG002|Overall Study|Adverse Event|12|||
142945742|NCT01126580|515339156|FG000|Overall Study|Withdrawal by Subject|11|||
142945743|NCT01126580|515339157|FG001|Overall Study|Withdrawal by Subject|19|||
142945744|NCT01126580|515339158|FG002|Overall Study|Withdrawal by Subject|14|||
142945745|NCT01126580|515339156|FG000|Overall Study|Sponsor Decision|5|||
142945746|NCT01126580|515339157|FG001|Overall Study|Sponsor Decision|4|||
142945747|NCT01126580|515339158|FG002|Overall Study|Sponsor Decision|7|||
142945748|NCT01126580|515339156|FG000|Overall Study|Physician Decision|1|||
142945749|NCT01126580|515339157|FG001|Overall Study|Physician Decision|1|||
142945750|NCT01126580|515339158|FG002|Overall Study|Physician Decision|2|||
142945751|NCT01126580|515339156|FG000|Overall Study|Entry Criteria Not Met|1|||
142945752|NCT01126580|515339157|FG001|Overall Study|Entry Criteria Not Met|1|||
142945753|NCT01126580|515339158|FG002|Overall Study|Entry Criteria Not Met|2|||
142945754|NCT01126580|515339156|FG000|Overall Study|Lack of Efficacy|2|||
142945755|NCT01126580|515339157|FG001|Overall Study|Lack of Efficacy|3|||
142945756|NCT01126580|515339158|FG002|Overall Study|Lack of Efficacy|4|||
142945757|NCT01126580|515339156|FG000|Overall Study|Protocol Violation|0|||
142945758|NCT01126580|515339157|FG001|Overall Study|Protocol Violation|1|||
142945759|NCT01126580|515339158|FG002|Overall Study|Protocol Violation|2|||
142945760|NCT01126580|515339156|FG000|Overall Study|Lost to Follow-up|15|||
142945761|NCT01126580|515339157|FG001|Overall Study|Lost to Follow-up|13|||
142945762|NCT01126580|515339158|FG002|Overall Study|Lost to Follow-up|9|||
142945763|NCT01126580|515339156|FG000|Overall Study|Treatment Non-compliance|0|||
142945764|NCT01126580|515339157|FG001|Overall Study|Treatment Non-compliance|2|||
142945765|NCT01126580|515339158|FG002|Overall Study|Treatment Non-compliance|3|||
142945766|NCT01731002|515339159|FG000|Overall Study|Adverse Event|0|||
142945767|NCT01731002|515339160|FG001|Overall Study|Adverse Event|2|||
142945768|NCT01731002|515339161|FG002|Overall Study|Adverse Event|2|||
142945769|NCT01731002|515339159|FG000|Overall Study|Non-Compliant|0|||
142945770|NCT01731002|515339160|FG001|Overall Study|Non-Compliant|1|||
142945771|NCT01731002|515339161|FG002|Overall Study|Non-Compliant|0|||
142945772|NCT01731002|515339159|FG000|Overall Study|Lost to Follow-up|1|||
142945773|NCT01731002|515339160|FG001|Overall Study|Lost to Follow-up|0|||
142945774|NCT01731002|515339161|FG002|Overall Study|Lost to Follow-up|0|||
142945775|NCT01731002|515339159|FG000|Overall Study|Test Agent Discontinuation|0|||
142945776|NCT01731002|515339160|FG001|Overall Study|Test Agent Discontinuation|1|||
142945777|NCT01731002|515339161|FG002|Overall Study|Test Agent Discontinuation|0|||
142945778|NCT01731002|515339159|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
142945779|NCT01731002|515339160|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
142945780|NCT01731002|515339161|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
142945781|NCT01731002|515339159|FG000|Overall Study|Elevated IOP|1|||
142945782|NCT01731002|515339160|FG001|Overall Study|Elevated IOP|0|||
142945783|NCT01731002|515339161|FG002|Overall Study|Elevated IOP|0|||
142945784|NCT01731002|515339159|FG000|Overall Study|Inappropriate use of study medications|0|||
142945785|NCT01731002|515339160|FG001|Overall Study|Inappropriate use of study medications|0|||
142945786|NCT01731002|515339161|FG002|Overall Study|Inappropriate use of study medications|1|||
142945787|NCT00947349|515339162|FG000|Triple Treatment Combination Period|Adverse Event|0|||
142945788|NCT00947349|515339163|FG001|Triple Treatment Combination Period|Adverse Event|1|||
142945789|NCT00947349|515339164|FG002|Triple Treatment Combination Period|Adverse Event|0|||
142945790|NCT00947349|515339165|FG003|Triple Treatment Combination Period|Adverse Event|0|||
142945791|NCT00947349|515339162|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
143454995|NCT02663518|517210768|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
143454996|NCT02663518|517210769|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
143454997|NCT02663518|517210770|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
143454998|NCT02663518|517210771|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
143454999|NCT02663518|517210772|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
143455000|NCT02663518|517210759|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
143455001|NCT02663518|517210760|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
143455002|NCT02663518|517210761|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
143455003|NCT02663518|517210762|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
143455004|NCT02663518|517210763|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
142945792|NCT00947349|515339163|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
142945793|NCT00947349|515339164|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
142945794|NCT00947349|515339165|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
142945795|NCT00947349|515339162|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
142945796|NCT00947349|515339163|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
142945797|NCT00947349|515339164|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
142945798|NCT00947349|515339165|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
142945799|NCT00947349|515339162|FG000|Overall Study Standard of Care|Other|0|||
142945800|NCT00947349|515339163|FG001|Overall Study Standard of Care|Other|0|||
142945801|NCT00947349|515339164|FG002|Overall Study Standard of Care|Other|0|||
142945802|NCT00947349|515339165|FG003|Overall Study Standard of Care|Other|1|||
142945803|NCT00538681|515339166|FG000|Overall Study|Progressive Disease|7|||
142945804|NCT00538681|515339167|FG001|Overall Study|Progressive Disease|0|||
142945805|NCT00538681|515339168|FG002|Overall Study|Progressive Disease|1|||
142945806|NCT00538681|515339169|FG003|Overall Study|Progressive Disease|0|||
142945807|NCT00538681|515339166|FG000|Overall Study|Sponsor Decision|1|||
142945808|NCT00538681|515339167|FG001|Overall Study|Sponsor Decision|3|||
142945809|NCT00538681|515339168|FG002|Overall Study|Sponsor Decision|8|||
142945810|NCT00538681|515339169|FG003|Overall Study|Sponsor Decision|9|||
142945811|NCT00538681|515339166|FG000|Overall Study|Adverse Event|1|||
142945812|NCT00538681|515339167|FG001|Overall Study|Adverse Event|1|||
142945813|NCT00538681|515339168|FG002|Overall Study|Adverse Event|1|||
142945814|NCT00538681|515339169|FG003|Overall Study|Adverse Event|0|||
142945815|NCT00538681|515339166|FG000|Overall Study|Death|0|||
142945816|NCT00538681|515339167|FG001|Overall Study|Death|0|||
142945817|NCT00538681|515339168|FG002|Overall Study|Death|1|||
142945818|NCT00538681|515339169|FG003|Overall Study|Death|1|||
142945819|NCT00538681|515339166|FG000|Overall Study|Investigator Decision|0|||
142945820|NCT00538681|515339167|FG001|Overall Study|Investigator Decision|0|||
142945821|NCT00538681|515339168|FG002|Overall Study|Investigator Decision|0|||
142945822|NCT00538681|515339169|FG003|Overall Study|Investigator Decision|1|||
142945823|NCT00140855|515339172|FG000|Overall Study|Progressive disease|2|||
142945824|NCT05262764|515339178|FG000|Overall Study|Case report form not collected|9|||
142945825|NCT05262764|515339178|FG000|Overall Study|No patient visits after entry|23|||
142945826|NCT05262764|515339178|FG000|Overall Study|Registration rule not followed|2|||
142945827|NCT05262764|515339178|FG000|Overall Study|Patient of non-chronic heart failure|1|||
142945828|NCT01331161|515339180|FG000|Overall Study|Physician Decision|1|||
142945829|NCT01331161|515339181|FG001|Overall Study|Physician Decision|0|||
142945830|NCT01331161|515339180|FG000|Overall Study|Lost to Follow-up|0|||
142945831|NCT01331161|515339181|FG001|Overall Study|Lost to Follow-up|1|||
142945832|NCT01331161|515339180|FG000|Overall Study|Pregnancy|0|||
142945833|NCT01331161|515339181|FG001|Overall Study|Pregnancy|1|||
142945834|NCT01682044|515339182|FG000|Overall Study|Death|1|||
142945835|NCT01682044|515339182|FG000|Overall Study|Progression|3|||
142945836|NCT03972488|515339183|FG000|Overall Study|Progressive disease|42|||
142945837|NCT03972488|515339184|FG001|Overall Study|Progressive disease|44|||
142945838|NCT03972488|515339183|FG000|Overall Study|Physician Decision|13|||
142945839|NCT03972488|515339184|FG001|Overall Study|Physician Decision|7|||
142945840|NCT03972488|515339183|FG000|Overall Study|Adverse Event|8|||
142945841|NCT03972488|515339184|FG001|Overall Study|Adverse Event|1|||
142945842|NCT03972488|515339183|FG000|Overall Study|Death|4|||
142945843|NCT03972488|515339184|FG001|Overall Study|Death|4|||
142945844|NCT03972488|515339183|FG000|Overall Study|Withdrawal by Subject|3|||
142945845|NCT03972488|515339184|FG001|Overall Study|Withdrawal by Subject|4|||
142945846|NCT03972488|515339183|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
142945847|NCT03972488|515339184|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
142945848|NCT04865731|515339186|FG000|Overall Study|Physician Decision|2|||
142945849|NCT04865731|515339187|FG001|Overall Study|Physician Decision|1|||
142945850|NCT04865731|515339186|FG000|Overall Study|Adverse Event|1|||
142945851|NCT04865731|515339187|FG001|Overall Study|Adverse Event|0|||
142945852|NCT04865731|515339186|FG000|Overall Study|Withdrawal by Subject|0|||
142945853|NCT04865731|515339187|FG001|Overall Study|Withdrawal by Subject|1|||
142945854|NCT01416181|515341420|FG000|Part 1|Other|10|||
142945855|NCT01416181|515341421|FG001|Part 1|Other|24|||
142945856|NCT01416181|515341420|FG000|Part 1|Death|0|||
142945857|NCT01416181|515341421|FG001|Part 1|Death|1|||
142945858|NCT01416181|515341420|FG000|Part 1|Investigator Decision|7|||
142945859|NCT01416181|515341421|FG001|Part 1|Investigator Decision|6|||
142945860|NCT01416181|515341420|FG000|Part 1|Withdrawal by Subject|74|||
142945861|NCT01416181|515341421|FG001|Part 1|Withdrawal by Subject|48|||
142945862|NCT01416181|515341420|FG000|Part 1|Lack of Efficacy|16|||
142945863|NCT01416181|515341421|FG001|Part 1|Lack of Efficacy|8|||
142945864|NCT01416181|515341420|FG000|Part 1|Lost to Follow-up|1|||
142945865|NCT01416181|515341421|FG001|Part 1|Lost to Follow-up|1|||
142945866|NCT01416181|515341420|FG000|Part 1|Adverse Event|15|||
142945867|NCT01416181|515341421|FG001|Part 1|Adverse Event|18|||
142945868|NCT01416181|515341420|FG000|Part 1|Ongoing in Follow-Up|14|||
142945869|NCT01416181|515341421|FG001|Part 1|Ongoing in Follow-Up|8|||
142945870|NCT01416181|515341420|FG000|Part 2|Adverse Event|11|||
142945871|NCT01416181|515341421|FG001|Part 2|Adverse Event|4|||
142945872|NCT01416181|515341420|FG000|Part 2|Other|234|||
142945873|NCT01416181|515341421|FG001|Part 2|Other|267|||
142945874|NCT01416181|515341420|FG000|Part 2|Investigator Decision|6|||
142945875|NCT01416181|515341421|FG001|Part 2|Investigator Decision|7|||
142945876|NCT01416181|515341420|FG000|Part 2|Withdrawal by Subject|14|||
142945877|NCT01416181|515341421|FG001|Part 2|Withdrawal by Subject|5|||
142945878|NCT01416181|515341420|FG000|Part 2|Lack of Efficacy|4|||
142945879|NCT01416181|515341421|FG001|Part 2|Lack of Efficacy|1|||
142945880|NCT01416181|515341420|FG000|Part 2|Lost to Follow-up|2|||
142945881|NCT01416181|515341421|FG001|Part 2|Lost to Follow-up|2|||
142945882|NCT00541307|515341426|FG000|Overall Study|Death|5|||
142945883|NCT00541307|515341426|FG000|Overall Study|Physician Decision|3|||
142945884|NCT00541307|515341426|FG000|Overall Study|Withdrawal by Subject|6|||
142945885|NCT00541307|515341426|FG000|Overall Study|Lost to Follow-up|4|||
142945886|NCT00541307|515341426|FG000|Overall Study|Subject returned early (outside window)|1|||
142945887|NCT00541307|515341426|FG000|Overall Study|Surgical Bypass|5|||
142945888|NCT02432807|515341427|FG000|Overall Study|Adverse Event|0|||
142945889|NCT02432807|515341428|FG001|Overall Study|Adverse Event|2|||
142945890|NCT02432807|515341427|FG000|Overall Study|Lost to Follow-up|1|||
142945891|NCT02432807|515341428|FG001|Overall Study|Lost to Follow-up|0|||
142945892|NCT02432807|515341427|FG000|Overall Study|Withdrawal by Subject|1|||
142945893|NCT02432807|515341428|FG001|Overall Study|Withdrawal by Subject|1|||
142945894|NCT02432807|515341427|FG000|Overall Study|Other|1|||
142945895|NCT02432807|515341428|FG001|Overall Study|Other|1|||
142945896|NCT03976401|515341435|FG000|Overall Study|Adverse Event|2|||
142945897|NCT03976401|515341436|FG001|Overall Study|Adverse Event|0|||
142945898|NCT03976401|515341437|FG002|Overall Study|Adverse Event|4|||
142945899|NCT03976401|515341438|FG003|Overall Study|Adverse Event|1|||
142945900|NCT03976401|515341439|FG004|Overall Study|Adverse Event|1|||
142945901|NCT03976401|515341440|FG005|Overall Study|Adverse Event|0|||
142945902|NCT03976401|515341435|FG000|Overall Study|Withdrawal by Subject|0|||
142945903|NCT03976401|515341436|FG001|Overall Study|Withdrawal by Subject|1|||
142945904|NCT03976401|515341437|FG002|Overall Study|Withdrawal by Subject|0|||
142945905|NCT03976401|515341438|FG003|Overall Study|Withdrawal by Subject|0|||
142945906|NCT03976401|515341439|FG004|Overall Study|Withdrawal by Subject|0|||
142945907|NCT03976401|515341440|FG005|Overall Study|Withdrawal by Subject|1|||
142945908|NCT03976401|515341435|FG000|Overall Study|Physician Decision|0|||
142945909|NCT03976401|515341436|FG001|Overall Study|Physician Decision|0|||
142945910|NCT03976401|515341437|FG002|Overall Study|Physician Decision|1|||
142945911|NCT03976401|515341438|FG003|Overall Study|Physician Decision|0|||
142945912|NCT03976401|515341439|FG004|Overall Study|Physician Decision|0|||
142945913|NCT03976401|515341440|FG005|Overall Study|Physician Decision|0|||
142945914|NCT03976401|515341435|FG000|Overall Study|Lost to Follow-up|1|||
142945915|NCT03976401|515341436|FG001|Overall Study|Lost to Follow-up|2|||
142945916|NCT03976401|515341437|FG002|Overall Study|Lost to Follow-up|0|||
142945917|NCT03976401|515341438|FG003|Overall Study|Lost to Follow-up|0|||
142945918|NCT03976401|515341439|FG004|Overall Study|Lost to Follow-up|0|||
142945919|NCT03976401|515341440|FG005|Overall Study|Lost to Follow-up|0|||
142945920|NCT03976401|515341435|FG000|Overall Study|Protocol Violation|0|||
142945921|NCT03976401|515341436|FG001|Overall Study|Protocol Violation|1|||
142945922|NCT03976401|515341437|FG002|Overall Study|Protocol Violation|0|||
142945923|NCT03976401|515341438|FG003|Overall Study|Protocol Violation|0|||
142945924|NCT03976401|515341439|FG004|Overall Study|Protocol Violation|0|||
142945925|NCT03976401|515341440|FG005|Overall Study|Protocol Violation|0|||
142945926|NCT03976401|515341435|FG000|Overall Study|Withdrew Consent|0|||
142945927|NCT03976401|515341436|FG001|Overall Study|Withdrew Consent|0|||
142945928|NCT03976401|515341437|FG002|Overall Study|Withdrew Consent|0|||
142945929|NCT03976401|515341438|FG003|Overall Study|Withdrew Consent|1|||
142945930|NCT03976401|515341439|FG004|Overall Study|Withdrew Consent|0|||
142945931|NCT03976401|515341440|FG005|Overall Study|Withdrew Consent|0|||
142945932|NCT01324830|515341443|FG000|Overall Study|Progressive Disease|3|||
142945933|NCT01324830|515341444|FG001|Overall Study|Progressive Disease|2|||
142945934|NCT01324830|515341445|FG002|Overall Study|Progressive Disease|3|||
142945935|NCT01324830|515341446|FG003|Overall Study|Progressive Disease|3|||
142945936|NCT01324830|515341447|FG004|Overall Study|Progressive Disease|6|||
142945937|NCT01324830|515341448|FG005|Overall Study|Progressive Disease|6|||
142945938|NCT01324830|515341449|FG006|Overall Study|Progressive Disease|3|||
142945939|NCT01324830|515341450|FG007|Overall Study|Progressive Disease|3|||
142945940|NCT01324830|515341451|FG008|Overall Study|Progressive Disease|3|||
142945941|NCT01324830|515341452|FG009|Overall Study|Progressive Disease|6|||
142945942|NCT01324830|515341453|FG010|Overall Study|Progressive Disease|2|||
142945943|NCT01324830|515341454|FG011|Overall Study|Progressive Disease|1|||
142945944|NCT01324830|515341455|FG012|Overall Study|Progressive Disease|1|||
142945945|NCT01324830|515341456|FG013|Overall Study|Progressive Disease|1|||
142945946|NCT01324830|515341457|FG014|Overall Study|Progressive Disease|1|||
142945947|NCT01324830|515341458|FG015|Overall Study|Progressive Disease|3|||
143455005|NCT02663518|517210764|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
142945948|NCT01324830|515341459|FG016|Overall Study|Progressive Disease|2|||
142945949|NCT01324830|515341460|FG017|Overall Study|Progressive Disease|3|||
142945950|NCT01324830|515341461|FG018|Overall Study|Progressive Disease|4|||
142945951|NCT01324830|515341443|FG000|Overall Study|Dose limiting toxicity|0|||
142945952|NCT01324830|515341444|FG001|Overall Study|Dose limiting toxicity|0|||
142945953|NCT01324830|515341445|FG002|Overall Study|Dose limiting toxicity|0|||
142945954|NCT01324830|515341446|FG003|Overall Study|Dose limiting toxicity|0|||
142945955|NCT01324830|515341447|FG004|Overall Study|Dose limiting toxicity|1|||
142945956|NCT01324830|515341448|FG005|Overall Study|Dose limiting toxicity|0|||
142945957|NCT01324830|515341449|FG006|Overall Study|Dose limiting toxicity|0|||
142945958|NCT01324830|515341450|FG007|Overall Study|Dose limiting toxicity|0|||
142945959|NCT01324830|515341451|FG008|Overall Study|Dose limiting toxicity|0|||
142945960|NCT01324830|515341452|FG009|Overall Study|Dose limiting toxicity|0|||
142945961|NCT01324830|515341453|FG010|Overall Study|Dose limiting toxicity|0|||
142945962|NCT01324830|515341454|FG011|Overall Study|Dose limiting toxicity|0|||
142945963|NCT01324830|515341455|FG012|Overall Study|Dose limiting toxicity|0|||
142945964|NCT01324830|515341456|FG013|Overall Study|Dose limiting toxicity|0|||
142945965|NCT01324830|515341457|FG014|Overall Study|Dose limiting toxicity|0|||
142945966|NCT01324830|515341458|FG015|Overall Study|Dose limiting toxicity|0|||
142945967|NCT01324830|515341459|FG016|Overall Study|Dose limiting toxicity|1|||
142945968|NCT01324830|515341460|FG017|Overall Study|Dose limiting toxicity|1|||
142945969|NCT01324830|515341461|FG018|Overall Study|Dose limiting toxicity|1|||
142945970|NCT01324830|515341443|FG000|Overall Study|Reason not mentioned above|0|||
142945971|NCT01324830|515341444|FG001|Overall Study|Reason not mentioned above|0|||
142945972|NCT01324830|515341445|FG002|Overall Study|Reason not mentioned above|0|||
142945973|NCT01324830|515341446|FG003|Overall Study|Reason not mentioned above|0|||
142945974|NCT01324830|515341447|FG004|Overall Study|Reason not mentioned above|0|||
142945975|NCT01324830|515341448|FG005|Overall Study|Reason not mentioned above|0|||
142945976|NCT01324830|515341449|FG006|Overall Study|Reason not mentioned above|0|||
142945977|NCT01324830|515341450|FG007|Overall Study|Reason not mentioned above|0|||
142945978|NCT01324830|515341451|FG008|Overall Study|Reason not mentioned above|0|||
142945979|NCT01324830|515341452|FG009|Overall Study|Reason not mentioned above|0|||
142945980|NCT01324830|515341453|FG010|Overall Study|Reason not mentioned above|0|||
142945981|NCT01324830|515341454|FG011|Overall Study|Reason not mentioned above|0|||
142945982|NCT01324830|515341455|FG012|Overall Study|Reason not mentioned above|0|||
142945983|NCT01324830|515341456|FG013|Overall Study|Reason not mentioned above|0|||
142945984|NCT01324830|515341457|FG014|Overall Study|Reason not mentioned above|0|||
142945985|NCT01324830|515341458|FG015|Overall Study|Reason not mentioned above|0|||
142945986|NCT01324830|515341459|FG016|Overall Study|Reason not mentioned above|0|||
142945987|NCT01324830|515341460|FG017|Overall Study|Reason not mentioned above|1|||
142945988|NCT01324830|515341461|FG018|Overall Study|Reason not mentioned above|0|||
142945989|NCT01324830|515341443|FG000|Overall Study|Adverse Event, serious fatal|0|||
142945990|NCT01324830|515341444|FG001|Overall Study|Adverse Event, serious fatal|1|||
142945991|NCT01324830|515341445|FG002|Overall Study|Adverse Event, serious fatal|0|||
142945992|NCT01324830|515341446|FG003|Overall Study|Adverse Event, serious fatal|0|||
142945993|NCT01324830|515341447|FG004|Overall Study|Adverse Event, serious fatal|0|||
142945994|NCT01324830|515341448|FG005|Overall Study|Adverse Event, serious fatal|0|||
142945995|NCT01324830|515341449|FG006|Overall Study|Adverse Event, serious fatal|0|||
142945996|NCT01324830|515341450|FG007|Overall Study|Adverse Event, serious fatal|0|||
142945997|NCT01324830|515341451|FG008|Overall Study|Adverse Event, serious fatal|0|||
142945998|NCT01324830|515341452|FG009|Overall Study|Adverse Event, serious fatal|0|||
142945999|NCT01324830|515341453|FG010|Overall Study|Adverse Event, serious fatal|0|||
142946000|NCT01324830|515341454|FG011|Overall Study|Adverse Event, serious fatal|0|||
142946001|NCT01324830|515341455|FG012|Overall Study|Adverse Event, serious fatal|0|||
142946002|NCT01324830|515341456|FG013|Overall Study|Adverse Event, serious fatal|0|||
142946003|NCT01324830|515341457|FG014|Overall Study|Adverse Event, serious fatal|0|||
142946004|NCT01324830|515341458|FG015|Overall Study|Adverse Event, serious fatal|0|||
142946005|NCT01324830|515341459|FG016|Overall Study|Adverse Event, serious fatal|0|||
142946006|NCT01324830|515341460|FG017|Overall Study|Adverse Event, serious fatal|0|||
142946007|NCT01324830|515341461|FG018|Overall Study|Adverse Event, serious fatal|0|||
142946008|NCT01324830|515341443|FG000|Overall Study|Adverse Event, non-fatal|0|||
142946009|NCT01324830|515341444|FG001|Overall Study|Adverse Event, non-fatal|0|||
142946010|NCT01324830|515341445|FG002|Overall Study|Adverse Event, non-fatal|0|||
142946011|NCT01324830|515341446|FG003|Overall Study|Adverse Event, non-fatal|0|||
142946012|NCT01324830|515341447|FG004|Overall Study|Adverse Event, non-fatal|0|||
142946013|NCT01324830|515341448|FG005|Overall Study|Adverse Event, non-fatal|0|||
142946014|NCT01324830|515341449|FG006|Overall Study|Adverse Event, non-fatal|0|||
142946015|NCT01324830|515341450|FG007|Overall Study|Adverse Event, non-fatal|0|||
142946016|NCT01324830|515341451|FG008|Overall Study|Adverse Event, non-fatal|2|||
142946017|NCT01324830|515341452|FG009|Overall Study|Adverse Event, non-fatal|0|||
142946018|NCT01324830|515341453|FG010|Overall Study|Adverse Event, non-fatal|1|||
142946019|NCT01324830|515341454|FG011|Overall Study|Adverse Event, non-fatal|0|||
142946020|NCT01324830|515341455|FG012|Overall Study|Adverse Event, non-fatal|0|||
142946021|NCT01324830|515341456|FG013|Overall Study|Adverse Event, non-fatal|0|||
142946022|NCT01324830|515341457|FG014|Overall Study|Adverse Event, non-fatal|0|||
142946023|NCT01324830|515341458|FG015|Overall Study|Adverse Event, non-fatal|0|||
142946024|NCT01324830|515341459|FG016|Overall Study|Adverse Event, non-fatal|0|||
142946025|NCT01324830|515341460|FG017|Overall Study|Adverse Event, non-fatal|1|||
142946026|NCT01324830|515341461|FG018|Overall Study|Adverse Event, non-fatal|0|||
142946027|NCT01324830|515341443|FG000|Overall Study|Withdrawal by Subject|0|||
142946028|NCT01324830|515341444|FG001|Overall Study|Withdrawal by Subject|0|||
142946029|NCT01324830|515341445|FG002|Overall Study|Withdrawal by Subject|0|||
142946030|NCT01324830|515341446|FG003|Overall Study|Withdrawal by Subject|0|||
142946031|NCT01324830|515341447|FG004|Overall Study|Withdrawal by Subject|0|||
142946032|NCT01324830|515341448|FG005|Overall Study|Withdrawal by Subject|1|||
142946033|NCT01324830|515341449|FG006|Overall Study|Withdrawal by Subject|0|||
142946034|NCT01324830|515341450|FG007|Overall Study|Withdrawal by Subject|0|||
142946035|NCT01324830|515341451|FG008|Overall Study|Withdrawal by Subject|0|||
142946036|NCT01324830|515341452|FG009|Overall Study|Withdrawal by Subject|0|||
142946037|NCT01324830|515341453|FG010|Overall Study|Withdrawal by Subject|1|||
142946038|NCT01324830|515341454|FG011|Overall Study|Withdrawal by Subject|0|||
142946039|NCT01324830|515341455|FG012|Overall Study|Withdrawal by Subject|0|||
142946040|NCT01324830|515341456|FG013|Overall Study|Withdrawal by Subject|0|||
142946041|NCT01324830|515341457|FG014|Overall Study|Withdrawal by Subject|0|||
142946042|NCT01324830|515341458|FG015|Overall Study|Withdrawal by Subject|0|||
142946043|NCT01324830|515341459|FG016|Overall Study|Withdrawal by Subject|0|||
142946044|NCT01324830|515341460|FG017|Overall Study|Withdrawal by Subject|0|||
142946045|NCT01324830|515341461|FG018|Overall Study|Withdrawal by Subject|1|||
142946046|NCT01485614|515341462|FG000|Randomization|Not Treated|1|||
142946047|NCT01485614|515341463|FG001|Randomization|Not Treated|0|||
142946048|NCT01485614|515341464|FG002|Randomization|Not Treated|0|||
142946049|NCT01485614|515341465|FG003|Randomization|Not Treated|0|||
142946050|NCT01485614|515341462|FG000|Weeks 0-20|Lost to Follow-up|2|||
142946051|NCT01485614|515341463|FG001|Weeks 0-20|Lost to Follow-up|0|||
142946052|NCT01485614|515341464|FG002|Weeks 0-20|Lost to Follow-up|0|||
142946053|NCT01485614|515341465|FG003|Weeks 0-20|Lost to Follow-up|0|||
142946054|NCT01485614|515341462|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
142946055|NCT01485614|515341463|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
142946056|NCT01485614|515341464|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
142946057|NCT01485614|515341465|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
142946058|NCT01485614|515341462|FG000|Weeks 0-20|Withdrawal by Subject|3|||
142946059|NCT01485614|515341463|FG001|Weeks 0-20|Withdrawal by Subject|2|||
142946060|NCT01485614|515341464|FG002|Weeks 0-20|Withdrawal by Subject|1|||
142946061|NCT01485614|515341465|FG003|Weeks 0-20|Withdrawal by Subject|0|||
142946062|NCT01485614|515341462|FG000|Weeks 20-54|Lost to Follow-up|4|||
142946063|NCT01485614|515341463|FG001|Weeks 20-54|Lost to Follow-up|3|||
142946064|NCT01485614|515341464|FG002|Weeks 20-54|Lost to Follow-up|1|||
142946065|NCT01485614|515341465|FG003|Weeks 20-54|Lost to Follow-up|0|||
142946066|NCT01485614|515341462|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
142946067|NCT01485614|515341463|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
142946068|NCT01485614|515341464|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
142946069|NCT01485614|515341465|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
142946070|NCT01485614|515341462|FG000|Weeks 20-54|Withdrawal by Subject|5|||
142946071|NCT01485614|515341463|FG001|Weeks 20-54|Withdrawal by Subject|3|||
142946072|NCT01485614|515341464|FG002|Weeks 20-54|Withdrawal by Subject|0|||
142946073|NCT01485614|515341465|FG003|Weeks 20-54|Withdrawal by Subject|0|||
142946074|NCT00733902|515341466|FG000|Overall Study|Death|0|||
142946075|NCT00733902|515341467|FG001|Overall Study|Death|0|||
142946076|NCT00733902|515341468|FG002|Overall Study|Death|0|||
142946077|NCT00733902|515341469|FG003|Overall Study|Death|1|||
142946078|NCT00733902|515341466|FG000|Overall Study|Adverse Event|3|||
142946079|NCT00733902|515341467|FG001|Overall Study|Adverse Event|4|||
142946080|NCT00733902|515341468|FG002|Overall Study|Adverse Event|7|||
142946081|NCT00733902|515341469|FG003|Overall Study|Adverse Event|11|||
142946082|NCT00733902|515341466|FG000|Overall Study|Lack of Efficacy|56|||
142946083|NCT00733902|515341467|FG001|Overall Study|Lack of Efficacy|21|||
142946084|NCT00733902|515341468|FG002|Overall Study|Lack of Efficacy|34|||
142946085|NCT00733902|515341469|FG003|Overall Study|Lack of Efficacy|23|||
142946086|NCT00733902|515341466|FG000|Overall Study|Protocol Violation|4|||
142946087|NCT00733902|515341467|FG001|Overall Study|Protocol Violation|6|||
142946088|NCT00733902|515341468|FG002|Overall Study|Protocol Violation|3|||
142946089|NCT00733902|515341469|FG003|Overall Study|Protocol Violation|3|||
142946090|NCT00733902|515341466|FG000|Overall Study|Withdrawal by Subject|10|||
142946091|NCT00733902|515341467|FG001|Overall Study|Withdrawal by Subject|5|||
142946092|NCT00733902|515341468|FG002|Overall Study|Withdrawal by Subject|4|||
142946093|NCT00733902|515341469|FG003|Overall Study|Withdrawal by Subject|16|||
142946094|NCT00733902|515341466|FG000|Overall Study|Entered extension study|89|||
142946095|NCT00733902|515341467|FG001|Overall Study|Entered extension study|124|||
142946096|NCT00733902|515341468|FG002|Overall Study|Entered extension study|111|||
142946097|NCT00733902|515341469|FG003|Overall Study|Entered extension study|109|||
142946098|NCT00733902|515341466|FG000|Overall Study|Randomized but not treated|2|||
142946099|NCT00733902|515341467|FG001|Overall Study|Randomized but not treated|2|||
142946100|NCT00733902|515341468|FG002|Overall Study|Randomized but not treated|2|||
142946101|NCT00733902|515341469|FG003|Overall Study|Randomized but not treated|1|||
142946102|NCT02210780|515341470|FG000|Overall Study|Adverse Event|0|||
142946103|NCT02210780|515341471|FG001|Overall Study|Adverse Event|5|||
142946104|NCT02210780|515341470|FG000|Overall Study|Lost to Follow-up|2|||
142946105|NCT02210780|515341471|FG001|Overall Study|Lost to Follow-up|1|||
142946106|NCT02210780|515341470|FG000|Overall Study|Withdrawal by Subject|1|||
142946107|NCT02210780|515341471|FG001|Overall Study|Withdrawal by Subject|1|||
142946108|NCT02210780|515341470|FG000|Overall Study|Physician Decision|1|||
142946109|NCT02210780|515341471|FG001|Overall Study|Physician Decision|0|||
142946110|NCT02210780|515341470|FG000|Overall Study|Protocol Violation|1|||
142946111|NCT02210780|515341471|FG001|Overall Study|Protocol Violation|0|||
142946112|NCT02210780|515341470|FG000|Overall Study|Other than specified above|0|||
142946113|NCT02210780|515341471|FG001|Overall Study|Other than specified above|1|||
142946114|NCT00942409|515341472|FG000|Overall Study|Lack of Efficacy|1|||
142946115|NCT00942409|515341472|FG000|Overall Study|study drug unavailable|2|||
142946116|NCT01503021|515341475|FG000|Overall Study|Adverse Event|7|||
142946117|NCT01503021|515341476|FG001|Overall Study|Adverse Event|6|||
142946118|NCT01503021|515341475|FG000|Overall Study|Death|0|||
142946119|NCT01503021|515341476|FG001|Overall Study|Death|2|||
142946120|NCT01503021|515341475|FG000|Overall Study|Lost to Follow-up|2|||
142946121|NCT01503021|515341476|FG001|Overall Study|Lost to Follow-up|0|||
142946122|NCT01503021|515341475|FG000|Overall Study|Physician Decision|3|||
142946123|NCT01503021|515341476|FG001|Overall Study|Physician Decision|0|||
142946124|NCT01503021|515341475|FG000|Overall Study|Protocol Violation|1|||
142946125|NCT01503021|515341476|FG001|Overall Study|Protocol Violation|3|||
142946126|NCT01503021|515341475|FG000|Overall Study|Withdrawal by Subject|9|||
142946127|NCT01503021|515341476|FG001|Overall Study|Withdrawal by Subject|8|||
142946128|NCT01503021|515341475|FG000|Overall Study|Moved, received transplant, etc.|5|||
142946129|NCT01503021|515341476|FG001|Overall Study|Moved, received transplant, etc.|7|||
142946130|NCT00817414|515341477|FG000|Overall Study|Adverse Event|1|||
142946131|NCT00817414|515341478|FG001|Overall Study|Adverse Event|1|||
142946132|NCT00817414|515341479|FG002|Overall Study|Adverse Event|1|||
142946133|NCT00817414|515341480|FG003|Overall Study|Adverse Event|0|||
142946134|NCT00817414|515341481|FG004|Overall Study|Adverse Event|0|||
142946135|NCT00817414|515341477|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
142946136|NCT00817414|515341478|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
142946137|NCT00817414|515341479|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
142946138|NCT00817414|515341480|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
142946139|NCT00817414|515341481|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
142946140|NCT00817414|515341477|FG000|Overall Study|Withdrawal by Subject|1|||
142946141|NCT00817414|515341478|FG001|Overall Study|Withdrawal by Subject|1|||
142946142|NCT00817414|515341479|FG002|Overall Study|Withdrawal by Subject|0|||
142946143|NCT00817414|515341480|FG003|Overall Study|Withdrawal by Subject|0|||
142946144|NCT00817414|515341481|FG004|Overall Study|Withdrawal by Subject|0|||
142946145|NCT00817414|515341477|FG000|Overall Study|Lost to Follow-up|0|||
142946146|NCT00817414|515341478|FG001|Overall Study|Lost to Follow-up|0|||
142946147|NCT00817414|515341479|FG002|Overall Study|Lost to Follow-up|1|||
142946148|NCT00817414|515341480|FG003|Overall Study|Lost to Follow-up|1|||
142946149|NCT00817414|515341481|FG004|Overall Study|Lost to Follow-up|1|||
142946150|NCT00817414|515341477|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
142946151|NCT00817414|515341478|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
142946152|NCT00817414|515341479|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
142946153|NCT00817414|515341480|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
142946154|NCT00817414|515341481|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
142946155|NCT00817414|515341477|FG000|Overall Study|Protocol Violation|0|||
142946156|NCT00817414|515341478|FG001|Overall Study|Protocol Violation|0|||
142946157|NCT00817414|515341479|FG002|Overall Study|Protocol Violation|0|||
142946158|NCT00817414|515341480|FG003|Overall Study|Protocol Violation|0|||
142946159|NCT00817414|515341481|FG004|Overall Study|Protocol Violation|1|||
142946160|NCT00886938|515341482|FG000|Overall Study|Adverse Event|1|||
142946161|NCT00886938|515341482|FG000|Overall Study|Withdrawal by Subject|1|||
142946162|NCT02966314|515341485|FG000|Overall Study|Lost to Follow-up|1|||
142946163|NCT02966314|515341486|FG001|Overall Study|Lost to Follow-up|0|||
142946164|NCT01242111|515341488|FG000|Overall Study|Adverse Event|1|||
142946165|NCT01242111|515341488|FG000|Overall Study|Withdrawal by Subject|1|||
142946166|NCT01242111|515341488|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
142946167|NCT00870688|515341489|FG000|Overall Study|Lost to Follow-up|2|||
142946168|NCT00870688|515341489|FG000|Overall Study|Death, Unrelated|1|||
142946169|NCT00870688|515341489|FG000|Overall Study|Granules in the Stools|1|||
142946170|NCT02015819|515341490|FG000|Overall Study|Rickham catheter was misaligned|0|||
142946171|NCT02015819|515341491|FG001|Overall Study|Rickham catheter was misaligned|0|||
142946172|NCT02015819|515341492|FG002|Overall Study|Rickham catheter was misaligned|0|||
142946173|NCT02015819|515341493|FG003|Overall Study|Rickham catheter was misaligned|1|||
142946174|NCT03872180|515341494|FG000|Overall Study|Adverse Event|4|||
142946175|NCT03872180|515341494|FG000|Overall Study|Lack of Efficacy|2|||
142946176|NCT01697215|515341497|FG000|Overall Study|Physician Decision|5|||
142946177|NCT01697215|515341497|FG000|Overall Study|Malfunction|9|||
142946178|NCT01697215|515341497|FG000|Overall Study|CXR not available|9|||
142946179|NCT01929083|515341498|FG000|Intervention 1|Lost to Follow-up|2|||
142946180|NCT01929083|515341499|FG001|Intervention 1|Lost to Follow-up|0|||
142946181|NCT01929083|515341498|FG000|Intervention 1|Nonadherent to study medications|1|||
142946182|NCT01929083|515341499|FG001|Intervention 1|Nonadherent to study medications|0|||
142946183|NCT01929083|515341498|FG000|Intervention 2|Adverse Event|0|||
142946184|NCT01929083|515341499|FG001|Intervention 2|Adverse Event|1|||
142946185|NCT02599402|515341500|FG000|Overall Study|Disease progression|153|||
142946186|NCT02599402|515341500|FG000|Overall Study|Study drug toxicity|201|||
142946187|NCT02599402|515341500|FG000|Overall Study|Death|26|||
142946188|NCT02599402|515341500|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
142946189|NCT02599402|515341500|FG000|Overall Study|Participant request to discontinue study treatment|13|||
142946190|NCT02599402|515341500|FG000|Overall Study|Participant withdrew consent|5|||
142946191|NCT02599402|515341500|FG000|Overall Study|Lost to Follow-up|1|||
142946192|NCT02599402|515341500|FG000|Overall Study|Maximum Clinical Benefit|7|||
142946193|NCT02599402|515341500|FG000|Overall Study|Poor/non-compliance|1|||
142946194|NCT02599402|515341500|FG000|Overall Study|Pregnancy|1|||
142946195|NCT02599402|515341500|FG000|Overall Study|Participant no longer met study criteria|7|||
142946196|NCT02599402|515341500|FG000|Overall Study|Other Reasons|95|||
142946197|NCT02945657|515341501|FG000|Overall Study|Adverse Event|1|||
142946198|NCT02945657|515341501|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
142946199|NCT00087438|515341508|FG000|Overall Study|Ineligible / No protocol treatment|4|||
142946200|NCT00811252|515341509|FG000|Overall Study|Adverse Event|6|||
142946201|NCT00811252|515341510|FG001|Overall Study|Adverse Event|10|||
142946202|NCT00811252|515341511|FG002|Overall Study|Adverse Event|15|||
142946203|NCT00811252|515341509|FG000|Overall Study|Lack of Efficacy|7|||
142946204|NCT00811252|515341510|FG001|Overall Study|Lack of Efficacy|2|||
142946205|NCT00811252|515341511|FG002|Overall Study|Lack of Efficacy|0|||
142946206|NCT00811252|515341509|FG000|Overall Study|Protocol Violation|3|||
142946207|NCT00811252|515341510|FG001|Overall Study|Protocol Violation|3|||
142946208|NCT00811252|515341511|FG002|Overall Study|Protocol Violation|2|||
142946209|NCT00811252|515341509|FG000|Overall Study|Withdrawal of Consent|1|||
142946210|NCT00811252|515341510|FG001|Overall Study|Withdrawal of Consent|2|||
142946211|NCT00811252|515341511|FG002|Overall Study|Withdrawal of Consent|2|||
142946212|NCT00811252|515341509|FG000|Overall Study|Lost to Follow-up|0|||
142946213|NCT00811252|515341510|FG001|Overall Study|Lost to Follow-up|0|||
142946214|NCT00811252|515341511|FG002|Overall Study|Lost to Follow-up|2|||
142946215|NCT00811252|515341509|FG000|Overall Study|Administrative or Other Reasons|0|||
142946216|NCT00811252|515341510|FG001|Overall Study|Administrative or Other Reasons|3|||
142946217|NCT00811252|515341511|FG002|Overall Study|Administrative or Other Reasons|2|||
142946218|NCT01157117|515341512|FG000|Overall Study|Dosing Symptoms|0|||
142946219|NCT01157117|515341513|FG001|Overall Study|Dosing Symptoms|4|||
142946220|NCT01157117|515341514|FG002|Overall Study|Dosing Symptoms|0|||
142946221|NCT01157117|515341512|FG000|Overall Study|Withdrawal by Subject|4|||
142946222|NCT01157117|515341513|FG001|Overall Study|Withdrawal by Subject|1|||
142946223|NCT01157117|515341514|FG002|Overall Study|Withdrawal by Subject|1|||
142946224|NCT01157117|515341512|FG000|Overall Study|Lack of Efficacy|1|||
142946225|NCT01157117|515341513|FG001|Overall Study|Lack of Efficacy|1|||
142946226|NCT01157117|515341514|FG002|Overall Study|Lack of Efficacy|0|||
142946227|NCT01157117|515341512|FG000|Overall Study|Lost to Follow-up|0|||
142946228|NCT01157117|515341513|FG001|Overall Study|Lost to Follow-up|0|||
142946229|NCT01157117|515341514|FG002|Overall Study|Lost to Follow-up|1|||
142946230|NCT01157117|515341512|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
142946231|NCT01157117|515341513|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
142946232|NCT01157117|515341514|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
142946233|NCT01486264|515341515|FG000|Overall Study|Death|1|||
142946234|NCT01486264|515341516|FG001|Overall Study|Death|1|||
142946235|NCT01486264|515341515|FG000|Overall Study|Adverse Event|3|||
142946236|NCT01486264|515341516|FG001|Overall Study|Adverse Event|3|||
142946237|NCT01486264|515341515|FG000|Overall Study|Lack of Efficacy|6|||
142946238|NCT01486264|515341516|FG001|Overall Study|Lack of Efficacy|10|||
142946239|NCT01486264|515341515|FG000|Overall Study|Withdrawal by Subject|7|||
142946240|NCT01486264|515341516|FG001|Overall Study|Withdrawal by Subject|18|||
142946241|NCT01486264|515341515|FG000|Overall Study|Physician Decision|1|||
142946242|NCT01486264|515341516|FG001|Overall Study|Physician Decision|1|||
142946243|NCT01486264|515341515|FG000|Overall Study|Protocol Violation|3|||
142946244|NCT01486264|515341516|FG001|Overall Study|Protocol Violation|0|||
142946245|NCT01486264|515341515|FG000|Overall Study|Lost to Follow-up|3|||
143455006|NCT02663518|517210765|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
143455007|NCT02663518|517210766|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
142946246|NCT01486264|515341516|FG001|Overall Study|Lost to Follow-up|2|||
142946247|NCT01486264|515341515|FG000|Overall Study|Other|5|||
142946248|NCT01486264|515341516|FG001|Overall Study|Other|11|||
142946249|NCT01486264|515341515|FG000|Overall Study|Not treated|0|||
142946250|NCT01486264|515341516|FG001|Overall Study|Not treated|1|||
142946251|NCT01931865|515341517|FG000|Overall Study|Lost to Follow-up|2|||
142946252|NCT01931865|515341517|FG000|Overall Study|Withdrawal by Subject|2|||
142946253|NCT00500071|515341519|FG000|Screening and Washout Phase|Protocol Violation|1|||
142946254|NCT00500071|515341519|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
142946255|NCT00500071|515341519|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
142946256|NCT00500071|515341519|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
142946257|NCT00500071|515341519|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
142946258|NCT00500071|515341519|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
142946259|NCT00500071|515341519|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
142946260|NCT00488631|515341538|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
142946261|NCT00488631|515341539|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
142946262|NCT00488631|515341540|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
142946263|NCT00488631|515341541|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
142946264|NCT00488631|515341542|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
142946265|NCT00488631|515341543|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
142946266|NCT00488631|515341544|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
142946267|NCT00488631|515341545|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
142946268|NCT00488631|515341546|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
142946269|NCT00488631|515341547|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
142946270|NCT00488631|515341538|FG000|Double Blind Period (Week 0-54)|Death|0|||
142946271|NCT00488631|515341539|FG001|Double Blind Period (Week 0-54)|Death|0|||
142946272|NCT00488631|515341540|FG002|Double Blind Period (Week 0-54)|Death|0|||
142946273|NCT00488631|515341541|FG003|Double Blind Period (Week 0-54)|Death|0|||
142946274|NCT00488631|515341542|FG004|Double Blind Period (Week 0-54)|Death|0|||
142946275|NCT00488631|515341543|FG005|Double Blind Period (Week 0-54)|Death|1|||
142946276|NCT00488631|515341544|FG006|Double Blind Period (Week 0-54)|Death|0|||
142946277|NCT00488631|515341545|FG007|Double Blind Period (Week 0-54)|Death|0|||
142946278|NCT00488631|515341546|FG008|Double Blind Period (Week 0-54)|Death|0|||
142946279|NCT00488631|515341547|FG009|Double Blind Period (Week 0-54)|Death|0|||
142946280|NCT00488631|515341538|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
142946281|NCT00488631|515341539|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
142946282|NCT00488631|515341540|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
142946283|NCT00488631|515341541|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
142946284|NCT00488631|515341542|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
142946285|NCT00488631|515341543|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
142946286|NCT00488631|515341544|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
142946287|NCT00488631|515341545|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
142946288|NCT00488631|515341546|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
142946289|NCT00488631|515341547|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
142946290|NCT00488631|515341538|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
142946291|NCT00488631|515341539|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
142946292|NCT00488631|515341540|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
142946293|NCT00488631|515341541|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
142946294|NCT00488631|515341542|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
142946295|NCT00488631|515341543|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
142946296|NCT00488631|515341544|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
142946297|NCT00488631|515341545|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
142946298|NCT00488631|515341546|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
142946299|NCT00488631|515341547|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
142946300|NCT00488631|515341538|FG000|Double Blind Period (Week 0-54)|Other|6|||
142946301|NCT00488631|515341539|FG001|Double Blind Period (Week 0-54)|Other|12|||
142946302|NCT00488631|515341540|FG002|Double Blind Period (Week 0-54)|Other|10|||
142946303|NCT00488631|515341541|FG003|Double Blind Period (Week 0-54)|Other|11|||
142946304|NCT00488631|515341542|FG004|Double Blind Period (Week 0-54)|Other|14|||
142946305|NCT00488631|515341543|FG005|Double Blind Period (Week 0-54)|Other|34|||
142946306|NCT00488631|515341544|FG006|Double Blind Period (Week 0-54)|Other|0|||
142946307|NCT00488631|515341545|FG007|Double Blind Period (Week 0-54)|Other|0|||
142946308|NCT00488631|515341546|FG008|Double Blind Period (Week 0-54)|Other|0|||
142946309|NCT00488631|515341547|FG009|Double Blind Period (Week 0-54)|Other|0|||
142946310|NCT00488631|515341538|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
142946311|NCT00488631|515341539|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
142946312|NCT00488631|515341540|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
142946313|NCT00488631|515341541|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
142946314|NCT00488631|515341542|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
142946315|NCT00488631|515341543|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
142946316|NCT00488631|515341544|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
142946317|NCT00488631|515341545|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
142946318|NCT00488631|515341546|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
142946319|NCT00488631|515341547|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
142946320|NCT00488631|515341538|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
142946321|NCT00488631|515341539|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
142946322|NCT00488631|515341540|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
142946323|NCT00488631|515341541|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
142946324|NCT00488631|515341542|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
142946325|NCT00488631|515341543|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
142946326|NCT00488631|515341544|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
142946327|NCT00488631|515341545|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
142946328|NCT00488631|515341546|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
142946329|NCT00488631|515341547|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
142946330|NCT00488631|515341538|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
142946331|NCT00488631|515341539|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
142946332|NCT00488631|515341540|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
142946333|NCT00488631|515341541|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
142946334|NCT00488631|515341542|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
142946335|NCT00488631|515341543|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
142946336|NCT00488631|515341544|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
142946337|NCT00488631|515341545|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
142946338|NCT00488631|515341546|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
142946339|NCT00488631|515341547|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
142946340|NCT00488631|515341538|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
142946341|NCT00488631|515341539|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
142946342|NCT00488631|515341540|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
142946343|NCT00488631|515341541|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
142946344|NCT00488631|515341542|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
142946345|NCT00488631|515341543|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
142946346|NCT00488631|515341544|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
142946347|NCT00488631|515341545|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
142946348|NCT00488631|515341546|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
142946349|NCT00488631|515341547|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
142946350|NCT00488631|515341538|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
142946351|NCT00488631|515341539|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
142946352|NCT00488631|515341540|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
142946353|NCT00488631|515341541|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
142946354|NCT00488631|515341542|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
142946355|NCT00488631|515341543|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
142946356|NCT00488631|515341544|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
142946357|NCT00488631|515341545|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
142946358|NCT00488631|515341546|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
142946359|NCT00488631|515341547|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
142946360|NCT00594399|515341548|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
142946361|NCT00594399|515341549|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
142946362|NCT00594399|515341550|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
142946363|NCT00594399|515341548|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
142946364|NCT00594399|515341549|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
142946365|NCT00594399|515341550|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
142946366|NCT00594399|515341548|FG000|Initial 3 Month Counseling|Personal issues|2|||
142946367|NCT00594399|515341549|FG001|Initial 3 Month Counseling|Personal issues|0|||
142946368|NCT00594399|515341550|FG002|Initial 3 Month Counseling|Personal issues|0|||
142946369|NCT00594399|515341548|FG000|Initial 3 Month Counseling|Too busy|7|||
142946370|NCT00594399|515341549|FG001|Initial 3 Month Counseling|Too busy|1|||
142946371|NCT00594399|515341550|FG002|Initial 3 Month Counseling|Too busy|0|||
142946372|NCT00594399|515341548|FG000|Initial 3 Month Counseling|Pain|2|||
142946373|NCT00594399|515341549|FG001|Initial 3 Month Counseling|Pain|0|||
142946374|NCT00594399|515341550|FG002|Initial 3 Month Counseling|Pain|0|||
142946375|NCT00594399|515341548|FG000|Initial 3 Month Counseling|Moved|1|||
142946376|NCT00594399|515341549|FG001|Initial 3 Month Counseling|Moved|0|||
142946377|NCT00594399|515341550|FG002|Initial 3 Month Counseling|Moved|0|||
142946378|NCT00594399|515341548|FG000|Initial 3 Month Counseling|Family illness|1|||
142946379|NCT00594399|515341549|FG001|Initial 3 Month Counseling|Family illness|0|||
142946380|NCT00594399|515341550|FG002|Initial 3 Month Counseling|Family illness|0|||
142946381|NCT00594399|515341548|FG000|Rerandomization Arm 1 Only|Death|2|||
142946382|NCT00594399|515341549|FG001|Rerandomization Arm 1 Only|Death|1|||
142946383|NCT00594399|515341550|FG002|Rerandomization Arm 1 Only|Death|0|||
142946384|NCT00594399|515341548|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
142946385|NCT00594399|515341549|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
142946386|NCT00594399|515341550|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
142946387|NCT00424398|515341552|FG000|Overall Study|Withdrawal by Subject|2|||
142946388|NCT00424398|515341553|FG001|Overall Study|Withdrawal by Subject|1|||
142946389|NCT00424398|515341554|FG002|Overall Study|Withdrawal by Subject|0|||
142946390|NCT00424398|515341552|FG000|Overall Study|Subject met exclusion criteria|1|||
142946391|NCT00424398|515341553|FG001|Overall Study|Subject met exclusion criteria|0|||
142946392|NCT00424398|515341554|FG002|Overall Study|Subject met exclusion criteria|0|||
142946393|NCT01309737|515341556|FG000|Week 0 to 16|Death|1|||
142946394|NCT01309737|515341557|FG001|Week 0 to 16|Death|0|||
142946395|NCT01309737|515341558|FG002|Week 0 to 16|Death|1|||
142946396|NCT01309737|515341559|FG003|Week 0 to 16|Death|0|||
142946397|NCT01309737|515341560|FG004|Week 0 to 16|Death|0|||
142946398|NCT01309737|515341556|FG000|Week 0 to 16|Adverse Event|11|||
142946399|NCT01309737|515341557|FG001|Week 0 to 16|Adverse Event|10|||
142946400|NCT01309737|515341558|FG002|Week 0 to 16|Adverse Event|5|||
142946401|NCT01309737|515341559|FG003|Week 0 to 16|Adverse Event|0|||
142946402|NCT01309737|515341560|FG004|Week 0 to 16|Adverse Event|0|||
142946403|NCT01309737|515341556|FG000|Week 0 to 16|Lack of Efficacy|15|||
142946404|NCT01309737|515341557|FG001|Week 0 to 16|Lack of Efficacy|2|||
142946405|NCT01309737|515341558|FG002|Week 0 to 16|Lack of Efficacy|24|||
142946406|NCT01309737|515341559|FG003|Week 0 to 16|Lack of Efficacy|0|||
142946407|NCT01309737|515341560|FG004|Week 0 to 16|Lack of Efficacy|0|||
142946408|NCT01309737|515341556|FG000|Week 0 to 16|Lost to Follow-up|7|||
142946409|NCT01309737|515341557|FG001|Week 0 to 16|Lost to Follow-up|8|||
142946410|NCT01309737|515341558|FG002|Week 0 to 16|Lost to Follow-up|3|||
142946411|NCT01309737|515341559|FG003|Week 0 to 16|Lost to Follow-up|0|||
142946412|NCT01309737|515341560|FG004|Week 0 to 16|Lost to Follow-up|0|||
142946413|NCT01309737|515341556|FG000|Week 0 to 16|Withdrawal by Subject|7|||
142946414|NCT01309737|515341557|FG001|Week 0 to 16|Withdrawal by Subject|6|||
142946415|NCT01309737|515341558|FG002|Week 0 to 16|Withdrawal by Subject|7|||
142946416|NCT01309737|515341559|FG003|Week 0 to 16|Withdrawal by Subject|0|||
142946417|NCT01309737|515341560|FG004|Week 0 to 16|Withdrawal by Subject|0|||
142946418|NCT01309737|515341556|FG000|Week 0 to 16|Other|10|||
142946419|NCT01309737|515341557|FG001|Week 0 to 16|Other|14|||
142946420|NCT01309737|515341558|FG002|Week 0 to 16|Other|4|||
142946421|NCT01309737|515341559|FG003|Week 0 to 16|Other|0|||
142946422|NCT01309737|515341560|FG004|Week 0 to 16|Other|0|||
142946423|NCT01309737|515341556|FG000|Week 0 to 16|Randomized, but not treated|1|||
142946424|NCT01309737|515341557|FG001|Week 0 to 16|Randomized, but not treated|0|||
142946425|NCT01309737|515341558|FG002|Week 0 to 16|Randomized, but not treated|0|||
142946426|NCT01309737|515341559|FG003|Week 0 to 16|Randomized, but not treated|0|||
142946427|NCT01309737|515341560|FG004|Week 0 to 16|Randomized, but not treated|0|||
142946428|NCT01309737|515341556|FG000|Week 16 to 52|Death|0|||
142946429|NCT01309737|515341557|FG001|Week 16 to 52|Death|0|||
142946430|NCT01309737|515341558|FG002|Week 16 to 52|Death|0|||
142946431|NCT01309737|515341559|FG003|Week 16 to 52|Death|0|||
142946432|NCT01309737|515341560|FG004|Week 16 to 52|Death|1|||
142946433|NCT01309737|515341556|FG000|Week 16 to 52|Adverse Event|7|||
142946434|NCT01309737|515341557|FG001|Week 16 to 52|Adverse Event|7|||
142946435|NCT01309737|515341558|FG002|Week 16 to 52|Adverse Event|0|||
142946436|NCT01309737|515341559|FG003|Week 16 to 52|Adverse Event|6|||
142946437|NCT01309737|515341560|FG004|Week 16 to 52|Adverse Event|5|||
142946438|NCT01309737|515341556|FG000|Week 16 to 52|Lack of Efficacy|107|||
142946439|NCT01309737|515341557|FG001|Week 16 to 52|Lack of Efficacy|76|||
142946440|NCT01309737|515341558|FG002|Week 16 to 52|Lack of Efficacy|0|||
142946441|NCT01309737|515341559|FG003|Week 16 to 52|Lack of Efficacy|25|||
142946442|NCT01309737|515341560|FG004|Week 16 to 52|Lack of Efficacy|21|||
142946443|NCT01309737|515341556|FG000|Week 16 to 52|Lost to Follow-up|4|||
142946444|NCT01309737|515341557|FG001|Week 16 to 52|Lost to Follow-up|2|||
142946445|NCT01309737|515341558|FG002|Week 16 to 52|Lost to Follow-up|0|||
142946446|NCT01309737|515341559|FG003|Week 16 to 52|Lost to Follow-up|1|||
142946447|NCT01309737|515341560|FG004|Week 16 to 52|Lost to Follow-up|4|||
142946448|NCT01309737|515341556|FG000|Week 16 to 52|Withdrawal by Subject|5|||
142946449|NCT01309737|515341557|FG001|Week 16 to 52|Withdrawal by Subject|6|||
142946450|NCT01309737|515341558|FG002|Week 16 to 52|Withdrawal by Subject|0|||
142946451|NCT01309737|515341559|FG003|Week 16 to 52|Withdrawal by Subject|0|||
142946452|NCT01309737|515341560|FG004|Week 16 to 52|Withdrawal by Subject|2|||
142946453|NCT01309737|515341556|FG000|Week 16 to 52|Other|10|||
142946454|NCT01309737|515341557|FG001|Week 16 to 52|Other|12|||
142946455|NCT01309737|515341558|FG002|Week 16 to 52|Other|0|||
142946456|NCT01309737|515341559|FG003|Week 16 to 52|Other|2|||
142946457|NCT01309737|515341560|FG004|Week 16 to 52|Other|0|||
142946458|NCT04233424|515341561|FG000|Overall Study|Death|15|||
142946459|NCT04233424|515341562|FG001|Overall Study|Death|16|||
142946460|NCT04233424|515341561|FG000|Overall Study|Withdrawal by Subject|2|||
142946461|NCT04233424|515341562|FG001|Overall Study|Withdrawal by Subject|8|||
142946462|NCT04233424|515341561|FG000|Overall Study|Physician Decision|1|||
142946463|NCT04233424|515341562|FG001|Overall Study|Physician Decision|3|||
142946464|NCT04233424|515341561|FG000|Overall Study|Protocol Violation|3|||
142946465|NCT04233424|515341562|FG001|Overall Study|Protocol Violation|1|||
142946466|NCT04233424|515341561|FG000|Overall Study|Lost to Follow-up|1|||
142946467|NCT04233424|515341562|FG001|Overall Study|Lost to Follow-up|3|||
142946468|NCT04233424|515341561|FG000|Overall Study|subject refuse to visit site|2|||
142946469|NCT04233424|515341562|FG001|Overall Study|subject refuse to visit site|0|||
142946470|NCT02240706|515341563|FG000|Overall Study|Lack of Efficacy|2|||
142946471|NCT02240706|515341564|FG001|Overall Study|Lack of Efficacy|2|||
142946472|NCT02240706|515341565|FG002|Overall Study|Lack of Efficacy|2|||
142946473|NCT02240706|515341566|FG003|Overall Study|Lack of Efficacy|2|||
142946474|NCT02240706|515341567|FG004|Overall Study|Lack of Efficacy|5|||
142946475|NCT02240706|515341568|FG005|Overall Study|Lack of Efficacy|0|||
142946476|NCT02240706|515341569|FG006|Overall Study|Lack of Efficacy|0|||
142946477|NCT02240706|515341563|FG000|Overall Study|Adverse Event|1|||
142946478|NCT02240706|515341564|FG001|Overall Study|Adverse Event|0|||
142946479|NCT02240706|515341565|FG002|Overall Study|Adverse Event|1|||
142946480|NCT02240706|515341566|FG003|Overall Study|Adverse Event|0|||
142946481|NCT02240706|515341567|FG004|Overall Study|Adverse Event|2|||
142946482|NCT02240706|515341568|FG005|Overall Study|Adverse Event|0|||
142946483|NCT02240706|515341569|FG006|Overall Study|Adverse Event|0|||
142946484|NCT02240706|515341563|FG000|Overall Study|Progressive disease|0|||
142946485|NCT02240706|515341564|FG001|Overall Study|Progressive disease|0|||
142946486|NCT02240706|515341565|FG002|Overall Study|Progressive disease|0|||
142946487|NCT02240706|515341566|FG003|Overall Study|Progressive disease|0|||
142946488|NCT02240706|515341567|FG004|Overall Study|Progressive disease|1|||
142946489|NCT02240706|515341568|FG005|Overall Study|Progressive disease|0|||
142946490|NCT02240706|515341569|FG006|Overall Study|Progressive disease|0|||
142946491|NCT02240706|515341563|FG000|Overall Study|Dose limiting toxicity|0|||
142946492|NCT02240706|515341564|FG001|Overall Study|Dose limiting toxicity|0|||
142946493|NCT02240706|515341565|FG002|Overall Study|Dose limiting toxicity|0|||
142946494|NCT02240706|515341566|FG003|Overall Study|Dose limiting toxicity|0|||
142946495|NCT02240706|515341567|FG004|Overall Study|Dose limiting toxicity|1|||
142946496|NCT02240706|515341568|FG005|Overall Study|Dose limiting toxicity|0|||
142946497|NCT02240706|515341569|FG006|Overall Study|Dose limiting toxicity|0|||
142946498|NCT02240706|515341563|FG000|Overall Study|Refused to continue taking medication|0|||
142946499|NCT02240706|515341564|FG001|Overall Study|Refused to continue taking medication|1|||
142946500|NCT02240706|515341565|FG002|Overall Study|Refused to continue taking medication|3|||
142946501|NCT02240706|515341566|FG003|Overall Study|Refused to continue taking medication|1|||
142946502|NCT02240706|515341567|FG004|Overall Study|Refused to continue taking medication|2|||
142946503|NCT02240706|515341568|FG005|Overall Study|Refused to continue taking medication|0|||
142946504|NCT02240706|515341569|FG006|Overall Study|Refused to continue taking medication|0|||
142946505|NCT02240706|515341563|FG000|Overall Study|Insurance billing concerns|0|||
142946506|NCT02240706|515341564|FG001|Overall Study|Insurance billing concerns|0|||
142946507|NCT02240706|515341565|FG002|Overall Study|Insurance billing concerns|0|||
142946508|NCT02240706|515341566|FG003|Overall Study|Insurance billing concerns|1|||
142946509|NCT02240706|515341567|FG004|Overall Study|Insurance billing concerns|0|||
142946510|NCT02240706|515341568|FG005|Overall Study|Insurance billing concerns|0|||
142946511|NCT02240706|515341569|FG006|Overall Study|Insurance billing concerns|0|||
142946512|NCT01076179|515341570|FG000|Overall Study|Withdrawal by Subject|1|||
142946513|NCT00986349|515341571|FG000|Overall Study|Unsuccessful implant procedure|3|||
142946514|NCT00986349|515341571|FG000|Overall Study|Adverse Event|2|||
142946515|NCT00986349|515341571|FG000|Overall Study|Physician Decision|1|||
142946516|NCT00986349|515341571|FG000|Overall Study|device migration|1|||
142946517|NCT02299934|515341572|FG000|Overall Study|Termination of study|13|||
142946518|NCT03577990|515341573|FG000|Overall Study|Lost to Follow-up|4|||
142946519|NCT03577990|515341574|FG001|Overall Study|Lost to Follow-up|6|||
142946520|NCT03577990|515341573|FG000|Overall Study|Withdrawal by Subject|4|||
142946521|NCT03577990|515341574|FG001|Overall Study|Withdrawal by Subject|7|||
142946522|NCT03248128|515341575|FG000|Overall Study|Lost to Follow-up|1|||
142946523|NCT03248128|515341576|FG001|Overall Study|Lost to Follow-up|0|||
143455008|NCT02663518|517210767|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
143455009|NCT02663518|517210768|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
143455010|NCT02663518|517210769|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
143455011|NCT02663518|517210770|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
143455012|NCT02663518|517210771|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
143455013|NCT02663518|517210772|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
143455014|NCT02663518|517210759|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
143455015|NCT02663518|517210760|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
143455016|NCT02663518|517210761|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
143455017|NCT02663518|517210762|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
143455018|NCT02663518|517210763|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
143455019|NCT02663518|517210764|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
143455020|NCT02663518|517210765|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
143455021|NCT02663518|517210766|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
143455022|NCT02663518|517210767|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
143455023|NCT02663518|517210768|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
143455024|NCT02663518|517210769|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
143455025|NCT02663518|517210770|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
143455026|NCT02663518|517210771|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
143455027|NCT02663518|517210772|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
142946524|NCT03248128|515341575|FG000|Overall Study|Withdrawal by Subject|16|||
142946525|NCT03248128|515341576|FG001|Overall Study|Withdrawal by Subject|14|||
142946526|NCT03248128|515341575|FG000|Overall Study|Site Closed|4|||
142946527|NCT03248128|515341576|FG001|Overall Study|Site Closed|3|||
142946528|NCT03248128|515341575|FG000|Overall Study|Randomized, but did not receive treatment|1|||
142946529|NCT03248128|515341576|FG001|Overall Study|Randomized, but did not receive treatment|3|||
142946530|NCT01914679|515341577|FG000|Overall Study|Lack of Efficacy|1|||
142946531|NCT01914679|515341577|FG000|Overall Study|Sponsor terminated study|4|||
142946532|NCT00256295|515341578|FG000|Overall Study|Withdrawal by Subject|3|||
142946533|NCT00256295|515341578|FG000|Overall Study|Death|1|||
142946534|NCT01446809|515341591|FG000|Overall Study|Adverse Event|0|||
142946535|NCT01446809|515341592|FG001|Overall Study|Adverse Event|0|||
142946536|NCT01446809|515341593|FG002|Overall Study|Adverse Event|1|||
142946537|NCT01446809|515341591|FG000|Overall Study|Failure to complete study procedures|0|||
142946538|NCT01446809|515341592|FG001|Overall Study|Failure to complete study procedures|0|||
142946539|NCT01446809|515341593|FG002|Overall Study|Failure to complete study procedures|1|||
142946540|NCT02581995|515341598|FG000|Overall Study|Unspecified other|3|||
142946541|NCT02581995|515341598|FG000|Overall Study|Adverse Event|6|||
142946542|NCT02581995|515341598|FG000|Overall Study|Lost to Follow-up|5|||
142946543|NCT02581995|515341598|FG000|Overall Study|Withdrawal by participant|12|||
142946544|NCT02581995|515341598|FG000|Overall Study|Physician Decision|1|||
142946545|NCT02581995|515341598|FG000|Overall Study|Death|4|||
142946546|NCT04723537|515342810|FG000|Overall Study|Withdrawal by Subject|3|||
142946547|NCT04723537|515342811|FG001|Overall Study|Withdrawal by Subject|0|||
142946548|NCT04723537|515342812|FG002|Overall Study|Withdrawal by Subject|0|||
142946549|NCT04723537|515342810|FG000|Overall Study|Physician Decision|0|||
142946550|NCT04723537|515342811|FG001|Overall Study|Physician Decision|0|||
142946551|NCT04723537|515342812|FG002|Overall Study|Physician Decision|1|||
142946552|NCT04723537|515342810|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
142946553|NCT04723537|515342811|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
142946554|NCT04723537|515342812|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
142946555|NCT03941548|515342815|FG000|Overall Study|Adverse Event|0|||
142946556|NCT03941548|515342816|FG001|Overall Study|Adverse Event|1|||
142946557|NCT03941548|515342815|FG000|Overall Study|Lost to Follow-up|0|||
142946558|NCT03941548|515342816|FG001|Overall Study|Lost to Follow-up|1|||
142946559|NCT03941548|515342815|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
142946560|NCT03941548|515342816|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
142946561|NCT00466505|515342819|FG000|Overall Study|disease progression|13|||
142946562|NCT00466505|515342819|FG000|Overall Study|Adverse Event|4|||
142946563|NCT01120626|515342829|FG000|Overall Study|Withdrawal by Subject|1|||
142946564|NCT01120626|515342830|FG001|Overall Study|Withdrawal by Subject|0|||
142946565|NCT00356915|515342832|FG000|Overall Study|Non compliance|1|||
142946566|NCT00356915|515342833|FG001|Overall Study|Non compliance|2|||
142946567|NCT00356915|515342834|FG002|Overall Study|Non compliance|1|||
142946568|NCT00356915|515342832|FG000|Overall Study|Protocol Violation|2|||
142946569|NCT00356915|515342833|FG001|Overall Study|Protocol Violation|3|||
142946570|NCT00356915|515342834|FG002|Overall Study|Protocol Violation|2|||
142946571|NCT00356915|515342832|FG000|Overall Study|Withdrawal by Subject|14|||
142946572|NCT00356915|515342833|FG001|Overall Study|Withdrawal by Subject|14|||
142946573|NCT00356915|515342834|FG002|Overall Study|Withdrawal by Subject|10|||
142946574|NCT00356915|515342832|FG000|Overall Study|Lack of Efficacy|0|||
142946575|NCT00356915|515342833|FG001|Overall Study|Lack of Efficacy|0|||
142946576|NCT00356915|515342834|FG002|Overall Study|Lack of Efficacy|3|||
142946577|NCT00356915|515342832|FG000|Overall Study|Lost to Follow-up|27|||
142946578|NCT00356915|515342833|FG001|Overall Study|Lost to Follow-up|34|||
142946579|NCT00356915|515342834|FG002|Overall Study|Lost to Follow-up|14|||
142946580|NCT00356915|515342832|FG000|Overall Study|Administrative Decision|0|||
142946581|NCT00356915|515342833|FG001|Overall Study|Administrative Decision|0|||
142946582|NCT00356915|515342834|FG002|Overall Study|Administrative Decision|1|||
142946583|NCT00356915|515342832|FG000|Overall Study|Physician Decision|0|||
142946584|NCT00356915|515342833|FG001|Overall Study|Physician Decision|2|||
142946585|NCT00356915|515342834|FG002|Overall Study|Physician Decision|0|||
142946586|NCT00356915|515342832|FG000|Overall Study|Adverse Event|21|||
142946587|NCT00356915|515342833|FG001|Overall Study|Adverse Event|31|||
142946588|NCT00356915|515342834|FG002|Overall Study|Adverse Event|8|||
142946589|NCT00356915|515342832|FG000|Overall Study|Miscellaneous reasons|11|||
142946590|NCT00356915|515342833|FG001|Overall Study|Miscellaneous reasons|8|||
142946591|NCT00356915|515342834|FG002|Overall Study|Miscellaneous reasons|3|||
142946592|NCT01772134|515342836|FG000|Overall Study|Adverse Event|6|||
142946593|NCT01772134|515342837|FG001|Overall Study|Adverse Event|5|||
142946594|NCT01772134|515342838|FG002|Overall Study|Adverse Event|10|||
142946595|NCT01772134|515342836|FG000|Overall Study|Withdrew Consent|3|||
142946596|NCT01772134|515342837|FG001|Overall Study|Withdrew Consent|1|||
142946597|NCT01772134|515342838|FG002|Overall Study|Withdrew Consent|5|||
142946598|NCT01772134|515342836|FG000|Overall Study|Lost to Follow-up|2|||
142946599|NCT01772134|515342837|FG001|Overall Study|Lost to Follow-up|0|||
142946600|NCT01772134|515342838|FG002|Overall Study|Lost to Follow-up|0|||
142946601|NCT01772134|515342836|FG000|Overall Study|Protocol Deviation|4|||
142946602|NCT01772134|515342837|FG001|Overall Study|Protocol Deviation|3|||
142946603|NCT01772134|515342838|FG002|Overall Study|Protocol Deviation|3|||
142946604|NCT01772134|515342836|FG000|Overall Study|Lack of Efficacy|11|||
142946605|NCT01772134|515342837|FG001|Overall Study|Lack of Efficacy|5|||
142946606|NCT01772134|515342838|FG002|Overall Study|Lack of Efficacy|3|||
142946607|NCT01772134|515342836|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
142946608|NCT01772134|515342837|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
142946609|NCT01772134|515342838|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
142946610|NCT01772134|515342836|FG000|Overall Study|Randomized Study Medication Not Received|2|||
142946611|NCT01772134|515342837|FG001|Overall Study|Randomized Study Medication Not Received|0|||
142946612|NCT01772134|515342838|FG002|Overall Study|Randomized Study Medication Not Received|1|||
142946613|NCT03830281|515342839|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
142946614|NCT03830281|515342840|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
142946615|NCT03830281|515342839|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
142946616|NCT03830281|515342840|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
142946617|NCT03830281|515342839|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
142946618|NCT03830281|515342840|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
142946619|NCT03830281|515342839|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
142946620|NCT03830281|515342840|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
142946621|NCT03830281|515342839|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
142946622|NCT03830281|515342840|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
142946623|NCT03830281|515342839|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
142946624|NCT03830281|515342840|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
142946625|NCT03830281|515342839|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
142946626|NCT03830281|515342840|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
142946627|NCT03830281|515342839|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
142946628|NCT03830281|515342840|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
142946629|NCT03830281|515342839|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
142946630|NCT03830281|515342840|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
142946631|NCT03293680|515342842|FG000|Overall Study|Death|1|||
142946632|NCT03293680|515342842|FG000|Overall Study|Did not meet inclusion criteria|8|||
142946633|NCT00922935|515342843|FG000|Overall Study|Protocol Violation|0|||
142946634|NCT00922935|515342844|FG001|Overall Study|Protocol Violation|3|||
142946635|NCT00922935|515342845|FG002|Overall Study|Protocol Violation|0|||
142946636|NCT00922935|515342843|FG000|Overall Study|Physician Decision|1|||
142946637|NCT00922935|515342844|FG001|Overall Study|Physician Decision|1|||
142946638|NCT00922935|515342845|FG002|Overall Study|Physician Decision|0|||
142946639|NCT00922935|515342843|FG000|Overall Study|Lost to Follow-up|0|||
142946640|NCT00922935|515342844|FG001|Overall Study|Lost to Follow-up|1|||
142946641|NCT00922935|515342845|FG002|Overall Study|Lost to Follow-up|0|||
142946642|NCT02201940|515342846|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
142946643|NCT02201940|515342847|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
142946644|NCT02201940|515342846|FG000|Overall Study|Lack of Efficacy|2|||
142946645|NCT02201940|515342847|FG001|Overall Study|Lack of Efficacy|113|||
142946646|NCT02201940|515342846|FG000|Overall Study|Lost to Follow-up|5|||
142946647|NCT02201940|515342847|FG001|Overall Study|Lost to Follow-up|0|||
142946648|NCT02201940|515342846|FG000|Overall Study|Withdrew Consent|2|||
142946649|NCT02201940|515342847|FG001|Overall Study|Withdrew Consent|1|||
142946650|NCT02201940|515342846|FG000|Overall Study|Investigator's Discretion|1|||
142946651|NCT02201940|515342847|FG001|Overall Study|Investigator's Discretion|1|||
142946652|NCT02201940|515342846|FG000|Overall Study|Death|1|||
142946653|NCT02201940|515342847|FG001|Overall Study|Death|0|||
142946654|NCT02201940|515342846|FG000|Overall Study|Adverse Event|0|||
142946655|NCT02201940|515342847|FG001|Overall Study|Adverse Event|1|||
142946656|NCT01442181|515342849|FG000|Overall Study|patient refused surgery|1|||
142946657|NCT01442181|515342850|FG001|Overall Study|patient refused surgery|0|||
142946658|NCT01442181|515342849|FG000|Overall Study|no insurance for surgery|1|||
142946659|NCT01442181|515342850|FG001|Overall Study|no insurance for surgery|0|||
142946660|NCT01442181|515342849|FG000|Overall Study|low ejection factor|0|||
142946661|NCT01442181|515342850|FG001|Overall Study|low ejection factor|1|||
142946662|NCT01442181|515342849|FG000|Overall Study|Lost to Follow-up|1|||
142946663|NCT01442181|515342850|FG001|Overall Study|Lost to Follow-up|1|||
142946664|NCT01442181|515342849|FG000|Overall Study|patient in an additional study|1|||
142946665|NCT01442181|515342850|FG001|Overall Study|patient in an additional study|0|||
142946666|NCT01442181|515342849|FG000|Overall Study|atrial fibrillation not noted|0|||
142946667|NCT01442181|515342850|FG001|Overall Study|atrial fibrillation not noted|1|||
142946668|NCT00709202|515342851|FG000|Overall Study|Withdrawal by Subject|6|||
142946669|NCT00709202|515342852|FG001|Overall Study|Withdrawal by Subject|6|||
142946670|NCT02333227|515342858|FG000|Overall Study|Lost to Follow-up|137|||
142946671|NCT02333227|515342859|FG001|Overall Study|Lost to Follow-up|106|||
142946672|NCT02333227|515342858|FG000|Overall Study|Pregnancy Interrupted|42|||
142946673|NCT02333227|515342859|FG001|Overall Study|Pregnancy Interrupted|89|||
142946674|NCT02333227|515342858|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
142946675|NCT02333227|515342859|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
142946676|NCT03022461|515342862|FG000|Overall Study|Death|3|||
142946677|NCT01982630|515342863|FG000|Overall Study|Adverse Event|2|||
142946678|NCT01982630|515342864|FG001|Overall Study|Adverse Event|0|||
142946679|NCT01982630|515342865|FG002|Overall Study|Adverse Event|1|||
142946680|NCT01982630|515342866|FG003|Overall Study|Adverse Event|0|||
142946681|NCT01982630|515342867|FG004|Overall Study|Adverse Event|1|||
142946682|NCT01982630|515342868|FG005|Overall Study|Adverse Event|2|||
142946683|NCT01982630|515342869|FG006|Overall Study|Adverse Event|1|||
142946684|NCT01982630|515342870|FG007|Overall Study|Adverse Event|0|||
142946685|NCT01982630|515342863|FG000|Overall Study|Physician Decision|1|||
142946686|NCT01982630|515342864|FG001|Overall Study|Physician Decision|0|||
142946687|NCT01982630|515342865|FG002|Overall Study|Physician Decision|2|||
142946688|NCT01982630|515342866|FG003|Overall Study|Physician Decision|1|||
142946689|NCT01982630|515342867|FG004|Overall Study|Physician Decision|2|||
142946690|NCT01982630|515342868|FG005|Overall Study|Physician Decision|0|||
142946691|NCT01982630|515342869|FG006|Overall Study|Physician Decision|0|||
142946692|NCT01982630|515342870|FG007|Overall Study|Physician Decision|0|||
142946693|NCT01982630|515342863|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
142946694|NCT01982630|515342864|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
142946695|NCT01982630|515342865|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
142946696|NCT01982630|515342866|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
142946697|NCT01982630|515342867|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
142946698|NCT01982630|515342868|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
142946699|NCT01982630|515342869|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
142946700|NCT01982630|515342870|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
142946701|NCT01982630|515342863|FG000|Overall Study|Withdrawal by Subject|0|||
142946702|NCT01982630|515342864|FG001|Overall Study|Withdrawal by Subject|0|||
142946703|NCT01982630|515342865|FG002|Overall Study|Withdrawal by Subject|0|||
142946704|NCT01982630|515342866|FG003|Overall Study|Withdrawal by Subject|0|||
142946705|NCT01982630|515342867|FG004|Overall Study|Withdrawal by Subject|0|||
142946706|NCT01982630|515342868|FG005|Overall Study|Withdrawal by Subject|1|||
142946707|NCT01982630|515342869|FG006|Overall Study|Withdrawal by Subject|0|||
142946708|NCT01982630|515342870|FG007|Overall Study|Withdrawal by Subject|0|||
142946709|NCT00004980|515342871|FG000|Overall Study|Withdrawal by Subject|1|||
142946710|NCT00004980|515342872|FG001|Overall Study|Withdrawal by Subject|0|||
142946711|NCT00004980|515342871|FG000|Overall Study|memory difficulties|1|||
142946712|NCT00004980|515342872|FG001|Overall Study|memory difficulties|1|||
142946713|NCT00004980|515342871|FG000|Overall Study|Physician Decision|0|||
142946714|NCT00004980|515342872|FG001|Overall Study|Physician Decision|1|||
142946715|NCT03212261|515342873|FG000|Overall Study|Became ineligible d/t tech|2|||
142946716|NCT03212261|515342873|FG000|Overall Study|Tech Trouble- No first study visit|1|||
142946717|NCT03212261|515342873|FG000|Overall Study|Lost to Follow-up|7|||
142946718|NCT03212261|515342873|FG000|Overall Study|Family Emergency|1|||
142946719|NCT03212261|515342873|FG000|Overall Study|Too busy/ No time|5|||
142946720|NCT03934684|515342874|FG000|Overall Study|Participants continuing in study|11|||
142946721|NCT03934684|515342875|FG001|Overall Study|Participants continuing in study|4|||
142946722|NCT03934684|515342874|FG000|Overall Study|Discontinuation of carfilzomib|20|||
142946723|NCT03934684|515342875|FG001|Overall Study|Discontinuation of carfilzomib|30|||
142946724|NCT03934684|515342874|FG000|Overall Study|Death|2|||
142946725|NCT03934684|515342875|FG001|Overall Study|Death|2|||
142946726|NCT03934684|515342874|FG000|Overall Study|Lost to Follow-up|2|||
142946727|NCT03934684|515342875|FG001|Overall Study|Lost to Follow-up|5|||
142946728|NCT03934684|515342874|FG000|Overall Study|Withdrawal by Subject|7|||
142946729|NCT03934684|515342875|FG001|Overall Study|Withdrawal by Subject|8|||
142946730|NCT05300087|515342876|FG000|Overall Study|Withdrawal by Subject|0|||
142946731|NCT05300087|515342877|FG001|Overall Study|Withdrawal by Subject|1|||
142946732|NCT05662332|515342878|FG000|Overall Study|Death|3|||
142946733|NCT05662332|515342879|FG001|Overall Study|Death|3|||
142946734|NCT05662332|515342878|FG000|Overall Study|Lost to Follow-up|3|||
142946735|NCT05662332|515342879|FG001|Overall Study|Lost to Follow-up|8|||
142946736|NCT05662332|515342878|FG000|Overall Study|Physician Decision|1|||
142946737|NCT05662332|515342879|FG001|Overall Study|Physician Decision|2|||
142946738|NCT05662332|515342878|FG000|Overall Study|Protocol Deviation|2|||
142946739|NCT05662332|515342879|FG001|Overall Study|Protocol Deviation|1|||
142946740|NCT05662332|515342878|FG000|Overall Study|Withdrawal by Subject|14|||
142946741|NCT05662332|515342879|FG001|Overall Study|Withdrawal by Subject|14|||
142946742|NCT05662332|515342878|FG000|Overall Study|Assigned Treatment by Mistake|5|||
142946743|NCT05662332|515342879|FG001|Overall Study|Assigned Treatment by Mistake|7|||
142946744|NCT05662332|515342878|FG000|Overall Study|Non-compliance with study drug|4|||
143455028|NCT02663518|517210759|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
142946745|NCT05662332|515342879|FG001|Overall Study|Non-compliance with study drug|1|||
142946746|NCT05662332|515342878|FG000|Overall Study|Due to Bariatric surgery|1|||
142946747|NCT05662332|515342879|FG001|Overall Study|Due to Bariatric surgery|0|||
142946748|NCT05662332|515342878|FG000|Overall Study|Subject Moving out of State|0|||
142946749|NCT05662332|515342879|FG001|Overall Study|Subject Moving out of State|1|||
142946750|NCT05662332|515342878|FG000|Overall Study|Subject Missed the Schedule|1|||
142946751|NCT05662332|515342879|FG001|Overall Study|Subject Missed the Schedule|0|||
142946752|NCT05662332|515342878|FG000|Overall Study|The Patient Moved to Another City|1|||
142946753|NCT05662332|515342879|FG001|Overall Study|The Patient Moved to Another City|0|||
142946754|NCT05369806|515342884|FG000|Overall Study|Lost to Follow-up|1|||
142946755|NCT00628355|515342885|FG000|Overall Study|Withdrawal by Subject|1|||
142946756|NCT00628355|515342886|FG001|Overall Study|Withdrawal by Subject|1|||
142946757|NCT03542682|515342890|FG000|Overall Study|COVID-19 Protocol|0|||
142946758|NCT03542682|515342891|FG001|Overall Study|COVID-19 Protocol|1|||
142946759|NCT01392183|515342893|FG000|First Drug Administration|Adverse Event|3|||
142946760|NCT01392183|515342894|FG001|First Drug Administration|Adverse Event|2|||
142946761|NCT01392183|515342893|FG000|First Drug Administration|Death|1|||
142946762|NCT01392183|515342894|FG001|First Drug Administration|Death|0|||
142946763|NCT01392183|515342893|FG000|First Drug Administration|Withdrawal by Subject|10|||
142946764|NCT01392183|515342894|FG001|First Drug Administration|Withdrawal by Subject|17|||
142946765|NCT04321343|515342895|FG000|Overall Study|Adverse Event|0|||
142946766|NCT04321343|515342896|FG001|Overall Study|Adverse Event|0|||
142946767|NCT04321343|515342897|FG002|Overall Study|Adverse Event|1|||
142946768|NCT04321343|515342898|FG003|Overall Study|Adverse Event|0|||
142946769|NCT04321343|515342895|FG000|Overall Study|Death|0|||
142946770|NCT04321343|515342896|FG001|Overall Study|Death|0|||
142946771|NCT04321343|515342897|FG002|Overall Study|Death|0|||
142946772|NCT04321343|515342898|FG003|Overall Study|Death|1|||
142946773|NCT04321343|515342895|FG000|Overall Study|Pregnancy|1|||
142946774|NCT04321343|515342896|FG001|Overall Study|Pregnancy|0|||
142946775|NCT04321343|515342897|FG002|Overall Study|Pregnancy|0|||
142946776|NCT04321343|515342898|FG003|Overall Study|Pregnancy|0|||
142946777|NCT04321343|515342895|FG000|Overall Study|Protocol Violation|1|||
142946778|NCT04321343|515342896|FG001|Overall Study|Protocol Violation|1|||
142946779|NCT04321343|515342897|FG002|Overall Study|Protocol Violation|1|||
142946780|NCT04321343|515342898|FG003|Overall Study|Protocol Violation|1|||
142946781|NCT04321343|515342895|FG000|Overall Study|Withdrawal by Subject|0|||
142946782|NCT04321343|515342896|FG001|Overall Study|Withdrawal by Subject|6|||
142946783|NCT04321343|515342897|FG002|Overall Study|Withdrawal by Subject|0|||
142946784|NCT04321343|515342898|FG003|Overall Study|Withdrawal by Subject|2|||
142946785|NCT04321343|515342895|FG000|Overall Study|Lost to Follow-up|2|||
142946786|NCT04321343|515342896|FG001|Overall Study|Lost to Follow-up|2|||
142946787|NCT04321343|515342897|FG002|Overall Study|Lost to Follow-up|1|||
142946788|NCT04321343|515342898|FG003|Overall Study|Lost to Follow-up|3|||
142946789|NCT03430310|515342899|FG000|Overall Study|Protocol Violation|2|||
142946790|NCT03430310|515342900|FG001|Overall Study|Protocol Violation|0|||
142946791|NCT03430310|515342899|FG000|Overall Study|Withdrawal by Subject|3|||
142946792|NCT03430310|515342900|FG001|Overall Study|Withdrawal by Subject|2|||
142946793|NCT03430310|515342899|FG000|Overall Study|COVID shutdown March 2020|0|||
142946794|NCT03430310|515342900|FG001|Overall Study|COVID shutdown March 2020|1|||
142946795|NCT03476239|515342901|FG000|Overall Study|Withdrawal by Subject|10|||
142946796|NCT03476239|515342901|FG000|Overall Study|Death|80|||
142946797|NCT03476239|515342901|FG000|Overall Study|Lost to Follow-up|8|||
142946798|NCT01097044|515342905|FG000|Overall Study|Withdrawal by Subject|4|||
142946799|NCT01097044|515342906|FG001|Overall Study|Withdrawal by Subject|4|||
142946800|NCT01097044|515342905|FG000|Overall Study|Lost to Follow-up|1|||
142946801|NCT01097044|515342906|FG001|Overall Study|Lost to Follow-up|0|||
142946802|NCT01097044|515342905|FG000|Overall Study|Withdrawal by Sponsor|0|||
142946803|NCT01097044|515342906|FG001|Overall Study|Withdrawal by Sponsor|1|||
142946804|NCT03232073|515342914|FG000|Overall Study|Death|1|||
142946805|NCT03232073|515342915|FG001|Overall Study|Death|0|||
142946806|NCT03232073|515342914|FG000|Overall Study|Adverse Event|7|||
142946807|NCT03232073|515342915|FG001|Overall Study|Adverse Event|12|||
142946808|NCT03232073|515342914|FG000|Overall Study|Lost to Follow-up|6|||
142946809|NCT03232073|515342915|FG001|Overall Study|Lost to Follow-up|6|||
143455029|NCT02663518|517210760|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
142946810|NCT03232073|515342914|FG000|Overall Study|Lack of Efficacy|10|||
142946811|NCT03232073|515342915|FG001|Overall Study|Lack of Efficacy|8|||
142946812|NCT03232073|515342914|FG000|Overall Study|Physician Decision|9|||
142946813|NCT03232073|515342915|FG001|Overall Study|Physician Decision|2|||
142946814|NCT03232073|515342914|FG000|Overall Study|Withdrawal by Subject|54|||
142946815|NCT03232073|515342915|FG001|Overall Study|Withdrawal by Subject|39|||
142946816|NCT02017444|515345034|FG000|Overall Study|Physician Decision|1|||
142946817|NCT02017444|515345035|FG001|Overall Study|Physician Decision|0|||
142946818|NCT02017444|515345034|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
142946819|NCT02017444|515345035|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
142946820|NCT01614457|515345036|FG000|Overall Study|Non-Compliance|1|||
142946821|NCT01614457|515345037|FG001|Overall Study|Non-Compliance|0|||
142946822|NCT01614457|515345036|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
142946823|NCT01614457|515345037|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
142946824|NCT00886821|515345038|FG000|Stage 2|Adverse Event|0|||
142946825|NCT00886821|515345039|FG001|Stage 2|Adverse Event|0|||
142946826|NCT00886821|515345040|FG002|Stage 2|Adverse Event|0|||
142946827|NCT00886821|515345041|FG003|Stage 2|Adverse Event|0|||
142946828|NCT00886821|515345042|FG004|Stage 2|Adverse Event|0|||
142946829|NCT00886821|515345043|FG005|Stage 2|Adverse Event|0|||
142946830|NCT00886821|515345044|FG006|Stage 2|Adverse Event|0|||
142946831|NCT00886821|515345045|FG007|Stage 2|Adverse Event|0|||
142946832|NCT00886821|515345046|FG008|Stage 2|Adverse Event|0|||
142946833|NCT00886821|515345047|FG009|Stage 2|Adverse Event|0|||
142946834|NCT00886821|515345048|FG010|Stage 2|Adverse Event|0|||
142946835|NCT00886821|515345049|FG011|Stage 2|Adverse Event|1|||
142946836|NCT00886821|515345050|FG012|Stage 2|Adverse Event|3|||
142946837|NCT00886821|515345051|FG013|Stage 2|Adverse Event|0|||
142946838|NCT00886821|515345038|FG000|Stage 2|Lost to Follow-up|0|||
142946839|NCT00886821|515345039|FG001|Stage 2|Lost to Follow-up|0|||
142946840|NCT00886821|515345040|FG002|Stage 2|Lost to Follow-up|0|||
142946841|NCT00886821|515345041|FG003|Stage 2|Lost to Follow-up|0|||
142946842|NCT00886821|515345042|FG004|Stage 2|Lost to Follow-up|0|||
142946843|NCT00886821|515345043|FG005|Stage 2|Lost to Follow-up|0|||
142946844|NCT00886821|515345044|FG006|Stage 2|Lost to Follow-up|0|||
142946845|NCT00886821|515345045|FG007|Stage 2|Lost to Follow-up|0|||
142946846|NCT00886821|515345046|FG008|Stage 2|Lost to Follow-up|0|||
142946847|NCT00886821|515345047|FG009|Stage 2|Lost to Follow-up|0|||
142946848|NCT00886821|515345048|FG010|Stage 2|Lost to Follow-up|0|||
142946849|NCT00886821|515345049|FG011|Stage 2|Lost to Follow-up|0|||
142946850|NCT00886821|515345050|FG012|Stage 2|Lost to Follow-up|2|||
142946851|NCT00886821|515345051|FG013|Stage 2|Lost to Follow-up|1|||
142946852|NCT00942162|515345052|FG000|Overall Study|Death|45|||
142946853|NCT00942162|515345053|FG001|Overall Study|Death|35|||
142946854|NCT00942162|515345054|FG002|Overall Study|Death|0|||
142946855|NCT00942162|515345052|FG000|Overall Study|Withdrawal by Subject|7|||
142946856|NCT00942162|515345053|FG001|Overall Study|Withdrawal by Subject|2|||
142946857|NCT00942162|515345054|FG002|Overall Study|Withdrawal by Subject|0|||
142946858|NCT00942162|515345052|FG000|Overall Study|Lost to Follow-up|4|||
142946859|NCT00942162|515345053|FG001|Overall Study|Lost to Follow-up|0|||
142946860|NCT00942162|515345054|FG002|Overall Study|Lost to Follow-up|0|||
142946861|NCT00942162|515345052|FG000|Overall Study|Other|14|||
142946862|NCT00942162|515345053|FG001|Overall Study|Other|13|||
142946863|NCT00942162|515345054|FG002|Overall Study|Other|2|||
142946864|NCT01006356|515345055|FG000|Overall Study|Adverse Event|6|||
142946865|NCT01006356|515345055|FG000|Overall Study|Physician Decision|1|||
142946866|NCT01006356|515345055|FG000|Overall Study|Paticipants did not cooperate|6|||
142946867|NCT01006356|515345055|FG000|Overall Study|Withdrawal by Subject|1|||
142946868|NCT01006356|515345055|FG000|Overall Study|Choice by participants|2|||
142946869|NCT01006356|515345055|FG000|Overall Study|Protocol Violation|3|||
142946870|NCT01006356|515345055|FG000|Overall Study|Other|23|||
142946871|NCT01756157|515345062|FG000|First Intervention Period|Withdrawal by Subject|1|||
142946872|NCT01756157|515345063|FG001|First Intervention Period|Withdrawal by Subject|0|||
142946873|NCT01756157|515345062|FG000|First Intervention Period|Lost to Follow-up|0|||
142946874|NCT01756157|515345063|FG001|First Intervention Period|Lost to Follow-up|2|||
142946875|NCT03368859|515345066|FG000|Overall Study|Withdrew Consent|5|||
142946876|NCT03368859|515345067|FG001|Overall Study|Withdrew Consent|4|||
142946877|NCT03368859|515345066|FG000|Overall Study|Death|12|||
142946878|NCT03368859|515345067|FG001|Overall Study|Death|6|||
142946879|NCT03368859|515345066|FG000|Overall Study|Study terminated by Sponsor|18|||
142946880|NCT03368859|515345067|FG001|Overall Study|Study terminated by Sponsor|23|||
142946881|NCT03368859|515345066|FG000|Overall Study|Other|1|||
142946882|NCT03368859|515345067|FG001|Overall Study|Other|1|||
142946883|NCT01713348|515345068|FG000|Overall Study|Withdrawal by Subject|3|||
142946884|NCT01713348|515345069|FG001|Overall Study|Withdrawal by Subject|2|||
142946885|NCT01713348|515345070|FG002|Overall Study|Withdrawal by Subject|2|||
142946886|NCT01713348|515345071|FG003|Overall Study|Withdrawal by Subject|0|||
142946887|NCT01713348|515345068|FG000|Overall Study|Lost to Follow-up|1|||
142946888|NCT01713348|515345069|FG001|Overall Study|Lost to Follow-up|0|||
142946889|NCT01713348|515345070|FG002|Overall Study|Lost to Follow-up|0|||
142946890|NCT01713348|515345071|FG003|Overall Study|Lost to Follow-up|0|||
142946891|NCT00621023|515345072|FG000|Overall Study|Death|5|||
142946892|NCT00621023|515345072|FG000|Overall Study|Follow up discontinued|1|||
142946893|NCT02559505|515345077|FG000|Overall Study|Lost to Follow-up|23|||
142946894|NCT02559505|515345078|FG001|Overall Study|Lost to Follow-up|20|||
142946895|NCT02559505|515345077|FG000|Overall Study|Withdrawal by Subject|4|||
142946896|NCT02559505|515345078|FG001|Overall Study|Withdrawal by Subject|2|||
142946897|NCT00698516|515345079|FG000|Overall Study|Study Termination|2|||
142946898|NCT00698516|515345079|FG000|Overall Study|Withdrawal by Subject|3|||
142946899|NCT04331899|515345082|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
142946900|NCT04331899|515345083|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
142946901|NCT04893265|515345086|FG000|Overall Study|Withdrawal by Subject|2|||
142946902|NCT04893265|515345087|FG001|Overall Study|Withdrawal by Subject|5|||
142946903|NCT04893265|515345086|FG000|Overall Study|Lost to Follow-up|0|||
142946904|NCT04893265|515345087|FG001|Overall Study|Lost to Follow-up|4|||
142946905|NCT00573131|515345089|FG000|Overall Study|Withdrawal by Subject|10|||
142946906|NCT00573131|515345090|FG001|Overall Study|Withdrawal by Subject|8|||
142946907|NCT03090191|515345091|FG000|Overall Study|Adverse Event|90|||
142946908|NCT03090191|515345092|FG001|Overall Study|Adverse Event|72|||
142946909|NCT03090191|515345091|FG000|Overall Study|Death|365|||
142946910|NCT03090191|515345092|FG001|Overall Study|Death|358|||
142946911|NCT03090191|515345091|FG000|Overall Study|Lost to Follow-up|382|||
142946912|NCT03090191|515345092|FG001|Overall Study|Lost to Follow-up|394|||
142946913|NCT03090191|515345091|FG000|Overall Study|Physician Decision|77|||
142946914|NCT03090191|515345092|FG001|Overall Study|Physician Decision|66|||
142946915|NCT03090191|515345091|FG000|Overall Study|Protocol Violation|43|||
142946916|NCT03090191|515345092|FG001|Overall Study|Protocol Violation|52|||
142946917|NCT03090191|515345091|FG000|Overall Study|Withdrawal by Subject|2160|||
142946918|NCT03090191|515345092|FG001|Overall Study|Withdrawal by Subject|2133|||
142946919|NCT03090191|515345091|FG000|Overall Study|Site terminated|7|||
142946920|NCT03090191|515345092|FG001|Overall Study|Site terminated|8|||
142946921|NCT03090191|515345091|FG000|Overall Study|Other|66|||
142946922|NCT03090191|515345092|FG001|Overall Study|Other|60|||
142946923|NCT03090191|515345091|FG000|Overall Study|Withdrawn before any study vaccination|43|||
142946924|NCT03090191|515345092|FG001|Overall Study|Withdrawn before any study vaccination|52|||
142946925|NCT00893789|515345094|FG000|Overall Study|Withdrawal by Subject|3|||
142946926|NCT00893789|515345095|FG001|Overall Study|Withdrawal by Subject|1|||
142946927|NCT00893789|515345096|FG002|Overall Study|Withdrawal by Subject|3|||
142946928|NCT00893789|515345097|FG003|Overall Study|Withdrawal by Subject|1|||
142946929|NCT00893789|515345094|FG000|Overall Study|Noncompliance With Study Drug|1|||
142946930|NCT00893789|515345095|FG001|Overall Study|Noncompliance With Study Drug|0|||
142946931|NCT00893789|515345096|FG002|Overall Study|Noncompliance With Study Drug|1|||
142946932|NCT00893789|515345097|FG003|Overall Study|Noncompliance With Study Drug|2|||
142946933|NCT00893789|515345094|FG000|Overall Study|Noncompliance With Study Procedures|1|||
142946934|NCT00893789|515345095|FG001|Overall Study|Noncompliance With Study Procedures|0|||
142946935|NCT00893789|515345096|FG002|Overall Study|Noncompliance With Study Procedures|0|||
142946936|NCT00893789|515345097|FG003|Overall Study|Noncompliance With Study Procedures|0|||
142946937|NCT00893789|515345094|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
142946938|NCT00893789|515345095|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
142946939|NCT00893789|515345096|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
142946940|NCT00893789|515345097|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
142946941|NCT00893789|515345094|FG000|Overall Study|Adverse Event|0|||
142946942|NCT00893789|515345095|FG001|Overall Study|Adverse Event|2|||
142946943|NCT00893789|515345096|FG002|Overall Study|Adverse Event|1|||
142946944|NCT00893789|515345097|FG003|Overall Study|Adverse Event|5|||
142946945|NCT00893789|515345094|FG000|Overall Study|Protocol Violation|0|||
142946946|NCT00893789|515345095|FG001|Overall Study|Protocol Violation|1|||
142946947|NCT00893789|515345096|FG002|Overall Study|Protocol Violation|1|||
142946948|NCT00893789|515345097|FG003|Overall Study|Protocol Violation|4|||
142946949|NCT00893789|515345094|FG000|Overall Study|Lost to Follow-up|0|||
142946950|NCT00893789|515345095|FG001|Overall Study|Lost to Follow-up|0|||
142946951|NCT00893789|515345096|FG002|Overall Study|Lost to Follow-up|0|||
142946952|NCT00893789|515345097|FG003|Overall Study|Lost to Follow-up|1|||
142946953|NCT04419506|515345098|FG000|Overall Study|Adverse Event|0|||
142946954|NCT04419506|515345099|FG001|Overall Study|Adverse Event|10|||
142946955|NCT04419506|515345100|FG002|Overall Study|Adverse Event|0|||
142946956|NCT04419506|515345101|FG003|Overall Study|Adverse Event|3|||
142946957|NCT04419506|515345098|FG000|Overall Study|Withdrawal by Subject|0|||
142946958|NCT04419506|515345099|FG001|Overall Study|Withdrawal by Subject|0|||
142946959|NCT04419506|515345100|FG002|Overall Study|Withdrawal by Subject|0|||
142946960|NCT04419506|515345101|FG003|Overall Study|Withdrawal by Subject|1|||
142946961|NCT04419506|515345098|FG000|Overall Study|poor-compliance|0|||
142946962|NCT04419506|515345099|FG001|Overall Study|poor-compliance|0|||
142946963|NCT04419506|515345100|FG002|Overall Study|poor-compliance|0|||
142946964|NCT04419506|515345101|FG003|Overall Study|poor-compliance|1|||
142946965|NCT00813748|515345107|FG000|Skin Test Substudy|Physician Decision|0|||
142946966|NCT00813748|515345108|FG001|Skin Test Substudy|Physician Decision|1|||
142946967|NCT01244737|515345111|FG000|Overall Study|Physician Decision|2|||
142946968|NCT01244737|515345112|FG001|Overall Study|Physician Decision|18|||
142946969|NCT01244737|515345113|FG002|Overall Study|Physician Decision|5|||
142946970|NCT01244737|515345111|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
142946971|NCT01244737|515345112|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
142946972|NCT01244737|515345113|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
142946973|NCT01244737|515345111|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
142946974|NCT01244737|515345112|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
142946975|NCT01244737|515345113|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
142946976|NCT01244737|515345111|FG000|Overall Study|MIB immunopathology results not available|3|||
142946977|NCT01244737|515345112|FG001|Overall Study|MIB immunopathology results not available|2|||
142946978|NCT01244737|515345113|FG002|Overall Study|MIB immunopathology results not available|0|||
142946979|NCT01244737|515345111|FG000|Overall Study|PET data failure|0|||
142946980|NCT01244737|515345112|FG001|Overall Study|PET data failure|1|||
142946981|NCT01244737|515345113|FG002|Overall Study|PET data failure|0|||
142946982|NCT01244737|515345111|FG000|Overall Study|Withdrawal by Subject|0|||
142946983|NCT01244737|515345112|FG001|Overall Study|Withdrawal by Subject|0|||
142946984|NCT01244737|515345113|FG002|Overall Study|Withdrawal by Subject|1|||
142946985|NCT03486314|515345120|FG000|Part A|Adverse Event|1|||
142946986|NCT03486314|515345121|FG001|Part A|Adverse Event|0|||
142946987|NCT03486314|515345122|FG002|Part A|Adverse Event|0|||
142946988|NCT03486314|515345120|FG000|Part A|Symptomatic Deterioration|2|||
142946989|NCT03486314|515345121|FG001|Part A|Symptomatic Deterioration|0|||
142946990|NCT03486314|515345122|FG002|Part A|Symptomatic Deterioration|0|||
142946991|NCT01985321|515345123|FG000|Overall Study|Protocol Violation|4|||
142946992|NCT01985321|515345124|FG001|Overall Study|Protocol Violation|3|||
142946993|NCT01985321|515345123|FG000|Overall Study|Withdrawal by Subject|1|||
142946994|NCT01985321|515345124|FG001|Overall Study|Withdrawal by Subject|0|||
142946995|NCT01985321|515345123|FG000|Overall Study|Lost to Follow-up|5|||
142946996|NCT01985321|515345124|FG001|Overall Study|Lost to Follow-up|2|||
142946997|NCT01985321|515345123|FG000|Overall Study|Subject treated wrong type of sore|1|||
142946998|NCT01985321|515345124|FG001|Overall Study|Subject treated wrong type of sore|0|||
142946999|NCT03953118|515345125|FG000|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
142947000|NCT03953118|515345126|FG001|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
142947001|NCT04283461|515345127|FG000|Overall Study|Enrolled in separate trial|0|||
142947002|NCT04283461|515345128|FG001|Overall Study|Enrolled in separate trial|0|||
142947003|NCT04283461|515345129|FG002|Overall Study|Enrolled in separate trial|8|||
142947004|NCT04283461|515345130|FG003|Overall Study|Enrolled in separate trial|13|||
142947005|NCT04283461|515345131|FG004|Overall Study|Enrolled in separate trial|12|||
142947006|NCT04283461|515345132|FG005|Overall Study|Enrolled in separate trial|0|||
142947007|NCT04283461|515345133|FG006|Overall Study|Enrolled in separate trial|0|||
142947008|NCT04283461|515345134|FG007|Overall Study|Enrolled in separate trial|8|||
142947009|NCT04283461|515345135|FG008|Overall Study|Enrolled in separate trial|0|||
142947010|NCT04283461|515345136|FG009|Overall Study|Enrolled in separate trial|0|||
142947011|NCT04283461|515345137|FG010|Overall Study|Enrolled in separate trial|0|||
142947012|NCT04283461|515345138|FG011|Overall Study|Enrolled in separate trial|7|||
142947013|NCT04283461|515345139|FG012|Overall Study|Enrolled in separate trial|0|||
142947014|NCT02604264|515345144|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
142947015|NCT02604264|515345145|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
142947016|NCT03192904|515345146|FG000|Overall Study|Physician Decision|3|||
142947017|NCT03192904|515345147|FG001|Overall Study|Physician Decision|1|||
142947018|NCT03192904|515345146|FG000|Overall Study|Lost to Follow-up|0|||
142947019|NCT03192904|515345147|FG001|Overall Study|Lost to Follow-up|1|||
142947020|NCT01023789|515345148|FG000|3 - Year Visit|Death|29|||
142947021|NCT01023789|515345148|FG000|3 - Year Visit|Withdrawal of consent|1|||
142947022|NCT01023789|515345148|FG000|3 - Year Visit|Lost to Follow-up|13|||
142947023|NCT02034123|515345151|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
142947024|NCT02034123|515345152|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
142947025|NCT02034123|515345153|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
142947026|NCT02034123|515345154|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
142947027|NCT02034123|515345155|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
142947028|NCT02034123|515345156|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
142947029|NCT02034123|515345157|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
142947030|NCT02034123|515345158|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
142947031|NCT02034123|515345159|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
142947032|NCT02034123|515345160|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
142947033|NCT02034123|515345161|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
142947034|NCT02034123|515345162|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
142947035|NCT02034123|515345163|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
142947036|NCT02034123|515345164|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
142947037|NCT02034123|515345165|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
142947038|NCT02034123|515345166|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
142947039|NCT02034123|515345167|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
142947040|NCT02034123|515345168|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
142947041|NCT02034123|515345151|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
142947042|NCT02034123|515345152|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
142947043|NCT02034123|515345153|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
142947044|NCT02034123|515345154|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
142947045|NCT02034123|515345155|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
142947046|NCT02034123|515345156|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
142947047|NCT02034123|515345157|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
142947048|NCT02034123|515345158|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
142947049|NCT02034123|515345159|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
142947050|NCT02034123|515345160|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
142947051|NCT02034123|515345161|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
142947052|NCT02034123|515345162|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
142947053|NCT02034123|515345163|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
143455030|NCT02663518|517210761|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
142947054|NCT02034123|515345164|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
142947055|NCT02034123|515345165|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
142947056|NCT02034123|515345166|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
142947057|NCT02034123|515345167|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
142947058|NCT02034123|515345168|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
142947059|NCT02034123|515345151|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
142947060|NCT02034123|515345152|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
142947061|NCT02034123|515345153|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
142947062|NCT02034123|515345154|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
142947063|NCT02034123|515345155|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
142947064|NCT02034123|515345156|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
142947065|NCT02034123|515345157|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
142947066|NCT02034123|515345158|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
142947067|NCT02034123|515345159|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
142947068|NCT02034123|515345160|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
142947069|NCT02034123|515345161|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
142947070|NCT02034123|515345162|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
142947071|NCT02034123|515345163|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
142947072|NCT02034123|515345164|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
142947073|NCT02034123|515345165|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
142947074|NCT02034123|515345166|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
142947075|NCT02034123|515345167|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
142947076|NCT02034123|515345168|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
142947077|NCT02034123|515345151|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
142947078|NCT02034123|515345152|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
142947079|NCT02034123|515345153|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
142947080|NCT02034123|515345154|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
142947081|NCT02034123|515345155|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
142947082|NCT02034123|515345156|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
142947083|NCT02034123|515345157|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
142947084|NCT02034123|515345158|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
142947085|NCT02034123|515345159|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
142947086|NCT02034123|515345160|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
142947087|NCT02034123|515345161|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
142947088|NCT02034123|515345162|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
142947089|NCT02034123|515345163|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
142947090|NCT02034123|515345164|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
142947091|NCT02034123|515345165|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
142947092|NCT02034123|515345166|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
142947093|NCT02034123|515345167|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
142947094|NCT02034123|515345168|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
142947095|NCT00246259|515345169|FG000|Overall Study|Other|3|||
142947096|NCT00246259|515345170|FG001|Overall Study|Other|3|||
142947097|NCT00246259|515345169|FG000|Overall Study|Not stable by Week 18|2|||
142947098|NCT00246259|515345170|FG001|Overall Study|Not stable by Week 18|1|||
142947099|NCT00246259|515345169|FG000|Overall Study|Participant non-compliant|4|||
142947100|NCT00246259|515345170|FG001|Overall Study|Participant non-compliant|9|||
142947101|NCT00246259|515345169|FG000|Overall Study|Lack of Efficacy|2|||
142947102|NCT00246259|515345170|FG001|Overall Study|Lack of Efficacy|2|||
142947103|NCT00246259|515345169|FG000|Overall Study|Investigator withdrew participant|2|||
142947104|NCT00246259|515345170|FG001|Overall Study|Investigator withdrew participant|0|||
142947105|NCT00246259|515345169|FG000|Overall Study|Adverse Event|5|||
142947106|NCT00246259|515345170|FG001|Overall Study|Adverse Event|0|||
142947107|NCT00246259|515345169|FG000|Overall Study|Lost to Follow-up|3|||
142947108|NCT00246259|515345170|FG001|Overall Study|Lost to Follow-up|4|||
142947109|NCT00246259|515345169|FG000|Overall Study|Withdrawal by Subject|5|||
142947110|NCT00246259|515345170|FG001|Overall Study|Withdrawal by Subject|1|||
142947111|NCT00246259|515345169|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
142947112|NCT00246259|515345170|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
142947113|NCT03133767|515345171|FG000|Overall Study|Lost to Follow-up|38|||
142947114|NCT03133767|515345172|FG001|Overall Study|Lost to Follow-up|24|||
142947115|NCT03133767|515345171|FG000|Overall Study|Protocol Violation|0|||
142947116|NCT03133767|515345172|FG001|Overall Study|Protocol Violation|1|||
142947117|NCT03301857|515345179|FG000|Overall Study|Death|0|||
142947118|NCT03301857|515345180|FG001|Overall Study|Death|2|||
142947119|NCT03301857|515345179|FG000|Overall Study|Lost to Follow-up|4|||
142947120|NCT03301857|515345180|FG001|Overall Study|Lost to Follow-up|2|||
142947121|NCT03301857|515345179|FG000|Overall Study|Decision by Sponsor|6|||
142947122|NCT03301857|515345180|FG001|Overall Study|Decision by Sponsor|0|||
142947123|NCT03301857|515345179|FG000|Overall Study|Withdrawal by Subject|12|||
142947124|NCT03301857|515345180|FG001|Overall Study|Withdrawal by Subject|4|||
142947125|NCT00855439|515345181|FG000|Overall Study|Withdrawal by Subject|2|||
142947126|NCT00855439|515345182|FG001|Overall Study|Withdrawal by Subject|0|||
142947127|NCT00855439|515345181|FG000|Overall Study|Pregnancy|1|||
142947128|NCT00855439|515345182|FG001|Overall Study|Pregnancy|0|||
142947129|NCT05502289|515345183|FG000|Period 1|Out Of Window|1|||
142947130|NCT05502289|515345184|FG001|Period 1|Out Of Window|0|||
142947131|NCT00613626|515345185|FG000|Overall Study|Ineligible|0|||
142947132|NCT00613626|515345186|FG001|Overall Study|Ineligible|1|||
142947133|NCT00613626|515345187|FG002|Overall Study|Ineligible|0|||
142947134|NCT04375878|515345190|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
142947135|NCT04375878|515345191|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
142947136|NCT04375878|515345192|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
142947137|NCT04375878|515345193|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
142947138|NCT04375878|515345194|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
142947139|NCT04375878|515345195|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
142947140|NCT04375878|515345190|FG000|Crossover First and Second Interventions|Adverse Event|0|||
142947141|NCT04375878|515345191|FG001|Crossover First and Second Interventions|Adverse Event|0|||
142947142|NCT04375878|515345192|FG002|Crossover First and Second Interventions|Adverse Event|1|||
142947143|NCT04375878|515345193|FG003|Crossover First and Second Interventions|Adverse Event|0|||
142947144|NCT04375878|515345194|FG004|Crossover First and Second Interventions|Adverse Event|0|||
142947145|NCT04375878|515345195|FG005|Crossover First and Second Interventions|Adverse Event|0|||
142947146|NCT04375878|515345190|FG000|Extension Phase|Withdrawal by Subject|0|||
142947147|NCT04375878|515345191|FG001|Extension Phase|Withdrawal by Subject|0|||
142947148|NCT04375878|515345192|FG002|Extension Phase|Withdrawal by Subject|0|||
142947149|NCT04375878|515345193|FG003|Extension Phase|Withdrawal by Subject|0|||
142947150|NCT04375878|515345194|FG004|Extension Phase|Withdrawal by Subject|1|||
142947151|NCT04375878|515345195|FG005|Extension Phase|Withdrawal by Subject|0|||
142947152|NCT00816036|515345196|FG000|Overall Study|Death|47|||
142947153|NCT00816036|515345197|FG001|Overall Study|Death|28|||
142947154|NCT00816036|515345196|FG000|Overall Study|Lost to Follow-up|75|||
142947155|NCT00816036|515345197|FG001|Overall Study|Lost to Follow-up|57|||
142947156|NCT00816036|515345196|FG000|Overall Study|Withdrawal by Subject|54|||
142947157|NCT00816036|515345197|FG001|Overall Study|Withdrawal by Subject|23|||
142947158|NCT01299025|515345198|FG000|Overall Study|Withdrawal by Subject|2|||
142947159|NCT01299025|515345199|FG001|Overall Study|Withdrawal by Subject|1|||
142947160|NCT01299025|515345198|FG000|Overall Study|Lost to Follow-up|1|||
142947161|NCT01299025|515345199|FG001|Overall Study|Lost to Follow-up|0|||
142947162|NCT01624194|515345200|FG000|Overall Study|Lost to Follow-up|1|||
142947163|NCT01624194|515345201|FG001|Overall Study|Lost to Follow-up|0|||
142947164|NCT01624194|515345200|FG000|Overall Study|Withdrawal by Subject|1|||
142947165|NCT01624194|515345201|FG001|Overall Study|Withdrawal by Subject|0|||
142947166|NCT05480514|515345202|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
142947167|NCT05480514|515345203|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
142947168|NCT05480514|515345202|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
142947169|NCT05480514|515345203|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
142947170|NCT05480514|515345202|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
142947171|NCT05480514|515345203|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
142947172|NCT05480514|515345202|FG000|Period 1|Covid-19 Related|1|||
142947173|NCT05480514|515345203|FG001|Period 1|Covid-19 Related|0|||
142947174|NCT05480514|515345202|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
142947175|NCT05480514|515345203|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
142947176|NCT03459040|515345204|FG000|Overall Study|Death|8|||
142947177|NCT03459040|515345204|FG000|Overall Study|Withdrawal by Subject|1|||
142947178|NCT00561353|515345205|FG000|Overall Study|Subject reached a virologic endpoint|2|||
142947179|NCT00561353|515345206|FG001|Overall Study|Subject reached a virologic endpoint|1|||
142947180|NCT00561353|515345207|FG002|Overall Study|Subject reached a virologic endpoint|1|||
142947181|NCT00561353|515345208|FG003|Overall Study|Subject reached a virologic endpoint|4|||
142947182|NCT00561353|515345209|FG004|Overall Study|Subject reached a virologic endpoint|1|||
142947183|NCT00561353|515345210|FG005|Overall Study|Subject reached a virologic endpoint|3|||
142947184|NCT00561353|515345211|FG006|Overall Study|Subject reached a virologic endpoint|4|||
142947185|NCT00561353|515345212|FG007|Overall Study|Subject reached a virologic endpoint|4|||
142947186|NCT00561353|515345213|FG008|Overall Study|Subject reached a virologic endpoint|5|||
142947187|NCT00561353|515345214|FG009|Overall Study|Subject reached a virologic endpoint|0|||
142947188|NCT00561353|515345205|FG000|Overall Study|Subject ineligible to continue the trial|0|||
142947189|NCT00561353|515345206|FG001|Overall Study|Subject ineligible to continue the trial|0|||
142947190|NCT00561353|515345207|FG002|Overall Study|Subject ineligible to continue the trial|0|||
142947191|NCT00561353|515345208|FG003|Overall Study|Subject ineligible to continue the trial|0|||
142947192|NCT00561353|515345209|FG004|Overall Study|Subject ineligible to continue the trial|0|||
142947193|NCT00561353|515345210|FG005|Overall Study|Subject ineligible to continue the trial|1|||
142947194|NCT00561353|515345211|FG006|Overall Study|Subject ineligible to continue the trial|1|||
142947195|NCT00561353|515345212|FG007|Overall Study|Subject ineligible to continue the trial|0|||
142947196|NCT00561353|515345213|FG008|Overall Study|Subject ineligible to continue the trial|2|||
142947197|NCT00561353|515345214|FG009|Overall Study|Subject ineligible to continue the trial|1|||
142947198|NCT00561353|515345205|FG000|Overall Study|Other|1|||
142947199|NCT00561353|515345206|FG001|Overall Study|Other|0|||
142947200|NCT00561353|515345207|FG002|Overall Study|Other|1|||
142947201|NCT00561353|515345208|FG003|Overall Study|Other|0|||
142947202|NCT00561353|515345209|FG004|Overall Study|Other|0|||
142947203|NCT00561353|515345210|FG005|Overall Study|Other|2|||
142947204|NCT00561353|515345211|FG006|Overall Study|Other|0|||
142947205|NCT00561353|515345212|FG007|Overall Study|Other|0|||
142947206|NCT00561353|515345213|FG008|Overall Study|Other|0|||
142947207|NCT00561353|515345214|FG009|Overall Study|Other|0|||
142947208|NCT00561353|515345205|FG000|Overall Study|Adverse Event|0|||
142947209|NCT00561353|515345206|FG001|Overall Study|Adverse Event|0|||
142947210|NCT00561353|515345207|FG002|Overall Study|Adverse Event|0|||
142947211|NCT00561353|515345208|FG003|Overall Study|Adverse Event|2|||
142947212|NCT00561353|515345209|FG004|Overall Study|Adverse Event|0|||
142947213|NCT00561353|515345210|FG005|Overall Study|Adverse Event|0|||
142947214|NCT00561353|515345211|FG006|Overall Study|Adverse Event|1|||
142947215|NCT00561353|515345212|FG007|Overall Study|Adverse Event|0|||
142947216|NCT00561353|515345213|FG008|Overall Study|Adverse Event|0|||
142947217|NCT00561353|515345214|FG009|Overall Study|Adverse Event|1|||
142947218|NCT00561353|515345205|FG000|Overall Study|Lost to Follow-up|2|||
142947219|NCT00561353|515345206|FG001|Overall Study|Lost to Follow-up|0|||
142947220|NCT00561353|515345207|FG002|Overall Study|Lost to Follow-up|1|||
142947221|NCT00561353|515345208|FG003|Overall Study|Lost to Follow-up|0|||
142947222|NCT00561353|515345209|FG004|Overall Study|Lost to Follow-up|0|||
142947223|NCT00561353|515345210|FG005|Overall Study|Lost to Follow-up|0|||
142947224|NCT00561353|515345211|FG006|Overall Study|Lost to Follow-up|0|||
142947225|NCT00561353|515345212|FG007|Overall Study|Lost to Follow-up|0|||
142947226|NCT00561353|515345213|FG008|Overall Study|Lost to Follow-up|0|||
142947227|NCT00561353|515345214|FG009|Overall Study|Lost to Follow-up|0|||
142947228|NCT00561353|515345205|FG000|Overall Study|Withdrawal by Subject|0|||
142947229|NCT00561353|515345206|FG001|Overall Study|Withdrawal by Subject|2|||
142947230|NCT00561353|515345207|FG002|Overall Study|Withdrawal by Subject|0|||
142947231|NCT00561353|515345208|FG003|Overall Study|Withdrawal by Subject|0|||
142947232|NCT00561353|515345209|FG004|Overall Study|Withdrawal by Subject|0|||
142947233|NCT00561353|515345210|FG005|Overall Study|Withdrawal by Subject|0|||
142947234|NCT00561353|515345211|FG006|Overall Study|Withdrawal by Subject|0|||
142947235|NCT00561353|515345212|FG007|Overall Study|Withdrawal by Subject|0|||
142947236|NCT00561353|515345213|FG008|Overall Study|Withdrawal by Subject|0|||
142947237|NCT00561353|515345214|FG009|Overall Study|Withdrawal by Subject|0|||
142947238|NCT01273818|515345215|FG000|Overall Study|Physician Decision|13|||
142947239|NCT01273818|515345216|FG001|Overall Study|Physician Decision|2|||
142947240|NCT01273818|515345217|FG002|Overall Study|Physician Decision|9|||
142947241|NCT03815175|515345218|FG000|Overall Study|Subject Lost to Follow-up|6|||
142947242|NCT03815175|515345218|FG000|Overall Study|Subject Withdrew Consent|48|||
142947243|NCT03815175|515345218|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
142947244|NCT03815175|515345218|FG000|Overall Study|Death|86|||
142947245|NCT03815175|515345218|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
142947246|NCT03815175|515345218|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
142947247|NCT03815175|515345218|FG000|Overall Study|Other Status Change Reason|1|||
142947248|NCT03815175|515345218|FG000|Overall Study|Missed Visit|12|||
142947249|NCT00820040|515345219|FG000|Overall Study|Death|1|||
142947250|NCT00820040|515345219|FG000|Overall Study|Sponsor terminated study|1|||
142947251|NCT00820040|515345219|FG000|Overall Study|Screen failure|1|||
142947252|NCT01672892|515346911|FG000|Overall Study|Protocol Violation|7|||
142947253|NCT01672892|515346912|FG001|Overall Study|Protocol Violation|3|||
142947254|NCT03518840|515346916|FG000|Overall Study|Lost to Follow-up|6|||
142947255|NCT00914628|515346917|FG000|Overall Study|Death|35|||
142947256|NCT00914628|515346918|FG001|Overall Study|Death|17|||
142947257|NCT00914628|515346917|FG000|Overall Study|Medical decision|4|||
142947258|NCT00914628|515346918|FG001|Overall Study|Medical decision|0|||
142947259|NCT00914628|515346917|FG000|Overall Study|Protocol Violation|1|||
142947260|NCT00914628|515346918|FG001|Overall Study|Protocol Violation|0|||
142947261|NCT00914628|515346917|FG000|Overall Study|Lack of Efficacy|1|||
142947262|NCT00914628|515346918|FG001|Overall Study|Lack of Efficacy|0|||
142947263|NCT00914628|515346917|FG000|Overall Study|non-randomized|1|||
142947264|NCT00914628|515346918|FG001|Overall Study|non-randomized|0|||
142947265|NCT00914628|515346917|FG000|Overall Study|Relapse|1|||
142947266|NCT00914628|515346918|FG001|Overall Study|Relapse|2|||
142947267|NCT00914628|515346917|FG000|Overall Study|Study terminated by Sponsor|14|||
142947268|NCT00914628|515346918|FG001|Overall Study|Study terminated by Sponsor|8|||
142947269|NCT00914628|515346917|FG000|Overall Study|Patients who did not receive a single dose|7|||
142947270|NCT00914628|515346918|FG001|Overall Study|Patients who did not receive a single dose|1|||
142947271|NCT03311126|515346919|FG000|Induction|Death|1|||
142947272|NCT03311126|515346919|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
142947273|NCT02981472|515346920|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
142947274|NCT02981472|515346921|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
142947275|NCT02981472|515346920|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
142947276|NCT02981472|515346921|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
142947277|NCT02981472|515346920|FG000|Treatment Period|Adverse Event|6|||
142947278|NCT02981472|515346921|FG001|Treatment Period|Adverse Event|1|||
142947279|NCT02981472|515346920|FG000|Treatment Period|Participant withdrew consent|1|||
142947280|NCT02981472|515346921|FG001|Treatment Period|Participant withdrew consent|0|||
142947281|NCT02981472|515346920|FG000|Treatment Period|Lost to Follow-up|0|||
142947282|NCT02981472|515346921|FG001|Treatment Period|Lost to Follow-up|1|||
142947283|NCT02424539|515346922|FG000|Overall Study|Adverse Event|0|||
142947284|NCT02424539|515346923|FG001|Overall Study|Adverse Event|0|||
142947285|NCT02424539|515346924|FG002|Overall Study|Adverse Event|1|||
142947286|NCT02424539|515346922|FG000|Overall Study|Physician Decision|0|||
142947287|NCT02424539|515346923|FG001|Overall Study|Physician Decision|0|||
142947288|NCT02424539|515346924|FG002|Overall Study|Physician Decision|1|||
142947289|NCT02424539|515346922|FG000|Overall Study|Withdrawal by Subject|3|||
142947290|NCT02424539|515346923|FG001|Overall Study|Withdrawal by Subject|1|||
142947291|NCT02424539|515346924|FG002|Overall Study|Withdrawal by Subject|0|||
142947292|NCT02424539|515346922|FG000|Overall Study|Other: Reached stopping criteria|11|||
142947293|NCT02424539|515346923|FG001|Overall Study|Other: Reached stopping criteria|7|||
142947294|NCT02424539|515346924|FG002|Overall Study|Other: Reached stopping criteria|6|||
142947295|NCT00719810|515346925|FG000|Overall Study|Adverse Event|0|||
142947296|NCT00719810|515346926|FG001|Overall Study|Adverse Event|2|||
142947297|NCT00719810|515346927|FG002|Overall Study|Adverse Event|3|||
142947298|NCT00719810|515346925|FG000|Overall Study|Lost to Follow-up|2|||
142947299|NCT00719810|515346926|FG001|Overall Study|Lost to Follow-up|0|||
142947300|NCT00719810|515346927|FG002|Overall Study|Lost to Follow-up|3|||
142947301|NCT00719810|515346925|FG000|Overall Study|Physician Decision|0|||
142947302|NCT00719810|515346926|FG001|Overall Study|Physician Decision|1|||
142947303|NCT00719810|515346927|FG002|Overall Study|Physician Decision|0|||
142947304|NCT00719810|515346925|FG000|Overall Study|Withdrawal by Subject|1|||
142947305|NCT00719810|515346926|FG001|Overall Study|Withdrawal by Subject|1|||
142947306|NCT00719810|515346927|FG002|Overall Study|Withdrawal by Subject|2|||
142947307|NCT02024464|515346930|FG000|Overall Study|Discontinued|5|||
142947308|NCT02024464|515346931|FG001|Overall Study|Discontinued|4|||
142947309|NCT02024464|515346930|FG000|Overall Study|Missed Visits|1|||
142947310|NCT02024464|515346931|FG001|Overall Study|Missed Visits|0|||
142947311|NCT02024464|515346930|FG000|Overall Study|Lost to Follow-up|4|||
142947312|NCT02024464|515346931|FG001|Overall Study|Lost to Follow-up|7|||
142947313|NCT05408858|515346934|FG000|Overall Study|no longer met eligibility criteria|1|||
142947314|NCT01845025|515346935|FG000|Overall Study|Adverse Event|6|||
142947315|NCT01845025|515346936|FG001|Overall Study|Adverse Event|3|||
142947316|NCT01845025|515346935|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
142947317|NCT01845025|515346936|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
142947318|NCT01845025|515346935|FG000|Overall Study|Withdrawal by Subject|48|||
142947319|NCT01845025|515346936|FG001|Overall Study|Withdrawal by Subject|44|||
142947320|NCT01845025|515346935|FG000|Overall Study|Lost to Follow-up|13|||
142947321|NCT01845025|515346936|FG001|Overall Study|Lost to Follow-up|13|||
143117114|NCT00551161|515970033|FG000|Overall Study|Withdrawal by Subject|1|||
143455031|NCT02663518|517210762|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
143455032|NCT02663518|517210763|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
143455033|NCT02663518|517210764|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
143455034|NCT02663518|517210765|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
143455035|NCT02663518|517210766|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
143455036|NCT02663518|517210767|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
143455037|NCT02663518|517210768|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
143455038|NCT02663518|517210769|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
143455039|NCT02663518|517210770|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
143455040|NCT02663518|517210771|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
143455041|NCT02663518|517210772|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
143455042|NCT02663518|517210759|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
143455043|NCT02663518|517210760|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
143455044|NCT02663518|517210761|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
143455045|NCT02663518|517210762|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
143455046|NCT02663518|517210763|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
143455047|NCT02663518|517210764|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
143455048|NCT02663518|517210765|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
143117115|NCT02565706|515970034|FG000|Overall Study|Withdrawal by Subject|5|||
143117116|NCT02565706|515970035|FG001|Overall Study|Withdrawal by Subject|7|||
143117117|NCT02565706|515970036|FG002|Overall Study|Withdrawal by Subject|7|||
142947322|NCT01845025|515346935|FG000|Overall Study|Administrative problems|8|||
142947323|NCT01845025|515346936|FG001|Overall Study|Administrative problems|8|||
142947324|NCT01845025|515346935|FG000|Overall Study|Death|2|||
142947325|NCT01845025|515346936|FG001|Overall Study|Death|0|||
142947326|NCT01845025|515346935|FG000|Overall Study|Protocol deviation|3|||
142947327|NCT01845025|515346936|FG001|Overall Study|Protocol deviation|6|||
142947328|NCT01845025|515346935|FG000|Overall Study|Missing|1|||
142947329|NCT01845025|515346936|FG001|Overall Study|Missing|1|||
142947330|NCT01973283|515346939|FG000|Overall Study|Lost to Follow-up|4|||
142947331|NCT04899271|515346945|FG000|Overall Study|Lost to Follow-up|1|||
142947332|NCT04899271|515346946|FG001|Overall Study|Lost to Follow-up|0|||
142947333|NCT04899271|515346945|FG000|Overall Study|Subject request/consent withdrawal|2|||
142947334|NCT04899271|515346946|FG001|Overall Study|Subject request/consent withdrawal|0|||
142947335|NCT00900796|515346951|FG000|Phase 1|Lacked sufficient information|4|||
142947336|NCT00900796|515346951|FG000|Phase 1|Missing information at Week 16|7|||
142947337|NCT00900796|515346951|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
142947338|NCT00900796|515346951|FG000|Phase 2|Lost to Follow-up|5|||
142947339|NCT02586805|515346955|FG000|Overall Study|Withdrawal by Subject|3|||
142947340|NCT02586805|515346956|FG001|Overall Study|Withdrawal by Subject|1|||
142947341|NCT02586805|515346957|FG002|Overall Study|Withdrawal by Subject|1|||
142947342|NCT02586805|515346958|FG003|Overall Study|Withdrawal by Subject|2|||
142947343|NCT02586805|515346955|FG000|Overall Study|Adverse Event|2|||
142947344|NCT02586805|515346956|FG001|Overall Study|Adverse Event|0|||
142947345|NCT02586805|515346957|FG002|Overall Study|Adverse Event|1|||
142947346|NCT02586805|515346958|FG003|Overall Study|Adverse Event|0|||
142947347|NCT02586805|515346955|FG000|Overall Study|Lost to Follow-up|0|||
142947348|NCT02586805|515346956|FG001|Overall Study|Lost to Follow-up|0|||
142947349|NCT02586805|515346957|FG002|Overall Study|Lost to Follow-up|1|||
142947350|NCT02586805|515346958|FG003|Overall Study|Lost to Follow-up|0|||
142947351|NCT02586805|515346955|FG000|Overall Study|Physician Decision|1|||
142947352|NCT02586805|515346956|FG001|Overall Study|Physician Decision|0|||
142947353|NCT02586805|515346957|FG002|Overall Study|Physician Decision|0|||
142947354|NCT02586805|515346958|FG003|Overall Study|Physician Decision|0|||
142947355|NCT01859403|515346959|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
142947356|NCT01859403|515346960|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
142947357|NCT01859403|515346959|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
142947358|NCT01859403|515346960|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
142947359|NCT01859403|515346959|FG000|Primary Endpoint Measure|Physician Decision|0|||
142947360|NCT01859403|515346960|FG001|Primary Endpoint Measure|Physician Decision|1|||
142947361|NCT01859403|515346959|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
142947362|NCT01859403|515346960|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
142947363|NCT01829048|515346963|FG000|Overall Study|Withdrawal by Subject|0|||
142947364|NCT01829048|515346964|FG001|Overall Study|Withdrawal by Subject|0|||
142947365|NCT01829048|515346965|FG002|Overall Study|Withdrawal by Subject|0|||
142947366|NCT01829048|515346966|FG003|Overall Study|Withdrawal by Subject|2|||
142947367|NCT01829048|515346967|FG004|Overall Study|Withdrawal by Subject|0|||
142947368|NCT01121406|515346968|FG000|Overall Study|Progressive disease RECIST|44|||
142947369|NCT01121406|515346969|FG001|Overall Study|Progressive disease RECIST|28|||
142947370|NCT01121406|515346968|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
142947371|NCT01121406|515346969|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
142947372|NCT01121406|515346968|FG000|Overall Study|Other AE|3|||
142947373|NCT01121406|515346969|FG001|Overall Study|Other AE|10|||
142947374|NCT01121406|515346968|FG000|Overall Study|Non-compliant with protocol|0|||
142947375|NCT01121406|515346969|FG001|Overall Study|Non-compliant with protocol|2|||
142947376|NCT01121406|515346968|FG000|Overall Study|Lost to Follow-up|0|||
142947377|NCT01121406|515346969|FG001|Overall Study|Lost to Follow-up|1|||
142947378|NCT01121406|515346968|FG000|Overall Study|Refused continuation of study med.|1|||
142947379|NCT01121406|515346969|FG001|Overall Study|Refused continuation of study med.|2|||
142947380|NCT01121406|515346968|FG000|Overall Study|Reason other than specified above|2|||
142947381|NCT01121406|515346969|FG001|Overall Study|Reason other than specified above|6|||
143455049|NCT02663518|517210766|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
143455050|NCT02663518|517210767|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
143455051|NCT02663518|517210768|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
143455052|NCT02663518|517210769|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
143455053|NCT02663518|517210770|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
143455054|NCT02663518|517210771|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
142947382|NCT01121406|515346968|FG000|Overall Study|Not treated|1|||
142947383|NCT01121406|515346969|FG001|Overall Study|Not treated|0|||
142947384|NCT00504257|515346970|FG000|Overall Study|Withdrawal by Subject|2|||
143455055|NCT02663518|517210772|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
143455056|NCT02663518|517210759|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
142947385|NCT00504257|515346970|FG000|Overall Study|ineligible histology|2|||
142947386|NCT00892437|515346971|FG000|Randomized Phase|Randomized but not treated|6|||
142947387|NCT00892437|515346972|FG001|Randomized Phase|Randomized but not treated|0|||
142947388|NCT00892437|515346971|FG000|Randomized Phase|Adverse Event|2|||
142947389|NCT00892437|515346972|FG001|Randomized Phase|Adverse Event|2|||
142947390|NCT00892437|515346971|FG000|Randomized Phase|Lost to Follow-up|1|||
142947391|NCT00892437|515346972|FG001|Randomized Phase|Lost to Follow-up|3|||
142947392|NCT00892437|515346971|FG000|Randomized Phase|Investigator's Discretion|1|||
142947393|NCT00892437|515346972|FG001|Randomized Phase|Investigator's Discretion|0|||
142947394|NCT00892437|515346971|FG000|Randomized Phase|Withdrew Consent|1|||
142947395|NCT00892437|515346972|FG001|Randomized Phase|Withdrew Consent|0|||
142947396|NCT00892437|515346971|FG000|Open-Label Extension Phase|Adverse Event|4|||
142947397|NCT00892437|515346972|FG001|Open-Label Extension Phase|Adverse Event|2|||
142947398|NCT00892437|515346971|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
142947399|NCT00892437|515346972|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
142947400|NCT00892437|515346971|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
142947401|NCT00892437|515346972|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
142947402|NCT00892437|515346971|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
142947403|NCT00892437|515346972|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
142947404|NCT00892437|515346971|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
142947405|NCT00892437|515346972|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
142947406|NCT03185130|515346974|FG000|Overall Study|Withdrawal by Subject|0|||
142947407|NCT03185130|515346975|FG001|Overall Study|Withdrawal by Subject|2|||
142947408|NCT02750410|515346976|FG000|Double-Blind Treatment Period|Adverse Event|2|||
142947409|NCT02750410|515346977|FG001|Double-Blind Treatment Period|Adverse Event|2|||
142947410|NCT02750410|515346976|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
142947411|NCT02750410|515346977|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
142947412|NCT02750410|515346976|FG000|Open-Label Extension Period|Adverse Event|5|||
142947413|NCT02750410|515346977|FG001|Open-Label Extension Period|Adverse Event|3|||
142947414|NCT02750410|515346976|FG000|Open-Label Extension Period|Protocol Violation|0|||
142947415|NCT02750410|515346977|FG001|Open-Label Extension Period|Protocol Violation|1|||
142947416|NCT02750410|515346976|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
142947417|NCT02750410|515346977|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
142947418|NCT02504541|515346978|FG000|Overall Study|Adverse Event|4|||
142947419|NCT02504541|515346978|FG000|Overall Study|Withdrawal by Subject|4|||
142947420|NCT02504541|515346978|FG000|Overall Study|Lost to Follow-up|1|||
142947421|NCT02504541|515346978|FG000|Overall Study|Met Stopping Criteria|1|||
142947422|NCT02504541|515346978|FG000|Overall Study|Protocol Violation|2|||
142947423|NCT02504541|515346978|FG000|Overall Study|Termination by Sponsor|1|||
142947424|NCT02504541|515346978|FG000|Overall Study|Other|2|||
142947425|NCT02504541|515346978|FG000|Overall Study|Multiple|5|||
142947426|NCT01531725|515346982|FG000|Overall Study|Protocol Violation|5|||
142947427|NCT03215277|515346983|FG000|Overall Study|Adverse Event|2|||
142947428|NCT03215277|515346984|FG001|Overall Study|Adverse Event|3|||
142947429|NCT03215277|515346983|FG000|Overall Study|Death|1|||
142947430|NCT03215277|515346984|FG001|Overall Study|Death|0|||
142947431|NCT03215277|515346983|FG000|Overall Study|Lost to Follow-up|0|||
142947432|NCT03215277|515346984|FG001|Overall Study|Lost to Follow-up|1|||
142947433|NCT03215277|515346983|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
142947434|NCT03215277|515346984|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
142947435|NCT00472303|515346986|FG000|Titration Phase|Adverse Event|22|||
142947436|NCT00472303|515346987|FG001|Titration Phase|Adverse Event|12|||
142947437|NCT00472303|515346988|FG002|Titration Phase|Adverse Event|0|||
142947438|NCT00472303|515346986|FG000|Titration Phase|Death|4|||
142947439|NCT00472303|515346987|FG001|Titration Phase|Death|2|||
142947440|NCT00472303|515346988|FG002|Titration Phase|Death|0|||
142947441|NCT00472303|515346986|FG000|Titration Phase|Lack of Efficacy|10|||
142947442|NCT00472303|515346987|FG001|Titration Phase|Lack of Efficacy|0|||
142947443|NCT00472303|515346988|FG002|Titration Phase|Lack of Efficacy|0|||
142947444|NCT00472303|515346986|FG000|Titration Phase|Withdrawal by Subject|16|||
142947445|NCT00472303|515346987|FG001|Titration Phase|Withdrawal by Subject|13|||
142947446|NCT00472303|515346988|FG002|Titration Phase|Withdrawal by Subject|0|||
142947447|NCT00472303|515346986|FG000|Titration Phase|Trial Medication non-compliant|4|||
142947448|NCT00472303|515346987|FG001|Titration Phase|Trial Medication non-compliant|1|||
142947449|NCT00472303|515346988|FG002|Titration Phase|Trial Medication non-compliant|0|||
142947450|NCT00472303|515346986|FG000|Titration Phase|Other|3|||
142947451|NCT00472303|515346987|FG001|Titration Phase|Other|1|||
142947452|NCT00472303|515346988|FG002|Titration Phase|Other|0|||
142947453|NCT00472303|515346986|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
142947454|NCT00472303|515346987|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
142947455|NCT00472303|515346988|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
142947456|NCT00472303|515346986|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
142947457|NCT00472303|515346987|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
142947458|NCT00472303|515346988|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
142947459|NCT00472303|515346986|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
142947460|NCT00472303|515346987|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
142947461|NCT00472303|515346988|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
142947462|NCT00472303|515346986|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
142947463|NCT00472303|515346987|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
142947464|NCT00472303|515346988|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
142947465|NCT00472303|515346986|FG000|Discontinuations After Titration Phase|Other|5|||
142947466|NCT00472303|515346987|FG001|Discontinuations After Titration Phase|Other|0|||
142947467|NCT00472303|515346988|FG002|Discontinuations After Titration Phase|Other|0|||
142947468|NCT00472303|515346986|FG000|Maintenance Phase|Adverse Event|5|||
142947469|NCT00472303|515346987|FG001|Maintenance Phase|Adverse Event|6|||
142947470|NCT00472303|515346988|FG002|Maintenance Phase|Adverse Event|6|||
142947471|NCT00472303|515346986|FG000|Maintenance Phase|Death|3|||
142947472|NCT00472303|515346987|FG001|Maintenance Phase|Death|0|||
142947473|NCT00472303|515346988|FG002|Maintenance Phase|Death|2|||
142947474|NCT00472303|515346986|FG000|Maintenance Phase|Lack of Efficacy|2|||
142947475|NCT00472303|515346987|FG001|Maintenance Phase|Lack of Efficacy|2|||
142947476|NCT00472303|515346988|FG002|Maintenance Phase|Lack of Efficacy|4|||
142947477|NCT00472303|515346986|FG000|Maintenance Phase|Withdrawal by Subject|6|||
142947478|NCT00472303|515346987|FG001|Maintenance Phase|Withdrawal by Subject|7|||
142947479|NCT00472303|515346988|FG002|Maintenance Phase|Withdrawal by Subject|3|||
142947480|NCT00472303|515346986|FG000|Maintenance Phase|Trial medication non-compliant|0|||
142947481|NCT00472303|515346987|FG001|Maintenance Phase|Trial medication non-compliant|0|||
142947482|NCT00472303|515346988|FG002|Maintenance Phase|Trial medication non-compliant|1|||
142947483|NCT00472303|515346986|FG000|Maintenance Phase|Resolution of pain|0|||
142947484|NCT00472303|515346987|FG001|Maintenance Phase|Resolution of pain|0|||
142947485|NCT00472303|515346988|FG002|Maintenance Phase|Resolution of pain|1|||
142947486|NCT00472303|515346986|FG000|Maintenance Phase|Other|1|||
142947487|NCT00472303|515346987|FG001|Maintenance Phase|Other|1|||
142947488|NCT00472303|515346988|FG002|Maintenance Phase|Other|0|||
142947489|NCT03596164|515346990|FG000|Overall Study|Adverse Event|0|||
142947490|NCT03596164|515346991|FG001|Overall Study|Adverse Event|1|||
142947491|NCT03596164|515346990|FG000|Overall Study|Death|1|||
142947492|NCT03596164|515346991|FG001|Overall Study|Death|0|||
142947493|NCT04112914|515346992|FG000|Overall Study|Lost to Follow-up|13|||
142947494|NCT04112914|515346993|FG001|Overall Study|Lost to Follow-up|9|||
142947495|NCT04112914|515346992|FG000|Overall Study|Withdrawal by Subject|1|||
142947496|NCT04112914|515346993|FG001|Overall Study|Withdrawal by Subject|0|||
142947497|NCT02835495|515347002|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
142947498|NCT02835495|515347003|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
142947499|NCT02835495|515347002|FG000|Overall Study|Declined in-person follow-up visit|4|||
142947500|NCT02835495|515347003|FG001|Overall Study|Declined in-person follow-up visit|2|||
142947501|NCT02318602|515347005|FG000|Overall Study|Adverse Event|0|||
142947502|NCT02318602|515347006|FG001|Overall Study|Adverse Event|1|||
142947503|NCT02318602|515347007|FG002|Overall Study|Adverse Event|1|||
142947504|NCT02318602|515347005|FG000|Overall Study|Withdrawal by Subject|0|||
142947505|NCT02318602|515347006|FG001|Overall Study|Withdrawal by Subject|3|||
142947506|NCT02318602|515347007|FG002|Overall Study|Withdrawal by Subject|0|||
142947507|NCT02318602|515347005|FG000|Overall Study|Death|1|||
142947508|NCT02318602|515347006|FG001|Overall Study|Death|0|||
142947509|NCT02318602|515347007|FG002|Overall Study|Death|0|||
142947510|NCT02318602|515347005|FG000|Overall Study|Guardian decision to withdraw|0|||
142947511|NCT02318602|515347006|FG001|Overall Study|Guardian decision to withdraw|0|||
142947512|NCT02318602|515347007|FG002|Overall Study|Guardian decision to withdraw|1|||
142947513|NCT05421754|515347008|FG000|Overall Study|Technical issue with sensor|1|||
142947514|NCT00730236|515347010|FG000|Overall Study|Adverse Event|4|||
142947515|NCT00730236|515347010|FG000|Overall Study|Withdrawal by Subject|1|||
142947516|NCT00730236|515347010|FG000|Overall Study|Non-compliance|1|||
142947517|NCT02388776|515347016|FG000|Overall Study|Death|1|||
142947518|NCT02388776|515347016|FG000|Overall Study|Lost to Follow-up|1|||
142947519|NCT03826914|515347017|FG000|Overall Study|Withdrawal by Subject|1|||
142947520|NCT03826914|515347018|FG001|Overall Study|Withdrawal by Subject|1|||
142947521|NCT00542828|515347019|FG000|Overall Study|Physician Decision|1|||
142947522|NCT00542828|515347019|FG000|Overall Study|Need for Prohibited Treatment|3|||
142947523|NCT00542828|515347019|FG000|Overall Study|Study Prematurely Discontinued|7|||
142947524|NCT00542828|515347019|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
142947525|NCT05139030|515347022|FG000|Overall Study|Withdrawal by Subject|1|||
142947526|NCT05139030|515347023|FG001|Overall Study|Withdrawal by Subject|3|||
142947527|NCT05139030|515347022|FG000|Overall Study|Adverse Event|0|||
142947528|NCT05139030|515347023|FG001|Overall Study|Adverse Event|1|||
142947529|NCT05139030|515347022|FG000|Overall Study|Failure to meet continuation criteria|0|||
142947530|NCT05139030|515347023|FG001|Overall Study|Failure to meet continuation criteria|1|||
142947531|NCT02296840|515347036|FG000|Overall Study|Adverse Event|1|||
142947532|NCT02296840|515347037|FG001|Overall Study|Adverse Event|1|||
142947533|NCT02296840|515347036|FG000|Overall Study|Protocol Violation|2|||
142947534|NCT02296840|515347037|FG001|Overall Study|Protocol Violation|1|||
142947535|NCT02296840|515347036|FG000|Overall Study|Lost to Follow-up|6|||
142947536|NCT02296840|515347037|FG001|Overall Study|Lost to Follow-up|17|||
142947537|NCT00104871|515347038|FG000|Overall Study|Not evaluable|1|||
142947538|NCT00761215|515347041|FG000|Overall Study|Randomized but didn't receive drug|1|||
142947539|NCT00761215|515347042|FG001|Overall Study|Randomized but didn't receive drug|1|||
142947540|NCT00761215|515347043|FG002|Overall Study|Randomized but didn't receive drug|2|||
142947541|NCT00761215|515347041|FG000|Overall Study|Lost to Follow-up|6|||
142947542|NCT00761215|515347042|FG001|Overall Study|Lost to Follow-up|3|||
142947543|NCT00761215|515347043|FG002|Overall Study|Lost to Follow-up|6|||
142947544|NCT00761215|515347041|FG000|Overall Study|Withdrawal by Subject|1|||
142947545|NCT00761215|515347042|FG001|Overall Study|Withdrawal by Subject|0|||
142947546|NCT00761215|515347043|FG002|Overall Study|Withdrawal by Subject|0|||
142947547|NCT00761215|515347041|FG000|Overall Study|Bacteremia|1|||
142947548|NCT00761215|515347042|FG001|Overall Study|Bacteremia|0|||
142947549|NCT00761215|515347043|FG002|Overall Study|Bacteremia|0|||
142947550|NCT00457639|515347044|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
142947551|NCT00457639|515347045|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
142947552|NCT00457639|515347044|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
142947553|NCT00457639|515347045|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
142947554|NCT00457639|515347044|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
142947555|NCT00457639|515347045|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
142947556|NCT02117687|515347046|FG000|Overall Study|Lost to Follow-up|0|||
142947557|NCT02117687|515347047|FG001|Overall Study|Lost to Follow-up|1|||
142947558|NCT02117687|515347046|FG000|Overall Study|Adverse Event|0|||
142947559|NCT02117687|515347047|FG001|Overall Study|Adverse Event|2|||
142947560|NCT02117687|515347046|FG000|Overall Study|Other Reasons|1|||
142947561|NCT02117687|515347047|FG001|Overall Study|Other Reasons|1|||
142947562|NCT00002850|515347048|FG000|Overall Study|Death|4|||
142947563|NCT00002850|515347049|FG001|Overall Study|Death|1|||
142947564|NCT00002850|515347050|FG002|Overall Study|Death|3|||
142947565|NCT00002850|515347048|FG000|Overall Study|Protocol Violation|1|||
142947566|NCT00002850|515347049|FG001|Overall Study|Protocol Violation|0|||
142947567|NCT00002850|515347050|FG002|Overall Study|Protocol Violation|1|||
142947568|NCT00002850|515347048|FG000|Overall Study|Withdrawal by Subject|0|||
142947569|NCT00002850|515347049|FG001|Overall Study|Withdrawal by Subject|1|||
142947570|NCT00002850|515347050|FG002|Overall Study|Withdrawal by Subject|0|||
142947571|NCT02932267|515347054|FG000|Overall Study|Withdrawal by Subject|3|||
142947572|NCT02932267|515347054|FG000|Overall Study|Lost to Follow-up|4|||
142947573|NCT02932267|515347054|FG000|Overall Study|Pregnancy|1|||
142947574|NCT01084252|515348791|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
142947575|NCT01084252|515348792|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
142947576|NCT01084252|515348793|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
142947577|NCT01084252|515348794|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
142947578|NCT01084252|515348795|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
142947579|NCT01084252|515348796|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
142947580|NCT01084252|515348797|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
142947581|NCT01084252|515348798|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
142947582|NCT01084252|515348799|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
142947583|NCT01084252|515348800|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
142947584|NCT01084252|515348801|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
142947585|NCT01084252|515348802|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
142947586|NCT01084252|515348803|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
142947587|NCT01084252|515348804|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
142947588|NCT04909463|515348805|FG000|Overall Study|Withdrawal by Subject|0|||
142947589|NCT04909463|515348806|FG001|Overall Study|Withdrawal by Subject|1|||
142947590|NCT04909463|515348807|FG002|Overall Study|Withdrawal by Subject|0|||
142947591|NCT04909463|515348808|FG003|Overall Study|Withdrawal by Subject|0|||
142947592|NCT04909463|515348805|FG000|Overall Study|Lost to Follow-up|2|||
142947593|NCT04909463|515348806|FG001|Overall Study|Lost to Follow-up|1|||
142947594|NCT04909463|515348807|FG002|Overall Study|Lost to Follow-up|1|||
142947595|NCT04909463|515348808|FG003|Overall Study|Lost to Follow-up|0|||
142947596|NCT00853632|515348809|FG000|Overall Study|Death|88|||
142947597|NCT00853632|515348809|FG000|Overall Study|Withdrawal by Subject|45|||
142947598|NCT00853632|515348809|FG000|Overall Study|Lost to Follow-up|30|||
142947599|NCT00853632|515348809|FG000|Overall Study|Reoperation/Explant|17|||
142947600|NCT00853632|515348809|FG000|Overall Study|Exit with other reason|22|||
142947601|NCT04493619|515348811|FG000|Overall Study|Death|4|||
142947602|NCT04493619|515348812|FG001|Overall Study|Death|3|||
142947603|NCT04493619|515348813|FG002|Overall Study|Death|3|||
142947604|NCT04493619|515348814|FG003|Overall Study|Death|4|||
142947605|NCT04493619|515348811|FG000|Overall Study|Study discontinued early|10|||
142947606|NCT04493619|515348812|FG001|Overall Study|Study discontinued early|0|||
142947607|NCT04493619|515348813|FG002|Overall Study|Study discontinued early|4|||
142947608|NCT04493619|515348814|FG003|Overall Study|Study discontinued early|8|||
143117118|NCT02565706|515970037|FG003|Overall Study|Withdrawal by Subject|11|||
142947609|NCT04493619|515348811|FG000|Overall Study|Lost to Follow-up|0|||
142947610|NCT04493619|515348812|FG001|Overall Study|Lost to Follow-up|0|||
142947611|NCT04493619|515348813|FG002|Overall Study|Lost to Follow-up|0|||
142947612|NCT04493619|515348814|FG003|Overall Study|Lost to Follow-up|1|||
142947613|NCT01826214|515348818|FG000|Overall Study|Adverse Event|7|||
142947614|NCT01826214|515348819|FG001|Overall Study|Adverse Event|6|||
142947615|NCT01826214|515348818|FG000|Overall Study|Death|3|||
142947616|NCT01826214|515348819|FG001|Overall Study|Death|1|||
142947617|NCT01826214|515348818|FG000|Overall Study|Lost to Follow-up|1|||
142947618|NCT01826214|515348819|FG001|Overall Study|Lost to Follow-up|0|||
142947619|NCT01826214|515348818|FG000|Overall Study|Physician Decision|0|||
142947620|NCT01826214|515348819|FG001|Overall Study|Physician Decision|2|||
142947621|NCT01826214|515348818|FG000|Overall Study|Progressive disease|22|||
142947622|NCT01826214|515348819|FG001|Overall Study|Progressive disease|21|||
142947623|NCT01826214|515348818|FG000|Overall Study|Study terminated by Sponsor|0|||
142947624|NCT01826214|515348819|FG001|Overall Study|Study terminated by Sponsor|1|||
142947625|NCT01826214|515348818|FG000|Overall Study|Subject/guardian decision|2|||
142947626|NCT01826214|515348819|FG001|Overall Study|Subject/guardian decision|3|||
142947627|NCT03528681|515348832|FG000|Open-Label Phase|Physician Decision|2|||
142947628|NCT03528681|515348833|FG001|Open-Label Phase|Physician Decision|0|||
142947629|NCT03528681|515348834|FG002|Open-Label Phase|Physician Decision|0|||
142947630|NCT03528681|515348835|FG003|Open-Label Phase|Physician Decision|0|||
142947631|NCT03528681|515348832|FG000|Open-Label Phase|Withdrawal by Subject|8|||
142947632|NCT03528681|515348833|FG001|Open-Label Phase|Withdrawal by Subject|0|||
142947633|NCT03528681|515348834|FG002|Open-Label Phase|Withdrawal by Subject|0|||
142947634|NCT03528681|515348835|FG003|Open-Label Phase|Withdrawal by Subject|0|||
142947635|NCT03528681|515348832|FG000|Open-Label Phase|(Not collected)|4|||
142947636|NCT03528681|515348833|FG001|Open-Label Phase|(Not collected)|0|||
142947637|NCT03528681|515348834|FG002|Open-Label Phase|(Not collected)|0|||
142947638|NCT03528681|515348835|FG003|Open-Label Phase|(Not collected)|0|||
142947639|NCT03528681|515348832|FG000|Randomized Treatment Phase|Lost to Follow-up|0|||
142947640|NCT03528681|515348833|FG001|Randomized Treatment Phase|Lost to Follow-up|0|||
142947641|NCT03528681|515348834|FG002|Randomized Treatment Phase|Lost to Follow-up|1|||
142947642|NCT03528681|515348835|FG003|Randomized Treatment Phase|Lost to Follow-up|0|||
142947643|NCT03528681|515348832|FG000|Randomized Treatment Phase|Physician Decision|0|||
142947644|NCT03528681|515348833|FG001|Randomized Treatment Phase|Physician Decision|5|||
142947645|NCT03528681|515348834|FG002|Randomized Treatment Phase|Physician Decision|1|||
142947646|NCT03528681|515348835|FG003|Randomized Treatment Phase|Physician Decision|2|||
142947647|NCT03528681|515348832|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
142947648|NCT03528681|515348833|FG001|Randomized Treatment Phase|Withdrawal by Subject|7|||
142947649|NCT03528681|515348834|FG002|Randomized Treatment Phase|Withdrawal by Subject|4|||
142947650|NCT03528681|515348835|FG003|Randomized Treatment Phase|Withdrawal by Subject|1|||
142947651|NCT03528681|515348832|FG000|Randomized Treatment Phase|(Study specific withdrawal criteria)|0|||
142947652|NCT03528681|515348833|FG001|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
142947653|NCT03528681|515348834|FG002|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
142947654|NCT03528681|515348835|FG003|Randomized Treatment Phase|(Study specific withdrawal criteria)|4|||
142947655|NCT03528681|515348832|FG000|Randomized Treatment Phase|(Not collected)|0|||
142947656|NCT03528681|515348833|FG001|Randomized Treatment Phase|(Not collected)|4|||
142947657|NCT03528681|515348834|FG002|Randomized Treatment Phase|(Not collected)|6|||
142947658|NCT03528681|515348835|FG003|Randomized Treatment Phase|(Not collected)|5|||
142947659|NCT00955110|515348836|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
142947660|NCT00955110|515348836|FG000|Treatment Phase|Adverse Event|2|||
142947661|NCT00955110|515348836|FG000|Treatment Phase|Administrative reasons|2|||
142947662|NCT00955110|515348836|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
142947663|NCT00955110|515348836|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
142947664|NCT02128490|515348837|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
142947665|NCT02128490|515348838|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
142947666|NCT02128490|515348839|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
142947667|NCT02128490|515348840|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
142947668|NCT02128490|515348841|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
142947669|NCT02128490|515348837|FG000|Overall Study|Major Protocol Deviation|1|||
142947670|NCT02128490|515348838|FG001|Overall Study|Major Protocol Deviation|2|||
142947671|NCT02128490|515348839|FG002|Overall Study|Major Protocol Deviation|0|||
142947672|NCT02128490|515348840|FG003|Overall Study|Major Protocol Deviation|2|||
142947673|NCT02128490|515348841|FG004|Overall Study|Major Protocol Deviation|2|||
142947674|NCT02128490|515348837|FG000|Overall Study|Lost to Follow-up|0|||
142947675|NCT02128490|515348838|FG001|Overall Study|Lost to Follow-up|0|||
142947676|NCT02128490|515348839|FG002|Overall Study|Lost to Follow-up|1|||
142947677|NCT02128490|515348840|FG003|Overall Study|Lost to Follow-up|1|||
142947678|NCT02128490|515348841|FG004|Overall Study|Lost to Follow-up|1|||
142947679|NCT02128490|515348837|FG000|Overall Study|Voluntary Withdrawal|3|||
142947680|NCT02128490|515348838|FG001|Overall Study|Voluntary Withdrawal|3|||
142947681|NCT02128490|515348839|FG002|Overall Study|Voluntary Withdrawal|1|||
142947682|NCT02128490|515348840|FG003|Overall Study|Voluntary Withdrawal|1|||
142947683|NCT02128490|515348841|FG004|Overall Study|Voluntary Withdrawal|2|||
142947684|NCT02128490|515348837|FG000|Overall Study|Lack of Efficacy|0|||
142947685|NCT02128490|515348838|FG001|Overall Study|Lack of Efficacy|1|||
142947686|NCT02128490|515348839|FG002|Overall Study|Lack of Efficacy|0|||
142947687|NCT02128490|515348840|FG003|Overall Study|Lack of Efficacy|0|||
142947688|NCT02128490|515348841|FG004|Overall Study|Lack of Efficacy|0|||
142947689|NCT02128490|515348837|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
142947690|NCT02128490|515348838|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
142947691|NCT02128490|515348839|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
142947692|NCT02128490|515348840|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
142947693|NCT02128490|515348841|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
142947694|NCT02128490|515348837|FG000|Overall Study|Other Miscellaneous Reasons|0|||
142947695|NCT02128490|515348838|FG001|Overall Study|Other Miscellaneous Reasons|0|||
142947696|NCT02128490|515348839|FG002|Overall Study|Other Miscellaneous Reasons|2|||
142947697|NCT02128490|515348840|FG003|Overall Study|Other Miscellaneous Reasons|1|||
142947698|NCT02128490|515348841|FG004|Overall Study|Other Miscellaneous Reasons|1|||
142947699|NCT02243176|515348842|FG000|Overall Study|Other reason|1|||
142947700|NCT02243176|515348843|FG001|Overall Study|Other reason|2|||
142947701|NCT02243176|515348842|FG000|Overall Study|protocol specified withdrawal critera|1|||
142947702|NCT02243176|515348843|FG001|Overall Study|protocol specified withdrawal critera|3|||
142947703|NCT02243176|515348842|FG000|Overall Study|Protocol Violation|2|||
142947704|NCT02243176|515348843|FG001|Overall Study|Protocol Violation|1|||
142947705|NCT02243176|515348842|FG000|Overall Study|Withdrawal by Subject|8|||
142947706|NCT02243176|515348843|FG001|Overall Study|Withdrawal by Subject|7|||
142947707|NCT02243176|515348842|FG000|Overall Study|Adverse Event|2|||
142947708|NCT02243176|515348843|FG001|Overall Study|Adverse Event|2|||
142947709|NCT02342171|515348850|FG000|Overall Study|Death|4|||
142947710|NCT02342171|515348851|FG001|Overall Study|Death|87|||
142947711|NCT02342171|515348850|FG000|Overall Study|Received favipiravir|10|||
142947712|NCT02342171|515348851|FG001|Overall Study|Received favipiravir|0|||
142947713|NCT02342171|515348850|FG000|Overall Study|Missing cycle treshold value|1|||
142947714|NCT02342171|515348851|FG001|Overall Study|Missing cycle treshold value|0|||
142947715|NCT02342171|515348850|FG000|Overall Study|Unknown outcome|0|||
142947716|NCT02342171|515348851|FG001|Overall Study|Unknown outcome|1|||
142947717|NCT02342171|515348850|FG000|Overall Study|Missing age data|0|||
142947718|NCT02342171|515348851|FG001|Overall Study|Missing age data|1|||
142947719|NCT00875420|515348854|FG000|Overall Study|Adverse Event|0|||
142947720|NCT00875420|515348855|FG001|Overall Study|Adverse Event|1|||
142947721|NCT00875420|515348856|FG002|Overall Study|Adverse Event|1|||
142947722|NCT00875420|515348857|FG003|Overall Study|Adverse Event|0|||
142947723|NCT00875420|515348858|FG004|Overall Study|Adverse Event|0|||
142947724|NCT00875420|515348854|FG000|Overall Study|Inability to complete study procedures|1|||
142947725|NCT00875420|515348855|FG001|Overall Study|Inability to complete study procedures|0|||
142947726|NCT00875420|515348856|FG002|Overall Study|Inability to complete study procedures|1|||
142947727|NCT00875420|515348857|FG003|Overall Study|Inability to complete study procedures|1|||
142947728|NCT00875420|515348858|FG004|Overall Study|Inability to complete study procedures|1|||
142947729|NCT00875420|515348854|FG000|Overall Study|Lost to Follow-up|1|||
142947730|NCT00875420|515348855|FG001|Overall Study|Lost to Follow-up|0|||
142947731|NCT00875420|515348856|FG002|Overall Study|Lost to Follow-up|0|||
142947732|NCT00875420|515348857|FG003|Overall Study|Lost to Follow-up|0|||
142947733|NCT00875420|515348858|FG004|Overall Study|Lost to Follow-up|0|||
142947734|NCT00875420|515348854|FG000|Overall Study|Personal reason|0|||
142947735|NCT00875420|515348855|FG001|Overall Study|Personal reason|0|||
142947736|NCT00875420|515348856|FG002|Overall Study|Personal reason|0|||
142947737|NCT00875420|515348857|FG003|Overall Study|Personal reason|0|||
142947738|NCT00875420|515348858|FG004|Overall Study|Personal reason|1|||
142947739|NCT00875420|515348854|FG000|Overall Study|Prohibited medication|0|||
142947740|NCT00875420|515348855|FG001|Overall Study|Prohibited medication|0|||
142947741|NCT00875420|515348856|FG002|Overall Study|Prohibited medication|0|||
142947742|NCT00875420|515348857|FG003|Overall Study|Prohibited medication|1|||
142947743|NCT00875420|515348858|FG004|Overall Study|Prohibited medication|0|||
142947744|NCT00875420|515348854|FG000|Overall Study|Sponsor decision|0|||
142947745|NCT00875420|515348855|FG001|Overall Study|Sponsor decision|1|||
142947746|NCT00875420|515348856|FG002|Overall Study|Sponsor decision|0|||
142947747|NCT00875420|515348857|FG003|Overall Study|Sponsor decision|0|||
142947748|NCT00875420|515348858|FG004|Overall Study|Sponsor decision|0|||
142947749|NCT00875420|515348854|FG000|Overall Study|Withdrawal by Subject|0|||
142947750|NCT00875420|515348855|FG001|Overall Study|Withdrawal by Subject|0|||
142947751|NCT00875420|515348856|FG002|Overall Study|Withdrawal by Subject|1|||
142947752|NCT00875420|515348857|FG003|Overall Study|Withdrawal by Subject|0|||
142947753|NCT00875420|515348858|FG004|Overall Study|Withdrawal by Subject|0|||
142947754|NCT03716726|515348861|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
142947755|NCT03716726|515348862|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
142947756|NCT03716726|515348861|FG000|12 Months Followup|Lost to Follow-up|10|||
142947757|NCT03716726|515348862|FG001|12 Months Followup|Lost to Follow-up|17|||
142947758|NCT02579603|515348863|FG000|Overall Study|Not treated|1|||
142947759|NCT02579603|515348864|FG001|Overall Study|Not treated|0|||
142947760|NCT02579603|515348863|FG000|Overall Study|Adverse Event|2|||
142947761|NCT02579603|515348864|FG001|Overall Study|Adverse Event|2|||
142947762|NCT02579603|515348863|FG000|Overall Study|Other than stated|1|||
142947763|NCT02579603|515348864|FG001|Overall Study|Other than stated|0|||
142947764|NCT00469079|515348865|FG000|Overall Study|Lack of Efficacy|3|||
142947765|NCT00469079|515348866|FG001|Overall Study|Lack of Efficacy|8|||
142947766|NCT00469079|515348867|FG002|Overall Study|Lack of Efficacy|5|||
142947767|NCT00469079|515348865|FG000|Overall Study|Adverse Event|1|||
142947768|NCT00469079|515348866|FG001|Overall Study|Adverse Event|3|||
142947769|NCT00469079|515348867|FG002|Overall Study|Adverse Event|2|||
142947770|NCT00469079|515348865|FG000|Overall Study|Lost to Follow-up|4|||
142947771|NCT00469079|515348866|FG001|Overall Study|Lost to Follow-up|8|||
142947772|NCT00469079|515348867|FG002|Overall Study|Lost to Follow-up|10|||
142947773|NCT00469079|515348865|FG000|Overall Study|Withdrawal by Subject|1|||
142947774|NCT00469079|515348866|FG001|Overall Study|Withdrawal by Subject|2|||
142947775|NCT00469079|515348867|FG002|Overall Study|Withdrawal by Subject|2|||
142947776|NCT00469079|515348865|FG000|Overall Study|Ineligible|0|||
142947777|NCT00469079|515348866|FG001|Overall Study|Ineligible|1|||
142947778|NCT00469079|515348867|FG002|Overall Study|Ineligible|0|||
142947779|NCT02799381|515348868|FG000|Overall Study|Withdrew consent|3|||
142947780|NCT02799381|515348869|FG001|Overall Study|Withdrew consent|2|||
142947781|NCT02799381|515348868|FG000|Overall Study|Adverse Event|0|||
142947782|NCT02799381|515348869|FG001|Overall Study|Adverse Event|1|||
142947783|NCT02799381|515348868|FG000|Overall Study|Participant did not take any study drug|1|||
142947784|NCT02799381|515348869|FG001|Overall Study|Participant did not take any study drug|0|||
142947785|NCT02698410|515348870|FG000|Overall Study|Adverse Event|2|||
142947786|NCT02698410|515348870|FG000|Overall Study|Withdrawal by Subject|1|||
142947787|NCT02698410|515348870|FG000|Overall Study|Other|1|||
142947788|NCT03952130|515348872|FG000|Overall Study|Adverse Event|0|||
142947789|NCT03952130|515348873|FG001|Overall Study|Adverse Event|1|||
142947790|NCT03952130|515348872|FG000|Overall Study|Lost to Follow-up|1|||
142947791|NCT03952130|515348873|FG001|Overall Study|Lost to Follow-up|0|||
142947792|NCT03952130|515348872|FG000|Overall Study|Withdrawal by Subject|1|||
142947793|NCT03952130|515348873|FG001|Overall Study|Withdrawal by Subject|5|||
142947794|NCT04430348|515348881|FG000|Overall Study|Death|3|||
142947795|NCT04430348|515348882|FG001|Overall Study|Death|2|||
142947796|NCT04430348|515348883|FG002|Overall Study|Death|2|||
142947797|NCT04430348|515348884|FG003|Overall Study|Death|2|||
142947798|NCT04430348|515348885|FG004|Overall Study|Death|2|||
142947799|NCT04430348|515348886|FG005|Overall Study|Death|3|||
142947800|NCT04430348|515348881|FG000|Overall Study|Lost to Follow-up|0|||
142947801|NCT04430348|515348882|FG001|Overall Study|Lost to Follow-up|0|||
142947802|NCT04430348|515348883|FG002|Overall Study|Lost to Follow-up|0|||
142947803|NCT04430348|515348884|FG003|Overall Study|Lost to Follow-up|1|||
142947804|NCT04430348|515348885|FG004|Overall Study|Lost to Follow-up|0|||
142947805|NCT04430348|515348886|FG005|Overall Study|Lost to Follow-up|0|||
142947806|NCT04430348|515348881|FG000|Overall Study|Adverse Event|0|||
142947807|NCT04430348|515348882|FG001|Overall Study|Adverse Event|0|||
142947808|NCT04430348|515348883|FG002|Overall Study|Adverse Event|0|||
142947809|NCT04430348|515348884|FG003|Overall Study|Adverse Event|0|||
142947810|NCT04430348|515348885|FG004|Overall Study|Adverse Event|0|||
142947811|NCT04430348|515348886|FG005|Overall Study|Adverse Event|1|||
142947812|NCT04430348|515348881|FG000|Overall Study|Withdrawal by Subject|0|||
142947813|NCT04430348|515348882|FG001|Overall Study|Withdrawal by Subject|1|||
142947814|NCT04430348|515348883|FG002|Overall Study|Withdrawal by Subject|0|||
142947815|NCT04430348|515348884|FG003|Overall Study|Withdrawal by Subject|0|||
142947816|NCT04430348|515348885|FG004|Overall Study|Withdrawal by Subject|0|||
142947817|NCT04430348|515348886|FG005|Overall Study|Withdrawal by Subject|1|||
142947818|NCT04430348|515348881|FG000|Overall Study|Study Terminated by Sponsor|0|||
142947819|NCT04430348|515348882|FG001|Overall Study|Study Terminated by Sponsor|0|||
142947820|NCT04430348|515348883|FG002|Overall Study|Study Terminated by Sponsor|2|||
142947821|NCT04430348|515348884|FG003|Overall Study|Study Terminated by Sponsor|0|||
142947822|NCT04430348|515348885|FG004|Overall Study|Study Terminated by Sponsor|1|||
142947823|NCT04430348|515348886|FG005|Overall Study|Study Terminated by Sponsor|1|||
142947824|NCT05882890|515348887|FG000|Overall Study|Exclusion was due to a score in xerostomia VASscale < 4.|1|||
142947825|NCT01584024|515348888|FG000|Overall Study|Lost to Follow-up|10|||
142947826|NCT01584024|515348888|FG000|Overall Study|Withdrawal by Subject|3|||
142947827|NCT00613314|515348889|FG000|Overall Study|Adverse Event|5|||
142947828|NCT00613314|515348889|FG000|Overall Study|Protocol Violation|14|||
142947829|NCT00613314|515348889|FG000|Overall Study|Lost to Follow-up|46|||
143455057|NCT02663518|517210760|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
142947830|NCT00613314|515348889|FG000|Overall Study|Other reason not defined above|90|||
142947831|NCT01021007|515348894|FG000|Overall Study|Lost to Follow-up|1|||
142947832|NCT01021007|515348895|FG001|Overall Study|Lost to Follow-up|1|||
142947833|NCT01021007|515348894|FG000|Overall Study|Adverse Event|1|||
142947834|NCT01021007|515348895|FG001|Overall Study|Adverse Event|3|||
142947835|NCT01126619|515348900|FG000|Overall Study|Not eligible for the study|2|||
142947836|NCT01126619|515348900|FG000|Overall Study|Investigator decision|4|||
142947837|NCT01126619|515348900|FG000|Overall Study|Serious adverse event|1|||
142947838|NCT01126619|515348900|FG000|Overall Study|Withdrawal by Subject|9|||
142947839|NCT01126619|515348900|FG000|Overall Study|Non-compliance|1|||
142947840|NCT00947154|515348901|FG000|Overall Study|Lost to Follow-up|1|||
142947841|NCT02580058|515348903|FG000|Overall Study|Adverse Event|16|||
142947842|NCT02580058|515348904|FG001|Overall Study|Adverse Event|30|||
142947843|NCT02580058|515348905|FG002|Overall Study|Adverse Event|20|||
142947844|NCT02580058|515348903|FG000|Overall Study|Death|4|||
142947845|NCT02580058|515348904|FG001|Overall Study|Death|4|||
142947846|NCT02580058|515348905|FG002|Overall Study|Death|5|||
142947847|NCT02580058|515348903|FG000|Overall Study|Physician Decision|1|||
142947848|NCT02580058|515348904|FG001|Overall Study|Physician Decision|3|||
142947849|NCT02580058|515348905|FG002|Overall Study|Physician Decision|11|||
142947850|NCT02580058|515348903|FG000|Overall Study|Other|5|||
142947851|NCT02580058|515348904|FG001|Overall Study|Other|1|||
142947852|NCT02580058|515348905|FG002|Overall Study|Other|3|||
142947853|NCT02580058|515348903|FG000|Overall Study|Withdrawal by Subject|4|||
142947854|NCT02580058|515348904|FG001|Overall Study|Withdrawal by Subject|7|||
142947855|NCT02580058|515348905|FG002|Overall Study|Withdrawal by Subject|31|||
142947856|NCT02580058|515348903|FG000|Overall Study|Global Deterioration of Health Status|19|||
142947857|NCT02580058|515348904|FG001|Overall Study|Global Deterioration of Health Status|18|||
142947858|NCT02580058|515348905|FG002|Overall Study|Global Deterioration of Health Status|24|||
142947859|NCT02580058|515348903|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
142947860|NCT02580058|515348904|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
142947861|NCT02580058|515348905|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
142947862|NCT02580058|515348903|FG000|Overall Study|Progressive Disease|137|||
142947863|NCT02580058|515348904|FG001|Overall Study|Progressive Disease|125|||
142947864|NCT02580058|515348905|FG002|Overall Study|Progressive Disease|94|||
142947865|NCT02580058|515348903|FG000|Overall Study|Non-Compliance With Study Drug|1|||
142947866|NCT02580058|515348904|FG001|Overall Study|Non-Compliance With Study Drug|0|||
142947867|NCT02580058|515348905|FG002|Overall Study|Non-Compliance With Study Drug|0|||
142947868|NCT01193335|515348906|FG000|After Infant Series|Lost to Follow-up|1|||
142947869|NCT01193335|515348907|FG001|After Infant Series|Lost to Follow-up|2|||
142947870|NCT01193335|515348906|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
142947871|NCT01193335|515348907|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
142947872|NCT01193335|515348906|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
142947873|NCT01193335|515348907|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
142947874|NCT01193335|515348906|FG000|1-Year Follow-up|Lost to Follow-up|4|||
142947875|NCT01193335|515348907|FG001|1-Year Follow-up|Lost to Follow-up|0|||
142947876|NCT01193335|515348906|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
142947877|NCT01193335|515348907|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
142947878|NCT01193335|515348906|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
142947879|NCT01193335|515348907|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
142947880|NCT01733329|515348908|FG000|Overall Study|Protocol Violation|1|||
142947881|NCT01733329|515348909|FG001|Overall Study|Protocol Violation|1|||
142947882|NCT01733329|515348908|FG000|Overall Study|Uterine artery injury|1|||
142947883|NCT01733329|515348909|FG001|Overall Study|Uterine artery injury|0|||
142947884|NCT02500550|515348913|FG000|Overall Study|Death|7|||
142947885|NCT00465569|515348914|FG000|Overall Study|persistent eczema during dose escalation|1|||
142947886|NCT00465569|515348915|FG001|Overall Study|persistent eczema during dose escalation|0|||
142947887|NCT00482001|515348916|FG000|Overall Study|Protocol Violation|1|||
142947888|NCT00482001|515348917|FG001|Overall Study|Protocol Violation|1|||
142947889|NCT01364467|515348920|FG000|Overall Study|Lost to Follow-up|1|||
142947890|NCT01364467|515348921|FG001|Overall Study|Lost to Follow-up|2|||
142947891|NCT02502864|515348922|FG000|Overall Study|Withdrawal by Subject|1|||
142947892|NCT02234622|515348924|FG000|Overall Study|Withdrawal by Subject|16|||
142947893|NCT02234622|515348925|FG001|Overall Study|Withdrawal by Subject|22|||
142947894|NCT02234622|515348924|FG000|Overall Study|Lost to Follow-up|27|||
142947895|NCT02234622|515348925|FG001|Overall Study|Lost to Follow-up|14|||
142947896|NCT00618956|515348926|FG000|Overall Study|Adverse Event|10|||
142947897|NCT00618956|515348927|FG001|Overall Study|Adverse Event|34|||
142947898|NCT00618956|515348926|FG000|Overall Study|Lack of Efficacy|2|||
142947899|NCT00618956|515348927|FG001|Overall Study|Lack of Efficacy|1|||
142947900|NCT00618956|515348926|FG000|Overall Study|Withdrawal by Subject|5|||
142947901|NCT00618956|515348927|FG001|Overall Study|Withdrawal by Subject|7|||
142947902|NCT00618956|515348926|FG000|Overall Study|Lost to Follow-up|4|||
142947903|NCT00618956|515348927|FG001|Overall Study|Lost to Follow-up|5|||
142947904|NCT00618956|515348926|FG000|Overall Study|Protocol Violation|2|||
142947905|NCT00618956|515348927|FG001|Overall Study|Protocol Violation|2|||
142947906|NCT00618956|515348926|FG000|Overall Study|did not meet criteria, non-compliance|2|||
142947907|NCT00618956|515348927|FG001|Overall Study|did not meet criteria, non-compliance|1|||
142947908|NCT03598777|515348928|FG000|Overall Study|Study Terminated by Sponsor|3|||
142947909|NCT03598777|515348929|FG001|Overall Study|Study Terminated by Sponsor|0|||
143455058|NCT02663518|517210761|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
142947910|NCT03598777|515348930|FG002|Overall Study|Study Terminated by Sponsor|0|||
142947911|NCT03598777|515348931|FG003|Overall Study|Study Terminated by Sponsor|0|||
142947912|NCT03598777|515348932|FG004|Overall Study|Study Terminated by Sponsor|15|||
142947913|NCT03598777|515348928|FG000|Overall Study|Withdrawal by Subject|1|||
142947914|NCT03598777|515348929|FG001|Overall Study|Withdrawal by Subject|1|||
142947915|NCT03598777|515348930|FG002|Overall Study|Withdrawal by Subject|0|||
142947916|NCT03598777|515348931|FG003|Overall Study|Withdrawal by Subject|0|||
142947917|NCT03598777|515348932|FG004|Overall Study|Withdrawal by Subject|0|||
142947918|NCT03598777|515348928|FG000|Overall Study|Adverse Event|1|||
142947919|NCT03598777|515348929|FG001|Overall Study|Adverse Event|0|||
142947920|NCT03598777|515348930|FG002|Overall Study|Adverse Event|0|||
142947921|NCT03598777|515348931|FG003|Overall Study|Adverse Event|0|||
142947922|NCT03598777|515348932|FG004|Overall Study|Adverse Event|0|||
142947923|NCT03598777|515348928|FG000|Overall Study|Lost to Follow-up|1|||
142947924|NCT03598777|515348929|FG001|Overall Study|Lost to Follow-up|0|||
142947925|NCT03598777|515348930|FG002|Overall Study|Lost to Follow-up|0|||
142947926|NCT03598777|515348931|FG003|Overall Study|Lost to Follow-up|0|||
142947927|NCT03598777|515348932|FG004|Overall Study|Lost to Follow-up|0|||
142947928|NCT02006576|515348933|FG000|Overall Study|Withdrawal by Subject|4|||
142947929|NCT02006576|515348934|FG001|Overall Study|Withdrawal by Subject|6|||
142947930|NCT02006576|515348935|FG002|Overall Study|Withdrawal by Subject|2|||
142947931|NCT02006576|515348933|FG000|Overall Study|Death|0|||
142947932|NCT02006576|515348934|FG001|Overall Study|Death|0|||
142947933|NCT02006576|515348935|FG002|Overall Study|Death|1|||
142947934|NCT02006576|515348933|FG000|Overall Study|Lost to Follow-up|1|||
142947935|NCT02006576|515348934|FG001|Overall Study|Lost to Follow-up|0|||
142947936|NCT02006576|515348935|FG002|Overall Study|Lost to Follow-up|1|||
142947937|NCT02006576|515348933|FG000|Overall Study|Screen Failure, too sick, other|13|||
142947938|NCT02006576|515348934|FG001|Overall Study|Screen Failure, too sick, other|1|||
142947939|NCT02006576|515348935|FG002|Overall Study|Screen Failure, too sick, other|13|||
142947940|NCT00785577|515348936|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
142947941|NCT00785577|515348937|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
142947942|NCT00785577|515348938|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
142947943|NCT00785577|515348939|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
142947944|NCT00785577|515348940|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
142947945|NCT00785577|515348936|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
142947946|NCT00785577|515348937|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
142947947|NCT00785577|515348938|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
142947948|NCT00785577|515348939|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
142947949|NCT00785577|515348940|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
142947950|NCT00785577|515348936|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
142947951|NCT00785577|515348937|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
142947952|NCT00785577|515348938|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
142947953|NCT00785577|515348939|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
142947954|NCT00785577|515348940|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
142947955|NCT00785577|515348936|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
142947956|NCT00785577|515348937|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
142947957|NCT00785577|515348938|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
142947958|NCT00785577|515348939|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
142947959|NCT00785577|515348940|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
142947960|NCT00785577|515348936|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
142947961|NCT00785577|515348937|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
142947962|NCT00785577|515348938|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
142947963|NCT00785577|515348939|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
142947964|NCT00785577|515348940|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
142947965|NCT00785577|515348936|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
142947966|NCT00785577|515348937|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
142947967|NCT00785577|515348938|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
142947968|NCT00785577|515348939|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
142947969|NCT00785577|515348940|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
142947970|NCT00785577|515348936|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
142947971|NCT00785577|515348937|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
142947972|NCT00785577|515348938|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
142947973|NCT00785577|515348939|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
142947974|NCT00785577|515348940|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
142947975|NCT00785577|515348936|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
142947976|NCT00785577|515348937|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
142947977|NCT00785577|515348938|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
142947978|NCT00785577|515348939|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
142947979|NCT00785577|515348940|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
142947980|NCT00785577|515348936|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
142947981|NCT00785577|515348937|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
142947982|NCT00785577|515348938|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
142947983|NCT00785577|515348939|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
142947984|NCT00785577|515348940|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
142947985|NCT00785577|515348936|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
142947986|NCT00785577|515348937|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
142947987|NCT00785577|515348938|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
142947988|NCT00785577|515348939|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
142947989|NCT00785577|515348940|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
142947990|NCT02515669|515348951|FG000|228 Week Open-Label Phase|Other|0|||
142947991|NCT02515669|515348952|FG001|228 Week Open-Label Phase|Other|0|||
142947992|NCT02515669|515348953|FG002|228 Week Open-Label Phase|Other|1|||
142947993|NCT02515669|515348954|FG003|228 Week Open-Label Phase|Other|4|||
142947994|NCT02515669|515348951|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
142947995|NCT02515669|515348952|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
142947996|NCT02515669|515348953|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
142947997|NCT02515669|515348954|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
142947998|NCT02515669|515348951|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
142947999|NCT02515669|515348952|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
142948000|NCT02515669|515348953|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
142948001|NCT02515669|515348954|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
142948002|NCT02515669|515348951|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
142948003|NCT02515669|515348952|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
142948004|NCT02515669|515348953|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
142948005|NCT02515669|515348954|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
142948006|NCT02515669|515348951|FG000|228 Week Open-Label Phase|Missing|0|||
142948007|NCT02515669|515348952|FG001|228 Week Open-Label Phase|Missing|2|||
142948008|NCT02515669|515348953|FG002|228 Week Open-Label Phase|Missing|2|||
142948009|NCT02515669|515348954|FG003|228 Week Open-Label Phase|Missing|2|||
142948010|NCT01901328|515348958|FG000|Overall Study|Lost to Follow-up|1|||
142948011|NCT01901328|515348959|FG001|Overall Study|Lost to Follow-up|0|||
142948012|NCT01901328|515348958|FG000|Overall Study|Physician Decision|0|||
142948013|NCT01901328|515348959|FG001|Overall Study|Physician Decision|1|||
142948014|NCT01901328|515348958|FG000|Overall Study|Protocol Violation|1|||
142948015|NCT01901328|515348959|FG001|Overall Study|Protocol Violation|1|||
142948016|NCT01901328|515348958|FG000|Overall Study|Study Terminated by Sponsor|19|||
142948017|NCT01901328|515348959|FG001|Overall Study|Study Terminated by Sponsor|16|||
142948018|NCT01901328|515348958|FG000|Overall Study|Withdrawal by Subject|1|||
142948019|NCT01901328|515348959|FG001|Overall Study|Withdrawal by Subject|2|||
142948020|NCT01901328|515348958|FG000|Overall Study|Lack of Efficacy|0|||
142948021|NCT01901328|515348959|FG001|Overall Study|Lack of Efficacy|1|||
142948022|NCT03395210|515350161|FG000|Overall Study|Other|0|||
142948023|NCT03395210|515350162|FG001|Overall Study|Other|0|||
142948024|NCT03395210|515350163|FG002|Overall Study|Other|0|||
142948025|NCT03395210|515350164|FG003|Overall Study|Other|0|||
142948026|NCT03395210|515350165|FG004|Overall Study|Other|1|||
142948027|NCT03395210|515350161|FG000|Overall Study|Participant Uncooperative or Noncompliant|0|||
142948028|NCT03395210|515350162|FG001|Overall Study|Participant Uncooperative or Noncompliant|0|||
142948029|NCT03395210|515350163|FG002|Overall Study|Participant Uncooperative or Noncompliant|0|||
142948030|NCT03395210|515350164|FG003|Overall Study|Participant Uncooperative or Noncompliant|0|||
142948031|NCT03395210|515350165|FG004|Overall Study|Participant Uncooperative or Noncompliant|1|||
142948032|NCT03395210|515350161|FG000|Overall Study|Adverse Event|1|||
142948033|NCT03395210|515350162|FG001|Overall Study|Adverse Event|0|||
142948034|NCT03395210|515350163|FG002|Overall Study|Adverse Event|2|||
142948035|NCT03395210|515350164|FG003|Overall Study|Adverse Event|4|||
142948036|NCT03395210|515350165|FG004|Overall Study|Adverse Event|3|||
142948037|NCT03395210|515350161|FG000|Overall Study|Need of Rescue Medication|1|||
142948038|NCT03395210|515350162|FG001|Overall Study|Need of Rescue Medication|0|||
142948039|NCT03395210|515350163|FG002|Overall Study|Need of Rescue Medication|1|||
142948040|NCT03395210|515350164|FG003|Overall Study|Need of Rescue Medication|4|||
142948041|NCT03395210|515350165|FG004|Overall Study|Need of Rescue Medication|0|||
142948042|NCT03395210|515350161|FG000|Overall Study|Lack of Response|0|||
142948043|NCT03395210|515350162|FG001|Overall Study|Lack of Response|0|||
142948044|NCT03395210|515350163|FG002|Overall Study|Lack of Response|0|||
142948045|NCT03395210|515350164|FG003|Overall Study|Lack of Response|5|||
142948046|NCT03395210|515350165|FG004|Overall Study|Lack of Response|5|||
142948047|NCT03395210|515350161|FG000|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
142948048|NCT03395210|515350162|FG001|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
142948049|NCT03395210|515350163|FG002|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
142948050|NCT03395210|515350164|FG003|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
142948051|NCT03395210|515350165|FG004|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
142948052|NCT03395210|515350161|FG000|Overall Study|Participant Decision|1|||
142948053|NCT03395210|515350162|FG001|Overall Study|Participant Decision|1|||
142948054|NCT03395210|515350163|FG002|Overall Study|Participant Decision|0|||
142948055|NCT03395210|515350164|FG003|Overall Study|Participant Decision|4|||
142948056|NCT03395210|515350165|FG004|Overall Study|Participant Decision|0|||
142948057|NCT03395210|515350161|FG000|Overall Study|Ongoing at the Time of Primary Completion Date|1|||
142948058|NCT03395210|515350162|FG001|Overall Study|Ongoing at the Time of Primary Completion Date|0|||
142948059|NCT03395210|515350163|FG002|Overall Study|Ongoing at the Time of Primary Completion Date|2|||
142948060|NCT03395210|515350164|FG003|Overall Study|Ongoing at the Time of Primary Completion Date|13|||
143455059|NCT02663518|517210762|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
142948061|NCT03395210|515350165|FG004|Overall Study|Ongoing at the Time of Primary Completion Date|11|||
142948062|NCT01843374|515350166|FG000|Overall Study|Death|155|||
142948063|NCT01843374|515350167|FG001|Overall Study|Death|313|||
142948064|NCT01843374|515350166|FG000|Overall Study|Withdrawal by Subject|14|||
142948065|NCT01843374|515350167|FG001|Overall Study|Withdrawal by Subject|20|||
142948066|NCT01843374|515350166|FG000|Overall Study|Withdrawing due to Other reason|20|||
142948067|NCT01843374|515350167|FG001|Overall Study|Withdrawing due to Other reason|46|||
142948068|NCT02517515|515350168|FG000|Overall Study|Adverse Event|0|||
142948069|NCT02517515|515350169|FG001|Overall Study|Adverse Event|1|||
142948070|NCT02517515|515350168|FG000|Overall Study|Withdrew Consent|0|||
142948071|NCT02517515|515350169|FG001|Overall Study|Withdrew Consent|1|||
142948072|NCT02517515|515350168|FG000|Overall Study|Lost to Follow-up|1|||
142948073|NCT02517515|515350169|FG001|Overall Study|Lost to Follow-up|0|||
142948074|NCT02517515|515350168|FG000|Overall Study|Other|1|||
142948075|NCT02517515|515350169|FG001|Overall Study|Other|0|||
142948076|NCT02638012|515350170|FG000|Overall Study|Lost to Follow-up|1|||
142948077|NCT03199911|515350174|FG000|Overall Study|Lost to Follow-up|5|||
142948078|NCT03199911|515350175|FG001|Overall Study|Lost to Follow-up|5|||
142948079|NCT03199911|515350174|FG000|Overall Study|Did not proceed with surgery|2|||
142948080|NCT03199911|515350175|FG001|Overall Study|Did not proceed with surgery|1|||
142948081|NCT02874794|515350180|FG000|Overall Study|Physician Decision|3|||
142948082|NCT02874794|515350181|FG001|Overall Study|Physician Decision|2|||
142948083|NCT02874794|515350180|FG000|Overall Study|Withdrawal by Subject|2|||
142948084|NCT02874794|515350181|FG001|Overall Study|Withdrawal by Subject|8|||
142948085|NCT02874794|515350180|FG000|Overall Study|Death|2|||
142948086|NCT02874794|515350181|FG001|Overall Study|Death|1|||
142948087|NCT01451515|515350207|FG000|Overall Study|Death|0|||
142948088|NCT01451515|515350208|FG001|Overall Study|Death|1|||
142948089|NCT01451515|515350209|FG002|Overall Study|Death|0|||
142948090|NCT01451515|515350207|FG000|Overall Study|Withdrawal by Subject|0|||
142948091|NCT01451515|515350208|FG001|Overall Study|Withdrawal by Subject|1|||
142948092|NCT01451515|515350209|FG002|Overall Study|Withdrawal by Subject|0|||
142948093|NCT01451515|515350207|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
142948094|NCT01451515|515350208|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
142948095|NCT01451515|515350209|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
142948096|NCT01451515|515350207|FG000|Overall Study|Relapse (except CNS)|1|||
142948097|NCT01451515|515350208|FG001|Overall Study|Relapse (except CNS)|1|||
142948098|NCT01451515|515350209|FG002|Overall Study|Relapse (except CNS)|0|||
142948099|NCT03427073|515350210|FG000|Overall Study|Disease Progression|1|||
142948100|NCT03427073|515350211|FG001|Overall Study|Disease Progression|1|||
142948101|NCT03427073|515350212|FG002|Overall Study|Disease Progression|1|||
142948102|NCT03427073|515350213|FG003|Overall Study|Disease Progression|3|||
142948103|NCT03427073|515350214|FG004|Overall Study|Disease Progression|3|||
142948104|NCT03427073|515350215|FG005|Overall Study|Disease Progression|4|||
142948105|NCT03427073|515350216|FG006|Overall Study|Disease Progression|2|||
142948106|NCT03427073|515350217|FG007|Overall Study|Disease Progression|3|||
142948107|NCT03427073|515350210|FG000|Overall Study|Physician Decision|0|||
142948108|NCT03427073|515350211|FG001|Overall Study|Physician Decision|0|||
142948109|NCT03427073|515350212|FG002|Overall Study|Physician Decision|0|||
142948110|NCT03427073|515350213|FG003|Overall Study|Physician Decision|0|||
142948111|NCT03427073|515350214|FG004|Overall Study|Physician Decision|0|||
142948112|NCT03427073|515350215|FG005|Overall Study|Physician Decision|0|||
142948113|NCT03427073|515350216|FG006|Overall Study|Physician Decision|1|||
142948114|NCT03427073|515350217|FG007|Overall Study|Physician Decision|1|||
142948115|NCT00095303|515350227|FG000|Main Study|Lost to Follow-up|91|||
142948116|NCT00095303|515350228|FG001|Main Study|Lost to Follow-up|87|||
142948117|NCT00095303|515350227|FG000|Follow Up Study|Lost to Follow-up|59|||
142948118|NCT00095303|515350228|FG001|Follow Up Study|Lost to Follow-up|58|||
142948119|NCT03228186|515350231|FG000|Overall Study|Patient never started treatment|1|||
142948120|NCT01634243|515350232|FG000|Overall Study|Adverse Event|5|||
142948121|NCT01634243|515350233|FG001|Overall Study|Adverse Event|5|||
142948122|NCT01634243|515350232|FG000|Overall Study|Lack of Efficacy|1|||
142948123|NCT01634243|515350233|FG001|Overall Study|Lack of Efficacy|0|||
142948124|NCT04246047|515350236|FG000|Overall Study|Death|50|||
142948125|NCT04246047|515350237|FG001|Overall Study|Death|77|||
142948126|NCT04246047|515350236|FG000|Overall Study|Lost to Follow-up|1|||
142948127|NCT04246047|515350237|FG001|Overall Study|Lost to Follow-up|3|||
142948128|NCT04246047|515350236|FG000|Overall Study|Physician Decision|4|||
142948129|NCT04246047|515350237|FG001|Overall Study|Physician Decision|10|||
142948130|NCT04246047|515350236|FG000|Overall Study|Withdrawal by Subject|19|||
142948131|NCT04246047|515350237|FG001|Overall Study|Withdrawal by Subject|26|||
142948132|NCT04246047|515350236|FG000|Overall Study|Ongoing|169|||
142948133|NCT04246047|515350237|FG001|Overall Study|Ongoing|135|||
142948134|NCT02485717|515350242|FG000|Overall Study|Lost to Follow-up|6|||
142948135|NCT02485717|515350243|FG001|Overall Study|Lost to Follow-up|0|||
142948136|NCT02485717|515350244|FG002|Overall Study|Lost to Follow-up|0|||
142948137|NCT02485717|515350242|FG000|Overall Study|Withdrawal by Subject|0|||
142948138|NCT02485717|515350243|FG001|Overall Study|Withdrawal by Subject|0|||
142948139|NCT02485717|515350244|FG002|Overall Study|Withdrawal by Subject|1|||
142948140|NCT02485717|515350242|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
142948141|NCT02485717|515350243|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
142948142|NCT02485717|515350244|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
142948143|NCT02485717|515350242|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
142948144|NCT02485717|515350243|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
142948145|NCT02485717|515350244|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
142948146|NCT00828451|515350247|FG000|Overall Study|Death|2|||
142948147|NCT00828451|515350247|FG000|Overall Study|Lack of intravenous line|7|||
142948148|NCT00828451|515350247|FG000|Overall Study|Withdrawal by Subject|1|||
142948149|NCT00828451|515350247|FG000|Overall Study|Deterioration in clinical status|1|||
142948150|NCT00667277|515350250|FG000|Overall Study|Withdrawal by Subject|2|||
142948151|NCT00519532|515350251|FG000|Overall Study|Adverse Event|11|||
142948152|NCT00519532|515350251|FG000|Overall Study|Withdrawal by Subject|5|||
142948153|NCT00519532|515350251|FG000|Overall Study|Lost to Follow-up|2|||
142948154|NCT00814710|515350254|FG000|Overall Study|Adverse Event|1|||
142948155|NCT00814710|515350255|FG001|Overall Study|Adverse Event|0|||
142948156|NCT00814710|515350254|FG000|Overall Study|Lost to Follow-up|7|||
142948157|NCT00814710|515350255|FG001|Overall Study|Lost to Follow-up|3|||
142948158|NCT03885284|515350257|FG000|Overall Study|Disease Progression|1|||
142948159|NCT03885284|515350258|FG001|Overall Study|Disease Progression|3|||
142948160|NCT03885284|515350257|FG000|Overall Study|Physician Decision|0|||
142948161|NCT03885284|515350258|FG001|Overall Study|Physician Decision|1|||
142948162|NCT01450540|515350263|FG000|Overall Study|Withdrawal by Subject|19|||
142948163|NCT01450540|515350264|FG001|Overall Study|Withdrawal by Subject|13|||
142948164|NCT01450540|515350263|FG000|Overall Study|protocol deviation|3|||
142948165|NCT01450540|515350264|FG001|Overall Study|protocol deviation|23|||
142948166|NCT01687673|515350270|FG000|Overall Study|Physician Decision|1|||
142948167|NCT03478683|515350272|FG000|Overall Study|Adverse Event|5|||
142948168|NCT03478683|515350273|FG001|Overall Study|Adverse Event|3|||
142948169|NCT03478683|515350272|FG000|Overall Study|Lost to Follow-up|0|||
142948170|NCT03478683|515350273|FG001|Overall Study|Lost to Follow-up|5|||
142948171|NCT03478683|515350272|FG000|Overall Study|Physician Decision|1|||
142948172|NCT03478683|515350273|FG001|Overall Study|Physician Decision|3|||
142948173|NCT03478683|515350272|FG000|Overall Study|Withdrawal by Subject|7|||
142948174|NCT03478683|515350273|FG001|Overall Study|Withdrawal by Subject|7|||
142948175|NCT01650805|515350274|FG000|Overall Study|Withdrawal by Subject|1|||
142948176|NCT01650805|515350275|FG001|Overall Study|Withdrawal by Subject|0|||
142948177|NCT00840463|515350278|FG000|Overall Study|Adverse Event|1|||
142948178|NCT00840463|515350279|FG001|Overall Study|Adverse Event|0|||
142948179|NCT02452359|515350280|FG000|Overall Study|Adverse Event|1|||
142948180|NCT02452359|515350280|FG000|Overall Study|Lost to Follow-up|15|||
142948181|NCT02452359|515350280|FG000|Overall Study|Pregnancy|1|||
142948182|NCT02452359|515350280|FG000|Overall Study|Withdrawal by Subject|4|||
142948183|NCT01887210|515350281|FG000|Overall Study|Withdrawal by Subject|1|||
142948184|NCT01887210|515350282|FG001|Overall Study|Withdrawal by Subject|3|||
142948185|NCT01887210|515350281|FG000|Overall Study|Lost to Follow-up|0|||
142948186|NCT01887210|515350282|FG001|Overall Study|Lost to Follow-up|1|||
142948187|NCT03750838|515350285|FG000|Overall Study|Lost to Follow-up|10|||
142948188|NCT03750838|515350286|FG001|Overall Study|Lost to Follow-up|6|||
142948189|NCT00630032|515350287|FG000|Overall Study|Death|55|||
142948190|NCT00630032|515350288|FG001|Overall Study|Death|49|||
142948191|NCT00630032|515350287|FG000|Overall Study|Withdrawal by Subject|3|||
142948192|NCT00630032|515350288|FG001|Overall Study|Withdrawal by Subject|2|||
142948193|NCT00630032|515350287|FG000|Overall Study|Lost to Follow-up|18|||
142948194|NCT00630032|515350288|FG001|Overall Study|Lost to Follow-up|31|||
142948195|NCT00630032|515350287|FG000|Overall Study|Protocol Violation|1|||
142948196|NCT00630032|515350288|FG001|Overall Study|Protocol Violation|0|||
142948197|NCT00630032|515350287|FG000|Overall Study|Patient has moved|1|||
142948198|NCT00630032|515350288|FG001|Overall Study|Patient has moved|1|||
142948199|NCT00630032|515350287|FG000|Overall Study|Disease progression|1|||
142948200|NCT00630032|515350288|FG001|Overall Study|Disease progression|1|||
142948201|NCT00630032|515350287|FG000|Overall Study|End of monitoring in US centers|11|||
142948202|NCT00630032|515350288|FG001|Overall Study|End of monitoring in US centers|11|||
142948203|NCT02332915|515350289|FG000|Overall Study|Moved out of region|3|||
142948204|NCT02332915|515350290|FG001|Overall Study|Moved out of region|0|||
142948205|NCT02332915|515350289|FG000|Overall Study|Unrelated illness|1|||
142948206|NCT02332915|515350290|FG001|Overall Study|Unrelated illness|1|||
142948207|NCT02332915|515350289|FG000|Overall Study|Travel distance prohibitive|0|||
142948208|NCT02332915|515350290|FG001|Overall Study|Travel distance prohibitive|1|||
142948209|NCT02332915|515350289|FG000|Overall Study|did not meet inclusion criteria|2|||
142948210|NCT02332915|515350290|FG001|Overall Study|did not meet inclusion criteria|4|||
142948211|NCT05847881|515350294|FG000|Overall Study|Principal Investigator Decision|8|||
142948212|NCT05847881|515350294|FG000|Overall Study|Withdrawal by Subject|2|||
142948213|NCT05781542|515351975|FG000|Overall Study|Lost to Follow-up|1|||
142948214|NCT05781542|515351976|FG001|Overall Study|Lost to Follow-up|0|||
142948215|NCT05781542|515351977|FG002|Overall Study|Lost to Follow-up|1|||
142948216|NCT05405166|515351978|FG000|Overall Study|Death|49|||
142948217|NCT05405166|515351979|FG001|Overall Study|Death|50|||
142948218|NCT05405166|515351978|FG000|Overall Study|Withdrawal by Subject|10|||
142948219|NCT05405166|515351979|FG001|Overall Study|Withdrawal by Subject|3|||
142948220|NCT05405166|515351978|FG000|Overall Study|Ongoing at the time of PCD|209|||
142948221|NCT05405166|515351979|FG001|Overall Study|Ongoing at the time of PCD|210|||
142948222|NCT01386385|515351982|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
142948223|NCT01386385|515351983|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
142948224|NCT01386385|515351984|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
142948225|NCT01386385|515351985|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
142948226|NCT01386385|515351986|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
142948227|NCT01386385|515351987|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
142948228|NCT01386385|515351988|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
142948229|NCT01386385|515351989|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
142948230|NCT01386385|515351982|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
142948231|NCT01386385|515351983|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
142948232|NCT01386385|515351984|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
142948233|NCT01386385|515351985|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
142948234|NCT01386385|515351986|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
142948235|NCT01386385|515351987|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
142948236|NCT01386385|515351988|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
142948237|NCT01386385|515351989|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
142948238|NCT01386385|515351982|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
142948239|NCT01386385|515351983|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
142948240|NCT01386385|515351984|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
142948241|NCT01386385|515351985|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
142948242|NCT01386385|515351986|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
142948243|NCT01386385|515351987|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
142948244|NCT01386385|515351988|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
142948245|NCT01386385|515351989|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
142948246|NCT01386385|515351982|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
142948247|NCT01386385|515351983|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
142948248|NCT01386385|515351984|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
142948249|NCT01386385|515351985|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
142948250|NCT01386385|515351986|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
142948251|NCT01386385|515351987|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
142948252|NCT01386385|515351988|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
142948253|NCT01386385|515351989|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
142948254|NCT01386385|515351982|FG000|Phase II Concurrent CRT|Adverse Event|0|||
142948255|NCT01386385|515351983|FG001|Phase II Concurrent CRT|Adverse Event|0|||
142948256|NCT01386385|515351984|FG002|Phase II Concurrent CRT|Adverse Event|0|||
142948257|NCT01386385|515351985|FG003|Phase II Concurrent CRT|Adverse Event|0|||
142948258|NCT01386385|515351986|FG004|Phase II Concurrent CRT|Adverse Event|0|||
142948259|NCT01386385|515351987|FG005|Phase II Concurrent CRT|Adverse Event|0|||
142948260|NCT01386385|515351988|FG006|Phase II Concurrent CRT|Adverse Event|3|||
142948261|NCT01386385|515351989|FG007|Phase II Concurrent CRT|Adverse Event|3|||
142948262|NCT01386385|515351982|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
142948263|NCT01386385|515351983|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
142948264|NCT01386385|515351984|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
142948265|NCT01386385|515351985|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
142948266|NCT01386385|515351986|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
142948267|NCT01386385|515351987|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
142948268|NCT01386385|515351988|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
142948269|NCT01386385|515351989|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
142948270|NCT01386385|515351982|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
142948271|NCT01386385|515351983|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
142948272|NCT01386385|515351984|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
142948273|NCT01386385|515351985|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
142948274|NCT01386385|515351986|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
142948275|NCT01386385|515351987|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
142948276|NCT01386385|515351988|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
142948277|NCT01386385|515351989|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
142948278|NCT01386385|515351982|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
142948279|NCT01386385|515351983|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
142948280|NCT01386385|515351984|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
142948281|NCT01386385|515351985|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
142948282|NCT01386385|515351986|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
143455060|NCT02663518|517210763|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
142948283|NCT01386385|515351987|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
142948284|NCT01386385|515351988|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
142948285|NCT01386385|515351989|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
142948286|NCT01386385|515351982|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
142948287|NCT01386385|515351983|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
142948288|NCT01386385|515351984|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
142948289|NCT01386385|515351985|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
142948290|NCT01386385|515351986|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
142948291|NCT01386385|515351987|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
142948292|NCT01386385|515351988|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
142948293|NCT01386385|515351989|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
142948294|NCT03746080|515351990|FG000|Overall Study|In follow up|2|||
142948295|NCT03746080|515351990|FG000|Overall Study|Death|15|||
142948296|NCT05738486|515351991|FG000|Overall Study|Continuing Study|194|||
142948297|NCT05738486|515351992|FG001|Overall Study|Continuing Study|196|||
142948298|NCT05738486|515351993|FG002|Overall Study|Continuing Study|193|||
142948299|NCT05738486|515351994|FG003|Overall Study|Continuing Study|191|||
142948300|NCT05738486|515351991|FG000|Overall Study|Withdrawal by Subject|8|||
142948301|NCT05738486|515351992|FG001|Overall Study|Withdrawal by Subject|5|||
142948302|NCT05738486|515351993|FG002|Overall Study|Withdrawal by Subject|7|||
142948303|NCT05738486|515351994|FG003|Overall Study|Withdrawal by Subject|13|||
142948304|NCT05738486|515351991|FG000|Overall Study|Adverse Event|4|||
142948305|NCT05738486|515351992|FG001|Overall Study|Adverse Event|6|||
142948306|NCT05738486|515351993|FG002|Overall Study|Adverse Event|4|||
142948307|NCT05738486|515351994|FG003|Overall Study|Adverse Event|5|||
142948308|NCT05738486|515351991|FG000|Overall Study|Physician Decision|0|||
142948309|NCT05738486|515351992|FG001|Overall Study|Physician Decision|2|||
142948310|NCT05738486|515351993|FG002|Overall Study|Physician Decision|4|||
142948311|NCT05738486|515351994|FG003|Overall Study|Physician Decision|1|||
142948312|NCT05738486|515351991|FG000|Overall Study|Lost to Follow-up|1|||
142948313|NCT05738486|515351992|FG001|Overall Study|Lost to Follow-up|1|||
142948314|NCT05738486|515351993|FG002|Overall Study|Lost to Follow-up|2|||
142948315|NCT05738486|515351994|FG003|Overall Study|Lost to Follow-up|1|||
142948316|NCT05738486|515351991|FG000|Overall Study|Participant was Non-ambulatory|0|||
142948317|NCT05738486|515351992|FG001|Overall Study|Participant was Non-ambulatory|0|||
142948318|NCT05738486|515351993|FG002|Overall Study|Participant was Non-ambulatory|1|||
142948319|NCT05738486|515351994|FG003|Overall Study|Participant was Non-ambulatory|0|||
142948320|NCT05738486|515351991|FG000|Overall Study|Participant had Poor Venous Access|0|||
142948321|NCT05738486|515351992|FG001|Overall Study|Participant had Poor Venous Access|0|||
142948322|NCT05738486|515351993|FG002|Overall Study|Participant had Poor Venous Access|0|||
142948323|NCT05738486|515351994|FG003|Overall Study|Participant had Poor Venous Access|1|||
142948324|NCT05738486|515351991|FG000|Overall Study|Assigned Treatment by Mistake|0|||
142948325|NCT05738486|515351992|FG001|Overall Study|Assigned Treatment by Mistake|0|||
142948326|NCT05738486|515351993|FG002|Overall Study|Assigned Treatment by Mistake|0|||
142948327|NCT05738486|515351994|FG003|Overall Study|Assigned Treatment by Mistake|1|||
142948328|NCT05738486|515351991|FG000|Overall Study|Death|0|||
142948329|NCT05738486|515351992|FG001|Overall Study|Death|0|||
142948330|NCT05738486|515351993|FG002|Overall Study|Death|1|||
142948331|NCT05738486|515351994|FG003|Overall Study|Death|0|||
142948332|NCT05738486|515351991|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|1|||
142948333|NCT05738486|515351992|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
142948334|NCT05738486|515351993|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
142948335|NCT05738486|515351994|FG003|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
142948336|NCT04364854|515351995|FG000|Overall Study|Withdrawal by Subject|1|||
142948337|NCT04364854|515351996|FG001|Overall Study|Withdrawal by Subject|0|||
142948338|NCT04364854|515351997|FG002|Overall Study|Withdrawal by Subject|1|||
142948339|NCT04364854|515351998|FG003|Overall Study|Withdrawal by Subject|3|||
142948340|NCT04364854|515351995|FG000|Overall Study|Death|1|||
142948341|NCT04364854|515351996|FG001|Overall Study|Death|0|||
142948342|NCT04364854|515351997|FG002|Overall Study|Death|0|||
142948343|NCT04364854|515351998|FG003|Overall Study|Death|0|||
142948344|NCT04364854|515351995|FG000|Overall Study|Lost to Follow-up|0|||
142948345|NCT04364854|515351996|FG001|Overall Study|Lost to Follow-up|0|||
142948346|NCT04364854|515351997|FG002|Overall Study|Lost to Follow-up|0|||
142948347|NCT04364854|515351998|FG003|Overall Study|Lost to Follow-up|1|||
142948348|NCT03704051|515351999|FG000|Overall Study|Withdrawal by Subject|4|||
142948349|NCT03704051|515352000|FG001|Overall Study|Withdrawal by Subject|0|||
142948350|NCT03113500|515352001|FG000|Overall Study|Withdrawal by Subject|1|||
142948351|NCT06400238|515352006|FG000|Overall Study|Started Protocol Therapy|2|||
143455061|NCT02663518|517210764|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
142948352|NCT06400238|515352006|FG000|Overall Study|Adverse Event|1|||
142948353|NCT06400238|515352006|FG000|Overall Study|Death|1|||
142948354|NCT06400238|515352006|FG000|Overall Study|Disease Progression|27|||
142948355|NCT06400238|515352006|FG000|Overall Study|Withdrawal by Subject|2|||
142948356|NCT06400238|515352006|FG000|Overall Study|Physician Decision|2|||
142948357|NCT01009463|515352009|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
142948358|NCT01009463|515352010|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
142948359|NCT01009463|515352011|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
142948360|NCT01009463|515352012|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
142948361|NCT01009463|515352013|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
142948362|NCT01009463|515352009|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
142948363|NCT01009463|515352010|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
142948364|NCT01009463|515352011|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
142948365|NCT01009463|515352012|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
142948366|NCT01009463|515352013|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
142948367|NCT01009463|515352009|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
142948368|NCT01009463|515352010|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
142948369|NCT01009463|515352011|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
142948370|NCT01009463|515352012|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
142948371|NCT01009463|515352013|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
142948372|NCT01009463|515352009|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
142948373|NCT01009463|515352010|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
142948374|NCT01009463|515352011|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
142948375|NCT01009463|515352012|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
142948376|NCT01009463|515352013|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
142948377|NCT01009463|515352009|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
142948378|NCT01009463|515352010|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
142948379|NCT01009463|515352011|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
142948380|NCT01009463|515352012|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
142948381|NCT01009463|515352013|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
142948382|NCT01009463|515352009|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
142948383|NCT01009463|515352010|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
142948384|NCT01009463|515352011|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
142948385|NCT01009463|515352012|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
142948386|NCT01009463|515352013|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
142948387|NCT01009463|515352009|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
142948388|NCT01009463|515352010|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
142948389|NCT01009463|515352011|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
142948390|NCT01009463|515352012|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
142948391|NCT01009463|515352013|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
142948392|NCT01009463|515352009|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
142948393|NCT01009463|515352010|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
142948394|NCT01009463|515352011|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
142948395|NCT01009463|515352012|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
142948396|NCT01009463|515352013|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
142948397|NCT01009463|515352009|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
142948398|NCT01009463|515352010|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
142948399|NCT01009463|515352011|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
142948400|NCT01009463|515352012|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
142948401|NCT01009463|515352013|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
142948402|NCT01009463|515352009|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
142948403|NCT01009463|515352010|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
142948404|NCT01009463|515352011|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
142948405|NCT01009463|515352012|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
142948406|NCT01009463|515352013|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
142948407|NCT01009463|515352009|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
142948408|NCT01009463|515352010|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
142948409|NCT01009463|515352011|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
142948410|NCT01009463|515352012|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
142948411|NCT01009463|515352013|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
142948412|NCT01009463|515352009|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
142948413|NCT01009463|515352010|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
142948414|NCT01009463|515352011|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
142948415|NCT01009463|515352012|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
142948416|NCT01009463|515352013|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
142948417|NCT01009463|515352009|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
142948418|NCT01009463|515352010|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
142948419|NCT01009463|515352011|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
142948420|NCT01009463|515352012|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
142948421|NCT01009463|515352013|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
142948422|NCT03523585|515352014|FG000|Overall Study|Progressive Disease|174|||
142948423|NCT03523585|515352015|FG001|Overall Study|Progressive Disease|64|||
142948424|NCT03523585|515352016|FG002|Overall Study|Progressive Disease|77|||
142948425|NCT03523585|515352014|FG000|Overall Study|Adverse Event|74|||
142948426|NCT03523585|515352015|FG001|Overall Study|Adverse Event|5|||
142948427|NCT03523585|515352016|FG002|Overall Study|Adverse Event|9|||
142948428|NCT03523585|515352014|FG000|Overall Study|Withdrawal by Subject|30|||
143455062|NCT02663518|517210765|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
143455063|NCT02663518|517210766|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
143455064|NCT02663518|517210767|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
143455065|NCT02663518|517210768|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
143455066|NCT02663518|517210769|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
142948429|NCT03523585|515352015|FG001|Overall Study|Withdrawal by Subject|11|||
142948430|NCT03523585|515352016|FG002|Overall Study|Withdrawal by Subject|6|||
142948431|NCT03523585|515352014|FG000|Overall Study|Clinical Progression|23|||
142948432|NCT03523585|515352015|FG001|Overall Study|Clinical Progression|5|||
142948433|NCT03523585|515352016|FG002|Overall Study|Clinical Progression|10|||
142948434|NCT03523585|515352014|FG000|Overall Study|Death|4|||
142948435|NCT03523585|515352015|FG001|Overall Study|Death|0|||
142948436|NCT03523585|515352016|FG002|Overall Study|Death|1|||
142948437|NCT03523585|515352014|FG000|Overall Study|Physician Decision|2|||
142948438|NCT03523585|515352015|FG001|Overall Study|Physician Decision|1|||
142948439|NCT03523585|515352016|FG002|Overall Study|Physician Decision|0|||
142948440|NCT03523585|515352014|FG000|Overall Study|Lost to Follow-up|1|||
142948441|NCT03523585|515352015|FG001|Overall Study|Lost to Follow-up|0|||
142948442|NCT03523585|515352016|FG002|Overall Study|Lost to Follow-up|0|||
142948443|NCT03523585|515352014|FG000|Overall Study|Miscellaneous|1|||
142948444|NCT03523585|515352015|FG001|Overall Study|Miscellaneous|0|||
142948445|NCT03523585|515352016|FG002|Overall Study|Miscellaneous|0|||
142948446|NCT03523585|515352014|FG000|Overall Study|Protocol Deviation|1|||
142948447|NCT03523585|515352015|FG001|Overall Study|Protocol Deviation|0|||
142948448|NCT03523585|515352016|FG002|Overall Study|Protocol Deviation|1|||
142948449|NCT03523585|515352014|FG000|Overall Study|Randomized But Not Treated|2|||
142948450|NCT03523585|515352015|FG001|Overall Study|Randomized But Not Treated|4|||
142948451|NCT03523585|515352016|FG002|Overall Study|Randomized But Not Treated|3|||
142948452|NCT04328623|515352017|FG000|Overall Study|Protocol Violation|0|||
142948453|NCT04328623|515352018|FG001|Overall Study|Protocol Violation|1|||
142948454|NCT01473004|515352019|FG000|Overall Study|Incomplete Lobar Treatment|1|||
142948455|NCT01473004|515352020|FG001|Overall Study|Incomplete Lobar Treatment|0|||
142948456|NCT03839524|515352022|FG000|Overall Study|Adverse Event|1|||
142948457|NCT05309668|515352024|FG000|Overall Study|Ongoing at data cut-off|14|||
142948458|NCT05309668|515352025|FG001|Overall Study|Ongoing at data cut-off|17|||
142948459|NCT05309668|515352026|FG002|Overall Study|Ongoing at data cut-off|4|||
142948460|NCT03715465|515352027|FG000|Overall Study|Withdrawal by Subject|1|||
142948461|NCT03715465|515352028|FG001|Overall Study|Withdrawal by Subject|2|||
142948462|NCT01062399|515352029|FG000|Overall Study|Protocol Violation|0|||
142948463|NCT01062399|515352030|FG001|Overall Study|Protocol Violation|1|||
142948464|NCT01062399|515352031|FG002|Overall Study|Protocol Violation|0|||
142948465|NCT01062399|515352032|FG003|Overall Study|Protocol Violation|6|||
142948466|NCT01062399|515352033|FG004|Overall Study|Protocol Violation|4|||
142948467|NCT02465034|515352054|FG000|Overall Study|Withdrawal by Subject|1|||
142948468|NCT02465034|515352055|FG001|Overall Study|Withdrawal by Subject|1|||
142948469|NCT02465034|515352054|FG000|Overall Study|Screen fail|2|||
142948470|NCT02465034|515352055|FG001|Overall Study|Screen fail|0|||
142948471|NCT02465034|515352054|FG000|Overall Study|Could not be scheduled for study visit|0|||
142948472|NCT02465034|515352055|FG001|Overall Study|Could not be scheduled for study visit|5|||
142948473|NCT01134614|515352057|FG000|Overall Study|Still on treatment as of March 2013|21|||
142948474|NCT01134614|515352058|FG001|Overall Study|Still on treatment as of March 2013|13|||
142948475|NCT01134614|515352057|FG000|Overall Study|Progressive disease|60|||
142948476|NCT01134614|515352058|FG001|Overall Study|Progressive disease|54|||
142948477|NCT01134614|515352057|FG000|Overall Study|Adverse Event|26|||
142948478|NCT01134614|515352058|FG001|Overall Study|Adverse Event|39|||
142948479|NCT01134614|515352057|FG000|Overall Study|Death|5|||
142948480|NCT01134614|515352058|FG001|Overall Study|Death|8|||
142948481|NCT01134614|515352057|FG000|Overall Study|Withdrawal by Subject|3|||
142948482|NCT01134614|515352058|FG001|Overall Study|Withdrawal by Subject|2|||
142948483|NCT01134614|515352057|FG000|Overall Study|Alternative therapy|2|||
142948484|NCT01134614|515352058|FG001|Overall Study|Alternative therapy|0|||
142948485|NCT01134614|515352057|FG000|Overall Study|Complicating disease|2|||
142948486|NCT01134614|515352058|FG001|Overall Study|Complicating disease|1|||
142948487|NCT01134614|515352057|FG000|Overall Study|Physician's decision|0|||
142948488|NCT01134614|515352058|FG001|Overall Study|Physician's decision|1|||
142948489|NCT01134614|515352057|FG000|Overall Study|Never started treatment|4|||
143117119|NCT02565706|515970034|FG000|Overall Study|Lost to Follow-up|72|||
142948490|NCT01134614|515352058|FG001|Overall Study|Never started treatment|1|||
142948491|NCT01134614|515352057|FG000|Overall Study|Pt received tx not allowed on study|0|||
142948492|NCT01134614|515352058|FG001|Overall Study|Pt received tx not allowed on study|1|||
143117120|NCT02565706|515970035|FG001|Overall Study|Lost to Follow-up|75|||
142948493|NCT01134614|515352057|FG000|Overall Study|Symptomatic deterioration|0|||
142948494|NCT01134614|515352058|FG001|Overall Study|Symptomatic deterioration|1|||
142948495|NCT01134614|515352057|FG000|Overall Study|Patient in hospice care|0|||
142948496|NCT01134614|515352058|FG001|Overall Study|Patient in hospice care|1|||
142948497|NCT04329949|515352064|FG000|Overall Study|Death|36|||
142948498|NCT04329949|515352064|FG000|Overall Study|Withdrawal by Subject|4|||
142948499|NCT04329949|515352064|FG000|Overall Study|Termination of study by sponsor|3|||
142948500|NCT03717922|515352067|FG000|Overall Study|Lost to Follow-up|2|||
142948501|NCT03717922|515352068|FG001|Overall Study|Lost to Follow-up|2|||
142948502|NCT01458340|515352069|FG000|Overall Study|Adverse Event|5|||
142948503|NCT01458340|515352070|FG001|Overall Study|Adverse Event|4|||
142948504|NCT01458340|515352071|FG002|Overall Study|Adverse Event|2|||
142948505|NCT01458340|515352069|FG000|Overall Study|Lost to Follow-up|3|||
142948506|NCT01458340|515352070|FG001|Overall Study|Lost to Follow-up|3|||
142948507|NCT01458340|515352071|FG002|Overall Study|Lost to Follow-up|10|||
142948508|NCT01458340|515352069|FG000|Overall Study|Miscellaneous|0|||
142948509|NCT01458340|515352070|FG001|Overall Study|Miscellaneous|1|||
142948510|NCT01458340|515352071|FG002|Overall Study|Miscellaneous|0|||
142948511|NCT01458340|515352069|FG000|Overall Study|Physician Decision|1|||
142948512|NCT01458340|515352070|FG001|Overall Study|Physician Decision|1|||
142948513|NCT01458340|515352071|FG002|Overall Study|Physician Decision|2|||
142948514|NCT01458340|515352069|FG000|Overall Study|Protocol Violation|6|||
142948515|NCT01458340|515352070|FG001|Overall Study|Protocol Violation|6|||
142948516|NCT01458340|515352071|FG002|Overall Study|Protocol Violation|5|||
142948517|NCT01458340|515352069|FG000|Overall Study|Withdrawal by Subject|12|||
142948518|NCT01458340|515352070|FG001|Overall Study|Withdrawal by Subject|6|||
142948519|NCT01458340|515352071|FG002|Overall Study|Withdrawal by Subject|4|||
142948520|NCT05218499|515352078|FG000|Overall Study|Not treated|1|||
142948521|NCT05218499|515352079|FG001|Overall Study|Not treated|1|||
142948522|NCT05218499|515352080|FG002|Overall Study|Not treated|8|||
142948523|NCT05218499|515352078|FG000|Overall Study|Death|2|||
142948524|NCT05218499|515352079|FG001|Overall Study|Death|0|||
142948525|NCT05218499|515352080|FG002|Overall Study|Death|0|||
142948526|NCT05218499|515352078|FG000|Overall Study|Other than listed|3|||
142948527|NCT05218499|515352079|FG001|Overall Study|Other than listed|7|||
142948528|NCT05218499|515352080|FG002|Overall Study|Other than listed|10|||
142948529|NCT05218499|515352078|FG000|Overall Study|Protocol deviation|5|||
142948530|NCT05218499|515352079|FG001|Overall Study|Protocol deviation|6|||
142948531|NCT05218499|515352080|FG002|Overall Study|Protocol deviation|4|||
142948532|NCT05218499|515352078|FG000|Overall Study|Technical problems|0|||
142948533|NCT05218499|515352079|FG001|Overall Study|Technical problems|1|||
142948534|NCT05218499|515352080|FG002|Overall Study|Technical problems|0|||
142948535|NCT05218499|515352078|FG000|Overall Study|Burden of trial procedures|0|||
142948536|NCT05218499|515352079|FG001|Overall Study|Burden of trial procedures|1|||
142948537|NCT05218499|515352080|FG002|Overall Study|Burden of trial procedures|2|||
142948538|NCT05218499|515352078|FG000|Overall Study|Clinical disease progression|6|||
142948539|NCT05218499|515352079|FG001|Overall Study|Clinical disease progression|6|||
142948540|NCT05218499|515352080|FG002|Overall Study|Clinical disease progression|11|||
142948541|NCT05218499|515352078|FG000|Overall Study|Objective disease progression|44|||
142948542|NCT05218499|515352079|FG001|Overall Study|Objective disease progression|61|||
142948543|NCT05218499|515352080|FG002|Overall Study|Objective disease progression|42|||
142948544|NCT05218499|515352078|FG000|Overall Study|Adverse Event|11|||
142948545|NCT05218499|515352079|FG001|Overall Study|Adverse Event|36|||
142948546|NCT05218499|515352080|FG002|Overall Study|Adverse Event|9|||
142948547|NCT05218499|515352078|FG000|Overall Study|On treatment at time of snapshot|18|||
142948548|NCT05218499|515352079|FG001|Overall Study|On treatment at time of snapshot|29|||
142948549|NCT05218499|515352080|FG002|Overall Study|On treatment at time of snapshot|0|||
142948550|NCT01575548|515352081|FG000|Overall Study|Adverse Event|15|||
142948551|NCT01575548|515352082|FG001|Overall Study|Adverse Event|2|||
142948552|NCT01575548|515352081|FG000|Overall Study|Disease progression|12|||
142948553|NCT01575548|515352082|FG001|Overall Study|Disease progression|25|||
142948554|NCT01575548|515352081|FG000|Overall Study|Death|1|||
142948555|NCT01575548|515352082|FG001|Overall Study|Death|0|||
142948556|NCT01575548|515352081|FG000|Overall Study|Other complicating disease|1|||
142948557|NCT01575548|515352082|FG001|Overall Study|Other complicating disease|0|||
142948558|NCT01575548|515352081|FG000|Overall Study|Withdrawal by Subject|7|||
142948559|NCT01575548|515352082|FG001|Overall Study|Withdrawal by Subject|3|||
142948560|NCT01575548|515352081|FG000|Overall Study|Noncompliance|1|||
142948561|NCT01575548|515352082|FG001|Overall Study|Noncompliance|0|||
142948562|NCT01575548|515352081|FG000|Overall Study|Anticipated surgery|0|||
142948563|NCT01575548|515352082|FG001|Overall Study|Anticipated surgery|1|||
142948564|NCT01575548|515352081|FG000|Overall Study|Never started protocol therapy|3|||
142948565|NCT01575548|515352082|FG001|Overall Study|Never started protocol therapy|2|||
142948566|NCT01702805|515352089|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
142948567|NCT01702805|515352090|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
142948568|NCT01702805|515352089|FG000|Overall Study|Incomplete Follow-up|18|||
142948569|NCT01702805|515352090|FG001|Overall Study|Incomplete Follow-up|15|||
142948570|NCT01702805|515352089|FG000|Overall Study|Vital Status Assessment Only|40|||
142948571|NCT01702805|515352090|FG001|Overall Study|Vital Status Assessment Only|39|||
142948572|NCT01702805|515352089|FG000|Overall Study|Lost to Follow-up|5|||
142948573|NCT01702805|515352090|FG001|Overall Study|Lost to Follow-up|5|||
142948574|NCT04876391|515352096|FG000|Overall Study|Withdrawal by Subject|1|||
142948575|NCT04876391|515352097|FG001|Overall Study|Withdrawal by Subject|10|||
142948576|NCT04876391|515352096|FG000|Overall Study|Lost to Follow-up|2|||
142948577|NCT04876391|515352097|FG001|Overall Study|Lost to Follow-up|4|||
142948578|NCT04876391|515352096|FG000|Overall Study|Lack of Efficacy|0|||
142948579|NCT04876391|515352097|FG001|Overall Study|Lack of Efficacy|2|||
142948580|NCT04876391|515352096|FG000|Overall Study|Adverse Event|3|||
142948581|NCT04876391|515352097|FG001|Overall Study|Adverse Event|1|||
142948582|NCT04876391|515352096|FG000|Overall Study|Patient non-compliance|0|||
142948583|NCT04876391|515352097|FG001|Overall Study|Patient non-compliance|1|||
142948584|NCT04876391|515352096|FG000|Overall Study|Personal reasons|0|||
142948585|NCT04876391|515352097|FG001|Overall Study|Personal reasons|1|||
142948586|NCT04876391|515352096|FG000|Overall Study|Withdrawn as per protocol|2|||
142948587|NCT04876391|515352097|FG001|Overall Study|Withdrawn as per protocol|2|||
142948588|NCT03293030|515352098|FG000|Overall Study|Withdrawal by Subject|3|||
142948589|NCT02317510|515352103|FG000|Overall Study|Adverse Event|0|||
142948590|NCT02317510|515352104|FG001|Overall Study|Adverse Event|1|||
142948591|NCT01238120|515352105|FG000|Overall Study|Withdrawal by Subject|4|||
142948592|NCT01238120|515352106|FG001|Overall Study|Withdrawal by Subject|1|||
142948593|NCT01238120|515352107|FG002|Overall Study|Withdrawal by Subject|2|||
142948594|NCT01238120|515352108|FG003|Overall Study|Withdrawal by Subject|5|||
142948595|NCT01238120|515352105|FG000|Overall Study|Lost to Follow-up|2|||
142948596|NCT01238120|515352106|FG001|Overall Study|Lost to Follow-up|0|||
142948597|NCT01238120|515352107|FG002|Overall Study|Lost to Follow-up|1|||
142948598|NCT01238120|515352108|FG003|Overall Study|Lost to Follow-up|1|||
142948599|NCT01238120|515352105|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
142948600|NCT01238120|515352106|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
142948601|NCT01238120|515352107|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
142948602|NCT01238120|515352108|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
142948603|NCT00881205|515352109|FG000|Overall Study|Adverse Event|8|||
142948604|NCT00881205|515352110|FG001|Overall Study|Adverse Event|3|||
142948605|NCT00881205|515352109|FG000|Overall Study|Withdrawal by Subject|1|||
142948606|NCT00881205|515352110|FG001|Overall Study|Withdrawal by Subject|2|||
142948607|NCT00881205|515352109|FG000|Overall Study|Lost to Follow-up|0|||
142948608|NCT00881205|515352110|FG001|Overall Study|Lost to Follow-up|1|||
142948609|NCT00881205|515352109|FG000|Overall Study|Administrative problems|1|||
142948610|NCT00881205|515352110|FG001|Overall Study|Administrative problems|1|||
142948611|NCT00881205|515352109|FG000|Overall Study|Condition no longer requires drug|1|||
142948612|NCT00881205|515352110|FG001|Overall Study|Condition no longer requires drug|0|||
142948613|NCT01486238|515352113|FG000|Overall Study|Death|0|||
142948614|NCT01486238|515352114|FG001|Overall Study|Death|2|||
142948615|NCT01486238|515352113|FG000|Overall Study|Withdrawal by Subject|2|||
142948616|NCT01486238|515352114|FG001|Overall Study|Withdrawal by Subject|1|||
142948617|NCT01486238|515352113|FG000|Overall Study|Lost to Follow-up|0|||
142948618|NCT01486238|515352114|FG001|Overall Study|Lost to Follow-up|3|||
142948619|NCT00693706|515352119|FG000|Overall Study|Protocol Violation|0|||
142948620|NCT00693706|515352120|FG001|Overall Study|Protocol Violation|1|||
142948621|NCT02498652|515352122|FG000|Overall Study|Protocol Violation|0|||
142948622|NCT02498652|515352123|FG001|Overall Study|Protocol Violation|1|||
142948623|NCT03047213|515352125|FG000|Overall Study|Withdrawal by Subject|2|||
142948624|NCT03047213|515352126|FG001|Overall Study|Withdrawal by Subject|0|||
142948625|NCT03047213|515352125|FG000|Overall Study|Adverse Event|2|||
142948626|NCT03047213|515352126|FG001|Overall Study|Adverse Event|0|||
142948627|NCT04786210|515352127|FG000|Overall Study|Lost to Follow-up|2|||
142948628|NCT04786210|515352127|FG000|Overall Study|Withdrawal by Subject|4|||
142948629|NCT04334148|515352128|FG000|Overall Study|positive nasal swab at baseline|0|||
142948630|NCT04334148|515352129|FG001|Overall Study|positive nasal swab at baseline|1|||
142948631|NCT00498173|515352130|FG000|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|2|||
142948632|NCT00498173|515352131|FG001|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|1|||
142948633|NCT00498173|515352132|FG002|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|0|||
142948634|NCT06129487|515352133|FG000|Overall Study|Data loss was due to technical issues related to eye tracking.|198|||
142948635|NCT06129487|515352134|FG001|Overall Study|Data loss was due to technical issues related to eye tracking.|206|||
142948636|NCT05490771|515352135|FG000|Overall Study|Disease progression|18|||
142948637|NCT05490771|515352135|FG000|Overall Study|Adverse Event|3|||
142948638|NCT05490771|515352135|FG000|Overall Study|Other complicating disease|1|||
142948639|NCT05490771|515352135|FG000|Overall Study|Withdrawal by Subject|3|||
142948640|NCT05490771|515352135|FG000|Overall Study|Physician Decision|1|||
142948641|NCT05490771|515352135|FG000|Overall Study|Still on treatment|2|||
142948642|NCT05490771|515352135|FG000|Overall Study|Never start protocol therapy|5|||
142948643|NCT05490771|515352135|FG000|Overall Study|Ineligible|2|||
142948644|NCT03772327|515352136|FG000|Overall Study|Lost to Follow-up|3|||
142948645|NCT03772327|515352137|FG001|Overall Study|Lost to Follow-up|4|||
142948646|NCT03772327|515352136|FG000|Overall Study|Withdrawal by Subject|2|||
142948647|NCT03772327|515352137|FG001|Overall Study|Withdrawal by Subject|3|||
142948648|NCT02493751|515352140|FG000|Overall Study|Withdrawal by Subject|2|||
142948649|NCT02493751|515352141|FG001|Overall Study|Withdrawal by Subject|8|||
142948650|NCT02493751|515352140|FG000|Overall Study|Death|6|||
142948651|NCT02493751|515352141|FG001|Overall Study|Death|13|||
142948652|NCT02493751|515352140|FG000|Overall Study|Lost to Follow-up|2|||
142948653|NCT02493751|515352141|FG001|Overall Study|Lost to Follow-up|3|||
142948654|NCT02493751|515352140|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
142948655|NCT02493751|515352141|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
142948656|NCT01259466|515352142|FG000|Overall Study|Withdrawal by Subject|1|||
142948657|NCT01259466|515352143|FG001|Overall Study|Withdrawal by Subject|9|||
142948658|NCT01824602|515352146|FG000|Overall Study|Withdrawal by Subject|0|||
142948659|NCT01824602|515352147|FG001|Overall Study|Withdrawal by Subject|0|||
142948660|NCT01824602|515352148|FG002|Overall Study|Withdrawal by Subject|1|||
142948661|NCT01824602|515352149|FG003|Overall Study|Withdrawal by Subject|2|||
142948662|NCT01824602|515352146|FG000|Overall Study|Patient non-compliance|0|||
142948663|NCT01824602|515352147|FG001|Overall Study|Patient non-compliance|0|||
142948664|NCT01824602|515352148|FG002|Overall Study|Patient non-compliance|1|||
142948665|NCT01824602|515352149|FG003|Overall Study|Patient non-compliance|0|||
142948666|NCT01824602|515352146|FG000|Overall Study|Adverse Event|1|||
142948667|NCT01824602|515352147|FG001|Overall Study|Adverse Event|0|||
142948668|NCT01824602|515352148|FG002|Overall Study|Adverse Event|2|||
142948669|NCT01824602|515352149|FG003|Overall Study|Adverse Event|2|||
142948670|NCT01824602|515352146|FG000|Overall Study|Treatment failure|0|||
142948671|NCT01824602|515352147|FG001|Overall Study|Treatment failure|0|||
142948672|NCT01824602|515352148|FG002|Overall Study|Treatment failure|0|||
142948673|NCT01824602|515352149|FG003|Overall Study|Treatment failure|1|||
142948674|NCT00184054|515352150|FG000|Overall Study|Adverse Event|1|||
143003058|NCT01049360|515548750|FG006|Period 1|Adverse Event|0|||
143003059|NCT01049360|515548751|FG007|Period 1|Adverse Event|1|||
143003060|NCT01049360|515548752|FG008|Period 1|Adverse Event|0|||
143003061|NCT01049360|515548753|FG009|Period 1|Adverse Event|0|||
143003062|NCT01049360|515548754|FG010|Period 1|Adverse Event|0|||
143003063|NCT01049360|515548755|FG011|Period 1|Adverse Event|0|||
143003064|NCT01049360|515548756|FG012|Period 1|Adverse Event|1|||
143003065|NCT01049360|515548757|FG013|Period 1|Adverse Event|1|||
143003066|NCT01049360|515548758|FG014|Period 1|Adverse Event|0|||
143003067|NCT01049360|515548759|FG015|Period 1|Adverse Event|0|||
143003068|NCT01049360|515548760|FG016|Period 1|Adverse Event|1|||
143003069|NCT01049360|515548761|FG017|Period 1|Adverse Event|0|||
143003070|NCT01049360|515548762|FG018|Period 1|Adverse Event|1|||
143003071|NCT01049360|515548763|FG019|Period 1|Adverse Event|0|||
143003072|NCT01049360|515548744|FG000|Period 1|Did not meet inc/exc criteria|0|||
143003073|NCT01049360|515548745|FG001|Period 1|Did not meet inc/exc criteria|0|||
143003074|NCT01049360|515548746|FG002|Period 1|Did not meet inc/exc criteria|0|||
143003075|NCT01049360|515548747|FG003|Period 1|Did not meet inc/exc criteria|0|||
143003076|NCT01049360|515548748|FG004|Period 1|Did not meet inc/exc criteria|0|||
143003077|NCT01049360|515548749|FG005|Period 1|Did not meet inc/exc criteria|0|||
143003078|NCT01049360|515548750|FG006|Period 1|Did not meet inc/exc criteria|0|||
143003079|NCT01049360|515548751|FG007|Period 1|Did not meet inc/exc criteria|1|||
143003080|NCT01049360|515548752|FG008|Period 1|Did not meet inc/exc criteria|1|||
143003081|NCT01049360|515548753|FG009|Period 1|Did not meet inc/exc criteria|0|||
143003082|NCT01049360|515548754|FG010|Period 1|Did not meet inc/exc criteria|0|||
143003083|NCT01049360|515548755|FG011|Period 1|Did not meet inc/exc criteria|0|||
143003084|NCT01049360|515548756|FG012|Period 1|Did not meet inc/exc criteria|0|||
143003085|NCT01049360|515548757|FG013|Period 1|Did not meet inc/exc criteria|0|||
143003086|NCT01049360|515548758|FG014|Period 1|Did not meet inc/exc criteria|0|||
143003087|NCT01049360|515548759|FG015|Period 1|Did not meet inc/exc criteria|0|||
143003088|NCT01049360|515548760|FG016|Period 1|Did not meet inc/exc criteria|0|||
143003089|NCT01049360|515548761|FG017|Period 1|Did not meet inc/exc criteria|0|||
143003090|NCT01049360|515548762|FG018|Period 1|Did not meet inc/exc criteria|0|||
143003091|NCT01049360|515548763|FG019|Period 1|Did not meet inc/exc criteria|0|||
143003092|NCT01049360|515548744|FG000|Period 1|Withdrawal by Subject|0|||
143003093|NCT01049360|515548745|FG001|Period 1|Withdrawal by Subject|0|||
143003094|NCT01049360|515548746|FG002|Period 1|Withdrawal by Subject|0|||
143003095|NCT01049360|515548747|FG003|Period 1|Withdrawal by Subject|0|||
143003096|NCT01049360|515548748|FG004|Period 1|Withdrawal by Subject|0|||
143003097|NCT01049360|515548749|FG005|Period 1|Withdrawal by Subject|0|||
143003098|NCT01049360|515548750|FG006|Period 1|Withdrawal by Subject|0|||
143003099|NCT01049360|515548751|FG007|Period 1|Withdrawal by Subject|0|||
143003100|NCT01049360|515548752|FG008|Period 1|Withdrawal by Subject|1|||
143003101|NCT01049360|515548753|FG009|Period 1|Withdrawal by Subject|0|||
143003102|NCT01049360|515548754|FG010|Period 1|Withdrawal by Subject|1|||
143003103|NCT01049360|515548755|FG011|Period 1|Withdrawal by Subject|0|||
143003104|NCT01049360|515548756|FG012|Period 1|Withdrawal by Subject|1|||
143003105|NCT01049360|515548757|FG013|Period 1|Withdrawal by Subject|0|||
143003106|NCT01049360|515548758|FG014|Period 1|Withdrawal by Subject|0|||
143003107|NCT01049360|515548759|FG015|Period 1|Withdrawal by Subject|0|||
142948675|NCT00917384|515353574|FG000|Overall Study|Lost to Follow-up|4|||
142948676|NCT00917384|515353575|FG001|Overall Study|Lost to Follow-up|2|||
142948677|NCT00917384|515353574|FG000|Overall Study|Withdrawal by Subject|10|||
142948678|NCT00917384|515353575|FG001|Overall Study|Withdrawal by Subject|2|||
142948679|NCT01389128|515353576|FG000|Overall Study|Fetal distress|1|||
142948680|NCT01389128|515353577|FG001|Overall Study|Fetal distress|0|||
142948681|NCT01389128|515353576|FG000|Overall Study|Cervix dilation stop|1|||
142948682|NCT01389128|515353577|FG001|Overall Study|Cervix dilation stop|2|||
142948683|NCT01389128|515353576|FG000|Overall Study|Rapid labor evolution|3|||
142948684|NCT01389128|515353577|FG001|Overall Study|Rapid labor evolution|2|||
142948685|NCT01389128|515353576|FG000|Overall Study|Intolerance to procedure|0|||
142948686|NCT01389128|515353577|FG001|Overall Study|Intolerance to procedure|2|||
142948687|NCT03180736|515353578|FG000|Overall Study|Adverse Event|3|||
142948688|NCT03180736|515353579|FG001|Overall Study|Adverse Event|4|||
142948689|NCT03180736|515353578|FG000|Overall Study|Death|10|||
142948690|NCT03180736|515353579|FG001|Overall Study|Death|7|||
142948691|NCT03180736|515353578|FG000|Overall Study|Withdrawal by Subject|5|||
142948692|NCT03180736|515353579|FG001|Overall Study|Withdrawal by Subject|12|||
142948693|NCT03180736|515353578|FG000|Overall Study|Lost to Follow-up|1|||
142948694|NCT03180736|515353579|FG001|Overall Study|Lost to Follow-up|0|||
142948695|NCT03180736|515353578|FG000|Overall Study|Lack of Efficacy|66|||
142948696|NCT03180736|515353579|FG001|Overall Study|Lack of Efficacy|87|||
142948697|NCT03180736|515353578|FG000|Overall Study|Physician Decision|4|||
142948698|NCT03180736|515353579|FG001|Overall Study|Physician Decision|7|||
142948699|NCT03180736|515353578|FG000|Overall Study|randomized but not treated|2|||
142948700|NCT03180736|515353579|FG001|Overall Study|randomized but not treated|3|||
142948701|NCT02286960|515353586|FG000|Overall Study|Lost to Follow-up|3|||
142948702|NCT02286960|515353587|FG001|Overall Study|Lost to Follow-up|3|||
142948703|NCT00258154|515353588|FG000|Overall Study|Adverse Event|1|||
142948704|NCT00258154|515353589|FG001|Overall Study|Adverse Event|0|||
142948705|NCT00258154|515353588|FG000|Overall Study|Lost to Follow-up|0|||
142948706|NCT00258154|515353589|FG001|Overall Study|Lost to Follow-up|1|||
142948707|NCT00258154|515353588|FG000|Overall Study|Protocol Violation|2|||
142948708|NCT00258154|515353589|FG001|Overall Study|Protocol Violation|1|||
142948709|NCT00258154|515353588|FG000|Overall Study|Withdrawal by Subject|3|||
142948710|NCT00258154|515353589|FG001|Overall Study|Withdrawal by Subject|4|||
142948711|NCT00258154|515353588|FG000|Overall Study|Patient Moved|3|||
142948712|NCT00258154|515353589|FG001|Overall Study|Patient Moved|1|||
142948713|NCT04689828|515353590|FG000|Overall Study|Subject decision|5|||
142948714|NCT04689828|515353591|FG001|Overall Study|Subject decision|5|||
142948715|NCT04689828|515353590|FG000|Overall Study|Adverse Event|12|||
142948716|NCT04689828|515353591|FG001|Overall Study|Adverse Event|12|||
142948717|NCT04689828|515353590|FG000|Overall Study|Physician Decision|24|||
142948718|NCT04689828|515353591|FG001|Overall Study|Physician Decision|32|||
142948719|NCT04689828|515353590|FG000|Overall Study|Progressive disease|54|||
142948720|NCT04689828|515353591|FG001|Overall Study|Progressive disease|173|||
142948721|NCT04689828|515353590|FG000|Overall Study|Death|0|||
142948722|NCT04689828|515353591|FG001|Overall Study|Death|1|||
142948723|NCT04689828|515353590|FG000|Overall Study|Lost to Follow-up|1|||
142948724|NCT04689828|515353591|FG001|Overall Study|Lost to Follow-up|0|||
142948725|NCT04689828|515353590|FG000|Overall Study|Treated but excluded from FAS because of protocol deviation|1|||
142948726|NCT04689828|515353591|FG001|Overall Study|Treated but excluded from FAS because of protocol deviation|0|||
142948727|NCT04689828|515353590|FG000|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|0|||
142948728|NCT04689828|515353591|FG001|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|9|||
142948729|NCT04689828|515353590|FG000|Overall Study|Participants not treated|7|||
142948730|NCT04689828|515353591|FG001|Overall Study|Participants not treated|2|||
142948731|NCT00971321|515353596|FG000|Up to Month 7|Withdrawal by Subject|1|||
142948732|NCT00971321|515353597|FG001|Up to Month 7|Withdrawal by Subject|0|||
142948733|NCT00971321|515353596|FG000|Up to Month 7|Migrated/moved from study area|3|||
142948734|NCT00971321|515353597|FG001|Up to Month 7|Migrated/moved from study area|2|||
142948735|NCT00971321|515353596|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
142948736|NCT00971321|515353597|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
142948737|NCT00971321|515353596|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
142948738|NCT00971321|515353597|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
142948739|NCT00971321|515353596|FG000|Up to Month 11-12|Lost to Follow-up|1|||
142948740|NCT00971321|515353597|FG001|Up to Month 11-12|Lost to Follow-up|0|||
142948741|NCT03819140|515353598|FG000|Overall Study|Lost to Follow-up|1|||
142948742|NCT03819140|515353599|FG001|Overall Study|Lost to Follow-up|2|||
142948743|NCT03819140|515353598|FG000|Overall Study|Withdrawal by Subject|3|||
142948744|NCT03819140|515353599|FG001|Overall Study|Withdrawal by Subject|2|||
142948745|NCT03819140|515353598|FG000|Overall Study|Adverse Event|0|||
142948746|NCT03819140|515353599|FG001|Overall Study|Adverse Event|1|||
142948747|NCT03819140|515353598|FG000|Overall Study|Unable to attend visit(s) due to contracting COVID|2|||
142948748|NCT03819140|515353599|FG001|Overall Study|Unable to attend visit(s) due to contracting COVID|1|||
142948749|NCT03819140|515353598|FG000|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|1|||
143003108|NCT01049360|515548760|FG016|Period 1|Withdrawal by Subject|0|||
142948750|NCT03819140|515353599|FG001|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|3|||
142948751|NCT02192359|515353600|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
142948752|NCT02192359|515353601|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
142948753|NCT02192359|515353602|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
142948754|NCT02192359|515353603|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
142948755|NCT02192359|515353600|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
142948756|NCT02192359|515353601|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
142948757|NCT02192359|515353602|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
142948758|NCT02192359|515353603|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
142948759|NCT02192359|515353600|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
142948760|NCT02192359|515353601|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
142948761|NCT02192359|515353602|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
142948762|NCT02192359|515353603|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
142948763|NCT03519178|515353604|FG000|PF-06873600 Treatment|Adverse Event|0|||
142948764|NCT03519178|515353605|FG001|PF-06873600 Treatment|Adverse Event|0|||
142948765|NCT03519178|515353606|FG002|PF-06873600 Treatment|Adverse Event|0|||
142948766|NCT03519178|515353607|FG003|PF-06873600 Treatment|Adverse Event|0|||
142948767|NCT03519178|515353608|FG004|PF-06873600 Treatment|Adverse Event|0|||
142948768|NCT03519178|515353609|FG005|PF-06873600 Treatment|Adverse Event|0|||
142948769|NCT03519178|515353610|FG006|PF-06873600 Treatment|Adverse Event|0|||
142948770|NCT03519178|515353611|FG007|PF-06873600 Treatment|Adverse Event|2|||
142948771|NCT03519178|515353612|FG008|PF-06873600 Treatment|Adverse Event|1|||
142948772|NCT03519178|515353613|FG009|PF-06873600 Treatment|Adverse Event|0|||
142948773|NCT03519178|515353614|FG010|PF-06873600 Treatment|Adverse Event|0|||
142948774|NCT03519178|515353615|FG011|PF-06873600 Treatment|Adverse Event|0|||
142948775|NCT03519178|515353616|FG012|PF-06873600 Treatment|Adverse Event|1|||
142948776|NCT03519178|515353617|FG013|PF-06873600 Treatment|Adverse Event|3|||
142948777|NCT03519178|515353618|FG014|PF-06873600 Treatment|Adverse Event|2|||
142948778|NCT03519178|515353604|FG000|PF-06873600 Treatment|Death|0|||
142948779|NCT03519178|515353605|FG001|PF-06873600 Treatment|Death|0|||
142948780|NCT03519178|515353606|FG002|PF-06873600 Treatment|Death|0|||
142948781|NCT03519178|515353607|FG003|PF-06873600 Treatment|Death|0|||
142948782|NCT03519178|515353608|FG004|PF-06873600 Treatment|Death|0|||
142948783|NCT03519178|515353609|FG005|PF-06873600 Treatment|Death|0|||
142948784|NCT03519178|515353610|FG006|PF-06873600 Treatment|Death|0|||
142948785|NCT03519178|515353611|FG007|PF-06873600 Treatment|Death|0|||
142948786|NCT03519178|515353612|FG008|PF-06873600 Treatment|Death|1|||
142948787|NCT03519178|515353613|FG009|PF-06873600 Treatment|Death|1|||
142948788|NCT03519178|515353614|FG010|PF-06873600 Treatment|Death|0|||
142948789|NCT03519178|515353615|FG011|PF-06873600 Treatment|Death|0|||
142948790|NCT03519178|515353616|FG012|PF-06873600 Treatment|Death|0|||
142948791|NCT03519178|515353617|FG013|PF-06873600 Treatment|Death|0|||
142948792|NCT03519178|515353618|FG014|PF-06873600 Treatment|Death|1|||
142948793|NCT03519178|515353604|FG000|PF-06873600 Treatment|Physician Decision|0|||
142948794|NCT03519178|515353605|FG001|PF-06873600 Treatment|Physician Decision|0|||
142948795|NCT03519178|515353606|FG002|PF-06873600 Treatment|Physician Decision|0|||
142948796|NCT03519178|515353607|FG003|PF-06873600 Treatment|Physician Decision|0|||
142948797|NCT03519178|515353608|FG004|PF-06873600 Treatment|Physician Decision|0|||
142948798|NCT03519178|515353609|FG005|PF-06873600 Treatment|Physician Decision|0|||
142948799|NCT03519178|515353610|FG006|PF-06873600 Treatment|Physician Decision|0|||
142948800|NCT03519178|515353611|FG007|PF-06873600 Treatment|Physician Decision|1|||
142948801|NCT03519178|515353612|FG008|PF-06873600 Treatment|Physician Decision|0|||
142948802|NCT03519178|515353613|FG009|PF-06873600 Treatment|Physician Decision|0|||
142948803|NCT03519178|515353614|FG010|PF-06873600 Treatment|Physician Decision|1|||
142948804|NCT03519178|515353615|FG011|PF-06873600 Treatment|Physician Decision|0|||
142948805|NCT03519178|515353616|FG012|PF-06873600 Treatment|Physician Decision|0|||
142948806|NCT03519178|515353617|FG013|PF-06873600 Treatment|Physician Decision|4|||
142948807|NCT03519178|515353618|FG014|PF-06873600 Treatment|Physician Decision|1|||
142948808|NCT03519178|515353604|FG000|PF-06873600 Treatment|Progressive disease|1|||
142948809|NCT03519178|515353605|FG001|PF-06873600 Treatment|Progressive disease|1|||
142948810|NCT03519178|515353606|FG002|PF-06873600 Treatment|Progressive disease|1|||
142948811|NCT03519178|515353607|FG003|PF-06873600 Treatment|Progressive disease|1|||
142948812|NCT03519178|515353608|FG004|PF-06873600 Treatment|Progressive disease|6|||
142948813|NCT03519178|515353609|FG005|PF-06873600 Treatment|Progressive disease|7|||
142948814|NCT03519178|515353610|FG006|PF-06873600 Treatment|Progressive disease|3|||
142948815|NCT03519178|515353611|FG007|PF-06873600 Treatment|Progressive disease|7|||
142948816|NCT03519178|515353612|FG008|PF-06873600 Treatment|Progressive disease|3|||
142948817|NCT03519178|515353613|FG009|PF-06873600 Treatment|Progressive disease|5|||
143455067|NCT02663518|517210770|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
143455068|NCT02663518|517210771|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
142948818|NCT03519178|515353614|FG010|PF-06873600 Treatment|Progressive disease|4|||
142948819|NCT03519178|515353615|FG011|PF-06873600 Treatment|Progressive disease|3|||
142948820|NCT03519178|515353616|FG012|PF-06873600 Treatment|Progressive disease|4|||
142948821|NCT03519178|515353617|FG013|PF-06873600 Treatment|Progressive disease|28|||
142948822|NCT03519178|515353618|FG014|PF-06873600 Treatment|Progressive disease|8|||
142948823|NCT03519178|515353604|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
142948824|NCT03519178|515353605|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
142948825|NCT03519178|515353606|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
142948826|NCT03519178|515353607|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
142948827|NCT03519178|515353608|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
142948828|NCT03519178|515353609|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
142948829|NCT03519178|515353610|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
142948830|NCT03519178|515353611|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
142948831|NCT03519178|515353612|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
142948832|NCT03519178|515353613|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
142948833|NCT03519178|515353614|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
142948834|NCT03519178|515353615|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
142948835|NCT03519178|515353616|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
142948836|NCT03519178|515353617|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
142948837|NCT03519178|515353618|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
142948838|NCT03519178|515353604|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
142948839|NCT03519178|515353605|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
142948840|NCT03519178|515353606|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
142948841|NCT03519178|515353607|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
142948842|NCT03519178|515353608|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
142948843|NCT03519178|515353609|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
142948844|NCT03519178|515353610|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
142948845|NCT03519178|515353611|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
142948846|NCT03519178|515353612|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
142948847|NCT03519178|515353613|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
142948848|NCT03519178|515353614|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
142948849|NCT03519178|515353615|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
142948850|NCT03519178|515353616|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
142948851|NCT03519178|515353617|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
142948852|NCT03519178|515353618|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
142948853|NCT03519178|515353604|FG000|PF-06873600 Treatment|Refused further treatment|0|||
142948854|NCT03519178|515353605|FG001|PF-06873600 Treatment|Refused further treatment|1|||
142948855|NCT03519178|515353606|FG002|PF-06873600 Treatment|Refused further treatment|0|||
142948856|NCT03519178|515353607|FG003|PF-06873600 Treatment|Refused further treatment|0|||
142948857|NCT03519178|515353608|FG004|PF-06873600 Treatment|Refused further treatment|1|||
142948858|NCT03519178|515353609|FG005|PF-06873600 Treatment|Refused further treatment|0|||
142948859|NCT03519178|515353610|FG006|PF-06873600 Treatment|Refused further treatment|0|||
142948860|NCT03519178|515353611|FG007|PF-06873600 Treatment|Refused further treatment|0|||
142948861|NCT03519178|515353612|FG008|PF-06873600 Treatment|Refused further treatment|0|||
142948862|NCT03519178|515353613|FG009|PF-06873600 Treatment|Refused further treatment|0|||
142948863|NCT03519178|515353614|FG010|PF-06873600 Treatment|Refused further treatment|0|||
142948864|NCT03519178|515353615|FG011|PF-06873600 Treatment|Refused further treatment|0|||
142948865|NCT03519178|515353616|FG012|PF-06873600 Treatment|Refused further treatment|0|||
142948866|NCT03519178|515353617|FG013|PF-06873600 Treatment|Refused further treatment|0|||
142948867|NCT03519178|515353618|FG014|PF-06873600 Treatment|Refused further treatment|1|||
142948868|NCT03519178|515353604|FG000|PF-06873600 Treatment|Other|0|||
142948869|NCT03519178|515353605|FG001|PF-06873600 Treatment|Other|0|||
142948870|NCT03519178|515353606|FG002|PF-06873600 Treatment|Other|0|||
142948871|NCT03519178|515353607|FG003|PF-06873600 Treatment|Other|0|||
142948872|NCT03519178|515353608|FG004|PF-06873600 Treatment|Other|0|||
142948873|NCT03519178|515353609|FG005|PF-06873600 Treatment|Other|0|||
142948874|NCT03519178|515353610|FG006|PF-06873600 Treatment|Other|0|||
142948875|NCT03519178|515353611|FG007|PF-06873600 Treatment|Other|0|||
142948876|NCT03519178|515353612|FG008|PF-06873600 Treatment|Other|1|||
142948877|NCT03519178|515353613|FG009|PF-06873600 Treatment|Other|0|||
142948878|NCT03519178|515353614|FG010|PF-06873600 Treatment|Other|0|||
142948879|NCT03519178|515353615|FG011|PF-06873600 Treatment|Other|0|||
142948880|NCT03519178|515353616|FG012|PF-06873600 Treatment|Other|0|||
142948881|NCT03519178|515353617|FG013|PF-06873600 Treatment|Other|1|||
142948882|NCT03519178|515353618|FG014|PF-06873600 Treatment|Other|3|||
142948883|NCT03519178|515353604|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
142948884|NCT03519178|515353605|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
142948885|NCT03519178|515353606|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
142948886|NCT03519178|515353607|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
142948887|NCT03519178|515353608|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
142948888|NCT03519178|515353609|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
142948889|NCT03519178|515353610|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
142948890|NCT03519178|515353611|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
142948891|NCT03519178|515353612|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
142948892|NCT03519178|515353613|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
142948893|NCT03519178|515353614|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
142948894|NCT03519178|515353615|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
142948895|NCT03519178|515353616|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
142948896|NCT03519178|515353617|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
142948897|NCT03519178|515353618|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
142948898|NCT03519178|515353604|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
142948899|NCT03519178|515353605|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
142948900|NCT03519178|515353606|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
142948901|NCT03519178|515353607|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
142948902|NCT03519178|515353608|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
142948903|NCT03519178|515353609|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
142948904|NCT03519178|515353610|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
142948905|NCT03519178|515353611|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
142948906|NCT03519178|515353612|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
142948907|NCT03519178|515353613|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
142948908|NCT03519178|515353614|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
142948909|NCT03519178|515353615|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
142948910|NCT03519178|515353616|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
142948911|NCT03519178|515353617|FG013|PF-06873600 Treatment|Study terminated by sponsor|5|||
142948912|NCT03519178|515353618|FG014|PF-06873600 Treatment|Study terminated by sponsor|9|||
142948913|NCT03519178|515353604|FG000|Fulvestrant. Treatment|Adverse Event|0|||
142948914|NCT03519178|515353605|FG001|Fulvestrant. Treatment|Adverse Event|0|||
142948915|NCT03519178|515353606|FG002|Fulvestrant. Treatment|Adverse Event|0|||
142948916|NCT03519178|515353607|FG003|Fulvestrant. Treatment|Adverse Event|0|||
142948917|NCT03519178|515353608|FG004|Fulvestrant. Treatment|Adverse Event|0|||
142948918|NCT03519178|515353609|FG005|Fulvestrant. Treatment|Adverse Event|0|||
142948919|NCT03519178|515353610|FG006|Fulvestrant. Treatment|Adverse Event|0|||
142948920|NCT03519178|515353611|FG007|Fulvestrant. Treatment|Adverse Event|0|||
142948921|NCT03519178|515353612|FG008|Fulvestrant. Treatment|Adverse Event|0|||
142948922|NCT03519178|515353613|FG009|Fulvestrant. Treatment|Adverse Event|0|||
142948923|NCT03519178|515353614|FG010|Fulvestrant. Treatment|Adverse Event|0|||
142948924|NCT03519178|515353615|FG011|Fulvestrant. Treatment|Adverse Event|0|||
142948925|NCT03519178|515353616|FG012|Fulvestrant. Treatment|Adverse Event|0|||
142948926|NCT03519178|515353617|FG013|Fulvestrant. Treatment|Adverse Event|1|||
142948927|NCT03519178|515353618|FG014|Fulvestrant. Treatment|Adverse Event|0|||
142948928|NCT03519178|515353604|FG000|Fulvestrant. Treatment|Death|0|||
142948929|NCT03519178|515353605|FG001|Fulvestrant. Treatment|Death|0|||
142948930|NCT03519178|515353606|FG002|Fulvestrant. Treatment|Death|0|||
142948931|NCT03519178|515353607|FG003|Fulvestrant. Treatment|Death|0|||
142948932|NCT03519178|515353608|FG004|Fulvestrant. Treatment|Death|0|||
142948933|NCT03519178|515353609|FG005|Fulvestrant. Treatment|Death|0|||
142948934|NCT03519178|515353610|FG006|Fulvestrant. Treatment|Death|0|||
142948935|NCT03519178|515353611|FG007|Fulvestrant. Treatment|Death|0|||
142948936|NCT03519178|515353612|FG008|Fulvestrant. Treatment|Death|0|||
142948937|NCT03519178|515353613|FG009|Fulvestrant. Treatment|Death|1|||
142948938|NCT03519178|515353614|FG010|Fulvestrant. Treatment|Death|0|||
142948939|NCT03519178|515353615|FG011|Fulvestrant. Treatment|Death|0|||
142948940|NCT03519178|515353616|FG012|Fulvestrant. Treatment|Death|0|||
142948941|NCT03519178|515353617|FG013|Fulvestrant. Treatment|Death|0|||
142948942|NCT03519178|515353618|FG014|Fulvestrant. Treatment|Death|1|||
142948943|NCT03519178|515353604|FG000|Fulvestrant. Treatment|Lost to Follow-up|0|||
142948944|NCT03519178|515353605|FG001|Fulvestrant. Treatment|Lost to Follow-up|0|||
142948945|NCT03519178|515353606|FG002|Fulvestrant. Treatment|Lost to Follow-up|0|||
142948946|NCT03519178|515353607|FG003|Fulvestrant. Treatment|Lost to Follow-up|0|||
142948947|NCT03519178|515353608|FG004|Fulvestrant. Treatment|Lost to Follow-up|0|||
142948948|NCT03519178|515353609|FG005|Fulvestrant. Treatment|Lost to Follow-up|0|||
142948949|NCT03519178|515353610|FG006|Fulvestrant. Treatment|Lost to Follow-up|0|||
142948950|NCT03519178|515353611|FG007|Fulvestrant. Treatment|Lost to Follow-up|0|||
142948951|NCT03519178|515353612|FG008|Fulvestrant. Treatment|Lost to Follow-up|0|||
142948952|NCT03519178|515353613|FG009|Fulvestrant. Treatment|Lost to Follow-up|0|||
142948953|NCT03519178|515353614|FG010|Fulvestrant. Treatment|Lost to Follow-up|0|||
142948954|NCT03519178|515353615|FG011|Fulvestrant. Treatment|Lost to Follow-up|0|||
143117121|NCT02565706|515970036|FG002|Overall Study|Lost to Follow-up|82|||
142948955|NCT03519178|515353616|FG012|Fulvestrant. Treatment|Lost to Follow-up|0|||
142948956|NCT03519178|515353617|FG013|Fulvestrant. Treatment|Lost to Follow-up|0|||
142948957|NCT03519178|515353618|FG014|Fulvestrant. Treatment|Lost to Follow-up|1|||
142948958|NCT03519178|515353604|FG000|Fulvestrant. Treatment|Physician Decision|0|||
142948959|NCT03519178|515353605|FG001|Fulvestrant. Treatment|Physician Decision|0|||
142948960|NCT03519178|515353606|FG002|Fulvestrant. Treatment|Physician Decision|0|||
142948961|NCT03519178|515353607|FG003|Fulvestrant. Treatment|Physician Decision|0|||
142948962|NCT03519178|515353608|FG004|Fulvestrant. Treatment|Physician Decision|0|||
142948963|NCT03519178|515353609|FG005|Fulvestrant. Treatment|Physician Decision|0|||
142948964|NCT03519178|515353610|FG006|Fulvestrant. Treatment|Physician Decision|0|||
142948965|NCT03519178|515353611|FG007|Fulvestrant. Treatment|Physician Decision|0|||
142948966|NCT03519178|515353612|FG008|Fulvestrant. Treatment|Physician Decision|0|||
142948967|NCT03519178|515353613|FG009|Fulvestrant. Treatment|Physician Decision|0|||
142948968|NCT03519178|515353614|FG010|Fulvestrant. Treatment|Physician Decision|0|||
142948969|NCT03519178|515353615|FG011|Fulvestrant. Treatment|Physician Decision|0|||
142948970|NCT03519178|515353616|FG012|Fulvestrant. Treatment|Physician Decision|0|||
142948971|NCT03519178|515353617|FG013|Fulvestrant. Treatment|Physician Decision|4|||
142948972|NCT03519178|515353618|FG014|Fulvestrant. Treatment|Physician Decision|2|||
142948973|NCT03519178|515353604|FG000|Fulvestrant. Treatment|Progressive disease|0|||
142948974|NCT03519178|515353605|FG001|Fulvestrant. Treatment|Progressive disease|0|||
142948975|NCT03519178|515353606|FG002|Fulvestrant. Treatment|Progressive disease|0|||
142948976|NCT03519178|515353607|FG003|Fulvestrant. Treatment|Progressive disease|0|||
142948977|NCT03519178|515353608|FG004|Fulvestrant. Treatment|Progressive disease|0|||
142948978|NCT03519178|515353609|FG005|Fulvestrant. Treatment|Progressive disease|0|||
142948979|NCT03519178|515353610|FG006|Fulvestrant. Treatment|Progressive disease|0|||
142948980|NCT03519178|515353611|FG007|Fulvestrant. Treatment|Progressive disease|0|||
142948981|NCT03519178|515353612|FG008|Fulvestrant. Treatment|Progressive disease|0|||
142948982|NCT03519178|515353613|FG009|Fulvestrant. Treatment|Progressive disease|5|||
142948983|NCT03519178|515353614|FG010|Fulvestrant. Treatment|Progressive disease|0|||
142948984|NCT03519178|515353615|FG011|Fulvestrant. Treatment|Progressive disease|0|||
142948985|NCT03519178|515353616|FG012|Fulvestrant. Treatment|Progressive disease|0|||
142948986|NCT03519178|515353617|FG013|Fulvestrant. Treatment|Progressive disease|30|||
142948987|NCT03519178|515353618|FG014|Fulvestrant. Treatment|Progressive disease|8|||
142948988|NCT03519178|515353604|FG000|Fulvestrant. Treatment|Study terminated by sponsor|0|||
142948989|NCT03519178|515353605|FG001|Fulvestrant. Treatment|Study terminated by sponsor|0|||
142948990|NCT03519178|515353606|FG002|Fulvestrant. Treatment|Study terminated by sponsor|0|||
142948991|NCT03519178|515353607|FG003|Fulvestrant. Treatment|Study terminated by sponsor|0|||
142948992|NCT03519178|515353608|FG004|Fulvestrant. Treatment|Study terminated by sponsor|0|||
142948993|NCT03519178|515353609|FG005|Fulvestrant. Treatment|Study terminated by sponsor|0|||
142948994|NCT03519178|515353610|FG006|Fulvestrant. Treatment|Study terminated by sponsor|0|||
142948995|NCT03519178|515353611|FG007|Fulvestrant. Treatment|Study terminated by sponsor|0|||
142948996|NCT03519178|515353612|FG008|Fulvestrant. Treatment|Study terminated by sponsor|0|||
142948997|NCT03519178|515353613|FG009|Fulvestrant. Treatment|Study terminated by sponsor|0|||
142948998|NCT03519178|515353614|FG010|Fulvestrant. Treatment|Study terminated by sponsor|0|||
142948999|NCT03519178|515353615|FG011|Fulvestrant. Treatment|Study terminated by sponsor|0|||
142949000|NCT03519178|515353616|FG012|Fulvestrant. Treatment|Study terminated by sponsor|0|||
142949001|NCT03519178|515353617|FG013|Fulvestrant. Treatment|Study terminated by sponsor|5|||
142949002|NCT03519178|515353618|FG014|Fulvestrant. Treatment|Study terminated by sponsor|9|||
142949003|NCT03519178|515353604|FG000|Fulvestrant. Treatment|Withdrawal by Subject|0|||
142949004|NCT03519178|515353605|FG001|Fulvestrant. Treatment|Withdrawal by Subject|0|||
142949005|NCT03519178|515353606|FG002|Fulvestrant. Treatment|Withdrawal by Subject|0|||
142949006|NCT03519178|515353607|FG003|Fulvestrant. Treatment|Withdrawal by Subject|0|||
142949007|NCT03519178|515353608|FG004|Fulvestrant. Treatment|Withdrawal by Subject|0|||
142949008|NCT03519178|515353609|FG005|Fulvestrant. Treatment|Withdrawal by Subject|0|||
142949009|NCT03519178|515353610|FG006|Fulvestrant. Treatment|Withdrawal by Subject|0|||
142949010|NCT03519178|515353611|FG007|Fulvestrant. Treatment|Withdrawal by Subject|0|||
142949011|NCT03519178|515353612|FG008|Fulvestrant. Treatment|Withdrawal by Subject|0|||
142949012|NCT03519178|515353613|FG009|Fulvestrant. Treatment|Withdrawal by Subject|2|||
142949013|NCT03519178|515353614|FG010|Fulvestrant. Treatment|Withdrawal by Subject|0|||
142949014|NCT03519178|515353615|FG011|Fulvestrant. Treatment|Withdrawal by Subject|0|||
142949015|NCT03519178|515353616|FG012|Fulvestrant. Treatment|Withdrawal by Subject|0|||
142949016|NCT03519178|515353617|FG013|Fulvestrant. Treatment|Withdrawal by Subject|1|||
142949017|NCT03519178|515353618|FG014|Fulvestrant. Treatment|Withdrawal by Subject|2|||
142949018|NCT03519178|515353604|FG000|Fulvestrant. Treatment|Global deterioration of health status|0|||
142949019|NCT03519178|515353605|FG001|Fulvestrant. Treatment|Global deterioration of health status|0|||
142949020|NCT03519178|515353606|FG002|Fulvestrant. Treatment|Global deterioration of health status|0|||
142949021|NCT03519178|515353607|FG003|Fulvestrant. Treatment|Global deterioration of health status|0|||
142949022|NCT03519178|515353608|FG004|Fulvestrant. Treatment|Global deterioration of health status|0|||
142949023|NCT03519178|515353609|FG005|Fulvestrant. Treatment|Global deterioration of health status|0|||
142949024|NCT03519178|515353610|FG006|Fulvestrant. Treatment|Global deterioration of health status|0|||
142949025|NCT03519178|515353611|FG007|Fulvestrant. Treatment|Global deterioration of health status|0|||
142949026|NCT03519178|515353612|FG008|Fulvestrant. Treatment|Global deterioration of health status|0|||
142949027|NCT03519178|515353613|FG009|Fulvestrant. Treatment|Global deterioration of health status|1|||
142949028|NCT03519178|515353614|FG010|Fulvestrant. Treatment|Global deterioration of health status|0|||
142949029|NCT03519178|515353615|FG011|Fulvestrant. Treatment|Global deterioration of health status|0|||
142949030|NCT03519178|515353616|FG012|Fulvestrant. Treatment|Global deterioration of health status|0|||
142949031|NCT03519178|515353617|FG013|Fulvestrant. Treatment|Global deterioration of health status|3|||
142949032|NCT03519178|515353618|FG014|Fulvestrant. Treatment|Global deterioration of health status|0|||
142949033|NCT03519178|515353604|FG000|Fulvestrant. Treatment|Refused further treatment|0|||
142949034|NCT03519178|515353605|FG001|Fulvestrant. Treatment|Refused further treatment|0|||
142949035|NCT03519178|515353606|FG002|Fulvestrant. Treatment|Refused further treatment|0|||
142949036|NCT03519178|515353607|FG003|Fulvestrant. Treatment|Refused further treatment|0|||
142949037|NCT03519178|515353608|FG004|Fulvestrant. Treatment|Refused further treatment|0|||
142949038|NCT03519178|515353609|FG005|Fulvestrant. Treatment|Refused further treatment|0|||
142949039|NCT03519178|515353610|FG006|Fulvestrant. Treatment|Refused further treatment|0|||
142949040|NCT03519178|515353611|FG007|Fulvestrant. Treatment|Refused further treatment|0|||
142949041|NCT03519178|515353612|FG008|Fulvestrant. Treatment|Refused further treatment|0|||
142949042|NCT03519178|515353613|FG009|Fulvestrant. Treatment|Refused further treatment|0|||
142949043|NCT03519178|515353614|FG010|Fulvestrant. Treatment|Refused further treatment|0|||
142949044|NCT03519178|515353615|FG011|Fulvestrant. Treatment|Refused further treatment|0|||
142949045|NCT03519178|515353616|FG012|Fulvestrant. Treatment|Refused further treatment|0|||
142949046|NCT03519178|515353617|FG013|Fulvestrant. Treatment|Refused further treatment|0|||
142949047|NCT03519178|515353618|FG014|Fulvestrant. Treatment|Refused further treatment|2|||
142949048|NCT03519178|515353604|FG000|Fulvestrant. Treatment|Other|0|||
142949049|NCT03519178|515353605|FG001|Fulvestrant. Treatment|Other|0|||
142949050|NCT03519178|515353606|FG002|Fulvestrant. Treatment|Other|0|||
142949051|NCT03519178|515353607|FG003|Fulvestrant. Treatment|Other|0|||
142949052|NCT03519178|515353608|FG004|Fulvestrant. Treatment|Other|0|||
142949053|NCT03519178|515353609|FG005|Fulvestrant. Treatment|Other|0|||
142949054|NCT03519178|515353610|FG006|Fulvestrant. Treatment|Other|0|||
142949055|NCT03519178|515353611|FG007|Fulvestrant. Treatment|Other|0|||
142949056|NCT03519178|515353612|FG008|Fulvestrant. Treatment|Other|0|||
142949057|NCT03519178|515353613|FG009|Fulvestrant. Treatment|Other|0|||
142949058|NCT03519178|515353614|FG010|Fulvestrant. Treatment|Other|0|||
142949059|NCT03519178|515353615|FG011|Fulvestrant. Treatment|Other|0|||
142949060|NCT03519178|515353616|FG012|Fulvestrant. Treatment|Other|0|||
142949061|NCT03519178|515353617|FG013|Fulvestrant. Treatment|Other|1|||
142949062|NCT03519178|515353618|FG014|Fulvestrant. Treatment|Other|3|||
142949063|NCT03519178|515353604|FG000|Letrozole Treatment|Physician Decision|0|||
142949064|NCT03519178|515353605|FG001|Letrozole Treatment|Physician Decision|0|||
142949065|NCT03519178|515353606|FG002|Letrozole Treatment|Physician Decision|0|||
142949066|NCT03519178|515353607|FG003|Letrozole Treatment|Physician Decision|0|||
142949067|NCT03519178|515353608|FG004|Letrozole Treatment|Physician Decision|0|||
142949068|NCT03519178|515353609|FG005|Letrozole Treatment|Physician Decision|0|||
142949069|NCT03519178|515353610|FG006|Letrozole Treatment|Physician Decision|0|||
142949070|NCT03519178|515353611|FG007|Letrozole Treatment|Physician Decision|0|||
142949071|NCT03519178|515353612|FG008|Letrozole Treatment|Physician Decision|0|||
142949072|NCT03519178|515353613|FG009|Letrozole Treatment|Physician Decision|0|||
142949073|NCT03519178|515353614|FG010|Letrozole Treatment|Physician Decision|1|||
142949074|NCT03519178|515353615|FG011|Letrozole Treatment|Physician Decision|0|||
142949075|NCT03519178|515353616|FG012|Letrozole Treatment|Physician Decision|0|||
142949076|NCT03519178|515353617|FG013|Letrozole Treatment|Physician Decision|0|||
142949077|NCT03519178|515353618|FG014|Letrozole Treatment|Physician Decision|0|||
142949078|NCT03519178|515353604|FG000|Letrozole Treatment|Progressive disease|0|||
142949079|NCT03519178|515353605|FG001|Letrozole Treatment|Progressive disease|0|||
142949080|NCT03519178|515353606|FG002|Letrozole Treatment|Progressive disease|0|||
142949081|NCT03519178|515353607|FG003|Letrozole Treatment|Progressive disease|0|||
142949082|NCT03519178|515353608|FG004|Letrozole Treatment|Progressive disease|0|||
142949083|NCT03519178|515353609|FG005|Letrozole Treatment|Progressive disease|0|||
142949084|NCT03519178|515353610|FG006|Letrozole Treatment|Progressive disease|0|||
142949085|NCT03519178|515353611|FG007|Letrozole Treatment|Progressive disease|0|||
142949086|NCT03519178|515353612|FG008|Letrozole Treatment|Progressive disease|0|||
142949087|NCT03519178|515353613|FG009|Letrozole Treatment|Progressive disease|0|||
142949088|NCT03519178|515353614|FG010|Letrozole Treatment|Progressive disease|4|||
142949089|NCT03519178|515353615|FG011|Letrozole Treatment|Progressive disease|0|||
142949090|NCT03519178|515353616|FG012|Letrozole Treatment|Progressive disease|0|||
142949091|NCT03519178|515353617|FG013|Letrozole Treatment|Progressive disease|0|||
142949092|NCT03519178|515353618|FG014|Letrozole Treatment|Progressive disease|0|||
142949093|NCT03519178|515353604|FG000|Letrozole Treatment|Global deterioration of health status|0|||
142949094|NCT03519178|515353605|FG001|Letrozole Treatment|Global deterioration of health status|0|||
142949095|NCT03519178|515353606|FG002|Letrozole Treatment|Global deterioration of health status|0|||
142949096|NCT03519178|515353607|FG003|Letrozole Treatment|Global deterioration of health status|0|||
142949097|NCT03519178|515353608|FG004|Letrozole Treatment|Global deterioration of health status|0|||
142949098|NCT03519178|515353609|FG005|Letrozole Treatment|Global deterioration of health status|0|||
142949099|NCT03519178|515353610|FG006|Letrozole Treatment|Global deterioration of health status|0|||
142949100|NCT03519178|515353611|FG007|Letrozole Treatment|Global deterioration of health status|0|||
142949101|NCT03519178|515353612|FG008|Letrozole Treatment|Global deterioration of health status|0|||
142949102|NCT03519178|515353613|FG009|Letrozole Treatment|Global deterioration of health status|0|||
142949103|NCT03519178|515353614|FG010|Letrozole Treatment|Global deterioration of health status|2|||
142949104|NCT03519178|515353615|FG011|Letrozole Treatment|Global deterioration of health status|0|||
142949105|NCT03519178|515353616|FG012|Letrozole Treatment|Global deterioration of health status|0|||
142949106|NCT03519178|515353617|FG013|Letrozole Treatment|Global deterioration of health status|0|||
142949107|NCT03519178|515353618|FG014|Letrozole Treatment|Global deterioration of health status|0|||
142949108|NCT03519178|515353604|FG000|Follow-Up|Death|0|||
142949109|NCT03519178|515353605|FG001|Follow-Up|Death|0|||
142949110|NCT03519178|515353606|FG002|Follow-Up|Death|0|||
142949111|NCT03519178|515353607|FG003|Follow-Up|Death|0|||
142949112|NCT03519178|515353608|FG004|Follow-Up|Death|0|||
142949113|NCT03519178|515353609|FG005|Follow-Up|Death|0|||
142949114|NCT03519178|515353610|FG006|Follow-Up|Death|0|||
142949115|NCT03519178|515353611|FG007|Follow-Up|Death|0|||
142949116|NCT03519178|515353612|FG008|Follow-Up|Death|3|||
142949117|NCT03519178|515353613|FG009|Follow-Up|Death|1|||
142949118|NCT03519178|515353614|FG010|Follow-Up|Death|0|||
142949119|NCT03519178|515353615|FG011|Follow-Up|Death|0|||
142949120|NCT03519178|515353616|FG012|Follow-Up|Death|2|||
142949121|NCT03519178|515353617|FG013|Follow-Up|Death|0|||
142949122|NCT03519178|515353618|FG014|Follow-Up|Death|0|||
142949123|NCT03519178|515353604|FG000|Follow-Up|Lost to Follow-up|0|||
142949124|NCT03519178|515353605|FG001|Follow-Up|Lost to Follow-up|0|||
142949125|NCT03519178|515353606|FG002|Follow-Up|Lost to Follow-up|0|||
142949126|NCT03519178|515353607|FG003|Follow-Up|Lost to Follow-up|0|||
142949127|NCT03519178|515353608|FG004|Follow-Up|Lost to Follow-up|0|||
142949128|NCT03519178|515353609|FG005|Follow-Up|Lost to Follow-up|3|||
142949129|NCT03519178|515353610|FG006|Follow-Up|Lost to Follow-up|1|||
142949130|NCT03519178|515353611|FG007|Follow-Up|Lost to Follow-up|4|||
142949131|NCT03519178|515353612|FG008|Follow-Up|Lost to Follow-up|1|||
142949132|NCT03519178|515353613|FG009|Follow-Up|Lost to Follow-up|0|||
142949133|NCT03519178|515353614|FG010|Follow-Up|Lost to Follow-up|0|||
142949134|NCT03519178|515353615|FG011|Follow-Up|Lost to Follow-up|0|||
142949135|NCT03519178|515353616|FG012|Follow-Up|Lost to Follow-up|0|||
142949136|NCT03519178|515353617|FG013|Follow-Up|Lost to Follow-up|0|||
142949137|NCT03519178|515353618|FG014|Follow-Up|Lost to Follow-up|0|||
142949138|NCT03519178|515353604|FG000|Follow-Up|Withdrawal by Subject|1|||
142949139|NCT03519178|515353605|FG001|Follow-Up|Withdrawal by Subject|2|||
142949140|NCT03519178|515353606|FG002|Follow-Up|Withdrawal by Subject|2|||
142949141|NCT03519178|515353607|FG003|Follow-Up|Withdrawal by Subject|3|||
142949142|NCT03519178|515353608|FG004|Follow-Up|Withdrawal by Subject|5|||
142949143|NCT03519178|515353609|FG005|Follow-Up|Withdrawal by Subject|1|||
142949144|NCT03519178|515353610|FG006|Follow-Up|Withdrawal by Subject|2|||
142949145|NCT03519178|515353611|FG007|Follow-Up|Withdrawal by Subject|6|||
142949146|NCT03519178|515353612|FG008|Follow-Up|Withdrawal by Subject|5|||
142949147|NCT03519178|515353613|FG009|Follow-Up|Withdrawal by Subject|2|||
142949148|NCT03519178|515353614|FG010|Follow-Up|Withdrawal by Subject|3|||
142949149|NCT03519178|515353615|FG011|Follow-Up|Withdrawal by Subject|5|||
142949150|NCT03519178|515353616|FG012|Follow-Up|Withdrawal by Subject|2|||
142949151|NCT03519178|515353617|FG013|Follow-Up|Withdrawal by Subject|0|||
142949152|NCT03519178|515353618|FG014|Follow-Up|Withdrawal by Subject|0|||
142949153|NCT03519178|515353604|FG000|Follow-Up|Other|0|||
142949154|NCT03519178|515353605|FG001|Follow-Up|Other|0|||
142949155|NCT03519178|515353606|FG002|Follow-Up|Other|0|||
142949156|NCT03519178|515353607|FG003|Follow-Up|Other|0|||
142949157|NCT03519178|515353608|FG004|Follow-Up|Other|0|||
142949158|NCT03519178|515353609|FG005|Follow-Up|Other|0|||
142949159|NCT03519178|515353610|FG006|Follow-Up|Other|0|||
142949160|NCT03519178|515353611|FG007|Follow-Up|Other|1|||
142949161|NCT03519178|515353612|FG008|Follow-Up|Other|0|||
142949162|NCT03519178|515353613|FG009|Follow-Up|Other|0|||
142949163|NCT03519178|515353614|FG010|Follow-Up|Other|0|||
142949164|NCT03519178|515353615|FG011|Follow-Up|Other|0|||
142949165|NCT03519178|515353616|FG012|Follow-Up|Other|0|||
142949166|NCT03519178|515353617|FG013|Follow-Up|Other|0|||
142949167|NCT03519178|515353618|FG014|Follow-Up|Other|0|||
142949168|NCT03519178|515353604|FG000|Long-term Follow-up|Death|0|||
142949169|NCT03519178|515353605|FG001|Long-term Follow-up|Death|0|||
142949170|NCT03519178|515353606|FG002|Long-term Follow-up|Death|0|||
142949171|NCT03519178|515353607|FG003|Long-term Follow-up|Death|0|||
142949172|NCT03519178|515353608|FG004|Long-term Follow-up|Death|0|||
142949173|NCT03519178|515353609|FG005|Long-term Follow-up|Death|0|||
142949174|NCT03519178|515353610|FG006|Long-term Follow-up|Death|0|||
142949175|NCT03519178|515353611|FG007|Long-term Follow-up|Death|0|||
142949176|NCT03519178|515353612|FG008|Long-term Follow-up|Death|0|||
142949177|NCT03519178|515353613|FG009|Long-term Follow-up|Death|0|||
142949178|NCT03519178|515353614|FG010|Long-term Follow-up|Death|0|||
142949179|NCT03519178|515353615|FG011|Long-term Follow-up|Death|0|||
142949180|NCT03519178|515353616|FG012|Long-term Follow-up|Death|0|||
142949181|NCT03519178|515353617|FG013|Long-term Follow-up|Death|4|||
142949182|NCT03519178|515353618|FG014|Long-term Follow-up|Death|4|||
142949183|NCT03519178|515353604|FG000|Long-term Follow-up|Lost to Follow-up|0|||
142949184|NCT03519178|515353605|FG001|Long-term Follow-up|Lost to Follow-up|0|||
142949185|NCT03519178|515353606|FG002|Long-term Follow-up|Lost to Follow-up|0|||
142949186|NCT03519178|515353607|FG003|Long-term Follow-up|Lost to Follow-up|0|||
142949187|NCT03519178|515353608|FG004|Long-term Follow-up|Lost to Follow-up|0|||
142949188|NCT03519178|515353609|FG005|Long-term Follow-up|Lost to Follow-up|0|||
142949189|NCT03519178|515353610|FG006|Long-term Follow-up|Lost to Follow-up|0|||
142949190|NCT03519178|515353611|FG007|Long-term Follow-up|Lost to Follow-up|0|||
142949191|NCT03519178|515353612|FG008|Long-term Follow-up|Lost to Follow-up|0|||
142949192|NCT03519178|515353613|FG009|Long-term Follow-up|Lost to Follow-up|0|||
142949193|NCT03519178|515353614|FG010|Long-term Follow-up|Lost to Follow-up|0|||
142949194|NCT03519178|515353615|FG011|Long-term Follow-up|Lost to Follow-up|0|||
142949195|NCT03519178|515353616|FG012|Long-term Follow-up|Lost to Follow-up|0|||
142949196|NCT03519178|515353617|FG013|Long-term Follow-up|Lost to Follow-up|1|||
142949197|NCT03519178|515353618|FG014|Long-term Follow-up|Lost to Follow-up|1|||
142949198|NCT03519178|515353604|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
142949199|NCT03519178|515353605|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
142949200|NCT03519178|515353606|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
142949201|NCT03519178|515353607|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
142949202|NCT03519178|515353608|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
142949203|NCT03519178|515353609|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
142949204|NCT03519178|515353610|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
142949205|NCT03519178|515353611|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
142949206|NCT03519178|515353612|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
142949207|NCT03519178|515353613|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
142949208|NCT03519178|515353614|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
142949209|NCT03519178|515353615|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
142949210|NCT03519178|515353616|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
142949211|NCT03519178|515353617|FG013|Long-term Follow-up|Study terminated by sponsor|32|||
142949212|NCT03519178|515353618|FG014|Long-term Follow-up|Study terminated by sponsor|19|||
142949213|NCT03519178|515353604|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
142949214|NCT03519178|515353605|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
142949215|NCT03519178|515353606|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
142949216|NCT03519178|515353607|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
142949217|NCT03519178|515353608|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
142949218|NCT03519178|515353609|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
142949219|NCT03519178|515353610|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
142949220|NCT03519178|515353611|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
142949221|NCT03519178|515353612|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
142949222|NCT03519178|515353613|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
142949223|NCT03519178|515353614|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
142949224|NCT03519178|515353615|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
142949225|NCT03519178|515353616|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
142949226|NCT03519178|515353617|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
142949227|NCT03519178|515353618|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
142949228|NCT03519178|515353604|FG000|Long-term Follow-up|Other|0|||
142949229|NCT03519178|515353605|FG001|Long-term Follow-up|Other|0|||
142949230|NCT03519178|515353606|FG002|Long-term Follow-up|Other|0|||
142949231|NCT03519178|515353607|FG003|Long-term Follow-up|Other|0|||
142949232|NCT03519178|515353608|FG004|Long-term Follow-up|Other|0|||
142949233|NCT03519178|515353609|FG005|Long-term Follow-up|Other|0|||
142949234|NCT03519178|515353610|FG006|Long-term Follow-up|Other|0|||
142949235|NCT03519178|515353611|FG007|Long-term Follow-up|Other|0|||
142949236|NCT03519178|515353612|FG008|Long-term Follow-up|Other|0|||
142949237|NCT03519178|515353613|FG009|Long-term Follow-up|Other|0|||
142949238|NCT03519178|515353614|FG010|Long-term Follow-up|Other|0|||
142949239|NCT03519178|515353615|FG011|Long-term Follow-up|Other|0|||
142949240|NCT03519178|515353616|FG012|Long-term Follow-up|Other|0|||
142949241|NCT03519178|515353617|FG013|Long-term Follow-up|Other|0|||
142949242|NCT03519178|515353618|FG014|Long-term Follow-up|Other|1|||
142949243|NCT03519178|515353604|FG000|Long-term Follow-up|Global deterioration of health status|0|||
142949244|NCT03519178|515353605|FG001|Long-term Follow-up|Global deterioration of health status|0|||
142949245|NCT03519178|515353606|FG002|Long-term Follow-up|Global deterioration of health status|0|||
142949246|NCT03519178|515353607|FG003|Long-term Follow-up|Global deterioration of health status|0|||
142949247|NCT03519178|515353608|FG004|Long-term Follow-up|Global deterioration of health status|0|||
142949248|NCT03519178|515353609|FG005|Long-term Follow-up|Global deterioration of health status|0|||
142949249|NCT03519178|515353610|FG006|Long-term Follow-up|Global deterioration of health status|0|||
142949250|NCT03519178|515353611|FG007|Long-term Follow-up|Global deterioration of health status|0|||
142949251|NCT03519178|515353612|FG008|Long-term Follow-up|Global deterioration of health status|0|||
142949252|NCT03519178|515353613|FG009|Long-term Follow-up|Global deterioration of health status|0|||
142949253|NCT03519178|515353614|FG010|Long-term Follow-up|Global deterioration of health status|0|||
142949254|NCT03519178|515353615|FG011|Long-term Follow-up|Global deterioration of health status|0|||
142949255|NCT03519178|515353616|FG012|Long-term Follow-up|Global deterioration of health status|0|||
142949256|NCT03519178|515353617|FG013|Long-term Follow-up|Global deterioration of health status|1|||
142949257|NCT03519178|515353618|FG014|Long-term Follow-up|Global deterioration of health status|0|||
142949258|NCT03249350|515353623|FG000|Overall Study|Participant did not initiate treatment|5|||
142949259|NCT03249350|515353624|FG001|Overall Study|Participant did not initiate treatment|8|||
142949260|NCT03256539|515353625|FG000|Overall Study|Withdrawal by Subject|0|||
142949261|NCT03256539|515353626|FG001|Overall Study|Withdrawal by Subject|3|||
142949262|NCT03256539|515353625|FG000|Overall Study|Unexpected closure of study components|8|||
143003109|NCT01049360|515548761|FG017|Period 1|Withdrawal by Subject|0|||
142949263|NCT03256539|515353626|FG001|Overall Study|Unexpected closure of study components|4|||
142949264|NCT02827877|515353627|FG000|Overall Study|Withdrawal by Subject|1|||
142949265|NCT05755438|515353628|FG000|12-week DBVC Period|Adverse Event|4|||
142949266|NCT05755438|515353629|FG001|12-week DBVC Period|Adverse Event|1|||
142949267|NCT05755438|515353628|FG000|12-week DBVC Period|Physician Decision|1|||
142949268|NCT05755438|515353629|FG001|12-week DBVC Period|Physician Decision|1|||
142949269|NCT05755438|515353628|FG000|12-week DBVC Period|Protocol Violation|4|||
142949270|NCT05755438|515353629|FG001|12-week DBVC Period|Protocol Violation|2|||
142949271|NCT05755438|515353628|FG000|12-week DBVC Period|Withdrawal by Subject|9|||
142949272|NCT05755438|515353629|FG001|12-week DBVC Period|Withdrawal by Subject|7|||
142949273|NCT05755438|515353628|FG000|12-week DBVC Period|Sponsor Decision|1|||
142949274|NCT05755438|515353629|FG001|12-week DBVC Period|Sponsor Decision|0|||
142949275|NCT05755438|515353628|FG000|40-week OLE Period|Adverse Event|0|||
142949276|NCT05755438|515353629|FG001|40-week OLE Period|Adverse Event|2|||
142949277|NCT05755438|515353628|FG000|40-week OLE Period|Lack of Efficacy|1|||
142949278|NCT05755438|515353629|FG001|40-week OLE Period|Lack of Efficacy|1|||
142949279|NCT05755438|515353628|FG000|40-week OLE Period|Lost to Follow-up|1|||
142949280|NCT05755438|515353629|FG001|40-week OLE Period|Lost to Follow-up|0|||
142949281|NCT05755438|515353628|FG000|40-week OLE Period|Physician Decision|1|||
142949282|NCT05755438|515353629|FG001|40-week OLE Period|Physician Decision|1|||
142949283|NCT05755438|515353628|FG000|40-week OLE Period|Protocol Violation|1|||
142949284|NCT05755438|515353629|FG001|40-week OLE Period|Protocol Violation|1|||
142949285|NCT05755438|515353628|FG000|40-week OLE Period|Withdrawal by Subject|6|||
142949286|NCT05755438|515353629|FG001|40-week OLE Period|Withdrawal by Subject|6|||
142949287|NCT05755438|515353628|FG000|40-week OLE Period|Sponsor Decision|3|||
142949288|NCT05755438|515353629|FG001|40-week OLE Period|Sponsor Decision|0|||
142949289|NCT05755438|515353628|FG000|40-week OLE Period|Did Not Complete Safety Follow-up Period|0|||
142949290|NCT05755438|515353629|FG001|40-week OLE Period|Did Not Complete Safety Follow-up Period|1|||
142949291|NCT05755438|515353628|FG000|40-week OLE Period|Ongoing|46|||
142949292|NCT05755438|515353629|FG001|40-week OLE Period|Ongoing|58|||
142949293|NCT03914300|515353631|FG000|Overall Study|Adverse Event|1|||
142949294|NCT01548638|515353639|FG000|Overall Study|Protocol Violation|3|||
142949295|NCT01548638|515353639|FG000|Overall Study|Withdrawal by Subject|1|||
142949296|NCT05445843|515353640|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|25|||
142949297|NCT05445843|515353641|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|5|||
142949298|NCT05445843|515353640|FG000|Overall Study|Progressive disease|17|||
142949299|NCT05445843|515353641|FG001|Overall Study|Progressive disease|9|||
142949300|NCT05445843|515353640|FG000|Overall Study|Physician Decision|16|||
142949301|NCT05445843|515353641|FG001|Overall Study|Physician Decision|4|||
142949302|NCT05445843|515353640|FG000|Overall Study|Death|6|||
142949303|NCT05445843|515353641|FG001|Overall Study|Death|3|||
142949304|NCT05445843|515353640|FG000|Overall Study|Subject decision|6|||
142949305|NCT05445843|515353641|FG001|Overall Study|Subject decision|2|||
142949306|NCT05445843|515353640|FG000|Overall Study|Adverse Event|2|||
142949307|NCT05445843|515353641|FG001|Overall Study|Adverse Event|0|||
142949308|NCT00144300|515353650|FG000|Overall Study|Adverse Event|18|||
142949309|NCT00144300|515353651|FG001|Overall Study|Adverse Event|16|||
142949310|NCT00144300|515353650|FG000|Overall Study|Protocol Violation|1|||
142949311|NCT00144300|515353651|FG001|Overall Study|Protocol Violation|3|||
142949312|NCT00144300|515353650|FG000|Overall Study|Lost to Follow-up|3|||
142949313|NCT00144300|515353651|FG001|Overall Study|Lost to Follow-up|0|||
142949314|NCT00144300|515353650|FG000|Overall Study|Withdrawal by Subject|6|||
142949315|NCT00144300|515353651|FG001|Overall Study|Withdrawal by Subject|6|||
142949316|NCT00144300|515353650|FG000|Overall Study|Other reason (not specified)|1|||
142949317|NCT00144300|515353651|FG001|Overall Study|Other reason (not specified)|3|||
142949318|NCT02426086|515353652|FG000|Overall Study|Death|33|||
142949319|NCT02426086|515353653|FG001|Overall Study|Death|36|||
142949320|NCT02426086|515353652|FG000|Overall Study|Lost to Follow-up|2|||
142949321|NCT02426086|515353653|FG001|Overall Study|Lost to Follow-up|0|||
142949322|NCT02426086|515353652|FG000|Overall Study|Study Terminated by Sponsor|5|||
142949323|NCT02426086|515353653|FG001|Overall Study|Study Terminated by Sponsor|14|||
142949324|NCT02426086|515353652|FG000|Overall Study|Withdrawal by Subject|8|||
142949325|NCT02426086|515353653|FG001|Overall Study|Withdrawal by Subject|9|||
142949326|NCT04070378|515353656|FG000|Overall Study|Withdrawal by Subject|2|||
142949327|NCT04070378|515353656|FG000|Overall Study|Screen Failure|6|||
142949328|NCT04070378|515353656|FG000|Overall Study|Physician Decision|1|||
142949329|NCT04070378|515353656|FG000|Overall Study|Adverse Event|1|||
142949330|NCT02462889|515353658|FG000|Overall Study|Withdrawal by Subject|2|||
142949331|NCT02462889|515353659|FG001|Overall Study|Withdrawal by Subject|6|||
142949332|NCT02462889|515353658|FG000|Overall Study|Death|1|||
142949333|NCT02462889|515353659|FG001|Overall Study|Death|5|||
142949334|NCT03596645|515353662|FG000|Overall Study|Adverse Event|17|||
142949335|NCT03596645|515353663|FG001|Overall Study|Adverse Event|0|||
142949336|NCT03596645|515353662|FG000|Overall Study|Lack of Efficacy|8|||
142949337|NCT03596645|515353663|FG001|Overall Study|Lack of Efficacy|0|||
142949338|NCT03596645|515353662|FG000|Overall Study|Lost to Follow-up|1|||
142949339|NCT03596645|515353663|FG001|Overall Study|Lost to Follow-up|1|||
142949340|NCT03596645|515353662|FG000|Overall Study|Physician Decision|1|||
142949341|NCT03596645|515353663|FG001|Overall Study|Physician Decision|1|||
142949342|NCT03596645|515353662|FG000|Overall Study|Protocol Violation|1|||
142949343|NCT03596645|515353663|FG001|Overall Study|Protocol Violation|0|||
142949344|NCT03596645|515353662|FG000|Overall Study|Initiated Prohibited Medication|1|||
142949345|NCT03596645|515353663|FG001|Overall Study|Initiated Prohibited Medication|0|||
142949346|NCT03596645|515353662|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
142949347|NCT03596645|515353663|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
142949348|NCT03596645|515353662|FG000|Overall Study|No mucosal healing achieved|1|||
142949349|NCT03596645|515353663|FG001|Overall Study|No mucosal healing achieved|0|||
142949350|NCT03596645|515353662|FG000|Overall Study|Disease progression|1|||
142949351|NCT03596645|515353663|FG001|Overall Study|Disease progression|0|||
142949352|NCT03596645|515353662|FG000|Overall Study|Ongoing|37|||
142949353|NCT03596645|515353663|FG001|Overall Study|Ongoing|12|||
142949354|NCT03596645|515353662|FG000|Overall Study|Randomized but not treated|0|||
142949355|NCT03596645|515353663|FG001|Overall Study|Randomized but not treated|1|||
142949356|NCT04636177|515353668|FG000|Two-arm, randomization portion|Withdrawal by Subject|1|||
142949357|NCT04636177|515353669|FG001|Two-arm, randomization portion|Withdrawal by Subject|1|||
142949358|NCT04636177|515353668|FG000|Two-arm, randomization portion|Lost to Follow-up|0|||
142949359|NCT04636177|515353669|FG001|Two-arm, randomization portion|Lost to Follow-up|1|||
142949360|NCT04636177|515353668|FG000|Single-arm portion|Withdrawal by Subject|1|||
142949361|NCT04636177|515353669|FG001|Single-arm portion|Withdrawal by Subject|0|||
142949362|NCT04636177|515353668|FG000|Single-arm portion|Adverse Event|1|||
142949363|NCT04636177|515353669|FG001|Single-arm portion|Adverse Event|0|||
142949364|NCT05278104|515353671|FG000|Overall Study|Not treated|1|||
142949365|NCT05278104|515353672|FG001|Overall Study|Not treated|0|||
142949366|NCT05278104|515353671|FG000|Overall Study|Adverse Event|2|||
142949367|NCT05278104|515353672|FG001|Overall Study|Adverse Event|1|||
142949368|NCT05278104|515353671|FG000|Overall Study|Exclusion criteria not met|1|||
142949369|NCT05278104|515353672|FG001|Overall Study|Exclusion criteria not met|0|||
142949370|NCT03439345|515354994|FG000|Overall Study|Lost to Follow-up|0|||
142949371|NCT03439345|515354995|FG001|Overall Study|Lost to Follow-up|1|||
142949372|NCT03439345|515354994|FG000|Overall Study|Consent withdrawn|0|||
142949373|NCT03439345|515354995|FG001|Overall Study|Consent withdrawn|1|||
142949374|NCT02495077|515355004|FG000|Overall Study|Adverse Event|0|||
142949375|NCT02495077|515355005|FG001|Overall Study|Adverse Event|1|||
142949376|NCT02495077|515355006|FG002|Overall Study|Adverse Event|1|||
142949377|NCT02495077|515355007|FG003|Overall Study|Adverse Event|0|||
142949378|NCT02495077|515355004|FG000|Overall Study|Death|3|||
142949379|NCT02495077|515355005|FG001|Overall Study|Death|5|||
142949380|NCT02495077|515355006|FG002|Overall Study|Death|0|||
142949381|NCT02495077|515355007|FG003|Overall Study|Death|0|||
142949382|NCT02495077|515355004|FG000|Overall Study|Lost to Follow-up|6|||
142949383|NCT02495077|515355005|FG001|Overall Study|Lost to Follow-up|4|||
142949384|NCT02495077|515355006|FG002|Overall Study|Lost to Follow-up|0|||
142949385|NCT02495077|515355007|FG003|Overall Study|Lost to Follow-up|0|||
142949386|NCT02495077|515355004|FG000|Overall Study|Physician Decision|2|||
142949387|NCT02495077|515355005|FG001|Overall Study|Physician Decision|1|||
142949388|NCT02495077|515355006|FG002|Overall Study|Physician Decision|4|||
142949389|NCT02495077|515355007|FG003|Overall Study|Physician Decision|0|||
142949390|NCT02495077|515355004|FG000|Overall Study|Protocol Violation|0|||
142949391|NCT02495077|515355005|FG001|Overall Study|Protocol Violation|1|||
142949392|NCT02495077|515355006|FG002|Overall Study|Protocol Violation|0|||
142949393|NCT02495077|515355007|FG003|Overall Study|Protocol Violation|0|||
142949394|NCT02495077|515355004|FG000|Overall Study|Screen Failure|0|||
142949395|NCT02495077|515355005|FG001|Overall Study|Screen Failure|0|||
142949396|NCT02495077|515355006|FG002|Overall Study|Screen Failure|0|||
142949397|NCT02495077|515355007|FG003|Overall Study|Screen Failure|48|||
142949398|NCT02495077|515355004|FG000|Overall Study|Withdrawal by Subject|7|||
142949399|NCT02495077|515355005|FG001|Overall Study|Withdrawal by Subject|7|||
142949400|NCT02495077|515355006|FG002|Overall Study|Withdrawal by Subject|7|||
142949401|NCT02495077|515355007|FG003|Overall Study|Withdrawal by Subject|0|||
142949402|NCT02495077|515355004|FG000|Overall Study|Covid-19 research restrictions|1|||
142949403|NCT02495077|515355005|FG001|Overall Study|Covid-19 research restrictions|0|||
143455069|NCT02663518|517210772|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
142949404|NCT02495077|515355006|FG002|Overall Study|Covid-19 research restrictions|0|||
142949405|NCT02495077|515355007|FG003|Overall Study|Covid-19 research restrictions|0|||
142949406|NCT02495077|515355004|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
142949407|NCT02495077|515355005|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
142949408|NCT02495077|515355006|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
142949409|NCT02495077|515355007|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
142949410|NCT02495077|515355004|FG000|Overall Study|Incarcerated|0|||
142949411|NCT02495077|515355005|FG001|Overall Study|Incarcerated|1|||
142949412|NCT02495077|515355006|FG002|Overall Study|Incarcerated|0|||
142949413|NCT02495077|515355007|FG003|Overall Study|Incarcerated|0|||
142949414|NCT02495077|515355004|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
142949415|NCT02495077|515355005|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
142949416|NCT02495077|515355006|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
142949417|NCT02495077|515355007|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
142949418|NCT02495077|515355004|FG000|Overall Study|Timing of transplant and randomization|0|||
142949419|NCT02495077|515355005|FG001|Overall Study|Timing of transplant and randomization|0|||
142949420|NCT02495077|515355006|FG002|Overall Study|Timing of transplant and randomization|5|||
142949421|NCT02495077|515355007|FG003|Overall Study|Timing of transplant and randomization|0|||
142949422|NCT02742649|515355008|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
142949423|NCT02742649|515355009|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
142949424|NCT02742649|515355010|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
142949425|NCT02742649|515355011|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
142949426|NCT02742649|515355012|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
142949427|NCT02742649|515355008|FG000|Double-Blind Treatment Period|Adverse Event|0|||
142949428|NCT02742649|515355009|FG001|Double-Blind Treatment Period|Adverse Event|1|||
142949429|NCT02742649|515355010|FG002|Double-Blind Treatment Period|Adverse Event|0|||
142949430|NCT02742649|515355011|FG003|Double-Blind Treatment Period|Adverse Event|0|||
142949431|NCT02742649|515355012|FG004|Double-Blind Treatment Period|Adverse Event|0|||
142949432|NCT02742649|515355008|FG000|Open-Label Period|Lost to Follow-up|0|||
142949433|NCT02742649|515355009|FG001|Open-Label Period|Lost to Follow-up|0|||
142949434|NCT02742649|515355010|FG002|Open-Label Period|Lost to Follow-up|0|||
142949435|NCT02742649|515355011|FG003|Open-Label Period|Lost to Follow-up|0|||
142949436|NCT02742649|515355012|FG004|Open-Label Period|Lost to Follow-up|1|||
142949437|NCT01981187|515355021|FG000|Overall Study|Participant/guardian decision|2|||
142949438|NCT01981187|515355021|FG000|Overall Study|Physician Decision|1|||
142949439|NCT01981187|515355021|FG000|Overall Study|Disease progression|2|||
142949440|NCT01981187|515355021|FG000|Overall Study|Adverse Event|7|||
142949441|NCT02082184|515355022|FG000|Overall Study|Adverse Event|1|||
142949442|NCT02082184|515355023|FG001|Overall Study|Adverse Event|0|||
142949443|NCT02082184|515355022|FG000|Overall Study|Medical diagnosis|1|||
142949444|NCT02082184|515355023|FG001|Overall Study|Medical diagnosis|2|||
142949445|NCT02082184|515355022|FG000|Overall Study|Device associated symptoms|5|||
142949446|NCT02082184|515355023|FG001|Overall Study|Device associated symptoms|0|||
142949447|NCT02082184|515355022|FG000|Overall Study|Withdrawal by Subject|3|||
142949448|NCT02082184|515355023|FG001|Overall Study|Withdrawal by Subject|2|||
142949449|NCT02082184|515355022|FG000|Overall Study|Protocol Violation|0|||
142949450|NCT02082184|515355023|FG001|Overall Study|Protocol Violation|6|||
142949451|NCT02082184|515355022|FG000|Overall Study|Lost to Follow-up|0|||
142949452|NCT02082184|515355023|FG001|Overall Study|Lost to Follow-up|2|||
142949453|NCT02082184|515355022|FG000|Overall Study|Subject non-compliance|0|||
142949454|NCT02082184|515355023|FG001|Overall Study|Subject non-compliance|1|||
142949455|NCT01362322|515355024|FG000|Overall Study|Withdrawal by Subject|3|||
142949456|NCT01362322|515355025|FG001|Overall Study|Withdrawal by Subject|1|||
142949457|NCT01362322|515355024|FG000|Overall Study|Lost to Follow-up|2|||
142949458|NCT01362322|515355025|FG001|Overall Study|Lost to Follow-up|6|||
142949459|NCT01943539|515355026|FG000|Overall Study|Non-compliance with at-home intervention|4|||
142949460|NCT01943539|515355027|FG001|Overall Study|Non-compliance with at-home intervention|0|||
142949461|NCT02401256|515355028|FG000|Overall Study|Adverse Event|5|||
142949462|NCT02401256|515355028|FG000|Overall Study|Withdrawal by Subject|12|||
142949463|NCT00430781|515355029|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
142949464|NCT00430781|515355030|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
142949465|NCT00430781|515355031|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
142949466|NCT00430781|515355029|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
142949467|NCT00430781|515355030|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
142949468|NCT00430781|515355031|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
142949469|NCT00430781|515355029|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
142949470|NCT00430781|515355030|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
142949471|NCT00430781|515355031|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
142949472|NCT00430781|515355029|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
142949473|NCT00430781|515355030|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
142949474|NCT00430781|515355031|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
142949475|NCT00430781|515355029|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
142949476|NCT00430781|515355030|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
142949477|NCT00430781|515355031|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
142949478|NCT00430781|515355029|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
142949479|NCT00430781|515355030|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
142949480|NCT00430781|515355031|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
142949481|NCT00430781|515355029|FG000|Interim Analysis; 11 February 2008|Death|0|||
142949482|NCT00430781|515355030|FG001|Interim Analysis; 11 February 2008|Death|1|||
142949483|NCT00430781|515355031|FG002|Interim Analysis; 11 February 2008|Death|0|||
142949484|NCT00430781|515355029|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
142949485|NCT00430781|515355030|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
142949486|NCT00430781|515355031|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
142949487|NCT00430781|515355029|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
142949488|NCT00430781|515355030|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
142949489|NCT00430781|515355031|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
142949490|NCT00430781|515355029|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
142949491|NCT00430781|515355030|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
142949492|NCT00430781|515355031|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
142949493|NCT00430781|515355029|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
142949494|NCT00430781|515355030|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
142949495|NCT00430781|515355031|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
142949496|NCT00430781|515355029|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
142949497|NCT00430781|515355030|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
142949498|NCT00430781|515355031|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
142949499|NCT00430781|515355029|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
142949500|NCT00430781|515355030|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
142949501|NCT00430781|515355031|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
142949502|NCT00430781|515355029|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
142949503|NCT00430781|515355030|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
142949504|NCT00430781|515355031|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
142949505|NCT00430781|515355029|FG000|Final Analysis; 31 July 2008|Other|0|||
142949506|NCT00430781|515355030|FG001|Final Analysis; 31 July 2008|Other|1|||
142949507|NCT00430781|515355031|FG002|Final Analysis; 31 July 2008|Other|0|||
142949508|NCT00430781|515355029|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
142949509|NCT00430781|515355030|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
142949510|NCT00430781|515355031|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
142949511|NCT00430781|515355029|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
142949512|NCT00430781|515355030|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
142949513|NCT00430781|515355031|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
142949514|NCT00430781|515355029|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
142949515|NCT00430781|515355030|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
142949516|NCT00430781|515355031|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
142949517|NCT00430781|515355029|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
142949518|NCT00430781|515355030|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
142949519|NCT00430781|515355031|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
142949520|NCT00430781|515355029|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
142949521|NCT00430781|515355030|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
142949522|NCT00430781|515355031|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
142949523|NCT00430781|515355029|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
142949524|NCT00430781|515355030|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
142949525|NCT00430781|515355031|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
142949526|NCT00430781|515355029|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
142949527|NCT00430781|515355030|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
142949528|NCT00430781|515355031|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
142949529|NCT02158533|515355034|FG000|Stage 1|Adverse Event|6|||
142949530|NCT02158533|515355035|FG001|Stage 1|Adverse Event|4|||
142949531|NCT02158533|515355036|FG002|Stage 1|Adverse Event|7|||
142949532|NCT02158533|515355037|FG003|Stage 1|Adverse Event|0|||
142949533|NCT02158533|515355038|FG004|Stage 1|Adverse Event|0|||
142949534|NCT02158533|515355039|FG005|Stage 1|Adverse Event|0|||
142949535|NCT02158533|515355034|FG000|Stage 1|Withdrawal by Subject|3|||
142949536|NCT02158533|515355035|FG001|Stage 1|Withdrawal by Subject|2|||
142949537|NCT02158533|515355036|FG002|Stage 1|Withdrawal by Subject|1|||
142949538|NCT02158533|515355037|FG003|Stage 1|Withdrawal by Subject|0|||
142949539|NCT02158533|515355038|FG004|Stage 1|Withdrawal by Subject|0|||
142949540|NCT02158533|515355039|FG005|Stage 1|Withdrawal by Subject|0|||
142949541|NCT02158533|515355034|FG000|Stage 1|Lack of Efficacy|1|||
142949542|NCT02158533|515355035|FG001|Stage 1|Lack of Efficacy|0|||
142949543|NCT02158533|515355036|FG002|Stage 1|Lack of Efficacy|0|||
142949544|NCT02158533|515355037|FG003|Stage 1|Lack of Efficacy|0|||
142949545|NCT02158533|515355038|FG004|Stage 1|Lack of Efficacy|0|||
142949546|NCT02158533|515355039|FG005|Stage 1|Lack of Efficacy|0|||
142949547|NCT02158533|515355034|FG000|Stage 1|Lost to Follow-up|3|||
142949548|NCT02158533|515355035|FG001|Stage 1|Lost to Follow-up|1|||
142949549|NCT02158533|515355036|FG002|Stage 1|Lost to Follow-up|0|||
142949550|NCT02158533|515355037|FG003|Stage 1|Lost to Follow-up|0|||
142949551|NCT02158533|515355038|FG004|Stage 1|Lost to Follow-up|0|||
142949552|NCT02158533|515355039|FG005|Stage 1|Lost to Follow-up|0|||
142949553|NCT02158533|515355034|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
142949554|NCT02158533|515355035|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
142949555|NCT02158533|515355036|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
142949556|NCT02158533|515355037|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
142949557|NCT02158533|515355038|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
142949558|NCT02158533|515355039|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
142949559|NCT02158533|515355034|FG000|Stage 1|Non-compliance with study visits|1|||
142949560|NCT02158533|515355035|FG001|Stage 1|Non-compliance with study visits|0|||
142949561|NCT02158533|515355036|FG002|Stage 1|Non-compliance with study visits|0|||
142949562|NCT02158533|515355037|FG003|Stage 1|Non-compliance with study visits|0|||
142949563|NCT02158533|515355038|FG004|Stage 1|Non-compliance with study visits|0|||
142949564|NCT02158533|515355039|FG005|Stage 1|Non-compliance with study visits|0|||
142949565|NCT02158533|515355034|FG000|Stage 2|Adverse Event|0|||
142949566|NCT02158533|515355035|FG001|Stage 2|Adverse Event|0|||
142949567|NCT02158533|515355036|FG002|Stage 2|Adverse Event|0|||
142949568|NCT02158533|515355037|FG003|Stage 2|Adverse Event|0|||
142949569|NCT02158533|515355038|FG004|Stage 2|Adverse Event|0|||
142949570|NCT02158533|515355039|FG005|Stage 2|Adverse Event|1|||
142949571|NCT02158533|515355034|FG000|Stage 2|Lack of Efficacy|0|||
142949572|NCT02158533|515355035|FG001|Stage 2|Lack of Efficacy|0|||
142949573|NCT02158533|515355036|FG002|Stage 2|Lack of Efficacy|0|||
142949574|NCT02158533|515355037|FG003|Stage 2|Lack of Efficacy|0|||
142949575|NCT02158533|515355038|FG004|Stage 2|Lack of Efficacy|1|||
142949576|NCT02158533|515355039|FG005|Stage 2|Lack of Efficacy|0|||
142949577|NCT02158533|515355034|FG000|Stage 2|Lost to Follow-up|0|||
142949578|NCT02158533|515355035|FG001|Stage 2|Lost to Follow-up|0|||
142949579|NCT02158533|515355036|FG002|Stage 2|Lost to Follow-up|0|||
142949580|NCT02158533|515355037|FG003|Stage 2|Lost to Follow-up|1|||
142949581|NCT02158533|515355038|FG004|Stage 2|Lost to Follow-up|1|||
142949582|NCT02158533|515355039|FG005|Stage 2|Lost to Follow-up|2|||
142949583|NCT02158533|515355034|FG000|Stage 2|Withdrawal by Subject|0|||
142949584|NCT02158533|515355035|FG001|Stage 2|Withdrawal by Subject|0|||
142949585|NCT02158533|515355036|FG002|Stage 2|Withdrawal by Subject|0|||
142949586|NCT02158533|515355037|FG003|Stage 2|Withdrawal by Subject|0|||
142949587|NCT02158533|515355038|FG004|Stage 2|Withdrawal by Subject|1|||
142949588|NCT02158533|515355039|FG005|Stage 2|Withdrawal by Subject|2|||
142949589|NCT02158533|515355034|FG000|Stage 2|Physician Decision|0|||
142949590|NCT02158533|515355035|FG001|Stage 2|Physician Decision|0|||
142949591|NCT02158533|515355036|FG002|Stage 2|Physician Decision|0|||
142949592|NCT02158533|515355037|FG003|Stage 2|Physician Decision|0|||
142949593|NCT02158533|515355038|FG004|Stage 2|Physician Decision|1|||
142949594|NCT02158533|515355039|FG005|Stage 2|Physician Decision|0|||
142949595|NCT02158533|515355034|FG000|Stage 2|Pregnancy|0|||
142949596|NCT02158533|515355035|FG001|Stage 2|Pregnancy|0|||
142949597|NCT02158533|515355036|FG002|Stage 2|Pregnancy|0|||
142949598|NCT02158533|515355037|FG003|Stage 2|Pregnancy|1|||
142949599|NCT02158533|515355038|FG004|Stage 2|Pregnancy|0|||
142949600|NCT02158533|515355039|FG005|Stage 2|Pregnancy|0|||
142949601|NCT02158533|515355034|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
142949602|NCT02158533|515355035|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
142949603|NCT02158533|515355036|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
142949604|NCT02158533|515355037|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
142949605|NCT02158533|515355038|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
142949606|NCT02158533|515355039|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
142949607|NCT02158533|515355034|FG000|Stage 2|Non-adherence with study visits|0|||
142949608|NCT02158533|515355035|FG001|Stage 2|Non-adherence with study visits|0|||
142949609|NCT02158533|515355036|FG002|Stage 2|Non-adherence with study visits|0|||
142949610|NCT02158533|515355037|FG003|Stage 2|Non-adherence with study visits|0|||
142949611|NCT02158533|515355038|FG004|Stage 2|Non-adherence with study visits|0|||
142949612|NCT02158533|515355039|FG005|Stage 2|Non-adherence with study visits|1|||
142949613|NCT02037919|515355042|FG000|Overall Study|Lost to Follow-up|30|||
142949614|NCT02037919|515355043|FG001|Overall Study|Lost to Follow-up|45|||
142949615|NCT01335971|515355044|FG000|Overall Study|Withdrawal by Subject|1|||
142949616|NCT01335971|515355045|FG001|Overall Study|Withdrawal by Subject|0|||
142949617|NCT01335971|515355046|FG002|Overall Study|Withdrawal by Subject|0|||
142949618|NCT01335971|515355044|FG000|Overall Study|Did not complete bronchoscopy|1|||
142949619|NCT01335971|515355045|FG001|Overall Study|Did not complete bronchoscopy|1|||
142949620|NCT01335971|515355046|FG002|Overall Study|Did not complete bronchoscopy|1|||
142949621|NCT00384956|515355047|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
142949622|NCT00149214|515355048|FG000|Overall Study|Adverse Event|12|||
142949623|NCT00149214|515355049|FG001|Overall Study|Adverse Event|9|||
142949624|NCT00149214|515355048|FG000|Overall Study|Withdrawal by Subject|4|||
142949625|NCT00149214|515355049|FG001|Overall Study|Withdrawal by Subject|1|||
142949626|NCT00149214|515355048|FG000|Overall Study|Physician Decision|3|||
142949627|NCT00149214|515355049|FG001|Overall Study|Physician Decision|3|||
142949628|NCT00149214|515355048|FG000|Overall Study|Sponsor Decision|0|||
142949629|NCT00149214|515355049|FG001|Overall Study|Sponsor Decision|1|||
142949630|NCT00149214|515355048|FG000|Overall Study|Progressive Disease|7|||
143455070|NCT02663518|517210759|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
143455071|NCT02663518|517210760|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
142949631|NCT00149214|515355049|FG001|Overall Study|Progressive Disease|3|||
142949632|NCT00174941|515355050|FG000|Overall Study|Adverse Event|1|||
142949633|NCT00174941|515355051|FG001|Overall Study|Adverse Event|10|||
142949634|NCT00174941|515355052|FG002|Overall Study|Adverse Event|2|||
142949635|NCT00174941|515355053|FG003|Overall Study|Adverse Event|13|||
142949636|NCT00174941|515355050|FG000|Overall Study|Protocol Violation|0|||
142949637|NCT00174941|515355051|FG001|Overall Study|Protocol Violation|1|||
142949638|NCT00174941|515355052|FG002|Overall Study|Protocol Violation|0|||
142949639|NCT00174941|515355053|FG003|Overall Study|Protocol Violation|1|||
142949640|NCT00174941|515355050|FG000|Overall Study|Lost to Follow-up|0|||
142949641|NCT00174941|515355051|FG001|Overall Study|Lost to Follow-up|3|||
142949642|NCT00174941|515355052|FG002|Overall Study|Lost to Follow-up|2|||
142949643|NCT00174941|515355053|FG003|Overall Study|Lost to Follow-up|5|||
142949644|NCT00174941|515355050|FG000|Overall Study|Personal Reason(s)|0|||
142949645|NCT00174941|515355051|FG001|Overall Study|Personal Reason(s)|14|||
142949646|NCT00174941|515355052|FG002|Overall Study|Personal Reason(s)|8|||
142949647|NCT00174941|515355053|FG003|Overall Study|Personal Reason(s)|22|||
142949648|NCT00174941|515355050|FG000|Overall Study|Gout Flare|0|||
142949649|NCT00174941|515355051|FG001|Overall Study|Gout Flare|4|||
142949650|NCT00174941|515355052|FG002|Overall Study|Gout Flare|4|||
142949651|NCT00174941|515355053|FG003|Overall Study|Gout Flare|8|||
142949652|NCT00174941|515355050|FG000|Overall Study|Reason Not Specified|1|||
142949653|NCT00174941|515355051|FG001|Overall Study|Reason Not Specified|6|||
142949654|NCT00174941|515355052|FG002|Overall Study|Reason Not Specified|2|||
142949655|NCT00174941|515355053|FG003|Overall Study|Reason Not Specified|9|||
142949656|NCT03230097|515355056|FG000|Overall Study|Adverse Event|2|||
142949657|NCT03230097|515355057|FG001|Overall Study|Adverse Event|1|||
142949658|NCT03230097|515355056|FG000|Overall Study|non-compliance|0|||
142949659|NCT03230097|515355057|FG001|Overall Study|non-compliance|1|||
142949660|NCT03230097|515355056|FG000|Overall Study|Lost to Follow-up|2|||
142949661|NCT03230097|515355057|FG001|Overall Study|Lost to Follow-up|4|||
142949662|NCT03230097|515355056|FG000|Overall Study|Withdrawal by Subject|7|||
143455072|NCT02663518|517210761|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
143455073|NCT02663518|517210762|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
142949663|NCT03230097|515355057|FG001|Overall Study|Withdrawal by Subject|3|||
142949664|NCT03230097|515355056|FG000|Overall Study|Trial termination|4|||
142949665|NCT03230097|515355057|FG001|Overall Study|Trial termination|5|||
142949666|NCT03230097|515355056|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
142949667|NCT03230097|515355057|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
142949668|NCT03230097|515355056|FG000|Overall Study|outcome event|0|||
142949669|NCT03230097|515355057|FG001|Overall Study|outcome event|1|||
142949670|NCT03056287|515355058|FG000|Overall Study|Withdrawal by Subject|0|||
142949671|NCT03056287|515355059|FG001|Overall Study|Withdrawal by Subject|1|||
142949672|NCT03056287|515355060|FG002|Overall Study|Withdrawal by Subject|0|||
142949673|NCT03056287|515355061|FG003|Overall Study|Withdrawal by Subject|0|||
142949674|NCT03056287|515355058|FG000|Overall Study|move out of area|0|||
142949675|NCT03056287|515355059|FG001|Overall Study|move out of area|0|||
142949676|NCT03056287|515355060|FG002|Overall Study|move out of area|1|||
142949677|NCT03056287|515355061|FG003|Overall Study|move out of area|1|||
142949678|NCT03700892|515355062|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
142949679|NCT03700892|515355063|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
142949680|NCT03700892|515355064|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
142949681|NCT00849212|515355065|FG000|Overall Study|Lack of Efficacy|1|||
142949682|NCT00849212|515355065|FG000|Overall Study|Withdrawal by Subject|3|||
142949683|NCT00849212|515355065|FG000|Overall Study|Adverse Event|2|||
142949684|NCT00849212|515355065|FG000|Overall Study|Miscellaneous|1|||
142949685|NCT01499576|515355066|FG000|Overall Study|Physician Decision|12|||
142949686|NCT01499576|515355066|FG000|Overall Study|Withdrawal by Subject|9|||
142949687|NCT01254344|515355078|FG000|Overall Study|Adverse Event|2|||
142949688|NCT01254344|515355079|FG001|Overall Study|Adverse Event|5|||
142949689|NCT01254344|515355078|FG000|Overall Study|Physician Decision|7|||
142949690|NCT01254344|515355079|FG001|Overall Study|Physician Decision|4|||
142949691|NCT01254344|515355078|FG000|Overall Study|Protocol Violation|1|||
142949692|NCT01254344|515355079|FG001|Overall Study|Protocol Violation|4|||
142949693|NCT01254344|515355078|FG000|Overall Study|Withdrawal by Subject|3|||
142949694|NCT01254344|515355079|FG001|Overall Study|Withdrawal by Subject|6|||
142949695|NCT00845429|515355080|FG000|Overall Study|Protocol Violation|5|||
142949696|NCT00845429|515355081|FG001|Overall Study|Protocol Violation|4|||
142949697|NCT00845429|515355082|FG002|Overall Study|Protocol Violation|7|||
142949698|NCT00845429|515355080|FG000|Overall Study|Lost to Follow-up|7|||
142949699|NCT00845429|515355081|FG001|Overall Study|Lost to Follow-up|9|||
142949700|NCT00845429|515355082|FG002|Overall Study|Lost to Follow-up|10|||
142949701|NCT00845429|515355080|FG000|Overall Study|Withdrawal by Subject|2|||
142949702|NCT00845429|515355081|FG001|Overall Study|Withdrawal by Subject|2|||
142949703|NCT00845429|515355082|FG002|Overall Study|Withdrawal by Subject|2|||
142949704|NCT00845429|515355080|FG000|Overall Study|Serious adverse event|0|||
142949705|NCT00845429|515355081|FG001|Overall Study|Serious adverse event|0|||
142949706|NCT00845429|515355082|FG002|Overall Study|Serious adverse event|1|||
142949707|NCT00195351|515355085|FG000|Overall Study|Lost to Follow-up|9|||
142949708|NCT00195351|515355086|FG001|Overall Study|Lost to Follow-up|9|||
142949709|NCT00195351|515355085|FG000|Overall Study|Withdrawal by Subject|6|||
142949710|NCT00195351|515355086|FG001|Overall Study|Withdrawal by Subject|3|||
142949711|NCT00195351|515355085|FG000|Overall Study|Protocol Deviation|3|||
142949712|NCT00195351|515355086|FG001|Overall Study|Protocol Deviation|2|||
142949713|NCT00195351|515355085|FG000|Overall Study|Death|3|||
142949714|NCT00195351|515355086|FG001|Overall Study|Death|1|||
142949715|NCT00195351|515355085|FG000|Overall Study|Lack of Efficacy|0|||
142949716|NCT00195351|515355086|FG001|Overall Study|Lack of Efficacy|1|||
142949717|NCT02111369|515355087|FG000|Overall Study|Lost to Follow-up|2|||
142949718|NCT02111369|515355087|FG000|Overall Study|Withdrawal by Subject|1|||
142949719|NCT00519623|515355091|FG000|Overall Study|Adverse Event|1|||
142949720|NCT01591330|515355094|FG000|Period 1|Adverse Event|1|||
142949721|NCT01591330|515355095|FG001|Period 1|Adverse Event|0|||
142949722|NCT01591330|515355096|FG002|Period 1|Adverse Event|0|||
142949723|NCT01591330|515355097|FG003|Period 1|Adverse Event|0|||
142949724|NCT01591330|515355094|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
142949725|NCT01591330|515355095|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
142949726|NCT01591330|515355096|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
142949727|NCT01591330|515355097|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
142949728|NCT01591330|515355094|FG000|Period 2|Adverse Event|1|||
142949729|NCT01591330|515355095|FG001|Period 2|Adverse Event|0|||
142949730|NCT01591330|515355096|FG002|Period 2|Adverse Event|0|||
142949731|NCT01591330|515355097|FG003|Period 2|Adverse Event|0|||
142949732|NCT01450137|515355098|FG000|Up to Week 12|Adverse Event|2|||
142949733|NCT01450137|515355099|FG001|Up to Week 12|Adverse Event|1|||
142949734|NCT01450137|515355098|FG000|Up to Week 12|Withdrawal by Subject|0|||
142949735|NCT01450137|515355099|FG001|Up to Week 12|Withdrawal by Subject|2|||
142949736|NCT01450137|515355098|FG000|Week 12 to Study End|Death|0|||
142949737|NCT01450137|515355099|FG001|Week 12 to Study End|Death|1|||
142949738|NCT01450137|515355098|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
142949739|NCT01450137|515355099|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
142949740|NCT04090164|515355106|FG000|Overall Study|incomplete data on file|245|||
142949741|NCT04090164|515355107|FG001|Overall Study|incomplete data on file|0|||
142949742|NCT03414359|515355111|FG000|Overall Study|Lack of Efficacy|1|||
142949743|NCT03414359|515355112|FG001|Overall Study|Lack of Efficacy|1|||
142949744|NCT03414359|515355111|FG000|Overall Study|Protocol Violation|0|||
142949745|NCT03414359|515355112|FG001|Overall Study|Protocol Violation|1|||
142949746|NCT00095121|515355113|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
142949747|NCT00095121|515355114|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
142949748|NCT00095121|515355113|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
142949749|NCT00095121|515355114|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
142949750|NCT02032524|515355117|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
142949751|NCT02032524|515355118|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
142949752|NCT02032524|515355119|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
142949753|NCT02032524|515355120|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
142949754|NCT02032524|515355121|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
142949755|NCT02032524|515355122|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
142949756|NCT02032524|515355117|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
142949757|NCT02032524|515355118|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
142949758|NCT02032524|515355119|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
142949759|NCT02032524|515355120|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
142949760|NCT02032524|515355121|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
142949761|NCT02032524|515355122|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
142949762|NCT02032524|515355117|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
142949763|NCT02032524|515355118|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
142949764|NCT02032524|515355119|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
142949765|NCT02032524|515355120|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
142949766|NCT02032524|515355121|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
142949767|NCT02032524|515355122|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
142949768|NCT02032524|515355117|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
142949769|NCT02032524|515355118|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
142949770|NCT02032524|515355119|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
142949771|NCT02032524|515355120|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
142949772|NCT02032524|515355121|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
142949773|NCT02032524|515355122|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
142949774|NCT02032524|515355117|FG000|Period 2: LTS13769 Study|Other|0|||
142949775|NCT02032524|515355118|FG001|Period 2: LTS13769 Study|Other|0|||
142949776|NCT02032524|515355119|FG002|Period 2: LTS13769 Study|Other|0|||
142949777|NCT02032524|515355120|FG003|Period 2: LTS13769 Study|Other|0|||
142949778|NCT02032524|515355121|FG004|Period 2: LTS13769 Study|Other|0|||
142949779|NCT02032524|515355122|FG005|Period 2: LTS13769 Study|Other|1|||
142949780|NCT02277444|515355126|FG000|Treatment Period (Week 0-52)|Adverse Event|11|||
142949781|NCT02277444|515355126|FG000|Treatment Period (Week 0-52)|Withdrawal by Subject|3|||
142949782|NCT02277444|515355126|FG000|Treatment Period (Week 0-52)|Other|1|||
142949783|NCT02277444|515355126|FG000|Treatment Period (Week 0-52)|Enrolled and not Treated|3|||
142949784|NCT02277444|515355126|FG000|LTE Period (Week 52 to Week 252)|Other|43|||
142949785|NCT02277444|515355126|FG000|ETP Period (Week 252 to Week 420)|Adverse Event|1|||
142949786|NCT02277444|515355126|FG000|ETP Period (Week 252 to Week 420)|Physician Decision|3|||
142949787|NCT02277444|515355126|FG000|ETP Period (Week 252 to Week 420)|Withdrawal by Subject|2|||
142949788|NCT02277444|515355126|FG000|ETP Period (Week 252 to Week 420)|Other|8|||
142949789|NCT03167619|515357345|FG000|Overall Study|Death|11|||
142949790|NCT03167619|515357346|FG001|Overall Study|Death|8|||
142949791|NCT03167619|515357345|FG000|Overall Study|Withdrawal by Subject|1|||
142949792|NCT03167619|515357346|FG001|Overall Study|Withdrawal by Subject|2|||
142949793|NCT03167619|515357345|FG000|Overall Study|Physician Decision|0|||
142949794|NCT03167619|515357346|FG001|Overall Study|Physician Decision|1|||
142949795|NCT01348919|515357349|FG000|Overall Study|Adverse Event|3|||
142949796|NCT01348919|515357350|FG001|Overall Study|Adverse Event|1|||
142949797|NCT01348919|515357351|FG002|Overall Study|Adverse Event|0|||
142949798|NCT01348919|515357349|FG000|Overall Study|Withdrawal by Subject|0|||
142949799|NCT01348919|515357350|FG001|Overall Study|Withdrawal by Subject|1|||
142949800|NCT01348919|515357351|FG002|Overall Study|Withdrawal by Subject|0|||
142949801|NCT01348919|515357349|FG000|Overall Study|Disease progression|0|||
142949802|NCT01348919|515357350|FG001|Overall Study|Disease progression|1|||
142949803|NCT01348919|515357351|FG002|Overall Study|Disease progression|1|||
142949804|NCT00443560|515357352|FG000|Overall Study|No intrathecal dose|58|||
142949805|NCT00443560|515357353|FG001|Overall Study|No intrathecal dose|26|||
142949806|NCT00443560|515357352|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
142949807|NCT00443560|515357353|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
142949808|NCT02333331|515357354|FG000|Overall Study|Adverse Event|1|||
142949809|NCT02333331|515357355|FG001|Overall Study|Adverse Event|0|||
142949810|NCT02333331|515357356|FG002|Overall Study|Adverse Event|4|||
142949811|NCT02333331|515357357|FG003|Overall Study|Adverse Event|1|||
142949812|NCT02333331|515357354|FG000|Overall Study|Death|0|||
142949813|NCT02333331|515357355|FG001|Overall Study|Death|0|||
142949814|NCT02333331|515357356|FG002|Overall Study|Death|2|||
142949815|NCT02333331|515357357|FG003|Overall Study|Death|0|||
142949816|NCT02333331|515357354|FG000|Overall Study|Lost to Follow-up|0|||
142949817|NCT02333331|515357355|FG001|Overall Study|Lost to Follow-up|0|||
142949818|NCT02333331|515357356|FG002|Overall Study|Lost to Follow-up|1|||
142949819|NCT02333331|515357357|FG003|Overall Study|Lost to Follow-up|0|||
142949820|NCT02333331|515357354|FG000|Overall Study|Physician Decision|0|||
142949821|NCT02333331|515357355|FG001|Overall Study|Physician Decision|1|||
142949822|NCT02333331|515357356|FG002|Overall Study|Physician Decision|0|||
142949823|NCT02333331|515357357|FG003|Overall Study|Physician Decision|0|||
142949824|NCT02333331|515357354|FG000|Overall Study|Protocol Deviation|0|||
142949825|NCT02333331|515357355|FG001|Overall Study|Protocol Deviation|3|||
142949826|NCT02333331|515357356|FG002|Overall Study|Protocol Deviation|2|||
142949827|NCT02333331|515357357|FG003|Overall Study|Protocol Deviation|1|||
142949828|NCT02333331|515357354|FG000|Overall Study|Patient/Guardian Decision|1|||
142949829|NCT02333331|515357355|FG001|Overall Study|Patient/Guardian Decision|2|||
142949830|NCT02333331|515357356|FG002|Overall Study|Patient/Guardian Decision|9|||
142949831|NCT02333331|515357357|FG003|Overall Study|Patient/Guardian Decision|1|||
142949832|NCT01059812|515357362|FG000|Overall Study|Adverse Event|9|||
142949833|NCT01059812|515357363|FG001|Overall Study|Adverse Event|5|||
142949834|NCT01059812|515357362|FG000|Overall Study|Lack of Efficacy|2|||
142949835|NCT01059812|515357363|FG001|Overall Study|Lack of Efficacy|2|||
142949836|NCT01059812|515357362|FG000|Overall Study|Protocol Violation|3|||
142949837|NCT01059812|515357363|FG001|Overall Study|Protocol Violation|1|||
142949838|NCT01059812|515357362|FG000|Overall Study|Withdrawal Criteria|9|||
142949839|NCT01059812|515357363|FG001|Overall Study|Withdrawal Criteria|4|||
142949840|NCT01059812|515357362|FG000|Overall Study|Unclassified|14|||
142949841|NCT01059812|515357363|FG001|Overall Study|Unclassified|4|||
142949842|NCT00756002|515357367|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
142949843|NCT00756002|515357368|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
142949844|NCT00756002|515357367|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
142949845|NCT00756002|515357368|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
142949846|NCT00756002|515357367|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
142949847|NCT00756002|515357368|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
142949848|NCT00756002|515357367|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
142949849|NCT00756002|515357368|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
142949850|NCT00756002|515357367|FG000|Double-Blind Treatment Period|Other|2|||
142949851|NCT00756002|515357368|FG001|Double-Blind Treatment Period|Other|2|||
142949852|NCT03126227|515357369|FG000|Overall Study|Adverse Event|43|||
142949853|NCT03126227|515357370|FG001|Overall Study|Adverse Event|4|||
142949854|NCT03126227|515357369|FG000|Overall Study|Death|0|||
142949855|NCT03126227|515357370|FG001|Overall Study|Death|1|||
142949856|NCT03126227|515357369|FG000|Overall Study|Lost to Follow-up|0|||
142949857|NCT03126227|515357370|FG001|Overall Study|Lost to Follow-up|1|||
142949858|NCT03126227|515357369|FG000|Overall Study|Physician Decision|2|||
142949859|NCT03126227|515357370|FG001|Overall Study|Physician Decision|0|||
142949860|NCT03126227|515357369|FG000|Overall Study|Protocol Violation|1|||
142949861|NCT03126227|515357370|FG001|Overall Study|Protocol Violation|0|||
142949862|NCT03126227|515357369|FG000|Overall Study|Withdrawal by Subject|19|||
143117122|NCT02565706|515970037|FG003|Overall Study|Lost to Follow-up|74|||
142949863|NCT03126227|515357370|FG001|Overall Study|Withdrawal by Subject|3|||
143003110|NCT01049360|515548762|FG018|Period 1|Withdrawal by Subject|0|||
142949864|NCT03126227|515357369|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
142949865|NCT03126227|515357370|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
142949866|NCT03126227|515357369|FG000|Overall Study|Lack of dosing compliance|2|||
142949867|NCT03126227|515357370|FG001|Overall Study|Lack of dosing compliance|0|||
142949868|NCT03126227|515357369|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
142949869|NCT03126227|515357370|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
142949870|NCT03126227|515357369|FG000|Overall Study|Scheduling conflict|1|||
142949871|NCT03126227|515357370|FG001|Overall Study|Scheduling conflict|0|||
142949872|NCT03351244|515357375|FG000|Overall Study|Adverse Event|7|||
142949873|NCT03351244|515357376|FG001|Overall Study|Adverse Event|11|||
142949874|NCT03351244|515357377|FG002|Overall Study|Adverse Event|12|||
142949875|NCT03351244|515357375|FG000|Overall Study|Investigator's decision|0|||
142949876|NCT03351244|515357376|FG001|Overall Study|Investigator's decision|0|||
142949877|NCT03351244|515357377|FG002|Overall Study|Investigator's decision|2|||
142949878|NCT03351244|515357375|FG000|Overall Study|System error|0|||
142949879|NCT03351244|515357376|FG001|Overall Study|System error|0|||
142949880|NCT03351244|515357377|FG002|Overall Study|System error|2|||
142949881|NCT03351244|515357375|FG000|Overall Study|COVID-19 restrictions|3|||
142949882|NCT03351244|515357376|FG001|Overall Study|COVID-19 restrictions|0|||
142949883|NCT03351244|515357377|FG002|Overall Study|COVID-19 restrictions|1|||
142949884|NCT03351244|515357375|FG000|Overall Study|Non-compliance|2|||
142949885|NCT03351244|515357376|FG001|Overall Study|Non-compliance|5|||
142949886|NCT03351244|515357377|FG002|Overall Study|Non-compliance|0|||
142949887|NCT03351244|515357375|FG000|Overall Study|Withdrawal by Subject|11|||
142949888|NCT03351244|515357376|FG001|Overall Study|Withdrawal by Subject|16|||
142949889|NCT03351244|515357377|FG002|Overall Study|Withdrawal by Subject|13|||
142949890|NCT03351244|515357375|FG000|Overall Study|Lost to Follow-up|2|||
142949891|NCT03351244|515357376|FG001|Overall Study|Lost to Follow-up|6|||
142949892|NCT03351244|515357377|FG002|Overall Study|Lost to Follow-up|4|||
142949893|NCT03351244|515357375|FG000|Overall Study|Protocol Violation|2|||
142949894|NCT03351244|515357376|FG001|Overall Study|Protocol Violation|2|||
142949895|NCT03351244|515357377|FG002|Overall Study|Protocol Violation|0|||
142949896|NCT00440401|515357394|FG000|Overall Study|Adverse Event|2|||
142949897|NCT00440401|515357395|FG001|Overall Study|Adverse Event|1|||
142949898|NCT00440401|515357394|FG000|Overall Study|Other|2|||
142949899|NCT00440401|515357395|FG001|Overall Study|Other|5|||
142949900|NCT01925703|515357396|FG000|Overall Study|Physician Decision|1|||
142949901|NCT01925703|515357396|FG000|Overall Study|Lost to Follow-up|2|||
142949902|NCT01925703|515357396|FG000|Overall Study|Discharge prior to full iron repletion|1|||
142949903|NCT01938625|515357397|FG000|Overall Study|Withdrawal by Subject|0|||
142949904|NCT01938625|515357398|FG001|Overall Study|Withdrawal by Subject|1|||
142949905|NCT01938625|515357397|FG000|Overall Study|Adverse Event|0|||
142949906|NCT01938625|515357398|FG001|Overall Study|Adverse Event|1|||
142949907|NCT01937312|515357399|FG000|Overall Study|Adverse Event|10|||
142949908|NCT01937312|515357400|FG001|Overall Study|Adverse Event|1|||
142949909|NCT01937312|515357399|FG000|Overall Study|Lack of Efficacy|0|||
142949910|NCT01937312|515357400|FG001|Overall Study|Lack of Efficacy|1|||
142949911|NCT01937312|515357399|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
142949912|NCT01937312|515357400|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
142949913|NCT00091793|515357401|FG000|Overall Study|Adverse Event|1|||
142949914|NCT00091793|515357402|FG001|Overall Study|Adverse Event|2|||
142949915|NCT00091793|515357401|FG000|Overall Study|Withdrawal by Subject|10|||
142949916|NCT00091793|515357402|FG001|Overall Study|Withdrawal by Subject|15|||
142949917|NCT00091793|515357401|FG000|Overall Study|Ineligibility determined|2|||
142949918|NCT00091793|515357402|FG001|Overall Study|Ineligibility determined|0|||
142949919|NCT00091793|515357401|FG000|Overall Study|Lost to Follow-up|7|||
142949920|NCT00091793|515357402|FG001|Overall Study|Lost to Follow-up|5|||
142949921|NCT00091793|515357401|FG000|Overall Study|Noncompliance|2|||
142949922|NCT00091793|515357402|FG001|Overall Study|Noncompliance|0|||
142949923|NCT00091793|515357401|FG000|Overall Study|Other|2|||
142949924|NCT00091793|515357402|FG001|Overall Study|Other|0|||
142949925|NCT03794986|515357403|FG000|Overall Study|0 Sessions Attended|34|||
142949926|NCT03794986|515357404|FG001|Overall Study|0 Sessions Attended|37|||
142949927|NCT03794986|515357403|FG000|Overall Study|Withdrawal by Subject|4|||
142949928|NCT03794986|515357404|FG001|Overall Study|Withdrawal by Subject|6|||
142949929|NCT03794986|515357403|FG000|Overall Study|Protocol Violation|1|||
142949930|NCT03794986|515357404|FG001|Overall Study|Protocol Violation|0|||
142949931|NCT05309083|515357405|FG000|Overall Study|Withdrawal by Subject|2|||
142949932|NCT00637728|515357409|FG000|Double-blind Phase|Adverse Event|1|||
142949933|NCT00637728|515357410|FG001|Double-blind Phase|Adverse Event|0|||
142949934|NCT00637728|515357411|FG002|Double-blind Phase|Adverse Event|0|||
143117367|NCT01313221|515971826|FG000|Overall Study|Non-compliance|3|||
142949935|NCT00637728|515357409|FG000|Double-blind Phase|Non-compliance|2|||
142949936|NCT00637728|515357410|FG001|Double-blind Phase|Non-compliance|0|||
142949937|NCT00637728|515357411|FG002|Double-blind Phase|Non-compliance|0|||
142949938|NCT00637728|515357409|FG000|Double-blind Phase|Study Discontinued|1|||
142949939|NCT00637728|515357410|FG001|Double-blind Phase|Study Discontinued|1|||
142949940|NCT00637728|515357411|FG002|Double-blind Phase|Study Discontinued|0|||
142949941|NCT00593112|515357414|FG000|Overall Study|Scan Anxiety|3|||
142949942|NCT00593112|515357415|FG001|Overall Study|Scan Anxiety|0|||
142949943|NCT00593112|515357414|FG000|Overall Study|Abnormal Scan|1|||
142949944|NCT00593112|515357415|FG001|Overall Study|Abnormal Scan|0|||
142949945|NCT00593112|515357414|FG000|Overall Study|Unreadable Scan|1|||
142949946|NCT00593112|515357415|FG001|Overall Study|Unreadable Scan|0|||
142949947|NCT00593112|515357414|FG000|Overall Study|Withdrawal by Subject|5|||
142949948|NCT00593112|515357415|FG001|Overall Study|Withdrawal by Subject|0|||
142949949|NCT03043365|515357416|FG000|Weeks 0 to Week 8|Adverse Event|1|||
142949950|NCT03043365|515357417|FG001|Weeks 0 to Week 8|Adverse Event|3|||
142949951|NCT03043365|515357416|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
142949952|NCT03043365|515357417|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
142949953|NCT03043365|515357416|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
142949954|NCT03043365|515357417|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
142949955|NCT02723630|515357418|FG000|Intervention Period 1|Adverse Event|1|||
142949956|NCT02723630|515357419|FG001|Intervention Period 1|Adverse Event|0|||
142949957|NCT02723630|515357420|FG002|Intervention Period 1|Adverse Event|0|||
142949958|NCT02723630|515357421|FG003|Intervention Period 1|Adverse Event|0|||
142949959|NCT02723630|515357422|FG004|Intervention Period 1|Adverse Event|0|||
142949960|NCT02723630|515357423|FG005|Intervention Period 1|Adverse Event|0|||
142949961|NCT02723630|515357418|FG000|Intervention Period 3|consumption of restricted item|0|||
142949962|NCT02723630|515357419|FG001|Intervention Period 3|consumption of restricted item|1|||
142949963|NCT02723630|515357420|FG002|Intervention Period 3|consumption of restricted item|0|||
142949964|NCT02723630|515357421|FG003|Intervention Period 3|consumption of restricted item|0|||
142949965|NCT02723630|515357422|FG004|Intervention Period 3|consumption of restricted item|0|||
142949966|NCT02723630|515357423|FG005|Intervention Period 3|consumption of restricted item|0|||
142949967|NCT00779038|515357424|FG000|Overall Study|Study Prematurely Terminated|13|||
142949968|NCT00537745|515357425|FG000|Overall Study|Did not meet eligibility criteria|2|||
142949969|NCT00537745|515357425|FG000|Overall Study|Withdrawal by Subject|2|||
142949970|NCT00537745|515357425|FG000|Overall Study|Subject unable to provide Interlock info|1|||
142949971|NCT05372315|515357426|FG000|Overall Study|Withdrawal by Subject|1|||
142949972|NCT05372315|515357427|FG001|Overall Study|Withdrawal by Subject|0|||
142949973|NCT01184989|515357428|FG000|Overall Study|Adverse Event|11|||
142949974|NCT01184989|515357428|FG000|Overall Study|Withdrawal by Subject|1|||
142949975|NCT01570491|515357429|FG000|Overall Study|Lost to Follow-up|3|||
142949976|NCT01570491|515357430|FG001|Overall Study|Lost to Follow-up|1|||
142949977|NCT01570491|515357429|FG000|Overall Study|treatment: not given or discontinued|2|||
142949978|NCT01570491|515357430|FG001|Overall Study|treatment: not given or discontinued|0|||
142949979|NCT05370157|515357433|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
142949980|NCT05370157|515357434|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
142949981|NCT05370157|515357433|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
142949982|NCT05370157|515357434|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
142949983|NCT01508676|515357435|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
142949984|NCT01508676|515357436|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
142949985|NCT01508676|515357435|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
142949986|NCT01508676|515357436|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
142949987|NCT01508676|515357435|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
142949988|NCT01508676|515357436|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
142949989|NCT01508676|515357435|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
142949990|NCT01508676|515357436|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
142949991|NCT01508676|515357435|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
142949992|NCT01508676|515357436|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
142949993|NCT04407507|515357438|FG000|Overall Study|Withdrawal by Subject|0|||
142949994|NCT04407507|515357439|FG001|Overall Study|Withdrawal by Subject|1|||
142949995|NCT00754390|515357440|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
142949996|NCT00754390|515357440|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
142949997|NCT00754390|515357440|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
142949998|NCT00754390|515357440|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
142949999|NCT00847613|515357441|FG000|Overall Study|Ongoing at cut-off date|250|||
142950000|NCT00847613|515357442|FG001|Overall Study|Ongoing at cut-off date|265|||
142950001|NCT00847613|515357443|FG002|Overall Study|Ongoing at cut-off date|64|||
142950002|NCT00847613|515357444|FG003|Overall Study|Ongoing at cut-off date|64|||
142950003|NCT00847613|515357441|FG000|Overall Study|Death|1|||
142950004|NCT00847613|515357442|FG001|Overall Study|Death|1|||
142950005|NCT00847613|515357443|FG002|Overall Study|Death|0|||
143455074|NCT02663518|517210763|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
142950006|NCT00847613|515357444|FG003|Overall Study|Death|0|||
142950007|NCT00847613|515357441|FG000|Overall Study|Adverse Event|36|||
142950008|NCT00847613|515357442|FG001|Overall Study|Adverse Event|26|||
142950009|NCT00847613|515357443|FG002|Overall Study|Adverse Event|5|||
142950010|NCT00847613|515357444|FG003|Overall Study|Adverse Event|6|||
142950011|NCT00847613|515357441|FG000|Overall Study|Lack of Efficacy|7|||
142950012|NCT00847613|515357442|FG001|Overall Study|Lack of Efficacy|3|||
142950013|NCT00847613|515357443|FG002|Overall Study|Lack of Efficacy|3|||
142950014|NCT00847613|515357444|FG003|Overall Study|Lack of Efficacy|1|||
142950015|NCT00847613|515357441|FG000|Overall Study|Study terminated by Sponsor|1|||
142950016|NCT00847613|515357442|FG001|Overall Study|Study terminated by Sponsor|0|||
142950017|NCT00847613|515357443|FG002|Overall Study|Study terminated by Sponsor|2|||
142950018|NCT00847613|515357444|FG003|Overall Study|Study terminated by Sponsor|1|||
142950019|NCT00847613|515357441|FG000|Overall Study|Lost to Follow-up|5|||
142950020|NCT00847613|515357442|FG001|Overall Study|Lost to Follow-up|0|||
142950021|NCT00847613|515357443|FG002|Overall Study|Lost to Follow-up|0|||
142950022|NCT00847613|515357444|FG003|Overall Study|Lost to Follow-up|3|||
142950023|NCT00847613|515357441|FG000|Overall Study|Protocol Violation|6|||
142950024|NCT00847613|515357442|FG001|Overall Study|Protocol Violation|6|||
142950025|NCT00847613|515357443|FG002|Overall Study|Protocol Violation|3|||
142950026|NCT00847613|515357444|FG003|Overall Study|Protocol Violation|1|||
142950027|NCT00847613|515357441|FG000|Overall Study|Pregnancy|1|||
142950028|NCT00847613|515357442|FG001|Overall Study|Pregnancy|1|||
142950029|NCT00847613|515357443|FG002|Overall Study|Pregnancy|0|||
142950030|NCT00847613|515357444|FG003|Overall Study|Pregnancy|0|||
142950031|NCT00847613|515357441|FG000|Overall Study|Site closure|1|||
142950032|NCT00847613|515357442|FG001|Overall Study|Site closure|0|||
142950033|NCT00847613|515357443|FG002|Overall Study|Site closure|0|||
142950034|NCT00847613|515357444|FG003|Overall Study|Site closure|1|||
142950035|NCT00847613|515357441|FG000|Overall Study|Withdrawal by Subject|8|||
142950036|NCT00847613|515357442|FG001|Overall Study|Withdrawal by Subject|11|||
142950037|NCT00847613|515357443|FG002|Overall Study|Withdrawal by Subject|2|||
142950038|NCT00847613|515357444|FG003|Overall Study|Withdrawal by Subject|2|||
142950039|NCT00847613|515357441|FG000|Overall Study|Participant moved|4|||
142950040|NCT00847613|515357442|FG001|Overall Study|Participant moved|1|||
142950041|NCT00847613|515357443|FG002|Overall Study|Participant moved|0|||
142950042|NCT00847613|515357444|FG003|Overall Study|Participant moved|0|||
142950043|NCT00847613|515357441|FG000|Overall Study|Sponsor request|0|||
142950044|NCT00847613|515357442|FG001|Overall Study|Sponsor request|1|||
142950045|NCT00847613|515357443|FG002|Overall Study|Sponsor request|0|||
142950046|NCT00847613|515357444|FG003|Overall Study|Sponsor request|0|||
142950047|NCT00847613|515357441|FG000|Overall Study|Randomized, but not treated|0|||
142950048|NCT00847613|515357442|FG001|Overall Study|Randomized, but not treated|3|||
142950049|NCT00847613|515357443|FG002|Overall Study|Randomized, but not treated|0|||
142950050|NCT00847613|515357444|FG003|Overall Study|Randomized, but not treated|0|||
142950051|NCT00847613|515357441|FG000|Overall Study|Other|1|||
142950052|NCT00847613|515357442|FG001|Overall Study|Other|1|||
142950053|NCT00847613|515357443|FG002|Overall Study|Other|2|||
142950054|NCT00847613|515357444|FG003|Overall Study|Other|0|||
142950055|NCT00587223|515357451|FG000|Overall Study|Adverse Event|1|||
142950056|NCT04332419|515357452|FG000|Overall Study|Withdrawal by Subject|1|||
142950057|NCT01480180|515357453|FG000|Main Phase|Withdrawal criteria|12|||
142950058|NCT01480180|515357454|FG001|Main Phase|Withdrawal criteria|1|||
142950059|NCT01480180|515357455|FG002|Main Phase|Withdrawal criteria|0|||
142950060|NCT01480180|515357456|FG003|Main Phase|Withdrawal criteria|0|||
142950061|NCT01480180|515357457|FG004|Main Phase|Withdrawal criteria|0|||
142950062|NCT01480180|515357458|FG005|Main Phase|Withdrawal criteria|0|||
142950063|NCT01480180|515357453|FG000|Main Phase|Lack of Efficacy|1|||
142950064|NCT01480180|515357454|FG001|Main Phase|Lack of Efficacy|0|||
142950065|NCT01480180|515357455|FG002|Main Phase|Lack of Efficacy|0|||
142950066|NCT01480180|515357456|FG003|Main Phase|Lack of Efficacy|0|||
142950067|NCT01480180|515357457|FG004|Main Phase|Lack of Efficacy|0|||
142950068|NCT01480180|515357458|FG005|Main Phase|Lack of Efficacy|0|||
142950069|NCT01480180|515357453|FG000|Main Phase|Non-compliance|3|||
142950070|NCT01480180|515357454|FG001|Main Phase|Non-compliance|0|||
142950071|NCT01480180|515357455|FG002|Main Phase|Non-compliance|0|||
142950072|NCT01480180|515357456|FG003|Main Phase|Non-compliance|0|||
142950073|NCT01480180|515357457|FG004|Main Phase|Non-compliance|0|||
142950074|NCT01480180|515357458|FG005|Main Phase|Non-compliance|0|||
142950075|NCT01480180|515357453|FG000|Main Phase|Unclassified|3|||
142950076|NCT01480180|515357454|FG001|Main Phase|Unclassified|0|||
142950077|NCT01480180|515357455|FG002|Main Phase|Unclassified|0|||
142950078|NCT01480180|515357456|FG003|Main Phase|Unclassified|0|||
142950079|NCT01480180|515357457|FG004|Main Phase|Unclassified|0|||
142950080|NCT01480180|515357458|FG005|Main Phase|Unclassified|0|||
142950081|NCT01480180|515357453|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
142950082|NCT01480180|515357454|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
142950083|NCT01480180|515357455|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
142950084|NCT01480180|515357456|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
142950085|NCT01480180|515357457|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
142950086|NCT01480180|515357458|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
142950087|NCT01480180|515357453|FG000|Extension Phase, Part 1|Unclassified|0|||
142950088|NCT01480180|515357454|FG001|Extension Phase, Part 1|Unclassified|0|||
142950089|NCT01480180|515357455|FG002|Extension Phase, Part 1|Unclassified|1|||
142950090|NCT01480180|515357456|FG003|Extension Phase, Part 1|Unclassified|0|||
142950091|NCT01480180|515357457|FG004|Extension Phase, Part 1|Unclassified|0|||
142950092|NCT01480180|515357458|FG005|Extension Phase, Part 1|Unclassified|0|||
142950093|NCT01480180|515357453|FG000|Extension Phase, Part 1|Adverse Event|0|||
142950094|NCT01480180|515357454|FG001|Extension Phase, Part 1|Adverse Event|0|||
142950095|NCT01480180|515357455|FG002|Extension Phase, Part 1|Adverse Event|4|||
142950096|NCT01480180|515357456|FG003|Extension Phase, Part 1|Adverse Event|1|||
142950097|NCT01480180|515357457|FG004|Extension Phase, Part 1|Adverse Event|0|||
142950098|NCT01480180|515357458|FG005|Extension Phase, Part 1|Adverse Event|0|||
142950099|NCT01480180|515357453|FG000|Extension Phase, Part 1|Change of treatment|0|||
142950100|NCT01480180|515357454|FG001|Extension Phase, Part 1|Change of treatment|0|||
142950101|NCT01480180|515357455|FG002|Extension Phase, Part 1|Change of treatment|0|||
142950102|NCT01480180|515357456|FG003|Extension Phase, Part 1|Change of treatment|9|||
142950103|NCT01480180|515357457|FG004|Extension Phase, Part 1|Change of treatment|0|||
142950104|NCT01480180|515357458|FG005|Extension Phase, Part 1|Change of treatment|0|||
142950105|NCT01480180|515357453|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
142950106|NCT01480180|515357454|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
142950107|NCT01480180|515357455|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
142950108|NCT01480180|515357456|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
142950109|NCT01480180|515357457|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
142950110|NCT01480180|515357458|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
142950111|NCT01480180|515357453|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
142950112|NCT01480180|515357454|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
142950113|NCT01480180|515357455|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
142950114|NCT01480180|515357456|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
142950115|NCT01480180|515357457|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
142950116|NCT01480180|515357458|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
142950117|NCT01480180|515357453|FG000|Extension Phase, Part 2|Unclassified|0|||
142950118|NCT01480180|515357454|FG001|Extension Phase, Part 2|Unclassified|0|||
142950119|NCT01480180|515357455|FG002|Extension Phase, Part 2|Unclassified|3|||
142950120|NCT01480180|515357456|FG003|Extension Phase, Part 2|Unclassified|1|||
142950121|NCT01480180|515357457|FG004|Extension Phase, Part 2|Unclassified|1|||
142950122|NCT01480180|515357458|FG005|Extension Phase, Part 2|Unclassified|0|||
142950123|NCT04222725|515357459|FG000|Overall Study|Adverse Event|0|||
142950124|NCT04222725|515357460|FG001|Overall Study|Adverse Event|1|||
142950125|NCT04222725|515357461|FG002|Overall Study|Adverse Event|0|||
142950126|NCT04222725|515357462|FG003|Overall Study|Adverse Event|0|||
142950127|NCT00658333|515357463|FG000|Overall Study|Adverse Event|2|||
142950128|NCT00658333|515357464|FG001|Overall Study|Adverse Event|1|||
142950129|NCT03443024|515357465|FG000|Overall Study|Adverse Event|2|||
142950130|NCT03443024|515357466|FG001|Overall Study|Adverse Event|4|||
142950131|NCT03443024|515357467|FG002|Overall Study|Adverse Event|3|||
142950132|NCT03443024|515357468|FG003|Overall Study|Adverse Event|1|||
142950133|NCT03443024|515357465|FG000|Overall Study|Lost to Follow-up|9|||
142950134|NCT03443024|515357466|FG001|Overall Study|Lost to Follow-up|9|||
142950135|NCT03443024|515357467|FG002|Overall Study|Lost to Follow-up|7|||
142950136|NCT03443024|515357468|FG003|Overall Study|Lost to Follow-up|5|||
142950137|NCT03443024|515357465|FG000|Overall Study|Withdrawal by Subject|8|||
142950138|NCT03443024|515357466|FG001|Overall Study|Withdrawal by Subject|15|||
142950139|NCT03443024|515357467|FG002|Overall Study|Withdrawal by Subject|9|||
142950140|NCT03443024|515357468|FG003|Overall Study|Withdrawal by Subject|23|||
142950141|NCT03443024|515357465|FG000|Overall Study|Physician Decision|1|||
142950142|NCT03443024|515357466|FG001|Overall Study|Physician Decision|2|||
142950143|NCT03443024|515357467|FG002|Overall Study|Physician Decision|0|||
142950144|NCT03443024|515357468|FG003|Overall Study|Physician Decision|1|||
142950145|NCT03443024|515357465|FG000|Overall Study|Sponsor Decision|1|||
142950146|NCT03443024|515357466|FG001|Overall Study|Sponsor Decision|1|||
142950147|NCT03443024|515357467|FG002|Overall Study|Sponsor Decision|0|||
142950148|NCT03443024|515357468|FG003|Overall Study|Sponsor Decision|0|||
142950149|NCT03443024|515357465|FG000|Overall Study|Protocol Deviation|0|||
142950150|NCT03443024|515357466|FG001|Overall Study|Protocol Deviation|0|||
142950151|NCT03443024|515357467|FG002|Overall Study|Protocol Deviation|0|||
142950152|NCT03443024|515357468|FG003|Overall Study|Protocol Deviation|2|||
142950153|NCT00624338|515357470|FG000|Overall Study|Adverse Event|14|||
142950154|NCT00624338|515357471|FG001|Overall Study|Adverse Event|14|||
142950155|NCT00624338|515357472|FG002|Overall Study|Adverse Event|18|||
142950156|NCT00624338|515357470|FG000|Overall Study|Lost to Follow-up|1|||
142950157|NCT00624338|515357471|FG001|Overall Study|Lost to Follow-up|0|||
142950158|NCT00624338|515357472|FG002|Overall Study|Lost to Follow-up|0|||
142950159|NCT00624338|515357470|FG000|Overall Study|Lack of Efficacy|11|||
142950160|NCT00624338|515357471|FG001|Overall Study|Lack of Efficacy|3|||
142950161|NCT00624338|515357472|FG002|Overall Study|Lack of Efficacy|14|||
142950162|NCT00624338|515357470|FG000|Overall Study|Protocol Violation|3|||
142950163|NCT00624338|515357471|FG001|Overall Study|Protocol Violation|3|||
142950164|NCT00624338|515357472|FG002|Overall Study|Protocol Violation|2|||
142950165|NCT00624338|515357470|FG000|Overall Study|Death|0|||
142950166|NCT00624338|515357471|FG001|Overall Study|Death|2|||
142950167|NCT00624338|515357472|FG002|Overall Study|Death|0|||
142950168|NCT00624338|515357470|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
142950169|NCT00624338|515357471|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
142950170|NCT00624338|515357472|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
142950171|NCT00624338|515357470|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
142950172|NCT00624338|515357471|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
142950173|NCT00624338|515357472|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
142950174|NCT00624338|515357470|FG000|Overall Study|Other|15|||
142950175|NCT00624338|515357471|FG001|Overall Study|Other|5|||
142950176|NCT00624338|515357472|FG002|Overall Study|Other|9|||
142950177|NCT00624338|515357470|FG000|Overall Study|Randomized but not treated|2|||
142950178|NCT00624338|515357471|FG001|Overall Study|Randomized but not treated|1|||
142950179|NCT00624338|515357472|FG002|Overall Study|Randomized but not treated|3|||
142950180|NCT05897853|515357473|FG000|Overall Study|Lost to Follow-up|2|||
142950181|NCT05897853|515357474|FG001|Overall Study|Lost to Follow-up|0|||
142950182|NCT05897853|515357473|FG000|Overall Study|Diagnostic criteria not met at baseline|0|||
142950183|NCT05897853|515357474|FG001|Overall Study|Diagnostic criteria not met at baseline|8|||
142950184|NCT01476787|515357478|FG000|Treatment|Progression|64|||
142950185|NCT01476787|515357479|FG001|Treatment|Progression|71|||
142950186|NCT01476787|515357478|FG000|Treatment|Toxicity|44|||
142950187|NCT01476787|515357479|FG001|Treatment|Toxicity|16|||
142950188|NCT01476787|515357478|FG000|Treatment|Death|0|||
142950189|NCT01476787|515357479|FG001|Treatment|Death|1|||
142950190|NCT01476787|515357478|FG000|Treatment|Withdrawal by Subject|3|||
142950191|NCT01476787|515357479|FG001|Treatment|Withdrawal by Subject|14|||
142950192|NCT01476787|515357478|FG000|Treatment|Major protocol violation|1|||
142950193|NCT01476787|515357479|FG001|Treatment|Major protocol violation|6|||
142950194|NCT01476787|515357478|FG000|Treatment|Other reasons|10|||
142950195|NCT01476787|515357479|FG001|Treatment|Other reasons|22|||
142950196|NCT01476787|515357478|FG000|Treatment|Concurrent illness|12|||
142950197|NCT01476787|515357479|FG001|Treatment|Concurrent illness|9|||
142950198|NCT01476787|515357478|FG000|Treatment|Insufficient response|15|||
142950199|NCT01476787|515357479|FG001|Treatment|Insufficient response|3|||
142950200|NCT01476787|515357478|FG000|Treatment|Voluntary treatment discontinuation|8|||
142950201|NCT01476787|515357479|FG001|Treatment|Voluntary treatment discontinuation|4|||
142950202|NCT04458857|515357483|FG000|Overall Study|Adverse Event|0|||
142950203|NCT04458857|515357484|FG001|Overall Study|Adverse Event|1|||
142950204|NCT04458857|515357485|FG002|Overall Study|Adverse Event|0|||
142950205|NCT04458857|515357483|FG000|Overall Study|Withdrawal by Subject|2|||
142950206|NCT04458857|515357484|FG001|Overall Study|Withdrawal by Subject|0|||
142950207|NCT04458857|515357485|FG002|Overall Study|Withdrawal by Subject|0|||
142950208|NCT04458857|515357483|FG000|Overall Study|Withdrawal by parent/guardian|0|||
142950209|NCT04458857|515357484|FG001|Overall Study|Withdrawal by parent/guardian|0|||
142950210|NCT04458857|515357485|FG002|Overall Study|Withdrawal by parent/guardian|1|||
142950211|NCT04458857|515357483|FG000|Overall Study|Non-compliance with study drug|0|||
142950212|NCT04458857|515357484|FG001|Overall Study|Non-compliance with study drug|1|||
142950213|NCT04458857|515357485|FG002|Overall Study|Non-compliance with study drug|0|||
142950214|NCT04458857|515357483|FG000|Overall Study|Lost to Follow-up|4|||
142950215|NCT04458857|515357484|FG001|Overall Study|Lost to Follow-up|1|||
142950216|NCT04458857|515357485|FG002|Overall Study|Lost to Follow-up|0|||
142950217|NCT02986373|515357486|FG000|Overall Study|Adverse Event|4|||
142950218|NCT02986373|515357486|FG000|Overall Study|Lost to Follow-up|1|||
142950219|NCT02986373|515357486|FG000|Overall Study|Withdrawal by Subject|10|||
142950220|NCT02986373|515357486|FG000|Overall Study|Other|24|||
142950221|NCT01919411|515357489|FG000|Overall Study|Lost to Follow-up|2|||
142950222|NCT01919411|515357490|FG001|Overall Study|Lost to Follow-up|4|||
142950223|NCT01919411|515357489|FG000|Overall Study|Physician Decision|1|||
142950224|NCT01919411|515357490|FG001|Overall Study|Physician Decision|0|||
142950225|NCT01919411|515357489|FG000|Overall Study|Protocol Violation|2|||
142950226|NCT01919411|515357490|FG001|Overall Study|Protocol Violation|1|||
142950227|NCT00524303|515357491|FG000|Overall Study|Lost to Follow-up|6|||
142950228|NCT00524303|515357492|FG001|Overall Study|Lost to Follow-up|0|||
142950229|NCT00524303|515357493|FG002|Overall Study|Lost to Follow-up|3|||
142950230|NCT00524303|515357491|FG000|Overall Study|Protocol Violation|0|||
142950231|NCT00524303|515357492|FG001|Overall Study|Protocol Violation|1|||
142950232|NCT00524303|515357493|FG002|Overall Study|Protocol Violation|1|||
142950233|NCT00524303|515357491|FG000|Overall Study|Withdrawal by Subject|3|||
142950234|NCT00524303|515357492|FG001|Overall Study|Withdrawal by Subject|0|||
142950235|NCT00524303|515357493|FG002|Overall Study|Withdrawal by Subject|4|||
142950236|NCT00524303|515357491|FG000|Overall Study|Death|0|||
142950237|NCT00524303|515357492|FG001|Overall Study|Death|2|||
142950238|NCT00524303|515357493|FG002|Overall Study|Death|3|||
143455075|NCT02663518|517210764|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
143455076|NCT02663518|517210765|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
143455077|NCT02663518|517210766|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
142950239|NCT00524303|515357491|FG000|Overall Study|Adverse Event|1|||
142950240|NCT00524303|515357492|FG001|Overall Study|Adverse Event|2|||
142950241|NCT00524303|515357493|FG002|Overall Study|Adverse Event|3|||
142950242|NCT00524303|515357491|FG000|Overall Study|Did not Complete Study Dosing|1|||
142950243|NCT00524303|515357492|FG001|Overall Study|Did not Complete Study Dosing|0|||
142950244|NCT00524303|515357493|FG002|Overall Study|Did not Complete Study Dosing|0|||
142950245|NCT00524303|515357491|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
142950246|NCT00524303|515357492|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
142950247|NCT00524303|515357493|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
142950248|NCT00524303|515357491|FG000|Overall Study|Disease Progression|0|||
142950249|NCT00524303|515357492|FG001|Overall Study|Disease Progression|4|||
142950250|NCT00524303|515357493|FG002|Overall Study|Disease Progression|1|||
142950251|NCT00524303|515357491|FG000|Overall Study|Disease Recurrence|0|||
142950252|NCT00524303|515357492|FG001|Overall Study|Disease Recurrence|1|||
142950253|NCT00524303|515357493|FG002|Overall Study|Disease Recurrence|0|||
142950254|NCT00524303|515357491|FG000|Overall Study|Sponsor Request|0|||
142950255|NCT00524303|515357492|FG001|Overall Study|Sponsor Request|0|||
142950256|NCT00524303|515357493|FG002|Overall Study|Sponsor Request|1|||
142950257|NCT00524303|515357491|FG000|Overall Study|Physician Decision|0|||
142950258|NCT00524303|515357492|FG001|Overall Study|Physician Decision|0|||
142950259|NCT00524303|515357493|FG002|Overall Study|Physician Decision|1|||
142950260|NCT00524303|515357491|FG000|Overall Study|Completed 5 years|0|||
142950261|NCT00524303|515357492|FG001|Overall Study|Completed 5 years|0|||
142950262|NCT00524303|515357493|FG002|Overall Study|Completed 5 years|1|||
142950263|NCT01607892|515357495|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
142950264|NCT01607892|515357496|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
142950265|NCT01607892|515357497|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
142950266|NCT01607892|515357498|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
142950267|NCT01607892|515357499|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
142950268|NCT01607892|515357495|FG000|Overall Study|Death|4|||
142950269|NCT01607892|515357496|FG001|Overall Study|Death|2|||
142950270|NCT01607892|515357497|FG002|Overall Study|Death|8|||
142950271|NCT01607892|515357498|FG003|Overall Study|Death|10|||
142950272|NCT01607892|515357499|FG004|Overall Study|Death|3|||
142950273|NCT01607892|515357495|FG000|Overall Study|Investigator discretion|2|||
142950274|NCT01607892|515357496|FG001|Overall Study|Investigator discretion|4|||
142950275|NCT01607892|515357497|FG002|Overall Study|Investigator discretion|4|||
142950276|NCT01607892|515357498|FG003|Overall Study|Investigator discretion|8|||
142950277|NCT01607892|515357499|FG004|Overall Study|Investigator discretion|0|||
142950278|NCT01607892|515357495|FG000|Overall Study|Other treatments became available|1|||
142950279|NCT01607892|515357496|FG001|Overall Study|Other treatments became available|1|||
142950280|NCT01607892|515357497|FG002|Overall Study|Other treatments became available|0|||
142950281|NCT01607892|515357498|FG003|Overall Study|Other treatments became available|0|||
142950282|NCT01607892|515357499|FG004|Overall Study|Other treatments became available|2|||
142950283|NCT01607892|515357495|FG000|Overall Study|Intercurrent illness|1|||
142950284|NCT01607892|515357496|FG001|Overall Study|Intercurrent illness|0|||
142950285|NCT01607892|515357497|FG002|Overall Study|Intercurrent illness|0|||
142950286|NCT01607892|515357498|FG003|Overall Study|Intercurrent illness|3|||
142950287|NCT01607892|515357499|FG004|Overall Study|Intercurrent illness|0|||
142950288|NCT01607892|515357495|FG000|Overall Study|Non-Compliance with study procedures|0|||
142950289|NCT01607892|515357496|FG001|Overall Study|Non-Compliance with study procedures|0|||
142950290|NCT01607892|515357497|FG002|Overall Study|Non-Compliance with study procedures|1|||
142950291|NCT01607892|515357498|FG003|Overall Study|Non-Compliance with study procedures|0|||
142950292|NCT01607892|515357499|FG004|Overall Study|Non-Compliance with study procedures|0|||
142950293|NCT01607892|515357495|FG000|Overall Study|Consent withdrawn by participant|9|||
142950294|NCT01607892|515357496|FG001|Overall Study|Consent withdrawn by participant|4|||
142950295|NCT01607892|515357497|FG002|Overall Study|Consent withdrawn by participant|24|||
142950296|NCT01607892|515357498|FG003|Overall Study|Consent withdrawn by participant|14|||
142950297|NCT01607892|515357499|FG004|Overall Study|Consent withdrawn by participant|4|||
142950298|NCT01607892|515357495|FG000|Overall Study|Disease progression|38|||
142950299|NCT01607892|515357496|FG001|Overall Study|Disease progression|13|||
142950300|NCT01607892|515357497|FG002|Overall Study|Disease progression|37|||
142950301|NCT01607892|515357498|FG003|Overall Study|Disease progression|57|||
142950302|NCT01607892|515357499|FG004|Overall Study|Disease progression|9|||
142950303|NCT01607892|515357495|FG000|Overall Study|Incidence or severity of Adverse events|3|||
142950304|NCT01607892|515357496|FG001|Overall Study|Incidence or severity of Adverse events|3|||
142950305|NCT01607892|515357497|FG002|Overall Study|Incidence or severity of Adverse events|7|||
143455078|NCT02663518|517210767|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
142950306|NCT01607892|515357498|FG003|Overall Study|Incidence or severity of Adverse events|2|||
142950307|NCT01607892|515357499|FG004|Overall Study|Incidence or severity of Adverse events|6|||
142950308|NCT03022422|515357501|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
142950309|NCT03022422|515357502|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
142950310|NCT03022422|515357503|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
142950311|NCT03022422|515357504|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
142950312|NCT03022422|515357505|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
142950313|NCT03022422|515357506|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
143455079|NCT02663518|517210768|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
143455080|NCT02663518|517210769|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
142950314|NCT01282814|515357507|FG000|First Intervention|Emesis During Dosing Interval|0|||
142950315|NCT01282814|515357508|FG001|First Intervention|Emesis During Dosing Interval|3|||
142950316|NCT01282814|515357507|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
142950317|NCT01282814|515357508|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
142950318|NCT00957372|515357509|FG000|PART I|Lost to Follow-up|0|||
142950319|NCT00957372|515357510|FG001|PART I|Lost to Follow-up|0|||
142950320|NCT00957372|515357511|FG002|PART I|Lost to Follow-up|1|||
142950321|NCT00957372|515357512|FG003|PART I|Lost to Follow-up|0|||
142950322|NCT00957372|515357509|FG000|PART II|Withdrawal by Subject|0|||
142950323|NCT00957372|515357510|FG001|PART II|Withdrawal by Subject|0|||
142950324|NCT00957372|515357511|FG002|PART II|Withdrawal by Subject|0|||
142950325|NCT00957372|515357512|FG003|PART II|Withdrawal by Subject|8|||
142950326|NCT00957372|515357509|FG000|PART II|Physician Decision|0|||
142950327|NCT00957372|515357510|FG001|PART II|Physician Decision|0|||
142950328|NCT00957372|515357511|FG002|PART II|Physician Decision|0|||
142950329|NCT00957372|515357512|FG003|PART II|Physician Decision|1|||
142950330|NCT00957372|515357509|FG000|PART II|Pregnancy|0|||
142950331|NCT00957372|515357510|FG001|PART II|Pregnancy|0|||
142950332|NCT00957372|515357511|FG002|PART II|Pregnancy|0|||
142950333|NCT00957372|515357512|FG003|PART II|Pregnancy|1|||
142950334|NCT00957372|515357509|FG000|PART II|Not Know|0|||
142950335|NCT00957372|515357510|FG001|PART II|Not Know|0|||
142950336|NCT00957372|515357511|FG002|PART II|Not Know|0|||
142950337|NCT00957372|515357512|FG003|PART II|Not Know|20|||
142950338|NCT00957372|515357509|FG000|PART II|Adverse Event|0|||
142950339|NCT00957372|515357510|FG001|PART II|Adverse Event|0|||
142950340|NCT00957372|515357511|FG002|PART II|Adverse Event|0|||
142950341|NCT00957372|515357512|FG003|PART II|Adverse Event|10|||
142950342|NCT00957372|515357509|FG000|PART II|Patient non-compliance|0|||
142950343|NCT00957372|515357510|FG001|PART II|Patient non-compliance|0|||
142950344|NCT00957372|515357511|FG002|PART II|Patient non-compliance|0|||
142950345|NCT00957372|515357512|FG003|PART II|Patient non-compliance|4|||
142950346|NCT02403206|515357513|FG000|Overall Study|Lost to Follow-up|4|||
142950347|NCT02403206|515357514|FG001|Overall Study|Lost to Follow-up|3|||
142950348|NCT02403206|515357513|FG000|Overall Study|Physician Decision|2|||
142950349|NCT02403206|515357514|FG001|Overall Study|Physician Decision|0|||
142950350|NCT02403206|515357513|FG000|Overall Study|Withdrawal by Subject|3|||
142950351|NCT02403206|515357514|FG001|Overall Study|Withdrawal by Subject|3|||
142950352|NCT02403206|515357513|FG000|Overall Study|Reason not given|2|||
142950353|NCT02403206|515357514|FG001|Overall Study|Reason not given|4|||
142950354|NCT01444391|515357517|FG000|Overall Study|Death|1|||
142950355|NCT01676116|515357518|FG000|Overall Study|Withdrawal criteria|2|||
142950356|NCT01676116|515357519|FG001|Overall Study|Withdrawal criteria|14|||
142950357|NCT01676116|515357518|FG000|Overall Study|Adverse Event|1|||
142950358|NCT01676116|515357519|FG001|Overall Study|Adverse Event|2|||
142950359|NCT01676116|515357518|FG000|Overall Study|Unclassified|4|||
142950360|NCT01676116|515357519|FG001|Overall Study|Unclassified|10|||
142950361|NCT01676116|515357518|FG000|Overall Study|Protocol Violation|9|||
142950362|NCT01676116|515357519|FG001|Overall Study|Protocol Violation|3|||
142950363|NCT01287117|515357520|FG000|Overall Study|Adverse Event|2|||
142950364|NCT01287117|515357521|FG001|Overall Study|Adverse Event|1|||
142950365|NCT01287117|515357522|FG002|Overall Study|Adverse Event|1|||
142950366|NCT01287117|515357523|FG003|Overall Study|Adverse Event|1|||
142950367|NCT01287117|515357520|FG000|Overall Study|Lost to Follow-up|1|||
142950368|NCT01287117|515357521|FG001|Overall Study|Lost to Follow-up|1|||
142950369|NCT01287117|515357522|FG002|Overall Study|Lost to Follow-up|0|||
142950370|NCT01287117|515357523|FG003|Overall Study|Lost to Follow-up|0|||
142950371|NCT01287117|515357520|FG000|Overall Study|Physician Decision|0|||
142950372|NCT01287117|515357521|FG001|Overall Study|Physician Decision|1|||
142950373|NCT01287117|515357522|FG002|Overall Study|Physician Decision|1|||
142950374|NCT01287117|515357523|FG003|Overall Study|Physician Decision|1|||
142950375|NCT01287117|515357520|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
142950376|NCT01287117|515357521|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
142950377|NCT01287117|515357522|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
142950378|NCT01287117|515357523|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
142950379|NCT01287117|515357520|FG000|Overall Study|Disease Progression|10|||
142950380|NCT01287117|515357521|FG001|Overall Study|Disease Progression|5|||
142950381|NCT01287117|515357522|FG002|Overall Study|Disease Progression|6|||
142950382|NCT01287117|515357523|FG003|Overall Study|Disease Progression|5|||
142950383|NCT01877655|515357524|FG000|Overall Study|Death|57|||
142950384|NCT01877655|515357525|FG001|Overall Study|Death|52|||
142950385|NCT01877655|515357524|FG000|Overall Study|Withdrawal by Subject|18|||
142950386|NCT01877655|515357525|FG001|Overall Study|Withdrawal by Subject|26|||
142950387|NCT01877655|515357524|FG000|Overall Study|Physician Decision|11|||
142950388|NCT01877655|515357525|FG001|Overall Study|Physician Decision|10|||
142950389|NCT01877655|515357524|FG000|Overall Study|Miscellaneous|4|||
142950390|NCT01877655|515357525|FG001|Overall Study|Miscellaneous|4|||
142950391|NCT01877655|515357524|FG000|Overall Study|Randomized but Never Received Drug|8|||
143117123|NCT01273155|515970038|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
142950392|NCT01877655|515357525|FG001|Overall Study|Randomized but Never Received Drug|5|||
142950393|NCT01769404|515357528|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
142950394|NCT01769404|515357529|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
142950395|NCT01769404|515357528|FG000|Treatment Period 1|Withdrawal by Subject|3|||
142950396|NCT01769404|515357529|FG001|Treatment Period 1|Withdrawal by Subject|0|||
142950397|NCT01769404|515357528|FG000|Treatment Period 1|Sponsor decision|1|||
142950398|NCT01769404|515357529|FG001|Treatment Period 1|Sponsor decision|0|||
142950399|NCT01769404|515357528|FG000|Treatment Period 2|Sponsor decision|7|||
142950400|NCT01769404|515357529|FG001|Treatment Period 2|Sponsor decision|0|||
142950401|NCT00538733|515357530|FG000|Overall Study|Adverse Event|8|||
142950402|NCT00538733|515357530|FG000|Overall Study|Death|1|||
142950403|NCT00538733|515357530|FG000|Overall Study|declined to participate|2|||
142950404|NCT00538733|515357530|FG000|Overall Study|still on therapy|1|||
142950405|NCT03567187|515357537|FG000|Overall Study|Lost to Follow-up|18|||
142950406|NCT03497689|515357538|FG000|Overall Study|Adverse Event|2|||
142950407|NCT03497689|515357538|FG000|Overall Study|Death|1|||
142950408|NCT03497689|515357538|FG000|Overall Study|Physician Decision|1|||
142950409|NCT03497689|515357538|FG000|Overall Study|Withdrawal by Subject|1|||
142950410|NCT03497689|515357538|FG000|Overall Study|Protocol Violation|2|||
142950411|NCT02032875|515357541|FG000|Treatment Period|Adverse Event|1|||
142950412|NCT02032875|515357542|FG001|Treatment Period|Adverse Event|0|||
142950413|NCT02032875|515357541|FG000|Treatment Period|Liver transplant, No extension needed|0|||
142950414|NCT02032875|515357542|FG001|Treatment Period|Liver transplant, No extension needed|1|||
142950415|NCT02032875|515357541|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
142950416|NCT02032875|515357542|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
142950417|NCT02032875|515357541|FG000|Follow-up Period|Death|0|||
142950418|NCT02032875|515357542|FG001|Follow-up Period|Death|1|||
142950419|NCT02032875|515357541|FG000|Follow-up Period|Virologic Relapse|3|||
142950420|NCT02032875|515357542|FG001|Follow-up Period|Virologic Relapse|10|||
142950421|NCT04358458|515357543|FG000|Overall Study|Death|1|||
142950422|NCT04358458|515357544|FG001|Overall Study|Death|1|||
142950423|NCT04358458|515357545|FG002|Overall Study|Death|3|||
142950424|NCT04358458|515357546|FG003|Overall Study|Death|8|||
142950425|NCT04358458|515357547|FG004|Overall Study|Death|1|||
142950426|NCT04358458|515357548|FG005|Overall Study|Death|6|||
142950427|NCT04358458|515357549|FG006|Overall Study|Death|2|||
142950428|NCT04358458|515357550|FG007|Overall Study|Death|3|||
142950429|NCT04358458|515357543|FG000|Overall Study|Lost to Follow-up|0|||
142950430|NCT04358458|515357544|FG001|Overall Study|Lost to Follow-up|0|||
142950431|NCT04358458|515357545|FG002|Overall Study|Lost to Follow-up|0|||
142950432|NCT04358458|515357546|FG003|Overall Study|Lost to Follow-up|0|||
142950433|NCT04358458|515357547|FG004|Overall Study|Lost to Follow-up|0|||
142950434|NCT04358458|515357548|FG005|Overall Study|Lost to Follow-up|0|||
142950435|NCT04358458|515357549|FG006|Overall Study|Lost to Follow-up|0|||
142950436|NCT04358458|515357550|FG007|Overall Study|Lost to Follow-up|1|||
142950437|NCT04358458|515357543|FG000|Overall Study|Site is closing study participation|0|||
142950438|NCT04358458|515357544|FG001|Overall Study|Site is closing study participation|0|||
142950439|NCT04358458|515357545|FG002|Overall Study|Site is closing study participation|0|||
142950440|NCT04358458|515357546|FG003|Overall Study|Site is closing study participation|1|||
142950441|NCT04358458|515357547|FG004|Overall Study|Site is closing study participation|0|||
142950442|NCT04358458|515357548|FG005|Overall Study|Site is closing study participation|0|||
142950443|NCT04358458|515357549|FG006|Overall Study|Site is closing study participation|0|||
142950444|NCT04358458|515357550|FG007|Overall Study|Site is closing study participation|0|||
142950445|NCT04358458|515357543|FG000|Overall Study|Sponsor request|2|||
142950446|NCT04358458|515357544|FG001|Overall Study|Sponsor request|3|||
142950447|NCT04358458|515357545|FG002|Overall Study|Sponsor request|3|||
142950448|NCT04358458|515357546|FG003|Overall Study|Sponsor request|0|||
142950449|NCT04358458|515357547|FG004|Overall Study|Sponsor request|2|||
142950450|NCT04358458|515357548|FG005|Overall Study|Sponsor request|3|||
142950451|NCT04358458|515357549|FG006|Overall Study|Sponsor request|1|||
142950452|NCT04358458|515357550|FG007|Overall Study|Sponsor request|1|||
142950453|NCT04358458|515357543|FG000|Overall Study|Withdrawal by Subject|0|||
142950454|NCT04358458|515357544|FG001|Overall Study|Withdrawal by Subject|0|||
142950455|NCT04358458|515357545|FG002|Overall Study|Withdrawal by Subject|1|||
142950456|NCT04358458|515357546|FG003|Overall Study|Withdrawal by Subject|1|||
142950457|NCT04358458|515357547|FG004|Overall Study|Withdrawal by Subject|0|||
142950458|NCT04358458|515357548|FG005|Overall Study|Withdrawal by Subject|1|||
142950459|NCT04358458|515357549|FG006|Overall Study|Withdrawal by Subject|0|||
142950460|NCT04358458|515357550|FG007|Overall Study|Withdrawal by Subject|1|||
142950461|NCT03191786|515357551|FG000|Overall Study|Death|236|||
142950462|NCT03191786|515357552|FG001|Overall Study|Death|127|||
142950463|NCT03191786|515357551|FG000|Overall Study|Lost to Follow-up|9|||
142950464|NCT03191786|515357552|FG001|Overall Study|Lost to Follow-up|3|||
142950465|NCT03191786|515357551|FG000|Overall Study|Physician Decision|1|||
142950466|NCT03191786|515357552|FG001|Overall Study|Physician Decision|0|||
142950467|NCT03191786|515357551|FG000|Overall Study|Moved to Post Trial Access Program|30|||
142950468|NCT03191786|515357552|FG001|Overall Study|Moved to Post Trial Access Program|5|||
142950469|NCT03191786|515357551|FG000|Overall Study|Withdrawal by Subject|26|||
142950470|NCT03191786|515357552|FG001|Overall Study|Withdrawal by Subject|16|||
142950471|NCT04513158|515357555|FG000|Overall Study|Screen Failure|1|||
142950472|NCT02786537|515359887|FG000|As Randomized|Adverse Event|0|||
142950473|NCT02786537|515359888|FG001|As Randomized|Adverse Event|11|||
142950474|NCT02786537|515359889|FG002|As Randomized|Adverse Event|0|||
142950475|NCT02786537|515359890|FG003|As Randomized|Adverse Event|4|||
142950476|NCT02786537|515359891|FG004|As Randomized|Adverse Event|6|||
142950477|NCT02786537|515359892|FG005|As Randomized|Adverse Event|2|||
142950478|NCT02786537|515359887|FG000|As Randomized|Lack of Efficacy|0|||
142950479|NCT02786537|515359888|FG001|As Randomized|Lack of Efficacy|0|||
142950480|NCT02786537|515359889|FG002|As Randomized|Lack of Efficacy|0|||
142950481|NCT02786537|515359890|FG003|As Randomized|Lack of Efficacy|1|||
142950482|NCT02786537|515359891|FG004|As Randomized|Lack of Efficacy|0|||
142950483|NCT02786537|515359892|FG005|As Randomized|Lack of Efficacy|0|||
142950484|NCT02786537|515359887|FG000|As Randomized|Withdrawal by Subject|1|||
142950485|NCT02786537|515359888|FG001|As Randomized|Withdrawal by Subject|2|||
142950486|NCT02786537|515359889|FG002|As Randomized|Withdrawal by Subject|0|||
142950487|NCT02786537|515359890|FG003|As Randomized|Withdrawal by Subject|1|||
142950488|NCT02786537|515359891|FG004|As Randomized|Withdrawal by Subject|1|||
142950489|NCT02786537|515359892|FG005|As Randomized|Withdrawal by Subject|0|||
142950490|NCT02786537|515359887|FG000|As Randomized|Death|0|||
142950491|NCT02786537|515359888|FG001|As Randomized|Death|2|||
142950492|NCT02786537|515359889|FG002|As Randomized|Death|0|||
142950493|NCT02786537|515359890|FG003|As Randomized|Death|3|||
142950494|NCT02786537|515359891|FG004|As Randomized|Death|1|||
142950495|NCT02786537|515359892|FG005|As Randomized|Death|0|||
142950496|NCT02786537|515359887|FG000|As Randomized|Non-compliance with study drug|1|||
142950497|NCT02786537|515359888|FG001|As Randomized|Non-compliance with study drug|11|||
142950498|NCT02786537|515359889|FG002|As Randomized|Non-compliance with study drug|0|||
142950499|NCT02786537|515359890|FG003|As Randomized|Non-compliance with study drug|1|||
142950500|NCT02786537|515359891|FG004|As Randomized|Non-compliance with study drug|0|||
142950501|NCT02786537|515359892|FG005|As Randomized|Non-compliance with study drug|1|||
142950502|NCT02786537|515359887|FG000|As Randomized|Lost to treatment follow-up|4|||
142950503|NCT02786537|515359888|FG001|As Randomized|Lost to treatment follow-up|32|||
142950504|NCT02786537|515359889|FG002|As Randomized|Lost to treatment follow-up|0|||
142950505|NCT02786537|515359890|FG003|As Randomized|Lost to treatment follow-up|24|||
142950506|NCT02786537|515359891|FG004|As Randomized|Lost to treatment follow-up|4|||
142950507|NCT02786537|515359892|FG005|As Randomized|Lost to treatment follow-up|4|||
142950508|NCT02786537|515359887|FG000|As Randomized|Incarceration|0|||
142950509|NCT02786537|515359888|FG001|As Randomized|Incarceration|1|||
142950510|NCT02786537|515359889|FG002|As Randomized|Incarceration|0|||
142950511|NCT02786537|515359890|FG003|As Randomized|Incarceration|0|||
142950512|NCT02786537|515359891|FG004|As Randomized|Incarceration|0|||
142950513|NCT02786537|515359892|FG005|As Randomized|Incarceration|0|||
142950514|NCT02786537|515359887|FG000|As Randomized|Opiate Dependency Relapse|0|||
142950515|NCT02786537|515359888|FG001|As Randomized|Opiate Dependency Relapse|1|||
142950516|NCT02786537|515359889|FG002|As Randomized|Opiate Dependency Relapse|0|||
142950517|NCT02786537|515359890|FG003|As Randomized|Opiate Dependency Relapse|0|||
142950518|NCT02786537|515359891|FG004|As Randomized|Opiate Dependency Relapse|0|||
142950519|NCT02786537|515359892|FG005|As Randomized|Opiate Dependency Relapse|0|||
142950520|NCT02786537|515359887|FG000|As Randomized|HCV drugs stolen from pt|0|||
142950521|NCT02786537|515359888|FG001|As Randomized|HCV drugs stolen from pt|1|||
142950522|NCT02786537|515359889|FG002|As Randomized|HCV drugs stolen from pt|0|||
142950523|NCT02786537|515359890|FG003|As Randomized|HCV drugs stolen from pt|0|||
142950524|NCT02786537|515359891|FG004|As Randomized|HCV drugs stolen from pt|0|||
142950525|NCT02786537|515359892|FG005|As Randomized|HCV drugs stolen from pt|0|||
142950526|NCT02786537|515359887|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
142950527|NCT02786537|515359888|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
142950528|NCT02786537|515359889|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
142950529|NCT02786537|515359890|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
142950530|NCT02786537|515359891|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
142950531|NCT02786537|515359892|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
142950532|NCT02786537|515359887|FG000|As Randomized|Subject lost insurance|0|||
142950533|NCT02786537|515359888|FG001|As Randomized|Subject lost insurance|0|||
142950534|NCT02786537|515359889|FG002|As Randomized|Subject lost insurance|0|||
142950535|NCT02786537|515359890|FG003|As Randomized|Subject lost insurance|1|||
142950536|NCT02786537|515359891|FG004|As Randomized|Subject lost insurance|0|||
142950537|NCT02786537|515359892|FG005|As Randomized|Subject lost insurance|0|||
142950538|NCT02786537|515359887|FG000|As Treated|Adverse Event|0|||
142950539|NCT02786537|515359888|FG001|As Treated|Adverse Event|11|||
143117124|NCT01273155|515970039|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
142950540|NCT02786537|515359889|FG002|As Treated|Adverse Event|0|||
142950541|NCT02786537|515359890|FG003|As Treated|Adverse Event|4|||
142950542|NCT02786537|515359891|FG004|As Treated|Adverse Event|6|||
142950543|NCT02786537|515359892|FG005|As Treated|Adverse Event|2|||
142950544|NCT02786537|515359887|FG000|As Treated|Death|0|||
142950545|NCT02786537|515359888|FG001|As Treated|Death|2|||
142950546|NCT02786537|515359889|FG002|As Treated|Death|0|||
142950547|NCT02786537|515359890|FG003|As Treated|Death|3|||
142950548|NCT02786537|515359891|FG004|As Treated|Death|1|||
142950549|NCT02786537|515359892|FG005|As Treated|Death|0|||
142950550|NCT02786537|515359887|FG000|As Treated|Lack of Efficacy|0|||
142950551|NCT02786537|515359888|FG001|As Treated|Lack of Efficacy|0|||
142950552|NCT02786537|515359889|FG002|As Treated|Lack of Efficacy|0|||
142950553|NCT02786537|515359890|FG003|As Treated|Lack of Efficacy|1|||
142950554|NCT02786537|515359891|FG004|As Treated|Lack of Efficacy|0|||
142950555|NCT02786537|515359892|FG005|As Treated|Lack of Efficacy|0|||
142950556|NCT02786537|515359887|FG000|As Treated|Lost to Follow-up|4|||
142950557|NCT02786537|515359888|FG001|As Treated|Lost to Follow-up|32|||
142950558|NCT02786537|515359889|FG002|As Treated|Lost to Follow-up|0|||
142950559|NCT02786537|515359890|FG003|As Treated|Lost to Follow-up|25|||
142950560|NCT02786537|515359891|FG004|As Treated|Lost to Follow-up|4|||
142950561|NCT02786537|515359892|FG005|As Treated|Lost to Follow-up|4|||
142950562|NCT02786537|515359887|FG000|As Treated|Non-compliance with study drug|1|||
143455081|NCT02663518|517210770|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
143455082|NCT02663518|517210771|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
143455083|NCT02663518|517210772|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
143455084|NCT02663518|517210759|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
142950563|NCT02786537|515359888|FG001|As Treated|Non-compliance with study drug|11|||
142950564|NCT02786537|515359889|FG002|As Treated|Non-compliance with study drug|0|||
142950565|NCT02786537|515359890|FG003|As Treated|Non-compliance with study drug|1|||
142950566|NCT02786537|515359891|FG004|As Treated|Non-compliance with study drug|0|||
142950567|NCT02786537|515359892|FG005|As Treated|Non-compliance with study drug|1|||
142950568|NCT02786537|515359887|FG000|As Treated|Lost insurance|0|||
142950569|NCT02786537|515359888|FG001|As Treated|Lost insurance|0|||
142950570|NCT02786537|515359889|FG002|As Treated|Lost insurance|0|||
142950571|NCT02786537|515359890|FG003|As Treated|Lost insurance|1|||
142950572|NCT02786537|515359891|FG004|As Treated|Lost insurance|0|||
142950573|NCT02786537|515359892|FG005|As Treated|Lost insurance|0|||
142950574|NCT02786537|515359887|FG000|As Treated|Withdrawal by Subject|1|||
142950575|NCT02786537|515359888|FG001|As Treated|Withdrawal by Subject|2|||
142950576|NCT02786537|515359889|FG002|As Treated|Withdrawal by Subject|0|||
142950577|NCT02786537|515359890|FG003|As Treated|Withdrawal by Subject|0|||
142950578|NCT02786537|515359891|FG004|As Treated|Withdrawal by Subject|1|||
142950579|NCT02786537|515359892|FG005|As Treated|Withdrawal by Subject|0|||
142950580|NCT02786537|515359887|FG000|As Treated|Incarceration|0|||
142950581|NCT02786537|515359888|FG001|As Treated|Incarceration|1|||
142950582|NCT02786537|515359889|FG002|As Treated|Incarceration|0|||
142950583|NCT02786537|515359890|FG003|As Treated|Incarceration|0|||
142950584|NCT02786537|515359891|FG004|As Treated|Incarceration|0|||
142950585|NCT02786537|515359892|FG005|As Treated|Incarceration|0|||
142950586|NCT02786537|515359887|FG000|As Treated|Opiate dependency relapse|0|||
142950587|NCT02786537|515359888|FG001|As Treated|Opiate dependency relapse|1|||
142950588|NCT02786537|515359889|FG002|As Treated|Opiate dependency relapse|0|||
142950589|NCT02786537|515359890|FG003|As Treated|Opiate dependency relapse|0|||
142950590|NCT02786537|515359891|FG004|As Treated|Opiate dependency relapse|0|||
142950591|NCT02786537|515359892|FG005|As Treated|Opiate dependency relapse|0|||
142950592|NCT02786537|515359887|FG000|As Treated|Drugs stolen from patient|0|||
142950593|NCT02786537|515359888|FG001|As Treated|Drugs stolen from patient|1|||
142950594|NCT02786537|515359889|FG002|As Treated|Drugs stolen from patient|0|||
142950595|NCT02786537|515359890|FG003|As Treated|Drugs stolen from patient|0|||
142950596|NCT02786537|515359891|FG004|As Treated|Drugs stolen from patient|0|||
142950597|NCT02786537|515359892|FG005|As Treated|Drugs stolen from patient|0|||
142950598|NCT02786537|515359887|FG000|As Treated|Advised to stop tx after loss of meds|0|||
142950599|NCT02786537|515359888|FG001|As Treated|Advised to stop tx after loss of meds|1|||
142950600|NCT02786537|515359889|FG002|As Treated|Advised to stop tx after loss of meds|0|||
142950601|NCT02786537|515359890|FG003|As Treated|Advised to stop tx after loss of meds|0|||
142950602|NCT02786537|515359891|FG004|As Treated|Advised to stop tx after loss of meds|0|||
142950603|NCT02786537|515359892|FG005|As Treated|Advised to stop tx after loss of meds|0|||
143455085|NCT02663518|517210760|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
143455086|NCT02663518|517210761|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
142950604|NCT02413255|515359899|FG000|Overall Study|Voluntary Withdrawal|0|||
142950605|NCT02413255|515359900|FG001|Overall Study|Voluntary Withdrawal|0|||
142950606|NCT02413255|515359901|FG002|Overall Study|Voluntary Withdrawal|0|||
142950607|NCT02413255|515359902|FG003|Overall Study|Voluntary Withdrawal|0|||
142950608|NCT02413255|515359903|FG004|Overall Study|Voluntary Withdrawal|0|||
142950609|NCT02413255|515359904|FG005|Overall Study|Voluntary Withdrawal|0|||
142950610|NCT02413255|515359905|FG006|Overall Study|Voluntary Withdrawal|0|||
142950611|NCT02413255|515359906|FG007|Overall Study|Voluntary Withdrawal|0|||
142950612|NCT02413255|515359907|FG008|Overall Study|Voluntary Withdrawal|0|||
142950613|NCT02413255|515359908|FG009|Overall Study|Voluntary Withdrawal|0|||
142950614|NCT02413255|515359909|FG010|Overall Study|Voluntary Withdrawal|0|||
142950615|NCT02413255|515359910|FG011|Overall Study|Voluntary Withdrawal|0|||
142950616|NCT02413255|515359911|FG012|Overall Study|Voluntary Withdrawal|0|||
142950617|NCT02413255|515359912|FG013|Overall Study|Voluntary Withdrawal|0|||
142950618|NCT02413255|515359913|FG014|Overall Study|Voluntary Withdrawal|1|||
142950619|NCT02413255|515359914|FG015|Overall Study|Voluntary Withdrawal|0|||
142950620|NCT02413255|515359915|FG016|Overall Study|Voluntary Withdrawal|0|||
142950621|NCT02413398|515359918|FG000|Overall Study|Lost to Follow-up|2|||
142950622|NCT02413398|515359919|FG001|Overall Study|Lost to Follow-up|4|||
142950623|NCT02413398|515359918|FG000|Overall Study|Withdrawal by Subject|1|||
142950624|NCT02413398|515359919|FG001|Overall Study|Withdrawal by Subject|1|||
142950625|NCT02413398|515359918|FG000|Overall Study|Other Eligibility criteria|1|||
142950626|NCT02413398|515359919|FG001|Overall Study|Other Eligibility criteria|2|||
142950627|NCT01494038|515359920|FG000|Overall Study|Protocol Violation|1|||
142950628|NCT01494038|515359921|FG001|Overall Study|Protocol Violation|1|||
142950629|NCT01494038|515359920|FG000|Overall Study|Lost to Follow-up|18|||
142950630|NCT01494038|515359921|FG001|Overall Study|Lost to Follow-up|20|||
142950631|NCT01494038|515359920|FG000|Overall Study|Withdrawal by Subject|44|||
142950632|NCT01494038|515359921|FG001|Overall Study|Withdrawal by Subject|34|||
142950633|NCT01494038|515359920|FG000|Overall Study|Not able to get to clinic|21|||
142950634|NCT01494038|515359921|FG001|Overall Study|Not able to get to clinic|15|||
142950635|NCT01494038|515359920|FG000|Overall Study|Not willing to adhere to reqs|2|||
142950636|NCT01494038|515359921|FG001|Overall Study|Not willing to adhere to reqs|9|||
142950637|NCT01494038|515359920|FG000|Overall Study|Death|2|||
142950638|NCT01494038|515359921|FG001|Overall Study|Death|4|||
142950639|NCT00537940|515359924|FG000|Overall Study|Adverse Event|20|||
142950640|NCT00537940|515359925|FG001|Overall Study|Adverse Event|19|||
142950641|NCT00537940|515359924|FG000|Overall Study|Lack of Efficacy|8|||
142950642|NCT00537940|515359925|FG001|Overall Study|Lack of Efficacy|16|||
142950643|NCT00537940|515359924|FG000|Overall Study|Lost to Follow-up|23|||
142950644|NCT00537940|515359925|FG001|Overall Study|Lost to Follow-up|29|||
142950645|NCT00537940|515359924|FG000|Overall Study|Withdrawal by Subject|113|||
142950646|NCT00537940|515359925|FG001|Overall Study|Withdrawal by Subject|95|||
142950647|NCT00537940|515359924|FG000|Overall Study|Protocol Violation|6|||
142950648|NCT00537940|515359925|FG001|Overall Study|Protocol Violation|4|||
142950649|NCT00537940|515359924|FG000|Overall Study|Pregnancy|1|||
142950650|NCT00537940|515359925|FG001|Overall Study|Pregnancy|1|||
142950651|NCT00537940|515359924|FG000|Overall Study|Study terminated by sponsor|2|||
142950652|NCT00537940|515359925|FG001|Overall Study|Study terminated by sponsor|3|||
142950653|NCT00537940|515359924|FG000|Overall Study|Other|10|||
142950654|NCT00537940|515359925|FG001|Overall Study|Other|12|||
142950655|NCT01978912|515359927|FG000|Overall Study|Adverse Event|0|||
142950656|NCT01978912|515359928|FG001|Overall Study|Adverse Event|1|||
142950657|NCT01978912|515359929|FG002|Overall Study|Adverse Event|0|||
142950658|NCT01978912|515359930|FG003|Overall Study|Adverse Event|0|||
142950659|NCT01978912|515359927|FG000|Overall Study|Lost to Follow-up|1|||
142950660|NCT01978912|515359928|FG001|Overall Study|Lost to Follow-up|1|||
142950661|NCT01978912|515359929|FG002|Overall Study|Lost to Follow-up|0|||
142950662|NCT01978912|515359930|FG003|Overall Study|Lost to Follow-up|1|||
142950663|NCT01978912|515359927|FG000|Overall Study|Withdrawal by Subject|1|||
142950664|NCT01978912|515359928|FG001|Overall Study|Withdrawal by Subject|0|||
142950665|NCT01978912|515359929|FG002|Overall Study|Withdrawal by Subject|2|||
142950666|NCT01978912|515359930|FG003|Overall Study|Withdrawal by Subject|2|||
142950667|NCT01978912|515359927|FG000|Overall Study|Lumbar Surgery|1|||
142950668|NCT01978912|515359928|FG001|Overall Study|Lumbar Surgery|0|||
142950669|NCT01978912|515359929|FG002|Overall Study|Lumbar Surgery|1|||
142950670|NCT01978912|515359930|FG003|Overall Study|Lumbar Surgery|0|||
142950671|NCT01978912|515359927|FG000|Overall Study|Intradiscal Steroid Injection|0|||
142950672|NCT01978912|515359928|FG001|Overall Study|Intradiscal Steroid Injection|1|||
142950673|NCT01978912|515359929|FG002|Overall Study|Intradiscal Steroid Injection|0|||
142950674|NCT01978912|515359930|FG003|Overall Study|Intradiscal Steroid Injection|0|||
142950675|NCT00685178|515359935|FG000|Overall Study|Adverse Event|1|||
142950676|NCT00685178|515359936|FG001|Overall Study|Adverse Event|5|||
142950677|NCT00685178|515359937|FG002|Overall Study|Adverse Event|2|||
142950678|NCT00685178|515359938|FG003|Overall Study|Adverse Event|4|||
142950679|NCT00685178|515359935|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
142950680|NCT00685178|515359936|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
142950681|NCT00685178|515359937|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
142950682|NCT00685178|515359938|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
143117125|NCT01273155|515970040|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
142950683|NCT00685178|515359935|FG000|Overall Study|voluntary study discharge|4|||
142950684|NCT00685178|515359936|FG001|Overall Study|voluntary study discharge|5|||
142950685|NCT00685178|515359937|FG002|Overall Study|voluntary study discharge|1|||
142950686|NCT00685178|515359938|FG003|Overall Study|voluntary study discharge|1|||
142950687|NCT00685178|515359935|FG000|Overall Study|incarcerated|1|||
142950688|NCT00685178|515359936|FG001|Overall Study|incarcerated|3|||
142950689|NCT00685178|515359937|FG002|Overall Study|incarcerated|7|||
142950690|NCT00685178|515359938|FG003|Overall Study|incarcerated|0|||
142950691|NCT00685178|515359935|FG000|Overall Study|administrative (disciplinary) discharge|0|||
142950692|NCT00685178|515359936|FG001|Overall Study|administrative (disciplinary) discharge|1|||
142950693|NCT00685178|515359937|FG002|Overall Study|administrative (disciplinary) discharge|0|||
142950694|NCT00685178|515359938|FG003|Overall Study|administrative (disciplinary) discharge|2|||
142950695|NCT00685178|515359935|FG000|Overall Study|Pregnancy|0|||
142950696|NCT00685178|515359936|FG001|Overall Study|Pregnancy|0|||
142950697|NCT00685178|515359937|FG002|Overall Study|Pregnancy|0|||
142950698|NCT00685178|515359938|FG003|Overall Study|Pregnancy|1|||
142950699|NCT00077623|515359944|FG000|Overall Study|Adverse Event|1|||
142950700|NCT00077623|515359945|FG001|Overall Study|Adverse Event|0|||
142950701|NCT00077623|515359946|FG002|Overall Study|Adverse Event|1|||
142950702|NCT00077623|515359944|FG000|Overall Study|Withdrawal by Subject|2|||
142950703|NCT00077623|515359945|FG001|Overall Study|Withdrawal by Subject|10|||
142950704|NCT00077623|515359946|FG002|Overall Study|Withdrawal by Subject|1|||
142950705|NCT00077623|515359944|FG000|Overall Study|Other-Non safety reason|18|||
142950706|NCT00077623|515359945|FG001|Overall Study|Other-Non safety reason|15|||
142950707|NCT00077623|515359946|FG002|Overall Study|Other-Non safety reason|19|||
142950708|NCT00077623|515359944|FG000|Overall Study|Insufficient therapeutic response|2|||
142950709|NCT00077623|515359945|FG001|Overall Study|Insufficient therapeutic response|0|||
142950710|NCT00077623|515359946|FG002|Overall Study|Insufficient therapeutic response|0|||
142950711|NCT00077623|515359944|FG000|Overall Study|Death|12|||
142950712|NCT00077623|515359945|FG001|Overall Study|Death|18|||
142950713|NCT00077623|515359946|FG002|Overall Study|Death|11|||
142950714|NCT00077623|515359944|FG000|Overall Study|Failure to return|1|||
142950715|NCT00077623|515359945|FG001|Overall Study|Failure to return|0|||
142950716|NCT00077623|515359946|FG002|Overall Study|Failure to return|0|||
142950717|NCT01334125|515359947|FG000|Overall Study|Lost to Follow-up|3|||
142950718|NCT01334125|515359948|FG001|Overall Study|Lost to Follow-up|3|||
142950719|NCT02138110|515359952|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
142950720|NCT02138110|515359952|FG000|Overall Scaffold Implantation|Death|3|||
142950721|NCT00882713|515359954|FG000|Overall Study|Adverse Event|2|||
142950722|NCT00882713|515359954|FG000|Overall Study|Death|3|||
142950723|NCT00882713|515359954|FG000|Overall Study|Administrative reasons|4|||
142950724|NCT00882713|515359954|FG000|Overall Study|refused treatment/withdrew consent|4|||
142950725|NCT00882713|515359954|FG000|Overall Study|Blood transfusion|2|||
142950726|NCT00882713|515359954|FG000|Overall Study|Insufficient therapeutic response|3|||
142950727|NCT00882713|515359954|FG000|Overall Study|Failure to return|2|||
142950728|NCT00882713|515359954|FG000|Overall Study|Other - Reasons|2|||
142950729|NCT00401973|515359957|FG000|Overall Study|Adverse Event|2|||
142950730|NCT00401973|515359958|FG001|Overall Study|Adverse Event|8|||
142950731|NCT00401973|515359959|FG002|Overall Study|Adverse Event|4|||
142950732|NCT00401973|515359957|FG000|Overall Study|Clinical Relapse|0|||
142950733|NCT00401973|515359958|FG001|Overall Study|Clinical Relapse|1|||
142950734|NCT00401973|515359959|FG002|Overall Study|Clinical Relapse|1|||
142950735|NCT00401973|515359957|FG000|Overall Study|Lack of Efficacy|0|||
142950736|NCT00401973|515359958|FG001|Overall Study|Lack of Efficacy|0|||
142950737|NCT00401973|515359959|FG002|Overall Study|Lack of Efficacy|3|||
142950738|NCT00401973|515359957|FG000|Overall Study|Lost to Follow-up|2|||
142950739|NCT00401973|515359958|FG001|Overall Study|Lost to Follow-up|2|||
142950740|NCT00401973|515359959|FG002|Overall Study|Lost to Follow-up|2|||
142950741|NCT00401973|515359957|FG000|Overall Study|Physician Decision|2|||
142950742|NCT00401973|515359958|FG001|Overall Study|Physician Decision|0|||
142950743|NCT00401973|515359959|FG002|Overall Study|Physician Decision|1|||
142950744|NCT00401973|515359957|FG000|Overall Study|Protocol Violation|1|||
142950745|NCT00401973|515359958|FG001|Overall Study|Protocol Violation|2|||
142950746|NCT00401973|515359959|FG002|Overall Study|Protocol Violation|3|||
142950747|NCT00401973|515359957|FG000|Overall Study|Sponsor Decision|0|||
142950748|NCT00401973|515359958|FG001|Overall Study|Sponsor Decision|1|||
142950749|NCT00401973|515359959|FG002|Overall Study|Sponsor Decision|0|||
142950750|NCT00401973|515359957|FG000|Overall Study|Withdrawal by Subject|4|||
142950751|NCT00401973|515359958|FG001|Overall Study|Withdrawal by Subject|12|||
142950752|NCT00401973|515359959|FG002|Overall Study|Withdrawal by Subject|9|||
142950753|NCT01408537|515359960|FG000|Overall Study|Withdrawal by Subject|2|||
142950754|NCT01408537|515359960|FG000|Overall Study|Protocol Violation|3|||
142950755|NCT01408537|515359960|FG000|Overall Study|Lost to Follow-up|3|||
142950756|NCT05523362|515359961|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
142950757|NCT05523362|515359961|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
142950758|NCT05523362|515359961|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
142950759|NCT05523362|515359961|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
142950760|NCT04075604|515359966|FG000|Overall Study|Adverse Event|0|||
142950761|NCT04075604|515359967|FG001|Overall Study|Adverse Event|0|||
142950762|NCT04075604|515359968|FG002|Overall Study|Adverse Event|3|||
142950763|NCT04075604|515359966|FG000|Overall Study|Participant request to discontinue study treatment|0|||
142950764|NCT04075604|515359967|FG001|Overall Study|Participant request to discontinue study treatment|0|||
142950765|NCT04075604|515359968|FG002|Overall Study|Participant request to discontinue study treatment|1|||
142950766|NCT04075604|515359966|FG000|Overall Study|Participant withdrew consent|0|||
142950767|NCT04075604|515359967|FG001|Overall Study|Participant withdrew consent|0|||
142950768|NCT04075604|515359968|FG002|Overall Study|Participant withdrew consent|1|||
142950769|NCT04075604|515359966|FG000|Overall Study|Other reasons|1|||
142950770|NCT04075604|515359967|FG001|Overall Study|Other reasons|0|||
142950771|NCT04075604|515359968|FG002|Overall Study|Other reasons|0|||
142950772|NCT04075604|515359966|FG000|Overall Study|Disease progression|0|||
142950773|NCT04075604|515359967|FG001|Overall Study|Disease progression|1|||
142950774|NCT04075604|515359968|FG002|Overall Study|Disease progression|0|||
142950775|NCT04075604|515359966|FG000|Overall Study|Study drug toxicity|0|||
142950776|NCT04075604|515359967|FG001|Overall Study|Study drug toxicity|5|||
142950777|NCT04075604|515359968|FG002|Overall Study|Study drug toxicity|1|||
142950778|NCT02760602|515359969|FG000|Overall Study|Withdrawal by Subject|1|||
142950779|NCT02760602|515359970|FG001|Overall Study|Withdrawal by Subject|0|||
142950780|NCT02760602|515359969|FG000|Overall Study|Terminated by sponsor|12|||
142950781|NCT02760602|515359970|FG001|Overall Study|Terminated by sponsor|13|||
142950782|NCT00345605|515359977|FG000|Arm 1|Adverse Event|0|||
142950783|NCT00345605|515359978|FG001|Arm 1|Adverse Event|1|||
142950784|NCT00345605|515359977|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
142950785|NCT00345605|515359978|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
142950786|NCT05299892|515359979|FG000|Overall Study|Withdrawal by Subject|2|||
142950787|NCT01260181|515359987|FG000|Overall Study|Decision of Investigator|1|||
142950788|NCT01588197|515359988|FG000|Overall Study|Lack of Efficacy|0|||
142950789|NCT01588197|515359989|FG001|Overall Study|Lack of Efficacy|1|||
142950790|NCT01588197|515359988|FG000|Overall Study|No MRI|1|||
142950791|NCT01588197|515359989|FG001|Overall Study|No MRI|0|||
142950792|NCT01844076|515359990|FG000|Overall Study|Adverse Event|1|||
142950793|NCT01844076|515359991|FG001|Overall Study|Adverse Event|0|||
142950794|NCT01844076|515359992|FG002|Overall Study|Adverse Event|0|||
142950795|NCT01844076|515359993|FG003|Overall Study|Adverse Event|0|||
142950796|NCT01844076|515359990|FG000|Overall Study|Withdrawal by Subject|1|||
142950797|NCT01844076|515359991|FG001|Overall Study|Withdrawal by Subject|0|||
142950798|NCT01844076|515359992|FG002|Overall Study|Withdrawal by Subject|0|||
142950799|NCT01844076|515359993|FG003|Overall Study|Withdrawal by Subject|0|||
142950800|NCT00635102|515359995|FG000|Overall Study|Withdrawal by Subject|7|||
142950801|NCT00635102|515359996|FG001|Overall Study|Withdrawal by Subject|8|||
142950802|NCT02088034|515359998|FG000|Overall Study|Lost to Follow-up|1|||
142950803|NCT02088034|515359999|FG001|Overall Study|Lost to Follow-up|1|||
142950804|NCT02088034|515360000|FG002|Overall Study|Lost to Follow-up|0|||
142950805|NCT02088034|515359998|FG000|Overall Study|Pregnancy|2|||
142950806|NCT02088034|515359999|FG001|Overall Study|Pregnancy|1|||
142950807|NCT02088034|515360000|FG002|Overall Study|Pregnancy|2|||
142950808|NCT01025336|515360004|FG000|Overall Study|Protocol Violation|0|||
142950809|NCT01025336|515360005|FG001|Overall Study|Protocol Violation|0|||
142950810|NCT01025336|515360006|FG002|Overall Study|Protocol Violation|0|||
142950811|NCT01025336|515360007|FG003|Overall Study|Protocol Violation|2|||
142950812|NCT01025336|515360008|FG004|Overall Study|Protocol Violation|0|||
142950813|NCT00474253|515360009|FG000|Overall Study|Withdrew consent|2|||
142950814|NCT00474253|515360010|FG001|Overall Study|Withdrew consent|0|||
142950815|NCT00474253|515360009|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
142950816|NCT00474253|515360010|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
142950817|NCT00474253|515360009|FG000|Overall Study|Lost to Follow-up|1|||
142950818|NCT00474253|515360010|FG001|Overall Study|Lost to Follow-up|0|||
142950819|NCT00474253|515360009|FG000|Overall Study|Discharged prior to study completion|0|||
142950820|NCT00474253|515360010|FG001|Overall Study|Discharged prior to study completion|1|||
142950821|NCT01165229|515360011|FG000|Overall Study|Serious Adverse Event|456|||
142950822|NCT01165229|515360012|FG001|Overall Study|Serious Adverse Event|487|||
142950823|NCT01165229|515360011|FG000|Overall Study|Non-Serious Adverse Event|47|||
142950824|NCT01165229|515360012|FG001|Overall Study|Non-Serious Adverse Event|15|||
142950825|NCT01165229|515360011|FG000|Overall Study|Protocol Violation|6|||
142950826|NCT01165229|515360012|FG001|Overall Study|Protocol Violation|8|||
142950827|NCT01165229|515360011|FG000|Overall Study|Withdrawal by Subject|387|||
142950828|NCT01165229|515360012|FG001|Overall Study|Withdrawal by Subject|396|||
142950829|NCT01165229|515360011|FG000|Overall Study|Migrated/moved from study area|51|||
142950830|NCT01165229|515360012|FG001|Overall Study|Migrated/moved from study area|46|||
142950831|NCT01165229|515360011|FG000|Overall Study|Lost to Follow-up|123|||
142950832|NCT01165229|515360012|FG001|Overall Study|Lost to Follow-up|133|||
142950833|NCT01165229|515360011|FG000|Overall Study|Suspected HZ Episode|2|||
142950834|NCT01165229|515360012|FG001|Overall Study|Suspected HZ Episode|2|||
143455087|NCT02663518|517210762|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
143455088|NCT02663518|517210763|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
143455089|NCT02663518|517210764|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
142950835|NCT01165229|515360011|FG000|Overall Study|No reason from the subject|108|||
142950836|NCT01165229|515360012|FG001|Overall Study|No reason from the subject|102|||
142950837|NCT01165229|515360011|FG000|Overall Study|Unknown completion status|0|||
142950838|NCT01165229|515360012|FG001|Overall Study|Unknown completion status|1|||
142950839|NCT00550238|515360013|FG000|Overall Study|Adverse Event|88|||
142950840|NCT00550238|515360013|FG000|Overall Study|Death|34|||
142950841|NCT00550238|515360013|FG000|Overall Study|Disease progression|46|||
142950842|NCT00550238|515360013|FG000|Overall Study|Withdrawal by Subject|167|||
142950843|NCT00550238|515360013|FG000|Overall Study|Physician Decision|31|||
142950844|NCT00550238|515360013|FG000|Overall Study|Patient noncompliance|25|||
142950845|NCT00550238|515360013|FG000|Overall Study|Lost to Follow-up|13|||
142950846|NCT00550238|515360013|FG000|Overall Study|Sponsor decision|55|||
142950847|NCT03133481|515360014|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
142950848|NCT03133481|515360015|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
142950849|NCT01873950|515360023|FG000|Period 5|Withdrawal by Subject|0|||
142950850|NCT01873950|515360024|FG001|Period 5|Withdrawal by Subject|0|||
142950851|NCT01873950|515360025|FG002|Period 5|Withdrawal by Subject|0|||
142950852|NCT01873950|515360026|FG003|Period 5|Withdrawal by Subject|1|||
142950853|NCT01873950|515360027|FG004|Period 5|Withdrawal by Subject|0|||
142950854|NCT00650585|515360028|FG000|Overall Study|Lost to Follow-up|505|||
142950855|NCT00650585|515360029|FG001|Overall Study|Lost to Follow-up|482|||
142950856|NCT00650585|515360028|FG000|Overall Study|No parental consent|935|||
142950857|NCT00650585|515360029|FG001|Overall Study|No parental consent|866|||
142950858|NCT00650585|515360028|FG000|Overall Study|Excluded/ruled ineligible|357|||
142950859|NCT00650585|515360029|FG001|Overall Study|Excluded/ruled ineligible|129|||
142950860|NCT02532543|515360030|FG000|Overall Study|Lost to Follow-up|0|||
142950861|NCT02532543|515360031|FG001|Overall Study|Lost to Follow-up|0|||
142950862|NCT02532543|515360032|FG002|Overall Study|Lost to Follow-up|1|||
142950863|NCT02532543|515360033|FG003|Overall Study|Lost to Follow-up|0|||
142950864|NCT00923091|515360035|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
142950865|NCT00923091|515360036|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
142950866|NCT00923091|515360037|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
142950867|NCT00923091|515360038|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
142950868|NCT00923091|515360039|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
142950869|NCT00923091|515360040|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
142950870|NCT00923091|515360041|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
142950871|NCT00923091|515360042|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
142950872|NCT00923091|515360043|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
142950873|NCT00923091|515360044|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
142950874|NCT00923091|515360045|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
142950875|NCT00923091|515360046|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
142950876|NCT00923091|515360047|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
142950877|NCT00923091|515360035|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
142950878|NCT00923091|515360036|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
142950879|NCT00923091|515360037|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
142950880|NCT00923091|515360038|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
142950881|NCT00923091|515360039|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
142950882|NCT00923091|515360040|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
142950883|NCT00923091|515360041|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
142950884|NCT00923091|515360042|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
142950885|NCT00923091|515360043|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
142950886|NCT00923091|515360044|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
142950887|NCT00923091|515360045|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
142950888|NCT00923091|515360046|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
142950889|NCT00923091|515360047|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
142950890|NCT00923091|515360035|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
142950891|NCT00923091|515360036|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
142950892|NCT00923091|515360037|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
142950893|NCT00923091|515360038|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
142950894|NCT00923091|515360039|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
142950895|NCT00923091|515360040|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
142950896|NCT00923091|515360041|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
142950897|NCT00923091|515360042|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
142950898|NCT00923091|515360043|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
142950899|NCT00923091|515360044|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
142950900|NCT00923091|515360045|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
142950901|NCT00923091|515360046|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
142950902|NCT00923091|515360047|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
142950903|NCT00923091|515360035|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
142950904|NCT00923091|515360036|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
142950905|NCT00923091|515360037|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
142950906|NCT00923091|515360038|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
142950907|NCT00923091|515360039|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
142950908|NCT00923091|515360040|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
142950909|NCT00923091|515360041|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
142950910|NCT00923091|515360042|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
142950911|NCT00923091|515360043|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
142950912|NCT00923091|515360044|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
142950913|NCT00923091|515360045|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
143003111|NCT01049360|515548763|FG019|Period 1|Withdrawal by Subject|0|||
142950914|NCT00923091|515360046|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
142950915|NCT00923091|515360047|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
142950916|NCT00923091|515360035|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
142950917|NCT00923091|515360036|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
142950918|NCT00923091|515360037|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
142950919|NCT00923091|515360038|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
142950920|NCT00923091|515360039|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
142950921|NCT00923091|515360040|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
142950922|NCT00923091|515360041|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
142950923|NCT00923091|515360042|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
142950924|NCT00923091|515360043|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
142950925|NCT00923091|515360044|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
142950926|NCT00923091|515360045|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
142950927|NCT00923091|515360046|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
142950928|NCT00923091|515360047|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
142950929|NCT00923091|515360035|FG000|Period III (Single-Blind)|Adverse Event|5|||
142950930|NCT00923091|515360036|FG001|Period III (Single-Blind)|Adverse Event|0|||
142950931|NCT00923091|515360037|FG002|Period III (Single-Blind)|Adverse Event|0|||
142950932|NCT00923091|515360038|FG003|Period III (Single-Blind)|Adverse Event|0|||
142950933|NCT00923091|515360039|FG004|Period III (Single-Blind)|Adverse Event|0|||
142950934|NCT00923091|515360040|FG005|Period III (Single-Blind)|Adverse Event|0|||
142950935|NCT00923091|515360041|FG006|Period III (Single-Blind)|Adverse Event|0|||
142950936|NCT00923091|515360042|FG007|Period III (Single-Blind)|Adverse Event|0|||
142950937|NCT00923091|515360043|FG008|Period III (Single-Blind)|Adverse Event|0|||
142950938|NCT00923091|515360044|FG009|Period III (Single-Blind)|Adverse Event|0|||
142950939|NCT00923091|515360045|FG010|Period III (Single-Blind)|Adverse Event|0|||
142950940|NCT00923091|515360046|FG011|Period III (Single-Blind)|Adverse Event|0|||
142950941|NCT00923091|515360047|FG012|Period III (Single-Blind)|Adverse Event|0|||
142950942|NCT00923091|515360035|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
142950943|NCT00923091|515360036|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
142950944|NCT00923091|515360037|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
142950945|NCT00923091|515360038|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
142950946|NCT00923091|515360039|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
142950947|NCT00923091|515360040|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
142950948|NCT00923091|515360041|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
142950949|NCT00923091|515360042|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
142950950|NCT00923091|515360043|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
142950951|NCT00923091|515360044|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
142950952|NCT00923091|515360045|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
142950953|NCT00923091|515360046|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
142950954|NCT00923091|515360047|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
142950955|NCT00923091|515360035|FG000|Period III (Single-Blind)|Protocol Violation|3|||
142950956|NCT00923091|515360036|FG001|Period III (Single-Blind)|Protocol Violation|0|||
142950957|NCT00923091|515360037|FG002|Period III (Single-Blind)|Protocol Violation|0|||
142950958|NCT00923091|515360038|FG003|Period III (Single-Blind)|Protocol Violation|0|||
142950959|NCT00923091|515360039|FG004|Period III (Single-Blind)|Protocol Violation|0|||
142950960|NCT00923091|515360040|FG005|Period III (Single-Blind)|Protocol Violation|0|||
142950961|NCT00923091|515360041|FG006|Period III (Single-Blind)|Protocol Violation|0|||
142950962|NCT00923091|515360042|FG007|Period III (Single-Blind)|Protocol Violation|0|||
142950963|NCT00923091|515360043|FG008|Period III (Single-Blind)|Protocol Violation|0|||
142950964|NCT00923091|515360044|FG009|Period III (Single-Blind)|Protocol Violation|0|||
142950965|NCT00923091|515360045|FG010|Period III (Single-Blind)|Protocol Violation|0|||
142950966|NCT00923091|515360046|FG011|Period III (Single-Blind)|Protocol Violation|0|||
142950967|NCT00923091|515360047|FG012|Period III (Single-Blind)|Protocol Violation|0|||
142950968|NCT00923091|515360035|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
142950969|NCT00923091|515360036|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
142950970|NCT00923091|515360037|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
142950971|NCT00923091|515360038|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
142950972|NCT00923091|515360039|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
142950973|NCT00923091|515360040|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
142950974|NCT00923091|515360041|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
142950975|NCT00923091|515360042|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
142950976|NCT00923091|515360043|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
142950977|NCT00923091|515360044|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
142950978|NCT00923091|515360045|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
142950979|NCT00923091|515360046|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
142950980|NCT00923091|515360047|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
142950981|NCT00923091|515360035|FG000|Period IV (Double-Blind)|Adverse Event|2|||
142950982|NCT00923091|515360036|FG001|Period IV (Double-Blind)|Adverse Event|0|||
142950983|NCT00923091|515360037|FG002|Period IV (Double-Blind)|Adverse Event|0|||
142950984|NCT00923091|515360038|FG003|Period IV (Double-Blind)|Adverse Event|0|||
142950985|NCT00923091|515360039|FG004|Period IV (Double-Blind)|Adverse Event|0|||
142950986|NCT00923091|515360040|FG005|Period IV (Double-Blind)|Adverse Event|0|||
142950987|NCT00923091|515360041|FG006|Period IV (Double-Blind)|Adverse Event|0|||
142950988|NCT00923091|515360042|FG007|Period IV (Double-Blind)|Adverse Event|0|||
142950989|NCT00923091|515360043|FG008|Period IV (Double-Blind)|Adverse Event|0|||
142950990|NCT00923091|515360044|FG009|Period IV (Double-Blind)|Adverse Event|0|||
142950991|NCT00923091|515360045|FG010|Period IV (Double-Blind)|Adverse Event|0|||
142950992|NCT00923091|515360046|FG011|Period IV (Double-Blind)|Adverse Event|0|||
142950993|NCT00923091|515360047|FG012|Period IV (Double-Blind)|Adverse Event|0|||
142950994|NCT00923091|515360035|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
142950995|NCT00923091|515360036|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
142950996|NCT00923091|515360037|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
142950997|NCT00923091|515360038|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
142950998|NCT00923091|515360039|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
142950999|NCT00923091|515360040|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
142951000|NCT00923091|515360041|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
142951001|NCT00923091|515360042|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
142951002|NCT00923091|515360043|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
142951003|NCT00923091|515360044|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
142951004|NCT00923091|515360045|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
142951005|NCT00923091|515360046|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
142951006|NCT00923091|515360047|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
142951007|NCT00923091|515360035|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
142951008|NCT00923091|515360036|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
142951009|NCT00923091|515360037|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
142951010|NCT00923091|515360038|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
142951011|NCT00923091|515360039|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
142951012|NCT00923091|515360040|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
142951013|NCT00923091|515360041|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
142951014|NCT00923091|515360042|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
142951015|NCT00923091|515360043|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
142951016|NCT00923091|515360044|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
142951017|NCT00923091|515360045|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
142951018|NCT00923091|515360046|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
142951019|NCT00923091|515360047|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
142951020|NCT00923091|515360035|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
142951021|NCT00923091|515360036|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
142951022|NCT00923091|515360037|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
142951023|NCT00923091|515360038|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
142951024|NCT00923091|515360039|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
142951025|NCT00923091|515360040|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
142951026|NCT00923091|515360041|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
142951027|NCT00923091|515360042|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
143455090|NCT02663518|517210765|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
143455091|NCT02663518|517210766|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
143455092|NCT02663518|517210767|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
143455093|NCT02663518|517210768|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
143455094|NCT02663518|517210769|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
143455095|NCT02663518|517210770|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
143455096|NCT02663518|517210771|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
143455097|NCT02663518|517210772|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
143455098|NCT02663518|517210759|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
143455099|NCT02663518|517210760|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
143455100|NCT02663518|517210761|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
143455101|NCT02663518|517210762|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
143455102|NCT02663518|517210763|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
143455103|NCT02663518|517210764|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
143455104|NCT02663518|517210765|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
143455105|NCT02663518|517210766|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
143455106|NCT02663518|517210767|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
143455107|NCT02663518|517210768|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
143455108|NCT02663518|517210769|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
143455109|NCT02663518|517210770|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
143455110|NCT02663518|517210771|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
143455111|NCT02663518|517210772|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
143455112|NCT02663518|517210759|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
143455113|NCT02663518|517210760|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
143455114|NCT02663518|517210761|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
143455115|NCT02663518|517210762|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
142951028|NCT00923091|515360043|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
142951029|NCT00923091|515360044|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
142951030|NCT00923091|515360045|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
142951031|NCT00923091|515360046|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
142951032|NCT00923091|515360047|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
142951033|NCT00923091|515360035|FG000|Period V (Double -Blind)|Protocol Violation|0|||
142951034|NCT00923091|515360036|FG001|Period V (Double -Blind)|Protocol Violation|0|||
142951035|NCT00923091|515360037|FG002|Period V (Double -Blind)|Protocol Violation|0|||
142951036|NCT00923091|515360038|FG003|Period V (Double -Blind)|Protocol Violation|0|||
142951037|NCT00923091|515360039|FG004|Period V (Double -Blind)|Protocol Violation|0|||
142951038|NCT00923091|515360040|FG005|Period V (Double -Blind)|Protocol Violation|0|||
142951039|NCT00923091|515360041|FG006|Period V (Double -Blind)|Protocol Violation|0|||
142951040|NCT00923091|515360042|FG007|Period V (Double -Blind)|Protocol Violation|0|||
142951041|NCT00923091|515360043|FG008|Period V (Double -Blind)|Protocol Violation|0|||
142951042|NCT00923091|515360044|FG009|Period V (Double -Blind)|Protocol Violation|0|||
142951043|NCT00923091|515360045|FG010|Period V (Double -Blind)|Protocol Violation|0|||
142951044|NCT00923091|515360046|FG011|Period V (Double -Blind)|Protocol Violation|0|||
142951045|NCT00923091|515360047|FG012|Period V (Double -Blind)|Protocol Violation|1|||
142951046|NCT00923091|515360035|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
142951047|NCT00923091|515360036|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
142951048|NCT00923091|515360037|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
142951049|NCT00923091|515360038|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
142951050|NCT00923091|515360039|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
142951051|NCT00923091|515360040|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
142951052|NCT00923091|515360041|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
142951053|NCT00923091|515360042|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
142951054|NCT00923091|515360043|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
142951055|NCT00923091|515360044|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
142951056|NCT00923091|515360045|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
142951057|NCT00923091|515360046|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
142951058|NCT00923091|515360047|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
142951059|NCT00923091|515360035|FG000|Period VI (Open-Label)|Adverse Event|17|||
142951060|NCT00923091|515360036|FG001|Period VI (Open-Label)|Adverse Event|0|||
142951061|NCT00923091|515360037|FG002|Period VI (Open-Label)|Adverse Event|4|||
142951062|NCT00923091|515360038|FG003|Period VI (Open-Label)|Adverse Event|1|||
142951063|NCT00923091|515360039|FG004|Period VI (Open-Label)|Adverse Event|1|||
142951064|NCT00923091|515360040|FG005|Period VI (Open-Label)|Adverse Event|0|||
142951065|NCT00923091|515360041|FG006|Period VI (Open-Label)|Adverse Event|0|||
142951066|NCT00923091|515360042|FG007|Period VI (Open-Label)|Adverse Event|0|||
142951067|NCT00923091|515360043|FG008|Period VI (Open-Label)|Adverse Event|0|||
142951068|NCT00923091|515360044|FG009|Period VI (Open-Label)|Adverse Event|0|||
142951069|NCT00923091|515360045|FG010|Period VI (Open-Label)|Adverse Event|0|||
142951070|NCT00923091|515360046|FG011|Period VI (Open-Label)|Adverse Event|0|||
142951071|NCT00923091|515360047|FG012|Period VI (Open-Label)|Adverse Event|0|||
142951072|NCT00923091|515360035|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
142951073|NCT00923091|515360036|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
142951074|NCT00923091|515360037|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
142951075|NCT00923091|515360038|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
142951076|NCT00923091|515360039|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
142951077|NCT00923091|515360040|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
142951078|NCT00923091|515360041|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
142951079|NCT00923091|515360042|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
142951080|NCT00923091|515360043|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
142951081|NCT00923091|515360044|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
142951082|NCT00923091|515360045|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
142951083|NCT00923091|515360046|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
142951084|NCT00923091|515360047|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
142951085|NCT00923091|515360035|FG000|Period VI (Open-Label)|Protocol Violation|6|||
142951086|NCT00923091|515360036|FG001|Period VI (Open-Label)|Protocol Violation|1|||
142951087|NCT00923091|515360037|FG002|Period VI (Open-Label)|Protocol Violation|3|||
142951088|NCT00923091|515360038|FG003|Period VI (Open-Label)|Protocol Violation|1|||
142951089|NCT00923091|515360039|FG004|Period VI (Open-Label)|Protocol Violation|4|||
142951090|NCT00923091|515360040|FG005|Period VI (Open-Label)|Protocol Violation|0|||
142951091|NCT00923091|515360041|FG006|Period VI (Open-Label)|Protocol Violation|0|||
142951092|NCT00923091|515360042|FG007|Period VI (Open-Label)|Protocol Violation|0|||
142951093|NCT00923091|515360043|FG008|Period VI (Open-Label)|Protocol Violation|0|||
142951094|NCT00923091|515360044|FG009|Period VI (Open-Label)|Protocol Violation|0|||
142951095|NCT00923091|515360045|FG010|Period VI (Open-Label)|Protocol Violation|0|||
142951096|NCT00923091|515360046|FG011|Period VI (Open-Label)|Protocol Violation|0|||
142951097|NCT00923091|515360047|FG012|Period VI (Open-Label)|Protocol Violation|0|||
142951098|NCT00923091|515360035|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
143117126|NCT01273155|515970041|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
142951099|NCT00923091|515360036|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
142951100|NCT00923091|515360037|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
142951101|NCT00923091|515360038|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
142951102|NCT00923091|515360039|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
142951103|NCT00923091|515360040|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
142951104|NCT00923091|515360041|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
142951105|NCT00923091|515360042|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
142951106|NCT00923091|515360043|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
142951107|NCT00923091|515360044|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
142951108|NCT00923091|515360045|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
142951109|NCT00923091|515360046|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
142951110|NCT00923091|515360047|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
142951111|NCT00923091|515360035|FG000|Period VI (Open-Label)|Other Reason|0|||
142951112|NCT00923091|515360036|FG001|Period VI (Open-Label)|Other Reason|0|||
142951113|NCT00923091|515360037|FG002|Period VI (Open-Label)|Other Reason|0|||
142951114|NCT00923091|515360038|FG003|Period VI (Open-Label)|Other Reason|1|||
142951115|NCT00923091|515360039|FG004|Period VI (Open-Label)|Other Reason|1|||
142951116|NCT00923091|515360040|FG005|Period VI (Open-Label)|Other Reason|0|||
142951117|NCT00923091|515360041|FG006|Period VI (Open-Label)|Other Reason|0|||
142951118|NCT00923091|515360042|FG007|Period VI (Open-Label)|Other Reason|0|||
142951119|NCT00923091|515360043|FG008|Period VI (Open-Label)|Other Reason|0|||
142951120|NCT00923091|515360044|FG009|Period VI (Open-Label)|Other Reason|0|||
142951121|NCT00923091|515360045|FG010|Period VI (Open-Label)|Other Reason|0|||
142951122|NCT00923091|515360046|FG011|Period VI (Open-Label)|Other Reason|0|||
142951123|NCT00923091|515360047|FG012|Period VI (Open-Label)|Other Reason|0|||
142951124|NCT01009294|515360048|FG000|Overall Study|Study discontinued by Sponsor|6|||
142951125|NCT04925570|515360049|FG000|Overall Study|Protocol Violation|24|||
142951126|NCT04925570|515360050|FG001|Overall Study|Protocol Violation|30|||
142951127|NCT04925570|515360049|FG000|Overall Study|Withdrawal by Subject|0|||
142951128|NCT04925570|515360050|FG001|Overall Study|Withdrawal by Subject|2|||
142951129|NCT05593432|515360056|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
142951130|NCT05593432|515360057|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
142951131|NCT05593432|515360058|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
142951132|NCT05593432|515360059|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
142951133|NCT05593432|515360056|FG000|16-Week OLE Period|Lack of Efficacy|0|||
142951134|NCT05593432|515360057|FG001|16-Week OLE Period|Lack of Efficacy|0|||
142951135|NCT05593432|515360058|FG002|16-Week OLE Period|Lack of Efficacy|0|||
142951136|NCT05593432|515360059|FG003|16-Week OLE Period|Lack of Efficacy|1|||
142951137|NCT05593432|515360056|FG000|16-Week OLE Period|Lost to Follow-up|0|||
142951138|NCT05593432|515360057|FG001|16-Week OLE Period|Lost to Follow-up|0|||
142951139|NCT05593432|515360058|FG002|16-Week OLE Period|Lost to Follow-up|1|||
142951140|NCT05593432|515360059|FG003|16-Week OLE Period|Lost to Follow-up|2|||
142951141|NCT05593432|515360056|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
142951142|NCT05593432|515360057|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
142951143|NCT05593432|515360058|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
142951144|NCT05593432|515360059|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
142951145|NCT02782715|515360060|FG000|Overall Study|Withdrawal by Subject|1|||
142951146|NCT02609399|515360061|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
142951147|NCT02609399|515360062|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
142951148|NCT02609399|515360061|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
142951149|NCT02609399|515360062|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
142951150|NCT02609399|515360061|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
142951151|NCT02609399|515360062|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
142951152|NCT04800315|515360071|FG000|Randomization|Did not receive study treatment|1|||
142951153|NCT04800315|515360072|FG001|Randomization|Did not receive study treatment|0|||
142951154|NCT04800315|515360073|FG002|Randomization|Did not receive study treatment|0|||
142951155|NCT04800315|515360074|FG003|Randomization|Did not receive study treatment|0|||
142951156|NCT04800315|515360071|FG000|Treatment Period|Adverse Event|4|||
142951157|NCT04800315|515360072|FG001|Treatment Period|Adverse Event|2|||
142951158|NCT04800315|515360073|FG002|Treatment Period|Adverse Event|1|||
142951159|NCT04800315|515360074|FG003|Treatment Period|Adverse Event|2|||
142951160|NCT04800315|515360071|FG000|Treatment Period|Lack of Efficacy|1|||
142951161|NCT04800315|515360072|FG001|Treatment Period|Lack of Efficacy|0|||
142951162|NCT04800315|515360073|FG002|Treatment Period|Lack of Efficacy|0|||
142951163|NCT04800315|515360074|FG003|Treatment Period|Lack of Efficacy|3|||
142951164|NCT04800315|515360071|FG000|Treatment Period|Lost to Follow-up|0|||
142951165|NCT04800315|515360072|FG001|Treatment Period|Lost to Follow-up|1|||
142951166|NCT04800315|515360073|FG002|Treatment Period|Lost to Follow-up|2|||
142951167|NCT04800315|515360074|FG003|Treatment Period|Lost to Follow-up|2|||
142951168|NCT04800315|515360071|FG000|Treatment Period|Withdrawal by participant|0|||
142951169|NCT04800315|515360072|FG001|Treatment Period|Withdrawal by participant|0|||
142951170|NCT04800315|515360073|FG002|Treatment Period|Withdrawal by participant|0|||
142951171|NCT04800315|515360074|FG003|Treatment Period|Withdrawal by participant|4|||
142951172|NCT04800315|515360071|FG000|Treatment Period|Other Reasons|0|||
142951173|NCT04800315|515360072|FG001|Treatment Period|Other Reasons|2|||
142951174|NCT04800315|515360073|FG002|Treatment Period|Other Reasons|0|||
142951175|NCT04800315|515360074|FG003|Treatment Period|Other Reasons|1|||
142951176|NCT00753922|515360075|FG000|Overall Study|Lost to Follow-up|155|||
142951177|NCT00753922|515360076|FG001|Overall Study|Lost to Follow-up|24|||
142951178|NCT00753922|515360077|FG002|Overall Study|Lost to Follow-up|28|||
142951179|NCT00753922|515360078|FG003|Overall Study|Lost to Follow-up|5|||
142951180|NCT00753922|515360075|FG000|Overall Study|Withdrawal by Subject|9|||
142951181|NCT00753922|515360076|FG001|Overall Study|Withdrawal by Subject|11|||
142951182|NCT00753922|515360077|FG002|Overall Study|Withdrawal by Subject|4|||
142951183|NCT00753922|515360078|FG003|Overall Study|Withdrawal by Subject|2|||
142951184|NCT00753922|515360075|FG000|Overall Study|Patient Non-compliance|55|||
142951185|NCT00753922|515360076|FG001|Overall Study|Patient Non-compliance|22|||
142951186|NCT00753922|515360077|FG002|Overall Study|Patient Non-compliance|14|||
142951187|NCT00753922|515360078|FG003|Overall Study|Patient Non-compliance|11|||
142951188|NCT00753922|515360075|FG000|Overall Study|Patients Not Completing Visit|11|||
142951189|NCT00753922|515360076|FG001|Overall Study|Patients Not Completing Visit|0|||
142951190|NCT00753922|515360077|FG002|Overall Study|Patients Not Completing Visit|1|||
142951191|NCT00753922|515360078|FG003|Overall Study|Patients Not Completing Visit|0|||
142951192|NCT00753922|515360075|FG000|Overall Study|Death|2|||
142951193|NCT00753922|515360076|FG001|Overall Study|Death|23|||
142951194|NCT00753922|515360077|FG002|Overall Study|Death|2|||
142951195|NCT00753922|515360078|FG003|Overall Study|Death|1|||
142951196|NCT00753922|515360075|FG000|Overall Study|Discontinuation Due to Explantation|14|||
142951197|NCT00753922|515360076|FG001|Overall Study|Discontinuation Due to Explantation|14|||
142951198|NCT00753922|515360077|FG002|Overall Study|Discontinuation Due to Explantation|14|||
142951199|NCT00753922|515360078|FG003|Overall Study|Discontinuation Due to Explantation|4|||
142951200|NCT01662999|515360079|FG000|Period 3|Withdrawal by Subject|0|||
142951201|NCT01662999|515360080|FG001|Period 3|Withdrawal by Subject|1|||
142951202|NCT01662999|515360081|FG002|Period 3|Withdrawal by Subject|0|||
142951203|NCT01662999|515360082|FG003|Period 3|Withdrawal by Subject|0|||
142951204|NCT01662999|515360083|FG004|Period 3|Withdrawal by Subject|0|||
142951205|NCT01662999|515360084|FG005|Period 3|Withdrawal by Subject|0|||
142951206|NCT01933672|515360089|FG000|Metformin Run-in Period|Adverse Event|1|||
142951207|NCT01933672|515360090|FG001|Metformin Run-in Period|Adverse Event|0|||
142951208|NCT01933672|515360091|FG002|Metformin Run-in Period|Adverse Event|0|||
142951209|NCT01933672|515360092|FG003|Metformin Run-in Period|Adverse Event|0|||
142951210|NCT01933672|515360093|FG004|Metformin Run-in Period|Adverse Event|0|||
142951211|NCT01933672|515360094|FG005|Metformin Run-in Period|Adverse Event|0|||
142951212|NCT01933672|515360095|FG006|Metformin Run-in Period|Adverse Event|0|||
142951213|NCT01933672|515360089|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
142951214|NCT01933672|515360090|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
142951215|NCT01933672|515360091|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
142951216|NCT01933672|515360092|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
142951217|NCT01933672|515360093|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
142951218|NCT01933672|515360094|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
142951219|NCT01933672|515360095|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
142951220|NCT01933672|515360089|FG000|Metformin Run-in Period|Other|5|||
142951221|NCT01933672|515360090|FG001|Metformin Run-in Period|Other|0|||
142951222|NCT01933672|515360091|FG002|Metformin Run-in Period|Other|0|||
142951223|NCT01933672|515360092|FG003|Metformin Run-in Period|Other|0|||
142951224|NCT01933672|515360093|FG004|Metformin Run-in Period|Other|0|||
142951225|NCT01933672|515360094|FG005|Metformin Run-in Period|Other|0|||
142951226|NCT01933672|515360095|FG006|Metformin Run-in Period|Other|0|||
142951227|NCT01933672|515360089|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
142951228|NCT01933672|515360090|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
142951229|NCT01933672|515360091|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
142951230|NCT01933672|515360092|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
142951231|NCT01933672|515360093|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
142951232|NCT01933672|515360094|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
142951233|NCT01933672|515360095|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
142951234|NCT01933672|515360089|FG000|First Intervention Period (12-16 Days)|Other|0|||
142951235|NCT01933672|515360090|FG001|First Intervention Period (12-16 Days)|Other|0|||
142951236|NCT01933672|515360091|FG002|First Intervention Period (12-16 Days)|Other|1|||
142951237|NCT01933672|515360092|FG003|First Intervention Period (12-16 Days)|Other|0|||
142951238|NCT01933672|515360093|FG004|First Intervention Period (12-16 Days)|Other|0|||
142951239|NCT01933672|515360094|FG005|First Intervention Period (12-16 Days)|Other|1|||
142951240|NCT01933672|515360095|FG006|First Intervention Period (12-16 Days)|Other|0|||
142951241|NCT01933672|515360089|FG000|Second Intervention Period (12-16 Days)|Other|0|||
142951242|NCT01933672|515360090|FG001|Second Intervention Period (12-16 Days)|Other|1|||
142951243|NCT01933672|515360091|FG002|Second Intervention Period (12-16 Days)|Other|1|||
142951244|NCT01933672|515360092|FG003|Second Intervention Period (12-16 Days)|Other|0|||
142951245|NCT01933672|515360093|FG004|Second Intervention Period (12-16 Days)|Other|0|||
142951246|NCT01933672|515360094|FG005|Second Intervention Period (12-16 Days)|Other|0|||
142951247|NCT01933672|515360095|FG006|Second Intervention Period (12-16 Days)|Other|0|||
142951248|NCT01933672|515360089|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
142951249|NCT01933672|515360090|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
142951250|NCT01933672|515360091|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
142951251|NCT01933672|515360092|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
142951252|NCT01933672|515360093|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
142951253|NCT01933672|515360094|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
142951254|NCT01933672|515360095|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
142951255|NCT01933672|515360089|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
142951256|NCT01933672|515360090|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
142951257|NCT01933672|515360091|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
142951258|NCT01933672|515360092|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
142951259|NCT01933672|515360093|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
142951260|NCT01933672|515360094|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
142951261|NCT01933672|515360095|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
142951262|NCT02273973|515360099|FG000|Overall Study|Adverse Event|4|||
142951263|NCT02273973|515360100|FG001|Overall Study|Adverse Event|0|||
142951264|NCT02273973|515360099|FG000|Overall Study|Withdrawal by Subject|2|||
142951265|NCT02273973|515360100|FG001|Overall Study|Withdrawal by Subject|3|||
142951266|NCT02273973|515360099|FG000|Overall Study|Death|1|||
142951267|NCT02273973|515360100|FG001|Overall Study|Death|0|||
142951268|NCT02273973|515360099|FG000|Overall Study|Non-compliance|1|||
142951269|NCT02273973|515360100|FG001|Overall Study|Non-compliance|0|||
142951270|NCT02273973|515360099|FG000|Overall Study|Protocol Violation|1|||
142951271|NCT02273973|515360100|FG001|Overall Study|Protocol Violation|0|||
142951272|NCT02273973|515360099|FG000|Overall Study|Progression of disease|0|||
142951273|NCT02273973|515360100|FG001|Overall Study|Progression of disease|2|||
142951274|NCT02273973|515360099|FG000|Overall Study|Lost to Follow-up|0|||
142951275|NCT02273973|515360100|FG001|Overall Study|Lost to Follow-up|1|||
142951276|NCT02273973|515360099|FG000|Overall Study|Physician Decision|0|||
142951277|NCT02273973|515360100|FG001|Overall Study|Physician Decision|1|||
142951278|NCT02273973|515360099|FG000|Overall Study|Reason not specified|0|||
142951279|NCT02273973|515360100|FG001|Overall Study|Reason not specified|1|||
142951280|NCT05635838|515361309|FG000|16-Week DBVC Period|Adverse Event|2|||
142951281|NCT05635838|515361310|FG001|16-Week DBVC Period|Adverse Event|0|||
142951282|NCT05635838|515361311|FG002|16-Week DBVC Period|Adverse Event|0|||
142951283|NCT05635838|515361312|FG003|16-Week DBVC Period|Adverse Event|0|||
142951284|NCT05635838|515361309|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
142951285|NCT05635838|515361310|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
142951286|NCT05635838|515361311|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
142951287|NCT05635838|515361312|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
142951288|NCT05635838|515361309|FG000|16-Week DBVC Period|Physician Decision|0|||
142951289|NCT05635838|515361310|FG001|16-Week DBVC Period|Physician Decision|1|||
142951290|NCT05635838|515361311|FG002|16-Week DBVC Period|Physician Decision|0|||
142951291|NCT05635838|515361312|FG003|16-Week DBVC Period|Physician Decision|0|||
142951292|NCT05635838|515361309|FG000|16-Week DBVC Period|Protocol Violation|1|||
142951293|NCT05635838|515361310|FG001|16-Week DBVC Period|Protocol Violation|0|||
142951294|NCT05635838|515361311|FG002|16-Week DBVC Period|Protocol Violation|0|||
142951295|NCT05635838|515361312|FG003|16-Week DBVC Period|Protocol Violation|0|||
142951296|NCT05635838|515361309|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
142951297|NCT05635838|515361310|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
142951298|NCT05635838|515361311|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
142951299|NCT05635838|515361312|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
142951300|NCT05635838|515361309|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
142951301|NCT05635838|515361310|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
142951302|NCT05635838|515361311|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
142951303|NCT05635838|515361312|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
142951304|NCT05635838|515361309|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
142951305|NCT05635838|515361310|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
142951306|NCT05635838|515361311|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
142951307|NCT05635838|515361312|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
142951308|NCT05635838|515361309|FG000|16-Week OLE Period|Adverse Event|0|||
142951309|NCT05635838|515361310|FG001|16-Week OLE Period|Adverse Event|0|||
142951310|NCT05635838|515361311|FG002|16-Week OLE Period|Adverse Event|0|||
142951311|NCT05635838|515361312|FG003|16-Week OLE Period|Adverse Event|2|||
142951312|NCT05635838|515361309|FG000|16-Week OLE Period|Lost to Follow-up|0|||
142951313|NCT05635838|515361310|FG001|16-Week OLE Period|Lost to Follow-up|0|||
142951314|NCT05635838|515361311|FG002|16-Week OLE Period|Lost to Follow-up|1|||
142951315|NCT05635838|515361312|FG003|16-Week OLE Period|Lost to Follow-up|3|||
142951316|NCT05635838|515361309|FG000|16-Week OLE Period|Physician Decision|0|||
142951317|NCT05635838|515361310|FG001|16-Week OLE Period|Physician Decision|0|||
142951318|NCT05635838|515361311|FG002|16-Week OLE Period|Physician Decision|0|||
143003112|NCT01049360|515548744|FG000|Period 2|Protocol Violation|0|||
143117368|NCT01313221|515971827|FG001|Overall Study|Non-compliance|0|||
142951319|NCT05635838|515361312|FG003|16-Week OLE Period|Physician Decision|1|||
142951320|NCT05635838|515361309|FG000|16-Week OLE Period|Protocol Violation|0|||
142951321|NCT05635838|515361310|FG001|16-Week OLE Period|Protocol Violation|0|||
142951322|NCT05635838|515361311|FG002|16-Week OLE Period|Protocol Violation|1|||
142951323|NCT05635838|515361312|FG003|16-Week OLE Period|Protocol Violation|1|||
142951324|NCT05635838|515361309|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
142951325|NCT05635838|515361310|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
142951326|NCT05635838|515361311|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
142951327|NCT05635838|515361312|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
142951328|NCT05635838|515361309|FG000|16-Week OLE Period|Pregnancy|0|||
142951329|NCT05635838|515361310|FG001|16-Week OLE Period|Pregnancy|0|||
142951330|NCT05635838|515361311|FG002|16-Week OLE Period|Pregnancy|1|||
142951331|NCT05635838|515361312|FG003|16-Week OLE Period|Pregnancy|0|||
142951332|NCT02031146|515361315|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
142951333|NCT02031146|515361316|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
142951334|NCT02031146|515361317|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
142951335|NCT02031146|515361318|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
142951336|NCT02031146|515361319|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
142951337|NCT02031146|515361320|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
142951338|NCT02031146|515361321|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
142951339|NCT05165394|515361322|FG000|Overall Study|Withdrawal by Subject|5|||
142951340|NCT05165394|515361323|FG001|Overall Study|Withdrawal by Subject|1|||
142951341|NCT05165394|515361322|FG000|Overall Study|Lost to Follow-up|1|||
142951342|NCT05165394|515361323|FG001|Overall Study|Lost to Follow-up|2|||
142951343|NCT05165394|515361322|FG000|Overall Study|Other Than Specified|0|||
142951344|NCT05165394|515361323|FG001|Overall Study|Other Than Specified|1|||
142951345|NCT00001259|515361326|FG000|Study 2|Adverse Event|0|||
142951346|NCT00001259|515361327|FG001|Study 2|Adverse Event|0|||
142951347|NCT00001259|515361328|FG002|Study 2|Adverse Event|0|||
142951348|NCT00001259|515361329|FG003|Study 2|Adverse Event|0|||
142951349|NCT00001259|515361330|FG004|Study 2|Adverse Event|2|||
142951350|NCT00001259|515361331|FG005|Study 2|Adverse Event|0|||
142951351|NCT00001259|515361332|FG006|Study 2|Adverse Event|0|||
142951352|NCT03705494|515361333|FG000|Overall Study|Lost to Follow-up|2|||
142951353|NCT03705494|515361334|FG001|Overall Study|Lost to Follow-up|1|||
142951354|NCT03705494|515361333|FG000|Overall Study|Withdrawal by Subject|5|||
142951355|NCT03705494|515361334|FG001|Overall Study|Withdrawal by Subject|2|||
142951356|NCT01582282|515361335|FG000|Overall Study|Adverse Event|1|||
142951357|NCT01582282|515361336|FG001|Overall Study|Adverse Event|1|||
142951358|NCT01582282|515361337|FG002|Overall Study|Adverse Event|0|||
142951359|NCT01582282|515361335|FG000|Overall Study|Lost to Follow-up|1|||
142951360|NCT01582282|515361336|FG001|Overall Study|Lost to Follow-up|0|||
142951361|NCT01582282|515361337|FG002|Overall Study|Lost to Follow-up|0|||
142951362|NCT01582282|515361335|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
142951363|NCT01582282|515361336|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
142951364|NCT01582282|515361337|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
142951365|NCT02629393|515361340|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
142951366|NCT02629393|515361340|FG000|Overall Study|Physician Decision|1|||
142951367|NCT03937986|515361341|FG000|Overall Study|COVID-19 Pandemic|1|||
142951368|NCT01853228|515361344|FG000|Phase 1|Lack of Efficacy|8|||
142951369|NCT01853228|515361345|FG001|Phase 1|Lack of Efficacy|0|||
142951370|NCT01853228|515361344|FG000|Phase 1|Other|1|||
142951371|NCT01853228|515361345|FG001|Phase 1|Other|0|||
142951372|NCT01853228|515361344|FG000|Phase 2|Physician Decision|0|||
142951373|NCT01853228|515361345|FG001|Phase 2|Physician Decision|1|||
142951374|NCT01853228|515361344|FG000|Phase 2|Proceed To Transplant|0|||
142951375|NCT01853228|515361345|FG001|Phase 2|Proceed To Transplant|3|||
142951376|NCT01853228|515361344|FG000|Phase 2|Lack of Efficacy|0|||
142951377|NCT01853228|515361345|FG001|Phase 2|Lack of Efficacy|4|||
142951378|NCT02839746|515361352|FG000|Overall Study|Not met selection criteria|12|||
142951379|NCT02089737|515361353|FG000|Overall Study|Survey form not completed|5|||
142951380|NCT02089737|515361353|FG000|Overall Study|Not treated|1|||
142951381|NCT01300286|515361354|FG000|Overall Study|did not get dosed|1|||
142951382|NCT02767570|515361355|FG000|Overall Study|Lost to Follow-up|3|||
142951383|NCT02767570|515361356|FG001|Overall Study|Lost to Follow-up|0|||
142951384|NCT02767570|515361355|FG000|Overall Study|COVID shutdown|2|||
142951385|NCT02767570|515361356|FG001|Overall Study|COVID shutdown|5|||
142951386|NCT02767570|515361355|FG000|Overall Study|Increased pain|2|||
142951387|NCT02767570|515361356|FG001|Overall Study|Increased pain|0|||
142951388|NCT02767570|515361355|FG000|Overall Study|Withdrawal by Subject|1|||
142951389|NCT02767570|515361356|FG001|Overall Study|Withdrawal by Subject|3|||
142951390|NCT02767570|515361355|FG000|Overall Study|Unrelated medical issue|1|||
143117127|NCT01273155|515970042|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
142951391|NCT02767570|515361356|FG001|Overall Study|Unrelated medical issue|1|||
142951392|NCT02767570|515361355|FG000|Overall Study|Received intra-articular injection|0|||
142951393|NCT02767570|515361356|FG001|Overall Study|Received intra-articular injection|1|||
142951394|NCT04426630|515361357|FG000|Overall Study|Death|4|||
142951395|NCT04426630|515361357|FG000|Overall Study|Lost to Follow-up|2|||
142951396|NCT01123889|515361358|FG000|Overall Study|Lost to Follow-up|3|||
142951397|NCT01123889|515361359|FG001|Overall Study|Lost to Follow-up|1|||
142951398|NCT01330381|515361360|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
142951399|NCT01330381|515361361|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
142951400|NCT01330381|515361362|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
142951401|NCT01330381|515361360|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
142951402|NCT01330381|515361361|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
142951403|NCT01330381|515361362|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
142951404|NCT01330381|515361360|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
142951405|NCT01330381|515361361|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
142951406|NCT01330381|515361362|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
142951407|NCT01330381|515361360|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
142951408|NCT01330381|515361361|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
142951409|NCT01330381|515361362|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
142951410|NCT01330381|515361360|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
142951411|NCT01330381|515361361|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
142951412|NCT01330381|515361362|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
142951413|NCT01330381|515361360|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
142951414|NCT01330381|515361361|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
142951415|NCT01330381|515361362|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
142951416|NCT01330381|515361360|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
142951417|NCT01330381|515361361|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
142951418|NCT01330381|515361362|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
142951419|NCT01330381|515361360|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
142951420|NCT01330381|515361361|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
142951421|NCT01330381|515361362|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
142951422|NCT01330381|515361360|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
142951423|NCT01330381|515361361|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
142951424|NCT01330381|515361362|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
142951425|NCT01330381|515361360|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
142951426|NCT01330381|515361361|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
142951427|NCT01330381|515361362|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
142951428|NCT04329923|515361366|FG000|Overall Study|Withdrawal by Subject|1|||
142951429|NCT04329923|515361367|FG001|Overall Study|Withdrawal by Subject|4|||
142951430|NCT04329923|515361368|FG002|Overall Study|Withdrawal by Subject|1|||
142951431|NCT04329923|515361369|FG003|Overall Study|Withdrawal by Subject|1|||
142951432|NCT04329923|515361370|FG004|Overall Study|Withdrawal by Subject|1|||
142951433|NCT04329923|515361371|FG005|Overall Study|Withdrawal by Subject|1|||
142951434|NCT04329923|515361366|FG000|Overall Study|early termination of study|0|||
142951435|NCT04329923|515361367|FG001|Overall Study|early termination of study|0|||
142951436|NCT04329923|515361368|FG002|Overall Study|early termination of study|0|||
142951437|NCT04329923|515361369|FG003|Overall Study|early termination of study|0|||
142951438|NCT04329923|515361370|FG004|Overall Study|early termination of study|1|||
142951439|NCT04329923|515361371|FG005|Overall Study|early termination of study|2|||
142951440|NCT04329923|515361366|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
142951441|NCT04329923|515361367|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
142951442|NCT04329923|515361368|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
142951443|NCT04329923|515361369|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
142951444|NCT04329923|515361370|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
142951445|NCT04329923|515361371|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
142951446|NCT03334214|515361372|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
142951447|NCT03334214|515361373|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
142951448|NCT03334214|515361372|FG000|Overall Study|Withdrawal by Subject|0|||
142951449|NCT03334214|515361373|FG001|Overall Study|Withdrawal by Subject|1|||
142951450|NCT03334214|515361372|FG000|Overall Study|Other|1|||
142951451|NCT03334214|515361373|FG001|Overall Study|Other|0|||
142951452|NCT00308620|515361375|FG000|Overall Study|Death|1|||
142951453|NCT00308620|515361376|FG001|Overall Study|Death|1|||
142951454|NCT00308620|515361377|FG002|Overall Study|Death|0|||
142951455|NCT00308620|515361375|FG000|Overall Study|Lost to Follow-up|0|||
142951456|NCT00308620|515361376|FG001|Overall Study|Lost to Follow-up|0|||
142951457|NCT00308620|515361377|FG002|Overall Study|Lost to Follow-up|1|||
142951458|NCT01357239|515361378|FG000|Stratum: All Patients|Adverse Event|0|||
142951459|NCT01357239|515361379|FG001|Stratum: All Patients|Adverse Event|0|||
142951460|NCT01357239|515361380|FG002|Stratum: All Patients|Adverse Event|1|||
142951461|NCT01357239|515361381|FG003|Stratum: All Patients|Adverse Event|1|||
142951462|NCT01357239|515361378|FG000|Stratum: All Patients|Subject withdrew consent|0|||
142951463|NCT01357239|515361379|FG001|Stratum: All Patients|Subject withdrew consent|0|||
142951464|NCT01357239|515361380|FG002|Stratum: All Patients|Subject withdrew consent|1|||
142951465|NCT01357239|515361381|FG003|Stratum: All Patients|Subject withdrew consent|1|||
142951466|NCT01357239|515361378|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
142951467|NCT01357239|515361379|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
142951468|NCT01357239|515361380|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
142951469|NCT01357239|515361381|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
142951470|NCT01357239|515361378|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
142951471|NCT01357239|515361379|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
142951472|NCT01357239|515361380|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
142951473|NCT01357239|515361381|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
142951474|NCT01357239|515361378|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
142951475|NCT01357239|515361379|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
142951476|NCT01357239|515361380|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
142951477|NCT01357239|515361381|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
142951478|NCT01050062|515361382|FG000|Overall Study|Adverse Event|75|||
142951479|NCT01050062|515361383|FG001|Overall Study|Adverse Event|22|||
142951480|NCT01050062|515361382|FG000|Overall Study|Lost to Follow-up|83|||
142951481|NCT01050062|515361383|FG001|Overall Study|Lost to Follow-up|35|||
142951482|NCT01050062|515361382|FG000|Overall Study|Lack of Efficacy|22|||
142951483|NCT01050062|515361383|FG001|Overall Study|Lack of Efficacy|35|||
142951484|NCT01050062|515361382|FG000|Overall Study|Physician Decision|74|||
142951485|NCT01050062|515361383|FG001|Overall Study|Physician Decision|9|||
142951486|NCT01050062|515361382|FG000|Overall Study|Others|17|||
142951487|NCT01050062|515361383|FG001|Overall Study|Others|11|||
142951488|NCT03894540|515361384|FG000|Overall Study|Adverse Event|0|||
142951489|NCT03894540|515361385|FG001|Overall Study|Adverse Event|0|||
142951490|NCT03894540|515361386|FG002|Overall Study|Adverse Event|0|||
142951491|NCT03894540|515361387|FG003|Overall Study|Adverse Event|0|||
142951492|NCT03894540|515361388|FG004|Overall Study|Adverse Event|1|||
142951493|NCT03894540|515361389|FG005|Overall Study|Adverse Event|0|||
142951494|NCT03894540|515361384|FG000|Overall Study|Withdrawal by Subject|0|||
142951495|NCT03894540|515361385|FG001|Overall Study|Withdrawal by Subject|0|||
142951496|NCT03894540|515361386|FG002|Overall Study|Withdrawal by Subject|0|||
142951497|NCT03894540|515361387|FG003|Overall Study|Withdrawal by Subject|0|||
142951498|NCT03894540|515361388|FG004|Overall Study|Withdrawal by Subject|1|||
142951499|NCT03894540|515361389|FG005|Overall Study|Withdrawal by Subject|0|||
142951500|NCT03894540|515361384|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
142951501|NCT03894540|515361385|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
142951502|NCT03894540|515361386|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
142951503|NCT03894540|515361387|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
142951504|NCT03894540|515361388|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
142951505|NCT03894540|515361389|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
142951506|NCT03894540|515361384|FG000|Overall Study|Progressive Disease Clinical|1|||
142951507|NCT03894540|515361385|FG001|Overall Study|Progressive Disease Clinical|1|||
142951508|NCT03894540|515361386|FG002|Overall Study|Progressive Disease Clinical|0|||
142951509|NCT03894540|515361387|FG003|Overall Study|Progressive Disease Clinical|1|||
142951510|NCT03894540|515361388|FG004|Overall Study|Progressive Disease Clinical|5|||
142951511|NCT03894540|515361389|FG005|Overall Study|Progressive Disease Clinical|1|||
142951512|NCT03894540|515361384|FG000|Overall Study|Study termination by sponsor|0|||
142951513|NCT03894540|515361385|FG001|Overall Study|Study termination by sponsor|0|||
142951514|NCT03894540|515361386|FG002|Overall Study|Study termination by sponsor|0|||
142951515|NCT03894540|515361387|FG003|Overall Study|Study termination by sponsor|0|||
142951516|NCT03894540|515361388|FG004|Overall Study|Study termination by sponsor|2|||
142951517|NCT03894540|515361389|FG005|Overall Study|Study termination by sponsor|0|||
142951518|NCT03000452|515361390|FG000|Treatment Period|Death|1|||
142951519|NCT03000452|515361390|FG000|Treatment Period|Progressive Disease (PD)|14|||
142951520|NCT03000452|515361390|FG000|Treatment Period|Physician Decision|1|||
142951521|NCT03000452|515361390|FG000|Treatment Period|Miscellaneous|2|||
142951522|NCT03000452|515361390|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
142951523|NCT03000452|515361390|FG000|Follow-Up Period|Death|3|||
142951524|NCT03000452|515361390|FG000|Follow-Up Period|Withdrawal by Subject|3|||
142951525|NCT00467649|515361402|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
142951526|NCT00467649|515361403|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
142951527|NCT00467649|515361404|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
142951528|NCT00467649|515361405|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
142951529|NCT00467649|515361406|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
142951530|NCT00467649|515361407|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
142951531|NCT00467649|515361402|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
142951532|NCT00467649|515361403|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
142951533|NCT00467649|515361404|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
142951534|NCT00467649|515361405|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
142951535|NCT00467649|515361406|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
142951536|NCT00467649|515361407|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
142951537|NCT00467649|515361402|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
142951538|NCT00467649|515361403|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
142951539|NCT00467649|515361404|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
142951540|NCT00467649|515361405|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
142951541|NCT00467649|515361406|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
142951542|NCT00467649|515361407|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
142951543|NCT00467649|515361402|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
142951544|NCT00467649|515361403|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
142951545|NCT00467649|515361404|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
142951546|NCT00467649|515361405|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
142951547|NCT00467649|515361406|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
142951548|NCT00467649|515361407|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
142951549|NCT00467649|515361402|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
142951550|NCT00467649|515361403|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
142951551|NCT00467649|515361404|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
142951552|NCT00467649|515361405|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
142951553|NCT00467649|515361406|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
142951554|NCT00467649|515361407|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
142951555|NCT00467649|515361402|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
142951556|NCT00467649|515361403|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
142951557|NCT00467649|515361404|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
142951558|NCT00467649|515361405|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
142951559|NCT00467649|515361406|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
142951560|NCT00467649|515361407|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
142951561|NCT00467649|515361402|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
142951562|NCT00467649|515361403|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
142951563|NCT00467649|515361404|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
142951564|NCT00467649|515361405|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
142951565|NCT00467649|515361406|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
142951566|NCT00467649|515361407|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
142951567|NCT03240081|515361408|FG000|Overall Study|Withdrawal by Subject|0|||
142951568|NCT03240081|515361409|FG001|Overall Study|Withdrawal by Subject|2|||
142951569|NCT03240081|515361408|FG000|Overall Study|Lost to Follow-up|0|||
142951570|NCT03240081|515361409|FG001|Overall Study|Lost to Follow-up|1|||
142951571|NCT00883753|515361410|FG000|Overall Study|Adverse Event|37|||
142951572|NCT00883753|515361410|FG000|Overall Study|Death|2|||
142951573|NCT00883753|515361410|FG000|Overall Study|Insufficient therapeutic response|16|||
142951574|NCT00883753|515361410|FG000|Overall Study|Lost to Follow-up|4|||
142951575|NCT00883753|515361410|FG000|Overall Study|Violation of selection criteria at entry|7|||
142951576|NCT00883753|515361410|FG000|Overall Study|Protocol Violation|2|||
142951577|NCT00883753|515361410|FG000|Overall Study|Refused treatment|4|||
142951578|NCT00883753|515361410|FG000|Overall Study|Withdrew consent|10|||
142951579|NCT00883753|515361410|FG000|Overall Study|Investigator's decision|17|||
142951580|NCT00883753|515361410|FG000|Overall Study|Administrative/Other|8|||
142951581|NCT03114969|515361411|FG000|Overall Study|Lost to Follow-up|0|||
142951582|NCT03114969|515361412|FG001|Overall Study|Lost to Follow-up|0|||
142951583|NCT03114969|515361413|FG002|Overall Study|Lost to Follow-up|3|||
142951584|NCT03114969|515361414|FG003|Overall Study|Lost to Follow-up|2|||
142951585|NCT03114969|515361415|FG004|Overall Study|Lost to Follow-up|0|||
142951586|NCT03114969|515361416|FG005|Overall Study|Lost to Follow-up|0|||
142951587|NCT03114969|515361417|FG006|Overall Study|Lost to Follow-up|0|||
142951588|NCT03114969|515361418|FG007|Overall Study|Lost to Follow-up|0|||
142951589|NCT03114969|515361419|FG008|Overall Study|Lost to Follow-up|0|||
142951590|NCT03114969|515361411|FG000|Overall Study|Adverse Event|0|||
142951591|NCT03114969|515361412|FG001|Overall Study|Adverse Event|0|||
142951592|NCT03114969|515361413|FG002|Overall Study|Adverse Event|1|||
142951593|NCT03114969|515361414|FG003|Overall Study|Adverse Event|0|||
142951594|NCT03114969|515361415|FG004|Overall Study|Adverse Event|0|||
142951595|NCT03114969|515361416|FG005|Overall Study|Adverse Event|1|||
142951596|NCT03114969|515361417|FG006|Overall Study|Adverse Event|1|||
142951597|NCT03114969|515361418|FG007|Overall Study|Adverse Event|0|||
142951598|NCT03114969|515361419|FG008|Overall Study|Adverse Event|2|||
142951599|NCT05121103|515361424|FG000|Overall Study|Progressive disease|2|||
142951600|NCT05121103|515361425|FG001|Overall Study|Progressive disease|1|||
142951601|NCT05121103|515361426|FG002|Overall Study|Progressive disease|6|||
142951602|NCT05121103|515361424|FG000|Overall Study|Physician Decision|2|||
142951603|NCT05121103|515361425|FG001|Overall Study|Physician Decision|1|||
142951604|NCT05121103|515361426|FG002|Overall Study|Physician Decision|0|||
142951605|NCT05121103|515361424|FG000|Overall Study|Withdrawal by Subject|0|||
142951606|NCT05121103|515361425|FG001|Overall Study|Withdrawal by Subject|1|||
142951607|NCT05121103|515361426|FG002|Overall Study|Withdrawal by Subject|0|||
142951608|NCT01926886|515361427|FG000|Overall Study|Administrative/other|1|||
142951609|NCT01926886|515361428|FG001|Overall Study|Administrative/other|0|||
142951610|NCT01926886|515361427|FG000|Overall Study|Adverse event/intercurrent illness|4|||
142951611|NCT01926886|515361428|FG001|Overall Study|Adverse event/intercurrent illness|0|||
142951612|NCT01926886|515361427|FG000|Overall Study|Disease progression/recurrence|4|||
142951613|NCT01926886|515361428|FG001|Overall Study|Disease progression/recurrence|0|||
142951614|NCT01926886|515361427|FG000|Overall Study|Withdrawal by Subject|15|||
142951615|NCT01926886|515361428|FG001|Overall Study|Withdrawal by Subject|0|||
142951616|NCT01926886|515361427|FG000|Overall Study|Failure to return|3|||
142951617|NCT01926886|515361428|FG001|Overall Study|Failure to return|0|||
142951618|NCT01926886|515361427|FG000|Overall Study|Recurrence of disease|1|||
142951619|NCT01926886|515361428|FG001|Overall Study|Recurrence of disease|0|||
142951620|NCT01926886|515361427|FG000|Overall Study|Progression of disease|2|||
142951621|NCT01926886|515361428|FG001|Overall Study|Progression of disease|0|||
142951622|NCT01926886|515361427|FG000|Overall Study|Death|1|||
142951623|NCT01926886|515361428|FG001|Overall Study|Death|0|||
142951624|NCT01926886|515361427|FG000|Overall Study|Did not cooperate|1|||
142951625|NCT01926886|515361428|FG001|Overall Study|Did not cooperate|0|||
142951626|NCT03368404|515361432|FG000|Overall Study|Adverse Event|2|||
142951627|NCT03368404|515361433|FG001|Overall Study|Adverse Event|1|||
142951628|NCT03368404|515361432|FG000|Overall Study|Withdrawal by Subject|1|||
142951629|NCT03368404|515361433|FG001|Overall Study|Withdrawal by Subject|1|||
142951630|NCT02983292|515361434|FG000|Overall Study|Participant unwell & cannot travel|2|||
142951631|NCT02983292|515361434|FG000|Overall Study|Lost to Follow-up|3|||
142951632|NCT02983292|515361434|FG000|Overall Study|Participant withdrew consent|2|||
142951633|NCT02983292|515361434|FG000|Overall Study|Revision|7|||
142951634|NCT02983292|515361434|FG000|Overall Study|Death|1|||
142951635|NCT02983292|515361434|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
142951636|NCT02983292|515361434|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
142951637|NCT02983292|515361434|FG000|Overall Study|Participant relocation|1|||
142951638|NCT00857246|515361435|FG000|Induction Regimen|Adverse Event|1|||
142951639|NCT00857246|515361435|FG000|Induction Regimen|disease-related complications|1|||
142951640|NCT00857246|515361435|FG000|Induction Regimen|Withdrawal by Subject|1|||
142951641|NCT00857246|515361435|FG000|Surgery (Curative)|disease progression|6|||
142951642|NCT00857246|515361435|FG000|ChemoRT|Withdrawal by Subject|1|||
142951643|NCT00857246|515361435|FG000|ChemoRT|Adverse Event|2|||
142951644|NCT00072189|515361436|FG000|Overall Study|Withdrawal by Subject|1|||
142951645|NCT01739595|515361437|FG000|Overall Study|Adverse Event|3|||
142951646|NCT01739595|515361438|FG001|Overall Study|Adverse Event|0|||
142951647|NCT01739595|515361439|FG002|Overall Study|Adverse Event|0|||
142951648|NCT01739595|515361437|FG000|Overall Study|Lost to Follow-up|2|||
142951649|NCT01739595|515361438|FG001|Overall Study|Lost to Follow-up|0|||
142951650|NCT01739595|515361439|FG002|Overall Study|Lost to Follow-up|0|||
142951651|NCT01739595|515361437|FG000|Overall Study|Withdrawal by Subject|2|||
142951652|NCT01739595|515361438|FG001|Overall Study|Withdrawal by Subject|1|||
142951653|NCT01739595|515361439|FG002|Overall Study|Withdrawal by Subject|2|||
142951654|NCT01739595|515361437|FG000|Overall Study|Eligibility issue|3|||
142951655|NCT01739595|515361438|FG001|Overall Study|Eligibility issue|0|||
142951656|NCT01739595|515361439|FG002|Overall Study|Eligibility issue|0|||
142951657|NCT01739595|515361437|FG000|Overall Study|Protocol Violation|1|||
142951658|NCT01739595|515361438|FG001|Overall Study|Protocol Violation|0|||
142951659|NCT01739595|515361439|FG002|Overall Study|Protocol Violation|0|||
142951660|NCT01739595|515361437|FG000|Overall Study|Lab assessment|1|||
142951661|NCT01739595|515361438|FG001|Overall Study|Lab assessment|0|||
142951662|NCT01739595|515361439|FG002|Overall Study|Lab assessment|0|||
142951663|NCT01739595|515361437|FG000|Overall Study|Drug discrepancy|1|||
142951664|NCT01739595|515361438|FG001|Overall Study|Drug discrepancy|0|||
142951665|NCT01739595|515361439|FG002|Overall Study|Drug discrepancy|0|||
142951666|NCT00778999|515361446|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
142951667|NCT00778999|515361447|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
142951668|NCT00778999|515361446|FG000|Overall Study|Did not receive recFSH|14|||
142951669|NCT00778999|515361447|FG001|Overall Study|Did not receive recFSH|20|||
142951670|NCT02424149|515362903|FG000|Overall Study|surgery cancelled|2|||
142951671|NCT02424149|515362904|FG001|Overall Study|surgery cancelled|0|||
142951672|NCT02424149|515362903|FG000|Overall Study|Withdrawal by Subject|0|||
142951673|NCT02424149|515362904|FG001|Overall Study|Withdrawal by Subject|1|||
142951674|NCT03455543|515362911|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
142951675|NCT03455543|515362912|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
142951676|NCT03455543|515362913|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
142951677|NCT03455543|515362911|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
142951678|NCT03455543|515362912|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
142951679|NCT03455543|515362913|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
142951680|NCT03455543|515362911|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
142951681|NCT03455543|515362912|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
142951682|NCT03455543|515362913|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
142951683|NCT03455543|515362911|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
142951684|NCT03455543|515362912|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
142951685|NCT03455543|515362913|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
142951686|NCT03455543|515362911|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
142951687|NCT03455543|515362912|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
142951688|NCT03455543|515362913|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
142951689|NCT03455543|515362911|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
142951690|NCT03455543|515362912|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
142951691|NCT03455543|515362913|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
142951692|NCT03455543|515362911|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
142951693|NCT03455543|515362912|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
142951694|NCT03455543|515362913|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
142951695|NCT03455543|515362911|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
142951696|NCT03455543|515362912|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
142951697|NCT03455543|515362913|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
142951698|NCT03455543|515362911|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
142951699|NCT03455543|515362912|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
142951700|NCT03455543|515362913|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
142951701|NCT00852930|515362914|FG000|Overall Study|Withdrawal by Subject|1|||
142951702|NCT00852930|515362915|FG001|Overall Study|Withdrawal by Subject|1|||
142951703|NCT00852930|515362916|FG002|Overall Study|Withdrawal by Subject|1|||
142951704|NCT00852930|515362914|FG000|Overall Study|Physician Decision|0|||
142951705|NCT00852930|515362915|FG001|Overall Study|Physician Decision|0|||
142951706|NCT00852930|515362916|FG002|Overall Study|Physician Decision|1|||
142951707|NCT01512368|515362917|FG000|Overall Study|Protocol Violation|3|||
142951708|NCT02640612|515362920|FG000|Overall Study|Adverse Event|6|||
142951709|NCT02640612|515362921|FG001|Overall Study|Adverse Event|7|||
142951710|NCT02640612|515362922|FG002|Overall Study|Adverse Event|2|||
142951711|NCT02640612|515362920|FG000|Overall Study|Death|1|||
142951712|NCT02640612|515362921|FG001|Overall Study|Death|0|||
142951713|NCT02640612|515362922|FG002|Overall Study|Death|0|||
142951714|NCT02640612|515362920|FG000|Overall Study|Withdrawal by Subject|10|||
142951715|NCT02640612|515362921|FG001|Overall Study|Withdrawal by Subject|3|||
142951716|NCT02640612|515362922|FG002|Overall Study|Withdrawal by Subject|3|||
142951717|NCT02640612|515362920|FG000|Overall Study|Lost to Follow-up|4|||
142951718|NCT02640612|515362921|FG001|Overall Study|Lost to Follow-up|1|||
142951719|NCT02640612|515362922|FG002|Overall Study|Lost to Follow-up|1|||
142951720|NCT02640612|515362920|FG000|Overall Study|Protocol Violation|0|||
142951721|NCT02640612|515362921|FG001|Overall Study|Protocol Violation|2|||
142951722|NCT02640612|515362922|FG002|Overall Study|Protocol Violation|0|||
142951723|NCT02640612|515362920|FG000|Overall Study|Lack of Efficacy|1|||
142951724|NCT02640612|515362921|FG001|Overall Study|Lack of Efficacy|1|||
142951725|NCT02640612|515362922|FG002|Overall Study|Lack of Efficacy|0|||
142951726|NCT03472534|515362926|FG000|Overall Study|Withdrawal by Subject|9|||
142951727|NCT03472534|515362926|FG000|Overall Study|Adverse Event|2|||
142951728|NCT02614794|515362927|FG000|Overall Study|Death|258|||
142951729|NCT02614794|515362928|FG001|Overall Study|Death|151|||
142951730|NCT02614794|515362927|FG000|Overall Study|Study closure by Sponsor|119|||
142951731|NCT02614794|515362928|FG001|Overall Study|Study closure by Sponsor|45|||
142951732|NCT02614794|515362927|FG000|Overall Study|Withdrawal by Subject|24|||
142951733|NCT02614794|515362928|FG001|Overall Study|Withdrawal by Subject|5|||
142951734|NCT02614794|515362927|FG000|Overall Study|Lost to Follow-up|7|||
142951735|NCT02614794|515362928|FG001|Overall Study|Lost to Follow-up|0|||
142951736|NCT02614794|515362927|FG000|Overall Study|Physician Decision|1|||
142951737|NCT02614794|515362928|FG001|Overall Study|Physician Decision|1|||
142951738|NCT02614794|515362927|FG000|Overall Study|Hospital closure|1|||
142951739|NCT02614794|515362928|FG001|Overall Study|Hospital closure|0|||
142951740|NCT03396471|515362931|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
142951741|NCT03396471|515362931|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
142951742|NCT03396471|515362931|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
142951743|NCT03396471|515362931|FG000|Study Treatment - Up to 22 Months|Death|2|||
142951744|NCT03396471|515362931|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
142951745|NCT03396471|515362931|FG000|Follow up - Up to 2 Years|Death|9|||
142951746|NCT03396471|515362931|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
142951747|NCT03396471|515362931|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
142951748|NCT03396471|515362931|FG000|Follow up - Up to 2 Years|study terminated|1|||
142951749|NCT03396471|515362931|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
142951750|NCT03396471|515362931|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
142951751|NCT01319929|515362935|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
142951752|NCT01319929|515362936|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
142951753|NCT01319929|515362935|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
142951754|NCT01319929|515362936|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
142951755|NCT01319929|515362935|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
142951756|NCT01319929|515362936|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
142951757|NCT01319929|515362935|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
142951758|NCT01319929|515362936|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
142951759|NCT01319929|515362935|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
142951760|NCT01319929|515362936|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
142951761|NCT03237845|515362937|FG000|Overall Study|Adverse Event|0|||
142951762|NCT03237845|515362938|FG001|Overall Study|Adverse Event|1|||
142951763|NCT03237845|515362937|FG000|Overall Study|Lost to Follow-up|13|||
142951764|NCT03237845|515362938|FG001|Overall Study|Lost to Follow-up|10|||
142951765|NCT03237845|515362937|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
142951766|NCT03237845|515362938|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
142951767|NCT03237845|515362937|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
142951768|NCT03237845|515362938|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
142951769|NCT03237845|515362937|FG000|Overall Study|Physician Decision|1|||
142951770|NCT03237845|515362938|FG001|Overall Study|Physician Decision|2|||
142951771|NCT03237845|515362937|FG000|Overall Study|Pregnancy|1|||
142951772|NCT03237845|515362938|FG001|Overall Study|Pregnancy|0|||
142951773|NCT03237845|515362937|FG000|Overall Study|Protocol Deviation|0|||
142951774|NCT03237845|515362938|FG001|Overall Study|Protocol Deviation|1|||
142951775|NCT03237845|515362937|FG000|Overall Study|Technical Problems|8|||
142951776|NCT03237845|515362938|FG001|Overall Study|Technical Problems|1|||
142951777|NCT03237845|515362937|FG000|Overall Study|Withdrawal by Subject|3|||
142951778|NCT03237845|515362938|FG001|Overall Study|Withdrawal by Subject|3|||
142951779|NCT03237845|515362937|FG000|Overall Study|Other Reasons|4|||
142951780|NCT03237845|515362938|FG001|Overall Study|Other Reasons|0|||
142951781|NCT01221233|515362939|FG000|Overall Study|Withdrawal by Subject|3|||
142951782|NCT01221233|515362940|FG001|Overall Study|Withdrawal by Subject|1|||
142951783|NCT03865407|515362944|FG000|Overall Study|Adverse Event|1|||
142951784|NCT03865407|515362945|FG001|Overall Study|Adverse Event|0|||
142951785|NCT03865407|515362944|FG000|Overall Study|Withdrawal by Subject|1|||
142951786|NCT03865407|515362945|FG001|Overall Study|Withdrawal by Subject|0|||
142951787|NCT03865407|515362944|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
142951788|NCT03865407|515362945|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
142951789|NCT01645280|515362947|FG000|Overall Study|Death|0|||
142951790|NCT01645280|515362948|FG001|Overall Study|Death|1|||
142951791|NCT01645280|515362949|FG002|Overall Study|Death|0|||
142951792|NCT01645280|515362950|FG003|Overall Study|Death|0|||
142951793|NCT01645280|515362951|FG004|Overall Study|Death|0|||
142951794|NCT01645280|515362947|FG000|Overall Study|Withdrawal by Subject|4|||
142951795|NCT01645280|515362948|FG001|Overall Study|Withdrawal by Subject|0|||
142951796|NCT01645280|515362949|FG002|Overall Study|Withdrawal by Subject|2|||
142951797|NCT01645280|515362950|FG003|Overall Study|Withdrawal by Subject|4|||
142951798|NCT01645280|515362951|FG004|Overall Study|Withdrawal by Subject|5|||
142951799|NCT01645280|515362947|FG000|Overall Study|Lost to Follow-up|0|||
142951800|NCT01645280|515362948|FG001|Overall Study|Lost to Follow-up|0|||
142951801|NCT01645280|515362949|FG002|Overall Study|Lost to Follow-up|0|||
142951802|NCT01645280|515362950|FG003|Overall Study|Lost to Follow-up|2|||
142951803|NCT01645280|515362951|FG004|Overall Study|Lost to Follow-up|1|||
142951804|NCT01645280|515362947|FG000|Overall Study|Other|1|||
142951805|NCT01645280|515362948|FG001|Overall Study|Other|1|||
142951806|NCT01645280|515362949|FG002|Overall Study|Other|2|||
142951807|NCT01645280|515362950|FG003|Overall Study|Other|0|||
142951808|NCT01645280|515362951|FG004|Overall Study|Other|0|||
142951809|NCT01645280|515362947|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
142951810|NCT01645280|515362948|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
142951811|NCT01645280|515362949|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
142951812|NCT01645280|515362950|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
142951813|NCT01645280|515362951|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
142951814|NCT00234104|515362956|FG000|Overall Study|Adverse Event|4|||
142951815|NCT00234104|515362957|FG001|Overall Study|Adverse Event|0|||
142951816|NCT00234104|515362958|FG002|Overall Study|Adverse Event|3|||
142951817|NCT00234104|515362959|FG003|Overall Study|Adverse Event|5|||
142951818|NCT00234104|515362956|FG000|Overall Study|Protocol Violation|0|||
142951819|NCT00234104|515362957|FG001|Overall Study|Protocol Violation|0|||
142951820|NCT00234104|515362958|FG002|Overall Study|Protocol Violation|0|||
142951821|NCT00234104|515362959|FG003|Overall Study|Protocol Violation|1|||
142951822|NCT00234104|515362956|FG000|Overall Study|Physician Decision|0|||
142951823|NCT00234104|515362957|FG001|Overall Study|Physician Decision|1|||
142951824|NCT00234104|515362958|FG002|Overall Study|Physician Decision|2|||
142951825|NCT00234104|515362959|FG003|Overall Study|Physician Decision|2|||
142951826|NCT00546819|515362962|FG000|Overall Study|Adverse Event|2|||
142951827|NCT00546819|515362963|FG001|Overall Study|Adverse Event|3|||
143117128|NCT01273155|515970043|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
142951828|NCT00546819|515362962|FG000|Overall Study|Lost to Follow-up|2|||
142951829|NCT00546819|515362963|FG001|Overall Study|Lost to Follow-up|1|||
142951830|NCT00546819|515362962|FG000|Overall Study|Withdrawal by Subject|4|||
142951831|NCT00546819|515362963|FG001|Overall Study|Withdrawal by Subject|2|||
142951832|NCT02460822|515362964|FG000|Overall Study|Withdrawal by Subject|1|||
142951833|NCT01633060|515362971|FG000|Randomization Phase|Protocol deviation|1|||
142951834|NCT01633060|515362972|FG001|Randomization Phase|Protocol deviation|2|||
142951835|NCT01633060|515362971|FG000|Randomization Phase|Technical problem|0|||
142951836|NCT01633060|515362972|FG001|Randomization Phase|Technical problem|1|||
142951837|NCT01633060|515362971|FG000|Treatment Phase|Adverse Event|24|||
142951838|NCT01633060|515362972|FG001|Treatment Phase|Adverse Event|3|||
142951839|NCT01633060|515362971|FG000|Treatment Phase|Lost to Follow-up|1|||
142951840|NCT01633060|515362972|FG001|Treatment Phase|Lost to Follow-up|0|||
142951841|NCT01633060|515362971|FG000|Treatment Phase|Physician Decision|16|||
142951842|NCT01633060|515362972|FG001|Treatment Phase|Physician Decision|7|||
142951843|NCT01633060|515362971|FG000|Treatment Phase|Progressive Disease|210|||
142951844|NCT01633060|515362972|FG001|Treatment Phase|Progressive Disease|120|||
142951845|NCT01633060|515362971|FG000|Treatment Phase|Protocol Deviation|1|||
142951846|NCT01633060|515362972|FG001|Treatment Phase|Protocol Deviation|0|||
142951847|NCT01633060|515362971|FG000|Treatment Phase|Study Terminated by sponsor|7|||
142951848|NCT01633060|515362972|FG001|Treatment Phase|Study Terminated by sponsor|3|||
142951849|NCT01633060|515362971|FG000|Treatment Phase|Subject/guardian decision|25|||
142951850|NCT01633060|515362972|FG001|Treatment Phase|Subject/guardian decision|4|||
142951851|NCT01633060|515362971|FG000|Treatment Phase|Death|4|||
142951852|NCT01633060|515362972|FG001|Treatment Phase|Death|3|||
142951853|NCT01633060|515362971|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
142951854|NCT01633060|515362972|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
142951855|NCT01633060|515362971|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
142951856|NCT01633060|515362972|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
142951857|NCT01633060|515362971|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
142951858|NCT01633060|515362972|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
142951859|NCT01633060|515362971|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
142951860|NCT01633060|515362972|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
142951861|NCT01633060|515362971|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
142951862|NCT01633060|515362972|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
142951863|NCT01633060|515362971|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
142951864|NCT01633060|515362972|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
142951865|NCT03633331|515362973|FG000|Overall Study|Withdrawal by Subject|1|||
142951866|NCT03233048|515362974|FG000|Overall Study|Withdrawal by Subject|1|||
142951867|NCT01856673|515362975|FG000|Overall Study|Withdrawal by Subject|44|||
142951868|NCT01856673|515362976|FG001|Overall Study|Withdrawal by Subject|50|||
142951869|NCT01856673|515362977|FG002|Overall Study|Withdrawal by Subject|33|||
142951870|NCT01856673|515362975|FG000|Overall Study|Lost to Follow-up|31|||
142951871|NCT01856673|515362976|FG001|Overall Study|Lost to Follow-up|34|||
142951872|NCT01856673|515362977|FG002|Overall Study|Lost to Follow-up|0|||
142951873|NCT01856673|515362975|FG000|Overall Study|Unknown reasons|9|||
142951874|NCT01856673|515362976|FG001|Overall Study|Unknown reasons|0|||
142951875|NCT01856673|515362977|FG002|Overall Study|Unknown reasons|0|||
142951876|NCT01856673|515362975|FG000|Overall Study|Psychologist decision|1|||
142951877|NCT01856673|515362976|FG001|Overall Study|Psychologist decision|0|||
142951878|NCT01856673|515362977|FG002|Overall Study|Psychologist decision|0|||
142951879|NCT01856673|515362975|FG000|Overall Study|Paperwork errors|8|||
142951880|NCT01856673|515362976|FG001|Overall Study|Paperwork errors|0|||
142951881|NCT01856673|515362977|FG002|Overall Study|Paperwork errors|0|||
142951882|NCT01856673|515362975|FG000|Overall Study|Death|1|||
142951883|NCT01856673|515362976|FG001|Overall Study|Death|1|||
142951884|NCT01856673|515362977|FG002|Overall Study|Death|0|||
142951885|NCT01856673|515362975|FG000|Overall Study|Protocol Violation|1|||
142951886|NCT01856673|515362976|FG001|Overall Study|Protocol Violation|0|||
142951887|NCT01856673|515362977|FG002|Overall Study|Protocol Violation|1|||
142951888|NCT01743027|515362984|FG000|Overall Study|Adverse Event|2|||
142951889|NCT01743027|515362985|FG001|Overall Study|Adverse Event|0|||
142951890|NCT01743027|515362986|FG002|Overall Study|Adverse Event|0|||
142951891|NCT01743027|515362987|FG003|Overall Study|Adverse Event|0|||
142951892|NCT01743027|515362984|FG000|Overall Study|Lost to Follow-up|0|||
142951893|NCT01743027|515362985|FG001|Overall Study|Lost to Follow-up|0|||
142951894|NCT01743027|515362986|FG002|Overall Study|Lost to Follow-up|2|||
142951895|NCT01743027|515362987|FG003|Overall Study|Lost to Follow-up|0|||
142951896|NCT01743027|515362984|FG000|Overall Study|Progressive Disease|1|||
142951897|NCT01743027|515362985|FG001|Overall Study|Progressive Disease|4|||
142951898|NCT01743027|515362986|FG002|Overall Study|Progressive Disease|3|||
142951899|NCT01743027|515362987|FG003|Overall Study|Progressive Disease|0|||
142951900|NCT01743027|515362984|FG000|Overall Study|Protocol Violation|1|||
142951901|NCT01743027|515362985|FG001|Overall Study|Protocol Violation|1|||
142951902|NCT01743027|515362986|FG002|Overall Study|Protocol Violation|1|||
142951903|NCT01743027|515362987|FG003|Overall Study|Protocol Violation|0|||
142951904|NCT01743027|515362984|FG000|Overall Study|Withdrawal by Subject|1|||
142951905|NCT01743027|515362985|FG001|Overall Study|Withdrawal by Subject|0|||
142951906|NCT01743027|515362986|FG002|Overall Study|Withdrawal by Subject|3|||
142951907|NCT01743027|515362987|FG003|Overall Study|Withdrawal by Subject|1|||
142951908|NCT00196937|515362993|FG000|Overall Study|Serious Adverse Event|1|||
142951909|NCT00196937|515362994|FG001|Overall Study|Serious Adverse Event|0|||
142951910|NCT00196937|515362995|FG002|Overall Study|Serious Adverse Event|0|||
142951911|NCT00196937|515362993|FG000|Overall Study|Non-serious adverse event|1|||
142951912|NCT00196937|515362994|FG001|Overall Study|Non-serious adverse event|1|||
142951913|NCT00196937|515362995|FG002|Overall Study|Non-serious adverse event|1|||
142951914|NCT00196937|515362993|FG000|Overall Study|Withdrawal by Subject|0|||
142951915|NCT00196937|515362994|FG001|Overall Study|Withdrawal by Subject|0|||
142951916|NCT00196937|515362995|FG002|Overall Study|Withdrawal by Subject|2|||
142951917|NCT00196937|515362993|FG000|Overall Study|Lost to Follow-up|4|||
142951918|NCT00196937|515362994|FG001|Overall Study|Lost to Follow-up|3|||
142951919|NCT00196937|515362995|FG002|Overall Study|Lost to Follow-up|3|||
142951920|NCT00196937|515362993|FG000|Overall Study|Other|3|||
142951921|NCT00196937|515362994|FG001|Overall Study|Other|1|||
142951922|NCT00196937|515362995|FG002|Overall Study|Other|1|||
142951923|NCT00995371|515362998|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
142951924|NCT00995371|515362999|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
142951925|NCT04725682|515363000|FG000|Overall Study|Withdrawal by Subject|7|||
142951926|NCT04725682|515363001|FG001|Overall Study|Withdrawal by Subject|5|||
142951927|NCT04725682|515363000|FG000|Overall Study|Failed to comply with the requirements|2|||
142951928|NCT04725682|515363001|FG001|Overall Study|Failed to comply with the requirements|1|||
142951929|NCT04725682|515363000|FG000|Overall Study|Adverse Event|1|||
142951930|NCT04725682|515363001|FG001|Overall Study|Adverse Event|1|||
142951931|NCT04725682|515363000|FG000|Overall Study|Death|0|||
142951932|NCT04725682|515363001|FG001|Overall Study|Death|1|||
142951933|NCT00964795|515363002|FG000|Overall Study|Withdrawal by Subject|79|||
142951934|NCT00964795|515363002|FG000|Overall Study|Adverse Event|12|||
142951935|NCT00964795|515363002|FG000|Overall Study|Death|14|||
142951936|NCT00964795|515363002|FG000|Overall Study|Lost to Follow-up|7|||
142951937|NCT00964795|515363002|FG000|Overall Study|Termination of Study by Sponsor|169|||
142951938|NCT00964795|515363002|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
142951939|NCT00964795|515363002|FG000|Overall Study|Other|23|||
142951940|NCT00586690|515363010|FG000|Overall Study|Death|2|||
142951941|NCT00586690|515363011|FG001|Overall Study|Death|0|||
142951942|NCT00586690|515363010|FG000|Overall Study|Disease Progression|10|||
142951943|NCT00586690|515363011|FG001|Overall Study|Disease Progression|0|||
142951944|NCT00586690|515363010|FG000|Overall Study|Adverse Event|1|||
142951945|NCT00586690|515363011|FG001|Overall Study|Adverse Event|0|||
142951946|NCT00586690|515363010|FG000|Overall Study|Lack of Efficacy|2|||
142951947|NCT00586690|515363011|FG001|Overall Study|Lack of Efficacy|0|||
142951948|NCT00586690|515363010|FG000|Overall Study|Lab can't accommodate|1|||
142951949|NCT00586690|515363011|FG001|Overall Study|Lab can't accommodate|0|||
142951950|NCT02453841|515363012|FG000|Overall Study|Protocol Violation|1|||
142951951|NCT02453841|515363012|FG000|Overall Study|Unable to obtain blood samples|2|||
142951952|NCT01751646|515363013|FG000|Overall Study|Lost to Follow-up|5|||
142951953|NCT01751646|515363014|FG001|Overall Study|Lost to Follow-up|1|||
142951954|NCT01751646|515363013|FG000|Overall Study|Withdrawal by Subject|0|||
142951955|NCT01751646|515363014|FG001|Overall Study|Withdrawal by Subject|4|||
142951956|NCT01751646|515363013|FG000|Overall Study|Starting hormone therapy|1|||
142951957|NCT01751646|515363014|FG001|Overall Study|Starting hormone therapy|0|||
142951958|NCT01751646|515363013|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
142951959|NCT01751646|515363014|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
142951960|NCT01751646|515363013|FG000|Overall Study|Inadvertent enrollment|1|||
142951961|NCT01751646|515363014|FG001|Overall Study|Inadvertent enrollment|1|||
142951962|NCT01751646|515363013|FG000|Overall Study|Moved out of the area|1|||
142951963|NCT01751646|515363014|FG001|Overall Study|Moved out of the area|5|||
142951964|NCT01751646|515363013|FG000|Overall Study|Inability to attend required visits|0|||
142951965|NCT01751646|515363014|FG001|Overall Study|Inability to attend required visits|1|||
142951966|NCT01751646|515363013|FG000|Overall Study|Off study due to multiple obligations|0|||
142951967|NCT01751646|515363014|FG001|Overall Study|Off study due to multiple obligations|1|||
142951968|NCT01751646|515363013|FG000|Overall Study|Fails to comply with study requirements|0|||
142951969|NCT01751646|515363014|FG001|Overall Study|Fails to comply with study requirements|1|||
143455116|NCT02663518|517210763|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
142951970|NCT01751646|515363013|FG000|Overall Study|Childcare issues|1|||
142951971|NCT01751646|515363014|FG001|Overall Study|Childcare issues|1|||
142951972|NCT02190591|515363015|FG000|Overall Study|Withdrawal by Subject|1|||
142951973|NCT02190591|515363016|FG001|Overall Study|Withdrawal by Subject|8|||
142951974|NCT02190591|515363015|FG000|Overall Study|Protocol Violation|1|||
142951975|NCT02190591|515363016|FG001|Overall Study|Protocol Violation|0|||
142951976|NCT02190591|515363015|FG000|Overall Study|did not use peanut ball as instructed|0|||
142951977|NCT02190591|515363016|FG001|Overall Study|did not use peanut ball as instructed|2|||
143003113|NCT01049360|515548745|FG001|Period 2|Protocol Violation|0|||
142951978|NCT02190591|515363015|FG000|Overall Study|face presentation so she was ineligible|0|||
142951979|NCT02190591|515363016|FG001|Overall Study|face presentation so she was ineligible|1|||
142951980|NCT03851510|515363017|FG000|Overall Study|Screen Fail|1|||
142951981|NCT03851510|515363017|FG000|Overall Study|Adverse Event|1|||
142951982|NCT03851510|515363017|FG000|Overall Study|Withdrawal by Subject|1|||
142951983|NCT01151137|515363020|FG000|Overall Study|Death|15|||
142951984|NCT01151137|515363021|FG001|Overall Study|Death|27|||
142951985|NCT01151137|515363020|FG000|Overall Study|Lost to Follow-up|1|||
142951986|NCT01151137|515363021|FG001|Overall Study|Lost to Follow-up|1|||
142951987|NCT02973815|515363022|FG000|Post Intervention|Death|1|||
142951988|NCT02973815|515363023|FG001|Post Intervention|Death|0|||
142951989|NCT02973815|515363022|FG000|Post Intervention|Lost to Follow-up|7|||
142951990|NCT02973815|515363023|FG001|Post Intervention|Lost to Follow-up|24|||
142951991|NCT02973815|515363022|FG000|Follow-up|Lost to Follow-up|2|||
142951992|NCT02973815|515363023|FG001|Follow-up|Lost to Follow-up|0|||
142951993|NCT04542291|515363024|FG000|Overall Study|Adverse Event|1|||
142951994|NCT04542291|515363024|FG000|Overall Study|Physician Decision|2|||
142951995|NCT04579393|515363028|FG000|Overall Study|Withdrawal by Subject|2|||
142951996|NCT04579393|515363029|FG001|Overall Study|Withdrawal by Subject|2|||
142951997|NCT04579393|515363028|FG000|Overall Study|Death|1|||
142951998|NCT04579393|515363029|FG001|Overall Study|Death|3|||
142951999|NCT01524289|515363031|FG000|Overall Study|Lost to Follow-up|0|||
142952000|NCT01524289|515363032|FG001|Overall Study|Lost to Follow-up|1|||
142952001|NCT01524289|515363031|FG000|Overall Study|Physician Decision|1|||
142952002|NCT01524289|515363032|FG001|Overall Study|Physician Decision|0|||
142952003|NCT01524289|515363031|FG000|Overall Study|Protocol Violation|5|||
142952004|NCT01524289|515363032|FG001|Overall Study|Protocol Violation|1|||
142952005|NCT01524289|515363031|FG000|Overall Study|Withdrawal by Subject|11|||
142952006|NCT01524289|515363032|FG001|Overall Study|Withdrawal by Subject|7|||
142952007|NCT01524289|515363031|FG000|Overall Study|Adverse Event|12|||
142952008|NCT01524289|515363032|FG001|Overall Study|Adverse Event|5|||
142952009|NCT01524289|515363031|FG000|Overall Study|Did not take study medication|1|||
142952010|NCT01524289|515363032|FG001|Overall Study|Did not take study medication|0|||
142952011|NCT02104180|515363033|FG000|Overall Study|Protocol Violation|1|||
142952012|NCT02104180|515363034|FG001|Overall Study|Protocol Violation|0|||
142952013|NCT02704429|515363037|FG000|Part A: 24 Weeks|Adverse Event|3|||
142952014|NCT02704429|515363038|FG001|Part A: 24 Weeks|Adverse Event|0|||
142952015|NCT02704429|515363037|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
142952016|NCT02704429|515363038|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
142952017|NCT00104104|515363039|FG000|Overall Study|Adverse Event|8|||
142952018|NCT00104104|515363040|FG001|Overall Study|Adverse Event|8|||
142952019|NCT00104104|515363039|FG000|Overall Study|Abnormal laboratory value(s)|20|||
142952020|NCT00104104|515363040|FG001|Overall Study|Abnormal laboratory value(s)|14|||
142952021|NCT00104104|515363039|FG000|Overall Study|Lack of Efficacy|0|||
142952022|NCT00104104|515363040|FG001|Overall Study|Lack of Efficacy|3|||
142952023|NCT00104104|515363039|FG000|Overall Study|Condition no longer requires study drug|7|||
142952024|NCT00104104|515363040|FG001|Overall Study|Condition no longer requires study drug|4|||
142952025|NCT00104104|515363039|FG000|Overall Study|Protocol Violation|5|||
142952026|NCT00104104|515363040|FG001|Overall Study|Protocol Violation|2|||
142952027|NCT00104104|515363039|FG000|Overall Study|Withdrawal by Subject|11|||
142952028|NCT00104104|515363040|FG001|Overall Study|Withdrawal by Subject|15|||
142952029|NCT00104104|515363039|FG000|Overall Study|Lost to Follow-up|3|||
142952030|NCT00104104|515363040|FG001|Overall Study|Lost to Follow-up|7|||
142952031|NCT00104104|515363039|FG000|Overall Study|Administrative problems|12|||
142952032|NCT00104104|515363040|FG001|Overall Study|Administrative problems|13|||
142952033|NCT00104104|515363039|FG000|Overall Study|Death|9|||
142952034|NCT00104104|515363040|FG001|Overall Study|Death|6|||
142952035|NCT01056523|515363048|FG000|Overall Study|Death|1|||
142952036|NCT01056523|515363049|FG001|Overall Study|Death|0|||
142952037|NCT01056523|515363050|FG002|Overall Study|Death|2|||
142952038|NCT01056523|515363051|FG003|Overall Study|Death|3|||
142952039|NCT01056523|515363052|FG004|Overall Study|Death|0|||
142952040|NCT01056523|515363053|FG005|Overall Study|Death|0|||
142952041|NCT01056523|515363054|FG006|Overall Study|Death|1|||
142952042|NCT01821677|515363055|FG000|Overall Study|Adverse Event|4|||
142952043|NCT01821677|515363056|FG001|Overall Study|Adverse Event|6|||
142952044|NCT01821677|515363057|FG002|Overall Study|Adverse Event|5|||
142952045|NCT01821677|515363055|FG000|Overall Study|Physician Decision|1|||
142952046|NCT01821677|515363056|FG001|Overall Study|Physician Decision|4|||
143117369|NCT01313221|515971828|FG002|Overall Study|Non-compliance|2|||
142952047|NCT01821677|515363057|FG002|Overall Study|Physician Decision|1|||
142952048|NCT01821677|515363055|FG000|Overall Study|Non-compliance|0|||
142952049|NCT01821677|515363056|FG001|Overall Study|Non-compliance|1|||
142952050|NCT01821677|515363057|FG002|Overall Study|Non-compliance|2|||
142952051|NCT01821677|515363055|FG000|Overall Study|Lost to Follow-up|2|||
142952052|NCT01821677|515363056|FG001|Overall Study|Lost to Follow-up|1|||
142952053|NCT01821677|515363057|FG002|Overall Study|Lost to Follow-up|3|||
142952054|NCT01821677|515363055|FG000|Overall Study|Protocol Violation|0|||
142952055|NCT01821677|515363056|FG001|Overall Study|Protocol Violation|0|||
142952056|NCT01821677|515363057|FG002|Overall Study|Protocol Violation|2|||
142952057|NCT01821677|515363055|FG000|Overall Study|Withdrawal by Subject|7|||
142952058|NCT01821677|515363056|FG001|Overall Study|Withdrawal by Subject|3|||
142952059|NCT01821677|515363057|FG002|Overall Study|Withdrawal by Subject|2|||
142952060|NCT01821677|515363055|FG000|Overall Study|Other|9|||
142952061|NCT01821677|515363056|FG001|Overall Study|Other|0|||
142952062|NCT01821677|515363057|FG002|Overall Study|Other|0|||
142952063|NCT04952389|515363062|FG000|Overall Study|Withdrawal by Subject|8|||
142952064|NCT04952389|515363063|FG001|Overall Study|Withdrawal by Subject|4|||
142952065|NCT01266148|515365017|FG000|Overall Study|Adverse Event|2|||
142952066|NCT01266148|515365018|FG001|Overall Study|Adverse Event|0|||
142952067|NCT01266148|515365017|FG000|Overall Study|Ongoing rejection|1|||
142952068|NCT01266148|515365018|FG001|Overall Study|Ongoing rejection|0|||
142952069|NCT01266148|515365017|FG000|Overall Study|2 2R rejections|1|||
142952070|NCT01266148|515365018|FG001|Overall Study|2 2R rejections|0|||
142952071|NCT01266148|515365017|FG000|Overall Study|Death|2|||
142952072|NCT01266148|515365018|FG001|Overall Study|Death|3|||
142952073|NCT01266148|515365017|FG000|Overall Study|missing mGFR value + AE|1|||
142952074|NCT01266148|515365018|FG001|Overall Study|missing mGFR value + AE|0|||
142952075|NCT01518699|515365019|FG000|Period 2|Protocol Violation|1|||
142952076|NCT01518699|515365020|FG001|Period 2|Protocol Violation|1|||
142952077|NCT01518699|515365021|FG002|Period 2|Protocol Violation|0|||
142952078|NCT01518699|515365022|FG003|Period 2|Protocol Violation|0|||
142952079|NCT01518699|515365023|FG004|Period 2|Protocol Violation|0|||
142952080|NCT01518699|515365024|FG005|Period 2|Protocol Violation|0|||
142952081|NCT01518699|515365019|FG000|Period 2|Lost to Follow-up|0|||
142952082|NCT01518699|515365020|FG001|Period 2|Lost to Follow-up|1|||
142952083|NCT01518699|515365021|FG002|Period 2|Lost to Follow-up|0|||
142952084|NCT01518699|515365022|FG003|Period 2|Lost to Follow-up|0|||
142952085|NCT01518699|515365023|FG004|Period 2|Lost to Follow-up|0|||
142952086|NCT01518699|515365024|FG005|Period 2|Lost to Follow-up|0|||
142952087|NCT01518699|515365019|FG000|Period 2|Adverse Event|1|||
142952088|NCT01518699|515365020|FG001|Period 2|Adverse Event|0|||
142952089|NCT01518699|515365021|FG002|Period 2|Adverse Event|0|||
142952090|NCT01518699|515365022|FG003|Period 2|Adverse Event|0|||
142952091|NCT01518699|515365023|FG004|Period 2|Adverse Event|0|||
142952092|NCT01518699|515365024|FG005|Period 2|Adverse Event|0|||
142952093|NCT00744055|515365025|FG000|Overall Study|Withdrawal by Subject|6|||
142952094|NCT00744055|515365026|FG001|Overall Study|Withdrawal by Subject|9|||
142952095|NCT00744055|515365025|FG000|Overall Study|Lack of Efficacy|0|||
142952096|NCT00744055|515365026|FG001|Overall Study|Lack of Efficacy|1|||
142952097|NCT00744055|515365025|FG000|Overall Study|Physician Decision|0|||
142952098|NCT00744055|515365026|FG001|Overall Study|Physician Decision|2|||
142952099|NCT00744055|515365025|FG000|Overall Study|Protocol Violation|1|||
142952100|NCT00744055|515365026|FG001|Overall Study|Protocol Violation|1|||
142952101|NCT00744055|515365025|FG000|Overall Study|Lost to Follow-up|0|||
142952102|NCT00744055|515365026|FG001|Overall Study|Lost to Follow-up|1|||
142952103|NCT03635190|515365027|FG000|Overall Study|Lost to Follow-up|4|||
142952104|NCT03635190|515365027|FG000|Overall Study|Death|3|||
142952105|NCT03635190|515365027|FG000|Overall Study|Withdrawal by Subject|1|||
142952106|NCT03635190|515365027|FG000|Overall Study|Patient moved and did not return for follow up|1|||
142952107|NCT03692910|515365028|FG000|Overall Study|Lost to Follow-up|4|||
142952108|NCT03692910|515365029|FG001|Overall Study|Lost to Follow-up|0|||
142952109|NCT03692910|515365030|FG002|Overall Study|Lost to Follow-up|0|||
142952110|NCT03692910|515365028|FG000|Overall Study|Withdrawal by Subject|2|||
142952111|NCT03692910|515365029|FG001|Overall Study|Withdrawal by Subject|0|||
142952112|NCT03692910|515365030|FG002|Overall Study|Withdrawal by Subject|0|||
142952113|NCT00417612|515365031|FG000|Overall Study|Errant diagnosis|0|||
142952114|NCT00417612|515365032|FG001|Overall Study|Errant diagnosis|1|||
142952115|NCT00417612|515365031|FG000|Overall Study|Adverse Event|2|||
142952116|NCT00417612|515365032|FG001|Overall Study|Adverse Event|0|||
142952117|NCT00417612|515365031|FG000|Overall Study|Protocol Violation|0|||
142952118|NCT00417612|515365032|FG001|Overall Study|Protocol Violation|2|||
142952119|NCT00417612|515365031|FG000|Overall Study|Lost to Follow-up|1|||
142952120|NCT00417612|515365032|FG001|Overall Study|Lost to Follow-up|0|||
142952121|NCT03846947|515365037|FG000|Overall Study|technical issues with imaging sequence|2|||
142952122|NCT03216265|515365038|FG000|Overall Study|Adverse Event|2|||
142952123|NCT03216265|515365039|FG001|Overall Study|Adverse Event|0|||
142952124|NCT03216265|515365040|FG002|Overall Study|Adverse Event|2|||
142952125|NCT03216265|515365038|FG000|Overall Study|Lost to Follow-up|0|||
142952126|NCT03216265|515365039|FG001|Overall Study|Lost to Follow-up|1|||
142952127|NCT03216265|515365040|FG002|Overall Study|Lost to Follow-up|0|||
142952128|NCT03216265|515365038|FG000|Overall Study|Withdrawal by Subject|0|||
142952129|NCT03216265|515365039|FG001|Overall Study|Withdrawal by Subject|0|||
142952130|NCT03216265|515365040|FG002|Overall Study|Withdrawal by Subject|1|||
142952131|NCT01306058|515365041|FG000|Overall Study|Death|1|||
142952132|NCT01306058|515365041|FG000|Overall Study|Enrolled but did not get treatment|1|||
142952133|NCT01539837|515365042|FG000|Overall Study|reduce neutrophil level|0|||
142952134|NCT01539837|515365043|FG001|Overall Study|reduce neutrophil level|1|||
142952135|NCT01539837|515365044|FG002|Overall Study|reduce neutrophil level|1|||
142952136|NCT01539837|515365042|FG000|Overall Study|bad compliance|0|||
142952137|NCT01539837|515365043|FG001|Overall Study|bad compliance|0|||
142952138|NCT01539837|515365044|FG002|Overall Study|bad compliance|1|||
142952139|NCT00849693|515365045|FG000|Acute Treatment Phase|Adverse Event|12|||
142952140|NCT00849693|515365046|FG001|Acute Treatment Phase|Adverse Event|7|||
142952141|NCT00849693|515365047|FG002|Acute Treatment Phase|Adverse Event|6|||
142952142|NCT00849693|515365048|FG003|Acute Treatment Phase|Adverse Event|4|||
142952143|NCT00849693|515365045|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
142952144|NCT00849693|515365046|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
142952145|NCT00849693|515365047|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
142952146|NCT00849693|515365048|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
142952147|NCT00849693|515365045|FG000|Acute Treatment Phase|Protocol Violation|1|||
142952148|NCT00849693|515365046|FG001|Acute Treatment Phase|Protocol Violation|5|||
142952149|NCT00849693|515365047|FG002|Acute Treatment Phase|Protocol Violation|2|||
142952150|NCT00849693|515365048|FG003|Acute Treatment Phase|Protocol Violation|6|||
142952151|NCT00849693|515365045|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
142952152|NCT00849693|515365046|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
142952153|NCT00849693|515365047|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
142952154|NCT00849693|515365048|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
142952155|NCT00849693|515365045|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
142952156|NCT00849693|515365046|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
142952157|NCT00849693|515365047|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
142952158|NCT00849693|515365048|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
142952159|NCT00849693|515365045|FG000|Acute Treatment Phase|Physician Decision|2|||
142952160|NCT00849693|515365046|FG001|Acute Treatment Phase|Physician Decision|1|||
142952161|NCT00849693|515365047|FG002|Acute Treatment Phase|Physician Decision|2|||
142952162|NCT00849693|515365048|FG003|Acute Treatment Phase|Physician Decision|1|||
142952163|NCT00849693|515365045|FG000|Acute Treatment Phase|Sponsor decision|0|||
142952164|NCT00849693|515365046|FG001|Acute Treatment Phase|Sponsor decision|0|||
142952165|NCT00849693|515365047|FG002|Acute Treatment Phase|Sponsor decision|1|||
142952166|NCT00849693|515365048|FG003|Acute Treatment Phase|Sponsor decision|0|||
142952167|NCT00849693|515365045|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
142952168|NCT00849693|515365046|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
142952169|NCT00849693|515365047|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
142952170|NCT00849693|515365048|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
142952171|NCT00849693|515365045|FG000|Extension Phase|Adverse Event|4|||
142952172|NCT00849693|515365046|FG001|Extension Phase|Adverse Event|6|||
142952173|NCT00849693|515365047|FG002|Extension Phase|Adverse Event|3|||
142952174|NCT00849693|515365048|FG003|Extension Phase|Adverse Event|7|||
142952175|NCT00849693|515365045|FG000|Extension Phase|Lost to Follow-up|7|||
142952176|NCT00849693|515365046|FG001|Extension Phase|Lost to Follow-up|5|||
142952177|NCT00849693|515365047|FG002|Extension Phase|Lost to Follow-up|6|||
142952178|NCT00849693|515365048|FG003|Extension Phase|Lost to Follow-up|6|||
142952179|NCT00849693|515365045|FG000|Extension Phase|Protocol Violation|0|||
142952180|NCT00849693|515365046|FG001|Extension Phase|Protocol Violation|3|||
142952181|NCT00849693|515365047|FG002|Extension Phase|Protocol Violation|2|||
142952182|NCT00849693|515365048|FG003|Extension Phase|Protocol Violation|3|||
142952183|NCT00849693|515365045|FG000|Extension Phase|Withdrawal by Subject|6|||
142952184|NCT00849693|515365046|FG001|Extension Phase|Withdrawal by Subject|9|||
142952185|NCT00849693|515365047|FG002|Extension Phase|Withdrawal by Subject|10|||
142952186|NCT00849693|515365048|FG003|Extension Phase|Withdrawal by Subject|15|||
142952187|NCT00849693|515365045|FG000|Extension Phase|Parent or caregiver decision|9|||
142952188|NCT00849693|515365046|FG001|Extension Phase|Parent or caregiver decision|4|||
142952189|NCT00849693|515365047|FG002|Extension Phase|Parent or caregiver decision|10|||
142952190|NCT00849693|515365048|FG003|Extension Phase|Parent or caregiver decision|5|||
142952191|NCT00849693|515365045|FG000|Extension Phase|Physician Decision|1|||
142952192|NCT00849693|515365046|FG001|Extension Phase|Physician Decision|1|||
142952193|NCT00849693|515365047|FG002|Extension Phase|Physician Decision|2|||
142952194|NCT00849693|515365048|FG003|Extension Phase|Physician Decision|0|||
142952195|NCT00849693|515365045|FG000|Extension Phase|Sponsor decision|1|||
142952196|NCT00849693|515365046|FG001|Extension Phase|Sponsor decision|0|||
142952197|NCT00849693|515365047|FG002|Extension Phase|Sponsor decision|0|||
142952198|NCT00849693|515365048|FG003|Extension Phase|Sponsor decision|1|||
142952199|NCT00849693|515365045|FG000|Extension Phase|Lack of Efficacy|2|||
142952200|NCT00849693|515365046|FG001|Extension Phase|Lack of Efficacy|2|||
142952201|NCT00849693|515365047|FG002|Extension Phase|Lack of Efficacy|2|||
142952202|NCT00849693|515365048|FG003|Extension Phase|Lack of Efficacy|1|||
142952203|NCT00224107|515365049|FG000|Overall Study|Adverse Event|20|||
142952204|NCT00224107|515365050|FG001|Overall Study|Adverse Event|6|||
142952205|NCT00224107|515365049|FG000|Overall Study|Protocol Violation|2|||
142952206|NCT00224107|515365050|FG001|Overall Study|Protocol Violation|3|||
142952207|NCT00224107|515365049|FG000|Overall Study|Withdrawal by Subject|1|||
142952208|NCT00224107|515365050|FG001|Overall Study|Withdrawal by Subject|4|||
142952209|NCT00224107|515365049|FG000|Overall Study|Lack of Efficacy|2|||
142952210|NCT00224107|515365050|FG001|Overall Study|Lack of Efficacy|0|||
142952211|NCT00224107|515365049|FG000|Overall Study|Lost to Follow-up|4|||
142952212|NCT00224107|515365050|FG001|Overall Study|Lost to Follow-up|0|||
142952213|NCT00224107|515365049|FG000|Overall Study|Physician Decision|1|||
142952214|NCT00224107|515365050|FG001|Overall Study|Physician Decision|0|||
142952215|NCT00224107|515365049|FG000|Overall Study|Other|1|||
142952216|NCT00224107|515365050|FG001|Overall Study|Other|1|||
142952217|NCT01650779|515365057|FG000|Overall Study|Withdrawal by Subject|1|||
142952218|NCT01272180|515365059|FG000|Overall Study|Adverse Event|0|||
142952219|NCT01272180|515365060|FG001|Overall Study|Adverse Event|0|||
142952220|NCT01272180|515365061|FG002|Overall Study|Adverse Event|1|||
142952221|NCT01272180|515365062|FG003|Overall Study|Adverse Event|0|||
142952222|NCT01272180|515365059|FG000|Overall Study|Withdrawal by Subject|2|||
142952223|NCT01272180|515365060|FG001|Overall Study|Withdrawal by Subject|6|||
142952224|NCT01272180|515365061|FG002|Overall Study|Withdrawal by Subject|3|||
142952225|NCT01272180|515365062|FG003|Overall Study|Withdrawal by Subject|2|||
142952226|NCT01272180|515365059|FG000|Overall Study|Lost to Follow-up|15|||
142952227|NCT01272180|515365060|FG001|Overall Study|Lost to Follow-up|14|||
142952228|NCT01272180|515365061|FG002|Overall Study|Lost to Follow-up|8|||
142952229|NCT01272180|515365062|FG003|Overall Study|Lost to Follow-up|10|||
142952230|NCT01272180|515365059|FG000|Overall Study|Inappropriate enrollment|0|||
142952231|NCT01272180|515365060|FG001|Overall Study|Inappropriate enrollment|0|||
143455117|NCT02663518|517210764|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
143455118|NCT02663518|517210765|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
143455119|NCT02663518|517210766|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
143455120|NCT02663518|517210767|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
143455121|NCT02663518|517210768|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
143455122|NCT02663518|517210769|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
143455123|NCT02663518|517210770|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
143455124|NCT02663518|517210771|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
143455125|NCT02663518|517210772|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
143455126|NCT01144052|517210775|FG000|Overall Study|Withdrawal by Subject|1|||
143455127|NCT01144052|517210776|FG001|Overall Study|Withdrawal by Subject|1|||
143455128|NCT03836716|517210777|FG000|Overall Study|Adverse Event|3|||
143455129|NCT03836716|517210777|FG000|Overall Study|Death|22|||
143455130|NCT03836716|517210777|FG000|Overall Study|Withdrawal by Subject|8|||
143455131|NCT03836716|517210777|FG000|Overall Study|Study terminated by sponsor|87|||
143455132|NCT01879722|517210778|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
143455133|NCT01879722|517210779|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
143455134|NCT01879722|517210780|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
143455135|NCT01879722|517210781|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
143455136|NCT01879722|517210782|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
143455137|NCT01879722|517210783|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
143455138|NCT01879722|517210784|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
143455139|NCT01879722|517210785|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
143455140|NCT01879722|517210786|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
143455141|NCT01879722|517210787|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
143455142|NCT01879722|517210778|FG000|Overall Study|Voluntary Withdrawal|0|||
143455143|NCT01879722|517210779|FG001|Overall Study|Voluntary Withdrawal|0|||
143455144|NCT01879722|517210780|FG002|Overall Study|Voluntary Withdrawal|0|||
143455145|NCT01879722|517210781|FG003|Overall Study|Voluntary Withdrawal|0|||
142952232|NCT01272180|515365061|FG002|Overall Study|Inappropriate enrollment|1|||
142952233|NCT01272180|515365062|FG003|Overall Study|Inappropriate enrollment|1|||
142952234|NCT01272180|515365059|FG000|Overall Study|Protocol Violation|0|||
142952235|NCT01272180|515365060|FG001|Overall Study|Protocol Violation|1|||
142952236|NCT01272180|515365061|FG002|Overall Study|Protocol Violation|0|||
142952237|NCT01272180|515365062|FG003|Overall Study|Protocol Violation|1|||
142952238|NCT02046564|515365063|FG000|Overall Study|Adverse Event|6|||
142952239|NCT02046564|515365064|FG001|Overall Study|Adverse Event|3|||
142952240|NCT02046564|515365063|FG000|Overall Study|Physician Decision|0|||
142952241|NCT02046564|515365064|FG001|Overall Study|Physician Decision|1|||
142952242|NCT02046564|515365063|FG000|Overall Study|Protocol Violation|3|||
142952243|NCT02046564|515365064|FG001|Overall Study|Protocol Violation|1|||
142952244|NCT02046564|515365063|FG000|Overall Study|Withdrawal by Subject|4|||
142952245|NCT02046564|515365064|FG001|Overall Study|Withdrawal by Subject|10|||
142952246|NCT02046564|515365063|FG000|Overall Study|Subject met withdrawal criteria|2|||
142952247|NCT02046564|515365064|FG001|Overall Study|Subject met withdrawal criteria|5|||
142952248|NCT03842709|515365065|FG000|Overall Study|Withdrawal by Subject|3|||
142952249|NCT03842709|515365066|FG001|Overall Study|Withdrawal by Subject|3|||
142952250|NCT03842709|515365065|FG000|Overall Study|Lost to Follow-up|1|||
142952251|NCT03842709|515365066|FG001|Overall Study|Lost to Follow-up|0|||
142952252|NCT02117050|515365072|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
142952253|NCT03849560|515365074|FG000|Overall Study|Withdrawal by Subject|1|||
142952254|NCT03849560|515365075|FG001|Overall Study|Withdrawal by Subject|0|||
142952255|NCT03849560|515365076|FG002|Overall Study|Withdrawal by Subject|0|||
142952256|NCT04045613|515365077|FG000|Overall Study|Adverse Event|2|||
142952257|NCT04045613|515365078|FG001|Overall Study|Adverse Event|2|||
142952258|NCT04045613|515365079|FG002|Overall Study|Adverse Event|1|||
142952259|NCT04045613|515365080|FG003|Overall Study|Adverse Event|1|||
142952260|NCT04045613|515365081|FG004|Overall Study|Adverse Event|0|||
142952261|NCT04045613|515365082|FG005|Overall Study|Adverse Event|0|||
142952262|NCT04045613|515365083|FG006|Overall Study|Adverse Event|1|||
142952263|NCT04045613|515365077|FG000|Overall Study|Withdrawal by Subject|0|||
142952264|NCT04045613|515365078|FG001|Overall Study|Withdrawal by Subject|5|||
142952265|NCT04045613|515365079|FG002|Overall Study|Withdrawal by Subject|0|||
142952266|NCT04045613|515365080|FG003|Overall Study|Withdrawal by Subject|0|||
142952267|NCT04045613|515365081|FG004|Overall Study|Withdrawal by Subject|0|||
142952268|NCT04045613|515365082|FG005|Overall Study|Withdrawal by Subject|1|||
142952269|NCT04045613|515365083|FG006|Overall Study|Withdrawal by Subject|0|||
142952270|NCT04045613|515365077|FG000|Overall Study|Physician Decision|2|||
142952271|NCT04045613|515365078|FG001|Overall Study|Physician Decision|0|||
142952272|NCT04045613|515365079|FG002|Overall Study|Physician Decision|0|||
142952273|NCT04045613|515365080|FG003|Overall Study|Physician Decision|0|||
142952274|NCT04045613|515365081|FG004|Overall Study|Physician Decision|1|||
142952275|NCT04045613|515365082|FG005|Overall Study|Physician Decision|0|||
142952276|NCT04045613|515365083|FG006|Overall Study|Physician Decision|0|||
142952277|NCT04045613|515365077|FG000|Overall Study|Death|3|||
142952278|NCT04045613|515365078|FG001|Overall Study|Death|0|||
142952279|NCT04045613|515365079|FG002|Overall Study|Death|0|||
142952280|NCT04045613|515365080|FG003|Overall Study|Death|0|||
142952281|NCT04045613|515365081|FG004|Overall Study|Death|0|||
142952282|NCT04045613|515365082|FG005|Overall Study|Death|0|||
142952283|NCT04045613|515365083|FG006|Overall Study|Death|1|||
142952284|NCT04045613|515365077|FG000|Overall Study|Other reasons|0|||
142952285|NCT04045613|515365078|FG001|Overall Study|Other reasons|1|||
142952286|NCT04045613|515365079|FG002|Overall Study|Other reasons|0|||
142952287|NCT04045613|515365080|FG003|Overall Study|Other reasons|0|||
142952288|NCT04045613|515365081|FG004|Overall Study|Other reasons|0|||
142952289|NCT04045613|515365082|FG005|Overall Study|Other reasons|0|||
142952290|NCT04045613|515365083|FG006|Overall Study|Other reasons|1|||
142952291|NCT04045613|515365077|FG000|Overall Study|Progressive disease: Clinical progression|1|||
142952292|NCT04045613|515365078|FG001|Overall Study|Progressive disease: Clinical progression|0|||
142952293|NCT04045613|515365079|FG002|Overall Study|Progressive disease: Clinical progression|3|||
142952294|NCT04045613|515365080|FG003|Overall Study|Progressive disease: Clinical progression|1|||
142952295|NCT04045613|515365081|FG004|Overall Study|Progressive disease: Clinical progression|1|||
142952296|NCT04045613|515365082|FG005|Overall Study|Progressive disease: Clinical progression|3|||
142952297|NCT04045613|515365083|FG006|Overall Study|Progressive disease: Clinical progression|3|||
142952298|NCT04045613|515365077|FG000|Overall Study|Progressive disease: Radiological progression|24|||
142952299|NCT04045613|515365078|FG001|Overall Study|Progressive disease: Radiological progression|6|||
142952300|NCT04045613|515365079|FG002|Overall Study|Progressive disease: Radiological progression|8|||
142952301|NCT04045613|515365080|FG003|Overall Study|Progressive disease: Radiological progression|0|||
142952302|NCT04045613|515365081|FG004|Overall Study|Progressive disease: Radiological progression|6|||
142952303|NCT04045613|515365082|FG005|Overall Study|Progressive disease: Radiological progression|6|||
142952304|NCT04045613|515365083|FG006|Overall Study|Progressive disease: Radiological progression|11|||
142952305|NCT00491530|515365093|FG000|Overall Study|Adverse Event|6|||
142952306|NCT00491530|515365094|FG001|Overall Study|Adverse Event|1|||
142952307|NCT00491530|515365095|FG002|Overall Study|Adverse Event|2|||
142952308|NCT00491530|515365093|FG000|Overall Study|Withdrawal by Subject|3|||
142952309|NCT00491530|515365094|FG001|Overall Study|Withdrawal by Subject|0|||
142952310|NCT00491530|515365095|FG002|Overall Study|Withdrawal by Subject|0|||
142952311|NCT00491530|515365093|FG000|Overall Study|Lost to Follow-up|3|||
142952312|NCT00491530|515365094|FG001|Overall Study|Lost to Follow-up|2|||
142952313|NCT00491530|515365095|FG002|Overall Study|Lost to Follow-up|2|||
142952314|NCT00491530|515365093|FG000|Overall Study|Lack of Efficacy|0|||
142952315|NCT00491530|515365094|FG001|Overall Study|Lack of Efficacy|1|||
142952316|NCT00491530|515365095|FG002|Overall Study|Lack of Efficacy|0|||
142952317|NCT00491530|515365093|FG000|Overall Study|Investigator Discretion|0|||
142952318|NCT00491530|515365094|FG001|Overall Study|Investigator Discretion|1|||
142952319|NCT00491530|515365095|FG002|Overall Study|Investigator Discretion|0|||
142952320|NCT00491530|515365093|FG000|Overall Study|Patient Request|0|||
142952321|NCT00491530|515365094|FG001|Overall Study|Patient Request|1|||
142952322|NCT00491530|515365095|FG002|Overall Study|Patient Request|0|||
142952323|NCT00491530|515365093|FG000|Overall Study|Use of Prohibited Medication|0|||
142952324|NCT00491530|515365094|FG001|Overall Study|Use of Prohibited Medication|0|||
142952325|NCT00491530|515365095|FG002|Overall Study|Use of Prohibited Medication|1|||
142952326|NCT02859415|515365096|FG000|Overall Study|Physician Decision|1|||
142952327|NCT02859415|515365097|FG001|Overall Study|Physician Decision|0|||
142952328|NCT02859415|515365096|FG000|Overall Study|Off treatment due to cardiac event|0|||
142952329|NCT02859415|515365097|FG001|Overall Study|Off treatment due to cardiac event|1|||
142952330|NCT01396525|515365098|FG000|Overall Study|Withdrawal by Subject|8|||
142952331|NCT01396525|515365098|FG000|Overall Study|Death|14|||
142952332|NCT01396525|515365098|FG000|Overall Study|Lost to Follow-up|4|||
142952333|NCT00949650|515365099|FG000|Overall Study|Progressive disease|188|||
142952334|NCT00949650|515365100|FG001|Overall Study|Progressive disease|19|||
142952335|NCT00949650|515365099|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
142952336|NCT00949650|515365100|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
142952337|NCT00949650|515365099|FG000|Overall Study|Other Adverse Event (AE)|28|||
142952338|NCT00949650|515365100|FG001|Overall Study|Other Adverse Event (AE)|17|||
142952339|NCT00949650|515365099|FG000|Overall Study|Protocol Violation|1|||
142952340|NCT00949650|515365100|FG001|Overall Study|Protocol Violation|4|||
142952341|NCT00949650|515365099|FG000|Overall Study|Refusal to continue medication|7|||
142952342|NCT00949650|515365100|FG001|Overall Study|Refusal to continue medication|11|||
142952343|NCT00949650|515365099|FG000|Overall Study|Not treated|1|||
142952344|NCT00949650|515365100|FG001|Overall Study|Not treated|4|||
142952345|NCT00949650|515365099|FG000|Overall Study|Other not specified above|5|||
142952346|NCT00949650|515365100|FG001|Overall Study|Other not specified above|0|||
142952347|NCT02436239|515365102|FG000|Open-Lable Treatment Period|Adverse Event|12|||
142952348|NCT02436239|515365103|FG001|Open-Lable Treatment Period|Adverse Event|3|||
142952349|NCT02436239|515365104|FG002|Open-Lable Treatment Period|Adverse Event|4|||
142952350|NCT02436239|515365105|FG003|Open-Lable Treatment Period|Adverse Event|2|||
142952351|NCT02436239|515365102|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
142952352|NCT02436239|515365103|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
142952353|NCT02436239|515365104|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
142952354|NCT02436239|515365105|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
142952355|NCT02436239|515365102|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
142952356|NCT02436239|515365103|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
142952357|NCT02436239|515365104|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
142952358|NCT02436239|515365105|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
142952359|NCT02436239|515365102|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
142952360|NCT02436239|515365103|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
142952361|NCT02436239|515365104|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
142952362|NCT02436239|515365105|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
142952363|NCT02436239|515365102|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
142952364|NCT02436239|515365103|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
142952365|NCT02436239|515365104|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
142952366|NCT02436239|515365105|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
142952367|NCT02436239|515365102|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
142952368|NCT02436239|515365103|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
142952369|NCT02436239|515365104|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
142952370|NCT02436239|515365105|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
142952371|NCT02436239|515365102|FG000|Open-Lable Treatment Period|Other Reason|1|||
142952372|NCT02436239|515365103|FG001|Open-Lable Treatment Period|Other Reason|1|||
142952373|NCT02436239|515365104|FG002|Open-Lable Treatment Period|Other Reason|0|||
142952374|NCT02436239|515365105|FG003|Open-Lable Treatment Period|Other Reason|0|||
142952375|NCT02436239|515365102|FG000|Down-Taper Period|Withdrawal by Subject|4|||
142952376|NCT02436239|515365103|FG001|Down-Taper Period|Withdrawal by Subject|4|||
142952377|NCT02436239|515365104|FG002|Down-Taper Period|Withdrawal by Subject|1|||
142952378|NCT02436239|515365105|FG003|Down-Taper Period|Withdrawal by Subject|2|||
142952379|NCT02168946|515365106|FG000|Overall Study|Adverse Event|8|||
142952380|NCT02168946|515365107|FG001|Overall Study|Adverse Event|5|||
142952381|NCT02168946|515365106|FG000|Overall Study|Lost to Follow-up|3|||
142952382|NCT02168946|515365107|FG001|Overall Study|Lost to Follow-up|0|||
142952383|NCT02168946|515365106|FG000|Overall Study|Subject unable to come back for visits|1|||
142952384|NCT02168946|515365107|FG001|Overall Study|Subject unable to come back for visits|0|||
142952385|NCT00450866|515365113|FG000|Overall Study|Adverse Event|0|||
142952386|NCT00450866|515365114|FG001|Overall Study|Adverse Event|1|||
142952387|NCT00450866|515365113|FG000|Overall Study|Withdrawal by Subject|5|||
142952388|NCT00450866|515365114|FG001|Overall Study|Withdrawal by Subject|2|||
142952389|NCT00450866|515365113|FG000|Overall Study|Death|1|||
142952390|NCT00450866|515365114|FG001|Overall Study|Death|0|||
142952391|NCT00450866|515365113|FG000|Overall Study|Physician Decision|1|||
142952392|NCT00450866|515365114|FG001|Overall Study|Physician Decision|0|||
142952393|NCT02498821|515365115|FG000|Overall Study|Screen failure|3|||
142952394|NCT02498821|515365116|FG001|Overall Study|Screen failure|5|||
142952395|NCT02111811|515365121|FG000|Treatment Phase|Lost to Follow-up|22|||
142952396|NCT02111811|515365122|FG001|Treatment Phase|Lost to Follow-up|18|||
142952397|NCT02111811|515365121|FG000|Treatment Phase|Death|2|||
142952398|NCT02111811|515365122|FG001|Treatment Phase|Death|0|||
142952399|NCT02111811|515365121|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
142952400|NCT02111811|515365122|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
142952401|NCT02111811|515365121|FG000|Follow up Period (Aim 2)|Death|2|||
142952402|NCT02111811|515365122|FG001|Follow up Period (Aim 2)|Death|0|||
142952403|NCT01359982|515365124|FG000|Overall Study|Adverse Event|2|||
142952404|NCT01359982|515365125|FG001|Overall Study|Adverse Event|0|||
142952405|NCT01359982|515365126|FG002|Overall Study|Adverse Event|0|||
142952406|NCT01359982|515365127|FG003|Overall Study|Adverse Event|1|||
142952407|NCT01359982|515365128|FG004|Overall Study|Adverse Event|0|||
142952408|NCT01359982|515365129|FG005|Overall Study|Adverse Event|0|||
142952409|NCT01359982|515365124|FG000|Overall Study|Death|1|||
142952410|NCT01359982|515365125|FG001|Overall Study|Death|0|||
142952411|NCT01359982|515365126|FG002|Overall Study|Death|0|||
142952412|NCT01359982|515365127|FG003|Overall Study|Death|0|||
142952413|NCT01359982|515365128|FG004|Overall Study|Death|0|||
142952414|NCT01359982|515365129|FG005|Overall Study|Death|0|||
142952415|NCT00069121|515365132|FG000|Overall Study|Death|286|||
142952416|NCT00069121|515365133|FG001|Overall Study|Death|242|||
142952417|NCT00069121|515365132|FG000|Overall Study|Withdrawal by Subject|18|||
142952418|NCT00069121|515365133|FG001|Overall Study|Withdrawal by Subject|20|||
142952419|NCT00069121|515365132|FG000|Overall Study|Lost to Follow-up|63|||
142952420|NCT00069121|515365133|FG001|Overall Study|Lost to Follow-up|63|||
142952421|NCT04538950|515365141|FG000|Overall Study|Pulmonary Issues|2|||
142952422|NCT04538950|515365141|FG000|Overall Study|illness|2|||
142952423|NCT00847561|515365148|FG000|Overall Study|Withdrawal by Subject|4|||
142952424|NCT00847561|515365149|FG001|Overall Study|Withdrawal by Subject|3|||
142952425|NCT00847561|515365148|FG000|Overall Study|Unable to schedule|9|||
142952426|NCT00847561|515365149|FG001|Overall Study|Unable to schedule|1|||
142952427|NCT00393458|515365150|FG000|Overall Study|Adverse Event|35|||
142952428|NCT00393458|515365151|FG001|Overall Study|Adverse Event|24|||
142952429|NCT00393458|515365152|FG002|Overall Study|Adverse Event|40|||
142952430|NCT00393458|515365153|FG003|Overall Study|Adverse Event|35|||
142952431|NCT00393458|515365150|FG000|Overall Study|Subject withdrew consent|27|||
142952432|NCT00393458|515365151|FG001|Overall Study|Subject withdrew consent|40|||
142952433|NCT00393458|515365152|FG002|Overall Study|Subject withdrew consent|33|||
142952434|NCT00393458|515365153|FG003|Overall Study|Subject withdrew consent|50|||
142952435|NCT00393458|515365150|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
142952436|NCT00393458|515365151|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
142952437|NCT00393458|515365152|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
142952438|NCT00393458|515365153|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
142952439|NCT00393458|515365150|FG000|Overall Study|Protocol deviation|11|||
142952440|NCT00393458|515365151|FG001|Overall Study|Protocol deviation|11|||
142952441|NCT00393458|515365152|FG002|Overall Study|Protocol deviation|11|||
142952442|NCT00393458|515365153|FG003|Overall Study|Protocol deviation|10|||
142952443|NCT00393458|515365150|FG000|Overall Study|Administrative problems|7|||
142952444|NCT00393458|515365151|FG001|Overall Study|Administrative problems|8|||
142952445|NCT00393458|515365152|FG002|Overall Study|Administrative problems|5|||
142952446|NCT00393458|515365153|FG003|Overall Study|Administrative problems|2|||
142952447|NCT00393458|515365150|FG000|Overall Study|Lost to Follow-up|5|||
142952448|NCT00393458|515365151|FG001|Overall Study|Lost to Follow-up|6|||
142952449|NCT00393458|515365152|FG002|Overall Study|Lost to Follow-up|5|||
142952450|NCT00393458|515365153|FG003|Overall Study|Lost to Follow-up|3|||
142952451|NCT00393458|515365150|FG000|Overall Study|Abnormal laboratory value(s)|1|||
142952452|NCT00393458|515365151|FG001|Overall Study|Abnormal laboratory value(s)|1|||
142952453|NCT00393458|515365152|FG002|Overall Study|Abnormal laboratory value(s)|0|||
142952454|NCT00393458|515365153|FG003|Overall Study|Abnormal laboratory value(s)|0|||
142952455|NCT00393458|515365150|FG000|Overall Study|Death|1|||
142952456|NCT00393458|515365151|FG001|Overall Study|Death|1|||
142952457|NCT00393458|515365152|FG002|Overall Study|Death|5|||
142952458|NCT00393458|515365153|FG003|Overall Study|Death|5|||
142952459|NCT00393458|515365150|FG000|Overall Study|Abnormal test procedure result(s)|0|||
142952460|NCT00393458|515365151|FG001|Overall Study|Abnormal test procedure result(s)|1|||
142952461|NCT00393458|515365152|FG002|Overall Study|Abnormal test procedure result(s)|1|||
142952462|NCT00393458|515365153|FG003|Overall Study|Abnormal test procedure result(s)|2|||
142952463|NCT00393458|515365150|FG000|Overall Study|Subject no longer requires study drug|0|||
142952464|NCT00393458|515365151|FG001|Overall Study|Subject no longer requires study drug|1|||
142952465|NCT00393458|515365152|FG002|Overall Study|Subject no longer requires study drug|0|||
142952466|NCT00393458|515365153|FG003|Overall Study|Subject no longer requires study drug|0|||
142952467|NCT02489630|515365163|FG000|Overall Study|Oversedation|1|||
142952468|NCT02489630|515365164|FG001|Overall Study|Oversedation|1|||
142952469|NCT02489630|515365163|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
142952470|NCT02489630|515365164|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
142952471|NCT01326962|515365165|FG000|Overall Study|Adverse Event|1|||
142952472|NCT01326962|515365165|FG000|Overall Study|Withdrawal by Subject|1|||
142952473|NCT01326962|515365165|FG000|Overall Study|Lost to Follow-up|3|||
142952474|NCT01326962|515365165|FG000|Overall Study|Other|2|||
142952475|NCT00793585|515365166|FG000|Overall Study|Adverse Event|1|||
142952476|NCT00793585|515365167|FG001|Overall Study|Adverse Event|1|||
142952477|NCT00793585|515365166|FG000|Overall Study|Protocol Violation|1|||
142952478|NCT00793585|515365167|FG001|Overall Study|Protocol Violation|2|||
142952479|NCT03429556|515365168|FG000|Overall Study|Lost to Follow-up|0|||
142952480|NCT03429556|515365169|FG001|Overall Study|Lost to Follow-up|1|||
142952481|NCT03429556|515365170|FG002|Overall Study|Lost to Follow-up|0|||
142952482|NCT03429556|515365171|FG003|Overall Study|Lost to Follow-up|0|||
142952483|NCT00035815|515365176|FG000|Overall Study|Withdrawal by Subject|17|||
142952484|NCT00035815|515365177|FG001|Overall Study|Withdrawal by Subject|11|||
142952485|NCT02209597|515365178|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
143003114|NCT01049360|515548746|FG002|Period 2|Protocol Violation|0|||
142952486|NCT02209597|515365178|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
142952487|NCT02209597|515365178|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
142952488|NCT02209597|515365178|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
142952489|NCT01855789|515365182|FG000|1) Baseline up to Week 24|Adverse Event|37|||
142952490|NCT01855789|515365183|FG001|1) Baseline up to Week 24|Adverse Event|0|||
142952491|NCT01855789|515365184|FG002|1) Baseline up to Week 24|Adverse Event|0|||
142952492|NCT01855789|515365185|FG003|1) Baseline up to Week 24|Adverse Event|0|||
142952493|NCT01855789|515365182|FG000|1) Baseline up to Week 24|Death|2|||
142952494|NCT01855789|515365183|FG001|1) Baseline up to Week 24|Death|0|||
142952495|NCT01855789|515365184|FG002|1) Baseline up to Week 24|Death|0|||
142952496|NCT01855789|515365185|FG003|1) Baseline up to Week 24|Death|0|||
142952497|NCT01855789|515365182|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
142952498|NCT01855789|515365183|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
142952499|NCT01855789|515365184|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
142952500|NCT01855789|515365185|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
142952501|NCT01855789|515365182|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
142952502|NCT01855789|515365183|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
142952503|NCT01855789|515365184|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
142952504|NCT01855789|515365185|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
142952505|NCT01855789|515365182|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
142952506|NCT01855789|515365183|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
142952507|NCT01855789|515365184|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
142952508|NCT01855789|515365185|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
142952509|NCT01855789|515365182|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
142952510|NCT01855789|515365183|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
142952511|NCT01855789|515365184|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
142952512|NCT01855789|515365185|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
142952513|NCT01855789|515365182|FG000|1) Baseline up to Week 24|Physician Decision|4|||
142952514|NCT01855789|515365183|FG001|1) Baseline up to Week 24|Physician Decision|0|||
142952515|NCT01855789|515365184|FG002|1) Baseline up to Week 24|Physician Decision|0|||
142952516|NCT01855789|515365185|FG003|1) Baseline up to Week 24|Physician Decision|0|||
142952517|NCT01855789|515365182|FG000|1) Baseline up to Week 24|Pregnancy|1|||
142952518|NCT01855789|515365183|FG001|1) Baseline up to Week 24|Pregnancy|0|||
142952519|NCT01855789|515365184|FG002|1) Baseline up to Week 24|Pregnancy|0|||
142952520|NCT01855789|515365185|FG003|1) Baseline up to Week 24|Pregnancy|0|||
142952521|NCT01855789|515365182|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
142952522|NCT01855789|515365183|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
142952523|NCT01855789|515365184|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
142952524|NCT01855789|515365185|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
142952525|NCT01855789|515365182|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
142952526|NCT01855789|515365183|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
142952527|NCT01855789|515365184|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
142952528|NCT01855789|515365185|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
142952529|NCT01855789|515365182|FG000|1) Baseline up to Week 24|Other|4|||
142952530|NCT01855789|515365183|FG001|1) Baseline up to Week 24|Other|0|||
142952531|NCT01855789|515365184|FG002|1) Baseline up to Week 24|Other|0|||
142952532|NCT01855789|515365185|FG003|1) Baseline up to Week 24|Other|0|||
142952533|NCT01855789|515365182|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
142952534|NCT01855789|515365183|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
142952535|NCT01855789|515365184|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
142952536|NCT01855789|515365185|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
142952537|NCT01855789|515365182|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
142952538|NCT01855789|515365183|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
142952539|NCT01855789|515365184|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
142952540|NCT01855789|515365185|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
142952541|NCT01855789|515365182|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
142952542|NCT01855789|515365183|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
142952543|NCT01855789|515365184|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
142952544|NCT01855789|515365185|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
142952545|NCT01855789|515365182|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
142952546|NCT01855789|515365183|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
142952547|NCT01855789|515365184|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
142952548|NCT01855789|515365185|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
142952549|NCT01855789|515365182|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
142952550|NCT01855789|515365183|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
142952551|NCT01855789|515365184|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
142952552|NCT01855789|515365185|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
142952553|NCT01855789|515365182|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
142952554|NCT01855789|515365183|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
142952555|NCT01855789|515365184|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
142952556|NCT01855789|515365185|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
142952557|NCT01855789|515365182|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
142952558|NCT01855789|515365183|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
142952559|NCT01855789|515365184|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
142952560|NCT01855789|515365185|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
142952561|NCT01855789|515365182|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
142952562|NCT01855789|515365183|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
142952563|NCT01855789|515365184|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
142952564|NCT01855789|515365185|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
142952565|NCT01855789|515365182|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
142952566|NCT01855789|515365183|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
142952567|NCT01855789|515365184|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
142952568|NCT01855789|515365185|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
142952569|NCT01855789|515365182|FG000|2) Week 24 up to End of Study|Other|0|||
142952570|NCT01855789|515365183|FG001|2) Week 24 up to End of Study|Other|0|||
142952571|NCT01855789|515365184|FG002|2) Week 24 up to End of Study|Other|0|||
142952572|NCT01855789|515365185|FG003|2) Week 24 up to End of Study|Other|1|||
142952573|NCT01863758|515365186|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
142952574|NCT01863758|515365186|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
142952575|NCT02369510|515365187|FG000|Overall Study|Spilled Medication|1|||
142952576|NCT02369510|515365188|FG001|Overall Study|Spilled Medication|2|||
142952577|NCT02369510|515365189|FG002|Overall Study|Spilled Medication|1|||
142952578|NCT02369510|515365187|FG000|Overall Study|Epidural Activation|1|||
142952579|NCT02369510|515365188|FG001|Overall Study|Epidural Activation|1|||
142952580|NCT02369510|515365189|FG002|Overall Study|Epidural Activation|5|||
142952581|NCT02606877|515365192|FG000|Overall Study|Adverse Event|3|||
142952582|NCT02606877|515365193|FG001|Overall Study|Adverse Event|0|||
142952583|NCT02606877|515365192|FG000|Overall Study|Non-compliance with protocol|0|||
142952584|NCT02606877|515365193|FG001|Overall Study|Non-compliance with protocol|1|||
142952585|NCT02606877|515365192|FG000|Overall Study|Other than listed above|1|||
142952586|NCT02606877|515365193|FG001|Overall Study|Other than listed above|0|||
142952587|NCT02050048|515365197|FG000|Overall Study|Lost to Follow-up|0|||
142952588|NCT02050048|515365198|FG001|Overall Study|Lost to Follow-up|1|||
142952589|NCT02050048|515365197|FG000|Overall Study|Death|1|||
142952590|NCT02050048|515365198|FG001|Overall Study|Death|0|||
142952591|NCT02050048|515365197|FG000|Overall Study|Ineligible after ERCP|4|||
142952592|NCT02050048|515365198|FG001|Overall Study|Ineligible after ERCP|1|||
142952593|NCT04285723|515365201|FG000|Overall Study|Subject decision|1|||
142952594|NCT04285723|515365202|FG001|Overall Study|Subject decision|2|||
142952595|NCT04285723|515365201|FG000|Overall Study|Physician Decision|1|||
142952596|NCT04285723|515365202|FG001|Overall Study|Physician Decision|0|||
142952597|NCT04285723|515365201|FG000|Overall Study|No efficiency|1|||
142952598|NCT04285723|515365202|FG001|Overall Study|No efficiency|0|||
142952599|NCT03067311|515365203|FG000|Overall Study|Lost to Follow-up|1|||
142952600|NCT03067311|515365204|FG001|Overall Study|Lost to Follow-up|1|||
142952601|NCT03067311|515365203|FG000|Overall Study|Moved away|1|||
142952602|NCT03067311|515365204|FG001|Overall Study|Moved away|1|||
142952603|NCT02975349|515365205|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
142952604|NCT02975349|515365206|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
142952605|NCT02975349|515365207|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
142952606|NCT02975349|515365208|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
142952607|NCT02975349|515365209|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
142952608|NCT02975349|515365210|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
142952609|NCT02975349|515365211|FG006|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
142952610|NCT02975349|515365205|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
142952611|NCT02975349|515365206|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
142952612|NCT02975349|515365207|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
142952613|NCT02975349|515365208|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
142952614|NCT02975349|515365209|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
142952615|NCT02975349|515365210|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
142952616|NCT02975349|515365211|FG006|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
142952617|NCT02975349|515365205|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
142952618|NCT02975349|515365206|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
142952619|NCT02975349|515365207|FG002|Active Treatment Period (24 Weeks)|Adverse Event|0|||
142952620|NCT02975349|515365208|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
142952621|NCT02975349|515365209|FG004|Active Treatment Period (24 Weeks)|Adverse Event|2|||
142952622|NCT02975349|515365210|FG005|Active Treatment Period (24 Weeks)|Adverse Event|6|||
142952623|NCT02975349|515365211|FG006|Active Treatment Period (24 Weeks)|Adverse Event|2|||
142952624|NCT02975349|515365205|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
142952625|NCT02975349|515365206|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
142952626|NCT02975349|515365207|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
143117129|NCT01273155|515970044|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
142952627|NCT02975349|515365208|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
142952628|NCT02975349|515365209|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|3|||
142952629|NCT02975349|515365210|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
142952630|NCT02975349|515365211|FG006|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
142952631|NCT02975349|515365205|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
142952632|NCT02975349|515365206|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
142952633|NCT02975349|515365207|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
142952634|NCT02975349|515365208|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
142952635|NCT02975349|515365209|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
142952636|NCT02975349|515365210|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
142952637|NCT02975349|515365211|FG006|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
142952638|NCT02975349|515365205|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
142952639|NCT02975349|515365206|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
142952640|NCT02975349|515365207|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
142952641|NCT02975349|515365208|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
142952642|NCT02975349|515365209|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
142952643|NCT02975349|515365210|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
142952644|NCT02975349|515365211|FG006|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
142952645|NCT02975349|515365205|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
142952646|NCT02975349|515365206|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
142952647|NCT02975349|515365207|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
142952648|NCT02975349|515365208|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
142952649|NCT02975349|515365209|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
142952650|NCT02975349|515365210|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
142952651|NCT02975349|515365211|FG006|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
142952652|NCT02975349|515365205|FG000|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
142952653|NCT02975349|515365206|FG001|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
142952654|NCT02975349|515365207|FG002|Open-label Extension Period (336 Weeks)|Adverse Event|3|||
142952655|NCT02975349|515365208|FG003|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
142952656|NCT02975349|515365209|FG004|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
142952657|NCT02975349|515365210|FG005|Open-label Extension Period (336 Weeks)|Adverse Event|1|||
142952658|NCT02975349|515365211|FG006|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
142952659|NCT02975349|515365205|FG000|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
142952660|NCT02975349|515365206|FG001|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
142952661|NCT02975349|515365207|FG002|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
142952662|NCT02975349|515365208|FG003|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
142952663|NCT02975349|515365209|FG004|Open-label Extension Period (336 Weeks)|Study reached its predefined end|1|||
142952664|NCT02975349|515365210|FG005|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
142952665|NCT02975349|515365211|FG006|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
142952666|NCT02975349|515365205|FG000|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
142952667|NCT02975349|515365206|FG001|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
142952668|NCT02975349|515365207|FG002|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
142952669|NCT02975349|515365208|FG003|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
142952670|NCT02975349|515365209|FG004|Open-label Extension Period (336 Weeks)|Lack of Efficacy|2|||
142952671|NCT02975349|515365210|FG005|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
142952672|NCT02975349|515365211|FG006|Open-label Extension Period (336 Weeks)|Lack of Efficacy|1|||
142952673|NCT02975349|515365205|FG000|Open-label Extension Period (336 Weeks)|Death|0|||
142952674|NCT02975349|515365206|FG001|Open-label Extension Period (336 Weeks)|Death|0|||
142952675|NCT02975349|515365207|FG002|Open-label Extension Period (336 Weeks)|Death|0|||
142952676|NCT02975349|515365208|FG003|Open-label Extension Period (336 Weeks)|Death|1|||
142952677|NCT02975349|515365209|FG004|Open-label Extension Period (336 Weeks)|Death|0|||
142952678|NCT02975349|515365210|FG005|Open-label Extension Period (336 Weeks)|Death|0|||
142952679|NCT02975349|515365211|FG006|Open-label Extension Period (336 Weeks)|Death|0|||
142952680|NCT02975349|515365205|FG000|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
142952681|NCT02975349|515365206|FG001|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
142952682|NCT02975349|515365207|FG002|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
142952683|NCT02975349|515365208|FG003|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
142952684|NCT02975349|515365209|FG004|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
142952685|NCT02975349|515365210|FG005|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
142952686|NCT02975349|515365211|FG006|Open-label Extension Period (336 Weeks)|COVID-19 Related|2|||
142952687|NCT02975349|515365205|FG000|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
142952688|NCT02975349|515365206|FG001|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
142952689|NCT02975349|515365207|FG002|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
142952690|NCT02975349|515365208|FG003|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
142952691|NCT02975349|515365209|FG004|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
142952692|NCT02975349|515365210|FG005|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
142952693|NCT02975349|515365211|FG006|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
142952694|NCT02975349|515365205|FG000|Open-label Extension Period (336 Weeks)|Other|0|||
142952695|NCT02975349|515365206|FG001|Open-label Extension Period (336 Weeks)|Other|0|||
142952696|NCT02975349|515365207|FG002|Open-label Extension Period (336 Weeks)|Other|3|||
142952697|NCT02975349|515365208|FG003|Open-label Extension Period (336 Weeks)|Other|3|||
142952698|NCT02975349|515365209|FG004|Open-label Extension Period (336 Weeks)|Other|1|||
142952699|NCT02975349|515365210|FG005|Open-label Extension Period (336 Weeks)|Other|2|||
142952700|NCT02975349|515365211|FG006|Open-label Extension Period (336 Weeks)|Other|3|||
142952701|NCT02975349|515365205|FG000|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
142952702|NCT02975349|515365206|FG001|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
142952703|NCT02975349|515365207|FG002|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
142952704|NCT02975349|515365208|FG003|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|7|||
142952705|NCT02975349|515365209|FG004|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
142952706|NCT02975349|515365210|FG005|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
142952707|NCT02975349|515365211|FG006|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
142952708|NCT02903511|515365212|FG000|Overall Study|Withdrawal by Subject|1|||
142952709|NCT02903511|515365213|FG001|Overall Study|Withdrawal by Subject|0|||
142952710|NCT02903511|515365212|FG000|Overall Study|Lost to Follow-up|3|||
142952711|NCT02903511|515365213|FG001|Overall Study|Lost to Follow-up|2|||
142952712|NCT00907738|515365214|FG000|Overall Study|Adverse Event|2|||
142952713|NCT00907738|515365215|FG001|Overall Study|Adverse Event|0|||
142952714|NCT00907738|515365216|FG002|Overall Study|Adverse Event|1|||
142952715|NCT00907738|515365217|FG003|Overall Study|Adverse Event|0|||
142952716|NCT00907738|515365218|FG004|Overall Study|Adverse Event|0|||
142952717|NCT00907738|515365214|FG000|Overall Study|not specified or withdrew consent|3|||
142952718|NCT00907738|515365215|FG001|Overall Study|not specified or withdrew consent|0|||
142952719|NCT00907738|515365216|FG002|Overall Study|not specified or withdrew consent|0|||
142952720|NCT00907738|515365217|FG003|Overall Study|not specified or withdrew consent|0|||
142952721|NCT00907738|515365218|FG004|Overall Study|not specified or withdrew consent|0|||
142952722|NCT00907738|515365214|FG000|Overall Study|Disease progression|8|||
142952723|NCT00907738|515365215|FG001|Overall Study|Disease progression|1|||
142952724|NCT00907738|515365216|FG002|Overall Study|Disease progression|6|||
142952725|NCT00907738|515365217|FG003|Overall Study|Disease progression|4|||
142952726|NCT00907738|515365218|FG004|Overall Study|Disease progression|2|||
142952727|NCT00486226|515366417|FG000|Overall Study|Death|3|||
142952728|NCT00486226|515366417|FG000|Overall Study|Adverse Event|1|||
142952729|NCT00486226|515366417|FG000|Overall Study|Withdrawal by Subject|1|||
142952730|NCT00486226|515366417|FG000|Overall Study|Lost to Follow-up|8|||
142952731|NCT00521339|515366420|FG000|Treatment Phase|Adverse Event|2|||
142952732|NCT00521339|515366421|FG001|Treatment Phase|Adverse Event|0|||
142952733|NCT00521339|515366422|FG002|Treatment Phase|Adverse Event|0|||
142952734|NCT00521339|515366420|FG000|Treatment Phase|Intolerability to study drug|2|||
142952735|NCT00521339|515366421|FG001|Treatment Phase|Intolerability to study drug|0|||
142952736|NCT00521339|515366422|FG002|Treatment Phase|Intolerability to study drug|0|||
142952737|NCT00521339|515366420|FG000|Treatment Phase|Lack of Efficacy|3|||
142952738|NCT00521339|515366421|FG001|Treatment Phase|Lack of Efficacy|0|||
142952739|NCT00521339|515366422|FG002|Treatment Phase|Lack of Efficacy|0|||
142952740|NCT00521339|515366420|FG000|Treatment Phase|Withdrawal by Subject|3|||
142952741|NCT00521339|515366421|FG001|Treatment Phase|Withdrawal by Subject|0|||
142952742|NCT00521339|515366422|FG002|Treatment Phase|Withdrawal by Subject|0|||
142952743|NCT00521339|515366420|FG000|Treatment Phase|Lost to Follow-up|1|||
142952744|NCT00521339|515366421|FG001|Treatment Phase|Lost to Follow-up|0|||
142952745|NCT00521339|515366422|FG002|Treatment Phase|Lost to Follow-up|0|||
142952746|NCT00521339|515366420|FG000|Treatment Phase|Protocol Violation|1|||
142952747|NCT00521339|515366421|FG001|Treatment Phase|Protocol Violation|0|||
142952748|NCT00521339|515366422|FG002|Treatment Phase|Protocol Violation|0|||
142952749|NCT00521339|515366420|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
142952750|NCT00521339|515366421|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
142952751|NCT00521339|515366422|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
142952752|NCT00521339|515366420|FG000|Treatment Extension Phase|Death|0|||
142952753|NCT00521339|515366421|FG001|Treatment Extension Phase|Death|0|||
142952754|NCT00521339|515366422|FG002|Treatment Extension Phase|Death|1|||
142952755|NCT02940886|515366423|FG000|Overall Study|Adverse Event|7|||
142952756|NCT02940886|515366424|FG001|Overall Study|Adverse Event|3|||
142952757|NCT02940886|515366423|FG000|Overall Study|Protocol Violation|0|||
142952758|NCT02940886|515366424|FG001|Overall Study|Protocol Violation|2|||
142952759|NCT02940886|515366423|FG000|Overall Study|Withdrawal by Subject|28|||
142952760|NCT02940886|515366424|FG001|Overall Study|Withdrawal by Subject|20|||
142952761|NCT02940886|515366423|FG000|Overall Study|Death|1|||
142952762|NCT02940886|515366424|FG001|Overall Study|Death|0|||
142952763|NCT02940886|515366423|FG000|Overall Study|Lack of Efficacy|1|||
142952764|NCT02940886|515366424|FG001|Overall Study|Lack of Efficacy|0|||
142952765|NCT02940886|515366423|FG000|Overall Study|Lost to Follow-up|49|||
142952766|NCT02940886|515366424|FG001|Overall Study|Lost to Follow-up|21|||
142952767|NCT02940886|515366423|FG000|Overall Study|Physician Decision|9|||
142952768|NCT02940886|515366424|FG001|Overall Study|Physician Decision|4|||
142952769|NCT02940886|515366423|FG000|Overall Study|Sponsor decision|0|||
142952770|NCT02940886|515366424|FG001|Overall Study|Sponsor decision|1|||
142952771|NCT02940886|515366423|FG000|Overall Study|No treatment|7|||
142952772|NCT02940886|515366424|FG001|Overall Study|No treatment|2|||
142952773|NCT02940886|515366423|FG000|Overall Study|Enrolment error|0|||
142952774|NCT02940886|515366424|FG001|Overall Study|Enrolment error|1|||
142952775|NCT00634543|515366429|FG000|Overall Study|Other|1|||
142952776|NCT00634543|515366430|FG001|Overall Study|Other|2|||
142952777|NCT00634543|515366429|FG000|Overall Study|Protocol Violation|3|||
142952778|NCT00634543|515366430|FG001|Overall Study|Protocol Violation|3|||
142952779|NCT00634543|515366429|FG000|Overall Study|Adverse Event|11|||
142952780|NCT00634543|515366430|FG001|Overall Study|Adverse Event|11|||
142952781|NCT00634543|515366429|FG000|Overall Study|Withdrawal by Subject|4|||
142952782|NCT00634543|515366430|FG001|Overall Study|Withdrawal by Subject|4|||
142952783|NCT00634543|515366429|FG000|Overall Study|Lost to Follow-up|0|||
142952784|NCT00634543|515366430|FG001|Overall Study|Lost to Follow-up|1|||
142952785|NCT03515538|515366431|FG000|Overall Study|Lack of Efficacy|2|||
142952786|NCT03515538|515366432|FG001|Overall Study|Lack of Efficacy|0|||
142952787|NCT03515538|515366433|FG002|Overall Study|Lack of Efficacy|2|||
142952788|NCT03515538|515366434|FG003|Overall Study|Lack of Efficacy|0|||
142952789|NCT03515538|515366431|FG000|Overall Study|Death|0|||
142952790|NCT03515538|515366432|FG001|Overall Study|Death|0|||
142952791|NCT03515538|515366433|FG002|Overall Study|Death|1|||
142952792|NCT03515538|515366434|FG003|Overall Study|Death|0|||
142952793|NCT03515538|515366431|FG000|Overall Study|Protocol Violation|0|||
142952794|NCT03515538|515366432|FG001|Overall Study|Protocol Violation|0|||
142952795|NCT03515538|515366433|FG002|Overall Study|Protocol Violation|0|||
142952796|NCT03515538|515366434|FG003|Overall Study|Protocol Violation|1|||
142952797|NCT03515538|515366431|FG000|Overall Study|Screen failure (baseline dropout)|0|||
142952798|NCT03515538|515366432|FG001|Overall Study|Screen failure (baseline dropout)|1|||
142952799|NCT03515538|515366433|FG002|Overall Study|Screen failure (baseline dropout)|0|||
142952800|NCT03515538|515366434|FG003|Overall Study|Screen failure (baseline dropout)|0|||
142952801|NCT03515538|515366431|FG000|Overall Study|Withdrawal by Subject|2|||
142952802|NCT03515538|515366432|FG001|Overall Study|Withdrawal by Subject|2|||
142952803|NCT03515538|515366433|FG002|Overall Study|Withdrawal by Subject|1|||
142952804|NCT03515538|515366434|FG003|Overall Study|Withdrawal by Subject|3|||
142952805|NCT03515538|515366431|FG000|Overall Study|Physician Decision|1|||
142952806|NCT03515538|515366432|FG001|Overall Study|Physician Decision|0|||
142952807|NCT03515538|515366433|FG002|Overall Study|Physician Decision|0|||
142952808|NCT03515538|515366434|FG003|Overall Study|Physician Decision|1|||
142952809|NCT02397655|515366442|FG000|Overall Study|data not completed|1301|||
142952810|NCT01736683|515366443|FG000|Overall Study|Disease Relapse|0|||
142952811|NCT01736683|515366444|FG001|Overall Study|Disease Relapse|0|||
142952812|NCT01736683|515366445|FG002|Overall Study|Disease Relapse|2|||
142952813|NCT01736683|515366446|FG003|Overall Study|Disease Relapse|1|||
142952814|NCT01736683|515366447|FG004|Overall Study|Disease Relapse|0|||
142952815|NCT01736683|515366443|FG000|Overall Study|Adverse Event|0|||
142952816|NCT01736683|515366444|FG001|Overall Study|Adverse Event|2|||
142952817|NCT01736683|515366445|FG002|Overall Study|Adverse Event|2|||
142952818|NCT01736683|515366446|FG003|Overall Study|Adverse Event|3|||
142952819|NCT01736683|515366447|FG004|Overall Study|Adverse Event|2|||
142952820|NCT01736683|515366443|FG000|Overall Study|Withdrawal by Subject|0|||
142952821|NCT01736683|515366444|FG001|Overall Study|Withdrawal by Subject|0|||
142952822|NCT01736683|515366445|FG002|Overall Study|Withdrawal by Subject|3|||
142952823|NCT01736683|515366446|FG003|Overall Study|Withdrawal by Subject|1|||
142952824|NCT01736683|515366447|FG004|Overall Study|Withdrawal by Subject|1|||
142952825|NCT01736683|515366443|FG000|Overall Study|Lack of Therapeutic Effect|7|||
142952826|NCT01736683|515366444|FG001|Overall Study|Lack of Therapeutic Effect|4|||
142952827|NCT01736683|515366445|FG002|Overall Study|Lack of Therapeutic Effect|13|||
142952828|NCT01736683|515366446|FG003|Overall Study|Lack of Therapeutic Effect|20|||
142952829|NCT01736683|515366447|FG004|Overall Study|Lack of Therapeutic Effect|1|||
142952830|NCT01736683|515366443|FG000|Overall Study|Progressive Disease|0|||
142952831|NCT01736683|515366444|FG001|Overall Study|Progressive Disease|0|||
142952832|NCT01736683|515366445|FG002|Overall Study|Progressive Disease|0|||
142952833|NCT01736683|515366446|FG003|Overall Study|Progressive Disease|1|||
142952834|NCT01736683|515366447|FG004|Overall Study|Progressive Disease|0|||
142952835|NCT01736683|515366443|FG000|Overall Study|Other|0|||
142952836|NCT01736683|515366444|FG001|Overall Study|Other|0|||
142952837|NCT01736683|515366445|FG002|Overall Study|Other|1|||
142952838|NCT01736683|515366446|FG003|Overall Study|Other|9|||
142952839|NCT01736683|515366447|FG004|Overall Study|Other|1|||
143117488|NCT01472939|515971861|FG000|Overall Study|Withdrawal By PI|1|||
142952840|NCT00098345|515366449|FG000|Overall Study|Adverse Event|7|||
142952841|NCT00098345|515366449|FG000|Overall Study|Withdrawal by Subject|2|||
142952842|NCT00098345|515366449|FG000|Overall Study|progression|4|||
142952843|NCT01183858|515366450|FG000|Overall Study|Death not related to Progressive Disease|5|||
142952844|NCT01183858|515366451|FG001|Overall Study|Death not related to Progressive Disease|6|||
142952845|NCT01183858|515366450|FG000|Overall Study|Adverse Event|14|||
142952846|NCT01183858|515366451|FG001|Overall Study|Adverse Event|11|||
142952847|NCT01183858|515366450|FG000|Overall Study|Investigator's Decision|0|||
142952848|NCT01183858|515366451|FG001|Overall Study|Investigator's Decision|3|||
142952849|NCT01183858|515366450|FG000|Overall Study|Insufficient Therapeutic Response|2|||
142952850|NCT01183858|515366451|FG001|Overall Study|Insufficient Therapeutic Response|0|||
142952851|NCT01183858|515366450|FG000|Overall Study|Refused Treatment|1|||
142952852|NCT01183858|515366451|FG001|Overall Study|Refused Treatment|4|||
142952853|NCT01183858|515366450|FG000|Overall Study|Withdrew Consent|4|||
142952854|NCT01183858|515366451|FG001|Overall Study|Withdrew Consent|4|||
142952855|NCT01183858|515366450|FG000|Overall Study|Discontinued Smoking|3|||
142952856|NCT01183858|515366451|FG001|Overall Study|Discontinued Smoking|1|||
142952857|NCT01183858|515366450|FG000|Overall Study|Protocol Violation|1|||
142952858|NCT01183858|515366451|FG001|Overall Study|Protocol Violation|0|||
142952859|NCT01183858|515366450|FG000|Overall Study|Administrative/Other|6|||
142952860|NCT01183858|515366451|FG001|Overall Study|Administrative/Other|6|||
142952861|NCT01183858|515366450|FG000|Overall Study|Progressive Disease|112|||
142952862|NCT01183858|515366451|FG001|Overall Study|Progressive Disease|115|||
142952863|NCT01183858|515366450|FG000|Overall Study|Death related to Progressive Disease|4|||
142952864|NCT01183858|515366451|FG001|Overall Study|Death related to Progressive Disease|5|||
142952865|NCT01183858|515366450|FG000|Overall Study|Lost to Follow-up|1|||
142952866|NCT01183858|515366451|FG001|Overall Study|Lost to Follow-up|1|||
142952867|NCT01295905|515366456|FG000|Overall Study|Did not meet inclusion criteria|1|||
142952868|NCT01295905|515366457|FG001|Overall Study|Did not meet inclusion criteria|0|||
142952869|NCT01295905|515366456|FG000|Overall Study|Met exclusion criteria|1|||
142952870|NCT01295905|515366457|FG001|Overall Study|Met exclusion criteria|0|||
142952871|NCT03707977|515366458|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
142952872|NCT03707977|515366459|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
142952873|NCT03707977|515366460|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
142952874|NCT03707977|515366458|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
142952875|NCT03707977|515366459|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
142952876|NCT03707977|515366460|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
142952877|NCT00641147|515366461|FG000|Completed 4 Months.|Physician Decision|1|||
142952878|NCT00641147|515366462|FG001|Completed 4 Months.|Physician Decision|0|||
142952879|NCT00641147|515366461|FG000|Completed 4 Months.|Adverse Event|1|||
142952880|NCT00641147|515366462|FG001|Completed 4 Months.|Adverse Event|0|||
142952881|NCT00641147|515366461|FG000|Completed 8 Months.|Physician Decision|2|||
142952882|NCT00641147|515366462|FG001|Completed 8 Months.|Physician Decision|1|||
142952883|NCT00641147|515366461|FG000|Completed 8 Months.|non compliance|1|||
142952884|NCT00641147|515366462|FG001|Completed 8 Months.|non compliance|0|||
142952885|NCT00641147|515366461|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
142952886|NCT00641147|515366462|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
142952887|NCT00641147|515366461|FG000|Completed 12 Months.|Physician Decision|1|||
142952888|NCT00641147|515366462|FG001|Completed 12 Months.|Physician Decision|1|||
142952889|NCT00641147|515366461|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
142952890|NCT00641147|515366462|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
142952891|NCT00641147|515366461|FG000|Completed 16 Months.|Physician Decision|1|||
142952892|NCT00641147|515366462|FG001|Completed 16 Months.|Physician Decision|0|||
142952893|NCT00641147|515366461|FG000|Completed 16 Months.|Lost to Follow-up|1|||
142952894|NCT00641147|515366462|FG001|Completed 16 Months.|Lost to Follow-up|0|||
142952895|NCT00791128|515366463|FG000|Overall Study|Adverse Event|4|||
142952896|NCT00791128|515366463|FG000|Overall Study|Device migration|2|||
142952897|NCT00791128|515366463|FG000|Overall Study|non-compliance by subject|2|||
142952898|NCT00791128|515366463|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
142952899|NCT01629667|515366464|FG000|Overall Study|Lost to Follow-up|0|||
142952900|NCT01629667|515366465|FG001|Overall Study|Lost to Follow-up|1|||
142952901|NCT01629667|515366466|FG002|Overall Study|Lost to Follow-up|1|||
142952902|NCT01629667|515366464|FG000|Overall Study|Withdrawal by Subject|31|||
142952903|NCT01629667|515366465|FG001|Overall Study|Withdrawal by Subject|20|||
142952904|NCT01629667|515366466|FG002|Overall Study|Withdrawal by Subject|28|||
142952905|NCT01629667|515366464|FG000|Overall Study|Death|1|||
142952906|NCT01629667|515366465|FG001|Overall Study|Death|5|||
142952907|NCT01629667|515366466|FG002|Overall Study|Death|3|||
142952908|NCT01629667|515366464|FG000|Overall Study|Randomized, not treated|2|||
142952909|NCT01629667|515366465|FG001|Overall Study|Randomized, not treated|1|||
142952910|NCT01629667|515366466|FG002|Overall Study|Randomized, not treated|0|||
142952911|NCT01629667|515366464|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
142952912|NCT01629667|515366465|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
143117130|NCT01273155|515970038|FG000|Overall Study|Change in liver function/no longer eval.|0|||
142952913|NCT01629667|515366466|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
142952914|NCT01629667|515366464|FG000|Overall Study|Requiring lung transplant|2|||
142952915|NCT01629667|515366465|FG001|Overall Study|Requiring lung transplant|1|||
142952916|NCT01629667|515366466|FG002|Overall Study|Requiring lung transplant|3|||
142952917|NCT01629667|515366464|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
142952918|NCT01629667|515366465|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
142952919|NCT01629667|515366466|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
142952920|NCT01629667|515366464|FG000|Overall Study|Started other medicine|1|||
142952921|NCT01629667|515366465|FG001|Overall Study|Started other medicine|0|||
142952922|NCT01629667|515366466|FG002|Overall Study|Started other medicine|1|||
142952923|NCT01629667|515366464|FG000|Overall Study|Site error in safety follow-up|0|||
142952924|NCT01629667|515366465|FG001|Overall Study|Site error in safety follow-up|0|||
142952925|NCT01629667|515366466|FG002|Overall Study|Site error in safety follow-up|1|||
142952926|NCT01629667|515366464|FG000|Overall Study|Enrolled in another clinical study|0|||
142952927|NCT01629667|515366465|FG001|Overall Study|Enrolled in another clinical study|1|||
142952928|NCT01629667|515366466|FG002|Overall Study|Enrolled in another clinical study|0|||
142952929|NCT01629667|515366464|FG000|Overall Study|Code break|1|||
142952930|NCT01629667|515366465|FG001|Overall Study|Code break|0|||
142952931|NCT01629667|515366466|FG002|Overall Study|Code break|0|||
142952932|NCT00984659|515366467|FG000|2-week Run-in Period|Adverse Event|8|||
142952933|NCT00984659|515366468|FG001|2-week Run-in Period|Adverse Event|0|||
142952934|NCT00984659|515366469|FG002|2-week Run-in Period|Adverse Event|0|||
142952935|NCT00984659|515366470|FG003|2-week Run-in Period|Adverse Event|0|||
142952936|NCT00984659|515366467|FG000|2-week Run-in Period|Protocol Violation|5|||
142952937|NCT00984659|515366468|FG001|2-week Run-in Period|Protocol Violation|0|||
142952938|NCT00984659|515366469|FG002|2-week Run-in Period|Protocol Violation|0|||
142952939|NCT00984659|515366470|FG003|2-week Run-in Period|Protocol Violation|0|||
142952940|NCT00984659|515366467|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
142952941|NCT00984659|515366468|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
142952942|NCT00984659|515366469|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
142952943|NCT00984659|515366470|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
142952944|NCT00984659|515366467|FG000|2-week Run-in Period|Lost to Follow-up|3|||
142952945|NCT00984659|515366468|FG001|2-week Run-in Period|Lost to Follow-up|0|||
142952946|NCT00984659|515366469|FG002|2-week Run-in Period|Lost to Follow-up|0|||
142952947|NCT00984659|515366470|FG003|2-week Run-in Period|Lost to Follow-up|0|||
142952948|NCT00984659|515366467|FG000|2-week Run-in Period|Physician Decision|10|||
142952949|NCT00984659|515366468|FG001|2-week Run-in Period|Physician Decision|0|||
142952950|NCT00984659|515366469|FG002|2-week Run-in Period|Physician Decision|0|||
142952951|NCT00984659|515366470|FG003|2-week Run-in Period|Physician Decision|0|||
142952952|NCT00984659|515366467|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
142952953|NCT00984659|515366468|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
142952954|NCT00984659|515366469|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
142952955|NCT00984659|515366470|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
142952956|NCT00984659|515366467|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
142952957|NCT00984659|515366468|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
142952958|NCT00984659|515366469|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
142952959|NCT00984659|515366470|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
142952960|NCT00984659|515366467|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
142952961|NCT00984659|515366468|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
142952962|NCT00984659|515366469|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
142952963|NCT00984659|515366470|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
142952964|NCT00984659|515366467|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
142952965|NCT00984659|515366468|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
142952966|NCT00984659|515366469|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
142952967|NCT00984659|515366470|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
142952968|NCT00984659|515366467|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
142952969|NCT00984659|515366468|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
142952970|NCT00984659|515366469|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
142952971|NCT00984659|515366470|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
142952972|NCT00984659|515366467|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
142952973|NCT00984659|515366468|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
142952974|NCT00984659|515366469|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
142952975|NCT00984659|515366470|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
142952976|NCT00984659|515366467|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
142952977|NCT00984659|515366468|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
142952978|NCT00984659|515366469|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
142952979|NCT00984659|515366470|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
143117489|NCT01472939|515971862|FG001|Overall Study|Withdrawal By PI|0|||
142952980|NCT00609609|515366475|FG000|Overall Study|Withdrawal by Subject|2|||
142952981|NCT00609609|515366476|FG001|Overall Study|Withdrawal by Subject|0|||
142952982|NCT00609609|515366475|FG000|Overall Study|Progression|4|||
142952983|NCT00609609|515366476|FG001|Overall Study|Progression|2|||
142952984|NCT00670111|515366477|FG000|Enrollment to One Month|Testing Failure|0|||
142952985|NCT00670111|515366478|FG001|Enrollment to One Month|Testing Failure|0|||
142952986|NCT00670111|515366479|FG002|Enrollment to One Month|Testing Failure|13|||
143003115|NCT01049360|515548747|FG003|Period 2|Protocol Violation|1|||
142952987|NCT00670111|515366477|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
142952988|NCT00670111|515366478|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
142952989|NCT00670111|515366479|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
142952990|NCT00670111|515366477|FG000|Enrollment to One Month|Physician Decision|1|||
142952991|NCT00670111|515366478|FG001|Enrollment to One Month|Physician Decision|0|||
142952992|NCT00670111|515366479|FG002|Enrollment to One Month|Physician Decision|0|||
142952993|NCT03988751|515366480|FG000|Overall Study|Withdrawal by Subject|1|||
142952994|NCT03988751|515366481|FG001|Overall Study|Withdrawal by Subject|0|||
142952995|NCT03988751|515366480|FG000|Overall Study|Protocol Violation|0|||
142952996|NCT03988751|515366481|FG001|Overall Study|Protocol Violation|1|||
142952997|NCT02623361|515366482|FG000|Overall Study|Protocol Violation|0|||
142952998|NCT02623361|515366483|FG001|Overall Study|Protocol Violation|1|||
142952999|NCT02623361|515366482|FG000|Overall Study|Withdrawal by Subject|0|||
142953000|NCT02623361|515366483|FG001|Overall Study|Withdrawal by Subject|1|||
142953001|NCT02441803|515366485|FG000|Overall Study|Physician Decision|0|||
142953002|NCT02441803|515366486|FG001|Overall Study|Physician Decision|2|||
142953003|NCT02441803|515366487|FG002|Overall Study|Physician Decision|2|||
142953004|NCT00537823|515366490|FG000|Overall Study|Adverse Event|2|||
142953005|NCT00537823|515366491|FG001|Overall Study|Adverse Event|0|||
142953006|NCT03065530|515366492|FG000|Overall Study|Lack of Efficacy|1|||
142953007|NCT03065530|515366493|FG001|Overall Study|Lack of Efficacy|1|||
142953008|NCT03065530|515366494|FG002|Overall Study|Lack of Efficacy|0|||
142953009|NCT03065530|515366495|FG003|Overall Study|Lack of Efficacy|1|||
142953010|NCT03065530|515366492|FG000|Overall Study|Protocol Violation|1|||
142953011|NCT03065530|515366493|FG001|Overall Study|Protocol Violation|0|||
142953012|NCT03065530|515366494|FG002|Overall Study|Protocol Violation|1|||
142953013|NCT03065530|515366495|FG003|Overall Study|Protocol Violation|1|||
142953014|NCT02873221|515366496|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
142953015|NCT02873221|515366497|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
142953016|NCT02873221|515366498|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
142953017|NCT02873221|515366496|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
142953018|NCT02873221|515366497|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
142953019|NCT02873221|515366498|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
142953020|NCT02873221|515366496|FG000|Treatment Period|Protocol Violation|2|||
142953021|NCT02873221|515366497|FG001|Treatment Period|Protocol Violation|5|||
142953022|NCT02873221|515366498|FG002|Treatment Period|Protocol Violation|8|||
142953023|NCT02873221|515366496|FG000|Treatment Period|Pregnancy|4|||
142953024|NCT02873221|515366497|FG001|Treatment Period|Pregnancy|6|||
142953025|NCT02873221|515366498|FG002|Treatment Period|Pregnancy|3|||
142953026|NCT02873221|515366496|FG000|Treatment Period|Lack of Qualifying Event|0|||
142953027|NCT02873221|515366497|FG001|Treatment Period|Lack of Qualifying Event|3|||
142953028|NCT02873221|515366498|FG002|Treatment Period|Lack of Qualifying Event|1|||
142953029|NCT02873221|515366496|FG000|Treatment Period|Withdrawal of Consent|52|||
142953030|NCT02873221|515366497|FG001|Treatment Period|Withdrawal of Consent|51|||
142953031|NCT02873221|515366498|FG002|Treatment Period|Withdrawal of Consent|41|||
142953032|NCT02873221|515366496|FG000|Treatment Period|Lack of Efficacy|0|||
142953033|NCT02873221|515366497|FG001|Treatment Period|Lack of Efficacy|17|||
142953034|NCT02873221|515366498|FG002|Treatment Period|Lack of Efficacy|12|||
142953035|NCT02873221|515366496|FG000|Treatment Period|Adverse Event|4|||
142953036|NCT02873221|515366497|FG001|Treatment Period|Adverse Event|9|||
142953037|NCT02873221|515366498|FG002|Treatment Period|Adverse Event|11|||
142953038|NCT02873221|515366496|FG000|Treatment Period|Lost to Follow-up|26|||
142953039|NCT02873221|515366497|FG001|Treatment Period|Lost to Follow-up|30|||
142953040|NCT02873221|515366498|FG002|Treatment Period|Lost to Follow-up|26|||
142953041|NCT02873221|515366496|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
142953042|NCT02873221|515366497|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
142953043|NCT02873221|515366498|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
142953044|NCT02873221|515366496|FG000|Safety Follow-up Period|Protocol Violation|0|||
142953045|NCT02873221|515366497|FG001|Safety Follow-up Period|Protocol Violation|0|||
142953046|NCT02873221|515366498|FG002|Safety Follow-up Period|Protocol Violation|1|||
142953047|NCT02873221|515366496|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
142953048|NCT02873221|515366497|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
142953049|NCT02873221|515366498|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
142953050|NCT02873221|515366496|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
142953051|NCT02873221|515366497|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
142953052|NCT02873221|515366498|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
142953053|NCT00328198|515366499|FG000|Treatment|Adverse Event|21|||
142953054|NCT00328198|515366499|FG000|Treatment|Death|1|||
142953055|NCT00328198|515366499|FG000|Treatment|Physician Decision|5|||
142953056|NCT00328198|515366499|FG000|Treatment|Withdrawal by Subject|5|||
142953057|NCT00328198|515366499|FG000|Treatment|Evidence of disease progression|2|||
142953058|NCT00328198|515366499|FG000|Treatment|Non-compliance|1|||
142953059|NCT00328198|515366499|FG000|Treatment|Confirmed complete response, MRD -|3|||
142953060|NCT00328198|515366499|FG000|Follow-up|Lost to Follow-up|4|||
142953061|NCT00328198|515366499|FG000|Follow-up|Death|31|||
142953062|NCT02717546|515366503|FG000|Overall Study|Lost to Follow-up|12|||
142953063|NCT02052960|515366510|FG000|Overall Study|Adverse Event|19|||
142953064|NCT02052960|515366511|FG001|Overall Study|Adverse Event|17|||
142953065|NCT02052960|515366510|FG000|Overall Study|Protocol Violation|4|||
142953066|NCT02052960|515366511|FG001|Overall Study|Protocol Violation|3|||
142953067|NCT02052960|515366510|FG000|Overall Study|Withdrawal by Subject|6|||
142953068|NCT02052960|515366511|FG001|Overall Study|Withdrawal by Subject|11|||
142953069|NCT02052960|515366510|FG000|Overall Study|Other|25|||
142953070|NCT02052960|515366511|FG001|Overall Study|Other|15|||
142953071|NCT02675517|515366512|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
142953072|NCT02675517|515366512|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
142953073|NCT01707147|515366518|FG000|Overall Study|Administered Trajenta prior to contract|5|||
142953074|NCT01707147|515366518|FG000|Overall Study|Patients who have not taken Trajenta|1|||
142953075|NCT01707147|515366518|FG000|Overall Study|Follow-up failure|17|||
142953076|NCT01707147|515366518|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
142953077|NCT00377299|515366519|FG000|Overall Study|Lost to Follow-up|14|||
142953078|NCT00377299|515366520|FG001|Overall Study|Lost to Follow-up|19|||
142953079|NCT00377299|515366519|FG000|Overall Study|Adverse Event|0|||
142953080|NCT00377299|515366520|FG001|Overall Study|Adverse Event|1|||
142953081|NCT00377299|515366519|FG000|Overall Study|Withdrawal by Subject|5|||
142953082|NCT00377299|515366520|FG001|Overall Study|Withdrawal by Subject|4|||
142953083|NCT01507246|515366523|FG000|Overall Study|Required different surgical procedures|2|||
142953084|NCT01507246|515366524|FG001|Overall Study|Required different surgical procedures|1|||
142953085|NCT05363293|515366525|FG000|Overall Study|Withdrawal by Subject|1|||
142953086|NCT05363293|515366526|FG001|Overall Study|Withdrawal by Subject|0|||
142953087|NCT05363293|515366527|FG002|Overall Study|Withdrawal by Subject|0|||
142953088|NCT05363293|515366528|FG003|Overall Study|Withdrawal by Subject|0|||
142953089|NCT05363293|515366529|FG004|Overall Study|Withdrawal by Subject|0|||
142953090|NCT05363293|515366530|FG005|Overall Study|Withdrawal by Subject|0|||
142953091|NCT05363293|515366531|FG006|Overall Study|Withdrawal by Subject|0|||
142953092|NCT05363293|515366532|FG007|Overall Study|Withdrawal by Subject|0|||
142953093|NCT05363293|515366533|FG008|Overall Study|Withdrawal by Subject|0|||
142953094|NCT05363293|515366534|FG009|Overall Study|Withdrawal by Subject|0|||
142953095|NCT05243550|515368041|FG000|Overall Study|Ongoing in the Study|171|||
142953096|NCT05243550|515368041|FG000|Overall Study|Withdrawal by Subject|10|||
142953097|NCT05243550|515368041|FG000|Overall Study|Lost to Follow-up|7|||
142953098|NCT05243550|515368041|FG000|Overall Study|Adverse Event|3|||
142953099|NCT05243550|515368041|FG000|Overall Study|Noncompliance|1|||
142953100|NCT05243550|515368041|FG000|Overall Study|Physician Decision|1|||
142953101|NCT05243550|515368041|FG000|Overall Study|Other Reason|4|||
142953102|NCT01894516|515368042|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
142953103|NCT01894516|515368043|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
142953104|NCT01894516|515368044|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
142953105|NCT01894516|515368045|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
142953106|NCT01894516|515368042|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
142953107|NCT01894516|515368043|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
142953108|NCT01894516|515368044|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
142953109|NCT01894516|515368045|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
142953110|NCT01894516|515368042|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
142953111|NCT01894516|515368043|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
142953112|NCT01894516|515368044|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
142953113|NCT01894516|515368045|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
142953114|NCT01894516|515368042|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
142953115|NCT01894516|515368043|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
142953116|NCT01894516|515368044|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
142953117|NCT01894516|515368045|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
142953118|NCT01894516|515368042|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
142953119|NCT01894516|515368043|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
143455146|NCT01879722|517210782|FG004|Overall Study|Voluntary Withdrawal|0|||
143455147|NCT01879722|517210783|FG005|Overall Study|Voluntary Withdrawal|0|||
143455148|NCT01879722|517210784|FG006|Overall Study|Voluntary Withdrawal|0|||
143455149|NCT01879722|517210785|FG007|Overall Study|Voluntary Withdrawal|0|||
143455150|NCT01879722|517210786|FG008|Overall Study|Voluntary Withdrawal|1|||
143455151|NCT01879722|517210787|FG009|Overall Study|Voluntary Withdrawal|0|||
142953120|NCT01894516|515368044|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
142953121|NCT01894516|515368045|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
142953122|NCT01894516|515368042|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
142953123|NCT01894516|515368043|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
142953124|NCT01894516|515368044|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
142953125|NCT01894516|515368045|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
142953126|NCT01894516|515368042|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
142953127|NCT01894516|515368043|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
143455152|NCT01983254|517210788|FG000|Overall Study|Death|6|||
142953128|NCT01894516|515368044|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
142953129|NCT01894516|515368045|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
142953130|NCT01894516|515368042|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
142953131|NCT01894516|515368043|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
142953132|NCT01894516|515368044|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
142953133|NCT01894516|515368045|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
142953134|NCT01486316|515368048|FG000|Overall Study|Device explanted with/without re-implant|3|||
142953135|NCT01486316|515368049|FG001|Overall Study|Device explanted with/without re-implant|2|||
142953136|NCT01486316|515368050|FG002|Overall Study|Device explanted with/without re-implant|0|||
142953137|NCT01486316|515368051|FG003|Overall Study|Device explanted with/without re-implant|2|||
142953138|NCT01486316|515368048|FG000|Overall Study|Not meeting eligibility criteria|0|||
142953139|NCT01486316|515368049|FG001|Overall Study|Not meeting eligibility criteria|0|||
142953140|NCT01486316|515368050|FG002|Overall Study|Not meeting eligibility criteria|1|||
142953141|NCT01486316|515368051|FG003|Overall Study|Not meeting eligibility criteria|0|||
142953142|NCT01486316|515368048|FG000|Overall Study|Withdrawal by Subject|1|||
142953143|NCT01486316|515368049|FG001|Overall Study|Withdrawal by Subject|0|||
142953144|NCT01486316|515368050|FG002|Overall Study|Withdrawal by Subject|3|||
142953145|NCT01486316|515368051|FG003|Overall Study|Withdrawal by Subject|0|||
142953146|NCT01486316|515368048|FG000|Overall Study|Physician Decision|0|||
142953147|NCT01486316|515368049|FG001|Overall Study|Physician Decision|0|||
142953148|NCT01486316|515368050|FG002|Overall Study|Physician Decision|1|||
142953149|NCT01486316|515368051|FG003|Overall Study|Physician Decision|0|||
142953150|NCT01486316|515368048|FG000|Overall Study|Death|0|||
142953151|NCT01486316|515368049|FG001|Overall Study|Death|1|||
142953152|NCT01486316|515368050|FG002|Overall Study|Death|0|||
142953153|NCT01486316|515368051|FG003|Overall Study|Death|0|||
142953154|NCT00375934|515368059|FG000|Overall Study|Adverse Event|1|||
142953155|NCT00375934|515368060|FG001|Overall Study|Adverse Event|1|||
142953156|NCT00375934|515368059|FG000|Overall Study|Withdrawal by Subject|2|||
142953157|NCT00375934|515368060|FG001|Overall Study|Withdrawal by Subject|2|||
142953158|NCT00375934|515368059|FG000|Overall Study|Lack of Efficacy|0|||
142953159|NCT00375934|515368060|FG001|Overall Study|Lack of Efficacy|2|||
142953160|NCT00375934|515368059|FG000|Overall Study|Physician Decision|0|||
142953161|NCT00375934|515368060|FG001|Overall Study|Physician Decision|1|||
142953162|NCT03191396|515368061|FG000|Overall Study|Lost to Follow-up|0|||
142953163|NCT03191396|515368062|FG001|Overall Study|Lost to Follow-up|3|||
142953164|NCT03191396|515368061|FG000|Overall Study|Withdrawal by Subject|3|||
142953165|NCT03191396|515368062|FG001|Overall Study|Withdrawal by Subject|2|||
142953166|NCT00893113|515368065|FG000|Overall Study|Lost to Follow-up|4|||
142953167|NCT00893113|515368066|FG001|Overall Study|Lost to Follow-up|8|||
142953168|NCT00893113|515368065|FG000|Overall Study|Early Termination|1|||
142953169|NCT00893113|515368066|FG001|Overall Study|Early Termination|1|||
142953170|NCT00893113|515368065|FG000|Overall Study|Withdrew Consent|8|||
142953171|NCT00893113|515368066|FG001|Overall Study|Withdrew Consent|7|||
142953172|NCT03270085|515368067|FG000|Overall Study|Withdrawal by Subject|1|||
142953173|NCT03270085|515368068|FG001|Overall Study|Withdrawal by Subject|0|||
142953174|NCT00151411|515368072|FG000|Overall Study|Lost to Follow-up|15|||
142953175|NCT00151411|515368073|FG001|Overall Study|Lost to Follow-up|19|||
142953176|NCT00151411|515368072|FG000|Overall Study|Withdrawal by Subject|12|||
142953177|NCT00151411|515368073|FG001|Overall Study|Withdrawal by Subject|20|||
142953178|NCT00151411|515368072|FG000|Overall Study|Adverse Event|6|||
142953179|NCT00151411|515368073|FG001|Overall Study|Adverse Event|0|||
142953180|NCT00151411|515368072|FG000|Overall Study|Pregnancy|0|||
142953181|NCT00151411|515368073|FG001|Overall Study|Pregnancy|4|||
142953182|NCT01283581|515368074|FG000|Overall Study|Lost to Follow-up|8|||
142953183|NCT01283581|515368075|FG001|Overall Study|Lost to Follow-up|6|||
142953184|NCT01283581|515368076|FG002|Overall Study|Lost to Follow-up|8|||
142953185|NCT01283581|515368074|FG000|Overall Study|Withdrawal by Subject|2|||
142953186|NCT01283581|515368075|FG001|Overall Study|Withdrawal by Subject|5|||
142953187|NCT01283581|515368076|FG002|Overall Study|Withdrawal by Subject|2|||
142953188|NCT01283581|515368074|FG000|Overall Study|Adverse Event|1|||
142953189|NCT01283581|515368075|FG001|Overall Study|Adverse Event|1|||
142953190|NCT01283581|515368076|FG002|Overall Study|Adverse Event|4|||
142953191|NCT01283581|515368074|FG000|Overall Study|Physician Decision|0|||
142953192|NCT01283581|515368075|FG001|Overall Study|Physician Decision|1|||
142953193|NCT01283581|515368076|FG002|Overall Study|Physician Decision|2|||
142953194|NCT01283581|515368074|FG000|Overall Study|Protocol Violation|0|||
142953195|NCT01283581|515368075|FG001|Overall Study|Protocol Violation|1|||
142953196|NCT01283581|515368076|FG002|Overall Study|Protocol Violation|2|||
142953197|NCT01283581|515368074|FG000|Overall Study|Noncompliance|1|||
142953198|NCT01283581|515368075|FG001|Overall Study|Noncompliance|0|||
142953199|NCT01283581|515368076|FG002|Overall Study|Noncompliance|0|||
142953200|NCT01283581|515368074|FG000|Overall Study|Investigator unblinded|0|||
142953201|NCT01283581|515368075|FG001|Overall Study|Investigator unblinded|0|||
142953202|NCT01283581|515368076|FG002|Overall Study|Investigator unblinded|1|||
143455153|NCT01983254|517210789|FG001|Overall Study|Death|6|||
143455154|NCT01983254|517210788|FG000|Overall Study|Lost to Follow-up|17|||
142953203|NCT01283581|515368074|FG000|Overall Study|"Early termination"|0|||
142953204|NCT01283581|515368075|FG001|Overall Study|"Early termination"|0|||
142953205|NCT01283581|515368076|FG002|Overall Study|"Early termination"|1|||
142953206|NCT01712438|515368077|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
142953207|NCT01712438|515368077|FG000|Overall Study|Ongoing ITI treatment|6|||
142953208|NCT01712438|515368077|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
142953209|NCT01712438|515368077|FG000|Overall Study|Prematurely Discontinued|25|||
142953210|NCT01259492|515368078|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
142953211|NCT01259492|515368079|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
142953212|NCT01259492|515368080|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
142953213|NCT01259492|515368081|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
142953214|NCT01259492|515368078|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
142953215|NCT01259492|515368079|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
142953216|NCT01259492|515368080|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
142953217|NCT01259492|515368081|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
142953218|NCT01259492|515368078|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
142953219|NCT01259492|515368079|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
142953220|NCT01259492|515368080|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
142953221|NCT01259492|515368081|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
142953222|NCT01259492|515368078|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
142953223|NCT01259492|515368079|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
142953224|NCT01259492|515368080|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
142953225|NCT01259492|515368081|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
142953226|NCT01259492|515368078|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
142953227|NCT01259492|515368079|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
142953228|NCT01259492|515368080|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
142953229|NCT01259492|515368081|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
142953230|NCT01259492|515368078|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
142953231|NCT01259492|515368079|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
142953232|NCT01259492|515368080|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
142953233|NCT01259492|515368081|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
142953234|NCT01259492|515368078|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
142953235|NCT01259492|515368079|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
142953236|NCT01259492|515368080|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
142953237|NCT01259492|515368081|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
142953238|NCT01259492|515368078|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
142953239|NCT01259492|515368079|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
142953240|NCT01259492|515368080|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
142953241|NCT01259492|515368081|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
142953242|NCT01259492|515368078|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
142953243|NCT01259492|515368079|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
142953244|NCT01259492|515368080|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
142953245|NCT01259492|515368081|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
142953246|NCT01259492|515368078|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
142953247|NCT01259492|515368079|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
142953248|NCT01259492|515368080|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
142953249|NCT01259492|515368081|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
142953250|NCT01259492|515368078|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
142953251|NCT01259492|515368079|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
142953252|NCT01259492|515368080|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
142953253|NCT01259492|515368081|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
142953254|NCT01259492|515368078|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
142953255|NCT01259492|515368079|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
142953256|NCT01259492|515368080|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
142953257|NCT01259492|515368081|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
142953258|NCT01259492|515368078|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
142953259|NCT01259492|515368079|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
142953260|NCT01259492|515368080|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
142953261|NCT01259492|515368081|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
142953262|NCT01259492|515368078|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
142953263|NCT01259492|515368079|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
142953264|NCT01259492|515368080|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
142953265|NCT01259492|515368081|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
142953266|NCT01259492|515368078|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
142953267|NCT01259492|515368079|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
142953268|NCT01259492|515368080|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
142953269|NCT01259492|515368081|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
142953270|NCT01259492|515368078|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
143003116|NCT01049360|515548748|FG004|Period 2|Protocol Violation|0|||
143117131|NCT01273155|515970039|FG001|Overall Study|Change in liver function/no longer eval.|1|||
142953271|NCT01259492|515368079|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
142953272|NCT01259492|515368080|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
142953273|NCT01259492|515368081|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
142953274|NCT01259492|515368078|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
142953275|NCT01259492|515368079|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
142953276|NCT01259492|515368080|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
142953277|NCT01259492|515368081|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
142953278|NCT01259492|515368078|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
142953279|NCT01259492|515368079|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
142953280|NCT01259492|515368080|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
142953281|NCT01259492|515368081|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
142953282|NCT01259492|515368078|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
142953283|NCT01259492|515368079|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
142953284|NCT01259492|515368080|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
142953285|NCT01259492|515368081|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
142953286|NCT01259492|515368078|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
142953287|NCT01259492|515368079|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
142953288|NCT01259492|515368080|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
142953289|NCT01259492|515368081|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
142953290|NCT01981122|515368082|FG000|Overall Study|Withdrawal by Subject|0|||
142953291|NCT01981122|515368083|FG001|Overall Study|Withdrawal by Subject|2|||
142953292|NCT01981122|515368082|FG000|Overall Study|Protocol Violation|0|||
142953293|NCT01981122|515368083|FG001|Overall Study|Protocol Violation|1|||
142953294|NCT01981122|515368082|FG000|Overall Study|Lost to Follow-up|0|||
142953295|NCT01981122|515368083|FG001|Overall Study|Lost to Follow-up|1|||
142953296|NCT01981122|515368082|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
142953297|NCT01981122|515368083|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
142953298|NCT01981122|515368082|FG000|Overall Study|Death|14|||
142953299|NCT01981122|515368083|FG001|Overall Study|Death|15|||
142953300|NCT00500149|515368089|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
142953301|NCT00500149|515368090|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
142953302|NCT00500149|515368089|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
142953303|NCT00500149|515368090|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
142953304|NCT00500149|515368089|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
142953305|NCT00500149|515368090|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
142953306|NCT00500149|515368089|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
142953307|NCT00500149|515368090|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
142953308|NCT00500149|515368089|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
142953309|NCT00500149|515368090|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
142953310|NCT00500149|515368089|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
142953311|NCT00500149|515368090|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
142953312|NCT00500149|515368089|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
142953313|NCT00500149|515368090|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
142953314|NCT01157169|515368093|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
142953315|NCT01157169|515368094|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
142953316|NCT01157169|515368093|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
142953317|NCT01157169|515368094|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
142953318|NCT01277289|515368095|FG000|Overall Study|fragile vein|1|||
142953319|NCT01277289|515368096|FG001|Overall Study|fragile vein|0|||
142953320|NCT01277289|515368095|FG000|Overall Study|Physician Decision|1|||
142953321|NCT01277289|515368096|FG001|Overall Study|Physician Decision|0|||
142953322|NCT01277289|515368095|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
142953323|NCT01277289|515368096|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
142953324|NCT01277289|515368095|FG000|Overall Study|Protocol Violation|1|||
142953325|NCT01277289|515368096|FG001|Overall Study|Protocol Violation|1|||
142953326|NCT01277289|515368095|FG000|Overall Study|Adverse Event|2|||
142953327|NCT01277289|515368096|FG001|Overall Study|Adverse Event|1|||
142953328|NCT01277289|515368095|FG000|Overall Study|consent withdrawn|1|||
142953329|NCT01277289|515368096|FG001|Overall Study|consent withdrawn|1|||
142953330|NCT01277289|515368095|FG000|Overall Study|premature closure of the study|4|||
142953331|NCT01277289|515368096|FG001|Overall Study|premature closure of the study|2|||
142953332|NCT00092547|515368097|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
142953333|NCT00092547|515368098|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
142953334|NCT00092547|515368099|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
142953335|NCT00092547|515368097|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
142953336|NCT00092547|515368098|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
142953337|NCT00092547|515368099|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
142953338|NCT00092547|515368097|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
142953339|NCT00092547|515368098|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
142953340|NCT00092547|515368099|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
142953341|NCT00092547|515368097|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
142953342|NCT00092547|515368098|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
142953343|NCT00092547|515368099|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
142953344|NCT00092547|515368097|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
142953345|NCT00092547|515368098|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
142953346|NCT00092547|515368099|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
142953347|NCT00092547|515368097|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
142953348|NCT00092547|515368098|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
142953349|NCT00092547|515368099|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
142953350|NCT00092547|515368097|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
142953351|NCT00092547|515368098|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
142953352|NCT00092547|515368099|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
142953353|NCT00092547|515368097|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
142953354|NCT00092547|515368098|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
142953355|NCT00092547|515368099|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
142953356|NCT00092547|515368097|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
142953357|NCT00092547|515368098|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
142953358|NCT00092547|515368099|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
142953359|NCT00092547|515368097|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
142953360|NCT00092547|515368098|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
142953361|NCT00092547|515368099|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
142953362|NCT00092547|515368097|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
142953363|NCT00092547|515368098|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
142953364|NCT00092547|515368099|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
142953365|NCT00092547|515368097|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
142953366|NCT00092547|515368098|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
142953367|NCT00092547|515368099|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
142953368|NCT00092547|515368097|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
142953369|NCT00092547|515368098|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
142953370|NCT00092547|515368099|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
142953371|NCT00092547|515368097|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
142953372|NCT00092547|515368098|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
142953373|NCT00092547|515368099|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
142953374|NCT00092547|515368097|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
142953375|NCT00092547|515368098|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
142953376|NCT00092547|515368099|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
142953377|NCT00092547|515368097|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
142953378|NCT00092547|515368098|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
142953379|NCT00092547|515368099|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
142953380|NCT00092547|515368097|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
142953381|NCT00092547|515368098|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
142953382|NCT00092547|515368099|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
142953383|NCT00092547|515368097|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
142953384|NCT00092547|515368098|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
142953385|NCT00092547|515368099|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
142953386|NCT00092547|515368097|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
142953387|NCT00092547|515368098|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
142953388|NCT00092547|515368099|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
142953389|NCT00092547|515368097|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
142953390|NCT00092547|515368098|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
142953391|NCT00092547|515368099|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
142953392|NCT00092547|515368097|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
142953393|NCT00092547|515368098|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
142953394|NCT00092547|515368099|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
142953395|NCT00414440|515368103|FG000|Core Period|Withdrawal by Subject|70|||
142953396|NCT00414440|515368104|FG001|Core Period|Withdrawal by Subject|32|||
142953397|NCT00414440|515368103|FG000|Extension Period|Lost to Follow-up|44|||
142953398|NCT00414440|515368104|FG001|Extension Period|Lost to Follow-up|52|||
142953399|NCT00414440|515368103|FG000|Extension Period|Did not consent to continue follow up|61|||
142953400|NCT00414440|515368104|FG001|Extension Period|Did not consent to continue follow up|54|||
142953401|NCT00414440|515368103|FG000|Extension Period|Other|1|||
142953402|NCT00414440|515368104|FG001|Extension Period|Other|1|||
142953403|NCT00414440|515368103|FG000|Extension Period|Administrative|16|||
142953404|NCT00414440|515368104|FG001|Extension Period|Administrative|16|||
142953405|NCT00414440|515368103|FG000|Extension Period|Death|1|||
142953406|NCT00414440|515368104|FG001|Extension Period|Death|2|||
142953407|NCT00414440|515368103|FG000|Extension Period|Withdrawal by Subject|9|||
142953408|NCT00414440|515368104|FG001|Extension Period|Withdrawal by Subject|7|||
142953409|NCT00414440|515368103|FG000|Extension Period|Not included in follow up period|18|||
142953410|NCT00414440|515368104|FG001|Extension Period|Not included in follow up period|8|||
142953411|NCT03671369|515368105|FG000|Overall Study|Other|1|||
142953412|NCT03671369|515368105|FG000|Overall Study|Withdrawal by Subject|289|||
142953413|NCT03671369|515368105|FG000|Overall Study|Not willing to be vaccinated|1|||
142953414|NCT01971476|515368106|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
142953415|NCT01971476|515368107|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
142953416|NCT01971476|515368108|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
142953417|NCT01971476|515368106|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
142953418|NCT01971476|515368107|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
142953419|NCT01971476|515368108|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
142953420|NCT01971476|515368106|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
142953421|NCT01971476|515368107|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
142953422|NCT01971476|515368108|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
142953423|NCT00138151|515368109|FG000|Overall Study|Withdrawal by Subject|3|||
142953424|NCT00138151|515368109|FG000|Overall Study|Physician Decision|1|||
142953425|NCT02619253|515368112|FG000|Overall Study|Adverse Event|0|||
142953426|NCT02619253|515368113|FG001|Overall Study|Adverse Event|0|||
142953427|NCT02619253|515368114|FG002|Overall Study|Adverse Event|1|||
142953428|NCT02619253|515368115|FG003|Overall Study|Adverse Event|1|||
142953429|NCT02619253|515368116|FG004|Overall Study|Adverse Event|3|||
143455155|NCT01983254|517210789|FG001|Overall Study|Lost to Follow-up|16|||
143455156|NCT01983254|517210788|FG000|Overall Study|too ill|11|||
143455157|NCT01983254|517210789|FG001|Overall Study|too ill|8|||
142953430|NCT02619253|515368112|FG000|Overall Study|Alternative Therapy|0|||
142953431|NCT02619253|515368113|FG001|Overall Study|Alternative Therapy|0|||
142953432|NCT02619253|515368114|FG002|Overall Study|Alternative Therapy|1|||
142953433|NCT02619253|515368115|FG003|Overall Study|Alternative Therapy|0|||
142953434|NCT02619253|515368116|FG004|Overall Study|Alternative Therapy|0|||
142953435|NCT02619253|515368112|FG000|Overall Study|Death|0|||
142953436|NCT02619253|515368113|FG001|Overall Study|Death|0|||
142953437|NCT02619253|515368114|FG002|Overall Study|Death|0|||
142953438|NCT02619253|515368115|FG003|Overall Study|Death|1|||
142953439|NCT02619253|515368116|FG004|Overall Study|Death|0|||
142953440|NCT02619253|515368112|FG000|Overall Study|Disease Progression|4|||
142953441|NCT02619253|515368113|FG001|Overall Study|Disease Progression|2|||
142953442|NCT02619253|515368114|FG002|Overall Study|Disease Progression|8|||
142953443|NCT02619253|515368115|FG003|Overall Study|Disease Progression|9|||
142953444|NCT02619253|515368116|FG004|Overall Study|Disease Progression|10|||
142953445|NCT02619253|515368112|FG000|Overall Study|Needed a disqualifying therapy|0|||
142953446|NCT02619253|515368113|FG001|Overall Study|Needed a disqualifying therapy|0|||
142953447|NCT02619253|515368114|FG002|Overall Study|Needed a disqualifying therapy|1|||
142953448|NCT02619253|515368115|FG003|Overall Study|Needed a disqualifying therapy|0|||
142953449|NCT02619253|515368116|FG004|Overall Study|Needed a disqualifying therapy|0|||
142953450|NCT02619253|515368112|FG000|Overall Study|Transferred to hospice|0|||
142953451|NCT02619253|515368113|FG001|Overall Study|Transferred to hospice|0|||
142953452|NCT02619253|515368114|FG002|Overall Study|Transferred to hospice|1|||
142953453|NCT02619253|515368115|FG003|Overall Study|Transferred to hospice|0|||
142953454|NCT02619253|515368116|FG004|Overall Study|Transferred to hospice|0|||
142953455|NCT02619253|515368112|FG000|Overall Study|Physician Decision|0|||
142953456|NCT02619253|515368113|FG001|Overall Study|Physician Decision|1|||
142953457|NCT02619253|515368114|FG002|Overall Study|Physician Decision|2|||
142953458|NCT02619253|515368115|FG003|Overall Study|Physician Decision|3|||
142953459|NCT02619253|515368116|FG004|Overall Study|Physician Decision|0|||
142953460|NCT02619253|515368112|FG000|Overall Study|Withdrawal by Subject|0|||
142953461|NCT02619253|515368113|FG001|Overall Study|Withdrawal by Subject|1|||
142953462|NCT02619253|515368114|FG002|Overall Study|Withdrawal by Subject|0|||
142953463|NCT02619253|515368115|FG003|Overall Study|Withdrawal by Subject|0|||
142953464|NCT02619253|515368116|FG004|Overall Study|Withdrawal by Subject|2|||
142953465|NCT00301067|515368118|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
142953466|NCT00301067|515368119|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
142953467|NCT00301067|515368120|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
143455158|NCT04988867|517210794|FG000|Overall Study|Study terminated by Sponsor|12|||
142953468|NCT00301067|515368121|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
142953469|NCT00301067|515368118|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
142953470|NCT00301067|515368119|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
142953471|NCT00301067|515368120|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
142953472|NCT00301067|515368121|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
142953473|NCT00301067|515368118|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
142953474|NCT00301067|515368119|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
143455159|NCT04988867|517210794|FG000|Overall Study|Adverse Event|2|||
142953475|NCT00301067|515368120|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
142953476|NCT00301067|515368121|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
142953477|NCT00301067|515368118|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
142953478|NCT00301067|515368119|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
142953479|NCT00301067|515368120|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
142953480|NCT00301067|515368121|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
142953481|NCT00301067|515368118|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
142953482|NCT00301067|515368119|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
142953483|NCT00301067|515368120|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
142953484|NCT00301067|515368121|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
142953485|NCT00301067|515368118|FG000|Follow up Until Death|Alive at last data cut point|1|||
142953486|NCT00301067|515368119|FG001|Follow up Until Death|Alive at last data cut point|0|||
142953487|NCT00301067|515368120|FG002|Follow up Until Death|Alive at last data cut point|0|||
142953488|NCT00301067|515368121|FG003|Follow up Until Death|Alive at last data cut point|1|||
142953489|NCT00149825|515368122|FG000|Overall Study|Intolerance to medication side effects|1|||
142953490|NCT00149825|515368123|FG001|Overall Study|Intolerance to medication side effects|2|||
142953491|NCT00149825|515368122|FG000|Overall Study|Time commitments|2|||
142953492|NCT00149825|515368123|FG001|Overall Study|Time commitments|1|||
142953493|NCT00149825|515368122|FG000|Overall Study|Not liking insomnia therapy|1|||
142953494|NCT00149825|515368123|FG001|Overall Study|Not liking insomnia therapy|0|||
142953495|NCT00149825|515368122|FG000|Overall Study|Other|1|||
142953496|NCT00149825|515368123|FG001|Overall Study|Other|0|||
142953497|NCT00942708|515368124|FG000|Overall Study|Withdrawal by Subject|1|||
142953498|NCT01457339|515368125|FG000|Period 3 (100 mg)|Adverse Event|0|||
142953499|NCT01457339|515368126|FG001|Period 3 (100 mg)|Adverse Event|1|||
142953500|NCT01457339|515368125|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
142953501|NCT01457339|515368126|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
142953502|NCT01457339|515368125|FG000|Period 6 (250 mg)|Family Emergency|1|||
142953503|NCT01457339|515368126|FG001|Period 6 (250 mg)|Family Emergency|0|||
142953504|NCT01457339|515368125|FG000|Period 6 (250 mg)|Personal appointment|0|||
142953505|NCT01457339|515368126|FG001|Period 6 (250 mg)|Personal appointment|1|||
142953506|NCT00306891|515368129|FG000|Part A|Withdrawal by Subject|1|||
142953507|NCT00306891|515368130|FG001|Part A|Withdrawal by Subject|1|||
142953508|NCT00306891|515368131|FG002|Part A|Withdrawal by Subject|0|||
142953509|NCT00306891|515368132|FG003|Part A|Withdrawal by Subject|0|||
142953510|NCT00306891|515368129|FG000|Part A|Condition under investigation worsened|2|||
142953511|NCT00306891|515368130|FG001|Part A|Condition under investigation worsened|2|||
142953512|NCT00306891|515368131|FG002|Part A|Condition under investigation worsened|0|||
142953513|NCT00306891|515368132|FG003|Part A|Condition under investigation worsened|0|||
142953514|NCT00306891|515368129|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
142953515|NCT00306891|515368130|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
142953516|NCT00306891|515368131|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
142953517|NCT00306891|515368132|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
142953518|NCT00306891|515368129|FG000|Part A|Partial bowel obstruction|1|||
142953519|NCT00306891|515368130|FG001|Part A|Partial bowel obstruction|0|||
142953520|NCT00306891|515368131|FG002|Part A|Partial bowel obstruction|0|||
142953521|NCT00306891|515368132|FG003|Part A|Partial bowel obstruction|0|||
142953522|NCT00306891|515368129|FG000|Part A|Reaccumul. of ascites following drainage|0|||
142953523|NCT00306891|515368130|FG001|Part A|Reaccumul. of ascites following drainage|1|||
142953524|NCT00306891|515368131|FG002|Part A|Reaccumul. of ascites following drainage|0|||
142953525|NCT00306891|515368132|FG003|Part A|Reaccumul. of ascites following drainage|0|||
142953526|NCT00306891|515368129|FG000|Part A|Suspicion of second malignancy|0|||
142953527|NCT00306891|515368130|FG001|Part A|Suspicion of second malignancy|1|||
142953528|NCT00306891|515368131|FG002|Part A|Suspicion of second malignancy|0|||
142953529|NCT00306891|515368132|FG003|Part A|Suspicion of second malignancy|0|||
142953530|NCT00306891|515368129|FG000|Part A|QTC interval outwith elig. criteria|1|||
142953531|NCT00306891|515368130|FG001|Part A|QTC interval outwith elig. criteria|0|||
142953532|NCT00306891|515368131|FG002|Part A|QTC interval outwith elig. criteria|0|||
142953533|NCT00306891|515368132|FG003|Part A|QTC interval outwith elig. criteria|0|||
142953534|NCT00306891|515368129|FG000|Part B|Death|0|||
142953535|NCT00306891|515368130|FG001|Part B|Death|0|||
142953536|NCT00306891|515368131|FG002|Part B|Death|1|||
142953537|NCT00306891|515368132|FG003|Part B|Death|2|||
142953538|NCT00306891|515368129|FG000|Part B|Adverse Event|0|||
142953539|NCT00306891|515368130|FG001|Part B|Adverse Event|0|||
142953540|NCT00306891|515368131|FG002|Part B|Adverse Event|5|||
142953541|NCT00306891|515368132|FG003|Part B|Adverse Event|5|||
142953542|NCT00306891|515368129|FG000|Part B|Withdrawal by Subject|0|||
142953543|NCT00306891|515368130|FG001|Part B|Withdrawal by Subject|0|||
142953544|NCT00306891|515368131|FG002|Part B|Withdrawal by Subject|3|||
142953545|NCT00306891|515368132|FG003|Part B|Withdrawal by Subject|1|||
142953546|NCT00306891|515368129|FG000|Part B|Condition under investigation worsened|0|||
142953547|NCT00306891|515368130|FG001|Part B|Condition under investigation worsened|0|||
142953548|NCT00306891|515368131|FG002|Part B|Condition under investigation worsened|2|||
142953549|NCT00306891|515368132|FG003|Part B|Condition under investigation worsened|8|||
142953550|NCT00306891|515368129|FG000|Part B|Development of study specific disc crit.|0|||
142953551|NCT00306891|515368130|FG001|Part B|Development of study specific disc crit.|0|||
142953552|NCT00306891|515368131|FG002|Part B|Development of study specific disc crit.|0|||
142953553|NCT00306891|515368132|FG003|Part B|Development of study specific disc crit.|1|||
142953554|NCT02613572|515368133|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
142953555|NCT02613572|515368134|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
142953556|NCT02613572|515368135|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
142953557|NCT02613572|515368133|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
142953558|NCT02613572|515368134|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
142953559|NCT02613572|515368135|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
142953560|NCT00231478|515368139|FG000|Overall Study|Protocol Violation|3|||
142953561|NCT00231478|515368140|FG001|Overall Study|Protocol Violation|2|||
142953562|NCT00231478|515368139|FG000|Overall Study|Refused Treatment|1|||
142953563|NCT00231478|515368140|FG001|Overall Study|Refused Treatment|1|||
142953564|NCT00231478|515368139|FG000|Overall Study|Withdrawal by Subject|1|||
142953565|NCT00231478|515368140|FG001|Overall Study|Withdrawal by Subject|0|||
142953566|NCT00231478|515368139|FG000|Overall Study|Adverse Event|0|||
142953567|NCT00231478|515368140|FG001|Overall Study|Adverse Event|1|||
142953568|NCT00231478|515368139|FG000|Overall Study|Administrative|3|||
142953569|NCT00231478|515368140|FG001|Overall Study|Administrative|2|||
142953570|NCT00970294|515368145|FG000|Overall Study|Physician Decision|4|||
142953571|NCT00970294|515368145|FG000|Overall Study|Withdrawal by Subject|1|||
142953572|NCT01333189|515368148|FG000|Overall Study|Time constraints|1|||
142953573|NCT01333189|515368149|FG001|Overall Study|Time constraints|0|||
142953574|NCT01333189|515368148|FG000|Overall Study|Adverse Event|1|||
142953575|NCT01333189|515368149|FG001|Overall Study|Adverse Event|0|||
142953576|NCT01333189|515368148|FG000|Overall Study|Transportation difficulties|0|||
142953577|NCT01333189|515368149|FG001|Overall Study|Transportation difficulties|1|||
142953578|NCT01333189|515368148|FG000|Overall Study|Moved from region|0|||
142953579|NCT01333189|515368149|FG001|Overall Study|Moved from region|1|||
142953580|NCT02053246|515368150|FG000|Overall Study|Withdrawal by Subject|3|||
142953581|NCT02053246|515368150|FG000|Overall Study|Physician Decision|1|||
142953582|NCT04799782|515368153|FG000|Washout|Physician Decision|2|||
142953583|NCT04799782|515368154|FG001|Washout|Physician Decision|0|||
142953584|NCT04799782|515368153|FG000|Washout|Withdrawal by Subject|0|||
142953585|NCT04799782|515368154|FG001|Washout|Withdrawal by Subject|2|||
142953586|NCT04799782|515368153|FG000|Washout|Lost to Follow-up|0|||
142953587|NCT04799782|515368154|FG001|Washout|Lost to Follow-up|1|||
142953588|NCT00969618|515368162|FG000|Overall Study|Adverse Event|29|||
142953589|NCT00969618|515368162|FG000|Overall Study|Entry Criteria Not Met|3|||
142953590|NCT00969618|515368162|FG000|Overall Study|Lack of Efficacy|2|||
142953591|NCT00969618|515368162|FG000|Overall Study|Lost to Follow-up|7|||
142953592|NCT00969618|515368162|FG000|Overall Study|Physician Decision|1|||
142953593|NCT00969618|515368162|FG000|Overall Study|Protocol Violation|9|||
142953594|NCT00969618|515368162|FG000|Overall Study|Withdrawal by Subject|27|||
142953595|NCT01318902|515368167|FG000|Overall Study|Symptomatic Deterioration|0|||
142953596|NCT01318902|515368168|FG001|Overall Study|Symptomatic Deterioration|1|||
142953597|NCT01318902|515368169|FG002|Overall Study|Symptomatic Deterioration|1|||
142953598|NCT01318902|515368170|FG003|Overall Study|Symptomatic Deterioration|2|||
142953599|NCT01318902|515368167|FG000|Overall Study|Withdrawal by Patient|0|||
142953600|NCT01318902|515368168|FG001|Overall Study|Withdrawal by Patient|1|||
142953601|NCT01318902|515368169|FG002|Overall Study|Withdrawal by Patient|0|||
142953602|NCT01318902|515368170|FG003|Overall Study|Withdrawal by Patient|3|||
142953603|NCT01318902|515368167|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
142953604|NCT01318902|515368168|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
143455160|NCT04988867|517210794|FG000|Overall Study|Study drug noncompliance|1|||
143455161|NCT01253304|517210795|FG000|Overall Study|Adverse Event|0|||
143455162|NCT01253304|517210796|FG001|Overall Study|Adverse Event|0|||
143455163|NCT01253304|517210797|FG002|Overall Study|Adverse Event|0|||
143455164|NCT01253304|517210798|FG003|Overall Study|Adverse Event|1|||
143455165|NCT01327495|517210799|FG000|Overall Study|Adverse Event|2|||
143455166|NCT01327495|517210800|FG001|Overall Study|Adverse Event|1|||
143455167|NCT01327495|517210801|FG002|Overall Study|Adverse Event|1|||
143455168|NCT01327495|517210802|FG003|Overall Study|Adverse Event|0|||
143455169|NCT01327495|517210803|FG004|Overall Study|Adverse Event|0|||
143455170|NCT01327495|517210804|FG005|Overall Study|Adverse Event|2|||
142953605|NCT01318902|515368169|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
142953606|NCT01318902|515368170|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
142953607|NCT01318902|515368167|FG000|Overall Study|Adverse Event|0|||
142953608|NCT01318902|515368168|FG001|Overall Study|Adverse Event|1|||
142953609|NCT01318902|515368169|FG002|Overall Study|Adverse Event|0|||
142953610|NCT01318902|515368170|FG003|Overall Study|Adverse Event|0|||
142953611|NCT01318902|515368167|FG000|Overall Study|Terminated by Sponsor|0|||
142953612|NCT01318902|515368168|FG001|Overall Study|Terminated by Sponsor|0|||
142953613|NCT01318902|515368169|FG002|Overall Study|Terminated by Sponsor|1|||
143455171|NCT01327495|517210799|FG000|Overall Study|Withdrawal by Subject|0|||
143455172|NCT01327495|517210800|FG001|Overall Study|Withdrawal by Subject|1|||
143455173|NCT01327495|517210801|FG002|Overall Study|Withdrawal by Subject|1|||
143455174|NCT01327495|517210802|FG003|Overall Study|Withdrawal by Subject|0|||
143455175|NCT01327495|517210803|FG004|Overall Study|Withdrawal by Subject|1|||
143455176|NCT01327495|517210804|FG005|Overall Study|Withdrawal by Subject|0|||
143455177|NCT01327495|517210799|FG000|Overall Study|Physician Decision|0|||
143455178|NCT01327495|517210800|FG001|Overall Study|Physician Decision|0|||
143455179|NCT01327495|517210801|FG002|Overall Study|Physician Decision|0|||
143455180|NCT01327495|517210802|FG003|Overall Study|Physician Decision|0|||
143455181|NCT01327495|517210803|FG004|Overall Study|Physician Decision|2|||
143455182|NCT01327495|517210804|FG005|Overall Study|Physician Decision|0|||
143455183|NCT01699503|517210805|FG000|Overall Study|Death|31|||
143455184|NCT01699503|517210806|FG001|Overall Study|Death|40|||
143455185|NCT01699503|517210805|FG000|Overall Study|Withdrawal by Subject|65|||
143455186|NCT01699503|517210806|FG001|Overall Study|Withdrawal by Subject|57|||
143455187|NCT01699503|517210805|FG000|Overall Study|Lost to Follow-up|121|||
143455188|NCT01699503|517210806|FG001|Overall Study|Lost to Follow-up|117|||
143455189|NCT01699503|517210805|FG000|Overall Study|Excluded due to quality|783|||
143455190|NCT01699503|517210806|FG001|Overall Study|Excluded due to quality|791|||
143455191|NCT00006011|517210807|FG000|Overall Study|Disease progression|13|||
143455192|NCT00006011|517210808|FG001|Overall Study|Disease progression|6|||
143455193|NCT00006011|517210809|FG002|Overall Study|Disease progression|26|||
143455194|NCT00006011|517210807|FG000|Overall Study|Refused further treatment|15|||
143455195|NCT00006011|517210808|FG001|Overall Study|Refused further treatment|13|||
143455196|NCT00006011|517210809|FG002|Overall Study|Refused further treatment|26|||
143455197|NCT00006011|517210807|FG000|Overall Study|Adverse Event|15|||
143455198|NCT00006011|517210808|FG001|Overall Study|Adverse Event|39|||
143455199|NCT00006011|517210809|FG002|Overall Study|Adverse Event|5|||
143455200|NCT00006011|517210807|FG000|Overall Study|Death|0|||
143455201|NCT00006011|517210808|FG001|Overall Study|Death|1|||
143455202|NCT00006011|517210809|FG002|Overall Study|Death|2|||
143455203|NCT00006011|517210807|FG000|Overall Study|Other|4|||
143455204|NCT00006011|517210808|FG001|Overall Study|Other|2|||
143455205|NCT00006011|517210809|FG002|Overall Study|Other|5|||
143455206|NCT00006011|517210807|FG000|Overall Study|Ineligible|18|||
143455207|NCT00006011|517210808|FG001|Overall Study|Ineligible|16|||
143455208|NCT00006011|517210809|FG002|Overall Study|Ineligible|9|||
143455209|NCT03020576|517210819|FG000|Overall Study|Withdrawal by Subject|1|||
143455210|NCT03020576|517210820|FG001|Overall Study|Withdrawal by Subject|2|||
143455211|NCT03500159|517210829|FG000|Overall Study|Study Terminated|2|||
143455212|NCT03500159|517210830|FG001|Overall Study|Study Terminated|1|||
143455213|NCT03484273|517210835|FG000|Overall Study|Equipment Malfunction|1|||
143455214|NCT03484273|517210835|FG000|Overall Study|Data excluded from analysis|1|||
143455215|NCT02217475|517210846|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
143455216|NCT02217475|517210847|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
142953614|NCT01318902|515368170|FG003|Overall Study|Terminated by Sponsor|0|||
142953615|NCT01089725|515368174|FG000|Overall Study|Adverse Event|1|||
142953616|NCT01089725|515368175|FG001|Overall Study|Adverse Event|1|||
142953617|NCT01089725|515368176|FG002|Overall Study|Adverse Event|0|||
142953618|NCT01089725|515368177|FG003|Overall Study|Adverse Event|0|||
142953619|NCT01089725|515368178|FG004|Overall Study|Adverse Event|2|||
142953620|NCT01089725|515368174|FG000|Overall Study|Lack of Efficacy|4|||
142953621|NCT01089725|515368175|FG001|Overall Study|Lack of Efficacy|3|||
142953622|NCT01089725|515368176|FG002|Overall Study|Lack of Efficacy|1|||
142953623|NCT01089725|515368177|FG003|Overall Study|Lack of Efficacy|0|||
142953624|NCT01089725|515368178|FG004|Overall Study|Lack of Efficacy|4|||
142953625|NCT01089725|515368174|FG000|Overall Study|Lost to Follow-up|2|||
142953626|NCT01089725|515368175|FG001|Overall Study|Lost to Follow-up|2|||
142953627|NCT01089725|515368176|FG002|Overall Study|Lost to Follow-up|0|||
142953628|NCT01089725|515368177|FG003|Overall Study|Lost to Follow-up|3|||
142953629|NCT01089725|515368178|FG004|Overall Study|Lost to Follow-up|0|||
142953630|NCT01089725|515368174|FG000|Overall Study|Protocol Violation|0|||
142953631|NCT01089725|515368175|FG001|Overall Study|Protocol Violation|0|||
142953632|NCT01089725|515368176|FG002|Overall Study|Protocol Violation|1|||
142953633|NCT01089725|515368177|FG003|Overall Study|Protocol Violation|1|||
142953634|NCT01089725|515368178|FG004|Overall Study|Protocol Violation|0|||
142953635|NCT01089725|515368174|FG000|Overall Study|Withdrawal by Subject|5|||
142953636|NCT01089725|515368175|FG001|Overall Study|Withdrawal by Subject|5|||
142953637|NCT01089725|515368176|FG002|Overall Study|Withdrawal by Subject|4|||
142953638|NCT01089725|515368177|FG003|Overall Study|Withdrawal by Subject|5|||
142953639|NCT01089725|515368178|FG004|Overall Study|Withdrawal by Subject|4|||
142953640|NCT01089725|515368174|FG000|Overall Study|Study Terminated by Sponsor|51|||
143455217|NCT02217475|517210848|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
143455218|NCT02217475|517210846|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
143455219|NCT02217475|517210847|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
142953641|NCT01089725|515368175|FG001|Overall Study|Study Terminated by Sponsor|56|||
142953642|NCT01089725|515368176|FG002|Overall Study|Study Terminated by Sponsor|53|||
143455220|NCT02217475|517210848|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
142953643|NCT01089725|515368177|FG003|Overall Study|Study Terminated by Sponsor|68|||
142953644|NCT01089725|515368178|FG004|Overall Study|Study Terminated by Sponsor|68|||
142953645|NCT01089725|515368174|FG000|Overall Study|Randomized, but not treated|0|||
142953646|NCT01089725|515368175|FG001|Overall Study|Randomized, but not treated|1|||
142953647|NCT01089725|515368176|FG002|Overall Study|Randomized, but not treated|2|||
142953648|NCT01089725|515368177|FG003|Overall Study|Randomized, but not treated|1|||
142953649|NCT01089725|515368178|FG004|Overall Study|Randomized, but not treated|2|||
142953650|NCT01089725|515368174|FG000|Overall Study|Other|3|||
142953651|NCT01089725|515368175|FG001|Overall Study|Other|0|||
142953652|NCT01089725|515368176|FG002|Overall Study|Other|0|||
142953653|NCT01089725|515368177|FG003|Overall Study|Other|1|||
142953654|NCT01089725|515368178|FG004|Overall Study|Other|0|||
142953655|NCT02452970|515369914|FG000|Overall Study|Adverse Event|1|||
142953656|NCT02400346|515369917|FG000|Overall Study|Adverse Event|24|||
142953657|NCT02400346|515369917|FG000|Overall Study|Lack of Efficacy|9|||
142953658|NCT02400346|515369917|FG000|Overall Study|Non-compliance with IMP|1|||
142953659|NCT02400346|515369917|FG000|Overall Study|Withdrawal by Subject|7|||
142953660|NCT02400346|515369917|FG000|Overall Study|Administrative or other reason(s)|2|||
142953661|NCT02400346|515369917|FG000|Overall Study|Lost to Follow-up|1|||
142953662|NCT01269125|515369918|FG000|Overall Study|Adverse Event|3|||
142953663|NCT01269125|515369919|FG001|Overall Study|Adverse Event|5|||
142953664|NCT01269125|515369920|FG002|Overall Study|Adverse Event|0|||
142953665|NCT01269125|515369918|FG000|Overall Study|Lost to Follow-up|4|||
142953666|NCT01269125|515369919|FG001|Overall Study|Lost to Follow-up|0|||
142953667|NCT01269125|515369920|FG002|Overall Study|Lost to Follow-up|0|||
142953668|NCT02114203|515369922|FG000|Overall Study|Adverse Event|0|||
142953669|NCT02114203|515369923|FG001|Overall Study|Adverse Event|1|||
142953670|NCT02114203|515369924|FG002|Overall Study|Adverse Event|0|||
142953671|NCT02114203|515369922|FG000|Overall Study|Withdrawal by Subject|0|||
142953672|NCT02114203|515369923|FG001|Overall Study|Withdrawal by Subject|1|||
142953673|NCT02114203|515369924|FG002|Overall Study|Withdrawal by Subject|0|||
142953674|NCT01040832|515369925|FG000|Overall Study|Adverse Event|4|||
142953675|NCT01040832|515369926|FG001|Overall Study|Adverse Event|5|||
142953676|NCT01040832|515369925|FG000|Overall Study|Death|4|||
142953677|NCT01040832|515369926|FG001|Overall Study|Death|6|||
142953678|NCT01040832|515369925|FG000|Overall Study|Withdrawal by Subject|2|||
142953679|NCT01040832|515369926|FG001|Overall Study|Withdrawal by Subject|3|||
142953680|NCT01040832|515369925|FG000|Overall Study|Progressive disease|32|||
142953681|NCT01040832|515369926|FG001|Overall Study|Progressive disease|17|||
142953682|NCT01040832|515369925|FG000|Overall Study|Symptomatic deterioration|2|||
142953683|NCT01040832|515369926|FG001|Overall Study|Symptomatic deterioration|5|||
142953684|NCT01040832|515369925|FG000|Overall Study|Other|2|||
142953685|NCT01040832|515369926|FG001|Overall Study|Other|1|||
142953686|NCT01058369|515369928|FG000|Overall Study|Adverse Event|1|||
142953687|NCT01058369|515369928|FG000|Overall Study|Early termination study|1|||
142953688|NCT00089843|515369929|FG000|Overall Study|Withdrawal by Subject|1|||
142953689|NCT00089843|515369930|FG001|Overall Study|Withdrawal by Subject|4|||
142953690|NCT00089843|515369931|FG002|Overall Study|Withdrawal by Subject|5|||
142953691|NCT00089843|515369932|FG003|Overall Study|Withdrawal by Subject|6|||
142953692|NCT00089843|515369929|FG000|Overall Study|Physician Decision|1|||
142953693|NCT00089843|515369930|FG001|Overall Study|Physician Decision|0|||
142953694|NCT00089843|515369931|FG002|Overall Study|Physician Decision|0|||
142953695|NCT00089843|515369932|FG003|Overall Study|Physician Decision|1|||
142953696|NCT00663858|515369933|FG000|Overall Study|Adverse Event|9|||
142953697|NCT00663858|515369934|FG001|Overall Study|Adverse Event|1|||
142953698|NCT00663858|515369935|FG002|Overall Study|Adverse Event|6|||
142953699|NCT00663858|515369933|FG000|Overall Study|Lack of Efficacy|5|||
142953700|NCT00663858|515369934|FG001|Overall Study|Lack of Efficacy|1|||
142953701|NCT00663858|515369935|FG002|Overall Study|Lack of Efficacy|3|||
142953702|NCT00663858|515369933|FG000|Overall Study|Withdrawal by Subject|7|||
142953703|NCT00663858|515369934|FG001|Overall Study|Withdrawal by Subject|3|||
142953704|NCT00663858|515369935|FG002|Overall Study|Withdrawal by Subject|3|||
142953705|NCT00663858|515369933|FG000|Overall Study|Protocol Violation|5|||
143455221|NCT02217475|517210846|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
143455222|NCT02217475|517210847|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
143455223|NCT02217475|517210848|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
142953706|NCT00663858|515369934|FG001|Overall Study|Protocol Violation|3|||
142953707|NCT00663858|515369935|FG002|Overall Study|Protocol Violation|4|||
142953708|NCT00663858|515369933|FG000|Overall Study|Other|8|||
142953709|NCT00663858|515369934|FG001|Overall Study|Other|2|||
142953710|NCT00663858|515369935|FG002|Overall Study|Other|4|||
142953711|NCT03060577|515369936|FG000|Overall Study|Withdrawal by Subject|25|||
142953712|NCT03060577|515369937|FG001|Overall Study|Withdrawal by Subject|5|||
142953713|NCT03060577|515369936|FG000|Overall Study|Physician Decision|4|||
142953714|NCT03060577|515369937|FG001|Overall Study|Physician Decision|3|||
142953715|NCT03060577|515369936|FG000|Overall Study|Lost to Follow-up|3|||
142953716|NCT03060577|515369937|FG001|Overall Study|Lost to Follow-up|0|||
142953717|NCT03060577|515369936|FG000|Overall Study|Death|7|||
142953718|NCT03060577|515369937|FG001|Overall Study|Death|1|||
142953719|NCT03060577|515369936|FG000|Overall Study|Adverse Event|9|||
142953720|NCT03060577|515369937|FG001|Overall Study|Adverse Event|1|||
142953721|NCT03060577|515369936|FG000|Overall Study|Inclusion/Exclusion|1|||
142953722|NCT03060577|515369937|FG001|Overall Study|Inclusion/Exclusion|0|||
142953723|NCT03060577|515369936|FG000|Overall Study|Other|8|||
142953724|NCT03060577|515369937|FG001|Overall Study|Other|2|||
142953725|NCT01936649|515369955|FG000|Overall Study|Withdrawal by Subject|4|||
142953726|NCT01936649|515369955|FG000|Overall Study|Physician Decision|2|||
142953727|NCT01936649|515369955|FG000|Overall Study|Protocol Violation|2|||
142953728|NCT01936649|515369955|FG000|Overall Study|Other than specified above|5|||
142953729|NCT01380093|515369960|FG000|Naloxone Challenge Phase|Screen failures|21|||
142953730|NCT01380093|515369961|FG001|Naloxone Challenge Phase|Screen failures|0|||
142953731|NCT01380093|515369962|FG002|Naloxone Challenge Phase|Screen failures|0|||
142953732|NCT01380093|515369963|FG003|Naloxone Challenge Phase|Screen failures|0|||
142953733|NCT01380093|515369964|FG004|Naloxone Challenge Phase|Screen failures|0|||
142953734|NCT01380093|515369965|FG005|Naloxone Challenge Phase|Screen failures|0|||
142953735|NCT01380093|515369966|FG006|Naloxone Challenge Phase|Screen failures|0|||
142953736|NCT01380093|515369967|FG007|Naloxone Challenge Phase|Screen failures|0|||
142953737|NCT01380093|515369968|FG008|Naloxone Challenge Phase|Screen failures|0|||
142953738|NCT01380093|515369960|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
142953739|NCT01380093|515369961|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
142953740|NCT01380093|515369962|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
142953741|NCT01380093|515369963|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
142953742|NCT01380093|515369964|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
142953743|NCT01380093|515369965|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
142953744|NCT01380093|515369966|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
142953745|NCT01380093|515369967|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
142953746|NCT01380093|515369968|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
142953747|NCT01380093|515369960|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
142953748|NCT01380093|515369961|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
142953749|NCT01380093|515369962|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
142953750|NCT01380093|515369963|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
142953751|NCT01380093|515369964|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
142953752|NCT01380093|515369965|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
142953753|NCT01380093|515369966|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
142953754|NCT01380093|515369967|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
142953755|NCT01380093|515369968|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
142953756|NCT01380093|515369960|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
142953757|NCT01380093|515369961|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
142953758|NCT01380093|515369962|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
142953759|NCT01380093|515369963|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
142953760|NCT01380093|515369964|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
142953761|NCT01380093|515369965|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
142953762|NCT01380093|515369966|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
142953763|NCT01380093|515369967|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
142953764|NCT01380093|515369968|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
142953765|NCT01380093|515369960|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
142953766|NCT01380093|515369961|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
142953767|NCT01380093|515369962|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
142953768|NCT01380093|515369963|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
142953769|NCT01380093|515369964|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
142953770|NCT01380093|515369965|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
142953771|NCT01380093|515369966|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
142953772|NCT01380093|515369967|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
142953773|NCT01380093|515369968|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
142953774|NCT01380093|515369960|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
142953775|NCT01380093|515369961|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
142953776|NCT01380093|515369962|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
142953777|NCT01380093|515369963|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
142953778|NCT01380093|515369964|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
142953779|NCT01380093|515369965|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
142953780|NCT01380093|515369966|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
142953781|NCT01380093|515369967|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
142953782|NCT01380093|515369968|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
142953783|NCT01380093|515369960|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
142953784|NCT01380093|515369961|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
142953785|NCT01380093|515369962|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
143455224|NCT02217475|517210846|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
142953786|NCT01380093|515369963|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
142953787|NCT01380093|515369964|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
142953788|NCT01380093|515369965|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
142953789|NCT01380093|515369966|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
142953790|NCT01380093|515369967|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
142953791|NCT01380093|515369968|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
142953792|NCT01380093|515369960|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
142953793|NCT01380093|515369961|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
142953794|NCT01380093|515369962|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
142953795|NCT01380093|515369963|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
142953796|NCT01380093|515369964|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
142953797|NCT01380093|515369965|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
142953798|NCT01380093|515369966|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
142953799|NCT01380093|515369967|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
142953800|NCT01380093|515369968|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
142953801|NCT01380093|515369960|FG000|Treatment Phase: Second Intervention|Other|0|||
142953802|NCT01380093|515369961|FG001|Treatment Phase: Second Intervention|Other|0|||
142953803|NCT01380093|515369962|FG002|Treatment Phase: Second Intervention|Other|0|||
142953804|NCT01380093|515369963|FG003|Treatment Phase: Second Intervention|Other|1|||
142953805|NCT01380093|515369964|FG004|Treatment Phase: Second Intervention|Other|0|||
142953806|NCT01380093|515369965|FG005|Treatment Phase: Second Intervention|Other|0|||
142953807|NCT01380093|515369966|FG006|Treatment Phase: Second Intervention|Other|0|||
142953808|NCT01380093|515369967|FG007|Treatment Phase: Second Intervention|Other|0|||
142953809|NCT01380093|515369968|FG008|Treatment Phase: Second Intervention|Other|0|||
142953810|NCT01380093|515369960|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
142953811|NCT01380093|515369961|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
142953812|NCT01380093|515369962|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
142953813|NCT01380093|515369963|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
142953814|NCT01380093|515369964|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
142953815|NCT01380093|515369965|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
142953816|NCT01380093|515369966|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
142953817|NCT01380093|515369967|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
142953818|NCT01380093|515369968|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
142953819|NCT01380093|515369960|FG000|Treatment Phase: Third Intervention|Other|0|||
142953820|NCT01380093|515369961|FG001|Treatment Phase: Third Intervention|Other|0|||
142953821|NCT01380093|515369962|FG002|Treatment Phase: Third Intervention|Other|0|||
142953822|NCT01380093|515369963|FG003|Treatment Phase: Third Intervention|Other|0|||
142953823|NCT01380093|515369964|FG004|Treatment Phase: Third Intervention|Other|0|||
142953824|NCT01380093|515369965|FG005|Treatment Phase: Third Intervention|Other|0|||
142953825|NCT01380093|515369966|FG006|Treatment Phase: Third Intervention|Other|0|||
142953826|NCT01380093|515369967|FG007|Treatment Phase: Third Intervention|Other|0|||
142953827|NCT01380093|515369968|FG008|Treatment Phase: Third Intervention|Other|1|||
142953828|NCT00546351|515369969|FG000|Overall Study|Adverse Event|76|||
142953829|NCT00546351|515369969|FG000|Overall Study|Lack of Efficacy|15|||
142953830|NCT00546351|515369969|FG000|Overall Study|Withdrawal by Subject|109|||
142953831|NCT00546351|515369969|FG000|Overall Study|Lost to Follow-up|9|||
142953832|NCT00546351|515369969|FG000|Overall Study|Protocol Deviation|1|||
142953833|NCT00546351|515369969|FG000|Overall Study|Unsatisfactory compliance|9|||
142953834|NCT00546351|515369969|FG000|Overall Study|Other reasons for premature termination|17|||
142953835|NCT03952650|515369970|FG000|Overall Study|TRAVEL|0|||
142953836|NCT03952650|515369971|FG001|Overall Study|TRAVEL|4|||
142953837|NCT03952650|515369972|FG002|Overall Study|TRAVEL|0|||
142953838|NCT03952650|515369973|FG003|Overall Study|TRAVEL|4|||
142953839|NCT03952650|515369974|FG004|Overall Study|TRAVEL|0|||
142953840|NCT03952650|515369975|FG005|Overall Study|TRAVEL|3|||
142953841|NCT03952650|515369976|FG006|Overall Study|TRAVEL|2|||
142953842|NCT03952650|515369970|FG000|Overall Study|Withdrawal by Subject|0|||
142953843|NCT03952650|515369971|FG001|Overall Study|Withdrawal by Subject|2|||
142953844|NCT03952650|515369972|FG002|Overall Study|Withdrawal by Subject|0|||
142953845|NCT03952650|515369973|FG003|Overall Study|Withdrawal by Subject|3|||
142953846|NCT03952650|515369974|FG004|Overall Study|Withdrawal by Subject|0|||
142953847|NCT03952650|515369975|FG005|Overall Study|Withdrawal by Subject|1|||
142953848|NCT03952650|515369976|FG006|Overall Study|Withdrawal by Subject|1|||
142953849|NCT03952650|515369970|FG000|Overall Study|Lost to Follow-up|0|||
142953850|NCT03952650|515369971|FG001|Overall Study|Lost to Follow-up|1|||
142953851|NCT03952650|515369972|FG002|Overall Study|Lost to Follow-up|0|||
142953852|NCT03952650|515369973|FG003|Overall Study|Lost to Follow-up|0|||
142953853|NCT03952650|515369974|FG004|Overall Study|Lost to Follow-up|0|||
142953854|NCT03952650|515369975|FG005|Overall Study|Lost to Follow-up|1|||
142953855|NCT03952650|515369976|FG006|Overall Study|Lost to Follow-up|1|||
142953856|NCT03952650|515369970|FG000|Overall Study|Received wrong vaccine and travelled|0|||
142953857|NCT03952650|515369971|FG001|Overall Study|Received wrong vaccine and travelled|0|||
142953858|NCT03952650|515369972|FG002|Overall Study|Received wrong vaccine and travelled|0|||
142953859|NCT03952650|515369973|FG003|Overall Study|Received wrong vaccine and travelled|0|||
142953860|NCT03952650|515369974|FG004|Overall Study|Received wrong vaccine and travelled|0|||
142953861|NCT03952650|515369975|FG005|Overall Study|Received wrong vaccine and travelled|1|||
142953862|NCT03952650|515369976|FG006|Overall Study|Received wrong vaccine and travelled|0|||
142953863|NCT03952650|515369970|FG000|Overall Study|Unable to make study visit|0|||
142953864|NCT03952650|515369971|FG001|Overall Study|Unable to make study visit|0|||
142953865|NCT03952650|515369972|FG002|Overall Study|Unable to make study visit|0|||
142953866|NCT03952650|515369973|FG003|Overall Study|Unable to make study visit|0|||
142953867|NCT03952650|515369974|FG004|Overall Study|Unable to make study visit|0|||
142953868|NCT03952650|515369975|FG005|Overall Study|Unable to make study visit|1|||
142953869|NCT03952650|515369976|FG006|Overall Study|Unable to make study visit|0|||
142953870|NCT04734873|515369977|FG000|Overall Study|Lost to Follow-up|1|||
142953871|NCT04734873|515369978|FG001|Overall Study|Lost to Follow-up|3|||
142953872|NCT04734873|515369979|FG002|Overall Study|Lost to Follow-up|2|||
142953873|NCT04734873|515369977|FG000|Overall Study|Randomized but not dosed|1|||
142953874|NCT04734873|515369978|FG001|Overall Study|Randomized but not dosed|0|||
142953875|NCT04734873|515369979|FG002|Overall Study|Randomized but not dosed|1|||
142953876|NCT00592683|515369980|FG000|Overall Study|Found ineligible|0|||
142953877|NCT00592683|515369981|FG001|Overall Study|Found ineligible|1|||
142953878|NCT00592683|515369980|FG000|Overall Study|Withdrawal by Subject|1|||
142953879|NCT00592683|515369981|FG001|Overall Study|Withdrawal by Subject|0|||
142953880|NCT00592683|515369980|FG000|Overall Study|Adverse Event|0|||
142953881|NCT00592683|515369981|FG001|Overall Study|Adverse Event|2|||
142953882|NCT00592683|515369980|FG000|Overall Study|Protocol Violation|1|||
142953883|NCT00592683|515369981|FG001|Overall Study|Protocol Violation|0|||
142953884|NCT00592683|515369980|FG000|Overall Study|Study drug expired|1|||
142953885|NCT00592683|515369981|FG001|Overall Study|Study drug expired|0|||
142953886|NCT00592683|515369980|FG000|Overall Study|Other|1|||
142953887|NCT00592683|515369981|FG001|Overall Study|Other|0|||
142953888|NCT00592683|515369980|FG000|Overall Study|Lost to Follow-up|0|||
142953889|NCT00592683|515369981|FG001|Overall Study|Lost to Follow-up|1|||
142953890|NCT00844883|515369987|FG000|Overall Study|Bridged to liver transplant|3|||
142953891|NCT00844883|515369987|FG000|Overall Study|Bridged to resection|1|||
142953892|NCT01325493|515369990|FG000|Overall Study|Protocol Violation|0|||
142953893|NCT01325493|515369991|FG001|Overall Study|Protocol Violation|1|||
142953894|NCT01325493|515369990|FG000|Overall Study|loss of neuromonitoring signals|0|||
142953895|NCT01325493|515369991|FG001|Overall Study|loss of neuromonitoring signals|2|||
142953896|NCT01325493|515369990|FG000|Overall Study|Allergy|1|||
142953897|NCT01325493|515369991|FG001|Overall Study|Allergy|0|||
142953898|NCT01720667|515369995|FG000|Overall Study|Adverse Event|1|||
142953899|NCT01720667|515369996|FG001|Overall Study|Adverse Event|1|||
142953900|NCT01720667|515369995|FG000|Overall Study|Withdrawal by Subject|3|||
142953901|NCT01720667|515369996|FG001|Overall Study|Withdrawal by Subject|0|||
142953902|NCT00909090|515369997|FG000|Overall Study|Lost to Follow-up|17|||
142953903|NCT00909090|515369998|FG001|Overall Study|Lost to Follow-up|17|||
142953904|NCT00718861|515370000|FG000|Overall Study|Withdrawal by Subject|15|||
142953905|NCT00718861|515370001|FG001|Overall Study|Withdrawal by Subject|10|||
142953906|NCT00718861|515370000|FG000|Overall Study|Adverse Event|2|||
142953907|NCT00718861|515370001|FG001|Overall Study|Adverse Event|1|||
142953908|NCT00718861|515370000|FG000|Overall Study|Lost to Follow-up|2|||
142953909|NCT00718861|515370001|FG001|Overall Study|Lost to Follow-up|1|||
142953910|NCT00718861|515370000|FG000|Overall Study|Administrative Problems|1|||
142953911|NCT00718861|515370001|FG001|Overall Study|Administrative Problems|1|||
142953912|NCT00718861|515370000|FG000|Overall Study|Death|1|||
142953913|NCT00718861|515370001|FG001|Overall Study|Death|5|||
142953914|NCT01174784|515370005|FG000|Overall Study|Screen fails|4|||
142953915|NCT04601272|515370006|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
142953916|NCT04601272|515370007|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
142953917|NCT04601272|515370008|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
142953918|NCT02732912|515370011|FG000|Overall Study|Discharged before night|2|||
142953919|NCT02732912|515370012|FG001|Overall Study|Discharged before night|6|||
142953920|NCT02732912|515370011|FG000|Overall Study|Incomplete completion of questionnaire|2|||
142953921|NCT02732912|515370012|FG001|Overall Study|Incomplete completion of questionnaire|3|||
142953922|NCT02732912|515370011|FG000|Overall Study|No outcome; discharged or refused|6|||
142953923|NCT02732912|515370012|FG001|Overall Study|No outcome; discharged or refused|9|||
142953924|NCT04382651|515370013|FG000|Overall Study|Death|26|||
142953925|NCT04382651|515370014|FG001|Overall Study|Death|23|||
142953926|NCT04382651|515370013|FG000|Overall Study|Lost to Follow-up|3|||
142953927|NCT04382651|515370014|FG001|Overall Study|Lost to Follow-up|4|||
142953928|NCT04382651|515370013|FG000|Overall Study|Withdrawal by Subject|2|||
142953929|NCT04382651|515370014|FG001|Overall Study|Withdrawal by Subject|0|||
142953930|NCT04382651|515370013|FG000|Overall Study|Physician Decision|0|||
142953931|NCT04382651|515370014|FG001|Overall Study|Physician Decision|1|||
142953932|NCT01873742|515370016|FG000|Overall Study|Lost to Follow-up|68|||
142953933|NCT01873742|515370017|FG001|Overall Study|Lost to Follow-up|76|||
142953934|NCT02612077|515370018|FG000|Overall Study|Adverse Event|3|||
142953935|NCT02612077|515370018|FG000|Overall Study|Withdrawal by Subject|9|||
142953936|NCT02612077|515370018|FG000|Overall Study|Protocol Violation|28|||
142953937|NCT02612077|515370018|FG000|Overall Study|Lost to Follow-up|20|||
142953938|NCT02612077|515370018|FG000|Overall Study|Death|377|||
142953939|NCT02612077|515370018|FG000|Overall Study|Moved or Changed Medical Team|23|||
142953940|NCT02612077|515370018|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
142953941|NCT02612077|515370018|FG000|Overall Study|Disease Progression|3|||
142953942|NCT02612077|515370018|FG000|Overall Study|Unknown reason|2|||
142953943|NCT00425438|515370019|FG000|Overall Study|Termination by Sponsor|25|||
142953944|NCT00425438|515370020|FG001|Overall Study|Termination by Sponsor|27|||
142953945|NCT01716169|515370021|FG000|Overall Study|Adverse Event|1|||
142953946|NCT01716169|515370021|FG000|Overall Study|Lost to Follow-up|1|||
142953947|NCT01716169|515370021|FG000|Overall Study|Withdrawal by Subject|1|||
142953948|NCT01716169|515370021|FG000|Overall Study|inconsistent dressing application|1|||
142953949|NCT00553787|515370022|FG000|Overall Study|Adverse Event|34|||
142953950|NCT00553787|515370023|FG001|Overall Study|Adverse Event|21|||
142953951|NCT00553787|515370024|FG002|Overall Study|Adverse Event|67|||
142953952|NCT00553787|515370022|FG000|Overall Study|Lost to Follow-up|132|||
142953953|NCT00553787|515370023|FG001|Overall Study|Lost to Follow-up|44|||
142953954|NCT00553787|515370024|FG002|Overall Study|Lost to Follow-up|78|||
142953955|NCT00553787|515370022|FG000|Overall Study|Withdrawal by Subject|151|||
142953956|NCT00553787|515370023|FG001|Overall Study|Withdrawal by Subject|40|||
142953957|NCT00553787|515370024|FG002|Overall Study|Withdrawal by Subject|83|||
142953958|NCT00553787|515370022|FG000|Overall Study|Lack of Efficacy|31|||
142953959|NCT00553787|515370023|FG001|Overall Study|Lack of Efficacy|1|||
142953960|NCT00553787|515370024|FG002|Overall Study|Lack of Efficacy|3|||
142953961|NCT00553787|515370022|FG000|Overall Study|Pregnancy|0|||
142953962|NCT00553787|515370023|FG001|Overall Study|Pregnancy|1|||
142953963|NCT00553787|515370024|FG002|Overall Study|Pregnancy|2|||
142953964|NCT00553787|515370022|FG000|Overall Study|non compliance|4|||
142953965|NCT00553787|515370023|FG001|Overall Study|non compliance|0|||
142953966|NCT00553787|515370024|FG002|Overall Study|non compliance|11|||
142953967|NCT00553787|515370022|FG000|Overall Study|Requirement for restricted medication|8|||
142953968|NCT00553787|515370023|FG001|Overall Study|Requirement for restricted medication|7|||
142953969|NCT00553787|515370024|FG002|Overall Study|Requirement for restricted medication|5|||
142953970|NCT00553787|515370022|FG000|Overall Study|Other|18|||
142953971|NCT00553787|515370023|FG001|Overall Study|Other|10|||
142953972|NCT00553787|515370024|FG002|Overall Study|Other|13|||
142953973|NCT01088412|515370025|FG000|Overall Study|Adverse Event|38|||
142953974|NCT01088412|515370026|FG001|Overall Study|Adverse Event|0|||
142953975|NCT01088412|515370027|FG002|Overall Study|Adverse Event|0|||
142953976|NCT01088412|515370025|FG000|Overall Study|Death|42|||
142953977|NCT01088412|515370026|FG001|Overall Study|Death|6|||
142953978|NCT01088412|515370027|FG002|Overall Study|Death|0|||
142953979|NCT01088412|515370025|FG000|Overall Study|Other Reason per Case Report Form|2089|||
142953980|NCT01088412|515370026|FG001|Overall Study|Other Reason per Case Report Form|103|||
142953981|NCT01088412|515370027|FG002|Overall Study|Other Reason per Case Report Form|9|||
142953982|NCT01088412|515370025|FG000|Overall Study|Withdrawal by Subject|1761|||
142953983|NCT01088412|515370026|FG001|Overall Study|Withdrawal by Subject|25|||
142953984|NCT01088412|515370027|FG002|Overall Study|Withdrawal by Subject|1|||
142953985|NCT01088412|515370025|FG000|Overall Study|Received Another GH Product|79|||
142953986|NCT01088412|515370026|FG001|Overall Study|Received Another GH Product|0|||
142953987|NCT01088412|515370027|FG002|Overall Study|Received Another GH Product|0|||
142953988|NCT01088412|515370025|FG000|Overall Study|Participant Moved|601|||
142953989|NCT01088412|515370026|FG001|Overall Study|Participant Moved|21|||
142953990|NCT01088412|515370027|FG002|Overall Study|Participant Moved|2|||
142953991|NCT01088412|515370025|FG000|Overall Study|Physician Decision|1041|||
142953992|NCT01088412|515370026|FG001|Overall Study|Physician Decision|8|||
142953993|NCT01088412|515370027|FG002|Overall Study|Physician Decision|4|||
142953994|NCT01088412|515370025|FG000|Overall Study|Sponsor Decision|4467|||
142953995|NCT01088412|515370026|FG001|Overall Study|Sponsor Decision|79|||
142953996|NCT01088412|515370027|FG002|Overall Study|Sponsor Decision|23|||
142953997|NCT01088412|515370025|FG000|Overall Study|Third Party Required to Change Brand|487|||
142953998|NCT01088412|515370026|FG001|Overall Study|Third Party Required to Change Brand|0|||
142953999|NCT01088412|515370027|FG002|Overall Study|Third Party Required to Change Brand|0|||
142954000|NCT01088412|515370025|FG000|Overall Study|Lost to Follow-up|3052|||
142954001|NCT01088412|515370026|FG001|Overall Study|Lost to Follow-up|130|||
142954002|NCT01088412|515370027|FG002|Overall Study|Lost to Follow-up|11|||
142954003|NCT01088412|515370025|FG000|Overall Study|Study Summary Not Completed|4360|||
142954004|NCT01088412|515370026|FG001|Overall Study|Study Summary Not Completed|64|||
142954005|NCT01088412|515370027|FG002|Overall Study|Study Summary Not Completed|22|||
142954006|NCT02285010|515370028|FG000|Overall Study|not abdominal hysterectomy|2|||
142954007|NCT02285010|515370029|FG001|Overall Study|not abdominal hysterectomy|0|||
142954008|NCT02285010|515370028|FG000|Overall Study|Not spinal anesthesia|3|||
142954009|NCT02285010|515370029|FG001|Overall Study|Not spinal anesthesia|1|||
142954010|NCT00532259|515370030|FG000|Overall Study|Withdrawal by Subject|2|||
142954011|NCT00532259|515370030|FG000|Overall Study|Adverse Event|1|||
143455225|NCT02217475|517210847|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
142954012|NCT00532259|515370030|FG000|Overall Study|Death|1|||
142954013|NCT00532259|515370030|FG000|Overall Study|Lack of Efficacy|21|||
142954014|NCT00532259|515370030|FG000|Overall Study|Lost to Follow-up|3|||
142954015|NCT00532259|515370030|FG000|Overall Study|Physician Decision|3|||
142954016|NCT00532259|515370030|FG000|Overall Study|Protocol Violation|1|||
142954017|NCT00793104|515370031|FG000|Overall Study|Lost to Follow-up|1|||
142954018|NCT03494725|515370032|FG000|Overall Study|Withdrawal by Subject|0|||
142954019|NCT03494725|515370033|FG001|Overall Study|Withdrawal by Subject|2|||
142954020|NCT03494725|515370032|FG000|Overall Study|Antibiotic use|1|||
142954021|NCT03494725|515370033|FG001|Overall Study|Antibiotic use|0|||
142954022|NCT00514449|515370034|FG000|Overall Study|Withdrawal by Subject|1|||
142954023|NCT00514449|515370035|FG001|Overall Study|Withdrawal by Subject|2|||
142954024|NCT00514449|515370034|FG000|Overall Study|Protocol Violation|1|||
142954025|NCT00514449|515370035|FG001|Overall Study|Protocol Violation|2|||
142954026|NCT00514449|515370034|FG000|Overall Study|Lost to Follow-up|1|||
142954027|NCT00514449|515370035|FG001|Overall Study|Lost to Follow-up|0|||
142954028|NCT01164501|515370040|FG000|Overall Study|Not treated|2|||
142954029|NCT01164501|515370041|FG001|Overall Study|Not treated|0|||
142954030|NCT01164501|515370042|FG002|Overall Study|Not treated|1|||
142954031|NCT01164501|515370040|FG000|Overall Study|Adverse Event|18|||
142954032|NCT01164501|515370041|FG001|Overall Study|Adverse Event|4|||
142954033|NCT01164501|515370042|FG002|Overall Study|Adverse Event|21|||
142954034|NCT01164501|515370040|FG000|Overall Study|Lack of Efficacy|0|||
142954035|NCT01164501|515370041|FG001|Overall Study|Lack of Efficacy|0|||
142954036|NCT01164501|515370042|FG002|Overall Study|Lack of Efficacy|1|||
142954037|NCT01164501|515370040|FG000|Overall Study|Non compliant with protocol|1|||
142954038|NCT01164501|515370041|FG001|Overall Study|Non compliant with protocol|1|||
142954039|NCT01164501|515370042|FG002|Overall Study|Non compliant with protocol|4|||
142954040|NCT01164501|515370040|FG000|Overall Study|Lost to Follow-up|3|||
142954041|NCT01164501|515370041|FG001|Overall Study|Lost to Follow-up|0|||
142954042|NCT01164501|515370042|FG002|Overall Study|Lost to Follow-up|3|||
142954043|NCT01164501|515370040|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
142954044|NCT01164501|515370041|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
142954045|NCT01164501|515370042|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
142954046|NCT01164501|515370040|FG000|Overall Study|Other reason not defined above|9|||
142954047|NCT01164501|515370041|FG001|Overall Study|Other reason not defined above|1|||
142954048|NCT01164501|515370042|FG002|Overall Study|Other reason not defined above|4|||
142954049|NCT01096667|515370044|FG000|Overall Study|Lost to Follow-up|1|||
142954050|NCT01096667|515370045|FG001|Overall Study|Lost to Follow-up|1|||
142954051|NCT01096667|515370046|FG002|Overall Study|Lost to Follow-up|1|||
142954052|NCT01096667|515370047|FG003|Overall Study|Lost to Follow-up|0|||
142954053|NCT01096667|515370048|FG004|Overall Study|Lost to Follow-up|0|||
142954054|NCT01096667|515370044|FG000|Overall Study|Withdrawal by Subject|1|||
142954055|NCT01096667|515370045|FG001|Overall Study|Withdrawal by Subject|0|||
142954056|NCT01096667|515370046|FG002|Overall Study|Withdrawal by Subject|0|||
142954057|NCT01096667|515370047|FG003|Overall Study|Withdrawal by Subject|1|||
142954058|NCT01096667|515370048|FG004|Overall Study|Withdrawal by Subject|0|||
142954059|NCT01096667|515370044|FG000|Overall Study|Reason not available|0|||
142954060|NCT01096667|515370045|FG001|Overall Study|Reason not available|1|||
142954061|NCT01096667|515370046|FG002|Overall Study|Reason not available|1|||
142954062|NCT01096667|515370047|FG003|Overall Study|Reason not available|1|||
142954063|NCT01096667|515370048|FG004|Overall Study|Reason not available|0|||
142954064|NCT01096667|515370044|FG000|Overall Study|Protocol Violation|0|||
142954065|NCT01096667|515370045|FG001|Overall Study|Protocol Violation|0|||
142954066|NCT01096667|515370046|FG002|Overall Study|Protocol Violation|0|||
142954067|NCT01096667|515370047|FG003|Overall Study|Protocol Violation|1|||
142954068|NCT01096667|515370048|FG004|Overall Study|Protocol Violation|0|||
142954069|NCT01096667|515370044|FG000|Overall Study|Not treated|1|||
142954070|NCT01096667|515370045|FG001|Overall Study|Not treated|0|||
142954071|NCT01096667|515370046|FG002|Overall Study|Not treated|0|||
142954072|NCT01096667|515370047|FG003|Overall Study|Not treated|0|||
142954073|NCT01096667|515370048|FG004|Overall Study|Not treated|0|||
142954074|NCT00673673|515370049|FG000|Overall Study|Progressive disease|27|||
142954075|NCT00673673|515370049|FG000|Overall Study|Adverse Event|4|||
142954076|NCT00673673|515370049|FG000|Overall Study|Withdrawal by Subject|3|||
142954077|NCT00673673|515370049|FG000|Overall Study|Investigators' discretion|2|||
142954078|NCT00206518|515370055|FG000|Overall Study|Lack of Efficacy|6|||
142954079|NCT00206518|515370056|FG001|Overall Study|Lack of Efficacy|4|||
142954080|NCT00206518|515370055|FG000|Overall Study|Adverse Event|2|||
142954081|NCT00206518|515370056|FG001|Overall Study|Adverse Event|1|||
142954082|NCT00206518|515370055|FG000|Overall Study|Physician Decision|1|||
142954083|NCT00206518|515370056|FG001|Overall Study|Physician Decision|0|||
142954084|NCT00206518|515370055|FG000|Overall Study|Protocol Violation|1|||
142954085|NCT00206518|515370056|FG001|Overall Study|Protocol Violation|1|||
142954086|NCT02335450|515370057|FG000|Overall Study|Pregnancy|1|||
142954087|NCT00853905|515370060|FG000|Overall Study|Lost to Follow-up|1|||
143117132|NCT01273155|515970040|FG002|Overall Study|Change in liver function/no longer eval.|0|||
142954088|NCT00853905|515370061|FG001|Overall Study|Lost to Follow-up|3|||
142954089|NCT00853905|515370060|FG000|Overall Study|Withdrawal by Subject|0|||
142954090|NCT00853905|515370061|FG001|Overall Study|Withdrawal by Subject|1|||
142954091|NCT00853905|515370060|FG000|Overall Study|never had surgery|1|||
142954092|NCT00853905|515370061|FG001|Overall Study|never had surgery|0|||
142954093|NCT05258058|515370067|FG000|Overall Study|Withdrawal by Subject|2|||
142954094|NCT00447421|515370080|FG000|Overall Study|Lack of Efficacy|1|||
142954095|NCT00447421|515370080|FG000|Overall Study|Adverse Event|3|||
142954096|NCT00447421|515370080|FG000|Overall Study|Sponsor Decision|2|||
142954097|NCT00465738|515370081|FG000|Overall Study|Lost to Follow-up|2|||
142954098|NCT00465738|515370082|FG001|Overall Study|Lost to Follow-up|0|||
142954099|NCT00465738|515370081|FG000|Overall Study|Adverse Event|0|||
142954100|NCT00465738|515370082|FG001|Overall Study|Adverse Event|1|||
142954101|NCT00465738|515370081|FG000|Overall Study|Withdrawal by Subject|2|||
142954102|NCT00465738|515370082|FG001|Overall Study|Withdrawal by Subject|0|||
142954103|NCT00465738|515370081|FG000|Overall Study|Other|2|||
142954104|NCT00465738|515370082|FG001|Overall Study|Other|5|||
142954105|NCT02725177|515370083|FG000|Overall Study|Physician Decision|4|||
142954106|NCT02725177|515370083|FG000|Overall Study|Adverse Event|1|||
142954107|NCT01589094|515370086|FG000|Overall Study|Did not receive treatment|2|||
142954108|NCT02531035|515371819|FG000|Overall Study|Death|0|||
142954109|NCT02531035|515371820|FG001|Overall Study|Death|1|||
142954110|NCT02531035|515371819|FG000|Overall Study|Protocol Violation|1|||
142954111|NCT02531035|515371820|FG001|Overall Study|Protocol Violation|1|||
142954112|NCT02531035|515371819|FG000|Overall Study|Noncompliance with study drug|8|||
142954113|NCT02531035|515371820|FG001|Overall Study|Noncompliance with study drug|3|||
142954114|NCT02531035|515371819|FG000|Overall Study|Physician Decision|1|||
142954115|NCT02531035|515371820|FG001|Overall Study|Physician Decision|0|||
142954116|NCT02531035|515371819|FG000|Overall Study|Adverse Event|16|||
142954117|NCT02531035|515371820|FG001|Overall Study|Adverse Event|45|||
142954118|NCT02531035|515371819|FG000|Overall Study|Other|3|||
142954119|NCT02531035|515371820|FG001|Overall Study|Other|2|||
142954120|NCT02531035|515371819|FG000|Overall Study|Withdrawal by Subject|42|||
142954121|NCT02531035|515371820|FG001|Overall Study|Withdrawal by Subject|32|||
142954122|NCT02531035|515371819|FG000|Overall Study|Lost to Follow-up|8|||
142954123|NCT02531035|515371820|FG001|Overall Study|Lost to Follow-up|10|||
142954124|NCT02531035|515371819|FG000|Overall Study|Randomized, not treated|2|||
142954125|NCT02531035|515371820|FG001|Overall Study|Randomized, not treated|1|||
142954126|NCT04168645|515371825|FG000|Overall Study|Lost to Follow-up|23|||
142954127|NCT04168645|515371826|FG001|Overall Study|Lost to Follow-up|28|||
142954128|NCT04168645|515371827|FG002|Overall Study|Lost to Follow-up|15|||
142954129|NCT04168645|515371828|FG003|Overall Study|Lost to Follow-up|12|||
142954130|NCT04168645|515371825|FG000|Overall Study|Death|1|||
142954131|NCT04168645|515371826|FG001|Overall Study|Death|1|||
142954132|NCT04168645|515371827|FG002|Overall Study|Death|0|||
142954133|NCT04168645|515371828|FG003|Overall Study|Death|0|||
142954134|NCT04168645|515371825|FG000|Overall Study|Withdrawal by Subject|5|||
142954135|NCT04168645|515371826|FG001|Overall Study|Withdrawal by Subject|2|||
142954136|NCT04168645|515371827|FG002|Overall Study|Withdrawal by Subject|2|||
142954137|NCT04168645|515371828|FG003|Overall Study|Withdrawal by Subject|2|||
142954138|NCT04168645|515371825|FG000|Overall Study|Administrative Withdrawal|3|||
142954139|NCT04168645|515371826|FG001|Overall Study|Administrative Withdrawal|1|||
142954140|NCT04168645|515371827|FG002|Overall Study|Administrative Withdrawal|1|||
142954141|NCT04168645|515371828|FG003|Overall Study|Administrative Withdrawal|3|||
142954142|NCT01158534|515371829|FG000|Overall Study|Withdrawal by Subject|1|||
142954143|NCT01158534|515371829|FG000|Overall Study|Death|1|||
142954144|NCT01158534|515371829|FG000|Overall Study|Other|1|||
142954145|NCT03042611|515371830|FG000|Core Phase|Withdrawal by Subject|13|||
142954146|NCT03042611|515371831|FG001|Core Phase|Withdrawal by Subject|4|||
142954147|NCT03042611|515371832|FG002|Core Phase|Withdrawal by Subject|0|||
142954148|NCT03042611|515371833|FG003|Core Phase|Withdrawal by Subject|0|||
142954149|NCT03042611|515371830|FG000|Core Phase|Death|232|||
142954150|NCT03042611|515371831|FG001|Core Phase|Death|110|||
142954151|NCT03042611|515371832|FG002|Core Phase|Death|0|||
142954152|NCT03042611|515371833|FG003|Core Phase|Death|0|||
142954153|NCT03042611|515371830|FG000|Core Phase|Lost to Follow-up|4|||
142954154|NCT03042611|515371831|FG001|Core Phase|Lost to Follow-up|7|||
142954155|NCT03042611|515371832|FG002|Core Phase|Lost to Follow-up|0|||
142954156|NCT03042611|515371833|FG003|Core Phase|Lost to Follow-up|0|||
142954157|NCT03042611|515371830|FG000|Core Phase|Physician Decision|7|||
142954158|NCT03042611|515371831|FG001|Core Phase|Physician Decision|2|||
142954159|NCT03042611|515371832|FG002|Core Phase|Physician Decision|0|||
142954160|NCT03042611|515371833|FG003|Core Phase|Physician Decision|0|||
142954161|NCT03042611|515371830|FG000|Core Phase|Study Closed|0|||
142954162|NCT03042611|515371831|FG001|Core Phase|Study Closed|1|||
142954163|NCT03042611|515371832|FG002|Core Phase|Study Closed|0|||
142954164|NCT03042611|515371833|FG003|Core Phase|Study Closed|0|||
142954165|NCT03042611|515371830|FG000|Extension Phase|Death|0|||
142954166|NCT03042611|515371831|FG001|Extension Phase|Death|0|||
142954167|NCT03042611|515371832|FG002|Extension Phase|Death|34|||
142954168|NCT03042611|515371833|FG003|Extension Phase|Death|16|||
142954169|NCT03042611|515371830|FG000|Extension Phase|Lost to Follow-up|0|||
142954170|NCT03042611|515371831|FG001|Extension Phase|Lost to Follow-up|0|||
142954171|NCT03042611|515371832|FG002|Extension Phase|Lost to Follow-up|1|||
142954172|NCT03042611|515371833|FG003|Extension Phase|Lost to Follow-up|1|||
142954173|NCT03042611|515371830|FG000|Extension Phase|Study Closed|0|||
142954174|NCT03042611|515371831|FG001|Extension Phase|Study Closed|0|||
142954175|NCT03042611|515371832|FG002|Extension Phase|Study Closed|17|||
142954176|NCT03042611|515371833|FG003|Extension Phase|Study Closed|11|||
142954177|NCT01666444|515371836|FG000|Overall Study|Did not initiate treatment|2|||
142954178|NCT01666444|515371837|FG001|Overall Study|Did not initiate treatment|1|||
142954179|NCT01371838|515371848|FG000|Overall Study|Withdrawal by Subject|27|||
142954180|NCT01371838|515371849|FG001|Overall Study|Withdrawal by Subject|33|||
142954181|NCT01371838|515371848|FG000|Overall Study|Lost to Follow-up|10|||
142954182|NCT01371838|515371849|FG001|Overall Study|Lost to Follow-up|20|||
142954183|NCT01371838|515371848|FG000|Overall Study|Death|3|||
142954184|NCT01371838|515371849|FG001|Overall Study|Death|4|||
142954185|NCT01371838|515371848|FG000|Overall Study|Protocol Violation|3|||
142954186|NCT01371838|515371849|FG001|Overall Study|Protocol Violation|0|||
142954187|NCT01371838|515371848|FG000|Overall Study|Investigator Decision|3|||
142954188|NCT01371838|515371849|FG001|Overall Study|Investigator Decision|8|||
142954189|NCT01371838|515371848|FG000|Overall Study|Last follow-up visit not conducted|2|||
142954190|NCT01371838|515371849|FG001|Overall Study|Last follow-up visit not conducted|0|||
142954191|NCT01371838|515371848|FG000|Overall Study|Lack of therapeutic response|0|||
142954192|NCT01371838|515371849|FG001|Overall Study|Lack of therapeutic response|1|||
142954193|NCT01371838|515371848|FG000|Overall Study|Surgery|1|||
142954194|NCT01371838|515371849|FG001|Overall Study|Surgery|0|||
142954195|NCT00641043|515371856|FG000|Overall Study|Adverse Event|6|||
142954196|NCT00641043|515371857|FG001|Overall Study|Adverse Event|4|||
142954197|NCT00641043|515371856|FG000|Overall Study|Protocol Violation|2|||
142954198|NCT00641043|515371857|FG001|Overall Study|Protocol Violation|3|||
142954199|NCT00641043|515371856|FG000|Overall Study|Lost to Follow-up|3|||
142954200|NCT00641043|515371857|FG001|Overall Study|Lost to Follow-up|2|||
142954201|NCT00641043|515371856|FG000|Overall Study|Withdrawal by Subject|4|||
142954202|NCT00641043|515371857|FG001|Overall Study|Withdrawal by Subject|4|||
142954203|NCT00641043|515371856|FG000|Overall Study|Other incl. lack of efficacy|4|||
142954204|NCT00641043|515371857|FG001|Overall Study|Other incl. lack of efficacy|2|||
142954205|NCT02584634|515371858|FG000|Overall Study|Adverse Event|3|||
142954206|NCT02584634|515371859|FG001|Overall Study|Adverse Event|5|||
142954207|NCT02584634|515371858|FG000|Overall Study|Death|0|||
142954208|NCT02584634|515371859|FG001|Overall Study|Death|1|||
142954209|NCT02584634|515371858|FG000|Overall Study|Lost to Follow-up|0|||
142954210|NCT02584634|515371859|FG001|Overall Study|Lost to Follow-up|1|||
142954211|NCT02584634|515371858|FG000|Overall Study|Physician Decision|1|||
142954212|NCT02584634|515371859|FG001|Overall Study|Physician Decision|2|||
142954213|NCT02584634|515371858|FG000|Overall Study|Progressive disease|7|||
142954214|NCT02584634|515371859|FG001|Overall Study|Progressive disease|15|||
142954215|NCT02584634|515371858|FG000|Overall Study|Withdrawal by Subject|1|||
142954216|NCT02584634|515371859|FG001|Overall Study|Withdrawal by Subject|1|||
142954217|NCT02584634|515371858|FG000|Overall Study|Other|0|||
142954218|NCT02584634|515371859|FG001|Overall Study|Other|6|||
142954219|NCT00474630|515371860|FG000|Overall Study|Adverse Event|98|||
142954220|NCT00474630|515371861|FG001|Overall Study|Adverse Event|26|||
142954221|NCT00474630|515371860|FG000|Overall Study|Lost to Follow-up|22|||
142954222|NCT00474630|515371861|FG001|Overall Study|Lost to Follow-up|15|||
142954223|NCT00474630|515371860|FG000|Overall Study|Withdrawal by Subject|21|||
142954224|NCT00474630|515371861|FG001|Overall Study|Withdrawal by Subject|15|||
142954225|NCT00474630|515371860|FG000|Overall Study|Protocol Violation|3|||
142954226|NCT00474630|515371861|FG001|Overall Study|Protocol Violation|4|||
142954227|NCT00474630|515371860|FG000|Overall Study|Lack of Efficacy|5|||
142954228|NCT00474630|515371861|FG001|Overall Study|Lack of Efficacy|6|||
142954229|NCT00474630|515371860|FG000|Overall Study|Drug noncompliance, other|11|||
142954230|NCT00474630|515371861|FG001|Overall Study|Drug noncompliance, other|4|||
142954231|NCT03088605|515371862|FG000|Overall Study|Withdrawal by Subject|1|||
142954232|NCT03088605|515371863|FG001|Overall Study|Withdrawal by Subject|0|||
142954233|NCT02225223|515371864|FG000|Overall Study|Death|10|||
142954234|NCT02225223|515371865|FG001|Overall Study|Death|1|||
142954235|NCT02225223|515371864|FG000|Overall Study|Lost to Follow-up|5|||
142954236|NCT02225223|515371865|FG001|Overall Study|Lost to Follow-up|0|||
142954237|NCT02225223|515371864|FG000|Overall Study|Other|1|||
142954238|NCT02225223|515371865|FG001|Overall Study|Other|2|||
142954239|NCT02225223|515371864|FG000|Overall Study|Physician Decision|1|||
142954240|NCT02225223|515371865|FG001|Overall Study|Physician Decision|0|||
142954241|NCT02225223|515371864|FG000|Overall Study|Withdrawal by Subject|2|||
142954242|NCT02225223|515371865|FG001|Overall Study|Withdrawal by Subject|2|||
142954243|NCT03666143|515371867|FG000|Overall Study|Death|158|||
142954244|NCT03666143|515371867|FG000|Overall Study|Sponsor Decision|31|||
142954245|NCT03666143|515371867|FG000|Overall Study|Withdrawal by Subject|11|||
142954246|NCT03666143|515371867|FG000|Overall Study|Lost to Follow-up|5|||
142954247|NCT03666143|515371867|FG000|Overall Study|Physician Decision|1|||
142954248|NCT03666143|515371867|FG000|Overall Study|Rolled into extension study|9|||
142954249|NCT03666143|515371867|FG000|Overall Study|Progressive Disease|1|||
143003117|NCT01049360|515548749|FG005|Period 2|Protocol Violation|0|||
142954250|NCT00958568|515371868|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
142954251|NCT00958568|515371869|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
142954252|NCT00958568|515371870|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
142954253|NCT00958568|515371871|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
142954254|NCT00958568|515371868|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
142954255|NCT00958568|515371869|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
142954256|NCT00958568|515371870|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
142954257|NCT00958568|515371871|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
142954258|NCT00958568|515371868|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
142954259|NCT00958568|515371869|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
142954260|NCT00958568|515371870|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
142954261|NCT00958568|515371871|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
142954262|NCT00958568|515371868|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
142954263|NCT00958568|515371869|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
142954264|NCT00958568|515371870|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
142954265|NCT00958568|515371871|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
142954266|NCT00958568|515371868|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
142954267|NCT00958568|515371869|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
142954268|NCT00958568|515371870|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
142954269|NCT00958568|515371871|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
142954270|NCT00958568|515371868|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
142954271|NCT00958568|515371869|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
142954272|NCT00958568|515371870|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
142954273|NCT00958568|515371871|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
142954274|NCT00958568|515371868|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
142954275|NCT00958568|515371869|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
142954276|NCT00958568|515371870|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
142954277|NCT00958568|515371871|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
142954278|NCT00958568|515371868|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
142954279|NCT00958568|515371869|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
142954280|NCT00958568|515371870|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
142954281|NCT00958568|515371871|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
142954282|NCT00958568|515371868|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
142954283|NCT00958568|515371869|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
142954284|NCT00958568|515371870|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
142954285|NCT00958568|515371871|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
142954286|NCT00958568|515371868|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
142954287|NCT00958568|515371869|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
142954288|NCT00958568|515371870|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
142954289|NCT00958568|515371871|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
142954290|NCT00958568|515371868|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
142954291|NCT00958568|515371869|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
142954292|NCT00958568|515371870|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
142954293|NCT00958568|515371871|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
142954294|NCT00958568|515371868|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
142954295|NCT00958568|515371869|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
142954296|NCT00958568|515371870|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
142954297|NCT00958568|515371871|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
142954298|NCT00958568|515371868|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
142954299|NCT00958568|515371869|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
142954300|NCT00958568|515371870|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
142954301|NCT00958568|515371871|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
142954302|NCT00958568|515371868|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
142954303|NCT00958568|515371869|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
142954304|NCT00958568|515371870|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
142954305|NCT00958568|515371871|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
142954306|NCT00958568|515371868|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
142954307|NCT00958568|515371869|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
142954308|NCT00958568|515371870|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
142954309|NCT00958568|515371871|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
142954310|NCT00958568|515371868|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
142954311|NCT00958568|515371869|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
142954312|NCT00958568|515371870|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
142954313|NCT00958568|515371871|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
142954314|NCT00958568|515371868|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
142954315|NCT00958568|515371869|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
142954316|NCT00958568|515371870|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
142954317|NCT00958568|515371871|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
142954318|NCT00958568|515371868|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
142954319|NCT00958568|515371869|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
142954320|NCT00958568|515371870|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
142954321|NCT00958568|515371871|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
142954322|NCT00958568|515371868|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
142954323|NCT00958568|515371869|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
142954324|NCT00958568|515371870|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
142954325|NCT00958568|515371871|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
142954326|NCT00958568|515371868|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
142954327|NCT00958568|515371869|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
142954328|NCT00958568|515371870|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
142954329|NCT00958568|515371871|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
142954330|NCT00958568|515371868|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
142954331|NCT00958568|515371869|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
142954332|NCT00958568|515371870|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
142954333|NCT00958568|515371871|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
142954334|NCT00958568|515371868|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
142954335|NCT00958568|515371869|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
142954336|NCT00958568|515371870|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
142954337|NCT00958568|515371871|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
142954338|NCT00958568|515371868|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
142954339|NCT00958568|515371869|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
142954340|NCT00958568|515371870|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
142954341|NCT00958568|515371871|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
142954342|NCT00958568|515371868|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
142954343|NCT00958568|515371869|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
142954344|NCT00958568|515371870|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
142954345|NCT00958568|515371871|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
142954346|NCT00958568|515371868|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
142954347|NCT00958568|515371869|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
142954348|NCT00958568|515371870|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
142954349|NCT00958568|515371871|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
142954350|NCT00958568|515371868|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
142954351|NCT00958568|515371869|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
142954352|NCT00958568|515371870|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
142954353|NCT00958568|515371871|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
142954354|NCT00958568|515371868|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
142954355|NCT00958568|515371869|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
142954356|NCT00958568|515371870|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
142954357|NCT00958568|515371871|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
142954358|NCT00958568|515371868|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
142954359|NCT00958568|515371869|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
142954360|NCT00958568|515371870|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
142954361|NCT00958568|515371871|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
142954362|NCT00958568|515371868|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
142954363|NCT00958568|515371869|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
142954364|NCT00958568|515371870|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
142954365|NCT00958568|515371871|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
142954366|NCT00283712|515371872|FG000|Overall Study|Death|0|||
142954367|NCT00283712|515371873|FG001|Overall Study|Death|1|||
142954368|NCT02747043|515371877|FG000|Overall Study|Other|1|||
142954369|NCT02747043|515371878|FG001|Overall Study|Other|1|||
142954370|NCT02747043|515371877|FG000|Overall Study|Adverse Event|3|||
142954371|NCT02747043|515371878|FG001|Overall Study|Adverse Event|1|||
142954372|NCT02747043|515371877|FG000|Overall Study|Withdrawal by Subject|1|||
142954373|NCT02747043|515371878|FG001|Overall Study|Withdrawal by Subject|1|||
142954374|NCT02747043|515371877|FG000|Overall Study|Physician Decision|1|||
142954375|NCT02747043|515371878|FG001|Overall Study|Physician Decision|1|||
142954376|NCT02747043|515371877|FG000|Overall Study|Protocol Violation|0|||
142954377|NCT02747043|515371878|FG001|Overall Study|Protocol Violation|1|||
142954378|NCT02747043|515371877|FG000|Overall Study|Disease progression|4|||
142954379|NCT02747043|515371878|FG001|Overall Study|Disease progression|0|||
142954380|NCT03069690|515371881|FG000|Pregnancy Intervention|Pregnancy loss|9|||
142954381|NCT03069690|515371882|FG001|Pregnancy Intervention|Pregnancy loss|4|||
142954382|NCT03069690|515371883|FG002|Pregnancy Intervention|Pregnancy loss|0|||
142954383|NCT03069690|515371884|FG003|Pregnancy Intervention|Pregnancy loss|0|||
142954384|NCT03069690|515371885|FG004|Pregnancy Intervention|Pregnancy loss|0|||
142954385|NCT03069690|515371886|FG005|Pregnancy Intervention|Pregnancy loss|0|||
142954386|NCT03069690|515371881|FG000|Pregnancy Intervention|Lost to Follow-up|16|||
142954387|NCT03069690|515371882|FG001|Pregnancy Intervention|Lost to Follow-up|14|||
142954388|NCT03069690|515371883|FG002|Pregnancy Intervention|Lost to Follow-up|0|||
142954389|NCT03069690|515371884|FG003|Pregnancy Intervention|Lost to Follow-up|0|||
142954390|NCT03069690|515371885|FG004|Pregnancy Intervention|Lost to Follow-up|0|||
142954391|NCT03069690|515371886|FG005|Pregnancy Intervention|Lost to Follow-up|0|||
142954392|NCT03069690|515371881|FG000|Postpartum Intervention|Lost to Follow-up|0|||
142954393|NCT03069690|515371882|FG001|Postpartum Intervention|Lost to Follow-up|0|||
142954394|NCT03069690|515371883|FG002|Postpartum Intervention|Lost to Follow-up|5|||
142954395|NCT03069690|515371884|FG003|Postpartum Intervention|Lost to Follow-up|5|||
142954396|NCT03069690|515371885|FG004|Postpartum Intervention|Lost to Follow-up|2|||
142954397|NCT03069690|515371886|FG005|Postpartum Intervention|Lost to Follow-up|4|||
142954398|NCT02564120|515371887|FG000|Overall Study|Did not return release forms|160|||
142954399|NCT02564120|515371887|FG000|Overall Study|Death|58|||
142954400|NCT02564120|515371887|FG000|Overall Study|Withdrawal by Subject|204|||
142954401|NCT02564120|515371887|FG000|Overall Study|Other medical condition|24|||
142954402|NCT00553059|515371895|FG000|Overall Study|Deemed ineligible|1|||
142954403|NCT00553059|515371896|FG001|Overall Study|Deemed ineligible|1|||
142954404|NCT00553059|515371895|FG000|Overall Study|Drug supply not available|0|||
142954405|NCT00553059|515371896|FG001|Overall Study|Drug supply not available|1|||
142954406|NCT01966731|515371897|FG000|Overall Study|Death|2|||
142954407|NCT01966731|515371897|FG000|Overall Study|Lost to Follow-up|1|||
142954408|NCT01966731|515371897|FG000|Overall Study|Physician Decision|2|||
142954409|NCT01966731|515371897|FG000|Overall Study|Follow up is not complete|600|||
142954410|NCT01966731|515371897|FG000|Overall Study|Screening Failure|29|||
142954411|NCT01966731|515371897|FG000|Overall Study|Found to be ineligible|1|||
142954412|NCT00201201|515371898|FG000|Overall Study|Death|0|||
142954413|NCT00201201|515371899|FG001|Overall Study|Death|2|||
142954414|NCT00201201|515371898|FG000|Overall Study|Withdrawal by Subject|5|||
142954415|NCT00201201|515371899|FG001|Overall Study|Withdrawal by Subject|5|||
142954416|NCT01342640|515371903|FG000|Overall Study|Adverse Event|3|||
142954417|NCT01342640|515371903|FG000|Overall Study|Protocol Violation|16|||
142954418|NCT01342640|515371903|FG000|Overall Study|Lost to Follow-up|21|||
142954419|NCT01342640|515371903|FG000|Overall Study|Other|1|||
142954420|NCT00891657|515371904|FG000|Overall Study|Withdrawal by Subject|1|||
142954421|NCT00891657|515371905|FG001|Overall Study|Withdrawal by Subject|1|||
142954422|NCT00545818|515371906|FG000|Overall Study|Protocol Violation|1|||
142954423|NCT00545818|515371907|FG001|Overall Study|Protocol Violation|0|||
142954424|NCT00545818|515371906|FG000|Overall Study|Adverse Event|1|||
142954425|NCT00545818|515371907|FG001|Overall Study|Adverse Event|1|||
142954426|NCT00545818|515371906|FG000|Overall Study|Lost to Follow-up|1|||
142954427|NCT00545818|515371907|FG001|Overall Study|Lost to Follow-up|6|||
142954428|NCT00479466|515371910|FG000|Overall Study|Adverse Event|5|||
142954429|NCT00479466|515371911|FG001|Overall Study|Adverse Event|1|||
142954430|NCT00479466|515371912|FG002|Overall Study|Adverse Event|0|||
142954431|NCT00479466|515371913|FG003|Overall Study|Adverse Event|1|||
142954432|NCT00479466|515371914|FG004|Overall Study|Adverse Event|2|||
142954433|NCT00479466|515371915|FG005|Overall Study|Adverse Event|0|||
142954434|NCT00479466|515371910|FG000|Overall Study|Hyperglycemia|0|||
142954435|NCT00479466|515371911|FG001|Overall Study|Hyperglycemia|0|||
142954436|NCT00479466|515371912|FG002|Overall Study|Hyperglycemia|0|||
142954437|NCT00479466|515371913|FG003|Overall Study|Hyperglycemia|0|||
142954438|NCT00479466|515371914|FG004|Overall Study|Hyperglycemia|0|||
142954439|NCT00479466|515371915|FG005|Overall Study|Hyperglycemia|1|||
142954440|NCT00479466|515371910|FG000|Overall Study|Lack of Efficacy|2|||
142954441|NCT00479466|515371911|FG001|Overall Study|Lack of Efficacy|0|||
142954442|NCT00479466|515371912|FG002|Overall Study|Lack of Efficacy|1|||
142954443|NCT00479466|515371913|FG003|Overall Study|Lack of Efficacy|0|||
142954444|NCT00479466|515371914|FG004|Overall Study|Lack of Efficacy|0|||
142954445|NCT00479466|515371915|FG005|Overall Study|Lack of Efficacy|0|||
142954446|NCT00479466|515371910|FG000|Overall Study|Lost to Follow-up|0|||
142954447|NCT00479466|515371911|FG001|Overall Study|Lost to Follow-up|1|||
142954448|NCT00479466|515371912|FG002|Overall Study|Lost to Follow-up|1|||
142954449|NCT00479466|515371913|FG003|Overall Study|Lost to Follow-up|0|||
142954450|NCT00479466|515371914|FG004|Overall Study|Lost to Follow-up|2|||
142954451|NCT00479466|515371915|FG005|Overall Study|Lost to Follow-up|2|||
142954452|NCT00479466|515371910|FG000|Overall Study|Physician Decision|2|||
142954453|NCT00479466|515371911|FG001|Overall Study|Physician Decision|1|||
142954454|NCT00479466|515371912|FG002|Overall Study|Physician Decision|1|||
142954455|NCT00479466|515371913|FG003|Overall Study|Physician Decision|0|||
142954456|NCT00479466|515371914|FG004|Overall Study|Physician Decision|0|||
142954457|NCT00479466|515371915|FG005|Overall Study|Physician Decision|0|||
142954458|NCT00479466|515371910|FG000|Overall Study|Pregnancy|0|||
142954459|NCT00479466|515371911|FG001|Overall Study|Pregnancy|0|||
142954460|NCT00479466|515371912|FG002|Overall Study|Pregnancy|0|||
142954461|NCT00479466|515371913|FG003|Overall Study|Pregnancy|0|||
142954462|NCT00479466|515371914|FG004|Overall Study|Pregnancy|1|||
142954463|NCT00479466|515371915|FG005|Overall Study|Pregnancy|0|||
142954464|NCT00479466|515371910|FG000|Overall Study|Protocol Violation|1|||
142954465|NCT00479466|515371911|FG001|Overall Study|Protocol Violation|0|||
142954466|NCT00479466|515371912|FG002|Overall Study|Protocol Violation|0|||
142954467|NCT00479466|515371913|FG003|Overall Study|Protocol Violation|0|||
142954468|NCT00479466|515371914|FG004|Overall Study|Protocol Violation|0|||
142954469|NCT00479466|515371915|FG005|Overall Study|Protocol Violation|0|||
142954470|NCT00479466|515371910|FG000|Overall Study|Withdrawal by Subject|3|||
142954471|NCT00479466|515371911|FG001|Overall Study|Withdrawal by Subject|5|||
142954472|NCT00479466|515371912|FG002|Overall Study|Withdrawal by Subject|0|||
142954473|NCT00479466|515371913|FG003|Overall Study|Withdrawal by Subject|2|||
142954474|NCT00479466|515371914|FG004|Overall Study|Withdrawal by Subject|3|||
142954475|NCT00479466|515371915|FG005|Overall Study|Withdrawal by Subject|1|||
142954476|NCT02927171|515371919|FG000|Overall Study|Lost to Follow-up|0|||
142954477|NCT02927171|515371920|FG001|Overall Study|Lost to Follow-up|1|||
142954478|NCT04101422|515371925|FG000|Overall Study|Ineligible|1|||
142954479|NCT04101422|515371926|FG001|Overall Study|Ineligible|0|||
142954480|NCT04101422|515371927|FG002|Overall Study|Ineligible|9|||
142954481|NCT04101422|515371928|FG003|Overall Study|Ineligible|0|||
142954482|NCT04101422|515371925|FG000|Overall Study|Withdrawal by Subject|0|||
142954483|NCT04101422|515371926|FG001|Overall Study|Withdrawal by Subject|0|||
142954484|NCT04101422|515371927|FG002|Overall Study|Withdrawal by Subject|1|||
142954485|NCT04101422|515371928|FG003|Overall Study|Withdrawal by Subject|0|||
142954486|NCT04101422|515371925|FG000|Overall Study|Not attending to the stimuli|0|||
142954487|NCT04101422|515371926|FG001|Overall Study|Not attending to the stimuli|0|||
142954488|NCT04101422|515371927|FG002|Overall Study|Not attending to the stimuli|4|||
142954489|NCT04101422|515371928|FG003|Overall Study|Not attending to the stimuli|0|||
142954490|NCT04101422|515371925|FG000|Overall Study|Did not download app|0|||
142954491|NCT04101422|515371926|FG001|Overall Study|Did not download app|0|||
142954492|NCT04101422|515371927|FG002|Overall Study|Did not download app|0|||
142954493|NCT04101422|515371928|FG003|Overall Study|Did not download app|17|||
142954494|NCT04101422|515371925|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
142954495|NCT04101422|515371926|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
142954496|NCT04101422|515371927|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
142954497|NCT04101422|515371928|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
142954498|NCT00850499|515371929|FG000|Overall Study|Adverse Event|3|||
142954499|NCT00850499|515371930|FG001|Overall Study|Adverse Event|1|||
142954500|NCT00850499|515371929|FG000|Overall Study|Lack of Efficacy|0|||
142954501|NCT00850499|515371930|FG001|Overall Study|Lack of Efficacy|1|||
142954502|NCT04498910|515371931|FG000|Overall Study|Lost to Follow-up|0|||
142954503|NCT04498910|515371932|FG001|Overall Study|Lost to Follow-up|1|||
142954504|NCT04498910|515371931|FG000|Overall Study|Withdrawal by Subject|2|||
142954505|NCT04498910|515371932|FG001|Overall Study|Withdrawal by Subject|1|||
142954506|NCT04498910|515371931|FG000|Overall Study|Adverse Event|1|||
142954507|NCT04498910|515371932|FG001|Overall Study|Adverse Event|0|||
142954508|NCT02926573|515371936|FG000|Overall Study|Nausea|1|||
142954509|NCT02926573|515371937|FG001|Overall Study|Nausea|0|||
142954510|NCT02926573|515371936|FG000|Overall Study|Remain intubated|2|||
142954511|NCT02926573|515371937|FG001|Overall Study|Remain intubated|2|||
142954512|NCT02926573|515371936|FG000|Overall Study|Change in surgery plan|3|||
142954513|NCT02926573|515371937|FG001|Overall Study|Change in surgery plan|1|||
142954514|NCT02926573|515371936|FG000|Overall Study|Change to outpatient status|5|||
142954515|NCT02926573|515371937|FG001|Overall Study|Change to outpatient status|1|||
142954516|NCT02926573|515371936|FG000|Overall Study|Withdrawal by Subject|0|||
142954517|NCT02926573|515371937|FG001|Overall Study|Withdrawal by Subject|2|||
142954518|NCT02926573|515371936|FG000|Overall Study|Return to operating room|0|||
142954519|NCT02926573|515371937|FG001|Overall Study|Return to operating room|2|||
142954520|NCT02926573|515371936|FG000|Overall Study|Delirium|0|||
142954521|NCT02926573|515371937|FG001|Overall Study|Delirium|1|||
142954522|NCT00611455|515371938|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
142954523|NCT00611455|515371939|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
142954524|NCT00611455|515371940|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
142954525|NCT00611455|515371938|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
142954526|NCT00611455|515371939|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
142954527|NCT00611455|515371940|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
142954528|NCT00611455|515371938|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
142954529|NCT00611455|515371939|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
142954530|NCT00611455|515371940|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
142954531|NCT00611455|515371938|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
142954532|NCT00611455|515371939|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
142954533|NCT00611455|515371940|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
142954534|NCT00611455|515371938|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
142954535|NCT00611455|515371939|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
142954536|NCT00611455|515371940|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
142954537|NCT00611455|515371938|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
142954538|NCT00611455|515371939|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
142954539|NCT00611455|515371940|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
142954540|NCT00611455|515371938|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
142954541|NCT00611455|515371939|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
142954542|NCT00611455|515371940|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
142954543|NCT00611455|515371938|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
142954544|NCT00611455|515371939|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
142954545|NCT00611455|515371940|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
142954546|NCT00611455|515371938|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
142954547|NCT00611455|515371939|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
142954548|NCT00611455|515371940|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
142954549|NCT00611455|515371938|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
142954550|NCT00611455|515371939|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
142954551|NCT00611455|515371940|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
142954552|NCT00611455|515371938|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
142954553|NCT00611455|515371939|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
142954554|NCT00611455|515371940|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
142954555|NCT00611455|515371938|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
142954556|NCT00611455|515371939|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
142954557|NCT00611455|515371940|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
142954558|NCT00611455|515371938|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
142954559|NCT00611455|515371939|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
142954560|NCT00611455|515371940|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
142954561|NCT00611455|515371938|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
142954562|NCT00611455|515371939|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
142954563|NCT00611455|515371940|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
142954564|NCT00611455|515371938|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
142954565|NCT00611455|515371939|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
142954566|NCT00611455|515371940|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
142954567|NCT00611455|515371938|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
142954568|NCT00611455|515371939|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
142954569|NCT00611455|515371940|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
142954570|NCT00611455|515371938|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
142954571|NCT00611455|515371939|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
142954572|NCT00611455|515371940|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
142954573|NCT00611455|515371938|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
142954574|NCT00611455|515371939|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
142954575|NCT00611455|515371940|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
142954576|NCT00611455|515371938|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
142954577|NCT00611455|515371939|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
142954578|NCT00611455|515371940|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
142954579|NCT00611455|515371938|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
142954580|NCT00611455|515371939|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
142954581|NCT00611455|515371940|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
142954582|NCT00611455|515371938|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
142954583|NCT00611455|515371939|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
142954584|NCT00611455|515371940|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
142954585|NCT00858702|515371943|FG000|Overall Study|Lack of Efficacy|1|||
142954586|NCT00858702|515371944|FG001|Overall Study|Lack of Efficacy|0|||
142954587|NCT00858702|515371943|FG000|Overall Study|Protocol Violation|1|||
142954588|NCT00858702|515371944|FG001|Overall Study|Protocol Violation|1|||
142954589|NCT00858702|515371943|FG000|Overall Study|Other|2|||
142954590|NCT00858702|515371944|FG001|Overall Study|Other|1|||
142954591|NCT00858702|515371943|FG000|Overall Study|Withdrawal by Subject|1|||
142954592|NCT00858702|515371944|FG001|Overall Study|Withdrawal by Subject|0|||
142954593|NCT01507545|515371945|FG000|Overall Study|Withdrawal by Subject|6|||
142954594|NCT01507545|515371946|FG001|Overall Study|Withdrawal by Subject|2|||
142954595|NCT01507545|515371945|FG000|Overall Study|Lost to Follow-up|1|||
142954596|NCT01507545|515371946|FG001|Overall Study|Lost to Follow-up|0|||
142954597|NCT01507545|515371945|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
142954598|NCT01507545|515371946|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
142954599|NCT01507545|515371945|FG000|Overall Study|Progressive disease|60|||
143455226|NCT02217475|517210848|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
143455227|NCT02217475|517210846|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
142954600|NCT01507545|515371946|FG001|Overall Study|Progressive disease|27|||
142954601|NCT01507545|515371945|FG000|Overall Study|Other|6|||
142954602|NCT01507545|515371946|FG001|Overall Study|Other|4|||
142954603|NCT00790296|515371948|FG000|Overall Study|Did not meet study eligibility criteria|1|||
142954604|NCT00790296|515371949|FG001|Overall Study|Did not meet study eligibility criteria|1|||
142954605|NCT00790296|515371948|FG000|Overall Study|Adverse Event|0|||
142954606|NCT00790296|515371949|FG001|Overall Study|Adverse Event|1|||
142954607|NCT01671488|515371950|FG000|Overall Study|Withdrawal by Subject|1|||
142954608|NCT01753518|515371951|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
142954609|NCT01753518|515371952|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
142954610|NCT01753518|515371951|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
142954611|NCT01753518|515371952|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
142954612|NCT01753518|515371951|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
142954613|NCT01753518|515371952|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
142954614|NCT01753518|515371951|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
142954615|NCT01753518|515371952|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
142954616|NCT01214434|515371955|FG000|Overall Study|Withdrawal by Subject|1|||
142954617|NCT01214434|515371956|FG001|Overall Study|Withdrawal by Subject|0|||
142954618|NCT01214434|515371955|FG000|Overall Study|Lost to Follow-up|2|||
142954619|NCT01214434|515371956|FG001|Overall Study|Lost to Follow-up|2|||
142954620|NCT01214434|515371955|FG000|Overall Study|Site error|1|||
142954621|NCT01214434|515371956|FG001|Overall Study|Site error|0|||
142954622|NCT00940342|515371957|FG000|Overall Study|Adverse Event|0|||
142954623|NCT00940342|515371958|FG001|Overall Study|Adverse Event|2|||
142954624|NCT00940342|515371959|FG002|Overall Study|Adverse Event|1|||
142954625|NCT03503773|515371960|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
142954626|NCT03503773|515371961|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
142954627|NCT03503773|515371960|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
142954628|NCT03503773|515371961|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
142954629|NCT03503773|515371960|FG000|Overall Study|Not completing the primary ABPM|3|||
142954630|NCT03503773|515371961|FG001|Overall Study|Not completing the primary ABPM|1|||
142954631|NCT03503773|515371960|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
142954632|NCT03503773|515371961|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
142954633|NCT00945191|515371966|FG000|Overall Study|Did not achieve a complete response|18|||
142954634|NCT00945191|515371966|FG000|Overall Study|Participant relocated to another state|1|||
142954635|NCT00945191|515371966|FG000|Overall Study|Disease progression|3|||
142954636|NCT00945191|515371966|FG000|Overall Study|Serious adverse event or adverse event|1|||
142954637|NCT00945191|515371966|FG000|Overall Study|Investigator's discretion|1|||
142954638|NCT01845077|515371967|FG000|Washout Period|Lost to Follow-up|0|||
142954639|NCT01845077|515371968|FG001|Washout Period|Lost to Follow-up|1|||
142954640|NCT01845077|515371969|FG002|Washout Period|Lost to Follow-up|0|||
142954641|NCT01845077|515371970|FG003|Washout Period|Lost to Follow-up|1|||
142954642|NCT01845077|515371971|FG004|Washout Period|Lost to Follow-up|0|||
142954643|NCT01845077|515371972|FG005|Washout Period|Lost to Follow-up|1|||
142954644|NCT01845077|515371967|FG000|Washout Period|Adverse Event|1|||
142954645|NCT01845077|515371968|FG001|Washout Period|Adverse Event|0|||
142954646|NCT01845077|515371969|FG002|Washout Period|Adverse Event|0|||
142954647|NCT01845077|515371970|FG003|Washout Period|Adverse Event|0|||
142954648|NCT01845077|515371971|FG004|Washout Period|Adverse Event|0|||
142954649|NCT01845077|515371972|FG005|Washout Period|Adverse Event|0|||
142954650|NCT01845077|515371967|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
142954651|NCT01845077|515371968|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
142954652|NCT01845077|515371969|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
142954653|NCT01845077|515371970|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
142954654|NCT01845077|515371971|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
142954655|NCT01845077|515371972|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
142954656|NCT01845077|515371967|FG000|Washout Period|Protocol Violation|0|||
142954657|NCT01845077|515371968|FG001|Washout Period|Protocol Violation|0|||
142954658|NCT01845077|515371969|FG002|Washout Period|Protocol Violation|0|||
142954659|NCT01845077|515371970|FG003|Washout Period|Protocol Violation|1|||
142954660|NCT01845077|515371971|FG004|Washout Period|Protocol Violation|1|||
142954661|NCT01845077|515371972|FG005|Washout Period|Protocol Violation|0|||
142954662|NCT00408681|515371975|FG000|Overall Study|Lack of Efficacy|2|||
142954663|NCT00408681|515371975|FG000|Overall Study|Adverse Event|7|||
142954664|NCT01787591|515371976|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
142954665|NCT01787591|515371977|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
142954666|NCT01787591|515371978|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
142954667|NCT01787591|515371979|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
142954668|NCT02707757|515371982|FG000|Overall Study|Protocol Violation|3|||
143455228|NCT02217475|517210847|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
142954669|NCT02707757|515371983|FG001|Overall Study|Protocol Violation|2|||
142954670|NCT02707757|515371982|FG000|Overall Study|Withdrawal by Subject|2|||
142954671|NCT02707757|515371983|FG001|Overall Study|Withdrawal by Subject|0|||
142954672|NCT02707757|515371982|FG000|Overall Study|Death|0|||
142954673|NCT02707757|515371983|FG001|Overall Study|Death|1|||
142954674|NCT02707757|515371982|FG000|Overall Study|Adverse Event|6|||
142954675|NCT02707757|515371983|FG001|Overall Study|Adverse Event|4|||
142954676|NCT02707757|515371982|FG000|Overall Study|Renal transplant/elective operation|1|||
142954677|NCT02707757|515371983|FG001|Overall Study|Renal transplant/elective operation|5|||
142954678|NCT00638846|515371984|FG000|Overall Study|Adverse Event|0|||
142954679|NCT00638846|515371985|FG001|Overall Study|Adverse Event|1|||
142954680|NCT00638846|515371984|FG000|Overall Study|Lost to Follow-up|3|||
142954681|NCT00638846|515371985|FG001|Overall Study|Lost to Follow-up|2|||
142954682|NCT00638846|515371984|FG000|Overall Study|lens issue|1|||
142954683|NCT00638846|515371985|FG001|Overall Study|lens issue|3|||
142954684|NCT00734929|515371990|FG000|Overall Study|Lost to Follow-up|1|||
142954685|NCT00734929|515371991|FG001|Overall Study|Lost to Follow-up|2|||
142954686|NCT00734929|515371990|FG000|Overall Study|No intervention/ screen fail|5|||
142954687|NCT00734929|515371991|FG001|Overall Study|No intervention/ screen fail|3|||
142954688|NCT02749370|515371992|FG000|Overall Study|Withdrawal by Subject|11|||
142954689|NCT02749370|515371992|FG000|Overall Study|Lost to Follow-up|3|||
142954690|NCT03894904|515371993|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
142954691|NCT03894904|515371994|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
142954692|NCT03894904|515371993|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
142954693|NCT03894904|515371994|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
142954694|NCT02190435|515371995|FG000|Overall Study|First 12 patients were lead-ins|12|||
142954695|NCT02190435|515371996|FG001|Overall Study|First 12 patients were lead-ins|0|||
142954696|NCT02190435|515371995|FG000|Overall Study|3 consented screen fails|3|||
142954697|NCT02190435|515371996|FG001|Overall Study|3 consented screen fails|0|||
142954698|NCT02699515|515373718|FG000|Overall Study|Death|3|||
142954699|NCT02699515|515373719|FG001|Overall Study|Death|3|||
142954700|NCT02699515|515373720|FG002|Overall Study|Death|3|||
142954701|NCT02699515|515373721|FG003|Overall Study|Death|23|||
142954702|NCT02699515|515373722|FG004|Overall Study|Death|22|||
142954703|NCT02699515|515373723|FG005|Overall Study|Death|23|||
142954704|NCT02699515|515373724|FG006|Overall Study|Death|3|||
142954705|NCT02699515|515373725|FG007|Overall Study|Death|5|||
142954706|NCT02699515|515373718|FG000|Overall Study|Withdrawal by Subject|0|||
142954707|NCT02699515|515373719|FG001|Overall Study|Withdrawal by Subject|0|||
142954708|NCT02699515|515373720|FG002|Overall Study|Withdrawal by Subject|3|||
142954709|NCT02699515|515373721|FG003|Overall Study|Withdrawal by Subject|1|||
142954710|NCT02699515|515373722|FG004|Overall Study|Withdrawal by Subject|5|||
142954711|NCT02699515|515373723|FG005|Overall Study|Withdrawal by Subject|3|||
142954712|NCT02699515|515373724|FG006|Overall Study|Withdrawal by Subject|0|||
142954713|NCT02699515|515373725|FG007|Overall Study|Withdrawal by Subject|1|||
142954714|NCT02699515|515373718|FG000|Overall Study|Other|1|||
142954715|NCT02699515|515373719|FG001|Overall Study|Other|0|||
142954716|NCT02699515|515373720|FG002|Overall Study|Other|1|||
142954717|NCT02699515|515373721|FG003|Overall Study|Other|6|||
142954718|NCT02699515|515373722|FG004|Overall Study|Other|4|||
142954719|NCT02699515|515373723|FG005|Overall Study|Other|3|||
142954720|NCT02699515|515373724|FG006|Overall Study|Other|0|||
142954721|NCT02699515|515373725|FG007|Overall Study|Other|0|||
142954722|NCT01013883|515373730|FG000|Overall Study|Lost to Follow-up|2|||
142954723|NCT01013883|515373731|FG001|Overall Study|Lost to Follow-up|2|||
142954724|NCT02241512|515373732|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
142954725|NCT02241512|515373733|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
142954726|NCT04275310|515373736|FG000|Overall Study|Non-randomized due to running out of funding|4|||
142954727|NCT04275310|515373737|FG001|Overall Study|Non-randomized due to running out of funding|0|||
142954728|NCT03567291|515373738|FG000|Period I|Adverse Event|14|||
142954729|NCT03567291|515373739|FG001|Period I|Adverse Event|0|||
142954730|NCT03567291|515373740|FG002|Period I|Adverse Event|0|||
142954731|NCT03567291|515373741|FG003|Period I|Adverse Event|0|||
142954732|NCT03567291|515373738|FG000|Period I|Protocol Violation|1|||
142954733|NCT03567291|515373739|FG001|Period I|Protocol Violation|0|||
142954734|NCT03567291|515373740|FG002|Period I|Protocol Violation|0|||
142954735|NCT03567291|515373741|FG003|Period I|Protocol Violation|0|||
142954736|NCT03567291|515373738|FG000|Period I|Withdrawal by Subject|23|||
142954737|NCT03567291|515373739|FG001|Period I|Withdrawal by Subject|0|||
142954738|NCT03567291|515373740|FG002|Period I|Withdrawal by Subject|0|||
142954739|NCT03567291|515373741|FG003|Period I|Withdrawal by Subject|0|||
142954740|NCT03567291|515373738|FG000|Period I|Lost to Follow-up|2|||
142954741|NCT03567291|515373739|FG001|Period I|Lost to Follow-up|0|||
142954742|NCT03567291|515373740|FG002|Period I|Lost to Follow-up|0|||
142954743|NCT03567291|515373741|FG003|Period I|Lost to Follow-up|0|||
142954744|NCT03567291|515373738|FG000|Period I|Terminated by sponsor|44|||
142954745|NCT03567291|515373739|FG001|Period I|Terminated by sponsor|0|||
142954746|NCT03567291|515373740|FG002|Period I|Terminated by sponsor|0|||
142954747|NCT03567291|515373741|FG003|Period I|Terminated by sponsor|0|||
142954748|NCT03567291|515373738|FG000|Period I|Missing or unknown|7|||
142954749|NCT03567291|515373739|FG001|Period I|Missing or unknown|0|||
142954750|NCT03567291|515373740|FG002|Period I|Missing or unknown|0|||
142954751|NCT03567291|515373741|FG003|Period I|Missing or unknown|0|||
142954752|NCT03567291|515373738|FG000|Period II|Adverse Event|0|||
142954753|NCT03567291|515373739|FG001|Period II|Adverse Event|1|||
142954754|NCT03567291|515373740|FG002|Period II|Adverse Event|0|||
142954755|NCT03567291|515373741|FG003|Period II|Adverse Event|0|||
142954756|NCT03567291|515373738|FG000|Period II|Missing or unknown|0|||
142954757|NCT03567291|515373739|FG001|Period II|Missing or unknown|2|||
142954758|NCT03567291|515373740|FG002|Period II|Missing or unknown|1|||
142954759|NCT03567291|515373741|FG003|Period II|Missing or unknown|0|||
142954760|NCT03567291|515373738|FG000|Period III|Adverse Event|0|||
142954761|NCT03567291|515373739|FG001|Period III|Adverse Event|0|||
142954762|NCT03567291|515373740|FG002|Period III|Adverse Event|0|||
142954763|NCT03567291|515373741|FG003|Period III|Adverse Event|4|||
142954764|NCT03567291|515373738|FG000|Period III|Withdrawal by Subject|0|||
142954765|NCT03567291|515373739|FG001|Period III|Withdrawal by Subject|0|||
142954766|NCT03567291|515373740|FG002|Period III|Withdrawal by Subject|0|||
142954767|NCT03567291|515373741|FG003|Period III|Withdrawal by Subject|4|||
142954768|NCT03567291|515373738|FG000|Period III|Lost to Follow-up|0|||
142954769|NCT03567291|515373739|FG001|Period III|Lost to Follow-up|0|||
142954770|NCT03567291|515373740|FG002|Period III|Lost to Follow-up|0|||
142954771|NCT03567291|515373741|FG003|Period III|Lost to Follow-up|1|||
142954772|NCT03567291|515373738|FG000|Period III|Terminated by sponsor|0|||
142954773|NCT03567291|515373739|FG001|Period III|Terminated by sponsor|0|||
142954774|NCT03567291|515373740|FG002|Period III|Terminated by sponsor|0|||
142954775|NCT03567291|515373741|FG003|Period III|Terminated by sponsor|68|||
142954776|NCT03567291|515373738|FG000|Period III|Missing or unknown|0|||
142954777|NCT03567291|515373739|FG001|Period III|Missing or unknown|0|||
142954778|NCT03567291|515373740|FG002|Period III|Missing or unknown|0|||
142954779|NCT03567291|515373741|FG003|Period III|Missing or unknown|8|||
142954780|NCT01103349|515373742|FG000|Overall Study|Adverse Event|8|||
142954781|NCT01103349|515373743|FG001|Overall Study|Adverse Event|5|||
142954782|NCT01103349|515373744|FG002|Overall Study|Adverse Event|3|||
142954783|NCT01103349|515373742|FG000|Overall Study|Consent withdrawn|1|||
142954784|NCT01103349|515373743|FG001|Overall Study|Consent withdrawn|0|||
142954785|NCT01103349|515373744|FG002|Overall Study|Consent withdrawn|0|||
142954786|NCT01103349|515373742|FG000|Overall Study|Incorrectly included in the trial|1|||
142954787|NCT01103349|515373743|FG001|Overall Study|Incorrectly included in the trial|0|||
142954788|NCT01103349|515373744|FG002|Overall Study|Incorrectly included in the trial|0|||
142954789|NCT01103349|515373742|FG000|Overall Study|Withdrawal by Subject|1|||
142954790|NCT01103349|515373743|FG001|Overall Study|Withdrawal by Subject|1|||
142954791|NCT01103349|515373744|FG002|Overall Study|Withdrawal by Subject|0|||
142954792|NCT01103349|515373742|FG000|Overall Study|did not want to take trial medication|0|||
142954793|NCT01103349|515373743|FG001|Overall Study|did not want to take trial medication|1|||
142954794|NCT01103349|515373744|FG002|Overall Study|did not want to take trial medication|0|||
142954795|NCT01103349|515373742|FG000|Overall Study|forgot to take medication|0|||
142954796|NCT01103349|515373743|FG001|Overall Study|forgot to take medication|0|||
142954797|NCT01103349|515373744|FG002|Overall Study|forgot to take medication|1|||
142954798|NCT00915005|515373746|FG000|Overall Study|Withdrawal by Subject|4|||
142954799|NCT00915005|515373747|FG001|Overall Study|Withdrawal by Subject|4|||
142954800|NCT00915005|515373746|FG000|Overall Study|Patient preferred protons therapy|6|||
142954801|NCT00915005|515373747|FG001|Overall Study|Patient preferred protons therapy|0|||
142954802|NCT00915005|515373746|FG000|Overall Study|Insurance denial|3|||
142954803|NCT00915005|515373747|FG001|Overall Study|Insurance denial|15|||
142954804|NCT00907478|515373748|FG000|Overall Study|Ineligibility determined|0|||
142954805|NCT00907478|515373749|FG001|Overall Study|Ineligibility determined|0|||
142954806|NCT00907478|515373750|FG002|Overall Study|Ineligibility determined|1|||
142954807|NCT00907478|515373748|FG000|Overall Study|Noncompliance|0|||
142954808|NCT00907478|515373749|FG001|Overall Study|Noncompliance|0|||
142954809|NCT00907478|515373750|FG002|Overall Study|Noncompliance|1|||
142954810|NCT00907478|515373748|FG000|Overall Study|Adverse Event|3|||
142954811|NCT00907478|515373749|FG001|Overall Study|Adverse Event|1|||
142954812|NCT00907478|515373750|FG002|Overall Study|Adverse Event|2|||
142954813|NCT00907478|515373748|FG000|Overall Study|Withdrawal by Subject|8|||
142954814|NCT00907478|515373749|FG001|Overall Study|Withdrawal by Subject|9|||
142954815|NCT00907478|515373750|FG002|Overall Study|Withdrawal by Subject|6|||
142954816|NCT00907478|515373748|FG000|Overall Study|Requirement for alternative therapy|1|||
142954817|NCT00907478|515373749|FG001|Overall Study|Requirement for alternative therapy|2|||
142954818|NCT00907478|515373750|FG002|Overall Study|Requirement for alternative therapy|3|||
142954819|NCT00907478|515373748|FG000|Overall Study|Physician Decision|2|||
142954820|NCT00907478|515373749|FG001|Overall Study|Physician Decision|0|||
142954821|NCT00907478|515373750|FG002|Overall Study|Physician Decision|3|||
142954822|NCT00907478|515373748|FG000|Overall Study|Death|4|||
142954823|NCT00907478|515373749|FG001|Overall Study|Death|2|||
142954824|NCT00907478|515373750|FG002|Overall Study|Death|1|||
142954825|NCT00907478|515373748|FG000|Overall Study|Protocol-specified criteria|5|||
142954826|NCT00907478|515373749|FG001|Overall Study|Protocol-specified criteria|2|||
142954827|NCT00907478|515373750|FG002|Overall Study|Protocol-specified criteria|3|||
142954828|NCT00907478|515373748|FG000|Overall Study|Pregnancy|0|||
142954829|NCT00907478|515373749|FG001|Overall Study|Pregnancy|1|||
142954830|NCT00907478|515373750|FG002|Overall Study|Pregnancy|1|||
142954831|NCT00907478|515373748|FG000|Overall Study|Lost to Follow-up|1|||
142954832|NCT00907478|515373749|FG001|Overall Study|Lost to Follow-up|0|||
142954833|NCT00907478|515373750|FG002|Overall Study|Lost to Follow-up|0|||
142954834|NCT00907478|515373748|FG000|Overall Study|Other|3|||
142954835|NCT00907478|515373749|FG001|Overall Study|Other|0|||
142954836|NCT00907478|515373750|FG002|Overall Study|Other|1|||
142954837|NCT03554005|515373751|FG000|Overall Study|Not in participant's best interest|0|||
142954838|NCT03554005|515373752|FG001|Overall Study|Not in participant's best interest|0|||
142954839|NCT03554005|515373753|FG002|Overall Study|Not in participant's best interest|0|||
142954840|NCT03554005|515373754|FG003|Overall Study|Not in participant's best interest|0|||
142954841|NCT03554005|515373755|FG004|Overall Study|Not in participant's best interest|0|||
142954842|NCT03554005|515373756|FG005|Overall Study|Not in participant's best interest|1|||
142954843|NCT03554005|515373751|FG000|Overall Study|Disease Progression|1|||
142954844|NCT03554005|515373752|FG001|Overall Study|Disease Progression|1|||
142954845|NCT03554005|515373753|FG002|Overall Study|Disease Progression|1|||
142954846|NCT03554005|515373754|FG003|Overall Study|Disease Progression|1|||
142954847|NCT03554005|515373755|FG004|Overall Study|Disease Progression|5|||
142954848|NCT03554005|515373756|FG005|Overall Study|Disease Progression|6|||
142954849|NCT03554005|515373751|FG000|Overall Study|Adverse Event|0|||
142954850|NCT03554005|515373752|FG001|Overall Study|Adverse Event|0|||
142954851|NCT03554005|515373753|FG002|Overall Study|Adverse Event|0|||
142954852|NCT03554005|515373754|FG003|Overall Study|Adverse Event|0|||
142954853|NCT03554005|515373755|FG004|Overall Study|Adverse Event|0|||
142954854|NCT03554005|515373756|FG005|Overall Study|Adverse Event|3|||
142954855|NCT03554005|515373751|FG000|Overall Study|Physician Decision|0|||
142954856|NCT03554005|515373752|FG001|Overall Study|Physician Decision|0|||
142954857|NCT03554005|515373753|FG002|Overall Study|Physician Decision|0|||
142954858|NCT03554005|515373754|FG003|Overall Study|Physician Decision|0|||
142954859|NCT03554005|515373755|FG004|Overall Study|Physician Decision|1|||
142954860|NCT03554005|515373756|FG005|Overall Study|Physician Decision|0|||
142954861|NCT03554005|515373751|FG000|Overall Study|Other|0|||
142954862|NCT03554005|515373752|FG001|Overall Study|Other|0|||
142954863|NCT03554005|515373753|FG002|Overall Study|Other|0|||
142954864|NCT03554005|515373754|FG003|Overall Study|Other|0|||
142954865|NCT03554005|515373755|FG004|Overall Study|Other|0|||
142954866|NCT03554005|515373756|FG005|Overall Study|Other|1|||
142954867|NCT00631488|515373757|FG000|Overall Study|Adverse Event|1|||
142954868|NCT00631488|515373758|FG001|Overall Study|Adverse Event|0|||
142954869|NCT00631488|515373759|FG002|Overall Study|Adverse Event|0|||
142954870|NCT00631488|515373757|FG000|Overall Study|Lost to Follow-up|2|||
142954871|NCT00631488|515373758|FG001|Overall Study|Lost to Follow-up|2|||
142954872|NCT00631488|515373759|FG002|Overall Study|Lost to Follow-up|0|||
142954873|NCT00631488|515373757|FG000|Overall Study|Physician Decision|1|||
142954874|NCT00631488|515373758|FG001|Overall Study|Physician Decision|0|||
142954875|NCT00631488|515373759|FG002|Overall Study|Physician Decision|1|||
142954876|NCT00631488|515373757|FG000|Overall Study|Protocol Violation|0|||
142954877|NCT00631488|515373758|FG001|Overall Study|Protocol Violation|0|||
142954878|NCT00631488|515373759|FG002|Overall Study|Protocol Violation|1|||
142954879|NCT03648476|515373760|FG000|Overall Study|Withdrawal by Subject|2|||
142954880|NCT03648476|515373761|FG001|Overall Study|Withdrawal by Subject|1|||
142954881|NCT02639182|515373762|FG000|Overall Study|Disease Progression|50|||
142954882|NCT02639182|515373763|FG001|Overall Study|Disease Progression|49|||
142954883|NCT02639182|515373762|FG000|Overall Study|Adverse Event|7|||
142954884|NCT02639182|515373763|FG001|Overall Study|Adverse Event|5|||
142954885|NCT02639182|515373762|FG000|Overall Study|Physician Decision|3|||
142954886|NCT02639182|515373763|FG001|Overall Study|Physician Decision|3|||
142954887|NCT02639182|515373762|FG000|Overall Study|Withdrew Consent|5|||
142954888|NCT02639182|515373763|FG001|Overall Study|Withdrew Consent|4|||
142954889|NCT02639182|515373762|FG000|Overall Study|Lost to Follow-up|0|||
142954890|NCT02639182|515373763|FG001|Overall Study|Lost to Follow-up|1|||
142954891|NCT02639182|515373762|FG000|Overall Study|Study Closure|1|||
142954892|NCT02639182|515373763|FG001|Overall Study|Study Closure|2|||
142954893|NCT02639182|515373762|FG000|Overall Study|Sponsor Ended Study|0|||
142954894|NCT02639182|515373763|FG001|Overall Study|Sponsor Ended Study|1|||
142954895|NCT02639182|515373762|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
142954896|NCT02639182|515373763|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
142954897|NCT02546856|515373764|FG000|4 Months Evaluation|Death|2|||
142954898|NCT02546856|515373765|FG001|4 Months Evaluation|Death|3|||
142954899|NCT02546856|515373764|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
142954900|NCT02546856|515373765|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
142954901|NCT02546856|515373764|FG000|4 Months Evaluation|Lost to Follow-up|3|||
142954902|NCT02546856|515373765|FG001|4 Months Evaluation|Lost to Follow-up|3|||
142954903|NCT02546856|515373764|FG000|4 Months Evaluation|Physician Decision|3|||
142954904|NCT02546856|515373765|FG001|4 Months Evaluation|Physician Decision|0|||
142954905|NCT02546856|515373764|FG000|4 Months Evaluation|Working or living abroad|5|||
142954906|NCT02546856|515373765|FG001|4 Months Evaluation|Working or living abroad|1|||
142954907|NCT02546856|515373764|FG000|4 Months Evaluation|reasons not due to titration|4|||
142954908|NCT02546856|515373765|FG001|4 Months Evaluation|reasons not due to titration|1|||
142954909|NCT02546856|515373764|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
142954910|NCT02546856|515373765|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
142954911|NCT02546856|515373764|FG000|6 Months Evaluation|Death|1|||
142954912|NCT02546856|515373765|FG001|6 Months Evaluation|Death|1|||
142954913|NCT02546856|515373764|FG000|6 Months Evaluation|Lost to Follow-up|1|||
142954914|NCT02546856|515373765|FG001|6 Months Evaluation|Lost to Follow-up|1|||
142954915|NCT02546856|515373764|FG000|6 Months Evaluation|Working or living abroad|6|||
142954916|NCT02546856|515373765|FG001|6 Months Evaluation|Working or living abroad|4|||
142954917|NCT02546856|515373764|FG000|6 Months Evaluation|reasons not due to titration|0|||
142954918|NCT02546856|515373765|FG001|6 Months Evaluation|reasons not due to titration|1|||
142954919|NCT01097616|515373766|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
142954920|NCT01097616|515373767|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
142954921|NCT01097616|515373768|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
142954922|NCT01097616|515373769|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
142954923|NCT01097616|515373770|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
142954924|NCT01097616|515373771|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
142954925|NCT01097616|515373772|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
142954926|NCT01097616|515373773|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
142954927|NCT01097616|515373766|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
142954928|NCT01097616|515373767|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
142954929|NCT01097616|515373768|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
142954930|NCT01097616|515373769|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
142954931|NCT01097616|515373770|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
142954932|NCT01097616|515373771|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
142954933|NCT01097616|515373772|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
142954934|NCT01097616|515373773|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
142954935|NCT01097616|515373766|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
142954936|NCT01097616|515373767|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
142954937|NCT01097616|515373768|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
142954938|NCT01097616|515373769|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
142954939|NCT01097616|515373770|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
142954940|NCT01097616|515373771|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
142954941|NCT01097616|515373772|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
142954942|NCT01097616|515373773|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
142954943|NCT01097616|515373766|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
142954944|NCT01097616|515373767|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
142954945|NCT01097616|515373768|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
142954946|NCT01097616|515373769|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
142954947|NCT01097616|515373770|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
142954948|NCT01097616|515373771|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
142954949|NCT01097616|515373772|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
142954950|NCT01097616|515373773|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
142954951|NCT01097616|515373766|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
142954952|NCT01097616|515373767|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
142954953|NCT01097616|515373768|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
142954954|NCT01097616|515373769|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
142954955|NCT01097616|515373770|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
142954956|NCT01097616|515373771|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
142954957|NCT01097616|515373772|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
142954958|NCT01097616|515373773|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
142954959|NCT01097616|515373766|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
142954960|NCT01097616|515373767|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
142954961|NCT01097616|515373768|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
142954962|NCT01097616|515373769|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
142954963|NCT01097616|515373770|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
142954964|NCT01097616|515373771|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
142954965|NCT01097616|515373772|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
142954966|NCT01097616|515373773|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
142954967|NCT01097616|515373766|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
142954968|NCT01097616|515373767|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
142954969|NCT01097616|515373768|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
142954970|NCT01097616|515373769|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
142954971|NCT01097616|515373770|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
142954972|NCT01097616|515373771|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
142954973|NCT01097616|515373772|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
142954974|NCT01097616|515373773|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
142954975|NCT01097616|515373766|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
142954976|NCT01097616|515373767|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
142954977|NCT01097616|515373768|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
142954978|NCT01097616|515373769|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
142954979|NCT01097616|515373770|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
142954980|NCT01097616|515373771|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
142954981|NCT01097616|515373772|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
142954982|NCT01097616|515373773|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
142954983|NCT01097616|515373766|FG000|Optional DB EXT Phase|Adverse Event|0|||
142954984|NCT01097616|515373767|FG001|Optional DB EXT Phase|Adverse Event|7|||
142954985|NCT01097616|515373768|FG002|Optional DB EXT Phase|Adverse Event|2|||
142954986|NCT01097616|515373769|FG003|Optional DB EXT Phase|Adverse Event|0|||
142954987|NCT01097616|515373770|FG004|Optional DB EXT Phase|Adverse Event|0|||
142954988|NCT01097616|515373771|FG005|Optional DB EXT Phase|Adverse Event|0|||
142954989|NCT01097616|515373772|FG006|Optional DB EXT Phase|Adverse Event|0|||
142954990|NCT01097616|515373773|FG007|Optional DB EXT Phase|Adverse Event|0|||
142954991|NCT01097616|515373766|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
142954992|NCT01097616|515373767|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
142954993|NCT01097616|515373768|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
142954994|NCT01097616|515373769|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
142954995|NCT01097616|515373770|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
142954996|NCT01097616|515373771|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
142954997|NCT01097616|515373772|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
142954998|NCT01097616|515373773|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
142954999|NCT01097616|515373766|FG000|Optional DB EXT Phase|Protocol Violation|0|||
142955000|NCT01097616|515373767|FG001|Optional DB EXT Phase|Protocol Violation|2|||
142955001|NCT01097616|515373768|FG002|Optional DB EXT Phase|Protocol Violation|3|||
142955002|NCT01097616|515373769|FG003|Optional DB EXT Phase|Protocol Violation|0|||
142955003|NCT01097616|515373770|FG004|Optional DB EXT Phase|Protocol Violation|0|||
142955004|NCT01097616|515373771|FG005|Optional DB EXT Phase|Protocol Violation|0|||
142955005|NCT01097616|515373772|FG006|Optional DB EXT Phase|Protocol Violation|0|||
142955006|NCT01097616|515373773|FG007|Optional DB EXT Phase|Protocol Violation|0|||
142955007|NCT01097616|515373766|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
142955008|NCT01097616|515373767|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
142955009|NCT01097616|515373768|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
142955010|NCT01097616|515373769|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
142955011|NCT01097616|515373770|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
142955012|NCT01097616|515373771|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
142955013|NCT01097616|515373772|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
142955014|NCT01097616|515373773|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
142955015|NCT01097616|515373766|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
142955016|NCT01097616|515373767|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
142955017|NCT01097616|515373768|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
142955018|NCT01097616|515373769|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
142955019|NCT01097616|515373770|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
142955020|NCT01097616|515373771|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
142955021|NCT01097616|515373772|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
142955022|NCT01097616|515373773|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
142955023|NCT01097616|515373766|FG000|Optional DB EXT Phase|Physician Decision|1|||
142955024|NCT01097616|515373767|FG001|Optional DB EXT Phase|Physician Decision|0|||
142955025|NCT01097616|515373768|FG002|Optional DB EXT Phase|Physician Decision|0|||
142955026|NCT01097616|515373769|FG003|Optional DB EXT Phase|Physician Decision|0|||
142955027|NCT01097616|515373770|FG004|Optional DB EXT Phase|Physician Decision|0|||
142955028|NCT01097616|515373771|FG005|Optional DB EXT Phase|Physician Decision|0|||
142955029|NCT01097616|515373772|FG006|Optional DB EXT Phase|Physician Decision|0|||
142955030|NCT01097616|515373773|FG007|Optional DB EXT Phase|Physician Decision|0|||
142955031|NCT01097616|515373766|FG000|DB RO Phase|Adverse Event|0|||
142955032|NCT01097616|515373767|FG001|DB RO Phase|Adverse Event|0|||
142955033|NCT01097616|515373768|FG002|DB RO Phase|Adverse Event|0|||
142955034|NCT01097616|515373769|FG003|DB RO Phase|Adverse Event|0|||
142955035|NCT01097616|515373770|FG004|DB RO Phase|Adverse Event|0|||
142955036|NCT01097616|515373771|FG005|DB RO Phase|Adverse Event|0|||
142955037|NCT01097616|515373772|FG006|DB RO Phase|Adverse Event|1|||
142955038|NCT01097616|515373773|FG007|DB RO Phase|Adverse Event|0|||
142955039|NCT01097616|515373766|FG000|DB RO Phase|Withdrawal by Subject|0|||
142955040|NCT01097616|515373767|FG001|DB RO Phase|Withdrawal by Subject|0|||
143455229|NCT02217475|517210848|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
142955041|NCT01097616|515373768|FG002|DB RO Phase|Withdrawal by Subject|0|||
143117133|NCT01273155|515970041|FG003|Overall Study|Change in liver function/no longer eval.|0|||
142955042|NCT01097616|515373769|FG003|DB RO Phase|Withdrawal by Subject|0|||
142955043|NCT01097616|515373770|FG004|DB RO Phase|Withdrawal by Subject|0|||
142955044|NCT01097616|515373771|FG005|DB RO Phase|Withdrawal by Subject|1|||
142955045|NCT01097616|515373772|FG006|DB RO Phase|Withdrawal by Subject|0|||
142955046|NCT01097616|515373773|FG007|DB RO Phase|Withdrawal by Subject|0|||
142955047|NCT01097616|515373766|FG000|DB RO Phase|Lost to Follow-up|0|||
142955048|NCT01097616|515373767|FG001|DB RO Phase|Lost to Follow-up|0|||
142955049|NCT01097616|515373768|FG002|DB RO Phase|Lost to Follow-up|0|||
142955050|NCT01097616|515373769|FG003|DB RO Phase|Lost to Follow-up|1|||
142955051|NCT01097616|515373770|FG004|DB RO Phase|Lost to Follow-up|1|||
142955052|NCT01097616|515373771|FG005|DB RO Phase|Lost to Follow-up|0|||
142955053|NCT01097616|515373772|FG006|DB RO Phase|Lost to Follow-up|0|||
142955054|NCT01097616|515373773|FG007|DB RO Phase|Lost to Follow-up|1|||
142955055|NCT01097616|515373766|FG000|DB RO Phase|Not Treated in RO|0|||
142955056|NCT01097616|515373767|FG001|DB RO Phase|Not Treated in RO|0|||
142955057|NCT01097616|515373768|FG002|DB RO Phase|Not Treated in RO|0|||
142955058|NCT01097616|515373769|FG003|DB RO Phase|Not Treated in RO|0|||
142955059|NCT01097616|515373770|FG004|DB RO Phase|Not Treated in RO|0|||
142955060|NCT01097616|515373771|FG005|DB RO Phase|Not Treated in RO|1|||
142955061|NCT01097616|515373772|FG006|DB RO Phase|Not Treated in RO|0|||
142955062|NCT01097616|515373773|FG007|DB RO Phase|Not Treated in RO|0|||
142955063|NCT04655586|515373774|FG000|Overall Study|Physician Decision|1|||
142955064|NCT04655586|515373775|FG001|Overall Study|Physician Decision|3|||
142955065|NCT04655586|515373776|FG002|Overall Study|Physician Decision|4|||
142955066|NCT04655586|515373774|FG000|Overall Study|Withdrawal by Subject|1|||
142955067|NCT04655586|515373775|FG001|Overall Study|Withdrawal by Subject|3|||
142955068|NCT04655586|515373776|FG002|Overall Study|Withdrawal by Subject|1|||
142955069|NCT03268746|515373779|FG000|Overall Study|Withdrawal by Subject|1|||
142955070|NCT00117338|515373780|FG000|Overall Study|Adverse Event|0|||
142955071|NCT00117338|515373781|FG001|Overall Study|Adverse Event|1|||
142955072|NCT00117338|515373780|FG000|Overall Study|Protocol Violation|3|||
142955073|NCT00117338|515373781|FG001|Overall Study|Protocol Violation|2|||
142955074|NCT00117338|515373780|FG000|Overall Study|Withdrawal by Subject|1|||
142955075|NCT00117338|515373781|FG001|Overall Study|Withdrawal by Subject|0|||
142955076|NCT00117338|515373780|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
142955077|NCT00117338|515373781|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
142955078|NCT00117338|515373780|FG000|Overall Study|Lack of Efficacy|0|||
142955079|NCT00117338|515373781|FG001|Overall Study|Lack of Efficacy|1|||
142955080|NCT02240628|515373782|FG000|Overall Study|Physician Decision|6|||
142955081|NCT02240628|515373783|FG001|Overall Study|Physician Decision|5|||
142955082|NCT04530825|515373784|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
142955083|NCT04530825|515373785|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
142955084|NCT04530825|515373786|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
142955085|NCT04530825|515373787|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
142955086|NCT04530825|515373784|FG000|Overall Study|Did not complete follow-up|3|||
142955087|NCT04530825|515373785|FG001|Overall Study|Did not complete follow-up|0|||
142955088|NCT04530825|515373786|FG002|Overall Study|Did not complete follow-up|0|||
142955089|NCT04530825|515373787|FG003|Overall Study|Did not complete follow-up|0|||
142955090|NCT01749735|515373788|FG000|Overall Study|Withdrawal by Subject|1|||
142955091|NCT01749735|515373789|FG001|Overall Study|Withdrawal by Subject|0|||
142955092|NCT01839188|515373790|FG000|Overall Study|Withdrawal by Subject|1|||
142955093|NCT04983901|515373791|FG000|Overall Study|Death|1|||
142955094|NCT04983901|515373792|FG001|Overall Study|Death|4|||
142955095|NCT04983901|515373791|FG000|Overall Study|Lost to Follow-up|3|||
142955096|NCT04983901|515373792|FG001|Overall Study|Lost to Follow-up|0|||
142955097|NCT04983901|515373791|FG000|Overall Study|Protocol Violation|1|||
142955098|NCT04983901|515373792|FG001|Overall Study|Protocol Violation|0|||
142955099|NCT04983901|515373791|FG000|Overall Study|Withdrawal by Subject|1|||
142955100|NCT04983901|515373792|FG001|Overall Study|Withdrawal by Subject|2|||
142955101|NCT02902809|515373800|FG000|Overall Study|Discontinuation of asthma program|28|||
142955102|NCT01208181|515373804|FG000|Part 1|Withdrawal by Subject|11|||
142955103|NCT01208181|515373805|FG001|Part 1|Withdrawal by Subject|10|||
142955104|NCT01208181|515373806|FG002|Part 1|Withdrawal by Subject|0|||
142955105|NCT01208181|515373807|FG003|Part 1|Withdrawal by Subject|0|||
142955106|NCT01208181|515373808|FG004|Part 1|Withdrawal by Subject|0|||
142955107|NCT01208181|515373804|FG000|Part 1|Technical problem|5|||
142955108|NCT01208181|515373805|FG001|Part 1|Technical problem|0|||
142955109|NCT01208181|515373806|FG002|Part 1|Technical problem|0|||
142955110|NCT01208181|515373807|FG003|Part 1|Technical problem|0|||
142955111|NCT01208181|515373808|FG004|Part 1|Technical problem|0|||
142955112|NCT01208181|515373804|FG000|Part 1|Protocol Violation|10|||
142955113|NCT01208181|515373805|FG001|Part 1|Protocol Violation|5|||
142955114|NCT01208181|515373806|FG002|Part 1|Protocol Violation|0|||
142955115|NCT01208181|515373807|FG003|Part 1|Protocol Violation|0|||
142955116|NCT01208181|515373808|FG004|Part 1|Protocol Violation|0|||
142955117|NCT01208181|515373804|FG000|Part 1|Physician Decision|4|||
142955118|NCT01208181|515373805|FG001|Part 1|Physician Decision|0|||
142955119|NCT01208181|515373806|FG002|Part 1|Physician Decision|0|||
142955120|NCT01208181|515373807|FG003|Part 1|Physician Decision|0|||
143455230|NCT02217475|517210846|FG000|Discontinued After Period 1|Adverse Event|1|||
142955121|NCT01208181|515373808|FG004|Part 1|Physician Decision|0|||
142955122|NCT01208181|515373804|FG000|Part 1|Non-compliance with study drug|1|||
142955123|NCT01208181|515373805|FG001|Part 1|Non-compliance with study drug|1|||
142955124|NCT01208181|515373806|FG002|Part 1|Non-compliance with study drug|0|||
142955125|NCT01208181|515373807|FG003|Part 1|Non-compliance with study drug|0|||
142955126|NCT01208181|515373808|FG004|Part 1|Non-compliance with study drug|0|||
142955127|NCT01208181|515373804|FG000|Part 1|Lost to Follow-up|5|||
142955128|NCT01208181|515373805|FG001|Part 1|Lost to Follow-up|3|||
142955129|NCT01208181|515373806|FG002|Part 1|Lost to Follow-up|0|||
142955130|NCT01208181|515373807|FG003|Part 1|Lost to Follow-up|0|||
142955131|NCT01208181|515373808|FG004|Part 1|Lost to Follow-up|1|||
142955132|NCT01208181|515373804|FG000|Part 1|Lack of Efficacy|37|||
142955133|NCT01208181|515373805|FG001|Part 1|Lack of Efficacy|12|||
142955134|NCT01208181|515373806|FG002|Part 1|Lack of Efficacy|0|||
142955135|NCT01208181|515373807|FG003|Part 1|Lack of Efficacy|0|||
142955136|NCT01208181|515373808|FG004|Part 1|Lack of Efficacy|17|||
142955137|NCT01208181|515373804|FG000|Part 1|Adverse Event|26|||
142955138|NCT01208181|515373805|FG001|Part 1|Adverse Event|24|||
142955139|NCT01208181|515373806|FG002|Part 1|Adverse Event|0|||
142955140|NCT01208181|515373807|FG003|Part 1|Adverse Event|0|||
142955141|NCT01208181|515373808|FG004|Part 1|Adverse Event|4|||
142955142|NCT01208181|515373804|FG000|Part 2|Adverse Event|0|||
142955143|NCT01208181|515373805|FG001|Part 2|Adverse Event|0|||
142955144|NCT01208181|515373806|FG002|Part 2|Adverse Event|6|||
142955145|NCT01208181|515373807|FG003|Part 2|Adverse Event|7|||
142955146|NCT01208181|515373808|FG004|Part 2|Adverse Event|0|||
142955147|NCT01208181|515373804|FG000|Part 2|Withdrawal by Subject|0|||
142955148|NCT01208181|515373805|FG001|Part 2|Withdrawal by Subject|0|||
142955149|NCT01208181|515373806|FG002|Part 2|Withdrawal by Subject|1|||
142955150|NCT01208181|515373807|FG003|Part 2|Withdrawal by Subject|1|||
142955151|NCT01208181|515373808|FG004|Part 2|Withdrawal by Subject|0|||
142955152|NCT01208181|515373804|FG000|Part 2|Protocol Violation|0|||
142955153|NCT01208181|515373805|FG001|Part 2|Protocol Violation|0|||
142955154|NCT01208181|515373806|FG002|Part 2|Protocol Violation|1|||
142955155|NCT01208181|515373807|FG003|Part 2|Protocol Violation|0|||
142955156|NCT01208181|515373808|FG004|Part 2|Protocol Violation|0|||
142955157|NCT01208181|515373804|FG000|Part 2|Physician Decision|0|||
142955158|NCT01208181|515373805|FG001|Part 2|Physician Decision|0|||
142955159|NCT01208181|515373806|FG002|Part 2|Physician Decision|1|||
142955160|NCT01208181|515373807|FG003|Part 2|Physician Decision|2|||
142955161|NCT01208181|515373808|FG004|Part 2|Physician Decision|0|||
142955162|NCT01208181|515373804|FG000|Part 2|Non-compliance with study drug|0|||
142955163|NCT01208181|515373805|FG001|Part 2|Non-compliance with study drug|0|||
142955164|NCT01208181|515373806|FG002|Part 2|Non-compliance with study drug|1|||
142955165|NCT01208181|515373807|FG003|Part 2|Non-compliance with study drug|1|||
142955166|NCT01208181|515373808|FG004|Part 2|Non-compliance with study drug|0|||
142955167|NCT01208181|515373804|FG000|Part 2|Lost to Follow-up|0|||
142955168|NCT01208181|515373805|FG001|Part 2|Lost to Follow-up|0|||
142955169|NCT01208181|515373806|FG002|Part 2|Lost to Follow-up|1|||
142955170|NCT01208181|515373807|FG003|Part 2|Lost to Follow-up|2|||
142955171|NCT01208181|515373808|FG004|Part 2|Lost to Follow-up|0|||
142955172|NCT01208181|515373804|FG000|Part 2|Lack of Efficacy|0|||
142955173|NCT01208181|515373805|FG001|Part 2|Lack of Efficacy|0|||
142955174|NCT01208181|515373806|FG002|Part 2|Lack of Efficacy|5|||
142955175|NCT01208181|515373807|FG003|Part 2|Lack of Efficacy|7|||
142955176|NCT01208181|515373808|FG004|Part 2|Lack of Efficacy|0|||
142955177|NCT01748760|515373809|FG000|Overall Study|Withdrawal by Subject|1|||
142955178|NCT01748760|515373810|FG001|Overall Study|Withdrawal by Subject|1|||
142955179|NCT01748760|515373809|FG000|Overall Study|Lost to Follow-up|5|||
142955180|NCT01748760|515373810|FG001|Overall Study|Lost to Follow-up|1|||
142955181|NCT03245814|515373811|FG000|Overall Study|Lost to Follow-up|5|||
142955182|NCT03245814|515373812|FG001|Overall Study|Lost to Follow-up|8|||
142955183|NCT03245814|515373811|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
142955184|NCT03245814|515373812|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
142955185|NCT02263365|515373816|FG000|Overall Study|Physician Decision|22|||
142955186|NCT02263365|515373817|FG001|Overall Study|Physician Decision|18|||
142955187|NCT00394914|515373820|FG000|Treatment Period|Adverse Event|0|||
142955188|NCT00394914|515373821|FG001|Treatment Period|Adverse Event|3|||
142955189|NCT00394914|515373822|FG002|Treatment Period|Adverse Event|1|||
142955190|NCT00394914|515373820|FG000|Treatment Period|Lost to Follow-up|0|||
142955191|NCT00394914|515373821|FG001|Treatment Period|Lost to Follow-up|1|||
142955192|NCT00394914|515373822|FG002|Treatment Period|Lost to Follow-up|0|||
142955193|NCT00394914|515373820|FG000|Treatment Period|Withdrawal by Subject|0|||
142955194|NCT00394914|515373821|FG001|Treatment Period|Withdrawal by Subject|2|||
142955195|NCT00394914|515373822|FG002|Treatment Period|Withdrawal by Subject|2|||
142955196|NCT00394914|515373820|FG000|Treatment Period|Noncompliance with protocol|0|||
142955197|NCT00394914|515373821|FG001|Treatment Period|Noncompliance with protocol|3|||
142955198|NCT00394914|515373822|FG002|Treatment Period|Noncompliance with protocol|2|||
142955199|NCT00394914|515373820|FG000|Treatment Period|Did not meet protocol eligibility|0|||
142955200|NCT00394914|515373821|FG001|Treatment Period|Did not meet protocol eligibility|1|||
142955201|NCT00394914|515373822|FG002|Treatment Period|Did not meet protocol eligibility|1|||
142955202|NCT00312377|515373826|FG000|Overall Study|Death|403|||
142955203|NCT00312377|515373827|FG001|Overall Study|Death|418|||
142955204|NCT00312377|515373826|FG000|Overall Study|Withdrawal by Subject|23|||
142955205|NCT00312377|515373827|FG001|Overall Study|Withdrawal by Subject|30|||
142955206|NCT00312377|515373826|FG000|Overall Study|Lost to Follow-up|9|||
142955207|NCT00312377|515373827|FG001|Overall Study|Lost to Follow-up|12|||
142955208|NCT00312377|515373826|FG000|Overall Study|Non-compliance|0|||
142955209|NCT00312377|515373827|FG001|Overall Study|Non-compliance|2|||
142955210|NCT00312377|515373826|FG000|Overall Study|Randomised but never received treatment|6|||
142955211|NCT00312377|515373827|FG001|Overall Study|Randomised but never received treatment|6|||
142955212|NCT00312377|515373826|FG000|Overall Study|Discontinue treatment survival follow up|202|||
142955213|NCT00312377|515373827|FG001|Overall Study|Discontinue treatment survival follow up|200|||
142955214|NCT00312377|515373826|FG000|Overall Study|Site ended participation in study|1|||
142955215|NCT00312377|515373827|FG001|Overall Study|Site ended participation in study|0|||
142955216|NCT00872898|515373828|FG000|Part Two - Double Blind|Adverse Event|4|||
142955217|NCT00872898|515373829|FG001|Part Two - Double Blind|Adverse Event|3|||
142955218|NCT00872898|515373828|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
142955219|NCT00872898|515373829|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
142955220|NCT00872898|515373828|FG000|Part Two - Double Blind|Protocol Violation|1|||
142955221|NCT00872898|515373829|FG001|Part Two - Double Blind|Protocol Violation|0|||
142955222|NCT00872898|515373828|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
142955223|NCT00872898|515373829|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
142955224|NCT00872898|515373828|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
142955225|NCT00872898|515373829|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
142955226|NCT00872898|515373828|FG000|Part Two - Double Blind|Other reasons|2|||
142955227|NCT00872898|515373829|FG001|Part Two - Double Blind|Other reasons|0|||
142955228|NCT01001494|515373834|FG000|Overall Study|Adverse Event|8|||
142955229|NCT01001494|515373835|FG001|Overall Study|Adverse Event|4|||
142955230|NCT01001494|515373836|FG002|Overall Study|Adverse Event|6|||
142955231|NCT01001494|515373834|FG000|Overall Study|Protocol Violation|0|||
142955232|NCT01001494|515373835|FG001|Overall Study|Protocol Violation|1|||
142955233|NCT01001494|515373836|FG002|Overall Study|Protocol Violation|1|||
142955234|NCT01001494|515373834|FG000|Overall Study|Lost to Follow-up|2|||
142955235|NCT01001494|515373835|FG001|Overall Study|Lost to Follow-up|0|||
142955236|NCT01001494|515373836|FG002|Overall Study|Lost to Follow-up|1|||
142955237|NCT01001494|515373834|FG000|Overall Study|Withdrawal by Subject|9|||
142955238|NCT01001494|515373835|FG001|Overall Study|Withdrawal by Subject|7|||
142955239|NCT01001494|515373836|FG002|Overall Study|Withdrawal by Subject|17|||
142955240|NCT01001494|515373834|FG000|Overall Study|COPD exacerbation|3|||
142955241|NCT01001494|515373835|FG001|Overall Study|COPD exacerbation|4|||
142955242|NCT01001494|515373836|FG002|Overall Study|COPD exacerbation|5|||
142955243|NCT01001494|515373834|FG000|Overall Study|Lack of Efficacy|2|||
142955244|NCT01001494|515373835|FG001|Overall Study|Lack of Efficacy|0|||
142955245|NCT01001494|515373836|FG002|Overall Study|Lack of Efficacy|8|||
142955246|NCT01001494|515373834|FG000|Overall Study|Other|0|||
142955247|NCT01001494|515373835|FG001|Overall Study|Other|1|||
142955248|NCT01001494|515373836|FG002|Overall Study|Other|3|||
142955249|NCT02519231|515373840|FG000|Overall Study|Lost to Follow-up|2|||
142955250|NCT02519231|515373841|FG001|Overall Study|Lost to Follow-up|5|||
142955251|NCT02519231|515373840|FG000|Overall Study|Withdrawal by Subject|0|||
142955252|NCT02519231|515373841|FG001|Overall Study|Withdrawal by Subject|1|||
142955253|NCT02792777|515373842|FG000|Overall Study|Withdrawal by Subject|2|||
142955254|NCT02792777|515373843|FG001|Overall Study|Withdrawal by Subject|0|||
142955255|NCT02792777|515373842|FG000|Overall Study|Recording malfunction|2|||
142955256|NCT02792777|515373843|FG001|Overall Study|Recording malfunction|0|||
142955257|NCT02792777|515373842|FG000|Overall Study|Later determined to be ineligible|2|||
142955258|NCT02792777|515373843|FG001|Overall Study|Later determined to be ineligible|0|||
142955259|NCT02792777|515373842|FG000|Overall Study|Participant interviewed twice|1|||
142955260|NCT02792777|515373843|FG001|Overall Study|Participant interviewed twice|0|||
142955261|NCT00815308|515373844|FG000|Overall Study|Adverse Event|4|||
142955262|NCT00815308|515373844|FG000|Overall Study|Withdrawal by Subject|0|||
142955263|NCT00815308|515373844|FG000|Overall Study|Protocol Violation|6|||
142955264|NCT03176966|515373852|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
142955265|NCT03176966|515373853|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
142955266|NCT03176966|515373852|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
142955267|NCT03176966|515373853|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
142955268|NCT03176966|515373852|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
142955269|NCT03176966|515373853|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
142955270|NCT03176966|515373852|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
142955271|NCT03176966|515373853|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
142955272|NCT03176966|515373852|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
142955273|NCT03176966|515373853|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
142955274|NCT03176966|515373852|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
142955275|NCT03176966|515373853|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
142955276|NCT03176966|515373852|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
142955277|NCT03176966|515373853|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
142955278|NCT01520922|515373854|FG000|Treatment Phase|Physician Decision|2|||
142955279|NCT01520922|515373855|FG001|Treatment Phase|Physician Decision|1|||
142955280|NCT01520922|515373854|FG000|Treatment Phase|Progression|0|||
142955281|NCT01520922|515373855|FG001|Treatment Phase|Progression|2|||
142955282|NCT01520922|515373854|FG000|Treatment Phase|Adverse Event|3|||
142955283|NCT01520922|515373855|FG001|Treatment Phase|Adverse Event|5|||
142955284|NCT01520922|515373854|FG000|Follow up|Lost to Follow-up|0|||
142955285|NCT01520922|515373855|FG001|Follow up|Lost to Follow-up|1|||
142955286|NCT01520922|515373854|FG000|Survival Follow-up|Withdrawal by Subject|1|||
142955287|NCT01520922|515373855|FG001|Survival Follow-up|Withdrawal by Subject|0|||
142955288|NCT01696877|515373858|FG000|Overall Study|Adverse Event|0|||
142955289|NCT01696877|515373859|FG001|Overall Study|Adverse Event|1|||
142955290|NCT00515463|515373860|FG000|Overall Study|Physician Decision|4|||
142955291|NCT00515463|515373861|FG001|Overall Study|Physician Decision|2|||
142955292|NCT00515463|515373860|FG000|Overall Study|Adverse Event|1|||
142955293|NCT00515463|515373861|FG001|Overall Study|Adverse Event|2|||
142955294|NCT00515463|515373860|FG000|Overall Study|Withdrawal by Subject|3|||
142955295|NCT00515463|515373861|FG001|Overall Study|Withdrawal by Subject|4|||
142955296|NCT00515463|515373860|FG000|Overall Study|Lost to Follow-up|6|||
142955297|NCT00515463|515373861|FG001|Overall Study|Lost to Follow-up|5|||
142955298|NCT00515463|515373860|FG000|Overall Study|Other|0|||
142955299|NCT00515463|515373861|FG001|Overall Study|Other|1|||
142955300|NCT00916721|515373862|FG000|Overall Study|Lost to Follow-up|0|||
142955301|NCT00916721|515373863|FG001|Overall Study|Lost to Follow-up|1|||
142955302|NCT00916721|515373862|FG000|Overall Study|Adverse Event|6|||
142955303|NCT00916721|515373863|FG001|Overall Study|Adverse Event|3|||
142955304|NCT00916721|515373862|FG000|Overall Study|Withdrawal by Subject|2|||
142955305|NCT00916721|515373863|FG001|Overall Study|Withdrawal by Subject|2|||
142955306|NCT00916721|515373862|FG000|Overall Study|Protocol Violation|2|||
142955307|NCT00916721|515373863|FG001|Overall Study|Protocol Violation|4|||
142955308|NCT01903434|515373867|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
142955309|NCT01903434|515373868|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
142955310|NCT01903434|515373867|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
142955311|NCT01903434|515373868|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
142955312|NCT01469052|515373871|FG000|Overall Study|Adverse Event|2|||
142955313|NCT01469052|515373872|FG001|Overall Study|Adverse Event|3|||
142955314|NCT01469052|515373873|FG002|Overall Study|Adverse Event|0|||
142955315|NCT01469052|515373874|FG003|Overall Study|Adverse Event|2|||
142955316|NCT01469052|515373875|FG004|Overall Study|Adverse Event|0|||
142955317|NCT01469052|515373876|FG005|Overall Study|Adverse Event|1|||
142955318|NCT01469052|515373871|FG000|Overall Study|Progressive disease|3|||
142955319|NCT01469052|515373872|FG001|Overall Study|Progressive disease|0|||
142955320|NCT01469052|515373873|FG002|Overall Study|Progressive disease|5|||
142955321|NCT01469052|515373874|FG003|Overall Study|Progressive disease|3|||
142955322|NCT01469052|515373875|FG004|Overall Study|Progressive disease|7|||
142955323|NCT01469052|515373876|FG005|Overall Study|Progressive disease|2|||
142955324|NCT01469052|515373871|FG000|Overall Study|Lack of Efficacy|0|||
142955325|NCT01469052|515373872|FG001|Overall Study|Lack of Efficacy|0|||
142955326|NCT01469052|515373873|FG002|Overall Study|Lack of Efficacy|0|||
142955327|NCT01469052|515373874|FG003|Overall Study|Lack of Efficacy|0|||
142955328|NCT01469052|515373875|FG004|Overall Study|Lack of Efficacy|0|||
142955329|NCT01469052|515373876|FG005|Overall Study|Lack of Efficacy|2|||
142955330|NCT01469052|515373871|FG000|Overall Study|Moved to rollover protocol|1|||
142955331|NCT01469052|515373872|FG001|Overall Study|Moved to rollover protocol|0|||
142955332|NCT01469052|515373873|FG002|Overall Study|Moved to rollover protocol|1|||
142955333|NCT01469052|515373874|FG003|Overall Study|Moved to rollover protocol|0|||
142955334|NCT01469052|515373875|FG004|Overall Study|Moved to rollover protocol|0|||
142955335|NCT01469052|515373876|FG005|Overall Study|Moved to rollover protocol|1|||
142955336|NCT01469052|515373871|FG000|Overall Study|Other|0|||
142955337|NCT01469052|515373872|FG001|Overall Study|Other|1|||
142955338|NCT01469052|515373873|FG002|Overall Study|Other|0|||
142955339|NCT01469052|515373874|FG003|Overall Study|Other|0|||
142955340|NCT01469052|515373875|FG004|Overall Study|Other|1|||
142955341|NCT01469052|515373876|FG005|Overall Study|Other|0|||
142955342|NCT01519427|515373880|FG000|Overall Study|disease progression|2|||
142955343|NCT00336492|515373881|FG000|Overall Study|Adverse Event|4|||
142955344|NCT00336492|515373882|FG001|Overall Study|Adverse Event|3|||
142955345|NCT00336492|515373883|FG002|Overall Study|Adverse Event|6|||
142955346|NCT00336492|515373881|FG000|Overall Study|Lack of Efficacy|6|||
142955347|NCT00336492|515373882|FG001|Overall Study|Lack of Efficacy|1|||
142955348|NCT00336492|515373883|FG002|Overall Study|Lack of Efficacy|4|||
142955349|NCT00336492|515373881|FG000|Overall Study|Other|5|||
142955350|NCT00336492|515373882|FG001|Overall Study|Other|0|||
142955351|NCT00336492|515373883|FG002|Overall Study|Other|1|||
142955352|NCT01781026|515373884|FG000|Overall Study|Lack of Efficacy|2|||
142955353|NCT02269319|515373885|FG000|Overall Study|Lost to Follow-up|4|||
142955354|NCT02269319|515373886|FG001|Overall Study|Lost to Follow-up|3|||
142955355|NCT02269319|515373885|FG000|Overall Study|Adverse Event|0|||
142955356|NCT02269319|515373886|FG001|Overall Study|Adverse Event|1|||
142955357|NCT02269319|515373885|FG000|Overall Study|Instructions not followed|1|||
142955358|NCT02269319|515373886|FG001|Overall Study|Instructions not followed|0|||
142955359|NCT03575468|515373889|FG000|Overall Study|Withdrawal by Subject|3|||
142955360|NCT03575468|515373890|FG001|Overall Study|Withdrawal by Subject|0|||
142955361|NCT03575468|515373889|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
142955362|NCT03575468|515373890|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
142955363|NCT03575468|515373889|FG000|Overall Study|Lost to Follow-up|13|||
142955364|NCT03575468|515373890|FG001|Overall Study|Lost to Follow-up|17|||
142955365|NCT00404768|515373891|FG000|Part A and B|Withdrawn due to labor progression|1|||
142955366|NCT00404768|515373892|FG001|Part A and B|Withdrawn due to labor progression|0|||
142955367|NCT00404768|515373893|FG002|Part A and B|Withdrawn due to labor progression|0|||
142955368|NCT00404768|515373894|FG003|Part A and B|Withdrawn due to labor progression|0|||
142955369|NCT00404768|515373891|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
142955370|NCT00404768|515373892|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
142955371|NCT00404768|515373893|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
142955372|NCT00404768|515373894|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
142955373|NCT00404768|515373891|FG000|Part C|Adverse Event|0|||
142955374|NCT00404768|515373892|FG001|Part C|Adverse Event|0|||
142955375|NCT00404768|515373893|FG002|Part C|Adverse Event|0|||
142955376|NCT00404768|515373894|FG003|Part C|Adverse Event|3|||
142955377|NCT00404768|515373891|FG000|Part C|Lost to Follow-up|0|||
142955378|NCT00404768|515373892|FG001|Part C|Lost to Follow-up|0|||
142955379|NCT00404768|515373893|FG002|Part C|Lost to Follow-up|3|||
142955380|NCT00404768|515373894|FG003|Part C|Lost to Follow-up|1|||
142955381|NCT00404768|515373891|FG000|Part C|Withdrawal by Subject|0|||
142955382|NCT00404768|515373892|FG001|Part C|Withdrawal by Subject|0|||
142955383|NCT00404768|515373893|FG002|Part C|Withdrawal by Subject|2|||
142955384|NCT00404768|515373894|FG003|Part C|Withdrawal by Subject|1|||
142955385|NCT00404768|515373891|FG000|Part C|Early withdrawal from study medication|0|||
142955386|NCT00404768|515373892|FG001|Part C|Early withdrawal from study medication|0|||
142955387|NCT00404768|515373893|FG002|Part C|Early withdrawal from study medication|1|||
142955388|NCT00404768|515373894|FG003|Part C|Early withdrawal from study medication|0|||
142955389|NCT00404768|515373891|FG000|Part C|Participant did not respond to therapy|0|||
142955390|NCT00404768|515373892|FG001|Part C|Participant did not respond to therapy|0|||
142955391|NCT00404768|515373893|FG002|Part C|Participant did not respond to therapy|1|||
142955392|NCT00404768|515373894|FG003|Part C|Participant did not respond to therapy|1|||
142955393|NCT00404768|515373891|FG000|Part C|Physician withdrew the study medication|0|||
142955394|NCT00404768|515373892|FG001|Part C|Physician withdrew the study medication|0|||
142955395|NCT00404768|515373893|FG002|Part C|Physician withdrew the study medication|1|||
142955396|NCT00404768|515373894|FG003|Part C|Physician withdrew the study medication|0|||
142955397|NCT00404768|515373891|FG000|Part C|Participant delivered baby|0|||
142955398|NCT00404768|515373892|FG001|Part C|Participant delivered baby|0|||
142955399|NCT00404768|515373893|FG002|Part C|Participant delivered baby|0|||
142955400|NCT00404768|515373894|FG003|Part C|Participant delivered baby|1|||
142955401|NCT00404768|515373891|FG000|Part C|Unsatisfactory uterine response to IP|0|||
142955402|NCT00404768|515373892|FG001|Part C|Unsatisfactory uterine response to IP|0|||
142955403|NCT00404768|515373893|FG002|Part C|Unsatisfactory uterine response to IP|0|||
142955404|NCT00404768|515373894|FG003|Part C|Unsatisfactory uterine response to IP|1|||
142955405|NCT00404768|515373891|FG000|Part C|Active labor|0|||
142955406|NCT00404768|515373892|FG001|Part C|Active labor|0|||
142955407|NCT00404768|515373893|FG002|Part C|Active labor|0|||
142955408|NCT00404768|515373894|FG003|Part C|Active labor|1|||
142955409|NCT00404768|515373891|FG000|Part C|Lack of Efficacy|0|||
142955410|NCT00404768|515373892|FG001|Part C|Lack of Efficacy|0|||
142955411|NCT00404768|515373893|FG002|Part C|Lack of Efficacy|0|||
142955412|NCT00404768|515373894|FG003|Part C|Lack of Efficacy|2|||
142955413|NCT00404768|515373891|FG000|Part C|Treatment failure|0|||
142955414|NCT00404768|515373892|FG001|Part C|Treatment failure|0|||
142955415|NCT00404768|515373893|FG002|Part C|Treatment failure|0|||
142955416|NCT00404768|515373894|FG003|Part C|Treatment failure|1|||
142955417|NCT00404768|515373891|FG000|Part C|Investigator discretion|0|||
142955418|NCT00404768|515373892|FG001|Part C|Investigator discretion|0|||
142955419|NCT00404768|515373893|FG002|Part C|Investigator discretion|0|||
142955420|NCT00404768|515373894|FG003|Part C|Investigator discretion|1|||
142955421|NCT00404768|515373891|FG000|Part C|Researcher suspended study medication|0|||
142955422|NCT00404768|515373892|FG001|Part C|Researcher suspended study medication|0|||
142955423|NCT00404768|515373893|FG002|Part C|Researcher suspended study medication|0|||
142955424|NCT00404768|515373894|FG003|Part C|Researcher suspended study medication|1|||
142955425|NCT04773041|515373897|FG000|Overall Study|Unable to data match|1|||
142955426|NCT04773041|515373898|FG001|Overall Study|Unable to data match|0|||
142955427|NCT04773041|515373899|FG002|Overall Study|Unable to data match|0|||
142955428|NCT05094154|515375384|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
142955429|NCT05094154|515375385|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
142955430|NCT05094154|515375384|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
142955431|NCT05094154|515375385|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
142955432|NCT02100657|515375386|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
142955433|NCT02100657|515375387|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
142955434|NCT02100657|515375388|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
142955435|NCT02100657|515375386|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
142955436|NCT02100657|515375387|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
142955437|NCT02100657|515375388|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
142955438|NCT02100657|515375386|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
142955439|NCT02100657|515375387|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
142955440|NCT02100657|515375388|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
142955441|NCT02100657|515375386|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
142955442|NCT02100657|515375387|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
142955443|NCT02100657|515375388|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
142955444|NCT02100657|515375386|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
142955445|NCT02100657|515375387|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
142955446|NCT02100657|515375388|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
142955447|NCT02100657|515375386|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
142955448|NCT02100657|515375387|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
142955449|NCT02100657|515375388|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
142955450|NCT02100657|515375386|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
142955451|NCT02100657|515375387|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
142955452|NCT02100657|515375388|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
142955453|NCT02100657|515375386|FG000|Cohort 3: Dose Level 3|Death|0|||
142955454|NCT02100657|515375387|FG001|Cohort 3: Dose Level 3|Death|0|||
142955455|NCT02100657|515375388|FG002|Cohort 3: Dose Level 3|Death|1|||
142955456|NCT02100657|515375386|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
142955457|NCT02100657|515375387|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
142955458|NCT02100657|515375388|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
142955459|NCT02100657|515375386|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
142955460|NCT02100657|515375387|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
142955461|NCT02100657|515375388|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
142955462|NCT02100657|515375386|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
142955463|NCT02100657|515375387|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
142955464|NCT02100657|515375388|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
142955465|NCT02100657|515375386|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
142955466|NCT02100657|515375387|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
142955467|NCT02100657|515375388|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
142955468|NCT02100657|515375386|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
142955469|NCT02100657|515375387|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
142955470|NCT02100657|515375388|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
142955471|NCT01240811|515375389|FG000|Overall Study|Physician Decision|0|||
142955472|NCT01240811|515375390|FG001|Overall Study|Physician Decision|1|||
142955473|NCT01240811|515375391|FG002|Overall Study|Physician Decision|0|||
142955474|NCT01240811|515375389|FG000|Overall Study|Withdrawal by Subject|0|||
142955475|NCT01240811|515375390|FG001|Overall Study|Withdrawal by Subject|0|||
142955476|NCT01240811|515375391|FG002|Overall Study|Withdrawal by Subject|1|||
142955477|NCT01543490|515375400|FG000|Overall Study|Adverse Event|4|||
142955478|NCT01543490|515375401|FG001|Overall Study|Adverse Event|0|||
142955479|NCT01543490|515375400|FG000|Overall Study|Physician Decision|1|||
142955480|NCT01543490|515375401|FG001|Overall Study|Physician Decision|0|||
142955481|NCT01543490|515375400|FG000|Overall Study|Lack of Efficacy|3|||
142955482|NCT01543490|515375401|FG001|Overall Study|Lack of Efficacy|3|||
142955483|NCT01543490|515375400|FG000|Overall Study|Lost to Follow-up|5|||
142955484|NCT01543490|515375401|FG001|Overall Study|Lost to Follow-up|0|||
142955485|NCT01543490|515375400|FG000|Overall Study|Withdrawal by Subject|2|||
142955486|NCT01543490|515375401|FG001|Overall Study|Withdrawal by Subject|0|||
142955487|NCT01543490|515375400|FG000|Overall Study|Other-Various Administrative Reasons|1|||
142955488|NCT01543490|515375401|FG001|Overall Study|Other-Various Administrative Reasons|2|||
142955489|NCT00128206|515375406|FG000|Overall Study|Lost to Follow-up|137|||
142955490|NCT00128206|515375407|FG001|Overall Study|Lost to Follow-up|118|||
142955491|NCT00128206|515375406|FG000|Overall Study|Adverse Event|0|||
142955492|NCT00128206|515375407|FG001|Overall Study|Adverse Event|2|||
142955493|NCT03032068|515375410|FG000|Overall Study|Adverse Event|1|||
142955494|NCT01597622|515375411|FG000|Overall Study|Adverse Event|7|||
142955495|NCT01597622|515375411|FG000|Overall Study|Lack of Efficacy|3|||
142955496|NCT01597622|515375411|FG000|Overall Study|Protocol Violation|1|||
142955497|NCT01597622|515375411|FG000|Overall Study|Lost to Follow-up|1|||
142955498|NCT01597622|515375411|FG000|Overall Study|Investigator Discretion|5|||
142955499|NCT01597622|515375411|FG000|Overall Study|Withdrawal by Subject|20|||
142955500|NCT01597622|515375411|FG000|Overall Study|Death|1|||
142955501|NCT03825042|515375413|FG000|Overall Study|Adverse Event|1|||
143455231|NCT02217475|517210847|FG001|Discontinued After Period 1|Adverse Event|2|||
142955502|NCT03825042|515375414|FG001|Overall Study|Adverse Event|0|||
142955503|NCT03825042|515375413|FG000|Overall Study|Withdrawal by Subject|1|||
142955504|NCT03825042|515375414|FG001|Overall Study|Withdrawal by Subject|0|||
142955505|NCT01988012|515375424|FG000|Overall Study|Adverse Event|5|||
142955506|NCT01988012|515375424|FG000|Overall Study|Insufficient Therapeutic Response|3|||
142955507|NCT01988012|515375424|FG000|Overall Study|Patient Withdrawal of Consent|4|||
142955508|NCT01988012|515375424|FG000|Overall Study|Lost to Follow-up|1|||
142955509|NCT01988012|515375424|FG000|Overall Study|Physician Decision|1|||
142955510|NCT01988012|515375424|FG000|Overall Study|Protocol Violation|1|||
142955511|NCT04003155|515375425|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
142955512|NCT04003155|515375426|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
142955513|NCT04003155|515375427|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
142955514|NCT04003155|515375428|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
142955515|NCT04003155|515375429|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
142955516|NCT04003155|515375425|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
142955517|NCT04003155|515375426|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
142955518|NCT04003155|515375427|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
142955519|NCT04003155|515375428|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
142955520|NCT04003155|515375429|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
142955521|NCT04003155|515375425|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
142955522|NCT04003155|515375426|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
142955523|NCT04003155|515375427|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
142955524|NCT04003155|515375428|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
142955525|NCT04003155|515375429|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
142955526|NCT04003155|515375425|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
142955527|NCT04003155|515375426|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
142955528|NCT04003155|515375427|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
142955529|NCT04003155|515375428|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
142955530|NCT04003155|515375429|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
142955531|NCT04003155|515375425|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
142955532|NCT04003155|515375426|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
142955533|NCT04003155|515375427|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
142955534|NCT04003155|515375428|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
142955535|NCT04003155|515375429|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
142955536|NCT04003155|515375425|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
142955537|NCT04003155|515375426|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
142955538|NCT04003155|515375427|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
142955539|NCT04003155|515375428|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
142955540|NCT04003155|515375429|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
142955541|NCT04003155|515375425|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
142955542|NCT04003155|515375426|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
142955543|NCT04003155|515375427|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
142955544|NCT04003155|515375428|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
142955545|NCT04003155|515375429|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
142955546|NCT04003155|515375425|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
142955547|NCT04003155|515375426|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
142955548|NCT04003155|515375427|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
142955549|NCT04003155|515375428|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
142955550|NCT04003155|515375429|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
142955551|NCT04003155|515375425|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
142955552|NCT04003155|515375426|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
142955553|NCT04003155|515375427|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
142955554|NCT04003155|515375428|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
142955555|NCT04003155|515375429|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
142955556|NCT00950690|515375433|FG000|Overall Study|Death|4|||
142955557|NCT00950690|515375433|FG000|Overall Study|Adverse Event|15|||
142955558|NCT00950690|515375433|FG000|Overall Study|Lack of Efficacy|22|||
142955559|NCT00950690|515375433|FG000|Overall Study|Lost to Follow-up|40|||
142955560|NCT00950690|515375433|FG000|Overall Study|Other|163|||
142955561|NCT01713036|515375434|FG000|Overall Study|Death|1|||
142955562|NCT00592358|515375435|FG000|Overall Study|Withdrawal by Subject|2|||
142955563|NCT00592358|515375435|FG000|Overall Study|Adverse Event|1|||
142955564|NCT00592358|515375435|FG000|Overall Study|Lack of Efficacy|2|||
142955565|NCT00592358|515375435|FG000|Overall Study|Inability to swallow pills|1|||
142955566|NCT00084682|515375436|FG000|Overall Study|Withdrawal by Subject|1|||
142955567|NCT01166659|515375437|FG000|Overall Study|Subject Decision|8|||
142955568|NCT01166659|515375437|FG000|Overall Study|Investigator Decision|2|||
142955569|NCT01166659|515375437|FG000|Overall Study|Death|1|||
142955570|NCT01166659|515375437|FG000|Overall Study|Lost to Follow-up|1|||
142955571|NCT01166659|515375437|FG000|Overall Study|Study Closed at Site|1|||
142955572|NCT03238248|515375442|FG000|Overall Study|Death|5|||
142955573|NCT03238248|515375442|FG000|Overall Study|Withdrawal by Subject|7|||
142955574|NCT03238248|515375442|FG000|Overall Study|Participant proceeding to transplant|10|||
142955575|NCT03238248|515375442|FG000|Overall Study|Lack of Efficacy|4|||
142955576|NCT03238248|515375442|FG000|Overall Study|Physician Decision|3|||
142955577|NCT03238248|515375442|FG000|Overall Study|Transitioning to another study|1|||
142955578|NCT03238248|515375442|FG000|Overall Study|No longer benefiting|1|||
142955579|NCT03238248|515375442|FG000|Overall Study|Other complicating disease|1|||
142955580|NCT03238248|515375442|FG000|Overall Study|Adverse Event|5|||
142955581|NCT03238248|515375442|FG000|Overall Study|Disease progression|26|||
142955582|NCT03238248|515375442|FG000|Overall Study|N/A participant is still on treatment|1|||
142955583|NCT03238248|515375442|FG000|Overall Study|Decline in condition|1|||
142955584|NCT03238248|515375442|FG000|Overall Study|Alternative therapy|2|||
142955585|NCT00130208|515375455|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
142955586|NCT00130208|515375456|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
142955587|NCT00130208|515375455|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
142955588|NCT00130208|515375456|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
142955589|NCT00130208|515375455|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
142955590|NCT00130208|515375456|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
142955591|NCT00130208|515375455|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
142955592|NCT00130208|515375456|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
142955593|NCT00130208|515375455|FG000|Maintenance Period (26 Weeks)|Other|1|||
142955594|NCT00130208|515375456|FG001|Maintenance Period (26 Weeks)|Other|1|||
142955595|NCT00130208|515375455|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
142955596|NCT00130208|515375456|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
142955597|NCT00130208|515375455|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
142955598|NCT00130208|515375456|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
142955599|NCT00130208|515375455|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
142955600|NCT00130208|515375456|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
142955601|NCT00130208|515375455|FG000|Washout Period (8 Weeks)|Other|1|||
142955602|NCT00130208|515375456|FG001|Washout Period (8 Weeks)|Other|1|||
142955603|NCT00589472|515375457|FG000|Overall Study|Adverse Event|1|||
142955604|NCT02385123|515375460|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
142955605|NCT00552305|515375464|FG000|Overall Study|Adverse Event|43|||
142955606|NCT00552305|515375464|FG000|Overall Study|Lack of Efficacy|120|||
142955607|NCT00552305|515375464|FG000|Overall Study|Lost to Follow-up|4|||
142955608|NCT00552305|515375464|FG000|Overall Study|Protocol Violation|3|||
142955609|NCT00552305|515375464|FG000|Overall Study|Withdrawal by Subject|44|||
142955610|NCT00552305|515375464|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
142955611|NCT00552305|515375464|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
142955612|NCT00552305|515375464|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
142955613|NCT00552305|515375464|FG000|Overall Study|Unsatisfactory compliance|11|||
142955614|NCT00552305|515375464|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
142955615|NCT00552305|515375464|FG000|Overall Study|AE/Other: prohibited drug required|1|||
142955616|NCT00552305|515375464|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
142955617|NCT00552305|515375464|FG000|Overall Study|Other: Site closed|4|||
142955618|NCT00552305|515375464|FG000|Overall Study|Other: Personal problems|1|||
142955619|NCT00552305|515375464|FG000|Overall Study|Other: Unable to attend visits|1|||
142955620|NCT00552305|515375464|FG000|Overall Study|Other: Subject underwent surgery|4|||
142955621|NCT00552305|515375464|FG000|Overall Study|Other: Subject became pregnant|1|||
142955622|NCT00552305|515375464|FG000|Overall Study|Other: Health problems, not drug related|1|||
142955623|NCT00552305|515375464|FG000|Overall Study|Other: Subject moved from area|2|||
142955624|NCT00552305|515375464|FG000|Overall Study|Other: Subject incarcerated|1|||
142955625|NCT00552305|515375464|FG000|Overall Study|Other: Subject went to rehab|1|||
142955626|NCT02345434|515375465|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
142955627|NCT02345434|515375466|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
142955628|NCT01703819|515375467|FG000|Overall Study|Adverse Event|0|||
142955629|NCT01703819|515375468|FG001|Overall Study|Adverse Event|1|||
142955630|NCT01703819|515375467|FG000|Overall Study|Withdrawal by Subject|0|||
142955631|NCT01703819|515375468|FG001|Overall Study|Withdrawal by Subject|1|||
142955632|NCT04230486|515375475|FG000|Overall Study|Screen Failure|1|||
142955633|NCT01302041|515375476|FG000|Overall Study|Death|5|||
142955634|NCT01302041|515375476|FG000|Overall Study|Withdrawal by Subject|4|||
142955635|NCT01302041|515375476|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
142955636|NCT01302041|515375476|FG000|Overall Study|Other-Miscellaneous Reason|2|||
142955637|NCT01022853|515375481|FG000|Overall Study|Progressive disease|2|||
142955638|NCT01022853|515375482|FG001|Overall Study|Progressive disease|3|||
142955639|NCT01022853|515375483|FG002|Overall Study|Progressive disease|11|||
142955640|NCT01022853|515375484|FG003|Overall Study|Progressive disease|7|||
142955641|NCT01022853|515375485|FG004|Overall Study|Progressive disease|1|||
142955642|NCT01022853|515375481|FG000|Overall Study|Dose-limiting toxicity|0|||
142955643|NCT01022853|515375482|FG001|Overall Study|Dose-limiting toxicity|0|||
142955644|NCT01022853|515375483|FG002|Overall Study|Dose-limiting toxicity|0|||
142955645|NCT01022853|515375484|FG003|Overall Study|Dose-limiting toxicity|0|||
142955646|NCT01022853|515375485|FG004|Overall Study|Dose-limiting toxicity|1|||
142955647|NCT01022853|515375481|FG000|Overall Study|Withdrawal by Subject|0|||
142955648|NCT01022853|515375482|FG001|Overall Study|Withdrawal by Subject|1|||
142955649|NCT01022853|515375483|FG002|Overall Study|Withdrawal by Subject|1|||
142955650|NCT01022853|515375484|FG003|Overall Study|Withdrawal by Subject|1|||
142955651|NCT01022853|515375485|FG004|Overall Study|Withdrawal by Subject|0|||
142955652|NCT01022853|515375481|FG000|Overall Study|Other not stated above|1|||
142955653|NCT01022853|515375482|FG001|Overall Study|Other not stated above|0|||
142955654|NCT01022853|515375483|FG002|Overall Study|Other not stated above|1|||
142955655|NCT01022853|515375484|FG003|Overall Study|Other not stated above|0|||
142955656|NCT01022853|515375485|FG004|Overall Study|Other not stated above|0|||
142955657|NCT02416908|515375486|FG000|Dose Escalation Phase|Adverse Event|0|||
142955658|NCT02416908|515375487|FG001|Dose Escalation Phase|Adverse Event|0|||
142955659|NCT02416908|515375488|FG002|Dose Escalation Phase|Adverse Event|3|||
142955660|NCT02416908|515375489|FG003|Dose Escalation Phase|Adverse Event|0|||
142955661|NCT02416908|515375486|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
142955662|NCT02416908|515375487|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
142955663|NCT02416908|515375488|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
142955664|NCT02416908|515375489|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
142955665|NCT03792750|515375490|FG000|Overall Study|Death|3|||
142955666|NCT01651052|515375491|FG000|Overall Study|Death|21|||
142955667|NCT01651052|515375491|FG000|Overall Study|Explant|1|||
142955668|NCT01651052|515375491|FG000|Overall Study|Withdrawal by Subject|1|||
142955669|NCT01651052|515375491|FG000|Overall Study|Lost to Follow-up|3|||
142955670|NCT01327339|515375492|FG000|Overall Study|Protocol Violation|8|||
142955671|NCT04983940|515375493|FG000|Overall Study|Lost to Follow-up|14|||
142955672|NCT04983940|515375493|FG000|Overall Study|Lack of Efficacy|2|||
142955673|NCT04156646|515375494|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
142955674|NCT04156646|515375495|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
142955675|NCT01478347|515375499|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
142955676|NCT01478347|515375499|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
142955677|NCT01478347|515375499|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
142955678|NCT01645930|515375500|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
142955679|NCT01645930|515375500|FG000|Overall Study|Progressive Disease|12|||
142955680|NCT01645930|515375500|FG000|Overall Study|Adverse Event|4|||
142955681|NCT01645930|515375500|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
142955682|NCT01645930|515375500|FG000|Overall Study|Withdrawal by Participant|2|||
142955683|NCT01645930|515375500|FG000|Overall Study|Reason not Defined|1|||
142955684|NCT00510692|515375501|FG000|Overall Study|Adverse Event|1|||
142955685|NCT00510692|515375502|FG001|Overall Study|Adverse Event|3|||
142955686|NCT00510692|515375501|FG000|Overall Study|Withdrawal by Subject|1|||
142955687|NCT00510692|515375502|FG001|Overall Study|Withdrawal by Subject|0|||
142955688|NCT01004146|515375504|FG000|Overall Study|Withdrawal by Subject|4|||
142955689|NCT01004146|515375505|FG001|Overall Study|Withdrawal by Subject|5|||
142955690|NCT03290300|515375508|FG000|Overall Study|Lost to Follow-up|3|||
142955691|NCT02179398|515375509|FG000|Overall Study|Lack of obligatory data|3|||
142955692|NCT02179398|515375510|FG001|Overall Study|Lack of obligatory data|3|||
142955693|NCT02179398|515375509|FG000|Overall Study|Lost to Follow-up|0|||
142955694|NCT02179398|515375510|FG001|Overall Study|Lost to Follow-up|1|||
142955695|NCT02795156|515375511|FG000|Overall Study|Progressive Disease|22|||
142955696|NCT02795156|515375512|FG001|Overall Study|Progressive Disease|7|||
142955697|NCT02795156|515375513|FG002|Overall Study|Progressive Disease|34|||
142955698|NCT02795156|515375514|FG003|Overall Study|Progressive Disease|7|||
142955699|NCT02795156|515375511|FG000|Overall Study|Adverse Event|13|||
142955700|NCT02795156|515375512|FG001|Overall Study|Adverse Event|2|||
142955701|NCT02795156|515375513|FG002|Overall Study|Adverse Event|3|||
142955702|NCT02795156|515375514|FG003|Overall Study|Adverse Event|2|||
142955703|NCT02795156|515375511|FG000|Overall Study|Death|1|||
142955704|NCT02795156|515375512|FG001|Overall Study|Death|1|||
142955705|NCT02795156|515375513|FG002|Overall Study|Death|1|||
142955706|NCT02795156|515375514|FG003|Overall Study|Death|0|||
142955707|NCT02795156|515375511|FG000|Overall Study|Physician Decision|1|||
142955708|NCT02795156|515375512|FG001|Overall Study|Physician Decision|0|||
142955709|NCT02795156|515375513|FG002|Overall Study|Physician Decision|1|||
142955710|NCT02795156|515375514|FG003|Overall Study|Physician Decision|0|||
142955711|NCT02795156|515375511|FG000|Overall Study|Withdrawal by Subject|2|||
142955712|NCT02795156|515375512|FG001|Overall Study|Withdrawal by Subject|0|||
142955713|NCT02795156|515375513|FG002|Overall Study|Withdrawal by Subject|3|||
142955714|NCT02795156|515375514|FG003|Overall Study|Withdrawal by Subject|0|||
142955715|NCT01228071|515376858|FG000|Overall Study|Protocol Violation|1|||
142955716|NCT01228071|515376858|FG000|Overall Study|Withdrawal by Subject|1|||
142955717|NCT03314519|515376859|FG000|Overall Study|Protocol Violation|3|||
142955718|NCT03314519|515376860|FG001|Overall Study|Protocol Violation|2|||
142955719|NCT04504032|515376861|FG000|Overall Study|Adverse Event|1|||
142955720|NCT04504032|515376862|FG001|Overall Study|Adverse Event|2|||
142955721|NCT04504032|515376861|FG000|Overall Study|Lost to Follow-up|6|||
142955722|NCT04504032|515376862|FG001|Overall Study|Lost to Follow-up|9|||
142955723|NCT04504032|515376861|FG000|Overall Study|Protocol Violation|2|||
142955724|NCT04504032|515376862|FG001|Overall Study|Protocol Violation|0|||
142955725|NCT04504032|515376861|FG000|Overall Study|Study terminated by sponsor|1|||
142955726|NCT04504032|515376862|FG001|Overall Study|Study terminated by sponsor|2|||
142955727|NCT04504032|515376861|FG000|Overall Study|Withdrawal by Subject|9|||
143003118|NCT01049360|515548750|FG006|Period 2|Protocol Violation|0|||
142955728|NCT04504032|515376862|FG001|Overall Study|Withdrawal by Subject|11|||
142955729|NCT04504032|515376861|FG000|Overall Study|Disease progression prior to dosing|15|||
142955730|NCT04504032|515376862|FG001|Overall Study|Disease progression prior to dosing|3|||
142955731|NCT04504032|515376861|FG000|Overall Study|Drug supply issues|1|||
142955732|NCT04504032|515376862|FG001|Overall Study|Drug supply issues|1|||
142955733|NCT04504032|515376861|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
142955734|NCT04504032|515376862|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
142955735|NCT00771030|515376863|FG000|Overall Study|Adverse Event|0|||
142955736|NCT00771030|515376864|FG001|Overall Study|Adverse Event|1|||
142955737|NCT00771030|515376865|FG002|Overall Study|Adverse Event|0|||
142955738|NCT00771030|515376866|FG003|Overall Study|Adverse Event|0|||
142955739|NCT00771030|515376867|FG004|Overall Study|Adverse Event|0|||
142955740|NCT00771030|515376868|FG005|Overall Study|Adverse Event|0|||
142955741|NCT00771030|515376869|FG006|Overall Study|Adverse Event|0|||
142955742|NCT02805907|515376870|FG000|Overall Study|Lost to Follow-up|3|||
142955743|NCT02805907|515376871|FG001|Overall Study|Lost to Follow-up|3|||
142955744|NCT01264965|515376883|FG000|Overall Study|Withdrawal by Subject|10|||
142955745|NCT02075255|515376886|FG000|Overall Study|Study specific withdrawal criteria|0|||
142955746|NCT02075255|515376887|FG001|Overall Study|Study specific withdrawal criteria|1|||
142955747|NCT02075255|515376888|FG002|Overall Study|Study specific withdrawal criteria|1|||
142955748|NCT02075255|515376886|FG000|Overall Study|Withdrawal by Subject|4|||
142955749|NCT02075255|515376887|FG001|Overall Study|Withdrawal by Subject|1|||
142955750|NCT02075255|515376888|FG002|Overall Study|Withdrawal by Subject|0|||
142955751|NCT02075255|515376886|FG000|Overall Study|Lost to Follow-up|0|||
142955752|NCT02075255|515376887|FG001|Overall Study|Lost to Follow-up|0|||
142955753|NCT02075255|515376888|FG002|Overall Study|Lost to Follow-up|1|||
142955754|NCT02075255|515376886|FG000|Overall Study|Adverse Event|0|||
142955755|NCT02075255|515376887|FG001|Overall Study|Adverse Event|0|||
142955756|NCT02075255|515376888|FG002|Overall Study|Adverse Event|1|||
142955757|NCT02075255|515376886|FG000|Overall Study|Death|0|||
142955758|NCT02075255|515376887|FG001|Overall Study|Death|2|||
142955759|NCT02075255|515376888|FG002|Overall Study|Death|0|||
142955760|NCT05232097|515376889|FG000|Overall Study|Physician Decision|1|||
142955761|NCT00871858|515376890|FG000|Overall Study|Protocol Violation|3|||
142955762|NCT00871858|515376891|FG001|Overall Study|Protocol Violation|4|||
142955763|NCT00871858|515376890|FG000|Overall Study|Adverse Event|1|||
142955764|NCT00871858|515376891|FG001|Overall Study|Adverse Event|1|||
142955765|NCT00871858|515376890|FG000|Overall Study|Withdrawal by Subject|1|||
142955766|NCT00871858|515376891|FG001|Overall Study|Withdrawal by Subject|1|||
142955767|NCT00871858|515376890|FG000|Overall Study|Lost to Follow-up|0|||
142955768|NCT00871858|515376891|FG001|Overall Study|Lost to Follow-up|1|||
142955769|NCT00700752|515376894|FG000|First Intervention|Withdrawal by Subject|0|||
142955770|NCT00700752|515376895|FG001|First Intervention|Withdrawal by Subject|2|||
142955771|NCT01302769|515376896|FG000|Overall Study|Lost to Follow-up|1|||
142955772|NCT01302769|515376897|FG001|Overall Study|Lost to Follow-up|1|||
142955773|NCT01097330|515376902|FG000|Overall Study|Study terminated early|7|||
142955774|NCT01097330|515376903|FG001|Overall Study|Study terminated early|5|||
142955775|NCT03078608|515376904|FG000|Overall Study|Death|1|||
142955776|NCT03078608|515376905|FG001|Overall Study|Death|2|||
142955777|NCT03078608|515376906|FG002|Overall Study|Death|0|||
142955778|NCT03078608|515376907|FG003|Overall Study|Death|0|||
142955779|NCT03078608|515376904|FG000|Overall Study|Withdrawal by Subject|8|||
142955780|NCT03078608|515376905|FG001|Overall Study|Withdrawal by Subject|1|||
142955781|NCT03078608|515376906|FG002|Overall Study|Withdrawal by Subject|0|||
142955782|NCT03078608|515376907|FG003|Overall Study|Withdrawal by Subject|0|||
142955783|NCT03078608|515376904|FG000|Overall Study|Lost to Follow-up|5|||
142955784|NCT03078608|515376905|FG001|Overall Study|Lost to Follow-up|8|||
142955785|NCT03078608|515376906|FG002|Overall Study|Lost to Follow-up|4|||
142955786|NCT03078608|515376907|FG003|Overall Study|Lost to Follow-up|1|||
142955787|NCT01426386|515376917|FG000|Overall Study|Adverse Event|0|||
142955788|NCT01426386|515376918|FG001|Overall Study|Adverse Event|1|||
142955789|NCT01426386|515376919|FG002|Overall Study|Adverse Event|0|||
142955790|NCT01426386|515376920|FG003|Overall Study|Adverse Event|0|||
142955791|NCT01426386|515376921|FG004|Overall Study|Adverse Event|0|||
142955792|NCT01426386|515376922|FG005|Overall Study|Adverse Event|0|||
142955793|NCT01426386|515376917|FG000|Overall Study|Did not attend scheduled visit|1|||
142955794|NCT01426386|515376918|FG001|Overall Study|Did not attend scheduled visit|4|||
142955795|NCT01426386|515376919|FG002|Overall Study|Did not attend scheduled visit|0|||
143455232|NCT02217475|517210848|FG002|Discontinued After Period 1|Adverse Event|0|||
143455233|NCT02217475|517210846|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
142955796|NCT01426386|515376920|FG003|Overall Study|Did not attend scheduled visit|0|||
142955797|NCT01426386|515376921|FG004|Overall Study|Did not attend scheduled visit|2|||
142955798|NCT01426386|515376922|FG005|Overall Study|Did not attend scheduled visit|1|||
142955799|NCT01426386|515376917|FG000|Overall Study|Poor response|2|||
142955800|NCT01426386|515376918|FG001|Overall Study|Poor response|1|||
142955801|NCT01426386|515376919|FG002|Overall Study|Poor response|2|||
142955802|NCT01426386|515376920|FG003|Overall Study|Poor response|0|||
142955803|NCT01426386|515376921|FG004|Overall Study|Poor response|1|||
142955804|NCT01426386|515376922|FG005|Overall Study|Poor response|0|||
142955805|NCT01426386|515376917|FG000|Overall Study|Personal reasons|0|||
142955806|NCT01426386|515376918|FG001|Overall Study|Personal reasons|0|||
142955807|NCT01426386|515376919|FG002|Overall Study|Personal reasons|0|||
142955808|NCT01426386|515376920|FG003|Overall Study|Personal reasons|0|||
142955809|NCT01426386|515376921|FG004|Overall Study|Personal reasons|1|||
142955810|NCT01426386|515376922|FG005|Overall Study|Personal reasons|0|||
142955811|NCT03694522|515376924|FG000|Overall Study|Withdrawal by Subject|8|||
142955812|NCT03694522|515376925|FG001|Overall Study|Withdrawal by Subject|10|||
142955813|NCT03694522|515376924|FG000|Overall Study|Physician Decision|53|||
142955814|NCT03694522|515376925|FG001|Overall Study|Physician Decision|54|||
142955815|NCT03694522|515376924|FG000|Overall Study|Other|1|||
142955816|NCT03694522|515376925|FG001|Overall Study|Other|1|||
142955817|NCT03694522|515376924|FG000|Overall Study|Lost to Follow-up|0|||
142955818|NCT03694522|515376925|FG001|Overall Study|Lost to Follow-up|1|||
142955819|NCT02760407|515376926|FG000|Overall Study|Death|2|||
142955820|NCT02760407|515376927|FG001|Overall Study|Death|3|||
142955821|NCT02760407|515376928|FG002|Overall Study|Death|1|||
142955822|NCT02760407|515376929|FG003|Overall Study|Death|1|||
142955823|NCT02760407|515376926|FG000|Overall Study|Lost to Follow-up|1|||
142955824|NCT02760407|515376927|FG001|Overall Study|Lost to Follow-up|7|||
142955825|NCT02760407|515376928|FG002|Overall Study|Lost to Follow-up|4|||
142955826|NCT02760407|515376929|FG003|Overall Study|Lost to Follow-up|6|||
142955827|NCT02760407|515376926|FG000|Overall Study|Withdrawal by Subject|25|||
142955828|NCT02760407|515376927|FG001|Overall Study|Withdrawal by Subject|31|||
142955829|NCT02760407|515376928|FG002|Overall Study|Withdrawal by Subject|37|||
142955830|NCT02760407|515376929|FG003|Overall Study|Withdrawal by Subject|25|||
142955831|NCT02760407|515376926|FG000|Overall Study|Violation of Eligibility criteria|0|||
142955832|NCT02760407|515376927|FG001|Overall Study|Violation of Eligibility criteria|0|||
142955833|NCT02760407|515376928|FG002|Overall Study|Violation of Eligibility criteria|1|||
142955834|NCT02760407|515376929|FG003|Overall Study|Violation of Eligibility criteria|1|||
142955835|NCT02760407|515376926|FG000|Overall Study|Personal reasons|0|||
142955836|NCT02760407|515376927|FG001|Overall Study|Personal reasons|0|||
142955837|NCT02760407|515376928|FG002|Overall Study|Personal reasons|0|||
142955838|NCT02760407|515376929|FG003|Overall Study|Personal reasons|1|||
142955839|NCT02760407|515376926|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
142955840|NCT02760407|515376927|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
142955841|NCT02760407|515376928|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
142955842|NCT02760407|515376929|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
142955843|NCT02760407|515376926|FG000|Overall Study|Use of prohibited Medication|0|||
142955844|NCT02760407|515376927|FG001|Overall Study|Use of prohibited Medication|0|||
142955845|NCT02760407|515376928|FG002|Overall Study|Use of prohibited Medication|1|||
142955846|NCT02760407|515376929|FG003|Overall Study|Use of prohibited Medication|0|||
142955847|NCT02760407|515376926|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
142955848|NCT02760407|515376927|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
142955849|NCT02760407|515376928|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
142955850|NCT02760407|515376929|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
142955851|NCT02760407|515376926|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
142955852|NCT02760407|515376927|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
142955853|NCT02760407|515376928|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
142955854|NCT02760407|515376929|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
142955855|NCT02760407|515376926|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
142955856|NCT02760407|515376927|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
142955857|NCT02760407|515376928|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
142955858|NCT02760407|515376929|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
142955859|NCT02760407|515376926|FG000|Overall Study|Inadequately Enrolled|0|||
142955860|NCT02760407|515376927|FG001|Overall Study|Inadequately Enrolled|0|||
142955861|NCT02760407|515376928|FG002|Overall Study|Inadequately Enrolled|0|||
142955862|NCT02760407|515376929|FG003|Overall Study|Inadequately Enrolled|1|||
142955863|NCT02760407|515376926|FG000|Overall Study|Withdrawal By PI's Decision|0|||
142955864|NCT02760407|515376927|FG001|Overall Study|Withdrawal By PI's Decision|1|||
142955865|NCT02760407|515376928|FG002|Overall Study|Withdrawal By PI's Decision|0|||
142955866|NCT02760407|515376929|FG003|Overall Study|Withdrawal By PI's Decision|0|||
142955867|NCT02760407|515376926|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
142955868|NCT02760407|515376927|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
142955869|NCT02760407|515376928|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
142955870|NCT02760407|515376929|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
142955871|NCT02760407|515376926|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
142955872|NCT02760407|515376927|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
142955873|NCT02760407|515376928|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
142955874|NCT02760407|515376929|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
142955875|NCT02760407|515376926|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
142955876|NCT02760407|515376927|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
142955877|NCT02760407|515376928|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
142955878|NCT02760407|515376929|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
142955879|NCT02760407|515376926|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
142955880|NCT02760407|515376927|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
142955881|NCT02760407|515376928|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
142955882|NCT02760407|515376929|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
142955883|NCT02760407|515376926|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
142955884|NCT02760407|515376927|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
142955885|NCT02760407|515376928|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
142955886|NCT02760407|515376929|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
142955887|NCT02760407|515376926|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
142955888|NCT02760407|515376927|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
142955889|NCT02760407|515376928|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
142955890|NCT02760407|515376929|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
142955891|NCT02760407|515376926|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
142955892|NCT02760407|515376927|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
142955893|NCT02760407|515376928|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
142955894|NCT02760407|515376929|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
142955895|NCT02760407|515376926|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
142955896|NCT02760407|515376927|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
142955897|NCT02760407|515376928|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
142955898|NCT02760407|515376929|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
142955899|NCT02760407|515376926|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
142955900|NCT02760407|515376927|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
142955901|NCT02760407|515376928|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
142955902|NCT02760407|515376929|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
142955903|NCT02522377|515376930|FG000|Overall Study|Withdrawal by Subject|1|||
142955904|NCT02522377|515376931|FG001|Overall Study|Withdrawal by Subject|0|||
142955905|NCT02522377|515376930|FG000|Overall Study|Remission Achieved|3|||
142955906|NCT02522377|515376931|FG001|Overall Study|Remission Achieved|0|||
142955907|NCT01158950|515376932|FG000|1st Intervention (1 Day)|Physician Decision|1|||
142955908|NCT01158950|515376933|FG001|1st Intervention (1 Day)|Physician Decision|2|||
142955909|NCT02116972|515376936|FG000|Overall Study|Adverse Event|4|||
142955910|NCT02116972|515376937|FG001|Overall Study|Adverse Event|4|||
142955911|NCT02116972|515376938|FG002|Overall Study|Adverse Event|1|||
142955912|NCT02116972|515376936|FG000|Overall Study|Withdrawal by Subject|1|||
142955913|NCT02116972|515376937|FG001|Overall Study|Withdrawal by Subject|1|||
142955914|NCT02116972|515376938|FG002|Overall Study|Withdrawal by Subject|5|||
142955915|NCT02116972|515376936|FG000|Overall Study|Protocol Violation|1|||
142955916|NCT02116972|515376937|FG001|Overall Study|Protocol Violation|0|||
142955917|NCT02116972|515376938|FG002|Overall Study|Protocol Violation|1|||
142955918|NCT02116972|515376936|FG000|Overall Study|Lost to Follow-up|4|||
142955919|NCT02116972|515376937|FG001|Overall Study|Lost to Follow-up|3|||
142955920|NCT02116972|515376938|FG002|Overall Study|Lost to Follow-up|1|||
142955921|NCT02116972|515376936|FG000|Overall Study|Lack of Efficacy|6|||
142955922|NCT02116972|515376937|FG001|Overall Study|Lack of Efficacy|6|||
142955923|NCT02116972|515376938|FG002|Overall Study|Lack of Efficacy|5|||
142955924|NCT02116972|515376936|FG000|Overall Study|scheduling conflicts and relocation|3|||
142955925|NCT02116972|515376937|FG001|Overall Study|scheduling conflicts and relocation|3|||
142955926|NCT02116972|515376938|FG002|Overall Study|scheduling conflicts and relocation|6|||
142955927|NCT00784784|515376939|FG000|Overall Study|Withdrawal by Subject|2|||
142955928|NCT00784784|515376940|FG001|Overall Study|Withdrawal by Subject|2|||
142955929|NCT00863928|515376941|FG000|Overall Study|Protocol Violation|26|||
142955930|NCT00863928|515376942|FG001|Overall Study|Protocol Violation|0|||
142955931|NCT00863928|515376941|FG000|Overall Study|Withdrawal by Subject|3|||
142955932|NCT00863928|515376942|FG001|Overall Study|Withdrawal by Subject|0|||
142955933|NCT00863928|515376941|FG000|Overall Study|surgery cancellation|4|||
142955934|NCT00863928|515376942|FG001|Overall Study|surgery cancellation|0|||
142955935|NCT00863928|515376941|FG000|Overall Study|medication allergy|3|||
142955936|NCT00863928|515376942|FG001|Overall Study|medication allergy|0|||
142955937|NCT02124798|515376944|FG000|Overall Study|Adverse Event|3|||
142955938|NCT02124798|515376944|FG000|Overall Study|Lost to Follow-up|1|||
142955939|NCT01797432|515376945|FG000|Overall Study|Lost to Follow-up|1|||
142955940|NCT01797432|515376945|FG000|Overall Study|Adverse Event|1|||
142955941|NCT01797432|515376945|FG000|Overall Study|Withdrawal by Subject|1|||
142955942|NCT01797432|515376945|FG000|Overall Study|lived too far from study site|1|||
142955943|NCT02746679|515376947|FG000|Overall Study|Lost to Follow-up|4|||
142955944|NCT02746679|515376948|FG001|Overall Study|Lost to Follow-up|6|||
142955945|NCT01171521|515376951|FG000|Overall Study|Lost to Follow-up|5|||
142955946|NCT01171521|515376951|FG000|Overall Study|screen failure|1|||
142955947|NCT01927562|515376952|FG000|Overall Study|Lost to Follow-up|30|||
142955948|NCT01927562|515376952|FG000|Overall Study|Withdrawal by Subject|3|||
142955949|NCT01927562|515376952|FG000|Overall Study|Physician Decision|5|||
142955950|NCT00492921|515376953|FG000|Overall Study|Death|1|||
142955951|NCT00492921|515376954|FG001|Overall Study|Death|0|||
142955952|NCT00492921|515376955|FG002|Overall Study|Death|1|||
142955953|NCT00652093|515376956|FG000|Overall Study|Withdrawal by Subject|0|||
142955954|NCT00652093|515376957|FG001|Overall Study|Withdrawal by Subject|0|||
142955955|NCT00652093|515376958|FG002|Overall Study|Withdrawal by Subject|1|||
142955956|NCT00652093|515376959|FG003|Overall Study|Withdrawal by Subject|0|||
142955957|NCT00652093|515376960|FG004|Overall Study|Withdrawal by Subject|1|||
142955958|NCT00652093|515376961|FG005|Overall Study|Withdrawal by Subject|0|||
142955959|NCT00652093|515376956|FG000|Overall Study|Physician Decision|0|||
142955960|NCT00652093|515376957|FG001|Overall Study|Physician Decision|0|||
142955961|NCT00652093|515376958|FG002|Overall Study|Physician Decision|0|||
142955962|NCT00652093|515376959|FG003|Overall Study|Physician Decision|0|||
142955963|NCT00652093|515376960|FG004|Overall Study|Physician Decision|1|||
142955964|NCT00652093|515376961|FG005|Overall Study|Physician Decision|0|||
142955965|NCT02961764|515376962|FG000|Overall Study|Protocol Violation|0|||
142955966|NCT02961764|515376963|FG001|Overall Study|Protocol Violation|1|||
142955967|NCT02961764|515376962|FG000|Overall Study|Death|2|||
142955968|NCT02961764|515376963|FG001|Overall Study|Death|0|||
142955969|NCT02961764|515376962|FG000|Overall Study|Lost to Follow-up|35|||
142955970|NCT02961764|515376963|FG001|Overall Study|Lost to Follow-up|24|||
142955971|NCT02961764|515376962|FG000|Overall Study|Withdrawal by Subject|2|||
142955972|NCT02961764|515376963|FG001|Overall Study|Withdrawal by Subject|0|||
142955973|NCT01422304|515376964|FG000|Overall Study|Adverse Event|0|||
142955974|NCT01422304|515376965|FG001|Overall Study|Adverse Event|1|||
142955975|NCT01422304|515376964|FG000|Overall Study|Lost to Follow-up|14|||
142955976|NCT01422304|515376965|FG001|Overall Study|Lost to Follow-up|20|||
142955977|NCT01422304|515376964|FG000|Overall Study|Never Entered Follow-up|2|||
142955978|NCT01422304|515376965|FG001|Overall Study|Never Entered Follow-up|1|||
142955979|NCT01422304|515376964|FG000|Overall Study|Protocol Violation|1|||
142955980|NCT01422304|515376965|FG001|Overall Study|Protocol Violation|0|||
142955981|NCT01422304|515376964|FG000|Overall Study|Withdrawal by Subject|4|||
142955982|NCT01422304|515376965|FG001|Overall Study|Withdrawal by Subject|2|||
142955983|NCT01422304|515376964|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
142955984|NCT01422304|515376965|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
142955985|NCT01422304|515376964|FG000|Overall Study|Not Treated|3|||
142955986|NCT01422304|515376965|FG001|Overall Study|Not Treated|11|||
142955987|NCT00469014|515376968|FG000|Initial Phase Randomization|Disease Progression|0|||
142955988|NCT00469014|515376969|FG001|Initial Phase Randomization|Disease Progression|1|||
142955989|NCT00469014|515376970|FG002|Initial Phase Randomization|Disease Progression|1|||
142955990|NCT00469014|515376971|FG003|Initial Phase Randomization|Disease Progression|0|||
142955991|NCT00469014|515376968|FG000|Initial Phase Randomization|No Response|1|||
142955992|NCT00469014|515376969|FG001|Initial Phase Randomization|No Response|0|||
142955993|NCT00469014|515376970|FG002|Initial Phase Randomization|No Response|0|||
142955994|NCT00469014|515376971|FG003|Initial Phase Randomization|No Response|1|||
142955995|NCT00469014|515376968|FG000|Adaptive Randomization|Not Evaluable|1|||
142955996|NCT00469014|515376969|FG001|Adaptive Randomization|Not Evaluable|0|||
142955997|NCT00469014|515376970|FG002|Adaptive Randomization|Not Evaluable|0|||
142955998|NCT00469014|515376971|FG003|Adaptive Randomization|Not Evaluable|1|||
142955999|NCT00469014|515376968|FG000|Adaptive Randomization|No Response|0|||
142956000|NCT00469014|515376969|FG001|Adaptive Randomization|No Response|1|||
142956001|NCT00469014|515376970|FG002|Adaptive Randomization|No Response|0|||
142956002|NCT00469014|515376971|FG003|Adaptive Randomization|No Response|0|||
142956003|NCT00469014|515376968|FG000|Adaptive Randomization|Death|0|||
142956004|NCT00469014|515376969|FG001|Adaptive Randomization|Death|0|||
142956005|NCT00469014|515376970|FG002|Adaptive Randomization|Death|1|||
142956006|NCT00469014|515376971|FG003|Adaptive Randomization|Death|0|||
142956007|NCT03461289|515376973|FG000|Overall Study|Death|1|||
142956008|NCT00866294|515376974|FG000|Overall Study|Adverse Event|12|||
142956009|NCT00866294|515376975|FG001|Overall Study|Adverse Event|13|||
142956010|NCT00866294|515376976|FG002|Overall Study|Adverse Event|9|||
142956011|NCT00866294|515376974|FG000|Overall Study|Lack of Efficacy|7|||
142956012|NCT00866294|515376975|FG001|Overall Study|Lack of Efficacy|1|||
142956013|NCT00866294|515376976|FG002|Overall Study|Lack of Efficacy|0|||
142956014|NCT00866294|515376974|FG000|Overall Study|Protocol Violation|2|||
142956015|NCT00866294|515376975|FG001|Overall Study|Protocol Violation|0|||
142956016|NCT00866294|515376976|FG002|Overall Study|Protocol Violation|0|||
142956017|NCT00866294|515376974|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
142956018|NCT00866294|515376975|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
142956019|NCT00866294|515376976|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
142956020|NCT00866294|515376974|FG000|Overall Study|Lost to Follow-up|1|||
142956021|NCT00866294|515376975|FG001|Overall Study|Lost to Follow-up|3|||
142956022|NCT00866294|515376976|FG002|Overall Study|Lost to Follow-up|0|||
142956023|NCT00866294|515376974|FG000|Overall Study|Physician Decision|6|||
142956024|NCT00866294|515376975|FG001|Overall Study|Physician Decision|2|||
142956025|NCT00866294|515376976|FG002|Overall Study|Physician Decision|1|||
142956026|NCT02119104|515376977|FG000|Overall Study|Protocol Violation|16|||
142956027|NCT01632878|515376978|FG000|Screening|Physician Decision|268|||
142956028|NCT01632878|515376978|FG000|Treatment|Lost to Follow-up|41|||
142956029|NCT01632878|515376978|FG000|Treatment|Withdrawal by Subject|36|||
142956030|NCT01632878|515376978|FG000|Treatment|Physician Decision|34|||
142956031|NCT01632878|515376978|FG000|Treatment|missing information|4|||
142956032|NCT01632878|515376978|FG000|Treatment|no information on study completion|43|||
142956033|NCT02698423|515376980|FG000|Overall Study|Lost to Follow-up|19|||
142956034|NCT02698423|515376981|FG001|Overall Study|Lost to Follow-up|24|||
142956035|NCT00081289|515376984|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
142956036|NCT00081289|515376985|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
142956037|NCT00081289|515376984|FG000|Overall Study|Ineligible / no protocol treatment|3|||
142956038|NCT00081289|515376985|FG001|Overall Study|Ineligible / no protocol treatment|4|||
142956039|NCT02508701|515376988|FG000|Overall Study|Lost to Follow-up|9|||
142956040|NCT02508701|515376989|FG001|Overall Study|Lost to Follow-up|5|||
142956041|NCT02508701|515376990|FG002|Overall Study|Lost to Follow-up|5|||
142956042|NCT02508701|515376991|FG003|Overall Study|Lost to Follow-up|3|||
142956043|NCT00530712|515376993|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
142956044|NCT00530712|515376993|FG000|30 Day Follow-up Visit|Missed Visit|5|||
142956045|NCT00530712|515376993|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
142956046|NCT00530712|515376993|FG000|6 Month Follow-up Visit|Missed Visit|3|||
142956047|NCT00530712|515376993|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
142956048|NCT00530712|515376993|FG000|6 Month Follow-up Visit|Death|2|||
142956049|NCT00530712|515376993|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
142956050|NCT00530712|515376993|FG000|12 Month Follow-up Visit|Missed Visit|3|||
142956051|NCT00530712|515376993|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
142956052|NCT00530712|515376993|FG000|12 Month Follow-up Visit|Death|9|||
142956053|NCT02260193|515377001|FG000|Overall Study|Lack of Efficacy|0|||
142956054|NCT02260193|515377002|FG001|Overall Study|Lack of Efficacy|1|||
142956055|NCT02260193|515377003|FG002|Overall Study|Lack of Efficacy|6|||
142956056|NCT02260193|515377001|FG000|Overall Study|Adverse Event|3|||
142956057|NCT02260193|515377002|FG001|Overall Study|Adverse Event|4|||
142956058|NCT02260193|515377003|FG002|Overall Study|Adverse Event|1|||
142956059|NCT02260193|515377001|FG000|Overall Study|Protocol Violation|0|||
142956060|NCT02260193|515377002|FG001|Overall Study|Protocol Violation|4|||
142956061|NCT02260193|515377003|FG002|Overall Study|Protocol Violation|0|||
142956062|NCT02260193|515377001|FG000|Overall Study|Withdrawal by Subject|3|||
142956063|NCT02260193|515377002|FG001|Overall Study|Withdrawal by Subject|0|||
142956064|NCT02260193|515377003|FG002|Overall Study|Withdrawal by Subject|2|||
142956065|NCT02260193|515377001|FG000|Overall Study|Kidney Transplantation|0|||
142956066|NCT02260193|515377002|FG001|Overall Study|Kidney Transplantation|0|||
142956067|NCT02260193|515377003|FG002|Overall Study|Kidney Transplantation|1|||
142956068|NCT01522651|515377006|FG000|Overall Study|Adverse Event|3|||
142956069|NCT01522651|515377007|FG001|Overall Study|Adverse Event|4|||
142956070|NCT01522651|515377008|FG002|Overall Study|Adverse Event|4|||
142956071|NCT01522651|515377009|FG003|Overall Study|Adverse Event|5|||
142956072|NCT01522651|515377010|FG004|Overall Study|Adverse Event|4|||
142956073|NCT01522651|515377006|FG000|Overall Study|Cardioversion|1|||
142956074|NCT01522651|515377007|FG001|Overall Study|Cardioversion|0|||
142956075|NCT01522651|515377008|FG002|Overall Study|Cardioversion|0|||
142956076|NCT01522651|515377009|FG003|Overall Study|Cardioversion|0|||
142956077|NCT01522651|515377010|FG004|Overall Study|Cardioversion|0|||
142956078|NCT01522651|515377006|FG000|Overall Study|Device Malfunction|0|||
142956079|NCT01522651|515377007|FG001|Overall Study|Device Malfunction|1|||
142956080|NCT01522651|515377008|FG002|Overall Study|Device Malfunction|0|||
142956081|NCT01522651|515377009|FG003|Overall Study|Device Malfunction|0|||
142956082|NCT01522651|515377010|FG004|Overall Study|Device Malfunction|0|||
142956083|NCT01522651|515377006|FG000|Overall Study|Investigator's Discretion|0|||
142956084|NCT01522651|515377007|FG001|Overall Study|Investigator's Discretion|1|||
142956085|NCT01522651|515377008|FG002|Overall Study|Investigator's Discretion|0|||
143455234|NCT02217475|517210847|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
143455235|NCT02217475|517210848|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
142956086|NCT01522651|515377009|FG003|Overall Study|Investigator's Discretion|0|||
142956087|NCT01522651|515377010|FG004|Overall Study|Investigator's Discretion|0|||
142956088|NCT01522651|515377006|FG000|Overall Study|Protocol Violation|3|||
142956089|NCT01522651|515377007|FG001|Overall Study|Protocol Violation|0|||
142956090|NCT01522651|515377008|FG002|Overall Study|Protocol Violation|0|||
142956091|NCT01522651|515377009|FG003|Overall Study|Protocol Violation|0|||
142956092|NCT01522651|515377010|FG004|Overall Study|Protocol Violation|0|||
142956093|NCT01522651|515377006|FG000|Overall Study|Reason Not Specified|0|||
142956094|NCT01522651|515377007|FG001|Overall Study|Reason Not Specified|0|||
142956095|NCT01522651|515377008|FG002|Overall Study|Reason Not Specified|0|||
142956096|NCT01522651|515377009|FG003|Overall Study|Reason Not Specified|1|||
142956097|NCT01522651|515377010|FG004|Overall Study|Reason Not Specified|0|||
142956098|NCT01522651|515377006|FG000|Overall Study|Participant Non-Compliance|1|||
142956099|NCT01522651|515377007|FG001|Overall Study|Participant Non-Compliance|0|||
142956100|NCT01522651|515377008|FG002|Overall Study|Participant Non-Compliance|0|||
142956101|NCT01522651|515377009|FG003|Overall Study|Participant Non-Compliance|0|||
142956102|NCT01522651|515377010|FG004|Overall Study|Participant Non-Compliance|0|||
142956103|NCT01522651|515377006|FG000|Overall Study|Withdrew Consent|1|||
142956104|NCT01522651|515377007|FG001|Overall Study|Withdrew Consent|1|||
142956105|NCT01522651|515377008|FG002|Overall Study|Withdrew Consent|0|||
142956106|NCT01522651|515377009|FG003|Overall Study|Withdrew Consent|1|||
142956107|NCT01522651|515377010|FG004|Overall Study|Withdrew Consent|1|||
142956108|NCT01522651|515377006|FG000|Overall Study|Randomized but Never Treated|0|||
142956109|NCT01522651|515377007|FG001|Overall Study|Randomized but Never Treated|1|||
142956110|NCT01522651|515377008|FG002|Overall Study|Randomized but Never Treated|0|||
142956111|NCT01522651|515377009|FG003|Overall Study|Randomized but Never Treated|1|||
142956112|NCT01522651|515377010|FG004|Overall Study|Randomized but Never Treated|1|||
142956113|NCT05270694|515378537|FG000|Overall Study|Death|1|||
142956114|NCT05270694|515378537|FG000|Overall Study|Medical issues impacted ability to participate|2|||
142956115|NCT05270694|515378537|FG000|Overall Study|Lost to Follow-up|3|||
142956116|NCT05270694|515378537|FG000|Overall Study|Withdrawal by Subject|3|||
142956117|NCT04543955|515378544|FG000|Overall Study|Company cancelled study|1|||
142956118|NCT04543955|515378545|FG001|Overall Study|Company cancelled study|0|||
142956119|NCT03918642|515378546|FG000|Overall Study|Lost to Follow-up|12|||
142956120|NCT03918642|515378547|FG001|Overall Study|Lost to Follow-up|10|||
142956121|NCT01614769|515378550|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
142956122|NCT01614769|515378551|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
142956123|NCT01614769|515378552|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
142956124|NCT01614769|515378553|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
142956125|NCT01614769|515378554|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
142956126|NCT01614769|515378555|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
142956127|NCT01614769|515378550|FG000|Period 1|Protocol Violation|0|||
142956128|NCT01614769|515378551|FG001|Period 1|Protocol Violation|0|||
142956129|NCT01614769|515378552|FG002|Period 1|Protocol Violation|0|||
142956130|NCT01614769|515378553|FG003|Period 1|Protocol Violation|1|||
142956131|NCT01614769|515378554|FG004|Period 1|Protocol Violation|0|||
142956132|NCT01614769|515378555|FG005|Period 1|Protocol Violation|0|||
142956133|NCT01614769|515378550|FG000|Period 1|Withdrawal by Subject|1|||
142956134|NCT01614769|515378551|FG001|Period 1|Withdrawal by Subject|0|||
142956135|NCT01614769|515378552|FG002|Period 1|Withdrawal by Subject|0|||
142956136|NCT01614769|515378553|FG003|Period 1|Withdrawal by Subject|0|||
142956137|NCT01614769|515378554|FG004|Period 1|Withdrawal by Subject|0|||
142956138|NCT01614769|515378555|FG005|Period 1|Withdrawal by Subject|0|||
142956139|NCT01614769|515378550|FG000|Period 3|Withdrawal by Subject|0|||
142956140|NCT01614769|515378551|FG001|Period 3|Withdrawal by Subject|0|||
142956141|NCT01614769|515378552|FG002|Period 3|Withdrawal by Subject|1|||
142956142|NCT01614769|515378553|FG003|Period 3|Withdrawal by Subject|0|||
142956143|NCT01614769|515378554|FG004|Period 3|Withdrawal by Subject|0|||
142956144|NCT01614769|515378555|FG005|Period 3|Withdrawal by Subject|0|||
142956145|NCT01912872|515378556|FG000|Overall Study|Lost to Follow-up|2|||
142956146|NCT01912872|515378557|FG001|Overall Study|Lost to Follow-up|3|||
142956147|NCT01912872|515378558|FG002|Overall Study|Lost to Follow-up|5|||
142956148|NCT01912872|515378559|FG003|Overall Study|Lost to Follow-up|5|||
142956149|NCT01912872|515378556|FG000|Overall Study|Other unspecified|3|||
142956150|NCT01912872|515378557|FG001|Overall Study|Other unspecified|1|||
142956151|NCT01912872|515378558|FG002|Overall Study|Other unspecified|3|||
142956152|NCT01912872|515378559|FG003|Overall Study|Other unspecified|0|||
142956153|NCT01912872|515378556|FG000|Overall Study|Informed consent withdrawn|0|||
142956154|NCT01912872|515378557|FG001|Overall Study|Informed consent withdrawn|0|||
142956155|NCT01912872|515378558|FG002|Overall Study|Informed consent withdrawn|1|||
142956156|NCT01912872|515378559|FG003|Overall Study|Informed consent withdrawn|1|||
142956157|NCT01912872|515378556|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
142956158|NCT01912872|515378557|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
142956159|NCT01912872|515378558|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
142956160|NCT01912872|515378559|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
142956161|NCT01912872|515378556|FG000|Overall Study|Protocol Violation|0|||
142956162|NCT01912872|515378557|FG001|Overall Study|Protocol Violation|0|||
142956163|NCT01912872|515378558|FG002|Overall Study|Protocol Violation|1|||
142956164|NCT01912872|515378559|FG003|Overall Study|Protocol Violation|0|||
142956165|NCT01912872|515378556|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
142956166|NCT01912872|515378557|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
142956167|NCT01912872|515378558|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
142956168|NCT01912872|515378559|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
142956169|NCT01912872|515378556|FG000|Overall Study|Withdrawal of study medication|0|||
142956170|NCT01912872|515378557|FG001|Overall Study|Withdrawal of study medication|0|||
142956171|NCT01912872|515378558|FG002|Overall Study|Withdrawal of study medication|0|||
142956172|NCT01912872|515378559|FG003|Overall Study|Withdrawal of study medication|2|||
142956173|NCT01912872|515378556|FG000|Overall Study|Missing|0|||
142956174|NCT01912872|515378557|FG001|Overall Study|Missing|0|||
142956175|NCT01912872|515378558|FG002|Overall Study|Missing|0|||
142956176|NCT01912872|515378559|FG003|Overall Study|Missing|1|||
142956177|NCT04760314|515378560|FG000|Induction Period|Withdrawal by Subject|0|||
142956178|NCT04760314|515378561|FG001|Induction Period|Withdrawal by Subject|1|||
142956179|NCT04760314|515378562|FG002|Induction Period|Withdrawal by Subject|1|||
142956180|NCT04760314|515378563|FG003|Induction Period|Withdrawal by Subject|0|||
142956181|NCT04760314|515378564|FG004|Induction Period|Withdrawal by Subject|0|||
142956182|NCT04760314|515378565|FG005|Induction Period|Withdrawal by Subject|0|||
142956183|NCT04760314|515378566|FG006|Induction Period|Withdrawal by Subject|0|||
142956184|NCT04760314|515378567|FG007|Induction Period|Withdrawal by Subject|0|||
142956185|NCT04760314|515378568|FG008|Induction Period|Withdrawal by Subject|0|||
142956186|NCT04760314|515378569|FG009|Induction Period|Withdrawal by Subject|0|||
142956187|NCT04760314|515378570|FG010|Induction Period|Withdrawal by Subject|0|||
142956188|NCT04760314|515378560|FG000|Induction Period|Adverse Event|0|||
142956189|NCT04760314|515378561|FG001|Induction Period|Adverse Event|0|||
142956190|NCT04760314|515378562|FG002|Induction Period|Adverse Event|2|||
142956191|NCT04760314|515378563|FG003|Induction Period|Adverse Event|0|||
142956192|NCT04760314|515378564|FG004|Induction Period|Adverse Event|0|||
142956193|NCT04760314|515378565|FG005|Induction Period|Adverse Event|0|||
142956194|NCT04760314|515378566|FG006|Induction Period|Adverse Event|0|||
142956195|NCT04760314|515378567|FG007|Induction Period|Adverse Event|0|||
142956196|NCT04760314|515378568|FG008|Induction Period|Adverse Event|0|||
142956197|NCT04760314|515378569|FG009|Induction Period|Adverse Event|0|||
142956198|NCT04760314|515378570|FG010|Induction Period|Adverse Event|0|||
142956199|NCT04760314|515378560|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
142956200|NCT04760314|515378561|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
142956201|NCT04760314|515378562|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
142956202|NCT04760314|515378563|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
142956203|NCT04760314|515378564|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
142956204|NCT04760314|515378565|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
142956205|NCT04760314|515378566|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
142956206|NCT04760314|515378567|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
142956207|NCT04760314|515378568|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
142956208|NCT04760314|515378569|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
142956209|NCT04760314|515378570|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
142956210|NCT04760314|515378560|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
142956211|NCT04760314|515378561|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
142956212|NCT04760314|515378562|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
142956213|NCT04760314|515378563|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
142956214|NCT04760314|515378564|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
142956215|NCT04760314|515378565|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
142956216|NCT04760314|515378566|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
142956217|NCT04760314|515378567|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
142956218|NCT04760314|515378568|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
142956219|NCT04760314|515378569|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
142956220|NCT04760314|515378570|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
142956221|NCT04760314|515378560|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
142956222|NCT04760314|515378561|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
142956223|NCT04760314|515378562|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
142956224|NCT04760314|515378563|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
142956225|NCT04760314|515378564|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
142956226|NCT04760314|515378565|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
142956227|NCT04760314|515378566|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
142956228|NCT04760314|515378567|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
142956229|NCT04760314|515378568|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
142956230|NCT04760314|515378569|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
143455236|NCT02217475|517210846|FG000|Discontinued After Period 1|Physician Decision|0|||
142956231|NCT04760314|515378570|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
142956232|NCT04760314|515378560|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
142956233|NCT04760314|515378561|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
142956234|NCT04760314|515378562|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
142956235|NCT04760314|515378563|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
142956236|NCT04760314|515378564|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
142956237|NCT04760314|515378565|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
142956238|NCT04760314|515378566|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
142956239|NCT04760314|515378567|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
142956240|NCT04760314|515378568|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
142956241|NCT04760314|515378569|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
142956242|NCT04760314|515378570|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
142956243|NCT04760314|515378560|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
142956244|NCT04760314|515378561|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
142956245|NCT04760314|515378562|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
142956246|NCT04760314|515378563|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
142956247|NCT04760314|515378564|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
142956248|NCT04760314|515378565|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
142956249|NCT04760314|515378566|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
142956250|NCT04760314|515378567|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
142956251|NCT04760314|515378568|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
142956252|NCT04760314|515378569|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
142956253|NCT04760314|515378570|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
142956254|NCT04760314|515378560|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
142956255|NCT04760314|515378561|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
142956256|NCT04760314|515378562|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
142956257|NCT04760314|515378563|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
142956258|NCT04760314|515378564|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
142956259|NCT04760314|515378565|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
142956260|NCT04760314|515378566|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
142956261|NCT04760314|515378567|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
142956262|NCT04760314|515378568|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
142956263|NCT04760314|515378569|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
142956264|NCT04760314|515378570|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
142956265|NCT04760314|515378560|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
142956266|NCT04760314|515378561|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
142956267|NCT04760314|515378562|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
142956268|NCT04760314|515378563|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
142956269|NCT04760314|515378564|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
142956270|NCT04760314|515378565|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
142956271|NCT04760314|515378566|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
142956272|NCT04760314|515378567|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
142956273|NCT04760314|515378568|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
142956274|NCT04760314|515378569|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
142956275|NCT04760314|515378570|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
142956276|NCT04760314|515378560|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
142956277|NCT04760314|515378561|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
142956278|NCT04760314|515378562|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
142956279|NCT04760314|515378563|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
142956280|NCT04760314|515378564|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
142956281|NCT04760314|515378565|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
142956282|NCT04760314|515378566|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
142956283|NCT04760314|515378567|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
142956284|NCT04760314|515378568|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
142956285|NCT04760314|515378569|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
142956286|NCT04760314|515378570|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
142956287|NCT02855411|515378579|FG000|Overall Study|Study terminated by sponsor|21|||
142956288|NCT02855411|515378579|FG000|Overall Study|Does not meet entrance criteria|14|||
142956289|NCT01372878|515378582|FG000|Overall Study|Withdrawal by Subject|63|||
142956290|NCT01372878|515378582|FG000|Overall Study|Protocol Violation|17|||
142956291|NCT01372878|515378582|FG000|Overall Study|incomplete study procedure|104|||
142956292|NCT02616029|515378586|FG000|Overall Study|Adverse Event|1|||
142956293|NCT02616029|515378587|FG001|Overall Study|Adverse Event|0|||
142956294|NCT02616029|515378586|FG000|Overall Study|Death|0|||
142956295|NCT02616029|515378587|FG001|Overall Study|Death|1|||
142956296|NCT02616029|515378586|FG000|Overall Study|Protocol Violation|1|||
142956297|NCT02616029|515378587|FG001|Overall Study|Protocol Violation|0|||
142956298|NCT02616029|515378586|FG000|Overall Study|Withdrew Consent|1|||
142956299|NCT02616029|515378587|FG001|Overall Study|Withdrew Consent|0|||
142956300|NCT02616029|515378586|FG000|Overall Study|Enrolled and Never Treated|1|||
142956301|NCT02616029|515378587|FG001|Overall Study|Enrolled and Never Treated|1|||
142956302|NCT01849848|515378588|FG000|Overall Study|Physician Decision|1|||
142956303|NCT01849848|515378588|FG000|Overall Study|Progression of the primary disease|3|||
142956304|NCT01070303|515378589|FG000|Overall Study|Adverse Event|39|||
142956305|NCT01070303|515378589|FG000|Overall Study|Withdrawal by Subject|20|||
142956306|NCT01070303|515378589|FG000|Overall Study|Lost to Follow-up|9|||
142956307|NCT01070303|515378589|FG000|Overall Study|Protocol Violation|0|||
142956308|NCT01070303|515378589|FG000|Overall Study|Lack of Efficacy|2|||
142956309|NCT01070303|515378589|FG000|Overall Study|Administrative Reason|1|||
142956310|NCT01070303|515378589|FG000|Overall Study|Other|18|||
142956311|NCT00859898|515378591|FG000|Overall Study|Lack of Efficacy|0|||
142956312|NCT00859898|515378592|FG001|Overall Study|Lack of Efficacy|1|||
142956313|NCT00859898|515378593|FG002|Overall Study|Lack of Efficacy|1|||
142956314|NCT00859898|515378591|FG000|Overall Study|Adverse Event|4|||
142956315|NCT00859898|515378592|FG001|Overall Study|Adverse Event|9|||
142956316|NCT00859898|515378593|FG002|Overall Study|Adverse Event|8|||
142956317|NCT00859898|515378591|FG000|Overall Study|Withdrawal by Subject|11|||
142956318|NCT00859898|515378592|FG001|Overall Study|Withdrawal by Subject|8|||
142956319|NCT00859898|515378593|FG002|Overall Study|Withdrawal by Subject|11|||
142956320|NCT00859898|515378591|FG000|Overall Study|Death|0|||
142956321|NCT00859898|515378592|FG001|Overall Study|Death|0|||
142956322|NCT00859898|515378593|FG002|Overall Study|Death|1|||
142956323|NCT00859898|515378591|FG000|Overall Study|Lost to Follow-up|10|||
142956324|NCT00859898|515378592|FG001|Overall Study|Lost to Follow-up|11|||
142956325|NCT00859898|515378593|FG002|Overall Study|Lost to Follow-up|5|||
142956326|NCT00859898|515378591|FG000|Overall Study|poor/non-compliance|2|||
142956327|NCT00859898|515378592|FG001|Overall Study|poor/non-compliance|0|||
142956328|NCT00859898|515378593|FG002|Overall Study|poor/non-compliance|0|||
142956329|NCT00859898|515378591|FG000|Overall Study|No longer meets criteria|0|||
142956330|NCT00859898|515378592|FG001|Overall Study|No longer meets criteria|1|||
142956331|NCT00859898|515378593|FG002|Overall Study|No longer meets criteria|0|||
142956332|NCT00859898|515378591|FG000|Overall Study|non-specified|1|||
142956333|NCT00859898|515378592|FG001|Overall Study|non-specified|1|||
142956334|NCT00859898|515378593|FG002|Overall Study|non-specified|1|||
142956335|NCT03215264|515378594|FG000|Dose Level 2|Adverse Event|0|||
142956336|NCT03215264|515378595|FG001|Dose Level 2|Adverse Event|1|||
142956337|NCT03215264|515378596|FG002|Dose Level 2|Adverse Event|0|||
142956338|NCT03215264|515378594|FG000|Dose Level 3|Withdrawal by Subject|0|||
142956339|NCT03215264|515378595|FG001|Dose Level 3|Withdrawal by Subject|0|||
142956340|NCT03215264|515378596|FG002|Dose Level 3|Withdrawal by Subject|1|||
142956341|NCT02145156|515378598|FG000|Overall Study|No match to vaccination records|60|||
142956342|NCT02145156|515378599|FG001|Overall Study|No match to vaccination records|52|||
142956343|NCT02145156|515378600|FG002|Overall Study|No match to vaccination records|41|||
142956344|NCT02064439|515378601|FG000|Overall Study|Adverse Event|51|||
142956345|NCT02064439|515378602|FG001|Overall Study|Adverse Event|47|||
142956346|NCT02064439|515378603|FG002|Overall Study|Adverse Event|46|||
142956347|NCT02064439|515378601|FG000|Overall Study|Death|0|||
142956348|NCT02064439|515378602|FG001|Overall Study|Death|2|||
142956349|NCT02064439|515378603|FG002|Overall Study|Death|3|||
142956350|NCT02064439|515378601|FG000|Overall Study|Withdrawal by Subject|29|||
142956351|NCT02064439|515378602|FG001|Overall Study|Withdrawal by Subject|18|||
142956352|NCT02064439|515378603|FG002|Overall Study|Withdrawal by Subject|26|||
142956353|NCT02064439|515378601|FG000|Overall Study|Protocol Violation|3|||
142956354|NCT02064439|515378602|FG001|Overall Study|Protocol Violation|5|||
142956355|NCT02064439|515378603|FG002|Overall Study|Protocol Violation|3|||
142956356|NCT02064439|515378601|FG000|Overall Study|Lost to Follow-up|1|||
142956357|NCT02064439|515378602|FG001|Overall Study|Lost to Follow-up|3|||
142956358|NCT02064439|515378603|FG002|Overall Study|Lost to Follow-up|4|||
142956359|NCT02064439|515378601|FG000|Overall Study|Non-compliance with study medication|21|||
142956360|NCT02064439|515378602|FG001|Overall Study|Non-compliance with study medication|19|||
142956361|NCT02064439|515378603|FG002|Overall Study|Non-compliance with study medication|23|||
142956362|NCT02064439|515378601|FG000|Overall Study|Physician Decision|0|||
142956363|NCT02064439|515378602|FG001|Overall Study|Physician Decision|1|||
142956364|NCT02064439|515378603|FG002|Overall Study|Physician Decision|1|||
142956365|NCT02064439|515378601|FG000|Overall Study|Logistical difficulties|6|||
142956366|NCT02064439|515378602|FG001|Overall Study|Logistical difficulties|5|||
142956367|NCT02064439|515378603|FG002|Overall Study|Logistical difficulties|2|||
142956368|NCT02064439|515378601|FG000|Overall Study|Efficacy outcome reached|18|||
142956369|NCT02064439|515378602|FG001|Overall Study|Efficacy outcome reached|16|||
142956370|NCT02064439|515378603|FG002|Overall Study|Efficacy outcome reached|57|||
142956371|NCT02064439|515378601|FG000|Overall Study|Safety outcome reached|12|||
142956372|NCT02064439|515378602|FG001|Overall Study|Safety outcome reached|20|||
142956373|NCT02064439|515378603|FG002|Overall Study|Safety outcome reached|10|||
142956374|NCT02064439|515378601|FG000|Overall Study|Other|2|||
142956375|NCT02064439|515378602|FG001|Overall Study|Other|2|||
142956376|NCT02064439|515378603|FG002|Overall Study|Other|7|||
142956377|NCT02433288|515378604|FG000|Overall Study|Severe non-compliance to protocol|13|||
142956378|NCT02433288|515378605|FG001|Overall Study|Severe non-compliance to protocol|7|||
142956379|NCT02433288|515378604|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
142956380|NCT02433288|515378605|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
142956381|NCT02433288|515378604|FG000|Overall Study|Withdrawal by Subject|101|||
142956382|NCT02433288|515378605|FG001|Overall Study|Withdrawal by Subject|99|||
142956383|NCT02433288|515378604|FG000|Overall Study|Lost to Follow-up|2|||
142956384|NCT02433288|515378605|FG001|Overall Study|Lost to Follow-up|14|||
142956385|NCT02433288|515378604|FG000|Overall Study|Death|0|||
142956386|NCT02433288|515378605|FG001|Overall Study|Death|3|||
142956387|NCT03350750|515378606|FG000|Overall Study|Death|1|||
142956388|NCT03350750|515378607|FG001|Overall Study|Death|1|||
142956389|NCT02234583|515378612|FG000|Overall Study|Adverse Event|172|||
142956390|NCT02234583|515378613|FG001|Overall Study|Adverse Event|156|||
142956391|NCT02234583|515378612|FG000|Overall Study|Withdrawal by Subject|109|||
142956392|NCT02234583|515378613|FG001|Overall Study|Withdrawal by Subject|157|||
142956393|NCT02234583|515378612|FG000|Overall Study|Lost to Follow-up|0|||
142956394|NCT02234583|515378613|FG001|Overall Study|Lost to Follow-up|1|||
142956395|NCT02234583|515378612|FG000|Overall Study|Lack of Efficacy|58|||
142956396|NCT02234583|515378613|FG001|Overall Study|Lack of Efficacy|103|||
142956397|NCT02234583|515378612|FG000|Overall Study|Protocol Violation|35|||
142956398|NCT02234583|515378613|FG001|Overall Study|Protocol Violation|42|||
142956399|NCT02234583|515378612|FG000|Overall Study|Other|39|||
142956400|NCT02234583|515378613|FG001|Overall Study|Other|97|||
142956401|NCT01849250|515378614|FG000|Overall Study|Withdrawal by Subject|1|||
142956402|NCT01849250|515378615|FG001|Overall Study|Withdrawal by Subject|0|||
142956403|NCT01849250|515378614|FG000|Overall Study|Not Evaluable|5|||
142956404|NCT01849250|515378615|FG001|Overall Study|Not Evaluable|3|||
142956405|NCT01849250|515378614|FG000|Overall Study|Screen Failure|1|||
142956406|NCT01849250|515378615|FG001|Overall Study|Screen Failure|0|||
142956407|NCT00367640|515378618|FG000|Overall Study|Adverse Event|3|||
142956408|NCT00367640|515378619|FG001|Overall Study|Adverse Event|6|||
142956409|NCT00367640|515378620|FG002|Overall Study|Adverse Event|8|||
142956410|NCT00367640|515378621|FG003|Overall Study|Adverse Event|0|||
142956411|NCT00367640|515378618|FG000|Overall Study|Withdrawal by Subject|8|||
142956412|NCT00367640|515378619|FG001|Overall Study|Withdrawal by Subject|11|||
142956413|NCT00367640|515378620|FG002|Overall Study|Withdrawal by Subject|8|||
142956414|NCT00367640|515378621|FG003|Overall Study|Withdrawal by Subject|6|||
142956415|NCT00367640|515378618|FG000|Overall Study|Any other reason not above-mentioned|7|||
142956416|NCT00367640|515378619|FG001|Overall Study|Any other reason not above-mentioned|5|||
142956417|NCT00367640|515378620|FG002|Overall Study|Any other reason not above-mentioned|3|||
142956418|NCT00367640|515378621|FG003|Overall Study|Any other reason not above-mentioned|4|||
142956419|NCT02795767|515378623|FG000|Overall Study|Received Commercial Emicizumab|1|||
142956420|NCT02795767|515378624|FG001|Overall Study|Received Commercial Emicizumab|0|||
142956421|NCT02795767|515378625|FG002|Overall Study|Received Commercial Emicizumab|0|||
142956422|NCT03964415|515378630|FG000|Overall Study|Sponsor's decision|1563|||
142956423|NCT03964415|515378631|FG001|Overall Study|Sponsor's decision|1528|||
142956424|NCT03964415|515378630|FG000|Overall Study|Lost to Follow-up|139|||
142956425|NCT03964415|515378631|FG001|Overall Study|Lost to Follow-up|146|||
142956426|NCT03964415|515378630|FG000|Overall Study|Withdrawal by Subject|68|||
142956427|NCT03964415|515378631|FG001|Overall Study|Withdrawal by Subject|72|||
142956428|NCT03964415|515378630|FG000|Overall Study|Physician Decision|34|||
142956429|NCT03964415|515378631|FG001|Overall Study|Physician Decision|48|||
142956430|NCT03964415|515378630|FG000|Overall Study|Adverse Event|3|||
142956431|NCT03964415|515378631|FG001|Overall Study|Adverse Event|0|||
142956432|NCT03964415|515378630|FG000|Overall Study|Death|4|||
142956433|NCT03964415|515378631|FG001|Overall Study|Death|6|||
142956434|NCT03964415|515378630|FG000|Overall Study|Protocol Violation|1|||
142956435|NCT03964415|515378631|FG001|Overall Study|Protocol Violation|4|||
142956436|NCT03964415|515378630|FG000|Overall Study|Other|35|||
142956437|NCT03964415|515378631|FG001|Overall Study|Other|38|||
142956438|NCT03964415|515378630|FG000|Overall Study|Randomized but not treated|6|||
142956439|NCT03964415|515378631|FG001|Overall Study|Randomized but not treated|7|||
142956440|NCT01137435|515378641|FG000|Overall Study|Lost to Follow-up|24|||
142956441|NCT01137435|515378641|FG000|Overall Study|Off label usage|4|||
142956442|NCT00487279|515378646|FG000|Overall Study|Death|1|||
142956443|NCT00487279|515378647|FG001|Overall Study|Death|0|||
142956444|NCT00487279|515378646|FG000|Overall Study|Withdrawal by Subject|0|||
142956445|NCT00487279|515378647|FG001|Overall Study|Withdrawal by Subject|2|||
142956446|NCT00501852|515378648|FG000|Overall Study|Adverse Event|3|||
143455237|NCT02217475|517210847|FG001|Discontinued After Period 1|Physician Decision|0|||
143455238|NCT02217475|517210848|FG002|Discontinued After Period 1|Physician Decision|1|||
143455239|NCT02217475|517210846|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
143455240|NCT02217475|517210847|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
142956447|NCT00501852|515378648|FG000|Overall Study|Withdrawal by Subject|2|||
142956448|NCT01416610|515378649|FG000|Overall Study|Adverse Event|4|||
142956449|NCT01416610|515378649|FG000|Overall Study|Adverse Event -Patient decision|3|||
142956450|NCT01416610|515378649|FG000|Overall Study|Lack of Efficacy|4|||
142956451|NCT01416610|515378649|FG000|Overall Study|No reason given|5|||
142956452|NCT01416610|515378649|FG000|Overall Study|Withdrawal by Subject|13|||
142956453|NCT01416610|515378649|FG000|Overall Study|Lost to Follow-up|7|||
142956454|NCT01416610|515378649|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
142956455|NCT01618656|515378654|FG000|Overall Study|Withdrawal by Subject|7|||
142956456|NCT01618656|515378655|FG001|Overall Study|Withdrawal by Subject|3|||
142956457|NCT01618656|515378654|FG000|Overall Study|Physician Decision|1|||
143117490|NCT01472939|515971863|FG002|Overall Study|Withdrawal By PI|0|||
142956458|NCT01618656|515378655|FG001|Overall Study|Physician Decision|1|||
142956459|NCT01899144|515378656|FG000|Treatment Period 2|Other|1|||
142956460|NCT01899144|515378656|FG000|Treatment Period 3|Other|2|||
142956461|NCT01899144|515378656|FG000|Treatment Period 5|Other|1|||
142956462|NCT03242759|515378662|FG000|Overall Study|Adverse Event|5|||
142956463|NCT03242759|515378663|FG001|Overall Study|Adverse Event|1|||
142956464|NCT03242759|515378662|FG000|Overall Study|Withdrawal by Subject|4|||
142956465|NCT03242759|515378663|FG001|Overall Study|Withdrawal by Subject|3|||
142956466|NCT03242759|515378662|FG000|Overall Study|Lost to Follow-up|3|||
142956467|NCT03242759|515378663|FG001|Overall Study|Lost to Follow-up|1|||
142956468|NCT03242759|515378662|FG000|Overall Study|Administrative problems|1|||
142956469|NCT03242759|515378663|FG001|Overall Study|Administrative problems|1|||
142956470|NCT03242759|515378662|FG000|Overall Study|Death|22|||
142956471|NCT03242759|515378663|FG001|Overall Study|Death|0|||
142956472|NCT03242759|515378662|FG000|Overall Study|Change visit schedule|0|||
142956473|NCT03242759|515378663|FG001|Overall Study|Change visit schedule|1|||
142956474|NCT02399475|515378666|FG000|Overall Study|Physician Decision|1|||
142956475|NCT02399475|515378667|FG001|Overall Study|Physician Decision|0|||
142956476|NCT02160977|515378670|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
142956477|NCT02160977|515378671|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
142956478|NCT02160977|515378670|FG000|Three Months After Surgery|Lost to Follow-up|0|||
142956479|NCT02160977|515378671|FG001|Three Months After Surgery|Lost to Follow-up|2|||
142956480|NCT02160977|515378670|FG000|Six Months After Surgery|Lost to Follow-up|2|||
142956481|NCT02160977|515378671|FG001|Six Months After Surgery|Lost to Follow-up|1|||
142956482|NCT02658656|515378673|FG000|Screening|Failed eligibility criteria|0|||
142956483|NCT02658656|515378674|FG001|Screening|Failed eligibility criteria|0|||
142956484|NCT02658656|515378675|FG002|Screening|Failed eligibility criteria|263|||
142956485|NCT02658656|515378673|FG000|Randomization|Withdrawal by Subject|8|||
142956486|NCT02658656|515378674|FG001|Randomization|Withdrawal by Subject|7|||
142956487|NCT02658656|515378675|FG002|Randomization|Withdrawal by Subject|0|||
142956488|NCT02658656|515378673|FG000|Randomization|Lost to Follow-up|1|||
142956489|NCT02658656|515378674|FG001|Randomization|Lost to Follow-up|3|||
142956490|NCT02658656|515378675|FG002|Randomization|Lost to Follow-up|0|||
142956491|NCT02658656|515378673|FG000|Randomization|Adverse Event|4|||
142956492|NCT02658656|515378674|FG001|Randomization|Adverse Event|0|||
142956493|NCT02658656|515378675|FG002|Randomization|Adverse Event|0|||
142956494|NCT02658656|515378673|FG000|Randomization|Administrative Termination|3|||
142956495|NCT02658656|515378674|FG001|Randomization|Administrative Termination|1|||
142956496|NCT02658656|515378675|FG002|Randomization|Administrative Termination|0|||
142956497|NCT02658656|515378673|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
142956498|NCT02658656|515378674|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
142956499|NCT02658656|515378675|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
142956500|NCT02658656|515378673|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
142956501|NCT02658656|515378674|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
142956502|NCT02658656|515378675|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
142956503|NCT02658656|515378673|FG000|Randomization|Not eligible for Randomization|1|||
142956504|NCT02658656|515378674|FG001|Randomization|Not eligible for Randomization|0|||
142956505|NCT02658656|515378675|FG002|Randomization|Not eligible for Randomization|0|||
142956506|NCT02658656|515378673|FG000|Randomization|Protocol Violation|1|||
142956507|NCT02658656|515378674|FG001|Randomization|Protocol Violation|0|||
142956508|NCT02658656|515378675|FG002|Randomization|Protocol Violation|0|||
142956509|NCT04267562|515380348|FG000|Assessed for Eligibility|Screen Failure|64|||
142956510|NCT04267562|515380348|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
142956511|NCT04267562|515380348|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
142956512|NCT04267562|515380348|FG000|Assessed for Eligibility|Site closure|6|||
142956513|NCT04267562|515380348|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
142956514|NCT04267562|515380348|FG000|Assessed for Eligibility|Physician Decision|1|||
142956515|NCT04267562|515380348|FG000|Month 24|Elective hysterectomy|1|||
142956516|NCT04267562|515380348|FG000|Month 24|Lost to Follow-up|1|||
142956517|NCT04267562|515380348|FG000|Month 36|Elective hysterectomy|2|||
142956518|NCT04267562|515380348|FG000|Month 36|Lost to Follow-up|3|||
142956519|NCT00408421|515380351|FG000|Treatment Initial Randomization|Adverse Event|5|||
142956520|NCT00408421|515380352|FG001|Treatment Initial Randomization|Adverse Event|9|||
142956521|NCT00408421|515380353|FG002|Treatment Initial Randomization|Adverse Event|0|||
142956522|NCT00408421|515380351|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
142956523|NCT00408421|515380352|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
142956524|NCT00408421|515380353|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
142956525|NCT00408421|515380351|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
142956526|NCT00408421|515380352|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
142956527|NCT00408421|515380353|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
142956528|NCT00408421|515380351|FG000|Treatment Initial Randomization|Physician Decision|1|||
142956529|NCT00408421|515380352|FG001|Treatment Initial Randomization|Physician Decision|0|||
142956530|NCT00408421|515380353|FG002|Treatment Initial Randomization|Physician Decision|0|||
142956531|NCT00408421|515380351|FG000|Treatment Initial Randomization|Protocol Violation|0|||
142956532|NCT00408421|515380352|FG001|Treatment Initial Randomization|Protocol Violation|1|||
143117134|NCT01273155|515970042|FG004|Overall Study|Change in liver function/no longer eval.|1|||
142956533|NCT00408421|515380353|FG002|Treatment Initial Randomization|Protocol Violation|0|||
142956534|NCT00408421|515380351|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
142956535|NCT00408421|515380352|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
142956536|NCT00408421|515380353|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
142956537|NCT00408421|515380351|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
142956538|NCT00408421|515380352|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
142956539|NCT00408421|515380353|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
142956540|NCT00408421|515380351|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
142956541|NCT00408421|515380352|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
142956542|NCT00408421|515380353|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
142956543|NCT00408421|515380351|FG000|Treatment Re-Randomization|Adverse Event|2|||
142956544|NCT00408421|515380352|FG001|Treatment Re-Randomization|Adverse Event|2|||
142956545|NCT00408421|515380353|FG002|Treatment Re-Randomization|Adverse Event|4|||
142956546|NCT00408421|515380351|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
142956547|NCT00408421|515380352|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
142956548|NCT00408421|515380353|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
142956549|NCT00408421|515380351|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
142956550|NCT00408421|515380352|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
142956551|NCT00408421|515380353|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
142956552|NCT00408421|515380351|FG000|Treatment Re-Randomization|Physician Decision|1|||
142956553|NCT00408421|515380352|FG001|Treatment Re-Randomization|Physician Decision|3|||
142956554|NCT00408421|515380353|FG002|Treatment Re-Randomization|Physician Decision|0|||
142956555|NCT00408421|515380351|FG000|Treatment Re-Randomization|Protocol Violation|1|||
142956556|NCT00408421|515380352|FG001|Treatment Re-Randomization|Protocol Violation|1|||
142956557|NCT00408421|515380353|FG002|Treatment Re-Randomization|Protocol Violation|0|||
142956558|NCT00408421|515380351|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
142956559|NCT00408421|515380352|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
142956560|NCT00408421|515380353|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
142956561|NCT03132805|515380356|FG000|Overall Study|Lost to Follow-up|142|||
142956562|NCT03132805|515380357|FG001|Overall Study|Lost to Follow-up|141|||
142956563|NCT03132805|515380358|FG002|Overall Study|Lost to Follow-up|113|||
142956564|NCT03009539|515380359|FG000|Overall Study|Lost to Follow-up|132|||
142956565|NCT03009539|515380360|FG001|Overall Study|Lost to Follow-up|113|||
142956566|NCT03009539|515380361|FG002|Overall Study|Lost to Follow-up|132|||
142956567|NCT03009539|515380362|FG003|Overall Study|Lost to Follow-up|113|||
142956568|NCT03151148|515380363|FG000|Overall Study|Lost to Follow-up|1|||
142956569|NCT03151148|515380364|FG001|Overall Study|Lost to Follow-up|0|||
142956570|NCT03151148|515380363|FG000|Overall Study|Withdrawal by Subject|1|||
142956571|NCT03151148|515380364|FG001|Overall Study|Withdrawal by Subject|0|||
142956572|NCT00710034|515380365|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
142956573|NCT00710034|515380366|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
142956574|NCT00710034|515380365|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
142956575|NCT00710034|515380366|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
142956576|NCT00710034|515380365|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
142956577|NCT00710034|515380366|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
142956578|NCT00710034|515380365|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
142956579|NCT00710034|515380366|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
142956580|NCT00710034|515380365|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
142956581|NCT00710034|515380366|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
142956582|NCT00710034|515380365|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
142956583|NCT00710034|515380366|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
142956584|NCT00710034|515380365|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
142956585|NCT00710034|515380366|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
142956586|NCT00710034|515380365|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
142956587|NCT00710034|515380366|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
142956588|NCT00710034|515380365|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
142956589|NCT00710034|515380366|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
142956590|NCT00710034|515380365|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
142956591|NCT00710034|515380366|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
142956592|NCT00710034|515380365|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
142956593|NCT00710034|515380366|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
142956594|NCT00494871|515380367|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
142956595|NCT00494871|515380368|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
142956596|NCT00494871|515380367|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
142956597|NCT00494871|515380368|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
142956598|NCT00494871|515380367|FG000|Double-blind (DB) Treatment Period|Death|8|||
143455241|NCT02217475|517210848|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
142956599|NCT00494871|515380368|FG001|Double-blind (DB) Treatment Period|Death|3|||
142956600|NCT00494871|515380367|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
142956601|NCT00494871|515380368|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
142956602|NCT00494871|515380367|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
142956603|NCT00494871|515380368|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
142956604|NCT00494871|515380367|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
142956605|NCT00494871|515380368|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
142956606|NCT00494871|515380367|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
142956607|NCT00494871|515380368|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
142956608|NCT00494871|515380367|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
142956609|NCT00494871|515380368|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
142956610|NCT00494871|515380367|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
142956611|NCT00494871|515380368|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
142956612|NCT00494871|515380367|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
142956613|NCT00494871|515380368|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
142956614|NCT00494871|515380367|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
142956615|NCT00494871|515380368|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
142956616|NCT00494871|515380367|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
142956617|NCT00494871|515380368|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
142956618|NCT00494871|515380367|FG000|Follow-up (FU) Period|Adverse Event|1|||
142956619|NCT00494871|515380368|FG001|Follow-up (FU) Period|Adverse Event|1|||
142956620|NCT00494871|515380367|FG000|Follow-up (FU) Period|Death|13|||
142956621|NCT00494871|515380368|FG001|Follow-up (FU) Period|Death|12|||
142956622|NCT00494871|515380367|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
142956623|NCT00494871|515380368|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
142956624|NCT00494871|515380367|FG000|Follow-up (FU) Period|Physician Decision|0|||
142956625|NCT00494871|515380368|FG001|Follow-up (FU) Period|Physician Decision|1|||
142956626|NCT00494871|515380367|FG000|Follow-up (FU) Period|Protocol Violation|1|||
142956627|NCT00494871|515380368|FG001|Follow-up (FU) Period|Protocol Violation|0|||
142956628|NCT00494871|515380367|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
142956629|NCT00494871|515380368|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
142956630|NCT00494871|515380367|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
142956631|NCT00494871|515380368|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
142956632|NCT02115815|515380373|FG000|Overall Study|Withdrawal by Subject|2|||
142956633|NCT02115815|515380374|FG001|Overall Study|Withdrawal by Subject|0|||
142956634|NCT02115815|515380375|FG002|Overall Study|Withdrawal by Subject|0|||
142956635|NCT02115815|515380376|FG003|Overall Study|Withdrawal by Subject|0|||
142956636|NCT02115815|515380377|FG004|Overall Study|Withdrawal by Subject|0|||
142956637|NCT02115815|515380378|FG005|Overall Study|Withdrawal by Subject|0|||
142956638|NCT02115815|515380379|FG006|Overall Study|Withdrawal by Subject|0|||
142956639|NCT02115815|515380373|FG000|Overall Study|Not enough drug to dose participant|0|||
142956640|NCT02115815|515380374|FG001|Overall Study|Not enough drug to dose participant|0|||
142956641|NCT02115815|515380375|FG002|Overall Study|Not enough drug to dose participant|0|||
142956642|NCT02115815|515380376|FG003|Overall Study|Not enough drug to dose participant|0|||
142956643|NCT02115815|515380377|FG004|Overall Study|Not enough drug to dose participant|0|||
142956644|NCT02115815|515380378|FG005|Overall Study|Not enough drug to dose participant|1|||
142956645|NCT02115815|515380379|FG006|Overall Study|Not enough drug to dose participant|0|||
142956646|NCT02115815|515380373|FG000|Overall Study|Missed appointment, randomized in error|0|||
142956647|NCT02115815|515380374|FG001|Overall Study|Missed appointment, randomized in error|0|||
142956648|NCT02115815|515380375|FG002|Overall Study|Missed appointment, randomized in error|0|||
142956649|NCT02115815|515380376|FG003|Overall Study|Missed appointment, randomized in error|0|||
142956650|NCT02115815|515380377|FG004|Overall Study|Missed appointment, randomized in error|0|||
142956651|NCT02115815|515380378|FG005|Overall Study|Missed appointment, randomized in error|1|||
142956652|NCT02115815|515380379|FG006|Overall Study|Missed appointment, randomized in error|0|||
142956653|NCT01958671|515380380|FG000|Overall Study|Adverse Event|1|||
142956654|NCT01958671|515380381|FG001|Overall Study|Adverse Event|1|||
142956655|NCT01958671|515380382|FG002|Overall Study|Adverse Event|5|||
142956656|NCT01958671|515380380|FG000|Overall Study|Death|1|||
142956657|NCT01958671|515380381|FG001|Overall Study|Death|0|||
142956658|NCT01958671|515380382|FG002|Overall Study|Death|0|||
142956659|NCT01958671|515380380|FG000|Overall Study|Excluded medication|0|||
142956660|NCT01958671|515380381|FG001|Overall Study|Excluded medication|0|||
142956661|NCT01958671|515380382|FG002|Overall Study|Excluded medication|1|||
142956662|NCT01958671|515380380|FG000|Overall Study|Hyperglycemia|0|||
142956663|NCT01958671|515380381|FG001|Overall Study|Hyperglycemia|0|||
142956664|NCT01958671|515380382|FG002|Overall Study|Hyperglycemia|2|||
142956665|NCT01958671|515380380|FG000|Overall Study|Lost to Follow-up|7|||
142956666|NCT01958671|515380381|FG001|Overall Study|Lost to Follow-up|11|||
142956667|NCT01958671|515380382|FG002|Overall Study|Lost to Follow-up|7|||
142956668|NCT01958671|515380380|FG000|Overall Study|Non-compliance with study drug|1|||
142956669|NCT01958671|515380381|FG001|Overall Study|Non-compliance with study drug|1|||
142956670|NCT01958671|515380382|FG002|Overall Study|Non-compliance with study drug|1|||
142956671|NCT01958671|515380380|FG000|Overall Study|Pregnancy|0|||
142956672|NCT01958671|515380381|FG001|Overall Study|Pregnancy|0|||
142956673|NCT01958671|515380382|FG002|Overall Study|Pregnancy|1|||
142956674|NCT01958671|515380380|FG000|Overall Study|Protocol Violation|0|||
142956675|NCT01958671|515380381|FG001|Overall Study|Protocol Violation|1|||
142956676|NCT01958671|515380382|FG002|Overall Study|Protocol Violation|0|||
142956677|NCT01958671|515380380|FG000|Overall Study|Study site terminated by sponsor|1|||
142956678|NCT01958671|515380381|FG001|Overall Study|Study site terminated by sponsor|0|||
142956679|NCT01958671|515380382|FG002|Overall Study|Study site terminated by sponsor|1|||
142956680|NCT01958671|515380380|FG000|Overall Study|Participant moved|0|||
142956681|NCT01958671|515380381|FG001|Overall Study|Participant moved|0|||
142956682|NCT01958671|515380382|FG002|Overall Study|Participant moved|1|||
142956683|NCT01958671|515380380|FG000|Overall Study|Withdrawal by Subject|8|||
142956684|NCT01958671|515380381|FG001|Overall Study|Withdrawal by Subject|10|||
142956685|NCT01958671|515380382|FG002|Overall Study|Withdrawal by Subject|13|||
142956686|NCT02778867|515380383|FG000|Phase 1|Withdrawal by Subject|2|||
142956687|NCT02778867|515380384|FG001|Phase 1|Withdrawal by Subject|3|||
142956688|NCT02778867|515380385|FG002|Phase 1|Withdrawal by Subject|0|||
142956689|NCT02778867|515380386|FG003|Phase 1|Withdrawal by Subject|0|||
142956690|NCT02778867|515380383|FG000|Phase 2|Withdrawal by Subject|0|||
142956691|NCT02778867|515380384|FG001|Phase 2|Withdrawal by Subject|0|||
142956692|NCT02778867|515380385|FG002|Phase 2|Withdrawal by Subject|1|||
142956693|NCT02778867|515380386|FG003|Phase 2|Withdrawal by Subject|0|||
142956694|NCT02778867|515380383|FG000|Phase 2|Physician Decision|0|||
142956695|NCT02778867|515380384|FG001|Phase 2|Physician Decision|0|||
142956696|NCT02778867|515380385|FG002|Phase 2|Physician Decision|0|||
142956697|NCT02778867|515380386|FG003|Phase 2|Physician Decision|1|||
142956698|NCT02778867|515380383|FG000|Phase 2|Adverse Event|0|||
142956699|NCT02778867|515380384|FG001|Phase 2|Adverse Event|0|||
142956700|NCT02778867|515380385|FG002|Phase 2|Adverse Event|0|||
142956701|NCT02778867|515380386|FG003|Phase 2|Adverse Event|1|||
142956702|NCT03504774|515380387|FG000|Overall Study|Adverse Event|2|||
142956703|NCT03504774|515380388|FG001|Overall Study|Adverse Event|0|||
142956704|NCT03504774|515380387|FG000|Overall Study|Lost to Follow-up|0|||
142956705|NCT03504774|515380388|FG001|Overall Study|Lost to Follow-up|1|||
142956706|NCT03504774|515380387|FG000|Overall Study|Protocol Violation|11|||
142956707|NCT03504774|515380388|FG001|Overall Study|Protocol Violation|3|||
142956708|NCT03504774|515380387|FG000|Overall Study|failed wk 52 DBPCFC|1|||
142956709|NCT03504774|515380388|FG001|Overall Study|failed wk 52 DBPCFC|0|||
142956710|NCT01703286|515380389|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
142956711|NCT01703286|515380390|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
142956712|NCT01703286|515380391|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
142956713|NCT01703286|515380392|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
142956714|NCT01703286|515380393|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
142956715|NCT01703286|515380394|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
142956716|NCT01703286|515380389|FG000|Period 2 Including Washout|Adverse Event|0|||
142956717|NCT01703286|515380390|FG001|Period 2 Including Washout|Adverse Event|0|||
142956718|NCT01703286|515380391|FG002|Period 2 Including Washout|Adverse Event|0|||
142956719|NCT01703286|515380392|FG003|Period 2 Including Washout|Adverse Event|1|||
142956720|NCT01703286|515380393|FG004|Period 2 Including Washout|Adverse Event|0|||
142956721|NCT01703286|515380394|FG005|Period 2 Including Washout|Adverse Event|0|||
142956722|NCT02421120|515380395|FG000|Overall Study|Adverse Event|1|||
142956723|NCT00931892|515380396|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
142956724|NCT00931892|515380397|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
142956725|NCT02207530|515380398|FG000|Overall Study|Worsening condition under investigation|78|||
142956726|NCT02207530|515380398|FG000|Overall Study|Patient decision to stop study treatment|5|||
142956727|NCT02207530|515380398|FG000|Overall Study|Adverse Event|8|||
142956728|NCT02345161|515380401|FG000|Overall Study|Withdrawal by Subject|25|||
142956729|NCT02345161|515380402|FG001|Overall Study|Withdrawal by Subject|33|||
142956730|NCT02345161|515380401|FG000|Overall Study|Adverse Event|16|||
142956731|NCT02345161|515380402|FG001|Overall Study|Adverse Event|19|||
142956732|NCT02345161|515380401|FG000|Overall Study|Physician Decision|4|||
142956733|NCT02345161|515380402|FG001|Overall Study|Physician Decision|4|||
142956734|NCT02345161|515380401|FG000|Overall Study|Lost to Follow-up|0|||
142956735|NCT02345161|515380402|FG001|Overall Study|Lost to Follow-up|1|||
142956736|NCT00972244|515380405|FG000|Overall Study|Incorrect Enrolment|1|||
142956737|NCT00972244|515380406|FG001|Overall Study|Incorrect Enrolment|0|||
142956738|NCT00972244|515380407|FG002|Overall Study|Incorrect Enrolment|0|||
142956739|NCT00972244|515380408|FG003|Overall Study|Incorrect Enrolment|0|||
142956740|NCT00972244|515380409|FG004|Overall Study|Incorrect Enrolment|0|||
142956741|NCT00972244|515380405|FG000|Overall Study|Adverse Event|0|||
142956742|NCT00972244|515380406|FG001|Overall Study|Adverse Event|1|||
142956743|NCT00972244|515380407|FG002|Overall Study|Adverse Event|1|||
142956744|NCT00972244|515380408|FG003|Overall Study|Adverse Event|0|||
142956745|NCT00972244|515380409|FG004|Overall Study|Adverse Event|0|||
142956746|NCT00972244|515380405|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
142956747|NCT00972244|515380406|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
142956748|NCT00972244|515380407|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
142956749|NCT00972244|515380408|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
142956750|NCT00972244|515380409|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
142956751|NCT00972244|515380405|FG000|Overall Study|Withdrawal by Subject|1|||
142956752|NCT00972244|515380406|FG001|Overall Study|Withdrawal by Subject|2|||
142956753|NCT00972244|515380407|FG002|Overall Study|Withdrawal by Subject|1|||
142956754|NCT00972244|515380408|FG003|Overall Study|Withdrawal by Subject|0|||
142956755|NCT00972244|515380409|FG004|Overall Study|Withdrawal by Subject|1|||
142956756|NCT00972244|515380405|FG000|Overall Study|Safety|0|||
142956757|NCT00972244|515380406|FG001|Overall Study|Safety|0|||
142956758|NCT00972244|515380407|FG002|Overall Study|Safety|0|||
142956759|NCT00972244|515380408|FG003|Overall Study|Safety|0|||
142956760|NCT00972244|515380409|FG004|Overall Study|Safety|1|||
142956761|NCT00972244|515380405|FG000|Overall Study|Death|1|||
142956762|NCT00972244|515380406|FG001|Overall Study|Death|0|||
142956763|NCT00972244|515380407|FG002|Overall Study|Death|0|||
142956764|NCT00972244|515380408|FG003|Overall Study|Death|0|||
142956765|NCT00972244|515380409|FG004|Overall Study|Death|0|||
142956766|NCT00972244|515380405|FG000|Overall Study|Various|0|||
142956767|NCT00972244|515380406|FG001|Overall Study|Various|0|||
142956768|NCT00972244|515380407|FG002|Overall Study|Various|0|||
142956769|NCT00972244|515380408|FG003|Overall Study|Various|0|||
142956770|NCT00972244|515380409|FG004|Overall Study|Various|2|||
142956771|NCT00090285|515380410|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
142956772|NCT00090285|515380411|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
142956773|NCT00090285|515380412|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
142956774|NCT00090285|515380413|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
142956775|NCT00090285|515380414|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
142956776|NCT00090285|515380415|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
142956777|NCT00090285|515380410|FG000|Base Study Vaccination Period|Adverse Event|2|||
142956778|NCT00090285|515380411|FG001|Base Study Vaccination Period|Adverse Event|4|||
142956779|NCT00090285|515380412|FG002|Base Study Vaccination Period|Adverse Event|0|||
142956780|NCT00090285|515380413|FG003|Base Study Vaccination Period|Adverse Event|0|||
142956781|NCT00090285|515380414|FG004|Base Study Vaccination Period|Adverse Event|0|||
142956782|NCT00090285|515380415|FG005|Base Study Vaccination Period|Adverse Event|0|||
142956783|NCT00090285|515380410|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
142956784|NCT00090285|515380411|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
142956785|NCT00090285|515380412|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
142956786|NCT00090285|515380413|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
142956787|NCT00090285|515380414|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
142956788|NCT00090285|515380415|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
142956789|NCT00090285|515380410|FG000|Base Study Vaccination Period|Protocol Violation|2|||
142956790|NCT00090285|515380411|FG001|Base Study Vaccination Period|Protocol Violation|3|||
142956791|NCT00090285|515380412|FG002|Base Study Vaccination Period|Protocol Violation|0|||
142956792|NCT00090285|515380413|FG003|Base Study Vaccination Period|Protocol Violation|0|||
142956793|NCT00090285|515380414|FG004|Base Study Vaccination Period|Protocol Violation|0|||
142956794|NCT00090285|515380415|FG005|Base Study Vaccination Period|Protocol Violation|0|||
142956795|NCT00090285|515380410|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
142956796|NCT00090285|515380411|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
142956797|NCT00090285|515380412|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
142956798|NCT00090285|515380413|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
142956799|NCT00090285|515380414|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
142956800|NCT00090285|515380415|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
142956801|NCT00090285|515380410|FG000|Base Study Vaccination Period|Uncooperative|2|||
142956802|NCT00090285|515380411|FG001|Base Study Vaccination Period|Uncooperative|2|||
142956803|NCT00090285|515380412|FG002|Base Study Vaccination Period|Uncooperative|0|||
142956804|NCT00090285|515380413|FG003|Base Study Vaccination Period|Uncooperative|0|||
142956805|NCT00090285|515380414|FG004|Base Study Vaccination Period|Uncooperative|0|||
142956806|NCT00090285|515380415|FG005|Base Study Vaccination Period|Uncooperative|0|||
142956807|NCT00090285|515380410|FG000|Base Study Vaccination Period|Moved|20|||
142956808|NCT00090285|515380411|FG001|Base Study Vaccination Period|Moved|21|||
142956809|NCT00090285|515380412|FG002|Base Study Vaccination Period|Moved|0|||
142956810|NCT00090285|515380413|FG003|Base Study Vaccination Period|Moved|0|||
142956811|NCT00090285|515380414|FG004|Base Study Vaccination Period|Moved|0|||
142956812|NCT00090285|515380415|FG005|Base Study Vaccination Period|Moved|0|||
142956813|NCT00090285|515380410|FG000|Base Study Vaccination Period|Site Terminated|1|||
143455242|NCT02217475|517210846|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
142956814|NCT00090285|515380411|FG001|Base Study Vaccination Period|Site Terminated|0|||
142956815|NCT00090285|515380412|FG002|Base Study Vaccination Period|Site Terminated|0|||
142956816|NCT00090285|515380413|FG003|Base Study Vaccination Period|Site Terminated|0|||
142956817|NCT00090285|515380414|FG004|Base Study Vaccination Period|Site Terminated|0|||
142956818|NCT00090285|515380415|FG005|Base Study Vaccination Period|Site Terminated|0|||
142956819|NCT00090285|515380410|FG000|Base Study Vaccination Period|Other|2|||
142956820|NCT00090285|515380411|FG001|Base Study Vaccination Period|Other|2|||
142956821|NCT00090285|515380412|FG002|Base Study Vaccination Period|Other|0|||
142956822|NCT00090285|515380413|FG003|Base Study Vaccination Period|Other|0|||
142956823|NCT00090285|515380414|FG004|Base Study Vaccination Period|Other|0|||
142956824|NCT00090285|515380415|FG005|Base Study Vaccination Period|Other|0|||
142956825|NCT00090285|515380410|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
142956826|NCT00090285|515380411|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
142956827|NCT00090285|515380412|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
143455243|NCT02217475|517210847|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
143455244|NCT02217475|517210848|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
143455245|NCT02217475|517210846|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
143455246|NCT02217475|517210847|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
143455247|NCT02217475|517210848|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
143455248|NCT02217475|517210846|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
143455249|NCT02217475|517210847|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
143455250|NCT02217475|517210848|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
143455251|NCT02217475|517210846|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
143455252|NCT02217475|517210847|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
143455253|NCT02217475|517210848|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
143455254|NCT04738292|517210853|FG000|Overall Study|Death|1|||
143455255|NCT03001076|517210854|FG000|Overall Study|Withdrawal by patient|2|||
143455256|NCT03001076|517210855|FG001|Overall Study|Withdrawal by patient|0|||
143455257|NCT03001076|517210854|FG000|Overall Study|Other|1|||
143455258|NCT03001076|517210855|FG001|Overall Study|Other|0|||
143455259|NCT03001076|517210854|FG000|Overall Study|Adverse Event|3|||
143455260|NCT03001076|517210855|FG001|Overall Study|Adverse Event|3|||
143455261|NCT03001076|517210854|FG000|Overall Study|Sponsor decision|1|||
142956828|NCT00090285|515380413|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
143455262|NCT03001076|517210855|FG001|Overall Study|Sponsor decision|0|||
142956829|NCT00090285|515380414|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
142956830|NCT00090285|515380415|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
142956831|NCT00090285|515380410|FG000|Base Study Vaccination Period|HIV positive|1|||
142956832|NCT00090285|515380411|FG001|Base Study Vaccination Period|HIV positive|1|||
142956833|NCT00090285|515380412|FG002|Base Study Vaccination Period|HIV positive|0|||
142956834|NCT00090285|515380413|FG003|Base Study Vaccination Period|HIV positive|0|||
142956835|NCT00090285|515380414|FG004|Base Study Vaccination Period|HIV positive|0|||
142956836|NCT00090285|515380415|FG005|Base Study Vaccination Period|HIV positive|0|||
142956837|NCT00090285|515380410|FG000|Base Study Follow-up Period|Adverse Event|3|||
142956838|NCT00090285|515380411|FG001|Base Study Follow-up Period|Adverse Event|10|||
142956839|NCT00090285|515380412|FG002|Base Study Follow-up Period|Adverse Event|0|||
142956840|NCT00090285|515380413|FG003|Base Study Follow-up Period|Adverse Event|0|||
142956841|NCT00090285|515380414|FG004|Base Study Follow-up Period|Adverse Event|0|||
142956842|NCT00090285|515380415|FG005|Base Study Follow-up Period|Adverse Event|0|||
142956843|NCT00090285|515380410|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
142956844|NCT00090285|515380411|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
142956845|NCT00090285|515380412|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
142956846|NCT00090285|515380413|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
142956847|NCT00090285|515380414|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
142956848|NCT00090285|515380415|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
142956849|NCT00090285|515380410|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
142956850|NCT00090285|515380411|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
142956851|NCT00090285|515380412|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
142956852|NCT00090285|515380413|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
142956853|NCT00090285|515380414|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
142956854|NCT00090285|515380415|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
142956855|NCT00090285|515380410|FG000|Base Study Follow-up Period|Moved|41|||
142956856|NCT00090285|515380411|FG001|Base Study Follow-up Period|Moved|36|||
142956857|NCT00090285|515380412|FG002|Base Study Follow-up Period|Moved|0|||
142956858|NCT00090285|515380413|FG003|Base Study Follow-up Period|Moved|0|||
142956859|NCT00090285|515380414|FG004|Base Study Follow-up Period|Moved|0|||
142956860|NCT00090285|515380415|FG005|Base Study Follow-up Period|Moved|0|||
142956861|NCT00090285|515380410|FG000|Base Study Follow-up Period|Other|2|||
142956862|NCT00090285|515380411|FG001|Base Study Follow-up Period|Other|0|||
142956863|NCT00090285|515380412|FG002|Base Study Follow-up Period|Other|0|||
143455263|NCT03001076|517210854|FG000|Overall Study|Lost to Follow-up|0|||
143455264|NCT03001076|517210855|FG001|Overall Study|Lost to Follow-up|2|||
143455265|NCT02270515|517210856|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
143455266|NCT02270515|517210856|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
143455267|NCT02270515|517210856|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
143455268|NCT02270515|517210856|FG000|Intervention Period 1: 0-6 Months|Death|7|||
143455269|NCT02270515|517210856|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
142956864|NCT00090285|515380413|FG003|Base Study Follow-up Period|Other|0|||
142956865|NCT00090285|515380414|FG004|Base Study Follow-up Period|Other|0|||
142956866|NCT00090285|515380415|FG005|Base Study Follow-up Period|Other|0|||
142956867|NCT00090285|515380410|FG000|Base Study Follow-up Period|Protocol Violation|1|||
142956868|NCT00090285|515380411|FG001|Base Study Follow-up Period|Protocol Violation|0|||
142956869|NCT00090285|515380412|FG002|Base Study Follow-up Period|Protocol Violation|0|||
142956870|NCT00090285|515380413|FG003|Base Study Follow-up Period|Protocol Violation|0|||
142956871|NCT00090285|515380414|FG004|Base Study Follow-up Period|Protocol Violation|0|||
142956872|NCT00090285|515380415|FG005|Base Study Follow-up Period|Protocol Violation|0|||
142956873|NCT00090285|515380410|FG000|Base Study Follow-up Period|Uncooperative|3|||
142956874|NCT00090285|515380411|FG001|Base Study Follow-up Period|Uncooperative|4|||
142956875|NCT00090285|515380412|FG002|Base Study Follow-up Period|Uncooperative|0|||
142956876|NCT00090285|515380413|FG003|Base Study Follow-up Period|Uncooperative|0|||
142956877|NCT00090285|515380414|FG004|Base Study Follow-up Period|Uncooperative|0|||
142956878|NCT00090285|515380415|FG005|Base Study Follow-up Period|Uncooperative|0|||
142956879|NCT00090285|515380410|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
142956880|NCT00090285|515380411|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
142956881|NCT00090285|515380412|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
142956882|NCT00090285|515380413|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
142956883|NCT00090285|515380414|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
142956884|NCT00090285|515380415|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
142956885|NCT00090285|515380410|FG000|Extension 1|Adverse Event|0|||
142956886|NCT00090285|515380411|FG001|Extension 1|Adverse Event|0|||
142956887|NCT00090285|515380412|FG002|Extension 1|Adverse Event|2|||
142956888|NCT00090285|515380413|FG003|Extension 1|Adverse Event|0|||
142956889|NCT00090285|515380414|FG004|Extension 1|Adverse Event|0|||
142956890|NCT00090285|515380415|FG005|Extension 1|Adverse Event|0|||
142956891|NCT00090285|515380410|FG000|Extension 1|Lost to Follow-up|0|||
142956892|NCT00090285|515380411|FG001|Extension 1|Lost to Follow-up|0|||
142956893|NCT00090285|515380412|FG002|Extension 1|Lost to Follow-up|35|||
142956894|NCT00090285|515380413|FG003|Extension 1|Lost to Follow-up|0|||
142956895|NCT00090285|515380414|FG004|Extension 1|Lost to Follow-up|0|||
142956896|NCT00090285|515380415|FG005|Extension 1|Lost to Follow-up|0|||
142956897|NCT00090285|515380410|FG000|Extension 1|Withdrawal by Subject|0|||
142956898|NCT00090285|515380411|FG001|Extension 1|Withdrawal by Subject|0|||
142956899|NCT00090285|515380412|FG002|Extension 1|Withdrawal by Subject|13|||
142956900|NCT00090285|515380413|FG003|Extension 1|Withdrawal by Subject|1|||
142956901|NCT00090285|515380414|FG004|Extension 1|Withdrawal by Subject|0|||
142956902|NCT00090285|515380415|FG005|Extension 1|Withdrawal by Subject|0|||
142956903|NCT00090285|515380410|FG000|Extension 1|Other|0|||
142956904|NCT00090285|515380411|FG001|Extension 1|Other|0|||
142956905|NCT00090285|515380412|FG002|Extension 1|Other|4|||
142956906|NCT00090285|515380413|FG003|Extension 1|Other|0|||
142956907|NCT00090285|515380414|FG004|Extension 1|Other|0|||
142956908|NCT00090285|515380415|FG005|Extension 1|Other|0|||
142956909|NCT00090285|515380410|FG000|Extension 1|Moved|0|||
142956910|NCT00090285|515380411|FG001|Extension 1|Moved|0|||
142956911|NCT00090285|515380412|FG002|Extension 1|Moved|3|||
142956912|NCT00090285|515380413|FG003|Extension 1|Moved|0|||
142956913|NCT00090285|515380414|FG004|Extension 1|Moved|0|||
142956914|NCT00090285|515380415|FG005|Extension 1|Moved|0|||
142956915|NCT00090285|515380410|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
142956916|NCT00090285|515380411|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
142956917|NCT00090285|515380412|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
142956918|NCT00090285|515380413|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
142956919|NCT00090285|515380414|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
142956920|NCT00090285|515380415|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
142956921|NCT00090285|515380410|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
142956922|NCT00090285|515380411|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
142956923|NCT00090285|515380412|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
142956924|NCT00090285|515380413|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
142956925|NCT00090285|515380414|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
142956926|NCT00090285|515380415|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
142956927|NCT00090285|515380410|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
142956928|NCT00090285|515380411|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
142956929|NCT00090285|515380412|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
143455270|NCT02270515|517210856|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
143455271|NCT02270515|517210856|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
143455272|NCT02270515|517210856|FG000|Intervention Period 2: 6-12 Months|Death|5|||
143455273|NCT02270515|517210856|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
142956930|NCT00090285|515380413|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
142956931|NCT00090285|515380414|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
142956932|NCT00090285|515380415|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
142956933|NCT00090285|515380410|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
142956934|NCT00090285|515380411|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
142956935|NCT00090285|515380412|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
142956936|NCT00090285|515380413|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
142956937|NCT00090285|515380414|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
142956938|NCT00090285|515380415|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
142956939|NCT00907881|515380420|FG000|Overall Study|Lost to Follow-up|59|||
142956940|NCT00907881|515380420|FG000|Overall Study|Noncompliance|5|||
142956941|NCT00907881|515380420|FG000|Overall Study|Withdrawal by Subject|5|||
142956942|NCT00907881|515380420|FG000|Overall Study|Protocol Violation|1|||
142956943|NCT00907881|515380420|FG000|Overall Study|Missing discontinuation information|15|||
142956944|NCT06094296|515380425|FG000|Overall Study|Progressive Disease|1|||
142956945|NCT06094296|515380426|FG001|Overall Study|Progressive Disease|0|||
142956946|NCT06094296|515380427|FG002|Overall Study|Progressive Disease|0|||
142956947|NCT06094296|515380428|FG003|Overall Study|Progressive Disease|0|||
142956948|NCT00986258|515380429|FG000|Observation Period|Not eligible to be dosed|11|||
142956949|NCT00986258|515380429|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
142956950|NCT00986258|515380429|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
142956951|NCT00986258|515380429|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
142956952|NCT00986258|515380429|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
142956953|NCT00986258|515380429|FG000|Titration and Optimal Dose Period|Other|1|||
142956954|NCT00986258|515380429|FG000|Maintenance Period|Adverse Event|5|||
142956955|NCT00986258|515380429|FG000|Maintenance Period|Lack of Efficacy|2|||
142956956|NCT00986258|515380429|FG000|Maintenance Period|Withdrawal by Subject|2|||
142956957|NCT04964063|515380430|FG000|Overall Study|Adverse Event|4|||
142956958|NCT04964063|515380430|FG000|Overall Study|Lost to Follow-up|47|||
142956959|NCT04964063|515380430|FG000|Overall Study|Withdrawal by Subject|5|||
142956960|NCT04964063|515380430|FG000|Overall Study|Baseline Tasks Expired|41|||
142956961|NCT04964063|515380430|FG000|Overall Study|Participant withdrawn in error|1|||
142956962|NCT01740440|515380433|FG000|Overall Study|Lost to Follow-up|3|||
142956963|NCT02417233|515380434|FG000|Overall Study|Death|4|||
142956964|NCT02417233|515380435|FG001|Overall Study|Death|10|||
142956965|NCT02417233|515380436|FG002|Overall Study|Death|14|||
142956966|NCT02417233|515380434|FG000|Overall Study|Lost to Follow-up|27|||
142956967|NCT02417233|515380435|FG001|Overall Study|Lost to Follow-up|39|||
142956968|NCT02417233|515380436|FG002|Overall Study|Lost to Follow-up|34|||
142956969|NCT02417233|515380434|FG000|Overall Study|Protocol Violation|2|||
142956970|NCT02417233|515380435|FG001|Overall Study|Protocol Violation|0|||
142956971|NCT02417233|515380436|FG002|Overall Study|Protocol Violation|2|||
142956972|NCT02417233|515380434|FG000|Overall Study|Withdrawal by Subject|2|||
142956973|NCT02417233|515380435|FG001|Overall Study|Withdrawal by Subject|1|||
142956974|NCT02417233|515380436|FG002|Overall Study|Withdrawal by Subject|8|||
142956975|NCT02417233|515380434|FG000|Overall Study|Relocation out of study area|1|||
142956976|NCT02417233|515380435|FG001|Overall Study|Relocation out of study area|0|||
142956977|NCT02417233|515380436|FG002|Overall Study|Relocation out of study area|1|||
142956978|NCT02417233|515380434|FG000|Overall Study|Mentally unstable|0|||
142956979|NCT02417233|515380435|FG001|Overall Study|Mentally unstable|1|||
142956980|NCT02417233|515380436|FG002|Overall Study|Mentally unstable|0|||
142956981|NCT01063751|515380437|FG000|Overall Study|Censored from analyses|42|||
142956982|NCT01063751|515380437|FG000|Overall Study|Withdrawal by Subject|34|||
142956983|NCT01063751|515380437|FG000|Overall Study|Lost to Follow-up|30|||
142956984|NCT01063751|515380437|FG000|Overall Study|Death|13|||
142956985|NCT01063751|515380437|FG000|Overall Study|Sponsored Terminated Study|60|||
142956986|NCT01063751|515380437|FG000|Overall Study|Cases terminated due to investigator leaving the site and site closure.|35|||
142956987|NCT01063751|515380437|FG000|Overall Study|Investigator site closed|10|||
142956988|NCT01063751|515380437|FG000|Overall Study|Revision|6|||
142956989|NCT01063751|515380437|FG000|Overall Study|Physician Decision|4|||
142956990|NCT01797783|515380443|FG000|Overall Study|Adverse Event|1|||
142956991|NCT01797783|515380444|FG001|Overall Study|Adverse Event|1|||
142956992|NCT01797783|515380443|FG000|Overall Study|Withdrawal by Subject|1|||
142956993|NCT01797783|515380444|FG001|Overall Study|Withdrawal by Subject|0|||
142956994|NCT03799718|515380446|FG000|Overall Study|Adverse Event|2|||
142956995|NCT01024465|515380447|FG000|Overall Study|Adverse Event|2|||
142956996|NCT01024465|515380447|FG000|Overall Study|Physician Decision|1|||
142956997|NCT01734993|515380448|FG000|Overall Study|Adverse Event|1|||
142956998|NCT01734993|515380448|FG000|Overall Study|Lack of Efficacy|1|||
142956999|NCT01400971|515380451|FG000|Overall Study|Death|82|||
142957000|NCT01400971|515380451|FG000|Overall Study|Lost to Follow-up|196|||
142957001|NCT01400971|515380451|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
142957002|NCT01400971|515380451|FG000|Overall Study|Physician Decision|57|||
142957003|NCT01400971|515380451|FG000|Overall Study|Withdrawal by Subject|158|||
142957004|NCT01400971|515380451|FG000|Overall Study|Other|422|||
142957005|NCT00642616|515380459|FG000|Overall Study|Adverse Event|2|||
142957006|NCT00642616|515380460|FG001|Overall Study|Adverse Event|0|||
142957007|NCT00642616|515380461|FG002|Overall Study|Adverse Event|1|||
142957008|NCT00642616|515380462|FG003|Overall Study|Adverse Event|0|||
142957009|NCT00642616|515380459|FG000|Overall Study|Study Terminated by Sponsor|7|||
142957010|NCT00642616|515380460|FG001|Overall Study|Study Terminated by Sponsor|6|||
142957011|NCT00642616|515380461|FG002|Overall Study|Study Terminated by Sponsor|4|||
142957012|NCT00642616|515380462|FG003|Overall Study|Study Terminated by Sponsor|5|||
142957013|NCT00642616|515380459|FG000|Overall Study|Withdrawal by Subject|0|||
142957014|NCT00642616|515380460|FG001|Overall Study|Withdrawal by Subject|1|||
142957015|NCT00642616|515380461|FG002|Overall Study|Withdrawal by Subject|1|||
142957016|NCT00642616|515380462|FG003|Overall Study|Withdrawal by Subject|1|||
142957017|NCT00642616|515380459|FG000|Overall Study|Protocol Violation|0|||
142957018|NCT00642616|515380460|FG001|Overall Study|Protocol Violation|0|||
142957019|NCT00642616|515380461|FG002|Overall Study|Protocol Violation|2|||
142957020|NCT00642616|515380462|FG003|Overall Study|Protocol Violation|0|||
142957021|NCT00642616|515380459|FG000|Overall Study|Physician Decision|0|||
142957022|NCT00642616|515380460|FG001|Overall Study|Physician Decision|0|||
142957023|NCT00642616|515380461|FG002|Overall Study|Physician Decision|1|||
142957024|NCT00642616|515380462|FG003|Overall Study|Physician Decision|1|||
142957025|NCT00399802|515380463|FG000|Overall Study|Adverse Event|0|||
142957026|NCT00399802|515380464|FG001|Overall Study|Adverse Event|2|||
142957027|NCT00399802|515380463|FG000|Overall Study|Participant discontinued by mistake|0|||
142957028|NCT00399802|515380464|FG001|Overall Study|Participant discontinued by mistake|1|||
142957029|NCT00542815|515380465|FG000|Overall Study|Adverse Event|19|||
142957030|NCT00542815|515380466|FG001|Overall Study|Adverse Event|6|||
142957031|NCT00542815|515380467|FG002|Overall Study|Adverse Event|9|||
142957032|NCT00542815|515380465|FG000|Overall Study|Death|10|||
142957033|NCT00542815|515380466|FG001|Overall Study|Death|7|||
142957034|NCT00542815|515380467|FG002|Overall Study|Death|3|||
142957035|NCT00542815|515380465|FG000|Overall Study|Lack of Efficacy|9|||
142957036|NCT00542815|515380466|FG001|Overall Study|Lack of Efficacy|2|||
142957037|NCT00542815|515380467|FG002|Overall Study|Lack of Efficacy|0|||
142957038|NCT00542815|515380465|FG000|Overall Study|Physician Decision|2|||
142957039|NCT00542815|515380466|FG001|Overall Study|Physician Decision|1|||
142957040|NCT00542815|515380467|FG002|Overall Study|Physician Decision|0|||
142957041|NCT00542815|515380465|FG000|Overall Study|Protocol Violation|1|||
142957042|NCT00542815|515380466|FG001|Overall Study|Protocol Violation|1|||
142957043|NCT00542815|515380467|FG002|Overall Study|Protocol Violation|2|||
142957044|NCT00542815|515380465|FG000|Overall Study|Withdrawal by Subject|41|||
142957045|NCT00542815|515380466|FG001|Overall Study|Withdrawal by Subject|5|||
142957046|NCT00542815|515380467|FG002|Overall Study|Withdrawal by Subject|8|||
142957047|NCT00542815|515380465|FG000|Overall Study|Other reasons|24|||
142957048|NCT00542815|515380466|FG001|Overall Study|Other reasons|10|||
142957049|NCT00542815|515380467|FG002|Overall Study|Other reasons|10|||
142957050|NCT01041573|515380470|FG000|Overall Study|Withdrawal by Subject|2|||
142957051|NCT01041573|515380471|FG001|Overall Study|Withdrawal by Subject|5|||
142957052|NCT01041573|515380472|FG002|Overall Study|Withdrawal by Subject|2|||
142957053|NCT01041573|515380473|FG003|Overall Study|Withdrawal by Subject|0|||
142957054|NCT01041573|515380470|FG000|Overall Study|Death|1|||
142957055|NCT01041573|515380471|FG001|Overall Study|Death|0|||
142957056|NCT01041573|515380472|FG002|Overall Study|Death|0|||
142957057|NCT01041573|515380473|FG003|Overall Study|Death|0|||
142957058|NCT01041573|515380470|FG000|Overall Study|Lost to Follow-up|0|||
142957059|NCT01041573|515380471|FG001|Overall Study|Lost to Follow-up|1|||
142957060|NCT01041573|515380472|FG002|Overall Study|Lost to Follow-up|2|||
142957061|NCT01041573|515380473|FG003|Overall Study|Lost to Follow-up|1|||
142957062|NCT01041573|515380470|FG000|Overall Study|Adverse Event|0|||
142957063|NCT01041573|515380471|FG001|Overall Study|Adverse Event|2|||
142957064|NCT01041573|515380472|FG002|Overall Study|Adverse Event|0|||
142957065|NCT01041573|515380473|FG003|Overall Study|Adverse Event|0|||
142957066|NCT01041573|515380470|FG000|Overall Study|relocation|1|||
142957067|NCT01041573|515380471|FG001|Overall Study|relocation|4|||
142957068|NCT01041573|515380472|FG002|Overall Study|relocation|3|||
142957069|NCT01041573|515380473|FG003|Overall Study|relocation|1|||
142957070|NCT01041573|515380470|FG000|Overall Study|further blood extraction|0|||
142957071|NCT01041573|515380471|FG001|Overall Study|further blood extraction|1|||
142957072|NCT01041573|515380472|FG002|Overall Study|further blood extraction|0|||
142957073|NCT01041573|515380473|FG003|Overall Study|further blood extraction|0|||
142957074|NCT01041573|515380470|FG000|Overall Study|positive to anti-HCV|1|||
142957075|NCT01041573|515380471|FG001|Overall Study|positive to anti-HCV|0|||
142957076|NCT01041573|515380472|FG002|Overall Study|positive to anti-HCV|0|||
142957077|NCT01041573|515380473|FG003|Overall Study|positive to anti-HCV|0|||
142957078|NCT02955186|515380474|FG000|Overall Study|Withdrawal by Subject|6|||
142957079|NCT02955186|515380475|FG001|Overall Study|Withdrawal by Subject|2|||
142957080|NCT02955186|515380474|FG000|Overall Study|Protocol Violation|1|||
142957081|NCT02955186|515380475|FG001|Overall Study|Protocol Violation|0|||
142957082|NCT00751881|515380480|FG000|Core Treatment Period|Not treated|1|||
142957083|NCT00751881|515380481|FG001|Core Treatment Period|Not treated|1|||
142957084|NCT00751881|515380482|FG002|Core Treatment Period|Not treated|2|||
142957085|NCT00751881|515380480|FG000|Core Treatment Period|Adverse Event|26|||
142957086|NCT00751881|515380481|FG001|Core Treatment Period|Adverse Event|54|||
142957087|NCT00751881|515380482|FG002|Core Treatment Period|Adverse Event|58|||
142957088|NCT00751881|515380480|FG000|Core Treatment Period|Lack of Efficacy|37|||
142957089|NCT00751881|515380481|FG001|Core Treatment Period|Lack of Efficacy|30|||
142957090|NCT00751881|515380482|FG002|Core Treatment Period|Lack of Efficacy|20|||
142957091|NCT00751881|515380480|FG000|Core Treatment Period|Poor compliance to protocol|15|||
142957092|NCT00751881|515380481|FG001|Core Treatment Period|Poor compliance to protocol|3|||
142957093|NCT00751881|515380482|FG002|Core Treatment Period|Poor compliance to protocol|4|||
142957094|NCT00751881|515380480|FG000|Core Treatment Period|Lost to Follow-up|6|||
142957095|NCT00751881|515380481|FG001|Core Treatment Period|Lost to Follow-up|4|||
142957096|NCT00751881|515380482|FG002|Core Treatment Period|Lost to Follow-up|3|||
142957097|NCT00751881|515380480|FG000|Core Treatment Period|Other: protocol deviation|3|||
142957098|NCT00751881|515380481|FG001|Core Treatment Period|Other: protocol deviation|3|||
142957099|NCT00751881|515380482|FG002|Core Treatment Period|Other: protocol deviation|7|||
142957100|NCT00751881|515380480|FG000|Core Treatment Period|Other: wish to parent|5|||
142957101|NCT00751881|515380481|FG001|Core Treatment Period|Other: wish to parent|7|||
142957102|NCT00751881|515380482|FG002|Core Treatment Period|Other: wish to parent|4|||
142957103|NCT00751881|515380480|FG000|Core Treatment Period|Other: personal/family constraints|6|||
142957104|NCT00751881|515380481|FG001|Core Treatment Period|Other: personal/family constraints|7|||
142957105|NCT00751881|515380482|FG002|Core Treatment Period|Other: personal/family constraints|10|||
142957106|NCT00751881|515380480|FG000|Core Treatment Period|Other: MS treatment change|6|||
142957107|NCT00751881|515380481|FG001|Core Treatment Period|Other: MS treatment change|4|||
142957108|NCT00751881|515380482|FG002|Core Treatment Period|Other: MS treatment change|4|||
142957109|NCT00751881|515380480|FG000|Core Treatment Period|Other: tolerability complaints|2|||
142957110|NCT00751881|515380481|FG001|Core Treatment Period|Other: tolerability complaints|0|||
142957111|NCT00751881|515380482|FG002|Core Treatment Period|Other: tolerability complaints|0|||
142957112|NCT00751881|515380480|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
142957113|NCT00751881|515380481|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
142957114|NCT00751881|515380482|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
142957115|NCT00751881|515380480|FG000|Extension Study Period|Adverse Event|18|||
142957116|NCT00751881|515380481|FG001|Extension Study Period|Adverse Event|20|||
142957117|NCT00751881|515380482|FG002|Extension Study Period|Adverse Event|21|||
142957118|NCT00751881|515380480|FG000|Extension Study Period|Lack of Efficacy|14|||
142957119|NCT00751881|515380481|FG001|Extension Study Period|Lack of Efficacy|10|||
142957120|NCT00751881|515380482|FG002|Extension Study Period|Lack of Efficacy|20|||
142957121|NCT00751881|515380480|FG000|Extension Study Period|Lost to Follow-up|4|||
142957122|NCT00751881|515380481|FG001|Extension Study Period|Lost to Follow-up|9|||
142957123|NCT00751881|515380482|FG002|Extension Study Period|Lost to Follow-up|6|||
142957124|NCT00751881|515380480|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
142957125|NCT00751881|515380481|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
142957126|NCT00751881|515380482|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
142957127|NCT00751881|515380480|FG000|Extension Study Period|Other than specified above|26|||
142957128|NCT00751881|515380481|FG001|Extension Study Period|Other than specified above|30|||
142957129|NCT00751881|515380482|FG002|Extension Study Period|Other than specified above|18|||
142957130|NCT04770155|515380483|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
142957131|NCT04770155|515380484|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
142957132|NCT04770155|515380485|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
142957133|NCT04770155|515380486|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
142957134|NCT04770155|515380487|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
142957135|NCT04770155|515380488|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
142957136|NCT04770155|515380489|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
142957137|NCT04770155|515380490|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
142957138|NCT00864227|515380491|FG000|Overall Study|Withdrawal by Subject|1|||
142957139|NCT00864227|515380491|FG000|Overall Study|Disease Relapse/Progression|3|||
142957140|NCT02144220|515380492|FG000|Overall Study|technology incompatibility|9|||
142957141|NCT02144220|515380492|FG000|Overall Study|Lack of Efficacy|4|||
142957142|NCT02144220|515380492|FG000|Overall Study|Physician Decision|3|||
142957143|NCT02144220|515380492|FG000|Overall Study|Withdrawal by Subject|2|||
142957144|NCT02144220|515380492|FG000|Overall Study|Protocol Violation|1|||
142957145|NCT00651118|515380498|FG000|Overall Study|Adverse Event|4|||
142957146|NCT00651118|515380499|FG001|Overall Study|Adverse Event|0|||
142957147|NCT00651118|515380500|FG002|Overall Study|Adverse Event|1|||
142957148|NCT00651118|515380501|FG003|Overall Study|Adverse Event|1|||
142957149|NCT00651118|515380498|FG000|Overall Study|Protocol Violation|2|||
142957150|NCT00651118|515380499|FG001|Overall Study|Protocol Violation|2|||
142957151|NCT00651118|515380500|FG002|Overall Study|Protocol Violation|6|||
142957152|NCT00651118|515380501|FG003|Overall Study|Protocol Violation|2|||
142957153|NCT00651118|515380498|FG000|Overall Study|Lost to Follow-up|2|||
142957154|NCT00651118|515380499|FG001|Overall Study|Lost to Follow-up|0|||
142957155|NCT00651118|515380500|FG002|Overall Study|Lost to Follow-up|1|||
142957156|NCT00651118|515380501|FG003|Overall Study|Lost to Follow-up|2|||
142957157|NCT00651118|515380498|FG000|Overall Study|administrative|1|||
142957158|NCT00651118|515380499|FG001|Overall Study|administrative|4|||
142957159|NCT00651118|515380500|FG002|Overall Study|administrative|2|||
143455274|NCT02270515|517210856|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
143455275|NCT02270515|517210856|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
143455276|NCT02270515|517210856|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
142957160|NCT00651118|515380501|FG003|Overall Study|administrative|1|||
142957161|NCT00651118|515380498|FG000|Overall Study|Withdrawal by Subject|0|||
143455277|NCT02270515|517210856|FG000|Intervention Period 3: 12-18 Months|Death|3|||
142957162|NCT00651118|515380499|FG001|Overall Study|Withdrawal by Subject|1|||
142957163|NCT00651118|515380500|FG002|Overall Study|Withdrawal by Subject|1|||
142957164|NCT00651118|515380501|FG003|Overall Study|Withdrawal by Subject|1|||
142957165|NCT03117049|515380502|FG000|Overall Study|Continued the follow-up period|109|||
142957166|NCT03117049|515380503|FG001|Overall Study|Continued the follow-up period|129|||
142957167|NCT03117049|515380502|FG000|Overall Study|Died|82|||
142957168|NCT03117049|515380503|FG001|Overall Study|Died|93|||
142957169|NCT03117049|515380502|FG000|Overall Study|Consent withdrawal|7|||
142957170|NCT03117049|515380503|FG001|Overall Study|Consent withdrawal|6|||
142957171|NCT03117049|515380502|FG000|Overall Study|Missing contact|3|||
142957172|NCT03117049|515380503|FG001|Overall Study|Missing contact|3|||
142957173|NCT00839098|515380504|FG000|Overall Study|Withdrawal by Subject|2|||
142957174|NCT00839098|515380505|FG001|Overall Study|Withdrawal by Subject|1|||
142957175|NCT00839098|515380506|FG002|Overall Study|Withdrawal by Subject|7|||
142957176|NCT00935220|515380509|FG000|Overall Study|Adverse Event|1|||
142957177|NCT00935220|515380509|FG000|Overall Study|Other reason (not specified)|1|||
142957178|NCT01415440|515380510|FG000|Overall Study|Lost to Follow-up|0|||
142957179|NCT01415440|515380511|FG001|Overall Study|Lost to Follow-up|1|||
142957180|NCT01415440|515380512|FG002|Overall Study|Lost to Follow-up|2|||
142957181|NCT01415440|515380510|FG000|Overall Study|Physician Decision|3|||
142957182|NCT01415440|515380511|FG001|Overall Study|Physician Decision|0|||
142957183|NCT01415440|515380512|FG002|Overall Study|Physician Decision|0|||
142957184|NCT01415440|515380510|FG000|Overall Study|Withdrawal by Subject|1|||
142957185|NCT01415440|515380511|FG001|Overall Study|Withdrawal by Subject|0|||
142957186|NCT01415440|515380512|FG002|Overall Study|Withdrawal by Subject|0|||
142957187|NCT00227877|515380513|FG000|Pre-visit Assessment|Technical difficulties|7|||
142957188|NCT00227877|515380514|FG001|Pre-visit Assessment|Technical difficulties|3|||
142957189|NCT00227877|515380515|FG002|Pre-visit Assessment|Technical difficulties|0|||
142957190|NCT00227877|515380516|FG003|Pre-visit Assessment|Technical difficulties|0|||
142957191|NCT00227877|515380513|FG000|Post-visit Checklist|Lost to Follow-up|24|||
142957192|NCT00227877|515380514|FG001|Post-visit Checklist|Lost to Follow-up|13|||
142957193|NCT00227877|515380515|FG002|Post-visit Checklist|Lost to Follow-up|1|||
142957194|NCT00227877|515380516|FG003|Post-visit Checklist|Lost to Follow-up|0|||
142957195|NCT00227877|515380513|FG000|3-months Follow-up|Completed late|135|||
142957196|NCT00227877|515380514|FG001|3-months Follow-up|Completed late|128|||
142957197|NCT00227877|515380515|FG002|3-months Follow-up|Completed late|34|||
142957198|NCT00227877|515380516|FG003|3-months Follow-up|Completed late|8|||
142957199|NCT00227877|515380513|FG000|3-months Follow-up|Lost to Follow-up|178|||
142957200|NCT00227877|515380514|FG001|3-months Follow-up|Lost to Follow-up|139|||
142957201|NCT00227877|515380515|FG002|3-months Follow-up|Lost to Follow-up|18|||
142957202|NCT00227877|515380516|FG003|3-months Follow-up|Lost to Follow-up|13|||
142957203|NCT00227877|515380513|FG000|12-months Follow-up|Completed late|78|||
142957204|NCT00227877|515380514|FG001|12-months Follow-up|Completed late|74|||
142957205|NCT00227877|515380515|FG002|12-months Follow-up|Completed late|1|||
142957206|NCT00227877|515380516|FG003|12-months Follow-up|Completed late|0|||
142957207|NCT00227877|515380513|FG000|12-months Follow-up|Lost to Follow-up|232|||
142957208|NCT00227877|515380514|FG001|12-months Follow-up|Lost to Follow-up|189|||
142957209|NCT00227877|515380515|FG002|12-months Follow-up|Lost to Follow-up|30|||
142957210|NCT00227877|515380516|FG003|12-months Follow-up|Lost to Follow-up|26|||
142957211|NCT00633139|515380517|FG000|Overall Study|Non compliance|0|||
142957212|NCT00633139|515380518|FG001|Overall Study|Non compliance|0|||
142957213|NCT00633139|515380519|FG002|Overall Study|Non compliance|1|||
142957214|NCT00633139|515380517|FG000|Overall Study|Withdrawal by Subject|0|||
142957215|NCT00633139|515380518|FG001|Overall Study|Withdrawal by Subject|1|||
142957216|NCT00633139|515380519|FG002|Overall Study|Withdrawal by Subject|0|||
142957217|NCT01118143|515380522|FG000|Overall Study|Withdrawal by Subject|2|||
142957218|NCT01118143|515380523|FG001|Overall Study|Withdrawal by Subject|5|||
142957219|NCT02112448|515380524|FG000|Overall Study|lab values precluding use of ketorolac|2|||
142957220|NCT02112448|515380525|FG001|Overall Study|lab values precluding use of ketorolac|2|||
142957221|NCT02112448|515380524|FG000|Overall Study|Protocol Violation|1|||
142957222|NCT02112448|515380525|FG001|Overall Study|Protocol Violation|2|||
142957223|NCT02112448|515380524|FG000|Overall Study|Physician Decision|4|||
142957224|NCT02112448|515380525|FG001|Overall Study|Physician Decision|6|||
143455278|NCT02270515|517210856|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
142957225|NCT02112448|515380524|FG000|Overall Study|required heparin so could not use ketoro|1|||
143455279|NCT01468181|517210857|FG000|Overall Study|Adverse Event|8|||
142957226|NCT02112448|515380525|FG001|Overall Study|required heparin so could not use ketoro|0|||
142957227|NCT01937130|515382666|FG000|Overall Study|Withdrawal by Subject|0|||
142957228|NCT01937130|515382667|FG001|Overall Study|Withdrawal by Subject|0|||
142957229|NCT01937130|515382668|FG002|Overall Study|Withdrawal by Subject|0|||
142957230|NCT01937130|515382669|FG003|Overall Study|Withdrawal by Subject|1|||
142957231|NCT01937130|515382666|FG000|Overall Study|Adverse Event|0|||
142957232|NCT01937130|515382667|FG001|Overall Study|Adverse Event|1|||
142957233|NCT01937130|515382668|FG002|Overall Study|Adverse Event|0|||
142957234|NCT01937130|515382669|FG003|Overall Study|Adverse Event|1|||
142957235|NCT01937130|515382666|FG000|Overall Study|Death|1|||
142957236|NCT01937130|515382667|FG001|Overall Study|Death|1|||
142957237|NCT01937130|515382668|FG002|Overall Study|Death|1|||
142957238|NCT01937130|515382669|FG003|Overall Study|Death|0|||
142957239|NCT01937130|515382666|FG000|Overall Study|Lost to Follow-up|2|||
142957240|NCT01937130|515382667|FG001|Overall Study|Lost to Follow-up|0|||
142957241|NCT01937130|515382668|FG002|Overall Study|Lost to Follow-up|2|||
142957242|NCT01937130|515382669|FG003|Overall Study|Lost to Follow-up|0|||
142957243|NCT01937130|515382666|FG000|Overall Study|Physician Decision|0|||
142957244|NCT01937130|515382667|FG001|Overall Study|Physician Decision|1|||
142957245|NCT01937130|515382668|FG002|Overall Study|Physician Decision|0|||
142957246|NCT01937130|515382669|FG003|Overall Study|Physician Decision|0|||
142957247|NCT01937130|515382666|FG000|Overall Study|Patients unable to swallow|0|||
142957248|NCT01937130|515382667|FG001|Overall Study|Patients unable to swallow|1|||
142957249|NCT01937130|515382668|FG002|Overall Study|Patients unable to swallow|0|||
142957250|NCT01937130|515382669|FG003|Overall Study|Patients unable to swallow|0|||
142957251|NCT01937130|515382666|FG000|Overall Study|Patient lost to FU due to death|2|||
142957252|NCT01937130|515382667|FG001|Overall Study|Patient lost to FU due to death|0|||
142957253|NCT01937130|515382668|FG002|Overall Study|Patient lost to FU due to death|0|||
142957254|NCT01937130|515382669|FG003|Overall Study|Patient lost to FU due to death|0|||
142957255|NCT01850563|515382670|FG000|Overall Study|Not eligible|3|||
142957256|NCT01850563|515382671|FG001|Overall Study|Not eligible|0|||
142957257|NCT02078713|515382672|FG000|Overall Study|Lost to Follow-up|49|||
142957258|NCT02078713|515382673|FG001|Overall Study|Lost to Follow-up|55|||
142957259|NCT02078713|515382674|FG002|Overall Study|Lost to Follow-up|0|||
142957260|NCT02078713|515382675|FG003|Overall Study|Lost to Follow-up|0|||
142957261|NCT02078713|515382672|FG000|Overall Study|Pregnant at baseline|3|||
142957262|NCT02078713|515382673|FG001|Overall Study|Pregnant at baseline|5|||
142957263|NCT02078713|515382674|FG002|Overall Study|Pregnant at baseline|0|||
142957264|NCT02078713|515382675|FG003|Overall Study|Pregnant at baseline|0|||
142957265|NCT02078713|515382672|FG000|Overall Study|Enrolled twice|0|||
142957266|NCT02078713|515382673|FG001|Overall Study|Enrolled twice|1|||
142957267|NCT02078713|515382674|FG002|Overall Study|Enrolled twice|0|||
142957268|NCT02078713|515382675|FG003|Overall Study|Enrolled twice|0|||
142957269|NCT00696657|515382680|FG000|Overall Study|Protocol Violation|0|||
142957270|NCT00696657|515382681|FG001|Overall Study|Protocol Violation|0|||
142957271|NCT00696657|515382682|FG002|Overall Study|Protocol Violation|0|||
142957272|NCT00696657|515382683|FG003|Overall Study|Protocol Violation|0|||
142957273|NCT00696657|515382684|FG004|Overall Study|Protocol Violation|0|||
142957274|NCT00696657|515382685|FG005|Overall Study|Protocol Violation|1|||
142957275|NCT00696657|515382686|FG006|Overall Study|Protocol Violation|0|||
142957276|NCT00696657|515382687|FG007|Overall Study|Protocol Violation|0|||
142957277|NCT00696657|515382688|FG008|Overall Study|Protocol Violation|1|||
142957278|NCT00696657|515382680|FG000|Overall Study|Lack of Efficacy|0|||
142957279|NCT00696657|515382681|FG001|Overall Study|Lack of Efficacy|1|||
142957280|NCT00696657|515382682|FG002|Overall Study|Lack of Efficacy|0|||
142957281|NCT00696657|515382683|FG003|Overall Study|Lack of Efficacy|0|||
142957282|NCT00696657|515382684|FG004|Overall Study|Lack of Efficacy|0|||
142957283|NCT00696657|515382685|FG005|Overall Study|Lack of Efficacy|0|||
142957284|NCT00696657|515382686|FG006|Overall Study|Lack of Efficacy|0|||
142957285|NCT00696657|515382687|FG007|Overall Study|Lack of Efficacy|0|||
142957286|NCT00696657|515382688|FG008|Overall Study|Lack of Efficacy|0|||
142957287|NCT00696657|515382680|FG000|Overall Study|Withdrawal criteria|1|||
142957288|NCT00696657|515382681|FG001|Overall Study|Withdrawal criteria|3|||
142957289|NCT00696657|515382682|FG002|Overall Study|Withdrawal criteria|2|||
142957290|NCT00696657|515382683|FG003|Overall Study|Withdrawal criteria|2|||
142957291|NCT00696657|515382684|FG004|Overall Study|Withdrawal criteria|0|||
142957292|NCT00696657|515382685|FG005|Overall Study|Withdrawal criteria|0|||
142957293|NCT00696657|515382686|FG006|Overall Study|Withdrawal criteria|1|||
142957294|NCT00696657|515382687|FG007|Overall Study|Withdrawal criteria|1|||
142957295|NCT00696657|515382688|FG008|Overall Study|Withdrawal criteria|2|||
142957296|NCT00696657|515382680|FG000|Overall Study|Unclassified|0|||
142957297|NCT00696657|515382681|FG001|Overall Study|Unclassified|1|||
142957298|NCT00696657|515382682|FG002|Overall Study|Unclassified|3|||
142957299|NCT00696657|515382683|FG003|Overall Study|Unclassified|2|||
142957300|NCT00696657|515382684|FG004|Overall Study|Unclassified|4|||
142957301|NCT00696657|515382685|FG005|Overall Study|Unclassified|2|||
142957302|NCT00696657|515382686|FG006|Overall Study|Unclassified|0|||
142957303|NCT00696657|515382687|FG007|Overall Study|Unclassified|0|||
142957304|NCT00696657|515382688|FG008|Overall Study|Unclassified|1|||
142957305|NCT00696657|515382680|FG000|Overall Study|Adverse Event|0|||
142957306|NCT00696657|515382681|FG001|Overall Study|Adverse Event|0|||
142957307|NCT00696657|515382682|FG002|Overall Study|Adverse Event|3|||
142957308|NCT00696657|515382683|FG003|Overall Study|Adverse Event|7|||
142957309|NCT00696657|515382684|FG004|Overall Study|Adverse Event|6|||
142957310|NCT00696657|515382685|FG005|Overall Study|Adverse Event|9|||
142957311|NCT00696657|515382686|FG006|Overall Study|Adverse Event|14|||
142957312|NCT00696657|515382687|FG007|Overall Study|Adverse Event|2|||
142957313|NCT00696657|515382688|FG008|Overall Study|Adverse Event|5|||
142957314|NCT02601001|515382689|FG000|Dosing Period 2|Adverse Event|0|||
142957315|NCT02601001|515382690|FG001|Dosing Period 2|Adverse Event|0|||
142957316|NCT02601001|515382691|FG002|Dosing Period 2|Adverse Event|0|||
142957317|NCT02601001|515382692|FG003|Dosing Period 2|Adverse Event|0|||
142957318|NCT02601001|515382693|FG004|Dosing Period 2|Adverse Event|0|||
142957319|NCT02601001|515382694|FG005|Dosing Period 2|Adverse Event|0|||
142957320|NCT02601001|515382695|FG006|Dosing Period 2|Adverse Event|1|||
142957321|NCT01115569|515382696|FG000|Conversion/Titration Phase|Adverse Event|59|||
142957322|NCT01115569|515382697|FG001|Conversion/Titration Phase|Adverse Event|0|||
142957323|NCT01115569|515382696|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
142957324|NCT01115569|515382697|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
142957325|NCT01115569|515382696|FG000|Conversion/Titration Phase|Physician Decision|5|||
142957326|NCT01115569|515382697|FG001|Conversion/Titration Phase|Physician Decision|0|||
142957327|NCT01115569|515382696|FG000|Conversion/Titration Phase|Protocol Violation|68|||
142957328|NCT01115569|515382697|FG001|Conversion/Titration Phase|Protocol Violation|0|||
142957329|NCT01115569|515382696|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
142957330|NCT01115569|515382697|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
142957331|NCT01115569|515382696|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
142957332|NCT01115569|515382697|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
142957333|NCT01115569|515382696|FG000|Maintenance Phase|Adverse Event|0|||
142957334|NCT01115569|515382697|FG001|Maintenance Phase|Adverse Event|43|||
142957335|NCT01115569|515382696|FG000|Maintenance Phase|Lost to Follow-up|0|||
142957336|NCT01115569|515382697|FG001|Maintenance Phase|Lost to Follow-up|8|||
142957337|NCT01115569|515382696|FG000|Maintenance Phase|Physician Decision|0|||
142957338|NCT01115569|515382697|FG001|Maintenance Phase|Physician Decision|3|||
142957339|NCT01115569|515382696|FG000|Maintenance Phase|Protocol Violation|0|||
142957340|NCT01115569|515382697|FG001|Maintenance Phase|Protocol Violation|9|||
142957341|NCT01115569|515382696|FG000|Maintenance Phase|Withdrawal by Subject|0|||
142957342|NCT01115569|515382697|FG001|Maintenance Phase|Withdrawal by Subject|27|||
142957343|NCT01115569|515382696|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
142957344|NCT01115569|515382697|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
142957345|NCT01115569|515382696|FG000|Maintenance Phase|Administrative|0|||
142957346|NCT01115569|515382697|FG001|Maintenance Phase|Administrative|1|||
142957347|NCT01989546|515382698|FG000|Overall Study|Clinical Progression|1|||
142957348|NCT01989546|515382698|FG000|Overall Study|Disease progression on study|8|||
142957349|NCT03123354|515382699|FG000|Overall Study|Physician Decision|6|||
142957350|NCT04439838|515382702|FG000|Overall Study|Withdrawal by Subject|0|||
142957351|NCT04439838|515382703|FG001|Overall Study|Withdrawal by Subject|0|||
142957352|NCT04439838|515382704|FG002|Overall Study|Withdrawal by Subject|0|||
142957353|NCT04439838|515382705|FG003|Overall Study|Withdrawal by Subject|0|||
142957354|NCT04439838|515382706|FG004|Overall Study|Withdrawal by Subject|0|||
142957355|NCT04439838|515382707|FG005|Overall Study|Withdrawal by Subject|0|||
142957356|NCT04439838|515382708|FG006|Overall Study|Withdrawal by Subject|0|||
142957357|NCT04439838|515382709|FG007|Overall Study|Withdrawal by Subject|0|||
142957358|NCT04439838|515382710|FG008|Overall Study|Withdrawal by Subject|1|||
142957359|NCT00960440|515382714|FG000|Overall Study|Death|0|||
142957360|NCT00960440|515382715|FG001|Overall Study|Death|0|||
142957361|NCT00960440|515382716|FG002|Overall Study|Death|0|||
142957362|NCT00960440|515382717|FG003|Overall Study|Death|1|||
142957363|NCT00960440|515382714|FG000|Overall Study|Adverse Event|12|||
142957364|NCT00960440|515382715|FG001|Overall Study|Adverse Event|12|||
142957365|NCT00960440|515382716|FG002|Overall Study|Adverse Event|4|||
142957366|NCT00960440|515382717|FG003|Overall Study|Adverse Event|4|||
142957367|NCT00960440|515382714|FG000|Overall Study|Lack of Efficacy|2|||
142957368|NCT00960440|515382715|FG001|Overall Study|Lack of Efficacy|5|||
142957369|NCT00960440|515382716|FG002|Overall Study|Lack of Efficacy|3|||
142957370|NCT00960440|515382717|FG003|Overall Study|Lack of Efficacy|8|||
142957371|NCT00960440|515382714|FG000|Overall Study|Protocol Violation|2|||
142957372|NCT00960440|515382715|FG001|Overall Study|Protocol Violation|8|||
142957373|NCT00960440|515382716|FG002|Overall Study|Protocol Violation|3|||
142957374|NCT00960440|515382717|FG003|Overall Study|Protocol Violation|4|||
142957375|NCT00960440|515382714|FG000|Overall Study|Withdrawal by Subject|9|||
142957376|NCT00960440|515382715|FG001|Overall Study|Withdrawal by Subject|5|||
142957377|NCT00960440|515382716|FG002|Overall Study|Withdrawal by Subject|2|||
142957378|NCT00960440|515382717|FG003|Overall Study|Withdrawal by Subject|1|||
142957379|NCT00960440|515382714|FG000|Overall Study|Other|1|||
143455280|NCT01468181|517210858|FG001|Overall Study|Adverse Event|1|||
143455281|NCT01468181|517210859|FG002|Overall Study|Adverse Event|6|||
142957380|NCT00960440|515382715|FG001|Overall Study|Other|1|||
142957381|NCT00960440|515382716|FG002|Overall Study|Other|1|||
142957382|NCT00960440|515382717|FG003|Overall Study|Other|0|||
142957383|NCT01781429|515382718|FG000|Overall Study|Death|0|||
143455282|NCT01468181|517210860|FG003|Overall Study|Adverse Event|2|||
142957384|NCT01781429|515382719|FG001|Overall Study|Death|0|||
142957385|NCT01781429|515382720|FG002|Overall Study|Death|0|||
142957386|NCT01781429|515382721|FG003|Overall Study|Death|0|||
142957387|NCT01781429|515382722|FG004|Overall Study|Death|0|||
142957388|NCT01781429|515382723|FG005|Overall Study|Death|0|||
142957389|NCT01781429|515382724|FG006|Overall Study|Death|0|||
142957390|NCT01781429|515382725|FG007|Overall Study|Death|0|||
142957391|NCT01781429|515382726|FG008|Overall Study|Death|0|||
142957392|NCT01781429|515382727|FG009|Overall Study|Death|1|||
142957393|NCT01781429|515382728|FG010|Overall Study|Death|0|||
142957394|NCT01781429|515382729|FG011|Overall Study|Death|0|||
142957395|NCT01781429|515382730|FG012|Overall Study|Death|1|||
142957396|NCT01781429|515382731|FG013|Overall Study|Death|0|||
142957397|NCT01781429|515382732|FG014|Overall Study|Death|1|||
142957398|NCT01781429|515382733|FG015|Overall Study|Death|0|||
142957399|NCT01781429|515382718|FG000|Overall Study|Withdrawal by Subject|0|||
142957400|NCT01781429|515382719|FG001|Overall Study|Withdrawal by Subject|0|||
142957401|NCT01781429|515382720|FG002|Overall Study|Withdrawal by Subject|0|||
142957402|NCT01781429|515382721|FG003|Overall Study|Withdrawal by Subject|0|||
142957403|NCT01781429|515382722|FG004|Overall Study|Withdrawal by Subject|0|||
142957404|NCT01781429|515382723|FG005|Overall Study|Withdrawal by Subject|0|||
142957405|NCT01781429|515382724|FG006|Overall Study|Withdrawal by Subject|0|||
142957406|NCT01781429|515382725|FG007|Overall Study|Withdrawal by Subject|0|||
142957407|NCT01781429|515382726|FG008|Overall Study|Withdrawal by Subject|1|||
142957408|NCT01781429|515382727|FG009|Overall Study|Withdrawal by Subject|3|||
142957409|NCT01781429|515382728|FG010|Overall Study|Withdrawal by Subject|1|||
142957410|NCT01781429|515382729|FG011|Overall Study|Withdrawal by Subject|1|||
142957411|NCT01781429|515382730|FG012|Overall Study|Withdrawal by Subject|5|||
142957412|NCT01781429|515382731|FG013|Overall Study|Withdrawal by Subject|2|||
142957413|NCT01781429|515382732|FG014|Overall Study|Withdrawal by Subject|3|||
142957414|NCT01781429|515382733|FG015|Overall Study|Withdrawal by Subject|0|||
142957415|NCT01781429|515382718|FG000|Overall Study|Disease Progression|1|||
142957416|NCT01781429|515382719|FG001|Overall Study|Disease Progression|0|||
142957417|NCT01781429|515382720|FG002|Overall Study|Disease Progression|1|||
142957418|NCT01781429|515382721|FG003|Overall Study|Disease Progression|1|||
142957419|NCT01781429|515382722|FG004|Overall Study|Disease Progression|1|||
142957420|NCT01781429|515382723|FG005|Overall Study|Disease Progression|4|||
142957421|NCT01781429|515382724|FG006|Overall Study|Disease Progression|7|||
142957422|NCT01781429|515382725|FG007|Overall Study|Disease Progression|4|||
142957423|NCT01781429|515382726|FG008|Overall Study|Disease Progression|6|||
142957424|NCT01781429|515382727|FG009|Overall Study|Disease Progression|15|||
142957425|NCT01781429|515382728|FG010|Overall Study|Disease Progression|15|||
142957426|NCT01781429|515382729|FG011|Overall Study|Disease Progression|15|||
142957427|NCT01781429|515382730|FG012|Overall Study|Disease Progression|15|||
142957428|NCT01781429|515382731|FG013|Overall Study|Disease Progression|4|||
142957429|NCT01781429|515382732|FG014|Overall Study|Disease Progression|11|||
142957430|NCT01781429|515382733|FG015|Overall Study|Disease Progression|0|||
142957431|NCT01781429|515382718|FG000|Overall Study|Unacceptable Toxicity|0|||
142957432|NCT01781429|515382719|FG001|Overall Study|Unacceptable Toxicity|0|||
142957433|NCT01781429|515382720|FG002|Overall Study|Unacceptable Toxicity|0|||
142957434|NCT01781429|515382721|FG003|Overall Study|Unacceptable Toxicity|0|||
142957435|NCT01781429|515382722|FG004|Overall Study|Unacceptable Toxicity|0|||
142957436|NCT01781429|515382723|FG005|Overall Study|Unacceptable Toxicity|0|||
142957437|NCT01781429|515382724|FG006|Overall Study|Unacceptable Toxicity|0|||
142957438|NCT01781429|515382725|FG007|Overall Study|Unacceptable Toxicity|0|||
142957439|NCT01781429|515382726|FG008|Overall Study|Unacceptable Toxicity|0|||
142957440|NCT01781429|515382727|FG009|Overall Study|Unacceptable Toxicity|0|||
142957441|NCT01781429|515382728|FG010|Overall Study|Unacceptable Toxicity|0|||
142957442|NCT01781429|515382729|FG011|Overall Study|Unacceptable Toxicity|2|||
142957443|NCT01781429|515382730|FG012|Overall Study|Unacceptable Toxicity|0|||
142957444|NCT01781429|515382731|FG013|Overall Study|Unacceptable Toxicity|0|||
142957445|NCT01781429|515382732|FG014|Overall Study|Unacceptable Toxicity|0|||
142957446|NCT01781429|515382733|FG015|Overall Study|Unacceptable Toxicity|0|||
142957447|NCT01781429|515382718|FG000|Overall Study|Patient Condition Changed|0|||
142957448|NCT01781429|515382719|FG001|Overall Study|Patient Condition Changed|0|||
142957449|NCT01781429|515382720|FG002|Overall Study|Patient Condition Changed|0|||
142957450|NCT01781429|515382721|FG003|Overall Study|Patient Condition Changed|0|||
142957451|NCT01781429|515382722|FG004|Overall Study|Patient Condition Changed|0|||
142957452|NCT01781429|515382723|FG005|Overall Study|Patient Condition Changed|0|||
142957453|NCT01781429|515382724|FG006|Overall Study|Patient Condition Changed|0|||
142957454|NCT01781429|515382725|FG007|Overall Study|Patient Condition Changed|0|||
142957455|NCT01781429|515382726|FG008|Overall Study|Patient Condition Changed|0|||
143455283|NCT01468181|517210861|FG004|Overall Study|Adverse Event|2|||
142957456|NCT01781429|515382727|FG009|Overall Study|Patient Condition Changed|4|||
142957457|NCT01781429|515382728|FG010|Overall Study|Patient Condition Changed|0|||
142957458|NCT01781429|515382729|FG011|Overall Study|Patient Condition Changed|1|||
142957459|NCT01781429|515382730|FG012|Overall Study|Patient Condition Changed|0|||
142957460|NCT01781429|515382731|FG013|Overall Study|Patient Condition Changed|1|||
142957461|NCT01781429|515382732|FG014|Overall Study|Patient Condition Changed|0|||
143117135|NCT01273155|515970043|FG005|Overall Study|Change in liver function/no longer eval.|0|||
142957462|NCT01781429|515382733|FG015|Overall Study|Patient Condition Changed|0|||
142957463|NCT01781429|515382718|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
142957464|NCT01781429|515382719|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
142957465|NCT01781429|515382720|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
142957466|NCT01781429|515382721|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
142957467|NCT01781429|515382722|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
142957468|NCT01781429|515382723|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
142957469|NCT01781429|515382724|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
142957470|NCT01781429|515382725|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
142957471|NCT01781429|515382726|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
142957472|NCT01781429|515382727|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
142957473|NCT01781429|515382728|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
142957474|NCT01781429|515382729|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
142957475|NCT01781429|515382730|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
142957476|NCT01781429|515382731|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
142957477|NCT01781429|515382732|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
142957478|NCT01781429|515382733|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
142957479|NCT01781429|515382718|FG000|Overall Study|Enrolled, but not treated|0|||
142957480|NCT01781429|515382719|FG001|Overall Study|Enrolled, but not treated|0|||
142957481|NCT01781429|515382720|FG002|Overall Study|Enrolled, but not treated|0|||
142957482|NCT01781429|515382721|FG003|Overall Study|Enrolled, but not treated|0|||
142957483|NCT01781429|515382722|FG004|Overall Study|Enrolled, but not treated|0|||
142957484|NCT01781429|515382723|FG005|Overall Study|Enrolled, but not treated|0|||
142957485|NCT01781429|515382724|FG006|Overall Study|Enrolled, but not treated|0|||
142957486|NCT01781429|515382725|FG007|Overall Study|Enrolled, but not treated|0|||
142957487|NCT01781429|515382726|FG008|Overall Study|Enrolled, but not treated|0|||
142957488|NCT01781429|515382727|FG009|Overall Study|Enrolled, but not treated|0|||
142957489|NCT01781429|515382728|FG010|Overall Study|Enrolled, but not treated|1|||
142957490|NCT01781429|515382729|FG011|Overall Study|Enrolled, but not treated|0|||
142957491|NCT01781429|515382730|FG012|Overall Study|Enrolled, but not treated|0|||
142957492|NCT01781429|515382731|FG013|Overall Study|Enrolled, but not treated|0|||
142957493|NCT01781429|515382732|FG014|Overall Study|Enrolled, but not treated|0|||
142957494|NCT01781429|515382733|FG015|Overall Study|Enrolled, but not treated|0|||
142957495|NCT00406315|515382743|FG000|Overall Study|Death|1|||
142957496|NCT00406315|515382743|FG000|Overall Study|Adverse Event|39|||
142957497|NCT00406315|515382743|FG000|Overall Study|Laboratory Abnormality|4|||
142957498|NCT00406315|515382743|FG000|Overall Study|Lack of Efficacy|13|||
142957499|NCT00406315|515382743|FG000|Overall Study|Other|33|||
142957500|NCT00406315|515382743|FG000|Overall Study|Lost to Follow-up|21|||
142957501|NCT00406315|515382743|FG000|Overall Study|Withdrawal by Subject|30|||
142957502|NCT01312428|515382744|FG000|Overall Study|Study Termination|3|||
142957503|NCT01312428|515382745|FG001|Overall Study|Study Termination|4|||
142957504|NCT00532883|515382746|FG000|Overall Study|Adverse Event|1|||
142957505|NCT00532883|515382747|FG001|Overall Study|Adverse Event|0|||
142957506|NCT00532883|515382748|FG002|Overall Study|Adverse Event|0|||
142957507|NCT00532883|515382749|FG003|Overall Study|Adverse Event|1|||
142957508|NCT00532883|515382746|FG000|Overall Study|Lost to Follow-up|1|||
142957509|NCT00532883|515382747|FG001|Overall Study|Lost to Follow-up|1|||
142957510|NCT00532883|515382748|FG002|Overall Study|Lost to Follow-up|1|||
142957511|NCT00532883|515382749|FG003|Overall Study|Lost to Follow-up|0|||
142957512|NCT00532883|515382746|FG000|Overall Study|Withdrawal by Subject|0|||
142957513|NCT00532883|515382747|FG001|Overall Study|Withdrawal by Subject|1|||
142957514|NCT00532883|515382748|FG002|Overall Study|Withdrawal by Subject|1|||
142957515|NCT00532883|515382749|FG003|Overall Study|Withdrawal by Subject|0|||
142957516|NCT00532883|515382746|FG000|Overall Study|Subject was Nonadherent|0|||
142957517|NCT00532883|515382747|FG001|Overall Study|Subject was Nonadherent|1|||
142957518|NCT00532883|515382748|FG002|Overall Study|Subject was Nonadherent|1|||
142957519|NCT00532883|515382749|FG003|Overall Study|Subject was Nonadherent|0|||
142957520|NCT00532883|515382746|FG000|Overall Study|Early Study Termination|4|||
142957521|NCT00532883|515382747|FG001|Overall Study|Early Study Termination|4|||
142957522|NCT00532883|515382748|FG002|Overall Study|Early Study Termination|1|||
142957523|NCT00532883|515382749|FG003|Overall Study|Early Study Termination|4|||
142957524|NCT02202031|515382750|FG000|Overall Study|Lost to Follow-up|1|||
142957525|NCT02202031|515382751|FG001|Overall Study|Lost to Follow-up|0|||
142957526|NCT02202031|515382750|FG000|Overall Study|Too Busy|1|||
142957527|NCT02202031|515382751|FG001|Overall Study|Too Busy|3|||
142957528|NCT02202031|515382750|FG000|Overall Study|Illness/Medical Reason|0|||
142957529|NCT02202031|515382751|FG001|Overall Study|Illness/Medical Reason|2|||
142957530|NCT02202031|515382750|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
142957531|NCT02202031|515382751|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
142957532|NCT02184143|515382752|FG000|Overall Study|Withdrawal by Subject|4|||
142957533|NCT02184143|515382753|FG001|Overall Study|Withdrawal by Subject|4|||
142957534|NCT02184143|515382752|FG000|Overall Study|Lost to Follow-up|5|||
142957535|NCT02184143|515382753|FG001|Overall Study|Lost to Follow-up|3|||
142957536|NCT02184143|515382752|FG000|Overall Study|Death|1|||
142957537|NCT02184143|515382753|FG001|Overall Study|Death|0|||
142957538|NCT00321984|515382757|FG000|Overall Study|Adverse Event|9|||
142957539|NCT00321984|515382758|FG001|Overall Study|Adverse Event|6|||
142957540|NCT00321984|515382759|FG002|Overall Study|Adverse Event|8|||
142957541|NCT00321984|515382757|FG000|Overall Study|Protocol Violation|0|||
142957542|NCT00321984|515382758|FG001|Overall Study|Protocol Violation|1|||
142957543|NCT00321984|515382759|FG002|Overall Study|Protocol Violation|1|||
142957544|NCT00321984|515382757|FG000|Overall Study|Lost to Follow-up|2|||
142957545|NCT00321984|515382758|FG001|Overall Study|Lost to Follow-up|4|||
142957546|NCT00321984|515382759|FG002|Overall Study|Lost to Follow-up|2|||
142957547|NCT00321984|515382757|FG000|Overall Study|Withdrawal by Subject|8|||
142957548|NCT00321984|515382758|FG001|Overall Study|Withdrawal by Subject|6|||
142957549|NCT00321984|515382759|FG002|Overall Study|Withdrawal by Subject|5|||
142957550|NCT00321984|515382757|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
142957551|NCT00321984|515382758|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
142957552|NCT00321984|515382759|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
142957553|NCT00321984|515382757|FG000|Overall Study|Lack of Efficacy|3|||
142957554|NCT00321984|515382758|FG001|Overall Study|Lack of Efficacy|1|||
142957555|NCT00321984|515382759|FG002|Overall Study|Lack of Efficacy|3|||
142957556|NCT00321984|515382757|FG000|Overall Study|Noncompliant|0|||
142957557|NCT00321984|515382758|FG001|Overall Study|Noncompliant|0|||
142957558|NCT00321984|515382759|FG002|Overall Study|Noncompliant|2|||
142957559|NCT00321984|515382757|FG000|Overall Study|Pregnancy|0|||
142957560|NCT00321984|515382758|FG001|Overall Study|Pregnancy|1|||
142957561|NCT00321984|515382759|FG002|Overall Study|Pregnancy|0|||
142957562|NCT00321984|515382757|FG000|Overall Study|Per Subject Request|1|||
142957563|NCT00321984|515382758|FG001|Overall Study|Per Subject Request|0|||
142957564|NCT00321984|515382759|FG002|Overall Study|Per Subject Request|0|||
142957565|NCT00321984|515382757|FG000|Overall Study|Per Investigator Request|1|||
142957566|NCT00321984|515382758|FG001|Overall Study|Per Investigator Request|0|||
142957567|NCT00321984|515382759|FG002|Overall Study|Per Investigator Request|0|||
142957568|NCT00321984|515382757|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
142957569|NCT00321984|515382758|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
142957570|NCT00321984|515382759|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
142957571|NCT02214186|515382762|FG000|Overall Study|Lost to Follow-up|1|||
142957572|NCT02214186|515382763|FG001|Overall Study|Lost to Follow-up|1|||
142957573|NCT02214186|515382762|FG000|Overall Study|Protocol Violation|1|||
142957574|NCT02214186|515382763|FG001|Overall Study|Protocol Violation|1|||
142957575|NCT01525849|515382764|FG000|Overall Study|Lost to Follow-up|3|||
142957576|NCT01525849|515382765|FG001|Overall Study|Lost to Follow-up|2|||
142957577|NCT01525849|515382764|FG000|Overall Study|Withdrawal by Subject|1|||
142957578|NCT01525849|515382765|FG001|Overall Study|Withdrawal by Subject|9|||
142957579|NCT01525849|515382764|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
142957580|NCT01525849|515382765|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
142957581|NCT01525849|515382764|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
142957582|NCT01525849|515382765|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
142957583|NCT00339183|515382766|FG000|Overall Study|Adverse Event|5|||
142957584|NCT00339183|515382767|FG001|Overall Study|Adverse Event|3|||
142957585|NCT00339183|515382766|FG000|Overall Study|Withdrawal by Subject|16|||
142957586|NCT00339183|515382767|FG001|Overall Study|Withdrawal by Subject|19|||
142957587|NCT00339183|515382766|FG000|Overall Study|Physician Decision|2|||
142957588|NCT00339183|515382767|FG001|Overall Study|Physician Decision|4|||
142957589|NCT00339183|515382766|FG000|Overall Study|Lost to Follow-up|17|||
142957590|NCT00339183|515382767|FG001|Overall Study|Lost to Follow-up|17|||
142957591|NCT00339183|515382766|FG000|Overall Study|Protocol-specified criteria|12|||
142957592|NCT00339183|515382767|FG001|Overall Study|Protocol-specified criteria|8|||
142957593|NCT00339183|515382766|FG000|Overall Study|Missing reason|3|||
142957594|NCT00339183|515382767|FG001|Overall Study|Missing reason|1|||
142957595|NCT00339183|515382766|FG000|Overall Study|Other|46|||
142957596|NCT00339183|515382767|FG001|Overall Study|Other|40|||
142957597|NCT00339183|515382766|FG000|Overall Study|Ongoing|20|||
142957598|NCT00339183|515382767|FG001|Overall Study|Ongoing|13|||
142957599|NCT00793819|515382768|FG000|Overall Study|Adverse Event|8|||
142957600|NCT00793819|515382769|FG001|Overall Study|Adverse Event|4|||
142957601|NCT00793819|515382768|FG000|Overall Study|Lack of Efficacy|1|||
142957602|NCT00793819|515382769|FG001|Overall Study|Lack of Efficacy|1|||
142957603|NCT00793819|515382768|FG000|Overall Study|Withdrawal by Subject|4|||
142957604|NCT00793819|515382769|FG001|Overall Study|Withdrawal by Subject|3|||
142957605|NCT00793819|515382768|FG000|Overall Study|Lost to Follow-up|1|||
143455284|NCT01468181|517210857|FG000|Overall Study|Protocol Violation|2|||
142957606|NCT00793819|515382769|FG001|Overall Study|Lost to Follow-up|1|||
142957607|NCT01172288|515382776|FG000|Overall Study|Adverse Event|1|||
142957608|NCT01172288|515382777|FG001|Overall Study|Adverse Event|0|||
143455285|NCT01468181|517210858|FG001|Overall Study|Protocol Violation|0|||
143455286|NCT01468181|517210859|FG002|Overall Study|Protocol Violation|1|||
142957609|NCT01172288|515382776|FG000|Overall Study|Protocol Violation|0|||
143455287|NCT01468181|517210860|FG003|Overall Study|Protocol Violation|0|||
142957610|NCT01172288|515382777|FG001|Overall Study|Protocol Violation|1|||
142957611|NCT01188798|515382780|FG000|Overall Study|Death|0|||
142957612|NCT01188798|515382781|FG001|Overall Study|Death|1|||
142957613|NCT01188798|515382780|FG000|Overall Study|Required additional transplant|1|||
142957614|NCT01188798|515382781|FG001|Overall Study|Required additional transplant|1|||
142957615|NCT01188798|515382780|FG000|Overall Study|Protocol closure|1|||
142957616|NCT01188798|515382781|FG001|Overall Study|Protocol closure|1|||
142957617|NCT00611130|515382784|FG000|Overall Study|Lost to Follow-up|25|||
142957618|NCT00611130|515382785|FG001|Overall Study|Lost to Follow-up|29|||
142957619|NCT00611130|515382784|FG000|Overall Study|Protocol noncompliance|7|||
142957620|NCT00611130|515382785|FG001|Overall Study|Protocol noncompliance|6|||
142957621|NCT00611130|515382784|FG000|Overall Study|Withdrawal by Subject|6|||
142957622|NCT00611130|515382785|FG001|Overall Study|Withdrawal by Subject|5|||
142957623|NCT00611130|515382784|FG000|Overall Study|Other|5|||
142957624|NCT00611130|515382785|FG001|Overall Study|Other|4|||
142957625|NCT00611130|515382784|FG000|Overall Study|Incarceration|3|||
142957626|NCT00611130|515382785|FG001|Overall Study|Incarceration|2|||
142957627|NCT00611130|515382784|FG000|Overall Study|Administrative|1|||
142957628|NCT00611130|515382785|FG001|Overall Study|Administrative|1|||
142957629|NCT00611130|515382784|FG000|Overall Study|Adverse Event|1|||
142957630|NCT00611130|515382785|FG001|Overall Study|Adverse Event|0|||
142957631|NCT00611130|515382784|FG000|Overall Study|Death|1|||
142957632|NCT00611130|515382785|FG001|Overall Study|Death|0|||
142957633|NCT03662334|515382787|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
142957634|NCT03662334|515382788|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
142957635|NCT02853331|515382791|FG000|Overall Study|Death|59|||
142957636|NCT02853331|515382792|FG001|Overall Study|Death|95|||
142957637|NCT02853331|515382791|FG000|Overall Study|Withdrawal by Subject|5|||
142957638|NCT02853331|515382792|FG001|Overall Study|Withdrawal by Subject|9|||
142957639|NCT02853331|515382791|FG000|Overall Study|Ongoing in study|368|||
142957640|NCT02853331|515382792|FG001|Overall Study|Ongoing in study|325|||
142957641|NCT01455428|515382793|FG000|Overall Study|Protocol Violation|2|||
142957642|NCT01455428|515382794|FG001|Overall Study|Protocol Violation|1|||
142957643|NCT01455428|515382793|FG000|Overall Study|Adverse Event|6|||
142957644|NCT01455428|515382794|FG001|Overall Study|Adverse Event|2|||
142957645|NCT01455428|515382793|FG000|Overall Study|Lost to Follow-up|1|||
142957646|NCT01455428|515382794|FG001|Overall Study|Lost to Follow-up|1|||
142957647|NCT01455428|515382793|FG000|Overall Study|Withdrawal by Subject|2|||
142957648|NCT01455428|515382794|FG001|Overall Study|Withdrawal by Subject|5|||
142957649|NCT01455428|515382793|FG000|Overall Study|Did not meet entrance criteria|0|||
142957650|NCT01455428|515382794|FG001|Overall Study|Did not meet entrance criteria|2|||
142957651|NCT01455428|515382793|FG000|Overall Study|Insufficient clinical response|0|||
142957652|NCT01455428|515382794|FG001|Overall Study|Insufficient clinical response|2|||
142957653|NCT01455428|515382793|FG000|Overall Study|Did not receive treatment|1|||
142957654|NCT01455428|515382794|FG001|Overall Study|Did not receive treatment|1|||
142957655|NCT01455428|515382793|FG000|Overall Study|Other|2|||
142957656|NCT01455428|515382794|FG001|Overall Study|Other|4|||
142957657|NCT03303339|515382795|FG000|Overall Study|Death|2|||
142957658|NCT03303339|515382796|FG001|Overall Study|Death|2|||
142957659|NCT03303339|515382797|FG002|Overall Study|Death|2|||
142957660|NCT03303339|515382798|FG003|Overall Study|Death|1|||
142957661|NCT03303339|515382799|FG004|Overall Study|Death|4|||
142957662|NCT03303339|515382800|FG005|Overall Study|Death|2|||
142957663|NCT03303339|515382801|FG006|Overall Study|Death|2|||
142957664|NCT03303339|515382802|FG007|Overall Study|Death|2|||
142957665|NCT03303339|515382803|FG008|Overall Study|Death|3|||
142957666|NCT03303339|515382804|FG009|Overall Study|Death|3|||
142957667|NCT03303339|515382805|FG010|Overall Study|Death|4|||
142957668|NCT03303339|515382806|FG011|Overall Study|Death|24|||
142957669|NCT03303339|515382795|FG000|Overall Study|Study Terminated by Sponsor|0|||
142957670|NCT03303339|515382796|FG001|Overall Study|Study Terminated by Sponsor|0|||
142957671|NCT03303339|515382797|FG002|Overall Study|Study Terminated by Sponsor|0|||
142957672|NCT03303339|515382798|FG003|Overall Study|Study Terminated by Sponsor|0|||
142957673|NCT03303339|515382799|FG004|Overall Study|Study Terminated by Sponsor|0|||
142957674|NCT03303339|515382800|FG005|Overall Study|Study Terminated by Sponsor|0|||
142957675|NCT03303339|515382801|FG006|Overall Study|Study Terminated by Sponsor|0|||
142957676|NCT03303339|515382802|FG007|Overall Study|Study Terminated by Sponsor|0|||
142957677|NCT03303339|515382803|FG008|Overall Study|Study Terminated by Sponsor|1|||
142957678|NCT03303339|515382804|FG009|Overall Study|Study Terminated by Sponsor|0|||
142957679|NCT03303339|515382805|FG010|Overall Study|Study Terminated by Sponsor|1|||
142957680|NCT03303339|515382806|FG011|Overall Study|Study Terminated by Sponsor|1|||
142957681|NCT03303339|515382795|FG000|Overall Study|Withdrawal by Subject|1|||
142957682|NCT03303339|515382796|FG001|Overall Study|Withdrawal by Subject|0|||
142957683|NCT03303339|515382797|FG002|Overall Study|Withdrawal by Subject|0|||
142957684|NCT03303339|515382798|FG003|Overall Study|Withdrawal by Subject|0|||
142957685|NCT03303339|515382799|FG004|Overall Study|Withdrawal by Subject|0|||
142957686|NCT03303339|515382800|FG005|Overall Study|Withdrawal by Subject|1|||
142957687|NCT03303339|515382801|FG006|Overall Study|Withdrawal by Subject|1|||
142957688|NCT03303339|515382802|FG007|Overall Study|Withdrawal by Subject|0|||
142957689|NCT03303339|515382803|FG008|Overall Study|Withdrawal by Subject|0|||
142957690|NCT03303339|515382804|FG009|Overall Study|Withdrawal by Subject|0|||
142957691|NCT03303339|515382805|FG010|Overall Study|Withdrawal by Subject|0|||
142957692|NCT03303339|515382806|FG011|Overall Study|Withdrawal by Subject|2|||
142957693|NCT03303339|515382795|FG000|Overall Study|Physician Decision|0|||
142957694|NCT03303339|515382796|FG001|Overall Study|Physician Decision|0|||
142957695|NCT03303339|515382797|FG002|Overall Study|Physician Decision|0|||
142957696|NCT03303339|515382798|FG003|Overall Study|Physician Decision|0|||
142957697|NCT03303339|515382799|FG004|Overall Study|Physician Decision|1|||
142957698|NCT03303339|515382800|FG005|Overall Study|Physician Decision|0|||
142957699|NCT03303339|515382801|FG006|Overall Study|Physician Decision|0|||
142957700|NCT03303339|515382802|FG007|Overall Study|Physician Decision|0|||
142957701|NCT03303339|515382803|FG008|Overall Study|Physician Decision|0|||
142957702|NCT03303339|515382804|FG009|Overall Study|Physician Decision|0|||
142957703|NCT03303339|515382805|FG010|Overall Study|Physician Decision|0|||
142957704|NCT03303339|515382806|FG011|Overall Study|Physician Decision|0|||
142957705|NCT03303339|515382795|FG000|Overall Study|Safety/Non-compliance|0|||
142957706|NCT03303339|515382796|FG001|Overall Study|Safety/Non-compliance|0|||
142957707|NCT03303339|515382797|FG002|Overall Study|Safety/Non-compliance|0|||
142957708|NCT03303339|515382798|FG003|Overall Study|Safety/Non-compliance|0|||
142957709|NCT03303339|515382799|FG004|Overall Study|Safety/Non-compliance|0|||
142957710|NCT03303339|515382800|FG005|Overall Study|Safety/Non-compliance|0|||
142957711|NCT03303339|515382801|FG006|Overall Study|Safety/Non-compliance|0|||
142957712|NCT03303339|515382802|FG007|Overall Study|Safety/Non-compliance|0|||
142957713|NCT03303339|515382803|FG008|Overall Study|Safety/Non-compliance|0|||
142957714|NCT03303339|515382804|FG009|Overall Study|Safety/Non-compliance|0|||
142957715|NCT03303339|515382805|FG010|Overall Study|Safety/Non-compliance|0|||
142957716|NCT03303339|515382806|FG011|Overall Study|Safety/Non-compliance|1|||
142957717|NCT00257192|515382807|FG000|Overall Study|Adverse Event|21|||
142957718|NCT00257192|515382808|FG001|Overall Study|Adverse Event|10|||
142957719|NCT00257192|515382807|FG000|Overall Study|Laboratory abnormality|1|||
142957720|NCT00257192|515382808|FG001|Overall Study|Laboratory abnormality|1|||
142957721|NCT00257192|515382807|FG000|Overall Study|Lost to Follow-up|3|||
142957722|NCT00257192|515382808|FG001|Overall Study|Lost to Follow-up|3|||
142957723|NCT00257192|515382807|FG000|Overall Study|Insufficient clinical response|18|||
142957724|NCT00257192|515382808|FG001|Overall Study|Insufficient clinical response|18|||
142957725|NCT00257192|515382807|FG000|Overall Study|Withdrawal by Subject|14|||
142957726|NCT00257192|515382808|FG001|Overall Study|Withdrawal by Subject|2|||
142957727|NCT00257192|515382807|FG000|Overall Study|Randomized but not treated|0|||
142957728|NCT00257192|515382808|FG001|Overall Study|Randomized but not treated|1|||
142957729|NCT00257192|515382807|FG000|Overall Study|Study terminated by sponsor|1|||
142957730|NCT00257192|515382808|FG001|Overall Study|Study terminated by sponsor|0|||
142957731|NCT00257192|515382807|FG000|Overall Study|Miscellaneous|0|||
142957732|NCT00257192|515382808|FG001|Overall Study|Miscellaneous|4|||
142957733|NCT00570739|515382809|FG000|Overall Study|Adverse Event|8|||
142957734|NCT00570739|515382810|FG001|Overall Study|Adverse Event|6|||
142957735|NCT00570739|515382811|FG002|Overall Study|Adverse Event|2|||
142957736|NCT00570739|515382812|FG003|Overall Study|Adverse Event|2|||
142957737|NCT00570739|515382809|FG000|Overall Study|Lost to Follow-up|4|||
142957738|NCT00570739|515382810|FG001|Overall Study|Lost to Follow-up|5|||
142957739|NCT00570739|515382811|FG002|Overall Study|Lost to Follow-up|4|||
142957740|NCT00570739|515382812|FG003|Overall Study|Lost to Follow-up|1|||
142957741|NCT00570739|515382809|FG000|Overall Study|Physician Decision|1|||
142957742|NCT00570739|515382810|FG001|Overall Study|Physician Decision|1|||
142957743|NCT00570739|515382811|FG002|Overall Study|Physician Decision|0|||
142957744|NCT00570739|515382812|FG003|Overall Study|Physician Decision|0|||
142957745|NCT00570739|515382809|FG000|Overall Study|Withdrawal by Subject|7|||
142957746|NCT00570739|515382810|FG001|Overall Study|Withdrawal by Subject|7|||
142957747|NCT00570739|515382811|FG002|Overall Study|Withdrawal by Subject|3|||
142957748|NCT00570739|515382812|FG003|Overall Study|Withdrawal by Subject|5|||
142957749|NCT00570739|515382809|FG000|Overall Study|Required restricted medication|0|||
142957750|NCT00570739|515382810|FG001|Overall Study|Required restricted medication|0|||
142957751|NCT00570739|515382811|FG002|Overall Study|Required restricted medication|1|||
142957752|NCT00570739|515382812|FG003|Overall Study|Required restricted medication|0|||
142957753|NCT00570739|515382809|FG000|Overall Study|Met discontinuation criteria|1|||
142957754|NCT00570739|515382810|FG001|Overall Study|Met discontinuation criteria|0|||
142957755|NCT00570739|515382811|FG002|Overall Study|Met discontinuation criteria|1|||
142957756|NCT00570739|515382812|FG003|Overall Study|Met discontinuation criteria|1|||
142957757|NCT00570739|515382809|FG000|Overall Study|Other|0|||
142957758|NCT00570739|515382810|FG001|Overall Study|Other|2|||
142957759|NCT00570739|515382811|FG002|Overall Study|Other|5|||
142957760|NCT00570739|515382812|FG003|Overall Study|Other|3|||
142957761|NCT02086565|515382813|FG000|Overall Study|Lost to Follow-up|9|||
142957762|NCT02086565|515382814|FG001|Overall Study|Lost to Follow-up|7|||
142957763|NCT02086565|515382813|FG000|Overall Study|Withdrawal by Subject|2|||
142957764|NCT02086565|515382814|FG001|Overall Study|Withdrawal by Subject|1|||
142957765|NCT02086565|515382813|FG000|Overall Study|Death|3|||
142957766|NCT02086565|515382814|FG001|Overall Study|Death|2|||
142957767|NCT02086565|515382813|FG000|Overall Study|withdrawn by research team|2|||
142957768|NCT02086565|515382814|FG001|Overall Study|withdrawn by research team|2|||
142957769|NCT03241173|515382820|FG000|Overall Study|Death|3|||
142957770|NCT03241173|515382821|FG001|Overall Study|Death|2|||
142957771|NCT03241173|515382822|FG002|Overall Study|Death|4|||
142957772|NCT03241173|515382823|FG003|Overall Study|Death|4|||
142957773|NCT03241173|515382824|FG004|Overall Study|Death|2|||
142957774|NCT03241173|515382825|FG005|Overall Study|Death|2|||
142957775|NCT03241173|515382826|FG006|Overall Study|Death|3|||
142957776|NCT03241173|515382827|FG007|Overall Study|Death|1|||
142957777|NCT03241173|515382828|FG008|Overall Study|Death|0|||
142957778|NCT03241173|515382829|FG009|Overall Study|Death|5|||
142957779|NCT03241173|515382830|FG010|Overall Study|Death|4|||
142957780|NCT03241173|515382831|FG011|Overall Study|Death|3|||
142957781|NCT03241173|515382832|FG012|Overall Study|Death|0|||
142957782|NCT03241173|515382833|FG013|Overall Study|Death|0|||
142957783|NCT03241173|515382834|FG014|Overall Study|Death|0|||
142957784|NCT03241173|515382820|FG000|Overall Study|Withdrawal by Subject|0|||
142957785|NCT03241173|515382821|FG001|Overall Study|Withdrawal by Subject|0|||
142957786|NCT03241173|515382822|FG002|Overall Study|Withdrawal by Subject|1|||
142957787|NCT03241173|515382823|FG003|Overall Study|Withdrawal by Subject|0|||
142957788|NCT03241173|515382824|FG004|Overall Study|Withdrawal by Subject|0|||
142957789|NCT03241173|515382825|FG005|Overall Study|Withdrawal by Subject|1|||
142957790|NCT03241173|515382826|FG006|Overall Study|Withdrawal by Subject|0|||
142957791|NCT03241173|515382827|FG007|Overall Study|Withdrawal by Subject|0|||
142957792|NCT03241173|515382828|FG008|Overall Study|Withdrawal by Subject|0|||
142957793|NCT03241173|515382829|FG009|Overall Study|Withdrawal by Subject|0|||
142957794|NCT03241173|515382830|FG010|Overall Study|Withdrawal by Subject|0|||
142957795|NCT03241173|515382831|FG011|Overall Study|Withdrawal by Subject|0|||
142957796|NCT03241173|515382832|FG012|Overall Study|Withdrawal by Subject|0|||
142957797|NCT03241173|515382833|FG013|Overall Study|Withdrawal by Subject|0|||
142957798|NCT03241173|515382834|FG014|Overall Study|Withdrawal by Subject|0|||
142957799|NCT03241173|515382820|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
142957800|NCT03241173|515382821|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
142957801|NCT03241173|515382822|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
142957802|NCT03241173|515382823|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
142957803|NCT03241173|515382824|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
142957804|NCT03241173|515382825|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
142957805|NCT03241173|515382826|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
142957806|NCT03241173|515382827|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
142957807|NCT03241173|515382828|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
142957808|NCT03241173|515382829|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
142957809|NCT03241173|515382830|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
142957810|NCT03241173|515382831|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
142957811|NCT03241173|515382832|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
142957812|NCT03241173|515382833|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
142957813|NCT03241173|515382834|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
142957814|NCT03241173|515382820|FG000|Overall Study|Lost to Follow-up|0|||
142957815|NCT03241173|515382821|FG001|Overall Study|Lost to Follow-up|0|||
142957816|NCT03241173|515382822|FG002|Overall Study|Lost to Follow-up|0|||
142957817|NCT03241173|515382823|FG003|Overall Study|Lost to Follow-up|0|||
142957818|NCT03241173|515382824|FG004|Overall Study|Lost to Follow-up|1|||
142957819|NCT03241173|515382825|FG005|Overall Study|Lost to Follow-up|0|||
142957820|NCT03241173|515382826|FG006|Overall Study|Lost to Follow-up|0|||
142957821|NCT03241173|515382827|FG007|Overall Study|Lost to Follow-up|0|||
142957822|NCT03241173|515382828|FG008|Overall Study|Lost to Follow-up|0|||
142957823|NCT03241173|515382829|FG009|Overall Study|Lost to Follow-up|1|||
142957824|NCT03241173|515382830|FG010|Overall Study|Lost to Follow-up|0|||
142957825|NCT03241173|515382831|FG011|Overall Study|Lost to Follow-up|0|||
142957826|NCT03241173|515382832|FG012|Overall Study|Lost to Follow-up|0|||
142957827|NCT03241173|515382833|FG013|Overall Study|Lost to Follow-up|0|||
142957828|NCT03241173|515382834|FG014|Overall Study|Lost to Follow-up|0|||
142957829|NCT01765764|515382835|FG000|Treatment Period|Adverse Event|1|||
142957830|NCT01765764|515382836|FG001|Treatment Period|Adverse Event|2|||
142957831|NCT01765764|515382837|FG002|Treatment Period|Adverse Event|1|||
142957832|NCT01765764|515382835|FG000|Treatment Period|Lost to Follow-up|0|||
142957833|NCT01765764|515382836|FG001|Treatment Period|Lost to Follow-up|3|||
142957834|NCT01765764|515382837|FG002|Treatment Period|Lost to Follow-up|2|||
142957835|NCT01765764|515382835|FG000|Treatment Period|Personal Reasons|1|||
142957836|NCT01765764|515382836|FG001|Treatment Period|Personal Reasons|2|||
142957837|NCT01765764|515382837|FG002|Treatment Period|Personal Reasons|1|||
142957838|NCT01765764|515382835|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
142957839|NCT01765764|515382836|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
142957840|NCT01765764|515382837|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
142957841|NCT00798967|515382844|FG000|Overall Study|Adverse Event|2|||
142957842|NCT00798967|515382845|FG001|Overall Study|Adverse Event|3|||
142957843|NCT00798967|515382844|FG000|Overall Study|Withdrawal by Subject|0|||
142957844|NCT00798967|515382845|FG001|Overall Study|Withdrawal by Subject|1|||
142957845|NCT00798967|515382844|FG000|Overall Study|Physician Decision|1|||
142957846|NCT00798967|515382845|FG001|Overall Study|Physician Decision|0|||
142957847|NCT00798967|515382844|FG000|Overall Study|Randomized in error by site|1|||
142957848|NCT00798967|515382845|FG001|Overall Study|Randomized in error by site|0|||
142957849|NCT02522481|515382850|FG000|Overall Study|discontinued|1|||
142957850|NCT02522481|515382850|FG000|Overall Study|Not dosed|2|||
142957851|NCT04359823|515384339|FG000|Overall Study|Lost to Follow-up|0|||
142957852|NCT04359823|515384340|FG001|Overall Study|Lost to Follow-up|1|||
142957853|NCT04359823|515384339|FG000|Overall Study|Withdrawal by Subject|0|||
142957854|NCT04359823|515384340|FG001|Overall Study|Withdrawal by Subject|1|||
142957855|NCT01431144|515384341|FG000|Overall Study|Implant mobility and removal|2|||
142957856|NCT01431144|515384342|FG001|Overall Study|Implant mobility and removal|0|||
142957857|NCT02322892|515384346|FG000|Overall Study|Surgery cancelled|1|||
142957858|NCT02322892|515384347|FG001|Overall Study|Surgery cancelled|2|||
142957859|NCT02322892|515384346|FG000|Overall Study|Met exclusion criteria|0|||
142957860|NCT02322892|515384347|FG001|Overall Study|Met exclusion criteria|1|||
142957861|NCT02322892|515384346|FG000|Overall Study|Protocol Violation|1|||
142957862|NCT02322892|515384347|FG001|Overall Study|Protocol Violation|0|||
142957863|NCT02125331|515384350|FG000|Overall Study|Protocol Violation|1|||
142957864|NCT02125331|515384351|FG001|Overall Study|Protocol Violation|0|||
142957865|NCT02125331|515384350|FG000|Overall Study|technical problem|2|||
142957866|NCT02125331|515384351|FG001|Overall Study|technical problem|0|||
142957867|NCT02125331|515384350|FG000|Overall Study|screen failure|2|||
142957868|NCT02125331|515384351|FG001|Overall Study|screen failure|0|||
142957869|NCT04494633|515384354|FG000|Overall Study|Lost to Follow-up|5|||
142957870|NCT04494633|515384355|FG001|Overall Study|Lost to Follow-up|3|||
142957871|NCT04494633|515384354|FG000|Overall Study|Protocol Violation|1|||
142957872|NCT04494633|515384355|FG001|Overall Study|Protocol Violation|1|||
142957873|NCT01254604|515384356|FG000|Overall Study|Lost to Follow-up|1|||
142957874|NCT01254604|515384357|FG001|Overall Study|Lost to Follow-up|1|||
142957875|NCT01254604|515384356|FG000|Overall Study|Protocol Violation|2|||
142957876|NCT01254604|515384357|FG001|Overall Study|Protocol Violation|2|||
142957877|NCT01254604|515384356|FG000|Overall Study|Withdrawal by Subject|2|||
142957878|NCT01254604|515384357|FG001|Overall Study|Withdrawal by Subject|4|||
142957879|NCT01254604|515384356|FG000|Overall Study|Adverse Event|3|||
142957880|NCT01254604|515384357|FG001|Overall Study|Adverse Event|2|||
142957881|NCT03074162|515384358|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
142957882|NCT03074162|515384359|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
142957883|NCT03074162|515384360|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
142957884|NCT03074162|515384361|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
142957885|NCT03074162|515384362|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
142957886|NCT03074162|515384363|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
142957887|NCT03074162|515384358|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
142957888|NCT03074162|515384359|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
142957889|NCT03074162|515384360|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
142957890|NCT03074162|515384361|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
142957891|NCT03074162|515384362|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
142957892|NCT03074162|515384363|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
142957893|NCT03074162|515384358|FG000|Period 3|Withdrawal by Subject|1|||
142957894|NCT03074162|515384359|FG001|Period 3|Withdrawal by Subject|0|||
142957895|NCT03074162|515384360|FG002|Period 3|Withdrawal by Subject|0|||
142957896|NCT03074162|515384361|FG003|Period 3|Withdrawal by Subject|0|||
142957897|NCT03074162|515384362|FG004|Period 3|Withdrawal by Subject|1|||
142957898|NCT03074162|515384363|FG005|Period 3|Withdrawal by Subject|0|||
142957899|NCT05070429|515384364|FG000|Overall Study|Death|0|||
142957900|NCT05070429|515384365|FG001|Overall Study|Death|4|||
142957901|NCT05070429|515384364|FG000|Overall Study|Withdrawal by Subject|2|||
142957902|NCT05070429|515384365|FG001|Overall Study|Withdrawal by Subject|1|||
142957903|NCT05070429|515384364|FG000|Overall Study|Other|15|||
142957904|NCT05070429|515384365|FG001|Overall Study|Other|5|||
142957905|NCT00390780|515384374|FG000|Overall Study|Not completed|10|||
142957906|NCT00390780|515384375|FG001|Overall Study|Not completed|4|||
142957907|NCT00390780|515384374|FG000|Overall Study|Protocol Violation|6|||
142957908|NCT00390780|515384375|FG001|Overall Study|Protocol Violation|4|||
142957909|NCT00390780|515384374|FG000|Overall Study|Lost to Follow-up|3|||
142957910|NCT00390780|515384375|FG001|Overall Study|Lost to Follow-up|6|||
142957911|NCT00390780|515384374|FG000|Overall Study|Adverse Event|2|||
142957912|NCT00390780|515384375|FG001|Overall Study|Adverse Event|3|||
142957913|NCT00390780|515384374|FG000|Overall Study|Death|1|||
142957914|NCT00390780|515384375|FG001|Overall Study|Death|3|||
142957915|NCT00390780|515384374|FG000|Overall Study|Withdrawal by Subject|1|||
142957916|NCT00390780|515384375|FG001|Overall Study|Withdrawal by Subject|2|||
142957917|NCT00390780|515384374|FG000|Overall Study|Inclusion criteria not satisfied|0|||
142957918|NCT00390780|515384375|FG001|Overall Study|Inclusion criteria not satisfied|2|||
142957919|NCT00390780|515384374|FG000|Overall Study|Lost to follow up and other reasons|0|||
142957920|NCT00390780|515384375|FG001|Overall Study|Lost to follow up and other reasons|1|||
142957921|NCT00390780|515384374|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
142957922|NCT00390780|515384375|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
142957923|NCT00390780|515384374|FG000|Overall Study|SAE, death|0|||
142957924|NCT00390780|515384375|FG001|Overall Study|SAE, death|1|||
142957925|NCT01585961|515384380|FG000|Overall Study|Death|6|||
142957926|NCT01585961|515384380|FG000|Overall Study|Physician Decision|1|||
142957927|NCT01585961|515384380|FG000|Overall Study|Decision to use non-study catheter|1|||
142957928|NCT01585961|515384380|FG000|Overall Study|Withdrawal by Subject|1|||
142957929|NCT01585961|515384380|FG000|Overall Study|Lost to Follow-up|23|||
142957930|NCT01585961|515384380|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
142957931|NCT00305006|515384381|FG000|Overall Study|Withdrawal by Subject|1|||
142957932|NCT00305006|515384382|FG001|Overall Study|Withdrawal by Subject|0|||
142957933|NCT00305006|515384381|FG000|Overall Study|Failure to complete pretest|0|||
142957934|NCT00305006|515384382|FG001|Overall Study|Failure to complete pretest|1|||
142957935|NCT02606045|515384383|FG000|Overall Study|Study closed before treament could begin|1|||
142957936|NCT02606045|515384384|FG001|Overall Study|Study closed before treament could begin|2|||
142957937|NCT01996319|515384385|FG000|Overall Study|Protocol Violation|1|||
142957938|NCT01996319|515384386|FG001|Overall Study|Protocol Violation|0|||
142957939|NCT01996319|515384385|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
142957940|NCT01996319|515384386|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
142957941|NCT01996319|515384385|FG000|Overall Study|Adverse Event|2|||
142957942|NCT01996319|515384386|FG001|Overall Study|Adverse Event|2|||
142957943|NCT01671085|515384387|FG000|Overall Study|Withdrawal by Subject|1|||
142957944|NCT01671085|515384388|FG001|Overall Study|Withdrawal by Subject|0|||
142957945|NCT00637273|515384389|FG000|Overall Study|Adverse Event|11|||
142957946|NCT00637273|515384390|FG001|Overall Study|Adverse Event|5|||
142957947|NCT00637273|515384391|FG002|Overall Study|Adverse Event|7|||
142957948|NCT00637273|515384389|FG000|Overall Study|Lost to Follow-up|8|||
142957949|NCT00637273|515384390|FG001|Overall Study|Lost to Follow-up|9|||
142957950|NCT00637273|515384391|FG002|Overall Study|Lost to Follow-up|13|||
142957951|NCT00637273|515384389|FG000|Overall Study|Protocol Violation|2|||
142957952|NCT00637273|515384390|FG001|Overall Study|Protocol Violation|4|||
142957953|NCT00637273|515384391|FG002|Overall Study|Protocol Violation|1|||
142957954|NCT00637273|515384389|FG000|Overall Study|Withdrawal of Consent|18|||
142957955|NCT00637273|515384390|FG001|Overall Study|Withdrawal of Consent|6|||
142957956|NCT00637273|515384391|FG002|Overall Study|Withdrawal of Consent|18|||
142957957|NCT00637273|515384389|FG000|Overall Study|Investigator Decision|1|||
142957958|NCT00637273|515384390|FG001|Overall Study|Investigator Decision|3|||
142957959|NCT00637273|515384391|FG002|Overall Study|Investigator Decision|1|||
142957960|NCT00637273|515384389|FG000|Overall Study|Administrative|2|||
142957961|NCT00637273|515384390|FG001|Overall Study|Administrative|0|||
142957962|NCT00637273|515384391|FG002|Overall Study|Administrative|0|||
142957963|NCT00637273|515384389|FG000|Overall Study|Loss of Glucose Control|1|||
142957964|NCT00637273|515384390|FG001|Overall Study|Loss of Glucose Control|1|||
142957965|NCT00637273|515384391|FG002|Overall Study|Loss of Glucose Control|1|||
142957966|NCT03332667|515384393|FG000|Overall Study|Adverse Event|0|||
142957967|NCT03332667|515384394|FG001|Overall Study|Adverse Event|0|||
142957968|NCT03332667|515384395|FG002|Overall Study|Adverse Event|2|||
142957969|NCT03332667|515384396|FG003|Overall Study|Adverse Event|1|||
142957970|NCT03332667|515384393|FG000|Overall Study|Withdrawal by Subject|2|||
142957971|NCT03332667|515384394|FG001|Overall Study|Withdrawal by Subject|1|||
142957972|NCT03332667|515384395|FG002|Overall Study|Withdrawal by Subject|5|||
142957973|NCT03332667|515384396|FG003|Overall Study|Withdrawal by Subject|1|||
142957974|NCT03332667|515384393|FG000|Overall Study|Disease Progression or Relapse|2|||
142957975|NCT03332667|515384394|FG001|Overall Study|Disease Progression or Relapse|1|||
142957976|NCT03332667|515384395|FG002|Overall Study|Disease Progression or Relapse|3|||
142957977|NCT03332667|515384396|FG003|Overall Study|Disease Progression or Relapse|0|||
142957978|NCT03332667|515384393|FG000|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
142957979|NCT03332667|515384394|FG001|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
142957980|NCT03332667|515384395|FG002|Overall Study|Initiation onto Another Anti-Cancer Therapy|3|||
142957981|NCT03332667|515384396|FG003|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
142957982|NCT03332667|515384393|FG000|Overall Study|No Treatment Received|0|||
142957983|NCT03332667|515384394|FG001|Overall Study|No Treatment Received|0|||
142957984|NCT03332667|515384395|FG002|Overall Study|No Treatment Received|1|||
142957985|NCT03332667|515384396|FG003|Overall Study|No Treatment Received|0|||
142957986|NCT01035606|515384397|FG000|Overall Study|change in health, job demands,family|3|||
142957987|NCT01035606|515384398|FG001|Overall Study|change in health, job demands,family|3|||
142957988|NCT01035606|515384399|FG002|Overall Study|change in health, job demands,family|4|||
142957989|NCT01809262|515384400|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
142957990|NCT01809262|515384401|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
142957991|NCT01809262|515384402|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
142957992|NCT01809262|515384403|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
142957993|NCT01809262|515384404|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
142957994|NCT01809262|515384405|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
142957995|NCT01809262|515384406|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
142957996|NCT01809262|515384407|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
142957997|NCT01809262|515384408|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
142957998|NCT01809262|515384409|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
142957999|NCT01809262|515384400|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
142958000|NCT01809262|515384401|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
142958001|NCT01809262|515384402|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
142958002|NCT01809262|515384403|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
142958003|NCT01809262|515384404|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
142958004|NCT01809262|515384405|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
142958005|NCT01809262|515384406|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
142958006|NCT01809262|515384407|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
142958007|NCT01809262|515384408|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
142958008|NCT01809262|515384409|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
142958009|NCT01505491|515384410|FG000|Overall Study|Other reason not listed|1|||
142958010|NCT01505491|515384411|FG001|Overall Study|Other reason not listed|0|||
142958011|NCT01505491|515384412|FG002|Overall Study|Other reason not listed|0|||
142958012|NCT01505491|515384410|FG000|Overall Study|Withdrawal by Subject|1|||
142958013|NCT01505491|515384411|FG001|Overall Study|Withdrawal by Subject|1|||
142958014|NCT01505491|515384412|FG002|Overall Study|Withdrawal by Subject|4|||
142958015|NCT01505491|515384410|FG000|Overall Study|Lost to Follow-up|0|||
142958016|NCT01505491|515384411|FG001|Overall Study|Lost to Follow-up|0|||
142958017|NCT01505491|515384412|FG002|Overall Study|Lost to Follow-up|1|||
142958018|NCT01120093|515384422|FG000|Treatment Period 1|Adverse Event|0|||
142958019|NCT01120093|515384423|FG001|Treatment Period 1|Adverse Event|0|||
142958020|NCT01120093|515384424|FG002|Treatment Period 1|Adverse Event|1|||
142958021|NCT01120093|515384425|FG003|Treatment Period 1|Adverse Event|0|||
142958022|NCT01120093|515384426|FG004|Treatment Period 1|Adverse Event|1|||
142958023|NCT01120093|515384422|FG000|Treatment Period 1|Withdrawal by Subject|0|||
142958024|NCT01120093|515384423|FG001|Treatment Period 1|Withdrawal by Subject|1|||
142958025|NCT01120093|515384424|FG002|Treatment Period 1|Withdrawal by Subject|0|||
142958026|NCT01120093|515384425|FG003|Treatment Period 1|Withdrawal by Subject|0|||
142958027|NCT01120093|515384426|FG004|Treatment Period 1|Withdrawal by Subject|0|||
142958028|NCT01120093|515384422|FG000|Treatment Period 2|Adverse Event|0|||
142958029|NCT01120093|515384423|FG001|Treatment Period 2|Adverse Event|0|||
142958030|NCT01120093|515384424|FG002|Treatment Period 2|Adverse Event|0|||
142958031|NCT01120093|515384425|FG003|Treatment Period 2|Adverse Event|1|||
142958032|NCT01120093|515384426|FG004|Treatment Period 2|Adverse Event|0|||
142958033|NCT01120093|515384422|FG000|Treatment Period 2|Withdrawal by Subject|0|||
142958034|NCT01120093|515384423|FG001|Treatment Period 2|Withdrawal by Subject|0|||
142958035|NCT01120093|515384424|FG002|Treatment Period 2|Withdrawal by Subject|0|||
142958036|NCT01120093|515384425|FG003|Treatment Period 2|Withdrawal by Subject|0|||
142958037|NCT01120093|515384426|FG004|Treatment Period 2|Withdrawal by Subject|1|||
142958038|NCT01120093|515384422|FG000|Treatment Period 3|Lack of Efficacy|0|||
142958039|NCT01120093|515384423|FG001|Treatment Period 3|Lack of Efficacy|0|||
142958040|NCT01120093|515384424|FG002|Treatment Period 3|Lack of Efficacy|0|||
142958041|NCT01120093|515384425|FG003|Treatment Period 3|Lack of Efficacy|1|||
142958042|NCT01120093|515384426|FG004|Treatment Period 3|Lack of Efficacy|0|||
142958043|NCT01120093|515384422|FG000|Treatment Period 3|Adverse Event|0|||
142958044|NCT01120093|515384423|FG001|Treatment Period 3|Adverse Event|0|||
142958045|NCT01120093|515384424|FG002|Treatment Period 3|Adverse Event|0|||
142958046|NCT01120093|515384425|FG003|Treatment Period 3|Adverse Event|0|||
142958047|NCT01120093|515384426|FG004|Treatment Period 3|Adverse Event|1|||
142958048|NCT01120093|515384422|FG000|Treatment Period 3|Withdrawal by Subject|0|||
142958049|NCT01120093|515384423|FG001|Treatment Period 3|Withdrawal by Subject|0|||
142958050|NCT01120093|515384424|FG002|Treatment Period 3|Withdrawal by Subject|1|||
142958051|NCT01120093|515384425|FG003|Treatment Period 3|Withdrawal by Subject|0|||
142958052|NCT01120093|515384426|FG004|Treatment Period 3|Withdrawal by Subject|0|||
142958053|NCT01120093|515384422|FG000|Treatment Period 4|Adverse Event|1|||
142958054|NCT01120093|515384423|FG001|Treatment Period 4|Adverse Event|0|||
142958055|NCT01120093|515384424|FG002|Treatment Period 4|Adverse Event|0|||
142958056|NCT01120093|515384425|FG003|Treatment Period 4|Adverse Event|0|||
142958057|NCT01120093|515384426|FG004|Treatment Period 4|Adverse Event|0|||
142958058|NCT01120093|515384422|FG000|Treatment Period 5|Adverse Event|0|||
142958059|NCT01120093|515384423|FG001|Treatment Period 5|Adverse Event|1|||
142958060|NCT01120093|515384424|FG002|Treatment Period 5|Adverse Event|0|||
142958061|NCT01120093|515384425|FG003|Treatment Period 5|Adverse Event|1|||
142958062|NCT01120093|515384426|FG004|Treatment Period 5|Adverse Event|0|||
142958063|NCT03649321|515384427|FG000|Overall Study|Withdrawal by Subject|1|||
142958064|NCT03649321|515384428|FG001|Overall Study|Withdrawal by Subject|0|||
142958065|NCT03649321|515384427|FG000|Overall Study|Death|1|||
142958066|NCT03649321|515384428|FG001|Overall Study|Death|0|||
142958067|NCT03408873|515384435|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
142958068|NCT03408873|515384435|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
142958069|NCT03408873|515384435|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
142958070|NCT03408873|515384435|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
142958071|NCT03408873|515384435|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
142958072|NCT03408873|515384435|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
142958073|NCT01469013|515384436|FG000|Part A (Treatment Period)|Adverse Event|1|||
142958074|NCT01469013|515384437|FG001|Part A (Treatment Period)|Adverse Event|0|||
142958075|NCT01469013|515384438|FG002|Part A (Treatment Period)|Adverse Event|0|||
142958076|NCT01469013|515384439|FG003|Part A (Treatment Period)|Adverse Event|0|||
142958077|NCT01469013|515384440|FG004|Part A (Treatment Period)|Adverse Event|1|||
142958078|NCT01469013|515384441|FG005|Part A (Treatment Period)|Adverse Event|0|||
142958079|NCT01469013|515384442|FG006|Part A (Treatment Period)|Adverse Event|0|||
142958080|NCT01469013|515384443|FG007|Part A (Treatment Period)|Adverse Event|0|||
142958081|NCT01469013|515384444|FG008|Part A (Treatment Period)|Adverse Event|0|||
142958082|NCT01469013|515384445|FG009|Part A (Treatment Period)|Adverse Event|0|||
142958083|NCT01469013|515384446|FG010|Part A (Treatment Period)|Adverse Event|0|||
142958084|NCT01469013|515384447|FG011|Part A (Treatment Period)|Adverse Event|0|||
142958085|NCT01469013|515384448|FG012|Part A (Treatment Period)|Adverse Event|0|||
142958086|NCT01469013|515384436|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
142958087|NCT01469013|515384437|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
142958088|NCT01469013|515384438|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
142958089|NCT01469013|515384439|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
142958090|NCT01469013|515384440|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
142958091|NCT01469013|515384441|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
142958092|NCT01469013|515384442|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
142958093|NCT01469013|515384443|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
142958094|NCT01469013|515384444|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
142958095|NCT01469013|515384445|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
142958096|NCT01469013|515384446|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
142958097|NCT01469013|515384447|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
142958098|NCT01469013|515384448|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
142958099|NCT01469013|515384436|FG000|Part B (Extension Period)|Adverse Event|0|||
142958100|NCT01469013|515384437|FG001|Part B (Extension Period)|Adverse Event|0|||
142958101|NCT01469013|515384438|FG002|Part B (Extension Period)|Adverse Event|0|||
142958102|NCT01469013|515384439|FG003|Part B (Extension Period)|Adverse Event|0|||
142958103|NCT01469013|515384440|FG004|Part B (Extension Period)|Adverse Event|0|||
142958104|NCT01469013|515384441|FG005|Part B (Extension Period)|Adverse Event|2|||
142958105|NCT01469013|515384442|FG006|Part B (Extension Period)|Adverse Event|5|||
142958106|NCT01469013|515384443|FG007|Part B (Extension Period)|Adverse Event|5|||
142958107|NCT01469013|515384444|FG008|Part B (Extension Period)|Adverse Event|3|||
142958108|NCT01469013|515384445|FG009|Part B (Extension Period)|Adverse Event|3|||
142958109|NCT01469013|515384446|FG010|Part B (Extension Period)|Adverse Event|1|||
142958110|NCT01469013|515384447|FG011|Part B (Extension Period)|Adverse Event|6|||
142958111|NCT01469013|515384448|FG012|Part B (Extension Period)|Adverse Event|3|||
142958112|NCT01469013|515384436|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
142958113|NCT01469013|515384437|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
142958114|NCT01469013|515384438|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
142958115|NCT01469013|515384439|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
142958116|NCT01469013|515384440|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
142958117|NCT01469013|515384441|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
142958118|NCT01469013|515384442|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
142958119|NCT01469013|515384443|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
142958120|NCT01469013|515384444|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
142958121|NCT01469013|515384445|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
142958122|NCT01469013|515384446|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
142958123|NCT01469013|515384447|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
142958124|NCT01469013|515384448|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
142958125|NCT00446446|515384449|FG000|Overall Study|Death|10|||
142958126|NCT00446446|515384449|FG000|Overall Study|Withdrawal by Subject|6|||
142958127|NCT00446446|515384449|FG000|Overall Study|Other|4|||
142958128|NCT00446446|515384449|FG000|Overall Study|Disease Progession|2|||
142958129|NCT00446446|515384449|FG000|Overall Study|Adverse Event|1|||
142958130|NCT00446446|515384449|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
142958131|NCT00723840|515384450|FG000|Overall Study|Lost to Follow-up|2|||
142958132|NCT00723840|515384450|FG000|Overall Study|Failure to return|18|||
142958133|NCT00723840|515384450|FG000|Overall Study|Withdrawal by Subject|55|||
142958134|NCT00723840|515384450|FG000|Overall Study|Serious Adverse Events|3|||
142958135|NCT00723840|515384450|FG000|Overall Study|Other Medical Event|2|||
142958136|NCT00723840|515384450|FG000|Overall Study|Unspecified reason|2|||
142958137|NCT02062151|515384452|FG000|Overall Study|screen failure|1|||
142958138|NCT00751101|515384454|FG000|Overall Study|Withdrawal by Subject|1|||
142958139|NCT00751101|515384455|FG001|Overall Study|Withdrawal by Subject|0|||
142958140|NCT00751101|515384454|FG000|Overall Study|No HFS / Never Started Patch/|0|||
142958141|NCT00751101|515384455|FG001|Overall Study|No HFS / Never Started Patch/|4|||
142958142|NCT00751101|515384454|FG000|Overall Study|Never began capecitabine|1|||
142958143|NCT00751101|515384455|FG001|Overall Study|Never began capecitabine|0|||
142958144|NCT00751101|515384454|FG000|Overall Study|Physician Decision|0|||
142958145|NCT00751101|515384455|FG001|Overall Study|Physician Decision|1|||
142958146|NCT00455858|515384456|FG000|Overall Study|Lost to Follow-up|2|||
142958147|NCT00455858|515384456|FG000|Overall Study|Protocol Violation|1|||
142958148|NCT00455858|515384456|FG000|Overall Study|Lack of Efficacy|1|||
142958149|NCT00455858|515384456|FG000|Overall Study|Well controlled FPG without insulin|1|||
142958150|NCT00455858|515384456|FG000|Overall Study|Withdrawal|1|||
142958151|NCT02137772|515384457|FG000|Overall Study|Adverse Event|6|||
142958152|NCT02137772|515384458|FG001|Overall Study|Adverse Event|3|||
142958153|NCT02137772|515384457|FG000|Overall Study|Death|71|||
142958154|NCT02137772|515384458|FG001|Overall Study|Death|44|||
142958155|NCT02137772|515384457|FG000|Overall Study|Lost to Follow-up|8|||
142958156|NCT02137772|515384458|FG001|Overall Study|Lost to Follow-up|4|||
142958157|NCT02137772|515384457|FG000|Overall Study|Physician Decision|15|||
142958158|NCT02137772|515384458|FG001|Overall Study|Physician Decision|5|||
142958159|NCT02137772|515384457|FG000|Overall Study|Withdrawal by Subject|28|||
142958160|NCT02137772|515384458|FG001|Overall Study|Withdrawal by Subject|17|||
142958161|NCT02137772|515384457|FG000|Overall Study|Non-compliance with study drug|1|||
142958162|NCT02137772|515384458|FG001|Overall Study|Non-compliance with study drug|0|||
142958163|NCT02137772|515384457|FG000|Overall Study|Not treated|3|||
142958164|NCT02137772|515384458|FG001|Overall Study|Not treated|2|||
142958165|NCT02092389|515384459|FG000|Overall Study|Adverse Event|1|||
142958166|NCT02092389|515384459|FG000|Overall Study|Other|5|||
142958167|NCT02375698|515384460|FG000|Overall Study|Withdrawal by Subject|0|||
142958168|NCT02375698|515384461|FG001|Overall Study|Withdrawal by Subject|2|||
142958169|NCT02375698|515384460|FG000|Overall Study|Physician Decision|2|||
142958170|NCT02375698|515384461|FG001|Overall Study|Physician Decision|0|||
142958171|NCT01161524|515384465|FG000|Core Study (23 Weeks)|Adverse Event|3|||
142958172|NCT01161524|515384466|FG001|Core Study (23 Weeks)|Adverse Event|0|||
142958173|NCT01161524|515384467|FG002|Core Study (23 Weeks)|Adverse Event|0|||
142958174|NCT01161524|515384465|FG000|Core Study (23 Weeks)|Other|1|||
142958175|NCT01161524|515384466|FG001|Core Study (23 Weeks)|Other|0|||
142958176|NCT01161524|515384467|FG002|Core Study (23 Weeks)|Other|0|||
142958177|NCT01161524|515384465|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
142958178|NCT01161524|515384466|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
142958179|NCT01161524|515384467|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
142958180|NCT01161524|515384465|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
142958181|NCT01161524|515384466|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
142958182|NCT01161524|515384467|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
142958183|NCT01161524|515384465|FG000|Core Study (23 Weeks)|Subject Choice|3|||
142958184|NCT01161524|515384466|FG001|Core Study (23 Weeks)|Subject Choice|2|||
142958185|NCT01161524|515384467|FG002|Core Study (23 Weeks)|Subject Choice|0|||
142958186|NCT01161524|515384465|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
142958187|NCT01161524|515384466|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
142958188|NCT01161524|515384467|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
142958189|NCT01161524|515384465|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
142958190|NCT01161524|515384466|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
142958191|NCT01161524|515384467|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
142958192|NCT01161524|515384465|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
142958193|NCT01161524|515384466|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
142958194|NCT01161524|515384467|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
142958195|NCT01161524|515384465|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
142958196|NCT01161524|515384466|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
142958197|NCT01161524|515384467|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
142958198|NCT01161524|515384465|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
142958199|NCT01161524|515384466|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
142958200|NCT01161524|515384467|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
142958201|NCT03634072|515384468|FG000|Overall Study|Early termination of overall study|1|||
142958202|NCT03634072|515384469|FG001|Overall Study|Early termination of overall study|0|||
142958203|NCT01558089|515384474|FG000|Overall Study|Adverse Event|1|||
142958204|NCT01558089|515384474|FG000|Overall Study|Lack of Efficacy|1|||
142958205|NCT01558089|515384474|FG000|Overall Study|Lost to Follow-up|5|||
142958206|NCT01558089|515384474|FG000|Overall Study|Withdrawal by Subject|6|||
142958207|NCT01952015|515384475|FG000|Induction|Protocol Violation|1|||
142958208|NCT01952015|515384475|FG000|Maintenance|Adverse Event|2|||
142958209|NCT01952015|515384475|FG000|Treatment Period 3|Physician Decision|9|||
142958210|NCT01597193|515384476|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
142958211|NCT01597193|515384477|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
142958212|NCT01597193|515384478|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
142958213|NCT01597193|515384479|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
142958214|NCT01597193|515384480|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
142958215|NCT01597193|515384481|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
142958216|NCT01597193|515384482|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
142958217|NCT01597193|515384476|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
142958218|NCT01597193|515384477|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
142958219|NCT01597193|515384478|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
142958220|NCT01597193|515384479|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
142958221|NCT01597193|515384480|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
143455288|NCT01468181|517210861|FG004|Overall Study|Protocol Violation|1|||
143455289|NCT01468181|517210857|FG000|Overall Study|Physician Decision|0|||
143455290|NCT01468181|517210858|FG001|Overall Study|Physician Decision|0|||
143455291|NCT01468181|517210859|FG002|Overall Study|Physician Decision|0|||
143455292|NCT01468181|517210860|FG003|Overall Study|Physician Decision|1|||
143455293|NCT01468181|517210861|FG004|Overall Study|Physician Decision|1|||
142958222|NCT01597193|515384481|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
142958223|NCT01597193|515384482|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
142958224|NCT01597193|515384476|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
142958225|NCT01597193|515384477|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
142958226|NCT01597193|515384478|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
142958227|NCT01597193|515384479|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
142958228|NCT01597193|515384480|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
142958229|NCT01597193|515384481|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
142958230|NCT01597193|515384482|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
142958231|NCT01597193|515384476|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
142958232|NCT01597193|515384477|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
142958233|NCT01597193|515384478|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
142958234|NCT01597193|515384479|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
142958235|NCT01597193|515384480|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
142958236|NCT01597193|515384481|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
142958237|NCT01597193|515384482|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
142958238|NCT01597193|515384476|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
142958239|NCT01597193|515384477|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
142958240|NCT01597193|515384478|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
142958241|NCT01597193|515384479|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
142958242|NCT01597193|515384480|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
142958243|NCT01597193|515384481|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
142958244|NCT01597193|515384482|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
142958245|NCT00365976|515384487|FG000|Overall Study|Withdrawal by Subject|1|||
142958246|NCT00365976|515384488|FG001|Overall Study|Withdrawal by Subject|5|||
142958247|NCT01963117|515384489|FG000|Overall Study|Death|1|||
142958248|NCT01000064|515384490|FG000|Overall Study|Withdrawal by Subject|1|||
142958249|NCT01000064|515384491|FG001|Overall Study|Withdrawal by Subject|1|||
142958250|NCT02518620|515384492|FG000|Overall Study|Adverse Event|23|||
142958251|NCT02518620|515384493|FG001|Overall Study|Adverse Event|11|||
142958252|NCT02518620|515384492|FG000|Overall Study|Lack of Efficacy|2|||
142958253|NCT02518620|515384493|FG001|Overall Study|Lack of Efficacy|0|||
143455294|NCT01468181|517210857|FG000|Overall Study|Lost to Follow-up|0|||
143455295|NCT01468181|517210858|FG001|Overall Study|Lost to Follow-up|0|||
143455296|NCT01468181|517210859|FG002|Overall Study|Lost to Follow-up|1|||
143455297|NCT01468181|517210860|FG003|Overall Study|Lost to Follow-up|0|||
143455298|NCT01468181|517210861|FG004|Overall Study|Lost to Follow-up|1|||
143455299|NCT01468181|517210857|FG000|Overall Study|Withdrawal by Subject|0|||
143455300|NCT01468181|517210858|FG001|Overall Study|Withdrawal by Subject|1|||
143455301|NCT01468181|517210859|FG002|Overall Study|Withdrawal by Subject|0|||
143455302|NCT01468181|517210860|FG003|Overall Study|Withdrawal by Subject|0|||
143455303|NCT01468181|517210861|FG004|Overall Study|Withdrawal by Subject|0|||
143455304|NCT02432196|517210864|FG000|Overall Study|Exit - did not receive study device|1|||
143455305|NCT02432196|517210864|FG000|Overall Study|Death|2|||
143455306|NCT02432196|517210864|FG000|Overall Study|Reoperation|3|||
143455307|NCT01934790|517210865|FG000|Treatment|Adverse Event|3|||
143455308|NCT01934790|517210865|FG000|Treatment|Clinical progression|6|||
143455309|NCT01934790|517210865|FG000|Treatment|Radiological progression|4|||
143455310|NCT01934790|517210865|FG000|Treatment|Withdrawal by Subject|2|||
143455311|NCT01934790|517210865|FG000|Treatment|Study drug never administered|1|||
143455312|NCT01934790|517210865|FG000|Active Follow up|Death|20|||
143455313|NCT01934790|517210865|FG000|Active Follow up|Physician Decision|2|||
143455314|NCT01934790|517210865|FG000|Active Follow up|Progressive disease|1|||
143455315|NCT01934790|517210865|FG000|Active Follow up|Other reason|1|||
143455316|NCT03541174|517212427|FG000|Part 1 Double-Blind|Adverse Event|6|||
143455317|NCT03541174|517212428|FG001|Part 1 Double-Blind|Adverse Event|5|||
143455318|NCT03541174|517212429|FG002|Part 1 Double-Blind|Adverse Event|2|||
143455319|NCT03541174|517212430|FG003|Part 1 Double-Blind|Adverse Event|0|||
143455320|NCT03541174|517212431|FG004|Part 1 Double-Blind|Adverse Event|0|||
143455321|NCT03541174|517212432|FG005|Part 1 Double-Blind|Adverse Event|0|||
142958254|NCT02518620|515384492|FG000|Overall Study|Non-Compliance with Study Drug|1|||
142958255|NCT02518620|515384493|FG001|Overall Study|Non-Compliance with Study Drug|0|||
143455322|NCT03541174|517212427|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
142958256|NCT02518620|515384492|FG000|Overall Study|Physician Decision|1|||
142958257|NCT02518620|515384493|FG001|Overall Study|Physician Decision|1|||
142958258|NCT02518620|515384492|FG000|Overall Study|Sponsor's Decision|0|||
142958259|NCT02518620|515384493|FG001|Overall Study|Sponsor's Decision|3|||
142958260|NCT02518620|515384492|FG000|Overall Study|Lost to Follow-up|1|||
142958261|NCT02518620|515384493|FG001|Overall Study|Lost to Follow-up|1|||
142958262|NCT02518620|515384492|FG000|Overall Study|Withdrawal by Subject|17|||
142958263|NCT02518620|515384493|FG001|Overall Study|Withdrawal by Subject|9|||
142958264|NCT02518620|515384492|FG000|Overall Study|Death|1|||
142958265|NCT02518620|515384493|FG001|Overall Study|Death|0|||
142958266|NCT02518620|515384492|FG000|Overall Study|Pregnancy Wish|3|||
142958267|NCT02518620|515384493|FG001|Overall Study|Pregnancy Wish|0|||
142958268|NCT02518620|515384492|FG000|Overall Study|Pregnancy|1|||
142958269|NCT02518620|515384493|FG001|Overall Study|Pregnancy|0|||
142958270|NCT02518620|515384492|FG000|Overall Study|Relocation|2|||
142958271|NCT02518620|515384493|FG001|Overall Study|Relocation|1|||
142958272|NCT01605396|515384496|FG000|Overall Study|Adverse Event|5|||
142958273|NCT01605396|515384497|FG001|Overall Study|Adverse Event|3|||
142958274|NCT01605396|515384496|FG000|Overall Study|Lost to Follow-up|1|||
142958275|NCT01605396|515384497|FG001|Overall Study|Lost to Follow-up|0|||
142958276|NCT01605396|515384496|FG000|Overall Study|Non-Compliance With Study Drug|1|||
142958277|NCT01605396|515384497|FG001|Overall Study|Non-Compliance With Study Drug|1|||
142958278|NCT01605396|515384496|FG000|Overall Study|Physician Decision|2|||
142958279|NCT01605396|515384497|FG001|Overall Study|Physician Decision|2|||
142958280|NCT01605396|515384496|FG000|Overall Study|Progressive Disease|23|||
142958281|NCT01605396|515384497|FG001|Overall Study|Progressive Disease|27|||
142958282|NCT01605396|515384496|FG000|Overall Study|Withdrawal by Subject|4|||
142958283|NCT01605396|515384497|FG001|Overall Study|Withdrawal by Subject|2|||
142958284|NCT01605396|515384496|FG000|Overall Study|Transfer Off Study|4|||
142958285|NCT01605396|515384497|FG001|Overall Study|Transfer Off Study|5|||
142958286|NCT03141307|515384500|FG000|In-Hospital|Withdrawal by Subject|0|||
142958287|NCT03141307|515384501|FG001|In-Hospital|Withdrawal by Subject|2|||
142958288|NCT03141307|515384500|FG000|In-Hospital|Protocol Violation|4|||
142958289|NCT03141307|515384501|FG001|In-Hospital|Protocol Violation|0|||
142958290|NCT03141307|515384500|FG000|Follow-Up|Lost to Follow-up|97|||
142958291|NCT03141307|515384501|FG001|Follow-Up|Lost to Follow-up|54|||
142958292|NCT03090737|515384502|FG000|Overall Study|Other reasons|1|||
142958293|NCT03090737|515384502|FG000|Overall Study|Completed treatment as per protocol|17|||
142958294|NCT03090737|515384502|FG000|Overall Study|Maximum clinical benefit|2|||
142958295|NCT03090737|515384502|FG000|Overall Study|Adverse event unrelated to study drug|7|||
142958296|NCT03090737|515384502|FG000|Overall Study|Study drug toxicity|4|||
142958297|NCT03090737|515384502|FG000|Overall Study|Disease progression|98|||
142958298|NCT03103750|515384503|FG000|Overall Study|Adverse Event|1|||
142958299|NCT03103750|515384504|FG001|Overall Study|Adverse Event|0|||
142958300|NCT03103750|515384503|FG000|Overall Study|Lost to Follow-up|1|||
142958301|NCT03103750|515384504|FG001|Overall Study|Lost to Follow-up|0|||
142958302|NCT03103750|515384503|FG000|Overall Study|PET Equipment Related|2|||
142958303|NCT03103750|515384504|FG001|Overall Study|PET Equipment Related|2|||
142958304|NCT01663740|515384505|FG000|Overall Study|Lost to Follow-up|1|||
142958305|NCT01663740|515384506|FG001|Overall Study|Lost to Follow-up|4|||
142958306|NCT01663740|515384505|FG000|Overall Study|Other|9|||
142958307|NCT01663740|515384506|FG001|Overall Study|Other|2|||
142958308|NCT01663740|515384505|FG000|Overall Study|Inclusion/Exclusion not met|1|||
142958309|NCT01663740|515384506|FG001|Overall Study|Inclusion/Exclusion not met|0|||
142958310|NCT01663740|515384505|FG000|Overall Study|Death|0|||
142958311|NCT01663740|515384506|FG001|Overall Study|Death|1|||
142958312|NCT01663740|515384505|FG000|Overall Study|Withdrawal by Subject|2|||
142958313|NCT01663740|515384506|FG001|Overall Study|Withdrawal by Subject|1|||
142958314|NCT01663740|515384505|FG000|Overall Study|No end of study status|3|||
142958315|NCT01663740|515384506|FG001|Overall Study|No end of study status|0|||
142958316|NCT03123939|515384509|FG000|Overall Study|Lack of Efficacy|6|||
142958317|NCT03123939|515384509|FG000|Overall Study|Death|5|||
142958318|NCT03123939|515384509|FG000|Overall Study|Physician Decision|2|||
142958319|NCT03123939|515384509|FG000|Overall Study|Subject/guardian decision|2|||
142958320|NCT03123939|515384509|FG000|Overall Study|Lost to Follow-up|1|||
142958321|NCT03123939|515384509|FG000|Overall Study|New therapy for study indication|1|||
142958322|NCT03123939|515384509|FG000|Overall Study|Protocol deviation|1|||
142958323|NCT03123939|515384509|FG000|Overall Study|Progressive disease|18|||
142958324|NCT03123939|515384509|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
142958325|NCT03123939|515384509|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
142958326|NCT04400318|515385856|FG000|Overall Study|Adverse Event|1|||
142958327|NCT04400318|515385857|FG001|Overall Study|Adverse Event|0|||
142958328|NCT04400318|515385856|FG000|Overall Study|Withdrawal by Subject|1|||
143455323|NCT03541174|517212428|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
142958329|NCT04400318|515385857|FG001|Overall Study|Withdrawal by Subject|1|||
142958330|NCT04400318|515385856|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
142958331|NCT04400318|515385857|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
142958332|NCT04191967|515385858|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
142958333|NCT04191967|515385858|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
142958334|NCT01790438|515385859|FG000|Overall Study|Adverse Event|3|||
142958335|NCT01790438|515385860|FG001|Overall Study|Adverse Event|2|||
142958336|NCT01790438|515385859|FG000|Overall Study|Death|4|||
142958337|NCT01790438|515385860|FG001|Overall Study|Death|0|||
142958338|NCT01790438|515385859|FG000|Overall Study|Lost to Follow-up|5|||
142958339|NCT01790438|515385860|FG001|Overall Study|Lost to Follow-up|2|||
142958340|NCT01790438|515385859|FG000|Overall Study|Withdrawal by Subject|13|||
142958341|NCT01790438|515385860|FG001|Overall Study|Withdrawal by Subject|2|||
142958342|NCT01790438|515385859|FG000|Overall Study|Physician Decision|3|||
142958343|NCT01790438|515385860|FG001|Overall Study|Physician Decision|1|||
142958344|NCT01790438|515385859|FG000|Overall Study|Sponsor Decision|0|||
142958345|NCT01790438|515385860|FG001|Overall Study|Sponsor Decision|3|||
142958346|NCT01790438|515385859|FG000|Overall Study|Protocol Required Discontinuation|7|||
142958347|NCT01790438|515385860|FG001|Overall Study|Protocol Required Discontinuation|1|||
142958348|NCT02433210|515385864|FG000|Overall Study|Physician Decision|1|||
142958349|NCT02433210|515385865|FG001|Overall Study|Physician Decision|0|||
142958350|NCT02433210|515385866|FG002|Overall Study|Physician Decision|0|||
142958351|NCT01881620|515385868|FG000|Overall Study|Protocol Violation|4|||
142958352|NCT01808118|515385871|FG000|Period 1|Adverse Event|15|||
142958353|NCT01808118|515385872|FG001|Period 1|Adverse Event|0|||
142958354|NCT01808118|515385873|FG002|Period 1|Adverse Event|0|||
142958355|NCT01808118|515385871|FG000|Period 1|Withdrew consent|24|||
142958356|NCT01808118|515385872|FG001|Period 1|Withdrew consent|0|||
142958357|NCT01808118|515385873|FG002|Period 1|Withdrew consent|0|||
142958358|NCT01808118|515385871|FG000|Period 1|Lost to Follow-up|9|||
142958359|NCT01808118|515385872|FG001|Period 1|Lost to Follow-up|0|||
142958360|NCT01808118|515385873|FG002|Period 1|Lost to Follow-up|0|||
142958361|NCT01808118|515385871|FG000|Period 1|Did not meet criteria for remission|303|||
142958362|NCT01808118|515385872|FG001|Period 1|Did not meet criteria for remission|0|||
142958363|NCT01808118|515385873|FG002|Period 1|Did not meet criteria for remission|0|||
142958364|NCT01808118|515385871|FG000|Period 1|Enrolled in error|7|||
142958365|NCT01808118|515385872|FG001|Period 1|Enrolled in error|0|||
142958366|NCT01808118|515385873|FG002|Period 1|Enrolled in error|0|||
142958367|NCT01808118|515385871|FG000|Period 1|Did not meet inclusion criteria|3|||
142958368|NCT01808118|515385872|FG001|Period 1|Did not meet inclusion criteria|0|||
142958369|NCT01808118|515385873|FG002|Period 1|Did not meet inclusion criteria|0|||
142958370|NCT01808118|515385871|FG000|Period 1|Non-conformance with inclusion criteria|3|||
142958371|NCT01808118|515385872|FG001|Period 1|Non-conformance with inclusion criteria|0|||
142958372|NCT01808118|515385873|FG002|Period 1|Non-conformance with inclusion criteria|0|||
142958373|NCT01808118|515385871|FG000|Period 1|Investigator decision: site closure|2|||
142958374|NCT01808118|515385872|FG001|Period 1|Investigator decision: site closure|0|||
142958375|NCT01808118|515385873|FG002|Period 1|Investigator decision: site closure|0|||
142958376|NCT01808118|515385871|FG000|Period 1|Non-compliance per sponsor|1|||
142958377|NCT01808118|515385872|FG001|Period 1|Non-compliance per sponsor|0|||
142958378|NCT01808118|515385873|FG002|Period 1|Non-compliance per sponsor|0|||
142958379|NCT01808118|515385871|FG000|Period 1|Lack of Efficacy|1|||
142958380|NCT01808118|515385872|FG001|Period 1|Lack of Efficacy|0|||
142958381|NCT01808118|515385873|FG002|Period 1|Lack of Efficacy|0|||
142958382|NCT01808118|515385871|FG000|Period 2|Adverse Event|0|||
142958383|NCT01808118|515385872|FG001|Period 2|Adverse Event|4|||
142958384|NCT01808118|515385873|FG002|Period 2|Adverse Event|0|||
142958385|NCT01808118|515385871|FG000|Period 2|Withdrew consent|0|||
142958386|NCT01808118|515385872|FG001|Period 2|Withdrew consent|7|||
142958387|NCT01808118|515385873|FG002|Period 2|Withdrew consent|6|||
142958388|NCT01808118|515385871|FG000|Period 2|Lost to Follow-up|0|||
142958389|NCT01808118|515385872|FG001|Period 2|Lost to Follow-up|0|||
142958390|NCT01808118|515385873|FG002|Period 2|Lost to Follow-up|2|||
142958391|NCT01808118|515385871|FG000|Period 2|Investigator no longer conducting trials|0|||
142958392|NCT01808118|515385872|FG001|Period 2|Investigator no longer conducting trials|1|||
142958393|NCT01808118|515385873|FG002|Period 2|Investigator no longer conducting trials|0|||
142958394|NCT01808118|515385871|FG000|Period 2|Switched to other therapy|0|||
142958395|NCT01808118|515385872|FG001|Period 2|Switched to other therapy|1|||
142958396|NCT01808118|515385873|FG002|Period 2|Switched to other therapy|0|||
142958397|NCT00625365|515385884|FG000|Overall Study|Withdrawal by Subject|1|||
142958398|NCT00625365|515385884|FG000|Overall Study|No IV access|5|||
142958399|NCT00625365|515385884|FG000|Overall Study|VSD|1|||
142958400|NCT01876732|515385885|FG000|Overall Study|MMA was not over 800mg/dL|75|||
142958401|NCT02341014|515385886|FG000|Overall Study|Adverse Event|0|||
142958402|NCT02341014|515385887|FG001|Overall Study|Adverse Event|1|||
143117491|NCT01472939|515971864|FG003|Overall Study|Withdrawal By PI|0|||
142958403|NCT02341014|515385888|FG002|Overall Study|Adverse Event|0|||
142958404|NCT02341014|515385889|FG003|Overall Study|Adverse Event|0|||
142958405|NCT02341014|515385890|FG004|Overall Study|Adverse Event|2|||
142958406|NCT02232516|515385891|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
142958407|NCT02232516|515385891|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
142958408|NCT02232516|515385891|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
142958409|NCT02232516|515385891|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
142958410|NCT02232516|515385891|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
142958411|NCT02232516|515385891|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
142958412|NCT02232516|515385891|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
142958413|NCT02232516|515385891|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
143003119|NCT01049360|515548751|FG007|Period 2|Protocol Violation|0|||
142958414|NCT02232516|515385891|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
142958415|NCT02232516|515385891|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
142958416|NCT02232516|515385891|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
142958417|NCT02232516|515385891|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
142958418|NCT02232516|515385891|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
142958419|NCT02232516|515385891|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
142958420|NCT02232516|515385891|FG000|Survival Follow-up|Death|15|||
142958421|NCT02232516|515385891|FG000|Survival Follow-up|Withdrawal by Subject|3|||
142958422|NCT02232516|515385891|FG000|Survival Follow-up|Lost to Follow-up|1|||
142958423|NCT02232516|515385891|FG000|Survival Follow-up|Still in follow-up|5|||
142958424|NCT00109733|515385894|FG000|Overall Study|Protocol Violation|0|||
142958425|NCT00109733|515385895|FG001|Overall Study|Protocol Violation|1|||
142958426|NCT00109733|515385894|FG000|Overall Study|Stopped taking study drug|1|||
142958427|NCT00109733|515385895|FG001|Overall Study|Stopped taking study drug|1|||
142958428|NCT00109733|515385894|FG000|Overall Study|Non-compliant|0|||
142958429|NCT00109733|515385895|FG001|Overall Study|Non-compliant|1|||
142958430|NCT00109733|515385894|FG000|Overall Study|Could not commit time for study|1|||
142958431|NCT00109733|515385895|FG001|Overall Study|Could not commit time for study|1|||
142958432|NCT00739297|515385899|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
142958433|NCT00739297|515385900|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
142958434|NCT00739297|515385901|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
142958435|NCT00739297|515385902|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
142958436|NCT00739297|515385903|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
142958437|NCT00739297|515385904|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
142958438|NCT00739297|515385905|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
142958439|NCT00739297|515385899|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
142958440|NCT00739297|515385900|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
142958441|NCT00739297|515385901|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
142958442|NCT00739297|515385902|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
142958443|NCT00739297|515385903|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
142958444|NCT00739297|515385904|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
142958445|NCT00739297|515385905|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
142958446|NCT01879618|515385906|FG000|Overall Study|Does not meet entrance criteria|1|||
142958447|NCT01879618|515385906|FG000|Overall Study|Withdrawal by Subject|1|||
142958448|NCT01879618|515385906|FG000|Overall Study|Surgery;changed schedule; not available|8|||
142958449|NCT01879618|515385906|FG000|Overall Study|Protocol Violation|6|||
142958450|NCT01879618|515385906|FG000|Overall Study|Adverse Event|5|||
142958451|NCT01905397|515385911|FG000|Overall Study|Death|0|||
142958452|NCT01905397|515385912|FG001|Overall Study|Death|1|||
142958453|NCT01905397|515385911|FG000|Overall Study|Withdrawal by Subject|2|||
142958454|NCT01905397|515385912|FG001|Overall Study|Withdrawal by Subject|0|||
142958455|NCT01905397|515385911|FG000|Overall Study|Surgery canceled/aborted|9|||
142958456|NCT01905397|515385912|FG001|Overall Study|Surgery canceled/aborted|5|||
142958457|NCT01905397|515385911|FG000|Overall Study|Incision < 7 cm|2|||
142958458|NCT01905397|515385912|FG001|Overall Study|Incision < 7 cm|0|||
142958459|NCT01905397|515385911|FG000|Overall Study|Wrong treatment|1|||
142958460|NCT01905397|515385912|FG001|Overall Study|Wrong treatment|1|||
142958461|NCT01905397|515385911|FG000|Overall Study|Device not applied|3|||
142958462|NCT01905397|515385912|FG001|Overall Study|Device not applied|0|||
142958463|NCT01905397|515385911|FG000|Overall Study|Dressing not applied in operating room|1|||
142958464|NCT01905397|515385912|FG001|Overall Study|Dressing not applied in operating room|0|||
142958465|NCT01905397|515385911|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
142958466|NCT01905397|515385912|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
142958467|NCT01921270|515385913|FG000|Overall Study|Withdrawal by Subject|1|||
142958468|NCT00844428|515385914|FG000|Screening Period|Screen Failure|3|||
142958469|NCT00844428|515385914|FG000|Extension Treatment Period|Death|1|||
142958470|NCT00844428|515385914|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
142958471|NCT00789477|515385915|FG000|Overall Study|Withdrawal by Subject|2|||
142958472|NCT00789477|515385916|FG001|Overall Study|Withdrawal by Subject|1|||
142958473|NCT00789477|515385917|FG002|Overall Study|Withdrawal by Subject|3|||
142958474|NCT00789477|515385918|FG003|Overall Study|Withdrawal by Subject|2|||
142958475|NCT00789477|515385919|FG004|Overall Study|Withdrawal by Subject|3|||
142958476|NCT00789477|515385915|FG000|Overall Study|Protocol Violation|1|||
142958477|NCT00789477|515385916|FG001|Overall Study|Protocol Violation|0|||
142958478|NCT00789477|515385917|FG002|Overall Study|Protocol Violation|0|||
142958479|NCT00789477|515385918|FG003|Overall Study|Protocol Violation|1|||
142958480|NCT00789477|515385919|FG004|Overall Study|Protocol Violation|0|||
142958481|NCT00789477|515385915|FG000|Overall Study|Adverse Event|3|||
142958482|NCT00789477|515385916|FG001|Overall Study|Adverse Event|3|||
142958483|NCT00789477|515385917|FG002|Overall Study|Adverse Event|1|||
142958484|NCT00789477|515385918|FG003|Overall Study|Adverse Event|0|||
143117136|NCT01273155|515970044|FG006|Overall Study|Change in liver function/no longer eval.|0|||
142958485|NCT00789477|515385919|FG004|Overall Study|Adverse Event|0|||
142958486|NCT00789477|515385915|FG000|Overall Study|Death|1|||
142958487|NCT00789477|515385916|FG001|Overall Study|Death|1|||
142958488|NCT00789477|515385917|FG002|Overall Study|Death|2|||
142958489|NCT00789477|515385918|FG003|Overall Study|Death|2|||
142958490|NCT00789477|515385919|FG004|Overall Study|Death|0|||
142958491|NCT00789477|515385915|FG000|Overall Study|Lost to Follow-up|0|||
142958492|NCT00789477|515385916|FG001|Overall Study|Lost to Follow-up|1|||
142958493|NCT00789477|515385917|FG002|Overall Study|Lost to Follow-up|4|||
142958494|NCT00789477|515385918|FG003|Overall Study|Lost to Follow-up|2|||
142958495|NCT00789477|515385919|FG004|Overall Study|Lost to Follow-up|4|||
142958496|NCT00789477|515385915|FG000|Overall Study|Lack of Efficacy|2|||
142958497|NCT00789477|515385916|FG001|Overall Study|Lack of Efficacy|0|||
142958498|NCT00789477|515385917|FG002|Overall Study|Lack of Efficacy|0|||
142958499|NCT00789477|515385918|FG003|Overall Study|Lack of Efficacy|0|||
142958500|NCT00789477|515385919|FG004|Overall Study|Lack of Efficacy|0|||
142958501|NCT00789477|515385915|FG000|Overall Study|Other|2|||
142958502|NCT00789477|515385916|FG001|Overall Study|Other|0|||
142958503|NCT00789477|515385917|FG002|Overall Study|Other|1|||
142958504|NCT00789477|515385918|FG003|Overall Study|Other|3|||
142958505|NCT00789477|515385919|FG004|Overall Study|Other|0|||
142958506|NCT01242020|515385920|FG000|Overall Study|Withdrawal by Subject|2|||
142958507|NCT01242020|515385921|FG001|Overall Study|Withdrawal by Subject|0|||
142958508|NCT01242020|515385920|FG000|Overall Study|Failed screening|1|||
142958509|NCT01242020|515385921|FG001|Overall Study|Failed screening|0|||
142958510|NCT01844700|515385922|FG000|Overall Study|Lack of Efficacy|1|||
142958511|NCT01844700|515385923|FG001|Overall Study|Lack of Efficacy|0|||
142958512|NCT01844700|515385922|FG000|Overall Study|refused medication switch|1|||
142958513|NCT01844700|515385923|FG001|Overall Study|refused medication switch|0|||
142958514|NCT01844700|515385922|FG000|Overall Study|Withdrawal by Subject|1|||
142958515|NCT01844700|515385923|FG001|Overall Study|Withdrawal by Subject|0|||
142958516|NCT01844700|515385922|FG000|Overall Study|stopped taking meds|0|||
142958517|NCT01844700|515385923|FG001|Overall Study|stopped taking meds|1|||
142958518|NCT02680847|515385924|FG000|Overall Study|Other|2|||
142958519|NCT02680847|515385925|FG001|Overall Study|Other|0|||
142958520|NCT02680847|515385926|FG002|Overall Study|Other|0|||
142958521|NCT02680847|515385924|FG000|Overall Study|No longer met eligibility criteria|2|||
142958522|NCT02680847|515385925|FG001|Overall Study|No longer met eligibility criteria|2|||
142958523|NCT02680847|515385926|FG002|Overall Study|No longer met eligibility criteria|0|||
142958524|NCT02680847|515385924|FG000|Overall Study|Unwilling to participate in study|1|||
142958525|NCT02680847|515385925|FG001|Overall Study|Unwilling to participate in study|1|||
142958526|NCT02680847|515385926|FG002|Overall Study|Unwilling to participate in study|0|||
142958527|NCT02680847|515385924|FG000|Overall Study|Lack of Efficacy|0|||
142958528|NCT02680847|515385925|FG001|Overall Study|Lack of Efficacy|0|||
142958529|NCT02680847|515385926|FG002|Overall Study|Lack of Efficacy|2|||
142958530|NCT02680847|515385924|FG000|Overall Study|Adverse Event|0|||
142958531|NCT02680847|515385925|FG001|Overall Study|Adverse Event|0|||
142958532|NCT02680847|515385926|FG002|Overall Study|Adverse Event|1|||
142958533|NCT00772967|515385927|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
142958534|NCT00772967|515385928|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
142958535|NCT00772967|515385929|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
142958536|NCT00772967|515385930|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
142958537|NCT00772967|515385931|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
142958538|NCT00772967|515385932|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
142958539|NCT00772967|515385927|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
142958540|NCT00772967|515385928|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
142958541|NCT00772967|515385929|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
142958542|NCT00772967|515385930|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
142958543|NCT00772967|515385931|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
142958544|NCT00772967|515385932|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
142958545|NCT00772967|515385927|FG000|Crossover Treatment 3|Adverse Event|0|||
142958546|NCT00772967|515385928|FG001|Crossover Treatment 3|Adverse Event|0|||
142958547|NCT00772967|515385929|FG002|Crossover Treatment 3|Adverse Event|0|||
142958548|NCT00772967|515385930|FG003|Crossover Treatment 3|Adverse Event|0|||
142958549|NCT00772967|515385931|FG004|Crossover Treatment 3|Adverse Event|1|||
142958550|NCT00772967|515385932|FG005|Crossover Treatment 3|Adverse Event|0|||
142958551|NCT01595646|515385933|FG000|Overall Study|Withdrawal by Subject|1|||
142958552|NCT01595646|515385934|FG001|Overall Study|Withdrawal by Subject|0|||
142958553|NCT01595646|515385935|FG002|Overall Study|Withdrawal by Subject|0|||
142958554|NCT04172831|515385937|FG000|Overall Study|Adverse Event|21|||
142958555|NCT04172831|515385938|FG001|Overall Study|Adverse Event|9|||
142958556|NCT04172831|515385937|FG000|Overall Study|Lack of Efficacy|2|||
142958557|NCT04172831|515385938|FG001|Overall Study|Lack of Efficacy|8|||
142958558|NCT04172831|515385937|FG000|Overall Study|Physician Decision|0|||
142958559|NCT04172831|515385938|FG001|Overall Study|Physician Decision|1|||
142958560|NCT04172831|515385937|FG000|Overall Study|Withdrawal by Subject|12|||
142958561|NCT04172831|515385938|FG001|Overall Study|Withdrawal by Subject|11|||
142958562|NCT04172831|515385937|FG000|Overall Study|Lost to Follow-up|4|||
142958563|NCT04172831|515385938|FG001|Overall Study|Lost to Follow-up|9|||
142958564|NCT04172831|515385937|FG000|Overall Study|COVID-19 related crisis|3|||
142958565|NCT04172831|515385938|FG001|Overall Study|COVID-19 related crisis|3|||
142958566|NCT04172831|515385937|FG000|Overall Study|Subject non-compliance|1|||
142958567|NCT04172831|515385938|FG001|Overall Study|Subject non-compliance|1|||
142958568|NCT04172831|515385937|FG000|Overall Study|Family emergency|1|||
142958569|NCT04172831|515385938|FG001|Overall Study|Family emergency|0|||
142958570|NCT01276847|515385941|FG000|Overall Study|Withdrawal by Subject|1|||
142958571|NCT01276847|515385942|FG001|Overall Study|Withdrawal by Subject|0|||
142958572|NCT01276847|515385943|FG002|Overall Study|Withdrawal by Subject|0|||
142958573|NCT00231062|515385944|FG000|Overall Study|Physician Decision|6|||
142958574|NCT02021812|515385950|FG000|Overall Study|Death|8|||
142958575|NCT02021812|515385950|FG000|Overall Study|Withdrawal by Subject|3|||
142958576|NCT02021812|515385950|FG000|Overall Study|Lost to Follow-up|2|||
142958577|NCT02021812|515385950|FG000|Overall Study|Refuse to return, COVD 19|2|||
142958578|NCT00564629|515385951|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
142958579|NCT00564629|515385952|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
142958580|NCT01651260|515385956|FG000|Overall Study|unable to apply product|3|||
142958581|NCT02239094|515385959|FG000|Overall Study|Withdrawal by Subject|1|||
142958582|NCT02239094|515385959|FG000|Overall Study|Remitted before started|1|||
142958583|NCT03184701|515385960|FG000|Overall Study|Death|3|||
142958584|NCT03184701|515385960|FG000|Overall Study|Physician Decision|3|||
142958585|NCT03184701|515385960|FG000|Overall Study|Withdrawal by Subject|6|||
142958586|NCT03184701|515385960|FG000|Overall Study|Lost to Follow-up|5|||
142958587|NCT03648996|515385961|FG000|Overall Study|Withdrawal by Subject|0|||
142958588|NCT03648996|515385962|FG001|Overall Study|Withdrawal by Subject|2|||
142958589|NCT03648996|515385963|FG002|Overall Study|Withdrawal by Subject|2|||
142958590|NCT03648996|515385961|FG000|Overall Study|Physician Decision|2|||
142958591|NCT03648996|515385962|FG001|Overall Study|Physician Decision|0|||
142958592|NCT03648996|515385963|FG002|Overall Study|Physician Decision|0|||
142958593|NCT00590681|515385968|FG000|Overall Study|Withdrawal by Subject|7|||
142958594|NCT00590681|515385968|FG000|Overall Study|Adverse Event|8|||
142958595|NCT00590681|515385968|FG000|Overall Study|Death|3|||
142958596|NCT00590681|515385968|FG000|Overall Study|Lost to Follow-up|1|||
142958597|NCT00590681|515385968|FG000|Overall Study|disease progression|1|||
142958598|NCT01259297|515385969|FG000|Double Blind Randomized Period|Death|1|||
142958599|NCT01259297|515385970|FG001|Double Blind Randomized Period|Death|1|||
142958600|NCT01259297|515385971|FG002|Double Blind Randomized Period|Death|1|||
142958601|NCT01259297|515385972|FG003|Double Blind Randomized Period|Death|2|||
142958602|NCT01259297|515385973|FG004|Double Blind Randomized Period|Death|1|||
142958603|NCT01259297|515385974|FG005|Double Blind Randomized Period|Death|5|||
142958604|NCT01259297|515385975|FG006|Double Blind Randomized Period|Death|2|||
142958605|NCT01259297|515385976|FG007|Double Blind Randomized Period|Death|1|||
142958606|NCT01259297|515385969|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
142958607|NCT01259297|515385970|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
142958608|NCT01259297|515385971|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
142958609|NCT01259297|515385972|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
142958610|NCT01259297|515385973|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
142958611|NCT01259297|515385974|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
142958612|NCT01259297|515385975|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
142958613|NCT01259297|515385976|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
142958614|NCT01259297|515385969|FG000|Double Blind Randomized Period|Other reasons|0|||
142958615|NCT01259297|515385970|FG001|Double Blind Randomized Period|Other reasons|1|||
142958616|NCT01259297|515385971|FG002|Double Blind Randomized Period|Other reasons|0|||
142958617|NCT01259297|515385972|FG003|Double Blind Randomized Period|Other reasons|0|||
142958618|NCT01259297|515385973|FG004|Double Blind Randomized Period|Other reasons|1|||
142958619|NCT01259297|515385974|FG005|Double Blind Randomized Period|Other reasons|2|||
142958620|NCT01259297|515385975|FG006|Double Blind Randomized Period|Other reasons|3|||
142958621|NCT01259297|515385976|FG007|Double Blind Randomized Period|Other reasons|1|||
142958622|NCT00443430|515385979|FG000|Overall Study|Lack of Efficacy|3|||
142958623|NCT00443430|515385980|FG001|Overall Study|Lack of Efficacy|3|||
142958624|NCT00443430|515385979|FG000|Overall Study|Adverse Event|1|||
142958625|NCT00443430|515385980|FG001|Overall Study|Adverse Event|1|||
142958626|NCT00592501|515385981|FG000|Overall Study|Withdrawal by Subject|1|||
142958627|NCT00592501|515385981|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
143117492|NCT01472939|515971861|FG000|Overall Study|Protocol Violation|3|||
142958628|NCT00053846|515385982|FG000|Overall Study|Changed mind|8|||
142958629|NCT00053846|515385983|FG001|Overall Study|Changed mind|13|||
142958630|NCT00053846|515385982|FG000|Overall Study|Became too ill|8|||
142958631|NCT00053846|515385983|FG001|Overall Study|Became too ill|7|||
142958632|NCT00053846|515385982|FG000|Overall Study|Expired|5|||
142958633|NCT00053846|515385983|FG001|Overall Study|Expired|0|||
142958634|NCT00053846|515385982|FG000|Overall Study|Became ineligible|3|||
142958635|NCT00053846|515385983|FG001|Overall Study|Became ineligible|1|||
142958636|NCT00053846|515385982|FG000|Overall Study|Did not return data|1|||
142958637|NCT00053846|515385983|FG001|Overall Study|Did not return data|2|||
142958638|NCT00053846|515385982|FG000|Overall Study|Quit due to side effects|1|||
142958639|NCT00053846|515385983|FG001|Overall Study|Quit due to side effects|3|||
142958640|NCT00053846|515385982|FG000|Overall Study|Pills too large|0|||
142958641|NCT00053846|515385983|FG001|Overall Study|Pills too large|1|||
142958642|NCT00064662|515385985|FG000|Overall Study|Death|1|||
142958643|NCT00064662|515385986|FG001|Overall Study|Death|1|||
142958644|NCT00064662|515385985|FG000|Overall Study|Lost to Follow-up|57|||
142958645|NCT00064662|515385986|FG001|Overall Study|Lost to Follow-up|44|||
142958646|NCT00064662|515385985|FG000|Overall Study|Withdrawal by Subject|14|||
142958647|NCT00064662|515385986|FG001|Overall Study|Withdrawal by Subject|14|||
142958648|NCT00064662|515385985|FG000|Overall Study|Administratively withdrawn|2|||
142958649|NCT00064662|515385986|FG001|Overall Study|Administratively withdrawn|2|||
142958650|NCT03880227|515385991|FG000|First Visit|Withdrawal by Subject|1|||
142958651|NCT03880227|515385992|FG001|First Visit|Withdrawal by Subject|0|||
142958652|NCT03880227|515385993|FG002|First Visit|Withdrawal by Subject|0|||
142958653|NCT03880227|515385994|FG003|First Visit|Withdrawal by Subject|0|||
142958654|NCT03880227|515385991|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
142958655|NCT03880227|515385992|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
142958656|NCT03880227|515385993|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
142958657|NCT03880227|515385994|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
142958658|NCT03880227|515385991|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
142958659|NCT03880227|515385992|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
142958660|NCT03880227|515385993|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
142958661|NCT03880227|515385994|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
142958662|NCT03880227|515385991|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
142958663|NCT03880227|515385992|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
142958664|NCT03880227|515385993|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
142958665|NCT03880227|515385994|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
142958666|NCT00504166|515385995|FG000|Overall Study|Adverse Event|1|||
142958667|NCT00504166|515385996|FG001|Overall Study|Adverse Event|4|||
142958668|NCT00504166|515385995|FG000|Overall Study|Withdrawal by Subject|3|||
142958669|NCT00504166|515385996|FG001|Overall Study|Withdrawal by Subject|6|||
142958670|NCT00504166|515385995|FG000|Overall Study|Physician Decision|1|||
142958671|NCT00504166|515385996|FG001|Overall Study|Physician Decision|1|||
142958672|NCT00504166|515385995|FG000|Overall Study|Lost to Follow-up|1|||
142958673|NCT00504166|515385996|FG001|Overall Study|Lost to Follow-up|3|||
142958674|NCT02229864|515385997|FG000|Overall Study|Death|2|||
142958675|NCT02229864|515385997|FG000|Overall Study|Lost to Follow-up|1|||
142958676|NCT01345786|515386002|FG000|Overall Study|Adverse Event|0|||
142958677|NCT01345786|515386003|FG001|Overall Study|Adverse Event|1|||
142958678|NCT01345786|515386004|FG002|Overall Study|Adverse Event|3|||
142958679|NCT01345786|515386005|FG003|Overall Study|Adverse Event|1|||
142958680|NCT01345786|515386002|FG000|Overall Study|Subject withdrew consent|2|||
142958681|NCT01345786|515386003|FG001|Overall Study|Subject withdrew consent|2|||
142958682|NCT01345786|515386004|FG002|Overall Study|Subject withdrew consent|1|||
142958683|NCT01345786|515386005|FG003|Overall Study|Subject withdrew consent|0|||
142958684|NCT01345786|515386002|FG000|Overall Study|Noncompliance with protocol|1|||
142958685|NCT01345786|515386003|FG001|Overall Study|Noncompliance with protocol|0|||
142958686|NCT01345786|515386004|FG002|Overall Study|Noncompliance with protocol|1|||
142958687|NCT01345786|515386005|FG003|Overall Study|Noncompliance with protocol|0|||
142958688|NCT01345786|515386002|FG000|Overall Study|Administrative|3|||
142958689|NCT01345786|515386003|FG001|Overall Study|Administrative|5|||
142958690|NCT01345786|515386004|FG002|Overall Study|Administrative|0|||
142958691|NCT01345786|515386005|FG003|Overall Study|Administrative|0|||
142958692|NCT01345786|515386002|FG000|Overall Study|Lost to Follow-up|0|||
142958693|NCT01345786|515386003|FG001|Overall Study|Lost to Follow-up|0|||
142958694|NCT01345786|515386004|FG002|Overall Study|Lost to Follow-up|0|||
142958695|NCT01345786|515386005|FG003|Overall Study|Lost to Follow-up|2|||
142958696|NCT04083222|515386008|FG000|Overall Study|Voluntary Withdrawal|0|||
142958697|NCT04083222|515386009|FG001|Overall Study|Voluntary Withdrawal|1|||
142958698|NCT04083222|515386008|FG000|Overall Study|Reason not Specified|0|||
142958699|NCT04083222|515386009|FG001|Overall Study|Reason not Specified|1|||
143455324|NCT03541174|517212429|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
143455325|NCT03541174|517212430|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
142958700|NCT03607682|515386010|FG000|Overall Study|Withdrawal by Subject|1|||
142958701|NCT03607682|515386010|FG000|Overall Study|Disease progression|1|||
142958702|NCT00376688|515386011|FG000|Overall Study|Adverse Event|3|||
142958703|NCT00376688|515386011|FG000|Overall Study|Death|1|||
142958704|NCT01770353|515386012|FG000|Overall Study|Progressive disease|2|||
142958705|NCT01770353|515386013|FG001|Overall Study|Progressive disease|1|||
142958706|NCT01770353|515386012|FG000|Overall Study|Adverse Event|0|||
142958707|NCT01770353|515386013|FG001|Overall Study|Adverse Event|1|||
142958708|NCT01770353|515386012|FG000|Overall Study|Protocol Violation|1|||
142958709|NCT01770353|515386013|FG001|Overall Study|Protocol Violation|0|||
143455326|NCT03541174|517212431|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
142958710|NCT01770353|515386012|FG000|Overall Study|Physician Decision|0|||
142958711|NCT01770353|515386013|FG001|Overall Study|Physician Decision|3|||
142958712|NCT01770353|515386012|FG000|Overall Study|Clinical deterioration|3|||
142958713|NCT01770353|515386013|FG001|Overall Study|Clinical deterioration|6|||
142958714|NCT01770353|515386012|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
142958715|NCT01770353|515386013|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
142958716|NCT02574312|515386014|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
142958717|NCT02574312|515386015|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
142958718|NCT00523341|515388007|FG000|Overall Study|Withdrawal by Subject|399|||
142958719|NCT00523341|515388008|FG001|Overall Study|Withdrawal by Subject|427|||
142958720|NCT00523341|515388007|FG000|Overall Study|Other|181|||
142958721|NCT00523341|515388008|FG001|Overall Study|Other|198|||
142958722|NCT00523341|515388007|FG000|Overall Study|Adverse Event|122|||
142958723|NCT00523341|515388008|FG001|Overall Study|Adverse Event|155|||
142958724|NCT00523341|515388007|FG000|Overall Study|Death|101|||
142958725|NCT00523341|515388008|FG001|Overall Study|Death|110|||
142958726|NCT00523341|515388007|FG000|Overall Study|Lost to Follow-up|73|||
142958727|NCT00523341|515388008|FG001|Overall Study|Lost to Follow-up|61|||
142958728|NCT00523341|515388007|FG000|Overall Study|Non-compliance|20|||
142958729|NCT00523341|515388008|FG001|Overall Study|Non-compliance|13|||
142958730|NCT00523341|515388007|FG000|Overall Study|Physician Decision|14|||
142958731|NCT00523341|515388008|FG001|Overall Study|Physician Decision|13|||
142958732|NCT00523341|515388007|FG000|Overall Study|Requirement for Alternative Therapy|4|||
142958733|NCT00523341|515388008|FG001|Overall Study|Requirement for Alternative Therapy|14|||
142958734|NCT00523341|515388007|FG000|Overall Study|Protocol Deviation|6|||
142958735|NCT00523341|515388008|FG001|Overall Study|Protocol Deviation|5|||
142958736|NCT00523341|515388007|FG000|Overall Study|Ineligibility Determined|3|||
142958737|NCT00523341|515388008|FG001|Overall Study|Ineligibility Determined|4|||
142958738|NCT00523341|515388007|FG000|Overall Study|Disease Progression|1|||
142958739|NCT00523341|515388008|FG001|Overall Study|Disease Progression|0|||
142958740|NCT00912015|515388009|FG000|Overall Study|Lack of Efficacy|1|||
142958741|NCT00912015|515388010|FG001|Overall Study|Lack of Efficacy|0|||
142958742|NCT00912015|515388011|FG002|Overall Study|Lack of Efficacy|0|||
142958743|NCT00912015|515388012|FG003|Overall Study|Lack of Efficacy|0|||
142958744|NCT00912015|515388009|FG000|Overall Study|Withdrawal by Subject|8|||
142958745|NCT00912015|515388010|FG001|Overall Study|Withdrawal by Subject|8|||
142958746|NCT00912015|515388011|FG002|Overall Study|Withdrawal by Subject|3|||
142958747|NCT00912015|515388012|FG003|Overall Study|Withdrawal by Subject|0|||
142958748|NCT00912015|515388009|FG000|Overall Study|Protocol Violation|1|||
142958749|NCT00912015|515388010|FG001|Overall Study|Protocol Violation|0|||
142958750|NCT00912015|515388011|FG002|Overall Study|Protocol Violation|0|||
142958751|NCT00912015|515388012|FG003|Overall Study|Protocol Violation|1|||
142958752|NCT00912015|515388009|FG000|Overall Study|Adverse Event|6|||
142958753|NCT00912015|515388010|FG001|Overall Study|Adverse Event|0|||
142958754|NCT00912015|515388011|FG002|Overall Study|Adverse Event|0|||
142958755|NCT00912015|515388012|FG003|Overall Study|Adverse Event|1|||
142958756|NCT02090114|515388013|FG000|Overall Study|Withdrawal by Subject|3|||
142958757|NCT02090114|515388014|FG001|Overall Study|Withdrawal by Subject|6|||
142958758|NCT02090114|515388015|FG002|Overall Study|Withdrawal by Subject|2|||
142958759|NCT02090114|515388016|FG003|Overall Study|Withdrawal by Subject|1|||
142958760|NCT02090114|515388013|FG000|Overall Study|Physician Decision|5|||
142958761|NCT02090114|515388014|FG001|Overall Study|Physician Decision|0|||
142958762|NCT02090114|515388015|FG002|Overall Study|Physician Decision|1|||
142958763|NCT02090114|515388016|FG003|Overall Study|Physician Decision|1|||
142958764|NCT02090114|515388013|FG000|Overall Study|Adverse Event|1|||
142958765|NCT02090114|515388014|FG001|Overall Study|Adverse Event|2|||
142958766|NCT02090114|515388015|FG002|Overall Study|Adverse Event|2|||
142958767|NCT02090114|515388016|FG003|Overall Study|Adverse Event|0|||
142958768|NCT02090114|515388013|FG000|Overall Study|Progressive Disease|20|||
142958769|NCT02090114|515388014|FG001|Overall Study|Progressive Disease|21|||
142958770|NCT02090114|515388015|FG002|Overall Study|Progressive Disease|23|||
142958771|NCT02090114|515388016|FG003|Overall Study|Progressive Disease|6|||
142958772|NCT02090114|515388013|FG000|Overall Study|Death|1|||
142958773|NCT02090114|515388014|FG001|Overall Study|Death|0|||
142958774|NCT02090114|515388015|FG002|Overall Study|Death|1|||
142958775|NCT02090114|515388016|FG003|Overall Study|Death|0|||
142958776|NCT01931462|515388017|FG000|Overall Study|Withdrawal by Subject|1|||
142958777|NCT01793051|515388022|FG000|Overall Study|Withdrawal by Subject|6|||
142958778|NCT01793051|515388023|FG001|Overall Study|Withdrawal by Subject|4|||
142958779|NCT01793051|515388022|FG000|Overall Study|Adverse Event|0|||
142958780|NCT01793051|515388023|FG001|Overall Study|Adverse Event|2|||
142958781|NCT01793051|515388022|FG000|Overall Study|Too ill to continue|1|||
142958782|NCT01793051|515388023|FG001|Overall Study|Too ill to continue|0|||
142958783|NCT01793051|515388022|FG000|Overall Study|Switched chemo|1|||
142958784|NCT01793051|515388023|FG001|Overall Study|Switched chemo|1|||
142958785|NCT01793051|515388022|FG000|Overall Study|Lack of compliance|1|||
142958786|NCT01793051|515388023|FG001|Overall Study|Lack of compliance|0|||
142958787|NCT01793051|515388022|FG000|Overall Study|Requested to be removed from the study|1|||
142958788|NCT01793051|515388023|FG001|Overall Study|Requested to be removed from the study|1|||
142958789|NCT00059215|515388025|FG000|Overall Study|Adverse Event|5|||
142958790|NCT00059215|515388026|FG001|Overall Study|Adverse Event|5|||
142958791|NCT00059215|515388027|FG002|Overall Study|Adverse Event|9|||
142958792|NCT00059215|515388028|FG003|Overall Study|Adverse Event|9|||
142958793|NCT00059215|515388025|FG000|Overall Study|Death|0|||
142958794|NCT00059215|515388026|FG001|Overall Study|Death|0|||
142958795|NCT00059215|515388027|FG002|Overall Study|Death|3|||
142958796|NCT00059215|515388028|FG003|Overall Study|Death|0|||
142958797|NCT00059215|515388025|FG000|Overall Study|Lost to Follow-up|1|||
142958798|NCT00059215|515388026|FG001|Overall Study|Lost to Follow-up|2|||
142958799|NCT00059215|515388027|FG002|Overall Study|Lost to Follow-up|0|||
142958800|NCT00059215|515388028|FG003|Overall Study|Lost to Follow-up|0|||
142958801|NCT00059215|515388025|FG000|Overall Study|Withdrawal by Subject|4|||
142958802|NCT00059215|515388026|FG001|Overall Study|Withdrawal by Subject|4|||
142958803|NCT00059215|515388027|FG002|Overall Study|Withdrawal by Subject|1|||
142958804|NCT00059215|515388028|FG003|Overall Study|Withdrawal by Subject|3|||
142958805|NCT00059215|515388025|FG000|Overall Study|Protocol Violation|1|||
142958806|NCT00059215|515388026|FG001|Overall Study|Protocol Violation|0|||
142958807|NCT00059215|515388027|FG002|Overall Study|Protocol Violation|1|||
142958808|NCT00059215|515388028|FG003|Overall Study|Protocol Violation|0|||
142958809|NCT00059215|515388025|FG000|Overall Study|Protocol entry criteria not met|1|||
142958810|NCT00059215|515388026|FG001|Overall Study|Protocol entry criteria not met|1|||
142958811|NCT00059215|515388027|FG002|Overall Study|Protocol entry criteria not met|0|||
142958812|NCT00059215|515388028|FG003|Overall Study|Protocol entry criteria not met|2|||
142958813|NCT00059215|515388025|FG000|Overall Study|Physician Decision|1|||
142958814|NCT00059215|515388026|FG001|Overall Study|Physician Decision|2|||
142958815|NCT00059215|515388027|FG002|Overall Study|Physician Decision|1|||
142958816|NCT00059215|515388028|FG003|Overall Study|Physician Decision|1|||
142958817|NCT04907539|515388031|FG000|Overall Study|Consent withdrawn|1|||
142958818|NCT04907539|515388032|FG001|Overall Study|Consent withdrawn|0|||
142958819|NCT04907539|515388031|FG000|Overall Study|Death|14|||
142958820|NCT04907539|515388032|FG001|Overall Study|Death|3|||
142958821|NCT00414310|515388034|FG000|Overall Study|Not treated|1|||
142958822|NCT00414310|515388035|FG001|Overall Study|Not treated|0|||
142958823|NCT02948777|515388039|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
142958824|NCT03242928|515388040|FG000|Overall Study|Adverse Event|2|||
142958825|NCT03242928|515388041|FG001|Overall Study|Adverse Event|1|||
142958826|NCT03242928|515388040|FG000|Overall Study|Lost to Follow-up|2|||
142958827|NCT03242928|515388041|FG001|Overall Study|Lost to Follow-up|0|||
142958828|NCT03242928|515388040|FG000|Overall Study|Physician Decision|0|||
142958829|NCT03242928|515388041|FG001|Overall Study|Physician Decision|1|||
142958830|NCT03242928|515388040|FG000|Overall Study|Withdrawal by Subject|5|||
142958831|NCT03242928|515388041|FG001|Overall Study|Withdrawal by Subject|3|||
142958832|NCT03276936|515388042|FG000|Overall Study|Adverse Event|4|||
142958833|NCT03276936|515388043|FG001|Overall Study|Adverse Event|2|||
142958834|NCT03276936|515388042|FG000|Overall Study|Lost to Follow-up|16|||
142958835|NCT03276936|515388043|FG001|Overall Study|Lost to Follow-up|13|||
142958836|NCT03276936|515388042|FG000|Overall Study|Withdrawal by Subject|30|||
142958837|NCT03276936|515388043|FG001|Overall Study|Withdrawal by Subject|20|||
142958838|NCT03276936|515388042|FG000|Overall Study|Not mentioned|6|||
142958839|NCT03276936|515388043|FG001|Overall Study|Not mentioned|3|||
142958840|NCT02043301|515388044|FG000|Overall Study|Discontinued|0|||
142958841|NCT02043301|515388045|FG001|Overall Study|Discontinued|1|||
142958842|NCT02043301|515388046|FG002|Overall Study|Discontinued|0|||
142958843|NCT03097328|515388047|FG000|Overall Study|Still on Therapy|2|||
142958844|NCT03097328|515388047|FG000|Overall Study|Progressive Disease|29|||
142958845|NCT03097328|515388047|FG000|Overall Study|Adverse Event|4|||
142958846|NCT03097328|515388047|FG000|Overall Study|Withdrawal by Subject|1|||
142958847|NCT03097328|515388047|FG000|Overall Study|Physician Decision|1|||
142958848|NCT03097328|515388047|FG000|Overall Study|Patient Decision|1|||
142958849|NCT03097328|515388047|FG000|Overall Study|Ineligible for Study Drug|1|||
142958850|NCT02653976|515388048|FG000|Overall Study|Withdrawal by Subject|5|||
142958851|NCT02653976|515388048|FG000|Overall Study|Death|4|||
142958852|NCT02023164|515388049|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
142958853|NCT02023164|515388050|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
142958854|NCT02436577|515388051|FG000|Overall Study|Protocol Deviation|0|||
142958855|NCT02436577|515388052|FG001|Overall Study|Protocol Deviation|1|||
142958856|NCT02436577|515388053|FG002|Overall Study|Protocol Deviation|0|||
142958857|NCT02436577|515388054|FG003|Overall Study|Protocol Deviation|0|||
142958858|NCT02436577|515388055|FG004|Overall Study|Protocol Deviation|0|||
142958859|NCT02436577|515388056|FG005|Overall Study|Protocol Deviation|0|||
142958860|NCT00615290|515388057|FG000|Overall Study|Adverse Event|2|||
142958861|NCT00615290|515388057|FG000|Overall Study|Lost to Follow-up|3|||
142958862|NCT00615290|515388057|FG000|Overall Study|Withdrawal by Subject|1|||
142958863|NCT00615290|515388057|FG000|Overall Study|Other|2|||
142958864|NCT03650452|515388058|FG000|Overall Study|Physician Decision|1|||
142958865|NCT03650452|515388059|FG001|Overall Study|Physician Decision|0|||
142958866|NCT03650452|515388058|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
142958867|NCT03650452|515388059|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
142958868|NCT03650452|515388058|FG000|Overall Study|Adverse Event|3|||
142958869|NCT03650452|515388059|FG001|Overall Study|Adverse Event|4|||
142958870|NCT03650452|515388058|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
142958871|NCT03650452|515388059|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
142958872|NCT02531373|515388062|FG000|Overall Study|Lack of Efficacy|0|||
142958873|NCT02531373|515388063|FG001|Overall Study|Lack of Efficacy|0|||
142958874|NCT02531373|515388064|FG002|Overall Study|Lack of Efficacy|0|||
142958875|NCT02531373|515388065|FG003|Overall Study|Lack of Efficacy|0|||
142958876|NCT02531373|515388066|FG004|Overall Study|Lack of Efficacy|3|||
142958877|NCT02531373|515388067|FG005|Overall Study|Lack of Efficacy|2|||
142958878|NCT02531373|515388068|FG006|Overall Study|Lack of Efficacy|4|||
142958879|NCT02531373|515388069|FG007|Overall Study|Lack of Efficacy|8|||
142958880|NCT02531373|515388070|FG008|Overall Study|Lack of Efficacy|5|||
142958881|NCT02531373|515388062|FG000|Overall Study|Lost to Follow-up|0|||
142958882|NCT02531373|515388063|FG001|Overall Study|Lost to Follow-up|0|||
142958883|NCT02531373|515388064|FG002|Overall Study|Lost to Follow-up|0|||
142958884|NCT02531373|515388065|FG003|Overall Study|Lost to Follow-up|0|||
142958885|NCT02531373|515388066|FG004|Overall Study|Lost to Follow-up|0|||
142958886|NCT02531373|515388067|FG005|Overall Study|Lost to Follow-up|2|||
142958887|NCT02531373|515388068|FG006|Overall Study|Lost to Follow-up|2|||
142958888|NCT02531373|515388069|FG007|Overall Study|Lost to Follow-up|0|||
142958889|NCT02531373|515388070|FG008|Overall Study|Lost to Follow-up|0|||
142958890|NCT02531373|515388062|FG000|Overall Study|Physician Decision|0|||
142958891|NCT02531373|515388063|FG001|Overall Study|Physician Decision|0|||
142958892|NCT02531373|515388064|FG002|Overall Study|Physician Decision|0|||
142958893|NCT02531373|515388065|FG003|Overall Study|Physician Decision|0|||
142958894|NCT02531373|515388066|FG004|Overall Study|Physician Decision|2|||
142958895|NCT02531373|515388067|FG005|Overall Study|Physician Decision|1|||
142958896|NCT02531373|515388068|FG006|Overall Study|Physician Decision|0|||
142958897|NCT02531373|515388069|FG007|Overall Study|Physician Decision|0|||
142958898|NCT02531373|515388070|FG008|Overall Study|Physician Decision|0|||
142958899|NCT02531373|515388062|FG000|Overall Study|Protocol Violation|0|||
142958900|NCT02531373|515388063|FG001|Overall Study|Protocol Violation|0|||
142958901|NCT02531373|515388064|FG002|Overall Study|Protocol Violation|0|||
142958902|NCT02531373|515388065|FG003|Overall Study|Protocol Violation|0|||
142958903|NCT02531373|515388066|FG004|Overall Study|Protocol Violation|0|||
142958904|NCT02531373|515388067|FG005|Overall Study|Protocol Violation|1|||
142958905|NCT02531373|515388068|FG006|Overall Study|Protocol Violation|1|||
142958906|NCT02531373|515388069|FG007|Overall Study|Protocol Violation|0|||
142958907|NCT02531373|515388070|FG008|Overall Study|Protocol Violation|1|||
142958908|NCT02531373|515388062|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
142958909|NCT02531373|515388063|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
142958910|NCT02531373|515388064|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
142958911|NCT02531373|515388065|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
142958912|NCT02531373|515388066|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
142958913|NCT02531373|515388067|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
142958914|NCT02531373|515388068|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
142958915|NCT02531373|515388069|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
142958916|NCT02531373|515388070|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
142958917|NCT02531373|515388062|FG000|Overall Study|Withdrawal by Subject|0|||
142958918|NCT02531373|515388063|FG001|Overall Study|Withdrawal by Subject|0|||
142958919|NCT02531373|515388064|FG002|Overall Study|Withdrawal by Subject|0|||
142958920|NCT02531373|515388065|FG003|Overall Study|Withdrawal by Subject|0|||
142958921|NCT02531373|515388066|FG004|Overall Study|Withdrawal by Subject|3|||
142958922|NCT02531373|515388067|FG005|Overall Study|Withdrawal by Subject|0|||
142958923|NCT02531373|515388068|FG006|Overall Study|Withdrawal by Subject|0|||
142958924|NCT02531373|515388069|FG007|Overall Study|Withdrawal by Subject|0|||
142958925|NCT02531373|515388070|FG008|Overall Study|Withdrawal by Subject|0|||
142958926|NCT00623467|515388071|FG000|Overall Study|Lost to Follow-up|1|||
142958927|NCT00623467|515388071|FG000|Overall Study|Protocol Violation|4|||
142958928|NCT00623467|515388071|FG000|Overall Study|Withdrawal by Subject|2|||
142958929|NCT02795988|515388080|FG000|Phase 1b|Withdrawal by Subject|0|||
142958930|NCT02795988|515388081|FG001|Phase 1b|Withdrawal by Subject|1|||
142958931|NCT02795988|515388082|FG002|Phase 1b|Withdrawal by Subject|0|||
142958932|NCT02795988|515388083|FG003|Phase 1b|Withdrawal by Subject|0|||
142958933|NCT02795988|515388084|FG004|Phase 1b|Withdrawal by Subject|0|||
142958934|NCT02795988|515388085|FG005|Phase 1b|Withdrawal by Subject|0|||
142958935|NCT02795988|515388086|FG006|Phase 1b|Withdrawal by Subject|0|||
142958936|NCT02795988|515388080|FG000|Phase 1b|Death|1|||
142958937|NCT02795988|515388081|FG001|Phase 1b|Death|2|||
142958938|NCT02795988|515388082|FG002|Phase 1b|Death|1|||
142958939|NCT02795988|515388083|FG003|Phase 1b|Death|0|||
142958940|NCT02795988|515388084|FG004|Phase 1b|Death|0|||
142958941|NCT02795988|515388085|FG005|Phase 1b|Death|0|||
142958942|NCT02795988|515388086|FG006|Phase 1b|Death|0|||
142958943|NCT02795988|515388080|FG000|Phase 1b|Physician Decision|0|||
142958944|NCT02795988|515388081|FG001|Phase 1b|Physician Decision|0|||
142958945|NCT02795988|515388082|FG002|Phase 1b|Physician Decision|1|||
142958946|NCT02795988|515388083|FG003|Phase 1b|Physician Decision|0|||
142958947|NCT02795988|515388084|FG004|Phase 1b|Physician Decision|0|||
142958948|NCT02795988|515388085|FG005|Phase 1b|Physician Decision|0|||
142958949|NCT02795988|515388086|FG006|Phase 1b|Physician Decision|0|||
142958950|NCT02795988|515388080|FG000|Phase 1b|Progressive Disease|2|||
142958951|NCT02795988|515388081|FG001|Phase 1b|Progressive Disease|2|||
142958952|NCT02795988|515388082|FG002|Phase 1b|Progressive Disease|0|||
142958953|NCT02795988|515388083|FG003|Phase 1b|Progressive Disease|0|||
142958954|NCT02795988|515388084|FG004|Phase 1b|Progressive Disease|0|||
142958955|NCT02795988|515388085|FG005|Phase 1b|Progressive Disease|0|||
142958956|NCT02795988|515388086|FG006|Phase 1b|Progressive Disease|0|||
142958957|NCT02795988|515388080|FG000|Phase 2|Withdrawal by Subject|0|||
142958958|NCT02795988|515388081|FG001|Phase 2|Withdrawal by Subject|0|||
142958959|NCT02795988|515388082|FG002|Phase 2|Withdrawal by Subject|0|||
142958960|NCT02795988|515388083|FG003|Phase 2|Withdrawal by Subject|1|||
142958961|NCT02795988|515388084|FG004|Phase 2|Withdrawal by Subject|0|||
142958962|NCT02795988|515388085|FG005|Phase 2|Withdrawal by Subject|0|||
142958963|NCT02795988|515388086|FG006|Phase 2|Withdrawal by Subject|0|||
142958964|NCT02795988|515388080|FG000|Phase 2|Death|0|||
142958965|NCT02795988|515388081|FG001|Phase 2|Death|0|||
142958966|NCT02795988|515388082|FG002|Phase 2|Death|0|||
142958967|NCT02795988|515388083|FG003|Phase 2|Death|17|||
142958968|NCT02795988|515388084|FG004|Phase 2|Death|17|||
142958969|NCT02795988|515388085|FG005|Phase 2|Death|0|||
142958970|NCT02795988|515388086|FG006|Phase 2|Death|0|||
142958971|NCT02795988|515388080|FG000|Phase 2|Other|0|||
142958972|NCT02795988|515388081|FG001|Phase 2|Other|0|||
142958973|NCT02795988|515388082|FG002|Phase 2|Other|0|||
142958974|NCT02795988|515388083|FG003|Phase 2|Other|1|||
142958975|NCT02795988|515388084|FG004|Phase 2|Other|0|||
142958976|NCT02795988|515388085|FG005|Phase 2|Other|0|||
142958977|NCT02795988|515388086|FG006|Phase 2|Other|0|||
142958978|NCT02795988|515388080|FG000|Phase 2 Extension|Death|0|||
142958979|NCT02795988|515388081|FG001|Phase 2 Extension|Death|0|||
142958980|NCT02795988|515388082|FG002|Phase 2 Extension|Death|0|||
142958981|NCT02795988|515388083|FG003|Phase 2 Extension|Death|0|||
142958982|NCT02795988|515388084|FG004|Phase 2 Extension|Death|0|||
142958983|NCT02795988|515388085|FG005|Phase 2 Extension|Death|5|||
142958984|NCT02795988|515388086|FG006|Phase 2 Extension|Death|6|||
142958985|NCT02795988|515388080|FG000|Phase 2 Extension|Other reasons|0|||
142958986|NCT02795988|515388081|FG001|Phase 2 Extension|Other reasons|0|||
142958987|NCT02795988|515388082|FG002|Phase 2 Extension|Other reasons|0|||
142958988|NCT02795988|515388083|FG003|Phase 2 Extension|Other reasons|0|||
142958989|NCT02795988|515388084|FG004|Phase 2 Extension|Other reasons|0|||
142958990|NCT02795988|515388085|FG005|Phase 2 Extension|Other reasons|2|||
142958991|NCT02795988|515388086|FG006|Phase 2 Extension|Other reasons|1|||
142958992|NCT02834403|515388087|FG000|Overall Study|Physician Decision|2|||
142958993|NCT02834403|515388088|FG001|Overall Study|Physician Decision|1|||
142958994|NCT02834403|515388089|FG002|Overall Study|Physician Decision|2|||
142958995|NCT02834403|515388090|FG003|Overall Study|Physician Decision|1|||
142958996|NCT02834403|515388091|FG004|Overall Study|Physician Decision|1|||
142958997|NCT02834403|515388092|FG005|Overall Study|Physician Decision|2|||
143455327|NCT03541174|517212432|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
143455328|NCT03541174|517212427|FG000|Part 1 Double-Blind|Other reasons|3|||
143455329|NCT03541174|517212428|FG001|Part 1 Double-Blind|Other reasons|2|||
143455330|NCT03541174|517212429|FG002|Part 1 Double-Blind|Other reasons|3|||
143455331|NCT03541174|517212430|FG003|Part 1 Double-Blind|Other reasons|0|||
143455332|NCT03541174|517212431|FG004|Part 1 Double-Blind|Other reasons|0|||
142958998|NCT02834403|515388093|FG006|Overall Study|Physician Decision|12|||
142958999|NCT02834403|515388087|FG000|Overall Study|Adverse Event|0|||
142959000|NCT02834403|515388088|FG001|Overall Study|Adverse Event|0|||
142959001|NCT02834403|515388089|FG002|Overall Study|Adverse Event|0|||
142959002|NCT02834403|515388090|FG003|Overall Study|Adverse Event|0|||
142959003|NCT02834403|515388091|FG004|Overall Study|Adverse Event|1|||
142959004|NCT02834403|515388092|FG005|Overall Study|Adverse Event|1|||
142959005|NCT02834403|515388093|FG006|Overall Study|Adverse Event|3|||
142959006|NCT02834403|515388087|FG000|Overall Study|Withdrawal by Subject|0|||
142959007|NCT02834403|515388088|FG001|Overall Study|Withdrawal by Subject|1|||
142959008|NCT02834403|515388089|FG002|Overall Study|Withdrawal by Subject|0|||
142959009|NCT02834403|515388090|FG003|Overall Study|Withdrawal by Subject|0|||
142959010|NCT02834403|515388091|FG004|Overall Study|Withdrawal by Subject|1|||
142959011|NCT02834403|515388092|FG005|Overall Study|Withdrawal by Subject|0|||
142959012|NCT02834403|515388093|FG006|Overall Study|Withdrawal by Subject|0|||
143455333|NCT03541174|517212432|FG005|Part 1 Double-Blind|Other reasons|0|||
143455334|NCT03541174|517212427|FG000|Part 2 Single-Blind|Adverse Event|0|||
143455335|NCT03541174|517212428|FG001|Part 2 Single-Blind|Adverse Event|0|||
142959013|NCT02834403|515388087|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
142959014|NCT02834403|515388088|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
142959015|NCT02834403|515388089|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
142959016|NCT02834403|515388090|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
142959017|NCT02834403|515388091|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
142959018|NCT02834403|515388092|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
142959019|NCT02834403|515388093|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
142959020|NCT05058664|515388103|FG000|Overall Study|No follow-up data provided|4|||
142959021|NCT05058664|515388104|FG001|Overall Study|No follow-up data provided|0|||
142959022|NCT05058664|515388105|FG002|Overall Study|No follow-up data provided|2|||
142959023|NCT05058664|515388103|FG000|Overall Study|Withdrawal by Subject|0|||
142959024|NCT05058664|515388104|FG001|Overall Study|Withdrawal by Subject|0|||
142959025|NCT05058664|515388105|FG002|Overall Study|Withdrawal by Subject|1|||
142959026|NCT01258348|515388106|FG000|Overall Study|Adverse Event|1|||
142959027|NCT01258348|515388107|FG001|Overall Study|Adverse Event|1|||
142959028|NCT01258348|515388108|FG002|Overall Study|Adverse Event|3|||
142959029|NCT01258348|515388109|FG003|Overall Study|Adverse Event|2|||
142959030|NCT01258348|515388110|FG004|Overall Study|Adverse Event|4|||
142959031|NCT01258348|515388106|FG000|Overall Study|Progressive Disease|0|||
142959032|NCT01258348|515388107|FG001|Overall Study|Progressive Disease|3|||
142959033|NCT01258348|515388108|FG002|Overall Study|Progressive Disease|0|||
142959034|NCT01258348|515388109|FG003|Overall Study|Progressive Disease|2|||
142959035|NCT01258348|515388110|FG004|Overall Study|Progressive Disease|2|||
142959036|NCT01258348|515388106|FG000|Overall Study|Physician Decision|0|||
142959037|NCT01258348|515388107|FG001|Overall Study|Physician Decision|0|||
142959038|NCT01258348|515388108|FG002|Overall Study|Physician Decision|0|||
142959039|NCT01258348|515388109|FG003|Overall Study|Physician Decision|2|||
142959040|NCT01258348|515388110|FG004|Overall Study|Physician Decision|0|||
142959041|NCT01258348|515388106|FG000|Overall Study|Withdrawal by Subject|0|||
142959042|NCT01258348|515388107|FG001|Overall Study|Withdrawal by Subject|1|||
142959043|NCT01258348|515388108|FG002|Overall Study|Withdrawal by Subject|0|||
142959044|NCT01258348|515388109|FG003|Overall Study|Withdrawal by Subject|0|||
142959045|NCT01258348|515388110|FG004|Overall Study|Withdrawal by Subject|0|||
142959046|NCT01234402|515388114|FG000|Overall Study|Lost to Follow-up|0|||
142959047|NCT01234402|515388115|FG001|Overall Study|Lost to Follow-up|1|||
142959048|NCT01234402|515388116|FG002|Overall Study|Lost to Follow-up|3|||
142959049|NCT01234402|515388114|FG000|Overall Study|Withdrawal by Subject|1|||
142959050|NCT01234402|515388115|FG001|Overall Study|Withdrawal by Subject|3|||
142959051|NCT01234402|515388116|FG002|Overall Study|Withdrawal by Subject|4|||
142959052|NCT01234402|515388114|FG000|Overall Study|Never treated: Death|0|||
142959053|NCT01234402|515388115|FG001|Overall Study|Never treated: Death|0|||
142959054|NCT01234402|515388116|FG002|Overall Study|Never treated: Death|1|||
142959055|NCT01234402|515388114|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
142959056|NCT01234402|515388115|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
142959057|NCT01234402|515388116|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
142959058|NCT01234402|515388114|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
142959059|NCT01234402|515388115|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
142959060|NCT01234402|515388116|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
142959061|NCT01702363|515388117|FG000|Overall Study|Adverse Event|14|||
142959062|NCT01702363|515388117|FG000|Overall Study|Lack of Efficacy|4|||
142959063|NCT01702363|515388117|FG000|Overall Study|Withdrawal by Subject|2|||
142959064|NCT02985450|515388125|FG000|Overall Study|Lost to Follow-up|7|||
142959065|NCT00431847|515388126|FG000|Overall Study|completion of less than two study visits|6|||
142959066|NCT00431847|515388127|FG001|Overall Study|completion of less than two study visits|3|||
142959067|NCT00431847|515388128|FG002|Overall Study|completion of less than two study visits|4|||
142959068|NCT00431847|515388129|FG003|Overall Study|completion of less than two study visits|14|||
142959069|NCT00431847|515388130|FG004|Overall Study|completion of less than two study visits|0|||
142959070|NCT00431847|515388126|FG000|Overall Study|Protocol Violation|0|||
142959071|NCT00431847|515388127|FG001|Overall Study|Protocol Violation|0|||
142959072|NCT00431847|515388128|FG002|Overall Study|Protocol Violation|0|||
142959073|NCT00431847|515388129|FG003|Overall Study|Protocol Violation|0|||
142959074|NCT00431847|515388130|FG004|Overall Study|Protocol Violation|1|||
142959075|NCT02142894|515388133|FG000|Overall Study|Protocol Violation|8|||
142959076|NCT02890329|515388139|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
142959077|NCT02890329|515388140|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
142959078|NCT02890329|515388141|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
142959079|NCT02890329|515388142|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
143455336|NCT03541174|517212429|FG002|Part 2 Single-Blind|Adverse Event|0|||
142959080|NCT02890329|515388143|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
142959081|NCT02890329|515388144|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
142959082|NCT02890329|515388139|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
142959083|NCT02890329|515388140|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
142959084|NCT02890329|515388141|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
142959085|NCT02890329|515388142|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
142959086|NCT02890329|515388143|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
142959087|NCT02890329|515388144|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
142959088|NCT02890329|515388139|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
142959089|NCT02890329|515388140|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
143003120|NCT01049360|515548752|FG008|Period 2|Protocol Violation|0|||
142959090|NCT02890329|515388141|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
142959091|NCT02890329|515388142|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
142959092|NCT02890329|515388143|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
142959093|NCT02890329|515388144|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
142959094|NCT02890329|515388139|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
142959095|NCT02890329|515388140|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
142959096|NCT02890329|515388141|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
142959097|NCT02890329|515388142|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
142959098|NCT02890329|515388143|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
142959099|NCT02890329|515388144|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
142959100|NCT02691247|515388148|FG000|Overall Study|Withdrawal by Subject|1|||
142959101|NCT02691247|515388149|FG001|Overall Study|Withdrawal by Subject|2|||
142959102|NCT02691247|515388150|FG002|Overall Study|Withdrawal by Subject|2|||
142959103|NCT02691247|515388148|FG000|Overall Study|Lost to Follow-up|2|||
142959104|NCT02691247|515388149|FG001|Overall Study|Lost to Follow-up|0|||
142959105|NCT02691247|515388150|FG002|Overall Study|Lost to Follow-up|1|||
142959106|NCT02552355|515388151|FG000|Overall Study|Adverse Event|0|||
142959107|NCT02552355|515388152|FG001|Overall Study|Adverse Event|2|||
142959108|NCT02552355|515388153|FG002|Overall Study|Adverse Event|2|||
142959109|NCT02552355|515388154|FG003|Overall Study|Adverse Event|0|||
142959110|NCT02552355|515388151|FG000|Overall Study|Withdrawal by Subject|0|||
142959111|NCT02552355|515388152|FG001|Overall Study|Withdrawal by Subject|0|||
142959112|NCT02552355|515388153|FG002|Overall Study|Withdrawal by Subject|0|||
142959113|NCT02552355|515388154|FG003|Overall Study|Withdrawal by Subject|1|||
142959114|NCT01519245|515388155|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
142959115|NCT01519245|515388156|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
142959116|NCT00803244|515388159|FG000|Overall Study|Adverse Event|1|||
142959117|NCT00803244|515388160|FG001|Overall Study|Adverse Event|2|||
142959118|NCT00803244|515388159|FG000|Overall Study|Withdrawal by Subject|2|||
142959119|NCT00803244|515388160|FG001|Overall Study|Withdrawal by Subject|3|||
142959120|NCT00803244|515388159|FG000|Overall Study|Any other reason not above-mentioned|4|||
142959121|NCT00803244|515388160|FG001|Overall Study|Any other reason not above-mentioned|10|||
142959122|NCT03321929|515388162|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
142959123|NCT01052012|515388163|FG000|Overall Study|Not treated|2|||
142959124|NCT01052012|515388164|FG001|Overall Study|Not treated|5|||
142959125|NCT01052012|515388165|FG002|Overall Study|Not treated|0|||
142959126|NCT01052012|515388166|FG003|Overall Study|Not treated|0|||
142959127|NCT01052012|515388167|FG004|Overall Study|Not treated|11|||
142959128|NCT01052012|515388168|FG005|Overall Study|Not treated|8|||
142959129|NCT01052012|515388163|FG000|Overall Study|Adverse Event|1|||
142959130|NCT01052012|515388164|FG001|Overall Study|Adverse Event|0|||
142959131|NCT01052012|515388165|FG002|Overall Study|Adverse Event|0|||
142959132|NCT01052012|515388166|FG003|Overall Study|Adverse Event|1|||
142959133|NCT01052012|515388167|FG004|Overall Study|Adverse Event|0|||
142959134|NCT01052012|515388168|FG005|Overall Study|Adverse Event|0|||
142959135|NCT01052012|515388163|FG000|Overall Study|Lost to Follow-up|0|||
142959136|NCT01052012|515388164|FG001|Overall Study|Lost to Follow-up|0|||
142959137|NCT01052012|515388165|FG002|Overall Study|Lost to Follow-up|0|||
142959138|NCT01052012|515388166|FG003|Overall Study|Lost to Follow-up|0|||
142959139|NCT01052012|515388167|FG004|Overall Study|Lost to Follow-up|1|||
142959140|NCT01052012|515388168|FG005|Overall Study|Lost to Follow-up|0|||
142959141|NCT01052012|515388163|FG000|Overall Study|Withdrawal by Subject|1|||
142959142|NCT01052012|515388164|FG001|Overall Study|Withdrawal by Subject|1|||
142959143|NCT01052012|515388165|FG002|Overall Study|Withdrawal by Subject|0|||
142959144|NCT01052012|515388166|FG003|Overall Study|Withdrawal by Subject|0|||
142959145|NCT01052012|515388167|FG004|Overall Study|Withdrawal by Subject|3|||
142959146|NCT01052012|515388168|FG005|Overall Study|Withdrawal by Subject|1|||
142959147|NCT01052012|515388163|FG000|Overall Study|Physician Decision|0|||
142959148|NCT01052012|515388164|FG001|Overall Study|Physician Decision|0|||
142959149|NCT01052012|515388165|FG002|Overall Study|Physician Decision|0|||
142959150|NCT01052012|515388166|FG003|Overall Study|Physician Decision|0|||
142959151|NCT01052012|515388167|FG004|Overall Study|Physician Decision|0|||
142959152|NCT01052012|515388168|FG005|Overall Study|Physician Decision|1|||
142959153|NCT01052012|515388163|FG000|Overall Study|Other|0|||
142959154|NCT01052012|515388164|FG001|Overall Study|Other|0|||
142959155|NCT01052012|515388165|FG002|Overall Study|Other|0|||
142959156|NCT01052012|515388166|FG003|Overall Study|Other|0|||
142959157|NCT01052012|515388167|FG004|Overall Study|Other|1|||
142959158|NCT01052012|515388168|FG005|Overall Study|Other|0|||
142959159|NCT02873715|515388169|FG000|Overall Study|Lost to Follow-up|84|||
142959160|NCT02873715|515388170|FG001|Overall Study|Lost to Follow-up|94|||
142959161|NCT02873715|515388169|FG000|Overall Study|Withdrawal by Subject|7|||
142959162|NCT02873715|515388170|FG001|Overall Study|Withdrawal by Subject|26|||
142959163|NCT01096550|515388171|FG000|Overall Study|discontinued site|10|||
142959164|NCT01096550|515388172|FG001|Overall Study|discontinued site|11|||
142959165|NCT01096550|515388171|FG000|Overall Study|non-regular treatment track at clinic|1|||
143003121|NCT01049360|515548753|FG009|Period 2|Protocol Violation|0|||
142959166|NCT01096550|515388172|FG001|Overall Study|non-regular treatment track at clinic|1|||
142959167|NCT01096550|515388171|FG000|Overall Study|clinic readmission|1|||
142959168|NCT01096550|515388172|FG001|Overall Study|clinic readmission|1|||
142959169|NCT01096550|515388171|FG000|Overall Study|Withdrawal by Subject|0|||
142959170|NCT01096550|515388172|FG001|Overall Study|Withdrawal by Subject|1|||
142959171|NCT01096550|515388171|FG000|Overall Study|non-African American participant|13|||
142959172|NCT01096550|515388172|FG001|Overall Study|non-African American participant|6|||
142959173|NCT01096550|515388171|FG000|Overall Study|Lost to Follow-up|12|||
142959174|NCT01096550|515388172|FG001|Overall Study|Lost to Follow-up|9|||
142959175|NCT01070784|515388176|FG000|Overall Study|Withdrawal by Subject|6|||
142959176|NCT01070784|515388177|FG001|Overall Study|Withdrawal by Subject|9|||
142959177|NCT01070784|515388176|FG000|Overall Study|Adverse Event|14|||
142959178|NCT01070784|515388177|FG001|Overall Study|Adverse Event|9|||
142959179|NCT01780389|515388179|FG000|Overall Study|Adverse Event|1|||
142959180|NCT02815397|515388182|FG000|Overall Study|Physician Decision|2|||
142959181|NCT00085540|515388183|FG000|Overall Study|Withdrawal by Subject|0|||
142959182|NCT00085540|515388184|FG001|Overall Study|Withdrawal by Subject|1|||
142959183|NCT00085540|515388183|FG000|Overall Study|Protocol Violation|0|||
142959184|NCT00085540|515388184|FG001|Overall Study|Protocol Violation|1|||
142959185|NCT01518192|515388185|FG000|Overall Study|Lost to Follow-up|29|||
142959186|NCT01518192|515388186|FG001|Overall Study|Lost to Follow-up|26|||
142959187|NCT01518192|515388187|FG002|Overall Study|Lost to Follow-up|35|||
142959188|NCT04598165|515388188|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
142959189|NCT04598165|515388189|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
142959190|NCT04598165|515388188|FG000|Completed 6-week Follow-up|Death|2|||
142959191|NCT04598165|515388189|FG001|Completed 6-week Follow-up|Death|1|||
142959192|NCT04598165|515388188|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
142959193|NCT04598165|515388189|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
142959194|NCT04598165|515388188|FG000|Completed 6-week Follow-up|Ineligible|4|||
142959195|NCT04598165|515388189|FG001|Completed 6-week Follow-up|Ineligible|3|||
142959196|NCT04598165|515388188|FG000|Completed 6-week Follow-up|Partner refusal|0|||
142959197|NCT04598165|515388189|FG001|Completed 6-week Follow-up|Partner refusal|1|||
142959198|NCT04598165|515388188|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
142959199|NCT04598165|515388189|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
142959200|NCT01323673|515388190|FG000|Overall Study|Adverse Event|0|||
142959201|NCT01323673|515388191|FG001|Overall Study|Adverse Event|1|||
142959202|NCT01323673|515388190|FG000|Overall Study|Lost to Follow-up|0|||
142959203|NCT01323673|515388191|FG001|Overall Study|Lost to Follow-up|1|||
142959204|NCT01323673|515388190|FG000|Overall Study|Protocol Violation|1|||
142959205|NCT01323673|515388191|FG001|Overall Study|Protocol Violation|0|||
142959206|NCT01323673|515388190|FG000|Overall Study|Withdrawal by Subject|2|||
142959207|NCT01323673|515388191|FG001|Overall Study|Withdrawal by Subject|3|||
142959208|NCT00783705|515388193|FG000|Overall Study|Adverse Event|2|||
142959209|NCT00783705|515388194|FG001|Overall Study|Adverse Event|0|||
142959210|NCT00783705|515388193|FG000|Overall Study|Withdrawal by Subject|3|||
142959211|NCT00783705|515388194|FG001|Overall Study|Withdrawal by Subject|2|||
142959212|NCT00783705|515388193|FG000|Overall Study|Lost to Follow-up|1|||
142959213|NCT00783705|515388194|FG001|Overall Study|Lost to Follow-up|3|||
142959214|NCT03844633|515388195|FG000|1 Week FU|Lost to Follow-up|0|||
142959215|NCT03844633|515388196|FG001|1 Week FU|Lost to Follow-up|1|||
142959216|NCT03844633|515388197|FG002|1 Week FU|Lost to Follow-up|4|||
142959217|NCT03844633|515388195|FG000|12-month Follow-up|Lost to Follow-up|7|||
142959218|NCT03844633|515388196|FG001|12-month Follow-up|Lost to Follow-up|5|||
142959219|NCT03844633|515388197|FG002|12-month Follow-up|Lost to Follow-up|8|||
142959220|NCT01200511|515388200|FG000|Overall Study|Lost to Follow-up|3|||
142959221|NCT01200511|515388200|FG000|Overall Study|Withdrawal by Subject|1|||
142959222|NCT01200511|515388200|FG000|Overall Study|Adverse Event|1|||
142959223|NCT04229446|515388203|FG000|Overall Study|Death|12|||
142959224|NCT04229446|515388204|FG001|Overall Study|Death|10|||
142959225|NCT04229446|515388203|FG000|Overall Study|Lost to Follow-up|5|||
142959226|NCT04229446|515388204|FG001|Overall Study|Lost to Follow-up|8|||
142959227|NCT00705224|515388205|FG000|Overall Study|Adverse Event|1|||
142959228|NCT00705224|515388205|FG000|Overall Study|Lack of Efficacy|2|||
142959229|NCT00705224|515388205|FG000|Overall Study|Withdrawal by Subject|3|||
142959230|NCT00705224|515388205|FG000|Overall Study|Lost to Follow-up|5|||
142959231|NCT00337467|515388206|FG000|Overall Study|Adverse Event|3|||
142959232|NCT00337467|515388206|FG000|Overall Study|Subject Withdrew Consent|2|||
142959233|NCT00337467|515388206|FG000|Overall Study|Pregnancy|1|||
142959234|NCT00337467|515388206|FG000|Overall Study|Lost to Follow-up|2|||
142959235|NCT00337467|515388206|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
142959236|NCT03625986|515390320|FG000|Randomization Period|Lost to Follow-up|7|||
142959237|NCT03625986|515390321|FG001|Randomization Period|Lost to Follow-up|12|||
142959238|NCT03625986|515390320|FG000|Randomization Period|Withdrawal by Subject|10|||
142959239|NCT03625986|515390321|FG001|Randomization Period|Withdrawal by Subject|6|||
143455337|NCT03541174|517212430|FG003|Part 2 Single-Blind|Adverse Event|25|||
143455338|NCT03541174|517212431|FG004|Part 2 Single-Blind|Adverse Event|0|||
142959240|NCT02410902|515390326|FG000|Overall Study|Adverse Event|2|||
142959241|NCT02410902|515390327|FG001|Overall Study|Adverse Event|3|||
142959242|NCT02410902|515390326|FG000|Overall Study|Lost to Follow-up|4|||
142959243|NCT02410902|515390327|FG001|Overall Study|Lost to Follow-up|1|||
142959244|NCT02410902|515390326|FG000|Overall Study|Protocol Violation|1|||
142959245|NCT02410902|515390327|FG001|Overall Study|Protocol Violation|4|||
142959246|NCT02410902|515390326|FG000|Overall Study|Withdrawal by Subject|6|||
142959247|NCT02410902|515390327|FG001|Overall Study|Withdrawal by Subject|8|||
142959248|NCT02410902|515390326|FG000|Overall Study|Non-Compliance|8|||
142959249|NCT02410902|515390327|FG001|Overall Study|Non-Compliance|2|||
142959250|NCT00747617|515390328|FG000|Overall Study|Lost to Follow-up|3|||
142959251|NCT00747617|515390329|FG001|Overall Study|Lost to Follow-up|1|||
142959252|NCT01746732|515390330|FG000|Lead-In Period|Withdrawal by Subject|1|||
142959253|NCT01746732|515390331|FG001|Lead-In Period|Withdrawal by Subject|0|||
142959254|NCT01746732|515390332|FG002|Lead-In Period|Withdrawal by Subject|0|||
142959255|NCT01746732|515390330|FG000|Period 1|Physician Decision|0|||
142959256|NCT01746732|515390331|FG001|Period 1|Physician Decision|1|||
142959257|NCT01746732|515390332|FG002|Period 1|Physician Decision|0|||
142959258|NCT01746732|515390330|FG000|Period 2|Withdrawal by Subject|0|||
142959259|NCT01746732|515390331|FG001|Period 2|Withdrawal by Subject|0|||
142959260|NCT01746732|515390332|FG002|Period 2|Withdrawal by Subject|2|||
142959261|NCT01746732|515390330|FG000|Period 2|Adverse Event|0|||
142959262|NCT01746732|515390331|FG001|Period 2|Adverse Event|0|||
142959263|NCT01746732|515390332|FG002|Period 2|Adverse Event|1|||
142959264|NCT01746732|515390330|FG000|Period 2|Lost to Follow-up|0|||
142959265|NCT01746732|515390331|FG001|Period 2|Lost to Follow-up|0|||
142959266|NCT01746732|515390332|FG002|Period 2|Lost to Follow-up|1|||
142959267|NCT02279524|515390333|FG000|Overall Study|Withdrawal by Subject|3|||
142959268|NCT02279524|515390334|FG001|Overall Study|Withdrawal by Subject|6|||
142959269|NCT02279524|515390335|FG002|Overall Study|Withdrawal by Subject|3|||
142959270|NCT02279524|515390333|FG000|Overall Study|Adverse Event|4|||
142959271|NCT02279524|515390334|FG001|Overall Study|Adverse Event|3|||
142959272|NCT02279524|515390335|FG002|Overall Study|Adverse Event|2|||
142959273|NCT02279524|515390333|FG000|Overall Study|Lost to Follow-up|1|||
142959274|NCT02279524|515390334|FG001|Overall Study|Lost to Follow-up|1|||
142959275|NCT02279524|515390335|FG002|Overall Study|Lost to Follow-up|0|||
142959276|NCT02279524|515390333|FG000|Overall Study|Disallowed medication|1|||
142959277|NCT02279524|515390334|FG001|Overall Study|Disallowed medication|1|||
142959278|NCT02279524|515390335|FG002|Overall Study|Disallowed medication|2|||
142959279|NCT02279524|515390333|FG000|Overall Study|Bariatric surgery|1|||
142959280|NCT02279524|515390334|FG001|Overall Study|Bariatric surgery|0|||
142959281|NCT02279524|515390335|FG002|Overall Study|Bariatric surgery|0|||
142959282|NCT03509207|515390336|FG000|Overall Study|Death|2|||
142959283|NCT01043185|515390337|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
142959284|NCT01043185|515390338|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
142959285|NCT01043185|515390339|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
142959286|NCT01043185|515390340|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
142959287|NCT01043185|515390341|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
142959288|NCT01043185|515390342|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
142959289|NCT01043185|515390343|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
142959290|NCT01043185|515390344|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
142959291|NCT01043185|515390345|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
142959292|NCT01043185|515390346|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
142959293|NCT02817555|515390347|FG000|Overall Study|Death|1|||
142959294|NCT02817555|515390348|FG001|Overall Study|Death|3|||
142959295|NCT02817555|515390347|FG000|Overall Study|moved away|1|||
142959296|NCT02817555|515390348|FG001|Overall Study|moved away|0|||
142959297|NCT02817555|515390347|FG000|Overall Study|transplant|1|||
142959298|NCT02817555|515390348|FG001|Overall Study|transplant|1|||
142959299|NCT02817555|515390347|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
142959300|NCT02817555|515390348|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
142959301|NCT00137436|515390349|FG000|Overall Study|Adverse Event|13|||
142959302|NCT00137436|515390349|FG000|Overall Study|Death|2|||
142959303|NCT00137436|515390349|FG000|Overall Study|Lack of Efficacy|17|||
142959304|NCT00137436|515390349|FG000|Overall Study|Withdrawal by Subject|6|||
142959305|NCT00137436|515390349|FG000|Overall Study|Other|5|||
142959306|NCT01432262|515390350|FG000|Overall Study|Withdrawal by Subject|2|||
142959307|NCT01432262|515390351|FG001|Overall Study|Withdrawal by Subject|1|||
142959308|NCT00165646|515390352|FG000|Overall Study|Adverse Event|1|||
142959309|NCT00165646|515390353|FG001|Overall Study|Adverse Event|1|||
142959310|NCT00165646|515390354|FG002|Overall Study|Adverse Event|1|||
142959311|NCT00165646|515390352|FG000|Overall Study|Lack of Efficacy|1|||
142959312|NCT00165646|515390353|FG001|Overall Study|Lack of Efficacy|2|||
142959313|NCT00165646|515390354|FG002|Overall Study|Lack of Efficacy|0|||
142959314|NCT00165646|515390352|FG000|Overall Study|Withdrawal by Subject|0|||
142959315|NCT00165646|515390353|FG001|Overall Study|Withdrawal by Subject|2|||
142959316|NCT00165646|515390354|FG002|Overall Study|Withdrawal by Subject|1|||
142959317|NCT00165646|515390352|FG000|Overall Study|Physician Decision|2|||
142959318|NCT00165646|515390353|FG001|Overall Study|Physician Decision|0|||
142959319|NCT00165646|515390354|FG002|Overall Study|Physician Decision|2|||
142959320|NCT00165646|515390352|FG000|Overall Study|Protocol Violation|1|||
142959321|NCT00165646|515390353|FG001|Overall Study|Protocol Violation|0|||
142959322|NCT00165646|515390354|FG002|Overall Study|Protocol Violation|0|||
142959323|NCT04657016|515390355|FG000|Overall Study|Adverse Event|2|||
142959324|NCT04657016|515390356|FG001|Overall Study|Adverse Event|4|||
142959325|NCT04657016|515390355|FG000|Overall Study|Death|1|||
142959326|NCT04657016|515390356|FG001|Overall Study|Death|1|||
142959327|NCT04657016|515390355|FG000|Overall Study|Lost to Follow-up|24|||
142959328|NCT04657016|515390356|FG001|Overall Study|Lost to Follow-up|12|||
142959329|NCT04657016|515390355|FG000|Overall Study|Physician Decision|1|||
142959330|NCT04657016|515390356|FG001|Overall Study|Physician Decision|2|||
142959331|NCT04657016|515390355|FG000|Overall Study|Pregnancy|2|||
142959332|NCT04657016|515390356|FG001|Overall Study|Pregnancy|2|||
142959333|NCT04657016|515390355|FG000|Overall Study|Protocol Deviation|1|||
142959334|NCT04657016|515390356|FG001|Overall Study|Protocol Deviation|0|||
142959335|NCT04657016|515390355|FG000|Overall Study|Withdrawal by Subject|28|||
142959336|NCT04657016|515390356|FG001|Overall Study|Withdrawal by Subject|14|||
142959337|NCT04657016|515390355|FG000|Overall Study|Other - as reported by the investigator|6|||
142959338|NCT04657016|515390356|FG001|Overall Study|Other - as reported by the investigator|0|||
142959339|NCT00701727|515390357|FG000|First Treatment Period|Adverse Event|0|||
142959340|NCT00701727|515390358|FG001|First Treatment Period|Adverse Event|0|||
142959341|NCT00701727|515390357|FG000|First Treatment Period|Withdrawal by Subject|1|||
142959342|NCT00701727|515390358|FG001|First Treatment Period|Withdrawal by Subject|0|||
142959343|NCT00701727|515390357|FG000|First Treatment Period|sponsor decision|0|||
142959344|NCT00701727|515390358|FG001|First Treatment Period|sponsor decision|1|||
142959345|NCT00701727|515390357|FG000|First Treatment Period|Lost to Follow-up|0|||
142959346|NCT00701727|515390358|FG001|First Treatment Period|Lost to Follow-up|1|||
142959347|NCT00701727|515390357|FG000|Second Treatment Period|Withdrawal by Subject|2|||
142959348|NCT00701727|515390358|FG001|Second Treatment Period|Withdrawal by Subject|0|||
142959349|NCT01104558|515390361|FG000|Overall Study|Protocol Violation|6|||
142959350|NCT01104558|515390361|FG000|Overall Study|Missing of primary efficacy assessment|10|||
142959351|NCT01104558|515390361|FG000|Overall Study|Missing of genetic analysis results|1|||
142959352|NCT01755195|515390365|FG000|Overall Study|Participant noncompliance|2|||
142959353|NCT01755195|515390365|FG000|Overall Study|Switched to alternative treatment|4|||
142959354|NCT01755195|515390365|FG000|Overall Study|Withdrawal by Subject|1|||
142959355|NCT01755195|515390365|FG000|Overall Study|Participant refused to start treatment|1|||
142959356|NCT01755195|515390365|FG000|Overall Study|Participant has been consented for another trial|1|||
142959357|NCT01755195|515390365|FG000|Overall Study|Refused further treatment|3|||
142959358|NCT01755195|515390365|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
142959359|NCT05137041|515390368|FG000|Overall Study|Lost to Follow-up|1|||
142959360|NCT05137041|515390369|FG001|Overall Study|Lost to Follow-up|1|||
142959361|NCT05137041|515390368|FG000|Overall Study|Withdrawal by Subject|0|||
142959362|NCT05137041|515390369|FG001|Overall Study|Withdrawal by Subject|2|||
142959363|NCT05137041|515390368|FG000|Overall Study|Reason not Specified|0|||
142959364|NCT05137041|515390369|FG001|Overall Study|Reason not Specified|1|||
142959365|NCT01356602|515390370|FG000|Overall Study|Protocol Deviation|0|||
142959366|NCT01356602|515390371|FG001|Overall Study|Protocol Deviation|1|||
142959367|NCT01356602|515390372|FG002|Overall Study|Protocol Deviation|1|||
142959368|NCT01356602|515390370|FG000|Overall Study|Administrative Problems|1|||
142959369|NCT01356602|515390371|FG001|Overall Study|Administrative Problems|4|||
142959370|NCT01356602|515390372|FG002|Overall Study|Administrative Problems|5|||
142959371|NCT01356602|515390370|FG000|Overall Study|Lost to Follow-up|4|||
142959372|NCT01356602|515390371|FG001|Overall Study|Lost to Follow-up|5|||
142959373|NCT01356602|515390372|FG002|Overall Study|Lost to Follow-up|6|||
142959374|NCT01356602|515390370|FG000|Overall Study|Withdrawal by Subject|4|||
142959375|NCT01356602|515390371|FG001|Overall Study|Withdrawal by Subject|3|||
142959376|NCT01356602|515390372|FG002|Overall Study|Withdrawal by Subject|7|||
142959377|NCT01356602|515390370|FG000|Overall Study|Lack of Efficacy|0|||
142959378|NCT01356602|515390371|FG001|Overall Study|Lack of Efficacy|1|||
142959379|NCT01356602|515390372|FG002|Overall Study|Lack of Efficacy|4|||
142959380|NCT01356602|515390370|FG000|Overall Study|Adverse Event|0|||
142959381|NCT01356602|515390371|FG001|Overall Study|Adverse Event|1|||
142959382|NCT01356602|515390372|FG002|Overall Study|Adverse Event|1|||
142959383|NCT00392171|515390373|FG000|Overall Study|Did not meet inclusion criteria|4|||
142959384|NCT00392171|515390373|FG000|Overall Study|Disease progression|101|||
142959385|NCT01605071|515390374|FG000|Overall Study|Withdrawal by Subject|3|||
142959386|NCT01605071|515390375|FG001|Overall Study|Withdrawal by Subject|2|||
142959387|NCT03470922|515390377|FG000|Overall Study|Death|107|||
142959388|NCT03470922|515390378|FG001|Overall Study|Death|118|||
142959389|NCT03470922|515390377|FG000|Overall Study|Lost to Follow-up|5|||
142959390|NCT03470922|515390378|FG001|Overall Study|Lost to Follow-up|5|||
142959391|NCT03470922|515390377|FG000|Overall Study|Participant Withdrew Consent|4|||
142959392|NCT03470922|515390378|FG001|Overall Study|Participant Withdrew Consent|9|||
142959393|NCT03470922|515390377|FG000|Overall Study|Other reasons|1|||
142959394|NCT03470922|515390378|FG001|Overall Study|Other reasons|0|||
142959395|NCT03470922|515390377|FG000|Overall Study|Not reported|1|||
142959396|NCT03470922|515390378|FG001|Overall Study|Not reported|0|||
142959397|NCT02819310|515390379|FG000|Overall Study|Withdrawal by Subject|37|||
142959398|NCT02819310|515390379|FG000|Overall Study|Lost to Follow-up|16|||
142959399|NCT02819310|515390379|FG000|Overall Study|Adverse Event|13|||
142959400|NCT02819310|515390379|FG000|Overall Study|Lack of Efficacy|5|||
142959401|NCT02819310|515390379|FG000|Overall Study|Physician Decision|8|||
142959402|NCT02819310|515390379|FG000|Overall Study|Protocol Violation|30|||
142959403|NCT01993329|515390382|FG000|Period 2|Adverse Event|0|||
142959404|NCT01993329|515390383|FG001|Period 2|Adverse Event|0|||
142959405|NCT01993329|515390384|FG002|Period 2|Adverse Event|0|||
142959406|NCT01993329|515390385|FG003|Period 2|Adverse Event|0|||
142959407|NCT01993329|515390386|FG004|Period 2|Adverse Event|0|||
142959408|NCT01993329|515390387|FG005|Period 2|Adverse Event|1|||
142959409|NCT01993329|515390382|FG000|Wash-out|Personal reasons|0|||
142959410|NCT01993329|515390383|FG001|Wash-out|Personal reasons|1|||
142959411|NCT01993329|515390384|FG002|Wash-out|Personal reasons|0|||
142959412|NCT01993329|515390385|FG003|Wash-out|Personal reasons|0|||
142959413|NCT01993329|515390386|FG004|Wash-out|Personal reasons|0|||
142959414|NCT01993329|515390387|FG005|Wash-out|Personal reasons|0|||
142959415|NCT02311478|515390388|FG000|Overall Study|Withdrawal by Subject|1|||
142959416|NCT02311478|515390388|FG000|Overall Study|Lost to Follow-up|5|||
142959417|NCT02311478|515390388|FG000|Overall Study|Failed IUD Insertion|1|||
142959418|NCT03041116|515390389|FG000|Double-blind|Death|0|||
142959419|NCT03041116|515390390|FG001|Double-blind|Death|2|||
142959420|NCT03041116|515390389|FG000|Double-blind|Withdrawal by Subject|0|||
142959421|NCT03041116|515390390|FG001|Double-blind|Withdrawal by Subject|4|||
142959422|NCT03041116|515390389|FG000|Open-label|Death|1|||
142959423|NCT03041116|515390390|FG001|Open-label|Death|0|||
142959424|NCT03041116|515390389|FG000|Open-label|Termination of the study by Sponsor|39|||
142959425|NCT03041116|515390390|FG001|Open-label|Termination of the study by Sponsor|37|||
142959426|NCT03041116|515390389|FG000|Open-label|Withdrawal by Subject|1|||
142959427|NCT03041116|515390390|FG001|Open-label|Withdrawal by Subject|0|||
142959428|NCT00943319|515390391|FG000|Overall Study|Death|1|||
142959429|NCT01798134|515390392|FG000|Overall Study|Lost to Follow-up|1|||
142959430|NCT01798134|515390392|FG000|Overall Study|Withdrawal by Subject|3|||
142959431|NCT01798134|515390392|FG000|Overall Study|Death|2|||
142959432|NCT01798134|515390392|FG000|Overall Study|Adverse Event|3|||
142959433|NCT01798134|515390392|FG000|Overall Study|Physician Decision|3|||
142959434|NCT01798134|515390392|FG000|Overall Study|Liver transplant/surgery|4|||
142959435|NCT03703375|515390393|FG000|Randomization Period|Withdrawal by Subject|0|||
142959436|NCT03703375|515390394|FG001|Randomization Period|Withdrawal by Subject|0|||
142959437|NCT03703375|515390395|FG002|Randomization Period|Withdrawal by Subject|0|||
142959438|NCT03703375|515390396|FG003|Randomization Period|Withdrawal by Subject|1|||
142959439|NCT03703375|515390393|FG000|Randomization Period|Completed safety run-in treatment|7|||
142959440|NCT03703375|515390394|FG001|Randomization Period|Completed safety run-in treatment|0|||
142959441|NCT03703375|515390395|FG002|Randomization Period|Completed safety run-in treatment|0|||
142959442|NCT03703375|515390396|FG003|Randomization Period|Completed safety run-in treatment|0|||
142959443|NCT03703375|515390393|FG000|Treatment Period|Other Reasons|0|||
142959444|NCT03703375|515390394|FG001|Treatment Period|Other Reasons|1|||
142959445|NCT03703375|515390395|FG002|Treatment Period|Other Reasons|0|||
142959446|NCT03703375|515390396|FG003|Treatment Period|Other Reasons|3|||
142959447|NCT03703375|515390393|FG000|Treatment Period|Consent Withdrawal|0|||
142959448|NCT03703375|515390394|FG001|Treatment Period|Consent Withdrawal|0|||
142959449|NCT03703375|515390395|FG002|Treatment Period|Consent Withdrawal|0|||
142959450|NCT03703375|515390396|FG003|Treatment Period|Consent Withdrawal|1|||
142959451|NCT03703375|515390393|FG000|Treatment Period|Death|1|||
142959452|NCT03703375|515390394|FG001|Treatment Period|Death|0|||
142959453|NCT03703375|515390395|FG002|Treatment Period|Death|1|||
142959454|NCT03703375|515390396|FG003|Treatment Period|Death|2|||
142959455|NCT03703375|515390393|FG000|Treatment Period|Toxicity of Study Treatment|2|||
142959456|NCT03703375|515390394|FG001|Treatment Period|Toxicity of Study Treatment|0|||
142959457|NCT03703375|515390395|FG002|Treatment Period|Toxicity of Study Treatment|4|||
142959458|NCT03703375|515390396|FG003|Treatment Period|Toxicity of Study Treatment|1|||
142959459|NCT03703375|515390393|FG000|Treatment Period|Progression|32|||
142959460|NCT03703375|515390394|FG001|Treatment Period|Progression|1|||
142959461|NCT03703375|515390395|FG002|Treatment Period|Progression|7|||
142959462|NCT03703375|515390396|FG003|Treatment Period|Progression|11|||
142959463|NCT03703375|515390393|FG000|Treatment Period|Completed treatment|7|||
142959464|NCT03703375|515390394|FG001|Treatment Period|Completed treatment|2|||
142959465|NCT03703375|515390395|FG002|Treatment Period|Completed treatment|0|||
142959466|NCT03703375|515390396|FG003|Treatment Period|Completed treatment|0|||
142959467|NCT00366548|515390397|FG000|Infant Series|Adverse Event|1|||
142959468|NCT00366548|515390398|FG001|Infant Series|Adverse Event|3|||
142959469|NCT00366548|515390397|FG000|Infant Series|Protocol Violation|0|||
142959470|NCT00366548|515390398|FG001|Infant Series|Protocol Violation|1|||
143117137|NCT01273155|515970038|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
142959471|NCT00366548|515390397|FG000|Infant Series|Withdrawal by Subject|3|||
142959472|NCT00366548|515390398|FG001|Infant Series|Withdrawal by Subject|1|||
142959473|NCT00366548|515390397|FG000|After Infant Series|Withdrawal by Subject|3|||
142959474|NCT00366548|515390398|FG001|After Infant Series|Withdrawal by Subject|1|||
142959475|NCT00366548|515390397|FG000|After Infant Series|Adverse Event|2|||
142959476|NCT00366548|515390398|FG001|After Infant Series|Adverse Event|0|||
142959477|NCT00366548|515390397|FG000|After Infant Series|Lost to Follow-up|1|||
142959478|NCT00366548|515390398|FG001|After Infant Series|Lost to Follow-up|0|||
142959479|NCT02849990|515390399|FG000|Overall Study|Adverse Event|1|||
142959480|NCT02849990|515390399|FG000|Overall Study|Withdrawal by Subject|1|||
142959481|NCT03539458|515390400|FG000|Overall Study|Death|1|||
142959482|NCT01984346|515390402|FG000|Overall Study|Physician Decision|4|||
142959483|NCT01984346|515390403|FG001|Overall Study|Physician Decision|2|||
142959484|NCT01984346|515390402|FG000|Overall Study|Withdrawal by Subject|2|||
142959485|NCT01984346|515390403|FG001|Overall Study|Withdrawal by Subject|2|||
142959486|NCT01984346|515390402|FG000|Overall Study|Enrollment Closed|8|||
142959487|NCT01984346|515390403|FG001|Overall Study|Enrollment Closed|1|||
142959488|NCT01984346|515390402|FG000|Overall Study|Insurance Coverage|1|||
142959489|NCT01984346|515390403|FG001|Overall Study|Insurance Coverage|0|||
142959490|NCT01984346|515390402|FG000|Overall Study|Intra-operative Exclusion|2|||
142959491|NCT01984346|515390403|FG001|Overall Study|Intra-operative Exclusion|0|||
142959492|NCT00536731|515390408|FG000|Overall Study|Adverse Event|3|||
142959493|NCT00536731|515390409|FG001|Overall Study|Adverse Event|2|||
142959494|NCT00536731|515390410|FG002|Overall Study|Adverse Event|3|||
142959495|NCT00536731|515390408|FG000|Overall Study|Withdrawal by Subject|0|||
142959496|NCT00536731|515390409|FG001|Overall Study|Withdrawal by Subject|2|||
142959497|NCT00536731|515390410|FG002|Overall Study|Withdrawal by Subject|0|||
142959498|NCT00536731|515390408|FG000|Overall Study|Intake of prohibited conc. medication|0|||
142959499|NCT00536731|515390409|FG001|Overall Study|Intake of prohibited conc. medication|0|||
142959500|NCT00536731|515390410|FG002|Overall Study|Intake of prohibited conc. medication|1|||
142959501|NCT00536731|515390408|FG000|Overall Study|Safety reasons|0|||
142959502|NCT00536731|515390409|FG001|Overall Study|Safety reasons|0|||
142959503|NCT00536731|515390410|FG002|Overall Study|Safety reasons|1|||
142959504|NCT00536731|515390408|FG000|Overall Study|Other|1|||
142959505|NCT00536731|515390409|FG001|Overall Study|Other|1|||
142959506|NCT00536731|515390410|FG002|Overall Study|Other|0|||
142959507|NCT00372190|515390411|FG000|Overall Study|Lost to Follow-up|3|||
142959508|NCT00372190|515390412|FG001|Overall Study|Lost to Follow-up|1|||
142959509|NCT04705597|515390413|FG000|Overall Study|Death|16|||
142959510|NCT04705597|515390414|FG001|Overall Study|Death|9|||
142959511|NCT04705597|515390413|FG000|Overall Study|Lost to Follow-up|1|||
142959512|NCT04705597|515390414|FG001|Overall Study|Lost to Follow-up|0|||
142959513|NCT04705597|515390413|FG000|Overall Study|Withdrawal by Subject|1|||
142959514|NCT04705597|515390414|FG001|Overall Study|Withdrawal by Subject|2|||
142959515|NCT00273858|515390415|FG000|Overall Study|Not completed 24 month observation time|334|||
142959516|NCT00273858|515390415|FG000|Overall Study|Lost to Follow-up|101|||
142959517|NCT00273858|515390415|FG000|Overall Study|Withdrawal by Subject|21|||
142959518|NCT00273858|515390415|FG000|Overall Study|Adverse Event|81|||
142959519|NCT01070550|515390417|FG000|Overall Study|Adverse Event|43|||
142959520|NCT01070550|515390418|FG001|Overall Study|Adverse Event|1|||
142959521|NCT01070550|515390419|FG002|Overall Study|Adverse Event|3|||
142959522|NCT01070550|515390420|FG003|Overall Study|Adverse Event|0|||
142959523|NCT01070550|515390421|FG004|Overall Study|Adverse Event|0|||
142959524|NCT01070550|515390422|FG005|Overall Study|Adverse Event|0|||
142959525|NCT01070550|515390417|FG000|Overall Study|Death|20|||
142959526|NCT01070550|515390418|FG001|Overall Study|Death|4|||
142959527|NCT01070550|515390419|FG002|Overall Study|Death|3|||
142959528|NCT01070550|515390420|FG003|Overall Study|Death|0|||
142959529|NCT01070550|515390421|FG004|Overall Study|Death|0|||
142959530|NCT01070550|515390422|FG005|Overall Study|Death|0|||
142959531|NCT01070550|515390417|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
142959532|NCT01070550|515390418|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
142959533|NCT01070550|515390419|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
142959534|NCT01070550|515390420|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
142959535|NCT01070550|515390421|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
142959536|NCT01070550|515390422|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
142959537|NCT01070550|515390417|FG000|Overall Study|Early termination|3|||
142959538|NCT01070550|515390418|FG001|Overall Study|Early termination|0|||
142959539|NCT01070550|515390419|FG002|Overall Study|Early termination|0|||
142959540|NCT01070550|515390420|FG003|Overall Study|Early termination|0|||
142959541|NCT01070550|515390421|FG004|Overall Study|Early termination|0|||
142959542|NCT01070550|515390422|FG005|Overall Study|Early termination|0|||
142959543|NCT01070550|515390417|FG000|Overall Study|Failed to return|450|||
142959544|NCT01070550|515390418|FG001|Overall Study|Failed to return|33|||
142959545|NCT01070550|515390419|FG002|Overall Study|Failed to return|144|||
142959546|NCT01070550|515390420|FG003|Overall Study|Failed to return|40|||
142959547|NCT01070550|515390421|FG004|Overall Study|Failed to return|1|||
142959548|NCT01070550|515390422|FG005|Overall Study|Failed to return|2|||
142959549|NCT01070550|515390417|FG000|Overall Study|Incomplete treatment|2|||
143117138|NCT01273155|515970039|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
142959550|NCT01070550|515390418|FG001|Overall Study|Incomplete treatment|0|||
142959551|NCT01070550|515390419|FG002|Overall Study|Incomplete treatment|0|||
142959552|NCT01070550|515390420|FG003|Overall Study|Incomplete treatment|0|||
142959553|NCT01070550|515390421|FG004|Overall Study|Incomplete treatment|0|||
142959554|NCT01070550|515390422|FG005|Overall Study|Incomplete treatment|0|||
142959555|NCT01070550|515390417|FG000|Overall Study|Lab test not done|22|||
142959556|NCT01070550|515390418|FG001|Overall Study|Lab test not done|3|||
142959557|NCT01070550|515390419|FG002|Overall Study|Lab test not done|4|||
142959558|NCT01070550|515390420|FG003|Overall Study|Lab test not done|1|||
142959559|NCT01070550|515390421|FG004|Overall Study|Lab test not done|0|||
142959560|NCT01070550|515390422|FG005|Overall Study|Lab test not done|1|||
142959561|NCT01070550|515390417|FG000|Overall Study|Lack of Efficacy|65|||
142959562|NCT01070550|515390418|FG001|Overall Study|Lack of Efficacy|1|||
142959563|NCT01070550|515390419|FG002|Overall Study|Lack of Efficacy|5|||
142959564|NCT01070550|515390420|FG003|Overall Study|Lack of Efficacy|5|||
142959565|NCT01070550|515390421|FG004|Overall Study|Lack of Efficacy|0|||
142959566|NCT01070550|515390422|FG005|Overall Study|Lack of Efficacy|1|||
142959567|NCT01070550|515390417|FG000|Overall Study|Miscellaneous|12|||
142959568|NCT01070550|515390418|FG001|Overall Study|Miscellaneous|2|||
142959569|NCT01070550|515390419|FG002|Overall Study|Miscellaneous|3|||
142959570|NCT01070550|515390420|FG003|Overall Study|Miscellaneous|1|||
142959571|NCT01070550|515390421|FG004|Overall Study|Miscellaneous|0|||
142959572|NCT01070550|515390422|FG005|Overall Study|Miscellaneous|0|||
142959573|NCT01070550|515390417|FG000|Overall Study|New treatment started|3|||
142959574|NCT01070550|515390418|FG001|Overall Study|New treatment started|1|||
142959575|NCT01070550|515390419|FG002|Overall Study|New treatment started|0|||
142959576|NCT01070550|515390420|FG003|Overall Study|New treatment started|2|||
142959577|NCT01070550|515390421|FG004|Overall Study|New treatment started|0|||
142959578|NCT01070550|515390422|FG005|Overall Study|New treatment started|0|||
142959579|NCT01070550|515390417|FG000|Overall Study|Non-responders|493|||
142959580|NCT01070550|515390418|FG001|Overall Study|Non-responders|4|||
142959581|NCT01070550|515390419|FG002|Overall Study|Non-responders|21|||
142959582|NCT01070550|515390420|FG003|Overall Study|Non-responders|20|||
142959583|NCT01070550|515390421|FG004|Overall Study|Non-responders|0|||
142959584|NCT01070550|515390422|FG005|Overall Study|Non-responders|2|||
142959585|NCT01070550|515390417|FG000|Overall Study|Not categorized|33|||
142959586|NCT01070550|515390418|FG001|Overall Study|Not categorized|2|||
142959587|NCT01070550|515390419|FG002|Overall Study|Not categorized|6|||
142959588|NCT01070550|515390420|FG003|Overall Study|Not categorized|1|||
142959589|NCT01070550|515390421|FG004|Overall Study|Not categorized|0|||
142959590|NCT01070550|515390422|FG005|Overall Study|Not categorized|1|||
142959591|NCT01070550|515390417|FG000|Overall Study|Protocol Violation|15|||
142959592|NCT01070550|515390418|FG001|Overall Study|Protocol Violation|1|||
142959593|NCT01070550|515390419|FG002|Overall Study|Protocol Violation|1|||
142959594|NCT01070550|515390420|FG003|Overall Study|Protocol Violation|1|||
142959595|NCT01070550|515390421|FG004|Overall Study|Protocol Violation|0|||
142959596|NCT01070550|515390422|FG005|Overall Study|Protocol Violation|0|||
142959597|NCT01070550|515390417|FG000|Overall Study|Relapse|44|||
142959598|NCT01070550|515390418|FG001|Overall Study|Relapse|5|||
142959599|NCT01070550|515390419|FG002|Overall Study|Relapse|14|||
142959600|NCT01070550|515390420|FG003|Overall Study|Relapse|4|||
142959601|NCT01070550|515390421|FG004|Overall Study|Relapse|0|||
142959602|NCT01070550|515390422|FG005|Overall Study|Relapse|0|||
142959603|NCT01070550|515390417|FG000|Overall Study|Result not available|3|||
142959604|NCT01070550|515390418|FG001|Overall Study|Result not available|1|||
142959605|NCT01070550|515390419|FG002|Overall Study|Result not available|3|||
142959606|NCT01070550|515390420|FG003|Overall Study|Result not available|0|||
142959607|NCT01070550|515390421|FG004|Overall Study|Result not available|0|||
142959608|NCT01070550|515390422|FG005|Overall Study|Result not available|0|||
142959609|NCT01070550|515390417|FG000|Overall Study|Screen failure|1|||
142959610|NCT01070550|515390418|FG001|Overall Study|Screen failure|0|||
142959611|NCT01070550|515390419|FG002|Overall Study|Screen failure|0|||
142959612|NCT01070550|515390420|FG003|Overall Study|Screen failure|0|||
142959613|NCT01070550|515390421|FG004|Overall Study|Screen failure|0|||
142959614|NCT01070550|515390422|FG005|Overall Study|Screen failure|0|||
142959615|NCT01070550|515390417|FG000|Overall Study|Sponsor decision|1|||
142959616|NCT01070550|515390418|FG001|Overall Study|Sponsor decision|0|||
142959617|NCT01070550|515390419|FG002|Overall Study|Sponsor decision|0|||
142959618|NCT01070550|515390420|FG003|Overall Study|Sponsor decision|0|||
142959619|NCT01070550|515390421|FG004|Overall Study|Sponsor decision|0|||
142959620|NCT01070550|515390422|FG005|Overall Study|Sponsor decision|0|||
142959621|NCT01070550|515390417|FG000|Overall Study|Treatment duration shortened|1|||
142959622|NCT01070550|515390418|FG001|Overall Study|Treatment duration shortened|0|||
142959623|NCT01070550|515390419|FG002|Overall Study|Treatment duration shortened|0|||
142959624|NCT01070550|515390420|FG003|Overall Study|Treatment duration shortened|0|||
142959625|NCT01070550|515390421|FG004|Overall Study|Treatment duration shortened|0|||
142959626|NCT01070550|515390422|FG005|Overall Study|Treatment duration shortened|0|||
142959627|NCT01070550|515390417|FG000|Overall Study|Treatment interrupted|7|||
142959628|NCT01070550|515390418|FG001|Overall Study|Treatment interrupted|0|||
142959629|NCT01070550|515390419|FG002|Overall Study|Treatment interrupted|1|||
142959630|NCT01070550|515390420|FG003|Overall Study|Treatment interrupted|1|||
142959631|NCT01070550|515390421|FG004|Overall Study|Treatment interrupted|0|||
142959632|NCT01070550|515390422|FG005|Overall Study|Treatment interrupted|0|||
142959633|NCT01070550|515390417|FG000|Overall Study|Treatment not started|14|||
142959634|NCT01070550|515390418|FG001|Overall Study|Treatment not started|2|||
142959635|NCT01070550|515390419|FG002|Overall Study|Treatment not started|4|||
142959636|NCT01070550|515390420|FG003|Overall Study|Treatment not started|0|||
142959637|NCT01070550|515390421|FG004|Overall Study|Treatment not started|0|||
142959638|NCT01070550|515390422|FG005|Overall Study|Treatment not started|0|||
142959639|NCT01070550|515390417|FG000|Overall Study|Treatment restarted|0|||
142959640|NCT01070550|515390418|FG001|Overall Study|Treatment restarted|1|||
142959641|NCT01070550|515390419|FG002|Overall Study|Treatment restarted|0|||
142959642|NCT01070550|515390420|FG003|Overall Study|Treatment restarted|0|||
142959643|NCT01070550|515390421|FG004|Overall Study|Treatment restarted|0|||
142959644|NCT01070550|515390422|FG005|Overall Study|Treatment restarted|0|||
142959645|NCT01070550|515390417|FG000|Overall Study|Treatment stopped|3|||
142959646|NCT01070550|515390418|FG001|Overall Study|Treatment stopped|0|||
142959647|NCT01070550|515390419|FG002|Overall Study|Treatment stopped|0|||
142959648|NCT01070550|515390420|FG003|Overall Study|Treatment stopped|0|||
142959649|NCT01070550|515390421|FG004|Overall Study|Treatment stopped|0|||
142959650|NCT01070550|515390422|FG005|Overall Study|Treatment stopped|0|||
142959651|NCT01070550|515390417|FG000|Overall Study|Treatment unavailable|1|||
142959652|NCT01070550|515390418|FG001|Overall Study|Treatment unavailable|0|||
142959653|NCT01070550|515390419|FG002|Overall Study|Treatment unavailable|0|||
142959654|NCT01070550|515390420|FG003|Overall Study|Treatment unavailable|0|||
142959655|NCT01070550|515390421|FG004|Overall Study|Treatment unavailable|0|||
142959656|NCT01070550|515390422|FG005|Overall Study|Treatment unavailable|0|||
142959657|NCT01070550|515390417|FG000|Overall Study|Treatment was stopped early|7|||
142959658|NCT01070550|515390418|FG001|Overall Study|Treatment was stopped early|0|||
142959659|NCT01070550|515390419|FG002|Overall Study|Treatment was stopped early|0|||
142959660|NCT01070550|515390420|FG003|Overall Study|Treatment was stopped early|0|||
142959661|NCT01070550|515390421|FG004|Overall Study|Treatment was stopped early|0|||
142959662|NCT01070550|515390422|FG005|Overall Study|Treatment was stopped early|0|||
142959663|NCT01070550|515390417|FG000|Overall Study|Other|5|||
142959664|NCT01070550|515390418|FG001|Overall Study|Other|0|||
142959665|NCT01070550|515390419|FG002|Overall Study|Other|0|||
142959666|NCT01070550|515390420|FG003|Overall Study|Other|1|||
142959667|NCT01070550|515390421|FG004|Overall Study|Other|0|||
142959668|NCT01070550|515390422|FG005|Overall Study|Other|0|||
142959669|NCT01070550|515390417|FG000|Overall Study|Withdrawal by Subject|35|||
142959670|NCT01070550|515390418|FG001|Overall Study|Withdrawal by Subject|0|||
142959671|NCT01070550|515390419|FG002|Overall Study|Withdrawal by Subject|3|||
142959672|NCT01070550|515390420|FG003|Overall Study|Withdrawal by Subject|0|||
142959673|NCT01070550|515390421|FG004|Overall Study|Withdrawal by Subject|0|||
142959674|NCT01070550|515390422|FG005|Overall Study|Withdrawal by Subject|0|||
142959675|NCT00069576|515390424|FG000|Original Trial|Lost to Follow-up|25|||
142959676|NCT00069576|515390425|FG001|Original Trial|Lost to Follow-up|33|||
142959677|NCT00069576|515390424|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
142959678|NCT00069576|515390425|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
142959679|NCT00002663|515390426|FG000|Overall Study|Death|4|||
142959680|NCT00002663|515390427|FG001|Overall Study|Death|1|||
142959681|NCT00002663|515390428|FG002|Overall Study|Death|1|||
142959682|NCT00002663|515390429|FG003|Overall Study|Death|0|||
142959683|NCT00002663|515390430|FG004|Overall Study|Death|0|||
142959684|NCT00002663|515390431|FG005|Overall Study|Death|13|||
142959685|NCT00002663|515390432|FG006|Overall Study|Death|0|||
142959686|NCT00002663|515390433|FG007|Overall Study|Death|1|||
142959687|NCT00002663|515390434|FG008|Overall Study|Death|1|||
142959688|NCT00002663|515390435|FG009|Overall Study|Death|1|||
142959689|NCT00002663|515390426|FG000|Overall Study|Lost to Follow-up|3|||
142959690|NCT00002663|515390427|FG001|Overall Study|Lost to Follow-up|0|||
142959691|NCT00002663|515390428|FG002|Overall Study|Lost to Follow-up|0|||
142959692|NCT00002663|515390429|FG003|Overall Study|Lost to Follow-up|1|||
142959693|NCT00002663|515390430|FG004|Overall Study|Lost to Follow-up|0|||
142959694|NCT00002663|515390431|FG005|Overall Study|Lost to Follow-up|1|||
142959695|NCT00002663|515390432|FG006|Overall Study|Lost to Follow-up|0|||
142959696|NCT00002663|515390433|FG007|Overall Study|Lost to Follow-up|0|||
142959697|NCT00002663|515390434|FG008|Overall Study|Lost to Follow-up|0|||
142959698|NCT00002663|515390435|FG009|Overall Study|Lost to Follow-up|0|||
142959699|NCT00002663|515390426|FG000|Overall Study|Other|0|||
142959700|NCT00002663|515390427|FG001|Overall Study|Other|1|||
142959701|NCT00002663|515390428|FG002|Overall Study|Other|0|||
142959702|NCT00002663|515390429|FG003|Overall Study|Other|0|||
142959703|NCT00002663|515390430|FG004|Overall Study|Other|0|||
142959704|NCT00002663|515390431|FG005|Overall Study|Other|1|||
142959705|NCT00002663|515390432|FG006|Overall Study|Other|1|||
142959706|NCT00002663|515390433|FG007|Overall Study|Other|0|||
142959707|NCT00002663|515390434|FG008|Overall Study|Other|0|||
142959708|NCT00002663|515390435|FG009|Overall Study|Other|0|||
142959709|NCT00002663|515390426|FG000|Overall Study|Physician Decision|0|||
142959710|NCT00002663|515390427|FG001|Overall Study|Physician Decision|0|||
142959711|NCT00002663|515390428|FG002|Overall Study|Physician Decision|0|||
142959712|NCT00002663|515390429|FG003|Overall Study|Physician Decision|0|||
142959713|NCT00002663|515390430|FG004|Overall Study|Physician Decision|1|||
142959714|NCT00002663|515390431|FG005|Overall Study|Physician Decision|0|||
142959715|NCT00002663|515390432|FG006|Overall Study|Physician Decision|0|||
142959716|NCT00002663|515390433|FG007|Overall Study|Physician Decision|0|||
142959717|NCT00002663|515390434|FG008|Overall Study|Physician Decision|1|||
142959718|NCT00002663|515390435|FG009|Overall Study|Physician Decision|1|||
142959719|NCT00002663|515390426|FG000|Overall Study|Adverse Event|0|||
142959720|NCT00002663|515390427|FG001|Overall Study|Adverse Event|0|||
142959721|NCT00002663|515390428|FG002|Overall Study|Adverse Event|0|||
142959722|NCT00002663|515390429|FG003|Overall Study|Adverse Event|1|||
142959723|NCT00002663|515390430|FG004|Overall Study|Adverse Event|0|||
142959724|NCT00002663|515390431|FG005|Overall Study|Adverse Event|0|||
142959725|NCT00002663|515390432|FG006|Overall Study|Adverse Event|0|||
142959726|NCT00002663|515390433|FG007|Overall Study|Adverse Event|1|||
142959727|NCT00002663|515390434|FG008|Overall Study|Adverse Event|0|||
142959728|NCT00002663|515390435|FG009|Overall Study|Adverse Event|0|||
142959729|NCT00905307|515390437|FG000|Overall Study|Switched to Open Label Rescue|7|||
142959730|NCT00905307|515390438|FG001|Overall Study|Switched to Open Label Rescue|17|||
142959731|NCT00905307|515390439|FG002|Overall Study|Switched to Open Label Rescue|11|||
142959732|NCT00905307|515390440|FG003|Overall Study|Switched to Open Label Rescue|11|||
142959733|NCT00905307|515390441|FG004|Overall Study|Switched to Open Label Rescue|4|||
142959734|NCT00905307|515390442|FG005|Overall Study|Switched to Open Label Rescue|15|||
142959735|NCT00905307|515390437|FG000|Overall Study|Lost to Follow-up|0|||
142959736|NCT00905307|515390438|FG001|Overall Study|Lost to Follow-up|0|||
142959737|NCT00905307|515390439|FG002|Overall Study|Lost to Follow-up|0|||
142959738|NCT00905307|515390440|FG003|Overall Study|Lost to Follow-up|0|||
142959739|NCT00905307|515390441|FG004|Overall Study|Lost to Follow-up|1|||
142959740|NCT00905307|515390442|FG005|Overall Study|Lost to Follow-up|1|||
142959741|NCT00905307|515390437|FG000|Overall Study|Adverse Event|3|||
142959742|NCT00905307|515390438|FG001|Overall Study|Adverse Event|4|||
142959743|NCT00905307|515390439|FG002|Overall Study|Adverse Event|5|||
142959744|NCT00905307|515390440|FG003|Overall Study|Adverse Event|11|||
142959745|NCT00905307|515390441|FG004|Overall Study|Adverse Event|3|||
142959746|NCT00905307|515390442|FG005|Overall Study|Adverse Event|5|||
142959747|NCT00905307|515390437|FG000|Overall Study|Withdrawal by Subject|5|||
142959748|NCT00905307|515390438|FG001|Overall Study|Withdrawal by Subject|13|||
142959749|NCT00905307|515390439|FG002|Overall Study|Withdrawal by Subject|15|||
142959750|NCT00905307|515390440|FG003|Overall Study|Withdrawal by Subject|11|||
142959751|NCT00905307|515390441|FG004|Overall Study|Withdrawal by Subject|4|||
142959752|NCT00905307|515390442|FG005|Overall Study|Withdrawal by Subject|13|||
142959753|NCT00905307|515390437|FG000|Overall Study|Protocol Violation|1|||
142959754|NCT00905307|515390438|FG001|Overall Study|Protocol Violation|0|||
142959755|NCT00905307|515390439|FG002|Overall Study|Protocol Violation|1|||
142959756|NCT00905307|515390440|FG003|Overall Study|Protocol Violation|0|||
142959757|NCT00905307|515390441|FG004|Overall Study|Protocol Violation|0|||
142959758|NCT00905307|515390442|FG005|Overall Study|Protocol Violation|0|||
142959759|NCT00905307|515390437|FG000|Overall Study|Lack of Efficacy|6|||
142959760|NCT00905307|515390438|FG001|Overall Study|Lack of Efficacy|3|||
142959761|NCT00905307|515390439|FG002|Overall Study|Lack of Efficacy|5|||
142959762|NCT00905307|515390440|FG003|Overall Study|Lack of Efficacy|4|||
142959763|NCT00905307|515390441|FG004|Overall Study|Lack of Efficacy|4|||
142959764|NCT00905307|515390442|FG005|Overall Study|Lack of Efficacy|8|||
142959765|NCT03838367|515390443|FG000|Overall Study|Early termination of study|3|||
142959766|NCT03838367|515390444|FG001|Overall Study|Early termination of study|4|||
142959767|NCT03838367|515390445|FG002|Overall Study|Early termination of study|3|||
142959768|NCT03838367|515390446|FG003|Overall Study|Early termination of study|0|||
142959769|NCT03406104|515390447|FG000|Overall Study|Lost to Follow-up|2|||
142959770|NCT03406104|515390447|FG000|Overall Study|Withdrawal by Subject|2|||
142959771|NCT03406104|515390447|FG000|Overall Study|due to Covid patient did not want to travel|1|||
142959772|NCT03406104|515390447|FG000|Overall Study|Death|2|||
142959773|NCT00525148|515390448|FG000|Overall Study|Other Adverse Event|3|||
142959774|NCT00525148|515390449|FG001|Overall Study|Other Adverse Event|5|||
142959775|NCT00525148|515390450|FG002|Overall Study|Other Adverse Event|1|||
142959776|NCT00525148|515390451|FG003|Overall Study|Other Adverse Event|8|||
142959777|NCT00525148|515390448|FG000|Overall Study|Progressive disease|18|||
142959778|NCT00525148|515390449|FG001|Overall Study|Progressive disease|30|||
142959779|NCT00525148|515390450|FG002|Overall Study|Progressive disease|6|||
142959780|NCT00525148|515390451|FG003|Overall Study|Progressive disease|49|||
142959781|NCT00525148|515390448|FG000|Overall Study|Refused continuation of study medication|0|||
142959782|NCT00525148|515390449|FG001|Overall Study|Refused continuation of study medication|2|||
142959783|NCT00525148|515390450|FG002|Overall Study|Refused continuation of study medication|0|||
142959784|NCT00525148|515390451|FG003|Overall Study|Refused continuation of study medication|1|||
142959785|NCT00525148|515390448|FG000|Overall Study|Other than stated|2|||
142959786|NCT00525148|515390449|FG001|Overall Study|Other than stated|1|||
142959787|NCT00525148|515390450|FG002|Overall Study|Other than stated|0|||
142959788|NCT00525148|515390451|FG003|Overall Study|Other than stated|3|||
142959789|NCT03015610|515390452|FG000|Overall Study|Lost to Follow-up|1|||
142959790|NCT03015610|515390453|FG001|Overall Study|Lost to Follow-up|5|||
142959791|NCT01603641|515390454|FG000|Overall Study|Did not Receive Treatment|3|||
142959792|NCT01603641|515390454|FG000|Overall Study|Adverse Event|1|||
142959793|NCT01603641|515390454|FG000|Overall Study|Lack of Efficacy|1|||
142959794|NCT01603641|515390454|FG000|Overall Study|Lost to Follow-up|6|||
142959795|NCT01603641|515390454|FG000|Overall Study|Personal Reasons|18|||
142959796|NCT01603641|515390454|FG000|Overall Study|Other Miscellaneous Reasons|6|||
142959797|NCT05100199|515390461|FG000|Overall Study|Lost to Follow-up|5|||
142959798|NCT05100199|515390462|FG001|Overall Study|Lost to Follow-up|8|||
142959799|NCT05100199|515390463|FG002|Overall Study|Lost to Follow-up|3|||
142959800|NCT05100199|515390464|FG003|Overall Study|Lost to Follow-up|6|||
142959801|NCT05100199|515390461|FG000|Overall Study|Withdrawal by Subject|3|||
142959802|NCT05100199|515390462|FG001|Overall Study|Withdrawal by Subject|3|||
142959803|NCT05100199|515390463|FG002|Overall Study|Withdrawal by Subject|9|||
142959804|NCT05100199|515390464|FG003|Overall Study|Withdrawal by Subject|7|||
142959805|NCT05100199|515390461|FG000|Overall Study|Other|0|||
142959806|NCT05100199|515390462|FG001|Overall Study|Other|0|||
142959807|NCT05100199|515390463|FG002|Overall Study|Other|1|||
142959808|NCT05100199|515390464|FG003|Overall Study|Other|1|||
142959809|NCT00114972|515390465|FG000|Overall Study|Withdrawal by Subject|40|||
142959810|NCT00114972|515390466|FG001|Overall Study|Withdrawal by Subject|7|||
142959811|NCT00114972|515390465|FG000|Overall Study|Lost to Follow-up|8|||
142959812|NCT00114972|515390466|FG001|Overall Study|Lost to Follow-up|5|||
142959813|NCT00616239|515390467|FG000|Overall Study|Withdrawal by Subject|2|||
142959814|NCT00933335|515390468|FG000|Overall Study|Lost to Follow-up|1|||
142959815|NCT00933335|515390469|FG001|Overall Study|Lost to Follow-up|3|||
142959816|NCT00933335|515390468|FG000|Overall Study|Withdrawal by Subject|0|||
142959817|NCT00933335|515390469|FG001|Overall Study|Withdrawal by Subject|1|||
142959818|NCT00933335|515390468|FG000|Overall Study|Progressive Disease|0|||
142959819|NCT00933335|515390469|FG001|Overall Study|Progressive Disease|11|||
142959820|NCT00933335|515390468|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
142959821|NCT00933335|515390469|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
142959822|NCT00933335|515390468|FG000|Overall Study|Co-morbid Illness|1|||
142959823|NCT00933335|515390469|FG001|Overall Study|Co-morbid Illness|0|||
142959824|NCT02650284|515390472|FG000|Overall Study|Lost to Follow-up|3|||
142959825|NCT02650284|515390473|FG001|Overall Study|Lost to Follow-up|3|||
142959826|NCT02650284|515390472|FG000|Overall Study|Consent incorrectly taken|0|||
142959827|NCT02650284|515390473|FG001|Overall Study|Consent incorrectly taken|1|||
142959828|NCT04590937|515390474|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
142959829|NCT01929044|515390478|FG000|Overall Study|Adverse Event|1|||
142959830|NCT01929044|515390479|FG001|Overall Study|Adverse Event|0|||
142959831|NCT01929044|515390478|FG000|Overall Study|Protocol Violation|9|||
142959832|NCT01929044|515390479|FG001|Overall Study|Protocol Violation|14|||
142959833|NCT01929044|515390478|FG000|Overall Study|Not Treated|1|||
142959834|NCT01929044|515390479|FG001|Overall Study|Not Treated|3|||
142959835|NCT02084134|515390486|FG000|Overall Study|Protocol Violation|4|||
142959836|NCT02084134|515390487|FG001|Overall Study|Protocol Violation|2|||
142959837|NCT02084134|515390486|FG000|Overall Study|Death|0|||
142959838|NCT02084134|515390487|FG001|Overall Study|Death|1|||
142959839|NCT02807454|515390488|FG000|Overall Study|Adverse Event|1|||
142959840|NCT02807454|515390489|FG001|Overall Study|Adverse Event|0|||
142959841|NCT02807454|515390488|FG000|Overall Study|Withdrawal by Subject|0|||
142959842|NCT02807454|515390489|FG001|Overall Study|Withdrawal by Subject|1|||
142959843|NCT02807454|515390488|FG000|Overall Study|Progressive Disease|30|||
142959844|NCT02807454|515390489|FG001|Overall Study|Progressive Disease|3|||
142959845|NCT02807454|515390488|FG000|Overall Study|Other Reasons|1|||
142959846|NCT02807454|515390489|FG001|Overall Study|Other Reasons|1|||
142959847|NCT05468086|515390490|FG000|Overall Study|Withdrawal by Subject|3|||
142959848|NCT05468086|515390490|FG000|Overall Study|Subject was found ineligible after consent|1|||
142959849|NCT01165203|515390491|FG000|Active Phase|Serious Adverse Event|1|||
142959850|NCT01165203|515390492|FG001|Active Phase|Serious Adverse Event|0|||
142959851|NCT01165203|515390491|FG000|Active Phase|Withdrawal by Subject|2|||
142959852|NCT01165203|515390492|FG001|Active Phase|Withdrawal by Subject|1|||
142959853|NCT01165203|515390491|FG000|Active Phase|Migrated/moved from study area|0|||
142959854|NCT01165203|515390492|FG001|Active Phase|Migrated/moved from study area|1|||
142959855|NCT01165203|515390491|FG000|Active Phase|Lost to Follow-up|2|||
142959856|NCT01165203|515390492|FG001|Active Phase|Lost to Follow-up|0|||
142959857|NCT01165203|515390491|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
142959858|NCT01165203|515390492|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
142959859|NCT01165203|515390491|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
142959860|NCT01165203|515390492|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
142959861|NCT01165203|515390491|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
142959862|NCT01165203|515390492|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
142959863|NCT01165203|515390491|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
142959864|NCT01165203|515390492|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
142959865|NCT01165203|515390491|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
142959866|NCT01165203|515390492|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
142959867|NCT00374907|515390493|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
142959868|NCT00374907|515390494|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
142959869|NCT00374907|515390493|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
142959870|NCT00374907|515390494|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
142959871|NCT00374907|515390493|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
142959872|NCT00374907|515390494|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
142959873|NCT00374907|515390493|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
142959874|NCT00374907|515390494|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
142959875|NCT00374907|515390493|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
142959876|NCT00374907|515390494|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
142959877|NCT01095250|515390495|FG000|Overall Study|administrative reasons|8|||
142959878|NCT01095250|515390496|FG001|Overall Study|administrative reasons|10|||
142959879|NCT01095250|515390497|FG002|Overall Study|administrative reasons|7|||
142959880|NCT01095250|515390498|FG003|Overall Study|administrative reasons|5|||
142959881|NCT01095250|515390495|FG000|Overall Study|Withdrawal by Subject|0|||
142959882|NCT01095250|515390496|FG001|Overall Study|Withdrawal by Subject|0|||
142959883|NCT01095250|515390497|FG002|Overall Study|Withdrawal by Subject|1|||
142959884|NCT01095250|515390498|FG003|Overall Study|Withdrawal by Subject|0|||
142959885|NCT02588248|515390499|FG000|Overall Study|Physician Decision|4|||
142959886|NCT02588248|515390500|FG001|Overall Study|Physician Decision|3|||
142959887|NCT00237796|515390501|FG000|Overall Study|Baseline and one other ILSS required|10|||
142959888|NCT00237796|515390502|FG001|Overall Study|Baseline and one other ILSS required|5|||
142959889|NCT03596177|515390504|FG000|Single Blind Period|Withdrawal by Subject|1|||
142959890|NCT03596177|515390505|FG001|Single Blind Period|Withdrawal by Subject|1|||
142959891|NCT03596177|515390504|FG000|Single Blind Period|Other|1|||
142959892|NCT03596177|515390505|FG001|Single Blind Period|Other|0|||
142959893|NCT03596177|515390504|FG000|Double Blind Period|Withdrawal by Subject|0|||
142959894|NCT03596177|515390505|FG001|Double Blind Period|Withdrawal by Subject|1|||
142959895|NCT03596177|515390504|FG000|Double Blind Period|Other|0|||
142959896|NCT03596177|515390505|FG001|Double Blind Period|Other|4|||
142959897|NCT03596177|515390504|FG000|Double Blind Period|Death during safety follow-up|0|||
142959898|NCT03596177|515390505|FG001|Double Blind Period|Death during safety follow-up|1|||
142959899|NCT02566525|515390506|FG000|Overall Study|Protocol Violation|3|||
142959900|NCT02566525|515390507|FG001|Overall Study|Protocol Violation|5|||
142959901|NCT03141086|515390510|FG000|Overall Study|Study Terminated By Sponsor|1|||
142959902|NCT03141086|515390511|FG001|Overall Study|Study Terminated By Sponsor|1|||
142959903|NCT03141086|515390510|FG000|Overall Study|Withdrawal by Subject|0|||
142959904|NCT03141086|515390511|FG001|Overall Study|Withdrawal by Subject|1|||
142959905|NCT03141086|515390510|FG000|Overall Study|Protocol Violation|0|||
142959906|NCT03141086|515390511|FG001|Overall Study|Protocol Violation|1|||
142959907|NCT03141086|515390510|FG000|Overall Study|Adverse Event|0|||
142959908|NCT03141086|515390511|FG001|Overall Study|Adverse Event|2|||
142959909|NCT04430582|515390512|FG000|Overall Study|Found to meet exclusionary criteria|1|||
142959910|NCT04430582|515390513|FG001|Overall Study|Found to meet exclusionary criteria|0|||
142959911|NCT04430582|515390512|FG000|Overall Study|Withdrawal by Subject|0|||
142959912|NCT04430582|515390513|FG001|Overall Study|Withdrawal by Subject|1|||
142959913|NCT05128162|515390514|FG000|Overall Study|Concerns about participant ability to follow study procedures|1|||
142959914|NCT05128162|515390514|FG000|Overall Study|Physician Decision|1|||
142959915|NCT04920084|515391632|FG000|Overall Study|Adverse Event|1|||
142959916|NCT04920084|515391632|FG000|Overall Study|Lost to Follow-up|2|||
142959917|NCT04920084|515391632|FG000|Overall Study|Withdrawal by Subject|2|||
142959918|NCT00620321|515391633|FG000|Overall Study|Adverse Event|1|||
142959919|NCT00620321|515391634|FG001|Overall Study|Adverse Event|1|||
142959920|NCT00620321|515391633|FG000|Overall Study|Death|1|||
142959921|NCT00620321|515391634|FG001|Overall Study|Death|1|||
142959922|NCT00620321|515391633|FG000|Overall Study|Physician Decision|0|||
142959923|NCT00620321|515391634|FG001|Overall Study|Physician Decision|7|||
142959924|NCT00620321|515391633|FG000|Overall Study|Progressive Disease|5|||
142959925|NCT00620321|515391634|FG001|Overall Study|Progressive Disease|5|||
142959926|NCT00620321|515391633|FG000|Overall Study|Sponsor Decision|0|||
142959927|NCT00620321|515391634|FG001|Overall Study|Sponsor Decision|1|||
142959928|NCT00620321|515391633|FG000|Overall Study|Withdrawal by Subject|1|||
143455339|NCT03541174|517212432|FG005|Part 2 Single-Blind|Adverse Event|0|||
142959929|NCT00620321|515391634|FG001|Overall Study|Withdrawal by Subject|1|||
142959930|NCT00953043|515391636|FG000|Overall Study|Withdrawal by Subject|4|||
142959931|NCT00953043|515391637|FG001|Overall Study|Withdrawal by Subject|0|||
142959932|NCT00953043|515391636|FG000|Overall Study|Physician Decision|0|||
142959933|NCT00953043|515391637|FG001|Overall Study|Physician Decision|2|||
142959934|NCT01675011|515391639|FG000|Overall Study|Trial terminated by Sponsor|3|||
142959935|NCT01675011|515391640|FG001|Overall Study|Trial terminated by Sponsor|1|||
142959936|NCT00718419|515391641|FG000|Overall Study|Adverse Event|2|||
142959937|NCT00718419|515391642|FG001|Overall Study|Adverse Event|1|||
143117139|NCT01273155|515970040|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
142959938|NCT00718419|515391641|FG000|Overall Study|Physician Decision|1|||
142959939|NCT00718419|515391642|FG001|Overall Study|Physician Decision|6|||
142959940|NCT00718419|515391641|FG000|Overall Study|Sponsor decision|0|||
142959941|NCT00718419|515391642|FG001|Overall Study|Sponsor decision|1|||
142959942|NCT00718419|515391641|FG000|Overall Study|Withdrawal by Subject|0|||
142959943|NCT00718419|515391642|FG001|Overall Study|Withdrawal by Subject|5|||
142959944|NCT00718419|515391641|FG000|Overall Study|Progressive Disease|7|||
142959945|NCT00718419|515391642|FG001|Overall Study|Progressive Disease|25|||
142959946|NCT00718419|515391641|FG000|Overall Study|Death Due to Progressive Disease|2|||
142959947|NCT00718419|515391642|FG001|Overall Study|Death Due to Progressive Disease|0|||
142959948|NCT00718419|515391641|FG000|Overall Study|Death Due to Study Drug Related|0|||
142959949|NCT00718419|515391642|FG001|Overall Study|Death Due to Study Drug Related|1|||
142959950|NCT00718419|515391641|FG000|Overall Study|Death Due to Adverse Events|1|||
142959951|NCT00718419|515391642|FG001|Overall Study|Death Due to Adverse Events|0|||
142959952|NCT00972478|515391650|FG000|Overall Study|Adverse Event|3|||
142959953|NCT00972478|515391651|FG001|Overall Study|Adverse Event|16|||
142959954|NCT00972478|515391650|FG000|Overall Study|Withdrawal by Subject|1|||
142959955|NCT00972478|515391651|FG001|Overall Study|Withdrawal by Subject|8|||
142959956|NCT00972478|515391650|FG000|Overall Study|Progression/Relapse|0|||
142959957|NCT00972478|515391651|FG001|Overall Study|Progression/Relapse|2|||
142959958|NCT00972478|515391650|FG000|Overall Study|Death|0|||
142959959|NCT00972478|515391651|FG001|Overall Study|Death|2|||
142959960|NCT00972478|515391650|FG000|Overall Study|Not protocol specified|1|||
142959961|NCT00972478|515391651|FG001|Overall Study|Not protocol specified|1|||
142959962|NCT00972478|515391650|FG000|Overall Study|Ineligible|1|||
142959963|NCT00972478|515391651|FG001|Overall Study|Ineligible|7|||
142959964|NCT00972478|515391650|FG000|Overall Study|Not start protocol treatment|1|||
142959965|NCT00972478|515391651|FG001|Overall Study|Not start protocol treatment|2|||
142959966|NCT02561000|515391652|FG000|Overall Study|Withdrawal by Subject|2|||
142959967|NCT02561000|515391653|FG001|Overall Study|Withdrawal by Subject|3|||
142959968|NCT02561000|515391654|FG002|Overall Study|Withdrawal by Subject|0|||
142959969|NCT02561000|515391652|FG000|Overall Study|Adverse Event|0|||
142959970|NCT02561000|515391653|FG001|Overall Study|Adverse Event|1|||
142959971|NCT02561000|515391654|FG002|Overall Study|Adverse Event|0|||
142959972|NCT03952468|515391655|FG000|Overall Study|Death|0|||
142959973|NCT03952468|515391656|FG001|Overall Study|Death|1|||
142959974|NCT03952468|515391655|FG000|Overall Study|Adverse Event|0|||
142959975|NCT03952468|515391656|FG001|Overall Study|Adverse Event|1|||
142959976|NCT03952468|515391655|FG000|Overall Study|Physician Decision|1|||
142959977|NCT03952468|515391656|FG001|Overall Study|Physician Decision|0|||
142959978|NCT03952468|515391655|FG000|Overall Study|Lost to Follow-up|3|||
142959979|NCT03952468|515391656|FG001|Overall Study|Lost to Follow-up|4|||
142959980|NCT03952468|515391655|FG000|Overall Study|Withdrawal by Subject|2|||
142959981|NCT03952468|515391656|FG001|Overall Study|Withdrawal by Subject|1|||
142959982|NCT00365716|515391657|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
142959983|NCT00365716|515391658|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
142959984|NCT00365716|515391659|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
142959985|NCT00365716|515391660|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
142959986|NCT00365716|515391661|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
142959987|NCT00365716|515391662|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
142959988|NCT00365716|515391663|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
142959989|NCT00365716|515391657|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
142959990|NCT00365716|515391658|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
142959991|NCT00365716|515391659|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
142959992|NCT00365716|515391660|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
142959993|NCT00365716|515391661|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
142959994|NCT00365716|515391662|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
142959995|NCT00365716|515391663|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
142959996|NCT00365716|515391657|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
142959997|NCT00365716|515391658|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
142959998|NCT00365716|515391659|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
142959999|NCT00365716|515391660|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
142960000|NCT00365716|515391661|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
142960001|NCT00365716|515391662|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
142960002|NCT00365716|515391663|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
142960003|NCT00365716|515391657|FG000|Base Study (Day 1 to Month 7)|Other|0|||
142960004|NCT00365716|515391658|FG001|Base Study (Day 1 to Month 7)|Other|1|||
142960005|NCT00365716|515391659|FG002|Base Study (Day 1 to Month 7)|Other|0|||
142960006|NCT00365716|515391660|FG003|Base Study (Day 1 to Month 7)|Other|0|||
142960007|NCT00365716|515391661|FG004|Base Study (Day 1 to Month 7)|Other|0|||
142960008|NCT00365716|515391662|FG005|Base Study (Day 1 to Month 7)|Other|0|||
142960009|NCT00365716|515391663|FG006|Base Study (Day 1 to Month 7)|Other|0|||
142960010|NCT00365716|515391657|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
142960011|NCT00365716|515391658|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
143117140|NCT01273155|515970041|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
142960012|NCT00365716|515391659|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
142960013|NCT00365716|515391660|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
142960014|NCT00365716|515391661|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
142960015|NCT00365716|515391662|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
142960016|NCT00365716|515391663|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
142960017|NCT00365716|515391657|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
142960018|NCT00365716|515391658|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
142960019|NCT00365716|515391659|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
142960020|NCT00365716|515391660|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
142960021|NCT00365716|515391661|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
142960022|NCT00365716|515391662|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
142960023|NCT00365716|515391663|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
142960024|NCT00365716|515391657|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
142960025|NCT00365716|515391658|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
142960026|NCT00365716|515391659|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
142960027|NCT00365716|515391660|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
142960028|NCT00365716|515391661|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
142960029|NCT00365716|515391662|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
142960030|NCT00365716|515391663|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
142960031|NCT00365716|515391657|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
142960032|NCT00365716|515391658|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
142960033|NCT00365716|515391659|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
142960034|NCT00365716|515391660|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
142960035|NCT00365716|515391661|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
142960036|NCT00365716|515391662|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
142960037|NCT00365716|515391663|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
142960038|NCT00365716|515391657|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
142960039|NCT00365716|515391658|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
142960040|NCT00365716|515391659|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
142960041|NCT00365716|515391660|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
142960042|NCT00365716|515391661|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
142960043|NCT00365716|515391662|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
142960044|NCT00365716|515391663|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
142960045|NCT00365716|515391657|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
142960046|NCT00365716|515391658|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
142960047|NCT00365716|515391659|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
142960048|NCT00365716|515391660|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
142960049|NCT00365716|515391661|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
142960050|NCT00365716|515391662|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
142960051|NCT00365716|515391663|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
142960052|NCT00365716|515391657|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
142960053|NCT00365716|515391658|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
142960054|NCT00365716|515391659|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
142960055|NCT00365716|515391660|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
142960056|NCT00365716|515391661|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
142960057|NCT00365716|515391662|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
142960058|NCT00365716|515391663|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
142960059|NCT00365716|515391657|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
142960060|NCT00365716|515391658|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
142960061|NCT00365716|515391659|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
142960062|NCT00365716|515391660|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
142960063|NCT00365716|515391661|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
142960064|NCT00365716|515391662|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
142960065|NCT00365716|515391663|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
142960066|NCT00365716|515391657|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
142960067|NCT00365716|515391658|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
142960068|NCT00365716|515391659|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
142960069|NCT00365716|515391660|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
142960070|NCT00365716|515391661|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
142960071|NCT00365716|515391662|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
142960072|NCT00365716|515391663|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
142960073|NCT00365716|515391657|FG000|Extension 1|Lost to Follow-up|0|||
142960074|NCT00365716|515391658|FG001|Extension 1|Lost to Follow-up|0|||
142960075|NCT00365716|515391659|FG002|Extension 1|Lost to Follow-up|0|||
142960076|NCT00365716|515391660|FG003|Extension 1|Lost to Follow-up|0|||
142960077|NCT00365716|515391661|FG004|Extension 1|Lost to Follow-up|0|||
142960078|NCT00365716|515391662|FG005|Extension 1|Lost to Follow-up|1|||
142960079|NCT00365716|515391663|FG006|Extension 1|Lost to Follow-up|0|||
142960080|NCT00365716|515391657|FG000|Extension 1|Other|0|||
142960081|NCT00365716|515391658|FG001|Extension 1|Other|0|||
142960082|NCT00365716|515391659|FG002|Extension 1|Other|0|||
142960083|NCT00365716|515391660|FG003|Extension 1|Other|0|||
142960084|NCT00365716|515391661|FG004|Extension 1|Other|0|||
142960085|NCT00365716|515391662|FG005|Extension 1|Other|9|||
142960086|NCT00365716|515391663|FG006|Extension 1|Other|0|||
142960087|NCT00365716|515391657|FG000|Extension 1|Moved|0|||
142960088|NCT00365716|515391658|FG001|Extension 1|Moved|0|||
142960089|NCT00365716|515391659|FG002|Extension 1|Moved|0|||
142960090|NCT00365716|515391660|FG003|Extension 1|Moved|0|||
142960091|NCT00365716|515391661|FG004|Extension 1|Moved|0|||
142960092|NCT00365716|515391662|FG005|Extension 1|Moved|4|||
142960093|NCT00365716|515391663|FG006|Extension 1|Moved|0|||
142960094|NCT00365716|515391657|FG000|Extension 1|Withdrawal by Subject|0|||
142960095|NCT00365716|515391658|FG001|Extension 1|Withdrawal by Subject|0|||
142960096|NCT00365716|515391659|FG002|Extension 1|Withdrawal by Subject|0|||
142960097|NCT00365716|515391660|FG003|Extension 1|Withdrawal by Subject|0|||
142960098|NCT00365716|515391661|FG004|Extension 1|Withdrawal by Subject|0|||
142960099|NCT00365716|515391662|FG005|Extension 1|Withdrawal by Subject|3|||
142960100|NCT00365716|515391663|FG006|Extension 1|Withdrawal by Subject|0|||
142960101|NCT00365716|515391657|FG000|Extension 1|Pregnancy|0|||
142960102|NCT00365716|515391658|FG001|Extension 1|Pregnancy|0|||
142960103|NCT00365716|515391659|FG002|Extension 1|Pregnancy|0|||
142960104|NCT00365716|515391660|FG003|Extension 1|Pregnancy|0|||
142960105|NCT00365716|515391661|FG004|Extension 1|Pregnancy|0|||
142960106|NCT00365716|515391662|FG005|Extension 1|Pregnancy|4|||
142960107|NCT00365716|515391663|FG006|Extension 1|Pregnancy|0|||
142960108|NCT00365716|515391657|FG000|Extension 1|Protocol Violation|0|||
142960109|NCT00365716|515391658|FG001|Extension 1|Protocol Violation|0|||
142960110|NCT00365716|515391659|FG002|Extension 1|Protocol Violation|0|||
142960111|NCT00365716|515391660|FG003|Extension 1|Protocol Violation|0|||
142960112|NCT00365716|515391661|FG004|Extension 1|Protocol Violation|0|||
142960113|NCT00365716|515391662|FG005|Extension 1|Protocol Violation|1|||
142960114|NCT00365716|515391663|FG006|Extension 1|Protocol Violation|0|||
142960115|NCT00365716|515391657|FG000|Extension 2|Lost to Follow-up|0|||
142960116|NCT00365716|515391658|FG001|Extension 2|Lost to Follow-up|0|||
142960117|NCT00365716|515391659|FG002|Extension 2|Lost to Follow-up|0|||
142960118|NCT00365716|515391660|FG003|Extension 2|Lost to Follow-up|0|||
142960119|NCT00365716|515391661|FG004|Extension 2|Lost to Follow-up|0|||
142960120|NCT00365716|515391662|FG005|Extension 2|Lost to Follow-up|0|||
142960121|NCT00365716|515391663|FG006|Extension 2|Lost to Follow-up|2|||
142960122|NCT00365716|515391657|FG000|Extension 2|Other|0|||
142960123|NCT00365716|515391658|FG001|Extension 2|Other|0|||
142960124|NCT00365716|515391659|FG002|Extension 2|Other|0|||
142960125|NCT00365716|515391660|FG003|Extension 2|Other|0|||
142960126|NCT00365716|515391661|FG004|Extension 2|Other|0|||
142960127|NCT00365716|515391662|FG005|Extension 2|Other|0|||
142960128|NCT00365716|515391663|FG006|Extension 2|Other|3|||
142960129|NCT00365716|515391657|FG000|Extension 2|Withdrawal by Subject|0|||
142960130|NCT00365716|515391658|FG001|Extension 2|Withdrawal by Subject|0|||
142960131|NCT00365716|515391659|FG002|Extension 2|Withdrawal by Subject|0|||
142960132|NCT00365716|515391660|FG003|Extension 2|Withdrawal by Subject|0|||
143455340|NCT03541174|517212427|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
143455341|NCT03541174|517212428|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
143455342|NCT03541174|517212429|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
143455343|NCT03541174|517212430|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
143455344|NCT03541174|517212431|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
143455345|NCT03541174|517212432|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
143455346|NCT03541174|517212427|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
143455347|NCT03541174|517212428|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
143455348|NCT03541174|517212429|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
143455349|NCT03541174|517212430|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
143455350|NCT03541174|517212431|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
143455351|NCT03541174|517212432|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
143455352|NCT03541174|517212427|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
143455353|NCT03541174|517212428|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
143455354|NCT03541174|517212429|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
143455355|NCT03541174|517212430|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
143455356|NCT03541174|517212431|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
143455357|NCT03541174|517212432|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
143455358|NCT03541174|517212427|FG000|Part 2 Single-Blind|Death|0|||
142960133|NCT00365716|515391661|FG004|Extension 2|Withdrawal by Subject|0|||
142960134|NCT00365716|515391662|FG005|Extension 2|Withdrawal by Subject|0|||
142960135|NCT00365716|515391663|FG006|Extension 2|Withdrawal by Subject|5|||
142960136|NCT02280291|515391664|FG000|Overall Study|Lost to Follow-up|2|||
142960137|NCT02280291|515391665|FG001|Overall Study|Lost to Follow-up|1|||
142960138|NCT02280291|515391666|FG002|Overall Study|Lost to Follow-up|3|||
142960139|NCT02280291|515391667|FG003|Overall Study|Lost to Follow-up|8|||
142960140|NCT02280291|515391664|FG000|Overall Study|Protocol Violation|1|||
142960141|NCT02280291|515391665|FG001|Overall Study|Protocol Violation|0|||
142960142|NCT02280291|515391666|FG002|Overall Study|Protocol Violation|0|||
142960143|NCT02280291|515391667|FG003|Overall Study|Protocol Violation|0|||
143455359|NCT03541174|517212428|FG001|Part 2 Single-Blind|Death|0|||
143455360|NCT03541174|517212429|FG002|Part 2 Single-Blind|Death|0|||
143455361|NCT03541174|517212430|FG003|Part 2 Single-Blind|Death|5|||
142960144|NCT02280291|515391664|FG000|Overall Study|Other|1|||
142960145|NCT02280291|515391665|FG001|Overall Study|Other|1|||
142960146|NCT02280291|515391666|FG002|Overall Study|Other|0|||
142960147|NCT02280291|515391667|FG003|Overall Study|Other|0|||
142960148|NCT00506077|515391669|FG000|Treatment Period 1|Adverse Event|2|||
142960149|NCT00506077|515391670|FG001|Treatment Period 1|Adverse Event|1|||
142960150|NCT00506077|515391669|FG000|Treatment Period 1|Lost to Follow-up|0|||
142960151|NCT00506077|515391670|FG001|Treatment Period 1|Lost to Follow-up|2|||
142960152|NCT00506077|515391669|FG000|Treatment Period 1|Withdrawal by Subject|2|||
142960153|NCT00506077|515391670|FG001|Treatment Period 1|Withdrawal by Subject|0|||
142960154|NCT00506077|515391669|FG000|Treatment Period 2|Adverse Event|0|||
142960155|NCT00506077|515391670|FG001|Treatment Period 2|Adverse Event|1|||
142960156|NCT00506077|515391669|FG000|Treatment Period 2|Withdrawal by Subject|1|||
142960157|NCT00506077|515391670|FG001|Treatment Period 2|Withdrawal by Subject|0|||
142960158|NCT00316303|515391672|FG000|Overall Study|Lost to Follow-up|11|||
142960159|NCT00316303|515391673|FG001|Overall Study|Lost to Follow-up|16|||
142960160|NCT02749721|515391680|FG000|Screening|Withdrawal by Subject|1|||
142960161|NCT02749721|515391680|FG000|Screening|Lost to Follow-up|2|||
142960162|NCT02749721|515391680|FG000|Screening|Protocol Violation|3|||
142960163|NCT02749721|515391680|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
142960164|NCT02749721|515391680|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
142960165|NCT02582749|515391688|FG000|Overall Study|Study terminated by funder|5|||
142960166|NCT02582749|515391689|FG001|Overall Study|Study terminated by funder|10|||
142960167|NCT02582749|515391688|FG000|Overall Study|Withdrawal by Subject|0|||
142960168|NCT02582749|515391689|FG001|Overall Study|Withdrawal by Subject|1|||
142960169|NCT00426751|515391693|FG000|Overall Study|Adverse Event|8|||
142960170|NCT00426751|515391694|FG001|Overall Study|Adverse Event|1|||
142960171|NCT00426751|515391693|FG000|Overall Study|Lost to Follow-up|7|||
142960172|NCT00426751|515391694|FG001|Overall Study|Lost to Follow-up|6|||
142960173|NCT00426751|515391693|FG000|Overall Study|Consent Withdrawn|0|||
142960174|NCT00426751|515391694|FG001|Overall Study|Consent Withdrawn|1|||
142960175|NCT00426751|515391693|FG000|Overall Study|Other Reasons|7|||
142960176|NCT00426751|515391694|FG001|Overall Study|Other Reasons|12|||
142960177|NCT03288779|515391699|FG000|Overall Study|Withdrawal by Subject|3|||
142960178|NCT01355068|515391703|FG000|First Intervention Period|Adverse Event|0|||
142960179|NCT01355068|515391704|FG001|First Intervention Period|Adverse Event|1|||
142960180|NCT01355068|515391703|FG000|First Intervention Period|Withdrawal by Subject|0|||
142960181|NCT01355068|515391704|FG001|First Intervention Period|Withdrawal by Subject|1|||
142960182|NCT00524745|515391705|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
142960183|NCT00524745|515391706|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
142960184|NCT00524745|515391707|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
142960185|NCT00524745|515391708|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
142960186|NCT02504892|515391709|FG000|Overall Study|Adverse event-pneumonitis|2|||
142960187|NCT00576693|515391710|FG000|Overall Study|Lost to Follow-up|7|||
142960188|NCT00576693|515391711|FG001|Overall Study|Lost to Follow-up|11|||
142960189|NCT00576693|515391710|FG000|Overall Study|Withdrawal by Subject|3|||
142960190|NCT00576693|515391711|FG001|Overall Study|Withdrawal by Subject|13|||
142960191|NCT01413178|515391712|FG000|Overall Study|Toxicity|1|||
142960192|NCT01413178|515391713|FG001|Overall Study|Toxicity|0|||
142960193|NCT01413178|515391712|FG000|Overall Study|Ineligible|0|||
142960194|NCT01413178|515391713|FG001|Overall Study|Ineligible|2|||
142960195|NCT00540449|515391714|FG000|Overall Study|Adverse Event|12|||
142960196|NCT00540449|515391715|FG001|Overall Study|Adverse Event|32|||
142960197|NCT00540449|515391714|FG000|Overall Study|Sponsor's Decision|1|||
142960198|NCT00540449|515391715|FG001|Overall Study|Sponsor's Decision|1|||
142960199|NCT00540449|515391714|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
142960200|NCT00540449|515391715|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
142960201|NCT00540449|515391714|FG000|Overall Study|Lost to Follow-up|19|||
142960202|NCT00540449|515391715|FG001|Overall Study|Lost to Follow-up|17|||
142960203|NCT00540449|515391714|FG000|Overall Study|Subject Non-Compliant|7|||
142960204|NCT00540449|515391715|FG001|Overall Study|Subject Non-Compliant|5|||
142960205|NCT00540449|515391714|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
142960206|NCT00540449|515391715|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
142960207|NCT00540449|515391714|FG000|Overall Study|Withdrawal by Subject|10|||
142960208|NCT00540449|515391715|FG001|Overall Study|Withdrawal by Subject|10|||
142960209|NCT00540449|515391714|FG000|Overall Study|Other|1|||
142960210|NCT00540449|515391715|FG001|Overall Study|Other|4|||
142960211|NCT00601523|515391716|FG000|Overall Study|Adverse Event|42|||
142960212|NCT00601523|515391717|FG001|Overall Study|Adverse Event|14|||
142960213|NCT00601523|515391716|FG000|Overall Study|Lack of Efficacy|3|||
142960214|NCT00601523|515391717|FG001|Overall Study|Lack of Efficacy|0|||
142960215|NCT00601523|515391716|FG000|Overall Study|Protocol Violation|5|||
143455362|NCT03541174|517212431|FG004|Part 2 Single-Blind|Death|0|||
142960216|NCT00601523|515391717|FG001|Overall Study|Protocol Violation|1|||
143455363|NCT03541174|517212432|FG005|Part 2 Single-Blind|Death|0|||
142960217|NCT00601523|515391716|FG000|Overall Study|Lost to Follow-up|0|||
142960218|NCT00601523|515391717|FG001|Overall Study|Lost to Follow-up|1|||
142960219|NCT00601523|515391716|FG000|Overall Study|Withdrawal by Subject|18|||
142960220|NCT00601523|515391717|FG001|Overall Study|Withdrawal by Subject|9|||
142960221|NCT00601523|515391716|FG000|Overall Study|Other|9|||
142960222|NCT00601523|515391717|FG001|Overall Study|Other|1|||
142960223|NCT03643432|515391718|FG000|Overall Study|Lost to Follow-up|1|||
142960224|NCT03643432|515391719|FG001|Overall Study|Lost to Follow-up|0|||
142960225|NCT00804193|515391720|FG000|Overall Study|Lack of baseline fungus|32|||
142960226|NCT00804193|515391721|FG001|Overall Study|Lack of baseline fungus|31|||
142960227|NCT00804193|515391722|FG002|Overall Study|Lack of baseline fungus|19|||
142960228|NCT00804193|515391720|FG000|Overall Study|Adverse Event|0|||
142960229|NCT00804193|515391721|FG001|Overall Study|Adverse Event|0|||
142960230|NCT00804193|515391722|FG002|Overall Study|Adverse Event|2|||
142960231|NCT00804193|515391720|FG000|Overall Study|Lack of Efficacy|1|||
142960232|NCT00804193|515391721|FG001|Overall Study|Lack of Efficacy|1|||
142960233|NCT00804193|515391722|FG002|Overall Study|Lack of Efficacy|3|||
142960234|NCT00804193|515391720|FG000|Overall Study|Protocol Violation|0|||
142960235|NCT00804193|515391721|FG001|Overall Study|Protocol Violation|8|||
142960236|NCT00804193|515391722|FG002|Overall Study|Protocol Violation|2|||
142960237|NCT00804193|515391720|FG000|Overall Study|Lost to Follow-up|3|||
142960238|NCT00804193|515391721|FG001|Overall Study|Lost to Follow-up|3|||
142960239|NCT00804193|515391722|FG002|Overall Study|Lost to Follow-up|4|||
142960240|NCT00804193|515391720|FG000|Overall Study|Withdrawal by Subject|3|||
142960241|NCT00804193|515391721|FG001|Overall Study|Withdrawal by Subject|1|||
142960242|NCT00804193|515391722|FG002|Overall Study|Withdrawal by Subject|2|||
142960243|NCT04072146|515391725|FG000|Overall Study|Adverse Event|0|||
142960244|NCT04072146|515391726|FG001|Overall Study|Adverse Event|1|||
142960245|NCT01617434|515391727|FG000|Overall Study|Adverse Event|12|||
142960246|NCT01617434|515391728|FG001|Overall Study|Adverse Event|3|||
142960247|NCT01617434|515391727|FG000|Overall Study|Protocol Violation|8|||
142960248|NCT01617434|515391728|FG001|Overall Study|Protocol Violation|7|||
142960249|NCT01617434|515391727|FG000|Overall Study|Withdrawal Criteria|12|||
142960250|NCT01617434|515391728|FG001|Overall Study|Withdrawal Criteria|37|||
142960251|NCT01617434|515391727|FG000|Overall Study|Unclassified|3|||
142960252|NCT01617434|515391728|FG001|Overall Study|Unclassified|4|||
142960253|NCT03283163|515391729|FG000|Overall Study|Lost to Follow-up|1|||
142960254|NCT03283163|515391729|FG000|Overall Study|other life commitments|6|||
142960255|NCT03283163|515391729|FG000|Overall Study|COVID-19 institution wide halting|1|||
142960256|NCT03283163|515391729|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
142960257|NCT03283163|515391729|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
142960258|NCT00968253|515391730|FG000|Overall Study|Death|0|||
142960259|NCT00968253|515391731|FG001|Overall Study|Death|0|||
142960260|NCT00968253|515391732|FG002|Overall Study|Death|2|||
142960261|NCT00968253|515391730|FG000|Overall Study|Withdrawal by Subject|0|||
142960262|NCT00968253|515391731|FG001|Overall Study|Withdrawal by Subject|0|||
142960263|NCT00968253|515391732|FG002|Overall Study|Withdrawal by Subject|1|||
142960264|NCT00968253|515391730|FG000|Overall Study|Disease Progression|0|||
142960265|NCT00968253|515391731|FG001|Overall Study|Disease Progression|3|||
142960266|NCT00968253|515391732|FG002|Overall Study|Disease Progression|3|||
142960267|NCT00968253|515391730|FG000|Overall Study|Adverse Event|0|||
142960268|NCT00968253|515391731|FG001|Overall Study|Adverse Event|0|||
142960269|NCT00968253|515391732|FG002|Overall Study|Adverse Event|1|||
142960270|NCT00370149|515391734|FG000|Overall Study|Physician Decision|16|||
142960271|NCT00370149|515391735|FG001|Overall Study|Physician Decision|16|||
142960272|NCT00370149|515391734|FG000|Overall Study|Protocol Violation|1|||
142960273|NCT00370149|515391735|FG001|Overall Study|Protocol Violation|0|||
142960274|NCT00370149|515391734|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
142960275|NCT00370149|515391735|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
142960276|NCT00370149|515391734|FG000|Overall Study|Pre-existing infection|0|||
142960277|NCT00370149|515391735|FG001|Overall Study|Pre-existing infection|1|||
142960278|NCT00370149|515391734|FG000|Overall Study|Antibiotic coated dressing placed|0|||
142960279|NCT00370149|515391735|FG001|Overall Study|Antibiotic coated dressing placed|1|||
142960280|NCT05306873|515392830|FG000|Stage 2|Study stopped|1|||
142960281|NCT05306873|515392831|FG001|Stage 2|Study stopped|1|||
142960282|NCT05306873|515392832|FG002|Stage 2|Study stopped|0|||
142960283|NCT05306873|515392833|FG003|Stage 2|Study stopped|0|||
142960284|NCT05306873|515392830|FG000|Stage 2|Stage 2 Treatment Failure|2|||
142960285|NCT05306873|515392831|FG001|Stage 2|Stage 2 Treatment Failure|3|||
142960286|NCT05306873|515392832|FG002|Stage 2|Stage 2 Treatment Failure|0|||
142960287|NCT05306873|515392833|FG003|Stage 2|Stage 2 Treatment Failure|0|||
142960288|NCT05306873|515392830|FG000|Stage 2|Logistical issues due to participant moving|1|||
142960289|NCT05306873|515392831|FG001|Stage 2|Logistical issues due to participant moving|0|||
142960290|NCT05306873|515392832|FG002|Stage 2|Logistical issues due to participant moving|0|||
142960291|NCT05306873|515392833|FG003|Stage 2|Logistical issues due to participant moving|0|||
142960292|NCT05306873|515392830|FG000|Stage 3|Stage 3 Treatment Failure|0|||
142960293|NCT05306873|515392831|FG001|Stage 3|Stage 3 Treatment Failure|0|||
142960294|NCT05306873|515392832|FG002|Stage 3|Stage 3 Treatment Failure|0|||
142960295|NCT05306873|515392833|FG003|Stage 3|Stage 3 Treatment Failure|1|||
142960296|NCT05306873|515392830|FG000|Stage 3|Study Stopped|0|||
142960297|NCT05306873|515392831|FG001|Stage 3|Study Stopped|0|||
142960298|NCT05306873|515392832|FG002|Stage 3|Study Stopped|1|||
142960299|NCT05306873|515392833|FG003|Stage 3|Study Stopped|0|||
142960300|NCT02340819|515392834|FG000|Overall Study|Adverse Event|1|||
142960301|NCT02340819|515392834|FG000|Overall Study|Withdrawal by Subject|2|||
142960302|NCT02340819|515392834|FG000|Overall Study|Discontinued with other reason|1|||
142960303|NCT02361762|515392835|FG000|Overall Study|Withdrawal by Subject|0|||
142960304|NCT02361762|515392836|FG001|Overall Study|Withdrawal by Subject|1|||
142960305|NCT02361762|515392835|FG000|Overall Study|Lost to Follow-up|0|||
142960306|NCT02361762|515392836|FG001|Overall Study|Lost to Follow-up|1|||
142960307|NCT00028002|515392839|FG000|Overall Study|Withdrawal by Subject|3|||
142960308|NCT00028002|515392839|FG000|Overall Study|Ineligible|8|||
142960309|NCT04467164|515392843|FG000|Washout (1 Week)|Lost to Follow-up|2|||
142960310|NCT04467164|515392844|FG001|Washout (1 Week)|Lost to Follow-up|0|||
142960311|NCT01701583|515392845|FG000|Overall Study|Withdrawal by Subject|2|||
142960312|NCT01701583|515392846|FG001|Overall Study|Withdrawal by Subject|0|||
142960313|NCT01441440|515392847|FG000|Overall Study|Death|1|||
142960314|NCT01441440|515392848|FG001|Overall Study|Death|0|||
142960315|NCT01441440|515392849|FG002|Overall Study|Death|1|||
142960316|NCT01441440|515392847|FG000|Overall Study|Adverse Event|2|||
142960317|NCT01441440|515392848|FG001|Overall Study|Adverse Event|9|||
142960318|NCT01441440|515392849|FG002|Overall Study|Adverse Event|9|||
142960319|NCT01441440|515392847|FG000|Overall Study|Lost to Follow-up|0|||
142960320|NCT01441440|515392848|FG001|Overall Study|Lost to Follow-up|2|||
142960321|NCT01441440|515392849|FG002|Overall Study|Lost to Follow-up|1|||
142960322|NCT01441440|515392847|FG000|Overall Study|Withdrawal by Subject|11|||
142960323|NCT01441440|515392848|FG001|Overall Study|Withdrawal by Subject|9|||
142960324|NCT01441440|515392849|FG002|Overall Study|Withdrawal by Subject|9|||
142960325|NCT01441440|515392847|FG000|Overall Study|Pregnancy|1|||
142960326|NCT01441440|515392848|FG001|Overall Study|Pregnancy|0|||
142960327|NCT01441440|515392849|FG002|Overall Study|Pregnancy|0|||
142960328|NCT01441440|515392847|FG000|Overall Study|Lack of Efficacy|1|||
142960329|NCT01441440|515392848|FG001|Overall Study|Lack of Efficacy|0|||
142960330|NCT01441440|515392849|FG002|Overall Study|Lack of Efficacy|1|||
142960331|NCT01441440|515392847|FG000|Overall Study|Moving|0|||
142960332|NCT01441440|515392848|FG001|Overall Study|Moving|1|||
142960333|NCT01441440|515392849|FG002|Overall Study|Moving|1|||
142960334|NCT01441440|515392847|FG000|Overall Study|Work-related matter|0|||
142960335|NCT01441440|515392848|FG001|Overall Study|Work-related matter|1|||
142960336|NCT01441440|515392849|FG002|Overall Study|Work-related matter|0|||
142960337|NCT01441440|515392847|FG000|Overall Study|Difficllty in keeping the schedule|1|||
142960338|NCT01441440|515392848|FG001|Overall Study|Difficllty in keeping the schedule|1|||
142960339|NCT01441440|515392849|FG002|Overall Study|Difficllty in keeping the schedule|0|||
142960340|NCT02750813|515392850|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
142960341|NCT02750813|515392851|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
142960342|NCT02750813|515392850|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
142960343|NCT02750813|515392851|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
142960344|NCT01345123|515392852|FG000|Overall Study|participants no longer with health plan|79|||
142960345|NCT01345123|515392853|FG001|Overall Study|participants no longer with health plan|85|||
142960346|NCT01345123|515392854|FG002|Overall Study|participants no longer with health plan|88|||
142960347|NCT00883558|515392855|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
142960348|NCT00883558|515392856|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
142960349|NCT00883558|515392857|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
142960350|NCT00883558|515392855|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
142960351|NCT00883558|515392856|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
142960352|NCT00883558|515392857|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
142960353|NCT00883558|515392855|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
142960354|NCT00883558|515392856|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
142960355|NCT00883558|515392857|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
142960356|NCT00883558|515392855|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
142960357|NCT00883558|515392856|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
142960358|NCT00883558|515392857|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
142960359|NCT00883558|515392855|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
142960360|NCT00883558|515392856|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
142960361|NCT00883558|515392857|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
142960362|NCT01252134|515392859|FG000|Period 1, 8 Hours|Personal Reasons|0|||
142960363|NCT01252134|515392860|FG001|Period 1, 8 Hours|Personal Reasons|1|||
142960364|NCT01252134|515392861|FG002|Period 1, 8 Hours|Personal Reasons|1|||
142960365|NCT01252134|515392862|FG003|Period 1, 8 Hours|Personal Reasons|0|||
142960366|NCT01252134|515392863|FG004|Period 1, 8 Hours|Personal Reasons|0|||
142960367|NCT01252134|515392864|FG005|Period 1, 8 Hours|Personal Reasons|0|||
143117493|NCT01472939|515971862|FG001|Overall Study|Protocol Violation|3|||
142960368|NCT02273050|515392866|FG000|Overall Study|Adverse Event|4|||
142960369|NCT02273050|515392867|FG001|Overall Study|Adverse Event|3|||
142960370|NCT02273050|515392868|FG002|Overall Study|Adverse Event|3|||
142960371|NCT02273050|515392866|FG000|Overall Study|Death|0|||
142960372|NCT02273050|515392867|FG001|Overall Study|Death|0|||
142960373|NCT02273050|515392868|FG002|Overall Study|Death|1|||
142960374|NCT02273050|515392866|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
142960375|NCT02273050|515392867|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
142960376|NCT02273050|515392868|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
142960377|NCT02273050|515392866|FG000|Overall Study|Lack of Efficacy|0|||
142960378|NCT02273050|515392867|FG001|Overall Study|Lack of Efficacy|1|||
142960379|NCT02273050|515392868|FG002|Overall Study|Lack of Efficacy|1|||
142960380|NCT02273050|515392866|FG000|Overall Study|Withdrawal by Subject|17|||
142960381|NCT02273050|515392867|FG001|Overall Study|Withdrawal by Subject|14|||
142960382|NCT02273050|515392868|FG002|Overall Study|Withdrawal by Subject|16|||
142960383|NCT02273050|515392866|FG000|Overall Study|Lost to Follow-up|0|||
142960384|NCT02273050|515392867|FG001|Overall Study|Lost to Follow-up|2|||
142960385|NCT02273050|515392868|FG002|Overall Study|Lost to Follow-up|3|||
142960386|NCT02273050|515392866|FG000|Overall Study|Protocol Violation|3|||
142960387|NCT02273050|515392867|FG001|Overall Study|Protocol Violation|1|||
142960388|NCT02273050|515392868|FG002|Overall Study|Protocol Violation|4|||
142960389|NCT02678741|515392869|FG000|Overall Study|Death|4|||
142960390|NCT02678741|515392869|FG000|Overall Study|Withdrawal by Subject|1|||
142960391|NCT02678741|515392869|FG000|Overall Study|ineligible|3|||
142960392|NCT02678741|515392869|FG000|Overall Study|Not RECIST Measurable|2|||
142960393|NCT02678741|515392869|FG000|Overall Study|Lack of Efficacy|10|||
142960394|NCT00903032|515392870|FG000|Overall Study|Withdrawal by Subject|5|||
142960395|NCT00903032|515392871|FG001|Overall Study|Withdrawal by Subject|3|||
142960396|NCT00903032|515392870|FG000|Overall Study|Lost to Follow-up|2|||
142960397|NCT00903032|515392871|FG001|Overall Study|Lost to Follow-up|2|||
142960398|NCT01795898|515392873|FG000|Overall Study|Adverse Event|27|||
142960399|NCT01795898|515392873|FG000|Overall Study|Lost to Follow-up|20|||
142960400|NCT01795898|515392873|FG000|Overall Study|Withdrawal of consent|6|||
142960401|NCT01795898|515392873|FG000|Overall Study|Diagnosed with metastasis|1|||
142960402|NCT01795898|515392873|FG000|Overall Study|No pain|1|||
142960403|NCT01795898|515392873|FG000|Overall Study|Death|1|||
142960404|NCT01795898|515392873|FG000|Overall Study|Withdrew consent & had adverse events|3|||
142960405|NCT01795898|515392873|FG000|Overall Study|Physician Decision|1|||
142960406|NCT01675531|515392874|FG000|Overall Study|Adverse Event|9|||
142960407|NCT01675531|515392874|FG000|Overall Study|Withdrawal by Subject|7|||
142960408|NCT01675531|515392874|FG000|Overall Study|Lack of Efficacy|1|||
142960409|NCT01675531|515392874|FG000|Overall Study|Protocol Violation|8|||
142960410|NCT01623531|515392875|FG000|Overall Study|Death|1|||
142960411|NCT01623531|515392876|FG001|Overall Study|Death|0|||
142960412|NCT01623531|515392875|FG000|Overall Study|Protocol Violation|2|||
142960413|NCT01623531|515392876|FG001|Overall Study|Protocol Violation|1|||
142960414|NCT01623531|515392875|FG000|Overall Study|Missing data at primary outcome time poi|1|||
142960415|NCT01623531|515392876|FG001|Overall Study|Missing data at primary outcome time poi|1|||
142960416|NCT04184622|515392878|FG000|Primary Treatment Period|Adverse Event|6|||
142960417|NCT04184622|515392879|FG001|Primary Treatment Period|Adverse Event|4|||
142960418|NCT04184622|515392880|FG002|Primary Treatment Period|Adverse Event|8|||
142960419|NCT04184622|515392881|FG003|Primary Treatment Period|Adverse Event|6|||
142960420|NCT04184622|515392878|FG000|Primary Treatment Period|Death|4|||
142960421|NCT04184622|515392879|FG001|Primary Treatment Period|Death|4|||
142960422|NCT04184622|515392880|FG002|Primary Treatment Period|Death|2|||
142960423|NCT04184622|515392881|FG003|Primary Treatment Period|Death|1|||
142960424|NCT04184622|515392878|FG000|Primary Treatment Period|Lost to Follow-up|41|||
142960425|NCT04184622|515392879|FG001|Primary Treatment Period|Lost to Follow-up|17|||
142960426|NCT04184622|515392880|FG002|Primary Treatment Period|Lost to Follow-up|15|||
142960427|NCT04184622|515392881|FG003|Primary Treatment Period|Lost to Follow-up|13|||
142960428|NCT04184622|515392878|FG000|Primary Treatment Period|Other - as reported by the investigator|21|||
142960429|NCT04184622|515392879|FG001|Primary Treatment Period|Other - as reported by the investigator|7|||
142960430|NCT04184622|515392880|FG002|Primary Treatment Period|Other - as reported by the investigator|6|||
142960431|NCT04184622|515392881|FG003|Primary Treatment Period|Other - as reported by the investigator|12|||
142960432|NCT04184622|515392878|FG000|Primary Treatment Period|Physician Decision|0|||
142960433|NCT04184622|515392879|FG001|Primary Treatment Period|Physician Decision|0|||
142960434|NCT04184622|515392880|FG002|Primary Treatment Period|Physician Decision|3|||
142960435|NCT04184622|515392881|FG003|Primary Treatment Period|Physician Decision|1|||
142960436|NCT04184622|515392878|FG000|Primary Treatment Period|Pregnancy|4|||
142960437|NCT04184622|515392879|FG001|Primary Treatment Period|Pregnancy|3|||
142960438|NCT04184622|515392880|FG002|Primary Treatment Period|Pregnancy|4|||
142960439|NCT04184622|515392881|FG003|Primary Treatment Period|Pregnancy|1|||
142960440|NCT04184622|515392878|FG000|Primary Treatment Period|Withdrawal by Subject|58|||
142960441|NCT04184622|515392879|FG001|Primary Treatment Period|Withdrawal by Subject|26|||
142960442|NCT04184622|515392880|FG002|Primary Treatment Period|Withdrawal by Subject|32|||
142960443|NCT04184622|515392881|FG003|Primary Treatment Period|Withdrawal by Subject|21|||
142960444|NCT04184622|515392878|FG000|Additional Treatment Period|Adverse Event|1|||
142960445|NCT04184622|515392879|FG001|Additional Treatment Period|Adverse Event|2|||
142960446|NCT04184622|515392880|FG002|Additional Treatment Period|Adverse Event|1|||
142960447|NCT04184622|515392881|FG003|Additional Treatment Period|Adverse Event|0|||
142960448|NCT04184622|515392878|FG000|Additional Treatment Period|Death|0|||
142960449|NCT04184622|515392879|FG001|Additional Treatment Period|Death|0|||
142960450|NCT04184622|515392880|FG002|Additional Treatment Period|Death|1|||
142960451|NCT04184622|515392881|FG003|Additional Treatment Period|Death|1|||
142960452|NCT04184622|515392878|FG000|Additional Treatment Period|Lost to Follow-up|6|||
142960453|NCT04184622|515392879|FG001|Additional Treatment Period|Lost to Follow-up|4|||
142960454|NCT04184622|515392880|FG002|Additional Treatment Period|Lost to Follow-up|8|||
142960455|NCT04184622|515392881|FG003|Additional Treatment Period|Lost to Follow-up|6|||
142960456|NCT04184622|515392878|FG000|Additional Treatment Period|Other - as reported by the investigator|2|||
142960457|NCT04184622|515392879|FG001|Additional Treatment Period|Other - as reported by the investigator|5|||
142960458|NCT04184622|515392880|FG002|Additional Treatment Period|Other - as reported by the investigator|2|||
142960459|NCT04184622|515392881|FG003|Additional Treatment Period|Other - as reported by the investigator|0|||
142960460|NCT04184622|515392878|FG000|Additional Treatment Period|Physician Decision|0|||
142960461|NCT04184622|515392879|FG001|Additional Treatment Period|Physician Decision|0|||
142960462|NCT04184622|515392880|FG002|Additional Treatment Period|Physician Decision|1|||
142960463|NCT04184622|515392881|FG003|Additional Treatment Period|Physician Decision|0|||
142960464|NCT04184622|515392878|FG000|Additional Treatment Period|Pregnancy|0|||
142960465|NCT04184622|515392879|FG001|Additional Treatment Period|Pregnancy|0|||
142960466|NCT04184622|515392880|FG002|Additional Treatment Period|Pregnancy|0|||
142960467|NCT04184622|515392881|FG003|Additional Treatment Period|Pregnancy|1|||
142960468|NCT04184622|515392878|FG000|Additional Treatment Period|Protocol deviation|0|||
142960469|NCT04184622|515392879|FG001|Additional Treatment Period|Protocol deviation|0|||
142960470|NCT04184622|515392880|FG002|Additional Treatment Period|Protocol deviation|1|||
142960471|NCT04184622|515392881|FG003|Additional Treatment Period|Protocol deviation|0|||
142960472|NCT04184622|515392878|FG000|Additional Treatment Period|Site closed|1|||
142960473|NCT04184622|515392879|FG001|Additional Treatment Period|Site closed|0|||
142960474|NCT04184622|515392880|FG002|Additional Treatment Period|Site closed|1|||
142960475|NCT04184622|515392881|FG003|Additional Treatment Period|Site closed|0|||
142960476|NCT04184622|515392878|FG000|Additional Treatment Period|Withdrawal by Subject|21|||
142960477|NCT04184622|515392879|FG001|Additional Treatment Period|Withdrawal by Subject|15|||
142960478|NCT04184622|515392880|FG002|Additional Treatment Period|Withdrawal by Subject|3|||
142960479|NCT04184622|515392881|FG003|Additional Treatment Period|Withdrawal by Subject|7|||
142960480|NCT04184622|515392878|FG000|Safety Follow-up Period|Adverse Event|6|||
142960481|NCT04184622|515392879|FG001|Safety Follow-up Period|Adverse Event|8|||
142960482|NCT04184622|515392880|FG002|Safety Follow-up Period|Adverse Event|9|||
142960483|NCT04184622|515392881|FG003|Safety Follow-up Period|Adverse Event|16|||
142960484|NCT04184622|515392878|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
142960485|NCT04184622|515392879|FG001|Safety Follow-up Period|Lost to Follow-up|4|||
142960486|NCT04184622|515392880|FG002|Safety Follow-up Period|Lost to Follow-up|10|||
142960487|NCT04184622|515392881|FG003|Safety Follow-up Period|Lost to Follow-up|3|||
142960488|NCT04184622|515392878|FG000|Safety Follow-up Period|Missing Weight at Week 176|3|||
142960489|NCT04184622|515392879|FG001|Safety Follow-up Period|Missing Weight at Week 176|2|||
142960490|NCT04184622|515392880|FG002|Safety Follow-up Period|Missing Weight at Week 176|2|||
142960491|NCT04184622|515392881|FG003|Safety Follow-up Period|Missing Weight at Week 176|2|||
142960492|NCT04184622|515392878|FG000|Safety Follow-up Period|Other - as reported by the investigator|10|||
142960493|NCT04184622|515392879|FG001|Safety Follow-up Period|Other - as reported by the investigator|5|||
142960494|NCT04184622|515392880|FG002|Safety Follow-up Period|Other - as reported by the investigator|6|||
142960495|NCT04184622|515392881|FG003|Safety Follow-up Period|Other - as reported by the investigator|5|||
142960496|NCT04184622|515392878|FG000|Safety Follow-up Period|Physician Decision|1|||
142960497|NCT04184622|515392879|FG001|Safety Follow-up Period|Physician Decision|0|||
142960498|NCT04184622|515392880|FG002|Safety Follow-up Period|Physician Decision|0|||
142960499|NCT04184622|515392881|FG003|Safety Follow-up Period|Physician Decision|1|||
142960500|NCT04184622|515392878|FG000|Safety Follow-up Period|Pregnancy|1|||
142960501|NCT04184622|515392879|FG001|Safety Follow-up Period|Pregnancy|3|||
142960502|NCT04184622|515392880|FG002|Safety Follow-up Period|Pregnancy|0|||
142960503|NCT04184622|515392881|FG003|Safety Follow-up Period|Pregnancy|6|||
142960504|NCT04184622|515392878|FG000|Safety Follow-up Period|Protocol deviation|1|||
142960505|NCT04184622|515392879|FG001|Safety Follow-up Period|Protocol deviation|0|||
142960506|NCT04184622|515392880|FG002|Safety Follow-up Period|Protocol deviation|0|||
142960507|NCT04184622|515392881|FG003|Safety Follow-up Period|Protocol deviation|0|||
142960508|NCT04184622|515392878|FG000|Safety Follow-up Period|Withdrawal by Subject|31|||
142960509|NCT04184622|515392879|FG001|Safety Follow-up Period|Withdrawal by Subject|13|||
142960510|NCT04184622|515392880|FG002|Safety Follow-up Period|Withdrawal by Subject|7|||
142960511|NCT04184622|515392881|FG003|Safety Follow-up Period|Withdrawal by Subject|9|||
142960512|NCT05761444|515392884|FG000|Overall Study|Protocol Violation|2|||
142960513|NCT05761444|515392885|FG001|Overall Study|Protocol Violation|1|||
142960514|NCT05761444|515392884|FG000|Overall Study|Adverse Event|2|||
142960515|NCT05761444|515392885|FG001|Overall Study|Adverse Event|2|||
142960516|NCT05761444|515392884|FG000|Overall Study|Withdrawal by Subject|3|||
142960517|NCT05761444|515392885|FG001|Overall Study|Withdrawal by Subject|2|||
142960518|NCT05761444|515392884|FG000|Overall Study|Other|1|||
142960519|NCT05761444|515392885|FG001|Overall Study|Other|0|||
142960520|NCT03508622|515392886|FG000|Overall Study|Protocol Violation|1|||
142960521|NCT03508622|515392887|FG001|Overall Study|Protocol Violation|0|||
142960522|NCT03508622|515392886|FG000|Overall Study|Withdrawal by Subject|1|||
142960523|NCT03508622|515392887|FG001|Overall Study|Withdrawal by Subject|0|||
142960524|NCT03508622|515392886|FG000|Overall Study|Lost to Follow-up|16|||
142960525|NCT03508622|515392887|FG001|Overall Study|Lost to Follow-up|0|||
142960526|NCT03508622|515392886|FG000|Overall Study|Incomplete data|0|||
142960527|NCT03508622|515392887|FG001|Overall Study|Incomplete data|24|||
142960528|NCT00850759|515392889|FG000|Overall Study|Lost to Follow-up|7|||
142960529|NCT00850759|515392890|FG001|Overall Study|Lost to Follow-up|5|||
142960530|NCT00850759|515392891|FG002|Overall Study|Lost to Follow-up|5|||
142960531|NCT00850759|515392892|FG003|Overall Study|Lost to Follow-up|3|||
142960532|NCT03196505|515392893|FG000|Overall Study|Physician Decision|26|||
142960533|NCT03196505|515392894|FG001|Overall Study|Physician Decision|26|||
142960534|NCT01005719|515392895|FG000|Period 1|Adverse Event|0|||
142960535|NCT01005719|515392896|FG001|Period 1|Adverse Event|0|||
142960536|NCT01005719|515392897|FG002|Period 1|Adverse Event|0|||
142960537|NCT01005719|515392898|FG003|Period 1|Adverse Event|1|||
142960538|NCT01005719|515392899|FG004|Period 1|Adverse Event|0|||
142960539|NCT01005719|515392900|FG005|Period 1|Adverse Event|0|||
142960540|NCT01005719|515392895|FG000|Period 1|Delay in completing study procedures|0|||
142960541|NCT01005719|515392896|FG001|Period 1|Delay in completing study procedures|0|||
142960542|NCT01005719|515392897|FG002|Period 1|Delay in completing study procedures|0|||
142960543|NCT01005719|515392898|FG003|Period 1|Delay in completing study procedures|0|||
142960544|NCT01005719|515392899|FG004|Period 1|Delay in completing study procedures|0|||
142960545|NCT01005719|515392900|FG005|Period 1|Delay in completing study procedures|1|||
142960546|NCT01005719|515392895|FG000|Period 2|Adverse Event|0|||
142960547|NCT01005719|515392896|FG001|Period 2|Adverse Event|0|||
142960548|NCT01005719|515392897|FG002|Period 2|Adverse Event|0|||
142960549|NCT01005719|515392898|FG003|Period 2|Adverse Event|0|||
142960550|NCT01005719|515392899|FG004|Period 2|Adverse Event|1|||
142960551|NCT01005719|515392900|FG005|Period 2|Adverse Event|1|||
142960552|NCT02389816|515392901|FG000|Overall Study|Randomized but Not Treated|1|||
142960553|NCT02389816|515392902|FG001|Overall Study|Randomized but Not Treated|0|||
142960554|NCT02389816|515392903|FG002|Overall Study|Randomized but Not Treated|0|||
142960555|NCT02389816|515392901|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
142960556|NCT02389816|515392902|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
142960557|NCT02389816|515392903|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
142960558|NCT02389816|515392901|FG000|Overall Study|Major Protocol Deviation|1|||
142960559|NCT02389816|515392902|FG001|Overall Study|Major Protocol Deviation|0|||
142960560|NCT02389816|515392903|FG002|Overall Study|Major Protocol Deviation|0|||
142960561|NCT02389816|515392901|FG000|Overall Study|Lost to Follow-up|1|||
142960562|NCT02389816|515392902|FG001|Overall Study|Lost to Follow-up|0|||
142960563|NCT02389816|515392903|FG002|Overall Study|Lost to Follow-up|0|||
142960564|NCT02389816|515392901|FG000|Overall Study|Withdrawal of Consent|6|||
142960565|NCT02389816|515392902|FG001|Overall Study|Withdrawal of Consent|4|||
142960566|NCT02389816|515392903|FG002|Overall Study|Withdrawal of Consent|4|||
142960567|NCT02389816|515392901|FG000|Overall Study|Lack of Efficacy|1|||
142960568|NCT02389816|515392902|FG001|Overall Study|Lack of Efficacy|0|||
142960569|NCT02389816|515392903|FG002|Overall Study|Lack of Efficacy|0|||
142960570|NCT02389816|515392901|FG000|Overall Study|Non Compliance with Study Drug|1|||
142960571|NCT02389816|515392902|FG001|Overall Study|Non Compliance with Study Drug|1|||
142960572|NCT02389816|515392903|FG002|Overall Study|Non Compliance with Study Drug|1|||
142960573|NCT02389816|515392901|FG000|Overall Study|Reason not Specified|0|||
142960574|NCT02389816|515392902|FG001|Overall Study|Reason not Specified|2|||
142960575|NCT02389816|515392903|FG002|Overall Study|Reason not Specified|0|||
142960576|NCT02918266|515392904|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
142960577|NCT02918266|515392905|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
142960578|NCT02918266|515392906|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
142960579|NCT02918266|515392907|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
142960580|NCT02918266|515392908|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
142960581|NCT02918266|515392909|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
142960582|NCT02918266|515392910|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
142960583|NCT02918266|515392911|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
142960584|NCT02918266|515392912|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
142960585|NCT02918266|515392913|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
142960586|NCT02918266|515392914|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
142960587|NCT01259856|515392921|FG000|Overall Study|Adverse Event|12|||
142960588|NCT01259856|515392922|FG001|Overall Study|Adverse Event|9|||
142960589|NCT01259856|515392921|FG000|Overall Study|Death|0|||
142960590|NCT01259856|515392922|FG001|Overall Study|Death|1|||
142960591|NCT01259856|515392921|FG000|Overall Study|Lack of Efficacy|3|||
142960592|NCT01259856|515392922|FG001|Overall Study|Lack of Efficacy|1|||
142960593|NCT01259856|515392921|FG000|Overall Study|Lost to Follow-up|1|||
142960594|NCT01259856|515392922|FG001|Overall Study|Lost to Follow-up|1|||
142960595|NCT01259856|515392921|FG000|Overall Study|Physician Decision|2|||
142960596|NCT01259856|515392922|FG001|Overall Study|Physician Decision|1|||
142960597|NCT01259856|515392921|FG000|Overall Study|Withdrawal by Subject|9|||
142960598|NCT01259856|515392922|FG001|Overall Study|Withdrawal by Subject|10|||
142960599|NCT01259856|515392921|FG000|Overall Study|Treatment never started|0|||
142960600|NCT01259856|515392922|FG001|Overall Study|Treatment never started|6|||
142960601|NCT01259856|515392921|FG000|Overall Study|Study closure by sponsor|40|||
142960602|NCT01259856|515392922|FG001|Overall Study|Study closure by sponsor|41|||
142960603|NCT01259856|515392921|FG000|Overall Study|Patient developed other disease|0|||
142960604|NCT01259856|515392922|FG001|Overall Study|Patient developed other disease|1|||
142960605|NCT01259856|515392921|FG000|Overall Study|Transfer to another study|0|||
142960606|NCT01259856|515392922|FG001|Overall Study|Transfer to another study|1|||
142960607|NCT01259856|515392921|FG000|Overall Study|Unknown/missing|2|||
142960608|NCT01259856|515392922|FG001|Overall Study|Unknown/missing|2|||
142960609|NCT01293032|515392923|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
142960610|NCT01293032|515392924|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
142960611|NCT01293032|515392925|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
142960612|NCT01293032|515392926|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
142960613|NCT01293032|515392923|FG000|Treatment|Adverse Event|0|||
142960614|NCT01293032|515392924|FG001|Treatment|Adverse Event|0|||
142960615|NCT01293032|515392925|FG002|Treatment|Adverse Event|1|||
142960616|NCT01293032|515392926|FG003|Treatment|Adverse Event|1|||
142960617|NCT01293032|515392923|FG000|Treatment|Withdrawal by Subject|2|||
142960618|NCT01293032|515392924|FG001|Treatment|Withdrawal by Subject|4|||
142960619|NCT01293032|515392925|FG002|Treatment|Withdrawal by Subject|0|||
142960620|NCT01293032|515392926|FG003|Treatment|Withdrawal by Subject|0|||
142960621|NCT01293032|515392923|FG000|Treatment|Disease Progression, relapse|0|||
142960622|NCT01293032|515392924|FG001|Treatment|Disease Progression, relapse|1|||
142960623|NCT01293032|515392925|FG002|Treatment|Disease Progression, relapse|0|||
142960624|NCT01293032|515392926|FG003|Treatment|Disease Progression, relapse|0|||
142960625|NCT01106534|515392929|FG000|Overall Study|Withdrawal by Subject|18|||
142960626|NCT01106534|515392929|FG000|Overall Study|Lost to Follow-up|2|||
142960627|NCT01106534|515392929|FG000|Overall Study|Death|16|||
142960628|NCT01106534|515392929|FG000|Overall Study|Physician Decision|1|||
142960629|NCT05590793|515392935|FG000|Overall Study|Withdrawal by Subject|6|||
142960630|NCT05590793|515392935|FG000|Overall Study|Physician Decision|1|||
142960631|NCT04060667|515392936|FG000|Overall Study|Lost to Follow-up|75|||
142960632|NCT04060667|515392937|FG001|Overall Study|Lost to Follow-up|10|||
142960633|NCT04488822|515392938|FG000|Overall Study|Adverse Event|8|||
142960634|NCT04488822|515392938|FG000|Overall Study|Withdrawal by Subject|1|||
142960635|NCT02499146|515392946|FG000|Overall Study|Lost to Follow-up|1|||
142960636|NCT02499146|515392946|FG000|Overall Study|Withdrawal by Subject|1|||
142960637|NCT02499146|515392946|FG000|Overall Study|Other|2|||
142960638|NCT02499146|515392946|FG000|Overall Study|Ongoing at date of cut-off|9|||
142960639|NCT02499146|515392946|FG000|Overall Study|Began other treatment/therapy|13|||
142960640|NCT03161678|515392947|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
142960641|NCT03161678|515392948|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
142960642|NCT03161678|515392949|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
142960643|NCT03161678|515392950|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
142960644|NCT03161678|515392951|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
142960645|NCT03161678|515392952|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
142960646|NCT03161678|515392947|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
142960647|NCT03161678|515392948|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
142960648|NCT03161678|515392949|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
142960649|NCT03161678|515392950|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
142960650|NCT03161678|515392951|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
142960651|NCT03161678|515392952|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
142960652|NCT03161678|515392947|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
142960653|NCT03161678|515392948|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
142960654|NCT03161678|515392949|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
142960655|NCT03161678|515392950|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
142960656|NCT03161678|515392951|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
142960657|NCT03161678|515392952|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
142960658|NCT03161678|515392947|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
142960659|NCT03161678|515392948|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
142960660|NCT03161678|515392949|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
142960661|NCT03161678|515392950|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
142960662|NCT03161678|515392951|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
142960663|NCT03161678|515392952|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
142960664|NCT00752609|515392953|FG000|Overall Study|Adverse Event|2|||
142960665|NCT00752609|515392954|FG001|Overall Study|Adverse Event|2|||
142960666|NCT00752609|515392953|FG000|Overall Study|Withdrawal by Subject|3|||
142960667|NCT00752609|515392954|FG001|Overall Study|Withdrawal by Subject|0|||
142960668|NCT00752609|515392953|FG000|Overall Study|Physician Decision|1|||
142960669|NCT00752609|515392954|FG001|Overall Study|Physician Decision|0|||
142960670|NCT00752609|515392953|FG000|Overall Study|Death|1|||
142960671|NCT00752609|515392954|FG001|Overall Study|Death|0|||
142960672|NCT00752609|515392953|FG000|Overall Study|Met exclusion criteria|1|||
142960673|NCT00752609|515392954|FG001|Overall Study|Met exclusion criteria|0|||
142960674|NCT00752609|515392953|FG000|Overall Study|Received Aranesp in error|1|||
142960675|NCT00752609|515392954|FG001|Overall Study|Received Aranesp in error|0|||
142960676|NCT05114590|515392955|FG000|Overall Study|Adverse Event|1|||
142960677|NCT05114590|515392955|FG000|Overall Study|Investigator decision|1|||
142960678|NCT05114590|515392955|FG000|Overall Study|Lost to Follow-up|5|||
142960679|NCT05114590|515392955|FG000|Overall Study|Withdrawal by Subject|5|||
142960680|NCT05114590|515392955|FG000|Overall Study|Other|2|||
142960681|NCT01757704|515392962|FG000|Overall Study|Protocol Violation|1|||
142960682|NCT01757704|515392963|FG001|Overall Study|Protocol Violation|3|||
142960683|NCT00938327|515392964|FG000|Overall Study|Adverse Event|2|||
142960684|NCT00938327|515392964|FG000|Overall Study|Protocol Violation|1|||
142960685|NCT00938327|515392964|FG000|Overall Study|Withdrawal by Subject|4|||
142960686|NCT00938327|515392964|FG000|Overall Study|Lost to Follow-up|37|||
142960687|NCT00938327|515392964|FG000|Overall Study|2nd dose received outside of the study|7|||
142960688|NCT00938327|515392964|FG000|Overall Study|Vaccine not received as out of stock|9|||
142960689|NCT01108809|515392965|FG000|Overall Study|Adverse Event|3|||
142960690|NCT01108809|515392965|FG000|Overall Study|Lost to Follow-up|1|||
142960691|NCT00051558|515394344|FG000|Overall Study|Adverse Event|30|||
142960692|NCT00051558|515394345|FG001|Overall Study|Adverse Event|18|||
142960693|NCT00051558|515394344|FG000|Overall Study|Withdrawal by Subject|29|||
142960694|NCT00051558|515394345|FG001|Overall Study|Withdrawal by Subject|42|||
142960695|NCT00051558|515394344|FG000|Overall Study|Death|9|||
142960696|NCT00051558|515394345|FG001|Overall Study|Death|15|||
142960697|NCT00051558|515394344|FG000|Overall Study|Lost to Follow-up|4|||
142960698|NCT00051558|515394345|FG001|Overall Study|Lost to Follow-up|13|||
142960699|NCT00051558|515394344|FG000|Overall Study|Protocol Violation|3|||
142960700|NCT00051558|515394345|FG001|Overall Study|Protocol Violation|4|||
142960701|NCT00051558|515394344|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
142960702|NCT00051558|515394345|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
142960703|NCT00051558|515394344|FG000|Overall Study|Sponsor Decision|6|||
142960704|NCT00051558|515394345|FG001|Overall Study|Sponsor Decision|1|||
142960705|NCT00051558|515394344|FG000|Overall Study|Other|2|||
142960706|NCT00051558|515394345|FG001|Overall Study|Other|1|||
142960707|NCT00051558|515394344|FG000|Overall Study|Significant Lab Value|2|||
142960708|NCT00051558|515394345|FG001|Overall Study|Significant Lab Value|0|||
142960709|NCT00051558|515394344|FG000|Overall Study|Physician Decision|5|||
142960710|NCT00051558|515394345|FG001|Overall Study|Physician Decision|0|||
142960711|NCT03100942|515394348|FG000|Randomized Treatment Period|Withdrew Consent|4|||
142960712|NCT03100942|515394349|FG001|Randomized Treatment Period|Withdrew Consent|5|||
142960713|NCT03100942|515394350|FG002|Randomized Treatment Period|Withdrew Consent|3|||
142960714|NCT03100942|515394351|FG003|Randomized Treatment Period|Withdrew Consent|3|||
142960715|NCT03100942|515394352|FG004|Randomized Treatment Period|Withdrew Consent|0|||
142960716|NCT03100942|515394353|FG005|Randomized Treatment Period|Withdrew Consent|0|||
142960717|NCT03100942|515394354|FG006|Randomized Treatment Period|Withdrew Consent|0|||
142960718|NCT03100942|515394348|FG000|Randomized Treatment Period|Adverse Event|5|||
142960719|NCT03100942|515394349|FG001|Randomized Treatment Period|Adverse Event|2|||
142960720|NCT03100942|515394350|FG002|Randomized Treatment Period|Adverse Event|1|||
142960721|NCT03100942|515394351|FG003|Randomized Treatment Period|Adverse Event|0|||
142960722|NCT03100942|515394352|FG004|Randomized Treatment Period|Adverse Event|0|||
142960723|NCT03100942|515394353|FG005|Randomized Treatment Period|Adverse Event|0|||
142960724|NCT03100942|515394354|FG006|Randomized Treatment Period|Adverse Event|0|||
142960725|NCT03100942|515394348|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
142960726|NCT03100942|515394349|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
142960727|NCT03100942|515394350|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
142960728|NCT03100942|515394351|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
142960729|NCT03100942|515394352|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
142960730|NCT03100942|515394353|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
142960731|NCT03100942|515394354|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
142960732|NCT03100942|515394348|FG000|Randomized Treatment Period|Protocol Violation|0|||
142960733|NCT03100942|515394349|FG001|Randomized Treatment Period|Protocol Violation|1|||
142960734|NCT03100942|515394350|FG002|Randomized Treatment Period|Protocol Violation|1|||
142960735|NCT03100942|515394351|FG003|Randomized Treatment Period|Protocol Violation|1|||
142960736|NCT03100942|515394352|FG004|Randomized Treatment Period|Protocol Violation|0|||
142960737|NCT03100942|515394353|FG005|Randomized Treatment Period|Protocol Violation|0|||
142960738|NCT03100942|515394354|FG006|Randomized Treatment Period|Protocol Violation|0|||
142960739|NCT03100942|515394348|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
142960740|NCT03100942|515394349|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
142960741|NCT03100942|515394350|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
142960742|NCT03100942|515394351|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
142960743|NCT03100942|515394352|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
142960744|NCT03100942|515394353|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
142960745|NCT03100942|515394354|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
142960746|NCT03100942|515394348|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
142960747|NCT03100942|515394349|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
142960748|NCT03100942|515394350|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
142960749|NCT03100942|515394351|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
142960750|NCT03100942|515394352|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
142960751|NCT03100942|515394353|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
142960752|NCT03100942|515394354|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
142960753|NCT03100942|515394348|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
142960754|NCT03100942|515394349|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
142960755|NCT03100942|515394350|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
142960756|NCT03100942|515394351|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
142960757|NCT03100942|515394352|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
142960758|NCT03100942|515394353|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
142960759|NCT03100942|515394354|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
142960760|NCT01429792|515394355|FG000|Overall Study|Other Reasons|67|||
142960761|NCT01429792|515394355|FG000|Overall Study|Unknown Disposition|94|||
142960762|NCT01429792|515394355|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
142960763|NCT01429792|515394355|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
142960764|NCT01429792|515394355|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
142960765|NCT01429792|515394355|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
142960766|NCT01429792|515394355|FG000|Overall Study|Withdrawal by Subject|70|||
142960767|NCT01429792|515394355|FG000|Overall Study|Lost to Follow-up|88|||
142960768|NCT01617681|515394356|FG000|Period 1 Double Blind|Adverse Event|2|||
142960769|NCT01617681|515394357|FG001|Period 1 Double Blind|Adverse Event|0|||
142960770|NCT01617681|515394358|FG002|Period 1 Double Blind|Adverse Event|0|||
142960771|NCT01617681|515394359|FG003|Period 1 Double Blind|Adverse Event|2|||
142960772|NCT01617681|515394360|FG004|Period 1 Double Blind|Adverse Event|0|||
142960773|NCT01617681|515394356|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
142960774|NCT01617681|515394357|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
142960775|NCT01617681|515394358|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
142960776|NCT01617681|515394359|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
142960777|NCT01617681|515394360|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
142960778|NCT01617681|515394356|FG000|Period 2 Open Label|Adverse Event|0|||
142960779|NCT01617681|515394357|FG001|Period 2 Open Label|Adverse Event|0|||
142960780|NCT01617681|515394358|FG002|Period 2 Open Label|Adverse Event|0|||
142960781|NCT01617681|515394359|FG003|Period 2 Open Label|Adverse Event|0|||
142960782|NCT01617681|515394360|FG004|Period 2 Open Label|Adverse Event|3|||
142960783|NCT01617681|515394356|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
142960784|NCT01617681|515394357|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
142960785|NCT01617681|515394358|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
142960786|NCT01617681|515394359|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
142960787|NCT01617681|515394360|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
142960788|NCT01597557|515394364|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
142960789|NCT01597557|515394365|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
142960790|NCT01263691|515394367|FG000|Overall Study|Lost to Follow-up|1|||
142960791|NCT01263691|515394368|FG001|Overall Study|Lost to Follow-up|0|||
142960792|NCT01263691|515394369|FG002|Overall Study|Lost to Follow-up|1|||
142960793|NCT01263691|515394370|FG003|Overall Study|Lost to Follow-up|1|||
142960794|NCT01263691|515394371|FG004|Overall Study|Lost to Follow-up|0|||
142960795|NCT01263691|515394372|FG005|Overall Study|Lost to Follow-up|0|||
142960796|NCT01263691|515394367|FG000|Overall Study|Withdrawal by Subject|1|||
142960797|NCT01263691|515394368|FG001|Overall Study|Withdrawal by Subject|0|||
142960798|NCT01263691|515394369|FG002|Overall Study|Withdrawal by Subject|0|||
142960799|NCT01263691|515394370|FG003|Overall Study|Withdrawal by Subject|0|||
142960800|NCT01263691|515394371|FG004|Overall Study|Withdrawal by Subject|0|||
142960801|NCT01263691|515394372|FG005|Overall Study|Withdrawal by Subject|0|||
142960802|NCT01263691|515394367|FG000|Overall Study|Adverse Event|1|||
142960803|NCT01263691|515394368|FG001|Overall Study|Adverse Event|0|||
142960804|NCT01263691|515394369|FG002|Overall Study|Adverse Event|0|||
142960805|NCT01263691|515394370|FG003|Overall Study|Adverse Event|0|||
142960806|NCT01263691|515394371|FG004|Overall Study|Adverse Event|0|||
142960807|NCT01263691|515394372|FG005|Overall Study|Adverse Event|0|||
142960808|NCT00879814|515394377|FG000|Overall Study|Adverse Event|0|||
142960809|NCT00879814|515394378|FG001|Overall Study|Adverse Event|1|||
142960810|NCT00879814|515394379|FG002|Overall Study|Adverse Event|0|||
142960811|NCT00879814|515394380|FG003|Overall Study|Adverse Event|0|||
142960812|NCT00879814|515394377|FG000|Overall Study|Lost to Follow-up|1|||
142960813|NCT00879814|515394378|FG001|Overall Study|Lost to Follow-up|0|||
142960814|NCT00879814|515394379|FG002|Overall Study|Lost to Follow-up|0|||
142960815|NCT00879814|515394380|FG003|Overall Study|Lost to Follow-up|2|||
142960816|NCT00879814|515394377|FG000|Overall Study|Participant Failed to Return|0|||
142960817|NCT00879814|515394378|FG001|Overall Study|Participant Failed to Return|0|||
142960818|NCT00879814|515394379|FG002|Overall Study|Participant Failed to Return|0|||
142960819|NCT00879814|515394380|FG003|Overall Study|Participant Failed to Return|1|||
142960820|NCT00879814|515394377|FG000|Overall Study|Withdrawal by Subject|3|||
142960821|NCT00879814|515394378|FG001|Overall Study|Withdrawal by Subject|1|||
142960822|NCT00879814|515394379|FG002|Overall Study|Withdrawal by Subject|1|||
142960823|NCT00879814|515394380|FG003|Overall Study|Withdrawal by Subject|2|||
142960824|NCT00879814|515394377|FG000|Overall Study|Physician Decision|0|||
142960825|NCT00879814|515394378|FG001|Overall Study|Physician Decision|0|||
142960826|NCT00879814|515394379|FG002|Overall Study|Physician Decision|1|||
142960827|NCT00879814|515394380|FG003|Overall Study|Physician Decision|0|||
142960828|NCT00879814|515394377|FG000|Overall Study|Other|0|||
142960829|NCT00879814|515394378|FG001|Overall Study|Other|0|||
142960830|NCT00879814|515394379|FG002|Overall Study|Other|1|||
142960831|NCT00879814|515394380|FG003|Overall Study|Other|0|||
142960832|NCT00358917|515394381|FG000|Overall Study|Adverse Event|14|||
142960833|NCT00358917|515394382|FG001|Overall Study|Adverse Event|21|||
142960834|NCT00358917|515394381|FG000|Overall Study|Withdrawal by Subject|5|||
142960835|NCT00358917|515394382|FG001|Overall Study|Withdrawal by Subject|7|||
142960836|NCT00358917|515394381|FG000|Overall Study|Lost to Follow-up|20|||
142960837|NCT00358917|515394382|FG001|Overall Study|Lost to Follow-up|17|||
142960838|NCT00358917|515394381|FG000|Overall Study|Noncompliance|12|||
142960839|NCT00358917|515394382|FG001|Overall Study|Noncompliance|11|||
142960840|NCT00358917|515394381|FG000|Overall Study|Death|2|||
142960841|NCT00358917|515394382|FG001|Overall Study|Death|3|||
142960842|NCT00358917|515394381|FG000|Overall Study|Virologic failure|11|||
142960843|NCT00358917|515394382|FG001|Overall Study|Virologic failure|8|||
142960844|NCT00358917|515394381|FG000|Overall Study|Unable to Continue Participation|2|||
142960845|NCT00358917|515394382|FG001|Overall Study|Unable to Continue Participation|2|||
142960846|NCT01425190|515394383|FG000|Overall Study|Full dose not consumed.|1|||
142960847|NCT01425190|515394384|FG001|Overall Study|Full dose not consumed.|0|||
142960848|NCT01425190|515394385|FG002|Overall Study|Full dose not consumed.|0|||
142960849|NCT01035255|515394387|FG000|Overall Study|Death|724|||
142960850|NCT01035255|515394388|FG001|Overall Study|Death|844|||
142960851|NCT01035255|515394387|FG000|Overall Study|Lost to Follow-up|2|||
142960852|NCT01035255|515394388|FG001|Overall Study|Lost to Follow-up|5|||
142960853|NCT01035255|515394387|FG000|Overall Study|patient's request|15|||
142960854|NCT01035255|515394388|FG001|Overall Study|patient's request|13|||
142960855|NCT00195260|515394391|FG000|Part 1: Dose Escalation|Adverse Event|0|||
142960856|NCT00195260|515394392|FG001|Part 1: Dose Escalation|Adverse Event|1|||
142960857|NCT00195260|515394393|FG002|Part 1: Dose Escalation|Adverse Event|0|||
142960858|NCT00195260|515394394|FG003|Part 1: Dose Escalation|Adverse Event|1|||
142960859|NCT00195260|515394395|FG004|Part 1: Dose Escalation|Adverse Event|1|||
142960860|NCT00195260|515394396|FG005|Part 1: Dose Escalation|Adverse Event|0|||
142960861|NCT00195260|515394397|FG006|Part 1: Dose Escalation|Adverse Event|3|||
142960862|NCT00195260|515394398|FG007|Part 1: Dose Escalation|Adverse Event|0|||
142960863|NCT00195260|515394399|FG008|Part 1: Dose Escalation|Adverse Event|0|||
142960864|NCT00195260|515394400|FG009|Part 1: Dose Escalation|Adverse Event|0|||
142960865|NCT00195260|515394401|FG010|Part 1: Dose Escalation|Adverse Event|0|||
142960866|NCT00195260|515394391|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
142960867|NCT00195260|515394392|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
142960868|NCT00195260|515394393|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
142960869|NCT00195260|515394394|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
142960870|NCT00195260|515394395|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
142960871|NCT00195260|515394396|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
142960872|NCT00195260|515394397|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
142960873|NCT00195260|515394398|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
142960874|NCT00195260|515394399|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
142960875|NCT00195260|515394400|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
142960876|NCT00195260|515394401|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
142960877|NCT00195260|515394391|FG000|Part 1: Dose Escalation|Death|0|||
142960878|NCT00195260|515394392|FG001|Part 1: Dose Escalation|Death|0|||
142960879|NCT00195260|515394393|FG002|Part 1: Dose Escalation|Death|0|||
143455364|NCT03541174|517212427|FG000|Part 2 Single-Blind|Pregnancy|0|||
143455365|NCT03541174|517212428|FG001|Part 2 Single-Blind|Pregnancy|0|||
142960880|NCT00195260|515394394|FG003|Part 1: Dose Escalation|Death|0|||
142960881|NCT00195260|515394395|FG004|Part 1: Dose Escalation|Death|0|||
143455366|NCT03541174|517212429|FG002|Part 2 Single-Blind|Pregnancy|0|||
142960882|NCT00195260|515394396|FG005|Part 1: Dose Escalation|Death|0|||
142960883|NCT00195260|515394397|FG006|Part 1: Dose Escalation|Death|0|||
142960884|NCT00195260|515394398|FG007|Part 1: Dose Escalation|Death|1|||
142960885|NCT00195260|515394399|FG008|Part 1: Dose Escalation|Death|0|||
142960886|NCT00195260|515394400|FG009|Part 1: Dose Escalation|Death|0|||
142960887|NCT00195260|515394401|FG010|Part 1: Dose Escalation|Death|0|||
142960888|NCT00195260|515394391|FG000|Part 1: Dose Escalation|Disease Progression|3|||
142960889|NCT00195260|515394392|FG001|Part 1: Dose Escalation|Disease Progression|2|||
143455367|NCT03541174|517212430|FG003|Part 2 Single-Blind|Pregnancy|1|||
142960890|NCT00195260|515394393|FG002|Part 1: Dose Escalation|Disease Progression|5|||
142960891|NCT00195260|515394394|FG003|Part 1: Dose Escalation|Disease Progression|6|||
142960892|NCT00195260|515394395|FG004|Part 1: Dose Escalation|Disease Progression|4|||
142960893|NCT00195260|515394396|FG005|Part 1: Dose Escalation|Disease Progression|6|||
142960894|NCT00195260|515394397|FG006|Part 1: Dose Escalation|Disease Progression|7|||
142960895|NCT00195260|515394398|FG007|Part 1: Dose Escalation|Disease Progression|4|||
142960896|NCT00195260|515394399|FG008|Part 1: Dose Escalation|Disease Progression|0|||
142960897|NCT00195260|515394400|FG009|Part 1: Dose Escalation|Disease Progression|0|||
142960898|NCT00195260|515394401|FG010|Part 1: Dose Escalation|Disease Progression|0|||
142960899|NCT00195260|515394391|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
142960900|NCT00195260|515394392|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
142960901|NCT00195260|515394393|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
142960902|NCT00195260|515394394|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
142960903|NCT00195260|515394395|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
142960904|NCT00195260|515394396|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
142960905|NCT00195260|515394397|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
142960906|NCT00195260|515394398|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
142960907|NCT00195260|515394399|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
142960908|NCT00195260|515394400|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
142960909|NCT00195260|515394401|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
142960910|NCT00195260|515394391|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
142960911|NCT00195260|515394392|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
142960912|NCT00195260|515394393|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
142960913|NCT00195260|515394394|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
142960914|NCT00195260|515394395|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
142960915|NCT00195260|515394396|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
142960916|NCT00195260|515394397|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
142960917|NCT00195260|515394398|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
142960918|NCT00195260|515394399|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
142960919|NCT00195260|515394400|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
142960920|NCT00195260|515394401|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
142960921|NCT00195260|515394391|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
142960922|NCT00195260|515394392|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
142960923|NCT00195260|515394393|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
142960924|NCT00195260|515394394|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
142960925|NCT00195260|515394395|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
142960926|NCT00195260|515394396|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
142960927|NCT00195260|515394397|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
142960928|NCT00195260|515394398|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
142960929|NCT00195260|515394399|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
142960930|NCT00195260|515394400|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
142960931|NCT00195260|515394401|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
142960932|NCT00195260|515394391|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
142960933|NCT00195260|515394392|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
142960934|NCT00195260|515394393|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
142960935|NCT00195260|515394394|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
142960936|NCT00195260|515394395|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
142960937|NCT00195260|515394396|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
142960938|NCT00195260|515394397|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
142960939|NCT00195260|515394398|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
142960940|NCT00195260|515394399|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
142960941|NCT00195260|515394400|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
142960942|NCT00195260|515394401|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
142960943|NCT00195260|515394391|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
142960944|NCT00195260|515394392|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
142960945|NCT00195260|515394393|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
142960946|NCT00195260|515394394|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
142960947|NCT00195260|515394395|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
142960948|NCT00195260|515394396|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
142960949|NCT00195260|515394397|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
142960950|NCT00195260|515394398|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
142960951|NCT00195260|515394399|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
142960952|NCT00195260|515394400|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
142960953|NCT00195260|515394401|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
142960954|NCT03007953|515394404|FG000|Overall Study|Withdrawal by Subject|5|||
142960955|NCT03007953|515394405|FG001|Overall Study|Withdrawal by Subject|2|||
142960956|NCT03007953|515394404|FG000|Overall Study|Death|5|||
143117141|NCT01273155|515970042|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
142960957|NCT03007953|515394405|FG001|Overall Study|Death|7|||
142960958|NCT03007953|515394404|FG000|Overall Study|Lost to Follow-up|3|||
142960959|NCT03007953|515394405|FG001|Overall Study|Lost to Follow-up|2|||
142960960|NCT03007953|515394404|FG000|Overall Study|Enrolled in Hospice|3|||
142960961|NCT03007953|515394405|FG001|Overall Study|Enrolled in Hospice|2|||
142960962|NCT02538666|515394408|FG000|Pre-Treatment|Disease progression|1|||
142960963|NCT02538666|515394409|FG001|Pre-Treatment|Disease progression|0|||
142960964|NCT02538666|515394410|FG002|Pre-Treatment|Disease progression|0|||
142960965|NCT02538666|515394408|FG000|Pre-Treatment|no longer meets study criteria|1|||
142960966|NCT02538666|515394409|FG001|Pre-Treatment|no longer meets study criteria|0|||
142960967|NCT02538666|515394410|FG002|Pre-Treatment|no longer meets study criteria|0|||
142960968|NCT02538666|515394408|FG000|Pre-Treatment|Withdrew Consent|0|||
142960969|NCT02538666|515394409|FG001|Pre-Treatment|Withdrew Consent|1|||
142960970|NCT02538666|515394410|FG002|Pre-Treatment|Withdrew Consent|1|||
142960971|NCT02538666|515394408|FG000|Treatment|Disease progression|270|||
142960972|NCT02538666|515394409|FG001|Treatment|Disease progression|227|||
142960973|NCT02538666|515394410|FG002|Treatment|Disease progression|165|||
142960974|NCT02538666|515394408|FG000|Treatment|Study drug toxicity|1|||
142960975|NCT02538666|515394409|FG001|Treatment|Study drug toxicity|29|||
142960976|NCT02538666|515394410|FG002|Treatment|Study drug toxicity|92|||
142960977|NCT02538666|515394408|FG000|Treatment|Death|0|||
142960978|NCT02538666|515394409|FG001|Treatment|Death|2|||
142960979|NCT02538666|515394410|FG002|Treatment|Death|3|||
142960980|NCT02538666|515394408|FG000|Treatment|Adverse event unrelated to study drug|8|||
142960981|NCT02538666|515394409|FG001|Treatment|Adverse event unrelated to study drug|10|||
142960982|NCT02538666|515394410|FG002|Treatment|Adverse event unrelated to study drug|15|||
142960983|NCT02538666|515394408|FG000|Treatment|Participant request to discontinue study treatment|3|||
142960984|NCT02538666|515394409|FG001|Treatment|Participant request to discontinue study treatment|6|||
142960985|NCT02538666|515394410|FG002|Treatment|Participant request to discontinue study treatment|11|||
142960986|NCT02538666|515394408|FG000|Treatment|Participant withdrew consent|2|||
142960987|NCT02538666|515394409|FG001|Treatment|Participant withdrew consent|5|||
142960988|NCT02538666|515394410|FG002|Treatment|Participant withdrew consent|3|||
142960989|NCT02538666|515394408|FG000|Treatment|Lost to Follow-up|0|||
142960990|NCT02538666|515394409|FG001|Treatment|Lost to Follow-up|1|||
142960991|NCT02538666|515394410|FG002|Treatment|Lost to Follow-up|1|||
142960992|NCT02538666|515394408|FG000|Treatment|Maximum clinical benefit|4|||
142960993|NCT02538666|515394409|FG001|Treatment|Maximum clinical benefit|3|||
142960994|NCT02538666|515394410|FG002|Treatment|Maximum clinical benefit|4|||
142960995|NCT02538666|515394408|FG000|Treatment|Poor/non-compliance|0|||
142960996|NCT02538666|515394409|FG001|Treatment|Poor/non-compliance|1|||
142960997|NCT02538666|515394410|FG002|Treatment|Poor/non-compliance|0|||
142960998|NCT02538666|515394408|FG000|Treatment|Participant no longer meets study criteria|0|||
142960999|NCT02538666|515394409|FG001|Treatment|Participant no longer meets study criteria|2|||
142961000|NCT02538666|515394410|FG002|Treatment|Participant no longer meets study criteria|0|||
142961001|NCT02538666|515394408|FG000|Treatment|Administrative reason by sponsor|0|||
142961002|NCT02538666|515394409|FG001|Treatment|Administrative reason by sponsor|0|||
142961003|NCT02538666|515394410|FG002|Treatment|Administrative reason by sponsor|1|||
142961004|NCT02538666|515394408|FG000|Treatment|Other reasons|8|||
142961005|NCT02538666|515394409|FG001|Treatment|Other reasons|15|||
142961006|NCT02538666|515394410|FG002|Treatment|Other reasons|5|||
142961007|NCT02538666|515394408|FG000|Treatment|Not reported|2|||
142961008|NCT02538666|515394409|FG001|Treatment|Not reported|2|||
142961009|NCT02538666|515394410|FG002|Treatment|Not reported|2|||
142961010|NCT00829166|515394411|FG000|Overall Study|Death|305|||
142961011|NCT00829166|515394412|FG001|Overall Study|Death|333|||
142961012|NCT00829166|515394411|FG000|Overall Study|Lost to Follow-up|5|||
142961013|NCT00829166|515394412|FG001|Overall Study|Lost to Follow-up|4|||
142961014|NCT00829166|515394411|FG000|Overall Study|Physician's Decision|4|||
142961015|NCT00829166|515394412|FG001|Overall Study|Physician's Decision|3|||
142961016|NCT00829166|515394411|FG000|Overall Study|Subject's Decision|41|||
142961017|NCT00829166|515394412|FG001|Overall Study|Subject's Decision|55|||
142961018|NCT00829166|515394411|FG000|Overall Study|Sponsor's Decision|137|||
142961019|NCT00829166|515394412|FG001|Overall Study|Sponsor's Decision|98|||
142961020|NCT00829166|515394411|FG000|Overall Study|Reason Not Specified|3|||
142961021|NCT00829166|515394412|FG001|Overall Study|Reason Not Specified|3|||
142961022|NCT01635933|515394413|FG000|Overall Study|Adverse Event|1|||
142961023|NCT01635933|515394414|FG001|Overall Study|Adverse Event|0|||
142961024|NCT01635933|515394413|FG000|Overall Study|Lost to Follow-up|0|||
142961025|NCT01635933|515394414|FG001|Overall Study|Lost to Follow-up|5|||
142961026|NCT01635933|515394413|FG000|Overall Study|Subject decision|1|||
142961027|NCT01635933|515394414|FG001|Overall Study|Subject decision|1|||
142961028|NCT01635933|515394413|FG000|Overall Study|Noncompliance|0|||
142961029|NCT01635933|515394414|FG001|Overall Study|Noncompliance|1|||
142961030|NCT01635933|515394413|FG000|Overall Study|No longer had transportation|0|||
142961031|NCT01635933|515394414|FG001|Overall Study|No longer had transportation|1|||
142961032|NCT01544595|515394417|FG000|Status at Week 68|Adverse Event|3|||
142961033|NCT01544595|515394418|FG001|Status at Week 68|Adverse Event|2|||
142961034|NCT01544595|515394419|FG002|Status at Week 68|Adverse Event|1|||
142961035|NCT01544595|515394420|FG003|Status at Week 68|Adverse Event|0|||
142961036|NCT01544595|515394421|FG004|Status at Week 68|Adverse Event|0|||
142961037|NCT01544595|515394422|FG005|Status at Week 68|Adverse Event|0|||
142961038|NCT01544595|515394417|FG000|Status at Week 68|Lack of Efficacy|1|||
142961039|NCT01544595|515394418|FG001|Status at Week 68|Lack of Efficacy|0|||
142961040|NCT01544595|515394419|FG002|Status at Week 68|Lack of Efficacy|0|||
142961041|NCT01544595|515394420|FG003|Status at Week 68|Lack of Efficacy|0|||
142961042|NCT01544595|515394421|FG004|Status at Week 68|Lack of Efficacy|0|||
142961043|NCT01544595|515394422|FG005|Status at Week 68|Lack of Efficacy|0|||
142961044|NCT01544595|515394417|FG000|Status at Week 68|Lost to Follow-up|1|||
142961045|NCT01544595|515394418|FG001|Status at Week 68|Lost to Follow-up|1|||
142961046|NCT01544595|515394419|FG002|Status at Week 68|Lost to Follow-up|0|||
142961047|NCT01544595|515394420|FG003|Status at Week 68|Lost to Follow-up|0|||
142961048|NCT01544595|515394421|FG004|Status at Week 68|Lost to Follow-up|0|||
142961049|NCT01544595|515394422|FG005|Status at Week 68|Lost to Follow-up|0|||
142961050|NCT01544595|515394417|FG000|Status at Week 68|Non-compliance with study treatment|1|||
142961051|NCT01544595|515394418|FG001|Status at Week 68|Non-compliance with study treatment|0|||
142961052|NCT01544595|515394419|FG002|Status at Week 68|Non-compliance with study treatment|0|||
142961053|NCT01544595|515394420|FG003|Status at Week 68|Non-compliance with study treatment|1|||
142961054|NCT01544595|515394421|FG004|Status at Week 68|Non-compliance with study treatment|0|||
142961055|NCT01544595|515394422|FG005|Status at Week 68|Non-compliance with study treatment|0|||
142961056|NCT01544595|515394417|FG000|Status at Week 68|Protocol Violation|2|||
142961057|NCT01544595|515394418|FG001|Status at Week 68|Protocol Violation|0|||
142961058|NCT01544595|515394419|FG002|Status at Week 68|Protocol Violation|1|||
142961059|NCT01544595|515394420|FG003|Status at Week 68|Protocol Violation|1|||
142961060|NCT01544595|515394421|FG004|Status at Week 68|Protocol Violation|0|||
142961061|NCT01544595|515394422|FG005|Status at Week 68|Protocol Violation|0|||
142961062|NCT01544595|515394417|FG000|Status at Week 68|Technical problems|1|||
142961063|NCT01544595|515394418|FG001|Status at Week 68|Technical problems|0|||
142961064|NCT01544595|515394419|FG002|Status at Week 68|Technical problems|0|||
142961065|NCT01544595|515394420|FG003|Status at Week 68|Technical problems|1|||
142961066|NCT01544595|515394421|FG004|Status at Week 68|Technical problems|0|||
142961067|NCT01544595|515394422|FG005|Status at Week 68|Technical problems|0|||
142961068|NCT01544595|515394417|FG000|Status at Week 68|Withdrawal by Subject|0|||
142961069|NCT01544595|515394418|FG001|Status at Week 68|Withdrawal by Subject|1|||
142961070|NCT01544595|515394419|FG002|Status at Week 68|Withdrawal by Subject|1|||
142961071|NCT01544595|515394420|FG003|Status at Week 68|Withdrawal by Subject|2|||
142961072|NCT01544595|515394421|FG004|Status at Week 68|Withdrawal by Subject|0|||
142961073|NCT01544595|515394422|FG005|Status at Week 68|Withdrawal by Subject|0|||
142961074|NCT01544595|515394417|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
142961075|NCT01544595|515394418|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
142961076|NCT01544595|515394419|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
142961077|NCT01544595|515394420|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
142961078|NCT01544595|515394421|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
142961079|NCT01544595|515394422|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
142961080|NCT01544595|515394417|FG000|Status at Week 156|Withdrawal by Subject|9|||
142961081|NCT01544595|515394418|FG001|Status at Week 156|Withdrawal by Subject|10|||
142961082|NCT01544595|515394419|FG002|Status at Week 156|Withdrawal by Subject|4|||
142961083|NCT01544595|515394420|FG003|Status at Week 156|Withdrawal by Subject|9|||
142961084|NCT01544595|515394421|FG004|Status at Week 156|Withdrawal by Subject|20|||
142961085|NCT01544595|515394422|FG005|Status at Week 156|Withdrawal by Subject|6|||
142961086|NCT01544595|515394417|FG000|Status at Week 156|Adverse Event|9|||
142961087|NCT01544595|515394418|FG001|Status at Week 156|Adverse Event|11|||
142961088|NCT01544595|515394419|FG002|Status at Week 156|Adverse Event|1|||
142961089|NCT01544595|515394420|FG003|Status at Week 156|Adverse Event|3|||
142961090|NCT01544595|515394421|FG004|Status at Week 156|Adverse Event|4|||
142961091|NCT01544595|515394422|FG005|Status at Week 156|Adverse Event|2|||
142961092|NCT01544595|515394417|FG000|Status at Week 156|Lost to Follow-up|4|||
142961093|NCT01544595|515394418|FG001|Status at Week 156|Lost to Follow-up|4|||
142961094|NCT01544595|515394419|FG002|Status at Week 156|Lost to Follow-up|0|||
142961095|NCT01544595|515394420|FG003|Status at Week 156|Lost to Follow-up|1|||
142961096|NCT01544595|515394421|FG004|Status at Week 156|Lost to Follow-up|4|||
142961097|NCT01544595|515394422|FG005|Status at Week 156|Lost to Follow-up|1|||
142961098|NCT01544595|515394417|FG000|Status at Week 156|Non-compliance with study treatement|0|||
142961099|NCT01544595|515394418|FG001|Status at Week 156|Non-compliance with study treatement|1|||
142961100|NCT01544595|515394419|FG002|Status at Week 156|Non-compliance with study treatement|0|||
142961101|NCT01544595|515394420|FG003|Status at Week 156|Non-compliance with study treatement|1|||
142961102|NCT01544595|515394421|FG004|Status at Week 156|Non-compliance with study treatement|0|||
142961103|NCT01544595|515394422|FG005|Status at Week 156|Non-compliance with study treatement|1|||
142961104|NCT01544595|515394417|FG000|Status at Week 156|Physician Decision|0|||
142961105|NCT01544595|515394418|FG001|Status at Week 156|Physician Decision|3|||
142961106|NCT01544595|515394419|FG002|Status at Week 156|Physician Decision|1|||
142961107|NCT01544595|515394420|FG003|Status at Week 156|Physician Decision|0|||
142961108|NCT01544595|515394421|FG004|Status at Week 156|Physician Decision|0|||
142961109|NCT01544595|515394422|FG005|Status at Week 156|Physician Decision|0|||
142961110|NCT01544595|515394417|FG000|Status at Week 156|Pregnancy|2|||
142961111|NCT01544595|515394418|FG001|Status at Week 156|Pregnancy|3|||
142961112|NCT01544595|515394419|FG002|Status at Week 156|Pregnancy|0|||
142961113|NCT01544595|515394420|FG003|Status at Week 156|Pregnancy|0|||
142961114|NCT01544595|515394421|FG004|Status at Week 156|Pregnancy|0|||
142961115|NCT01544595|515394422|FG005|Status at Week 156|Pregnancy|0|||
142961116|NCT01544595|515394417|FG000|Status at Week 156|Protocol Violation|3|||
142961117|NCT01544595|515394418|FG001|Status at Week 156|Protocol Violation|1|||
142961118|NCT01544595|515394419|FG002|Status at Week 156|Protocol Violation|2|||
142961119|NCT01544595|515394420|FG003|Status at Week 156|Protocol Violation|2|||
142961120|NCT01544595|515394421|FG004|Status at Week 156|Protocol Violation|0|||
142961121|NCT01544595|515394422|FG005|Status at Week 156|Protocol Violation|0|||
142961122|NCT01544595|515394417|FG000|Status at Week 156|Technical problems|3|||
142961123|NCT01544595|515394418|FG001|Status at Week 156|Technical problems|1|||
142961124|NCT01544595|515394419|FG002|Status at Week 156|Technical problems|0|||
142961125|NCT01544595|515394420|FG003|Status at Week 156|Technical problems|1|||
142961126|NCT01544595|515394421|FG004|Status at Week 156|Technical problems|0|||
142961127|NCT01544595|515394422|FG005|Status at Week 156|Technical problems|0|||
142961128|NCT01544595|515394417|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
142961129|NCT01544595|515394418|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
142961130|NCT01544595|515394419|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
142961131|NCT01544595|515394420|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
142961132|NCT01544595|515394421|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
142961133|NCT01544595|515394422|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
142961134|NCT01544595|515394417|FG000|Status at Week 156|Lack of Efficacy|1|||
142961135|NCT01544595|515394418|FG001|Status at Week 156|Lack of Efficacy|0|||
142961136|NCT01544595|515394419|FG002|Status at Week 156|Lack of Efficacy|1|||
142961137|NCT01544595|515394420|FG003|Status at Week 156|Lack of Efficacy|4|||
142961138|NCT01544595|515394421|FG004|Status at Week 156|Lack of Efficacy|10|||
142961139|NCT01544595|515394422|FG005|Status at Week 156|Lack of Efficacy|5|||
142961140|NCT01555463|515394423|FG000|Treatment|Adverse Event|6|||
142961141|NCT01555463|515394424|FG001|Treatment|Adverse Event|12|||
142961142|NCT01555463|515394423|FG000|Treatment|Withdrawal by Subject|24|||
142961143|NCT01555463|515394424|FG001|Treatment|Withdrawal by Subject|36|||
142961144|NCT01555463|515394423|FG000|Treatment|Lost to Follow-up|28|||
142961145|NCT01555463|515394424|FG001|Treatment|Lost to Follow-up|23|||
142961146|NCT01555463|515394423|FG000|Treatment|Protocol Violation|4|||
142961147|NCT01555463|515394424|FG001|Treatment|Protocol Violation|5|||
142961148|NCT01555463|515394423|FG000|Treatment|Other reason|2|||
142961149|NCT01555463|515394424|FG001|Treatment|Other reason|3|||
142961150|NCT01555463|515394423|FG000|Follow up|Adverse Event|2|||
142961151|NCT01555463|515394424|FG001|Follow up|Adverse Event|5|||
142961152|NCT01555463|515394423|FG000|Follow up|Death|0|||
142961153|NCT01555463|515394424|FG001|Follow up|Death|1|||
142961154|NCT01555463|515394423|FG000|Follow up|Withdrawal by Subject|22|||
142961155|NCT01555463|515394424|FG001|Follow up|Withdrawal by Subject|22|||
142961156|NCT01555463|515394423|FG000|Follow up|Lost to Follow-up|9|||
142961157|NCT01555463|515394424|FG001|Follow up|Lost to Follow-up|10|||
142961158|NCT01555463|515394423|FG000|Follow up|Protocol Violation|2|||
142961159|NCT01555463|515394424|FG001|Follow up|Protocol Violation|4|||
142961160|NCT01555463|515394423|FG000|Follow up|Other reason|3|||
142961161|NCT01555463|515394424|FG001|Follow up|Other reason|3|||
142961162|NCT02026271|515394425|FG000|Overall Study|Adverse Event|2|||
142961163|NCT02026271|515394426|FG001|Overall Study|Adverse Event|3|||
142961164|NCT02026271|515394427|FG002|Overall Study|Adverse Event|2|||
142961165|NCT02026271|515394428|FG003|Overall Study|Adverse Event|3|||
142961166|NCT02026271|515394429|FG004|Overall Study|Adverse Event|0|||
142961167|NCT02026271|515394425|FG000|Overall Study|Withdrawal by Subject|0|||
142961168|NCT02026271|515394426|FG001|Overall Study|Withdrawal by Subject|0|||
142961169|NCT02026271|515394427|FG002|Overall Study|Withdrawal by Subject|0|||
142961170|NCT02026271|515394428|FG003|Overall Study|Withdrawal by Subject|0|||
142961171|NCT02026271|515394429|FG004|Overall Study|Withdrawal by Subject|1|||
142961172|NCT04333433|515394430|FG000|Overall Study|Withdrawal by Subject|6|||
142961173|NCT04333433|515394431|FG001|Overall Study|Withdrawal by Subject|3|||
142961174|NCT04333433|515394430|FG000|Overall Study|Death|3|||
142961175|NCT04333433|515394431|FG001|Overall Study|Death|0|||
142961176|NCT04333433|515394430|FG000|Overall Study|Lost to Follow-up|6|||
142961177|NCT04333433|515394431|FG001|Overall Study|Lost to Follow-up|1|||
142961178|NCT04333433|515394430|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
142961179|NCT04333433|515394431|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
142961180|NCT02275026|515394434|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
142961181|NCT02275026|515394434|FG000|Overall Study|Withdrawal by Subject|4|||
142961182|NCT02275026|515394434|FG000|Overall Study|Ineligible due to medical history|13|||
142961183|NCT02275026|515394434|FG000|Overall Study|MRI malfunction precluded testing|1|||
142961184|NCT02275026|515394434|FG000|Overall Study|Ineligible after MRI findings|1|||
142961185|NCT02275026|515394434|FG000|Overall Study|Lost to Follow-up|2|||
142961186|NCT02275026|515394434|FG000|Overall Study|Scanner failure|1|||
142961187|NCT02213198|515394435|FG000|Baseline|No show for intake|7|||
142961188|NCT02213198|515394436|FG001|Baseline|No show for intake|9|||
142961189|NCT02213198|515394435|FG000|Baseline|Withdrawal by Subject|34|||
142961190|NCT02213198|515394436|FG001|Baseline|Withdrawal by Subject|11|||
142961191|NCT02213198|515394435|FG000|Baseline|transferred out of clinic|7|||
142961192|NCT02213198|515394436|FG001|Baseline|transferred out of clinic|9|||
142961193|NCT02213198|515394435|FG000|Baseline|Lost to Follow-up|40|||
142961194|NCT02213198|515394436|FG001|Baseline|Lost to Follow-up|21|||
142961195|NCT02213198|515394435|FG000|Baseline|incarcerated,violent|0|||
142961196|NCT02213198|515394436|FG001|Baseline|incarcerated,violent|1|||
142961197|NCT02213198|515394435|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
142961198|NCT02213198|515394436|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
142961199|NCT02213198|515394435|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
142961200|NCT02213198|515394436|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
142961201|NCT02213198|515394435|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
142961202|NCT02213198|515394436|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
142961203|NCT02213198|515394435|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
142961204|NCT02213198|515394436|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
142961205|NCT02213198|515394435|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
142961206|NCT02213198|515394436|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
142961207|NCT02213198|515394435|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
142961208|NCT02213198|515394436|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
142961209|NCT00001262|515394437|FG000|Overall Study|Death|10|||
142961210|NCT00001262|515394438|FG001|Overall Study|Death|11|||
142961211|NCT00001262|515394439|FG002|Overall Study|Death|0|||
142961212|NCT00001262|515394437|FG000|Overall Study|Withdrawal by Subject|0|||
142961213|NCT00001262|515394438|FG001|Overall Study|Withdrawal by Subject|3|||
142961214|NCT00001262|515394439|FG002|Overall Study|Withdrawal by Subject|0|||
142961215|NCT02379923|515394440|FG000|Overall Study|Death|5|||
142961216|NCT04238663|515394441|FG000|Overall Study|Lost to Follow-up|0|||
142961217|NCT04238663|515394442|FG001|Overall Study|Lost to Follow-up|1|||
142961218|NCT04238663|515394443|FG002|Overall Study|Lost to Follow-up|0|||
142961219|NCT01193348|515394444|FG000|Screening Period|Screen Failure|5|||
142961220|NCT01193348|515394444|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
142961221|NCT01193348|515394444|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
142961222|NCT01193348|515394444|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
142961223|NCT01193348|515394444|FG000|Extension Treatment Period|Physician Decision|1|||
142961224|NCT01193348|515394444|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
142961225|NCT03259334|515394445|FG000|Overall Study|Adverse Event|3|||
142961226|NCT03259334|515394446|FG001|Overall Study|Adverse Event|8|||
142961227|NCT03259334|515394447|FG002|Overall Study|Adverse Event|5|||
142961228|NCT03259334|515394445|FG000|Overall Study|Withdrawal by Subject|4|||
142961229|NCT03259334|515394446|FG001|Overall Study|Withdrawal by Subject|2|||
142961230|NCT03259334|515394447|FG002|Overall Study|Withdrawal by Subject|4|||
142961231|NCT03259334|515394445|FG000|Overall Study|Physician Decision|1|||
142961232|NCT03259334|515394446|FG001|Overall Study|Physician Decision|0|||
142961233|NCT03259334|515394447|FG002|Overall Study|Physician Decision|0|||
142961234|NCT03259334|515394445|FG000|Overall Study|Lost to Follow-up|0|||
142961235|NCT03259334|515394446|FG001|Overall Study|Lost to Follow-up|2|||
142961236|NCT03259334|515394447|FG002|Overall Study|Lost to Follow-up|1|||
142961237|NCT03259334|515394445|FG000|Overall Study|Protocol Deviation|0|||
142961238|NCT03259334|515394446|FG001|Overall Study|Protocol Deviation|3|||
142961239|NCT03259334|515394447|FG002|Overall Study|Protocol Deviation|2|||
142961240|NCT03259334|515394445|FG000|Overall Study|Lack of Efficacy|2|||
142961241|NCT03259334|515394446|FG001|Overall Study|Lack of Efficacy|0|||
142961242|NCT03259334|515394447|FG002|Overall Study|Lack of Efficacy|1|||
142961243|NCT03259334|515394445|FG000|Overall Study|Randomized but never treated|0|||
142961244|NCT03259334|515394446|FG001|Overall Study|Randomized but never treated|2|||
142961245|NCT03259334|515394447|FG002|Overall Study|Randomized but never treated|0|||
142961246|NCT02928406|515394452|FG000|Overall Study|Death|780|||
142961247|NCT02928406|515394452|FG000|Overall Study|Progressive disease|3|||
142961248|NCT02928406|515394452|FG000|Overall Study|Lost to Follow-up|49|||
142961249|NCT02928406|515394452|FG000|Overall Study|Non-compliance|2|||
142961250|NCT02928406|515394452|FG000|Overall Study|Withdrawal by Subject|40|||
142961251|NCT02928406|515394452|FG000|Overall Study|Study terminated by sponsor|57|||
143455368|NCT03541174|517212431|FG004|Part 2 Single-Blind|Pregnancy|0|||
143455369|NCT03541174|517212432|FG005|Part 2 Single-Blind|Pregnancy|0|||
143455370|NCT03541174|517212427|FG000|Part 2 Single-Blind|Other reasons|0|||
142961252|NCT02928406|515394452|FG000|Overall Study|Physician Decision|1|||
143455371|NCT03541174|517212428|FG001|Part 2 Single-Blind|Other reasons|0|||
142961253|NCT02928406|515394452|FG000|Overall Study|Various reasons|72|||
142961254|NCT00786838|515394454|FG000|Overall Study|Physician Decision|4|||
142961255|NCT00786838|515394454|FG000|Overall Study|Death|4|||
143455372|NCT03541174|517212429|FG002|Part 2 Single-Blind|Other reasons|0|||
143455373|NCT03541174|517212430|FG003|Part 2 Single-Blind|Other reasons|32|||
143455374|NCT03541174|517212431|FG004|Part 2 Single-Blind|Other reasons|0|||
143455375|NCT03541174|517212432|FG005|Part 2 Single-Blind|Other reasons|0|||
142961256|NCT00786838|515394454|FG000|Overall Study|Adverse Event|6|||
142961257|NCT00786838|515394454|FG000|Overall Study|Progressive disease|31|||
142961258|NCT00786838|515394454|FG000|Overall Study|Withdrawal by Subject|4|||
142961259|NCT02488759|515394455|FG000|Overall Study|Disease progression|73|||
142961260|NCT02488759|515394456|FG001|Overall Study|Disease progression|111|||
142961261|NCT02488759|515394457|FG002|Overall Study|Disease progression|62|||
142961262|NCT02488759|515394458|FG003|Overall Study|Disease progression|7|||
142961263|NCT02488759|515394459|FG004|Overall Study|Disease progression|4|||
142961264|NCT02488759|515394460|FG005|Overall Study|Disease progression|2|||
142961265|NCT02488759|515394455|FG000|Overall Study|Study drug toxicity|11|||
142961266|NCT02488759|515394456|FG001|Overall Study|Study drug toxicity|33|||
142961267|NCT02488759|515394457|FG002|Overall Study|Study drug toxicity|31|||
142961268|NCT02488759|515394458|FG003|Overall Study|Study drug toxicity|0|||
142961269|NCT02488759|515394459|FG004|Overall Study|Study drug toxicity|0|||
142961270|NCT02488759|515394460|FG005|Overall Study|Study drug toxicity|2|||
142961271|NCT02488759|515394455|FG000|Overall Study|Adverse event unrelated to study drug|9|||
142961272|NCT02488759|515394456|FG001|Overall Study|Adverse event unrelated to study drug|11|||
142961273|NCT02488759|515394457|FG002|Overall Study|Adverse event unrelated to study drug|7|||
142961274|NCT02488759|515394458|FG003|Overall Study|Adverse event unrelated to study drug|0|||
142961275|NCT02488759|515394459|FG004|Overall Study|Adverse event unrelated to study drug|1|||
142961276|NCT02488759|515394460|FG005|Overall Study|Adverse event unrelated to study drug|0|||
142961277|NCT02488759|515394455|FG000|Overall Study|Participant request to discontinue study treatment|6|||
142961278|NCT02488759|515394456|FG001|Overall Study|Participant request to discontinue study treatment|8|||
142961279|NCT02488759|515394457|FG002|Overall Study|Participant request to discontinue study treatment|4|||
142961280|NCT02488759|515394458|FG003|Overall Study|Participant request to discontinue study treatment|0|||
142961281|NCT02488759|515394459|FG004|Overall Study|Participant request to discontinue study treatment|0|||
142961282|NCT02488759|515394460|FG005|Overall Study|Participant request to discontinue study treatment|0|||
142961283|NCT02488759|515394455|FG000|Overall Study|Withdrawal by Subject|4|||
142961284|NCT02488759|515394456|FG001|Overall Study|Withdrawal by Subject|0|||
142961285|NCT02488759|515394457|FG002|Overall Study|Withdrawal by Subject|3|||
142961286|NCT02488759|515394458|FG003|Overall Study|Withdrawal by Subject|0|||
142961287|NCT02488759|515394459|FG004|Overall Study|Withdrawal by Subject|0|||
142961288|NCT02488759|515394460|FG005|Overall Study|Withdrawal by Subject|2|||
142961289|NCT02488759|515394455|FG000|Overall Study|Lost to Follow-up|0|||
142961290|NCT02488759|515394456|FG001|Overall Study|Lost to Follow-up|0|||
142961291|NCT02488759|515394457|FG002|Overall Study|Lost to Follow-up|2|||
142961292|NCT02488759|515394458|FG003|Overall Study|Lost to Follow-up|0|||
142961293|NCT02488759|515394459|FG004|Overall Study|Lost to Follow-up|0|||
142961294|NCT02488759|515394460|FG005|Overall Study|Lost to Follow-up|0|||
142961295|NCT02488759|515394455|FG000|Overall Study|Maximum clinical benefit|3|||
142961296|NCT02488759|515394456|FG001|Overall Study|Maximum clinical benefit|0|||
142961297|NCT02488759|515394457|FG002|Overall Study|Maximum clinical benefit|1|||
142961298|NCT02488759|515394458|FG003|Overall Study|Maximum clinical benefit|0|||
142961299|NCT02488759|515394459|FG004|Overall Study|Maximum clinical benefit|0|||
142961300|NCT02488759|515394460|FG005|Overall Study|Maximum clinical benefit|0|||
142961301|NCT02488759|515394455|FG000|Overall Study|Other reasons|7|||
142961302|NCT02488759|515394456|FG001|Overall Study|Other reasons|32|||
142961303|NCT02488759|515394457|FG002|Overall Study|Other reasons|23|||
142961304|NCT02488759|515394458|FG003|Overall Study|Other reasons|1|||
142961305|NCT02488759|515394459|FG004|Overall Study|Other reasons|1|||
142961306|NCT02488759|515394460|FG005|Overall Study|Other reasons|1|||
142961307|NCT03860844|515394461|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
142961308|NCT03860844|515394462|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
142961309|NCT03860844|515394463|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
142961310|NCT03860844|515394461|FG000|Overall Study|Progressive disease|5|||
142961311|NCT03860844|515394462|FG001|Overall Study|Progressive disease|3|||
142961312|NCT03860844|515394463|FG002|Overall Study|Progressive disease|4|||
142961313|NCT03860844|515394461|FG000|Overall Study|Other, Not related to COVID-19|0|||
142961314|NCT03860844|515394462|FG001|Overall Study|Other, Not related to COVID-19|1|||
142961315|NCT03860844|515394463|FG002|Overall Study|Other, Not related to COVID-19|0|||
142961316|NCT01678807|515394471|FG000|Overall Study|Adverse Event|4|||
142961317|NCT01678807|515394472|FG001|Overall Study|Adverse Event|4|||
142961318|NCT01678807|515394473|FG002|Overall Study|Adverse Event|0|||
142961319|NCT01678807|515394471|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
142961320|NCT01678807|515394472|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
142961321|NCT01678807|515394473|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
142961322|NCT02429427|515394474|FG000|Overall Study|Adverse Event|220|||
142961323|NCT02429427|515394475|FG001|Overall Study|Adverse Event|92|||
143455376|NCT03541174|517212427|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
143455377|NCT03541174|517212428|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
142961324|NCT02429427|515394474|FG000|Overall Study|Protocol Violation|10|||
142961325|NCT02429427|515394475|FG001|Overall Study|Protocol Violation|6|||
142961326|NCT02429427|515394474|FG000|Overall Study|Lost to Follow-up|15|||
142961327|NCT02429427|515394475|FG001|Overall Study|Lost to Follow-up|6|||
142961328|NCT02429427|515394474|FG000|Overall Study|Withdrawal by Subject|64|||
142961329|NCT02429427|515394475|FG001|Overall Study|Withdrawal by Subject|34|||
142961330|NCT02429427|515394474|FG000|Overall Study|Other|62|||
142961331|NCT02429427|515394475|FG001|Overall Study|Other|41|||
142961332|NCT00719732|515394476|FG000|Overall Study|Lost to Follow-up|20|||
142961333|NCT00719732|515394476|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
143455378|NCT03541174|517212429|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
143455379|NCT03541174|517212430|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
143455380|NCT03541174|517212431|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
143455381|NCT03541174|517212432|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
143455382|NCT03541174|517212427|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
143455383|NCT03541174|517212428|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
143455384|NCT03541174|517212429|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
143455385|NCT03541174|517212430|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
143455386|NCT03541174|517212431|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
143455387|NCT03541174|517212432|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
143455388|NCT03541174|517212427|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
143455389|NCT03541174|517212428|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
143455390|NCT03541174|517212429|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
143455391|NCT03541174|517212430|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
143455392|NCT03541174|517212431|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
143455393|NCT03541174|517212432|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
143455394|NCT03541174|517212427|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
143455395|NCT03541174|517212428|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
143455396|NCT03541174|517212429|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
143455397|NCT03541174|517212430|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
143455398|NCT03541174|517212431|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
143455399|NCT03541174|517212432|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
143455400|NCT03541174|517212427|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
143455401|NCT03541174|517212428|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
143455402|NCT03541174|517212429|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
143455403|NCT03541174|517212430|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
143455404|NCT03541174|517212431|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
143455405|NCT03541174|517212432|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
143455406|NCT01342341|517212433|FG000|Overall Study|Lost to Follow-up|4|||
143455407|NCT01342341|517212434|FG001|Overall Study|Lost to Follow-up|4|||
143455408|NCT02914275|517212435|FG000|Overall Study|Lost to Follow-up|84|||
143455409|NCT02914275|517212436|FG001|Overall Study|Lost to Follow-up|29|||
142961334|NCT00719732|515394476|FG000|Overall Study|Illness not associated with device|1|||
142961335|NCT01096446|515396169|FG000|Overall Study|Death|1|||
142961336|NCT01096446|515396170|FG001|Overall Study|Death|0|||
142961337|NCT01096446|515396169|FG000|Overall Study|Protocol Violation|2|||
142961338|NCT01096446|515396170|FG001|Overall Study|Protocol Violation|0|||
142961339|NCT02626819|515396171|FG000|Overall Study|Lost to Follow-up|3|||
142961340|NCT02626819|515396172|FG001|Overall Study|Lost to Follow-up|2|||
142961341|NCT02626819|515396171|FG000|Overall Study|Withdrawal by Subject|1|||
142961342|NCT02626819|515396172|FG001|Overall Study|Withdrawal by Subject|0|||
142961343|NCT02626819|515396171|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
142961344|NCT02626819|515396172|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
142961345|NCT02163993|515396175|FG000|Treatment Period|Adverse Event|0|||
142961346|NCT02163993|515396176|FG001|Treatment Period|Adverse Event|1|||
142961347|NCT02163993|515396177|FG002|Treatment Period|Adverse Event|0|||
142961348|NCT02163993|515396178|FG003|Treatment Period|Adverse Event|0|||
142961349|NCT02163993|515396179|FG004|Treatment Period|Adverse Event|1|||
142961350|NCT02163993|515396175|FG000|Treatment Period|Lost to Follow-up|2|||
142961351|NCT02163993|515396176|FG001|Treatment Period|Lost to Follow-up|3|||
142961352|NCT02163993|515396177|FG002|Treatment Period|Lost to Follow-up|1|||
142961353|NCT02163993|515396178|FG003|Treatment Period|Lost to Follow-up|3|||
142961354|NCT02163993|515396179|FG004|Treatment Period|Lost to Follow-up|1|||
142961355|NCT02163993|515396175|FG000|Treatment Period|Physician Decision|1|||
142961356|NCT02163993|515396176|FG001|Treatment Period|Physician Decision|0|||
142961357|NCT02163993|515396177|FG002|Treatment Period|Physician Decision|0|||
142961358|NCT02163993|515396178|FG003|Treatment Period|Physician Decision|0|||
142961359|NCT02163993|515396179|FG004|Treatment Period|Physician Decision|0|||
142961360|NCT02163993|515396175|FG000|Treatment Period|Protocol Violation|2|||
142961361|NCT02163993|515396176|FG001|Treatment Period|Protocol Violation|1|||
142961362|NCT02163993|515396177|FG002|Treatment Period|Protocol Violation|0|||
143455410|NCT02914275|517212435|FG000|Overall Study|Withdrawal by Subject|26|||
142961363|NCT02163993|515396178|FG003|Treatment Period|Protocol Violation|1|||
142961364|NCT02163993|515396179|FG004|Treatment Period|Protocol Violation|2|||
142961365|NCT02163993|515396175|FG000|Treatment Period|Withdrawal by Subject|6|||
142961366|NCT02163993|515396176|FG001|Treatment Period|Withdrawal by Subject|4|||
142961367|NCT02163993|515396177|FG002|Treatment Period|Withdrawal by Subject|1|||
142961368|NCT02163993|515396178|FG003|Treatment Period|Withdrawal by Subject|4|||
142961369|NCT02163993|515396179|FG004|Treatment Period|Withdrawal by Subject|1|||
142961370|NCT02163993|515396175|FG000|Treatment Period|Not treated|1|||
142961371|NCT02163993|515396176|FG001|Treatment Period|Not treated|0|||
142961372|NCT02163993|515396177|FG002|Treatment Period|Not treated|0|||
142961373|NCT02163993|515396178|FG003|Treatment Period|Not treated|1|||
142961374|NCT02163993|515396179|FG004|Treatment Period|Not treated|2|||
142961375|NCT02163993|515396175|FG000|Post-treatment Period|Adverse Event|0|||
142961376|NCT02163993|515396176|FG001|Post-treatment Period|Adverse Event|0|||
142961377|NCT02163993|515396177|FG002|Post-treatment Period|Adverse Event|1|||
142961378|NCT02163993|515396178|FG003|Post-treatment Period|Adverse Event|0|||
142961379|NCT02163993|515396179|FG004|Post-treatment Period|Adverse Event|0|||
142961380|NCT02163993|515396175|FG000|Post-treatment Period|Lost to Follow-up|2|||
142961381|NCT02163993|515396176|FG001|Post-treatment Period|Lost to Follow-up|2|||
142961382|NCT02163993|515396177|FG002|Post-treatment Period|Lost to Follow-up|3|||
142961383|NCT02163993|515396178|FG003|Post-treatment Period|Lost to Follow-up|1|||
142961384|NCT02163993|515396179|FG004|Post-treatment Period|Lost to Follow-up|0|||
142961385|NCT02163993|515396175|FG000|Post-treatment Period|Protocol Violation|0|||
142961386|NCT02163993|515396176|FG001|Post-treatment Period|Protocol Violation|0|||
142961387|NCT02163993|515396177|FG002|Post-treatment Period|Protocol Violation|0|||
142961388|NCT02163993|515396178|FG003|Post-treatment Period|Protocol Violation|0|||
142961389|NCT02163993|515396179|FG004|Post-treatment Period|Protocol Violation|1|||
142961390|NCT02163993|515396175|FG000|Post-treatment Period|Withdrawal by Subject|2|||
142961391|NCT02163993|515396176|FG001|Post-treatment Period|Withdrawal by Subject|4|||
142961392|NCT02163993|515396177|FG002|Post-treatment Period|Withdrawal by Subject|0|||
142961393|NCT02163993|515396178|FG003|Post-treatment Period|Withdrawal by Subject|1|||
142961394|NCT02163993|515396179|FG004|Post-treatment Period|Withdrawal by Subject|2|||
142961395|NCT01051986|515396180|FG000|Overall Study|Death|1|||
142961396|NCT01051986|515396181|FG001|Overall Study|Death|0|||
142961397|NCT01051986|515396180|FG000|Overall Study|Withdrawal by Subject|2|||
142961398|NCT01051986|515396181|FG001|Overall Study|Withdrawal by Subject|1|||
142961399|NCT01051986|515396180|FG000|Overall Study|Protocol Violation|2|||
142961400|NCT01051986|515396181|FG001|Overall Study|Protocol Violation|3|||
142961401|NCT02273752|515396183|FG000|Overall Study|Trial was terminated early|2|||
142961402|NCT01725152|515396184|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
142961403|NCT01725152|515396185|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
142961404|NCT01725152|515396184|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
142961405|NCT01725152|515396185|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
142961406|NCT01725152|515396184|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
142961407|NCT01725152|515396185|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
142961408|NCT01725152|515396184|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
142961409|NCT01725152|515396185|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
142961410|NCT02044159|515396186|FG000|Overall Study|Consent declined (deferred consent)|2|||
142961411|NCT02044159|515396187|FG001|Overall Study|Consent declined (deferred consent)|4|||
142961412|NCT02044159|515396186|FG000|Overall Study|No longer eligible, drug not given|1|||
142961413|NCT02044159|515396187|FG001|Overall Study|No longer eligible, drug not given|0|||
142961414|NCT02044159|515396186|FG000|Overall Study|Nurse declined to give study drug|1|||
142961415|NCT02044159|515396187|FG001|Overall Study|Nurse declined to give study drug|0|||
142961416|NCT01111539|515396188|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
142961417|NCT01111539|515396189|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
142961418|NCT01111539|515396190|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
142961419|NCT01111539|515396191|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
142961420|NCT01111539|515396192|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
142961421|NCT01111539|515396188|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
142961422|NCT01111539|515396189|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
142961423|NCT01111539|515396190|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
142961424|NCT01111539|515396191|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
142961425|NCT01111539|515396192|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
142961426|NCT01111539|515396188|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
142961427|NCT01111539|515396189|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
142961428|NCT01111539|515396190|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
143455411|NCT02914275|517212436|FG001|Overall Study|Withdrawal by Subject|10|||
142961429|NCT01111539|515396191|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
142961430|NCT01111539|515396192|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
142961431|NCT01111539|515396188|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
143455412|NCT02914275|517212435|FG000|Overall Study|Protocol Violation|1|||
143455413|NCT02914275|517212436|FG001|Overall Study|Protocol Violation|1|||
142961432|NCT01111539|515396189|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
142961433|NCT01111539|515396190|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
142961434|NCT01111539|515396191|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
142961435|NCT01111539|515396192|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
142961436|NCT01111539|515396188|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
142961437|NCT01111539|515396189|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
142961438|NCT01111539|515396190|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
142961439|NCT01111539|515396191|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
142961440|NCT01111539|515396192|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
142961441|NCT01111539|515396188|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
142961442|NCT01111539|515396189|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
142961443|NCT01111539|515396190|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
142961444|NCT01111539|515396191|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
142961445|NCT01111539|515396192|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
142961446|NCT01111539|515396188|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
142961447|NCT01111539|515396189|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
142961448|NCT01111539|515396190|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
142961449|NCT01111539|515396191|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
142961450|NCT01111539|515396192|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
142961451|NCT01111539|515396188|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
142961452|NCT01111539|515396189|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
142961453|NCT01111539|515396190|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
142961454|NCT01111539|515396191|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
142961455|NCT01111539|515396192|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
142961456|NCT01111539|515396188|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
142961457|NCT01111539|515396189|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
142961458|NCT01111539|515396190|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
142961459|NCT01111539|515396191|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
142961460|NCT01111539|515396192|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
142961461|NCT01111539|515396188|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
142961462|NCT01111539|515396189|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
142961463|NCT01111539|515396190|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
142961464|NCT01111539|515396191|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
142961465|NCT01111539|515396192|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
142961466|NCT01111539|515396188|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
142961467|NCT01111539|515396189|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
142961468|NCT01111539|515396190|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
142961469|NCT01111539|515396191|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
142961470|NCT01111539|515396192|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
142961471|NCT01111539|515396188|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
142961472|NCT01111539|515396189|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
142961473|NCT01111539|515396190|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
142961474|NCT01111539|515396191|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
142961475|NCT01111539|515396192|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
142961476|NCT01111539|515396188|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
142961477|NCT01111539|515396189|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
142961478|NCT01111539|515396190|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
142961479|NCT01111539|515396191|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
142961480|NCT01111539|515396192|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
142961481|NCT01111539|515396188|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
142961482|NCT01111539|515396189|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
142961483|NCT01111539|515396190|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
142961484|NCT01111539|515396191|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
142961485|NCT01111539|515396192|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
142961486|NCT03580382|515396193|FG000|Overall Study|Early Termination of Study|0|||
142961487|NCT03580382|515396194|FG001|Overall Study|Early Termination of Study|3|||
142961488|NCT02808312|515396195|FG000|Overall Study|Enrolled but Never Treated|0|||
142961489|NCT02808312|515396196|FG001|Overall Study|Enrolled but Never Treated|0|||
142961490|NCT02808312|515396197|FG002|Overall Study|Enrolled but Never Treated|1|||
142961491|NCT02808312|515396198|FG003|Overall Study|Enrolled but Never Treated|0|||
142961492|NCT02808312|515396199|FG004|Overall Study|Enrolled but Never Treated|0|||
142961493|NCT03628417|515396200|FG000|Overall Study|Death|1|||
142961494|NCT03628417|515396201|FG001|Overall Study|Death|1|||
143117142|NCT01273155|515970043|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
143455414|NCT02914275|517212435|FG000|Overall Study|Physician Decision|3|||
143455415|NCT02914275|517212436|FG001|Overall Study|Physician Decision|1|||
142961495|NCT02042404|515396205|FG000|Overall Study|Death|1|||
142961496|NCT02042404|515396206|FG001|Overall Study|Death|0|||
142961497|NCT02042404|515396205|FG000|Overall Study|Unrelated Adverse Event|3|||
142961498|NCT02042404|515396206|FG001|Overall Study|Unrelated Adverse Event|0|||
142961499|NCT02042404|515396205|FG000|Overall Study|Inability to meet time requirements|1|||
142961500|NCT02042404|515396206|FG001|Overall Study|Inability to meet time requirements|0|||
142961501|NCT05619172|515396207|FG000|Safety Cohort 1|Death|7|||
142961502|NCT05619172|515396208|FG001|Safety Cohort 1|Death|0|||
142961503|NCT05619172|515396207|FG000|Safety Cohort 1|Study terminated by sponsor|7|||
142961504|NCT05619172|515396208|FG001|Safety Cohort 1|Study terminated by sponsor|0|||
142961505|NCT05619172|515396207|FG000|Safety Cohort 2|Death|0|||
142961506|NCT05619172|515396208|FG001|Safety Cohort 2|Death|1|||
142961507|NCT05619172|515396207|FG000|Safety Cohort 2|Study terminated by sponsor|0|||
142961508|NCT05619172|515396208|FG001|Safety Cohort 2|Study terminated by sponsor|1|||
142961509|NCT00726323|515396209|FG000|Overall Study|Withdrawal by Subject|3|||
142961510|NCT00726323|515396210|FG001|Overall Study|Withdrawal by Subject|1|||
142961511|NCT00726323|515396209|FG000|Overall Study|Physician Decision|1|||
142961512|NCT00726323|515396210|FG001|Overall Study|Physician Decision|0|||
142961513|NCT00726323|515396209|FG000|Overall Study|Progressive disease|23|||
142961514|NCT00726323|515396210|FG001|Overall Study|Progressive disease|16|||
142961515|NCT00726323|515396209|FG000|Overall Study|Clinical progression|0|||
142961516|NCT00726323|515396210|FG001|Overall Study|Clinical progression|3|||
142961517|NCT00726323|515396209|FG000|Overall Study|Adverse Event|9|||
142961518|NCT00726323|515396210|FG001|Overall Study|Adverse Event|9|||
142961519|NCT00726323|515396209|FG000|Overall Study|Death|1|||
142961520|NCT00726323|515396210|FG001|Overall Study|Death|0|||
142961521|NCT00726323|515396209|FG000|Overall Study|Participant wished to discontinue|0|||
142961522|NCT00726323|515396210|FG001|Overall Study|Participant wished to discontinue|1|||
142961523|NCT00726323|515396209|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
142961524|NCT00726323|515396210|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
142961525|NCT00630812|515396221|FG000|Randomisation to First Dose|Adverse Event|1|||
142961526|NCT00630812|515396222|FG001|Randomisation to First Dose|Adverse Event|1|||
142961527|NCT00630812|515396221|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
142961528|NCT00630812|515396222|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
142961529|NCT00630812|515396221|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
142961530|NCT00630812|515396222|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
142961531|NCT00630812|515396221|FG000|Randomisation to First Dose|Protocol Violation|4|||
142961532|NCT00630812|515396222|FG001|Randomisation to First Dose|Protocol Violation|1|||
142961533|NCT00630812|515396221|FG000|Double Blind Treatment Period|Adverse Event|13|||
142961534|NCT00630812|515396222|FG001|Double Blind Treatment Period|Adverse Event|5|||
142961535|NCT00630812|515396221|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
142961536|NCT00630812|515396222|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
142961537|NCT00630812|515396221|FG000|Double Blind Treatment Period|Physician Decision|2|||
142961538|NCT00630812|515396222|FG001|Double Blind Treatment Period|Physician Decision|1|||
142961539|NCT00630812|515396221|FG000|Double Blind Treatment Period|Protocol Violation|1|||
142961540|NCT00630812|515396222|FG001|Double Blind Treatment Period|Protocol Violation|0|||
142961541|NCT00630812|515396221|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
142961542|NCT00630812|515396222|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
142961543|NCT00630812|515396221|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
142961544|NCT00630812|515396222|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
142961545|NCT00630812|515396221|FG000|Double Blind Treatment Period|Non-compliance|0|||
142961546|NCT00630812|515396222|FG001|Double Blind Treatment Period|Non-compliance|1|||
142961547|NCT01522976|515396223|FG000|Overall Study|Ineligible|4|||
142961548|NCT01522976|515396224|FG001|Overall Study|Ineligible|0|||
142961549|NCT01522976|515396225|FG002|Overall Study|Ineligible|1|||
142961550|NCT01522976|515396223|FG000|Overall Study|Death|7|||
142961551|NCT01522976|515396224|FG001|Overall Study|Death|6|||
142961552|NCT01522976|515396225|FG002|Overall Study|Death|2|||
142961553|NCT01522976|515396223|FG000|Overall Study|Still on treatment|9|||
142961554|NCT01522976|515396224|FG001|Overall Study|Still on treatment|9|||
142961555|NCT01522976|515396225|FG002|Overall Study|Still on treatment|6|||
142961556|NCT01522976|515396223|FG000|Overall Study|Disease progression|28|||
142961557|NCT01522976|515396224|FG001|Overall Study|Disease progression|30|||
142961558|NCT01522976|515396225|FG002|Overall Study|Disease progression|25|||
142961559|NCT01522976|515396223|FG000|Overall Study|Adverse Event|17|||
142961560|NCT01522976|515396224|FG001|Overall Study|Adverse Event|7|||
142961561|NCT01522976|515396225|FG002|Overall Study|Adverse Event|18|||
142961562|NCT01522976|515396223|FG000|Overall Study|Refusal unrelated to adverse event|10|||
142961563|NCT01522976|515396224|FG001|Overall Study|Refusal unrelated to adverse event|13|||
142961564|NCT01522976|515396225|FG002|Overall Study|Refusal unrelated to adverse event|14|||
142961565|NCT01522976|515396223|FG000|Overall Study|Not protocol specified|22|||
142961566|NCT01522976|515396224|FG001|Overall Study|Not protocol specified|27|||
142961567|NCT01522976|515396225|FG002|Overall Study|Not protocol specified|27|||
142961568|NCT03430245|515396228|FG000|Overall Study|Withdrawal by Subject|6|||
142961569|NCT03430245|515396228|FG000|Overall Study|Lost to Follow-up|1|||
142961570|NCT05628181|515396229|FG000|Overall Study|Death|2|||
142961571|NCT05628181|515396230|FG001|Overall Study|Death|4|||
142961572|NCT05628181|515396231|FG002|Overall Study|Death|0|||
142961573|NCT04102098|515396232|FG000|Main Study Period|Ongoing in study|302|||
142961574|NCT04102098|515396233|FG001|Main Study Period|Ongoing in study|291|||
142961575|NCT04102098|515396232|FG000|Main Study Period|Death|20|||
142961576|NCT04102098|515396233|FG001|Main Study Period|Death|27|||
142961577|NCT04102098|515396232|FG000|Main Study Period|Lost to Follow-up|1|||
142961578|NCT04102098|515396233|FG001|Main Study Period|Lost to Follow-up|1|||
142961579|NCT04102098|515396232|FG000|Main Study Period|Physician Decision|0|||
142961580|NCT04102098|515396233|FG001|Main Study Period|Physician Decision|1|||
142961581|NCT04102098|515396232|FG000|Main Study Period|Withdrawal by Subject|11|||
142961582|NCT04102098|515396233|FG001|Main Study Period|Withdrawal by Subject|14|||
142961583|NCT04102098|515396232|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
142961584|NCT04102098|515396233|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
142961585|NCT04102098|515396232|FG000|Crossover: AS Who Crossed Over|Death|11|||
142961586|NCT04102098|515396233|FG001|Crossover: AS Who Crossed Over|Death|0|||
142961587|NCT04102098|515396232|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
142961588|NCT04102098|515396233|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
142961589|NCT04742907|515396240|FG000|Overall Study|Adverse Event|1|||
142961590|NCT04742907|515396241|FG001|Overall Study|Adverse Event|0|||
142961591|NCT04742907|515396242|FG002|Overall Study|Adverse Event|1|||
142961592|NCT04742907|515396240|FG000|Overall Study|Lost to Follow-up|3|||
142961593|NCT04742907|515396241|FG001|Overall Study|Lost to Follow-up|3|||
142961594|NCT04742907|515396242|FG002|Overall Study|Lost to Follow-up|2|||
142961595|NCT04742907|515396240|FG000|Overall Study|Physician Decision|0|||
142961596|NCT04742907|515396241|FG001|Overall Study|Physician Decision|1|||
142961597|NCT04742907|515396242|FG002|Overall Study|Physician Decision|0|||
142961598|NCT04742907|515396240|FG000|Overall Study|Protocol Violation|1|||
142961599|NCT04742907|515396241|FG001|Overall Study|Protocol Violation|1|||
142961600|NCT04742907|515396242|FG002|Overall Study|Protocol Violation|1|||
142961601|NCT04742907|515396240|FG000|Overall Study|Withdrawal by Subject|5|||
142961602|NCT04742907|515396241|FG001|Overall Study|Withdrawal by Subject|6|||
142961603|NCT04742907|515396242|FG002|Overall Study|Withdrawal by Subject|4|||
142961604|NCT04742907|515396240|FG000|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
142961605|NCT04742907|515396241|FG001|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|5|||
142961606|NCT04742907|515396242|FG002|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
142961607|NCT04742907|515396240|FG000|Overall Study|Did Not Receive the Study Drug|2|||
142961608|NCT04742907|515396241|FG001|Overall Study|Did Not Receive the Study Drug|4|||
142961609|NCT04742907|515396242|FG002|Overall Study|Did Not Receive the Study Drug|4|||
142961610|NCT01428063|515396244|FG000|Overall Study|Lack of Efficacy|8|||
142961611|NCT01428063|515396245|FG001|Overall Study|Lack of Efficacy|4|||
142961612|NCT01428063|515396246|FG002|Overall Study|Lack of Efficacy|1|||
142961613|NCT01428063|515396244|FG000|Overall Study|Adverse Event|2|||
142961614|NCT01428063|515396245|FG001|Overall Study|Adverse Event|3|||
142961615|NCT01428063|515396246|FG002|Overall Study|Adverse Event|0|||
142961616|NCT01428063|515396244|FG000|Overall Study|Lost to Follow-up|0|||
142961617|NCT01428063|515396245|FG001|Overall Study|Lost to Follow-up|2|||
142961618|NCT01428063|515396246|FG002|Overall Study|Lost to Follow-up|0|||
142961619|NCT01428063|515396244|FG000|Overall Study|No longer meets study criteria|0|||
142961620|NCT01428063|515396245|FG001|Overall Study|No longer meets study criteria|1|||
142961621|NCT01428063|515396246|FG002|Overall Study|No longer meets study criteria|0|||
142961622|NCT06150573|515396247|FG000|Overall Study|Did not meet study criteria|1|||
142961623|NCT06150573|515396248|FG001|Overall Study|Did not meet study criteria|0|||
142961624|NCT06150573|515396247|FG000|Overall Study|Adverse Event|1|||
142961625|NCT06150573|515396248|FG001|Overall Study|Adverse Event|0|||
142961626|NCT06150573|515396247|FG000|Overall Study|Lost to Follow-up|0|||
142961627|NCT06150573|515396248|FG001|Overall Study|Lost to Follow-up|1|||
142961628|NCT06150573|515396247|FG000|Overall Study|Protocol Violation|0|||
142961629|NCT06150573|515396248|FG001|Overall Study|Protocol Violation|1|||
142961630|NCT06150573|515396247|FG000|Overall Study|Withdrawal by Subject|2|||
142961631|NCT06150573|515396248|FG001|Overall Study|Withdrawal by Subject|0|||
142961632|NCT00069095|515396249|FG000|Primary Treatment Phase|Ongoing|0|||
142961633|NCT00069095|515396250|FG001|Primary Treatment Phase|Ongoing|0|||
142961634|NCT00069095|515396251|FG002|Primary Treatment Phase|Ongoing|5|||
142961635|NCT00069095|515396252|FG003|Primary Treatment Phase|Ongoing|7|||
142961636|NCT00069095|515396253|FG004|Primary Treatment Phase|Ongoing|7|||
142961637|NCT00069095|515396254|FG005|Primary Treatment Phase|Ongoing|4|||
142961638|NCT00069095|515396249|FG000|Primary Treatment Phase|Admin/Other|29|||
142961639|NCT00069095|515396250|FG001|Primary Treatment Phase|Admin/Other|38|||
142961640|NCT00069095|515396251|FG002|Primary Treatment Phase|Admin/Other|31|||
142961641|NCT00069095|515396252|FG003|Primary Treatment Phase|Admin/Other|45|||
142961642|NCT00069095|515396253|FG004|Primary Treatment Phase|Admin/Other|48|||
142961643|NCT00069095|515396254|FG005|Primary Treatment Phase|Admin/Other|42|||
142961644|NCT00069095|515396249|FG000|Primary Treatment Phase|Adverse Event|99|||
142961645|NCT00069095|515396250|FG001|Primary Treatment Phase|Adverse Event|92|||
142961646|NCT00069095|515396251|FG002|Primary Treatment Phase|Adverse Event|71|||
142961647|NCT00069095|515396252|FG003|Primary Treatment Phase|Adverse Event|72|||
142961648|NCT00069095|515396253|FG004|Primary Treatment Phase|Adverse Event|109|||
142961649|NCT00069095|515396254|FG005|Primary Treatment Phase|Adverse Event|101|||
142961650|NCT00069095|515396249|FG000|Primary Treatment Phase|Death|14|||
142961651|NCT00069095|515396250|FG001|Primary Treatment Phase|Death|8|||
142961652|NCT00069095|515396251|FG002|Primary Treatment Phase|Death|2|||
142961653|NCT00069095|515396252|FG003|Primary Treatment Phase|Death|5|||
142961654|NCT00069095|515396253|FG004|Primary Treatment Phase|Death|8|||
142961655|NCT00069095|515396254|FG005|Primary Treatment Phase|Death|8|||
142961656|NCT00069095|515396249|FG000|Primary Treatment Phase|Failure to return|5|||
142961657|NCT00069095|515396250|FG001|Primary Treatment Phase|Failure to return|5|||
142961658|NCT00069095|515396251|FG002|Primary Treatment Phase|Failure to return|0|||
142961659|NCT00069095|515396252|FG003|Primary Treatment Phase|Failure to return|0|||
142961660|NCT00069095|515396253|FG004|Primary Treatment Phase|Failure to return|0|||
142961661|NCT00069095|515396254|FG005|Primary Treatment Phase|Failure to return|2|||
142961662|NCT00069095|515396249|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
142961663|NCT00069095|515396250|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
142961664|NCT00069095|515396251|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
142961665|NCT00069095|515396252|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
142961666|NCT00069095|515396253|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
142961667|NCT00069095|515396254|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
142961668|NCT00069095|515396249|FG000|Primary Treatment Phase|Refused treatment|15|||
142961669|NCT00069095|515396250|FG001|Primary Treatment Phase|Refused treatment|26|||
142961670|NCT00069095|515396251|FG002|Primary Treatment Phase|Refused treatment|17|||
142961671|NCT00069095|515396252|FG003|Primary Treatment Phase|Refused treatment|31|||
142961672|NCT00069095|515396253|FG004|Primary Treatment Phase|Refused treatment|24|||
142961673|NCT00069095|515396254|FG005|Primary Treatment Phase|Refused treatment|27|||
142961674|NCT00069095|515396249|FG000|Primary Treatment Phase|Withdrew|2|||
142961675|NCT00069095|515396250|FG001|Primary Treatment Phase|Withdrew|3|||
142961676|NCT00069095|515396251|FG002|Primary Treatment Phase|Withdrew|8|||
142961677|NCT00069095|515396252|FG003|Primary Treatment Phase|Withdrew|2|||
142961678|NCT00069095|515396253|FG004|Primary Treatment Phase|Withdrew|4|||
142961679|NCT00069095|515396254|FG005|Primary Treatment Phase|Withdrew|9|||
142961680|NCT00069095|515396249|FG000|Primary Treatment Phase|Other Violation|0|||
142961681|NCT00069095|515396250|FG001|Primary Treatment Phase|Other Violation|1|||
142961682|NCT00069095|515396251|FG002|Primary Treatment Phase|Other Violation|1|||
142961683|NCT00069095|515396252|FG003|Primary Treatment Phase|Other Violation|1|||
142961684|NCT00069095|515396253|FG004|Primary Treatment Phase|Other Violation|0|||
142961685|NCT00069095|515396254|FG005|Primary Treatment Phase|Other Violation|1|||
142961686|NCT00069095|515396249|FG000|Primary Treatment Phase|Violation criteria|0|||
142961687|NCT00069095|515396250|FG001|Primary Treatment Phase|Violation criteria|2|||
142961688|NCT00069095|515396251|FG002|Primary Treatment Phase|Violation criteria|4|||
142961689|NCT00069095|515396252|FG003|Primary Treatment Phase|Violation criteria|3|||
142961690|NCT00069095|515396253|FG004|Primary Treatment Phase|Violation criteria|1|||
142961691|NCT00069095|515396254|FG005|Primary Treatment Phase|Violation criteria|5|||
142961692|NCT00069095|515396249|FG000|Post-study Treatment Phase|Missing reason|1|||
142961693|NCT00069095|515396250|FG001|Post-study Treatment Phase|Missing reason|3|||
142961694|NCT00069095|515396251|FG002|Post-study Treatment Phase|Missing reason|12|||
142961695|NCT00069095|515396252|FG003|Post-study Treatment Phase|Missing reason|8|||
142961696|NCT00069095|515396253|FG004|Post-study Treatment Phase|Missing reason|18|||
142961697|NCT00069095|515396254|FG005|Post-study Treatment Phase|Missing reason|17|||
142961698|NCT00069095|515396249|FG000|Post-study Treatment Phase|Adverse Event|2|||
142961699|NCT00069095|515396250|FG001|Post-study Treatment Phase|Adverse Event|3|||
142961700|NCT00069095|515396251|FG002|Post-study Treatment Phase|Adverse Event|1|||
142961701|NCT00069095|515396252|FG003|Post-study Treatment Phase|Adverse Event|0|||
142961702|NCT00069095|515396253|FG004|Post-study Treatment Phase|Adverse Event|5|||
142961703|NCT00069095|515396254|FG005|Post-study Treatment Phase|Adverse Event|1|||
142961704|NCT00069095|515396249|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
142961705|NCT00069095|515396250|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
142961706|NCT00069095|515396251|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
142961707|NCT00069095|515396252|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
142961708|NCT00069095|515396253|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
142961709|NCT00069095|515396254|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
142961710|NCT00069095|515396249|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
142961711|NCT00069095|515396250|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
142961712|NCT00069095|515396251|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
142961713|NCT00069095|515396252|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
142961714|NCT00069095|515396253|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
142961715|NCT00069095|515396254|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
142961716|NCT00069095|515396249|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
142961717|NCT00069095|515396250|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
142961718|NCT00069095|515396251|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
142961719|NCT00069095|515396252|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
142961720|NCT00069095|515396253|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
142961721|NCT00069095|515396254|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
142961722|NCT00069095|515396249|FG000|Post-study Treatment Phase|Participant had complete response|1|||
142961723|NCT00069095|515396250|FG001|Post-study Treatment Phase|Participant had complete response|1|||
142961724|NCT00069095|515396251|FG002|Post-study Treatment Phase|Participant had complete response|0|||
142961725|NCT00069095|515396252|FG003|Post-study Treatment Phase|Participant had complete response|0|||
142961726|NCT00069095|515396253|FG004|Post-study Treatment Phase|Participant had complete response|0|||
142961727|NCT00069095|515396254|FG005|Post-study Treatment Phase|Participant had complete response|0|||
142961728|NCT00069095|515396249|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
142961729|NCT00069095|515396250|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
142961730|NCT00069095|515396251|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
142961731|NCT00069095|515396252|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
142961732|NCT00069095|515396253|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
142961733|NCT00069095|515396254|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
142961734|NCT00069095|515396249|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
142961735|NCT00069095|515396250|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
142961736|NCT00069095|515396251|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
142961737|NCT00069095|515396252|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
142961738|NCT00069095|515396253|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
142961739|NCT00069095|515396254|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
142961740|NCT00069095|515396249|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
142961741|NCT00069095|515396250|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
142961742|NCT00069095|515396251|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
142961743|NCT00069095|515396252|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
142961744|NCT00069095|515396253|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
142961745|NCT00069095|515396254|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
142961746|NCT00069095|515396249|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
142961747|NCT00069095|515396250|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
142961748|NCT00069095|515396251|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
142961749|NCT00069095|515396252|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
142961750|NCT00069095|515396253|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
142961751|NCT00069095|515396254|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
142961752|NCT00069095|515396249|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
142961753|NCT00069095|515396250|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
142961754|NCT00069095|515396251|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
142961755|NCT00069095|515396252|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
142961756|NCT00069095|515396253|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
142961757|NCT00069095|515396254|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
142961758|NCT00069095|515396249|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
142961759|NCT00069095|515396250|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
142961760|NCT00069095|515396251|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
142961761|NCT00069095|515396252|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
142961762|NCT00069095|515396253|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
142961763|NCT00069095|515396254|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
142961764|NCT00069095|515396249|FG000|Post-study Treatment Phase|Surgery|0|||
142961765|NCT00069095|515396250|FG001|Post-study Treatment Phase|Surgery|0|||
142961766|NCT00069095|515396251|FG002|Post-study Treatment Phase|Surgery|0|||
142961767|NCT00069095|515396252|FG003|Post-study Treatment Phase|Surgery|1|||
142961768|NCT00069095|515396253|FG004|Post-study Treatment Phase|Surgery|1|||
142961769|NCT00069095|515396254|FG005|Post-study Treatment Phase|Surgery|0|||
142961770|NCT00069095|515396249|FG000|Post-study Treatment Phase|Death|0|||
142961771|NCT00069095|515396250|FG001|Post-study Treatment Phase|Death|0|||
142961772|NCT00069095|515396251|FG002|Post-study Treatment Phase|Death|0|||
142961773|NCT00069095|515396252|FG003|Post-study Treatment Phase|Death|0|||
142961774|NCT00069095|515396253|FG004|Post-study Treatment Phase|Death|1|||
142961775|NCT00069095|515396254|FG005|Post-study Treatment Phase|Death|0|||
142961776|NCT00069095|515396249|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
142961777|NCT00069095|515396250|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
142961778|NCT00069095|515396251|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
142961779|NCT00069095|515396252|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
142961780|NCT00069095|515396253|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
142961781|NCT00069095|515396254|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
142961782|NCT00069095|515396249|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
142961783|NCT00069095|515396250|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
142961784|NCT00069095|515396251|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
142961785|NCT00069095|515396252|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
142961786|NCT00069095|515396253|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
142961787|NCT00069095|515396254|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
142961788|NCT00069095|515396249|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
142961789|NCT00069095|515396250|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
142961790|NCT00069095|515396251|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
142961791|NCT00069095|515396252|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
142961792|NCT00069095|515396253|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
142961793|NCT00069095|515396254|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
142961794|NCT00069095|515396249|FG000|Post-study Treatment Phase|Investigator decision|0|||
142961795|NCT00069095|515396250|FG001|Post-study Treatment Phase|Investigator decision|0|||
142961796|NCT00069095|515396251|FG002|Post-study Treatment Phase|Investigator decision|0|||
142961797|NCT00069095|515396252|FG003|Post-study Treatment Phase|Investigator decision|0|||
142961798|NCT00069095|515396253|FG004|Post-study Treatment Phase|Investigator decision|0|||
142961799|NCT00069095|515396254|FG005|Post-study Treatment Phase|Investigator decision|1|||
142961800|NCT00069095|515396249|FG000|Follow-up Phase|Death|174|||
142961801|NCT00069095|515396250|FG001|Follow-up Phase|Death|206|||
142961802|NCT00069095|515396251|FG002|Follow-up Phase|Death|120|||
142961803|NCT00069095|515396252|FG003|Follow-up Phase|Death|112|||
142961804|NCT00069095|515396253|FG004|Follow-up Phase|Death|92|||
142961805|NCT00069095|515396254|FG005|Follow-up Phase|Death|101|||
142961806|NCT04716933|515396258|FG000|Overall Study|Sponsor Decision|36|||
142961807|NCT04716933|515396259|FG001|Overall Study|Sponsor Decision|33|||
142961808|NCT04716933|515396258|FG000|Overall Study|Death|65|||
142961809|NCT04716933|515396259|FG001|Overall Study|Death|67|||
142961810|NCT03249792|515396264|FG000|Arms 1, 2, and 4|Death|1|||
142961811|NCT03249792|515396265|FG001|Arms 1, 2, and 4|Death|1|||
142961812|NCT03249792|515396266|FG002|Arms 1, 2, and 4|Death|0|||
142961813|NCT03249792|515396267|FG003|Arms 1, 2, and 4|Death|2|||
142961814|NCT03249792|515396268|FG004|Arms 1, 2, and 4|Death|3|||
142961815|NCT03249792|515396269|FG005|Arms 1, 2, and 4|Death|2|||
142961816|NCT03249792|515396270|FG006|Arms 1, 2, and 4|Death|2|||
142961817|NCT03249792|515396271|FG007|Arms 1, 2, and 4|Death|4|||
142961818|NCT03249792|515396272|FG008|Arms 1, 2, and 4|Death|2|||
142961819|NCT03249792|515396273|FG009|Arms 1, 2, and 4|Death|1|||
142961820|NCT03249792|515396274|FG010|Arms 1, 2, and 4|Death|7|||
142961821|NCT03249792|515396275|FG011|Arms 1, 2, and 4|Death|7|||
142961822|NCT03249792|515396276|FG012|Arms 1, 2, and 4|Death|12|||
142961823|NCT03249792|515396277|FG013|Arms 1, 2, and 4|Death|7|||
142961824|NCT03249792|515396278|FG014|Arms 1, 2, and 4|Death|0|||
142961825|NCT03249792|515396279|FG015|Arms 1, 2, and 4|Death|4|||
142961826|NCT03249792|515396280|FG016|Arms 1, 2, and 4|Death|4|||
142961827|NCT03249792|515396281|FG017|Arms 1, 2, and 4|Death|12|||
142961828|NCT03249792|515396282|FG018|Arms 1, 2, and 4|Death|6|||
142961829|NCT03249792|515396283|FG019|Arms 1, 2, and 4|Death|4|||
142961830|NCT03249792|515396284|FG020|Arms 1, 2, and 4|Death|2|||
142961831|NCT03249792|515396285|FG021|Arms 1, 2, and 4|Death|3|||
142961832|NCT03249792|515396286|FG022|Arms 1, 2, and 4|Death|1|||
142961833|NCT03249792|515396287|FG023|Arms 1, 2, and 4|Death|1|||
142961834|NCT03249792|515396288|FG024|Arms 1, 2, and 4|Death|4|||
142961835|NCT03249792|515396289|FG025|Arms 1, 2, and 4|Death|0|||
142961836|NCT03249792|515396290|FG026|Arms 1, 2, and 4|Death|0|||
142961837|NCT03249792|515396291|FG027|Arms 1, 2, and 4|Death|0|||
142961838|NCT03249792|515396292|FG028|Arms 1, 2, and 4|Death|0|||
142961839|NCT03249792|515396293|FG029|Arms 1, 2, and 4|Death|0|||
142961840|NCT03249792|515396294|FG030|Arms 1, 2, and 4|Death|0|||
142961841|NCT03249792|515396295|FG031|Arms 1, 2, and 4|Death|0|||
142961842|NCT03249792|515396296|FG032|Arms 1, 2, and 4|Death|0|||
142961843|NCT03249792|515396264|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
142961844|NCT03249792|515396265|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
142961845|NCT03249792|515396266|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
142961846|NCT03249792|515396267|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
142961847|NCT03249792|515396268|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
142961848|NCT03249792|515396269|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
142961849|NCT03249792|515396270|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
142961850|NCT03249792|515396271|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
142961851|NCT03249792|515396272|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
142961852|NCT03249792|515396273|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
142961853|NCT03249792|515396274|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
142961854|NCT03249792|515396275|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
142961855|NCT03249792|515396276|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
142961856|NCT03249792|515396277|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
142961857|NCT03249792|515396278|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
142961858|NCT03249792|515396279|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
143117494|NCT01472939|515971863|FG002|Overall Study|Protocol Violation|0|||
142961859|NCT03249792|515396280|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
142961860|NCT03249792|515396281|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
142961861|NCT03249792|515396282|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
142961862|NCT03249792|515396283|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
142961863|NCT03249792|515396284|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
142961864|NCT03249792|515396285|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
142961865|NCT03249792|515396286|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
142961866|NCT03249792|515396287|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
142961867|NCT03249792|515396288|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
142961868|NCT03249792|515396289|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
142961869|NCT03249792|515396290|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
142961870|NCT03249792|515396291|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
142961871|NCT03249792|515396292|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
142961872|NCT03249792|515396293|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
142961873|NCT03249792|515396294|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
142961874|NCT03249792|515396295|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
142961875|NCT03249792|515396296|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
142961876|NCT03249792|515396264|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
142961877|NCT03249792|515396265|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
142961878|NCT03249792|515396266|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
142961879|NCT03249792|515396267|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
142961880|NCT03249792|515396268|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
142961881|NCT03249792|515396269|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
142961882|NCT03249792|515396270|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
142961883|NCT03249792|515396271|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
142961884|NCT03249792|515396272|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
142961885|NCT03249792|515396273|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
142961886|NCT03249792|515396274|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
142961887|NCT03249792|515396275|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
142961888|NCT03249792|515396276|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
142961889|NCT03249792|515396277|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
142961890|NCT03249792|515396278|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
142961891|NCT03249792|515396279|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
142961892|NCT03249792|515396280|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
142961893|NCT03249792|515396281|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
142961894|NCT03249792|515396282|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
142961895|NCT03249792|515396283|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
142961896|NCT03249792|515396284|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
142961897|NCT03249792|515396285|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
142961898|NCT03249792|515396286|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
142961899|NCT03249792|515396287|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
142961900|NCT03249792|515396288|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
142961901|NCT03249792|515396289|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
142961902|NCT03249792|515396290|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
142961903|NCT03249792|515396291|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
142961904|NCT03249792|515396292|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
142961905|NCT03249792|515396293|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
142961906|NCT03249792|515396294|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
142961907|NCT03249792|515396295|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
142961908|NCT03249792|515396296|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
142961909|NCT03249792|515396264|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
142961910|NCT03249792|515396265|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
142961911|NCT03249792|515396266|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
142961912|NCT03249792|515396267|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
142961913|NCT03249792|515396268|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
142961914|NCT03249792|515396269|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
142961915|NCT03249792|515396270|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
142961916|NCT03249792|515396271|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
142961917|NCT03249792|515396272|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
142961918|NCT03249792|515396273|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
142961919|NCT03249792|515396274|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
142961920|NCT03249792|515396275|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
142961921|NCT03249792|515396276|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
142961922|NCT03249792|515396277|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
142961923|NCT03249792|515396278|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
142961924|NCT03249792|515396279|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
142961925|NCT03249792|515396280|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
142961926|NCT03249792|515396281|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
142961927|NCT03249792|515396282|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
142961928|NCT03249792|515396283|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
142961929|NCT03249792|515396284|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
142961930|NCT03249792|515396285|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
142961931|NCT03249792|515396286|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
142961932|NCT03249792|515396287|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
142961933|NCT03249792|515396288|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
143117495|NCT01472939|515971864|FG003|Overall Study|Protocol Violation|1|||
142961934|NCT03249792|515396289|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
142961935|NCT03249792|515396290|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
142961936|NCT03249792|515396291|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
142961937|NCT03249792|515396292|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
142961938|NCT03249792|515396293|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
142961939|NCT03249792|515396294|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
142961940|NCT03249792|515396295|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
142961941|NCT03249792|515396296|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
142961942|NCT03249792|515396264|FG000|Switch Over Period|Withdrawal by Subject|0|||
142961943|NCT03249792|515396265|FG001|Switch Over Period|Withdrawal by Subject|0|||
142961944|NCT03249792|515396266|FG002|Switch Over Period|Withdrawal by Subject|0|||
142961945|NCT03249792|515396267|FG003|Switch Over Period|Withdrawal by Subject|0|||
142961946|NCT03249792|515396268|FG004|Switch Over Period|Withdrawal by Subject|0|||
142961947|NCT03249792|515396269|FG005|Switch Over Period|Withdrawal by Subject|0|||
142961948|NCT03249792|515396270|FG006|Switch Over Period|Withdrawal by Subject|0|||
142961949|NCT03249792|515396271|FG007|Switch Over Period|Withdrawal by Subject|0|||
142961950|NCT03249792|515396272|FG008|Switch Over Period|Withdrawal by Subject|0|||
142961951|NCT03249792|515396273|FG009|Switch Over Period|Withdrawal by Subject|0|||
142961952|NCT03249792|515396274|FG010|Switch Over Period|Withdrawal by Subject|0|||
142961953|NCT03249792|515396275|FG011|Switch Over Period|Withdrawal by Subject|0|||
142961954|NCT03249792|515396276|FG012|Switch Over Period|Withdrawal by Subject|0|||
142961955|NCT03249792|515396277|FG013|Switch Over Period|Withdrawal by Subject|0|||
142961956|NCT03249792|515396278|FG014|Switch Over Period|Withdrawal by Subject|0|||
142961957|NCT03249792|515396279|FG015|Switch Over Period|Withdrawal by Subject|0|||
142961958|NCT03249792|515396280|FG016|Switch Over Period|Withdrawal by Subject|0|||
142961959|NCT03249792|515396281|FG017|Switch Over Period|Withdrawal by Subject|0|||
142961960|NCT03249792|515396282|FG018|Switch Over Period|Withdrawal by Subject|0|||
142961961|NCT03249792|515396283|FG019|Switch Over Period|Withdrawal by Subject|0|||
142961962|NCT03249792|515396284|FG020|Switch Over Period|Withdrawal by Subject|0|||
142961963|NCT03249792|515396285|FG021|Switch Over Period|Withdrawal by Subject|0|||
142961964|NCT03249792|515396286|FG022|Switch Over Period|Withdrawal by Subject|0|||
142961965|NCT03249792|515396287|FG023|Switch Over Period|Withdrawal by Subject|0|||
142961966|NCT03249792|515396288|FG024|Switch Over Period|Withdrawal by Subject|0|||
142961967|NCT03249792|515396289|FG025|Switch Over Period|Withdrawal by Subject|0|||
142961968|NCT03249792|515396290|FG026|Switch Over Period|Withdrawal by Subject|0|||
142961969|NCT03249792|515396291|FG027|Switch Over Period|Withdrawal by Subject|0|||
142961970|NCT03249792|515396292|FG028|Switch Over Period|Withdrawal by Subject|0|||
142961971|NCT03249792|515396293|FG029|Switch Over Period|Withdrawal by Subject|0|||
142961972|NCT03249792|515396294|FG030|Switch Over Period|Withdrawal by Subject|0|||
142961973|NCT03249792|515396295|FG031|Switch Over Period|Withdrawal by Subject|1|||
142961974|NCT03249792|515396296|FG032|Switch Over Period|Withdrawal by Subject|0|||
142961975|NCT03249792|515396264|FG000|Switch Over Period|Progressive Disease|0|||
142961976|NCT03249792|515396265|FG001|Switch Over Period|Progressive Disease|0|||
142961977|NCT03249792|515396266|FG002|Switch Over Period|Progressive Disease|0|||
142961978|NCT03249792|515396267|FG003|Switch Over Period|Progressive Disease|0|||
142961979|NCT03249792|515396268|FG004|Switch Over Period|Progressive Disease|0|||
142961980|NCT03249792|515396269|FG005|Switch Over Period|Progressive Disease|0|||
142961981|NCT03249792|515396270|FG006|Switch Over Period|Progressive Disease|0|||
142961982|NCT03249792|515396271|FG007|Switch Over Period|Progressive Disease|0|||
142961983|NCT03249792|515396272|FG008|Switch Over Period|Progressive Disease|0|||
142961984|NCT03249792|515396273|FG009|Switch Over Period|Progressive Disease|0|||
142961985|NCT03249792|515396274|FG010|Switch Over Period|Progressive Disease|0|||
142961986|NCT03249792|515396275|FG011|Switch Over Period|Progressive Disease|0|||
142961987|NCT03249792|515396276|FG012|Switch Over Period|Progressive Disease|0|||
142961988|NCT03249792|515396277|FG013|Switch Over Period|Progressive Disease|0|||
142961989|NCT03249792|515396278|FG014|Switch Over Period|Progressive Disease|0|||
142961990|NCT03249792|515396279|FG015|Switch Over Period|Progressive Disease|0|||
142961991|NCT03249792|515396280|FG016|Switch Over Period|Progressive Disease|0|||
142961992|NCT03249792|515396281|FG017|Switch Over Period|Progressive Disease|0|||
142961993|NCT03249792|515396282|FG018|Switch Over Period|Progressive Disease|0|||
142961994|NCT03249792|515396283|FG019|Switch Over Period|Progressive Disease|0|||
142961995|NCT03249792|515396284|FG020|Switch Over Period|Progressive Disease|0|||
142961996|NCT03249792|515396285|FG021|Switch Over Period|Progressive Disease|0|||
142961997|NCT03249792|515396286|FG022|Switch Over Period|Progressive Disease|0|||
142961998|NCT03249792|515396287|FG023|Switch Over Period|Progressive Disease|0|||
142961999|NCT03249792|515396288|FG024|Switch Over Period|Progressive Disease|0|||
142962000|NCT03249792|515396289|FG025|Switch Over Period|Progressive Disease|0|||
142962001|NCT03249792|515396290|FG026|Switch Over Period|Progressive Disease|1|||
142962002|NCT03249792|515396291|FG027|Switch Over Period|Progressive Disease|0|||
142962003|NCT03249792|515396292|FG028|Switch Over Period|Progressive Disease|1|||
142962004|NCT03249792|515396293|FG029|Switch Over Period|Progressive Disease|2|||
142962005|NCT03249792|515396294|FG030|Switch Over Period|Progressive Disease|1|||
142962006|NCT03249792|515396295|FG031|Switch Over Period|Progressive Disease|0|||
142962007|NCT03249792|515396296|FG032|Switch Over Period|Progressive Disease|1|||
142962008|NCT03249792|515396264|FG000|Switch Over Period|Adverse Event|0|||
142962009|NCT03249792|515396265|FG001|Switch Over Period|Adverse Event|0|||
142962010|NCT03249792|515396266|FG002|Switch Over Period|Adverse Event|0|||
142962011|NCT03249792|515396267|FG003|Switch Over Period|Adverse Event|0|||
142962012|NCT03249792|515396268|FG004|Switch Over Period|Adverse Event|0|||
142962013|NCT03249792|515396269|FG005|Switch Over Period|Adverse Event|0|||
142962014|NCT03249792|515396270|FG006|Switch Over Period|Adverse Event|0|||
142962015|NCT03249792|515396271|FG007|Switch Over Period|Adverse Event|0|||
142962016|NCT03249792|515396272|FG008|Switch Over Period|Adverse Event|0|||
142962017|NCT03249792|515396273|FG009|Switch Over Period|Adverse Event|0|||
142962018|NCT03249792|515396274|FG010|Switch Over Period|Adverse Event|0|||
142962019|NCT03249792|515396275|FG011|Switch Over Period|Adverse Event|0|||
142962020|NCT03249792|515396276|FG012|Switch Over Period|Adverse Event|0|||
142962021|NCT03249792|515396277|FG013|Switch Over Period|Adverse Event|0|||
142962022|NCT03249792|515396278|FG014|Switch Over Period|Adverse Event|0|||
142962023|NCT03249792|515396279|FG015|Switch Over Period|Adverse Event|0|||
142962024|NCT03249792|515396280|FG016|Switch Over Period|Adverse Event|0|||
142962025|NCT03249792|515396281|FG017|Switch Over Period|Adverse Event|0|||
142962026|NCT03249792|515396282|FG018|Switch Over Period|Adverse Event|0|||
142962027|NCT03249792|515396283|FG019|Switch Over Period|Adverse Event|0|||
142962028|NCT03249792|515396284|FG020|Switch Over Period|Adverse Event|0|||
142962029|NCT03249792|515396285|FG021|Switch Over Period|Adverse Event|0|||
142962030|NCT03249792|515396286|FG022|Switch Over Period|Adverse Event|0|||
142962031|NCT03249792|515396287|FG023|Switch Over Period|Adverse Event|0|||
142962032|NCT03249792|515396288|FG024|Switch Over Period|Adverse Event|0|||
142962033|NCT03249792|515396289|FG025|Switch Over Period|Adverse Event|1|||
142962034|NCT03249792|515396290|FG026|Switch Over Period|Adverse Event|0|||
142962035|NCT03249792|515396291|FG027|Switch Over Period|Adverse Event|1|||
142962036|NCT03249792|515396292|FG028|Switch Over Period|Adverse Event|0|||
142962037|NCT03249792|515396293|FG029|Switch Over Period|Adverse Event|0|||
142962038|NCT03249792|515396294|FG030|Switch Over Period|Adverse Event|0|||
142962039|NCT03249792|515396295|FG031|Switch Over Period|Adverse Event|0|||
142962040|NCT03249792|515396296|FG032|Switch Over Period|Adverse Event|0|||
142962041|NCT02284906|515396301|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
142962042|NCT02284906|515396302|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
142962043|NCT02284906|515396303|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
142962044|NCT02284906|515396301|FG000|Overall Study|Major Protocol Deviation|0|||
142962045|NCT02284906|515396302|FG001|Overall Study|Major Protocol Deviation|1|||
142962046|NCT02284906|515396303|FG002|Overall Study|Major Protocol Deviation|0|||
142962047|NCT02284906|515396301|FG000|Overall Study|Voluntary Withdrawal|2|||
142962048|NCT02284906|515396302|FG001|Overall Study|Voluntary Withdrawal|4|||
142962049|NCT02284906|515396303|FG002|Overall Study|Voluntary Withdrawal|5|||
142962050|NCT02284906|515396301|FG000|Overall Study|Study Termination|0|||
142962051|NCT02284906|515396302|FG001|Overall Study|Study Termination|11|||
142962052|NCT02284906|515396303|FG002|Overall Study|Study Termination|14|||
142962053|NCT02284906|515396301|FG000|Overall Study|Reason not Specified|1|||
142962054|NCT02284906|515396302|FG001|Overall Study|Reason not Specified|1|||
142962055|NCT02284906|515396303|FG002|Overall Study|Reason not Specified|0|||
142962056|NCT01753076|515396304|FG000|Overall Study|Adverse Event|17|||
142962057|NCT01753076|515396305|FG001|Overall Study|Adverse Event|18|||
142962058|NCT01753076|515396304|FG000|Overall Study|Lack of Efficacy|3|||
142962059|NCT01753076|515396305|FG001|Overall Study|Lack of Efficacy|1|||
142962060|NCT01753076|515396304|FG000|Overall Study|Lost to Follow-up|2|||
142962061|NCT01753076|515396305|FG001|Overall Study|Lost to Follow-up|1|||
142962062|NCT01753076|515396304|FG000|Overall Study|Physician Decision|4|||
142962063|NCT01753076|515396305|FG001|Overall Study|Physician Decision|2|||
142962064|NCT01753076|515396304|FG000|Overall Study|Withdrawal by Subject|14|||
142962065|NCT01753076|515396305|FG001|Overall Study|Withdrawal by Subject|24|||
142962066|NCT01753076|515396304|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
142962067|NCT01753076|515396305|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
142962068|NCT02575079|515396306|FG000|Overall Study|Death|3|||
142962069|NCT02575079|515396307|FG001|Overall Study|Death|0|||
142962070|NCT02575079|515396306|FG000|Overall Study|Withdrawal by Subject|3|||
142962071|NCT02575079|515396307|FG001|Overall Study|Withdrawal by Subject|0|||
142962072|NCT01594476|515396308|FG000|Overall Study|Protocol Violation|1|||
142962073|NCT01594476|515396309|FG001|Overall Study|Protocol Violation|3|||
142962074|NCT03116399|515396312|FG000|Overall Study|Death|8|||
142962075|NCT03116399|515396313|FG001|Overall Study|Death|3|||
142962076|NCT03116399|515396312|FG000|Overall Study|Lost to Follow-up|7|||
142962077|NCT03116399|515396313|FG001|Overall Study|Lost to Follow-up|11|||
142962078|NCT03116399|515396312|FG000|Overall Study|Investigator Decision|1|||
142962079|NCT03116399|515396313|FG001|Overall Study|Investigator Decision|1|||
142962080|NCT03116399|515396312|FG000|Overall Study|Withdrawal by Subject|24|||
142962081|NCT03116399|515396313|FG001|Overall Study|Withdrawal by Subject|9|||
142962082|NCT05692154|515396314|FG000|Overall Study|Adverse Event|0|||
142962083|NCT05692154|515396315|FG001|Overall Study|Adverse Event|1|||
142962084|NCT01379534|515396316|FG000|Treatment Phase|Withdrawal by Subject|2|||
142962085|NCT01379534|515396317|FG001|Treatment Phase|Withdrawal by Subject|2|||
142962086|NCT01379534|515396316|FG000|Treatment Phase|Progressive disease|13|||
142962087|NCT01379534|515396317|FG001|Treatment Phase|Progressive disease|22|||
142962088|NCT01379534|515396316|FG000|Treatment Phase|Adverse Event|7|||
142962089|NCT01379534|515396317|FG001|Treatment Phase|Adverse Event|7|||
142962090|NCT01379534|515396316|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
142962091|NCT01379534|515396317|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
143003122|NCT01049360|515548754|FG010|Period 2|Protocol Violation|0|||
142962092|NCT01379534|515396316|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
142962093|NCT01379534|515396317|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
142962094|NCT01379534|515396316|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
142962095|NCT01379534|515396317|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
142962096|NCT01379534|515396316|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
142962097|NCT01379534|515396317|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
142962098|NCT04743635|515396321|FG000|Overall Study|Lost to Follow-up|2|||
142962099|NCT04743635|515396322|FG001|Overall Study|Lost to Follow-up|0|||
142962100|NCT00878072|515396323|FG000|Overall Study|Withdrew consent|2|||
142962101|NCT01954121|515396329|FG000|Overall Study|Lack of Efficacy|94|||
142962102|NCT01954121|515396330|FG001|Overall Study|Lack of Efficacy|41|||
142962103|NCT01954121|515396329|FG000|Overall Study|Protocol Violation|0|||
142962104|NCT01954121|515396330|FG001|Overall Study|Protocol Violation|2|||
142962105|NCT01954121|515396329|FG000|Overall Study|Lost to Follow-up|5|||
142962106|NCT01954121|515396330|FG001|Overall Study|Lost to Follow-up|6|||
142962107|NCT01954121|515396329|FG000|Overall Study|Withdrawal by Subject|18|||
142962108|NCT01954121|515396330|FG001|Overall Study|Withdrawal by Subject|12|||
142962109|NCT01954121|515396329|FG000|Overall Study|Pregnancy|1|||
142962110|NCT01954121|515396330|FG001|Overall Study|Pregnancy|1|||
142962111|NCT01954121|515396329|FG000|Overall Study|AE, serious fatal|1|||
142962112|NCT01954121|515396330|FG001|Overall Study|AE, serious fatal|0|||
142962113|NCT01954121|515396329|FG000|Overall Study|AE, non-serious non-fatal|5|||
142962114|NCT01954121|515396330|FG001|Overall Study|AE, non-serious non-fatal|22|||
142962115|NCT01954121|515396329|FG000|Overall Study|SAE, non-fatal|1|||
142962116|NCT01954121|515396330|FG001|Overall Study|SAE, non-fatal|4|||
142962117|NCT01954121|515396329|FG000|Overall Study|Non-compliant with study procedures|1|||
142962118|NCT01954121|515396330|FG001|Overall Study|Non-compliant with study procedures|0|||
142962119|NCT01954121|515396329|FG000|Overall Study|Non-compliant patient|1|||
142962120|NCT01954121|515396330|FG001|Overall Study|Non-compliant patient|1|||
142962121|NCT01954121|515396329|FG000|Overall Study|Subject did not follow instructions|0|||
142962122|NCT01954121|515396330|FG001|Overall Study|Subject did not follow instructions|2|||
142962123|NCT03382899|515396332|FG000|Overall Study|Ineligibility Determined|0|||
142962124|NCT03382899|515396333|FG001|Overall Study|Ineligibility Determined|1|||
142962125|NCT03382899|515396332|FG000|Overall Study|Lost to Follow-up|0|||
142962126|NCT03382899|515396333|FG001|Overall Study|Lost to Follow-up|1|||
142962127|NCT03382899|515396332|FG000|Overall Study|Sponsor's decision|31|||
142962128|NCT03382899|515396333|FG001|Overall Study|Sponsor's decision|28|||
142962129|NCT03382899|515396332|FG000|Overall Study|Withdrawal by Subject|0|||
142962130|NCT03382899|515396333|FG001|Overall Study|Withdrawal by Subject|5|||
142962131|NCT00872170|515396334|FG000|Overall Study|Adverse Event|1|||
142962132|NCT00872170|515396335|FG001|Overall Study|Adverse Event|0|||
142962133|NCT01987986|515396336|FG000|Overall Study|Lost to Follow-up|1|||
142962134|NCT01987986|515396337|FG001|Overall Study|Lost to Follow-up|0|||
142962135|NCT01987986|515396338|FG002|Overall Study|Lost to Follow-up|0|||
142962136|NCT01987986|515396339|FG003|Overall Study|Lost to Follow-up|0|||
142962137|NCT01987986|515396336|FG000|Overall Study|Adverse Event|1|||
142962138|NCT01987986|515396337|FG001|Overall Study|Adverse Event|0|||
142962139|NCT01987986|515396338|FG002|Overall Study|Adverse Event|2|||
142962140|NCT01987986|515396339|FG003|Overall Study|Adverse Event|0|||
142962141|NCT01721408|515396340|FG000|Overall Study|Adverse Event|6|||
142962142|NCT01721408|515396341|FG001|Overall Study|Adverse Event|1|||
142962143|NCT01721408|515396340|FG000|Overall Study|Death|1|||
142962144|NCT01721408|515396341|FG001|Overall Study|Death|0|||
142962145|NCT01721408|515396340|FG000|Overall Study|Insufficient clinical response|15|||
142962146|NCT01721408|515396341|FG001|Overall Study|Insufficient clinical response|6|||
142962147|NCT01721408|515396340|FG000|Overall Study|No longer willing to participate study|9|||
142962148|NCT01721408|515396341|FG001|Overall Study|No longer willing to participate study|10|||
142962149|NCT01721408|515396340|FG000|Overall Study|Protocol Violation|0|||
142962150|NCT01721408|515396341|FG001|Overall Study|Protocol Violation|2|||
142962151|NCT01721408|515396340|FG000|Overall Study|Other|3|||
142962152|NCT01721408|515396341|FG001|Overall Study|Other|3|||
142962153|NCT01721408|515396340|FG000|Overall Study|Lost to Follow-up|1|||
142962154|NCT01721408|515396341|FG001|Overall Study|Lost to Follow-up|2|||
142962155|NCT01721408|515396340|FG000|Overall Study|Does not meet entrance criteria|1|||
142962156|NCT01721408|515396341|FG001|Overall Study|Does not meet entrance criteria|0|||
142962157|NCT03987620|515396342|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
142962158|NCT03987620|515396343|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
142962159|NCT03987620|515396342|FG000|Overall Study|Adverse Event|3|||
142962160|NCT03987620|515396343|FG001|Overall Study|Adverse Event|0|||
142962161|NCT03987620|515396342|FG000|Overall Study|Lost to Follow-up|1|||
142962162|NCT03987620|515396343|FG001|Overall Study|Lost to Follow-up|2|||
142962163|NCT03987620|515396342|FG000|Overall Study|Physician Decision|0|||
142962164|NCT03987620|515396343|FG001|Overall Study|Physician Decision|1|||
142962165|NCT03987620|515396342|FG000|Overall Study|Pregnancy|1|||
142962166|NCT03987620|515396343|FG001|Overall Study|Pregnancy|0|||
142962167|NCT03987620|515396342|FG000|Overall Study|Withdrawal by Subject|7|||
142962168|NCT03987620|515396343|FG001|Overall Study|Withdrawal by Subject|1|||
142962169|NCT03987620|515396342|FG000|Overall Study|Other|2|||
142962170|NCT03987620|515396343|FG001|Overall Study|Other|5|||
142962171|NCT02149836|515396344|FG000|Overall Study|Withdrawal by Subject|1|||
142962172|NCT01745393|515396345|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
142962173|NCT01745393|515396346|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
142962174|NCT01745393|515396345|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
142962175|NCT01745393|515396346|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
142962176|NCT01745393|515396345|FG000|12-month Follow-up|Lost to Follow-up|6|||
142962177|NCT01745393|515396346|FG001|12-month Follow-up|Lost to Follow-up|5|||
142962178|NCT00905021|515396349|FG000|Overall Study|Adverse Event|2|||
142962179|NCT01064648|515396350|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
142962180|NCT01064648|515396351|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
142962181|NCT01064648|515396352|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
142962182|NCT01064648|515396353|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
142962183|NCT01064648|515396350|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
142962184|NCT01064648|515396351|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
142962185|NCT01064648|515396352|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
142962186|NCT01064648|515396353|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
142962187|NCT01064648|515396350|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
142962188|NCT01064648|515396351|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
142962189|NCT01064648|515396352|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
142962190|NCT01064648|515396353|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
142962191|NCT01064648|515396350|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
142962192|NCT01064648|515396351|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
142962193|NCT01064648|515396352|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
142962194|NCT01064648|515396353|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
142962195|NCT01064648|515396350|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
142962196|NCT01064648|515396351|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
142962197|NCT01064648|515396352|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
142962198|NCT01064648|515396353|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
142962199|NCT01064648|515396350|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
142962200|NCT01064648|515396351|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
142962201|NCT01064648|515396352|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
142962202|NCT01064648|515396353|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
142962203|NCT01064648|515396350|FG000|Phase II|Adverse Event|0|||
142962204|NCT01064648|515396351|FG001|Phase II|Adverse Event|0|||
142962205|NCT01064648|515396352|FG002|Phase II|Adverse Event|15|||
142962206|NCT01064648|515396353|FG003|Phase II|Adverse Event|8|||
142962207|NCT01064648|515396350|FG000|Phase II|Death|0|||
142962208|NCT01064648|515396351|FG001|Phase II|Death|0|||
142962209|NCT01064648|515396352|FG002|Phase II|Death|4|||
142962210|NCT01064648|515396353|FG003|Phase II|Death|5|||
142962211|NCT01064648|515396350|FG000|Phase II|Withdrawal by Subject|0|||
142962212|NCT01064648|515396351|FG001|Phase II|Withdrawal by Subject|0|||
142962213|NCT01064648|515396352|FG002|Phase II|Withdrawal by Subject|2|||
142962214|NCT01064648|515396353|FG003|Phase II|Withdrawal by Subject|5|||
142962215|NCT01064648|515396350|FG000|Phase II|Progression|0|||
142962216|NCT01064648|515396351|FG001|Phase II|Progression|0|||
142962217|NCT01064648|515396352|FG002|Phase II|Progression|21|||
142962218|NCT01064648|515396353|FG003|Phase II|Progression|27|||
142962219|NCT01064648|515396350|FG000|Phase II|Non-protocol specified|0|||
142962220|NCT01064648|515396351|FG001|Phase II|Non-protocol specified|0|||
142962221|NCT01064648|515396352|FG002|Phase II|Non-protocol specified|5|||
142962222|NCT01064648|515396353|FG003|Phase II|Non-protocol specified|3|||
142962223|NCT01064648|515396350|FG000|Phase II|Under Review|0|||
142962224|NCT01064648|515396351|FG001|Phase II|Under Review|0|||
142962225|NCT01064648|515396352|FG002|Phase II|Under Review|2|||
142962226|NCT01064648|515396353|FG003|Phase II|Under Review|0|||
142962227|NCT05281523|515396354|FG000|Overall Study|Adverse Event|1|||
142962228|NCT05281523|515396355|FG001|Overall Study|Adverse Event|1|||
142962229|NCT05281523|515396354|FG000|Overall Study|Physician Decision|1|||
142962230|NCT05281523|515396355|FG001|Overall Study|Physician Decision|1|||
142962231|NCT05281523|515396354|FG000|Overall Study|Withdrawal by Subject|5|||
142962232|NCT05281523|515396355|FG001|Overall Study|Withdrawal by Subject|15|||
142962233|NCT05281523|515396354|FG000|Overall Study|GCP violations|3|||
142962234|NCT05281523|515396355|FG001|Overall Study|GCP violations|4|||
142962235|NCT05513391|515396356|FG000|Overall Study|Adverse Event|1|||
142962236|NCT05513391|515396357|FG001|Overall Study|Adverse Event|0|||
142962237|NCT05513391|515396356|FG000|Overall Study|Protocol Deviation|0|||
142962238|NCT05513391|515396357|FG001|Overall Study|Protocol Deviation|1|||
142962239|NCT05513391|515396356|FG000|Overall Study|Withdrawal by Subject|3|||
143455416|NCT02914275|517212435|FG000|Overall Study|Other|4|||
142962240|NCT05513391|515396357|FG001|Overall Study|Withdrawal by Subject|1|||
142962241|NCT05513391|515396356|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
142962242|NCT05513391|515396357|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
142962243|NCT05513391|515396356|FG000|Overall Study|Lost to Follow-up|0|||
142962244|NCT05513391|515396357|FG001|Overall Study|Lost to Follow-up|2|||
142962245|NCT04038255|515397968|FG000|Overall Study|Lost to Follow-up|0|||
142962246|NCT04038255|515397969|FG001|Overall Study|Lost to Follow-up|9|||
142962247|NCT04038255|515397970|FG002|Overall Study|Lost to Follow-up|5|||
142962248|NCT04038255|515397968|FG000|Overall Study|Withdrawal by Subject|0|||
142962249|NCT04038255|515397969|FG001|Overall Study|Withdrawal by Subject|0|||
142962250|NCT04038255|515397970|FG002|Overall Study|Withdrawal by Subject|1|||
142962251|NCT04491877|515397971|FG000|Overall Study|Protocol Deviation|1|||
142962252|NCT04491877|515397972|FG001|Overall Study|Protocol Deviation|0|||
142962253|NCT04491877|515397973|FG002|Overall Study|Protocol Deviation|2|||
142962254|NCT04491877|515397974|FG003|Overall Study|Protocol Deviation|0|||
142962255|NCT04491877|515397975|FG004|Overall Study|Protocol Deviation|0|||
142962256|NCT04491877|515397976|FG005|Overall Study|Protocol Deviation|0|||
142962257|NCT04491877|515397977|FG006|Overall Study|Protocol Deviation|1|||
142962258|NCT04491877|515397978|FG007|Overall Study|Protocol Deviation|1|||
142962259|NCT04491877|515397979|FG008|Overall Study|Protocol Deviation|0|||
142962260|NCT04491877|515397971|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
142962261|NCT04491877|515397972|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
142962262|NCT04491877|515397973|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
142962263|NCT04491877|515397974|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
142962264|NCT04491877|515397975|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
142962265|NCT04491877|515397976|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
142962266|NCT04491877|515397977|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
142962267|NCT04491877|515397978|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
142962268|NCT04491877|515397979|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
142962269|NCT04491877|515397971|FG000|Overall Study|Lost to Follow-up|0|||
142962270|NCT04491877|515397972|FG001|Overall Study|Lost to Follow-up|2|||
142962271|NCT04491877|515397973|FG002|Overall Study|Lost to Follow-up|0|||
142962272|NCT04491877|515397974|FG003|Overall Study|Lost to Follow-up|0|||
142962273|NCT04491877|515397975|FG004|Overall Study|Lost to Follow-up|0|||
142962274|NCT04491877|515397976|FG005|Overall Study|Lost to Follow-up|0|||
142962275|NCT04491877|515397977|FG006|Overall Study|Lost to Follow-up|2|||
142962276|NCT04491877|515397978|FG007|Overall Study|Lost to Follow-up|1|||
142962277|NCT04491877|515397979|FG008|Overall Study|Lost to Follow-up|1|||
142962278|NCT00074412|515397983|FG000|Overall Study|Death|30|||
142962279|NCT00074412|515397984|FG001|Overall Study|Death|26|||
142962280|NCT00074412|515397983|FG000|Overall Study|Lost to Follow-up|52|||
142962281|NCT00074412|515397984|FG001|Overall Study|Lost to Follow-up|58|||
142962282|NCT00418834|515397987|FG000|Overall Study|Adverse Event|16|||
142962283|NCT00418834|515397988|FG001|Overall Study|Adverse Event|9|||
142962284|NCT00418834|515397987|FG000|Overall Study|Lost to Follow-up|0|||
142962285|NCT00418834|515397988|FG001|Overall Study|Lost to Follow-up|1|||
142962286|NCT00418834|515397987|FG000|Overall Study|Protocol Violation|4|||
142962287|NCT00418834|515397988|FG001|Overall Study|Protocol Violation|3|||
142962288|NCT00418834|515397987|FG000|Overall Study|Withdrawal by Subject|3|||
142962289|NCT00418834|515397988|FG001|Overall Study|Withdrawal by Subject|7|||
142962290|NCT01953328|515397989|FG000|Overall Study|Withdrawal by Subject|0|||
142962291|NCT01953328|515397990|FG001|Overall Study|Withdrawal by Subject|0|||
142962292|NCT01953328|515397991|FG002|Overall Study|Withdrawal by Subject|0|||
142962293|NCT01953328|515397992|FG003|Overall Study|Withdrawal by Subject|0|||
142962294|NCT01953328|515397993|FG004|Overall Study|Withdrawal by Subject|1|||
142962295|NCT01953328|515397994|FG005|Overall Study|Withdrawal by Subject|0|||
142962296|NCT01953328|515397995|FG006|Overall Study|Withdrawal by Subject|0|||
142962297|NCT01953328|515397996|FG007|Overall Study|Withdrawal by Subject|0|||
142962298|NCT01953328|515397989|FG000|Overall Study|Lost to Follow-up|0|||
142962299|NCT01953328|515397990|FG001|Overall Study|Lost to Follow-up|0|||
142962300|NCT01953328|515397991|FG002|Overall Study|Lost to Follow-up|0|||
142962301|NCT01953328|515397992|FG003|Overall Study|Lost to Follow-up|0|||
142962302|NCT01953328|515397993|FG004|Overall Study|Lost to Follow-up|1|||
142962303|NCT01953328|515397994|FG005|Overall Study|Lost to Follow-up|0|||
142962304|NCT01953328|515397995|FG006|Overall Study|Lost to Follow-up|0|||
142962305|NCT01953328|515397996|FG007|Overall Study|Lost to Follow-up|0|||
142962306|NCT05113953|515397998|FG000|Overall Study|Adverse Event|5|||
142962307|NCT05113953|515397999|FG001|Overall Study|Adverse Event|0|||
142962308|NCT05113953|515398000|FG002|Overall Study|Adverse Event|3|||
142962309|NCT05113953|515397998|FG000|Overall Study|Lost to Follow-up|3|||
142962310|NCT05113953|515397999|FG001|Overall Study|Lost to Follow-up|4|||
142962311|NCT05113953|515398000|FG002|Overall Study|Lost to Follow-up|2|||
142962312|NCT05113953|515397998|FG000|Overall Study|Non-compliance with Study Drug|1|||
142962313|NCT05113953|515397999|FG001|Overall Study|Non-compliance with Study Drug|0|||
142962314|NCT05113953|515398000|FG002|Overall Study|Non-compliance with Study Drug|0|||
142962315|NCT05113953|515397998|FG000|Overall Study|Withdrawal by Subject|2|||
142962316|NCT05113953|515397999|FG001|Overall Study|Withdrawal by Subject|6|||
142962317|NCT05113953|515398000|FG002|Overall Study|Withdrawal by Subject|4|||
142962318|NCT05113953|515397998|FG000|Overall Study|Reason not Specified|2|||
142962319|NCT05113953|515397999|FG001|Overall Study|Reason not Specified|0|||
142962320|NCT05113953|515398000|FG002|Overall Study|Reason not Specified|0|||
142962321|NCT00492856|515398001|FG000|Induction|Adverse Event|2|||
142962322|NCT00492856|515398002|FG001|Induction|Adverse Event|0|||
142962323|NCT00492856|515398003|FG002|Induction|Adverse Event|0|||
142962324|NCT00492856|515398004|FG003|Induction|Adverse Event|0|||
142962325|NCT00492856|515398001|FG000|Induction|Withdrawal by Subject|1|||
142962326|NCT00492856|515398002|FG001|Induction|Withdrawal by Subject|0|||
142962327|NCT00492856|515398003|FG002|Induction|Withdrawal by Subject|0|||
142962328|NCT00492856|515398004|FG003|Induction|Withdrawal by Subject|0|||
142962329|NCT00492856|515398001|FG000|Induction|Death|3|||
142962330|NCT00492856|515398002|FG001|Induction|Death|0|||
142962331|NCT00492856|515398003|FG002|Induction|Death|0|||
142962332|NCT00492856|515398004|FG003|Induction|Death|0|||
142962333|NCT00492856|515398001|FG000|Consolidation|Adverse Event|6|||
142962334|NCT00492856|515398002|FG001|Consolidation|Adverse Event|0|||
142962335|NCT00492856|515398003|FG002|Consolidation|Adverse Event|0|||
142962336|NCT00492856|515398004|FG003|Consolidation|Adverse Event|0|||
142962337|NCT00492856|515398001|FG000|Consolidation|Not protocol specified|2|||
142962338|NCT00492856|515398002|FG001|Consolidation|Not protocol specified|0|||
142962339|NCT00492856|515398003|FG002|Consolidation|Not protocol specified|0|||
142962340|NCT00492856|515398004|FG003|Consolidation|Not protocol specified|0|||
142962341|NCT00492856|515398001|FG000|Consolidation|Lost to Follow-up|1|||
142962342|NCT00492856|515398002|FG001|Consolidation|Lost to Follow-up|0|||
142962343|NCT00492856|515398003|FG002|Consolidation|Lost to Follow-up|0|||
142962344|NCT00492856|515398004|FG003|Consolidation|Lost to Follow-up|0|||
142962345|NCT00492856|515398001|FG000|Post-consolidation|Adverse Event|0|||
142962346|NCT00492856|515398002|FG001|Post-consolidation|Adverse Event|4|||
142962347|NCT00492856|515398003|FG002|Post-consolidation|Adverse Event|0|||
142962348|NCT00492856|515398004|FG003|Post-consolidation|Adverse Event|1|||
142962349|NCT00492856|515398001|FG000|Post-consolidation|Withdrawal by Subject|0|||
142962350|NCT00492856|515398002|FG001|Post-consolidation|Withdrawal by Subject|4|||
142962351|NCT00492856|515398003|FG002|Post-consolidation|Withdrawal by Subject|0|||
142962352|NCT00492856|515398004|FG003|Post-consolidation|Withdrawal by Subject|0|||
142962353|NCT00492856|515398001|FG000|Post-consolidation|Death|0|||
142962354|NCT00492856|515398002|FG001|Post-consolidation|Death|1|||
142962355|NCT00492856|515398003|FG002|Post-consolidation|Death|0|||
142962356|NCT00492856|515398004|FG003|Post-consolidation|Death|0|||
142962357|NCT00492856|515398001|FG000|Post-consolidation|Not protocol specified|0|||
142962358|NCT00492856|515398002|FG001|Post-consolidation|Not protocol specified|1|||
142962359|NCT00492856|515398003|FG002|Post-consolidation|Not protocol specified|0|||
142962360|NCT00492856|515398004|FG003|Post-consolidation|Not protocol specified|0|||
142962361|NCT00492856|515398001|FG000|Post-consolidation|Lost to Follow-up|0|||
142962362|NCT00492856|515398002|FG001|Post-consolidation|Lost to Follow-up|2|||
142962363|NCT00492856|515398003|FG002|Post-consolidation|Lost to Follow-up|0|||
142962364|NCT00492856|515398004|FG003|Post-consolidation|Lost to Follow-up|0|||
142962365|NCT00492856|515398001|FG000|Post-consolidation|Observation Arm|0|||
142962366|NCT00492856|515398002|FG001|Post-consolidation|Observation Arm|0|||
142962367|NCT00492856|515398003|FG002|Post-consolidation|Observation Arm|27|||
142962368|NCT00492856|515398004|FG003|Post-consolidation|Observation Arm|0|||
142962369|NCT01520324|515398005|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
142962370|NCT03488472|515398006|FG000|Overall Study|disease progression additional mets|1|||
142962371|NCT00502307|515398007|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
142962372|NCT00502307|515398008|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
142962373|NCT00502307|515398009|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
142962374|NCT00502307|515398007|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
142962375|NCT00502307|515398008|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
142962376|NCT00502307|515398009|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
142962377|NCT00502307|515398007|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
142962378|NCT00502307|515398008|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
142962379|NCT00502307|515398009|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
142962380|NCT00502307|515398007|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
142962381|NCT00502307|515398008|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
142962382|NCT00502307|515398009|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
142962383|NCT00502307|515398007|FG000|Maintenance Period|Progressive disease|80|||
142962384|NCT00502307|515398008|FG001|Maintenance Period|Progressive disease|0|||
142962385|NCT00502307|515398009|FG002|Maintenance Period|Progressive disease|0|||
142962386|NCT00502307|515398007|FG000|Maintenance Period|Discontinued due to other reasons|68|||
142962387|NCT00502307|515398008|FG001|Maintenance Period|Discontinued due to other reasons|0|||
142962388|NCT00502307|515398009|FG002|Maintenance Period|Discontinued due to other reasons|0|||
142962389|NCT02245568|515398011|FG000|Overall Study|Study terminated by Sponsor|346|||
142962390|NCT02245568|515398011|FG000|Overall Study|Adverse Event|144|||
142962391|NCT02245568|515398011|FG000|Overall Study|Lack of Efficacy|98|||
142962392|NCT02245568|515398011|FG000|Overall Study|Withdrawal by Caregiver|85|||
142962393|NCT02245568|515398011|FG000|Overall Study|Withdrawal by Subject|77|||
142962394|NCT02245568|515398011|FG000|Overall Study|Withdrawal by Legal Representative|31|||
142962395|NCT02245568|515398011|FG000|Overall Study|Missing (Site closure)|16|||
142962396|NCT02245568|515398011|FG000|Overall Study|Physician Decision|14|||
142962397|NCT02245568|515398011|FG000|Overall Study|Non-compliance with study drug|11|||
142962398|NCT02245568|515398011|FG000|Overall Study|Death|9|||
142962399|NCT02245568|515398011|FG000|Overall Study|Blue staining|6|||
142962400|NCT02245568|515398011|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
142962401|NCT02245568|515398011|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
142962402|NCT02245568|515398011|FG000|Overall Study|Lost to Follow-up|5|||
142962403|NCT01856595|515398012|FG000|Overall Study|Withdrawal by Subject|0|||
142962404|NCT01856595|515398013|FG001|Overall Study|Withdrawal by Subject|1|||
142962405|NCT01856595|515398014|FG002|Overall Study|Withdrawal by Subject|0|||
142962406|NCT01856595|515398015|FG003|Overall Study|Withdrawal by Subject|0|||
142962407|NCT01856595|515398016|FG004|Overall Study|Withdrawal by Subject|0|||
142962408|NCT01856595|515398017|FG005|Overall Study|Withdrawal by Subject|0|||
142962409|NCT01856595|515398018|FG006|Overall Study|Withdrawal by Subject|1|||
142962410|NCT01856595|515398019|FG007|Overall Study|Withdrawal by Subject|0|||
142962411|NCT01856595|515398020|FG008|Overall Study|Withdrawal by Subject|0|||
142962412|NCT04426825|515398021|FG000|Overall Study|Death|17|||
142962413|NCT04426825|515398021|FG000|Overall Study|Lost to Follow-up|1|||
142962414|NCT04426825|515398021|FG000|Overall Study|Study terminated by sponsor|5|||
142962415|NCT01863849|515398027|FG000|Overall Study|Lost to Follow-up|1|||
142962416|NCT01863849|515398028|FG001|Overall Study|Lost to Follow-up|0|||
142962417|NCT03456713|515398029|FG000|Overall Study|Lost to Follow-up|1|||
142962418|NCT03456713|515398030|FG001|Overall Study|Lost to Follow-up|0|||
142962419|NCT03456713|515398031|FG002|Overall Study|Lost to Follow-up|0|||
142962420|NCT03456713|515398032|FG003|Overall Study|Lost to Follow-up|0|||
142962421|NCT04402008|515398038|FG000|Overall Study|Adverse Event|0|||
142962422|NCT04402008|515398039|FG001|Overall Study|Adverse Event|0|||
142962423|NCT04402008|515398040|FG002|Overall Study|Adverse Event|0|||
142962424|NCT04402008|515398041|FG003|Overall Study|Adverse Event|1|||
142962425|NCT04402008|515398042|FG004|Overall Study|Adverse Event|0|||
142962426|NCT04402008|515398043|FG005|Overall Study|Adverse Event|0|||
142962427|NCT04402008|515398044|FG006|Overall Study|Adverse Event|0|||
142962428|NCT04402008|515398038|FG000|Overall Study|Disease Progression|3|||
142962429|NCT04402008|515398039|FG001|Overall Study|Disease Progression|2|||
142962430|NCT04402008|515398040|FG002|Overall Study|Disease Progression|3|||
142962431|NCT04402008|515398041|FG003|Overall Study|Disease Progression|3|||
142962432|NCT04402008|515398042|FG004|Overall Study|Disease Progression|4|||
142962433|NCT04402008|515398043|FG005|Overall Study|Disease Progression|3|||
142962434|NCT04402008|515398044|FG006|Overall Study|Disease Progression|10|||
142962435|NCT04402008|515398038|FG000|Overall Study|Withdrawal by Subject|0|||
142962436|NCT04402008|515398039|FG001|Overall Study|Withdrawal by Subject|1|||
142962437|NCT04402008|515398040|FG002|Overall Study|Withdrawal by Subject|0|||
142962438|NCT04402008|515398041|FG003|Overall Study|Withdrawal by Subject|0|||
142962439|NCT04402008|515398042|FG004|Overall Study|Withdrawal by Subject|1|||
142962440|NCT04402008|515398043|FG005|Overall Study|Withdrawal by Subject|0|||
142962441|NCT04402008|515398044|FG006|Overall Study|Withdrawal by Subject|0|||
142962442|NCT04402008|515398038|FG000|Overall Study|Sponsor Decision|0|||
142962443|NCT04402008|515398039|FG001|Overall Study|Sponsor Decision|0|||
142962444|NCT04402008|515398040|FG002|Overall Study|Sponsor Decision|0|||
142962445|NCT04402008|515398041|FG003|Overall Study|Sponsor Decision|0|||
142962446|NCT04402008|515398042|FG004|Overall Study|Sponsor Decision|0|||
142962447|NCT04402008|515398043|FG005|Overall Study|Sponsor Decision|0|||
142962448|NCT04402008|515398044|FG006|Overall Study|Sponsor Decision|3|||
142962449|NCT04402008|515398038|FG000|Overall Study|Death|0|||
142962450|NCT04402008|515398039|FG001|Overall Study|Death|0|||
142962451|NCT04402008|515398040|FG002|Overall Study|Death|0|||
142962452|NCT04402008|515398041|FG003|Overall Study|Death|0|||
142962453|NCT04402008|515398042|FG004|Overall Study|Death|1|||
142962454|NCT04402008|515398043|FG005|Overall Study|Death|0|||
142962455|NCT04402008|515398044|FG006|Overall Study|Death|2|||
142962456|NCT04402008|515398038|FG000|Overall Study|Other|0|||
142962457|NCT04402008|515398039|FG001|Overall Study|Other|0|||
142962458|NCT04402008|515398040|FG002|Overall Study|Other|0|||
142962459|NCT04402008|515398041|FG003|Overall Study|Other|0|||
142962460|NCT04402008|515398042|FG004|Overall Study|Other|0|||
142962461|NCT04402008|515398043|FG005|Overall Study|Other|0|||
142962462|NCT04402008|515398044|FG006|Overall Study|Other|5|||
142962463|NCT01028651|515398045|FG000|Overall Study|Death|2|||
142962464|NCT01028651|515398045|FG000|Overall Study|Adverse Event|1|||
142962465|NCT04075266|515398046|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
142962466|NCT04075266|515398047|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
142962467|NCT04075266|515398046|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
142962468|NCT04075266|515398047|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
142962469|NCT05132569|515398048|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
142962470|NCT05132569|515398049|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
142962471|NCT05132569|515398048|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
143455417|NCT02914275|517212436|FG001|Overall Study|Other|1|||
142962472|NCT05132569|515398049|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
142962473|NCT05132569|515398048|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
142962474|NCT05132569|515398049|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
142962475|NCT01554956|515398050|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
142962476|NCT01554956|515398051|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
142962477|NCT01554956|515398052|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
142962478|NCT01554956|515398050|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
142962479|NCT01554956|515398051|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
142962480|NCT01554956|515398052|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
142962481|NCT01554956|515398050|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
142962482|NCT01554956|515398051|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
142962483|NCT01554956|515398052|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
142962484|NCT03656926|515398053|FG000|Overall Study|Adverse Event|5|||
142962485|NCT03656926|515398054|FG001|Overall Study|Adverse Event|4|||
142962486|NCT03656926|515398053|FG000|Overall Study|Withdrawal by Subject|7|||
142962487|NCT03656926|515398054|FG001|Overall Study|Withdrawal by Subject|2|||
142962488|NCT03656926|515398053|FG000|Overall Study|Screen fail after randomization|1|||
142962489|NCT03656926|515398054|FG001|Overall Study|Screen fail after randomization|0|||
142962490|NCT03656926|515398053|FG000|Overall Study|PI decision due to patient condition|1|||
142962491|NCT03656926|515398054|FG001|Overall Study|PI decision due to patient condition|0|||
142962492|NCT03656926|515398053|FG000|Overall Study|Patient unresponsiveness|1|||
142962493|NCT03656926|515398054|FG001|Overall Study|Patient unresponsiveness|0|||
142962494|NCT00788775|515398055|FG000|Overall Study|Progressive Disease|8|||
142962495|NCT00788775|515398056|FG001|Overall Study|Progressive Disease|6|||
142962496|NCT00788775|515398055|FG000|Overall Study|Withdrawal by Subject|0|||
142962497|NCT00788775|515398056|FG001|Overall Study|Withdrawal by Subject|2|||
142962498|NCT00788775|515398055|FG000|Overall Study|Patient Non-Compliance|1|||
142962499|NCT00788775|515398056|FG001|Overall Study|Patient Non-Compliance|0|||
142962500|NCT00788775|515398055|FG000|Overall Study|Patient's measurable disease resected.|1|||
142962501|NCT00788775|515398056|FG001|Overall Study|Patient's measurable disease resected.|0|||
142962502|NCT00578864|515398057|FG000|Overall Study|Death|1|||
142962503|NCT00578864|515398058|FG001|Overall Study|Death|0|||
142962504|NCT01217190|515398062|FG000|Second Dosing|Withdrawal by Subject|0|||
142962505|NCT01217190|515398063|FG001|Second Dosing|Withdrawal by Subject|2|||
142962506|NCT01087528|515398064|FG000|Overall Study|Withdrawal by Subject|1|||
142962507|NCT01087528|515398064|FG000|Overall Study|Incomplete CE procedure|6|||
142962508|NCT01201798|515398066|FG000|Overall Study|Adverse Event|2|||
142962509|NCT01201798|515398067|FG001|Overall Study|Adverse Event|0|||
142962510|NCT01201798|515398066|FG000|Overall Study|Lost to Follow-up|3|||
142962511|NCT01201798|515398067|FG001|Overall Study|Lost to Follow-up|5|||
142962512|NCT01201798|515398066|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
142962513|NCT01201798|515398067|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
142962514|NCT01201798|515398066|FG000|Overall Study|Noncompliance|1|||
142962515|NCT01201798|515398067|FG001|Overall Study|Noncompliance|0|||
142962516|NCT01201798|515398066|FG000|Overall Study|Protocol Violation|1|||
142962517|NCT01201798|515398067|FG001|Overall Study|Protocol Violation|1|||
142962518|NCT01201798|515398066|FG000|Overall Study|Treatment Failure|1|||
142962519|NCT01201798|515398067|FG001|Overall Study|Treatment Failure|8|||
142962520|NCT01465178|515398074|FG000|Overall Study|Withdrawal by Subject|1|||
142962521|NCT01465178|515398075|FG001|Overall Study|Withdrawal by Subject|0|||
142962522|NCT01187901|515398082|FG000|Overall Study|Protocol Violation|1|||
142962523|NCT01187901|515398083|FG001|Overall Study|Protocol Violation|0|||
142962524|NCT01187901|515398082|FG000|Overall Study|Lost to Follow-up|1|||
142962525|NCT01187901|515398083|FG001|Overall Study|Lost to Follow-up|2|||
142962526|NCT01187901|515398082|FG000|Overall Study|Unrelated Health Reasons|1|||
142962527|NCT01187901|515398083|FG001|Overall Study|Unrelated Health Reasons|2|||
142962528|NCT01187901|515398082|FG000|Overall Study|Suspected Allergic Reaction|1|||
142962529|NCT01187901|515398083|FG001|Overall Study|Suspected Allergic Reaction|1|||
142962530|NCT01187901|515398082|FG000|Overall Study|Adverse Event|3|||
142962531|NCT01187901|515398083|FG001|Overall Study|Adverse Event|0|||
142962532|NCT01187901|515398082|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
142962533|NCT01187901|515398083|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
142962534|NCT01187901|515398082|FG000|Overall Study|Pregnancy|0|||
142962535|NCT01187901|515398083|FG001|Overall Study|Pregnancy|2|||
142962536|NCT04160468|515398084|FG000|Overall Study|Lost to Follow-up|19|||
142962537|NCT04160468|515398085|FG001|Overall Study|Lost to Follow-up|4|||
142962538|NCT04160468|515398084|FG000|Overall Study|Randomized but not dosed|6|||
142962539|NCT04160468|515398085|FG001|Overall Study|Randomized but not dosed|0|||
142962540|NCT04160468|515398084|FG000|Overall Study|Withdrawal by Subject|4|||
142962541|NCT04160468|515398085|FG001|Overall Study|Withdrawal by Subject|1|||
142962542|NCT04160468|515398084|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
142962543|NCT04160468|515398085|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
142962544|NCT04160468|515398084|FG000|Overall Study|Participant incarcerated|1|||
142962545|NCT04160468|515398085|FG001|Overall Study|Participant incarcerated|0|||
142962546|NCT01402284|515398086|FG000|Overall Study|Withdrawal consent|2|||
142962547|NCT01402284|515398086|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
142962548|NCT01402284|515398086|FG000|Overall Study|Physician Decision|1|||
142962549|NCT01402284|515398086|FG000|Overall Study|Disease progression on study|10|||
142962550|NCT00540436|515398087|FG000|First 12-Week Treatment Period|Adverse Event|1|||
142962551|NCT00540436|515398087|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
142962552|NCT00540436|515398087|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
142962553|NCT00540436|515398087|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
142962554|NCT04937816|515398090|FG000|Overall Study|Study drug stopped, reason missing|5|||
142962555|NCT04937816|515398091|FG001|Overall Study|Study drug stopped, reason missing|3|||
142962556|NCT04937816|515398092|FG002|Overall Study|Study drug stopped, reason missing|4|||
142962557|NCT04937816|515398093|FG003|Overall Study|Study drug stopped, reason missing|6|||
142962558|NCT04937816|515398094|FG004|Overall Study|Study drug stopped, reason missing|1|||
142962559|NCT04937816|515398095|FG005|Overall Study|Study drug stopped, reason missing|0|||
142962560|NCT04937816|515398096|FG006|Overall Study|Study drug stopped, reason missing|0|||
142962561|NCT04937816|515398090|FG000|Overall Study|Other than stated below|173|||
142962562|NCT04937816|515398091|FG001|Overall Study|Other than stated below|143|||
142962563|NCT04937816|515398092|FG002|Overall Study|Other than stated below|125|||
142962564|NCT04937816|515398093|FG003|Overall Study|Other than stated below|44|||
142962565|NCT04937816|515398094|FG004|Overall Study|Other than stated below|45|||
142962566|NCT04937816|515398095|FG005|Overall Study|Other than stated below|28|||
142962567|NCT04937816|515398096|FG006|Overall Study|Other than stated below|31|||
142962568|NCT04937816|515398090|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
142962569|NCT04937816|515398091|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
142962570|NCT04937816|515398092|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
142962571|NCT04937816|515398093|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
142962572|NCT04937816|515398094|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
142962573|NCT04937816|515398095|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
142962574|NCT04937816|515398096|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
142962575|NCT04937816|515398090|FG000|Overall Study|Lost to Follow-up|15|||
142962576|NCT04937816|515398091|FG001|Overall Study|Lost to Follow-up|9|||
142962577|NCT04937816|515398092|FG002|Overall Study|Lost to Follow-up|6|||
142962578|NCT04937816|515398093|FG003|Overall Study|Lost to Follow-up|6|||
142962579|NCT04937816|515398094|FG004|Overall Study|Lost to Follow-up|16|||
142962580|NCT04937816|515398095|FG005|Overall Study|Lost to Follow-up|11|||
142962581|NCT04937816|515398096|FG006|Overall Study|Lost to Follow-up|17|||
142962582|NCT04937816|515398090|FG000|Overall Study|Protocol Violation|15|||
142962583|NCT04937816|515398091|FG001|Overall Study|Protocol Violation|15|||
142962584|NCT04937816|515398092|FG002|Overall Study|Protocol Violation|12|||
142962585|NCT04937816|515398093|FG003|Overall Study|Protocol Violation|30|||
142962586|NCT04937816|515398094|FG004|Overall Study|Protocol Violation|24|||
142962587|NCT04937816|515398095|FG005|Overall Study|Protocol Violation|5|||
142962588|NCT04937816|515398096|FG006|Overall Study|Protocol Violation|5|||
142962589|NCT04937816|515398090|FG000|Overall Study|Adverse Event|303|||
142962590|NCT04937816|515398091|FG001|Overall Study|Adverse Event|267|||
142962591|NCT04937816|515398092|FG002|Overall Study|Adverse Event|273|||
142962592|NCT04937816|515398093|FG003|Overall Study|Adverse Event|553|||
142962593|NCT04937816|515398094|FG004|Overall Study|Adverse Event|575|||
142962594|NCT04937816|515398095|FG005|Overall Study|Adverse Event|343|||
142962595|NCT04937816|515398096|FG006|Overall Study|Adverse Event|337|||
142962596|NCT04937816|515398090|FG000|Overall Study|Not treated|4|||
142962597|NCT04937816|515398091|FG001|Overall Study|Not treated|2|||
142962598|NCT04937816|515398092|FG002|Overall Study|Not treated|2|||
142962599|NCT04937816|515398093|FG003|Overall Study|Not treated|2|||
142962600|NCT04937816|515398094|FG004|Overall Study|Not treated|1|||
142962601|NCT04937816|515398095|FG005|Overall Study|Not treated|4|||
142962602|NCT04937816|515398096|FG006|Overall Study|Not treated|0|||
142962603|NCT05513053|515398097|FG000|Overall Study|Lost to Follow-up|9|||
142962604|NCT05513053|515398098|FG001|Overall Study|Lost to Follow-up|11|||
142962605|NCT05513053|515398097|FG000|Overall Study|Withdrawal by parent/guardian|2|||
142962606|NCT05513053|515398098|FG001|Overall Study|Withdrawal by parent/guardian|0|||
142962607|NCT05513053|515398097|FG000|Overall Study|Withdrawal by Subject|2|||
142962608|NCT05513053|515398098|FG001|Overall Study|Withdrawal by Subject|9|||
142962609|NCT05513053|515398097|FG000|Overall Study|Protocol Violation|6|||
142962610|NCT05513053|515398098|FG001|Overall Study|Protocol Violation|3|||
142962611|NCT05513053|515398097|FG000|Overall Study|Adverse Event|0|||
142962612|NCT05513053|515398098|FG001|Overall Study|Adverse Event|2|||
142962613|NCT05183867|515399992|FG000|Overall Study|Withdrawal by Subject|3|||
142962614|NCT05183867|515399993|FG001|Overall Study|Withdrawal by Subject|2|||
142962615|NCT05183867|515399994|FG002|Overall Study|Withdrawal by Subject|0|||
142962616|NCT02364947|515400004|FG000|Overall Study|Withdrawal by Subject|10|||
142962617|NCT02364947|515400005|FG001|Overall Study|Withdrawal by Subject|8|||
142962618|NCT02364947|515400006|FG002|Overall Study|Withdrawal by Subject|9|||
142962619|NCT02364947|515400004|FG000|Overall Study|Adverse Event|45|||
142962620|NCT02364947|515400005|FG001|Overall Study|Adverse Event|33|||
142962621|NCT02364947|515400006|FG002|Overall Study|Adverse Event|11|||
142962622|NCT02364947|515400004|FG000|Overall Study|Protocol Violation|1|||
142962623|NCT02364947|515400005|FG001|Overall Study|Protocol Violation|1|||
142962624|NCT02364947|515400006|FG002|Overall Study|Protocol Violation|1|||
142962625|NCT02364947|515400004|FG000|Overall Study|Physician Decision|3|||
142962626|NCT02364947|515400005|FG001|Overall Study|Physician Decision|2|||
142962627|NCT02364947|515400006|FG002|Overall Study|Physician Decision|5|||
142962628|NCT02364947|515400004|FG000|Overall Study|Death|0|||
142962629|NCT02364947|515400005|FG001|Overall Study|Death|1|||
142962630|NCT02364947|515400006|FG002|Overall Study|Death|0|||
142962631|NCT00423085|515400007|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
142962632|NCT00423085|515400008|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
142962633|NCT00423085|515400009|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
142962634|NCT00423085|515400010|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
142962635|NCT00423085|515400007|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
142962636|NCT00423085|515400008|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
142962637|NCT00423085|515400009|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
142962638|NCT00423085|515400010|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
142962639|NCT00423085|515400007|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
142962640|NCT00423085|515400008|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
142962641|NCT00423085|515400009|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
142962642|NCT00423085|515400010|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
142962643|NCT00423085|515400007|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
142962644|NCT00423085|515400008|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
142962645|NCT00423085|515400009|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
142962646|NCT00423085|515400010|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
142962647|NCT00423085|515400007|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
142962648|NCT00423085|515400008|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
142962649|NCT00423085|515400009|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
142962650|NCT00423085|515400010|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
142962651|NCT00423085|515400007|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
142962652|NCT00423085|515400008|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
142962653|NCT00423085|515400009|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
142962654|NCT00423085|515400010|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
142962655|NCT00423085|515400007|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
142962656|NCT00423085|515400008|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
142962657|NCT00423085|515400009|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
142962658|NCT00423085|515400010|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
142962659|NCT00423085|515400007|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
142962660|NCT00423085|515400008|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
142962661|NCT00423085|515400009|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
142962662|NCT00423085|515400010|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
142962663|NCT00423085|515400007|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
142962664|NCT00423085|515400008|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
142962665|NCT00423085|515400009|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
142962666|NCT00423085|515400010|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
142962667|NCT00423085|515400007|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
142962668|NCT00423085|515400008|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
142962669|NCT00423085|515400009|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
142962670|NCT00423085|515400010|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
142962671|NCT00423085|515400007|FG000|52-Week Open-Label Extension Phase|Death|0|||
142962672|NCT00423085|515400008|FG001|52-Week Open-Label Extension Phase|Death|0|||
142962673|NCT00423085|515400009|FG002|52-Week Open-Label Extension Phase|Death|0|||
142962674|NCT00423085|515400010|FG003|52-Week Open-Label Extension Phase|Death|2|||
142962675|NCT00853489|515400011|FG000|Overall Study|Lost to Follow-up|5|||
142962676|NCT00853489|515400012|FG001|Overall Study|Lost to Follow-up|2|||
142962677|NCT05525975|515400013|FG000|Overall Study|Surgery cancellation|4|||
142962678|NCT05525975|515400014|FG001|Overall Study|Surgery cancellation|5|||
142962679|NCT05525975|515400013|FG000|Overall Study|didn't fill prescription|1|||
142962680|NCT05525975|515400014|FG001|Overall Study|didn't fill prescription|0|||
142962681|NCT05525975|515400013|FG000|Overall Study|Withdrawal by Subject|0|||
142962682|NCT05525975|515400014|FG001|Overall Study|Withdrawal by Subject|3|||
142962683|NCT01998581|515400015|FG000|Overall Study|Refused repeat treatment|20|||
142962684|NCT01998581|515400016|FG001|Overall Study|Refused repeat treatment|4|||
142962685|NCT01998581|515400015|FG000|Overall Study|Protocol Violation|1|||
142962686|NCT01998581|515400016|FG001|Overall Study|Protocol Violation|0|||
142962687|NCT01998581|515400015|FG000|Overall Study|Withdrawal by Subject|8|||
142962688|NCT01998581|515400016|FG001|Overall Study|Withdrawal by Subject|1|||
142962689|NCT01998581|515400015|FG000|Overall Study|Lost to Follow-up|12|||
142962690|NCT01998581|515400016|FG001|Overall Study|Lost to Follow-up|4|||
142962691|NCT01998581|515400015|FG000|Overall Study|Adverse Event|1|||
142962692|NCT01998581|515400016|FG001|Overall Study|Adverse Event|1|||
142962693|NCT01998581|515400015|FG000|Overall Study|Other reasons|3|||
142962694|NCT01998581|515400016|FG001|Overall Study|Other reasons|2|||
142962695|NCT01998581|515400015|FG000|Overall Study|Randomized but withdrew before treatment|1|||
142962696|NCT01998581|515400016|FG001|Overall Study|Randomized but withdrew before treatment|0|||
142962697|NCT01251276|515400017|FG000|Overall Study|Protocol Violation|1|||
142962698|NCT01251276|515400018|FG001|Overall Study|Protocol Violation|0|||
142962699|NCT01251276|515400017|FG000|Overall Study|Lost to Follow-up|0|||
142962700|NCT01251276|515400018|FG001|Overall Study|Lost to Follow-up|1|||
142962701|NCT00441441|515400022|FG000|Overall Study|Adverse Event|2|||
142962702|NCT00441441|515400023|FG001|Overall Study|Adverse Event|1|||
142962703|NCT00441441|515400022|FG000|Overall Study|Protocol Violation|4|||
142962704|NCT00441441|515400023|FG001|Overall Study|Protocol Violation|6|||
142962705|NCT00441441|515400022|FG000|Overall Study|Exacerbation of asthma|1|||
142962706|NCT00441441|515400023|FG001|Overall Study|Exacerbation of asthma|2|||
142962707|NCT00441441|515400022|FG000|Overall Study|Withdrawal by Subject|1|||
142962708|NCT00441441|515400023|FG001|Overall Study|Withdrawal by Subject|2|||
142962709|NCT00441441|515400022|FG000|Overall Study|Other|3|||
142962710|NCT00441441|515400023|FG001|Overall Study|Other|3|||
142962711|NCT04263142|515400024|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
142962712|NCT04263142|515400025|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
142962713|NCT04263142|515400026|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
142962714|NCT04263142|515400027|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
142962715|NCT04263142|515400028|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
142962716|NCT04263142|515400024|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
142962717|NCT04263142|515400025|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
142962718|NCT04263142|515400026|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
142962719|NCT04263142|515400027|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
142962720|NCT04263142|515400028|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
142962721|NCT00769704|515400030|FG000|Overall Study|Lost to Follow-up|3|||
142962722|NCT00769704|515400031|FG001|Overall Study|Lost to Follow-up|2|||
142962723|NCT00769704|515400030|FG000|Overall Study|Death|95|||
142962724|NCT00769704|515400031|FG001|Overall Study|Death|190|||
142962725|NCT00769704|515400030|FG000|Overall Study|Withdrawal by Subject|12|||
142962726|NCT00769704|515400031|FG001|Overall Study|Withdrawal by Subject|5|||
142962727|NCT00769704|515400030|FG000|Overall Study|Other|1|||
142962728|NCT00769704|515400031|FG001|Overall Study|Other|2|||
142962729|NCT00450372|515400032|FG000|Overall Study|Physician Decision|1|||
142962730|NCT00520676|515400036|FG000|Overall Study|Death|84|||
142962731|NCT00520676|515400037|FG001|Overall Study|Death|81|||
142962732|NCT00520676|515400036|FG000|Overall Study|Lost to Follow-up|6|||
142962733|NCT00520676|515400037|FG001|Overall Study|Lost to Follow-up|10|||
142962734|NCT00520676|515400036|FG000|Overall Study|Physician Decision|4|||
142962735|NCT00520676|515400037|FG001|Overall Study|Physician Decision|1|||
142962736|NCT00520676|515400036|FG000|Overall Study|Withdrawal by Subject|7|||
142962737|NCT00520676|515400037|FG001|Overall Study|Withdrawal by Subject|11|||
142962738|NCT05131451|515400040|FG000|Overall Study|Protocol Violation|1|||
142962739|NCT05131451|515400041|FG001|Overall Study|Protocol Violation|0|||
142962740|NCT04346628|515400052|FG000|Overall Study|Lost to Follow-up|4|||
142962741|NCT04346628|515400053|FG001|Overall Study|Lost to Follow-up|4|||
142962742|NCT04346628|515400052|FG000|Overall Study|Withdrew (had personal reasons)|2|||
142962743|NCT04346628|515400053|FG001|Overall Study|Withdrew (had personal reasons)|5|||
142962744|NCT04346628|515400052|FG000|Overall Study|Withdrew (medication intolerant)|0|||
142962745|NCT04346628|515400053|FG001|Overall Study|Withdrew (medication intolerant)|3|||
142962746|NCT04346628|515400052|FG000|Overall Study|Withdrew (declined intervention)|0|||
142962747|NCT04346628|515400053|FG001|Overall Study|Withdrew (declined intervention)|1|||
142962748|NCT01763905|515400054|FG000|Overall Study|Withdrawal by Subject|1|||
142962749|NCT01763905|515400055|FG001|Overall Study|Withdrawal by Subject|1|||
142962750|NCT01763905|515400056|FG002|Overall Study|Withdrawal by Subject|0|||
142962751|NCT01763905|515400057|FG003|Overall Study|Withdrawal by Subject|1|||
142962752|NCT01763905|515400054|FG000|Overall Study|Decision by sponsor|5|||
142962753|NCT01763905|515400055|FG001|Overall Study|Decision by sponsor|0|||
142962754|NCT01763905|515400056|FG002|Overall Study|Decision by sponsor|8|||
142962755|NCT01763905|515400057|FG003|Overall Study|Decision by sponsor|0|||
142962756|NCT01763905|515400054|FG000|Overall Study|Lost to Follow-up|0|||
142962757|NCT01763905|515400055|FG001|Overall Study|Lost to Follow-up|0|||
142962758|NCT01763905|515400056|FG002|Overall Study|Lost to Follow-up|1|||
142962759|NCT01763905|515400057|FG003|Overall Study|Lost to Follow-up|0|||
142962760|NCT03165721|515400058|FG000|Overall Study|Refused further treatment|3|||
142962761|NCT03165721|515400059|FG001|Overall Study|Refused further treatment|0|||
142962762|NCT03165721|515400060|FG002|Overall Study|Refused further treatment|0|||
142962763|NCT03165721|515400058|FG000|Overall Study|Physician Decision|1|||
142962764|NCT03165721|515400059|FG001|Overall Study|Physician Decision|0|||
142962765|NCT03165721|515400060|FG002|Overall Study|Physician Decision|0|||
142962766|NCT01457118|515400061|FG000|Overall Study|Adverse Event|1|||
142962767|NCT01457118|515400062|FG001|Overall Study|Adverse Event|0|||
142962768|NCT01457118|515400063|FG002|Overall Study|Adverse Event|0|||
142962769|NCT01457118|515400064|FG003|Overall Study|Adverse Event|1|||
142962770|NCT01457118|515400061|FG000|Overall Study|Clinical Progression|0|||
142962771|NCT01457118|515400062|FG001|Overall Study|Clinical Progression|1|||
142962772|NCT01457118|515400063|FG002|Overall Study|Clinical Progression|0|||
142962773|NCT01457118|515400064|FG003|Overall Study|Clinical Progression|1|||
142962774|NCT01457118|515400061|FG000|Overall Study|Physician Decision|2|||
142962775|NCT01457118|515400062|FG001|Overall Study|Physician Decision|0|||
142962776|NCT01457118|515400063|FG002|Overall Study|Physician Decision|0|||
142962777|NCT01457118|515400064|FG003|Overall Study|Physician Decision|0|||
142962778|NCT01457118|515400061|FG000|Overall Study|Progressive Disease by RECIST|12|||
142962779|NCT01457118|515400062|FG001|Overall Study|Progressive Disease by RECIST|3|||
142962780|NCT01457118|515400063|FG002|Overall Study|Progressive Disease by RECIST|1|||
142962781|NCT01457118|515400064|FG003|Overall Study|Progressive Disease by RECIST|0|||
142962782|NCT01457118|515400061|FG000|Overall Study|Withdrawal by Subject|5|||
142962783|NCT01457118|515400062|FG001|Overall Study|Withdrawal by Subject|0|||
142962784|NCT01457118|515400063|FG002|Overall Study|Withdrawal by Subject|0|||
142962785|NCT01457118|515400064|FG003|Overall Study|Withdrawal by Subject|0|||
142962786|NCT02750800|515400068|FG000|Overall Study|Adverse Event|18|||
142962787|NCT02750800|515400068|FG000|Overall Study|Lost to Follow-up|12|||
142962788|NCT02750800|515400068|FG000|Overall Study|Investigator decision|53|||
142962789|NCT02750800|515400068|FG000|Overall Study|Patient request|12|||
142962790|NCT02750800|515400068|FG000|Overall Study|Other, not specified|3|||
142962791|NCT01202227|515400073|FG000|Overall Study|Adverse Event|16|||
142962792|NCT01202227|515400073|FG000|Overall Study|Withdrawal by Subject|2|||
142962793|NCT01202227|515400073|FG000|Overall Study|Lack of Efficacy|1|||
142962794|NCT01894477|515400074|FG000|Overall Study|Protocol Violation|0|||
142962795|NCT01894477|515400075|FG001|Overall Study|Protocol Violation|1|||
142962796|NCT01894477|515400074|FG000|Overall Study|protocol changed due SC changed to cord|0|||
142962797|NCT01894477|515400075|FG001|Overall Study|protocol changed due SC changed to cord|1|||
142962798|NCT00913978|515400077|FG000|Overall Study|Surgeon choice|1|||
142962799|NCT00913978|515400078|FG001|Overall Study|Surgeon choice|3|||
142962800|NCT05610176|515400079|FG000|Overall Study|Death|6|||
142962801|NCT00210158|515400080|FG000|Overall Study|Protocol Violation|0|||
142962802|NCT00210158|515400081|FG001|Overall Study|Protocol Violation|2|||
142962803|NCT01912729|515400090|FG000|Overall Study|Withdrawal by Subject|0|||
142962804|NCT01912729|515400091|FG001|Overall Study|Withdrawal by Subject|1|||
142962805|NCT04285346|515400097|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
142962806|NCT04285346|515400098|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
142962807|NCT04285346|515400097|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
142962808|NCT04285346|515400098|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
142962809|NCT04285346|515400097|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
142962810|NCT04285346|515400098|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
142962811|NCT01975272|515400099|FG000|Overall Study|Excluded after protocol amendment|1|||
142962812|NCT01975272|515400100|FG001|Overall Study|Excluded after protocol amendment|1|||
142962813|NCT01975272|515400101|FG002|Overall Study|Excluded after protocol amendment|2|||
142962814|NCT00850460|515400103|FG000|Overall Study|Lost to Follow-up|4|||
142962815|NCT00850460|515400104|FG001|Overall Study|Lost to Follow-up|4|||
142962816|NCT05372575|515400107|FG000|Overall Study|Protocol Violation|7|||
142962817|NCT05372575|515400108|FG001|Overall Study|Protocol Violation|16|||
142962818|NCT03196297|515400109|FG000|Main Period|Withdrawal by Subject|4|||
142962819|NCT03196297|515400109|FG000|Extension Period|Withdrawal by Subject|1|||
142962820|NCT03196297|515400109|FG000|Extension Period|Lack of Efficacy|2|||
142962821|NCT03510663|515400110|FG000|Overall Study|Withdrawal by Subject|0|||
142962822|NCT03510663|515400111|FG001|Overall Study|Withdrawal by Subject|1|||
142962823|NCT03510663|515400112|FG002|Overall Study|Withdrawal by Subject|0|||
142962824|NCT03510663|515400113|FG003|Overall Study|Withdrawal by Subject|0|||
142962825|NCT03510663|515400114|FG004|Overall Study|Withdrawal by Subject|0|||
142962826|NCT03510663|515400115|FG005|Overall Study|Withdrawal by Subject|0|||
142962827|NCT03510663|515400116|FG006|Overall Study|Withdrawal by Subject|0|||
142962828|NCT03510663|515400117|FG007|Overall Study|Withdrawal by Subject|0|||
142962829|NCT00320385|515400126|FG000|Overall Study|Lost to Follow-up|7|||
142962830|NCT00320385|515400127|FG001|Overall Study|Lost to Follow-up|10|||
142962831|NCT00320385|515400126|FG000|Overall Study|Withdrawal by Subject|6|||
142962832|NCT00320385|515400127|FG001|Overall Study|Withdrawal by Subject|7|||
142962833|NCT00320385|515400126|FG000|Overall Study|Sponsor Terminated Study|2|||
142962834|NCT00320385|515400127|FG001|Overall Study|Sponsor Terminated Study|1|||
142962835|NCT00320385|515400126|FG000|Overall Study|Investigator Decision|0|||
142962836|NCT00320385|515400127|FG001|Overall Study|Investigator Decision|1|||
142962837|NCT00320385|515400126|FG000|Overall Study|Death|1|||
142962838|NCT00320385|515400127|FG001|Overall Study|Death|2|||
142962839|NCT00320385|515400126|FG000|Overall Study|Serious Adverse Event|1|||
142962840|NCT00320385|515400127|FG001|Overall Study|Serious Adverse Event|0|||
142962841|NCT00320385|515400126|FG000|Overall Study|Withdrew Consent|1|||
142962842|NCT00320385|515400127|FG001|Overall Study|Withdrew Consent|0|||
142962843|NCT00320385|515400126|FG000|Overall Study|Adverse Event|0|||
142962844|NCT00320385|515400127|FG001|Overall Study|Adverse Event|1|||
142962845|NCT04370028|515400128|FG000|Overall Study|Withdrawal by Subject|695|||
142962846|NCT04370028|515400128|FG000|Overall Study|Protocol Violation|9|||
142962847|NCT04370028|515400128|FG000|Overall Study|Adverse Event|3|||
142962848|NCT02775864|515400134|FG000|Overall Study|Data ended end of 2010|1764|||
142962849|NCT02775864|515400135|FG001|Overall Study|Data ended end of 2010|2880|||
142962850|NCT02775864|515400136|FG002|Overall Study|Data ended end of 2010|1140|||
142962851|NCT02775864|515400137|FG003|Overall Study|Data ended end of 2010|1194|||
142962852|NCT02775864|515400134|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
142962853|NCT02775864|515400135|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
142962854|NCT02775864|515400136|FG002|Overall Study|Medicaid eligibility discontinued|720|||
142962855|NCT02775864|515400137|FG003|Overall Study|Medicaid eligibility discontinued|890|||
142962856|NCT03552549|515400138|FG000|Overall Study|Disease progression|25|||
142962857|NCT03552549|515400139|FG001|Overall Study|Disease progression|17|||
142962858|NCT03552549|515400138|FG000|Overall Study|Adverse event in first 12 months|12|||
142962859|NCT03552549|515400139|FG001|Overall Study|Adverse event in first 12 months|8|||
142962860|NCT03552549|515400138|FG000|Overall Study|Withdrawal by Subject|7|||
142962861|NCT03552549|515400139|FG001|Overall Study|Withdrawal by Subject|7|||
142962862|NCT03552549|515400138|FG000|Overall Study|Unknown (no reason provided)|4|||
142962863|NCT03552549|515400139|FG001|Overall Study|Unknown (no reason provided)|2|||
142962864|NCT03552549|515400138|FG000|Overall Study|Not in participant's best interest|2|||
142962865|NCT03552549|515400139|FG001|Overall Study|Not in participant's best interest|1|||
142962866|NCT03552549|515400138|FG000|Overall Study|Did not complete study treatment|2|||
142962867|NCT03552549|515400139|FG001|Overall Study|Did not complete study treatment|3|||
142962868|NCT03552549|515400138|FG000|Overall Study|Did not meet eligibility criteria|1|||
142962869|NCT03552549|515400139|FG001|Overall Study|Did not meet eligibility criteria|0|||
142962870|NCT03552549|515400138|FG000|Overall Study|Administrative|0|||
142962871|NCT03552549|515400139|FG001|Overall Study|Administrative|14|||
142962872|NCT01930799|515400148|FG000|Overall Study|Withdrawal by Subject|3|||
142962873|NCT01930799|515400148|FG000|Overall Study|Lost to Follow-up|5|||
142962874|NCT00875017|515400149|FG000|First Intervention|Withdrawal by Subject|1|||
142962875|NCT00875017|515400150|FG001|First Intervention|Withdrawal by Subject|0|||
142962876|NCT00875017|515400151|FG002|First Intervention|Withdrawal by Subject|1|||
142962877|NCT00875017|515400152|FG003|First Intervention|Withdrawal by Subject|0|||
142962878|NCT00875017|515400153|FG004|First Intervention|Withdrawal by Subject|0|||
142962879|NCT00875017|515400154|FG005|First Intervention|Withdrawal by Subject|0|||
142962880|NCT00875017|515400149|FG000|First Intervention|Adverse Event|0|||
142962881|NCT00875017|515400150|FG001|First Intervention|Adverse Event|0|||
142962882|NCT00875017|515400151|FG002|First Intervention|Adverse Event|0|||
142962883|NCT00875017|515400152|FG003|First Intervention|Adverse Event|1|||
142962884|NCT00875017|515400153|FG004|First Intervention|Adverse Event|0|||
142962885|NCT00875017|515400154|FG005|First Intervention|Adverse Event|0|||
142962886|NCT00875017|515400149|FG000|First Intervention|Problems collecting rectal effluent|1|||
142962887|NCT00875017|515400150|FG001|First Intervention|Problems collecting rectal effluent|0|||
142962888|NCT00875017|515400151|FG002|First Intervention|Problems collecting rectal effluent|0|||
142962889|NCT00875017|515400152|FG003|First Intervention|Problems collecting rectal effluent|0|||
142962890|NCT00875017|515400153|FG004|First Intervention|Problems collecting rectal effluent|0|||
142962891|NCT00875017|515400154|FG005|First Intervention|Problems collecting rectal effluent|0|||
142962892|NCT00875017|515400149|FG000|First Intervention|Intolerance to nasogastric tube|0|||
142962893|NCT00875017|515400150|FG001|First Intervention|Intolerance to nasogastric tube|0|||
142962894|NCT00875017|515400151|FG002|First Intervention|Intolerance to nasogastric tube|0|||
142962895|NCT00875017|515400152|FG003|First Intervention|Intolerance to nasogastric tube|0|||
142962896|NCT00875017|515400153|FG004|First Intervention|Intolerance to nasogastric tube|1|||
142962897|NCT00875017|515400154|FG005|First Intervention|Intolerance to nasogastric tube|0|||
142962898|NCT00875017|515400149|FG000|Washout|Problem collecting rectal effluent|0|||
142962899|NCT00875017|515400150|FG001|Washout|Problem collecting rectal effluent|0|||
142962900|NCT00875017|515400151|FG002|Washout|Problem collecting rectal effluent|1|||
142962901|NCT00875017|515400152|FG003|Washout|Problem collecting rectal effluent|0|||
142962902|NCT00875017|515400153|FG004|Washout|Problem collecting rectal effluent|0|||
142962903|NCT00875017|515400154|FG005|Washout|Problem collecting rectal effluent|0|||
142962904|NCT00875017|515400149|FG000|Second Intervention|Adverse Event|0|||
142962905|NCT00875017|515400150|FG001|Second Intervention|Adverse Event|0|||
142962906|NCT00875017|515400151|FG002|Second Intervention|Adverse Event|0|||
142962907|NCT00875017|515400152|FG003|Second Intervention|Adverse Event|1|||
142962908|NCT00875017|515400153|FG004|Second Intervention|Adverse Event|0|||
142962909|NCT00875017|515400154|FG005|Second Intervention|Adverse Event|0|||
142962910|NCT00875017|515400149|FG000|Washout|Problems collecting rectal effluent|0|||
142962911|NCT00875017|515400150|FG001|Washout|Problems collecting rectal effluent|1|||
142962912|NCT00875017|515400151|FG002|Washout|Problems collecting rectal effluent|0|||
142962913|NCT00875017|515400152|FG003|Washout|Problems collecting rectal effluent|0|||
142962914|NCT00875017|515400153|FG004|Washout|Problems collecting rectal effluent|0|||
142962915|NCT00875017|515400154|FG005|Washout|Problems collecting rectal effluent|0|||
142962916|NCT00875017|515400149|FG000|Third Intervention|Adverse Event|0|||
142962917|NCT00875017|515400150|FG001|Third Intervention|Adverse Event|1|||
142962918|NCT00875017|515400151|FG002|Third Intervention|Adverse Event|1|||
142962919|NCT00875017|515400152|FG003|Third Intervention|Adverse Event|0|||
142962920|NCT00875017|515400153|FG004|Third Intervention|Adverse Event|0|||
142962921|NCT00875017|515400154|FG005|Third Intervention|Adverse Event|0|||
142962922|NCT00875017|515400149|FG000|Washout|Withdrawal by Subject|0|||
142962923|NCT00875017|515400150|FG001|Washout|Withdrawal by Subject|0|||
142962924|NCT00875017|515400151|FG002|Washout|Withdrawal by Subject|0|||
142962925|NCT00875017|515400152|FG003|Washout|Withdrawal by Subject|0|||
142962926|NCT00875017|515400153|FG004|Washout|Withdrawal by Subject|1|||
142962927|NCT00875017|515400154|FG005|Washout|Withdrawal by Subject|0|||
142962928|NCT00875017|515400149|FG000|Fourth Intervention|Inability to comply with fasting|0|||
142962929|NCT00875017|515400150|FG001|Fourth Intervention|Inability to comply with fasting|0|||
142962930|NCT00875017|515400151|FG002|Fourth Intervention|Inability to comply with fasting|0|||
142962931|NCT00875017|515400152|FG003|Fourth Intervention|Inability to comply with fasting|0|||
142962932|NCT00875017|515400153|FG004|Fourth Intervention|Inability to comply with fasting|0|||
142962933|NCT00875017|515400154|FG005|Fourth Intervention|Inability to comply with fasting|1|||
142962934|NCT02689219|515400155|FG000|Overall Study|Death|1|||
142962935|NCT02689219|515400156|FG001|Overall Study|Death|1|||
142962936|NCT02689219|515400155|FG000|Overall Study|Disease Progression|10|||
142962937|NCT02689219|515400156|FG001|Overall Study|Disease Progression|6|||
142962938|NCT03342469|515400157|FG000|Overall Study|Withdrawal by Subject|0|||
142962939|NCT03342469|515400158|FG001|Overall Study|Withdrawal by Subject|1|||
142962940|NCT03342469|515400159|FG002|Overall Study|Withdrawal by Subject|0|||
142962941|NCT03342469|515400160|FG003|Overall Study|Withdrawal by Subject|0|||
142962942|NCT01204658|515400162|FG000|Primary Phase|Adverse Event|0|||
142962943|NCT01204658|515400163|FG001|Primary Phase|Adverse Event|0|||
142962944|NCT01204658|515400164|FG002|Primary Phase|Adverse Event|1|||
142962945|NCT01204658|515400165|FG003|Primary Phase|Adverse Event|0|||
142962946|NCT00436215|515400170|FG000|Overall Study|Refused further treatment|3|||
142962947|NCT00436215|515400170|FG000|Overall Study|Small bowel obstruction|1|||
142962948|NCT03050359|515401650|FG000|Overall Study|Randomized But Not Treated|2|||
142962949|NCT03050359|515401651|FG001|Overall Study|Randomized But Not Treated|0|||
142962950|NCT03050359|515401650|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
142962951|NCT03050359|515401651|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
142962952|NCT03050359|515401650|FG000|Overall Study|Significant Protocol Deviation|2|||
142962953|NCT03050359|515401651|FG001|Overall Study|Significant Protocol Deviation|3|||
142962954|NCT03050359|515401650|FG000|Overall Study|Lost to Follow-up|2|||
142962955|NCT03050359|515401651|FG001|Overall Study|Lost to Follow-up|1|||
142962956|NCT03050359|515401650|FG000|Overall Study|Voluntary Withdrawal|4|||
142962957|NCT03050359|515401651|FG001|Overall Study|Voluntary Withdrawal|6|||
142962958|NCT03050359|515401650|FG000|Overall Study|Pregnancy|1|||
142962959|NCT03050359|515401651|FG001|Overall Study|Pregnancy|0|||
142962960|NCT03050359|515401650|FG000|Overall Study|Reason Not Specified|1|||
142962961|NCT03050359|515401651|FG001|Overall Study|Reason Not Specified|0|||
142962962|NCT02614287|515401652|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
142962963|NCT02614287|515401653|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
142962964|NCT02614287|515401652|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
142962965|NCT02614287|515401653|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
142962966|NCT02614287|515401652|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
142962967|NCT02614287|515401653|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
142962968|NCT02614287|515401652|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
142962969|NCT02614287|515401653|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
142962970|NCT02614287|515401652|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
142962971|NCT02614287|515401653|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
142962972|NCT02614287|515401652|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
142962973|NCT02614287|515401653|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
142962974|NCT02614287|515401652|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
142962975|NCT02614287|515401653|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
142962976|NCT02614287|515401652|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
142962977|NCT02614287|515401653|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
142962978|NCT01328249|515401655|FG000|Overall Study|Adverse Event|3|||
142962979|NCT01328249|515401656|FG001|Overall Study|Adverse Event|0|||
142962980|NCT01328249|515401655|FG000|Overall Study|Disease progression|1|||
142962981|NCT01328249|515401656|FG001|Overall Study|Disease progression|0|||
142962982|NCT01328249|515401655|FG000|Overall Study|Withdrawal by Subject|1|||
142962983|NCT01328249|515401656|FG001|Overall Study|Withdrawal by Subject|1|||
142962984|NCT01328249|515401655|FG000|Overall Study|Moved before end of treatment visit|1|||
142962985|NCT01328249|515401656|FG001|Overall Study|Moved before end of treatment visit|0|||
142962986|NCT01328249|515401655|FG000|Overall Study|Subject choice|1|||
142962987|NCT01328249|515401656|FG001|Overall Study|Subject choice|1|||
142962988|NCT01328249|515401655|FG000|Overall Study|Protocol Violation|0|||
142962989|NCT01328249|515401656|FG001|Overall Study|Protocol Violation|1|||
142962990|NCT00748553|515401657|FG000|Overall Study|Adverse Event|0|||
142962991|NCT00748553|515401658|FG001|Overall Study|Adverse Event|1|||
142962992|NCT00748553|515401657|FG000|Overall Study|disease progression|2|||
142962993|NCT00748553|515401658|FG001|Overall Study|disease progression|0|||
142962994|NCT00748553|515401657|FG000|Overall Study|noncompliance|1|||
142962995|NCT00748553|515401658|FG001|Overall Study|noncompliance|0|||
142962996|NCT00948818|515401659|FG000|Overall Study|Adverse Event|10|||
142962997|NCT00948818|515401660|FG001|Overall Study|Adverse Event|32|||
142962998|NCT00948818|515401659|FG000|Overall Study|Protocol Violation|9|||
142962999|NCT00948818|515401660|FG001|Overall Study|Protocol Violation|10|||
142963000|NCT00948818|515401659|FG000|Overall Study|Withdrawal by Subject|25|||
142963001|NCT00948818|515401660|FG001|Overall Study|Withdrawal by Subject|25|||
142963002|NCT00948818|515401659|FG000|Overall Study|Lost to Follow-up|10|||
142963003|NCT00948818|515401660|FG001|Overall Study|Lost to Follow-up|17|||
142963004|NCT00948818|515401659|FG000|Overall Study|Lack of Efficacy|4|||
142963005|NCT00948818|515401660|FG001|Overall Study|Lack of Efficacy|5|||
142963006|NCT00948818|515401659|FG000|Overall Study|Other Reason|4|||
142963007|NCT00948818|515401660|FG001|Overall Study|Other Reason|5|||
142963008|NCT02330549|515401661|FG000|Overall Study|Adverse Event|1|||
142963009|NCT02330549|515401662|FG001|Overall Study|Adverse Event|0|||
142963010|NCT02330549|515401661|FG000|Overall Study|Subject withdrew consent|2|||
142963011|NCT02330549|515401662|FG001|Overall Study|Subject withdrew consent|1|||
142963012|NCT02330549|515401661|FG000|Overall Study|Failure to meet randomization criteria|1|||
142963013|NCT02330549|515401662|FG001|Overall Study|Failure to meet randomization criteria|0|||
142963014|NCT00745368|515401663|FG000|Overall Study|Unable to provide sample|3|||
142963015|NCT02326467|515401666|FG000|Overall Study|Withdrawal by Subject|1|||
142963016|NCT00262080|515401673|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
142963017|NCT00262080|515401674|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
142963018|NCT00262080|515401675|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
142963019|NCT00262080|515401673|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
142963020|NCT00262080|515401674|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
142963021|NCT00262080|515401675|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
142963022|NCT00262080|515401673|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
142963023|NCT00262080|515401674|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
142963024|NCT00262080|515401675|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
142963025|NCT00262080|515401673|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
142963026|NCT00262080|515401674|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
142963027|NCT00262080|515401675|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
142963028|NCT00262080|515401673|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
142963029|NCT00262080|515401674|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
142963030|NCT00262080|515401675|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
142963031|NCT00262080|515401673|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
142963032|NCT00262080|515401674|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
142963033|NCT00262080|515401675|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
142963034|NCT03010423|515401678|FG000|Overall Study|Study termination|8|||
142963035|NCT03484923|515401679|FG000|Overall Study|Adverse Event|3|||
142963036|NCT03484923|515401680|FG001|Overall Study|Adverse Event|3|||
142963037|NCT03484923|515401681|FG002|Overall Study|Adverse Event|5|||
142963038|NCT03484923|515401682|FG003|Overall Study|Adverse Event|11|||
142963039|NCT03484923|515401683|FG004|Overall Study|Adverse Event|1|||
142963040|NCT03484923|515401679|FG000|Overall Study|Death|2|||
142963041|NCT03484923|515401680|FG001|Overall Study|Death|2|||
142963042|NCT03484923|515401681|FG002|Overall Study|Death|3|||
142963043|NCT03484923|515401682|FG003|Overall Study|Death|0|||
142963044|NCT03484923|515401683|FG004|Overall Study|Death|1|||
142963045|NCT03484923|515401679|FG000|Overall Study|Physician Decision|6|||
142963046|NCT03484923|515401680|FG001|Overall Study|Physician Decision|7|||
142963047|NCT03484923|515401681|FG002|Overall Study|Physician Decision|6|||
142963048|NCT03484923|515401682|FG003|Overall Study|Physician Decision|3|||
142963049|NCT03484923|515401683|FG004|Overall Study|Physician Decision|2|||
142963050|NCT03484923|515401679|FG000|Overall Study|Progressive disease|33|||
142963051|NCT03484923|515401680|FG001|Overall Study|Progressive disease|28|||
142963052|NCT03484923|515401681|FG002|Overall Study|Progressive disease|26|||
142963053|NCT03484923|515401682|FG003|Overall Study|Progressive disease|30|||
142963054|NCT03484923|515401683|FG004|Overall Study|Progressive disease|16|||
142963055|NCT03484923|515401679|FG000|Overall Study|Subject Decision|1|||
142963056|NCT03484923|515401680|FG001|Overall Study|Subject Decision|3|||
142963057|NCT03484923|515401681|FG002|Overall Study|Subject Decision|3|||
142963058|NCT03484923|515401682|FG003|Overall Study|Subject Decision|0|||
142963059|NCT03484923|515401683|FG004|Overall Study|Subject Decision|1|||
142963060|NCT03439748|515401684|FG000|Overall Study|Withdrawal by Subject|11|||
142963061|NCT03439748|515401685|FG001|Overall Study|Withdrawal by Subject|17|||
142963062|NCT02324842|515401692|FG000|Overall Study|Lost to Follow-up|1|||
142963063|NCT02324842|515401693|FG001|Overall Study|Lost to Follow-up|1|||
142963064|NCT02324842|515401694|FG002|Overall Study|Lost to Follow-up|2|||
142963065|NCT03298412|515401695|FG000|Run-in Period|Other, Not Specified|1|||
142963066|NCT03298412|515401695|FG000|Run-in Period|Disease Progression|1|||
142963067|NCT03298412|515401695|FG000|Run-in Period|Ineligibility Determined|1|||
143117143|NCT01273155|515970044|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
142963068|NCT03298412|515401695|FG000|Run-in Period|Decision by Sponsor|6|||
142963069|NCT00643487|515401696|FG000|Overall Study|Technical difficulty|3|||
142963070|NCT01533935|515401699|FG000|Overall Study|Adverse Event|5|||
143117144|NCT01273155|515970038|FG000|Overall Study|Died during Cycle 1|0|||
142963071|NCT01533935|515401700|FG001|Overall Study|Adverse Event|7|||
142963072|NCT01533935|515401701|FG002|Overall Study|Adverse Event|1|||
142963073|NCT01533935|515401702|FG003|Overall Study|Adverse Event|5|||
142963074|NCT01533935|515401703|FG004|Overall Study|Adverse Event|3|||
142963075|NCT01533935|515401699|FG000|Overall Study|Protocol Violation|0|||
142963076|NCT01533935|515401700|FG001|Overall Study|Protocol Violation|2|||
142963077|NCT01533935|515401701|FG002|Overall Study|Protocol Violation|0|||
142963078|NCT01533935|515401702|FG003|Overall Study|Protocol Violation|0|||
142963079|NCT01533935|515401703|FG004|Overall Study|Protocol Violation|0|||
142963080|NCT01533935|515401699|FG000|Overall Study|Lost to Follow-up|0|||
142963081|NCT01533935|515401700|FG001|Overall Study|Lost to Follow-up|0|||
142963082|NCT01533935|515401701|FG002|Overall Study|Lost to Follow-up|1|||
142963083|NCT01533935|515401702|FG003|Overall Study|Lost to Follow-up|0|||
142963084|NCT01533935|515401703|FG004|Overall Study|Lost to Follow-up|0|||
142963085|NCT01533935|515401699|FG000|Overall Study|Withdrawal by Subject|0|||
142963086|NCT01533935|515401700|FG001|Overall Study|Withdrawal by Subject|4|||
142963087|NCT01533935|515401701|FG002|Overall Study|Withdrawal by Subject|5|||
142963088|NCT01533935|515401702|FG003|Overall Study|Withdrawal by Subject|2|||
142963089|NCT01533935|515401703|FG004|Overall Study|Withdrawal by Subject|4|||
142963090|NCT01533935|515401699|FG000|Overall Study|Other reason not defined above|1|||
142963091|NCT01533935|515401700|FG001|Overall Study|Other reason not defined above|0|||
142963092|NCT01533935|515401701|FG002|Overall Study|Other reason not defined above|1|||
142963093|NCT01533935|515401702|FG003|Overall Study|Other reason not defined above|0|||
142963094|NCT01533935|515401703|FG004|Overall Study|Other reason not defined above|1|||
142963095|NCT05631548|515401704|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
142963096|NCT05631548|515401705|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
142963097|NCT01327651|515401708|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
142963098|NCT01327651|515401709|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
142963099|NCT01327651|515401710|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
142963100|NCT01327651|515401711|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
142963101|NCT01327651|515401712|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
142963102|NCT01327651|515401713|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
142963103|NCT01327651|515401714|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
142963104|NCT01327651|515401715|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
142963105|NCT01327651|515401716|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
142963106|NCT01327651|515401708|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
142963107|NCT01327651|515401709|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
142963108|NCT01327651|515401710|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
142963109|NCT01327651|515401711|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
142963110|NCT01327651|515401712|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
142963111|NCT01327651|515401713|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
142963112|NCT01327651|515401714|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
142963113|NCT01327651|515401715|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
142963114|NCT01327651|515401716|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
142963115|NCT01327651|515401708|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
142963116|NCT01327651|515401709|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
142963117|NCT01327651|515401710|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
142963118|NCT01327651|515401711|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
142963119|NCT01327651|515401712|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
142963120|NCT01327651|515401713|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
142963121|NCT01327651|515401714|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
142963122|NCT01327651|515401715|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
142963123|NCT01327651|515401716|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
142963124|NCT01327651|515401708|FG000|Post Study Follow-up|Lost to Follow-up|0|||
142963125|NCT01327651|515401709|FG001|Post Study Follow-up|Lost to Follow-up|1|||
142963126|NCT01327651|515401710|FG002|Post Study Follow-up|Lost to Follow-up|1|||
142963127|NCT01327651|515401711|FG003|Post Study Follow-up|Lost to Follow-up|0|||
142963128|NCT01327651|515401712|FG004|Post Study Follow-up|Lost to Follow-up|0|||
142963129|NCT01327651|515401713|FG005|Post Study Follow-up|Lost to Follow-up|0|||
142963130|NCT01327651|515401714|FG006|Post Study Follow-up|Lost to Follow-up|4|||
142963131|NCT01327651|515401715|FG007|Post Study Follow-up|Lost to Follow-up|1|||
142963132|NCT01327651|515401716|FG008|Post Study Follow-up|Lost to Follow-up|2|||
142963133|NCT00532948|515401718|FG000|Overall Study|Protocol Violation|1|||
142963134|NCT00532948|515401719|FG001|Overall Study|Protocol Violation|0|||
142963135|NCT00532948|515401720|FG002|Overall Study|Protocol Violation|0|||
142963136|NCT00532948|515401718|FG000|Overall Study|Death|3|||
142963137|NCT00532948|515401719|FG001|Overall Study|Death|3|||
142963138|NCT00532948|515401720|FG002|Overall Study|Death|4|||
142963139|NCT00532948|515401718|FG000|Overall Study|Violation of selection criteria at entry|0|||
142963140|NCT00532948|515401719|FG001|Overall Study|Violation of selection criteria at entry|1|||
142963141|NCT00532948|515401720|FG002|Overall Study|Violation of selection criteria at entry|0|||
142963142|NCT00532948|515401718|FG000|Overall Study|Failure to return|0|||
142963143|NCT00532948|515401719|FG001|Overall Study|Failure to return|1|||
142963144|NCT00532948|515401720|FG002|Overall Study|Failure to return|0|||
142963145|NCT01253044|515401724|FG000|Overall Study|Lost to Follow-up|38|||
142963146|NCT01253044|515401725|FG001|Overall Study|Lost to Follow-up|29|||
142963147|NCT03885726|515401726|FG000|Overall Study|Staffing issues/lost interest|1|||
142963148|NCT03885726|515401726|FG000|Overall Study|Early discharge from hospital|3|||
142963149|NCT02868216|515401729|FG000|Overall Study|Death|0|||
142963150|NCT02868216|515401730|FG001|Overall Study|Death|1|||
142963151|NCT02868216|515401729|FG000|Overall Study|coronary artery bypass|1|||
142963152|NCT02868216|515401730|FG001|Overall Study|coronary artery bypass|0|||
142963153|NCT02868216|515401729|FG000|Overall Study|Withdrawal by Subject|7|||
142963154|NCT02868216|515401730|FG001|Overall Study|Withdrawal by Subject|5|||
142963155|NCT02702193|515401733|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
142963156|NCT02702193|515401734|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
142963157|NCT02702193|515401733|FG000|4 Month Follow up|Withdrawal by Subject|1|||
142963158|NCT02702193|515401734|FG001|4 Month Follow up|Withdrawal by Subject|0|||
142963159|NCT02702193|515401733|FG000|4 Month Follow up|Lost to Follow-up|17|||
142963160|NCT02702193|515401734|FG001|4 Month Follow up|Lost to Follow-up|18|||
142963161|NCT02702193|515401733|FG000|8 Month Follow up|Withdrawal by Subject|1|||
142963162|NCT02702193|515401734|FG001|8 Month Follow up|Withdrawal by Subject|0|||
142963163|NCT02702193|515401733|FG000|8 Month Follow up|Lost to Follow-up|14|||
142963164|NCT02702193|515401734|FG001|8 Month Follow up|Lost to Follow-up|18|||
142963165|NCT02702193|515401733|FG000|12 Month Follow up|Withdrawal by Subject|1|||
142963166|NCT02702193|515401734|FG001|12 Month Follow up|Withdrawal by Subject|0|||
142963167|NCT02702193|515401733|FG000|12 Month Follow up|Lost to Follow-up|16|||
142963168|NCT02702193|515401734|FG001|12 Month Follow up|Lost to Follow-up|18|||
142963169|NCT03609359|515401736|FG000|Overall Study|Progression of primary disease (PD)|25|||
142963170|NCT03609359|515401736|FG000|Overall Study|Patient's refusal|1|||
142963171|NCT03609359|515401736|FG000|Overall Study|Physician Decision|1|||
142963172|NCT03609359|515401736|FG000|Overall Study|The protocol treatment was discontinued for undergoing primary tumor resection.|1|||
142963173|NCT03345836|515401741|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
142963174|NCT03345836|515401742|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
142963175|NCT03345836|515401743|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
142963176|NCT03345836|515401744|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
142963177|NCT03345836|515401745|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
142963178|NCT03345836|515401746|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
142963179|NCT03345836|515401741|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
142963180|NCT03345836|515401742|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
142963181|NCT03345836|515401743|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
142963182|NCT03345836|515401744|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
142963183|NCT03345836|515401745|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
142963184|NCT03345836|515401746|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
142963185|NCT03345836|515401741|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
142963186|NCT03345836|515401742|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
142963187|NCT03345836|515401743|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
142963188|NCT03345836|515401744|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
142963189|NCT03345836|515401745|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
142963190|NCT03345836|515401746|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
142963191|NCT03345836|515401741|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
142963192|NCT03345836|515401742|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
142963193|NCT03345836|515401743|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
142963194|NCT03345836|515401744|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
142963195|NCT03345836|515401745|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
142963196|NCT03345836|515401746|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
142963197|NCT03345836|515401741|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
142963198|NCT03345836|515401742|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
142963199|NCT03345836|515401743|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
142963200|NCT03345836|515401744|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
142963201|NCT03345836|515401745|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
142963202|NCT03345836|515401746|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
142963203|NCT03345836|515401741|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
142963204|NCT03345836|515401742|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
142963205|NCT03345836|515401743|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
142963206|NCT03345836|515401744|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
142963207|NCT03345836|515401745|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
142963208|NCT03345836|515401746|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
142963209|NCT03345836|515401741|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
143003123|NCT01049360|515548755|FG011|Period 2|Protocol Violation|0|||
142963210|NCT03345836|515401742|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
142963211|NCT03345836|515401743|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
142963212|NCT03345836|515401744|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
142963213|NCT03345836|515401745|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
142963214|NCT03345836|515401746|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
142963215|NCT03345836|515401741|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
142963216|NCT03345836|515401742|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
142963217|NCT03345836|515401743|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
142963218|NCT03345836|515401744|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
142963219|NCT03345836|515401745|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
142963220|NCT03345836|515401746|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
142963221|NCT03345836|515401741|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
142963222|NCT03345836|515401742|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
142963223|NCT03345836|515401743|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
142963224|NCT03345836|515401744|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
142963225|NCT03345836|515401745|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
142963226|NCT03345836|515401746|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
142963227|NCT03345836|515401741|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
142963228|NCT03345836|515401742|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
142963229|NCT03345836|515401743|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
142963230|NCT03345836|515401744|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
142963231|NCT03345836|515401745|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
142963232|NCT03345836|515401746|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
142963233|NCT03345836|515401741|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
142963234|NCT03345836|515401742|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
142963235|NCT03345836|515401743|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
142963236|NCT03345836|515401744|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
142963237|NCT03345836|515401745|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
142963238|NCT03345836|515401746|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
142963239|NCT00222729|515401749|FG000|Overall Study|Adverse Event|3|||
142963240|NCT01915849|515401752|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
142963241|NCT01915849|515401753|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
142963242|NCT01915849|515401754|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
142963243|NCT01915849|515401755|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
142963244|NCT01915849|515401752|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
142963245|NCT01915849|515401753|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
142963246|NCT01915849|515401754|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
142963247|NCT01915849|515401755|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
142963248|NCT01798706|515401756|FG000|Overall Study|Adverse Event|15|||
142963249|NCT01798706|515401757|FG001|Overall Study|Adverse Event|10|||
142963250|NCT01798706|515401756|FG000|Overall Study|Lack of Efficacy|0|||
142963251|NCT01798706|515401757|FG001|Overall Study|Lack of Efficacy|2|||
142963252|NCT01798706|515401756|FG000|Overall Study|Poor compliance to protocol|1|||
142963253|NCT01798706|515401757|FG001|Overall Study|Poor compliance to protocol|0|||
142963254|NCT01798706|515401756|FG000|Overall Study|Other than specified above|5|||
142963255|NCT01798706|515401757|FG001|Overall Study|Other than specified above|9|||
142963256|NCT02028338|515401758|FG000|Overall Study|Withdrawal by Subject|3|||
142963257|NCT02028338|515401759|FG001|Overall Study|Withdrawal by Subject|1|||
142963258|NCT02028338|515401758|FG000|Overall Study|Unable to contact participant|1|||
142963259|NCT02028338|515401759|FG001|Overall Study|Unable to contact participant|0|||
142963260|NCT02761993|515401766|FG000|Overall Study|Adverse Event|0|||
142963261|NCT02761993|515401767|FG001|Overall Study|Adverse Event|2|||
142963262|NCT02761993|515401768|FG002|Overall Study|Adverse Event|0|||
142963263|NCT02761993|515401766|FG000|Overall Study|Lost to Follow-up|1|||
142963264|NCT02761993|515401767|FG001|Overall Study|Lost to Follow-up|3|||
142963265|NCT02761993|515401768|FG002|Overall Study|Lost to Follow-up|2|||
142963266|NCT02761993|515401766|FG000|Overall Study|Withdrawal by Subject|1|||
142963267|NCT02761993|515401767|FG001|Overall Study|Withdrawal by Subject|1|||
142963268|NCT02761993|515401768|FG002|Overall Study|Withdrawal by Subject|2|||
142963269|NCT00256867|515401769|FG000|Overall Study|Adverse Event|0|||
142963270|NCT00256867|515401770|FG001|Overall Study|Adverse Event|1|||
142963271|NCT00256867|515401771|FG002|Overall Study|Adverse Event|1|||
142963272|NCT00256867|515401772|FG003|Overall Study|Adverse Event|1|||
142963273|NCT00256867|515401773|FG004|Overall Study|Adverse Event|2|||
142963274|NCT00256867|515401774|FG005|Overall Study|Adverse Event|2|||
142963275|NCT00256867|515401775|FG006|Overall Study|Adverse Event|1|||
142963276|NCT00256867|515401776|FG007|Overall Study|Adverse Event|4|||
143455418|NCT02914275|517212435|FG000|Overall Study|Excluded due to invalid informed consent|3|||
143455419|NCT02914275|517212436|FG001|Overall Study|Excluded due to invalid informed consent|0|||
142963277|NCT00256867|515401769|FG000|Overall Study|Lost to Follow-up|2|||
142963278|NCT00256867|515401770|FG001|Overall Study|Lost to Follow-up|2|||
142963279|NCT00256867|515401771|FG002|Overall Study|Lost to Follow-up|2|||
142963280|NCT00256867|515401772|FG003|Overall Study|Lost to Follow-up|3|||
142963281|NCT00256867|515401773|FG004|Overall Study|Lost to Follow-up|2|||
142963282|NCT00256867|515401774|FG005|Overall Study|Lost to Follow-up|0|||
142963283|NCT00256867|515401775|FG006|Overall Study|Lost to Follow-up|1|||
142963284|NCT00256867|515401776|FG007|Overall Study|Lost to Follow-up|2|||
142963285|NCT00256867|515401769|FG000|Overall Study|Protocol Violation|0|||
142963286|NCT00256867|515401770|FG001|Overall Study|Protocol Violation|0|||
142963287|NCT00256867|515401771|FG002|Overall Study|Protocol Violation|0|||
142963288|NCT00256867|515401772|FG003|Overall Study|Protocol Violation|1|||
142963289|NCT00256867|515401773|FG004|Overall Study|Protocol Violation|0|||
142963290|NCT00256867|515401774|FG005|Overall Study|Protocol Violation|1|||
142963291|NCT00256867|515401775|FG006|Overall Study|Protocol Violation|0|||
142963292|NCT00256867|515401776|FG007|Overall Study|Protocol Violation|1|||
142963293|NCT00256867|515401769|FG000|Overall Study|Withdrawal by Subject|0|||
142963294|NCT00256867|515401770|FG001|Overall Study|Withdrawal by Subject|0|||
142963295|NCT00256867|515401771|FG002|Overall Study|Withdrawal by Subject|1|||
142963296|NCT00256867|515401772|FG003|Overall Study|Withdrawal by Subject|1|||
142963297|NCT00256867|515401773|FG004|Overall Study|Withdrawal by Subject|2|||
142963298|NCT00256867|515401774|FG005|Overall Study|Withdrawal by Subject|2|||
142963299|NCT00256867|515401775|FG006|Overall Study|Withdrawal by Subject|3|||
142963300|NCT00256867|515401776|FG007|Overall Study|Withdrawal by Subject|2|||
142963301|NCT00256867|515401769|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
142963302|NCT00256867|515401770|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
142963303|NCT00256867|515401771|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
142963304|NCT00256867|515401772|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
142963305|NCT00256867|515401773|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
142963306|NCT00256867|515401774|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
142963307|NCT00256867|515401775|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
142963308|NCT00256867|515401776|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
142963309|NCT00256867|515401769|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
142963310|NCT00256867|515401770|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
142963311|NCT00256867|515401771|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
142963312|NCT00256867|515401772|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
142963313|NCT00256867|515401773|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
142963314|NCT00256867|515401774|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
142963315|NCT00256867|515401775|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
142963316|NCT00256867|515401776|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
142963317|NCT00256867|515401769|FG000|Overall Study|Investigator's Decision|0|||
142963318|NCT00256867|515401770|FG001|Overall Study|Investigator's Decision|0|||
142963319|NCT00256867|515401771|FG002|Overall Study|Investigator's Decision|0|||
142963320|NCT00256867|515401772|FG003|Overall Study|Investigator's Decision|0|||
142963321|NCT00256867|515401773|FG004|Overall Study|Investigator's Decision|1|||
142963322|NCT00256867|515401774|FG005|Overall Study|Investigator's Decision|0|||
142963323|NCT00256867|515401775|FG006|Overall Study|Investigator's Decision|0|||
142963324|NCT00256867|515401776|FG007|Overall Study|Investigator's Decision|0|||
142963325|NCT00256867|515401769|FG000|Overall Study|Non-compliance with study medication|0|||
142963326|NCT00256867|515401770|FG001|Overall Study|Non-compliance with study medication|0|||
142963327|NCT00256867|515401771|FG002|Overall Study|Non-compliance with study medication|0|||
142963328|NCT00256867|515401772|FG003|Overall Study|Non-compliance with study medication|0|||
142963329|NCT00256867|515401773|FG004|Overall Study|Non-compliance with study medication|0|||
142963330|NCT00256867|515401774|FG005|Overall Study|Non-compliance with study medication|0|||
142963331|NCT00256867|515401775|FG006|Overall Study|Non-compliance with study medication|0|||
142963332|NCT00256867|515401776|FG007|Overall Study|Non-compliance with study medication|1|||
142963333|NCT00256867|515401769|FG000|Overall Study|Participant travelled Overseas|0|||
142963334|NCT00256867|515401770|FG001|Overall Study|Participant travelled Overseas|1|||
142963335|NCT00256867|515401771|FG002|Overall Study|Participant travelled Overseas|0|||
142963336|NCT00256867|515401772|FG003|Overall Study|Participant travelled Overseas|0|||
142963337|NCT00256867|515401773|FG004|Overall Study|Participant travelled Overseas|0|||
142963338|NCT00256867|515401774|FG005|Overall Study|Participant travelled Overseas|0|||
142963339|NCT00256867|515401775|FG006|Overall Study|Participant travelled Overseas|0|||
142963340|NCT00256867|515401776|FG007|Overall Study|Participant travelled Overseas|0|||
142963341|NCT00256867|515401769|FG000|Overall Study|Participant out of assessment window|0|||
142963342|NCT00256867|515401770|FG001|Overall Study|Participant out of assessment window|0|||
142963343|NCT00256867|515401771|FG002|Overall Study|Participant out of assessment window|1|||
142963344|NCT00256867|515401772|FG003|Overall Study|Participant out of assessment window|0|||
142963345|NCT00256867|515401773|FG004|Overall Study|Participant out of assessment window|0|||
142963346|NCT00256867|515401774|FG005|Overall Study|Participant out of assessment window|0|||
142963347|NCT00256867|515401775|FG006|Overall Study|Participant out of assessment window|0|||
142963348|NCT00256867|515401776|FG007|Overall Study|Participant out of assessment window|0|||
142963349|NCT00256867|515401769|FG000|Overall Study|Withdrawal by participant|0|||
142963350|NCT00256867|515401770|FG001|Overall Study|Withdrawal by participant|0|||
142963351|NCT00256867|515401771|FG002|Overall Study|Withdrawal by participant|0|||
142963352|NCT00256867|515401772|FG003|Overall Study|Withdrawal by participant|0|||
142963353|NCT00256867|515401773|FG004|Overall Study|Withdrawal by participant|0|||
142963354|NCT00256867|515401774|FG005|Overall Study|Withdrawal by participant|1|||
142963355|NCT00256867|515401775|FG006|Overall Study|Withdrawal by participant|0|||
142963356|NCT00256867|515401776|FG007|Overall Study|Withdrawal by participant|0|||
142963357|NCT05515601|515401781|FG000|Overall Study|Withdrawal by Subject|1|||
142963358|NCT05515601|515401782|FG001|Overall Study|Withdrawal by Subject|3|||
142963359|NCT05515601|515401783|FG002|Overall Study|Withdrawal by Subject|2|||
142963360|NCT05515601|515401784|FG003|Overall Study|Withdrawal by Subject|1|||
142963361|NCT05515601|515401785|FG004|Overall Study|Withdrawal by Subject|1|||
142963362|NCT05515601|515401786|FG005|Overall Study|Withdrawal by Subject|1|||
142963363|NCT05515601|515401781|FG000|Overall Study|Lost to Follow-up|0|||
142963364|NCT05515601|515401782|FG001|Overall Study|Lost to Follow-up|0|||
142963365|NCT05515601|515401783|FG002|Overall Study|Lost to Follow-up|0|||
142963366|NCT05515601|515401784|FG003|Overall Study|Lost to Follow-up|0|||
142963367|NCT05515601|515401785|FG004|Overall Study|Lost to Follow-up|1|||
142963368|NCT05515601|515401786|FG005|Overall Study|Lost to Follow-up|0|||
142963369|NCT00777491|515401787|FG000|Overall Study|Protocol Violation|0|||
142963370|NCT00777491|515401788|FG001|Overall Study|Protocol Violation|2|||
142963371|NCT00777491|515401787|FG000|Overall Study|Did not receive any protocol treatment|2|||
142963372|NCT00777491|515401788|FG001|Overall Study|Did not receive any protocol treatment|0|||
142963373|NCT01912768|515401789|FG000|Overall Study|Adverse Event|2|||
142963374|NCT01912768|515401790|FG001|Overall Study|Adverse Event|0|||
142963375|NCT01912768|515401789|FG000|Overall Study|Lost to Follow-up|2|||
142963376|NCT01912768|515401790|FG001|Overall Study|Lost to Follow-up|1|||
142963377|NCT01912768|515401789|FG000|Overall Study|Withdrawal by Subject|5|||
142963378|NCT01912768|515401790|FG001|Overall Study|Withdrawal by Subject|3|||
142963379|NCT01912768|515401789|FG000|Overall Study|Randomized in error|1|||
142963380|NCT01912768|515401790|FG001|Overall Study|Randomized in error|0|||
142963381|NCT02426658|515401791|FG000|Overall Study|Withdrawal by Subject|1|||
142963382|NCT02426658|515401791|FG000|Overall Study|Patient expired before treatment|2|||
142963383|NCT00524316|515401794|FG000|Overall Study|Withdrawal by Subject|2|||
142963384|NCT00524316|515401794|FG000|Overall Study|Adverse Event|7|||
142963385|NCT00524316|515401794|FG000|Overall Study|Disease Progression|7|||
142963386|NCT04594239|515401802|FG000|Overall Study|Withdrawal by Subject|3|||
142963387|NCT04594239|515401803|FG001|Overall Study|Withdrawal by Subject|4|||
142963388|NCT04594239|515401804|FG002|Overall Study|Withdrawal by Subject|2|||
142963389|NCT04594239|515401805|FG003|Overall Study|Withdrawal by Subject|4|||
142963390|NCT04594239|515401802|FG000|Overall Study|Lost to Follow-up|8|||
142963391|NCT04594239|515401803|FG001|Overall Study|Lost to Follow-up|5|||
142963392|NCT04594239|515401804|FG002|Overall Study|Lost to Follow-up|4|||
142963393|NCT04594239|515401805|FG003|Overall Study|Lost to Follow-up|6|||
142963394|NCT04594239|515401802|FG000|Overall Study|Subject relocated|0|||
142963395|NCT04594239|515401803|FG001|Overall Study|Subject relocated|0|||
142963396|NCT04594239|515401804|FG002|Overall Study|Subject relocated|0|||
142963397|NCT04594239|515401805|FG003|Overall Study|Subject relocated|1|||
142963398|NCT00309777|515401806|FG000|Overall Study|Adverse Event|13|||
142963399|NCT00309777|515401807|FG001|Overall Study|Adverse Event|2|||
142963400|NCT00309777|515401808|FG002|Overall Study|Adverse Event|8|||
142963401|NCT00309777|515401809|FG003|Overall Study|Adverse Event|1|||
142963402|NCT00309777|515401806|FG000|Overall Study|Protocol Violation|4|||
142963403|NCT00309777|515401807|FG001|Overall Study|Protocol Violation|1|||
142963404|NCT00309777|515401808|FG002|Overall Study|Protocol Violation|3|||
142963405|NCT00309777|515401809|FG003|Overall Study|Protocol Violation|1|||
142963406|NCT00309777|515401806|FG000|Overall Study|Withdrawal by Subject|6|||
142963407|NCT00309777|515401807|FG001|Overall Study|Withdrawal by Subject|5|||
142963408|NCT00309777|515401808|FG002|Overall Study|Withdrawal by Subject|7|||
142963409|NCT00309777|515401809|FG003|Overall Study|Withdrawal by Subject|2|||
142963410|NCT00309777|515401806|FG000|Overall Study|Lost to Follow-up|0|||
142963411|NCT00309777|515401807|FG001|Overall Study|Lost to Follow-up|0|||
142963412|NCT00309777|515401808|FG002|Overall Study|Lost to Follow-up|1|||
142963413|NCT00309777|515401809|FG003|Overall Study|Lost to Follow-up|0|||
142963414|NCT00309777|515401806|FG000|Overall Study|Death|0|||
142963415|NCT00309777|515401807|FG001|Overall Study|Death|1|||
142963416|NCT00309777|515401808|FG002|Overall Study|Death|0|||
142963417|NCT00309777|515401809|FG003|Overall Study|Death|0|||
142963418|NCT01575197|515403215|FG000|Overall Study|Migration out of study area|1|||
142963419|NCT01575197|515403216|FG001|Overall Study|Migration out of study area|5|||
142963420|NCT01575197|515403217|FG002|Overall Study|Migration out of study area|4|||
142963421|NCT01575197|515403215|FG000|Overall Study|SAE|0|||
142963422|NCT01575197|515403216|FG001|Overall Study|SAE|1|||
142963423|NCT01575197|515403217|FG002|Overall Study|SAE|0|||
142963424|NCT01575197|515403215|FG000|Overall Study|Lost to Follow-up|0|||
142963425|NCT01575197|515403216|FG001|Overall Study|Lost to Follow-up|1|||
142963426|NCT01575197|515403217|FG002|Overall Study|Lost to Follow-up|0|||
142963427|NCT01575197|515403215|FG000|Overall Study|Withdrawal by Subject|0|||
142963428|NCT01575197|515403216|FG001|Overall Study|Withdrawal by Subject|1|||
142963429|NCT01575197|515403217|FG002|Overall Study|Withdrawal by Subject|1|||
142963430|NCT01575197|515403215|FG000|Overall Study|Protocol Violation|2|||
142963431|NCT01575197|515403216|FG001|Overall Study|Protocol Violation|1|||
142963432|NCT01575197|515403217|FG002|Overall Study|Protocol Violation|1|||
142963433|NCT01030458|515403223|FG000|Overall Study|Lost to Follow-up|9|||
142963434|NCT01030458|515403224|FG001|Overall Study|Lost to Follow-up|10|||
142963435|NCT01030458|515403223|FG000|Overall Study|Withdrawal by Subject|2|||
142963436|NCT01030458|515403224|FG001|Overall Study|Withdrawal by Subject|3|||
142963437|NCT01030458|515403223|FG000|Overall Study|Logistical reasons|9|||
142963438|NCT01030458|515403224|FG001|Overall Study|Logistical reasons|5|||
142963439|NCT01030458|515403223|FG000|Overall Study|Moved or changed job|6|||
142963440|NCT01030458|515403224|FG001|Overall Study|Moved or changed job|13|||
142963441|NCT01030458|515403223|FG000|Overall Study|Side effect of medication|1|||
142963442|NCT01030458|515403224|FG001|Overall Study|Side effect of medication|1|||
142963443|NCT02420223|515403225|FG000|Overall Study|Adverse Event|1|||
142963444|NCT02420223|515403226|FG001|Overall Study|Adverse Event|0|||
142963445|NCT02420223|515403225|FG000|Overall Study|Physician Decision|0|||
142963446|NCT02420223|515403226|FG001|Overall Study|Physician Decision|2|||
142963447|NCT01361009|515403227|FG000|Overall Study|Protocol Violation|116|||
142963448|NCT01826422|515403228|FG000|Overall Study|Withdrawal by Subject|1|||
142963449|NCT01826422|515403229|FG001|Overall Study|Withdrawal by Subject|3|||
142963450|NCT04009096|515403233|FG000|Overall Study|Withdrawal by Subject|0|||
142963451|NCT04009096|515403234|FG001|Overall Study|Withdrawal by Subject|7|||
142963452|NCT04009096|515403235|FG002|Overall Study|Withdrawal by Subject|0|||
142963453|NCT04009096|515403233|FG000|Overall Study|Physician Decision|0|||
142963454|NCT04009096|515403234|FG001|Overall Study|Physician Decision|1|||
142963455|NCT04009096|515403235|FG002|Overall Study|Physician Decision|0|||
142963456|NCT05151471|515403236|FG000|Overall Study|Adverse Event|21|||
142963457|NCT05151471|515403237|FG001|Overall Study|Adverse Event|16|||
142963458|NCT05151471|515403236|FG000|Overall Study|Death|1|||
142963459|NCT05151471|515403237|FG001|Overall Study|Death|0|||
142963460|NCT05151471|515403236|FG000|Overall Study|Lost to Follow-up|0|||
142963461|NCT05151471|515403237|FG001|Overall Study|Lost to Follow-up|1|||
142963462|NCT05151471|515403236|FG000|Overall Study|Withdrawal by Subject|7|||
142963463|NCT05151471|515403237|FG001|Overall Study|Withdrawal by Subject|9|||
142963464|NCT05151471|515403236|FG000|Overall Study|Study terminated by sponsor|49|||
142963465|NCT05151471|515403237|FG001|Overall Study|Study terminated by sponsor|47|||
142963466|NCT05151471|515403236|FG000|Overall Study|Other|2|||
142963467|NCT05151471|515403237|FG001|Overall Study|Other|1|||
142963468|NCT00115349|515403240|FG000|Overall Study|Study closed due to low enrollment.|11|||
142963469|NCT00115349|515403241|FG001|Overall Study|Study closed due to low enrollment.|9|||
142963470|NCT02935634|515403242|FG000|Randomization|Participant withdrew consent|0|||
142963471|NCT02935634|515403243|FG001|Randomization|Participant withdrew consent|1|||
142963472|NCT02935634|515403244|FG002|Randomization|Participant withdrew consent|0|||
142963473|NCT02935634|515403245|FG003|Randomization|Participant withdrew consent|0|||
142963474|NCT02935634|515403246|FG004|Randomization|Participant withdrew consent|0|||
142963475|NCT02935634|515403247|FG005|Randomization|Participant withdrew consent|0|||
142963476|NCT02935634|515403242|FG000|Randomization|Death|2|||
142963477|NCT02935634|515403243|FG001|Randomization|Death|1|||
142963478|NCT02935634|515403244|FG002|Randomization|Death|1|||
142963479|NCT02935634|515403245|FG003|Randomization|Death|0|||
142963480|NCT02935634|515403246|FG004|Randomization|Death|0|||
142963481|NCT02935634|515403247|FG005|Randomization|Death|0|||
142963482|NCT02935634|515403242|FG000|Randomization|Other reasons|0|||
142963483|NCT02935634|515403243|FG001|Randomization|Other reasons|2|||
142963484|NCT02935634|515403244|FG002|Randomization|Other reasons|2|||
142963485|NCT02935634|515403245|FG003|Randomization|Other reasons|0|||
142963486|NCT02935634|515403246|FG004|Randomization|Other reasons|0|||
142963487|NCT02935634|515403247|FG005|Randomization|Other reasons|0|||
142963488|NCT02935634|515403242|FG000|Treatment: Track 1|Disease progression|15|||
142963489|NCT02935634|515403243|FG001|Treatment: Track 1|Disease progression|17|||
142963490|NCT02935634|515403244|FG002|Treatment: Track 1|Disease progression|28|||
142963491|NCT02935634|515403245|FG003|Treatment: Track 1|Disease progression|4|||
142963492|NCT02935634|515403246|FG004|Treatment: Track 1|Disease progression|6|||
142963493|NCT02935634|515403247|FG005|Treatment: Track 1|Disease progression|2|||
142963494|NCT02935634|515403242|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
142963495|NCT02935634|515403243|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
142963496|NCT02935634|515403244|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
142963497|NCT02935634|515403245|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
142963498|NCT02935634|515403246|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
142963499|NCT02935634|515403247|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
142963500|NCT02935634|515403242|FG000|Treatment: Track 1|Lost to Follow-up|1|||
142963501|NCT02935634|515403243|FG001|Treatment: Track 1|Lost to Follow-up|0|||
142963502|NCT02935634|515403244|FG002|Treatment: Track 1|Lost to Follow-up|0|||
142963503|NCT02935634|515403245|FG003|Treatment: Track 1|Lost to Follow-up|0|||
142963504|NCT02935634|515403246|FG004|Treatment: Track 1|Lost to Follow-up|0|||
142963505|NCT02935634|515403247|FG005|Treatment: Track 1|Lost to Follow-up|0|||
142963506|NCT02935634|515403242|FG000|Treatment: Track 1|Study drug toxicity|2|||
142963507|NCT02935634|515403243|FG001|Treatment: Track 1|Study drug toxicity|1|||
142963508|NCT02935634|515403244|FG002|Treatment: Track 1|Study drug toxicity|3|||
142963509|NCT02935634|515403245|FG003|Treatment: Track 1|Study drug toxicity|0|||
142963510|NCT02935634|515403246|FG004|Treatment: Track 1|Study drug toxicity|0|||
142963511|NCT02935634|515403247|FG005|Treatment: Track 1|Study drug toxicity|1|||
142963512|NCT02935634|515403242|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
142963513|NCT02935634|515403243|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
142963514|NCT02935634|515403244|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
142963515|NCT02935634|515403245|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
142963516|NCT02935634|515403246|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
142963517|NCT02935634|515403247|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
142963518|NCT02935634|515403242|FG000|Treatment: Track 1|Participant withdrew consent|2|||
142963519|NCT02935634|515403243|FG001|Treatment: Track 1|Participant withdrew consent|0|||
142963520|NCT02935634|515403244|FG002|Treatment: Track 1|Participant withdrew consent|1|||
142963521|NCT02935634|515403245|FG003|Treatment: Track 1|Participant withdrew consent|0|||
142963522|NCT02935634|515403246|FG004|Treatment: Track 1|Participant withdrew consent|1|||
142963523|NCT02935634|515403247|FG005|Treatment: Track 1|Participant withdrew consent|0|||
142963524|NCT02935634|515403242|FG000|Treatment: Track 1|Other reasons|0|||
142963525|NCT02935634|515403243|FG001|Treatment: Track 1|Other reasons|0|||
142963526|NCT02935634|515403244|FG002|Treatment: Track 1|Other reasons|2|||
142963527|NCT02935634|515403245|FG003|Treatment: Track 1|Other reasons|0|||
142963528|NCT02935634|515403246|FG004|Treatment: Track 1|Other reasons|0|||
142963529|NCT02935634|515403247|FG005|Treatment: Track 1|Other reasons|0|||
142963530|NCT02935634|515403242|FG000|Treatment: Track 2|Disease progression|13|||
142963531|NCT02935634|515403243|FG001|Treatment: Track 2|Disease progression|26|||
142963532|NCT02935634|515403244|FG002|Treatment: Track 2|Disease progression|20|||
142963533|NCT02935634|515403245|FG003|Treatment: Track 2|Disease progression|5|||
142963534|NCT02935634|515403246|FG004|Treatment: Track 2|Disease progression|1|||
142963535|NCT02935634|515403247|FG005|Treatment: Track 2|Disease progression|4|||
142963536|NCT02935634|515403242|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
142963537|NCT02935634|515403243|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
142963538|NCT02935634|515403244|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
142963539|NCT02935634|515403245|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
142963540|NCT02935634|515403246|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
142963541|NCT02935634|515403247|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
142963542|NCT02935634|515403242|FG000|Treatment: Track 2|Study drug toxicity|7|||
142963543|NCT02935634|515403243|FG001|Treatment: Track 2|Study drug toxicity|3|||
142963544|NCT02935634|515403244|FG002|Treatment: Track 2|Study drug toxicity|0|||
142963545|NCT02935634|515403245|FG003|Treatment: Track 2|Study drug toxicity|0|||
142963546|NCT02935634|515403246|FG004|Treatment: Track 2|Study drug toxicity|0|||
142963547|NCT02935634|515403247|FG005|Treatment: Track 2|Study drug toxicity|0|||
142963548|NCT02935634|515403242|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
142963549|NCT02935634|515403243|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
142963550|NCT02935634|515403244|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
142963551|NCT02935634|515403245|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
142963552|NCT02935634|515403246|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
142963553|NCT02935634|515403247|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
142963554|NCT02935634|515403242|FG000|Treatment: Track 2|Participant withdrew consent|0|||
142963555|NCT02935634|515403243|FG001|Treatment: Track 2|Participant withdrew consent|1|||
142963556|NCT02935634|515403244|FG002|Treatment: Track 2|Participant withdrew consent|1|||
142963557|NCT02935634|515403245|FG003|Treatment: Track 2|Participant withdrew consent|0|||
142963558|NCT02935634|515403246|FG004|Treatment: Track 2|Participant withdrew consent|1|||
142963559|NCT02935634|515403247|FG005|Treatment: Track 2|Participant withdrew consent|0|||
142963560|NCT01727713|515403254|FG000|Overall Study|Lost to Follow-up|5|||
142963561|NCT01727713|515403254|FG000|Overall Study|Adverse Event|10|||
142963562|NCT01727713|515403254|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
142963563|NCT01727713|515403254|FG000|Overall Study|Withdrawal by Subject|13|||
142963564|NCT01727713|515403254|FG000|Overall Study|Protocol Deviation|2|||
142963565|NCT00995345|515403256|FG000|Overall Study|Withdrawal by Subject|4|||
142963566|NCT00995345|515403257|FG001|Overall Study|Withdrawal by Subject|2|||
142963567|NCT00995345|515403258|FG002|Overall Study|Withdrawal by Subject|1|||
142963568|NCT00995345|515403259|FG003|Overall Study|Withdrawal by Subject|3|||
142963569|NCT00995345|515403260|FG004|Overall Study|Withdrawal by Subject|1|||
142963570|NCT00995345|515403256|FG000|Overall Study|Adverse Event|3|||
142963571|NCT00995345|515403257|FG001|Overall Study|Adverse Event|1|||
142963572|NCT00995345|515403258|FG002|Overall Study|Adverse Event|2|||
142963573|NCT00995345|515403259|FG003|Overall Study|Adverse Event|0|||
142963574|NCT00995345|515403260|FG004|Overall Study|Adverse Event|1|||
142963575|NCT00995345|515403256|FG000|Overall Study|Lost to Follow-up|2|||
142963576|NCT00995345|515403257|FG001|Overall Study|Lost to Follow-up|2|||
142963577|NCT00995345|515403258|FG002|Overall Study|Lost to Follow-up|2|||
142963578|NCT00995345|515403259|FG003|Overall Study|Lost to Follow-up|1|||
142963579|NCT00995345|515403260|FG004|Overall Study|Lost to Follow-up|0|||
142963580|NCT00995345|515403256|FG000|Overall Study|all other reasons combined|2|||
142963581|NCT00995345|515403257|FG001|Overall Study|all other reasons combined|2|||
142963582|NCT00995345|515403258|FG002|Overall Study|all other reasons combined|2|||
142963583|NCT00995345|515403259|FG003|Overall Study|all other reasons combined|1|||
142963584|NCT00995345|515403260|FG004|Overall Study|all other reasons combined|3|||
142963585|NCT02651194|515403261|FG000|Overall Study|Lost to Follow-up|3|||
142963586|NCT02651194|515403261|FG000|Overall Study|Other|2|||
142963587|NCT01842308|515403262|FG000|Overall Study|Withdrawal by Subject|0|||
142963588|NCT01842308|515403263|FG001|Overall Study|Withdrawal by Subject|0|||
142963589|NCT01842308|515403264|FG002|Overall Study|Withdrawal by Subject|0|||
142963590|NCT01842308|515403265|FG003|Overall Study|Withdrawal by Subject|0|||
142963591|NCT01842308|515403266|FG004|Overall Study|Withdrawal by Subject|1|||
142963592|NCT05122650|515403273|FG000|Overall Study|Adverse Event|4|||
142963593|NCT05122650|515403274|FG001|Overall Study|Adverse Event|16|||
142963594|NCT05122650|515403275|FG002|Overall Study|Adverse Event|11|||
142963595|NCT05122650|515403276|FG003|Overall Study|Adverse Event|12|||
142963596|NCT05122650|515403273|FG000|Overall Study|Lack of Efficacy|0|||
142963597|NCT05122650|515403274|FG001|Overall Study|Lack of Efficacy|1|||
142963598|NCT05122650|515403275|FG002|Overall Study|Lack of Efficacy|1|||
142963599|NCT05122650|515403276|FG003|Overall Study|Lack of Efficacy|2|||
142963600|NCT05122650|515403273|FG000|Overall Study|Lost to Follow-up|1|||
142963601|NCT05122650|515403274|FG001|Overall Study|Lost to Follow-up|1|||
142963602|NCT05122650|515403275|FG002|Overall Study|Lost to Follow-up|3|||
142963603|NCT05122650|515403276|FG003|Overall Study|Lost to Follow-up|0|||
142963604|NCT05122650|515403273|FG000|Overall Study|Non-compliance with study intervention|0|||
142963605|NCT05122650|515403274|FG001|Overall Study|Non-compliance with study intervention|0|||
142963606|NCT05122650|515403275|FG002|Overall Study|Non-compliance with study intervention|0|||
142963607|NCT05122650|515403276|FG003|Overall Study|Non-compliance with study intervention|2|||
142963608|NCT05122650|515403273|FG000|Overall Study|Protocol Violation|0|||
142963609|NCT05122650|515403274|FG001|Overall Study|Protocol Violation|1|||
142963610|NCT05122650|515403275|FG002|Overall Study|Protocol Violation|0|||
142963611|NCT05122650|515403276|FG003|Overall Study|Protocol Violation|1|||
142963612|NCT05122650|515403273|FG000|Overall Study|Randomized by mistake|0|||
142963613|NCT05122650|515403274|FG001|Overall Study|Randomized by mistake|0|||
142963614|NCT05122650|515403275|FG002|Overall Study|Randomized by mistake|3|||
142963615|NCT05122650|515403276|FG003|Overall Study|Randomized by mistake|2|||
142963616|NCT05122650|515403273|FG000|Overall Study|Sponsor request|0|||
142963617|NCT05122650|515403274|FG001|Overall Study|Sponsor request|1|||
142963618|NCT05122650|515403275|FG002|Overall Study|Sponsor request|1|||
142963619|NCT05122650|515403276|FG003|Overall Study|Sponsor request|2|||
142963620|NCT05122650|515403273|FG000|Overall Study|Withdrawal by Subject|3|||
142963621|NCT05122650|515403274|FG001|Overall Study|Withdrawal by Subject|7|||
142963622|NCT05122650|515403275|FG002|Overall Study|Withdrawal by Subject|4|||
142963623|NCT05122650|515403276|FG003|Overall Study|Withdrawal by Subject|8|||
142963624|NCT05122650|515403273|FG000|Overall Study|Other|5|||
142963625|NCT05122650|515403274|FG001|Overall Study|Other|0|||
142963626|NCT05122650|515403275|FG002|Overall Study|Other|0|||
142963627|NCT05122650|515403276|FG003|Overall Study|Other|0|||
142963628|NCT00830037|515403277|FG000|Overall Study|Withdrawal by Subject|2|||
142963629|NCT00830037|515403278|FG001|Overall Study|Withdrawal by Subject|3|||
142963630|NCT00830037|515403277|FG000|Overall Study|Lost to Follow-up|1|||
142963631|NCT00830037|515403278|FG001|Overall Study|Lost to Follow-up|2|||
142963632|NCT00830037|515403277|FG000|Overall Study|Active when terminated by DSMB|15|||
142963633|NCT00830037|515403278|FG001|Overall Study|Active when terminated by DSMB|14|||
142963634|NCT00610935|515403279|FG000|Overall Study|Lost to Follow-up|0|||
142963635|NCT00610935|515403280|FG001|Overall Study|Lost to Follow-up|1|||
142963636|NCT00610935|515403279|FG000|Overall Study|Withdrawal by Subject|0|||
142963637|NCT00610935|515403280|FG001|Overall Study|Withdrawal by Subject|2|||
142963638|NCT00610935|515403279|FG000|Overall Study|Sponsor Discontinuation|1|||
142963639|NCT00610935|515403280|FG001|Overall Study|Sponsor Discontinuation|0|||
142963640|NCT02399813|515403286|FG000|Overall Study|Progressive Disease-Radiographic|2|||
142963641|NCT02399813|515403286|FG000|Overall Study|Death|20|||
142963642|NCT02399813|515403286|FG000|Overall Study|Withdrawal by Subject|3|||
142963643|NCT02399813|515403286|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
142963644|NCT02399813|515403286|FG000|Overall Study|Lost to Follow-up|2|||
142963645|NCT02399813|515403286|FG000|Overall Study|Other than specified|5|||
142963646|NCT00988559|515403287|FG000|Overall Study|Withdrawal by Subject|1|||
142963647|NCT00988559|515403288|FG001|Overall Study|Withdrawal by Subject|1|||
142963648|NCT00988559|515403289|FG002|Overall Study|Withdrawal by Subject|0|||
142963649|NCT00988559|515403290|FG003|Overall Study|Withdrawal by Subject|1|||
142963650|NCT00988559|515403287|FG000|Overall Study|Pregnancy|0|||
142963651|NCT00988559|515403288|FG001|Overall Study|Pregnancy|1|||
142963652|NCT00988559|515403289|FG002|Overall Study|Pregnancy|1|||
142963653|NCT00988559|515403290|FG003|Overall Study|Pregnancy|0|||
142963654|NCT00988559|515403287|FG000|Overall Study|Lost to Follow-up|0|||
142963655|NCT00988559|515403288|FG001|Overall Study|Lost to Follow-up|0|||
142963656|NCT00988559|515403289|FG002|Overall Study|Lost to Follow-up|1|||
142963657|NCT00988559|515403290|FG003|Overall Study|Lost to Follow-up|0|||
142963658|NCT02224846|515403291|FG000|Period 1 (Month 3)|Adverse Event|2|||
142963659|NCT02224846|515403292|FG001|Period 1 (Month 3)|Adverse Event|1|||
142963660|NCT02224846|515403291|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
142963661|NCT02224846|515403292|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
142963662|NCT02224846|515403291|FG000|Period 1 (Month 3)|Protocol Violation|4|||
142963663|NCT02224846|515403292|FG001|Period 1 (Month 3)|Protocol Violation|8|||
142963664|NCT02224846|515403291|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
142963665|NCT02224846|515403292|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
142963666|NCT02224846|515403291|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
142963667|NCT02224846|515403292|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
142963668|NCT02224846|515403291|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
142963669|NCT02224846|515403292|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
142963670|NCT02224846|515403291|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
142963671|NCT02224846|515403292|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
142963672|NCT02224846|515403291|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
142963673|NCT02224846|515403292|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
142963674|NCT02224846|515403291|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
142963675|NCT02224846|515403292|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
142963676|NCT02224846|515403291|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
142963677|NCT02224846|515403292|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
142963678|NCT02224846|515403291|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
142963679|NCT02224846|515403292|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
142963680|NCT02224846|515403291|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
142963681|NCT02224846|515403292|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
142963682|NCT02224846|515403291|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
142963683|NCT02224846|515403292|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
142963684|NCT02224846|515403291|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
142963685|NCT02224846|515403292|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
142963686|NCT02224846|515403291|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
142963687|NCT02224846|515403292|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
142963688|NCT02224846|515403291|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
142963689|NCT02224846|515403292|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
142963690|NCT02224846|515403291|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
142963691|NCT02224846|515403292|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
142963692|NCT03280550|515403293|FG000|Overall Study|Withdrawal by Subject|2|||
142963693|NCT03280550|515403294|FG001|Overall Study|Withdrawal by Subject|2|||
142963694|NCT03280550|515403293|FG000|Overall Study|Physician Decision|0|||
142963695|NCT03280550|515403294|FG001|Overall Study|Physician Decision|1|||
142963696|NCT00496873|515403297|FG000|Overall Study|Ineligible|2|||
142963697|NCT00496873|515403297|FG000|Overall Study|Death|2|||
142963698|NCT00496873|515403297|FG000|Overall Study|Withdrawal by Subject|3|||
142963699|NCT00748540|515403298|FG000|Overall Study|Physician Decision|1|||
142963700|NCT01842620|515403300|FG000|Period 1|Withdrawal by Subject|1|||
142963701|NCT01842620|515403301|FG001|Period 1|Withdrawal by Subject|0|||
142963702|NCT02739594|515403302|FG000|Overall Study|Undesired Event|3|||
142963703|NCT02739594|515403303|FG001|Overall Study|Undesired Event|4|||
142963704|NCT02739594|515403302|FG000|Overall Study|Violation of Eligibility Criteria|1|||
142963705|NCT02739594|515403303|FG001|Overall Study|Violation of Eligibility Criteria|2|||
142963706|NCT02739594|515403302|FG000|Overall Study|Protocol Violation|5|||
142963707|NCT02739594|515403303|FG001|Overall Study|Protocol Violation|6|||
142963708|NCT02739594|515403302|FG000|Overall Study|Death|4|||
142963709|NCT02739594|515403303|FG001|Overall Study|Death|2|||
142963710|NCT02739594|515403302|FG000|Overall Study|Renal Insufficiency|4|||
142963711|NCT02739594|515403303|FG001|Overall Study|Renal Insufficiency|6|||
142963712|NCT02739594|515403302|FG000|Overall Study|Administrative Reasons|1|||
142963713|NCT02739594|515403303|FG001|Overall Study|Administrative Reasons|3|||
142963714|NCT02739594|515403302|FG000|Overall Study|Withdrawal by Subject|1|||
142963715|NCT02739594|515403303|FG001|Overall Study|Withdrawal by Subject|1|||
142963716|NCT02739594|515403302|FG000|Overall Study|Lost to Follow-up|0|||
142963717|NCT02739594|515403303|FG001|Overall Study|Lost to Follow-up|1|||
142963718|NCT02739594|515403302|FG000|Overall Study|Elevated Serum Creatinine|0|||
142963719|NCT02739594|515403303|FG001|Overall Study|Elevated Serum Creatinine|1|||
142963720|NCT02739594|515403302|FG000|Overall Study|Other|6|||
142963721|NCT02739594|515403303|FG001|Overall Study|Other|2|||
142963722|NCT01511419|515403308|FG000|Dose 2|Physician Decision|1|||
142963723|NCT01511419|515403309|FG001|Dose 2|Physician Decision|0|||
143117145|NCT01273155|515970039|FG001|Overall Study|Died during Cycle 1|0|||
142963724|NCT02065622|515403310|FG000|Induction Study|Adverse Event|13|||
142963725|NCT02065622|515403311|FG001|Induction Study|Adverse Event|19|||
142963726|NCT02065622|515403312|FG002|Induction Study|Adverse Event|0|||
142963727|NCT02065622|515403313|FG003|Induction Study|Adverse Event|0|||
142963728|NCT02065622|515403314|FG004|Induction Study|Adverse Event|0|||
142963729|NCT02065622|515403310|FG000|Induction Study|Withdrawal by Subject|3|||
142963730|NCT02065622|515403311|FG001|Induction Study|Withdrawal by Subject|5|||
142963731|NCT02065622|515403312|FG002|Induction Study|Withdrawal by Subject|0|||
142963732|NCT02065622|515403313|FG003|Induction Study|Withdrawal by Subject|0|||
142963733|NCT02065622|515403314|FG004|Induction Study|Withdrawal by Subject|0|||
142963734|NCT02065622|515403310|FG000|Induction Study|Lost to Follow-up|1|||
142963735|NCT02065622|515403311|FG001|Induction Study|Lost to Follow-up|0|||
142963736|NCT02065622|515403312|FG002|Induction Study|Lost to Follow-up|0|||
142963737|NCT02065622|515403313|FG003|Induction Study|Lost to Follow-up|0|||
142963738|NCT02065622|515403314|FG004|Induction Study|Lost to Follow-up|0|||
142963739|NCT02065622|515403310|FG000|Induction Study|Lack of Efficacy|22|||
142963740|NCT02065622|515403311|FG001|Induction Study|Lack of Efficacy|27|||
142963741|NCT02065622|515403312|FG002|Induction Study|Lack of Efficacy|0|||
142963742|NCT02065622|515403313|FG003|Induction Study|Lack of Efficacy|0|||
142963743|NCT02065622|515403314|FG004|Induction Study|Lack of Efficacy|0|||
142963744|NCT02065622|515403310|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
142963745|NCT02065622|515403311|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
142963746|NCT02065622|515403312|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
142963747|NCT02065622|515403313|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
142963748|NCT02065622|515403314|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
142963749|NCT02065622|515403310|FG000|Induction Study|Subject Noncompliance|1|||
142963750|NCT02065622|515403311|FG001|Induction Study|Subject Noncompliance|1|||
142963751|NCT02065622|515403312|FG002|Induction Study|Subject Noncompliance|0|||
142963752|NCT02065622|515403313|FG003|Induction Study|Subject Noncompliance|0|||
142963753|NCT02065622|515403314|FG004|Induction Study|Subject Noncompliance|0|||
142963754|NCT02065622|515403310|FG000|Induction Study|Other, Not Specified|3|||
142963755|NCT02065622|515403311|FG001|Induction Study|Other, Not Specified|2|||
142963756|NCT02065622|515403312|FG002|Induction Study|Other, Not Specified|0|||
142963757|NCT02065622|515403313|FG003|Induction Study|Other, Not Specified|0|||
142963758|NCT02065622|515403314|FG004|Induction Study|Other, Not Specified|0|||
142963759|NCT02065622|515403310|FG000|Maintenance Study|Adverse Event|0|||
142963760|NCT02065622|515403311|FG001|Maintenance Study|Adverse Event|0|||
142963761|NCT02065622|515403312|FG002|Maintenance Study|Adverse Event|25|||
142963762|NCT02065622|515403313|FG003|Maintenance Study|Adverse Event|22|||
142963763|NCT02065622|515403314|FG004|Maintenance Study|Adverse Event|11|||
142963764|NCT02065622|515403310|FG000|Maintenance Study|Withdrawal by Subject|0|||
142963765|NCT02065622|515403311|FG001|Maintenance Study|Withdrawal by Subject|0|||
142963766|NCT02065622|515403312|FG002|Maintenance Study|Withdrawal by Subject|11|||
142963767|NCT02065622|515403313|FG003|Maintenance Study|Withdrawal by Subject|5|||
142963768|NCT02065622|515403314|FG004|Maintenance Study|Withdrawal by Subject|7|||
142963769|NCT02065622|515403310|FG000|Maintenance Study|Lost to Follow-up|0|||
142963770|NCT02065622|515403311|FG001|Maintenance Study|Lost to Follow-up|0|||
142963771|NCT02065622|515403312|FG002|Maintenance Study|Lost to Follow-up|4|||
142963772|NCT02065622|515403313|FG003|Maintenance Study|Lost to Follow-up|1|||
142963773|NCT02065622|515403314|FG004|Maintenance Study|Lost to Follow-up|1|||
142963774|NCT02065622|515403310|FG000|Maintenance Study|Lack of Efficacy|0|||
142963775|NCT02065622|515403311|FG001|Maintenance Study|Lack of Efficacy|0|||
142963776|NCT02065622|515403312|FG002|Maintenance Study|Lack of Efficacy|70|||
142963777|NCT02065622|515403313|FG003|Maintenance Study|Lack of Efficacy|55|||
142963778|NCT02065622|515403314|FG004|Maintenance Study|Lack of Efficacy|19|||
142963779|NCT02065622|515403310|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
142963780|NCT02065622|515403311|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
142963781|NCT02065622|515403312|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
142963782|NCT02065622|515403313|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
142963783|NCT02065622|515403314|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
142963784|NCT02065622|515403310|FG000|Maintenance Study|Subject Non-Compliance|0|||
142963785|NCT02065622|515403311|FG001|Maintenance Study|Subject Non-Compliance|0|||
142963786|NCT02065622|515403312|FG002|Maintenance Study|Subject Non-Compliance|1|||
142963787|NCT02065622|515403313|FG003|Maintenance Study|Subject Non-Compliance|3|||
142963788|NCT02065622|515403314|FG004|Maintenance Study|Subject Non-Compliance|2|||
142963789|NCT02065622|515403310|FG000|Maintenance Study|Other, Not Specified|0|||
142963790|NCT02065622|515403311|FG001|Maintenance Study|Other, Not Specified|0|||
142963791|NCT02065622|515403312|FG002|Maintenance Study|Other, Not Specified|6|||
142963792|NCT02065622|515403313|FG003|Maintenance Study|Other, Not Specified|14|||
142963793|NCT02065622|515403314|FG004|Maintenance Study|Other, Not Specified|2|||
142963794|NCT02065622|515403310|FG000|Maintenance Study|Unknown Reason|0|||
142963795|NCT02065622|515403311|FG001|Maintenance Study|Unknown Reason|0|||
142963796|NCT02065622|515403312|FG002|Maintenance Study|Unknown Reason|0|||
142963797|NCT02065622|515403313|FG003|Maintenance Study|Unknown Reason|1|||
142963798|NCT02065622|515403314|FG004|Maintenance Study|Unknown Reason|0|||
142963799|NCT04973228|515403315|FG000|Overall Study|Adverse Event|2|||
142963800|NCT04973228|515403316|FG001|Overall Study|Adverse Event|3|||
142963801|NCT04973228|515403315|FG000|Overall Study|Lack of Efficacy|1|||
142963802|NCT04973228|515403316|FG001|Overall Study|Lack of Efficacy|3|||
142963803|NCT04973228|515403315|FG000|Overall Study|Lost to Follow-up|12|||
142963804|NCT04973228|515403316|FG001|Overall Study|Lost to Follow-up|4|||
142963805|NCT04973228|515403315|FG000|Overall Study|Withdrawal by Subject|11|||
142963806|NCT04973228|515403316|FG001|Overall Study|Withdrawal by Subject|4|||
142963807|NCT04973228|515403315|FG000|Overall Study|Did not tolerate application|1|||
142963808|NCT04973228|515403316|FG001|Overall Study|Did not tolerate application|0|||
142963809|NCT04973228|515403315|FG000|Overall Study|Wanted to early terminate and use own product|0|||
142963810|NCT04973228|515403316|FG001|Overall Study|Wanted to early terminate and use own product|1|||
142963811|NCT04973228|515403315|FG000|Overall Study|Missed visits due to new work schedule|1|||
142963812|NCT04973228|515403316|FG001|Overall Study|Missed visits due to new work schedule|0|||
142963813|NCT02678780|515403317|FG000|Overall Study|Adverse Event|11|||
142963814|NCT02678780|515403318|FG001|Overall Study|Adverse Event|14|||
142963815|NCT02678780|515403317|FG000|Overall Study|Withdrawal by Subject|2|||
142963816|NCT02678780|515403318|FG001|Overall Study|Withdrawal by Subject|1|||
142963817|NCT02678780|515403317|FG000|Overall Study|Sponsor discontinuation|7|||
142963818|NCT02678780|515403318|FG001|Overall Study|Sponsor discontinuation|4|||
142963819|NCT02678780|515403317|FG000|Overall Study|Death|1|||
142963820|NCT02678780|515403318|FG001|Overall Study|Death|1|||
142963821|NCT02678780|515403317|FG000|Overall Study|Other|6|||
142963822|NCT02678780|515403318|FG001|Overall Study|Other|8|||
142963823|NCT00091390|515403332|FG000|Overall Study|Protocol Violation|1|||
142963824|NCT00091390|515403332|FG000|Overall Study|No protocol treatment|3|||
142963825|NCT03229759|515403340|FG000|Overall Study|Screen Failure|30|||
142963826|NCT03364335|515404756|FG000|Overall Study|Adverse Event|3|||
142963827|NCT03364335|515404757|FG001|Overall Study|Adverse Event|4|||
142963828|NCT03364335|515404758|FG002|Overall Study|Adverse Event|1|||
142963829|NCT03364335|515404759|FG003|Overall Study|Adverse Event|2|||
142963830|NCT03364335|515404760|FG004|Overall Study|Adverse Event|0|||
142963831|NCT03364335|515404756|FG000|Overall Study|Lost to Follow-up|7|||
142963832|NCT03364335|515404757|FG001|Overall Study|Lost to Follow-up|7|||
142963833|NCT03364335|515404758|FG002|Overall Study|Lost to Follow-up|10|||
142963834|NCT03364335|515404759|FG003|Overall Study|Lost to Follow-up|11|||
142963835|NCT03364335|515404760|FG004|Overall Study|Lost to Follow-up|11|||
142963836|NCT03725202|515404761|FG000|Period 1 (Baseline - Week 52)|Adverse Event|13|||
142963837|NCT03725202|515404762|FG001|Period 1 (Baseline - Week 52)|Adverse Event|11|||
142963838|NCT03725202|515404763|FG002|Period 1 (Baseline - Week 52)|Adverse Event|17|||
142963839|NCT03725202|515404764|FG003|Period 1 (Baseline - Week 52)|Adverse Event|0|||
142963840|NCT03725202|515404765|FG004|Period 1 (Baseline - Week 52)|Adverse Event|0|||
142963841|NCT03725202|515404766|FG005|Period 1 (Baseline - Week 52)|Adverse Event|0|||
142963842|NCT03725202|515404767|FG006|Period 1 (Baseline - Week 52)|Adverse Event|0|||
142963843|NCT03725202|515404768|FG007|Period 1 (Baseline - Week 52)|Adverse Event|0|||
142963844|NCT03725202|515404761|FG000|Period 1 (Baseline - Week 52)|Withdrew consent|5|||
142963845|NCT03725202|515404762|FG001|Period 1 (Baseline - Week 52)|Withdrew consent|6|||
142963846|NCT03725202|515404763|FG002|Period 1 (Baseline - Week 52)|Withdrew consent|10|||
142963847|NCT03725202|515404764|FG003|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
142963848|NCT03725202|515404765|FG004|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
142963849|NCT03725202|515404766|FG005|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
142963850|NCT03725202|515404767|FG006|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
142963851|NCT03725202|515404768|FG007|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
142963852|NCT03725202|515404761|FG000|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|1|||
142963853|NCT03725202|515404762|FG001|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
142963854|NCT03725202|515404763|FG002|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
142963855|NCT03725202|515404764|FG003|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
142963856|NCT03725202|515404765|FG004|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
142963857|NCT03725202|515404766|FG005|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
142963858|NCT03725202|515404767|FG006|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
142963859|NCT03725202|515404768|FG007|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
142963860|NCT03725202|515404761|FG000|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|2|||
142963861|NCT03725202|515404762|FG001|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
142963862|NCT03725202|515404763|FG002|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
142963863|NCT03725202|515404764|FG003|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
142963864|NCT03725202|515404765|FG004|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
142963865|NCT03725202|515404766|FG005|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
142963866|NCT03725202|515404767|FG006|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
142963867|NCT03725202|515404768|FG007|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
142963868|NCT03725202|515404761|FG000|Period 1 (Baseline - Week 52)|Other, not specified|5|||
142963869|NCT03725202|515404762|FG001|Period 1 (Baseline - Week 52)|Other, not specified|5|||
142963870|NCT03725202|515404763|FG002|Period 1 (Baseline - Week 52)|Other, not specified|5|||
142963871|NCT03725202|515404764|FG003|Period 1 (Baseline - Week 52)|Other, not specified|0|||
142963872|NCT03725202|515404765|FG004|Period 1 (Baseline - Week 52)|Other, not specified|0|||
142963873|NCT03725202|515404766|FG005|Period 1 (Baseline - Week 52)|Other, not specified|0|||
142963874|NCT03725202|515404767|FG006|Period 1 (Baseline - Week 52)|Other, not specified|0|||
143003124|NCT01049360|515548756|FG012|Period 2|Protocol Violation|0|||
142963875|NCT03725202|515404768|FG007|Period 1 (Baseline - Week 52)|Other, not specified|0|||
142963876|NCT03725202|515404761|FG000|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
142963877|NCT03725202|515404762|FG001|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
142963878|NCT03725202|515404763|FG002|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|1|||
142963879|NCT03725202|515404764|FG003|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
142963880|NCT03725202|515404765|FG004|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
142963881|NCT03725202|515404766|FG005|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
142963882|NCT03725202|515404767|FG006|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
142963883|NCT03725202|515404768|FG007|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
142963884|NCT03725202|515404761|FG000|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
142963885|NCT03725202|515404762|FG001|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
142963886|NCT03725202|515404763|FG002|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
142963887|NCT03725202|515404764|FG003|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|19|||
142963888|NCT03725202|515404765|FG004|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|11|||
142963889|NCT03725202|515404766|FG005|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|2|||
142963890|NCT03725202|515404767|FG006|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|27|||
142963891|NCT03725202|515404768|FG007|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|8|||
142963892|NCT03725202|515404761|FG000|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
142963893|NCT03725202|515404762|FG001|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
142963894|NCT03725202|515404763|FG002|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
142963895|NCT03725202|515404764|FG003|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
142963896|NCT03725202|515404765|FG004|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
142963897|NCT03725202|515404766|FG005|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
142963898|NCT03725202|515404767|FG006|Period 2 (Week 52 - Week 104)|Adverse Event|4|||
142963899|NCT03725202|515404768|FG007|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
142963900|NCT03725202|515404761|FG000|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
142963901|NCT03725202|515404762|FG001|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
142963902|NCT03725202|515404763|FG002|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
142963903|NCT03725202|515404764|FG003|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
142963904|NCT03725202|515404765|FG004|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
142963905|NCT03725202|515404766|FG005|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
142963906|NCT03725202|515404767|FG006|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
142963907|NCT03725202|515404768|FG007|Period 2 (Week 52 - Week 104)|Withdrew consent|2|||
142963908|NCT03725202|515404761|FG000|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
142963909|NCT03725202|515404762|FG001|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
142963910|NCT03725202|515404763|FG002|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
142963911|NCT03725202|515404764|FG003|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
142963912|NCT03725202|515404765|FG004|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
142963913|NCT03725202|515404766|FG005|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
142963914|NCT03725202|515404767|FG006|Period 2 (Week 52 - Week 104)|Lost to Follow-up|1|||
142963915|NCT03725202|515404768|FG007|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
142963916|NCT03725202|515404761|FG000|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
142963917|NCT03725202|515404762|FG001|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
142963918|NCT03725202|515404763|FG002|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
142963919|NCT03725202|515404764|FG003|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
142963920|NCT03725202|515404765|FG004|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
142963921|NCT03725202|515404766|FG005|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|1|||
142963922|NCT03725202|515404767|FG006|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
142963923|NCT03725202|515404768|FG007|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
142963924|NCT03725202|515404761|FG000|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
142963925|NCT03725202|515404762|FG001|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
142963926|NCT03725202|515404763|FG002|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
142963927|NCT03725202|515404764|FG003|Period 2 (Week 52 - Week 104)|Other, not specified|2|||
142963928|NCT03725202|515404765|FG004|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
142963929|NCT03725202|515404766|FG005|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
142963930|NCT03725202|515404767|FG006|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
142963931|NCT03725202|515404768|FG007|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
142963932|NCT04281030|515404773|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
142963933|NCT04281030|515404774|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
142963934|NCT04281030|515404773|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
142963935|NCT04281030|515404774|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
142963936|NCT00782418|515404777|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
142963937|NCT00782418|515404778|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
142963938|NCT00782418|515404779|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
142963939|NCT00782418|515404780|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
142963940|NCT00782418|515404781|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
142963941|NCT00782418|515404782|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
142963942|NCT00782418|515404783|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
142963943|NCT00782418|515404777|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
142963944|NCT00782418|515404778|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
142963945|NCT00782418|515404779|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
142963946|NCT00782418|515404780|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
142963947|NCT00782418|515404781|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
142963948|NCT00782418|515404782|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
142963949|NCT00782418|515404783|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
142963950|NCT01718509|515404786|FG000|Overall Study|Lost to Follow-up|18|||
142963951|NCT01718509|515404787|FG001|Overall Study|Lost to Follow-up|15|||
142963952|NCT01718509|515404786|FG000|Overall Study|Withdrawal by Subject|7|||
142963953|NCT01718509|515404787|FG001|Overall Study|Withdrawal by Subject|13|||
142963954|NCT01718509|515404786|FG000|Overall Study|Adverse Event|5|||
142963955|NCT01718509|515404787|FG001|Overall Study|Adverse Event|7|||
142963956|NCT01718509|515404786|FG000|Overall Study|Other|13|||
142963957|NCT01718509|515404787|FG001|Overall Study|Other|11|||
142963958|NCT01718509|515404786|FG000|Overall Study|Protocol Violation|4|||
142963959|NCT01718509|515404787|FG001|Overall Study|Protocol Violation|2|||
142963960|NCT01718509|515404786|FG000|Overall Study|Lack of Efficacy|1|||
142963961|NCT01718509|515404787|FG001|Overall Study|Lack of Efficacy|0|||
142963962|NCT01219959|515404790|FG000|Overall Study|Adverse Event|6|||
142963963|NCT01219959|515404791|FG001|Overall Study|Adverse Event|14|||
142963964|NCT01219959|515404790|FG000|Overall Study|Physician Decision|0|||
142963965|NCT01219959|515404791|FG001|Overall Study|Physician Decision|4|||
142963966|NCT01219959|515404790|FG000|Overall Study|Withdrawal by Subject|0|||
142963967|NCT01219959|515404791|FG001|Overall Study|Withdrawal by Subject|2|||
142963968|NCT01219959|515404790|FG000|Overall Study|Renal Transplantation|0|||
142963969|NCT01219959|515404791|FG001|Overall Study|Renal Transplantation|3|||
142963970|NCT01219959|515404790|FG000|Overall Study|Other|1|||
142963971|NCT01219959|515404791|FG001|Overall Study|Other|0|||
142963972|NCT05906732|515404792|FG000|Overall Study|Withdrawal by Subject|1|||
142963973|NCT05906732|515404793|FG001|Overall Study|Withdrawal by Subject|0|||
142963974|NCT05906732|515404794|FG002|Overall Study|Withdrawal by Subject|0|||
142963975|NCT05906732|515404795|FG003|Overall Study|Withdrawal by Subject|0|||
142963976|NCT05906732|515404792|FG000|Overall Study|Physician Decision|2|||
142963977|NCT05906732|515404793|FG001|Overall Study|Physician Decision|4|||
142963978|NCT05906732|515404794|FG002|Overall Study|Physician Decision|0|||
142963979|NCT05906732|515404795|FG003|Overall Study|Physician Decision|0|||
142963980|NCT01980706|515404800|FG000|Overall Study|Withdrawal by Subject|9|||
142963981|NCT01980706|515404801|FG001|Overall Study|Withdrawal by Subject|6|||
142963982|NCT01980706|515404802|FG002|Overall Study|Withdrawal by Subject|2|||
142963983|NCT01980706|515404800|FG000|Overall Study|Adverse Event|1|||
142963984|NCT01980706|515404801|FG001|Overall Study|Adverse Event|2|||
142963985|NCT01980706|515404802|FG002|Overall Study|Adverse Event|5|||
142963986|NCT01980706|515404800|FG000|Overall Study|Lost to Follow-up|3|||
142963987|NCT01980706|515404801|FG001|Overall Study|Lost to Follow-up|4|||
142963988|NCT01980706|515404802|FG002|Overall Study|Lost to Follow-up|3|||
142963989|NCT01980706|515404800|FG000|Overall Study|miscellaneous|4|||
142963990|NCT01980706|515404801|FG001|Overall Study|miscellaneous|5|||
142963991|NCT01980706|515404802|FG002|Overall Study|miscellaneous|3|||
142963992|NCT04171037|515404807|FG000|Overall Study|Lost to Follow-up|1|||
142963993|NCT04171037|515404808|FG001|Overall Study|Lost to Follow-up|0|||
142963994|NCT04171037|515404807|FG000|Overall Study|Physician Decision|3|||
142963995|NCT04171037|515404808|FG001|Overall Study|Physician Decision|3|||
142963996|NCT00987623|515404811|FG000|Overall Study|Lost to Follow-up|2|||
142963997|NCT00987623|515404812|FG001|Overall Study|Lost to Follow-up|1|||
142963998|NCT00987623|515404811|FG000|Overall Study|Time/job conflict|2|||
142963999|NCT00987623|515404812|FG001|Overall Study|Time/job conflict|0|||
142964000|NCT00987623|515404811|FG000|Overall Study|Discomfort|1|||
142964001|NCT00987623|515404812|FG001|Overall Study|Discomfort|0|||
142964002|NCT00987623|515404811|FG000|Overall Study|Biomicroscopy|0|||
142964003|NCT00987623|515404812|FG001|Overall Study|Biomicroscopy|1|||
142964004|NCT00987623|515404811|FG000|Overall Study|Influenza|0|||
142964005|NCT00987623|515404812|FG001|Overall Study|Influenza|1|||
142964006|NCT01864018|515404814|FG000|Overall Study|Ineligible|3|||
142964007|NCT01864018|515404815|FG001|Overall Study|Ineligible|1|||
142964008|NCT04056455|515404816|FG000|Overall Study|Adverse Event|1|||
142964009|NCT04056455|515404817|FG001|Overall Study|Adverse Event|0|||
142964010|NCT03521687|515404819|FG000|Overall Study|Adverse Event|4|||
142964011|NCT03521687|515404819|FG000|Overall Study|Physician Decision|1|||
142964012|NCT04891770|515404823|FG000|Overall Study|Withdrew consent|1|||
142964013|NCT04891770|515404824|FG001|Overall Study|Withdrew consent|3|||
142964014|NCT04891770|515404825|FG002|Overall Study|Withdrew consent|0|||
142964015|NCT04891770|515404823|FG000|Overall Study|Enrolled but never treated|0|||
142964016|NCT04891770|515404824|FG001|Overall Study|Enrolled but never treated|0|||
143003125|NCT01049360|515548757|FG013|Period 2|Protocol Violation|0|||
142964017|NCT04891770|515404825|FG002|Overall Study|Enrolled but never treated|1|||
142964018|NCT04891770|515404823|FG000|Overall Study|Investigator's discretion|0|||
142964019|NCT04891770|515404824|FG001|Overall Study|Investigator's discretion|1|||
142964020|NCT04891770|515404825|FG002|Overall Study|Investigator's discretion|0|||
142964021|NCT01952834|515404826|FG000|Overall Study|Adverse Event|1|||
142964022|NCT05091060|515404827|FG000|Overall Study|Lost to Follow-up|1|||
142964023|NCT00527111|515404829|FG000|Overall Study|Adverse Event|14|||
142964024|NCT00527111|515404830|FG001|Overall Study|Adverse Event|13|||
142964025|NCT00527111|515404829|FG000|Overall Study|Death|0|||
142964026|NCT00527111|515404830|FG001|Overall Study|Death|1|||
142964027|NCT00527111|515404829|FG000|Overall Study|Investigator Request|2|||
142964028|NCT00527111|515404830|FG001|Overall Study|Investigator Request|1|||
142964029|NCT00527111|515404829|FG000|Overall Study|Patient Request|2|||
142964030|NCT00527111|515404830|FG001|Overall Study|Patient Request|5|||
142964031|NCT00527111|515404829|FG000|Overall Study|Other|2|||
142964032|NCT00527111|515404830|FG001|Overall Study|Other|2|||
142964033|NCT01477892|515404831|FG000|Overall Study|Withdrawal by Subject|0|||
142964034|NCT01477892|515404832|FG001|Overall Study|Withdrawal by Subject|2|||
142964035|NCT01921257|515404833|FG000|Overall Study|Adverse Event|1|||
142964036|NCT01921257|515404833|FG000|Overall Study|Protocol Violation|1|||
142964037|NCT01921257|515404833|FG000|Overall Study|Withdrawal by Subject|1|||
142964038|NCT01689207|515404834|FG000|Overall Study|Adverse Event|0|||
142964039|NCT01689207|515404835|FG001|Overall Study|Adverse Event|1|||
142964040|NCT01689207|515404836|FG002|Overall Study|Adverse Event|0|||
142964041|NCT01689207|515404837|FG003|Overall Study|Adverse Event|0|||
142964042|NCT01689207|515404838|FG004|Overall Study|Adverse Event|2|||
142964043|NCT01689207|515404839|FG005|Overall Study|Adverse Event|1|||
142964044|NCT01689207|515404840|FG006|Overall Study|Adverse Event|0|||
142964045|NCT01689207|515404841|FG007|Overall Study|Adverse Event|0|||
142964046|NCT01689207|515404842|FG008|Overall Study|Adverse Event|1|||
142964047|NCT01689207|515404843|FG009|Overall Study|Adverse Event|0|||
142964048|NCT01689207|515404844|FG010|Overall Study|Adverse Event|0|||
142964049|NCT00364845|515404845|FG000|Overall Study|Adverse Event|1|||
142964050|NCT00364845|515404846|FG001|Overall Study|Adverse Event|0|||
142964051|NCT00364845|515404845|FG000|Overall Study|Withdrawal by Subject|2|||
142964052|NCT00364845|515404846|FG001|Overall Study|Withdrawal by Subject|1|||
142964053|NCT00364845|515404845|FG000|Overall Study|Physician Decision|8|||
142964054|NCT00364845|515404846|FG001|Overall Study|Physician Decision|8|||
142964055|NCT00364845|515404845|FG000|Overall Study|Lost to Follow-up|0|||
142964056|NCT00364845|515404846|FG001|Overall Study|Lost to Follow-up|1|||
142964057|NCT00364845|515404845|FG000|Overall Study|Death|0|||
142964058|NCT00364845|515404846|FG001|Overall Study|Death|1|||
142964059|NCT01199263|515404847|FG000|Overall Study|Ineligible|0|||
142964060|NCT01199263|515404848|FG001|Overall Study|Ineligible|2|||
142964061|NCT01199263|515404847|FG000|Overall Study|Never Treated|6|||
142964062|NCT01199263|515404848|FG001|Overall Study|Never Treated|0|||
142964063|NCT00488033|515404849|FG000|Overall Study|Withdrawal by Subject|1|||
142964064|NCT00488033|515404850|FG001|Overall Study|Withdrawal by Subject|0|||
142964065|NCT03255291|515404851|FG000|Overall Study|Determined to be ineligible|10|||
142964066|NCT03255291|515404852|FG001|Overall Study|Determined to be ineligible|12|||
142964067|NCT03255291|515404853|FG002|Overall Study|Determined to be ineligible|6|||
142964068|NCT03255291|515404854|FG003|Overall Study|Determined to be ineligible|6|||
142964069|NCT03255291|515404855|FG004|Overall Study|Determined to be ineligible|5|||
142964070|NCT03255291|515404856|FG005|Overall Study|Determined to be ineligible|10|||
142964071|NCT03255291|515404851|FG000|Overall Study|Baseline data collection issues|3|||
142964072|NCT03255291|515404852|FG001|Overall Study|Baseline data collection issues|0|||
142964073|NCT03255291|515404853|FG002|Overall Study|Baseline data collection issues|0|||
142964074|NCT03255291|515404854|FG003|Overall Study|Baseline data collection issues|0|||
142964075|NCT03255291|515404855|FG004|Overall Study|Baseline data collection issues|2|||
142964076|NCT03255291|515404856|FG005|Overall Study|Baseline data collection issues|0|||
142964077|NCT01515306|515404857|FG000|Overall Study|Adverse Event|3|||
142964078|NCT01515306|515404858|FG001|Overall Study|Adverse Event|2|||
142964079|NCT01515306|515404857|FG000|Overall Study|Progressive Disease|19|||
142964080|NCT01515306|515404858|FG001|Overall Study|Progressive Disease|9|||
142964081|NCT01515306|515404857|FG000|Overall Study|Withdrawal by Subject|1|||
142964082|NCT01515306|515404858|FG001|Overall Study|Withdrawal by Subject|2|||
142964083|NCT01515306|515404857|FG000|Overall Study|Physician Decision|1|||
142964084|NCT01515306|515404858|FG001|Overall Study|Physician Decision|1|||
142964085|NCT03591146|515404869|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
142964086|NCT03591146|515404870|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
142964087|NCT03591146|515404871|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
142964088|NCT03591146|515404872|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
142964089|NCT03591146|515404873|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
142964090|NCT03591146|515404869|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
142964091|NCT03591146|515404870|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
142964092|NCT03591146|515404871|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
142964093|NCT03591146|515404872|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
142964094|NCT03591146|515404873|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
142964095|NCT03591146|515404869|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
142964096|NCT03591146|515404870|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
142964097|NCT03591146|515404871|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
142964098|NCT03591146|515404872|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
142964099|NCT03591146|515404873|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
142964100|NCT03591146|515404869|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
142964101|NCT03591146|515404870|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
142964102|NCT03591146|515404871|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
142964103|NCT03591146|515404872|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
142964104|NCT03591146|515404873|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
142964105|NCT04737031|515404874|FG000|Overall Study|Patients who did not have a treatment visit|0|||
142964106|NCT04737031|515404875|FG001|Overall Study|Patients who did not have a treatment visit|31|||
142964107|NCT04737031|515404876|FG002|Overall Study|Patients who did not have a treatment visit|93|||
142964108|NCT04737031|515404877|FG003|Overall Study|Patients who did not have a treatment visit|227|||
142964109|NCT04369430|515404878|FG000|Overall Study|Adverse Event|2|||
142964110|NCT04369430|515404879|FG001|Overall Study|Adverse Event|3|||
142964111|NCT04369430|515404878|FG000|Overall Study|Death|1|||
142964112|NCT04369430|515404879|FG001|Overall Study|Death|0|||
142964113|NCT04369430|515404878|FG000|Overall Study|Withdrawal by Subject|4|||
142964114|NCT04369430|515404879|FG001|Overall Study|Withdrawal by Subject|3|||
142964115|NCT04369430|515404878|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
142964116|NCT04369430|515404879|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
142964117|NCT04369430|515404878|FG000|Overall Study|Lost to Follow-up|0|||
142964118|NCT04369430|515404879|FG001|Overall Study|Lost to Follow-up|1|||
142964119|NCT00444626|515404884|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
142964120|NCT00444626|515404884|FG000|Initial Treatment Period|Adverse Event|1|||
142964121|NCT00444626|515404884|FG000|Initial Treatment Period|Lost to Follow-up|9|||
142964122|NCT00008138|515404885|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
142964123|NCT00008138|515404885|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
142964124|NCT00008138|515404885|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
142964125|NCT00008138|515404885|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
142964126|NCT00008138|515404885|FG000|Interval Debulking|Withdrawal by Subject|2|||
142964127|NCT00008138|515404885|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
142964128|NCT00008138|515404885|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
142964129|NCT00008138|515404885|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
142964130|NCT03453151|515404886|FG000|Overall Study|Withdrawal by Subject|1|||
142964131|NCT03453151|515404886|FG000|Overall Study|Physician Decision|3|||
142964132|NCT00142519|515404887|FG000|Overall Study|Not Treated|7|||
142964133|NCT00142519|515404888|FG001|Overall Study|Not Treated|9|||
142964134|NCT00142519|515404887|FG000|Overall Study|Protocol Violation|1|||
142964135|NCT00142519|515404888|FG001|Overall Study|Protocol Violation|0|||
142964136|NCT00142519|515404887|FG000|Overall Study|Withdrawal by Subject|10|||
142964137|NCT00142519|515404888|FG001|Overall Study|Withdrawal by Subject|7|||
142964138|NCT01468909|515404896|FG000|Overall Study|Never Treated|2|||
142964139|NCT01468909|515404897|FG001|Overall Study|Never Treated|2|||
142964140|NCT02635737|515404898|FG000|Overall Study|Protocol Violation|1|||
142964141|NCT00937768|515404899|FG000|Overall Study|Refused Further Treatment|3|||
142964142|NCT00937768|515404900|FG001|Overall Study|Refused Further Treatment|2|||
142964143|NCT00937768|515404899|FG000|Overall Study|Disease Progression|1|||
142964144|NCT00937768|515404900|FG001|Overall Study|Disease Progression|1|||
142964145|NCT00937768|515404899|FG000|Overall Study|Alternate Treatment|0|||
142964146|NCT00937768|515404900|FG001|Overall Study|Alternate Treatment|1|||
142964147|NCT00937768|515404899|FG000|Overall Study|No Further Funding|4|||
142964148|NCT00937768|515404900|FG001|Overall Study|No Further Funding|4|||
142964149|NCT00406640|515404907|FG000|Acute Phase|Adverse Event|18|||
142964150|NCT00406640|515404908|FG001|Acute Phase|Adverse Event|13|||
142964151|NCT00406640|515404907|FG000|Acute Phase|Failed to Return|5|||
142964152|NCT00406640|515404908|FG001|Acute Phase|Failed to Return|1|||
142964153|NCT00406640|515404907|FG000|Acute Phase|Physician Decision|0|||
142964154|NCT00406640|515404908|FG001|Acute Phase|Physician Decision|1|||
142964155|NCT00406640|515404907|FG000|Acute Phase|Lost to Follow-up|7|||
142964156|NCT00406640|515404908|FG001|Acute Phase|Lost to Follow-up|4|||
142964157|NCT00406640|515404907|FG000|Acute Phase|Protocol deviation|4|||
142964158|NCT00406640|515404908|FG001|Acute Phase|Protocol deviation|10|||
142964159|NCT00406640|515404907|FG000|Acute Phase|Protocol Violation|3|||
143455420|NCT01238900|517212437|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
142964160|NCT00406640|515404908|FG001|Acute Phase|Protocol Violation|2|||
142964161|NCT00406640|515404907|FG000|Acute Phase|Withdrawal by Subject|11|||
142964162|NCT00406640|515404908|FG001|Acute Phase|Withdrawal by Subject|9|||
142964163|NCT00406640|515404907|FG000|Acute Phase|Lack of Efficacy|3|||
142964164|NCT00406640|515404908|FG001|Acute Phase|Lack of Efficacy|3|||
142964165|NCT00406640|515404907|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
142964166|NCT00406640|515404908|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
142964167|NCT00406640|515404907|FG000|DB Continuation Phase for Responders|Death|1|||
142964168|NCT00406640|515404908|FG001|DB Continuation Phase for Responders|Death|0|||
142964169|NCT00406640|515404907|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
142964170|NCT00406640|515404908|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
142964171|NCT00406640|515404907|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
142964172|NCT00406640|515404908|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
142964173|NCT00406640|515404907|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
142964174|NCT00406640|515404908|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
142964175|NCT00406640|515404907|FG000|DB Continuation Phase for Responders|non-compliance|7|||
142964176|NCT00406640|515404908|FG001|DB Continuation Phase for Responders|non-compliance|5|||
142964177|NCT00406640|515404907|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
142964178|NCT00406640|515404908|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
142964179|NCT00406640|515404907|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
142964180|NCT00406640|515404908|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
142964181|NCT00406640|515404907|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
142964182|NCT00406640|515404908|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
142964183|NCT00406640|515404907|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
142964184|NCT00406640|515404908|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
142964185|NCT00406640|515404907|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
142964186|NCT00406640|515404908|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
142964187|NCT00406640|515404907|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
142964188|NCT00406640|515404908|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
142964189|NCT00406640|515404907|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
142964190|NCT00406640|515404908|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
142964191|NCT00406640|515404907|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
142964192|NCT00406640|515404908|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
142964193|NCT00406640|515404907|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
142964194|NCT00406640|515404908|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
142964195|NCT00406640|515404907|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
142964196|NCT00406640|515404908|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
142964197|NCT00488618|515404910|FG000|Overall Study|Adverse Event|13|||
142964198|NCT00488618|515404911|FG001|Overall Study|Adverse Event|17|||
142964199|NCT00488618|515404910|FG000|Overall Study|Insufficient Therapeutic Response|18|||
142964200|NCT00488618|515404911|FG001|Overall Study|Insufficient Therapeutic Response|11|||
142964201|NCT00488618|515404910|FG000|Overall Study|Protocol Violation|0|||
142964202|NCT00488618|515404911|FG001|Overall Study|Protocol Violation|2|||
142964203|NCT00488618|515404910|FG000|Overall Study|Withdrawal of Consent|15|||
142964204|NCT00488618|515404911|FG001|Overall Study|Withdrawal of Consent|13|||
142964205|NCT00488618|515404910|FG000|Overall Study|Lost to Follow-up|1|||
142964206|NCT00488618|515404911|FG001|Overall Study|Lost to Follow-up|0|||
142964207|NCT00315705|515406444|FG000|Phase 1|Refused further treatment|1|||
142964208|NCT00315705|515406444|FG000|Phase 1|Failure to achieve response|8|||
142964209|NCT00315705|515406444|FG000|Phase 1|Disease relapse|4|||
142964210|NCT00315705|515406444|FG000|Phase 1|Scheduled for transplant|9|||
142964211|NCT00315705|515406444|FG000|Phase 1|Death|3|||
142964212|NCT00315705|515406444|FG000|Phase 2|Physician Decision|4|||
142964213|NCT00315705|515406444|FG000|Phase 2|Adverse Event|1|||
142964214|NCT00315705|515406444|FG000|Phase 2|Failure to achieve response|3|||
142964215|NCT00315705|515406444|FG000|Phase 2|Disease relapse|1|||
142964216|NCT00315705|515406444|FG000|Phase 2|Scheduled for transplant|8|||
142964217|NCT00315705|515406444|FG000|Phase 2|Other|1|||
142964218|NCT00315705|515406444|FG000|Phase 2|Death|7|||
142964219|NCT00495495|515406446|FG000|Overall Study|Protocol Violation|99|||
142964220|NCT00789958|515406452|FG000|Overall Study|Adverse Event|3|||
142964221|NCT00789958|515406452|FG000|Overall Study|Withdrawal by Subject|4|||
142964222|NCT00789958|515406452|FG000|Overall Study|Progression|3|||
142964223|NCT00789958|515406452|FG000|Overall Study|not protocol specified|1|||
142964224|NCT00789958|515406452|FG000|Overall Study|Not eligible/not analyzable|26|||
142964225|NCT03331666|515406455|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
142964226|NCT03331666|515406456|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
142964227|NCT00434512|515406457|FG000|Overall Study|Migrated/moved from study area|0|||
142964228|NCT00434512|515406458|FG001|Overall Study|Migrated/moved from study area|0|||
142964229|NCT00434512|515406459|FG002|Overall Study|Migrated/moved from study area|0|||
142964230|NCT00434512|515406460|FG003|Overall Study|Migrated/moved from study area|1|||
142964231|NCT00434512|515406461|FG004|Overall Study|Migrated/moved from study area|1|||
142964232|NCT00434512|515406462|FG005|Overall Study|Migrated/moved from study area|1|||
142964233|NCT00434512|515406457|FG000|Overall Study|Other|0|||
142964234|NCT00434512|515406458|FG001|Overall Study|Other|1|||
142964235|NCT00434512|515406459|FG002|Overall Study|Other|0|||
142964236|NCT00434512|515406460|FG003|Overall Study|Other|0|||
142964237|NCT00434512|515406461|FG004|Overall Study|Other|0|||
142964238|NCT00434512|515406462|FG005|Overall Study|Other|0|||
142964239|NCT00111475|515406463|FG000|Overall Study|Lost to Follow-up|0|||
142964240|NCT00111475|515406464|FG001|Overall Study|Lost to Follow-up|0|||
142964241|NCT00111475|515406465|FG002|Overall Study|Lost to Follow-up|0|||
142964242|NCT00111475|515406466|FG003|Overall Study|Lost to Follow-up|0|||
142964243|NCT00111475|515406467|FG004|Overall Study|Lost to Follow-up|0|||
142964244|NCT00111475|515406468|FG005|Overall Study|Lost to Follow-up|1|||
142964245|NCT00111475|515406469|FG006|Overall Study|Lost to Follow-up|0|||
142964246|NCT00111475|515406470|FG007|Overall Study|Lost to Follow-up|0|||
142964247|NCT00111475|515406471|FG008|Overall Study|Lost to Follow-up|0|||
142964248|NCT00111475|515406472|FG009|Overall Study|Lost to Follow-up|0|||
142964249|NCT03303092|515406473|FG000|Overall Study|Adverse Event|1|||
142964250|NCT03303092|515406474|FG001|Overall Study|Adverse Event|0|||
142964251|NCT03303092|515406475|FG002|Overall Study|Adverse Event|1|||
142964252|NCT03303092|515406473|FG000|Overall Study|Protocol Violation|1|||
142964253|NCT03303092|515406474|FG001|Overall Study|Protocol Violation|5|||
142964254|NCT03303092|515406475|FG002|Overall Study|Protocol Violation|1|||
142964255|NCT03303092|515406473|FG000|Overall Study|Withdrawal by Subject|1|||
142964256|NCT03303092|515406474|FG001|Overall Study|Withdrawal by Subject|1|||
142964257|NCT03303092|515406475|FG002|Overall Study|Withdrawal by Subject|3|||
142964258|NCT01995136|515406479|FG000|Overall Study|Change in residence|1|||
142964259|NCT03544268|515406480|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
142964260|NCT03544268|515406481|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
142964261|NCT00833248|515406488|FG000|Overall Study|Adverse Event|3|||
142964262|NCT00833248|515406489|FG001|Overall Study|Adverse Event|0|||
142964263|NCT00833248|515406488|FG000|Overall Study|Protocol Violation|1|||
142964264|NCT00833248|515406489|FG001|Overall Study|Protocol Violation|2|||
142964265|NCT00833248|515406488|FG000|Overall Study|Withdrawal by Subject|0|||
142964266|NCT00833248|515406489|FG001|Overall Study|Withdrawal by Subject|1|||
142964267|NCT01830543|515406490|FG000|Overall Study|Subject Decision|19|||
142964268|NCT01830543|515406491|FG001|Overall Study|Subject Decision|21|||
142964269|NCT01830543|515406492|FG002|Overall Study|Subject Decision|57|||
142964270|NCT01830543|515406490|FG000|Overall Study|Adverse Event|91|||
142964271|NCT01830543|515406491|FG001|Overall Study|Adverse Event|77|||
142964272|NCT01830543|515406492|FG002|Overall Study|Adverse Event|76|||
142964273|NCT01830543|515406490|FG000|Overall Study|Death|20|||
142964274|NCT01830543|515406491|FG001|Overall Study|Death|22|||
142964275|NCT01830543|515406492|FG002|Overall Study|Death|22|||
142964276|NCT01830543|515406490|FG000|Overall Study|Protocol Violation|3|||
142964277|NCT01830543|515406491|FG001|Overall Study|Protocol Violation|7|||
142964278|NCT01830543|515406492|FG002|Overall Study|Protocol Violation|7|||
142964279|NCT01830543|515406490|FG000|Overall Study|Physician Decision|11|||
142964280|NCT01830543|515406491|FG001|Overall Study|Physician Decision|5|||
142964281|NCT01830543|515406492|FG002|Overall Study|Physician Decision|12|||
142964282|NCT01830543|515406490|FG000|Overall Study|Withdrawal by consent|3|||
142964283|NCT01830543|515406491|FG001|Overall Study|Withdrawal by consent|3|||
142964284|NCT01830543|515406492|FG002|Overall Study|Withdrawal by consent|3|||
142964285|NCT01830543|515406490|FG000|Overall Study|Other|12|||
142964286|NCT01830543|515406491|FG001|Overall Study|Other|17|||
142964287|NCT01830543|515406492|FG002|Overall Study|Other|37|||
142964288|NCT01395368|515406496|FG000|Overall Study|Physician Decision|14|||
142964289|NCT01395368|515406496|FG000|Overall Study|Withdrawal by Subject|2|||
142964290|NCT00288860|515406501|FG000|Overall Study|Did not complete intake|4|||
142964291|NCT00288860|515406502|FG001|Overall Study|Did not complete intake|8|||
142964292|NCT00288860|515406501|FG000|Overall Study|Death|4|||
142964293|NCT00288860|515406502|FG001|Overall Study|Death|3|||
142964294|NCT00288860|515406501|FG000|Overall Study|Withdrawal by Subject|20|||
142964295|NCT00288860|515406502|FG001|Overall Study|Withdrawal by Subject|15|||
142964296|NCT00288860|515406501|FG000|Overall Study|Lost to Follow-up|74|||
142964297|NCT00288860|515406502|FG001|Overall Study|Lost to Follow-up|71|||
142964298|NCT05142332|515406503|FG000|Overall Study|Withdrawal by Subject|0|||
142964299|NCT05142332|515406504|FG001|Overall Study|Withdrawal by Subject|1|||
142964300|NCT05142332|515406505|FG002|Overall Study|Withdrawal by Subject|2|||
142964301|NCT05142332|515406506|FG003|Overall Study|Withdrawal by Subject|0|||
142964302|NCT05142332|515406507|FG004|Overall Study|Withdrawal by Subject|0|||
142964303|NCT05142332|515406508|FG005|Overall Study|Withdrawal by Subject|2|||
142964304|NCT05142332|515406509|FG006|Overall Study|Withdrawal by Subject|6|||
142964305|NCT05142332|515406503|FG000|Overall Study|Left ED|3|||
142964306|NCT05142332|515406504|FG001|Overall Study|Left ED|0|||
142964307|NCT05142332|515406505|FG002|Overall Study|Left ED|4|||
142964308|NCT05142332|515406506|FG003|Overall Study|Left ED|6|||
142964309|NCT05142332|515406507|FG004|Overall Study|Left ED|1|||
142964310|NCT05142332|515406508|FG005|Overall Study|Left ED|2|||
142964311|NCT05142332|515406509|FG006|Overall Study|Left ED|6|||
142964312|NCT05142332|515406503|FG000|Overall Study|Physician Decision|0|||
142964313|NCT05142332|515406504|FG001|Overall Study|Physician Decision|0|||
142964314|NCT05142332|515406505|FG002|Overall Study|Physician Decision|2|||
142964315|NCT05142332|515406506|FG003|Overall Study|Physician Decision|1|||
142964316|NCT05142332|515406507|FG004|Overall Study|Physician Decision|0|||
142964317|NCT05142332|515406508|FG005|Overall Study|Physician Decision|0|||
142964318|NCT05142332|515406509|FG006|Overall Study|Physician Decision|3|||
142964319|NCT05142332|515406503|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
143003126|NCT01049360|515548758|FG014|Period 2|Protocol Violation|1|||
142964320|NCT05142332|515406504|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
142964321|NCT05142332|515406505|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
142964322|NCT05142332|515406506|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
142964323|NCT05142332|515406507|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
142964324|NCT05142332|515406508|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
142964325|NCT05142332|515406509|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
142964326|NCT01728584|515406510|FG000|Overall Study|Adverse Event|1|||
142964327|NCT01728584|515406511|FG001|Overall Study|Adverse Event|0|||
142964328|NCT01728584|515406512|FG002|Overall Study|Adverse Event|0|||
142964329|NCT01728584|515406513|FG003|Overall Study|Adverse Event|0|||
142964330|NCT01728584|515406510|FG000|Overall Study|Physician Decision|4|||
142964331|NCT01728584|515406511|FG001|Overall Study|Physician Decision|0|||
142964332|NCT01728584|515406512|FG002|Overall Study|Physician Decision|1|||
142964333|NCT01728584|515406513|FG003|Overall Study|Physician Decision|0|||
142964334|NCT01728584|515406510|FG000|Overall Study|Withdrawal by Subject|1|||
142964335|NCT01728584|515406511|FG001|Overall Study|Withdrawal by Subject|0|||
142964336|NCT01728584|515406512|FG002|Overall Study|Withdrawal by Subject|0|||
142964337|NCT01728584|515406513|FG003|Overall Study|Withdrawal by Subject|0|||
142964338|NCT01728584|515406510|FG000|Overall Study|Screen failure|1|||
142964339|NCT01728584|515406511|FG001|Overall Study|Screen failure|0|||
142964340|NCT01728584|515406512|FG002|Overall Study|Screen failure|0|||
142964341|NCT01728584|515406513|FG003|Overall Study|Screen failure|0|||
142964342|NCT01728584|515406510|FG000|Overall Study|Other reason (not specified)|1|||
142964343|NCT01728584|515406511|FG001|Overall Study|Other reason (not specified)|0|||
142964344|NCT01728584|515406512|FG002|Overall Study|Other reason (not specified)|0|||
142964345|NCT01728584|515406513|FG003|Overall Study|Other reason (not specified)|1|||
142964346|NCT02052778|515406514|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
142964347|NCT02052778|515406515|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
142964348|NCT02052778|515406516|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
142964349|NCT02052778|515406517|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
142964350|NCT02052778|515406518|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
142964351|NCT02052778|515406519|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
142964352|NCT02052778|515406520|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
142964353|NCT02052778|515406521|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
142964354|NCT02052778|515406522|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
142964355|NCT02052778|515406523|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
142964356|NCT02052778|515406524|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
142964357|NCT02052778|515406525|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
142964358|NCT02052778|515406526|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
142964359|NCT02052778|515406527|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
142964360|NCT02052778|515406528|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
142964361|NCT02052778|515406529|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
142964362|NCT02052778|515406530|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
142964363|NCT02052778|515406531|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
142964364|NCT02052778|515406532|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
142964365|NCT02052778|515406533|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
142964366|NCT02052778|515406534|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
142964367|NCT02052778|515406535|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
142964368|NCT02052778|515406536|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
142964369|NCT02052778|515406514|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
142964370|NCT02052778|515406515|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
142964371|NCT02052778|515406516|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
142964372|NCT02052778|515406517|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
142964373|NCT02052778|515406518|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
142964374|NCT02052778|515406519|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
142964375|NCT02052778|515406520|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
142964376|NCT02052778|515406521|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
142964377|NCT02052778|515406522|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
142964378|NCT02052778|515406523|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
142964379|NCT02052778|515406524|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
142964380|NCT02052778|515406525|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
142964381|NCT02052778|515406526|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
142964382|NCT02052778|515406527|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
142964383|NCT02052778|515406528|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
142964384|NCT02052778|515406529|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
142964385|NCT02052778|515406530|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
142964386|NCT02052778|515406531|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
142964387|NCT02052778|515406532|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
142964388|NCT02052778|515406533|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
142964389|NCT02052778|515406534|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
142964390|NCT02052778|515406535|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
142964391|NCT02052778|515406536|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
142964392|NCT02052778|515406514|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
142964393|NCT02052778|515406515|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
142964394|NCT02052778|515406516|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
142964395|NCT02052778|515406517|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
142964396|NCT02052778|515406518|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
142964397|NCT02052778|515406519|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
142964398|NCT02052778|515406520|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
142964399|NCT02052778|515406521|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
142964400|NCT02052778|515406522|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
142964401|NCT02052778|515406523|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
142964402|NCT02052778|515406524|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
142964403|NCT02052778|515406525|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
142964404|NCT02052778|515406526|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
142964405|NCT02052778|515406527|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
142964406|NCT02052778|515406528|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
142964407|NCT02052778|515406529|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
142964408|NCT02052778|515406530|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
142964409|NCT02052778|515406531|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
142964410|NCT02052778|515406532|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
142964411|NCT02052778|515406533|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
142964412|NCT02052778|515406534|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
142964413|NCT02052778|515406535|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
142964414|NCT02052778|515406536|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
142964415|NCT02052778|515406514|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
142964416|NCT02052778|515406515|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
142964417|NCT02052778|515406516|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
142964418|NCT02052778|515406517|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
142964419|NCT02052778|515406518|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
142964420|NCT02052778|515406519|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
142964421|NCT02052778|515406520|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
142964422|NCT02052778|515406521|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
142964423|NCT02052778|515406522|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
142964424|NCT02052778|515406523|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
142964425|NCT02052778|515406524|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
142964426|NCT02052778|515406525|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
142964427|NCT02052778|515406526|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
142964428|NCT02052778|515406527|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
142964429|NCT02052778|515406528|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
142964430|NCT02052778|515406529|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
142964431|NCT02052778|515406530|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
142964432|NCT02052778|515406531|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
142964433|NCT02052778|515406532|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
142964434|NCT02052778|515406533|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
142964435|NCT02052778|515406534|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
142964436|NCT02052778|515406535|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
142964437|NCT02052778|515406536|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
142964438|NCT02052778|515406514|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
142964439|NCT02052778|515406515|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
142964440|NCT02052778|515406516|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
142964441|NCT02052778|515406517|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
142964442|NCT02052778|515406518|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
142964443|NCT02052778|515406519|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
142964444|NCT02052778|515406520|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
142964445|NCT02052778|515406521|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
142964446|NCT02052778|515406522|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
142964447|NCT02052778|515406523|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
143003127|NCT01049360|515548759|FG015|Period 2|Protocol Violation|1|||
142964448|NCT02052778|515406524|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
142964449|NCT02052778|515406525|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
142964450|NCT02052778|515406526|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
142964451|NCT02052778|515406527|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
142964452|NCT02052778|515406528|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
142964453|NCT02052778|515406529|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
142964454|NCT02052778|515406530|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
142964455|NCT02052778|515406531|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
142964456|NCT02052778|515406532|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
142964457|NCT02052778|515406533|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
142964458|NCT02052778|515406534|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
142964459|NCT02052778|515406535|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
142964460|NCT02052778|515406536|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
142964461|NCT02052778|515406514|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
142964462|NCT02052778|515406515|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
142964463|NCT02052778|515406516|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
142964464|NCT02052778|515406517|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
142964465|NCT02052778|515406518|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
142964466|NCT02052778|515406519|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
142964467|NCT02052778|515406520|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
142964468|NCT02052778|515406521|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
142964469|NCT02052778|515406522|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
142964470|NCT02052778|515406523|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
142964471|NCT02052778|515406524|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
142964472|NCT02052778|515406525|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
142964473|NCT02052778|515406526|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
142964474|NCT02052778|515406527|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
142964475|NCT02052778|515406528|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
142964476|NCT02052778|515406529|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
142964477|NCT02052778|515406530|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
142964478|NCT02052778|515406531|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
142964479|NCT02052778|515406532|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
142964480|NCT02052778|515406533|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
142964481|NCT02052778|515406534|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
142964482|NCT02052778|515406535|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
142964483|NCT02052778|515406536|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
142964484|NCT02052778|515406514|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
142964485|NCT02052778|515406515|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
142964486|NCT02052778|515406516|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
142964487|NCT02052778|515406517|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
142964488|NCT02052778|515406518|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
142964489|NCT02052778|515406519|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
142964490|NCT02052778|515406520|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
142964491|NCT02052778|515406521|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
142964492|NCT02052778|515406522|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
142964493|NCT02052778|515406523|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
142964494|NCT02052778|515406524|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
142964495|NCT02052778|515406525|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
142964496|NCT02052778|515406526|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
142964497|NCT02052778|515406527|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
142964498|NCT02052778|515406528|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
142964499|NCT02052778|515406529|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
142964500|NCT02052778|515406530|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
142964501|NCT02052778|515406531|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
142964502|NCT02052778|515406532|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
142964503|NCT02052778|515406533|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
142964504|NCT02052778|515406534|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
142964505|NCT02052778|515406535|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
142964506|NCT02052778|515406536|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
142964507|NCT02052778|515406514|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
143003128|NCT01049360|515548760|FG016|Period 2|Protocol Violation|0|||
142964508|NCT02052778|515406515|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
142964509|NCT02052778|515406516|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
142964510|NCT02052778|515406517|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
142964511|NCT02052778|515406518|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
142964512|NCT02052778|515406519|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
142964513|NCT02052778|515406520|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
142964514|NCT02052778|515406521|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
142964515|NCT02052778|515406522|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
142964516|NCT02052778|515406523|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
142964517|NCT02052778|515406524|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
142964518|NCT02052778|515406525|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
142964519|NCT02052778|515406526|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
142964520|NCT02052778|515406527|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
142964521|NCT02052778|515406528|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
142964522|NCT02052778|515406529|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
142964523|NCT02052778|515406530|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
142964524|NCT02052778|515406531|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
142964525|NCT02052778|515406532|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
142964526|NCT02052778|515406533|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
142964527|NCT02052778|515406534|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
142964528|NCT02052778|515406535|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
142964529|NCT02052778|515406536|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
142964530|NCT02052778|515406514|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
142964531|NCT02052778|515406515|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
142964532|NCT02052778|515406516|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
142964533|NCT02052778|515406517|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
142964534|NCT02052778|515406518|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
142964535|NCT02052778|515406519|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
142964536|NCT02052778|515406520|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
142964537|NCT02052778|515406521|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
142964538|NCT02052778|515406522|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
142964539|NCT02052778|515406523|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
142964540|NCT02052778|515406524|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
142964541|NCT02052778|515406525|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
142964542|NCT02052778|515406526|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
142964543|NCT02052778|515406527|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
142964544|NCT02052778|515406528|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
142964545|NCT02052778|515406529|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
142964546|NCT02052778|515406530|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
142964547|NCT02052778|515406531|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
142964548|NCT02052778|515406532|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
142964549|NCT02052778|515406533|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
142964550|NCT02052778|515406534|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
142964551|NCT02052778|515406535|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
142964552|NCT02052778|515406536|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
142964553|NCT02052778|515406514|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
142964554|NCT02052778|515406515|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
142964555|NCT02052778|515406516|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
142964556|NCT02052778|515406517|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
142964557|NCT02052778|515406518|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
142964558|NCT02052778|515406519|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
142964559|NCT02052778|515406520|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
142964560|NCT02052778|515406521|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
142964561|NCT02052778|515406522|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
142964562|NCT02052778|515406523|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
142964563|NCT02052778|515406524|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
142964564|NCT02052778|515406525|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
142964565|NCT02052778|515406526|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
142964566|NCT02052778|515406527|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
142964567|NCT02052778|515406528|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
143003129|NCT01049360|515548761|FG017|Period 2|Protocol Violation|0|||
143455421|NCT01238900|517212437|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
142964568|NCT02052778|515406529|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
142964569|NCT02052778|515406530|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
142964570|NCT02052778|515406531|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
142964571|NCT02052778|515406532|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
142964572|NCT02052778|515406533|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
142964573|NCT02052778|515406534|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
142964574|NCT02052778|515406535|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
142964575|NCT02052778|515406536|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
142964576|NCT02052778|515406514|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
142964577|NCT02052778|515406515|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
142964578|NCT02052778|515406516|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
142964579|NCT02052778|515406517|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
142964580|NCT02052778|515406518|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
142964581|NCT02052778|515406519|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
142964582|NCT02052778|515406520|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
142964583|NCT02052778|515406521|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
142964584|NCT02052778|515406522|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
142964585|NCT02052778|515406523|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
142964586|NCT02052778|515406524|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
142964587|NCT02052778|515406525|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
142964588|NCT02052778|515406526|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
142964589|NCT02052778|515406527|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
142964590|NCT02052778|515406528|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
142964591|NCT02052778|515406529|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
142964592|NCT02052778|515406530|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
142964593|NCT02052778|515406531|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
142964594|NCT02052778|515406532|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
142964595|NCT02052778|515406533|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
142964596|NCT02052778|515406534|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
142964597|NCT02052778|515406535|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
142964598|NCT02052778|515406536|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
142964599|NCT02052778|515406514|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
142964600|NCT02052778|515406515|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
142964601|NCT02052778|515406516|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
142964602|NCT02052778|515406517|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
142964603|NCT02052778|515406518|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
142964604|NCT02052778|515406519|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
142964605|NCT02052778|515406520|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
142964606|NCT02052778|515406521|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
142964607|NCT02052778|515406522|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
142964608|NCT02052778|515406523|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
142964609|NCT02052778|515406524|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
142964610|NCT02052778|515406525|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
142964611|NCT02052778|515406526|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
142964612|NCT02052778|515406527|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
142964613|NCT02052778|515406528|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
142964614|NCT02052778|515406529|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
142964615|NCT02052778|515406530|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
142964616|NCT02052778|515406531|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
142964617|NCT02052778|515406532|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
142964618|NCT02052778|515406533|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
142964619|NCT02052778|515406534|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
142964620|NCT02052778|515406535|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
142964621|NCT02052778|515406536|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
142964622|NCT02052778|515406514|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
142964623|NCT02052778|515406515|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
142964624|NCT02052778|515406516|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
142964625|NCT02052778|515406517|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
142964626|NCT02052778|515406518|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
142964627|NCT02052778|515406519|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
142964628|NCT02052778|515406520|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
142964629|NCT02052778|515406521|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
142964630|NCT02052778|515406522|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
142964631|NCT02052778|515406523|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
143455422|NCT03573583|517212440|FG000|Overall Study|Lost to Follow-up|1|||
142964632|NCT02052778|515406524|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
142964633|NCT02052778|515406525|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
142964634|NCT02052778|515406526|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
142964635|NCT02052778|515406527|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
142964636|NCT02052778|515406528|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
142964637|NCT02052778|515406529|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
142964638|NCT02052778|515406530|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
142964639|NCT02052778|515406531|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
142964640|NCT02052778|515406532|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
142964641|NCT02052778|515406533|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
142964642|NCT02052778|515406534|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
142964643|NCT02052778|515406535|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
142964644|NCT02052778|515406536|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
142964645|NCT02052778|515406514|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
142964646|NCT02052778|515406515|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
142964647|NCT02052778|515406516|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
142964648|NCT02052778|515406517|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
142964649|NCT02052778|515406518|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
142964650|NCT02052778|515406519|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
142964651|NCT02052778|515406520|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
142964652|NCT02052778|515406521|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
142964653|NCT02052778|515406522|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
142964654|NCT02052778|515406523|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
142964655|NCT02052778|515406524|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
142964656|NCT02052778|515406525|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
142964657|NCT02052778|515406526|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
142964658|NCT02052778|515406527|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
142964659|NCT02052778|515406528|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
142964660|NCT02052778|515406529|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
142964661|NCT02052778|515406530|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
142964662|NCT02052778|515406531|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
142964663|NCT02052778|515406532|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
142964664|NCT02052778|515406533|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
142964665|NCT02052778|515406534|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
142964666|NCT02052778|515406535|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
142964667|NCT02052778|515406536|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
142964668|NCT02052778|515406514|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
142964669|NCT02052778|515406515|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
142964670|NCT02052778|515406516|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
142964671|NCT02052778|515406517|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
142964672|NCT02052778|515406518|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
142964673|NCT02052778|515406519|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
142964674|NCT02052778|515406520|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
142964675|NCT02052778|515406521|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
142964676|NCT02052778|515406522|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
142964677|NCT02052778|515406523|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
142964678|NCT02052778|515406524|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
142964679|NCT02052778|515406525|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
142964680|NCT02052778|515406526|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
142964681|NCT02052778|515406527|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
142964682|NCT02052778|515406528|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
142964683|NCT02052778|515406529|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
142964684|NCT02052778|515406530|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
142964685|NCT02052778|515406531|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
142964686|NCT02052778|515406532|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
142964687|NCT02052778|515406533|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
142964688|NCT02052778|515406534|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
142964689|NCT02052778|515406535|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
142964690|NCT02052778|515406536|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
142964691|NCT02052778|515406514|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
142964692|NCT02052778|515406515|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
142964693|NCT02052778|515406516|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
142964694|NCT02052778|515406517|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
142964695|NCT02052778|515406518|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
142964696|NCT02052778|515406519|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
142964697|NCT02052778|515406520|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
143003130|NCT01049360|515548762|FG018|Period 2|Protocol Violation|0|||
142964698|NCT02052778|515406521|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
142964699|NCT02052778|515406522|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
142964700|NCT02052778|515406523|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
142964701|NCT02052778|515406524|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
142964702|NCT02052778|515406525|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
142964703|NCT02052778|515406526|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
142964704|NCT02052778|515406527|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
142964705|NCT02052778|515406528|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
142964706|NCT02052778|515406529|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
142964707|NCT02052778|515406530|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
142964708|NCT02052778|515406531|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
142964709|NCT02052778|515406532|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
142964710|NCT02052778|515406533|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
142964711|NCT02052778|515406534|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
142964712|NCT02052778|515406535|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
142964713|NCT02052778|515406536|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
142964714|NCT02052778|515406514|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
142964715|NCT02052778|515406515|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
142964716|NCT02052778|515406516|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
142964717|NCT02052778|515406517|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
142964718|NCT02052778|515406518|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
142964719|NCT02052778|515406519|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
142964720|NCT02052778|515406520|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
142964721|NCT02052778|515406521|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
142964722|NCT02052778|515406522|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
142964723|NCT02052778|515406523|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
142964724|NCT02052778|515406524|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
142964725|NCT02052778|515406525|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
142964726|NCT02052778|515406526|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
142964727|NCT02052778|515406527|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
142964728|NCT02052778|515406528|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
142964729|NCT02052778|515406529|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
142964730|NCT02052778|515406530|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
142964731|NCT02052778|515406531|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
142964732|NCT02052778|515406532|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
142964733|NCT02052778|515406533|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
142964734|NCT02052778|515406534|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
142964735|NCT02052778|515406535|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
142964736|NCT02052778|515406536|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
142964737|NCT02052778|515406514|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
142964738|NCT02052778|515406515|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
142964739|NCT02052778|515406516|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
142964740|NCT02052778|515406517|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
142964741|NCT02052778|515406518|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
142964742|NCT02052778|515406519|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
142964743|NCT02052778|515406520|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
142964744|NCT02052778|515406521|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
142964745|NCT02052778|515406522|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
142964746|NCT02052778|515406523|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
142964747|NCT02052778|515406524|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
142964748|NCT02052778|515406525|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
142964749|NCT02052778|515406526|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
142964750|NCT02052778|515406527|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
142964751|NCT02052778|515406528|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
142964752|NCT02052778|515406529|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
142964753|NCT02052778|515406530|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
142964754|NCT02052778|515406531|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
142964755|NCT02052778|515406532|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
142964756|NCT02052778|515406533|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
142964757|NCT02052778|515406534|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
142964758|NCT02052778|515406535|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
142964759|NCT02052778|515406536|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
142964760|NCT02052778|515406514|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
142964761|NCT02052778|515406515|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
142964762|NCT02052778|515406516|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
142964763|NCT02052778|515406517|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
142964764|NCT02052778|515406518|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
142964765|NCT02052778|515406519|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
142964766|NCT02052778|515406520|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
142964767|NCT02052778|515406521|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
142964768|NCT02052778|515406522|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
142964769|NCT02052778|515406523|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
142964770|NCT02052778|515406524|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
142964771|NCT02052778|515406525|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
142964772|NCT02052778|515406526|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
142964773|NCT02052778|515406527|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
142964774|NCT02052778|515406528|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
142964775|NCT02052778|515406529|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
142964776|NCT02052778|515406530|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
142964777|NCT02052778|515406531|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
142964778|NCT02052778|515406532|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
142964779|NCT02052778|515406533|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
142964780|NCT02052778|515406534|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
142964781|NCT02052778|515406535|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
142964782|NCT02052778|515406536|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
142964783|NCT02052778|515406514|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
142964784|NCT02052778|515406515|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
142964785|NCT02052778|515406516|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
142964786|NCT02052778|515406517|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
142964787|NCT02052778|515406518|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
142964788|NCT02052778|515406519|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
142964789|NCT02052778|515406520|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
142964790|NCT02052778|515406521|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
142964791|NCT02052778|515406522|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
142964792|NCT02052778|515406523|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
142964793|NCT02052778|515406524|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
142964794|NCT02052778|515406525|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
142964795|NCT02052778|515406526|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
142964796|NCT02052778|515406527|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
142964797|NCT02052778|515406528|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
142964798|NCT02052778|515406529|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
142964799|NCT02052778|515406530|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
142964800|NCT02052778|515406531|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
142964801|NCT02052778|515406532|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
142964802|NCT02052778|515406533|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
142964803|NCT02052778|515406534|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
142964804|NCT02052778|515406535|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
142964805|NCT02052778|515406536|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
142964806|NCT01358877|515406541|FG000|Overall Study|Death|80|||
142964807|NCT01358877|515406542|FG001|Overall Study|Death|89|||
142964808|NCT01358877|515406541|FG000|Overall Study|Ongoing follow-up for post-recurrence|87|||
142964809|NCT01358877|515406542|FG001|Overall Study|Ongoing follow-up for post-recurrence|108|||
142964810|NCT01358877|515406541|FG000|Overall Study|Ongoing follow-up for IDFS event|2084|||
142964811|NCT01358877|515406542|FG001|Overall Study|Ongoing follow-up for IDFS event|2073|||
142964812|NCT01358877|515406541|FG000|Overall Study|Ongoing follow-up for overall survival|7|||
142964813|NCT01358877|515406542|FG001|Overall Study|Ongoing follow-up for overall survival|5|||
142964814|NCT01358877|515406541|FG000|Overall Study|Other|142|||
142964815|NCT01358877|515406542|FG001|Overall Study|Other|129|||
142964816|NCT01994226|515406547|FG000|Overall Study|Protocol Violation|13|||
142964817|NCT01994226|515406548|FG001|Overall Study|Protocol Violation|10|||
142964818|NCT01994226|515406547|FG000|Overall Study|Early Cessation of treatment|6|||
142964819|NCT01994226|515406548|FG001|Overall Study|Early Cessation of treatment|11|||
142964820|NCT01409031|515406549|FG000|Overall Study|transferred to other hosp|1|||
142964821|NCT01409031|515406550|FG001|Overall Study|transferred to other hosp|0|||
142964822|NCT02345252|515406551|FG000|Double-Blind Phase|Adverse Event|2|||
142964823|NCT02345252|515406552|FG001|Double-Blind Phase|Adverse Event|3|||
142964824|NCT02345252|515406551|FG000|Double-Blind Phase|Death|1|||
142964825|NCT02345252|515406552|FG001|Double-Blind Phase|Death|2|||
142964826|NCT02345252|515406551|FG000|Double-Blind Phase|Lack of Efficacy|1|||
142964827|NCT02345252|515406552|FG001|Double-Blind Phase|Lack of Efficacy|0|||
142964828|NCT02345252|515406551|FG000|Double-Blind Phase|Investigator's Discretion|4|||
142964829|NCT02345252|515406552|FG001|Double-Blind Phase|Investigator's Discretion|6|||
142964830|NCT02345252|515406551|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
142964831|NCT02345252|515406552|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
142964832|NCT02345252|515406551|FG000|Double-Blind Phase|Protocol Violation|2|||
142964833|NCT02345252|515406552|FG001|Double-Blind Phase|Protocol Violation|1|||
143003131|NCT01049360|515548763|FG019|Period 2|Protocol Violation|0|||
142964834|NCT02345252|515406551|FG000|Double-Blind Phase|Withdrew Consent|21|||
142964835|NCT02345252|515406552|FG001|Double-Blind Phase|Withdrew Consent|23|||
142964836|NCT02345252|515406551|FG000|Double-Blind Phase|Lost to Follow-up|8|||
142964837|NCT02345252|515406552|FG001|Double-Blind Phase|Lost to Follow-up|10|||
142964838|NCT02345252|515406551|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
142964839|NCT02345252|515406552|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
142964840|NCT00471536|515406553|FG000|Overall Study|Withdrawal by Subject|1|||
142964841|NCT01094730|515406554|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
142964842|NCT01094730|515406555|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
142964843|NCT01094730|515406554|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
142964844|NCT01094730|515406555|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
142964845|NCT01094730|515406554|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
142964846|NCT01094730|515406555|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
142964847|NCT01094730|515406554|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
142964848|NCT01094730|515406555|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
142964849|NCT01094730|515406554|FG000|Period 2 (14 Days)|Protocol Violation|2|||
142964850|NCT01094730|515406555|FG001|Period 2 (14 Days)|Protocol Violation|0|||
142964851|NCT01094730|515406554|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
142964852|NCT01094730|515406555|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
142964853|NCT01094730|515406554|FG000|Period 2 (14 Days)|Adverse Event|0|||
142964854|NCT01094730|515406555|FG001|Period 2 (14 Days)|Adverse Event|1|||
142964855|NCT01094730|515406554|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
142964856|NCT01094730|515406555|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
142964857|NCT01100307|515406556|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
142964858|NCT01100307|515406557|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
142964859|NCT01100307|515406556|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
142964860|NCT01100307|515406557|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
142964861|NCT01100307|515406556|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
142964862|NCT01100307|515406557|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
142964863|NCT01100307|515406556|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
142964864|NCT01100307|515406557|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
142964865|NCT01100307|515406556|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
142964866|NCT01100307|515406557|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
142964867|NCT01100307|515406556|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
142964868|NCT01100307|515406557|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
142964869|NCT00740779|515406561|FG000|Overall Study|Adverse Event|4|||
142964870|NCT00740779|515406562|FG001|Overall Study|Adverse Event|6|||
142964871|NCT00740779|515406563|FG002|Overall Study|Adverse Event|3|||
142964872|NCT00740779|515406561|FG000|Overall Study|Protocol Violation|1|||
142964873|NCT00740779|515406562|FG001|Overall Study|Protocol Violation|1|||
142964874|NCT00740779|515406563|FG002|Overall Study|Protocol Violation|1|||
142964875|NCT00740779|515406561|FG000|Overall Study|Lack of Efficacy|0|||
142964876|NCT00740779|515406562|FG001|Overall Study|Lack of Efficacy|0|||
142964877|NCT00740779|515406563|FG002|Overall Study|Lack of Efficacy|2|||
142964878|NCT00740779|515406561|FG000|Overall Study|Withdrawal by Subject|2|||
142964879|NCT00740779|515406562|FG001|Overall Study|Withdrawal by Subject|4|||
142964880|NCT00740779|515406563|FG002|Overall Study|Withdrawal by Subject|2|||
142964881|NCT00740779|515406561|FG000|Overall Study|Lost to Follow-up|2|||
142964882|NCT00740779|515406562|FG001|Overall Study|Lost to Follow-up|3|||
142964883|NCT00740779|515406563|FG002|Overall Study|Lost to Follow-up|5|||
142964884|NCT02203838|515406564|FG000|Overall Study|Lack of Efficacy|7|||
142964885|NCT02203838|515406565|FG001|Overall Study|Lack of Efficacy|0|||
142964886|NCT02203838|515406566|FG002|Overall Study|Lack of Efficacy|1|||
142964887|NCT02203838|515406567|FG003|Overall Study|Lack of Efficacy|1|||
142964888|NCT02203838|515406564|FG000|Overall Study|Adverse Event|46|||
142964889|NCT02203838|515406565|FG001|Overall Study|Adverse Event|6|||
142964890|NCT02203838|515406566|FG002|Overall Study|Adverse Event|3|||
142964891|NCT02203838|515406567|FG003|Overall Study|Adverse Event|2|||
142964892|NCT02203838|515406564|FG000|Overall Study|Lost to Follow-up|39|||
142964893|NCT02203838|515406565|FG001|Overall Study|Lost to Follow-up|3|||
142964894|NCT02203838|515406566|FG002|Overall Study|Lost to Follow-up|2|||
142964895|NCT02203838|515406567|FG003|Overall Study|Lost to Follow-up|1|||
142964896|NCT02203838|515406564|FG000|Overall Study|Protocol Violation|7|||
142964897|NCT02203838|515406565|FG001|Overall Study|Protocol Violation|3|||
142964898|NCT02203838|515406566|FG002|Overall Study|Protocol Violation|0|||
142964899|NCT02203838|515406567|FG003|Overall Study|Protocol Violation|0|||
142964900|NCT02203838|515406564|FG000|Overall Study|Withdrawal by Subject|83|||
142964901|NCT02203838|515406565|FG001|Overall Study|Withdrawal by Subject|10|||
142964902|NCT02203838|515406566|FG002|Overall Study|Withdrawal by Subject|8|||
142964903|NCT02203838|515406567|FG003|Overall Study|Withdrawal by Subject|11|||
142964904|NCT02203838|515406564|FG000|Overall Study|Physician Decision|27|||
142964905|NCT02203838|515406565|FG001|Overall Study|Physician Decision|0|||
142964906|NCT02203838|515406566|FG002|Overall Study|Physician Decision|2|||
142964907|NCT02203838|515406567|FG003|Overall Study|Physician Decision|3|||
142964908|NCT02203838|515406564|FG000|Overall Study|Other|1|||
142964909|NCT02203838|515406565|FG001|Overall Study|Other|0|||
142964910|NCT02203838|515406566|FG002|Overall Study|Other|0|||
142964911|NCT02203838|515406567|FG003|Overall Study|Other|0|||
142964912|NCT01318083|515406568|FG000|Overall Study|Adverse Event|4|||
142964913|NCT01318083|515406569|FG001|Overall Study|Adverse Event|1|||
142964914|NCT01318083|515406570|FG002|Overall Study|Adverse Event|2|||
142964915|NCT01318083|515406568|FG000|Overall Study|Withdrawal by Subject|1|||
142964916|NCT01318083|515406569|FG001|Overall Study|Withdrawal by Subject|0|||
142964917|NCT01318083|515406570|FG002|Overall Study|Withdrawal by Subject|2|||
142964918|NCT01318083|515406568|FG000|Overall Study|Lack of Efficacy|0|||
142964919|NCT01318083|515406569|FG001|Overall Study|Lack of Efficacy|0|||
142964920|NCT01318083|515406570|FG002|Overall Study|Lack of Efficacy|1|||
142964921|NCT01318083|515406568|FG000|Overall Study|Treatment Complications|1|||
142964922|NCT01318083|515406569|FG001|Overall Study|Treatment Complications|0|||
142964923|NCT01318083|515406570|FG002|Overall Study|Treatment Complications|0|||
142964924|NCT01318083|515406568|FG000|Overall Study|Lack of Study Medication Compliance|0|||
142964925|NCT01318083|515406569|FG001|Overall Study|Lack of Study Medication Compliance|1|||
142964926|NCT01318083|515406570|FG002|Overall Study|Lack of Study Medication Compliance|0|||
142964927|NCT03827473|515406573|FG000|Overall Study|Withdrawal by Subject|1|||
142964928|NCT03827473|515406574|FG001|Overall Study|Withdrawal by Subject|0|||
142964929|NCT00952289|515406575|FG000|All Participants|Death|9|||
142964930|NCT00952289|515406576|FG001|All Participants|Death|9|||
142964931|NCT00952289|515406575|FG000|All Participants|Adverse Event|8|||
142964932|NCT00952289|515406576|FG001|All Participants|Adverse Event|8|||
142964933|NCT00952289|515406575|FG000|All Participants|Disease progression|3|||
142964934|NCT00952289|515406576|FG001|All Participants|Disease progression|12|||
142964935|NCT00952289|515406575|FG000|All Participants|Withdrawal by Subject|1|||
142964936|NCT00952289|515406576|FG001|All Participants|Withdrawal by Subject|10|||
142964937|NCT00952289|515406575|FG000|All Participants|Data lost during site relocation|0|||
142964938|NCT00952289|515406576|FG001|All Participants|Data lost during site relocation|1|||
142964939|NCT00952289|515406575|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
142964940|NCT00952289|515406576|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
142964941|NCT00952289|515406575|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
142964942|NCT00952289|515406576|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
142964943|NCT00952289|515406575|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
142964944|NCT00952289|515406576|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
142964945|NCT00952289|515406575|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
142964946|NCT00952289|515406576|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
142964947|NCT00952289|515406575|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
142964948|NCT00952289|515406576|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
142964949|NCT01423617|515406583|FG000|Overall Study|Lost to Follow-up|0|||
142964950|NCT01423617|515406584|FG001|Overall Study|Lost to Follow-up|1|||
142964951|NCT00634244|515406585|FG000|Overall Study|Never started treatment|0|||
142964952|NCT00634244|515406586|FG001|Overall Study|Never started treatment|1|||
142964953|NCT00634244|515406587|FG002|Overall Study|Never started treatment|0|||
142964954|NCT00634244|515406585|FG000|Overall Study|Death|1|||
142964955|NCT00634244|515406586|FG001|Overall Study|Death|6|||
142964956|NCT00634244|515406587|FG002|Overall Study|Death|0|||
142964957|NCT00634244|515406585|FG000|Overall Study|Adverse Event|0|||
142964958|NCT00634244|515406586|FG001|Overall Study|Adverse Event|2|||
142964959|NCT00634244|515406587|FG002|Overall Study|Adverse Event|0|||
142964960|NCT00634244|515406585|FG000|Overall Study|Withdrawal by Subject|0|||
142964961|NCT00634244|515406586|FG001|Overall Study|Withdrawal by Subject|1|||
142964962|NCT00634244|515406587|FG002|Overall Study|Withdrawal by Subject|0|||
142964963|NCT00634244|515406585|FG000|Overall Study|Physician Decision|0|||
142964964|NCT00634244|515406586|FG001|Overall Study|Physician Decision|1|||
142964965|NCT00634244|515406587|FG002|Overall Study|Physician Decision|0|||
142964966|NCT00634244|515406585|FG000|Overall Study|Disease progression/relapse|0|||
142964967|NCT00634244|515406586|FG001|Overall Study|Disease progression/relapse|1|||
142964968|NCT00634244|515406587|FG002|Overall Study|Disease progression/relapse|0|||
142964969|NCT00634244|515406585|FG000|Overall Study|Other complicating disease|0|||
142964970|NCT00634244|515406586|FG001|Overall Study|Other complicating disease|1|||
142964971|NCT00634244|515406587|FG002|Overall Study|Other complicating disease|0|||
142964972|NCT03855137|515406590|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
142964973|NCT03855137|515406591|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
142964974|NCT03855137|515406592|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
142964975|NCT03855137|515406590|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
142964976|NCT03855137|515406591|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
142964977|NCT03855137|515406592|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
142964978|NCT03855137|515406590|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
142964979|NCT03855137|515406591|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
142964980|NCT03855137|515406592|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
142964981|NCT03855137|515406590|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
142964982|NCT03855137|515406591|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
142964983|NCT03855137|515406592|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
142964984|NCT03855137|515406590|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
142964985|NCT03855137|515406591|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
142964986|NCT03855137|515406592|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
142964987|NCT03855137|515406590|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
142964988|NCT03855137|515406591|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
142964989|NCT03855137|515406592|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
142964990|NCT03855137|515406590|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
142964991|NCT03855137|515406591|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
142964992|NCT03855137|515406592|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
142964993|NCT03855137|515406590|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
142964994|NCT03855137|515406591|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
142964995|NCT03855137|515406592|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
142964996|NCT03855137|515406590|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
142964997|NCT03855137|515406591|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
142964998|NCT03855137|515406592|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
142964999|NCT03855137|515406590|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
142965000|NCT03855137|515406591|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
142965001|NCT03855137|515406592|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
142965002|NCT02435277|515406593|FG000|Overall Study|Adverse Event|1|||
142965003|NCT02435277|515406594|FG001|Overall Study|Adverse Event|1|||
142965004|NCT02435277|515406595|FG002|Overall Study|Adverse Event|0|||
142965005|NCT02435277|515406596|FG003|Overall Study|Adverse Event|0|||
142965006|NCT02435277|515406593|FG000|Overall Study|Withdrawal by Subject|1|||
142965007|NCT02435277|515406594|FG001|Overall Study|Withdrawal by Subject|0|||
142965008|NCT02435277|515406595|FG002|Overall Study|Withdrawal by Subject|0|||
142965009|NCT02435277|515406596|FG003|Overall Study|Withdrawal by Subject|0|||
142965010|NCT01067508|515406597|FG000|Overall Study|Physician Decision|0|||
142965011|NCT01067508|515406598|FG001|Overall Study|Physician Decision|1|||
142965012|NCT01067508|515406597|FG000|Overall Study|Withdrawal by Subject|0|||
142965013|NCT01067508|515406598|FG001|Overall Study|Withdrawal by Subject|1|||
142965014|NCT04715230|515406599|FG000|Overall Study|Withdrawal by Subject|1|||
142965015|NCT04715230|515406600|FG001|Overall Study|Withdrawal by Subject|0|||
142965016|NCT04715230|515406601|FG002|Overall Study|Withdrawal by Subject|0|||
142965017|NCT04715230|515406599|FG000|Overall Study|Lost to Follow-up|0|||
142965018|NCT04715230|515406600|FG001|Overall Study|Lost to Follow-up|5|||
142965019|NCT04715230|515406601|FG002|Overall Study|Lost to Follow-up|1|||
142965020|NCT01687413|515406614|FG000|Overall Study|Withdrawal by Subject|0|||
142965021|NCT01687413|515406615|FG001|Overall Study|Withdrawal by Subject|2|||
142965022|NCT01687413|515406614|FG000|Overall Study|Not eligible|0|||
142965023|NCT01687413|515406615|FG001|Overall Study|Not eligible|2|||
142965024|NCT01687413|515406614|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
142965025|NCT01687413|515406615|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
142965026|NCT00992446|515406621|FG000|Overall Study|Disease Progression|1|||
142965027|NCT00992446|515406621|FG000|Overall Study|Withdrawal by Subject|2|||
142965028|NCT00992446|515406621|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
142965029|NCT02669862|515408352|FG000|Overall Study|Lost to Follow-up|0|||
142965030|NCT02669862|515408353|FG001|Overall Study|Lost to Follow-up|2|||
142965031|NCT02669862|515408354|FG002|Overall Study|Lost to Follow-up|1|||
142965032|NCT02669862|515408352|FG000|Overall Study|Withdrawal by Subject|2|||
142965033|NCT02669862|515408353|FG001|Overall Study|Withdrawal by Subject|2|||
142965034|NCT02669862|515408354|FG002|Overall Study|Withdrawal by Subject|3|||
142965035|NCT02669862|515408352|FG000|Overall Study|moved|0|||
142965036|NCT02669862|515408353|FG001|Overall Study|moved|1|||
142965037|NCT02669862|515408354|FG002|Overall Study|moved|0|||
142965038|NCT02669862|515408352|FG000|Overall Study|Protocol Violation|0|||
142965039|NCT02669862|515408353|FG001|Overall Study|Protocol Violation|0|||
142965040|NCT02669862|515408354|FG002|Overall Study|Protocol Violation|1|||
142965041|NCT03987919|515408356|FG000|Overall Study|Adverse Event|1|||
142965042|NCT03987919|515408357|FG001|Overall Study|Adverse Event|4|||
142965043|NCT03987919|515408358|FG002|Overall Study|Adverse Event|1|||
142965044|NCT03987919|515408359|FG003|Overall Study|Adverse Event|3|||
142965045|NCT03987919|515408356|FG000|Overall Study|Death|4|||
142965046|NCT03987919|515408357|FG001|Overall Study|Death|4|||
142965047|NCT03987919|515408358|FG002|Overall Study|Death|4|||
142965048|NCT03987919|515408359|FG003|Overall Study|Death|1|||
142965049|NCT03987919|515408356|FG000|Overall Study|Lost to Follow-up|5|||
142965050|NCT03987919|515408357|FG001|Overall Study|Lost to Follow-up|6|||
142965051|NCT03987919|515408358|FG002|Overall Study|Lost to Follow-up|8|||
142965052|NCT03987919|515408359|FG003|Overall Study|Lost to Follow-up|12|||
142965053|NCT03987919|515408356|FG000|Overall Study|Physician Decision|0|||
142965054|NCT03987919|515408357|FG001|Overall Study|Physician Decision|2|||
142965055|NCT03987919|515408358|FG002|Overall Study|Physician Decision|0|||
143455423|NCT03573583|517212441|FG001|Overall Study|Lost to Follow-up|0|||
142965056|NCT03987919|515408359|FG003|Overall Study|Physician Decision|4|||
142965057|NCT03987919|515408356|FG000|Overall Study|Pregnancy|1|||
142965058|NCT03987919|515408357|FG001|Overall Study|Pregnancy|0|||
142965059|NCT03987919|515408358|FG002|Overall Study|Pregnancy|1|||
142965060|NCT03987919|515408359|FG003|Overall Study|Pregnancy|1|||
142965061|NCT03987919|515408356|FG000|Overall Study|Protocol Violation|0|||
142965062|NCT03987919|515408357|FG001|Overall Study|Protocol Violation|1|||
142965063|NCT03987919|515408358|FG002|Overall Study|Protocol Violation|0|||
142965064|NCT03987919|515408359|FG003|Overall Study|Protocol Violation|0|||
142965065|NCT03987919|515408356|FG000|Overall Study|Site terminated by Sponsor|0|||
142965066|NCT03987919|515408357|FG001|Overall Study|Site terminated by Sponsor|0|||
142965067|NCT03987919|515408358|FG002|Overall Study|Site terminated by Sponsor|0|||
142965068|NCT03987919|515408359|FG003|Overall Study|Site terminated by Sponsor|1|||
142965069|NCT03987919|515408356|FG000|Overall Study|Withdrawal by Subject|7|||
142965070|NCT03987919|515408357|FG001|Overall Study|Withdrawal by Subject|7|||
142965071|NCT03987919|515408358|FG002|Overall Study|Withdrawal by Subject|8|||
142965072|NCT03987919|515408359|FG003|Overall Study|Withdrawal by Subject|4|||
142965073|NCT03987919|515408356|FG000|Overall Study|Other - as reported by the investigator|1|||
142965074|NCT03987919|515408357|FG001|Overall Study|Other - as reported by the investigator|3|||
142965075|NCT03987919|515408358|FG002|Overall Study|Other - as reported by the investigator|2|||
142965076|NCT03987919|515408359|FG003|Overall Study|Other - as reported by the investigator|0|||
142965077|NCT01194804|515408360|FG000|Overall Study|Withdrawal by Subject|1|||
142965078|NCT02670915|515408361|FG000|Overall Study|Withdrawal by Subject|0|||
142965079|NCT02670915|515408362|FG001|Overall Study|Withdrawal by Subject|1|||
142965080|NCT02670915|515408363|FG002|Overall Study|Withdrawal by Subject|4|||
142965081|NCT02670915|515408361|FG000|Overall Study|Withdrawal by parent/guardian|4|||
142965082|NCT02670915|515408362|FG001|Overall Study|Withdrawal by parent/guardian|4|||
142965083|NCT02670915|515408363|FG002|Overall Study|Withdrawal by parent/guardian|1|||
142965084|NCT02670915|515408361|FG000|Overall Study|Unclassified|0|||
142965085|NCT02670915|515408362|FG001|Overall Study|Unclassified|3|||
142965086|NCT02670915|515408363|FG002|Overall Study|Unclassified|0|||
142965087|NCT00818207|515408364|FG000|Overall Study|Adverse Event|6|||
142965088|NCT00818207|515408365|FG001|Overall Study|Adverse Event|0|||
142965089|NCT00818207|515408364|FG000|Overall Study|Lost to Follow-up|160|||
142965090|NCT00818207|515408365|FG001|Overall Study|Lost to Follow-up|146|||
142965091|NCT00818207|515408364|FG000|Overall Study|Multiple reasons|11|||
142965092|NCT00818207|515408365|FG001|Overall Study|Multiple reasons|12|||
142965093|NCT00818207|515408364|FG000|Overall Study|Withdrawal by Subject|42|||
142965094|NCT00818207|515408365|FG001|Overall Study|Withdrawal by Subject|104|||
142965095|NCT00818207|515408364|FG000|Overall Study|Death|3|||
142965096|NCT00818207|515408365|FG001|Overall Study|Death|5|||
142965097|NCT02494778|515408366|FG000|Overall Study|Death|3|||
142965098|NCT02494778|515408366|FG000|Overall Study|Other|173|||
142965099|NCT02494778|515408366|FG000|Overall Study|Lack of Efficacy|4|||
142965100|NCT02494778|515408366|FG000|Overall Study|Adverse Event|18|||
142965101|NCT02494778|515408366|FG000|Overall Study|Withdrawal by Subject|20|||
142965102|NCT02494778|515408366|FG000|Overall Study|Lost to Follow-up|2|||
142965103|NCT02494778|515408366|FG000|Overall Study|Noncompliant with study drug admin.|1|||
142965104|NCT01303380|515408367|FG000|Overall Study|Lack of compliance to study procedures|1|||
142965105|NCT03621943|515408368|FG000|First Randomized Intervention|Lost to Follow-up|51|||
142965106|NCT03621943|515408369|FG001|First Randomized Intervention|Lost to Follow-up|54|||
142965107|NCT03621943|515408368|FG000|First Randomized Intervention|Withdrawal by Subject|3|||
142965108|NCT03621943|515408369|FG001|First Randomized Intervention|Withdrawal by Subject|3|||
142965109|NCT03621943|515408368|FG000|Crossover Randomized Intervention|Lost to Follow-up|75|||
142965110|NCT03621943|515408369|FG001|Crossover Randomized Intervention|Lost to Follow-up|45|||
142965111|NCT03621943|515408368|FG000|Crossover Randomized Intervention|Withdrawal by Subject|0|||
142965112|NCT03621943|515408369|FG001|Crossover Randomized Intervention|Withdrawal by Subject|5|||
142965113|NCT02174861|515408370|FG000|Overall Study|Decision by sponsor|8|||
142965114|NCT02174861|515408370|FG000|Overall Study|Withdrawal by Subject|124|||
142965115|NCT02174861|515408370|FG000|Overall Study|Lost to Follow-up|26|||
142965116|NCT01215734|515408371|FG000|Overall Study|Death|0|||
142965117|NCT01215734|515408372|FG001|Overall Study|Death|1|||
142965118|NCT01346371|515408373|FG000|Overall Study|Lost to Follow-up|2|||
142965119|NCT01346371|515408374|FG001|Overall Study|Lost to Follow-up|0|||
142965120|NCT01716533|515408375|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
142965121|NCT01716533|515408376|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
142965122|NCT01716533|515408377|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
142965123|NCT01716533|515408378|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
142965124|NCT01716533|515408375|FG000|Overall Study|Withdrawal by Subject|0|||
142965125|NCT01716533|515408376|FG001|Overall Study|Withdrawal by Subject|0|||
142965126|NCT01716533|515408377|FG002|Overall Study|Withdrawal by Subject|0|||
142965127|NCT01716533|515408378|FG003|Overall Study|Withdrawal by Subject|5|||
142965128|NCT01716533|515408375|FG000|Overall Study|Death|0|||
142965129|NCT01716533|515408376|FG001|Overall Study|Death|0|||
142965130|NCT01716533|515408377|FG002|Overall Study|Death|0|||
142965131|NCT01716533|515408378|FG003|Overall Study|Death|2|||
142965132|NCT01716533|515408375|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
142965133|NCT01716533|515408376|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
142965134|NCT01716533|515408377|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
142965135|NCT01716533|515408378|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
142965136|NCT02702518|515408386|FG000|Overall Study|Lost to Follow-up|3|||
142965137|NCT02702518|515408387|FG001|Overall Study|Lost to Follow-up|4|||
142965138|NCT01670656|515408388|FG000|Overall Study|Non-compliance with study drug|0|||
142965139|NCT01670656|515408389|FG001|Overall Study|Non-compliance with study drug|0|||
142965140|NCT01670656|515408390|FG002|Overall Study|Non-compliance with study drug|3|||
142965141|NCT01670656|515408391|FG003|Overall Study|Non-compliance with study drug|0|||
142965142|NCT01670656|515408392|FG004|Overall Study|Non-compliance with study drug|1|||
142965143|NCT01670656|515408388|FG000|Overall Study|Pregnancy|0|||
142965144|NCT01670656|515408389|FG001|Overall Study|Pregnancy|0|||
142965145|NCT01670656|515408390|FG002|Overall Study|Pregnancy|0|||
142965146|NCT01670656|515408391|FG003|Overall Study|Pregnancy|0|||
142965147|NCT01670656|515408392|FG004|Overall Study|Pregnancy|1|||
142965148|NCT01670656|515408388|FG000|Overall Study|Withdrawal by Subject|1|||
142965149|NCT01670656|515408389|FG001|Overall Study|Withdrawal by Subject|1|||
142965150|NCT01670656|515408390|FG002|Overall Study|Withdrawal by Subject|0|||
142965151|NCT01670656|515408391|FG003|Overall Study|Withdrawal by Subject|0|||
142965152|NCT01670656|515408392|FG004|Overall Study|Withdrawal by Subject|0|||
142965153|NCT01670656|515408388|FG000|Overall Study|Non-compliance with protocol|0|||
142965154|NCT01670656|515408389|FG001|Overall Study|Non-compliance with protocol|3|||
142965155|NCT01670656|515408390|FG002|Overall Study|Non-compliance with protocol|1|||
142965156|NCT01670656|515408391|FG003|Overall Study|Non-compliance with protocol|1|||
142965157|NCT01670656|515408392|FG004|Overall Study|Non-compliance with protocol|2|||
142965158|NCT01670656|515408388|FG000|Overall Study|Adverse Event|2|||
142965159|NCT01670656|515408389|FG001|Overall Study|Adverse Event|2|||
142965160|NCT01670656|515408390|FG002|Overall Study|Adverse Event|2|||
142965161|NCT01670656|515408391|FG003|Overall Study|Adverse Event|3|||
142965162|NCT01670656|515408392|FG004|Overall Study|Adverse Event|3|||
142965163|NCT01670656|515408388|FG000|Overall Study|Subject withdrew consent|0|||
142965164|NCT01670656|515408389|FG001|Overall Study|Subject withdrew consent|1|||
142965165|NCT01670656|515408390|FG002|Overall Study|Subject withdrew consent|2|||
142965166|NCT01670656|515408391|FG003|Overall Study|Subject withdrew consent|1|||
142965167|NCT01670656|515408392|FG004|Overall Study|Subject withdrew consent|1|||
142965168|NCT01670656|515408388|FG000|Overall Study|Lost to Follow-up|0|||
142965169|NCT01670656|515408389|FG001|Overall Study|Lost to Follow-up|0|||
142965170|NCT01670656|515408390|FG002|Overall Study|Lost to Follow-up|0|||
142965171|NCT01670656|515408391|FG003|Overall Study|Lost to Follow-up|0|||
142965172|NCT01670656|515408392|FG004|Overall Study|Lost to Follow-up|3|||
142965173|NCT01670656|515408388|FG000|Overall Study|Subject moved|0|||
142965174|NCT01670656|515408389|FG001|Overall Study|Subject moved|0|||
142965175|NCT01670656|515408390|FG002|Overall Study|Subject moved|0|||
142965176|NCT01670656|515408391|FG003|Overall Study|Subject moved|1|||
142965177|NCT01670656|515408392|FG004|Overall Study|Subject moved|0|||
142965178|NCT00254293|515408393|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
142965179|NCT00254293|515408394|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
142965180|NCT00254293|515408395|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
142965181|NCT00254293|515408396|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
142965182|NCT00254293|515408397|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
142965183|NCT00254293|515408398|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
142965184|NCT00254293|515408399|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
142965185|NCT00254293|515408393|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
142965186|NCT00254293|515408394|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
142965187|NCT00254293|515408395|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
142965188|NCT00254293|515408396|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
142965189|NCT00254293|515408397|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
142965190|NCT00254293|515408398|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
142965191|NCT00254293|515408399|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
142965192|NCT00254293|515408393|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
142965193|NCT00254293|515408394|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
142965194|NCT00254293|515408395|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
142965195|NCT00254293|515408396|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
142965196|NCT00254293|515408397|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
142965197|NCT00254293|515408398|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
142965198|NCT00254293|515408399|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
142965199|NCT00254293|515408393|FG000|LTE Open Label Variable SC Dosing|Death|0|||
142965200|NCT00254293|515408394|FG001|LTE Open Label Variable SC Dosing|Death|0|||
142965201|NCT00254293|515408395|FG002|LTE Open Label Variable SC Dosing|Death|1|||
143003132|NCT01049360|515548744|FG000|Period 2|Adverse Event|0|||
143455424|NCT03573583|517212440|FG000|Overall Study|Withdrawal by Subject|1|||
142965202|NCT00254293|515408396|FG003|LTE Open Label Variable SC Dosing|Death|0|||
142965203|NCT00254293|515408397|FG004|LTE Open Label Variable SC Dosing|Death|0|||
142965204|NCT00254293|515408398|FG005|LTE Open Label Variable SC Dosing|Death|0|||
142965205|NCT00254293|515408399|FG006|LTE Open Label Variable SC Dosing|Death|0|||
142965206|NCT00254293|515408393|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
142965207|NCT00254293|515408394|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
142965208|NCT00254293|515408395|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
142965209|NCT00254293|515408396|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
142965210|NCT00254293|515408397|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
142965211|NCT00254293|515408398|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
142965212|NCT00254293|515408399|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
142965213|NCT00254293|515408393|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
142965214|NCT00254293|515408394|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
142965215|NCT00254293|515408395|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
142965216|NCT00254293|515408396|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
142965217|NCT00254293|515408397|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
142965218|NCT00254293|515408398|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
142965219|NCT00254293|515408399|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
142965220|NCT00254293|515408393|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
142965221|NCT00254293|515408394|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
142965222|NCT00254293|515408395|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
142965223|NCT00254293|515408396|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
142965224|NCT00254293|515408397|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
142965225|NCT00254293|515408398|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
142965226|NCT00254293|515408399|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
142965227|NCT00254293|515408393|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
142965228|NCT00254293|515408394|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
142965229|NCT00254293|515408395|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
142965230|NCT00254293|515408396|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
142965231|NCT00254293|515408397|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
142965232|NCT00254293|515408398|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
142965233|NCT00254293|515408399|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
142965234|NCT00254293|515408393|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
142965235|NCT00254293|515408394|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
142965236|NCT00254293|515408395|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
142965237|NCT00254293|515408396|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
142965238|NCT00254293|515408397|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
142965239|NCT00254293|515408398|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
142965240|NCT00254293|515408399|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
142965241|NCT00254293|515408393|FG000|LTE Open Label Variable SC Dosing|Other|0|||
142965242|NCT00254293|515408394|FG001|LTE Open Label Variable SC Dosing|Other|0|||
142965243|NCT00254293|515408395|FG002|LTE Open Label Variable SC Dosing|Other|2|||
142965244|NCT00254293|515408396|FG003|LTE Open Label Variable SC Dosing|Other|0|||
142965245|NCT00254293|515408397|FG004|LTE Open Label Variable SC Dosing|Other|0|||
142965246|NCT00254293|515408398|FG005|LTE Open Label Variable SC Dosing|Other|0|||
142965247|NCT00254293|515408399|FG006|LTE Open Label Variable SC Dosing|Other|0|||
142965248|NCT00254293|515408393|FG000|LTE Open Label Fixed Dosing|Death|0|||
142965249|NCT00254293|515408394|FG001|LTE Open Label Fixed Dosing|Death|0|||
142965250|NCT00254293|515408395|FG002|LTE Open Label Fixed Dosing|Death|0|||
142965251|NCT00254293|515408396|FG003|LTE Open Label Fixed Dosing|Death|0|||
142965252|NCT00254293|515408397|FG004|LTE Open Label Fixed Dosing|Death|0|||
142965253|NCT00254293|515408398|FG005|LTE Open Label Fixed Dosing|Death|0|||
142965254|NCT00254293|515408399|FG006|LTE Open Label Fixed Dosing|Death|3|||
142965255|NCT00254293|515408393|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
142965256|NCT00254293|515408394|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
142965257|NCT00254293|515408395|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
142965258|NCT00254293|515408396|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
142965259|NCT00254293|515408397|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
142965260|NCT00254293|515408398|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
142965261|NCT00254293|515408399|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
142965262|NCT00254293|515408393|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
142965263|NCT00254293|515408394|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
142965264|NCT00254293|515408395|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
142965265|NCT00254293|515408396|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
142965266|NCT00254293|515408397|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
142965267|NCT00254293|515408398|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
142965268|NCT00254293|515408399|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
142965269|NCT00254293|515408393|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
142965270|NCT00254293|515408394|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
142965271|NCT00254293|515408395|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
142965272|NCT00254293|515408396|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
142965273|NCT00254293|515408397|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
142965274|NCT00254293|515408398|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
142965275|NCT00254293|515408399|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
142965276|NCT00254293|515408393|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
142965277|NCT00254293|515408394|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
142965278|NCT00254293|515408395|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
142965279|NCT00254293|515408396|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
142965280|NCT00254293|515408397|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
142965281|NCT00254293|515408398|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
142965282|NCT00254293|515408399|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
142965283|NCT00254293|515408393|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
142965284|NCT00254293|515408394|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
142965285|NCT00254293|515408395|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
142965286|NCT00254293|515408396|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
142965287|NCT00254293|515408397|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
142965288|NCT00254293|515408398|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
142965289|NCT00254293|515408399|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
142965290|NCT00254293|515408393|FG000|LTE Open Label Fixed Dosing|Other|0|||
142965291|NCT00254293|515408394|FG001|LTE Open Label Fixed Dosing|Other|0|||
142965292|NCT00254293|515408395|FG002|LTE Open Label Fixed Dosing|Other|0|||
142965293|NCT00254293|515408396|FG003|LTE Open Label Fixed Dosing|Other|0|||
142965294|NCT00254293|515408397|FG004|LTE Open Label Fixed Dosing|Other|0|||
142965295|NCT00254293|515408398|FG005|LTE Open Label Fixed Dosing|Other|0|||
142965296|NCT00254293|515408399|FG006|LTE Open Label Fixed Dosing|Other|1|||
142965297|NCT01000727|515408403|FG000|Overall Study|Lost to Follow-up|41|||
142965298|NCT01000727|515408404|FG001|Overall Study|Lost to Follow-up|43|||
142965299|NCT01000727|515408403|FG000|Overall Study|Withdrawal by Subject|111|||
142965300|NCT01000727|515408404|FG001|Overall Study|Withdrawal by Subject|109|||
142965301|NCT01000727|515408403|FG000|Overall Study|Study closed/terminated|23|||
142965302|NCT01000727|515408404|FG001|Overall Study|Study closed/terminated|24|||
142965303|NCT03196193|515408405|FG000|Overall Study|Adverse Event|1|||
142965304|NCT03196193|515408406|FG001|Overall Study|Adverse Event|0|||
142965305|NCT03196193|515408405|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
142965306|NCT03196193|515408406|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
142965307|NCT02006667|515408410|FG000|Overall Study|Adverse Event|3|||
142965308|NCT02006667|515408410|FG000|Overall Study|Death|2|||
142965309|NCT02006667|515408410|FG000|Overall Study|Withdrawal by Subject|1|||
142965310|NCT02179515|515408413|FG000|Overall Study|switched to alternative treatment|0|||
142965311|NCT02179515|515408414|FG001|Overall Study|switched to alternative treatment|1|||
142965312|NCT02179515|515408415|FG002|Overall Study|switched to alternative treatment|1|||
142965313|NCT02179515|515408413|FG000|Overall Study|Death|0|||
142965314|NCT02179515|515408414|FG001|Overall Study|Death|1|||
142965315|NCT02179515|515408415|FG002|Overall Study|Death|1|||
142965316|NCT02179515|515408413|FG000|Overall Study|refused further treatment|0|||
142965317|NCT02179515|515408414|FG001|Overall Study|refused further treatment|3|||
142965318|NCT02179515|515408415|FG002|Overall Study|refused further treatment|4|||
142965319|NCT02179515|515408413|FG000|Overall Study|Disease progression on study|2|||
142965320|NCT02179515|515408414|FG001|Overall Study|Disease progression on study|11|||
142965321|NCT02179515|515408415|FG002|Overall Study|Disease progression on study|8|||
142965322|NCT02116660|515408416|FG000|Overall Study|Deteriorating renal function|0|||
142965323|NCT02116660|515408417|FG001|Overall Study|Deteriorating renal function|1|||
142965324|NCT02116660|515408416|FG000|Overall Study|Adverse Event|1|||
142965325|NCT02116660|515408417|FG001|Overall Study|Adverse Event|1|||
142965326|NCT02116660|515408416|FG000|Overall Study|Withdrawal by Subject|0|||
142965327|NCT02116660|515408417|FG001|Overall Study|Withdrawal by Subject|2|||
142965328|NCT02116660|515408416|FG000|Overall Study|Organization reason|1|||
142965329|NCT02116660|515408417|FG001|Overall Study|Organization reason|0|||
142965330|NCT00411788|515408418|FG000|Overall Study|Protocol Violation|1|||
142965331|NCT00411788|515408418|FG000|Overall Study|Adverse Event|1|||
142965332|NCT00390416|515408420|FG000|Overall Study|Withdrawal by Subject|1|||
142965333|NCT00390416|515408420|FG000|Overall Study|Not treated|3|||
142965334|NCT01592409|515408421|FG000|Overall Study|Withdrawal by Subject|0|||
142965335|NCT01592409|515408422|FG001|Overall Study|Withdrawal by Subject|1|||
142965336|NCT02232087|515408424|FG000|Overall Study|Withdrawal by Subject|2|||
142965337|NCT02232087|515408425|FG001|Overall Study|Withdrawal by Subject|0|||
142965338|NCT02232087|515408426|FG002|Overall Study|Withdrawal by Subject|0|||
142965339|NCT02232087|515408427|FG003|Overall Study|Withdrawal by Subject|0|||
142965340|NCT02232087|515408428|FG004|Overall Study|Withdrawal by Subject|0|||
142965341|NCT02232087|515408429|FG005|Overall Study|Withdrawal by Subject|1|||
142965342|NCT02232087|515408424|FG000|Overall Study|poor inhalation technique|0|||
142965343|NCT02232087|515408425|FG001|Overall Study|poor inhalation technique|1|||
142965344|NCT02232087|515408426|FG002|Overall Study|poor inhalation technique|0|||
142965345|NCT02232087|515408427|FG003|Overall Study|poor inhalation technique|0|||
143003133|NCT01049360|515548745|FG001|Period 2|Adverse Event|1|||
142965346|NCT02232087|515408428|FG004|Overall Study|poor inhalation technique|0|||
142965347|NCT02232087|515408429|FG005|Overall Study|poor inhalation technique|2|||
142965348|NCT02232087|515408424|FG000|Overall Study|protocol stop criteria|0|||
142965349|NCT02232087|515408425|FG001|Overall Study|protocol stop criteria|1|||
142965350|NCT02232087|515408426|FG002|Overall Study|protocol stop criteria|0|||
142965351|NCT02232087|515408427|FG003|Overall Study|protocol stop criteria|1|||
142965352|NCT02232087|515408428|FG004|Overall Study|protocol stop criteria|0|||
142965353|NCT02232087|515408429|FG005|Overall Study|protocol stop criteria|0|||
142965354|NCT02232087|515408424|FG000|Overall Study|Adverse Event|0|||
142965355|NCT02232087|515408425|FG001|Overall Study|Adverse Event|0|||
142965356|NCT02232087|515408426|FG002|Overall Study|Adverse Event|0|||
142965357|NCT02232087|515408427|FG003|Overall Study|Adverse Event|0|||
142965358|NCT02232087|515408428|FG004|Overall Study|Adverse Event|1|||
142965359|NCT02232087|515408429|FG005|Overall Study|Adverse Event|0|||
142965360|NCT01958125|515408430|FG000|Overall Study|Missing diary data|2|||
142965361|NCT01958125|515408431|FG001|Overall Study|Missing diary data|6|||
142965362|NCT01958125|515408430|FG000|Overall Study|No headache attacks|0|||
142965363|NCT01958125|515408431|FG001|Overall Study|No headache attacks|2|||
142965364|NCT04096326|515408432|FG000|Overall Study|Withdrawal by Subject|0|||
142965365|NCT04096326|515408433|FG001|Overall Study|Withdrawal by Subject|0|||
142965366|NCT04096326|515408434|FG002|Overall Study|Withdrawal by Subject|0|||
142965367|NCT04096326|515408435|FG003|Overall Study|Withdrawal by Subject|0|||
142965368|NCT04096326|515408436|FG004|Overall Study|Withdrawal by Subject|0|||
142965369|NCT04096326|515408437|FG005|Overall Study|Withdrawal by Subject|0|||
142965370|NCT04096326|515408438|FG006|Overall Study|Withdrawal by Subject|1|||
142965371|NCT04096326|515408439|FG007|Overall Study|Withdrawal by Subject|0|||
142965372|NCT04096326|515408440|FG008|Overall Study|Withdrawal by Subject|0|||
142965373|NCT04096326|515408441|FG009|Overall Study|Withdrawal by Subject|0|||
142965374|NCT04096326|515408432|FG000|Overall Study|Lost to Follow-up|0|||
142965375|NCT04096326|515408433|FG001|Overall Study|Lost to Follow-up|1|||
142965376|NCT04096326|515408434|FG002|Overall Study|Lost to Follow-up|0|||
142965377|NCT04096326|515408435|FG003|Overall Study|Lost to Follow-up|0|||
142965378|NCT04096326|515408436|FG004|Overall Study|Lost to Follow-up|0|||
142965379|NCT04096326|515408437|FG005|Overall Study|Lost to Follow-up|0|||
142965380|NCT04096326|515408438|FG006|Overall Study|Lost to Follow-up|0|||
142965381|NCT04096326|515408439|FG007|Overall Study|Lost to Follow-up|0|||
142965382|NCT04096326|515408440|FG008|Overall Study|Lost to Follow-up|0|||
142965383|NCT04096326|515408441|FG009|Overall Study|Lost to Follow-up|0|||
142965384|NCT04096326|515408432|FG000|Overall Study|COVID-19-related reasons|0|||
142965385|NCT04096326|515408433|FG001|Overall Study|COVID-19-related reasons|0|||
142965386|NCT04096326|515408434|FG002|Overall Study|COVID-19-related reasons|0|||
142965387|NCT04096326|515408435|FG003|Overall Study|COVID-19-related reasons|0|||
142965388|NCT04096326|515408436|FG004|Overall Study|COVID-19-related reasons|1|||
142965389|NCT04096326|515408437|FG005|Overall Study|COVID-19-related reasons|5|||
142965390|NCT04096326|515408438|FG006|Overall Study|COVID-19-related reasons|0|||
142965391|NCT04096326|515408439|FG007|Overall Study|COVID-19-related reasons|0|||
142965392|NCT04096326|515408440|FG008|Overall Study|COVID-19-related reasons|0|||
142965393|NCT04096326|515408441|FG009|Overall Study|COVID-19-related reasons|0|||
142965394|NCT04804033|515408443|FG000|Period 1: DBT Phase|Adverse Event|1|||
142965395|NCT04804033|515408444|FG001|Period 1: DBT Phase|Adverse Event|5|||
142965396|NCT04804033|515408445|FG002|Period 1: DBT Phase|Adverse Event|3|||
142965397|NCT04804033|515408446|FG003|Period 1: DBT Phase|Adverse Event|4|||
142965398|NCT04804033|515408443|FG000|Period 1: DBT Phase|Death|1|||
142965399|NCT04804033|515408444|FG001|Period 1: DBT Phase|Death|0|||
142965400|NCT04804033|515408445|FG002|Period 1: DBT Phase|Death|0|||
142965401|NCT04804033|515408446|FG003|Period 1: DBT Phase|Death|0|||
142965402|NCT04804033|515408443|FG000|Period 1: DBT Phase|Lost to Follow-up|3|||
142965403|NCT04804033|515408444|FG001|Period 1: DBT Phase|Lost to Follow-up|7|||
142965404|NCT04804033|515408445|FG002|Period 1: DBT Phase|Lost to Follow-up|1|||
142965405|NCT04804033|515408446|FG003|Period 1: DBT Phase|Lost to Follow-up|3|||
142965406|NCT04804033|515408443|FG000|Period 1: DBT Phase|Non-compliance|1|||
142965407|NCT04804033|515408444|FG001|Period 1: DBT Phase|Non-compliance|0|||
142965408|NCT04804033|515408445|FG002|Period 1: DBT Phase|Non-compliance|1|||
142965409|NCT04804033|515408446|FG003|Period 1: DBT Phase|Non-compliance|2|||
142965410|NCT04804033|515408443|FG000|Period 1: DBT Phase|Other|0|||
142965411|NCT04804033|515408444|FG001|Period 1: DBT Phase|Other|1|||
142965412|NCT04804033|515408445|FG002|Period 1: DBT Phase|Other|0|||
142965413|NCT04804033|515408446|FG003|Period 1: DBT Phase|Other|0|||
142965414|NCT04804033|515408443|FG000|Period 1: DBT Phase|Pregnancy|2|||
142965415|NCT04804033|515408444|FG001|Period 1: DBT Phase|Pregnancy|0|||
142965416|NCT04804033|515408445|FG002|Period 1: DBT Phase|Pregnancy|0|||
142965417|NCT04804033|515408446|FG003|Period 1: DBT Phase|Pregnancy|0|||
142965418|NCT04804033|515408443|FG000|Period 1: DBT Phase|Study terminated by sponsor|15|||
142965419|NCT04804033|515408444|FG001|Period 1: DBT Phase|Study terminated by sponsor|16|||
142965420|NCT04804033|515408445|FG002|Period 1: DBT Phase|Study terminated by sponsor|5|||
142965421|NCT04804033|515408446|FG003|Period 1: DBT Phase|Study terminated by sponsor|9|||
142965422|NCT04804033|515408443|FG000|Period 1: DBT Phase|Withdrawal by Subject|6|||
142965423|NCT04804033|515408444|FG001|Period 1: DBT Phase|Withdrawal by Subject|12|||
142965424|NCT04804033|515408445|FG002|Period 1: DBT Phase|Withdrawal by Subject|7|||
142965425|NCT04804033|515408446|FG003|Period 1: DBT Phase|Withdrawal by Subject|6|||
142965426|NCT04804033|515408443|FG000|Period 1: DBT Phase|Randomized but not treated|5|||
142965427|NCT04804033|515408444|FG001|Period 1: DBT Phase|Randomized but not treated|5|||
142965428|NCT04804033|515408445|FG002|Period 1: DBT Phase|Randomized but not treated|2|||
142965429|NCT04804033|515408446|FG003|Period 1: DBT Phase|Randomized but not treated|0|||
142965430|NCT04804033|515408443|FG000|Period 2: OLE Phase|Adverse Event|3|||
142965431|NCT04804033|515408444|FG001|Period 2: OLE Phase|Adverse Event|4|||
142965432|NCT04804033|515408445|FG002|Period 2: OLE Phase|Adverse Event|2|||
142965433|NCT04804033|515408446|FG003|Period 2: OLE Phase|Adverse Event|0|||
142965434|NCT04804033|515408443|FG000|Period 2: OLE Phase|Lost to Follow-up|8|||
142965435|NCT04804033|515408444|FG001|Period 2: OLE Phase|Lost to Follow-up|4|||
142965436|NCT04804033|515408445|FG002|Period 2: OLE Phase|Lost to Follow-up|3|||
142965437|NCT04804033|515408446|FG003|Period 2: OLE Phase|Lost to Follow-up|4|||
142965438|NCT04804033|515408443|FG000|Period 2: OLE Phase|Non-compliance|2|||
142965439|NCT04804033|515408444|FG001|Period 2: OLE Phase|Non-compliance|2|||
142965440|NCT04804033|515408445|FG002|Period 2: OLE Phase|Non-compliance|0|||
142965441|NCT04804033|515408446|FG003|Period 2: OLE Phase|Non-compliance|1|||
142965442|NCT04804033|515408443|FG000|Period 2: OLE Phase|Other|0|||
142965443|NCT04804033|515408444|FG001|Period 2: OLE Phase|Other|2|||
142965444|NCT04804033|515408445|FG002|Period 2: OLE Phase|Other|0|||
142965445|NCT04804033|515408446|FG003|Period 2: OLE Phase|Other|0|||
142965446|NCT04804033|515408443|FG000|Period 2: OLE Phase|Physician Decision|1|||
142965447|NCT04804033|515408444|FG001|Period 2: OLE Phase|Physician Decision|1|||
142965448|NCT04804033|515408445|FG002|Period 2: OLE Phase|Physician Decision|0|||
142965449|NCT04804033|515408446|FG003|Period 2: OLE Phase|Physician Decision|0|||
142965450|NCT04804033|515408443|FG000|Period 2: OLE Phase|Pregnancy|0|||
142965451|NCT04804033|515408444|FG001|Period 2: OLE Phase|Pregnancy|0|||
142965452|NCT04804033|515408445|FG002|Period 2: OLE Phase|Pregnancy|2|||
142965453|NCT04804033|515408446|FG003|Period 2: OLE Phase|Pregnancy|0|||
142965454|NCT04804033|515408443|FG000|Period 2: OLE Phase|Study terminated by sponsor|41|||
142965455|NCT04804033|515408444|FG001|Period 2: OLE Phase|Study terminated by sponsor|37|||
142965456|NCT04804033|515408445|FG002|Period 2: OLE Phase|Study terminated by sponsor|17|||
142965457|NCT04804033|515408446|FG003|Period 2: OLE Phase|Study terminated by sponsor|19|||
142965458|NCT04804033|515408443|FG000|Period 2: OLE Phase|Withdrawal by Subject|16|||
142965459|NCT04804033|515408444|FG001|Period 2: OLE Phase|Withdrawal by Subject|8|||
142965460|NCT04804033|515408445|FG002|Period 2: OLE Phase|Withdrawal by Subject|3|||
142965461|NCT04804033|515408446|FG003|Period 2: OLE Phase|Withdrawal by Subject|7|||
142965462|NCT04804033|515408443|FG000|Period 2: OLE Phase|Not reported|0|||
142965463|NCT04804033|515408444|FG001|Period 2: OLE Phase|Not reported|2|||
142965464|NCT04804033|515408445|FG002|Period 2: OLE Phase|Not reported|0|||
142965465|NCT04804033|515408446|FG003|Period 2: OLE Phase|Not reported|0|||
142965466|NCT04804033|515408443|FG000|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
142965467|NCT04804033|515408444|FG001|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
142965468|NCT04804033|515408445|FG002|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
142965469|NCT04804033|515408446|FG003|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
142965470|NCT04804033|515408443|FG000|Period 3: Follow-up Phase|Lost to Follow-up|5|||
142965471|NCT04804033|515408444|FG001|Period 3: Follow-up Phase|Lost to Follow-up|9|||
142965472|NCT04804033|515408445|FG002|Period 3: Follow-up Phase|Lost to Follow-up|0|||
142965473|NCT04804033|515408446|FG003|Period 3: Follow-up Phase|Lost to Follow-up|1|||
142965474|NCT04804033|515408443|FG000|Period 3: Follow-up Phase|Other|0|||
142965475|NCT04804033|515408444|FG001|Period 3: Follow-up Phase|Other|1|||
142965476|NCT04804033|515408445|FG002|Period 3: Follow-up Phase|Other|2|||
142965477|NCT04804033|515408446|FG003|Period 3: Follow-up Phase|Other|1|||
142965478|NCT04804033|515408443|FG000|Period 3: Follow-up Phase|Withdrawal by Subject|7|||
142965479|NCT04804033|515408444|FG001|Period 3: Follow-up Phase|Withdrawal by Subject|6|||
142965480|NCT04804033|515408445|FG002|Period 3: Follow-up Phase|Withdrawal by Subject|3|||
142965481|NCT04804033|515408446|FG003|Period 3: Follow-up Phase|Withdrawal by Subject|4|||
142965482|NCT04804033|515408443|FG000|Period 3: Follow-up Phase|Not reported|18|||
142965483|NCT04804033|515408444|FG001|Period 3: Follow-up Phase|Not reported|15|||
142965484|NCT04804033|515408445|FG002|Period 3: Follow-up Phase|Not reported|1|||
142965485|NCT04804033|515408446|FG003|Period 3: Follow-up Phase|Not reported|4|||
142965486|NCT01106625|515408460|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
142965487|NCT01106625|515408461|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
142965488|NCT01106625|515408462|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
142965489|NCT01106625|515408460|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
142965490|NCT01106625|515408461|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
142965491|NCT01106625|515408462|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
142965492|NCT01106625|515408460|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
142965493|NCT01106625|515408461|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
142965494|NCT01106625|515408462|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
142965495|NCT01106625|515408460|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
142965496|NCT01106625|515408461|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
142965497|NCT01106625|515408462|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
142965498|NCT01106625|515408460|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
142965499|NCT01106625|515408461|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
142965500|NCT01106625|515408462|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
142965501|NCT01106625|515408460|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
142965502|NCT01106625|515408461|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
142965503|NCT01106625|515408462|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
142965504|NCT01106625|515408460|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
142965505|NCT01106625|515408461|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
142965506|NCT01106625|515408462|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
142965507|NCT01106625|515408460|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
142965508|NCT01106625|515408461|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
142965509|NCT01106625|515408462|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
142965510|NCT01106625|515408460|FG000|Core Period: Baseline to Week 26|Other|8|||
142965511|NCT01106625|515408461|FG001|Core Period: Baseline to Week 26|Other|7|||
142965512|NCT01106625|515408462|FG002|Core Period: Baseline to Week 26|Other|4|||
142965513|NCT01106625|515408460|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
142965514|NCT01106625|515408461|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
142965515|NCT01106625|515408462|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
142965516|NCT01106625|515408460|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
142965517|NCT01106625|515408461|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
142965518|NCT01106625|515408462|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
142965519|NCT01106625|515408460|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
142965520|NCT01106625|515408461|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
142965521|NCT01106625|515408462|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
142965522|NCT01106625|515408460|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
142965523|NCT01106625|515408461|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
142965524|NCT01106625|515408462|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
142965525|NCT01106625|515408460|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
142965526|NCT01106625|515408461|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
142965527|NCT01106625|515408462|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
142965528|NCT01106625|515408460|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
142965529|NCT01106625|515408461|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
142965530|NCT01106625|515408462|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
142965531|NCT01106625|515408460|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
142965532|NCT01106625|515408461|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
142965533|NCT01106625|515408462|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
142965534|NCT01106625|515408460|FG000|Extension Period: Week 26 to Week 52|Other|5|||
142965535|NCT01106625|515408461|FG001|Extension Period: Week 26 to Week 52|Other|5|||
142965536|NCT01106625|515408462|FG002|Extension Period: Week 26 to Week 52|Other|4|||
142965537|NCT02496585|515408463|FG000|Overall Study|Death|3|||
142965538|NCT02496585|515408464|FG001|Overall Study|Death|0|||
142965539|NCT02496585|515408463|FG000|Overall Study|Lost to Follow-up|2|||
142965540|NCT02496585|515408464|FG001|Overall Study|Lost to Follow-up|0|||
142965541|NCT02496585|515408463|FG000|Overall Study|Withdrawal by Subject|1|||
142965542|NCT02496585|515408464|FG001|Overall Study|Withdrawal by Subject|2|||
142965543|NCT02496585|515408463|FG000|Overall Study|Progression of Malignancy|4|||
142965544|NCT02496585|515408464|FG001|Overall Study|Progression of Malignancy|1|||
142965545|NCT00668200|515408465|FG000|Overall Study|Withdrawal by Subject|2|||
142965546|NCT00668200|515408465|FG000|Overall Study|Lost to Follow-up|1|||
142965547|NCT01496430|515408466|FG000|Overall Study|Adverse Event|0|||
142965548|NCT01496430|515408467|FG001|Overall Study|Adverse Event|0|||
142965549|NCT01496430|515408468|FG002|Overall Study|Adverse Event|1|||
142965550|NCT01496430|515408466|FG000|Overall Study|Major Protocol Deviation|0|||
142965551|NCT01496430|515408467|FG001|Overall Study|Major Protocol Deviation|0|||
142965552|NCT01496430|515408468|FG002|Overall Study|Major Protocol Deviation|1|||
142965553|NCT01496430|515408466|FG000|Overall Study|Lost to Follow-up|2|||
142965554|NCT01496430|515408467|FG001|Overall Study|Lost to Follow-up|3|||
142965555|NCT01496430|515408468|FG002|Overall Study|Lost to Follow-up|1|||
142965556|NCT01496430|515408466|FG000|Overall Study|Voluntary Withdrawal|2|||
142965557|NCT01496430|515408467|FG001|Overall Study|Voluntary Withdrawal|1|||
142965558|NCT01496430|515408468|FG002|Overall Study|Voluntary Withdrawal|6|||
142965559|NCT01496430|515408466|FG000|Overall Study|Principal Investigator Discretion|0|||
142965560|NCT01496430|515408467|FG001|Overall Study|Principal Investigator Discretion|1|||
142965561|NCT01496430|515408468|FG002|Overall Study|Principal Investigator Discretion|1|||
142965562|NCT01496430|515408466|FG000|Overall Study|Other|2|||
142965563|NCT01496430|515408467|FG001|Overall Study|Other|0|||
142965564|NCT01496430|515408468|FG002|Overall Study|Other|0|||
142965565|NCT00997321|515408469|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
142965566|NCT00997321|515408470|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
142965567|NCT02509598|515408471|FG000|Overall Study|Withdrawal by Subject|1|||
142965568|NCT02512068|515408472|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
142965569|NCT02512068|515408473|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
142965570|NCT02512068|515408472|FG000|Overall Study|Major Protocol Deviation|1|||
142965571|NCT02512068|515408473|FG001|Overall Study|Major Protocol Deviation|0|||
142965572|NCT02512068|515408472|FG000|Overall Study|Voluntary Withdrawal|0|||
142965573|NCT02512068|515408473|FG001|Overall Study|Voluntary Withdrawal|1|||
142965574|NCT02512068|515408472|FG000|Overall Study|Lack of Efficacy|0|||
142965575|NCT02512068|515408473|FG001|Overall Study|Lack of Efficacy|1|||
142965576|NCT02512068|515408472|FG000|Overall Study|Reason Not Specified|3|||
142965577|NCT02512068|515408473|FG001|Overall Study|Reason Not Specified|5|||
142965578|NCT01151579|515408481|FG000|Overall Study|Physician Decision|3|||
142965579|NCT01151579|515408482|FG001|Overall Study|Physician Decision|1|||
142965580|NCT01151579|515408481|FG000|Overall Study|Withdrawal by Subject|3|||
142965581|NCT01151579|515408482|FG001|Overall Study|Withdrawal by Subject|2|||
142965582|NCT01151579|515408481|FG000|Overall Study|Not meet inclusion criteria|6|||
142965583|NCT01151579|515408482|FG001|Overall Study|Not meet inclusion criteria|4|||
142965584|NCT01276457|515408483|FG000|Core Study|Adverse Event|6|||
142965585|NCT01276457|515408484|FG001|Core Study|Adverse Event|3|||
142965586|NCT01276457|515408483|FG000|Core Study|Lost to Follow-up|1|||
142965587|NCT01276457|515408484|FG001|Core Study|Lost to Follow-up|2|||
142965588|NCT01276457|515408483|FG000|Core Study|Administrative problems|1|||
142965589|NCT01276457|515408484|FG001|Core Study|Administrative problems|1|||
142965590|NCT01276457|515408483|FG000|Core Study|Death|2|||
142965591|NCT01276457|515408484|FG001|Core Study|Death|2|||
142965592|NCT01276457|515408483|FG000|Core Study|Lack of Efficacy|3|||
142965593|NCT01276457|515408484|FG001|Core Study|Lack of Efficacy|12|||
142965594|NCT01276457|515408483|FG000|Extension Study|Lost to Follow-up|3|||
142965595|NCT01276457|515408484|FG001|Extension Study|Lost to Follow-up|0|||
142965596|NCT01276457|515408483|FG000|Extension Study|Death|0|||
142965597|NCT01276457|515408484|FG001|Extension Study|Death|1|||
142965598|NCT01276457|515408483|FG000|Extension Study|Lack of Efficacy|3|||
142965599|NCT01276457|515408484|FG001|Extension Study|Lack of Efficacy|1|||
142965600|NCT04360187|515408489|FG000|Double-Blind Treatment|Adverse Event|9|||
142965601|NCT04360187|515408490|FG001|Double-Blind Treatment|Adverse Event|11|||
142965602|NCT04360187|515408489|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
142965603|NCT04360187|515408490|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
142965604|NCT04360187|515408489|FG000|Double-Blind Treatment|Physician Decision|1|||
142965605|NCT04360187|515408490|FG001|Double-Blind Treatment|Physician Decision|0|||
142965606|NCT04360187|515408489|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
142965607|NCT04360187|515408490|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
142965608|NCT04360187|515408489|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
142965609|NCT04360187|515408490|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
142965610|NCT04360187|515408489|FG000|Follow-Up|Lost to Follow-up|1|||
142965611|NCT04360187|515408490|FG001|Follow-Up|Lost to Follow-up|0|||
142965612|NCT04436822|515408497|FG000|Overall Study|Physician Decision|2|||
142965613|NCT04436822|515408498|FG001|Overall Study|Physician Decision|0|||
142965614|NCT04436822|515408497|FG000|Overall Study|Sponsor request|1|||
142965615|NCT04436822|515408498|FG001|Overall Study|Sponsor request|0|||
142965616|NCT04436822|515408497|FG000|Overall Study|Withdrawal by parent/guardian|0|||
142965617|NCT04436822|515408498|FG001|Overall Study|Withdrawal by parent/guardian|3|||
142965618|NCT04436822|515408497|FG000|Overall Study|Unsuccessful procedure|0|||
142965619|NCT04436822|515408498|FG001|Overall Study|Unsuccessful procedure|1|||
142965620|NCT04436822|515408497|FG000|Overall Study|Withdrawal due to Covid-19|8|||
142965621|NCT04436822|515408498|FG001|Overall Study|Withdrawal due to Covid-19|1|||
142965622|NCT04436822|515408497|FG000|Overall Study|Withdrawal by Subject|1|||
142965623|NCT04436822|515408498|FG001|Overall Study|Withdrawal by Subject|0|||
142965624|NCT04436822|515408497|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
142965625|NCT04436822|515408498|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
142965626|NCT00471445|515408507|FG000|Overall Study|Withdrawal by Subject|1|||
142965627|NCT00471445|515408508|FG001|Overall Study|Withdrawal by Subject|1|||
142965628|NCT00471445|515408507|FG000|Overall Study|Ineligible|1|||
142965629|NCT00471445|515408508|FG001|Overall Study|Ineligible|0|||
142965630|NCT00471445|515408507|FG000|Overall Study|Protocol Violation|0|||
142965631|NCT00471445|515408508|FG001|Overall Study|Protocol Violation|1|||
142965632|NCT02427477|515408509|FG000|Period 1|Adverse Event|1|||
142965633|NCT02427477|515408510|FG001|Period 1|Adverse Event|0|||
142965634|NCT01552928|515408511|FG000|Period 3|Adverse Event|0|||
142965635|NCT01552928|515408512|FG001|Period 3|Adverse Event|0|||
142965636|NCT01552928|515408513|FG002|Period 3|Adverse Event|1|||
142965637|NCT01552928|515408514|FG003|Period 3|Adverse Event|0|||
142965638|NCT01767194|515408515|FG000|Overall Study|Adverse Event|1|||
142965639|NCT01767194|515408516|FG001|Overall Study|Adverse Event|1|||
142965640|NCT01767194|515408515|FG000|Overall Study|Death|0|||
142965641|NCT01767194|515408516|FG001|Overall Study|Death|1|||
142965642|NCT01767194|515408515|FG000|Overall Study|Lack of Efficacy|12|||
143117146|NCT01273155|515970040|FG002|Overall Study|Died during Cycle 1|1|||
142965643|NCT01767194|515408516|FG001|Overall Study|Lack of Efficacy|11|||
142965644|NCT01767194|515408515|FG000|Overall Study|Physician Decision|2|||
142965645|NCT01767194|515408516|FG001|Overall Study|Physician Decision|23|||
142965646|NCT01767194|515408515|FG000|Overall Study|Withdrawal by Subject|0|||
142965647|NCT01767194|515408516|FG001|Overall Study|Withdrawal by Subject|1|||
142965648|NCT01767194|515408515|FG000|Overall Study|Ineligible|1|||
142965649|NCT01767194|515408516|FG001|Overall Study|Ineligible|1|||
142965650|NCT01767194|515408515|FG000|Overall Study|Refusal by patient/parent|2|||
142965651|NCT01767194|515408516|FG001|Overall Study|Refusal by patient/parent|4|||
142965652|NCT01767194|515408515|FG000|Overall Study|Criteria not met on time for next cycle|0|||
142965653|NCT01767194|515408516|FG001|Overall Study|Criteria not met on time for next cycle|1|||
142965654|NCT02020031|515410741|FG000|Overall Study|Physician Decision|1|||
142965655|NCT02020031|515410742|FG001|Overall Study|Physician Decision|1|||
142965656|NCT00755846|515410743|FG000|Overall Study|Adverse Event|0|||
142965657|NCT00755846|515410744|FG001|Overall Study|Adverse Event|0|||
142965658|NCT00755846|515410745|FG002|Overall Study|Adverse Event|0|||
142965659|NCT00755846|515410746|FG003|Overall Study|Adverse Event|1|||
142965660|NCT00755846|515410747|FG004|Overall Study|Adverse Event|3|||
142965661|NCT00755846|515410748|FG005|Overall Study|Adverse Event|2|||
142965662|NCT00755846|515410743|FG000|Overall Study|Protocol Violation|1|||
142965663|NCT00755846|515410744|FG001|Overall Study|Protocol Violation|1|||
142965664|NCT00755846|515410745|FG002|Overall Study|Protocol Violation|1|||
142965665|NCT00755846|515410746|FG003|Overall Study|Protocol Violation|1|||
142965666|NCT00755846|515410747|FG004|Overall Study|Protocol Violation|1|||
142965667|NCT00755846|515410748|FG005|Overall Study|Protocol Violation|1|||
142965668|NCT00755846|515410743|FG000|Overall Study|Lost to Follow-up|0|||
142965669|NCT00755846|515410744|FG001|Overall Study|Lost to Follow-up|2|||
142965670|NCT00755846|515410745|FG002|Overall Study|Lost to Follow-up|1|||
142965671|NCT00755846|515410746|FG003|Overall Study|Lost to Follow-up|0|||
142965672|NCT00755846|515410747|FG004|Overall Study|Lost to Follow-up|4|||
142965673|NCT00755846|515410748|FG005|Overall Study|Lost to Follow-up|2|||
142965674|NCT00755846|515410743|FG000|Overall Study|Withdrawal by Subject|2|||
142965675|NCT00755846|515410744|FG001|Overall Study|Withdrawal by Subject|3|||
142965676|NCT00755846|515410745|FG002|Overall Study|Withdrawal by Subject|5|||
142965677|NCT00755846|515410746|FG003|Overall Study|Withdrawal by Subject|2|||
142965678|NCT00755846|515410747|FG004|Overall Study|Withdrawal by Subject|0|||
142965679|NCT00755846|515410748|FG005|Overall Study|Withdrawal by Subject|1|||
142965680|NCT00755846|515410743|FG000|Overall Study|Hyperglycemic Rescue|21|||
142965681|NCT00755846|515410744|FG001|Overall Study|Hyperglycemic Rescue|7|||
142965682|NCT00755846|515410745|FG002|Overall Study|Hyperglycemic Rescue|5|||
142965683|NCT00755846|515410746|FG003|Overall Study|Hyperglycemic Rescue|8|||
142965684|NCT00755846|515410747|FG004|Overall Study|Hyperglycemic Rescue|8|||
142965685|NCT00755846|515410748|FG005|Overall Study|Hyperglycemic Rescue|7|||
142965686|NCT00755846|515410743|FG000|Overall Study|Physician Decision|1|||
142965687|NCT00755846|515410744|FG001|Overall Study|Physician Decision|3|||
142965688|NCT00755846|515410745|FG002|Overall Study|Physician Decision|0|||
142965689|NCT00755846|515410746|FG003|Overall Study|Physician Decision|1|||
142965690|NCT00755846|515410747|FG004|Overall Study|Physician Decision|0|||
142965691|NCT00755846|515410748|FG005|Overall Study|Physician Decision|1|||
142965692|NCT00755846|515410743|FG000|Overall Study|Administrative Error|0|||
142965693|NCT00755846|515410744|FG001|Overall Study|Administrative Error|1|||
142965694|NCT00755846|515410745|FG002|Overall Study|Administrative Error|0|||
142965695|NCT00755846|515410746|FG003|Overall Study|Administrative Error|0|||
143455425|NCT03573583|517212441|FG001|Overall Study|Withdrawal by Subject|1|||
143455426|NCT00037830|517212442|FG000|Overall Study|Adverse Event|2|||
143455427|NCT00037830|517212443|FG001|Overall Study|Adverse Event|0|||
143455428|NCT00037830|517212444|FG002|Overall Study|Adverse Event|0|||
143455429|NCT00037830|517212442|FG000|Overall Study|Withdrawal by Subject|4|||
142965696|NCT00755846|515410747|FG004|Overall Study|Administrative Error|0|||
142965697|NCT00755846|515410748|FG005|Overall Study|Administrative Error|0|||
142965698|NCT00755846|515410743|FG000|Overall Study|Participant Non-compliance|0|||
142965699|NCT00755846|515410744|FG001|Overall Study|Participant Non-compliance|0|||
143455430|NCT00037830|517212443|FG001|Overall Study|Withdrawal by Subject|5|||
142965700|NCT00755846|515410745|FG002|Overall Study|Participant Non-compliance|0|||
142965701|NCT00755846|515410746|FG003|Overall Study|Participant Non-compliance|0|||
142965702|NCT00755846|515410747|FG004|Overall Study|Participant Non-compliance|1|||
142965703|NCT00755846|515410748|FG005|Overall Study|Participant Non-compliance|0|||
142965704|NCT00786032|515410756|FG000|Overall Study|Death|4|||
142965705|NCT00786032|515410756|FG000|Overall Study|Withdrawal by Subject|14|||
142965706|NCT00786032|515410756|FG000|Overall Study|Did not complete in the timeframe|6|||
142965707|NCT02294318|515410757|FG000|Overall Study|Worsening of drinking|3|||
142965708|NCT02294318|515410758|FG001|Overall Study|Worsening of drinking|0|||
142965709|NCT02294318|515410757|FG000|Overall Study|Not exposed to intervention|0|||
142965710|NCT02294318|515410758|FG001|Overall Study|Not exposed to intervention|2|||
142965711|NCT02429258|515410759|FG000|Overall Study|Withdrawal by Subject|2|||
142965712|NCT02429258|515410760|FG001|Overall Study|Withdrawal by Subject|0|||
142965713|NCT02429258|515410759|FG000|Overall Study|Protocol Violation|0|||
142965714|NCT02429258|515410760|FG001|Overall Study|Protocol Violation|1|||
143455431|NCT00037830|517212444|FG002|Overall Study|Withdrawal by Subject|1|||
142965715|NCT01694420|515410763|FG000|Overall Study|Lost to Follow-up|3|||
142965716|NCT00762372|515410764|FG000|Overall Study|Adverse Event|1|||
142965717|NCT00762372|515410765|FG001|Overall Study|Adverse Event|0|||
142965718|NCT00762372|515410766|FG002|Overall Study|Adverse Event|0|||
142965719|NCT02616185|515410767|FG000|Overall Study|Death|0|||
142965720|NCT02616185|515410768|FG001|Overall Study|Death|0|||
142965721|NCT02616185|515410769|FG002|Overall Study|Death|0|||
142965722|NCT02616185|515410770|FG003|Overall Study|Death|1|||
142965723|NCT02616185|515410771|FG004|Overall Study|Death|2|||
142965724|NCT02616185|515410772|FG005|Overall Study|Death|0|||
142965725|NCT02616185|515410773|FG006|Overall Study|Death|0|||
142965726|NCT02616185|515410774|FG007|Overall Study|Death|2|||
142965727|NCT02616185|515410775|FG008|Overall Study|Death|1|||
142965728|NCT02616185|515410767|FG000|Overall Study|Study terminated by sponsor|0|||
142965729|NCT02616185|515410768|FG001|Overall Study|Study terminated by sponsor|0|||
142965730|NCT02616185|515410769|FG002|Overall Study|Study terminated by sponsor|1|||
142965731|NCT02616185|515410770|FG003|Overall Study|Study terminated by sponsor|0|||
142965732|NCT02616185|515410771|FG004|Overall Study|Study terminated by sponsor|0|||
142965733|NCT02616185|515410772|FG005|Overall Study|Study terminated by sponsor|0|||
142965734|NCT02616185|515410773|FG006|Overall Study|Study terminated by sponsor|5|||
142965735|NCT02616185|515410774|FG007|Overall Study|Study terminated by sponsor|2|||
142965736|NCT02616185|515410775|FG008|Overall Study|Study terminated by sponsor|0|||
142965737|NCT02616185|515410767|FG000|Overall Study|Participant refused further follow-up|1|||
142965738|NCT02616185|515410768|FG001|Overall Study|Participant refused further follow-up|1|||
142965739|NCT02616185|515410769|FG002|Overall Study|Participant refused further follow-up|2|||
142965740|NCT02616185|515410770|FG003|Overall Study|Participant refused further follow-up|3|||
142965741|NCT02616185|515410771|FG004|Overall Study|Participant refused further follow-up|4|||
142965742|NCT02616185|515410772|FG005|Overall Study|Participant refused further follow-up|0|||
142965743|NCT02616185|515410773|FG006|Overall Study|Participant refused further follow-up|3|||
142965744|NCT02616185|515410774|FG007|Overall Study|Participant refused further follow-up|4|||
142965745|NCT02616185|515410775|FG008|Overall Study|Participant refused further follow-up|3|||
142965746|NCT02616185|515410767|FG000|Overall Study|Not reported|0|||
142965747|NCT02616185|515410768|FG001|Overall Study|Not reported|0|||
142965748|NCT02616185|515410769|FG002|Overall Study|Not reported|0|||
142965749|NCT02616185|515410770|FG003|Overall Study|Not reported|1|||
142965750|NCT02616185|515410771|FG004|Overall Study|Not reported|3|||
142965751|NCT02616185|515410772|FG005|Overall Study|Not reported|1|||
142965752|NCT02616185|515410773|FG006|Overall Study|Not reported|0|||
142965753|NCT02616185|515410774|FG007|Overall Study|Not reported|5|||
142965754|NCT02616185|515410775|FG008|Overall Study|Not reported|2|||
142965755|NCT03137121|515410778|FG000|Overall Study|Withdrawal by Subject|0|||
142965756|NCT03137121|515410779|FG001|Overall Study|Withdrawal by Subject|1|||
142965757|NCT02709083|515410782|FG000|Overall Study|Original PI left institution|7|||
142965758|NCT01026389|515410786|FG000|Overall Study|Withdrawal by Subject|1|||
142965759|NCT01026389|515410787|FG001|Overall Study|Withdrawal by Subject|3|||
142965760|NCT01026389|515410786|FG000|Overall Study|change of treatment, patient moved|4|||
142965761|NCT01026389|515410787|FG001|Overall Study|change of treatment, patient moved|2|||
142965762|NCT04410198|515410788|FG000|Overall Study|Death|10|||
142965763|NCT04410198|515410788|FG000|Overall Study|Withdrawal by Subject|7|||
142965764|NCT04410198|515410788|FG000|Overall Study|Transferred/Relocation|4|||
142965765|NCT04410198|515410788|FG000|Overall Study|Kidney Transplant|9|||
142965766|NCT04410198|515410788|FG000|Overall Study|Adverse Event|4|||
142965767|NCT04410198|515410788|FG000|Overall Study|Physician Decision|2|||
142965768|NCT04410198|515410788|FG000|Overall Study|Other than specified|1|||
142965769|NCT02939937|515410791|FG000|Overall Study|Adverse Event|5|||
142965770|NCT02939937|515410792|FG001|Overall Study|Adverse Event|0|||
142965771|NCT02939937|515410791|FG000|Overall Study|Lost to Follow-up|1|||
142965772|NCT02939937|515410792|FG001|Overall Study|Lost to Follow-up|3|||
142965773|NCT00871377|515410799|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
142965774|NCT00871377|515410800|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
142965775|NCT00871377|515410801|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
142965776|NCT00871377|515410802|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
142965777|NCT00871377|515410803|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
142965778|NCT00871377|515410804|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
142965779|NCT00871377|515410799|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
142965780|NCT00871377|515410800|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
142965781|NCT00871377|515410801|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
142965782|NCT00871377|515410802|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
142965783|NCT00871377|515410803|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
142965784|NCT00871377|515410804|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
142965785|NCT00871377|515410799|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
142965786|NCT00871377|515410800|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
142965787|NCT00871377|515410801|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
142965788|NCT00871377|515410802|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
142965789|NCT00871377|515410803|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
142965790|NCT00871377|515410804|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
142965791|NCT00871377|515410799|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
142965792|NCT00871377|515410800|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
142965793|NCT00871377|515410801|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
142965794|NCT00871377|515410802|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
142965795|NCT00871377|515410803|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
142965796|NCT00871377|515410804|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
142965797|NCT00871377|515410799|FG000|Third Intervention (10 Weeks)|Death|0|||
142965798|NCT00871377|515410800|FG001|Third Intervention (10 Weeks)|Death|0|||
142965799|NCT00871377|515410801|FG002|Third Intervention (10 Weeks)|Death|0|||
142965800|NCT00871377|515410802|FG003|Third Intervention (10 Weeks)|Death|1|||
142965801|NCT00871377|515410803|FG004|Third Intervention (10 Weeks)|Death|0|||
142965802|NCT00871377|515410804|FG005|Third Intervention (10 Weeks)|Death|0|||
142965803|NCT00937560|515410807|FG000|Initial Treatment|Death|6|||
142965804|NCT00937560|515410807|FG000|Initial Treatment|Withdraw consent|3|||
142965805|NCT00937560|515410807|FG000|Initial Treatment|Adverse Event|1|||
142965806|NCT00937560|515410807|FG000|Initial Treatment|Lost to Follow-up|1|||
142965807|NCT00937560|515410807|FG000|Initial Treatment|No end of study page|10|||
142965808|NCT00937560|515410807|FG000|Maintenance Treatment|Death|12|||
142965809|NCT00937560|515410807|FG000|Maintenance Treatment|Withdraw consent|5|||
142965810|NCT00937560|515410807|FG000|Maintenance Treatment|According to protocol|1|||
142965811|NCT00848549|515410808|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
142965812|NCT00848549|515410809|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
142965813|NCT00848549|515410808|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
142965814|NCT00848549|515410809|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
142965815|NCT00848549|515410808|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
142965816|NCT00848549|515410809|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
142965817|NCT00848549|515410808|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
142965818|NCT00848549|515410809|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
142965819|NCT00848549|515410808|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
142965820|NCT00848549|515410809|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
142965821|NCT00848549|515410808|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
142965822|NCT00848549|515410809|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
142965823|NCT00848549|515410808|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
142965824|NCT00848549|515410809|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
142965825|NCT00848549|515410808|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
142965826|NCT00848549|515410809|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
142965827|NCT00848549|515410808|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
142965828|NCT00848549|515410809|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
142965829|NCT00848549|515410808|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
142965830|NCT00848549|515410809|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
142965831|NCT00848549|515410808|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
142965832|NCT00848549|515410809|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
142965833|NCT00848549|515410808|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
142965834|NCT00848549|515410809|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
142965835|NCT00848549|515410808|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
142965836|NCT00848549|515410809|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
142965837|NCT00848549|515410808|FG000|E2090-E044-314 (Extension Study)|Other|5|||
142965838|NCT00848549|515410809|FG001|E2090-E044-314 (Extension Study)|Other|6|||
142965839|NCT02561299|515410810|FG000|Overall Study|Death|2|||
142965840|NCT02561299|515410811|FG001|Overall Study|Death|4|||
142965841|NCT02561299|515410810|FG000|Overall Study|Lost to Follow-up|1|||
142965842|NCT02561299|515410811|FG001|Overall Study|Lost to Follow-up|0|||
142965843|NCT02561299|515410810|FG000|Overall Study|Withdrawal by Subject|2|||
142965844|NCT02561299|515410811|FG001|Overall Study|Withdrawal by Subject|2|||
142965845|NCT01248130|515410812|FG000|Overall Study|Protocol Violation|1|||
142965846|NCT01248130|515410813|FG001|Overall Study|Protocol Violation|0|||
142965847|NCT01248130|515410812|FG000|Overall Study|Ineligible|1|||
142965848|NCT01248130|515410813|FG001|Overall Study|Ineligible|0|||
142965849|NCT01911845|515410818|FG000|Overall Study|Adverse Event|2|||
142965850|NCT01911845|515410818|FG000|Overall Study|Lost to Follow-up|1|||
142965851|NCT01911845|515410818|FG000|Overall Study|Other (not specified)|3|||
142965852|NCT00501046|515410819|FG000|Overall Study|Adverse Event|21|||
142965853|NCT00501046|515410820|FG001|Overall Study|Adverse Event|25|||
142965854|NCT00501046|515410819|FG000|Overall Study|Death|23|||
142965855|NCT00501046|515410820|FG001|Overall Study|Death|30|||
142965856|NCT00501046|515410819|FG000|Overall Study|Lost to Follow-up|14|||
142965857|NCT00501046|515410820|FG001|Overall Study|Lost to Follow-up|13|||
142965858|NCT00501046|515410819|FG000|Overall Study|Physician Decision|7|||
142965859|NCT00501046|515410820|FG001|Overall Study|Physician Decision|2|||
142965860|NCT00501046|515410819|FG000|Overall Study|Pregnancy|0|||
142965861|NCT00501046|515410820|FG001|Overall Study|Pregnancy|3|||
142965862|NCT00501046|515410819|FG000|Overall Study|Protocol Violation|2|||
142965863|NCT00501046|515410820|FG001|Overall Study|Protocol Violation|1|||
142965864|NCT00501046|515410819|FG000|Overall Study|Withdrawal by Subject|84|||
142965865|NCT00501046|515410820|FG001|Overall Study|Withdrawal by Subject|83|||
142965866|NCT00501046|515410819|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
142965867|NCT00501046|515410820|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
142965868|NCT02546674|515410832|FG000|Overall Study|Adverse Event|19|||
142965869|NCT02546674|515410832|FG000|Overall Study|Death|1|||
142965870|NCT02546674|515410832|FG000|Overall Study|Lost to Follow-up|1|||
142965871|NCT02546674|515410832|FG000|Overall Study|Physician Decision|13|||
142965872|NCT02546674|515410832|FG000|Overall Study|Pregnancy|1|||
142965873|NCT02546674|515410832|FG000|Overall Study|Progressive Disease|2|||
142965874|NCT02546674|515410832|FG000|Overall Study|Protocol Deviation|2|||
142965875|NCT02546674|515410832|FG000|Overall Study|Subject/Guardian Decision|6|||
142965876|NCT02546674|515410832|FG000|Overall Study|Withdrawal of Informed Consent|3|||
142965877|NCT01860534|515410833|FG000|ROP #1|Needed treatment for ROP|0|||
142965878|NCT01860534|515410834|FG001|ROP #1|Needed treatment for ROP|1|||
142965879|NCT01860534|515410833|FG000|ROP #2|discharged prior to ROP #2|1|||
142965880|NCT01860534|515410834|FG001|ROP #2|discharged prior to ROP #2|0|||
142965881|NCT01188564|515410835|FG000|Double-blind Phase|randomized not treated|1|||
142965882|NCT01188564|515410836|FG001|Double-blind Phase|randomized not treated|0|||
142965883|NCT01934894|515410837|FG000|Overall Study|Adverse Event|1|||
142965884|NCT01934894|515410838|FG001|Overall Study|Adverse Event|2|||
142965885|NCT01934894|515410837|FG000|Overall Study|Death|2|||
142965886|NCT01934894|515410838|FG001|Overall Study|Death|0|||
142965887|NCT01934894|515410837|FG000|Overall Study|Withdrawal by Subject|0|||
142965888|NCT01934894|515410838|FG001|Overall Study|Withdrawal by Subject|1|||
142965889|NCT01934894|515410837|FG000|Overall Study|Progressive Disease|3|||
142965890|NCT01934894|515410838|FG001|Overall Study|Progressive Disease|2|||
142965891|NCT02864940|515410844|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
142965892|NCT02864940|515410845|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
142965893|NCT02175771|515410846|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
142965894|NCT02175771|515410847|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
142965895|NCT02175771|515410848|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
142965896|NCT02175771|515410849|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
142965897|NCT02175771|515410850|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
142965898|NCT02175771|515410851|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
142965899|NCT02175771|515410852|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
142965900|NCT02175771|515410853|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
142965901|NCT02175771|515410854|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
142965902|NCT02175771|515410846|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
142965903|NCT02175771|515410847|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
142965904|NCT02175771|515410848|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
142965905|NCT02175771|515410849|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
142965906|NCT02175771|515410850|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
142965907|NCT02175771|515410851|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
142965908|NCT02175771|515410852|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
142965909|NCT02175771|515410853|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
142965910|NCT02175771|515410854|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
142965911|NCT02175771|515410846|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
142965912|NCT02175771|515410847|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
142965913|NCT02175771|515410848|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
142965914|NCT02175771|515410849|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
142965915|NCT02175771|515410850|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
142965916|NCT02175771|515410851|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
142965917|NCT02175771|515410852|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
142965918|NCT02175771|515410853|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
142965919|NCT02175771|515410854|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
142965920|NCT02175771|515410846|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
142965921|NCT02175771|515410847|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
142965922|NCT02175771|515410848|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
142965923|NCT02175771|515410849|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
142965924|NCT02175771|515410850|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
142965925|NCT02175771|515410851|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
142965926|NCT02175771|515410852|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
142965927|NCT02175771|515410853|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
142965928|NCT02175771|515410854|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
142965929|NCT02175771|515410846|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
142965930|NCT02175771|515410847|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
142965931|NCT02175771|515410848|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
143003134|NCT01049360|515548746|FG002|Period 2|Adverse Event|0|||
142965932|NCT02175771|515410849|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
142965933|NCT02175771|515410850|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
142965934|NCT02175771|515410851|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
142965935|NCT02175771|515410852|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
142965936|NCT02175771|515410853|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
142965937|NCT02175771|515410854|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
142965938|NCT02175771|515410846|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
142965939|NCT02175771|515410847|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
142965940|NCT02175771|515410848|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
142965941|NCT02175771|515410849|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
142965942|NCT02175771|515410850|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
142965943|NCT02175771|515410851|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
142965944|NCT02175771|515410852|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
142965945|NCT02175771|515410853|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
142965946|NCT02175771|515410854|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
142965947|NCT02175771|515410846|FG000|Run-In Period (Pre-assignment)|Other|8|||
142965948|NCT02175771|515410847|FG001|Run-In Period (Pre-assignment)|Other|0|||
142965949|NCT02175771|515410848|FG002|Run-In Period (Pre-assignment)|Other|0|||
142965950|NCT02175771|515410849|FG003|Run-In Period (Pre-assignment)|Other|0|||
142965951|NCT02175771|515410850|FG004|Run-In Period (Pre-assignment)|Other|0|||
142965952|NCT02175771|515410851|FG005|Run-In Period (Pre-assignment)|Other|0|||
142965953|NCT02175771|515410852|FG006|Run-In Period (Pre-assignment)|Other|0|||
142965954|NCT02175771|515410853|FG007|Run-In Period (Pre-assignment)|Other|0|||
142965955|NCT02175771|515410854|FG008|Run-In Period (Pre-assignment)|Other|0|||
142965956|NCT02175771|515410846|FG000|Treatment Period|Adverse Event|0|||
142965957|NCT02175771|515410847|FG001|Treatment Period|Adverse Event|2|||
142965958|NCT02175771|515410848|FG002|Treatment Period|Adverse Event|1|||
142965959|NCT02175771|515410849|FG003|Treatment Period|Adverse Event|1|||
142965960|NCT02175771|515410850|FG004|Treatment Period|Adverse Event|1|||
142965961|NCT02175771|515410851|FG005|Treatment Period|Adverse Event|3|||
142965962|NCT02175771|515410852|FG006|Treatment Period|Adverse Event|2|||
142965963|NCT02175771|515410853|FG007|Treatment Period|Adverse Event|0|||
142965964|NCT02175771|515410854|FG008|Treatment Period|Adverse Event|1|||
142965965|NCT02175771|515410846|FG000|Treatment Period|Withdrawal by Subject|0|||
142965966|NCT02175771|515410847|FG001|Treatment Period|Withdrawal by Subject|9|||
142965967|NCT02175771|515410848|FG002|Treatment Period|Withdrawal by Subject|3|||
142965968|NCT02175771|515410849|FG003|Treatment Period|Withdrawal by Subject|6|||
142965969|NCT02175771|515410850|FG004|Treatment Period|Withdrawal by Subject|2|||
142965970|NCT02175771|515410851|FG005|Treatment Period|Withdrawal by Subject|4|||
142965971|NCT02175771|515410852|FG006|Treatment Period|Withdrawal by Subject|2|||
142965972|NCT02175771|515410853|FG007|Treatment Period|Withdrawal by Subject|9|||
142965973|NCT02175771|515410854|FG008|Treatment Period|Withdrawal by Subject|2|||
142965974|NCT02175771|515410846|FG000|Treatment Period|Noncompliance|0|||
142965975|NCT02175771|515410847|FG001|Treatment Period|Noncompliance|1|||
142965976|NCT02175771|515410848|FG002|Treatment Period|Noncompliance|2|||
142965977|NCT02175771|515410849|FG003|Treatment Period|Noncompliance|0|||
142965978|NCT02175771|515410850|FG004|Treatment Period|Noncompliance|0|||
142965979|NCT02175771|515410851|FG005|Treatment Period|Noncompliance|0|||
142965980|NCT02175771|515410852|FG006|Treatment Period|Noncompliance|0|||
142965981|NCT02175771|515410853|FG007|Treatment Period|Noncompliance|0|||
142965982|NCT02175771|515410854|FG008|Treatment Period|Noncompliance|1|||
142965983|NCT02175771|515410846|FG000|Treatment Period|Protocol Violation|0|||
142965984|NCT02175771|515410847|FG001|Treatment Period|Protocol Violation|0|||
142965985|NCT02175771|515410848|FG002|Treatment Period|Protocol Violation|0|||
142965986|NCT02175771|515410849|FG003|Treatment Period|Protocol Violation|0|||
142965987|NCT02175771|515410850|FG004|Treatment Period|Protocol Violation|0|||
142965988|NCT02175771|515410851|FG005|Treatment Period|Protocol Violation|0|||
142965989|NCT02175771|515410852|FG006|Treatment Period|Protocol Violation|0|||
142965990|NCT02175771|515410853|FG007|Treatment Period|Protocol Violation|1|||
142965991|NCT02175771|515410854|FG008|Treatment Period|Protocol Violation|0|||
142965992|NCT02175771|515410846|FG000|Treatment Period|Disease progression|0|||
142965993|NCT02175771|515410847|FG001|Treatment Period|Disease progression|0|||
142965994|NCT02175771|515410848|FG002|Treatment Period|Disease progression|0|||
142965995|NCT02175771|515410849|FG003|Treatment Period|Disease progression|0|||
142965996|NCT02175771|515410850|FG004|Treatment Period|Disease progression|0|||
142965997|NCT02175771|515410851|FG005|Treatment Period|Disease progression|0|||
142965998|NCT02175771|515410852|FG006|Treatment Period|Disease progression|0|||
142965999|NCT02175771|515410853|FG007|Treatment Period|Disease progression|2|||
142966000|NCT02175771|515410854|FG008|Treatment Period|Disease progression|0|||
142966001|NCT02175771|515410846|FG000|Treatment Period|Lost to Follow-up|0|||
142966002|NCT02175771|515410847|FG001|Treatment Period|Lost to Follow-up|3|||
142966003|NCT02175771|515410848|FG002|Treatment Period|Lost to Follow-up|1|||
142966004|NCT02175771|515410849|FG003|Treatment Period|Lost to Follow-up|3|||
142966005|NCT02175771|515410850|FG004|Treatment Period|Lost to Follow-up|1|||
142966006|NCT02175771|515410851|FG005|Treatment Period|Lost to Follow-up|2|||
142966007|NCT02175771|515410852|FG006|Treatment Period|Lost to Follow-up|1|||
142966008|NCT02175771|515410853|FG007|Treatment Period|Lost to Follow-up|2|||
142966009|NCT02175771|515410854|FG008|Treatment Period|Lost to Follow-up|2|||
142966010|NCT02175771|515410846|FG000|Treatment Period|Lack of Efficacy|0|||
142966011|NCT02175771|515410847|FG001|Treatment Period|Lack of Efficacy|0|||
142966012|NCT02175771|515410848|FG002|Treatment Period|Lack of Efficacy|0|||
142966013|NCT02175771|515410849|FG003|Treatment Period|Lack of Efficacy|0|||
142966014|NCT02175771|515410850|FG004|Treatment Period|Lack of Efficacy|0|||
142966015|NCT02175771|515410851|FG005|Treatment Period|Lack of Efficacy|1|||
142966016|NCT02175771|515410852|FG006|Treatment Period|Lack of Efficacy|0|||
142966017|NCT02175771|515410853|FG007|Treatment Period|Lack of Efficacy|1|||
142966018|NCT02175771|515410854|FG008|Treatment Period|Lack of Efficacy|0|||
142966019|NCT02175771|515410846|FG000|Treatment Period|Other|0|||
142966020|NCT02175771|515410847|FG001|Treatment Period|Other|1|||
142966021|NCT02175771|515410848|FG002|Treatment Period|Other|0|||
142966022|NCT02175771|515410849|FG003|Treatment Period|Other|3|||
142966023|NCT02175771|515410850|FG004|Treatment Period|Other|1|||
142966024|NCT02175771|515410851|FG005|Treatment Period|Other|0|||
142966025|NCT02175771|515410852|FG006|Treatment Period|Other|0|||
142966026|NCT02175771|515410853|FG007|Treatment Period|Other|2|||
142966027|NCT02175771|515410854|FG008|Treatment Period|Other|0|||
142966028|NCT03364673|515410855|FG000|Overall Study|Withdrawal by Subject|2|||
142966029|NCT03364673|515410855|FG000|Overall Study|Injury unrelated to study|3|||
142966030|NCT02208024|515410856|FG000|Overall Study|Withdrawal by Subject|1|||
142966031|NCT00779324|515410857|FG000|Overall Study|Lost to Follow-up|2|||
142966032|NCT00779324|515410858|FG001|Overall Study|Lost to Follow-up|1|||
142966033|NCT00779324|515410857|FG000|Overall Study|Withdrawal by Subject|4|||
142966034|NCT00779324|515410858|FG001|Overall Study|Withdrawal by Subject|2|||
142966035|NCT00779324|515410857|FG000|Overall Study|Missed visit|1|||
142966036|NCT00779324|515410858|FG001|Overall Study|Missed visit|1|||
142966037|NCT02207556|515410859|FG000|Overall Study|Physician Decision|1|||
142966038|NCT02207556|515410860|FG001|Overall Study|Physician Decision|0|||
142966039|NCT02207556|515410859|FG000|Overall Study|Withdrawal by Subject|1|||
142966040|NCT02207556|515410860|FG001|Overall Study|Withdrawal by Subject|0|||
142966041|NCT02207556|515410859|FG000|Overall Study|Death|0|||
142966042|NCT02207556|515410860|FG001|Overall Study|Death|5|||
142966043|NCT03558555|515410861|FG000|Overall Study|Lost to Follow-up|2|||
142966044|NCT03558555|515410862|FG001|Overall Study|Lost to Follow-up|1|||
142966045|NCT00194025|515410863|FG000|Overall Study|Adverse Event|1|||
142966046|NCT00194025|515410863|FG000|Overall Study|non-adherence with study medication|4|||
142966047|NCT01098461|515410864|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
142966048|NCT01098461|515410865|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
142966049|NCT01098461|515410866|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
142966050|NCT01098461|515410867|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
142966051|NCT01098461|515410864|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
142966052|NCT01098461|515410865|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
142966053|NCT01098461|515410866|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
142966054|NCT01098461|515410867|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
142966055|NCT01098461|515410864|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
142966056|NCT01098461|515410865|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
142966057|NCT01098461|515410866|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
142966058|NCT01098461|515410867|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
142966059|NCT01098461|515410864|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
142966060|NCT01098461|515410865|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
142966061|NCT01098461|515410866|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
142966062|NCT01098461|515410867|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
142966063|NCT01098461|515410864|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
142966064|NCT01098461|515410865|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
142966065|NCT01098461|515410866|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
142966066|NCT01098461|515410867|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
142966067|NCT01098461|515410864|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
142966068|NCT01098461|515410865|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
143455432|NCT00037830|517212442|FG000|Overall Study|Protocol Violation|2|||
143455433|NCT00037830|517212443|FG001|Overall Study|Protocol Violation|2|||
143455434|NCT00037830|517212444|FG002|Overall Study|Protocol Violation|0|||
142966069|NCT01098461|515410866|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
142966070|NCT01098461|515410867|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
142966071|NCT01098461|515410864|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
142966072|NCT01098461|515410865|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
142966073|NCT01098461|515410866|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
142966074|NCT01098461|515410867|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
142966075|NCT01153763|515410868|FG000|Overall Study|Study Closed|16|||
142966076|NCT01153763|515410868|FG000|Overall Study|Lost to Follow-up|1|||
142966077|NCT01153763|515410868|FG000|Overall Study|Physician Decision|2|||
142966078|NCT01153763|515410868|FG000|Overall Study|Withdrawal by Subject|2|||
142966079|NCT01401010|515410869|FG000|Overall Study|Could not interpret assay results|1|||
142966080|NCT01401010|515410870|FG001|Overall Study|Could not interpret assay results|0|||
142966081|NCT04544709|515410874|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
142966082|NCT03238235|515410875|FG000|Overall Study|Adverse Event|2|||
142966083|NCT03238235|515410876|FG001|Overall Study|Adverse Event|0|||
142966084|NCT03238235|515410875|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
142966085|NCT03238235|515410876|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
142966086|NCT05896761|515410877|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
142966087|NCT05896761|515410878|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
142966088|NCT05896761|515410877|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
142966089|NCT05896761|515410878|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
142966090|NCT02065869|515410880|FG000|Overall Study|Death|7|||
142966091|NCT02065869|515410880|FG000|Overall Study|Disease relapse|16|||
142966092|NCT02065869|515410880|FG000|Overall Study|Lost to Follow-up|4|||
142966093|NCT02065869|515410880|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
142966094|NCT02065869|515410880|FG000|Overall Study|Withdrawal by Subject|1|||
142966095|NCT02993224|515410881|FG000|Core Phase - Period 1|Adverse Event|4|||
142966096|NCT02993224|515410881|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
142966097|NCT02993224|515410881|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
142966098|NCT02993224|515410881|FG000|Core Phase- Period 2|Adverse Event|1|||
142966099|NCT02993224|515410881|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
142966100|NCT02993224|515410881|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
142966101|NCT02993224|515410881|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
142966102|NCT02993224|515410881|FG000|Extension Phase|Adverse Event|3|||
142966103|NCT02993224|515410881|FG000|Extension Phase|Withdrawal by Subject|3|||
142966104|NCT02993224|515410881|FG000|Extension Phase|Lost to Follow-up|2|||
142966105|NCT02993224|515410881|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
142966106|NCT03807739|515410882|FG000|Overall Study|Adverse Event|1|||
142966107|NCT03807739|515410883|FG001|Overall Study|Adverse Event|0|||
142966108|NCT03807739|515410884|FG002|Overall Study|Adverse Event|0|||
142966109|NCT03807739|515410885|FG003|Overall Study|Adverse Event|0|||
142966110|NCT03807739|515410882|FG000|Overall Study|Withdrawal by Subject|1|||
142966111|NCT03807739|515410883|FG001|Overall Study|Withdrawal by Subject|0|||
142966112|NCT03807739|515410884|FG002|Overall Study|Withdrawal by Subject|0|||
142966113|NCT03807739|515410885|FG003|Overall Study|Withdrawal by Subject|0|||
142966114|NCT02371759|515410886|FG000|Overall Study|Protocol Violation|3|||
142966115|NCT02371759|515410887|FG001|Overall Study|Protocol Violation|1|||
142966116|NCT02371759|515410888|FG002|Overall Study|Protocol Violation|1|||
142966117|NCT02371759|515410889|FG003|Overall Study|Protocol Violation|0|||
142966118|NCT02371759|515410890|FG004|Overall Study|Protocol Violation|3|||
142966119|NCT02371759|515410891|FG005|Overall Study|Protocol Violation|1|||
142966120|NCT02371759|515410892|FG006|Overall Study|Protocol Violation|0|||
142966121|NCT02371759|515410893|FG007|Overall Study|Protocol Violation|3|||
142966122|NCT02371759|515410886|FG000|Overall Study|Withdrawal by Subject|0|||
142966123|NCT02371759|515410887|FG001|Overall Study|Withdrawal by Subject|0|||
142966124|NCT02371759|515410888|FG002|Overall Study|Withdrawal by Subject|0|||
142966125|NCT02371759|515410889|FG003|Overall Study|Withdrawal by Subject|0|||
142966126|NCT02371759|515410890|FG004|Overall Study|Withdrawal by Subject|0|||
142966127|NCT02371759|515410891|FG005|Overall Study|Withdrawal by Subject|0|||
142966128|NCT02371759|515410892|FG006|Overall Study|Withdrawal by Subject|0|||
142966129|NCT02371759|515410893|FG007|Overall Study|Withdrawal by Subject|1|||
142966130|NCT03375112|515410897|FG000|Overall Study|Withdrawal by Subject|3|||
142966131|NCT03375112|515410898|FG001|Overall Study|Withdrawal by Subject|0|||
142966132|NCT00243230|515410899|FG000|Double-Blind Period|Adverse Event|0|||
142966133|NCT00243230|515410900|FG001|Double-Blind Period|Adverse Event|2|||
142966134|NCT00243230|515410901|FG002|Double-Blind Period|Adverse Event|2|||
142966135|NCT00243230|515410902|FG003|Double-Blind Period|Adverse Event|0|||
142966136|NCT00243230|515410899|FG000|Double-Blind Period|Withdrawal by Subject|1|||
142966137|NCT00243230|515410900|FG001|Double-Blind Period|Withdrawal by Subject|0|||
142966138|NCT00243230|515410901|FG002|Double-Blind Period|Withdrawal by Subject|0|||
142966139|NCT00243230|515410902|FG003|Double-Blind Period|Withdrawal by Subject|0|||
142966140|NCT00243230|515410899|FG000|Double-Blind Period|Protocol Violation|0|||
142966141|NCT00243230|515410900|FG001|Double-Blind Period|Protocol Violation|0|||
142966142|NCT00243230|515410901|FG002|Double-Blind Period|Protocol Violation|1|||
142966143|NCT00243230|515410902|FG003|Double-Blind Period|Protocol Violation|0|||
142966144|NCT00243230|515410899|FG000|Double-Blind Period|Randomized but Not Treated|0|||
142966145|NCT00243230|515410900|FG001|Double-Blind Period|Randomized but Not Treated|0|||
142966146|NCT00243230|515410901|FG002|Double-Blind Period|Randomized but Not Treated|2|||
142966147|NCT00243230|515410902|FG003|Double-Blind Period|Randomized but Not Treated|0|||
142966148|NCT00243230|515410899|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
143003135|NCT01049360|515548747|FG003|Period 2|Adverse Event|0|||
142966149|NCT00243230|515410900|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
142966150|NCT00243230|515410901|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
142966151|NCT00243230|515410902|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
142966152|NCT00243230|515410899|FG000|Open Label Period|Adverse Event|0|||
142966153|NCT00243230|515410900|FG001|Open Label Period|Adverse Event|0|||
142966154|NCT00243230|515410901|FG002|Open Label Period|Adverse Event|0|||
142966155|NCT00243230|515410902|FG003|Open Label Period|Adverse Event|2|||
142966156|NCT00243230|515410899|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
142966157|NCT00243230|515410900|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
142966158|NCT00243230|515410901|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
142966159|NCT00243230|515410902|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
142966160|NCT00243230|515410899|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
142966161|NCT00243230|515410900|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
142966162|NCT00243230|515410901|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
142966163|NCT00243230|515410902|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
142966164|NCT00243230|515410899|FG000|Open Label Period|Lost to Follow-up|0|||
142966165|NCT00243230|515410900|FG001|Open Label Period|Lost to Follow-up|0|||
142966166|NCT00243230|515410901|FG002|Open Label Period|Lost to Follow-up|0|||
142966167|NCT00243230|515410902|FG003|Open Label Period|Lost to Follow-up|2|||
142966168|NCT00243230|515410899|FG000|Open Label Period|Withdrawal by Subject|0|||
142966169|NCT00243230|515410900|FG001|Open Label Period|Withdrawal by Subject|0|||
142966170|NCT00243230|515410901|FG002|Open Label Period|Withdrawal by Subject|0|||
142966171|NCT00243230|515410902|FG003|Open Label Period|Withdrawal by Subject|2|||
142966172|NCT00243230|515410899|FG000|Open Label Period|Protocol Violation|0|||
142966173|NCT00243230|515410900|FG001|Open Label Period|Protocol Violation|0|||
142966174|NCT00243230|515410901|FG002|Open Label Period|Protocol Violation|0|||
142966175|NCT00243230|515410902|FG003|Open Label Period|Protocol Violation|2|||
142966176|NCT00243230|515410899|FG000|Open Label Period|Administrative Reason|0|||
142966177|NCT00243230|515410900|FG001|Open Label Period|Administrative Reason|0|||
142966178|NCT00243230|515410901|FG002|Open Label Period|Administrative Reason|0|||
142966179|NCT00243230|515410902|FG003|Open Label Period|Administrative Reason|63|||
142966180|NCT03136185|515410905|FG000|Overall Study|Adverse Event|0|||
142966181|NCT03136185|515410906|FG001|Overall Study|Adverse Event|1|||
142966182|NCT03136185|515410907|FG002|Overall Study|Adverse Event|3|||
142966183|NCT03136185|515410908|FG003|Overall Study|Adverse Event|1|||
142966184|NCT03136185|515410909|FG004|Overall Study|Adverse Event|2|||
142966185|NCT03136185|515410910|FG005|Overall Study|Adverse Event|2|||
142966186|NCT03136185|515410911|FG006|Overall Study|Adverse Event|5|||
142966187|NCT03136185|515410912|FG007|Overall Study|Adverse Event|1|||
142966188|NCT03136185|515410913|FG008|Overall Study|Adverse Event|1|||
142966189|NCT03136185|515410905|FG000|Overall Study|Death|0|||
142966190|NCT03136185|515410906|FG001|Overall Study|Death|0|||
142966191|NCT03136185|515410907|FG002|Overall Study|Death|0|||
142966192|NCT03136185|515410908|FG003|Overall Study|Death|1|||
142966193|NCT03136185|515410909|FG004|Overall Study|Death|1|||
142966194|NCT03136185|515410910|FG005|Overall Study|Death|0|||
142966195|NCT03136185|515410911|FG006|Overall Study|Death|1|||
142966196|NCT03136185|515410912|FG007|Overall Study|Death|0|||
142966197|NCT03136185|515410913|FG008|Overall Study|Death|0|||
142966198|NCT03136185|515410905|FG000|Overall Study|Physician Decision|3|||
142966199|NCT03136185|515410906|FG001|Overall Study|Physician Decision|1|||
142966200|NCT03136185|515410907|FG002|Overall Study|Physician Decision|1|||
142966201|NCT03136185|515410908|FG003|Overall Study|Physician Decision|2|||
142966202|NCT03136185|515410909|FG004|Overall Study|Physician Decision|1|||
142966203|NCT03136185|515410910|FG005|Overall Study|Physician Decision|2|||
142966204|NCT03136185|515410911|FG006|Overall Study|Physician Decision|1|||
142966205|NCT03136185|515410912|FG007|Overall Study|Physician Decision|0|||
142966206|NCT03136185|515410913|FG008|Overall Study|Physician Decision|1|||
142966207|NCT03136185|515410905|FG000|Overall Study|Protocol Defined Disease Progression|0|||
142966208|NCT03136185|515410906|FG001|Overall Study|Protocol Defined Disease Progression|0|||
142966209|NCT03136185|515410907|FG002|Overall Study|Protocol Defined Disease Progression|1|||
142966210|NCT03136185|515410908|FG003|Overall Study|Protocol Defined Disease Progression|0|||
142966211|NCT03136185|515410909|FG004|Overall Study|Protocol Defined Disease Progression|0|||
142966212|NCT03136185|515410910|FG005|Overall Study|Protocol Defined Disease Progression|1|||
143455435|NCT00037830|517212442|FG000|Overall Study|Unrelated Medical Problem|2|||
142966213|NCT03136185|515410911|FG006|Overall Study|Protocol Defined Disease Progression|0|||
142966214|NCT03136185|515410912|FG007|Overall Study|Protocol Defined Disease Progression|1|||
142966215|NCT03136185|515410913|FG008|Overall Study|Protocol Defined Disease Progression|1|||
142966216|NCT03136185|515410905|FG000|Overall Study|Withdrawal by Subject|1|||
142966217|NCT03136185|515410906|FG001|Overall Study|Withdrawal by Subject|0|||
142966218|NCT03136185|515410907|FG002|Overall Study|Withdrawal by Subject|1|||
142966219|NCT03136185|515410908|FG003|Overall Study|Withdrawal by Subject|1|||
142966220|NCT03136185|515410909|FG004|Overall Study|Withdrawal by Subject|1|||
142966221|NCT03136185|515410910|FG005|Overall Study|Withdrawal by Subject|1|||
142966222|NCT03136185|515410911|FG006|Overall Study|Withdrawal by Subject|2|||
142966223|NCT03136185|515410912|FG007|Overall Study|Withdrawal by Subject|3|||
142966224|NCT03136185|515410913|FG008|Overall Study|Withdrawal by Subject|3|||
142966225|NCT03136185|515410905|FG000|Overall Study|Not Reported|4|||
142966226|NCT03136185|515410906|FG001|Overall Study|Not Reported|1|||
142966227|NCT03136185|515410907|FG002|Overall Study|Not Reported|0|||
142966228|NCT03136185|515410908|FG003|Overall Study|Not Reported|1|||
142966229|NCT03136185|515410909|FG004|Overall Study|Not Reported|0|||
142966230|NCT03136185|515410910|FG005|Overall Study|Not Reported|2|||
142966231|NCT03136185|515410911|FG006|Overall Study|Not Reported|1|||
142966232|NCT03136185|515410912|FG007|Overall Study|Not Reported|1|||
142966233|NCT03136185|515410913|FG008|Overall Study|Not Reported|0|||
142966234|NCT00369668|515410914|FG000|Overall Study|Lack of Efficacy|4|||
142966235|NCT00369668|515410915|FG001|Overall Study|Lack of Efficacy|5|||
142966236|NCT00369668|515410916|FG002|Overall Study|Lack of Efficacy|7|||
142966237|NCT00303108|515410917|FG000|Overall Study|Adverse Event|5|||
142966238|NCT00303108|515410918|FG001|Overall Study|Adverse Event|6|||
142966239|NCT00303108|515410919|FG002|Overall Study|Adverse Event|7|||
142966240|NCT00303108|515410917|FG000|Overall Study|Patient Request|4|||
142966241|NCT00303108|515410918|FG001|Overall Study|Patient Request|2|||
142966242|NCT00303108|515410919|FG002|Overall Study|Patient Request|8|||
142966243|NCT00303108|515410917|FG000|Overall Study|Failed Entry|1|||
142966244|NCT00303108|515410918|FG001|Overall Study|Failed Entry|0|||
142966245|NCT00303108|515410919|FG002|Overall Study|Failed Entry|1|||
142966246|NCT00303108|515410917|FG000|Overall Study|ineligible|2|||
142966247|NCT00303108|515410918|FG001|Overall Study|ineligible|1|||
142966248|NCT00303108|515410919|FG002|Overall Study|ineligible|0|||
142966249|NCT00894413|515410922|FG000|Overall Study|Physician Decision|0|||
142966250|NCT00894413|515410923|FG001|Overall Study|Physician Decision|2|||
142966251|NCT00894413|515410922|FG000|Overall Study|Adverse Event|0|||
142966252|NCT00894413|515410923|FG001|Overall Study|Adverse Event|2|||
142966253|NCT00894413|515410922|FG000|Overall Study|Withdrawal by Subject|0|||
142966254|NCT00894413|515410923|FG001|Overall Study|Withdrawal by Subject|4|||
142966255|NCT03201198|515410924|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
142966256|NCT03201198|515410925|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
142966257|NCT03201198|515410924|FG000|Overall Study|Withdrawal by Subject|2|||
142966258|NCT03201198|515410925|FG001|Overall Study|Withdrawal by Subject|3|||
142966259|NCT03213626|515410926|FG000|Overall Study|Adverse Event|1|||
142966260|NCT03213626|515410926|FG000|Overall Study|Progressive Disease|6|||
142966261|NCT01454401|515410927|FG000|Overall Study|Death|1|||
142966262|NCT01454401|515410927|FG000|Overall Study|hospitalised|1|||
142966263|NCT01454401|515410927|FG000|Overall Study|osteomyelitis|2|||
142966264|NCT01454401|515410927|FG000|Overall Study|non-adherence|1|||
142966265|NCT00683475|515412640|FG000|Overall Study|Withdrawal by Subject|1|||
142966266|NCT00683475|515412641|FG001|Overall Study|Withdrawal by Subject|0|||
142966267|NCT00683475|515412640|FG000|Overall Study|Never Treated: Adverse Event|2|||
142966268|NCT00683475|515412641|FG001|Overall Study|Never Treated: Adverse Event|3|||
142966269|NCT00683475|515412640|FG000|Overall Study|Never Treated: Progressive Disease|1|||
142966270|NCT00683475|515412641|FG001|Overall Study|Never Treated: Progressive Disease|0|||
142966271|NCT02922634|515412642|FG000|Overall Study|Withdrawal by Subject|5|||
142966272|NCT02922634|515412642|FG000|Overall Study|Did not have their surgery|5|||
142966273|NCT02723604|515412643|FG000|Overall Study|ineligible|1|||
142966274|NCT02723604|515412643|FG000|Overall Study|never received treatment|1|||
142966275|NCT00352755|515412646|FG000|Overall Study|Physician Decision|1|||
142966276|NCT00352755|515412646|FG000|Overall Study|Adverse Event|1|||
142966277|NCT00311181|515412647|FG000|Overall Study|Final DFTs were not obtained|96|||
142966278|NCT02397694|515412650|FG000|Double-Blinded Phase|Adverse Event|1|||
142966279|NCT02397694|515412651|FG001|Double-Blinded Phase|Adverse Event|0|||
142966280|NCT02397694|515412650|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
142966281|NCT02397694|515412651|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
142966282|NCT02397694|515412650|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
142966283|NCT02397694|515412651|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
142966284|NCT02397694|515412650|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
142966285|NCT02397694|515412651|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
142966286|NCT02397694|515412650|FG000|Open Label Extension Phase|Protocol Violation|1|||
142966287|NCT02397694|515412651|FG001|Open Label Extension Phase|Protocol Violation|0|||
142966288|NCT02397694|515412650|FG000|Open Label Extension Phase|Withdrew Consent|3|||
142966289|NCT02397694|515412651|FG001|Open Label Extension Phase|Withdrew Consent|1|||
142966290|NCT02397694|515412650|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
142966291|NCT02397694|515412651|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
142966292|NCT00506948|515412656|FG000|Overall Study|Death|4|||
142966293|NCT00506948|515412656|FG000|Overall Study|Adverse Event|5|||
142966294|NCT00506948|515412656|FG000|Overall Study|Physician Decision|1|||
142966295|NCT02395653|515412657|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
142966296|NCT02395653|515412657|FG000|Overall Study|Consent Withdrawn at Screening|1|||
142966297|NCT02395653|515412657|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
142966298|NCT02395653|515412657|FG000|Overall Study|Investigator Decision at Screening|1|||
142966299|NCT02395653|515412657|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
142966300|NCT02395653|515412657|FG000|Overall Study|Withdrawal by Subject|1|||
142966301|NCT02395653|515412657|FG000|Overall Study|Lost to Follow-up|1|||
142966302|NCT00165841|515412658|FG000|Overall Study|Adverse Event|2|||
142966303|NCT00165841|515412659|FG001|Overall Study|Adverse Event|3|||
142966304|NCT00165841|515412658|FG000|Overall Study|Lack of Efficacy|6|||
142966305|NCT00165841|515412659|FG001|Overall Study|Lack of Efficacy|33|||
142966306|NCT00165841|515412658|FG000|Overall Study|Lost to Follow-up|4|||
142966307|NCT00165841|515412659|FG001|Overall Study|Lost to Follow-up|4|||
142966308|NCT00165841|515412658|FG000|Overall Study|Withdrawal by Subject|7|||
142966309|NCT00165841|515412659|FG001|Overall Study|Withdrawal by Subject|8|||
142966310|NCT00165841|515412658|FG000|Overall Study|Physician Decision|1|||
142966311|NCT00165841|515412659|FG001|Overall Study|Physician Decision|0|||
142966312|NCT00165841|515412658|FG000|Overall Study|Protocol Violation|6|||
142966313|NCT00165841|515412659|FG001|Overall Study|Protocol Violation|8|||
142966314|NCT00165841|515412658|FG000|Overall Study|Other|3|||
142966315|NCT00165841|515412659|FG001|Overall Study|Other|5|||
142966316|NCT00165841|515412658|FG000|Overall Study|Medication Noncompliance|1|||
142966317|NCT00165841|515412659|FG001|Overall Study|Medication Noncompliance|1|||
142966318|NCT00296725|515412660|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
142966319|NCT00296725|515412660|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
142966320|NCT00296725|515412660|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
142966321|NCT00836277|515412665|FG000|Overall Study|Not evaluable for response|6|||
142966322|NCT01697267|515412666|FG000|Overall Study|Death|3|||
142966323|NCT01697267|515412667|FG001|Overall Study|Death|1|||
142966324|NCT01697267|515412666|FG000|Overall Study|Withdrawal by Subject|5|||
142966325|NCT01697267|515412667|FG001|Overall Study|Withdrawal by Subject|5|||
142966326|NCT01697267|515412666|FG000|Overall Study|Adverse Event|2|||
142966327|NCT01697267|515412667|FG001|Overall Study|Adverse Event|1|||
142966328|NCT01697267|515412666|FG000|Overall Study|Lost to Follow-up|2|||
142966329|NCT01697267|515412667|FG001|Overall Study|Lost to Follow-up|4|||
142966330|NCT01697267|515412666|FG000|Overall Study|Physician Decision|2|||
142966331|NCT01697267|515412667|FG001|Overall Study|Physician Decision|4|||
142966332|NCT01626352|515412668|FG000|Overall Study|Disease Progression|3|||
142966333|NCT01626352|515412668|FG000|Overall Study|Intercurrent Illness|2|||
142966334|NCT01626352|515412668|FG000|Overall Study|Death|2|||
142966335|NCT01626352|515412668|FG000|Overall Study|Withdrawal by Subject|1|||
142966336|NCT01626352|515412668|FG000|Overall Study|Non-Compliance|1|||
142966337|NCT01626352|515412668|FG000|Overall Study|Never Treated|1|||
142966338|NCT02681055|515412670|FG000|Weeks 5-12|Adverse Event|1|||
142966339|NCT02695524|515412671|FG000|Overall Study|Lost to Follow-up|3|||
142966340|NCT02695524|515412672|FG001|Overall Study|Lost to Follow-up|2|||
142966341|NCT02695524|515412671|FG000|Overall Study|Death|0|||
142966342|NCT02695524|515412672|FG001|Overall Study|Death|1|||
142966343|NCT00377611|515412675|FG000|Overall Study|Adverse Event|2|||
142966344|NCT00377611|515412676|FG001|Overall Study|Adverse Event|9|||
142966345|NCT00377611|515412675|FG000|Overall Study|Protocol Violation|2|||
142966346|NCT00377611|515412676|FG001|Overall Study|Protocol Violation|0|||
142966347|NCT00377611|515412675|FG000|Overall Study|Withdrawal by Subject|0|||
142966348|NCT00377611|515412676|FG001|Overall Study|Withdrawal by Subject|5|||
142966349|NCT00377611|515412675|FG000|Overall Study|Lost to Follow-up|18|||
142966350|NCT00377611|515412676|FG001|Overall Study|Lost to Follow-up|16|||
142966351|NCT00377611|515412675|FG000|Overall Study|Other|0|||
142966352|NCT00377611|515412676|FG001|Overall Study|Other|3|||
142966353|NCT00111917|515412679|FG000|Overall Study|Withdrawal by Subject|1|||
142966354|NCT00111917|515412680|FG001|Overall Study|Withdrawal by Subject|1|||
142966355|NCT03446651|515412681|FG000|Overall Study|Lost to Follow-up|4|||
142966356|NCT03446651|515412682|FG001|Overall Study|Lost to Follow-up|0|||
142966357|NCT03446651|515412681|FG000|Overall Study|Open Label Participants|5|||
142966358|NCT03446651|515412682|FG001|Overall Study|Open Label Participants|0|||
142966359|NCT00798655|515412683|FG000|Overall Study|Did not receive at least one dose of pan|2|||
142966360|NCT00343291|515412684|FG000|Overall Study|Adverse Event|13|||
142966361|NCT00343291|515412685|FG001|Overall Study|Adverse Event|13|||
142966362|NCT00343291|515412684|FG000|Overall Study|Death|3|||
142966363|NCT00343291|515412685|FG001|Overall Study|Death|2|||
142966364|NCT00343291|515412684|FG000|Overall Study|Progressive disease|33|||
142966365|NCT00343291|515412685|FG001|Overall Study|Progressive disease|34|||
142966366|NCT00343291|515412684|FG000|Overall Study|Withdrawal by Subject|0|||
142966367|NCT00343291|515412685|FG001|Overall Study|Withdrawal by Subject|2|||
142966368|NCT00343291|515412684|FG000|Overall Study|Other|8|||
142966369|NCT00343291|515412685|FG001|Overall Study|Other|5|||
142966370|NCT03712345|515412686|FG000|Overall Study|Failure to meet randomization criteria|0|||
142966371|NCT03712345|515412687|FG001|Overall Study|Failure to meet randomization criteria|0|||
142966372|NCT03712345|515412688|FG002|Overall Study|Failure to meet randomization criteria|1|||
142966373|NCT00960934|515412691|FG000|Overall Study|Adverse Event|2|||
142966374|NCT00960934|515412692|FG001|Overall Study|Adverse Event|3|||
142966375|NCT00960934|515412693|FG002|Overall Study|Adverse Event|3|||
142966376|NCT00960934|515412694|FG003|Overall Study|Adverse Event|2|||
142966377|NCT00960934|515412695|FG004|Overall Study|Adverse Event|4|||
142966378|NCT00960934|515412696|FG005|Overall Study|Adverse Event|3|||
142966379|NCT00960934|515412691|FG000|Overall Study|Lack of Efficacy|1|||
142966380|NCT00960934|515412692|FG001|Overall Study|Lack of Efficacy|0|||
142966381|NCT00960934|515412693|FG002|Overall Study|Lack of Efficacy|0|||
142966382|NCT00960934|515412694|FG003|Overall Study|Lack of Efficacy|0|||
142966383|NCT00960934|515412695|FG004|Overall Study|Lack of Efficacy|0|||
142966384|NCT00960934|515412696|FG005|Overall Study|Lack of Efficacy|0|||
142966385|NCT00960934|515412691|FG000|Overall Study|Lost to Follow-up|0|||
142966386|NCT00960934|515412692|FG001|Overall Study|Lost to Follow-up|1|||
142966387|NCT00960934|515412693|FG002|Overall Study|Lost to Follow-up|0|||
142966388|NCT00960934|515412694|FG003|Overall Study|Lost to Follow-up|0|||
142966389|NCT00960934|515412695|FG004|Overall Study|Lost to Follow-up|0|||
142966390|NCT00960934|515412696|FG005|Overall Study|Lost to Follow-up|0|||
142966391|NCT00960934|515412691|FG000|Overall Study|Other|2|||
142966392|NCT00960934|515412692|FG001|Overall Study|Other|1|||
142966393|NCT00960934|515412693|FG002|Overall Study|Other|5|||
142966394|NCT00960934|515412694|FG003|Overall Study|Other|4|||
142966395|NCT00960934|515412695|FG004|Overall Study|Other|2|||
142966396|NCT00960934|515412696|FG005|Overall Study|Other|2|||
142966397|NCT00960934|515412691|FG000|Overall Study|Physician Decision|0|||
142966398|NCT00960934|515412692|FG001|Overall Study|Physician Decision|1|||
142966399|NCT00960934|515412693|FG002|Overall Study|Physician Decision|0|||
142966400|NCT00960934|515412694|FG003|Overall Study|Physician Decision|0|||
142966401|NCT00960934|515412695|FG004|Overall Study|Physician Decision|0|||
142966402|NCT00960934|515412696|FG005|Overall Study|Physician Decision|0|||
142966403|NCT00960934|515412691|FG000|Overall Study|Progressive Disease|1|||
142966404|NCT00960934|515412692|FG001|Overall Study|Progressive Disease|1|||
142966405|NCT00960934|515412693|FG002|Overall Study|Progressive Disease|0|||
142966406|NCT00960934|515412694|FG003|Overall Study|Progressive Disease|0|||
142966407|NCT00960934|515412695|FG004|Overall Study|Progressive Disease|1|||
142966408|NCT00960934|515412696|FG005|Overall Study|Progressive Disease|1|||
142966409|NCT00960934|515412691|FG000|Overall Study|Protocol Violation|3|||
142966410|NCT00960934|515412692|FG001|Overall Study|Protocol Violation|4|||
142966411|NCT00960934|515412693|FG002|Overall Study|Protocol Violation|0|||
142966412|NCT00960934|515412694|FG003|Overall Study|Protocol Violation|3|||
142966413|NCT00960934|515412695|FG004|Overall Study|Protocol Violation|3|||
142966414|NCT00960934|515412696|FG005|Overall Study|Protocol Violation|2|||
142966415|NCT00960934|515412691|FG000|Overall Study|Withdrawal by Subject|5|||
142966416|NCT00960934|515412692|FG001|Overall Study|Withdrawal by Subject|6|||
142966417|NCT00960934|515412693|FG002|Overall Study|Withdrawal by Subject|4|||
142966418|NCT00960934|515412694|FG003|Overall Study|Withdrawal by Subject|5|||
142966419|NCT00960934|515412695|FG004|Overall Study|Withdrawal by Subject|5|||
142966420|NCT00960934|515412696|FG005|Overall Study|Withdrawal by Subject|7|||
142966421|NCT00960934|515412691|FG000|Overall Study|Study Terminated by Sponsor|50|||
142966422|NCT00960934|515412692|FG001|Overall Study|Study Terminated by Sponsor|46|||
142966423|NCT00960934|515412693|FG002|Overall Study|Study Terminated by Sponsor|52|||
142966424|NCT00960934|515412694|FG003|Overall Study|Study Terminated by Sponsor|50|||
142966425|NCT00960934|515412695|FG004|Overall Study|Study Terminated by Sponsor|49|||
142966426|NCT00960934|515412696|FG005|Overall Study|Study Terminated by Sponsor|49|||
142966427|NCT01640925|515412701|FG000|Overall Study|Withdrawal by Subject|1|||
142966428|NCT01640925|515412702|FG001|Overall Study|Withdrawal by Subject|0|||
142966429|NCT01640925|515412701|FG000|Overall Study|Previously enrolled in this trial|13|||
142966430|NCT01640925|515412702|FG001|Overall Study|Previously enrolled in this trial|11|||
142966431|NCT02156492|515412703|FG000|Period 1|No Reason Given|0|||
142966432|NCT02156492|515412704|FG001|Period 1|No Reason Given|1|||
142966433|NCT02156492|515412705|FG002|Period 1|No Reason Given|0|||
142966434|NCT02156492|515412703|FG000|Period 3|Adverse Event|0|||
142966435|NCT02156492|515412704|FG001|Period 3|Adverse Event|1|||
142966436|NCT02156492|515412705|FG002|Period 3|Adverse Event|0|||
142966437|NCT05254613|515412728|FG000|Overall Study|Lost to Follow-up|0|||
142966438|NCT05254613|515412729|FG001|Overall Study|Lost to Follow-up|0|||
142966439|NCT05254613|515412730|FG002|Overall Study|Lost to Follow-up|1|||
142966440|NCT02338492|515412731|FG000|Overall Study|Death|32|||
142966441|NCT02338492|515412731|FG000|Overall Study|Adverse Event|3|||
142966442|NCT02338492|515412731|FG000|Overall Study|Lost to Follow-up|4|||
142966443|NCT02338492|515412731|FG000|Overall Study|Reason not captured above|6|||
142966444|NCT00839423|515412734|FG000|Overall Study|Adverse Event|4|||
142966445|NCT00839423|515412735|FG001|Overall Study|Adverse Event|3|||
142966446|NCT00839423|515412736|FG002|Overall Study|Adverse Event|7|||
142966447|NCT00839423|515412737|FG003|Overall Study|Adverse Event|16|||
142966448|NCT00839423|515412734|FG000|Overall Study|Lack of Efficacy|6|||
142966449|NCT00839423|515412735|FG001|Overall Study|Lack of Efficacy|6|||
142966450|NCT00839423|515412736|FG002|Overall Study|Lack of Efficacy|3|||
142966451|NCT00839423|515412737|FG003|Overall Study|Lack of Efficacy|2|||
142966452|NCT00839423|515412734|FG000|Overall Study|Non-compliance|0|||
142966453|NCT00839423|515412735|FG001|Overall Study|Non-compliance|0|||
142966454|NCT00839423|515412736|FG002|Overall Study|Non-compliance|0|||
142966455|NCT00839423|515412737|FG003|Overall Study|Non-compliance|1|||
142966456|NCT00839423|515412734|FG000|Overall Study|Protocol Violation|0|||
142966457|NCT00839423|515412735|FG001|Overall Study|Protocol Violation|1|||
142966458|NCT00839423|515412736|FG002|Overall Study|Protocol Violation|2|||
142966459|NCT00839423|515412737|FG003|Overall Study|Protocol Violation|0|||
142966460|NCT00839423|515412734|FG000|Overall Study|Withdrawal of consent|4|||
142966461|NCT00839423|515412735|FG001|Overall Study|Withdrawal of consent|0|||
142966462|NCT00839423|515412736|FG002|Overall Study|Withdrawal of consent|4|||
142966463|NCT00839423|515412737|FG003|Overall Study|Withdrawal of consent|1|||
142966464|NCT00839423|515412734|FG000|Overall Study|Lost to Follow-up|1|||
142966465|NCT00839423|515412735|FG001|Overall Study|Lost to Follow-up|0|||
142966466|NCT00839423|515412736|FG002|Overall Study|Lost to Follow-up|1|||
142966467|NCT00839423|515412737|FG003|Overall Study|Lost to Follow-up|0|||
142966468|NCT00839423|515412734|FG000|Overall Study|Administrative or other reasons|3|||
142966469|NCT00839423|515412735|FG001|Overall Study|Administrative or other reasons|0|||
142966470|NCT00839423|515412736|FG002|Overall Study|Administrative or other reasons|1|||
142966471|NCT00839423|515412737|FG003|Overall Study|Administrative or other reasons|0|||
142966472|NCT01071096|515412738|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
142966473|NCT01071096|515412739|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
142966474|NCT02585999|515412740|FG000|Overall Study|Lost to Follow-up|1|||
142966475|NCT02585999|515412740|FG000|Overall Study|Protocol Violation|1|||
142966476|NCT01332019|515412741|FG000|Overall Study|Was Not Dosed|1|||
142966477|NCT01332019|515412742|FG001|Overall Study|Was Not Dosed|0|||
142966478|NCT01332019|515412741|FG000|Overall Study|Other|16|||
142966479|NCT01332019|515412742|FG001|Overall Study|Other|18|||
142966480|NCT01332019|515412741|FG000|Overall Study|Death|2|||
142966481|NCT01332019|515412742|FG001|Overall Study|Death|1|||
142966482|NCT01332019|515412741|FG000|Overall Study|Physician Decision|4|||
142966483|NCT01332019|515412742|FG001|Overall Study|Physician Decision|3|||
142966484|NCT01332019|515412741|FG000|Overall Study|Withdrawal by Subject|73|||
142966485|NCT01332019|515412742|FG001|Overall Study|Withdrawal by Subject|71|||
142966486|NCT01332019|515412741|FG000|Overall Study|Lost to Follow-up|4|||
142966487|NCT01332019|515412742|FG001|Overall Study|Lost to Follow-up|7|||
142966488|NCT01332019|515412741|FG000|Overall Study|Adverse Event|13|||
142966489|NCT01332019|515412742|FG001|Overall Study|Adverse Event|22|||
142966490|NCT01369849|515412743|FG000|Overall Study|Ineligible prior to treatment|0|||
142966491|NCT01369849|515412744|FG001|Overall Study|Ineligible prior to treatment|0|||
142966492|NCT01369849|515412745|FG002|Overall Study|Ineligible prior to treatment|1|||
142966493|NCT01369849|515412743|FG000|Overall Study|Ineligible after receiving treatment|0|||
142966494|NCT01369849|515412744|FG001|Overall Study|Ineligible after receiving treatment|1|||
142966495|NCT01369849|515412745|FG002|Overall Study|Ineligible after receiving treatment|0|||
142966496|NCT00120289|515412746|FG000|Overall Study|Death|96|||
142966497|NCT00120289|515412747|FG001|Overall Study|Death|82|||
142966498|NCT00120289|515412746|FG000|Overall Study|Lost to Follow-up|11|||
142966499|NCT00120289|515412747|FG001|Overall Study|Lost to Follow-up|14|||
142966500|NCT00120289|515412746|FG000|Overall Study|Withdrawal by Subject|14|||
142966501|NCT00120289|515412747|FG001|Overall Study|Withdrawal by Subject|13|||
142966502|NCT00882999|515412749|FG000|Overall Study|Adverse Event|0|||
142966503|NCT00882999|515412750|FG001|Overall Study|Adverse Event|0|||
142966504|NCT00882999|515412751|FG002|Overall Study|Adverse Event|0|||
142966505|NCT00882999|515412752|FG003|Overall Study|Adverse Event|0|||
142966506|NCT00882999|515412753|FG004|Overall Study|Adverse Event|1|||
142966507|NCT00882999|515412754|FG005|Overall Study|Adverse Event|0|||
142966508|NCT00882999|515412755|FG006|Overall Study|Adverse Event|0|||
142966509|NCT00882999|515412749|FG000|Overall Study|Death|0|||
142966510|NCT00882999|515412750|FG001|Overall Study|Death|1|||
142966511|NCT00882999|515412751|FG002|Overall Study|Death|0|||
142966512|NCT00882999|515412752|FG003|Overall Study|Death|0|||
142966513|NCT00882999|515412753|FG004|Overall Study|Death|0|||
142966514|NCT00882999|515412754|FG005|Overall Study|Death|0|||
142966515|NCT00882999|515412755|FG006|Overall Study|Death|0|||
142966516|NCT00882999|515412749|FG000|Overall Study|Withdrawal by Subject|7|||
142966517|NCT00882999|515412750|FG001|Overall Study|Withdrawal by Subject|6|||
142966518|NCT00882999|515412751|FG002|Overall Study|Withdrawal by Subject|3|||
142966519|NCT00882999|515412752|FG003|Overall Study|Withdrawal by Subject|3|||
142966520|NCT00882999|515412753|FG004|Overall Study|Withdrawal by Subject|6|||
142966521|NCT00882999|515412754|FG005|Overall Study|Withdrawal by Subject|5|||
142966522|NCT00882999|515412755|FG006|Overall Study|Withdrawal by Subject|5|||
142966523|NCT00882999|515412749|FG000|Overall Study|Lost to Follow-up|0|||
142966524|NCT00882999|515412750|FG001|Overall Study|Lost to Follow-up|1|||
142966525|NCT00882999|515412751|FG002|Overall Study|Lost to Follow-up|1|||
142966526|NCT00882999|515412752|FG003|Overall Study|Lost to Follow-up|2|||
142966527|NCT00882999|515412753|FG004|Overall Study|Lost to Follow-up|1|||
142966528|NCT00882999|515412754|FG005|Overall Study|Lost to Follow-up|1|||
142966529|NCT00882999|515412755|FG006|Overall Study|Lost to Follow-up|2|||
142966530|NCT00882999|515412749|FG000|Overall Study|Physician Decision|1|||
142966531|NCT00882999|515412750|FG001|Overall Study|Physician Decision|0|||
142966532|NCT00882999|515412751|FG002|Overall Study|Physician Decision|0|||
142966533|NCT00882999|515412752|FG003|Overall Study|Physician Decision|0|||
142966534|NCT00882999|515412753|FG004|Overall Study|Physician Decision|0|||
142966535|NCT00882999|515412754|FG005|Overall Study|Physician Decision|1|||
142966536|NCT00882999|515412755|FG006|Overall Study|Physician Decision|1|||
142966537|NCT01757405|515412756|FG000|Overall Study|Lost to Follow-up|1|||
142966538|NCT01757405|515412757|FG001|Overall Study|Lost to Follow-up|1|||
142966539|NCT01757405|515412756|FG000|Overall Study|Withdrawal by Subject|0|||
142966540|NCT01757405|515412757|FG001|Overall Study|Withdrawal by Subject|1|||
142966541|NCT00238303|515412758|FG000|Overall Study|Withdrawal by Subject|11|||
142966542|NCT00238303|515412759|FG001|Overall Study|Withdrawal by Subject|1|||
142966543|NCT00238303|515412760|FG002|Overall Study|Withdrawal by Subject|2|||
142966544|NCT00238303|515412758|FG000|Overall Study|Death|1|||
142966545|NCT00238303|515412759|FG001|Overall Study|Death|0|||
142966546|NCT00238303|515412760|FG002|Overall Study|Death|1|||
142966547|NCT00238303|515412758|FG000|Overall Study|Other Medical Problems|2|||
142966548|NCT00238303|515412759|FG001|Overall Study|Other Medical Problems|0|||
142966549|NCT00238303|515412760|FG002|Overall Study|Other Medical Problems|2|||
142966550|NCT00238303|515412758|FG000|Overall Study|Poor tolerance of study treatment|1|||
142966551|NCT00238303|515412759|FG001|Overall Study|Poor tolerance of study treatment|0|||
142966552|NCT00238303|515412760|FG002|Overall Study|Poor tolerance of study treatment|1|||
142966553|NCT00238303|515412758|FG000|Overall Study|Adverse Event|0|||
142966554|NCT00238303|515412759|FG001|Overall Study|Adverse Event|1|||
142966555|NCT00238303|515412760|FG002|Overall Study|Adverse Event|3|||
142966556|NCT02488551|515412763|FG000|Overall Study|Lost to Follow-up|4|||
142966557|NCT02488551|515412764|FG001|Overall Study|Lost to Follow-up|7|||
142966558|NCT02488551|515412765|FG002|Overall Study|Lost to Follow-up|0|||
142966559|NCT02488551|515412766|FG003|Overall Study|Lost to Follow-up|0|||
142966560|NCT02488551|515412763|FG000|Overall Study|Military Deployment|1|||
142966561|NCT02488551|515412764|FG001|Overall Study|Military Deployment|1|||
142966562|NCT02488551|515412765|FG002|Overall Study|Military Deployment|0|||
142966563|NCT02488551|515412766|FG003|Overall Study|Military Deployment|0|||
142966564|NCT01474746|515412774|FG000|Overall Study|Lost to Follow-up|1|||
142966565|NCT01474746|515412775|FG001|Overall Study|Lost to Follow-up|1|||
142966566|NCT01474746|515412774|FG000|Overall Study|Withdrawal by Subject|2|||
142966567|NCT01474746|515412775|FG001|Overall Study|Withdrawal by Subject|1|||
142966568|NCT01766336|515412777|FG000|Overall Study|Adverse Event|11|||
142966569|NCT01766336|515412778|FG001|Overall Study|Adverse Event|8|||
142966570|NCT01766336|515412777|FG000|Overall Study|Death|4|||
142966571|NCT01766336|515412778|FG001|Overall Study|Death|3|||
142966572|NCT01766336|515412777|FG000|Overall Study|Lost to Follow-up|1|||
142966573|NCT01766336|515412778|FG001|Overall Study|Lost to Follow-up|3|||
142966574|NCT01766336|515412777|FG000|Overall Study|Physician Decision|4|||
142966575|NCT01766336|515412778|FG001|Overall Study|Physician Decision|2|||
142966576|NCT01766336|515412777|FG000|Overall Study|Protocol Violation|0|||
142966577|NCT01766336|515412778|FG001|Overall Study|Protocol Violation|1|||
142966578|NCT01766336|515412777|FG000|Overall Study|Sponsor Decision|52|||
142966579|NCT01766336|515412778|FG001|Overall Study|Sponsor Decision|43|||
142966580|NCT01766336|515412777|FG000|Overall Study|Withdrawal by Subject|18|||
142966581|NCT01766336|515412778|FG001|Overall Study|Withdrawal by Subject|15|||
142966582|NCT02605447|515412779|FG000|Overall Study|Death|66|||
142966583|NCT02605447|515412779|FG000|Overall Study|Physician Decision|1|||
142966584|NCT02605447|515412779|FG000|Overall Study|Lost to Follow-up|24|||
142966585|NCT02605447|515412779|FG000|Overall Study|Withdrawal by Subject|10|||
142966586|NCT02605447|515412779|FG000|Overall Study|Not disclosed|1|||
142966587|NCT02045212|515412780|FG000|Overall Study|Adverse Event|0|||
142966588|NCT02045212|515412781|FG001|Overall Study|Adverse Event|1|||
142966589|NCT02045212|515412780|FG000|Overall Study|Withdrawal by Subject|1|||
142966590|NCT02045212|515412781|FG001|Overall Study|Withdrawal by Subject|0|||
142966591|NCT02045212|515412780|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
142966592|NCT02045212|515412781|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
142966593|NCT00515008|515412785|FG000|Overall Study|Lost to Follow-up|1|||
142966594|NCT00515008|515412786|FG001|Overall Study|Lost to Follow-up|0|||
142966595|NCT00515008|515412785|FG000|Overall Study|Declined|0|||
142966596|NCT00515008|515412786|FG001|Overall Study|Declined|3|||
142966597|NCT00515008|515412785|FG000|Overall Study|Left the Boston Area|1|||
142966598|NCT00515008|515412786|FG001|Overall Study|Left the Boston Area|1|||
142966599|NCT00515008|515412785|FG000|Overall Study|Scheduling conflict|1|||
142966600|NCT00515008|515412786|FG001|Overall Study|Scheduling conflict|0|||
142966601|NCT03135028|515412787|FG000|Overall Study|Death|6|||
142966602|NCT03135028|515412787|FG000|Overall Study|Study Terminated by Sponsor|2|||
142966603|NCT03135028|515412787|FG000|Overall Study|Withdrew Consent|1|||
142966604|NCT01814800|515412790|FG000|Overall Study|Adverse Event|2|||
142966605|NCT01814800|515412790|FG000|Overall Study|Pregnancy|1|||
142966606|NCT01814800|515412790|FG000|Overall Study|Sponsor decision|1|||
142966607|NCT01814800|515412790|FG000|Overall Study|Subject relocation|1|||
142966608|NCT05118386|515412791|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
142966609|NCT05118386|515412792|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
142966610|NCT05118386|515412793|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
142966611|NCT05118386|515412794|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
142966612|NCT05118386|515412795|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
142966613|NCT05118386|515412796|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
143003136|NCT01049360|515548748|FG004|Period 2|Adverse Event|0|||
142966614|NCT05118386|515412791|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
142966615|NCT05118386|515412792|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
142966616|NCT05118386|515412793|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
142966617|NCT05118386|515412794|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
142966618|NCT05118386|515412795|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
142966619|NCT05118386|515412796|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
142966620|NCT04348656|515414580|FG000|Overall Study|Withdrawal by Subject|2|||
142966621|NCT04348656|515414581|FG001|Overall Study|Withdrawal by Subject|0|||
142966622|NCT04348656|515414580|FG000|Overall Study|Lost to Follow-up|11|||
142966623|NCT04348656|515414581|FG001|Overall Study|Lost to Follow-up|6|||
142966624|NCT01576016|515414588|FG000|Lead Safety|Death|132|||
142966625|NCT01576016|515414589|FG001|Lead Safety|Death|0|||
142966626|NCT01576016|515414588|FG000|Lead Safety|Withdrawal by Subject|81|||
142966627|NCT01576016|515414589|FG001|Lead Safety|Withdrawal by Subject|0|||
142966628|NCT01576016|515414588|FG000|Lead Safety|System Explanted without Replacement|24|||
142966629|NCT01576016|515414589|FG001|Lead Safety|System Explanted without Replacement|0|||
142966630|NCT01576016|515414588|FG000|Lead Safety|Physician Decision|14|||
142966631|NCT01576016|515414589|FG001|Lead Safety|Physician Decision|0|||
142966632|NCT01576016|515414588|FG000|Lead Safety|Lost to Follow-up|13|||
142966633|NCT01576016|515414589|FG001|Lead Safety|Lost to Follow-up|0|||
142966634|NCT01576016|515414588|FG000|Lead Safety|Unsuccessful implant|2|||
142966635|NCT01576016|515414589|FG001|Lead Safety|Unsuccessful implant|0|||
142966636|NCT01576016|515414588|FG000|Lead Safety|Sponsor request|1|||
142966637|NCT01576016|515414589|FG001|Lead Safety|Sponsor request|0|||
142966638|NCT01576016|515414588|FG000|Lead Safety|Device replaced with CRT-D|1|||
142966639|NCT01576016|515414589|FG001|Lead Safety|Device replaced with CRT-D|0|||
142966640|NCT01576016|515414588|FG000|Lead Safety|Patient on Palliative Care|1|||
142966641|NCT01576016|515414589|FG001|Lead Safety|Patient on Palliative Care|0|||
142966642|NCT01576016|515414588|FG000|Lead Safety|Patient noncompliance|1|||
142966643|NCT01576016|515414589|FG001|Lead Safety|Patient noncompliance|0|||
142966644|NCT01576016|515414588|FG000|Lead Safety|Too far from study site|1|||
142966645|NCT01576016|515414589|FG001|Lead Safety|Too far from study site|0|||
142966646|NCT01576016|515414588|FG000|Lead Safety|System deactivated|1|||
142966647|NCT01576016|515414589|FG001|Lead Safety|System deactivated|0|||
142966648|NCT01576016|515414588|FG000|Lead Safety|Patient no longer followed by study PI|1|||
142966649|NCT01576016|515414589|FG001|Lead Safety|Patient no longer followed by study PI|0|||
142966650|NCT01576016|515414588|FG000|MRI Safety|Withdrawal by Subject|0|||
142966651|NCT01576016|515414589|FG001|MRI Safety|Withdrawal by Subject|10|||
142966652|NCT01576016|515414588|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
142966653|NCT01576016|515414589|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
142966654|NCT01576016|515414588|FG000|MRI Safety|Has not yet completed MRI scan|0|||
142966655|NCT01576016|515414589|FG001|MRI Safety|Has not yet completed MRI scan|56|||
142966656|NCT01576016|515414588|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
142966657|NCT01576016|515414589|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
142966658|NCT04507867|515414592|FG000|Overall Study|Death|7|||
142966659|NCT04507867|515414593|FG001|Overall Study|Death|1|||
142966660|NCT00543569|515414594|FG000|Overall Study|Death|2|||
142966661|NCT00543569|515414595|FG001|Overall Study|Death|2|||
142966662|NCT00543569|515414596|FG002|Overall Study|Death|3|||
142966663|NCT00543569|515414597|FG003|Overall Study|Death|1|||
142966664|NCT00543569|515414594|FG000|Overall Study|Lost to Follow-up|0|||
142966665|NCT00543569|515414595|FG001|Overall Study|Lost to Follow-up|0|||
142966666|NCT00543569|515414596|FG002|Overall Study|Lost to Follow-up|1|||
142966667|NCT00543569|515414597|FG003|Overall Study|Lost to Follow-up|1|||
142966668|NCT00543569|515414594|FG000|Overall Study|Miscellaneous Reasons|7|||
142966669|NCT00543569|515414595|FG001|Overall Study|Miscellaneous Reasons|3|||
142966670|NCT00543569|515414596|FG002|Overall Study|Miscellaneous Reasons|11|||
142966671|NCT00543569|515414597|FG003|Overall Study|Miscellaneous Reasons|4|||
142966672|NCT00543569|515414594|FG000|Overall Study|Randomized but never received study drug|3|||
142966673|NCT00543569|515414595|FG001|Overall Study|Randomized but never received study drug|3|||
142966674|NCT00543569|515414596|FG002|Overall Study|Randomized but never received study drug|5|||
142966675|NCT00543569|515414597|FG003|Overall Study|Randomized but never received study drug|3|||
142966676|NCT00862849|515414598|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
142966677|NCT00862849|515414599|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
142966678|NCT00862849|515414600|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
142966679|NCT00862849|515414601|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
142966680|NCT00862849|515414602|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
142966681|NCT00862849|515414603|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
142966682|NCT00862849|515414598|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
142966683|NCT00862849|515414599|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
142966684|NCT00862849|515414600|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
142966685|NCT00862849|515414601|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
142966686|NCT00862849|515414602|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
142966687|NCT00862849|515414603|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
142966688|NCT00617409|515414604|FG000|Overall Study|Withdrawal by Subject|4|||
142966689|NCT00617409|515414605|FG001|Overall Study|Withdrawal by Subject|1|||
142966690|NCT00617409|515414606|FG002|Overall Study|Withdrawal by Subject|2|||
142966691|NCT00617409|515414604|FG000|Overall Study|Adverse Event|0|||
142966692|NCT00617409|515414605|FG001|Overall Study|Adverse Event|2|||
142966693|NCT00617409|515414606|FG002|Overall Study|Adverse Event|3|||
142966694|NCT00617409|515414604|FG000|Overall Study|Disease Progression|8|||
142966695|NCT00617409|515414605|FG001|Overall Study|Disease Progression|8|||
142966696|NCT00617409|515414606|FG002|Overall Study|Disease Progression|18|||
142966697|NCT00617409|515414604|FG000|Overall Study|Death|3|||
142966698|NCT00617409|515414605|FG001|Overall Study|Death|5|||
142966699|NCT00617409|515414606|FG002|Overall Study|Death|4|||
142966700|NCT00617409|515414604|FG000|Overall Study|Alternative Therapy|1|||
142966701|NCT00617409|515414605|FG001|Overall Study|Alternative Therapy|2|||
142966702|NCT00617409|515414606|FG002|Overall Study|Alternative Therapy|0|||
142966703|NCT02108951|515414609|FG000|Overall Study|Lost to Follow-up|1|||
142966704|NCT02108951|515414609|FG000|Overall Study|Patient's/guardian's decision|1|||
142966705|NCT02108951|515414609|FG000|Overall Study|Study Terminated by Sponsor|14|||
142966706|NCT00718666|515414610|FG000|Booster Phase Year 5|No active participation request|0|||
142966707|NCT00718666|515414611|FG001|Booster Phase Year 5|No active participation request|0|||
142966708|NCT00718666|515414612|FG002|Booster Phase Year 5|No active participation request|1|||
142966709|NCT00718666|515414610|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
142966710|NCT00718666|515414611|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
142966711|NCT00718666|515414612|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
142966712|NCT00718666|515414610|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
142966713|NCT00718666|515414611|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
142966714|NCT00718666|515414612|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
142966715|NCT00718666|515414610|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
142966716|NCT00718666|515414611|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
142966717|NCT00718666|515414612|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
142966718|NCT02196038|515414615|FG000|Overall Study|Death|16|||
142966719|NCT02196038|515414616|FG001|Overall Study|Death|21|||
142966720|NCT02196038|515414615|FG000|Overall Study|Withdrawal by Subject|0|||
142966721|NCT02196038|515414616|FG001|Overall Study|Withdrawal by Subject|1|||
142966722|NCT02196038|515414615|FG000|Overall Study|Lost to Follow-up|1|||
142966723|NCT02196038|515414616|FG001|Overall Study|Lost to Follow-up|0|||
142966724|NCT00421343|515414620|FG000|Overall Study|Death|1|||
142966725|NCT00421343|515414620|FG000|Overall Study|Withdrawal by Subject|2|||
142966726|NCT00421343|515414620|FG000|Overall Study|Lost to Follow-up|3|||
142966727|NCT03471767|515414625|FG000|Overall Study|Withdrawal by Subject|3|||
142966728|NCT03471767|515414626|FG001|Overall Study|Withdrawal by Subject|1|||
142966729|NCT03471767|515414625|FG000|Overall Study|Adverse Event|1|||
142966730|NCT03471767|515414626|FG001|Overall Study|Adverse Event|0|||
142966731|NCT03471767|515414625|FG000|Overall Study|Lost to Follow-up|1|||
142966732|NCT03471767|515414626|FG001|Overall Study|Lost to Follow-up|0|||
142966733|NCT03471767|515414625|FG000|Overall Study|PI Withdrawal|1|||
142966734|NCT03471767|515414626|FG001|Overall Study|PI Withdrawal|3|||
142966735|NCT01952730|515414627|FG000|Overall Study|FDA shut down core lab used by study|1|||
142966736|NCT01357915|515414628|FG000|Overall Study|Lost to Follow-up|3|||
142966737|NCT01357915|515414629|FG001|Overall Study|Lost to Follow-up|0|||
142966738|NCT00305253|515414630|FG000|Overall Study|Withdrawal by Subject|0|||
142966739|NCT00305253|515414631|FG001|Overall Study|Withdrawal by Subject|1|||
142966740|NCT01514188|515414633|FG000|Overall Study|Adverse Event|3|||
142966741|NCT01514188|515414634|FG001|Overall Study|Adverse Event|5|||
142966742|NCT01514188|515414633|FG000|Overall Study|Withdrawal by Subject|2|||
142966743|NCT01514188|515414634|FG001|Overall Study|Withdrawal by Subject|4|||
142966744|NCT01514188|515414633|FG000|Overall Study|Protocol Violation|2|||
142966745|NCT01514188|515414634|FG001|Overall Study|Protocol Violation|4|||
142966746|NCT01514188|515414633|FG000|Overall Study|Physician Decision|0|||
142966747|NCT01514188|515414634|FG001|Overall Study|Physician Decision|2|||
142966748|NCT01514188|515414633|FG000|Overall Study|Disease Progression|13|||
142966749|NCT01514188|515414634|FG001|Overall Study|Disease Progression|14|||
142966750|NCT01514188|515414633|FG000|Overall Study|Death|1|||
142966751|NCT01514188|515414634|FG001|Overall Study|Death|3|||
142966752|NCT01514188|515414633|FG000|Overall Study|Other|2|||
142966753|NCT01514188|515414634|FG001|Overall Study|Other|1|||
142966754|NCT01019486|515414635|FG000|Overall Study|Withdrawal by Subject|1|||
142966755|NCT01019486|515414636|FG001|Overall Study|Withdrawal by Subject|1|||
142966756|NCT01019486|515414637|FG002|Overall Study|Withdrawal by Subject|1|||
143455436|NCT00037830|517212443|FG001|Overall Study|Unrelated Medical Problem|0|||
142966757|NCT05373706|515414643|FG000|Overall Study|Lost to Follow-up|2|||
142966758|NCT05373706|515414644|FG001|Overall Study|Lost to Follow-up|2|||
142966759|NCT03633227|515414645|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
142966760|NCT03633227|515414646|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
142966761|NCT03633227|515414645|FG000|Double Blind (DB), up to Week 48|Death|2|||
142966762|NCT03633227|515414646|FG001|Double Blind (DB), up to Week 48|Death|1|||
142966763|NCT03633227|515414645|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
142966764|NCT03633227|515414646|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
142966765|NCT03633227|515414645|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
142966766|NCT03633227|515414646|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
142966767|NCT03633227|515414645|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
142966768|NCT03633227|515414646|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
142966769|NCT03633227|515414645|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
142966770|NCT03633227|515414646|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
142966771|NCT03633227|515414645|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
142966772|NCT03633227|515414646|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
142966773|NCT03633227|515414645|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
142966774|NCT03633227|515414646|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
142966775|NCT03633227|515414645|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
142966776|NCT03633227|515414646|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
142966777|NCT03633227|515414645|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
142966778|NCT03633227|515414646|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
142966779|NCT03633227|515414645|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
142966780|NCT03633227|515414646|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
142966781|NCT03633227|515414645|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
142966782|NCT03633227|515414646|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
142966783|NCT01479374|515414655|FG000|Overall Study|Adverse Event|2|||
142966784|NCT01479374|515414656|FG001|Overall Study|Adverse Event|1|||
142966785|NCT01479374|515414657|FG002|Overall Study|Adverse Event|0|||
142966786|NCT01479374|515414655|FG000|Overall Study|Lost to Follow-up|1|||
142966787|NCT01479374|515414656|FG001|Overall Study|Lost to Follow-up|2|||
142966788|NCT01479374|515414657|FG002|Overall Study|Lost to Follow-up|0|||
142966789|NCT01479374|515414655|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
142966790|NCT01479374|515414656|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
142966791|NCT01479374|515414657|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
142966792|NCT01479374|515414655|FG000|Overall Study|Other|0|||
142966793|NCT01479374|515414656|FG001|Overall Study|Other|4|||
142966794|NCT01479374|515414657|FG002|Overall Study|Other|5|||
142966795|NCT01606761|515414658|FG000|Prior to Week 24|Lost to Follow-up|0|||
142966796|NCT01606761|515414659|FG001|Prior to Week 24|Lost to Follow-up|3|||
142966797|NCT01606761|515414660|FG002|Prior to Week 24|Lost to Follow-up|2|||
142966798|NCT01606761|515414661|FG003|Prior to Week 24|Lost to Follow-up|0|||
142966799|NCT01606761|515414662|FG004|Prior to Week 24|Lost to Follow-up|0|||
142966800|NCT01606761|515414658|FG000|Prior to Week 24|Withdrawal by Subject|12|||
142966801|NCT01606761|515414659|FG001|Prior to Week 24|Withdrawal by Subject|10|||
142966802|NCT01606761|515414660|FG002|Prior to Week 24|Withdrawal by Subject|9|||
142966803|NCT01606761|515414661|FG003|Prior to Week 24|Withdrawal by Subject|0|||
142966804|NCT01606761|515414662|FG004|Prior to Week 24|Withdrawal by Subject|0|||
142966805|NCT01606761|515414658|FG000|Prior to Week 24|Adverse Event|11|||
142966806|NCT01606761|515414659|FG001|Prior to Week 24|Adverse Event|18|||
142966807|NCT01606761|515414660|FG002|Prior to Week 24|Adverse Event|22|||
142966808|NCT01606761|515414661|FG003|Prior to Week 24|Adverse Event|0|||
142966809|NCT01606761|515414662|FG004|Prior to Week 24|Adverse Event|0|||
142966810|NCT01606761|515414658|FG000|Prior to Week 24|Lack of Efficacy|15|||
142966811|NCT01606761|515414659|FG001|Prior to Week 24|Lack of Efficacy|14|||
142966812|NCT01606761|515414660|FG002|Prior to Week 24|Lack of Efficacy|8|||
142966813|NCT01606761|515414661|FG003|Prior to Week 24|Lack of Efficacy|0|||
142966814|NCT01606761|515414662|FG004|Prior to Week 24|Lack of Efficacy|0|||
142966815|NCT01606761|515414658|FG000|Prior to Week 24|Physician Decision|0|||
142966816|NCT01606761|515414659|FG001|Prior to Week 24|Physician Decision|3|||
142966817|NCT01606761|515414660|FG002|Prior to Week 24|Physician Decision|1|||
142966818|NCT01606761|515414661|FG003|Prior to Week 24|Physician Decision|0|||
142966819|NCT01606761|515414662|FG004|Prior to Week 24|Physician Decision|0|||
142966820|NCT01606761|515414658|FG000|Prior to Week 24|Other|4|||
142966821|NCT01606761|515414659|FG001|Prior to Week 24|Other|7|||
142966822|NCT01606761|515414660|FG002|Prior to Week 24|Other|5|||
142966823|NCT01606761|515414661|FG003|Prior to Week 24|Other|0|||
142966824|NCT01606761|515414662|FG004|Prior to Week 24|Other|0|||
142966825|NCT01606761|515414658|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
142966826|NCT01606761|515414659|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
142966827|NCT01606761|515414660|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
143117147|NCT01273155|515970041|FG003|Overall Study|Died during Cycle 1|1|||
142966828|NCT01606761|515414661|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
142966829|NCT01606761|515414662|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
142966830|NCT01606761|515414658|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
142966831|NCT01606761|515414659|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
142966832|NCT01606761|515414660|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
142966833|NCT01606761|515414661|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
142966834|NCT01606761|515414662|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
142966835|NCT01606761|515414658|FG000|Week 24 to Week 52|Adverse Event|0|||
142966836|NCT01606761|515414659|FG001|Week 24 to Week 52|Adverse Event|11|||
142966837|NCT01606761|515414660|FG002|Week 24 to Week 52|Adverse Event|14|||
142966838|NCT01606761|515414661|FG003|Week 24 to Week 52|Adverse Event|3|||
142966839|NCT01606761|515414662|FG004|Week 24 to Week 52|Adverse Event|15|||
142966840|NCT01606761|515414658|FG000|Week 24 to Week 52|Death|0|||
142966841|NCT01606761|515414659|FG001|Week 24 to Week 52|Death|0|||
142966842|NCT01606761|515414660|FG002|Week 24 to Week 52|Death|2|||
142966843|NCT01606761|515414661|FG003|Week 24 to Week 52|Death|1|||
142966844|NCT01606761|515414662|FG004|Week 24 to Week 52|Death|0|||
142966845|NCT01606761|515414658|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
142966846|NCT01606761|515414659|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
142966847|NCT01606761|515414660|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
142966848|NCT01606761|515414661|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
142966849|NCT01606761|515414662|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
142966850|NCT01606761|515414658|FG000|Week 24 to Week 52|Physician Decision|0|||
142966851|NCT01606761|515414659|FG001|Week 24 to Week 52|Physician Decision|1|||
142966852|NCT01606761|515414660|FG002|Week 24 to Week 52|Physician Decision|1|||
142966853|NCT01606761|515414661|FG003|Week 24 to Week 52|Physician Decision|0|||
142966854|NCT01606761|515414662|FG004|Week 24 to Week 52|Physician Decision|0|||
142966855|NCT01606761|515414658|FG000|Week 24 to Week 52|Other|0|||
142966856|NCT01606761|515414659|FG001|Week 24 to Week 52|Other|1|||
142966857|NCT01606761|515414660|FG002|Week 24 to Week 52|Other|5|||
142966858|NCT01606761|515414661|FG003|Week 24 to Week 52|Other|2|||
142966859|NCT01606761|515414662|FG004|Week 24 to Week 52|Other|2|||
142966860|NCT01606761|515414658|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
142966861|NCT01606761|515414659|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
142966862|NCT01606761|515414660|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
142966863|NCT01606761|515414661|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
142966864|NCT01606761|515414662|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
142966865|NCT01606761|515414658|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
142966866|NCT01606761|515414659|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
142966867|NCT01606761|515414660|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
142966868|NCT01606761|515414661|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
142966869|NCT01606761|515414662|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
142966870|NCT01606761|515414658|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
142966871|NCT01606761|515414659|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
142966872|NCT01606761|515414660|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
142966873|NCT01606761|515414661|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
142966874|NCT01606761|515414662|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
142966875|NCT01606761|515414658|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
142966876|NCT01606761|515414659|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
142966877|NCT01606761|515414660|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
142966878|NCT01606761|515414661|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
142966879|NCT01606761|515414662|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
142966880|NCT05086289|515414663|FG000|Overall Study|Adverse Event|4|||
142966881|NCT05086289|515414664|FG001|Overall Study|Adverse Event|2|||
142966882|NCT05086289|515414663|FG000|Overall Study|Lost to Follow-up|2|||
142966883|NCT05086289|515414664|FG001|Overall Study|Lost to Follow-up|0|||
142966884|NCT05086289|515414663|FG000|Overall Study|Non-compliance with study drug|2|||
142966885|NCT05086289|515414664|FG001|Overall Study|Non-compliance with study drug|1|||
142966886|NCT05086289|515414663|FG000|Overall Study|Physician Decision|2|||
142966887|NCT05086289|515414664|FG001|Overall Study|Physician Decision|0|||
142966888|NCT05086289|515414663|FG000|Overall Study|Withdrawal by Subject|5|||
142966889|NCT05086289|515414664|FG001|Overall Study|Withdrawal by Subject|2|||
142966890|NCT02402218|515414670|FG000|Overall Study|Did not pickup study medication|12|||
142966891|NCT02402218|515414671|FG001|Overall Study|Did not pickup study medication|9|||
142966892|NCT02402218|515414672|FG002|Overall Study|Did not pickup study medication|13|||
142966893|NCT02402218|515414670|FG000|Overall Study|Lack of Efficacy|0|||
142966894|NCT02402218|515414671|FG001|Overall Study|Lack of Efficacy|1|||
142966895|NCT02402218|515414672|FG002|Overall Study|Lack of Efficacy|1|||
142966896|NCT02402218|515414670|FG000|Overall Study|Death|1|||
142966897|NCT02402218|515414671|FG001|Overall Study|Death|0|||
142966898|NCT02402218|515414672|FG002|Overall Study|Death|0|||
142966899|NCT02402218|515414670|FG000|Overall Study|Reinfection|0|||
142966900|NCT02402218|515414671|FG001|Overall Study|Reinfection|0|||
142966901|NCT02402218|515414672|FG002|Overall Study|Reinfection|1|||
142966902|NCT02402218|515414670|FG000|Overall Study|Adverse Event|0|||
142966903|NCT02402218|515414671|FG001|Overall Study|Adverse Event|2|||
142966904|NCT02402218|515414672|FG002|Overall Study|Adverse Event|1|||
142966905|NCT02402218|515414670|FG000|Overall Study|Withdrawal by Subject|1|||
142966906|NCT02402218|515414671|FG001|Overall Study|Withdrawal by Subject|1|||
142966907|NCT02402218|515414672|FG002|Overall Study|Withdrawal by Subject|1|||
142966908|NCT03599141|515414676|FG000|Overall Study|Lost to Follow-up|3|||
142966909|NCT03599141|515414677|FG001|Overall Study|Lost to Follow-up|1|||
142966910|NCT03011840|515414678|FG000|Overall Study|Not received PIL in post PIL phase|0|||
142966911|NCT03011840|515414679|FG001|Overall Study|Not received PIL in post PIL phase|21|||
142966912|NCT03738566|515414680|FG000|Initial Study Phase|Withdrawal by Subject|1|||
142966913|NCT03738566|515414681|FG001|Initial Study Phase|Withdrawal by Subject|1|||
142966914|NCT03738566|515414682|FG002|Initial Study Phase|Withdrawal by Subject|2|||
142966915|NCT03738566|515414683|FG003|Initial Study Phase|Withdrawal by Subject|0|||
142966916|NCT03738566|515414680|FG000|Initial Study Phase|Death|0|||
142966917|NCT03738566|515414681|FG001|Initial Study Phase|Death|1|||
142966918|NCT03738566|515414682|FG002|Initial Study Phase|Death|0|||
142966919|NCT03738566|515414683|FG003|Initial Study Phase|Death|0|||
142966920|NCT03738566|515414680|FG000|Initial Study Phase|Treatment failure|5|||
142966921|NCT03738566|515414681|FG001|Initial Study Phase|Treatment failure|0|||
142966922|NCT03738566|515414682|FG002|Initial Study Phase|Treatment failure|0|||
142966923|NCT03738566|515414683|FG003|Initial Study Phase|Treatment failure|0|||
142966924|NCT03738566|515414680|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
142966925|NCT03738566|515414681|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
142966926|NCT03738566|515414682|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
142966927|NCT03738566|515414683|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
142966928|NCT03126539|515414691|FG000|Overall Study|Lost to Follow-up|1|||
142966929|NCT03126539|515414692|FG001|Overall Study|Lost to Follow-up|1|||
142966930|NCT03126539|515414693|FG002|Overall Study|Lost to Follow-up|1|||
142966931|NCT03126539|515414694|FG003|Overall Study|Lost to Follow-up|0|||
142966932|NCT03126539|515414695|FG004|Overall Study|Lost to Follow-up|0|||
142966933|NCT02596711|515414698|FG000|Overall Study|Lost to Follow-up|1|||
142966934|NCT02596711|515414699|FG001|Overall Study|Lost to Follow-up|2|||
142966935|NCT02596711|515414700|FG002|Overall Study|Lost to Follow-up|3|||
142966936|NCT01005732|515414701|FG000|Overall Study|Lost to Follow-up|10|||
142966937|NCT01005732|515414701|FG000|Overall Study|Death|1|||
142966938|NCT00632463|515414703|FG000|Overall Study|Adverse Event|0|||
142966939|NCT00632463|515414704|FG001|Overall Study|Adverse Event|1|||
142966940|NCT00632463|515414705|FG002|Overall Study|Adverse Event|0|||
142966941|NCT02998554|515414709|FG000|Overall Study|Adverse Event|8|||
142966942|NCT02998554|515414710|FG001|Overall Study|Adverse Event|3|||
142966943|NCT02998554|515414709|FG000|Overall Study|Protocol deviation|1|||
142966944|NCT02998554|515414710|FG001|Overall Study|Protocol deviation|0|||
142966945|NCT02998554|515414709|FG000|Overall Study|Withdrawal by Subject|2|||
142966946|NCT02998554|515414710|FG001|Overall Study|Withdrawal by Subject|6|||
142966947|NCT02998554|515414709|FG000|Overall Study|Lost to Follow-up|0|||
142966948|NCT02998554|515414710|FG001|Overall Study|Lost to Follow-up|1|||
142966949|NCT02998554|515414709|FG000|Overall Study|Lack of Efficacy|0|||
142966950|NCT02998554|515414710|FG001|Overall Study|Lack of Efficacy|1|||
142966951|NCT00946530|515414711|FG000|Overall Study|Withdrawal by Subject|0|||
142966952|NCT00946530|515414712|FG001|Overall Study|Withdrawal by Subject|3|||
142966953|NCT00946530|515414713|FG002|Overall Study|Withdrawal by Subject|0|||
142966954|NCT00946530|515414714|FG003|Overall Study|Withdrawal by Subject|3|||
142966955|NCT00946530|515414711|FG000|Overall Study|Physician Decision|1|||
142966956|NCT00946530|515414712|FG001|Overall Study|Physician Decision|1|||
142966957|NCT00946530|515414713|FG002|Overall Study|Physician Decision|1|||
142966958|NCT00946530|515414714|FG003|Overall Study|Physician Decision|1|||
142966959|NCT02112994|515414715|FG000|Overall Study|Progressive Disease|0|||
142966960|NCT02112994|515414716|FG001|Overall Study|Progressive Disease|0|||
142966961|NCT02112994|515414717|FG002|Overall Study|Progressive Disease|1|||
142966962|NCT02112994|515414715|FG000|Overall Study|Pregnancy|0|||
142966963|NCT02112994|515414716|FG001|Overall Study|Pregnancy|1|||
142966964|NCT02112994|515414717|FG002|Overall Study|Pregnancy|1|||
142966965|NCT02112994|515414715|FG000|Overall Study|Liver Transplant|0|||
142966966|NCT02112994|515414716|FG001|Overall Study|Liver Transplant|1|||
142966967|NCT02112994|515414717|FG002|Overall Study|Liver Transplant|0|||
142966968|NCT02112994|515414715|FG000|Overall Study|Withdrawal by Subject|0|||
142966969|NCT02112994|515414716|FG001|Overall Study|Withdrawal by Subject|0|||
142966970|NCT02112994|515414717|FG002|Overall Study|Withdrawal by Subject|1|||
142966971|NCT01683071|515414721|FG000|Part 1|Lack of Efficacy|1|||
142966972|NCT01683071|515414722|FG001|Part 1|Lack of Efficacy|0|||
142966973|NCT01683071|515414723|FG002|Part 1|Lack of Efficacy|0|||
142966974|NCT01683071|515414724|FG003|Part 1|Lack of Efficacy|3|||
142966975|NCT01683071|515414725|FG004|Part 1|Lack of Efficacy|0|||
142966976|NCT01683071|515414726|FG005|Part 1|Lack of Efficacy|0|||
142966977|NCT01683071|515414721|FG000|Part 1|Withdrawal by Subject|1|||
142966978|NCT01683071|515414722|FG001|Part 1|Withdrawal by Subject|2|||
142966979|NCT01683071|515414723|FG002|Part 1|Withdrawal by Subject|2|||
142966980|NCT01683071|515414724|FG003|Part 1|Withdrawal by Subject|1|||
142966981|NCT01683071|515414725|FG004|Part 1|Withdrawal by Subject|0|||
142966982|NCT01683071|515414726|FG005|Part 1|Withdrawal by Subject|0|||
142966983|NCT01683071|515414721|FG000|Part 1|Surgery Cancelled|1|||
142966984|NCT01683071|515414722|FG001|Part 1|Surgery Cancelled|0|||
142966985|NCT01683071|515414723|FG002|Part 1|Surgery Cancelled|0|||
142966986|NCT01683071|515414724|FG003|Part 1|Surgery Cancelled|0|||
142966987|NCT01683071|515414725|FG004|Part 1|Surgery Cancelled|0|||
142966988|NCT01683071|515414726|FG005|Part 1|Surgery Cancelled|0|||
142966989|NCT01683071|515414721|FG000|Part 1|Did not receive study drug|1|||
142966990|NCT01683071|515414722|FG001|Part 1|Did not receive study drug|0|||
142966991|NCT01683071|515414723|FG002|Part 1|Did not receive study drug|0|||
142966992|NCT01683071|515414724|FG003|Part 1|Did not receive study drug|1|||
142966993|NCT01683071|515414725|FG004|Part 1|Did not receive study drug|0|||
142966994|NCT01683071|515414726|FG005|Part 1|Did not receive study drug|0|||
142966995|NCT01683071|515414721|FG000|Part 1|Early termination; met exclusion criteria|0|||
142966996|NCT01683071|515414722|FG001|Part 1|Early termination; met exclusion criteria|2|||
142966997|NCT01683071|515414723|FG002|Part 1|Early termination; met exclusion criteria|1|||
142966998|NCT01683071|515414724|FG003|Part 1|Early termination; met exclusion criteria|0|||
142966999|NCT01683071|515414725|FG004|Part 1|Early termination; met exclusion criteria|0|||
143455437|NCT00037830|517212444|FG002|Overall Study|Unrelated Medical Problem|0|||
143455438|NCT01639560|517212446|FG000|Overall Study|Withdrawal by Subject|9|||
143455439|NCT01639560|517212447|FG001|Overall Study|Withdrawal by Subject|14|||
143455440|NCT01639560|517212446|FG000|Overall Study|Lack of Efficacy|1|||
143455441|NCT01639560|517212447|FG001|Overall Study|Lack of Efficacy|2|||
143455442|NCT01639560|517212446|FG000|Overall Study|Lost to Follow-up|9|||
143455443|NCT01639560|517212447|FG001|Overall Study|Lost to Follow-up|11|||
143455444|NCT01639560|517212446|FG000|Overall Study|Adverse Event|0|||
143455445|NCT01639560|517212447|FG001|Overall Study|Adverse Event|2|||
143455446|NCT00911937|517212454|FG000|Overall Study|Death|1|||
142967000|NCT01683071|515414726|FG005|Part 1|Early termination; met exclusion criteria|0|||
142967001|NCT01683071|515414721|FG000|Part 2|Lack of Efficacy|0|||
142967002|NCT01683071|515414722|FG001|Part 2|Lack of Efficacy|0|||
142967003|NCT01683071|515414723|FG002|Part 2|Lack of Efficacy|0|||
142967004|NCT01683071|515414724|FG003|Part 2|Lack of Efficacy|0|||
142967005|NCT01683071|515414725|FG004|Part 2|Lack of Efficacy|3|||
142967006|NCT01683071|515414726|FG005|Part 2|Lack of Efficacy|4|||
142967007|NCT01683071|515414721|FG000|Part 2|Lost to Follow-up|0|||
142967008|NCT01683071|515414722|FG001|Part 2|Lost to Follow-up|0|||
142967009|NCT01683071|515414723|FG002|Part 2|Lost to Follow-up|0|||
142967010|NCT01683071|515414724|FG003|Part 2|Lost to Follow-up|0|||
142967011|NCT01683071|515414725|FG004|Part 2|Lost to Follow-up|2|||
142967012|NCT01683071|515414726|FG005|Part 2|Lost to Follow-up|0|||
142967013|NCT01683071|515414721|FG000|Part 2|Withdrawal by Subject|0|||
142967014|NCT01683071|515414722|FG001|Part 2|Withdrawal by Subject|0|||
142967015|NCT01683071|515414723|FG002|Part 2|Withdrawal by Subject|0|||
142967016|NCT01683071|515414724|FG003|Part 2|Withdrawal by Subject|0|||
142967017|NCT01683071|515414725|FG004|Part 2|Withdrawal by Subject|3|||
142967018|NCT01683071|515414726|FG005|Part 2|Withdrawal by Subject|3|||
142967019|NCT01683071|515414721|FG000|Part 2|Surgery cancelled|0|||
142967020|NCT01683071|515414722|FG001|Part 2|Surgery cancelled|0|||
142967021|NCT01683071|515414723|FG002|Part 2|Surgery cancelled|0|||
142967022|NCT01683071|515414724|FG003|Part 2|Surgery cancelled|0|||
142967023|NCT01683071|515414725|FG004|Part 2|Surgery cancelled|4|||
142967024|NCT01683071|515414726|FG005|Part 2|Surgery cancelled|2|||
142967025|NCT01683071|515414721|FG000|Part 2|Did not receive study drug|0|||
142967026|NCT01683071|515414722|FG001|Part 2|Did not receive study drug|0|||
142967027|NCT01683071|515414723|FG002|Part 2|Did not receive study drug|0|||
142967028|NCT01683071|515414724|FG003|Part 2|Did not receive study drug|0|||
142967029|NCT01683071|515414725|FG004|Part 2|Did not receive study drug|2|||
142967030|NCT01683071|515414726|FG005|Part 2|Did not receive study drug|1|||
142967031|NCT01683071|515414721|FG000|Part 2|Met exclusion criterion|0|||
142967032|NCT01683071|515414722|FG001|Part 2|Met exclusion criterion|0|||
142967033|NCT01683071|515414723|FG002|Part 2|Met exclusion criterion|0|||
142967034|NCT01683071|515414724|FG003|Part 2|Met exclusion criterion|0|||
142967035|NCT01683071|515414725|FG004|Part 2|Met exclusion criterion|1|||
142967036|NCT01683071|515414726|FG005|Part 2|Met exclusion criterion|1|||
142967037|NCT01683071|515414721|FG000|Part 2|Protocol deviation|0|||
142967038|NCT01683071|515414722|FG001|Part 2|Protocol deviation|0|||
142967039|NCT01683071|515414723|FG002|Part 2|Protocol deviation|0|||
142967040|NCT01683071|515414724|FG003|Part 2|Protocol deviation|0|||
142967041|NCT01683071|515414725|FG004|Part 2|Protocol deviation|1|||
142967042|NCT01683071|515414726|FG005|Part 2|Protocol deviation|2|||
142967043|NCT01683071|515414721|FG000|Part 2|Withdrawal by investigator decision|0|||
142967044|NCT01683071|515414722|FG001|Part 2|Withdrawal by investigator decision|0|||
142967045|NCT01683071|515414723|FG002|Part 2|Withdrawal by investigator decision|0|||
142967046|NCT01683071|515414724|FG003|Part 2|Withdrawal by investigator decision|0|||
142967047|NCT01683071|515414725|FG004|Part 2|Withdrawal by investigator decision|1|||
142967048|NCT01683071|515414726|FG005|Part 2|Withdrawal by investigator decision|2|||
142967049|NCT03675737|515414727|FG000|Overall Study|Death|593|||
142967050|NCT03675737|515414728|FG001|Overall Study|Death|660|||
142967051|NCT03675737|515414727|FG000|Overall Study|Lost to Follow-up|1|||
142967052|NCT03675737|515414728|FG001|Overall Study|Lost to Follow-up|5|||
142967053|NCT03675737|515414727|FG000|Overall Study|Physician Decision|1|||
142967054|NCT03675737|515414728|FG001|Overall Study|Physician Decision|0|||
142967055|NCT03675737|515414727|FG000|Overall Study|Withdrawal by Subject|14|||
142967056|NCT03675737|515414728|FG001|Overall Study|Withdrawal by Subject|12|||
142967057|NCT03675737|515414727|FG000|Overall Study|Ongoing in Study|181|||
143455447|NCT00911937|517212455|FG001|Overall Study|Death|0|||
142967058|NCT03675737|515414728|FG001|Overall Study|Ongoing in Study|112|||
142967059|NCT02349789|515415945|FG000|Overall Study|Withdrawal by Subject|2|||
142967060|NCT02625324|515415948|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
142967061|NCT02625324|515415948|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
142967062|NCT02625324|515415948|FG000|6-Month Follow-up Subject Accountability|Death|5|||
143003137|NCT01049360|515548749|FG005|Period 2|Adverse Event|0|||
142967063|NCT02625324|515415948|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
142967064|NCT02625324|515415948|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
142967065|NCT02625324|515415948|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
142967066|NCT02625324|515415948|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
142967067|NCT02625324|515415948|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
142967068|NCT02625324|515415948|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
142967069|NCT02625324|515415948|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
142967070|NCT02625324|515415948|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
142967071|NCT02625324|515415948|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
142967072|NCT02625324|515415948|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
142967073|NCT02625324|515415948|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
142967074|NCT02625324|515415948|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
142967075|NCT02625324|515415948|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
142967076|NCT02625324|515415948|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
142967077|NCT02457182|515415949|FG000|Overall Study|Lost to Follow-up|1|||
142967078|NCT02457182|515415950|FG001|Overall Study|Lost to Follow-up|0|||
142967079|NCT01116687|515415951|FG000|Overall Study|Withdrawal by Subject|4|||
142967080|NCT00424528|515415952|FG000|Overall Study|Adverse Event|2|||
142967081|NCT00424528|515415953|FG001|Overall Study|Adverse Event|1|||
142967082|NCT00424528|515415954|FG002|Overall Study|Adverse Event|2|||
142967083|NCT00424528|515415952|FG000|Overall Study|Protocol Violation|1|||
142967084|NCT00424528|515415953|FG001|Overall Study|Protocol Violation|1|||
142967085|NCT00424528|515415954|FG002|Overall Study|Protocol Violation|0|||
142967086|NCT00424528|515415952|FG000|Overall Study|Lost to Follow-up|0|||
142967087|NCT00424528|515415953|FG001|Overall Study|Lost to Follow-up|1|||
142967088|NCT00424528|515415954|FG002|Overall Study|Lost to Follow-up|0|||
142967089|NCT00424528|515415952|FG000|Overall Study|noncompliance with study requirements|2|||
142967090|NCT00424528|515415953|FG001|Overall Study|noncompliance with study requirements|1|||
142967091|NCT00424528|515415954|FG002|Overall Study|noncompliance with study requirements|2|||
142967092|NCT02115113|515415955|FG000|Participants in Run-in Period|Death|0|||
142967093|NCT02115113|515415956|FG001|Participants in Run-in Period|Death|0|||
142967094|NCT02115113|515415957|FG002|Participants in Run-in Period|Death|1|||
142967095|NCT02115113|515415955|FG000|Participants in Run-in Period|Administrative problems|0|||
142967096|NCT02115113|515415956|FG001|Participants in Run-in Period|Administrative problems|0|||
142967097|NCT02115113|515415957|FG002|Participants in Run-in Period|Administrative problems|1|||
142967098|NCT02115113|515415955|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
142967099|NCT02115113|515415956|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
142967100|NCT02115113|515415957|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
142967101|NCT02115113|515415955|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
142967102|NCT02115113|515415956|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
142967103|NCT02115113|515415957|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
142967104|NCT02115113|515415955|FG000|Participants Randomized|Lost to Follow-up|1|||
142967105|NCT02115113|515415956|FG001|Participants Randomized|Lost to Follow-up|0|||
142967106|NCT02115113|515415957|FG002|Participants Randomized|Lost to Follow-up|0|||
142967107|NCT02115113|515415955|FG000|Participants Randomized|Death|1|||
142967108|NCT02115113|515415956|FG001|Participants Randomized|Death|0|||
142967109|NCT02115113|515415957|FG002|Participants Randomized|Death|0|||
142967110|NCT00789191|515415959|FG000|Overall Study|Adverse Event|2|||
142967111|NCT00789191|515415960|FG001|Overall Study|Adverse Event|4|||
142967112|NCT00789191|515415959|FG000|Overall Study|Lack of Efficacy|0|||
142967113|NCT00789191|515415960|FG001|Overall Study|Lack of Efficacy|5|||
142967114|NCT00789191|515415959|FG000|Overall Study|Protocol Violation|5|||
142967115|NCT00789191|515415960|FG001|Overall Study|Protocol Violation|3|||
142967116|NCT00789191|515415959|FG000|Overall Study|Withdrawal Criteria|2|||
142967117|NCT00789191|515415960|FG001|Overall Study|Withdrawal Criteria|4|||
142967118|NCT00789191|515415959|FG000|Overall Study|Unclassified|5|||
142967119|NCT00789191|515415960|FG001|Overall Study|Unclassified|3|||
142967120|NCT03497429|515415961|FG000|Overall Study|Progressive disease|3|||
142967121|NCT03497429|515415962|FG001|Overall Study|Progressive disease|4|||
142967122|NCT03497429|515415961|FG000|Overall Study|Adverse Event|0|||
142967123|NCT03497429|515415962|FG001|Overall Study|Adverse Event|2|||
142967124|NCT01009983|515415963|FG000|Overall Study|necessary scans not completed|1|||
142967125|NCT00967226|515415967|FG000|Overall Study|Adverse Event|0|||
142967126|NCT00967226|515415968|FG001|Overall Study|Adverse Event|5|||
142967127|NCT00967226|515415967|FG000|Overall Study|Protocol Violation|2|||
142967128|NCT00967226|515415968|FG001|Overall Study|Protocol Violation|0|||
142967129|NCT00967226|515415967|FG000|Overall Study|Physician Decision|0|||
142967130|NCT00967226|515415968|FG001|Overall Study|Physician Decision|1|||
142967131|NCT00605722|515415969|FG000|Overall Study|Adverse Event|6|||
142967132|NCT00605722|515415969|FG000|Overall Study|Insufficient therapeutic response|44|||
142967133|NCT00605722|515415969|FG000|Overall Study|Failure to return|1|||
142967134|NCT02622724|515415975|FG000|Overall Study|Death|51|||
142967135|NCT02622724|515415976|FG001|Overall Study|Death|53|||
142967136|NCT02622724|515415975|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
142967137|NCT02622724|515415976|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
142967138|NCT02622724|515415975|FG000|Overall Study|Early termination of study|38|||
142967139|NCT02622724|515415976|FG001|Overall Study|Early termination of study|43|||
142967140|NCT00487084|515415977|FG000|Overall Study|Did not receive intervention|4|||
142967141|NCT00487084|515415978|FG001|Overall Study|Did not receive intervention|3|||
142967142|NCT00487084|515415979|FG002|Overall Study|Did not receive intervention|5|||
142967143|NCT00356863|515415980|FG000|Overall Study|Death|16|||
142967144|NCT00356863|515415981|FG001|Overall Study|Death|32|||
142967145|NCT00356863|515415980|FG000|Overall Study|Lost to Follow-up|76|||
142967146|NCT00356863|515415981|FG001|Overall Study|Lost to Follow-up|43|||
142967147|NCT00333619|515415984|FG000|Overall Study|Death|12|||
142967148|NCT00333619|515415985|FG001|Overall Study|Death|6|||
142967149|NCT00333619|515415984|FG000|Overall Study|Withdrawal by Subject|6|||
142967150|NCT00333619|515415985|FG001|Overall Study|Withdrawal by Subject|1|||
142967151|NCT00333619|515415984|FG000|Overall Study|Lost to Follow-up|3|||
142967152|NCT00333619|515415985|FG001|Overall Study|Lost to Follow-up|3|||
142967153|NCT00280150|515415986|FG000|Overall Study|Adverse Event|0|||
142967154|NCT00280150|515415987|FG001|Overall Study|Adverse Event|1|||
142967155|NCT00280150|515415988|FG002|Overall Study|Adverse Event|2|||
142967156|NCT00280150|515415989|FG003|Overall Study|Adverse Event|3|||
142967157|NCT00280150|515415986|FG000|Overall Study|Lack of Efficacy|0|||
142967158|NCT00280150|515415987|FG001|Overall Study|Lack of Efficacy|0|||
142967159|NCT00280150|515415988|FG002|Overall Study|Lack of Efficacy|0|||
142967160|NCT00280150|515415989|FG003|Overall Study|Lack of Efficacy|3|||
142967161|NCT00280150|515415986|FG000|Overall Study|Physician Decision|0|||
142967162|NCT00280150|515415987|FG001|Overall Study|Physician Decision|0|||
142967163|NCT00280150|515415988|FG002|Overall Study|Physician Decision|0|||
142967164|NCT00280150|515415989|FG003|Overall Study|Physician Decision|1|||
142967165|NCT00280150|515415986|FG000|Overall Study|Protocol Violation|0|||
142967166|NCT00280150|515415987|FG001|Overall Study|Protocol Violation|0|||
142967167|NCT00280150|515415988|FG002|Overall Study|Protocol Violation|0|||
142967168|NCT00280150|515415989|FG003|Overall Study|Protocol Violation|1|||
142967169|NCT00280150|515415986|FG000|Overall Study|Withdrawal by Subject|0|||
142967170|NCT00280150|515415987|FG001|Overall Study|Withdrawal by Subject|0|||
142967171|NCT00280150|515415988|FG002|Overall Study|Withdrawal by Subject|0|||
142967172|NCT00280150|515415989|FG003|Overall Study|Withdrawal by Subject|1|||
142967173|NCT00280150|515415986|FG000|Overall Study|Did not get consolidation therapy|3|||
142967174|NCT00280150|515415987|FG001|Overall Study|Did not get consolidation therapy|0|||
142967175|NCT00280150|515415988|FG002|Overall Study|Did not get consolidation therapy|3|||
142967176|NCT00280150|515415989|FG003|Overall Study|Did not get consolidation therapy|0|||
142967177|NCT00280150|515415986|FG000|Overall Study|Declining Performance Status|0|||
142967178|NCT00280150|515415987|FG001|Overall Study|Declining Performance Status|0|||
142967179|NCT00280150|515415988|FG002|Overall Study|Declining Performance Status|0|||
142967180|NCT00280150|515415989|FG003|Overall Study|Declining Performance Status|1|||
142967181|NCT02871401|515415990|FG000|Overall Study|Adverse Event|1|||
142967182|NCT02871401|515415991|FG001|Overall Study|Adverse Event|0|||
142967183|NCT04031404|515415994|FG000|Baseline|Lost to Follow-up|0|||
142967184|NCT04031404|515415995|FG001|Baseline|Lost to Follow-up|1|||
142967185|NCT04031404|515415994|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
142967186|NCT04031404|515415995|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
142967187|NCT04031404|515415994|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
142967188|NCT04031404|515415995|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
142967189|NCT04031404|515415994|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
142967190|NCT04031404|515415995|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
142967191|NCT04031404|515415994|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
142967192|NCT04031404|515415995|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
142967193|NCT00568958|515415998|FG000|Allocation|Withdrawal by Subject|7|||
142967194|NCT00568958|515415999|FG001|Allocation|Withdrawal by Subject|3|||
142967195|NCT00568958|515415998|FG000|Allocation|Physician Decision|2|||
142967196|NCT00568958|515415999|FG001|Allocation|Physician Decision|0|||
142967197|NCT00568958|515415998|FG000|Follow-Up|Withdrawal by Subject|6|||
142967198|NCT00568958|515415999|FG001|Follow-Up|Withdrawal by Subject|6|||
142967199|NCT00568958|515415998|FG000|Follow-Up|Physician Decision|1|||
142967200|NCT00568958|515415999|FG001|Follow-Up|Physician Decision|1|||
142967201|NCT00568958|515415998|FG000|Follow-Up|Family Emergency|1|||
142967202|NCT00568958|515415999|FG001|Follow-Up|Family Emergency|0|||
142967203|NCT00568958|515415998|FG000|Follow-Up|Adverse Event|1|||
142967204|NCT00568958|515415999|FG001|Follow-Up|Adverse Event|0|||
142967205|NCT03583372|515416004|FG000|Overall Study|Withdrawal by Subject|6|||
142967206|NCT03583372|515416005|FG001|Overall Study|Withdrawal by Subject|11|||
142967207|NCT03583372|515416006|FG002|Overall Study|Withdrawal by Subject|7|||
142967208|NCT03583372|515416007|FG003|Overall Study|Withdrawal by Subject|8|||
142967209|NCT03583372|515416004|FG000|Overall Study|Lost to Follow-up|4|||
142967210|NCT03583372|515416005|FG001|Overall Study|Lost to Follow-up|6|||
142967211|NCT03583372|515416006|FG002|Overall Study|Lost to Follow-up|3|||
142967212|NCT03583372|515416007|FG003|Overall Study|Lost to Follow-up|2|||
142967213|NCT03583372|515416004|FG000|Overall Study|Adverse Event|1|||
142967214|NCT03583372|515416005|FG001|Overall Study|Adverse Event|3|||
142967215|NCT03583372|515416006|FG002|Overall Study|Adverse Event|4|||
142967216|NCT03583372|515416007|FG003|Overall Study|Adverse Event|4|||
142967217|NCT03583372|515416004|FG000|Overall Study|Physician Decision|0|||
142967218|NCT03583372|515416005|FG001|Overall Study|Physician Decision|1|||
142967219|NCT03583372|515416006|FG002|Overall Study|Physician Decision|1|||
142967220|NCT03583372|515416007|FG003|Overall Study|Physician Decision|1|||
142967221|NCT03583372|515416004|FG000|Overall Study|Lack of Efficacy|0|||
142967222|NCT03583372|515416005|FG001|Overall Study|Lack of Efficacy|1|||
142967223|NCT03583372|515416006|FG002|Overall Study|Lack of Efficacy|0|||
142967224|NCT03583372|515416007|FG003|Overall Study|Lack of Efficacy|1|||
142967225|NCT03583372|515416004|FG000|Overall Study|Death|1|||
142967226|NCT03583372|515416005|FG001|Overall Study|Death|0|||
142967227|NCT03583372|515416006|FG002|Overall Study|Death|0|||
142967228|NCT03583372|515416007|FG003|Overall Study|Death|0|||
142967229|NCT03583372|515416004|FG000|Overall Study|Protocol Violation|0|||
142967230|NCT03583372|515416005|FG001|Overall Study|Protocol Violation|1|||
142967231|NCT03583372|515416006|FG002|Overall Study|Protocol Violation|0|||
142967232|NCT03583372|515416007|FG003|Overall Study|Protocol Violation|0|||
142967233|NCT03583372|515416004|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
142967234|NCT03583372|515416005|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
142967235|NCT03583372|515416006|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
142967236|NCT03583372|515416007|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
142967237|NCT03583372|515416004|FG000|Overall Study|Did Not Receive Study Drug|0|||
142967238|NCT03583372|515416005|FG001|Overall Study|Did Not Receive Study Drug|1|||
142967239|NCT03583372|515416006|FG002|Overall Study|Did Not Receive Study Drug|0|||
142967240|NCT03583372|515416007|FG003|Overall Study|Did Not Receive Study Drug|0|||
142967241|NCT03583372|515416004|FG000|Overall Study|Captured as Other in the Database|1|||
142967242|NCT03583372|515416005|FG001|Overall Study|Captured as Other in the Database|2|||
142967243|NCT03583372|515416006|FG002|Overall Study|Captured as Other in the Database|4|||
142967244|NCT03583372|515416007|FG003|Overall Study|Captured as Other in the Database|1|||
142967245|NCT02796391|515416008|FG000|Overall Study|Lost to Follow-up|2|||
142967246|NCT02796391|515416009|FG001|Overall Study|Lost to Follow-up|2|||
142967247|NCT02796391|515416010|FG002|Overall Study|Lost to Follow-up|13|||
142967248|NCT02796391|515416011|FG003|Overall Study|Lost to Follow-up|8|||
142967249|NCT02796391|515416012|FG004|Overall Study|Lost to Follow-up|14|||
142967250|NCT02796391|515416013|FG005|Overall Study|Lost to Follow-up|13|||
142967251|NCT02796391|515416008|FG000|Overall Study|COVID|0|||
142967252|NCT02796391|515416009|FG001|Overall Study|COVID|0|||
142967253|NCT02796391|515416010|FG002|Overall Study|COVID|5|||
142967254|NCT02796391|515416011|FG003|Overall Study|COVID|5|||
142967255|NCT02796391|515416012|FG004|Overall Study|COVID|2|||
142967256|NCT02796391|515416013|FG005|Overall Study|COVID|4|||
142967257|NCT02796391|515416008|FG000|Overall Study|Participant did not like study cigarettes|0|||
142967258|NCT02796391|515416009|FG001|Overall Study|Participant did not like study cigarettes|0|||
142967259|NCT02796391|515416010|FG002|Overall Study|Participant did not like study cigarettes|3|||
142967260|NCT02796391|515416011|FG003|Overall Study|Participant did not like study cigarettes|0|||
142967261|NCT02796391|515416012|FG004|Overall Study|Participant did not like study cigarettes|0|||
142967262|NCT02796391|515416013|FG005|Overall Study|Participant did not like study cigarettes|0|||
142967263|NCT02796391|515416008|FG000|Overall Study|Withdrawal by Subject|1|||
142967264|NCT02796391|515416009|FG001|Overall Study|Withdrawal by Subject|1|||
142967265|NCT02796391|515416010|FG002|Overall Study|Withdrawal by Subject|4|||
142967266|NCT02796391|515416011|FG003|Overall Study|Withdrawal by Subject|3|||
142967267|NCT02796391|515416012|FG004|Overall Study|Withdrawal by Subject|4|||
142967268|NCT02796391|515416013|FG005|Overall Study|Withdrawal by Subject|3|||
142967269|NCT02796391|515416008|FG000|Overall Study|Adverse Event|0|||
142967270|NCT02796391|515416009|FG001|Overall Study|Adverse Event|0|||
142967271|NCT02796391|515416010|FG002|Overall Study|Adverse Event|0|||
142967272|NCT02796391|515416011|FG003|Overall Study|Adverse Event|1|||
142967273|NCT02796391|515416012|FG004|Overall Study|Adverse Event|0|||
142967274|NCT02796391|515416013|FG005|Overall Study|Adverse Event|0|||
142967275|NCT02796391|515416008|FG000|Overall Study|Protocol Violation|0|||
142967276|NCT02796391|515416009|FG001|Overall Study|Protocol Violation|0|||
142967277|NCT02796391|515416010|FG002|Overall Study|Protocol Violation|0|||
142967278|NCT02796391|515416011|FG003|Overall Study|Protocol Violation|1|||
142967279|NCT02796391|515416012|FG004|Overall Study|Protocol Violation|0|||
142967280|NCT02796391|515416013|FG005|Overall Study|Protocol Violation|0|||
142967281|NCT00831441|515416014|FG000|Randomized|Death|82|||
142967282|NCT00831441|515416015|FG001|Randomized|Death|81|||
142967283|NCT00831441|515416014|FG000|Randomized|Adverse Event|248|||
142967284|NCT00831441|515416015|FG001|Randomized|Adverse Event|321|||
142967285|NCT00831441|515416014|FG000|Randomized|Emergency procedure|2|||
142967286|NCT00831441|515416015|FG001|Randomized|Emergency procedure|2|||
142967287|NCT00831441|515416014|FG000|Randomized|Elective procedure|26|||
142967288|NCT00831441|515416015|FG001|Randomized|Elective procedure|25|||
142967289|NCT00831441|515416014|FG000|Randomized|Physician Decision|26|||
142967290|NCT00831441|515416015|FG001|Randomized|Physician Decision|35|||
142967291|NCT00831441|515416014|FG000|Randomized|No longer met criteria|13|||
142967292|NCT00831441|515416015|FG001|Randomized|No longer met criteria|19|||
142967293|NCT00831441|515416014|FG000|Randomized|Withdrawal by Subject|178|||
142967294|NCT00831441|515416015|FG001|Randomized|Withdrawal by Subject|212|||
142967295|NCT00831441|515416014|FG000|Randomized|Lost to Follow-up|26|||
142967296|NCT00831441|515416015|FG001|Randomized|Lost to Follow-up|35|||
142967297|NCT00831441|515416014|FG000|Randomized|Administrative reason by sponsor|2780|||
142967298|NCT00831441|515416015|FG001|Randomized|Administrative reason by sponsor|2671|||
142967299|NCT00831441|515416014|FG000|Randomized|poor/non-compliance|30|||
142967300|NCT00831441|515416015|FG001|Randomized|poor/non-compliance|38|||
142967301|NCT00831441|515416014|FG000|Randomized|non-specified|276|||
142967302|NCT00831441|515416015|FG001|Randomized|non-specified|266|||
142967303|NCT00831441|515416014|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
142967304|NCT00831441|515416015|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
142967305|NCT00831441|515416014|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
142967306|NCT00831441|515416015|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
142967307|NCT00831441|515416014|FG000|Follow Up (30 Days)|Death|63|||
142967308|NCT00831441|515416015|FG001|Follow Up (30 Days)|Death|86|||
142967309|NCT00831441|515416014|FG000|Follow Up (30 Days)|non-specified|16|||
142967310|NCT00831441|515416015|FG001|Follow Up (30 Days)|non-specified|26|||
142967311|NCT00831441|515416014|FG000|Follow Up (30 Days)|missing end of study status|0|||
142967312|NCT00831441|515416015|FG001|Follow Up (30 Days)|missing end of study status|1|||
142967313|NCT05674344|515416016|FG000|Overall Study|Screen Fail|21|||
142967314|NCT05674344|515416016|FG000|Overall Study|Incomplete study procedures|3|||
142967315|NCT04831515|515416017|FG000|First Intervention|Adverse Event|0|||
142967316|NCT04831515|515416018|FG001|First Intervention|Adverse Event|1|||
142967317|NCT00756886|515416019|FG000|Overall Study|Lost to Follow-up|1|||
142967318|NCT00756886|515416020|FG001|Overall Study|Lost to Follow-up|0|||
142967319|NCT00756886|515416019|FG000|Overall Study|Adverse Event|0|||
142967320|NCT00756886|515416020|FG001|Overall Study|Adverse Event|3|||
142967321|NCT00756886|515416019|FG000|Overall Study|Lack of Efficacy|1|||
142967322|NCT00756886|515416020|FG001|Overall Study|Lack of Efficacy|0|||
142967323|NCT00756886|515416019|FG000|Overall Study|Ineligible|9|||
142967324|NCT00756886|515416020|FG001|Overall Study|Ineligible|4|||
142967325|NCT00174785|515416024|FG000|Overall Study|Adverse Event|293|||
142967326|NCT00174785|515416025|FG001|Overall Study|Adverse Event|191|||
142967327|NCT00174785|515416024|FG000|Overall Study|Protocol Violation|14|||
142967328|NCT00174785|515416025|FG001|Overall Study|Protocol Violation|14|||
142967329|NCT00174785|515416024|FG000|Overall Study|Withdrawal by Subject|173|||
142967330|NCT00174785|515416025|FG001|Overall Study|Withdrawal by Subject|175|||
142967331|NCT00174785|515416024|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
142967332|NCT00174785|515416025|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
142967333|NCT00174785|515416024|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
142967334|NCT00174785|515416025|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
142967335|NCT00174785|515416024|FG000|Overall Study|Other prohibited medication|5|||
142967336|NCT00174785|515416025|FG001|Overall Study|Other prohibited medication|3|||
142967337|NCT00174785|515416024|FG000|Overall Study|Family request|6|||
142967338|NCT00174785|515416025|FG001|Overall Study|Family request|8|||
142967339|NCT00174785|515416024|FG000|Overall Study|Not pre-specified/Not coded|56|||
142967340|NCT00174785|515416025|FG001|Overall Study|Not pre-specified/Not coded|70|||
142967341|NCT00310388|515416027|FG000|Primary Reporting Phase|Adverse Event|101|||
142967342|NCT00310388|515416028|FG001|Primary Reporting Phase|Adverse Event|0|||
142967343|NCT00310388|515416027|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
142967344|NCT00310388|515416028|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
142967345|NCT00310388|515416027|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
142967346|NCT00310388|515416028|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
142967347|NCT00310388|515416027|FG000|Primary Reporting Phase|Protocol Violation|10|||
142967348|NCT00310388|515416028|FG001|Primary Reporting Phase|Protocol Violation|0|||
142967349|NCT00310388|515416027|FG000|Primary Reporting Phase|Pregnancy|3|||
142967350|NCT00310388|515416028|FG001|Primary Reporting Phase|Pregnancy|0|||
142967351|NCT00310388|515416027|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
142967352|NCT00310388|515416028|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
142967353|NCT00310388|515416027|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
142967354|NCT00310388|515416028|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
142967355|NCT00310388|515416027|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
142967356|NCT00310388|515416028|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
142967357|NCT00310388|515416027|FG000|Primary Reporting Phase|Physician Decision|2|||
142967358|NCT00310388|515416028|FG001|Primary Reporting Phase|Physician Decision|0|||
142967359|NCT00310388|515416027|FG000|Primary Reporting Phase|Request of the sponsor|19|||
142967360|NCT00310388|515416028|FG001|Primary Reporting Phase|Request of the sponsor|0|||
142967361|NCT00310388|515416027|FG000|Primary Reporting Phase|Failed to return|8|||
142967362|NCT00310388|515416028|FG001|Primary Reporting Phase|Failed to return|0|||
142967363|NCT00310388|515416027|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
142967364|NCT00310388|515416028|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
142967365|NCT00310388|515416027|FG000|Primary Reporting Phase|Participant request|2|||
142967366|NCT00310388|515416028|FG001|Primary Reporting Phase|Participant request|0|||
143003138|NCT01049360|515548750|FG006|Period 2|Adverse Event|0|||
142967367|NCT00310388|515416027|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
142967368|NCT00310388|515416028|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
142967369|NCT00310388|515416027|FG000|Primary Reporting Phase|Discontinuation of study|1|||
142967370|NCT00310388|515416028|FG001|Primary Reporting Phase|Discontinuation of study|0|||
142967371|NCT00310388|515416027|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
142967372|NCT00310388|515416028|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
142967373|NCT00310388|515416027|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
142967374|NCT00310388|515416028|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
142967375|NCT00310388|515416027|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
142967376|NCT00310388|515416028|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
142967377|NCT00310388|515416027|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
142967378|NCT00310388|515416028|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
142967379|NCT00310388|515416027|FG000|Primary Reporting Phase|Participant passed away|1|||
142967380|NCT00310388|515416028|FG001|Primary Reporting Phase|Participant passed away|0|||
142967381|NCT00310388|515416027|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
142967382|NCT00310388|515416028|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
142967383|NCT00310388|515416027|FG000|Primary Reporting Phase|Missing|1|||
142967384|NCT00310388|515416028|FG001|Primary Reporting Phase|Missing|0|||
142967385|NCT00310388|515416027|FG000|Primary Reporting Phase|Other|1|||
142967386|NCT00310388|515416028|FG001|Primary Reporting Phase|Other|0|||
142967387|NCT00310388|515416027|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
142967388|NCT00310388|515416028|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
142967389|NCT00310388|515416027|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
142967390|NCT00310388|515416028|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
142967391|NCT00310388|515416027|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
142967392|NCT00310388|515416028|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
142967393|NCT00310388|515416027|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
142967394|NCT00310388|515416028|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
142967395|NCT03072719|515416033|FG000|Overall Study|Adverse Event|1|||
142967396|NCT03072719|515416034|FG001|Overall Study|Adverse Event|1|||
142967397|NCT02387372|515416035|FG000|Overall Study|Not Treated|1|||
142967398|NCT02387372|515416036|FG001|Overall Study|Not Treated|0|||
142967399|NCT00082758|515416037|FG000|Overall Study|Adverse Event|0|||
142967400|NCT00082758|515416038|FG001|Overall Study|Adverse Event|2|||
142967401|NCT00082758|515416039|FG002|Overall Study|Adverse Event|0|||
142967402|NCT00082758|515416037|FG000|Overall Study|Lack of Efficacy|12|||
142967403|NCT00082758|515416038|FG001|Overall Study|Lack of Efficacy|13|||
142967404|NCT00082758|515416039|FG002|Overall Study|Lack of Efficacy|0|||
142967405|NCT00082758|515416037|FG000|Overall Study|Physician Decision|0|||
142967406|NCT00082758|515416038|FG001|Overall Study|Physician Decision|1|||
142967407|NCT00082758|515416039|FG002|Overall Study|Physician Decision|0|||
142967408|NCT00082758|515416037|FG000|Overall Study|Withdrawal by Subject|3|||
142967409|NCT00082758|515416038|FG001|Overall Study|Withdrawal by Subject|0|||
142967410|NCT00082758|515416039|FG002|Overall Study|Withdrawal by Subject|0|||
142967411|NCT00082758|515416037|FG000|Overall Study|Protocol Violation|0|||
142967412|NCT00082758|515416038|FG001|Overall Study|Protocol Violation|1|||
142967413|NCT00082758|515416039|FG002|Overall Study|Protocol Violation|0|||
142967414|NCT02106455|515416043|FG000|Overall Study|Case Report Form Uncollected|6|||
142967415|NCT02106455|515416043|FG000|Overall Study|Protocol Deviation|2|||
142967416|NCT01260467|515416044|FG000|Overall Study|Withdrawal by Subject|2|||
143455448|NCT00911937|517212454|FG000|Overall Study|Lost to Follow-up|8|||
143455449|NCT00911937|517212455|FG001|Overall Study|Lost to Follow-up|5|||
143455450|NCT00911937|517212454|FG000|Overall Study|Withdrawal by Subject|10|||
143455451|NCT00911937|517212455|FG001|Overall Study|Withdrawal by Subject|7|||
143455452|NCT00911937|517212454|FG000|Overall Study|Withdrawn due to pregnancy|1|||
143455453|NCT00911937|517212455|FG001|Overall Study|Withdrawn due to pregnancy|0|||
143455454|NCT00911937|517212454|FG000|Overall Study|Adverse Event|11|||
143455455|NCT00911937|517212455|FG001|Overall Study|Adverse Event|25|||
143455456|NCT00911937|517212454|FG000|Overall Study|Lack of Efficacy|11|||
143455457|NCT00911937|517212455|FG001|Overall Study|Lack of Efficacy|6|||
143455458|NCT00911937|517212454|FG000|Overall Study|Did not meet inclusion criteria|9|||
143455459|NCT00911937|517212455|FG001|Overall Study|Did not meet inclusion criteria|11|||
143455460|NCT00911937|517212454|FG000|Overall Study|Protocol Violation|14|||
143455461|NCT00911937|517212455|FG001|Overall Study|Protocol Violation|23|||
143455462|NCT00911937|517212454|FG000|Overall Study|Randomized but not treated|13|||
143455463|NCT00911937|517212455|FG001|Overall Study|Randomized but not treated|13|||
143455464|NCT00911937|517212454|FG000|Overall Study|Other|9|||
142967417|NCT00436566|515416049|FG000|Overall Study|Withdrawal by Subject|2|||
142967418|NCT00436566|515416049|FG000|Overall Study|Protocol Violation|1|||
142967419|NCT01954251|515416052|FG000|Overall Study|Adverse Event|5|||
142967420|NCT01954251|515416053|FG001|Overall Study|Adverse Event|7|||
142967421|NCT01954251|515416052|FG000|Overall Study|Lost to Follow-up|6|||
142967422|NCT01954251|515416053|FG001|Overall Study|Lost to Follow-up|6|||
142967423|NCT01954251|515416052|FG000|Overall Study|Withdrawal by Subject|2|||
142967424|NCT01954251|515416053|FG001|Overall Study|Withdrawal by Subject|6|||
142967425|NCT02504268|515416056|FG000|Overall Study|Adverse Event|18|||
142967426|NCT02504268|515416057|FG001|Overall Study|Adverse Event|8|||
142967427|NCT02504268|515416058|FG002|Overall Study|Adverse Event|14|||
142967428|NCT02504268|515416059|FG003|Overall Study|Adverse Event|0|||
142967429|NCT02504268|515416060|FG004|Overall Study|Adverse Event|0|||
142967430|NCT02504268|515416061|FG005|Overall Study|Adverse Event|0|||
142967431|NCT02504268|515416062|FG006|Overall Study|Adverse Event|0|||
142967432|NCT02504268|515416063|FG007|Overall Study|Adverse Event|0|||
142967433|NCT02504268|515416064|FG008|Overall Study|Adverse Event|0|||
142967434|NCT02504268|515416056|FG000|Overall Study|Withdrawal of Consent|11|||
142967435|NCT02504268|515416057|FG001|Overall Study|Withdrawal of Consent|10|||
142967436|NCT02504268|515416058|FG002|Overall Study|Withdrawal of Consent|3|||
142967437|NCT02504268|515416059|FG003|Overall Study|Withdrawal of Consent|0|||
142967438|NCT02504268|515416060|FG004|Overall Study|Withdrawal of Consent|0|||
142967439|NCT02504268|515416061|FG005|Overall Study|Withdrawal of Consent|0|||
142967440|NCT02504268|515416062|FG006|Overall Study|Withdrawal of Consent|0|||
142967441|NCT02504268|515416063|FG007|Overall Study|Withdrawal of Consent|0|||
142967442|NCT02504268|515416064|FG008|Overall Study|Withdrawal of Consent|0|||
142967443|NCT02504268|515416056|FG000|Overall Study|Pregnancy|2|||
142967444|NCT02504268|515416057|FG001|Overall Study|Pregnancy|0|||
142967445|NCT02504268|515416058|FG002|Overall Study|Pregnancy|0|||
142967446|NCT02504268|515416059|FG003|Overall Study|Pregnancy|0|||
142967447|NCT02504268|515416060|FG004|Overall Study|Pregnancy|0|||
142967448|NCT02504268|515416061|FG005|Overall Study|Pregnancy|0|||
142967449|NCT02504268|515416062|FG006|Overall Study|Pregnancy|0|||
142967450|NCT02504268|515416063|FG007|Overall Study|Pregnancy|0|||
142967451|NCT02504268|515416064|FG008|Overall Study|Pregnancy|0|||
142967452|NCT02504268|515416056|FG000|Overall Study|Lost to Follow-up|3|||
142967453|NCT02504268|515416057|FG001|Overall Study|Lost to Follow-up|6|||
142967454|NCT02504268|515416058|FG002|Overall Study|Lost to Follow-up|4|||
142967455|NCT02504268|515416059|FG003|Overall Study|Lost to Follow-up|0|||
142967456|NCT02504268|515416060|FG004|Overall Study|Lost to Follow-up|0|||
142967457|NCT02504268|515416061|FG005|Overall Study|Lost to Follow-up|0|||
142967458|NCT02504268|515416062|FG006|Overall Study|Lost to Follow-up|0|||
142967459|NCT02504268|515416063|FG007|Overall Study|Lost to Follow-up|0|||
142967460|NCT02504268|515416064|FG008|Overall Study|Lost to Follow-up|0|||
142967461|NCT02504268|515416056|FG000|Overall Study|Death|1|||
142967462|NCT02504268|515416057|FG001|Overall Study|Death|1|||
142967463|NCT02504268|515416058|FG002|Overall Study|Death|0|||
142967464|NCT02504268|515416059|FG003|Overall Study|Death|0|||
142967465|NCT02504268|515416060|FG004|Overall Study|Death|0|||
142967466|NCT02504268|515416061|FG005|Overall Study|Death|0|||
142967467|NCT02504268|515416062|FG006|Overall Study|Death|0|||
142967468|NCT02504268|515416063|FG007|Overall Study|Death|0|||
142967469|NCT02504268|515416064|FG008|Overall Study|Death|0|||
142967470|NCT02504268|515416056|FG000|Overall Study|Subject Request to Discontinue|11|||
142967471|NCT02504268|515416057|FG001|Overall Study|Subject Request to Discontinue|3|||
142967472|NCT02504268|515416058|FG002|Overall Study|Subject Request to Discontinue|6|||
142967473|NCT02504268|515416059|FG003|Overall Study|Subject Request to Discontinue|0|||
142967474|NCT02504268|515416060|FG004|Overall Study|Subject Request to Discontinue|0|||
142967475|NCT02504268|515416061|FG005|Overall Study|Subject Request to Discontinue|0|||
142967476|NCT02504268|515416062|FG006|Overall Study|Subject Request to Discontinue|0|||
142967477|NCT02504268|515416063|FG007|Overall Study|Subject Request to Discontinue|0|||
142967478|NCT02504268|515416064|FG008|Overall Study|Subject Request to Discontinue|0|||
142967479|NCT02504268|515416056|FG000|Overall Study|No Longer Meets Study Criteria|2|||
142967480|NCT02504268|515416057|FG001|Overall Study|No Longer Meets Study Criteria|3|||
142967481|NCT02504268|515416058|FG002|Overall Study|No Longer Meets Study Criteria|0|||
142967482|NCT02504268|515416059|FG003|Overall Study|No Longer Meets Study Criteria|0|||
142967483|NCT02504268|515416060|FG004|Overall Study|No Longer Meets Study Criteria|0|||
142967484|NCT02504268|515416061|FG005|Overall Study|No Longer Meets Study Criteria|0|||
142967485|NCT02504268|515416062|FG006|Overall Study|No Longer Meets Study Criteria|0|||
142967486|NCT02504268|515416063|FG007|Overall Study|No Longer Meets Study Criteria|0|||
142967487|NCT02504268|515416064|FG008|Overall Study|No Longer Meets Study Criteria|0|||
142967488|NCT02504268|515416056|FG000|Overall Study|Lack of Efficacy|11|||
142967489|NCT02504268|515416057|FG001|Overall Study|Lack of Efficacy|35|||
142967490|NCT02504268|515416058|FG002|Overall Study|Lack of Efficacy|9|||
142967491|NCT02504268|515416059|FG003|Overall Study|Lack of Efficacy|0|||
142967492|NCT02504268|515416060|FG004|Overall Study|Lack of Efficacy|0|||
142967493|NCT02504268|515416061|FG005|Overall Study|Lack of Efficacy|0|||
142967494|NCT02504268|515416062|FG006|Overall Study|Lack of Efficacy|0|||
142967495|NCT02504268|515416063|FG007|Overall Study|Lack of Efficacy|0|||
142967496|NCT02504268|515416064|FG008|Overall Study|Lack of Efficacy|0|||
142967497|NCT02504268|515416056|FG000|Overall Study|Poor/Non-Compliance|3|||
142967498|NCT02504268|515416057|FG001|Overall Study|Poor/Non-Compliance|2|||
142967499|NCT02504268|515416058|FG002|Overall Study|Poor/Non-Compliance|3|||
142967500|NCT02504268|515416059|FG003|Overall Study|Poor/Non-Compliance|0|||
142967501|NCT02504268|515416060|FG004|Overall Study|Poor/Non-Compliance|0|||
142967502|NCT02504268|515416061|FG005|Overall Study|Poor/Non-Compliance|0|||
142967503|NCT02504268|515416062|FG006|Overall Study|Poor/Non-Compliance|0|||
142967504|NCT02504268|515416063|FG007|Overall Study|Poor/Non-Compliance|0|||
142967505|NCT02504268|515416064|FG008|Overall Study|Poor/Non-Compliance|0|||
142967506|NCT02504268|515416056|FG000|Overall Study|Not Disclosed|1|||
142967507|NCT02504268|515416057|FG001|Overall Study|Not Disclosed|0|||
142967508|NCT02504268|515416058|FG002|Overall Study|Not Disclosed|2|||
142967509|NCT02504268|515416059|FG003|Overall Study|Not Disclosed|0|||
142967510|NCT02504268|515416060|FG004|Overall Study|Not Disclosed|0|||
142967511|NCT02504268|515416061|FG005|Overall Study|Not Disclosed|0|||
142967512|NCT02504268|515416062|FG006|Overall Study|Not Disclosed|0|||
142967513|NCT02504268|515416063|FG007|Overall Study|Not Disclosed|0|||
142967514|NCT02504268|515416064|FG008|Overall Study|Not Disclosed|0|||
142967515|NCT03025217|515416065|FG000|Overall Study|Pregnancy|1|||
142967516|NCT03025217|515416065|FG000|Overall Study|Lost to Follow-up|1|||
142967517|NCT03025217|515416065|FG000|Overall Study|Not eligible, poor English|2|||
142967518|NCT02124707|515416072|FG000|Overall Study|Adverse Event|5|||
142967519|NCT02124707|515416072|FG000|Overall Study|Physician Decision|1|||
142967520|NCT02124707|515416072|FG000|Overall Study|Death|1|||
142967521|NCT01072539|515416073|FG000|Overall Study|Treated prior to the Site Initiation|1|||
142967522|NCT01072539|515416073|FG000|Overall Study|Protocol Violation|2|||
142967523|NCT02768194|515416074|FG000|Period 1|Adverse Event|0|||
142967524|NCT02768194|515416075|FG001|Period 1|Adverse Event|0|||
142967525|NCT02768194|515416076|FG002|Period 1|Adverse Event|0|||
142967526|NCT02768194|515416077|FG003|Period 1|Adverse Event|1|||
142967527|NCT02768194|515416078|FG004|Period 1|Adverse Event|0|||
142967528|NCT02768194|515416079|FG005|Period 1|Adverse Event|0|||
142967529|NCT02768194|515416074|FG000|Period 2|Other (Reason not specified)|1|||
142967530|NCT02768194|515416075|FG001|Period 2|Other (Reason not specified)|0|||
142967531|NCT02768194|515416076|FG002|Period 2|Other (Reason not specified)|0|||
142967532|NCT02768194|515416077|FG003|Period 2|Other (Reason not specified)|0|||
142967533|NCT02768194|515416078|FG004|Period 2|Other (Reason not specified)|0|||
142967534|NCT02768194|515416079|FG005|Period 2|Other (Reason not specified)|0|||
142967535|NCT02768194|515416074|FG000|Period 3|Other (Reason not specified)|0|||
142967536|NCT02768194|515416075|FG001|Period 3|Other (Reason not specified)|1|||
142967537|NCT02768194|515416076|FG002|Period 3|Other (Reason not specified)|0|||
142967538|NCT02768194|515416077|FG003|Period 3|Other (Reason not specified)|0|||
142967539|NCT02768194|515416078|FG004|Period 3|Other (Reason not specified)|0|||
142967540|NCT02768194|515416079|FG005|Period 3|Other (Reason not specified)|0|||
142967541|NCT01536119|515416083|FG000|Overall Study|Lost to Follow-up|17|||
142967542|NCT01536119|515416084|FG001|Overall Study|Lost to Follow-up|14|||
142967543|NCT03655717|515416085|FG000|Overall Study|Withdrawal by Subject|4|||
142967544|NCT03655717|515416086|FG001|Overall Study|Withdrawal by Subject|8|||
142967545|NCT03655717|515416087|FG002|Overall Study|Withdrawal by Subject|1|||
142967546|NCT03655717|515416088|FG003|Overall Study|Withdrawal by Subject|0|||
142967547|NCT03655717|515416089|FG004|Overall Study|Withdrawal by Subject|0|||
142967548|NCT03655717|515416090|FG005|Overall Study|Withdrawal by Subject|1|||
142967549|NCT03655717|515416091|FG006|Overall Study|Withdrawal by Subject|3|||
142967550|NCT03655717|515416092|FG007|Overall Study|Withdrawal by Subject|1|||
142967551|NCT03655717|515416093|FG008|Overall Study|Withdrawal by Subject|2|||
142967552|NCT03655717|515416094|FG009|Overall Study|Withdrawal by Subject|0|||
142967553|NCT03655717|515416095|FG010|Overall Study|Withdrawal by Subject|0|||
142967554|NCT03655717|515416096|FG011|Overall Study|Withdrawal by Subject|1|||
142967555|NCT03655717|515416097|FG012|Overall Study|Withdrawal by Subject|0|||
142967556|NCT03655717|515416098|FG013|Overall Study|Withdrawal by Subject|3|||
142967557|NCT03655717|515416099|FG014|Overall Study|Withdrawal by Subject|0|||
142967558|NCT03655717|515416100|FG015|Overall Study|Withdrawal by Subject|1|||
142967559|NCT03655717|515416101|FG016|Overall Study|Withdrawal by Subject|0|||
142967560|NCT03655717|515416102|FG017|Overall Study|Withdrawal by Subject|0|||
142967561|NCT03655717|515416103|FG018|Overall Study|Withdrawal by Subject|1|||
142967562|NCT03655717|515416104|FG019|Overall Study|Withdrawal by Subject|0|||
142967563|NCT03655717|515416105|FG020|Overall Study|Withdrawal by Subject|0|||
142967564|NCT03655717|515416106|FG021|Overall Study|Withdrawal by Subject|1|||
142967565|NCT03655717|515416107|FG022|Overall Study|Withdrawal by Subject|2|||
142967566|NCT03655717|515416108|FG023|Overall Study|Withdrawal by Subject|1|||
142967567|NCT03655717|515416109|FG024|Overall Study|Withdrawal by Subject|1|||
142967568|NCT03655717|515416110|FG025|Overall Study|Withdrawal by Subject|0|||
142967569|NCT03655717|515416085|FG000|Overall Study|Physician Decision|3|||
142967570|NCT03655717|515416086|FG001|Overall Study|Physician Decision|3|||
142967571|NCT03655717|515416087|FG002|Overall Study|Physician Decision|0|||
142967572|NCT03655717|515416088|FG003|Overall Study|Physician Decision|0|||
142967573|NCT03655717|515416089|FG004|Overall Study|Physician Decision|0|||
142967574|NCT03655717|515416090|FG005|Overall Study|Physician Decision|0|||
142967575|NCT03655717|515416091|FG006|Overall Study|Physician Decision|0|||
142967576|NCT03655717|515416092|FG007|Overall Study|Physician Decision|0|||
142967577|NCT03655717|515416093|FG008|Overall Study|Physician Decision|0|||
142967578|NCT03655717|515416094|FG009|Overall Study|Physician Decision|1|||
142967579|NCT03655717|515416095|FG010|Overall Study|Physician Decision|0|||
142967580|NCT03655717|515416096|FG011|Overall Study|Physician Decision|0|||
142967581|NCT03655717|515416097|FG012|Overall Study|Physician Decision|0|||
142967582|NCT03655717|515416098|FG013|Overall Study|Physician Decision|0|||
142967583|NCT03655717|515416099|FG014|Overall Study|Physician Decision|0|||
142967584|NCT03655717|515416100|FG015|Overall Study|Physician Decision|0|||
142967585|NCT03655717|515416101|FG016|Overall Study|Physician Decision|0|||
142967586|NCT03655717|515416102|FG017|Overall Study|Physician Decision|0|||
142967587|NCT03655717|515416103|FG018|Overall Study|Physician Decision|0|||
142967588|NCT03655717|515416104|FG019|Overall Study|Physician Decision|1|||
142967589|NCT03655717|515416105|FG020|Overall Study|Physician Decision|0|||
142967590|NCT03655717|515416106|FG021|Overall Study|Physician Decision|0|||
142967591|NCT03655717|515416107|FG022|Overall Study|Physician Decision|0|||
142967592|NCT03655717|515416108|FG023|Overall Study|Physician Decision|1|||
142967593|NCT03655717|515416109|FG024|Overall Study|Physician Decision|0|||
142967594|NCT03655717|515416110|FG025|Overall Study|Physician Decision|0|||
142967595|NCT03655717|515416085|FG000|Overall Study|Lost to Follow-up|3|||
142967596|NCT03655717|515416086|FG001|Overall Study|Lost to Follow-up|1|||
142967597|NCT03655717|515416087|FG002|Overall Study|Lost to Follow-up|0|||
142967598|NCT03655717|515416088|FG003|Overall Study|Lost to Follow-up|1|||
142967599|NCT03655717|515416089|FG004|Overall Study|Lost to Follow-up|0|||
142967600|NCT03655717|515416090|FG005|Overall Study|Lost to Follow-up|1|||
142967601|NCT03655717|515416091|FG006|Overall Study|Lost to Follow-up|0|||
142967602|NCT03655717|515416092|FG007|Overall Study|Lost to Follow-up|0|||
142967603|NCT03655717|515416093|FG008|Overall Study|Lost to Follow-up|0|||
142967604|NCT03655717|515416094|FG009|Overall Study|Lost to Follow-up|0|||
142967605|NCT03655717|515416095|FG010|Overall Study|Lost to Follow-up|0|||
142967606|NCT03655717|515416096|FG011|Overall Study|Lost to Follow-up|1|||
142967607|NCT03655717|515416097|FG012|Overall Study|Lost to Follow-up|0|||
142967608|NCT03655717|515416098|FG013|Overall Study|Lost to Follow-up|0|||
142967609|NCT03655717|515416099|FG014|Overall Study|Lost to Follow-up|0|||
142967610|NCT03655717|515416100|FG015|Overall Study|Lost to Follow-up|0|||
142967611|NCT03655717|515416101|FG016|Overall Study|Lost to Follow-up|0|||
142967612|NCT03655717|515416102|FG017|Overall Study|Lost to Follow-up|0|||
142967613|NCT03655717|515416103|FG018|Overall Study|Lost to Follow-up|0|||
142967614|NCT03655717|515416104|FG019|Overall Study|Lost to Follow-up|0|||
142967615|NCT03655717|515416105|FG020|Overall Study|Lost to Follow-up|0|||
142967616|NCT03655717|515416106|FG021|Overall Study|Lost to Follow-up|0|||
142967617|NCT03655717|515416107|FG022|Overall Study|Lost to Follow-up|0|||
142967618|NCT03655717|515416108|FG023|Overall Study|Lost to Follow-up|0|||
142967619|NCT03655717|515416109|FG024|Overall Study|Lost to Follow-up|0|||
142967620|NCT03655717|515416110|FG025|Overall Study|Lost to Follow-up|0|||
142967621|NCT01810042|515416111|FG000|Overall Study|Lost to Follow-up|10|||
142967622|NCT02690207|515418615|FG000|Overall Study|Lost to Follow-up|48|||
142967623|NCT02690207|515418615|FG000|Overall Study|Withdrawal by Subject|46|||
142967624|NCT02690207|515418615|FG000|Overall Study|Protocol Violation|2|||
142967625|NCT02690207|515418615|FG000|Overall Study|Serious adverse event|110|||
142967626|NCT02690207|515418615|FG000|Overall Study|Non-serious Adverse Event|18|||
142967627|NCT02690207|515418615|FG000|Overall Study|Migrated/moved from study area|5|||
142967628|NCT02690207|515418615|FG000|Overall Study|Suspected HZ Episode|1|||
142967629|NCT02690207|515418615|FG000|Overall Study|Other reasons for withdrawal|23|||
142967630|NCT01120379|515418616|FG000|One Year Timepoint|Withdrawal by Subject|41|||
142967631|NCT01120379|515418616|FG000|One Year Timepoint|Lost to Follow-up|115|||
142967632|NCT01120379|515418616|FG000|One Year Timepoint|Death|108|||
142967633|NCT01120379|515418616|FG000|One Year Timepoint|Physician Decision|9|||
142967634|NCT01120379|515418616|FG000|One Year Timepoint|Any other reason for early termination|5|||
142967635|NCT01120379|515418616|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
142967636|NCT01120379|515418616|FG000|Two Year Timepoint|Lost to Follow-up|87|||
142967637|NCT01120379|515418616|FG000|Two Year Timepoint|Death|123|||
142967638|NCT01120379|515418616|FG000|Two Year Timepoint|Physician Decision|12|||
142967639|NCT01120379|515418616|FG000|Two Year Timepoint|Any other reason for early termination|4|||
142967640|NCT01120379|515418616|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
142967641|NCT01120379|515418616|FG000|Three Year Timepoint|Lost to Follow-up|43|||
142967642|NCT01120379|515418616|FG000|Three Year Timepoint|Death|120|||
142967643|NCT01120379|515418616|FG000|Three Year Timepoint|Physician Decision|9|||
142967644|NCT01120379|515418616|FG000|Three Year Timepoint|Any other reason for early termination|17|||
142967645|NCT01120379|515418616|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
142967646|NCT01120379|515418616|FG000|Four Year Timepoint|Lost to Follow-up|10|||
142967647|NCT01120379|515418616|FG000|Four Year Timepoint|Death|131|||
142967648|NCT01120379|515418616|FG000|Four Year Timepoint|Physician Decision|5|||
142967649|NCT01120379|515418616|FG000|Four Year Timepoint|Any other reason for early termination|217|||
142967650|NCT01354353|515418617|FG000|Overall Study|Adverse Event|1|||
142967651|NCT01354353|515418618|FG001|Overall Study|Adverse Event|0|||
142967652|NCT01354353|515418619|FG002|Overall Study|Adverse Event|0|||
142967653|NCT01354353|515418620|FG003|Overall Study|Adverse Event|4|||
142967654|NCT01354353|515418621|FG004|Overall Study|Adverse Event|0|||
142967655|NCT01354353|515418622|FG005|Overall Study|Adverse Event|5|||
142967656|NCT01354353|515418617|FG000|Overall Study|Entry Criteria Not Met|0|||
143455465|NCT00911937|517212455|FG001|Overall Study|Other|5|||
142967657|NCT01354353|515418618|FG001|Overall Study|Entry Criteria Not Met|0|||
143003139|NCT01049360|515548751|FG007|Period 2|Adverse Event|0|||
142967658|NCT01354353|515418619|FG002|Overall Study|Entry Criteria Not Met|0|||
142967659|NCT01354353|515418620|FG003|Overall Study|Entry Criteria Not Met|1|||
142967660|NCT01354353|515418621|FG004|Overall Study|Entry Criteria Not Met|1|||
142967661|NCT01354353|515418622|FG005|Overall Study|Entry Criteria Not Met|0|||
142967662|NCT01354353|515418617|FG000|Overall Study|Physician Decision|0|||
142967663|NCT01354353|515418618|FG001|Overall Study|Physician Decision|1|||
142967664|NCT01354353|515418619|FG002|Overall Study|Physician Decision|1|||
142967665|NCT01354353|515418620|FG003|Overall Study|Physician Decision|0|||
142967666|NCT01354353|515418621|FG004|Overall Study|Physician Decision|0|||
142967667|NCT01354353|515418622|FG005|Overall Study|Physician Decision|0|||
142967668|NCT01354353|515418617|FG000|Overall Study|Withdrawal by Subject|2|||
142967669|NCT01354353|515418618|FG001|Overall Study|Withdrawal by Subject|0|||
142967670|NCT01354353|515418619|FG002|Overall Study|Withdrawal by Subject|1|||
142967671|NCT01354353|515418620|FG003|Overall Study|Withdrawal by Subject|0|||
142967672|NCT01354353|515418621|FG004|Overall Study|Withdrawal by Subject|0|||
142967673|NCT01354353|515418622|FG005|Overall Study|Withdrawal by Subject|1|||
142967674|NCT00485589|515418624|FG000|Overall Study|Death|2|||
142967675|NCT00485589|515418625|FG001|Overall Study|Death|2|||
142967676|NCT00485589|515418626|FG002|Overall Study|Death|0|||
142967677|NCT00485589|515418624|FG000|Overall Study|Failure to return|6|||
142967678|NCT00485589|515418625|FG001|Overall Study|Failure to return|5|||
142967679|NCT00485589|515418626|FG002|Overall Study|Failure to return|1|||
142967680|NCT00485589|515418624|FG000|Overall Study|Protocol Violation|1|||
142967681|NCT00485589|515418625|FG001|Overall Study|Protocol Violation|0|||
142967682|NCT00485589|515418626|FG002|Overall Study|Protocol Violation|0|||
142967683|NCT00485589|515418624|FG000|Overall Study|Violation of selection criteria at entry|0|||
142967684|NCT00485589|515418625|FG001|Overall Study|Violation of selection criteria at entry|3|||
142967685|NCT00485589|515418626|FG002|Overall Study|Violation of selection criteria at entry|1|||
142967686|NCT00485589|515418624|FG000|Overall Study|Administrative/Other|1|||
142967687|NCT00485589|515418625|FG001|Overall Study|Administrative/Other|2|||
142967688|NCT00485589|515418626|FG002|Overall Study|Administrative/Other|1|||
142967689|NCT00485589|515418624|FG000|Overall Study|Insufficient therapeutic response|10|||
142967690|NCT00485589|515418625|FG001|Overall Study|Insufficient therapeutic response|3|||
142967691|NCT00485589|515418626|FG002|Overall Study|Insufficient therapeutic response|1|||
142967692|NCT00485589|515418624|FG000|Overall Study|Refused treatment/did not cooperate|1|||
142967693|NCT00485589|515418625|FG001|Overall Study|Refused treatment/did not cooperate|0|||
142967694|NCT00485589|515418626|FG002|Overall Study|Refused treatment/did not cooperate|2|||
142967695|NCT00485589|515418624|FG000|Overall Study|Withdrawal by Subject|3|||
142967696|NCT00485589|515418625|FG001|Overall Study|Withdrawal by Subject|2|||
142967697|NCT00485589|515418626|FG002|Overall Study|Withdrawal by Subject|2|||
142967698|NCT00485589|515418624|FG000|Overall Study|Adverse Event|3|||
142967699|NCT00485589|515418625|FG001|Overall Study|Adverse Event|3|||
142967700|NCT00485589|515418626|FG002|Overall Study|Adverse Event|10|||
142967701|NCT01944969|515418627|FG000|Overall Study|Adverse Event|1|||
142967702|NCT01944969|515418627|FG000|Overall Study|Lack of Efficacy|1|||
142967703|NCT01944969|515418627|FG000|Overall Study|Non-compliance with IMP|1|||
142967704|NCT01944969|515418627|FG000|Overall Study|Administrative or other reasons|23|||
142967705|NCT01104584|515418628|FG000|Overall Study|Study drug never administered|21|||
142967706|NCT01104584|515418628|FG000|Overall Study|Study prematurely discontinued|2|||
142967707|NCT04017442|515418629|FG000|Overall Study|Withdrawal by Subject|0|||
142967708|NCT04017442|515418630|FG001|Overall Study|Withdrawal by Subject|3|||
142967709|NCT04017442|515418629|FG000|Overall Study|Lost to Follow-up|21|||
142967710|NCT04017442|515418630|FG001|Overall Study|Lost to Follow-up|19|||
142967711|NCT02586233|515418631|FG000|Overall Study|Randomized but did not receive treatment|0|||
142967712|NCT02586233|515418632|FG001|Overall Study|Randomized but did not receive treatment|1|||
142967713|NCT02586233|515418633|FG002|Overall Study|Randomized but did not receive treatment|0|||
142967714|NCT02586233|515418634|FG003|Overall Study|Randomized but did not receive treatment|0|||
142967715|NCT02586233|515418635|FG004|Overall Study|Randomized but did not receive treatment|0|||
142967716|NCT02586233|515418636|FG005|Overall Study|Randomized but did not receive treatment|2|||
142967717|NCT02586233|515418637|FG006|Overall Study|Randomized but did not receive treatment|2|||
142967718|NCT02586233|515418631|FG000|Overall Study|Death|0|||
142967719|NCT02586233|515418632|FG001|Overall Study|Death|1|||
142967720|NCT02586233|515418633|FG002|Overall Study|Death|0|||
142967721|NCT02586233|515418634|FG003|Overall Study|Death|0|||
142967722|NCT02586233|515418635|FG004|Overall Study|Death|2|||
142967723|NCT02586233|515418636|FG005|Overall Study|Death|0|||
142967724|NCT02586233|515418637|FG006|Overall Study|Death|0|||
142967725|NCT00781599|515418638|FG000|Overall Study|Lost to Follow-up|7|||
142967726|NCT00781599|515418639|FG001|Overall Study|Lost to Follow-up|4|||
142967727|NCT01088438|515418656|FG000|Overall Study|Withdrawal by Subject|11|||
142967728|NCT01088438|515418657|FG001|Overall Study|Withdrawal by Subject|6|||
142967729|NCT01088438|515418656|FG000|Overall Study|Lost to Follow-up|18|||
142967730|NCT01088438|515418657|FG001|Overall Study|Lost to Follow-up|30|||
142967731|NCT00089479|515418658|FG000|Overall Study|Death|108|||
142967732|NCT00089479|515418659|FG001|Overall Study|Death|75|||
142967733|NCT00089479|515418658|FG000|Overall Study|Withdrawal by Subject|86|||
143003140|NCT01049360|515548752|FG008|Period 2|Adverse Event|1|||
142967734|NCT00089479|515418659|FG001|Overall Study|Withdrawal by Subject|107|||
142967735|NCT00089479|515418658|FG000|Overall Study|Lost to Follow-up|137|||
142967736|NCT00089479|515418659|FG001|Overall Study|Lost to Follow-up|107|||
142967737|NCT01363713|515418660|FG000|Overall Study|Adverse Event|1|||
142967738|NCT01363713|515418660|FG000|Overall Study|Protocol Violation|3|||
142967739|NCT01363713|515418660|FG000|Overall Study|Withdrawal by Subject|2|||
142967740|NCT00511342|515418665|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
142967741|NCT00511342|515418666|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
142967742|NCT00511342|515418665|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
142967743|NCT00511342|515418666|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
142967744|NCT00511342|515418665|FG000|Overall Study|Pregnancy|0|||
142967745|NCT00511342|515418666|FG001|Overall Study|Pregnancy|1|||
142967746|NCT00511342|515418665|FG000|Overall Study|Pregnancy wish|0|||
142967747|NCT00511342|515418666|FG001|Overall Study|Pregnancy wish|1|||
142967748|NCT00511342|515418665|FG000|Overall Study|Lost to Follow-up|1|||
142967749|NCT00511342|515418666|FG001|Overall Study|Lost to Follow-up|5|||
142967750|NCT00511342|515418665|FG000|Overall Study|Other Reason|2|||
142967751|NCT00511342|515418666|FG001|Overall Study|Other Reason|2|||
142967752|NCT01124448|515418667|FG000|Overall Study|Lost to Follow-up|0|||
142967753|NCT01124448|515418668|FG001|Overall Study|Lost to Follow-up|3|||
142967754|NCT01124448|515418667|FG000|Overall Study|Protocol Violation|2|||
142967755|NCT01124448|515418668|FG001|Overall Study|Protocol Violation|0|||
142967756|NCT02432040|515418669|FG000|Overall Study|Lack of Efficacy|3|||
142967757|NCT02432040|515418670|FG001|Overall Study|Lack of Efficacy|0|||
142967758|NCT02432040|515418669|FG000|Overall Study|Lost to Follow-up|4|||
142967759|NCT02432040|515418670|FG001|Overall Study|Lost to Follow-up|5|||
142967760|NCT02432040|515418669|FG000|Overall Study|Physician Decision|1|||
142967761|NCT02432040|515418670|FG001|Overall Study|Physician Decision|1|||
142967762|NCT03198754|515418677|FG000|Overall Study|Withdrawal by Subject|5|||
142967763|NCT03198754|515418678|FG001|Overall Study|Withdrawal by Subject|4|||
142967764|NCT03198754|515418677|FG000|Overall Study|Lost to Follow-up|4|||
142967765|NCT03198754|515418678|FG001|Overall Study|Lost to Follow-up|3|||
142967766|NCT03198754|515418677|FG000|Overall Study|Ineligible|2|||
142967767|NCT03198754|515418678|FG001|Overall Study|Ineligible|1|||
142967768|NCT03806179|515418682|FG000|Overall Study|Progressive disease|0|||
142967769|NCT03806179|515418683|FG001|Overall Study|Progressive disease|2|||
142967770|NCT00608530|515418686|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
142967771|NCT00608530|515418687|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
142967772|NCT00608530|515418688|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
142967773|NCT00608530|515418689|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
142967774|NCT00608530|515418686|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
142967775|NCT00608530|515418687|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
142967776|NCT00608530|515418688|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
142967777|NCT00608530|515418689|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
142967778|NCT00608530|515418686|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
142967779|NCT00608530|515418687|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
142967780|NCT00608530|515418688|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
142967781|NCT00608530|515418689|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
142967782|NCT00608530|515418686|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
142967783|NCT00608530|515418687|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
142967784|NCT00608530|515418688|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
142967785|NCT00608530|515418689|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
142967786|NCT00608530|515418686|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
142967787|NCT00608530|515418687|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
142967788|NCT00608530|515418688|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
142967789|NCT00608530|515418689|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
142967790|NCT00608530|515418686|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
142967791|NCT00608530|515418687|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
142967792|NCT00608530|515418688|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
142967793|NCT00608530|515418689|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
142967794|NCT01996748|515418692|FG000|Overall Study|Personal reason|1|||
142967795|NCT01996748|515418693|FG001|Overall Study|Personal reason|0|||
142967796|NCT01996748|515418692|FG000|Overall Study|Physician Decision|2|||
142967797|NCT01996748|515418693|FG001|Overall Study|Physician Decision|0|||
142967798|NCT01996748|515418692|FG000|Overall Study|Adverse Event|1|||
142967799|NCT01996748|515418693|FG001|Overall Study|Adverse Event|4|||
142967800|NCT01996748|515418692|FG000|Overall Study|Withdrawal by Subject|0|||
142967801|NCT01996748|515418693|FG001|Overall Study|Withdrawal by Subject|1|||
142967802|NCT01996748|515418692|FG000|Overall Study|Lost to Follow-up|4|||
142967803|NCT01996748|515418693|FG001|Overall Study|Lost to Follow-up|1|||
142967804|NCT03628508|515418694|FG000|Overall Study|Lost to Follow-up|1|||
142967805|NCT02951988|515418695|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
142967806|NCT02951988|515418696|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
142967807|NCT02951988|515418697|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
142967808|NCT02951988|515418698|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
142967809|NCT02951988|515418695|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
142967810|NCT02951988|515418696|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
142967811|NCT02951988|515418697|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
142967812|NCT02951988|515418698|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
142967813|NCT02951988|515418695|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
142967814|NCT02951988|515418696|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
142967815|NCT02951988|515418697|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
142967816|NCT02951988|515418698|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
142967817|NCT02951988|515418695|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
142967818|NCT02951988|515418696|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
142967819|NCT02951988|515418697|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
142967820|NCT02951988|515418698|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
142967821|NCT02951988|515418695|FG000|Open-Label Treatment Period|Protocol Violation|22|||
142967822|NCT02951988|515418696|FG001|Open-Label Treatment Period|Protocol Violation|0|||
142967823|NCT02951988|515418697|FG002|Open-Label Treatment Period|Protocol Violation|0|||
142967824|NCT02951988|515418698|FG003|Open-Label Treatment Period|Protocol Violation|0|||
142967825|NCT02951988|515418695|FG000|Open-Label Treatment Period|Pregnancy|2|||
142967826|NCT02951988|515418696|FG001|Open-Label Treatment Period|Pregnancy|0|||
142967827|NCT02951988|515418697|FG002|Open-Label Treatment Period|Pregnancy|0|||
142967828|NCT02951988|515418698|FG003|Open-Label Treatment Period|Pregnancy|0|||
142967829|NCT02951988|515418695|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
142967830|NCT02951988|515418696|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
142967831|NCT02951988|515418697|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
142967832|NCT02951988|515418698|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
142967833|NCT02951988|515418695|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
142967834|NCT02951988|515418696|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
142967835|NCT02951988|515418697|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
142967836|NCT02951988|515418698|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
142967837|NCT02951988|515418695|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
142967838|NCT02951988|515418696|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
142967839|NCT02951988|515418697|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
142967840|NCT02951988|515418698|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
142967841|NCT02951988|515418695|FG000|Open-Label Treatment Period|Adverse Event|45|||
142967842|NCT02951988|515418696|FG001|Open-Label Treatment Period|Adverse Event|0|||
142967843|NCT02951988|515418697|FG002|Open-Label Treatment Period|Adverse Event|0|||
142967844|NCT02951988|515418698|FG003|Open-Label Treatment Period|Adverse Event|0|||
142967845|NCT02951988|515418695|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
142967846|NCT02951988|515418696|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
142967847|NCT02951988|515418697|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
142967848|NCT02951988|515418698|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
142967849|NCT02951988|515418695|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
142967850|NCT02951988|515418696|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
142967851|NCT02951988|515418697|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
142967852|NCT02951988|515418698|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
142967853|NCT02951988|515418695|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
142967854|NCT02951988|515418696|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
142967855|NCT02951988|515418697|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
142967856|NCT02951988|515418698|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
142967857|NCT02951988|515418695|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
142967858|NCT02951988|515418696|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
142967859|NCT02951988|515418697|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
142967860|NCT02951988|515418698|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
142967861|NCT02951988|515418695|FG000|Double-Blind Treatment Period|Pregnancy|0|||
142967862|NCT02951988|515418696|FG001|Double-Blind Treatment Period|Pregnancy|1|||
142967863|NCT02951988|515418697|FG002|Double-Blind Treatment Period|Pregnancy|1|||
142967864|NCT02951988|515418698|FG003|Double-Blind Treatment Period|Pregnancy|0|||
142967865|NCT02951988|515418695|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
142967866|NCT02951988|515418696|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
142967867|NCT02951988|515418697|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
142967868|NCT02951988|515418698|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
142967869|NCT02951988|515418695|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
142967870|NCT02951988|515418696|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
142967871|NCT02951988|515418697|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
142967872|NCT02951988|515418698|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
142967873|NCT02951988|515418695|FG000|Double-Blind Treatment Period|Adverse Event|0|||
142967874|NCT02951988|515418696|FG001|Double-Blind Treatment Period|Adverse Event|8|||
143455466|NCT03412747|517212457|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
142967875|NCT02951988|515418697|FG002|Double-Blind Treatment Period|Adverse Event|3|||
142967876|NCT02951988|515418698|FG003|Double-Blind Treatment Period|Adverse Event|6|||
142967877|NCT02951988|515418695|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
142967878|NCT02951988|515418696|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
142967879|NCT02951988|515418697|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
142967880|NCT02951988|515418698|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
142967881|NCT01419665|515418699|FG000|Combination Treatment|Adverse Event|7|||
142967882|NCT01419665|515418700|FG001|Combination Treatment|Adverse Event|10|||
142967883|NCT01419665|515418699|FG000|Combination Treatment|Physician Decision|5|||
142967884|NCT01419665|515418700|FG001|Combination Treatment|Physician Decision|8|||
142967885|NCT01419665|515418699|FG000|Combination Treatment|Protocol Violation|6|||
142967886|NCT01419665|515418700|FG001|Combination Treatment|Protocol Violation|2|||
142967887|NCT01419665|515418699|FG000|Combination Treatment|disease progression|10|||
142967888|NCT01419665|515418700|FG001|Combination Treatment|disease progression|9|||
142967889|NCT01419665|515418699|FG000|Combination Treatment|Death|5|||
142967890|NCT01419665|515418700|FG001|Combination Treatment|Death|7|||
142967891|NCT01419665|515418699|FG000|Combination Treatment|administrative problems|0|||
142967892|NCT01419665|515418700|FG001|Combination Treatment|administrative problems|1|||
142967893|NCT01419665|515418699|FG000|Combination Treatment|Withdrawal by Subject|5|||
142967894|NCT01419665|515418700|FG001|Combination Treatment|Withdrawal by Subject|4|||
142967895|NCT01419665|515418699|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
142967896|NCT01419665|515418700|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
142967897|NCT01419665|515418699|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
142967898|NCT01419665|515418700|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
142967899|NCT01419665|515418699|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
142967900|NCT01419665|515418700|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
142967901|NCT01419665|515418699|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
142967902|NCT01419665|515418700|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
142967903|NCT01419665|515418699|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
142967904|NCT01419665|515418700|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
142967905|NCT01419665|515418699|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
142967906|NCT01419665|515418700|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
142967907|NCT01419665|515418699|FG000|Maintenance Treatment and/or Follow up|Death|1|||
142967908|NCT01419665|515418700|FG001|Maintenance Treatment and/or Follow up|Death|2|||
142967909|NCT01419665|515418699|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
142967910|NCT01419665|515418700|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
142967911|NCT01419665|515418699|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
142967912|NCT01419665|515418700|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
142967913|NCT01419665|515418699|FG000|Open Label Phase|Death|1|||
142967914|NCT01419665|515418700|FG001|Open Label Phase|Death|0|||
142967915|NCT01419665|515418699|FG000|Open Label Phase|disease progression|0|||
142967916|NCT01419665|515418700|FG001|Open Label Phase|disease progression|1|||
142967917|NCT02632110|515418703|FG000|Overall Study|Withdrawal by Subject|1|||
142967918|NCT02632110|515418704|FG001|Overall Study|Withdrawal by Subject|1|||
142967919|NCT02632110|515418705|FG002|Overall Study|Withdrawal by Subject|0|||
142967920|NCT02632110|515418706|FG003|Overall Study|Withdrawal by Subject|0|||
142967921|NCT02632110|515418707|FG004|Overall Study|Withdrawal by Subject|1|||
142967922|NCT02632110|515418708|FG005|Overall Study|Withdrawal by Subject|1|||
142967923|NCT02632110|515418709|FG006|Overall Study|Withdrawal by Subject|3|||
142967924|NCT02632110|515418710|FG007|Overall Study|Withdrawal by Subject|3|||
142967925|NCT02632110|515418711|FG008|Overall Study|Withdrawal by Subject|1|||
142967926|NCT02632110|515418712|FG009|Overall Study|Withdrawal by Subject|1|||
142967927|NCT03352414|515418713|FG000|Overall Study|Ineligible by operative criteria|12|||
142967928|NCT03352414|515418714|FG001|Overall Study|Ineligible by operative criteria|10|||
142967929|NCT00516269|515418715|FG000|Overall Study|Adverse Event|2|||
142967930|NCT00516269|515418716|FG001|Overall Study|Adverse Event|1|||
142967931|NCT00516269|515418715|FG000|Overall Study|Lost to Follow-up|0|||
142967932|NCT00516269|515418716|FG001|Overall Study|Lost to Follow-up|1|||
142967933|NCT00516269|515418715|FG000|Overall Study|Protocol Violation|0|||
142967934|NCT00516269|515418716|FG001|Overall Study|Protocol Violation|1|||
142967935|NCT00586924|515418718|FG000|Overall Study|Adverse event/serious adverse event|0|||
142967936|NCT00586924|515418719|FG001|Overall Study|Adverse event/serious adverse event|0|||
142967937|NCT00586924|515418720|FG002|Overall Study|Adverse event/serious adverse event|0|||
142967938|NCT00586924|515418721|FG003|Overall Study|Adverse event/serious adverse event|1|||
142967939|NCT00586924|515418722|FG004|Overall Study|Adverse event/serious adverse event|0|||
142967940|NCT00586924|515418723|FG005|Overall Study|Adverse event/serious adverse event|2|||
142967941|NCT00586924|515418718|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
142967942|NCT00586924|515418719|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
142967943|NCT00586924|515418720|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
142967944|NCT00586924|515418721|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
142967945|NCT00586924|515418722|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
142967946|NCT00586924|515418723|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
142967947|NCT00586924|515418718|FG000|Overall Study|Disease progression|0|||
142967948|NCT00586924|515418719|FG001|Overall Study|Disease progression|0|||
142967949|NCT00586924|515418720|FG002|Overall Study|Disease progression|0|||
142967950|NCT00586924|515418721|FG003|Overall Study|Disease progression|1|||
142967951|NCT00586924|515418722|FG004|Overall Study|Disease progression|1|||
142967952|NCT00586924|515418723|FG005|Overall Study|Disease progression|0|||
142967953|NCT00586924|515418718|FG000|Overall Study|Development of neutralizing antibodies|2|||
142967954|NCT00586924|515418719|FG001|Overall Study|Development of neutralizing antibodies|2|||
142967955|NCT00586924|515418720|FG002|Overall Study|Development of neutralizing antibodies|2|||
142967956|NCT00586924|515418721|FG003|Overall Study|Development of neutralizing antibodies|0|||
142967957|NCT00586924|515418722|FG004|Overall Study|Development of neutralizing antibodies|0|||
142967958|NCT00586924|515418723|FG005|Overall Study|Development of neutralizing antibodies|22|||
142967959|NCT00586924|515418718|FG000|Overall Study|Complete response|0|||
142967960|NCT00586924|515418719|FG001|Overall Study|Complete response|1|||
142967961|NCT00586924|515418720|FG002|Overall Study|Complete response|0|||
142967962|NCT00586924|515418721|FG003|Overall Study|Complete response|0|||
142967963|NCT00586924|515418722|FG004|Overall Study|Complete response|2|||
142967964|NCT00586924|515418723|FG005|Overall Study|Complete response|2|||
142967965|NCT00586924|515418718|FG000|Overall Study|Other|1|||
142967966|NCT00586924|515418719|FG001|Overall Study|Other|0|||
142967967|NCT00586924|515418720|FG002|Overall Study|Other|1|||
142967968|NCT00586924|515418721|FG003|Overall Study|Other|1|||
142967969|NCT00586924|515418722|FG004|Overall Study|Other|1|||
142967970|NCT00586924|515418723|FG005|Overall Study|Other|6|||
142967971|NCT04570657|515418724|FG000|Overall Study|Adverse Event|0|||
142967972|NCT04570657|515418725|FG001|Overall Study|Adverse Event|0|||
142967973|NCT04570657|515418726|FG002|Overall Study|Adverse Event|1|||
142967974|NCT04570657|515418724|FG000|Overall Study|Lost to Follow-up|0|||
142967975|NCT04570657|515418725|FG001|Overall Study|Lost to Follow-up|0|||
142967976|NCT04570657|515418726|FG002|Overall Study|Lost to Follow-up|1|||
142967977|NCT04570657|515418724|FG000|Overall Study|Physician Decision|0|||
142967978|NCT04570657|515418725|FG001|Overall Study|Physician Decision|1|||
142967979|NCT04570657|515418726|FG002|Overall Study|Physician Decision|0|||
142967980|NCT04570657|515418724|FG000|Overall Study|Withdrawal by Subject|1|||
142967981|NCT04570657|515418725|FG001|Overall Study|Withdrawal by Subject|2|||
142967982|NCT04570657|515418726|FG002|Overall Study|Withdrawal by Subject|2|||
142967983|NCT01079962|515418727|FG000|Overall Study|Adverse Event|2|||
142967984|NCT01079962|515418728|FG001|Overall Study|Adverse Event|2|||
142967985|NCT01079962|515418727|FG000|Overall Study|Withdrawal by Subject|5|||
142967986|NCT01079962|515418728|FG001|Overall Study|Withdrawal by Subject|7|||
142967987|NCT01079962|515418727|FG000|Overall Study|Protocol Violation|2|||
142967988|NCT01079962|515418728|FG001|Overall Study|Protocol Violation|2|||
142967989|NCT01079962|515418727|FG000|Overall Study|No blood pressure (BP) control|3|||
142967990|NCT01079962|515418728|FG001|Overall Study|No blood pressure (BP) control|0|||
142967991|NCT01079962|515418727|FG000|Overall Study|Inclusion/exclusion criteria|1|||
142967992|NCT01079962|515418728|FG001|Overall Study|Inclusion/exclusion criteria|3|||
142967993|NCT01079962|515418727|FG000|Overall Study|Participant not returning for next visit|1|||
142967994|NCT01079962|515418728|FG001|Overall Study|Participant not returning for next visit|0|||
142967995|NCT01079962|515418727|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
142967996|NCT01079962|515418728|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
142967997|NCT01331239|515418729|FG000|Part II: Core Study|Adverse Event|0|||
142967998|NCT01331239|515418730|FG001|Part II: Core Study|Adverse Event|3|||
142967999|NCT01331239|515418731|FG002|Part II: Core Study|Adverse Event|0|||
142968000|NCT01331239|515418729|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
142968001|NCT01331239|515418730|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
142968002|NCT01331239|515418731|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
142968003|NCT01331239|515418729|FG000|Part II: Core Study|Withdrawal by Subject|0|||
142968004|NCT01331239|515418730|FG001|Part II: Core Study|Withdrawal by Subject|2|||
142968005|NCT01331239|515418731|FG002|Part II: Core Study|Withdrawal by Subject|0|||
142968006|NCT01331239|515418729|FG000|Part II: Core Study|Administrative problems|0|||
142968007|NCT01331239|515418730|FG001|Part II: Core Study|Administrative problems|1|||
142968008|NCT01331239|515418731|FG002|Part II: Core Study|Administrative problems|0|||
142968009|NCT01008995|515418732|FG000|Controlled Period|Adverse Event|1|||
142968010|NCT01008995|515418733|FG001|Controlled Period|Adverse Event|2|||
142968011|NCT01008995|515418734|FG002|Controlled Period|Adverse Event|0|||
142968012|NCT01008995|515418735|FG003|Controlled Period|Adverse Event|0|||
142968013|NCT01008995|515418732|FG000|Controlled Period|Other|2|||
142968014|NCT01008995|515418733|FG001|Controlled Period|Other|1|||
142968015|NCT01008995|515418734|FG002|Controlled Period|Other|0|||
142968016|NCT01008995|515418735|FG003|Controlled Period|Other|0|||
142968017|NCT01008995|515418732|FG000|After Controlled Period|Adverse Event|0|||
142968018|NCT01008995|515418733|FG001|After Controlled Period|Adverse Event|0|||
142968019|NCT01008995|515418734|FG002|After Controlled Period|Adverse Event|1|||
142968020|NCT01008995|515418735|FG003|After Controlled Period|Adverse Event|1|||
143117148|NCT01273155|515970042|FG004|Overall Study|Died during Cycle 1|0|||
142968021|NCT01008995|515418732|FG000|After Controlled Period|Other|0|||
142968022|NCT01008995|515418733|FG001|After Controlled Period|Other|0|||
142968023|NCT01008995|515418734|FG002|After Controlled Period|Other|1|||
142968024|NCT01008995|515418735|FG003|After Controlled Period|Other|0|||
142968025|NCT00115804|515418736|FG000|Overall Study|Adverse Event|2|||
142968026|NCT00621855|515418737|FG000|Overall Study|Adverse Event|32|||
142968027|NCT00621855|515418738|FG001|Overall Study|Adverse Event|31|||
142968028|NCT00621855|515418739|FG002|Overall Study|Adverse Event|48|||
142968029|NCT00621855|515418740|FG003|Overall Study|Adverse Event|34|||
142968030|NCT00621855|515418741|FG004|Overall Study|Adverse Event|31|||
142968031|NCT00621855|515418737|FG000|Overall Study|Lost to Follow-up|0|||
142968032|NCT00621855|515418738|FG001|Overall Study|Lost to Follow-up|1|||
142968033|NCT00621855|515418739|FG002|Overall Study|Lost to Follow-up|3|||
142968034|NCT00621855|515418740|FG003|Overall Study|Lost to Follow-up|4|||
142968035|NCT00621855|515418741|FG004|Overall Study|Lost to Follow-up|1|||
142968036|NCT00621855|515418737|FG000|Overall Study|Protocol Violation|16|||
142968037|NCT00621855|515418738|FG001|Overall Study|Protocol Violation|8|||
142968038|NCT00621855|515418739|FG002|Overall Study|Protocol Violation|6|||
142968039|NCT00621855|515418740|FG003|Overall Study|Protocol Violation|7|||
142968040|NCT00621855|515418741|FG004|Overall Study|Protocol Violation|8|||
142968041|NCT00621855|515418737|FG000|Overall Study|Withdrawal by Subject|16|||
142968042|NCT00621855|515418738|FG001|Overall Study|Withdrawal by Subject|11|||
142968043|NCT00621855|515418739|FG002|Overall Study|Withdrawal by Subject|13|||
142968044|NCT00621855|515418740|FG003|Overall Study|Withdrawal by Subject|13|||
142968045|NCT00621855|515418741|FG004|Overall Study|Withdrawal by Subject|9|||
142968046|NCT00621855|515418737|FG000|Overall Study|Other|9|||
142968047|NCT00621855|515418738|FG001|Overall Study|Other|7|||
142968048|NCT00621855|515418739|FG002|Overall Study|Other|6|||
142968049|NCT00621855|515418740|FG003|Overall Study|Other|5|||
142968050|NCT00621855|515418741|FG004|Overall Study|Other|4|||
142968051|NCT00621855|515418737|FG000|Overall Study|Patients did not receive study drug|3|||
142968052|NCT00621855|515418738|FG001|Overall Study|Patients did not receive study drug|3|||
142968053|NCT00621855|515418739|FG002|Overall Study|Patients did not receive study drug|5|||
142968054|NCT00621855|515418740|FG003|Overall Study|Patients did not receive study drug|4|||
142968055|NCT00621855|515418741|FG004|Overall Study|Patients did not receive study drug|2|||
142968056|NCT02953782|515418742|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
142968057|NCT02953782|515418743|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
142968058|NCT02953782|515418744|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
142968059|NCT02953782|515418745|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
142968060|NCT02953782|515418746|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
142968061|NCT02953782|515418747|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
142968062|NCT02953782|515418748|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
142968063|NCT02953782|515418749|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
142968064|NCT02953782|515418742|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
142968065|NCT02953782|515418743|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
142968066|NCT02953782|515418744|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
142968067|NCT02953782|515418745|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
142968068|NCT02953782|515418746|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
142968069|NCT02953782|515418747|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
142968070|NCT02953782|515418748|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
142968071|NCT02953782|515418749|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
142968072|NCT02953782|515418742|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
142968073|NCT02953782|515418743|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
142968074|NCT02953782|515418744|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
142968075|NCT02953782|515418745|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
142968076|NCT02953782|515418746|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
142968077|NCT02953782|515418747|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
142968078|NCT02953782|515418748|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
143455467|NCT03412747|517212458|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
143455468|NCT03412747|517212459|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
143455469|NCT03412747|517212457|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
142968079|NCT02953782|515418749|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
142968080|NCT02953782|515418742|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
142968081|NCT02953782|515418743|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
142968082|NCT02953782|515418744|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
142968083|NCT02953782|515418745|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
142968084|NCT02953782|515418746|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
142968085|NCT02953782|515418747|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
142968086|NCT02953782|515418748|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
142968087|NCT02953782|515418749|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
142968088|NCT02953782|515418742|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
142968089|NCT02953782|515418743|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
142968090|NCT02953782|515418744|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
142968091|NCT02953782|515418745|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
142968092|NCT02953782|515418746|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
142968093|NCT02953782|515418747|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
142968094|NCT02953782|515418748|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
142968095|NCT02953782|515418749|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
142968096|NCT02953782|515418742|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
142968097|NCT02953782|515418743|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
142968098|NCT02953782|515418744|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
142968099|NCT02953782|515418745|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
142968100|NCT02953782|515418746|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
142968101|NCT02953782|515418747|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
142968102|NCT02953782|515418748|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
142968103|NCT02953782|515418749|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
142968104|NCT02953782|515418742|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
142968105|NCT02953782|515418743|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
142968106|NCT02953782|515418744|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
142968107|NCT02953782|515418745|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
142968108|NCT02953782|515418746|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
142968109|NCT02953782|515418747|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
142968110|NCT02953782|515418748|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
142968111|NCT02953782|515418749|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
142968112|NCT02953782|515418742|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
142968113|NCT02953782|515418743|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
142968114|NCT02953782|515418744|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
142968115|NCT02953782|515418745|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
142968116|NCT02953782|515418746|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
142968117|NCT02953782|515418747|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
142968118|NCT02953782|515418748|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
142968119|NCT02953782|515418749|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
142968120|NCT01737840|515418752|FG000|Overall Study|Diagnosed with an other pathology|2|||
142968121|NCT01737840|515418753|FG001|Overall Study|Diagnosed with an other pathology|2|||
142968122|NCT03105700|515418758|FG000|Overall Study|screen fail|3|||
142968123|NCT03105700|515418758|FG000|Overall Study|Lost to Follow-up|4|||
142968124|NCT00403559|515418759|FG000|Overall Study|Adverse Event|0|||
142968125|NCT00403559|515418760|FG001|Overall Study|Adverse Event|1|||
142968126|NCT00403559|515418759|FG000|Overall Study|Lost to Follow-up|3|||
142968127|NCT00403559|515418760|FG001|Overall Study|Lost to Follow-up|3|||
142968128|NCT00403559|515418759|FG000|Overall Study|Withdrawal by Subject|1|||
142968129|NCT00403559|515418760|FG001|Overall Study|Withdrawal by Subject|0|||
142968130|NCT04105244|515418761|FG000|Overall Study|Withdrawal by Subject|10|||
142968131|NCT04105244|515418762|FG001|Overall Study|Withdrawal by Subject|12|||
142968132|NCT04105244|515418761|FG000|Overall Study|Lost to Follow-up|20|||
142968133|NCT04105244|515418762|FG001|Overall Study|Lost to Follow-up|15|||
142968134|NCT04105244|515418761|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
142968135|NCT04105244|515418762|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
142968136|NCT04105244|515418761|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
142968137|NCT04105244|515418762|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
142968138|NCT01982773|515418763|FG000|Overall Study|Withdrawal by Subject|1|||
142968139|NCT01982773|515418764|FG001|Overall Study|Withdrawal by Subject|3|||
142968140|NCT01982773|515418763|FG000|Overall Study|Lost to Follow-up|7|||
142968141|NCT01982773|515418764|FG001|Overall Study|Lost to Follow-up|1|||
142968142|NCT01029886|515418765|FG000|Overall Study|Adverse Event|12|||
142968143|NCT01029886|515418766|FG001|Overall Study|Adverse Event|25|||
142968144|NCT01029886|515418765|FG000|Overall Study|Lost to Follow-up|1|||
142968145|NCT01029886|515418766|FG001|Overall Study|Lost to Follow-up|0|||
142968146|NCT01029886|515418765|FG000|Overall Study|Physician Decision|2|||
142968147|NCT01029886|515418766|FG001|Overall Study|Physician Decision|6|||
142968148|NCT01029886|515418765|FG000|Overall Study|Protocol Violation|17|||
142968149|NCT01029886|515418766|FG001|Overall Study|Protocol Violation|5|||
142968150|NCT01029886|515418765|FG000|Overall Study|Withdrawal by Subject|8|||
142968151|NCT01029886|515418766|FG001|Overall Study|Withdrawal by Subject|18|||
142968152|NCT01029886|515418765|FG000|Overall Study|Entry Criteria Not Met|13|||
142968153|NCT01029886|515418766|FG001|Overall Study|Entry Criteria Not Met|5|||
142968154|NCT01029886|515418765|FG000|Overall Study|Sponsor Decision|1|||
142968155|NCT01029886|515418766|FG001|Overall Study|Sponsor Decision|0|||
142968156|NCT01029886|515418765|FG000|Overall Study|Loss Glucose Control|7|||
142968157|NCT01029886|515418766|FG001|Overall Study|Loss Glucose Control|1|||
142968158|NCT01778127|515418771|FG000|Overall Study|Lost to Follow-up|5|||
142968159|NCT01778127|515418772|FG001|Overall Study|Lost to Follow-up|1|||
142968160|NCT01778127|515418773|FG002|Overall Study|Lost to Follow-up|2|||
142968161|NCT01778127|515418771|FG000|Overall Study|Withdrawal by Subject|3|||
142968162|NCT01778127|515418772|FG001|Overall Study|Withdrawal by Subject|1|||
142968163|NCT01778127|515418773|FG002|Overall Study|Withdrawal by Subject|4|||
142968164|NCT02720016|515418774|FG000|Overall Study|Separation of couple|6|||
142968165|NCT02720016|515418775|FG001|Overall Study|Separation of couple|8|||
142968166|NCT02720016|515418776|FG002|Overall Study|Separation of couple|2|||
142968167|NCT02720016|515418774|FG000|Overall Study|Withdrawal by Subject|6|||
142968168|NCT02720016|515418775|FG001|Overall Study|Withdrawal by Subject|6|||
142968169|NCT02720016|515418776|FG002|Overall Study|Withdrawal by Subject|4|||
142968170|NCT02720016|515418774|FG000|Overall Study|Scheduling issues|2|||
142968171|NCT02720016|515418775|FG001|Overall Study|Scheduling issues|4|||
142968172|NCT02720016|515418776|FG002|Overall Study|Scheduling issues|7|||
142968173|NCT02720016|515418774|FG000|Overall Study|Childcare|2|||
142968174|NCT02720016|515418775|FG001|Overall Study|Childcare|0|||
142968175|NCT02720016|515418776|FG002|Overall Study|Childcare|2|||
142968176|NCT02720016|515418774|FG000|Overall Study|Withdrawal by PI|2|||
142968177|NCT02720016|515418775|FG001|Overall Study|Withdrawal by PI|2|||
142968178|NCT02720016|515418776|FG002|Overall Study|Withdrawal by PI|0|||
142968179|NCT02720016|515418774|FG000|Overall Study|Moved away|2|||
142968180|NCT02720016|515418775|FG001|Overall Study|Moved away|0|||
142968181|NCT02720016|515418776|FG002|Overall Study|Moved away|0|||
142968182|NCT02720016|515418774|FG000|Overall Study|Not Primary Health Concern|0|||
142968183|NCT02720016|515418775|FG001|Overall Study|Not Primary Health Concern|0|||
142968184|NCT02720016|515418776|FG002|Overall Study|Not Primary Health Concern|2|||
142968185|NCT02720016|515418774|FG000|Overall Study|Transportation issues|0|||
142968186|NCT02720016|515418775|FG001|Overall Study|Transportation issues|0|||
142968187|NCT02720016|515418776|FG002|Overall Study|Transportation issues|1|||
142968188|NCT02720016|515418774|FG000|Overall Study|Other|0|||
142968189|NCT02720016|515418775|FG001|Overall Study|Other|0|||
142968190|NCT02720016|515418776|FG002|Overall Study|Other|2|||
142968191|NCT05319080|515418779|FG000|Overall Study|Withdrawal by Subject|2|||
142968192|NCT05319080|515418779|FG000|Overall Study|Physician Decision|4|||
142968193|NCT00751114|515418780|FG000|Overall Study|Adverse Event|2|||
142968194|NCT00751114|515418781|FG001|Overall Study|Adverse Event|4|||
142968195|NCT00751114|515418780|FG000|Overall Study|Protocol Violation|8|||
142968196|NCT00751114|515418781|FG001|Overall Study|Protocol Violation|9|||
142968197|NCT00751114|515418780|FG000|Overall Study|Withdrawal by Subject|9|||
142968198|NCT00751114|515418781|FG001|Overall Study|Withdrawal by Subject|4|||
142968199|NCT00751114|515418780|FG000|Overall Study|Lost to Follow-up|4|||
142968200|NCT00751114|515418781|FG001|Overall Study|Lost to Follow-up|7|||
142968201|NCT00751114|515418780|FG000|Overall Study|Lack of Efficacy|0|||
142968202|NCT00751114|515418781|FG001|Overall Study|Lack of Efficacy|7|||
142968203|NCT00751114|515418780|FG000|Overall Study|Not Treated|13|||
142968204|NCT00751114|515418781|FG001|Overall Study|Not Treated|1|||
142968205|NCT00751114|515418780|FG000|Overall Study|Out of country for 2 months|1|||
142968206|NCT00751114|515418781|FG001|Overall Study|Out of country for 2 months|0|||
142968207|NCT00751114|515418780|FG000|Overall Study|Move to another city|1|||
142968208|NCT00751114|515418781|FG001|Overall Study|Move to another city|0|||
142968209|NCT00448916|515418782|FG000|Overall Study|Adverse Event|2|||
142968210|NCT00448916|515418783|FG001|Overall Study|Adverse Event|2|||
142968211|NCT00448916|515418784|FG002|Overall Study|Adverse Event|3|||
142968212|NCT00448916|515418785|FG003|Overall Study|Adverse Event|2|||
142968213|NCT00448916|515418782|FG000|Overall Study|Lack of Efficacy|1|||
142968214|NCT00448916|515418783|FG001|Overall Study|Lack of Efficacy|0|||
142968215|NCT00448916|515418784|FG002|Overall Study|Lack of Efficacy|2|||
142968216|NCT00448916|515418785|FG003|Overall Study|Lack of Efficacy|1|||
142968217|NCT00448916|515418782|FG000|Overall Study|Withdrawal by Subject|3|||
142968218|NCT00448916|515418783|FG001|Overall Study|Withdrawal by Subject|3|||
142968219|NCT00448916|515418784|FG002|Overall Study|Withdrawal by Subject|1|||
142968220|NCT00448916|515418785|FG003|Overall Study|Withdrawal by Subject|1|||
142968221|NCT00448916|515418782|FG000|Overall Study|Other|1|||
142968222|NCT00448916|515418783|FG001|Overall Study|Other|0|||
142968223|NCT00448916|515418784|FG002|Overall Study|Other|0|||
142968224|NCT00448916|515418785|FG003|Overall Study|Other|0|||
142968225|NCT00448916|515418782|FG000|Overall Study|Lost to Follow-up|0|||
142968226|NCT00448916|515418783|FG001|Overall Study|Lost to Follow-up|1|||
142968227|NCT00448916|515418784|FG002|Overall Study|Lost to Follow-up|0|||
142968228|NCT00448916|515418785|FG003|Overall Study|Lost to Follow-up|1|||
142968229|NCT00448916|515418782|FG000|Overall Study|Protocol Violation|0|||
142968230|NCT00448916|515418783|FG001|Overall Study|Protocol Violation|0|||
142968231|NCT00448916|515418784|FG002|Overall Study|Protocol Violation|0|||
142968232|NCT00448916|515418785|FG003|Overall Study|Protocol Violation|1|||
142968233|NCT03521193|515418786|FG000|Overall Study|Withdrawal by Subject|8|||
142968234|NCT03521193|515418787|FG001|Overall Study|Withdrawal by Subject|0|||
142968235|NCT03521193|515418786|FG000|Overall Study|non compliant to ASA treatment|8|||
142968236|NCT03521193|515418787|FG001|Overall Study|non compliant to ASA treatment|0|||
142968237|NCT01752842|515418790|FG000|Overall Study|Adverse Event|3|||
142968238|NCT01752842|515418791|FG001|Overall Study|Adverse Event|0|||
142968239|NCT01752842|515418790|FG000|Overall Study|Withdrawal by Subject|0|||
142968240|NCT01752842|515418791|FG001|Overall Study|Withdrawal by Subject|2|||
142968241|NCT03707158|515418792|FG000|Midtreatment|Lost to Follow-up|16|||
142968242|NCT03707158|515418793|FG001|Midtreatment|Lost to Follow-up|7|||
142968243|NCT03707158|515418792|FG000|Midtreatment|Withdrawal by Subject|28|||
142968244|NCT03707158|515418793|FG001|Midtreatment|Withdrawal by Subject|19|||
142968245|NCT03707158|515418792|FG000|Posttreatment|Lost to Follow-up|0|||
142968246|NCT03707158|515418793|FG001|Posttreatment|Lost to Follow-up|5|||
142968247|NCT03707158|515418792|FG000|Follow-up|Lost to Follow-up|19|||
142968248|NCT03707158|515418793|FG001|Follow-up|Lost to Follow-up|18|||
142968249|NCT03707158|515418792|FG000|Follow-up|Withdrawal by Subject|13|||
142968250|NCT03707158|515418793|FG001|Follow-up|Withdrawal by Subject|6|||
142968251|NCT01208038|515418795|FG000|Overall Study|Withdrawal by Subject|1|||
142968252|NCT03260205|515418796|FG000|Overall Study|Adverse Event|2|||
142968253|NCT03260205|515418797|FG001|Overall Study|Adverse Event|0|||
142968254|NCT03260205|515418798|FG002|Overall Study|Adverse Event|2|||
142968255|NCT03260205|515418799|FG003|Overall Study|Adverse Event|2|||
142968256|NCT03260205|515418800|FG004|Overall Study|Adverse Event|4|||
142968257|NCT03260205|515418796|FG000|Overall Study|Lost to Follow-up|2|||
142968258|NCT03260205|515418797|FG001|Overall Study|Lost to Follow-up|2|||
142968259|NCT03260205|515418798|FG002|Overall Study|Lost to Follow-up|1|||
142968260|NCT03260205|515418799|FG003|Overall Study|Lost to Follow-up|1|||
142968261|NCT03260205|515418800|FG004|Overall Study|Lost to Follow-up|5|||
142968262|NCT03260205|515418796|FG000|Overall Study|Protocol Violation|0|||
142968263|NCT03260205|515418797|FG001|Overall Study|Protocol Violation|0|||
142968264|NCT03260205|515418798|FG002|Overall Study|Protocol Violation|2|||
142968265|NCT03260205|515418799|FG003|Overall Study|Protocol Violation|0|||
142968266|NCT03260205|515418800|FG004|Overall Study|Protocol Violation|1|||
142968267|NCT03260205|515418796|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
142968268|NCT03260205|515418797|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
142968269|NCT03260205|515418798|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
142968270|NCT03260205|515418799|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
142968271|NCT03260205|515418800|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
142968272|NCT03260205|515418796|FG000|Overall Study|Other: Unspecified|0|||
142968273|NCT03260205|515418797|FG001|Overall Study|Other: Unspecified|0|||
142968274|NCT03260205|515418798|FG002|Overall Study|Other: Unspecified|3|||
142968275|NCT03260205|515418799|FG003|Overall Study|Other: Unspecified|1|||
142968276|NCT03260205|515418800|FG004|Overall Study|Other: Unspecified|1|||
142968277|NCT03260205|515418796|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
142968278|NCT03260205|515418797|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
142968279|NCT03260205|515418798|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
142968280|NCT03260205|515418799|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
142968281|NCT03260205|515418800|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
142968282|NCT01877382|515418803|FG000|Dose Escalation|Progressive disease|2|||
142968283|NCT01877382|515418804|FG001|Dose Escalation|Progressive disease|0|||
142968284|NCT01877382|515418805|FG002|Dose Escalation|Progressive disease|1|||
142968285|NCT01877382|515418806|FG003|Dose Escalation|Progressive disease|6|||
142968286|NCT01877382|515418807|FG004|Dose Escalation|Progressive disease|1|||
142968287|NCT01877382|515418808|FG005|Dose Escalation|Progressive disease|0|||
142968288|NCT01877382|515418809|FG006|Dose Escalation|Progressive disease|3|||
142968289|NCT01877382|515418810|FG007|Dose Escalation|Progressive disease|10|||
142968290|NCT01877382|515418811|FG008|Dose Escalation|Progressive disease|4|||
142968291|NCT01877382|515418812|FG009|Dose Escalation|Progressive disease|2|||
142968292|NCT01877382|515418813|FG010|Dose Escalation|Progressive disease|3|||
142968293|NCT01877382|515418814|FG011|Dose Escalation|Progressive disease|3|||
142968294|NCT01877382|515418815|FG012|Dose Escalation|Progressive disease|13|||
142968295|NCT01877382|515418816|FG013|Dose Escalation|Progressive disease|1|||
142968296|NCT01877382|515418817|FG014|Dose Escalation|Progressive disease|0|||
142968297|NCT01877382|515418803|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
142968298|NCT01877382|515418804|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
142968299|NCT01877382|515418805|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
142968300|NCT01877382|515418806|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
142968301|NCT01877382|515418807|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
142968302|NCT01877382|515418808|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
142968303|NCT01877382|515418809|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
142968304|NCT01877382|515418810|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
142968305|NCT01877382|515418811|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
142968306|NCT01877382|515418812|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
142968307|NCT01877382|515418813|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
142968308|NCT01877382|515418814|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
142968309|NCT01877382|515418815|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
142968310|NCT01877382|515418816|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
142968311|NCT01877382|515418817|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
142968312|NCT01877382|515418803|FG000|Dose Escalation|Clinical progression|0|||
142968313|NCT01877382|515418804|FG001|Dose Escalation|Clinical progression|1|||
142968314|NCT01877382|515418805|FG002|Dose Escalation|Clinical progression|0|||
142968315|NCT01877382|515418806|FG003|Dose Escalation|Clinical progression|2|||
142968316|NCT01877382|515418807|FG004|Dose Escalation|Clinical progression|0|||
142968317|NCT01877382|515418808|FG005|Dose Escalation|Clinical progression|0|||
142968318|NCT01877382|515418809|FG006|Dose Escalation|Clinical progression|1|||
142968319|NCT01877382|515418810|FG007|Dose Escalation|Clinical progression|0|||
142968320|NCT01877382|515418811|FG008|Dose Escalation|Clinical progression|0|||
142968321|NCT01877382|515418812|FG009|Dose Escalation|Clinical progression|1|||
142968322|NCT01877382|515418813|FG010|Dose Escalation|Clinical progression|0|||
142968323|NCT01877382|515418814|FG011|Dose Escalation|Clinical progression|0|||
142968324|NCT01877382|515418815|FG012|Dose Escalation|Clinical progression|2|||
142968325|NCT01877382|515418816|FG013|Dose Escalation|Clinical progression|1|||
142968326|NCT01877382|515418817|FG014|Dose Escalation|Clinical progression|0|||
142968327|NCT01877382|515418803|FG000|Dose Escalation|Adverse Event|0|||
142968328|NCT01877382|515418804|FG001|Dose Escalation|Adverse Event|0|||
142968329|NCT01877382|515418805|FG002|Dose Escalation|Adverse Event|0|||
142968330|NCT01877382|515418806|FG003|Dose Escalation|Adverse Event|4|||
142968331|NCT01877382|515418807|FG004|Dose Escalation|Adverse Event|1|||
142968332|NCT01877382|515418808|FG005|Dose Escalation|Adverse Event|2|||
142968333|NCT01877382|515418809|FG006|Dose Escalation|Adverse Event|1|||
142968334|NCT01877382|515418810|FG007|Dose Escalation|Adverse Event|2|||
142968335|NCT01877382|515418811|FG008|Dose Escalation|Adverse Event|0|||
142968336|NCT01877382|515418812|FG009|Dose Escalation|Adverse Event|0|||
142968337|NCT01877382|515418813|FG010|Dose Escalation|Adverse Event|0|||
142968338|NCT01877382|515418814|FG011|Dose Escalation|Adverse Event|0|||
142968339|NCT01877382|515418815|FG012|Dose Escalation|Adverse Event|1|||
142968340|NCT01877382|515418816|FG013|Dose Escalation|Adverse Event|0|||
142968341|NCT01877382|515418817|FG014|Dose Escalation|Adverse Event|0|||
142968342|NCT01877382|515418803|FG000|Dose Escalation|Withdrawal by Subject|0|||
142968343|NCT01877382|515418804|FG001|Dose Escalation|Withdrawal by Subject|0|||
142968344|NCT01877382|515418805|FG002|Dose Escalation|Withdrawal by Subject|0|||
142968345|NCT01877382|515418806|FG003|Dose Escalation|Withdrawal by Subject|0|||
142968346|NCT01877382|515418807|FG004|Dose Escalation|Withdrawal by Subject|0|||
142968347|NCT01877382|515418808|FG005|Dose Escalation|Withdrawal by Subject|3|||
142968348|NCT01877382|515418809|FG006|Dose Escalation|Withdrawal by Subject|2|||
142968349|NCT01877382|515418810|FG007|Dose Escalation|Withdrawal by Subject|1|||
142968350|NCT01877382|515418811|FG008|Dose Escalation|Withdrawal by Subject|1|||
142968351|NCT01877382|515418812|FG009|Dose Escalation|Withdrawal by Subject|0|||
142968352|NCT01877382|515418813|FG010|Dose Escalation|Withdrawal by Subject|0|||
142968353|NCT01877382|515418814|FG011|Dose Escalation|Withdrawal by Subject|0|||
142968354|NCT01877382|515418815|FG012|Dose Escalation|Withdrawal by Subject|0|||
142968355|NCT01877382|515418816|FG013|Dose Escalation|Withdrawal by Subject|0|||
142968356|NCT01877382|515418817|FG014|Dose Escalation|Withdrawal by Subject|0|||
142968357|NCT01877382|515418803|FG000|Dose Escalation|Protocol Violation|0|||
142968358|NCT01877382|515418804|FG001|Dose Escalation|Protocol Violation|0|||
142968359|NCT01877382|515418805|FG002|Dose Escalation|Protocol Violation|0|||
142968360|NCT01877382|515418806|FG003|Dose Escalation|Protocol Violation|0|||
142968361|NCT01877382|515418807|FG004|Dose Escalation|Protocol Violation|0|||
142968362|NCT01877382|515418808|FG005|Dose Escalation|Protocol Violation|0|||
142968363|NCT01877382|515418809|FG006|Dose Escalation|Protocol Violation|1|||
142968364|NCT01877382|515418810|FG007|Dose Escalation|Protocol Violation|0|||
142968365|NCT01877382|515418811|FG008|Dose Escalation|Protocol Violation|0|||
142968366|NCT01877382|515418812|FG009|Dose Escalation|Protocol Violation|0|||
142968367|NCT01877382|515418813|FG010|Dose Escalation|Protocol Violation|0|||
142968368|NCT01877382|515418814|FG011|Dose Escalation|Protocol Violation|0|||
142968369|NCT01877382|515418815|FG012|Dose Escalation|Protocol Violation|0|||
142968370|NCT01877382|515418816|FG013|Dose Escalation|Protocol Violation|0|||
142968371|NCT01877382|515418817|FG014|Dose Escalation|Protocol Violation|0|||
142968372|NCT01877382|515418803|FG000|Dose Escalation|Study terminated by sponsor|0|||
143455470|NCT03412747|517212458|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
143455471|NCT03412747|517212459|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
143455472|NCT03412747|517212457|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
143455473|NCT03412747|517212458|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
143455474|NCT03412747|517212459|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
143455475|NCT03412747|517212457|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
143455476|NCT03412747|517212458|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
143455477|NCT03412747|517212459|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
143455478|NCT03412747|517212457|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
143455479|NCT03412747|517212458|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
142968373|NCT01877382|515418804|FG001|Dose Escalation|Study terminated by sponsor|0|||
142968374|NCT01877382|515418805|FG002|Dose Escalation|Study terminated by sponsor|0|||
142968375|NCT01877382|515418806|FG003|Dose Escalation|Study terminated by sponsor|0|||
142968376|NCT01877382|515418807|FG004|Dose Escalation|Study terminated by sponsor|0|||
142968377|NCT01877382|515418808|FG005|Dose Escalation|Study terminated by sponsor|0|||
142968378|NCT01877382|515418809|FG006|Dose Escalation|Study terminated by sponsor|0|||
142968379|NCT01877382|515418810|FG007|Dose Escalation|Study terminated by sponsor|1|||
142968380|NCT01877382|515418811|FG008|Dose Escalation|Study terminated by sponsor|1|||
142968381|NCT01877382|515418812|FG009|Dose Escalation|Study terminated by sponsor|0|||
142968382|NCT01877382|515418813|FG010|Dose Escalation|Study terminated by sponsor|0|||
142968383|NCT01877382|515418814|FG011|Dose Escalation|Study terminated by sponsor|0|||
142968384|NCT01877382|515418815|FG012|Dose Escalation|Study terminated by sponsor|3|||
142968385|NCT01877382|515418816|FG013|Dose Escalation|Study terminated by sponsor|0|||
142968386|NCT01877382|515418817|FG014|Dose Escalation|Study terminated by sponsor|0|||
142968387|NCT01877382|515418803|FG000|Dose Escalation|Death|0|||
142968388|NCT01877382|515418804|FG001|Dose Escalation|Death|0|||
142968389|NCT01877382|515418805|FG002|Dose Escalation|Death|0|||
142968390|NCT01877382|515418806|FG003|Dose Escalation|Death|0|||
142968391|NCT01877382|515418807|FG004|Dose Escalation|Death|0|||
142968392|NCT01877382|515418808|FG005|Dose Escalation|Death|0|||
142968393|NCT01877382|515418809|FG006|Dose Escalation|Death|0|||
142968394|NCT01877382|515418810|FG007|Dose Escalation|Death|1|||
142968395|NCT01877382|515418811|FG008|Dose Escalation|Death|0|||
142968396|NCT01877382|515418812|FG009|Dose Escalation|Death|0|||
142968397|NCT01877382|515418813|FG010|Dose Escalation|Death|0|||
142968398|NCT01877382|515418814|FG011|Dose Escalation|Death|0|||
142968399|NCT01877382|515418815|FG012|Dose Escalation|Death|1|||
142968400|NCT01877382|515418816|FG013|Dose Escalation|Death|1|||
142968401|NCT01877382|515418817|FG014|Dose Escalation|Death|0|||
142968402|NCT01877382|515418803|FG000|Dose Expansion|Progressive disease|0|||
142968403|NCT01877382|515418804|FG001|Dose Expansion|Progressive disease|0|||
142968404|NCT01877382|515418805|FG002|Dose Expansion|Progressive disease|0|||
142968405|NCT01877382|515418806|FG003|Dose Expansion|Progressive disease|0|||
142968406|NCT01877382|515418807|FG004|Dose Expansion|Progressive disease|0|||
142968407|NCT01877382|515418808|FG005|Dose Expansion|Progressive disease|0|||
142968408|NCT01877382|515418809|FG006|Dose Expansion|Progressive disease|0|||
142968409|NCT01877382|515418810|FG007|Dose Expansion|Progressive disease|0|||
142968410|NCT01877382|515418811|FG008|Dose Expansion|Progressive disease|0|||
142968411|NCT01877382|515418812|FG009|Dose Expansion|Progressive disease|0|||
142968412|NCT01877382|515418813|FG010|Dose Expansion|Progressive disease|0|||
142968413|NCT01877382|515418814|FG011|Dose Expansion|Progressive disease|0|||
142968414|NCT01877382|515418815|FG012|Dose Expansion|Progressive disease|0|||
142968415|NCT01877382|515418816|FG013|Dose Expansion|Progressive disease|0|||
142968416|NCT01877382|515418817|FG014|Dose Expansion|Progressive disease|11|||
142968417|NCT01877382|515418803|FG000|Dose Expansion|Clinical progression|0|||
142968418|NCT01877382|515418804|FG001|Dose Expansion|Clinical progression|0|||
142968419|NCT01877382|515418805|FG002|Dose Expansion|Clinical progression|0|||
142968420|NCT01877382|515418806|FG003|Dose Expansion|Clinical progression|0|||
142968421|NCT01877382|515418807|FG004|Dose Expansion|Clinical progression|0|||
142968422|NCT01877382|515418808|FG005|Dose Expansion|Clinical progression|0|||
142968423|NCT01877382|515418809|FG006|Dose Expansion|Clinical progression|0|||
142968424|NCT01877382|515418810|FG007|Dose Expansion|Clinical progression|0|||
142968425|NCT01877382|515418811|FG008|Dose Expansion|Clinical progression|0|||
142968426|NCT01877382|515418812|FG009|Dose Expansion|Clinical progression|0|||
142968427|NCT01877382|515418813|FG010|Dose Expansion|Clinical progression|0|||
142968428|NCT01877382|515418814|FG011|Dose Expansion|Clinical progression|0|||
142968429|NCT01877382|515418815|FG012|Dose Expansion|Clinical progression|0|||
142968430|NCT01877382|515418816|FG013|Dose Expansion|Clinical progression|0|||
142968431|NCT01877382|515418817|FG014|Dose Expansion|Clinical progression|6|||
142968432|NCT01877382|515418803|FG000|Dose Expansion|Adverse Event|0|||
142968433|NCT01877382|515418804|FG001|Dose Expansion|Adverse Event|0|||
142968434|NCT01877382|515418805|FG002|Dose Expansion|Adverse Event|0|||
142968435|NCT01877382|515418806|FG003|Dose Expansion|Adverse Event|0|||
142968436|NCT01877382|515418807|FG004|Dose Expansion|Adverse Event|0|||
142968437|NCT01877382|515418808|FG005|Dose Expansion|Adverse Event|0|||
142968438|NCT01877382|515418809|FG006|Dose Expansion|Adverse Event|0|||
142968439|NCT01877382|515418810|FG007|Dose Expansion|Adverse Event|0|||
142968440|NCT01877382|515418811|FG008|Dose Expansion|Adverse Event|0|||
142968441|NCT01877382|515418812|FG009|Dose Expansion|Adverse Event|0|||
142968442|NCT01877382|515418813|FG010|Dose Expansion|Adverse Event|0|||
142968443|NCT01877382|515418814|FG011|Dose Expansion|Adverse Event|0|||
142968444|NCT01877382|515418815|FG012|Dose Expansion|Adverse Event|0|||
142968445|NCT01877382|515418816|FG013|Dose Expansion|Adverse Event|0|||
142968446|NCT01877382|515418817|FG014|Dose Expansion|Adverse Event|1|||
142968447|NCT01877382|515418803|FG000|Dose Expansion|Death|0|||
142968448|NCT01877382|515418804|FG001|Dose Expansion|Death|0|||
142968449|NCT01877382|515418805|FG002|Dose Expansion|Death|0|||
142968450|NCT01877382|515418806|FG003|Dose Expansion|Death|0|||
142968451|NCT01877382|515418807|FG004|Dose Expansion|Death|0|||
142968452|NCT01877382|515418808|FG005|Dose Expansion|Death|0|||
142968453|NCT01877382|515418809|FG006|Dose Expansion|Death|0|||
142968454|NCT01877382|515418810|FG007|Dose Expansion|Death|0|||
142968455|NCT01877382|515418811|FG008|Dose Expansion|Death|0|||
142968456|NCT01877382|515418812|FG009|Dose Expansion|Death|0|||
142968457|NCT01877382|515418813|FG010|Dose Expansion|Death|0|||
142968458|NCT01877382|515418814|FG011|Dose Expansion|Death|0|||
142968459|NCT01877382|515418815|FG012|Dose Expansion|Death|0|||
142968460|NCT01877382|515418816|FG013|Dose Expansion|Death|0|||
142968461|NCT01877382|515418817|FG014|Dose Expansion|Death|1|||
142968462|NCT01877382|515418803|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
142968463|NCT01877382|515418804|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
142968464|NCT01877382|515418805|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
142968465|NCT01877382|515418806|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
142968466|NCT01877382|515418807|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
142968467|NCT01877382|515418808|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
142968468|NCT01877382|515418809|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
142968469|NCT01877382|515418810|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
142968470|NCT01877382|515418811|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
142968471|NCT01877382|515418812|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
142968472|NCT01877382|515418813|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
142968473|NCT01877382|515418814|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
142968474|NCT01877382|515418815|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
142968475|NCT01877382|515418816|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
142968476|NCT01877382|515418817|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
142968477|NCT04092816|515420954|FG000|Overall Study|Lost to Follow-up|1|||
142968478|NCT04092816|515420955|FG001|Overall Study|Lost to Follow-up|2|||
142968479|NCT03073213|515420958|FG000|Multiple Dose Period|Protocol Violation|0|||
142968480|NCT03073213|515420959|FG001|Multiple Dose Period|Protocol Violation|0|||
142968481|NCT03073213|515420960|FG002|Multiple Dose Period|Protocol Violation|1|||
142968482|NCT03162055|515420965|FG000|Overall Study|Adverse Event|6|||
142968483|NCT03162055|515420966|FG001|Overall Study|Adverse Event|5|||
142968484|NCT03162055|515420965|FG000|Overall Study|Death|3|||
142968485|NCT03162055|515420966|FG001|Overall Study|Death|3|||
142968486|NCT03162055|515420965|FG000|Overall Study|Lost to Follow-up|0|||
142968487|NCT03162055|515420966|FG001|Overall Study|Lost to Follow-up|1|||
142968488|NCT03162055|515420965|FG000|Overall Study|Study-specific withdrawal criteria|22|||
142968489|NCT03162055|515420966|FG001|Overall Study|Study-specific withdrawal criteria|14|||
142968490|NCT03162055|515420965|FG000|Overall Study|Withdrawal by Subject|17|||
142968491|NCT03162055|515420966|FG001|Overall Study|Withdrawal by Subject|2|||
142968492|NCT03162055|515420965|FG000|Overall Study|Did not receive treatment|2|||
142968493|NCT03162055|515420966|FG001|Overall Study|Did not receive treatment|0|||
142968494|NCT03162055|515420965|FG000|Overall Study|Incorrect randomization|4|||
142968495|NCT03162055|515420966|FG001|Overall Study|Incorrect randomization|3|||
142968496|NCT03162055|515420965|FG000|Overall Study|Other|8|||
142968497|NCT03162055|515420966|FG001|Overall Study|Other|15|||
142968498|NCT01993615|515420970|FG000|Overall Study|Death|1|||
142968499|NCT01993615|515420971|FG001|Overall Study|Death|0|||
142968500|NCT01617655|515420972|FG000|Overall Study|Adverse Event|2|||
142968501|NCT01617655|515420973|FG001|Overall Study|Adverse Event|3|||
142968502|NCT01617655|515420972|FG000|Overall Study|Poor compliance to protocol|1|||
142968503|NCT01617655|515420973|FG001|Overall Study|Poor compliance to protocol|4|||
142968504|NCT01617655|515420972|FG000|Overall Study|Participants moved|0|||
142968505|NCT01617655|515420973|FG001|Overall Study|Participants moved|4|||
142968506|NCT01617655|515420972|FG000|Overall Study|Consent withdrawn by participant|1|||
142968507|NCT01617655|515420973|FG001|Overall Study|Consent withdrawn by participant|1|||
142968508|NCT01617655|515420972|FG000|Overall Study|Last visit outside protocol visit window|1|||
142968509|NCT01617655|515420973|FG001|Overall Study|Last visit outside protocol visit window|10|||
142968510|NCT01617655|515420972|FG000|Overall Study|Site closure|3|||
142968511|NCT01617655|515420973|FG001|Overall Study|Site closure|5|||
142968512|NCT01617655|515420972|FG000|Overall Study|Other than specified above|1|||
142968513|NCT01617655|515420973|FG001|Overall Study|Other than specified above|2|||
142968514|NCT02282982|515420974|FG000|Overall Study|Lost to Follow-up|15|||
143455480|NCT03412747|517212459|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
142968515|NCT02282982|515420974|FG000|Overall Study|Withdrew consent|2|||
142968516|NCT02282982|515420974|FG000|Overall Study|Death|4|||
143455481|NCT03412747|517212457|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
143455482|NCT03412747|517212458|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
142968517|NCT02282982|515420974|FG000|Overall Study|Lack of product|156|||
143455483|NCT03412747|517212459|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
142968518|NCT02282982|515420974|FG000|Overall Study|Palivizumab is ended|11|||
142968519|NCT02282982|515420974|FG000|Overall Study|Other, not specified|18|||
142968520|NCT02924688|515420975|FG000|Overall Study|Adverse Event|9|||
142968521|NCT02924688|515420976|FG001|Overall Study|Adverse Event|3|||
142968522|NCT02924688|515420977|FG002|Overall Study|Adverse Event|2|||
142968523|NCT02924688|515420978|FG003|Overall Study|Adverse Event|2|||
142968524|NCT02924688|515420979|FG004|Overall Study|Adverse Event|3|||
142968525|NCT02924688|515420980|FG005|Overall Study|Adverse Event|2|||
142968526|NCT02924688|515420975|FG000|Overall Study|Lack of Efficacy|2|||
142968527|NCT02924688|515420976|FG001|Overall Study|Lack of Efficacy|3|||
142968528|NCT02924688|515420977|FG002|Overall Study|Lack of Efficacy|4|||
142968529|NCT02924688|515420978|FG003|Overall Study|Lack of Efficacy|2|||
142968530|NCT02924688|515420979|FG004|Overall Study|Lack of Efficacy|1|||
142968531|NCT02924688|515420980|FG005|Overall Study|Lack of Efficacy|1|||
142968532|NCT02924688|515420975|FG000|Overall Study|Protocol Violation|3|||
142968533|NCT02924688|515420976|FG001|Overall Study|Protocol Violation|7|||
142968534|NCT02924688|515420977|FG002|Overall Study|Protocol Violation|5|||
142968535|NCT02924688|515420978|FG003|Overall Study|Protocol Violation|6|||
142968536|NCT02924688|515420979|FG004|Overall Study|Protocol Violation|2|||
142968537|NCT02924688|515420980|FG005|Overall Study|Protocol Violation|2|||
142968538|NCT02924688|515420975|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
142968539|NCT02924688|515420976|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
142968540|NCT02924688|515420977|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
142968541|NCT02924688|515420978|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
142968542|NCT02924688|515420979|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
142968543|NCT02924688|515420980|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
142968544|NCT02924688|515420975|FG000|Overall Study|Lost to Follow-up|2|||
142968545|NCT02924688|515420976|FG001|Overall Study|Lost to Follow-up|4|||
142968546|NCT02924688|515420977|FG002|Overall Study|Lost to Follow-up|2|||
142968547|NCT02924688|515420978|FG003|Overall Study|Lost to Follow-up|4|||
142968548|NCT02924688|515420979|FG004|Overall Study|Lost to Follow-up|2|||
142968549|NCT02924688|515420980|FG005|Overall Study|Lost to Follow-up|4|||
142968550|NCT02924688|515420975|FG000|Overall Study|Physician Decision|2|||
142968551|NCT02924688|515420976|FG001|Overall Study|Physician Decision|1|||
142968552|NCT02924688|515420977|FG002|Overall Study|Physician Decision|0|||
142968553|NCT02924688|515420978|FG003|Overall Study|Physician Decision|1|||
142968554|NCT02924688|515420979|FG004|Overall Study|Physician Decision|1|||
142968555|NCT02924688|515420980|FG005|Overall Study|Physician Decision|1|||
142968556|NCT02924688|515420975|FG000|Overall Study|Withdrawal by Subject|14|||
142968557|NCT02924688|515420976|FG001|Overall Study|Withdrawal by Subject|13|||
142968558|NCT02924688|515420977|FG002|Overall Study|Withdrawal by Subject|9|||
142968559|NCT02924688|515420978|FG003|Overall Study|Withdrawal by Subject|12|||
142968560|NCT02924688|515420979|FG004|Overall Study|Withdrawal by Subject|13|||
142968561|NCT02924688|515420980|FG005|Overall Study|Withdrawal by Subject|14|||
142968562|NCT00848250|515420990|FG000|Overall Study|surgery was completed without cardiopulm|0|||
142968563|NCT00848250|515420991|FG001|Overall Study|surgery was completed without cardiopulm|1|||
142968564|NCT03421964|515420997|FG000|Overall Study|Lost to Follow-up|11|||
142968565|NCT03421964|515420998|FG001|Overall Study|Lost to Follow-up|21|||
142968566|NCT03421964|515420997|FG000|Overall Study|Withdrawal by Subject|9|||
142968567|NCT03421964|515420998|FG001|Overall Study|Withdrawal by Subject|3|||
142968568|NCT03421964|515420997|FG000|Overall Study|Incarcerated|1|||
142968569|NCT03421964|515420998|FG001|Overall Study|Incarcerated|0|||
142968570|NCT03421964|515420997|FG000|Overall Study|Inpt Treatment Facility|1|||
142968571|NCT03421964|515420998|FG001|Overall Study|Inpt Treatment Facility|1|||
142968572|NCT03421964|515420997|FG000|Overall Study|Virtual Platform Issues|1|||
142968573|NCT03421964|515420998|FG001|Overall Study|Virtual Platform Issues|1|||
142968574|NCT02938585|515420999|FG000|Overall Study|Withdrawal by parent or guardian|0|||
142968575|NCT02938585|515421000|FG001|Overall Study|Withdrawal by parent or guardian|1|||
142968576|NCT02938585|515421001|FG002|Overall Study|Withdrawal by parent or guardian|0|||
142968577|NCT02938585|515421002|FG003|Overall Study|Withdrawal by parent or guardian|0|||
142968578|NCT02938585|515420999|FG000|Overall Study|Withdrawal by Subject|0|||
142968579|NCT02938585|515421000|FG001|Overall Study|Withdrawal by Subject|0|||
142968580|NCT02938585|515421001|FG002|Overall Study|Withdrawal by Subject|0|||
142968581|NCT02938585|515421002|FG003|Overall Study|Withdrawal by Subject|5|||
142968582|NCT00213980|515421007|FG000|Overall Study|Withdrawal by Subject|3|||
142968583|NCT00213980|515421008|FG001|Overall Study|Withdrawal by Subject|1|||
142968584|NCT00213980|515421007|FG000|Overall Study|Adverse Event|1|||
142968585|NCT00213980|515421008|FG001|Overall Study|Adverse Event|1|||
142968586|NCT00213980|515421007|FG000|Overall Study|Disease progression|0|||
142968587|NCT00213980|515421008|FG001|Overall Study|Disease progression|2|||
142968588|NCT00213980|515421007|FG000|Overall Study|Developed ovarian cancer|1|||
142968589|NCT00213980|515421008|FG001|Overall Study|Developed ovarian cancer|0|||
142968590|NCT00213980|515421007|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
142968591|NCT00213980|515421008|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
142968592|NCT03607838|515421009|FG000|Overall Study|Lack of Efficacy|14|||
142968593|NCT03607838|515421010|FG001|Overall Study|Lack of Efficacy|20|||
142968594|NCT03607838|515421009|FG000|Overall Study|Withdrawal by Subject|13|||
142968595|NCT03607838|515421010|FG001|Overall Study|Withdrawal by Subject|8|||
142968596|NCT03607838|515421009|FG000|Overall Study|Lost to Follow-up|6|||
142968597|NCT03607838|515421010|FG001|Overall Study|Lost to Follow-up|11|||
142968598|NCT03607838|515421009|FG000|Overall Study|Adverse Event|2|||
142968599|NCT03607838|515421010|FG001|Overall Study|Adverse Event|2|||
142968600|NCT03607838|515421009|FG000|Overall Study|Physician Decision|2|||
142968601|NCT03607838|515421010|FG001|Overall Study|Physician Decision|0|||
142968602|NCT03607838|515421009|FG000|Overall Study|Failure to meet randomization criteria|1|||
142968603|NCT03607838|515421010|FG001|Overall Study|Failure to meet randomization criteria|2|||
142968604|NCT03607838|515421009|FG000|Overall Study|Pregnancy|1|||
142968605|NCT03607838|515421010|FG001|Overall Study|Pregnancy|0|||
142968606|NCT03607838|515421009|FG000|Overall Study|Protocol Violation|1|||
142968607|NCT03607838|515421010|FG001|Overall Study|Protocol Violation|0|||
142968608|NCT03607838|515421009|FG000|Overall Study|Due to work|1|||
142968609|NCT03607838|515421010|FG001|Overall Study|Due to work|0|||
142968610|NCT03607838|515421009|FG000|Overall Study|Litigation|0|||
142968611|NCT03607838|515421010|FG001|Overall Study|Litigation|1|||
142968612|NCT03607838|515421009|FG000|Overall Study|Temperature excursion for study drug|0|||
142968613|NCT03607838|515421010|FG001|Overall Study|Temperature excursion for study drug|1|||
142968614|NCT03607838|515421009|FG000|Overall Study|Change of mind|0|||
142968615|NCT03607838|515421010|FG001|Overall Study|Change of mind|1|||
142968616|NCT03888391|515421013|FG000|Overall Study|Lost to Follow-up|15|||
142968617|NCT00423735|515421014|FG000|Overall Study|Ineligible / No protocol treatment|8|||
142968618|NCT00423735|515421015|FG001|Overall Study|Ineligible / No protocol treatment|6|||
142968619|NCT00423735|515421016|FG002|Overall Study|Ineligible / No protocol treatment|0|||
142968620|NCT00579501|515421021|FG000|Overall Study|Death|1|||
142968621|NCT00579501|515421021|FG000|Overall Study|End of neoadjuvant therapy|25|||
142968622|NCT00579501|515421021|FG000|Overall Study|toxicity|1|||
142968623|NCT00579501|515421021|FG000|Overall Study|Secondary lesion|1|||
142968624|NCT00579501|515421021|FG000|Overall Study|Radiation therapy before surgery|1|||
142968625|NCT01089582|515421022|FG000|Overall Study|Death|2|||
142968626|NCT01089582|515421022|FG000|Overall Study|Adverse Event|15|||
142968627|NCT01089582|515421022|FG000|Overall Study|Lost to Follow-up|8|||
142968628|NCT01089582|515421022|FG000|Overall Study|Other|4|||
142968629|NCT01089582|515421022|FG000|Overall Study|Withdrawal by Subject|1|||
142968630|NCT00502320|515421023|FG000|Overall Study|Lost to Follow-up|1|||
142968631|NCT00502320|515421024|FG001|Overall Study|Lost to Follow-up|1|||
142968632|NCT00502320|515421023|FG000|Overall Study|Withdrew Consent|1|||
142968633|NCT00502320|515421024|FG001|Overall Study|Withdrew Consent|0|||
142968634|NCT00502320|515421023|FG000|Overall Study|No longer met criteria|1|||
142968635|NCT00502320|515421024|FG001|Overall Study|No longer met criteria|0|||
142968636|NCT00502320|515421023|FG000|Overall Study|Screen Failure|0|||
142968637|NCT00502320|515421024|FG001|Overall Study|Screen Failure|1|||
142968638|NCT00502320|515421023|FG000|Overall Study|Adverse Event|3|||
142968639|NCT00502320|515421024|FG001|Overall Study|Adverse Event|5|||
142968640|NCT03654755|515421027|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
142968641|NCT03654755|515421028|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
142968642|NCT03654755|515421029|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
142968643|NCT03654755|515421027|FG000|Overall Study|Withdrawal by Subject|2|||
142968644|NCT03654755|515421028|FG001|Overall Study|Withdrawal by Subject|4|||
142968645|NCT03654755|515421029|FG002|Overall Study|Withdrawal by Subject|8|||
142968646|NCT03654755|515421027|FG000|Overall Study|Lost to Follow-up|1|||
142968647|NCT03654755|515421028|FG001|Overall Study|Lost to Follow-up|3|||
142968648|NCT03654755|515421029|FG002|Overall Study|Lost to Follow-up|7|||
142968649|NCT03654755|515421027|FG000|Overall Study|Physician Decision|0|||
142968650|NCT03654755|515421028|FG001|Overall Study|Physician Decision|1|||
142968651|NCT03654755|515421029|FG002|Overall Study|Physician Decision|0|||
142968652|NCT03654755|515421027|FG000|Overall Study|Adverse Event|0|||
142968653|NCT03654755|515421028|FG001|Overall Study|Adverse Event|0|||
142968654|NCT03654755|515421029|FG002|Overall Study|Adverse Event|4|||
142968655|NCT03654755|515421027|FG000|Overall Study|Lack of Efficacy|0|||
142968656|NCT03654755|515421028|FG001|Overall Study|Lack of Efficacy|0|||
142968657|NCT03654755|515421029|FG002|Overall Study|Lack of Efficacy|1|||
142968658|NCT00209170|515421030|FG000|Overall Study|Adverse Event|0|||
142968659|NCT00209170|515421031|FG001|Overall Study|Adverse Event|1|||
142968660|NCT00209170|515421030|FG000|Overall Study|Withdrawal by Subject|2|||
142968661|NCT00209170|515421031|FG001|Overall Study|Withdrawal by Subject|1|||
142968662|NCT00209170|515421030|FG000|Overall Study|Lack of Efficacy|0|||
142968663|NCT00209170|515421031|FG001|Overall Study|Lack of Efficacy|1|||
142968664|NCT04032171|515421033|FG000|Overall Study|Study Termination|1|||
142968665|NCT04032171|515421034|FG001|Overall Study|Study Termination|0|||
142968666|NCT00992784|515421035|FG000|Overall Study|Adverse Event|2|||
142968667|NCT00992784|515421036|FG001|Overall Study|Adverse Event|1|||
143117149|NCT01273155|515970043|FG005|Overall Study|Died during Cycle 1|2|||
142968668|NCT00992784|515421037|FG002|Overall Study|Adverse Event|0|||
142968669|NCT00992784|515421035|FG000|Overall Study|Withdrawal by Subject|1|||
142968670|NCT00992784|515421036|FG001|Overall Study|Withdrawal by Subject|1|||
142968671|NCT00992784|515421037|FG002|Overall Study|Withdrawal by Subject|1|||
142968672|NCT00289185|515421038|FG000|Overall Study|Withdrawal by Subject|4|||
142968673|NCT00289185|515421039|FG001|Overall Study|Withdrawal by Subject|8|||
142968674|NCT00289185|515421038|FG000|Overall Study|Lost to Follow-up|23|||
142968675|NCT00289185|515421039|FG001|Overall Study|Lost to Follow-up|17|||
142968676|NCT00289185|515421038|FG000|Overall Study|Death|1|||
142968677|NCT00289185|515421039|FG001|Overall Study|Death|1|||
142968678|NCT01199055|515421040|FG000|Overall Study|Death|0|||
142968679|NCT01199055|515421041|FG001|Overall Study|Death|1|||
142968680|NCT01199055|515421042|FG002|Overall Study|Death|0|||
142968681|NCT01199055|515421040|FG000|Overall Study|Physician Decision|0|||
142968682|NCT01199055|515421041|FG001|Overall Study|Physician Decision|1|||
142968683|NCT01199055|515421042|FG002|Overall Study|Physician Decision|1|||
142968684|NCT01199055|515421040|FG000|Overall Study|Progressive disease|2|||
142968685|NCT01199055|515421041|FG001|Overall Study|Progressive disease|1|||
142968686|NCT01199055|515421042|FG002|Overall Study|Progressive disease|2|||
142968687|NCT01199055|515421040|FG000|Overall Study|Withdrawal by Subject|0|||
142968688|NCT01199055|515421041|FG001|Overall Study|Withdrawal by Subject|0|||
142968689|NCT01199055|515421042|FG002|Overall Study|Withdrawal by Subject|1|||
142968690|NCT00678587|515421046|FG000|Overall Study|Adverse Event|3|||
142968691|NCT00678587|515421047|FG001|Overall Study|Adverse Event|3|||
142968692|NCT00678587|515421046|FG000|Overall Study|Lack of Efficacy|1|||
142968693|NCT00678587|515421047|FG001|Overall Study|Lack of Efficacy|0|||
142968694|NCT00678587|515421046|FG000|Overall Study|Protocol Violation|2|||
142968695|NCT00678587|515421047|FG001|Overall Study|Protocol Violation|1|||
142968696|NCT00678587|515421046|FG000|Overall Study|Study Closed/Terminated|1|||
142968697|NCT00678587|515421047|FG001|Overall Study|Study Closed/Terminated|0|||
142968698|NCT00678587|515421046|FG000|Overall Study|Lost to Follow-up|3|||
142968699|NCT00678587|515421047|FG001|Overall Study|Lost to Follow-up|5|||
142968700|NCT00678587|515421046|FG000|Overall Study|Investigator Discretion|2|||
142968701|NCT00678587|515421047|FG001|Overall Study|Investigator Discretion|6|||
142968702|NCT00678587|515421046|FG000|Overall Study|Withdrew Consent|8|||
142968703|NCT00678587|515421047|FG001|Overall Study|Withdrew Consent|3|||
142968704|NCT00077610|515421048|FG000|Overall Study|Adverse Event|9|||
142968705|NCT00077610|515421049|FG001|Overall Study|Adverse Event|7|||
142968706|NCT00077610|515421050|FG002|Overall Study|Adverse Event|1|||
142968707|NCT00077610|515421048|FG000|Overall Study|Lost to Follow-up|0|||
142968708|NCT00077610|515421049|FG001|Overall Study|Lost to Follow-up|1|||
142968709|NCT00077610|515421050|FG002|Overall Study|Lost to Follow-up|2|||
142968710|NCT00077610|515421048|FG000|Overall Study|Withdrawal by Subject|4|||
142968711|NCT00077610|515421049|FG001|Overall Study|Withdrawal by Subject|10|||
142968712|NCT00077610|515421050|FG002|Overall Study|Withdrawal by Subject|6|||
142968713|NCT00077610|515421048|FG000|Overall Study|Death|17|||
142968714|NCT00077610|515421049|FG001|Overall Study|Death|13|||
142968715|NCT00077610|515421050|FG002|Overall Study|Death|13|||
142968716|NCT00077610|515421048|FG000|Overall Study|Renal transplant|12|||
142968717|NCT00077610|515421049|FG001|Overall Study|Renal transplant|15|||
142968718|NCT00077610|515421050|FG002|Overall Study|Renal transplant|11|||
142968719|NCT00077610|515421048|FG000|Overall Study|Withdrew from dialysis care|5|||
142968720|NCT00077610|515421049|FG001|Overall Study|Withdrew from dialysis care|0|||
142968721|NCT00077610|515421050|FG002|Overall Study|Withdrew from dialysis care|3|||
142968722|NCT00077610|515421048|FG000|Overall Study|Insufficient Therapeutic Response|1|||
142968723|NCT00077610|515421049|FG001|Overall Study|Insufficient Therapeutic Response|0|||
142968724|NCT00077610|515421050|FG002|Overall Study|Insufficient Therapeutic Response|0|||
142968725|NCT00077610|515421048|FG000|Overall Study|Multiple blood transfusions|0|||
142968726|NCT00077610|515421049|FG001|Overall Study|Multiple blood transfusions|0|||
142968727|NCT00077610|515421050|FG002|Overall Study|Multiple blood transfusions|1|||
142968728|NCT00077610|515421048|FG000|Overall Study|Principal Investigator's decision|1|||
142968729|NCT00077610|515421049|FG001|Overall Study|Principal Investigator's decision|0|||
142968730|NCT00077610|515421050|FG002|Overall Study|Principal Investigator's decision|1|||
142968731|NCT00077610|515421048|FG000|Overall Study|Worsening of health condition|1|||
142968732|NCT00077610|515421049|FG001|Overall Study|Worsening of health condition|1|||
142968733|NCT00077610|515421050|FG002|Overall Study|Worsening of health condition|0|||
142968734|NCT00077610|515421048|FG000|Overall Study|Given Epogen in hospital|1|||
142968735|NCT00077610|515421049|FG001|Overall Study|Given Epogen in hospital|0|||
142968736|NCT00077610|515421050|FG002|Overall Study|Given Epogen in hospital|0|||
142968737|NCT00077610|515421048|FG000|Overall Study|Transferred to other unit|0|||
142968738|NCT00077610|515421049|FG001|Overall Study|Transferred to other unit|0|||
142968739|NCT00077610|515421050|FG002|Overall Study|Transferred to other unit|1|||
142968740|NCT00077610|515421048|FG000|Overall Study|Transferred to nursing home|0|||
142968741|NCT00077610|515421049|FG001|Overall Study|Transferred to nursing home|0|||
142968742|NCT00077610|515421050|FG002|Overall Study|Transferred to nursing home|1|||
142968743|NCT00077610|515421048|FG000|Overall Study|Transfer to satellite unit|1|||
142968744|NCT00077610|515421049|FG001|Overall Study|Transfer to satellite unit|0|||
143455484|NCT03412747|517212457|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
143455485|NCT03412747|517212458|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
142968745|NCT00077610|515421050|FG002|Overall Study|Transfer to satellite unit|0|||
142968746|NCT00077610|515421048|FG000|Overall Study|Transfer to other center for surgery|1|||
142968747|NCT00077610|515421049|FG001|Overall Study|Transfer to other center for surgery|0|||
142968748|NCT00077610|515421050|FG002|Overall Study|Transfer to other center for surgery|0|||
142968749|NCT00077610|515421048|FG000|Overall Study|Change in dialysis modality|1|||
142968750|NCT00077610|515421049|FG001|Overall Study|Change in dialysis modality|0|||
142968751|NCT00077610|515421050|FG002|Overall Study|Change in dialysis modality|0|||
142968752|NCT00077610|515421048|FG000|Overall Study|Relocation|0|||
142968753|NCT00077610|515421049|FG001|Overall Study|Relocation|8|||
142968754|NCT00077610|515421050|FG002|Overall Study|Relocation|5|||
142968755|NCT00077610|515421048|FG000|Overall Study|Financial issues|0|||
142968756|NCT00077610|515421049|FG001|Overall Study|Financial issues|1|||
142968757|NCT00077610|515421050|FG002|Overall Study|Financial issues|0|||
142968758|NCT00077610|515421048|FG000|Overall Study|Sponsors decision to withdraw|0|||
142968759|NCT00077610|515421049|FG001|Overall Study|Sponsors decision to withdraw|0|||
142968760|NCT00077610|515421050|FG002|Overall Study|Sponsors decision to withdraw|1|||
142968761|NCT02662985|515421063|FG000|Treatment Period 1|Adverse Event|0|||
142968762|NCT02662985|515421064|FG001|Treatment Period 1|Adverse Event|2|||
142968763|NCT02662985|515421063|FG000|Treatment Period 1|Protocol Violation|0|||
142968764|NCT02662985|515421064|FG001|Treatment Period 1|Protocol Violation|1|||
142968765|NCT02662985|515421063|FG000|Treatment Period 1|Physician Decision|1|||
142968766|NCT02662985|515421064|FG001|Treatment Period 1|Physician Decision|0|||
142968767|NCT02662985|515421063|FG000|Treatment Period 1|Withdrawal by Subject|0|||
142968768|NCT02662985|515421064|FG001|Treatment Period 1|Withdrawal by Subject|1|||
142968769|NCT02662985|515421063|FG000|Treatment Period 2|Lack of Efficacy|0|||
142968770|NCT02662985|515421064|FG001|Treatment Period 2|Lack of Efficacy|1|||
142968771|NCT02662985|515421063|FG000|Treatment Period 2|Lost to Follow-up|1|||
142968772|NCT02662985|515421064|FG001|Treatment Period 2|Lost to Follow-up|0|||
142968773|NCT02662985|515421063|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
142968774|NCT02662985|515421064|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
142968775|NCT02662985|515421063|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
142968776|NCT02662985|515421064|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
142968777|NCT02662985|515421063|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
142968778|NCT02662985|515421064|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
142968779|NCT02662985|515421063|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
142968780|NCT02662985|515421064|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
142968781|NCT02662985|515421063|FG000|Treatment Period 3 (Extension Period)|Death|0|||
142968782|NCT02662985|515421064|FG001|Treatment Period 3 (Extension Period)|Death|1|||
142968783|NCT02932332|515421065|FG000|Overall Study|Withdrawal by Subject|1|||
142968784|NCT02932332|515421066|FG001|Overall Study|Withdrawal by Subject|1|||
142968785|NCT02932332|515421067|FG002|Overall Study|Withdrawal by Subject|0|||
142968786|NCT02932332|515421068|FG003|Overall Study|Withdrawal by Subject|1|||
142968787|NCT02932332|515421065|FG000|Overall Study|Chest pain|0|||
142968788|NCT02932332|515421066|FG001|Overall Study|Chest pain|0|||
142968789|NCT02932332|515421067|FG002|Overall Study|Chest pain|0|||
142968790|NCT02932332|515421068|FG003|Overall Study|Chest pain|1|||
142968791|NCT02932332|515421065|FG000|Overall Study|Not Dyspneic cough|1|||
143455486|NCT03412747|517212459|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
143455487|NCT03412747|517212457|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
143455488|NCT03412747|517212458|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
143455489|NCT03412747|517212459|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
143455490|NCT03412747|517212457|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
143455491|NCT03412747|517212458|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
143455492|NCT03412747|517212459|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
143455493|NCT03412747|517212457|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
143455494|NCT03412747|517212458|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
143455495|NCT03412747|517212459|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
143455496|NCT03412747|517212457|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
143455497|NCT03412747|517212458|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
143455498|NCT03412747|517212459|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
143455499|NCT03412747|517212457|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
143455500|NCT03412747|517212458|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
143455501|NCT03412747|517212459|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
142968792|NCT02932332|515421066|FG001|Overall Study|Not Dyspneic cough|2|||
142968793|NCT02932332|515421067|FG002|Overall Study|Not Dyspneic cough|1|||
142968794|NCT02932332|515421068|FG003|Overall Study|Not Dyspneic cough|0|||
142968795|NCT03442829|515421069|FG000|Overall Study|Scheduling clash|3|||
142968796|NCT03442829|515421070|FG001|Overall Study|Scheduling clash|1|||
142968797|NCT03442829|515421069|FG000|Overall Study|Illness unrelated to study|1|||
142968798|NCT03442829|515421070|FG001|Overall Study|Illness unrelated to study|1|||
142968799|NCT01486784|515421071|FG000|Overall Study|Withdrawal by Subject|0|||
142968800|NCT01486784|515421072|FG001|Overall Study|Withdrawal by Subject|0|||
142968801|NCT01486784|515421073|FG002|Overall Study|Withdrawal by Subject|1|||
142968802|NCT01486784|515421074|FG003|Overall Study|Withdrawal by Subject|0|||
142968803|NCT01486784|515421075|FG004|Overall Study|Withdrawal by Subject|1|||
142968804|NCT01486784|515421076|FG005|Overall Study|Withdrawal by Subject|2|||
142968805|NCT01486784|515421071|FG000|Overall Study|Subject did not meet entry criteria|0|||
142968806|NCT01486784|515421072|FG001|Overall Study|Subject did not meet entry criteria|0|||
142968807|NCT01486784|515421073|FG002|Overall Study|Subject did not meet entry criteria|0|||
142968808|NCT01486784|515421074|FG003|Overall Study|Subject did not meet entry criteria|0|||
142968809|NCT01486784|515421075|FG004|Overall Study|Subject did not meet entry criteria|1|||
142968810|NCT01486784|515421076|FG005|Overall Study|Subject did not meet entry criteria|0|||
142968811|NCT01486784|515421071|FG000|Overall Study|Death|0|||
142968812|NCT01486784|515421072|FG001|Overall Study|Death|0|||
142968813|NCT01486784|515421073|FG002|Overall Study|Death|0|||
142968814|NCT01486784|515421074|FG003|Overall Study|Death|0|||
142968815|NCT01486784|515421075|FG004|Overall Study|Death|0|||
142968816|NCT01486784|515421076|FG005|Overall Study|Death|1|||
142968817|NCT01021852|515421077|FG000|Treatment Period 1|Adverse Event|3|||
142968818|NCT01021852|515421078|FG001|Treatment Period 1|Adverse Event|1|||
142968819|NCT01021852|515421079|FG002|Treatment Period 1|Adverse Event|1|||
142968820|NCT01021852|515421080|FG003|Treatment Period 1|Adverse Event|0|||
142968821|NCT01021852|515421081|FG004|Treatment Period 1|Adverse Event|2|||
142968822|NCT01021852|515421082|FG005|Treatment Period 1|Adverse Event|2|||
142968823|NCT01021852|515421083|FG006|Treatment Period 1|Adverse Event|0|||
142968824|NCT01021852|515421084|FG007|Treatment Period 1|Adverse Event|0|||
142968825|NCT01021852|515421077|FG000|Treatment Period 1|Pregnancy|0|||
142968826|NCT01021852|515421078|FG001|Treatment Period 1|Pregnancy|0|||
142968827|NCT01021852|515421079|FG002|Treatment Period 1|Pregnancy|1|||
142968828|NCT01021852|515421080|FG003|Treatment Period 1|Pregnancy|0|||
142968829|NCT01021852|515421081|FG004|Treatment Period 1|Pregnancy|0|||
142968830|NCT01021852|515421082|FG005|Treatment Period 1|Pregnancy|0|||
142968831|NCT01021852|515421083|FG006|Treatment Period 1|Pregnancy|0|||
142968832|NCT01021852|515421084|FG007|Treatment Period 1|Pregnancy|0|||
142968833|NCT01021852|515421077|FG000|Treatment Period 1|Withdrawal by Subject|0|||
142968834|NCT01021852|515421078|FG001|Treatment Period 1|Withdrawal by Subject|0|||
142968835|NCT01021852|515421079|FG002|Treatment Period 1|Withdrawal by Subject|0|||
142968836|NCT01021852|515421080|FG003|Treatment Period 1|Withdrawal by Subject|0|||
142968837|NCT01021852|515421081|FG004|Treatment Period 1|Withdrawal by Subject|1|||
142968838|NCT01021852|515421082|FG005|Treatment Period 1|Withdrawal by Subject|0|||
142968839|NCT01021852|515421083|FG006|Treatment Period 1|Withdrawal by Subject|0|||
142968840|NCT01021852|515421084|FG007|Treatment Period 1|Withdrawal by Subject|1|||
142968841|NCT01021852|515421077|FG000|Treatment Period 1|Not Treated|0|||
142968842|NCT01021852|515421078|FG001|Treatment Period 1|Not Treated|0|||
142968843|NCT01021852|515421079|FG002|Treatment Period 1|Not Treated|0|||
142968844|NCT01021852|515421080|FG003|Treatment Period 1|Not Treated|2|||
142968845|NCT01021852|515421081|FG004|Treatment Period 1|Not Treated|0|||
142968846|NCT01021852|515421082|FG005|Treatment Period 1|Not Treated|0|||
142968847|NCT01021852|515421083|FG006|Treatment Period 1|Not Treated|0|||
142968848|NCT01021852|515421084|FG007|Treatment Period 1|Not Treated|0|||
142968849|NCT01021852|515421077|FG000|Washout Period-Placebo|Adverse Event|0|||
142968850|NCT01021852|515421078|FG001|Washout Period-Placebo|Adverse Event|0|||
142968851|NCT01021852|515421079|FG002|Washout Period-Placebo|Adverse Event|0|||
142968852|NCT01021852|515421080|FG003|Washout Period-Placebo|Adverse Event|1|||
142968853|NCT01021852|515421081|FG004|Washout Period-Placebo|Adverse Event|0|||
142968854|NCT01021852|515421082|FG005|Washout Period-Placebo|Adverse Event|1|||
142968855|NCT01021852|515421083|FG006|Washout Period-Placebo|Adverse Event|0|||
142968856|NCT01021852|515421084|FG007|Washout Period-Placebo|Adverse Event|0|||
142968857|NCT01021852|515421077|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
142968858|NCT01021852|515421078|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
142968859|NCT01021852|515421079|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
142968860|NCT01021852|515421080|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
142968861|NCT01021852|515421081|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
142968862|NCT01021852|515421082|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
142968863|NCT01021852|515421083|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
142968864|NCT01021852|515421084|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
142968865|NCT01021852|515421077|FG000|Washout Period-Placebo|Protocol Violation|0|||
142968866|NCT01021852|515421078|FG001|Washout Period-Placebo|Protocol Violation|0|||
142968867|NCT01021852|515421079|FG002|Washout Period-Placebo|Protocol Violation|0|||
142968868|NCT01021852|515421080|FG003|Washout Period-Placebo|Protocol Violation|0|||
142968869|NCT01021852|515421081|FG004|Washout Period-Placebo|Protocol Violation|0|||
142968870|NCT01021852|515421082|FG005|Washout Period-Placebo|Protocol Violation|0|||
143455502|NCT03412747|517212457|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
142968871|NCT01021852|515421083|FG006|Washout Period-Placebo|Protocol Violation|1|||
142968872|NCT01021852|515421084|FG007|Washout Period-Placebo|Protocol Violation|0|||
142968873|NCT01021852|515421077|FG000|Washout Period-No Drug|Adverse Event|1|||
142968874|NCT01021852|515421078|FG001|Washout Period-No Drug|Adverse Event|0|||
142968875|NCT01021852|515421079|FG002|Washout Period-No Drug|Adverse Event|0|||
142968876|NCT01021852|515421080|FG003|Washout Period-No Drug|Adverse Event|0|||
142968877|NCT01021852|515421081|FG004|Washout Period-No Drug|Adverse Event|0|||
142968878|NCT01021852|515421082|FG005|Washout Period-No Drug|Adverse Event|1|||
142968879|NCT01021852|515421083|FG006|Washout Period-No Drug|Adverse Event|0|||
142968880|NCT01021852|515421084|FG007|Washout Period-No Drug|Adverse Event|0|||
142968881|NCT01021852|515421077|FG000|Treatment Period 2|Adverse Event|0|||
142968882|NCT01021852|515421078|FG001|Treatment Period 2|Adverse Event|1|||
142968883|NCT01021852|515421079|FG002|Treatment Period 2|Adverse Event|0|||
142968884|NCT01021852|515421080|FG003|Treatment Period 2|Adverse Event|0|||
142968885|NCT01021852|515421081|FG004|Treatment Period 2|Adverse Event|1|||
142968886|NCT01021852|515421082|FG005|Treatment Period 2|Adverse Event|0|||
142968887|NCT01021852|515421083|FG006|Treatment Period 2|Adverse Event|1|||
142968888|NCT01021852|515421084|FG007|Treatment Period 2|Adverse Event|0|||
142968889|NCT01021852|515421077|FG000|Treatment Period 2|Lack of Efficacy|0|||
142968890|NCT01021852|515421078|FG001|Treatment Period 2|Lack of Efficacy|0|||
142968891|NCT01021852|515421079|FG002|Treatment Period 2|Lack of Efficacy|0|||
142968892|NCT01021852|515421080|FG003|Treatment Period 2|Lack of Efficacy|0|||
142968893|NCT01021852|515421081|FG004|Treatment Period 2|Lack of Efficacy|0|||
142968894|NCT01021852|515421082|FG005|Treatment Period 2|Lack of Efficacy|1|||
142968895|NCT01021852|515421083|FG006|Treatment Period 2|Lack of Efficacy|0|||
142968896|NCT01021852|515421084|FG007|Treatment Period 2|Lack of Efficacy|0|||
142968897|NCT01021852|515421077|FG000|Treatment Period 2|Physician Decision|0|||
142968898|NCT01021852|515421078|FG001|Treatment Period 2|Physician Decision|0|||
142968899|NCT01021852|515421079|FG002|Treatment Period 2|Physician Decision|1|||
142968900|NCT01021852|515421080|FG003|Treatment Period 2|Physician Decision|0|||
142968901|NCT01021852|515421081|FG004|Treatment Period 2|Physician Decision|0|||
142968902|NCT01021852|515421082|FG005|Treatment Period 2|Physician Decision|0|||
142968903|NCT01021852|515421083|FG006|Treatment Period 2|Physician Decision|0|||
142968904|NCT01021852|515421084|FG007|Treatment Period 2|Physician Decision|0|||
142968905|NCT01021852|515421077|FG000|Treatment Period 2|Protocol Violation|0|||
142968906|NCT01021852|515421078|FG001|Treatment Period 2|Protocol Violation|0|||
142968907|NCT01021852|515421079|FG002|Treatment Period 2|Protocol Violation|0|||
142968908|NCT01021852|515421080|FG003|Treatment Period 2|Protocol Violation|0|||
142968909|NCT01021852|515421081|FG004|Treatment Period 2|Protocol Violation|1|||
142968910|NCT01021852|515421082|FG005|Treatment Period 2|Protocol Violation|0|||
142968911|NCT01021852|515421083|FG006|Treatment Period 2|Protocol Violation|1|||
142968912|NCT01021852|515421084|FG007|Treatment Period 2|Protocol Violation|0|||
142968913|NCT01021852|515421077|FG000|Treatment Period 2|Withdrawal by Subject|0|||
142968914|NCT01021852|515421078|FG001|Treatment Period 2|Withdrawal by Subject|0|||
142968915|NCT01021852|515421079|FG002|Treatment Period 2|Withdrawal by Subject|0|||
142968916|NCT01021852|515421080|FG003|Treatment Period 2|Withdrawal by Subject|0|||
142968917|NCT01021852|515421081|FG004|Treatment Period 2|Withdrawal by Subject|0|||
142968918|NCT01021852|515421082|FG005|Treatment Period 2|Withdrawal by Subject|0|||
142968919|NCT01021852|515421083|FG006|Treatment Period 2|Withdrawal by Subject|1|||
142968920|NCT01021852|515421084|FG007|Treatment Period 2|Withdrawal by Subject|2|||
142968921|NCT02841787|515421085|FG000|Overall Study|Lost to Follow-up|1|||
142968922|NCT02841787|515421086|FG001|Overall Study|Lost to Follow-up|0|||
142968923|NCT02841787|515421087|FG002|Overall Study|Lost to Follow-up|0|||
142968924|NCT02841787|515421085|FG000|Overall Study|Symptoms dropped below threshold|1|||
142968925|NCT02841787|515421086|FG001|Overall Study|Symptoms dropped below threshold|0|||
142968926|NCT02841787|515421087|FG002|Overall Study|Symptoms dropped below threshold|0|||
142968927|NCT02841787|515421085|FG000|Overall Study|Withdrawal by Subject|1|||
142968928|NCT02841787|515421086|FG001|Overall Study|Withdrawal by Subject|4|||
142968929|NCT02841787|515421087|FG002|Overall Study|Withdrawal by Subject|0|||
142968930|NCT03491553|515421088|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
142968931|NCT03491553|515421089|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
142968932|NCT03491553|515421090|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
142968933|NCT03491553|515421091|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
142968934|NCT03491553|515421092|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
142968935|NCT03491553|515421093|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
142968936|NCT03491553|515421088|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
142968937|NCT03491553|515421089|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
142968938|NCT03491553|515421090|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
142968939|NCT03491553|515421091|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
142968940|NCT03491553|515421092|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
142968941|NCT03491553|515421093|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
142968942|NCT03029650|515421096|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
142968943|NCT03029650|515421097|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
142968944|NCT03029650|515421096|FG000|Washout (1 Week)|Physician Decision|0|||
142968945|NCT03029650|515421097|FG001|Washout (1 Week)|Physician Decision|1|||
142968946|NCT01875367|515421098|FG000|Overall Study|Not complete at least 2 questionaries|4|||
142968947|NCT01875367|515421099|FG001|Overall Study|Not complete at least 2 questionaries|2|||
142968948|NCT01875367|515421098|FG000|Overall Study|Not receive study treatment|1|||
142968949|NCT01875367|515421099|FG001|Overall Study|Not receive study treatment|0|||
142968950|NCT02237157|515421102|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
142968951|NCT02237157|515421103|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
142968952|NCT02237157|515421104|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
142968953|NCT02237157|515421105|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
142968954|NCT02237157|515421102|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
142968955|NCT02237157|515421103|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
142968956|NCT02237157|515421104|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
142968957|NCT02237157|515421105|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
142968958|NCT04533815|515421106|FG000|Overall Study|Adverse Event|2|||
142968959|NCT04533815|515421106|FG000|Overall Study|Site withdrew|5|||
142968960|NCT05836818|515421107|FG000|Overall Study|Physician Decision|1|||
142968961|NCT05836818|515421108|FG001|Overall Study|Physician Decision|1|||
142968962|NCT05836818|515421109|FG002|Overall Study|Physician Decision|0|||
142968963|NCT05836818|515421107|FG000|Overall Study|Withdrawal by Subject|0|||
142968964|NCT05836818|515421108|FG001|Overall Study|Withdrawal by Subject|0|||
142968965|NCT05836818|515421109|FG002|Overall Study|Withdrawal by Subject|1|||
142968966|NCT05836818|515421107|FG000|Overall Study|Later found to be previously vaccinated|0|||
142968967|NCT05836818|515421108|FG001|Overall Study|Later found to be previously vaccinated|1|||
142968968|NCT05836818|515421109|FG002|Overall Study|Later found to be previously vaccinated|3|||
142968969|NCT05836818|515421107|FG000|Overall Study|Pregnancy|0|||
142968970|NCT05836818|515421108|FG001|Overall Study|Pregnancy|1|||
142968971|NCT05836818|515421109|FG002|Overall Study|Pregnancy|0|||
142968972|NCT05836818|515421107|FG000|Overall Study|Allergic to vaccines|0|||
142968973|NCT05836818|515421108|FG001|Overall Study|Allergic to vaccines|1|||
142968974|NCT05836818|515421109|FG002|Overall Study|Allergic to vaccines|0|||
142968975|NCT01165021|515421110|FG000|Overall Study|Death|1|||
142968976|NCT02491073|515421111|FG000|Overall Study|screen failure|1|||
142968977|NCT02491073|515421112|FG001|Overall Study|screen failure|0|||
142968978|NCT03977727|515421113|FG000|Second Treatment|Lost to Follow-up|0|||
142968979|NCT03977727|515421114|FG001|Second Treatment|Lost to Follow-up|3|||
142968980|NCT01655823|515421116|FG000|Overall Study|Lost to Follow-up|0|||
142968981|NCT01655823|515421117|FG001|Overall Study|Lost to Follow-up|1|||
142968982|NCT01655823|515421118|FG002|Overall Study|Lost to Follow-up|0|||
142968983|NCT01655823|515421119|FG003|Overall Study|Lost to Follow-up|0|||
142968984|NCT01655823|515421120|FG004|Overall Study|Lost to Follow-up|1|||
142968985|NCT01655823|515421116|FG000|Overall Study|Withdrawal by Subject|0|||
142968986|NCT01655823|515421117|FG001|Overall Study|Withdrawal by Subject|1|||
142968987|NCT01655823|515421118|FG002|Overall Study|Withdrawal by Subject|0|||
142968988|NCT01655823|515421119|FG003|Overall Study|Withdrawal by Subject|1|||
142968989|NCT01655823|515421120|FG004|Overall Study|Withdrawal by Subject|0|||
142968990|NCT01627067|515421121|FG000|Overall Study|Screen Failure|1|||
142968991|NCT00926796|515421125|FG000|Overall Study|Did not receive randomized treatment|4|||
142968992|NCT00926796|515421126|FG001|Overall Study|Did not receive randomized treatment|7|||
142968993|NCT00926796|515421125|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
142968994|NCT00926796|515421126|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
142968995|NCT00926796|515421125|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
142968996|NCT00926796|515421126|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
142968997|NCT00926796|515421125|FG000|Overall Study|Adverse Event|7|||
142968998|NCT00926796|515421126|FG001|Overall Study|Adverse Event|14|||
142968999|NCT00926796|515421125|FG000|Overall Study|Lost to Follow-up|22|||
142969000|NCT00926796|515421126|FG001|Overall Study|Lost to Follow-up|13|||
142969001|NCT00926796|515421125|FG000|Overall Study|Protocol Violation|15|||
142969002|NCT00926796|515421126|FG001|Overall Study|Protocol Violation|11|||
142969003|NCT00926796|515421125|FG000|Overall Study|Withdrawal by Subject|1|||
142969004|NCT00926796|515421126|FG001|Overall Study|Withdrawal by Subject|0|||
142969005|NCT01341652|515421130|FG000|Overall Study|Incorrect Random Assignment|0|||
142969006|NCT01341652|515421131|FG001|Overall Study|Incorrect Random Assignment|1|||
142969007|NCT01341652|515421130|FG000|Overall Study|ineligible; presence metastatic disease|0|||
142969008|NCT01341652|515421131|FG001|Overall Study|ineligible; presence metastatic disease|1|||
142969009|NCT04167306|515421135|FG000|Overall Study|Lost to Follow-up|2|||
142969010|NCT04167306|515421136|FG001|Overall Study|Lost to Follow-up|2|||
143455503|NCT03412747|517212458|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
143455504|NCT03412747|517212459|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
143455505|NCT03412747|517212457|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
143455506|NCT03412747|517212458|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
143455507|NCT03412747|517212459|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
143455508|NCT03412747|517212457|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
143455509|NCT03412747|517212458|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
143455510|NCT03412747|517212459|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
142969011|NCT04167306|515421137|FG002|Overall Study|Lost to Follow-up|5|||
142969012|NCT04167306|515421138|FG003|Overall Study|Lost to Follow-up|5|||
142969013|NCT04167306|515421135|FG000|Overall Study|Adverse Event|13|||
142969014|NCT04167306|515421136|FG001|Overall Study|Adverse Event|14|||
142969015|NCT04167306|515421137|FG002|Overall Study|Adverse Event|5|||
142969016|NCT04167306|515421138|FG003|Overall Study|Adverse Event|4|||
142969017|NCT04167306|515421135|FG000|Overall Study|Withdrawal by Subject|4|||
142969018|NCT04167306|515421136|FG001|Overall Study|Withdrawal by Subject|6|||
142969019|NCT04167306|515421137|FG002|Overall Study|Withdrawal by Subject|8|||
142969020|NCT04167306|515421138|FG003|Overall Study|Withdrawal by Subject|3|||
142969021|NCT04167306|515421135|FG000|Overall Study|covid|1|||
142969022|NCT04167306|515421136|FG001|Overall Study|covid|1|||
142969023|NCT04167306|515421137|FG002|Overall Study|covid|2|||
142969024|NCT04167306|515421138|FG003|Overall Study|covid|1|||
142969025|NCT04167306|515421135|FG000|Overall Study|concomitant medication|0|||
142969026|NCT04167306|515421136|FG001|Overall Study|concomitant medication|0|||
142969027|NCT04167306|515421137|FG002|Overall Study|concomitant medication|0|||
142969028|NCT04167306|515421138|FG003|Overall Study|concomitant medication|1|||
142969029|NCT04167306|515421135|FG000|Overall Study|Alcohol treatment|0|||
142969030|NCT04167306|515421136|FG001|Overall Study|Alcohol treatment|4|||
142969031|NCT04167306|515421137|FG002|Overall Study|Alcohol treatment|3|||
142969032|NCT04167306|515421138|FG003|Overall Study|Alcohol treatment|2|||
142969033|NCT04167306|515421135|FG000|Overall Study|non-compliance|0|||
142969034|NCT04167306|515421136|FG001|Overall Study|non-compliance|0|||
142969035|NCT04167306|515421137|FG002|Overall Study|non-compliance|1|||
142969036|NCT04167306|515421138|FG003|Overall Study|non-compliance|0|||
142969037|NCT04167306|515421135|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
142969038|NCT04167306|515421136|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
142969039|NCT04167306|515421137|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
142969040|NCT04167306|515421138|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
142969041|NCT01934192|515421143|FG000|Overall Study|Protocol Violation|0|||
142969042|NCT01934192|515421144|FG001|Overall Study|Protocol Violation|0|||
142969043|NCT01934192|515421145|FG002|Overall Study|Protocol Violation|0|||
142969044|NCT01934192|515421146|FG003|Overall Study|Protocol Violation|1|||
142969045|NCT01934192|515421143|FG000|Overall Study|Other: reached stopping criteria|6|||
142969046|NCT01934192|515421144|FG001|Overall Study|Other: reached stopping criteria|5|||
142969047|NCT01934192|515421145|FG002|Overall Study|Other: reached stopping criteria|1|||
142969048|NCT01934192|515421146|FG003|Overall Study|Other: reached stopping criteria|0|||
142969049|NCT01934192|515421143|FG000|Overall Study|Physician Decision|3|||
142969050|NCT01934192|515421144|FG001|Overall Study|Physician Decision|2|||
142969051|NCT01934192|515421145|FG002|Overall Study|Physician Decision|0|||
142969052|NCT01934192|515421146|FG003|Overall Study|Physician Decision|0|||
142969053|NCT02357849|515421147|FG000|Overall Study|Withdrawal by Subject|2|||
142969054|NCT02357849|515421148|FG001|Overall Study|Withdrawal by Subject|3|||
142969055|NCT00547378|515421149|FG000|Randomized Cohort|Withdrawal by Subject|7|||
142969056|NCT00547378|515421150|FG001|Randomized Cohort|Withdrawal by Subject|5|||
142969057|NCT00547378|515421151|FG002|Randomized Cohort|Withdrawal by Subject|0|||
142969058|NCT00547378|515421149|FG000|Randomized Cohort|Death|0|||
142969059|NCT00547378|515421150|FG001|Randomized Cohort|Death|1|||
142969060|NCT00547378|515421151|FG002|Randomized Cohort|Death|0|||
142969061|NCT00547378|515421149|FG000|Randomized Cohort|Lost to Follow-up|1|||
142969062|NCT00547378|515421150|FG001|Randomized Cohort|Lost to Follow-up|0|||
142969063|NCT00547378|515421151|FG002|Randomized Cohort|Lost to Follow-up|0|||
142969064|NCT00547378|515421149|FG000|Randomized Cohort|Adverse Event|1|||
142969065|NCT00547378|515421150|FG001|Randomized Cohort|Adverse Event|0|||
142969066|NCT00547378|515421151|FG002|Randomized Cohort|Adverse Event|0|||
142969067|NCT00547378|515421149|FG000|Randomized Cohort|Other reasons|2|||
142969068|NCT00547378|515421150|FG001|Randomized Cohort|Other reasons|0|||
142969069|NCT00547378|515421151|FG002|Randomized Cohort|Other reasons|0|||
142969070|NCT00547378|515421149|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
142969071|NCT00547378|515421150|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
142969072|NCT00547378|515421151|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
142969073|NCT00547378|515421149|FG000|All Implanted Cohort|Adverse Event|4|||
142969074|NCT00547378|515421150|FG001|All Implanted Cohort|Adverse Event|10|||
142969075|NCT00547378|515421151|FG002|All Implanted Cohort|Adverse Event|17|||
142969076|NCT00547378|515421149|FG000|All Implanted Cohort|Lost to Follow-up|0|||
142969077|NCT00547378|515421150|FG001|All Implanted Cohort|Lost to Follow-up|1|||
142969078|NCT00547378|515421151|FG002|All Implanted Cohort|Lost to Follow-up|14|||
142969079|NCT00547378|515421149|FG000|All Implanted Cohort|Death|3|||
142969080|NCT00547378|515421150|FG001|All Implanted Cohort|Death|1|||
142969081|NCT00547378|515421151|FG002|All Implanted Cohort|Death|4|||
142969082|NCT00547378|515421149|FG000|All Implanted Cohort|Physician Decision|0|||
142969083|NCT00547378|515421150|FG001|All Implanted Cohort|Physician Decision|2|||
142969084|NCT00547378|515421151|FG002|All Implanted Cohort|Physician Decision|6|||
142969085|NCT00547378|515421149|FG000|All Implanted Cohort|Site closure|2|||
142969086|NCT00547378|515421150|FG001|All Implanted Cohort|Site closure|0|||
142969087|NCT00547378|515421151|FG002|All Implanted Cohort|Site closure|1|||
142969088|NCT00547378|515421149|FG000|All Implanted Cohort|Other reasons|1|||
142969089|NCT00547378|515421150|FG001|All Implanted Cohort|Other reasons|0|||
142969090|NCT00547378|515421151|FG002|All Implanted Cohort|Other reasons|1|||
142969091|NCT04633473|515421152|FG000|Overall Study|Withdrawal by Subject|6|||
142969092|NCT00430521|515421155|FG000|Overall Study|Adverse Event|0|||
142969093|NCT00430521|515421156|FG001|Overall Study|Adverse Event|0|||
142969094|NCT00430521|515421157|FG002|Overall Study|Adverse Event|0|||
142969095|NCT00430521|515421158|FG003|Overall Study|Adverse Event|0|||
142969096|NCT00430521|515421159|FG004|Overall Study|Adverse Event|0|||
142969097|NCT00430521|515421160|FG005|Overall Study|Adverse Event|2|||
142969098|NCT00430521|515421161|FG006|Overall Study|Adverse Event|1|||
142969099|NCT00430521|515421162|FG007|Overall Study|Adverse Event|0|||
142969100|NCT00430521|515421155|FG000|Overall Study|Lost to Follow-up|7|||
142969101|NCT00430521|515421156|FG001|Overall Study|Lost to Follow-up|8|||
142969102|NCT00430521|515421157|FG002|Overall Study|Lost to Follow-up|3|||
142969103|NCT00430521|515421158|FG003|Overall Study|Lost to Follow-up|5|||
142969104|NCT00430521|515421159|FG004|Overall Study|Lost to Follow-up|5|||
142969105|NCT00430521|515421160|FG005|Overall Study|Lost to Follow-up|2|||
142969106|NCT00430521|515421161|FG006|Overall Study|Lost to Follow-up|8|||
142969107|NCT00430521|515421162|FG007|Overall Study|Lost to Follow-up|10|||
142969108|NCT00430521|515421155|FG000|Overall Study|Pregnancy|0|||
142969109|NCT00430521|515421156|FG001|Overall Study|Pregnancy|0|||
142969110|NCT00430521|515421157|FG002|Overall Study|Pregnancy|0|||
142969111|NCT00430521|515421158|FG003|Overall Study|Pregnancy|0|||
142969112|NCT00430521|515421159|FG004|Overall Study|Pregnancy|0|||
142969113|NCT00430521|515421160|FG005|Overall Study|Pregnancy|0|||
142969114|NCT00430521|515421161|FG006|Overall Study|Pregnancy|1|||
142969115|NCT00430521|515421162|FG007|Overall Study|Pregnancy|0|||
142969116|NCT00430521|515421155|FG000|Overall Study|Vaccine Expired|0|||
142969117|NCT00430521|515421156|FG001|Overall Study|Vaccine Expired|0|||
142969118|NCT00430521|515421157|FG002|Overall Study|Vaccine Expired|0|||
142969119|NCT00430521|515421158|FG003|Overall Study|Vaccine Expired|0|||
142969120|NCT00430521|515421159|FG004|Overall Study|Vaccine Expired|0|||
142969121|NCT00430521|515421160|FG005|Overall Study|Vaccine Expired|1|||
142969122|NCT00430521|515421161|FG006|Overall Study|Vaccine Expired|0|||
142969123|NCT00430521|515421162|FG007|Overall Study|Vaccine Expired|0|||
142969124|NCT00430521|515421155|FG000|Overall Study|Protocol Violation|1|||
142969125|NCT00430521|515421156|FG001|Overall Study|Protocol Violation|0|||
142969126|NCT00430521|515421157|FG002|Overall Study|Protocol Violation|0|||
142969127|NCT00430521|515421158|FG003|Overall Study|Protocol Violation|0|||
142969128|NCT00430521|515421159|FG004|Overall Study|Protocol Violation|0|||
142969129|NCT00430521|515421160|FG005|Overall Study|Protocol Violation|0|||
142969130|NCT00430521|515421161|FG006|Overall Study|Protocol Violation|0|||
142969131|NCT00430521|515421162|FG007|Overall Study|Protocol Violation|0|||
142969132|NCT00430521|515421155|FG000|Overall Study|Withdrawal by Subject|3|||
142969133|NCT00430521|515421156|FG001|Overall Study|Withdrawal by Subject|1|||
142969134|NCT00430521|515421157|FG002|Overall Study|Withdrawal by Subject|0|||
142969135|NCT00430521|515421158|FG003|Overall Study|Withdrawal by Subject|3|||
142969136|NCT00430521|515421159|FG004|Overall Study|Withdrawal by Subject|0|||
142969137|NCT00430521|515421160|FG005|Overall Study|Withdrawal by Subject|0|||
142969138|NCT00430521|515421161|FG006|Overall Study|Withdrawal by Subject|0|||
142969139|NCT00430521|515421162|FG007|Overall Study|Withdrawal by Subject|2|||
142969140|NCT02370498|515422652|FG000|Overall Study|Adverse Event|10|||
142969141|NCT02370498|515422653|FG001|Overall Study|Adverse Event|8|||
142969142|NCT02370498|515422652|FG000|Overall Study|Death|263|||
142969143|NCT02370498|515422653|FG001|Overall Study|Death|265|||
142969144|NCT02370498|515422652|FG000|Overall Study|Protocol Violation|1|||
142969145|NCT02370498|515422653|FG001|Overall Study|Protocol Violation|2|||
142969146|NCT02370498|515422652|FG000|Overall Study|Withdrawal by Subject|7|||
142969147|NCT02370498|515422653|FG001|Overall Study|Withdrawal by Subject|12|||
142969148|NCT02370498|515422652|FG000|Overall Study|Sponsor's decision|15|||
142969149|NCT02370498|515422653|FG001|Overall Study|Sponsor's decision|9|||
142969150|NCT03364608|515422654|FG000|Overall Study|Withdrawal by Subject|4|||
142969151|NCT03364608|515422654|FG000|Overall Study|Protocol Violation|2|||
142969152|NCT03364608|515422654|FG000|Overall Study|Lost to Follow-up|2|||
142969153|NCT03004469|515422655|FG000|Overall Study|Adverse Event|6|||
142969154|NCT03004469|515422656|FG001|Overall Study|Adverse Event|4|||
142969155|NCT03004469|515422657|FG002|Overall Study|Adverse Event|6|||
142969156|NCT03004469|515422655|FG000|Overall Study|Lack of Efficacy|1|||
142969157|NCT03004469|515422656|FG001|Overall Study|Lack of Efficacy|0|||
142969158|NCT03004469|515422657|FG002|Overall Study|Lack of Efficacy|1|||
142969159|NCT03004469|515422655|FG000|Overall Study|Lost to Follow-up|23|||
142969160|NCT03004469|515422656|FG001|Overall Study|Lost to Follow-up|14|||
142969161|NCT03004469|515422657|FG002|Overall Study|Lost to Follow-up|6|||
142969162|NCT03004469|515422655|FG000|Overall Study|Non-Compliance with Study Drug|2|||
142969163|NCT03004469|515422656|FG001|Overall Study|Non-Compliance with Study Drug|0|||
142969164|NCT03004469|515422657|FG002|Overall Study|Non-Compliance with Study Drug|0|||
142969165|NCT03004469|515422655|FG000|Overall Study|Protocol Violation|0|||
142969166|NCT03004469|515422656|FG001|Overall Study|Protocol Violation|0|||
142969167|NCT03004469|515422657|FG002|Overall Study|Protocol Violation|1|||
142969168|NCT03004469|515422655|FG000|Overall Study|Withdrawal by Subject|29|||
142969169|NCT03004469|515422656|FG001|Overall Study|Withdrawal by Subject|27|||
142969170|NCT03004469|515422657|FG002|Overall Study|Withdrawal by Subject|10|||
142969171|NCT03004469|515422655|FG000|Overall Study|Other unspecified reason|0|||
142969172|NCT03004469|515422656|FG001|Overall Study|Other unspecified reason|4|||
142969173|NCT03004469|515422657|FG002|Overall Study|Other unspecified reason|1|||
142969174|NCT02492997|515422658|FG000|Overall Study|Withdrawal by Subject|1|||
142969175|NCT02492997|515422659|FG001|Overall Study|Withdrawal by Subject|0|||
142969176|NCT02492997|515422658|FG000|Overall Study|Gained Weight|1|||
142969177|NCT02492997|515422659|FG001|Overall Study|Gained Weight|0|||
142969178|NCT02492997|515422658|FG000|Overall Study|Lost to Follow-up|0|||
142969179|NCT02492997|515422659|FG001|Overall Study|Lost to Follow-up|1|||
142969180|NCT04069156|515422661|FG000|Modified Intent-to-Treat (mITT)|Death|1|||
142969181|NCT04069156|515422662|FG001|Modified Intent-to-Treat (mITT)|Death|2|||
142969182|NCT04069156|515422661|FG000|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|9|||
142969183|NCT04069156|515422662|FG001|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|7|||
142969184|NCT04069156|515422661|FG000|Modified Intent-to-Treat (mITT)|Transitioned to open label|8|||
142969185|NCT04069156|515422662|FG001|Modified Intent-to-Treat (mITT)|Transitioned to open label|12|||
142969186|NCT04069156|515422661|FG000|Principal Analysis|Withdrawn without primary end point event|25|||
142969187|NCT04069156|515422662|FG001|Principal Analysis|Withdrawn without primary end point event|20|||
142969188|NCT02394808|515422666|FG000|Period 1|Unsatisfactory lens fitting|0|||
142969189|NCT02394808|515422667|FG001|Period 1|Unsatisfactory lens fitting|1|||
142969190|NCT02394808|515422666|FG000|Period 2|Lost to Follow-up|1|||
142969191|NCT02394808|515422667|FG001|Period 2|Lost to Follow-up|0|||
142969192|NCT02130427|515422669|FG000|Overall Study|Imaging results not interpretable|30|||
142969193|NCT04146467|515422673|FG000|Overall Study|Adverse Event|0|||
142969194|NCT04146467|515422674|FG001|Overall Study|Adverse Event|1|||
142969195|NCT04146467|515422673|FG000|Overall Study|Lost to Follow-up|0|||
142969196|NCT04146467|515422674|FG001|Overall Study|Lost to Follow-up|2|||
142969197|NCT03731364|515422675|FG000|Overall Study|Adverse Event|0|||
142969198|NCT03731364|515422676|FG001|Overall Study|Adverse Event|0|||
142969199|NCT03731364|515422677|FG002|Overall Study|Adverse Event|1|||
142969200|NCT03731364|515422678|FG003|Overall Study|Adverse Event|2|||
142969201|NCT03731364|515422679|FG004|Overall Study|Adverse Event|1|||
142969202|NCT01189435|515422680|FG000|Overall Study|Withdrawal by Subject|1|||
142969203|NCT01189435|515422680|FG000|Overall Study|Physician Decision|1|||
142969204|NCT01253421|515422681|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
142969205|NCT01253421|515422682|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
142969206|NCT01253421|515422683|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
142969207|NCT01253421|515422684|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
142969208|NCT01253421|515422685|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
142969209|NCT01253421|515422681|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
142969210|NCT01253421|515422682|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
142969211|NCT01253421|515422683|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
142969212|NCT01253421|515422684|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
142969213|NCT01253421|515422685|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
142969214|NCT01253421|515422681|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
142969215|NCT01253421|515422682|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
142969216|NCT01253421|515422683|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
142969217|NCT01253421|515422684|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
142969218|NCT01253421|515422685|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
142969219|NCT01253421|515422681|FG000|Assessment and Scheduling|Physician Decision|1|||
142969220|NCT01253421|515422682|FG001|Assessment and Scheduling|Physician Decision|0|||
142969221|NCT01253421|515422683|FG002|Assessment and Scheduling|Physician Decision|0|||
142969222|NCT01253421|515422684|FG003|Assessment and Scheduling|Physician Decision|0|||
142969223|NCT01253421|515422685|FG004|Assessment and Scheduling|Physician Decision|0|||
142969224|NCT01253421|515422681|FG000|Drug+Scanning Visit|Physician Decision|0|||
142969225|NCT01253421|515422682|FG001|Drug+Scanning Visit|Physician Decision|0|||
142969226|NCT01253421|515422683|FG002|Drug+Scanning Visit|Physician Decision|0|||
142969227|NCT01253421|515422684|FG003|Drug+Scanning Visit|Physician Decision|0|||
142969228|NCT01253421|515422685|FG004|Drug+Scanning Visit|Physician Decision|1|||
142969229|NCT01586156|515422686|FG000|Overall Study|Pregnancy|0|||
142969230|NCT01586156|515422687|FG001|Overall Study|Pregnancy|1|||
142969231|NCT01586156|515422688|FG002|Overall Study|Pregnancy|0|||
142969232|NCT01449682|515422689|FG000|Overall Study|Death|0|||
142969233|NCT01449682|515422690|FG001|Overall Study|Death|1|||
142969234|NCT01449682|515422689|FG000|Overall Study|Adverse Event|1|||
142969235|NCT01449682|515422690|FG001|Overall Study|Adverse Event|0|||
142969236|NCT04863014|515422692|FG000|Overall Study|Lost to Follow-up|3|||
142969237|NCT04863014|515422693|FG001|Overall Study|Lost to Follow-up|2|||
142969238|NCT04863014|515422692|FG000|Overall Study|Subject Decision|0|||
142969239|NCT04863014|515422693|FG001|Overall Study|Subject Decision|4|||
142969240|NCT04387136|515422694|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
142969241|NCT04387136|515422695|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
143455511|NCT03412747|517212457|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
143455512|NCT03412747|517212458|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
143455513|NCT03412747|517212459|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
143455514|NCT01263665|517212462|FG000|Overall Study|Withdrew Consent|1|||
143455515|NCT01263665|517212462|FG000|Overall Study|Lost to Follow-up|3|||
143455516|NCT01263665|517212462|FG000|Overall Study|Death|2|||
142969242|NCT03294681|515422699|FG000|Overall Study|Withdrawal by Subject|1|||
142969243|NCT03089216|515422700|FG000|Overall Study|Adverse Event|0|||
142969244|NCT03089216|515422701|FG001|Overall Study|Adverse Event|0|||
143455517|NCT01263665|517212462|FG000|Overall Study|Amputation above the ankle|1|||
142969245|NCT03089216|515422702|FG002|Overall Study|Adverse Event|0|||
142969246|NCT03089216|515422703|FG003|Overall Study|Adverse Event|1|||
142969247|NCT00417976|515422706|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
142969248|NCT00417976|515422706|FG000|Overall Study|Treatment -related toxicity|2|||
142969249|NCT01348425|515422707|FG000|Overall Study|Imaging was not taken.|1|||
142969250|NCT01348425|515422708|FG001|Overall Study|Imaging was not taken.|1|||
142969251|NCT01968954|515422711|FG000|Overall Study|Adverse Event|6|||
142969252|NCT01968954|515422712|FG001|Overall Study|Adverse Event|3|||
142969253|NCT01968954|515422711|FG000|Overall Study|Death|1|||
142969254|NCT01968954|515422712|FG001|Overall Study|Death|2|||
142969255|NCT01968954|515422711|FG000|Overall Study|Lost to Follow-up|6|||
142969256|NCT01968954|515422712|FG001|Overall Study|Lost to Follow-up|4|||
142969257|NCT01968954|515422711|FG000|Overall Study|Withdrawal by Subject|20|||
142969258|NCT01968954|515422712|FG001|Overall Study|Withdrawal by Subject|23|||
142969259|NCT01968954|515422711|FG000|Overall Study|Other|7|||
142969260|NCT01968954|515422712|FG001|Overall Study|Other|8|||
142969261|NCT01968954|515422711|FG000|Overall Study|Protocol Violation|0|||
142969262|NCT01968954|515422712|FG001|Overall Study|Protocol Violation|1|||
142969263|NCT01968954|515422711|FG000|Overall Study|Did not met inclusion criteria|0|||
142969264|NCT01968954|515422712|FG001|Overall Study|Did not met inclusion criteria|2|||
142969265|NCT02358369|515422713|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
142969266|NCT02358369|515422714|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
142969267|NCT02358369|515422715|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
142969268|NCT02358369|515422716|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
142969269|NCT02358369|515422717|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
142969270|NCT02358369|515422713|FG000|Treatment Period A/B|Adverse Event|0|||
142969271|NCT02358369|515422714|FG001|Treatment Period A/B|Adverse Event|0|||
142969272|NCT02358369|515422715|FG002|Treatment Period A/B|Adverse Event|1|||
142969273|NCT02358369|515422716|FG003|Treatment Period A/B|Adverse Event|2|||
142969274|NCT02358369|515422717|FG004|Treatment Period A/B|Adverse Event|0|||
142969275|NCT02358369|515422713|FG000|Treatment Period A/B|Death|0|||
142969276|NCT02358369|515422714|FG001|Treatment Period A/B|Death|0|||
142969277|NCT02358369|515422715|FG002|Treatment Period A/B|Death|1|||
142969278|NCT02358369|515422716|FG003|Treatment Period A/B|Death|0|||
142969279|NCT02358369|515422717|FG004|Treatment Period A/B|Death|0|||
142969280|NCT02358369|515422713|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
142969281|NCT02358369|515422714|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
142969282|NCT02358369|515422715|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
142969283|NCT02358369|515422716|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
142969284|NCT02358369|515422717|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
142969285|NCT02358369|515422713|FG000|Treatment Period C|Adverse Event|0|||
142969286|NCT02358369|515422714|FG001|Treatment Period C|Adverse Event|0|||
142969287|NCT02358369|515422715|FG002|Treatment Period C|Adverse Event|0|||
142969288|NCT02358369|515422716|FG003|Treatment Period C|Adverse Event|0|||
142969289|NCT02358369|515422717|FG004|Treatment Period C|Adverse Event|7|||
142969290|NCT03095521|515422722|FG000|Overall Study|Withdrawal by Subject|0|||
142969291|NCT03095521|515422723|FG001|Overall Study|Withdrawal by Subject|1|||
142969292|NCT03095521|515422722|FG000|Overall Study|Lost to Follow-up|0|||
142969293|NCT03095521|515422723|FG001|Overall Study|Lost to Follow-up|1|||
142969294|NCT03259490|515422724|FG000|Period 1|Withdrawal by Subject|0|||
142969295|NCT03259490|515422725|FG001|Period 1|Withdrawal by Subject|1|||
142969296|NCT03259490|515422724|FG000|Period 2|Protocol Violation|1|||
142969297|NCT03259490|515422725|FG001|Period 2|Protocol Violation|0|||
142969298|NCT00434122|515422726|FG000|Overall Study|Non-compliance with protocol|0|||
142969299|NCT00434122|515422727|FG001|Overall Study|Non-compliance with protocol|1|||
142969300|NCT00434122|515422726|FG000|Overall Study|loss of subject contact|1|||
142969301|NCT00434122|515422727|FG001|Overall Study|loss of subject contact|1|||
142969302|NCT00434122|515422726|FG000|Overall Study|Personal reasons|1|||
142969303|NCT00434122|515422727|FG001|Overall Study|Personal reasons|1|||
142969304|NCT00434122|515422726|FG000|Overall Study|Large follicle size|2|||
142969305|NCT00434122|515422727|FG001|Overall Study|Large follicle size|2|||
142969306|NCT00434122|515422726|FG000|Overall Study|Low follicular response.|1|||
142969307|NCT00434122|515422727|FG001|Overall Study|Low follicular response.|2|||
142969308|NCT00434122|515422726|FG000|Overall Study|Travelling of subject.|1|||
142969309|NCT00434122|515422727|FG001|Overall Study|Travelling of subject.|0|||
142969310|NCT00255086|515422729|FG000|Overall Study|Adverse Event|1|||
142969311|NCT00255086|515422730|FG001|Overall Study|Adverse Event|1|||
142969312|NCT00255086|515422729|FG000|Overall Study|Protocol Violation|1|||
142969313|NCT00255086|515422730|FG001|Overall Study|Protocol Violation|1|||
143455518|NCT01263665|517212462|FG000|Overall Study|Surgical Bypass|2|||
142969314|NCT01963208|515422731|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
142969315|NCT01963208|515422732|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
142969316|NCT01963208|515422733|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
142969317|NCT01963208|515422734|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
142969318|NCT01963208|515422735|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
142969319|NCT01963208|515422736|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
142969320|NCT01963208|515422731|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
142969321|NCT01963208|515422732|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
142969322|NCT01963208|515422733|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
142969323|NCT01963208|515422734|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
142969324|NCT01963208|515422735|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
142969325|NCT01963208|515422736|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
142969326|NCT01963208|515422731|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
142969327|NCT01963208|515422732|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
142969328|NCT01963208|515422733|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
142969329|NCT01963208|515422734|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
142969330|NCT01963208|515422735|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
142969331|NCT01963208|515422736|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
142969332|NCT01963208|515422731|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
142969333|NCT01963208|515422732|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
142969334|NCT01963208|515422733|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
142969335|NCT01963208|515422734|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
142969336|NCT01963208|515422735|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
142969337|NCT01963208|515422736|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
142969338|NCT01963208|515422731|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
142969339|NCT01963208|515422732|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
142969340|NCT01963208|515422733|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
142969341|NCT01963208|515422734|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
142969342|NCT01963208|515422735|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
142969343|NCT01963208|515422736|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
142969344|NCT01963208|515422731|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
142969345|NCT01963208|515422732|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
142969346|NCT01963208|515422733|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
142969347|NCT01963208|515422734|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
142969348|NCT01963208|515422735|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
142969349|NCT01963208|515422736|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
142969350|NCT01963208|515422731|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
142969351|NCT01963208|515422732|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
142969352|NCT01963208|515422733|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
142969353|NCT01963208|515422734|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
142969354|NCT01963208|515422735|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
142969355|NCT01963208|515422736|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
142969356|NCT01963208|515422731|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
142969357|NCT01963208|515422732|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
142969358|NCT01963208|515422733|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
142969359|NCT01963208|515422734|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
142969360|NCT01963208|515422735|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
142969361|NCT01963208|515422736|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
142969362|NCT01963208|515422731|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
142969363|NCT01963208|515422732|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
142969364|NCT01963208|515422733|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
142969365|NCT01963208|515422734|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
142969366|NCT01963208|515422735|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
142969367|NCT01963208|515422736|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
142969368|NCT01963208|515422731|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
142969369|NCT01963208|515422732|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
142969370|NCT01963208|515422733|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
142969371|NCT01963208|515422734|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
142969372|NCT01963208|515422735|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
142969373|NCT01963208|515422736|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
142969374|NCT01963208|515422731|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
142969375|NCT01963208|515422732|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
142969376|NCT01963208|515422733|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
142969377|NCT01963208|515422734|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
142969378|NCT01963208|515422735|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
142969379|NCT01963208|515422736|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
142969380|NCT01963208|515422731|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
142969381|NCT01963208|515422732|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
142969382|NCT01963208|515422733|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
142969383|NCT01963208|515422734|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
142969384|NCT01963208|515422735|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
142969385|NCT01963208|515422736|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
142969386|NCT01963208|515422731|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
142969387|NCT01963208|515422732|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
142969388|NCT01963208|515422733|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
142969389|NCT01963208|515422734|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
142969390|NCT01963208|515422735|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
142969391|NCT01963208|515422736|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
142969392|NCT01963208|515422731|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
142969393|NCT01963208|515422732|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
142969394|NCT01963208|515422733|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
142969395|NCT01963208|515422734|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
142969396|NCT01963208|515422735|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
142969397|NCT01963208|515422736|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
142969398|NCT04191577|515422739|FG000|Overall Study|Withdrawal by Subject|2|||
142969399|NCT04191577|515422740|FG001|Overall Study|Withdrawal by Subject|2|||
142969400|NCT04191577|515422741|FG002|Overall Study|Withdrawal by Subject|1|||
142969401|NCT04191577|515422739|FG000|Overall Study|Physician Decision|1|||
142969402|NCT04191577|515422740|FG001|Overall Study|Physician Decision|1|||
142969403|NCT04191577|515422741|FG002|Overall Study|Physician Decision|0|||
142969404|NCT04191577|515422739|FG000|Overall Study|Adverse Event|0|||
142969405|NCT04191577|515422740|FG001|Overall Study|Adverse Event|0|||
142969406|NCT04191577|515422741|FG002|Overall Study|Adverse Event|1|||
142969407|NCT04191577|515422739|FG000|Overall Study|Death|0|||
142969408|NCT04191577|515422740|FG001|Overall Study|Death|0|||
142969409|NCT04191577|515422741|FG002|Overall Study|Death|1|||
142969410|NCT01185249|515422742|FG000|Overall Study|Patients discharged or change in status|42|||
142969411|NCT01973452|515422743|FG000|Overall Study|Lack of Efficacy|0|||
142969412|NCT01973452|515422744|FG001|Overall Study|Lack of Efficacy|1|||
142969413|NCT01973452|515422743|FG000|Overall Study|Lost to Follow-up|1|||
142969414|NCT01973452|515422744|FG001|Overall Study|Lost to Follow-up|0|||
142969415|NCT01973452|515422743|FG000|Overall Study|Withdrawal by Subject|10|||
142969416|NCT01973452|515422744|FG001|Overall Study|Withdrawal by Subject|9|||
142969417|NCT01973452|515422743|FG000|Overall Study|Ineligible|1|||
142969418|NCT01973452|515422744|FG001|Overall Study|Ineligible|1|||
142969419|NCT01973452|515422743|FG000|Overall Study|Surgery canceled by participant|5|||
142969420|NCT01973452|515422744|FG001|Overall Study|Surgery canceled by participant|3|||
142969421|NCT00406783|515422747|FG000|Overall Study|Adverse Event|4|||
142969422|NCT00406783|515422748|FG001|Overall Study|Adverse Event|4|||
142969423|NCT00406783|515422747|FG000|Overall Study|Treatment Failure|2|||
142969424|NCT00406783|515422748|FG001|Overall Study|Treatment Failure|3|||
142969425|NCT00406783|515422747|FG000|Overall Study|Lost to Follow-up|3|||
142969426|NCT00406783|515422748|FG001|Overall Study|Lost to Follow-up|0|||
142969427|NCT00406783|515422747|FG000|Overall Study|Withdrawal by Subject|1|||
142969428|NCT00406783|515422748|FG001|Overall Study|Withdrawal by Subject|4|||
142969429|NCT00406783|515422747|FG000|Overall Study|Protocol Violation|4|||
142969430|NCT00406783|515422748|FG001|Overall Study|Protocol Violation|4|||
142969431|NCT00064350|515422749|FG000|Induction Treatment|Disease Progression|5|||
142969432|NCT00064350|515422750|FG001|Induction Treatment|Disease Progression|1|||
142969433|NCT00064350|515422751|FG002|Induction Treatment|Disease Progression|110|||
142969434|NCT00064350|515422749|FG000|Induction Treatment|Adverse Event|0|||
142969435|NCT00064350|515422750|FG001|Induction Treatment|Adverse Event|2|||
142969436|NCT00064350|515422751|FG002|Induction Treatment|Adverse Event|49|||
142969437|NCT00064350|515422749|FG000|Induction Treatment|Death|0|||
142969438|NCT00064350|515422750|FG001|Induction Treatment|Death|0|||
142969439|NCT00064350|515422751|FG002|Induction Treatment|Death|9|||
142969440|NCT00064350|515422749|FG000|Induction Treatment|Withdrawal by Subject|0|||
142969441|NCT00064350|515422750|FG001|Induction Treatment|Withdrawal by Subject|0|||
142969442|NCT00064350|515422751|FG002|Induction Treatment|Withdrawal by Subject|21|||
142969443|NCT00064350|515422749|FG000|Induction Treatment|Ineligible or never started treatment|3|||
142969444|NCT00064350|515422750|FG001|Induction Treatment|Ineligible or never started treatment|6|||
142969445|NCT00064350|515422751|FG002|Induction Treatment|Ineligible or never started treatment|34|||
142969446|NCT00064350|515422749|FG000|Induction Treatment|Other|0|||
142969447|NCT00064350|515422750|FG001|Induction Treatment|Other|0|||
142969448|NCT00064350|515422751|FG002|Induction Treatment|Other|13|||
142969449|NCT00064350|515422749|FG000|Randomization|Adverse Event|8|||
142969450|NCT00064350|515422750|FG001|Randomization|Adverse Event|3|||
142969451|NCT00064350|515422751|FG002|Randomization|Adverse Event|0|||
142969452|NCT00064350|515422749|FG000|Randomization|Death|3|||
142969453|NCT00064350|515422750|FG001|Randomization|Death|0|||
142969454|NCT00064350|515422751|FG002|Randomization|Death|0|||
142969455|NCT00064350|515422749|FG000|Randomization|Withdrawal by Subject|1|||
142969456|NCT00064350|515422750|FG001|Randomization|Withdrawal by Subject|0|||
142969457|NCT00064350|515422751|FG002|Randomization|Withdrawal by Subject|0|||
142969458|NCT00064350|515422749|FG000|Randomization|Ineligible or never started treatment|9|||
142969459|NCT00064350|515422750|FG001|Randomization|Ineligible or never started treatment|15|||
142969460|NCT00064350|515422751|FG002|Randomization|Ineligible or never started treatment|0|||
142969461|NCT00064350|515422749|FG000|Randomization|Other|5|||
142969462|NCT00064350|515422750|FG001|Randomization|Other|0|||
142969463|NCT00064350|515422751|FG002|Randomization|Other|0|||
142969464|NCT00064350|515422749|FG000|Cross-Over|Adverse Event|0|||
142969465|NCT00064350|515422750|FG001|Cross-Over|Adverse Event|1|||
142969466|NCT00064350|515422751|FG002|Cross-Over|Adverse Event|0|||
142969467|NCT00064350|515422749|FG000|Cross-Over|Death|1|||
142969468|NCT00064350|515422750|FG001|Cross-Over|Death|3|||
142969469|NCT00064350|515422751|FG002|Cross-Over|Death|0|||
142969470|NCT00064350|515422749|FG000|Cross-Over|Withdrawal by Subject|2|||
142969471|NCT00064350|515422750|FG001|Cross-Over|Withdrawal by Subject|2|||
142969472|NCT00064350|515422751|FG002|Cross-Over|Withdrawal by Subject|0|||
142969473|NCT00064350|515422749|FG000|Cross-Over|Ineligible or never started treatment|3|||
142969474|NCT00064350|515422750|FG001|Cross-Over|Ineligible or never started treatment|6|||
142969475|NCT00064350|515422751|FG002|Cross-Over|Ineligible or never started treatment|0|||
142969476|NCT00064350|515422749|FG000|Cross-Over|Other|0|||
142969477|NCT00064350|515422750|FG001|Cross-Over|Other|2|||
142969478|NCT00064350|515422751|FG002|Cross-Over|Other|0|||
142969479|NCT00012012|515422752|FG000|Overall Study|Protocol Violation|1|||
142969480|NCT00012012|515422753|FG001|Overall Study|Protocol Violation|1|||
142969481|NCT00012012|515422752|FG000|Overall Study|Withdrawal by Subject|0|||
142969482|NCT00012012|515422753|FG001|Overall Study|Withdrawal by Subject|2|||
142969483|NCT02034474|515422754|FG000|Overall Study|Adverse Event|3|||
142969484|NCT02034474|515422755|FG001|Overall Study|Adverse Event|2|||
142969485|NCT02034474|515422754|FG000|Overall Study|Withdrawal by Subject|1|||
142969486|NCT02034474|515422755|FG001|Overall Study|Withdrawal by Subject|2|||
142969487|NCT01391819|515422756|FG000|Overall Study|Withdrawal by Subject|56|||
142969488|NCT01391819|515422756|FG000|Overall Study|Migrated/moved from study area|82|||
142969489|NCT01391819|515422756|FG000|Overall Study|Lost to Follow-up|252|||
142969490|NCT01391819|515422756|FG000|Overall Study|Death|3|||
142969491|NCT01391819|515422756|FG000|Overall Study|Other|9|||
142969492|NCT01927419|515422757|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
142969493|NCT01927419|515422758|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
142969494|NCT01927419|515422757|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
142969495|NCT01927419|515422758|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
142969496|NCT01927419|515422757|FG000|Treatment Period|Disease progression|17|||
142969497|NCT01927419|515422758|FG001|Treatment Period|Disease progression|20|||
142969498|NCT01927419|515422757|FG000|Treatment Period|Study drug toxicity|48|||
142969499|NCT01927419|515422758|FG001|Treatment Period|Study drug toxicity|10|||
142969500|NCT01927419|515422757|FG000|Treatment Period|Death|0|||
142969501|NCT01927419|515422758|FG001|Treatment Period|Death|1|||
142969502|NCT01927419|515422757|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
142969503|NCT01927419|515422758|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
142969504|NCT01927419|515422757|FG000|Treatment Period|Participant request to discontinue|12|||
142969505|NCT01927419|515422758|FG001|Treatment Period|Participant request to discontinue|4|||
142969506|NCT01927419|515422757|FG000|Treatment Period|Withdrawal by Subject|1|||
142969507|NCT01927419|515422758|FG001|Treatment Period|Withdrawal by Subject|1|||
142969508|NCT01927419|515422757|FG000|Treatment Period|Maximum Clinical Benefit|6|||
142969509|NCT01927419|515422758|FG001|Treatment Period|Maximum Clinical Benefit|2|||
142969510|NCT01927419|515422757|FG000|Treatment Period|Other reasons|3|||
142969511|NCT01927419|515422758|FG001|Treatment Period|Other reasons|4|||
142969512|NCT01927419|515422757|FG000|Treatment Period|Not Reported|1|||
142969513|NCT01927419|515422758|FG001|Treatment Period|Not Reported|1|||
142969514|NCT00995670|515422759|FG000|Overall Study|Failed arterial cannulation|1|||
142969515|NCT00995670|515422760|FG001|Overall Study|Failed arterial cannulation|0|||
142969516|NCT00995670|515422761|FG002|Overall Study|Failed arterial cannulation|3|||
142969517|NCT03600714|515422762|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
142969518|NCT01935336|515422763|FG000|Overall Study|Adverse Event|1|||
142969519|NCT01935336|515422764|FG001|Overall Study|Adverse Event|0|||
142969520|NCT01935336|515422765|FG002|Overall Study|Adverse Event|0|||
142969521|NCT01935336|515422766|FG003|Overall Study|Adverse Event|0|||
142969522|NCT01935336|515422763|FG000|Overall Study|Progressive disease|5|||
142969523|NCT01935336|515422764|FG001|Overall Study|Progressive disease|3|||
142969524|NCT01935336|515422765|FG002|Overall Study|Progressive disease|47|||
142969525|NCT01935336|515422766|FG003|Overall Study|Progressive disease|66|||
142969526|NCT00592553|515422767|FG000|Overall Study|Protocol Noncompliance|1|||
142969527|NCT00592553|515422768|FG001|Overall Study|Protocol Noncompliance|0|||
142969528|NCT00592553|515422769|FG002|Overall Study|Protocol Noncompliance|0|||
142969529|NCT02164513|515422770|FG000|Overall Study|Adverse Event|162|||
142969530|NCT02164513|515422771|FG001|Overall Study|Adverse Event|180|||
142969531|NCT02164513|515422772|FG002|Overall Study|Adverse Event|111|||
142969532|NCT02164513|515422770|FG000|Overall Study|Other: Study Closed or terminated|5|||
142969533|NCT02164513|515422771|FG001|Overall Study|Other: Study Closed or terminated|2|||
143455519|NCT00560066|517212465|FG000|Overall Study|Death|2|||
142969534|NCT02164513|515422772|FG002|Overall Study|Other: Study Closed or terminated|4|||
142969535|NCT02164513|515422770|FG000|Overall Study|Lost to Follow-up|30|||
142969536|NCT02164513|515422771|FG001|Overall Study|Lost to Follow-up|36|||
142969537|NCT02164513|515422772|FG002|Overall Study|Lost to Follow-up|22|||
142969538|NCT02164513|515422770|FG000|Overall Study|Physician Decision|47|||
142969539|NCT02164513|515422771|FG001|Overall Study|Physician Decision|57|||
142969540|NCT02164513|515422772|FG002|Overall Study|Physician Decision|28|||
142969541|NCT02164513|515422770|FG000|Overall Study|Withdrawal by Subject|192|||
142969542|NCT02164513|515422771|FG001|Overall Study|Withdrawal by Subject|261|||
142969543|NCT02164513|515422772|FG002|Overall Study|Withdrawal by Subject|130|||
142969544|NCT02164513|515422770|FG000|Overall Study|Other: Reason not provided by site|1|||
142969545|NCT02164513|515422771|FG001|Overall Study|Other: Reason not provided by site|0|||
142969546|NCT02164513|515422772|FG002|Overall Study|Other: Reason not provided by site|0|||
142969547|NCT02773238|515422774|FG000|Overall Study|Lack of Efficacy|4|||
142969548|NCT01968187|515422775|FG000|Overall Study|Adverse Event|0|||
142969549|NCT01968187|515422776|FG001|Overall Study|Adverse Event|1|||
142969550|NCT01968187|515422775|FG000|Overall Study|Randomized but not treated|1|||
142969551|NCT01968187|515422776|FG001|Overall Study|Randomized but not treated|0|||
142969552|NCT03829332|515422779|FG000|Overall Study|Death|225|||
142969553|NCT03829332|515422780|FG001|Overall Study|Death|230|||
142969554|NCT03829332|515422779|FG000|Overall Study|Lost to Follow-up|1|||
142969555|NCT03829332|515422780|FG001|Overall Study|Lost to Follow-up|3|||
142969556|NCT03829332|515422779|FG000|Overall Study|Physician Decision|1|||
142969557|NCT03829332|515422780|FG001|Overall Study|Physician Decision|0|||
142969558|NCT03829332|515422779|FG000|Overall Study|Sponsor Decision|71|||
142969559|NCT03829332|515422780|FG001|Overall Study|Sponsor Decision|72|||
142969560|NCT03829332|515422779|FG000|Overall Study|Withdrawal by Subject|11|||
142969561|NCT03829332|515422780|FG001|Overall Study|Withdrawal by Subject|9|||
142969562|NCT05108805|515422781|FG000|Overall Study|T-cell expansion was not successful.|5|||
142969563|NCT04095286|515422782|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
142969564|NCT04095286|515422783|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
142969565|NCT04095286|515422784|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
142969566|NCT04095286|515422785|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
142969567|NCT04095286|515422786|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
142969568|NCT04095286|515422787|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
142969569|NCT04095286|515422782|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
142969570|NCT04095286|515422783|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
142969571|NCT04095286|515422784|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
142969572|NCT04095286|515422785|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
142969573|NCT04095286|515422786|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
142969574|NCT04095286|515422787|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
142969575|NCT04095286|515422782|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
142969576|NCT04095286|515422783|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
142969577|NCT04095286|515422784|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
142969578|NCT04095286|515422785|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
142969579|NCT04095286|515422786|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
142969580|NCT04095286|515422787|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
142969581|NCT04095286|515422782|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
142969582|NCT04095286|515422783|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
142969583|NCT04095286|515422784|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
142969584|NCT04095286|515422785|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
142969585|NCT04095286|515422786|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
142969586|NCT04095286|515422787|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
142969587|NCT04095286|515422782|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
142969588|NCT04095286|515422783|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
142969589|NCT04095286|515422784|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
142969590|NCT04095286|515422785|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
142969591|NCT04095286|515422786|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
142969592|NCT04095286|515422787|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
142969593|NCT00479557|515422788|FG000|Overall Study|Death|0|||
142969594|NCT00479557|515422789|FG001|Overall Study|Death|0|||
142969595|NCT00479557|515422790|FG002|Overall Study|Death|0|||
142969596|NCT00479557|515422791|FG003|Overall Study|Death|0|||
142969597|NCT00479557|515422792|FG004|Overall Study|Death|0|||
142969598|NCT00479557|515422793|FG005|Overall Study|Death|1|||
142969599|NCT00479557|515422794|FG006|Overall Study|Death|0|||
142969600|NCT00479557|515422788|FG000|Overall Study|Lack of Efficacy|1|||
142969601|NCT00479557|515422789|FG001|Overall Study|Lack of Efficacy|0|||
142969602|NCT00479557|515422790|FG002|Overall Study|Lack of Efficacy|0|||
142969603|NCT00479557|515422791|FG003|Overall Study|Lack of Efficacy|0|||
142969604|NCT00479557|515422792|FG004|Overall Study|Lack of Efficacy|0|||
142969605|NCT00479557|515422793|FG005|Overall Study|Lack of Efficacy|0|||
142969606|NCT00479557|515422794|FG006|Overall Study|Lack of Efficacy|0|||
142969607|NCT00479557|515422788|FG000|Overall Study|Lost to Follow-up|0|||
142969608|NCT00479557|515422789|FG001|Overall Study|Lost to Follow-up|2|||
142969609|NCT00479557|515422790|FG002|Overall Study|Lost to Follow-up|0|||
142969610|NCT00479557|515422791|FG003|Overall Study|Lost to Follow-up|2|||
142969611|NCT00479557|515422792|FG004|Overall Study|Lost to Follow-up|0|||
142969612|NCT00479557|515422793|FG005|Overall Study|Lost to Follow-up|0|||
142969613|NCT00479557|515422794|FG006|Overall Study|Lost to Follow-up|0|||
142969614|NCT00479557|515422788|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
142969615|NCT00479557|515422789|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
142969616|NCT00479557|515422790|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
142969617|NCT00479557|515422791|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
142969618|NCT00479557|515422792|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
142969619|NCT00479557|515422793|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
142969620|NCT00479557|515422794|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
142969621|NCT00479557|515422788|FG000|Overall Study|AE not related to Study Drug|1|||
142969622|NCT00479557|515422789|FG001|Overall Study|AE not related to Study Drug|3|||
142969623|NCT00479557|515422790|FG002|Overall Study|AE not related to Study Drug|0|||
142969624|NCT00479557|515422791|FG003|Overall Study|AE not related to Study Drug|0|||
142969625|NCT00479557|515422792|FG004|Overall Study|AE not related to Study Drug|2|||
142969626|NCT00479557|515422793|FG005|Overall Study|AE not related to Study Drug|2|||
142969627|NCT00479557|515422794|FG006|Overall Study|AE not related to Study Drug|1|||
142969628|NCT00479557|515422788|FG000|Overall Study|Caregiver Request|2|||
142969629|NCT00479557|515422789|FG001|Overall Study|Caregiver Request|2|||
142969630|NCT00479557|515422790|FG002|Overall Study|Caregiver Request|2|||
142969631|NCT00479557|515422791|FG003|Overall Study|Caregiver Request|0|||
142969632|NCT00479557|515422792|FG004|Overall Study|Caregiver Request|1|||
142969633|NCT00479557|515422793|FG005|Overall Study|Caregiver Request|2|||
142969634|NCT00479557|515422794|FG006|Overall Study|Caregiver Request|0|||
142969635|NCT00479557|515422788|FG000|Overall Study|Investigator Request|0|||
142969636|NCT00479557|515422789|FG001|Overall Study|Investigator Request|0|||
142969637|NCT00479557|515422790|FG002|Overall Study|Investigator Request|1|||
142969638|NCT00479557|515422791|FG003|Overall Study|Investigator Request|0|||
142969639|NCT00479557|515422792|FG004|Overall Study|Investigator Request|0|||
142969640|NCT00479557|515422793|FG005|Overall Study|Investigator Request|0|||
142969641|NCT00479557|515422794|FG006|Overall Study|Investigator Request|0|||
142969642|NCT00479557|515422788|FG000|Overall Study|Subject Request|3|||
142969643|NCT00479557|515422789|FG001|Overall Study|Subject Request|0|||
142969644|NCT00479557|515422790|FG002|Overall Study|Subject Request|1|||
142969645|NCT00479557|515422791|FG003|Overall Study|Subject Request|1|||
142969646|NCT00479557|515422792|FG004|Overall Study|Subject Request|1|||
142969647|NCT00479557|515422793|FG005|Overall Study|Subject Request|4|||
142969648|NCT00479557|515422794|FG006|Overall Study|Subject Request|1|||
142969649|NCT00479557|515422788|FG000|Overall Study|Other|2|||
142969650|NCT00479557|515422789|FG001|Overall Study|Other|3|||
142969651|NCT00479557|515422790|FG002|Overall Study|Other|1|||
142969652|NCT00479557|515422791|FG003|Overall Study|Other|0|||
142969653|NCT00479557|515422792|FG004|Overall Study|Other|0|||
142969654|NCT00479557|515422793|FG005|Overall Study|Other|3|||
142969655|NCT00479557|515422794|FG006|Overall Study|Other|0|||
142969656|NCT02509494|515422795|FG000|Overall Study|Lost to Follow-up|8|||
142969657|NCT02509494|515422796|FG001|Overall Study|Lost to Follow-up|47|||
142969658|NCT02509494|515422797|FG002|Overall Study|Lost to Follow-up|19|||
142969659|NCT02509494|515422798|FG003|Overall Study|Lost to Follow-up|6|||
142969660|NCT02509494|515422799|FG004|Overall Study|Lost to Follow-up|3|||
142969661|NCT02509494|515422800|FG005|Overall Study|Lost to Follow-up|3|||
142969662|NCT02509494|515422801|FG006|Overall Study|Lost to Follow-up|1|||
142969663|NCT02509494|515422802|FG007|Overall Study|Lost to Follow-up|3|||
142969664|NCT02509494|515422803|FG008|Overall Study|Lost to Follow-up|1|||
142969665|NCT02509494|515422795|FG000|Overall Study|Physician Decision|2|||
142969666|NCT02509494|515422796|FG001|Overall Study|Physician Decision|1|||
142969667|NCT02509494|515422797|FG002|Overall Study|Physician Decision|0|||
142969668|NCT02509494|515422798|FG003|Overall Study|Physician Decision|0|||
142969669|NCT02509494|515422799|FG004|Overall Study|Physician Decision|0|||
142969670|NCT02509494|515422800|FG005|Overall Study|Physician Decision|0|||
142969671|NCT02509494|515422801|FG006|Overall Study|Physician Decision|0|||
142969672|NCT02509494|515422802|FG007|Overall Study|Physician Decision|0|||
142969673|NCT02509494|515422803|FG008|Overall Study|Physician Decision|0|||
142969674|NCT02509494|515422795|FG000|Overall Study|Withdrawal by Subject|4|||
142969675|NCT02509494|515422796|FG001|Overall Study|Withdrawal by Subject|17|||
142969676|NCT02509494|515422797|FG002|Overall Study|Withdrawal by Subject|7|||
142969677|NCT02509494|515422798|FG003|Overall Study|Withdrawal by Subject|5|||
142969678|NCT02509494|515422799|FG004|Overall Study|Withdrawal by Subject|0|||
142969679|NCT02509494|515422800|FG005|Overall Study|Withdrawal by Subject|6|||
142969680|NCT02509494|515422801|FG006|Overall Study|Withdrawal by Subject|1|||
142969681|NCT02509494|515422802|FG007|Overall Study|Withdrawal by Subject|2|||
143117150|NCT01273155|515970044|FG006|Overall Study|Died during Cycle 1|2|||
143117151|NCT01273155|515970038|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
142969682|NCT02509494|515422803|FG008|Overall Study|Withdrawal by Subject|1|||
142969683|NCT02509494|515422795|FG000|Overall Study|Death|0|||
142969684|NCT02509494|515422796|FG001|Overall Study|Death|1|||
142969685|NCT02509494|515422797|FG002|Overall Study|Death|0|||
142969686|NCT02509494|515422798|FG003|Overall Study|Death|0|||
142969687|NCT02509494|515422799|FG004|Overall Study|Death|1|||
142969688|NCT02509494|515422800|FG005|Overall Study|Death|0|||
142969689|NCT02509494|515422801|FG006|Overall Study|Death|0|||
142969690|NCT02509494|515422802|FG007|Overall Study|Death|1|||
142969691|NCT02509494|515422803|FG008|Overall Study|Death|0|||
142969692|NCT02509494|515422795|FG000|Overall Study|Other|0|||
142969693|NCT02509494|515422796|FG001|Overall Study|Other|4|||
142969694|NCT02509494|515422797|FG002|Overall Study|Other|5|||
142969695|NCT02509494|515422798|FG003|Overall Study|Other|0|||
142969696|NCT02509494|515422799|FG004|Overall Study|Other|0|||
142969697|NCT02509494|515422800|FG005|Overall Study|Other|0|||
142969698|NCT02509494|515422801|FG006|Overall Study|Other|0|||
142969699|NCT02509494|515422802|FG007|Overall Study|Other|0|||
142969700|NCT02509494|515422803|FG008|Overall Study|Other|0|||
142969701|NCT02509494|515422795|FG000|Overall Study|Non-Compliance With Study Drug|1|||
142969702|NCT02509494|515422796|FG001|Overall Study|Non-Compliance With Study Drug|11|||
142969703|NCT02509494|515422797|FG002|Overall Study|Non-Compliance With Study Drug|7|||
142969704|NCT02509494|515422798|FG003|Overall Study|Non-Compliance With Study Drug|0|||
142969705|NCT02509494|515422799|FG004|Overall Study|Non-Compliance With Study Drug|1|||
142969706|NCT02509494|515422800|FG005|Overall Study|Non-Compliance With Study Drug|2|||
142969707|NCT02509494|515422801|FG006|Overall Study|Non-Compliance With Study Drug|1|||
142969708|NCT02509494|515422802|FG007|Overall Study|Non-Compliance With Study Drug|1|||
142969709|NCT02509494|515422803|FG008|Overall Study|Non-Compliance With Study Drug|0|||
142969710|NCT04752189|515422804|FG000|Overall Study|Withdrawal by Subject|0|||
142969711|NCT04752189|515422805|FG001|Overall Study|Withdrawal by Subject|150|||
142969712|NCT04752189|515422804|FG000|Overall Study|Lost to Follow-up|261|||
142969713|NCT04752189|515422805|FG001|Overall Study|Lost to Follow-up|126|||
142969714|NCT00975195|515422806|FG000|Overall Study|Adverse Event|108|||
142969715|NCT00975195|515422807|FG001|Overall Study|Adverse Event|101|||
142969716|NCT00975195|515422806|FG000|Overall Study|Lack of Efficacy|6|||
142969717|NCT00975195|515422807|FG001|Overall Study|Lack of Efficacy|6|||
142969718|NCT00975195|515422806|FG000|Overall Study|Protocol Violation|27|||
142969719|NCT00975195|515422807|FG001|Overall Study|Protocol Violation|23|||
142969720|NCT00975195|515422806|FG000|Overall Study|Lost to Follow-up|9|||
142969721|NCT00975195|515422807|FG001|Overall Study|Lost to Follow-up|7|||
142969722|NCT00975195|515422806|FG000|Overall Study|Withdrawal by Subject|48|||
142969723|NCT00975195|515422807|FG001|Overall Study|Withdrawal by Subject|61|||
142969724|NCT00975195|515422806|FG000|Overall Study|Other reason not defined above|29|||
142969725|NCT00975195|515422807|FG001|Overall Study|Other reason not defined above|33|||
142969726|NCT00975195|515422806|FG000|Overall Study|Not treated|1|||
142969727|NCT00975195|515422807|FG001|Overall Study|Not treated|2|||
142969728|NCT02198651|515424718|FG000|Lead-in Period|Withdrew consent|13|||
142969729|NCT02198651|515424719|FG001|Lead-in Period|Withdrew consent|0|||
142969730|NCT02198651|515424720|FG002|Lead-in Period|Withdrew consent|0|||
142969731|NCT02198651|515424721|FG003|Lead-in Period|Withdrew consent|0|||
142969732|NCT02198651|515424722|FG004|Lead-in Period|Withdrew consent|0|||
142969733|NCT02198651|515424718|FG000|Lead-in Period|Adverse Event|2|||
142969734|NCT02198651|515424719|FG001|Lead-in Period|Adverse Event|0|||
142969735|NCT02198651|515424720|FG002|Lead-in Period|Adverse Event|0|||
142969736|NCT02198651|515424721|FG003|Lead-in Period|Adverse Event|0|||
142969737|NCT02198651|515424722|FG004|Lead-in Period|Adverse Event|0|||
142969738|NCT02198651|515424718|FG000|Lead-in Period|Other, not specified|22|||
142969739|NCT02198651|515424719|FG001|Lead-in Period|Other, not specified|0|||
142969740|NCT02198651|515424720|FG002|Lead-in Period|Other, not specified|0|||
142969741|NCT02198651|515424721|FG003|Lead-in Period|Other, not specified|0|||
142969742|NCT02198651|515424722|FG004|Lead-in Period|Other, not specified|0|||
142969743|NCT02198651|515424718|FG000|Double-blind Period|Withdrew consent|0|||
142969744|NCT02198651|515424719|FG001|Double-blind Period|Withdrew consent|4|||
142969745|NCT02198651|515424720|FG002|Double-blind Period|Withdrew consent|0|||
142969746|NCT02198651|515424721|FG003|Double-blind Period|Withdrew consent|0|||
142969747|NCT02198651|515424722|FG004|Double-blind Period|Withdrew consent|0|||
142969748|NCT02198651|515424718|FG000|Double-blind Period|Adverse Event|0|||
142969749|NCT02198651|515424719|FG001|Double-blind Period|Adverse Event|1|||
142969750|NCT02198651|515424720|FG002|Double-blind Period|Adverse Event|0|||
142969751|NCT02198651|515424721|FG003|Double-blind Period|Adverse Event|0|||
142969752|NCT02198651|515424722|FG004|Double-blind Period|Adverse Event|0|||
142969753|NCT02198651|515424718|FG000|Double-blind Period|Other, not specified|0|||
142969754|NCT02198651|515424719|FG001|Double-blind Period|Other, not specified|4|||
142969755|NCT02198651|515424720|FG002|Double-blind Period|Other, not specified|1|||
142969756|NCT02198651|515424721|FG003|Double-blind Period|Other, not specified|0|||
142969757|NCT02198651|515424722|FG004|Double-blind Period|Other, not specified|0|||
142969758|NCT02198651|515424718|FG000|Open-label Rescue Period|Withdrew consent|0|||
142969759|NCT02198651|515424719|FG001|Open-label Rescue Period|Withdrew consent|0|||
142969760|NCT02198651|515424720|FG002|Open-label Rescue Period|Withdrew consent|0|||
142969761|NCT02198651|515424721|FG003|Open-label Rescue Period|Withdrew consent|2|||
142969762|NCT02198651|515424722|FG004|Open-label Rescue Period|Withdrew consent|0|||
142969763|NCT02198651|515424718|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
142969764|NCT02198651|515424719|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
142969765|NCT02198651|515424720|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
142969766|NCT02198651|515424721|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
142969767|NCT02198651|515424722|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
142969768|NCT00369967|515424724|FG000|Overall Study|Lost to Follow-up|23|||
142969769|NCT00369967|515424725|FG001|Overall Study|Lost to Follow-up|12|||
142969770|NCT01175213|515424733|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
142969771|NCT01175213|515424734|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
142969772|NCT01175213|515424733|FG000|IGSC, 10%/rHuPH20|Death|1|||
142969773|NCT01175213|515424734|FG001|IGSC, 10%/rHuPH20|Death|0|||
142969774|NCT01175213|515424733|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
142969775|NCT01175213|515424734|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
142969776|NCT01175213|515424733|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
142969777|NCT01175213|515424734|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
142969778|NCT01175213|515424733|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
142969779|NCT01175213|515424734|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
142969780|NCT01175213|515424733|FG000|Safety Follow-up|Adverse Event|1|||
142969781|NCT01175213|515424734|FG001|Safety Follow-up|Adverse Event|0|||
142969782|NCT03057951|515424741|FG000|Overall Study|Adverse Event|553|||
142969783|NCT03057951|515424742|FG001|Overall Study|Adverse Event|575|||
142969784|NCT03057951|515424741|FG000|Overall Study|Protocol Violation|30|||
142969785|NCT03057951|515424742|FG001|Overall Study|Protocol Violation|24|||
142969786|NCT03057951|515424741|FG000|Overall Study|Lost to Follow-up|6|||
142969787|NCT03057951|515424742|FG001|Overall Study|Lost to Follow-up|16|||
142969788|NCT03057951|515424741|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
142969789|NCT03057951|515424742|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
142969790|NCT03057951|515424741|FG000|Overall Study|Study drug stopped, reason missing|6|||
142969791|NCT03057951|515424742|FG001|Overall Study|Study drug stopped, reason missing|1|||
142969792|NCT03057951|515424741|FG000|Overall Study|Medical advice|6|||
142969793|NCT03057951|515424742|FG001|Overall Study|Medical advice|2|||
142969794|NCT03057951|515424741|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
142969795|NCT03057951|515424742|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
142969796|NCT03057951|515424741|FG000|Overall Study|Investigator decision|2|||
142969797|NCT03057951|515424742|FG001|Overall Study|Investigator decision|0|||
142969798|NCT03057951|515424741|FG000|Overall Study|Patient decision|5|||
142969799|NCT03057951|515424742|FG001|Overall Study|Patient decision|2|||
142969800|NCT03057951|515424741|FG000|Overall Study|Not attending study visits|3|||
142969801|NCT03057951|515424742|FG001|Overall Study|Not attending study visits|0|||
142969802|NCT03057951|515424741|FG000|Overall Study|Patient moved away|3|||
142969803|NCT03057951|515424742|FG001|Overall Study|Patient moved away|4|||
142969804|NCT03057951|515424741|FG000|Overall Study|Other reason than stated above|23|||
142969805|NCT03057951|515424742|FG001|Overall Study|Other reason than stated above|29|||
142969806|NCT03057951|515424741|FG000|Overall Study|Not treated|2|||
142969807|NCT03057951|515424742|FG001|Overall Study|Not treated|1|||
142969808|NCT01205451|515424752|FG000|Overall Study|Lost to Follow-up|1|||
142969809|NCT01205451|515424753|FG001|Overall Study|Lost to Follow-up|1|||
142969810|NCT01205451|515424752|FG000|Overall Study|Withdrawal by Subject|5|||
142969811|NCT01205451|515424753|FG001|Overall Study|Withdrawal by Subject|9|||
142969812|NCT00229203|515424757|FG000|Overall Study|Progressive disease|18|||
142969813|NCT00229203|515424758|FG001|Overall Study|Progressive disease|9|||
142969814|NCT00229203|515424757|FG000|Overall Study|Toxicity|6|||
142969815|NCT00229203|515424758|FG001|Overall Study|Toxicity|1|||
142969816|NCT00229203|515424757|FG000|Overall Study|Death|4|||
142969817|NCT00229203|515424758|FG001|Overall Study|Death|2|||
142969818|NCT00229203|515424757|FG000|Overall Study|Other|3|||
142969819|NCT00229203|515424758|FG001|Overall Study|Other|3|||
142969820|NCT00229203|515424757|FG000|Overall Study|Withdrawal by Subject|1|||
142969821|NCT00229203|515424758|FG001|Overall Study|Withdrawal by Subject|4|||
142969822|NCT03457103|515424759|FG000|Overall Study|illness/hospitalization|4|||
142969823|NCT03457103|515424760|FG001|Overall Study|illness/hospitalization|2|||
142969824|NCT03457103|515424759|FG000|Overall Study|Lost to Follow-up|2|||
142969825|NCT03457103|515424760|FG001|Overall Study|Lost to Follow-up|1|||
142969826|NCT03457103|515424759|FG000|Overall Study|Withdrawal by Subject|1|||
142969827|NCT03457103|515424760|FG001|Overall Study|Withdrawal by Subject|2|||
142969828|NCT03457103|515424759|FG000|Overall Study|financial/ insurance issues|1|||
142969829|NCT03457103|515424760|FG001|Overall Study|financial/ insurance issues|1|||
142969830|NCT02411201|515424761|FG000|Overall Study|Adverse Event|2|||
142969831|NCT02411201|515424761|FG000|Overall Study|Withdrawal by Subject|2|||
142969832|NCT02411201|515424761|FG000|Overall Study|Age group completed|2|||
142969833|NCT00798694|515424762|FG000|Overall Study|Lost to Follow-up|1|||
142969834|NCT00798694|515424763|FG001|Overall Study|Lost to Follow-up|1|||
142969835|NCT00798694|515424762|FG000|Overall Study|Physician Decision|1|||
142969836|NCT00798694|515424763|FG001|Overall Study|Physician Decision|0|||
142969837|NCT01774344|515424765|FG000|Overall Study|Withdrawal by Subject|3|||
142969838|NCT01774344|515424766|FG001|Overall Study|Withdrawal by Subject|10|||
142969839|NCT01774344|515424765|FG000|Overall Study|Protocol Violation|0|||
142969840|NCT01774344|515424766|FG001|Overall Study|Protocol Violation|1|||
142969841|NCT01774344|515424765|FG000|Overall Study|Lost to Follow-up|4|||
142969842|NCT01774344|515424766|FG001|Overall Study|Lost to Follow-up|10|||
142969843|NCT01774344|515424765|FG000|Overall Study|End of survival follow-up not available|2|||
142969844|NCT01774344|515424766|FG001|Overall Study|End of survival follow-up not available|2|||
142969845|NCT01774344|515424765|FG000|Overall Study|Data collection finished|4|||
142969846|NCT01774344|515424766|FG001|Overall Study|Data collection finished|14|||
142969847|NCT01774344|515424765|FG000|Overall Study|Other|0|||
142969848|NCT01774344|515424766|FG001|Overall Study|Other|1|||
142969849|NCT01774344|515424765|FG000|Overall Study|Did not enter Survival Follow up|49|||
142969850|NCT01774344|515424766|FG001|Overall Study|Did not enter Survival Follow up|83|||
142969851|NCT01163253|515424777|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
142969852|NCT01163253|515424778|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
142969853|NCT01163253|515424777|FG000|Overall Study|Study Terminated by Sponsor|978|||
142969854|NCT01163253|515424778|FG001|Overall Study|Study Terminated by Sponsor|349|||
142969855|NCT01163253|515424777|FG000|Overall Study|Protocol Violation|43|||
142969856|NCT01163253|515424778|FG001|Overall Study|Protocol Violation|12|||
142969857|NCT01163253|515424777|FG000|Overall Study|Withdrawal by Subject|199|||
142969858|NCT01163253|515424778|FG001|Overall Study|Withdrawal by Subject|50|||
142969859|NCT01163253|515424777|FG000|Overall Study|Medication Error|1|||
142969860|NCT01163253|515424778|FG001|Overall Study|Medication Error|0|||
142969861|NCT01163253|515424777|FG000|Overall Study|Lost to Follow-up|125|||
142969862|NCT01163253|515424778|FG001|Overall Study|Lost to Follow-up|23|||
142969863|NCT01163253|515424777|FG000|Overall Study|Insufficient Clinical Response|423|||
142969864|NCT01163253|515424778|FG001|Overall Study|Insufficient Clinical Response|29|||
142969865|NCT01163253|515424777|FG000|Overall Study|Adverse Event|300|||
142969866|NCT01163253|515424778|FG001|Overall Study|Adverse Event|78|||
142969867|NCT01163253|515424777|FG000|Overall Study|Death|17|||
142969868|NCT01163253|515424778|FG001|Overall Study|Death|5|||
142969869|NCT01163253|515424777|FG000|Overall Study|Ongoing|13|||
142969870|NCT01163253|515424778|FG001|Overall Study|Ongoing|4|||
142969871|NCT01163253|515424777|FG000|Overall Study|Other Unspecified|170|||
142969872|NCT01163253|515424778|FG001|Overall Study|Other Unspecified|34|||
142969873|NCT02108600|515424783|FG000|Overall Study|Withdrawal by Subject|2|||
142969874|NCT02108600|515424784|FG001|Overall Study|Withdrawal by Subject|0|||
142969875|NCT02108600|515424783|FG000|Overall Study|Lost to Follow-up|1|||
142969876|NCT02108600|515424784|FG001|Overall Study|Lost to Follow-up|1|||
142969877|NCT03150095|515424787|FG000|Overall Study|Death|0|||
142969878|NCT03150095|515424788|FG001|Overall Study|Death|1|||
142969879|NCT03150095|515424787|FG000|Overall Study|Lost to Follow-up|1|||
142969880|NCT03150095|515424788|FG001|Overall Study|Lost to Follow-up|1|||
142969881|NCT03150095|515424787|FG000|Overall Study|Withdrawal by Subject|4|||
142969882|NCT03150095|515424788|FG001|Overall Study|Withdrawal by Subject|0|||
142969883|NCT03150095|515424787|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
142969884|NCT03150095|515424788|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
142969885|NCT01295580|515424789|FG000|Overall Study|Protocol Violation|4|||
142969886|NCT01295580|515424790|FG001|Overall Study|Protocol Violation|2|||
142969887|NCT01295580|515424789|FG000|Overall Study|Withdrawal by Subject|1|||
142969888|NCT01295580|515424790|FG001|Overall Study|Withdrawal by Subject|4|||
142969889|NCT01295580|515424789|FG000|Overall Study|Adverse Event|2|||
142969890|NCT01295580|515424790|FG001|Overall Study|Adverse Event|1|||
142969891|NCT01295580|515424789|FG000|Overall Study|Lost to Follow-up|1|||
142969892|NCT01295580|515424790|FG001|Overall Study|Lost to Follow-up|0|||
142969893|NCT01295580|515424789|FG000|Overall Study|Lack of Efficacy|1|||
142969894|NCT01295580|515424790|FG001|Overall Study|Lack of Efficacy|0|||
142969895|NCT01295580|515424789|FG000|Overall Study|Other: inconvenience|1|||
142969896|NCT01295580|515424790|FG001|Overall Study|Other: inconvenience|0|||
142969897|NCT01295580|515424789|FG000|Overall Study|Other: family objection|0|||
142969898|NCT01295580|515424790|FG001|Overall Study|Other: family objection|1|||
142969899|NCT03943953|515424793|FG000|Trial of ITG 1|Lost to Follow-up|19|||
142969900|NCT03943953|515424794|FG001|Trial of ITG 1|Lost to Follow-up|1|||
142969901|NCT03943953|515424793|FG000|Trial of ITG 2|Lost to Follow-up|8|||
142969902|NCT03943953|515424794|FG001|Trial of ITG 2|Lost to Follow-up|0|||
142969903|NCT03943953|515424793|FG000|Trial of ITG 3|Lost to Follow-up|2|||
142969904|NCT03943953|515424794|FG001|Trial of ITG 3|Lost to Follow-up|0|||
142969905|NCT03943953|515424793|FG000|Trial of ITG 4|Lost to Follow-up|2|||
142969906|NCT03943953|515424794|FG001|Trial of ITG 4|Lost to Follow-up|0|||
142969907|NCT01742078|515424797|FG000|Overall Study|Withdrawal by Subject|0|||
142969908|NCT01742078|515424798|FG001|Overall Study|Withdrawal by Subject|0|||
142969909|NCT01742078|515424799|FG002|Overall Study|Withdrawal by Subject|0|||
142969910|NCT01742078|515424800|FG003|Overall Study|Withdrawal by Subject|1|||
142969911|NCT01742078|515424801|FG004|Overall Study|Withdrawal by Subject|0|||
142969912|NCT01742078|515424802|FG005|Overall Study|Withdrawal by Subject|0|||
142969913|NCT01742078|515424803|FG006|Overall Study|Withdrawal by Subject|0|||
142969914|NCT01742078|515424804|FG007|Overall Study|Withdrawal by Subject|0|||
142969915|NCT01742078|515424805|FG008|Overall Study|Withdrawal by Subject|0|||
142969916|NCT03247413|515424809|FG000|Overall Study|Lost to Follow-up|28|||
142969917|NCT00642746|515424810|FG000|Overall Study|Patient unevaluable|1|||
142969918|NCT00642746|515424811|FG001|Overall Study|Patient unevaluable|0|||
142969919|NCT00424294|515424812|FG000|Overall Study|Adverse Event|4|||
142969920|NCT00424294|515424813|FG001|Overall Study|Adverse Event|10|||
142969921|NCT00424294|515424812|FG000|Overall Study|Lack of Efficacy|2|||
142969922|NCT00424294|515424813|FG001|Overall Study|Lack of Efficacy|1|||
142969923|NCT00424294|515424812|FG000|Overall Study|Withdrawal by Subject|1|||
142969924|NCT00424294|515424813|FG001|Overall Study|Withdrawal by Subject|2|||
142969925|NCT00424294|515424812|FG000|Overall Study|Other|0|||
142969926|NCT00424294|515424813|FG001|Overall Study|Other|2|||
142969927|NCT00424294|515424812|FG000|Overall Study|Randomized but not Treated|1|||
142969928|NCT00424294|515424813|FG001|Overall Study|Randomized but not Treated|0|||
142969929|NCT03337152|515424816|FG000|Overall Study|Physician Decision|1|||
142969930|NCT03337152|515424817|FG001|Overall Study|Physician Decision|0|||
142969931|NCT03337152|515424816|FG000|Overall Study|Lost to Follow-up|1|||
142969932|NCT03337152|515424817|FG001|Overall Study|Lost to Follow-up|3|||
142969933|NCT03337152|515424816|FG000|Overall Study|Adverse Event|3|||
142969934|NCT03337152|515424817|FG001|Overall Study|Adverse Event|1|||
142969935|NCT03337152|515424816|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
142969936|NCT03337152|515424817|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
142969937|NCT00976950|515424818|FG000|Overall Study|Adverse Event|3|||
142969938|NCT00976950|515424818|FG000|Overall Study|Events with no relationship to Aptivus|3|||
142969939|NCT02493426|515424821|FG000|Overall Study|Withdrawal by Subject|0|||
142969940|NCT02493426|515424822|FG001|Overall Study|Withdrawal by Subject|1|||
142969941|NCT01069523|515424823|FG000|Overall Study|Withdrawal by Subject|4|||
142969942|NCT01069523|515424824|FG001|Overall Study|Withdrawal by Subject|7|||
142969943|NCT00488592|515424828|FG000|Overall Study|Withdrawal by Subject|1|||
142969944|NCT00488592|515424828|FG000|Overall Study|Disease progression|1|||
142969945|NCT00488592|515424828|FG000|Overall Study|Enrolled but not treated|1|||
142969946|NCT00441103|515424829|FG000|Overall Study|Adverse Event|2|||
142969947|NCT00441103|515424830|FG001|Overall Study|Adverse Event|1|||
142969948|NCT00441103|515424829|FG000|Overall Study|Death|1|||
142969949|NCT00441103|515424830|FG001|Overall Study|Death|0|||
142969950|NCT00441103|515424829|FG000|Overall Study|Disease Progression|2|||
142969951|NCT00441103|515424830|FG001|Overall Study|Disease Progression|0|||
142969952|NCT00441103|515424829|FG000|Overall Study|Lost to Follow-up|1|||
142969953|NCT00441103|515424830|FG001|Overall Study|Lost to Follow-up|0|||
142969954|NCT00441103|515424829|FG000|Overall Study|Protocol Violation|1|||
142969955|NCT00441103|515424830|FG001|Overall Study|Protocol Violation|0|||
142969956|NCT00441103|515424829|FG000|Overall Study|Participant unable to use Rebiject II|1|||
142969957|NCT00441103|515424830|FG001|Overall Study|Participant unable to use Rebiject II|0|||
142969958|NCT00441103|515424829|FG000|Overall Study|Participant refused MRI|1|||
142969959|NCT00441103|515424830|FG001|Overall Study|Participant refused MRI|0|||
142969960|NCT00441103|515424829|FG000|Overall Study|Inclusion criteria absent|1|||
142969961|NCT00441103|515424830|FG001|Overall Study|Inclusion criteria absent|0|||
142969962|NCT00441103|515424829|FG000|Overall Study|Non-compliant|0|||
142969963|NCT00441103|515424830|FG001|Overall Study|Non-compliant|1|||
142969964|NCT00441103|515424829|FG000|Overall Study|Participant decided to withdraw|1|||
142969965|NCT00441103|515424830|FG001|Overall Study|Participant decided to withdraw|0|||
142969966|NCT00441103|515424829|FG000|Overall Study|Participant's reason|0|||
142969967|NCT00441103|515424830|FG001|Overall Study|Participant's reason|1|||
142969968|NCT00441103|515424829|FG000|Overall Study|Participant decided to stop|0|||
142969969|NCT00441103|515424830|FG001|Overall Study|Participant decided to stop|1|||
142969970|NCT00807846|515424831|FG000|Overall Study|Adverse Event|5|||
142969971|NCT00807846|515424832|FG001|Overall Study|Adverse Event|0|||
142969972|NCT00807846|515424831|FG000|Overall Study|Lack of Efficacy|2|||
142969973|NCT00807846|515424832|FG001|Overall Study|Lack of Efficacy|0|||
142969974|NCT00807846|515424831|FG000|Overall Study|Protocol Violation|2|||
142969975|NCT00807846|515424832|FG001|Overall Study|Protocol Violation|1|||
142969976|NCT00807846|515424831|FG000|Overall Study|Withdrawal by Subject|2|||
142969977|NCT00807846|515424832|FG001|Overall Study|Withdrawal by Subject|1|||
142969978|NCT00807846|515424831|FG000|Overall Study|Other|1|||
142969979|NCT00807846|515424832|FG001|Overall Study|Other|2|||
142969980|NCT01081873|515424833|FG000|Overall Study|Death|86|||
142969981|NCT01081873|515424833|FG000|Overall Study|Withdrawal by Subject|10|||
142969982|NCT01081873|515424833|FG000|Overall Study|Lost to Follow-up|142|||
142969983|NCT01081873|515424833|FG000|Overall Study|Progression of prostate cancer|13|||
142969984|NCT01081873|515424833|FG000|Overall Study|Other|47|||
142969985|NCT00603980|515424835|FG000|Study Qualification|Protocol Violation|3|||
142969986|NCT00603980|515424835|FG000|Study Qualification|Inconsistent data reporting|13|||
142969987|NCT00603980|515424835|FG000|Main Study|14th subject completed trial|1|||
142969988|NCT02683525|515424836|FG000|Overall Study|Lost to Follow-up|1|||
142969989|NCT02683525|515424836|FG000|Overall Study|Physician Decision|1|||
142969990|NCT02683525|515424836|FG000|Overall Study|Disease Progression|6|||
142969991|NCT00125190|515424837|FG000|Overall Study|Subject/Parent Decision|7|||
142969992|NCT00125190|515424837|FG000|Overall Study|Non-compliance|2|||
142969993|NCT00125190|515424837|FG000|Overall Study|Adverse Event|1|||
143455520|NCT00560066|517212466|FG001|Overall Study|Death|1|||
143455521|NCT00560066|517212465|FG000|Overall Study|Withdrawal by Subject|0|||
142969994|NCT00125190|515424837|FG000|Overall Study|Other|1|||
142969995|NCT00125190|515424837|FG000|Overall Study|Lost to Follow-up|4|||
142969996|NCT02128763|515424838|FG000|Overall Study|Death|1|||
142969997|NCT02128763|515424839|FG001|Overall Study|Death|0|||
142969998|NCT02128763|515424838|FG000|Overall Study|Lost to Follow-up|19|||
142969999|NCT02128763|515424839|FG001|Overall Study|Lost to Follow-up|16|||
142970000|NCT00264849|515424840|FG000|Overall Study|Adverse Event|7|||
142970001|NCT00264849|515424841|FG001|Overall Study|Adverse Event|2|||
142970002|NCT00264849|515424840|FG000|Overall Study|Withdrawal by Subject|7|||
142970003|NCT00264849|515424841|FG001|Overall Study|Withdrawal by Subject|11|||
142970004|NCT00264849|515424840|FG000|Overall Study|Protocol Violation|5|||
142970005|NCT00264849|515424841|FG001|Overall Study|Protocol Violation|3|||
142970006|NCT00264849|515424840|FG000|Overall Study|Lack of Efficacy|1|||
142970007|NCT00264849|515424841|FG001|Overall Study|Lack of Efficacy|6|||
142970008|NCT00264849|515424840|FG000|Overall Study|Lost to Follow-up|0|||
142970009|NCT00264849|515424841|FG001|Overall Study|Lost to Follow-up|2|||
142970010|NCT00264849|515424840|FG000|Overall Study|Death|0|||
142970011|NCT00264849|515424841|FG001|Overall Study|Death|1|||
142970012|NCT00264849|515424840|FG000|Overall Study|Administrative Problems|2|||
142970013|NCT00264849|515424841|FG001|Overall Study|Administrative Problems|0|||
142970014|NCT03488251|515424842|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
142970015|NCT03488251|515424843|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
142970016|NCT03488251|515424844|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
142970017|NCT03488251|515424845|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
142970018|NCT03488251|515424842|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
142970019|NCT03488251|515424843|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
142970020|NCT03488251|515424844|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
142970021|NCT03488251|515424845|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
142970022|NCT03488251|515424842|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
142970023|NCT03488251|515424843|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
142970024|NCT03488251|515424844|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
142970025|NCT03488251|515424845|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
142970026|NCT03488251|515424842|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
142970027|NCT03488251|515424843|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
142970028|NCT03488251|515424844|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
142970029|NCT03488251|515424845|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
142970030|NCT03488251|515424842|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
142970031|NCT03488251|515424843|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
142970032|NCT03488251|515424844|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
142970033|NCT03488251|515424845|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
142970034|NCT01244191|515424846|FG000|Overall Study|Progressive disease|295|||
142970035|NCT01244191|515424847|FG001|Overall Study|Progressive disease|350|||
142970036|NCT01244191|515424846|FG000|Overall Study|Clinical disease progression|54|||
142970037|NCT01244191|515424847|FG001|Overall Study|Clinical disease progression|36|||
142970038|NCT01244191|515424846|FG000|Overall Study|Adverse Event|65|||
142970039|NCT01244191|515424847|FG001|Overall Study|Adverse Event|48|||
142970040|NCT01244191|515424846|FG000|Overall Study|Death|22|||
142970041|NCT01244191|515424847|FG001|Overall Study|Death|29|||
142970042|NCT01244191|515424846|FG000|Overall Study|Lost to Follow-up|0|||
142970043|NCT01244191|515424847|FG001|Overall Study|Lost to Follow-up|2|||
142970044|NCT01244191|515424846|FG000|Overall Study|Protocol Violation|1|||
142970045|NCT01244191|515424847|FG001|Overall Study|Protocol Violation|2|||
142970046|NCT01244191|515424846|FG000|Overall Study|Withdrawal by Subject|31|||
142970047|NCT01244191|515424847|FG001|Overall Study|Withdrawal by Subject|23|||
142970048|NCT01244191|515424846|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
142970049|NCT01244191|515424847|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
142970050|NCT05301322|515424850|FG000|Overall Study|Adverse Event|7|||
142970051|NCT05301322|515424851|FG001|Overall Study|Adverse Event|3|||
142970052|NCT05301322|515424850|FG000|Overall Study|Death|0|||
142970053|NCT05301322|515424851|FG001|Overall Study|Death|1|||
142970054|NCT05301322|515424850|FG000|Overall Study|Lost to Follow-up|2|||
142970055|NCT05301322|515424851|FG001|Overall Study|Lost to Follow-up|1|||
142970056|NCT05301322|515424850|FG000|Overall Study|Protocol Violation|3|||
142970057|NCT05301322|515424851|FG001|Overall Study|Protocol Violation|1|||
142970058|NCT05301322|515424850|FG000|Overall Study|Withdrawal by Subject|3|||
142970059|NCT05301322|515424851|FG001|Overall Study|Withdrawal by Subject|0|||
142970060|NCT05301322|515424850|FG000|Overall Study|Other|4|||
142970061|NCT05301322|515424851|FG001|Overall Study|Other|0|||
142970062|NCT03422133|515424852|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
142970063|NCT03422133|515424853|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
142970064|NCT03003403|515424854|FG000|Overall Study|Ineligible|8|||
142970065|NCT03003403|515424855|FG001|Overall Study|Ineligible|7|||
142970066|NCT03003403|515424854|FG000|Overall Study|Withdrawal by Subject|3|||
142970067|NCT03003403|515424855|FG001|Overall Study|Withdrawal by Subject|1|||
142970068|NCT01885078|515426929|FG000|Treatment Period|Adverse Event|52|||
142970069|NCT01885078|515426930|FG001|Treatment Period|Adverse Event|136|||
143117152|NCT01273155|515970039|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
142970070|NCT01885078|515426931|FG002|Treatment Period|Adverse Event|30|||
142970071|NCT01885078|515426932|FG003|Treatment Period|Adverse Event|73|||
142970072|NCT01885078|515426933|FG004|Treatment Period|Adverse Event|17|||
142970073|NCT01885078|515426934|FG005|Treatment Period|Adverse Event|72|||
142970074|NCT01885078|515426935|FG006|Treatment Period|Adverse Event|24|||
142970075|NCT01885078|515426936|FG007|Treatment Period|Adverse Event|5|||
142970076|NCT01885078|515426937|FG008|Treatment Period|Adverse Event|0|||
142970077|NCT01885078|515426938|FG009|Treatment Period|Adverse Event|0|||
142970078|NCT01885078|515426929|FG000|Treatment Period|Death|13|||
142970079|NCT01885078|515426930|FG001|Treatment Period|Death|33|||
142970080|NCT01885078|515426931|FG002|Treatment Period|Death|5|||
142970081|NCT01885078|515426932|FG003|Treatment Period|Death|9|||
142970082|NCT01885078|515426933|FG004|Treatment Period|Death|2|||
142970083|NCT01885078|515426934|FG005|Treatment Period|Death|10|||
142970084|NCT01885078|515426935|FG006|Treatment Period|Death|3|||
142970085|NCT01885078|515426936|FG007|Treatment Period|Death|2|||
142970086|NCT01885078|515426937|FG008|Treatment Period|Death|0|||
142970087|NCT01885078|515426938|FG009|Treatment Period|Death|0|||
142970088|NCT01885078|515426929|FG000|Treatment Period|Lack of Efficacy|12|||
142970089|NCT01885078|515426930|FG001|Treatment Period|Lack of Efficacy|33|||
142970090|NCT01885078|515426931|FG002|Treatment Period|Lack of Efficacy|10|||
142970091|NCT01885078|515426932|FG003|Treatment Period|Lack of Efficacy|23|||
142970092|NCT01885078|515426933|FG004|Treatment Period|Lack of Efficacy|24|||
142970093|NCT01885078|515426934|FG005|Treatment Period|Lack of Efficacy|58|||
142970094|NCT01885078|515426935|FG006|Treatment Period|Lack of Efficacy|9|||
142970095|NCT01885078|515426936|FG007|Treatment Period|Lack of Efficacy|5|||
142970096|NCT01885078|515426937|FG008|Treatment Period|Lack of Efficacy|0|||
142970097|NCT01885078|515426938|FG009|Treatment Period|Lack of Efficacy|0|||
142970098|NCT01885078|515426929|FG000|Treatment Period|Lost to Follow-up|16|||
142970099|NCT01885078|515426930|FG001|Treatment Period|Lost to Follow-up|19|||
142970100|NCT01885078|515426931|FG002|Treatment Period|Lost to Follow-up|7|||
142970101|NCT01885078|515426932|FG003|Treatment Period|Lost to Follow-up|9|||
142970102|NCT01885078|515426933|FG004|Treatment Period|Lost to Follow-up|2|||
142970103|NCT01885078|515426934|FG005|Treatment Period|Lost to Follow-up|8|||
142970104|NCT01885078|515426935|FG006|Treatment Period|Lost to Follow-up|2|||
142970105|NCT01885078|515426936|FG007|Treatment Period|Lost to Follow-up|0|||
142970106|NCT01885078|515426937|FG008|Treatment Period|Lost to Follow-up|0|||
142970107|NCT01885078|515426938|FG009|Treatment Period|Lost to Follow-up|0|||
142970108|NCT01885078|515426929|FG000|Treatment Period|Physician Decision|19|||
142970109|NCT01885078|515426930|FG001|Treatment Period|Physician Decision|21|||
142970110|NCT01885078|515426931|FG002|Treatment Period|Physician Decision|5|||
142970111|NCT01885078|515426932|FG003|Treatment Period|Physician Decision|12|||
142970112|NCT01885078|515426933|FG004|Treatment Period|Physician Decision|9|||
142970113|NCT01885078|515426934|FG005|Treatment Period|Physician Decision|24|||
142970114|NCT01885078|515426935|FG006|Treatment Period|Physician Decision|4|||
142970115|NCT01885078|515426936|FG007|Treatment Period|Physician Decision|3|||
142970116|NCT01885078|515426937|FG008|Treatment Period|Physician Decision|0|||
142970117|NCT01885078|515426938|FG009|Treatment Period|Physician Decision|0|||
142970118|NCT01885078|515426929|FG000|Treatment Period|Protocol Violation|3|||
142970119|NCT01885078|515426930|FG001|Treatment Period|Protocol Violation|5|||
142970120|NCT01885078|515426931|FG002|Treatment Period|Protocol Violation|0|||
142970121|NCT01885078|515426932|FG003|Treatment Period|Protocol Violation|3|||
142970122|NCT01885078|515426933|FG004|Treatment Period|Protocol Violation|1|||
142970123|NCT01885078|515426934|FG005|Treatment Period|Protocol Violation|6|||
142970124|NCT01885078|515426935|FG006|Treatment Period|Protocol Violation|0|||
142970125|NCT01885078|515426936|FG007|Treatment Period|Protocol Violation|0|||
142970126|NCT01885078|515426937|FG008|Treatment Period|Protocol Violation|0|||
142970127|NCT01885078|515426938|FG009|Treatment Period|Protocol Violation|0|||
142970128|NCT01885078|515426929|FG000|Treatment Period|Sponsor Decision|245|||
142970129|NCT01885078|515426930|FG001|Treatment Period|Sponsor Decision|648|||
142970130|NCT01885078|515426931|FG002|Treatment Period|Sponsor Decision|49|||
142970131|NCT01885078|515426932|FG003|Treatment Period|Sponsor Decision|90|||
142970132|NCT01885078|515426933|FG004|Treatment Period|Sponsor Decision|20|||
142970133|NCT01885078|515426934|FG005|Treatment Period|Sponsor Decision|38|||
142970134|NCT01885078|515426935|FG006|Treatment Period|Sponsor Decision|162|||
142970135|NCT01885078|515426936|FG007|Treatment Period|Sponsor Decision|3|||
142970136|NCT01885078|515426937|FG008|Treatment Period|Sponsor Decision|0|||
142970137|NCT01885078|515426938|FG009|Treatment Period|Sponsor Decision|0|||
142970138|NCT01885078|515426929|FG000|Treatment Period|Withdrawal by Subject|72|||
142970139|NCT01885078|515426930|FG001|Treatment Period|Withdrawal by Subject|132|||
142970140|NCT01885078|515426931|FG002|Treatment Period|Withdrawal by Subject|25|||
142970141|NCT01885078|515426932|FG003|Treatment Period|Withdrawal by Subject|63|||
142970142|NCT01885078|515426933|FG004|Treatment Period|Withdrawal by Subject|15|||
142970143|NCT01885078|515426934|FG005|Treatment Period|Withdrawal by Subject|34|||
142970144|NCT01885078|515426935|FG006|Treatment Period|Withdrawal by Subject|17|||
142970145|NCT01885078|515426936|FG007|Treatment Period|Withdrawal by Subject|10|||
142970146|NCT01885078|515426937|FG008|Treatment Period|Withdrawal by Subject|0|||
142970147|NCT01885078|515426938|FG009|Treatment Period|Withdrawal by Subject|0|||
142970148|NCT01885078|515426929|FG000|Treatment Period|Other|0|||
142970149|NCT01885078|515426930|FG001|Treatment Period|Other|0|||
142970150|NCT01885078|515426931|FG002|Treatment Period|Other|0|||
142970151|NCT01885078|515426932|FG003|Treatment Period|Other|1|||
142970152|NCT01885078|515426933|FG004|Treatment Period|Other|0|||
142970153|NCT01885078|515426934|FG005|Treatment Period|Other|0|||
142970154|NCT01885078|515426935|FG006|Treatment Period|Other|0|||
142970155|NCT01885078|515426936|FG007|Treatment Period|Other|0|||
142970156|NCT01885078|515426937|FG008|Treatment Period|Other|0|||
142970157|NCT01885078|515426938|FG009|Treatment Period|Other|0|||
142970158|NCT01885078|515426929|FG000|Step-down Period|Sponsor Decision|0|||
142970159|NCT01885078|515426930|FG001|Step-down Period|Sponsor Decision|0|||
142970160|NCT01885078|515426931|FG002|Step-down Period|Sponsor Decision|0|||
142970161|NCT01885078|515426932|FG003|Step-down Period|Sponsor Decision|0|||
142970162|NCT01885078|515426933|FG004|Step-down Period|Sponsor Decision|0|||
142970163|NCT01885078|515426934|FG005|Step-down Period|Sponsor Decision|0|||
142970164|NCT01885078|515426935|FG006|Step-down Period|Sponsor Decision|0|||
142970165|NCT01885078|515426936|FG007|Step-down Period|Sponsor Decision|0|||
142970166|NCT01885078|515426937|FG008|Step-down Period|Sponsor Decision|1|||
142970167|NCT01885078|515426938|FG009|Step-down Period|Sponsor Decision|1|||
142970168|NCT01885078|515426929|FG000|Step-down Period|Adverse Event|0|||
142970169|NCT01885078|515426930|FG001|Step-down Period|Adverse Event|0|||
142970170|NCT01885078|515426931|FG002|Step-down Period|Adverse Event|0|||
142970171|NCT01885078|515426932|FG003|Step-down Period|Adverse Event|0|||
142970172|NCT01885078|515426933|FG004|Step-down Period|Adverse Event|0|||
142970173|NCT01885078|515426934|FG005|Step-down Period|Adverse Event|0|||
142970174|NCT01885078|515426935|FG006|Step-down Period|Adverse Event|0|||
142970175|NCT01885078|515426936|FG007|Step-down Period|Adverse Event|0|||
142970176|NCT01885078|515426937|FG008|Step-down Period|Adverse Event|29|||
142970177|NCT01885078|515426938|FG009|Step-down Period|Adverse Event|38|||
142970178|NCT01885078|515426929|FG000|Step-down Period|Withdrawal by Subject|0|||
142970179|NCT01885078|515426930|FG001|Step-down Period|Withdrawal by Subject|0|||
142970180|NCT01885078|515426931|FG002|Step-down Period|Withdrawal by Subject|0|||
142970181|NCT01885078|515426932|FG003|Step-down Period|Withdrawal by Subject|0|||
142970182|NCT01885078|515426933|FG004|Step-down Period|Withdrawal by Subject|0|||
142970183|NCT01885078|515426934|FG005|Step-down Period|Withdrawal by Subject|0|||
142970184|NCT01885078|515426935|FG006|Step-down Period|Withdrawal by Subject|0|||
142970185|NCT01885078|515426936|FG007|Step-down Period|Withdrawal by Subject|0|||
142970186|NCT01885078|515426937|FG008|Step-down Period|Withdrawal by Subject|25|||
142970187|NCT01885078|515426938|FG009|Step-down Period|Withdrawal by Subject|15|||
142970188|NCT01885078|515426929|FG000|Step-down Period|Physician Decision|0|||
142970189|NCT01885078|515426930|FG001|Step-down Period|Physician Decision|0|||
142970190|NCT01885078|515426931|FG002|Step-down Period|Physician Decision|0|||
142970191|NCT01885078|515426932|FG003|Step-down Period|Physician Decision|0|||
142970192|NCT01885078|515426933|FG004|Step-down Period|Physician Decision|0|||
142970193|NCT01885078|515426934|FG005|Step-down Period|Physician Decision|0|||
142970194|NCT01885078|515426935|FG006|Step-down Period|Physician Decision|0|||
142970195|NCT01885078|515426936|FG007|Step-down Period|Physician Decision|0|||
142970196|NCT01885078|515426937|FG008|Step-down Period|Physician Decision|7|||
142970197|NCT01885078|515426938|FG009|Step-down Period|Physician Decision|2|||
142970198|NCT01885078|515426929|FG000|Step-down Period|Death|0|||
142970199|NCT01885078|515426930|FG001|Step-down Period|Death|0|||
142970200|NCT01885078|515426931|FG002|Step-down Period|Death|0|||
142970201|NCT01885078|515426932|FG003|Step-down Period|Death|0|||
142970202|NCT01885078|515426933|FG004|Step-down Period|Death|0|||
142970203|NCT01885078|515426934|FG005|Step-down Period|Death|0|||
142970204|NCT01885078|515426935|FG006|Step-down Period|Death|0|||
142970205|NCT01885078|515426936|FG007|Step-down Period|Death|0|||
142970206|NCT01885078|515426937|FG008|Step-down Period|Death|4|||
142970207|NCT01885078|515426938|FG009|Step-down Period|Death|3|||
142970208|NCT01885078|515426929|FG000|Step-down Period|Lost to Follow-up|0|||
142970209|NCT01885078|515426930|FG001|Step-down Period|Lost to Follow-up|0|||
142970210|NCT01885078|515426931|FG002|Step-down Period|Lost to Follow-up|0|||
142970211|NCT01885078|515426932|FG003|Step-down Period|Lost to Follow-up|0|||
142970212|NCT01885078|515426933|FG004|Step-down Period|Lost to Follow-up|0|||
142970213|NCT01885078|515426934|FG005|Step-down Period|Lost to Follow-up|0|||
142970214|NCT01885078|515426935|FG006|Step-down Period|Lost to Follow-up|0|||
142970215|NCT01885078|515426936|FG007|Step-down Period|Lost to Follow-up|0|||
142970216|NCT01885078|515426937|FG008|Step-down Period|Lost to Follow-up|1|||
142970217|NCT01885078|515426938|FG009|Step-down Period|Lost to Follow-up|1|||
142970218|NCT01885078|515426929|FG000|Step-down Period|Lack of Efficacy|0|||
142970219|NCT01885078|515426930|FG001|Step-down Period|Lack of Efficacy|0|||
142970220|NCT01885078|515426931|FG002|Step-down Period|Lack of Efficacy|0|||
142970221|NCT01885078|515426932|FG003|Step-down Period|Lack of Efficacy|0|||
142970222|NCT01885078|515426933|FG004|Step-down Period|Lack of Efficacy|0|||
142970223|NCT01885078|515426934|FG005|Step-down Period|Lack of Efficacy|0|||
142970224|NCT01885078|515426935|FG006|Step-down Period|Lack of Efficacy|0|||
142970225|NCT01885078|515426936|FG007|Step-down Period|Lack of Efficacy|0|||
142970226|NCT01885078|515426937|FG008|Step-down Period|Lack of Efficacy|1|||
142970227|NCT01885078|515426938|FG009|Step-down Period|Lack of Efficacy|0|||
142970228|NCT01885078|515426929|FG000|Step-down Period|Protocol Violation|0|||
142970229|NCT01885078|515426930|FG001|Step-down Period|Protocol Violation|0|||
142970230|NCT01885078|515426931|FG002|Step-down Period|Protocol Violation|0|||
142970231|NCT01885078|515426932|FG003|Step-down Period|Protocol Violation|0|||
142970232|NCT01885078|515426933|FG004|Step-down Period|Protocol Violation|0|||
142970233|NCT01885078|515426934|FG005|Step-down Period|Protocol Violation|0|||
142970234|NCT01885078|515426935|FG006|Step-down Period|Protocol Violation|0|||
142970235|NCT01885078|515426936|FG007|Step-down Period|Protocol Violation|0|||
142970236|NCT01885078|515426937|FG008|Step-down Period|Protocol Violation|1|||
142970237|NCT01885078|515426938|FG009|Step-down Period|Protocol Violation|1|||
142970238|NCT03225716|515426939|FG000|Overall Study|Withdrawal by Subject|2|||
142970239|NCT03225716|515426940|FG001|Overall Study|Withdrawal by Subject|2|||
142970240|NCT03225716|515426941|FG002|Overall Study|Withdrawal by Subject|0|||
142970241|NCT03225716|515426939|FG000|Overall Study|Lack of Efficacy|1|||
142970242|NCT03225716|515426940|FG001|Overall Study|Lack of Efficacy|0|||
142970243|NCT03225716|515426941|FG002|Overall Study|Lack of Efficacy|0|||
142970244|NCT03225716|515426939|FG000|Overall Study|Adverse Event|2|||
142970245|NCT03225716|515426940|FG001|Overall Study|Adverse Event|0|||
142970246|NCT03225716|515426941|FG002|Overall Study|Adverse Event|1|||
142970247|NCT03225716|515426939|FG000|Overall Study|Study early termination by Sponsor|0|||
142970248|NCT03225716|515426940|FG001|Overall Study|Study early termination by Sponsor|0|||
142970249|NCT03225716|515426941|FG002|Overall Study|Study early termination by Sponsor|2|||
142970250|NCT02680587|515426942|FG000|Overall Study|Withdrawal by Subject|1|||
142970251|NCT02680587|515426943|FG001|Overall Study|Withdrawal by Subject|0|||
142970252|NCT00571688|515426950|FG000|Overall Study|Lost to Follow-up|3|||
142970253|NCT00571688|515426951|FG001|Overall Study|Lost to Follow-up|6|||
142970254|NCT00571688|515426950|FG000|Overall Study|subject did not tolerate Consta|1|||
142970255|NCT00571688|515426951|FG001|Overall Study|subject did not tolerate Consta|0|||
142970256|NCT00571688|515426950|FG000|Overall Study|subject moved out of the area|1|||
142970257|NCT00571688|515426951|FG001|Overall Study|subject moved out of the area|0|||
142970258|NCT01397552|515426952|FG000|Overall Study|Adverse Event|1|||
142970259|NCT01397552|515426953|FG001|Overall Study|Adverse Event|0|||
142970260|NCT01397552|515426952|FG000|Overall Study|Withdrawal by Subject|2|||
142970261|NCT01397552|515426953|FG001|Overall Study|Withdrawal by Subject|1|||
142970262|NCT04580394|515426954|FG000|First Intervention|Incorrectly Randomized|1|||
142970263|NCT04580394|515426954|FG000|First Intervention|Physician Decision|1|||
142970264|NCT04580394|515426954|FG000|First Intervention|Lost to Follow-up|1|||
142970265|NCT04580394|515426954|FG000|Washout (One Week)|Withdrawal by Subject|1|||
142970266|NCT04580394|515426954|FG000|Washout (One Week)|Adverse Event|1|||
142970267|NCT04580394|515426954|FG000|Washout (One Week)|Withdrawal by Subject|2|||
142970268|NCT04580394|515426954|FG000|Third Intervention|Adverse Event|1|||
142970269|NCT04580394|515426954|FG000|Third Intervention|Withdrawal by Subject|1|||
142970270|NCT04580394|515426954|FG000|Washout (One Week)|Withdrawal by Subject|2|||
142970271|NCT04397718|515426957|FG000|Overall Study|Death|7|||
142970272|NCT04397718|515426958|FG001|Overall Study|Death|11|||
142970273|NCT04397718|515426957|FG000|Overall Study|Lost to Follow-up|0|||
142970274|NCT04397718|515426958|FG001|Overall Study|Lost to Follow-up|4|||
142970275|NCT00304915|515426959|FG000|Overall Study|Lost to Follow-up|11|||
142970276|NCT00304915|515426960|FG001|Overall Study|Lost to Follow-up|11|||
142970277|NCT00304915|515426959|FG000|Overall Study|Death|4|||
142970278|NCT00304915|515426960|FG001|Overall Study|Death|5|||
142970279|NCT00304915|515426959|FG000|Overall Study|Withdrawal by Subject|3|||
142970280|NCT00304915|515426960|FG001|Overall Study|Withdrawal by Subject|0|||
142970281|NCT01025817|515426961|FG000|Completed Study Medication|Adverse Event|66|||
142970282|NCT01025817|515426962|FG001|Completed Study Medication|Adverse Event|39|||
142970283|NCT01025817|515426961|FG000|Completed Study Medication|Protocol Deviation|9|||
142970284|NCT01025817|515426962|FG001|Completed Study Medication|Protocol Deviation|8|||
142970285|NCT01025817|515426961|FG000|Completed Study Medication|Withdrawal by Subject|8|||
142970286|NCT01025817|515426962|FG001|Completed Study Medication|Withdrawal by Subject|9|||
142970287|NCT01025817|515426961|FG000|Completed Study Medication|Administrative problems|7|||
142970288|NCT01025817|515426962|FG001|Completed Study Medication|Administrative problems|5|||
142970289|NCT01025817|515426961|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
142970290|NCT01025817|515426962|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
142970291|NCT01025817|515426961|FG000|Completed Study Medication|Abnormal test procedure|4|||
142970292|NCT01025817|515426962|FG001|Completed Study Medication|Abnormal test procedure|0|||
142970293|NCT01025817|515426961|FG000|Completed Study Medication|Graft loss|2|||
142970294|NCT01025817|515426962|FG001|Completed Study Medication|Graft loss|5|||
142970295|NCT01025817|515426961|FG000|Completed Study Medication|Death|2|||
142970296|NCT01025817|515426962|FG001|Completed Study Medication|Death|2|||
142970297|NCT01025817|515426961|FG000|Completed Study Medication|Abnormal lab values|0|||
142970298|NCT01025817|515426962|FG001|Completed Study Medication|Abnormal lab values|2|||
142970299|NCT01025817|515426961|FG000|Completed Study Medication|Subject no longer required study drug|0|||
142970300|NCT01025817|515426962|FG001|Completed Study Medication|Subject no longer required study drug|1|||
142970301|NCT01025817|515426961|FG000|Completed Study Medication|Lost to Follow-up|0|||
142970302|NCT01025817|515426962|FG001|Completed Study Medication|Lost to Follow-up|1|||
143003141|NCT01049360|515548753|FG009|Period 2|Adverse Event|0|||
142970303|NCT01025817|515426961|FG000|Completed Study|Withdrawal by Subject|8|||
142970304|NCT01025817|515426962|FG001|Completed Study|Withdrawal by Subject|16|||
142970305|NCT01025817|515426961|FG000|Completed Study|Death|6|||
142970306|NCT01025817|515426962|FG001|Completed Study|Death|5|||
142970307|NCT01025817|515426961|FG000|Completed Study|Missing|2|||
142970308|NCT01025817|515426962|FG001|Completed Study|Missing|0|||
142970309|NCT01025817|515426961|FG000|Completed Study|Lost to Follow-up|0|||
142970310|NCT01025817|515426962|FG001|Completed Study|Lost to Follow-up|1|||
142970311|NCT04799405|515426976|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
142970312|NCT01029002|515426977|FG000|Overall Study|Lost to Follow-up|2|||
142970313|NCT01029002|515426978|FG001|Overall Study|Lost to Follow-up|4|||
142970314|NCT02618928|515426981|FG000|Overall Study|Failure to Return|28|||
142970315|NCT02618928|515426981|FG000|Overall Study|Insufficient Virological Response|1|||
142970316|NCT02618928|515426981|FG000|Overall Study|Withdrawal by Subject|2|||
142970317|NCT02618928|515426981|FG000|Overall Study|Death|3|||
142970318|NCT02618928|515426981|FG000|Overall Study|Other|11|||
142970319|NCT02618928|515426981|FG000|Overall Study|Missing|6|||
142970320|NCT02618928|515426981|FG000|Overall Study|Treatment Never Started|7|||
142970321|NCT01096849|515426986|FG000|Overall Study|Consent Withdrawn|1|||
142970322|NCT01096849|515426987|FG001|Overall Study|Consent Withdrawn|4|||
142970323|NCT01096849|515426988|FG002|Overall Study|Consent Withdrawn|2|||
142970324|NCT01096849|515426986|FG000|Overall Study|Lack of Efficacy|0|||
142970325|NCT01096849|515426987|FG001|Overall Study|Lack of Efficacy|2|||
142970326|NCT01096849|515426988|FG002|Overall Study|Lack of Efficacy|0|||
142970327|NCT01096849|515426986|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
142970328|NCT01096849|515426987|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
142970329|NCT01096849|515426988|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
142970330|NCT01096849|515426986|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
142970331|NCT01096849|515426987|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
142970332|NCT01096849|515426988|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
142970333|NCT01096849|515426986|FG000|Overall Study|Administrative Reasons|0|||
142970334|NCT01096849|515426987|FG001|Overall Study|Administrative Reasons|1|||
142970335|NCT01096849|515426988|FG002|Overall Study|Administrative Reasons|2|||
142970336|NCT01096849|515426986|FG000|Overall Study|Lost to Follow-up|1|||
142970337|NCT01096849|515426987|FG001|Overall Study|Lost to Follow-up|3|||
142970338|NCT01096849|515426988|FG002|Overall Study|Lost to Follow-up|1|||
142970339|NCT00118482|515426990|FG000|Overall Study|Lost to Follow-up|7|||
142970340|NCT00118482|515426991|FG001|Overall Study|Lost to Follow-up|7|||
142970341|NCT00118482|515426990|FG000|Overall Study|Withdrawal by Subject|23|||
142970342|NCT00118482|515426991|FG001|Overall Study|Withdrawal by Subject|22|||
142970343|NCT00916370|515426993|FG000|Overall Study|Death|3|||
142970344|NCT00916370|515426994|FG001|Overall Study|Death|1|||
142970345|NCT00916370|515426993|FG000|Overall Study|Withdrawal by Subject|2|||
142970346|NCT00916370|515426994|FG001|Overall Study|Withdrawal by Subject|0|||
142970347|NCT00916370|515426993|FG000|Overall Study|Physician Decision|0|||
142970348|NCT00916370|515426994|FG001|Overall Study|Physician Decision|1|||
142970349|NCT02921919|515426996|FG000|Overall Study|Other|5|||
142970350|NCT02921919|515426997|FG001|Overall Study|Other|6|||
142970351|NCT02921919|515426996|FG000|Overall Study|Lost to Follow-up|0|||
142970352|NCT02921919|515426997|FG001|Overall Study|Lost to Follow-up|1|||
142970353|NCT02921919|515426996|FG000|Overall Study|Withdrawal by Subject|5|||
142970354|NCT02921919|515426997|FG001|Overall Study|Withdrawal by Subject|1|||
142970355|NCT02921919|515426996|FG000|Overall Study|Disease Progression|47|||
142970356|NCT02921919|515426997|FG001|Overall Study|Disease Progression|38|||
142970357|NCT02921919|515426996|FG000|Overall Study|Physician Decision|3|||
142970358|NCT02921919|515426997|FG001|Overall Study|Physician Decision|2|||
142970359|NCT02921919|515426996|FG000|Overall Study|Adverse Event|6|||
142970360|NCT02921919|515426997|FG001|Overall Study|Adverse Event|4|||
142970361|NCT00980980|515426998|FG000|Overall Study|Withdrawal by Hospital|0|||
142970362|NCT00980980|515426999|FG001|Overall Study|Withdrawal by Hospital|1|||
142970363|NCT00980980|515427000|FG002|Overall Study|Withdrawal by Hospital|0|||
142970364|NCT03666858|515427001|FG000|Cohort 1|Adverse Event|1|||
142970365|NCT03666858|515427002|FG001|Cohort 1|Adverse Event|0|||
142970366|NCT03666858|515427001|FG000|Cohort 2|Adverse Event|0|||
142970367|NCT03666858|515427002|FG001|Cohort 2|Adverse Event|1|||
142970368|NCT00121992|515427003|FG000|Overall Study|Treatment not received|2|||
142970369|NCT00121992|515427004|FG001|Overall Study|Treatment not received|11|||
142970370|NCT00414960|515427005|FG000|Overall Study|Adverse Event|4|||
142970371|NCT00414960|515427006|FG001|Overall Study|Adverse Event|0|||
142970372|NCT00414960|515427005|FG000|Overall Study|Withdrawal by Subject|3|||
142970373|NCT00414960|515427006|FG001|Overall Study|Withdrawal by Subject|0|||
142970374|NCT00414960|515427005|FG000|Overall Study|Physician Decision|0|||
142970375|NCT00414960|515427006|FG001|Overall Study|Physician Decision|1|||
142970376|NCT01608724|515427011|FG000|Overall Study|Withdrawal by Subject|131|||
142970377|NCT01608724|515427011|FG000|Overall Study|Lost to Follow-up|41|||
142970378|NCT01608724|515427011|FG000|Overall Study|Study-specific discontinuation criteria|32|||
142970379|NCT01608724|515427011|FG000|Overall Study|Adverse Event|29|||
142970380|NCT01608724|515427011|FG000|Overall Study|Protocol Violation|6|||
142970381|NCT01608724|515427011|FG000|Overall Study|bood sugar too high, etc.|3|||
142970382|NCT01608724|515427011|FG000|Overall Study|Safety reasons|1|||
142970383|NCT00363246|515427012|FG000|Overall Study|Death|40|||
142970384|NCT00363246|515427012|FG000|Overall Study|Withdrawal by Subject|19|||
142970385|NCT00363246|515427012|FG000|Overall Study|Lost to Follow-up|14|||
142970386|NCT00363246|515427012|FG000|Overall Study|Bad health|6|||
142970387|NCT00363246|515427012|FG000|Overall Study|Stopped using wheelchair|11|||
142970388|NCT00363246|515427012|FG000|Overall Study|Subject expressed security concerns|2|||
142970389|NCT00363246|515427012|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
142970390|NCT00099359|515427013|FG000|Overall Study|Death|11|||
142970391|NCT00099359|515427014|FG001|Overall Study|Death|15|||
142970392|NCT00099359|515427015|FG002|Overall Study|Death|17|||
142970393|NCT00099359|515427013|FG000|Overall Study|Withdrawal by Subject|19|||
142970394|NCT00099359|515427014|FG001|Overall Study|Withdrawal by Subject|19|||
142970395|NCT00099359|515427015|FG002|Overall Study|Withdrawal by Subject|23|||
142970396|NCT00099359|515427013|FG000|Overall Study|Lost to Follow-up|15|||
142970397|NCT00099359|515427014|FG001|Overall Study|Lost to Follow-up|24|||
142970398|NCT00099359|515427015|FG002|Overall Study|Lost to Follow-up|24|||
142970399|NCT00099359|515427013|FG000|Overall Study|moved out of area|9|||
142970400|NCT00099359|515427014|FG001|Overall Study|moved out of area|7|||
142970401|NCT00099359|515427015|FG002|Overall Study|moved out of area|4|||
142970402|NCT00717366|515427016|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
142970403|NCT00717366|515427017|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
142970404|NCT00717366|515427016|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
142970405|NCT00717366|515427017|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
142970406|NCT00717366|515427016|FG000|Core Study Period (20 Weeks)|Death|0|||
142970407|NCT00717366|515427017|FG001|Core Study Period (20 Weeks)|Death|1|||
142970408|NCT00717366|515427016|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
142970409|NCT00717366|515427017|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
142970410|NCT00717366|515427016|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
142970411|NCT00717366|515427017|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
142970412|NCT00717366|515427016|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
142970413|NCT00717366|515427017|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
142970414|NCT00717366|515427016|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
142970415|NCT00717366|515427017|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
142970416|NCT02756650|515427018|FG000|Overall Study|Physician Decision|1|||
142970417|NCT02756650|515427018|FG000|Overall Study|Adverse Event|1|||
142970418|NCT04348591|515427019|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
142970419|NCT04348591|515427020|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
142970420|NCT04348591|515427019|FG000|Imaging Session (120 Min)|Physician Decision|0|||
142970421|NCT04348591|515427020|FG001|Imaging Session (120 Min)|Physician Decision|1|||
142970422|NCT04348591|515427019|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
142970423|NCT04348591|515427020|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
142970424|NCT02104804|515427022|FG000|Overall Study|Did not take study medication|0|||
142970425|NCT02104804|515427023|FG001|Overall Study|Did not take study medication|1|||
142970426|NCT02104804|515427022|FG000|Overall Study|Study specific discontinuation criteria|6|||
142970427|NCT02104804|515427023|FG001|Overall Study|Study specific discontinuation criteria|1|||
142970428|NCT02104804|515427022|FG000|Overall Study|Other listed|2|||
142970429|NCT02104804|515427023|FG001|Overall Study|Other listed|1|||
142970430|NCT02104804|515427022|FG000|Overall Study|Protocol Violation|0|||
142970431|NCT02104804|515427023|FG001|Overall Study|Protocol Violation|1|||
142970432|NCT02104804|515427022|FG000|Overall Study|Adverse Event|4|||
142970433|NCT02104804|515427023|FG001|Overall Study|Adverse Event|3|||
142970434|NCT02104804|515427022|FG000|Overall Study|Withdrawal by Subject|4|||
142970435|NCT02104804|515427023|FG001|Overall Study|Withdrawal by Subject|12|||
142970436|NCT03722784|515427026|FG000|Overall Study|Withdrawal by Subject|1|||
142970437|NCT03722784|515427027|FG001|Overall Study|Withdrawal by Subject|0|||
142970438|NCT03722784|515427026|FG000|Overall Study|Physician Decision|1|||
142970439|NCT03722784|515427027|FG001|Overall Study|Physician Decision|1|||
142970440|NCT03722784|515427026|FG000|Overall Study|Protocol Violation|0|||
142970441|NCT03722784|515427027|FG001|Overall Study|Protocol Violation|1|||
142970442|NCT04501679|515427028|FG000|Overall Study|Pregnancy|0|||
142970443|NCT04501679|515427029|FG001|Overall Study|Pregnancy|1|||
142970444|NCT04501679|515427028|FG000|Overall Study|Adverse Event|4|||
142970445|NCT04501679|515427029|FG001|Overall Study|Adverse Event|2|||
142970446|NCT04501679|515427028|FG000|Overall Study|Withdrawal by Subject|2|||
143117153|NCT01273155|515970040|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
142970447|NCT04501679|515427029|FG001|Overall Study|Withdrawal by Subject|0|||
142970448|NCT04501679|515427028|FG000|Overall Study|Physician Decision|1|||
142970449|NCT04501679|515427029|FG001|Overall Study|Physician Decision|0|||
142970450|NCT04501679|515427028|FG000|Overall Study|Lost to Follow-up|2|||
142970451|NCT04501679|515427029|FG001|Overall Study|Lost to Follow-up|0|||
142970452|NCT02121756|515427036|FG000|Overall Study|Adverse Event|3|||
142970453|NCT02121756|515427037|FG001|Overall Study|Adverse Event|0|||
142970454|NCT02121756|515427036|FG000|Overall Study|Protocol Violation|1|||
142970455|NCT02121756|515427037|FG001|Overall Study|Protocol Violation|1|||
142970456|NCT02121756|515427036|FG000|Overall Study|Physician Decision|2|||
142970457|NCT02121756|515427037|FG001|Overall Study|Physician Decision|1|||
142970458|NCT00438399|515427039|FG000|Overall Study|Lost to Follow-up|2|||
142970459|NCT00438399|515427040|FG001|Overall Study|Lost to Follow-up|2|||
142970460|NCT00438399|515427041|FG002|Overall Study|Lost to Follow-up|1|||
142970461|NCT00438399|515427042|FG003|Overall Study|Lost to Follow-up|1|||
142970462|NCT00438399|515427043|FG004|Overall Study|Lost to Follow-up|1|||
142970463|NCT00438399|515427044|FG005|Overall Study|Lost to Follow-up|1|||
142970464|NCT00438399|515427039|FG000|Overall Study|Adverse Event|0|||
142970465|NCT00438399|515427040|FG001|Overall Study|Adverse Event|0|||
142970466|NCT00438399|515427041|FG002|Overall Study|Adverse Event|1|||
142970467|NCT00438399|515427042|FG003|Overall Study|Adverse Event|1|||
142970468|NCT00438399|515427043|FG004|Overall Study|Adverse Event|0|||
142970469|NCT00438399|515427044|FG005|Overall Study|Adverse Event|1|||
142970470|NCT00438399|515427039|FG000|Overall Study|Withdrawal by Subject|5|||
142970471|NCT00438399|515427040|FG001|Overall Study|Withdrawal by Subject|6|||
142970472|NCT00438399|515427041|FG002|Overall Study|Withdrawal by Subject|3|||
142970473|NCT00438399|515427042|FG003|Overall Study|Withdrawal by Subject|2|||
142970474|NCT00438399|515427043|FG004|Overall Study|Withdrawal by Subject|2|||
142970475|NCT00438399|515427044|FG005|Overall Study|Withdrawal by Subject|2|||
142970476|NCT00438399|515427039|FG000|Overall Study|Protocol Violation|0|||
142970477|NCT00438399|515427040|FG001|Overall Study|Protocol Violation|0|||
142970478|NCT00438399|515427041|FG002|Overall Study|Protocol Violation|1|||
142970479|NCT00438399|515427042|FG003|Overall Study|Protocol Violation|0|||
142970480|NCT00438399|515427043|FG004|Overall Study|Protocol Violation|0|||
142970481|NCT00438399|515427044|FG005|Overall Study|Protocol Violation|1|||
142970482|NCT00438399|515427039|FG000|Overall Study|Subje stopped study|0|||
142970483|NCT00438399|515427040|FG001|Overall Study|Subje stopped study|0|||
142970484|NCT00438399|515427041|FG002|Overall Study|Subje stopped study|1|||
142970485|NCT00438399|515427042|FG003|Overall Study|Subje stopped study|0|||
142970486|NCT00438399|515427043|FG004|Overall Study|Subje stopped study|0|||
142970487|NCT00438399|515427044|FG005|Overall Study|Subje stopped study|0|||
142970488|NCT00438399|515427039|FG000|Overall Study|Pregnancy|0|||
142970489|NCT00438399|515427040|FG001|Overall Study|Pregnancy|0|||
142970490|NCT00438399|515427041|FG002|Overall Study|Pregnancy|0|||
142970491|NCT00438399|515427042|FG003|Overall Study|Pregnancy|0|||
142970492|NCT00438399|515427043|FG004|Overall Study|Pregnancy|0|||
142970493|NCT00438399|515427044|FG005|Overall Study|Pregnancy|1|||
142970494|NCT00438399|515427039|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
142970495|NCT00438399|515427040|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
142970496|NCT00438399|515427041|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
142970497|NCT00438399|515427042|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
142970498|NCT00438399|515427043|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
142970499|NCT00438399|515427044|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
142970500|NCT02365584|515427046|FG000|Overall Study|Adverse Event|2|||
142970501|NCT02365584|515427047|FG001|Overall Study|Adverse Event|2|||
142970502|NCT02365584|515427046|FG000|Overall Study|Withdrawal by Subject|1|||
142970503|NCT02365584|515427047|FG001|Overall Study|Withdrawal by Subject|0|||
142970504|NCT02365584|515427046|FG000|Overall Study|Disease Progression|9|||
142970505|NCT02365584|515427047|FG001|Overall Study|Disease Progression|12|||
142970506|NCT05294211|515427049|FG000|Overall Study|Withdrawal by Subject|3|||
142970507|NCT05294211|515427049|FG000|Overall Study|Physician Decision|2|||
142970508|NCT05294211|515427049|FG000|Overall Study|Progressed to active labor|1|||
142970509|NCT05294211|515427049|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
142970510|NCT05294211|515427049|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
142970511|NCT00838916|515427050|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
142970512|NCT00838916|515427051|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
142970513|NCT00838916|515427050|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
142970514|NCT00838916|515427051|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
142970515|NCT00838916|515427050|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
142970516|NCT00838916|515427051|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
142970517|NCT00838916|515427050|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
142970518|NCT00838916|515427051|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
142970519|NCT00838916|515427050|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
142970520|NCT00838916|515427051|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
142970521|NCT00838916|515427050|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
142970522|NCT00838916|515427051|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
142970523|NCT00838916|515427050|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
142970524|NCT00838916|515427051|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
142970525|NCT00838916|515427050|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
142970526|NCT00838916|515427051|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
142970527|NCT00838916|515427050|FG000|Treatment Period (156 Weeks)|Missing|3|||
142970528|NCT00838916|515427051|FG001|Treatment Period (156 Weeks)|Missing|1|||
142970529|NCT00838916|515427050|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
142970530|NCT00838916|515427051|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
142970531|NCT00838916|515427050|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
142970532|NCT00838916|515427051|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
142970533|NCT00838916|515427050|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
142970534|NCT00838916|515427051|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
142970535|NCT00838916|515427050|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
142970536|NCT00838916|515427051|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
142970537|NCT00838916|515427050|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
143455522|NCT00560066|517212466|FG001|Overall Study|Withdrawal by Subject|3|||
143455523|NCT00560066|517212465|FG000|Overall Study|Lost to Follow-up|4|||
143455524|NCT00560066|517212466|FG001|Overall Study|Lost to Follow-up|10|||
143455525|NCT00560066|517212465|FG000|Overall Study|Protocol Violation|0|||
142970538|NCT00838916|515427051|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
142970539|NCT00838916|515427050|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
142970540|NCT00838916|515427051|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
142970541|NCT00838916|515427050|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
142970542|NCT00838916|515427051|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
142970543|NCT00838916|515427050|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
142970544|NCT00838916|515427051|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
142970545|NCT00838916|515427050|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
142970546|NCT00838916|515427051|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
142970547|NCT00838916|515427050|FG000|Follow-up Period (8 Weeks)|Missing|3|||
142970548|NCT00838916|515427051|FG001|Follow-up Period (8 Weeks)|Missing|0|||
142970549|NCT01842607|515427052|FG000|Overall Study|Adverse Event|11|||
142970550|NCT01842607|515427052|FG000|Overall Study|Lack of Efficacy|19|||
142970551|NCT01842607|515427052|FG000|Overall Study|Protocol Violation|8|||
142970552|NCT01842607|515427052|FG000|Overall Study|Protocol defined stopping criteria|2|||
142970553|NCT01842607|515427052|FG000|Overall Study|Lost to Follow-up|3|||
142970554|NCT01842607|515427052|FG000|Overall Study|Physician Decision|9|||
142970555|NCT01842607|515427052|FG000|Overall Study|Withdrawal by Subject|14|||
142970556|NCT02159469|515427053|FG000|Overall Study|Missing Completion status|1|||
142970557|NCT02159469|515427053|FG000|Overall Study|Adverse Event|5|||
142970558|NCT02159469|515427053|FG000|Overall Study|Non-compliance|2|||
142970559|NCT02159469|515427053|FG000|Overall Study|Withdrawal by Subject|9|||
142970560|NCT02159469|515427053|FG000|Overall Study|Lost to Follow-up|1|||
142970561|NCT02159469|515427053|FG000|Overall Study|Sponsor's request|2|||
142970562|NCT02159469|515427053|FG000|Overall Study|Met Stopping Criteria|3|||
142970563|NCT02159469|515427053|FG000|Overall Study|Other|1|||
142970564|NCT02159469|515427053|FG000|Overall Study|Multiple|29|||
142970565|NCT03629041|515427054|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
142970566|NCT03629041|515427055|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
142970567|NCT03629041|515427056|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
142970568|NCT03629041|515427057|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
142970569|NCT03730194|515427064|FG000|First Stage Treatment|Withdrawal by Subject|1|||
142970570|NCT03730194|515427065|FG001|First Stage Treatment|Withdrawal by Subject|1|||
142970571|NCT03730194|515427066|FG002|First Stage Treatment|Withdrawal by Subject|0|||
142970572|NCT03730194|515427067|FG003|First Stage Treatment|Withdrawal by Subject|0|||
142970573|NCT03730194|515427068|FG004|First Stage Treatment|Withdrawal by Subject|0|||
142970574|NCT03730194|515427069|FG005|First Stage Treatment|Withdrawal by Subject|0|||
142970575|NCT03730194|515427064|FG000|First Stage Treatment|Protocol Violation|3|||
142970576|NCT03730194|515427065|FG001|First Stage Treatment|Protocol Violation|3|||
142970577|NCT03730194|515427066|FG002|First Stage Treatment|Protocol Violation|0|||
142970578|NCT03730194|515427067|FG003|First Stage Treatment|Protocol Violation|0|||
142970579|NCT03730194|515427068|FG004|First Stage Treatment|Protocol Violation|0|||
142970580|NCT03730194|515427069|FG005|First Stage Treatment|Protocol Violation|0|||
142970581|NCT00115765|515427072|FG000|Overall Study|Withdrawal by Subject|22|||
142970582|NCT00115765|515427073|FG001|Overall Study|Withdrawal by Subject|53|||
143455526|NCT00560066|517212466|FG001|Overall Study|Protocol Violation|1|||
143455527|NCT00560066|517212465|FG000|Overall Study|Administrative reason|0|||
143455528|NCT00560066|517212466|FG001|Overall Study|Administrative reason|5|||
142970583|NCT00115765|515427074|FG002|Overall Study|Withdrawal by Subject|76|||
142970584|NCT00115765|515427075|FG003|Overall Study|Withdrawal by Subject|15|||
142970585|NCT00115765|515427072|FG000|Overall Study|Physician Decision|4|||
142970586|NCT00115765|515427073|FG001|Overall Study|Physician Decision|15|||
142970587|NCT00115765|515427074|FG002|Overall Study|Physician Decision|18|||
142970588|NCT00115765|515427075|FG003|Overall Study|Physician Decision|13|||
142970589|NCT00115765|515427072|FG000|Overall Study|Lost to Follow-up|3|||
142970590|NCT00115765|515427073|FG001|Overall Study|Lost to Follow-up|20|||
142970591|NCT00115765|515427074|FG002|Overall Study|Lost to Follow-up|18|||
142970592|NCT00115765|515427075|FG003|Overall Study|Lost to Follow-up|1|||
142970593|NCT00115765|515427072|FG000|Overall Study|Other|6|||
142970594|NCT00115765|515427073|FG001|Overall Study|Other|12|||
142970595|NCT00115765|515427074|FG002|Overall Study|Other|9|||
142970596|NCT00115765|515427075|FG003|Overall Study|Other|2|||
142970597|NCT00675103|515427076|FG000|Overall Study|Lack of Efficacy|2|||
142970598|NCT00675103|515427076|FG000|Overall Study|Adverse Event|1|||
142970599|NCT00808249|515427085|FG000|Overall Study|Adverse Event|4|||
142970600|NCT00808249|515427086|FG001|Overall Study|Adverse Event|7|||
142970601|NCT00808249|515427087|FG002|Overall Study|Adverse Event|10|||
142970602|NCT00808249|515427088|FG003|Overall Study|Adverse Event|6|||
142970603|NCT00808249|515427085|FG000|Overall Study|Lost to Follow-up|2|||
142970604|NCT00808249|515427086|FG001|Overall Study|Lost to Follow-up|3|||
142970605|NCT00808249|515427087|FG002|Overall Study|Lost to Follow-up|3|||
142970606|NCT00808249|515427088|FG003|Overall Study|Lost to Follow-up|5|||
142970607|NCT00808249|515427085|FG000|Overall Study|Withdrawal by Subject|4|||
142970608|NCT00808249|515427086|FG001|Overall Study|Withdrawal by Subject|0|||
142970609|NCT00808249|515427087|FG002|Overall Study|Withdrawal by Subject|2|||
142970610|NCT00808249|515427088|FG003|Overall Study|Withdrawal by Subject|4|||
142970611|NCT00808249|515427085|FG000|Overall Study|Protocol Violation|3|||
142970612|NCT00808249|515427086|FG001|Overall Study|Protocol Violation|3|||
142970613|NCT00808249|515427087|FG002|Overall Study|Protocol Violation|3|||
142970614|NCT00808249|515427088|FG003|Overall Study|Protocol Violation|0|||
142970615|NCT00808249|515427085|FG000|Overall Study|Lack of Efficacy|1|||
142970616|NCT00808249|515427086|FG001|Overall Study|Lack of Efficacy|1|||
142970617|NCT00808249|515427087|FG002|Overall Study|Lack of Efficacy|0|||
142970618|NCT00808249|515427088|FG003|Overall Study|Lack of Efficacy|0|||
142970619|NCT00808249|515427085|FG000|Overall Study|study specific discontinuation criteria|1|||
142970620|NCT00808249|515427086|FG001|Overall Study|study specific discontinuation criteria|0|||
142970621|NCT00808249|515427087|FG002|Overall Study|study specific discontinuation criteria|1|||
142970622|NCT00808249|515427088|FG003|Overall Study|study specific discontinuation criteria|0|||
142970623|NCT00808249|515427085|FG000|Overall Study|All other reasons|2|||
142970624|NCT00808249|515427086|FG001|Overall Study|All other reasons|1|||
142970625|NCT00808249|515427087|FG002|Overall Study|All other reasons|3|||
142970626|NCT00808249|515427088|FG003|Overall Study|All other reasons|1|||
142970627|NCT01511107|515427091|FG000|Overall Study|Ineligible|3|||
142970628|NCT01511107|515427092|FG001|Overall Study|Ineligible|2|||
142970629|NCT01511107|515427091|FG000|Overall Study|Lost to Follow-up|10|||
142970630|NCT01511107|515427092|FG001|Overall Study|Lost to Follow-up|19|||
142970631|NCT01511107|515427091|FG000|Overall Study|Withdrawal by Subject|9|||
142970632|NCT01511107|515427092|FG001|Overall Study|Withdrawal by Subject|20|||
142970633|NCT01146951|515428615|FG000|Overall Study|Adverse Event|4|||
142970634|NCT01146951|515428616|FG001|Overall Study|Adverse Event|1|||
142970635|NCT01747811|515428620|FG000|Overall Study|Lack of Efficacy|2|||
142970636|NCT01747811|515428621|FG001|Overall Study|Lack of Efficacy|4|||
142970637|NCT02064205|515428626|FG000|Overall Study|Withdrawal by Subject|1|||
142970638|NCT02700919|515428627|FG000|Overall Study|Physician Decision|1|||
142970639|NCT02700919|515428628|FG001|Overall Study|Physician Decision|0|||
142970640|NCT02700919|515428629|FG002|Overall Study|Physician Decision|0|||
142970641|NCT02700919|515428627|FG000|Overall Study|Protocol Violation|1|||
142970642|NCT02700919|515428628|FG001|Overall Study|Protocol Violation|0|||
142970643|NCT02700919|515428629|FG002|Overall Study|Protocol Violation|0|||
142970644|NCT02700919|515428627|FG000|Overall Study|Adverse Event|1|||
142970645|NCT02700919|515428628|FG001|Overall Study|Adverse Event|3|||
142970646|NCT02700919|515428629|FG002|Overall Study|Adverse Event|1|||
142970647|NCT02700919|515428627|FG000|Overall Study|Withdrawal by Subject|5|||
142970648|NCT02700919|515428628|FG001|Overall Study|Withdrawal by Subject|8|||
142970649|NCT02700919|515428629|FG002|Overall Study|Withdrawal by Subject|2|||
142970650|NCT02700919|515428627|FG000|Overall Study|Lost to Follow-up|2|||
142970651|NCT02700919|515428628|FG001|Overall Study|Lost to Follow-up|0|||
142970652|NCT02700919|515428629|FG002|Overall Study|Lost to Follow-up|0|||
142970653|NCT02700919|515428627|FG000|Overall Study|Other|2|||
142970654|NCT02700919|515428628|FG001|Overall Study|Other|1|||
143117154|NCT01273155|515970041|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
142970655|NCT02700919|515428629|FG002|Overall Study|Other|1|||
142970656|NCT03434418|515428630|FG000|Overall Study|Disease Progression|11|||
142970657|NCT03434418|515428630|FG000|Overall Study|Adverse Event|2|||
142970658|NCT03434418|515428630|FG000|Overall Study|Physician Decision|1|||
142970659|NCT03434418|515428630|FG000|Overall Study|Decline in Performance Status (PS)|1|||
142970660|NCT00696436|515428631|FG000|Overall Study|Adverse Event|7|||
142970661|NCT00696436|515428632|FG001|Overall Study|Adverse Event|9|||
142970662|NCT00696436|515428633|FG002|Overall Study|Adverse Event|8|||
142970663|NCT00696436|515428634|FG003|Overall Study|Adverse Event|6|||
142970664|NCT00696436|515428635|FG004|Overall Study|Adverse Event|4|||
142970665|NCT00696436|515428631|FG000|Overall Study|Protocol Violation|3|||
142970666|NCT00696436|515428632|FG001|Overall Study|Protocol Violation|2|||
142970667|NCT00696436|515428633|FG002|Overall Study|Protocol Violation|2|||
142970668|NCT00696436|515428634|FG003|Overall Study|Protocol Violation|0|||
142970669|NCT00696436|515428635|FG004|Overall Study|Protocol Violation|1|||
142970670|NCT00696436|515428631|FG000|Overall Study|Lost to Follow-up|1|||
142970671|NCT00696436|515428632|FG001|Overall Study|Lost to Follow-up|6|||
142970672|NCT00696436|515428633|FG002|Overall Study|Lost to Follow-up|2|||
142970673|NCT00696436|515428634|FG003|Overall Study|Lost to Follow-up|4|||
142970674|NCT00696436|515428635|FG004|Overall Study|Lost to Follow-up|3|||
142970675|NCT00696436|515428631|FG000|Overall Study|Withdrawal by Subject|4|||
142970676|NCT00696436|515428632|FG001|Overall Study|Withdrawal by Subject|11|||
142970677|NCT00696436|515428633|FG002|Overall Study|Withdrawal by Subject|5|||
142970678|NCT00696436|515428634|FG003|Overall Study|Withdrawal by Subject|7|||
142970679|NCT00696436|515428635|FG004|Overall Study|Withdrawal by Subject|1|||
142970680|NCT00696436|515428631|FG000|Overall Study|Lack of Efficacy|3|||
142970681|NCT00696436|515428632|FG001|Overall Study|Lack of Efficacy|1|||
142970682|NCT00696436|515428633|FG002|Overall Study|Lack of Efficacy|5|||
142970683|NCT00696436|515428634|FG003|Overall Study|Lack of Efficacy|2|||
142970684|NCT00696436|515428635|FG004|Overall Study|Lack of Efficacy|4|||
142970685|NCT00696436|515428631|FG000|Overall Study|Participant Unavailability|2|||
142970686|NCT00696436|515428632|FG001|Overall Study|Participant Unavailability|0|||
142970687|NCT00696436|515428633|FG002|Overall Study|Participant Unavailability|2|||
142970688|NCT00696436|515428634|FG003|Overall Study|Participant Unavailability|1|||
142970689|NCT00696436|515428635|FG004|Overall Study|Participant Unavailability|0|||
142970690|NCT00696436|515428631|FG000|Overall Study|Administrative Error|2|||
142970691|NCT00696436|515428632|FG001|Overall Study|Administrative Error|0|||
142970692|NCT00696436|515428633|FG002|Overall Study|Administrative Error|2|||
142970693|NCT00696436|515428634|FG003|Overall Study|Administrative Error|0|||
142970694|NCT00696436|515428635|FG004|Overall Study|Administrative Error|0|||
142970695|NCT00696436|515428631|FG000|Overall Study|Participant Non-compliance|0|||
142970696|NCT00696436|515428632|FG001|Overall Study|Participant Non-compliance|0|||
142970697|NCT00696436|515428633|FG002|Overall Study|Participant Non-compliance|1|||
142970698|NCT00696436|515428634|FG003|Overall Study|Participant Non-compliance|2|||
142970699|NCT00696436|515428635|FG004|Overall Study|Participant Non-compliance|0|||
142970700|NCT00696436|515428631|FG000|Overall Study|Administrative Decision|1|||
142970701|NCT00696436|515428632|FG001|Overall Study|Administrative Decision|0|||
142970702|NCT00696436|515428633|FG002|Overall Study|Administrative Decision|0|||
142970703|NCT00696436|515428634|FG003|Overall Study|Administrative Decision|0|||
142970704|NCT00696436|515428635|FG004|Overall Study|Administrative Decision|0|||
142970705|NCT00696436|515428631|FG000|Overall Study|Missing|0|||
142970706|NCT00696436|515428632|FG001|Overall Study|Missing|1|||
142970707|NCT00696436|515428633|FG002|Overall Study|Missing|1|||
142970708|NCT00696436|515428634|FG003|Overall Study|Missing|0|||
142970709|NCT00696436|515428635|FG004|Overall Study|Missing|0|||
142970710|NCT03039738|515428637|FG000|Overall Study|Incomplete data sets|54|||
142970711|NCT03039738|515428638|FG001|Overall Study|Incomplete data sets|0|||
142970712|NCT01517412|515428641|FG000|Overall Study|Adverse Event|10|||
142970713|NCT01517412|515428642|FG001|Overall Study|Adverse Event|11|||
142970714|NCT01517412|515428641|FG000|Overall Study|Lack of Efficacy|10|||
142970715|NCT01517412|515428642|FG001|Overall Study|Lack of Efficacy|5|||
142970716|NCT01517412|515428641|FG000|Overall Study|Poor compliance to protocol|8|||
142970717|NCT01517412|515428642|FG001|Overall Study|Poor compliance to protocol|3|||
142970718|NCT01517412|515428641|FG000|Overall Study|Other than specified above|8|||
142970719|NCT01517412|515428642|FG001|Overall Study|Other than specified above|5|||
142970720|NCT02062463|515428643|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
142970721|NCT02062463|515428644|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
142970722|NCT02062463|515428645|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
142970723|NCT02062463|515428646|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
142970724|NCT02062463|515428643|FG000|Stage 2|Adverse Event|0|||
142970725|NCT02062463|515428644|FG001|Stage 2|Adverse Event|0|||
142970726|NCT02062463|515428645|FG002|Stage 2|Adverse Event|12|||
142970727|NCT02062463|515428646|FG003|Stage 2|Adverse Event|20|||
142970728|NCT02062463|515428643|FG000|Stage 2|Lack of Efficacy|0|||
142970729|NCT02062463|515428644|FG001|Stage 2|Lack of Efficacy|0|||
142970730|NCT02062463|515428645|FG002|Stage 2|Lack of Efficacy|3|||
142970731|NCT02062463|515428646|FG003|Stage 2|Lack of Efficacy|4|||
142970732|NCT02062463|515428643|FG000|Stage 2|Lost to Follow-up|0|||
142970733|NCT02062463|515428644|FG001|Stage 2|Lost to Follow-up|0|||
142970734|NCT02062463|515428645|FG002|Stage 2|Lost to Follow-up|20|||
142970735|NCT02062463|515428646|FG003|Stage 2|Lost to Follow-up|20|||
143455529|NCT00560066|517212465|FG000|Overall Study|Missing primary reason|0|||
142970736|NCT02062463|515428643|FG000|Stage 2|Non-Compliance|0|||
142970737|NCT02062463|515428644|FG001|Stage 2|Non-Compliance|0|||
142970738|NCT02062463|515428645|FG002|Stage 2|Non-Compliance|0|||
142970739|NCT02062463|515428646|FG003|Stage 2|Non-Compliance|1|||
142970740|NCT02062463|515428643|FG000|Stage 2|Other than specified|0|||
142970741|NCT02062463|515428644|FG001|Stage 2|Other than specified|0|||
142970742|NCT02062463|515428645|FG002|Stage 2|Other than specified|3|||
142970743|NCT02062463|515428646|FG003|Stage 2|Other than specified|1|||
142970744|NCT02062463|515428643|FG000|Stage 2|Withdrawal by Subject|0|||
142970745|NCT02062463|515428644|FG001|Stage 2|Withdrawal by Subject|0|||
142970746|NCT02062463|515428645|FG002|Stage 2|Withdrawal by Subject|15|||
142970747|NCT02062463|515428646|FG003|Stage 2|Withdrawal by Subject|10|||
142970748|NCT00363051|515428656|FG000|Overall Study|Adminstrative problems|1|||
142970749|NCT00363051|515428657|FG001|Overall Study|Adminstrative problems|1|||
142970750|NCT00363051|515428656|FG000|Overall Study|Adverse Event|21|||
142970751|NCT00363051|515428657|FG001|Overall Study|Adverse Event|12|||
142970752|NCT00363051|515428656|FG000|Overall Study|New Cancer Therapy|2|||
142970753|NCT00363051|515428657|FG001|Overall Study|New Cancer Therapy|1|||
142970754|NCT00363051|515428656|FG000|Overall Study|Withdrawal by Subject|11|||
142970755|NCT00363051|515428657|FG001|Overall Study|Withdrawal by Subject|3|||
142970756|NCT00363051|515428656|FG000|Overall Study|Lost to Follow-up|0|||
142970757|NCT00363051|515428657|FG001|Overall Study|Lost to Follow-up|1|||
142970758|NCT00363051|515428656|FG000|Overall Study|Protocol Violation|0|||
142970759|NCT00363051|515428657|FG001|Overall Study|Protocol Violation|2|||
142970760|NCT00363051|515428656|FG000|Overall Study|Death|3|||
142970761|NCT00363051|515428657|FG001|Overall Study|Death|2|||
142970762|NCT00205699|515428660|FG000|Overall Study|Lost to Follow-up|1|||
142970763|NCT00205699|515428661|FG001|Overall Study|Lost to Follow-up|3|||
142970764|NCT00205699|515428662|FG002|Overall Study|Lost to Follow-up|5|||
142970765|NCT00205699|515428660|FG000|Overall Study|Adverse Event|1|||
142970766|NCT00205699|515428661|FG001|Overall Study|Adverse Event|0|||
142970767|NCT00205699|515428662|FG002|Overall Study|Adverse Event|0|||
142970768|NCT00205699|515428660|FG000|Overall Study|Withdrawal by Subject|1|||
142970769|NCT00205699|515428661|FG001|Overall Study|Withdrawal by Subject|2|||
142970770|NCT00205699|515428662|FG002|Overall Study|Withdrawal by Subject|1|||
142970771|NCT00205699|515428660|FG000|Overall Study|Lack of Efficacy|0|||
142970772|NCT00205699|515428661|FG001|Overall Study|Lack of Efficacy|1|||
142970773|NCT00205699|515428662|FG002|Overall Study|Lack of Efficacy|0|||
142970774|NCT00830115|515428666|FG000|Overall Study|Adverse Event|2|||
142970775|NCT00830115|515428666|FG000|Overall Study|Improvement/recovery|1|||
142970776|NCT01754922|515428677|FG000|Overall Study|Adverse Event|0|||
142970777|NCT01754922|515428678|FG001|Overall Study|Adverse Event|1|||
142970778|NCT01207388|515428679|FG000|Overall Study|Death|67|||
142970779|NCT01207388|515428679|FG000|Overall Study|Withdrawal by Subject|1|||
142970780|NCT01610076|515428680|FG000|Overall Study|Technical issue with video|0|||
142970781|NCT01610076|515428681|FG001|Overall Study|Technical issue with video|1|||
142970782|NCT01610076|515428680|FG000|Overall Study|Lost to Follow-up|3|||
142970783|NCT01610076|515428681|FG001|Overall Study|Lost to Follow-up|4|||
142970784|NCT01895452|515428685|FG000|Overall Study|Adverse Event|1|||
142970785|NCT01895452|515428686|FG001|Overall Study|Adverse Event|4|||
142970786|NCT01895452|515428685|FG000|Overall Study|Lost to Follow-up|1|||
142970787|NCT01895452|515428686|FG001|Overall Study|Lost to Follow-up|5|||
142970788|NCT01895452|515428685|FG000|Overall Study|Pregnancy|0|||
142970789|NCT01895452|515428686|FG001|Overall Study|Pregnancy|1|||
142970790|NCT01895452|515428685|FG000|Overall Study|Withdrawal by Subject|2|||
142970791|NCT01895452|515428686|FG001|Overall Study|Withdrawal by Subject|14|||
142970792|NCT01895452|515428685|FG000|Overall Study|Underlying disease|0|||
142970793|NCT01895452|515428686|FG001|Overall Study|Underlying disease|3|||
142970794|NCT01895452|515428685|FG000|Overall Study|Noncompliance with study drug|0|||
142970795|NCT01895452|515428686|FG001|Overall Study|Noncompliance with study drug|1|||
142970796|NCT01653158|515428687|FG000|Overall Study|Death|0|||
142970797|NCT01653158|515428688|FG001|Overall Study|Death|0|||
142970798|NCT01653158|515428689|FG002|Overall Study|Death|0|||
142970799|NCT01653158|515428690|FG003|Overall Study|Death|1|||
142970800|NCT01653158|515428691|FG004|Overall Study|Death|0|||
142970801|NCT01653158|515428692|FG005|Overall Study|Death|0|||
142970802|NCT01653158|515428693|FG006|Overall Study|Death|0|||
142970803|NCT01653158|515428694|FG007|Overall Study|Death|2|||
142970804|NCT01653158|515428687|FG000|Overall Study|Adverse Event|0|||
142970805|NCT01653158|515428688|FG001|Overall Study|Adverse Event|0|||
142970806|NCT01653158|515428689|FG002|Overall Study|Adverse Event|0|||
142970807|NCT01653158|515428690|FG003|Overall Study|Adverse Event|1|||
142970808|NCT01653158|515428691|FG004|Overall Study|Adverse Event|0|||
142970809|NCT01653158|515428692|FG005|Overall Study|Adverse Event|0|||
142970810|NCT01653158|515428693|FG006|Overall Study|Adverse Event|0|||
142970811|NCT01653158|515428694|FG007|Overall Study|Adverse Event|3|||
143455530|NCT00560066|517212466|FG001|Overall Study|Missing primary reason|2|||
143455531|NCT01435616|517212467|FG000|Overall Study|Adverse Event|39|||
142970812|NCT01653158|515428687|FG000|Overall Study|Other|0|||
142970813|NCT01653158|515428688|FG001|Overall Study|Other|0|||
142970814|NCT01653158|515428689|FG002|Overall Study|Other|0|||
142970815|NCT01653158|515428690|FG003|Overall Study|Other|0|||
142970816|NCT01653158|515428691|FG004|Overall Study|Other|0|||
142970817|NCT01653158|515428692|FG005|Overall Study|Other|0|||
142970818|NCT01653158|515428693|FG006|Overall Study|Other|0|||
142970819|NCT01653158|515428694|FG007|Overall Study|Other|1|||
142970820|NCT01653158|515428687|FG000|Overall Study|Progressive disease|0|||
142970821|NCT01653158|515428688|FG001|Overall Study|Progressive disease|0|||
142970822|NCT01653158|515428689|FG002|Overall Study|Progressive disease|0|||
142970823|NCT01653158|515428690|FG003|Overall Study|Progressive disease|0|||
142970824|NCT01653158|515428691|FG004|Overall Study|Progressive disease|1|||
142970825|NCT01653158|515428692|FG005|Overall Study|Progressive disease|1|||
142970826|NCT01653158|515428693|FG006|Overall Study|Progressive disease|2|||
142970827|NCT01653158|515428694|FG007|Overall Study|Progressive disease|9|||
142970828|NCT01653158|515428687|FG000|Overall Study|Withdrawal by Subject|1|||
142970829|NCT01653158|515428688|FG001|Overall Study|Withdrawal by Subject|0|||
142970830|NCT01653158|515428689|FG002|Overall Study|Withdrawal by Subject|0|||
142970831|NCT01653158|515428690|FG003|Overall Study|Withdrawal by Subject|0|||
142970832|NCT01653158|515428691|FG004|Overall Study|Withdrawal by Subject|0|||
142970833|NCT01653158|515428692|FG005|Overall Study|Withdrawal by Subject|0|||
142970834|NCT01653158|515428693|FG006|Overall Study|Withdrawal by Subject|0|||
142970835|NCT01653158|515428694|FG007|Overall Study|Withdrawal by Subject|0|||
142970836|NCT01194869|515428699|FG000|Overall Study|Disease Progression|2|||
142970837|NCT01194869|515428699|FG000|Overall Study|Toxicity|2|||
142970838|NCT04321252|515428700|FG000|Overall Study|Withdrawal by Subject|0|||
142970839|NCT04321252|515428701|FG001|Overall Study|Withdrawal by Subject|0|||
142970840|NCT04321252|515428702|FG002|Overall Study|Withdrawal by Subject|0|||
142970841|NCT04321252|515428703|FG003|Overall Study|Withdrawal by Subject|0|||
142970842|NCT04321252|515428704|FG004|Overall Study|Withdrawal by Subject|0|||
142970843|NCT04321252|515428705|FG005|Overall Study|Withdrawal by Subject|1|||
142970844|NCT04321252|515428706|FG006|Overall Study|Withdrawal by Subject|0|||
142970845|NCT04321252|515428707|FG007|Overall Study|Withdrawal by Subject|0|||
142970846|NCT04321252|515428708|FG008|Overall Study|Withdrawal by Subject|0|||
142970847|NCT00190983|515428711|FG000|Overall Study|Inevaluable (never treated)|2|||
142970848|NCT02287402|515428713|FG000|Treatment Period|Adverse Event|17|||
142970849|NCT02287402|515428713|FG000|Treatment Period|Voluntary Withdrawal|10|||
142970850|NCT02287402|515428713|FG000|Follow-up|Lost to Follow-up|1|||
142970851|NCT02287402|515428713|FG000|Follow-up|Voluntary Withdrawal|2|||
142970852|NCT01844830|515428714|FG000|Overall Study|Withdrawal by Subject|1|||
142970853|NCT01844830|515428715|FG001|Overall Study|Withdrawal by Subject|0|||
142970854|NCT04247815|515428716|FG000|Overall Study|Adverse Event|1|||
142970855|NCT04247815|515428717|FG001|Overall Study|Adverse Event|0|||
142970856|NCT04247815|515428716|FG000|Overall Study|Withdrawal by Subject|1|||
142970857|NCT04247815|515428717|FG001|Overall Study|Withdrawal by Subject|0|||
142970858|NCT04247815|515428716|FG000|Overall Study|Protocol Violation|0|||
142970859|NCT04247815|515428717|FG001|Overall Study|Protocol Violation|1|||
142970860|NCT01658579|515428734|FG000|Treatment Period A|Other|0|||
142970861|NCT01658579|515428735|FG001|Treatment Period A|Other|0|||
142970862|NCT01658579|515428736|FG002|Treatment Period A|Other|1|||
142970863|NCT01658579|515428737|FG003|Treatment Period A|Other|1|||
142970864|NCT01658579|515428734|FG000|Treatment Period A|Adverse Event|1|||
142970865|NCT01658579|515428735|FG001|Treatment Period A|Adverse Event|0|||
142970866|NCT01658579|515428736|FG002|Treatment Period A|Adverse Event|0|||
142970867|NCT01658579|515428737|FG003|Treatment Period A|Adverse Event|0|||
142970868|NCT01658579|515428734|FG000|Treatment Period B|Other|0|||
142970869|NCT01658579|515428735|FG001|Treatment Period B|Other|0|||
142970870|NCT01658579|515428736|FG002|Treatment Period B|Other|0|||
142970871|NCT01658579|515428737|FG003|Treatment Period B|Other|1|||
142970872|NCT01464788|515428738|FG000|Overall Study|Lost to Follow-up|0|||
142970873|NCT01464788|515428739|FG001|Overall Study|Lost to Follow-up|1|||
142970874|NCT01464788|515428740|FG002|Overall Study|Lost to Follow-up|0|||
142970875|NCT01464788|515428738|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
142970876|NCT01464788|515428739|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
142970877|NCT01464788|515428740|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
142970878|NCT00973921|515428741|FG000|Overall Study|IVUS results were not available|9|||
142970879|NCT02120157|515428742|FG000|Overall Study|Death|8|||
142970880|NCT01153893|515428745|FG000|Overall Study|Adverse Event|1|||
142970881|NCT01153893|515428746|FG001|Overall Study|Adverse Event|0|||
142970882|NCT01354431|515428747|FG000|Pre-Treatment Period|Not reported|1|||
142970883|NCT01354431|515428748|FG001|Pre-Treatment Period|Not reported|0|||
142970884|NCT01354431|515428749|FG002|Pre-Treatment Period|Not reported|0|||
142970885|NCT01354431|515428747|FG000|Treatment Period|Disease Progression|50|||
142970886|NCT01354431|515428748|FG001|Treatment Period|Disease Progression|40|||
142970887|NCT01354431|515428749|FG002|Treatment Period|Disease Progression|44|||
142970888|NCT01354431|515428747|FG000|Treatment Period|Study Drug Toxicity|5|||
142970889|NCT01354431|515428748|FG001|Treatment Period|Study Drug Toxicity|8|||
142970890|NCT01354431|515428749|FG002|Treatment Period|Study Drug Toxicity|4|||
142970891|NCT01354431|515428747|FG000|Treatment Period|Death|0|||
143455532|NCT01435616|517212468|FG001|Overall Study|Adverse Event|21|||
142970892|NCT01354431|515428748|FG001|Treatment Period|Death|1|||
142970893|NCT01354431|515428749|FG002|Treatment Period|Death|0|||
142970894|NCT01354431|515428747|FG000|Treatment Period|AE unrelated to study drug|1|||
142970895|NCT01354431|515428748|FG001|Treatment Period|AE unrelated to study drug|2|||
142970896|NCT01354431|515428749|FG002|Treatment Period|AE unrelated to study drug|5|||
142970897|NCT01354431|515428747|FG000|Treatment Period|Participant request to discontinue|2|||
142970898|NCT01354431|515428748|FG001|Treatment Period|Participant request to discontinue|2|||
142970899|NCT01354431|515428749|FG002|Treatment Period|Participant request to discontinue|1|||
142970900|NCT01354431|515428747|FG000|Treatment Period|Participant withdrew consent|0|||
142970901|NCT01354431|515428748|FG001|Treatment Period|Participant withdrew consent|1|||
142970902|NCT01354431|515428749|FG002|Treatment Period|Participant withdrew consent|0|||
142970903|NCT01354431|515428747|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
142970904|NCT01354431|515428748|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
142970905|NCT01354431|515428749|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
142970906|NCT01599754|515428750|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
142970907|NCT01599754|515428751|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
142970908|NCT01599754|515428750|FG000|Overall Study|Participant noncompliance|4|||
142970909|NCT01599754|515428751|FG001|Overall Study|Participant noncompliance|4|||
142970910|NCT01599754|515428750|FG000|Overall Study|Lost to Follow-up|13|||
142970911|NCT01599754|515428751|FG001|Overall Study|Lost to Follow-up|6|||
142970912|NCT01599754|515428750|FG000|Overall Study|Death|31|||
142970913|NCT01599754|515428751|FG001|Overall Study|Death|33|||
142970914|NCT01599754|515428750|FG000|Overall Study|Adverse Event|3|||
142970915|NCT01599754|515428751|FG001|Overall Study|Adverse Event|2|||
142970916|NCT01599754|515428750|FG000|Overall Study|Investigator decision|1|||
142970917|NCT01599754|515428751|FG001|Overall Study|Investigator decision|3|||
142970918|NCT01599754|515428750|FG000|Overall Study|Withdrawal by Subject|24|||
142970919|NCT01599754|515428751|FG001|Overall Study|Withdrawal by Subject|25|||
142970920|NCT01599754|515428750|FG000|Overall Study|Study terminated by sponsor|282|||
142970921|NCT01599754|515428751|FG001|Overall Study|Study terminated by sponsor|285|||
142970922|NCT01551758|515428760|FG000|Overall Study|Adverse Event|29|||
142970923|NCT01551758|515428761|FG001|Overall Study|Adverse Event|43|||
142970924|NCT01551758|515428760|FG000|Overall Study|Lack of Efficacy|0|||
142970925|NCT01551758|515428761|FG001|Overall Study|Lack of Efficacy|1|||
142970926|NCT01551758|515428760|FG000|Overall Study|Protocol Violation|5|||
142970927|NCT01551758|515428761|FG001|Overall Study|Protocol Violation|6|||
142970928|NCT01551758|515428760|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
142970929|NCT01551758|515428761|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
142970930|NCT01551758|515428760|FG000|Overall Study|Lost to Follow-up|29|||
142970931|NCT01551758|515428761|FG001|Overall Study|Lost to Follow-up|25|||
142970932|NCT01551758|515428760|FG000|Overall Study|Physician Decision|9|||
142970933|NCT01551758|515428761|FG001|Overall Study|Physician Decision|3|||
142970934|NCT01551758|515428760|FG000|Overall Study|Withdrawal by Subject|14|||
142970935|NCT01551758|515428761|FG001|Overall Study|Withdrawal by Subject|17|||
142970936|NCT03670641|515428762|FG000|Overall Study|Lost to Follow-up|3|||
142970937|NCT01232894|515428763|FG000|Overall Study|Lost to Follow-up|0|||
142970938|NCT01232894|515428764|FG001|Overall Study|Lost to Follow-up|1|||
142970939|NCT01232894|515428763|FG000|Overall Study|Death|1|||
142970940|NCT01232894|515428764|FG001|Overall Study|Death|0|||
142970941|NCT01232894|515428763|FG000|Overall Study|Protocol Violation|1|||
142970942|NCT01232894|515428764|FG001|Overall Study|Protocol Violation|1|||
142970943|NCT01232894|515428763|FG000|Overall Study|Withdrawal by Subject|8|||
142970944|NCT01232894|515428764|FG001|Overall Study|Withdrawal by Subject|5|||
142970945|NCT01232894|515428763|FG000|Overall Study|Physician Decision|2|||
142970946|NCT01232894|515428764|FG001|Overall Study|Physician Decision|1|||
142970947|NCT01255306|515430606|FG000|Overall Study|Physician Decision|1|||
142970948|NCT01255306|515430607|FG001|Overall Study|Physician Decision|1|||
142970949|NCT01179347|515430608|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
142970950|NCT01179347|515430609|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
142970951|NCT01179347|515430608|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
142970952|NCT01179347|515430609|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
142970953|NCT01179347|515430608|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
142970954|NCT01179347|515430609|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
142970955|NCT01179347|515430608|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
142970956|NCT01179347|515430609|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
142970957|NCT01179347|515430608|FG000|Double-blind Period (12 Weeks)|Other|2|||
142970958|NCT01179347|515430609|FG001|Double-blind Period (12 Weeks)|Other|4|||
142970959|NCT01179347|515430608|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
142970960|NCT01179347|515430609|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
142970961|NCT01179347|515430608|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
142970962|NCT01179347|515430609|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
142970963|NCT01179347|515430608|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
142970964|NCT01179347|515430609|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
142970965|NCT01179347|515430608|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
142970966|NCT01179347|515430609|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
142970967|NCT01179347|515430608|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
142970968|NCT01179347|515430609|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
142970969|NCT01179347|515430608|FG000|Open-label Period (12 Weeks)|Other|7|||
142970970|NCT01179347|515430609|FG001|Open-label Period (12 Weeks)|Other|4|||
142970971|NCT01337167|515430610|FG000|Infant Series|Adverse Event|1|||
142970972|NCT01337167|515430611|FG001|Infant Series|Adverse Event|1|||
142970973|NCT01337167|515430610|FG000|Infant Series|Death|1|||
143117155|NCT01273155|515970042|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
143117156|NCT01273155|515970043|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
142970974|NCT01337167|515430611|FG001|Infant Series|Death|1|||
142970975|NCT01337167|515430610|FG000|Infant Series|Lost to Follow-up|13|||
142970976|NCT01337167|515430611|FG001|Infant Series|Lost to Follow-up|7|||
142970977|NCT01337167|515430610|FG000|Infant Series|Non-compliance with study drug|2|||
142970978|NCT01337167|515430611|FG001|Infant Series|Non-compliance with study drug|1|||
142970979|NCT01337167|515430610|FG000|Infant Series|Physician Decision|3|||
142970980|NCT01337167|515430611|FG001|Infant Series|Physician Decision|1|||
142970981|NCT01337167|515430610|FG000|Infant Series|Protocol Violation|22|||
142970982|NCT01337167|515430611|FG001|Infant Series|Protocol Violation|9|||
142970983|NCT01337167|515430610|FG000|Infant Series|Withdrawal by Subject|15|||
142970984|NCT01337167|515430611|FG001|Infant Series|Withdrawal by Subject|4|||
142970985|NCT01337167|515430610|FG000|Infant Series|Randomized but not vaccinated|5|||
142970986|NCT01337167|515430611|FG001|Infant Series|Randomized but not vaccinated|3|||
142970987|NCT01337167|515430610|FG000|Interim Period|Lost to Follow-up|51|||
142970988|NCT01337167|515430611|FG001|Interim Period|Lost to Follow-up|23|||
142970989|NCT01337167|515430610|FG000|Interim Period|Non-compliance with study drug|1|||
142970990|NCT01337167|515430611|FG001|Interim Period|Non-compliance with study drug|0|||
142970991|NCT01337167|515430610|FG000|Interim Period|Physician Decision|6|||
142970992|NCT01337167|515430611|FG001|Interim Period|Physician Decision|3|||
142970993|NCT01337167|515430610|FG000|Interim Period|Protocol Violation|5|||
142970994|NCT01337167|515430611|FG001|Interim Period|Protocol Violation|3|||
142970995|NCT01337167|515430610|FG000|Interim Period|Withdrawal by Subject|18|||
142970996|NCT01337167|515430611|FG001|Interim Period|Withdrawal by Subject|10|||
142970997|NCT01337167|515430610|FG000|Interim Period|Other protocol criterion not met|0|||
142970998|NCT01337167|515430611|FG001|Interim Period|Other protocol criterion not met|1|||
142970999|NCT01337167|515430610|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
142971000|NCT01337167|515430611|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
142971001|NCT01337167|515430610|FG000|Toddler Vaccinations|Protocol Violation|0|||
142971002|NCT01337167|515430611|FG001|Toddler Vaccinations|Protocol Violation|1|||
142971003|NCT01337167|515430610|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
142971004|NCT01337167|515430611|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
142971005|NCT03363919|515430614|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
142971006|NCT03363919|515430615|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
142971007|NCT03363919|515430614|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
142971008|NCT03363919|515430615|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
142971009|NCT01646398|515430616|FG000|Overall Study|Withdrawal by Subject|1|||
142971010|NCT01646398|515430617|FG001|Overall Study|Withdrawal by Subject|0|||
142971011|NCT01827319|515430618|FG000|Overall Study|Lost to Follow-up|3|||
142971012|NCT00571519|515430619|FG000|Overall Study|Subject withdrew consent|0|||
142971013|NCT00571519|515430620|FG001|Overall Study|Subject withdrew consent|1|||
142971014|NCT00571519|515430621|FG002|Overall Study|Subject withdrew consent|0|||
142971015|NCT00571519|515430622|FG003|Overall Study|Subject withdrew consent|2|||
142971016|NCT00571519|515430623|FG004|Overall Study|Subject withdrew consent|1|||
142971017|NCT00571519|515430624|FG005|Overall Study|Subject withdrew consent|1|||
142971018|NCT00571519|515430625|FG006|Overall Study|Subject withdrew consent|2|||
142971019|NCT00571519|515430619|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
142971020|NCT00571519|515430620|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
142971021|NCT00571519|515430621|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
142971022|NCT00571519|515430622|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
142971023|NCT00571519|515430623|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
142971024|NCT00571519|515430624|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
142971025|NCT00571519|515430625|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
142971026|NCT00571519|515430619|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
142971027|NCT00571519|515430620|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
142971028|NCT00571519|515430621|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
142971029|NCT00571519|515430622|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
142971030|NCT00571519|515430623|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
142971031|NCT00571519|515430624|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
142971032|NCT00571519|515430625|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
142971033|NCT00571519|515430619|FG000|Overall Study|Termination of study by Sponsor|2|||
142971034|NCT00571519|515430620|FG001|Overall Study|Termination of study by Sponsor|7|||
142971035|NCT00571519|515430621|FG002|Overall Study|Termination of study by Sponsor|10|||
142971036|NCT00571519|515430622|FG003|Overall Study|Termination of study by Sponsor|24|||
142971037|NCT00571519|515430623|FG004|Overall Study|Termination of study by Sponsor|8|||
142971038|NCT00571519|515430624|FG005|Overall Study|Termination of study by Sponsor|9|||
142971039|NCT00571519|515430625|FG006|Overall Study|Termination of study by Sponsor|22|||
142971040|NCT00571519|515430619|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
142971041|NCT00571519|515430620|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
142971042|NCT00571519|515430621|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
142971043|NCT00571519|515430622|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
142971044|NCT00571519|515430623|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
142971045|NCT00571519|515430624|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
142971046|NCT00571519|515430625|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
142971047|NCT03947255|515430627|FG000|Overall Study|Study Closure by Sponsor|2|||
142971048|NCT03947255|515430628|FG001|Overall Study|Study Closure by Sponsor|2|||
142971049|NCT03947255|515430627|FG000|Overall Study|Withdrawal by Subject|2|||
142971050|NCT03947255|515430628|FG001|Overall Study|Withdrawal by Subject|2|||
142971051|NCT03947255|515430627|FG000|Overall Study|Lost to Follow-up|2|||
142971052|NCT03947255|515430628|FG001|Overall Study|Lost to Follow-up|0|||
142971053|NCT03947255|515430627|FG000|Overall Study|Death|0|||
142971054|NCT03947255|515430628|FG001|Overall Study|Death|2|||
142971055|NCT02499575|515430629|FG000|Overall Study|Protocol Violation|0|||
142971056|NCT02499575|515430630|FG001|Overall Study|Protocol Violation|1|||
142971057|NCT00574119|515430631|FG000|Overall Study|Adverse Event|1|||
142971058|NCT00574119|515430631|FG000|Overall Study|Protocol Violation|1|||
142971059|NCT00574119|515430631|FG000|Overall Study|Withdrawal by Subject|1|||
142971060|NCT00574119|515430631|FG000|Overall Study|Physician Decision|1|||
142971061|NCT04656418|515430639|FG000|Overall Study|Withdrawal by Subject|1|||
142971062|NCT04656418|515430640|FG001|Overall Study|Withdrawal by Subject|3|||
142971063|NCT02586077|515430641|FG000|Overall Study|Withdrawal by Subject|1|||
142971064|NCT02586077|515430641|FG000|Overall Study|Physician Decision|4|||
142971065|NCT02586077|515430641|FG000|Overall Study|Lost to Follow-up|3|||
142971066|NCT01245764|515430642|FG000|Study Phase A|Other|3|||
142971067|NCT01245764|515430643|FG001|Study Phase A|Other|2|||
142971068|NCT01245764|515430644|FG002|Study Phase A|Other|3|||
142971069|NCT01245764|515430645|FG003|Study Phase A|Other|1|||
142971070|NCT01245764|515430642|FG000|Study Phase A|Protocol Violation|6|||
142971071|NCT01245764|515430643|FG001|Study Phase A|Protocol Violation|3|||
142971072|NCT01245764|515430644|FG002|Study Phase A|Protocol Violation|2|||
142971073|NCT01245764|515430645|FG003|Study Phase A|Protocol Violation|2|||
142971074|NCT01245764|515430642|FG000|Study Phase A|Lost to Follow-up|0|||
142971075|NCT01245764|515430643|FG001|Study Phase A|Lost to Follow-up|0|||
142971076|NCT01245764|515430644|FG002|Study Phase A|Lost to Follow-up|5|||
142971077|NCT01245764|515430645|FG003|Study Phase A|Lost to Follow-up|0|||
142971078|NCT00003476|515430646|FG000|Overall Study|Not evaluable|1|||
142971079|NCT02475850|515430647|FG000|Overall Study|Death|155|||
142971080|NCT02475850|515430648|FG001|Overall Study|Death|141|||
142971081|NCT02475850|515430647|FG000|Overall Study|Lost to Follow-up|217|||
142971082|NCT02475850|515430648|FG001|Overall Study|Lost to Follow-up|188|||
142971083|NCT02475850|515430647|FG000|Overall Study|Withdrawal by Subject|221|||
142971084|NCT02475850|515430648|FG001|Overall Study|Withdrawal by Subject|155|||
142971085|NCT00781963|515430653|FG000|Overall Study|Death|3|||
142971086|NCT00781963|515430654|FG001|Overall Study|Death|0|||
142971087|NCT00781963|515430653|FG000|Overall Study|Lost to Follow-up|2|||
142971088|NCT00781963|515430654|FG001|Overall Study|Lost to Follow-up|1|||
142971089|NCT00781963|515430653|FG000|Overall Study|Withdrawal by Subject|3|||
142971090|NCT00781963|515430654|FG001|Overall Study|Withdrawal by Subject|1|||
142971091|NCT00781963|515430653|FG000|Overall Study|Refused follow-up|9|||
142971092|NCT00781963|515430654|FG001|Overall Study|Refused follow-up|0|||
142971093|NCT03297216|515430655|FG000|Overall Study|Death|0|||
142971094|NCT03297216|515430656|FG001|Overall Study|Death|1|||
142971095|NCT03297216|515430655|FG000|Overall Study|Miscarriage|0|||
142971096|NCT03297216|515430656|FG001|Overall Study|Miscarriage|2|||
142971097|NCT03297216|515430655|FG000|Overall Study|Lost to Follow-up|3|||
142971098|NCT03297216|515430656|FG001|Overall Study|Lost to Follow-up|2|||
142971099|NCT00912340|515430662|FG000|Overall Study|Adverse Event|2|||
142971100|NCT00912340|515430663|FG001|Overall Study|Adverse Event|4|||
142971101|NCT00912340|515430664|FG002|Overall Study|Adverse Event|0|||
142971102|NCT00912340|515430662|FG000|Overall Study|Protocol revised to remove arm|0|||
142971103|NCT00912340|515430663|FG001|Overall Study|Protocol revised to remove arm|0|||
142971104|NCT00912340|515430664|FG002|Overall Study|Protocol revised to remove arm|4|||
142971105|NCT01830816|515430671|FG000|Overall Study|Progressive Disease|12|||
142971106|NCT01830816|515430672|FG001|Overall Study|Progressive Disease|7|||
142971107|NCT01830816|515430673|FG002|Overall Study|Progressive Disease|7|||
142971108|NCT01830816|515430671|FG000|Overall Study|Adverse Event|3|||
142971109|NCT01830816|515430672|FG001|Overall Study|Adverse Event|4|||
142971110|NCT01830816|515430673|FG002|Overall Study|Adverse Event|0|||
142971111|NCT01830816|515430671|FG000|Overall Study|Study Terminated by Sponsor|1|||
142971112|NCT01830816|515430672|FG001|Overall Study|Study Terminated by Sponsor|1|||
142971113|NCT01830816|515430673|FG002|Overall Study|Study Terminated by Sponsor|0|||
142971114|NCT01830816|515430671|FG000|Overall Study|Withdrawal by Subject|1|||
142971115|NCT01830816|515430672|FG001|Overall Study|Withdrawal by Subject|1|||
142971116|NCT01830816|515430673|FG002|Overall Study|Withdrawal by Subject|0|||
142971117|NCT01830816|515430671|FG000|Overall Study|Lost to Follow-up|0|||
142971118|NCT01830816|515430672|FG001|Overall Study|Lost to Follow-up|1|||
142971119|NCT01830816|515430673|FG002|Overall Study|Lost to Follow-up|0|||
142971120|NCT01830816|515430671|FG000|Overall Study|Symptomatic Deterioration|1|||
142971121|NCT01830816|515430672|FG001|Overall Study|Symptomatic Deterioration|0|||
142971122|NCT01830816|515430673|FG002|Overall Study|Symptomatic Deterioration|0|||
142971123|NCT01830816|515430671|FG000|Overall Study|Reason not Specified|2|||
142971124|NCT01830816|515430672|FG001|Overall Study|Reason not Specified|0|||
142971125|NCT01830816|515430673|FG002|Overall Study|Reason not Specified|0|||
142971126|NCT04124692|515430674|FG000|Overall Study|Medical reason|0|||
143117157|NCT01273155|515970044|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
142971127|NCT04124692|515430675|FG001|Overall Study|Medical reason|1|||
142971128|NCT04124692|515430674|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
142971129|NCT04124692|515430675|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
142971130|NCT04124692|515430674|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
142971131|NCT04124692|515430675|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
142971132|NCT04124692|515430674|FG000|Overall Study|Lost to Follow-up|2|||
142971133|NCT04124692|515430675|FG001|Overall Study|Lost to Follow-up|4|||
142971134|NCT04124692|515430674|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
142971135|NCT04124692|515430675|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
142971136|NCT02716194|515430676|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
142971137|NCT02716194|515430677|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
142971138|NCT02716194|515430678|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
142971139|NCT01925612|515430682|FG000|Overall Study|Progressive Disease|1|||
142971140|NCT01925612|515430683|FG001|Overall Study|Progressive Disease|1|||
142971141|NCT01925612|515430684|FG002|Overall Study|Progressive Disease|1|||
142971142|NCT01925612|515430685|FG003|Overall Study|Progressive Disease|0|||
142971143|NCT01925612|515430686|FG004|Overall Study|Progressive Disease|0|||
142971144|NCT01925612|515430682|FG000|Overall Study|Adverse Event|3|||
142971145|NCT01925612|515430683|FG001|Overall Study|Adverse Event|3|||
142971146|NCT01925612|515430684|FG002|Overall Study|Adverse Event|0|||
142971147|NCT01925612|515430685|FG003|Overall Study|Adverse Event|1|||
142971148|NCT01925612|515430686|FG004|Overall Study|Adverse Event|2|||
142971149|NCT01677507|515430690|FG000|Initial Assignment|Adverse Event|0|||
142971150|NCT01677507|515430691|FG001|Initial Assignment|Adverse Event|1|||
142971151|NCT01677507|515430690|FG000|Initial Assignment|Protocol Violation|0|||
142971152|NCT01677507|515430691|FG001|Initial Assignment|Protocol Violation|1|||
142971153|NCT01677507|515430690|FG000|Second Assigment|Withdrawal by Subject|2|||
142971154|NCT01677507|515430691|FG001|Second Assigment|Withdrawal by Subject|2|||
142971155|NCT01677507|515430690|FG000|Second Assigment|Adverse Event|1|||
142971156|NCT01677507|515430691|FG001|Second Assigment|Adverse Event|3|||
142971157|NCT00259740|515430692|FG000|Overall Study|Physician Decision|1|||
142971158|NCT00259740|515430693|FG001|Overall Study|Physician Decision|1|||
142971159|NCT00259740|515430692|FG000|Overall Study|Adverse Event|0|||
142971160|NCT00259740|515430693|FG001|Overall Study|Adverse Event|2|||
142971161|NCT00259740|515430692|FG000|Overall Study|Withdrawal by Subject|2|||
142971162|NCT00259740|515430693|FG001|Overall Study|Withdrawal by Subject|6|||
142971163|NCT00259740|515430692|FG000|Overall Study|Death|1|||
142971164|NCT00259740|515430693|FG001|Overall Study|Death|1|||
142971165|NCT00259740|515430692|FG000|Overall Study|Disease progression|19|||
142971166|NCT00259740|515430693|FG001|Overall Study|Disease progression|36|||
142971167|NCT00259740|515430692|FG000|Overall Study|Ongoing|17|||
142971168|NCT00259740|515430693|FG001|Overall Study|Ongoing|3|||
142971169|NCT00259740|515430692|FG000|Overall Study|Other|3|||
142971170|NCT00259740|515430693|FG001|Overall Study|Other|0|||
142971171|NCT00259740|515430692|FG000|Overall Study|Requirement for alternative therapy|0|||
142971172|NCT00259740|515430693|FG001|Overall Study|Requirement for alternative therapy|4|||
142971173|NCT03495453|515430694|FG000|Overall Study|Withdrawal by Subject|0|||
142971174|NCT03495453|515430695|FG001|Overall Study|Withdrawal by Subject|1|||
142971175|NCT01360762|515430700|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
142971176|NCT01360762|515430700|FG000|Main Study Period (12-month Treatment)|Death|5|||
142971177|NCT01360762|515430700|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
142971178|NCT01360762|515430700|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
142971179|NCT01360762|515430700|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
142971180|NCT01360762|515430700|FG000|Whole Study Period|Lost to Follow-up|10|||
142971181|NCT01360762|515430700|FG000|Whole Study Period|Death|7|||
142971182|NCT01360762|515430700|FG000|Whole Study Period|Patient relapsed|18|||
142971183|NCT01360762|515430700|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
142971184|NCT03341923|515430701|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
142971185|NCT03341923|515430702|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
142971186|NCT02767856|515430714|FG000|Overall Study|Lost to Follow-up|9|||
142971187|NCT02767856|515430715|FG001|Overall Study|Lost to Follow-up|1|||
142971188|NCT02767856|515430714|FG000|Overall Study|Withdrawal by Subject|2|||
143455533|NCT01435616|517212467|FG000|Overall Study|Death|7|||
143455534|NCT01435616|517212468|FG001|Overall Study|Death|2|||
143455535|NCT01435616|517212467|FG000|Overall Study|Lost to Follow-up|22|||
143455536|NCT01435616|517212468|FG001|Overall Study|Lost to Follow-up|13|||
143455537|NCT01435616|517212467|FG000|Overall Study|Protocol Violation|16|||
143455538|NCT01435616|517212468|FG001|Overall Study|Protocol Violation|13|||
143455539|NCT01435616|517212467|FG000|Overall Study|Withdrawal by Subject|66|||
143455540|NCT01435616|517212468|FG001|Overall Study|Withdrawal by Subject|24|||
143455541|NCT01435616|517212467|FG000|Overall Study|Physician Decision|20|||
143455542|NCT01435616|517212468|FG001|Overall Study|Physician Decision|7|||
143455543|NCT01435616|517212467|FG000|Overall Study|Sponsor Decision|1|||
143455544|NCT01435616|517212468|FG001|Overall Study|Sponsor Decision|0|||
142971189|NCT02767856|515430715|FG001|Overall Study|Withdrawal by Subject|1|||
142971190|NCT00091026|515430716|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
142971191|NCT00091026|515430717|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
143455545|NCT02442336|517212476|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
142971192|NCT00091026|515430716|FG000|Overall Study|Patient withdrew and never received trea|0|||
142971193|NCT00091026|515430717|FG001|Overall Study|Patient withdrew and never received trea|2|||
142971194|NCT00091026|515430716|FG000|Overall Study|Unknown-never received treatment|0|||
142971195|NCT00091026|515430717|FG001|Overall Study|Unknown-never received treatment|1|||
142971196|NCT01797965|515430720|FG000|Overall Study|Adverse Event|104|||
142971197|NCT01797965|515430721|FG001|Overall Study|Adverse Event|129|||
142971198|NCT01797965|515430722|FG002|Overall Study|Adverse Event|4|||
142971199|NCT01797965|515430723|FG003|Overall Study|Adverse Event|21|||
142971200|NCT01797965|515430720|FG000|Overall Study|Lost to Follow-up|9|||
142971201|NCT01797965|515430721|FG001|Overall Study|Lost to Follow-up|8|||
142971202|NCT01797965|515430722|FG002|Overall Study|Lost to Follow-up|1|||
142971203|NCT01797965|515430723|FG003|Overall Study|Lost to Follow-up|2|||
142971204|NCT01797965|515430720|FG000|Overall Study|Consent withdrawn|130|||
142971205|NCT01797965|515430721|FG001|Overall Study|Consent withdrawn|117|||
142971206|NCT01797965|515430722|FG002|Overall Study|Consent withdrawn|3|||
142971207|NCT01797965|515430723|FG003|Overall Study|Consent withdrawn|35|||
142971208|NCT01797965|515430720|FG000|Overall Study|Investigator decision|21|||
142971209|NCT01797965|515430721|FG001|Overall Study|Investigator decision|15|||
142971210|NCT01797965|515430722|FG002|Overall Study|Investigator decision|0|||
142971211|NCT01797965|515430723|FG003|Overall Study|Investigator decision|0|||
142971212|NCT01797965|515430720|FG000|Overall Study|Death|2|||
142971213|NCT01797965|515430721|FG001|Overall Study|Death|4|||
142971214|NCT01797965|515430722|FG002|Overall Study|Death|0|||
142971215|NCT01797965|515430723|FG003|Overall Study|Death|0|||
142971216|NCT01797965|515430720|FG000|Overall Study|Disease progression, defined by protocol|3|||
142971217|NCT01797965|515430721|FG001|Overall Study|Disease progression, defined by protocol|1|||
142971218|NCT01797965|515430722|FG002|Overall Study|Disease progression, defined by protocol|0|||
142971219|NCT01797965|515430723|FG003|Overall Study|Disease progression, defined by protocol|0|||
143455546|NCT02442336|517212476|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
143455547|NCT02442336|517212476|FG000|Overall Study|Lost to Follow-up|11|||
142971220|NCT01797965|515430720|FG000|Overall Study|Reason Not Specified|280|||
142971221|NCT01797965|515430721|FG001|Overall Study|Reason Not Specified|295|||
142971222|NCT01797965|515430722|FG002|Overall Study|Reason Not Specified|0|||
142971223|NCT01797965|515430723|FG003|Overall Study|Reason Not Specified|15|||
142971224|NCT00702052|515430724|FG000|Overall Study|Adverse Event|23|||
143455548|NCT04602221|517212477|FG000|Overall Study|Discontinuation of trial treatment|0|||
143455549|NCT04602221|517212478|FG001|Overall Study|Discontinuation of trial treatment|0|||
143455550|NCT04602221|517212479|FG002|Overall Study|Discontinuation of trial treatment|1|||
143455551|NCT04602221|517212480|FG003|Overall Study|Discontinuation of trial treatment|0|||
143455552|NCT04602221|517212481|FG004|Overall Study|Discontinuation of trial treatment|0|||
143455553|NCT04602221|517212482|FG005|Overall Study|Discontinuation of trial treatment|0|||
143455554|NCT04602221|517212483|FG006|Overall Study|Discontinuation of trial treatment|0|||
143455555|NCT04602221|517212484|FG007|Overall Study|Discontinuation of trial treatment|0|||
143455556|NCT04602221|517212485|FG008|Overall Study|Discontinuation of trial treatment|0|||
143455557|NCT04602221|517212486|FG009|Overall Study|Discontinuation of trial treatment|0|||
143455558|NCT04602221|517212487|FG010|Overall Study|Discontinuation of trial treatment|0|||
143455559|NCT04602221|517212488|FG011|Overall Study|Discontinuation of trial treatment|0|||
143455560|NCT04602221|517212489|FG012|Overall Study|Discontinuation of trial treatment|0|||
143455561|NCT04602221|517212490|FG013|Overall Study|Discontinuation of trial treatment|0|||
143455562|NCT04602221|517212491|FG014|Overall Study|Discontinuation of trial treatment|0|||
143455563|NCT04602221|517212492|FG015|Overall Study|Discontinuation of trial treatment|0|||
143455564|NCT04602221|517212493|FG016|Overall Study|Discontinuation of trial treatment|0|||
143455565|NCT04602221|517212494|FG017|Overall Study|Discontinuation of trial treatment|0|||
143455566|NCT04602221|517212477|FG000|Overall Study|Other than listed|0|||
143455567|NCT04602221|517212478|FG001|Overall Study|Other than listed|0|||
143455568|NCT04602221|517212479|FG002|Overall Study|Other than listed|0|||
143455569|NCT04602221|517212480|FG003|Overall Study|Other than listed|0|||
143455570|NCT04602221|517212481|FG004|Overall Study|Other than listed|0|||
143455571|NCT04602221|517212482|FG005|Overall Study|Other than listed|0|||
143455572|NCT04602221|517212483|FG006|Overall Study|Other than listed|0|||
143455573|NCT04602221|517212484|FG007|Overall Study|Other than listed|0|||
143455574|NCT04602221|517212485|FG008|Overall Study|Other than listed|0|||
143455575|NCT04602221|517212486|FG009|Overall Study|Other than listed|0|||
143455576|NCT04602221|517212487|FG010|Overall Study|Other than listed|0|||
143455577|NCT04602221|517212488|FG011|Overall Study|Other than listed|0|||
143455578|NCT04602221|517212489|FG012|Overall Study|Other than listed|0|||
143455579|NCT04602221|517212490|FG013|Overall Study|Other than listed|0|||
143455580|NCT04602221|517212491|FG014|Overall Study|Other than listed|0|||
143455581|NCT04602221|517212492|FG015|Overall Study|Other than listed|1|||
143455582|NCT04602221|517212493|FG016|Overall Study|Other than listed|0|||
143455583|NCT04602221|517212494|FG017|Overall Study|Other than listed|1|||
143455584|NCT04602221|517212477|FG000|Overall Study|Withdrawal by Subject|0|||
143455585|NCT04602221|517212478|FG001|Overall Study|Withdrawal by Subject|0|||
143455586|NCT04602221|517212479|FG002|Overall Study|Withdrawal by Subject|0|||
143455587|NCT04602221|517212480|FG003|Overall Study|Withdrawal by Subject|0|||
142971225|NCT00702052|515430724|FG000|Overall Study|Disease Progression|30|||
142971226|NCT00702052|515430724|FG000|Overall Study|Withdrawal by Subject|5|||
142971227|NCT00242580|515430726|FG000|Overall Study|Adverse Event|3|||
142971228|NCT00242580|515430727|FG001|Overall Study|Adverse Event|0|||
142971229|NCT00242580|515430728|FG002|Overall Study|Adverse Event|2|||
142971230|NCT00242580|515430726|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
142971231|NCT00242580|515430727|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
142971232|NCT00242580|515430728|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
142971233|NCT00242580|515430726|FG000|Overall Study|Protocol Violation|0|||
142971234|NCT00242580|515430727|FG001|Overall Study|Protocol Violation|0|||
142971235|NCT00242580|515430728|FG002|Overall Study|Protocol Violation|1|||
142971236|NCT00242580|515430726|FG000|Overall Study|Subject withdrew consent|2|||
142971237|NCT00242580|515430727|FG001|Overall Study|Subject withdrew consent|2|||
142971238|NCT00242580|515430728|FG002|Overall Study|Subject withdrew consent|5|||
142971239|NCT00242580|515430726|FG000|Overall Study|Lost to Follow-up|0|||
142971240|NCT00242580|515430727|FG001|Overall Study|Lost to Follow-up|3|||
142971241|NCT00242580|515430728|FG002|Overall Study|Lost to Follow-up|0|||
142971242|NCT00242580|515430726|FG000|Overall Study|Death|1|||
142971243|NCT00242580|515430727|FG001|Overall Study|Death|2|||
142971244|NCT00242580|515430728|FG002|Overall Study|Death|1|||
142971245|NCT03970395|515430731|FG000|Overall Study|Withdrawal by Subject|3|||
142971246|NCT03970395|515430732|FG001|Overall Study|Withdrawal by Subject|4|||
142971247|NCT03970395|515430731|FG000|Overall Study|Lost to Follow-up|4|||
142971248|NCT03970395|515430732|FG001|Overall Study|Lost to Follow-up|8|||
142971249|NCT00929734|515430733|FG000|Overall Study|Lost to Follow-up|2|||
142971250|NCT00929734|515430734|FG001|Overall Study|Lost to Follow-up|1|||
142971251|NCT00929734|515430733|FG000|Overall Study|Withdrawal by Subject|0|||
142971252|NCT00929734|515430734|FG001|Overall Study|Withdrawal by Subject|2|||
142971253|NCT03282357|515430735|FG000|Overall Study|Lost to Follow-up|3|||
142971254|NCT03282357|515430735|FG000|Overall Study|Withdrawal by Subject|4|||
142971255|NCT03282357|515430735|FG000|Overall Study|Adverse Event|1|||
142971256|NCT03282357|515430735|FG000|Overall Study|Other|9|||
142971257|NCT01318512|515430736|FG000|Maintenance Period (6 Months)|Death|2|||
142971258|NCT01318512|515430736|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
142971259|NCT01822691|515430739|FG000|Overall Study|Withdrawal by Subject|2|||
142971260|NCT01553916|515430740|FG000|Overall Study|Withdrawal by Subject|2|||
142971261|NCT01553916|515430740|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
142971262|NCT00910429|515430745|FG000|Overall Study|Death|18|||
142971263|NCT00910429|515430746|FG001|Overall Study|Death|12|||
142971264|NCT00910429|515430745|FG000|Overall Study|Withdrawal by Subject|3|||
142971265|NCT00910429|515430746|FG001|Overall Study|Withdrawal by Subject|2|||
142971266|NCT00910429|515430745|FG000|Overall Study|Protocol Violation|1|||
142971267|NCT00910429|515430746|FG001|Overall Study|Protocol Violation|0|||
142971268|NCT00910429|515430745|FG000|Overall Study|Lost to Follow-up|2|||
142971269|NCT00910429|515430746|FG001|Overall Study|Lost to Follow-up|1|||
142971270|NCT00910429|515430745|FG000|Overall Study|Adverse Event|10|||
142971271|NCT00910429|515430746|FG001|Overall Study|Adverse Event|5|||
142971272|NCT00910429|515430745|FG000|Overall Study|Drug non-compliance|1|||
142971273|NCT00910429|515430746|FG001|Overall Study|Drug non-compliance|0|||
142971274|NCT00910429|515430745|FG000|Overall Study|Lack of Efficacy|4|||
142971275|NCT00910429|515430746|FG001|Overall Study|Lack of Efficacy|1|||
142971276|NCT01317615|515430747|FG000|Overall Study|Disease progression|25|||
142971277|NCT01317615|515430747|FG000|Overall Study|New cancer therapy|5|||
142971278|NCT01317615|515430747|FG000|Overall Study|Death|6|||
142971279|NCT01317615|515430747|FG000|Overall Study|Withdrawal by Subject|5|||
142971280|NCT01317615|515430747|FG000|Overall Study|Abnormal laboratory value(s)|1|||
142971281|NCT01317615|515430747|FG000|Overall Study|Adverse Event|7|||
142971282|NCT04465396|515430750|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
142971283|NCT04465396|515430751|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
142971284|NCT04465396|515430752|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
142971285|NCT04465396|515430753|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
142971286|NCT02648724|515430755|FG000|Overall Study|Withdrawal by Subject|0|||
142971287|NCT02648724|515430756|FG001|Overall Study|Withdrawal by Subject|1|||
142971288|NCT02648724|515430757|FG002|Overall Study|Withdrawal by Subject|1|||
142971289|NCT02648724|515430758|FG003|Overall Study|Withdrawal by Subject|0|||
142971290|NCT02648724|515430759|FG004|Overall Study|Withdrawal by Subject|1|||
142971291|NCT02648724|515430760|FG005|Overall Study|Withdrawal by Subject|0|||
142971292|NCT02648724|515430761|FG006|Overall Study|Withdrawal by Subject|0|||
142971293|NCT02648724|515430755|FG000|Overall Study|Progressive disease|2|||
142971294|NCT02648724|515430756|FG001|Overall Study|Progressive disease|2|||
142971295|NCT02648724|515430757|FG002|Overall Study|Progressive disease|2|||
142971296|NCT02648724|515430758|FG003|Overall Study|Progressive disease|3|||
142971297|NCT02648724|515430759|FG004|Overall Study|Progressive disease|22|||
142971298|NCT02648724|515430760|FG005|Overall Study|Progressive disease|7|||
142971299|NCT02648724|515430761|FG006|Overall Study|Progressive disease|8|||
142971300|NCT02648724|515430755|FG000|Overall Study|Other reason (unknown)|1|||
142971301|NCT02648724|515430756|FG001|Overall Study|Other reason (unknown)|0|||
142971302|NCT02648724|515430757|FG002|Overall Study|Other reason (unknown)|0|||
142971303|NCT02648724|515430758|FG003|Overall Study|Other reason (unknown)|0|||
142971304|NCT02648724|515430759|FG004|Overall Study|Other reason (unknown)|0|||
142971305|NCT02648724|515430760|FG005|Overall Study|Other reason (unknown)|0|||
142971306|NCT02648724|515430761|FG006|Overall Study|Other reason (unknown)|0|||
142971307|NCT02648724|515430755|FG000|Overall Study|Protocol Violation|0|||
142971308|NCT02648724|515430756|FG001|Overall Study|Protocol Violation|0|||
142971309|NCT02648724|515430757|FG002|Overall Study|Protocol Violation|0|||
142971310|NCT02648724|515430758|FG003|Overall Study|Protocol Violation|0|||
142971311|NCT02648724|515430759|FG004|Overall Study|Protocol Violation|1|||
142971312|NCT02648724|515430760|FG005|Overall Study|Protocol Violation|0|||
142971313|NCT02648724|515430761|FG006|Overall Study|Protocol Violation|0|||
142971314|NCT02648724|515430755|FG000|Overall Study|Death|0|||
142971315|NCT02648724|515430756|FG001|Overall Study|Death|0|||
142971316|NCT02648724|515430757|FG002|Overall Study|Death|0|||
142971317|NCT02648724|515430758|FG003|Overall Study|Death|0|||
142971318|NCT02648724|515430759|FG004|Overall Study|Death|0|||
142971319|NCT02648724|515430760|FG005|Overall Study|Death|0|||
142971320|NCT02648724|515430761|FG006|Overall Study|Death|3|||
142971321|NCT02648724|515430755|FG000|Overall Study|Physician Decision|0|||
142971322|NCT02648724|515430756|FG001|Overall Study|Physician Decision|0|||
142971323|NCT02648724|515430757|FG002|Overall Study|Physician Decision|0|||
142971324|NCT02648724|515430758|FG003|Overall Study|Physician Decision|0|||
142971325|NCT02648724|515430759|FG004|Overall Study|Physician Decision|1|||
142971326|NCT02648724|515430760|FG005|Overall Study|Physician Decision|0|||
142971327|NCT02648724|515430761|FG006|Overall Study|Physician Decision|1|||
142971328|NCT02648724|515430755|FG000|Overall Study|Transferred to named patient program|0|||
142971329|NCT02648724|515430756|FG001|Overall Study|Transferred to named patient program|0|||
142971330|NCT02648724|515430757|FG002|Overall Study|Transferred to named patient program|0|||
142971331|NCT02648724|515430758|FG003|Overall Study|Transferred to named patient program|0|||
142971332|NCT02648724|515430759|FG004|Overall Study|Transferred to named patient program|0|||
142971333|NCT02648724|515430760|FG005|Overall Study|Transferred to named patient program|1|||
142971334|NCT02648724|515430761|FG006|Overall Study|Transferred to named patient program|0|||
142971335|NCT03076190|515430762|FG000|Overall Study|Lost to Follow-up|9|||
142971336|NCT03076190|515430763|FG001|Overall Study|Lost to Follow-up|34|||
142971337|NCT03076190|515430762|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
142971338|NCT03076190|515430763|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
142971339|NCT00819585|515430764|FG000|Core Study|Adverse Event|2|||
142971340|NCT00819585|515430765|FG001|Core Study|Adverse Event|1|||
142971341|NCT00819585|515430766|FG002|Core Study|Adverse Event|1|||
142971342|NCT00819585|515430767|FG003|Core Study|Adverse Event|4|||
142971343|NCT00819585|515430768|FG004|Core Study|Adverse Event|1|||
142971344|NCT00819585|515430769|FG005|Core Study|Adverse Event|0|||
142971345|NCT00819585|515430770|FG006|Core Study|Adverse Event|2|||
142971346|NCT00819585|515430771|FG007|Core Study|Adverse Event|0|||
142971347|NCT00819585|515430772|FG008|Core Study|Adverse Event|0|||
142971348|NCT00819585|515430773|FG009|Core Study|Adverse Event|0|||
142971349|NCT00819585|515430774|FG010|Core Study|Adverse Event|0|||
142971350|NCT00819585|515430764|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
142971351|NCT00819585|515430765|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
142971352|NCT00819585|515430766|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
142971353|NCT00819585|515430767|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
142971354|NCT00819585|515430768|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
142971355|NCT00819585|515430769|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
142971356|NCT00819585|515430770|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
142971357|NCT00819585|515430771|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
142971358|NCT00819585|515430772|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
142971359|NCT00819585|515430773|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
142971360|NCT00819585|515430774|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
142971361|NCT00819585|515430764|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
142971362|NCT00819585|515430765|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
142971363|NCT00819585|515430766|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
142971364|NCT00819585|515430767|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
142971365|NCT00819585|515430768|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
142971366|NCT00819585|515430769|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
142971367|NCT00819585|515430770|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
142971368|NCT00819585|515430771|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
142971369|NCT00819585|515430772|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
142971370|NCT00819585|515430773|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
142971371|NCT00819585|515430774|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
142971372|NCT00819585|515430764|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
142971373|NCT00819585|515430765|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
142971374|NCT00819585|515430766|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
142971375|NCT00819585|515430767|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
142971376|NCT00819585|515430768|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
142971377|NCT00819585|515430769|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
142971378|NCT00819585|515430770|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
142971379|NCT00819585|515430771|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
142971380|NCT00819585|515430772|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
142971381|NCT00819585|515430773|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
142971382|NCT00819585|515430774|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
142971383|NCT00819585|515430764|FG000|Core Study|Subject Withdrew Consent|0|||
142971384|NCT00819585|515430765|FG001|Core Study|Subject Withdrew Consent|3|||
142971385|NCT00819585|515430766|FG002|Core Study|Subject Withdrew Consent|2|||
142971386|NCT00819585|515430767|FG003|Core Study|Subject Withdrew Consent|1|||
142971387|NCT00819585|515430768|FG004|Core Study|Subject Withdrew Consent|0|||
142971388|NCT00819585|515430769|FG005|Core Study|Subject Withdrew Consent|0|||
142971389|NCT00819585|515430770|FG006|Core Study|Subject Withdrew Consent|3|||
142971390|NCT00819585|515430771|FG007|Core Study|Subject Withdrew Consent|0|||
142971391|NCT00819585|515430772|FG008|Core Study|Subject Withdrew Consent|0|||
142971392|NCT00819585|515430773|FG009|Core Study|Subject Withdrew Consent|0|||
142971393|NCT00819585|515430774|FG010|Core Study|Subject Withdrew Consent|0|||
142971394|NCT00819585|515430764|FG000|Core Study|Lost to Follow-up|2|||
142971395|NCT00819585|515430765|FG001|Core Study|Lost to Follow-up|1|||
142971396|NCT00819585|515430766|FG002|Core Study|Lost to Follow-up|2|||
142971397|NCT00819585|515430767|FG003|Core Study|Lost to Follow-up|0|||
142971398|NCT00819585|515430768|FG004|Core Study|Lost to Follow-up|1|||
142971399|NCT00819585|515430769|FG005|Core Study|Lost to Follow-up|1|||
142971400|NCT00819585|515430770|FG006|Core Study|Lost to Follow-up|1|||
142971401|NCT00819585|515430771|FG007|Core Study|Lost to Follow-up|0|||
142971402|NCT00819585|515430772|FG008|Core Study|Lost to Follow-up|0|||
142971403|NCT00819585|515430773|FG009|Core Study|Lost to Follow-up|0|||
142971404|NCT00819585|515430774|FG010|Core Study|Lost to Follow-up|0|||
142971405|NCT00819585|515430764|FG000|Core Study|Administrative Problems|0|||
142971406|NCT00819585|515430765|FG001|Core Study|Administrative Problems|0|||
142971407|NCT00819585|515430766|FG002|Core Study|Administrative Problems|0|||
142971408|NCT00819585|515430767|FG003|Core Study|Administrative Problems|0|||
142971409|NCT00819585|515430768|FG004|Core Study|Administrative Problems|0|||
142971410|NCT00819585|515430769|FG005|Core Study|Administrative Problems|0|||
142971411|NCT00819585|515430770|FG006|Core Study|Administrative Problems|2|||
142971412|NCT00819585|515430771|FG007|Core Study|Administrative Problems|0|||
142971413|NCT00819585|515430772|FG008|Core Study|Administrative Problems|0|||
142971414|NCT00819585|515430773|FG009|Core Study|Administrative Problems|0|||
142971415|NCT00819585|515430774|FG010|Core Study|Administrative Problems|0|||
142971416|NCT00819585|515430764|FG000|Core Study|Death|0|||
142971417|NCT00819585|515430765|FG001|Core Study|Death|0|||
142971418|NCT00819585|515430766|FG002|Core Study|Death|0|||
142971419|NCT00819585|515430767|FG003|Core Study|Death|0|||
142971420|NCT00819585|515430768|FG004|Core Study|Death|0|||
142971421|NCT00819585|515430769|FG005|Core Study|Death|0|||
142971422|NCT00819585|515430770|FG006|Core Study|Death|1|||
142971423|NCT00819585|515430771|FG007|Core Study|Death|0|||
142971424|NCT00819585|515430772|FG008|Core Study|Death|0|||
142971425|NCT00819585|515430773|FG009|Core Study|Death|0|||
142971426|NCT00819585|515430774|FG010|Core Study|Death|0|||
142971427|NCT00819585|515430764|FG000|Core Study|Protocol Violation|0|||
142971428|NCT00819585|515430765|FG001|Core Study|Protocol Violation|0|||
142971429|NCT00819585|515430766|FG002|Core Study|Protocol Violation|1|||
142971430|NCT00819585|515430767|FG003|Core Study|Protocol Violation|0|||
142971431|NCT00819585|515430768|FG004|Core Study|Protocol Violation|0|||
142971432|NCT00819585|515430769|FG005|Core Study|Protocol Violation|1|||
142971433|NCT00819585|515430770|FG006|Core Study|Protocol Violation|3|||
142971434|NCT00819585|515430771|FG007|Core Study|Protocol Violation|0|||
142971435|NCT00819585|515430772|FG008|Core Study|Protocol Violation|0|||
142971436|NCT00819585|515430773|FG009|Core Study|Protocol Violation|0|||
142971437|NCT00819585|515430774|FG010|Core Study|Protocol Violation|0|||
142971438|NCT00819585|515430764|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
142971439|NCT00819585|515430765|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
142971440|NCT00819585|515430766|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
142971441|NCT00819585|515430767|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
142971442|NCT00819585|515430768|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
142971443|NCT00819585|515430769|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
142971444|NCT00819585|515430770|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
142971445|NCT00819585|515430771|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
142971446|NCT00819585|515430772|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
142971447|NCT00819585|515430773|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
142971448|NCT00819585|515430774|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
142971449|NCT00819585|515430764|FG000|Extension Study|Subject Withdrew Consent|0|||
142971450|NCT00819585|515430765|FG001|Extension Study|Subject Withdrew Consent|0|||
142971451|NCT00819585|515430766|FG002|Extension Study|Subject Withdrew Consent|0|||
142971452|NCT00819585|515430767|FG003|Extension Study|Subject Withdrew Consent|0|||
142971453|NCT00819585|515430768|FG004|Extension Study|Subject Withdrew Consent|0|||
142971454|NCT00819585|515430769|FG005|Extension Study|Subject Withdrew Consent|0|||
142971455|NCT00819585|515430770|FG006|Extension Study|Subject Withdrew Consent|0|||
142971456|NCT00819585|515430771|FG007|Extension Study|Subject Withdrew Consent|0|||
142971457|NCT00819585|515430772|FG008|Extension Study|Subject Withdrew Consent|3|||
142971458|NCT00819585|515430773|FG009|Extension Study|Subject Withdrew Consent|0|||
142971459|NCT00819585|515430774|FG010|Extension Study|Subject Withdrew Consent|1|||
142971460|NCT00819585|515430764|FG000|Extension Study|Lost to Follow-up|0|||
142971461|NCT00819585|515430765|FG001|Extension Study|Lost to Follow-up|0|||
142971462|NCT00819585|515430766|FG002|Extension Study|Lost to Follow-up|0|||
142971463|NCT00819585|515430767|FG003|Extension Study|Lost to Follow-up|0|||
142971464|NCT00819585|515430768|FG004|Extension Study|Lost to Follow-up|0|||
142971465|NCT00819585|515430769|FG005|Extension Study|Lost to Follow-up|0|||
142971466|NCT00819585|515430770|FG006|Extension Study|Lost to Follow-up|0|||
142971467|NCT00819585|515430771|FG007|Extension Study|Lost to Follow-up|0|||
142971468|NCT00819585|515430772|FG008|Extension Study|Lost to Follow-up|2|||
142971469|NCT00819585|515430773|FG009|Extension Study|Lost to Follow-up|1|||
142971470|NCT00819585|515430774|FG010|Extension Study|Lost to Follow-up|1|||
142971471|NCT00819585|515430764|FG000|Extension Study|Death|0|||
142971472|NCT00819585|515430765|FG001|Extension Study|Death|0|||
142971473|NCT00819585|515430766|FG002|Extension Study|Death|0|||
142971474|NCT00819585|515430767|FG003|Extension Study|Death|0|||
142971475|NCT00819585|515430768|FG004|Extension Study|Death|0|||
142971476|NCT00819585|515430769|FG005|Extension Study|Death|0|||
142971477|NCT00819585|515430770|FG006|Extension Study|Death|0|||
142971478|NCT00819585|515430771|FG007|Extension Study|Death|0|||
142971479|NCT00819585|515430772|FG008|Extension Study|Death|2|||
142971480|NCT00819585|515430773|FG009|Extension Study|Death|0|||
142971481|NCT00819585|515430774|FG010|Extension Study|Death|0|||
142971482|NCT00349752|515430775|FG000|Overall Study|Adverse Event|8|||
142971483|NCT00349752|515430776|FG001|Overall Study|Adverse Event|12|||
142971484|NCT00349752|515430775|FG000|Overall Study|Lack of Efficacy|37|||
142971485|NCT00349752|515430776|FG001|Overall Study|Lack of Efficacy|42|||
142971486|NCT00349752|515430775|FG000|Overall Study|Lost to Follow-up|4|||
142971487|NCT00349752|515430776|FG001|Overall Study|Lost to Follow-up|2|||
142971488|NCT00349752|515430775|FG000|Overall Study|Personal reasons|6|||
142971489|NCT00349752|515430776|FG001|Overall Study|Personal reasons|5|||
142971490|NCT00349752|515430775|FG000|Overall Study|Other: Required exclusionary medication|0|||
142971491|NCT00349752|515430776|FG001|Overall Study|Other: Required exclusionary medication|1|||
142971492|NCT00349752|515430775|FG000|Overall Study|Other: Non compliance|0|||
142971493|NCT00349752|515430776|FG001|Overall Study|Other: Non compliance|1|||
142971494|NCT00349752|515430775|FG000|Overall Study|Other: Patient stopped steroids|0|||
142971495|NCT00349752|515430776|FG001|Overall Study|Other: Patient stopped steroids|1|||
142971496|NCT00349752|515430775|FG000|Overall Study|Other: Patient's steroid use|1|||
142971497|NCT00349752|515430776|FG001|Overall Study|Other: Patient's steroid use|0|||
142971498|NCT00349752|515430775|FG000|Overall Study|Other: Ineligible|1|||
142971499|NCT00349752|515430776|FG001|Overall Study|Other: Ineligible|0|||
142971500|NCT00349752|515430775|FG000|Overall Study|Other: Inadvertently unblinded|1|||
142971501|NCT00349752|515430776|FG001|Overall Study|Other: Inadvertently unblinded|0|||
142971502|NCT00349752|515430775|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
142971503|NCT00349752|515430776|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
142971504|NCT00632541|515430777|FG000|Overall Study|Adverse Event|7|||
142971505|NCT00383721|515430780|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
142971506|NCT00383721|515430781|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
142971507|NCT00383721|515430782|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
142971508|NCT00383721|515430783|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
142971509|NCT00383721|515430784|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
142971510|NCT00383721|515430780|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
142971511|NCT00383721|515430781|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
142971512|NCT00383721|515430782|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
142971513|NCT00383721|515430783|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
142971514|NCT00383721|515430784|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
142971515|NCT00383721|515430780|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
142971516|NCT00383721|515430781|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
142971517|NCT00383721|515430782|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
142971518|NCT00383721|515430783|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
142971519|NCT00383721|515430784|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
142971520|NCT00383721|515430780|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
142971521|NCT00383721|515430781|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
142971522|NCT00383721|515430782|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
142971523|NCT00383721|515430783|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
142971524|NCT00383721|515430784|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
142971525|NCT00383721|515430780|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
142971526|NCT00383721|515430781|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
142971527|NCT00383721|515430782|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
142971528|NCT00383721|515430783|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
143003142|NCT01049360|515548754|FG010|Period 2|Adverse Event|0|||
142971529|NCT00383721|515430784|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
142971530|NCT00383721|515430780|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
142971531|NCT00383721|515430781|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
142971532|NCT00383721|515430782|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
142971533|NCT00383721|515430783|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
142971534|NCT00383721|515430784|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
142971535|NCT00383721|515430780|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
142971536|NCT00383721|515430781|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
142971537|NCT00383721|515430782|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
142971538|NCT00383721|515430783|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
142971539|NCT00383721|515430784|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
142971540|NCT00383721|515430780|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
142971541|NCT00383721|515430781|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
142971542|NCT00383721|515430782|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
142971543|NCT00383721|515430783|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
142971544|NCT00383721|515430784|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
142971545|NCT00383721|515430780|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
142971546|NCT00383721|515430781|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
142971547|NCT00383721|515430782|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
142971548|NCT00383721|515430783|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
142971549|NCT00383721|515430784|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
142971550|NCT00383721|515430780|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
142971551|NCT00383721|515430781|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
142971552|NCT00383721|515430782|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
142971553|NCT00383721|515430783|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
142971554|NCT00383721|515430784|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
142971555|NCT00383721|515430780|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
142971556|NCT00383721|515430781|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
142971557|NCT00383721|515430782|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
142971558|NCT00383721|515430783|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
142971559|NCT00383721|515430784|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
142971560|NCT00383721|515430780|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
142971561|NCT00383721|515430781|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
142971562|NCT00383721|515430782|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
142971563|NCT00383721|515430783|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
142971564|NCT00383721|515430784|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
142971565|NCT00383721|515430780|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
142971566|NCT00383721|515430781|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
142971567|NCT00383721|515430782|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
142971568|NCT00383721|515430783|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
142971569|NCT00383721|515430784|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
142971570|NCT00383721|515430780|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
142971571|NCT00383721|515430781|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
142971572|NCT00383721|515430782|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
142971573|NCT00383721|515430783|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
142971574|NCT00383721|515430784|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
142971575|NCT00383721|515430780|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
142971576|NCT00383721|515430781|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
142971577|NCT00383721|515430782|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
142971578|NCT00383721|515430783|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
142971579|NCT00383721|515430784|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
142971580|NCT00383721|515430780|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
142971581|NCT00383721|515430781|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
142971582|NCT00383721|515430782|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
142971583|NCT00383721|515430783|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
142971584|NCT00383721|515430784|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
142971585|NCT00383721|515430780|FG000|26-Week Treatment Safety Extension|Administrative|1|||
142971586|NCT00383721|515430781|FG001|26-Week Treatment Safety Extension|Administrative|2|||
142971587|NCT00383721|515430782|FG002|26-Week Treatment Safety Extension|Administrative|3|||
142971588|NCT00383721|515430783|FG003|26-Week Treatment Safety Extension|Administrative|1|||
142971589|NCT00383721|515430784|FG004|26-Week Treatment Safety Extension|Administrative|0|||
142971590|NCT03519516|515430785|FG000|Overall Study|Adverse Event|0|||
142971591|NCT03519516|515430786|FG001|Overall Study|Adverse Event|1|||
142971592|NCT02379390|515430787|FG000|Overall Study|Adverse Event|1|||
142971593|NCT02379390|515430788|FG001|Overall Study|Adverse Event|1|||
142971594|NCT02379390|515430787|FG000|Overall Study|Investigator's decision|1|||
142971595|NCT02379390|515430788|FG001|Overall Study|Investigator's decision|0|||
142971596|NCT02379390|515430787|FG000|Overall Study|Study Termination|0|||
142971597|NCT02379390|515430788|FG001|Overall Study|Study Termination|1|||
142971598|NCT03833817|515432729|FG000|Overall Study|Withdrawal by Subject|3|||
142971599|NCT03833817|515432730|FG001|Overall Study|Withdrawal by Subject|3|||
142971600|NCT03833817|515432729|FG000|Overall Study|Lost to Follow-up|3|||
142971601|NCT03833817|515432730|FG001|Overall Study|Lost to Follow-up|3|||
142971602|NCT00884221|515432731|FG000|Overall Study|Withdrawal by Subject|0|||
142971603|NCT00884221|515432732|FG001|Overall Study|Withdrawal by Subject|3|||
142971604|NCT00884221|515432731|FG000|Overall Study|Adverse Event|6|||
142971605|NCT00884221|515432732|FG001|Overall Study|Adverse Event|3|||
142971606|NCT00884221|515432731|FG000|Overall Study|Protocol Violation|16|||
142971607|NCT00884221|515432732|FG001|Overall Study|Protocol Violation|13|||
142971608|NCT00884221|515432731|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
142971609|NCT00884221|515432732|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
142971610|NCT02126670|515432737|FG000|Overall Study|Withdrawal by Subject|1|||
142971611|NCT02126670|515432738|FG001|Overall Study|Withdrawal by Subject|0|||
142971612|NCT02126670|515432739|FG002|Overall Study|Withdrawal by Subject|0|||
142971613|NCT02126670|515432740|FG003|Overall Study|Withdrawal by Subject|1|||
142971614|NCT01107405|515432741|FG000|Overall Study|Adverse Event|1|||
142971615|NCT01107405|515432742|FG001|Overall Study|Adverse Event|1|||
142971616|NCT01107405|515432743|FG002|Overall Study|Adverse Event|0|||
142971617|NCT01107405|515432744|FG003|Overall Study|Adverse Event|0|||
142971618|NCT01107405|515432745|FG004|Overall Study|Adverse Event|2|||
142971619|NCT01107405|515432741|FG000|Overall Study|Withdrawal by Subject|1|||
142971620|NCT01107405|515432742|FG001|Overall Study|Withdrawal by Subject|0|||
142971621|NCT01107405|515432743|FG002|Overall Study|Withdrawal by Subject|1|||
142971622|NCT01107405|515432744|FG003|Overall Study|Withdrawal by Subject|2|||
142971623|NCT01107405|515432745|FG004|Overall Study|Withdrawal by Subject|1|||
142971624|NCT01107405|515432741|FG000|Overall Study|Protocol Violation|0|||
142971625|NCT01107405|515432742|FG001|Overall Study|Protocol Violation|0|||
142971626|NCT01107405|515432743|FG002|Overall Study|Protocol Violation|1|||
142971627|NCT01107405|515432744|FG003|Overall Study|Protocol Violation|1|||
142971628|NCT01107405|515432745|FG004|Overall Study|Protocol Violation|0|||
142971629|NCT01840228|515432747|FG000|Overall Study|Lost to Follow-up|1|||
142971630|NCT01840228|515432748|FG001|Overall Study|Lost to Follow-up|1|||
142971631|NCT01103778|515432749|FG000|Overall Study|Lost to Follow-up|1|||
142971632|NCT01103778|515432749|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
142971633|NCT01103778|515432749|FG000|Overall Study|Screen failure|1|||
142971634|NCT04511819|515432750|FG000|Overall Study|Non-compliance with study drug|5|||
142971635|NCT04511819|515432751|FG001|Overall Study|Non-compliance with study drug|1|||
142971636|NCT04511819|515432750|FG000|Overall Study|Withdrawal by Subject|0|||
142971637|NCT04511819|515432751|FG001|Overall Study|Withdrawal by Subject|3|||
142971638|NCT04511819|515432750|FG000|Overall Study|Adverse Event|0|||
142971639|NCT04511819|515432751|FG001|Overall Study|Adverse Event|1|||
142971640|NCT04511819|515432750|FG000|Overall Study|Protocol deviation|1|||
142971641|NCT04511819|515432751|FG001|Overall Study|Protocol deviation|0|||
142971642|NCT00865189|515432752|FG000|Overall Study|Other|1|||
142971643|NCT00865189|515432753|FG001|Overall Study|Other|2|||
142971644|NCT00865189|515432752|FG000|Overall Study|Death|4|||
142971645|NCT00865189|515432753|FG001|Overall Study|Death|11|||
142971646|NCT00865189|515432752|FG000|Overall Study|Lost to Follow-up|6|||
142971647|NCT00865189|515432753|FG001|Overall Study|Lost to Follow-up|6|||
142971648|NCT00865189|515432752|FG000|Overall Study|Withdrawal by Subject|1|||
142971649|NCT00865189|515432753|FG001|Overall Study|Withdrawal by Subject|0|||
142971650|NCT05590767|515432757|FG000|Overall Study|Protocol Violation|1|||
142971651|NCT05590767|515432757|FG000|Overall Study|surgery canceled|1|||
142971652|NCT05590767|515432757|FG000|Overall Study|interscalene brachial block not performed|1|||
142971653|NCT00084929|515432758|FG000|Overall Study|ineligible - medical contraindication|1|||
142971654|NCT00084929|515432758|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
142971655|NCT00084929|515432758|FG000|Overall Study|Ineligible - Medical history|6|||
142971656|NCT00084929|515432758|FG000|Overall Study|Withdrawal by Subject|10|||
142971657|NCT00084929|515432758|FG000|Overall Study|Missing/incomplete CTC exam|9|||
142971658|NCT00084929|515432758|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
142971659|NCT00844649|515432759|FG000|Overall Study|Progressive Disease|196|||
142971660|NCT00844649|515432760|FG001|Overall Study|Progressive Disease|245|||
142971661|NCT00844649|515432759|FG000|Overall Study|Adverse Event|128|||
142971662|NCT00844649|515432760|FG001|Overall Study|Adverse Event|73|||
142971663|NCT00844649|515432759|FG000|Overall Study|Physician Decision|25|||
142971664|NCT00844649|515432760|FG001|Overall Study|Physician Decision|18|||
142971665|NCT00844649|515432759|FG000|Overall Study|Protocol Violation|10|||
142971666|NCT00844649|515432760|FG001|Overall Study|Protocol Violation|6|||
142971667|NCT00844649|515432759|FG000|Overall Study|Withdrawal by Subject|28|||
142971668|NCT00844649|515432760|FG001|Overall Study|Withdrawal by Subject|39|||
142971669|NCT00844649|515432759|FG000|Overall Study|Other|7|||
142971670|NCT00844649|515432760|FG001|Overall Study|Other|10|||
142971671|NCT00844649|515432759|FG000|Overall Study|Withdrew prior to starting treatment|11|||
142971672|NCT00844649|515432760|FG001|Overall Study|Withdrew prior to starting treatment|27|||
142971673|NCT00065442|515432763|FG000|Overall Study|Lost to Follow-up|1|||
142971674|NCT00065442|515432764|FG001|Overall Study|Lost to Follow-up|1|||
142971675|NCT00065442|515432763|FG000|Overall Study|Death|121|||
142971676|NCT00065442|515432764|FG001|Overall Study|Death|210|||
142971677|NCT00065442|515432763|FG000|Overall Study|Withdrawal by Subject|3|||
142971678|NCT00065442|515432764|FG001|Overall Study|Withdrawal by Subject|9|||
142971679|NCT01594333|515432766|FG000|Overall Study|Death|96|||
142971680|NCT01594333|515432767|FG001|Overall Study|Death|83|||
142971681|NCT01594333|515432766|FG000|Overall Study|Lost to Follow-up|5|||
142971682|NCT01594333|515432767|FG001|Overall Study|Lost to Follow-up|5|||
142971683|NCT01594333|515432766|FG000|Overall Study|Withdrawal by Subject|60|||
142971684|NCT01594333|515432767|FG001|Overall Study|Withdrawal by Subject|63|||
142971685|NCT00589979|515432768|FG000|Run-In Period|Adverse Event|5|||
142971686|NCT00589979|515432769|FG001|Run-In Period|Adverse Event|0|||
142971687|NCT00589979|515432770|FG002|Run-In Period|Adverse Event|0|||
142971688|NCT00589979|515432768|FG000|Run-In Period|Protocol Violation|3|||
142971689|NCT00589979|515432769|FG001|Run-In Period|Protocol Violation|0|||
142971690|NCT00589979|515432770|FG002|Run-In Period|Protocol Violation|0|||
142971691|NCT00589979|515432768|FG000|Run-In Period|Did not qualify for randomization|54|||
142971692|NCT00589979|515432769|FG001|Run-In Period|Did not qualify for randomization|0|||
142971693|NCT00589979|515432770|FG002|Run-In Period|Did not qualify for randomization|0|||
142971694|NCT00589979|515432768|FG000|Run-In Period|Withdrawal by Subject|10|||
142971695|NCT00589979|515432769|FG001|Run-In Period|Withdrawal by Subject|0|||
142971696|NCT00589979|515432770|FG002|Run-In Period|Withdrawal by Subject|0|||
142971697|NCT00589979|515432768|FG000|Run-In Period|Informed Consent Withdrawn|4|||
142971698|NCT00589979|515432769|FG001|Run-In Period|Informed Consent Withdrawn|0|||
142971699|NCT00589979|515432770|FG002|Run-In Period|Informed Consent Withdrawn|0|||
142971700|NCT00589979|515432768|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
142971701|NCT00589979|515432769|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
142971702|NCT00589979|515432770|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
142971703|NCT00589979|515432768|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
142971704|NCT00589979|515432769|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
142971705|NCT00589979|515432770|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
142971706|NCT00589979|515432768|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
142971707|NCT00589979|515432769|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
142971708|NCT00589979|515432770|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
142971709|NCT00589979|515432768|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
142971710|NCT00589979|515432769|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
142971711|NCT00589979|515432770|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
142971712|NCT00589979|515432768|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
142971713|NCT00589979|515432769|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
142971714|NCT00589979|515432770|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
142971715|NCT00589979|515432768|FG000|Double-Blind Treatment Period 2|Other|0|||
142971716|NCT00589979|515432769|FG001|Double-Blind Treatment Period 2|Other|0|||
142971717|NCT00589979|515432770|FG002|Double-Blind Treatment Period 2|Other|1|||
142971718|NCT00589979|515432768|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
142971719|NCT00589979|515432769|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
142971720|NCT00589979|515432770|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
142971721|NCT00589979|515432768|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
142971722|NCT00589979|515432769|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
142971723|NCT00589979|515432770|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
142971724|NCT00712322|515432772|FG000|Overall Study|Protocol deviation|0|||
142971725|NCT00712322|515432773|FG001|Overall Study|Protocol deviation|1|||
142971726|NCT00712322|515432774|FG002|Overall Study|Protocol deviation|0|||
142971727|NCT02670330|515432777|FG000|Overall Study|Protocol Deviation|1|||
142971728|NCT02670330|515432778|FG001|Overall Study|Protocol Deviation|0|||
142971729|NCT02670330|515432777|FG000|Overall Study|Study Terminated By Sponsor|36|||
142971730|NCT02670330|515432778|FG001|Overall Study|Study Terminated By Sponsor|43|||
142971731|NCT02670330|515432777|FG000|Overall Study|Adverse Event|1|||
142971732|NCT02670330|515432778|FG001|Overall Study|Adverse Event|3|||
142971733|NCT02670330|515432777|FG000|Overall Study|Withdrawal by Subject|34|||
142971734|NCT02670330|515432778|FG001|Overall Study|Withdrawal by Subject|29|||
142971735|NCT02670330|515432777|FG000|Overall Study|Lost to Follow-up|3|||
142971736|NCT02670330|515432778|FG001|Overall Study|Lost to Follow-up|2|||
142971737|NCT04404010|515432779|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
142971738|NCT04404010|515432780|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
142971739|NCT02802878|515432784|FG000|Overall Study|Withdrawal by Subject|3|||
142971740|NCT02802878|515432785|FG001|Overall Study|Withdrawal by Subject|3|||
142971741|NCT02802878|515432784|FG000|Overall Study|Protocol Violation|1|||
142971742|NCT02802878|515432785|FG001|Overall Study|Protocol Violation|0|||
142971743|NCT01577160|515432786|FG000|Overall Study|Adverse Event|9|||
142971744|NCT01577160|515432786|FG000|Overall Study|Lack of Efficacy|15|||
142971745|NCT01577160|515432786|FG000|Overall Study|Lost to Follow-up|40|||
142971746|NCT01577160|515432786|FG000|Overall Study|Withdrawal by Subject|18|||
142971747|NCT01577160|515432786|FG000|Overall Study|Subject Uncooperative|7|||
142971748|NCT01577160|515432786|FG000|Overall Study|Other|9|||
142971749|NCT00101192|515432787|FG000|Overall Study|Ineligible|6|||
142971750|NCT00101192|515432787|FG000|Overall Study|Inevaluable|1|||
142971751|NCT03691610|515432788|FG000|Overall Study|Adverse Event|0|||
142971752|NCT03691610|515432789|FG001|Overall Study|Adverse Event|1|||
142971753|NCT03691610|515432790|FG002|Overall Study|Adverse Event|0|||
142971754|NCT03691610|515432791|FG003|Overall Study|Adverse Event|0|||
142971755|NCT03691610|515432788|FG000|Overall Study|Protocol Deviation|15|||
142971756|NCT03691610|515432789|FG001|Overall Study|Protocol Deviation|8|||
142971757|NCT03691610|515432790|FG002|Overall Study|Protocol Deviation|1|||
142971758|NCT03691610|515432791|FG003|Overall Study|Protocol Deviation|2|||
142971759|NCT03691610|515432788|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
142971760|NCT03691610|515432789|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
142971761|NCT03691610|515432790|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
142971762|NCT03691610|515432791|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
142971763|NCT03691610|515432788|FG000|Overall Study|Lost to Follow-up|20|||
142971764|NCT03691610|515432789|FG001|Overall Study|Lost to Follow-up|11|||
142971765|NCT03691610|515432790|FG002|Overall Study|Lost to Follow-up|5|||
142971766|NCT03691610|515432791|FG003|Overall Study|Lost to Follow-up|2|||
142971767|NCT03550131|515432796|FG000|Overall Study|Lost to Follow-up|16|||
142971768|NCT03550131|515432797|FG001|Overall Study|Lost to Follow-up|24|||
142971769|NCT03550131|515432796|FG000|Overall Study|Withdrawal by Subject|36|||
142971770|NCT03550131|515432797|FG001|Overall Study|Withdrawal by Subject|28|||
142971771|NCT03550131|515432796|FG000|Overall Study|Illness of dyad member|10|||
142971772|NCT03550131|515432797|FG001|Overall Study|Illness of dyad member|2|||
142971773|NCT03550131|515432796|FG000|Overall Study|Death of person with dementia|4|||
142971774|NCT03550131|515432797|FG001|Overall Study|Death of person with dementia|8|||
142971775|NCT00622869|515432800|FG000|Overall Study|Subject Withdrew Consent|13|||
142971776|NCT00622869|515432801|FG001|Overall Study|Subject Withdrew Consent|17|||
142971777|NCT00622869|515432802|FG002|Overall Study|Subject Withdrew Consent|11|||
142971778|NCT00622869|515432800|FG000|Overall Study|Administrative Problems|11|||
142971779|NCT00622869|515432801|FG001|Overall Study|Administrative Problems|17|||
142971780|NCT00622869|515432802|FG002|Overall Study|Administrative Problems|13|||
142971781|NCT00622869|515432800|FG000|Overall Study|Death|12|||
142971782|NCT00622869|515432801|FG001|Overall Study|Death|15|||
142971783|NCT00622869|515432802|FG002|Overall Study|Death|10|||
142971784|NCT00622869|515432800|FG000|Overall Study|Lost to Follow-up|2|||
142971785|NCT00622869|515432801|FG001|Overall Study|Lost to Follow-up|4|||
142971786|NCT00622869|515432802|FG002|Overall Study|Lost to Follow-up|2|||
142971787|NCT00622869|515432800|FG000|Overall Study|Graft Loss|5|||
142971788|NCT00622869|515432801|FG001|Overall Study|Graft Loss|3|||
142971789|NCT00622869|515432802|FG002|Overall Study|Graft Loss|2|||
142971790|NCT00622869|515432800|FG000|Overall Study|Missing|0|||
142971791|NCT00622869|515432801|FG001|Overall Study|Missing|1|||
142971792|NCT00622869|515432802|FG002|Overall Study|Missing|1|||
142971793|NCT00645567|515432803|FG000|Overall Study|Adverse Event|1|||
142971794|NCT04664855|515432804|FG000|Overall Study|Withdrawal by Subject|0|||
142971795|NCT04664855|515432805|FG001|Overall Study|Withdrawal by Subject|2|||
142971796|NCT01364233|515432806|FG000|Overall Study|Lost to Follow-up|1|||
142971797|NCT00302718|515432810|FG000|Overall Study|Participant left the hospital|1|||
142971798|NCT00302718|515432811|FG001|Overall Study|Participant left the hospital|0|||
142971799|NCT00302718|515432812|FG002|Overall Study|Participant left the hospital|0|||
142971800|NCT00302718|515432813|FG003|Overall Study|Participant left the hospital|1|||
142971801|NCT00302718|515432810|FG000|Overall Study|Withdrawal by Subject|0|||
142971802|NCT00302718|515432811|FG001|Overall Study|Withdrawal by Subject|1|||
142971803|NCT00302718|515432812|FG002|Overall Study|Withdrawal by Subject|0|||
142971804|NCT00302718|515432813|FG003|Overall Study|Withdrawal by Subject|0|||
142971805|NCT00302718|515432810|FG000|Overall Study|Participant left primary care setting|0|||
142971806|NCT00302718|515432811|FG001|Overall Study|Participant left primary care setting|0|||
142971807|NCT00302718|515432812|FG002|Overall Study|Participant left primary care setting|2|||
142971808|NCT00302718|515432813|FG003|Overall Study|Participant left primary care setting|1|||
142971809|NCT00738374|515432814|FG000|Induction Treatment Phase|Adverse Event|14|||
142971810|NCT00738374|515432815|FG001|Induction Treatment Phase|Adverse Event|0|||
142971811|NCT00738374|515432816|FG002|Induction Treatment Phase|Adverse Event|0|||
142971812|NCT00738374|515432817|FG003|Induction Treatment Phase|Adverse Event|0|||
142971813|NCT00738374|515432814|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
142971814|NCT00738374|515432815|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
142971815|NCT00738374|515432816|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
142971816|NCT00738374|515432817|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
142971817|NCT00738374|515432814|FG000|Induction Treatment Phase|Physician Decision|2|||
142971818|NCT00738374|515432815|FG001|Induction Treatment Phase|Physician Decision|0|||
142971819|NCT00738374|515432816|FG002|Induction Treatment Phase|Physician Decision|0|||
142971820|NCT00738374|515432817|FG003|Induction Treatment Phase|Physician Decision|0|||
142971821|NCT00738374|515432814|FG000|Induction Treatment Phase|Protocol Violation|2|||
142971822|NCT00738374|515432815|FG001|Induction Treatment Phase|Protocol Violation|0|||
142971823|NCT00738374|515432816|FG002|Induction Treatment Phase|Protocol Violation|0|||
142971824|NCT00738374|515432817|FG003|Induction Treatment Phase|Protocol Violation|0|||
142971825|NCT00738374|515432814|FG000|Induction Treatment Phase|Non-compliance|1|||
142971826|NCT00738374|515432815|FG001|Induction Treatment Phase|Non-compliance|0|||
142971827|NCT00738374|515432816|FG002|Induction Treatment Phase|Non-compliance|0|||
142971828|NCT00738374|515432817|FG003|Induction Treatment Phase|Non-compliance|0|||
142971829|NCT00738374|515432814|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
142971830|NCT00738374|515432815|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
142971831|NCT00738374|515432816|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
142971832|NCT00738374|515432817|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
142971833|NCT00738374|515432814|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
142971834|NCT00738374|515432815|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
142971835|NCT00738374|515432816|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
142971836|NCT00738374|515432817|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
142971837|NCT00738374|515432814|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
142971838|NCT00738374|515432815|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
142971839|NCT00738374|515432816|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
142971840|NCT00738374|515432817|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
142971841|NCT00738374|515432814|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
142971842|NCT00738374|515432815|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
142971843|NCT00738374|515432816|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
142971844|NCT00738374|515432817|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
142971845|NCT00738374|515432814|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
142971846|NCT00738374|515432815|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
142971847|NCT00738374|515432816|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
142971848|NCT00738374|515432817|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
142971849|NCT00738374|515432814|FG000|Maintenance Treatment/Observation Phase|Other|0|||
142971850|NCT00738374|515432815|FG001|Maintenance Treatment/Observation Phase|Other|1|||
142971851|NCT00738374|515432816|FG002|Maintenance Treatment/Observation Phase|Other|0|||
142971852|NCT00738374|515432817|FG003|Maintenance Treatment/Observation Phase|Other|0|||
142971853|NCT03334396|515432818|FG000|Overall Study|Adverse Event|1|||
142971854|NCT03334396|515432819|FG001|Overall Study|Adverse Event|0|||
142971855|NCT03334396|515432820|FG002|Overall Study|Adverse Event|1|||
142971856|NCT03334396|515432821|FG003|Overall Study|Adverse Event|0|||
142971857|NCT03334396|515432822|FG004|Overall Study|Adverse Event|0|||
142971858|NCT03334396|515432823|FG005|Overall Study|Adverse Event|0|||
142971859|NCT03334396|515432824|FG006|Overall Study|Adverse Event|0|||
142971860|NCT03334396|515432825|FG007|Overall Study|Adverse Event|0|||
142971861|NCT03334396|515432818|FG000|Overall Study|Lack of Efficacy|10|||
142971862|NCT03334396|515432819|FG001|Overall Study|Lack of Efficacy|4|||
142971863|NCT03334396|515432820|FG002|Overall Study|Lack of Efficacy|1|||
142971864|NCT03334396|515432821|FG003|Overall Study|Lack of Efficacy|3|||
142971865|NCT03334396|515432822|FG004|Overall Study|Lack of Efficacy|1|||
142971866|NCT03334396|515432823|FG005|Overall Study|Lack of Efficacy|0|||
142971867|NCT03334396|515432824|FG006|Overall Study|Lack of Efficacy|0|||
142971868|NCT03334396|515432825|FG007|Overall Study|Lack of Efficacy|1|||
142971869|NCT03334396|515432818|FG000|Overall Study|Lost to Follow-up|0|||
142971870|NCT03334396|515432819|FG001|Overall Study|Lost to Follow-up|0|||
142971871|NCT03334396|515432820|FG002|Overall Study|Lost to Follow-up|1|||
142971872|NCT03334396|515432821|FG003|Overall Study|Lost to Follow-up|0|||
142971873|NCT03334396|515432822|FG004|Overall Study|Lost to Follow-up|0|||
142971874|NCT03334396|515432823|FG005|Overall Study|Lost to Follow-up|0|||
142971875|NCT03334396|515432824|FG006|Overall Study|Lost to Follow-up|1|||
142971876|NCT03334396|515432825|FG007|Overall Study|Lost to Follow-up|0|||
142971877|NCT03334396|515432818|FG000|Overall Study|Physician Decision|1|||
142971878|NCT03334396|515432819|FG001|Overall Study|Physician Decision|0|||
142971879|NCT03334396|515432820|FG002|Overall Study|Physician Decision|0|||
142971880|NCT03334396|515432821|FG003|Overall Study|Physician Decision|0|||
142971881|NCT03334396|515432822|FG004|Overall Study|Physician Decision|0|||
142971882|NCT03334396|515432823|FG005|Overall Study|Physician Decision|0|||
142971883|NCT03334396|515432824|FG006|Overall Study|Physician Decision|0|||
142971884|NCT03334396|515432825|FG007|Overall Study|Physician Decision|0|||
142971885|NCT03334396|515432818|FG000|Overall Study|Withdrawal by Subject|10|||
142971886|NCT03334396|515432819|FG001|Overall Study|Withdrawal by Subject|5|||
142971887|NCT03334396|515432820|FG002|Overall Study|Withdrawal by Subject|7|||
142971888|NCT03334396|515432821|FG003|Overall Study|Withdrawal by Subject|2|||
142971889|NCT03334396|515432822|FG004|Overall Study|Withdrawal by Subject|2|||
142971890|NCT03334396|515432823|FG005|Overall Study|Withdrawal by Subject|1|||
142971891|NCT03334396|515432824|FG006|Overall Study|Withdrawal by Subject|2|||
142971892|NCT03334396|515432825|FG007|Overall Study|Withdrawal by Subject|0|||
142971893|NCT03334396|515432818|FG000|Overall Study|Pregnancy|0|||
142971894|NCT03334396|515432819|FG001|Overall Study|Pregnancy|1|||
142971895|NCT03334396|515432820|FG002|Overall Study|Pregnancy|0|||
142971896|NCT03334396|515432821|FG003|Overall Study|Pregnancy|0|||
142971897|NCT03334396|515432822|FG004|Overall Study|Pregnancy|0|||
142971898|NCT03334396|515432823|FG005|Overall Study|Pregnancy|0|||
142971899|NCT03334396|515432824|FG006|Overall Study|Pregnancy|0|||
142971900|NCT03334396|515432825|FG007|Overall Study|Pregnancy|0|||
142971901|NCT03334396|515432818|FG000|Overall Study|Ineligible|0|||
142971902|NCT03334396|515432819|FG001|Overall Study|Ineligible|1|||
142971903|NCT03334396|515432820|FG002|Overall Study|Ineligible|0|||
142971904|NCT03334396|515432821|FG003|Overall Study|Ineligible|0|||
142971905|NCT03334396|515432822|FG004|Overall Study|Ineligible|0|||
142971906|NCT03334396|515432823|FG005|Overall Study|Ineligible|0|||
142971907|NCT03334396|515432824|FG006|Overall Study|Ineligible|0|||
142971908|NCT03334396|515432825|FG007|Overall Study|Ineligible|0|||
142971909|NCT03334396|515432818|FG000|Overall Study|Started New Job|1|||
142971910|NCT03334396|515432819|FG001|Overall Study|Started New Job|0|||
142971911|NCT03334396|515432820|FG002|Overall Study|Started New Job|0|||
142971912|NCT03334396|515432821|FG003|Overall Study|Started New Job|0|||
142971913|NCT03334396|515432822|FG004|Overall Study|Started New Job|0|||
142971914|NCT03334396|515432823|FG005|Overall Study|Started New Job|0|||
142971915|NCT03334396|515432824|FG006|Overall Study|Started New Job|0|||
142971916|NCT03334396|515432825|FG007|Overall Study|Started New Job|0|||
142971917|NCT02927873|515432829|FG000|Overall Study|Lost to Follow-up|0|||
142971918|NCT02927873|515432830|FG001|Overall Study|Lost to Follow-up|1|||
142971919|NCT02927873|515432831|FG002|Overall Study|Lost to Follow-up|0|||
142971920|NCT02927873|515432832|FG003|Overall Study|Lost to Follow-up|0|||
142971921|NCT02927873|515432833|FG004|Overall Study|Lost to Follow-up|0|||
142971922|NCT02927873|515432834|FG005|Overall Study|Lost to Follow-up|0|||
142971923|NCT02927873|515432829|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
142971924|NCT02927873|515432830|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
142971925|NCT02927873|515432831|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
142971926|NCT02927873|515432832|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
142971927|NCT02927873|515432833|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
142971928|NCT02927873|515432834|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
142971929|NCT02927873|515432829|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
142971930|NCT02927873|515432830|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
142971931|NCT02927873|515432831|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
142971932|NCT02927873|515432832|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
142971933|NCT02927873|515432833|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
142971934|NCT02927873|515432834|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
142971935|NCT02927873|515432829|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
142971936|NCT02927873|515432830|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
142971937|NCT02927873|515432831|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
142971938|NCT02927873|515432832|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
142971939|NCT02927873|515432833|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
142971940|NCT02927873|515432834|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
142971941|NCT02927873|515432829|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
142971942|NCT02927873|515432830|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
142971943|NCT02927873|515432831|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
142971944|NCT02927873|515432832|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
142971945|NCT02927873|515432833|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
142971946|NCT02927873|515432834|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
142971947|NCT02927873|515432829|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
142971948|NCT02927873|515432830|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
142971949|NCT02927873|515432831|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
142971950|NCT02927873|515432832|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
142971951|NCT02927873|515432833|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
142971952|NCT02927873|515432834|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
142971953|NCT01766817|515432836|FG000|Overall Study|Drug-related adverse event|1|||
142971954|NCT01766817|515432837|FG001|Overall Study|Drug-related adverse event|2|||
142971955|NCT01766817|515432838|FG002|Overall Study|Drug-related adverse event|1|||
142971956|NCT01766817|515432836|FG000|Overall Study|Drug-unrelated adverse event|3|||
142971957|NCT01766817|515432837|FG001|Overall Study|Drug-unrelated adverse event|3|||
142971958|NCT01766817|515432838|FG002|Overall Study|Drug-unrelated adverse event|3|||
142971959|NCT01766817|515432836|FG000|Overall Study|Death|1|||
142971960|NCT01766817|515432837|FG001|Overall Study|Death|1|||
142971961|NCT01766817|515432838|FG002|Overall Study|Death|0|||
142971962|NCT01766817|515432836|FG000|Overall Study|Unable to take study drug|0|||
142971963|NCT01766817|515432837|FG001|Overall Study|Unable to take study drug|1|||
143117158|NCT01256385|515970045|FG000|Overall Study|Physician Decision|1|||
143117159|NCT01256385|515970046|FG001|Overall Study|Physician Decision|1|||
142971964|NCT01766817|515432838|FG002|Overall Study|Unable to take study drug|0|||
142971965|NCT01766817|515432836|FG000|Overall Study|Withdrawal by Subject|2|||
142971966|NCT01766817|515432837|FG001|Overall Study|Withdrawal by Subject|0|||
142971967|NCT01766817|515432838|FG002|Overall Study|Withdrawal by Subject|3|||
142971968|NCT01766817|515432836|FG000|Overall Study|Subject non-compliance|0|||
142971969|NCT01766817|515432837|FG001|Overall Study|Subject non-compliance|1|||
142971970|NCT01766817|515432838|FG002|Overall Study|Subject non-compliance|2|||
142971971|NCT01766817|515432836|FG000|Overall Study|Physician Decision|3|||
142971972|NCT01766817|515432837|FG001|Overall Study|Physician Decision|3|||
142971973|NCT01766817|515432838|FG002|Overall Study|Physician Decision|4|||
142971974|NCT01766817|515432836|FG000|Overall Study|Other|1|||
142971975|NCT01766817|515432837|FG001|Overall Study|Other|0|||
142971976|NCT01766817|515432838|FG002|Overall Study|Other|0|||
142971977|NCT03814590|515432844|FG000|Overall Study|Adverse Event|0|||
142971978|NCT03814590|515432845|FG001|Overall Study|Adverse Event|0|||
142971979|NCT03814590|515432846|FG002|Overall Study|Adverse Event|0|||
142971980|NCT03814590|515432847|FG003|Overall Study|Adverse Event|0|||
142971981|NCT03814590|515432848|FG004|Overall Study|Adverse Event|0|||
142971982|NCT03814590|515432849|FG005|Overall Study|Adverse Event|1|||
142971983|NCT03814590|515432850|FG006|Overall Study|Adverse Event|1|||
142971984|NCT03814590|515432851|FG007|Overall Study|Adverse Event|1|||
142971985|NCT03814590|515432852|FG008|Overall Study|Adverse Event|0|||
142971986|NCT03814590|515432853|FG009|Overall Study|Adverse Event|0|||
142971987|NCT03814590|515432854|FG010|Overall Study|Adverse Event|1|||
142971988|NCT03814590|515432855|FG011|Overall Study|Adverse Event|0|||
142971989|NCT03814590|515432856|FG012|Overall Study|Adverse Event|3|||
142971990|NCT03814590|515432857|FG013|Overall Study|Adverse Event|0|||
142971991|NCT03814590|515432844|FG000|Overall Study|Lost to Follow-up|0|||
142971992|NCT03814590|515432845|FG001|Overall Study|Lost to Follow-up|2|||
142971993|NCT03814590|515432846|FG002|Overall Study|Lost to Follow-up|1|||
142971994|NCT03814590|515432847|FG003|Overall Study|Lost to Follow-up|0|||
142971995|NCT03814590|515432848|FG004|Overall Study|Lost to Follow-up|1|||
142971996|NCT03814590|515432849|FG005|Overall Study|Lost to Follow-up|1|||
142971997|NCT03814590|515432850|FG006|Overall Study|Lost to Follow-up|1|||
142971998|NCT03814590|515432851|FG007|Overall Study|Lost to Follow-up|1|||
142971999|NCT03814590|515432852|FG008|Overall Study|Lost to Follow-up|0|||
142972000|NCT03814590|515432853|FG009|Overall Study|Lost to Follow-up|0|||
142972001|NCT03814590|515432854|FG010|Overall Study|Lost to Follow-up|1|||
142972002|NCT03814590|515432855|FG011|Overall Study|Lost to Follow-up|0|||
142972003|NCT03814590|515432856|FG012|Overall Study|Lost to Follow-up|0|||
142972004|NCT03814590|515432857|FG013|Overall Study|Lost to Follow-up|1|||
142972005|NCT03814590|515432844|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
142972006|NCT03814590|515432845|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
142972007|NCT03814590|515432846|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
142972008|NCT03814590|515432847|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
142972009|NCT03814590|515432848|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
142972010|NCT03814590|515432849|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
142972011|NCT03814590|515432850|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
142972012|NCT03814590|515432851|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
142972013|NCT03814590|515432852|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
142972014|NCT03814590|515432853|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
142972015|NCT03814590|515432854|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
142972016|NCT03814590|515432855|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
142972017|NCT03814590|515432856|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
142972018|NCT03814590|515432857|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
142972019|NCT03814590|515432844|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
142972020|NCT03814590|515432845|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
142972021|NCT03814590|515432846|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
142972022|NCT03814590|515432847|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
142972023|NCT03814590|515432848|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
142972024|NCT03814590|515432849|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
142972025|NCT03814590|515432850|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
142972026|NCT03814590|515432851|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
142972027|NCT03814590|515432852|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
142972028|NCT03814590|515432853|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
142972029|NCT03814590|515432854|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
142972030|NCT03814590|515432855|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
142972031|NCT03814590|515432856|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
142972032|NCT03814590|515432857|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
142972033|NCT03814590|515432844|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
142972034|NCT03814590|515432845|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
142972035|NCT03814590|515432846|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
142972036|NCT03814590|515432847|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
142972037|NCT03814590|515432848|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
142972038|NCT03814590|515432849|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
142972039|NCT03814590|515432850|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
142972040|NCT03814590|515432851|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
142972041|NCT03814590|515432852|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
142972042|NCT03814590|515432853|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
142972043|NCT03814590|515432854|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
142972044|NCT03814590|515432855|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
142972045|NCT03814590|515432856|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
142972046|NCT03814590|515432857|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
142972047|NCT03814590|515432844|FG000|Overall Study|UNKNOWN REASON|0|||
142972048|NCT03814590|515432845|FG001|Overall Study|UNKNOWN REASON|0|||
142972049|NCT03814590|515432846|FG002|Overall Study|UNKNOWN REASON|0|||
142972050|NCT03814590|515432847|FG003|Overall Study|UNKNOWN REASON|0|||
142972051|NCT03814590|515432848|FG004|Overall Study|UNKNOWN REASON|0|||
142972052|NCT03814590|515432849|FG005|Overall Study|UNKNOWN REASON|0|||
142972053|NCT03814590|515432850|FG006|Overall Study|UNKNOWN REASON|0|||
142972054|NCT03814590|515432851|FG007|Overall Study|UNKNOWN REASON|1|||
142972055|NCT03814590|515432852|FG008|Overall Study|UNKNOWN REASON|0|||
142972056|NCT03814590|515432853|FG009|Overall Study|UNKNOWN REASON|0|||
142972057|NCT03814590|515432854|FG010|Overall Study|UNKNOWN REASON|0|||
142972058|NCT03814590|515432855|FG011|Overall Study|UNKNOWN REASON|0|||
142972059|NCT03814590|515432856|FG012|Overall Study|UNKNOWN REASON|0|||
142972060|NCT03814590|515432857|FG013|Overall Study|UNKNOWN REASON|0|||
142972061|NCT03245723|515432866|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
142972062|NCT03245723|515432867|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
142972063|NCT03245723|515432866|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
142972064|NCT03245723|515432867|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
142972065|NCT03245723|515432866|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
142972066|NCT03245723|515432867|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
142972067|NCT03245723|515432866|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
142972068|NCT03245723|515432867|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
142972069|NCT00077376|515432868|FG000|Overall Study|Adverse Event|8|||
142972070|NCT00077376|515432868|FG000|Overall Study|Withdrawal by Subject|2|||
142972071|NCT00077376|515432868|FG000|Overall Study|Death|1|||
142972072|NCT00077376|515432868|FG000|Overall Study|Physician Decision|1|||
142972073|NCT00077376|515432868|FG000|Overall Study|Alternative therapy|5|||
142972074|NCT00077376|515432868|FG000|Overall Study|Complicating disease|1|||
142972075|NCT00077376|515432868|FG000|Overall Study|Still on treatment|1|||
142972076|NCT00077376|515432868|FG000|Overall Study|Symptomatic deterioration|1|||
142972077|NCT00077376|515432868|FG000|Overall Study|Surgery|1|||
142972078|NCT00077376|515432868|FG000|Overall Study|Insurance ran out|1|||
142972079|NCT03784027|515432869|FG000|Period 1|Withdrawal by Subject|0|||
142972080|NCT03784027|515432870|FG001|Period 1|Withdrawal by Subject|1|||
142972081|NCT01253187|515434409|FG000|Period 2|Withdrawal by Subject|0|||
142972082|NCT01253187|515434410|FG001|Period 2|Withdrawal by Subject|0|||
142972083|NCT01253187|515434411|FG002|Period 2|Withdrawal by Subject|0|||
142972084|NCT01253187|515434412|FG003|Period 2|Withdrawal by Subject|0|||
142972085|NCT01253187|515434413|FG004|Period 2|Withdrawal by Subject|1|||
142972086|NCT01253187|515434414|FG005|Period 2|Withdrawal by Subject|0|||
142972087|NCT01253187|515434409|FG000|Period 3|Pregnancy|1|||
142972088|NCT01253187|515434410|FG001|Period 3|Pregnancy|0|||
142972089|NCT01253187|515434411|FG002|Period 3|Pregnancy|0|||
142972090|NCT01253187|515434412|FG003|Period 3|Pregnancy|0|||
142972091|NCT01253187|515434413|FG004|Period 3|Pregnancy|0|||
142972092|NCT01253187|515434414|FG005|Period 3|Pregnancy|0|||
142972093|NCT01253187|515434409|FG000|Period 3|difficulty with blood sampling|0|||
142972094|NCT01253187|515434410|FG001|Period 3|difficulty with blood sampling|1|||
142972095|NCT01253187|515434411|FG002|Period 3|difficulty with blood sampling|0|||
142972096|NCT01253187|515434412|FG003|Period 3|difficulty with blood sampling|0|||
142972097|NCT01253187|515434413|FG004|Period 3|difficulty with blood sampling|0|||
142972098|NCT01253187|515434414|FG005|Period 3|difficulty with blood sampling|0|||
142972099|NCT01253187|515434409|FG000|Period 3|non-compliance|0|||
142972100|NCT01253187|515434410|FG001|Period 3|non-compliance|0|||
142972101|NCT01253187|515434411|FG002|Period 3|non-compliance|0|||
142972102|NCT01253187|515434412|FG003|Period 3|non-compliance|0|||
142972103|NCT01253187|515434413|FG004|Period 3|non-compliance|1|||
142972104|NCT01253187|515434414|FG005|Period 3|non-compliance|0|||
142972105|NCT00600028|515434416|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
142972106|NCT00600028|515434417|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
142972107|NCT00600028|515434416|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
142972108|NCT00600028|515434417|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
142972109|NCT00600028|515434416|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
142972110|NCT00600028|515434417|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
142972111|NCT03172481|515434418|FG000|Double-blind|Withdrawal by Subject|1|||
142972112|NCT03172481|515434419|FG001|Double-blind|Withdrawal by Subject|0|||
142972113|NCT02759562|515434420|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
142972114|NCT02759562|515434421|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
142972115|NCT02759562|515434420|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
142972116|NCT02759562|515434421|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
142972117|NCT03587584|515434422|FG000|Overall Study|SOC deviations|4|||
142972118|NCT03587584|515434423|FG001|Overall Study|SOC deviations|6|||
142972119|NCT03587584|515434422|FG000|Overall Study|Incomplete data|0|||
142972120|NCT03587584|515434423|FG001|Overall Study|Incomplete data|3|||
142972121|NCT01061736|515434424|FG000|Overall Study|Dose regimen not selected|0|||
142972122|NCT01061736|515434425|FG001|Overall Study|Dose regimen not selected|0|||
142972123|NCT01061736|515434426|FG002|Overall Study|Dose regimen not selected|0|||
142972124|NCT01061736|515434427|FG003|Overall Study|Dose regimen not selected|0|||
142972125|NCT01061736|515434428|FG004|Overall Study|Dose regimen not selected|0|||
142972126|NCT01061736|515434429|FG005|Overall Study|Dose regimen not selected|0|||
142972127|NCT01061736|515434430|FG006|Overall Study|Dose regimen not selected|79|||
142972128|NCT01061736|515434431|FG007|Overall Study|Dose regimen not selected|0|||
142972129|NCT01061736|515434432|FG008|Overall Study|Dose regimen not selected|0|||
142972130|NCT01061736|515434433|FG009|Overall Study|Dose regimen not selected|0|||
142972131|NCT01061736|515434424|FG000|Overall Study|Adverse Event|13|||
142972132|NCT01061736|515434425|FG001|Overall Study|Adverse Event|1|||
142972133|NCT01061736|515434426|FG002|Overall Study|Adverse Event|3|||
142972134|NCT01061736|515434427|FG003|Overall Study|Adverse Event|2|||
142972135|NCT01061736|515434428|FG004|Overall Study|Adverse Event|4|||
142972136|NCT01061736|515434429|FG005|Overall Study|Adverse Event|1|||
142972137|NCT01061736|515434430|FG006|Overall Study|Adverse Event|4|||
142972138|NCT01061736|515434431|FG007|Overall Study|Adverse Event|63|||
142972139|NCT01061736|515434432|FG008|Overall Study|Adverse Event|67|||
142972140|NCT01061736|515434433|FG009|Overall Study|Adverse Event|34|||
142972141|NCT01061736|515434424|FG000|Overall Study|Lack of Efficacy|0|||
142972142|NCT01061736|515434425|FG001|Overall Study|Lack of Efficacy|2|||
142972143|NCT01061736|515434426|FG002|Overall Study|Lack of Efficacy|1|||
142972144|NCT01061736|515434427|FG003|Overall Study|Lack of Efficacy|1|||
142972145|NCT01061736|515434428|FG004|Overall Study|Lack of Efficacy|1|||
142972146|NCT01061736|515434429|FG005|Overall Study|Lack of Efficacy|2|||
142972147|NCT01061736|515434430|FG006|Overall Study|Lack of Efficacy|1|||
142972148|NCT01061736|515434431|FG007|Overall Study|Lack of Efficacy|9|||
142972149|NCT01061736|515434432|FG008|Overall Study|Lack of Efficacy|9|||
142972150|NCT01061736|515434433|FG009|Overall Study|Lack of Efficacy|10|||
142972151|NCT01061736|515434424|FG000|Overall Study|Poor compliance to protocol|0|||
142972152|NCT01061736|515434425|FG001|Overall Study|Poor compliance to protocol|0|||
142972153|NCT01061736|515434426|FG002|Overall Study|Poor compliance to protocol|0|||
142972154|NCT01061736|515434427|FG003|Overall Study|Poor compliance to protocol|0|||
142972155|NCT01061736|515434428|FG004|Overall Study|Poor compliance to protocol|0|||
142972156|NCT01061736|515434429|FG005|Overall Study|Poor compliance to protocol|0|||
142972157|NCT01061736|515434430|FG006|Overall Study|Poor compliance to protocol|0|||
142972158|NCT01061736|515434431|FG007|Overall Study|Poor compliance to protocol|2|||
142972159|NCT01061736|515434432|FG008|Overall Study|Poor compliance to protocol|5|||
142972160|NCT01061736|515434433|FG009|Overall Study|Poor compliance to protocol|9|||
142972161|NCT01061736|515434424|FG000|Overall Study|Not treated|0|||
142972162|NCT01061736|515434425|FG001|Overall Study|Not treated|0|||
142972163|NCT01061736|515434426|FG002|Overall Study|Not treated|0|||
142972164|NCT01061736|515434427|FG003|Overall Study|Not treated|0|||
142972165|NCT01061736|515434428|FG004|Overall Study|Not treated|1|||
142972166|NCT01061736|515434429|FG005|Overall Study|Not treated|0|||
142972167|NCT01061736|515434430|FG006|Overall Study|Not treated|0|||
142972168|NCT01061736|515434431|FG007|Overall Study|Not treated|2|||
142972169|NCT01061736|515434432|FG008|Overall Study|Not treated|1|||
142972170|NCT01061736|515434433|FG009|Overall Study|Not treated|0|||
142972171|NCT01061736|515434424|FG000|Overall Study|Other than specified above|0|||
142972172|NCT01061736|515434425|FG001|Overall Study|Other than specified above|1|||
142972173|NCT01061736|515434426|FG002|Overall Study|Other than specified above|2|||
142972174|NCT01061736|515434427|FG003|Overall Study|Other than specified above|0|||
142972175|NCT01061736|515434428|FG004|Overall Study|Other than specified above|1|||
142972176|NCT01061736|515434429|FG005|Overall Study|Other than specified above|0|||
142972177|NCT01061736|515434430|FG006|Overall Study|Other than specified above|0|||
142972178|NCT01061736|515434431|FG007|Overall Study|Other than specified above|18|||
142972179|NCT01061736|515434432|FG008|Overall Study|Other than specified above|15|||
142972180|NCT01061736|515434433|FG009|Overall Study|Other than specified above|21|||
142972181|NCT01093755|515434437|FG000|Overall Study|Withdrawal by Subject|3|||
142972182|NCT01093755|515434438|FG001|Overall Study|Withdrawal by Subject|4|||
142972183|NCT03115112|515434439|FG000|Overall Study|Adverse Event|5|||
142972184|NCT03115112|515434440|FG001|Overall Study|Adverse Event|1|||
142972185|NCT03115112|515434439|FG000|Overall Study|Withdrawal by Subject|4|||
142972186|NCT03115112|515434440|FG001|Overall Study|Withdrawal by Subject|2|||
142972187|NCT03115112|515434439|FG000|Overall Study|Lost to Follow-up|0|||
142972188|NCT03115112|515434440|FG001|Overall Study|Lost to Follow-up|1|||
142972189|NCT03115112|515434439|FG000|Overall Study|Death|1|||
142972190|NCT03115112|515434440|FG001|Overall Study|Death|0|||
142972191|NCT03115112|515434439|FG000|Overall Study|Pregnancy|1|||
142972192|NCT03115112|515434440|FG001|Overall Study|Pregnancy|0|||
142972193|NCT03115112|515434439|FG000|Overall Study|Site closure|1|||
142972194|NCT03115112|515434440|FG001|Overall Study|Site closure|1|||
142972195|NCT04019795|515434442|FG000|Overall Study|Withdrawal by Subject|1|||
142972196|NCT04019795|515434443|FG001|Overall Study|Withdrawal by Subject|2|||
142972197|NCT04019795|515434444|FG002|Overall Study|Withdrawal by Subject|2|||
142972198|NCT04019795|515434445|FG003|Overall Study|Withdrawal by Subject|1|||
142972199|NCT04019795|515434442|FG000|Overall Study|Lost to Follow-up|0|||
142972200|NCT04019795|515434443|FG001|Overall Study|Lost to Follow-up|1|||
142972201|NCT04019795|515434444|FG002|Overall Study|Lost to Follow-up|1|||
142972202|NCT04019795|515434445|FG003|Overall Study|Lost to Follow-up|2|||
142972203|NCT04019795|515434442|FG000|Overall Study|Treatment non-compliance|3|||
142972204|NCT04019795|515434443|FG001|Overall Study|Treatment non-compliance|1|||
142972205|NCT04019795|515434444|FG002|Overall Study|Treatment non-compliance|2|||
142972206|NCT04019795|515434445|FG003|Overall Study|Treatment non-compliance|0|||
142972207|NCT04019795|515434442|FG000|Overall Study|Physician Decision|0|||
142972208|NCT04019795|515434443|FG001|Overall Study|Physician Decision|0|||
142972209|NCT04019795|515434444|FG002|Overall Study|Physician Decision|1|||
142972210|NCT04019795|515434445|FG003|Overall Study|Physician Decision|0|||
142972211|NCT04019795|515434442|FG000|Overall Study|Adverse Event|1|||
142972212|NCT04019795|515434443|FG001|Overall Study|Adverse Event|0|||
142972213|NCT04019795|515434444|FG002|Overall Study|Adverse Event|0|||
142972214|NCT04019795|515434445|FG003|Overall Study|Adverse Event|0|||
142972215|NCT00980343|515434450|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
142972216|NCT00980343|515434451|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
142972217|NCT02899377|515434461|FG000|Overall Study|Adverse Event|1|||
142972218|NCT02899377|515434462|FG001|Overall Study|Adverse Event|0|||
142972219|NCT01231607|515434463|FG000|Overall Study|Adverse Event|0|||
142972220|NCT01231607|515434464|FG001|Overall Study|Adverse Event|8|||
142972221|NCT01231607|515434465|FG002|Overall Study|Adverse Event|4|||
142972222|NCT01231607|515434466|FG003|Overall Study|Adverse Event|4|||
142972223|NCT01231607|515434467|FG004|Overall Study|Adverse Event|5|||
142972224|NCT01231607|515434463|FG000|Overall Study|Lost to Follow-up|13|||
142972225|NCT01231607|515434464|FG001|Overall Study|Lost to Follow-up|11|||
142972226|NCT01231607|515434465|FG002|Overall Study|Lost to Follow-up|10|||
142972227|NCT01231607|515434466|FG003|Overall Study|Lost to Follow-up|10|||
142972228|NCT01231607|515434467|FG004|Overall Study|Lost to Follow-up|4|||
142972229|NCT01231607|515434463|FG000|Overall Study|Physician Decision|4|||
142972230|NCT01231607|515434464|FG001|Overall Study|Physician Decision|4|||
142972231|NCT01231607|515434465|FG002|Overall Study|Physician Decision|3|||
142972232|NCT01231607|515434466|FG003|Overall Study|Physician Decision|5|||
142972233|NCT01231607|515434467|FG004|Overall Study|Physician Decision|4|||
142972234|NCT01231607|515434463|FG000|Overall Study|Protocol Violation|3|||
142972235|NCT01231607|515434464|FG001|Overall Study|Protocol Violation|2|||
142972236|NCT01231607|515434465|FG002|Overall Study|Protocol Violation|0|||
142972237|NCT01231607|515434466|FG003|Overall Study|Protocol Violation|2|||
142972238|NCT01231607|515434467|FG004|Overall Study|Protocol Violation|2|||
142972239|NCT01231607|515434463|FG000|Overall Study|Withdrawal by Subject|9|||
142972240|NCT01231607|515434464|FG001|Overall Study|Withdrawal by Subject|9|||
142972241|NCT01231607|515434465|FG002|Overall Study|Withdrawal by Subject|14|||
142972242|NCT01231607|515434466|FG003|Overall Study|Withdrawal by Subject|17|||
142972243|NCT01231607|515434467|FG004|Overall Study|Withdrawal by Subject|9|||
142972244|NCT01204697|515434469|FG000|Overall Study|Death|26|||
142972245|NCT01204697|515434470|FG001|Overall Study|Death|27|||
142972246|NCT01204697|515434469|FG000|Overall Study|Lost to Follow-up|3|||
142972247|NCT01204697|515434470|FG001|Overall Study|Lost to Follow-up|4|||
142972248|NCT01204697|515434469|FG000|Overall Study|Withdrawal by Subject|2|||
142972249|NCT01204697|515434470|FG001|Overall Study|Withdrawal by Subject|4|||
142972250|NCT01204697|515434469|FG000|Overall Study|Randomized, but not treated|0|||
142972251|NCT01204697|515434470|FG001|Overall Study|Randomized, but not treated|1|||
142972252|NCT01170702|515434471|FG000|Overall Study|Exclusion criteria met after consent|1|||
142972253|NCT01170702|515434472|FG001|Overall Study|Exclusion criteria met after consent|2|||
142972254|NCT01170702|515434473|FG002|Overall Study|Exclusion criteria met after consent|0|||
142972255|NCT01170702|515434474|FG003|Overall Study|Exclusion criteria met after consent|2|||
142972256|NCT00098020|515434477|FG000|Overall Study|Adverse Event|2|||
142972257|NCT00098020|515434477|FG000|Overall Study|Lost to Follow-up|1|||
142972258|NCT00098020|515434477|FG000|Overall Study|elevated liver enzymes|1|||
142972259|NCT00098020|515434477|FG000|Overall Study|Low urine PCR|1|||
142972260|NCT00098020|515434477|FG000|Overall Study|Low epidermal growth factor receptor|1|||
142972261|NCT01453998|515434478|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
142972262|NCT01453998|515434479|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
142972263|NCT01453998|515434480|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
142972264|NCT00712933|515434483|FG000|Overall Study|Adverse Event|69|||
142972265|NCT00712933|515434483|FG000|Overall Study|Lack of Efficacy|6|||
142972266|NCT00712933|515434483|FG000|Overall Study|Lost to Follow-up|22|||
142972267|NCT00712933|515434483|FG000|Overall Study|Non-compliance with study drug|13|||
142972268|NCT00712933|515434483|FG000|Overall Study|Other Pregnancy|37|||
142972269|NCT00712933|515434483|FG000|Overall Study|Sponsor decision|14|||
142972270|NCT00712933|515434483|FG000|Overall Study|Withdrew consent|4|||
142972271|NCT00712933|515434483|FG000|Overall Study|Hip replacement surgery|1|||
142972272|NCT00712933|515434483|FG000|Overall Study|Involved in Clinical research|3|||
142972273|NCT00712933|515434483|FG000|Overall Study|Participant hospitalized|1|||
142972274|NCT00712933|515434483|FG000|Overall Study|Participant travelled overseas|2|||
142972275|NCT00712933|515434483|FG000|Overall Study|Death of patient|1|||
142972276|NCT00712933|515434483|FG000|Overall Study|Other Physician decision|1|||
142972277|NCT00712933|515434483|FG000|Overall Study|Not committed to contraception|1|||
142972278|NCT00712933|515434483|FG000|Overall Study|Participant received medication|1|||
142972279|NCT00712933|515434483|FG000|Overall Study|Physician Decision|36|||
142972280|NCT00712933|515434483|FG000|Overall Study|Protocol Violation|4|||
142972281|NCT00712933|515434483|FG000|Overall Study|Withdrawal by Subject|151|||
142972282|NCT00085917|515434484|FG000|Overall Study|Adverse Event|4|||
142972283|NCT00085917|515434485|FG001|Overall Study|Adverse Event|3|||
142972284|NCT02022033|515434489|FG000|Overall Study|Physician Decision|1|||
142972285|NCT01429077|515434490|FG000|Overall Study|Lost to Follow-up|0|||
142972286|NCT01429077|515434491|FG001|Overall Study|Lost to Follow-up|3|||
142972287|NCT01413542|515434493|FG000|Overall Study|Physician Decision|1|||
142972288|NCT01413542|515434494|FG001|Overall Study|Physician Decision|0|||
142972289|NCT01413542|515434495|FG002|Overall Study|Physician Decision|3|||
142972290|NCT01413542|515434496|FG003|Overall Study|Physician Decision|0|||
142972291|NCT01413542|515434493|FG000|Overall Study|Adverse Event|0|||
142972292|NCT01413542|515434494|FG001|Overall Study|Adverse Event|0|||
142972293|NCT01413542|515434495|FG002|Overall Study|Adverse Event|0|||
142972294|NCT01413542|515434496|FG003|Overall Study|Adverse Event|1|||
142972295|NCT01879319|515434499|FG000|Overall Study|Withdrawal by Subject|1|||
142972296|NCT01879319|515434500|FG001|Overall Study|Withdrawal by Subject|0|||
142972297|NCT01879319|515434499|FG000|Overall Study|Lost to Follow-up|1|||
142972298|NCT01879319|515434500|FG001|Overall Study|Lost to Follow-up|5|||
142972299|NCT04724733|515434501|FG000|Overall Study|Lost to Follow-up|1|||
142972300|NCT04724733|515434502|FG001|Overall Study|Lost to Follow-up|1|||
142972301|NCT04724733|515434503|FG002|Overall Study|Lost to Follow-up|1|||
142972302|NCT03067129|515434504|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
142972303|NCT03067129|515434505|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
142972304|NCT03067129|515434506|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
142972305|NCT03067129|515434507|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
142972306|NCT03067129|515434504|FG000|Overall Study|Withdrawal by Subject|0|||
142972307|NCT03067129|515434505|FG001|Overall Study|Withdrawal by Subject|0|||
142972308|NCT03067129|515434506|FG002|Overall Study|Withdrawal by Subject|1|||
142972309|NCT03067129|515434507|FG003|Overall Study|Withdrawal by Subject|2|||
142972310|NCT03067129|515434504|FG000|Overall Study|Lost to Follow-up|5|||
142972311|NCT03067129|515434505|FG001|Overall Study|Lost to Follow-up|5|||
142972312|NCT03067129|515434506|FG002|Overall Study|Lost to Follow-up|4|||
142972313|NCT03067129|515434507|FG003|Overall Study|Lost to Follow-up|3|||
142972314|NCT03084718|515434508|FG000|Overall Study|Withdrawal by Subject|4|||
142972315|NCT03084718|515434509|FG001|Overall Study|Withdrawal by Subject|3|||
142972316|NCT03084718|515434510|FG002|Overall Study|Withdrawal by Subject|4|||
142972317|NCT03084718|515434511|FG003|Overall Study|Withdrawal by Subject|0|||
142972318|NCT03084718|515434512|FG004|Overall Study|Withdrawal by Subject|0|||
142972319|NCT03084718|515434508|FG000|Overall Study|Physician Decision|1|||
142972320|NCT03084718|515434509|FG001|Overall Study|Physician Decision|0|||
142972321|NCT03084718|515434510|FG002|Overall Study|Physician Decision|0|||
142972322|NCT03084718|515434511|FG003|Overall Study|Physician Decision|0|||
142972323|NCT03084718|515434512|FG004|Overall Study|Physician Decision|0|||
142972324|NCT03084718|515434508|FG000|Overall Study|Adverse Event|3|||
142972325|NCT03084718|515434509|FG001|Overall Study|Adverse Event|5|||
142972326|NCT03084718|515434510|FG002|Overall Study|Adverse Event|5|||
142972327|NCT03084718|515434511|FG003|Overall Study|Adverse Event|8|||
142972328|NCT03084718|515434512|FG004|Overall Study|Adverse Event|2|||
142972329|NCT03084718|515434508|FG000|Overall Study|Lack of Efficacy|2|||
142972330|NCT03084718|515434509|FG001|Overall Study|Lack of Efficacy|0|||
142972331|NCT03084718|515434510|FG002|Overall Study|Lack of Efficacy|1|||
142972332|NCT03084718|515434511|FG003|Overall Study|Lack of Efficacy|4|||
142972333|NCT03084718|515434512|FG004|Overall Study|Lack of Efficacy|0|||
142972334|NCT03084718|515434508|FG000|Overall Study|Lost to Follow-up|0|||
142972335|NCT03084718|515434509|FG001|Overall Study|Lost to Follow-up|1|||
142972336|NCT03084718|515434510|FG002|Overall Study|Lost to Follow-up|0|||
143117160|NCT01256385|515970045|FG000|Overall Study|Withdrawal by Subject|2|||
142972337|NCT03084718|515434511|FG003|Overall Study|Lost to Follow-up|0|||
142972338|NCT03084718|515434512|FG004|Overall Study|Lost to Follow-up|2|||
142972339|NCT03084718|515434508|FG000|Overall Study|Protocol Violation|0|||
142972340|NCT03084718|515434509|FG001|Overall Study|Protocol Violation|0|||
142972341|NCT03084718|515434510|FG002|Overall Study|Protocol Violation|1|||
142972342|NCT03084718|515434511|FG003|Overall Study|Protocol Violation|0|||
142972343|NCT03084718|515434512|FG004|Overall Study|Protocol Violation|0|||
142972344|NCT03084718|515434508|FG000|Overall Study|Death|0|||
142972345|NCT03084718|515434509|FG001|Overall Study|Death|1|||
142972346|NCT03084718|515434510|FG002|Overall Study|Death|0|||
142972347|NCT03084718|515434511|FG003|Overall Study|Death|0|||
142972348|NCT03084718|515434512|FG004|Overall Study|Death|0|||
142972349|NCT03084718|515434508|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
142972350|NCT03084718|515434509|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
142972351|NCT03084718|515434510|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
142972352|NCT03084718|515434511|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
142972353|NCT03084718|515434512|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
142972354|NCT02806947|515434513|FG000|Overall Study|Withdrawal by Subject|5|||
142972355|NCT02806947|515434514|FG001|Overall Study|Withdrawal by Subject|1|||
142972356|NCT03986190|515434515|FG000|Overall Study|Withdrawal by Subject|12|||
142972357|NCT03986190|515434516|FG001|Overall Study|Withdrawal by Subject|0|||
142972358|NCT04929613|515434517|FG000|Overall Study|Withdrawal by Subject|12|||
142972359|NCT00418379|515434519|FG000|Year 1|Adverse Event|9|||
142972360|NCT00418379|515434520|FG001|Year 1|Adverse Event|15|||
142972361|NCT00418379|515434521|FG002|Year 1|Adverse Event|3|||
142972362|NCT00418379|515434519|FG000|Year 1|Withdrawal by Subject|7|||
142972363|NCT00418379|515434520|FG001|Year 1|Withdrawal by Subject|8|||
142972364|NCT00418379|515434521|FG002|Year 1|Withdrawal by Subject|5|||
142972365|NCT00418379|515434519|FG000|Year 1|Any other reason not above-mentioned|2|||
142972366|NCT00418379|515434520|FG001|Year 1|Any other reason not above-mentioned|5|||
142972367|NCT00418379|515434521|FG002|Year 1|Any other reason not above-mentioned|7|||
142972368|NCT00418379|515434519|FG000|Year 2|Adverse Event|5|||
142972369|NCT00418379|515434520|FG001|Year 2|Adverse Event|2|||
142972370|NCT00418379|515434521|FG002|Year 2|Adverse Event|1|||
142972371|NCT00418379|515434519|FG000|Year 2|Withdrawal by Subject|1|||
142972372|NCT00418379|515434520|FG001|Year 2|Withdrawal by Subject|1|||
142972373|NCT00418379|515434521|FG002|Year 2|Withdrawal by Subject|3|||
142972374|NCT00418379|515434519|FG000|Year 2|Any other reason not above-mentioned|2|||
142972375|NCT00418379|515434520|FG001|Year 2|Any other reason not above-mentioned|1|||
142972376|NCT00418379|515434521|FG002|Year 2|Any other reason not above-mentioned|6|||
142972377|NCT00418379|515434519|FG000|Year 3|Withdrawal by Subject|1|||
142972378|NCT00418379|515434520|FG001|Year 3|Withdrawal by Subject|1|||
142972379|NCT00418379|515434521|FG002|Year 3|Withdrawal by Subject|2|||
142972380|NCT00418379|515434519|FG000|Year 3|Any other reason not above-mentioned|2|||
142972381|NCT00418379|515434520|FG001|Year 3|Any other reason not above-mentioned|1|||
142972382|NCT00418379|515434521|FG002|Year 3|Any other reason not above-mentioned|1|||
142972383|NCT00418379|515434519|FG000|Year 4|Adverse Event|0|||
142972384|NCT00418379|515434520|FG001|Year 4|Adverse Event|1|||
142972385|NCT00418379|515434521|FG002|Year 4|Adverse Event|0|||
142972386|NCT00418379|515434519|FG000|Year 4|Withdrawal by Subject|2|||
142972387|NCT00418379|515434520|FG001|Year 4|Withdrawal by Subject|3|||
142972388|NCT00418379|515434521|FG002|Year 4|Withdrawal by Subject|2|||
142972389|NCT00418379|515434519|FG000|Year 4|Any other reason not above-mentioned|1|||
142972390|NCT00418379|515434520|FG001|Year 4|Any other reason not above-mentioned|1|||
142972391|NCT00418379|515434521|FG002|Year 4|Any other reason not above-mentioned|0|||
142972392|NCT00418379|515434519|FG000|Year 5|Adverse Event|0|||
142972393|NCT00418379|515434520|FG001|Year 5|Adverse Event|1|||
142972394|NCT00418379|515434521|FG002|Year 5|Adverse Event|0|||
142972395|NCT00418379|515434519|FG000|Year 5|Any other reason not above-mentioned|2|||
142972396|NCT00418379|515434520|FG001|Year 5|Any other reason not above-mentioned|4|||
142972397|NCT00418379|515434521|FG002|Year 5|Any other reason not above-mentioned|3|||
142972398|NCT03483116|515434525|FG000|Overall Study|Adverse Event|0|||
142972399|NCT03483116|515434526|FG001|Overall Study|Adverse Event|1|||
142972400|NCT03483116|515434527|FG002|Overall Study|Adverse Event|0|||
142972401|NCT03483116|515434528|FG003|Overall Study|Adverse Event|1|||
142972402|NCT03483116|515434525|FG000|Overall Study|Protocol Violation|1|||
142972403|NCT03483116|515434526|FG001|Overall Study|Protocol Violation|0|||
142972404|NCT03483116|515434527|FG002|Overall Study|Protocol Violation|0|||
142972405|NCT03483116|515434528|FG003|Overall Study|Protocol Violation|7|||
142972406|NCT03483116|515434525|FG000|Overall Study|Lost to Follow-up|9|||
142972407|NCT03483116|515434526|FG001|Overall Study|Lost to Follow-up|4|||
142972408|NCT03483116|515434527|FG002|Overall Study|Lost to Follow-up|9|||
142972409|NCT03483116|515434528|FG003|Overall Study|Lost to Follow-up|5|||
143455588|NCT04602221|517212481|FG004|Overall Study|Withdrawal by Subject|0|||
143455589|NCT04602221|517212482|FG005|Overall Study|Withdrawal by Subject|0|||
142972410|NCT03483116|515434525|FG000|Overall Study|Death|1|||
142972411|NCT03483116|515434526|FG001|Overall Study|Death|0|||
142972412|NCT03483116|515434527|FG002|Overall Study|Death|2|||
142972413|NCT03483116|515434528|FG003|Overall Study|Death|1|||
142972414|NCT03483116|515434525|FG000|Overall Study|Withdrawal by Subject|14|||
142972415|NCT03483116|515434526|FG001|Overall Study|Withdrawal by Subject|16|||
142972416|NCT03483116|515434527|FG002|Overall Study|Withdrawal by Subject|14|||
142972417|NCT03483116|515434528|FG003|Overall Study|Withdrawal by Subject|16|||
142972418|NCT03483116|515434525|FG000|Overall Study|Unknown other reason|3|||
142972419|NCT03483116|515434526|FG001|Overall Study|Unknown other reason|2|||
142972420|NCT03483116|515434527|FG002|Overall Study|Unknown other reason|1|||
142972421|NCT03483116|515434528|FG003|Overall Study|Unknown other reason|1|||
142972422|NCT00239837|515434530|FG000|Overall Study|Lost to Follow-up|3|||
142972423|NCT00239837|515434531|FG001|Overall Study|Lost to Follow-up|7|||
142972424|NCT01838590|515434532|FG000|Overall Study|Lack of Efficacy|12|||
142972425|NCT01838590|515434533|FG001|Overall Study|Lack of Efficacy|4|||
142972426|NCT01838590|515434532|FG000|Overall Study|Lost to Follow-up|0|||
142972427|NCT01838590|515434533|FG001|Overall Study|Lost to Follow-up|1|||
142972428|NCT04685499|515434534|FG000|Overall Study|Study Terminated Early|1|||
142972429|NCT03176277|515434535|FG000|Part A Dose Escalation Study|Adverse Event|1|||
142972430|NCT03176277|515434536|FG001|Part A Dose Escalation Study|Adverse Event|0|||
142972431|NCT03176277|515434537|FG002|Part A Dose Escalation Study|Adverse Event|1|||
142972432|NCT03176277|515434538|FG003|Part A Dose Escalation Study|Adverse Event|0|||
142972433|NCT03176277|515434535|FG000|Part A Dose Escalation Study|Physician Decision|1|||
142972434|NCT03176277|515434536|FG001|Part A Dose Escalation Study|Physician Decision|1|||
142972435|NCT03176277|515434537|FG002|Part A Dose Escalation Study|Physician Decision|2|||
142972436|NCT03176277|515434538|FG003|Part A Dose Escalation Study|Physician Decision|0|||
142972437|NCT03176277|515434535|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
142972438|NCT03176277|515434536|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
142972439|NCT03176277|515434537|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
142972440|NCT03176277|515434538|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
142972441|NCT03176277|515434535|FG000|Part A Dose Escalation Study|Progressive disease|3|||
142972442|NCT03176277|515434536|FG001|Part A Dose Escalation Study|Progressive disease|1|||
142972443|NCT03176277|515434537|FG002|Part A Dose Escalation Study|Progressive disease|3|||
142972444|NCT03176277|515434538|FG003|Part A Dose Escalation Study|Progressive disease|0|||
142972445|NCT00634114|515434539|FG000|Overall Study|Adverse Event|6|||
142972446|NCT00634114|515434540|FG001|Overall Study|Adverse Event|8|||
142972447|NCT00634114|515434541|FG002|Overall Study|Adverse Event|3|||
142972448|NCT00634114|515434539|FG000|Overall Study|Withdrawal by Subject|9|||
142972449|NCT00634114|515434540|FG001|Overall Study|Withdrawal by Subject|6|||
142972450|NCT00634114|515434541|FG002|Overall Study|Withdrawal by Subject|11|||
142972451|NCT00634114|515434539|FG000|Overall Study|Lost to Follow-up|0|||
142972452|NCT00634114|515434540|FG001|Overall Study|Lost to Follow-up|0|||
142972453|NCT00634114|515434541|FG002|Overall Study|Lost to Follow-up|1|||
142972454|NCT00634114|515434539|FG000|Overall Study|Protocol Violation|3|||
142972455|NCT00634114|515434540|FG001|Overall Study|Protocol Violation|3|||
142972456|NCT00634114|515434541|FG002|Overall Study|Protocol Violation|1|||
142972457|NCT00634114|515434539|FG000|Overall Study|Pregnancy|1|||
142972458|NCT00634114|515434540|FG001|Overall Study|Pregnancy|0|||
142972459|NCT00634114|515434541|FG002|Overall Study|Pregnancy|0|||
142972460|NCT00634114|515434539|FG000|Overall Study|Incorrect enrolment|0|||
142972461|NCT00634114|515434540|FG001|Overall Study|Incorrect enrolment|1|||
142972462|NCT00634114|515434541|FG002|Overall Study|Incorrect enrolment|0|||
142972463|NCT00634114|515434539|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
142972464|NCT00634114|515434540|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
142972465|NCT00634114|515434541|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
142972466|NCT00634114|515434539|FG000|Overall Study|Difficult to continue|3|||
142972467|NCT00634114|515434540|FG001|Overall Study|Difficult to continue|1|||
142972468|NCT00634114|515434541|FG002|Overall Study|Difficult to continue|1|||
142972469|NCT00634114|515434539|FG000|Overall Study|Other reason|1|||
142972470|NCT00634114|515434540|FG001|Overall Study|Other reason|1|||
142972471|NCT00634114|515434541|FG002|Overall Study|Other reason|1|||
142972472|NCT02475395|515434546|FG000|Overall Study|Protocol Violation|30|||
142972473|NCT02475395|515434547|FG001|Overall Study|Protocol Violation|3|||
142972474|NCT00393913|515434548|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
142972475|NCT00393913|515434548|FG000|Initial Assessment|Withdrawal by Subject|16|||
142972476|NCT00393913|515434548|FG000|CPAP|Withdrawal by Subject|3|||
142972477|NCT00393913|515434548|FG000|CPAP|Physician Decision|1|||
142972478|NCT00393913|515434548|FG000|CPAP|TEchnical problem with CPAP|3|||
142972479|NCT01518244|515434549|FG000|Overall Study|Adverse Event|3|||
142972480|NCT00870818|515434550|FG000|Overall Study|Lost to Follow-up|3|||
142972481|NCT00870818|515434551|FG001|Overall Study|Lost to Follow-up|2|||
142972482|NCT00870818|515434552|FG002|Overall Study|Lost to Follow-up|1|||
142972483|NCT00870818|515434553|FG003|Overall Study|Lost to Follow-up|0|||
142972484|NCT00870818|515434554|FG004|Overall Study|Lost to Follow-up|0|||
142972485|NCT00870818|515434550|FG000|Overall Study|Withdrawal by Subject|0|||
142972486|NCT00870818|515434551|FG001|Overall Study|Withdrawal by Subject|0|||
142972487|NCT00870818|515434552|FG002|Overall Study|Withdrawal by Subject|1|||
142972488|NCT00870818|515434553|FG003|Overall Study|Withdrawal by Subject|2|||
142972489|NCT00870818|515434554|FG004|Overall Study|Withdrawal by Subject|0|||
142972490|NCT00870818|515434550|FG000|Overall Study|Terminated by sponsor|29|||
142972491|NCT00870818|515434551|FG001|Overall Study|Terminated by sponsor|70|||
142972492|NCT00870818|515434552|FG002|Overall Study|Terminated by sponsor|36|||
142972493|NCT00870818|515434553|FG003|Overall Study|Terminated by sponsor|36|||
142972494|NCT00870818|515434554|FG004|Overall Study|Terminated by sponsor|38|||
142972495|NCT00870818|515434550|FG000|Overall Study|Other|0|||
142972496|NCT00870818|515434551|FG001|Overall Study|Other|1|||
142972497|NCT00870818|515434552|FG002|Overall Study|Other|0|||
142972498|NCT00870818|515434553|FG003|Overall Study|Other|0|||
142972499|NCT00870818|515434554|FG004|Overall Study|Other|0|||
142972500|NCT04900038|515434557|FG000|Overall Study|Adverse Event|1|||
142972501|NCT04900038|515434558|FG001|Overall Study|Adverse Event|0|||
142972502|NCT04900038|515434559|FG002|Overall Study|Adverse Event|1|||
142972503|NCT04900038|515434560|FG003|Overall Study|Adverse Event|1|||
142972504|NCT04900038|515434557|FG000|Overall Study|Withdrawal by Subject|0|||
142972505|NCT04900038|515434558|FG001|Overall Study|Withdrawal by Subject|1|||
142972506|NCT04900038|515434559|FG002|Overall Study|Withdrawal by Subject|0|||
142972507|NCT04900038|515434560|FG003|Overall Study|Withdrawal by Subject|0|||
142972508|NCT04900038|515434557|FG000|Overall Study|Study terminated by sponsor|18|||
142972509|NCT04900038|515434558|FG001|Overall Study|Study terminated by sponsor|15|||
142972510|NCT04900038|515434559|FG002|Overall Study|Study terminated by sponsor|17|||
142972511|NCT04900038|515434560|FG003|Overall Study|Study terminated by sponsor|14|||
142972512|NCT04900038|515434557|FG000|Overall Study|Protocol Deviation|1|||
142972513|NCT04900038|515434558|FG001|Overall Study|Protocol Deviation|1|||
142972514|NCT04900038|515434559|FG002|Overall Study|Protocol Deviation|0|||
142972515|NCT04900038|515434560|FG003|Overall Study|Protocol Deviation|0|||
142972516|NCT04900038|515434557|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
142972517|NCT04900038|515434558|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
142972518|NCT04900038|515434559|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
142972519|NCT04900038|515434560|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
142972520|NCT04900038|515434557|FG000|Overall Study|Lost to Follow-up|0|||
142972521|NCT04900038|515434558|FG001|Overall Study|Lost to Follow-up|0|||
142972522|NCT04900038|515434559|FG002|Overall Study|Lost to Follow-up|0|||
142972523|NCT04900038|515434560|FG003|Overall Study|Lost to Follow-up|1|||
142972524|NCT00986427|515434562|FG000|Overall Study|Lost to Follow-up|2|||
142972525|NCT00986427|515434563|FG001|Overall Study|Lost to Follow-up|0|||
142972526|NCT00986427|515434562|FG000|Overall Study|Lack of Efficacy|1|||
142972527|NCT00986427|515434563|FG001|Overall Study|Lack of Efficacy|0|||
142972528|NCT00986427|515434562|FG000|Overall Study|Withdrawal by Subject|1|||
142972529|NCT00986427|515434563|FG001|Overall Study|Withdrawal by Subject|0|||
142972530|NCT06025396|515436124|FG000|Overall Study|Protocol-Specified Withdrawal|5|||
142972531|NCT06025396|515436125|FG001|Overall Study|Protocol-Specified Withdrawal|0|||
142972532|NCT06025396|515436126|FG002|Overall Study|Protocol-Specified Withdrawal|0|||
142972533|NCT06025396|515436127|FG003|Overall Study|Protocol-Specified Withdrawal|1|||
142972534|NCT06025396|515436128|FG004|Overall Study|Protocol-Specified Withdrawal|1|||
142972535|NCT06025396|515436124|FG000|Overall Study|Withdrawal by Subject|0|||
142972536|NCT06025396|515436125|FG001|Overall Study|Withdrawal by Subject|1|||
142972537|NCT06025396|515436126|FG002|Overall Study|Withdrawal by Subject|1|||
142972538|NCT06025396|515436127|FG003|Overall Study|Withdrawal by Subject|0|||
142972539|NCT06025396|515436128|FG004|Overall Study|Withdrawal by Subject|0|||
142972540|NCT01512108|515436129|FG000|Overall Study|Adverse Event|9|||
142972541|NCT01512108|515436130|FG001|Overall Study|Adverse Event|4|||
142972542|NCT01512108|515436129|FG000|Overall Study|Protocol Violation|1|||
142972543|NCT01512108|515436130|FG001|Overall Study|Protocol Violation|2|||
142972544|NCT01512108|515436129|FG000|Overall Study|Withdrawal Criteria|1|||
142972545|NCT01512108|515436130|FG001|Overall Study|Withdrawal Criteria|0|||
142972546|NCT01512108|515436129|FG000|Overall Study|Unclassified|11|||
142972547|NCT01512108|515436130|FG001|Overall Study|Unclassified|3|||
142972548|NCT01283997|515436135|FG000|Overall Study|Physician Decision|8|||
142972549|NCT01283997|515436136|FG001|Overall Study|Physician Decision|10|||
142972550|NCT01283997|515436135|FG000|Overall Study|Withdrawal by Subject|3|||
142972551|NCT01283997|515436136|FG001|Overall Study|Withdrawal by Subject|2|||
142972552|NCT01283997|515436135|FG000|Overall Study|Physically unable to continue|0|||
142972553|NCT01283997|515436136|FG001|Overall Study|Physically unable to continue|1|||
142972554|NCT01283997|515436135|FG000|Overall Study|Progressive disease|1|||
142972555|NCT01283997|515436136|FG001|Overall Study|Progressive disease|0|||
142972556|NCT01283997|515436135|FG000|Overall Study|Other|4|||
142972557|NCT01283997|515436136|FG001|Overall Study|Other|4|||
142972558|NCT02017899|515436137|FG000|Overall Study|Withdrawal by Subject|0|||
142972559|NCT02017899|515436138|FG001|Overall Study|Withdrawal by Subject|0|||
142972560|NCT02017899|515436139|FG002|Overall Study|Withdrawal by Subject|0|||
142972561|NCT02017899|515436140|FG003|Overall Study|Withdrawal by Subject|1|||
142972562|NCT02017899|515436141|FG004|Overall Study|Withdrawal by Subject|1|||
142972563|NCT02017899|515436142|FG005|Overall Study|Withdrawal by Subject|0|||
142972564|NCT02843178|515436145|FG000|Overall Study|Lost to Follow-up|8|||
142972565|NCT02843178|515436146|FG001|Overall Study|Lost to Follow-up|8|||
142972566|NCT02843178|515436147|FG002|Overall Study|Lost to Follow-up|6|||
142972567|NCT02843178|515436148|FG003|Overall Study|Lost to Follow-up|3|||
142972568|NCT02843178|515436145|FG000|Overall Study|Withdrawal by Subject|0|||
142972569|NCT02843178|515436146|FG001|Overall Study|Withdrawal by Subject|0|||
142972570|NCT02843178|515436147|FG002|Overall Study|Withdrawal by Subject|1|||
142972571|NCT02843178|515436148|FG003|Overall Study|Withdrawal by Subject|1|||
142972572|NCT02109744|515436150|FG000|Overall Study|Death|1|||
142972573|NCT02109744|515436151|FG001|Overall Study|Death|1|||
142972574|NCT02109744|515436150|FG000|Overall Study|no marrow exam|1|||
142972575|NCT02109744|515436151|FG001|Overall Study|no marrow exam|0|||
142972576|NCT01975246|515436152|FG000|Overall Study|Adverse Event|2|||
142972577|NCT01975246|515436153|FG001|Overall Study|Adverse Event|1|||
142972578|NCT01975246|515436152|FG000|Overall Study|Lack of Efficacy|1|||
142972579|NCT01975246|515436153|FG001|Overall Study|Lack of Efficacy|0|||
142972580|NCT01975246|515436152|FG000|Overall Study|Protocol Violation|1|||
142972581|NCT01975246|515436153|FG001|Overall Study|Protocol Violation|0|||
142972582|NCT01975246|515436152|FG000|Overall Study|Other than stated|0|||
142972583|NCT01975246|515436153|FG001|Overall Study|Other than stated|1|||
142972584|NCT00255034|515436154|FG000|Overall Study|Withdrawal by Subject|15|||
142972585|NCT00255034|515436155|FG001|Overall Study|Withdrawal by Subject|38|||
142972586|NCT01263093|515436156|FG000|Washout|Physician Decision|1|||
142972587|NCT01263093|515436157|FG001|Washout|Physician Decision|0|||
142972588|NCT01263093|515436156|FG000|Period 2|Adverse Event|1|||
142972589|NCT01263093|515436157|FG001|Period 2|Adverse Event|0|||
142972590|NCT00424346|515436158|FG000|Core Study|Adverse Event|5|||
142972591|NCT00424346|515436159|FG001|Core Study|Adverse Event|3|||
142972592|NCT00424346|515436160|FG002|Core Study|Adverse Event|1|||
142972593|NCT00424346|515436161|FG003|Core Study|Adverse Event|1|||
142972594|NCT00424346|515436158|FG000|Core Study|Abnormal Laboratory Values|0|||
142972595|NCT00424346|515436159|FG001|Core Study|Abnormal Laboratory Values|1|||
142972596|NCT00424346|515436160|FG002|Core Study|Abnormal Laboratory Values|0|||
142972597|NCT00424346|515436161|FG003|Core Study|Abnormal Laboratory Values|0|||
142972598|NCT00424346|515436158|FG000|Core Study|Lack of Efficacy|1|||
142972599|NCT00424346|515436159|FG001|Core Study|Lack of Efficacy|3|||
142972600|NCT00424346|515436160|FG002|Core Study|Lack of Efficacy|0|||
142972601|NCT00424346|515436161|FG003|Core Study|Lack of Efficacy|4|||
142972602|NCT00424346|515436158|FG000|Core Study|Withdrawal by Subject|1|||
142972603|NCT00424346|515436159|FG001|Core Study|Withdrawal by Subject|0|||
142972604|NCT00424346|515436160|FG002|Core Study|Withdrawal by Subject|0|||
142972605|NCT00424346|515436161|FG003|Core Study|Withdrawal by Subject|2|||
142972606|NCT00424346|515436158|FG000|Core Study|Lost to Follow-up|1|||
142972607|NCT00424346|515436159|FG001|Core Study|Lost to Follow-up|1|||
142972608|NCT00424346|515436160|FG002|Core Study|Lost to Follow-up|0|||
142972609|NCT00424346|515436161|FG003|Core Study|Lost to Follow-up|0|||
142972610|NCT00424346|515436158|FG000|Core Study|Administrative Problems|1|||
142972611|NCT00424346|515436159|FG001|Core Study|Administrative Problems|0|||
142972612|NCT00424346|515436160|FG002|Core Study|Administrative Problems|1|||
142972613|NCT00424346|515436161|FG003|Core Study|Administrative Problems|0|||
142972614|NCT00424346|515436158|FG000|Core Study|Protocol Violation|0|||
142972615|NCT00424346|515436159|FG001|Core Study|Protocol Violation|0|||
142972616|NCT00424346|515436160|FG002|Core Study|Protocol Violation|2|||
142972617|NCT00424346|515436161|FG003|Core Study|Protocol Violation|0|||
142972618|NCT00424346|515436158|FG000|Extension Phase|Adverse Event|0|||
142972619|NCT00424346|515436159|FG001|Extension Phase|Adverse Event|9|||
142972620|NCT00424346|515436160|FG002|Extension Phase|Adverse Event|5|||
142972621|NCT00424346|515436161|FG003|Extension Phase|Adverse Event|4|||
142972622|NCT00424346|515436158|FG000|Extension Phase|Lack of Efficacy|0|||
142972623|NCT00424346|515436159|FG001|Extension Phase|Lack of Efficacy|16|||
142972624|NCT00424346|515436160|FG002|Extension Phase|Lack of Efficacy|14|||
142972625|NCT00424346|515436161|FG003|Extension Phase|Lack of Efficacy|11|||
142972626|NCT00424346|515436158|FG000|Extension Phase|Withdrawal by Subject|0|||
142972627|NCT00424346|515436159|FG001|Extension Phase|Withdrawal by Subject|5|||
142972628|NCT00424346|515436160|FG002|Extension Phase|Withdrawal by Subject|3|||
142972629|NCT00424346|515436161|FG003|Extension Phase|Withdrawal by Subject|4|||
142972630|NCT00424346|515436158|FG000|Extension Phase|Lost to Follow-up|0|||
142972631|NCT00424346|515436159|FG001|Extension Phase|Lost to Follow-up|2|||
142972632|NCT00424346|515436160|FG002|Extension Phase|Lost to Follow-up|0|||
142972633|NCT00424346|515436161|FG003|Extension Phase|Lost to Follow-up|0|||
142972634|NCT00424346|515436158|FG000|Extension Phase|Administrative Problems|0|||
142972635|NCT00424346|515436159|FG001|Extension Phase|Administrative Problems|69|||
142972636|NCT00424346|515436160|FG002|Extension Phase|Administrative Problems|32|||
142972637|NCT00424346|515436161|FG003|Extension Phase|Administrative Problems|35|||
142972638|NCT00424346|515436158|FG000|Extension Phase|Death|0|||
142972639|NCT00424346|515436159|FG001|Extension Phase|Death|0|||
142972640|NCT00424346|515436160|FG002|Extension Phase|Death|0|||
142972641|NCT00424346|515436161|FG003|Extension Phase|Death|1|||
142972642|NCT00424346|515436158|FG000|Extension Phase|Protocol Violation|0|||
142972643|NCT00424346|515436159|FG001|Extension Phase|Protocol Violation|1|||
142972644|NCT00424346|515436160|FG002|Extension Phase|Protocol Violation|1|||
142972645|NCT00424346|515436161|FG003|Extension Phase|Protocol Violation|0|||
142972646|NCT02658968|515436162|FG000|Received Rituximab|Adverse Event|0|||
142972647|NCT02658968|515436163|FG001|Received Rituximab|Adverse Event|0|||
142972648|NCT02658968|515436164|FG002|Received Rituximab|Adverse Event|0|||
142972649|NCT02658968|515436165|FG003|Received Rituximab|Adverse Event|0|||
142972650|NCT02658968|515436166|FG004|Received Rituximab|Adverse Event|1|||
142972651|NCT02658968|515436162|FG000|Received Rituximab|Progressive disease|0|||
142972652|NCT02658968|515436163|FG001|Received Rituximab|Progressive disease|0|||
142972653|NCT02658968|515436164|FG002|Received Rituximab|Progressive disease|0|||
142972654|NCT02658968|515436165|FG003|Received Rituximab|Progressive disease|0|||
142972655|NCT02658968|515436166|FG004|Received Rituximab|Progressive disease|1|||
142972656|NCT02658968|515436162|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
142972657|NCT02658968|515436163|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
142972658|NCT02658968|515436164|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
142972659|NCT02658968|515436165|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
142972660|NCT02658968|515436166|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
142972661|NCT02658968|515436162|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
142972662|NCT02658968|515436163|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
142972663|NCT02658968|515436164|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
142972664|NCT02658968|515436165|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
142972665|NCT02658968|515436166|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
142972666|NCT02658968|515436162|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
142972667|NCT02658968|515436163|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
142972668|NCT02658968|515436164|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
142972669|NCT02658968|515436165|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
142972670|NCT02658968|515436166|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
142972671|NCT02658968|515436162|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
142972672|NCT02658968|515436163|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
142972673|NCT02658968|515436164|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
142972674|NCT02658968|515436165|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
142972675|NCT02658968|515436166|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
142972676|NCT02658968|515436162|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
142972677|NCT02658968|515436163|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
142972678|NCT02658968|515436164|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
142972679|NCT02658968|515436165|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
142972680|NCT02658968|515436166|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
142972681|NCT03287245|515436169|FG000|Overall Study|Study terminated by sponsor|3|||
142972682|NCT03287245|515436170|FG001|Overall Study|Study terminated by sponsor|0|||
142972683|NCT03287245|515436171|FG002|Overall Study|Study terminated by sponsor|3|||
142972684|NCT03287245|515436172|FG003|Overall Study|Study terminated by sponsor|1|||
142972685|NCT03287245|515436169|FG000|Overall Study|Adverse Event|1|||
142972686|NCT03287245|515436170|FG001|Overall Study|Adverse Event|0|||
142972687|NCT03287245|515436171|FG002|Overall Study|Adverse Event|0|||
142972688|NCT03287245|515436172|FG003|Overall Study|Adverse Event|0|||
142972689|NCT03287245|515436169|FG000|Overall Study|Withdrawal by Subject|8|||
142972690|NCT03287245|515436170|FG001|Overall Study|Withdrawal by Subject|3|||
142972691|NCT03287245|515436171|FG002|Overall Study|Withdrawal by Subject|3|||
142972692|NCT03287245|515436172|FG003|Overall Study|Withdrawal by Subject|0|||
142972693|NCT03287245|515436169|FG000|Overall Study|Physician Decision|3|||
142972694|NCT03287245|515436170|FG001|Overall Study|Physician Decision|2|||
142972695|NCT03287245|515436171|FG002|Overall Study|Physician Decision|0|||
142972696|NCT03287245|515436172|FG003|Overall Study|Physician Decision|0|||
142972697|NCT02701192|515436173|FG000|Overall Study|Protocol Violation|2|||
142972698|NCT02701192|515436173|FG000|Overall Study|Lost to Follow-up|4|||
142972699|NCT02862548|515436174|FG000|Randomized Phase (Up to Week 48)|Death|0|||
142972700|NCT02862548|515436175|FG001|Randomized Phase (Up to Week 48)|Death|1|||
142972701|NCT02862548|515436174|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
142972702|NCT02862548|515436175|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
142972703|NCT02862548|515436174|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
142972704|NCT02862548|515436175|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
142972705|NCT02862548|515436174|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
142972706|NCT02862548|515436175|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
142972707|NCT00880763|515436176|FG000|Extension Period (Part 2)|Adverse Event|0|||
142972708|NCT00880763|515436177|FG001|Extension Period (Part 2)|Adverse Event|0|||
142972709|NCT00880763|515436178|FG002|Extension Period (Part 2)|Adverse Event|1|||
142972710|NCT00880763|515436179|FG003|Extension Period (Part 2)|Adverse Event|1|||
142972711|NCT00880763|515436176|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
142972712|NCT00880763|515436177|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
142972713|NCT00880763|515436178|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
142972714|NCT00880763|515436179|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
142972715|NCT00880763|515436176|FG000|Extension Period (Part 2)|Physician Decision|0|||
142972716|NCT00880763|515436177|FG001|Extension Period (Part 2)|Physician Decision|1|||
142972717|NCT00880763|515436178|FG002|Extension Period (Part 2)|Physician Decision|1|||
142972718|NCT00880763|515436179|FG003|Extension Period (Part 2)|Physician Decision|0|||
142972719|NCT00880763|515436176|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
142972720|NCT00880763|515436177|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
142972721|NCT00880763|515436178|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
142972722|NCT00880763|515436179|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
142972723|NCT02667457|515436181|FG000|Overall Study|Withdrawal by Subject|1|||
142972724|NCT02667457|515436182|FG001|Overall Study|Withdrawal by Subject|0|||
142972725|NCT02667457|515436181|FG000|Overall Study|Other Reason|0|||
142972726|NCT02667457|515436182|FG001|Overall Study|Other Reason|2|||
142972727|NCT00603733|515436185|FG000|Active Phase ITT|Adverse Event|8|||
142972728|NCT00603733|515436186|FG001|Active Phase ITT|Adverse Event|7|||
142972729|NCT00603733|515436185|FG000|Active Phase ITT|Withdrawal by Subject|0|||
142972730|NCT00603733|515436186|FG001|Active Phase ITT|Withdrawal by Subject|3|||
142972731|NCT00603733|515436185|FG000|Active Phase ITT|Lost to Follow-up|0|||
142972732|NCT00603733|515436186|FG001|Active Phase ITT|Lost to Follow-up|1|||
142972733|NCT00603733|515436185|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
142972734|NCT00603733|515436186|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
142972735|NCT00603733|515436185|FG000|Active Phase ITT|Lack of Efficacy|1|||
142972736|NCT00603733|515436186|FG001|Active Phase ITT|Lack of Efficacy|2|||
142972737|NCT00603733|515436185|FG000|Active Phase ITT|Subject moved, site closed|1|||
142972738|NCT00603733|515436186|FG001|Active Phase ITT|Subject moved, site closed|1|||
142972739|NCT00603733|515436185|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
142972740|NCT00603733|515436186|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
142972741|NCT00603733|515436185|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
142972742|NCT00603733|515436186|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
142972743|NCT00603733|515436185|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
142972744|NCT00603733|515436186|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
142972745|NCT00603733|515436185|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
142972746|NCT00603733|515436186|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
142972747|NCT00603733|515436185|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
142972748|NCT00603733|515436186|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
142972749|NCT00603733|515436185|FG000|Maintenance Phase ITT|Adverse Event|3|||
142972750|NCT00603733|515436186|FG001|Maintenance Phase ITT|Adverse Event|6|||
142972751|NCT00603733|515436185|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
142972752|NCT00603733|515436186|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
142972753|NCT00603733|515436185|FG000|Maintenance Phase ITT|Protocol Violation|1|||
142972754|NCT00603733|515436186|FG001|Maintenance Phase ITT|Protocol Violation|1|||
142972755|NCT00603733|515436185|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
142972756|NCT00603733|515436186|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
142972757|NCT00603733|515436185|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
142972758|NCT00603733|515436186|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
142972759|NCT00603733|515436185|FG000|Maintenance Phase ITT|Physician Decision|0|||
142972760|NCT00603733|515436186|FG001|Maintenance Phase ITT|Physician Decision|1|||
142972761|NCT00603733|515436185|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
142972762|NCT00603733|515436186|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
142972763|NCT01293006|515436197|FG000|Period 2|Lost to Follow-up|1|||
142972764|NCT01293006|515436198|FG001|Period 2|Lost to Follow-up|0|||
142972765|NCT01293006|515436199|FG002|Period 2|Lost to Follow-up|0|||
142972766|NCT01293006|515436200|FG003|Period 2|Lost to Follow-up|0|||
142972767|NCT01494987|515436201|FG000|Overall Study|Adverse Event|6|||
142972768|NCT01494987|515436202|FG001|Overall Study|Adverse Event|5|||
142972769|NCT01494987|515436201|FG000|Overall Study|Hyperglycemia|6|||
142972770|NCT01494987|515436202|FG001|Overall Study|Hyperglycemia|4|||
142972771|NCT01494987|515436201|FG000|Overall Study|Investigator's Discretion|1|||
142972772|NCT01494987|515436202|FG001|Overall Study|Investigator's Discretion|2|||
142972773|NCT01494987|515436201|FG000|Overall Study|Lost to Follow-up|1|||
142972774|NCT01494987|515436202|FG001|Overall Study|Lost to Follow-up|1|||
142972775|NCT01494987|515436201|FG000|Overall Study|Protocol Violation|3|||
142972776|NCT01494987|515436202|FG001|Overall Study|Protocol Violation|3|||
142972777|NCT01494987|515436201|FG000|Overall Study|Subject Non-Compliance|9|||
142972778|NCT01494987|515436202|FG001|Overall Study|Subject Non-Compliance|10|||
142972779|NCT01494987|515436201|FG000|Overall Study|Subject Withdrew Consent|2|||
142972780|NCT01494987|515436202|FG001|Overall Study|Subject Withdrew Consent|3|||
142972781|NCT00436982|515436203|FG000|Overall Study|Withdrawal by Subject|3|||
142972782|NCT00436982|515436204|FG001|Overall Study|Withdrawal by Subject|1|||
142972783|NCT00436982|515436203|FG000|Overall Study|Did not receive allocated intervention|0|||
142972784|NCT00436982|515436204|FG001|Overall Study|Did not receive allocated intervention|1|||
142972785|NCT00436982|515436203|FG000|Overall Study|no RSA data|1|||
142972786|NCT00436982|515436204|FG001|Overall Study|no RSA data|2|||
142972787|NCT00953225|515436205|FG000|Overall Study|Withdrawal by Subject|2|||
142972788|NCT00953225|515436206|FG001|Overall Study|Withdrawal by Subject|0|||
142972789|NCT01956240|515436212|FG000|Overall Study|Lost to Follow-up|6|||
142972790|NCT01956240|515436213|FG001|Overall Study|Lost to Follow-up|20|||
142972791|NCT01956240|515436212|FG000|Overall Study|Adverse Event|17|||
142972792|NCT01956240|515436213|FG001|Overall Study|Adverse Event|4|||
142972793|NCT01957709|515436217|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
142972794|NCT02168803|515436221|FG000|Overall Study|Lost to Follow-up|1|||
142972795|NCT02168803|515436222|FG001|Overall Study|Lost to Follow-up|0|||
142972796|NCT02168803|515436223|FG002|Overall Study|Lost to Follow-up|1|||
142972797|NCT02168803|515436221|FG000|Overall Study|Withdrawal by Subject|1|||
142972798|NCT02168803|515436222|FG001|Overall Study|Withdrawal by Subject|1|||
142972799|NCT02168803|515436223|FG002|Overall Study|Withdrawal by Subject|2|||
142972800|NCT02168803|515436221|FG000|Overall Study|Physician Decision|0|||
142972801|NCT02168803|515436222|FG001|Overall Study|Physician Decision|1|||
142972802|NCT02168803|515436223|FG002|Overall Study|Physician Decision|0|||
142972803|NCT02168803|515436221|FG000|Overall Study|Adverse Event|0|||
142972804|NCT02168803|515436222|FG001|Overall Study|Adverse Event|1|||
142972805|NCT02168803|515436223|FG002|Overall Study|Adverse Event|1|||
142972806|NCT02168803|515436221|FG000|Overall Study|Death|0|||
142972807|NCT02168803|515436222|FG001|Overall Study|Death|0|||
142972808|NCT02168803|515436223|FG002|Overall Study|Death|1|||
142972809|NCT02168803|515436221|FG000|Overall Study|Sponsor Decision|0|||
142972810|NCT02168803|515436222|FG001|Overall Study|Sponsor Decision|0|||
142972811|NCT02168803|515436223|FG002|Overall Study|Sponsor Decision|1|||
142972812|NCT01114373|515436224|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
142972813|NCT01114373|515436225|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
142972814|NCT01114373|515436224|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
142972815|NCT01114373|515436225|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
142972816|NCT01114373|515436224|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
142972817|NCT01114373|515436225|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
142972818|NCT01114373|515436224|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
142972819|NCT01114373|515436225|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
142972820|NCT03444870|515436226|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
142972821|NCT03444870|515436227|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
142972822|NCT03444870|515436228|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
142972823|NCT03444870|515436229|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
142972824|NCT03444870|515436230|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
142972825|NCT03444870|515436231|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
142972826|NCT03444870|515436226|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
142972827|NCT03444870|515436227|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
142972828|NCT03444870|515436228|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
142972829|NCT03444870|515436229|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
142972830|NCT03444870|515436230|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
142972831|NCT03444870|515436231|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
142972832|NCT03444870|515436226|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
142972833|NCT03444870|515436227|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
142972834|NCT03444870|515436228|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
142972835|NCT03444870|515436229|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
142972836|NCT03444870|515436230|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
142972837|NCT03444870|515436231|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
142972838|NCT03444870|515436226|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
142972839|NCT03444870|515436227|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
142972840|NCT03444870|515436228|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
142972841|NCT03444870|515436229|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
142972842|NCT03444870|515436230|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
142972843|NCT03444870|515436231|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
142972844|NCT03444870|515436226|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
142972845|NCT03444870|515436227|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
142972846|NCT03444870|515436228|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
142972847|NCT03444870|515436229|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
142972848|NCT03444870|515436230|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
142972849|NCT03444870|515436231|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
142972850|NCT03444870|515436226|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
142972851|NCT03444870|515436227|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
142972852|NCT03444870|515436228|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
142972853|NCT03444870|515436229|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
142972854|NCT03444870|515436230|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
142972855|NCT03444870|515436231|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
142972856|NCT03444870|515436226|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
142972857|NCT03444870|515436227|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
142972858|NCT03444870|515436228|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
142972859|NCT03444870|515436229|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
143455590|NCT04602221|517212483|FG006|Overall Study|Withdrawal by Subject|0|||
142972860|NCT03444870|515436230|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
142972861|NCT03444870|515436231|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
142972862|NCT03444870|515436226|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
142972863|NCT03444870|515436227|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
142972864|NCT03444870|515436228|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
142972865|NCT03444870|515436229|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
142972866|NCT03444870|515436230|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
142972867|NCT03444870|515436231|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
142972868|NCT03444870|515436226|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
142972869|NCT03444870|515436227|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
142972870|NCT03444870|515436228|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
142972871|NCT03444870|515436229|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
142972872|NCT03444870|515436230|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
142972873|NCT03444870|515436231|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
142972874|NCT03444870|515436226|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
142972875|NCT03444870|515436227|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
142972876|NCT03444870|515436228|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
142972877|NCT03444870|515436229|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
142972878|NCT03444870|515436230|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
142972879|NCT03444870|515436231|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
142972880|NCT03444870|515436226|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
142972881|NCT03444870|515436227|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
142972882|NCT03444870|515436228|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
142972883|NCT03444870|515436229|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
142972884|NCT03444870|515436230|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
142972885|NCT03444870|515436231|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
142972886|NCT03444870|515436226|FG000|Open-Label Extension (OLE) Period|Death|0|||
142972887|NCT03444870|515436227|FG001|Open-Label Extension (OLE) Period|Death|0|||
142972888|NCT03444870|515436228|FG002|Open-Label Extension (OLE) Period|Death|0|||
142972889|NCT03444870|515436229|FG003|Open-Label Extension (OLE) Period|Death|0|||
142972890|NCT03444870|515436230|FG004|Open-Label Extension (OLE) Period|Death|1|||
142972891|NCT03444870|515436231|FG005|Open-Label Extension (OLE) Period|Death|0|||
142972892|NCT02310906|515436232|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
142972893|NCT02310906|515436233|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
142972894|NCT02310906|515436234|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
142972895|NCT02310906|515436235|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
142972896|NCT02310906|515436232|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
142972897|NCT02310906|515436233|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
142972898|NCT02310906|515436234|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
142972899|NCT02310906|515436235|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
142972900|NCT02310906|515436232|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
142972901|NCT02310906|515436233|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
142972902|NCT02310906|515436234|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
142972903|NCT02310906|515436235|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
142972904|NCT02310906|515436232|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
142972905|NCT02310906|515436233|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
142972906|NCT02310906|515436234|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
142972907|NCT02310906|515436235|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
142972908|NCT02267278|515436238|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
142972909|NCT02267278|515436238|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
142972910|NCT02267278|515436238|FG000|Overall Study|Developed new cancer diagnoses|2|||
142972911|NCT02267278|515436238|FG000|Overall Study|prescribed prohibited medication|1|||
142972912|NCT00469209|515436243|FG000|Overall Study|Adverse Event|1|||
142972913|NCT00469209|515436244|FG001|Overall Study|Adverse Event|0|||
142972914|NCT00469209|515436245|FG002|Overall Study|Adverse Event|1|||
142972915|NCT04268004|515436246|FG000|Overall Study|Excluded from analyses|0|||
142972916|NCT04268004|515436247|FG001|Overall Study|Excluded from analyses|1|||
142972917|NCT01082367|515436248|FG000|Double-blind Period|Administrative problems|0|||
142972918|NCT01082367|515436249|FG001|Double-blind Period|Administrative problems|1|||
142972919|NCT01082367|515436248|FG000|Double-blind Period|Lack of Efficacy|5|||
142972920|NCT01082367|515436249|FG001|Double-blind Period|Lack of Efficacy|11|||
142972921|NCT01082367|515436248|FG000|Double-blind Period|Adverse Event|0|||
142972922|NCT01082367|515436249|FG001|Double-blind Period|Adverse Event|1|||
142972923|NCT01082367|515436248|FG000|Follow-up (F-U) Period|Administrative problems|1|||
142972924|NCT01082367|515436249|FG001|Follow-up (F-U) Period|Administrative problems|0|||
142972925|NCT01082367|515436248|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
142972926|NCT01082367|515436249|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
142972927|NCT01082367|515436248|FG000|Follow-up (F-U) Period|Adverse Event|0|||
142972928|NCT01082367|515436249|FG001|Follow-up (F-U) Period|Adverse Event|1|||
142972929|NCT03372603|515436255|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
142972930|NCT03372603|515436256|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
142972931|NCT03372603|515436255|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
142972932|NCT03372603|515436256|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
142972933|NCT00664209|515436262|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
142972934|NCT00664209|515436262|FG000|Study Treatment Period|Physician Decision|4|||
142972935|NCT00664209|515436262|FG000|Study Treatment Period|Withdrawal by Subject|2|||
142972936|NCT00843843|515436263|FG000|Overall Study|Physician Decision|1|||
142972937|NCT00843843|515436264|FG001|Overall Study|Physician Decision|1|||
142972938|NCT00843843|515436263|FG000|Overall Study|Protocol Violation|1|||
142972939|NCT00843843|515436264|FG001|Overall Study|Protocol Violation|1|||
142972940|NCT01764256|515436265|FG000|Received All Vaccinations|Adverse Event|1|||
142972941|NCT01764256|515436266|FG001|Received All Vaccinations|Adverse Event|1|||
142972942|NCT01764256|515436267|FG002|Received All Vaccinations|Adverse Event|0|||
142972943|NCT01764256|515436268|FG003|Received All Vaccinations|Adverse Event|0|||
142972944|NCT01764256|515436265|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
142972945|NCT01764256|515436266|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
142972946|NCT01764256|515436267|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
142972947|NCT01764256|515436268|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
142972948|NCT01764256|515436265|FG000|Received All Vaccinations|Lost to Follow-up|1|||
142972949|NCT01764256|515436266|FG001|Received All Vaccinations|Lost to Follow-up|0|||
142972950|NCT01764256|515436267|FG002|Received All Vaccinations|Lost to Follow-up|0|||
142972951|NCT01764256|515436268|FG003|Received All Vaccinations|Lost to Follow-up|0|||
142972952|NCT01764256|515436265|FG000|Completed Study|Lost to Follow-up|0|||
142972953|NCT01764256|515436266|FG001|Completed Study|Lost to Follow-up|0|||
142972954|NCT01764256|515436267|FG002|Completed Study|Lost to Follow-up|0|||
142972955|NCT01764256|515436268|FG003|Completed Study|Lost to Follow-up|1|||
142972956|NCT00565058|515436269|FG000|Overall Study|Adverse Event|1|||
142972957|NCT00565058|515436270|FG001|Overall Study|Adverse Event|0|||
142972958|NCT02029638|515436271|FG000|Overall Study|Death|0|||
142972959|NCT02029638|515436272|FG001|Overall Study|Death|0|||
142972960|NCT02029638|515436273|FG002|Overall Study|Death|1|||
142972961|NCT02029638|515436271|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
142972962|NCT02029638|515436272|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
142972963|NCT02029638|515436273|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
142972964|NCT01153841|515436274|FG000|Overall Study|Adverse Event|1|||
142972965|NCT01153841|515436275|FG001|Overall Study|Adverse Event|0|||
142972966|NCT01153841|515436274|FG000|Overall Study|Withdrawal by Subject|1|||
142972967|NCT01153841|515436275|FG001|Overall Study|Withdrawal by Subject|0|||
142972968|NCT01153841|515436274|FG000|Overall Study|Protocol Violation|2|||
142972969|NCT01153841|515436275|FG001|Overall Study|Protocol Violation|0|||
142972970|NCT01153841|515436274|FG000|Overall Study|Lost to Follow-up|2|||
142972971|NCT01153841|515436275|FG001|Overall Study|Lost to Follow-up|0|||
142972972|NCT00536978|515436285|FG000|Overall Study|Not eligible for Adback Infusion|22|||
142972973|NCT06422377|515438141|FG000|Overall Study|Study Terminated by Sponsor|1|||
142972974|NCT00646113|515438142|FG000|Overall Study|Lost to Follow-up|5|||
142972975|NCT00646113|515438142|FG000|Overall Study|Adverse Event|3|||
142972976|NCT04095442|515438145|FG000|Overall Study|Lost to Follow-up|0|||
142972977|NCT04095442|515438146|FG001|Overall Study|Lost to Follow-up|1|||
142972978|NCT04095442|515438145|FG000|Overall Study|Screen failure|1|||
142972979|NCT04095442|515438146|FG001|Overall Study|Screen failure|0|||
142972980|NCT01677624|515438151|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
142972981|NCT00804843|515438152|FG000|Overall Study|Protocol Violation|1|||
142972982|NCT00804843|515438153|FG001|Overall Study|Protocol Violation|0|||
142972983|NCT00804843|515438152|FG000|Overall Study|Adverse Event|8|||
142972984|NCT00804843|515438153|FG001|Overall Study|Adverse Event|5|||
142972985|NCT00804843|515438152|FG000|Overall Study|Withdrawal by Subject|1|||
142972986|NCT00804843|515438153|FG001|Overall Study|Withdrawal by Subject|2|||
142972987|NCT02420795|515438156|FG000|Overall Study|Withdrawal by Subject|1|||
142972988|NCT02420795|515438157|FG001|Overall Study|Withdrawal by Subject|0|||
142972989|NCT02420795|515438158|FG002|Overall Study|Withdrawal by Subject|0|||
142972990|NCT02420795|515438156|FG000|Overall Study|Adverse Event|1|||
142972991|NCT02420795|515438157|FG001|Overall Study|Adverse Event|0|||
142972992|NCT02420795|515438158|FG002|Overall Study|Adverse Event|0|||
142972993|NCT02420795|515438156|FG000|Overall Study|Progressive disease|2|||
142972994|NCT02420795|515438157|FG001|Overall Study|Progressive disease|2|||
142972995|NCT02420795|515438158|FG002|Overall Study|Progressive disease|4|||
142972996|NCT02420795|515438156|FG000|Overall Study|Death|0|||
142972997|NCT02420795|515438157|FG001|Overall Study|Death|0|||
142972998|NCT02420795|515438158|FG002|Overall Study|Death|1|||
142972999|NCT03097614|515438160|FG000|Overall Study|Adverse Event|3|||
142973000|NCT02254551|515438161|FG000|Dose Escalation|Physician Decision|1|||
142973001|NCT02254551|515438161|FG000|Dose Escalation|Dose-limiting toxicity|2|||
142973002|NCT02293993|515438164|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
143003143|NCT01049360|515548755|FG011|Period 2|Adverse Event|0|||
142973003|NCT02293993|515438165|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
142973004|NCT02293993|515438166|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
142973005|NCT02293993|515438167|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
142973006|NCT02293993|515438164|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
142973007|NCT02293993|515438165|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
142973008|NCT02293993|515438166|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
142973009|NCT02293993|515438167|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
142973010|NCT02293993|515438164|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
142973011|NCT02293993|515438165|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
142973012|NCT02293993|515438166|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
142973013|NCT02293993|515438167|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
142973014|NCT02293993|515438164|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
142973015|NCT02293993|515438165|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
142973016|NCT02293993|515438166|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
142973017|NCT02293993|515438167|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
142973018|NCT02293993|515438164|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
142973019|NCT02293993|515438165|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
142973020|NCT02293993|515438166|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
142973021|NCT02293993|515438167|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
142973022|NCT00387348|515438168|FG000|Overall Study|Death|1|||
142973023|NCT00387348|515438169|FG001|Overall Study|Death|1|||
142973024|NCT00387348|515438170|FG002|Overall Study|Death|0|||
142973025|NCT00387348|515438168|FG000|Overall Study|Physician Decision|1|||
142973026|NCT00387348|515438169|FG001|Overall Study|Physician Decision|0|||
142973027|NCT00387348|515438170|FG002|Overall Study|Physician Decision|1|||
142973028|NCT00387348|515438168|FG000|Overall Study|Withdrawal by Subject|0|||
142973029|NCT00387348|515438169|FG001|Overall Study|Withdrawal by Subject|2|||
142973030|NCT00387348|515438170|FG002|Overall Study|Withdrawal by Subject|2|||
142973031|NCT00387348|515438168|FG000|Overall Study|Adverse Event|1|||
142973032|NCT00387348|515438169|FG001|Overall Study|Adverse Event|0|||
142973033|NCT00387348|515438170|FG002|Overall Study|Adverse Event|1|||
142973034|NCT00505752|515438171|FG000|Overall Study|Adverse Event|1|||
142973035|NCT00505752|515438172|FG001|Overall Study|Adverse Event|0|||
142973036|NCT00505752|515438173|FG002|Overall Study|Adverse Event|1|||
142973037|NCT00505752|515438174|FG003|Overall Study|Adverse Event|0|||
142973038|NCT00505752|515438171|FG000|Overall Study|Lost to Follow-up|1|||
142973039|NCT00505752|515438172|FG001|Overall Study|Lost to Follow-up|0|||
142973040|NCT00505752|515438173|FG002|Overall Study|Lost to Follow-up|0|||
142973041|NCT00505752|515438174|FG003|Overall Study|Lost to Follow-up|0|||
142973042|NCT00505752|515438171|FG000|Overall Study|Lack of ovarian response|1|||
142973043|NCT00505752|515438172|FG001|Overall Study|Lack of ovarian response|3|||
142973044|NCT00505752|515438173|FG002|Overall Study|Lack of ovarian response|0|||
142973045|NCT00505752|515438174|FG003|Overall Study|Lack of ovarian response|0|||
142973046|NCT00505752|515438171|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
142973047|NCT00505752|515438172|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
142973048|NCT00505752|515438173|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
142973049|NCT00505752|515438174|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
142973050|NCT00505752|515438171|FG000|Overall Study|No oocytes retrieved|0|||
142973051|NCT00505752|515438172|FG001|Overall Study|No oocytes retrieved|2|||
142973052|NCT00505752|515438173|FG002|Overall Study|No oocytes retrieved|0|||
142973053|NCT00505752|515438174|FG003|Overall Study|No oocytes retrieved|1|||
142973054|NCT00505752|515438171|FG000|Overall Study|No Fertilization|1|||
142973055|NCT00505752|515438172|FG001|Overall Study|No Fertilization|1|||
142973056|NCT00505752|515438173|FG002|Overall Study|No Fertilization|2|||
142973057|NCT00505752|515438174|FG003|Overall Study|No Fertilization|1|||
142973058|NCT00505752|515438171|FG000|Overall Study|All embryos/blastocysts discarded|0|||
142973059|NCT00505752|515438172|FG001|Overall Study|All embryos/blastocysts discarded|0|||
142973060|NCT00505752|515438173|FG002|Overall Study|All embryos/blastocysts discarded|1|||
142973061|NCT00505752|515438174|FG003|Overall Study|All embryos/blastocysts discarded|1|||
142973062|NCT00505752|515438171|FG000|Overall Study|Other|1|||
142973063|NCT00505752|515438172|FG001|Overall Study|Other|2|||
142973064|NCT00505752|515438173|FG002|Overall Study|Other|1|||
142973065|NCT00505752|515438174|FG003|Overall Study|Other|2|||
142973066|NCT04624672|515438177|FG000|Overall Study|Early Study Closure|2|||
142973067|NCT04624672|515438178|FG001|Overall Study|Early Study Closure|1|||
142973068|NCT02769832|515438179|FG000|Overall Study|Death|30|||
142973069|NCT02685995|515438187|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
142973070|NCT02685995|515438188|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
142973071|NCT03819218|515438189|FG000|Overall Study|Protocol Violation|1|||
142973072|NCT01797445|515438190|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
142973073|NCT01797445|515438191|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
142973074|NCT01797445|515438190|FG000|Double-Blind Phase|Adverse Event|3|||
142973075|NCT01797445|515438191|FG001|Double-Blind Phase|Adverse Event|0|||
142973076|NCT01797445|515438190|FG000|Double-Blind Phase|Death|5|||
142973077|NCT01797445|515438191|FG001|Double-Blind Phase|Death|4|||
142973078|NCT01797445|515438190|FG000|Double-Blind Phase|Pregnancy|0|||
142973079|NCT01797445|515438191|FG001|Double-Blind Phase|Pregnancy|1|||
142973080|NCT01797445|515438190|FG000|Double-Blind Phase|Lack of Efficacy|1|||
142973081|NCT01797445|515438191|FG001|Double-Blind Phase|Lack of Efficacy|2|||
142973082|NCT01797445|515438190|FG000|Double-Blind Phase|Investigator's Discretion|15|||
142973083|NCT01797445|515438191|FG001|Double-Blind Phase|Investigator's Discretion|17|||
142973084|NCT01797445|515438190|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
142973085|NCT01797445|515438191|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
142973086|NCT01797445|515438190|FG000|Double-Blind Phase|Protocol Violation|0|||
142973087|NCT01797445|515438191|FG001|Double-Blind Phase|Protocol Violation|1|||
142973088|NCT01797445|515438190|FG000|Double-Blind Phase|Withdrew Consent|20|||
142973089|NCT01797445|515438191|FG001|Double-Blind Phase|Withdrew Consent|35|||
142973090|NCT01797445|515438190|FG000|Double-Blind Phase|Lost to Follow-up|34|||
142973091|NCT01797445|515438191|FG001|Double-Blind Phase|Lost to Follow-up|26|||
142973092|NCT01797445|515438190|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
142973093|NCT01797445|515438191|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
142973094|NCT01595438|515438194|FG000|Overall Study|Lost to Follow-up|20|||
142973095|NCT01595438|515438195|FG001|Overall Study|Lost to Follow-up|20|||
142973096|NCT01595438|515438194|FG000|Overall Study|Withdrawal by Subject|12|||
142973097|NCT01595438|515438195|FG001|Overall Study|Withdrawal by Subject|12|||
142973098|NCT01595438|515438194|FG000|Overall Study|Other Eligibility criteria|11|||
142973099|NCT01595438|515438195|FG001|Overall Study|Other Eligibility criteria|9|||
142973100|NCT00650091|515438196|FG000|Amended Study Design|Withdrawal by Subject|12|||
142973101|NCT00650091|515438197|FG001|Amended Study Design|Withdrawal by Subject|11|||
142973102|NCT00650091|515438198|FG002|Amended Study Design|Withdrawal by Subject|0|||
142973103|NCT00650091|515438196|FG000|Amended Study Design|Physician Decision|5|||
142973104|NCT00650091|515438197|FG001|Amended Study Design|Physician Decision|0|||
142973105|NCT00650091|515438198|FG002|Amended Study Design|Physician Decision|0|||
142973106|NCT00650091|515438196|FG000|Amended Study Design|Adverse Event|1|||
142973107|NCT00650091|515438197|FG001|Amended Study Design|Adverse Event|4|||
142973108|NCT00650091|515438198|FG002|Amended Study Design|Adverse Event|0|||
142973109|NCT00650091|515438196|FG000|Amended Study Design|Lung transplantation|4|||
142973110|NCT00650091|515438197|FG001|Amended Study Design|Lung transplantation|2|||
142973111|NCT00650091|515438198|FG002|Amended Study Design|Lung transplantation|0|||
142973112|NCT00650091|515438196|FG000|Amended Study Design|Other|1|||
142973113|NCT00650091|515438197|FG001|Amended Study Design|Other|3|||
142973114|NCT00650091|515438198|FG002|Amended Study Design|Other|0|||
142973115|NCT03428997|515438199|FG000|Overall Study|Sponsor decision.|1|||
142973116|NCT03428997|515438199|FG000|Overall Study|Withdrawal by Subject|3|||
142973117|NCT03428997|515438199|FG000|Overall Study|Lost to Follow-up|4|||
142973118|NCT01397448|515438200|FG000|Overall Study|Adverse Event|4|||
142973119|NCT01397448|515438201|FG001|Overall Study|Adverse Event|4|||
142973120|NCT01397448|515438202|FG002|Overall Study|Adverse Event|6|||
142973121|NCT01397448|515438200|FG000|Overall Study|Withdrawal by Subject|4|||
142973122|NCT01397448|515438201|FG001|Overall Study|Withdrawal by Subject|4|||
142973123|NCT01397448|515438202|FG002|Overall Study|Withdrawal by Subject|3|||
142973124|NCT01397448|515438200|FG000|Overall Study|Lack of Efficacy|2|||
142973125|NCT01397448|515438201|FG001|Overall Study|Lack of Efficacy|0|||
142973126|NCT01397448|515438202|FG002|Overall Study|Lack of Efficacy|5|||
142973127|NCT01397448|515438200|FG000|Overall Study|Other|8|||
142973128|NCT01397448|515438201|FG001|Overall Study|Other|7|||
142973129|NCT01397448|515438202|FG002|Overall Study|Other|4|||
142973130|NCT02180217|515438207|FG000|Overall Study|Adverse Event|3|||
142973131|NCT02180217|515438208|FG001|Overall Study|Adverse Event|2|||
142973132|NCT02180217|515438209|FG002|Overall Study|Adverse Event|22|||
142973133|NCT02180217|515438207|FG000|Overall Study|Death|1|||
142973134|NCT02180217|515438208|FG001|Overall Study|Death|1|||
142973135|NCT02180217|515438209|FG002|Overall Study|Death|0|||
142973136|NCT02180217|515438207|FG000|Overall Study|Withdrawal by Subject|1|||
142973137|NCT02180217|515438208|FG001|Overall Study|Withdrawal by Subject|1|||
142973138|NCT02180217|515438209|FG002|Overall Study|Withdrawal by Subject|4|||
142973139|NCT02180217|515438207|FG000|Overall Study|Subject/Guardian decision|5|||
142973140|NCT02180217|515438208|FG001|Overall Study|Subject/Guardian decision|3|||
142973141|NCT02180217|515438209|FG002|Overall Study|Subject/Guardian decision|6|||
142973142|NCT02180217|515438207|FG000|Overall Study|Physician Decision|1|||
142973143|NCT02180217|515438208|FG001|Overall Study|Physician Decision|1|||
142973144|NCT02180217|515438209|FG002|Overall Study|Physician Decision|6|||
142973145|NCT02180217|515438207|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
142973146|NCT02180217|515438208|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
142973147|NCT02180217|515438209|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
142973148|NCT02553317|515438210|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
142973149|NCT02553317|515438211|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
142973150|NCT02553317|515438210|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
142973151|NCT02553317|515438211|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
142973152|NCT02553317|515438210|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
142973153|NCT02553317|515438211|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
142973154|NCT02553317|515438210|FG000|Overall Treatment Period + Follow-up|Death|1|||
142973155|NCT02553317|515438211|FG001|Overall Treatment Period + Follow-up|Death|3|||
142973156|NCT02553317|515438210|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
142973157|NCT02553317|515438211|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
142973158|NCT02553317|515438210|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
142973159|NCT02553317|515438211|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
142973160|NCT02553317|515438210|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
142973161|NCT02553317|515438211|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
142973162|NCT02553317|515438210|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
142973163|NCT02553317|515438211|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
142973164|NCT02553317|515438210|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
142973165|NCT02553317|515438211|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
142973166|NCT02553317|515438210|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
142973167|NCT02553317|515438211|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
142973168|NCT00878215|515438217|FG000|Overall Study|Determined to be ineligible|0|||
142973169|NCT00878215|515438218|FG001|Overall Study|Determined to be ineligible|10|||
142973170|NCT00878215|515438219|FG002|Overall Study|Determined to be ineligible|0|||
142973171|NCT00878215|515438220|FG003|Overall Study|Determined to be ineligible|0|||
142973172|NCT00574496|515438223|FG000|Overall Study|Withdrawal by Subject|1|||
142973173|NCT01969799|515438224|FG000|Overall Study|Adverse Event|0|||
142973174|NCT01969799|515438225|FG001|Overall Study|Adverse Event|1|||
142973175|NCT01969799|515438224|FG000|Overall Study|Death|16|||
142973176|NCT01969799|515438225|FG001|Overall Study|Death|11|||
142973177|NCT01969799|515438224|FG000|Overall Study|Lost to Follow-up|0|||
142973178|NCT01969799|515438225|FG001|Overall Study|Lost to Follow-up|2|||
142973179|NCT01969799|515438224|FG000|Overall Study|Physician Decision|1|||
142973180|NCT01969799|515438225|FG001|Overall Study|Physician Decision|0|||
142973181|NCT03956225|515438226|FG000|Overall Study|Lack of Efficacy|1|||
142973182|NCT03956225|515438227|FG001|Overall Study|Lack of Efficacy|1|||
142973183|NCT03956225|515438226|FG000|Overall Study|Lost to Follow-up|0|||
142973184|NCT03956225|515438227|FG001|Overall Study|Lost to Follow-up|1|||
142973185|NCT03956225|515438226|FG000|Overall Study|Withdrawal by Subject|2|||
142973186|NCT03956225|515438227|FG001|Overall Study|Withdrawal by Subject|1|||
142973187|NCT03956225|515438226|FG000|Overall Study|Other Reasons|2|||
142973188|NCT03956225|515438227|FG001|Overall Study|Other Reasons|1|||
142973189|NCT04093258|515438228|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
142973190|NCT04093258|515438229|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
142973191|NCT01890512|515438232|FG000|Overall Study|Physician Decision|1|||
142973192|NCT01890512|515438232|FG000|Overall Study|Withdrawal by Subject|1|||
142973193|NCT01890512|515438232|FG000|Overall Study|Protocol Violation|1|||
142973194|NCT01529385|515438233|FG000|Overall Study|Lost to Follow-up|2|||
142973195|NCT01529385|515438234|FG001|Overall Study|Lost to Follow-up|1|||
142973196|NCT01401465|515438235|FG000|Treatment Period 1|Adverse Event|4|||
142973197|NCT01401465|515438236|FG001|Treatment Period 1|Adverse Event|1|||
142973198|NCT01401465|515438235|FG000|Treatment Period 1|Pregnancy|0|||
142973199|NCT01401465|515438236|FG001|Treatment Period 1|Pregnancy|1|||
142973200|NCT01401465|515438235|FG000|Treatment Period 1|Protocol Violation|5|||
142973201|NCT01401465|515438236|FG001|Treatment Period 1|Protocol Violation|0|||
142973202|NCT01401465|515438235|FG000|Treatment Period 1|Withdrawal by Subject|1|||
142973203|NCT01401465|515438236|FG001|Treatment Period 1|Withdrawal by Subject|4|||
142973204|NCT01401465|515438235|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
142973205|NCT01401465|515438236|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
142973206|NCT01401465|515438235|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
142973207|NCT01401465|515438236|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
142973208|NCT01401465|515438235|FG000|Treatment Period 1|Scheduling Difficulties|1|||
142973209|NCT01401465|515438236|FG001|Treatment Period 1|Scheduling Difficulties|1|||
142973210|NCT01401465|515438235|FG000|Treatment Period 2|Lost to Follow-up|0|||
142973211|NCT01401465|515438236|FG001|Treatment Period 2|Lost to Follow-up|1|||
142973212|NCT01401465|515438235|FG000|Treatment Period 2|Withdrawal by Subject|0|||
142973213|NCT01401465|515438236|FG001|Treatment Period 2|Withdrawal by Subject|1|||
142973214|NCT01115738|515438237|FG000|Overall Study|Death|1|||
142973215|NCT01115738|515438238|FG001|Overall Study|Death|0|||
142973216|NCT01115738|515438239|FG002|Overall Study|Death|0|||
142973217|NCT01115738|515438237|FG000|Overall Study|Lost to Follow-up|0|||
142973218|NCT01115738|515438238|FG001|Overall Study|Lost to Follow-up|0|||
142973219|NCT01115738|515438239|FG002|Overall Study|Lost to Follow-up|1|||
142973220|NCT01115738|515438237|FG000|Overall Study|Physician Decision|18|||
142973221|NCT01115738|515438238|FG001|Overall Study|Physician Decision|15|||
142973222|NCT01115738|515438239|FG002|Overall Study|Physician Decision|17|||
142973223|NCT01115738|515438237|FG000|Overall Study|Withdrawal by Subject|6|||
142973224|NCT01115738|515438238|FG001|Overall Study|Withdrawal by Subject|6|||
142973225|NCT01115738|515438239|FG002|Overall Study|Withdrawal by Subject|9|||
142973226|NCT00575094|515438247|FG000|Overall Study|Adverse Event|2|||
142973227|NCT00575094|515438247|FG000|Overall Study|Withdrawal by Subject|1|||
142973228|NCT00772382|515438249|FG000|Overall Study|Adverse Event|19|||
142973229|NCT00772382|515438249|FG000|Overall Study|Death|6|||
142973230|NCT00772382|515438249|FG000|Overall Study|Lack of Efficacy|4|||
142973231|NCT00772382|515438249|FG000|Overall Study|Physician Decision|5|||
142973232|NCT00772382|515438249|FG000|Overall Study|Protocol Violation|1|||
142973233|NCT00772382|515438249|FG000|Overall Study|Withdrawal by Subject|10|||
142973234|NCT00772382|515438249|FG000|Overall Study|Other Reasons|10|||
142973235|NCT00643604|515438252|FG000|Overall Study|Death|1|||
142973236|NCT02702011|515438253|FG000|Overall Study|Withdrawal by Subject|0|||
142973237|NCT02702011|515438254|FG001|Overall Study|Withdrawal by Subject|1|||
142973238|NCT02702011|515438255|FG002|Overall Study|Withdrawal by Subject|0|||
142973239|NCT02702011|515438256|FG003|Overall Study|Withdrawal by Subject|0|||
142973240|NCT02921763|515438257|FG000|Overall Study|Adverse Event|4|||
142973241|NCT02921763|515438257|FG000|Overall Study|Lost to Follow-up|4|||
142973242|NCT02921763|515438257|FG000|Overall Study|Lack of Efficacy|3|||
142973243|NCT02921763|515438257|FG000|Overall Study|Protocol Violation|2|||
142973244|NCT02921763|515438257|FG000|Overall Study|Withdrawal by Subject|2|||
142973245|NCT02921763|515438257|FG000|Overall Study|Physician Decision|1|||
142973246|NCT02921763|515438257|FG000|Overall Study|No data obtained|2|||
142973247|NCT01582971|515438262|FG000|Overall Study|Death|2|||
142973248|NCT01582971|515438263|FG001|Overall Study|Death|1|||
142973249|NCT01582971|515438262|FG000|Overall Study|Lost to Follow-up|18|||
142973250|NCT01582971|515438263|FG001|Overall Study|Lost to Follow-up|21|||
142973251|NCT01582971|515438262|FG000|Overall Study|Withdrawal by Subject|4|||
142973252|NCT01582971|515438263|FG001|Overall Study|Withdrawal by Subject|2|||
142973253|NCT01582971|515438262|FG000|Overall Study|Other|15|||
142973254|NCT01582971|515438263|FG001|Overall Study|Other|13|||
142973255|NCT01054976|515438264|FG000|Overall Study|Adverse Event|16|||
142973256|NCT01054976|515438264|FG000|Overall Study|Uncooperative participations to study|7|||
142973257|NCT01054976|515438264|FG000|Overall Study|Withdrawal by Subject|4|||
142973258|NCT01054976|515438264|FG000|Overall Study|Other|8|||
142973259|NCT01763866|515438266|FG000|Overall Study|Withdrawal by Subject|2|||
142973260|NCT01763866|515438267|FG001|Overall Study|Withdrawal by Subject|1|||
142973261|NCT01763866|515438268|FG002|Overall Study|Withdrawal by Subject|4|||
142973262|NCT01763866|515438269|FG003|Overall Study|Withdrawal by Subject|0|||
142973263|NCT01763866|515438270|FG004|Overall Study|Withdrawal by Subject|0|||
142973264|NCT01763866|515438271|FG005|Overall Study|Withdrawal by Subject|3|||
142973265|NCT01763866|515438272|FG006|Overall Study|Withdrawal by Subject|4|||
142973266|NCT01763866|515438273|FG007|Overall Study|Withdrawal by Subject|0|||
142973267|NCT01763866|515438274|FG008|Overall Study|Withdrawal by Subject|1|||
142973268|NCT01763866|515438275|FG009|Overall Study|Withdrawal by Subject|1|||
142973269|NCT01763866|515438276|FG010|Overall Study|Withdrawal by Subject|2|||
142973270|NCT01763866|515438277|FG011|Overall Study|Withdrawal by Subject|2|||
142973271|NCT01763866|515438278|FG012|Overall Study|Withdrawal by Subject|2|||
142973272|NCT01763866|515438279|FG013|Overall Study|Withdrawal by Subject|0|||
142973273|NCT01763866|515438280|FG014|Overall Study|Withdrawal by Subject|6|||
142973274|NCT01763866|515438281|FG015|Overall Study|Withdrawal by Subject|3|||
142973275|NCT01763866|515438282|FG016|Overall Study|Withdrawal by Subject|0|||
142973276|NCT01763866|515438283|FG017|Overall Study|Withdrawal by Subject|1|||
142973277|NCT01763866|515438284|FG018|Overall Study|Withdrawal by Subject|1|||
142973278|NCT01763866|515438285|FG019|Overall Study|Withdrawal by Subject|1|||
142973279|NCT01763866|515438286|FG020|Overall Study|Withdrawal by Subject|2|||
142973280|NCT01763866|515438287|FG021|Overall Study|Withdrawal by Subject|1|||
142973281|NCT01763866|515438288|FG022|Overall Study|Withdrawal by Subject|2|||
142973282|NCT01763866|515438289|FG023|Overall Study|Withdrawal by Subject|1|||
142973283|NCT01763866|515438266|FG000|Overall Study|Decision by sponsor|0|||
142973284|NCT01763866|515438267|FG001|Overall Study|Decision by sponsor|0|||
142973285|NCT01763866|515438268|FG002|Overall Study|Decision by sponsor|1|||
142973286|NCT01763866|515438269|FG003|Overall Study|Decision by sponsor|0|||
142973287|NCT01763866|515438270|FG004|Overall Study|Decision by sponsor|2|||
142973288|NCT01763866|515438271|FG005|Overall Study|Decision by sponsor|0|||
142973289|NCT01763866|515438272|FG006|Overall Study|Decision by sponsor|2|||
142973290|NCT01763866|515438273|FG007|Overall Study|Decision by sponsor|0|||
142973291|NCT01763866|515438274|FG008|Overall Study|Decision by sponsor|2|||
142973292|NCT01763866|515438275|FG009|Overall Study|Decision by sponsor|0|||
142973293|NCT01763866|515438276|FG010|Overall Study|Decision by sponsor|6|||
142973294|NCT01763866|515438277|FG011|Overall Study|Decision by sponsor|0|||
142973295|NCT01763866|515438278|FG012|Overall Study|Decision by sponsor|1|||
142973296|NCT01763866|515438279|FG013|Overall Study|Decision by sponsor|0|||
142973297|NCT01763866|515438280|FG014|Overall Study|Decision by sponsor|5|||
142973298|NCT01763866|515438281|FG015|Overall Study|Decision by sponsor|0|||
142973299|NCT01763866|515438282|FG016|Overall Study|Decision by sponsor|0|||
142973300|NCT01763866|515438283|FG017|Overall Study|Decision by sponsor|0|||
142973301|NCT01763866|515438284|FG018|Overall Study|Decision by sponsor|4|||
142973302|NCT01763866|515438285|FG019|Overall Study|Decision by sponsor|0|||
142973303|NCT01763866|515438286|FG020|Overall Study|Decision by sponsor|2|||
142973304|NCT01763866|515438287|FG021|Overall Study|Decision by sponsor|0|||
142973305|NCT01763866|515438288|FG022|Overall Study|Decision by sponsor|1|||
142973306|NCT01763866|515438289|FG023|Overall Study|Decision by sponsor|0|||
142973307|NCT01763866|515438266|FG000|Overall Study|Lost to Follow-up|0|||
142973308|NCT01763866|515438267|FG001|Overall Study|Lost to Follow-up|0|||
142973309|NCT01763866|515438268|FG002|Overall Study|Lost to Follow-up|0|||
142973310|NCT01763866|515438269|FG003|Overall Study|Lost to Follow-up|0|||
142973311|NCT01763866|515438270|FG004|Overall Study|Lost to Follow-up|0|||
142973312|NCT01763866|515438271|FG005|Overall Study|Lost to Follow-up|0|||
142973313|NCT01763866|515438272|FG006|Overall Study|Lost to Follow-up|1|||
142973314|NCT01763866|515438273|FG007|Overall Study|Lost to Follow-up|0|||
142973315|NCT01763866|515438274|FG008|Overall Study|Lost to Follow-up|0|||
142973316|NCT01763866|515438275|FG009|Overall Study|Lost to Follow-up|0|||
142973317|NCT01763866|515438276|FG010|Overall Study|Lost to Follow-up|0|||
142973318|NCT01763866|515438277|FG011|Overall Study|Lost to Follow-up|0|||
142973319|NCT01763866|515438278|FG012|Overall Study|Lost to Follow-up|1|||
142973320|NCT01763866|515438279|FG013|Overall Study|Lost to Follow-up|0|||
142973321|NCT01763866|515438280|FG014|Overall Study|Lost to Follow-up|1|||
142973322|NCT01763866|515438281|FG015|Overall Study|Lost to Follow-up|0|||
142973323|NCT01763866|515438282|FG016|Overall Study|Lost to Follow-up|0|||
142973324|NCT01763866|515438283|FG017|Overall Study|Lost to Follow-up|0|||
142973325|NCT01763866|515438284|FG018|Overall Study|Lost to Follow-up|1|||
142973326|NCT01763866|515438285|FG019|Overall Study|Lost to Follow-up|1|||
142973327|NCT01763866|515438286|FG020|Overall Study|Lost to Follow-up|0|||
142973328|NCT01763866|515438287|FG021|Overall Study|Lost to Follow-up|0|||
142973329|NCT01763866|515438288|FG022|Overall Study|Lost to Follow-up|0|||
142973330|NCT01763866|515438289|FG023|Overall Study|Lost to Follow-up|1|||
142973331|NCT01763866|515438266|FG000|Overall Study|Death|0|||
142973332|NCT01763866|515438267|FG001|Overall Study|Death|0|||
142973333|NCT01763866|515438268|FG002|Overall Study|Death|0|||
142973334|NCT01763866|515438269|FG003|Overall Study|Death|0|||
142973335|NCT01763866|515438270|FG004|Overall Study|Death|0|||
142973336|NCT01763866|515438271|FG005|Overall Study|Death|0|||
142973337|NCT01763866|515438272|FG006|Overall Study|Death|0|||
142973338|NCT01763866|515438273|FG007|Overall Study|Death|0|||
142973339|NCT01763866|515438274|FG008|Overall Study|Death|0|||
142973340|NCT01763866|515438275|FG009|Overall Study|Death|0|||
142973341|NCT01763866|515438276|FG010|Overall Study|Death|0|||
142973342|NCT01763866|515438277|FG011|Overall Study|Death|0|||
142973343|NCT01763866|515438278|FG012|Overall Study|Death|0|||
142973344|NCT01763866|515438279|FG013|Overall Study|Death|0|||
142973345|NCT01763866|515438280|FG014|Overall Study|Death|0|||
142973346|NCT01763866|515438281|FG015|Overall Study|Death|0|||
142973347|NCT01763866|515438282|FG016|Overall Study|Death|1|||
142973348|NCT01763866|515438283|FG017|Overall Study|Death|0|||
142973349|NCT01763866|515438284|FG018|Overall Study|Death|0|||
142973350|NCT01763866|515438285|FG019|Overall Study|Death|0|||
142973351|NCT01763866|515438286|FG020|Overall Study|Death|0|||
142973352|NCT01763866|515438287|FG021|Overall Study|Death|0|||
142973353|NCT01763866|515438288|FG022|Overall Study|Death|0|||
142973354|NCT01763866|515438289|FG023|Overall Study|Death|0|||
142973355|NCT01669811|515438293|FG000|Overall Study|Investigator decision|0|||
142973356|NCT01669811|515438294|FG001|Overall Study|Investigator decision|1|||
142973357|NCT01669811|515438293|FG000|Overall Study|Withdrawal by Subject|1|||
142973358|NCT01669811|515438294|FG001|Overall Study|Withdrawal by Subject|2|||
142973359|NCT01669811|515438293|FG000|Overall Study|Adverse Event|2|||
142973360|NCT01669811|515438294|FG001|Overall Study|Adverse Event|6|||
142973361|NCT01669811|515438293|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
142973362|NCT01669811|515438294|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
142973363|NCT03337139|515438297|FG000|Phase I|Withdrawal by Subject|10|||
142973364|NCT03337139|515438298|FG001|Phase I|Withdrawal by Subject|0|||
142973365|NCT03288493|515438299|FG000|Overall Study|Withdrawal by Subject|4|||
142973366|NCT03288493|515438300|FG001|Overall Study|Withdrawal by Subject|0|||
142973367|NCT03288493|515438301|FG002|Overall Study|Withdrawal by Subject|0|||
142973368|NCT03288493|515438302|FG003|Overall Study|Withdrawal by Subject|0|||
142973369|NCT03288493|515438303|FG004|Overall Study|Withdrawal by Subject|0|||
142973370|NCT03288493|515438304|FG005|Overall Study|Withdrawal by Subject|2|||
142973371|NCT03288493|515438305|FG006|Overall Study|Withdrawal by Subject|0|||
142973372|NCT03288493|515438299|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
142973373|NCT03288493|515438300|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
142973374|NCT03288493|515438301|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
142973375|NCT03288493|515438302|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
142973376|NCT03288493|515438303|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
142973377|NCT03288493|515438304|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
142973378|NCT03288493|515438305|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
142973379|NCT03288493|515438299|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
142973380|NCT03288493|515438300|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
142973381|NCT03288493|515438301|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
142973382|NCT03288493|515438302|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
142973383|NCT03288493|515438303|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
142973384|NCT03288493|515438304|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
142973385|NCT03288493|515438305|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
142973386|NCT03288493|515438299|FG000|Overall Study|Death|2|||
142973387|NCT03288493|515438300|FG001|Overall Study|Death|0|||
142973388|NCT03288493|515438301|FG002|Overall Study|Death|0|||
142973389|NCT03288493|515438302|FG003|Overall Study|Death|0|||
142973390|NCT03288493|515438303|FG004|Overall Study|Death|0|||
142973391|NCT03288493|515438304|FG005|Overall Study|Death|0|||
142973392|NCT03288493|515438305|FG006|Overall Study|Death|0|||
142973393|NCT03288493|515438299|FG000|Overall Study|other reason not listed above|2|||
143117161|NCT01256385|515970046|FG001|Overall Study|Withdrawal by Subject|2|||
142973394|NCT03288493|515438300|FG001|Overall Study|other reason not listed above|0|||
142973395|NCT03288493|515438301|FG002|Overall Study|other reason not listed above|0|||
142973396|NCT03288493|515438302|FG003|Overall Study|other reason not listed above|0|||
142973397|NCT03288493|515438303|FG004|Overall Study|other reason not listed above|0|||
142973398|NCT03288493|515438304|FG005|Overall Study|other reason not listed above|0|||
142973399|NCT03288493|515438305|FG006|Overall Study|other reason not listed above|0|||
142973400|NCT04058158|515439795|FG000|Period 1|Death|1|||
142973401|NCT04058158|515439796|FG001|Period 1|Death|0|||
142973402|NCT04058158|515439795|FG000|Period 1|Adverse Event|1|||
142973403|NCT04058158|515439796|FG001|Period 1|Adverse Event|1|||
142973404|NCT04058158|515439795|FG000|Period 1|Pregnancy|0|||
142973405|NCT04058158|515439796|FG001|Period 1|Pregnancy|1|||
143455591|NCT04602221|517212484|FG007|Overall Study|Withdrawal by Subject|0|||
143455592|NCT04602221|517212485|FG008|Overall Study|Withdrawal by Subject|0|||
143455593|NCT04602221|517212486|FG009|Overall Study|Withdrawal by Subject|0|||
143455594|NCT04602221|517212487|FG010|Overall Study|Withdrawal by Subject|0|||
143455595|NCT04602221|517212488|FG011|Overall Study|Withdrawal by Subject|0|||
143455596|NCT04602221|517212489|FG012|Overall Study|Withdrawal by Subject|1|||
143455597|NCT04602221|517212490|FG013|Overall Study|Withdrawal by Subject|0|||
143455598|NCT04602221|517212491|FG014|Overall Study|Withdrawal by Subject|0|||
143455599|NCT04602221|517212492|FG015|Overall Study|Withdrawal by Subject|0|||
143455600|NCT04602221|517212493|FG016|Overall Study|Withdrawal by Subject|0|||
143455601|NCT04602221|517212494|FG017|Overall Study|Withdrawal by Subject|0|||
143455602|NCT04602221|517212477|FG000|Overall Study|Lost to Follow-up|0|||
143455603|NCT04602221|517212478|FG001|Overall Study|Lost to Follow-up|0|||
143455604|NCT04602221|517212479|FG002|Overall Study|Lost to Follow-up|0|||
143455605|NCT04602221|517212480|FG003|Overall Study|Lost to Follow-up|0|||
142973406|NCT02215616|515439797|FG000|Overall Study|Sponsor requested to stop study drug|0|||
142973407|NCT02215616|515439798|FG001|Overall Study|Sponsor requested to stop study drug|0|||
142973408|NCT02215616|515439799|FG002|Overall Study|Sponsor requested to stop study drug|1|||
142973409|NCT02215616|515439800|FG003|Overall Study|Sponsor requested to stop study drug|4|||
142973410|NCT02215616|515439797|FG000|Overall Study|Death|1|||
142973411|NCT02215616|515439798|FG001|Overall Study|Death|0|||
142973412|NCT02215616|515439799|FG002|Overall Study|Death|0|||
142973413|NCT02215616|515439800|FG003|Overall Study|Death|0|||
142973414|NCT02215616|515439797|FG000|Overall Study|Adverse Event|7|||
142973415|NCT02215616|515439798|FG001|Overall Study|Adverse Event|4|||
142973416|NCT02215616|515439799|FG002|Overall Study|Adverse Event|9|||
142973417|NCT02215616|515439800|FG003|Overall Study|Adverse Event|2|||
142973418|NCT02215616|515439797|FG000|Overall Study|Withdrawal by Subject|1|||
142973419|NCT02215616|515439798|FG001|Overall Study|Withdrawal by Subject|8|||
142973420|NCT02215616|515439799|FG002|Overall Study|Withdrawal by Subject|2|||
142973421|NCT02215616|515439800|FG003|Overall Study|Withdrawal by Subject|5|||
142973422|NCT02215616|515439797|FG000|Overall Study|Non-compliance|0|||
142973423|NCT02215616|515439798|FG001|Overall Study|Non-compliance|2|||
142973424|NCT02215616|515439799|FG002|Overall Study|Non-compliance|1|||
142973425|NCT02215616|515439800|FG003|Overall Study|Non-compliance|0|||
142973426|NCT02215616|515439797|FG000|Overall Study|Protocol Violation|0|||
142973427|NCT02215616|515439798|FG001|Overall Study|Protocol Violation|2|||
142973428|NCT02215616|515439799|FG002|Overall Study|Protocol Violation|0|||
142973429|NCT02215616|515439800|FG003|Overall Study|Protocol Violation|0|||
142973430|NCT02215616|515439797|FG000|Overall Study|Lost to Follow-up|1|||
142973431|NCT02215616|515439798|FG001|Overall Study|Lost to Follow-up|1|||
142973432|NCT02215616|515439799|FG002|Overall Study|Lost to Follow-up|0|||
142973433|NCT02215616|515439800|FG003|Overall Study|Lost to Follow-up|1|||
143455606|NCT04602221|517212481|FG004|Overall Study|Lost to Follow-up|0|||
142973434|NCT02215616|515439797|FG000|Overall Study|Other than specified|1|||
142973435|NCT02215616|515439798|FG001|Overall Study|Other than specified|0|||
142973436|NCT02215616|515439799|FG002|Overall Study|Other than specified|1|||
142973437|NCT02215616|515439800|FG003|Overall Study|Other than specified|1|||
142973438|NCT01634113|515439801|FG000|Overall Study|Not treated|0|||
142973439|NCT01634113|515439802|FG001|Overall Study|Not treated|0|||
142973440|NCT01634113|515439803|FG002|Overall Study|Not treated|1|||
142973441|NCT01352845|515439804|FG000|Overall Study|Lost to Follow-up|313|||
142973442|NCT01352845|515439805|FG001|Overall Study|Lost to Follow-up|92|||
142973443|NCT01352845|515439804|FG000|Overall Study|No Longer Willing to Participate|205|||
142973444|NCT01352845|515439805|FG001|Overall Study|No Longer Willing to Participate|58|||
142973445|NCT01352845|515439804|FG000|Overall Study|Withdrawal by Subject|48|||
142973446|NCT01352845|515439805|FG001|Overall Study|Withdrawal by Subject|16|||
142973447|NCT01352845|515439804|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
142973448|NCT01352845|515439805|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
142973449|NCT01352845|515439804|FG000|Overall Study|Pregnancy|27|||
142973450|NCT01352845|515439805|FG001|Overall Study|Pregnancy|7|||
142973451|NCT01352845|515439804|FG000|Overall Study|Adverse Event|22|||
142973452|NCT01352845|515439805|FG001|Overall Study|Adverse Event|6|||
142973453|NCT01352845|515439804|FG000|Overall Study|Other|17|||
142973454|NCT01352845|515439805|FG001|Overall Study|Other|7|||
142973455|NCT01352845|515439804|FG000|Overall Study|Protocol Violation|12|||
142973456|NCT01352845|515439805|FG001|Overall Study|Protocol Violation|6|||
142973457|NCT01352845|515439804|FG000|Overall Study|Death|3|||
142973458|NCT01352845|515439805|FG001|Overall Study|Death|0|||
142973459|NCT01149343|515439806|FG000|Overall Study|Withdrawal by Subject|1|||
142973460|NCT01149343|515439807|FG001|Overall Study|Withdrawal by Subject|1|||
142973461|NCT01149343|515439808|FG002|Overall Study|Withdrawal by Subject|1|||
142973462|NCT01149343|515439809|FG003|Overall Study|Withdrawal by Subject|5|||
142973463|NCT01149343|515439806|FG000|Overall Study|Death|10|||
142973464|NCT01149343|515439807|FG001|Overall Study|Death|13|||
142973465|NCT01149343|515439808|FG002|Overall Study|Death|18|||
142973466|NCT01149343|515439809|FG003|Overall Study|Death|18|||
142973467|NCT01149343|515439806|FG000|Overall Study|Lost to Follow-up|1|||
142973468|NCT01149343|515439807|FG001|Overall Study|Lost to Follow-up|0|||
142973469|NCT01149343|515439808|FG002|Overall Study|Lost to Follow-up|0|||
142973470|NCT01149343|515439809|FG003|Overall Study|Lost to Follow-up|1|||
142973471|NCT01149343|515439806|FG000|Overall Study|Other|8|||
142973472|NCT01149343|515439807|FG001|Overall Study|Other|10|||
142973473|NCT01149343|515439808|FG002|Overall Study|Other|2|||
142973474|NCT01149343|515439809|FG003|Overall Study|Other|14|||
142973475|NCT01149343|515439806|FG000|Overall Study|Sponsor study termination|0|||
142973476|NCT01149343|515439807|FG001|Overall Study|Sponsor study termination|0|||
142973477|NCT01149343|515439808|FG002|Overall Study|Sponsor study termination|0|||
142973478|NCT01149343|515439809|FG003|Overall Study|Sponsor study termination|2|||
142973479|NCT01149343|515439806|FG000|Overall Study|Recurrence / Progressive disease|0|||
142973480|NCT01149343|515439807|FG001|Overall Study|Recurrence / Progressive disease|0|||
142973481|NCT01149343|515439808|FG002|Overall Study|Recurrence / Progressive disease|1|||
142973482|NCT01149343|515439809|FG003|Overall Study|Recurrence / Progressive disease|0|||
142973483|NCT03625141|515439810|FG000|Overall Study|Adverse Event|0|||
142973484|NCT03625141|515439811|FG001|Overall Study|Adverse Event|2|||
142973485|NCT03625141|515439810|FG000|Overall Study|Study Terminated By Sponsor|1|||
142973486|NCT03625141|515439811|FG001|Overall Study|Study Terminated By Sponsor|13|||
142973487|NCT03625141|515439810|FG000|Overall Study|Withdrawal by Subject|3|||
142973488|NCT03625141|515439811|FG001|Overall Study|Withdrawal by Subject|0|||
142973489|NCT03625141|515439810|FG000|Overall Study|Withdrawal Of Consent|0|||
142973490|NCT03625141|515439811|FG001|Overall Study|Withdrawal Of Consent|1|||
142973491|NCT03625141|515439810|FG000|Overall Study|Death|11|||
142973492|NCT03625141|515439811|FG001|Overall Study|Death|47|||
142973493|NCT03625141|515439810|FG000|Overall Study|Progressive Disease|0|||
142973494|NCT03625141|515439811|FG001|Overall Study|Progressive Disease|2|||
142973495|NCT03250377|515439812|FG000|Overall Study|Adverse Event|2|||
142973496|NCT03250377|515439813|FG001|Overall Study|Adverse Event|4|||
142973497|NCT03250377|515439814|FG002|Overall Study|Adverse Event|0|||
142973498|NCT03250377|515439815|FG003|Overall Study|Adverse Event|4|||
142973499|NCT03250377|515439812|FG000|Overall Study|Lack of Efficacy|5|||
142973500|NCT03250377|515439813|FG001|Overall Study|Lack of Efficacy|14|||
142973501|NCT03250377|515439814|FG002|Overall Study|Lack of Efficacy|1|||
142973502|NCT03250377|515439815|FG003|Overall Study|Lack of Efficacy|3|||
142973503|NCT03250377|515439812|FG000|Overall Study|Protocol Violation|0|||
142973504|NCT03250377|515439813|FG001|Overall Study|Protocol Violation|2|||
142973505|NCT03250377|515439814|FG002|Overall Study|Protocol Violation|0|||
142973506|NCT03250377|515439815|FG003|Overall Study|Protocol Violation|1|||
142973507|NCT03250377|515439812|FG000|Overall Study|Lost to Follow-up|0|||
142973508|NCT03250377|515439813|FG001|Overall Study|Lost to Follow-up|1|||
142973509|NCT03250377|515439814|FG002|Overall Study|Lost to Follow-up|0|||
142973510|NCT03250377|515439815|FG003|Overall Study|Lost to Follow-up|0|||
142973511|NCT03250377|515439812|FG000|Overall Study|Withdrawal by Subject|7|||
142973512|NCT03250377|515439813|FG001|Overall Study|Withdrawal by Subject|7|||
143003144|NCT01049360|515548756|FG012|Period 2|Adverse Event|0|||
142973513|NCT03250377|515439814|FG002|Overall Study|Withdrawal by Subject|0|||
142973514|NCT03250377|515439815|FG003|Overall Study|Withdrawal by Subject|4|||
142973515|NCT03250377|515439812|FG000|Overall Study|Investigator's Judgment|1|||
142973516|NCT03250377|515439813|FG001|Overall Study|Investigator's Judgment|0|||
142973517|NCT03250377|515439814|FG002|Overall Study|Investigator's Judgment|0|||
142973518|NCT03250377|515439815|FG003|Overall Study|Investigator's Judgment|0|||
142973519|NCT03250377|515439812|FG000|Overall Study|She wanted to change other therapeutic medication|1|||
142973520|NCT03250377|515439813|FG001|Overall Study|She wanted to change other therapeutic medication|0|||
142973521|NCT03250377|515439814|FG002|Overall Study|She wanted to change other therapeutic medication|0|||
142973522|NCT03250377|515439815|FG003|Overall Study|She wanted to change other therapeutic medication|0|||
142973523|NCT03250377|515439812|FG000|Overall Study|The Subject Go Abroad and Not Return|1|||
142973524|NCT03250377|515439813|FG001|Overall Study|The Subject Go Abroad and Not Return|0|||
142973525|NCT03250377|515439814|FG002|Overall Study|The Subject Go Abroad and Not Return|0|||
142973526|NCT03250377|515439815|FG003|Overall Study|The Subject Go Abroad and Not Return|0|||
142973527|NCT03250377|515439812|FG000|Overall Study|Epilepsy Surgery|0|||
142973528|NCT03250377|515439813|FG001|Overall Study|Epilepsy Surgery|1|||
142973529|NCT03250377|515439814|FG002|Overall Study|Epilepsy Surgery|2|||
142973530|NCT03250377|515439815|FG003|Overall Study|Epilepsy Surgery|0|||
142973531|NCT03250377|515439812|FG000|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
142973532|NCT03250377|515439813|FG001|Overall Study|Subject moved to kanagawa (faraway from clinic)|1|||
142973533|NCT03250377|515439814|FG002|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
142973534|NCT03250377|515439815|FG003|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
142973535|NCT03250377|515439812|FG000|Overall Study|Request From The Sponsor|0|||
142973536|NCT03250377|515439813|FG001|Overall Study|Request From The Sponsor|1|||
142973537|NCT03250377|515439814|FG002|Overall Study|Request From The Sponsor|0|||
142973538|NCT03250377|515439815|FG003|Overall Study|Request From The Sponsor|0|||
142973539|NCT03250377|515439812|FG000|Overall Study|Subject did not follow procedure or study drug|0|||
142973540|NCT03250377|515439813|FG001|Overall Study|Subject did not follow procedure or study drug|1|||
142973541|NCT03250377|515439814|FG002|Overall Study|Subject did not follow procedure or study drug|0|||
142973542|NCT03250377|515439815|FG003|Overall Study|Subject did not follow procedure or study drug|0|||
142973543|NCT03250377|515439812|FG000|Overall Study|Subject stopped drug; did not wish to continue|0|||
142973544|NCT03250377|515439813|FG001|Overall Study|Subject stopped drug; did not wish to continue|1|||
142973545|NCT03250377|515439814|FG002|Overall Study|Subject stopped drug; did not wish to continue|0|||
142973546|NCT03250377|515439815|FG003|Overall Study|Subject stopped drug; did not wish to continue|0|||
142973547|NCT03250377|515439812|FG000|Overall Study|Subjects did not follow procedures or medication|0|||
142973548|NCT03250377|515439813|FG001|Overall Study|Subjects did not follow procedures or medication|1|||
142973549|NCT03250377|515439814|FG002|Overall Study|Subjects did not follow procedures or medication|0|||
142973550|NCT03250377|515439815|FG003|Overall Study|Subjects did not follow procedures or medication|0|||
142973551|NCT03250377|515439812|FG000|Overall Study|Pregnancy Event|0|||
142973552|NCT03250377|515439813|FG001|Overall Study|Pregnancy Event|1|||
142973553|NCT03250377|515439814|FG002|Overall Study|Pregnancy Event|0|||
142973554|NCT03250377|515439815|FG003|Overall Study|Pregnancy Event|0|||
142973555|NCT03250377|515439812|FG000|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
142973556|NCT03250377|515439813|FG001|Overall Study|PI's opinion:Subject noncompliant with medication|1|||
142973557|NCT03250377|515439814|FG002|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
142973558|NCT03250377|515439815|FG003|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
142973559|NCT03250377|515439812|FG000|Overall Study|Subjects felt no effect;want to discontinue study|0|||
142973560|NCT03250377|515439813|FG001|Overall Study|Subjects felt no effect;want to discontinue study|1|||
142973561|NCT03250377|515439814|FG002|Overall Study|Subjects felt no effect;want to discontinue study|0|||
142973562|NCT03250377|515439815|FG003|Overall Study|Subjects felt no effect;want to discontinue study|0|||
142973563|NCT03250377|515439812|FG000|Overall Study|Subjects underweight; intolerant to study drugs|0|||
142973564|NCT03250377|515439813|FG001|Overall Study|Subjects underweight; intolerant to study drugs|1|||
142973565|NCT03250377|515439814|FG002|Overall Study|Subjects underweight; intolerant to study drugs|0|||
142973566|NCT03250377|515439815|FG003|Overall Study|Subjects underweight; intolerant to study drugs|0|||
142973567|NCT03250377|515439812|FG000|Overall Study|Patient requested to change hospital|0|||
142973568|NCT03250377|515439813|FG001|Overall Study|Patient requested to change hospital|0|||
142973569|NCT03250377|515439814|FG002|Overall Study|Patient requested to change hospital|0|||
142973570|NCT03250377|515439815|FG003|Overall Study|Patient requested to change hospital|1|||
142973571|NCT03250377|515439812|FG000|Overall Study|Admission To Geriatric Health Facility|0|||
142973572|NCT03250377|515439813|FG001|Overall Study|Admission To Geriatric Health Facility|0|||
142973573|NCT03250377|515439814|FG002|Overall Study|Admission To Geriatric Health Facility|0|||
142973574|NCT03250377|515439815|FG003|Overall Study|Admission To Geriatric Health Facility|1|||
142973575|NCT00868166|515439816|FG000|Overall Study|Death|58|||
142973576|NCT00868166|515439817|FG001|Overall Study|Death|65|||
142973577|NCT00868166|515439816|FG000|Overall Study|Withdrawal by Subject|33|||
143455607|NCT04602221|517212482|FG005|Overall Study|Lost to Follow-up|1|||
143455608|NCT04602221|517212483|FG006|Overall Study|Lost to Follow-up|0|||
142973578|NCT00868166|515439817|FG001|Overall Study|Withdrawal by Subject|25|||
142973579|NCT00868166|515439816|FG000|Overall Study|Protocol Violation|1|||
142973580|NCT00868166|515439817|FG001|Overall Study|Protocol Violation|0|||
142973581|NCT00868166|515439816|FG000|Overall Study|Lost to Follow-up|1|||
142973582|NCT00868166|515439817|FG001|Overall Study|Lost to Follow-up|3|||
142973583|NCT00868166|515439816|FG000|Overall Study|Adverse Event|9|||
142973584|NCT00868166|515439817|FG001|Overall Study|Adverse Event|10|||
142973585|NCT00868166|515439816|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
142973586|NCT00868166|515439817|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
142973587|NCT00868166|515439816|FG000|Overall Study|Non-compliance with IMP|1|||
142973588|NCT00868166|515439817|FG001|Overall Study|Non-compliance with IMP|1|||
142973589|NCT02034552|515439822|FG000|Overall Study|Never treated|3|||
142973590|NCT02034552|515439823|FG001|Overall Study|Never treated|2|||
142973591|NCT02034552|515439824|FG002|Overall Study|Never treated|0|||
142973592|NCT02034552|515439822|FG000|Overall Study|Radiological progression|3|||
142973593|NCT02034552|515439823|FG001|Overall Study|Radiological progression|5|||
142973594|NCT02034552|515439824|FG002|Overall Study|Radiological progression|4|||
142973595|NCT02034552|515439822|FG000|Overall Study|AE not assoc. with disease progression|1|||
142973596|NCT02034552|515439823|FG001|Overall Study|AE not assoc. with disease progression|4|||
142973597|NCT02034552|515439824|FG002|Overall Study|AE not assoc. with disease progression|2|||
142973598|NCT02034552|515439822|FG000|Overall Study|AE associated with disease progression|0|||
142973599|NCT02034552|515439823|FG001|Overall Study|AE associated with disease progression|1|||
142973600|NCT02034552|515439824|FG002|Overall Study|AE associated with disease progression|0|||
142973601|NCT02034552|515439822|FG000|Overall Study|Withdrawal by Subject|2|||
142973602|NCT02034552|515439823|FG001|Overall Study|Withdrawal by Subject|1|||
142973603|NCT02034552|515439824|FG002|Overall Study|Withdrawal by Subject|1|||
142973604|NCT02034552|515439822|FG000|Overall Study|Non-compliance with study drug|0|||
142973605|NCT02034552|515439823|FG001|Overall Study|Non-compliance with study drug|0|||
142973606|NCT02034552|515439824|FG002|Overall Study|Non-compliance with study drug|1|||
142973607|NCT02034552|515439822|FG000|Overall Study|Clinical progression|5|||
142973608|NCT02034552|515439823|FG001|Overall Study|Clinical progression|7|||
142973609|NCT02034552|515439824|FG002|Overall Study|Clinical progression|9|||
142973610|NCT04295356|515439832|FG000|Overall Study|Physician Decision|1|||
142973611|NCT04295356|515439833|FG001|Overall Study|Physician Decision|0|||
142973612|NCT04295356|515439832|FG000|Overall Study|Lost to Follow-up|0|||
142973613|NCT04295356|515439833|FG001|Overall Study|Lost to Follow-up|3|||
142973614|NCT04295356|515439832|FG000|Overall Study|Protocol Violation|0|||
142973615|NCT04295356|515439833|FG001|Overall Study|Protocol Violation|1|||
142973616|NCT01280266|515439834|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
142973617|NCT01280266|515439835|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
142973618|NCT01280266|515439834|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
142973619|NCT01280266|515439835|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
142973620|NCT01106391|515439843|FG000|Overall Study|Death|12|||
142973621|NCT01106391|515439843|FG000|Overall Study|Withdrawal by Subject|7|||
142973622|NCT04116073|515439844|FG000|Overall Study|Withdrawal by Subject|2|||
142973623|NCT04116073|515439844|FG000|Overall Study|failed to maintained eligibility|1|||
142973624|NCT03939637|515439847|FG000|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|2|||
142973625|NCT03939637|515439848|FG001|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|0|||
142973626|NCT03939637|515439847|FG000|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
142973627|NCT03939637|515439848|FG001|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
142973628|NCT03783442|515439851|FG000|Overall Study|Death|252|||
142973629|NCT03783442|515439852|FG001|Overall Study|Death|268|||
142973630|NCT03783442|515439851|FG000|Overall Study|Withdrawal by Subject|19|||
142973631|NCT03783442|515439852|FG001|Overall Study|Withdrawal by Subject|21|||
142973632|NCT03783442|515439851|FG000|Overall Study|Lost to Follow-up|7|||
142973633|NCT03783442|515439852|FG001|Overall Study|Lost to Follow-up|6|||
142973634|NCT03783442|515439851|FG000|Overall Study|Sponsor Ended Study|48|||
142973635|NCT03783442|515439852|FG001|Overall Study|Sponsor Ended Study|28|||
142973636|NCT04325906|515439853|FG000|Overall Study|Withdrawal by Subject|2|||
142973637|NCT04325906|515439854|FG001|Overall Study|Withdrawal by Subject|0|||
142973638|NCT01381718|515439855|FG000|Overall Study|Withdrawal by Subject|2|||
142973639|NCT01381718|515439856|FG001|Overall Study|Withdrawal by Subject|5|||
142973640|NCT01381718|515439855|FG000|Overall Study|Lost to Follow-up|3|||
142973641|NCT01381718|515439856|FG001|Overall Study|Lost to Follow-up|5|||
142973642|NCT01381718|515439855|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
142973643|NCT01381718|515439856|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
142973644|NCT00830804|515439866|FG000|Overall Study|Lost to Follow-up|4|||
142973645|NCT00830804|515439866|FG000|Overall Study|Death|1|||
142973646|NCT00830804|515439866|FG000|Overall Study|Unable to get to clinic|7|||
142973647|NCT00830804|515439866|FG000|Overall Study|Consent withdrawn|2|||
142973648|NCT00830804|515439866|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
142973649|NCT00510068|515439873|FG000|Double-blind Period|Disease progression|98|||
143117162|NCT00401960|515970047|FG000|Overall Study|Lost to Follow-up|3|||
142973650|NCT00510068|515439874|FG001|Double-blind Period|Disease progression|169|||
142973651|NCT00510068|515439873|FG000|Double-blind Period|Final primary analysis|52|||
142973652|NCT00510068|515439874|FG001|Double-blind Period|Final primary analysis|18|||
142973653|NCT00510068|515439873|FG000|Double-blind Period|Adverse Event|37|||
142973654|NCT00510068|515439874|FG001|Double-blind Period|Adverse Event|7|||
142973655|NCT00510068|515439873|FG000|Double-blind Period|Withdrawal by Subject|8|||
142973656|NCT00510068|515439874|FG001|Double-blind Period|Withdrawal by Subject|6|||
142973657|NCT00510068|515439873|FG000|Double-blind Period|Death|4|||
142973658|NCT00510068|515439874|FG001|Double-blind Period|Death|3|||
142973659|NCT00510068|515439873|FG000|Double-blind Period|Abnormal test result (s)|1|||
142973660|NCT00510068|515439874|FG001|Double-blind Period|Abnormal test result (s)|0|||
142973661|NCT00510068|515439873|FG000|Double-blind Period|Lost to Follow-up|1|||
142973662|NCT00510068|515439874|FG001|Double-blind Period|Lost to Follow-up|0|||
142973663|NCT00510068|515439873|FG000|Double-blind Period|Protocol Violation|6|||
142973664|NCT00510068|515439874|FG001|Double-blind Period|Protocol Violation|0|||
142973665|NCT00510068|515439873|FG000|Open-label Period|Disease Progression|124|||
142973666|NCT00510068|515439874|FG001|Open-label Period|Disease Progression|0|||
142973667|NCT00510068|515439873|FG000|Open-label Period|Adverse Event|46|||
142973668|NCT00510068|515439874|FG001|Open-label Period|Adverse Event|0|||
142973669|NCT00510068|515439873|FG000|Open-label Period|Withdrawal by Subject|21|||
142973670|NCT00510068|515439874|FG001|Open-label Period|Withdrawal by Subject|0|||
142973671|NCT00510068|515439873|FG000|Open-label Period|Administrative problems|17|||
142973672|NCT00510068|515439874|FG001|Open-label Period|Administrative problems|0|||
142973673|NCT00510068|515439873|FG000|Open-label Period|Death|7|||
142973674|NCT00510068|515439874|FG001|Open-label Period|Death|0|||
142973675|NCT00510068|515439873|FG000|Open-label Period|New cancer therapy|7|||
142973676|NCT00510068|515439874|FG001|Open-label Period|New cancer therapy|0|||
142973677|NCT00510068|515439873|FG000|Open-label Period|Protocol Violation|2|||
142973678|NCT00510068|515439874|FG001|Open-label Period|Protocol Violation|0|||
142973679|NCT00510068|515439873|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
142973680|NCT00510068|515439874|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
142973681|NCT00400712|515439875|FG000|Overall Study|Death|1|||
142973682|NCT00400712|515439876|FG001|Overall Study|Death|0|||
142973683|NCT00400712|515439875|FG000|Overall Study|Withdrawal by Subject|11|||
142973684|NCT00400712|515439876|FG001|Overall Study|Withdrawal by Subject|12|||
142973685|NCT00400712|515439875|FG000|Overall Study|Physician Decision|5|||
142973686|NCT00400712|515439876|FG001|Overall Study|Physician Decision|4|||
142973687|NCT00776555|515439877|FG000|Overall Study|Study terminated|3|||
142973688|NCT00776555|515439878|FG001|Overall Study|Study terminated|0|||
142973689|NCT01181102|515439879|FG000|Overall Study|Adverse Event|28|||
142973690|NCT01181102|515439880|FG001|Overall Study|Adverse Event|26|||
142973691|NCT01181102|515439879|FG000|Overall Study|Lack of Efficacy|3|||
142973692|NCT01181102|515439880|FG001|Overall Study|Lack of Efficacy|1|||
142973693|NCT01181102|515439879|FG000|Overall Study|Lost to Follow-up|2|||
142973694|NCT01181102|515439880|FG001|Overall Study|Lost to Follow-up|0|||
142973695|NCT01181102|515439879|FG000|Overall Study|Physician Decision|3|||
142973696|NCT01181102|515439880|FG001|Overall Study|Physician Decision|1|||
142973697|NCT01181102|515439879|FG000|Overall Study|Protocol Violation|5|||
142973698|NCT01181102|515439880|FG001|Overall Study|Protocol Violation|6|||
142973699|NCT01181102|515439879|FG000|Overall Study|Withdrawal by Subject|10|||
142973700|NCT01181102|515439880|FG001|Overall Study|Withdrawal by Subject|12|||
142973701|NCT01309841|515439881|FG000|Overall Study|Other|0|||
142973702|NCT01309841|515439882|FG001|Overall Study|Other|1|||
142973703|NCT01309841|515439883|FG002|Overall Study|Other|1|||
142973704|NCT01309841|515439881|FG000|Overall Study|Lost to Follow-up|7|||
142973705|NCT01309841|515439882|FG001|Overall Study|Lost to Follow-up|6|||
142973706|NCT01309841|515439883|FG002|Overall Study|Lost to Follow-up|4|||
142973707|NCT01309841|515439881|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
142973708|NCT01309841|515439882|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
142973709|NCT01309841|515439883|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
142973710|NCT01309841|515439881|FG000|Overall Study|Lack of Efficacy|0|||
142973711|NCT01309841|515439882|FG001|Overall Study|Lack of Efficacy|0|||
142973712|NCT01309841|515439883|FG002|Overall Study|Lack of Efficacy|2|||
142973713|NCT01309841|515439881|FG000|Overall Study|Adverse Event|9|||
142973714|NCT01309841|515439882|FG001|Overall Study|Adverse Event|22|||
142973715|NCT01309841|515439883|FG002|Overall Study|Adverse Event|11|||
142973716|NCT01309841|515439881|FG000|Overall Study|Death|1|||
142973717|NCT01309841|515439882|FG001|Overall Study|Death|0|||
142973718|NCT01309841|515439883|FG002|Overall Study|Death|0|||
142973719|NCT01309841|515439881|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
143455609|NCT04602221|517212484|FG007|Overall Study|Lost to Follow-up|0|||
143455610|NCT04602221|517212485|FG008|Overall Study|Lost to Follow-up|0|||
142973720|NCT01309841|515439882|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
142973721|NCT01309841|515439883|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
142973722|NCT01309841|515439881|FG000|Overall Study|Withdrawal by Subject|17|||
142973723|NCT01309841|515439882|FG001|Overall Study|Withdrawal by Subject|6|||
142973724|NCT01309841|515439883|FG002|Overall Study|Withdrawal by Subject|13|||
142973725|NCT01309841|515439881|FG000|Overall Study|Did Not Receive Treatment|2|||
142973726|NCT01309841|515439882|FG001|Overall Study|Did Not Receive Treatment|0|||
142973727|NCT01309841|515439883|FG002|Overall Study|Did Not Receive Treatment|1|||
142973728|NCT01309841|515439881|FG000|Overall Study|Severe non-compliance with protocol|0|||
142973729|NCT01309841|515439882|FG001|Overall Study|Severe non-compliance with protocol|5|||
142973730|NCT01309841|515439883|FG002|Overall Study|Severe non-compliance with protocol|2|||
142973731|NCT01996904|515439884|FG000|Overall Study|Lost to Follow-up|38|||
142973732|NCT01996904|515439885|FG001|Overall Study|Lost to Follow-up|27|||
142973733|NCT01324622|515439886|FG000|Overall Study|Lost to Follow-up|7|||
142973734|NCT01324622|515439887|FG001|Overall Study|Lost to Follow-up|7|||
142973735|NCT01324622|515439886|FG000|Overall Study|Death|1|||
142973736|NCT01324622|515439887|FG001|Overall Study|Death|0|||
142973737|NCT01324622|515439886|FG000|Overall Study|Lack of Efficacy|1|||
142973738|NCT01324622|515439887|FG001|Overall Study|Lack of Efficacy|0|||
142973739|NCT02219087|515439888|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
142973740|NCT02219087|515439889|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
142973741|NCT00618449|515439890|FG000|Overall Study|Lost to Follow-up|98|||
142973742|NCT00618449|515439891|FG001|Overall Study|Lost to Follow-up|110|||
142973743|NCT05127421|515439892|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
142973744|NCT05127421|515439893|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
142973745|NCT05127421|515439894|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
142973746|NCT05127421|515439895|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
142973747|NCT05127421|515439892|FG000|4-Week Double-Blind Period|Physician Decision|1|||
142973748|NCT05127421|515439893|FG001|4-Week Double-Blind Period|Physician Decision|0|||
142973749|NCT05127421|515439894|FG002|4-Week Double-Blind Period|Physician Decision|0|||
142973750|NCT05127421|515439895|FG003|4-Week Double-Blind Period|Physician Decision|0|||
142973751|NCT05127421|515439892|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
142973752|NCT05127421|515439893|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
142973753|NCT05127421|515439894|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
142973754|NCT05127421|515439895|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
142973755|NCT05127421|515439892|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
142973756|NCT05127421|515439893|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
142973757|NCT05127421|515439894|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
142973758|NCT05127421|515439895|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
142973759|NCT05127421|515439892|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
142973760|NCT05127421|515439893|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
142973761|NCT05127421|515439894|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
142973762|NCT05127421|515439895|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
142973763|NCT05127421|515439892|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
142973764|NCT05127421|515439893|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
142973765|NCT05127421|515439894|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
142973766|NCT05127421|515439895|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
142973767|NCT05127421|515439892|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
142973768|NCT05127421|515439893|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
142973769|NCT05127421|515439894|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
142973770|NCT05127421|515439895|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
142973771|NCT05127421|515439892|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
142973772|NCT05127421|515439893|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
142973773|NCT05127421|515439894|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
142973774|NCT05127421|515439895|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
142973775|NCT01441115|515439896|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
142973776|NCT00178464|515439901|FG000|Overall Study|Withdrawal by Subject|1|||
142973777|NCT00178464|515439901|FG000|Overall Study|Physician Decision|1|||
142973778|NCT02227108|515439902|FG000|Overall Study|Did not receive treatment|2|||
142973779|NCT02227108|515439902|FG000|Overall Study|Other|3|||
142973780|NCT02227108|515439902|FG000|Overall Study|Progressive disease|17|||
142973781|NCT02227108|515439902|FG000|Overall Study|Initiation of alternative therapy|2|||
142973782|NCT02227108|515439902|FG000|Overall Study|Investigator discretion|1|||
142973783|NCT02227108|515439902|FG000|Overall Study|Adverse Event|6|||
142973784|NCT02486952|515439903|FG000|Overall Study|Not Started Induction Therapy|3|||
142973785|NCT02486952|515439903|FG000|Overall Study|Adverse Event|1|||
142973786|NCT02486952|515439903|FG000|Overall Study|Death|15|||
142973787|NCT02486952|515439903|FG000|Overall Study|Lack of Efficacy|3|||
142973788|NCT02486952|515439903|FG000|Overall Study|Lost to Follow-up|26|||
142973789|NCT02486952|515439903|FG000|Overall Study|Other|2|||
142973790|NCT04111107|515439904|FG000|Overall Study|Withdrawal by Subject|6|||
142973791|NCT04111107|515439904|FG000|Overall Study|Declining Health|5|||
142973792|NCT02260648|515439905|FG000|Overall Study|Adverse Event|3|||
142973793|NCT02260648|515439906|FG001|Overall Study|Adverse Event|0|||
142973794|NCT02260648|515439907|FG002|Overall Study|Adverse Event|1|||
142973795|NCT02260648|515439905|FG000|Overall Study|Withdrawal by Subject|1|||
142973796|NCT02260648|515439906|FG001|Overall Study|Withdrawal by Subject|1|||
142973797|NCT02260648|515439907|FG002|Overall Study|Withdrawal by Subject|0|||
142973798|NCT02260648|515439905|FG000|Overall Study|Protocol Violation|1|||
142973799|NCT02260648|515439906|FG001|Overall Study|Protocol Violation|0|||
142973800|NCT02260648|515439907|FG002|Overall Study|Protocol Violation|0|||
142973801|NCT02260648|515439905|FG000|Overall Study|Discontinue Due to Study Termination|13|||
142973802|NCT02260648|515439906|FG001|Overall Study|Discontinue Due to Study Termination|12|||
142973803|NCT02260648|515439907|FG002|Overall Study|Discontinue Due to Study Termination|7|||
142973804|NCT00594204|515439908|FG000|Overall Study|Adverse Event|15|||
142973805|NCT00594204|515439909|FG001|Overall Study|Adverse Event|3|||
142973806|NCT00594204|515439908|FG000|Overall Study|Lost to Follow-up|9|||
142973807|NCT00594204|515439909|FG001|Overall Study|Lost to Follow-up|5|||
142973808|NCT00594204|515439908|FG000|Overall Study|Withdrawal by Subject|23|||
142973809|NCT00594204|515439909|FG001|Overall Study|Withdrawal by Subject|29|||
142973810|NCT00594204|515439908|FG000|Overall Study|Other|4|||
142973811|NCT00594204|515439909|FG001|Overall Study|Other|3|||
142973812|NCT00594204|515439908|FG000|Overall Study|Lack of Efficacy|3|||
142973813|NCT00594204|515439909|FG001|Overall Study|Lack of Efficacy|4|||
142973814|NCT00594204|515439908|FG000|Overall Study|Randomized but not treated|4|||
142973815|NCT00594204|515439909|FG001|Overall Study|Randomized but not treated|1|||
142973816|NCT00567541|515439910|FG000|Overall Study|Adverse Event|0|||
142973817|NCT00567541|515439911|FG001|Overall Study|Adverse Event|1|||
142973818|NCT02721251|515439915|FG000|Overall Study|Withdrawal by Subject|8|||
142973819|NCT02721251|515439916|FG001|Overall Study|Withdrawal by Subject|7|||
142973820|NCT02721251|515439917|FG002|Overall Study|Withdrawal by Subject|9|||
142973821|NCT02721251|515439915|FG000|Overall Study|poor adherence|2|||
142973822|NCT02721251|515439916|FG001|Overall Study|poor adherence|2|||
142973823|NCT02721251|515439917|FG002|Overall Study|poor adherence|2|||
142973824|NCT00862121|515439920|FG000|Overall Study|Adverse Event|1|||
142973825|NCT00862121|515439921|FG001|Overall Study|Adverse Event|2|||
142973826|NCT00862121|515439920|FG000|Overall Study|Lack of Efficacy|0|||
142973827|NCT00862121|515439921|FG001|Overall Study|Lack of Efficacy|3|||
142973828|NCT00862121|515439920|FG000|Overall Study|Protocol Violation|0|||
142973829|NCT00862121|515439921|FG001|Overall Study|Protocol Violation|1|||
142973830|NCT00862121|515439920|FG000|Overall Study|Exclusion criterion violation|0|||
142973831|NCT00862121|515439921|FG001|Overall Study|Exclusion criterion violation|1|||
142973832|NCT00862121|515439920|FG000|Overall Study|Incorrect randomisation|0|||
142973833|NCT00862121|515439921|FG001|Overall Study|Incorrect randomisation|1|||
142973834|NCT02007954|515439922|FG000|Overall Study|Received liver transplant|3|||
142973835|NCT02007954|515439922|FG000|Overall Study|Switch in treatment modality|2|||
142973836|NCT02007954|515439922|FG000|Overall Study|Disease progression and unrelated AE|1|||
142973837|NCT02007954|515439922|FG000|Overall Study|Death|1|||
142973838|NCT01195363|515439927|FG000|Overall Study|Lost to Follow-up|7|||
142973839|NCT01195363|515439928|FG001|Overall Study|Lost to Follow-up|4|||
142973840|NCT01195363|515439927|FG000|Overall Study|Adverse Event|3|||
142973841|NCT01195363|515439928|FG001|Overall Study|Adverse Event|1|||
142973842|NCT01195363|515439927|FG000|Overall Study|Lack of Efficacy|0|||
142973843|NCT01195363|515439928|FG001|Overall Study|Lack of Efficacy|4|||
142973844|NCT01195363|515439927|FG000|Overall Study|incarceration|1|||
142973845|NCT01195363|515439928|FG001|Overall Study|incarceration|0|||
142973846|NCT00171314|515439930|FG000|Overall Study|Adverse Event|44|||
142973847|NCT00171314|515439931|FG001|Overall Study|Adverse Event|41|||
142973848|NCT00171314|515439930|FG000|Overall Study|Lack of Efficacy|19|||
142973849|NCT00171314|515439931|FG001|Overall Study|Lack of Efficacy|14|||
142973850|NCT00171314|515439930|FG000|Overall Study|Withdrawal by Subject|9|||
142973851|NCT00171314|515439931|FG001|Overall Study|Withdrawal by Subject|6|||
142973852|NCT00171314|515439930|FG000|Overall Study|Abnormal Test Procedure Results|9|||
142973853|NCT00171314|515439931|FG001|Overall Study|Abnormal Test Procedure Results|3|||
142973854|NCT00171314|515439930|FG000|Overall Study|Protocol Violation|3|||
142973855|NCT00171314|515439931|FG001|Overall Study|Protocol Violation|7|||
142973856|NCT00171314|515439930|FG000|Overall Study|Administrative Problems|4|||
142973857|NCT00171314|515439931|FG001|Overall Study|Administrative Problems|3|||
142973858|NCT00171314|515439930|FG000|Overall Study|Lost to Follow-up|1|||
142973859|NCT00171314|515439931|FG001|Overall Study|Lost to Follow-up|3|||
142973860|NCT00171314|515439930|FG000|Overall Study|Death|2|||
142973861|NCT00171314|515439931|FG001|Overall Study|Death|1|||
142973862|NCT02559206|515439933|FG000|Overall Study|Adverse Event|0|||
142973863|NCT02559206|515439934|FG001|Overall Study|Adverse Event|4|||
142973864|NCT02559206|515439935|FG002|Overall Study|Adverse Event|1|||
142973865|NCT02559206|515439936|FG003|Overall Study|Adverse Event|5|||
142973866|NCT02559206|515439937|FG004|Overall Study|Adverse Event|3|||
142973867|NCT02559206|515439938|FG005|Overall Study|Adverse Event|0|||
142973868|NCT02559206|515439939|FG006|Overall Study|Adverse Event|1|||
142973869|NCT02559206|515439940|FG007|Overall Study|Adverse Event|0|||
142973870|NCT02559206|515439933|FG000|Overall Study|Protocol Violation|1|||
142973871|NCT02559206|515439934|FG001|Overall Study|Protocol Violation|0|||
142973872|NCT02559206|515439935|FG002|Overall Study|Protocol Violation|1|||
142973873|NCT02559206|515439936|FG003|Overall Study|Protocol Violation|0|||
142973874|NCT02559206|515439937|FG004|Overall Study|Protocol Violation|0|||
142973875|NCT02559206|515439938|FG005|Overall Study|Protocol Violation|2|||
142973876|NCT02559206|515439939|FG006|Overall Study|Protocol Violation|0|||
142973877|NCT02559206|515439940|FG007|Overall Study|Protocol Violation|0|||
142973878|NCT02559206|515439933|FG000|Overall Study|Withdrawal by Subject|3|||
142973879|NCT02559206|515439934|FG001|Overall Study|Withdrawal by Subject|3|||
142973880|NCT02559206|515439935|FG002|Overall Study|Withdrawal by Subject|1|||
142973881|NCT02559206|515439936|FG003|Overall Study|Withdrawal by Subject|3|||
142973882|NCT02559206|515439937|FG004|Overall Study|Withdrawal by Subject|5|||
142973883|NCT02559206|515439938|FG005|Overall Study|Withdrawal by Subject|4|||
142973884|NCT02559206|515439939|FG006|Overall Study|Withdrawal by Subject|1|||
142973885|NCT02559206|515439940|FG007|Overall Study|Withdrawal by Subject|2|||
142973886|NCT02559206|515439933|FG000|Overall Study|Lost to Follow-up|3|||
142973887|NCT02559206|515439934|FG001|Overall Study|Lost to Follow-up|5|||
142973888|NCT02559206|515439935|FG002|Overall Study|Lost to Follow-up|3|||
142973889|NCT02559206|515439936|FG003|Overall Study|Lost to Follow-up|3|||
142973890|NCT02559206|515439937|FG004|Overall Study|Lost to Follow-up|2|||
142973891|NCT02559206|515439938|FG005|Overall Study|Lost to Follow-up|5|||
142973892|NCT02559206|515439939|FG006|Overall Study|Lost to Follow-up|1|||
142973893|NCT02559206|515439940|FG007|Overall Study|Lost to Follow-up|4|||
142973894|NCT02559206|515439933|FG000|Overall Study|Lack of Efficacy|1|||
142973895|NCT02559206|515439934|FG001|Overall Study|Lack of Efficacy|0|||
142973896|NCT02559206|515439935|FG002|Overall Study|Lack of Efficacy|3|||
142973897|NCT02559206|515439936|FG003|Overall Study|Lack of Efficacy|2|||
142973898|NCT02559206|515439937|FG004|Overall Study|Lack of Efficacy|2|||
142973899|NCT02559206|515439938|FG005|Overall Study|Lack of Efficacy|3|||
142973900|NCT02559206|515439939|FG006|Overall Study|Lack of Efficacy|3|||
142973901|NCT02559206|515439940|FG007|Overall Study|Lack of Efficacy|3|||
142973902|NCT02559206|515439933|FG000|Overall Study|Other Not Specified|0|||
142973903|NCT02559206|515439934|FG001|Overall Study|Other Not Specified|0|||
142973904|NCT02559206|515439935|FG002|Overall Study|Other Not Specified|0|||
142973905|NCT02559206|515439936|FG003|Overall Study|Other Not Specified|1|||
142973906|NCT02559206|515439937|FG004|Overall Study|Other Not Specified|0|||
142973907|NCT02559206|515439938|FG005|Overall Study|Other Not Specified|0|||
142973908|NCT02559206|515439939|FG006|Overall Study|Other Not Specified|0|||
142973909|NCT02559206|515439940|FG007|Overall Study|Other Not Specified|0|||
142973910|NCT01871896|515439943|FG000|Overall Study|Lost to Follow-up|1|||
142973911|NCT00453180|515442038|FG000|Overall Study|Lost to Follow-up|2|||
142973912|NCT00453180|515442039|FG001|Overall Study|Lost to Follow-up|1|||
142973913|NCT00453180|515442038|FG000|Overall Study|Adverse Event|1|||
142973914|NCT00453180|515442039|FG001|Overall Study|Adverse Event|2|||
142973915|NCT00949910|515442040|FG000|Overall Study|Progressive Disease|3750|||
142973916|NCT00949910|515442040|FG000|Overall Study|Symptomatic Deterioration|1088|||
142973917|NCT00949910|515442040|FG000|Overall Study|Lost to Follow-up|100|||
142973918|NCT00949910|515442040|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
142973919|NCT00949910|515442040|FG000|Overall Study|Participant Refusal|390|||
142973920|NCT00949910|515442040|FG000|Overall Study|Death Due to Malignant Disease|456|||
142973921|NCT00949910|515442040|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
142973922|NCT00949910|515442040|FG000|Overall Study|Death Due to Adverse Event|115|||
142973923|NCT00949910|515442040|FG000|Overall Study|Death Due to Toxicity|3|||
142973924|NCT00949910|515442040|FG000|Overall Study|Death from Unknown Cause|5|||
142973925|NCT00949910|515442040|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
142973926|NCT00949910|515442040|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
142973927|NCT00949910|515442040|FG000|Overall Study|Switched to Commercial Treatment|4|||
142973928|NCT00949910|515442040|FG000|Overall Study|Violation of Eligibility|23|||
142973929|NCT00949910|515442040|FG000|Overall Study|Logistical Reasons|13|||
142973930|NCT00949910|515442040|FG000|Overall Study|Non-Compliance|10|||
142973931|NCT00949910|515442040|FG000|Overall Study|Prolonged Dosing Interruption|4|||
142973932|NCT00949910|515442040|FG000|Overall Study|Adverse Event|83|||
142973933|NCT00949910|515442040|FG000|Overall Study|Serious Adverse Event|6|||
142973934|NCT00949910|515442040|FG000|Overall Study|Physician/Participant Decision|7|||
142973935|NCT00949910|515442040|FG000|Overall Study|Other|4|||
142973936|NCT00949910|515442040|FG000|Overall Study|No Data|9|||
142973937|NCT03287869|515442043|FG000|Overall Study|Adverse Event|14|||
142973938|NCT03287869|515442044|FG001|Overall Study|Adverse Event|12|||
142973939|NCT03287869|515442043|FG000|Overall Study|Lack of Efficacy|1|||
142973940|NCT03287869|515442044|FG001|Overall Study|Lack of Efficacy|0|||
142973941|NCT03287869|515442043|FG000|Overall Study|Lost to Follow-up|13|||
142973942|NCT03287869|515442044|FG001|Overall Study|Lost to Follow-up|19|||
142973943|NCT03287869|515442043|FG000|Overall Study|Non-Compliance With Study Drug|5|||
142973944|NCT03287869|515442044|FG001|Overall Study|Non-Compliance With Study Drug|9|||
142973945|NCT03287869|515442043|FG000|Overall Study|Progressive Disease|1|||
142973946|NCT03287869|515442044|FG001|Overall Study|Progressive Disease|0|||
142973947|NCT03287869|515442043|FG000|Overall Study|Protocol Deviation|2|||
142973948|NCT03287869|515442044|FG001|Overall Study|Protocol Deviation|1|||
142973949|NCT03287869|515442043|FG000|Overall Study|Withdrawal by Subject|36|||
142973950|NCT03287869|515442044|FG001|Overall Study|Withdrawal by Subject|43|||
142973951|NCT03287869|515442043|FG000|Overall Study|Early Closure of the Site|0|||
142973952|NCT03287869|515442044|FG001|Overall Study|Early Closure of the Site|1|||
142973953|NCT03287869|515442043|FG000|Overall Study|Physician Decision|5|||
142973954|NCT03287869|515442044|FG001|Overall Study|Physician Decision|5|||
142973955|NCT03287869|515442043|FG000|Overall Study|Reason not Specified|6|||
142973956|NCT03287869|515442044|FG001|Overall Study|Reason not Specified|3|||
142973957|NCT01297309|515442046|FG000|Overall Study|Eligibility failure|2|||
142973958|NCT01297309|515442046|FG000|Overall Study|Screen failure|2|||
142973959|NCT01297309|515442046|FG000|Overall Study|Withdrawal by Subject|5|||
142973960|NCT01297309|515442046|FG000|Overall Study|Adverse Event|1|||
142973961|NCT01297309|515442046|FG000|Overall Study|Investigator Decision|2|||
142973962|NCT01297309|515442046|FG000|Overall Study|Death|1|||
142973963|NCT01297309|515442046|FG000|Overall Study|Participant not entering extensionperiod|1|||
142973964|NCT02670928|515442047|FG000|Overall Study|Adverse Event|3|||
142973965|NCT02670928|515442048|FG001|Overall Study|Adverse Event|1|||
142973966|NCT02670928|515442047|FG000|Overall Study|Withdrawal by Subject|4|||
142973967|NCT02670928|515442048|FG001|Overall Study|Withdrawal by Subject|0|||
142973968|NCT02670928|515442047|FG000|Overall Study|Lost to Follow-up|1|||
142973969|NCT02670928|515442048|FG001|Overall Study|Lost to Follow-up|0|||
142973970|NCT02670928|515442047|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
142973971|NCT02670928|515442048|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
142973972|NCT02678312|515442049|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
142973973|NCT02678312|515442050|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
142973974|NCT02678312|515442051|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
142973975|NCT02678312|515442052|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
142973976|NCT02678312|515442053|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
142973977|NCT02678312|515442049|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
142973978|NCT02678312|515442050|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
142973979|NCT02678312|515442051|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
142973980|NCT02678312|515442052|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
142973981|NCT02678312|515442053|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
142973982|NCT02678312|515442049|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
142973983|NCT02678312|515442050|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
142973984|NCT02678312|515442051|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
142973985|NCT02678312|515442052|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
142973986|NCT02678312|515442053|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
142973987|NCT02678312|515442049|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
142973988|NCT02678312|515442050|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
142973989|NCT02678312|515442051|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
142973990|NCT02678312|515442052|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
142973991|NCT02678312|515442053|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
142973992|NCT02678312|515442049|FG000|Part 2 Double Blind Epoch|Death|0|||
142973993|NCT02678312|515442050|FG001|Part 2 Double Blind Epoch|Death|0|||
142973994|NCT02678312|515442051|FG002|Part 2 Double Blind Epoch|Death|0|||
142973995|NCT02678312|515442052|FG003|Part 2 Double Blind Epoch|Death|8|||
142973996|NCT02678312|515442053|FG004|Part 2 Double Blind Epoch|Death|12|||
142973997|NCT02678312|515442049|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
142973998|NCT02678312|515442050|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
142973999|NCT02678312|515442051|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
142974000|NCT02678312|515442052|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
142974001|NCT02678312|515442053|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
142974002|NCT02678312|515442049|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
142974003|NCT02678312|515442050|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
142974004|NCT02678312|515442051|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
142974005|NCT02678312|515442052|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
142974006|NCT02678312|515442053|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
142974007|NCT02678312|515442049|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
142974008|NCT02678312|515442050|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
142974009|NCT02678312|515442051|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
142974010|NCT02678312|515442052|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
142974011|NCT02678312|515442053|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
142974012|NCT00656084|515442054|FG000|Overall Study|Adverse Event|4|||
142974013|NCT00656084|515442054|FG000|Overall Study|Withdrawal by Subject|1|||
142974014|NCT00656084|515442054|FG000|Overall Study|Patient Request|1|||
142974015|NCT00656084|515442054|FG000|Overall Study|Investigator Request|1|||
142974016|NCT00640146|515442058|FG000|Overall Study|Adverse Event|2|||
142974017|NCT00640146|515442059|FG001|Overall Study|Adverse Event|0|||
142974018|NCT00640146|515442058|FG000|Overall Study|Lost to Follow-up|0|||
142974019|NCT00640146|515442059|FG001|Overall Study|Lost to Follow-up|1|||
142974020|NCT00640146|515442058|FG000|Overall Study|Lack of Efficacy|0|||
142974021|NCT00640146|515442059|FG001|Overall Study|Lack of Efficacy|1|||
142974022|NCT00640146|515442058|FG000|Overall Study|Withdrawal by Subject|1|||
142974023|NCT00640146|515442059|FG001|Overall Study|Withdrawal by Subject|1|||
142974024|NCT00640146|515442058|FG000|Overall Study|Randomized but not treated|1|||
142974025|NCT00640146|515442059|FG001|Overall Study|Randomized but not treated|3|||
142974026|NCT04847141|515442060|FG000|Overall Study|Adverse Event|1|||
142974027|NCT04847141|515442061|FG001|Overall Study|Adverse Event|0|||
142974028|NCT04847141|515442062|FG002|Overall Study|Adverse Event|1|||
142974029|NCT04847141|515442060|FG000|Overall Study|Withdrawal by Subject|2|||
142974030|NCT04847141|515442061|FG001|Overall Study|Withdrawal by Subject|4|||
142974031|NCT04847141|515442062|FG002|Overall Study|Withdrawal by Subject|3|||
142974032|NCT04847141|515442060|FG000|Overall Study|Lost to Follow-up|7|||
142974033|NCT04847141|515442061|FG001|Overall Study|Lost to Follow-up|5|||
142974034|NCT04847141|515442062|FG002|Overall Study|Lost to Follow-up|7|||
142974035|NCT04847141|515442060|FG000|Overall Study|Reason not Specified|0|||
142974036|NCT04847141|515442061|FG001|Overall Study|Reason not Specified|1|||
142974037|NCT04847141|515442062|FG002|Overall Study|Reason not Specified|0|||
142974038|NCT00324740|515442063|FG000|Overall Study|Withdrawal by Subject|1|||
142974039|NCT00324740|515442064|FG001|Overall Study|Withdrawal by Subject|0|||
142974040|NCT00324740|515442065|FG002|Overall Study|Withdrawal by Subject|1|||
142974041|NCT00520299|515442068|FG000|Overall Study|Withdrawal by Subject|0|||
142974042|NCT00520299|515442069|FG001|Overall Study|Withdrawal by Subject|0|||
142974043|NCT00520299|515442070|FG002|Overall Study|Withdrawal by Subject|2|||
142974044|NCT00520299|515442068|FG000|Overall Study|Progressive disease|0|||
142974045|NCT00520299|515442069|FG001|Overall Study|Progressive disease|3|||
142974046|NCT00520299|515442070|FG002|Overall Study|Progressive disease|4|||
142974047|NCT00971425|515442074|FG000|Overall Study|Adverse Event|1|||
142974048|NCT00971425|515442075|FG001|Overall Study|Adverse Event|1|||
142974049|NCT00971425|515442074|FG000|Overall Study|Withdrawal by Subject|0|||
142974050|NCT00971425|515442075|FG001|Overall Study|Withdrawal by Subject|1|||
142974051|NCT01357980|515442078|FG000|Overall Study|Lack of Efficacy|0|||
142974052|NCT01357980|515442079|FG001|Overall Study|Lack of Efficacy|1|||
142974053|NCT01357980|515442080|FG002|Overall Study|Lack of Efficacy|0|||
142974054|NCT01357980|515442081|FG003|Overall Study|Lack of Efficacy|0|||
142974055|NCT01357980|515442078|FG000|Overall Study|Consent withdrawn|0|||
142974056|NCT01357980|515442079|FG001|Overall Study|Consent withdrawn|0|||
142974057|NCT01357980|515442080|FG002|Overall Study|Consent withdrawn|1|||
142974058|NCT01357980|515442081|FG003|Overall Study|Consent withdrawn|0|||
142974059|NCT02528253|515442082|FG000|Overall Study|Adverse Event|3|||
142974060|NCT02528253|515442083|FG001|Overall Study|Adverse Event|4|||
142974061|NCT02528253|515442084|FG002|Overall Study|Adverse Event|4|||
142974062|NCT02528253|515442085|FG003|Overall Study|Adverse Event|8|||
142974063|NCT02528253|515442086|FG004|Overall Study|Adverse Event|18|||
142974064|NCT02528253|515442082|FG000|Overall Study|Death|2|||
142974065|NCT02528253|515442083|FG001|Overall Study|Death|2|||
142974066|NCT02528253|515442084|FG002|Overall Study|Death|1|||
142974067|NCT02528253|515442085|FG003|Overall Study|Death|0|||
142974068|NCT02528253|515442086|FG004|Overall Study|Death|1|||
142974069|NCT02528253|515442082|FG000|Overall Study|Insufficient clinical response|7|||
142974070|NCT02528253|515442083|FG001|Overall Study|Insufficient clinical response|10|||
142974071|NCT02528253|515442084|FG002|Overall Study|Insufficient clinical response|13|||
142974072|NCT02528253|515442085|FG003|Overall Study|Insufficient clinical response|12|||
142974073|NCT02528253|515442086|FG004|Overall Study|Insufficient clinical response|16|||
142974074|NCT02528253|515442082|FG000|Overall Study|Lost to Follow-up|16|||
142974075|NCT02528253|515442083|FG001|Overall Study|Lost to Follow-up|9|||
142974076|NCT02528253|515442084|FG002|Overall Study|Lost to Follow-up|31|||
142974077|NCT02528253|515442085|FG003|Overall Study|Lost to Follow-up|16|||
142974078|NCT02528253|515442086|FG004|Overall Study|Lost to Follow-up|34|||
142974079|NCT02528253|515442082|FG000|Overall Study|Other|21|||
142974080|NCT02528253|515442083|FG001|Overall Study|Other|22|||
142974081|NCT02528253|515442084|FG002|Overall Study|Other|58|||
142974082|NCT02528253|515442085|FG003|Overall Study|Other|52|||
142974083|NCT02528253|515442086|FG004|Overall Study|Other|76|||
142974084|NCT02528253|515442082|FG000|Overall Study|Withdrawal by Subject|25|||
142974085|NCT02528253|515442083|FG001|Overall Study|Withdrawal by Subject|20|||
142974086|NCT02528253|515442084|FG002|Overall Study|Withdrawal by Subject|29|||
142974087|NCT02528253|515442085|FG003|Overall Study|Withdrawal by Subject|48|||
142974088|NCT02528253|515442086|FG004|Overall Study|Withdrawal by Subject|73|||
142974089|NCT02528253|515442082|FG000|Overall Study|Protocol Violation|1|||
142974090|NCT02528253|515442083|FG001|Overall Study|Protocol Violation|2|||
142974091|NCT02528253|515442084|FG002|Overall Study|Protocol Violation|4|||
142974092|NCT02528253|515442085|FG003|Overall Study|Protocol Violation|0|||
142974093|NCT02528253|515442086|FG004|Overall Study|Protocol Violation|4|||
142974094|NCT02528253|515442082|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
142974095|NCT02528253|515442083|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
142974096|NCT02528253|515442084|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
142974097|NCT02528253|515442085|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
142974098|NCT02528253|515442086|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
142974099|NCT03472040|515442094|FG000|Overall Study|Physician Decision|0|||
142974100|NCT03472040|515442095|FG001|Overall Study|Physician Decision|3|||
142974101|NCT03472040|515442094|FG000|Overall Study|Withdrawal by Subject|10|||
142974102|NCT03472040|515442095|FG001|Overall Study|Withdrawal by Subject|23|||
142974103|NCT03472040|515442094|FG000|Overall Study|Perceived Lack of Efficacy|29|||
142974104|NCT03472040|515442095|FG001|Overall Study|Perceived Lack of Efficacy|30|||
142974105|NCT03472040|515442094|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
142974106|NCT03472040|515442095|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
142974107|NCT03472040|515442094|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
142974108|NCT03472040|515442095|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
142974109|NCT03472040|515442094|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
142974110|NCT03472040|515442095|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
142974111|NCT03472040|515442094|FG000|Overall Study|Subject Non-compliance|2|||
142974112|NCT03472040|515442095|FG001|Overall Study|Subject Non-compliance|5|||
142974113|NCT03472040|515442094|FG000|Overall Study|Discontinuation due to Rash|0|||
142974114|NCT03472040|515442095|FG001|Overall Study|Discontinuation due to Rash|1|||
142974115|NCT03472040|515442094|FG000|Overall Study|Subsequent Ineligibility|0|||
142974116|NCT03472040|515442095|FG001|Overall Study|Subsequent Ineligibility|2|||
142974117|NCT03472040|515442094|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
142974118|NCT03472040|515442095|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
142974119|NCT00225147|515442100|FG000|Open-label Phase|Lost to Follow-up|0|||
142974120|NCT00225147|515442101|FG001|Open-label Phase|Lost to Follow-up|0|||
142974121|NCT00225147|515442102|FG002|Open-label Phase|Lost to Follow-up|0|||
142974122|NCT00225147|515442103|FG003|Open-label Phase|Lost to Follow-up|4|||
142974123|NCT00225147|515442100|FG000|Open-label Phase|Withdrawal by Subject|0|||
142974124|NCT00225147|515442101|FG001|Open-label Phase|Withdrawal by Subject|0|||
142974125|NCT00225147|515442102|FG002|Open-label Phase|Withdrawal by Subject|0|||
142974126|NCT00225147|515442103|FG003|Open-label Phase|Withdrawal by Subject|6|||
142974127|NCT00433446|515442106|FG000|Overall Study|Adverse Event|4|||
142974128|NCT00433446|515442106|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
142974129|NCT00433446|515442106|FG000|Overall Study|Progression|44|||
142974130|NCT00433446|515442106|FG000|Overall Study|Other - Not Protocol specified|3|||
142974131|NCT00433446|515442106|FG000|Overall Study|Ineligible|9|||
142974132|NCT01188538|515442107|FG000|Overall Study|Lost to Follow-up|0|||
142974133|NCT01188538|515442108|FG001|Overall Study|Lost to Follow-up|1|||
142974134|NCT02501902|515442109|FG000|Overall Study|Subject Refused Further Follow-up|0|||
142974135|NCT02501902|515442110|FG001|Overall Study|Subject Refused Further Follow-up|0|||
142974136|NCT02501902|515442111|FG002|Overall Study|Subject Refused Further Follow-up|0|||
142974137|NCT02501902|515442112|FG003|Overall Study|Subject Refused Further Follow-up|0|||
142974138|NCT02501902|515442113|FG004|Overall Study|Subject Refused Further Follow-up|0|||
142974139|NCT02501902|515442114|FG005|Overall Study|Subject Refused Further Follow-up|0|||
142974140|NCT02501902|515442115|FG006|Overall Study|Subject Refused Further Follow-up|0|||
142974141|NCT02501902|515442116|FG007|Overall Study|Subject Refused Further Follow-up|1|||
142974142|NCT02501902|515442109|FG000|Overall Study|Study Terminated by Sponsor|0|||
142974143|NCT02501902|515442110|FG001|Overall Study|Study Terminated by Sponsor|3|||
142974144|NCT02501902|515442111|FG002|Overall Study|Study Terminated by Sponsor|0|||
142974145|NCT02501902|515442112|FG003|Overall Study|Study Terminated by Sponsor|1|||
142974146|NCT02501902|515442113|FG004|Overall Study|Study Terminated by Sponsor|1|||
142974147|NCT02501902|515442114|FG005|Overall Study|Study Terminated by Sponsor|0|||
142974148|NCT02501902|515442115|FG006|Overall Study|Study Terminated by Sponsor|2|||
142974149|NCT02501902|515442116|FG007|Overall Study|Study Terminated by Sponsor|4|||
142974150|NCT02501902|515442109|FG000|Overall Study|Death|3|||
142974151|NCT02501902|515442110|FG001|Overall Study|Death|4|||
142974152|NCT02501902|515442111|FG002|Overall Study|Death|4|||
142974153|NCT02501902|515442112|FG003|Overall Study|Death|10|||
142974154|NCT02501902|515442113|FG004|Overall Study|Death|10|||
142974155|NCT02501902|515442114|FG005|Overall Study|Death|11|||
142974156|NCT02501902|515442115|FG006|Overall Study|Death|7|||
142974157|NCT02501902|515442116|FG007|Overall Study|Death|15|||
142974158|NCT02384395|515442117|FG000|Overall Study|Physician Decision|4|||
142974159|NCT02384395|515442117|FG000|Overall Study|Withdrawal by Subject|3|||
142974160|NCT02384395|515442117|FG000|Overall Study|Lost to Follow-up|3|||
142974161|NCT02513771|515442118|FG000|Overall Study|Lost to Follow-up|1|||
142974162|NCT02513771|515442119|FG001|Overall Study|Lost to Follow-up|1|||
142974163|NCT02513771|515442118|FG000|Overall Study|Not being able to get to clinic|1|||
142974164|NCT02513771|515442119|FG001|Overall Study|Not being able to get to clinic|0|||
142974165|NCT00688545|515442122|FG000|Overall Study|Lost to Follow-up|1|||
142974166|NCT00688545|515442123|FG001|Overall Study|Lost to Follow-up|4|||
142974167|NCT00688545|515442122|FG000|Overall Study|Insurance/cost of drug|0|||
142974168|NCT00688545|515442123|FG001|Overall Study|Insurance/cost of drug|1|||
142974169|NCT00688545|515442122|FG000|Overall Study|Withdrawal by Subject|2|||
142974170|NCT00688545|515442123|FG001|Overall Study|Withdrawal by Subject|3|||
142974171|NCT00688545|515442122|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
142974172|NCT00688545|515442123|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
142974173|NCT01878097|515442124|FG000|Baseline|Surveys not fully completed|2497|||
142974174|NCT01878097|515442125|FG001|Baseline|Surveys not fully completed|1800|||
142974175|NCT01878097|515442124|FG000|Implementation Year 1|Surveys not fully completed|3202|||
142974176|NCT01878097|515442125|FG001|Implementation Year 1|Surveys not fully completed|2549|||
142974177|NCT01878097|515442124|FG000|Implementation Year 2|Surveys not fully completed|3281|||
142974178|NCT01878097|515442125|FG001|Implementation Year 2|Surveys not fully completed|2841|||
142974179|NCT01878097|515442124|FG000|Implementation Year 3|Surveys not fully completed|3494|||
142974180|NCT01878097|515442125|FG001|Implementation Year 3|Surveys not fully completed|2980|||
142974181|NCT01878097|515442124|FG000|Implementation Year 4|Surveys not fully completed|3604|||
142974182|NCT01878097|515442125|FG001|Implementation Year 4|Surveys not fully completed|3007|||
142974183|NCT03004976|515442126|FG000|Overall Study|Lost to Follow-up|7|||
142974184|NCT03004976|515442127|FG001|Overall Study|Lost to Follow-up|5|||
142974185|NCT03004976|515442126|FG000|Overall Study|Physician Decision|1|||
142974186|NCT03004976|515442127|FG001|Overall Study|Physician Decision|0|||
142974187|NCT03004976|515442126|FG000|Overall Study|Withdrawal by Subject|1|||
142974188|NCT03004976|515442127|FG001|Overall Study|Withdrawal by Subject|0|||
142974189|NCT03004976|515442126|FG000|Overall Study|Death|4|||
142974190|NCT03004976|515442127|FG001|Overall Study|Death|1|||
142974191|NCT00168064|515442131|FG000|Overall Study|Adverse Event|26|||
142974192|NCT00168064|515442132|FG001|Overall Study|Adverse Event|22|||
142974193|NCT00168064|515442131|FG000|Overall Study|Withdrawal by Subject|3|||
142974194|NCT00168064|515442132|FG001|Overall Study|Withdrawal by Subject|4|||
142974195|NCT00168064|515442131|FG000|Overall Study|Lack of Efficacy|4|||
142974196|NCT00168064|515442132|FG001|Overall Study|Lack of Efficacy|4|||
142974197|NCT00168064|515442131|FG000|Overall Study|Lost to Follow-up|4|||
142974198|NCT00168064|515442132|FG001|Overall Study|Lost to Follow-up|3|||
142974199|NCT00168064|515442131|FG000|Overall Study|Non-compliance|2|||
142974200|NCT00168064|515442132|FG001|Overall Study|Non-compliance|3|||
142974201|NCT00168064|515442131|FG000|Overall Study|Concurrent Illness|4|||
142974202|NCT00168064|515442132|FG001|Overall Study|Concurrent Illness|3|||
142974203|NCT00168064|515442131|FG000|Overall Study|Subject's Best interest|2|||
142974204|NCT00168064|515442132|FG001|Overall Study|Subject's Best interest|2|||
142974205|NCT00168064|515442131|FG000|Overall Study|Various|4|||
142974206|NCT00168064|515442132|FG001|Overall Study|Various|3|||
142974207|NCT05489081|515442135|FG000|Overall Study|student left classroom|0|||
142974208|NCT05489081|515442136|FG001|Overall Study|student left classroom|1|||
142974209|NCT05489081|515442135|FG000|Overall Study|teacher left school|0|||
142974210|NCT05489081|515442136|FG001|Overall Study|teacher left school|2|||
142974211|NCT05159362|515442137|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
142974212|NCT05159362|515442138|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
142974213|NCT05159362|515442139|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
142974214|NCT02940626|515442140|FG000|Overall Study|Death|40|||
142974215|NCT02940626|515442141|FG001|Overall Study|Death|32|||
142974216|NCT02940626|515442140|FG000|Overall Study|Lost to Follow-up|5|||
142974217|NCT02940626|515442141|FG001|Overall Study|Lost to Follow-up|2|||
142974218|NCT02940626|515442140|FG000|Overall Study|Withdrawal by Subject|1|||
142974219|NCT02940626|515442141|FG001|Overall Study|Withdrawal by Subject|0|||
142974220|NCT02940626|515442140|FG000|Overall Study|Transfer to Hospice Care|1|||
142974221|NCT02940626|515442141|FG001|Overall Study|Transfer to Hospice Care|0|||
142974222|NCT02940626|515442140|FG000|Overall Study|Prohibited Concomitant Medication|0|||
142974223|NCT02940626|515442141|FG001|Overall Study|Prohibited Concomitant Medication|1|||
142974224|NCT00585923|515442143|FG000|Overall Study|Physician decided not to continue|31|||
142974225|NCT00585923|515442144|FG001|Overall Study|Physician decided not to continue|33|||
142974226|NCT00138424|515442147|FG000|Overall Study|Physician Decision|0|||
142974227|NCT00138424|515442148|FG001|Overall Study|Physician Decision|1|||
142974228|NCT00138424|515442149|FG002|Overall Study|Physician Decision|0|||
142974229|NCT00138424|515442150|FG003|Overall Study|Physician Decision|0|||
142974230|NCT04311177|515442151|FG000|Overall Study|Adverse Event|3|||
142974231|NCT04311177|515442152|FG001|Overall Study|Adverse Event|1|||
142974232|NCT04311177|515442151|FG000|Overall Study|Physician Decision|4|||
142974233|NCT04311177|515442152|FG001|Overall Study|Physician Decision|3|||
142974234|NCT04311177|515442151|FG000|Overall Study|Withdrawal by Subject|1|||
142974235|NCT04311177|515442152|FG001|Overall Study|Withdrawal by Subject|0|||
142974236|NCT00413062|515442157|FG000|Overall Study|Adverse event/serious adverse event|289|||
142974237|NCT00413062|515442158|FG001|Overall Study|Adverse event/serious adverse event|56|||
142974238|NCT00413062|515442157|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
142974239|NCT00413062|515442158|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
142974240|NCT00413062|515442157|FG000|Overall Study|Withdrawal of informed consent|111|||
142974241|NCT00413062|515442158|FG001|Overall Study|Withdrawal of informed consent|36|||
142974242|NCT00413062|515442157|FG000|Overall Study|Pregnancy|15|||
142974243|NCT00413062|515442158|FG001|Overall Study|Pregnancy|5|||
142974244|NCT00413062|515442157|FG000|Overall Study|Pregnancy wish|17|||
142974245|NCT00413062|515442158|FG001|Overall Study|Pregnancy wish|6|||
142974246|NCT00413062|515442157|FG000|Overall Study|Lost to Follow-up|175|||
142974247|NCT00413062|515442158|FG001|Overall Study|Lost to Follow-up|73|||
142974248|NCT00413062|515442157|FG000|Overall Study|Other reason|70|||
142974249|NCT00413062|515442158|FG001|Overall Study|Other reason|34|||
142974250|NCT02176291|515442159|FG000|Overall Study|Death|1|||
142974251|NCT02176291|515442160|FG001|Overall Study|Death|0|||
142974252|NCT02176291|515442159|FG000|Overall Study|non compliance with protocol|2|||
142974253|NCT02176291|515442160|FG001|Overall Study|non compliance with protocol|0|||
142974254|NCT02176291|515442159|FG000|Overall Study|Withdrawal by Subject|2|||
142974255|NCT02176291|515442160|FG001|Overall Study|Withdrawal by Subject|0|||
142974256|NCT02815293|515442163|FG000|Overall Study|Study termination by sponsor|10|||
142974257|NCT02815293|515442164|FG001|Overall Study|Study termination by sponsor|7|||
142974258|NCT02815293|515442165|FG002|Overall Study|Study termination by sponsor|0|||
142974259|NCT02815293|515442163|FG000|Overall Study|Participants not randomized|0|||
142974260|NCT02815293|515442164|FG001|Overall Study|Participants not randomized|0|||
142974261|NCT02815293|515442165|FG002|Overall Study|Participants not randomized|18|||
142974262|NCT02815293|515442163|FG000|Overall Study|Adverse Event|0|||
142974263|NCT02815293|515442164|FG001|Overall Study|Adverse Event|1|||
142974264|NCT02815293|515442165|FG002|Overall Study|Adverse Event|0|||
142974265|NCT00006604|515442166|FG000|Overall Study|Met study objective - no further FU|1|||
142974266|NCT00006604|515442167|FG001|Overall Study|Met study objective - no further FU|0|||
142974267|NCT00006604|515442168|FG002|Overall Study|Met study objective - no further FU|0|||
142974268|NCT00006604|515442169|FG003|Overall Study|Met study objective - no further FU|0|||
142974269|NCT00006604|515442170|FG004|Overall Study|Met study objective - no further FU|0|||
142974270|NCT00006604|515442171|FG005|Overall Study|Met study objective - no further FU|0|||
142974271|NCT00006604|515442172|FG006|Overall Study|Met study objective - no further FU|0|||
142974272|NCT00006604|515442173|FG007|Overall Study|Met study objective - no further FU|0|||
142974273|NCT00006604|515442174|FG008|Overall Study|Met study objective - no further FU|0|||
142974274|NCT00006604|515442175|FG009|Overall Study|Met study objective - no further FU|0|||
142974275|NCT00006604|515442176|FG010|Overall Study|Met study objective - no further FU|0|||
142974276|NCT00006604|515442177|FG011|Overall Study|Met study objective - no further FU|0|||
142974277|NCT00006604|515442178|FG012|Overall Study|Met study objective - no further FU|0|||
142974278|NCT00006604|515442179|FG013|Overall Study|Met study objective - no further FU|0|||
142974279|NCT00006604|515442180|FG014|Overall Study|Met study objective - no further FU|1|||
142974280|NCT00006604|515442181|FG015|Overall Study|Met study objective - no further FU|1|||
142974281|NCT00006604|515442182|FG016|Overall Study|Met study objective - no further FU|0|||
142974282|NCT00006604|515442166|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
142974283|NCT00006604|515442167|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
142974284|NCT00006604|515442168|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
142974285|NCT00006604|515442169|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
142974286|NCT00006604|515442170|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
142974287|NCT00006604|515442171|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
142974288|NCT00006604|515442172|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
142974289|NCT00006604|515442173|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
142974290|NCT00006604|515442174|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
142974291|NCT00006604|515442175|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
142974292|NCT00006604|515442176|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
142974293|NCT00006604|515442177|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
142974294|NCT00006604|515442178|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
142974295|NCT00006604|515442179|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
142974296|NCT00006604|515442180|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
142974297|NCT00006604|515442181|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
142974298|NCT00006604|515442182|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
142974299|NCT00006604|515442166|FG000|Overall Study|Death|0|||
142974300|NCT00006604|515442167|FG001|Overall Study|Death|0|||
142974301|NCT00006604|515442168|FG002|Overall Study|Death|0|||
142974302|NCT00006604|515442169|FG003|Overall Study|Death|0|||
142974303|NCT00006604|515442170|FG004|Overall Study|Death|0|||
142974304|NCT00006604|515442171|FG005|Overall Study|Death|0|||
142974305|NCT00006604|515442172|FG006|Overall Study|Death|0|||
142974306|NCT00006604|515442173|FG007|Overall Study|Death|0|||
142974307|NCT00006604|515442174|FG008|Overall Study|Death|0|||
142974308|NCT00006604|515442175|FG009|Overall Study|Death|1|||
142974309|NCT00006604|515442176|FG010|Overall Study|Death|1|||
142974310|NCT00006604|515442177|FG011|Overall Study|Death|1|||
142974311|NCT00006604|515442178|FG012|Overall Study|Death|0|||
142974312|NCT00006604|515442179|FG013|Overall Study|Death|0|||
142974313|NCT00006604|515442180|FG014|Overall Study|Death|0|||
142974314|NCT00006604|515442181|FG015|Overall Study|Death|0|||
142974315|NCT00006604|515442182|FG016|Overall Study|Death|0|||
142974316|NCT00006604|515442166|FG000|Overall Study|Severe debilitation, unable to continue|0|||
142974317|NCT00006604|515442167|FG001|Overall Study|Severe debilitation, unable to continue|0|||
142974318|NCT00006604|515442168|FG002|Overall Study|Severe debilitation, unable to continue|0|||
142974319|NCT00006604|515442169|FG003|Overall Study|Severe debilitation, unable to continue|0|||
142974320|NCT00006604|515442170|FG004|Overall Study|Severe debilitation, unable to continue|0|||
142974321|NCT00006604|515442171|FG005|Overall Study|Severe debilitation, unable to continue|0|||
142974322|NCT00006604|515442172|FG006|Overall Study|Severe debilitation, unable to continue|3|||
142974323|NCT00006604|515442173|FG007|Overall Study|Severe debilitation, unable to continue|0|||
142974324|NCT00006604|515442174|FG008|Overall Study|Severe debilitation, unable to continue|0|||
142974325|NCT00006604|515442175|FG009|Overall Study|Severe debilitation, unable to continue|5|||
142974326|NCT00006604|515442176|FG010|Overall Study|Severe debilitation, unable to continue|0|||
142974327|NCT00006604|515442177|FG011|Overall Study|Severe debilitation, unable to continue|2|||
142974328|NCT00006604|515442178|FG012|Overall Study|Severe debilitation, unable to continue|1|||
142974329|NCT00006604|515442179|FG013|Overall Study|Severe debilitation, unable to continue|0|||
142974330|NCT00006604|515442180|FG014|Overall Study|Severe debilitation, unable to continue|2|||
142974331|NCT00006604|515442181|FG015|Overall Study|Severe debilitation, unable to continue|0|||
142974332|NCT00006604|515442182|FG016|Overall Study|Severe debilitation, unable to continue|0|||
142974333|NCT00006604|515442166|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
142974334|NCT00006604|515442167|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
142974335|NCT00006604|515442168|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
142974336|NCT00006604|515442169|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
142974337|NCT00006604|515442170|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
142974338|NCT00006604|515442171|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
142974339|NCT00006604|515442172|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
142974340|NCT00006604|515442173|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
142974341|NCT00006604|515442174|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
142974342|NCT00006604|515442175|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
142974343|NCT00006604|515442176|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
142974344|NCT00006604|515442177|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
142974345|NCT00006604|515442178|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
142974346|NCT00006604|515442179|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
142974347|NCT00006604|515442180|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
142974348|NCT00006604|515442181|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
142974349|NCT00006604|515442182|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
142974350|NCT00006604|515442166|FG000|Overall Study|Site closing|0|||
142974351|NCT00006604|515442167|FG001|Overall Study|Site closing|0|||
142974352|NCT00006604|515442168|FG002|Overall Study|Site closing|1|||
142974353|NCT00006604|515442169|FG003|Overall Study|Site closing|1|||
142974354|NCT00006604|515442170|FG004|Overall Study|Site closing|0|||
142974355|NCT00006604|515442171|FG005|Overall Study|Site closing|0|||
142974356|NCT00006604|515442172|FG006|Overall Study|Site closing|0|||
142974357|NCT00006604|515442173|FG007|Overall Study|Site closing|1|||
142974358|NCT00006604|515442174|FG008|Overall Study|Site closing|0|||
142974359|NCT00006604|515442175|FG009|Overall Study|Site closing|0|||
142974360|NCT00006604|515442176|FG010|Overall Study|Site closing|0|||
142974361|NCT00006604|515442177|FG011|Overall Study|Site closing|1|||
142974362|NCT00006604|515442178|FG012|Overall Study|Site closing|1|||
142974363|NCT00006604|515442179|FG013|Overall Study|Site closing|1|||
142974364|NCT00006604|515442180|FG014|Overall Study|Site closing|0|||
142974365|NCT00006604|515442181|FG015|Overall Study|Site closing|0|||
142974366|NCT00006604|515442182|FG016|Overall Study|Site closing|1|||
142974367|NCT00006604|515442166|FG000|Overall Study|Withdrawal by Subject|1|||
142974368|NCT00006604|515442167|FG001|Overall Study|Withdrawal by Subject|0|||
142974369|NCT00006604|515442168|FG002|Overall Study|Withdrawal by Subject|2|||
142974370|NCT00006604|515442169|FG003|Overall Study|Withdrawal by Subject|0|||
142974371|NCT00006604|515442170|FG004|Overall Study|Withdrawal by Subject|1|||
142974372|NCT00006604|515442171|FG005|Overall Study|Withdrawal by Subject|2|||
142974373|NCT00006604|515442172|FG006|Overall Study|Withdrawal by Subject|2|||
142974374|NCT00006604|515442173|FG007|Overall Study|Withdrawal by Subject|0|||
142974375|NCT00006604|515442174|FG008|Overall Study|Withdrawal by Subject|1|||
142974376|NCT00006604|515442175|FG009|Overall Study|Withdrawal by Subject|3|||
142974377|NCT00006604|515442176|FG010|Overall Study|Withdrawal by Subject|2|||
142974378|NCT00006604|515442177|FG011|Overall Study|Withdrawal by Subject|0|||
142974379|NCT00006604|515442178|FG012|Overall Study|Withdrawal by Subject|1|||
142974380|NCT00006604|515442179|FG013|Overall Study|Withdrawal by Subject|2|||
142974381|NCT00006604|515442180|FG014|Overall Study|Withdrawal by Subject|1|||
142974382|NCT00006604|515442181|FG015|Overall Study|Withdrawal by Subject|0|||
142974383|NCT00006604|515442182|FG016|Overall Study|Withdrawal by Subject|1|||
142974384|NCT00006604|515442166|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
142974385|NCT00006604|515442167|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
142974386|NCT00006604|515442168|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
142974387|NCT00006604|515442169|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
142974388|NCT00006604|515442170|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
142974389|NCT00006604|515442171|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
142974390|NCT00006604|515442172|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
142974391|NCT00006604|515442173|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
142974392|NCT00006604|515442174|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
142974393|NCT00006604|515442175|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
142974394|NCT00006604|515442176|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
142974395|NCT00006604|515442177|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
142974396|NCT00006604|515442178|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
142974397|NCT00006604|515442179|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
142974398|NCT00006604|515442180|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
142974399|NCT00006604|515442181|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
142974400|NCT00006604|515442182|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
143117163|NCT00401960|515970048|FG001|Overall Study|Lost to Follow-up|0|||
142974401|NCT00006604|515442166|FG000|Overall Study|Lost to Follow-up|0|||
142974402|NCT00006604|515442167|FG001|Overall Study|Lost to Follow-up|0|||
142974403|NCT00006604|515442168|FG002|Overall Study|Lost to Follow-up|0|||
142974404|NCT00006604|515442169|FG003|Overall Study|Lost to Follow-up|0|||
142974405|NCT00006604|515442170|FG004|Overall Study|Lost to Follow-up|0|||
142974406|NCT00006604|515442171|FG005|Overall Study|Lost to Follow-up|0|||
142974407|NCT00006604|515442172|FG006|Overall Study|Lost to Follow-up|0|||
142974408|NCT00006604|515442173|FG007|Overall Study|Lost to Follow-up|1|||
142974409|NCT00006604|515442174|FG008|Overall Study|Lost to Follow-up|0|||
142974410|NCT00006604|515442175|FG009|Overall Study|Lost to Follow-up|2|||
142974411|NCT00006604|515442176|FG010|Overall Study|Lost to Follow-up|0|||
142974412|NCT00006604|515442177|FG011|Overall Study|Lost to Follow-up|0|||
142974413|NCT00006604|515442178|FG012|Overall Study|Lost to Follow-up|0|||
142974414|NCT00006604|515442179|FG013|Overall Study|Lost to Follow-up|0|||
142974415|NCT00006604|515442180|FG014|Overall Study|Lost to Follow-up|0|||
142974416|NCT00006604|515442181|FG015|Overall Study|Lost to Follow-up|1|||
142974417|NCT00006604|515442182|FG016|Overall Study|Lost to Follow-up|3|||
142974418|NCT00006604|515442166|FG000|Overall Study|Other Reason|0|||
142974419|NCT00006604|515442167|FG001|Overall Study|Other Reason|0|||
142974420|NCT00006604|515442168|FG002|Overall Study|Other Reason|0|||
142974421|NCT00006604|515442169|FG003|Overall Study|Other Reason|0|||
142974422|NCT00006604|515442170|FG004|Overall Study|Other Reason|0|||
142974423|NCT00006604|515442171|FG005|Overall Study|Other Reason|1|||
142974424|NCT00006604|515442172|FG006|Overall Study|Other Reason|0|||
142974425|NCT00006604|515442173|FG007|Overall Study|Other Reason|0|||
142974426|NCT00006604|515442174|FG008|Overall Study|Other Reason|0|||
142974427|NCT00006604|515442175|FG009|Overall Study|Other Reason|1|||
142974428|NCT00006604|515442176|FG010|Overall Study|Other Reason|0|||
142974429|NCT00006604|515442177|FG011|Overall Study|Other Reason|0|||
142974430|NCT00006604|515442178|FG012|Overall Study|Other Reason|0|||
142974431|NCT00006604|515442179|FG013|Overall Study|Other Reason|0|||
142974432|NCT00006604|515442180|FG014|Overall Study|Other Reason|0|||
142974433|NCT00006604|515442181|FG015|Overall Study|Other Reason|0|||
142974434|NCT00006604|515442182|FG016|Overall Study|Other Reason|0|||
142974435|NCT02431468|515442183|FG000|Overall Study|Adverse Event|2|||
142974436|NCT02431468|515442184|FG001|Overall Study|Adverse Event|4|||
142974437|NCT02431468|515442185|FG002|Overall Study|Adverse Event|5|||
142974438|NCT02431468|515442183|FG000|Overall Study|Withdrawal by Subject|4|||
142974439|NCT02431468|515442184|FG001|Overall Study|Withdrawal by Subject|12|||
142974440|NCT02431468|515442185|FG002|Overall Study|Withdrawal by Subject|2|||
142974441|NCT02431468|515442183|FG000|Overall Study|noncompliance, investigator termination,|2|||
142974442|NCT02431468|515442184|FG001|Overall Study|noncompliance, investigator termination,|2|||
142974443|NCT02431468|515442185|FG002|Overall Study|noncompliance, investigator termination,|2|||
142974444|NCT01361919|515442188|FG000|Overall Study|technical issues|10|||
142974445|NCT01361919|515442189|FG001|Overall Study|technical issues|12|||
142974446|NCT01361919|515442190|FG002|Overall Study|technical issues|10|||
142974447|NCT01056341|515442191|FG000|Overall Study|Treatment Intolerance|0|||
142974448|NCT01056341|515442192|FG001|Overall Study|Treatment Intolerance|2|||
142974449|NCT01056341|515442193|FG002|Overall Study|Treatment Intolerance|0|||
142974450|NCT01056341|515442194|FG003|Overall Study|Treatment Intolerance|2|||
142974451|NCT01056341|515442195|FG004|Overall Study|Treatment Intolerance|0|||
142974452|NCT01056341|515442191|FG000|Overall Study|Lack of Efficacy|32|||
142974453|NCT01056341|515442192|FG001|Overall Study|Lack of Efficacy|30|||
142974454|NCT01056341|515442193|FG002|Overall Study|Lack of Efficacy|7|||
142974455|NCT01056341|515442194|FG003|Overall Study|Lack of Efficacy|25|||
142974456|NCT01056341|515442195|FG004|Overall Study|Lack of Efficacy|9|||
142974457|NCT01056341|515442191|FG000|Overall Study|Other reasons|4|||
142974458|NCT01056341|515442192|FG001|Overall Study|Other reasons|4|||
142974459|NCT01056341|515442193|FG002|Overall Study|Other reasons|8|||
142974460|NCT01056341|515442194|FG003|Overall Study|Other reasons|9|||
142974461|NCT01056341|515442195|FG004|Overall Study|Other reasons|5|||
142974462|NCT01086150|515442196|FG000|Overall Study|Withdrawal by Subject|0|||
142974463|NCT01086150|515442197|FG001|Overall Study|Withdrawal by Subject|4|||
142974464|NCT01086150|515442198|FG002|Overall Study|Withdrawal by Subject|1|||
142974465|NCT01086150|515442196|FG000|Overall Study|Lost to Follow-up|0|||
142974466|NCT01086150|515442197|FG001|Overall Study|Lost to Follow-up|1|||
142974467|NCT01086150|515442198|FG002|Overall Study|Lost to Follow-up|0|||
142974468|NCT01086150|515442196|FG000|Overall Study|Screen Failure|0|||
142974469|NCT01086150|515442197|FG001|Overall Study|Screen Failure|1|||
142974470|NCT01086150|515442198|FG002|Overall Study|Screen Failure|0|||
142974471|NCT01681576|515442203|FG000|Period 1|Adverse Event|1|||
142974472|NCT01681576|515442204|FG001|Period 1|Adverse Event|0|||
142974473|NCT01681576|515442203|FG000|Period 1|Protocol Deviation|1|||
142974474|NCT01681576|515442204|FG001|Period 1|Protocol Deviation|0|||
142974475|NCT01681576|515442203|FG000|Period 2|subject/guardian decision|3|||
142974476|NCT01681576|515442204|FG001|Period 2|subject/guardian decision|1|||
142974477|NCT01681576|515442203|FG000|Period 2|Non-compliance with study treatment|1|||
142974478|NCT01681576|515442204|FG001|Period 2|Non-compliance with study treatment|0|||
142974479|NCT03543358|515442206|FG000|Overall Study|Death|1|||
142974480|NCT03543358|515442207|FG001|Overall Study|Death|0|||
142974481|NCT03543358|515442206|FG000|Overall Study|Disease Progression|1|||
142974482|NCT03543358|515442207|FG001|Overall Study|Disease Progression|0|||
142974483|NCT03543358|515442206|FG000|Overall Study|Parent Study Closure|1|||
142974484|NCT03543358|515442207|FG001|Overall Study|Parent Study Closure|0|||
142974485|NCT03589885|515442208|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
142974486|NCT03589885|515442209|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
142974487|NCT03589885|515442210|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
142974488|NCT03589885|515442211|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
142974489|NCT03589885|515442212|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
142974490|NCT03589885|515442208|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
142974491|NCT03589885|515442209|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
142974492|NCT03589885|515442210|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
142974493|NCT03589885|515442211|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
142974494|NCT03589885|515442212|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
142974495|NCT03589885|515442208|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
142974496|NCT03589885|515442209|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
142974497|NCT03589885|515442210|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
142974498|NCT03589885|515442211|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
142974499|NCT03589885|515442212|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
142974500|NCT03589885|515442208|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
142974501|NCT03589885|515442209|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
142974502|NCT03589885|515442210|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
142974503|NCT03589885|515442211|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
142974504|NCT03589885|515442212|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
142974505|NCT03589885|515442208|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
142974506|NCT03589885|515442209|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
142974507|NCT03589885|515442210|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
142974508|NCT03589885|515442211|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
142974509|NCT03589885|515442212|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
142974510|NCT03589885|515442208|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
142974511|NCT03589885|515442209|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
142974512|NCT03589885|515442210|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
142974513|NCT03589885|515442211|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
142974514|NCT03589885|515442212|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
142974515|NCT03589885|515442208|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
142974516|NCT03589885|515442209|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
142974517|NCT03589885|515442210|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
142974518|NCT03589885|515442211|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
142974519|NCT03589885|515442212|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
142974520|NCT03589885|515442208|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
142974521|NCT03589885|515442209|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
142974522|NCT03589885|515442210|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
142974523|NCT03589885|515442211|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
142974524|NCT03589885|515442212|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
142974525|NCT00805545|515442215|FG000|Overall Study|Protocol Violation|3|||
142974526|NCT00805545|515442216|FG001|Overall Study|Protocol Violation|2|||
142974527|NCT00805545|515442215|FG000|Overall Study|Protocol Violation|3|||
142974528|NCT00805545|515442216|FG001|Overall Study|Protocol Violation|1|||
142974529|NCT02157506|515442219|FG000|Overall Study|Adverse Event|0|||
142974530|NCT02157506|515442220|FG001|Overall Study|Adverse Event|1|||
142974531|NCT02157506|515442221|FG002|Overall Study|Adverse Event|0|||
142974532|NCT02157506|515442222|FG003|Overall Study|Adverse Event|0|||
142974533|NCT02157506|515442223|FG004|Overall Study|Adverse Event|0|||
142974534|NCT02157506|515442219|FG000|Overall Study|Lost to Follow-up|0|||
142974535|NCT02157506|515442220|FG001|Overall Study|Lost to Follow-up|0|||
142974536|NCT02157506|515442221|FG002|Overall Study|Lost to Follow-up|1|||
142974537|NCT02157506|515442222|FG003|Overall Study|Lost to Follow-up|0|||
142974538|NCT02157506|515442223|FG004|Overall Study|Lost to Follow-up|0|||
142974539|NCT01736254|515442234|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
142974540|NCT01736254|515442234|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
142974541|NCT05691829|515444015|FG000|Overall Study|Physician Decision|2|||
142974542|NCT05691829|515444015|FG000|Overall Study|Eligibility criteria not met|3|||
142974543|NCT03326869|515444020|FG000|Overall Study|Study data has been lost to natural disa|1|||
142974544|NCT03326869|515444021|FG001|Overall Study|Study data has been lost to natural disa|1|||
142974545|NCT01002742|515444024|FG000|Overall Study|Determined to be ineligible|0|||
142974546|NCT01002742|515444025|FG001|Overall Study|Determined to be ineligible|1|||
142974547|NCT03927911|515444026|FG000|Overall Study|problems with eDiary|0|||
142974548|NCT03927911|515444027|FG001|Overall Study|problems with eDiary|1|||
142974549|NCT03927911|515444028|FG002|Overall Study|problems with eDiary|0|||
142974550|NCT03927911|515444029|FG003|Overall Study|problems with eDiary|1|||
142974551|NCT03927911|515444030|FG004|Overall Study|problems with eDiary|0|||
142974552|NCT03927911|515444031|FG005|Overall Study|problems with eDiary|4|||
142974553|NCT03927911|515444026|FG000|Overall Study|Adverse Event|0|||
142974554|NCT03927911|515444027|FG001|Overall Study|Adverse Event|0|||
142974555|NCT03927911|515444028|FG002|Overall Study|Adverse Event|0|||
142974556|NCT03927911|515444029|FG003|Overall Study|Adverse Event|0|||
142974557|NCT03927911|515444030|FG004|Overall Study|Adverse Event|0|||
142974558|NCT03927911|515444031|FG005|Overall Study|Adverse Event|1|||
142974559|NCT03927911|515444026|FG000|Overall Study|not treated -study terminated by sponsor|0|||
142974560|NCT03927911|515444027|FG001|Overall Study|not treated -study terminated by sponsor|1|||
142974561|NCT03927911|515444028|FG002|Overall Study|not treated -study terminated by sponsor|0|||
142974562|NCT03927911|515444029|FG003|Overall Study|not treated -study terminated by sponsor|0|||
142974563|NCT03927911|515444030|FG004|Overall Study|not treated -study terminated by sponsor|0|||
142974564|NCT03927911|515444031|FG005|Overall Study|not treated -study terminated by sponsor|0|||
142974565|NCT03927911|515444026|FG000|Overall Study|Surgery cancelled|0|||
142974566|NCT03927911|515444027|FG001|Overall Study|Surgery cancelled|0|||
142974567|NCT03927911|515444028|FG002|Overall Study|Surgery cancelled|0|||
142974568|NCT03927911|515444029|FG003|Overall Study|Surgery cancelled|1|||
142974569|NCT03927911|515444030|FG004|Overall Study|Surgery cancelled|0|||
142974570|NCT03927911|515444031|FG005|Overall Study|Surgery cancelled|1|||
142974571|NCT03927911|515444026|FG000|Overall Study|Protocol Violation|0|||
142974572|NCT03927911|515444027|FG001|Overall Study|Protocol Violation|0|||
142974573|NCT03927911|515444028|FG002|Overall Study|Protocol Violation|0|||
142974574|NCT03927911|515444029|FG003|Overall Study|Protocol Violation|0|||
142974575|NCT03927911|515444030|FG004|Overall Study|Protocol Violation|0|||
142974576|NCT03927911|515444031|FG005|Overall Study|Protocol Violation|1|||
142974577|NCT00562640|515444032|FG000|Overall Study|Death|0|||
142974578|NCT00562640|515444033|FG001|Overall Study|Death|1|||
142974579|NCT00562640|515444034|FG002|Overall Study|Death|1|||
142974580|NCT00562640|515444035|FG003|Overall Study|Death|0|||
142974581|NCT05263921|515444036|FG000|Overall Study|Other: family emergency.|0|||
142974582|NCT05263921|515444037|FG001|Overall Study|Other: family emergency.|0|||
142974583|NCT05263921|515444038|FG002|Overall Study|Other: family emergency.|1|||
142974584|NCT05263921|515444039|FG003|Overall Study|Other: family emergency.|0|||
142974585|NCT01412151|515444040|FG000|Week 0 - 306 - Treatment Period|Death|1|||
142974586|NCT01412151|515444040|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
142974587|NCT01412151|515444040|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
142974588|NCT01412151|515444040|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
142974589|NCT03127852|515444041|FG000|Overall Study|Withdrawal by Subject|4|||
142974590|NCT03127852|515444042|FG001|Overall Study|Withdrawal by Subject|1|||
142974591|NCT03127852|515444041|FG000|Overall Study|Death|1|||
142974592|NCT03127852|515444042|FG001|Overall Study|Death|1|||
142974593|NCT02591238|515444043|FG000|Overall Study|Pregnancy|1|||
142974594|NCT02591238|515444044|FG001|Overall Study|Pregnancy|0|||
142974595|NCT02591238|515444045|FG002|Overall Study|Pregnancy|0|||
142974596|NCT02591238|515444046|FG003|Overall Study|Pregnancy|0|||
142974597|NCT02591238|515444043|FG000|Overall Study|Withdrawal by Subject|0|||
142974598|NCT02591238|515444044|FG001|Overall Study|Withdrawal by Subject|0|||
142974599|NCT02591238|515444045|FG002|Overall Study|Withdrawal by Subject|0|||
142974600|NCT02591238|515444046|FG003|Overall Study|Withdrawal by Subject|1|||
142974601|NCT02591238|515444043|FG000|Overall Study|influenza|0|||
142974602|NCT02591238|515444044|FG001|Overall Study|influenza|0|||
142974603|NCT02591238|515444045|FG002|Overall Study|influenza|0|||
142974604|NCT02591238|515444046|FG003|Overall Study|influenza|1|||
142974605|NCT02591238|515444043|FG000|Overall Study|personal circumstances|0|||
142974606|NCT02591238|515444044|FG001|Overall Study|personal circumstances|0|||
142974607|NCT02591238|515444045|FG002|Overall Study|personal circumstances|0|||
142974608|NCT02591238|515444046|FG003|Overall Study|personal circumstances|1|||
142974609|NCT02591238|515444043|FG000|Overall Study|personal circumstances|0|||
142974610|NCT02591238|515444044|FG001|Overall Study|personal circumstances|1|||
142974611|NCT02591238|515444045|FG002|Overall Study|personal circumstances|0|||
142974612|NCT02591238|515444046|FG003|Overall Study|personal circumstances|0|||
142974613|NCT02455388|515444047|FG000|Overall Study|Protocol Violation|1|||
142974614|NCT02455388|515444048|FG001|Overall Study|Protocol Violation|0|||
142974615|NCT02455388|515444049|FG002|Overall Study|Protocol Violation|4|||
142974616|NCT02455388|515444047|FG000|Overall Study|Withdrawal by Subject|0|||
142974617|NCT02455388|515444048|FG001|Overall Study|Withdrawal by Subject|0|||
142974618|NCT02455388|515444049|FG002|Overall Study|Withdrawal by Subject|7|||
142974619|NCT00094835|515444052|FG000|Overall Study|Physician Decision|1|||
142974620|NCT00094835|515444053|FG001|Overall Study|Physician Decision|0|||
142974621|NCT00094835|515444054|FG002|Overall Study|Physician Decision|0|||
142974622|NCT00094835|515444055|FG003|Overall Study|Physician Decision|0|||
142974623|NCT00094835|515444056|FG004|Overall Study|Physician Decision|0|||
142974624|NCT00094835|515444057|FG005|Overall Study|Physician Decision|1|||
142974625|NCT00094835|515444058|FG006|Overall Study|Physician Decision|0|||
142974626|NCT00094835|515444052|FG000|Overall Study|Withdrawal by Subject|0|||
142974627|NCT00094835|515444053|FG001|Overall Study|Withdrawal by Subject|0|||
143117164|NCT00401960|515970047|FG000|Overall Study|Death|2|||
142974628|NCT00094835|515444054|FG002|Overall Study|Withdrawal by Subject|0|||
142974629|NCT00094835|515444055|FG003|Overall Study|Withdrawal by Subject|0|||
142974630|NCT00094835|515444056|FG004|Overall Study|Withdrawal by Subject|0|||
142974631|NCT00094835|515444057|FG005|Overall Study|Withdrawal by Subject|0|||
142974632|NCT00094835|515444058|FG006|Overall Study|Withdrawal by Subject|1|||
142974633|NCT00094835|515444052|FG000|Overall Study|Lost to Follow-up|0|||
142974634|NCT00094835|515444053|FG001|Overall Study|Lost to Follow-up|0|||
142974635|NCT00094835|515444054|FG002|Overall Study|Lost to Follow-up|0|||
142974636|NCT00094835|515444055|FG003|Overall Study|Lost to Follow-up|0|||
142974637|NCT00094835|515444056|FG004|Overall Study|Lost to Follow-up|1|||
142974638|NCT00094835|515444057|FG005|Overall Study|Lost to Follow-up|0|||
142974639|NCT00094835|515444058|FG006|Overall Study|Lost to Follow-up|0|||
142974640|NCT00094835|515444052|FG000|Overall Study|Death|1|||
142974641|NCT00094835|515444053|FG001|Overall Study|Death|0|||
142974642|NCT00094835|515444054|FG002|Overall Study|Death|0|||
142974643|NCT00094835|515444055|FG003|Overall Study|Death|0|||
142974644|NCT00094835|515444056|FG004|Overall Study|Death|1|||
142974645|NCT00094835|515444057|FG005|Overall Study|Death|0|||
142974646|NCT00094835|515444058|FG006|Overall Study|Death|0|||
142974647|NCT00094835|515444052|FG000|Overall Study|Non-compliance|1|||
142974648|NCT00094835|515444053|FG001|Overall Study|Non-compliance|2|||
142974649|NCT00094835|515444054|FG002|Overall Study|Non-compliance|2|||
142974650|NCT00094835|515444055|FG003|Overall Study|Non-compliance|0|||
142974651|NCT00094835|515444056|FG004|Overall Study|Non-compliance|2|||
142974652|NCT00094835|515444057|FG005|Overall Study|Non-compliance|2|||
142974653|NCT00094835|515444058|FG006|Overall Study|Non-compliance|1|||
142974654|NCT00094835|515444052|FG000|Overall Study|Other|1|||
142974655|NCT00094835|515444053|FG001|Overall Study|Other|1|||
142974656|NCT00094835|515444054|FG002|Overall Study|Other|1|||
142974657|NCT00094835|515444055|FG003|Overall Study|Other|1|||
142974658|NCT00094835|515444056|FG004|Overall Study|Other|0|||
142974659|NCT00094835|515444057|FG005|Overall Study|Other|0|||
142974660|NCT00094835|515444058|FG006|Overall Study|Other|0|||
142974661|NCT03628599|515444059|FG000|Overall Study|Adverse Event|0|||
142974662|NCT03628599|515444060|FG001|Overall Study|Adverse Event|1|||
142974663|NCT01624506|515444061|FG000|Overall Study|Lost to Follow-up|29|||
142974664|NCT01624506|515444062|FG001|Overall Study|Lost to Follow-up|15|||
142974665|NCT01624506|515444061|FG000|Overall Study|Withdrawal by Subject|9|||
142974666|NCT01624506|515444062|FG001|Overall Study|Withdrawal by Subject|2|||
142974667|NCT01624506|515444061|FG000|Overall Study|Death|1|||
142974668|NCT01624506|515444062|FG001|Overall Study|Death|0|||
142974669|NCT01624506|515444061|FG000|Overall Study|LINX explants|23|||
142974670|NCT01624506|515444062|FG001|Overall Study|LINX explants|0|||
142974671|NCT01624506|515444061|FG000|Overall Study|Adverse Event|3|||
142974672|NCT01624506|515444062|FG001|Overall Study|Adverse Event|0|||
142974673|NCT00132314|515444063|FG000|Overall Study|Lost to Follow-up|70|||
142974674|NCT00132314|515444064|FG001|Overall Study|Lost to Follow-up|62|||
142974675|NCT00132314|515444063|FG000|Overall Study|Lacked SSN|1|||
142974676|NCT00132314|515444064|FG001|Overall Study|Lacked SSN|3|||
142974677|NCT00132314|515444063|FG000|Overall Study|Refused intervention at baseline|2|||
142974678|NCT00132314|515444064|FG001|Overall Study|Refused intervention at baseline|7|||
142974679|NCT02966353|515444069|FG000|Overall Study|Withdrawal by Subject|7|||
142974680|NCT02966353|515444069|FG000|Overall Study|Adverse Event|4|||
142974681|NCT02966353|515444069|FG000|Overall Study|Death|4|||
142974682|NCT02966353|515444069|FG000|Overall Study|Physician Decision|3|||
142974683|NCT02966353|515444069|FG000|Overall Study|Progressive disease|2|||
142974684|NCT02966353|515444069|FG000|Overall Study|Protocol deviation|2|||
142974685|NCT00093470|515444072|FG000|Overall Study|Disease progression|39|||
142974686|NCT00093470|515444073|FG001|Overall Study|Disease progression|0|||
142974687|NCT00093470|515444072|FG000|Overall Study|Adverse Event|15|||
142974688|NCT00093470|515444073|FG001|Overall Study|Adverse Event|0|||
142974689|NCT00093470|515444072|FG000|Overall Study|Death|2|||
142974690|NCT00093470|515444073|FG001|Overall Study|Death|0|||
142974691|NCT00093470|515444072|FG000|Overall Study|Withdrawal by Subject|8|||
142974692|NCT00093470|515444073|FG001|Overall Study|Withdrawal by Subject|0|||
142974693|NCT00093470|515444072|FG000|Overall Study|Alternative therapy|2|||
142974694|NCT00093470|515444073|FG001|Overall Study|Alternative therapy|0|||
142974695|NCT00093470|515444072|FG000|Overall Study|Other complicating disease|3|||
142974696|NCT00093470|515444073|FG001|Overall Study|Other complicating disease|0|||
142974697|NCT00093470|515444072|FG000|Overall Study|Physician Decision|2|||
142974698|NCT00093470|515444073|FG001|Overall Study|Physician Decision|0|||
142974699|NCT00093470|515444072|FG000|Overall Study|Never started treatment|1|||
142974700|NCT00093470|515444073|FG001|Overall Study|Never started treatment|0|||
142974701|NCT00093470|515444072|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
142974702|NCT00093470|515444073|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
142974703|NCT05905601|515444074|FG000|Overall Study|Lost to Follow-up|1|||
142974704|NCT05905601|515444075|FG001|Overall Study|Lost to Follow-up|3|||
142974705|NCT02514772|515444076|FG000|Overall Study|Adverse Event|1|||
142974706|NCT02514772|515444077|FG001|Overall Study|Adverse Event|0|||
142974707|NCT02514772|515444076|FG000|Overall Study|Death|0|||
142974708|NCT02514772|515444077|FG001|Overall Study|Death|1|||
142974709|NCT02514772|515444076|FG000|Overall Study|Withdrawal by Subject|2|||
142974710|NCT02514772|515444077|FG001|Overall Study|Withdrawal by Subject|1|||
142974711|NCT00877006|515444078|FG000|Treatment Period|Death|2|||
142974712|NCT00877006|515444079|FG001|Treatment Period|Death|1|||
142974713|NCT00877006|515444078|FG000|Treatment Period|Adverse Event|10|||
142974714|NCT00877006|515444079|FG001|Treatment Period|Adverse Event|3|||
142974715|NCT00877006|515444078|FG000|Treatment Period|Withdrawal by Subject|2|||
142974716|NCT00877006|515444079|FG001|Treatment Period|Withdrawal by Subject|3|||
142974717|NCT00877006|515444078|FG000|Treatment Period|Protocol Violation|1|||
142974718|NCT00877006|515444079|FG001|Treatment Period|Protocol Violation|0|||
142974719|NCT00877006|515444078|FG000|Treatment Period|Lost to Follow-up|0|||
142974720|NCT00877006|515444079|FG001|Treatment Period|Lost to Follow-up|1|||
142974721|NCT00877006|515444078|FG000|Treatment Period|Disease Progression|1|||
142974722|NCT00877006|515444079|FG001|Treatment Period|Disease Progression|2|||
142974723|NCT00877006|515444078|FG000|Treatment Period|Started New Treatment Regimen|2|||
142974724|NCT00877006|515444079|FG001|Treatment Period|Started New Treatment Regimen|5|||
142974725|NCT00877006|515444078|FG000|Treatment Period|Other|4|||
142974726|NCT00877006|515444079|FG001|Treatment Period|Other|4|||
142974727|NCT00877006|515444078|FG000|Treatment Period|Randomized but Not Treated|3|||
142974728|NCT00877006|515444079|FG001|Treatment Period|Randomized but Not Treated|8|||
142974729|NCT00877006|515444078|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
142974730|NCT00877006|515444079|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
142974731|NCT00877006|515444078|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
142974732|NCT00877006|515444079|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
142974733|NCT00877006|515444078|FG000|Long-Term Follow-up Period|Death|26|||
142974734|NCT00877006|515444079|FG001|Long-Term Follow-up Period|Death|18|||
142974735|NCT00877006|515444078|FG000|Long-Term Follow-up Period|Other|7|||
142974736|NCT00877006|515444079|FG001|Long-Term Follow-up Period|Other|9|||
142974737|NCT03024255|515444080|FG000|Overall Study|Adverse Event|1|||
142974738|NCT03024255|515444081|FG001|Overall Study|Adverse Event|4|||
142974739|NCT03024255|515444082|FG002|Overall Study|Adverse Event|8|||
142974740|NCT03024255|515444083|FG003|Overall Study|Adverse Event|0|||
142974741|NCT03024255|515444080|FG000|Overall Study|Withdrawal by Subject|3|||
142974742|NCT03024255|515444081|FG001|Overall Study|Withdrawal by Subject|1|||
142974743|NCT03024255|515444082|FG002|Overall Study|Withdrawal by Subject|0|||
142974744|NCT03024255|515444083|FG003|Overall Study|Withdrawal by Subject|3|||
142974745|NCT03024255|515444080|FG000|Overall Study|Protocol Violation|0|||
142974746|NCT03024255|515444081|FG001|Overall Study|Protocol Violation|0|||
142974747|NCT03024255|515444082|FG002|Overall Study|Protocol Violation|2|||
142974748|NCT03024255|515444083|FG003|Overall Study|Protocol Violation|0|||
142974749|NCT03024255|515444080|FG000|Overall Study|Lost to Follow-up|1|||
142974750|NCT03024255|515444081|FG001|Overall Study|Lost to Follow-up|2|||
142974751|NCT03024255|515444082|FG002|Overall Study|Lost to Follow-up|1|||
142974752|NCT03024255|515444083|FG003|Overall Study|Lost to Follow-up|1|||
142974753|NCT03024255|515444080|FG000|Overall Study|Lack of Efficacy|1|||
142974754|NCT03024255|515444081|FG001|Overall Study|Lack of Efficacy|0|||
142974755|NCT03024255|515444082|FG002|Overall Study|Lack of Efficacy|0|||
142974756|NCT03024255|515444083|FG003|Overall Study|Lack of Efficacy|0|||
142974757|NCT03024255|515444080|FG000|Overall Study|Protocol Noncompliance|1|||
142974758|NCT03024255|515444081|FG001|Overall Study|Protocol Noncompliance|1|||
142974759|NCT03024255|515444082|FG002|Overall Study|Protocol Noncompliance|0|||
142974760|NCT03024255|515444083|FG003|Overall Study|Protocol Noncompliance|1|||
142974761|NCT03583606|515444084|FG000|Overall Study|Lost to Follow-up|0|||
142974762|NCT03583606|515444085|FG001|Overall Study|Lost to Follow-up|1|||
142974763|NCT03583606|515444086|FG002|Overall Study|Lost to Follow-up|0|||
142974764|NCT03583606|515444084|FG000|Overall Study|Ineligible at baseline|1|||
142974765|NCT03583606|515444085|FG001|Overall Study|Ineligible at baseline|0|||
142974766|NCT03583606|515444086|FG002|Overall Study|Ineligible at baseline|0|||
142974767|NCT01415908|515444087|FG000|Overall Study|Withdrawal by Subject|1|||
142974768|NCT01415908|515444088|FG001|Overall Study|Withdrawal by Subject|0|||
142974769|NCT00817206|515444089|FG000|Overall Study|Adverse Event|10|||
142974770|NCT00817206|515444090|FG001|Overall Study|Adverse Event|3|||
142974771|NCT00817206|515444089|FG000|Overall Study|Protocol Violation|0|||
142974772|NCT00817206|515444090|FG001|Overall Study|Protocol Violation|2|||
142974773|NCT00817206|515444089|FG000|Overall Study|Lost to Follow-up|0|||
142974774|NCT00817206|515444090|FG001|Overall Study|Lost to Follow-up|1|||
142974775|NCT00817206|515444089|FG000|Overall Study|Death|2|||
142974776|NCT00817206|515444090|FG001|Overall Study|Death|0|||
142974777|NCT00817206|515444089|FG000|Overall Study|Withdrawal by Subject|7|||
142974778|NCT00817206|515444090|FG001|Overall Study|Withdrawal by Subject|3|||
142974779|NCT00817206|515444089|FG000|Overall Study|Physician Decision|2|||
142974780|NCT00817206|515444090|FG001|Overall Study|Physician Decision|0|||
142974781|NCT00126581|515444091|FG000|Overall Study|Adverse Event|3|||
142974782|NCT00126581|515444092|FG001|Overall Study|Adverse Event|7|||
142974783|NCT00126581|515444091|FG000|Overall Study|Death|3|||
142974784|NCT00126581|515444092|FG001|Overall Study|Death|2|||
142974785|NCT00126581|515444091|FG000|Overall Study|Withdrawal by Subject|1|||
142974786|NCT00126581|515444092|FG001|Overall Study|Withdrawal by Subject|4|||
142974787|NCT00126581|515444091|FG000|Overall Study|Alternative therapy|3|||
142974788|NCT00126581|515444092|FG001|Overall Study|Alternative therapy|3|||
142974789|NCT00126581|515444091|FG000|Overall Study|Other illness/MD discretion|3|||
142974790|NCT00126581|515444092|FG001|Overall Study|Other illness/MD discretion|4|||
142974791|NCT00793182|515444093|FG000|Overall Study|Adverse Event|0|||
142974792|NCT00793182|515444094|FG001|Overall Study|Adverse Event|1|||
142974793|NCT03728140|515444096|FG000|Overall Study|Abnormal embryo transfer operation|10|||
142974794|NCT03728140|515444097|FG001|Overall Study|Abnormal embryo transfer operation|7|||
142974795|NCT00851253|515444103|FG000|Overall Study|Disease Progression|1|||
142974796|NCT00851253|515444104|FG001|Overall Study|Disease Progression|0|||
142974797|NCT02197897|515444105|FG000|Overall Study|not eligible|1|||
142974798|NCT00291499|515444109|FG000|Overall Study|Adverse Event|3|||
142974799|NCT00291499|515444110|FG001|Overall Study|Adverse Event|8|||
142974800|NCT00291499|515444109|FG000|Overall Study|Change to other therapy|2|||
142974801|NCT00291499|515444110|FG001|Overall Study|Change to other therapy|1|||
142974802|NCT00291499|515444109|FG000|Overall Study|Intercurrent illness|1|||
142974803|NCT00291499|515444110|FG001|Overall Study|Intercurrent illness|0|||
142974804|NCT00291499|515444109|FG000|Overall Study|Protocol Violation|2|||
142974805|NCT00291499|515444110|FG001|Overall Study|Protocol Violation|2|||
142974806|NCT00291499|515444109|FG000|Overall Study|Other reasons|1|||
142974807|NCT00291499|515444110|FG001|Overall Study|Other reasons|4|||
142974808|NCT01143714|515444114|FG000|Overall Study|Adverse Event|4|||
142974809|NCT01143714|515444115|FG001|Overall Study|Adverse Event|2|||
142974810|NCT01143714|515444114|FG000|Overall Study|Withdrawal by Subject|1|||
142974811|NCT01143714|515444115|FG001|Overall Study|Withdrawal by Subject|0|||
142974812|NCT01143714|515444114|FG000|Overall Study|Subject non-compliance|0|||
142974813|NCT01143714|515444115|FG001|Overall Study|Subject non-compliance|1|||
142974814|NCT01143714|515444114|FG000|Overall Study|wound closed = deemed healed|1|||
142974815|NCT01143714|515444115|FG001|Overall Study|wound closed = deemed healed|0|||
142974816|NCT01143714|515444114|FG000|Overall Study|wound size increased|1|||
142974817|NCT01143714|515444115|FG001|Overall Study|wound size increased|0|||
142974818|NCT01387074|515444116|FG000|Overall Study|Lost to Follow-up|7|||
142974819|NCT01387074|515444116|FG000|Overall Study|Lack of Efficacy|1|||
142974820|NCT00150345|515444119|FG000|Overall Study|Death|5|||
142974821|NCT00150345|515444120|FG001|Overall Study|Death|2|||
142974822|NCT00150345|515444119|FG000|Overall Study|Adverse Event|8|||
142974823|NCT00150345|515444120|FG001|Overall Study|Adverse Event|6|||
142974824|NCT00150345|515444119|FG000|Overall Study|Lack of Efficacy|5|||
142974825|NCT00150345|515444120|FG001|Overall Study|Lack of Efficacy|4|||
142974826|NCT00150345|515444119|FG000|Overall Study|Withdrawal by Subject|3|||
142974827|NCT00150345|515444120|FG001|Overall Study|Withdrawal by Subject|4|||
142974828|NCT00150345|515444119|FG000|Overall Study|Laboratory abnormality|1|||
142974829|NCT00150345|515444120|FG001|Overall Study|Laboratory abnormality|2|||
142974830|NCT00150345|515444119|FG000|Overall Study|Other|12|||
142974831|NCT00150345|515444120|FG001|Overall Study|Other|14|||
142974832|NCT02505542|515444131|FG000|Part A: Open-Label Period|Adverse Event|31|||
142974833|NCT02505542|515444132|FG001|Part A: Open-Label Period|Adverse Event|0|||
142974834|NCT02505542|515444133|FG002|Part A: Open-Label Period|Adverse Event|0|||
142974835|NCT02505542|515444134|FG003|Part A: Open-Label Period|Adverse Event|0|||
142974836|NCT02505542|515444131|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
142974837|NCT02505542|515444132|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
142974838|NCT02505542|515444133|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
142974839|NCT02505542|515444134|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
142974840|NCT02505542|515444131|FG000|Part A: Open-Label Period|Protocol Violation|1|||
142974841|NCT02505542|515444132|FG001|Part A: Open-Label Period|Protocol Violation|0|||
142974842|NCT02505542|515444133|FG002|Part A: Open-Label Period|Protocol Violation|0|||
142974843|NCT02505542|515444134|FG003|Part A: Open-Label Period|Protocol Violation|0|||
142974844|NCT02505542|515444131|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
142974845|NCT02505542|515444132|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
142974846|NCT02505542|515444133|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
142974847|NCT02505542|515444134|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
142974848|NCT02505542|515444131|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
142974849|NCT02505542|515444132|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
142974850|NCT02505542|515444133|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
142974851|NCT02505542|515444134|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
142974852|NCT02505542|515444131|FG000|Part A: Open-Label Period|New medical history available|1|||
142974853|NCT02505542|515444132|FG001|Part A: Open-Label Period|New medical history available|0|||
142974854|NCT02505542|515444133|FG002|Part A: Open-Label Period|New medical history available|0|||
142974855|NCT02505542|515444134|FG003|Part A: Open-Label Period|New medical history available|0|||
142974856|NCT02505542|515444131|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
142974857|NCT02505542|515444132|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
142974858|NCT02505542|515444133|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
142974859|NCT02505542|515444134|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
143117165|NCT00401960|515970048|FG001|Overall Study|Death|0|||
142974860|NCT02505542|515444131|FG000|Part A: Open-Label Period|Pregnancy|2|||
142974861|NCT02505542|515444132|FG001|Part A: Open-Label Period|Pregnancy|0|||
142974862|NCT02505542|515444133|FG002|Part A: Open-Label Period|Pregnancy|0|||
142974863|NCT02505542|515444134|FG003|Part A: Open-Label Period|Pregnancy|0|||
142974864|NCT02505542|515444131|FG000|Part A: Open-Label Period|Sponsor directive|1|||
142974865|NCT02505542|515444132|FG001|Part A: Open-Label Period|Sponsor directive|0|||
142974866|NCT02505542|515444133|FG002|Part A: Open-Label Period|Sponsor directive|0|||
142974867|NCT02505542|515444134|FG003|Part A: Open-Label Period|Sponsor directive|0|||
142974868|NCT02505542|515444131|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
142974869|NCT02505542|515444132|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
142974870|NCT02505542|515444133|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
142974871|NCT02505542|515444134|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
142974872|NCT02505542|515444131|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
142974873|NCT02505542|515444132|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
142974874|NCT02505542|515444133|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
142974875|NCT02505542|515444134|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
142974876|NCT02505542|515444131|FG000|Part A: Open-Label Period|Non-compliance|1|||
142974877|NCT02505542|515444132|FG001|Part A: Open-Label Period|Non-compliance|0|||
142974878|NCT02505542|515444133|FG002|Part A: Open-Label Period|Non-compliance|0|||
142974879|NCT02505542|515444134|FG003|Part A: Open-Label Period|Non-compliance|0|||
142974880|NCT02505542|515444131|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
142974881|NCT02505542|515444132|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
142974882|NCT02505542|515444133|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
142974883|NCT02505542|515444134|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
142974884|NCT02505542|515444131|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
142974885|NCT02505542|515444132|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
142974886|NCT02505542|515444133|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
142974887|NCT02505542|515444134|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
142974888|NCT02505542|515444131|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
142974889|NCT02505542|515444132|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
142974890|NCT02505542|515444133|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
142974891|NCT02505542|515444134|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
142974892|NCT02505542|515444131|FG000|Part B: Double-Blind Period|Adverse Event|0|||
142974893|NCT02505542|515444132|FG001|Part B: Double-Blind Period|Adverse Event|0|||
142974894|NCT02505542|515444133|FG002|Part B: Double-Blind Period|Adverse Event|1|||
142974895|NCT02505542|515444134|FG003|Part B: Double-Blind Period|Adverse Event|3|||
142974896|NCT02505542|515444131|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
142974897|NCT02505542|515444132|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
142974898|NCT02505542|515444133|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
142974899|NCT02505542|515444134|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
142974900|NCT02505542|515444131|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
142974901|NCT02505542|515444132|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
142974902|NCT02505542|515444133|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
142974903|NCT02505542|515444134|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
142974904|NCT02505542|515444131|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
142974905|NCT02505542|515444132|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
142974906|NCT02505542|515444133|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
142974907|NCT02505542|515444134|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
142974908|NCT02505542|515444131|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
142974909|NCT02505542|515444132|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
142974910|NCT02505542|515444133|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
142974911|NCT02505542|515444134|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
142974912|NCT02505542|515444131|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
142974913|NCT02505542|515444132|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
142974914|NCT02505542|515444133|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
142974915|NCT02505542|515444134|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
142974916|NCT02505542|515444131|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
142974917|NCT02505542|515444132|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
142974918|NCT02505542|515444133|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
142974919|NCT02505542|515444134|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
142974920|NCT02505542|515444131|FG000|Part B: Double-Blind Period|Miscalculation|0|||
142974921|NCT02505542|515444132|FG001|Part B: Double-Blind Period|Miscalculation|1|||
142974922|NCT02505542|515444133|FG002|Part B: Double-Blind Period|Miscalculation|0|||
142974923|NCT02505542|515444134|FG003|Part B: Double-Blind Period|Miscalculation|0|||
142974924|NCT02505542|515444131|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
142974925|NCT02505542|515444132|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
142974926|NCT02505542|515444133|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
142974927|NCT02505542|515444134|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
142974928|NCT00992186|515444135|FG000|Overall Study|Withdrawal by Subject|2|||
142974929|NCT00992186|515444135|FG000|Overall Study|Protocol Violation|1|||
142974930|NCT00992186|515444135|FG000|Overall Study|Physician Decision|1|||
142974931|NCT00992186|515444135|FG000|Overall Study|Adverse Event|9|||
142974932|NCT00992186|515444135|FG000|Overall Study|Progressive Disease|30|||
142974933|NCT00992186|515444135|FG000|Overall Study|Refusal To Receive Study Agent|3|||
142974934|NCT00973622|515444136|FG000|Overall Study|did not attend MRI|14|||
142974935|NCT00973622|515444137|FG001|Overall Study|did not attend MRI|3|||
142974936|NCT00973622|515444136|FG000|Overall Study|did not pass MRI screen|6|||
142974937|NCT00973622|515444137|FG001|Overall Study|did not pass MRI screen|0|||
142974938|NCT00973622|515444136|FG000|Overall Study|did not complete rTMS sessions|11|||
142974939|NCT00973622|515444137|FG001|Overall Study|did not complete rTMS sessions|2|||
142974940|NCT00225212|515444146|FG000|Overall Study|Disease progression|2|||
142974941|NCT00225212|515444146|FG000|Overall Study|Death|1|||
142974942|NCT00225212|515444146|FG000|Overall Study|Adverse Event|2|||
142974943|NCT00225212|515444146|FG000|Overall Study|Intercurrent illness|1|||
142974944|NCT01335698|515444149|FG000|Treatment Stage 1|Lack of Efficacy|3|||
142974945|NCT01335698|515444150|FG001|Treatment Stage 1|Lack of Efficacy|1|||
142974946|NCT01335698|515444151|FG002|Treatment Stage 1|Lack of Efficacy|3|||
142974947|NCT01335698|515444152|FG003|Treatment Stage 1|Lack of Efficacy|3|||
142974948|NCT01335698|515444153|FG004|Treatment Stage 1|Lack of Efficacy|1|||
142974949|NCT01335698|515444149|FG000|Treatment Stage 1|Adverse Event|1|||
142974950|NCT01335698|515444150|FG001|Treatment Stage 1|Adverse Event|2|||
142974951|NCT01335698|515444151|FG002|Treatment Stage 1|Adverse Event|2|||
142974952|NCT01335698|515444152|FG003|Treatment Stage 1|Adverse Event|1|||
142974953|NCT01335698|515444153|FG004|Treatment Stage 1|Adverse Event|1|||
142974954|NCT01335698|515444149|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
142974955|NCT01335698|515444150|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
142974956|NCT01335698|515444151|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
142974957|NCT01335698|515444152|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
142974958|NCT01335698|515444153|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
142974959|NCT01335698|515444149|FG000|Treatment Stage 1|Lost to Follow-up|1|||
142974960|NCT01335698|515444150|FG001|Treatment Stage 1|Lost to Follow-up|1|||
142974961|NCT01335698|515444151|FG002|Treatment Stage 1|Lost to Follow-up|0|||
142974962|NCT01335698|515444152|FG003|Treatment Stage 1|Lost to Follow-up|0|||
142974963|NCT01335698|515444153|FG004|Treatment Stage 1|Lost to Follow-up|0|||
142974964|NCT01335698|515444149|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
142974965|NCT01335698|515444150|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
142974966|NCT01335698|515444151|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
142974967|NCT01335698|515444152|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
142974968|NCT01335698|515444153|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
142974969|NCT01335698|515444149|FG000|Treatment Stage 1|No longer meets study criteria|1|||
142974970|NCT01335698|515444150|FG001|Treatment Stage 1|No longer meets study criteria|1|||
142974971|NCT01335698|515444151|FG002|Treatment Stage 1|No longer meets study criteria|0|||
142974972|NCT01335698|515444152|FG003|Treatment Stage 1|No longer meets study criteria|1|||
142974973|NCT01335698|515444153|FG004|Treatment Stage 1|No longer meets study criteria|0|||
142974974|NCT01335698|515444149|FG000|Treatment Stage 1|Other|1|||
142974975|NCT01335698|515444150|FG001|Treatment Stage 1|Other|0|||
142974976|NCT01335698|515444151|FG002|Treatment Stage 1|Other|0|||
142974977|NCT01335698|515444152|FG003|Treatment Stage 1|Other|1|||
142974978|NCT01335698|515444153|FG004|Treatment Stage 1|Other|0|||
142974979|NCT01335698|515444149|FG000|Treatment Stage 2|Lack of Efficacy|2|||
142974980|NCT01335698|515444150|FG001|Treatment Stage 2|Lack of Efficacy|1|||
142974981|NCT01335698|515444151|FG002|Treatment Stage 2|Lack of Efficacy|3|||
142974982|NCT01335698|515444152|FG003|Treatment Stage 2|Lack of Efficacy|1|||
142974983|NCT01335698|515444153|FG004|Treatment Stage 2|Lack of Efficacy|0|||
142974984|NCT01335698|515444149|FG000|Treatment Stage 2|Adverse Event|2|||
142974985|NCT01335698|515444150|FG001|Treatment Stage 2|Adverse Event|0|||
142974986|NCT01335698|515444151|FG002|Treatment Stage 2|Adverse Event|0|||
142974987|NCT01335698|515444152|FG003|Treatment Stage 2|Adverse Event|3|||
142974988|NCT01335698|515444153|FG004|Treatment Stage 2|Adverse Event|0|||
142974989|NCT01335698|515444149|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
142974990|NCT01335698|515444150|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
142974991|NCT01335698|515444151|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
142974992|NCT01335698|515444152|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
142974993|NCT01335698|515444153|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
142974994|NCT01335698|515444149|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
142974995|NCT01335698|515444150|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
142974996|NCT01335698|515444151|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
142974997|NCT01335698|515444152|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
142974998|NCT01335698|515444153|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
142974999|NCT01335698|515444149|FG000|Treatment Stage 2|Lost to Follow-up|1|||
142975000|NCT01335698|515444150|FG001|Treatment Stage 2|Lost to Follow-up|0|||
142975001|NCT01335698|515444151|FG002|Treatment Stage 2|Lost to Follow-up|0|||
142975002|NCT01335698|515444152|FG003|Treatment Stage 2|Lost to Follow-up|0|||
142975003|NCT01335698|515444153|FG004|Treatment Stage 2|Lost to Follow-up|0|||
142975004|NCT01335698|515444149|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
142975005|NCT01335698|515444150|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
142975006|NCT01335698|515444151|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
142975007|NCT01335698|515444152|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
142975008|NCT01335698|515444153|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
142975009|NCT01335698|515444149|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
142975010|NCT01335698|515444150|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
142975011|NCT01335698|515444151|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
142975012|NCT01335698|515444152|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
142975013|NCT01335698|515444153|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
142975014|NCT01335698|515444149|FG000|Treatment Stage 2|Switched to another formulation|1|||
142975015|NCT01335698|515444150|FG001|Treatment Stage 2|Switched to another formulation|1|||
142975016|NCT01335698|515444151|FG002|Treatment Stage 2|Switched to another formulation|0|||
142975017|NCT01335698|515444152|FG003|Treatment Stage 2|Switched to another formulation|0|||
142975018|NCT01335698|515444153|FG004|Treatment Stage 2|Switched to another formulation|0|||
142975019|NCT01182337|515444155|FG000|Overall Study|Withdrawal by Subject|3|||
142975020|NCT01182337|515444156|FG001|Overall Study|Withdrawal by Subject|1|||
142975021|NCT01182337|515444155|FG000|Overall Study|Lost to Follow-up|0|||
142975022|NCT01182337|515444156|FG001|Overall Study|Lost to Follow-up|1|||
142975023|NCT03448224|515444157|FG000|Overall Study|Provided same answer to every question|1|||
142975024|NCT03448224|515444158|FG001|Overall Study|Provided same answer to every question|0|||
142975025|NCT03498287|515444162|FG000|Overall Study|Withdrawal by Subject|3|||
142975026|NCT03498287|515444163|FG001|Overall Study|Withdrawal by Subject|0|||
142975027|NCT03498287|515444162|FG000|Overall Study|Protocol Violation|0|||
142975028|NCT03498287|515444163|FG001|Overall Study|Protocol Violation|4|||
142975029|NCT03498287|515444162|FG000|Overall Study|Adverse Event|0|||
142975030|NCT03498287|515444163|FG001|Overall Study|Adverse Event|1|||
142975031|NCT01714817|515444164|FG000|Year 1 Period|Lack of Efficacy|11|||
142975032|NCT01714817|515444165|FG001|Year 1 Period|Lack of Efficacy|9|||
142975033|NCT01714817|515444164|FG000|Year 1 Period|Adverse Event|20|||
142975034|NCT01714817|515444165|FG001|Year 1 Period|Adverse Event|17|||
142975035|NCT01714817|515444164|FG000|Year 1 Period|Withdrawal by Subject|6|||
142975036|NCT01714817|515444165|FG001|Year 1 Period|Withdrawal by Subject|7|||
142975037|NCT01714817|515444164|FG000|Year 1 Period|Death|1|||
142975038|NCT01714817|515444165|FG001|Year 1 Period|Death|1|||
142975039|NCT01714817|515444164|FG000|Year 1 Period|Lost to Follow-up|0|||
142975040|NCT01714817|515444165|FG001|Year 1 Period|Lost to Follow-up|2|||
142975041|NCT01714817|515444164|FG000|Year 1 Period|Poor / non-compliance|0|||
142975042|NCT01714817|515444165|FG001|Year 1 Period|Poor / non-compliance|1|||
142975043|NCT01714817|515444164|FG000|Year 1 Period|Pregnancy|2|||
142975044|NCT01714817|515444165|FG001|Year 1 Period|Pregnancy|0|||
143455611|NCT04602221|517212486|FG009|Overall Study|Lost to Follow-up|0|||
143455612|NCT04602221|517212487|FG010|Overall Study|Lost to Follow-up|0|||
143455613|NCT04602221|517212488|FG011|Overall Study|Lost to Follow-up|0|||
143455614|NCT04602221|517212489|FG012|Overall Study|Lost to Follow-up|0|||
143455615|NCT04602221|517212490|FG013|Overall Study|Lost to Follow-up|0|||
143455616|NCT04602221|517212491|FG014|Overall Study|Lost to Follow-up|0|||
143455617|NCT04602221|517212492|FG015|Overall Study|Lost to Follow-up|0|||
143455618|NCT04602221|517212493|FG016|Overall Study|Lost to Follow-up|0|||
143455619|NCT04602221|517212494|FG017|Overall Study|Lost to Follow-up|0|||
143455620|NCT01056718|517212495|FG000|Overall Study|Withdrawal by Subject|2|||
143455621|NCT01056718|517212495|FG000|Overall Study|Ischemia on baseline stress test|1|||
143455622|NCT01011387|517212496|FG000|Overall Study|Withdrawal by Subject|3|||
143455623|NCT01011387|517212496|FG000|Overall Study|Adverse Event|2|||
143455624|NCT01011387|517212496|FG000|Overall Study|Protocol Violation|1|||
143455625|NCT01139580|517212497|FG000|Overall Study|Adverse Event|5|||
143455626|NCT01139580|517212498|FG001|Overall Study|Adverse Event|4|||
143455627|NCT01139580|517212497|FG000|Overall Study|Lost to Follow-up|9|||
143455628|NCT01139580|517212498|FG001|Overall Study|Lost to Follow-up|1|||
143455629|NCT01139580|517212497|FG000|Overall Study|Lack of Efficacy|0|||
143455630|NCT01139580|517212498|FG001|Overall Study|Lack of Efficacy|2|||
143455631|NCT01139580|517212497|FG000|Overall Study|Withdrawal by Subject|6|||
143455632|NCT01139580|517212498|FG001|Overall Study|Withdrawal by Subject|9|||
142975045|NCT01714817|515444164|FG000|Year 1 Period|Participant no longer meets criteria|6|||
143455633|NCT01139580|517212497|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
143455634|NCT01139580|517212498|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
143455635|NCT01139580|517212497|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
143455636|NCT01139580|517212498|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
143455637|NCT01139580|517212497|FG000|Overall Study|Misrandomized|1|||
143455638|NCT01139580|517212498|FG001|Overall Study|Misrandomized|0|||
143455639|NCT01139580|517212497|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
143455640|NCT01139580|517212498|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
142975046|NCT01714817|515444165|FG001|Year 1 Period|Participant no longer meets criteria|2|||
143455641|NCT01139580|517212497|FG000|Overall Study|Participant Randomization in Error|0|||
142975047|NCT01714817|515444164|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
142975048|NCT01714817|515444165|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
142975049|NCT01714817|515444164|FG000|Year 1 Period|Change in Concomitant Medication|0|||
142975050|NCT01714817|515444165|FG001|Year 1 Period|Change in Concomitant Medication|1|||
142975051|NCT01714817|515444164|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
142975052|NCT01714817|515444165|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
142975053|NCT01714817|515444164|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
142975054|NCT01714817|515444165|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
142975055|NCT01714817|515444164|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
142975056|NCT01714817|515444165|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
142975057|NCT01714817|515444164|FG000|Year 2 Period|Lack of Efficacy|4|||
142975058|NCT01714817|515444165|FG001|Year 2 Period|Lack of Efficacy|12|||
142975059|NCT01714817|515444164|FG000|Year 2 Period|Adverse Event|7|||
142975060|NCT01714817|515444165|FG001|Year 2 Period|Adverse Event|6|||
142975061|NCT01714817|515444164|FG000|Year 2 Period|Participant request to stop treatment|4|||
142975062|NCT01714817|515444165|FG001|Year 2 Period|Participant request to stop treatment|4|||
142975063|NCT01714817|515444164|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
142975064|NCT01714817|515444165|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
142975065|NCT01714817|515444164|FG000|Year 2 Period|Participant withdrew consent|1|||
142975066|NCT01714817|515444165|FG001|Year 2 Period|Participant withdrew consent|5|||
142975067|NCT01714817|515444164|FG000|Year 2 Period|Participant no longer meets criteria|1|||
142975068|NCT01714817|515444165|FG001|Year 2 Period|Participant no longer meets criteria|4|||
142975069|NCT01714817|515444164|FG000|Year 2 Period|Lost to Follow-up|2|||
142975070|NCT01714817|515444165|FG001|Year 2 Period|Lost to Follow-up|0|||
142975071|NCT01714817|515444164|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
142975072|NCT01714817|515444165|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
142975073|NCT01714817|515444164|FG000|Year 2 Period|Pregnancy|1|||
142975074|NCT01714817|515444165|FG001|Year 2 Period|Pregnancy|1|||
142975075|NCT01714817|515444164|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
142975076|NCT01714817|515444165|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
142975077|NCT01714817|515444164|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
142975078|NCT01714817|515444165|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
142975079|NCT01714817|515444164|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
142975080|NCT01714817|515444165|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
142975081|NCT01714817|515444164|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
142975082|NCT01714817|515444165|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
142975083|NCT01714817|515444164|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
142975084|NCT01714817|515444165|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
142975085|NCT01714817|515444164|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
142975086|NCT01714817|515444165|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
142975087|NCT01714817|515444164|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
142975088|NCT01714817|515444165|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
142975089|NCT01714817|515444164|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
142975090|NCT01714817|515444165|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
142975091|NCT01714817|515444164|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
142975092|NCT01714817|515444165|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
142975093|NCT01714817|515444164|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
142975094|NCT01714817|515444165|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
142975095|NCT01714817|515444164|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
142975096|NCT01714817|515444165|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
142975097|NCT01714817|515444164|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
142975098|NCT01714817|515444165|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
142975099|NCT01714817|515444164|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
142975100|NCT01714817|515444165|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
142975101|NCT01714817|515444164|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
142975102|NCT01714817|515444165|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
142975103|NCT01714817|515444164|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
142975104|NCT01714817|515444165|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
142975105|NCT01714817|515444164|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
142975106|NCT01714817|515444165|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
142975107|NCT01740388|515444168|FG000|Overall Study|Withdrawal by Subject|1|||
142975108|NCT01740388|515444169|FG001|Overall Study|Withdrawal by Subject|2|||
142975109|NCT01740388|515444168|FG000|Overall Study|Lost to Follow-up|2|||
142975110|NCT01740388|515444169|FG001|Overall Study|Lost to Follow-up|0|||
142975111|NCT01740388|515444168|FG000|Overall Study|Physician Decision|2|||
142975112|NCT01740388|515444169|FG001|Overall Study|Physician Decision|6|||
142975113|NCT01740388|515444168|FG000|Overall Study|Subjects missing data, completed|41|||
142975114|NCT01740388|515444169|FG001|Overall Study|Subjects missing data, completed|36|||
142975115|NCT04142216|515444170|FG000|Overall Study|Hospitalization|0|||
142975116|NCT04142216|515444171|FG001|Overall Study|Hospitalization|2|||
142975117|NCT04142216|515444170|FG000|Overall Study|Death|3|||
142975118|NCT04142216|515444171|FG001|Overall Study|Death|1|||
142975119|NCT04142216|515444170|FG000|Overall Study|Referral to another hemodialysis unit|3|||
142975120|NCT04142216|515444171|FG001|Overall Study|Referral to another hemodialysis unit|2|||
142975121|NCT04142216|515444170|FG000|Overall Study|Use of clove|0|||
142975122|NCT04142216|515444171|FG001|Overall Study|Use of clove|1|||
142975123|NCT01641991|515444172|FG000|Overall Study|Physician Decision|0|||
142975124|NCT01641991|515444173|FG001|Overall Study|Physician Decision|1|||
142975125|NCT01641991|515444174|FG002|Overall Study|Physician Decision|7|||
142975126|NCT01641991|515444175|FG003|Overall Study|Physician Decision|5|||
142975127|NCT01641991|515444172|FG000|Overall Study|Withdrawal by Subject|4|||
142975128|NCT01641991|515444173|FG001|Overall Study|Withdrawal by Subject|2|||
142975129|NCT01641991|515444174|FG002|Overall Study|Withdrawal by Subject|1|||
142975130|NCT01641991|515444175|FG003|Overall Study|Withdrawal by Subject|5|||
142975131|NCT01641991|515444172|FG000|Overall Study|Adverse Event|2|||
142975132|NCT01641991|515444173|FG001|Overall Study|Adverse Event|1|||
142975133|NCT01641991|515444174|FG002|Overall Study|Adverse Event|2|||
142975134|NCT01641991|515444175|FG003|Overall Study|Adverse Event|1|||
142975135|NCT01641991|515444172|FG000|Overall Study|Lost to Follow-up|0|||
142975136|NCT01641991|515444173|FG001|Overall Study|Lost to Follow-up|2|||
142975137|NCT01641991|515444174|FG002|Overall Study|Lost to Follow-up|3|||
142975138|NCT01641991|515444175|FG003|Overall Study|Lost to Follow-up|1|||
142975139|NCT01641991|515444172|FG000|Overall Study|Protocol Violation|1|||
142975140|NCT01641991|515444173|FG001|Overall Study|Protocol Violation|1|||
142975141|NCT01641991|515444174|FG002|Overall Study|Protocol Violation|3|||
142975142|NCT01641991|515444175|FG003|Overall Study|Protocol Violation|0|||
142975143|NCT01641991|515444172|FG000|Overall Study|Pregnancy|0|||
142975144|NCT01641991|515444173|FG001|Overall Study|Pregnancy|0|||
142975145|NCT01641991|515444174|FG002|Overall Study|Pregnancy|1|||
142975146|NCT01641991|515444175|FG003|Overall Study|Pregnancy|0|||
142975147|NCT01641991|515444172|FG000|Overall Study|no longer eligible|2|||
142975148|NCT01641991|515444173|FG001|Overall Study|no longer eligible|1|||
142975149|NCT01641991|515444174|FG002|Overall Study|no longer eligible|0|||
142975150|NCT01641991|515444175|FG003|Overall Study|no longer eligible|4|||
142975151|NCT02555657|515444176|FG000|Overall Study|Death|274|||
142975152|NCT02555657|515444177|FG001|Overall Study|Death|262|||
142975153|NCT02555657|515444176|FG000|Overall Study|Physician Decision|0|||
142975154|NCT02555657|515444177|FG001|Overall Study|Physician Decision|1|||
142975155|NCT02555657|515444176|FG000|Overall Study|Sponsor Decision|27|||
142975156|NCT02555657|515444177|FG001|Overall Study|Sponsor Decision|15|||
142975157|NCT02555657|515444176|FG000|Overall Study|Withdrawal by Subject|11|||
142975158|NCT02555657|515444177|FG001|Overall Study|Withdrawal by Subject|32|||
142975159|NCT01578785|515444179|FG000|Overall Study|Withdrawal by Subject|0|||
142975160|NCT01578785|515444180|FG001|Overall Study|Withdrawal by Subject|1|||
142975161|NCT01578785|515444179|FG000|Overall Study|Study terminated by sponsor|59|||
142975162|NCT01578785|515444180|FG001|Overall Study|Study terminated by sponsor|118|||
142975163|NCT01164865|515444181|FG000|Overall Study|Lost to Follow-up|2|||
142975164|NCT01164865|515444182|FG001|Overall Study|Lost to Follow-up|1|||
142975165|NCT00599027|515444183|FG000|Overall Study|Withdrawal by Subject|1|||
142975166|NCT00599027|515444184|FG001|Overall Study|Withdrawal by Subject|1|||
142975167|NCT00599027|515444183|FG000|Overall Study|Adverse Event|0|||
142975168|NCT00599027|515444184|FG001|Overall Study|Adverse Event|1|||
142975169|NCT00599027|515444183|FG000|Overall Study|Treatment Failure|0|||
142975170|NCT00599027|515444184|FG001|Overall Study|Treatment Failure|1|||
142975171|NCT00475540|515444185|FG000|36 Months|Lost to Follow-up|4|||
142975172|NCT00475540|515444186|FG001|36 Months|Lost to Follow-up|4|||
142975173|NCT00475540|515444185|FG000|36 Months|Death|1|||
142975174|NCT00475540|515444186|FG001|36 Months|Death|2|||
142975175|NCT00475540|515444185|FG000|36 Months|Censored due to reoperation|3|||
142975176|NCT00475540|515444186|FG001|36 Months|Censored due to reoperation|0|||
142975177|NCT00377429|515444187|FG000|Overall Study|Withdrawal by Subject|5|||
142975178|NCT00377429|515444187|FG000|Overall Study|Adverse Event|8|||
142975179|NCT00377429|515444187|FG000|Overall Study|Physician Decision|1|||
142975180|NCT00377429|515444187|FG000|Overall Study|Patient non-compliance|1|||
142975181|NCT02554253|515444190|FG000|Overall Study|ineligible after enrollment|1|||
142975182|NCT02554253|515444191|FG001|Overall Study|ineligible after enrollment|0|||
142975183|NCT02554253|515444190|FG000|Overall Study|converted to transcatheter procedure|0|||
142975184|NCT02554253|515444191|FG001|Overall Study|converted to transcatheter procedure|1|||
142975185|NCT02554253|515444190|FG000|Overall Study|received both drugs|0|||
142975186|NCT02554253|515444191|FG001|Overall Study|received both drugs|1|||
142975187|NCT00859573|515445875|FG000|Overall Study|Withdrawal by Subject|4|||
142975188|NCT00859573|515445876|FG001|Overall Study|Withdrawal by Subject|1|||
142975189|NCT00859573|515445875|FG000|Overall Study|Physician Decision|1|||
142975190|NCT00859573|515445876|FG001|Overall Study|Physician Decision|1|||
142975191|NCT01824693|515445888|FG000|Overall Study|Death|0|||
142975192|NCT01824693|515445889|FG001|Overall Study|Death|1|||
142975193|NCT01824693|515445890|FG002|Overall Study|Death|0|||
142975194|NCT01824693|515445888|FG000|Overall Study|Physician Decision|1|||
142975195|NCT01824693|515445889|FG001|Overall Study|Physician Decision|1|||
142975196|NCT01824693|515445890|FG002|Overall Study|Physician Decision|1|||
142975197|NCT01824693|515445888|FG000|Overall Study|Withdrawal by Subject|0|||
142975198|NCT01824693|515445889|FG001|Overall Study|Withdrawal by Subject|0|||
142975199|NCT01824693|515445890|FG002|Overall Study|Withdrawal by Subject|1|||
142975200|NCT01824693|515445888|FG000|Overall Study|Progressive Disease|0|||
142975201|NCT01824693|515445889|FG001|Overall Study|Progressive Disease|5|||
142975202|NCT01824693|515445890|FG002|Overall Study|Progressive Disease|0|||
142975203|NCT01824693|515445888|FG000|Overall Study|Ineligible|0|||
142975204|NCT01824693|515445889|FG001|Overall Study|Ineligible|0|||
142975205|NCT01824693|515445890|FG002|Overall Study|Ineligible|3|||
142975206|NCT01824693|515445888|FG000|Overall Study|No Transplant Planned|0|||
142975207|NCT01824693|515445889|FG001|Overall Study|No Transplant Planned|0|||
142975208|NCT01824693|515445890|FG002|Overall Study|No Transplant Planned|10|||
142975209|NCT02150213|515445892|FG000|Overall Study|Lost to Follow-up|1|||
142975210|NCT02150213|515445892|FG000|Overall Study|Withdrawal by Subject|1|||
142975211|NCT03488238|515445893|FG000|Overall Study|Equipment malfunction|1|||
142975212|NCT03488238|515445893|FG000|Overall Study|Adverse Event|1|||
142975213|NCT00525785|515445897|FG000|Overall Study|Withdrawal by Subject|1|||
142975214|NCT00525785|515445897|FG000|Overall Study|Lack of Efficacy|1|||
142975215|NCT00525785|515445897|FG000|Overall Study|Physician Decision|1|||
142975216|NCT01316939|515445898|FG000|Overall Study|Study closed/terminated|26|||
142975217|NCT01316939|515445899|FG001|Overall Study|Study closed/terminated|25|||
142975218|NCT01316939|515445900|FG002|Overall Study|Study closed/terminated|23|||
142975219|NCT01316939|515445898|FG000|Overall Study|Lack of Efficacy|24|||
142975220|NCT01316939|515445899|FG001|Overall Study|Lack of Efficacy|25|||
142975221|NCT01316939|515445900|FG002|Overall Study|Lack of Efficacy|25|||
142975222|NCT01316939|515445898|FG000|Overall Study|Adverse Event|9|||
142975223|NCT01316939|515445899|FG001|Overall Study|Adverse Event|12|||
142975224|NCT01316939|515445900|FG002|Overall Study|Adverse Event|11|||
142975225|NCT01316939|515445898|FG000|Overall Study|Withdrawal by Subject|1|||
142975226|NCT01316939|515445899|FG001|Overall Study|Withdrawal by Subject|3|||
142975227|NCT01316939|515445900|FG002|Overall Study|Withdrawal by Subject|6|||
142975228|NCT01316939|515445898|FG000|Overall Study|Physician Decision|2|||
142975229|NCT01316939|515445899|FG001|Overall Study|Physician Decision|2|||
142975230|NCT01316939|515445900|FG002|Overall Study|Physician Decision|1|||
142975231|NCT01316939|515445898|FG000|Overall Study|Lost to Follow-up|0|||
142975232|NCT01316939|515445899|FG001|Overall Study|Lost to Follow-up|0|||
142975233|NCT01316939|515445900|FG002|Overall Study|Lost to Follow-up|2|||
142975234|NCT01316939|515445898|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
142975235|NCT01316939|515445899|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
142975236|NCT01316939|515445900|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
142975237|NCT01316939|515445898|FG000|Overall Study|Protocol Violation|0|||
142975238|NCT01316939|515445899|FG001|Overall Study|Protocol Violation|1|||
142975239|NCT01316939|515445900|FG002|Overall Study|Protocol Violation|0|||
142975240|NCT01432457|515445901|FG000|Overall Study|Adverse Event|7|||
142975241|NCT01432457|515445902|FG001|Overall Study|Adverse Event|10|||
142975242|NCT01432457|515445903|FG002|Overall Study|Adverse Event|16|||
142975243|NCT01432457|515445901|FG000|Overall Study|Lack of Efficacy|2|||
142975244|NCT01432457|515445902|FG001|Overall Study|Lack of Efficacy|1|||
142975245|NCT01432457|515445903|FG002|Overall Study|Lack of Efficacy|1|||
142975246|NCT01432457|515445901|FG000|Overall Study|Lost to Follow-up|11|||
142975247|NCT01432457|515445902|FG001|Overall Study|Lost to Follow-up|15|||
142975248|NCT01432457|515445903|FG002|Overall Study|Lost to Follow-up|20|||
142975249|NCT01432457|515445901|FG000|Overall Study|Protocol Violation|3|||
142975250|NCT01432457|515445902|FG001|Overall Study|Protocol Violation|2|||
142975251|NCT01432457|515445903|FG002|Overall Study|Protocol Violation|6|||
142975252|NCT01432457|515445901|FG000|Overall Study|Withdrawal by Subject|6|||
142975253|NCT01432457|515445902|FG001|Overall Study|Withdrawal by Subject|11|||
142975254|NCT01432457|515445903|FG002|Overall Study|Withdrawal by Subject|9|||
142975255|NCT01432457|515445901|FG000|Overall Study|Reasons not defined|2|||
142975256|NCT01432457|515445902|FG001|Overall Study|Reasons not defined|3|||
142975257|NCT01432457|515445903|FG002|Overall Study|Reasons not defined|4|||
142975258|NCT01432457|515445901|FG000|Overall Study|Did not take study drug|6|||
142975259|NCT01432457|515445902|FG001|Overall Study|Did not take study drug|6|||
142975260|NCT01432457|515445903|FG002|Overall Study|Did not take study drug|3|||
142975261|NCT04507776|515445904|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
142975262|NCT01188096|515445921|FG000|Overall Study|progression of disease|4|||
142975263|NCT01188096|515445921|FG000|Overall Study|Withdrawal by Subject|2|||
142975264|NCT02786836|515445922|FG000|Overall Study|Death|1|||
142975265|NCT02786836|515445922|FG000|Overall Study|Lack of Efficacy|2|||
142975266|NCT02786836|515445922|FG000|Overall Study|Protocol Violation|3|||
142975267|NCT02786836|515445922|FG000|Overall Study|Withdrawal by Subject|3|||
142975268|NCT02786836|515445922|FG000|Overall Study|Liver Transplantation|2|||
142975269|NCT02786836|515445922|FG000|Overall Study|Device or Pharmacy Issues|3|||
142975270|NCT03892707|515445925|FG000|Overall Study|Screen failure|6|||
142975271|NCT03892707|515445926|FG001|Overall Study|Screen failure|0|||
142975272|NCT03892707|515445925|FG000|Overall Study|Pain resolution|0|||
142975273|NCT03892707|515445926|FG001|Overall Study|Pain resolution|4|||
142975274|NCT03892707|515445925|FG000|Overall Study|Withdrawal by Subject|0|||
142975275|NCT03892707|515445926|FG001|Overall Study|Withdrawal by Subject|1|||
142975276|NCT03892707|515445925|FG000|Overall Study|Other (long business trip)|0|||
142975277|NCT03892707|515445926|FG001|Overall Study|Other (long business trip)|1|||
142975278|NCT05224076|515445930|FG000|Overall Study|Lost to Follow-up|24|||
142975279|NCT01807949|515445932|FG000|Overall Study|Adverse Event|1|||
142975280|NCT01807949|515445933|FG001|Overall Study|Adverse Event|2|||
142975281|NCT01807949|515445934|FG002|Overall Study|Adverse Event|2|||
142975282|NCT01807949|515445932|FG000|Overall Study|Withdrawal by Subject|1|||
142975283|NCT01807949|515445933|FG001|Overall Study|Withdrawal by Subject|2|||
142975284|NCT01807949|515445934|FG002|Overall Study|Withdrawal by Subject|2|||
142975285|NCT01807949|515445932|FG000|Overall Study|Non-Compliance|0|||
142975286|NCT01807949|515445933|FG001|Overall Study|Non-Compliance|0|||
142975287|NCT01807949|515445934|FG002|Overall Study|Non-Compliance|1|||
142975288|NCT01807949|515445932|FG000|Overall Study|Undefined|0|||
142975289|NCT01807949|515445933|FG001|Overall Study|Undefined|1|||
142975290|NCT01807949|515445934|FG002|Overall Study|Undefined|2|||
142975291|NCT01807949|515445932|FG000|Overall Study|Randomized But Not Treated|0|||
142975292|NCT01807949|515445933|FG001|Overall Study|Randomized But Not Treated|2|||
142975293|NCT01807949|515445934|FG002|Overall Study|Randomized But Not Treated|2|||
142975294|NCT04190186|515445935|FG000|Overall Study|ILR is no longer functioning|0|||
142975295|NCT04190186|515445936|FG001|Overall Study|ILR is no longer functioning|1|||
142975296|NCT04190186|515445935|FG000|Overall Study|Lost to Follow-up|0|||
142975297|NCT04190186|515445936|FG001|Overall Study|Lost to Follow-up|1|||
142975298|NCT04190186|515445935|FG000|Overall Study|Withdrawal by Subject|2|||
142975299|NCT04190186|515445936|FG001|Overall Study|Withdrawal by Subject|0|||
142975300|NCT04190186|515445935|FG000|Overall Study|Subject choice to explant|1|||
142975301|NCT04190186|515445936|FG001|Overall Study|Subject choice to explant|0|||
142975302|NCT04190186|515445935|FG000|Overall Study|Physician Decision|0|||
142975303|NCT04190186|515445936|FG001|Overall Study|Physician Decision|1|||
142975304|NCT04190186|515445935|FG000|Overall Study|Study was stopped|4|||
142975305|NCT04190186|515445936|FG001|Overall Study|Study was stopped|5|||
142975306|NCT02016898|515445937|FG000|Overall Study|Death|1|||
142975307|NCT02016898|515445938|FG001|Overall Study|Death|1|||
142975308|NCT02016898|515445937|FG000|Overall Study|Lost to Follow-up|4|||
142975309|NCT02016898|515445938|FG001|Overall Study|Lost to Follow-up|4|||
142975310|NCT01665768|515445939|FG000|Overall Study|Adverse Event|3|||
142975311|NCT01665768|515445939|FG000|Overall Study|Lack of Efficacy|19|||
142975312|NCT01665768|515445939|FG000|Overall Study|Withdrawal by Subject|1|||
142975313|NCT02151682|515445940|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
142975314|NCT02151682|515445941|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
142975315|NCT02151682|515445942|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
142975316|NCT02151682|515445943|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
142975317|NCT02151682|515445944|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
142975318|NCT02151682|515445945|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
142975319|NCT02151682|515445940|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
142975320|NCT02151682|515445941|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
142975321|NCT02151682|515445942|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
142975322|NCT02151682|515445943|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
142975323|NCT02151682|515445944|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
142975324|NCT02151682|515445945|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
142975325|NCT02151682|515445940|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
142975326|NCT02151682|515445941|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
142975327|NCT02151682|515445942|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
142975328|NCT02151682|515445943|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
142975329|NCT02151682|515445944|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
142975330|NCT02151682|515445945|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
142975331|NCT02151682|515445940|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
142975332|NCT02151682|515445941|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
142975333|NCT02151682|515445942|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
142975334|NCT02151682|515445943|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
142975335|NCT02151682|515445944|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
142975336|NCT02151682|515445945|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
142975337|NCT02151682|515445940|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
142975338|NCT02151682|515445941|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
142975339|NCT02151682|515445942|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
143117166|NCT03301844|515970055|FG000|Overall Study|suspected colon cancer|1|||
143117167|NCT03301844|515970056|FG001|Overall Study|suspected colon cancer|1|||
143117168|NCT01217385|515970057|FG000|Overall Study|Withdrawal by Subject|3|||
143117169|NCT01217385|515970057|FG000|Overall Study|DOSI not performed/not eval|12|||
143117170|NCT01217385|515970057|FG000|Overall Study|Central Path not Available|1|||
142975340|NCT02151682|515445943|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
142975341|NCT02151682|515445944|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
142975342|NCT02151682|515445945|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
142975343|NCT02151682|515445940|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
142975344|NCT02151682|515445941|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
142975345|NCT02151682|515445942|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
142975346|NCT02151682|515445943|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
142975347|NCT02151682|515445944|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
142975348|NCT02151682|515445945|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
142975349|NCT02151682|515445940|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
142975350|NCT02151682|515445941|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
142975351|NCT02151682|515445942|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
142975352|NCT02151682|515445943|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
142975353|NCT02151682|515445944|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
142975354|NCT02151682|515445945|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
142975355|NCT02151682|515445940|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
142975356|NCT02151682|515445941|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
142975357|NCT02151682|515445942|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
142975358|NCT02151682|515445943|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
142975359|NCT02151682|515445944|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
142975360|NCT02151682|515445945|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
142975361|NCT02151682|515445940|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
142975362|NCT02151682|515445941|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
142975363|NCT02151682|515445942|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
142975364|NCT02151682|515445943|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
142975365|NCT02151682|515445944|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
142975366|NCT02151682|515445945|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
142975367|NCT02151682|515445940|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
142975368|NCT02151682|515445941|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
142975369|NCT02151682|515445942|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
142975370|NCT02151682|515445943|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
142975371|NCT02151682|515445944|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
142975372|NCT02151682|515445945|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
142975373|NCT02151682|515445940|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
142975374|NCT02151682|515445941|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
142975375|NCT02151682|515445942|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
142975376|NCT02151682|515445943|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
142975377|NCT02151682|515445944|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
142975378|NCT02151682|515445945|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
142975379|NCT02151682|515445940|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
142975380|NCT02151682|515445941|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
142975381|NCT02151682|515445942|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
142975382|NCT02151682|515445943|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
142975383|NCT02151682|515445944|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
142975384|NCT02151682|515445945|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
142975385|NCT02151682|515445940|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
142975386|NCT02151682|515445941|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
142975387|NCT02151682|515445942|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
142975388|NCT02151682|515445943|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
142975389|NCT02151682|515445944|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
142975390|NCT02151682|515445945|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
142975391|NCT02151682|515445940|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
142975392|NCT02151682|515445941|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
142975393|NCT02151682|515445942|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
142975394|NCT02151682|515445943|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
142975395|NCT02151682|515445944|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
142975396|NCT02151682|515445945|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
142975397|NCT02151682|515445940|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
142975398|NCT02151682|515445941|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
142975399|NCT02151682|515445942|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
142975400|NCT02151682|515445943|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
142975401|NCT02151682|515445944|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
142975402|NCT02151682|515445945|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
142975403|NCT02151682|515445940|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
142975404|NCT02151682|515445941|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
142975405|NCT02151682|515445942|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
142975406|NCT02151682|515445943|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
142975407|NCT02151682|515445944|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
142975408|NCT02151682|515445945|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
142975409|NCT02151682|515445940|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
142975410|NCT02151682|515445941|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
142975411|NCT02151682|515445942|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
142975412|NCT02151682|515445943|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
142975413|NCT02151682|515445944|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
142975414|NCT02151682|515445945|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
142975415|NCT02151682|515445940|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
142975416|NCT02151682|515445941|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
142975417|NCT02151682|515445942|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
142975418|NCT02151682|515445943|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
142975419|NCT02151682|515445944|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
142975420|NCT02151682|515445945|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
142975421|NCT03260894|515445946|FG000|Overall Study|Death|6|||
142975422|NCT03260894|515445947|FG001|Overall Study|Death|8|||
142975423|NCT03260894|515445946|FG000|Overall Study|Withdrawal by Subject|4|||
142975424|NCT03260894|515445947|FG001|Overall Study|Withdrawal by Subject|11|||
142975425|NCT03260894|515445946|FG000|Overall Study|On-going at clinical cut off date|36|||
142975426|NCT03260894|515445947|FG001|Overall Study|On-going at clinical cut off date|31|||
142975427|NCT00318565|515445948|FG000|Overall Study|Excluded per protocol|24|||
142975428|NCT00282867|515445949|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
142975429|NCT00282867|515445950|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
142975430|NCT00282867|515445951|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
142975431|NCT01409993|515445952|FG000|Overall Study|Adverse Event|4|||
142975432|NCT01409993|515445953|FG001|Overall Study|Adverse Event|4|||
142975433|NCT01409993|515445954|FG002|Overall Study|Adverse Event|3|||
142975434|NCT01409993|515445955|FG003|Overall Study|Adverse Event|1|||
142975435|NCT01409993|515445952|FG000|Overall Study|Withdrawal by Subject|0|||
142975436|NCT01409993|515445953|FG001|Overall Study|Withdrawal by Subject|0|||
142975437|NCT01409993|515445954|FG002|Overall Study|Withdrawal by Subject|0|||
142975438|NCT01409993|515445955|FG003|Overall Study|Withdrawal by Subject|4|||
142975439|NCT01409993|515445952|FG000|Overall Study|Lost to Follow-up|0|||
142975440|NCT01409993|515445953|FG001|Overall Study|Lost to Follow-up|1|||
142975441|NCT01409993|515445954|FG002|Overall Study|Lost to Follow-up|0|||
142975442|NCT01409993|515445955|FG003|Overall Study|Lost to Follow-up|0|||
142975443|NCT02677220|515445956|FG000|Overall Study|Adverse Event|1|||
142975444|NCT00965146|515445957|FG000|Overall Study|Death|7|||
142975445|NCT00965146|515445957|FG000|Overall Study|Lost to Follow-up|22|||
142975446|NCT00965146|515445957|FG000|Overall Study|Withdrawal by Subject|17|||
142975447|NCT00965146|515445957|FG000|Overall Study|Unable to return|1|||
142975448|NCT00965146|515445957|FG000|Overall Study|Unwilling to return|11|||
142975449|NCT00965146|515445957|FG000|Overall Study|Intercurrent illness|1|||
142975450|NCT00965146|515445957|FG000|Overall Study|Revision / Removal of Study Implant|6|||
142975451|NCT00965146|515445957|FG000|Overall Study|Overall Study Termination|145|||
142975452|NCT00067470|515445958|FG000|Overall Study|Withdrawal by Subject|0|||
142975453|NCT00067470|515445959|FG001|Overall Study|Withdrawal by Subject|1|||
142975454|NCT00830960|515445960|FG000|Overall Study|Death|5|||
142975455|NCT00830960|515445961|FG001|Overall Study|Death|4|||
142975456|NCT00830960|515445962|FG002|Overall Study|Death|3|||
142975457|NCT00830960|515445963|FG003|Overall Study|Death|2|||
142975458|NCT00830960|515445964|FG004|Overall Study|Death|6|||
142975459|NCT00830960|515445965|FG005|Overall Study|Death|1|||
142975460|NCT00830960|515445960|FG000|Overall Study|Lost to Follow-up|1|||
142975461|NCT00830960|515445961|FG001|Overall Study|Lost to Follow-up|1|||
142975462|NCT00830960|515445962|FG002|Overall Study|Lost to Follow-up|1|||
142975463|NCT00830960|515445963|FG003|Overall Study|Lost to Follow-up|0|||
142975464|NCT00830960|515445964|FG004|Overall Study|Lost to Follow-up|0|||
142975465|NCT00830960|515445965|FG005|Overall Study|Lost to Follow-up|1|||
142975466|NCT00830960|515445960|FG000|Overall Study|Withdrawal by Subject|19|||
142975467|NCT00830960|515445961|FG001|Overall Study|Withdrawal by Subject|19|||
142975468|NCT00830960|515445962|FG002|Overall Study|Withdrawal by Subject|18|||
142975469|NCT00830960|515445963|FG003|Overall Study|Withdrawal by Subject|23|||
142975470|NCT00830960|515445964|FG004|Overall Study|Withdrawal by Subject|16|||
142975471|NCT00830960|515445965|FG005|Overall Study|Withdrawal by Subject|21|||
142975472|NCT00830960|515445960|FG000|Overall Study|Sponsor Decision|1|||
142975473|NCT00830960|515445961|FG001|Overall Study|Sponsor Decision|2|||
142975474|NCT00830960|515445962|FG002|Overall Study|Sponsor Decision|3|||
142975475|NCT00830960|515445963|FG003|Overall Study|Sponsor Decision|4|||
142975476|NCT00830960|515445964|FG004|Overall Study|Sponsor Decision|5|||
142975477|NCT00830960|515445965|FG005|Overall Study|Sponsor Decision|7|||
142975478|NCT00830960|515445960|FG000|Overall Study|No study drug received|7|||
142975479|NCT00830960|515445961|FG001|Overall Study|No study drug received|2|||
142975480|NCT00830960|515445962|FG002|Overall Study|No study drug received|4|||
142975481|NCT00830960|515445963|FG003|Overall Study|No study drug received|3|||
142975482|NCT00830960|515445964|FG004|Overall Study|No study drug received|5|||
142975483|NCT00830960|515445965|FG005|Overall Study|No study drug received|7|||
142975484|NCT03074149|515445968|FG000|Overall Study|Reason unknown|22|||
142975485|NCT03074149|515445969|FG001|Overall Study|Reason unknown|35|||
142975486|NCT03074149|515445968|FG000|Overall Study|Death|10|||
142975487|NCT03074149|515445969|FG001|Overall Study|Death|45|||
142975488|NCT02855450|515445972|FG000|Overall Study|Adverse Event|1|||
142975489|NCT02855450|515445973|FG001|Overall Study|Adverse Event|0|||
142975490|NCT02855450|515445972|FG000|Overall Study|Lost to Follow-up|4|||
142975491|NCT02855450|515445973|FG001|Overall Study|Lost to Follow-up|0|||
142975492|NCT01504971|515445974|FG000|Overall Study|Physician Decision|13|||
142975493|NCT01803711|515445975|FG000|Overall Study|Adverse Event|1|||
142975494|NCT01803711|515445976|FG001|Overall Study|Adverse Event|1|||
142975495|NCT01376245|515445977|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
142975496|NCT01376245|515445978|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
142975497|NCT01376245|515445979|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
142975498|NCT01376245|515445980|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
142975499|NCT01376245|515445981|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
142975500|NCT01376245|515445977|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
142975501|NCT01376245|515445978|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
142975502|NCT01376245|515445979|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
142975503|NCT01376245|515445980|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
142975504|NCT01376245|515445981|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
142975505|NCT01376245|515445977|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
142975506|NCT01376245|515445978|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
142975507|NCT01376245|515445979|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
142975508|NCT01376245|515445980|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
142975509|NCT01376245|515445981|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
142975510|NCT01376245|515445977|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
142975511|NCT01376245|515445978|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
142975512|NCT01376245|515445979|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
142975513|NCT01376245|515445980|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
142975514|NCT01376245|515445981|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
142975515|NCT01376245|515445977|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
142975516|NCT01376245|515445978|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
142975517|NCT01376245|515445979|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
142975518|NCT01376245|515445980|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
142975519|NCT01376245|515445981|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
142975520|NCT01376245|515445977|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
142975521|NCT01376245|515445978|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
142975522|NCT01376245|515445979|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
142975523|NCT01376245|515445980|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
142975524|NCT01376245|515445981|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
142975525|NCT01376245|515445977|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
142975526|NCT01376245|515445978|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
142975527|NCT01376245|515445979|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
142975528|NCT01376245|515445980|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
142975529|NCT01376245|515445981|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
142975530|NCT01376245|515445977|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
142975531|NCT01376245|515445978|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
142975532|NCT01376245|515445979|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
142975533|NCT01376245|515445980|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
142975534|NCT01376245|515445981|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
142975535|NCT01376245|515445977|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
142975536|NCT01376245|515445978|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
142975537|NCT01376245|515445979|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
142975538|NCT01376245|515445980|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
142975539|NCT01376245|515445981|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
142975540|NCT01376245|515445977|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
142975541|NCT01376245|515445978|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
142975542|NCT01376245|515445979|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
142975543|NCT01376245|515445980|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
142975544|NCT01376245|515445981|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
142975545|NCT01376245|515445977|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
142975546|NCT01376245|515445978|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
142975547|NCT01376245|515445979|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
142975548|NCT01376245|515445980|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
142975549|NCT01376245|515445981|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
142975550|NCT01376245|515445977|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
142975551|NCT01376245|515445978|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
142975552|NCT01376245|515445979|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
142975553|NCT01376245|515445980|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
142975554|NCT01376245|515445981|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
142975555|NCT01357889|515445982|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
142975556|NCT01357889|515445983|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
142975557|NCT01357889|515445982|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
142975558|NCT01357889|515445983|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
142975559|NCT01357889|515445982|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
142975560|NCT01357889|515445983|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
142975561|NCT01357889|515445982|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
142975562|NCT01357889|515445983|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
142975563|NCT01357889|515445982|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
142975564|NCT01357889|515445983|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
142975565|NCT01357889|515445982|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
142975566|NCT01357889|515445983|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
142975567|NCT01357889|515445982|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
142975568|NCT01357889|515445983|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
142975569|NCT01357889|515445982|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
142975570|NCT01357889|515445983|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
142975571|NCT01357889|515445982|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
142975572|NCT01357889|515445983|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
142975573|NCT01357889|515445982|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
142975574|NCT01357889|515445983|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
142975575|NCT01357889|515445982|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
142975576|NCT01357889|515445983|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
142975577|NCT01357889|515445982|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
142975578|NCT01357889|515445983|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
142975579|NCT01357889|515445982|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
142975580|NCT01357889|515445983|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
142975581|NCT03454412|515445988|FG000|Baseline Assesment|Physician Decision|12|||
142975582|NCT01167582|515445989|FG000|Overall Study|Lost to Follow-up|0|||
142975583|NCT01167582|515445990|FG001|Overall Study|Lost to Follow-up|1|||
142975584|NCT01928485|515445991|FG000|Overall Study|Physician Decision|0|||
142975585|NCT01928485|515445992|FG001|Overall Study|Physician Decision|1|||
142975586|NCT00039741|515445993|FG000|Overall Study|Death|0|||
142975587|NCT00039741|515445994|FG001|Overall Study|Death|1|||
142975588|NCT00039741|515445995|FG002|Overall Study|Death|0|||
142975589|NCT00039741|515445996|FG003|Overall Study|Death|0|||
142975590|NCT00039741|515445993|FG000|Overall Study|Lost to Follow-up|3|||
142975591|NCT00039741|515445994|FG001|Overall Study|Lost to Follow-up|1|||
142975592|NCT00039741|515445995|FG002|Overall Study|Lost to Follow-up|5|||
142975593|NCT00039741|515445996|FG003|Overall Study|Lost to Follow-up|2|||
142975594|NCT00039741|515445993|FG000|Overall Study|Confounding medical condition|1|||
142975595|NCT00039741|515445994|FG001|Overall Study|Confounding medical condition|0|||
142975596|NCT00039741|515445995|FG002|Overall Study|Confounding medical condition|0|||
142975597|NCT00039741|515445996|FG003|Overall Study|Confounding medical condition|0|||
142975598|NCT00039741|515445993|FG000|Overall Study|Not able to get to clinic|5|||
142975599|NCT00039741|515445994|FG001|Overall Study|Not able to get to clinic|2|||
142975600|NCT00039741|515445995|FG002|Overall Study|Not able to get to clinic|0|||
142975601|NCT00039741|515445996|FG003|Overall Study|Not able to get to clinic|3|||
142975602|NCT00039741|515445993|FG000|Overall Study|Moved|3|||
142975603|NCT00039741|515445994|FG001|Overall Study|Moved|2|||
142975604|NCT00039741|515445995|FG002|Overall Study|Moved|3|||
142975605|NCT00039741|515445996|FG003|Overall Study|Moved|6|||
142975606|NCT00039741|515445993|FG000|Overall Study|Non-compliance with protocol|1|||
142975607|NCT00039741|515445994|FG001|Overall Study|Non-compliance with protocol|0|||
142975608|NCT00039741|515445995|FG002|Overall Study|Non-compliance with protocol|1|||
142975609|NCT00039741|515445996|FG003|Overall Study|Non-compliance with protocol|0|||
142975610|NCT00039741|515445993|FG000|Overall Study|Withdrew consent|0|||
142975611|NCT00039741|515445994|FG001|Overall Study|Withdrew consent|5|||
142975612|NCT00039741|515445995|FG002|Overall Study|Withdrew consent|0|||
142975613|NCT00039741|515445996|FG003|Overall Study|Withdrew consent|1|||
142975614|NCT00039741|515445993|FG000|Overall Study|Missed final visit|2|||
142975615|NCT00039741|515445994|FG001|Overall Study|Missed final visit|1|||
142975616|NCT00039741|515445995|FG002|Overall Study|Missed final visit|2|||
142975617|NCT00039741|515445996|FG003|Overall Study|Missed final visit|2|||
142975618|NCT00946881|515445997|FG000|First Treatment|Withdrawal by Subject|1|||
142975619|NCT00946881|515445997|FG000|First Treatment|Patient relocated to another state|1|||
142975620|NCT00946881|515445997|FG000|Retreatment|Withdrawal by Subject|1|||
142975621|NCT00293423|515445998|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
142975622|NCT00293423|515445999|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
142975623|NCT00293423|515445998|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
142975624|NCT00293423|515445999|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
142975625|NCT00293423|515445998|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
142975626|NCT00293423|515445999|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
142975627|NCT00293423|515445998|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
142975628|NCT00293423|515445999|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
142975629|NCT00293423|515445998|FG000|Surgical Resection|processing error during surgical resection|1|||
142975630|NCT00293423|515445999|FG001|Surgical Resection|processing error during surgical resection|0|||
142975631|NCT00293423|515445998|FG000|Surgical Resection|Withdrawal by Subject|4|||
142975632|NCT00293423|515445999|FG001|Surgical Resection|Withdrawal by Subject|0|||
142975633|NCT00293423|515445998|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
142975634|NCT00293423|515445999|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
142975635|NCT00507416|515446000|FG000|Overall Study|Adverse Event|58|||
142975636|NCT00507416|515446001|FG001|Overall Study|Adverse Event|67|||
142975637|NCT00507416|515446002|FG002|Overall Study|Adverse Event|65|||
142975638|NCT00507416|515446000|FG000|Overall Study|Protocol Violation|1|||
142975639|NCT00507416|515446001|FG001|Overall Study|Protocol Violation|2|||
142975640|NCT00507416|515446002|FG002|Overall Study|Protocol Violation|0|||
142975641|NCT00507416|515446000|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
142975642|NCT00507416|515446001|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
142975643|NCT00507416|515446002|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
142975644|NCT00507416|515446000|FG000|Overall Study|Progressive Disease|20|||
142975645|NCT00507416|515446001|FG001|Overall Study|Progressive Disease|10|||
142975646|NCT00507416|515446002|FG002|Overall Study|Progressive Disease|13|||
142975647|NCT00507416|515446000|FG000|Overall Study|Patient declined further treatment|18|||
142975648|NCT00507416|515446001|FG001|Overall Study|Patient declined further treatment|14|||
142975649|NCT00507416|515446002|FG002|Overall Study|Patient declined further treatment|11|||
142975650|NCT00507416|515446000|FG000|Overall Study|Other|11|||
142975651|NCT00507416|515446001|FG001|Overall Study|Other|16|||
142975652|NCT00507416|515446002|FG002|Overall Study|Other|13|||
142975653|NCT00507416|515446000|FG000|Overall Study|Did not Receive Study Treatment|3|||
142975654|NCT00507416|515446001|FG001|Overall Study|Did not Receive Study Treatment|9|||
142975655|NCT00507416|515446002|FG002|Overall Study|Did not Receive Study Treatment|4|||
142975656|NCT00964158|515446003|FG000|Overall Study|Lost to Follow-up|0|||
142975657|NCT00964158|515446004|FG001|Overall Study|Lost to Follow-up|1|||
142975658|NCT00964158|515446005|FG002|Overall Study|Lost to Follow-up|2|||
142975659|NCT00964158|515446003|FG000|Overall Study|Withdrawal by Subject|0|||
142975660|NCT00964158|515446004|FG001|Overall Study|Withdrawal by Subject|0|||
142975661|NCT00964158|515446005|FG002|Overall Study|Withdrawal by Subject|6|||
142975662|NCT01021813|515446006|FG000|DB Treatment Phase|Adverse Event|60|||
142975663|NCT01021813|515446007|FG001|DB Treatment Phase|Adverse Event|22|||
142975664|NCT01021813|515446008|FG002|DB Treatment Phase|Adverse Event|0|||
142975665|NCT01021813|515446009|FG003|DB Treatment Phase|Adverse Event|0|||
142975666|NCT01021813|515446010|FG004|DB Treatment Phase|Adverse Event|0|||
142975667|NCT01021813|515446006|FG000|DB Treatment Phase|Lack of Efficacy|44|||
142975668|NCT01021813|515446007|FG001|DB Treatment Phase|Lack of Efficacy|28|||
142975669|NCT01021813|515446008|FG002|DB Treatment Phase|Lack of Efficacy|0|||
142975670|NCT01021813|515446009|FG003|DB Treatment Phase|Lack of Efficacy|0|||
142975671|NCT01021813|515446010|FG004|DB Treatment Phase|Lack of Efficacy|0|||
142975672|NCT01021813|515446006|FG000|DB Treatment Phase|Lost to Follow-up|14|||
142975673|NCT01021813|515446007|FG001|DB Treatment Phase|Lost to Follow-up|12|||
142975674|NCT01021813|515446008|FG002|DB Treatment Phase|Lost to Follow-up|0|||
142975675|NCT01021813|515446009|FG003|DB Treatment Phase|Lost to Follow-up|0|||
142975676|NCT01021813|515446010|FG004|DB Treatment Phase|Lost to Follow-up|0|||
142975677|NCT01021813|515446006|FG000|DB Treatment Phase|Physician Decision|17|||
142975678|NCT01021813|515446007|FG001|DB Treatment Phase|Physician Decision|8|||
142975679|NCT01021813|515446008|FG002|DB Treatment Phase|Physician Decision|0|||
142975680|NCT01021813|515446009|FG003|DB Treatment Phase|Physician Decision|0|||
142975681|NCT01021813|515446010|FG004|DB Treatment Phase|Physician Decision|0|||
142975682|NCT01021813|515446006|FG000|DB Treatment Phase|Pregnancy|1|||
142975683|NCT01021813|515446007|FG001|DB Treatment Phase|Pregnancy|0|||
142975684|NCT01021813|515446008|FG002|DB Treatment Phase|Pregnancy|0|||
142975685|NCT01021813|515446009|FG003|DB Treatment Phase|Pregnancy|0|||
142975686|NCT01021813|515446010|FG004|DB Treatment Phase|Pregnancy|0|||
142975687|NCT01021813|515446006|FG000|DB Treatment Phase|Protocol Violation|4|||
142975688|NCT01021813|515446007|FG001|DB Treatment Phase|Protocol Violation|3|||
142975689|NCT01021813|515446008|FG002|DB Treatment Phase|Protocol Violation|0|||
143117171|NCT01217385|515970057|FG000|Overall Study|Normal Breast TOI not available|10|||
142975690|NCT01021813|515446009|FG003|DB Treatment Phase|Protocol Violation|0|||
142975691|NCT01021813|515446010|FG004|DB Treatment Phase|Protocol Violation|0|||
142975692|NCT01021813|515446006|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
142975693|NCT01021813|515446007|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
142975694|NCT01021813|515446008|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
142975695|NCT01021813|515446009|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
142975696|NCT01021813|515446010|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
142975697|NCT01021813|515446006|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
142975698|NCT01021813|515446007|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
142975699|NCT01021813|515446008|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
142975700|NCT01021813|515446009|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
142975701|NCT01021813|515446010|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
142975702|NCT01021813|515446006|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
142975703|NCT01021813|515446007|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
142975704|NCT01021813|515446008|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
142975705|NCT01021813|515446009|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
142975706|NCT01021813|515446010|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
142975707|NCT01021813|515446006|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
142975708|NCT01021813|515446007|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
142975709|NCT01021813|515446008|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
142975710|NCT01021813|515446009|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
142975711|NCT01021813|515446010|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
142975712|NCT01021813|515446006|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
142975713|NCT01021813|515446007|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
142975714|NCT01021813|515446008|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
142975715|NCT01021813|515446009|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
142975716|NCT01021813|515446010|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
142975717|NCT01021813|515446006|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
142975718|NCT01021813|515446007|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
142975719|NCT01021813|515446008|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
142975720|NCT01021813|515446009|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
142975721|NCT01021813|515446010|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
142975722|NCT03103906|515446011|FG000|Overall Study|Adverse Event|2|||
142975723|NCT03103906|515446012|FG001|Overall Study|Adverse Event|3|||
142975724|NCT03103906|515446011|FG000|Overall Study|Other|2|||
142975725|NCT03103906|515446012|FG001|Overall Study|Other|0|||
142975726|NCT00764478|515446013|FG000|Overall Study|Adverse Event|1|||
142975727|NCT00764478|515446014|FG001|Overall Study|Adverse Event|1|||
142975728|NCT00764478|515446015|FG002|Overall Study|Adverse Event|1|||
142975729|NCT00764478|515446013|FG000|Overall Study|Withdrawal by Subject|7|||
142975730|NCT00764478|515446014|FG001|Overall Study|Withdrawal by Subject|12|||
142975731|NCT00764478|515446015|FG002|Overall Study|Withdrawal by Subject|1|||
142975732|NCT00764478|515446013|FG000|Overall Study|Lost to Follow-up|7|||
142975733|NCT00764478|515446014|FG001|Overall Study|Lost to Follow-up|8|||
142975734|NCT00764478|515446015|FG002|Overall Study|Lost to Follow-up|5|||
142975735|NCT00764478|515446013|FG000|Overall Study|Protocol Violation|0|||
142975736|NCT00764478|515446014|FG001|Overall Study|Protocol Violation|1|||
142975737|NCT00764478|515446015|FG002|Overall Study|Protocol Violation|1|||
142975738|NCT03571256|515446016|FG000|Overall Study|Adverse Event|3|||
142975739|NCT03571256|515446017|FG001|Overall Study|Adverse Event|0|||
142975740|NCT03571256|515446018|FG002|Overall Study|Adverse Event|1|||
142975741|NCT03571256|515446016|FG000|Overall Study|Withdrawal by Subject|3|||
142975742|NCT03571256|515446017|FG001|Overall Study|Withdrawal by Subject|1|||
142975743|NCT03571256|515446018|FG002|Overall Study|Withdrawal by Subject|1|||
142975744|NCT03571256|515446016|FG000|Overall Study|Other than specified|0|||
142975745|NCT03571256|515446017|FG001|Overall Study|Other than specified|1|||
142975746|NCT03571256|515446018|FG002|Overall Study|Other than specified|1|||
142975747|NCT03571256|515446016|FG000|Overall Study|Protocol Violation|0|||
142975748|NCT03571256|515446017|FG001|Overall Study|Protocol Violation|1|||
142975749|NCT03571256|515446018|FG002|Overall Study|Protocol Violation|1|||
142975750|NCT02270684|515446019|FG000|Overall Study|Lost to Follow-up|0|||
142975751|NCT02270684|515446020|FG001|Overall Study|Lost to Follow-up|3|||
142975752|NCT02270684|515446019|FG000|Overall Study|Study terminated|1|||
142975753|NCT02270684|515446020|FG001|Overall Study|Study terminated|0|||
142975754|NCT03371732|515446026|FG000|Overall Study|Withdrawal by Subject|9|||
142975755|NCT03371732|515446027|FG001|Overall Study|Withdrawal by Subject|3|||
142975756|NCT03371732|515446026|FG000|Overall Study|Refusal to continue|3|||
142975757|NCT03371732|515446027|FG001|Overall Study|Refusal to continue|4|||
142975758|NCT00405821|515446028|FG000|Overall Study|Death|5|||
142975759|NCT00405821|515446029|FG001|Overall Study|Death|7|||
142975760|NCT00405821|515446028|FG000|Overall Study|Lost to Follow-up|7|||
142975761|NCT00405821|515446029|FG001|Overall Study|Lost to Follow-up|7|||
142975762|NCT00405821|515446028|FG000|Overall Study|Protocol Violation|1|||
142975763|NCT00405821|515446029|FG001|Overall Study|Protocol Violation|0|||
142975764|NCT00405821|515446028|FG000|Overall Study|initiated ART|9|||
142975765|NCT00405821|515446029|FG001|Overall Study|initiated ART|8|||
142975766|NCT02394795|515446032|FG000|Overall Study|Adverse Event|92|||
142975767|NCT02394795|515446033|FG001|Overall Study|Adverse Event|70|||
142975768|NCT02394795|515446032|FG000|Overall Study|Lost to Follow-up|0|||
142975769|NCT02394795|515446033|FG001|Overall Study|Lost to Follow-up|1|||
142975770|NCT02394795|515446032|FG000|Overall Study|Withdrawal by Subject|17|||
142975771|NCT02394795|515446033|FG001|Overall Study|Withdrawal by Subject|26|||
142975772|NCT02394795|515446032|FG000|Overall Study|Lack of Efficacy|181|||
142975773|NCT02394795|515446033|FG001|Overall Study|Lack of Efficacy|211|||
142975774|NCT02394795|515446032|FG000|Overall Study|Death|4|||
142975775|NCT02394795|515446033|FG001|Overall Study|Death|5|||
142975776|NCT02394795|515446032|FG000|Overall Study|Physician Decision|109|||
142975777|NCT02394795|515446033|FG001|Overall Study|Physician Decision|93|||
142975778|NCT02939599|515446040|FG000|Overall Study|Adverse Event|1|||
142975779|NCT02939599|515446041|FG001|Overall Study|Adverse Event|0|||
142975780|NCT02939599|515446040|FG000|Overall Study|Study Terminated By Sponsor|2|||
142975781|NCT02939599|515446041|FG001|Overall Study|Study Terminated By Sponsor|2|||
142975782|NCT01561560|515446052|FG000|First Two Weeks of Wear|Time/job conflict|0|||
142975783|NCT01561560|515446053|FG001|First Two Weeks of Wear|Time/job conflict|1|||
142975784|NCT01561560|515446052|FG000|First Two Weeks of Wear|Adverse Event|0|||
142975785|NCT01561560|515446053|FG001|First Two Weeks of Wear|Adverse Event|1|||
142975786|NCT01561560|515446052|FG000|Second Two Weeks of Wear|Adverse Event|0|||
142975787|NCT01561560|515446053|FG001|Second Two Weeks of Wear|Adverse Event|1|||
142975788|NCT03485222|515447583|FG000|Overall Study|Death|0|||
142975789|NCT03485222|515447584|FG001|Overall Study|Death|1|||
142975790|NCT03485222|515447583|FG000|Overall Study|Lost to Follow-up|2|||
142975791|NCT03485222|515447584|FG001|Overall Study|Lost to Follow-up|1|||
142975792|NCT00367341|515447588|FG000|Overall Study|Physician Decision|1|||
142975793|NCT00367341|515447589|FG001|Overall Study|Physician Decision|0|||
142975794|NCT00367341|515447588|FG000|Overall Study|Protocol Violation|1|||
142975795|NCT00367341|515447589|FG001|Overall Study|Protocol Violation|0|||
142975796|NCT02119026|515447592|FG000|1st-line Treatment|Adverse Event|9|||
142975797|NCT02119026|515447593|FG001|1st-line Treatment|Adverse Event|14|||
142975798|NCT02119026|515447592|FG000|1st-line Treatment|Physician Decision|3|||
142975799|NCT02119026|515447593|FG001|1st-line Treatment|Physician Decision|8|||
142975800|NCT02119026|515447592|FG000|1st-line Treatment|Withdrawal by Subject|4|||
142975801|NCT02119026|515447593|FG001|1st-line Treatment|Withdrawal by Subject|10|||
142975802|NCT02119026|515447592|FG000|1st-line Treatment|Patient condition or compliance|6|||
142975803|NCT02119026|515447593|FG001|1st-line Treatment|Patient condition or compliance|4|||
142975804|NCT02119026|515447592|FG000|1st-line Treatment|Surgery of metastases|2|||
142975805|NCT02119026|515447593|FG001|1st-line Treatment|Surgery of metastases|1|||
142975806|NCT02119026|515447592|FG000|1st-line Treatment|Death|2|||
142975807|NCT02119026|515447593|FG001|1st-line Treatment|Death|1|||
142975808|NCT02119026|515447592|FG000|2nd-line Treatment|Lost to Follow-up|2|||
142975809|NCT02119026|515447593|FG001|2nd-line Treatment|Lost to Follow-up|0|||
142975810|NCT02119026|515447592|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
142975811|NCT02119026|515447593|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
142975812|NCT02119026|515447592|FG000|2nd-line Treatment|Adverse Event|4|||
142975813|NCT02119026|515447593|FG001|2nd-line Treatment|Adverse Event|1|||
142975814|NCT01373918|515447594|FG000|Overall Study|Physician Decision|0|||
142975815|NCT01373918|515447595|FG001|Overall Study|Physician Decision|1|||
142975816|NCT00340834|515447596|FG000|Core Phase of Study|Adverse Event|26|||
142975817|NCT00340834|515447597|FG001|Core Phase of Study|Adverse Event|9|||
142975818|NCT00340834|515447598|FG002|Core Phase of Study|Adverse Event|9|||
142975819|NCT00340834|515447599|FG003|Core Phase of Study|Adverse Event|0|||
142975820|NCT00340834|515447600|FG004|Core Phase of Study|Adverse Event|0|||
142975821|NCT00340834|515447596|FG000|Core Phase of Study|Withdrawal by Subject|11|||
142975822|NCT00340834|515447597|FG001|Core Phase of Study|Withdrawal by Subject|9|||
142975823|NCT00340834|515447598|FG002|Core Phase of Study|Withdrawal by Subject|16|||
142975824|NCT00340834|515447599|FG003|Core Phase of Study|Withdrawal by Subject|0|||
142975825|NCT00340834|515447600|FG004|Core Phase of Study|Withdrawal by Subject|0|||
142975826|NCT00340834|515447596|FG000|Core Phase of Study|Administrative Problems|6|||
142975827|NCT00340834|515447597|FG001|Core Phase of Study|Administrative Problems|2|||
142975828|NCT00340834|515447598|FG002|Core Phase of Study|Administrative Problems|7|||
142975829|NCT00340834|515447599|FG003|Core Phase of Study|Administrative Problems|0|||
142975830|NCT00340834|515447600|FG004|Core Phase of Study|Administrative Problems|0|||
142975831|NCT00340834|515447596|FG000|Core Phase of Study|Lack of Efficacy|3|||
142975832|NCT00340834|515447597|FG001|Core Phase of Study|Lack of Efficacy|3|||
143455642|NCT01139580|517212498|FG001|Overall Study|Participant Randomization in Error|1|||
142975833|NCT00340834|515447598|FG002|Core Phase of Study|Lack of Efficacy|7|||
142975834|NCT00340834|515447599|FG003|Core Phase of Study|Lack of Efficacy|0|||
142975835|NCT00340834|515447600|FG004|Core Phase of Study|Lack of Efficacy|0|||
142975836|NCT00340834|515447596|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
142975837|NCT00340834|515447597|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
142975838|NCT00340834|515447598|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
142975839|NCT00340834|515447599|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
142975840|NCT00340834|515447600|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
142975841|NCT00340834|515447596|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
142975842|NCT00340834|515447597|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
142975843|NCT00340834|515447598|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
142975844|NCT00340834|515447599|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
142975845|NCT00340834|515447600|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
142975846|NCT00340834|515447596|FG000|Core Phase of Study|Lost to Follow-up|1|||
142975847|NCT00340834|515447597|FG001|Core Phase of Study|Lost to Follow-up|1|||
142975848|NCT00340834|515447598|FG002|Core Phase of Study|Lost to Follow-up|4|||
142975849|NCT00340834|515447599|FG003|Core Phase of Study|Lost to Follow-up|0|||
142975850|NCT00340834|515447600|FG004|Core Phase of Study|Lost to Follow-up|0|||
142975851|NCT00340834|515447596|FG000|Core Phase of Study|Death|2|||
142975852|NCT00340834|515447597|FG001|Core Phase of Study|Death|0|||
142975853|NCT00340834|515447598|FG002|Core Phase of Study|Death|0|||
142975854|NCT00340834|515447599|FG003|Core Phase of Study|Death|0|||
142975855|NCT00340834|515447600|FG004|Core Phase of Study|Death|0|||
142975856|NCT00340834|515447596|FG000|Core Phase of Study|Protocol Violation|0|||
142975857|NCT00340834|515447597|FG001|Core Phase of Study|Protocol Violation|0|||
142975858|NCT00340834|515447598|FG002|Core Phase of Study|Protocol Violation|2|||
142975859|NCT00340834|515447599|FG003|Core Phase of Study|Protocol Violation|0|||
142975860|NCT00340834|515447600|FG004|Core Phase of Study|Protocol Violation|0|||
142975861|NCT00340834|515447596|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
142975862|NCT00340834|515447597|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
142975863|NCT00340834|515447598|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
142975864|NCT00340834|515447599|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
142975865|NCT00340834|515447600|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
142975866|NCT00340834|515447596|FG000|Extension Phase of Study|Subject withdrew consent|26|||
142975867|NCT00340834|515447597|FG001|Extension Phase of Study|Subject withdrew consent|31|||
142975868|NCT00340834|515447598|FG002|Extension Phase of Study|Subject withdrew consent|0|||
142975869|NCT00340834|515447599|FG003|Extension Phase of Study|Subject withdrew consent|12|||
142975870|NCT00340834|515447600|FG004|Extension Phase of Study|Subject withdrew consent|15|||
142975871|NCT00340834|515447596|FG000|Extension Phase of Study|Adverse Event|21|||
142975872|NCT00340834|515447597|FG001|Extension Phase of Study|Adverse Event|22|||
142975873|NCT00340834|515447598|FG002|Extension Phase of Study|Adverse Event|0|||
142975874|NCT00340834|515447599|FG003|Extension Phase of Study|Adverse Event|19|||
142975875|NCT00340834|515447600|FG004|Extension Phase of Study|Adverse Event|7|||
142975876|NCT00340834|515447596|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
142975877|NCT00340834|515447597|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
142975878|NCT00340834|515447598|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
142975879|NCT00340834|515447599|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
142975880|NCT00340834|515447600|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
142975881|NCT00340834|515447596|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
142975882|NCT00340834|515447597|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
142975883|NCT00340834|515447598|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
142975884|NCT00340834|515447599|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
142975885|NCT00340834|515447600|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
142975886|NCT00340834|515447596|FG000|Extension Phase of Study|Lost to Follow-up|1|||
142975887|NCT00340834|515447597|FG001|Extension Phase of Study|Lost to Follow-up|1|||
142975888|NCT00340834|515447598|FG002|Extension Phase of Study|Lost to Follow-up|0|||
142975889|NCT00340834|515447599|FG003|Extension Phase of Study|Lost to Follow-up|2|||
142975890|NCT00340834|515447600|FG004|Extension Phase of Study|Lost to Follow-up|3|||
142975891|NCT00340834|515447596|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
142975892|NCT00340834|515447597|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
142975893|NCT00340834|515447598|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
142975894|NCT00340834|515447599|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
142975895|NCT00340834|515447600|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
142975896|NCT00340834|515447596|FG000|Extension Phase of Study|Administrative problems|3|||
142975897|NCT00340834|515447597|FG001|Extension Phase of Study|Administrative problems|0|||
142975898|NCT00340834|515447598|FG002|Extension Phase of Study|Administrative problems|0|||
142975899|NCT00340834|515447599|FG003|Extension Phase of Study|Administrative problems|1|||
142975900|NCT00340834|515447600|FG004|Extension Phase of Study|Administrative problems|1|||
142975901|NCT00340834|515447596|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
142975902|NCT00340834|515447597|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
142975903|NCT00340834|515447598|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
142975904|NCT00340834|515447599|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
142975905|NCT00340834|515447600|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
142975906|NCT00340834|515447596|FG000|Extension Phase of Study|Protocol Violation|3|||
142975907|NCT00340834|515447597|FG001|Extension Phase of Study|Protocol Violation|0|||
142975908|NCT00340834|515447598|FG002|Extension Phase of Study|Protocol Violation|0|||
142975909|NCT00340834|515447599|FG003|Extension Phase of Study|Protocol Violation|0|||
142975910|NCT00340834|515447600|FG004|Extension Phase of Study|Protocol Violation|0|||
142975911|NCT00340834|515447596|FG000|Extension Phase of Study|Death|0|||
142975912|NCT00340834|515447597|FG001|Extension Phase of Study|Death|0|||
142975913|NCT00340834|515447598|FG002|Extension Phase of Study|Death|0|||
142975914|NCT00340834|515447599|FG003|Extension Phase of Study|Death|0|||
142975915|NCT00340834|515447600|FG004|Extension Phase of Study|Death|1|||
142975916|NCT01532570|515447601|FG000|Overall Study|Lack of Efficacy|1|||
142975917|NCT01532570|515447602|FG001|Overall Study|Lack of Efficacy|0|||
142975918|NCT01532570|515447603|FG002|Overall Study|Lack of Efficacy|0|||
142975919|NCT01532570|515447604|FG003|Overall Study|Lack of Efficacy|0|||
142975920|NCT01532570|515447601|FG000|Overall Study|Withdrawal by Subject|0|||
142975921|NCT01532570|515447602|FG001|Overall Study|Withdrawal by Subject|1|||
142975922|NCT01532570|515447603|FG002|Overall Study|Withdrawal by Subject|0|||
142975923|NCT01532570|515447604|FG003|Overall Study|Withdrawal by Subject|0|||
142975924|NCT02137837|515447605|FG000|Overall Study|Adverse Event|0|||
142975925|NCT02137837|515447606|FG001|Overall Study|Adverse Event|2|||
142975926|NCT02137837|515447607|FG002|Overall Study|Adverse Event|1|||
142975927|NCT02137837|515447605|FG000|Overall Study|Refusal unrelated to adverse event|2|||
142975928|NCT02137837|515447606|FG001|Overall Study|Refusal unrelated to adverse event|2|||
142975929|NCT02137837|515447607|FG002|Overall Study|Refusal unrelated to adverse event|1|||
142975930|NCT02137837|515447605|FG000|Overall Study|Progression/relapse|9|||
142975931|NCT02137837|515447606|FG001|Overall Study|Progression/relapse|7|||
142975932|NCT02137837|515447607|FG002|Overall Study|Progression/relapse|7|||
142975933|NCT02137837|515447605|FG000|Overall Study|Not protocol specified|2|||
142975934|NCT02137837|515447606|FG001|Overall Study|Not protocol specified|1|||
142975935|NCT02137837|515447607|FG002|Overall Study|Not protocol specified|3|||
142975936|NCT01329341|515447610|FG000|Overall Study|Withdrawal by Subject|44|||
142975937|NCT03017846|515447611|FG000|Overall Study|Lost to Follow-up|3|||
142975938|NCT03017846|515447611|FG000|Overall Study|Adverse Event|2|||
142975939|NCT04603391|515447613|FG000|First Intervention (4 Days)|Adverse Event|1|||
142975940|NCT04603391|515447614|FG001|First Intervention (4 Days)|Adverse Event|0|||
142975941|NCT04603391|515447613|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
142975942|NCT04603391|515447614|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
142975943|NCT02759861|515447615|FG000|Overall Study|Death|1|||
142975944|NCT00618995|515447616|FG000|Period 1|Adverse Event|0|||
142975945|NCT00618995|515447617|FG001|Period 1|Adverse Event|0|||
142975946|NCT00618995|515447618|FG002|Period 1|Adverse Event|1|||
142975947|NCT00618995|515447619|FG003|Period 1|Adverse Event|0|||
142975948|NCT00618995|515447616|FG000|Period 1|Protocol Violation|0|||
142975949|NCT00618995|515447617|FG001|Period 1|Protocol Violation|1|||
142975950|NCT00618995|515447618|FG002|Period 1|Protocol Violation|1|||
142975951|NCT00618995|515447619|FG003|Period 1|Protocol Violation|0|||
142975952|NCT00618995|515447616|FG000|Period 2|Protocol Violation|0|||
142975953|NCT00618995|515447617|FG001|Period 2|Protocol Violation|0|||
142975954|NCT00618995|515447618|FG002|Period 2|Protocol Violation|1|||
142975955|NCT00618995|515447619|FG003|Period 2|Protocol Violation|0|||
142975956|NCT00618995|515447616|FG000|Period 4|Adverse Event|1|||
142975957|NCT00618995|515447617|FG001|Period 4|Adverse Event|0|||
142975958|NCT00618995|515447618|FG002|Period 4|Adverse Event|0|||
142975959|NCT00618995|515447619|FG003|Period 4|Adverse Event|0|||
142975960|NCT02988219|515447622|FG000|Overall Study|Lack of Efficacy|1|||
142975961|NCT02988219|515447623|FG001|Overall Study|Lack of Efficacy|1|||
142975962|NCT02988219|515447622|FG000|Overall Study|Withdrawal by Subject|0|||
142975963|NCT02988219|515447623|FG001|Overall Study|Withdrawal by Subject|2|||
142975964|NCT01306032|515447624|FG000|First Intervention|Adverse Event|1|||
142975965|NCT01306032|515447625|FG001|First Intervention|Adverse Event|0|||
142975966|NCT01306032|515447626|FG002|First Intervention|Adverse Event|1|||
142975967|NCT01306032|515447627|FG003|First Intervention|Adverse Event|0|||
142975968|NCT01306032|515447628|FG004|First Intervention|Adverse Event|0|||
142975969|NCT01306032|515447629|FG005|First Intervention|Adverse Event|1|||
142975970|NCT01306032|515447624|FG000|First Intervention|Withdrawal by Subject|0|||
142975971|NCT01306032|515447625|FG001|First Intervention|Withdrawal by Subject|2|||
142975972|NCT01306032|515447626|FG002|First Intervention|Withdrawal by Subject|0|||
142975973|NCT01306032|515447627|FG003|First Intervention|Withdrawal by Subject|1|||
142975974|NCT01306032|515447628|FG004|First Intervention|Withdrawal by Subject|0|||
142975975|NCT01306032|515447629|FG005|First Intervention|Withdrawal by Subject|0|||
142975976|NCT01306032|515447624|FG000|First Intervention|Death|0|||
142975977|NCT01306032|515447625|FG001|First Intervention|Death|0|||
142975978|NCT01306032|515447626|FG002|First Intervention|Death|1|||
142975979|NCT01306032|515447627|FG003|First Intervention|Death|0|||
142975980|NCT01306032|515447628|FG004|First Intervention|Death|0|||
142975981|NCT01306032|515447629|FG005|First Intervention|Death|0|||
142975982|NCT01306032|515447624|FG000|First Intervention|Ineligible|0|||
142975983|NCT01306032|515447625|FG001|First Intervention|Ineligible|0|||
142975984|NCT01306032|515447626|FG002|First Intervention|Ineligible|0|||
142975985|NCT01306032|515447627|FG003|First Intervention|Ineligible|0|||
142975986|NCT01306032|515447628|FG004|First Intervention|Ineligible|0|||
142975987|NCT01306032|515447629|FG005|First Intervention|Ineligible|1|||
142975988|NCT01306032|515447624|FG000|First Intervention|Progressive disease|0|||
142975989|NCT01306032|515447625|FG001|First Intervention|Progressive disease|0|||
142975990|NCT01306032|515447626|FG002|First Intervention|Progressive disease|0|||
142975991|NCT01306032|515447627|FG003|First Intervention|Progressive disease|0|||
142975992|NCT01306032|515447628|FG004|First Intervention|Progressive disease|2|||
142975993|NCT01306032|515447629|FG005|First Intervention|Progressive disease|0|||
142975994|NCT01306032|515447624|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
142975995|NCT01306032|515447625|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
142975996|NCT01306032|515447626|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
142975997|NCT01306032|515447627|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
142975998|NCT01306032|515447628|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
142975999|NCT01306032|515447629|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
142976000|NCT01306032|515447624|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
142976001|NCT01306032|515447625|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
142976002|NCT01306032|515447626|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
142976003|NCT01306032|515447627|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
142976004|NCT01306032|515447628|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
142976005|NCT01306032|515447629|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
142976006|NCT01213264|515447630|FG000|Overall Study|Adverse Event|1|||
142976007|NCT01213264|515447631|FG001|Overall Study|Adverse Event|0|||
142976008|NCT01213264|515447632|FG002|Overall Study|Adverse Event|0|||
142976009|NCT01213264|515447630|FG000|Overall Study|Lost to Follow-up|1|||
142976010|NCT01213264|515447631|FG001|Overall Study|Lost to Follow-up|2|||
142976011|NCT01213264|515447632|FG002|Overall Study|Lost to Follow-up|6|||
142976012|NCT01522443|515447634|FG000|Overall Study|No longer receiving clinical benefit|36|||
142976013|NCT01522443|515447635|FG001|Overall Study|No longer receiving clinical benefit|28|||
142976014|NCT01522443|515447634|FG000|Overall Study|Adverse Event|10|||
142976015|NCT01522443|515447635|FG001|Overall Study|Adverse Event|15|||
142976016|NCT01522443|515447634|FG000|Overall Study|Withdrawal by Subject|5|||
142976017|NCT01522443|515447635|FG001|Overall Study|Withdrawal by Subject|8|||
142976018|NCT01522443|515447634|FG000|Overall Study|No study treatment given|1|||
142976019|NCT01522443|515447635|FG001|Overall Study|No study treatment given|1|||
142976020|NCT01522443|515447634|FG000|Overall Study|Other|1|||
142976021|NCT01522443|515447635|FG001|Overall Study|Other|3|||
142976022|NCT02378883|515447636|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
142976023|NCT02378883|515447636|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
142976024|NCT02378883|515447636|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
142976025|NCT02378883|515447636|FG000|30 Day Follow-Up|Physician Decision|2|||
142976026|NCT02378883|515447636|FG000|30 Day Follow-Up|Missed Visit|2|||
142976027|NCT02378883|515447636|FG000|30 Day Follow-Up|Death|1|||
142976028|NCT02378883|515447636|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
142976029|NCT02378883|515447636|FG000|12 Months Follow-Up|Death|2|||
142976030|NCT00691093|515447637|FG000|Overall Study|Adverse Event|1|||
142976031|NCT00691093|515447637|FG000|Overall Study|Lost to Follow-up|1|||
142976032|NCT00691093|515447637|FG000|Overall Study|Lack of Efficacy|1|||
142976033|NCT00691093|515447637|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
142976034|NCT01588353|515447639|FG000|Step2|Withdrawal by Subject|0|||
142976035|NCT01588353|515447640|FG001|Step2|Withdrawal by Subject|1|||
142976036|NCT01588353|515447641|FG002|Step2|Withdrawal by Subject|0|||
142976037|NCT01588353|515447639|FG000|Step3|Adverse Event|0|||
142976038|NCT01588353|515447640|FG001|Step3|Adverse Event|0|||
142976039|NCT01588353|515447641|FG002|Step3|Adverse Event|2|||
142976040|NCT03814005|515447644|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
142976041|NCT03814005|515447645|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
142976042|NCT03814005|515447646|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
142976043|NCT03814005|515447644|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
142976044|NCT03814005|515447645|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
142976045|NCT03814005|515447646|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
142976046|NCT03814005|515447644|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
142976047|NCT03814005|515447645|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
142976048|NCT03814005|515447646|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
142976049|NCT03814005|515447644|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
142976050|NCT03814005|515447645|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
142976051|NCT03814005|515447646|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
142976052|NCT03814005|515447644|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
142976053|NCT03814005|515447645|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
142976054|NCT03814005|515447646|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
142976055|NCT03814005|515447644|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
142976056|NCT03814005|515447645|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
142976057|NCT03814005|515447646|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
142976058|NCT00810810|515447647|FG000|Overall Study|Withdrawal by Subject|0|||
142976059|NCT00810810|515447648|FG001|Overall Study|Withdrawal by Subject|8|||
142976060|NCT00810810|515447649|FG002|Overall Study|Withdrawal by Subject|10|||
142976061|NCT00810810|515447650|FG003|Overall Study|Withdrawal by Subject|8|||
142976062|NCT00810810|515447647|FG000|Overall Study|Physician Decision|0|||
142976063|NCT00810810|515447648|FG001|Overall Study|Physician Decision|3|||
142976064|NCT00810810|515447649|FG002|Overall Study|Physician Decision|1|||
142976065|NCT00810810|515447650|FG003|Overall Study|Physician Decision|5|||
142976066|NCT01896856|515447651|FG000|Overall Study|Transportation issues / Non-compliance|0|||
142976067|NCT01896856|515447652|FG001|Overall Study|Transportation issues / Non-compliance|0|||
142976068|NCT01896856|515447653|FG002|Overall Study|Transportation issues / Non-compliance|1|||
142976069|NCT01896856|515447654|FG003|Overall Study|Transportation issues / Non-compliance|0|||
142976070|NCT01896856|515447655|FG004|Overall Study|Transportation issues / Non-compliance|0|||
142976071|NCT01896856|515447656|FG005|Overall Study|Transportation issues / Non-compliance|0|||
142976072|NCT02563925|515447659|FG000|Overall Study|Withdrawal by Subject|2|||
142976073|NCT01700985|515447660|FG000|Overall Study|Incarcerated|0|||
142976074|NCT01700985|515447661|FG001|Overall Study|Incarcerated|1|||
142976075|NCT01135017|515447662|FG000|Overall Study|Adverse Event|3|||
142976076|NCT01135017|515447663|FG001|Overall Study|Adverse Event|8|||
142976077|NCT01135017|515447662|FG000|Overall Study|Other than above|3|||
142976078|NCT01135017|515447663|FG001|Overall Study|Other than above|4|||
142976079|NCT00050622|515447664|FG000|Overall Study|Adverse Event|1|||
142976080|NCT00936117|515447667|FG000|Overall Study|Adverse Event|7|||
142976081|NCT00936117|515447667|FG000|Overall Study|Unable to continue oral medication|3|||
142976082|NCT04581863|515447668|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
142976083|NCT04581863|515447669|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
142976084|NCT01170221|515447673|FG000|Overall Study|Lost to Follow-up|22|||
142976085|NCT01170221|515447674|FG001|Overall Study|Lost to Follow-up|21|||
142976086|NCT01170221|515447673|FG000|Overall Study|Withdrawal by Subject|9|||
142976087|NCT01170221|515447674|FG001|Overall Study|Withdrawal by Subject|7|||
142976088|NCT01170221|515447673|FG000|Overall Study|Subject completed only screening and LFU|1|||
142976089|NCT01170221|515447674|FG001|Overall Study|Subject completed only screening and LFU|0|||
143117172|NCT00501059|515970058|FG000|Overall Study|Protocol Violation|80|||
143117173|NCT00501059|515970059|FG001|Overall Study|Protocol Violation|69|||
143117174|NCT00501059|515970058|FG000|Overall Study|Death|140|||
143117175|NCT00501059|515970059|FG001|Overall Study|Death|137|||
143117176|NCT00501059|515970058|FG000|Overall Study|Other|236|||
143117177|NCT00501059|515970059|FG001|Overall Study|Other|239|||
143117178|NCT00501059|515970058|FG000|Overall Study|Missing end-of-study page|91|||
143117179|NCT00501059|515970059|FG001|Overall Study|Missing end-of-study page|92|||
143117180|NCT00501059|515970058|FG000|Overall Study|Clinical endpoint reached|110|||
143117181|NCT00501059|515970059|FG001|Overall Study|Clinical endpoint reached|123|||
143117182|NCT00501059|515970058|FG000|Overall Study|Insufficient therapeutic effect|4|||
143117183|NCT00501059|515970059|FG001|Overall Study|Insufficient therapeutic effect|5|||
143117184|NCT00501059|515970058|FG000|Overall Study|Consent withdrawn by subject|817|||
143117185|NCT00501059|515970059|FG001|Overall Study|Consent withdrawn by subject|873|||
143117186|NCT00501059|515970058|FG000|Overall Study|Non-compliant with study treatment|23|||
143117187|NCT00501059|515970059|FG001|Overall Study|Non-compliant with study treatment|16|||
143117188|NCT00501059|515970058|FG000|Overall Study|Reason not given|3|||
143117189|NCT00501059|515970059|FG001|Overall Study|Reason not given|1|||
143117190|NCT00501059|515970058|FG000|Overall Study|Adverse Event|129|||
143117191|NCT00501059|515970059|FG001|Overall Study|Adverse Event|122|||
143117192|NCT00501059|515970058|FG000|Overall Study|Lost to Follow-up|210|||
143117193|NCT00501059|515970059|FG001|Overall Study|Lost to Follow-up|198|||
143117194|NCT00501059|515970058|FG000|Overall Study|Not treated|25|||
143117195|NCT00501059|515970059|FG001|Overall Study|Not treated|17|||
143117196|NCT00157248|515970062|FG000|Overall Study|Adverse Event|36|||
143117197|NCT00157248|515970063|FG001|Overall Study|Adverse Event|25|||
143117198|NCT00157248|515970064|FG002|Overall Study|Adverse Event|13|||
143117199|NCT00157248|515970065|FG003|Overall Study|Adverse Event|33|||
143117200|NCT00157248|515970062|FG000|Overall Study|Protocol Violation|4|||
143117201|NCT00157248|515970063|FG001|Overall Study|Protocol Violation|0|||
143117202|NCT00157248|515970064|FG002|Overall Study|Protocol Violation|2|||
143117203|NCT00157248|515970065|FG003|Overall Study|Protocol Violation|2|||
143117204|NCT00157248|515970062|FG000|Overall Study|Lost to Follow-up|0|||
143117205|NCT00157248|515970063|FG001|Overall Study|Lost to Follow-up|1|||
143117206|NCT00157248|515970064|FG002|Overall Study|Lost to Follow-up|0|||
143117207|NCT00157248|515970065|FG003|Overall Study|Lost to Follow-up|0|||
143117208|NCT00157248|515970062|FG000|Overall Study|Withdrawal by Subject|1|||
143117209|NCT00157248|515970063|FG001|Overall Study|Withdrawal by Subject|4|||
143117210|NCT00157248|515970064|FG002|Overall Study|Withdrawal by Subject|3|||
143117211|NCT00157248|515970065|FG003|Overall Study|Withdrawal by Subject|3|||
143117212|NCT00157248|515970062|FG000|Overall Study|site closures, subject moving|7|||
143117213|NCT00157248|515970063|FG001|Overall Study|site closures, subject moving|7|||
143117214|NCT00157248|515970064|FG002|Overall Study|site closures, subject moving|3|||
143117215|NCT00157248|515970065|FG003|Overall Study|site closures, subject moving|9|||
143117216|NCT01447927|515970066|FG000|Overall Study|Adverse Event|4|||
143117217|NCT01447927|515970067|FG001|Overall Study|Adverse Event|3|||
143117218|NCT01447927|515970066|FG000|Overall Study|Withdrawal by Subject|1|||
142976090|NCT01170221|515447673|FG000|Overall Study|Randomized but not treated|1|||
142976091|NCT01170221|515447674|FG001|Overall Study|Randomized but not treated|0|||
142976092|NCT02693691|515447675|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
142976093|NCT02693691|515447675|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
142976094|NCT02693691|515447675|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
142976095|NCT02693691|515447675|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
142976096|NCT02693691|515447675|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
142976097|NCT02693691|515447675|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
142976098|NCT02693691|515447675|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
142976099|NCT00050960|515447679|FG000|Overall Study|Progressive Disease|137|||
142976100|NCT00050960|515447680|FG001|Overall Study|Progressive Disease|93|||
142976101|NCT00050960|515447679|FG000|Overall Study|Stable Disease|19|||
142976102|NCT00050960|515447680|FG001|Overall Study|Stable Disease|48|||
142976103|NCT00050960|515447679|FG000|Overall Study|Partial Response|14|||
142976104|NCT00050960|515447680|FG001|Overall Study|Partial Response|19|||
142976105|NCT00050960|515447679|FG000|Overall Study|Complete Response|0|||
142976106|NCT00050960|515447680|FG001|Overall Study|Complete Response|2|||
142976107|NCT00050960|515447679|FG000|Overall Study|Adverse Event|62|||
142976108|NCT00050960|515447680|FG001|Overall Study|Adverse Event|61|||
142976109|NCT00050960|515447679|FG000|Overall Study|Lost to Follow-up|0|||
142976110|NCT00050960|515447680|FG001|Overall Study|Lost to Follow-up|1|||
142976111|NCT00050960|515447679|FG000|Overall Study|Withdrawal by Subject|23|||
142976112|NCT00050960|515447680|FG001|Overall Study|Withdrawal by Subject|18|||
142976113|NCT00050960|515447679|FG000|Overall Study|Administrative|31|||
142976114|NCT00050960|515447680|FG001|Overall Study|Administrative|46|||
142976115|NCT00050960|515447679|FG000|Overall Study|Non-compliance|3|||
142976116|NCT00050960|515447680|FG001|Overall Study|Non-compliance|1|||
142976117|NCT00050960|515447679|FG000|Overall Study|Death|13|||
142976118|NCT00050960|515447680|FG001|Overall Study|Death|15|||
142976119|NCT02727660|515447681|FG000|Overall Study|Lack of Efficacy|40|||
142976120|NCT02727660|515447682|FG001|Overall Study|Lack of Efficacy|40|||
142976121|NCT02727660|515447683|FG002|Overall Study|Lack of Efficacy|70|||
142976122|NCT02727660|515447681|FG000|Overall Study|Adverse Event|28|||
142976123|NCT02727660|515447682|FG001|Overall Study|Adverse Event|21|||
142976124|NCT02727660|515447683|FG002|Overall Study|Adverse Event|32|||
142976125|NCT02727660|515447681|FG000|Overall Study|Withdrawal by Subject|26|||
142976126|NCT02727660|515447682|FG001|Overall Study|Withdrawal by Subject|25|||
142976127|NCT02727660|515447683|FG002|Overall Study|Withdrawal by Subject|30|||
142976128|NCT02727660|515447681|FG000|Overall Study|Physician Decision|3|||
142976129|NCT02727660|515447682|FG001|Overall Study|Physician Decision|8|||
142976130|NCT02727660|515447683|FG002|Overall Study|Physician Decision|14|||
142976131|NCT02727660|515447681|FG000|Overall Study|Lost to Follow-up|5|||
142976132|NCT02727660|515447682|FG001|Overall Study|Lost to Follow-up|9|||
142976133|NCT02727660|515447683|FG002|Overall Study|Lost to Follow-up|8|||
142976134|NCT02727660|515447681|FG000|Overall Study|Protocol Violation|7|||
142976135|NCT02727660|515447682|FG001|Overall Study|Protocol Violation|5|||
142976136|NCT02727660|515447683|FG002|Overall Study|Protocol Violation|5|||
142976137|NCT02727660|515447681|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
142976138|NCT02727660|515447682|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
142976139|NCT02727660|515447683|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
142976140|NCT02727660|515447681|FG000|Overall Study|Administrative Reasons|2|||
142976141|NCT02727660|515447682|FG001|Overall Study|Administrative Reasons|3|||
142976142|NCT02727660|515447683|FG002|Overall Study|Administrative Reasons|4|||
142976143|NCT00105560|515447684|FG000|Overall Study|Lost to Follow-up|1|||
142976144|NCT00764946|515447685|FG000|Overall Study|Lack of Efficacy|1|||
142976145|NCT00764946|515447686|FG001|Overall Study|Lack of Efficacy|0|||
142976146|NCT00764946|515447687|FG002|Overall Study|Lack of Efficacy|0|||
142976147|NCT00764946|515447685|FG000|Overall Study|Lost to Follow-up|3|||
142976148|NCT00764946|515447686|FG001|Overall Study|Lost to Follow-up|4|||
142976149|NCT00764946|515447687|FG002|Overall Study|Lost to Follow-up|0|||
142976150|NCT00764946|515447685|FG000|Overall Study|Physician Decision|2|||
142976151|NCT00764946|515447686|FG001|Overall Study|Physician Decision|4|||
142976152|NCT00764946|515447687|FG002|Overall Study|Physician Decision|0|||
142976153|NCT00764946|515447685|FG000|Overall Study|Adverse Event|3|||
142976154|NCT00764946|515447686|FG001|Overall Study|Adverse Event|2|||
142976155|NCT00764946|515447687|FG002|Overall Study|Adverse Event|1|||
142976156|NCT00764946|515447685|FG000|Overall Study|Withdrawal by Subject|3|||
142976157|NCT00764946|515447686|FG001|Overall Study|Withdrawal by Subject|6|||
142976158|NCT00764946|515447687|FG002|Overall Study|Withdrawal by Subject|2|||
142976159|NCT00764946|515447685|FG000|Overall Study|Never Treated|1|||
142976160|NCT00764946|515447686|FG001|Overall Study|Never Treated|1|||
142976161|NCT00764946|515447687|FG002|Overall Study|Never Treated|1|||
142976162|NCT01162304|515447688|FG000|Overall Study|Beck scale to high|11|||
142976163|NCT03699631|515447689|FG000|Overall Study|Adverse Event|3|||
142976164|NCT03695393|515447692|FG000|Overall Study|Death|3|||
142976165|NCT03695393|515447693|FG001|Overall Study|Death|1|||
142976166|NCT03695393|515447692|FG000|Overall Study|Lost to Follow-up|0|||
142976167|NCT03695393|515447693|FG001|Overall Study|Lost to Follow-up|1|||
142976168|NCT00673894|515447696|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
142976169|NCT00673894|515447697|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
142976170|NCT00673894|515447696|FG000|First Intervention 4 Weeks|Adverse Event|1|||
142976171|NCT00673894|515447697|FG001|First Intervention 4 Weeks|Adverse Event|0|||
142976172|NCT01033487|515447698|FG000|Fourth Intervention Period|Adverse Event|0|||
142976173|NCT01033487|515447699|FG001|Fourth Intervention Period|Adverse Event|0|||
142976174|NCT01033487|515447700|FG002|Fourth Intervention Period|Adverse Event|0|||
142976175|NCT01033487|515447701|FG003|Fourth Intervention Period|Adverse Event|0|||
142976176|NCT01033487|515447702|FG004|Fourth Intervention Period|Adverse Event|0|||
142976177|NCT01033487|515447703|FG005|Fourth Intervention Period|Adverse Event|0|||
142976178|NCT01033487|515447704|FG006|Fourth Intervention Period|Adverse Event|0|||
142976179|NCT01033487|515447705|FG007|Fourth Intervention Period|Adverse Event|0|||
142976180|NCT01033487|515447706|FG008|Fourth Intervention Period|Adverse Event|1|||
142976181|NCT01033487|515447707|FG009|Fourth Intervention Period|Adverse Event|0|||
142976182|NCT02133742|515447720|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
142976183|NCT02133742|515447720|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
142976184|NCT02133742|515447720|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
142976185|NCT02133742|515447720|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
142976186|NCT02133742|515447720|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
142976187|NCT03479216|515447721|FG000|Overall Study|Withdrawal by Subject|3|||
142976188|NCT03479216|515447722|FG001|Overall Study|Withdrawal by Subject|2|||
142976189|NCT03479216|515447721|FG000|Overall Study|Physician Decision|2|||
142976190|NCT03479216|515447722|FG001|Overall Study|Physician Decision|3|||
142976191|NCT02031432|515447723|FG000|Overall Study|Protocol Violation|1|||
142976192|NCT02031432|515447723|FG000|Overall Study|Lack of Efficacy|5|||
142976193|NCT02031432|515447723|FG000|Overall Study|Cancer Progression|2|||
142976194|NCT02031432|515447723|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
142976195|NCT02031432|515447723|FG000|Overall Study|Adverse Event|8|||
142976196|NCT02031432|515447723|FG000|Overall Study|Withdrawal by Subject|5|||
142976197|NCT02031432|515447723|FG000|Overall Study|Lost to Follow-up|1|||
142976198|NCT02031432|515447723|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
142976199|NCT02031432|515447723|FG000|Overall Study|Death|10|||
142976200|NCT01181778|515447724|FG000|Overall Study|Physician Decision|48|||
142976201|NCT02148211|515447725|FG000|Overall Study|Lost to Follow-up|352|||
142976202|NCT02726113|515447726|FG000|Total Enrollment|Physician Decision|0|||
142976203|NCT02726113|515447727|FG001|Total Enrollment|Physician Decision|1|||
142976204|NCT02726113|515447726|FG000|Total Enrollment|Protocol Violation|1|||
142976205|NCT02726113|515447727|FG001|Total Enrollment|Protocol Violation|0|||
142976206|NCT02726113|515447726|FG000|Total Enrollment|Withdrawal by Subject|2|||
142976207|NCT02726113|515447727|FG001|Total Enrollment|Withdrawal by Subject|1|||
142976208|NCT02726113|515447726|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
142976209|NCT02726113|515447727|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
142976210|NCT02726113|515447726|FG000|Genomic Analysis|Protocol Violation|1|||
142976211|NCT02726113|515447727|FG001|Genomic Analysis|Protocol Violation|0|||
142976212|NCT02726113|515447726|FG000|Genomic Analysis|Withdrawal by Subject|2|||
142976213|NCT02726113|515447727|FG001|Genomic Analysis|Withdrawal by Subject|1|||
142976214|NCT02726113|515447726|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
142976215|NCT02726113|515447727|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
142976216|NCT01617187|515447730|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
142976217|NCT01617187|515447731|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
142976218|NCT01617187|515447732|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
142976219|NCT01617187|515447733|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
142976220|NCT01617187|515447730|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
142976221|NCT01617187|515447731|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
142976222|NCT01617187|515447732|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
142976223|NCT01617187|515447733|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
142976224|NCT01617187|515447730|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
142976225|NCT01617187|515447731|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
142976226|NCT01617187|515447732|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
142976227|NCT01617187|515447733|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
142976228|NCT01617187|515447730|FG000|Treatment Through Study Completion|Adverse Event|1|||
142976229|NCT01617187|515447731|FG001|Treatment Through Study Completion|Adverse Event|1|||
142976230|NCT01617187|515447732|FG002|Treatment Through Study Completion|Adverse Event|0|||
142976231|NCT01617187|515447733|FG003|Treatment Through Study Completion|Adverse Event|1|||
142976232|NCT01617187|515447730|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
142976233|NCT01617187|515447731|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
142976234|NCT01617187|515447732|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
142976235|NCT01617187|515447733|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
142976236|NCT01617187|515447730|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
142976237|NCT01617187|515447731|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
142976238|NCT01617187|515447732|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
142976239|NCT01617187|515447733|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
142976240|NCT01617187|515447730|FG000|Treatment Through Study Completion|Protocol Violation|1|||
142976241|NCT01617187|515447731|FG001|Treatment Through Study Completion|Protocol Violation|0|||
142976242|NCT01617187|515447732|FG002|Treatment Through Study Completion|Protocol Violation|0|||
142976243|NCT01617187|515447733|FG003|Treatment Through Study Completion|Protocol Violation|1|||
142976244|NCT03862131|515447734|FG000|Overall Study|Lost to Follow-up|1|||
142976245|NCT03862131|515447735|FG001|Overall Study|Lost to Follow-up|0|||
142976246|NCT03862131|515447736|FG002|Overall Study|Lost to Follow-up|1|||
142976247|NCT03862131|515447734|FG000|Overall Study|Determined to be ineligible|0|||
142976248|NCT03862131|515447735|FG001|Overall Study|Determined to be ineligible|0|||
142976249|NCT03862131|515447736|FG002|Overall Study|Determined to be ineligible|5|||
142976250|NCT03862131|515447734|FG000|Overall Study|Death|4|||
142976251|NCT03862131|515447735|FG001|Overall Study|Death|4|||
142976252|NCT03862131|515447736|FG002|Overall Study|Death|0|||
142976253|NCT03862131|515447734|FG000|Overall Study|Withdrawal by Subject|5|||
142976254|NCT03862131|515447735|FG001|Overall Study|Withdrawal by Subject|3|||
142976255|NCT03862131|515447736|FG002|Overall Study|Withdrawal by Subject|0|||
142976256|NCT03862131|515447734|FG000|Overall Study|Physician Decision|0|||
142976257|NCT03862131|515447735|FG001|Overall Study|Physician Decision|1|||
142976258|NCT03862131|515447736|FG002|Overall Study|Physician Decision|0|||
142976259|NCT00728936|515449684|FG000|Overall Study|Withdrawal by Subject|0|||
142976260|NCT00728936|515449685|FG001|Overall Study|Withdrawal by Subject|0|||
142976261|NCT00728936|515449686|FG002|Overall Study|Withdrawal by Subject|0|||
142976262|NCT00728936|515449687|FG003|Overall Study|Withdrawal by Subject|0|||
142976263|NCT00728936|515449688|FG004|Overall Study|Withdrawal by Subject|0|||
142976264|NCT00728936|515449689|FG005|Overall Study|Withdrawal by Subject|1|||
142976265|NCT00728936|515449690|FG006|Overall Study|Withdrawal by Subject|0|||
142976266|NCT02905825|515449695|FG000|Overall Study|Protocol Violation|11|||
142976267|NCT02905825|515449695|FG000|Overall Study|Device Malfunction|1|||
142976268|NCT01281189|515449696|FG000|Overall Study|Adverse Event|7|||
142976269|NCT01281189|515449697|FG001|Overall Study|Adverse Event|9|||
142976270|NCT01281189|515449696|FG000|Overall Study|Lost to Follow-up|6|||
142976271|NCT01281189|515449697|FG001|Overall Study|Lost to Follow-up|4|||
142976272|NCT01281189|515449696|FG000|Overall Study|Withdrawal by Subject|21|||
142976273|NCT01281189|515449697|FG001|Overall Study|Withdrawal by Subject|24|||
142976274|NCT01281189|515449696|FG000|Overall Study|Physician Decision|2|||
142976275|NCT01281189|515449697|FG001|Overall Study|Physician Decision|3|||
142976276|NCT01281189|515449696|FG000|Overall Study|Death|103|||
142976277|NCT01281189|515449697|FG001|Overall Study|Death|91|||
142976278|NCT01281189|515449696|FG000|Overall Study|Other|8|||
142976279|NCT01281189|515449697|FG001|Overall Study|Other|12|||
142976280|NCT05355818|515449698|FG000|Overall Study|Adverse Event|1|||
142976281|NCT05355818|515449699|FG001|Overall Study|Adverse Event|1|||
142976282|NCT05355818|515449698|FG000|Overall Study|Lack of Efficacy|2|||
142976283|NCT05355818|515449699|FG001|Overall Study|Lack of Efficacy|1|||
142976284|NCT05355818|515449698|FG000|Overall Study|Lost to Follow-up|0|||
142976285|NCT05355818|515449699|FG001|Overall Study|Lost to Follow-up|1|||
142976286|NCT01136746|515449700|FG000|Overall Study|Lost to Follow-up|0|||
142976287|NCT01136746|515449701|FG001|Overall Study|Lost to Follow-up|2|||
142976288|NCT01136746|515449700|FG000|Overall Study|Protocol Violation|2|||
142976289|NCT01136746|515449701|FG001|Overall Study|Protocol Violation|1|||
142976290|NCT01136746|515449700|FG000|Overall Study|Death|1|||
142976291|NCT01136746|515449701|FG001|Overall Study|Death|0|||
142976292|NCT01175590|515449702|FG000|Overall Study|Lost to Follow-up|1|||
142976293|NCT01175590|515449703|FG001|Overall Study|Lost to Follow-up|0|||
142976294|NCT01175590|515449702|FG000|Overall Study|Withdrawal by Subject|0|||
142976295|NCT01175590|515449703|FG001|Overall Study|Withdrawal by Subject|2|||
142976296|NCT01175590|515449702|FG000|Overall Study|Adverse Event|4|||
142976297|NCT01175590|515449703|FG001|Overall Study|Adverse Event|0|||
142976298|NCT01175590|515449702|FG000|Overall Study|Physician Decision|1|||
142976299|NCT01175590|515449703|FG001|Overall Study|Physician Decision|4|||
142976300|NCT01175590|515449702|FG000|Overall Study|Lack of Efficacy|1|||
142976301|NCT01175590|515449703|FG001|Overall Study|Lack of Efficacy|1|||
142976302|NCT01175590|515449702|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
142976303|NCT01175590|515449703|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
142976304|NCT01175590|515449702|FG000|Overall Study|Treated not as randomized|3|||
142976305|NCT01175590|515449703|FG001|Overall Study|Treated not as randomized|2|||
142976306|NCT01175590|515449702|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
142976307|NCT01175590|515449703|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
142976308|NCT01175590|515449702|FG000|Overall Study|Protocol Violation|0|||
142976309|NCT01175590|515449703|FG001|Overall Study|Protocol Violation|1|||
142976310|NCT03518034|515449711|FG000|Overall Study|Not Treated|5|||
142976311|NCT03518034|515449712|FG001|Overall Study|Not Treated|1|||
142976312|NCT03518034|515449711|FG000|Overall Study|Withdrawal by Subject|309|||
142976313|NCT03518034|515449712|FG001|Overall Study|Withdrawal by Subject|351|||
142976314|NCT03518034|515449711|FG000|Overall Study|Lost to Follow-up|446|||
142976315|NCT03518034|515449712|FG001|Overall Study|Lost to Follow-up|458|||
142976316|NCT03518034|515449711|FG000|Overall Study|Adverse Event|138|||
142976317|NCT03518034|515449712|FG001|Overall Study|Adverse Event|130|||
142976318|NCT03518034|515449711|FG000|Overall Study|Lack of Efficacy|11|||
142976319|NCT03518034|515449712|FG001|Overall Study|Lack of Efficacy|23|||
142976320|NCT03518034|515449711|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
142976321|NCT03518034|515449712|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
142976322|NCT03518034|515449711|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
142976323|NCT03518034|515449712|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
142976324|NCT03518034|515449711|FG000|Overall Study|Other, Not Specified|84|||
142976325|NCT03518034|515449712|FG001|Overall Study|Other, Not Specified|53|||
142976326|NCT03518034|515449711|FG000|Overall Study|Reason Missing|2|||
142976327|NCT03518034|515449712|FG001|Overall Study|Reason Missing|3|||
142976328|NCT00010803|515449718|FG000|Overall Study|Withdrawal by Subject|97|||
142976329|NCT00010803|515449719|FG001|Overall Study|Withdrawal by Subject|98|||
142976330|NCT01019252|515449720|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
142976331|NCT01019252|515449721|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
142976332|NCT01019252|515449720|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
142976333|NCT01019252|515449721|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
142976334|NCT01019252|515449720|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
142976335|NCT01019252|515449721|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
142976336|NCT01019252|515449720|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
142976337|NCT01019252|515449721|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
142976338|NCT04671342|515449722|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
142976339|NCT04671342|515449722|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
142976340|NCT04671342|515449722|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
142976341|NCT04671342|515449722|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
142976342|NCT04671342|515449722|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
142976343|NCT04671342|515449722|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
142976344|NCT02273037|515449724|FG000|Overall Study|Lost to Follow-up|1|||
142976345|NCT02273037|515449725|FG001|Overall Study|Lost to Follow-up|0|||
142976346|NCT02273037|515449724|FG000|Overall Study|Delivered before monitoring initiated|1|||
142976347|NCT02273037|515449725|FG001|Overall Study|Delivered before monitoring initiated|3|||
142976348|NCT02273037|515449724|FG000|Overall Study|Breech delivery|2|||
142976349|NCT02273037|515449725|FG001|Overall Study|Breech delivery|3|||
142976350|NCT02273037|515449724|FG000|Overall Study|Multiple delivery|2|||
142976351|NCT02273037|515449725|FG001|Overall Study|Multiple delivery|2|||
142976352|NCT02273037|515449724|FG000|Overall Study|Other complication|2|||
142976353|NCT02273037|515449725|FG001|Overall Study|Other complication|0|||
142976354|NCT02062398|515449726|FG000|Overall Study|Implant removal|1|||
142976355|NCT01779648|515449727|FG000|Overall Study|Protocol Violation|1|||
142976356|NCT01779648|515449728|FG001|Overall Study|Protocol Violation|0|||
142976357|NCT00415519|515449731|FG000|Overall Study|Adverse Event|1|||
142976358|NCT00415519|515449732|FG001|Overall Study|Adverse Event|0|||
142976359|NCT00415519|515449731|FG000|Overall Study|Withdrawal by Subject|2|||
142976360|NCT00415519|515449732|FG001|Overall Study|Withdrawal by Subject|0|||
142976361|NCT00415519|515449731|FG000|Overall Study|Patient's convenience|1|||
142976362|NCT00415519|515449732|FG001|Overall Study|Patient's convenience|0|||
142976363|NCT03351478|515449737|FG000|Overall Study|At the subject's own request|11|||
142976364|NCT03351478|515449738|FG001|Overall Study|At the subject's own request|12|||
142976365|NCT03351478|515449739|FG002|Overall Study|At the subject's own request|5|||
142976366|NCT03351478|515449737|FG000|Overall Study|Adverse Event|1|||
142976367|NCT03351478|515449738|FG001|Overall Study|Adverse Event|2|||
142976368|NCT03351478|515449739|FG002|Overall Study|Adverse Event|1|||
142976369|NCT03351478|515449737|FG000|Overall Study|Poor compliance to protocol|1|||
142976370|NCT03351478|515449738|FG001|Overall Study|Poor compliance to protocol|0|||
142976371|NCT03351478|515449739|FG002|Overall Study|Poor compliance to protocol|0|||
142976372|NCT03351478|515449737|FG000|Overall Study|Reason not Specified|1|||
142976373|NCT03351478|515449738|FG001|Overall Study|Reason not Specified|3|||
142976374|NCT03351478|515449739|FG002|Overall Study|Reason not Specified|0|||
142976375|NCT03351478|515449737|FG000|Overall Study|Lost to Follow-up|0|||
142976376|NCT03351478|515449738|FG001|Overall Study|Lost to Follow-up|0|||
142976377|NCT03351478|515449739|FG002|Overall Study|Lost to Follow-up|1|||
142976378|NCT03657810|515449740|FG000|Overall Study|Adverse Event|0|||
142976379|NCT03657810|515449741|FG001|Overall Study|Adverse Event|1|||
142976380|NCT03657810|515449742|FG002|Overall Study|Adverse Event|0|||
142976381|NCT03657810|515449740|FG000|Overall Study|Lack of Efficacy|4|||
142976382|NCT03657810|515449741|FG001|Overall Study|Lack of Efficacy|1|||
142976383|NCT03657810|515449742|FG002|Overall Study|Lack of Efficacy|3|||
142976384|NCT03657810|515449740|FG000|Overall Study|Protocol Violation|1|||
142976385|NCT03657810|515449741|FG001|Overall Study|Protocol Violation|0|||
142976386|NCT03657810|515449742|FG002|Overall Study|Protocol Violation|0|||
142976387|NCT03657810|515449740|FG000|Overall Study|Lost to Follow-up|0|||
143117219|NCT01447927|515970067|FG001|Overall Study|Withdrawal by Subject|0|||
142976388|NCT03657810|515449741|FG001|Overall Study|Lost to Follow-up|1|||
142976389|NCT03657810|515449742|FG002|Overall Study|Lost to Follow-up|0|||
142976390|NCT03657810|515449740|FG000|Overall Study|Not provided|0|||
142976391|NCT03657810|515449741|FG001|Overall Study|Not provided|1|||
142976392|NCT03657810|515449742|FG002|Overall Study|Not provided|0|||
142976393|NCT03911869|515449743|FG000|Safety Lead-in Phase|Death|7|||
142976394|NCT03911869|515449744|FG001|Safety Lead-in Phase|Death|0|||
142976395|NCT03911869|515449745|FG002|Safety Lead-in Phase|Death|0|||
142976396|NCT03911869|515449743|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
142976397|NCT03911869|515449744|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
142976398|NCT03911869|515449745|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
142976399|NCT03911869|515449743|FG000|Safety Lead-in Phase|Other|1|||
142976400|NCT03911869|515449744|FG001|Safety Lead-in Phase|Other|0|||
142976401|NCT03911869|515449745|FG002|Safety Lead-in Phase|Other|0|||
142976402|NCT03911869|515449743|FG000|Phase 2|Death|0|||
142976403|NCT03911869|515449744|FG001|Phase 2|Death|3|||
142976404|NCT03911869|515449745|FG002|Phase 2|Death|0|||
142976405|NCT00985738|515449747|FG000|Overall Study|Study closed prematurely|8|||
142976406|NCT00985738|515449748|FG001|Overall Study|Study closed prematurely|8|||
142976407|NCT03325556|515449752|FG000|Open-label Period|Lack of Response in OL period|70|||
142976408|NCT03325556|515449753|FG001|Open-label Period|Lack of Response in OL period|0|||
142976409|NCT03325556|515449754|FG002|Open-label Period|Lack of Response in OL period|0|||
142976410|NCT03325556|515449752|FG000|Open-label Period|Adverse Event|27|||
142976411|NCT03325556|515449753|FG001|Open-label Period|Adverse Event|0|||
142976412|NCT03325556|515449754|FG002|Open-label Period|Adverse Event|0|||
142976413|NCT03325556|515449752|FG000|Open-label Period|Death|1|||
142976414|NCT03325556|515449753|FG001|Open-label Period|Death|0|||
142976415|NCT03325556|515449754|FG002|Open-label Period|Death|0|||
142976416|NCT03325556|515449752|FG000|Open-label Period|Lost to Follow-up|1|||
142976417|NCT03325556|515449753|FG001|Open-label Period|Lost to Follow-up|0|||
142976418|NCT03325556|515449754|FG002|Open-label Period|Lost to Follow-up|0|||
142976419|NCT03325556|515449752|FG000|Open-label Period|Non-compliance with study drug|5|||
142976420|NCT03325556|515449753|FG001|Open-label Period|Non-compliance with study drug|0|||
142976421|NCT03325556|515449754|FG002|Open-label Period|Non-compliance with study drug|0|||
142976422|NCT03325556|515449752|FG000|Open-label Period|Use of prohibited medication|1|||
142976423|NCT03325556|515449753|FG001|Open-label Period|Use of prohibited medication|0|||
142976424|NCT03325556|515449754|FG002|Open-label Period|Use of prohibited medication|0|||
142976425|NCT03325556|515449752|FG000|Open-label Period|Protocol Violation|4|||
142976426|NCT03325556|515449753|FG001|Open-label Period|Protocol Violation|0|||
142976427|NCT03325556|515449754|FG002|Open-label Period|Protocol Violation|0|||
142976428|NCT03325556|515449752|FG000|Open-label Period|Withdrawal by Subject|17|||
142976429|NCT03325556|515449753|FG001|Open-label Period|Withdrawal by Subject|0|||
142976430|NCT03325556|515449754|FG002|Open-label Period|Withdrawal by Subject|0|||
142976431|NCT03325556|515449752|FG000|Open-label Period|Not otherwise specified|8|||
142976432|NCT03325556|515449753|FG001|Open-label Period|Not otherwise specified|0|||
142976433|NCT03325556|515449754|FG002|Open-label Period|Not otherwise specified|0|||
142976434|NCT03325556|515449752|FG000|Open-label Period|Administrative discont. at study termination|41|||
142976435|NCT03325556|515449753|FG001|Open-label Period|Administrative discont. at study termination|0|||
142976436|NCT03325556|515449754|FG002|Open-label Period|Administrative discont. at study termination|0|||
142976437|NCT03325556|515449752|FG000|Double-blind Period|Relapse|0|||
142976438|NCT03325556|515449753|FG001|Double-blind Period|Relapse|15|||
142976439|NCT03325556|515449754|FG002|Double-blind Period|Relapse|34|||
142976440|NCT03325556|515449752|FG000|Double-blind Period|Adverse Event|0|||
142976441|NCT03325556|515449753|FG001|Double-blind Period|Adverse Event|3|||
142976442|NCT03325556|515449754|FG002|Double-blind Period|Adverse Event|1|||
142976443|NCT03325556|515449752|FG000|Double-blind Period|Noncompliance with study drug|0|||
142976444|NCT03325556|515449753|FG001|Double-blind Period|Noncompliance with study drug|0|||
142976445|NCT03325556|515449754|FG002|Double-blind Period|Noncompliance with study drug|1|||
142976446|NCT03325556|515449752|FG000|Double-blind Period|Use of prohibited medication|0|||
142976447|NCT03325556|515449753|FG001|Double-blind Period|Use of prohibited medication|1|||
142976448|NCT03325556|515449754|FG002|Double-blind Period|Use of prohibited medication|0|||
142976449|NCT03325556|515449752|FG000|Double-blind Period|Physician Decision|0|||
142976450|NCT03325556|515449753|FG001|Double-blind Period|Physician Decision|0|||
142976451|NCT03325556|515449754|FG002|Double-blind Period|Physician Decision|1|||
142976452|NCT03325556|515449752|FG000|Double-blind Period|Withdrawal by Subject|0|||
142976453|NCT03325556|515449753|FG001|Double-blind Period|Withdrawal by Subject|6|||
142976454|NCT03325556|515449754|FG002|Double-blind Period|Withdrawal by Subject|4|||
142976455|NCT03325556|515449752|FG000|Double-blind Period|Not otherwise specified|0|||
142976456|NCT03325556|515449753|FG001|Double-blind Period|Not otherwise specified|1|||
142976457|NCT03325556|515449754|FG002|Double-blind Period|Not otherwise specified|5|||
142976458|NCT03325556|515449752|FG000|Double-blind Period|Administrative discont. at study termination|0|||
142976459|NCT03325556|515449753|FG001|Double-blind Period|Administrative discont. at study termination|35|||
142976460|NCT03325556|515449754|FG002|Double-blind Period|Administrative discont. at study termination|31|||
142976461|NCT01705587|515449755|FG000|Overall Study|Withdrawal by Subject|0|||
142976462|NCT01705587|515449756|FG001|Overall Study|Withdrawal by Subject|1|||
142976463|NCT02227849|515449757|FG000|Overall Study|Adverse Event|4|||
142976464|NCT02227849|515449757|FG000|Overall Study|Physician Decision|1|||
142976465|NCT02227849|515449757|FG000|Overall Study|Withdrawal by Subject|3|||
142976466|NCT00762268|515449760|FG000|Overall Study|Withdrawal by Subject|3|||
142976467|NCT00762268|515449761|FG001|Overall Study|Withdrawal by Subject|3|||
142976468|NCT02533401|515449762|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
142976469|NCT02533401|515449762|FG000|Overall Study|Death|5|||
142976470|NCT02533401|515449762|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
142976471|NCT02533401|515449762|FG000|Overall Study|Lost to Follow-up|1|||
142976472|NCT02533401|515449762|FG000|Overall Study|Violation of Selection Criteria|1|||
142976473|NCT00881361|515449767|FG000|Overall Study|Terminated prior to surgery|27|||
142976474|NCT00881361|515449768|FG001|Overall Study|Terminated prior to surgery|7|||
142976475|NCT00881361|515449769|FG002|Overall Study|Terminated prior to surgery|0|||
142976476|NCT00881361|515449767|FG000|Overall Study|Ineligible|17|||
142976477|NCT00881361|515449768|FG001|Overall Study|Ineligible|2|||
142976478|NCT00881361|515449769|FG002|Overall Study|Ineligible|2|||
142976479|NCT02141217|515449770|FG000|Overall Study|Adverse Event|1|||
142976480|NCT02141217|515449771|FG001|Overall Study|Adverse Event|2|||
142976481|NCT02141217|515449770|FG000|Overall Study|Protocol Violation|1|||
142976482|NCT02141217|515449771|FG001|Overall Study|Protocol Violation|4|||
142976483|NCT02141217|515449770|FG000|Overall Study|Withdrawal by Subject|6|||
142976484|NCT02141217|515449771|FG001|Overall Study|Withdrawal by Subject|0|||
142976485|NCT02141217|515449770|FG000|Overall Study|Lost to Follow-up|1|||
142976486|NCT02141217|515449771|FG001|Overall Study|Lost to Follow-up|1|||
142976487|NCT02141217|515449770|FG000|Overall Study|Physician Decision|1|||
142976488|NCT02141217|515449771|FG001|Overall Study|Physician Decision|0|||
142976489|NCT02141217|515449770|FG000|Overall Study|Surgical Intervention|1|||
142976490|NCT02141217|515449771|FG001|Overall Study|Surgical Intervention|1|||
142976491|NCT01181141|515449774|FG000|Overall Study|Adverse Event|2|||
142976492|NCT01181141|515449775|FG001|Overall Study|Adverse Event|1|||
142976493|NCT01181141|515449774|FG000|Overall Study|Lack of Efficacy|1|||
142976494|NCT01181141|515449775|FG001|Overall Study|Lack of Efficacy|0|||
142976495|NCT01181141|515449774|FG000|Overall Study|Lost to Follow-up|1|||
142976496|NCT01181141|515449775|FG001|Overall Study|Lost to Follow-up|1|||
142976497|NCT01181141|515449774|FG000|Overall Study|Physician Decision|2|||
142976498|NCT01181141|515449775|FG001|Overall Study|Physician Decision|0|||
142976499|NCT01181141|515449774|FG000|Overall Study|Protocol Violation|3|||
142976500|NCT01181141|515449775|FG001|Overall Study|Protocol Violation|1|||
142976501|NCT01181141|515449774|FG000|Overall Study|Withdrawal by Subject|3|||
142976502|NCT01181141|515449775|FG001|Overall Study|Withdrawal by Subject|1|||
142976503|NCT00290589|515449777|FG000|Overall Study|Lost to Follow-up|2|||
142976504|NCT00290589|515449778|FG001|Overall Study|Lost to Follow-up|2|||
142976505|NCT05067452|515449779|FG000|Overall Study|Lost to Follow-up|0|||
142976506|NCT05067452|515449780|FG001|Overall Study|Lost to Follow-up|4|||
142976507|NCT01148693|515449781|FG000|Overall Study|Attempts for cannulation were failed|13|||
142976508|NCT01148693|515449782|FG001|Overall Study|Attempts for cannulation were failed|10|||
142976509|NCT01342952|515449785|FG000|Overall Study|Adverse Event|0|||
142976510|NCT01342952|515449786|FG001|Overall Study|Adverse Event|5|||
142976511|NCT01342952|515449787|FG002|Overall Study|Adverse Event|1|||
142976512|NCT01342952|515449788|FG003|Overall Study|Adverse Event|0|||
142976513|NCT01342952|515449785|FG000|Overall Study|Lost to Follow-up|0|||
142976514|NCT01342952|515449786|FG001|Overall Study|Lost to Follow-up|2|||
142976515|NCT01342952|515449787|FG002|Overall Study|Lost to Follow-up|0|||
142976516|NCT01342952|515449788|FG003|Overall Study|Lost to Follow-up|0|||
142976517|NCT01342952|515449785|FG000|Overall Study|Withdrawal by Subject|1|||
142976518|NCT01342952|515449786|FG001|Overall Study|Withdrawal by Subject|1|||
142976519|NCT01342952|515449787|FG002|Overall Study|Withdrawal by Subject|0|||
142976520|NCT01342952|515449788|FG003|Overall Study|Withdrawal by Subject|0|||
142976521|NCT01342952|515449785|FG000|Overall Study|Physician Decision|3|||
142976522|NCT01342952|515449786|FG001|Overall Study|Physician Decision|3|||
142976523|NCT01342952|515449787|FG002|Overall Study|Physician Decision|1|||
142976524|NCT01342952|515449788|FG003|Overall Study|Physician Decision|0|||
142976525|NCT00426556|515449789|FG000|Phase I - Core Phase|Disease Progression|0|||
143455643|NCT01142115|517212499|FG000|First Intervention|Lack of Efficacy|1|||
142976526|NCT00426556|515449790|FG001|Phase I - Core Phase|Disease Progression|6|||
142976527|NCT00426556|515449791|FG002|Phase I - Core Phase|Disease Progression|2|||
142976528|NCT00426556|515449792|FG003|Phase I - Core Phase|Disease Progression|0|||
142976529|NCT00426556|515449789|FG000|Phase I - Core Phase|Adverse Event|1|||
142976530|NCT00426556|515449790|FG001|Phase I - Core Phase|Adverse Event|3|||
142976531|NCT00426556|515449791|FG002|Phase I - Core Phase|Adverse Event|1|||
142976532|NCT00426556|515449792|FG003|Phase I - Core Phase|Adverse Event|0|||
142976533|NCT00426556|515449789|FG000|Phase I - Core Phase|Death|0|||
142976534|NCT00426556|515449790|FG001|Phase I - Core Phase|Death|1|||
142976535|NCT00426556|515449791|FG002|Phase I - Core Phase|Death|0|||
143455644|NCT01142115|517212500|FG001|First Intervention|Lack of Efficacy|1|||
142976536|NCT00426556|515449792|FG003|Phase I - Core Phase|Death|0|||
142976537|NCT00426556|515449789|FG000|Phase I - Extension Phase|Adverse Event|0|||
142976538|NCT00426556|515449790|FG001|Phase I - Extension Phase|Adverse Event|1|||
142976539|NCT00426556|515449791|FG002|Phase I - Extension Phase|Adverse Event|1|||
142976540|NCT00426556|515449792|FG003|Phase I - Extension Phase|Adverse Event|0|||
142976541|NCT00426556|515449789|FG000|Phase I - Extension Phase|Disease Progression|5|||
142976542|NCT00426556|515449790|FG001|Phase I - Extension Phase|Disease Progression|5|||
142976543|NCT00426556|515449791|FG002|Phase I - Extension Phase|Disease Progression|6|||
142976544|NCT00426556|515449792|FG003|Phase I - Extension Phase|Disease Progression|0|||
142976545|NCT00426556|515449789|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
142976546|NCT00426556|515449790|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
142976547|NCT00426556|515449791|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
142976548|NCT00426556|515449792|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
142976549|NCT00426556|515449789|FG000|Phase II - Core Phase|Disease Progression|0|||
142976550|NCT00426556|515449790|FG001|Phase II - Core Phase|Disease Progression|0|||
142976551|NCT00426556|515449791|FG002|Phase II - Core Phase|Disease Progression|0|||
142976552|NCT00426556|515449792|FG003|Phase II - Core Phase|Disease Progression|16|||
142976553|NCT00426556|515449789|FG000|Phase II - Core Phase|Adverse Event|0|||
142976554|NCT00426556|515449790|FG001|Phase II - Core Phase|Adverse Event|0|||
142976555|NCT00426556|515449791|FG002|Phase II - Core Phase|Adverse Event|0|||
142976556|NCT00426556|515449792|FG003|Phase II - Core Phase|Adverse Event|8|||
142976557|NCT00426556|515449789|FG000|Phase II - Extension Phase|Disease Progression|0|||
142976558|NCT00426556|515449790|FG001|Phase II - Extension Phase|Disease Progression|0|||
142976559|NCT00426556|515449791|FG002|Phase II - Extension Phase|Disease Progression|0|||
142976560|NCT00426556|515449792|FG003|Phase II - Extension Phase|Disease Progression|21|||
142976561|NCT00426556|515449789|FG000|Phase II - Extension Phase|Adverse Event|0|||
142976562|NCT00426556|515449790|FG001|Phase II - Extension Phase|Adverse Event|0|||
142976563|NCT00426556|515449791|FG002|Phase II - Extension Phase|Adverse Event|0|||
142976564|NCT00426556|515449792|FG003|Phase II - Extension Phase|Adverse Event|2|||
142976565|NCT03970824|515449793|FG000|Overall Study|Withdrawal by Subject|1|||
142976566|NCT03970824|515449794|FG001|Overall Study|Withdrawal by Subject|1|||
142976567|NCT03970824|515449795|FG002|Overall Study|Withdrawal by Subject|3|||
142976568|NCT03970824|515449793|FG000|Overall Study|Lost to Follow-up|0|||
142976569|NCT03970824|515449794|FG001|Overall Study|Lost to Follow-up|2|||
142976570|NCT03970824|515449795|FG002|Overall Study|Lost to Follow-up|1|||
142976571|NCT03970824|515449793|FG000|Overall Study|Adverse Event|1|||
142976572|NCT03970824|515449794|FG001|Overall Study|Adverse Event|0|||
142976573|NCT03970824|515449795|FG002|Overall Study|Adverse Event|0|||
142976574|NCT00416312|515449796|FG000|Overall Study|tumors not visible on imaging|2|||
142976575|NCT01192204|515449798|FG000|Overall Study|could not keep recall appointments|1|||
142976576|NCT01192204|515449799|FG001|Overall Study|could not keep recall appointments|0|||
142976577|NCT02146248|515449800|FG000|Overall Study|Withdrawal by Subject|2|||
142976578|NCT01767519|515449804|FG000|Overall Study|Other Reasons|4|||
142976579|NCT01767519|515449805|FG001|Overall Study|Other Reasons|4|||
142976580|NCT01767519|515449806|FG002|Overall Study|Other Reasons|2|||
142976581|NCT01767519|515449804|FG000|Overall Study|Protocol Violation|0|||
142976582|NCT01767519|515449805|FG001|Overall Study|Protocol Violation|3|||
142976583|NCT01767519|515449806|FG002|Overall Study|Protocol Violation|0|||
142976584|NCT01767519|515449804|FG000|Overall Study|Personal Reasons|1|||
142976585|NCT01767519|515449805|FG001|Overall Study|Personal Reasons|0|||
142976586|NCT01767519|515449806|FG002|Overall Study|Personal Reasons|0|||
142976587|NCT01767519|515449804|FG000|Overall Study|Lost to Follow-up|3|||
142976588|NCT01767519|515449805|FG001|Overall Study|Lost to Follow-up|1|||
142976589|NCT01767519|515449806|FG002|Overall Study|Lost to Follow-up|2|||
142976590|NCT01767519|515449804|FG000|Overall Study|Lack of Efficacy|1|||
142976591|NCT01767519|515449805|FG001|Overall Study|Lack of Efficacy|0|||
142976592|NCT01767519|515449806|FG002|Overall Study|Lack of Efficacy|0|||
142976593|NCT01767519|515449804|FG000|Overall Study|Adverse Event|5|||
142976594|NCT01767519|515449805|FG001|Overall Study|Adverse Event|5|||
142976595|NCT01767519|515449806|FG002|Overall Study|Adverse Event|1|||
142976596|NCT03101514|515449809|FG000|Overall Study|Withdrawal by Subject|4|||
142976597|NCT03101514|515449809|FG000|Overall Study|Protocol Violation|2|||
142976598|NCT03101514|515449809|FG000|Overall Study|patient's information was incomplete|1|||
142976599|NCT02247401|515449810|FG000|Overall Study|Adverse Event|1|||
142976600|NCT02247401|515449811|FG001|Overall Study|Adverse Event|0|||
142976601|NCT02247401|515449812|FG002|Overall Study|Adverse Event|0|||
142976602|NCT02247401|515449810|FG000|Overall Study|Withdrawal by Subject|4|||
142976603|NCT02247401|515449811|FG001|Overall Study|Withdrawal by Subject|1|||
142976604|NCT02247401|515449812|FG002|Overall Study|Withdrawal by Subject|1|||
142976605|NCT02247401|515449810|FG000|Overall Study|Lost to Follow-up|1|||
142976606|NCT02247401|515449811|FG001|Overall Study|Lost to Follow-up|1|||
142976607|NCT02247401|515449812|FG002|Overall Study|Lost to Follow-up|1|||
142976608|NCT00493974|515449813|FG000|Overall Study|Death|1|||
142976609|NCT00493974|515449814|FG001|Overall Study|Death|2|||
142976610|NCT00493974|515449813|FG000|Overall Study|Withdrawal by Subject|8|||
142976611|NCT00493974|515449814|FG001|Overall Study|Withdrawal by Subject|6|||
142976612|NCT00493974|515449813|FG000|Overall Study|Lost to Follow-up|4|||
142976613|NCT00493974|515449814|FG001|Overall Study|Lost to Follow-up|6|||
142976614|NCT02807363|515449815|FG000|Dosing Period|Adverse Event|0|||
142976615|NCT02807363|515449816|FG001|Dosing Period|Adverse Event|1|||
142976616|NCT02807363|515449817|FG002|Dosing Period|Adverse Event|0|||
142976617|NCT02807363|515449818|FG003|Dosing Period|Adverse Event|0|||
142976618|NCT00966693|515449819|FG000|Overall Study|Adverse Event|0|||
142976619|NCT00966693|515449820|FG001|Overall Study|Adverse Event|0|||
142976620|NCT00966693|515449821|FG002|Overall Study|Adverse Event|1|||
142976621|NCT00966693|515449822|FG003|Overall Study|Adverse Event|2|||
142976622|NCT00966693|515449819|FG000|Overall Study|Death|0|||
142976623|NCT00966693|515449820|FG001|Overall Study|Death|0|||
142976624|NCT00966693|515449821|FG002|Overall Study|Death|1|||
142976625|NCT00966693|515449822|FG003|Overall Study|Death|0|||
142976626|NCT00966693|515449819|FG000|Overall Study|Withdrawal by Subject|1|||
142976627|NCT00966693|515449820|FG001|Overall Study|Withdrawal by Subject|0|||
142976628|NCT00966693|515449821|FG002|Overall Study|Withdrawal by Subject|0|||
142976629|NCT00966693|515449822|FG003|Overall Study|Withdrawal by Subject|5|||
142976630|NCT00966693|515449819|FG000|Overall Study|Disease Progression|0|||
142976631|NCT00966693|515449820|FG001|Overall Study|Disease Progression|0|||
142976632|NCT00966693|515449821|FG002|Overall Study|Disease Progression|1|||
142976633|NCT00966693|515449822|FG003|Overall Study|Disease Progression|16|||
142976634|NCT00192036|515449823|FG000|Overall Study|Protocol Violation|3|||
142976635|NCT00192036|515449823|FG000|Overall Study|Adverse Event|6|||
142976636|NCT00192036|515449823|FG000|Overall Study|Patient/Physician Perception|1|||
142976637|NCT00192036|515449823|FG000|Overall Study|Objective Tumor Progression|4|||
142976638|NCT00192036|515449823|FG000|Overall Study|Clinical Disease Progression|1|||
142976639|NCT00192036|515449823|FG000|Overall Study|Death|1|||
142976640|NCT00192036|515449823|FG000|Overall Study|Unknown or Not Specified|5|||
142976641|NCT02581982|515449826|FG000|Overall Study|Lack of Efficacy|12|||
142976642|NCT02581982|515449826|FG000|Overall Study|Adverse Event|3|||
142976643|NCT02581982|515449826|FG000|Overall Study|Physician Decision|1|||
142976644|NCT00476996|515449830|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
142976645|NCT00476996|515449831|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
142976646|NCT00476996|515449832|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
142976647|NCT00476996|515449833|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
142976648|NCT00476996|515449830|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
142976649|NCT00476996|515449831|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
142976650|NCT00476996|515449832|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
142976651|NCT00476996|515449833|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
142976652|NCT00476996|515449830|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
142976653|NCT00476996|515449831|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
142976654|NCT00476996|515449832|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
142976655|NCT00476996|515449833|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
142976656|NCT00476996|515449830|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
142976657|NCT00476996|515449831|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
142976658|NCT00476996|515449832|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
142976659|NCT00476996|515449833|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
142976660|NCT00476996|515449830|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
142976661|NCT00476996|515449831|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
142976662|NCT00476996|515449832|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
142976663|NCT00476996|515449833|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
142976664|NCT00476996|515449830|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
142976665|NCT00476996|515449831|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
142976666|NCT00476996|515449832|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
142976667|NCT00476996|515449833|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
142976668|NCT00476996|515449830|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
142976669|NCT00476996|515449831|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
142976670|NCT00476996|515449832|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
142976671|NCT00476996|515449833|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
142976672|NCT00476996|515449830|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
142976673|NCT00476996|515449831|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
142976674|NCT00476996|515449832|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
142976675|NCT00476996|515449833|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
142976676|NCT00476996|515449830|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
142976677|NCT00476996|515449831|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
142976678|NCT00476996|515449832|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
142976679|NCT00476996|515449833|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
142976680|NCT00476996|515449830|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
142976681|NCT00476996|515449831|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
142976682|NCT00476996|515449832|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
142976683|NCT00476996|515449833|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
142976684|NCT00476996|515449830|FG000|OLE Phase (From Week 48)|Death|0|||
142976685|NCT00476996|515449831|FG001|OLE Phase (From Week 48)|Death|0|||
142976686|NCT00476996|515449832|FG002|OLE Phase (From Week 48)|Death|0|||
142976687|NCT00476996|515449833|FG003|OLE Phase (From Week 48)|Death|7|||
142976688|NCT00476996|515449830|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
142976689|NCT00476996|515449831|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
142976690|NCT00476996|515449832|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
142976691|NCT00476996|515449833|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
142976692|NCT00476996|515449830|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
142976693|NCT00476996|515449831|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
142976694|NCT00476996|515449832|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
142976695|NCT00476996|515449833|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
142976696|NCT00476996|515449830|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
142976697|NCT00476996|515449831|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
142976698|NCT00476996|515449832|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
142976699|NCT00476996|515449833|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
142976700|NCT00476996|515449830|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
142976701|NCT00476996|515449831|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
142976702|NCT00476996|515449832|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
142976703|NCT00476996|515449833|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
142976704|NCT00862654|515449834|FG000|Overall Study|Lack of Efficacy|1|||
142976705|NCT00862654|515449835|FG001|Overall Study|Lack of Efficacy|0|||
142976706|NCT00862654|515449836|FG002|Overall Study|Lack of Efficacy|1|||
142976707|NCT00862654|515449837|FG003|Overall Study|Lack of Efficacy|0|||
142976708|NCT00862654|515449834|FG000|Overall Study|Lost to Follow-up|1|||
142976709|NCT00862654|515449835|FG001|Overall Study|Lost to Follow-up|2|||
142976710|NCT00862654|515449836|FG002|Overall Study|Lost to Follow-up|1|||
142976711|NCT00862654|515449837|FG003|Overall Study|Lost to Follow-up|3|||
142976712|NCT00862654|515449834|FG000|Overall Study|Adverse Event|0|||
142976713|NCT00862654|515449835|FG001|Overall Study|Adverse Event|1|||
142976714|NCT00862654|515449836|FG002|Overall Study|Adverse Event|1|||
142976715|NCT00862654|515449837|FG003|Overall Study|Adverse Event|0|||
142976716|NCT00862654|515449834|FG000|Overall Study|Pregnancy|1|||
142976717|NCT00862654|515449835|FG001|Overall Study|Pregnancy|1|||
142976718|NCT00862654|515449836|FG002|Overall Study|Pregnancy|0|||
142976719|NCT00862654|515449837|FG003|Overall Study|Pregnancy|0|||
142976720|NCT00862654|515449834|FG000|Overall Study|Withdrawal by Subject|2|||
142976721|NCT00862654|515449835|FG001|Overall Study|Withdrawal by Subject|2|||
142976722|NCT00862654|515449836|FG002|Overall Study|Withdrawal by Subject|2|||
142976723|NCT00862654|515449837|FG003|Overall Study|Withdrawal by Subject|3|||
142976724|NCT00862654|515449834|FG000|Overall Study|Subject mistake|0|||
142976725|NCT00862654|515449835|FG001|Overall Study|Subject mistake|1|||
142976726|NCT00862654|515449836|FG002|Overall Study|Subject mistake|0|||
142976727|NCT00862654|515449837|FG003|Overall Study|Subject mistake|0|||
142976728|NCT00862654|515449834|FG000|Overall Study|Familly constraint|0|||
142976729|NCT00862654|515449835|FG001|Overall Study|Familly constraint|1|||
142976730|NCT00862654|515449836|FG002|Overall Study|Familly constraint|0|||
142976731|NCT00862654|515449837|FG003|Overall Study|Familly constraint|0|||
142976732|NCT00862654|515449834|FG000|Overall Study|Never used study drugs|1|||
142976733|NCT00862654|515449835|FG001|Overall Study|Never used study drugs|0|||
142976734|NCT00862654|515449836|FG002|Overall Study|Never used study drugs|0|||
142976735|NCT00862654|515449837|FG003|Overall Study|Never used study drugs|0|||
142976736|NCT00862654|515449834|FG000|Overall Study|Included after end of inclusions|0|||
142976737|NCT00862654|515449835|FG001|Overall Study|Included after end of inclusions|0|||
142976738|NCT00862654|515449836|FG002|Overall Study|Included after end of inclusions|1|||
142976739|NCT00862654|515449837|FG003|Overall Study|Included after end of inclusions|0|||
142976740|NCT01769469|515449838|FG000|Overall Study|Consent Withdrawn|5|||
142976741|NCT01769469|515449838|FG000|Overall Study|Moved Out Of Area|3|||
142976742|NCT01769469|515449838|FG000|Overall Study|Lost to Follow-up|17|||
142976743|NCT01769469|515449838|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
142976744|NCT01769469|515449838|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
142976745|NCT03954444|515449842|FG000|Overall Study|Withdrawal by Subject|5|||
142976746|NCT03954444|515449843|FG001|Overall Study|Withdrawal by Subject|5|||
142976747|NCT03954444|515449844|FG002|Overall Study|Withdrawal by Subject|5|||
142976748|NCT03954444|515449842|FG000|Overall Study|Adverse Event|1|||
142976749|NCT03954444|515449843|FG001|Overall Study|Adverse Event|3|||
142976750|NCT03954444|515449844|FG002|Overall Study|Adverse Event|2|||
142976751|NCT03954444|515449842|FG000|Overall Study|Protocol Violation|0|||
142976752|NCT03954444|515449843|FG001|Overall Study|Protocol Violation|3|||
142976753|NCT03954444|515449844|FG002|Overall Study|Protocol Violation|5|||
143117220|NCT00787917|515970069|FG000|Blinded Treatment|Adverse Event|1|||
142976754|NCT03954444|515449842|FG000|Overall Study|Use of prohibited therapy|1|||
142976755|NCT03954444|515449843|FG001|Overall Study|Use of prohibited therapy|1|||
142976756|NCT03954444|515449844|FG002|Overall Study|Use of prohibited therapy|2|||
142976757|NCT03954444|515449842|FG000|Overall Study|Lost to Follow-up|1|||
142976758|NCT03954444|515449843|FG001|Overall Study|Lost to Follow-up|0|||
142976759|NCT03954444|515449844|FG002|Overall Study|Lost to Follow-up|1|||
142976760|NCT03954444|515449842|FG000|Overall Study|Non-compliant with study drug application|2|||
142976761|NCT03954444|515449843|FG001|Overall Study|Non-compliant with study drug application|2|||
142976762|NCT03954444|515449844|FG002|Overall Study|Non-compliant with study drug application|0|||
142976763|NCT03954444|515449842|FG000|Overall Study|Administrative reasons|0|||
142976764|NCT03954444|515449843|FG001|Overall Study|Administrative reasons|0|||
142976765|NCT03954444|515449844|FG002|Overall Study|Administrative reasons|1|||
143455645|NCT01142115|517212499|FG000|First Intervention|Adverse Event|1|||
142976766|NCT03954444|515449842|FG000|Overall Study|Miscellaneous|3|||
142976767|NCT03954444|515449843|FG001|Overall Study|Miscellaneous|2|||
142976768|NCT03954444|515449844|FG002|Overall Study|Miscellaneous|1|||
142976769|NCT02447458|515449845|FG000|Overall Study|Other|0|||
142976770|NCT02447458|515449846|FG001|Overall Study|Other|0|||
142976771|NCT02447458|515449847|FG002|Overall Study|Other|1|||
142976772|NCT02447458|515449848|FG003|Overall Study|Other|0|||
142976773|NCT02447458|515449849|FG004|Overall Study|Other|0|||
142976774|NCT02447458|515449850|FG005|Overall Study|Other|0|||
142976775|NCT03094832|515449857|FG000|Overall Study|Lost to Follow-up|0|||
142976776|NCT03094832|515449858|FG001|Overall Study|Lost to Follow-up|0|||
142976777|NCT03094832|515449859|FG002|Overall Study|Lost to Follow-up|0|||
142976778|NCT03094832|515449860|FG003|Overall Study|Lost to Follow-up|1|||
142976779|NCT03094832|515449861|FG004|Overall Study|Lost to Follow-up|1|||
142976780|NCT03094832|515449857|FG000|Overall Study|Death|1|||
142976781|NCT03094832|515449858|FG001|Overall Study|Death|0|||
142976782|NCT03094832|515449859|FG002|Overall Study|Death|0|||
142976783|NCT03094832|515449860|FG003|Overall Study|Death|0|||
142976784|NCT03094832|515449861|FG004|Overall Study|Death|0|||
142976785|NCT03094832|515449857|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
142976786|NCT03094832|515449858|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
142976787|NCT03094832|515449859|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
142976788|NCT03094832|515449860|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
142976789|NCT03094832|515449861|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
142976790|NCT03094832|515449857|FG000|Overall Study|Other|13|||
142976791|NCT03094832|515449858|FG001|Overall Study|Other|20|||
142976792|NCT03094832|515449859|FG002|Overall Study|Other|1|||
142976793|NCT03094832|515449860|FG003|Overall Study|Other|7|||
142976794|NCT03094832|515449861|FG004|Overall Study|Other|1|||
142976795|NCT02674685|515449862|FG000|Overall Study|Withdrawal by Subject|4|||
142976796|NCT00903370|515449866|FG000|Overall Study|Death|13|||
142976797|NCT00903370|515449867|FG001|Overall Study|Death|10|||
142976798|NCT00903370|515449866|FG000|Overall Study|Withdrawal by Subject|9|||
142976799|NCT00903370|515449867|FG001|Overall Study|Withdrawal by Subject|6|||
142976800|NCT00903370|515449866|FG000|Overall Study|Lost to Follow-up|6|||
142976801|NCT00903370|515449867|FG001|Overall Study|Lost to Follow-up|8|||
142976802|NCT03148756|515449868|FG000|Overall Study|Study Terminated|0|||
142976803|NCT03148756|515449869|FG001|Overall Study|Study Terminated|1|||
142976804|NCT01265420|515449870|FG000|Overall Study|Lost to Follow-up|1|||
142976805|NCT05406440|515452105|FG000|Overall Study|Lost to Follow-up|0|||
142976806|NCT05406440|515452106|FG001|Overall Study|Lost to Follow-up|0|||
142976807|NCT05406440|515452107|FG002|Overall Study|Lost to Follow-up|0|||
142976808|NCT05406440|515452108|FG003|Overall Study|Lost to Follow-up|0|||
142976809|NCT05406440|515452109|FG004|Overall Study|Lost to Follow-up|2|||
142976810|NCT05406440|515452110|FG005|Overall Study|Lost to Follow-up|0|||
142976811|NCT05406440|515452111|FG006|Overall Study|Lost to Follow-up|0|||
142976812|NCT05406440|515452105|FG000|Overall Study|Physician Decision|0|||
142976813|NCT05406440|515452106|FG001|Overall Study|Physician Decision|0|||
142976814|NCT05406440|515452107|FG002|Overall Study|Physician Decision|0|||
142976815|NCT05406440|515452108|FG003|Overall Study|Physician Decision|0|||
142976816|NCT05406440|515452109|FG004|Overall Study|Physician Decision|1|||
142976817|NCT05406440|515452110|FG005|Overall Study|Physician Decision|0|||
142976818|NCT05406440|515452111|FG006|Overall Study|Physician Decision|0|||
142976819|NCT05406440|515452105|FG000|Overall Study|Withdrawal by Subject|0|||
142976820|NCT05406440|515452106|FG001|Overall Study|Withdrawal by Subject|0|||
142976821|NCT05406440|515452107|FG002|Overall Study|Withdrawal by Subject|0|||
142976822|NCT05406440|515452108|FG003|Overall Study|Withdrawal by Subject|0|||
142976823|NCT05406440|515452109|FG004|Overall Study|Withdrawal by Subject|0|||
142976824|NCT05406440|515452110|FG005|Overall Study|Withdrawal by Subject|2|||
142976825|NCT05406440|515452111|FG006|Overall Study|Withdrawal by Subject|0|||
142976826|NCT05742841|515452113|FG000|Overall Study|Withdrawal by Subject|1|||
142976827|NCT05742841|515452113|FG000|Overall Study|Lost to Follow-up|1|||
143455646|NCT01142115|517212500|FG001|First Intervention|Adverse Event|0|||
143455647|NCT00633880|517212501|FG000|Open Label Titration|Lack of Efficacy|1|||
143455648|NCT00633880|517212502|FG001|Open Label Titration|Lack of Efficacy|0|||
143455649|NCT00633880|517212503|FG002|Open Label Titration|Lack of Efficacy|0|||
143455650|NCT00633880|517212501|FG000|Open Label Titration|Adverse Event|13|||
143455651|NCT00633880|517212502|FG001|Open Label Titration|Adverse Event|0|||
142976828|NCT00801892|515452114|FG000|Main Study Period|Withdrawal by Subject|0|||
142976829|NCT00801892|515452115|FG001|Main Study Period|Withdrawal by Subject|1|||
142976830|NCT00801892|515452114|FG000|Sham Crossover Period|Lost to Follow-up|0|||
142976831|NCT00801892|515452115|FG001|Sham Crossover Period|Lost to Follow-up|2|||
143455652|NCT00633880|517212503|FG002|Open Label Titration|Adverse Event|0|||
143455653|NCT00633880|517212501|FG000|Open Label Titration|Treatment Failure|55|||
143455654|NCT00633880|517212502|FG001|Open Label Titration|Treatment Failure|0|||
142976832|NCT01711541|515452116|FG000|Overall Study|Cancel prior to treatment|0|||
142976833|NCT01711541|515452117|FG001|Overall Study|Cancel prior to treatment|0|||
142976834|NCT01711541|515452118|FG002|Overall Study|Cancel prior to treatment|0|||
142976835|NCT01711541|515452119|FG003|Overall Study|Cancel prior to treatment|1|||
142976836|NCT01711541|515452120|FG004|Overall Study|Cancel prior to treatment|0|||
142976837|NCT01711541|515452116|FG000|Overall Study|Ineligible|0|||
142976838|NCT01711541|515452117|FG001|Overall Study|Ineligible|1|||
142976839|NCT01711541|515452118|FG002|Overall Study|Ineligible|0|||
142976840|NCT01711541|515452119|FG003|Overall Study|Ineligible|0|||
142976841|NCT01711541|515452120|FG004|Overall Study|Ineligible|0|||
142976842|NCT00438464|515452121|FG000|Overall Study|Terminated Early|14|||
142976843|NCT00438464|515452122|FG001|Overall Study|Terminated Early|5|||
142976844|NCT00438464|515452121|FG000|Overall Study|Incomplete data submission|0|||
142976845|NCT00438464|515452122|FG001|Overall Study|Incomplete data submission|2|||
142976846|NCT03943446|515452123|FG000|Overall Study|Lost to Follow-up|0|||
142976847|NCT03943446|515452124|FG001|Overall Study|Lost to Follow-up|0|||
142976848|NCT03943446|515452125|FG002|Overall Study|Lost to Follow-up|1|||
142976849|NCT03943446|515452123|FG000|Overall Study|Withdrawal by Subject|1|||
142976850|NCT03943446|515452124|FG001|Overall Study|Withdrawal by Subject|1|||
142976851|NCT03943446|515452125|FG002|Overall Study|Withdrawal by Subject|2|||
142976852|NCT03943446|515452123|FG000|Overall Study|Study Terminated by Sponsor|1|||
142976853|NCT03943446|515452124|FG001|Overall Study|Study Terminated by Sponsor|2|||
142976854|NCT03943446|515452125|FG002|Overall Study|Study Terminated by Sponsor|1|||
142976855|NCT03943446|515452123|FG000|Overall Study|Reason not Specified|5|||
142976856|NCT03943446|515452124|FG001|Overall Study|Reason not Specified|1|||
142976857|NCT03943446|515452125|FG002|Overall Study|Reason not Specified|3|||
142976858|NCT00092677|515452131|FG000|Overall Study|Lost to Follow-up|0|||
142976859|NCT00092677|515452132|FG001|Overall Study|Lost to Follow-up|2|||
142976860|NCT00092677|515452131|FG000|Overall Study|Adminstrative|5|||
142976861|NCT00092677|515452132|FG001|Overall Study|Adminstrative|9|||
142976862|NCT01601704|515452133|FG000|Overall Study|Randomized but not dispensed study med|1|||
142976863|NCT01601704|515452134|FG001|Overall Study|Randomized but not dispensed study med|4|||
142976864|NCT01090102|515452135|FG000|First 12 Weeks|Withdrawal by Subject|1|||
142976865|NCT01090102|515452136|FG001|First 12 Weeks|Withdrawal by Subject|1|||
142976866|NCT01090102|515452135|FG000|First 12 Weeks|Adverse Event|2|||
142976867|NCT01090102|515452136|FG001|First 12 Weeks|Adverse Event|0|||
142976868|NCT01090102|515452135|FG000|First 12 Weeks|Death|1|||
142976869|NCT01090102|515452136|FG001|First 12 Weeks|Death|1|||
142976870|NCT01090102|515452135|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
142976871|NCT01090102|515452136|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
142976872|NCT00510484|515452137|FG000|Wash-out Period|Adverse Event|0|||
142976873|NCT00510484|515452138|FG001|Wash-out Period|Adverse Event|1|||
142976874|NCT01590212|515452139|FG000|Overall Study|Withdrawal by Subject|2|||
142976875|NCT01590212|515452140|FG001|Overall Study|Withdrawal by Subject|2|||
142976876|NCT01590212|515452141|FG002|Overall Study|Withdrawal by Subject|2|||
142976877|NCT01590212|515452139|FG000|Overall Study|Lost to Follow-up|1|||
142976878|NCT01590212|515452140|FG001|Overall Study|Lost to Follow-up|2|||
142976879|NCT01590212|515452141|FG002|Overall Study|Lost to Follow-up|3|||
142976880|NCT04897594|515452142|FG000|Overall Study|Lost to Follow-up|0|||
142976881|NCT04897594|515452143|FG001|Overall Study|Lost to Follow-up|1|||
142976882|NCT04897594|515452144|FG002|Overall Study|Lost to Follow-up|1|||
142976883|NCT04897594|515452142|FG000|Overall Study|Sponsor Decision|0|||
142976884|NCT04897594|515452143|FG001|Overall Study|Sponsor Decision|0|||
142976885|NCT04897594|515452144|FG002|Overall Study|Sponsor Decision|1|||
142976886|NCT04897594|515452142|FG000|Overall Study|Withdrawal by Subject|1|||
142976887|NCT04897594|515452143|FG001|Overall Study|Withdrawal by Subject|0|||
142976888|NCT04897594|515452144|FG002|Overall Study|Withdrawal by Subject|1|||
142976889|NCT01457924|515452151|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
142976890|NCT01457924|515452152|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
142976891|NCT01457924|515452153|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
142976892|NCT01457924|515452154|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
142976893|NCT01457924|515452155|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
142976894|NCT01457924|515452151|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
142976895|NCT01457924|515452152|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
142976896|NCT01457924|515452153|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
142976897|NCT01457924|515452154|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
142976898|NCT01457924|515452155|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
142976899|NCT01457924|515452151|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
142976900|NCT01457924|515452152|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
142976901|NCT01457924|515452153|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
142976902|NCT01457924|515452154|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
142976903|NCT01457924|515452155|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
142976904|NCT01457924|515452151|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
142976905|NCT01457924|515452152|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
142976906|NCT01457924|515452153|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
142976907|NCT01457924|515452154|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
142976908|NCT01457924|515452155|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
142976909|NCT01457924|515452151|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
142976910|NCT01457924|515452152|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
142976911|NCT01457924|515452153|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
142976912|NCT01457924|515452154|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
142976913|NCT01457924|515452155|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
142976914|NCT01457924|515452151|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
142976915|NCT01457924|515452152|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
142976916|NCT01457924|515452153|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
142976917|NCT01457924|515452154|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
142976918|NCT01457924|515452155|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
142976919|NCT01457924|515452151|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
142976920|NCT01457924|515452152|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
142976921|NCT01457924|515452153|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
142976922|NCT01457924|515452154|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
142976923|NCT01457924|515452155|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
142976924|NCT01457924|515452151|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
142976925|NCT01457924|515452152|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
142976926|NCT01457924|515452153|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
142976927|NCT01457924|515452154|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
142976928|NCT01457924|515452155|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
142976929|NCT01457924|515452151|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
142976930|NCT01457924|515452152|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
142976931|NCT01457924|515452153|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
142976932|NCT01457924|515452154|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
142976933|NCT01457924|515452155|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
142976934|NCT01457924|515452151|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
142976935|NCT01457924|515452152|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
142976936|NCT01457924|515452153|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
142976937|NCT01457924|515452154|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
142976938|NCT01457924|515452155|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
142976939|NCT01457924|515452151|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
142976940|NCT01457924|515452152|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
142976941|NCT01457924|515452153|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
142976942|NCT01457924|515452154|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
142976943|NCT01457924|515452155|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
142976944|NCT01457924|515452151|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
142976945|NCT01457924|515452152|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
142976946|NCT01457924|515452153|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
142976947|NCT01457924|515452154|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
142976948|NCT01457924|515452155|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
142976949|NCT01457924|515452151|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
142976950|NCT01457924|515452152|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
142976951|NCT01457924|515452153|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
142976952|NCT01457924|515452154|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
142976953|NCT01457924|515452155|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
142976954|NCT00448760|515452156|FG000|Overall Study|Death|3|||
142976955|NCT00118911|515452161|FG000|Overall Study|Withdrawal by Subject|2|||
142976956|NCT00118911|515452162|FG001|Overall Study|Withdrawal by Subject|5|||
142976957|NCT05014542|515452163|FG000|Week 1-24, Between Group Analysis|Withdrawal by Subject|6|||
142976958|NCT05014542|515452164|FG001|Week 1-24, Between Group Analysis|Withdrawal by Subject|3|||
142976959|NCT05014542|515452163|FG000|Week 1-24, Between Group Analysis|Lost to Follow-up|1|||
142976960|NCT05014542|515452164|FG001|Week 1-24, Between Group Analysis|Lost to Follow-up|0|||
142976961|NCT05014542|515452163|FG000|Week 25-39, Within Group Analysis|Withdrawal by Subject|0|||
142976962|NCT05014542|515452164|FG001|Week 25-39, Within Group Analysis|Withdrawal by Subject|5|||
142976963|NCT05014542|515452163|FG000|Week 25-39, Within Group Analysis|Lost to Follow-up|2|||
142976964|NCT05014542|515452164|FG001|Week 25-39, Within Group Analysis|Lost to Follow-up|1|||
142976965|NCT05507580|515452165|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
142976966|NCT05507580|515452166|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
142976967|NCT05507580|515452167|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
142976968|NCT05507580|515452168|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
142976969|NCT05507580|515452169|FG004|Double-Blind Treatment Period|Lost to Follow-up|0|||
142976970|NCT05507580|515452170|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
142976971|NCT05507580|515452165|FG000|Double-Blind Treatment Period|Withdrawal by Subject|7|||
142976972|NCT05507580|515452166|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
142976973|NCT05507580|515452167|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
142976974|NCT05507580|515452168|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
142976975|NCT05507580|515452169|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
142976976|NCT05507580|515452170|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
142976977|NCT05507580|515452165|FG000|Double-Blind Treatment Period|Other, not specified|5|||
142976978|NCT05507580|515452166|FG001|Double-Blind Treatment Period|Other, not specified|4|||
142976979|NCT05507580|515452167|FG002|Double-Blind Treatment Period|Other, not specified|0|||
142976980|NCT05507580|515452168|FG003|Double-Blind Treatment Period|Other, not specified|0|||
142976981|NCT05507580|515452169|FG004|Double-Blind Treatment Period|Other, not specified|0|||
142976982|NCT05507580|515452170|FG005|Double-Blind Treatment Period|Other, not specified|0|||
142976983|NCT05507580|515452165|FG000|Single-Blind Treatment Period|Lost to Follow-up|0|||
142976984|NCT05507580|515452166|FG001|Single-Blind Treatment Period|Lost to Follow-up|0|||
142976985|NCT05507580|515452167|FG002|Single-Blind Treatment Period|Lost to Follow-up|0|||
142976986|NCT05507580|515452168|FG003|Single-Blind Treatment Period|Lost to Follow-up|0|||
142976987|NCT05507580|515452169|FG004|Single-Blind Treatment Period|Lost to Follow-up|2|||
142976988|NCT05507580|515452170|FG005|Single-Blind Treatment Period|Lost to Follow-up|1|||
142976989|NCT05507580|515452165|FG000|Single-Blind Treatment Period|Withdrawal by Subject|0|||
142976990|NCT05507580|515452166|FG001|Single-Blind Treatment Period|Withdrawal by Subject|0|||
142976991|NCT05507580|515452167|FG002|Single-Blind Treatment Period|Withdrawal by Subject|0|||
142976992|NCT05507580|515452168|FG003|Single-Blind Treatment Period|Withdrawal by Subject|5|||
142976993|NCT05507580|515452169|FG004|Single-Blind Treatment Period|Withdrawal by Subject|2|||
142976994|NCT05507580|515452170|FG005|Single-Blind Treatment Period|Withdrawal by Subject|6|||
142976995|NCT05507580|515452165|FG000|Single-Blind Treatment Period|Other, not specified|0|||
142976996|NCT05507580|515452166|FG001|Single-Blind Treatment Period|Other, not specified|0|||
142976997|NCT05507580|515452167|FG002|Single-Blind Treatment Period|Other, not specified|2|||
142976998|NCT05507580|515452168|FG003|Single-Blind Treatment Period|Other, not specified|7|||
142976999|NCT05507580|515452169|FG004|Single-Blind Treatment Period|Other, not specified|3|||
142977000|NCT05507580|515452170|FG005|Single-Blind Treatment Period|Other, not specified|5|||
142977001|NCT01438307|515452172|FG000|Overall Study|Death|1|||
142977002|NCT01438307|515452173|FG001|Overall Study|Death|1|||
142977003|NCT00555568|515452174|FG000|Overall Study|Lost to Follow-up|26|||
142977004|NCT00555568|515452175|FG001|Overall Study|Lost to Follow-up|16|||
142977005|NCT00555568|515452176|FG002|Overall Study|Lost to Follow-up|16|||
142977006|NCT00493467|515452177|FG000|Overall Study|Death|1|||
142977007|NCT03395223|515452178|FG000|Overall Study|Lost to Follow-up|3|||
142977008|NCT03395223|515452178|FG000|Overall Study|Other|1|||
142977009|NCT01074658|515452179|FG000|Overall Study|No implant attempted|19|||
142977010|NCT00425100|515452188|FG000|Overall Study|Adverse Event|36|||
142977011|NCT00425100|515452188|FG000|Overall Study|Lack of Efficacy|4|||
142977012|NCT00425100|515452188|FG000|Overall Study|Lost to Follow-up|2|||
142977013|NCT00425100|515452188|FG000|Overall Study|Protocol Violation|4|||
142977014|NCT00425100|515452188|FG000|Overall Study|Withdrawal by Subject|7|||
142977015|NCT02188719|515452189|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
142977016|NCT02188719|515452190|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
142977017|NCT02188719|515452191|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
142977018|NCT02188719|515452192|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
142977019|NCT00555906|515452199|FG000|Phase 1|Objective Progression or Relapse|3|||
142977020|NCT00555906|515452200|FG001|Phase 1|Objective Progression or Relapse|5|||
142977021|NCT00555906|515452201|FG002|Phase 1|Objective Progression or Relapse|3|||
142977022|NCT00555906|515452202|FG003|Phase 1|Objective Progression or Relapse|1|||
142977023|NCT00555906|515452203|FG004|Phase 1|Objective Progression or Relapse|0|||
142977024|NCT00555906|515452199|FG000|Phase 1|Global Deterioration of Health Status|0|||
142977025|NCT00555906|515452200|FG001|Phase 1|Global Deterioration of Health Status|1|||
142977026|NCT00555906|515452201|FG002|Phase 1|Global Deterioration of Health Status|1|||
142977027|NCT00555906|515452202|FG003|Phase 1|Global Deterioration of Health Status|1|||
142977028|NCT00555906|515452203|FG004|Phase 1|Global Deterioration of Health Status|0|||
142977029|NCT00555906|515452199|FG000|Phase 1|Adverse Event|0|||
142977030|NCT00555906|515452200|FG001|Phase 1|Adverse Event|0|||
142977031|NCT00555906|515452201|FG002|Phase 1|Adverse Event|3|||
142977032|NCT00555906|515452202|FG003|Phase 1|Adverse Event|2|||
142977033|NCT00555906|515452203|FG004|Phase 1|Adverse Event|0|||
142977034|NCT00555906|515452199|FG000|Phase 1|Withdrawal by Subject|0|||
142977035|NCT00555906|515452200|FG001|Phase 1|Withdrawal by Subject|0|||
142977036|NCT00555906|515452201|FG002|Phase 1|Withdrawal by Subject|0|||
142977037|NCT00555906|515452202|FG003|Phase 1|Withdrawal by Subject|1|||
142977038|NCT00555906|515452203|FG004|Phase 1|Withdrawal by Subject|0|||
142977039|NCT00555906|515452199|FG000|Phase 2|Adverse Event|0|||
142977040|NCT00555906|515452200|FG001|Phase 2|Adverse Event|0|||
142977041|NCT00555906|515452201|FG002|Phase 2|Adverse Event|0|||
142977042|NCT00555906|515452202|FG003|Phase 2|Adverse Event|0|||
142977043|NCT00555906|515452203|FG004|Phase 2|Adverse Event|4|||
142977044|NCT00555906|515452199|FG000|Phase 2|Global Deterioration of Health Status|0|||
142977045|NCT00555906|515452200|FG001|Phase 2|Global Deterioration of Health Status|0|||
142977046|NCT00555906|515452201|FG002|Phase 2|Global Deterioration of Health Status|0|||
142977047|NCT00555906|515452202|FG003|Phase 2|Global Deterioration of Health Status|0|||
142977048|NCT00555906|515452203|FG004|Phase 2|Global Deterioration of Health Status|2|||
142977049|NCT00555906|515452199|FG000|Phase 2|Objective Progression or Relapse|0|||
142977050|NCT00555906|515452200|FG001|Phase 2|Objective Progression or Relapse|0|||
142977051|NCT00555906|515452201|FG002|Phase 2|Objective Progression or Relapse|0|||
142977052|NCT00555906|515452202|FG003|Phase 2|Objective Progression or Relapse|0|||
142977053|NCT00555906|515452203|FG004|Phase 2|Objective Progression or Relapse|16|||
142977054|NCT00555906|515452199|FG000|Phase 2|Withdrawal by Subject|0|||
142977055|NCT00555906|515452200|FG001|Phase 2|Withdrawal by Subject|0|||
142977056|NCT00555906|515452201|FG002|Phase 2|Withdrawal by Subject|0|||
142977057|NCT00555906|515452202|FG003|Phase 2|Withdrawal by Subject|0|||
142977058|NCT00555906|515452203|FG004|Phase 2|Withdrawal by Subject|2|||
142977059|NCT00555906|515452199|FG000|Phase 2|Other|0|||
142977060|NCT00555906|515452200|FG001|Phase 2|Other|0|||
142977061|NCT00555906|515452201|FG002|Phase 2|Other|0|||
142977062|NCT00555906|515452202|FG003|Phase 2|Other|0|||
142977063|NCT00555906|515452203|FG004|Phase 2|Other|6|||
142977064|NCT00555906|515452199|FG000|Phase 2|Randomized but not Treated|0|||
142977065|NCT00555906|515452200|FG001|Phase 2|Randomized but not Treated|0|||
142977066|NCT00555906|515452201|FG002|Phase 2|Randomized but not Treated|0|||
142977067|NCT00555906|515452202|FG003|Phase 2|Randomized but not Treated|0|||
142977068|NCT00555906|515452203|FG004|Phase 2|Randomized but not Treated|2|||
142977069|NCT02193828|515452204|FG000|Overall Study|Withdrawal by Subject|0|||
142977070|NCT02193828|515452205|FG001|Overall Study|Withdrawal by Subject|0|||
142977071|NCT02193828|515452206|FG002|Overall Study|Withdrawal by Subject|1|||
142977072|NCT02193828|515452207|FG003|Overall Study|Withdrawal by Subject|1|||
142977073|NCT03219567|515452208|FG000|Overall Study|Withdrawal by Subject|0|||
142977074|NCT03219567|515452209|FG001|Overall Study|Withdrawal by Subject|1|||
142977075|NCT00889681|515452210|FG000|Overall Study|Not meeting qualification Criteria|2|||
142977076|NCT00889681|515452210|FG000|Overall Study|Insurance disapproval|1|||
142977077|NCT01313208|515452211|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
142977078|NCT01313208|515452212|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
142977079|NCT01313208|515452211|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
142977080|NCT01313208|515452212|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
142977081|NCT01313208|515452211|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
142977082|NCT01313208|515452212|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
142977083|NCT01313208|515452211|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
142977084|NCT01313208|515452212|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
142977085|NCT01313208|515452211|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
142977086|NCT01313208|515452212|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
142977087|NCT01313208|515452211|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
142977088|NCT01313208|515452212|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
142977089|NCT01313208|515452211|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
142977090|NCT01313208|515452212|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
142977091|NCT01313208|515452211|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
142977092|NCT01313208|515452212|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
142977093|NCT01313208|515452211|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
142977094|NCT01313208|515452212|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
142977095|NCT01957787|515452213|FG000|Overall Study|Death|18|||
142977096|NCT01957787|515452213|FG000|Overall Study|Lost to Follow-up|3|||
142977097|NCT01957787|515452213|FG000|Overall Study|Withdrawal by Subject|3|||
142977098|NCT01957787|515452213|FG000|Overall Study|Entered Hospice or Similar Program|2|||
142977099|NCT01957787|515452213|FG000|Overall Study|Index Tumor(s) Resected|2|||
142977100|NCT01957787|515452213|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
142977101|NCT01957787|515452213|FG000|Overall Study|Local therapy, not cryoablation|6|||
142977102|NCT03505749|515452214|FG000|Overall Study|Lost to Follow-up|7|||
142977103|NCT03505749|515452215|FG001|Overall Study|Lost to Follow-up|11|||
142977104|NCT03505749|515452214|FG000|Overall Study|Withdrawal by Subject|6|||
142977105|NCT03505749|515452215|FG001|Overall Study|Withdrawal by Subject|0|||
142977106|NCT03505749|515452214|FG000|Overall Study|Discharged from treatment|3|||
142977107|NCT03505749|515452215|FG001|Overall Study|Discharged from treatment|6|||
142977108|NCT03846219|515452216|FG000|Overall Study|Withdrawal by Subject|3|||
142977109|NCT03846219|515452217|FG001|Overall Study|Withdrawal by Subject|2|||
142977110|NCT03846219|515452218|FG002|Overall Study|Withdrawal by Subject|2|||
142977111|NCT03846219|515452216|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
142977112|NCT03846219|515452217|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
142977113|NCT03846219|515452218|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
142977114|NCT03846219|515452216|FG000|Overall Study|Physician Decision|0|||
142977115|NCT03846219|515452217|FG001|Overall Study|Physician Decision|0|||
142977116|NCT03846219|515452218|FG002|Overall Study|Physician Decision|2|||
142977117|NCT05109702|515452219|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
142977118|NCT05109702|515452220|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
142977119|NCT05109702|515452221|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
142977120|NCT05109702|515452219|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
142977121|NCT05109702|515452220|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
142977122|NCT05109702|515452221|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
142977123|NCT05109702|515452219|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
142977124|NCT05109702|515452220|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
142977125|NCT05109702|515452221|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
142977126|NCT05109702|515452219|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
142977127|NCT05109702|515452220|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
142977128|NCT05109702|515452221|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
142977129|NCT05109702|515452219|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
142977130|NCT05109702|515452220|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
142977131|NCT05109702|515452221|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
142977132|NCT01392378|515452224|FG000|Infant Series|Adverse Event|0|||
142977133|NCT01392378|515452225|FG001|Infant Series|Adverse Event|0|||
142977134|NCT01392378|515452226|FG002|Infant Series|Adverse Event|0|||
142977135|NCT01392378|515452227|FG003|Infant Series|Adverse Event|1|||
142977136|NCT01392378|515452228|FG004|Infant Series|Adverse Event|0|||
142977137|NCT01392378|515452224|FG000|Infant Series|Lost to Follow-up|0|||
142977138|NCT01392378|515452225|FG001|Infant Series|Lost to Follow-up|0|||
142977139|NCT01392378|515452226|FG002|Infant Series|Lost to Follow-up|0|||
142977140|NCT01392378|515452227|FG003|Infant Series|Lost to Follow-up|1|||
142977141|NCT01392378|515452228|FG004|Infant Series|Lost to Follow-up|0|||
142977142|NCT01392378|515452224|FG000|Infant Series|Protocol Violation|0|||
142977143|NCT01392378|515452225|FG001|Infant Series|Protocol Violation|1|||
142977144|NCT01392378|515452226|FG002|Infant Series|Protocol Violation|0|||
142977145|NCT01392378|515452227|FG003|Infant Series|Protocol Violation|0|||
142977146|NCT01392378|515452228|FG004|Infant Series|Protocol Violation|0|||
142977147|NCT01392378|515452224|FG000|Infant Series|Withdrawal by Parent|4|||
142977148|NCT01392378|515452225|FG001|Infant Series|Withdrawal by Parent|1|||
142977149|NCT01392378|515452226|FG002|Infant Series|Withdrawal by Parent|0|||
142977150|NCT01392378|515452227|FG003|Infant Series|Withdrawal by Parent|0|||
142977151|NCT01392378|515452228|FG004|Infant Series|Withdrawal by Parent|0|||
142977152|NCT01392378|515452224|FG000|After Infant Series|Lost to Follow-up|0|||
142977153|NCT01392378|515452225|FG001|After Infant Series|Lost to Follow-up|0|||
142977154|NCT01392378|515452226|FG002|After Infant Series|Lost to Follow-up|1|||
142977155|NCT01392378|515452227|FG003|After Infant Series|Lost to Follow-up|0|||
142977156|NCT01392378|515452228|FG004|After Infant Series|Lost to Follow-up|0|||
142977157|NCT01392378|515452224|FG000|After Infant Series|Withdrawal by Parent|0|||
142977158|NCT01392378|515452225|FG001|After Infant Series|Withdrawal by Parent|1|||
142977159|NCT01392378|515452226|FG002|After Infant Series|Withdrawal by Parent|1|||
142977160|NCT01392378|515452227|FG003|After Infant Series|Withdrawal by Parent|0|||
142977161|NCT01392378|515452228|FG004|After Infant Series|Withdrawal by Parent|1|||
142977162|NCT01392378|515452224|FG000|Toddler Dose|Lost to Follow-up|0|||
142977163|NCT01392378|515452225|FG001|Toddler Dose|Lost to Follow-up|0|||
142977164|NCT01392378|515452226|FG002|Toddler Dose|Lost to Follow-up|0|||
142977165|NCT01392378|515452227|FG003|Toddler Dose|Lost to Follow-up|1|||
142977166|NCT01392378|515452228|FG004|Toddler Dose|Lost to Follow-up|0|||
142977167|NCT01392378|515452224|FG000|Toddler Dose|Withdrawal by Parent|0|||
142977168|NCT01392378|515452225|FG001|Toddler Dose|Withdrawal by Parent|1|||
142977169|NCT01392378|515452226|FG002|Toddler Dose|Withdrawal by Parent|0|||
142977170|NCT01392378|515452227|FG003|Toddler Dose|Withdrawal by Parent|1|||
142977171|NCT01392378|515452228|FG004|Toddler Dose|Withdrawal by Parent|1|||
142977172|NCT00788697|515452232|FG000|Overall Study|No study drug administered|12|||
142977173|NCT00788697|515452232|FG000|Overall Study|Training Patients|74|||
142977174|NCT00788697|515452232|FG000|Overall Study|no truth standard procedure available|5|||
142977175|NCT00788697|515452232|FG000|Overall Study|Technically inadequate truth standard|1|||
142977176|NCT00788697|515452232|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
142977177|NCT01998880|515452234|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
142977178|NCT01998880|515452235|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
142977179|NCT01998880|515452234|FG000|Overall Study|Disease Progression|1|||
142977180|NCT01998880|515452235|FG001|Overall Study|Disease Progression|8|||
142977181|NCT01998880|515452234|FG000|Overall Study|Withdrew Consent|2|||
142977182|NCT01998880|515452235|FG001|Overall Study|Withdrew Consent|1|||
142977183|NCT01998880|515452234|FG000|Overall Study|Death|3|||
142977184|NCT01998880|515452235|FG001|Overall Study|Death|6|||
142977185|NCT01998880|515452234|FG000|Overall Study|Insufficient Therapeutic Response|1|||
142977186|NCT01998880|515452235|FG001|Overall Study|Insufficient Therapeutic Response|5|||
142977187|NCT01998880|515452234|FG000|Overall Study|Administrative/Other|1|||
142977188|NCT01998880|515452235|FG001|Overall Study|Administrative/Other|1|||
142977189|NCT01998880|515452234|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
142977190|NCT01998880|515452235|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
142977191|NCT01998880|515452234|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
143117221|NCT00787917|515970070|FG001|Blinded Treatment|Adverse Event|0|||
142977192|NCT01998880|515452235|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
142977193|NCT01998880|515452234|FG000|Overall Study|Did Not Receive Treatment|3|||
142977194|NCT01998880|515452235|FG001|Overall Study|Did Not Receive Treatment|2|||
142977195|NCT04186663|515452238|FG000|Overall Study|Lost to Follow-up|1|||
142977196|NCT04186663|515452238|FG000|Overall Study|Unable to complete blood draw|3|||
142977197|NCT00719862|515452246|FG000|Overall Study|Adverse Event|1|||
142977198|NCT00719862|515452247|FG001|Overall Study|Adverse Event|2|||
142977199|NCT00719862|515452246|FG000|Overall Study|Lack of Efficacy|3|||
142977200|NCT00719862|515452247|FG001|Overall Study|Lack of Efficacy|0|||
142977201|NCT00719862|515452246|FG000|Overall Study|Non-Compliance|1|||
142977202|NCT00719862|515452247|FG001|Overall Study|Non-Compliance|0|||
142977203|NCT00719862|515452246|FG000|Overall Study|Withdrawal by Subject|1|||
142977204|NCT00719862|515452247|FG001|Overall Study|Withdrawal by Subject|0|||
142977205|NCT00719862|515452246|FG000|Overall Study|Lost to Follow-up|0|||
142977206|NCT00719862|515452247|FG001|Overall Study|Lost to Follow-up|1|||
142977207|NCT00719862|515452246|FG000|Overall Study|Other|2|||
142977208|NCT00719862|515452247|FG001|Overall Study|Other|3|||
142977209|NCT01184846|515452248|FG000|Overall Study|Adverse Event|2|||
142977210|NCT01184846|515452248|FG000|Overall Study|Insufficient response|1|||
142977211|NCT01999946|515452249|FG000|Overall Study|Participant not released from jail|2|||
142977212|NCT01999946|515452250|FG001|Overall Study|Participant not released from jail|2|||
142977213|NCT01999946|515452251|FG002|Overall Study|Participant not released from jail|0|||
142977214|NCT01999946|515452249|FG000|Overall Study|Not included in primary outcome analysis|0|||
142977215|NCT01999946|515452250|FG001|Overall Study|Not included in primary outcome analysis|0|||
142977216|NCT01999946|515452251|FG002|Overall Study|Not included in primary outcome analysis|79|||
142977217|NCT00719953|515452254|FG000|Overall Study|Adverse Event|4|||
142977218|NCT01626989|515452255|FG000|Screening Period|Screen Failure|15|||
142977219|NCT01626989|515452256|FG001|Screening Period|Screen Failure|0|||
142977220|NCT01626989|515452257|FG002|Screening Period|Screen Failure|0|||
142977221|NCT01626989|515452255|FG000|Screening Period|Withdrawal by Subject|2|||
142977222|NCT01626989|515452256|FG001|Screening Period|Withdrawal by Subject|0|||
142977223|NCT01626989|515452257|FG002|Screening Period|Withdrawal by Subject|0|||
142977224|NCT02293902|515452260|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
142977225|NCT02293902|515452261|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
142977226|NCT02293902|515452262|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
142977227|NCT02293902|515452263|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
142977228|NCT02293902|515452264|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
142977229|NCT02293902|515452260|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
142977230|NCT02293902|515452261|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
142977231|NCT02293902|515452262|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
142977232|NCT02293902|515452263|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
142977233|NCT02293902|515452264|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
142977234|NCT02293902|515452260|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
142977235|NCT02293902|515452261|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
142977236|NCT02293902|515452262|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
142977237|NCT02293902|515452263|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
142977238|NCT02293902|515452264|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
142977239|NCT02293902|515452260|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
142977240|NCT02293902|515452261|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
142977241|NCT02293902|515452262|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
142977242|NCT02293902|515452263|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
142977243|NCT02293902|515452264|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
142977244|NCT02293902|515452260|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
142977245|NCT02293902|515452261|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
142977246|NCT02293902|515452262|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
142977247|NCT02293902|515452263|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
142977248|NCT02293902|515452264|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
142977249|NCT02947022|515452265|FG000|Overall Study|Study Stopped|1|||
143003145|NCT01049360|515548757|FG013|Period 2|Adverse Event|0|||
143003146|NCT01049360|515548758|FG014|Period 2|Adverse Event|0|||
143003147|NCT01049360|515548759|FG015|Period 2|Adverse Event|0|||
143003148|NCT01049360|515548760|FG016|Period 2|Adverse Event|0|||
143003149|NCT01049360|515548761|FG017|Period 2|Adverse Event|0|||
143003150|NCT01049360|515548762|FG018|Period 2|Adverse Event|0|||
143003151|NCT01049360|515548763|FG019|Period 2|Adverse Event|1|||
143003152|NCT01049360|515548744|FG000|Period 2|Withdrawal by Subject|0|||
143003153|NCT01049360|515548745|FG001|Period 2|Withdrawal by Subject|0|||
143003154|NCT01049360|515548746|FG002|Period 2|Withdrawal by Subject|0|||
143003155|NCT01049360|515548747|FG003|Period 2|Withdrawal by Subject|1|||
143003156|NCT01049360|515548748|FG004|Period 2|Withdrawal by Subject|0|||
143003157|NCT01049360|515548749|FG005|Period 2|Withdrawal by Subject|0|||
143003158|NCT01049360|515548750|FG006|Period 2|Withdrawal by Subject|0|||
143003159|NCT01049360|515548751|FG007|Period 2|Withdrawal by Subject|0|||
143003160|NCT01049360|515548752|FG008|Period 2|Withdrawal by Subject|0|||
143003161|NCT01049360|515548753|FG009|Period 2|Withdrawal by Subject|0|||
143003162|NCT01049360|515548754|FG010|Period 2|Withdrawal by Subject|0|||
143117222|NCT00787917|515970069|FG000|Blinded Treatment|Lack of Efficacy|1|||
143455655|NCT00633880|517212503|FG002|Open Label Titration|Treatment Failure|0|||
143003163|NCT01049360|515548755|FG011|Period 2|Withdrawal by Subject|0|||
143003164|NCT01049360|515548756|FG012|Period 2|Withdrawal by Subject|0|||
143003165|NCT01049360|515548757|FG013|Period 2|Withdrawal by Subject|0|||
142977250|NCT01770145|515453802|FG000|Baseline|Adverse Event|20|||
142977251|NCT01770145|515453802|FG000|Baseline|Withdrawal by Subject|1|||
142977252|NCT01770145|515453802|FG000|Baseline|Lost to Follow-up|1|||
142977253|NCT01770145|515453802|FG000|Baseline|Unable to define optimal dose|4|||
142977254|NCT01770145|515453802|FG000|Treatment|Adverse Event|3|||
142977255|NCT01770145|515453802|FG000|Treatment|Withdrawal by Subject|1|||
142977256|NCT04268303|515453803|FG000|Overall Study|Lost to Follow-up|1|||
142977257|NCT04268303|515453804|FG001|Overall Study|Lost to Follow-up|1|||
142977258|NCT04268303|515453805|FG002|Overall Study|Lost to Follow-up|2|||
142977259|NCT04268303|515453803|FG000|Overall Study|Withdrawal by Subject|0|||
142977260|NCT04268303|515453804|FG001|Overall Study|Withdrawal by Subject|1|||
142977261|NCT04268303|515453805|FG002|Overall Study|Withdrawal by Subject|1|||
142977262|NCT04268303|515453803|FG000|Overall Study|Adverse Event|2|||
142977263|NCT04268303|515453804|FG001|Overall Study|Adverse Event|0|||
142977264|NCT04268303|515453805|FG002|Overall Study|Adverse Event|0|||
142977265|NCT00355134|515453806|FG000|Core Phase|Withdrawal by Subject|35|||
142977266|NCT00355134|515453807|FG001|Core Phase|Withdrawal by Subject|24|||
142977267|NCT00355134|515453808|FG002|Core Phase|Withdrawal by Subject|35|||
142977268|NCT00355134|515453809|FG003|Core Phase|Withdrawal by Subject|0|||
142977269|NCT00355134|515453810|FG004|Core Phase|Withdrawal by Subject|0|||
142977270|NCT00355134|515453806|FG000|Core Phase|Adverse Event|28|||
142977271|NCT00355134|515453807|FG001|Core Phase|Adverse Event|22|||
142977272|NCT00355134|515453808|FG002|Core Phase|Adverse Event|16|||
142977273|NCT00355134|515453809|FG003|Core Phase|Adverse Event|0|||
142977274|NCT00355134|515453810|FG004|Core Phase|Adverse Event|0|||
142977275|NCT00355134|515453806|FG000|Core Phase|Lost to Follow-up|17|||
142977276|NCT00355134|515453807|FG001|Core Phase|Lost to Follow-up|13|||
142977277|NCT00355134|515453808|FG002|Core Phase|Lost to Follow-up|21|||
142977278|NCT00355134|515453809|FG003|Core Phase|Lost to Follow-up|0|||
142977279|NCT00355134|515453810|FG004|Core Phase|Lost to Follow-up|0|||
142977280|NCT00355134|515453806|FG000|Core Phase|Abnormal laboratory value(s)|19|||
142977281|NCT00355134|515453807|FG001|Core Phase|Abnormal laboratory value(s)|14|||
142977282|NCT00355134|515453808|FG002|Core Phase|Abnormal laboratory value(s)|2|||
142977283|NCT00355134|515453809|FG003|Core Phase|Abnormal laboratory value(s)|0|||
142977284|NCT00355134|515453810|FG004|Core Phase|Abnormal laboratory value(s)|0|||
142977285|NCT00355134|515453806|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
142977286|NCT00355134|515453807|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
142977287|NCT00355134|515453808|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
142977288|NCT00355134|515453809|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
142977289|NCT00355134|515453810|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
142977290|NCT00355134|515453806|FG000|Core Phase|Administrative problems|5|||
142977291|NCT00355134|515453807|FG001|Core Phase|Administrative problems|3|||
142977292|NCT00355134|515453808|FG002|Core Phase|Administrative problems|5|||
142977293|NCT00355134|515453809|FG003|Core Phase|Administrative problems|0|||
142977294|NCT00355134|515453810|FG004|Core Phase|Administrative problems|0|||
142977295|NCT00355134|515453806|FG000|Core Phase|Protocol Violation|3|||
142977296|NCT00355134|515453807|FG001|Core Phase|Protocol Violation|2|||
142977297|NCT00355134|515453808|FG002|Core Phase|Protocol Violation|2|||
142977298|NCT00355134|515453809|FG003|Core Phase|Protocol Violation|0|||
142977299|NCT00355134|515453810|FG004|Core Phase|Protocol Violation|0|||
142977300|NCT00355134|515453806|FG000|Core Phase|Abnormal test procedure result(s)|1|||
142977301|NCT00355134|515453807|FG001|Core Phase|Abnormal test procedure result(s)|2|||
142977302|NCT00355134|515453808|FG002|Core Phase|Abnormal test procedure result(s)|1|||
142977303|NCT00355134|515453809|FG003|Core Phase|Abnormal test procedure result(s)|0|||
142977304|NCT00355134|515453810|FG004|Core Phase|Abnormal test procedure result(s)|0|||
142977305|NCT00355134|515453806|FG000|Core Phase|Condition no longer requires study drug|1|||
142977306|NCT00355134|515453807|FG001|Core Phase|Condition no longer requires study drug|0|||
142977307|NCT00355134|515453808|FG002|Core Phase|Condition no longer requires study drug|1|||
142977308|NCT00355134|515453809|FG003|Core Phase|Condition no longer requires study drug|0|||
142977309|NCT00355134|515453810|FG004|Core Phase|Condition no longer requires study drug|0|||
142977310|NCT00355134|515453806|FG000|Extension Phase|Withdrawal by Subject|7|||
142977311|NCT00355134|515453807|FG001|Extension Phase|Withdrawal by Subject|11|||
142977312|NCT00355134|515453808|FG002|Extension Phase|Withdrawal by Subject|0|||
142977313|NCT00355134|515453809|FG003|Extension Phase|Withdrawal by Subject|7|||
142977314|NCT00355134|515453810|FG004|Extension Phase|Withdrawal by Subject|5|||
142977315|NCT00355134|515453806|FG000|Extension Phase|Adverse Event|13|||
142977316|NCT00355134|515453807|FG001|Extension Phase|Adverse Event|9|||
142977317|NCT00355134|515453808|FG002|Extension Phase|Adverse Event|0|||
142977318|NCT00355134|515453809|FG003|Extension Phase|Adverse Event|3|||
142977319|NCT00355134|515453810|FG004|Extension Phase|Adverse Event|5|||
142977320|NCT00355134|515453806|FG000|Extension Phase|Lost to Follow-up|2|||
142977321|NCT00355134|515453807|FG001|Extension Phase|Lost to Follow-up|6|||
142977322|NCT00355134|515453808|FG002|Extension Phase|Lost to Follow-up|0|||
142977323|NCT00355134|515453809|FG003|Extension Phase|Lost to Follow-up|2|||
142977324|NCT00355134|515453810|FG004|Extension Phase|Lost to Follow-up|4|||
142977325|NCT00355134|515453806|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
142977326|NCT00355134|515453807|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
142977327|NCT00355134|515453808|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
142977328|NCT00355134|515453809|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
142977329|NCT00355134|515453810|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
142977330|NCT00355134|515453806|FG000|Extension Phase|Administrative problems|2|||
142977331|NCT00355134|515453807|FG001|Extension Phase|Administrative problems|4|||
142977332|NCT00355134|515453808|FG002|Extension Phase|Administrative problems|0|||
142977333|NCT00355134|515453809|FG003|Extension Phase|Administrative problems|1|||
142977334|NCT00355134|515453810|FG004|Extension Phase|Administrative problems|1|||
142977335|NCT00355134|515453806|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
142977336|NCT00355134|515453807|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
142977337|NCT00355134|515453808|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
142977338|NCT00355134|515453809|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
142977339|NCT00355134|515453810|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
142977340|NCT00355134|515453806|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
142977341|NCT00355134|515453807|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
142977342|NCT00355134|515453808|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
142977343|NCT00355134|515453809|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
142977344|NCT00355134|515453810|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
142977345|NCT00355134|515453806|FG000|Extension Phase|Protocol Violation|0|||
142977346|NCT00355134|515453807|FG001|Extension Phase|Protocol Violation|0|||
142977347|NCT00355134|515453808|FG002|Extension Phase|Protocol Violation|0|||
142977348|NCT00355134|515453809|FG003|Extension Phase|Protocol Violation|1|||
142977349|NCT00355134|515453810|FG004|Extension Phase|Protocol Violation|0|||
142977350|NCT03621189|515453816|FG000|Overall Study|Withdrawal by Subject|0|||
142977351|NCT03621189|515453817|FG001|Overall Study|Withdrawal by Subject|3|||
142977352|NCT03621189|515453816|FG000|Overall Study|Physician Decision|0|||
142977353|NCT03621189|515453817|FG001|Overall Study|Physician Decision|2|||
142977354|NCT01135394|515453818|FG000|Screening|Lost to Follow-up|2|||
142977355|NCT01135394|515453818|FG000|Screening|Withdrawal by Subject|10|||
142977356|NCT01135394|515453818|FG000|Screening|Screening failure|16|||
142977357|NCT01135394|515453818|FG000|Screening|Physician Decision|5|||
142977358|NCT01135394|515453818|FG000|Baseline Assessment|Withdrawal by Subject|9|||
142977359|NCT01135394|515453818|FG000|Baseline Assessment|Physician Decision|3|||
142977360|NCT01135394|515453818|FG000|Baseline Assessment|Lost to Follow-up|2|||
142977361|NCT01135394|515453818|FG000|Baseline Assessment|Adverse Event|1|||
142977362|NCT01135394|515453818|FG000|Study Treatment|Withdrawal by Subject|1|||
142977363|NCT01135394|515453818|FG000|Study Treatment|Physician Decision|1|||
142977364|NCT01135394|515453818|FG000|Study Treatment|Adverse Event|2|||
142977365|NCT04432376|515453819|FG000|Double-blind Treatment Period|Adverse Event|2|||
142977366|NCT04432376|515453820|FG001|Double-blind Treatment Period|Adverse Event|6|||
142977367|NCT04432376|515453821|FG002|Double-blind Treatment Period|Adverse Event|0|||
142977368|NCT04432376|515453819|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
142977369|NCT04432376|515453820|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
142977370|NCT04432376|515453821|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
142977371|NCT04432376|515453819|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
142977372|NCT04432376|515453820|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
142977373|NCT04432376|515453821|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
142977374|NCT04432376|515453819|FG000|Double-blind Treatment Period|Protocol Violation|0|||
142977375|NCT04432376|515453820|FG001|Double-blind Treatment Period|Protocol Violation|1|||
142977376|NCT04432376|515453821|FG002|Double-blind Treatment Period|Protocol Violation|0|||
142977377|NCT04432376|515453819|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
142977378|NCT04432376|515453820|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
142977379|NCT04432376|515453821|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
142977380|NCT04134728|515453822|FG000|Overall Study|Adverse Event|3|||
142977381|NCT04134728|515453823|FG001|Overall Study|Adverse Event|2|||
142977382|NCT04134728|515453824|FG002|Overall Study|Adverse Event|9|||
142977383|NCT04134728|515453825|FG003|Overall Study|Adverse Event|0|||
142977384|NCT04134728|515453826|FG004|Overall Study|Adverse Event|0|||
142977385|NCT04134728|515453827|FG005|Overall Study|Adverse Event|0|||
142977386|NCT04134728|515453822|FG000|Overall Study|Lack of Efficacy|3|||
142977387|NCT04134728|515453823|FG001|Overall Study|Lack of Efficacy|3|||
142977388|NCT04134728|515453824|FG002|Overall Study|Lack of Efficacy|1|||
142977389|NCT04134728|515453825|FG003|Overall Study|Lack of Efficacy|2|||
142977390|NCT04134728|515453826|FG004|Overall Study|Lack of Efficacy|0|||
142977391|NCT04134728|515453827|FG005|Overall Study|Lack of Efficacy|0|||
142977392|NCT04134728|515453822|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
142977393|NCT04134728|515453823|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
142977394|NCT04134728|515453824|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
142977395|NCT04134728|515453825|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
142977396|NCT04134728|515453826|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
143455656|NCT00633880|517212501|FG000|Open Label Titration|Protocol Violation|6|||
143455657|NCT00633880|517212502|FG001|Open Label Titration|Protocol Violation|0|||
143455658|NCT00633880|517212503|FG002|Open Label Titration|Protocol Violation|0|||
142977397|NCT04134728|515453827|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
142977398|NCT04134728|515453822|FG000|Overall Study|Protocol Deviation|0|||
142977399|NCT04134728|515453823|FG001|Overall Study|Protocol Deviation|0|||
142977400|NCT04134728|515453824|FG002|Overall Study|Protocol Deviation|1|||
142977401|NCT04134728|515453825|FG003|Overall Study|Protocol Deviation|0|||
142977402|NCT04134728|515453826|FG004|Overall Study|Protocol Deviation|0|||
142977403|NCT04134728|515453827|FG005|Overall Study|Protocol Deviation|0|||
142977404|NCT04134728|515453822|FG000|Overall Study|Informed Consent Withdrawn|3|||
142977405|NCT04134728|515453823|FG001|Overall Study|Informed Consent Withdrawn|6|||
142977406|NCT04134728|515453824|FG002|Overall Study|Informed Consent Withdrawn|8|||
142977407|NCT04134728|515453825|FG003|Overall Study|Informed Consent Withdrawn|1|||
142977408|NCT04134728|515453826|FG004|Overall Study|Informed Consent Withdrawn|1|||
142977409|NCT04134728|515453827|FG005|Overall Study|Informed Consent Withdrawn|0|||
142977410|NCT04134728|515453822|FG000|Overall Study|Physician Decision|2|||
142977411|NCT04134728|515453823|FG001|Overall Study|Physician Decision|0|||
142977412|NCT04134728|515453824|FG002|Overall Study|Physician Decision|0|||
142977413|NCT04134728|515453825|FG003|Overall Study|Physician Decision|0|||
142977414|NCT04134728|515453826|FG004|Overall Study|Physician Decision|0|||
142977415|NCT04134728|515453827|FG005|Overall Study|Physician Decision|0|||
142977416|NCT04134728|515453822|FG000|Overall Study|Lost to Follow-up|1|||
142977417|NCT04134728|515453823|FG001|Overall Study|Lost to Follow-up|2|||
142977418|NCT04134728|515453824|FG002|Overall Study|Lost to Follow-up|1|||
142977419|NCT04134728|515453825|FG003|Overall Study|Lost to Follow-up|0|||
142977420|NCT04134728|515453826|FG004|Overall Study|Lost to Follow-up|0|||
142977421|NCT04134728|515453827|FG005|Overall Study|Lost to Follow-up|1|||
142977422|NCT04134728|515453822|FG000|Overall Study|Investigator Site Closed|0|||
142977423|NCT04134728|515453823|FG001|Overall Study|Investigator Site Closed|1|||
142977424|NCT04134728|515453824|FG002|Overall Study|Investigator Site Closed|1|||
142977425|NCT04134728|515453825|FG003|Overall Study|Investigator Site Closed|0|||
142977426|NCT04134728|515453826|FG004|Overall Study|Investigator Site Closed|0|||
142977427|NCT04134728|515453827|FG005|Overall Study|Investigator Site Closed|0|||
142977428|NCT04702984|515453830|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
142977429|NCT06000501|515453833|FG000|Overall Study|Screen failure|3|||
142977430|NCT06000501|515453833|FG000|Overall Study|Severe past drug dependence determined by the MINI|2|||
142977431|NCT06000501|515453833|FG000|Overall Study|Physician Decision|4|||
142977432|NCT06000501|515453833|FG000|Overall Study|Positive Urine Drug Test (UDT)|1|||
142977433|NCT06000501|515453833|FG000|Overall Study|Scheduling issues|2|||
142977434|NCT03496662|515453834|FG000|Overall Study|Adverse Event|0|||
142977435|NCT03496662|515453835|FG001|Overall Study|Adverse Event|0|||
142977436|NCT03496662|515453836|FG002|Overall Study|Adverse Event|4|||
142977437|NCT03496662|515453834|FG000|Overall Study|Withdrawal by Subject|1|||
142977438|NCT03496662|515453835|FG001|Overall Study|Withdrawal by Subject|0|||
142977439|NCT03496662|515453836|FG002|Overall Study|Withdrawal by Subject|2|||
142977440|NCT03496662|515453834|FG000|Overall Study|Death|0|||
142977441|NCT03496662|515453835|FG001|Overall Study|Death|0|||
142977442|NCT03496662|515453836|FG002|Overall Study|Death|2|||
142977443|NCT03496662|515453834|FG000|Overall Study|Noncompliance|0|||
142977444|NCT03496662|515453835|FG001|Overall Study|Noncompliance|0|||
142977445|NCT03496662|515453836|FG002|Overall Study|Noncompliance|1|||
142977446|NCT01467661|515453837|FG000|Overall Study|Adverse Event|16|||
142977447|NCT01467661|515453837|FG000|Overall Study|Withdrawal by Subject|1|||
142977448|NCT01467661|515453837|FG000|Overall Study|Lack of Efficacy|3|||
142977449|NCT01467661|515453837|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
142977450|NCT03037307|515453838|FG000|Period 1|Did Not Meet Study Criteria|0|||
142977451|NCT03037307|515453839|FG001|Period 1|Did Not Meet Study Criteria|0|||
142977452|NCT03037307|515453840|FG002|Period 1|Did Not Meet Study Criteria|0|||
142977453|NCT03037307|515453841|FG003|Period 1|Did Not Meet Study Criteria|1|||
142977454|NCT03037307|515453842|FG004|Period 1|Did Not Meet Study Criteria|0|||
142977455|NCT03037307|515453843|FG005|Period 1|Did Not Meet Study Criteria|0|||
142977456|NCT00270998|515453846|FG000|3 Month Follow-up|Adverse Event|1|||
142977457|NCT00270998|515453847|FG001|3 Month Follow-up|Adverse Event|0|||
142977458|NCT00270998|515453848|FG002|3 Month Follow-up|Adverse Event|0|||
142977459|NCT00270998|515453846|FG000|3 Month Follow-up|Lack of Efficacy|1|||
142977460|NCT00270998|515453847|FG001|3 Month Follow-up|Lack of Efficacy|2|||
142977461|NCT00270998|515453848|FG002|3 Month Follow-up|Lack of Efficacy|1|||
142977462|NCT00270998|515453846|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
142977463|NCT00270998|515453847|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
142977464|NCT00270998|515453848|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
142977465|NCT00270998|515453846|FG000|3 Month Follow-up|Pessary did not fit|12|||
142977466|NCT00270998|515453847|FG001|3 Month Follow-up|Pessary did not fit|0|||
142977467|NCT00270998|515453848|FG002|3 Month Follow-up|Pessary did not fit|0|||
142977468|NCT00270998|515453846|FG000|3 Month Follow-up|Personal/family health|1|||
142977469|NCT00270998|515453847|FG001|3 Month Follow-up|Personal/family health|1|||
142977470|NCT00270998|515453848|FG002|3 Month Follow-up|Personal/family health|0|||
142977471|NCT00270998|515453846|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
142977472|NCT00270998|515453847|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
142977473|NCT00270998|515453848|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
142977474|NCT00270998|515453846|FG000|12 Month Follow-up|Lack of Efficacy|5|||
142977475|NCT00270998|515453847|FG001|12 Month Follow-up|Lack of Efficacy|4|||
142977476|NCT00270998|515453848|FG002|12 Month Follow-up|Lack of Efficacy|3|||
142977477|NCT00270998|515453846|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
142977478|NCT00270998|515453847|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
142977479|NCT00270998|515453848|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
142977480|NCT00270998|515453846|FG000|12 Month Follow-up|Pessary did not fit|1|||
142977481|NCT00270998|515453847|FG001|12 Month Follow-up|Pessary did not fit|0|||
142977482|NCT00270998|515453848|FG002|12 Month Follow-up|Pessary did not fit|0|||
142977483|NCT00270998|515453846|FG000|12 Month Follow-up|Personal/family health|0|||
142977484|NCT00270998|515453847|FG001|12 Month Follow-up|Personal/family health|5|||
142977485|NCT00270998|515453848|FG002|12 Month Follow-up|Personal/family health|1|||
142977486|NCT00270998|515453846|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
142977487|NCT00270998|515453847|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
142977488|NCT00270998|515453848|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
142977489|NCT01855945|515453852|FG000|Overall Study|Adverse Event|0|||
142977490|NCT01855945|515453853|FG001|Overall Study|Adverse Event|0|||
142977491|NCT01855945|515453854|FG002|Overall Study|Adverse Event|0|||
142977492|NCT01855945|515453855|FG003|Overall Study|Adverse Event|0|||
142977493|NCT01855945|515453856|FG004|Overall Study|Adverse Event|0|||
142977494|NCT01855945|515453857|FG005|Overall Study|Adverse Event|0|||
142977495|NCT01855945|515453858|FG006|Overall Study|Adverse Event|1|||
142977496|NCT01855945|515453859|FG007|Overall Study|Adverse Event|0|||
142977497|NCT01855945|515453860|FG008|Overall Study|Adverse Event|0|||
142977498|NCT01855945|515453861|FG009|Overall Study|Adverse Event|0|||
142977499|NCT01855945|515453862|FG010|Overall Study|Adverse Event|0|||
142977500|NCT01855945|515453863|FG011|Overall Study|Adverse Event|0|||
142977501|NCT01855945|515453852|FG000|Overall Study|Death|0|||
142977502|NCT01855945|515453853|FG001|Overall Study|Death|0|||
142977503|NCT01855945|515453854|FG002|Overall Study|Death|0|||
142977504|NCT01855945|515453855|FG003|Overall Study|Death|0|||
142977505|NCT01855945|515453856|FG004|Overall Study|Death|0|||
142977506|NCT01855945|515453857|FG005|Overall Study|Death|0|||
142977507|NCT01855945|515453858|FG006|Overall Study|Death|2|||
142977508|NCT01855945|515453859|FG007|Overall Study|Death|0|||
142977509|NCT01855945|515453860|FG008|Overall Study|Death|0|||
142977510|NCT01855945|515453861|FG009|Overall Study|Death|0|||
142977511|NCT01855945|515453862|FG010|Overall Study|Death|0|||
142977512|NCT01855945|515453863|FG011|Overall Study|Death|0|||
142977513|NCT01855945|515453852|FG000|Overall Study|Lost to Follow-up|11|||
142977514|NCT01855945|515453853|FG001|Overall Study|Lost to Follow-up|10|||
142977515|NCT01855945|515453854|FG002|Overall Study|Lost to Follow-up|7|||
142977516|NCT01855945|515453855|FG003|Overall Study|Lost to Follow-up|3|||
142977517|NCT01855945|515453856|FG004|Overall Study|Lost to Follow-up|0|||
142977518|NCT01855945|515453857|FG005|Overall Study|Lost to Follow-up|3|||
142977519|NCT01855945|515453858|FG006|Overall Study|Lost to Follow-up|4|||
142977520|NCT01855945|515453859|FG007|Overall Study|Lost to Follow-up|7|||
142977521|NCT01855945|515453860|FG008|Overall Study|Lost to Follow-up|2|||
142977522|NCT01855945|515453861|FG009|Overall Study|Lost to Follow-up|0|||
142977523|NCT01855945|515453862|FG010|Overall Study|Lost to Follow-up|0|||
142977524|NCT01855945|515453863|FG011|Overall Study|Lost to Follow-up|2|||
142977525|NCT01855945|515453852|FG000|Overall Study|Other - Unclassified|1|||
142977526|NCT01855945|515453853|FG001|Overall Study|Other - Unclassified|1|||
142977527|NCT01855945|515453854|FG002|Overall Study|Other - Unclassified|1|||
142977528|NCT01855945|515453855|FG003|Overall Study|Other - Unclassified|0|||
142977529|NCT01855945|515453856|FG004|Overall Study|Other - Unclassified|0|||
142977530|NCT01855945|515453857|FG005|Overall Study|Other - Unclassified|0|||
142977531|NCT01855945|515453858|FG006|Overall Study|Other - Unclassified|2|||
142977532|NCT01855945|515453859|FG007|Overall Study|Other - Unclassified|1|||
142977533|NCT01855945|515453860|FG008|Overall Study|Other - Unclassified|0|||
142977534|NCT01855945|515453861|FG009|Overall Study|Other - Unclassified|0|||
142977535|NCT01855945|515453862|FG010|Overall Study|Other - Unclassified|1|||
142977536|NCT01855945|515453863|FG011|Overall Study|Other - Unclassified|0|||
142977537|NCT01855945|515453852|FG000|Overall Study|Withdrawal by Subject|4|||
142977538|NCT01855945|515453853|FG001|Overall Study|Withdrawal by Subject|0|||
142977539|NCT01855945|515453854|FG002|Overall Study|Withdrawal by Subject|4|||
142977540|NCT01855945|515453855|FG003|Overall Study|Withdrawal by Subject|1|||
142977541|NCT01855945|515453856|FG004|Overall Study|Withdrawal by Subject|1|||
142977542|NCT01855945|515453857|FG005|Overall Study|Withdrawal by Subject|0|||
142977543|NCT01855945|515453858|FG006|Overall Study|Withdrawal by Subject|1|||
142977544|NCT01855945|515453859|FG007|Overall Study|Withdrawal by Subject|0|||
142977545|NCT01855945|515453860|FG008|Overall Study|Withdrawal by Subject|0|||
142977546|NCT01855945|515453861|FG009|Overall Study|Withdrawal by Subject|2|||
142977547|NCT01855945|515453862|FG010|Overall Study|Withdrawal by Subject|4|||
142977548|NCT01855945|515453863|FG011|Overall Study|Withdrawal by Subject|1|||
142977549|NCT00432562|515453864|FG000|Overall Study|Death|3|||
142977550|NCT00432562|515453865|FG001|Overall Study|Death|0|||
142977551|NCT00636441|515453866|FG000|Overall Study|Adverse Event|0|||
142977552|NCT00636441|515453867|FG001|Overall Study|Adverse Event|1|||
142977553|NCT00636441|515453868|FG002|Overall Study|Adverse Event|1|||
142977554|NCT00636441|515453869|FG003|Overall Study|Adverse Event|0|||
142977555|NCT00636441|515453870|FG004|Overall Study|Adverse Event|0|||
142977556|NCT00636441|515453871|FG005|Overall Study|Adverse Event|1|||
142977557|NCT00636441|515453872|FG006|Overall Study|Adverse Event|0|||
142977558|NCT00636441|515453866|FG000|Overall Study|Late, ineligible|0|||
142977559|NCT00636441|515453867|FG001|Overall Study|Late, ineligible|0|||
142977560|NCT00636441|515453868|FG002|Overall Study|Late, ineligible|0|||
142977561|NCT00636441|515453869|FG003|Overall Study|Late, ineligible|0|||
142977562|NCT00636441|515453870|FG004|Overall Study|Late, ineligible|0|||
142977563|NCT00636441|515453871|FG005|Overall Study|Late, ineligible|0|||
142977564|NCT00636441|515453872|FG006|Overall Study|Late, ineligible|1|||
142977565|NCT00636441|515453866|FG000|Overall Study|Screen Failure|0|||
142977566|NCT00636441|515453867|FG001|Overall Study|Screen Failure|0|||
142977567|NCT00636441|515453868|FG002|Overall Study|Screen Failure|0|||
142977568|NCT00636441|515453869|FG003|Overall Study|Screen Failure|0|||
142977569|NCT00636441|515453870|FG004|Overall Study|Screen Failure|0|||
142977570|NCT00636441|515453871|FG005|Overall Study|Screen Failure|0|||
142977571|NCT00636441|515453872|FG006|Overall Study|Screen Failure|17|||
142977572|NCT00305604|515453873|FG000|Overall Study|Adverse Event|6|||
142977573|NCT00305604|515453874|FG001|Overall Study|Adverse Event|3|||
142977574|NCT00305604|515453873|FG000|Overall Study|Lack of Efficacy|11|||
142977575|NCT00305604|515453874|FG001|Overall Study|Lack of Efficacy|18|||
142977576|NCT00305604|515453873|FG000|Overall Study|Lost to Follow-up|0|||
142977577|NCT00305604|515453874|FG001|Overall Study|Lost to Follow-up|4|||
142977578|NCT00305604|515453873|FG000|Overall Study|Protocol Violation|2|||
142977579|NCT00305604|515453874|FG001|Overall Study|Protocol Violation|1|||
142977580|NCT00305604|515453873|FG000|Overall Study|Withdrawal by Subject|12|||
142977581|NCT00305604|515453874|FG001|Overall Study|Withdrawal by Subject|21|||
142977582|NCT00305604|515453873|FG000|Overall Study|Patient moved|1|||
142977583|NCT00305604|515453874|FG001|Overall Study|Patient moved|0|||
142977584|NCT01248364|515453875|FG000|Overall Study|Adverse Event|0|||
142977585|NCT01248364|515453876|FG001|Overall Study|Adverse Event|1|||
142977586|NCT01248364|515453877|FG002|Overall Study|Adverse Event|0|||
142977587|NCT01248364|515453878|FG003|Overall Study|Adverse Event|0|||
142977588|NCT01315847|515453879|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
142977589|NCT01315847|515453880|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
142977590|NCT01315847|515453879|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
142977591|NCT01315847|515453880|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
142977592|NCT03495817|515453882|FG000|26 Week Open Label|Adverse Event|3|||
142977593|NCT03495817|515453882|FG000|26 Week Open Label|Withdrawal by Subject|4|||
142977594|NCT03495817|515453882|FG000|26 Week Open Label|Lost to Follow-up|1|||
142977595|NCT03495817|515453882|FG000|26 Week Extension|Lost to Follow-up|2|||
142977596|NCT01117012|515453883|FG000|Overall Study|Adverse Event|0|||
142977597|NCT01117012|515453884|FG001|Overall Study|Adverse Event|1|||
142977598|NCT01117012|515453883|FG000|Overall Study|Death|1|||
142977599|NCT01117012|515453884|FG001|Overall Study|Death|1|||
142977600|NCT01117012|515453883|FG000|Overall Study|Withdrawal by Subject|3|||
142977601|NCT01117012|515453884|FG001|Overall Study|Withdrawal by Subject|0|||
142977602|NCT01117012|515453883|FG000|Overall Study|Undefined|4|||
142977603|NCT01117012|515453884|FG001|Overall Study|Undefined|3|||
142977604|NCT04169061|515453885|FG000|Overall Study|Adverse Event|2|||
142977605|NCT04169061|515453885|FG000|Overall Study|Death|1|||
142977606|NCT04169061|515453885|FG000|Overall Study|Withdrawal by Subject|1|||
142977607|NCT04169061|515453885|FG000|Overall Study|Protocol Violation|1|||
142977608|NCT04585451|515453886|FG000|Overall Study|Withdrawal by Subject|26|||
142977609|NCT04585451|515453887|FG001|Overall Study|Withdrawal by Subject|0|||
142977610|NCT01586806|515453888|FG000|Overall Study|Protocol Violation|0|||
142977611|NCT01586806|515453889|FG001|Overall Study|Protocol Violation|1|||
142977612|NCT01586806|515453890|FG002|Overall Study|Protocol Violation|0|||
142977613|NCT01586806|515453888|FG000|Overall Study|Withdrawal by Subject|1|||
142977614|NCT01586806|515453889|FG001|Overall Study|Withdrawal by Subject|0|||
142977615|NCT01586806|515453890|FG002|Overall Study|Withdrawal by Subject|0|||
142977616|NCT01586806|515453888|FG000|Overall Study|Lost to Follow-up|2|||
142977617|NCT01586806|515453889|FG001|Overall Study|Lost to Follow-up|3|||
142977618|NCT01586806|515453890|FG002|Overall Study|Lost to Follow-up|2|||
142977619|NCT02849626|515453891|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
142977620|NCT02849626|515453892|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
142977621|NCT02849626|515453893|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
142977622|NCT02849626|515453894|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
142977623|NCT02849626|515453891|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
142977624|NCT02849626|515453892|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
142977625|NCT02849626|515453893|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
142977626|NCT02849626|515453894|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
142977627|NCT02849626|515453891|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
142977628|NCT02849626|515453892|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
142977629|NCT02849626|515453893|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
142977630|NCT02849626|515453894|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
142977631|NCT02849626|515453891|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
142977632|NCT02849626|515453892|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
142977633|NCT02849626|515453893|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
142977634|NCT02849626|515453894|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
142977635|NCT02849626|515453891|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
142977636|NCT02849626|515453892|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
142977637|NCT02849626|515453893|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
142977638|NCT02849626|515453894|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
142977639|NCT02849626|515453891|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
142977640|NCT02849626|515453892|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
142977641|NCT02849626|515453893|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
142977642|NCT02849626|515453894|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
142977643|NCT02849626|515453891|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
142977644|NCT02849626|515453892|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
142977645|NCT02849626|515453893|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
142977646|NCT02849626|515453894|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
142977647|NCT02849626|515453891|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
142977648|NCT02849626|515453892|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
142977649|NCT02849626|515453893|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
142977650|NCT02849626|515453894|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
142977651|NCT02849626|515453891|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
142977652|NCT02849626|515453892|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
142977653|NCT02849626|515453893|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
142977654|NCT02849626|515453894|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
142977655|NCT02849626|515453891|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
142977656|NCT02849626|515453892|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
142977657|NCT02849626|515453893|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
142977658|NCT02849626|515453894|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
142977659|NCT02849626|515453891|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
142977660|NCT02849626|515453892|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
142977661|NCT02849626|515453893|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
142977662|NCT02849626|515453894|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
142977663|NCT04176445|515453897|FG000|Overall Study|Adverse Event|0|||
142977664|NCT04176445|515453898|FG001|Overall Study|Adverse Event|1|||
142977665|NCT04176445|515453897|FG000|Overall Study|change plans weaning after first intervention|0|||
142977666|NCT04176445|515453898|FG001|Overall Study|change plans weaning after first intervention|1|||
142977667|NCT04046341|515453899|FG000|Overall Study|Lost to Follow-up|2|||
142977668|NCT04046341|515453899|FG000|Overall Study|Withdrawal by Subject|1|||
142977669|NCT02248857|515453902|FG000|3 Month|Withdrawal by Subject|9|||
142977670|NCT02248857|515453903|FG001|3 Month|Withdrawal by Subject|3|||
142977671|NCT02248857|515453904|FG002|3 Month|Withdrawal by Subject|4|||
142977672|NCT02248857|515453902|FG000|3 Month|Unable to reach for 3 month|35|||
142977673|NCT02248857|515453903|FG001|3 Month|Unable to reach for 3 month|29|||
142977674|NCT02248857|515453904|FG002|3 Month|Unable to reach for 3 month|26|||
142977675|NCT02248857|515453902|FG000|3 Month|Partially completed, unable to finish|2|||
142977676|NCT02248857|515453903|FG001|3 Month|Partially completed, unable to finish|2|||
142977677|NCT02248857|515453904|FG002|3 Month|Partially completed, unable to finish|1|||
142977678|NCT02248857|515453902|FG000|6 Month|Lost to Follow-up|27|||
142977679|NCT02248857|515453903|FG001|6 Month|Lost to Follow-up|26|||
142977680|NCT02248857|515453904|FG002|6 Month|Lost to Follow-up|15|||
142977681|NCT02248857|515453902|FG000|6 Month|Partially completed, unable to finish|0|||
142977682|NCT02248857|515453903|FG001|6 Month|Partially completed, unable to finish|1|||
142977683|NCT02248857|515453904|FG002|6 Month|Partially completed, unable to finish|0|||
142977684|NCT02248857|515453902|FG000|6 Month|Withdrawal by Subject|0|||
142977685|NCT02248857|515453903|FG001|6 Month|Withdrawal by Subject|2|||
142977686|NCT02248857|515453904|FG002|6 Month|Withdrawal by Subject|2|||
142977687|NCT02248857|515453902|FG000|6 Month|Death|1|||
142977688|NCT02248857|515453903|FG001|6 Month|Death|0|||
142977689|NCT02248857|515453904|FG002|6 Month|Death|0|||
142977690|NCT02671461|515453905|FG000|Treatment|Adverse Event|0|||
142977691|NCT02671461|515453906|FG001|Treatment|Adverse Event|0|||
142977692|NCT02671461|515453907|FG002|Treatment|Adverse Event|1|||
142977693|NCT02671461|515453905|FG000|Treatment|Administrative Reason by Sponsor|1|||
142977694|NCT02671461|515453906|FG001|Treatment|Administrative Reason by Sponsor|3|||
142977695|NCT02671461|515453907|FG002|Treatment|Administrative Reason by Sponsor|4|||
142977696|NCT02671461|515453905|FG000|Treatment|Randomized, not treated|1|||
142977697|NCT02671461|515453906|FG001|Treatment|Randomized, not treated|0|||
142977698|NCT02671461|515453907|FG002|Treatment|Randomized, not treated|0|||
142977699|NCT02671461|515453905|FG000|Follow-up|Withdrawal by Subject|1|||
142977700|NCT02671461|515453906|FG001|Follow-up|Withdrawal by Subject|0|||
142977701|NCT02671461|515453907|FG002|Follow-up|Withdrawal by Subject|0|||
142977702|NCT02671461|515453905|FG000|Follow-up|Lost to Follow-up|0|||
142977703|NCT02671461|515453906|FG001|Follow-up|Lost to Follow-up|0|||
142977704|NCT02671461|515453907|FG002|Follow-up|Lost to Follow-up|1|||
142977705|NCT02671461|515453905|FG000|Follow-up|Administrative Reason by Sponsor|0|||
142977706|NCT02671461|515453906|FG001|Follow-up|Administrative Reason by Sponsor|1|||
142977707|NCT02671461|515453907|FG002|Follow-up|Administrative Reason by Sponsor|0|||
142977708|NCT02261883|515453908|FG000|Overall Study|Death|3|||
142977709|NCT02261883|515453909|FG001|Overall Study|Death|2|||
142977710|NCT02261883|515453908|FG000|Overall Study|Physician Decision|1|||
142977711|NCT02261883|515453909|FG001|Overall Study|Physician Decision|0|||
142977712|NCT02261883|515453908|FG000|Overall Study|Protocol Violation|1|||
142977713|NCT02261883|515453909|FG001|Overall Study|Protocol Violation|0|||
142977714|NCT02261883|515453908|FG000|Overall Study|Withdrawal by Subject|0|||
142977715|NCT02261883|515453909|FG001|Overall Study|Withdrawal by Subject|1|||
142977716|NCT02261883|515453908|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
142977717|NCT02261883|515453909|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
142977718|NCT01412060|515453910|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
142977719|NCT01412060|515453911|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
142977720|NCT01412060|515453912|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
142977721|NCT01412060|515453910|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
142977722|NCT01412060|515453911|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
142977723|NCT01412060|515453912|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
142977724|NCT01412060|515453910|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
142977725|NCT01412060|515453911|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
142977726|NCT01412060|515453912|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
142977727|NCT01412060|515453910|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
142977728|NCT01412060|515453911|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
142977729|NCT01412060|515453912|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
142977730|NCT01412060|515453910|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
142977731|NCT01412060|515453911|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
142977732|NCT01412060|515453912|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
142977733|NCT01412060|515453910|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
142977734|NCT01412060|515453911|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
142977735|NCT01412060|515453912|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
142977736|NCT01412060|515453910|FG000|Period Between RIP and SP|Adverse Event|4|||
142977737|NCT01412060|515453911|FG001|Period Between RIP and SP|Adverse Event|0|||
142977738|NCT01412060|515453912|FG002|Period Between RIP and SP|Adverse Event|0|||
142977739|NCT01412060|515453910|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
142977740|NCT01412060|515453911|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
142977741|NCT01412060|515453912|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
142977742|NCT01412060|515453910|FG000|Period Between RIP and SP|Protocol Violation|2|||
142977743|NCT01412060|515453911|FG001|Period Between RIP and SP|Protocol Violation|0|||
142977744|NCT01412060|515453912|FG002|Period Between RIP and SP|Protocol Violation|0|||
142977745|NCT01412060|515453910|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
142977746|NCT01412060|515453911|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
142977747|NCT01412060|515453912|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
142977748|NCT01412060|515453910|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
142977749|NCT01412060|515453911|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
142977750|NCT01412060|515453912|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
142977751|NCT01412060|515453910|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
142977752|NCT01412060|515453911|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
142977753|NCT01412060|515453912|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
142977754|NCT01412060|515453910|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
142977755|NCT01412060|515453911|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
142977756|NCT01412060|515453912|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
142977757|NCT01412060|515453910|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
142977758|NCT01412060|515453911|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
142977759|NCT01412060|515453912|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
142977760|NCT01412060|515453910|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
142977761|NCT01412060|515453911|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
142977762|NCT01412060|515453912|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
142977763|NCT01412060|515453910|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
142977764|NCT01412060|515453911|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
142977765|NCT01412060|515453912|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
142977766|NCT01412060|515453910|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
142977767|NCT01412060|515453911|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
142977768|NCT01412060|515453912|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
142977769|NCT01412060|515453910|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
143003166|NCT01049360|515548758|FG014|Period 2|Withdrawal by Subject|1|||
143455659|NCT00633880|517212501|FG000|Open Label Titration|Physician Decision|1|||
142977770|NCT01412060|515453911|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
142977771|NCT01412060|515453912|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
142977772|NCT01412060|515453910|FG000|Period Between SP and DBP|Protocol Violation|2|||
142977773|NCT01412060|515453911|FG001|Period Between SP and DBP|Protocol Violation|0|||
142977774|NCT01412060|515453912|FG002|Period Between SP and DBP|Protocol Violation|0|||
142977775|NCT01412060|515453910|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
142977776|NCT01412060|515453911|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
142977777|NCT01412060|515453912|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
142977778|NCT01412060|515453910|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
142977779|NCT01412060|515453911|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
142977780|NCT01412060|515453912|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
142977781|NCT01412060|515453910|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
142977782|NCT01412060|515453911|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
142977783|NCT01412060|515453912|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
142977784|NCT01412060|515453910|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
142977785|NCT01412060|515453911|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
142977786|NCT01412060|515453912|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
142977787|NCT01412060|515453910|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
142977788|NCT01412060|515453911|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
142977789|NCT01412060|515453912|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
142977790|NCT01412060|515453910|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
142977791|NCT01412060|515453911|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
142977792|NCT01412060|515453912|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
142977793|NCT01412060|515453910|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
142977794|NCT01412060|515453911|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
142977795|NCT01412060|515453912|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
142977796|NCT01412060|515453910|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
142977797|NCT01412060|515453911|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
142977798|NCT01412060|515453912|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
142977799|NCT01412060|515453910|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
142977800|NCT01412060|515453911|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
142977801|NCT01412060|515453912|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
142977802|NCT01412060|515453910|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
142977803|NCT01412060|515453911|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
142977804|NCT01412060|515453912|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
142977805|NCT00004732|515453914|FG000|Overall Study|Withdrawal by Subject|36|||
142977806|NCT00004732|515453915|FG001|Overall Study|Withdrawal by Subject|64|||
142977807|NCT00004732|515453914|FG000|Overall Study|Lost to Follow-up|33|||
142977808|NCT00004732|515453915|FG001|Overall Study|Lost to Follow-up|47|||
142977809|NCT01688635|515453917|FG000|Washout 1|Withdrawal by Subject|1|||
142977810|NCT01688635|515453918|FG001|Washout 1|Withdrawal by Subject|0|||
142977811|NCT01688635|515453917|FG000|Washout 1|Adverse Event|0|||
142977812|NCT01688635|515453918|FG001|Washout 1|Adverse Event|1|||
142977813|NCT01688635|515453917|FG000|Washout 1|Physician Decision|0|||
142977814|NCT01688635|515453918|FG001|Washout 1|Physician Decision|1|||
142977815|NCT01688635|515453917|FG000|Washout 2|Physician Decision|1|||
142977816|NCT01688635|515453918|FG001|Washout 2|Physician Decision|0|||
142977817|NCT01688635|515453917|FG000|Washout 2|Withdrawal by Subject|1|||
142977818|NCT01688635|515453918|FG001|Washout 2|Withdrawal by Subject|0|||
142977819|NCT01688635|515453917|FG000|Washout 2|Sponsor Decision|1|||
142977820|NCT01688635|515453918|FG001|Washout 2|Sponsor Decision|2|||
142977821|NCT01688635|515453917|FG000|Washout 3|Withdrawal by Subject|1|||
142977822|NCT01688635|515453918|FG001|Washout 3|Withdrawal by Subject|0|||
142977823|NCT02713789|515453919|FG000|Overall Study|Lost to Follow-up|0|||
142977824|NCT02713789|515453920|FG001|Overall Study|Lost to Follow-up|1|||
142977825|NCT02713789|515453921|FG002|Overall Study|Lost to Follow-up|1|||
142977826|NCT03549117|515453928|FG000|Overall Study|Withdrawal by Subject|1|||
142977827|NCT03549117|515453929|FG001|Overall Study|Withdrawal by Subject|0|||
142977828|NCT02661464|515453930|FG000|Overall Study|Lost to Follow-up|28|||
142977829|NCT02661464|515453931|FG001|Overall Study|Lost to Follow-up|0|||
142977830|NCT02661464|515453932|FG002|Overall Study|Lost to Follow-up|0|||
142977831|NCT02661464|515453933|FG003|Overall Study|Lost to Follow-up|0|||
142977832|NCT02661464|515453930|FG000|Overall Study|Withdrawal by Subject|3|||
142977833|NCT02661464|515453931|FG001|Overall Study|Withdrawal by Subject|1|||
142977834|NCT02661464|515453932|FG002|Overall Study|Withdrawal by Subject|0|||
142977835|NCT02661464|515453933|FG003|Overall Study|Withdrawal by Subject|0|||
142977836|NCT02661464|515453930|FG000|Overall Study|Participants terminated prematurely|288|||
142977837|NCT02661464|515453931|FG001|Overall Study|Participants terminated prematurely|52|||
142977838|NCT02661464|515453932|FG002|Overall Study|Participants terminated prematurely|1|||
142977839|NCT02661464|515453933|FG003|Overall Study|Participants terminated prematurely|1|||
142977840|NCT02661464|515453930|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
142977841|NCT02661464|515453931|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
142977842|NCT02661464|515453932|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
142977843|NCT02661464|515453933|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
142977844|NCT00014911|515453934|FG000|Overall Study|Adverse Event|1|||
142977845|NCT00014911|515453934|FG000|Overall Study|Lost to Follow-up|1|||
142977846|NCT00014911|515453934|FG000|Overall Study|Withdrawal by Subject|6|||
142977847|NCT00014911|515453934|FG000|Overall Study|Unknown Reasons|2|||
142977848|NCT00014911|515453934|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
142977849|NCT00141037|515453939|FG000|Overall Study|Physician Decision|1|||
142977850|NCT00141037|515453940|FG001|Overall Study|Physician Decision|2|||
142977851|NCT00141037|515453939|FG000|Overall Study|Lost to Follow-up|3|||
142977852|NCT00141037|515453940|FG001|Overall Study|Lost to Follow-up|1|||
142977853|NCT00141037|515453939|FG000|Overall Study|Protocol Violation|0|||
142977854|NCT00141037|515453940|FG001|Overall Study|Protocol Violation|2|||
142977855|NCT00141037|515453939|FG000|Overall Study|Withdrawal by Subject|2|||
142977856|NCT00141037|515453940|FG001|Overall Study|Withdrawal by Subject|1|||
142977857|NCT00141037|515453939|FG000|Overall Study|Other|0|||
142977858|NCT00141037|515453940|FG001|Overall Study|Other|1|||
142977859|NCT00141037|515453939|FG000|Overall Study|Moved from area|1|||
142977860|NCT00141037|515453940|FG001|Overall Study|Moved from area|7|||
142977861|NCT00141037|515453939|FG000|Overall Study|Graft Failure|3|||
142977862|NCT00141037|515453940|FG001|Overall Study|Graft Failure|4|||
142977863|NCT00888615|515453941|FG000|Overall Study|No treatment|2|||
142977864|NCT00637377|515453942|FG000|Overall Study|Adverse Event|2|||
142977865|NCT00637377|515453943|FG001|Overall Study|Adverse Event|6|||
142977866|NCT00637377|515453944|FG002|Overall Study|Adverse Event|8|||
142977867|NCT00637377|515453945|FG003|Overall Study|Adverse Event|9|||
142977868|NCT00637377|515453942|FG000|Overall Study|Death|1|||
142977869|NCT00637377|515453943|FG001|Overall Study|Death|3|||
142977870|NCT00637377|515453944|FG002|Overall Study|Death|2|||
142977871|NCT00637377|515453945|FG003|Overall Study|Death|1|||
142977872|NCT00637377|515453942|FG000|Overall Study|Lack of Efficacy|0|||
142977873|NCT00637377|515453943|FG001|Overall Study|Lack of Efficacy|0|||
142977874|NCT00637377|515453944|FG002|Overall Study|Lack of Efficacy|1|||
142977875|NCT00637377|515453945|FG003|Overall Study|Lack of Efficacy|1|||
142977876|NCT00637377|515453942|FG000|Overall Study|Lost to Follow-up|4|||
142977877|NCT00637377|515453943|FG001|Overall Study|Lost to Follow-up|1|||
142977878|NCT00637377|515453944|FG002|Overall Study|Lost to Follow-up|2|||
142977879|NCT00637377|515453945|FG003|Overall Study|Lost to Follow-up|2|||
142977880|NCT00637377|515453942|FG000|Overall Study|Protocol Violation|2|||
142977881|NCT00637377|515453943|FG001|Overall Study|Protocol Violation|1|||
142977882|NCT00637377|515453944|FG002|Overall Study|Protocol Violation|1|||
142977883|NCT00637377|515453945|FG003|Overall Study|Protocol Violation|0|||
142977884|NCT00637377|515453942|FG000|Overall Study|Withdrawal by Subject|11|||
142977885|NCT00637377|515453943|FG001|Overall Study|Withdrawal by Subject|15|||
142977886|NCT00637377|515453944|FG002|Overall Study|Withdrawal by Subject|13|||
142977887|NCT00637377|515453945|FG003|Overall Study|Withdrawal by Subject|11|||
142977888|NCT00637377|515453942|FG000|Overall Study|Other (no further information available)|7|||
142977889|NCT00637377|515453943|FG001|Overall Study|Other (no further information available)|6|||
142977890|NCT00637377|515453944|FG002|Overall Study|Other (no further information available)|10|||
142977891|NCT00637377|515453945|FG003|Overall Study|Other (no further information available)|5|||
142977892|NCT01293084|515453948|FG000|Overall Study|Physician Decision|3|||
142977893|NCT01293084|515453948|FG000|Overall Study|Withdrawal by Subject|2|||
142977894|NCT03175562|515453949|FG000|Overall Study|Adverse Event|1|||
142977895|NCT03175562|515453949|FG000|Overall Study|Lost to Follow-up|3|||
142977896|NCT03175562|515453949|FG000|Overall Study|Withdrawal by Subject|7|||
142977897|NCT03175562|515453949|FG000|Overall Study|Other (Not Specified)|5|||
142977898|NCT01230749|515453951|FG000|Overall Study|Adverse Event|0|||
142977899|NCT01230749|515453952|FG001|Overall Study|Adverse Event|0|||
142977900|NCT01230749|515453953|FG002|Overall Study|Adverse Event|0|||
142977901|NCT01230749|515453954|FG003|Overall Study|Adverse Event|1|||
142977902|NCT01230749|515453951|FG000|Overall Study|Physician Decision|0|||
142977903|NCT01230749|515453952|FG001|Overall Study|Physician Decision|0|||
142977904|NCT01230749|515453953|FG002|Overall Study|Physician Decision|1|||
142977905|NCT01230749|515453954|FG003|Overall Study|Physician Decision|0|||
142977906|NCT01230749|515453951|FG000|Overall Study|Withdrawal by Subject|0|||
142977907|NCT01230749|515453952|FG001|Overall Study|Withdrawal by Subject|1|||
142977908|NCT01230749|515453953|FG002|Overall Study|Withdrawal by Subject|0|||
142977909|NCT01230749|515453954|FG003|Overall Study|Withdrawal by Subject|0|||
142977910|NCT01230749|515453951|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
142977911|NCT01230749|515453952|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
142977912|NCT01230749|515453953|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
142977913|NCT01230749|515453954|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
142977914|NCT04021706|515455836|FG000|Overall Study|Adverse Event|2|||
142977915|NCT04021706|515455837|FG001|Overall Study|Adverse Event|0|||
142977916|NCT04021706|515455836|FG000|Overall Study|Withdrawal by Subject|1|||
142977917|NCT04021706|515455837|FG001|Overall Study|Withdrawal by Subject|2|||
142977918|NCT04021706|515455836|FG000|Overall Study|Physician Decision|1|||
142977919|NCT04021706|515455837|FG001|Overall Study|Physician Decision|0|||
142977920|NCT00595868|515455838|FG000|Overall Study|Lost to Follow-up|45|||
142977921|NCT00595868|515455839|FG001|Overall Study|Lost to Follow-up|50|||
142977922|NCT03788967|515455842|FG000|Overall Study|Lost to Follow-up|14|||
142977923|NCT03788967|515455843|FG001|Overall Study|Lost to Follow-up|10|||
142977924|NCT03788967|515455842|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
142977925|NCT03788967|515455843|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
142977926|NCT03788967|515455842|FG000|Overall Study|Participant Withdrawal of Consent|13|||
142977927|NCT03788967|515455843|FG001|Overall Study|Participant Withdrawal of Consent|5|||
142977928|NCT03788967|515455842|FG000|Overall Study|Adverse Event|1|||
142977929|NCT03788967|515455843|FG001|Overall Study|Adverse Event|1|||
142977930|NCT03788967|515455842|FG000|Overall Study|COVID-19|1|||
142977931|NCT03788967|515455843|FG001|Overall Study|COVID-19|2|||
142977932|NCT00462488|515455844|FG000|Overall Study|Protocol Violation|1|||
142977933|NCT00462488|515455845|FG001|Overall Study|Protocol Violation|0|||
142977934|NCT00462488|515455844|FG000|Overall Study|Lack of Efficacy|19|||
142977935|NCT00462488|515455845|FG001|Overall Study|Lack of Efficacy|17|||
142977936|NCT01742091|515455852|FG000|Overall Study|Adverse Event|0|||
142977937|NCT01742091|515455853|FG001|Overall Study|Adverse Event|0|||
142977938|NCT01742091|515455854|FG002|Overall Study|Adverse Event|0|||
142977939|NCT01742091|515455855|FG003|Overall Study|Adverse Event|0|||
142977940|NCT01742091|515455856|FG004|Overall Study|Adverse Event|1|||
142977941|NCT01742091|515455857|FG005|Overall Study|Adverse Event|0|||
142977942|NCT01742091|515455852|FG000|Overall Study|Physician Decision|0|||
142977943|NCT01742091|515455853|FG001|Overall Study|Physician Decision|0|||
142977944|NCT01742091|515455854|FG002|Overall Study|Physician Decision|0|||
142977945|NCT01742091|515455855|FG003|Overall Study|Physician Decision|0|||
142977946|NCT01742091|515455856|FG004|Overall Study|Physician Decision|0|||
142977947|NCT01742091|515455857|FG005|Overall Study|Physician Decision|1|||
142977948|NCT01742091|515455852|FG000|Overall Study|Withdrawal by Subject|0|||
142977949|NCT01742091|515455853|FG001|Overall Study|Withdrawal by Subject|0|||
142977950|NCT01742091|515455854|FG002|Overall Study|Withdrawal by Subject|0|||
142977951|NCT01742091|515455855|FG003|Overall Study|Withdrawal by Subject|1|||
142977952|NCT01742091|515455856|FG004|Overall Study|Withdrawal by Subject|0|||
142977953|NCT01742091|515455857|FG005|Overall Study|Withdrawal by Subject|0|||
142977954|NCT01742091|515455852|FG000|Overall Study|Lost to Follow-up|0|||
142977955|NCT01742091|515455853|FG001|Overall Study|Lost to Follow-up|0|||
142977956|NCT01742091|515455854|FG002|Overall Study|Lost to Follow-up|0|||
142977957|NCT01742091|515455855|FG003|Overall Study|Lost to Follow-up|0|||
142977958|NCT01742091|515455856|FG004|Overall Study|Lost to Follow-up|0|||
142977959|NCT01742091|515455857|FG005|Overall Study|Lost to Follow-up|1|||
142977960|NCT02088541|515455858|FG000|Overall Study|Adverse Event|3|||
142977961|NCT02088541|515455859|FG001|Overall Study|Adverse Event|0|||
142977962|NCT02088541|515455860|FG002|Overall Study|Adverse Event|3|||
142977963|NCT02088541|515455861|FG003|Overall Study|Adverse Event|3|||
142977964|NCT02088541|515455862|FG004|Overall Study|Adverse Event|0|||
142977965|NCT02088541|515455858|FG000|Overall Study|Death|51|||
142977966|NCT02088541|515455859|FG001|Overall Study|Death|21|||
142977967|NCT02088541|515455860|FG002|Overall Study|Death|85|||
142977968|NCT02088541|515455861|FG003|Overall Study|Death|28|||
142977969|NCT02088541|515455862|FG004|Overall Study|Death|38|||
142977970|NCT02088541|515455858|FG000|Overall Study|Lost to Follow-up|2|||
142977971|NCT02088541|515455859|FG001|Overall Study|Lost to Follow-up|0|||
142977972|NCT02088541|515455860|FG002|Overall Study|Lost to Follow-up|1|||
142977973|NCT02088541|515455861|FG003|Overall Study|Lost to Follow-up|0|||
142977974|NCT02088541|515455862|FG004|Overall Study|Lost to Follow-up|0|||
142977975|NCT02088541|515455858|FG000|Overall Study|Physician Decision|2|||
142977976|NCT02088541|515455859|FG001|Overall Study|Physician Decision|1|||
142977977|NCT02088541|515455860|FG002|Overall Study|Physician Decision|2|||
142977978|NCT02088541|515455861|FG003|Overall Study|Physician Decision|0|||
142977979|NCT02088541|515455862|FG004|Overall Study|Physician Decision|2|||
142977980|NCT02088541|515455858|FG000|Overall Study|Disease progression|7|||
142977981|NCT02088541|515455859|FG001|Overall Study|Disease progression|1|||
142977982|NCT02088541|515455860|FG002|Overall Study|Disease progression|2|||
142977983|NCT02088541|515455861|FG003|Overall Study|Disease progression|3|||
142977984|NCT02088541|515455862|FG004|Overall Study|Disease progression|1|||
142977985|NCT02088541|515455858|FG000|Overall Study|Study terminated by sponsor|1|||
142977986|NCT02088541|515455859|FG001|Overall Study|Study terminated by sponsor|1|||
142977987|NCT02088541|515455860|FG002|Overall Study|Study terminated by sponsor|12|||
142977988|NCT02088541|515455861|FG003|Overall Study|Study terminated by sponsor|2|||
142977989|NCT02088541|515455862|FG004|Overall Study|Study terminated by sponsor|6|||
142977990|NCT02088541|515455858|FG000|Overall Study|Withdrawal by Subject|3|||
142977991|NCT02088541|515455859|FG001|Overall Study|Withdrawal by Subject|2|||
142977992|NCT02088541|515455860|FG002|Overall Study|Withdrawal by Subject|9|||
142977993|NCT02088541|515455861|FG003|Overall Study|Withdrawal by Subject|7|||
142977994|NCT02088541|515455862|FG004|Overall Study|Withdrawal by Subject|10|||
142977995|NCT02088541|515455858|FG000|Overall Study|Other|2|||
142977996|NCT02088541|515455859|FG001|Overall Study|Other|1|||
142977997|NCT02088541|515455860|FG002|Overall Study|Other|3|||
142977998|NCT02088541|515455861|FG003|Overall Study|Other|1|||
142977999|NCT02088541|515455862|FG004|Overall Study|Other|1|||
142978000|NCT00212758|515455865|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
142978001|NCT00212758|515455866|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
142978002|NCT00212758|515455865|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
142978003|NCT00212758|515455866|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
142978004|NCT02574481|515455867|FG000|Overall Study|Withdrawal by Subject|29|||
142978005|NCT02574481|515455868|FG001|Overall Study|Withdrawal by Subject|15|||
142978006|NCT02574481|515455869|FG002|Overall Study|Withdrawal by Subject|4|||
142978007|NCT02574481|515455870|FG003|Overall Study|Withdrawal by Subject|1|||
142978008|NCT02574481|515455867|FG000|Overall Study|Adverse Event|5|||
142978009|NCT02574481|515455868|FG001|Overall Study|Adverse Event|1|||
142978010|NCT02574481|515455869|FG002|Overall Study|Adverse Event|1|||
142978011|NCT02574481|515455870|FG003|Overall Study|Adverse Event|0|||
142978012|NCT02574481|515455867|FG000|Overall Study|Visit Missed|15|||
142978013|NCT02574481|515455868|FG001|Overall Study|Visit Missed|7|||
142978014|NCT02574481|515455869|FG002|Overall Study|Visit Missed|5|||
142978015|NCT02574481|515455870|FG003|Overall Study|Visit Missed|0|||
142978016|NCT02574481|515455867|FG000|Overall Study|Other|7|||
142978017|NCT02574481|515455868|FG001|Overall Study|Other|2|||
142978018|NCT02574481|515455869|FG002|Overall Study|Other|0|||
142978019|NCT02574481|515455870|FG003|Overall Study|Other|0|||
142978020|NCT02574481|515455867|FG000|Overall Study|Death|48|||
142978021|NCT02574481|515455868|FG001|Overall Study|Death|26|||
142978022|NCT02574481|515455869|FG002|Overall Study|Death|12|||
142978023|NCT02574481|515455870|FG003|Overall Study|Death|4|||
142978024|NCT02574481|515455867|FG000|Overall Study|Physician Decision|5|||
142978025|NCT02574481|515455868|FG001|Overall Study|Physician Decision|2|||
142978026|NCT02574481|515455869|FG002|Overall Study|Physician Decision|0|||
142978027|NCT02574481|515455870|FG003|Overall Study|Physician Decision|0|||
142978028|NCT02574481|515455867|FG000|Overall Study|Lost to Follow-up|5|||
142978029|NCT02574481|515455868|FG001|Overall Study|Lost to Follow-up|1|||
142978030|NCT02574481|515455869|FG002|Overall Study|Lost to Follow-up|3|||
142978031|NCT02574481|515455870|FG003|Overall Study|Lost to Follow-up|0|||
142978032|NCT01105936|515455871|FG000|Period 1|Adverse Event|0|||
142978033|NCT01105936|515455872|FG001|Period 1|Adverse Event|0|||
142978034|NCT01105936|515455873|FG002|Period 1|Adverse Event|0|||
142978035|NCT01105936|515455874|FG003|Period 1|Adverse Event|1|||
142978036|NCT01105936|515455871|FG000|Period 2|Adverse Event|1|||
142978037|NCT01105936|515455872|FG001|Period 2|Adverse Event|0|||
142978038|NCT01105936|515455873|FG002|Period 2|Adverse Event|0|||
142978039|NCT01105936|515455874|FG003|Period 2|Adverse Event|0|||
142978040|NCT01105936|515455871|FG000|Period 3|Protocol Violation|0|||
142978041|NCT01105936|515455872|FG001|Period 3|Protocol Violation|2|||
142978042|NCT01105936|515455873|FG002|Period 3|Protocol Violation|0|||
142978043|NCT01105936|515455874|FG003|Period 3|Protocol Violation|0|||
142978044|NCT00379236|515455875|FG000|Double-blind|Adverse Event|11|||
142978045|NCT00379236|515455876|FG001|Double-blind|Adverse Event|6|||
142978046|NCT00379236|515455877|FG002|Double-blind|Adverse Event|0|||
142978047|NCT00379236|515455875|FG000|Double-blind|Protocol Violation|3|||
142978048|NCT00379236|515455876|FG001|Double-blind|Protocol Violation|3|||
142978049|NCT00379236|515455877|FG002|Double-blind|Protocol Violation|0|||
142978050|NCT00379236|515455875|FG000|Double-blind|Withdrawal by Subject|12|||
142978051|NCT00379236|515455876|FG001|Double-blind|Withdrawal by Subject|13|||
142978052|NCT00379236|515455877|FG002|Double-blind|Withdrawal by Subject|0|||
142978053|NCT00379236|515455875|FG000|Double-blind|Lost to Follow-up|4|||
142978054|NCT00379236|515455876|FG001|Double-blind|Lost to Follow-up|3|||
142978055|NCT00379236|515455877|FG002|Double-blind|Lost to Follow-up|0|||
142978056|NCT00379236|515455875|FG000|Double-blind|Use of exclusionary medication|1|||
142978057|NCT00379236|515455876|FG001|Double-blind|Use of exclusionary medication|2|||
142978058|NCT00379236|515455877|FG002|Double-blind|Use of exclusionary medication|0|||
142978059|NCT00379236|515455875|FG000|Double-blind|Other|3|||
142978060|NCT00379236|515455876|FG001|Double-blind|Other|7|||
142978061|NCT00379236|515455877|FG002|Double-blind|Other|0|||
142978062|NCT00379236|515455875|FG000|Double-blind|Data could not be retrieved|2|||
142978063|NCT00379236|515455876|FG001|Double-blind|Data could not be retrieved|2|||
142978064|NCT00379236|515455877|FG002|Double-blind|Data could not be retrieved|0|||
142978065|NCT00379236|515455875|FG000|Open-label Extension|Adverse Event|0|||
142978066|NCT00379236|515455876|FG001|Open-label Extension|Adverse Event|0|||
142978067|NCT00379236|515455877|FG002|Open-label Extension|Adverse Event|13|||
142978068|NCT00379236|515455875|FG000|Open-label Extension|Protocol Violation|0|||
142978069|NCT00379236|515455876|FG001|Open-label Extension|Protocol Violation|0|||
142978070|NCT00379236|515455877|FG002|Open-label Extension|Protocol Violation|7|||
142978071|NCT00379236|515455875|FG000|Open-label Extension|Withdrawal by Subject|0|||
142978072|NCT00379236|515455876|FG001|Open-label Extension|Withdrawal by Subject|0|||
142978073|NCT00379236|515455877|FG002|Open-label Extension|Withdrawal by Subject|13|||
142978074|NCT00379236|515455875|FG000|Open-label Extension|Lost to Follow-up|0|||
142978075|NCT00379236|515455876|FG001|Open-label Extension|Lost to Follow-up|0|||
142978076|NCT00379236|515455877|FG002|Open-label Extension|Lost to Follow-up|12|||
142978077|NCT00379236|515455875|FG000|Open-label Extension|Use of exclusionary medication|0|||
142978078|NCT00379236|515455876|FG001|Open-label Extension|Use of exclusionary medication|0|||
142978079|NCT00379236|515455877|FG002|Open-label Extension|Use of exclusionary medication|3|||
142978080|NCT00379236|515455875|FG000|Open-label Extension|Other|0|||
142978081|NCT00379236|515455876|FG001|Open-label Extension|Other|0|||
142978082|NCT00379236|515455877|FG002|Open-label Extension|Other|7|||
142978083|NCT03382262|515455885|FG000|Overall Study|Physician Decision|0|||
142978084|NCT03382262|515455886|FG001|Overall Study|Physician Decision|0|||
142978085|NCT03382262|515455887|FG002|Overall Study|Physician Decision|1|||
142978086|NCT03382262|515455888|FG003|Overall Study|Physician Decision|0|||
142978087|NCT03382262|515455885|FG000|Overall Study|Withdrawal by Subject|0|||
142978088|NCT03382262|515455886|FG001|Overall Study|Withdrawal by Subject|0|||
142978089|NCT03382262|515455887|FG002|Overall Study|Withdrawal by Subject|0|||
142978090|NCT03382262|515455888|FG003|Overall Study|Withdrawal by Subject|1|||
142978091|NCT02940860|515455889|FG000|Overall Study|Non-serious AE|1|||
142978092|NCT02940860|515455890|FG001|Overall Study|Non-serious AE|2|||
142978093|NCT02940860|515455889|FG000|Overall Study|Serious AE|7|||
142978094|NCT02940860|515455890|FG001|Overall Study|Serious AE|3|||
142978095|NCT02940860|515455889|FG000|Overall Study|Withdrawal by Subject|19|||
142978096|NCT02940860|515455890|FG001|Overall Study|Withdrawal by Subject|9|||
142978097|NCT02940860|515455889|FG000|Overall Study|Lost to Follow-up|13|||
142978098|NCT02940860|515455890|FG001|Overall Study|Lost to Follow-up|7|||
142978099|NCT02940860|515455889|FG000|Overall Study|Physician Decision|5|||
142978100|NCT02940860|515455890|FG001|Overall Study|Physician Decision|3|||
142978101|NCT02940860|515455889|FG000|Overall Study|Sponsor Decision|0|||
142978102|NCT02940860|515455890|FG001|Overall Study|Sponsor Decision|1|||
142978103|NCT02940860|515455889|FG000|Overall Study|Protocol Violation|0|||
142978104|NCT02940860|515455890|FG001|Overall Study|Protocol Violation|2|||
142978105|NCT02940860|515455889|FG000|Overall Study|Death|3|||
142978106|NCT02940860|515455890|FG001|Overall Study|Death|2|||
142978107|NCT02940860|515455889|FG000|Overall Study|Moved, poor venous access, transport|6|||
142978108|NCT02940860|515455890|FG001|Overall Study|Moved, poor venous access, transport|4|||
142978109|NCT02940860|515455889|FG000|Overall Study|Not treated|2|||
142978110|NCT02940860|515455890|FG001|Overall Study|Not treated|2|||
142978111|NCT04914819|515455891|FG000|Overall Study|Pregnancy|3|||
142978112|NCT04914819|515455892|FG001|Overall Study|Pregnancy|1|||
142978113|NCT04914819|515455891|FG000|Overall Study|Discontinued study|4|||
142978114|NCT04914819|515455892|FG001|Overall Study|Discontinued study|1|||
142978115|NCT04914819|515455891|FG000|Overall Study|Lost to Follow-up|7|||
142978116|NCT04914819|515455892|FG001|Overall Study|Lost to Follow-up|0|||
142978117|NCT02715804|515455893|FG000|Overall Study|Death|222|||
142978118|NCT02715804|515455894|FG001|Overall Study|Death|106|||
142978119|NCT02715804|515455893|FG000|Overall Study|Withdrawal by Subject|5|||
142978120|NCT02715804|515455894|FG001|Overall Study|Withdrawal by Subject|4|||
142978121|NCT02715804|515455893|FG000|Overall Study|Other than specified|2|||
142978122|NCT02715804|515455894|FG001|Overall Study|Other than specified|3|||
142978123|NCT00511108|515455900|FG000|Overall Study|Adverse Event|2|||
142978124|NCT00511108|515455901|FG001|Overall Study|Adverse Event|0|||
142978125|NCT00511108|515455902|FG002|Overall Study|Adverse Event|1|||
142978126|NCT00511108|515455903|FG003|Overall Study|Adverse Event|2|||
142978127|NCT00511108|515455900|FG000|Overall Study|Lost to Follow-up|0|||
142978128|NCT00511108|515455901|FG001|Overall Study|Lost to Follow-up|2|||
142978129|NCT00511108|515455902|FG002|Overall Study|Lost to Follow-up|1|||
142978130|NCT00511108|515455903|FG003|Overall Study|Lost to Follow-up|0|||
142978131|NCT00511108|515455900|FG000|Overall Study|Physician Decision|0|||
142978132|NCT00511108|515455901|FG001|Overall Study|Physician Decision|0|||
142978133|NCT00511108|515455902|FG002|Overall Study|Physician Decision|0|||
142978134|NCT00511108|515455903|FG003|Overall Study|Physician Decision|1|||
142978135|NCT00511108|515455900|FG000|Overall Study|Withdrawal by Subject|4|||
142978136|NCT00511108|515455901|FG001|Overall Study|Withdrawal by Subject|0|||
142978137|NCT00511108|515455902|FG002|Overall Study|Withdrawal by Subject|3|||
142978138|NCT00511108|515455903|FG003|Overall Study|Withdrawal by Subject|2|||
142978139|NCT02147691|515455904|FG000|Overall Study|Withdrawal by Subject|2|||
142978140|NCT02147691|515455905|FG001|Overall Study|Withdrawal by Subject|0|||
142978141|NCT02147691|515455904|FG000|Overall Study|Adverse Event|2|||
142978142|NCT02147691|515455905|FG001|Overall Study|Adverse Event|0|||
142978143|NCT02147691|515455904|FG000|Overall Study|Lost to Follow-up|0|||
142978144|NCT02147691|515455905|FG001|Overall Study|Lost to Follow-up|1|||
142978145|NCT01989754|515455906|FG000|Overall Study|Withdrawal by Subject|10|||
142978146|NCT01989754|515455907|FG001|Overall Study|Withdrawal by Subject|14|||
142978147|NCT01989754|515455906|FG000|Overall Study|Lost to Follow-up|28|||
142978148|NCT01989754|515455907|FG001|Overall Study|Lost to Follow-up|20|||
142978149|NCT01989754|515455906|FG000|Overall Study|Closed Site|1|||
142978150|NCT01989754|515455907|FG001|Overall Study|Closed Site|1|||
142978151|NCT01369225|515455910|FG000|Overall Study|Withdrawal by Subject|1|||
142978152|NCT01369225|515455911|FG001|Overall Study|Withdrawal by Subject|0|||
142978153|NCT01369225|515455912|FG002|Overall Study|Withdrawal by Subject|2|||
142978154|NCT01369225|515455913|FG003|Overall Study|Withdrawal by Subject|1|||
142978155|NCT01369225|515455914|FG004|Overall Study|Withdrawal by Subject|0|||
142978156|NCT01369225|515455915|FG005|Overall Study|Withdrawal by Subject|0|||
142978157|NCT01369225|515455910|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
142978158|NCT01369225|515455911|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
142978159|NCT01369225|515455912|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
142978160|NCT01369225|515455913|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
142978161|NCT01369225|515455914|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
142978162|NCT01369225|515455915|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
142978163|NCT01369225|515455910|FG000|Overall Study|Other|1|||
142978164|NCT01369225|515455911|FG001|Overall Study|Other|0|||
142978165|NCT01369225|515455912|FG002|Overall Study|Other|0|||
142978166|NCT01369225|515455913|FG003|Overall Study|Other|0|||
142978167|NCT01369225|515455914|FG004|Overall Study|Other|1|||
142978168|NCT01369225|515455915|FG005|Overall Study|Other|0|||
142978169|NCT01369225|515455910|FG000|Overall Study|Adverse Event|0|||
142978170|NCT01369225|515455911|FG001|Overall Study|Adverse Event|0|||
142978171|NCT01369225|515455912|FG002|Overall Study|Adverse Event|0|||
142978172|NCT01369225|515455913|FG003|Overall Study|Adverse Event|1|||
142978173|NCT01369225|515455914|FG004|Overall Study|Adverse Event|1|||
142978174|NCT01369225|515455915|FG005|Overall Study|Adverse Event|0|||
142978175|NCT02156804|515455916|FG000|Overall Study|Withdrawal by Subject|1|||
142978176|NCT02559713|515455920|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
142978177|NCT01374217|515455923|FG000|Overall Study|Lack of Efficacy|13|||
142978178|NCT00326417|515455931|FG000|Overall Study|Withdrawal by Subject|0|||
142978179|NCT00326417|515455932|FG001|Overall Study|Withdrawal by Subject|0|||
142978180|NCT00326417|515455933|FG002|Overall Study|Withdrawal by Subject|1|||
142978181|NCT00326417|515455934|FG003|Overall Study|Withdrawal by Subject|0|||
142978182|NCT00326417|515455931|FG000|Overall Study|Arm Closed|7|||
142978183|NCT00326417|515455932|FG001|Overall Study|Arm Closed|0|||
142978184|NCT00326417|515455933|FG002|Overall Study|Arm Closed|0|||
142978185|NCT00326417|515455934|FG003|Overall Study|Arm Closed|3|||
142978186|NCT00326417|515455931|FG000|Overall Study|Death|7|||
142978187|NCT00326417|515455932|FG001|Overall Study|Death|0|||
142978188|NCT00326417|515455933|FG002|Overall Study|Death|0|||
142978189|NCT00326417|515455934|FG003|Overall Study|Death|0|||
142978190|NCT00844285|515455935|FG000|Overall Study|Other|0|||
142978191|NCT00844285|515455936|FG001|Overall Study|Other|1|||
142978192|NCT00844285|515455937|FG002|Overall Study|Other|0|||
142978193|NCT00844285|515455935|FG000|Overall Study|Other than specified|95|||
142978194|NCT00844285|515455936|FG001|Overall Study|Other than specified|129|||
142978195|NCT00844285|515455937|FG002|Overall Study|Other than specified|12|||
142978196|NCT00844285|515455935|FG000|Overall Study|Site closure|256|||
142978197|NCT00844285|515455936|FG001|Overall Study|Site closure|450|||
142978198|NCT00844285|515455937|FG002|Overall Study|Site closure|50|||
142978199|NCT00844285|515455935|FG000|Overall Study|Follow-up < 8 years|16|||
142978200|NCT00844285|515455936|FG001|Overall Study|Follow-up < 8 years|23|||
142978201|NCT00844285|515455937|FG002|Overall Study|Follow-up < 8 years|4|||
142978202|NCT00844285|515455935|FG000|Overall Study|Protocol Violation|26|||
142978203|NCT00844285|515455936|FG001|Overall Study|Protocol Violation|28|||
142978204|NCT00844285|515455937|FG002|Overall Study|Protocol Violation|54|||
142978205|NCT00844285|515455935|FG000|Overall Study|Death|22|||
142978206|NCT00844285|515455936|FG001|Overall Study|Death|21|||
142978207|NCT00844285|515455937|FG002|Overall Study|Death|8|||
142978208|NCT00844285|515455935|FG000|Overall Study|Withdrew Consent|344|||
142978209|NCT00844285|515455936|FG001|Overall Study|Withdrew Consent|466|||
142978210|NCT00844285|515455937|FG002|Overall Study|Withdrew Consent|70|||
142978211|NCT00844285|515455935|FG000|Overall Study|Lost to Follow-up|330|||
142978212|NCT00844285|515455936|FG001|Overall Study|Lost to Follow-up|486|||
142978213|NCT00844285|515455937|FG002|Overall Study|Lost to Follow-up|74|||
142978214|NCT05425719|515455940|FG000|Overall Study|Lost to Follow-up|4|||
142978215|NCT05425719|515455941|FG001|Overall Study|Lost to Follow-up|0|||
142978216|NCT05425719|515455940|FG000|Overall Study|Withdrew consent|1|||
142978217|NCT05425719|515455941|FG001|Overall Study|Withdrew consent|1|||
142978218|NCT04682353|515455942|FG000|Overall Study|Lost to Follow-up|0|||
142978219|NCT04682353|515455943|FG001|Overall Study|Lost to Follow-up|1|||
142978220|NCT04682353|515455944|FG002|Overall Study|Lost to Follow-up|0|||
142978221|NCT04682353|515455945|FG003|Overall Study|Lost to Follow-up|1|||
142978222|NCT04682353|515455942|FG000|Overall Study|Personal reasons|0|||
142978223|NCT04682353|515455943|FG001|Overall Study|Personal reasons|1|||
142978224|NCT04682353|515455944|FG002|Overall Study|Personal reasons|0|||
142978225|NCT04682353|515455945|FG003|Overall Study|Personal reasons|0|||
142978226|NCT04377672|515455946|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
142978227|NCT00405652|515455950|FG000|Overall Study|Adverse Event|4|||
142978228|NCT00435994|515455951|FG000|Overall Study|Lost to Follow-up|7|||
142978229|NCT00435994|515455952|FG001|Overall Study|Lost to Follow-up|0|||
142978230|NCT00435994|515455953|FG002|Overall Study|Lost to Follow-up|0|||
142978231|NCT02322411|515455957|FG000|Overall Study|Lost to Follow-up|4|||
142978232|NCT02322411|515455958|FG001|Overall Study|Lost to Follow-up|7|||
142978233|NCT02322411|515455957|FG000|Overall Study|Withdrawal by Subject|1|||
142978234|NCT02322411|515455958|FG001|Overall Study|Withdrawal by Subject|0|||
142978235|NCT00367432|515455961|FG000|First Period (16 Weeks)|Adverse Event|6|||
142978236|NCT00367432|515455962|FG001|First Period (16 Weeks)|Adverse Event|0|||
142978237|NCT00367432|515455961|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
142978238|NCT00367432|515455962|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
142978239|NCT00367432|515455961|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
142978240|NCT00367432|515455962|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
142978241|NCT00367432|515455961|FG000|First Period (16 Weeks)|Other Reason|2|||
142978242|NCT00367432|515455962|FG001|First Period (16 Weeks)|Other Reason|0|||
142978243|NCT00367432|515455961|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
142978244|NCT00367432|515455962|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
142978245|NCT00367432|515455961|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
142978246|NCT00367432|515455962|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
142978247|NCT00367432|515455961|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
142978248|NCT00367432|515455962|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
142978249|NCT00367432|515455961|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
142978250|NCT00367432|515455962|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
142978251|NCT00367432|515455961|FG000|Second Period (up to 54 Months)|Other Reason|6|||
142978252|NCT00367432|515455962|FG001|Second Period (up to 54 Months)|Other Reason|2|||
142978253|NCT05567393|515455963|FG000|Overall Study|Voluntary Withdrawal|0|||
142978254|NCT05567393|515455964|FG001|Overall Study|Voluntary Withdrawal|0|||
142978255|NCT05567393|515455965|FG002|Overall Study|Voluntary Withdrawal|0|||
142978256|NCT05567393|515455966|FG003|Overall Study|Voluntary Withdrawal|0|||
142978257|NCT05567393|515455967|FG004|Overall Study|Voluntary Withdrawal|0|||
142978258|NCT05567393|515455968|FG005|Overall Study|Voluntary Withdrawal|0|||
142978259|NCT05567393|515455969|FG006|Overall Study|Voluntary Withdrawal|0|||
142978260|NCT05567393|515455970|FG007|Overall Study|Voluntary Withdrawal|0|||
142978261|NCT05567393|515455971|FG008|Overall Study|Voluntary Withdrawal|0|||
142978262|NCT05567393|515455972|FG009|Overall Study|Voluntary Withdrawal|0|||
142978263|NCT05567393|515455973|FG010|Overall Study|Voluntary Withdrawal|0|||
142978264|NCT05567393|515455974|FG011|Overall Study|Voluntary Withdrawal|0|||
142978265|NCT05567393|515455975|FG012|Overall Study|Voluntary Withdrawal|0|||
142978266|NCT05567393|515455976|FG013|Overall Study|Voluntary Withdrawal|1|||
142978267|NCT05567393|515455977|FG014|Overall Study|Voluntary Withdrawal|0|||
142978268|NCT05567393|515455978|FG015|Overall Study|Voluntary Withdrawal|0|||
142978269|NCT05567393|515455979|FG016|Overall Study|Voluntary Withdrawal|0|||
142978270|NCT05567393|515455980|FG017|Overall Study|Voluntary Withdrawal|0|||
142978271|NCT02177175|515455985|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
142978272|NCT02177175|515455986|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
142978273|NCT01924299|515455987|FG000|Period 2|Withdrawal by Subject|1|||
142978274|NCT01924299|515455988|FG001|Period 2|Withdrawal by Subject|0|||
142978275|NCT01924299|515455987|FG000|Period 2|Adverse Event|0|||
142978276|NCT01924299|515455988|FG001|Period 2|Adverse Event|1|||
142978277|NCT04199793|515455989|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
142978278|NCT04199793|515455990|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
142978279|NCT04199793|515455989|FG000|Overall Study|Withdrawal by Subject|1|||
142978280|NCT04199793|515455990|FG001|Overall Study|Withdrawal by Subject|1|||
142978281|NCT03820726|515455991|FG000|Overall Study|Other than listed|23|||
142978282|NCT03820726|515455991|FG000|Overall Study|Withdrawal by Subject|37|||
142978283|NCT03820726|515455991|FG000|Overall Study|Lost to Follow-up|3|||
142978284|NCT03820726|515455991|FG000|Overall Study|Protocol deviation|1|||
142978285|NCT03820726|515455991|FG000|Overall Study|Adverse Event|146|||
142978286|NCT03820726|515455991|FG000|Overall Study|Not treated|1|||
142978287|NCT00345540|515455999|FG000|Overall Study|Withdrawal by Subject|1|||
142978288|NCT01406652|515456000|FG000|Overall Study|Lost-to-follow-up|3|||
142978289|NCT01406652|515456001|FG001|Overall Study|Lost-to-follow-up|4|||
142978290|NCT01406652|515456000|FG000|Overall Study|Withdrawal by Subject|2|||
142978291|NCT01406652|515456001|FG001|Overall Study|Withdrawal by Subject|2|||
142978292|NCT01406652|515456000|FG000|Overall Study|Insufficient follow-up|5|||
142978293|NCT01406652|515456001|FG001|Overall Study|Insufficient follow-up|4|||
142978294|NCT01406652|515456000|FG000|Overall Study|Infection not sure|10|||
142978295|NCT01406652|515456001|FG001|Overall Study|Infection not sure|10|||
142978296|NCT04179786|515456002|FG000|Overall Study|Withdrawal by Subject|8|||
142978297|NCT03136367|515456007|FG000|T1 Consultation|discontinued mistakenly included|2|||
142978298|NCT03136367|515456008|FG001|T1 Consultation|discontinued mistakenly included|6|||
142978299|NCT03136367|515456009|FG002|T1 Consultation|discontinued mistakenly included|1|||
142978300|NCT03136367|515456007|FG000|T1 Consultation|Discontinued other|0|||
142978301|NCT03136367|515456008|FG001|T1 Consultation|Discontinued other|1|||
142978302|NCT03136367|515456009|FG002|T1 Consultation|Discontinued other|0|||
142978303|NCT03136367|515456007|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
142978304|NCT03136367|515456008|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
142978305|NCT03136367|515456009|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
142978306|NCT03136367|515456007|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
142978307|NCT03136367|515456008|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
142978308|NCT03136367|515456009|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
142978309|NCT03136367|515456007|FG000|T2 Post-consultation|Discontinued other|0|||
142978310|NCT03136367|515456008|FG001|T2 Post-consultation|Discontinued other|2|||
142978311|NCT03136367|515456009|FG002|T2 Post-consultation|Discontinued other|6|||
142978312|NCT03136367|515456007|FG000|T2 Post-consultation|Discontinued transferred care|0|||
142978313|NCT03136367|515456008|FG001|T2 Post-consultation|Discontinued transferred care|0|||
142978314|NCT03136367|515456009|FG002|T2 Post-consultation|Discontinued transferred care|3|||
142978315|NCT03136367|515456007|FG000|T2 Post-consultation|Discontinued lost contact|0|||
142978316|NCT03136367|515456008|FG001|T2 Post-consultation|Discontinued lost contact|1|||
142978317|NCT03136367|515456009|FG002|T2 Post-consultation|Discontinued lost contact|0|||
142978318|NCT03136367|515456007|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
142978319|NCT03136367|515456008|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
142978320|NCT03136367|515456009|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
142978321|NCT03136367|515456007|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
142978322|NCT03136367|515456008|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
142978323|NCT03136367|515456009|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
142978324|NCT03136367|515456007|FG000|T3 1 Week After Surgery|other discontinued|2|||
142978325|NCT03136367|515456008|FG001|T3 1 Week After Surgery|other discontinued|4|||
142978326|NCT03136367|515456009|FG002|T3 1 Week After Surgery|other discontinued|3|||
142978327|NCT03136367|515456007|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
142978328|NCT03136367|515456008|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
142978329|NCT03136367|515456009|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
142978330|NCT03136367|515456007|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
142978331|NCT03136367|515456008|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
142978332|NCT03136367|515456009|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
142978333|NCT03136367|515456007|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
142978334|NCT03136367|515456008|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
142978335|NCT03136367|515456009|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
142978336|NCT03136367|515456007|FG000|T4 12 Weeks After Surgery|Death|0|||
142978337|NCT03136367|515456008|FG001|T4 12 Weeks After Surgery|Death|1|||
142978338|NCT03136367|515456009|FG002|T4 12 Weeks After Surgery|Death|3|||
142978339|NCT03136367|515456007|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
142978340|NCT03136367|515456008|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
142978341|NCT03136367|515456009|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
142978342|NCT03136367|515456007|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
142978343|NCT03136367|515456008|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
142978344|NCT03136367|515456009|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
142978345|NCT03136367|515456007|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
142978346|NCT03136367|515456008|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
142978347|NCT03136367|515456009|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
142978348|NCT03136367|515456007|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
142978349|NCT03136367|515456008|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
142978350|NCT03136367|515456009|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
142978351|NCT03136367|515456007|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
142978352|NCT03136367|515456008|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
142978353|NCT03136367|515456009|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
142978354|NCT03136367|515456007|FG000|T5 1 Year After Surgery|Death|0|||
142978355|NCT03136367|515456008|FG001|T5 1 Year After Surgery|Death|0|||
142978356|NCT03136367|515456009|FG002|T5 1 Year After Surgery|Death|1|||
142978357|NCT03136367|515456007|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
142978358|NCT03136367|515456008|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
142978359|NCT03136367|515456009|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
142978360|NCT03136367|515456007|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
142978361|NCT03136367|515456008|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
142978362|NCT03136367|515456009|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
142978363|NCT03136367|515456007|FG000|T5 1 Year After Surgery|study ended before due|31|||
142978364|NCT03136367|515456008|FG001|T5 1 Year After Surgery|study ended before due|103|||
142978365|NCT03136367|515456009|FG002|T5 1 Year After Surgery|study ended before due|110|||
142978366|NCT03136367|515456007|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
142978367|NCT03136367|515456008|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
142978368|NCT03136367|515456009|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
142978369|NCT03307629|515456013|FG000|Overall Study|Withdrawal by Subject|0|||
142978370|NCT03307629|515456014|FG001|Overall Study|Withdrawal by Subject|0|||
142978371|NCT03307629|515456015|FG002|Overall Study|Withdrawal by Subject|0|||
142978372|NCT03307629|515456016|FG003|Overall Study|Withdrawal by Subject|2|||
142978373|NCT03307629|515456013|FG000|Overall Study|Disease Progression|0|||
142978374|NCT03307629|515456014|FG001|Overall Study|Disease Progression|0|||
142978375|NCT03307629|515456015|FG002|Overall Study|Disease Progression|0|||
142978376|NCT03307629|515456016|FG003|Overall Study|Disease Progression|3|||
142978377|NCT03307629|515456013|FG000|Overall Study|Death|0|||
142978378|NCT03307629|515456014|FG001|Overall Study|Death|3|||
142978379|NCT03307629|515456015|FG002|Overall Study|Death|0|||
142978380|NCT03307629|515456016|FG003|Overall Study|Death|1|||
142978381|NCT02853032|515456017|FG000|Overall Study|Adverse Event|4|||
142978382|NCT02853032|515456018|FG001|Overall Study|Adverse Event|0|||
142978383|NCT02853032|515456017|FG000|Overall Study|Withdrawal by Subject|3|||
142978384|NCT02853032|515456018|FG001|Overall Study|Withdrawal by Subject|1|||
142978385|NCT02853032|515456017|FG000|Overall Study|Requested to withdraw from all treatment|2|||
142978386|NCT02853032|515456018|FG001|Overall Study|Requested to withdraw from all treatment|2|||
142978387|NCT02146833|515456019|FG000|Overall Study|Death|10|||
142978388|NCT02146833|515456019|FG000|Overall Study|No longer consented to study treatment|1|||
142978389|NCT01375647|515457905|FG000|Overall Study|Lost to Follow-up|3|||
142978390|NCT01375647|515457906|FG001|Overall Study|Lost to Follow-up|3|||
142978391|NCT01375647|515457907|FG002|Overall Study|Lost to Follow-up|7|||
142978392|NCT01375647|515457908|FG003|Overall Study|Lost to Follow-up|10|||
142978393|NCT01375647|515457905|FG000|Overall Study|Death|1|||
142978394|NCT01375647|515457906|FG001|Overall Study|Death|2|||
142978395|NCT01375647|515457907|FG002|Overall Study|Death|1|||
142978396|NCT01375647|515457908|FG003|Overall Study|Death|0|||
142978397|NCT01375647|515457905|FG000|Overall Study|Withdrawal by Subject|17|||
142978398|NCT01375647|515457906|FG001|Overall Study|Withdrawal by Subject|20|||
142978399|NCT01375647|515457907|FG002|Overall Study|Withdrawal by Subject|26|||
142978400|NCT01375647|515457908|FG003|Overall Study|Withdrawal by Subject|14|||
142978401|NCT01375647|515457905|FG000|Overall Study|Physician Decision|1|||
142978402|NCT01375647|515457906|FG001|Overall Study|Physician Decision|0|||
142978403|NCT01375647|515457907|FG002|Overall Study|Physician Decision|0|||
142978404|NCT01375647|515457908|FG003|Overall Study|Physician Decision|0|||
142978405|NCT02332798|515457911|FG000|Overall Study|Unwilling to Participate in Study|0|||
142978406|NCT02332798|515457912|FG001|Overall Study|Unwilling to Participate in Study|1|||
142978407|NCT02332798|515457913|FG002|Overall Study|Unwilling to Participate in Study|1|||
142978408|NCT02332798|515457911|FG000|Overall Study|Positive Urine Drug Test|0|||
142978409|NCT02332798|515457912|FG001|Overall Study|Positive Urine Drug Test|1|||
142978410|NCT02332798|515457913|FG002|Overall Study|Positive Urine Drug Test|0|||
142978411|NCT02332798|515457911|FG000|Overall Study|Abnormal Laboratory Findings|1|||
142978412|NCT02332798|515457912|FG001|Overall Study|Abnormal Laboratory Findings|0|||
142978413|NCT02332798|515457913|FG002|Overall Study|Abnormal Laboratory Findings|0|||
142978414|NCT01102140|515457914|FG000|Overall Study|Lost to Follow-up|1|||
142978415|NCT01102140|515457915|FG001|Overall Study|Lost to Follow-up|0|||
142978416|NCT01102140|515457914|FG000|Overall Study|Investigator terminated study|2|||
142978417|NCT01102140|515457915|FG001|Overall Study|Investigator terminated study|2|||
142978418|NCT03750240|515457917|FG000|Overall Study|Technical Difficulties|2|||
142978419|NCT01625611|515457923|FG000|Overall Study|No adlib drinks Lab 1|3|||
142978420|NCT01625611|515457924|FG001|Overall Study|No adlib drinks Lab 1|0|||
142978421|NCT01625611|515457923|FG000|Overall Study|Technical issues with PET|1|||
142978422|NCT01625611|515457924|FG001|Overall Study|Technical issues with PET|0|||
142978423|NCT01625611|515457923|FG000|Overall Study|Unable to complete study procedures|1|||
142978424|NCT01625611|515457924|FG001|Overall Study|Unable to complete study procedures|0|||
142978425|NCT01625611|515457923|FG000|Overall Study|Withdrawal by Subject|3|||
142978426|NCT01625611|515457924|FG001|Overall Study|Withdrawal by Subject|0|||
142978427|NCT02038790|515457925|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
142978428|NCT02038790|515457926|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
142978429|NCT00948194|515457927|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
142978430|NCT00948194|515457928|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
142978431|NCT02431793|515457929|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
142978432|NCT02431793|515457930|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
142978433|NCT02431793|515457931|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
142978434|NCT02431793|515457929|FG000|Overall Study|Withdrawal by Subject|7|||
142978435|NCT02431793|515457930|FG001|Overall Study|Withdrawal by Subject|5|||
142978436|NCT02431793|515457931|FG002|Overall Study|Withdrawal by Subject|5|||
142978437|NCT02431793|515457929|FG000|Overall Study|Lost to Follow-up|101|||
142978438|NCT02431793|515457930|FG001|Overall Study|Lost to Follow-up|122|||
142978439|NCT02431793|515457931|FG002|Overall Study|Lost to Follow-up|104|||
142978440|NCT00233324|515457932|FG000|Main Study|Death|68|||
142978441|NCT00233324|515457933|FG001|Main Study|Death|60|||
142978442|NCT00233324|515457934|FG002|Main Study|Death|62|||
142978443|NCT00233324|515457935|FG003|Main Study|Death|47|||
142978444|NCT00233324|515457932|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
142978445|NCT00233324|515457933|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
142978446|NCT00233324|515457934|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
142978447|NCT00233324|515457935|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
142978448|NCT00233324|515457932|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
142978449|NCT00233324|515457933|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
142978450|NCT00233324|515457934|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
142978451|NCT00233324|515457935|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
142978452|NCT03170258|515457944|FG000|Overall Study|Physician Decision|4|||
142978453|NCT03170258|515457945|FG001|Overall Study|Physician Decision|0|||
142978454|NCT03170258|515457944|FG000|Overall Study|Equipment issues|1|||
142978455|NCT03170258|515457945|FG001|Overall Study|Equipment issues|0|||
142978456|NCT03170258|515457944|FG000|Overall Study|Medication|1|||
142978457|NCT03170258|515457945|FG001|Overall Study|Medication|0|||
142978458|NCT03170258|515457944|FG000|Overall Study|Sleep issues|1|||
142978459|NCT03170258|515457945|FG001|Overall Study|Sleep issues|0|||
142978460|NCT02707601|515457948|FG000|Overall Study|Death|0|||
142978461|NCT02707601|515457949|FG001|Overall Study|Death|1|||
142978462|NCT02707601|515457948|FG000|Overall Study|Lack of Efficacy|0|||
142978463|NCT02707601|515457949|FG001|Overall Study|Lack of Efficacy|1|||
142978464|NCT02707601|515457948|FG000|Overall Study|Investigator's Discretion|1|||
142978465|NCT02707601|515457949|FG001|Overall Study|Investigator's Discretion|0|||
142978466|NCT02707601|515457948|FG000|Overall Study|Withdrew Consent|0|||
142978467|NCT02707601|515457949|FG001|Overall Study|Withdrew Consent|1|||
142978468|NCT02707601|515457948|FG000|Overall Study|Lost to Follow-up|1|||
142978469|NCT02707601|515457949|FG001|Overall Study|Lost to Follow-up|1|||
142978470|NCT02707601|515457948|FG000|Overall Study|Participants Randomized but Not Treated|2|||
142978471|NCT02707601|515457949|FG001|Overall Study|Participants Randomized but Not Treated|0|||
142978472|NCT03907969|515457951|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
142978473|NCT03907969|515457952|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
142978474|NCT03907969|515457953|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
142978475|NCT03907969|515457954|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
142978476|NCT03907969|515457955|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
142978477|NCT03907969|515457956|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
142978478|NCT03907969|515457957|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
142978479|NCT03907969|515457958|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
142978480|NCT03907969|515457959|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
142978481|NCT03907969|515457960|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
142978482|NCT03907969|515457961|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
142978483|NCT03907969|515457951|FG000|Monotherapy Part A|Progressive Disease|0|||
142978484|NCT03907969|515457952|FG001|Monotherapy Part A|Progressive Disease|1|||
142978485|NCT03907969|515457953|FG002|Monotherapy Part A|Progressive Disease|0|||
142978486|NCT03907969|515457954|FG003|Monotherapy Part A|Progressive Disease|0|||
142978487|NCT03907969|515457955|FG004|Monotherapy Part A|Progressive Disease|0|||
142978488|NCT03907969|515457956|FG005|Monotherapy Part A|Progressive Disease|1|||
142978489|NCT03907969|515457957|FG006|Monotherapy Part A|Progressive Disease|2|||
142978490|NCT03907969|515457958|FG007|Monotherapy Part A|Progressive Disease|0|||
142978491|NCT03907969|515457959|FG008|Monotherapy Part A|Progressive Disease|0|||
142978492|NCT03907969|515457960|FG009|Monotherapy Part A|Progressive Disease|0|||
142978493|NCT03907969|515457961|FG010|Monotherapy Part A|Progressive Disease|0|||
142978494|NCT03907969|515457951|FG000|Monotherapy Part A|Death|0|||
142978495|NCT03907969|515457952|FG001|Monotherapy Part A|Death|0|||
142978496|NCT03907969|515457953|FG002|Monotherapy Part A|Death|1|||
142978497|NCT03907969|515457954|FG003|Monotherapy Part A|Death|1|||
142978498|NCT03907969|515457955|FG004|Monotherapy Part A|Death|0|||
142978499|NCT03907969|515457956|FG005|Monotherapy Part A|Death|1|||
142978500|NCT03907969|515457957|FG006|Monotherapy Part A|Death|0|||
142978501|NCT03907969|515457958|FG007|Monotherapy Part A|Death|0|||
142978502|NCT03907969|515457959|FG008|Monotherapy Part A|Death|0|||
142978503|NCT03907969|515457960|FG009|Monotherapy Part A|Death|0|||
142978504|NCT03907969|515457961|FG010|Monotherapy Part A|Death|0|||
142978505|NCT03907969|515457951|FG000|Combination Therapy Part A|Adverse Event|0|||
142978506|NCT03907969|515457952|FG001|Combination Therapy Part A|Adverse Event|0|||
142978507|NCT03907969|515457953|FG002|Combination Therapy Part A|Adverse Event|0|||
142978508|NCT03907969|515457954|FG003|Combination Therapy Part A|Adverse Event|0|||
142978509|NCT03907969|515457955|FG004|Combination Therapy Part A|Adverse Event|0|||
142978510|NCT03907969|515457956|FG005|Combination Therapy Part A|Adverse Event|0|||
142978511|NCT03907969|515457957|FG006|Combination Therapy Part A|Adverse Event|0|||
142978512|NCT03907969|515457958|FG007|Combination Therapy Part A|Adverse Event|0|||
142978513|NCT03907969|515457959|FG008|Combination Therapy Part A|Adverse Event|0|||
142978514|NCT03907969|515457960|FG009|Combination Therapy Part A|Adverse Event|1|||
142978515|NCT03907969|515457961|FG010|Combination Therapy Part A|Adverse Event|1|||
142978516|NCT03907969|515457951|FG000|Combination Therapy Part A|Progressive disease|0|||
142978517|NCT03907969|515457952|FG001|Combination Therapy Part A|Progressive disease|0|||
142978518|NCT03907969|515457953|FG002|Combination Therapy Part A|Progressive disease|0|||
142978519|NCT03907969|515457954|FG003|Combination Therapy Part A|Progressive disease|0|||
142978520|NCT03907969|515457955|FG004|Combination Therapy Part A|Progressive disease|0|||
142978521|NCT03907969|515457956|FG005|Combination Therapy Part A|Progressive disease|0|||
142978522|NCT03907969|515457957|FG006|Combination Therapy Part A|Progressive disease|0|||
142978523|NCT03907969|515457958|FG007|Combination Therapy Part A|Progressive disease|1|||
142978524|NCT03907969|515457959|FG008|Combination Therapy Part A|Progressive disease|0|||
142978525|NCT03907969|515457960|FG009|Combination Therapy Part A|Progressive disease|2|||
142978526|NCT03907969|515457961|FG010|Combination Therapy Part A|Progressive disease|3|||
142978527|NCT03907969|515457951|FG000|Combination Therapy Part A|Death|0|||
142978528|NCT03907969|515457952|FG001|Combination Therapy Part A|Death|0|||
142978529|NCT03907969|515457953|FG002|Combination Therapy Part A|Death|0|||
142978530|NCT03907969|515457954|FG003|Combination Therapy Part A|Death|0|||
142978531|NCT03907969|515457955|FG004|Combination Therapy Part A|Death|0|||
142978532|NCT03907969|515457956|FG005|Combination Therapy Part A|Death|0|||
142978533|NCT03907969|515457957|FG006|Combination Therapy Part A|Death|0|||
142978534|NCT03907969|515457958|FG007|Combination Therapy Part A|Death|0|||
142978535|NCT03907969|515457959|FG008|Combination Therapy Part A|Death|1|||
142978536|NCT03907969|515457960|FG009|Combination Therapy Part A|Death|0|||
142978537|NCT03907969|515457961|FG010|Combination Therapy Part A|Death|1|||
142978538|NCT03907969|515457951|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
142978539|NCT03907969|515457952|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
142978540|NCT03907969|515457953|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
142978541|NCT03907969|515457954|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
142978542|NCT03907969|515457955|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
142978543|NCT03907969|515457956|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
142978544|NCT03907969|515457957|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
142978545|NCT03907969|515457958|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
142978546|NCT03907969|515457959|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
142978547|NCT03907969|515457960|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
142978548|NCT03907969|515457961|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
142978549|NCT03907969|515457951|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
142978550|NCT03907969|515457952|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
142978551|NCT03907969|515457953|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
142978552|NCT03907969|515457954|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
142978553|NCT03907969|515457955|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
142978554|NCT03907969|515457956|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
142978555|NCT03907969|515457957|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
142978556|NCT03907969|515457958|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
142978557|NCT03907969|515457959|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
142978558|NCT03907969|515457960|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
142978559|NCT03907969|515457961|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
142978560|NCT03907969|515457951|FG000|Combination Therapy Part A|Physician Decision|0|||
142978561|NCT03907969|515457952|FG001|Combination Therapy Part A|Physician Decision|0|||
142978562|NCT03907969|515457953|FG002|Combination Therapy Part A|Physician Decision|0|||
142978563|NCT03907969|515457954|FG003|Combination Therapy Part A|Physician Decision|0|||
142978564|NCT03907969|515457955|FG004|Combination Therapy Part A|Physician Decision|0|||
142978565|NCT03907969|515457956|FG005|Combination Therapy Part A|Physician Decision|0|||
142978566|NCT03907969|515457957|FG006|Combination Therapy Part A|Physician Decision|0|||
142978567|NCT03907969|515457958|FG007|Combination Therapy Part A|Physician Decision|1|||
142978568|NCT03907969|515457959|FG008|Combination Therapy Part A|Physician Decision|0|||
142978569|NCT03907969|515457960|FG009|Combination Therapy Part A|Physician Decision|0|||
142978570|NCT03907969|515457961|FG010|Combination Therapy Part A|Physician Decision|1|||
142978571|NCT00063986|515457965|FG000|Overall Study|Withdrawal by Subject|1|||
142978572|NCT00063986|515457965|FG000|Overall Study|Ineligible|1|||
142978573|NCT00063986|515457965|FG000|Overall Study|Intra-operatively ineligible|4|||
142978574|NCT01419015|515457966|FG000|Overall Study|Death|2|||
142978575|NCT04209530|515457967|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
142978576|NCT04209530|515457968|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
142978577|NCT04209530|515457967|FG000|Overall Study|Withdrawal by Subject|0|||
142978578|NCT04209530|515457968|FG001|Overall Study|Withdrawal by Subject|1|||
142978579|NCT00607919|515457969|FG000|Acute Phase|Adverse Event|9|||
142978580|NCT00607919|515457970|FG001|Acute Phase|Adverse Event|2|||
142978581|NCT00607919|515457969|FG000|Acute Phase|Entry Criteria Not Met|1|||
142978582|NCT00607919|515457970|FG001|Acute Phase|Entry Criteria Not Met|1|||
142978583|NCT00607919|515457969|FG000|Acute Phase|Lack of Efficacy|1|||
142978584|NCT00607919|515457970|FG001|Acute Phase|Lack of Efficacy|2|||
142978585|NCT00607919|515457969|FG000|Acute Phase|Lost to Follow-up|9|||
142978586|NCT00607919|515457970|FG001|Acute Phase|Lost to Follow-up|3|||
142978587|NCT00607919|515457969|FG000|Acute Phase|Parent/Caregiver Decision|6|||
142978588|NCT00607919|515457970|FG001|Acute Phase|Parent/Caregiver Decision|4|||
142978589|NCT00607919|515457969|FG000|Acute Phase|Protocol Violation|5|||
142978590|NCT00607919|515457970|FG001|Acute Phase|Protocol Violation|1|||
142978591|NCT00607919|515457969|FG000|Acute Phase|Withdrawal by Subject|3|||
142978592|NCT00607919|515457970|FG001|Acute Phase|Withdrawal by Subject|3|||
142978593|NCT00607919|515457969|FG000|Open-Label Phase|Adverse Event|1|||
142978594|NCT00607919|515457970|FG001|Open-Label Phase|Adverse Event|5|||
142978595|NCT00607919|515457969|FG000|Open-Label Phase|Lost to Follow-up|4|||
142978596|NCT00607919|515457970|FG001|Open-Label Phase|Lost to Follow-up|1|||
142978597|NCT00607919|515457969|FG000|Open-Label Phase|Protocol Violation|2|||
142978598|NCT00607919|515457970|FG001|Open-Label Phase|Protocol Violation|2|||
142978599|NCT00607919|515457969|FG000|Open-Label Phase|Withdrawal by Subject|2|||
142978600|NCT00607919|515457970|FG001|Open-Label Phase|Withdrawal by Subject|2|||
142978601|NCT00607919|515457969|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
142978602|NCT00607919|515457970|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
142978603|NCT01709708|515457971|FG000|Overall Study|Protocol Violation|1|||
142978604|NCT01709708|515457972|FG001|Overall Study|Protocol Violation|2|||
142978605|NCT01527110|515457973|FG000|Overall Study|Adverse Event|1|||
142978606|NCT00527072|515457976|FG000|Overall Study|Adverse Event|13|||
142978607|NCT00527072|515457976|FG000|Overall Study|Lack of Efficacy|11|||
142978608|NCT00527072|515457976|FG000|Overall Study|Lost to Follow-up|3|||
142978609|NCT00527072|515457976|FG000|Overall Study|Protocol Violation|2|||
142978610|NCT00527072|515457976|FG000|Overall Study|Withdrawal by Subject|7|||
142978611|NCT00608881|515457977|FG000|Overall Study|Death|22|||
142978612|NCT00608881|515457978|FG001|Overall Study|Death|13|||
142978613|NCT00608881|515457977|FG000|Overall Study|Adverse Event|5|||
142978614|NCT00608881|515457978|FG001|Overall Study|Adverse Event|3|||
142978615|NCT00608881|515457977|FG000|Overall Study|Lost to Follow-up|28|||
142978616|NCT00608881|515457978|FG001|Overall Study|Lost to Follow-up|14|||
142978617|NCT00608881|515457977|FG000|Overall Study|Withdrawal by Subject|18|||
142978618|NCT00608881|515457978|FG001|Overall Study|Withdrawal by Subject|29|||
142978619|NCT00608881|515457977|FG000|Overall Study|Physician Decision|5|||
142978620|NCT00608881|515457978|FG001|Overall Study|Physician Decision|5|||
142978621|NCT00608881|515457977|FG000|Overall Study|Institutionalized|1|||
142978622|NCT00608881|515457978|FG001|Overall Study|Institutionalized|2|||
142978623|NCT01998958|515457981|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
142978624|NCT01998958|515457982|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
142978625|NCT01998958|515457983|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
142978626|NCT01998958|515457984|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
142978627|NCT01998958|515457985|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
142978628|NCT01998958|515457986|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
142978629|NCT01998958|515457987|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
142978630|NCT01998958|515457988|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
142978631|NCT01998958|515457989|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
142978632|NCT01998958|515457990|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
142978633|NCT01998958|515457991|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
142978634|NCT01998958|515457992|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
142978635|NCT01998958|515457993|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
142978636|NCT01998958|515457994|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
142978637|NCT01998958|515457995|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
142978638|NCT01998958|515457996|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
142978639|NCT01998958|515457997|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
142978640|NCT01998958|515457998|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
142978641|NCT01998958|515457999|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
142978642|NCT01998958|515458000|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
142978643|NCT01998958|515458001|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
142978644|NCT01998958|515458002|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
142978645|NCT01998958|515458003|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
142978646|NCT01998958|515458004|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
142978647|NCT01998958|515458005|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
142978648|NCT01998958|515458006|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
142978649|NCT01998958|515458007|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
142978650|NCT01998958|515458008|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
142978651|NCT01998958|515458009|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
142978652|NCT01998958|515458010|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
142978653|NCT01998958|515458011|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
142978654|NCT01998958|515458012|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
142978655|NCT01998958|515457981|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
142978656|NCT01998958|515457982|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
142978657|NCT01998958|515457983|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
142978658|NCT01998958|515457984|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
142978659|NCT01998958|515457985|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
142978660|NCT01998958|515457986|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
142978661|NCT01998958|515457987|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
142978662|NCT01998958|515457988|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
142978663|NCT01998958|515457989|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
142978664|NCT01998958|515457990|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
142978665|NCT01998958|515457991|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
142978666|NCT01998958|515457992|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
142978667|NCT01998958|515457993|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
142978668|NCT01998958|515457994|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
142978669|NCT01998958|515457995|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
142978670|NCT01998958|515457996|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
142978671|NCT01998958|515457997|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
142978672|NCT01998958|515457998|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
142978673|NCT01998958|515457999|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
142978674|NCT01998958|515458000|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
142978675|NCT01998958|515458001|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
142978676|NCT01998958|515458002|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
142978677|NCT01998958|515458003|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
142978678|NCT01998958|515458004|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
142978679|NCT01998958|515458005|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
142978680|NCT01998958|515458006|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
142978681|NCT01998958|515458007|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
142978682|NCT01998958|515458008|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
142978683|NCT01998958|515458009|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
142978684|NCT01998958|515458010|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
142978685|NCT01998958|515458011|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
142978686|NCT01998958|515458012|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
142978687|NCT01998958|515457981|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
142978688|NCT01998958|515457982|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
142978689|NCT01998958|515457983|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
142978690|NCT01998958|515457984|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
142978691|NCT01998958|515457985|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
142978692|NCT01998958|515457986|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
142978693|NCT01998958|515457987|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
142978694|NCT01998958|515457988|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
142978695|NCT01998958|515457989|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
142978696|NCT01998958|515457990|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
142978697|NCT01998958|515457991|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
142978698|NCT01998958|515457992|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
142978699|NCT01998958|515457993|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
142978700|NCT01998958|515457994|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
142978701|NCT01998958|515457995|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
142978702|NCT01998958|515457996|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
142978703|NCT01998958|515457997|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
142978704|NCT01998958|515457998|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
142978705|NCT01998958|515457999|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
142978706|NCT01998958|515458000|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
142978707|NCT01998958|515458001|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
142978708|NCT01998958|515458002|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
142978709|NCT01998958|515458003|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
142978710|NCT01998958|515458004|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
142978711|NCT01998958|515458005|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
142978712|NCT01998958|515458006|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
142978713|NCT01998958|515458007|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
142978714|NCT01998958|515458008|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
142978715|NCT01998958|515458009|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
142978716|NCT01998958|515458010|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
142978717|NCT01998958|515458011|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
142978718|NCT01998958|515458012|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
142978719|NCT01998958|515457981|FG000|Period 1 (Panel A and B)|Other|1|||
142978720|NCT01998958|515457982|FG001|Period 1 (Panel A and B)|Other|0|||
142978721|NCT01998958|515457983|FG002|Period 1 (Panel A and B)|Other|0|||
142978722|NCT01998958|515457984|FG003|Period 1 (Panel A and B)|Other|0|||
142978723|NCT01998958|515457985|FG004|Period 1 (Panel A and B)|Other|0|||
142978724|NCT01998958|515457986|FG005|Period 1 (Panel A and B)|Other|0|||
142978725|NCT01998958|515457987|FG006|Period 1 (Panel A and B)|Other|0|||
142978726|NCT01998958|515457988|FG007|Period 1 (Panel A and B)|Other|0|||
142978727|NCT01998958|515457989|FG008|Period 1 (Panel A and B)|Other|0|||
142978728|NCT01998958|515457990|FG009|Period 1 (Panel A and B)|Other|0|||
142978729|NCT01998958|515457991|FG010|Period 1 (Panel A and B)|Other|0|||
142978730|NCT01998958|515457992|FG011|Period 1 (Panel A and B)|Other|0|||
142978731|NCT01998958|515457993|FG012|Period 1 (Panel A and B)|Other|0|||
142978732|NCT01998958|515457994|FG013|Period 1 (Panel A and B)|Other|0|||
142978733|NCT01998958|515457995|FG014|Period 1 (Panel A and B)|Other|0|||
142978734|NCT01998958|515457996|FG015|Period 1 (Panel A and B)|Other|0|||
142978735|NCT01998958|515457997|FG016|Period 1 (Panel A and B)|Other|0|||
142978736|NCT01998958|515457998|FG017|Period 1 (Panel A and B)|Other|0|||
142978737|NCT01998958|515457999|FG018|Period 1 (Panel A and B)|Other|0|||
142978738|NCT01998958|515458000|FG019|Period 1 (Panel A and B)|Other|0|||
142978739|NCT01998958|515458001|FG020|Period 1 (Panel A and B)|Other|0|||
142978740|NCT01998958|515458002|FG021|Period 1 (Panel A and B)|Other|0|||
142978741|NCT01998958|515458003|FG022|Period 1 (Panel A and B)|Other|0|||
142978742|NCT01998958|515458004|FG023|Period 1 (Panel A and B)|Other|0|||
142978743|NCT01998958|515458005|FG024|Period 1 (Panel A and B)|Other|0|||
142978744|NCT01998958|515458006|FG025|Period 1 (Panel A and B)|Other|0|||
142978745|NCT01998958|515458007|FG026|Period 1 (Panel A and B)|Other|0|||
142978746|NCT01998958|515458008|FG027|Period 1 (Panel A and B)|Other|0|||
142978747|NCT01998958|515458009|FG028|Period 1 (Panel A and B)|Other|0|||
142978748|NCT01998958|515458010|FG029|Period 1 (Panel A and B)|Other|0|||
142978749|NCT01998958|515458011|FG030|Period 1 (Panel A and B)|Other|0|||
142978750|NCT01998958|515458012|FG031|Period 1 (Panel A and B)|Other|0|||
142978751|NCT01998958|515457981|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
142978752|NCT01998958|515457982|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
142978753|NCT01998958|515457983|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
142978754|NCT01998958|515457984|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
142978755|NCT01998958|515457985|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
142978756|NCT01998958|515457986|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
142978757|NCT01998958|515457987|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
142978758|NCT01998958|515457988|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
142978759|NCT01998958|515457989|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
142978760|NCT01998958|515457990|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
142978761|NCT01998958|515457991|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
142978762|NCT01998958|515457992|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
142978763|NCT01998958|515457993|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
142978764|NCT01998958|515457994|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
142978765|NCT01998958|515457995|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
142978766|NCT01998958|515457996|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
142978767|NCT01998958|515457997|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
142978768|NCT01998958|515457998|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
142978769|NCT01998958|515457999|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
142978770|NCT01998958|515458000|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
142978771|NCT01998958|515458001|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
142978772|NCT01998958|515458002|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
142978773|NCT01998958|515458003|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
142978774|NCT01998958|515458004|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
142978775|NCT01998958|515458005|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
142978776|NCT01998958|515458006|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
142978777|NCT01998958|515458007|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
142978778|NCT01998958|515458008|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
142978779|NCT01998958|515458009|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
142978780|NCT01998958|515458010|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
142978781|NCT01998958|515458011|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
142978782|NCT01998958|515458012|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
142978783|NCT01998958|515457981|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
142978784|NCT01998958|515457982|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
142978785|NCT01998958|515457983|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
142978786|NCT01998958|515457984|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
142978787|NCT01998958|515457985|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
142978788|NCT01998958|515457986|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
142978789|NCT01998958|515457987|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
142978790|NCT01998958|515457988|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
142978791|NCT01998958|515457989|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
142978792|NCT01998958|515457990|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
142978793|NCT01998958|515457991|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
142978794|NCT01998958|515457992|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
142978795|NCT01998958|515457993|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
142978796|NCT01998958|515457994|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
142978797|NCT01998958|515457995|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
142978798|NCT01998958|515457996|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
142978799|NCT01998958|515457997|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
142978800|NCT01998958|515457998|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
142978801|NCT01998958|515457999|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
142978802|NCT01998958|515458000|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
142978803|NCT01998958|515458001|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
142978804|NCT01998958|515458002|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
142978805|NCT01998958|515458003|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
142978806|NCT01998958|515458004|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
142978807|NCT01998958|515458005|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
142978808|NCT01998958|515458006|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
142978809|NCT01998958|515458007|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
142978810|NCT01998958|515458008|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
142978811|NCT01998958|515458009|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
142978812|NCT01998958|515458010|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
142978813|NCT01998958|515458011|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
142978814|NCT01998958|515458012|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
142978815|NCT01998958|515457981|FG000|Open Label Phase (Optional)|Adverse Event|0|||
142978816|NCT01998958|515457982|FG001|Open Label Phase (Optional)|Adverse Event|0|||
142978817|NCT01998958|515457983|FG002|Open Label Phase (Optional)|Adverse Event|0|||
142978818|NCT01998958|515457984|FG003|Open Label Phase (Optional)|Adverse Event|0|||
142978819|NCT01998958|515457985|FG004|Open Label Phase (Optional)|Adverse Event|0|||
142978820|NCT01998958|515457986|FG005|Open Label Phase (Optional)|Adverse Event|0|||
142978821|NCT01998958|515457987|FG006|Open Label Phase (Optional)|Adverse Event|0|||
142978822|NCT01998958|515457988|FG007|Open Label Phase (Optional)|Adverse Event|0|||
142978823|NCT01998958|515457989|FG008|Open Label Phase (Optional)|Adverse Event|0|||
142978824|NCT01998958|515457990|FG009|Open Label Phase (Optional)|Adverse Event|0|||
142978825|NCT01998958|515457991|FG010|Open Label Phase (Optional)|Adverse Event|0|||
142978826|NCT01998958|515457992|FG011|Open Label Phase (Optional)|Adverse Event|0|||
143455660|NCT00633880|517212502|FG001|Open Label Titration|Physician Decision|0|||
143455661|NCT00633880|517212503|FG002|Open Label Titration|Physician Decision|0|||
142978827|NCT01998958|515457993|FG012|Open Label Phase (Optional)|Adverse Event|0|||
142978828|NCT01998958|515457994|FG013|Open Label Phase (Optional)|Adverse Event|0|||
142978829|NCT01998958|515457995|FG014|Open Label Phase (Optional)|Adverse Event|0|||
142978830|NCT01998958|515457996|FG015|Open Label Phase (Optional)|Adverse Event|0|||
142978831|NCT01998958|515457997|FG016|Open Label Phase (Optional)|Adverse Event|0|||
142978832|NCT01998958|515457998|FG017|Open Label Phase (Optional)|Adverse Event|0|||
142978833|NCT01998958|515457999|FG018|Open Label Phase (Optional)|Adverse Event|0|||
142978834|NCT01998958|515458000|FG019|Open Label Phase (Optional)|Adverse Event|0|||
142978835|NCT01998958|515458001|FG020|Open Label Phase (Optional)|Adverse Event|0|||
142978836|NCT01998958|515458002|FG021|Open Label Phase (Optional)|Adverse Event|0|||
142978837|NCT01998958|515458003|FG022|Open Label Phase (Optional)|Adverse Event|0|||
142978838|NCT01998958|515458004|FG023|Open Label Phase (Optional)|Adverse Event|1|||
142978839|NCT01998958|515458005|FG024|Open Label Phase (Optional)|Adverse Event|0|||
142978840|NCT01998958|515458006|FG025|Open Label Phase (Optional)|Adverse Event|0|||
142978841|NCT01998958|515458007|FG026|Open Label Phase (Optional)|Adverse Event|0|||
142978842|NCT01998958|515458008|FG027|Open Label Phase (Optional)|Adverse Event|0|||
142978843|NCT01998958|515458009|FG028|Open Label Phase (Optional)|Adverse Event|0|||
142978844|NCT01998958|515458010|FG029|Open Label Phase (Optional)|Adverse Event|0|||
142978845|NCT01998958|515458011|FG030|Open Label Phase (Optional)|Adverse Event|0|||
142978846|NCT01998958|515458012|FG031|Open Label Phase (Optional)|Adverse Event|0|||
142978847|NCT01998958|515457981|FG000|Open Label Phase (Optional)|Other|0|||
142978848|NCT01998958|515457982|FG001|Open Label Phase (Optional)|Other|0|||
142978849|NCT01998958|515457983|FG002|Open Label Phase (Optional)|Other|0|||
142978850|NCT01998958|515457984|FG003|Open Label Phase (Optional)|Other|0|||
142978851|NCT01998958|515457985|FG004|Open Label Phase (Optional)|Other|0|||
142978852|NCT01998958|515457986|FG005|Open Label Phase (Optional)|Other|0|||
142978853|NCT01998958|515457987|FG006|Open Label Phase (Optional)|Other|0|||
142978854|NCT01998958|515457988|FG007|Open Label Phase (Optional)|Other|0|||
142978855|NCT01998958|515457989|FG008|Open Label Phase (Optional)|Other|0|||
142978856|NCT01998958|515457990|FG009|Open Label Phase (Optional)|Other|0|||
142978857|NCT01998958|515457991|FG010|Open Label Phase (Optional)|Other|0|||
142978858|NCT01998958|515457992|FG011|Open Label Phase (Optional)|Other|0|||
142978859|NCT01998958|515457993|FG012|Open Label Phase (Optional)|Other|0|||
142978860|NCT01998958|515457994|FG013|Open Label Phase (Optional)|Other|0|||
142978861|NCT01998958|515457995|FG014|Open Label Phase (Optional)|Other|0|||
142978862|NCT01998958|515457996|FG015|Open Label Phase (Optional)|Other|0|||
142978863|NCT01998958|515457997|FG016|Open Label Phase (Optional)|Other|0|||
142978864|NCT01998958|515457998|FG017|Open Label Phase (Optional)|Other|0|||
142978865|NCT01998958|515457999|FG018|Open Label Phase (Optional)|Other|0|||
142978866|NCT01998958|515458000|FG019|Open Label Phase (Optional)|Other|0|||
142978867|NCT01998958|515458001|FG020|Open Label Phase (Optional)|Other|0|||
142978868|NCT01998958|515458002|FG021|Open Label Phase (Optional)|Other|0|||
142978869|NCT01998958|515458003|FG022|Open Label Phase (Optional)|Other|5|||
142978870|NCT01998958|515458004|FG023|Open Label Phase (Optional)|Other|1|||
142978871|NCT01998958|515458005|FG024|Open Label Phase (Optional)|Other|0|||
142978872|NCT01998958|515458006|FG025|Open Label Phase (Optional)|Other|0|||
142978873|NCT01998958|515458007|FG026|Open Label Phase (Optional)|Other|0|||
142978874|NCT01998958|515458008|FG027|Open Label Phase (Optional)|Other|0|||
142978875|NCT01998958|515458009|FG028|Open Label Phase (Optional)|Other|0|||
142978876|NCT01998958|515458010|FG029|Open Label Phase (Optional)|Other|0|||
142978877|NCT01998958|515458011|FG030|Open Label Phase (Optional)|Other|0|||
142978878|NCT01998958|515458012|FG031|Open Label Phase (Optional)|Other|0|||
142978879|NCT01998958|515457981|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
142978880|NCT01998958|515457982|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
142978881|NCT01998958|515457983|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
142978882|NCT01998958|515457984|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
142978883|NCT01998958|515457985|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
142978884|NCT01998958|515457986|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
142978885|NCT01998958|515457987|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
142978886|NCT01998958|515457988|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
142978887|NCT01998958|515457989|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
142978888|NCT01998958|515457990|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
142978889|NCT01998958|515457991|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
142978890|NCT01998958|515457992|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
142978891|NCT01998958|515457993|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
142978892|NCT01998958|515457994|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
143455662|NCT00633880|517212501|FG000|Open Label Titration|Withdrawal by Subject|4|||
142978893|NCT01998958|515457995|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
142978894|NCT01998958|515457996|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
142978895|NCT01998958|515457997|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
142978896|NCT01998958|515457998|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
142978897|NCT01998958|515457999|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
142978898|NCT01998958|515458000|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
142978899|NCT01998958|515458001|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
142978900|NCT01998958|515458002|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
142978901|NCT01998958|515458003|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
142978902|NCT01998958|515458004|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
142978903|NCT01998958|515458005|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
142978904|NCT01998958|515458006|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
142978905|NCT01998958|515458007|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
142978906|NCT01998958|515458008|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
142978907|NCT01998958|515458009|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
142978908|NCT01998958|515458010|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
142978909|NCT01998958|515458011|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
142978910|NCT01998958|515458012|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
142978911|NCT01998958|515457981|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
142978912|NCT01998958|515457982|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
142978913|NCT01998958|515457983|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
142978914|NCT01998958|515457984|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
142978915|NCT01998958|515457985|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
142978916|NCT01998958|515457986|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
142978917|NCT01998958|515457987|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
142978918|NCT01998958|515457988|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
142978919|NCT01998958|515457989|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
142978920|NCT01998958|515457990|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
142978921|NCT01998958|515457991|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
142978922|NCT01998958|515457992|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
142978923|NCT01998958|515457993|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
142978924|NCT01998958|515457994|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
142978925|NCT01998958|515457995|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
142978926|NCT01998958|515457996|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
142978927|NCT01998958|515457997|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
142978928|NCT01998958|515457998|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
142978929|NCT01998958|515457999|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
142978930|NCT01998958|515458000|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
142978931|NCT01998958|515458001|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
142978932|NCT01998958|515458002|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
142978933|NCT01998958|515458003|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
142978934|NCT01998958|515458004|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
142978935|NCT01998958|515458005|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
142978936|NCT01998958|515458006|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
142978937|NCT01998958|515458007|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
142978938|NCT01998958|515458008|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
142978939|NCT01998958|515458009|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
142978940|NCT01998958|515458010|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
142978941|NCT01998958|515458011|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
142978942|NCT01998958|515458012|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
142978943|NCT01998958|515457981|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
142978944|NCT01998958|515457982|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
142978945|NCT01998958|515457983|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
142978946|NCT01998958|515457984|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
142978947|NCT01998958|515457985|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
142978948|NCT01998958|515457986|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
142978949|NCT01998958|515457987|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
142978950|NCT01998958|515457988|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
142978951|NCT01998958|515457989|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
142978952|NCT01998958|515457990|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
142978953|NCT01998958|515457991|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
142978954|NCT01998958|515457992|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
142978955|NCT01998958|515457993|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
142978956|NCT01998958|515457994|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
142978957|NCT01998958|515457995|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
142978958|NCT01998958|515457996|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
142978959|NCT01998958|515457997|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
142978960|NCT01998958|515457998|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
142978961|NCT01998958|515457999|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
142978962|NCT01998958|515458000|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
143117223|NCT00787917|515970070|FG001|Blinded Treatment|Lack of Efficacy|0|||
142978963|NCT01998958|515458001|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
142978964|NCT01998958|515458002|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
142978965|NCT01998958|515458003|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
142978966|NCT01998958|515458004|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
142978967|NCT01998958|515458005|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
142978968|NCT01998958|515458006|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
142978969|NCT01998958|515458007|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
142978970|NCT01998958|515458008|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
142978971|NCT01998958|515458009|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
142978972|NCT01998958|515458010|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
142978973|NCT01998958|515458011|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
142978974|NCT01998958|515458012|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
142978975|NCT00561340|515458013|FG000|Overall Study|refused to drink pediasure|6|||
142978976|NCT00561340|515458014|FG001|Overall Study|refused to drink pediasure|0|||
142978977|NCT05441540|515458015|FG000|Overall Study|Withdrawal by Subject|2|||
142978978|NCT00105183|515458019|FG000|Overall Study|Death|19|||
142978979|NCT00105183|515458020|FG001|Overall Study|Death|13|||
142978980|NCT00105183|515458021|FG002|Overall Study|Death|15|||
142978981|NCT00105183|515458019|FG000|Overall Study|Withdrawal by Subject|1|||
142978982|NCT00105183|515458020|FG001|Overall Study|Withdrawal by Subject|1|||
142978983|NCT00105183|515458021|FG002|Overall Study|Withdrawal by Subject|4|||
142978984|NCT00105183|515458019|FG000|Overall Study|Physician Decision|1|||
142978985|NCT00105183|515458020|FG001|Overall Study|Physician Decision|2|||
142978986|NCT00105183|515458021|FG002|Overall Study|Physician Decision|3|||
142978987|NCT00105183|515458019|FG000|Overall Study|Lost to Follow-up|0|||
142978988|NCT00105183|515458020|FG001|Overall Study|Lost to Follow-up|1|||
142978989|NCT00105183|515458021|FG002|Overall Study|Lost to Follow-up|1|||
142978990|NCT00105183|515458019|FG000|Overall Study|Other reason|1|||
142978991|NCT00105183|515458020|FG001|Overall Study|Other reason|2|||
142978992|NCT00105183|515458021|FG002|Overall Study|Other reason|0|||
142978993|NCT04539262|515458022|FG000|Overall Study|Adverse Event|0|||
142978994|NCT04539262|515458023|FG001|Overall Study|Adverse Event|0|||
142978995|NCT04539262|515458024|FG002|Overall Study|Adverse Event|1|||
142978996|NCT04539262|515458025|FG003|Overall Study|Adverse Event|0|||
142978997|NCT04539262|515458026|FG004|Overall Study|Adverse Event|0|||
142978998|NCT04539262|515458027|FG005|Overall Study|Adverse Event|0|||
142978999|NCT04539262|515458028|FG006|Overall Study|Adverse Event|0|||
142979000|NCT04539262|515458029|FG007|Overall Study|Adverse Event|0|||
142979001|NCT04539262|515458022|FG000|Overall Study|Withdrew Consent|0|||
142979002|NCT04539262|515458023|FG001|Overall Study|Withdrew Consent|0|||
142979003|NCT04539262|515458024|FG002|Overall Study|Withdrew Consent|0|||
142979004|NCT04539262|515458025|FG003|Overall Study|Withdrew Consent|1|||
142979005|NCT04539262|515458026|FG004|Overall Study|Withdrew Consent|0|||
142979006|NCT04539262|515458027|FG005|Overall Study|Withdrew Consent|0|||
142979007|NCT04539262|515458028|FG006|Overall Study|Withdrew Consent|0|||
142979008|NCT04539262|515458029|FG007|Overall Study|Withdrew Consent|0|||
142979009|NCT04539262|515458022|FG000|Overall Study|Randomized, Not treated|0|||
142979010|NCT04539262|515458023|FG001|Overall Study|Randomized, Not treated|1|||
142979011|NCT04539262|515458024|FG002|Overall Study|Randomized, Not treated|0|||
142979012|NCT04539262|515458025|FG003|Overall Study|Randomized, Not treated|0|||
142979013|NCT04539262|515458026|FG004|Overall Study|Randomized, Not treated|0|||
142979014|NCT04539262|515458027|FG005|Overall Study|Randomized, Not treated|0|||
142979015|NCT04539262|515458028|FG006|Overall Study|Randomized, Not treated|1|||
142979016|NCT04539262|515458029|FG007|Overall Study|Randomized, Not treated|0|||
142979017|NCT03673956|515458031|FG000|Overall Study|Lost to Follow-up|1|||
142979018|NCT03673956|515458032|FG001|Overall Study|Lost to Follow-up|0|||
142979019|NCT03673956|515458033|FG002|Overall Study|Lost to Follow-up|0|||
142979020|NCT03673956|515458034|FG003|Overall Study|Lost to Follow-up|0|||
142979021|NCT03673956|515458031|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
142979022|NCT03673956|515458032|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
142979023|NCT03673956|515458033|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
142979024|NCT03673956|515458034|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
142979025|NCT03228394|515458035|FG000|Overall Study|Lost to Follow-up|0|||
142979026|NCT03228394|515458036|FG001|Overall Study|Lost to Follow-up|0|||
142979027|NCT03228394|515458037|FG002|Overall Study|Lost to Follow-up|1|||
142979028|NCT03228394|515458038|FG003|Overall Study|Lost to Follow-up|1|||
142979029|NCT03228394|515458039|FG004|Overall Study|Lost to Follow-up|0|||
142979030|NCT03228394|515458040|FG005|Overall Study|Lost to Follow-up|0|||
142979031|NCT03228394|515458041|FG006|Overall Study|Lost to Follow-up|2|||
142979032|NCT03228394|515458042|FG007|Overall Study|Lost to Follow-up|0|||
142979033|NCT03228394|515458035|FG000|Overall Study|Withdrawal by Subject|0|||
142979034|NCT03228394|515458036|FG001|Overall Study|Withdrawal by Subject|0|||
142979035|NCT03228394|515458037|FG002|Overall Study|Withdrawal by Subject|1|||
142979036|NCT03228394|515458038|FG003|Overall Study|Withdrawal by Subject|0|||
142979037|NCT03228394|515458039|FG004|Overall Study|Withdrawal by Subject|0|||
142979038|NCT03228394|515458040|FG005|Overall Study|Withdrawal by Subject|0|||
142979039|NCT03228394|515458041|FG006|Overall Study|Withdrawal by Subject|1|||
142979040|NCT03228394|515458042|FG007|Overall Study|Withdrawal by Subject|3|||
142979041|NCT03228394|515458035|FG000|Overall Study|Protocol Violation|0|||
142979042|NCT03228394|515458036|FG001|Overall Study|Protocol Violation|0|||
142979043|NCT03228394|515458037|FG002|Overall Study|Protocol Violation|0|||
142979044|NCT03228394|515458038|FG003|Overall Study|Protocol Violation|1|||
142979045|NCT03228394|515458039|FG004|Overall Study|Protocol Violation|0|||
142979046|NCT03228394|515458040|FG005|Overall Study|Protocol Violation|0|||
142979047|NCT03228394|515458041|FG006|Overall Study|Protocol Violation|0|||
142979048|NCT03228394|515458042|FG007|Overall Study|Protocol Violation|0|||
142979049|NCT03228394|515458035|FG000|Overall Study|Physician Decision|0|||
142979050|NCT03228394|515458036|FG001|Overall Study|Physician Decision|0|||
142979051|NCT03228394|515458037|FG002|Overall Study|Physician Decision|0|||
142979052|NCT03228394|515458038|FG003|Overall Study|Physician Decision|0|||
142979053|NCT03228394|515458039|FG004|Overall Study|Physician Decision|0|||
142979054|NCT03228394|515458040|FG005|Overall Study|Physician Decision|0|||
142979055|NCT03228394|515458041|FG006|Overall Study|Physician Decision|1|||
142979056|NCT03228394|515458042|FG007|Overall Study|Physician Decision|0|||
142979057|NCT03228394|515458035|FG000|Overall Study|Noncompliance|0|||
142979058|NCT03228394|515458036|FG001|Overall Study|Noncompliance|0|||
142979059|NCT03228394|515458037|FG002|Overall Study|Noncompliance|0|||
142979060|NCT03228394|515458038|FG003|Overall Study|Noncompliance|0|||
142979061|NCT03228394|515458039|FG004|Overall Study|Noncompliance|0|||
142979062|NCT03228394|515458040|FG005|Overall Study|Noncompliance|0|||
142979063|NCT03228394|515458041|FG006|Overall Study|Noncompliance|1|||
142979064|NCT03228394|515458042|FG007|Overall Study|Noncompliance|0|||
142979065|NCT02076334|515458047|FG000|Overall Study|Protocol Violation|1|||
142979066|NCT02076334|515458048|FG001|Overall Study|Protocol Violation|0|||
142979067|NCT02076334|515458049|FG002|Overall Study|Protocol Violation|0|||
142979068|NCT02076334|515458050|FG003|Overall Study|Protocol Violation|0|||
142979069|NCT02076334|515458047|FG000|Overall Study|Lost to Follow-up|0|||
142979070|NCT02076334|515458048|FG001|Overall Study|Lost to Follow-up|1|||
142979071|NCT02076334|515458049|FG002|Overall Study|Lost to Follow-up|1|||
142979072|NCT02076334|515458050|FG003|Overall Study|Lost to Follow-up|0|||
142979073|NCT02076334|515458047|FG000|Overall Study|muscle soreness|0|||
142979074|NCT02076334|515458048|FG001|Overall Study|muscle soreness|0|||
142979075|NCT02076334|515458049|FG002|Overall Study|muscle soreness|0|||
142979076|NCT02076334|515458050|FG003|Overall Study|muscle soreness|1|||
142979077|NCT03379376|515458051|FG000|Overall Study|Lost to Follow-up|2|||
142979078|NCT03379376|515458051|FG000|Overall Study|Did not wish to complete follow up|1|||
142979079|NCT03379376|515458051|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
142979080|NCT03379376|515458051|FG000|Overall Study|Death|1|||
142979081|NCT00753623|515458052|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
142979082|NCT00753623|515458053|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
142979083|NCT00753623|515458052|FG000|Phase I (14 Days)|Physician Decision|1|||
142979084|NCT00753623|515458053|FG001|Phase I (14 Days)|Physician Decision|2|||
142979085|NCT00753623|515458052|FG000|Phase I (14 Days)|Adverse Event|0|||
142979086|NCT00753623|515458053|FG001|Phase I (14 Days)|Adverse Event|1|||
142979087|NCT00753623|515458052|FG000|Washout (7 Days)|Physician Decision|1|||
142979088|NCT00753623|515458053|FG001|Washout (7 Days)|Physician Decision|0|||
142979089|NCT00753623|515458052|FG000|Phase II (14 Days)|Physician Decision|0|||
142979090|NCT00753623|515458053|FG001|Phase II (14 Days)|Physician Decision|1|||
142979091|NCT03332303|515458054|FG000|Overall Study|Participant did not dose|1|||
142979092|NCT03332303|515458055|FG001|Overall Study|Participant did not dose|2|||
142979093|NCT03332303|515458056|FG002|Overall Study|Participant did not dose|0|||
142979094|NCT03332303|515458054|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
142979095|NCT03332303|515458055|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
142979096|NCT03332303|515458056|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
142979097|NCT03332303|515458054|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
142979098|NCT03332303|515458055|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
142979099|NCT03332303|515458056|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
142979100|NCT03332303|515458054|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
142979101|NCT03332303|515458055|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
142979102|NCT03332303|515458056|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
142979103|NCT03332303|515458054|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
142979104|NCT03332303|515458055|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
142979105|NCT03332303|515458056|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
142979106|NCT03332303|515458054|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
142979107|NCT03332303|515458055|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
142979108|NCT03332303|515458056|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
142979109|NCT03332303|515458054|FG000|Overall Study|Participant had a significant protocol deviation|0|||
142979110|NCT03332303|515458055|FG001|Overall Study|Participant had a significant protocol deviation|1|||
142979111|NCT03332303|515458056|FG002|Overall Study|Participant had a significant protocol deviation|0|||
142979112|NCT01296698|515458057|FG000|Overall Study|Adverse Event|1|||
142979113|NCT01296698|515458058|FG001|Overall Study|Adverse Event|0|||
142979114|NCT01296698|515458057|FG000|Overall Study|Death|1|||
142979115|NCT01296698|515458058|FG001|Overall Study|Death|0|||
142979116|NCT01296698|515458057|FG000|Overall Study|Lost to Follow-up|19|||
142979117|NCT01296698|515458058|FG001|Overall Study|Lost to Follow-up|1|||
142979118|NCT01296698|515458057|FG000|Overall Study|Withdrawal by Subject|12|||
142979119|NCT01296698|515458058|FG001|Overall Study|Withdrawal by Subject|0|||
142979120|NCT01296698|515458057|FG000|Overall Study|Difficulty Contacting Subject|2|||
142979121|NCT01296698|515458058|FG001|Overall Study|Difficulty Contacting Subject|0|||
142979122|NCT01296698|515458057|FG000|Overall Study|Study Terminated by Sponsor|209|||
142979123|NCT01296698|515458058|FG001|Overall Study|Study Terminated by Sponsor|12|||
142979124|NCT03639987|515458059|FG000|Overall Study|Study terminated by sponsor|26|||
142979125|NCT03639987|515458060|FG001|Overall Study|Study terminated by sponsor|25|||
142979126|NCT03639987|515458059|FG000|Overall Study|Lost to Follow-up|0|||
142979127|NCT03639987|515458060|FG001|Overall Study|Lost to Follow-up|1|||
142979128|NCT01185704|515458061|FG000|Overall Study|Randomized but not treated|3|||
142979129|NCT01185704|515458062|FG001|Overall Study|Randomized but not treated|3|||
142979130|NCT01185704|515458061|FG000|Overall Study|Lack of ovarian response|5|||
142979131|NCT01185704|515458062|FG001|Overall Study|Lack of ovarian response|1|||
142979132|NCT01185704|515458061|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
142979133|NCT01185704|515458062|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
142979134|NCT01185704|515458061|FG000|Overall Study|Ectopic pregnancy|0|||
142979135|NCT01185704|515458062|FG001|Overall Study|Ectopic pregnancy|1|||
142979136|NCT00187889|515458063|FG000|Overall Study|Withdrawal by Subject|6|||
142979137|NCT00187889|515458064|FG001|Overall Study|Withdrawal by Subject|4|||
142979138|NCT01151540|515458065|FG000|Overall Study|Other|2|||
142979139|NCT01151540|515458065|FG000|Overall Study|Adverse event, non-fatal|4|||
142979140|NCT01151540|515458065|FG000|Overall Study|Withdrawal by Subject|7|||
142979141|NCT00628758|515458066|FG000|Overall Study|Adverse Event|2|||
142979142|NCT00628758|515458067|FG001|Overall Study|Adverse Event|3|||
142979143|NCT00628758|515458066|FG000|Overall Study|Withdrawal by Subject|6|||
142979144|NCT00628758|515458067|FG001|Overall Study|Withdrawal by Subject|3|||
142979145|NCT00628758|515458066|FG000|Overall Study|Death|1|||
142979146|NCT00628758|515458067|FG001|Overall Study|Death|0|||
142979147|NCT00628758|515458066|FG000|Overall Study|Protocol Violation|5|||
142979148|NCT00628758|515458067|FG001|Overall Study|Protocol Violation|1|||
142979149|NCT00628758|515458066|FG000|Overall Study|Lost to Follow-up|25|||
142979150|NCT00628758|515458067|FG001|Overall Study|Lost to Follow-up|31|||
142979151|NCT00628758|515458066|FG000|Overall Study|Pregnancy|2|||
142979152|NCT00628758|515458067|FG001|Overall Study|Pregnancy|2|||
142979153|NCT00628758|515458066|FG000|Overall Study|Investigator Moved|3|||
142979154|NCT00628758|515458067|FG001|Overall Study|Investigator Moved|0|||
142979155|NCT00628758|515458066|FG000|Overall Study|Treatment Failure|0|||
142979156|NCT00628758|515458067|FG001|Overall Study|Treatment Failure|2|||
142979157|NCT01938001|515458068|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
142979158|NCT01938001|515458069|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
142979159|NCT01938001|515458068|FG000|Pre-Treatment|Death|1|||
142979160|NCT01938001|515458069|FG001|Pre-Treatment|Death|0|||
142979161|NCT01938001|515458068|FG000|Treatment|Death|2|||
142979162|NCT01938001|515458069|FG001|Treatment|Death|0|||
142979163|NCT01938001|515458068|FG000|Treatment|Adverse Event|14|||
142979164|NCT01938001|515458069|FG001|Treatment|Adverse Event|8|||
142979165|NCT01938001|515458068|FG000|Treatment|Progressive Disease|21|||
142979166|NCT01938001|515458069|FG001|Treatment|Progressive Disease|54|||
142979167|NCT01938001|515458068|FG000|Treatment|Withdrawal by Subject|13|||
142979168|NCT01938001|515458069|FG001|Treatment|Withdrawal by Subject|7|||
142979169|NCT01938001|515458068|FG000|Treatment|Other reasons|2|||
142979170|NCT01938001|515458069|FG001|Treatment|Other reasons|1|||
142979171|NCT03310580|515458070|FG000|Overall Study|Adverse Event|0|||
142979172|NCT03310580|515458071|FG001|Overall Study|Adverse Event|1|||
142979173|NCT03310580|515458072|FG002|Overall Study|Adverse Event|0|||
142979174|NCT03205982|515458073|FG000|Overall Study|Lost to Follow-up|20|||
142979175|NCT03205982|515458074|FG001|Overall Study|Lost to Follow-up|19|||
142979176|NCT03205982|515458073|FG000|Overall Study|Withdrawal by Subject|4|||
142979177|NCT03205982|515458074|FG001|Overall Study|Withdrawal by Subject|3|||
142979178|NCT03205982|515458073|FG000|Overall Study|Withdrawal by PI|0|||
142979179|NCT03205982|515458074|FG001|Overall Study|Withdrawal by PI|1|||
142979180|NCT00994162|515458077|FG000|Overall Study|Withdrawal by Subject|1|||
142979181|NCT00994162|515458077|FG000|Overall Study|Lost to Follow-up|2|||
142979182|NCT00994162|515458077|FG000|Overall Study|Product Complaint|1|||
142979183|NCT00994162|515458077|FG000|Overall Study|Poor Compliance|5|||
142979184|NCT00994162|515458077|FG000|Overall Study|Lack of Response|3|||
142979185|NCT00994162|515458077|FG000|Overall Study|Discharged from Hospital|4|||
142979186|NCT00994162|515458077|FG000|Overall Study|Death|2|||
142979187|NCT00994162|515458077|FG000|Overall Study|Care Transferred to Another Physician|2|||
142979188|NCT00994162|515458077|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
142979189|NCT00994162|515458077|FG000|Overall Study|Physician Decision|2|||
142979190|NCT00994162|515458077|FG000|Overall Study|Surrounding Wound Erythematous|1|||
142979191|NCT00994162|515458077|FG000|Overall Study|Machine Losing Vaccum|1|||
142979192|NCT00994162|515458077|FG000|Overall Study|Patient Lived Too Far Away|1|||
142979193|NCT00994162|515458077|FG000|Overall Study|Above Knee Amputation|1|||
142979194|NCT00994162|515458077|FG000|Overall Study|Reason Not Reported By Site|1|||
142979195|NCT02983799|515458078|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
142979196|NCT02983799|515458079|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
142979197|NCT02983799|515458080|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
142979198|NCT02983799|515458081|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
142979199|NCT02983799|515458082|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
142979200|NCT02983799|515458078|FG000|Overall Study|Death|20|||
142979201|NCT02983799|515458079|FG001|Overall Study|Death|5|||
142979202|NCT02983799|515458080|FG002|Overall Study|Death|23|||
142979203|NCT02983799|515458081|FG003|Overall Study|Death|47|||
142979204|NCT02983799|515458082|FG004|Overall Study|Death|7|||
142979205|NCT02983799|515458078|FG000|Overall Study|Withdrawal by Subject|1|||
142979206|NCT02983799|515458079|FG001|Overall Study|Withdrawal by Subject|0|||
142979207|NCT02983799|515458080|FG002|Overall Study|Withdrawal by Subject|3|||
142979208|NCT02983799|515458081|FG003|Overall Study|Withdrawal by Subject|4|||
142979209|NCT02983799|515458082|FG004|Overall Study|Withdrawal by Subject|1|||
142979210|NCT02983799|515458078|FG000|Overall Study|Protocol Violation|0|||
142979211|NCT02983799|515458079|FG001|Overall Study|Protocol Violation|1|||
142979212|NCT02983799|515458080|FG002|Overall Study|Protocol Violation|0|||
142979213|NCT02983799|515458081|FG003|Overall Study|Protocol Violation|0|||
142979214|NCT02983799|515458082|FG004|Overall Study|Protocol Violation|1|||
142979215|NCT02983799|515458078|FG000|Overall Study|Lost to Follow-up|1|||
142979216|NCT02983799|515458079|FG001|Overall Study|Lost to Follow-up|0|||
142979217|NCT02983799|515458080|FG002|Overall Study|Lost to Follow-up|1|||
142979218|NCT02983799|515458081|FG003|Overall Study|Lost to Follow-up|0|||
142979219|NCT02983799|515458082|FG004|Overall Study|Lost to Follow-up|0|||
142979220|NCT01468701|515458087|FG000|Overall Study|Not eligible|91|||
142979221|NCT01468701|515458088|FG001|Overall Study|Not eligible|140|||
142979222|NCT01468701|515458089|FG002|Overall Study|Not eligible|29|||
142979223|NCT01468701|515458090|FG003|Overall Study|Not eligible|12|||
142979224|NCT01468701|515458091|FG004|Overall Study|Not eligible|22|||
142979225|NCT01468701|515458092|FG005|Overall Study|Not eligible|2|||
142979226|NCT01468701|515458093|FG006|Overall Study|Not eligible|39|||
142979227|NCT01468701|515458094|FG007|Overall Study|Not eligible|1|||
142979228|NCT01468701|515458095|FG008|Overall Study|Not eligible|40|||
142979229|NCT01468701|515458096|FG009|Overall Study|Not eligible|126|||
142979230|NCT01468701|515458097|FG010|Overall Study|Not eligible|39|||
142979231|NCT01468701|515458098|FG011|Overall Study|Not eligible|33|||
142979232|NCT01468701|515458099|FG012|Overall Study|Not eligible|1|||
142979233|NCT01468701|515458100|FG013|Overall Study|Not eligible|19|||
142979234|NCT01468701|515458101|FG014|Overall Study|Not eligible|1|||
142979235|NCT01468701|515458102|FG015|Overall Study|Not eligible|32|||
142979236|NCT01468701|515458103|FG016|Overall Study|Not eligible|0|||
142979237|NCT01468701|515458087|FG000|Overall Study|Lost to Follow-up|306|||
142979238|NCT01468701|515458088|FG001|Overall Study|Lost to Follow-up|0|||
142979239|NCT01468701|515458089|FG002|Overall Study|Lost to Follow-up|0|||
142979240|NCT01468701|515458090|FG003|Overall Study|Lost to Follow-up|0|||
142979241|NCT01468701|515458091|FG004|Overall Study|Lost to Follow-up|0|||
142979242|NCT01468701|515458092|FG005|Overall Study|Lost to Follow-up|0|||
142979243|NCT01468701|515458093|FG006|Overall Study|Lost to Follow-up|0|||
142979244|NCT01468701|515458094|FG007|Overall Study|Lost to Follow-up|0|||
142979245|NCT01468701|515458095|FG008|Overall Study|Lost to Follow-up|215|||
142979246|NCT01468701|515458096|FG009|Overall Study|Lost to Follow-up|309|||
142979247|NCT01468701|515458097|FG010|Overall Study|Lost to Follow-up|224|||
142979248|NCT01468701|515458098|FG011|Overall Study|Lost to Follow-up|212|||
142979249|NCT01468701|515458099|FG012|Overall Study|Lost to Follow-up|11|||
142979250|NCT01468701|515458100|FG013|Overall Study|Lost to Follow-up|164|||
142979251|NCT01468701|515458101|FG014|Overall Study|Lost to Follow-up|17|||
142979252|NCT01468701|515458102|FG015|Overall Study|Lost to Follow-up|127|||
142979253|NCT01468701|515458103|FG016|Overall Study|Lost to Follow-up|1|||
142979254|NCT01468701|515458087|FG000|Overall Study|Withdrawal by Subject|165|||
142979255|NCT01468701|515458088|FG001|Overall Study|Withdrawal by Subject|0|||
142979256|NCT01468701|515458089|FG002|Overall Study|Withdrawal by Subject|0|||
142979257|NCT01468701|515458090|FG003|Overall Study|Withdrawal by Subject|0|||
142979258|NCT01468701|515458091|FG004|Overall Study|Withdrawal by Subject|0|||
142979259|NCT01468701|515458092|FG005|Overall Study|Withdrawal by Subject|0|||
142979260|NCT01468701|515458093|FG006|Overall Study|Withdrawal by Subject|0|||
142979261|NCT01468701|515458094|FG007|Overall Study|Withdrawal by Subject|0|||
142979262|NCT01468701|515458095|FG008|Overall Study|Withdrawal by Subject|83|||
142979263|NCT01468701|515458096|FG009|Overall Study|Withdrawal by Subject|88|||
142979264|NCT01468701|515458097|FG010|Overall Study|Withdrawal by Subject|100|||
142979265|NCT01468701|515458098|FG011|Overall Study|Withdrawal by Subject|114|||
142979266|NCT01468701|515458099|FG012|Overall Study|Withdrawal by Subject|9|||
142979267|NCT01468701|515458100|FG013|Overall Study|Withdrawal by Subject|47|||
142979268|NCT01468701|515458101|FG014|Overall Study|Withdrawal by Subject|6|||
142979269|NCT01468701|515458102|FG015|Overall Study|Withdrawal by Subject|31|||
142979270|NCT01468701|515458103|FG016|Overall Study|Withdrawal by Subject|0|||
142979271|NCT01468701|515458087|FG000|Overall Study|Other reasons than listed|437|||
143455663|NCT00633880|517212502|FG001|Open Label Titration|Withdrawal by Subject|0|||
142979272|NCT01468701|515458088|FG001|Overall Study|Other reasons than listed|0|||
142979273|NCT01468701|515458089|FG002|Overall Study|Other reasons than listed|0|||
142979274|NCT01468701|515458090|FG003|Overall Study|Other reasons than listed|0|||
142979275|NCT01468701|515458091|FG004|Overall Study|Other reasons than listed|0|||
142979276|NCT01468701|515458092|FG005|Overall Study|Other reasons than listed|0|||
142979277|NCT01468701|515458093|FG006|Overall Study|Other reasons than listed|0|||
142979278|NCT01468701|515458094|FG007|Overall Study|Other reasons than listed|0|||
142979279|NCT01468701|515458095|FG008|Overall Study|Other reasons than listed|318|||
142979280|NCT01468701|515458096|FG009|Overall Study|Other reasons than listed|658|||
142979281|NCT01468701|515458097|FG010|Overall Study|Other reasons than listed|433|||
142979282|NCT01468701|515458098|FG011|Overall Study|Other reasons than listed|504|||
142979283|NCT01468701|515458099|FG012|Overall Study|Other reasons than listed|28|||
142979284|NCT01468701|515458100|FG013|Overall Study|Other reasons than listed|239|||
142979285|NCT01468701|515458101|FG014|Overall Study|Other reasons than listed|39|||
142979286|NCT01468701|515458102|FG015|Overall Study|Other reasons than listed|172|||
142979287|NCT01468701|515458103|FG016|Overall Study|Other reasons than listed|0|||
142979288|NCT01468701|515458087|FG000|Overall Study|No end of study case report form|0|||
142979289|NCT01468701|515458088|FG001|Overall Study|No end of study case report form|0|||
142979290|NCT01468701|515458089|FG002|Overall Study|No end of study case report form|0|||
142979291|NCT01468701|515458090|FG003|Overall Study|No end of study case report form|0|||
142979292|NCT01468701|515458091|FG004|Overall Study|No end of study case report form|0|||
142979293|NCT01468701|515458092|FG005|Overall Study|No end of study case report form|0|||
142979294|NCT01468701|515458093|FG006|Overall Study|No end of study case report form|0|||
142979295|NCT01468701|515458094|FG007|Overall Study|No end of study case report form|0|||
142979296|NCT01468701|515458095|FG008|Overall Study|No end of study case report form|4|||
142979297|NCT01468701|515458096|FG009|Overall Study|No end of study case report form|1|||
142979298|NCT01468701|515458097|FG010|Overall Study|No end of study case report form|2|||
142979299|NCT01468701|515458098|FG011|Overall Study|No end of study case report form|3|||
142979300|NCT01468701|515458099|FG012|Overall Study|No end of study case report form|0|||
142979301|NCT01468701|515458100|FG013|Overall Study|No end of study case report form|1|||
142979302|NCT01468701|515458101|FG014|Overall Study|No end of study case report form|0|||
142979303|NCT01468701|515458102|FG015|Overall Study|No end of study case report form|0|||
142979304|NCT01468701|515458103|FG016|Overall Study|No end of study case report form|0|||
142979305|NCT01468701|515458087|FG000|Overall Study|Not being followed up|0|||
142979306|NCT01468701|515458088|FG001|Overall Study|Not being followed up|4963|||
142979307|NCT01468701|515458089|FG002|Overall Study|Not being followed up|1755|||
142979308|NCT01468701|515458090|FG003|Overall Study|Not being followed up|703|||
142979309|NCT01468701|515458091|FG004|Overall Study|Not being followed up|1714|||
142979310|NCT01468701|515458092|FG005|Overall Study|Not being followed up|126|||
142979311|NCT01468701|515458093|FG006|Overall Study|Not being followed up|1170|||
142979312|NCT01468701|515458094|FG007|Overall Study|Not being followed up|4|||
142979313|NCT01468701|515458095|FG008|Overall Study|Not being followed up|0|||
142979314|NCT01468701|515458096|FG009|Overall Study|Not being followed up|0|||
142979315|NCT01468701|515458097|FG010|Overall Study|Not being followed up|0|||
142979316|NCT01468701|515458098|FG011|Overall Study|Not being followed up|0|||
142979317|NCT01468701|515458099|FG012|Overall Study|Not being followed up|0|||
142979318|NCT01468701|515458100|FG013|Overall Study|Not being followed up|0|||
142979319|NCT01468701|515458101|FG014|Overall Study|Not being followed up|0|||
142979320|NCT01468701|515458102|FG015|Overall Study|Not being followed up|0|||
142979321|NCT01468701|515458103|FG016|Overall Study|Not being followed up|0|||
142979322|NCT01822223|515458104|FG000|Overall Study|Death|0|||
142979323|NCT01822223|515458105|FG001|Overall Study|Death|1|||
142979324|NCT00631540|515458106|FG000|Overall Study|Withdrawal by Subject|5|||
142979325|NCT00631540|515458106|FG000|Overall Study|Death|4|||
142979326|NCT00631540|515458106|FG000|Overall Study|Lost to Follow-up|2|||
142979327|NCT00631540|515458106|FG000|Overall Study|Core Lab Data Unavailable|3|||
142979328|NCT02091921|515458109|FG000|Overall Study|Adverse Event|3|||
142979329|NCT04876599|515458114|FG000|Overall Study|Missed|2|||
142979330|NCT04876599|515458115|FG001|Overall Study|Missed|0|||
142979331|NCT04876599|515458114|FG000|Overall Study|Declined|2|||
142979332|NCT04876599|515458115|FG001|Overall Study|Declined|3|||
142979333|NCT03366844|515460162|FG000|Overall Study|Physician Decision|1|||
142979334|NCT03366844|515460162|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
142979335|NCT02688153|515460163|FG000|Overall Study|Death|7|||
142979336|NCT02688153|515460164|FG001|Overall Study|Death|5|||
142979337|NCT02688153|515460163|FG000|Overall Study|Withdrawal by Subject|4|||
142979338|NCT02688153|515460164|FG001|Overall Study|Withdrawal by Subject|2|||
142979339|NCT02688153|515460163|FG000|Overall Study|Valve Explant|1|||
142979340|NCT02688153|515460164|FG001|Overall Study|Valve Explant|0|||
142979341|NCT02688153|515460163|FG000|Overall Study|Conversion to Commercial Valve|3|||
142979342|NCT02688153|515460164|FG001|Overall Study|Conversion to Commercial Valve|0|||
142979343|NCT00107172|515460165|FG000|Overall Study|Withdrawal by Subject|1|||
142979344|NCT00107172|515460166|FG001|Overall Study|Withdrawal by Subject|0|||
142979345|NCT00107172|515460165|FG000|Overall Study|Death|0|||
142979346|NCT00107172|515460166|FG001|Overall Study|Death|2|||
142979347|NCT00107172|515460165|FG000|Overall Study|Other Reason|4|||
142979348|NCT00107172|515460166|FG001|Overall Study|Other Reason|3|||
142979349|NCT03682055|515460167|FG000|Overall Study|Lack of Efficacy|1|||
142979350|NCT03682055|515460168|FG001|Overall Study|Lack of Efficacy|2|||
142979351|NCT03682055|515460169|FG002|Overall Study|Lack of Efficacy|1|||
142979352|NCT03682055|515460170|FG003|Overall Study|Lack of Efficacy|2|||
142979353|NCT03682055|515460171|FG004|Overall Study|Lack of Efficacy|1|||
142979354|NCT03682055|515460172|FG005|Overall Study|Lack of Efficacy|3|||
142979355|NCT03682055|515460167|FG000|Overall Study|Withdrawal by Subject|0|||
142979356|NCT03682055|515460168|FG001|Overall Study|Withdrawal by Subject|0|||
142979357|NCT03682055|515460169|FG002|Overall Study|Withdrawal by Subject|0|||
142979358|NCT03682055|515460170|FG003|Overall Study|Withdrawal by Subject|0|||
142979359|NCT03682055|515460171|FG004|Overall Study|Withdrawal by Subject|0|||
142979360|NCT03682055|515460172|FG005|Overall Study|Withdrawal by Subject|1|||
142979361|NCT03682055|515460167|FG000|Overall Study|Termination of Study by Sponsor|0|||
142979362|NCT03682055|515460168|FG001|Overall Study|Termination of Study by Sponsor|0|||
142979363|NCT03682055|515460169|FG002|Overall Study|Termination of Study by Sponsor|0|||
142979364|NCT03682055|515460170|FG003|Overall Study|Termination of Study by Sponsor|0|||
142979365|NCT03682055|515460171|FG004|Overall Study|Termination of Study by Sponsor|0|||
142979366|NCT03682055|515460172|FG005|Overall Study|Termination of Study by Sponsor|3|||
142979367|NCT02687711|515460173|FG000|Overall Study|Adverse Event|89|||
142979368|NCT02687711|515460173|FG000|Overall Study|Lack of Efficacy|70|||
142979369|NCT02687711|515460173|FG000|Overall Study|Lost to Follow-up|20|||
142979370|NCT02687711|515460173|FG000|Overall Study|Consent withdrawn|15|||
142979371|NCT02687711|515460173|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
142979372|NCT02687711|515460173|FG000|Overall Study|Too expensive|4|||
142979373|NCT02687711|515460173|FG000|Overall Study|Participant moved abroad|1|||
142979374|NCT02687711|515460173|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
142979375|NCT02687711|515460173|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
142979376|NCT02687711|515460173|FG000|Overall Study|Disliked taste|1|||
142979377|NCT02687711|515460173|FG000|Overall Study|Low mood|1|||
142979378|NCT02687711|515460173|FG000|Overall Study|Side effects|1|||
142979379|NCT02687711|515460173|FG000|Overall Study|Change of Hospital|1|||
142979380|NCT02687711|515460173|FG000|Overall Study|Liver Encephalopathy|1|||
142979381|NCT02687711|515460173|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
142979382|NCT02687711|515460173|FG000|Overall Study|Withdrawn due to intake interruption|1|||
142979383|NCT02687711|515460173|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
142979384|NCT02687711|515460173|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
142979385|NCT02687711|515460173|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
142979386|NCT00191386|515460174|FG000|Overall Study|Adverse Event|16|||
142979387|NCT00191386|515460174|FG000|Overall Study|Lost to Follow-up|1|||
142979388|NCT00191386|515460174|FG000|Overall Study|Entry Criteria Exclusion|3|||
142979389|NCT00191386|515460174|FG000|Overall Study|Protocol Violation|18|||
142979390|NCT00191386|515460174|FG000|Overall Study|Withdrawal by Subject|96|||
142979391|NCT00191386|515460174|FG000|Overall Study|Physician Decision|11|||
142979392|NCT00191386|515460174|FG000|Overall Study|Lack of Efficacy|15|||
142979393|NCT03706040|515460175|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
142979394|NCT03706040|515460176|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
142979395|NCT03706040|515460177|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
142979396|NCT03706040|515460178|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
142979397|NCT03706040|515460179|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
142979398|NCT03706040|515460180|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
142979399|NCT03706040|515460181|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
142979400|NCT03706040|515460175|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
142979401|NCT03706040|515460176|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
142979402|NCT03706040|515460177|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
142979403|NCT03706040|515460178|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
142979404|NCT03706040|515460179|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
142979405|NCT03706040|515460180|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
142979406|NCT03706040|515460181|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
142979407|NCT03706040|515460175|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
142979408|NCT03706040|515460176|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
142979409|NCT03706040|515460177|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
142979410|NCT03706040|515460178|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
142979411|NCT03706040|515460179|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
142979412|NCT03706040|515460180|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
142979413|NCT03706040|515460181|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
142979414|NCT03706040|515460175|FG000|Period A (Week 0 to Week 16)|Other|2|||
142979415|NCT03706040|515460176|FG001|Period A (Week 0 to Week 16)|Other|0|||
142979416|NCT03706040|515460177|FG002|Period A (Week 0 to Week 16)|Other|2|||
142979417|NCT03706040|515460178|FG003|Period A (Week 0 to Week 16)|Other|0|||
142979418|NCT03706040|515460179|FG004|Period A (Week 0 to Week 16)|Other|0|||
142979419|NCT03706040|515460180|FG005|Period A (Week 0 to Week 16)|Other|0|||
142979420|NCT03706040|515460181|FG006|Period A (Week 0 to Week 16)|Other|0|||
142979421|NCT03706040|515460175|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
143455664|NCT00633880|517212503|FG002|Open Label Titration|Withdrawal by Subject|0|||
142979422|NCT03706040|515460176|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
142979423|NCT03706040|515460177|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
142979424|NCT03706040|515460178|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
142979425|NCT03706040|515460179|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
142979426|NCT03706040|515460180|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
142979427|NCT03706040|515460181|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
142979428|NCT03706040|515460175|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
142979429|NCT03706040|515460176|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
142979430|NCT03706040|515460177|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
142979431|NCT03706040|515460178|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
142979432|NCT03706040|515460179|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
142979433|NCT03706040|515460180|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
142979434|NCT03706040|515460181|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
142979435|NCT03706040|515460175|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
142979436|NCT03706040|515460176|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
142979437|NCT03706040|515460177|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
142979438|NCT03706040|515460178|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
142979439|NCT03706040|515460179|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
142979440|NCT03706040|515460180|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
142979441|NCT03706040|515460181|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
142979442|NCT03706040|515460175|FG000|Period B (Week 16 to Week 52)|Other|0|||
142979443|NCT03706040|515460176|FG001|Period B (Week 16 to Week 52)|Other|0|||
142979444|NCT03706040|515460177|FG002|Period B (Week 16 to Week 52)|Other|0|||
142979445|NCT03706040|515460178|FG003|Period B (Week 16 to Week 52)|Other|4|||
142979446|NCT03706040|515460179|FG004|Period B (Week 16 to Week 52)|Other|5|||
142979447|NCT03706040|515460180|FG005|Period B (Week 16 to Week 52)|Other|23|||
142979448|NCT03706040|515460181|FG006|Period B (Week 16 to Week 52)|Other|17|||
142979449|NCT00927758|515460182|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
142979450|NCT00927758|515460183|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
142979451|NCT00927758|515460184|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
142979452|NCT00927758|515460185|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
142979453|NCT00927758|515460186|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
142979454|NCT00927758|515460187|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
142979455|NCT00927758|515460182|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
142979456|NCT00927758|515460183|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
142979457|NCT00927758|515460184|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
142979458|NCT00927758|515460185|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
142979459|NCT00927758|515460186|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
142979460|NCT00927758|515460187|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
142979461|NCT00439725|515460189|FG000|Treatment Period|Withdrawal by Subject|22|||
142979462|NCT00439725|515460190|FG001|Treatment Period|Withdrawal by Subject|19|||
142979463|NCT00439725|515460189|FG000|Treatment Period|Study terminated by sponsor|156|||
142979464|NCT00439725|515460190|FG001|Treatment Period|Study terminated by sponsor|148|||
142979465|NCT00439725|515460189|FG000|Treatment Period|Site closed by investigator|1|||
142979466|NCT00439725|515460190|FG001|Treatment Period|Site closed by investigator|2|||
142979467|NCT00439725|515460189|FG000|Treatment Period|Adverse Event|39|||
142979468|NCT00439725|515460190|FG001|Treatment Period|Adverse Event|18|||
142979469|NCT00439725|515460189|FG000|Treatment Period|Physician Decision|1|||
142979470|NCT00439725|515460190|FG001|Treatment Period|Physician Decision|1|||
142979471|NCT00439725|515460189|FG000|Treatment Period|Protocol Violation|2|||
142979472|NCT00439725|515460190|FG001|Treatment Period|Protocol Violation|1|||
142979473|NCT00439725|515460189|FG000|Treatment Period|Clinical endpoint reached|6|||
142979474|NCT00439725|515460190|FG001|Treatment Period|Clinical endpoint reached|50|||
142979475|NCT00439725|515460189|FG000|Treatment Period|Technical problems|1|||
142979476|NCT00439725|515460190|FG001|Treatment Period|Technical problems|0|||
142979477|NCT00439725|515460189|FG000|Treatment Period|Lost to Follow-up|1|||
142979478|NCT00439725|515460190|FG001|Treatment Period|Lost to Follow-up|1|||
142979479|NCT00439725|515460189|FG000|Treatment Period|Participant convenience|1|||
142979480|NCT00439725|515460190|FG001|Treatment Period|Participant convenience|0|||
142979481|NCT00439725|515460189|FG000|Treatment Period|Protocol driven decision point|1|||
142979482|NCT00439725|515460190|FG001|Treatment Period|Protocol driven decision point|1|||
142979483|NCT00439725|515460189|FG000|Treatment Period|Death|1|||
142979484|NCT00439725|515460190|FG001|Treatment Period|Death|1|||
142979485|NCT00439725|515460189|FG000|Treatment Period|Participant did not receive treatment|4|||
142979486|NCT00439725|515460190|FG001|Treatment Period|Participant did not receive treatment|4|||
142979487|NCT00439725|515460189|FG000|Observational Period|Withdrawal by Subject|2|||
142979488|NCT00439725|515460190|FG001|Observational Period|Withdrawal by Subject|2|||
142979489|NCT00439725|515460189|FG000|Observational Period|Lost to Follow-up|0|||
142979490|NCT00439725|515460190|FG001|Observational Period|Lost to Follow-up|1|||
142979491|NCT00439725|515460189|FG000|Observational Period|Death|0|||
142979492|NCT00439725|515460190|FG001|Observational Period|Death|2|||
142979493|NCT00439725|515460189|FG000|Observational Period|Study termination by sponsor|1|||
142979494|NCT00439725|515460190|FG001|Observational Period|Study termination by sponsor|1|||
142979495|NCT00439725|515460189|FG000|Observational Period|Clinical endpoint reached|3|||
142979496|NCT00439725|515460190|FG001|Observational Period|Clinical endpoint reached|1|||
142979497|NCT00439725|515460189|FG000|Observational Period|Technical problems|1|||
142979498|NCT00439725|515460190|FG001|Observational Period|Technical problems|0|||
142979499|NCT00439725|515460189|FG000|Observational Period|Participant convenience|1|||
142979500|NCT00439725|515460190|FG001|Observational Period|Participant convenience|0|||
142979501|NCT03077243|515460191|FG000|Overall Study|Death|1|||
142979502|NCT03077243|515460192|FG001|Overall Study|Death|2|||
142979503|NCT03077243|515460193|FG002|Overall Study|Death|0|||
142979504|NCT03077243|515460194|FG003|Overall Study|Death|0|||
142979505|NCT03077243|515460191|FG000|Overall Study|Withdrawal by Subject|1|||
142979506|NCT03077243|515460192|FG001|Overall Study|Withdrawal by Subject|3|||
142979507|NCT03077243|515460193|FG002|Overall Study|Withdrawal by Subject|0|||
142979508|NCT03077243|515460194|FG003|Overall Study|Withdrawal by Subject|0|||
142979509|NCT03077243|515460191|FG000|Overall Study|Physician Decision|1|||
142979510|NCT03077243|515460192|FG001|Overall Study|Physician Decision|0|||
142979511|NCT03077243|515460193|FG002|Overall Study|Physician Decision|0|||
142979512|NCT03077243|515460194|FG003|Overall Study|Physician Decision|0|||
142979513|NCT03077243|515460191|FG000|Overall Study|Research at two study sites terminated early|0|||
142979514|NCT03077243|515460192|FG001|Overall Study|Research at two study sites terminated early|0|||
142979515|NCT03077243|515460193|FG002|Overall Study|Research at two study sites terminated early|0|||
142979516|NCT03077243|515460194|FG003|Overall Study|Research at two study sites terminated early|69|||
142979517|NCT02848313|515460195|FG000|Overall Study|Adverse Event|1|||
142979518|NCT02848313|515460196|FG001|Overall Study|Adverse Event|2|||
142979519|NCT02848313|515460195|FG000|Overall Study|Lack of Efficacy|0|||
142979520|NCT02848313|515460196|FG001|Overall Study|Lack of Efficacy|1|||
142979521|NCT02848313|515460195|FG000|Overall Study|Withdrawal by Subject|1|||
142979522|NCT02848313|515460196|FG001|Overall Study|Withdrawal by Subject|1|||
142979523|NCT02848313|515460195|FG000|Overall Study|Lost to follow up|1|||
142979524|NCT02848313|515460196|FG001|Overall Study|Lost to follow up|0|||
142979525|NCT01544478|515460198|FG000|Overall Study|Adverse Event|1|||
142979526|NCT01544478|515460198|FG000|Overall Study|Death|1|||
142979527|NCT01544478|515460198|FG000|Overall Study|Lost to Follow-up|48|||
142979528|NCT01544478|515460198|FG000|Overall Study|Physician Decision|15|||
142979529|NCT01544478|515460198|FG000|Overall Study|Pregnancy|1|||
142979530|NCT01544478|515460198|FG000|Overall Study|Withdrawal by Subject|52|||
142979531|NCT03984812|515460199|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
142979532|NCT03984812|515460200|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
142979533|NCT03984812|515460201|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
142979534|NCT03984812|515460202|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
142979535|NCT03984812|515460203|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
142979536|NCT03984812|515460204|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
142979537|NCT03984812|515460205|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
142979538|NCT03984812|515460206|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
142979539|NCT03984812|515460207|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
142979540|NCT03984812|515460208|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
142979541|NCT03984812|515460209|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
142979542|NCT03510910|515460210|FG000|Overall Study|Incomplete Survey|2|||
142979543|NCT03510910|515460211|FG001|Overall Study|Incomplete Survey|3|||
142979544|NCT01673490|515460212|FG000|Overall Study|Lost to Follow-up|1|||
142979545|NCT01673490|515460212|FG000|Overall Study|Adverse Event|3|||
142979546|NCT01673490|515460212|FG000|Overall Study|Withdrawal by Subject|3|||
142979547|NCT04038385|515460214|FG000|Overall Study|Completed baseline assessment only|7|||
142979548|NCT04038385|515460215|FG001|Overall Study|Completed baseline assessment only|4|||
142979549|NCT04038385|515460214|FG000|Overall Study|Moved out of area|4|||
142979550|NCT04038385|515460215|FG001|Overall Study|Moved out of area|2|||
142979551|NCT04038385|515460214|FG000|Overall Study|Discontinued study involvement|6|||
142979552|NCT04038385|515460215|FG001|Overall Study|Discontinued study involvement|1|||
142979553|NCT01563107|515460216|FG000|Overall Study|Physician Decision|0|||
142979554|NCT01563107|515460217|FG001|Overall Study|Physician Decision|1|||
142979555|NCT01563107|515460218|FG002|Overall Study|Physician Decision|1|||
142979556|NCT01563107|515460219|FG003|Overall Study|Physician Decision|3|||
142979557|NCT01563107|515460216|FG000|Overall Study|Withdrawal by Subject|1|||
142979558|NCT01563107|515460217|FG001|Overall Study|Withdrawal by Subject|2|||
142979559|NCT01563107|515460218|FG002|Overall Study|Withdrawal by Subject|1|||
142979560|NCT01563107|515460219|FG003|Overall Study|Withdrawal by Subject|2|||
142979561|NCT00247273|515460227|FG000|Overall Study|Adverse Event|85|||
142979562|NCT00247273|515460228|FG001|Overall Study|Adverse Event|80|||
142979563|NCT00247273|515460227|FG000|Overall Study|Physician Decision|6|||
142979564|NCT00247273|515460228|FG001|Overall Study|Physician Decision|3|||
142979565|NCT00247273|515460227|FG000|Overall Study|Lost to Follow-up|7|||
142979566|NCT00247273|515460228|FG001|Overall Study|Lost to Follow-up|7|||
142979567|NCT00247273|515460227|FG000|Overall Study|Withdrawal by Subject|46|||
142979568|NCT00247273|515460228|FG001|Overall Study|Withdrawal by Subject|47|||
142979569|NCT00247273|515460227|FG000|Overall Study|Did not take any study drug|2|||
142979570|NCT00247273|515460228|FG001|Overall Study|Did not take any study drug|0|||
142979571|NCT03276572|515460229|FG000|Overall Study|In follow-up|0|||
142979572|NCT03276572|515460230|FG001|Overall Study|In follow-up|0|||
142979573|NCT03276572|515460231|FG002|Overall Study|In follow-up|0|||
142979574|NCT03276572|515460232|FG003|Overall Study|In follow-up|0|||
142979575|NCT03276572|515460233|FG004|Overall Study|In follow-up|0|||
142979576|NCT03276572|515460234|FG005|Overall Study|In follow-up|1|||
142979577|NCT03276572|515460235|FG006|Overall Study|In follow-up|1|||
142979578|NCT03276572|515460229|FG000|Overall Study|Lost to Follow-up|0|||
142979579|NCT03276572|515460230|FG001|Overall Study|Lost to Follow-up|0|||
142979580|NCT03276572|515460231|FG002|Overall Study|Lost to Follow-up|0|||
142979581|NCT03276572|515460232|FG003|Overall Study|Lost to Follow-up|0|||
142979582|NCT03276572|515460233|FG004|Overall Study|Lost to Follow-up|0|||
142979583|NCT03276572|515460234|FG005|Overall Study|Lost to Follow-up|0|||
142979584|NCT03276572|515460235|FG006|Overall Study|Lost to Follow-up|1|||
142979585|NCT02580240|515460236|FG000|Overall Study|Physician Decision|2|||
142979586|NCT02580240|515460237|FG001|Overall Study|Physician Decision|0|||
142979587|NCT02007252|515460250|FG000|Overall Study|Administrative problems|3|||
142979588|NCT02007252|515460251|FG001|Overall Study|Administrative problems|7|||
142979589|NCT02007252|515460250|FG000|Overall Study|Abnormal laboratory value(s)|1|||
142979590|NCT02007252|515460251|FG001|Overall Study|Abnormal laboratory value(s)|0|||
142979591|NCT02007252|515460250|FG000|Overall Study|Adverse Event|7|||
142979592|NCT02007252|515460251|FG001|Overall Study|Adverse Event|4|||
142979593|NCT02657434|515460252|FG000|Overall Study|Study Terminated By Sponsor|64|||
142979594|NCT02657434|515460253|FG001|Overall Study|Study Terminated By Sponsor|82|||
142979595|NCT02657434|515460252|FG000|Overall Study|Death|189|||
142979596|NCT02657434|515460253|FG001|Overall Study|Death|190|||
142979597|NCT02657434|515460252|FG000|Overall Study|Lost to Follow-up|2|||
142979598|NCT02657434|515460253|FG001|Overall Study|Lost to Follow-up|2|||
142979599|NCT02657434|515460252|FG000|Overall Study|Randomization by Error|2|||
142979600|NCT02657434|515460253|FG001|Overall Study|Randomization by Error|0|||
142979601|NCT02657434|515460252|FG000|Overall Study|Withdrawal by Subject|28|||
142979602|NCT02657434|515460253|FG001|Overall Study|Withdrawal by Subject|17|||
142979603|NCT02657434|515460252|FG000|Overall Study|Protocol Violation|1|||
142979604|NCT02657434|515460253|FG001|Overall Study|Protocol Violation|0|||
142979605|NCT02657434|515460252|FG000|Overall Study|Physician Decision|0|||
142979606|NCT02657434|515460253|FG001|Overall Study|Physician Decision|1|||
142979607|NCT02954952|515460258|FG000|Overall Study|Withdrawal by Subject|1|||
142979608|NCT02954952|515460259|FG001|Overall Study|Withdrawal by Subject|0|||
142979609|NCT02954952|515460260|FG002|Overall Study|Withdrawal by Subject|0|||
142979610|NCT02954952|515460258|FG000|Overall Study|No data collected|0|||
142979611|NCT02954952|515460259|FG001|Overall Study|No data collected|1|||
142979612|NCT02954952|515460260|FG002|Overall Study|No data collected|0|||
142979613|NCT01392742|515460261|FG000|Overall Study|Premature study termination|42|||
142979614|NCT01392742|515460261|FG000|Overall Study|Failure to return|35|||
142979615|NCT01392742|515460261|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
142979616|NCT01392742|515460261|FG000|Overall Study|Lost to Follow-up|34|||
142979617|NCT01392742|515460261|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
142979618|NCT01392742|515460261|FG000|Overall Study|ITR and Protocol deviation|1|||
142979619|NCT01392742|515460261|FG000|Overall Study|Adverse event/intercurrent illness|17|||
142979620|NCT01392742|515460261|FG000|Overall Study|Protocol Violation|14|||
142979621|NCT01392742|515460261|FG000|Overall Study|Other|3|||
142979622|NCT01392742|515460261|FG000|Overall Study|Missing information|13|||
142979623|NCT02432703|515460262|FG000|Overall Study|Adverse Event|1|||
142979624|NCT02432703|515460263|FG001|Overall Study|Adverse Event|4|||
142979625|NCT02432703|515460262|FG000|Overall Study|Lack of Efficacy|1|||
142979626|NCT02432703|515460263|FG001|Overall Study|Lack of Efficacy|0|||
142979627|NCT02432703|515460262|FG000|Overall Study|Lost to Follow-up|5|||
142979628|NCT02432703|515460263|FG001|Overall Study|Lost to Follow-up|3|||
142979629|NCT02432703|515460262|FG000|Overall Study|Withdrawal by Subject|9|||
142979630|NCT02432703|515460263|FG001|Overall Study|Withdrawal by Subject|6|||
142979631|NCT02432703|515460262|FG000|Overall Study|Other|6|||
142979632|NCT02432703|515460263|FG001|Overall Study|Other|5|||
142979633|NCT00724815|515460266|FG000|Overall Study|Randomized, not treated|31|||
142979634|NCT00724815|515460267|FG001|Overall Study|Randomized, not treated|30|||
142979635|NCT00724815|515460266|FG000|Overall Study|Adverse Event|5|||
142979636|NCT00724815|515460267|FG001|Overall Study|Adverse Event|3|||
142979637|NCT00724815|515460266|FG000|Overall Study|Lost to Follow-up|4|||
142979638|NCT00724815|515460267|FG001|Overall Study|Lost to Follow-up|1|||
142979639|NCT00724815|515460266|FG000|Overall Study|Other Various|3|||
142979640|NCT00724815|515460267|FG001|Overall Study|Other Various|5|||
142979641|NCT00810043|515460268|FG000|Overall Study|Withdrawal by Subject|1|||
142979642|NCT00810043|515460269|FG001|Overall Study|Withdrawal by Subject|0|||
142979643|NCT00810043|515460270|FG002|Overall Study|Withdrawal by Subject|2|||
142979644|NCT00810043|515460268|FG000|Overall Study|Lost to Follow-up|1|||
142979645|NCT00810043|515460269|FG001|Overall Study|Lost to Follow-up|0|||
142979646|NCT00810043|515460270|FG002|Overall Study|Lost to Follow-up|0|||
142979647|NCT00810043|515460268|FG000|Overall Study|Physician Decision|0|||
142979648|NCT00810043|515460269|FG001|Overall Study|Physician Decision|0|||
142979649|NCT00810043|515460270|FG002|Overall Study|Physician Decision|2|||
142979650|NCT00810043|515460268|FG000|Overall Study|Death|2|||
142979651|NCT00810043|515460269|FG001|Overall Study|Death|0|||
142979652|NCT00810043|515460270|FG002|Overall Study|Death|0|||
142979653|NCT00810043|515460268|FG000|Overall Study|Unrelated medical problem|0|||
142979654|NCT00810043|515460269|FG001|Overall Study|Unrelated medical problem|1|||
142979655|NCT00810043|515460270|FG002|Overall Study|Unrelated medical problem|0|||
142979656|NCT00810043|515460268|FG000|Overall Study|Non-medical problem|0|||
142979657|NCT00810043|515460269|FG001|Overall Study|Non-medical problem|0|||
142979658|NCT00810043|515460270|FG002|Overall Study|Non-medical problem|1|||
142979659|NCT00810043|515460268|FG000|Overall Study|No longer met enrollment criteria|0|||
142979660|NCT00810043|515460269|FG001|Overall Study|No longer met enrollment criteria|0|||
142979661|NCT00810043|515460270|FG002|Overall Study|No longer met enrollment criteria|3|||
142979662|NCT01628393|515460271|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
142979663|NCT01628393|515460272|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
142979664|NCT01628393|515460273|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
142979665|NCT01628393|515460274|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
142979666|NCT01628393|515460275|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
142979667|NCT01628393|515460271|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
142979668|NCT01628393|515460272|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
142979669|NCT01628393|515460273|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
142979670|NCT01628393|515460274|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
142979671|NCT01628393|515460275|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
142979672|NCT01628393|515460271|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
142979673|NCT01628393|515460272|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
142979674|NCT01628393|515460273|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
142979675|NCT01628393|515460274|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
142979676|NCT01628393|515460275|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
142979677|NCT01628393|515460271|FG000|Blinded Active Extension Period|Adverse Event|0|||
142979678|NCT01628393|515460272|FG001|Blinded Active Extension Period|Adverse Event|1|||
142979679|NCT01628393|515460273|FG002|Blinded Active Extension Period|Adverse Event|0|||
142979680|NCT01628393|515460274|FG003|Blinded Active Extension Period|Adverse Event|2|||
142979681|NCT01628393|515460275|FG004|Blinded Active Extension Period|Adverse Event|2|||
142979682|NCT01628393|515460271|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
142979683|NCT01628393|515460272|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
142979684|NCT01628393|515460273|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
142979685|NCT01628393|515460274|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
142979686|NCT01628393|515460275|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
142979687|NCT01628393|515460271|FG000|Blinded Active Extension Period|Physician Decision|0|||
142979688|NCT01628393|515460272|FG001|Blinded Active Extension Period|Physician Decision|3|||
142979689|NCT01628393|515460273|FG002|Blinded Active Extension Period|Physician Decision|0|||
142979690|NCT01628393|515460274|FG003|Blinded Active Extension Period|Physician Decision|1|||
142979691|NCT01628393|515460275|FG004|Blinded Active Extension Period|Physician Decision|0|||
142979692|NCT01628393|515460271|FG000|Blinded Active Extension Period|Protocol Violation|0|||
142979693|NCT01628393|515460272|FG001|Blinded Active Extension Period|Protocol Violation|0|||
142979694|NCT01628393|515460273|FG002|Blinded Active Extension Period|Protocol Violation|2|||
142979695|NCT01628393|515460274|FG003|Blinded Active Extension Period|Protocol Violation|1|||
142979696|NCT01628393|515460275|FG004|Blinded Active Extension Period|Protocol Violation|0|||
142979697|NCT01628393|515460271|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
142979698|NCT01628393|515460272|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
142979699|NCT01628393|515460273|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
142979700|NCT01628393|515460274|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
142979701|NCT01628393|515460275|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
142979702|NCT02001688|515460276|FG000|Overall Study|Withdrawal by Subject|0|||
142979703|NCT02001688|515460277|FG001|Overall Study|Withdrawal by Subject|0|||
142979704|NCT02001688|515460278|FG002|Overall Study|Withdrawal by Subject|1|||
142979705|NCT02001688|515460276|FG000|Overall Study|Adverse Event|0|||
142979706|NCT02001688|515460277|FG001|Overall Study|Adverse Event|1|||
142979707|NCT02001688|515460278|FG002|Overall Study|Adverse Event|0|||
142979708|NCT00445341|515460279|FG000|Overall Study|refused further treatment|1|||
142979709|NCT00445341|515460279|FG000|Overall Study|taken off treatment too early|1|||
142979710|NCT03051217|515460280|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
142979711|NCT03051217|515460281|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
142979712|NCT03051217|515460282|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
142979713|NCT03051217|515460283|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
142979714|NCT03051217|515460284|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
142979715|NCT03051217|515460285|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
142979716|NCT03051217|515460286|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
142979717|NCT03051217|515460280|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
142979718|NCT03051217|515460281|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
142979719|NCT03051217|515460282|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
142979720|NCT03051217|515460283|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
142979721|NCT03051217|515460284|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
142979722|NCT03051217|515460285|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
142979723|NCT03051217|515460286|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
142979724|NCT03051217|515460280|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
142979725|NCT03051217|515460281|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
142979726|NCT03051217|515460282|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
142979727|NCT03051217|515460283|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
142979728|NCT03051217|515460284|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
142979729|NCT03051217|515460285|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
142979730|NCT03051217|515460286|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
142979731|NCT03051217|515460280|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
142979732|NCT03051217|515460281|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
142979733|NCT03051217|515460282|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
142979734|NCT03051217|515460283|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
142979735|NCT03051217|515460284|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
142979736|NCT03051217|515460285|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
142979737|NCT03051217|515460286|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
142979738|NCT03051217|515460280|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
142979739|NCT03051217|515460281|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
142979740|NCT03051217|515460282|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
142979741|NCT03051217|515460283|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
142979742|NCT03051217|515460284|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
142979743|NCT03051217|515460285|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
142979744|NCT03051217|515460286|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
142979745|NCT03051217|515460280|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
142979746|NCT03051217|515460281|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
142979747|NCT03051217|515460282|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
142979748|NCT03051217|515460283|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
142979749|NCT03051217|515460284|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
142979750|NCT03051217|515460285|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
142979751|NCT03051217|515460286|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
142979752|NCT03051217|515460280|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
142979753|NCT03051217|515460281|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
142979754|NCT03051217|515460282|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
142979755|NCT03051217|515460283|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
142979756|NCT03051217|515460284|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
142979757|NCT03051217|515460285|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
142979758|NCT03051217|515460286|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
142979759|NCT03051217|515460280|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
142979760|NCT03051217|515460281|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
142979761|NCT03051217|515460282|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
142979762|NCT03051217|515460283|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
142979763|NCT03051217|515460284|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
142979764|NCT03051217|515460285|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
142979765|NCT03051217|515460286|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
142979766|NCT00641706|515460289|FG000|Overall Study|Adverse Event|2|||
142979767|NCT00641706|515460290|FG001|Overall Study|Adverse Event|1|||
142979768|NCT00641706|515460289|FG000|Overall Study|Withdrawal by Subject|6|||
142979769|NCT00641706|515460290|FG001|Overall Study|Withdrawal by Subject|1|||
142979770|NCT00641706|515460289|FG000|Overall Study|Clinical Decline|1|||
142979771|NCT00641706|515460290|FG001|Overall Study|Clinical Decline|0|||
142979772|NCT00641706|515460289|FG000|Overall Study|Lead Investigator Decision|0|||
142979773|NCT00641706|515460290|FG001|Overall Study|Lead Investigator Decision|1|||
142979774|NCT01675141|515460291|FG000|Overall Study|Lenalidomide outside NIH|3|||
142979775|NCT01675141|515460291|FG000|Overall Study|Withdrawal by Subject|3|||
142979776|NCT01675141|515460291|FG000|Overall Study|Physician Decision|4|||
142979777|NCT01675141|515460291|FG000|Overall Study|No treatment, per protocol|1|||
142979778|NCT00109772|515460294|FG000|Double-blind Treatment|Adverse Event|14|||
142979779|NCT00109772|515460295|FG001|Double-blind Treatment|Adverse Event|5|||
142979780|NCT00109772|515460294|FG000|Double-blind Treatment|Lack of Efficacy|1|||
142979781|NCT00109772|515460295|FG001|Double-blind Treatment|Lack of Efficacy|0|||
142979782|NCT00109772|515460294|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
142979783|NCT00109772|515460295|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
142979784|NCT00109772|515460294|FG000|Double-blind Treatment|Lost to Follow-up|2|||
142979785|NCT00109772|515460295|FG001|Double-blind Treatment|Lost to Follow-up|3|||
142979786|NCT00109772|515460294|FG000|Double-blind Treatment|Protocol Violation|0|||
142979787|NCT00109772|515460295|FG001|Double-blind Treatment|Protocol Violation|1|||
142979788|NCT00109772|515460294|FG000|Double-blind Treatment|Other|0|||
142979789|NCT00109772|515460295|FG001|Double-blind Treatment|Other|4|||
142979790|NCT00109772|515460294|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
142979791|NCT00109772|515460295|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
142979792|NCT00109772|515460294|FG000|Open-label Extension|Adverse Event|10|||
142979793|NCT00109772|515460295|FG001|Open-label Extension|Adverse Event|19|||
142979794|NCT00109772|515460294|FG000|Open-label Extension|Lack of Efficacy|19|||
142979795|NCT00109772|515460295|FG001|Open-label Extension|Lack of Efficacy|11|||
142979796|NCT00109772|515460294|FG000|Open-label Extension|Withdrawal by Subject|9|||
142979797|NCT00109772|515460295|FG001|Open-label Extension|Withdrawal by Subject|6|||
142979798|NCT00109772|515460294|FG000|Open-label Extension|Lost to Follow-up|1|||
142979799|NCT00109772|515460295|FG001|Open-label Extension|Lost to Follow-up|0|||
142979800|NCT00109772|515460294|FG000|Open-label Extension|Death|0|||
142979801|NCT00109772|515460295|FG001|Open-label Extension|Death|1|||
142979802|NCT00109772|515460294|FG000|Open-label Extension|Protocol Violation|2|||
142979803|NCT00109772|515460295|FG001|Open-label Extension|Protocol Violation|2|||
142979804|NCT00109772|515460294|FG000|Open-label Extension|Other|4|||
142979805|NCT00109772|515460295|FG001|Open-label Extension|Other|10|||
142979806|NCT00813917|515460299|FG000|Overall Study|Adverse Event|0|||
142979807|NCT00813917|515460300|FG001|Overall Study|Adverse Event|1|||
142979808|NCT00813917|515460299|FG000|Overall Study|Withdrawal by Subject|3|||
142979809|NCT00813917|515460300|FG001|Overall Study|Withdrawal by Subject|4|||
142979810|NCT00813917|515460299|FG000|Overall Study|Lost to Follow-up|3|||
142979811|NCT00813917|515460300|FG001|Overall Study|Lost to Follow-up|1|||
142979812|NCT00792701|515460308|FG000|Overall Study|Adverse Event|0|||
142979813|NCT00792701|515460309|FG001|Overall Study|Adverse Event|22|||
142979814|NCT00792701|515460308|FG000|Overall Study|Ineligible|1|||
142979815|NCT00792701|515460309|FG001|Overall Study|Ineligible|3|||
142979816|NCT00792701|515460308|FG000|Overall Study|Withdrawal by Subject|1|||
142979817|NCT00792701|515460309|FG001|Overall Study|Withdrawal by Subject|19|||
142979818|NCT00792701|515460308|FG000|Overall Study|Not protocol specified|17|||
142979819|NCT00792701|515460309|FG001|Overall Study|Not protocol specified|0|||
142979820|NCT00064077|515460316|FG000|Overall Study|Improper prior treatment|1|||
142979821|NCT00064077|515460317|FG001|Overall Study|Improper prior treatment|0|||
142979822|NCT00064077|515460318|FG002|Overall Study|Improper prior treatment|0|||
142979823|NCT00064077|515460319|FG003|Overall Study|Improper prior treatment|0|||
142979824|NCT00064077|515460316|FG000|Overall Study|Poor risk|2|||
142979825|NCT00064077|515460317|FG001|Overall Study|Poor risk|0|||
142979826|NCT00064077|515460318|FG002|Overall Study|Poor risk|1|||
142979827|NCT00064077|515460319|FG003|Overall Study|Poor risk|1|||
142979828|NCT00064077|515460316|FG000|Overall Study|Pathology|10|||
142979829|NCT00064077|515460317|FG001|Overall Study|Pathology|7|||
142979830|NCT00064077|515460318|FG002|Overall Study|Pathology|3|||
142979831|NCT00064077|515460319|FG003|Overall Study|Pathology|4|||
142979832|NCT00064077|515460316|FG000|Overall Study|No surgery|0|||
142979833|NCT00064077|515460317|FG001|Overall Study|No surgery|0|||
142979834|NCT00064077|515460318|FG002|Overall Study|No surgery|1|||
142979835|NCT00064077|515460319|FG003|Overall Study|No surgery|0|||
142979836|NCT00064077|515460316|FG000|Overall Study|No tumor|0|||
142979837|NCT00064077|515460317|FG001|Overall Study|No tumor|0|||
142979838|NCT00064077|515460318|FG002|Overall Study|No tumor|1|||
142979839|NCT00064077|515460319|FG003|Overall Study|No tumor|0|||
142979840|NCT00064077|515460316|FG000|Overall Study|Other reasons|2|||
142979841|NCT00064077|515460317|FG001|Overall Study|Other reasons|2|||
142979842|NCT00064077|515460318|FG002|Overall Study|Other reasons|1|||
142979843|NCT00064077|515460319|FG003|Overall Study|Other reasons|2|||
142979844|NCT01156532|515460322|FG000|Overall Study|Family Reasons|1|||
142979845|NCT01156532|515460322|FG000|Overall Study|Lost to Follow-up|1|||
142979846|NCT01809197|515460323|FG000|Overall Study|Lost to Follow-up|4|||
142979847|NCT01809197|515460324|FG001|Overall Study|Lost to Follow-up|2|||
142979848|NCT01809197|515460323|FG000|Overall Study|Adverse Event|2|||
142979849|NCT01809197|515460324|FG001|Overall Study|Adverse Event|3|||
142979850|NCT01809197|515460323|FG000|Overall Study|Failed slit lamp exam|1|||
142979851|NCT01809197|515460324|FG001|Overall Study|Failed slit lamp exam|0|||
142979852|NCT01809197|515460323|FG000|Overall Study|Non-Compliance|1|||
142979853|NCT01809197|515460324|FG001|Overall Study|Non-Compliance|1|||
142979854|NCT01809197|515460323|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
142979855|NCT01809197|515460324|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
142979856|NCT01809197|515460323|FG000|Overall Study|Withdrawal by Subject|1|||
142979857|NCT01809197|515460324|FG001|Overall Study|Withdrawal by Subject|1|||
142979858|NCT01809197|515460323|FG000|Overall Study|Product not available|0|||
142979859|NCT01809197|515460324|FG001|Overall Study|Product not available|1|||
142979860|NCT00294684|515460327|FG000|Overall Study|Lost to Follow-up|5|||
143455665|NCT03208036|517212504|FG000|Baseline Assessment|Withdrawal by Subject|1|||
142979861|NCT00294684|515460328|FG001|Overall Study|Lost to Follow-up|8|||
142979862|NCT02443805|515460329|FG000|Overall Study|Adverse Event|100|||
142979863|NCT02443805|515460330|FG001|Overall Study|Adverse Event|18|||
142979864|NCT02443805|515460329|FG000|Overall Study|Withdrawal by Subject|73|||
142979865|NCT02443805|515460330|FG001|Overall Study|Withdrawal by Subject|74|||
142979866|NCT02443805|515460329|FG000|Overall Study|Lost to Follow-up|19|||
142979867|NCT02443805|515460330|FG001|Overall Study|Lost to Follow-up|14|||
142979868|NCT02443805|515460329|FG000|Overall Study|Pregnancy|6|||
142979869|NCT02443805|515460330|FG001|Overall Study|Pregnancy|5|||
142979870|NCT02443805|515460329|FG000|Overall Study|Protocol Violation|2|||
142979871|NCT02443805|515460330|FG001|Overall Study|Protocol Violation|4|||
142979872|NCT02443805|515460329|FG000|Overall Study|Lack of Efficacy|1|||
142979873|NCT02443805|515460330|FG001|Overall Study|Lack of Efficacy|1|||
142979874|NCT02443805|515460329|FG000|Overall Study|Non-compliance with study drug|6|||
142979875|NCT02443805|515460330|FG001|Overall Study|Non-compliance with study drug|4|||
142979876|NCT02443805|515460329|FG000|Overall Study|Withdrawal by parent/guardian|3|||
142979877|NCT02443805|515460330|FG001|Overall Study|Withdrawal by parent/guardian|5|||
142979878|NCT02443805|515460329|FG000|Overall Study|Any other reason not above-mentioned|3|||
142979879|NCT02443805|515460330|FG001|Overall Study|Any other reason not above-mentioned|2|||
142979880|NCT00968708|515460331|FG000|Overall Study|Adverse Event|169|||
142979881|NCT00968708|515460332|FG001|Overall Study|Adverse Event|150|||
142979882|NCT00968708|515460331|FG000|Overall Study|Major Protocol Deviation|0|||
142979883|NCT00968708|515460332|FG001|Overall Study|Major Protocol Deviation|1|||
142979884|NCT00968708|515460331|FG000|Overall Study|Lost to Follow-up|19|||
142979885|NCT00968708|515460332|FG001|Overall Study|Lost to Follow-up|11|||
142979886|NCT00968708|515460331|FG000|Overall Study|Voluntary Withdrawal|104|||
142979887|NCT00968708|515460332|FG001|Overall Study|Voluntary Withdrawal|101|||
142979888|NCT00968708|515460331|FG000|Overall Study|Investigator Discretion|0|||
142979889|NCT00968708|515460332|FG001|Overall Study|Investigator Discretion|1|||
142979890|NCT00968708|515460331|FG000|Overall Study|Other|26|||
142979891|NCT00968708|515460332|FG001|Overall Study|Other|34|||
142979892|NCT02708966|515460333|FG000|Overall Study|Lost to Follow-up|2|||
142979893|NCT02708966|515460334|FG001|Overall Study|Lost to Follow-up|2|||
142979894|NCT00389441|515460337|FG000|Overall Study|Adverse Event|7|||
142979895|NCT00389441|515460337|FG000|Overall Study|Death|4|||
142979896|NCT00389441|515460337|FG000|Overall Study|Lost to Follow-up|2|||
142979897|NCT00389441|515460337|FG000|Overall Study|Withdrawal by Subject|4|||
142979898|NCT00389441|515460337|FG000|Overall Study|Physician Decision|1|||
142979899|NCT00389441|515460337|FG000|Overall Study|Protocol Violation|1|||
142979900|NCT00389441|515460337|FG000|Overall Study|Global deterioration of health status|4|||
142979901|NCT00389441|515460337|FG000|Overall Study|Objective progression or relapse|26|||
142979902|NCT00389441|515460337|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
142979903|NCT00389441|515460337|FG000|Overall Study|Clinical progression|1|||
142979904|NCT02260388|515460338|FG000|Overall Study|Lost to Follow-up|2|||
142979905|NCT02260388|515460339|FG001|Overall Study|Lost to Follow-up|8|||
142979906|NCT02260388|515460340|FG002|Overall Study|Lost to Follow-up|3|||
142979907|NCT02260388|515460341|FG003|Overall Study|Lost to Follow-up|4|||
142979908|NCT02762708|515460344|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
142979909|NCT02762708|515460345|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
142979910|NCT02762708|515460346|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
142979911|NCT02762708|515460347|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
142979912|NCT02483078|515460356|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
142979913|NCT02483078|515460357|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
142979914|NCT02483078|515460356|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
142979915|NCT02483078|515460357|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
142979916|NCT02483078|515460356|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
142979917|NCT02483078|515460357|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
142979918|NCT02483078|515460356|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
142979919|NCT02483078|515460357|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
142979920|NCT02483078|515460356|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
142979921|NCT02483078|515460357|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
142979922|NCT02483078|515460356|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
142979923|NCT02483078|515460357|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
142979924|NCT01981109|515462231|FG000|Overall Study|Death|36|||
142979925|NCT01981109|515462231|FG000|Overall Study|Withdrawal by Subject|40|||
142979926|NCT01981109|515462231|FG000|Overall Study|Lost to Follow-up|9|||
142979927|NCT01981109|515462231|FG000|Overall Study|No Discontinuation Documentation|37|||
142979928|NCT01981109|515462231|FG000|Overall Study|Study Termination|100|||
142979929|NCT01981109|515462231|FG000|Overall Study|No data available|2|||
142979930|NCT02023268|515462232|FG000|Overall Study|Lack of Efficacy|0|||
142979931|NCT02023268|515462233|FG001|Overall Study|Lack of Efficacy|1|||
142979932|NCT02023268|515462232|FG000|Overall Study|Adverse Event|0|||
142979933|NCT02023268|515462233|FG001|Overall Study|Adverse Event|2|||
142979934|NCT02023268|515462232|FG000|Overall Study|Withdrawal by Subject|0|||
142979935|NCT02023268|515462233|FG001|Overall Study|Withdrawal by Subject|1|||
142979936|NCT03407170|515462234|FG000|Overall Study|Adverse Event|1|||
142979937|NCT01001234|515462236|FG000|Overall Study|Withdrawal by Subject|2|||
142979938|NCT01001234|515462237|FG001|Overall Study|Withdrawal by Subject|0|||
142979939|NCT01001234|515462238|FG002|Overall Study|Withdrawal by Subject|3|||
142979940|NCT01001234|515462239|FG003|Overall Study|Withdrawal by Subject|0|||
142979941|NCT01001234|515462240|FG004|Overall Study|Withdrawal by Subject|0|||
142979942|NCT01001234|515462236|FG000|Overall Study|Protocol Violation|34|||
142979943|NCT01001234|515462237|FG001|Overall Study|Protocol Violation|3|||
142979944|NCT01001234|515462238|FG002|Overall Study|Protocol Violation|19|||
142979945|NCT01001234|515462239|FG003|Overall Study|Protocol Violation|18|||
142979946|NCT01001234|515462240|FG004|Overall Study|Protocol Violation|0|||
142979947|NCT01001234|515462236|FG000|Overall Study|Lost to Follow-up|0|||
142979948|NCT01001234|515462237|FG001|Overall Study|Lost to Follow-up|0|||
142979949|NCT01001234|515462238|FG002|Overall Study|Lost to Follow-up|1|||
142979950|NCT01001234|515462239|FG003|Overall Study|Lost to Follow-up|2|||
142979951|NCT01001234|515462240|FG004|Overall Study|Lost to Follow-up|0|||
142979952|NCT01001234|515462236|FG000|Overall Study|Physician Decision|1|||
142979953|NCT01001234|515462237|FG001|Overall Study|Physician Decision|0|||
142979954|NCT01001234|515462238|FG002|Overall Study|Physician Decision|0|||
142979955|NCT01001234|515462239|FG003|Overall Study|Physician Decision|0|||
142979956|NCT01001234|515462240|FG004|Overall Study|Physician Decision|0|||
142979957|NCT01001234|515462236|FG000|Overall Study|Not Treated: Adverse Event|1|||
142979958|NCT01001234|515462237|FG001|Overall Study|Not Treated: Adverse Event|0|||
142979959|NCT01001234|515462238|FG002|Overall Study|Not Treated: Adverse Event|0|||
142979960|NCT01001234|515462239|FG003|Overall Study|Not Treated: Adverse Event|0|||
142979961|NCT01001234|515462240|FG004|Overall Study|Not Treated: Adverse Event|0|||
142979962|NCT01001234|515462236|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
142979963|NCT01001234|515462237|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
142979964|NCT01001234|515462238|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
142979965|NCT01001234|515462239|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
142979966|NCT01001234|515462240|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
142979967|NCT01001234|515462236|FG000|Overall Study|Not Treated: Protocol Violation|3|||
142979968|NCT01001234|515462237|FG001|Overall Study|Not Treated: Protocol Violation|0|||
142979969|NCT01001234|515462238|FG002|Overall Study|Not Treated: Protocol Violation|0|||
142979970|NCT01001234|515462239|FG003|Overall Study|Not Treated: Protocol Violation|0|||
142979971|NCT01001234|515462240|FG004|Overall Study|Not Treated: Protocol Violation|0|||
142979972|NCT01001234|515462236|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
142979973|NCT01001234|515462237|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
142979974|NCT01001234|515462238|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
142979975|NCT01001234|515462239|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
142979976|NCT01001234|515462240|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
142979977|NCT01001234|515462236|FG000|Overall Study|Not Treated: Pregnancy|3|||
142979978|NCT01001234|515462237|FG001|Overall Study|Not Treated: Pregnancy|0|||
142979979|NCT01001234|515462238|FG002|Overall Study|Not Treated: Pregnancy|0|||
142979980|NCT01001234|515462239|FG003|Overall Study|Not Treated: Pregnancy|0|||
142979981|NCT01001234|515462240|FG004|Overall Study|Not Treated: Pregnancy|0|||
142979982|NCT01001234|515462236|FG000|Overall Study|Not Treated: Physician Decision|37|||
142979983|NCT01001234|515462237|FG001|Overall Study|Not Treated: Physician Decision|4|||
142979984|NCT01001234|515462238|FG002|Overall Study|Not Treated: Physician Decision|0|||
142979985|NCT01001234|515462239|FG003|Overall Study|Not Treated: Physician Decision|0|||
142979986|NCT01001234|515462240|FG004|Overall Study|Not Treated: Physician Decision|0|||
142979987|NCT01001234|515462236|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
142979988|NCT01001234|515462237|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
142979989|NCT01001234|515462238|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
142979990|NCT01001234|515462239|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
142979991|NCT01001234|515462240|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
142979992|NCT01851863|515462243|FG000|Overall Study|Did not receive study medication|2|||
142979993|NCT01851863|515462244|FG001|Overall Study|Did not receive study medication|5|||
142979994|NCT01851863|515462245|FG002|Overall Study|Did not receive study medication|3|||
142979995|NCT01851863|515462246|FG003|Overall Study|Did not receive study medication|0|||
142979996|NCT01851863|515462243|FG000|Overall Study|Lost to Follow-up|3|||
142979997|NCT01851863|515462244|FG001|Overall Study|Lost to Follow-up|4|||
142979998|NCT01851863|515462245|FG002|Overall Study|Lost to Follow-up|2|||
142979999|NCT01851863|515462246|FG003|Overall Study|Lost to Follow-up|3|||
142980000|NCT01611298|515462247|FG000|Overall Study|Relapsed|2|||
142980001|NCT00928512|515462248|FG000|Overall Study|Adverse Event|4|||
142980002|NCT00928512|515462249|FG001|Overall Study|Adverse Event|3|||
142980003|NCT00928512|515462250|FG002|Overall Study|Adverse Event|2|||
142980004|NCT00928512|515462251|FG003|Overall Study|Adverse Event|8|||
142980005|NCT00928512|515462252|FG004|Overall Study|Adverse Event|6|||
142980006|NCT00928512|515462248|FG000|Overall Study|Lack of Efficacy|2|||
142980007|NCT00928512|515462249|FG001|Overall Study|Lack of Efficacy|0|||
142980008|NCT00928512|515462250|FG002|Overall Study|Lack of Efficacy|4|||
142980009|NCT00928512|515462251|FG003|Overall Study|Lack of Efficacy|7|||
142980010|NCT00928512|515462252|FG004|Overall Study|Lack of Efficacy|3|||
142980011|NCT00928512|515462248|FG000|Overall Study|Protocol Violation|0|||
142980012|NCT00928512|515462249|FG001|Overall Study|Protocol Violation|1|||
142980013|NCT00928512|515462250|FG002|Overall Study|Protocol Violation|0|||
142980014|NCT00928512|515462251|FG003|Overall Study|Protocol Violation|1|||
142980015|NCT00928512|515462252|FG004|Overall Study|Protocol Violation|3|||
142980016|NCT00928512|515462248|FG000|Overall Study|Withdrawal by Subject|3|||
142980017|NCT00928512|515462249|FG001|Overall Study|Withdrawal by Subject|0|||
142980018|NCT00928512|515462250|FG002|Overall Study|Withdrawal by Subject|3|||
142980019|NCT00928512|515462251|FG003|Overall Study|Withdrawal by Subject|4|||
142980020|NCT00928512|515462252|FG004|Overall Study|Withdrawal by Subject|0|||
142980021|NCT00928512|515462248|FG000|Overall Study|Lost to Follow-up|1|||
142980022|NCT00928512|515462249|FG001|Overall Study|Lost to Follow-up|1|||
142980023|NCT00928512|515462250|FG002|Overall Study|Lost to Follow-up|2|||
142980024|NCT00928512|515462251|FG003|Overall Study|Lost to Follow-up|1|||
142980025|NCT00928512|515462252|FG004|Overall Study|Lost to Follow-up|3|||
142980026|NCT00928512|515462248|FG000|Overall Study|Administrative Problems|0|||
142980027|NCT00928512|515462249|FG001|Overall Study|Administrative Problems|1|||
142980028|NCT00928512|515462250|FG002|Overall Study|Administrative Problems|0|||
142980029|NCT00928512|515462251|FG003|Overall Study|Administrative Problems|0|||
142980030|NCT00928512|515462252|FG004|Overall Study|Administrative Problems|0|||
142980031|NCT04153929|515462253|FG000|Overall Study|Other than listed|2|||
142980032|NCT04153929|515462254|FG001|Overall Study|Other than listed|2|||
142980033|NCT04153929|515462255|FG002|Overall Study|Other than listed|0|||
142980034|NCT04153929|515462256|FG003|Overall Study|Other than listed|1|||
142980035|NCT04153929|515462257|FG004|Overall Study|Other than listed|0|||
142980036|NCT04153929|515462258|FG005|Overall Study|Other than listed|2|||
142980037|NCT04153929|515462259|FG006|Overall Study|Other than listed|2|||
142980038|NCT04153929|515462260|FG007|Overall Study|Other than listed|1|||
142980039|NCT04153929|515462253|FG000|Overall Study|Lost to Follow-up|2|||
142980040|NCT04153929|515462254|FG001|Overall Study|Lost to Follow-up|1|||
142980041|NCT04153929|515462255|FG002|Overall Study|Lost to Follow-up|0|||
142980042|NCT04153929|515462256|FG003|Overall Study|Lost to Follow-up|1|||
142980043|NCT04153929|515462257|FG004|Overall Study|Lost to Follow-up|1|||
142980044|NCT04153929|515462258|FG005|Overall Study|Lost to Follow-up|0|||
142980045|NCT04153929|515462259|FG006|Overall Study|Lost to Follow-up|0|||
142980046|NCT04153929|515462260|FG007|Overall Study|Lost to Follow-up|0|||
142980047|NCT04153929|515462253|FG000|Overall Study|Withdrawal by Subject|3|||
142980048|NCT04153929|515462254|FG001|Overall Study|Withdrawal by Subject|1|||
142980049|NCT04153929|515462255|FG002|Overall Study|Withdrawal by Subject|0|||
142980050|NCT04153929|515462256|FG003|Overall Study|Withdrawal by Subject|3|||
142980051|NCT04153929|515462257|FG004|Overall Study|Withdrawal by Subject|1|||
142980052|NCT04153929|515462258|FG005|Overall Study|Withdrawal by Subject|0|||
142980053|NCT04153929|515462259|FG006|Overall Study|Withdrawal by Subject|1|||
142980054|NCT04153929|515462260|FG007|Overall Study|Withdrawal by Subject|0|||
142980055|NCT04153929|515462253|FG000|Overall Study|Protocol Violation|0|||
142980056|NCT04153929|515462254|FG001|Overall Study|Protocol Violation|0|||
142980057|NCT04153929|515462255|FG002|Overall Study|Protocol Violation|0|||
142980058|NCT04153929|515462256|FG003|Overall Study|Protocol Violation|0|||
142980059|NCT04153929|515462257|FG004|Overall Study|Protocol Violation|0|||
142980060|NCT04153929|515462258|FG005|Overall Study|Protocol Violation|0|||
142980061|NCT04153929|515462259|FG006|Overall Study|Protocol Violation|1|||
142980062|NCT04153929|515462260|FG007|Overall Study|Protocol Violation|2|||
142980063|NCT04153929|515462253|FG000|Overall Study|Adverse Event|3|||
142980064|NCT04153929|515462254|FG001|Overall Study|Adverse Event|5|||
142980065|NCT04153929|515462255|FG002|Overall Study|Adverse Event|5|||
142980066|NCT04153929|515462256|FG003|Overall Study|Adverse Event|11|||
142980067|NCT04153929|515462257|FG004|Overall Study|Adverse Event|15|||
142980068|NCT04153929|515462258|FG005|Overall Study|Adverse Event|4|||
142980069|NCT04153929|515462259|FG006|Overall Study|Adverse Event|8|||
142980070|NCT04153929|515462260|FG007|Overall Study|Adverse Event|2|||
142980071|NCT04153929|515462253|FG000|Overall Study|Not treated|1|||
142980072|NCT04153929|515462254|FG001|Overall Study|Not treated|0|||
142980073|NCT04153929|515462255|FG002|Overall Study|Not treated|0|||
142980074|NCT04153929|515462256|FG003|Overall Study|Not treated|0|||
142980075|NCT04153929|515462257|FG004|Overall Study|Not treated|0|||
142980076|NCT04153929|515462258|FG005|Overall Study|Not treated|0|||
142980077|NCT04153929|515462259|FG006|Overall Study|Not treated|1|||
142980078|NCT04153929|515462260|FG007|Overall Study|Not treated|0|||
142980079|NCT04083794|515462261|FG000|Overall Study|Lost to Follow-up|9|||
142980080|NCT01975675|515462266|FG000|Overall Study|Death|0|||
142980081|NCT01975675|515462267|FG001|Overall Study|Death|1|||
142980082|NCT01975675|515462268|FG002|Overall Study|Death|0|||
142980083|NCT01975675|515462269|FG003|Overall Study|Death|0|||
142980084|NCT00224003|515462270|FG000|Overall Study|Adverse Event|1|||
142980085|NCT00224003|515462270|FG000|Overall Study|Protocol Violation|2|||
142980086|NCT00224003|515462270|FG000|Overall Study|Withdrawal by Subject|1|||
142980087|NCT00224003|515462270|FG000|Overall Study|unk|3|||
142980088|NCT00996593|515462278|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
142980089|NCT00996593|515462278|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
142980090|NCT00996593|515462278|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
142980091|NCT00996593|515462278|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
142980092|NCT00996593|515462278|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
142980093|NCT00996593|515462278|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
142980094|NCT00996593|515462278|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
142980095|NCT00996593|515462278|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
142980096|NCT00996593|515462278|FG000|Long-Term Follow-Up|Site Closed|1|||
142980097|NCT01202760|515462279|FG000|Overall Study|Entry Criteria Not Met|0|||
142980098|NCT01202760|515462280|FG001|Overall Study|Entry Criteria Not Met|3|||
142980099|NCT01202760|515462281|FG002|Overall Study|Entry Criteria Not Met|1|||
142980100|NCT01202760|515462279|FG000|Overall Study|Adverse Event|11|||
142980101|NCT01202760|515462280|FG001|Overall Study|Adverse Event|9|||
142980102|NCT01202760|515462281|FG002|Overall Study|Adverse Event|10|||
142980103|NCT01202760|515462279|FG000|Overall Study|Death|2|||
142980104|NCT01202760|515462280|FG001|Overall Study|Death|1|||
142980105|NCT01202760|515462281|FG002|Overall Study|Death|0|||
142980106|NCT01202760|515462279|FG000|Overall Study|Lack of Efficacy|6|||
142980107|NCT01202760|515462280|FG001|Overall Study|Lack of Efficacy|8|||
142980108|NCT01202760|515462281|FG002|Overall Study|Lack of Efficacy|7|||
142980109|NCT01202760|515462279|FG000|Overall Study|Lost to Follow-up|0|||
142980110|NCT01202760|515462280|FG001|Overall Study|Lost to Follow-up|2|||
142980111|NCT01202760|515462281|FG002|Overall Study|Lost to Follow-up|1|||
142980112|NCT01202760|515462279|FG000|Overall Study|Parent / Caregiver Decision|0|||
142980113|NCT01202760|515462280|FG001|Overall Study|Parent / Caregiver Decision|1|||
142980114|NCT01202760|515462281|FG002|Overall Study|Parent / Caregiver Decision|0|||
142980115|NCT01202760|515462279|FG000|Overall Study|Withdrawal by Subject|17|||
142980116|NCT01202760|515462280|FG001|Overall Study|Withdrawal by Subject|18|||
142980117|NCT01202760|515462281|FG002|Overall Study|Withdrawal by Subject|14|||
142980118|NCT01202760|515462279|FG000|Overall Study|Physician Decision|0|||
142980119|NCT01202760|515462280|FG001|Overall Study|Physician Decision|1|||
142980120|NCT01202760|515462281|FG002|Overall Study|Physician Decision|0|||
142980121|NCT01202760|515462279|FG000|Overall Study|Protocol Violation|7|||
142980122|NCT01202760|515462280|FG001|Overall Study|Protocol Violation|5|||
142980123|NCT01202760|515462281|FG002|Overall Study|Protocol Violation|2|||
142980124|NCT01202760|515462279|FG000|Overall Study|Sponsor Decision|4|||
142980125|NCT01202760|515462280|FG001|Overall Study|Sponsor Decision|4|||
142980126|NCT01202760|515462281|FG002|Overall Study|Sponsor Decision|0|||
142980127|NCT01654523|515462282|FG000|Overall Study|Withdrawal by Subject|1|||
142980128|NCT04354155|515462285|FG000|Overall Study|Withdrawal by Subject|1|||
142980129|NCT04354155|515462285|FG000|Overall Study|Did not meet criteria for study intervention|1|||
142980130|NCT01686958|515462286|FG000|Overall Study|Withdrawal by Subject|1|||
142980131|NCT03199638|515462296|FG000|Overall Study|inability to drink glutamine during regularly|0|||
142980132|NCT03199638|515462297|FG001|Overall Study|inability to drink glutamine during regularly|2|||
142980133|NCT01575899|515462298|FG000|Overall Study|Lost to Follow-up|3|||
142980134|NCT01575899|515462299|FG001|Overall Study|Lost to Follow-up|4|||
142980135|NCT01575899|515462300|FG002|Overall Study|Lost to Follow-up|2|||
142980136|NCT01575899|515462298|FG000|Overall Study|Protocol Violation|2|||
142980137|NCT01575899|515462299|FG001|Overall Study|Protocol Violation|1|||
142980138|NCT01575899|515462300|FG002|Overall Study|Protocol Violation|0|||
142980139|NCT03097029|515462301|FG000|Overall Study|Withdrawal by Subject|1|||
142980140|NCT00108953|515462303|FG000|Follow-up|Death|18|||
142980141|NCT00108953|515462304|FG001|Follow-up|Death|26|||
142980142|NCT00108953|515462303|FG000|Follow-up|Lost to Follow-up|1|||
142980143|NCT00108953|515462304|FG001|Follow-up|Lost to Follow-up|1|||
142980144|NCT00108953|515462303|FG000|Follow-up|Study terminated by sponsor|10|||
142980145|NCT00108953|515462304|FG001|Follow-up|Study terminated by sponsor|6|||
142980146|NCT04294095|515462305|FG000|Overall Study|Adverse Event|1|||
142980147|NCT04294095|515462306|FG001|Overall Study|Adverse Event|0|||
142980148|NCT03803202|515462309|FG000|Overall Study|Other|0|||
142980149|NCT03803202|515462310|FG001|Overall Study|Other|1|||
142980150|NCT03803202|515462311|FG002|Overall Study|Other|0|||
142980151|NCT03803202|515462312|FG003|Overall Study|Other|0|||
142980152|NCT03803202|515462313|FG004|Overall Study|Other|0|||
142980153|NCT03803202|515462314|FG005|Overall Study|Other|0|||
142980154|NCT03803202|515462315|FG006|Overall Study|Other|0|||
142980155|NCT03803202|515462316|FG007|Overall Study|Other|0|||
142980156|NCT03803202|515462317|FG008|Overall Study|Other|0|||
142980157|NCT03803202|515462309|FG000|Overall Study|Death|0|||
142980158|NCT03803202|515462310|FG001|Overall Study|Death|0|||
142980159|NCT03803202|515462311|FG002|Overall Study|Death|0|||
142980160|NCT03803202|515462312|FG003|Overall Study|Death|0|||
142980161|NCT03803202|515462313|FG004|Overall Study|Death|0|||
142980162|NCT03803202|515462314|FG005|Overall Study|Death|1|||
142980163|NCT03803202|515462315|FG006|Overall Study|Death|0|||
142980164|NCT03803202|515462316|FG007|Overall Study|Death|0|||
142980165|NCT03803202|515462317|FG008|Overall Study|Death|0|||
142980166|NCT03803202|515462309|FG000|Overall Study|Withdrawal by Subject|0|||
142980167|NCT03803202|515462310|FG001|Overall Study|Withdrawal by Subject|0|||
142980168|NCT03803202|515462311|FG002|Overall Study|Withdrawal by Subject|1|||
142980169|NCT03803202|515462312|FG003|Overall Study|Withdrawal by Subject|0|||
142980170|NCT03803202|515462313|FG004|Overall Study|Withdrawal by Subject|0|||
142980171|NCT03803202|515462314|FG005|Overall Study|Withdrawal by Subject|0|||
142980172|NCT03803202|515462315|FG006|Overall Study|Withdrawal by Subject|0|||
142980173|NCT03803202|515462316|FG007|Overall Study|Withdrawal by Subject|1|||
142980174|NCT03803202|515462317|FG008|Overall Study|Withdrawal by Subject|0|||
142980175|NCT03803202|515462309|FG000|Overall Study|Lost to Follow-up|0|||
142980176|NCT03803202|515462310|FG001|Overall Study|Lost to Follow-up|0|||
142980177|NCT03803202|515462311|FG002|Overall Study|Lost to Follow-up|0|||
142980178|NCT03803202|515462312|FG003|Overall Study|Lost to Follow-up|1|||
142980179|NCT03803202|515462313|FG004|Overall Study|Lost to Follow-up|1|||
142980180|NCT03803202|515462314|FG005|Overall Study|Lost to Follow-up|0|||
142980181|NCT03803202|515462315|FG006|Overall Study|Lost to Follow-up|1|||
142980182|NCT03803202|515462316|FG007|Overall Study|Lost to Follow-up|0|||
142980183|NCT03803202|515462317|FG008|Overall Study|Lost to Follow-up|0|||
142980184|NCT02224638|515462318|FG000|Overall Study|Adverse Event|1|||
142980185|NCT02224638|515462319|FG001|Overall Study|Adverse Event|1|||
142980186|NCT00861380|515462320|FG000|Overall Study|Withdrawal Information not recorded|8427|||
142980187|NCT00861380|515462321|FG001|Overall Study|Withdrawal Information not recorded|9112|||
142980188|NCT00861380|515462322|FG002|Overall Study|Withdrawal Information not recorded|8872|||
142980189|NCT00861380|515462323|FG003|Overall Study|Withdrawal Information not recorded|3689|||
142980190|NCT00861380|515462324|FG004|Overall Study|Withdrawal Information not recorded|1812|||
142980191|NCT00861380|515462325|FG005|Overall Study|Withdrawal Information not recorded|6249|||
142980192|NCT00861380|515462326|FG006|Overall Study|Withdrawal Information not recorded|3020|||
142980193|NCT01998399|515462336|FG000|Overall Study|Lost to Follow-up|1|||
142980194|NCT01998399|515462337|FG001|Overall Study|Lost to Follow-up|3|||
142980195|NCT01998399|515462336|FG000|Overall Study|Death|4|||
142980196|NCT01998399|515462337|FG001|Overall Study|Death|2|||
142980197|NCT01998399|515462336|FG000|Overall Study|Study stopped before dosing completed|3|||
142980198|NCT01998399|515462337|FG001|Overall Study|Study stopped before dosing completed|3|||
142980199|NCT01998399|515462336|FG000|Overall Study|Withdrawal by Subject|0|||
142980200|NCT01998399|515462337|FG001|Overall Study|Withdrawal by Subject|1|||
142980201|NCT00376246|515462341|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
142980202|NCT00376246|515462342|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
142980203|NCT00376246|515462341|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
142980204|NCT00376246|515462342|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
142980205|NCT00376246|515462341|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
142980206|NCT00376246|515462342|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
142980207|NCT01455415|515462348|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
142980208|NCT01455415|515462349|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
142980209|NCT01455415|515462348|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
142980210|NCT01455415|515462349|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
142980211|NCT01455415|515462348|FG000|Period 1|Drug Error not Associated to AE|0|||
142980212|NCT01455415|515462349|FG001|Period 1|Drug Error not Associated to AE|1|||
142980213|NCT01455415|515462348|FG000|Period 1|AE Not Related to Study Drug|2|||
142980214|NCT01455415|515462349|FG001|Period 1|AE Not Related to Study Drug|6|||
142980215|NCT01455415|515462348|FG000|Period 1|Withdrawal by Subject|4|||
142980216|NCT01455415|515462349|FG001|Period 1|Withdrawal by Subject|5|||
142980217|NCT01455415|515462348|FG000|Period 1|Unspecified Reason|1|||
142980218|NCT01455415|515462349|FG001|Period 1|Unspecified Reason|1|||
142980219|NCT01455415|515462348|FG000|Period 1|Protocol Violation|0|||
142980220|NCT01455415|515462349|FG001|Period 1|Protocol Violation|2|||
142980221|NCT01455415|515462348|FG000|Washout|AE Related to Study Drug|2|||
142980222|NCT01455415|515462349|FG001|Washout|AE Related to Study Drug|0|||
142980223|NCT01455415|515462348|FG000|Washout|Lost to Follow-up|1|||
142980224|NCT01455415|515462349|FG001|Washout|Lost to Follow-up|0|||
142980225|NCT01455415|515462348|FG000|Washout|Drug Error not Associated to AE|2|||
142980226|NCT01455415|515462349|FG001|Washout|Drug Error not Associated to AE|1|||
142980227|NCT01455415|515462348|FG000|Washout|AE Not Related to Study Drug|2|||
142980228|NCT01455415|515462349|FG001|Washout|AE Not Related to Study Drug|3|||
142980229|NCT01455415|515462348|FG000|Washout|Unspecified Reason|1|||
142980230|NCT01455415|515462349|FG001|Washout|Unspecified Reason|2|||
142980231|NCT01455415|515462348|FG000|Washout|Protocol Violation|0|||
142980232|NCT01455415|515462349|FG001|Washout|Protocol Violation|1|||
142980233|NCT01455415|515462348|FG000|Period 2|AE Related to Study Drug|1|||
142980234|NCT01455415|515462349|FG001|Period 2|AE Related to Study Drug|2|||
142980235|NCT01455415|515462348|FG000|Period 2|Lost to Follow-up|2|||
142980236|NCT01455415|515462349|FG001|Period 2|Lost to Follow-up|1|||
142980237|NCT01455415|515462348|FG000|Period 2|AE Not Related to Study Drug|2|||
142980238|NCT01455415|515462349|FG001|Period 2|AE Not Related to Study Drug|1|||
142980239|NCT01455415|515462348|FG000|Period 2|Lack of Efficacy|2|||
142980240|NCT01455415|515462349|FG001|Period 2|Lack of Efficacy|0|||
142980241|NCT01455415|515462348|FG000|Period 2|Withdrawal by Subject|2|||
142980242|NCT01455415|515462349|FG001|Period 2|Withdrawal by Subject|3|||
142980243|NCT01455415|515462348|FG000|Period 2|Unspecified Reason|2|||
142980244|NCT01455415|515462349|FG001|Period 2|Unspecified Reason|3|||
142980245|NCT01455415|515462348|FG000|Period 2|Protocol Violation|2|||
142980246|NCT01455415|515462349|FG001|Period 2|Protocol Violation|0|||
142980247|NCT01455415|515462348|FG000|Follow-up|AE Related to Study Drug|0|||
142980248|NCT01455415|515462349|FG001|Follow-up|AE Related to Study Drug|1|||
142980249|NCT01455415|515462348|FG000|Follow-up|Lack of Efficacy|0|||
142980250|NCT01455415|515462349|FG001|Follow-up|Lack of Efficacy|1|||
142980251|NCT01455415|515462348|FG000|Follow-up|Withdrawal by Subject|2|||
142980252|NCT01455415|515462349|FG001|Follow-up|Withdrawal by Subject|0|||
142980253|NCT01455415|515462348|FG000|Follow-up|Unspecified Reason|1|||
142980254|NCT01455415|515462349|FG001|Follow-up|Unspecified Reason|0|||
142980255|NCT00719537|515462350|FG000|Overall Study|Withdrawal by Subject|1|||
142980256|NCT00719537|515462351|FG001|Overall Study|Withdrawal by Subject|0|||
142980257|NCT00719537|515462350|FG000|Overall Study|Lost to Follow-up|0|||
142980258|NCT00719537|515462351|FG001|Overall Study|Lost to Follow-up|1|||
142980259|NCT01068717|515462354|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
142980260|NCT01068717|515462355|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
142980261|NCT01068717|515462356|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
142980262|NCT01068717|515462357|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
142980263|NCT02679781|515462358|FG000|Overall Study|Lost to Follow-up|1|||
142980264|NCT02679781|515462359|FG001|Overall Study|Lost to Follow-up|2|||
142980265|NCT02679781|515462358|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
142980266|NCT02679781|515462359|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
142980267|NCT00970268|515462368|FG000|Overall Study|Withdrawal by Subject|12|||
142980268|NCT00970268|515462369|FG001|Overall Study|Withdrawal by Subject|19|||
142980269|NCT00970268|515462368|FG000|Overall Study|Adverse Event|15|||
142980270|NCT00970268|515462369|FG001|Overall Study|Adverse Event|12|||
142980271|NCT00970268|515462368|FG000|Overall Study|Lack of Efficacy|3|||
142980272|NCT00970268|515462369|FG001|Overall Study|Lack of Efficacy|6|||
142980273|NCT00970268|515462368|FG000|Overall Study|Protocol Violation|4|||
142980274|NCT00970268|515462369|FG001|Overall Study|Protocol Violation|7|||
142980275|NCT00970268|515462368|FG000|Overall Study|Other Reason|3|||
142980276|NCT00970268|515462369|FG001|Overall Study|Other Reason|1|||
142980277|NCT00970268|515462368|FG000|Overall Study|COPD Exacerbation|4|||
142980278|NCT00970268|515462369|FG001|Overall Study|COPD Exacerbation|2|||
142980279|NCT00970268|515462368|FG000|Overall Study|Lost to Follow-up|1|||
142980280|NCT00970268|515462369|FG001|Overall Study|Lost to Follow-up|2|||
142980281|NCT00970268|515462368|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
142980282|NCT00970268|515462369|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
142980283|NCT05200455|515462371|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
142980284|NCT01602549|515462372|FG000|Overall Study|Protocol Violation|0|||
142980285|NCT01602549|515462373|FG001|Overall Study|Protocol Violation|1|||
142980286|NCT01602549|515462372|FG000|Overall Study|Withdrawal by Subject|1|||
142980287|NCT01602549|515462373|FG001|Overall Study|Withdrawal by Subject|0|||
142980288|NCT00676208|515462380|FG000|Overall Study|Lost to Follow-up|0|||
142980289|NCT00676208|515462381|FG001|Overall Study|Lost to Follow-up|2|||
142980290|NCT00676208|515462380|FG000|Overall Study|Incomplete data|2|||
142980291|NCT00676208|515462381|FG001|Overall Study|Incomplete data|4|||
142980292|NCT03700736|515462384|FG000|Overall Study|Pregnancy|1|||
142980293|NCT03700736|515462385|FG001|Overall Study|Pregnancy|1|||
142980294|NCT03700736|515462384|FG000|Overall Study|Withdrawal by Subject|2|||
142980295|NCT03700736|515462385|FG001|Overall Study|Withdrawal by Subject|6|||
142980296|NCT03726333|515462387|FG000|Overall Study|Progressive Disease|0|||
142980297|NCT03726333|515462388|FG001|Overall Study|Progressive Disease|0|||
142980298|NCT03726333|515462389|FG002|Overall Study|Progressive Disease|1|||
142980299|NCT03726333|515462390|FG003|Overall Study|Progressive Disease|0|||
142980300|NCT03726333|515462391|FG004|Overall Study|Progressive Disease|0|||
142980301|NCT01410799|515462392|FG000|Overall Study|PI decision|13|||
142980302|NCT04126031|515462394|FG000|Part A|Withdrawal by Subject|0|||
142980303|NCT04126031|515462395|FG001|Part A|Withdrawal by Subject|0|||
142980304|NCT04126031|515462396|FG002|Part A|Withdrawal by Subject|1|||
142980305|NCT04126031|515462397|FG003|Part A|Withdrawal by Subject|0|||
142980306|NCT04126031|515462398|FG004|Part A|Withdrawal by Subject|0|||
142980307|NCT04126031|515462399|FG005|Part A|Withdrawal by Subject|0|||
142980308|NCT04126031|515462394|FG000|Part A|Other|1|||
142980309|NCT04126031|515462395|FG001|Part A|Other|0|||
142980310|NCT04126031|515462396|FG002|Part A|Other|0|||
142980311|NCT04126031|515462397|FG003|Part A|Other|0|||
142980312|NCT04126031|515462398|FG004|Part A|Other|0|||
142980313|NCT04126031|515462399|FG005|Part A|Other|0|||
142980314|NCT04126031|515462394|FG000|Part B|Adverse Event|0|||
142980315|NCT04126031|515462395|FG001|Part B|Adverse Event|0|||
142980316|NCT04126031|515462396|FG002|Part B|Adverse Event|0|||
142980317|NCT04126031|515462397|FG003|Part B|Adverse Event|0|||
142980318|NCT04126031|515462398|FG004|Part B|Adverse Event|0|||
142980319|NCT04126031|515462399|FG005|Part B|Adverse Event|2|||
142980320|NCT04126031|515462394|FG000|Part B|Pre-existing hypertransaminasemia|0|||
142980321|NCT04126031|515462395|FG001|Part B|Pre-existing hypertransaminasemia|0|||
142980322|NCT04126031|515462396|FG002|Part B|Pre-existing hypertransaminasemia|0|||
142980323|NCT04126031|515462397|FG003|Part B|Pre-existing hypertransaminasemia|0|||
142980324|NCT04126031|515462398|FG004|Part B|Pre-existing hypertransaminasemia|1|||
142980325|NCT04126031|515462399|FG005|Part B|Pre-existing hypertransaminasemia|0|||
142980326|NCT00617656|515462400|FG000|Overall Study|Inclusion error|4|||
142980327|NCT00617656|515462401|FG001|Overall Study|Inclusion error|4|||
142980328|NCT00617656|515462402|FG002|Overall Study|Inclusion error|0|||
142980329|NCT00617656|515462403|FG003|Overall Study|Inclusion error|0|||
142980330|NCT00617656|515462400|FG000|Overall Study|Missing data|44|||
142980331|NCT00617656|515462401|FG001|Overall Study|Missing data|30|||
142980332|NCT00617656|515462402|FG002|Overall Study|Missing data|13|||
142980333|NCT00617656|515462403|FG003|Overall Study|Missing data|6|||
142980334|NCT00617656|515462400|FG000|Overall Study|Withdrawal by Subject|0|||
142980335|NCT00617656|515462401|FG001|Overall Study|Withdrawal by Subject|2|||
142980336|NCT00617656|515462402|FG002|Overall Study|Withdrawal by Subject|0|||
142980337|NCT00617656|515462403|FG003|Overall Study|Withdrawal by Subject|0|||
142980338|NCT00239356|515464458|FG000|Overall Study|Lack of Efficacy|1|||
142980339|NCT00239356|515464459|FG001|Overall Study|Lack of Efficacy|0|||
142980340|NCT00239356|515464458|FG000|Overall Study|Adverse Event|6|||
142980341|NCT00239356|515464459|FG001|Overall Study|Adverse Event|0|||
142980342|NCT00239356|515464458|FG000|Overall Study|Withdrawal by Subject|15|||
142980343|NCT00239356|515464459|FG001|Overall Study|Withdrawal by Subject|6|||
142980344|NCT00239356|515464458|FG000|Overall Study|Lost to Follow-up|3|||
142980345|NCT00239356|515464459|FG001|Overall Study|Lost to Follow-up|0|||
142980346|NCT00239356|515464458|FG000|Overall Study|poor/non-compliance|2|||
142980347|NCT00239356|515464459|FG001|Overall Study|poor/non-compliance|0|||
142980348|NCT00239356|515464458|FG000|Overall Study|Pregnancy|1|||
142980349|NCT00239356|515464459|FG001|Overall Study|Pregnancy|0|||
142980350|NCT00239356|515464458|FG000|Overall Study|Administrative reason|0|||
142980351|NCT00239356|515464459|FG001|Overall Study|Administrative reason|1|||
142980352|NCT00239356|515464458|FG000|Overall Study|Drug available on market|11|||
142980353|NCT00239356|515464459|FG001|Overall Study|Drug available on market|2|||
142980354|NCT02044822|515464460|FG000|Overall Study|Study Terminated by Sponsor|77|||
142980355|NCT02044822|515464460|FG000|Overall Study|Investigator's Discretion|10|||
142980356|NCT02044822|515464460|FG000|Overall Study|Withdrew Consent|3|||
142980357|NCT02044822|515464460|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
142980358|NCT02044822|515464460|FG000|Overall Study|Lost to Follow-up|1|||
142980359|NCT01237223|515464461|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
142980360|NCT01237223|515464462|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
142980361|NCT01237223|515464463|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
142980362|NCT01237223|515464464|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
142980363|NCT01237223|515464465|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
142980364|NCT01237223|515464466|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
142980365|NCT01237223|515464461|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
142980366|NCT01237223|515464462|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
142980367|NCT01237223|515464463|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
142980368|NCT01237223|515464464|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
142980369|NCT01237223|515464465|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
142980370|NCT01237223|515464466|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
142980371|NCT01237223|515464461|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
142980372|NCT01237223|515464462|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
142980373|NCT01237223|515464463|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
142980374|NCT01237223|515464464|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
142980375|NCT01237223|515464465|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
142980376|NCT01237223|515464466|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
142980377|NCT01237223|515464461|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
142980378|NCT01237223|515464462|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
142980379|NCT01237223|515464463|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
142980380|NCT01237223|515464464|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
142980381|NCT01237223|515464465|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
142980382|NCT01237223|515464466|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
142980383|NCT01237223|515464461|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
142980384|NCT01237223|515464462|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
142980385|NCT01237223|515464463|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
142980386|NCT01237223|515464464|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
142980387|NCT01237223|515464465|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
142980388|NCT01237223|515464466|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
142980389|NCT01237223|515464461|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
142980390|NCT01237223|515464462|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
142980391|NCT01237223|515464463|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
142980392|NCT01237223|515464464|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
142980393|NCT01237223|515464465|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
142980394|NCT01237223|515464466|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
142980395|NCT01237223|515464461|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
142980396|NCT01237223|515464462|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
142980397|NCT01237223|515464463|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
142980398|NCT01237223|515464464|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
142980399|NCT01237223|515464465|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
142980400|NCT01237223|515464466|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
142980401|NCT01237223|515464461|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
142980402|NCT01237223|515464462|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
142980403|NCT01237223|515464463|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
142980404|NCT01237223|515464464|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
142980405|NCT01237223|515464465|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
142980406|NCT01237223|515464466|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
142980407|NCT01237223|515464461|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
142980408|NCT01237223|515464462|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
142980409|NCT01237223|515464463|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
142980410|NCT01237223|515464464|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
142980411|NCT01237223|515464465|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
142980412|NCT01237223|515464466|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
142980413|NCT01237223|515464461|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
142980414|NCT01237223|515464462|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
142980415|NCT01237223|515464463|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
142980416|NCT01237223|515464464|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
142980417|NCT01237223|515464465|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
142980418|NCT01237223|515464466|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
142980419|NCT01359046|515464470|FG000|Overall Study|Did not receive allocated intervention|6|||
142980420|NCT01359046|515464471|FG001|Overall Study|Did not receive allocated intervention|6|||
142980421|NCT01359046|515464470|FG000|Overall Study|Physician Decision|1|||
142980422|NCT01359046|515464471|FG001|Overall Study|Physician Decision|11|||
142980423|NCT02980692|515464474|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
142980424|NCT02980692|515464475|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
142980425|NCT02980692|515464476|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
142980426|NCT02980692|515464477|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
142980427|NCT02980692|515464478|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
142980428|NCT02980692|515464474|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
142980429|NCT02980692|515464475|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
142980430|NCT02980692|515464476|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
142980431|NCT02980692|515464477|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
142980432|NCT02980692|515464478|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
142980433|NCT02980692|515464474|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
142980434|NCT02980692|515464475|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
142980435|NCT02980692|515464476|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
142980436|NCT02980692|515464477|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
142980437|NCT02980692|515464478|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
142980438|NCT02980692|515464474|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
142980439|NCT02980692|515464475|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
142980440|NCT02980692|515464476|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
142980441|NCT02980692|515464477|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
142980442|NCT02980692|515464478|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
142980443|NCT02980692|515464474|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
142980444|NCT02980692|515464475|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
142980445|NCT02980692|515464476|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
142980446|NCT02980692|515464477|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
142980447|NCT02980692|515464478|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
142980448|NCT02980692|515464474|FG000|Double Blind Placebo Controlled Period|Other|1|||
142980449|NCT02980692|515464475|FG001|Double Blind Placebo Controlled Period|Other|0|||
142980450|NCT02980692|515464476|FG002|Double Blind Placebo Controlled Period|Other|0|||
142980451|NCT02980692|515464477|FG003|Double Blind Placebo Controlled Period|Other|0|||
142980452|NCT02980692|515464478|FG004|Double Blind Placebo Controlled Period|Other|1|||
142980453|NCT02980692|515464474|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
142980454|NCT02980692|515464475|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
142980455|NCT02980692|515464476|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
142980456|NCT02980692|515464477|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
143003167|NCT01049360|515548759|FG015|Period 2|Withdrawal by Subject|0|||
142980457|NCT02980692|515464478|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
142980458|NCT02980692|515464474|FG000|Double-blind Follow-up Period|Adverse Event|0|||
142980459|NCT02980692|515464475|FG001|Double-blind Follow-up Period|Adverse Event|0|||
142980460|NCT02980692|515464476|FG002|Double-blind Follow-up Period|Adverse Event|0|||
142980461|NCT02980692|515464477|FG003|Double-blind Follow-up Period|Adverse Event|1|||
142980462|NCT02980692|515464478|FG004|Double-blind Follow-up Period|Adverse Event|1|||
142980463|NCT02980692|515464474|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
142980464|NCT02980692|515464475|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
142980465|NCT02980692|515464476|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
142980466|NCT02980692|515464477|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
142980467|NCT02980692|515464478|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
142980468|NCT02980692|515464474|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
142980469|NCT02980692|515464475|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
142980470|NCT02980692|515464476|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
142980471|NCT02980692|515464477|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
142980472|NCT02980692|515464478|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
142980473|NCT02980692|515464474|FG000|Double-blind Follow-up Period|Pregnancy|0|||
142980474|NCT02980692|515464475|FG001|Double-blind Follow-up Period|Pregnancy|0|||
142980475|NCT02980692|515464476|FG002|Double-blind Follow-up Period|Pregnancy|1|||
142980476|NCT02980692|515464477|FG003|Double-blind Follow-up Period|Pregnancy|1|||
142980477|NCT02980692|515464478|FG004|Double-blind Follow-up Period|Pregnancy|0|||
142980478|NCT02980692|515464474|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
142980479|NCT02980692|515464475|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
142980480|NCT02980692|515464476|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
142980481|NCT02980692|515464477|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
142980482|NCT02980692|515464478|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
142980483|NCT02980692|515464474|FG000|Double-blind Follow-up Period|Other|0|||
142980484|NCT02980692|515464475|FG001|Double-blind Follow-up Period|Other|0|||
142980485|NCT02980692|515464476|FG002|Double-blind Follow-up Period|Other|1|||
142980486|NCT02980692|515464477|FG003|Double-blind Follow-up Period|Other|1|||
142980487|NCT02980692|515464478|FG004|Double-blind Follow-up Period|Other|3|||
142980488|NCT03725293|515464482|FG000|Overall Study|Physician Decision|9|||
142980489|NCT03725293|515464483|FG001|Overall Study|Physician Decision|6|||
142980490|NCT03725293|515464482|FG000|Overall Study|alternative vascular access needs|1|||
142980491|NCT03725293|515464483|FG001|Overall Study|alternative vascular access needs|2|||
142980492|NCT03725293|515464482|FG000|Overall Study|venous anatomy screen failures|2|||
142980493|NCT03725293|515464483|FG001|Overall Study|venous anatomy screen failures|1|||
142980494|NCT02143141|515464486|FG000|Overall Study|pain scores at 24 hours not collected|1|||
142980495|NCT02143141|515464487|FG001|Overall Study|pain scores at 24 hours not collected|0|||
142980496|NCT04583969|515464488|FG000|Overall Study|Death|31|||
142980497|NCT04583969|515464489|FG001|Overall Study|Death|38|||
142980498|NCT04583969|515464488|FG000|Overall Study|Lost to Follow-up|16|||
142980499|NCT04583969|515464489|FG001|Overall Study|Lost to Follow-up|13|||
142980500|NCT04583969|515464488|FG000|Overall Study|Protocol Violation|1|||
142980501|NCT04583969|515464489|FG001|Overall Study|Protocol Violation|0|||
142980502|NCT04583969|515464488|FG000|Overall Study|Withdrawal by Subject|3|||
142980503|NCT04583969|515464489|FG001|Overall Study|Withdrawal by Subject|3|||
142980504|NCT04583969|515464488|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
142980505|NCT04583969|515464489|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
142980506|NCT04583969|515464488|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
142980507|NCT04583969|515464489|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
142980508|NCT04583969|515464488|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
142980509|NCT04583969|515464489|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
142980510|NCT04583969|515464488|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
142980511|NCT04583969|515464489|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
142980512|NCT04583969|515464488|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
142980513|NCT04583969|515464489|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
142980514|NCT03862495|515464490|FG000|Overall Study|Lost to Follow-up|37|||
142980515|NCT03862495|515464491|FG001|Overall Study|Lost to Follow-up|35|||
142980516|NCT00615914|515464492|FG000|Overall Study|Adverse Event|274|||
142980517|NCT00615914|515464492|FG000|Overall Study|Death|20|||
142980518|NCT00615914|515464492|FG000|Overall Study|Lack of Efficacy|59|||
142980519|NCT00615914|515464492|FG000|Overall Study|Lost to Follow-up|187|||
142980520|NCT00615914|515464492|FG000|Overall Study|Withdrawal by Subject|16|||
142980521|NCT00615914|515464492|FG000|Overall Study|Physician Decision|4|||
142980522|NCT00615914|515464492|FG000|Overall Study|No data was collected.|65|||
142980523|NCT00615914|515464492|FG000|Overall Study|No treatment|2|||
142980524|NCT00615914|515464492|FG000|Overall Study|Irregularly enrolled patients|10|||
142980525|NCT04397796|515464493|FG000|Overall Study|Death|3|||
142980526|NCT04397796|515464494|FG001|Overall Study|Death|1|||
142980527|NCT01057862|515464497|FG000|Overall Study|Withdrawal by Subject|1|||
142980528|NCT01057862|515464498|FG001|Overall Study|Withdrawal by Subject|2|||
142980529|NCT00802867|515464501|FG000|Overall Study|Lost to Follow-up|6|||
142980530|NCT00802867|515464501|FG000|Overall Study|Protocol Violation|6|||
142980531|NCT00802867|515464501|FG000|Overall Study|Withdrawal by Subject|1|||
142980532|NCT04075396|515464502|FG000|Overall Study|Death|11|||
142980533|NCT04075396|515464503|FG001|Overall Study|Death|9|||
142980534|NCT04075396|515464502|FG000|Overall Study|Withdrawal by Subject|1|||
142980535|NCT04075396|515464503|FG001|Overall Study|Withdrawal by Subject|2|||
142980536|NCT04075396|515464502|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
142980537|NCT04075396|515464503|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
142980538|NCT04075396|515464502|FG000|Overall Study|Enrolled but not-treated|0|||
142980539|NCT04075396|515464503|FG001|Overall Study|Enrolled but not-treated|1|||
142980540|NCT03363165|515464504|FG000|3-month Follow-up|Death|0|||
142980541|NCT03363165|515464505|FG001|3-month Follow-up|Death|1|||
142980542|NCT03363165|515464504|FG000|6-month Follow-up|Death|0|||
142980543|NCT03363165|515464505|FG001|6-month Follow-up|Death|1|||
142980544|NCT03363165|515464504|FG000|6-month Follow-up|Withdrawal by Subject|1|||
142980545|NCT03363165|515464505|FG001|6-month Follow-up|Withdrawal by Subject|1|||
142980546|NCT03363165|515464504|FG000|12-month Follow-up|Death|1|||
142980547|NCT03363165|515464505|FG001|12-month Follow-up|Death|1|||
142980548|NCT03363165|515464504|FG000|12-month Follow-up|Withdrawal by Subject|1|||
142980549|NCT03363165|515464505|FG001|12-month Follow-up|Withdrawal by Subject|1|||
142980550|NCT02255760|515464506|FG000|Overall Study|Lost to Follow-up|0|||
142980551|NCT02255760|515464507|FG001|Overall Study|Lost to Follow-up|1|||
142980552|NCT02255760|515464508|FG002|Overall Study|Lost to Follow-up|0|||
142980553|NCT02255760|515464509|FG003|Overall Study|Lost to Follow-up|0|||
142980554|NCT02255760|515464510|FG004|Overall Study|Lost to Follow-up|0|||
142980555|NCT00003838|515464511|FG000|Overall Study|Death|0|||
142980556|NCT00003838|515464512|FG001|Overall Study|Death|12|||
142980557|NCT00003838|515464513|FG002|Overall Study|Death|7|||
142980558|NCT00003838|515464511|FG000|Overall Study|Lost to Follow-up|0|||
142980559|NCT00003838|515464512|FG001|Overall Study|Lost to Follow-up|1|||
142980560|NCT00003838|515464513|FG002|Overall Study|Lost to Follow-up|1|||
142980561|NCT00003838|515464511|FG000|Overall Study|Disease Progression|0|||
142980562|NCT00003838|515464512|FG001|Overall Study|Disease Progression|12|||
142980563|NCT00003838|515464513|FG002|Overall Study|Disease Progression|0|||
142980564|NCT00618813|515464514|FG000|Overall Study|Lack of Efficacy|1|||
142980565|NCT00618813|515464514|FG000|Overall Study|Physician Decision|2|||
142980566|NCT00618813|515464514|FG000|Overall Study|Withdrawal by Subject|1|||
142980567|NCT01819506|515464517|FG000|Overall Study|Physician Decision|5|||
142980568|NCT01819506|515464518|FG001|Overall Study|Physician Decision|2|||
142980569|NCT01819506|515464517|FG000|Overall Study|Withdrawal by Subject|3|||
142980570|NCT01819506|515464518|FG001|Overall Study|Withdrawal by Subject|3|||
142980571|NCT00425113|515464519|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
142980572|NCT00425113|515464520|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
142980573|NCT00425113|515464519|FG000|Overall Study|diagnosis of abdominal TB|0|||
142980574|NCT00425113|515464520|FG001|Overall Study|diagnosis of abdominal TB|1|||
142980575|NCT00425113|515464519|FG000|Overall Study|missing study drug more than 14 days|0|||
142980576|NCT00425113|515464520|FG001|Overall Study|missing study drug more than 14 days|1|||
142980577|NCT00425113|515464519|FG000|Overall Study|Withdrawal by Subject|1|||
142980578|NCT00425113|515464520|FG001|Overall Study|Withdrawal by Subject|0|||
142980579|NCT00879437|515464523|FG000|Overall Study|Protocol Violation|0|||
142980580|NCT00879437|515464524|FG001|Overall Study|Protocol Violation|1|||
142980581|NCT00879437|515464523|FG000|Overall Study|Death|1|||
142980582|NCT00879437|515464524|FG001|Overall Study|Death|0|||
142980583|NCT00268463|515464525|FG000|Overall Study|study terminated due to low accrual|10|||
142980584|NCT00268463|515464526|FG001|Overall Study|study terminated due to low accrual|12|||
142980585|NCT03000686|515464528|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
142980586|NCT03000686|515464529|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
142980587|NCT03000686|515464530|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
142980588|NCT03000686|515464531|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
142980589|NCT02920450|515464532|FG000|Overall Study|Death|1|||
142980590|NCT02920450|515464533|FG001|Overall Study|Death|0|||
142980591|NCT02920450|515464534|FG002|Overall Study|Death|0|||
142980592|NCT02920450|515464535|FG003|Overall Study|Death|0|||
142980593|NCT02920450|515464532|FG000|Overall Study|Withdrawal by Subject|1|||
142980594|NCT02920450|515464533|FG001|Overall Study|Withdrawal by Subject|0|||
142980595|NCT02920450|515464534|FG002|Overall Study|Withdrawal by Subject|0|||
142980596|NCT02920450|515464535|FG003|Overall Study|Withdrawal by Subject|0|||
142980597|NCT01112982|515464539|FG000|Overall Study|Withdrawal by Subject|1|||
142980598|NCT01112982|515464539|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
142980599|NCT00126672|515464543|FG000|Overall Study|Adverse Event|4|||
142980600|NCT00126672|515464543|FG000|Overall Study|Lost to Follow-up|4|||
142980601|NCT00729326|515464544|FG000|Overall Study|Lost to Follow-up|2|||
143455666|NCT03208036|517212505|FG001|Baseline Assessment|Withdrawal by Subject|1|||
142980602|NCT00729326|515464545|FG001|Overall Study|Lost to Follow-up|0|||
142980603|NCT00729326|515464544|FG000|Overall Study|Physician Decision|0|||
142980604|NCT00729326|515464545|FG001|Overall Study|Physician Decision|1|||
142980605|NCT00729326|515464544|FG000|Overall Study|Protocol Violation|3|||
142980606|NCT00729326|515464545|FG001|Overall Study|Protocol Violation|2|||
142980607|NCT00729326|515464544|FG000|Overall Study|Subject Decision|4|||
142980608|NCT00729326|515464545|FG001|Overall Study|Subject Decision|4|||
142980609|NCT00729326|515464544|FG000|Overall Study|Sponsor Decision|1|||
142980610|NCT00729326|515464545|FG001|Overall Study|Sponsor Decision|2|||
142980611|NCT01235728|515464546|FG000|Overall Study|Protocol Violation|0|||
142980612|NCT01235728|515464547|FG001|Overall Study|Protocol Violation|0|||
142980613|NCT01235728|515464548|FG002|Overall Study|Protocol Violation|0|||
142980614|NCT01235728|515464549|FG003|Overall Study|Protocol Violation|1|||
142980615|NCT01235728|515464550|FG004|Overall Study|Protocol Violation|0|||
142980616|NCT01235728|515464551|FG005|Overall Study|Protocol Violation|0|||
142980617|NCT01235728|515464552|FG006|Overall Study|Protocol Violation|0|||
142980618|NCT01235728|515464553|FG007|Overall Study|Protocol Violation|0|||
142980619|NCT00871572|515464554|FG000|Overall Study|Adverse Event|0|||
142980620|NCT00871572|515464555|FG001|Overall Study|Adverse Event|2|||
142980621|NCT00871572|515464556|FG002|Overall Study|Adverse Event|0|||
142980622|NCT00871572|515464557|FG003|Overall Study|Adverse Event|3|||
142980623|NCT00871572|515464554|FG000|Overall Study|Investigator Decision|0|||
142980624|NCT00871572|515464555|FG001|Overall Study|Investigator Decision|1|||
142980625|NCT00871572|515464556|FG002|Overall Study|Investigator Decision|0|||
142980626|NCT00871572|515464557|FG003|Overall Study|Investigator Decision|1|||
142980627|NCT00871572|515464554|FG000|Overall Study|Lost to Follow-up|0|||
142980628|NCT00871572|515464555|FG001|Overall Study|Lost to Follow-up|1|||
142980629|NCT00871572|515464556|FG002|Overall Study|Lost to Follow-up|0|||
142980630|NCT00871572|515464557|FG003|Overall Study|Lost to Follow-up|1|||
142980631|NCT00871572|515464554|FG000|Overall Study|Protocol Violation|0|||
142980632|NCT00871572|515464555|FG001|Overall Study|Protocol Violation|0|||
142980633|NCT00871572|515464556|FG002|Overall Study|Protocol Violation|1|||
142980634|NCT00871572|515464557|FG003|Overall Study|Protocol Violation|1|||
142980635|NCT00871572|515464554|FG000|Overall Study|Sponsor Decision|1|||
142980636|NCT00871572|515464555|FG001|Overall Study|Sponsor Decision|0|||
142980637|NCT00871572|515464556|FG002|Overall Study|Sponsor Decision|0|||
142980638|NCT00871572|515464557|FG003|Overall Study|Sponsor Decision|0|||
142980639|NCT00871572|515464554|FG000|Overall Study|Withdrawal by Subject|1|||
142980640|NCT00871572|515464555|FG001|Overall Study|Withdrawal by Subject|2|||
142980641|NCT00871572|515464556|FG002|Overall Study|Withdrawal by Subject|3|||
142980642|NCT00871572|515464557|FG003|Overall Study|Withdrawal by Subject|1|||
142980643|NCT00260429|515464564|FG000|Overall Study|failure to follow appointments|1|||
142980644|NCT00260429|515464565|FG001|Overall Study|failure to follow appointments|0|||
142980645|NCT00260429|515464564|FG000|Overall Study|scheduled hand surgery|1|||
142980646|NCT00260429|515464565|FG001|Overall Study|scheduled hand surgery|0|||
142980647|NCT00617591|515464568|FG000|Overall Study|Withdrew consent during Induction|4|||
142980648|NCT00617591|515464568|FG000|Overall Study|Withdrew consent during Maintenance|6|||
142980649|NCT00587301|515464572|FG000|Overall Study|Screen Failure|9|||
142980650|NCT00587301|515464572|FG000|Overall Study|Lost to Follow-up|22|||
142980651|NCT00587301|515464572|FG000|Overall Study|Withdrawal by Subject|7|||
142980652|NCT00587301|515464572|FG000|Overall Study|Protocol Violation|7|||
142980653|NCT02758613|515464574|FG000|Treatment|Physician and Sponsor Decision|1|||
142980654|NCT02758613|515464575|FG001|Treatment|Physician and Sponsor Decision|0|||
142980655|NCT02758613|515464576|FG002|Treatment|Physician and Sponsor Decision|0|||
142980656|NCT02758613|515464577|FG003|Treatment|Physician and Sponsor Decision|0|||
142980657|NCT02758613|515464574|FG000|Treatment|Withdrawal by Subject|1|||
142980658|NCT02758613|515464575|FG001|Treatment|Withdrawal by Subject|0|||
142980659|NCT02758613|515464576|FG002|Treatment|Withdrawal by Subject|1|||
142980660|NCT02758613|515464577|FG003|Treatment|Withdrawal by Subject|0|||
142980661|NCT01496274|515464578|FG000|Overall Study|Protocol Violation|0|||
142980662|NCT01496274|515464579|FG001|Overall Study|Protocol Violation|1|||
142980663|NCT01496274|515464578|FG000|Overall Study|Adverse Event|1|||
142980664|NCT01496274|515464579|FG001|Overall Study|Adverse Event|1|||
143117224|NCT00787917|515970069|FG000|Blinded Treatment|Administrative problems|3|||
142980665|NCT01496274|515464578|FG000|Overall Study|Withdrawal by Subject|2|||
142980666|NCT01496274|515464579|FG001|Overall Study|Withdrawal by Subject|0|||
142980667|NCT01496274|515464578|FG000|Overall Study|Lost to Follow-up|0|||
142980668|NCT01496274|515464579|FG001|Overall Study|Lost to Follow-up|3|||
142980669|NCT00418717|515464580|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
142980670|NCT00418717|515464580|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
142980671|NCT01400139|515464582|FG000|HYD Core Study|Adverse Event|210|||
142980672|NCT01400139|515464582|FG000|HYD Core Study|Lack of Efficacy|59|||
142980673|NCT01400139|515464582|FG000|HYD Core Study|Withdrawal by Subject|114|||
142980674|NCT01400139|515464582|FG000|HYD Core Study|Lost to Follow-up|39|||
142980675|NCT01400139|515464582|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
142980676|NCT01400139|515464582|FG000|HYD Core Study|Administrative|56|||
142980677|NCT01400139|515464582|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
142980678|NCT01400139|515464582|FG000|HYD Extension Period|Adverse Event|8|||
142980679|NCT01400139|515464582|FG000|HYD Extension Period|Withdrawal by Subject|5|||
142980680|NCT01400139|515464582|FG000|HYD Extension Period|Administrative|10|||
142980681|NCT00351819|515464584|FG000|Overall Study|Lost to Follow-up|4|||
142980682|NCT00351819|515464585|FG001|Overall Study|Lost to Follow-up|4|||
142980683|NCT00351819|515464584|FG000|Overall Study|Withdrawal by Subject|0|||
142980684|NCT00351819|515464585|FG001|Overall Study|Withdrawal by Subject|4|||
142980685|NCT00351819|515464584|FG000|Overall Study|Elevated PSA|1|||
142980686|NCT00351819|515464585|FG001|Overall Study|Elevated PSA|1|||
142980687|NCT00351819|515464584|FG000|Overall Study|Traumatic ankle fracture|1|||
142980688|NCT00351819|515464585|FG001|Overall Study|Traumatic ankle fracture|0|||
142980689|NCT00351819|515464584|FG000|Overall Study|Unprofessional behavior|1|||
142980690|NCT00351819|515464585|FG001|Overall Study|Unprofessional behavior|0|||
142980691|NCT00351819|515464584|FG000|Overall Study|Non-compliance|0|||
142980692|NCT00351819|515464585|FG001|Overall Study|Non-compliance|1|||
142980693|NCT00351819|515464584|FG000|Overall Study|Incarcerated|0|||
142980694|NCT00351819|515464585|FG001|Overall Study|Incarcerated|1|||
142980695|NCT00351819|515464584|FG000|Overall Study|Enrolled in another trial|0|||
142980696|NCT00351819|515464585|FG001|Overall Study|Enrolled in another trial|1|||
142980697|NCT00249795|515464586|FG000|Overall Study|Not treated|16|||
142980698|NCT00249795|515464587|FG001|Overall Study|Not treated|14|||
142980699|NCT00249795|515464586|FG000|Overall Study|Symptomatic hypotension|127|||
142980700|NCT00249795|515464587|FG001|Overall Study|Symptomatic hypotension|64|||
142980701|NCT00249795|515464586|FG000|Overall Study|Other Serious Adverse Event|84|||
142980702|NCT00249795|515464587|FG001|Overall Study|Other Serious Adverse Event|93|||
142980703|NCT00249795|515464586|FG000|Overall Study|Qualifying condition not present|26|||
142980704|NCT00249795|515464587|FG001|Overall Study|Qualifying condition not present|29|||
142980705|NCT00249795|515464586|FG000|Overall Study|Withdrawal by Subject|678|||
142980706|NCT00249795|515464587|FG001|Overall Study|Withdrawal by Subject|742|||
142980707|NCT00249795|515464586|FG000|Overall Study|Thromboembolic / outcome event|39|||
142980708|NCT00249795|515464587|FG001|Overall Study|Thromboembolic / outcome event|45|||
142980709|NCT00249795|515464586|FG000|Overall Study|Oral anticoagulant required|2|||
142980710|NCT00249795|515464587|FG001|Overall Study|Oral anticoagulant required|0|||
142980711|NCT00249795|515464586|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
142980712|NCT00249795|515464587|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
142980713|NCT00249795|515464586|FG000|Overall Study|Non-compliance|71|||
142980714|NCT00249795|515464587|FG001|Overall Study|Non-compliance|69|||
142980715|NCT00249795|515464586|FG000|Overall Study|Study drug intolerance|3|||
142980716|NCT00249795|515464587|FG001|Overall Study|Study drug intolerance|3|||
142980717|NCT00249795|515464586|FG000|Overall Study|Other adverse events (non-serious)|188|||
142980718|NCT00249795|515464587|FG001|Overall Study|Other adverse events (non-serious)|159|||
142980719|NCT00249795|515464586|FG000|Overall Study|Physician withdrew consent|71|||
142980720|NCT00249795|515464587|FG001|Overall Study|Physician withdrew consent|63|||
142980721|NCT00249795|515464586|FG000|Overall Study|Surgery / procedure|4|||
142980722|NCT00249795|515464587|FG001|Overall Study|Surgery / procedure|5|||
142980723|NCT00249795|515464586|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
142980724|NCT00249795|515464587|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
142980725|NCT00249795|515464586|FG000|Overall Study|Lightheadedness / dizziness|15|||
142980726|NCT00249795|515464587|FG001|Overall Study|Lightheadedness / dizziness|11|||
142980727|NCT00249795|515464586|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
142980728|NCT00249795|515464587|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
142980729|NCT00249795|515464586|FG000|Overall Study|Other contraindicated medication|1|||
142980730|NCT00249795|515464587|FG001|Overall Study|Other contraindicated medication|1|||
142980731|NCT00249795|515464586|FG000|Overall Study|Event related to cardiac condition|17|||
142980732|NCT00249795|515464587|FG001|Overall Study|Event related to cardiac condition|16|||
142980733|NCT00249795|515464586|FG000|Overall Study|Patient not wish to continue after May08|4|||
142980734|NCT00249795|515464587|FG001|Overall Study|Patient not wish to continue after May08|6|||
142980735|NCT00249795|515464586|FG000|Overall Study|Site not agree to continue after May08|1|||
142980736|NCT00249795|515464587|FG001|Overall Study|Site not agree to continue after May08|1|||
142980737|NCT00249795|515464586|FG000|Overall Study|Lost to Follow-up|0|||
142980738|NCT00249795|515464587|FG001|Overall Study|Lost to Follow-up|2|||
142980739|NCT00249795|515464586|FG000|Overall Study|Missing|0|||
142980740|NCT00249795|515464587|FG001|Overall Study|Missing|1|||
142980741|NCT01142193|515464590|FG000|Overall Study|Adverse Event|12|||
142980742|NCT01142193|515464591|FG001|Overall Study|Adverse Event|4|||
142980743|NCT01142193|515464590|FG000|Overall Study|Lack of Efficacy|2|||
142980744|NCT01142193|515464591|FG001|Overall Study|Lack of Efficacy|1|||
142980745|NCT01142193|515464590|FG000|Overall Study|Physician Decision|1|||
142980746|NCT01142193|515464591|FG001|Overall Study|Physician Decision|1|||
142980747|NCT01142193|515464590|FG000|Overall Study|Withdrawal by Subject|4|||
142980748|NCT01142193|515464591|FG001|Overall Study|Withdrawal by Subject|3|||
142980749|NCT01142193|515464590|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
142980750|NCT01142193|515464591|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
142980751|NCT01142193|515464590|FG000|Overall Study|Other|1|||
142980752|NCT01142193|515464591|FG001|Overall Study|Other|2|||
142980753|NCT01425749|515464594|FG000|Overall Study|progression of melanoma|0|||
142980754|NCT01425749|515464595|FG001|Overall Study|progression of melanoma|1|||
142980755|NCT02910219|515464596|FG000|Overall Study|Withdrawal by Subject|1|||
142980756|NCT02910219|515464597|FG001|Overall Study|Withdrawal by Subject|1|||
142980757|NCT02096042|515464598|FG000|Overall Study|Disease Progression|1|||
142980758|NCT02096042|515464599|FG001|Overall Study|Disease Progression|0|||
142980759|NCT02096042|515464600|FG002|Overall Study|Disease Progression|0|||
142980760|NCT00701441|515464603|FG000|Overall Study|failure in cpap compliance|0|||
142980761|NCT00701441|515464604|FG001|Overall Study|failure in cpap compliance|4|||
142980762|NCT00795509|515464610|FG000|Overall Study|Protocol Violation|31|||
142980763|NCT01079195|515464611|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
142980764|NCT01079195|515464611|FG000|Overall Study|No Documentation Available|437|||
142980765|NCT01079195|515464611|FG000|Overall Study|Adverse Event|157|||
142980766|NCT01079195|515464611|FG000|Overall Study|Reason Unknown|39|||
142980767|NCT01079195|515464611|FG000|Overall Study|Withdrawal by Subject|18|||
142980768|NCT01079195|515464611|FG000|Overall Study|Financial Reasons|15|||
142980769|NCT01079195|515464611|FG000|Overall Study|Lack of Effectiveness|12|||
142980770|NCT01079195|515464611|FG000|Overall Study|Physician Decision|4|||
142980771|NCT01079195|515464611|FG000|Overall Study|Improved Status of Participant|4|||
142980772|NCT01079195|515464611|FG000|Overall Study|No Follow-up Documentation Available|4|||
142980773|NCT01079195|515464611|FG000|Overall Study|Non-compliance|2|||
142980774|NCT03693404|515464614|FG000|Overall Study|Withdrawal by Subject|1|||
142980775|NCT03693404|515464615|FG001|Overall Study|Withdrawal by Subject|0|||
142980776|NCT03693404|515464614|FG000|Overall Study|Lost to Follow-up|0|||
142980777|NCT03693404|515464615|FG001|Overall Study|Lost to Follow-up|5|||
142980778|NCT03693404|515464614|FG000|Overall Study|Excluded from Analysis|0|||
142980779|NCT03693404|515464615|FG001|Overall Study|Excluded from Analysis|1|||
142980780|NCT00892957|515464617|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
142980781|NCT00892957|515464618|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
142980782|NCT00892957|515464617|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
142980783|NCT00892957|515464618|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
142980784|NCT00642018|515464624|FG000|Overall Study|Adverse Event|11|||
142980785|NCT00642018|515464625|FG001|Overall Study|Adverse Event|36|||
142980786|NCT00642018|515464624|FG000|Overall Study|Withdrawal by Subject|4|||
142980787|NCT00642018|515464625|FG001|Overall Study|Withdrawal by Subject|10|||
142980788|NCT00642018|515464624|FG000|Overall Study|Progressive Disease|13|||
142980789|NCT00642018|515464625|FG001|Overall Study|Progressive Disease|18|||
142980790|NCT00642018|515464624|FG000|Overall Study|Physician Decision|0|||
142980791|NCT00642018|515464625|FG001|Overall Study|Physician Decision|10|||
142980792|NCT00642018|515464624|FG000|Overall Study|Protocol Violation|0|||
142980793|NCT00642018|515464625|FG001|Overall Study|Protocol Violation|1|||
142980794|NCT00642018|515464624|FG000|Overall Study|Death|0|||
142980795|NCT00642018|515464625|FG001|Overall Study|Death|3|||
142980796|NCT00642018|515464624|FG000|Overall Study|Entry Criteria Not Met|0|||
142980797|NCT00642018|515464625|FG001|Overall Study|Entry Criteria Not Met|1|||
142980798|NCT00131664|515464626|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
142980799|NCT00131664|515464627|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
142980800|NCT00131664|515464628|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
142980801|NCT00131664|515464629|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
142980802|NCT00131664|515464630|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
142980803|NCT00131664|515464631|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
142980804|NCT00131664|515464626|FG000|First Period (First 6 Months)|Death|0|||
142980805|NCT00131664|515464627|FG001|First Period (First 6 Months)|Death|1|||
142980806|NCT00131664|515464628|FG002|First Period (First 6 Months)|Death|0|||
142980807|NCT00131664|515464629|FG003|First Period (First 6 Months)|Death|0|||
142980808|NCT00131664|515464630|FG004|First Period (First 6 Months)|Death|0|||
142980809|NCT00131664|515464631|FG005|First Period (First 6 Months)|Death|0|||
142980810|NCT00131664|515464626|FG000|First Period (First 6 Months)|Protocol Violation|2|||
142980811|NCT00131664|515464627|FG001|First Period (First 6 Months)|Protocol Violation|2|||
142980812|NCT00131664|515464628|FG002|First Period (First 6 Months)|Protocol Violation|1|||
142980813|NCT00131664|515464629|FG003|First Period (First 6 Months)|Protocol Violation|0|||
142980814|NCT00131664|515464630|FG004|First Period (First 6 Months)|Protocol Violation|0|||
142980815|NCT00131664|515464631|FG005|First Period (First 6 Months)|Protocol Violation|0|||
142980816|NCT00131664|515464626|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
142980817|NCT00131664|515464627|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
142980818|NCT00131664|515464628|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
142980819|NCT00131664|515464629|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
142980820|NCT00131664|515464630|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
142980821|NCT00131664|515464631|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
142980822|NCT00131664|515464626|FG000|First Period (First 6 Months)|Adverse Event|9|||
142980823|NCT00131664|515464627|FG001|First Period (First 6 Months)|Adverse Event|4|||
142980824|NCT00131664|515464628|FG002|First Period (First 6 Months)|Adverse Event|5|||
142980825|NCT00131664|515464629|FG003|First Period (First 6 Months)|Adverse Event|0|||
142980826|NCT00131664|515464630|FG004|First Period (First 6 Months)|Adverse Event|0|||
142980827|NCT00131664|515464631|FG005|First Period (First 6 Months)|Adverse Event|0|||
142980828|NCT00131664|515464626|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
142980829|NCT00131664|515464627|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
142980830|NCT00131664|515464628|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
142980831|NCT00131664|515464629|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
142980832|NCT00131664|515464630|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
142980833|NCT00131664|515464631|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
142980834|NCT00131664|515464626|FG000|First Period (First 6 Months)|Administrative reasons|2|||
142980835|NCT00131664|515464627|FG001|First Period (First 6 Months)|Administrative reasons|0|||
142980836|NCT00131664|515464628|FG002|First Period (First 6 Months)|Administrative reasons|5|||
142980837|NCT00131664|515464629|FG003|First Period (First 6 Months)|Administrative reasons|0|||
142980838|NCT00131664|515464630|FG004|First Period (First 6 Months)|Administrative reasons|0|||
142980839|NCT00131664|515464631|FG005|First Period (First 6 Months)|Administrative reasons|0|||
142980840|NCT00131664|515464626|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
142980841|NCT00131664|515464627|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
142980842|NCT00131664|515464628|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
142980843|NCT00131664|515464629|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
142980844|NCT00131664|515464630|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
142980845|NCT00131664|515464631|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
142980846|NCT00131664|515464626|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
142980847|NCT00131664|515464627|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
142980848|NCT00131664|515464628|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
142980849|NCT00131664|515464629|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
142980850|NCT00131664|515464630|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
142980851|NCT00131664|515464631|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
142980852|NCT00131664|515464626|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
142980853|NCT00131664|515464627|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
142980854|NCT00131664|515464628|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
142980855|NCT00131664|515464629|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
142980856|NCT00131664|515464630|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
142980857|NCT00131664|515464631|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
142980858|NCT00131664|515464626|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
142980859|NCT00131664|515464627|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
142980860|NCT00131664|515464628|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
142980861|NCT00131664|515464629|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
142980862|NCT00131664|515464630|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
142980863|NCT00131664|515464631|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
142980864|NCT00131664|515464626|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
142980865|NCT00131664|515464627|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
142980866|NCT00131664|515464628|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
142980867|NCT00131664|515464629|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
142980868|NCT00131664|515464630|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
142980869|NCT00131664|515464631|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
142980870|NCT00131664|515464626|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
142980871|NCT00131664|515464627|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
142980872|NCT00131664|515464628|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
142980873|NCT00131664|515464629|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
142980874|NCT00131664|515464630|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
142980875|NCT00131664|515464631|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
142980876|NCT01946412|515464632|FG000|Overall Study|Adverse Event|1|||
142980877|NCT01946412|515464632|FG000|Overall Study|Non-Compliance|1|||
142980878|NCT01946412|515464632|FG000|Overall Study|Continued with commercial Kalydeco|2|||
142980879|NCT01946412|515464632|FG000|Overall Study|Difficulty in swallowing|1|||
142980880|NCT00323310|515467218|FG000|Overall Study|Withdrawal by Subject|1|||
142980881|NCT00323310|515467218|FG000|Overall Study|a parent refused blood draw|1|||
142980882|NCT00323310|515467218|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
142980883|NCT00446641|515467219|FG000|Overall Study|Withdrawal by Subject|8|||
142980884|NCT00446641|515467220|FG001|Overall Study|Withdrawal by Subject|3|||
142980885|NCT00446641|515467219|FG000|Overall Study|poor compliance|8|||
142980886|NCT00446641|515467220|FG001|Overall Study|poor compliance|6|||
142980887|NCT00446641|515467219|FG000|Overall Study|Lost to Follow-up|1|||
142980888|NCT00446641|515467220|FG001|Overall Study|Lost to Follow-up|1|||
142980889|NCT03565991|515467222|FG000|Overall Study|Other|11|||
142980890|NCT03565991|515467223|FG001|Overall Study|Other|0|||
142980891|NCT03565991|515467222|FG000|Overall Study|Global deterioration of health status|14|||
142980892|NCT03565991|515467223|FG001|Overall Study|Global deterioration of health status|4|||
142980893|NCT03565991|515467222|FG000|Overall Study|Withdrawal by Subject|2|||
143003168|NCT01049360|515548760|FG016|Period 2|Withdrawal by Subject|0|||
142980894|NCT03565991|515467223|FG001|Overall Study|Withdrawal by Subject|6|||
142980895|NCT03565991|515467222|FG000|Overall Study|Progressive disease|121|||
142980896|NCT03565991|515467223|FG001|Overall Study|Progressive disease|29|||
142980897|NCT03565991|515467222|FG000|Overall Study|Death|3|||
142980898|NCT03565991|515467223|FG001|Overall Study|Death|0|||
142980899|NCT03565991|515467222|FG000|Overall Study|Adverse Event|7|||
142980900|NCT03565991|515467223|FG001|Overall Study|Adverse Event|2|||
142980901|NCT01826448|515467224|FG000|Overall Study|Adverse Event|1|||
142980902|NCT01826448|515467225|FG001|Overall Study|Adverse Event|3|||
142980903|NCT01826448|515467224|FG000|Overall Study|Disease progression|2|||
142980904|NCT01826448|515467225|FG001|Overall Study|Disease progression|4|||
142980905|NCT01826448|515467224|FG000|Overall Study|Withdrawal by Subject|1|||
142980906|NCT01826448|515467225|FG001|Overall Study|Withdrawal by Subject|0|||
142980907|NCT01826448|515467224|FG000|Overall Study|Physician Decision|0|||
142980908|NCT01826448|515467225|FG001|Overall Study|Physician Decision|1|||
142980909|NCT01826448|515467224|FG000|Overall Study|2 active cancers|0|||
142980910|NCT01826448|515467225|FG001|Overall Study|2 active cancers|1|||
142980911|NCT00880100|515467226|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
142980912|NCT00880100|515467226|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
142980913|NCT00880100|515467226|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
142980914|NCT02971007|515467230|FG000|Overall Study|Adverse Event|1|||
142980915|NCT02971007|515467231|FG001|Overall Study|Adverse Event|0|||
142980916|NCT02971007|515467232|FG002|Overall Study|Adverse Event|0|||
142980917|NCT02971007|515467230|FG000|Overall Study|Lost to Follow-up|0|||
142980918|NCT02971007|515467231|FG001|Overall Study|Lost to Follow-up|1|||
142980919|NCT02971007|515467232|FG002|Overall Study|Lost to Follow-up|1|||
142980920|NCT02971007|515467230|FG000|Overall Study|Withdrawal by Subject|0|||
142980921|NCT02971007|515467231|FG001|Overall Study|Withdrawal by Subject|1|||
142980922|NCT02971007|515467232|FG002|Overall Study|Withdrawal by Subject|0|||
142980923|NCT02971007|515467230|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
142980924|NCT02971007|515467231|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
142980925|NCT02971007|515467232|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
142980926|NCT02971007|515467230|FG000|Overall Study|Patient discontinued study drug|0|||
142980927|NCT02971007|515467231|FG001|Overall Study|Patient discontinued study drug|1|||
142980928|NCT02971007|515467232|FG002|Overall Study|Patient discontinued study drug|0|||
142980929|NCT00784459|515467237|FG000|Overall Study|Adverse Event|0|||
142980930|NCT00784459|515467238|FG001|Overall Study|Adverse Event|2|||
142980931|NCT02431702|515467239|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
142980932|NCT02431702|515467240|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
142980933|NCT02431702|515467241|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
142980934|NCT02431702|515467242|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
142980935|NCT02431702|515467243|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
142980936|NCT02431702|515467244|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
142980937|NCT02431702|515467245|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
142980938|NCT02431702|515467239|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
142980939|NCT02431702|515467240|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
142980940|NCT02431702|515467241|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
142980941|NCT02431702|515467242|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
142980942|NCT02431702|515467243|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
142980943|NCT02431702|515467244|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
142980944|NCT02431702|515467245|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
142980945|NCT02431702|515467239|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
142980946|NCT02431702|515467240|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
142980947|NCT02431702|515467241|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
142980948|NCT02431702|515467242|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
142980949|NCT02431702|515467243|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
142980950|NCT02431702|515467244|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
142980951|NCT02431702|515467245|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
142980952|NCT02431702|515467239|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
142980953|NCT02431702|515467240|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
142980954|NCT02431702|515467241|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
142980955|NCT02431702|515467242|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
142980956|NCT02431702|515467243|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
142980957|NCT02431702|515467244|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
142980958|NCT02431702|515467245|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
142980959|NCT02431702|515467239|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
142980960|NCT02431702|515467240|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
142980961|NCT02431702|515467241|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
142980962|NCT02431702|515467242|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
142980963|NCT02431702|515467243|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
142980964|NCT02431702|515467244|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
143003169|NCT01049360|515548761|FG017|Period 2|Withdrawal by Subject|0|||
142980965|NCT02431702|515467245|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
142980966|NCT02431702|515467239|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
142980967|NCT02431702|515467240|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
142980968|NCT02431702|515467241|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
142980969|NCT02431702|515467242|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
142980970|NCT02431702|515467243|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
142980971|NCT02431702|515467244|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
142980972|NCT02431702|515467245|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
142980973|NCT02431702|515467239|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
142980974|NCT02431702|515467240|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
142980975|NCT02431702|515467241|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
142980976|NCT02431702|515467242|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
142980977|NCT02431702|515467243|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
142980978|NCT02431702|515467244|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
142980979|NCT02431702|515467245|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
142980980|NCT02431702|515467239|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
142980981|NCT02431702|515467240|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
142980982|NCT02431702|515467241|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
142980983|NCT02431702|515467242|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
142980984|NCT02431702|515467243|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
142980985|NCT02431702|515467244|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
142980986|NCT02431702|515467245|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
142980987|NCT02431702|515467239|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
142980988|NCT02431702|515467240|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
142980989|NCT02431702|515467241|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
142980990|NCT02431702|515467242|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
142980991|NCT02431702|515467243|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
142980992|NCT02431702|515467244|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
142980993|NCT02431702|515467245|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
142980994|NCT02431702|515467239|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
142980995|NCT02431702|515467240|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
142980996|NCT02431702|515467241|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
142980997|NCT02431702|515467242|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
142980998|NCT02431702|515467243|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
142980999|NCT02431702|515467244|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
142981000|NCT02431702|515467245|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
142981001|NCT02431702|515467239|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
142981002|NCT02431702|515467240|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
142981003|NCT02431702|515467241|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
142981004|NCT02431702|515467242|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
142981005|NCT02431702|515467243|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
142981006|NCT02431702|515467244|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
142981007|NCT02431702|515467245|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
142981008|NCT02431702|515467239|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
142981009|NCT02431702|515467240|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
142981010|NCT02431702|515467241|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
142981011|NCT02431702|515467242|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
142981012|NCT02431702|515467243|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
142981013|NCT02431702|515467244|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
142981014|NCT02431702|515467245|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
142981015|NCT02431702|515467239|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
142981016|NCT02431702|515467240|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
142981017|NCT02431702|515467241|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
142981018|NCT02431702|515467242|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
142981019|NCT02431702|515467243|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
142981020|NCT02431702|515467244|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
142981021|NCT02431702|515467245|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
142981022|NCT02431702|515467239|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
142981023|NCT02431702|515467240|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
142981024|NCT02431702|515467241|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
142981025|NCT02431702|515467242|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
142981026|NCT02431702|515467243|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
142981027|NCT02431702|515467244|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
142981028|NCT02431702|515467245|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
142981029|NCT02431702|515467239|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
142981030|NCT02431702|515467240|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
142981031|NCT02431702|515467241|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
142981032|NCT02431702|515467242|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
142981033|NCT02431702|515467243|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
142981034|NCT02431702|515467244|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
142981035|NCT02431702|515467245|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
142981036|NCT02471586|515467254|FG000|Overall Study|Lost to Follow-up|3|||
142981037|NCT02471586|515467255|FG001|Overall Study|Lost to Follow-up|8|||
142981038|NCT02471586|515467256|FG002|Overall Study|Lost to Follow-up|4|||
142981039|NCT02471586|515467254|FG000|Overall Study|Death|2|||
142981040|NCT02471586|515467255|FG001|Overall Study|Death|2|||
142981041|NCT02471586|515467256|FG002|Overall Study|Death|0|||
142981042|NCT04839393|515467266|FG000|Overall Study|Adverse Event|0|||
142981043|NCT04839393|515467267|FG001|Overall Study|Adverse Event|0|||
142981044|NCT04839393|515467268|FG002|Overall Study|Adverse Event|2|||
142981045|NCT04839393|515467266|FG000|Overall Study|Withdrawal by participant|0|||
142981046|NCT04839393|515467267|FG001|Overall Study|Withdrawal by participant|0|||
142981047|NCT04839393|515467268|FG002|Overall Study|Withdrawal by participant|1|||
142981048|NCT00254163|515467275|FG000|Overall Study|Adverse Event|29|||
142981049|NCT00254163|515467276|FG001|Overall Study|Adverse Event|26|||
142981050|NCT00254163|515467275|FG000|Overall Study|Patient request/withdrew consent|6|||
142981051|NCT00254163|515467276|FG001|Overall Study|Patient request/withdrew consent|4|||
142981052|NCT00254163|515467275|FG000|Overall Study|Investigator request|1|||
142981053|NCT00254163|515467276|FG001|Overall Study|Investigator request|3|||
142981054|NCT00254163|515467275|FG000|Overall Study|Failed entry|1|||
142981055|NCT00254163|515467276|FG001|Overall Study|Failed entry|3|||
142981056|NCT00254163|515467275|FG000|Overall Study|Progressive disease|0|||
142981057|NCT00254163|515467276|FG001|Overall Study|Progressive disease|1|||
142981058|NCT00254163|515467275|FG000|Overall Study|Death|0|||
142981059|NCT00254163|515467276|FG001|Overall Study|Death|1|||
142981060|NCT00254163|515467275|FG000|Overall Study|Other|8|||
142981061|NCT00254163|515467276|FG001|Overall Study|Other|8|||
142981062|NCT00633893|515467277|FG000|Overall Study|Death|1|||
142981063|NCT00633893|515467278|FG001|Overall Study|Death|3|||
142981064|NCT00633893|515467279|FG002|Overall Study|Death|9|||
142981065|NCT00633893|515467277|FG000|Overall Study|Adverse Event|65|||
142981066|NCT00633893|515467278|FG001|Overall Study|Adverse Event|58|||
142981067|NCT00633893|515467279|FG002|Overall Study|Adverse Event|126|||
142981068|NCT00633893|515467277|FG000|Overall Study|Withdrawal by Subject|7|||
142981069|NCT00633893|515467278|FG001|Overall Study|Withdrawal by Subject|12|||
142981070|NCT00633893|515467279|FG002|Overall Study|Withdrawal by Subject|6|||
142981071|NCT00633893|515467277|FG000|Overall Study|Lost to Follow-up|2|||
142981072|NCT00633893|515467278|FG001|Overall Study|Lost to Follow-up|4|||
142981073|NCT00633893|515467279|FG002|Overall Study|Lost to Follow-up|8|||
142981074|NCT00633893|515467277|FG000|Overall Study|Poor/non-compliance|5|||
142981075|NCT00633893|515467278|FG001|Overall Study|Poor/non-compliance|12|||
142981076|NCT00633893|515467279|FG002|Overall Study|Poor/non-compliance|3|||
142981077|NCT00633893|515467277|FG000|Overall Study|Pregnancy|2|||
142981078|NCT00633893|515467278|FG001|Overall Study|Pregnancy|1|||
142981079|NCT00633893|515467279|FG002|Overall Study|Pregnancy|1|||
142981080|NCT00633893|515467277|FG000|Overall Study|Not meet/no longer meets criteria|4|||
142981081|NCT00633893|515467278|FG001|Overall Study|Not meet/no longer meets criteria|6|||
142981082|NCT00633893|515467279|FG002|Overall Study|Not meet/no longer meets criteria|4|||
142981083|NCT00633893|515467277|FG000|Overall Study|Other|28|||
142981084|NCT00633893|515467278|FG001|Overall Study|Other|33|||
142981085|NCT00633893|515467279|FG002|Overall Study|Other|31|||
142981086|NCT03551626|515467286|FG000|Overall Study|Adverse Event|88|||
142981087|NCT03551626|515467286|FG000|Overall Study|Disease relapse|18|||
142981088|NCT03551626|515467286|FG000|Overall Study|Withdrawal of informed consent|6|||
142981089|NCT03551626|515467286|FG000|Overall Study|Patient decision|5|||
142981090|NCT03551626|515467286|FG000|Overall Study|Physician Decision|4|||
142981091|NCT03551626|515467286|FG000|Overall Study|Lost to Follow-up|3|||
142981092|NCT03551626|515467286|FG000|Overall Study|Pregnancy|1|||
142981093|NCT03551626|515467286|FG000|Overall Study|Protocol deviation|1|||
142981094|NCT03551626|515467286|FG000|Overall Study|Technical problems|1|||
142981095|NCT00653328|515467287|FG000|Overall Study|Withdrawal by Subject|1|||
142981096|NCT00653328|515467287|FG000|Overall Study|Adverse Event|2|||
142981097|NCT00653328|515467287|FG000|Overall Study|Disease progression|10|||
142981098|NCT00653328|515467287|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
142981099|NCT02911519|515467288|FG000|Overall Study|Lost to Follow-up|2|||
142981100|NCT02911519|515467289|FG001|Overall Study|Lost to Follow-up|2|||
142981101|NCT02911519|515467288|FG000|Overall Study|Death|0|||
142981102|NCT02911519|515467289|FG001|Overall Study|Death|2|||
142981103|NCT01017549|515467298|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
142981104|NCT01017549|515467298|FG000|One-year Follow-up|Lost to Follow-up|2|||
142981105|NCT01017549|515467298|FG000|One-year Follow-up|Withdrawal by Subject|5|||
142981106|NCT01017549|515467298|FG000|5 Year Follow-up|Lost to Follow-up|9|||
142981107|NCT01017549|515467298|FG000|5 Year Follow-up|Mastectomy|3|||
142981108|NCT01444898|515467306|FG000|Overall Study|Withdrawal by Subject|1|||
142981109|NCT03235726|515467307|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
142981110|NCT03235726|515467308|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
142981111|NCT03235726|515467309|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
142981112|NCT03235726|515467310|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
142981113|NCT03235726|515467311|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
142981114|NCT03235726|515467312|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
142981115|NCT03235726|515467313|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
142981116|NCT03235726|515467314|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
142981117|NCT03235726|515467315|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
142981118|NCT03235726|515467316|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
142981119|NCT03235726|515467307|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
142981120|NCT03235726|515467308|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
142981121|NCT03235726|515467309|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
142981122|NCT03235726|515467310|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
142981123|NCT03235726|515467311|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
142981124|NCT03235726|515467312|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
142981125|NCT03235726|515467313|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
142981126|NCT03235726|515467314|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
142981127|NCT03235726|515467315|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
142981128|NCT03235726|515467316|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
142981129|NCT00443846|515467317|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
142981130|NCT00443846|515467318|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
142981131|NCT00443846|515467317|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
142981132|NCT00443846|515467318|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
142981133|NCT00443846|515467317|FG000|Overall Study|Adverse Event|0|||
142981134|NCT00443846|515467318|FG001|Overall Study|Adverse Event|1|||
142981135|NCT00443846|515467317|FG000|Overall Study|Personal reason|8|||
142981136|NCT00443846|515467318|FG001|Overall Study|Personal reason|3|||
142981137|NCT00443846|515467317|FG000|Overall Study|Lost to Follow-up|1|||
142981138|NCT00443846|515467318|FG001|Overall Study|Lost to Follow-up|2|||
142981139|NCT00391807|515467325|FG000|Overall Study|Did not receive study medication|23|||
142981140|NCT00391807|515467325|FG000|Overall Study|Adverse Event|177|||
142981141|NCT00391807|515467325|FG000|Overall Study|Pregnancy|25|||
142981142|NCT00391807|515467325|FG000|Overall Study|Lost to Follow-up|227|||
142981143|NCT00391807|515467325|FG000|Overall Study|Withdrawal by Subject|147|||
142981144|NCT00391807|515467325|FG000|Overall Study|Protocol Violation|20|||
142981145|NCT00391807|515467325|FG000|Overall Study|Various|96|||
142981146|NCT00282568|515467334|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
142981147|NCT00282568|515467334|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
142981148|NCT00282568|515467334|FG000|Extended Treatment Period|Adverse Event|17|||
142981149|NCT00282568|515467334|FG000|Extended Treatment Period|Non-compliance|4|||
142981150|NCT00282568|515467334|FG000|Extended Treatment Period|Physician Decision|1|||
142981151|NCT00282568|515467334|FG000|Extended Treatment Period|Lost to Follow-up|2|||
142981152|NCT00990249|515467339|FG000|Overall Study|Disease Progression|8|||
142981153|NCT00990249|515467339|FG000|Overall Study|Non-Compliance|1|||
142981154|NCT00990249|515467339|FG000|Overall Study|Death|2|||
142981155|NCT00990249|515467339|FG000|Overall Study|Not treated|2|||
142981156|NCT00415584|515467340|FG000|Overall Study|Withdrawal by Subject|1|||
142981157|NCT01831804|515467341|FG000|Overall Study|Adverse Event|0|||
142981158|NCT01831804|515467342|FG001|Overall Study|Adverse Event|0|||
142981159|NCT01831804|515467343|FG002|Overall Study|Adverse Event|0|||
142981160|NCT01831804|515467344|FG003|Overall Study|Adverse Event|0|||
142981161|NCT01831804|515467345|FG004|Overall Study|Adverse Event|0|||
142981162|NCT01831804|515467346|FG005|Overall Study|Adverse Event|0|||
142981163|NCT01831804|515467347|FG006|Overall Study|Adverse Event|1|||
142981164|NCT01831804|515467348|FG007|Overall Study|Adverse Event|0|||
142981165|NCT01831804|515467349|FG008|Overall Study|Adverse Event|1|||
142981166|NCT01831804|515467341|FG000|Overall Study|Protocol Violation|0|||
142981167|NCT01831804|515467342|FG001|Overall Study|Protocol Violation|0|||
142981168|NCT01831804|515467343|FG002|Overall Study|Protocol Violation|2|||
142981169|NCT01831804|515467344|FG003|Overall Study|Protocol Violation|0|||
142981170|NCT01831804|515467345|FG004|Overall Study|Protocol Violation|0|||
142981171|NCT01831804|515467346|FG005|Overall Study|Protocol Violation|0|||
142981172|NCT01831804|515467347|FG006|Overall Study|Protocol Violation|0|||
142981173|NCT01831804|515467348|FG007|Overall Study|Protocol Violation|0|||
142981174|NCT01831804|515467349|FG008|Overall Study|Protocol Violation|0|||
142981175|NCT01831804|515467341|FG000|Overall Study|Protocol defined stopping criteria|1|||
142981176|NCT01831804|515467342|FG001|Overall Study|Protocol defined stopping criteria|1|||
142981177|NCT01831804|515467343|FG002|Overall Study|Protocol defined stopping criteria|3|||
142981178|NCT01831804|515467344|FG003|Overall Study|Protocol defined stopping criteria|0|||
142981179|NCT01831804|515467345|FG004|Overall Study|Protocol defined stopping criteria|1|||
142981180|NCT01831804|515467346|FG005|Overall Study|Protocol defined stopping criteria|0|||
142981181|NCT01831804|515467347|FG006|Overall Study|Protocol defined stopping criteria|0|||
142981182|NCT01831804|515467348|FG007|Overall Study|Protocol defined stopping criteria|0|||
142981183|NCT01831804|515467349|FG008|Overall Study|Protocol defined stopping criteria|0|||
142981184|NCT01831804|515467341|FG000|Overall Study|Lost to Follow-up|0|||
142981185|NCT01831804|515467342|FG001|Overall Study|Lost to Follow-up|0|||
142981186|NCT01831804|515467343|FG002|Overall Study|Lost to Follow-up|1|||
142981187|NCT01831804|515467344|FG003|Overall Study|Lost to Follow-up|0|||
142981188|NCT01831804|515467345|FG004|Overall Study|Lost to Follow-up|0|||
142981189|NCT01831804|515467346|FG005|Overall Study|Lost to Follow-up|0|||
142981190|NCT01831804|515467347|FG006|Overall Study|Lost to Follow-up|0|||
142981191|NCT01831804|515467348|FG007|Overall Study|Lost to Follow-up|0|||
142981192|NCT01831804|515467349|FG008|Overall Study|Lost to Follow-up|1|||
142981193|NCT01831804|515467341|FG000|Overall Study|Investigator discretion|0|||
142981194|NCT01831804|515467342|FG001|Overall Study|Investigator discretion|0|||
142981195|NCT01831804|515467343|FG002|Overall Study|Investigator discretion|0|||
142981196|NCT01831804|515467344|FG003|Overall Study|Investigator discretion|0|||
142981197|NCT01831804|515467345|FG004|Overall Study|Investigator discretion|1|||
142981198|NCT01831804|515467346|FG005|Overall Study|Investigator discretion|0|||
142981199|NCT01831804|515467347|FG006|Overall Study|Investigator discretion|0|||
142981200|NCT01831804|515467348|FG007|Overall Study|Investigator discretion|1|||
142981201|NCT01831804|515467349|FG008|Overall Study|Investigator discretion|0|||
142981202|NCT01831804|515467341|FG000|Overall Study|Withdrew Consent|0|||
142981203|NCT01831804|515467342|FG001|Overall Study|Withdrew Consent|1|||
142981204|NCT01831804|515467343|FG002|Overall Study|Withdrew Consent|0|||
142981205|NCT01831804|515467344|FG003|Overall Study|Withdrew Consent|0|||
142981206|NCT01831804|515467345|FG004|Overall Study|Withdrew Consent|0|||
142981207|NCT01831804|515467346|FG005|Overall Study|Withdrew Consent|0|||
142981208|NCT01831804|515467347|FG006|Overall Study|Withdrew Consent|0|||
142981209|NCT01831804|515467348|FG007|Overall Study|Withdrew Consent|2|||
142981210|NCT01831804|515467349|FG008|Overall Study|Withdrew Consent|0|||
142981211|NCT01061567|515467350|FG000|Overall Study|Adverse Event|32|||
142981212|NCT01061567|515467350|FG000|Overall Study|Death|2|||
142981213|NCT01061567|515467350|FG000|Overall Study|Lack of Efficacy|3|||
142981214|NCT01061567|515467350|FG000|Overall Study|Lost to Follow-up|24|||
142981215|NCT01061567|515467350|FG000|Overall Study|Protocol Violation|1|||
142981216|NCT01061567|515467350|FG000|Overall Study|Withdrawal by Subject|11|||
142981217|NCT01061567|515467350|FG000|Overall Study|Other reason than stated above|3|||
142981218|NCT00563368|515467351|FG000|Overall Study|Lost to Follow-up|14|||
142981219|NCT00563368|515467352|FG001|Overall Study|Lost to Follow-up|14|||
142981220|NCT00563368|515467353|FG002|Overall Study|Lost to Follow-up|12|||
142981221|NCT00563368|515467354|FG003|Overall Study|Lost to Follow-up|6|||
142981222|NCT00563368|515467355|FG004|Overall Study|Lost to Follow-up|9|||
142981223|NCT00563368|515467356|FG005|Overall Study|Lost to Follow-up|8|||
142981224|NCT00563368|515467357|FG006|Overall Study|Lost to Follow-up|9|||
142981225|NCT00563368|515467351|FG000|Overall Study|Adverse Event|3|||
142981226|NCT00563368|515467352|FG001|Overall Study|Adverse Event|4|||
142981227|NCT00563368|515467353|FG002|Overall Study|Adverse Event|5|||
142981228|NCT00563368|515467354|FG003|Overall Study|Adverse Event|9|||
142981229|NCT00563368|515467355|FG004|Overall Study|Adverse Event|6|||
142981230|NCT00563368|515467356|FG005|Overall Study|Adverse Event|10|||
142981231|NCT00563368|515467357|FG006|Overall Study|Adverse Event|17|||
142981232|NCT00563368|515467351|FG000|Overall Study|Withdrawal by Subject|11|||
142981233|NCT00563368|515467352|FG001|Overall Study|Withdrawal by Subject|6|||
142981234|NCT00563368|515467353|FG002|Overall Study|Withdrawal by Subject|5|||
142981235|NCT00563368|515467354|FG003|Overall Study|Withdrawal by Subject|7|||
142981236|NCT00563368|515467355|FG004|Overall Study|Withdrawal by Subject|8|||
142981237|NCT00563368|515467356|FG005|Overall Study|Withdrawal by Subject|5|||
142981238|NCT00563368|515467357|FG006|Overall Study|Withdrawal by Subject|4|||
142981239|NCT00563368|515467351|FG000|Overall Study|protocol non-compliance|1|||
142981240|NCT00563368|515467352|FG001|Overall Study|protocol non-compliance|1|||
142981241|NCT00563368|515467353|FG002|Overall Study|protocol non-compliance|2|||
142981242|NCT00563368|515467354|FG003|Overall Study|protocol non-compliance|1|||
142981243|NCT00563368|515467355|FG004|Overall Study|protocol non-compliance|0|||
142981244|NCT00563368|515467356|FG005|Overall Study|protocol non-compliance|1|||
142981245|NCT00563368|515467357|FG006|Overall Study|protocol non-compliance|3|||
142981246|NCT00563368|515467351|FG000|Overall Study|Pregnancy|1|||
142981247|NCT00563368|515467352|FG001|Overall Study|Pregnancy|0|||
142981248|NCT00563368|515467353|FG002|Overall Study|Pregnancy|1|||
142981249|NCT00563368|515467354|FG003|Overall Study|Pregnancy|2|||
142981250|NCT00563368|515467355|FG004|Overall Study|Pregnancy|1|||
142981251|NCT00563368|515467356|FG005|Overall Study|Pregnancy|2|||
142981252|NCT00563368|515467357|FG006|Overall Study|Pregnancy|0|||
142981253|NCT00563368|515467351|FG000|Overall Study|requirement for restricted medication|0|||
142981254|NCT00563368|515467352|FG001|Overall Study|requirement for restricted medication|0|||
142981255|NCT00563368|515467353|FG002|Overall Study|requirement for restricted medication|2|||
142981256|NCT00563368|515467354|FG003|Overall Study|requirement for restricted medication|0|||
142981257|NCT00563368|515467355|FG004|Overall Study|requirement for restricted medication|0|||
142981258|NCT00563368|515467356|FG005|Overall Study|requirement for restricted medication|0|||
142981259|NCT00563368|515467357|FG006|Overall Study|requirement for restricted medication|0|||
142981260|NCT00563368|515467351|FG000|Overall Study|Other|5|||
142981261|NCT00563368|515467352|FG001|Overall Study|Other|5|||
142981262|NCT00563368|515467353|FG002|Overall Study|Other|3|||
142981263|NCT00563368|515467354|FG003|Overall Study|Other|4|||
142981264|NCT00563368|515467355|FG004|Overall Study|Other|4|||
142981265|NCT00563368|515467356|FG005|Overall Study|Other|4|||
142981266|NCT00563368|515467357|FG006|Overall Study|Other|0|||
142981267|NCT02640755|515467358|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
142981268|NCT02640755|515467359|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
142981269|NCT02640755|515467358|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
142981270|NCT02640755|515467359|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
142981271|NCT02640755|515467358|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
142981272|NCT02640755|515467359|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
142981273|NCT00615459|515467361|FG000|Period I|Adverse Event|2|||
142981274|NCT00615459|515467362|FG001|Period I|Adverse Event|0|||
142981275|NCT00615459|515467363|FG002|Period I|Adverse Event|1|||
142981276|NCT00615459|515467364|FG003|Period I|Adverse Event|0|||
142981277|NCT00615459|515467361|FG000|Period I|Subject withdrew consent|1|||
142981278|NCT00615459|515467362|FG001|Period I|Subject withdrew consent|0|||
142981279|NCT00615459|515467363|FG002|Period I|Subject withdrew consent|0|||
142981280|NCT00615459|515467364|FG003|Period I|Subject withdrew consent|1|||
142981281|NCT00615459|515467361|FG000|Period I|Abnormal test procedure results|1|||
142981282|NCT00615459|515467362|FG001|Period I|Abnormal test procedure results|1|||
142981283|NCT00615459|515467363|FG002|Period I|Abnormal test procedure results|1|||
142981284|NCT00615459|515467364|FG003|Period I|Abnormal test procedure results|0|||
142981285|NCT00615459|515467361|FG000|Period II|Adverse Event|1|||
142981286|NCT00615459|515467362|FG001|Period II|Adverse Event|0|||
142981287|NCT00615459|515467363|FG002|Period II|Adverse Event|0|||
142981288|NCT00615459|515467364|FG003|Period II|Adverse Event|0|||
142981289|NCT00615459|515467361|FG000|Period II|Lost to Follow-up|0|||
142981290|NCT00615459|515467362|FG001|Period II|Lost to Follow-up|0|||
142981291|NCT00615459|515467363|FG002|Period II|Lost to Follow-up|0|||
142981292|NCT00615459|515467364|FG003|Period II|Lost to Follow-up|1|||
142981293|NCT00615459|515467361|FG000|Period III|Adverse Event|0|||
142981294|NCT00615459|515467362|FG001|Period III|Adverse Event|1|||
142981295|NCT00615459|515467363|FG002|Period III|Adverse Event|0|||
142981296|NCT00615459|515467364|FG003|Period III|Adverse Event|0|||
142981297|NCT00615459|515467361|FG000|Period III|Administrative problems|0|||
142981298|NCT00615459|515467362|FG001|Period III|Administrative problems|1|||
142981299|NCT00615459|515467363|FG002|Period III|Administrative problems|1|||
142981300|NCT00615459|515467364|FG003|Period III|Administrative problems|0|||
142981301|NCT00615459|515467361|FG000|Period III|Unsatisfactory therapeutic effect|0|||
142981302|NCT00615459|515467362|FG001|Period III|Unsatisfactory therapeutic effect|1|||
142981303|NCT00615459|515467363|FG002|Period III|Unsatisfactory therapeutic effect|0|||
142981304|NCT00615459|515467364|FG003|Period III|Unsatisfactory therapeutic effect|0|||
142981305|NCT00918346|515467370|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
142981306|NCT00918346|515467371|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
142981307|NCT03238352|515467372|FG000|Overall Study|Lost to Follow-up|0|||
142981308|NCT03238352|515467373|FG001|Overall Study|Lost to Follow-up|2|||
142981309|NCT03238352|515467374|FG002|Overall Study|Lost to Follow-up|1|||
142981310|NCT03238352|515467372|FG000|Overall Study|Withdrawal by Subject|0|||
142981311|NCT03238352|515467373|FG001|Overall Study|Withdrawal by Subject|1|||
142981312|NCT03238352|515467374|FG002|Overall Study|Withdrawal by Subject|0|||
142981313|NCT02810951|515467375|FG000|Overall Study|Adverse Event|1|||
142981314|NCT02807844|515467376|FG000|Overall Study|Physician Decision|0|||
142981315|NCT02807844|515467377|FG001|Overall Study|Physician Decision|0|||
142981316|NCT02807844|515467378|FG002|Overall Study|Physician Decision|0|||
142981317|NCT02807844|515467379|FG003|Overall Study|Physician Decision|0|||
142981318|NCT02807844|515467380|FG004|Overall Study|Physician Decision|0|||
142981319|NCT02807844|515467381|FG005|Overall Study|Physician Decision|0|||
142981320|NCT02807844|515467382|FG006|Overall Study|Physician Decision|3|||
142981321|NCT02807844|515467383|FG007|Overall Study|Physician Decision|0|||
142981322|NCT02807844|515467384|FG008|Overall Study|Physician Decision|1|||
142981323|NCT02807844|515467385|FG009|Overall Study|Physician Decision|2|||
142981324|NCT02807844|515467376|FG000|Overall Study|Death|0|||
142981325|NCT02807844|515467377|FG001|Overall Study|Death|0|||
142981326|NCT02807844|515467378|FG002|Overall Study|Death|2|||
142981327|NCT02807844|515467379|FG003|Overall Study|Death|4|||
142981328|NCT02807844|515467380|FG004|Overall Study|Death|1|||
142981329|NCT02807844|515467381|FG005|Overall Study|Death|2|||
142981330|NCT02807844|515467382|FG006|Overall Study|Death|1|||
142981331|NCT02807844|515467383|FG007|Overall Study|Death|2|||
142981332|NCT02807844|515467384|FG008|Overall Study|Death|0|||
142981333|NCT02807844|515467385|FG009|Overall Study|Death|1|||
142981334|NCT02807844|515467376|FG000|Overall Study|Withdrawal by Subject|0|||
142981335|NCT02807844|515467377|FG001|Overall Study|Withdrawal by Subject|0|||
142981336|NCT02807844|515467378|FG002|Overall Study|Withdrawal by Subject|2|||
142981337|NCT02807844|515467379|FG003|Overall Study|Withdrawal by Subject|1|||
142981338|NCT02807844|515467380|FG004|Overall Study|Withdrawal by Subject|1|||
142981339|NCT02807844|515467381|FG005|Overall Study|Withdrawal by Subject|0|||
142981340|NCT02807844|515467382|FG006|Overall Study|Withdrawal by Subject|1|||
142981341|NCT02807844|515467383|FG007|Overall Study|Withdrawal by Subject|0|||
142981342|NCT02807844|515467384|FG008|Overall Study|Withdrawal by Subject|0|||
142981343|NCT02807844|515467385|FG009|Overall Study|Withdrawal by Subject|0|||
142981344|NCT02807844|515467376|FG000|Overall Study|Progressive disease|5|||
142981345|NCT02807844|515467377|FG001|Overall Study|Progressive disease|12|||
142981346|NCT02807844|515467378|FG002|Overall Study|Progressive disease|8|||
142981347|NCT02807844|515467379|FG003|Overall Study|Progressive disease|8|||
142981348|NCT02807844|515467380|FG004|Overall Study|Progressive disease|3|||
142981349|NCT02807844|515467381|FG005|Overall Study|Progressive disease|8|||
142981350|NCT02807844|515467382|FG006|Overall Study|Progressive disease|14|||
142981351|NCT02807844|515467383|FG007|Overall Study|Progressive disease|17|||
142981352|NCT02807844|515467384|FG008|Overall Study|Progressive disease|19|||
142981353|NCT02807844|515467385|FG009|Overall Study|Progressive disease|15|||
142981354|NCT02807844|515467376|FG000|Overall Study|Adverse Event|1|||
142981355|NCT02807844|515467377|FG001|Overall Study|Adverse Event|0|||
142981356|NCT02807844|515467378|FG002|Overall Study|Adverse Event|0|||
142981357|NCT02807844|515467379|FG003|Overall Study|Adverse Event|0|||
142981358|NCT02807844|515467380|FG004|Overall Study|Adverse Event|1|||
142981359|NCT02807844|515467381|FG005|Overall Study|Adverse Event|1|||
142981360|NCT02807844|515467382|FG006|Overall Study|Adverse Event|1|||
142981361|NCT02807844|515467383|FG007|Overall Study|Adverse Event|1|||
142981362|NCT02807844|515467384|FG008|Overall Study|Adverse Event|1|||
142981363|NCT02807844|515467385|FG009|Overall Study|Adverse Event|2|||
142981364|NCT00709124|515467386|FG000|Overall Study|Death|3|||
142981365|NCT00709124|515467387|FG001|Overall Study|Death|1|||
142981366|NCT00709124|515467386|FG000|Overall Study|encephalopathy; can't do assessment|1|||
142981367|NCT00709124|515467387|FG001|Overall Study|encephalopathy; can't do assessment|0|||
142981368|NCT00373490|515467388|FG000|Overall Study|Adverse Event|0|||
142981369|NCT00373490|515467389|FG001|Overall Study|Adverse Event|1|||
142981370|NCT00373490|515467388|FG000|Overall Study|Lack of Efficacy|9|||
142981371|NCT00373490|515467389|FG001|Overall Study|Lack of Efficacy|4|||
142981372|NCT00373490|515467388|FG000|Overall Study|Withdrawal by Subject|0|||
142981373|NCT00373490|515467389|FG001|Overall Study|Withdrawal by Subject|1|||
142981374|NCT00753688|515467396|FG000|Overall Study|Death|102|||
142981375|NCT00753688|515467397|FG001|Overall Study|Death|203|||
142981376|NCT00753688|515467396|FG000|Overall Study|Missing|4|||
142981377|NCT00753688|515467397|FG001|Overall Study|Missing|9|||
142981378|NCT00753688|515467396|FG000|Overall Study|Participant Withdrew Consent|2|||
142981379|NCT00753688|515467397|FG001|Overall Study|Participant Withdrew Consent|2|||
142981380|NCT00753688|515467396|FG000|Overall Study|Ongoing - in Follow-up|15|||
142981381|NCT00753688|515467397|FG001|Overall Study|Ongoing - in Follow-up|31|||
142981382|NCT00753688|515467396|FG000|Overall Study|Adverse Event|0|||
142981383|NCT00753688|515467397|FG001|Overall Study|Adverse Event|1|||
142981384|NCT02999100|515467399|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
142981385|NCT02999100|515467400|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
142981386|NCT02999100|515467401|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
142981387|NCT02999100|515467402|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
142981388|NCT02999100|515467403|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
142981389|NCT02999100|515467404|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
142981390|NCT02999100|515467399|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
142981391|NCT02999100|515467400|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
142981392|NCT02999100|515467401|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
142981393|NCT02999100|515467402|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
142981394|NCT02999100|515467403|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
142981395|NCT02999100|515467404|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
142981396|NCT02999100|515467399|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
142981397|NCT02999100|515467400|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
142981398|NCT02999100|515467401|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
142981399|NCT02999100|515467402|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
142981400|NCT02999100|515467403|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
142981401|NCT02999100|515467404|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
142981402|NCT03595384|515467405|FG000|Overall Study|Other time commitments|8|||
142981403|NCT03595384|515467405|FG000|Overall Study|Changes to session time|7|||
142981404|NCT03595384|515467405|FG000|Overall Study|Relocation out of country|1|||
142981405|NCT00293241|515467406|FG000|Overall Study|Lost to Follow-up|9|||
142981406|NCT00293241|515467407|FG001|Overall Study|Lost to Follow-up|16|||
142981407|NCT00293241|515467406|FG000|Overall Study|Physician Decision|23|||
142981408|NCT00293241|515467407|FG001|Overall Study|Physician Decision|17|||
142981409|NCT00293241|515467406|FG000|Overall Study|Withdrawal by Subject|4|||
142981410|NCT00293241|515467407|FG001|Overall Study|Withdrawal by Subject|8|||
142981411|NCT01125293|515467408|FG000|Overall Study|Disease Progression|1|||
142981412|NCT01125293|515467409|FG001|Overall Study|Disease Progression|3|||
142981413|NCT01125293|515467410|FG002|Overall Study|Disease Progression|4|||
142981414|NCT01125293|515467411|FG003|Overall Study|Disease Progression|3|||
142981415|NCT01125293|515467412|FG004|Overall Study|Disease Progression|5|||
142981416|NCT01125293|515467413|FG005|Overall Study|Disease Progression|12|||
142981417|NCT01125293|515467408|FG000|Overall Study|Adverse Event|1|||
142981418|NCT01125293|515467409|FG001|Overall Study|Adverse Event|0|||
142981419|NCT01125293|515467410|FG002|Overall Study|Adverse Event|0|||
142981420|NCT01125293|515467411|FG003|Overall Study|Adverse Event|0|||
142981421|NCT01125293|515467412|FG004|Overall Study|Adverse Event|2|||
142981422|NCT01125293|515467413|FG005|Overall Study|Adverse Event|8|||
142981423|NCT01125293|515467408|FG000|Overall Study|Symptomatic Deterioration|1|||
142981424|NCT01125293|515467409|FG001|Overall Study|Symptomatic Deterioration|0|||
142981425|NCT01125293|515467410|FG002|Overall Study|Symptomatic Deterioration|0|||
142981426|NCT01125293|515467411|FG003|Overall Study|Symptomatic Deterioration|0|||
142981427|NCT01125293|515467412|FG004|Overall Study|Symptomatic Deterioration|0|||
142981428|NCT01125293|515467413|FG005|Overall Study|Symptomatic Deterioration|0|||
142981429|NCT01125293|515467408|FG000|Overall Study|Death|0|||
142981430|NCT01125293|515467409|FG001|Overall Study|Death|0|||
142981431|NCT01125293|515467410|FG002|Overall Study|Death|0|||
142981432|NCT01125293|515467411|FG003|Overall Study|Death|0|||
142981433|NCT01125293|515467412|FG004|Overall Study|Death|1|||
142981434|NCT01125293|515467413|FG005|Overall Study|Death|0|||
142981435|NCT01125293|515467408|FG000|Overall Study|Withdrawal by Subject|0|||
142981436|NCT01125293|515467409|FG001|Overall Study|Withdrawal by Subject|0|||
142981437|NCT01125293|515467410|FG002|Overall Study|Withdrawal by Subject|0|||
142981438|NCT01125293|515467411|FG003|Overall Study|Withdrawal by Subject|0|||
142981439|NCT01125293|515467412|FG004|Overall Study|Withdrawal by Subject|2|||
142981440|NCT01125293|515467413|FG005|Overall Study|Withdrawal by Subject|1|||
142981441|NCT01125293|515467408|FG000|Overall Study|Physician Decision|0|||
142981442|NCT01125293|515467409|FG001|Overall Study|Physician Decision|0|||
142981443|NCT01125293|515467410|FG002|Overall Study|Physician Decision|0|||
142981444|NCT01125293|515467411|FG003|Overall Study|Physician Decision|0|||
142981445|NCT01125293|515467412|FG004|Overall Study|Physician Decision|0|||
142981446|NCT01125293|515467413|FG005|Overall Study|Physician Decision|2|||
142981447|NCT01270958|515467415|FG000|Overall Study|Lost to Follow-up|2|||
142981448|NCT01270958|515467415|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
142981449|NCT00659126|515467416|FG000|Overall Study|Adverse Event|2|||
142981450|NCT00659126|515467417|FG001|Overall Study|Adverse Event|2|||
142981451|NCT00659126|515467416|FG000|Overall Study|Screen failure|1|||
142981452|NCT00659126|515467417|FG001|Overall Study|Screen failure|1|||
142981453|NCT00659126|515467416|FG000|Overall Study|Technical problems with MRI|0|||
142981454|NCT00659126|515467417|FG001|Overall Study|Technical problems with MRI|1|||
142981455|NCT02633046|515467421|FG000|Overall Study|Adverse Event|8|||
142981456|NCT02633046|515467421|FG000|Overall Study|Physician Decision|7|||
142981457|NCT02633046|515467421|FG000|Overall Study|Withdrawal by Subject|8|||
142981458|NCT02633046|515467421|FG000|Overall Study|Increased proteinuria|2|||
142981459|NCT02633046|515467421|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
142981460|NCT02633046|515467421|FG000|Overall Study|Mutual decision patient and physician|1|||
142981461|NCT02925312|515467422|FG000|Overall Study|Lost to Follow-up|25|||
142981462|NCT02925312|515467423|FG001|Overall Study|Lost to Follow-up|0|||
142981463|NCT02925312|515467422|FG000|Overall Study|Adverse Event|2|||
142981464|NCT02925312|515467423|FG001|Overall Study|Adverse Event|0|||
142981465|NCT02142504|515467424|FG000|Overall Study|Protocol Violation|2|||
142981466|NCT02142504|515467425|FG001|Overall Study|Protocol Violation|1|||
142981467|NCT02142504|515467426|FG002|Overall Study|Protocol Violation|2|||
142981468|NCT02142504|515467424|FG000|Overall Study|Adverse Event|2|||
142981469|NCT02142504|515467425|FG001|Overall Study|Adverse Event|3|||
142981470|NCT02142504|515467426|FG002|Overall Study|Adverse Event|4|||
142981471|NCT02142504|515467424|FG000|Overall Study|Lost to Follow-up|12|||
142981472|NCT02142504|515467425|FG001|Overall Study|Lost to Follow-up|19|||
142981473|NCT02142504|515467426|FG002|Overall Study|Lost to Follow-up|17|||
142981474|NCT02142504|515467424|FG000|Overall Study|Withdrawal by Subject|7|||
142981475|NCT02142504|515467425|FG001|Overall Study|Withdrawal by Subject|9|||
142981476|NCT02142504|515467426|FG002|Overall Study|Withdrawal by Subject|11|||
142981477|NCT02142504|515467424|FG000|Overall Study|Pregnancy|4|||
142981478|NCT02142504|515467425|FG001|Overall Study|Pregnancy|4|||
142981479|NCT02142504|515467426|FG002|Overall Study|Pregnancy|2|||
142981480|NCT02142504|515467424|FG000|Overall Study|Physician Decision|0|||
142981481|NCT02142504|515467425|FG001|Overall Study|Physician Decision|1|||
142981482|NCT02142504|515467426|FG002|Overall Study|Physician Decision|3|||
142981483|NCT02142504|515467424|FG000|Overall Study|Reason Not Specified|4|||
142981484|NCT02142504|515467425|FG001|Overall Study|Reason Not Specified|5|||
142981485|NCT02142504|515467426|FG002|Overall Study|Reason Not Specified|4|||
142981486|NCT02460978|515467429|FG000|Overall Study|Adverse Event|17|||
142981487|NCT02460978|515467430|FG001|Overall Study|Adverse Event|11|||
142981488|NCT02460978|515467431|FG002|Overall Study|Adverse Event|11|||
142981489|NCT02460978|515467429|FG000|Overall Study|Withdrawal by Subject|5|||
142981490|NCT02460978|515467430|FG001|Overall Study|Withdrawal by Subject|5|||
142981491|NCT02460978|515467431|FG002|Overall Study|Withdrawal by Subject|14|||
142981492|NCT02460978|515467429|FG000|Overall Study|Lost to Follow-up|2|||
142981493|NCT02460978|515467430|FG001|Overall Study|Lost to Follow-up|3|||
142981494|NCT02460978|515467431|FG002|Overall Study|Lost to Follow-up|1|||
142981495|NCT02460978|515467429|FG000|Overall Study|Protocol Violation|1|||
142981496|NCT02460978|515467430|FG001|Overall Study|Protocol Violation|1|||
142981497|NCT02460978|515467431|FG002|Overall Study|Protocol Violation|1|||
142981498|NCT02460978|515467429|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
142981499|NCT02460978|515467430|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
142981500|NCT02460978|515467431|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
142981501|NCT02460978|515467429|FG000|Overall Study|Pregnancy|0|||
142981502|NCT02460978|515467430|FG001|Overall Study|Pregnancy|0|||
142981503|NCT02460978|515467431|FG002|Overall Study|Pregnancy|2|||
142981504|NCT03549429|515467432|FG000|Overall Study|Protocol Violation|5|||
142981505|NCT03549429|515467433|FG001|Overall Study|Protocol Violation|3|||
142981506|NCT01225172|515467436|FG000|Overall Study|Subject decision to stop|1|||
142981507|NCT01225172|515467437|FG001|Overall Study|Subject decision to stop|0|||
142981508|NCT01225172|515467436|FG000|Overall Study|Subject request to discontinue treatment|3|||
142981509|NCT01225172|515467437|FG001|Overall Study|Subject request to discontinue treatment|1|||
142981510|NCT01225172|515467436|FG000|Overall Study|Subject no longer meets study criteria|1|||
142981511|NCT01225172|515467437|FG001|Overall Study|Subject no longer meets study criteria|0|||
142981512|NCT01225172|515467436|FG000|Overall Study|Withdrawal by Subject|1|||
142981513|NCT01225172|515467437|FG001|Overall Study|Withdrawal by Subject|0|||
142981514|NCT01203787|515467438|FG000|Overall Study|Death|12|||
142981515|NCT01203787|515467439|FG001|Overall Study|Death|10|||
142981516|NCT01203787|515467438|FG000|Overall Study|Withdrawal by Subject|6|||
142981517|NCT01203787|515467439|FG001|Overall Study|Withdrawal by Subject|2|||
142981518|NCT01203787|515467438|FG000|Overall Study|Lost to Follow-up|2|||
142981519|NCT01203787|515467439|FG001|Overall Study|Lost to Follow-up|0|||
142981520|NCT01203787|515467438|FG000|Overall Study|Adverse Event|11|||
142981521|NCT01203787|515467439|FG001|Overall Study|Adverse Event|15|||
142981522|NCT02079519|515467440|FG000|Overall Study|Disease Progression|9|||
142981523|NCT02079519|515467440|FG000|Overall Study|Adverse Event|1|||
142981524|NCT00669032|515467443|FG000|Overall Study|Lost to Follow-up|6|||
142981525|NCT00669032|515467444|FG001|Overall Study|Lost to Follow-up|5|||
142981526|NCT00669032|515467443|FG000|Overall Study|Lack of Efficacy|8|||
142981527|NCT00669032|515467444|FG001|Overall Study|Lack of Efficacy|19|||
142981528|NCT00669032|515467443|FG000|Overall Study|Withdrawal by Subject|12|||
142981529|NCT00669032|515467444|FG001|Overall Study|Withdrawal by Subject|13|||
142981530|NCT00669032|515467443|FG000|Overall Study|Adverse Event|12|||
142981531|NCT00669032|515467444|FG001|Overall Study|Adverse Event|16|||
142981532|NCT00669032|515467443|FG000|Overall Study|Physician Decision|1|||
142981533|NCT00669032|515467444|FG001|Overall Study|Physician Decision|1|||
142981534|NCT00669032|515467443|FG000|Overall Study|No fulfilment of the selection criteria|5|||
142981535|NCT00669032|515467444|FG001|Overall Study|No fulfilment of the selection criteria|5|||
142981536|NCT01607073|515467445|FG000|Overall Study|Adverse Event|1|||
142981537|NCT00086385|515469129|FG000|Overall Study|Death|2|||
142981538|NCT00086385|515469130|FG001|Overall Study|Death|2|||
142981539|NCT00086385|515469131|FG002|Overall Study|Death|1|||
142981540|NCT00086385|515469132|FG003|Overall Study|Death|1|||
142981541|NCT01376388|515469133|FG000|Overall Study|Adverse Event|13|||
142981542|NCT01376388|515469133|FG000|Overall Study|Lack of Efficacy|2|||
142981543|NCT01376388|515469133|FG000|Overall Study|Withdrawal by Subject|3|||
142981544|NCT00666536|515469134|FG000|Overall Study|Adverse Event|9|||
142981545|NCT00666536|515469135|FG001|Overall Study|Adverse Event|19|||
142981546|NCT00666536|515469134|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
142981547|NCT00666536|515469135|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
142981548|NCT00666536|515469134|FG000|Overall Study|Protocol deviation(s)|8|||
142981549|NCT00666536|515469135|FG001|Overall Study|Protocol deviation(s)|6|||
142981550|NCT00666536|515469134|FG000|Overall Study|Withdrawal by Subject|10|||
142981551|NCT00666536|515469135|FG001|Overall Study|Withdrawal by Subject|9|||
142981552|NCT00666536|515469134|FG000|Overall Study|Lost to Follow-up|4|||
142981553|NCT00666536|515469135|FG001|Overall Study|Lost to Follow-up|3|||
142981554|NCT03805971|515469136|FG000|Overall Study|Withdrawal by Subject|1|||
142981555|NCT03805971|515469136|FG000|Overall Study|Protocol Violation|2|||
142981556|NCT02741310|515469139|FG000|Overall Study|Sponsor Decision|2|||
142981557|NCT02741310|515469140|FG001|Overall Study|Sponsor Decision|2|||
142981558|NCT05091918|515469141|FG000|Overall Study|Adverse Event|1|||
142981559|NCT05091918|515469141|FG000|Overall Study|Withdrawal by Subject|81|||
142981560|NCT00369278|515469145|FG000|Overall Study|Adverse Event|14|||
142981561|NCT00369278|515469146|FG001|Overall Study|Adverse Event|11|||
142981562|NCT00369278|515469145|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
142981563|NCT00369278|515469146|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
142981564|NCT00369278|515469145|FG000|Overall Study|Protocol Violation|2|||
142981565|NCT00369278|515469146|FG001|Overall Study|Protocol Violation|1|||
142981566|NCT00369278|515469145|FG000|Overall Study|Withdrawal by Subject|2|||
142981567|NCT00369278|515469146|FG001|Overall Study|Withdrawal by Subject|2|||
142981568|NCT00369278|515469145|FG000|Overall Study|Lost to Follow-up|1|||
142981569|NCT00369278|515469146|FG001|Overall Study|Lost to Follow-up|0|||
142981570|NCT00369278|515469145|FG000|Overall Study|Graft loss|1|||
142981571|NCT00369278|515469146|FG001|Overall Study|Graft loss|2|||
142981572|NCT03417505|515469147|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
142981573|NCT03417505|515469148|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
142981574|NCT02025530|515469149|FG000|Overall Study|No longer met elligibility criteria|5|||
142981575|NCT02025530|515469150|FG001|Overall Study|No longer met elligibility criteria|1|||
142981576|NCT02873208|515469151|FG000|Overall Study|Withdrawal by Subject|36|||
142981577|NCT02873208|515469151|FG000|Overall Study|Lost to Follow-up|22|||
142981578|NCT02873208|515469151|FG000|Overall Study|Adverse Event|15|||
142981579|NCT02873208|515469151|FG000|Overall Study|Non-compliance with study drug|12|||
142981580|NCT02873208|515469151|FG000|Overall Study|Protocol Violation|8|||
142981581|NCT02873208|515469151|FG000|Overall Study|Pregnancy|2|||
142981582|NCT02873208|515469151|FG000|Overall Study|Incarceration|1|||
142981583|NCT02873208|515469151|FG000|Overall Study|Lack of Efficacy|1|||
142981584|NCT02873208|515469151|FG000|Overall Study|Physician Decision|1|||
142981585|NCT03434041|515469152|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
142981586|NCT03434041|515469153|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
142981587|NCT03434041|515469152|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
142981588|NCT03434041|515469153|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
142981589|NCT03434041|515469152|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
142981590|NCT03434041|515469153|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
142981591|NCT03434041|515469152|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
142981592|NCT03434041|515469153|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
142981593|NCT03434041|515469152|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
142981594|NCT03434041|515469153|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
142981595|NCT03434041|515469152|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
142981596|NCT03434041|515469153|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
142981597|NCT03434041|515469152|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
142981598|NCT03434041|515469153|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
142981599|NCT03434041|515469152|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
142981600|NCT03434041|515469153|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
142981601|NCT03434041|515469152|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
142981602|NCT03434041|515469153|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
142981603|NCT03434041|515469152|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
142981604|NCT03434041|515469153|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
142981605|NCT03434041|515469152|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
142981606|NCT03434041|515469153|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
142981607|NCT00770224|515469155|FG000|Step 1: Induction|Adverse Event|3|||
142981608|NCT00770224|515469156|FG001|Step 1: Induction|Adverse Event|0|||
142981609|NCT00770224|515469155|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
142981610|NCT00770224|515469156|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
142981611|NCT00770224|515469155|FG000|Step 1: Induction|Other reason not protocol specified|2|||
142981612|NCT00770224|515469156|FG001|Step 1: Induction|Other reason not protocol specified|0|||
142981613|NCT00770224|515469155|FG000|Step 1: Induction|Ineligible|2|||
142981614|NCT00770224|515469156|FG001|Step 1: Induction|Ineligible|0|||
142981615|NCT00770224|515469155|FG000|Step 1: Induction|No protocol treatment given|1|||
142981616|NCT00770224|515469156|FG001|Step 1: Induction|No protocol treatment given|0|||
142981617|NCT00770224|515469155|FG000|Step 2: Maintenance|Adverse Event|0|||
142981618|NCT00770224|515469156|FG001|Step 2: Maintenance|Adverse Event|10|||
142981619|NCT00770224|515469155|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
142981620|NCT00770224|515469156|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
142981621|NCT00770224|515469155|FG000|Step 2: Maintenance|Progression/relapse|0|||
142981622|NCT00770224|515469156|FG001|Step 2: Maintenance|Progression/relapse|1|||
142981623|NCT00770224|515469155|FG000|Step 2: Maintenance|Death|0|||
142981624|NCT00770224|515469156|FG001|Step 2: Maintenance|Death|2|||
142981625|NCT00770224|515469155|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
142981626|NCT00770224|515469156|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
142981627|NCT00770224|515469155|FG000|Step 2: Maintenance|Ineligible|0|||
142981628|NCT00770224|515469156|FG001|Step 2: Maintenance|Ineligible|2|||
142981629|NCT04737759|515469157|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
142981630|NCT04737759|515469158|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
142981631|NCT04737759|515469157|FG000|Overall Study|Death|2|||
142981632|NCT04737759|515469158|FG001|Overall Study|Death|0|||
142981633|NCT04737759|515469157|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
142981634|NCT04737759|515469158|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
142981635|NCT04737759|515469157|FG000|Overall Study|Lost to Follow-up|4|||
142981636|NCT04737759|515469158|FG001|Overall Study|Lost to Follow-up|12|||
142981637|NCT01484561|515469167|FG000|Overall Study|Lack of Efficacy|3|||
142981638|NCT01484561|515469168|FG001|Overall Study|Lack of Efficacy|1|||
142981639|NCT01484561|515469167|FG000|Overall Study|Lost to Follow-up|1|||
142981640|NCT01484561|515469168|FG001|Overall Study|Lost to Follow-up|0|||
142981641|NCT01484561|515469167|FG000|Overall Study|Withdrawal by Subject|3|||
142981642|NCT01484561|515469168|FG001|Overall Study|Withdrawal by Subject|0|||
142981643|NCT01484561|515469167|FG000|Overall Study|Other|1|||
142981644|NCT01484561|515469168|FG001|Overall Study|Other|1|||
142981645|NCT01484561|515469167|FG000|Overall Study|Adverse Event|1|||
142981646|NCT01484561|515469168|FG001|Overall Study|Adverse Event|4|||
142981647|NCT03371251|515469169|FG000|Overall Study|Withdrawal by Subject|1|||
142981648|NCT03371251|515469170|FG001|Overall Study|Withdrawal by Subject|0|||
142981649|NCT03371251|515469171|FG002|Overall Study|Withdrawal by Subject|1|||
142981650|NCT03371251|515469172|FG003|Overall Study|Withdrawal by Subject|0|||
142981651|NCT03371251|515469173|FG004|Overall Study|Withdrawal by Subject|2|||
142981652|NCT03371251|515469174|FG005|Overall Study|Withdrawal by Subject|2|||
142981653|NCT03371251|515469169|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
142981654|NCT03371251|515469170|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
142981655|NCT03371251|515469171|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
142981656|NCT03371251|515469172|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
142981657|NCT03371251|515469173|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
142981658|NCT03371251|515469174|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
142981659|NCT03371251|515469169|FG000|Overall Study|Adverse Event|0|||
142981660|NCT03371251|515469170|FG001|Overall Study|Adverse Event|0|||
142981661|NCT03371251|515469171|FG002|Overall Study|Adverse Event|0|||
142981662|NCT03371251|515469172|FG003|Overall Study|Adverse Event|0|||
142981663|NCT03371251|515469173|FG004|Overall Study|Adverse Event|1|||
142981664|NCT03371251|515469174|FG005|Overall Study|Adverse Event|0|||
142981665|NCT03371251|515469169|FG000|Overall Study|Decision by Sponsor|0|||
142981666|NCT03371251|515469170|FG001|Overall Study|Decision by Sponsor|0|||
142981667|NCT03371251|515469171|FG002|Overall Study|Decision by Sponsor|0|||
142981668|NCT03371251|515469172|FG003|Overall Study|Decision by Sponsor|0|||
142981669|NCT03371251|515469173|FG004|Overall Study|Decision by Sponsor|2|||
142981670|NCT03371251|515469174|FG005|Overall Study|Decision by Sponsor|0|||
142981671|NCT00291187|515469175|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
142981672|NCT00291187|515469176|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
142981673|NCT00291187|515469177|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
142981674|NCT00291187|515469178|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
142981675|NCT00114218|515469179|FG000|Overall Study|Wrong Cell Type|2|||
142981676|NCT00114218|515469179|FG000|Overall Study|Wrong Primary|1|||
142981677|NCT00114218|515469179|FG000|Overall Study|Never Treated|1|||
142981678|NCT01505114|515469180|FG000|Overall Study|Withdrawal by Subject|5|||
142981679|NCT01505114|515469181|FG001|Overall Study|Withdrawal by Subject|4|||
142981680|NCT01505114|515469182|FG002|Overall Study|Withdrawal by Subject|4|||
142981681|NCT01505114|515469183|FG003|Overall Study|Withdrawal by Subject|7|||
142981682|NCT01505114|515469180|FG000|Overall Study|Death|1|||
142981683|NCT01505114|515469181|FG001|Overall Study|Death|0|||
142981684|NCT01505114|515469182|FG002|Overall Study|Death|0|||
142981685|NCT01505114|515469183|FG003|Overall Study|Death|1|||
142981686|NCT01505114|515469180|FG000|Overall Study|unable to adhere to visit schedule|3|||
142981687|NCT01505114|515469181|FG001|Overall Study|unable to adhere to visit schedule|2|||
142981688|NCT01505114|515469182|FG002|Overall Study|unable to adhere to visit schedule|3|||
142981689|NCT01505114|515469183|FG003|Overall Study|unable to adhere to visit schedule|3|||
142981690|NCT01505114|515469180|FG000|Overall Study|Lost to Follow-up|11|||
142981691|NCT01505114|515469181|FG001|Overall Study|Lost to Follow-up|5|||
142981692|NCT01505114|515469182|FG002|Overall Study|Lost to Follow-up|8|||
142981693|NCT01505114|515469183|FG003|Overall Study|Lost to Follow-up|7|||
142981694|NCT01505114|515469180|FG000|Overall Study|relocated|4|||
142981695|NCT01505114|515469181|FG001|Overall Study|relocated|2|||
142981696|NCT01505114|515469182|FG002|Overall Study|relocated|2|||
142981697|NCT01505114|515469183|FG003|Overall Study|relocated|3|||
142981698|NCT01505114|515469180|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
142981699|NCT01505114|515469181|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
142981700|NCT01505114|515469182|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
142981701|NCT01505114|515469183|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
142981702|NCT01505114|515469180|FG000|Overall Study|staff safety concerns|0|||
142981703|NCT01505114|515469181|FG001|Overall Study|staff safety concerns|0|||
142981704|NCT01505114|515469182|FG002|Overall Study|staff safety concerns|0|||
142981705|NCT01505114|515469183|FG003|Overall Study|staff safety concerns|1|||
142981706|NCT01505114|515469180|FG000|Overall Study|investigator decision|1|||
142981707|NCT01505114|515469181|FG001|Overall Study|investigator decision|0|||
142981708|NCT01505114|515469182|FG002|Overall Study|investigator decision|1|||
142981709|NCT01505114|515469183|FG003|Overall Study|investigator decision|0|||
142981710|NCT01040845|515469185|FG000|Overall Study|Withdrawal by Subject|1|||
142981711|NCT01040845|515469186|FG001|Overall Study|Withdrawal by Subject|1|||
142981712|NCT01040845|515469185|FG000|Overall Study|Physician Decision|1|||
142981713|NCT01040845|515469186|FG001|Overall Study|Physician Decision|0|||
142981714|NCT04362813|515469187|FG000|Overall Study|Death|12|||
142981715|NCT04362813|515469188|FG001|Overall Study|Death|16|||
142981716|NCT04362813|515469187|FG000|Overall Study|Withdrawal by Subject|3|||
142981717|NCT04362813|515469188|FG001|Overall Study|Withdrawal by Subject|1|||
142981718|NCT04362813|515469187|FG000|Overall Study|Protocol Violation|0|||
142981719|NCT04362813|515469188|FG001|Overall Study|Protocol Violation|3|||
142981720|NCT04362813|515469187|FG000|Overall Study|Lost to Follow-up|1|||
142981721|NCT04362813|515469188|FG001|Overall Study|Lost to Follow-up|1|||
142981722|NCT04362813|515469187|FG000|Overall Study|Enrolled but did not receive treatment|2|||
142981723|NCT04362813|515469188|FG001|Overall Study|Enrolled but did not receive treatment|4|||
142981724|NCT00961116|515469189|FG000|Washout Period of 7 Days|Adverse Event|1|||
142981725|NCT00961116|515469190|FG001|Washout Period of 7 Days|Adverse Event|1|||
142981726|NCT00961116|515469189|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
142981727|NCT00961116|515469190|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
142981728|NCT00961116|515469189|FG000|Washout Period of 7 Days|Protocol Violation|0|||
142981729|NCT00961116|515469190|FG001|Washout Period of 7 Days|Protocol Violation|1|||
142981730|NCT01732107|515469195|FG000|Overall Study|Adverse Event|2|||
142981731|NCT01732107|515469195|FG000|Overall Study|Disease Progression|8|||
142981732|NCT01732107|515469195|FG000|Overall Study|Physician Decision|1|||
142981733|NCT01732107|515469195|FG000|Overall Study|Withdrawal by Subject|2|||
142981734|NCT02959190|515469197|FG000|Open Label|Adverse Event|5|||
142981735|NCT02959190|515469198|FG001|Open Label|Adverse Event|7|||
142981736|NCT02959190|515469199|FG002|Open Label|Adverse Event|3|||
142981737|NCT02959190|515469200|FG003|Open Label|Adverse Event|4|||
142981738|NCT02959190|515469197|FG000|Open Label|Pregnancy|0|||
142981739|NCT02959190|515469198|FG001|Open Label|Pregnancy|1|||
142981740|NCT02959190|515469199|FG002|Open Label|Pregnancy|0|||
142981741|NCT02959190|515469200|FG003|Open Label|Pregnancy|0|||
142981742|NCT02959190|515469197|FG000|Open Label|Withdrawal by Subject|2|||
142981743|NCT02959190|515469198|FG001|Open Label|Withdrawal by Subject|8|||
142981744|NCT02959190|515469199|FG002|Open Label|Withdrawal by Subject|0|||
142981745|NCT02959190|515469200|FG003|Open Label|Withdrawal by Subject|0|||
142981746|NCT02959190|515469197|FG000|Open Label|Physician Decision|0|||
142981747|NCT02959190|515469198|FG001|Open Label|Physician Decision|0|||
142981748|NCT02959190|515469199|FG002|Open Label|Physician Decision|1|||
142981749|NCT02959190|515469200|FG003|Open Label|Physician Decision|0|||
142981750|NCT02959190|515469197|FG000|Open Label|Protocol Violation|0|||
142981751|NCT02959190|515469198|FG001|Open Label|Protocol Violation|0|||
142981752|NCT02959190|515469199|FG002|Open Label|Protocol Violation|0|||
142981753|NCT02959190|515469200|FG003|Open Label|Protocol Violation|2|||
142981754|NCT02959190|515469197|FG000|Post Treatment Follow Up|Adverse Event|1|||
142981755|NCT02959190|515469198|FG001|Post Treatment Follow Up|Adverse Event|1|||
142981756|NCT02959190|515469199|FG002|Post Treatment Follow Up|Adverse Event|0|||
142981757|NCT02959190|515469200|FG003|Post Treatment Follow Up|Adverse Event|0|||
142981758|NCT02959190|515469197|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
142981759|NCT02959190|515469198|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
142981760|NCT02959190|515469199|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
142981761|NCT02959190|515469200|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
142981762|NCT04445688|515469201|FG000|Washout (One Week)|Adverse Event|2|||
142981763|NCT04445688|515469201|FG000|Washout (One Week)|Withdrawal by Subject|1|||
142981764|NCT01235507|515469203|FG000|Overall Study|Adverse Event|1|||
142981765|NCT01235507|515469203|FG000|Overall Study|Withdrawal by Subject|1|||
142981766|NCT02017704|515469209|FG000|Overall Study|Withdrawal by Subject|2|||
142981767|NCT02017704|515469210|FG001|Overall Study|Withdrawal by Subject|0|||
142981768|NCT01587274|515469211|FG000|Overall Study|Lost to Follow-up|4|||
142981769|NCT01587274|515469212|FG001|Overall Study|Lost to Follow-up|5|||
142981770|NCT01587274|515469213|FG002|Overall Study|Lost to Follow-up|3|||
142981771|NCT01963780|515469214|FG000|Overall Study|Death|7|||
142981772|NCT03383614|515469215|FG000|Overall Study|Withdrawal by Subject|0|||
142981773|NCT03383614|515469216|FG001|Overall Study|Withdrawal by Subject|1|||
142981774|NCT03383614|515469217|FG002|Overall Study|Withdrawal by Subject|0|||
142981775|NCT03383614|515469218|FG003|Overall Study|Withdrawal by Subject|0|||
142981776|NCT01000025|515469222|FG000|Overall Study|Adverse Event|43|||
142981777|NCT01000025|515469223|FG001|Overall Study|Adverse Event|2|||
142981778|NCT01000025|515469222|FG000|Overall Study|Withdrawal by Subject|13|||
142981779|NCT01000025|515469223|FG001|Overall Study|Withdrawal by Subject|8|||
142981780|NCT01000025|515469222|FG000|Overall Study|Death|23|||
142981781|NCT01000025|515469223|FG001|Overall Study|Death|13|||
142981782|NCT01000025|515469222|FG000|Overall Study|Lack of Efficacy|363|||
142981783|NCT01000025|515469223|FG001|Overall Study|Lack of Efficacy|208|||
142981784|NCT01000025|515469222|FG000|Overall Study|Intercurrent Illness|26|||
142981785|NCT01000025|515469223|FG001|Overall Study|Intercurrent Illness|7|||
142981786|NCT04423757|515469224|FG000|Overall Study|Adverse Event|2|||
142981787|NCT04423757|515469225|FG001|Overall Study|Adverse Event|0|||
142981788|NCT04423757|515469224|FG000|Overall Study|Not treated|1|||
142981789|NCT04423757|515469225|FG001|Overall Study|Not treated|1|||
142981790|NCT00422669|515469226|FG000|Overall Study|The study was terminated early.|98|||
142981791|NCT00422669|515469227|FG001|Overall Study|The study was terminated early.|100|||
142981792|NCT00422669|515469228|FG002|Overall Study|The study was terminated early.|7|||
142981793|NCT02709109|515469229|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
142981794|NCT02709109|515469230|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
142981795|NCT02709109|515469231|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
142981796|NCT02709109|515469232|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
142981797|NCT02709109|515469229|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
142981798|NCT02709109|515469230|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
142981799|NCT02709109|515469231|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
142981800|NCT02709109|515469232|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
142981801|NCT02709109|515469229|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
142981802|NCT02709109|515469230|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
142981803|NCT02709109|515469231|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
142981804|NCT02709109|515469232|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
142981805|NCT02709109|515469229|FG000|Washout Period (28 Days)|Other|2|||
142981806|NCT02709109|515469230|FG001|Washout Period (28 Days)|Other|2|||
142981807|NCT02709109|515469231|FG002|Washout Period (28 Days)|Other|3|||
142981808|NCT02709109|515469232|FG003|Washout Period (28 Days)|Other|0|||
142981809|NCT02709109|515469229|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
142981810|NCT02709109|515469230|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
142981811|NCT02709109|515469231|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
142981812|NCT02709109|515469232|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
142981813|NCT02709109|515469229|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
142981814|NCT02709109|515469230|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
142981815|NCT02709109|515469231|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
142981816|NCT02709109|515469232|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
142981817|NCT02709109|515469229|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
142981818|NCT02709109|515469230|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
142981819|NCT02709109|515469231|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
142981820|NCT02709109|515469232|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
142981821|NCT02709109|515469229|FG000|Treatment Period 2 (28 Days)|Other|0|||
142981822|NCT02709109|515469230|FG001|Treatment Period 2 (28 Days)|Other|0|||
142981823|NCT02709109|515469231|FG002|Treatment Period 2 (28 Days)|Other|1|||
142981824|NCT02709109|515469232|FG003|Treatment Period 2 (28 Days)|Other|0|||
142981825|NCT02738580|515469233|FG000|Overall Study|Adverse Event|1|||
142981826|NCT02738580|515469234|FG001|Overall Study|Adverse Event|0|||
142981827|NCT02738580|515469233|FG000|Overall Study|Lack of Efficacy|3|||
142981828|NCT02738580|515469234|FG001|Overall Study|Lack of Efficacy|2|||
142981829|NCT02738580|515469233|FG000|Overall Study|Withdrawal by Subject|0|||
142981830|NCT02738580|515469234|FG001|Overall Study|Withdrawal by Subject|1|||
142981831|NCT02738580|515469233|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
142981832|NCT02738580|515469234|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
142981833|NCT01250756|515469237|FG000|Infant Series|Withdrawal by Subject|4|||
142981834|NCT01250756|515469238|FG001|Infant Series|Withdrawal by Subject|5|||
142981835|NCT01250756|515469237|FG000|Infant Series|Randomized, Not Vaccinated|2|||
142981836|NCT01250756|515469238|FG001|Infant Series|Randomized, Not Vaccinated|2|||
142981837|NCT01250756|515469237|FG000|Infant Series|Other|22|||
142981838|NCT01250756|515469238|FG001|Infant Series|Other|0|||
142981839|NCT01250756|515469237|FG000|After Infant Series|Adverse Event|5|||
142981840|NCT01250756|515469238|FG001|After Infant Series|Adverse Event|2|||
142981841|NCT01250756|515469237|FG000|After Infant Series|Withdrawal by Subject|4|||
142981842|NCT01250756|515469238|FG001|After Infant Series|Withdrawal by Subject|1|||
142981843|NCT01250756|515469237|FG000|After Infant Series|Other|2|||
142981844|NCT01250756|515469238|FG001|After Infant Series|Other|1|||
142981845|NCT01250756|515469237|FG000|Toddler Dose|Adverse Event|0|||
142981846|NCT01250756|515469238|FG001|Toddler Dose|Adverse Event|1|||
142981847|NCT01250756|515469237|FG000|After Toddler Dose|Adverse Event|0|||
142981848|NCT01250756|515469238|FG001|After Toddler Dose|Adverse Event|1|||
142981849|NCT01313078|515469241|FG000|Overall Study|Death|1|||
142981850|NCT01313078|515469241|FG000|Overall Study|Discontinued study drug|1|||
142981851|NCT01313078|515469241|FG000|Overall Study|Withdrawal by Subject|1|||
142981852|NCT04209400|515469245|FG000|Overall Study|Withdrawal by Subject|0|||
142981853|NCT04209400|515469246|FG001|Overall Study|Withdrawal by Subject|1|||
142981854|NCT03404518|515469247|FG000|Overall Study|Lost to Follow-up|28|||
142981855|NCT03404518|515469248|FG001|Overall Study|Lost to Follow-up|30|||
142981856|NCT03404518|515469247|FG000|Overall Study|Protocol Violation|13|||
142981857|NCT03404518|515469248|FG001|Overall Study|Protocol Violation|6|||
142981858|NCT00807014|515469249|FG000|Overall Study|Participant Considered Disease Cured|13|||
142981859|NCT00807014|515469250|FG001|Overall Study|Participant Considered Disease Cured|2|||
142981860|NCT00807014|515469249|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
142981861|NCT00807014|515469250|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
142981862|NCT00807014|515469249|FG000|Overall Study|Protocol Violation|2|||
142981863|NCT00807014|515469250|FG001|Overall Study|Protocol Violation|8|||
142981864|NCT00807014|515469249|FG000|Overall Study|Adverse Event|0|||
142981865|NCT00807014|515469250|FG001|Overall Study|Adverse Event|2|||
142981866|NCT00807014|515469249|FG000|Overall Study|Lost to Follow-up|9|||
142981867|NCT00807014|515469250|FG001|Overall Study|Lost to Follow-up|7|||
142981868|NCT00807014|515469249|FG000|Overall Study|Recovery|1|||
142981869|NCT00807014|515469250|FG001|Overall Study|Recovery|0|||
142981870|NCT00807014|515469249|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
142981871|NCT00807014|515469250|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
142981872|NCT01576406|515469251|FG000|Overall Study|Lost to Follow-up|1|||
142981873|NCT01576406|515469252|FG001|Overall Study|Lost to Follow-up|2|||
142981874|NCT01576406|515469253|FG002|Overall Study|Lost to Follow-up|0|||
142981875|NCT01576406|515469254|FG003|Overall Study|Lost to Follow-up|0|||
142981876|NCT01576406|515469255|FG004|Overall Study|Lost to Follow-up|0|||
142981877|NCT01576406|515469256|FG005|Overall Study|Lost to Follow-up|0|||
142981878|NCT01576406|515469251|FG000|Overall Study|Death|3|||
142981879|NCT01576406|515469252|FG001|Overall Study|Death|4|||
142981880|NCT01576406|515469253|FG002|Overall Study|Death|8|||
142981881|NCT01576406|515469254|FG003|Overall Study|Death|5|||
142981882|NCT01576406|515469255|FG004|Overall Study|Death|7|||
142981883|NCT01576406|515469256|FG005|Overall Study|Death|9|||
142981884|NCT01576406|515469251|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
142981885|NCT01576406|515469252|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
142981886|NCT01576406|515469253|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
142981887|NCT01576406|515469254|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
142981888|NCT01576406|515469255|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
142981889|NCT01576406|515469256|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
142981890|NCT01576406|515469251|FG000|Overall Study|Withdrawal the consent|2|||
142981891|NCT01576406|515469252|FG001|Overall Study|Withdrawal the consent|2|||
142981892|NCT01576406|515469253|FG002|Overall Study|Withdrawal the consent|5|||
142981893|NCT01576406|515469254|FG003|Overall Study|Withdrawal the consent|1|||
142981894|NCT01576406|515469255|FG004|Overall Study|Withdrawal the consent|1|||
142981895|NCT01576406|515469256|FG005|Overall Study|Withdrawal the consent|3|||
142981896|NCT01576406|515469251|FG000|Overall Study|Other|0|||
142981897|NCT01576406|515469252|FG001|Overall Study|Other|0|||
142981898|NCT01576406|515469253|FG002|Overall Study|Other|2|||
142981899|NCT01576406|515469254|FG003|Overall Study|Other|2|||
142981900|NCT01576406|515469255|FG004|Overall Study|Other|0|||
142981901|NCT01576406|515469256|FG005|Overall Study|Other|0|||
142981902|NCT00651313|515469257|FG000|Overall Study|Adverse Event|0|||
142981903|NCT00651313|515469258|FG001|Overall Study|Adverse Event|1|||
142981904|NCT00651313|515469257|FG000|Overall Study|Withdrawal by Subject|3|||
142981905|NCT00651313|515469258|FG001|Overall Study|Withdrawal by Subject|1|||
142981906|NCT00651313|515469257|FG000|Overall Study|Lost to Follow-up|1|||
142981907|NCT00651313|515469258|FG001|Overall Study|Lost to Follow-up|1|||
142981908|NCT00651313|515469257|FG000|Overall Study|Adminstrative Discontinuation|2|||
142981909|NCT00651313|515469258|FG001|Overall Study|Adminstrative Discontinuation|3|||
142981910|NCT03906136|515470998|FG000|Overall Study|Adverse Event|1|||
142981911|NCT03906136|515470999|FG001|Overall Study|Adverse Event|0|||
142981912|NCT03906136|515470998|FG000|Overall Study|Lost to Follow-up|7|||
142981913|NCT03906136|515470999|FG001|Overall Study|Lost to Follow-up|4|||
142981914|NCT03906136|515470998|FG000|Overall Study|Physician Decision|1|||
142981915|NCT03906136|515470999|FG001|Overall Study|Physician Decision|0|||
142981916|NCT03906136|515470998|FG000|Overall Study|Withdrawal by Subject|3|||
142981917|NCT03906136|515470999|FG001|Overall Study|Withdrawal by Subject|7|||
142981918|NCT01280812|515471003|FG000|Overall Study|Withdrawal by Subject|2|||
142981919|NCT01280812|515471004|FG001|Overall Study|Withdrawal by Subject|1|||
142981920|NCT01280812|515471005|FG002|Overall Study|Withdrawal by Subject|0|||
142981921|NCT01280812|515471003|FG000|Overall Study|Lost to Follow-up|1|||
142981922|NCT01280812|515471004|FG001|Overall Study|Lost to Follow-up|1|||
142981923|NCT01280812|515471005|FG002|Overall Study|Lost to Follow-up|1|||
142981924|NCT00959894|515471006|FG000|Overall Study|Lost to Follow-up|10|||
142981925|NCT00959894|515471006|FG000|Overall Study|Adverse Event|3|||
142981926|NCT00959894|515471006|FG000|Overall Study|Withdrawal by Subject|1|||
142981927|NCT00959894|515471006|FG000|Overall Study|Need for contraindicated medication|1|||
142981928|NCT00959894|515471006|FG000|Overall Study|Subject moved out of town|1|||
142981929|NCT03424044|515471011|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
142981930|NCT03424044|515471012|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
142981931|NCT03424044|515471013|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
142981932|NCT03424044|515471014|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
142981933|NCT03424044|515471015|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
142981934|NCT03424044|515471016|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
142981935|NCT03424044|515471017|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
142981936|NCT03424044|515471018|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
142981937|NCT03424044|515471019|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
142981938|NCT03424044|515471011|FG000|First Intervention (76 Hours)|Adverse Event|0|||
142981939|NCT03424044|515471012|FG001|First Intervention (76 Hours)|Adverse Event|0|||
142981940|NCT03424044|515471013|FG002|First Intervention (76 Hours)|Adverse Event|0|||
142981941|NCT03424044|515471014|FG003|First Intervention (76 Hours)|Adverse Event|0|||
142981942|NCT03424044|515471015|FG004|First Intervention (76 Hours)|Adverse Event|1|||
142981943|NCT03424044|515471016|FG005|First Intervention (76 Hours)|Adverse Event|0|||
142981944|NCT03424044|515471017|FG006|First Intervention (76 Hours)|Adverse Event|0|||
142981945|NCT03424044|515471018|FG007|First Intervention (76 Hours)|Adverse Event|0|||
142981946|NCT03424044|515471019|FG008|First Intervention (76 Hours)|Adverse Event|0|||
142981947|NCT03424044|515471011|FG000|First Intervention (76 Hours)|device issues|0|||
142981948|NCT03424044|515471012|FG001|First Intervention (76 Hours)|device issues|0|||
142981949|NCT03424044|515471013|FG002|First Intervention (76 Hours)|device issues|0|||
142981950|NCT03424044|515471014|FG003|First Intervention (76 Hours)|device issues|0|||
142981951|NCT03424044|515471015|FG004|First Intervention (76 Hours)|device issues|0|||
142981952|NCT03424044|515471016|FG005|First Intervention (76 Hours)|device issues|0|||
142981953|NCT03424044|515471017|FG006|First Intervention (76 Hours)|device issues|1|||
142981954|NCT03424044|515471018|FG007|First Intervention (76 Hours)|device issues|1|||
142981955|NCT03424044|515471019|FG008|First Intervention (76 Hours)|device issues|1|||
142981956|NCT03424044|515471011|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
142981957|NCT03424044|515471012|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
142981958|NCT03424044|515471013|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
142981959|NCT03424044|515471014|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
142981960|NCT03424044|515471015|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
142981961|NCT03424044|515471016|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
142981962|NCT03424044|515471017|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
142981963|NCT03424044|515471018|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
142981964|NCT03424044|515471019|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
142981965|NCT03424044|515471011|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
142981966|NCT03424044|515471012|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
142981967|NCT03424044|515471013|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
142981968|NCT03424044|515471014|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
142981969|NCT03424044|515471015|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
142981970|NCT03424044|515471016|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
142981971|NCT03424044|515471017|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
142981972|NCT03424044|515471018|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
142981973|NCT03424044|515471019|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
142981974|NCT00402285|515471020|FG000|Overall Study|insufficient RNA quality|7|||
142981975|NCT00402285|515471021|FG001|Overall Study|insufficient RNA quality|6|||
142981976|NCT00402285|515471022|FG002|Overall Study|insufficient RNA quality|2|||
142981977|NCT02009930|515471030|FG000|Overall Study|withdrawn|5|||
142981978|NCT02959970|515471033|FG000|Overall Study|Adverse Event|1|||
142981979|NCT02959970|515471034|FG001|Overall Study|Adverse Event|0|||
142981980|NCT02959970|515471033|FG000|Overall Study|Withdrawal by Subject|0|||
142981981|NCT02959970|515471034|FG001|Overall Study|Withdrawal by Subject|2|||
142981982|NCT02959970|515471033|FG000|Overall Study|Lost to Follow-up|1|||
142981983|NCT02959970|515471034|FG001|Overall Study|Lost to Follow-up|5|||
142981984|NCT00693420|515471035|FG000|Overall Study|Adverse Event|4|||
142981985|NCT00693420|515471036|FG001|Overall Study|Adverse Event|4|||
142981986|NCT00693420|515471035|FG000|Overall Study|Lost to Follow-up|0|||
142981987|NCT00693420|515471036|FG001|Overall Study|Lost to Follow-up|3|||
142981988|NCT00693420|515471035|FG000|Overall Study|Withdrawal by Subject|1|||
142981989|NCT00693420|515471036|FG001|Overall Study|Withdrawal by Subject|0|||
142981990|NCT00693420|515471035|FG000|Overall Study|Protocol Violation|0|||
142981991|NCT00693420|515471036|FG001|Overall Study|Protocol Violation|2|||
142981992|NCT00693420|515471035|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
142981993|NCT00693420|515471036|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
142981994|NCT00693420|515471035|FG000|Overall Study|Personal Reasons|1|||
142981995|NCT00693420|515471036|FG001|Overall Study|Personal Reasons|4|||
142981996|NCT03250624|515471039|FG000|Overall Study|Lack of Efficacy|1|||
142981997|NCT03250624|515471040|FG001|Overall Study|Lack of Efficacy|4|||
142981998|NCT03250624|515471039|FG000|Overall Study|Adverse Event|0|||
142981999|NCT03250624|515471040|FG001|Overall Study|Adverse Event|1|||
142982000|NCT03250624|515471039|FG000|Overall Study|Other|1|||
142982001|NCT03250624|515471040|FG001|Overall Study|Other|2|||
142982002|NCT00509028|515471043|FG000|Overall Study|Adverse Event|2|||
142982003|NCT00509028|515471044|FG001|Overall Study|Adverse Event|0|||
142982004|NCT00509028|515471043|FG000|Overall Study|Withdrawal by Subject|4|||
142982005|NCT00509028|515471044|FG001|Overall Study|Withdrawal by Subject|3|||
142982006|NCT00509028|515471043|FG000|Overall Study|Lost to Follow-up|0|||
142982007|NCT00509028|515471044|FG001|Overall Study|Lost to Follow-up|1|||
142982008|NCT00509028|515471043|FG000|Overall Study|Protocol Violation|4|||
142982009|NCT00509028|515471044|FG001|Overall Study|Protocol Violation|2|||
142982010|NCT00509028|515471043|FG000|Overall Study|Non-compliance|2|||
142982011|NCT00509028|515471044|FG001|Overall Study|Non-compliance|1|||
142982012|NCT00948428|515471045|FG000|Overall Study|Withdrawal by Subject|6|||
142982013|NCT00948428|515471046|FG001|Overall Study|Withdrawal by Subject|12|||
142982014|NCT00948428|515471047|FG002|Overall Study|Withdrawal by Subject|7|||
142982015|NCT00948428|515471045|FG000|Overall Study|Adverse Event|6|||
142982016|NCT00948428|515471046|FG001|Overall Study|Adverse Event|3|||
142982017|NCT00948428|515471047|FG002|Overall Study|Adverse Event|0|||
142982018|NCT00948428|515471045|FG000|Overall Study|Lost to Follow-up|2|||
142982019|NCT00948428|515471046|FG001|Overall Study|Lost to Follow-up|1|||
142982020|NCT00948428|515471047|FG002|Overall Study|Lost to Follow-up|1|||
142982021|NCT00948428|515471045|FG000|Overall Study|Death|2|||
142982022|NCT00948428|515471046|FG001|Overall Study|Death|0|||
142982023|NCT00948428|515471047|FG002|Overall Study|Death|0|||
142982024|NCT00948428|515471045|FG000|Overall Study|Intercurrent Illness|1|||
142982025|NCT00948428|515471046|FG001|Overall Study|Intercurrent Illness|0|||
142982026|NCT00948428|515471047|FG002|Overall Study|Intercurrent Illness|0|||
142982027|NCT00948428|515471045|FG000|Overall Study|Non-compliance|1|||
142982028|NCT00948428|515471046|FG001|Overall Study|Non-compliance|2|||
142982029|NCT00948428|515471047|FG002|Overall Study|Non-compliance|0|||
142982030|NCT05283499|515471050|FG000|Overall Study|Did not receive intervention|1|||
142982031|NCT05283499|515471051|FG001|Overall Study|Did not receive intervention|2|||
142982032|NCT02408484|515471052|FG000|Overall Study|Withdrawal by Subject|3|||
142982033|NCT02408484|515471052|FG000|Overall Study|Not treated during study period|1|||
142982034|NCT05516134|515471055|FG000|Overall Study|Lost to Follow-up|1|||
142982035|NCT05516134|515471056|FG001|Overall Study|Lost to Follow-up|0|||
142982036|NCT05516134|515471057|FG002|Overall Study|Lost to Follow-up|0|||
142982037|NCT00517413|515471063|FG000|Overall Study|Adverse Event|7|||
142982038|NCT00517413|515471063|FG000|Overall Study|Death|13|||
142982039|NCT00517413|515471063|FG000|Overall Study|Protocol Violation|15|||
142982040|NCT00517413|515471063|FG000|Overall Study|Withdrawal by Subject|2|||
142982041|NCT00517413|515471063|FG000|Overall Study|Failure to return|1|||
142982042|NCT00517413|515471063|FG000|Overall Study|Other-Reasons|23|||
142982043|NCT01510028|515471064|FG000|Overall Study|Lack of Efficacy|1|||
142982044|NCT01510028|515471065|FG001|Overall Study|Lack of Efficacy|0|||
142982045|NCT01510028|515471066|FG002|Overall Study|Lack of Efficacy|0|||
142982046|NCT01510028|515471067|FG003|Overall Study|Lack of Efficacy|0|||
142982047|NCT01355497|515471068|FG000|Overall Study|Death|19|||
142982048|NCT01355497|515471069|FG001|Overall Study|Death|18|||
142982049|NCT01355497|515471068|FG000|Overall Study|Lost to Follow-up|3|||
142982050|NCT01355497|515471069|FG001|Overall Study|Lost to Follow-up|0|||
142982051|NCT01355497|515471068|FG000|Overall Study|Protocol Violation|0|||
142982052|NCT01355497|515471069|FG001|Overall Study|Protocol Violation|1|||
142982053|NCT01355497|515471068|FG000|Overall Study|other-not provided|9|||
142982054|NCT01355497|515471069|FG001|Overall Study|other-not provided|4|||
142982055|NCT01355497|515471068|FG000|Overall Study|Withdrawal by Subject|12|||
142982056|NCT01355497|515471069|FG001|Overall Study|Withdrawal by Subject|20|||
142982057|NCT01355497|515471068|FG000|Overall Study|noncompliance|1|||
142982058|NCT01355497|515471069|FG001|Overall Study|noncompliance|2|||
142982059|NCT01355497|515471068|FG000|Overall Study|progressive disease|11|||
142982060|NCT01355497|515471069|FG001|Overall Study|progressive disease|8|||
142982061|NCT01355497|515471068|FG000|Overall Study|Adverse Event|11|||
142982062|NCT01355497|515471069|FG001|Overall Study|Adverse Event|10|||
142982063|NCT01100658|515471075|FG000|Overall Study|Withdrawal by Subject|1|||
142982064|NCT01784211|515471076|FG000|Part A (Days 1-15)|Adverse Event|1|||
142982065|NCT01784211|515471077|FG001|Part A (Days 1-15)|Adverse Event|1|||
142982066|NCT01784211|515471078|FG002|Part A (Days 1-15)|Adverse Event|0|||
142982067|NCT01784211|515471079|FG003|Part A (Days 1-15)|Adverse Event|0|||
142982068|NCT01784211|515471080|FG004|Part A (Days 1-15)|Adverse Event|0|||
142982069|NCT01784211|515471081|FG005|Part A (Days 1-15)|Adverse Event|0|||
142982070|NCT01784211|515471076|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
142982071|NCT01784211|515471077|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
142982072|NCT01784211|515471078|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
142982073|NCT01784211|515471079|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
142982074|NCT01784211|515471080|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
142982075|NCT01784211|515471081|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
142982076|NCT01001572|515471084|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
142982077|NCT01001572|515471085|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
142982078|NCT01001572|515471086|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
142982079|NCT01001572|515471084|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
142982080|NCT01001572|515471085|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
142982081|NCT01001572|515471086|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
142982082|NCT01001572|515471084|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
142982083|NCT01001572|515471085|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
142982084|NCT01001572|515471086|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
142982085|NCT01001572|515471084|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
142982086|NCT01001572|515471085|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
142982087|NCT01001572|515471086|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
142982088|NCT01001572|515471084|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
142982089|NCT01001572|515471085|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
142982090|NCT01001572|515471086|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
142982091|NCT01001572|515471084|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
142982092|NCT01001572|515471085|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
142982093|NCT01001572|515471086|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
142982094|NCT01001572|515471084|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
142982095|NCT01001572|515471085|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
142982096|NCT01001572|515471086|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
142982097|NCT01001572|515471084|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
142982098|NCT01001572|515471085|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
142982099|NCT01001572|515471086|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
142982100|NCT01001572|515471084|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
142982101|NCT01001572|515471085|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
142982102|NCT01001572|515471086|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
142982103|NCT01001572|515471084|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
142982104|NCT01001572|515471085|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
142982105|NCT01001572|515471086|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
142982106|NCT01001572|515471084|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
142982107|NCT01001572|515471085|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
142982108|NCT01001572|515471086|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
142982109|NCT01001572|515471084|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
142982110|NCT01001572|515471085|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
142982111|NCT01001572|515471086|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
142982112|NCT01001572|515471084|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
142982113|NCT01001572|515471085|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
142982114|NCT01001572|515471086|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
142982115|NCT01001572|515471084|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
142982116|NCT01001572|515471085|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
142982117|NCT01001572|515471086|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
142982118|NCT01094808|515471087|FG000|Overall Study|Withdrawal by Subject|1|||
142982119|NCT01094808|515471088|FG001|Overall Study|Withdrawal by Subject|1|||
142982120|NCT01094808|515471089|FG002|Overall Study|Withdrawal by Subject|0|||
142982121|NCT00441727|515471090|FG000|Overall Study|Protocol Violation|19|||
142982122|NCT00441727|515471091|FG001|Overall Study|Protocol Violation|28|||
142982123|NCT00441727|515471092|FG002|Overall Study|Protocol Violation|32|||
142982124|NCT00441727|515471090|FG000|Overall Study|Adverse Event|26|||
142982125|NCT00441727|515471091|FG001|Overall Study|Adverse Event|33|||
142982126|NCT00441727|515471092|FG002|Overall Study|Adverse Event|28|||
142982127|NCT00441727|515471090|FG000|Overall Study|Lack of Efficacy|7|||
142982128|NCT00441727|515471091|FG001|Overall Study|Lack of Efficacy|8|||
142982129|NCT00441727|515471092|FG002|Overall Study|Lack of Efficacy|48|||
142982130|NCT00441727|515471090|FG000|Overall Study|Withdrawal by Subject|40|||
142982131|NCT00441727|515471091|FG001|Overall Study|Withdrawal by Subject|34|||
142982132|NCT00441727|515471092|FG002|Overall Study|Withdrawal by Subject|47|||
142982133|NCT00441727|515471090|FG000|Overall Study|Lost to Follow-up|5|||
142982134|NCT00441727|515471091|FG001|Overall Study|Lost to Follow-up|6|||
142982135|NCT00441727|515471092|FG002|Overall Study|Lost to Follow-up|5|||
142982136|NCT00441727|515471090|FG000|Overall Study|Safety Reasons|3|||
142982137|NCT00441727|515471091|FG001|Overall Study|Safety Reasons|1|||
142982138|NCT00441727|515471092|FG002|Overall Study|Safety Reasons|3|||
142982139|NCT00441727|515471090|FG000|Overall Study|Various reason specified|6|||
142982140|NCT00441727|515471091|FG001|Overall Study|Various reason specified|8|||
142982141|NCT00441727|515471092|FG002|Overall Study|Various reason specified|5|||
142982142|NCT04211961|515471093|FG000|Overall Study|Death|0|||
142982143|NCT04211961|515471094|FG001|Overall Study|Death|1|||
142982144|NCT04211961|515471093|FG000|Overall Study|Lost to Follow-up|0|||
142982145|NCT04211961|515471094|FG001|Overall Study|Lost to Follow-up|1|||
142982146|NCT04211961|515471093|FG000|Overall Study|Withdrawal by Subject|0|||
142982147|NCT04211961|515471094|FG001|Overall Study|Withdrawal by Subject|1|||
142982148|NCT04882072|515471095|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
142982149|NCT04882072|515471096|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
142982150|NCT04882072|515471095|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
142982151|NCT04882072|515471096|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
142982152|NCT04882072|515471095|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
142982153|NCT04882072|515471096|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
142982154|NCT01548417|515471097|FG000|Overall Study|Withdrawal by Subject|0|||
142982155|NCT01548417|515471098|FG001|Overall Study|Withdrawal by Subject|2|||
142982156|NCT00841672|515471099|FG000|Overall Study|Adverse Event|7|||
142982157|NCT00841672|515471100|FG001|Overall Study|Adverse Event|16|||
142982158|NCT00841672|515471099|FG000|Overall Study|Abnormal test procedure result(s)|0|||
142982159|NCT00841672|515471100|FG001|Overall Study|Abnormal test procedure result(s)|1|||
142982160|NCT00841672|515471099|FG000|Overall Study|Subject withdrew consent|2|||
142982161|NCT00841672|515471100|FG001|Overall Study|Subject withdrew consent|4|||
142982162|NCT00841672|515471099|FG000|Overall Study|Lost to Follow-up|1|||
142982163|NCT00841672|515471100|FG001|Overall Study|Lost to Follow-up|1|||
142982164|NCT00841672|515471099|FG000|Overall Study|Administrative problems|9|||
142982165|NCT00841672|515471100|FG001|Overall Study|Administrative problems|9|||
142982166|NCT00841672|515471099|FG000|Overall Study|Misrandomized|1|||
142982167|NCT00841672|515471100|FG001|Overall Study|Misrandomized|0|||
142982168|NCT00841672|515471099|FG000|Overall Study|Protocol Deviation|0|||
142982169|NCT00841672|515471100|FG001|Overall Study|Protocol Deviation|1|||
142982170|NCT01451398|515471101|FG000|Overall Study|Adverse Event|7|||
142982171|NCT01451398|515471102|FG001|Overall Study|Adverse Event|9|||
142982172|NCT01451398|515471101|FG000|Overall Study|Protocol Violation|1|||
142982173|NCT01451398|515471102|FG001|Overall Study|Protocol Violation|2|||
142982174|NCT01451398|515471101|FG000|Overall Study|Physician Decision|1|||
142982175|NCT01451398|515471102|FG001|Overall Study|Physician Decision|1|||
142982176|NCT01451398|515471101|FG000|Overall Study|Withdrawal by Subject|10|||
142982177|NCT01451398|515471102|FG001|Overall Study|Withdrawal by Subject|14|||
142982178|NCT01451398|515471101|FG000|Overall Study|Lost to Follow-up|6|||
142982179|NCT01451398|515471102|FG001|Overall Study|Lost to Follow-up|4|||
142982180|NCT01451398|515471101|FG000|Overall Study|Non-compliance with study drug|1|||
142982181|NCT01451398|515471102|FG001|Overall Study|Non-compliance with study drug|3|||
142982182|NCT01451398|515471101|FG000|Overall Study|Non-compliance with protocol|1|||
142982183|NCT01451398|515471102|FG001|Overall Study|Non-compliance with protocol|1|||
142982184|NCT01451398|515471101|FG000|Overall Study|Moved out of country|0|||
142982185|NCT01451398|515471102|FG001|Overall Study|Moved out of country|1|||
142982186|NCT01451398|515471101|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
142982187|NCT01451398|515471102|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
142982188|NCT01451398|515471101|FG000|Overall Study|Lack of Efficacy|0|||
142982189|NCT01451398|515471102|FG001|Overall Study|Lack of Efficacy|1|||
142982190|NCT01928082|515471104|FG000|Overall Study|Study terminated.|1|||
142982191|NCT01815580|515471108|FG000|Overall Study|Lost to Follow-up|4|||
142982192|NCT01815580|515471109|FG001|Overall Study|Lost to Follow-up|7|||
142982193|NCT01815580|515471108|FG000|Overall Study|Withdrawal by Subject|3|||
142982194|NCT01815580|515471109|FG001|Overall Study|Withdrawal by Subject|4|||
142982195|NCT01815580|515471108|FG000|Overall Study|Excluded from analysis|5|||
142982196|NCT01815580|515471109|FG001|Overall Study|Excluded from analysis|4|||
142982197|NCT02228564|515471110|FG000|Overall Study|Withdrawal by Subject|10|||
142982198|NCT02228564|515471110|FG000|Overall Study|Death|11|||
142982199|NCT02228564|515471110|FG000|Overall Study|Physician Decision|5|||
142982200|NCT02228564|515471110|FG000|Overall Study|Lost to Follow-up|17|||
142982201|NCT02228564|515471110|FG000|Overall Study|Other|6|||
142982202|NCT04114539|515471114|FG000|Overall Study|Adverse Event|14|||
142982203|NCT04114539|515471114|FG000|Overall Study|Lost to Follow-up|2|||
142982204|NCT04114539|515471114|FG000|Overall Study|Non-compliance with Protocol|2|||
142982205|NCT04114539|515471114|FG000|Overall Study|Non-compliance with Study Drug|1|||
142982206|NCT04114539|515471114|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
142982207|NCT04114539|515471114|FG000|Overall Study|Withdrew consent|10|||
142982208|NCT04114539|515471114|FG000|Overall Study|Others not specified|5|||
142982209|NCT04114539|515471114|FG000|Overall Study|Investigator Decision|2|||
142982210|NCT00166517|515471118|FG000|Overall Study|Lost to Follow-up|1|||
142982211|NCT00166517|515471119|FG001|Overall Study|Lost to Follow-up|0|||
142982212|NCT00166517|515471118|FG000|Overall Study|Protocol Violation|4|||
142982213|NCT00166517|515471119|FG001|Overall Study|Protocol Violation|1|||
142982214|NCT00166517|515471118|FG000|Overall Study|Withdrawal by Subject|0|||
142982215|NCT00166517|515471119|FG001|Overall Study|Withdrawal by Subject|1|||
142982216|NCT04285853|515471125|FG000|Overall Study|Withdrawal by Subject|1|||
142982217|NCT04285853|515471126|FG001|Overall Study|Withdrawal by Subject|0|||
142982218|NCT04285853|515471125|FG000|Overall Study|Lost to Follow-up|9|||
142982219|NCT04285853|515471126|FG001|Overall Study|Lost to Follow-up|5|||
142982220|NCT01072448|515471127|FG000|Overall Study|Adverse Event|9|||
142982221|NCT01072448|515471128|FG001|Overall Study|Adverse Event|10|||
142982222|NCT01072448|515471127|FG000|Overall Study|Subject withdrew consent|4|||
142982223|NCT01072448|515471128|FG001|Overall Study|Subject withdrew consent|9|||
142982224|NCT01072448|515471127|FG000|Overall Study|Protocol deviation|3|||
142982225|NCT01072448|515471128|FG001|Overall Study|Protocol deviation|4|||
142982226|NCT01072448|515471127|FG000|Overall Study|Abnormal test procedure result(s)|1|||
142982227|NCT01072448|515471128|FG001|Overall Study|Abnormal test procedure result(s)|0|||
142982228|NCT01072448|515471127|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
142982229|NCT01072448|515471128|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
142982230|NCT01072448|515471127|FG000|Overall Study|Lost to Follow-up|1|||
142982231|NCT01072448|515471128|FG001|Overall Study|Lost to Follow-up|1|||
142982232|NCT01072448|515471127|FG000|Overall Study|Abnormal laboratory value(s)|0|||
142982233|NCT01072448|515471128|FG001|Overall Study|Abnormal laboratory value(s)|1|||
142982234|NCT01072448|515471127|FG000|Overall Study|Death|0|||
142982235|NCT01072448|515471128|FG001|Overall Study|Death|2|||
142982236|NCT00588523|515471136|FG000|Overall Study|Not treated|3|||
142982237|NCT01459068|515471137|FG000|Overall Study|Withdrawal by Subject|8|||
142982238|NCT01459068|515471138|FG001|Overall Study|Withdrawal by Subject|18|||
142982239|NCT01459068|515471137|FG000|Overall Study|Lost to Follow-up|31|||
142982240|NCT01459068|515471138|FG001|Overall Study|Lost to Follow-up|15|||
142982241|NCT01459068|515471137|FG000|Overall Study|Death|0|||
142982242|NCT01459068|515471138|FG001|Overall Study|Death|1|||
142982243|NCT01015820|515471139|FG000|Overall Study|Suboptimal measurements|1|||
142982244|NCT01015820|515471140|FG001|Overall Study|Suboptimal measurements|0|||
142982245|NCT03136484|515471141|FG000|Overall Study|Withdrawal by Subject|19|||
142982246|NCT03136484|515471142|FG001|Overall Study|Withdrawal by Subject|14|||
142982247|NCT03136484|515471141|FG000|Overall Study|Lost to Follow-up|7|||
142982248|NCT03136484|515471142|FG001|Overall Study|Lost to Follow-up|8|||
142982249|NCT03136484|515471141|FG000|Overall Study|Death|1|||
142982250|NCT03136484|515471142|FG001|Overall Study|Death|0|||
142982251|NCT01449955|515471147|FG000|Overall Study|Withdrawal by Subject|1|||
142982252|NCT01449955|515471148|FG001|Overall Study|Withdrawal by Subject|2|||
142982253|NCT01601470|515471149|FG000|Period 2 - LCZ696|Physician Decision|1|||
142982254|NCT03032510|515471150|FG000|Overall Study|Adverse Event|5|||
142982255|NCT03032510|515471151|FG001|Overall Study|Adverse Event|2|||
142982256|NCT03032510|515471150|FG000|Overall Study|Lost to Follow-up|8|||
142982257|NCT03032510|515471151|FG001|Overall Study|Lost to Follow-up|7|||
142982258|NCT03032510|515471150|FG000|Overall Study|Withdrawal by Subject|8|||
142982259|NCT03032510|515471151|FG001|Overall Study|Withdrawal by Subject|7|||
142982260|NCT03032510|515471150|FG000|Overall Study|Subject noncompliance|4|||
142982261|NCT03032510|515471151|FG001|Overall Study|Subject noncompliance|2|||
142982262|NCT03032510|515471150|FG000|Overall Study|Physician Decision|2|||
142982263|NCT03032510|515471151|FG001|Overall Study|Physician Decision|0|||
142982264|NCT02999191|515471152|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
142982265|NCT02999191|515471153|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
142982266|NCT02999191|515471154|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
142982267|NCT01176240|515471159|FG000|Study 306A|Lack of Efficacy|2|||
142982268|NCT01176240|515471160|FG001|Study 306A|Lack of Efficacy|1|||
142982269|NCT01176240|515471159|FG000|Study 306A|Protocol Violation|0|||
142982270|NCT01176240|515471160|FG001|Study 306A|Protocol Violation|1|||
142982271|NCT01176240|515471159|FG000|Study 306A|Withdrawal by Subject|0|||
142982272|NCT01176240|515471160|FG001|Study 306A|Withdrawal by Subject|1|||
142982273|NCT01176240|515471159|FG000|Study 306A|Stop due to diverse problems|1|||
142982274|NCT01176240|515471160|FG001|Study 306A|Stop due to diverse problems|0|||
142982275|NCT01176240|515471159|FG000|Study 306B|Lack of Efficacy|5|||
142982276|NCT01176240|515471160|FG001|Study 306B|Lack of Efficacy|3|||
142982277|NCT01176240|515471159|FG000|Study 306B|Adverse Event|10|||
142982278|NCT01176240|515471160|FG001|Study 306B|Adverse Event|5|||
142982279|NCT01176240|515471159|FG000|Study 306B|Protocol Violation|2|||
142982280|NCT01176240|515471160|FG001|Study 306B|Protocol Violation|3|||
142982281|NCT01176240|515471159|FG000|Study 306B|Withdrawal by Subject|4|||
142982282|NCT01176240|515471160|FG001|Study 306B|Withdrawal by Subject|1|||
142982283|NCT01176240|515471159|FG000|Study 306B|Physician Decision|2|||
142982284|NCT01176240|515471160|FG001|Study 306B|Physician Decision|1|||
142982285|NCT01176240|515471159|FG000|Study 306B|Supine Hypertension|1|||
142982286|NCT01176240|515471160|FG001|Study 306B|Supine Hypertension|2|||
142982287|NCT01176240|515471159|FG000|Study 306B|Lost to Follow-up|0|||
142982288|NCT01176240|515471160|FG001|Study 306B|Lost to Follow-up|1|||
142982289|NCT01176240|515471159|FG000|Study 306B|withdrew prior to dosing|2|||
142982290|NCT01176240|515471160|FG001|Study 306B|withdrew prior to dosing|1|||
142982291|NCT03627494|515471164|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
142982292|NCT03627494|515471165|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
142982293|NCT03627494|515471166|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
142982294|NCT03627494|515471167|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
142982295|NCT03627494|515471168|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
142982296|NCT03627494|515471169|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
142982297|NCT03627494|515471170|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
142982298|NCT03627494|515471171|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
142982299|NCT03627494|515471172|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
142982300|NCT03627494|515471173|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
142982301|NCT03627494|515471174|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
142982302|NCT03627494|515471175|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
142982303|NCT03627494|515471164|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
142982304|NCT03627494|515471165|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
142982305|NCT03627494|515471166|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
142982306|NCT03627494|515471167|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
142982307|NCT03627494|515471168|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
142982308|NCT03627494|515471169|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
142982309|NCT03627494|515471170|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
142982310|NCT03627494|515471171|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
142982311|NCT03627494|515471172|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
142982312|NCT03627494|515471173|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
142982313|NCT03627494|515471174|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
142982314|NCT03627494|515471175|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
142982315|NCT03627494|515471164|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
142982316|NCT03627494|515471165|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
142982317|NCT03627494|515471166|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
142982318|NCT03627494|515471167|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
142982319|NCT03627494|515471168|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
142982320|NCT03627494|515471169|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
142982321|NCT03627494|515471170|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
142982322|NCT03627494|515471171|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
142982323|NCT03627494|515471172|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
142982324|NCT03627494|515471173|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
142982325|NCT03627494|515471174|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
142982326|NCT03627494|515471175|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
142982327|NCT00937326|515473522|FG000|Overall Study|Adverse Event|0|||
142982328|NCT00937326|515473523|FG001|Overall Study|Adverse Event|3|||
142982329|NCT00937326|515473524|FG002|Overall Study|Adverse Event|1|||
142982330|NCT00937326|515473525|FG003|Overall Study|Adverse Event|1|||
142982331|NCT00937326|515473526|FG004|Overall Study|Adverse Event|2|||
142982332|NCT00937326|515473522|FG000|Overall Study|Death|0|||
142982333|NCT00937326|515473523|FG001|Overall Study|Death|0|||
142982334|NCT00937326|515473524|FG002|Overall Study|Death|1|||
142982335|NCT00937326|515473525|FG003|Overall Study|Death|0|||
142982336|NCT00937326|515473526|FG004|Overall Study|Death|0|||
142982337|NCT00937326|515473522|FG000|Overall Study|Withdrawal by Subject|3|||
142982338|NCT00937326|515473523|FG001|Overall Study|Withdrawal by Subject|4|||
142982339|NCT00937326|515473524|FG002|Overall Study|Withdrawal by Subject|1|||
142982340|NCT00937326|515473525|FG003|Overall Study|Withdrawal by Subject|4|||
142982341|NCT00937326|515473526|FG004|Overall Study|Withdrawal by Subject|3|||
142982342|NCT00937326|515473522|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
142982343|NCT00937326|515473523|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
142982344|NCT00937326|515473524|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
142982345|NCT00937326|515473525|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
142982346|NCT00937326|515473526|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
142982347|NCT02578992|515473527|FG000|Overall Study|equipment not available or malfunction|3|||
142982348|NCT02578992|515473528|FG001|Overall Study|equipment not available or malfunction|3|||
142982349|NCT00790218|515473529|FG000|Overall Study|Death|1|||
142982350|NCT00790218|515473530|FG001|Overall Study|Death|0|||
142982351|NCT00790218|515473531|FG002|Overall Study|Death|0|||
142982352|NCT02443155|515473532|FG000|Overall Study|Adverse Event|3|||
142982353|NCT02443155|515473533|FG001|Overall Study|Adverse Event|4|||
142982354|NCT02443155|515473534|FG002|Overall Study|Adverse Event|1|||
142982355|NCT02443155|515473535|FG003|Overall Study|Adverse Event|2|||
142982356|NCT02443155|515473532|FG000|Overall Study|Unclassified|0|||
142982357|NCT02443155|515473533|FG001|Overall Study|Unclassified|0|||
142982358|NCT02443155|515473534|FG002|Overall Study|Unclassified|2|||
142982359|NCT02443155|515473535|FG003|Overall Study|Unclassified|1|||
142982360|NCT02443155|515473532|FG000|Overall Study|Withdrawal by Subject|4|||
142982361|NCT02443155|515473533|FG001|Overall Study|Withdrawal by Subject|7|||
142982362|NCT02443155|515473534|FG002|Overall Study|Withdrawal by Subject|3|||
142982363|NCT02443155|515473535|FG003|Overall Study|Withdrawal by Subject|9|||
142982364|NCT02443155|515473532|FG000|Overall Study|Pregnancy|3|||
142982365|NCT02443155|515473533|FG001|Overall Study|Pregnancy|1|||
142982366|NCT02443155|515473534|FG002|Overall Study|Pregnancy|1|||
142982367|NCT02443155|515473535|FG003|Overall Study|Pregnancy|2|||
142982368|NCT02443155|515473532|FG000|Overall Study|Lost to Follow-up|1|||
142982369|NCT02443155|515473533|FG001|Overall Study|Lost to Follow-up|2|||
142982370|NCT02443155|515473534|FG002|Overall Study|Lost to Follow-up|0|||
142982371|NCT02443155|515473535|FG003|Overall Study|Lost to Follow-up|1|||
142982372|NCT02443155|515473532|FG000|Overall Study|Protocol Violation|1|||
142982373|NCT02443155|515473533|FG001|Overall Study|Protocol Violation|0|||
142982374|NCT02443155|515473534|FG002|Overall Study|Protocol Violation|1|||
142982375|NCT02443155|515473535|FG003|Overall Study|Protocol Violation|1|||
142982376|NCT02443155|515473532|FG000|Overall Study|Death|0|||
142982377|NCT02443155|515473533|FG001|Overall Study|Death|0|||
142982378|NCT02443155|515473534|FG002|Overall Study|Death|1|||
142982379|NCT02443155|515473535|FG003|Overall Study|Death|0|||
142982380|NCT00405275|515473541|FG000|Overall Study|Death|1|||
142982381|NCT00405275|515473542|FG001|Overall Study|Death|0|||
142982382|NCT00405275|515473541|FG000|Overall Study|Lost to Follow-up|5|||
142982383|NCT00405275|515473542|FG001|Overall Study|Lost to Follow-up|1|||
142982384|NCT00405275|515473541|FG000|Overall Study|Withdrawal by Subject|7|||
142982385|NCT00405275|515473542|FG001|Overall Study|Withdrawal by Subject|9|||
142982386|NCT00405275|515473541|FG000|Overall Study|Unwilling to continue|10|||
142982387|NCT00405275|515473542|FG001|Overall Study|Unwilling to continue|9|||
142982388|NCT00731666|515473543|FG000|Overall Study|Adverse Event|2|||
143117225|NCT00787917|515970070|FG001|Blinded Treatment|Administrative problems|2|||
142982389|NCT00731666|515473543|FG000|Overall Study|Lost to Follow-up|8|||
142982390|NCT00731666|515473543|FG000|Overall Study|Withdrawal by Subject|2|||
142982391|NCT00088595|515473544|FG000|Overall Study|Adverse Event|11|||
142982392|NCT00088595|515473544|FG000|Overall Study|Withdrawal by Subject|8|||
143003170|NCT01049360|515548762|FG018|Period 2|Withdrawal by Subject|0|||
142982393|NCT00088595|515473544|FG000|Overall Study|Ongoing (After Core)|7|||
142982394|NCT00088595|515473544|FG000|Overall Study|New Cancer Therapy|2|||
142982395|NCT02853123|515473549|FG000|Treatment Period 1|Adverse Event|0|||
142982396|NCT02853123|515473550|FG001|Treatment Period 1|Adverse Event|3|||
142982397|NCT02853123|515473549|FG000|Washout Period|Worsening of COPD|0|||
142982398|NCT02853123|515473550|FG001|Washout Period|Worsening of COPD|3|||
142982399|NCT02853123|515473549|FG000|Washout Period|Adverse Event|1|||
142982400|NCT02853123|515473550|FG001|Washout Period|Adverse Event|0|||
142982401|NCT01224106|515473552|FG000|Double-Blind Treatment Phase|Death|3|||
142982402|NCT01224106|515473553|FG001|Double-Blind Treatment Phase|Death|0|||
142982403|NCT01224106|515473554|FG002|Double-Blind Treatment Phase|Death|0|||
142982404|NCT01224106|515473555|FG003|Double-Blind Treatment Phase|Death|0|||
142982405|NCT01224106|515473556|FG004|Double-Blind Treatment Phase|Death|0|||
142982406|NCT01224106|515473552|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
142982407|NCT01224106|515473553|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
142982408|NCT01224106|515473554|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
142982409|NCT01224106|515473555|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
142982410|NCT01224106|515473556|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
142982411|NCT01224106|515473552|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
142982412|NCT01224106|515473553|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
142982413|NCT01224106|515473554|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
142982414|NCT01224106|515473555|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
142982415|NCT01224106|515473556|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
142982416|NCT01224106|515473552|FG000|Double-Blind Treatment Phase|Other|0|||
142982417|NCT01224106|515473553|FG001|Double-Blind Treatment Phase|Other|0|||
142982418|NCT01224106|515473554|FG002|Double-Blind Treatment Phase|Other|1|||
142982419|NCT01224106|515473555|FG003|Double-Blind Treatment Phase|Other|0|||
142982420|NCT01224106|515473556|FG004|Double-Blind Treatment Phase|Other|0|||
142982421|NCT01224106|515473552|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
142982422|NCT01224106|515473553|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
142982423|NCT01224106|515473554|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
142982424|NCT01224106|515473555|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
142982425|NCT01224106|515473556|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
142982426|NCT01224106|515473552|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
142982427|NCT01224106|515473553|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
142982428|NCT01224106|515473554|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
142982429|NCT01224106|515473555|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
142982430|NCT01224106|515473556|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
142982431|NCT01224106|515473552|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
142982432|NCT01224106|515473553|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
142982433|NCT01224106|515473554|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
142982434|NCT01224106|515473555|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
142982435|NCT01224106|515473556|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
142982436|NCT01224106|515473552|FG000|Open-Label Extension (OLE) Phase|Death|0|||
142982437|NCT01224106|515473553|FG001|Open-Label Extension (OLE) Phase|Death|0|||
142982438|NCT01224106|515473554|FG002|Open-Label Extension (OLE) Phase|Death|0|||
142982439|NCT01224106|515473555|FG003|Open-Label Extension (OLE) Phase|Death|1|||
142982440|NCT01224106|515473556|FG004|Open-Label Extension (OLE) Phase|Death|3|||
142982441|NCT01224106|515473552|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
142982442|NCT01224106|515473553|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
142982443|NCT01224106|515473554|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
142982444|NCT01224106|515473555|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
142982445|NCT01224106|515473556|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
142982446|NCT01224106|515473552|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
142982447|NCT01224106|515473553|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
142982448|NCT01224106|515473554|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
142982449|NCT01224106|515473555|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
142982450|NCT01224106|515473556|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
142982451|NCT01224106|515473552|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
142982452|NCT01224106|515473553|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
142982453|NCT01224106|515473554|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
142982454|NCT01224106|515473555|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
142982455|NCT01224106|515473556|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
142982456|NCT01224106|515473552|FG000|Open-Label Extension (OLE) Phase|Other|0|||
142982457|NCT01224106|515473553|FG001|Open-Label Extension (OLE) Phase|Other|0|||
142982458|NCT01224106|515473554|FG002|Open-Label Extension (OLE) Phase|Other|0|||
142982459|NCT01224106|515473555|FG003|Open-Label Extension (OLE) Phase|Other|5|||
142982460|NCT01224106|515473556|FG004|Open-Label Extension (OLE) Phase|Other|3|||
142982461|NCT02133001|515473557|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
142982462|NCT02133001|515473558|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
143003171|NCT01049360|515548763|FG019|Period 2|Withdrawal by Subject|1|||
142982463|NCT02133001|515473557|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
142982464|NCT02133001|515473558|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
142982465|NCT02133001|515473557|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
142982466|NCT02133001|515473558|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
142982467|NCT02133001|515473557|FG000|Double Blind (Day 1-25)|Other|2|||
142982468|NCT02133001|515473558|FG001|Double Blind (Day 1-25)|Other|2|||
142982469|NCT02133001|515473557|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
142982470|NCT02133001|515473558|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
142982471|NCT02133001|515473557|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
142982472|NCT02133001|515473558|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
142982473|NCT02133001|515473557|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
142982474|NCT02133001|515473558|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
142982475|NCT02133001|515473557|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
142982476|NCT02133001|515473558|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
142982477|NCT03210220|515473561|FG000|Overall Study|Physician Decision|1|||
142982478|NCT03210220|515473562|FG001|Overall Study|Physician Decision|0|||
142982479|NCT00839436|515473563|FG000|Overall Study|Developed exclusionary condition|1|||
142982480|NCT00839436|515473564|FG001|Overall Study|Developed exclusionary condition|0|||
142982481|NCT00839436|515473565|FG002|Overall Study|Developed exclusionary condition|0|||
142982482|NCT00839436|515473563|FG000|Overall Study|Withdrawal by Subject|0|||
142982483|NCT00839436|515473564|FG001|Overall Study|Withdrawal by Subject|1|||
142982484|NCT00839436|515473565|FG002|Overall Study|Withdrawal by Subject|0|||
142982485|NCT00839436|515473563|FG000|Overall Study|Study drug no longer available|0|||
142982486|NCT00839436|515473564|FG001|Overall Study|Study drug no longer available|0|||
142982487|NCT00839436|515473565|FG002|Overall Study|Study drug no longer available|1|||
142982488|NCT00407550|515473566|FG000|Overall Study|Adverse Event|0|||
142982489|NCT00407550|515473567|FG001|Overall Study|Adverse Event|1|||
142982490|NCT00407550|515473566|FG000|Overall Study|Withdrawal by Subject|0|||
142982491|NCT00407550|515473567|FG001|Overall Study|Withdrawal by Subject|2|||
142982492|NCT00407550|515473566|FG000|Overall Study|Death|1|||
142982493|NCT00407550|515473567|FG001|Overall Study|Death|0|||
142982494|NCT00407550|515473566|FG000|Overall Study|Insurance or Other medical condition|2|||
142982495|NCT00407550|515473567|FG001|Overall Study|Insurance or Other medical condition|1|||
142982496|NCT02580591|515473569|FG000|Overall Study|Adverse Event|0|||
142982497|NCT02580591|515473570|FG001|Overall Study|Adverse Event|1|||
142982498|NCT02580591|515473571|FG002|Overall Study|Adverse Event|2|||
142982499|NCT02580591|515473572|FG003|Overall Study|Adverse Event|5|||
142982500|NCT02580591|515473569|FG000|Overall Study|Protocol Violation|3|||
142982501|NCT02580591|515473570|FG001|Overall Study|Protocol Violation|2|||
142982502|NCT02580591|515473571|FG002|Overall Study|Protocol Violation|1|||
142982503|NCT02580591|515473572|FG003|Overall Study|Protocol Violation|1|||
142982504|NCT02580591|515473569|FG000|Overall Study|Lost to Follow-up|5|||
142982505|NCT02580591|515473570|FG001|Overall Study|Lost to Follow-up|3|||
142982506|NCT02580591|515473571|FG002|Overall Study|Lost to Follow-up|3|||
142982507|NCT02580591|515473572|FG003|Overall Study|Lost to Follow-up|1|||
142982508|NCT02580591|515473569|FG000|Overall Study|Withdrawal by Subject|6|||
142982509|NCT02580591|515473570|FG001|Overall Study|Withdrawal by Subject|1|||
142982510|NCT02580591|515473571|FG002|Overall Study|Withdrawal by Subject|2|||
142982511|NCT02580591|515473572|FG003|Overall Study|Withdrawal by Subject|3|||
142982512|NCT02580591|515473569|FG000|Overall Study|Not treated|1|||
142982513|NCT02580591|515473570|FG001|Overall Study|Not treated|1|||
142982514|NCT02580591|515473571|FG002|Overall Study|Not treated|0|||
142982515|NCT02580591|515473572|FG003|Overall Study|Not treated|0|||
142982516|NCT02580591|515473569|FG000|Overall Study|Other than specified|3|||
142982517|NCT02580591|515473570|FG001|Overall Study|Other than specified|2|||
142982518|NCT02580591|515473571|FG002|Overall Study|Other than specified|5|||
142982519|NCT02580591|515473572|FG003|Overall Study|Other than specified|2|||
142982520|NCT01599806|515473575|FG000|Overall Study|Lost to Follow-up|20|||
142982521|NCT01599806|515473576|FG001|Overall Study|Lost to Follow-up|20|||
142982522|NCT01599806|515473575|FG000|Overall Study|Withdrawal by Subject|12|||
142982523|NCT01599806|515473576|FG001|Overall Study|Withdrawal by Subject|12|||
142982524|NCT01599806|515473575|FG000|Overall Study|Other Eligibility criteria|11|||
142982525|NCT01599806|515473576|FG001|Overall Study|Other Eligibility criteria|9|||
142982526|NCT03006926|515473580|FG000|Overall Study|Adverse Event|0|||
142982527|NCT03006926|515473581|FG001|Overall Study|Adverse Event|27|||
142982528|NCT03006926|515473580|FG000|Overall Study|Withdrawal by Subject|0|||
142982529|NCT03006926|515473581|FG001|Overall Study|Withdrawal by Subject|1|||
142982530|NCT03006926|515473580|FG000|Overall Study|Radiological Disease Progression|0|||
142982531|NCT03006926|515473581|FG001|Overall Study|Radiological Disease Progression|52|||
142982532|NCT03006926|515473580|FG000|Overall Study|Clinical Disease Progression|0|||
142982533|NCT03006926|515473581|FG001|Overall Study|Clinical Disease Progression|10|||
142982534|NCT03006926|515473580|FG000|Overall Study|Other|0|||
142982535|NCT03006926|515473581|FG001|Overall Study|Other|8|||
142982536|NCT02417064|515473582|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
142982537|NCT02417064|515473583|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
142982538|NCT02417064|515473584|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
142982539|NCT02417064|515473582|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
142982540|NCT02417064|515473583|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
142982541|NCT02417064|515473584|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
142982542|NCT02417064|515473582|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
142982543|NCT02417064|515473583|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
142982544|NCT02417064|515473584|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
142982545|NCT02417064|515473582|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
142982546|NCT02417064|515473583|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
142982547|NCT02417064|515473584|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
142982548|NCT02417064|515473582|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
142982549|NCT02417064|515473583|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
142982550|NCT02417064|515473584|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
142982551|NCT02417064|515473582|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
142982552|NCT02417064|515473583|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
142982553|NCT02417064|515473584|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
142982554|NCT02417064|515473582|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
142982555|NCT02417064|515473583|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
142982556|NCT02417064|515473584|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
142982557|NCT02417064|515473582|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
142982558|NCT02417064|515473583|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
142982559|NCT02417064|515473584|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
142982560|NCT02417064|515473582|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
142982561|NCT02417064|515473583|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
142982562|NCT02417064|515473584|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
142982563|NCT02417064|515473582|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
142982564|NCT02417064|515473583|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
142982565|NCT02417064|515473584|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
142982566|NCT02417064|515473582|FG000|Follow-up Phase (24 Weeks)|Other|2|||
142982567|NCT02417064|515473583|FG001|Follow-up Phase (24 Weeks)|Other|2|||
142982568|NCT02417064|515473584|FG002|Follow-up Phase (24 Weeks)|Other|3|||
142982569|NCT01585168|515473593|FG000|Overall Study|Lost to Follow-up|3|||
142982570|NCT01585168|515473594|FG001|Overall Study|Lost to Follow-up|1|||
142982571|NCT01585168|515473595|FG002|Overall Study|Lost to Follow-up|1|||
142982572|NCT01585168|515473596|FG003|Overall Study|Lost to Follow-up|1|||
142982573|NCT01194414|515473597|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
142982574|NCT01194414|515473598|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
142982575|NCT01194414|515473599|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
142982576|NCT01194414|515473600|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
142982577|NCT01194414|515473597|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
142982578|NCT01194414|515473598|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
142982579|NCT01194414|515473599|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
142982580|NCT01194414|515473600|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
142982581|NCT01194414|515473597|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
142982582|NCT01194414|515473598|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
142982583|NCT01194414|515473599|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
142982584|NCT01194414|515473600|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
142982585|NCT01194414|515473597|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
142982586|NCT01194414|515473598|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
142982587|NCT01194414|515473599|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
142982588|NCT01194414|515473600|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
142982589|NCT01194414|515473597|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
142982590|NCT01194414|515473598|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
142982591|NCT01194414|515473599|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
142982592|NCT01194414|515473600|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
142982593|NCT01194414|515473597|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
142982594|NCT01194414|515473598|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
142982595|NCT01194414|515473599|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
142982596|NCT01194414|515473600|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
142982597|NCT01194414|515473597|FG000|24 Weeks Double Blind Period|Other|0|||
142982598|NCT01194414|515473598|FG001|24 Weeks Double Blind Period|Other|1|||
142982599|NCT01194414|515473599|FG002|24 Weeks Double Blind Period|Other|0|||
142982600|NCT01194414|515473600|FG003|24 Weeks Double Blind Period|Other|0|||
142982601|NCT01194414|515473597|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
142982602|NCT01194414|515473598|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
142982603|NCT01194414|515473599|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
142982604|NCT01194414|515473600|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
142982605|NCT01194414|515473597|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
142982606|NCT01194414|515473598|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
142982607|NCT01194414|515473599|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
142982608|NCT01194414|515473600|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
142982609|NCT01194414|515473597|FG000|24 Weeks Double Blind Period|Death|0|||
142982610|NCT01194414|515473598|FG001|24 Weeks Double Blind Period|Death|1|||
142982611|NCT01194414|515473599|FG002|24 Weeks Double Blind Period|Death|0|||
142982612|NCT01194414|515473600|FG003|24 Weeks Double Blind Period|Death|0|||
142982613|NCT01194414|515473597|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
142982614|NCT01194414|515473598|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
142982615|NCT01194414|515473599|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
142982616|NCT01194414|515473600|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
142982617|NCT01194414|515473597|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
142982618|NCT01194414|515473598|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
142982619|NCT01194414|515473599|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
142982620|NCT01194414|515473600|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
142982621|NCT01194414|515473597|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
142982622|NCT01194414|515473598|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
142982623|NCT01194414|515473599|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
142982624|NCT01194414|515473600|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
142982625|NCT01194414|515473597|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
142982626|NCT01194414|515473598|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
142982627|NCT01194414|515473599|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
142982628|NCT01194414|515473600|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
142982629|NCT01194414|515473597|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
142982630|NCT01194414|515473598|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
142982631|NCT01194414|515473599|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
142982632|NCT01194414|515473600|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
142982633|NCT01194414|515473597|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
142982634|NCT01194414|515473598|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
142982635|NCT01194414|515473599|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
142982636|NCT01194414|515473600|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
142982637|NCT01194414|515473597|FG000|72 Weeks Open Label Extension|Other|2|||
142982638|NCT01194414|515473598|FG001|72 Weeks Open Label Extension|Other|1|||
142982639|NCT01194414|515473599|FG002|72 Weeks Open Label Extension|Other|0|||
142982640|NCT01194414|515473600|FG003|72 Weeks Open Label Extension|Other|0|||
142982641|NCT01194414|515473597|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
142982642|NCT01194414|515473598|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
142982643|NCT01194414|515473599|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
142982644|NCT01194414|515473600|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
142982645|NCT01194414|515473597|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
142982646|NCT01194414|515473598|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
142982647|NCT01194414|515473599|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
142982648|NCT01194414|515473600|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
142982649|NCT01194414|515473597|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
142982650|NCT01194414|515473598|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
142982651|NCT01194414|515473599|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
142982652|NCT01194414|515473600|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
142982653|NCT01194414|515473597|FG000|72 Weeks Open Label Extension|Death|1|||
142982654|NCT01194414|515473598|FG001|72 Weeks Open Label Extension|Death|2|||
142982655|NCT01194414|515473599|FG002|72 Weeks Open Label Extension|Death|0|||
142982656|NCT01194414|515473600|FG003|72 Weeks Open Label Extension|Death|2|||
142982657|NCT01192100|515473601|FG000|Overall Study|Withdrawal by Subject|0|||
142982658|NCT01192100|515473602|FG001|Overall Study|Withdrawal by Subject|0|||
142982659|NCT01192100|515473603|FG002|Overall Study|Withdrawal by Subject|0|||
142982660|NCT01192100|515473604|FG003|Overall Study|Withdrawal by Subject|0|||
142982661|NCT01192100|515473605|FG004|Overall Study|Withdrawal by Subject|1|||
142982662|NCT01192100|515473606|FG005|Overall Study|Withdrawal by Subject|0|||
142982663|NCT01192100|515473601|FG000|Overall Study|Protocol Violation|0|||
142982664|NCT01192100|515473602|FG001|Overall Study|Protocol Violation|0|||
142982665|NCT01192100|515473603|FG002|Overall Study|Protocol Violation|0|||
142982666|NCT01192100|515473604|FG003|Overall Study|Protocol Violation|1|||
142982667|NCT01192100|515473605|FG004|Overall Study|Protocol Violation|0|||
142982668|NCT01192100|515473606|FG005|Overall Study|Protocol Violation|0|||
142982669|NCT02057068|515473607|FG000|Overall Study|Withdrawal by Subject|2|||
142982670|NCT02057068|515473608|FG001|Overall Study|Withdrawal by Subject|2|||
142982671|NCT02057068|515473607|FG000|Overall Study|Caregiver (CG) Health|0|||
142982672|NCT02057068|515473608|FG001|Overall Study|Caregiver (CG) Health|2|||
142982673|NCT02057068|515473607|FG000|Overall Study|Carepartner (CP) Health|4|||
142982674|NCT02057068|515473608|FG001|Overall Study|Carepartner (CP) Health|2|||
142982675|NCT02057068|515473607|FG000|Overall Study|Lost to Follow-up|2|||
142982676|NCT02057068|515473608|FG001|Overall Study|Lost to Follow-up|2|||
142982677|NCT00865046|515473610|FG000|Overall Study|Lost to Follow-up|1|||
142982678|NCT00865046|515473611|FG001|Overall Study|Lost to Follow-up|4|||
142982679|NCT00865046|515473612|FG002|Overall Study|Lost to Follow-up|0|||
142982680|NCT00865046|515473610|FG000|Overall Study|Death|0|||
142982681|NCT00865046|515473611|FG001|Overall Study|Death|1|||
142982682|NCT00865046|515473612|FG002|Overall Study|Death|1|||
142982683|NCT00865046|515473610|FG000|Overall Study|Withdrawal by Subject|5|||
142982684|NCT00865046|515473611|FG001|Overall Study|Withdrawal by Subject|0|||
142982685|NCT00865046|515473612|FG002|Overall Study|Withdrawal by Subject|0|||
142982686|NCT03447821|515473616|FG000|Overall Study|Withdrawal by Subject|1|||
142982687|NCT03447821|515473617|FG001|Overall Study|Withdrawal by Subject|1|||
142982688|NCT03447821|515473618|FG002|Overall Study|Withdrawal by Subject|0|||
142982689|NCT03447821|515473616|FG000|Overall Study|Lost to Follow-up|0|||
142982690|NCT03447821|515473617|FG001|Overall Study|Lost to Follow-up|0|||
142982691|NCT03447821|515473618|FG002|Overall Study|Lost to Follow-up|1|||
142982692|NCT04685538|515473619|FG000|Overall Study|Adverse Event|0|||
142982693|NCT04685538|515473620|FG001|Overall Study|Adverse Event|1|||
142982694|NCT04685538|515473619|FG000|Overall Study|Lost to Follow-up|0|||
142982695|NCT04685538|515473620|FG001|Overall Study|Lost to Follow-up|2|||
142982696|NCT03168555|515473622|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
142982697|NCT03168555|515473622|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
142982698|NCT03168555|515473622|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
142982699|NCT03168555|515473622|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
142982700|NCT02475629|515473623|FG000|Overall Study|Adverse Event|1|||
142982701|NCT02475629|515473623|FG000|Overall Study|Death|4|||
142982702|NCT02475629|515473623|FG000|Overall Study|Physician Decision|1|||
142982703|NCT02475629|515473623|FG000|Overall Study|Withdrawal by Subject|1|||
142982704|NCT02475629|515473623|FG000|Overall Study|Lost to Follow-up|1|||
142982705|NCT02475629|515473623|FG000|Overall Study|Subject non-compliance|1|||
142982706|NCT01421069|515473624|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
142982707|NCT01421069|515473624|FG000|Parent Study|Failed to return|3|||
142982708|NCT01421069|515473624|FG000|Parent Study|Withdrawal by Subject|1|||
142982709|NCT01421069|515473624|FG000|Parent Study|Lost to Follow-up|2|||
142982710|NCT01421069|515473624|FG000|Parent Study|Lack of Efficacy|1|||
142982711|NCT01421069|515473624|FG000|Overall Period for Extension Study|Other|2|||
142982712|NCT01421069|515473624|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
142982713|NCT01421069|515473624|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
142982714|NCT01421069|515473624|FG000|Overall Period for Extension Study|Pregnancy|1|||
142982715|NCT01421069|515473624|FG000|Overall Period for Extension Study|Adverse Event|1|||
142982716|NCT01421069|515473624|FG000|Overall Period for Extension Study|Protocol Violation|1|||
142982717|NCT01421069|515473624|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
142982718|NCT01421069|515473624|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
142982719|NCT01421069|515473624|FG000|Active Treatment Period|Other|1|||
142982720|NCT01421069|515473624|FG000|Active Treatment Period|No longer willing to participate in study|8|||
142982721|NCT01421069|515473624|FG000|Active Treatment Period|Insufficient clinical response|1|||
142982722|NCT01421069|515473624|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
142982723|NCT01421069|515473624|FG000|Active Treatment Period|Pregnancy|1|||
142982724|NCT01421069|515473624|FG000|Active Treatment Period|Adverse Event|1|||
142982725|NCT01421069|515473624|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
142982726|NCT01421069|515473624|FG000|Active Treatment Period|Enrolled in observational period|29|||
142982727|NCT01421069|515473624|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
142982728|NCT01421069|515473624|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
142982729|NCT01421069|515473624|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
142982730|NCT01421069|515473624|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
142982731|NCT01421069|515473624|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
142982732|NCT01421069|515473624|FG000|2b. Retreatment Period|Protocol Violation|1|||
142982733|NCT01421069|515473624|FG000|Observational Period|Other|1|||
142982734|NCT01421069|515473624|FG000|Observational Period|No longer willing to participate in study|4|||
142982735|NCT01421069|515473624|FG000|Observational Period|Lost to Follow-up|3|||
142982736|NCT01641081|515473630|FG000|Period 1|Sponsor request (potential unblinding)|0|||
142982737|NCT01641081|515473631|FG001|Period 1|Sponsor request (potential unblinding)|0|||
142982738|NCT01641081|515473632|FG002|Period 1|Sponsor request (potential unblinding)|0|||
142982739|NCT01641081|515473633|FG003|Period 1|Sponsor request (potential unblinding)|0|||
142982740|NCT01641081|515473634|FG004|Period 1|Sponsor request (potential unblinding)|0|||
142982741|NCT01641081|515473635|FG005|Period 1|Sponsor request (potential unblinding)|0|||
142982742|NCT01641081|515473636|FG006|Period 1|Sponsor request (potential unblinding)|1|||
142982743|NCT01641081|515473637|FG007|Period 1|Sponsor request (potential unblinding)|0|||
142982744|NCT01641081|515473638|FG008|Period 1|Sponsor request (potential unblinding)|0|||
142982745|NCT01641081|515473639|FG009|Period 1|Sponsor request (potential unblinding)|0|||
142982746|NCT01641081|515473630|FG000|Period 1|Protocol Violation|0|||
142982747|NCT01641081|515473631|FG001|Period 1|Protocol Violation|0|||
142982748|NCT01641081|515473632|FG002|Period 1|Protocol Violation|0|||
142982749|NCT01641081|515473633|FG003|Period 1|Protocol Violation|0|||
142982750|NCT01641081|515473634|FG004|Period 1|Protocol Violation|1|||
142982751|NCT01641081|515473635|FG005|Period 1|Protocol Violation|0|||
142982752|NCT01641081|515473636|FG006|Period 1|Protocol Violation|0|||
142982753|NCT01641081|515473637|FG007|Period 1|Protocol Violation|1|||
142982754|NCT01641081|515473638|FG008|Period 1|Protocol Violation|0|||
142982755|NCT01641081|515473639|FG009|Period 1|Protocol Violation|0|||
142982756|NCT01641081|515473630|FG000|Period 1|Adverse Event|1|||
142982757|NCT01641081|515473631|FG001|Period 1|Adverse Event|0|||
142982758|NCT01641081|515473632|FG002|Period 1|Adverse Event|0|||
142982759|NCT01641081|515473633|FG003|Period 1|Adverse Event|0|||
142982760|NCT01641081|515473634|FG004|Period 1|Adverse Event|0|||
142982761|NCT01641081|515473635|FG005|Period 1|Adverse Event|0|||
142982762|NCT01641081|515473636|FG006|Period 1|Adverse Event|0|||
142982763|NCT01641081|515473637|FG007|Period 1|Adverse Event|2|||
142982764|NCT01641081|515473638|FG008|Period 1|Adverse Event|0|||
142982765|NCT01641081|515473639|FG009|Period 1|Adverse Event|0|||
142982766|NCT01641081|515473630|FG000|Period 2|Adverse Event|0|||
142982767|NCT01641081|515473631|FG001|Period 2|Adverse Event|0|||
142982768|NCT01641081|515473632|FG002|Period 2|Adverse Event|0|||
142982769|NCT01641081|515473633|FG003|Period 2|Adverse Event|0|||
142982770|NCT01641081|515473634|FG004|Period 2|Adverse Event|0|||
142982771|NCT01641081|515473635|FG005|Period 2|Adverse Event|1|||
142982772|NCT01641081|515473636|FG006|Period 2|Adverse Event|0|||
142982773|NCT01641081|515473637|FG007|Period 2|Adverse Event|0|||
142982774|NCT01641081|515473638|FG008|Period 2|Adverse Event|0|||
142982775|NCT01641081|515473639|FG009|Period 2|Adverse Event|0|||
142982776|NCT01641081|515473630|FG000|Period 2|Withdrawal by Subject|0|||
142982777|NCT01641081|515473631|FG001|Period 2|Withdrawal by Subject|0|||
142982778|NCT01641081|515473632|FG002|Period 2|Withdrawal by Subject|0|||
142982779|NCT01641081|515473633|FG003|Period 2|Withdrawal by Subject|1|||
142982780|NCT01641081|515473634|FG004|Period 2|Withdrawal by Subject|0|||
142982781|NCT01641081|515473635|FG005|Period 2|Withdrawal by Subject|0|||
142982782|NCT01641081|515473636|FG006|Period 2|Withdrawal by Subject|2|||
142982783|NCT01641081|515473637|FG007|Period 2|Withdrawal by Subject|0|||
142982784|NCT01641081|515473638|FG008|Period 2|Withdrawal by Subject|0|||
142982785|NCT01641081|515473639|FG009|Period 2|Withdrawal by Subject|0|||
142982786|NCT01641081|515473630|FG000|Period 2|Protocol Violation|1|||
142982787|NCT01641081|515473631|FG001|Period 2|Protocol Violation|0|||
142982788|NCT01641081|515473632|FG002|Period 2|Protocol Violation|0|||
142982789|NCT01641081|515473633|FG003|Period 2|Protocol Violation|0|||
142982790|NCT01641081|515473634|FG004|Period 2|Protocol Violation|0|||
142982791|NCT01641081|515473635|FG005|Period 2|Protocol Violation|0|||
142982792|NCT01641081|515473636|FG006|Period 2|Protocol Violation|0|||
142982793|NCT01641081|515473637|FG007|Period 2|Protocol Violation|0|||
142982794|NCT01641081|515473638|FG008|Period 2|Protocol Violation|0|||
142982795|NCT01641081|515473639|FG009|Period 2|Protocol Violation|0|||
142982796|NCT01641081|515473630|FG000|Period 3|Adverse Event|0|||
142982797|NCT01641081|515473631|FG001|Period 3|Adverse Event|0|||
142982798|NCT01641081|515473632|FG002|Period 3|Adverse Event|1|||
142982799|NCT01641081|515473633|FG003|Period 3|Adverse Event|0|||
142982800|NCT01641081|515473634|FG004|Period 3|Adverse Event|0|||
142982801|NCT01641081|515473635|FG005|Period 3|Adverse Event|0|||
142982802|NCT01641081|515473636|FG006|Period 3|Adverse Event|0|||
142982803|NCT01641081|515473637|FG007|Period 3|Adverse Event|0|||
142982804|NCT01641081|515473638|FG008|Period 3|Adverse Event|0|||
142982805|NCT01641081|515473639|FG009|Period 3|Adverse Event|0|||
142982806|NCT01641081|515473630|FG000|Period 3|Withdrawal by Subject|0|||
142982807|NCT01641081|515473631|FG001|Period 3|Withdrawal by Subject|0|||
142982808|NCT01641081|515473632|FG002|Period 3|Withdrawal by Subject|0|||
142982809|NCT01641081|515473633|FG003|Period 3|Withdrawal by Subject|0|||
142982810|NCT01641081|515473634|FG004|Period 3|Withdrawal by Subject|0|||
142982811|NCT01641081|515473635|FG005|Period 3|Withdrawal by Subject|0|||
142982812|NCT01641081|515473636|FG006|Period 3|Withdrawal by Subject|0|||
142982813|NCT01641081|515473637|FG007|Period 3|Withdrawal by Subject|0|||
142982814|NCT01641081|515473638|FG008|Period 3|Withdrawal by Subject|1|||
142982815|NCT01641081|515473639|FG009|Period 3|Withdrawal by Subject|0|||
142982816|NCT01641081|515473630|FG000|Period 4|Adverse Event|0|||
142982817|NCT01641081|515473631|FG001|Period 4|Adverse Event|1|||
142982818|NCT01641081|515473632|FG002|Period 4|Adverse Event|0|||
142982819|NCT01641081|515473633|FG003|Period 4|Adverse Event|1|||
142982820|NCT01641081|515473634|FG004|Period 4|Adverse Event|0|||
142982821|NCT01641081|515473635|FG005|Period 4|Adverse Event|0|||
142982822|NCT01641081|515473636|FG006|Period 4|Adverse Event|0|||
142982823|NCT01641081|515473637|FG007|Period 4|Adverse Event|0|||
142982824|NCT01641081|515473638|FG008|Period 4|Adverse Event|0|||
142982825|NCT01641081|515473639|FG009|Period 4|Adverse Event|0|||
142982826|NCT01641081|515473630|FG000|Period 5|Adverse Event|0|||
142982827|NCT01641081|515473631|FG001|Period 5|Adverse Event|0|||
142982828|NCT01641081|515473632|FG002|Period 5|Adverse Event|2|||
142982829|NCT01641081|515473633|FG003|Period 5|Adverse Event|0|||
142982830|NCT01641081|515473634|FG004|Period 5|Adverse Event|0|||
142982831|NCT01641081|515473635|FG005|Period 5|Adverse Event|0|||
142982832|NCT01641081|515473636|FG006|Period 5|Adverse Event|0|||
142982833|NCT01641081|515473637|FG007|Period 5|Adverse Event|0|||
142982834|NCT01641081|515473638|FG008|Period 5|Adverse Event|0|||
142982835|NCT01641081|515473639|FG009|Period 5|Adverse Event|0|||
142982836|NCT01095666|515473643|FG000|Overall Study|Lack of Efficacy|0|||
142982837|NCT01095666|515473644|FG001|Overall Study|Lack of Efficacy|0|||
142982838|NCT01095666|515473645|FG002|Overall Study|Lack of Efficacy|1|||
142982839|NCT01095666|515473643|FG000|Overall Study|Adverse Event|2|||
142982840|NCT01095666|515473644|FG001|Overall Study|Adverse Event|1|||
142982841|NCT01095666|515473645|FG002|Overall Study|Adverse Event|3|||
142982842|NCT01095666|515473643|FG000|Overall Study|Lost to Follow-up|2|||
142982843|NCT01095666|515473644|FG001|Overall Study|Lost to Follow-up|2|||
142982844|NCT01095666|515473645|FG002|Overall Study|Lost to Follow-up|0|||
142982845|NCT01095666|515473643|FG000|Overall Study|Withdrawal by Subject|6|||
142982846|NCT01095666|515473644|FG001|Overall Study|Withdrawal by Subject|6|||
142982847|NCT01095666|515473645|FG002|Overall Study|Withdrawal by Subject|1|||
142982848|NCT01095666|515473643|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
142982849|NCT01095666|515473644|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
142982850|NCT01095666|515473645|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
142982851|NCT01749800|515473647|FG000|Overall Study|not meeting inclusion criteria|3|||
142982852|NCT01749800|515473648|FG001|Overall Study|not meeting inclusion criteria|0|||
142982853|NCT01749800|515473649|FG002|Overall Study|not meeting inclusion criteria|0|||
142982854|NCT01749800|515473647|FG000|Overall Study|Withdrawal by Subject|0|||
142982855|NCT01749800|515473648|FG001|Overall Study|Withdrawal by Subject|1|||
142982856|NCT01749800|515473649|FG002|Overall Study|Withdrawal by Subject|0|||
142982857|NCT00842361|515473654|FG000|Overall Study|Protocol Violation|1|||
142982858|NCT00842361|515473655|FG001|Overall Study|Protocol Violation|0|||
142982859|NCT00842361|515473654|FG000|Overall Study|Unclassified|0|||
142982860|NCT00842361|515473655|FG001|Overall Study|Unclassified|2|||
142982861|NCT03094611|515473656|FG000|Overall Study|Lack of Efficacy|1|||
142982862|NCT03094611|515473656|FG000|Overall Study|Stem Cell Transplant|1|||
142982863|NCT02186561|515473657|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
142982864|NCT02186561|515473657|FG000|Enrollment|Enrollment Cap Reached|5|||
142982865|NCT02186561|515473657|FG000|Enrollment|Insurance Denial|2|||
142982866|NCT02186561|515473657|FG000|Enrollment|Withdrawal by Subject|2|||
142982867|NCT02186561|515473657|FG000|Enrollment|Investigator Withdrew Consent|1|||
142982868|NCT02186561|515473657|FG000|30-Day Post Index Procedure Visit|Death|1|||
142982869|NCT02186561|515473657|FG000|1- Year Post Index Procedure Visit|Death|1|||
142982870|NCT02186561|515473657|FG000|1- Year Post Index Procedure Visit|Missed|1|||
142982871|NCT00924729|515473658|FG000|Overall Study|insufficient volume for analysis|1|||
142982872|NCT00924729|515473659|FG001|Overall Study|insufficient volume for analysis|0|||
142982873|NCT00924729|515473658|FG000|Overall Study|Protocol Violation|1|||
142982874|NCT00924729|515473659|FG001|Overall Study|Protocol Violation|0|||
142982875|NCT02023112|515473662|FG000|Overall Study|Withdrawal by Subject|2|||
142982876|NCT02023112|515473663|FG001|Overall Study|Withdrawal by Subject|1|||
142982877|NCT01814826|515473664|FG000|Overall Study|Other|3|||
142982878|NCT01814826|515473665|FG001|Overall Study|Other|5|||
142982879|NCT01814826|515473666|FG002|Overall Study|Other|0|||
142982880|NCT01814826|515473664|FG000|Overall Study|Death|29|||
142982881|NCT01814826|515473665|FG001|Overall Study|Death|24|||
142982882|NCT01814826|515473666|FG002|Overall Study|Death|3|||
142982883|NCT03339401|515473667|FG000|Overall Study|Death|2|||
142982884|NCT03339401|515473668|FG001|Overall Study|Death|1|||
142982885|NCT03339401|515473667|FG000|Overall Study|Withdrawal by Subject|2|||
142982886|NCT03339401|515473668|FG001|Overall Study|Withdrawal by Subject|0|||
142982887|NCT03339401|515473667|FG000|Overall Study|Study terminated|4|||
142982888|NCT03339401|515473668|FG001|Overall Study|Study terminated|3|||
142982889|NCT03339401|515473667|FG000|Overall Study|Investigator Decision|1|||
142982890|NCT03339401|515473668|FG001|Overall Study|Investigator Decision|0|||
142982891|NCT00718523|515473669|FG000|Overall Study|Withdrawal by Subject|5|||
142982892|NCT00718523|515473670|FG001|Overall Study|Withdrawal by Subject|7|||
142982893|NCT00718523|515473669|FG000|Overall Study|Death|13|||
142982894|NCT00718523|515473670|FG001|Overall Study|Death|17|||
142982895|NCT01042938|515473671|FG000|Overall Study|Withdrawal by Subject|1|||
142982896|NCT01042938|515473672|FG001|Overall Study|Withdrawal by Subject|1|||
142982897|NCT01042938|515473671|FG000|Overall Study|Protocol Violation|1|||
142982898|NCT01042938|515473672|FG001|Overall Study|Protocol Violation|1|||
142982899|NCT01042938|515473671|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
142982900|NCT01042938|515473672|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
142982901|NCT02566109|515473678|FG000|Overall Study|Withdrawal by Subject|1|||
142982902|NCT01802515|515473679|FG000|Overall Study|Withdrawal by Subject|3|||
142982903|NCT01802515|515473680|FG001|Overall Study|Withdrawal by Subject|0|||
142982904|NCT01802515|515473681|FG002|Overall Study|Withdrawal by Subject|0|||
142982905|NCT01906476|515473684|FG000|Overall Study|Lost to Follow-up|17|||
142982906|NCT01906476|515473685|FG001|Overall Study|Lost to Follow-up|16|||
142982907|NCT01041404|515473689|FG000|Overall Study|Adverse Event|45|||
142982908|NCT01041404|515473690|FG001|Overall Study|Adverse Event|35|||
142982909|NCT01041404|515473689|FG000|Overall Study|Lack of Efficacy|200|||
142982910|NCT01041404|515473690|FG001|Overall Study|Lack of Efficacy|210|||
142982911|NCT01041404|515473689|FG000|Overall Study|Violation of Selection Criteria|0|||
142982912|NCT01041404|515473690|FG001|Overall Study|Violation of Selection Criteria|1|||
142982913|NCT01041404|515473689|FG000|Overall Study|Protocol Violation|4|||
142982914|NCT01041404|515473690|FG001|Overall Study|Protocol Violation|0|||
142982915|NCT01041404|515473689|FG000|Overall Study|Withdrawal by Subject|29|||
142982916|NCT01041404|515473690|FG001|Overall Study|Withdrawal by Subject|23|||
142982917|NCT01041404|515473689|FG000|Overall Study|Failure to Return|1|||
142982918|NCT01041404|515473690|FG001|Overall Study|Failure to Return|2|||
142982919|NCT01041404|515473689|FG000|Overall Study|Other|11|||
142982920|NCT01041404|515473690|FG001|Overall Study|Other|23|||
142982921|NCT01993667|515473691|FG000|Overall Study|Insufficient data to analyze|16|||
142982922|NCT01993667|515473692|FG001|Overall Study|Insufficient data to analyze|16|||
142982923|NCT01993667|515473691|FG000|Overall Study|Insufficient altitude reached|3|||
142982924|NCT01993667|515473692|FG001|Overall Study|Insufficient altitude reached|1|||
142982925|NCT01993667|515473691|FG000|Overall Study|Lost to Follow-up|2|||
142982926|NCT01993667|515473692|FG001|Overall Study|Lost to Follow-up|2|||
142982927|NCT01931150|515473693|FG000|Overall Study|Withdrawal by Subject|1|||
142982928|NCT01931150|515473694|FG001|Overall Study|Withdrawal by Subject|2|||
142982929|NCT00383708|515473695|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
142982930|NCT00383708|515473695|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
142982931|NCT00383708|515473695|FG000|Run-in Period|Protocol Violation|4|||
142982932|NCT00383708|515473695|FG000|Run-in Period|Adverse Event|2|||
142982933|NCT00383708|515473695|FG000|Run-in Period|Claustrophobia|1|||
142982934|NCT00383708|515473695|FG000|Co-administration Period|Adverse Event|5|||
142982935|NCT01750840|515473698|FG000|Overall Study|Lost to Follow-up|4|||
142982936|NCT02650895|515473699|FG000|Overall Study|Withdrawal by Subject|0|||
142982937|NCT02650895|515473700|FG001|Overall Study|Withdrawal by Subject|1|||
142982938|NCT02650895|515473701|FG002|Overall Study|Withdrawal by Subject|0|||
142982939|NCT02650895|515473702|FG003|Overall Study|Withdrawal by Subject|0|||
142982940|NCT02650895|515473703|FG004|Overall Study|Withdrawal by Subject|0|||
142982941|NCT02650895|515473704|FG005|Overall Study|Withdrawal by Subject|0|||
142982942|NCT02712008|515475489|FG000|Baseline (Day 1) up to Week 12|Death|3|||
142982943|NCT02712008|515475490|FG001|Baseline (Day 1) up to Week 12|Death|0|||
142982944|NCT02712008|515475491|FG002|Baseline (Day 1) up to Week 12|Death|0|||
142982945|NCT02712008|515475492|FG003|Baseline (Day 1) up to Week 12|Death|0|||
142982946|NCT02712008|515475493|FG004|Baseline (Day 1) up to Week 12|Death|0|||
142982947|NCT02712008|515475494|FG005|Baseline (Day 1) up to Week 12|Death|0|||
142982948|NCT02712008|515475495|FG006|Baseline (Day 1) up to Week 12|Death|0|||
142982949|NCT02712008|515475496|FG007|Baseline (Day 1) up to Week 12|Death|0|||
142982950|NCT02712008|515475489|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
142982951|NCT02712008|515475490|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
142982952|NCT02712008|515475491|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
142982953|NCT02712008|515475492|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
142982954|NCT02712008|515475493|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
142982955|NCT02712008|515475494|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
142982956|NCT02712008|515475495|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
142982957|NCT02712008|515475496|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
142982958|NCT02712008|515475489|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
142982959|NCT02712008|515475490|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
142982960|NCT02712008|515475491|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
142982961|NCT02712008|515475492|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
142982962|NCT02712008|515475493|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
142982963|NCT02712008|515475494|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
142982964|NCT02712008|515475495|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
142982965|NCT02712008|515475496|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
142982966|NCT02712008|515475489|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
142982967|NCT02712008|515475490|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
142982968|NCT02712008|515475491|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
142982969|NCT02712008|515475492|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
142982970|NCT02712008|515475493|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
142982971|NCT02712008|515475494|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
142982972|NCT02712008|515475495|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
142982973|NCT02712008|515475496|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
142982974|NCT02712008|515475489|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
142982975|NCT02712008|515475490|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
142982976|NCT02712008|515475491|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
142982977|NCT02712008|515475492|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
142982978|NCT02712008|515475493|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
142982979|NCT02712008|515475494|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
142982980|NCT02712008|515475495|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
142982981|NCT02712008|515475496|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
142982982|NCT02712008|515475489|FG000|From Week 12 up to Week 36|Adverse Event|0|||
142982983|NCT02712008|515475490|FG001|From Week 12 up to Week 36|Adverse Event|0|||
142982984|NCT02712008|515475491|FG002|From Week 12 up to Week 36|Adverse Event|0|||
142982985|NCT02712008|515475492|FG003|From Week 12 up to Week 36|Adverse Event|0|||
142982986|NCT02712008|515475493|FG004|From Week 12 up to Week 36|Adverse Event|1|||
142982987|NCT02712008|515475494|FG005|From Week 12 up to Week 36|Adverse Event|0|||
142982988|NCT02712008|515475495|FG006|From Week 12 up to Week 36|Adverse Event|0|||
142982989|NCT02712008|515475496|FG007|From Week 12 up to Week 36|Adverse Event|2|||
142982990|NCT02712008|515475489|FG000|From Week 12 up to Week 36|Death|1|||
142982991|NCT02712008|515475490|FG001|From Week 12 up to Week 36|Death|0|||
142982992|NCT02712008|515475491|FG002|From Week 12 up to Week 36|Death|0|||
142982993|NCT02712008|515475492|FG003|From Week 12 up to Week 36|Death|0|||
142982994|NCT02712008|515475493|FG004|From Week 12 up to Week 36|Death|0|||
142982995|NCT02712008|515475494|FG005|From Week 12 up to Week 36|Death|0|||
142982996|NCT02712008|515475495|FG006|From Week 12 up to Week 36|Death|1|||
142982997|NCT02712008|515475496|FG007|From Week 12 up to Week 36|Death|0|||
142982998|NCT02712008|515475489|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
142982999|NCT02712008|515475490|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
142983000|NCT02712008|515475491|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
142983001|NCT02712008|515475492|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
142983002|NCT02712008|515475493|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
142983003|NCT02712008|515475494|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
142983004|NCT02712008|515475495|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
142983005|NCT02712008|515475496|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
142983006|NCT02712008|515475489|FG000|From Week 12 up to Week 36|Physician Decision|0|||
142983007|NCT02712008|515475490|FG001|From Week 12 up to Week 36|Physician Decision|0|||
142983008|NCT02712008|515475491|FG002|From Week 12 up to Week 36|Physician Decision|0|||
142983009|NCT02712008|515475492|FG003|From Week 12 up to Week 36|Physician Decision|1|||
142983010|NCT02712008|515475493|FG004|From Week 12 up to Week 36|Physician Decision|1|||
142983011|NCT02712008|515475494|FG005|From Week 12 up to Week 36|Physician Decision|0|||
142983012|NCT02712008|515475495|FG006|From Week 12 up to Week 36|Physician Decision|0|||
142983013|NCT02712008|515475496|FG007|From Week 12 up to Week 36|Physician Decision|0|||
142983014|NCT02712008|515475489|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
142983015|NCT02712008|515475490|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
142983016|NCT02712008|515475491|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
142983017|NCT02712008|515475492|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
142983018|NCT02712008|515475493|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
142983019|NCT02712008|515475494|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
142983020|NCT02712008|515475495|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
142983021|NCT02712008|515475496|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
142983022|NCT01731990|515475497|FG000|Overall Study|Adverse Event|1|||
142983023|NCT01731990|515475498|FG001|Overall Study|Adverse Event|5|||
142983024|NCT01731990|515475497|FG000|Overall Study|Withdrawal by Subject|1|||
142983025|NCT01731990|515475498|FG001|Overall Study|Withdrawal by Subject|1|||
142983026|NCT01731990|515475497|FG000|Overall Study|Protocol deviation|1|||
142983027|NCT01731990|515475498|FG001|Overall Study|Protocol deviation|2|||
142983028|NCT01731990|515475497|FG000|Overall Study|Death|1|||
142983029|NCT01731990|515475498|FG001|Overall Study|Death|0|||
142983030|NCT01131078|515475503|FG000|Overall Study|Adverse Event|22|||
142983031|NCT01131078|515475504|FG001|Overall Study|Adverse Event|12|||
142983032|NCT01131078|515475505|FG002|Overall Study|Adverse Event|17|||
142983033|NCT01131078|515475503|FG000|Overall Study|Progressive Disease|58|||
142983034|NCT01131078|515475504|FG001|Overall Study|Progressive Disease|77|||
142983035|NCT01131078|515475505|FG002|Overall Study|Progressive Disease|71|||
142983036|NCT01131078|515475503|FG000|Overall Study|Protocol Violation|1|||
142983037|NCT01131078|515475504|FG001|Overall Study|Protocol Violation|0|||
142983038|NCT01131078|515475505|FG002|Overall Study|Protocol Violation|0|||
142983039|NCT01131078|515475503|FG000|Overall Study|Lost to Follow-up|1|||
142983040|NCT01131078|515475504|FG001|Overall Study|Lost to Follow-up|1|||
142983041|NCT01131078|515475505|FG002|Overall Study|Lost to Follow-up|1|||
142983042|NCT01131078|515475503|FG000|Overall Study|Withdrawal by Subject|2|||
142983043|NCT01131078|515475504|FG001|Overall Study|Withdrawal by Subject|4|||
142983044|NCT01131078|515475505|FG002|Overall Study|Withdrawal by Subject|3|||
142983045|NCT01131078|515475503|FG000|Overall Study|Non-compliance|3|||
142983046|NCT01131078|515475504|FG001|Overall Study|Non-compliance|0|||
142983047|NCT01131078|515475505|FG002|Overall Study|Non-compliance|0|||
142983048|NCT01131078|515475503|FG000|Overall Study|Physician Decision|10|||
142983049|NCT01131078|515475504|FG001|Overall Study|Physician Decision|6|||
142983050|NCT01131078|515475505|FG002|Overall Study|Physician Decision|8|||
142983051|NCT01131078|515475503|FG000|Overall Study|Death|4|||
142983052|NCT01131078|515475504|FG001|Overall Study|Death|0|||
142983053|NCT01131078|515475505|FG002|Overall Study|Death|2|||
142983054|NCT01131078|515475503|FG000|Overall Study|Other|0|||
142983055|NCT01131078|515475504|FG001|Overall Study|Other|1|||
142983056|NCT01131078|515475505|FG002|Overall Study|Other|0|||
142983057|NCT03267511|515475506|FG000|Overall Study|Lost to Follow-up|0|||
142983058|NCT03267511|515475507|FG001|Overall Study|Lost to Follow-up|0|||
142983059|NCT03267511|515475508|FG002|Overall Study|Lost to Follow-up|0|||
142983060|NCT03267511|515475509|FG003|Overall Study|Lost to Follow-up|1|||
142983061|NCT00364351|515475510|FG000|Overall Study|Adverse Event|90|||
142983062|NCT00364351|515475511|FG001|Overall Study|Adverse Event|44|||
142983063|NCT00364351|515475510|FG000|Overall Study|Condition under investigation worsened|469|||
142983064|NCT00364351|515475511|FG001|Overall Study|Condition under investigation worsened|497|||
142983065|NCT00364351|515475510|FG000|Overall Study|Prohibited concomitant medication|0|||
142983066|NCT00364351|515475511|FG001|Overall Study|Prohibited concomitant medication|2|||
142983067|NCT00364351|515475510|FG000|Overall Study|Lost to Follow-up|1|||
142983068|NCT00364351|515475511|FG001|Overall Study|Lost to Follow-up|1|||
142983069|NCT00364351|515475510|FG000|Overall Study|Withdrawal by Subject|30|||
142983070|NCT00364351|515475511|FG001|Overall Study|Withdrawal by Subject|29|||
142983071|NCT00364351|515475510|FG000|Overall Study|Incorrect enrollment|1|||
142983072|NCT00364351|515475511|FG001|Overall Study|Incorrect enrollment|1|||
142983073|NCT00364351|515475510|FG000|Overall Study|Sponsor decision|1|||
142983074|NCT00364351|515475511|FG001|Overall Study|Sponsor decision|0|||
142983075|NCT00364351|515475510|FG000|Overall Study|Poor treatment compliance|0|||
142983076|NCT00364351|515475511|FG001|Overall Study|Poor treatment compliance|3|||
142983077|NCT00364351|515475510|FG000|Overall Study|Investigator error|0|||
142983078|NCT00364351|515475511|FG001|Overall Study|Investigator error|2|||
142983079|NCT00364351|515475510|FG000|Overall Study|Patient could not travel to site|0|||
142983080|NCT00364351|515475511|FG001|Overall Study|Patient could not travel to site|1|||
142983081|NCT00364351|515475510|FG000|Overall Study|Randomised treatment not started|0|||
142983082|NCT00364351|515475511|FG001|Overall Study|Randomised treatment not started|3|||
142983083|NCT00922974|515475512|FG000|Phase II Component|Protocol Violation|2|||
142983084|NCT00922974|515475513|FG001|Phase II Component|Protocol Violation|0|||
142983085|NCT00922974|515475512|FG000|Phase II Component|Not evaluable for treatment review|5|||
142983086|NCT00922974|515475513|FG001|Phase II Component|Not evaluable for treatment review|0|||
142983087|NCT00922974|515475512|FG000|Phase III Component|Protocol Violation|8|||
142983088|NCT00922974|515475513|FG001|Phase III Component|Protocol Violation|6|||
142983089|NCT02944513|515475514|FG000|Overall Study|Withdrawal by Subject|4|||
142983090|NCT02944513|515475515|FG001|Overall Study|Withdrawal by Subject|1|||
142983091|NCT00608894|515475519|FG000|Overall Study|Withdrawal by Subject|0|||
142983092|NCT00608894|515475520|FG001|Overall Study|Withdrawal by Subject|2|||
142983093|NCT01308853|515475526|FG000|Overall Study|Adverse Event|1|||
142983094|NCT01308853|515475526|FG000|Overall Study|Lost to Follow-up|2|||
142983095|NCT01308853|515475526|FG000|Overall Study|Insertion of permanent implants|1|||
142983096|NCT00106249|515475527|FG000|Overall Study|Lost to Follow-up|3|||
142983097|NCT00106249|515475528|FG001|Overall Study|Lost to Follow-up|2|||
142983098|NCT01117181|515475531|FG000|Overall Study|Lost to Follow-up|1|||
142983099|NCT01117181|515475532|FG001|Overall Study|Lost to Follow-up|0|||
142983100|NCT01117181|515475531|FG000|Overall Study|Withdrawal by Subject|0|||
142983101|NCT01117181|515475532|FG001|Overall Study|Withdrawal by Subject|2|||
142983102|NCT01495689|515475536|FG000|Overall Study|Death|0|||
142983103|NCT01495689|515475537|FG001|Overall Study|Death|1|||
142983104|NCT01495689|515475536|FG000|Overall Study|Withdrawal by Subject|3|||
142983105|NCT01495689|515475537|FG001|Overall Study|Withdrawal by Subject|0|||
142983106|NCT01495689|515475536|FG000|Overall Study|Lost to Follow-up|7|||
142983107|NCT01495689|515475537|FG001|Overall Study|Lost to Follow-up|6|||
142983108|NCT00606177|515475542|FG000|Overall Study|Adverse Event|9|||
142983109|NCT00606177|515475543|FG001|Overall Study|Adverse Event|5|||
142983110|NCT00606177|515475542|FG000|Overall Study|Lack of Efficacy|3|||
142983111|NCT00606177|515475543|FG001|Overall Study|Lack of Efficacy|7|||
142983112|NCT00606177|515475542|FG000|Overall Study|Physician Decision|1|||
142983113|NCT00606177|515475543|FG001|Overall Study|Physician Decision|0|||
142983114|NCT00606177|515475542|FG000|Overall Study|Protocol Violation|1|||
142983115|NCT00606177|515475543|FG001|Overall Study|Protocol Violation|4|||
142983116|NCT00606177|515475542|FG000|Overall Study|Withdrawal by Subject|5|||
142983117|NCT00606177|515475543|FG001|Overall Study|Withdrawal by Subject|6|||
142983118|NCT00606177|515475542|FG000|Overall Study|Progression to depressive phase|6|||
142983119|NCT00606177|515475543|FG001|Overall Study|Progression to depressive phase|1|||
142983120|NCT00606177|515475542|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
142983121|NCT00606177|515475543|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
142983122|NCT00606177|515475542|FG000|Overall Study|Change of residence or other commitments|1|||
142983123|NCT00606177|515475543|FG001|Overall Study|Change of residence or other commitments|1|||
142983124|NCT00136357|515475544|FG000|Overall Study|Withdrawal by Subject|3|||
142983125|NCT00136357|515475545|FG001|Overall Study|Withdrawal by Subject|2|||
142983126|NCT02603172|515475547|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
142983127|NCT02603172|515475548|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
142983128|NCT02603172|515475549|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
142983129|NCT02603172|515475550|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
142983130|NCT02603172|515475551|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
142983131|NCT02603172|515475552|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
142983132|NCT02603172|515475553|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
142983133|NCT02603172|515475554|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
142983134|NCT00420342|515475559|FG000|Overall Study|Lost to Follow-up|1|||
142983135|NCT00420342|515475560|FG001|Overall Study|Lost to Follow-up|0|||
142983136|NCT00420342|515475561|FG002|Overall Study|Lost to Follow-up|1|||
142983137|NCT00420342|515475559|FG000|Overall Study|Withdrawal by Subject|0|||
142983138|NCT00420342|515475560|FG001|Overall Study|Withdrawal by Subject|2|||
142983139|NCT00420342|515475561|FG002|Overall Study|Withdrawal by Subject|0|||
142983140|NCT05784129|515475562|FG000|Overall Study|Study terminated by sponsor|2|||
142983141|NCT05784129|515475563|FG001|Overall Study|Study terminated by sponsor|2|||
142983142|NCT01266070|515475565|FG000|Overall Study|Adverse Event|3|||
142983143|NCT01266070|515475565|FG000|Overall Study|Protocol Violation|1|||
142983144|NCT03689972|515475566|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
142983145|NCT03689972|515475567|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
142983146|NCT03689972|515475568|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
142983147|NCT03689972|515475569|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
142983148|NCT03689972|515475570|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
142983149|NCT03689972|515475566|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
142983150|NCT03689972|515475567|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
142983151|NCT03689972|515475568|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
142983152|NCT03689972|515475569|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
142983153|NCT03689972|515475570|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
142983154|NCT03689972|515475566|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
142983155|NCT03689972|515475567|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
142983156|NCT03689972|515475568|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
142983157|NCT03689972|515475569|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
142983158|NCT03689972|515475570|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
142983159|NCT03689972|515475566|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
142983160|NCT03689972|515475567|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
142983161|NCT03689972|515475568|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
142983162|NCT03689972|515475569|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
142983163|NCT03689972|515475570|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
142983164|NCT03689972|515475566|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
142983165|NCT03689972|515475567|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
142983166|NCT03689972|515475568|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
142983167|NCT03689972|515475569|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
142983168|NCT03689972|515475570|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
142983169|NCT03689972|515475566|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
142983170|NCT03689972|515475567|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
142983171|NCT03689972|515475568|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
142983172|NCT03689972|515475569|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
142983173|NCT03689972|515475570|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
142983174|NCT03689972|515475566|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
142983175|NCT03689972|515475567|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
142983176|NCT03689972|515475568|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
142983177|NCT03689972|515475569|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
142983178|NCT03689972|515475570|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
142983179|NCT03689972|515475566|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
142983180|NCT03689972|515475567|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
142983181|NCT03689972|515475568|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
142983182|NCT03689972|515475569|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
142983183|NCT03689972|515475570|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
142983184|NCT03689972|515475566|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
142983185|NCT03689972|515475567|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
142983186|NCT03689972|515475568|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
142983187|NCT03689972|515475569|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
142983188|NCT03689972|515475570|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
142983189|NCT03689972|515475566|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
142983190|NCT03689972|515475567|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
142983191|NCT03689972|515475568|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
142983192|NCT03689972|515475569|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
142983193|NCT03689972|515475570|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
142983194|NCT03689972|515475566|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
142983195|NCT03689972|515475567|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
142983196|NCT03689972|515475568|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
142983197|NCT03689972|515475569|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
142983198|NCT03689972|515475570|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
142983199|NCT03689972|515475566|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
142983200|NCT03689972|515475567|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
142983201|NCT03689972|515475568|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
142983202|NCT03689972|515475569|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
142983203|NCT03689972|515475570|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
142983204|NCT03689972|515475566|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
142983205|NCT03689972|515475567|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
142983206|NCT03689972|515475568|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
142983207|NCT03689972|515475569|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
142983208|NCT03689972|515475570|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
142983209|NCT03689972|515475566|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
142983210|NCT03689972|515475567|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
142983211|NCT03689972|515475568|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
142983212|NCT03689972|515475569|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
142983213|NCT03689972|515475570|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
142983214|NCT03689972|515475566|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
142983215|NCT03689972|515475567|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
142983216|NCT03689972|515475568|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
142983217|NCT03689972|515475569|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
142983218|NCT03689972|515475570|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
142983219|NCT03689972|515475566|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
142983220|NCT03689972|515475567|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
142983221|NCT03689972|515475568|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
142983222|NCT03689972|515475569|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
142983223|NCT03689972|515475570|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
142983224|NCT03689972|515475566|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
142983225|NCT03689972|515475567|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
142983226|NCT03689972|515475568|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
142983227|NCT03689972|515475569|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
142983228|NCT03689972|515475570|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
142983229|NCT03689972|515475566|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
142983230|NCT03689972|515475567|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
142983231|NCT03689972|515475568|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
142983232|NCT03689972|515475569|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
142983233|NCT03689972|515475570|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
142983234|NCT03689972|515475566|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
142983235|NCT03689972|515475567|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
142983236|NCT03689972|515475568|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
142983237|NCT03689972|515475569|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
142983238|NCT03689972|515475570|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
142983239|NCT01838213|515475571|FG000|Overall Study|Ineligible|166|||
142983240|NCT01838213|515475572|FG001|Overall Study|Ineligible|191|||
142983241|NCT00732238|515475575|FG000|Overall Study|Bacteremia|4|||
142983242|NCT00732238|515475576|FG001|Overall Study|Bacteremia|1|||
142983243|NCT00732238|515475575|FG000|Overall Study|Asymptomatic bacteriuria|1|||
142983244|NCT00732238|515475576|FG001|Overall Study|Asymptomatic bacteriuria|0|||
142983245|NCT02910089|515475577|FG000|Overall Study|Lost insurance eligibility|22|||
142983246|NCT02910089|515475578|FG001|Overall Study|Lost insurance eligibility|16|||
142983247|NCT04080752|515475579|FG000|Overall Study|Adverse Event|2|||
142983248|NCT04080752|515475580|FG001|Overall Study|Adverse Event|3|||
142983249|NCT04080752|515475579|FG000|Overall Study|Lack of Efficacy|1|||
142983250|NCT04080752|515475580|FG001|Overall Study|Lack of Efficacy|0|||
142983251|NCT04080752|515475579|FG000|Overall Study|Lost to Follow-up|1|||
142983252|NCT04080752|515475580|FG001|Overall Study|Lost to Follow-up|0|||
142983253|NCT04080752|515475579|FG000|Overall Study|Pregnancy|0|||
142983254|NCT04080752|515475580|FG001|Overall Study|Pregnancy|1|||
142983255|NCT04080752|515475579|FG000|Overall Study|Withdrawal by Subject|7|||
142983256|NCT04080752|515475580|FG001|Overall Study|Withdrawal by Subject|0|||
142983257|NCT04080752|515475579|FG000|Overall Study|Non-Compliance with Study Drug|0|||
142983258|NCT04080752|515475580|FG001|Overall Study|Non-Compliance with Study Drug|1|||
142983259|NCT04080752|515475579|FG000|Overall Study|Other|2|||
142983260|NCT04080752|515475580|FG001|Overall Study|Other|1|||
142983261|NCT03605836|515475581|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
142983262|NCT03605836|515475582|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
142983263|NCT03605836|515475583|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
142983264|NCT03605836|515475584|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
142983265|NCT03605836|515475581|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
142983266|NCT03605836|515475582|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
142983267|NCT03605836|515475583|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
142983268|NCT03605836|515475584|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
142983269|NCT03605836|515475581|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
142983270|NCT03605836|515475582|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
142983271|NCT03605836|515475583|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
142983272|NCT03605836|515475584|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
142983273|NCT03605836|515475581|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
142983274|NCT03605836|515475582|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
142983275|NCT03605836|515475583|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
142983276|NCT03605836|515475584|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
142983277|NCT03605836|515475581|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
142983278|NCT03605836|515475582|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
142983279|NCT03605836|515475583|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
142983280|NCT03605836|515475584|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
142983281|NCT03605836|515475581|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
142983282|NCT03605836|515475582|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
142983283|NCT03605836|515475583|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
142983284|NCT03605836|515475584|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
142983285|NCT03605836|515475581|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
142983286|NCT03605836|515475582|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
142983287|NCT03605836|515475583|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
142983288|NCT03605836|515475584|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
142983289|NCT03605836|515475581|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
142983290|NCT03605836|515475582|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
142983291|NCT03605836|515475583|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
142983292|NCT03605836|515475584|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
142983293|NCT03605836|515475581|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
142983294|NCT03605836|515475582|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
142983295|NCT03605836|515475583|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
142983296|NCT03605836|515475584|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
142983297|NCT03605836|515475581|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
142983298|NCT03605836|515475582|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
142983299|NCT03605836|515475583|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
142983300|NCT03605836|515475584|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
142983301|NCT03605836|515475581|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
142983302|NCT03605836|515475582|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
142983303|NCT03605836|515475583|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
142983304|NCT03605836|515475584|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
142983305|NCT03605836|515475581|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
142983306|NCT03605836|515475582|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
142983307|NCT03605836|515475583|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
142983308|NCT03605836|515475584|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
142983309|NCT03605836|515475581|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
142983310|NCT03605836|515475582|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
142983311|NCT03605836|515475583|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
142983312|NCT03605836|515475584|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
142983313|NCT03605836|515475581|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
142983314|NCT03605836|515475582|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
142983315|NCT03605836|515475583|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
142983316|NCT03605836|515475584|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
142983317|NCT03605836|515475581|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
142983318|NCT03605836|515475582|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
142983319|NCT03605836|515475583|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
142983320|NCT03605836|515475584|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
142983321|NCT03605836|515475581|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
142983322|NCT03605836|515475582|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
142983323|NCT03605836|515475583|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
142983324|NCT03605836|515475584|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
142983325|NCT03605836|515475581|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
142983326|NCT03605836|515475582|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
142983327|NCT03605836|515475583|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
142983328|NCT03605836|515475584|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
142983329|NCT03605836|515475581|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
142983330|NCT03605836|515475582|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
142983331|NCT03605836|515475583|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
142983332|NCT03605836|515475584|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
142983333|NCT03605836|515475581|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
142983334|NCT03605836|515475582|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
142983335|NCT03605836|515475583|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
142983336|NCT03605836|515475584|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
142983337|NCT03605836|515475581|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
142983338|NCT03605836|515475582|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
142983339|NCT03605836|515475583|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
142983340|NCT03605836|515475584|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
142983341|NCT03605836|515475581|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
142983342|NCT03605836|515475582|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
142983343|NCT03605836|515475583|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
142983344|NCT03605836|515475584|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
142983345|NCT03605836|515475581|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
142983346|NCT03605836|515475582|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
142983347|NCT03605836|515475583|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
142983348|NCT03605836|515475584|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
142983349|NCT02977507|515475585|FG000|Overall Study|Protocol Deviation|1|||
142983350|NCT02977507|515475586|FG001|Overall Study|Protocol Deviation|0|||
142983351|NCT02977507|515475585|FG000|Overall Study|Lost to Follow-up|1|||
142983352|NCT02977507|515475586|FG001|Overall Study|Lost to Follow-up|0|||
142983353|NCT00741260|515475598|FG000|Overall Study|Disease Progression|3|||
142983354|NCT00741260|515475599|FG001|Overall Study|Disease Progression|5|||
142983355|NCT00741260|515475600|FG002|Overall Study|Disease Progression|3|||
142983356|NCT00741260|515475601|FG003|Overall Study|Disease Progression|3|||
142983357|NCT00741260|515475602|FG004|Overall Study|Disease Progression|5|||
142983358|NCT00741260|515475603|FG005|Overall Study|Disease Progression|37|||
142983359|NCT00741260|515475604|FG006|Overall Study|Disease Progression|4|||
142983360|NCT00741260|515475598|FG000|Overall Study|Death|0|||
142983361|NCT00741260|515475599|FG001|Overall Study|Death|1|||
142983362|NCT00741260|515475600|FG002|Overall Study|Death|0|||
142983363|NCT00741260|515475601|FG003|Overall Study|Death|1|||
142983364|NCT00741260|515475602|FG004|Overall Study|Death|2|||
142983365|NCT00741260|515475603|FG005|Overall Study|Death|2|||
142983366|NCT00741260|515475604|FG006|Overall Study|Death|1|||
142983367|NCT00741260|515475598|FG000|Overall Study|Withdrawal by Subject|0|||
142983368|NCT00741260|515475599|FG001|Overall Study|Withdrawal by Subject|0|||
142983369|NCT00741260|515475600|FG002|Overall Study|Withdrawal by Subject|0|||
142983370|NCT00741260|515475601|FG003|Overall Study|Withdrawal by Subject|0|||
142983371|NCT00741260|515475602|FG004|Overall Study|Withdrawal by Subject|1|||
142983372|NCT00741260|515475603|FG005|Overall Study|Withdrawal by Subject|3|||
142983373|NCT00741260|515475604|FG006|Overall Study|Withdrawal by Subject|1|||
142983374|NCT00741260|515475598|FG000|Overall Study|Physician Decision|1|||
142983375|NCT00741260|515475599|FG001|Overall Study|Physician Decision|1|||
142983376|NCT00741260|515475600|FG002|Overall Study|Physician Decision|0|||
142983377|NCT00741260|515475601|FG003|Overall Study|Physician Decision|0|||
142983378|NCT00741260|515475602|FG004|Overall Study|Physician Decision|0|||
142983379|NCT00741260|515475603|FG005|Overall Study|Physician Decision|0|||
142983380|NCT00741260|515475604|FG006|Overall Study|Physician Decision|0|||
142983381|NCT00741260|515475598|FG000|Overall Study|Other|2|||
142983382|NCT00741260|515475599|FG001|Overall Study|Other|1|||
142983383|NCT00741260|515475600|FG002|Overall Study|Other|1|||
142983384|NCT00741260|515475601|FG003|Overall Study|Other|2|||
142983385|NCT00741260|515475602|FG004|Overall Study|Other|1|||
142983386|NCT00741260|515475603|FG005|Overall Study|Other|3|||
142983387|NCT00741260|515475604|FG006|Overall Study|Other|1|||
142983388|NCT02565615|515475605|FG000|Overall Study|Death|0|||
142983389|NCT02565615|515475606|FG001|Overall Study|Death|1|||
142983390|NCT02565615|515475607|FG002|Overall Study|Death|0|||
142983391|NCT02565615|515475608|FG003|Overall Study|Death|0|||
142983392|NCT02565615|515475609|FG004|Overall Study|Death|4|||
142983393|NCT02565615|515475605|FG000|Overall Study|Not willing to participate in study|2|||
142983394|NCT02565615|515475606|FG001|Overall Study|Not willing to participate in study|21|||
142983395|NCT02565615|515475607|FG002|Overall Study|Not willing to participate in study|0|||
142983396|NCT02565615|515475608|FG003|Overall Study|Not willing to participate in study|1|||
142983397|NCT02565615|515475609|FG004|Overall Study|Not willing to participate in study|169|||
142983398|NCT02565615|515475605|FG000|Overall Study|Lost to Follow-up|0|||
142983399|NCT02565615|515475606|FG001|Overall Study|Lost to Follow-up|4|||
142983400|NCT02565615|515475607|FG002|Overall Study|Lost to Follow-up|0|||
142983401|NCT02565615|515475608|FG003|Overall Study|Lost to Follow-up|1|||
142983402|NCT02565615|515475609|FG004|Overall Study|Lost to Follow-up|765|||
142983403|NCT02565615|515475605|FG000|Overall Study|Not meeting eligibility criteria|0|||
142983404|NCT02565615|515475606|FG001|Overall Study|Not meeting eligibility criteria|7|||
142983405|NCT02565615|515475607|FG002|Overall Study|Not meeting eligibility criteria|0|||
142983406|NCT02565615|515475608|FG003|Overall Study|Not meeting eligibility criteria|0|||
142983407|NCT02565615|515475609|FG004|Overall Study|Not meeting eligibility criteria|25|||
142983408|NCT02565615|515475605|FG000|Overall Study|Reason not defined|0|||
142983409|NCT02565615|515475606|FG001|Overall Study|Reason not defined|2|||
142983410|NCT02565615|515475607|FG002|Overall Study|Reason not defined|0|||
142983411|NCT02565615|515475608|FG003|Overall Study|Reason not defined|1|||
142983412|NCT02565615|515475609|FG004|Overall Study|Reason not defined|62|||
142983413|NCT02565615|515475605|FG000|Overall Study|Adverse Event|1|||
142983414|NCT02565615|515475606|FG001|Overall Study|Adverse Event|1|||
142983415|NCT02565615|515475607|FG002|Overall Study|Adverse Event|0|||
142983416|NCT02565615|515475608|FG003|Overall Study|Adverse Event|0|||
142983417|NCT02565615|515475609|FG004|Overall Study|Adverse Event|9|||
142983418|NCT02565615|515475605|FG000|Overall Study|Untreated|0|||
142983419|NCT02565615|515475606|FG001|Overall Study|Untreated|0|||
142983420|NCT02565615|515475607|FG002|Overall Study|Untreated|0|||
142983421|NCT02565615|515475608|FG003|Overall Study|Untreated|0|||
142983422|NCT02565615|515475609|FG004|Overall Study|Untreated|567|||
142983423|NCT05563714|515475610|FG000|Overall Study|Death|2|||
142983424|NCT05563714|515475611|FG001|Overall Study|Death|2|||
142983425|NCT05563714|515475612|FG002|Overall Study|Death|0|||
142983426|NCT05563714|515475613|FG003|Overall Study|Death|0|||
142983427|NCT05563714|515475610|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
142983428|NCT05563714|515475611|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
142983429|NCT05563714|515475612|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
142983430|NCT05563714|515475613|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
142983431|NCT05563714|515475610|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
142983432|NCT05563714|515475611|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
142983433|NCT05563714|515475612|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
142983434|NCT05563714|515475613|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
142983435|NCT05563714|515475610|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
142983436|NCT05563714|515475611|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
142983437|NCT05563714|515475612|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
142983438|NCT05563714|515475613|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
142983439|NCT05563714|515475610|FG000|Overall Study|Lost to Follow-up|22|||
142983440|NCT05563714|515475611|FG001|Overall Study|Lost to Follow-up|19|||
142983441|NCT05563714|515475612|FG002|Overall Study|Lost to Follow-up|0|||
142983442|NCT05563714|515475613|FG003|Overall Study|Lost to Follow-up|0|||
142983443|NCT02427100|515475617|FG000|Overall Study|Lost to Follow-up|0|||
142983444|NCT02427100|515475618|FG001|Overall Study|Lost to Follow-up|2|||
142983445|NCT02120352|515475619|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
142983446|NCT02120352|515475620|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
142983447|NCT02120352|515475621|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
142983448|NCT02120352|515475622|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
142983449|NCT02120352|515475623|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
142983450|NCT02120352|515475624|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
142983451|NCT02120352|515475625|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
142983452|NCT02120352|515475619|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
142983453|NCT02120352|515475620|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
142983454|NCT02120352|515475621|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
142983455|NCT02120352|515475622|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
142983456|NCT02120352|515475623|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
142983457|NCT02120352|515475624|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
142983458|NCT02120352|515475625|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
142983459|NCT02120352|515475619|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
142983460|NCT02120352|515475620|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
142983461|NCT02120352|515475621|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
142983462|NCT02120352|515475622|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
142983463|NCT02120352|515475623|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
142983464|NCT02120352|515475624|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
142983465|NCT02120352|515475625|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
142983466|NCT02120352|515475619|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
142983467|NCT02120352|515475620|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
142983468|NCT02120352|515475621|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
142983469|NCT02120352|515475622|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
142983470|NCT02120352|515475623|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
142983471|NCT02120352|515475624|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
142983472|NCT02120352|515475625|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
142983473|NCT02120352|515475619|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
142983474|NCT02120352|515475620|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
142983475|NCT02120352|515475621|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
142983476|NCT02120352|515475622|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
142983477|NCT02120352|515475623|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
142983478|NCT02120352|515475624|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
142983479|NCT02120352|515475625|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
142983480|NCT02120352|515475619|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
142983481|NCT02120352|515475620|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
142983482|NCT02120352|515475621|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
142983483|NCT02120352|515475622|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
142983484|NCT02120352|515475623|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
142983485|NCT02120352|515475624|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
142983486|NCT02120352|515475625|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
142983487|NCT02120352|515475619|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
142983488|NCT02120352|515475620|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
142983489|NCT02120352|515475621|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
142983490|NCT02120352|515475622|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
142983491|NCT02120352|515475623|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
142983492|NCT02120352|515475624|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
142983493|NCT02120352|515475625|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
142983494|NCT02120352|515475619|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
142983495|NCT02120352|515475620|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
142983496|NCT02120352|515475621|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
142983497|NCT02120352|515475622|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
142983498|NCT02120352|515475623|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
142983499|NCT02120352|515475624|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
142983500|NCT02120352|515475625|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
142983501|NCT02120352|515475619|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
142983502|NCT02120352|515475620|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
142983503|NCT02120352|515475621|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
142983504|NCT02120352|515475622|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
142983505|NCT02120352|515475623|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
142983506|NCT02120352|515475624|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
142983507|NCT02120352|515475625|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
142983508|NCT02120352|515475619|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
142983509|NCT02120352|515475620|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
142983510|NCT02120352|515475621|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
142983511|NCT02120352|515475622|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
142983512|NCT02120352|515475623|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
142983513|NCT02120352|515475624|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
142983514|NCT02120352|515475625|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
142983515|NCT02120352|515475619|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
142983516|NCT02120352|515475620|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
142983517|NCT02120352|515475621|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
142983518|NCT02120352|515475622|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
142983519|NCT02120352|515475623|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
142983520|NCT02120352|515475624|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
142983521|NCT02120352|515475625|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
142983522|NCT02120352|515475619|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
142983523|NCT02120352|515475620|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
142983524|NCT02120352|515475621|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
142983525|NCT02120352|515475622|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
142983526|NCT02120352|515475623|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
142983527|NCT02120352|515475624|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
142983528|NCT02120352|515475625|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
142983529|NCT02120352|515475619|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
142983530|NCT02120352|515475620|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
142983531|NCT02120352|515475621|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
142983532|NCT02120352|515475622|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
142983533|NCT02120352|515475623|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
142983534|NCT02120352|515475624|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
142983535|NCT02120352|515475625|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
142983536|NCT02120352|515475619|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
142983537|NCT02120352|515475620|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
142983538|NCT02120352|515475621|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
142983539|NCT02120352|515475622|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
142983540|NCT02120352|515475623|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
142983541|NCT02120352|515475624|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
142983542|NCT02120352|515475625|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
142983543|NCT02120352|515475619|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
142983544|NCT02120352|515475620|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
142983545|NCT02120352|515475621|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
142983546|NCT02120352|515475622|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
142983547|NCT02120352|515475623|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
142983548|NCT02120352|515475624|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
142983549|NCT02120352|515475625|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
142983550|NCT02120352|515475619|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
142983551|NCT02120352|515475620|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
142983552|NCT02120352|515475621|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
142983553|NCT02120352|515475622|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
142983554|NCT02120352|515475623|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
142983555|NCT02120352|515475624|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
142983556|NCT02120352|515475625|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
142983557|NCT02120352|515475619|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
142983558|NCT02120352|515475620|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
142983559|NCT02120352|515475621|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
142983560|NCT02120352|515475622|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
142983561|NCT02120352|515475623|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
142983562|NCT02120352|515475624|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
142983563|NCT02120352|515475625|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
142983564|NCT02120352|515475619|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
142983565|NCT02120352|515475620|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
142983566|NCT02120352|515475621|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
142983567|NCT02120352|515475622|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
142983568|NCT02120352|515475623|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
142983569|NCT02120352|515475624|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
142983570|NCT02120352|515475625|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
142983571|NCT02120352|515475619|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
142983572|NCT02120352|515475620|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
142983573|NCT02120352|515475621|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
142983574|NCT02120352|515475622|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
142983575|NCT02120352|515475623|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
142983576|NCT02120352|515475624|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
142983577|NCT02120352|515475625|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
142983578|NCT02120352|515475619|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
142983579|NCT02120352|515475620|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
142983580|NCT02120352|515475621|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
142983581|NCT02120352|515475622|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
142983582|NCT02120352|515475623|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
142983583|NCT02120352|515475624|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
142983584|NCT02120352|515475625|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
142983585|NCT02120352|515475619|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
142983586|NCT02120352|515475620|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
142983587|NCT02120352|515475621|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
142983588|NCT02120352|515475622|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
142983589|NCT02120352|515475623|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
142983590|NCT02120352|515475624|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
142983591|NCT02120352|515475625|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
142983592|NCT02120352|515475619|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
142983593|NCT02120352|515475620|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
142983594|NCT02120352|515475621|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
142983595|NCT02120352|515475622|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
142983596|NCT02120352|515475623|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
142983597|NCT02120352|515475624|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
142983598|NCT02120352|515475625|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
142983599|NCT01610206|515475628|FG000|Overall Study|Adverse Event|10|||
142983600|NCT01610206|515475629|FG001|Overall Study|Adverse Event|30|||
142983601|NCT00196196|515475630|FG000|Overall Study|Withdrawal by Subject|2|||
142983602|NCT00196196|515475630|FG000|Overall Study|Did not have required condition (hydroce|5|||
142983603|NCT01915095|515475631|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
142983604|NCT01915095|515475632|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
142983605|NCT01915095|515475633|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
142983606|NCT01915095|515475634|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
142983607|NCT01915095|515475635|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
143003172|NCT01049360|515548744|FG000|Period 2|Lack of Efficacy|0|||
142983608|NCT04018612|515475636|FG000|Overall Study|Withdrawal by Subject|1|||
142983609|NCT04018612|515475637|FG001|Overall Study|Withdrawal by Subject|0|||
142983610|NCT04018612|515475638|FG002|Overall Study|Withdrawal by Subject|1|||
142983611|NCT00361218|515475639|FG000|Overall Study|Lost to Follow-up|11|||
142983612|NCT00361218|515475639|FG000|Overall Study|Personal Reasons|7|||
142983613|NCT00361218|515475639|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
142983614|NCT02671760|515475641|FG000|Overall Study|Lost to Follow-up|0|||
142983615|NCT02671760|515475642|FG001|Overall Study|Lost to Follow-up|1|||
142983616|NCT02671760|515475643|FG002|Overall Study|Lost to Follow-up|0|||
142983617|NCT01685203|515475648|FG000|Overall Study|Lost to Follow-up|3|||
142983618|NCT01685203|515475649|FG001|Overall Study|Lost to Follow-up|3|||
142983619|NCT01685203|515475650|FG002|Overall Study|Lost to Follow-up|0|||
142983620|NCT01685203|515475651|FG003|Overall Study|Lost to Follow-up|1|||
142983621|NCT01685203|515475652|FG004|Overall Study|Lost to Follow-up|0|||
142983622|NCT01685203|515475653|FG005|Overall Study|Lost to Follow-up|0|||
142983623|NCT01685203|515475654|FG006|Overall Study|Lost to Follow-up|0|||
142983624|NCT01685203|515475648|FG000|Overall Study|Adverse Event|0|||
142983625|NCT01685203|515475649|FG001|Overall Study|Adverse Event|0|||
142983626|NCT01685203|515475650|FG002|Overall Study|Adverse Event|0|||
142983627|NCT01685203|515475651|FG003|Overall Study|Adverse Event|0|||
142983628|NCT01685203|515475652|FG004|Overall Study|Adverse Event|0|||
142983629|NCT01685203|515475653|FG005|Overall Study|Adverse Event|2|||
142983630|NCT01685203|515475654|FG006|Overall Study|Adverse Event|0|||
142983631|NCT01685203|515475648|FG000|Overall Study|Adverse event and withdrew consent|1|||
142983632|NCT01685203|515475649|FG001|Overall Study|Adverse event and withdrew consent|0|||
142983633|NCT01685203|515475650|FG002|Overall Study|Adverse event and withdrew consent|0|||
142983634|NCT01685203|515475651|FG003|Overall Study|Adverse event and withdrew consent|0|||
142983635|NCT01685203|515475652|FG004|Overall Study|Adverse event and withdrew consent|0|||
142983636|NCT01685203|515475653|FG005|Overall Study|Adverse event and withdrew consent|0|||
142983637|NCT01685203|515475654|FG006|Overall Study|Adverse event and withdrew consent|0|||
142983638|NCT01685203|515475648|FG000|Overall Study|Patient's decision|0|||
142983639|NCT01685203|515475649|FG001|Overall Study|Patient's decision|0|||
142983640|NCT01685203|515475650|FG002|Overall Study|Patient's decision|0|||
142983641|NCT01685203|515475651|FG003|Overall Study|Patient's decision|0|||
142983642|NCT01685203|515475652|FG004|Overall Study|Patient's decision|0|||
142983643|NCT01685203|515475653|FG005|Overall Study|Patient's decision|1|||
142983644|NCT01685203|515475654|FG006|Overall Study|Patient's decision|0|||
142983645|NCT00318370|515475655|FG000|Period 1|Lack of Efficacy|5|||
142983646|NCT00318370|515475656|FG001|Period 1|Lack of Efficacy|0|||
142983647|NCT00318370|515475657|FG002|Period 1|Lack of Efficacy|0|||
142983648|NCT00318370|515475655|FG000|Period 1|Physician Decision|1|||
142983649|NCT00318370|515475656|FG001|Period 1|Physician Decision|0|||
142983650|NCT00318370|515475657|FG002|Period 1|Physician Decision|0|||
142983651|NCT00318370|515475655|FG000|Period 1|Withdrawal by Subject|1|||
142983652|NCT00318370|515475656|FG001|Period 1|Withdrawal by Subject|0|||
142983653|NCT00318370|515475657|FG002|Period 1|Withdrawal by Subject|0|||
142983654|NCT00318370|515475655|FG000|Period 2|Adverse Event|0|||
142983655|NCT00318370|515475656|FG001|Period 2|Adverse Event|3|||
142983656|NCT00318370|515475657|FG002|Period 2|Adverse Event|0|||
142983657|NCT00318370|515475655|FG000|Period 2|Lack of Efficacy|0|||
142983658|NCT00318370|515475656|FG001|Period 2|Lack of Efficacy|5|||
142983659|NCT00318370|515475657|FG002|Period 2|Lack of Efficacy|0|||
142983660|NCT00318370|515475655|FG000|Period 2|Physician Decision|0|||
142983661|NCT00318370|515475656|FG001|Period 2|Physician Decision|1|||
142983662|NCT00318370|515475657|FG002|Period 2|Physician Decision|0|||
142983663|NCT00318370|515475655|FG000|Period 2|Withdrawal by Subject|0|||
142983664|NCT00318370|515475656|FG001|Period 2|Withdrawal by Subject|1|||
142983665|NCT00318370|515475657|FG002|Period 2|Withdrawal by Subject|0|||
142983666|NCT00318370|515475655|FG000|Period 2|Other|0|||
142983667|NCT00318370|515475656|FG001|Period 2|Other|1|||
142983668|NCT00318370|515475657|FG002|Period 2|Other|0|||
142983669|NCT00318370|515475655|FG000|Period 3|Adverse Event|0|||
142983670|NCT00318370|515475656|FG001|Period 3|Adverse Event|0|||
142983671|NCT00318370|515475657|FG002|Period 3|Adverse Event|1|||
142983672|NCT00318370|515475655|FG000|Period 3|Lack of Efficacy|0|||
142983673|NCT00318370|515475656|FG001|Period 3|Lack of Efficacy|0|||
142983674|NCT00318370|515475657|FG002|Period 3|Lack of Efficacy|24|||
142983675|NCT00318370|515475655|FG000|Period 3|Death|0|||
142983676|NCT00318370|515475656|FG001|Period 3|Death|0|||
142983677|NCT00318370|515475657|FG002|Period 3|Death|1|||
142983678|NCT00318370|515475655|FG000|Period 3|Physician Decision|0|||
142983679|NCT00318370|515475656|FG001|Period 3|Physician Decision|0|||
142983680|NCT00318370|515475657|FG002|Period 3|Physician Decision|1|||
142983681|NCT00318370|515475655|FG000|Period 3|Withdrawal by Subject|0|||
142983682|NCT00318370|515475656|FG001|Period 3|Withdrawal by Subject|0|||
142983683|NCT00318370|515475657|FG002|Period 3|Withdrawal by Subject|3|||
142983684|NCT00318370|515475655|FG000|Period 3|Other|0|||
142983685|NCT00318370|515475656|FG001|Period 3|Other|0|||
142983686|NCT00318370|515475657|FG002|Period 3|Other|3|||
142983687|NCT01997281|515475660|FG000|Overall Study|Withdrawal by Subject|1|||
142983688|NCT01997281|515475661|FG001|Overall Study|Withdrawal by Subject|0|||
142983689|NCT00368472|515475662|FG000|Overall Study|Adverse Event|22|||
142983690|NCT00368472|515475662|FG000|Overall Study|Medication non-compliance|4|||
142983691|NCT00368472|515475662|FG000|Overall Study|Protocol Violation|2|||
142983692|NCT00368472|515475662|FG000|Overall Study|Request of Investigator or Sponsor|3|||
142983693|NCT00368472|515475662|FG000|Overall Study|Withdrawal by Subject|40|||
142983694|NCT00368472|515475662|FG000|Overall Study|Diary non-compliance|1|||
142983695|NCT00368472|515475662|FG000|Overall Study|Other|32|||
142983696|NCT00368472|515475662|FG000|Overall Study|Missing Final Disposition Date|1|||
142983697|NCT03619837|515475666|FG000|Screening|received organs from HCV-negative donors|47|||
142983698|NCT03619837|515475666|FG000|Screening|died on the wait-list|2|||
142983699|NCT03619837|515475666|FG000|Screening|remained on the wait list|40|||
142983700|NCT03619837|515475666|FG000|Screening|didn't meet eligibility criteria|3|||
142983701|NCT03619837|515475666|FG000|Screening|withdrew consent|2|||
142983702|NCT03619837|515475666|FG000|Screening|never listed for HCV-viremic donor|1|||
142983703|NCT03619837|515475666|FG000|Screening|developed exclusion criteria|2|||
142983704|NCT03619837|515475666|FG000|Screening|excluded by the investigator due to non-compliance|1|||
142983705|NCT00880607|515475667|FG000|Overall Study|Physician Decision|2|||
142983706|NCT00880607|515475668|FG001|Overall Study|Physician Decision|2|||
142983707|NCT00880607|515475667|FG000|Overall Study|Protocol Violation|2|||
142983708|NCT00880607|515475668|FG001|Overall Study|Protocol Violation|1|||
142983709|NCT00880607|515475667|FG000|Overall Study|surgery did not extend past L1 level|3|||
142983710|NCT00880607|515475668|FG001|Overall Study|surgery did not extend past L1 level|0|||
142983711|NCT00981682|515475673|FG000|Overall Study|Adverse Event|48|||
142983712|NCT00981682|515475673|FG000|Overall Study|Withdrawal by Subject|52|||
142983713|NCT00981682|515475673|FG000|Overall Study|Lost to Follow-up|14|||
142983714|NCT00981682|515475673|FG000|Overall Study|Lack of Efficacy|13|||
142983715|NCT00981682|515475673|FG000|Overall Study|Protocol Violation|6|||
142983716|NCT00981682|515475673|FG000|Overall Study|administrative|9|||
142983717|NCT01696396|515477428|FG000|Overall Study|Withdrawal by Subject|19|||
142983718|NCT01696396|515477429|FG001|Overall Study|Withdrawal by Subject|5|||
142983719|NCT01696396|515477430|FG002|Overall Study|Withdrawal by Subject|19|||
142983720|NCT01696396|515477431|FG003|Overall Study|Withdrawal by Subject|11|||
142983721|NCT01696396|515477428|FG000|Overall Study|Decision by Sponsor|3|||
142983722|NCT01696396|515477429|FG001|Overall Study|Decision by Sponsor|1|||
142983723|NCT01696396|515477430|FG002|Overall Study|Decision by Sponsor|2|||
142983724|NCT01696396|515477431|FG003|Overall Study|Decision by Sponsor|2|||
142983725|NCT01696396|515477428|FG000|Overall Study|Lost to Follow-up|9|||
142983726|NCT01696396|515477429|FG001|Overall Study|Lost to Follow-up|1|||
142983727|NCT01696396|515477430|FG002|Overall Study|Lost to Follow-up|4|||
142983728|NCT01696396|515477431|FG003|Overall Study|Lost to Follow-up|1|||
142983729|NCT01696396|515477428|FG000|Overall Study|Death|0|||
142983730|NCT01696396|515477429|FG001|Overall Study|Death|0|||
142983731|NCT01696396|515477430|FG002|Overall Study|Death|1|||
142983732|NCT01696396|515477431|FG003|Overall Study|Death|0|||
142983733|NCT00634751|515477438|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
142983734|NCT00634751|515477439|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
142983735|NCT00634751|515477440|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
142983736|NCT00634751|515477441|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
142983737|NCT00634751|515477438|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
142983738|NCT00634751|515477439|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
142983739|NCT00634751|515477440|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
142983740|NCT00634751|515477441|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
142983741|NCT00634751|515477438|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
142983742|NCT00634751|515477439|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
142983743|NCT00634751|515477440|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
142983744|NCT00634751|515477441|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
142983745|NCT04402385|515477444|FG000|Overall Study|Withdrawal by Subject|4|||
142983746|NCT04402385|515477445|FG001|Overall Study|Withdrawal by Subject|4|||
142983747|NCT04402385|515477444|FG000|Overall Study|Lost to Follow-up|1|||
142983748|NCT04402385|515477445|FG001|Overall Study|Lost to Follow-up|1|||
142983749|NCT04402385|515477444|FG000|Overall Study|Physician Decision|0|||
142983750|NCT04402385|515477445|FG001|Overall Study|Physician Decision|1|||
142983751|NCT01473355|515477447|FG000|Overall Study|Protocol Violation|2|||
142983752|NCT01473355|515477447|FG000|Overall Study|Adverse Event|2|||
142983753|NCT01473355|515477447|FG000|Overall Study|Lost to Follow-up|2|||
142983754|NCT02809118|515477448|FG000|Overall Study|Withdrawal by Subject|0|||
142983755|NCT02809118|515477449|FG001|Overall Study|Withdrawal by Subject|1|||
142983756|NCT02809118|515477450|FG002|Overall Study|Withdrawal by Subject|1|||
142983757|NCT01235338|515477451|FG000|Overall Study|Adverse Event|3|||
142983758|NCT01235338|515477452|FG001|Overall Study|Adverse Event|2|||
142983759|NCT01235338|515477451|FG000|Overall Study|Protocol Violation|1|||
142983760|NCT01235338|515477452|FG001|Overall Study|Protocol Violation|1|||
142983761|NCT01235338|515477451|FG000|Overall Study|Withdrawal by Subject|5|||
142983762|NCT01235338|515477452|FG001|Overall Study|Withdrawal by Subject|0|||
142983763|NCT01235338|515477451|FG000|Overall Study|Exclusion criteria violations|1|||
142983764|NCT01235338|515477452|FG001|Overall Study|Exclusion criteria violations|1|||
142983765|NCT01235338|515477451|FG000|Overall Study|Positive drug screen|0|||
142983766|NCT01235338|515477452|FG001|Overall Study|Positive drug screen|1|||
142983767|NCT01235338|515477451|FG000|Overall Study|Prohibited meds|1|||
142983768|NCT01235338|515477452|FG001|Overall Study|Prohibited meds|0|||
142983769|NCT02436915|515477454|FG000|Overall Study|Withdrawal by Subject|0|||
142983770|NCT02436915|515477455|FG001|Overall Study|Withdrawal by Subject|1|||
142983771|NCT00446797|515477458|FG000|Overall Study|Lack of Efficacy|0|||
142983772|NCT00446797|515477459|FG001|Overall Study|Lack of Efficacy|2|||
142983773|NCT00446797|515477458|FG000|Overall Study|Lost to Follow-up|5|||
142983774|NCT00446797|515477459|FG001|Overall Study|Lost to Follow-up|3|||
142983775|NCT00446797|515477458|FG000|Overall Study|Withdrawal by Subject|2|||
142983776|NCT00446797|515477459|FG001|Overall Study|Withdrawal by Subject|2|||
142983777|NCT00446797|515477458|FG000|Overall Study|Protocol Violation|1|||
142983778|NCT00446797|515477459|FG001|Overall Study|Protocol Violation|3|||
142983779|NCT00446797|515477458|FG000|Overall Study|subject entered at another site|0|||
142983780|NCT00446797|515477459|FG001|Overall Study|subject entered at another site|1|||
142983781|NCT00446797|515477458|FG000|Overall Study|did not meet entrance criteria|0|||
142983782|NCT00446797|515477459|FG001|Overall Study|did not meet entrance criteria|1|||
142983783|NCT01440972|515477464|FG000|Overall Study|Withdrawal by Subject|3|||
142983784|NCT01440972|515477465|FG001|Overall Study|Withdrawal by Subject|2|||
142983785|NCT03933215|515477466|FG000|Overall Study|Other|6|||
142983786|NCT03933215|515477466|FG000|Overall Study|Sponsor decision|5|||
142983787|NCT03933215|515477466|FG000|Overall Study|Protocol Violation|5|||
142983788|NCT03933215|515477466|FG000|Overall Study|Withdrawal by Subject|6|||
142983789|NCT03933215|515477466|FG000|Overall Study|Lost to Follow-up|6|||
142983790|NCT03933215|515477466|FG000|Overall Study|Enrolled but not treated|38|||
142983791|NCT02473289|515477467|FG000|Overall Study|Adverse Event|2|||
142983792|NCT02473289|515477468|FG001|Overall Study|Adverse Event|3|||
142983793|NCT02473289|515477467|FG000|Overall Study|Lost to Follow-up|1|||
142983794|NCT02473289|515477468|FG001|Overall Study|Lost to Follow-up|1|||
142983795|NCT02473289|515477467|FG000|Overall Study|Protocol Violation|0|||
142983796|NCT02473289|515477468|FG001|Overall Study|Protocol Violation|1|||
142983797|NCT02473289|515477467|FG000|Overall Study|Withdrawal of consent|6|||
142983798|NCT02473289|515477468|FG001|Overall Study|Withdrawal of consent|7|||
142983799|NCT02473289|515477467|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
142983800|NCT02473289|515477468|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
142983801|NCT02473289|515477467|FG000|Overall Study|Other|2|||
142983802|NCT02473289|515477468|FG001|Overall Study|Other|0|||
142983803|NCT03745989|515477470|FG000|Overall Study|Death|3|||
142983804|NCT03745989|515477471|FG001|Overall Study|Death|7|||
142983805|NCT03745989|515477472|FG002|Overall Study|Death|4|||
142983806|NCT03745989|515477470|FG000|Overall Study|Lost to Follow-up|0|||
142983807|NCT03745989|515477471|FG001|Overall Study|Lost to Follow-up|2|||
142983808|NCT03745989|515477472|FG002|Overall Study|Lost to Follow-up|0|||
142983809|NCT03745989|515477470|FG000|Overall Study|Sponsor Decision|0|||
142983810|NCT03745989|515477471|FG001|Overall Study|Sponsor Decision|2|||
142983811|NCT03745989|515477472|FG002|Overall Study|Sponsor Decision|8|||
142983812|NCT03745989|515477470|FG000|Overall Study|Withdrawal by Subject|0|||
142983813|NCT03745989|515477471|FG001|Overall Study|Withdrawal by Subject|1|||
142983814|NCT03745989|515477472|FG002|Overall Study|Withdrawal by Subject|3|||
142983815|NCT02918318|515477478|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
142983816|NCT02918318|515477479|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
142983817|NCT02918318|515477480|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
142983818|NCT02918318|515477481|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
142983819|NCT02918318|515477482|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
142983820|NCT02918318|515477478|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
142983821|NCT02918318|515477479|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
142983822|NCT02918318|515477480|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
142983823|NCT02918318|515477481|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
142983824|NCT02918318|515477482|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
142983825|NCT02918318|515477478|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
142983826|NCT02918318|515477479|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
142983827|NCT02918318|515477480|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
142983828|NCT02918318|515477481|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
142983829|NCT02918318|515477482|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
142983830|NCT02918318|515477478|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
142983831|NCT02918318|515477479|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
142983832|NCT02918318|515477480|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
142983833|NCT02918318|515477481|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
142983834|NCT02918318|515477482|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
142983835|NCT02918318|515477478|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
142983836|NCT02918318|515477479|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
142983837|NCT02918318|515477480|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
142983838|NCT02918318|515477481|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
142983839|NCT02918318|515477482|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
142983840|NCT02918318|515477478|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
142983841|NCT02918318|515477479|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
142983842|NCT02918318|515477480|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
142983843|NCT02918318|515477481|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
142983844|NCT02918318|515477482|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
142983845|NCT02918318|515477478|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
142983846|NCT02918318|515477479|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
142983847|NCT02918318|515477480|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
142983848|NCT02918318|515477481|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
142983849|NCT02918318|515477482|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
142983850|NCT02918318|515477478|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
142983851|NCT02918318|515477479|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
142983852|NCT02918318|515477480|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
142983853|NCT02918318|515477481|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
142983854|NCT02918318|515477482|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
142983855|NCT02918318|515477478|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
142983856|NCT02918318|515477479|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
142983857|NCT02918318|515477480|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
142983858|NCT02918318|515477481|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
142983859|NCT02918318|515477482|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
142983860|NCT02918318|515477478|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
142983861|NCT02918318|515477479|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
142983862|NCT02918318|515477480|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
142983863|NCT02918318|515477481|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
142983864|NCT02918318|515477482|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
142983865|NCT02918318|515477478|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
142983866|NCT02918318|515477479|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
142983867|NCT02918318|515477480|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
142983868|NCT02918318|515477481|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
142983869|NCT02918318|515477482|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
142983870|NCT02918318|515477478|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
142983871|NCT02918318|515477479|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
142983872|NCT02918318|515477480|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
142983873|NCT02918318|515477481|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
142983874|NCT02918318|515477482|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
142983875|NCT03185819|515477483|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
142983876|NCT03185819|515477484|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
142983877|NCT03185819|515477485|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
142983878|NCT03185819|515477486|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
142983879|NCT03185819|515477483|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
142983880|NCT03185819|515477484|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
142983881|NCT03185819|515477485|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
142983882|NCT03185819|515477486|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
142983883|NCT03185819|515477483|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
142983884|NCT03185819|515477484|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
142983885|NCT03185819|515477485|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
142983886|NCT03185819|515477486|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
142983887|NCT03185819|515477483|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
142983888|NCT03185819|515477484|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
142983889|NCT03185819|515477485|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
142983890|NCT03185819|515477486|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
142983891|NCT03185819|515477483|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
142983892|NCT03185819|515477484|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
142983893|NCT03185819|515477485|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
142983894|NCT03185819|515477486|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
142983895|NCT03185819|515477483|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
142983896|NCT03185819|515477484|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
142983897|NCT03185819|515477485|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
142983898|NCT03185819|515477486|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
142983899|NCT03185819|515477483|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
142983900|NCT03185819|515477484|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
143117226|NCT00787917|515970069|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
142983901|NCT03185819|515477485|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
142983902|NCT03185819|515477486|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
142983903|NCT03185819|515477483|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
142983904|NCT03185819|515477484|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
142983905|NCT03185819|515477485|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
142983906|NCT03185819|515477486|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
142983907|NCT03185819|515477483|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
142983908|NCT03185819|515477484|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
142983909|NCT03185819|515477485|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
142983910|NCT03185819|515477486|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
142983911|NCT03185819|515477483|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
142983912|NCT03185819|515477484|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
142983913|NCT03185819|515477485|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
142983914|NCT03185819|515477486|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
142983915|NCT03185819|515477483|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
142983916|NCT03185819|515477484|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
142983917|NCT03185819|515477485|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
142983918|NCT03185819|515477486|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
142983919|NCT03185819|515477483|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
142983920|NCT03185819|515477484|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
142983921|NCT03185819|515477485|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
142983922|NCT03185819|515477486|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
142983923|NCT03185819|515477483|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
142983924|NCT03185819|515477484|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
142983925|NCT03185819|515477485|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
142983926|NCT03185819|515477486|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
142983927|NCT03097133|515477487|FG000|Overall Study|Lost to Follow-up|3|||
142983928|NCT03097133|515477488|FG001|Overall Study|Lost to Follow-up|2|||
142983929|NCT03097133|515477487|FG000|Overall Study|Withdrawal by Subject|2|||
142983930|NCT03097133|515477488|FG001|Overall Study|Withdrawal by Subject|5|||
142983931|NCT03097133|515477487|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
142983932|NCT03097133|515477488|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
142983933|NCT03097133|515477487|FG000|Overall Study|Other|3|||
142983934|NCT03097133|515477488|FG001|Overall Study|Other|2|||
142983935|NCT03097133|515477487|FG000|Overall Study|Adverse Event|1|||
142983936|NCT03097133|515477488|FG001|Overall Study|Adverse Event|0|||
142983937|NCT00732641|515477489|FG000|Overall Study|Relapse or Progressive Disease|65|||
142983938|NCT00732641|515477490|FG001|Overall Study|Relapse or Progressive Disease|101|||
142983939|NCT00732641|515477489|FG000|Overall Study|Serious Adverse Events|12|||
142983940|NCT00732641|515477490|FG001|Overall Study|Serious Adverse Events|3|||
142983941|NCT00732641|515477489|FG000|Overall Study|Physician Decision|6|||
142983942|NCT00732641|515477490|FG001|Overall Study|Physician Decision|0|||
142983943|NCT00732641|515477489|FG000|Overall Study|Withdrawal by Subject|4|||
142983944|NCT00732641|515477490|FG001|Overall Study|Withdrawal by Subject|2|||
142983945|NCT00732641|515477489|FG000|Overall Study|Unable to Complete|1|||
142983946|NCT00732641|515477490|FG001|Overall Study|Unable to Complete|1|||
142983947|NCT00732641|515477489|FG000|Overall Study|Other|18|||
142983948|NCT00732641|515477490|FG001|Overall Study|Other|5|||
142983949|NCT02939976|515477491|FG000|Overall Study|Lost to Follow-up|7|||
142983950|NCT02939976|515477492|FG001|Overall Study|Lost to Follow-up|1|||
142983951|NCT02939976|515477493|FG002|Overall Study|Lost to Follow-up|1|||
142983952|NCT02939976|515477494|FG003|Overall Study|Lost to Follow-up|2|||
142983953|NCT02939976|515477491|FG000|Overall Study|Withdrawal by Subject|4|||
142983954|NCT02939976|515477492|FG001|Overall Study|Withdrawal by Subject|0|||
142983955|NCT02939976|515477493|FG002|Overall Study|Withdrawal by Subject|2|||
142983956|NCT02939976|515477494|FG003|Overall Study|Withdrawal by Subject|4|||
142983957|NCT02939976|515477491|FG000|Overall Study|Due to early study closure|4|||
142983958|NCT02939976|515477492|FG001|Overall Study|Due to early study closure|3|||
142983959|NCT02939976|515477493|FG002|Overall Study|Due to early study closure|2|||
142983960|NCT02939976|515477494|FG003|Overall Study|Due to early study closure|3|||
142983961|NCT04159701|515477495|FG000|Period 1: Treatment Period|Pregnancy|1|||
142983962|NCT04159701|515477496|FG001|Period 1: Treatment Period|Pregnancy|0|||
142983963|NCT04159701|515477495|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
142983964|NCT04159701|515477496|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
142983965|NCT04159701|515477495|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
142983966|NCT04159701|515477496|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
142983967|NCT04159701|515477495|FG000|Washout Period|site terminated by sponsor|0|||
142983968|NCT04159701|515477496|FG001|Washout Period|site terminated by sponsor|1|||
142983969|NCT04159701|515477495|FG000|Washout Period|study terminated by sponsor|10|||
142983970|NCT04159701|515477496|FG001|Washout Period|study terminated by sponsor|3|||
142983971|NCT04159701|515477495|FG000|Washout Period|Withdrawal by Subject|1|||
142983972|NCT04159701|515477496|FG001|Washout Period|Withdrawal by Subject|0|||
142983973|NCT04159701|515477495|FG000|Washout Period|Inadvertent Enrollment|1|||
142983974|NCT04159701|515477496|FG001|Washout Period|Inadvertent Enrollment|0|||
142983975|NCT04159701|515477495|FG000|Washout Period|Miscellaneous|1|||
142983976|NCT04159701|515477496|FG001|Washout Period|Miscellaneous|0|||
142983977|NCT04159701|515477495|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
142983978|NCT04159701|515477496|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
142983979|NCT04159701|515477495|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
142983980|NCT04159701|515477496|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
142983981|NCT04159701|515477495|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
142983982|NCT04159701|515477496|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
142983983|NCT04159701|515477495|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
142983984|NCT04159701|515477496|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
142983985|NCT04159701|515477495|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
142983986|NCT04159701|515477496|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
142983987|NCT00654420|515477504|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
142983988|NCT00654420|515477505|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
142983989|NCT00654420|515477506|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
142983990|NCT00654420|515477507|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
142983991|NCT00654420|515477504|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
142983992|NCT00654420|515477505|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
142983993|NCT00654420|515477506|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
142983994|NCT00654420|515477507|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
142983995|NCT00654420|515477504|FG000|Phase II|Adverse Event|0|||
142983996|NCT00654420|515477505|FG001|Phase II|Adverse Event|0|||
142983997|NCT00654420|515477506|FG002|Phase II|Adverse Event|3|||
142983998|NCT00654420|515477507|FG003|Phase II|Adverse Event|3|||
142983999|NCT00654420|515477504|FG000|Phase II|Lost to Follow-up|0|||
142984000|NCT00654420|515477505|FG001|Phase II|Lost to Follow-up|0|||
142984001|NCT00654420|515477506|FG002|Phase II|Lost to Follow-up|0|||
142984002|NCT00654420|515477507|FG003|Phase II|Lost to Follow-up|1|||
142984003|NCT00654420|515477504|FG000|Phase II|Physician Decision|0|||
142984004|NCT00654420|515477505|FG001|Phase II|Physician Decision|0|||
142984005|NCT00654420|515477506|FG002|Phase II|Physician Decision|0|||
142984006|NCT00654420|515477507|FG003|Phase II|Physician Decision|4|||
142984007|NCT00654420|515477504|FG000|Phase II|Progressive Disease|0|||
142984008|NCT00654420|515477505|FG001|Phase II|Progressive Disease|0|||
142984009|NCT00654420|515477506|FG002|Phase II|Progressive Disease|29|||
142984010|NCT00654420|515477507|FG003|Phase II|Progressive Disease|29|||
142984011|NCT00654420|515477504|FG000|Phase II|Withdrawal by Subject|0|||
142984012|NCT00654420|515477505|FG001|Phase II|Withdrawal by Subject|0|||
142984013|NCT00654420|515477506|FG002|Phase II|Withdrawal by Subject|4|||
142984014|NCT00654420|515477507|FG003|Phase II|Withdrawal by Subject|1|||
142984015|NCT00654420|515477504|FG000|Phase II|Missing Disposition Record|0|||
142984016|NCT00654420|515477505|FG001|Phase II|Missing Disposition Record|0|||
142984017|NCT00654420|515477506|FG002|Phase II|Missing Disposition Record|1|||
142984018|NCT00654420|515477507|FG003|Phase II|Missing Disposition Record|0|||
142984019|NCT03034057|515477523|FG000|Overall Study|Withdrawal by Subject|10|||
142984020|NCT03034057|515477523|FG000|Overall Study|Protocol Violation|1|||
142984021|NCT03034057|515477523|FG000|Overall Study|Not defined|2|||
142984022|NCT03034057|515477523|FG000|Overall Study|Lost to Follow-up|19|||
142984023|NCT03034057|515477523|FG000|Overall Study|Adverse Event|22|||
142984024|NCT03034057|515477523|FG000|Overall Study|Medication error without associated AE|1|||
142984025|NCT02917629|515477524|FG000|Overall Study|Withdrawal by Subject|0|||
142984026|NCT02917629|515477525|FG001|Overall Study|Withdrawal by Subject|1|||
142984027|NCT03271307|515477526|FG000|Overall Study|Lost to Follow-up|0|||
142984028|NCT03271307|515477527|FG001|Overall Study|Lost to Follow-up|0|||
142984029|NCT03271307|515477528|FG002|Overall Study|Lost to Follow-up|0|||
142984030|NCT03271307|515477529|FG003|Overall Study|Lost to Follow-up|28|||
142984031|NCT03271307|515477530|FG004|Overall Study|Lost to Follow-up|91|||
142984032|NCT03997760|515477531|FG000|Overall Study|Protocol Deviation|0|||
142984033|NCT03997760|515477532|FG001|Overall Study|Protocol Deviation|1|||
142984034|NCT03997760|515477533|FG002|Overall Study|Protocol Deviation|0|||
142984035|NCT03997760|515477534|FG003|Overall Study|Protocol Deviation|0|||
142984036|NCT00856986|515477535|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
142984037|NCT00856986|515477536|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
142984038|NCT00856986|515477537|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
142984039|NCT00856986|515477538|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
142984040|NCT00856986|515477539|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
142984041|NCT00856986|515477535|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
142984042|NCT00856986|515477536|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
142984043|NCT00856986|515477537|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
142984044|NCT00856986|515477538|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
142984045|NCT00856986|515477539|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
142984046|NCT00856986|515477535|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
142984047|NCT00856986|515477536|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
142984048|NCT00856986|515477537|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
143003173|NCT01049360|515548745|FG001|Period 2|Lack of Efficacy|0|||
142984049|NCT00856986|515477538|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
142984050|NCT00856986|515477539|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
142984051|NCT00856986|515477535|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
142984052|NCT00856986|515477536|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
142984053|NCT00856986|515477537|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
142984054|NCT00856986|515477538|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
142984055|NCT00856986|515477539|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
142984056|NCT00856986|515477535|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
142984057|NCT00856986|515477536|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
142984058|NCT00856986|515477537|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
142984059|NCT00856986|515477538|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
142984060|NCT00856986|515477539|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
142984061|NCT00856986|515477535|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
142984062|NCT00856986|515477536|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
142984063|NCT00856986|515477537|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
142984064|NCT00856986|515477538|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
142984065|NCT00856986|515477539|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
142984066|NCT00856986|515477535|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
142984067|NCT00856986|515477536|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
142984068|NCT00856986|515477537|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
142984069|NCT00856986|515477538|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
142984070|NCT00856986|515477539|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
142984071|NCT00856986|515477535|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
142984072|NCT00856986|515477536|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
142984073|NCT00856986|515477537|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
142984074|NCT00856986|515477538|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
142984075|NCT00856986|515477539|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
142984076|NCT00856986|515477535|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
142984077|NCT00856986|515477536|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
142984078|NCT00856986|515477537|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
142984079|NCT00856986|515477538|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
142984080|NCT00856986|515477539|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
142984081|NCT00856986|515477535|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
142984082|NCT00856986|515477536|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
142984083|NCT00856986|515477537|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
142984084|NCT00856986|515477538|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
142984085|NCT00856986|515477539|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
142984086|NCT00856986|515477535|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
142984087|NCT00856986|515477536|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
142984088|NCT00856986|515477537|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
142984089|NCT00856986|515477538|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
142984090|NCT00856986|515477539|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
142984091|NCT00856986|515477535|FG000|Main Period, Weeks 0-26|Unclassified|7|||
142984092|NCT00856986|515477536|FG001|Main Period, Weeks 0-26|Unclassified|6|||
142984093|NCT00856986|515477537|FG002|Main Period, Weeks 0-26|Unclassified|7|||
142984094|NCT00856986|515477538|FG003|Main Period, Weeks 0-26|Unclassified|0|||
142984095|NCT00856986|515477539|FG004|Main Period, Weeks 0-26|Unclassified|0|||
142984096|NCT00856986|515477535|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
142984097|NCT00856986|515477536|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
142984098|NCT00856986|515477537|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
142984099|NCT00856986|515477538|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
142984100|NCT00856986|515477539|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
142984101|NCT00856986|515477535|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
142984102|NCT00856986|515477536|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
142984103|NCT00856986|515477537|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
142984104|NCT00856986|515477538|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
142984105|NCT00856986|515477539|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
142984106|NCT00856986|515477535|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
142984107|NCT00856986|515477536|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
142984108|NCT00856986|515477537|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
142984109|NCT00856986|515477538|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
142984110|NCT00856986|515477539|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
142984111|NCT00856986|515477535|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
142984112|NCT00856986|515477536|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
142984113|NCT00856986|515477537|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
142984114|NCT00856986|515477538|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
142984115|NCT00856986|515477539|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
142984116|NCT00856986|515477535|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
142984117|NCT00856986|515477536|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
142984118|NCT00856986|515477537|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
142984119|NCT00856986|515477538|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
142984120|NCT00856986|515477539|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
142984121|NCT00856986|515477535|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
142984122|NCT00856986|515477536|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
142984123|NCT00856986|515477537|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
142984124|NCT00856986|515477538|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
142984125|NCT00856986|515477539|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
142984126|NCT05041062|515477542|FG000|Overall Study|Adverse Event|2|||
142984127|NCT04968353|515477545|FG000|Overall Study|Non-compliance|1|||
142984128|NCT04968353|515477546|FG001|Overall Study|Non-compliance|0|||
142984129|NCT04968353|515477547|FG002|Overall Study|Non-compliance|2|||
142984130|NCT04968353|515477548|FG003|Overall Study|Non-compliance|0|||
142984131|NCT02896192|515477549|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
142984132|NCT02896192|515477549|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
142984133|NCT02896192|515477549|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
142984134|NCT00479167|515477551|FG000|Overall Study|Withdrawal by Subject|1|||
142984135|NCT00560794|515477552|FG000|Overall Study|Adverse Event|2|||
142984136|NCT00560794|515477552|FG000|Overall Study|Patient was not Compliant|1|||
142984137|NCT00560794|515477552|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
142984138|NCT00560794|515477552|FG000|Overall Study|Hematological Relapse|1|||
142984139|NCT00560794|515477552|FG000|Overall Study|Received Bone Marrow Transplant|6|||
142984140|NCT04857892|515477553|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
142984141|NCT04857892|515477554|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
142984142|NCT04857892|515477555|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
142984143|NCT04857892|515477556|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
142984144|NCT04857892|515477557|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
142984145|NCT04857892|515477553|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
142984146|NCT04857892|515477554|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
142984147|NCT04857892|515477555|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
142984148|NCT04857892|515477556|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
142984149|NCT04857892|515477557|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
142984150|NCT04857892|515477553|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
142984151|NCT04857892|515477554|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
142984152|NCT04857892|515477555|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
142984153|NCT04857892|515477556|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
142984154|NCT04857892|515477557|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
142984155|NCT02371980|515479507|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
142984156|NCT02371980|515479508|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
142984157|NCT02371980|515479509|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
142984158|NCT02371980|515479510|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
142984159|NCT02371980|515479511|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
142984160|NCT02371980|515479507|FG000|Open-label Period|Significant Protocol Deviation|19|||
142984161|NCT02371980|515479508|FG001|Open-label Period|Significant Protocol Deviation|0|||
142984162|NCT02371980|515479509|FG002|Open-label Period|Significant Protocol Deviation|0|||
142984163|NCT02371980|515479510|FG003|Open-label Period|Significant Protocol Deviation|0|||
142984164|NCT02371980|515479511|FG004|Open-label Period|Significant Protocol Deviation|0|||
142984165|NCT02371980|515479507|FG000|Open-label Period|Noncompliance with Study Drug|10|||
142984166|NCT02371980|515479508|FG001|Open-label Period|Noncompliance with Study Drug|0|||
142984167|NCT02371980|515479509|FG002|Open-label Period|Noncompliance with Study Drug|0|||
142984168|NCT02371980|515479510|FG003|Open-label Period|Noncompliance with Study Drug|0|||
142984169|NCT02371980|515479511|FG004|Open-label Period|Noncompliance with Study Drug|0|||
142984170|NCT02371980|515479507|FG000|Open-label Period|Lost to Follow-up|55|||
142984171|NCT02371980|515479508|FG001|Open-label Period|Lost to Follow-up|0|||
142984172|NCT02371980|515479509|FG002|Open-label Period|Lost to Follow-up|0|||
142984173|NCT02371980|515479510|FG003|Open-label Period|Lost to Follow-up|0|||
142984174|NCT02371980|515479511|FG004|Open-label Period|Lost to Follow-up|0|||
142984175|NCT02371980|515479507|FG000|Open-label Period|Voluntary Withdrawal|91|||
142984176|NCT02371980|515479508|FG001|Open-label Period|Voluntary Withdrawal|0|||
142984177|NCT02371980|515479509|FG002|Open-label Period|Voluntary Withdrawal|0|||
142984178|NCT02371980|515479510|FG003|Open-label Period|Voluntary Withdrawal|0|||
142984179|NCT02371980|515479511|FG004|Open-label Period|Voluntary Withdrawal|0|||
142984180|NCT02371980|515479507|FG000|Open-label Period|Pregnancy|1|||
142984181|NCT02371980|515479508|FG001|Open-label Period|Pregnancy|0|||
142984182|NCT02371980|515479509|FG002|Open-label Period|Pregnancy|0|||
142984183|NCT02371980|515479510|FG003|Open-label Period|Pregnancy|0|||
142984184|NCT02371980|515479511|FG004|Open-label Period|Pregnancy|0|||
142984185|NCT02371980|515479507|FG000|Open-label Period|Lack of Efficacy|116|||
142984186|NCT02371980|515479508|FG001|Open-label Period|Lack of Efficacy|0|||
142984187|NCT02371980|515479509|FG002|Open-label Period|Lack of Efficacy|0|||
142984188|NCT02371980|515479510|FG003|Open-label Period|Lack of Efficacy|0|||
142984189|NCT02371980|515479511|FG004|Open-label Period|Lack of Efficacy|0|||
142984190|NCT02371980|515479507|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
142984191|NCT02371980|515479508|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
142984192|NCT02371980|515479509|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
142984193|NCT02371980|515479510|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
142984194|NCT02371980|515479511|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
142984195|NCT02371980|515479507|FG000|Open-label Period|Reason not Specified|9|||
142984196|NCT02371980|515479508|FG001|Open-label Period|Reason not Specified|0|||
142984197|NCT02371980|515479509|FG002|Open-label Period|Reason not Specified|0|||
142984198|NCT02371980|515479510|FG003|Open-label Period|Reason not Specified|0|||
142984199|NCT02371980|515479511|FG004|Open-label Period|Reason not Specified|0|||
142984200|NCT02371980|515479507|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
142984201|NCT02371980|515479508|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
142984202|NCT02371980|515479509|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
142984203|NCT02371980|515479510|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
142984204|NCT02371980|515479511|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
142984205|NCT02371980|515479507|FG000|Double-blind Period|Significant Protocol Deviation|0|||
142984206|NCT02371980|515479508|FG001|Double-blind Period|Significant Protocol Deviation|2|||
142984207|NCT02371980|515479509|FG002|Double-blind Period|Significant Protocol Deviation|7|||
142984208|NCT02371980|515479510|FG003|Double-blind Period|Significant Protocol Deviation|3|||
142984209|NCT02371980|515479511|FG004|Double-blind Period|Significant Protocol Deviation|3|||
142984210|NCT02371980|515479507|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
142984211|NCT02371980|515479508|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
142984212|NCT02371980|515479509|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
142984213|NCT02371980|515479510|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
142984214|NCT02371980|515479511|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
142984215|NCT02371980|515479507|FG000|Double-blind Period|Lost to Follow-up|0|||
142984216|NCT02371980|515479508|FG001|Double-blind Period|Lost to Follow-up|8|||
142984217|NCT02371980|515479509|FG002|Double-blind Period|Lost to Follow-up|8|||
142984218|NCT02371980|515479510|FG003|Double-blind Period|Lost to Follow-up|6|||
142984219|NCT02371980|515479511|FG004|Double-blind Period|Lost to Follow-up|5|||
142984220|NCT02371980|515479507|FG000|Double-blind Period|Voluntary Withdrawal|0|||
142984221|NCT02371980|515479508|FG001|Double-blind Period|Voluntary Withdrawal|12|||
142984222|NCT02371980|515479509|FG002|Double-blind Period|Voluntary Withdrawal|8|||
142984223|NCT02371980|515479510|FG003|Double-blind Period|Voluntary Withdrawal|9|||
142984224|NCT02371980|515479511|FG004|Double-blind Period|Voluntary Withdrawal|11|||
142984225|NCT02371980|515479507|FG000|Double-blind Period|Relapse|0|||
142984226|NCT02371980|515479508|FG001|Double-blind Period|Relapse|50|||
142984227|NCT02371980|515479509|FG002|Double-blind Period|Relapse|25|||
142984228|NCT02371980|515479510|FG003|Double-blind Period|Relapse|25|||
142984229|NCT02371980|515479511|FG004|Double-blind Period|Relapse|26|||
142984230|NCT02371980|515479507|FG000|Double-blind Period|Reason not Specified|0|||
142984231|NCT02371980|515479508|FG001|Double-blind Period|Reason not Specified|3|||
142984232|NCT02371980|515479509|FG002|Double-blind Period|Reason not Specified|3|||
142984233|NCT02371980|515479510|FG003|Double-blind Period|Reason not Specified|2|||
142984234|NCT02371980|515479511|FG004|Double-blind Period|Reason not Specified|1|||
142984235|NCT02371980|515479507|FG000|Double-blind Period|Missing|0|||
142984236|NCT02371980|515479508|FG001|Double-blind Period|Missing|1|||
142984237|NCT02371980|515479509|FG002|Double-blind Period|Missing|0|||
142984238|NCT02371980|515479510|FG003|Double-blind Period|Missing|0|||
142984239|NCT02371980|515479511|FG004|Double-blind Period|Missing|0|||
142984240|NCT04483544|515479512|FG000|Treatment (Completed 1 or More Cycles)|Death|1|||
142984241|NCT04483544|515479512|FG000|Post-Treatment|Admitted to hospice|2|||
142984242|NCT04483544|515479512|FG000|Post-Treatment|Study terminated|3|||
142984243|NCT04315298|515479517|FG000|Overall Study|Withdrawal by Subject|0|||
142984244|NCT04315298|515479518|FG001|Overall Study|Withdrawal by Subject|0|||
142984245|NCT04315298|515479519|FG002|Overall Study|Withdrawal by Subject|0|||
142984246|NCT04315298|515479520|FG003|Overall Study|Withdrawal by Subject|2|||
142984247|NCT04315298|515479521|FG004|Overall Study|Withdrawal by Subject|2|||
142984248|NCT04315298|515479522|FG005|Overall Study|Withdrawal by Subject|2|||
142984249|NCT04315298|515479523|FG006|Overall Study|Withdrawal by Subject|0|||
142984250|NCT04315298|515479524|FG007|Overall Study|Withdrawal by Subject|1|||
142984251|NCT04315298|515479525|FG008|Overall Study|Withdrawal by Subject|1|||
142984252|NCT04315298|515479526|FG009|Overall Study|Withdrawal by Subject|1|||
142984253|NCT04315298|515479527|FG010|Overall Study|Withdrawal by Subject|0|||
142984254|NCT04315298|515479528|FG011|Overall Study|Withdrawal by Subject|0|||
142984255|NCT04315298|515479529|FG012|Overall Study|Withdrawal by Subject|0|||
142984256|NCT04315298|515479530|FG013|Overall Study|Withdrawal by Subject|0|||
142984257|NCT04315298|515479531|FG014|Overall Study|Withdrawal by Subject|0|||
142984258|NCT04315298|515479532|FG015|Overall Study|Withdrawal by Subject|0|||
142984259|NCT04315298|515479533|FG016|Overall Study|Withdrawal by Subject|0|||
142984260|NCT04315298|515479534|FG017|Overall Study|Withdrawal by Subject|0|||
142984261|NCT04315298|515479535|FG018|Overall Study|Withdrawal by Subject|0|||
143117227|NCT00787917|515970070|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
142984262|NCT04315298|515479517|FG000|Overall Study|Physician Decision|0|||
142984263|NCT04315298|515479518|FG001|Overall Study|Physician Decision|0|||
142984264|NCT04315298|515479519|FG002|Overall Study|Physician Decision|0|||
142984265|NCT04315298|515479520|FG003|Overall Study|Physician Decision|0|||
142984266|NCT04315298|515479521|FG004|Overall Study|Physician Decision|1|||
142984267|NCT04315298|515479522|FG005|Overall Study|Physician Decision|0|||
142984268|NCT04315298|515479523|FG006|Overall Study|Physician Decision|0|||
142984269|NCT04315298|515479524|FG007|Overall Study|Physician Decision|0|||
142984270|NCT04315298|515479525|FG008|Overall Study|Physician Decision|0|||
142984271|NCT04315298|515479526|FG009|Overall Study|Physician Decision|0|||
142984272|NCT04315298|515479527|FG010|Overall Study|Physician Decision|0|||
142984273|NCT04315298|515479528|FG011|Overall Study|Physician Decision|0|||
142984274|NCT04315298|515479529|FG012|Overall Study|Physician Decision|0|||
142984275|NCT04315298|515479530|FG013|Overall Study|Physician Decision|0|||
142984276|NCT04315298|515479531|FG014|Overall Study|Physician Decision|0|||
142984277|NCT04315298|515479532|FG015|Overall Study|Physician Decision|0|||
142984278|NCT04315298|515479533|FG016|Overall Study|Physician Decision|0|||
142984279|NCT04315298|515479534|FG017|Overall Study|Physician Decision|0|||
142984280|NCT04315298|515479535|FG018|Overall Study|Physician Decision|0|||
142984281|NCT04315298|515479517|FG000|Overall Study|Lost to Follow-up|5|||
142984282|NCT04315298|515479518|FG001|Overall Study|Lost to Follow-up|10|||
142984283|NCT04315298|515479519|FG002|Overall Study|Lost to Follow-up|6|||
142984284|NCT04315298|515479520|FG003|Overall Study|Lost to Follow-up|8|||
142984285|NCT04315298|515479521|FG004|Overall Study|Lost to Follow-up|12|||
142984286|NCT04315298|515479522|FG005|Overall Study|Lost to Follow-up|13|||
142984287|NCT04315298|515479523|FG006|Overall Study|Lost to Follow-up|9|||
142984288|NCT04315298|515479524|FG007|Overall Study|Lost to Follow-up|16|||
142984289|NCT04315298|515479525|FG008|Overall Study|Lost to Follow-up|14|||
142984290|NCT04315298|515479526|FG009|Overall Study|Lost to Follow-up|0|||
142984291|NCT04315298|515479527|FG010|Overall Study|Lost to Follow-up|2|||
142984292|NCT04315298|515479528|FG011|Overall Study|Lost to Follow-up|1|||
142984293|NCT04315298|515479529|FG012|Overall Study|Lost to Follow-up|0|||
142984294|NCT04315298|515479530|FG013|Overall Study|Lost to Follow-up|0|||
142984295|NCT04315298|515479531|FG014|Overall Study|Lost to Follow-up|0|||
142984296|NCT04315298|515479532|FG015|Overall Study|Lost to Follow-up|2|||
142984297|NCT04315298|515479533|FG016|Overall Study|Lost to Follow-up|0|||
142984298|NCT04315298|515479534|FG017|Overall Study|Lost to Follow-up|0|||
142984299|NCT04315298|515479535|FG018|Overall Study|Lost to Follow-up|0|||
142984300|NCT04315298|515479517|FG000|Overall Study|Death|24|||
142984301|NCT04315298|515479518|FG001|Overall Study|Death|60|||
142984302|NCT04315298|515479519|FG002|Overall Study|Death|49|||
142984303|NCT04315298|515479520|FG003|Overall Study|Death|59|||
142984304|NCT04315298|515479521|FG004|Overall Study|Death|70|||
142984305|NCT04315298|515479522|FG005|Overall Study|Death|114|||
142984306|NCT04315298|515479523|FG006|Overall Study|Death|9|||
142984307|NCT04315298|515479524|FG007|Overall Study|Death|12|||
142984308|NCT04315298|515479525|FG008|Overall Study|Death|21|||
142984309|NCT04315298|515479526|FG009|Overall Study|Death|16|||
142984310|NCT04315298|515479527|FG010|Overall Study|Death|40|||
142984311|NCT04315298|515479528|FG011|Overall Study|Death|40|||
142984312|NCT04315298|515479529|FG012|Overall Study|Death|3|||
142984313|NCT04315298|515479530|FG013|Overall Study|Death|4|||
142984314|NCT04315298|515479531|FG014|Overall Study|Death|6|||
142984315|NCT04315298|515479532|FG015|Overall Study|Death|4|||
142984316|NCT04315298|515479533|FG016|Overall Study|Death|3|||
142984317|NCT04315298|515479534|FG017|Overall Study|Death|1|||
142984318|NCT04315298|515479535|FG018|Overall Study|Death|0|||
142984319|NCT01199198|515479536|FG000|Overall Study|Adverse Event|3|||
142984320|NCT01199198|515479537|FG001|Overall Study|Adverse Event|0|||
142984321|NCT01199198|515479536|FG000|Overall Study|Lost to Follow-up|1|||
142984322|NCT01199198|515479537|FG001|Overall Study|Lost to Follow-up|5|||
142984323|NCT01199198|515479536|FG000|Overall Study|Withdrawal by Subject|1|||
142984324|NCT01199198|515479537|FG001|Overall Study|Withdrawal by Subject|2|||
142984325|NCT01199198|515479536|FG000|Overall Study|ICU Transfer|1|||
142984326|NCT01199198|515479537|FG001|Overall Study|ICU Transfer|2|||
142984327|NCT01199198|515479536|FG000|Overall Study|Hospice-care transfer|1|||
142984328|NCT01199198|515479537|FG001|Overall Study|Hospice-care transfer|2|||
142984329|NCT00736385|515479538|FG000|Overall Study|Withdrawal by Subject|2|||
142984330|NCT00736385|515479539|FG001|Overall Study|Withdrawal by Subject|2|||
142984331|NCT00736385|515479538|FG000|Overall Study|Adverse Event|0|||
142984332|NCT00736385|515479539|FG001|Overall Study|Adverse Event|1|||
142984333|NCT01183104|515479540|FG000|Overall Study|Adverse Event|8|||
142984334|NCT01183104|515479541|FG001|Overall Study|Adverse Event|6|||
142984335|NCT01183104|515479540|FG000|Overall Study|Death|0|||
142984336|NCT01183104|515479541|FG001|Overall Study|Death|1|||
142984337|NCT01183104|515479540|FG000|Overall Study|Lost to Follow-up|14|||
142984338|NCT01183104|515479541|FG001|Overall Study|Lost to Follow-up|7|||
142984339|NCT01183104|515479540|FG000|Overall Study|Physician Decision|5|||
142984340|NCT01183104|515479541|FG001|Overall Study|Physician Decision|8|||
142984341|NCT01183104|515479540|FG000|Overall Study|Withdrawal by Subject|6|||
142984342|NCT01183104|515479541|FG001|Overall Study|Withdrawal by Subject|11|||
142984343|NCT01183104|515479540|FG000|Overall Study|Nonparticipation in Extension Study|39|||
142984344|NCT01183104|515479541|FG001|Overall Study|Nonparticipation in Extension Study|50|||
142984345|NCT01183104|515479540|FG000|Overall Study|Did not receive study drug|5|||
142984346|NCT01183104|515479541|FG001|Overall Study|Did not receive study drug|9|||
142984347|NCT01594749|515479542|FG000|Overall Study|Adverse Event|2|||
142984348|NCT01594749|515479543|FG001|Overall Study|Adverse Event|1|||
142984349|NCT01594749|515479542|FG000|Overall Study|Withdrawal by Subject|2|||
142984350|NCT01594749|515479543|FG001|Overall Study|Withdrawal by Subject|2|||
142984351|NCT01594749|515479542|FG000|Overall Study|Protocol Violation|2|||
142984352|NCT01594749|515479543|FG001|Overall Study|Protocol Violation|0|||
142984353|NCT01594749|515479542|FG000|Overall Study|Physician Decision|1|||
142984354|NCT01594749|515479543|FG001|Overall Study|Physician Decision|1|||
142984355|NCT01594749|515479542|FG000|Overall Study|Non-compliance with Protocol|0|||
142984356|NCT01594749|515479543|FG001|Overall Study|Non-compliance with Protocol|1|||
142984357|NCT01594749|515479542|FG000|Overall Study|Lost to Follow-up|1|||
142984358|NCT01594749|515479543|FG001|Overall Study|Lost to Follow-up|0|||
142984359|NCT01594749|515479542|FG000|Overall Study|Death|9|||
142984360|NCT01594749|515479543|FG001|Overall Study|Death|3|||
142984361|NCT01594749|515479542|FG000|Overall Study|Not Treated|4|||
142984362|NCT01594749|515479543|FG001|Overall Study|Not Treated|10|||
142984363|NCT01594749|515479542|FG000|Overall Study|Lost Source Documentation|1|||
142984364|NCT01594749|515479543|FG001|Overall Study|Lost Source Documentation|0|||
142984365|NCT00653068|515479544|FG000|Overall Study|Death|9|||
142984366|NCT00653068|515479544|FG000|Overall Study|Lack of Efficacy|34|||
142984367|NCT00653068|515479544|FG000|Overall Study|Physician Decision|4|||
142984368|NCT00653068|515479544|FG000|Overall Study|Withdrawal by Subject|1|||
142984369|NCT00653068|515479544|FG000|Overall Study|Ineligible|2|||
142984370|NCT01305941|515479545|FG000|Overall Study|Adverse Event|6|||
142984371|NCT01305941|515479545|FG000|Overall Study|Clinical decline|2|||
142984372|NCT01305941|515479545|FG000|Overall Study|Withdrawal by Subject|1|||
142984373|NCT01305941|515479545|FG000|Overall Study|Death|1|||
142984374|NCT03950440|515479546|FG000|Overall Study|Death|8|||
142984375|NCT03950440|515479547|FG001|Overall Study|Death|2|||
142984376|NCT03950440|515479548|FG002|Overall Study|Death|1|||
142984377|NCT02892734|515479549|FG000|Treatment on Study|Progressive Disease|2|||
142984378|NCT02892734|515479549|FG000|Follow up for 2 Years|Death|2|||
142984379|NCT02892734|515479549|FG000|Follow up for 2 Years|Study closed early|1|||
142984380|NCT02043509|515479550|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
142984381|NCT02043509|515479551|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
142984382|NCT02043509|515479550|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
142984383|NCT02043509|515479551|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
142984384|NCT02043509|515479550|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
142984385|NCT02043509|515479551|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
142984386|NCT02043509|515479550|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
142984387|NCT02043509|515479551|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
142984388|NCT00608244|515479556|FG000|Overall Study|Adverse Event|1|||
142984389|NCT00608244|515479556|FG000|Overall Study|Low trough levels|1|||
142984390|NCT01977040|515479565|FG000|Overall Study|Vasa previa not confirmed|2|||
142984391|NCT01685060|515479566|FG000|Overall Study|Rollover patients|16|||
142984392|NCT01685060|515479566|FG000|Overall Study|Adverse Event|12|||
142984393|NCT01685060|515479566|FG000|Overall Study|Progressive disease|69|||
142984394|NCT01685060|515479566|FG000|Overall Study|Physician Decision|14|||
142984395|NCT01685060|515479566|FG000|Overall Study|Subject/guardian decision|20|||
142984396|NCT01685060|515479566|FG000|Overall Study|Lost to Follow-up|1|||
142984397|NCT01685060|515479566|FG000|Overall Study|Death|8|||
142984398|NCT03597503|515479567|FG000|Overall Study|Withdrawal by Subject|0|||
142984399|NCT03597503|515479568|FG001|Overall Study|Withdrawal by Subject|2|||
142984400|NCT03597503|515479567|FG000|Overall Study|Lost to Follow-up|1|||
142984401|NCT03597503|515479568|FG001|Overall Study|Lost to Follow-up|2|||
142984402|NCT03597503|515479567|FG000|Overall Study|Protocol Violation|1|||
142984403|NCT03597503|515479568|FG001|Overall Study|Protocol Violation|0|||
142984404|NCT02000219|515479573|FG000|14-Week Study Period|Physician Decision|1|||
142984405|NCT02000219|515479573|FG000|14-Week Study Period|Adverse Event|1|||
142984406|NCT02000219|515479573|FG000|14-Week Study Period|Underwent transplantation|1|||
142984407|NCT02000219|515479573|FG000|Continuation Period|Withdrawal by Subject|1|||
142984408|NCT02000219|515479573|FG000|Continuation Period|Had liver transplant|2|||
142984409|NCT02000219|515479573|FG000|Continuation Period|Non-compliance with study drug|2|||
142984410|NCT01843205|515479576|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
142984411|NCT01843205|515479577|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
142984412|NCT03938636|515479578|FG000|Overall Study|Protocol Violation|0|||
142984413|NCT03938636|515479579|FG001|Overall Study|Protocol Violation|1|||
142984414|NCT03938636|515479580|FG002|Overall Study|Protocol Violation|1|||
142984415|NCT03938636|515479578|FG000|Overall Study|Subject withdrew due to death in family|0|||
142984416|NCT03938636|515479579|FG001|Overall Study|Subject withdrew due to death in family|1|||
142984417|NCT03938636|515479580|FG002|Overall Study|Subject withdrew due to death in family|0|||
142984418|NCT03938636|515479578|FG000|Overall Study|Missed visit|0|||
142984419|NCT03938636|515479579|FG001|Overall Study|Missed visit|1|||
142984420|NCT03938636|515479580|FG002|Overall Study|Missed visit|0|||
142984421|NCT03938636|515479578|FG000|Overall Study|Adverse Event|0|||
142984422|NCT03938636|515479579|FG001|Overall Study|Adverse Event|0|||
142984423|NCT03938636|515479580|FG002|Overall Study|Adverse Event|1|||
142984424|NCT03938636|515479578|FG000|Overall Study|Lost to Follow-up|0|||
142984425|NCT03938636|515479579|FG001|Overall Study|Lost to Follow-up|0|||
142984426|NCT03938636|515479580|FG002|Overall Study|Lost to Follow-up|1|||
142984427|NCT01518309|515479581|FG000|Overall Study|Adverse Event|6|||
142984428|NCT01518309|515479581|FG000|Overall Study|Death|6|||
142984429|NCT01518309|515479581|FG000|Overall Study|Lack of Efficacy|7|||
142984430|NCT01518309|515479581|FG000|Overall Study|Withdrawal by Subject|6|||
142984431|NCT01518309|515479581|FG000|Overall Study|Physician Decision|3|||
142984432|NCT01518309|515479581|FG000|Overall Study|Sponsor Decision|2|||
142984433|NCT01518309|515479581|FG000|Overall Study|Not in Predefined Categories|9|||
142984434|NCT00863317|515479582|FG000|Overall Study|Lost to Follow-up|8|||
142984435|NCT00863317|515479583|FG001|Overall Study|Lost to Follow-up|9|||
142984436|NCT02579863|515479584|FG000|Overall Study|Final Disposition Unknown|2|||
142984437|NCT02579863|515479585|FG001|Overall Study|Final Disposition Unknown|1|||
142984438|NCT02579863|515479584|FG000|Overall Study|Adverse Event|18|||
142984439|NCT02579863|515479585|FG001|Overall Study|Adverse Event|11|||
142984440|NCT02579863|515479584|FG000|Overall Study|Death|31|||
142984441|NCT02579863|515479585|FG001|Overall Study|Death|29|||
142984442|NCT02579863|515479584|FG000|Overall Study|Lost to Follow-up|2|||
142984443|NCT02579863|515479585|FG001|Overall Study|Lost to Follow-up|1|||
142984444|NCT02579863|515479584|FG000|Overall Study|Physician Decision|1|||
142984445|NCT02579863|515479585|FG001|Overall Study|Physician Decision|2|||
142984446|NCT02579863|515479584|FG000|Overall Study|Screen Failure|0|||
142984447|NCT02579863|515479585|FG001|Overall Study|Screen Failure|2|||
142984448|NCT02579863|515479584|FG000|Overall Study|Study Terminated at Selected Sites|82|||
142984449|NCT02579863|515479585|FG001|Overall Study|Study Terminated at Selected Sites|88|||
142984450|NCT02579863|515479584|FG000|Overall Study|Withdrawal by Subject|20|||
142984451|NCT02579863|515479585|FG001|Overall Study|Withdrawal by Subject|20|||
142984452|NCT00216086|515479588|FG000|Overall Study|Protocol Violation|1|||
142984453|NCT00216086|515479588|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
142984454|NCT00216086|515479588|FG000|Overall Study|Social Reasons|2|||
142984455|NCT00038142|515479589|FG000|Overall Study|Ineligible|1|||
142984456|NCT00038142|515479590|FG001|Overall Study|Ineligible|0|||
142984457|NCT00038142|515479589|FG000|Overall Study|Progressive Disease|11|||
142984458|NCT00038142|515479590|FG001|Overall Study|Progressive Disease|7|||
142984459|NCT00038142|515479589|FG000|Overall Study|Death|1|||
142984460|NCT00038142|515479590|FG001|Overall Study|Death|0|||
142984461|NCT00038142|515479589|FG000|Overall Study|Adverse Event|1|||
142984462|NCT00038142|515479590|FG001|Overall Study|Adverse Event|0|||
142984463|NCT00038142|515479589|FG000|Overall Study|Unknown Reason|8|||
142984464|NCT00038142|515479590|FG001|Overall Study|Unknown Reason|0|||
142984465|NCT00809614|515479591|FG000|Overall Study|Lack of Efficacy|2|||
142984466|NCT00809614|515479592|FG001|Overall Study|Lack of Efficacy|3|||
142984467|NCT00809614|515479591|FG000|Overall Study|Withdrawal by Subject|1|||
142984468|NCT00809614|515479592|FG001|Overall Study|Withdrawal by Subject|1|||
142984469|NCT01080625|515479593|FG000|Overall Study|Physician Decision|0|||
142984470|NCT01080625|515479594|FG001|Overall Study|Physician Decision|2|||
142984471|NCT01080625|515479595|FG002|Overall Study|Physician Decision|1|||
142984472|NCT00364832|515479596|FG000|Core Period|Early Withdrawals|2|||
142984473|NCT00364832|515479597|FG001|Core Period|Early Withdrawals|2|||
142984474|NCT00364832|515479598|FG002|Core Period|Early Withdrawals|1|||
142984475|NCT00364832|515479599|FG003|Core Period|Early Withdrawals|1|||
142984476|NCT00364832|515479600|FG004|Core Period|Early Withdrawals|0|||
142984477|NCT00364832|515479601|FG005|Core Period|Early Withdrawals|0|||
142984478|NCT00364832|515479602|FG006|Core Period|Early Withdrawals|4|||
142984479|NCT00364832|515479603|FG007|Core Period|Early Withdrawals|1|||
142984480|NCT00364832|515479604|FG008|Core Period|Early Withdrawals|0|||
142984481|NCT00364832|515479605|FG009|Core Period|Early Withdrawals|0|||
142984482|NCT00364832|515479606|FG010|Core Period|Early Withdrawals|0|||
142984483|NCT00364832|515479607|FG011|Core Period|Early Withdrawals|0|||
142984484|NCT00364832|515479596|FG000|Extension Year 1|Early Withdrawals|0|||
142984485|NCT00364832|515479597|FG001|Extension Year 1|Early Withdrawals|0|||
142984486|NCT00364832|515479598|FG002|Extension Year 1|Early Withdrawals|0|||
142984487|NCT00364832|515479599|FG003|Extension Year 1|Early Withdrawals|0|||
142984488|NCT00364832|515479600|FG004|Extension Year 1|Early Withdrawals|0|||
142984489|NCT00364832|515479601|FG005|Extension Year 1|Early Withdrawals|0|||
142984490|NCT00364832|515479602|FG006|Extension Year 1|Early Withdrawals|0|||
143117228|NCT00787917|515970069|FG000|Open Label|Administrative problems|3|||
142984491|NCT00364832|515479603|FG007|Extension Year 1|Early Withdrawals|0|||
142984492|NCT00364832|515479604|FG008|Extension Year 1|Early Withdrawals|0|||
142984493|NCT00364832|515479605|FG009|Extension Year 1|Early Withdrawals|4|||
142984494|NCT00364832|515479606|FG010|Extension Year 1|Early Withdrawals|2|||
142984495|NCT00364832|515479607|FG011|Extension Year 1|Early Withdrawals|10|||
142984496|NCT00364832|515479596|FG000|Extension Year 2|Early Withdrawals|0|||
142984497|NCT00364832|515479597|FG001|Extension Year 2|Early Withdrawals|0|||
142984498|NCT00364832|515479598|FG002|Extension Year 2|Early Withdrawals|0|||
142984499|NCT00364832|515479599|FG003|Extension Year 2|Early Withdrawals|0|||
142984500|NCT00364832|515479600|FG004|Extension Year 2|Early Withdrawals|0|||
142984501|NCT00364832|515479601|FG005|Extension Year 2|Early Withdrawals|0|||
142984502|NCT00364832|515479602|FG006|Extension Year 2|Early Withdrawals|0|||
142984503|NCT00364832|515479603|FG007|Extension Year 2|Early Withdrawals|0|||
142984504|NCT00364832|515479604|FG008|Extension Year 2|Early Withdrawals|0|||
142984505|NCT00364832|515479605|FG009|Extension Year 2|Early Withdrawals|5|||
142984506|NCT00364832|515479606|FG010|Extension Year 2|Early Withdrawals|5|||
142984507|NCT00364832|515479607|FG011|Extension Year 2|Early Withdrawals|3|||
142984508|NCT01156363|515479613|FG000|Overall Study|Adverse Event|6|||
142984509|NCT01156363|515479613|FG000|Overall Study|Insufficient Therapeutic Response|5|||
142984510|NCT01156363|515479613|FG000|Overall Study|Failure to Return|1|||
142984511|NCT01156363|515479613|FG000|Overall Study|Refused Treatment|4|||
142984512|NCT01156363|515479613|FG000|Overall Study|Other|6|||
142984513|NCT03135262|515479614|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
142984514|NCT03135262|515479615|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
142984515|NCT03135262|515479616|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
142984516|NCT03135262|515479617|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
142984517|NCT03135262|515479618|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
142984518|NCT03135262|515479614|FG000|Overall Study|Progression of disease|0|||
142984519|NCT03135262|515479615|FG001|Overall Study|Progression of disease|0|||
142984520|NCT03135262|515479616|FG002|Overall Study|Progression of disease|0|||
142984521|NCT03135262|515479617|FG003|Overall Study|Progression of disease|1|||
142984522|NCT03135262|515479618|FG004|Overall Study|Progression of disease|0|||
142984523|NCT03135262|515479614|FG000|Overall Study|Death|6|||
142984524|NCT03135262|515479615|FG001|Overall Study|Death|2|||
142984525|NCT03135262|515479616|FG002|Overall Study|Death|2|||
142984526|NCT03135262|515479617|FG003|Overall Study|Death|2|||
142984527|NCT03135262|515479618|FG004|Overall Study|Death|0|||
142984528|NCT03135262|515479614|FG000|Overall Study|Withdrawal by Subject|0|||
142984529|NCT03135262|515479615|FG001|Overall Study|Withdrawal by Subject|0|||
142984530|NCT03135262|515479616|FG002|Overall Study|Withdrawal by Subject|1|||
142984531|NCT03135262|515479617|FG003|Overall Study|Withdrawal by Subject|0|||
142984532|NCT03135262|515479618|FG004|Overall Study|Withdrawal by Subject|1|||
142984533|NCT03135262|515479614|FG000|Overall Study|Study terminated by sponsor|2|||
142984534|NCT03135262|515479615|FG001|Overall Study|Study terminated by sponsor|4|||
142984535|NCT03135262|515479616|FG002|Overall Study|Study terminated by sponsor|4|||
142984536|NCT03135262|515479617|FG003|Overall Study|Study terminated by sponsor|3|||
142984537|NCT03135262|515479618|FG004|Overall Study|Study terminated by sponsor|0|||
142984538|NCT03285490|515479619|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
142984539|NCT03285490|515479620|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
142984540|NCT03285490|515479619|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
142984541|NCT03285490|515479620|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
142984542|NCT03981744|515479621|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
142984543|NCT03981744|515479622|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
142984544|NCT03981744|515479623|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
142984545|NCT03981744|515479624|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
142984546|NCT03981744|515479621|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
142984547|NCT03981744|515479622|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
142984548|NCT03981744|515479623|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
142984549|NCT03981744|515479624|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
142984550|NCT03981744|515479621|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
142984551|NCT03981744|515479622|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
142984552|NCT03981744|515479623|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
142984553|NCT03981744|515479624|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
142984554|NCT04338321|515479625|FG000|Overall Study|Adverse Event|4|||
142984555|NCT04338321|515479626|FG001|Overall Study|Adverse Event|10|||
142984556|NCT04338321|515479625|FG000|Overall Study|Death|1|||
142984557|NCT04338321|515479626|FG001|Overall Study|Death|1|||
142984558|NCT04338321|515479625|FG000|Overall Study|Lost to Follow-up|4|||
142984559|NCT04338321|515479626|FG001|Overall Study|Lost to Follow-up|9|||
142984560|NCT04338321|515479625|FG000|Overall Study|Withdrawal by Subject|45|||
142984561|NCT04338321|515479626|FG001|Overall Study|Withdrawal by Subject|69|||
142984562|NCT04338321|515479625|FG000|Overall Study|Physician Decision|5|||
142984563|NCT04338321|515479626|FG001|Overall Study|Physician Decision|9|||
142984564|NCT04338321|515479625|FG000|Overall Study|Other|3|||
142984565|NCT04338321|515479626|FG001|Overall Study|Other|10|||
142984566|NCT02438787|515479627|FG000|Overall Study|Adverse Event|1|||
142984567|NCT02438787|515479628|FG001|Overall Study|Adverse Event|0|||
142984568|NCT02438787|515479629|FG002|Overall Study|Adverse Event|2|||
142984569|NCT02438787|515479627|FG000|Overall Study|Lack of Efficacy|1|||
142984570|NCT02438787|515479628|FG001|Overall Study|Lack of Efficacy|2|||
142984571|NCT02438787|515479629|FG002|Overall Study|Lack of Efficacy|0|||
142984572|NCT02438787|515479627|FG000|Overall Study|Lost to Follow-up|0|||
142984573|NCT02438787|515479628|FG001|Overall Study|Lost to Follow-up|1|||
142984574|NCT02438787|515479629|FG002|Overall Study|Lost to Follow-up|0|||
142984575|NCT02438787|515479627|FG000|Overall Study|Protocol Violation|0|||
142984576|NCT02438787|515479628|FG001|Overall Study|Protocol Violation|0|||
142984577|NCT02438787|515479629|FG002|Overall Study|Protocol Violation|1|||
142984578|NCT02438787|515479627|FG000|Overall Study|Withdrawal by Subject|15|||
142984579|NCT02438787|515479628|FG001|Overall Study|Withdrawal by Subject|7|||
142984580|NCT02438787|515479629|FG002|Overall Study|Withdrawal by Subject|10|||
142984581|NCT02438787|515479627|FG000|Overall Study|Study discontinued by sponsor|64|||
142984582|NCT02438787|515479628|FG001|Overall Study|Study discontinued by sponsor|72|||
142984583|NCT02438787|515479629|FG002|Overall Study|Study discontinued by sponsor|69|||
142984584|NCT02438787|515479627|FG000|Overall Study|Other|0|||
142984585|NCT02438787|515479628|FG001|Overall Study|Other|1|||
142984586|NCT02438787|515479629|FG002|Overall Study|Other|0|||
142984587|NCT02438787|515479627|FG000|Overall Study|Site terminated by sponsor|0|||
142984588|NCT02438787|515479628|FG001|Overall Study|Site terminated by sponsor|0|||
142984589|NCT02438787|515479629|FG002|Overall Study|Site terminated by sponsor|1|||
142984590|NCT01782885|515479630|FG000|Overall Study|Lost to Follow-up|4|||
142984591|NCT01782885|515479631|FG001|Overall Study|Lost to Follow-up|6|||
142984592|NCT00633360|515479632|FG000|Overall Study|Lost to Follow-up|1|||
142984593|NCT00633360|515479633|FG001|Overall Study|Lost to Follow-up|1|||
142984594|NCT00633360|515479632|FG000|Overall Study|Adverse Event|3|||
142984595|NCT00633360|515479633|FG001|Overall Study|Adverse Event|1|||
142984596|NCT00633360|515479632|FG000|Overall Study|Protocol Violation|0|||
142984597|NCT00633360|515479633|FG001|Overall Study|Protocol Violation|1|||
142984598|NCT00329784|515479634|FG000|Overall Study|Lost to Follow-up|0|||
142984599|NCT00329784|515479635|FG001|Overall Study|Lost to Follow-up|1|||
142984600|NCT00329784|515479636|FG002|Overall Study|Lost to Follow-up|0|||
142984601|NCT00329784|515479637|FG003|Overall Study|Lost to Follow-up|0|||
142984602|NCT00329784|515479634|FG000|Overall Study|Withdrawal by Subject|4|||
142984603|NCT00329784|515479635|FG001|Overall Study|Withdrawal by Subject|2|||
142984604|NCT00329784|515479636|FG002|Overall Study|Withdrawal by Subject|0|||
142984605|NCT00329784|515479637|FG003|Overall Study|Withdrawal by Subject|0|||
142984606|NCT00329784|515479634|FG000|Overall Study|Other|1|||
142984607|NCT00329784|515479635|FG001|Overall Study|Other|2|||
142984608|NCT00329784|515479636|FG002|Overall Study|Other|0|||
142984609|NCT00329784|515479637|FG003|Overall Study|Other|0|||
142984610|NCT01098032|515479638|FG000|Overall Study|Withdrawal by Subject|1|||
142984611|NCT01098032|515479639|FG001|Overall Study|Withdrawal by Subject|1|||
142984612|NCT01594411|515479643|FG000|Overall Study|Lost to Follow-up|2|||
142984613|NCT01929707|515479649|FG000|Intervention Period 1|Lost to Follow-up|0|||
142984614|NCT01929707|515479650|FG001|Intervention Period 1|Lost to Follow-up|0|||
142984615|NCT01929707|515479651|FG002|Intervention Period 1|Lost to Follow-up|0|||
142984616|NCT01929707|515479652|FG003|Intervention Period 1|Lost to Follow-up|1|||
142984617|NCT01929707|515479653|FG004|Intervention Period 1|Lost to Follow-up|0|||
142984618|NCT01929707|515479654|FG005|Intervention Period 1|Lost to Follow-up|0|||
142984619|NCT01929707|515479655|FG006|Intervention Period 1|Lost to Follow-up|0|||
142984620|NCT01929707|515479656|FG007|Intervention Period 1|Lost to Follow-up|0|||
142984621|NCT01929707|515479649|FG000|Intervention Period 1|Withdrawal by Subject|0|||
142984622|NCT01929707|515479650|FG001|Intervention Period 1|Withdrawal by Subject|0|||
142984623|NCT01929707|515479651|FG002|Intervention Period 1|Withdrawal by Subject|0|||
142984624|NCT01929707|515479652|FG003|Intervention Period 1|Withdrawal by Subject|2|||
142984625|NCT01929707|515479653|FG004|Intervention Period 1|Withdrawal by Subject|0|||
142984626|NCT01929707|515479654|FG005|Intervention Period 1|Withdrawal by Subject|0|||
142984627|NCT01929707|515479655|FG006|Intervention Period 1|Withdrawal by Subject|0|||
142984628|NCT01929707|515479656|FG007|Intervention Period 1|Withdrawal by Subject|0|||
142984629|NCT01929707|515479649|FG000|Intervention Period 2|Withdrawal by Subject|0|||
142984630|NCT01929707|515479650|FG001|Intervention Period 2|Withdrawal by Subject|0|||
142984631|NCT01929707|515479651|FG002|Intervention Period 2|Withdrawal by Subject|0|||
142984632|NCT01929707|515479652|FG003|Intervention Period 2|Withdrawal by Subject|0|||
142984633|NCT01929707|515479653|FG004|Intervention Period 2|Withdrawal by Subject|0|||
142984634|NCT01929707|515479654|FG005|Intervention Period 2|Withdrawal by Subject|2|||
142984635|NCT01929707|515479655|FG006|Intervention Period 2|Withdrawal by Subject|0|||
142984636|NCT01929707|515479656|FG007|Intervention Period 2|Withdrawal by Subject|0|||
142984637|NCT02343952|515479657|FG000|Study Treatment|Disease Progression|23|||
142984638|NCT02343952|515479657|FG000|Study Treatment|Death|3|||
142984639|NCT02343952|515479657|FG000|Study Treatment|Adverse Event|19|||
142984640|NCT02343952|515479657|FG000|Study Treatment|Withdrawal by Subject|7|||
142984641|NCT02343952|515479657|FG000|Study Treatment|other complicating Diseases|1|||
142984642|NCT02343952|515479657|FG000|Follow up|Withdrawal by Subject|3|||
142984643|NCT02343952|515479657|FG000|Follow up|Death|33|||
142984644|NCT02343952|515479657|FG000|Follow up|Patient does not meet eligibility for study.|1|||
142984645|NCT02343952|515479657|FG000|Follow up|Research department closed by the practice.|5|||
142984646|NCT02343952|515479657|FG000|Follow up|Patient went home to Russia|1|||
142984647|NCT02343952|515479657|FG000|Follow up|Disease Progression|1|||
142984648|NCT02343952|515479657|FG000|Follow up|study terminated|1|||
142984649|NCT02067533|515479658|FG000|Overall Study|Lost to Follow-up|4|||
142984650|NCT02067533|515479659|FG001|Overall Study|Lost to Follow-up|2|||
142984651|NCT00565812|515479660|FG000|Overall Study|Death|2|||
142984652|NCT00565812|515479661|FG001|Overall Study|Death|1|||
142984653|NCT00565812|515479662|FG002|Overall Study|Death|3|||
142984654|NCT00565812|515479660|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
142984655|NCT00565812|515479661|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
142984656|NCT00565812|515479662|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
142984657|NCT00565812|515479660|FG000|Overall Study|Lost to Follow-up|10|||
142984658|NCT00565812|515479661|FG001|Overall Study|Lost to Follow-up|8|||
142984659|NCT00565812|515479662|FG002|Overall Study|Lost to Follow-up|8|||
142984660|NCT00565812|515479660|FG000|Overall Study|Withdrawal by Subject|58|||
142984661|NCT00565812|515479661|FG001|Overall Study|Withdrawal by Subject|47|||
142984662|NCT00565812|515479662|FG002|Overall Study|Withdrawal by Subject|48|||
142984663|NCT00565812|515479660|FG000|Overall Study|Work Schedule|5|||
142984664|NCT00565812|515479661|FG001|Overall Study|Work Schedule|3|||
142984665|NCT00565812|515479662|FG002|Overall Study|Work Schedule|1|||
142984666|NCT00565812|515479660|FG000|Overall Study|Protocol Violation|2|||
142984667|NCT00565812|515479661|FG001|Overall Study|Protocol Violation|6|||
142984668|NCT00565812|515479662|FG002|Overall Study|Protocol Violation|4|||
142984669|NCT00565812|515479660|FG000|Overall Study|Adverse Event|41|||
142984670|NCT00565812|515479661|FG001|Overall Study|Adverse Event|54|||
142984671|NCT00565812|515479662|FG002|Overall Study|Adverse Event|40|||
142984672|NCT00565812|515479660|FG000|Overall Study|Jury Duty|1|||
142984673|NCT00565812|515479661|FG001|Overall Study|Jury Duty|0|||
142984674|NCT00565812|515479662|FG002|Overall Study|Jury Duty|0|||
142984675|NCT00565812|515479660|FG000|Overall Study|Relocated Out of Area|5|||
142984676|NCT00565812|515479661|FG001|Overall Study|Relocated Out of Area|8|||
142984677|NCT00565812|515479662|FG002|Overall Study|Relocated Out of Area|9|||
142984678|NCT00565812|515479660|FG000|Overall Study|Sponsor Decision|1|||
142984679|NCT00565812|515479661|FG001|Overall Study|Sponsor Decision|5|||
143455667|NCT03208036|517212504|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
143455668|NCT03208036|517212505|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
143455669|NCT03208036|517212504|FG000|Intervention|Withdrawal by Subject|3|||
143455670|NCT03208036|517212505|FG001|Intervention|Withdrawal by Subject|2|||
143455671|NCT03208036|517212504|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
142984680|NCT00565812|515479662|FG002|Overall Study|Sponsor Decision|1|||
142984681|NCT00565812|515479660|FG000|Overall Study|Domestic Reasons|7|||
142984682|NCT00565812|515479661|FG001|Overall Study|Domestic Reasons|1|||
142984683|NCT00565812|515479662|FG002|Overall Study|Domestic Reasons|3|||
142984684|NCT00565812|515479660|FG000|Overall Study|Research Site Closure|6|||
142984685|NCT00565812|515479661|FG001|Overall Study|Research Site Closure|1|||
142984686|NCT00565812|515479662|FG002|Overall Study|Research Site Closure|8|||
142984687|NCT00565812|515479660|FG000|Overall Study|Surgical Intervention|0|||
142984688|NCT00565812|515479661|FG001|Overall Study|Surgical Intervention|1|||
142984689|NCT00565812|515479662|FG002|Overall Study|Surgical Intervention|2|||
142984690|NCT00565812|515479660|FG000|Overall Study|Low Compliance|1|||
142984691|NCT00565812|515479661|FG001|Overall Study|Low Compliance|0|||
142984692|NCT00565812|515479662|FG002|Overall Study|Low Compliance|1|||
142984693|NCT00565812|515479660|FG000|Overall Study|Follow-up Visit Not Completed|2|||
142984694|NCT00565812|515479661|FG001|Overall Study|Follow-up Visit Not Completed|0|||
142984695|NCT00565812|515479662|FG002|Overall Study|Follow-up Visit Not Completed|1|||
142984696|NCT00565812|515479660|FG000|Overall Study|Physician Decision|2|||
142984697|NCT00565812|515479661|FG001|Overall Study|Physician Decision|0|||
142984698|NCT00565812|515479662|FG002|Overall Study|Physician Decision|0|||
142984699|NCT00845845|515479663|FG000|Overall Study|Lost to Follow-up|0|||
142984700|NCT00845845|515479664|FG001|Overall Study|Lost to Follow-up|4|||
142984701|NCT01570309|515479667|FG000|Overall Study|Withdrawal by Subject|3|||
142984702|NCT01570309|515479668|FG001|Overall Study|Withdrawal by Subject|3|||
142984703|NCT02177786|515481605|FG000|Overall Study|Withdrew Consent|2|||
142984704|NCT02177786|515481606|FG001|Overall Study|Withdrew Consent|6|||
142984705|NCT02177786|515481607|FG002|Overall Study|Withdrew Consent|9|||
142984706|NCT02177786|515481608|FG003|Overall Study|Withdrew Consent|5|||
142984707|NCT02177786|515481605|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
142984708|NCT02177786|515481606|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
142984709|NCT02177786|515481607|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
142984710|NCT02177786|515481608|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
142984711|NCT02177786|515481605|FG000|Overall Study|Adverse Event|1|||
142984712|NCT02177786|515481606|FG001|Overall Study|Adverse Event|1|||
142984713|NCT02177786|515481607|FG002|Overall Study|Adverse Event|2|||
142984714|NCT02177786|515481608|FG003|Overall Study|Adverse Event|3|||
142984715|NCT02177786|515481605|FG000|Overall Study|Death|1|||
142984716|NCT02177786|515481606|FG001|Overall Study|Death|1|||
142984717|NCT02177786|515481607|FG002|Overall Study|Death|1|||
142984718|NCT02177786|515481608|FG003|Overall Study|Death|1|||
142984719|NCT02177786|515481605|FG000|Overall Study|Lost to Follow-up|0|||
142984720|NCT02177786|515481606|FG001|Overall Study|Lost to Follow-up|0|||
142984721|NCT02177786|515481607|FG002|Overall Study|Lost to Follow-up|2|||
142984722|NCT02177786|515481608|FG003|Overall Study|Lost to Follow-up|2|||
142984723|NCT02177786|515481605|FG000|Overall Study|Non-Compliance with Study Drug|0|||
142984724|NCT02177786|515481606|FG001|Overall Study|Non-Compliance with Study Drug|1|||
142984725|NCT02177786|515481607|FG002|Overall Study|Non-Compliance with Study Drug|0|||
142984726|NCT02177786|515481608|FG003|Overall Study|Non-Compliance with Study Drug|1|||
142984727|NCT02177786|515481605|FG000|Overall Study|Protocol Violation|0|||
142984728|NCT02177786|515481606|FG001|Overall Study|Protocol Violation|0|||
142984729|NCT02177786|515481607|FG002|Overall Study|Protocol Violation|2|||
142984730|NCT02177786|515481608|FG003|Overall Study|Protocol Violation|0|||
142984731|NCT02177786|515481605|FG000|Overall Study|Progressive Disease|0|||
142984732|NCT02177786|515481606|FG001|Overall Study|Progressive Disease|1|||
142984733|NCT02177786|515481607|FG002|Overall Study|Progressive Disease|0|||
142984734|NCT02177786|515481608|FG003|Overall Study|Progressive Disease|0|||
142984735|NCT02177786|515481605|FG000|Overall Study|Missing study completion status|0|||
142984736|NCT02177786|515481606|FG001|Overall Study|Missing study completion status|1|||
142984737|NCT02177786|515481607|FG002|Overall Study|Missing study completion status|0|||
142984738|NCT02177786|515481608|FG003|Overall Study|Missing study completion status|0|||
142984739|NCT01957215|515481609|FG000|Overall Study|Adverse Event|2|||
142984740|NCT01957215|515481610|FG001|Overall Study|Adverse Event|2|||
142984741|NCT01957215|515481609|FG000|Overall Study|Lost to Follow-up|3|||
142984742|NCT01957215|515481610|FG001|Overall Study|Lost to Follow-up|3|||
142984743|NCT01957215|515481609|FG000|Overall Study|Protocol Violation|1|||
142984744|NCT01957215|515481610|FG001|Overall Study|Protocol Violation|2|||
142984745|NCT01957215|515481609|FG000|Overall Study|Withdrawal by Subject|7|||
142984746|NCT01957215|515481610|FG001|Overall Study|Withdrawal by Subject|5|||
142984747|NCT00688623|515481611|FG000|Overall Study|Adverse Event|22|||
142984748|NCT00688623|515481611|FG000|Overall Study|abnormal lab value|1|||
142984749|NCT00688623|515481611|FG000|Overall Study|Withdrawal by Subject|4|||
142984750|NCT00688623|515481611|FG000|Overall Study|Death|3|||
142984751|NCT00688623|515481611|FG000|Overall Study|disease progression|23|||
142984752|NCT00688623|515481611|FG000|Overall Study|Protocol Violation|2|||
142984753|NCT02667236|515481612|FG000|Overall Study|Adverse Event|1|||
142984754|NCT02667236|515481613|FG001|Overall Study|Adverse Event|1|||
142984755|NCT02667236|515481612|FG000|Overall Study|Withdrawal by Subject|2|||
142984756|NCT02667236|515481613|FG001|Overall Study|Withdrawal by Subject|0|||
142984757|NCT03654560|515481616|FG000|Overall Study|Death|3|||
142984758|NCT03654560|515481617|FG001|Overall Study|Death|1|||
142984759|NCT03654560|515481616|FG000|Overall Study|Lost to Follow-up|1|||
142984760|NCT03654560|515481617|FG001|Overall Study|Lost to Follow-up|0|||
142984761|NCT01119963|515481621|FG000|Overall Study|Lost to Follow-up|1|||
142984762|NCT01119963|515481622|FG001|Overall Study|Lost to Follow-up|1|||
142984763|NCT04072575|515481633|FG000|Overall Study|Physician Decision|1|||
142984764|NCT04072575|515481633|FG000|Overall Study|Adverse Event|7|||
142984765|NCT04072575|515481633|FG000|Overall Study|Withdrawal by Subject|14|||
142984766|NCT04072575|515481633|FG000|Overall Study|Other|2|||
142984767|NCT02498392|515481634|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
142984768|NCT02498392|515481635|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
142984769|NCT02498392|515481634|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
142984770|NCT02498392|515481635|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
142984771|NCT02498392|515481634|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
142984772|NCT02498392|515481635|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
142984773|NCT02498392|515481634|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
142984774|NCT02498392|515481635|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
142984775|NCT02498392|515481634|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
142984776|NCT02498392|515481635|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
142984777|NCT02498392|515481634|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
142984778|NCT02498392|515481635|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
142984779|NCT02244619|515481636|FG000|Overall Study|Did not receive study intervention|8|||
142984780|NCT02244619|515481637|FG001|Overall Study|Did not receive study intervention|21|||
142984781|NCT02728206|515481638|FG000|Overall Study|Death|1|||
142984782|NCT00735072|515481639|FG000|Overall Study|interrupted study med during ARV change|1|||
142984783|NCT00735072|515481640|FG001|Overall Study|interrupted study med during ARV change|0|||
142984784|NCT00735072|515481639|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
142984785|NCT00735072|515481640|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
142984786|NCT00429572|515481646|FG000|Overall Study|Disease progression|1|||
142984787|NCT02773368|515481647|FG000|Overall Study|Lost to Follow-up|4|||
142984788|NCT02773368|515481648|FG001|Overall Study|Lost to Follow-up|1|||
142984789|NCT02773368|515481647|FG000|Overall Study|Withdrawal by Subject|5|||
142984790|NCT02773368|515481648|FG001|Overall Study|Withdrawal by Subject|1|||
142984791|NCT02773368|515481647|FG000|Overall Study|Unclassified|1|||
142984792|NCT02773368|515481648|FG001|Overall Study|Unclassified|1|||
142984793|NCT02773368|515481647|FG000|Overall Study|Missing|0|||
142984794|NCT02773368|515481648|FG001|Overall Study|Missing|1|||
142984795|NCT01366534|515481650|FG000|Overall Study|Lost to Follow-up|1|||
142984796|NCT01366534|515481651|FG001|Overall Study|Lost to Follow-up|0|||
142984797|NCT01366534|515481652|FG002|Overall Study|Lost to Follow-up|0|||
142984798|NCT01366534|515481650|FG000|Overall Study|Migrated|1|||
142984799|NCT01366534|515481651|FG001|Overall Study|Migrated|1|||
142984800|NCT01366534|515481652|FG002|Overall Study|Migrated|0|||
142984801|NCT01366534|515481650|FG000|Overall Study|Declined challenged|0|||
142984802|NCT01366534|515481651|FG001|Overall Study|Declined challenged|1|||
142984803|NCT01366534|515481652|FG002|Overall Study|Declined challenged|0|||
142984804|NCT01929018|515481655|FG000|Overall Study|Lost to Follow-up|1|||
142984805|NCT01929018|515481656|FG001|Overall Study|Lost to Follow-up|0|||
142984806|NCT01929018|515481655|FG000|Overall Study|Hospitalization|0|||
142984807|NCT01929018|515481656|FG001|Overall Study|Hospitalization|1|||
142984808|NCT01047436|515481658|FG000|Overall Study|Protocol Violation|1|||
142984809|NCT01047436|515481659|FG001|Overall Study|Protocol Violation|0|||
142984810|NCT01678313|515481663|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
142984811|NCT01678313|515481664|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
142984812|NCT01678313|515481663|FG000|Completed the 3-month Therapy|Physician Decision|3|||
142984813|NCT01678313|515481664|FG001|Completed the 3-month Therapy|Physician Decision|4|||
142984814|NCT01678313|515481663|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
142984815|NCT01678313|515481664|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
142984816|NCT01678313|515481663|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
142984817|NCT01678313|515481664|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
142984818|NCT02635867|515481666|FG000|Overall Study|Lost to Follow-up|4|||
142984819|NCT02635867|515481667|FG001|Overall Study|Lost to Follow-up|3|||
142984820|NCT02635867|515481668|FG002|Overall Study|Lost to Follow-up|3|||
142984821|NCT02635867|515481669|FG003|Overall Study|Lost to Follow-up|4|||
142984822|NCT02635867|515481670|FG004|Overall Study|Lost to Follow-up|1|||
142984823|NCT01131130|515481672|FG000|Period 1 - Baseline|Pregnancy|1|||
142984824|NCT01131130|515481672|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
142984825|NCT02782104|515481673|FG000|Overall Study|Other|215|||
142984826|NCT02782104|515481673|FG000|Overall Study|Induction Day 28 Non Responder|9|||
142984827|NCT02782104|515481673|FG000|Overall Study|Non-Compliance with Study Drug|2|||
142984828|NCT02782104|515481673|FG000|Overall Study|Death|8|||
142984829|NCT02782104|515481673|FG000|Overall Study|Pregnancy|6|||
142984830|NCT02782104|515481673|FG000|Overall Study|Withdrawal by Subject|63|||
142984831|NCT02782104|515481673|FG000|Overall Study|Protocol Violation|7|||
142984832|NCT02782104|515481673|FG000|Overall Study|Lack of Efficacy|61|||
142984833|NCT02782104|515481673|FG000|Overall Study|Lost to Follow-up|23|||
142984834|NCT02782104|515481673|FG000|Overall Study|Adverse Event|74|||
142984835|NCT03464136|515481674|FG000|Overall Study|Lost to Follow-up|5|||
142984836|NCT03464136|515481675|FG001|Overall Study|Lost to Follow-up|8|||
142984837|NCT03464136|515481674|FG000|Overall Study|Withdrawal by Subject|16|||
142984838|NCT03464136|515481675|FG001|Overall Study|Withdrawal by Subject|13|||
142984839|NCT03464136|515481674|FG000|Overall Study|Death|1|||
142984840|NCT03464136|515481675|FG001|Overall Study|Death|0|||
142984841|NCT03464136|515481674|FG000|Overall Study|Other|8|||
142984842|NCT03464136|515481675|FG001|Overall Study|Other|4|||
142984843|NCT03375203|515481676|FG000|Overall Study|Protocol Violation|0|||
142984844|NCT03375203|515481677|FG001|Overall Study|Protocol Violation|0|||
142984845|NCT03375203|515481678|FG002|Overall Study|Protocol Violation|1|||
142984846|NCT03375203|515481679|FG003|Overall Study|Protocol Violation|0|||
142984847|NCT03375203|515481680|FG004|Overall Study|Protocol Violation|0|||
142984848|NCT03375203|515481676|FG000|Overall Study|Adverse Event|2|||
142984849|NCT03375203|515481677|FG001|Overall Study|Adverse Event|3|||
142984850|NCT03375203|515481678|FG002|Overall Study|Adverse Event|0|||
142984851|NCT03375203|515481679|FG003|Overall Study|Adverse Event|2|||
142984852|NCT03375203|515481680|FG004|Overall Study|Adverse Event|2|||
142984853|NCT03375203|515481676|FG000|Overall Study|Withdrawal by Subject|3|||
142984854|NCT03375203|515481677|FG001|Overall Study|Withdrawal by Subject|0|||
142984855|NCT03375203|515481678|FG002|Overall Study|Withdrawal by Subject|1|||
142984856|NCT03375203|515481679|FG003|Overall Study|Withdrawal by Subject|0|||
142984857|NCT03375203|515481680|FG004|Overall Study|Withdrawal by Subject|2|||
142984858|NCT03375203|515481676|FG000|Overall Study|Non-compliance with study drug|1|||
142984859|NCT03375203|515481677|FG001|Overall Study|Non-compliance with study drug|0|||
142984860|NCT03375203|515481678|FG002|Overall Study|Non-compliance with study drug|0|||
142984861|NCT03375203|515481679|FG003|Overall Study|Non-compliance with study drug|0|||
142984862|NCT03375203|515481680|FG004|Overall Study|Non-compliance with study drug|0|||
142984863|NCT03375203|515481676|FG000|Overall Study|Randomized, not treated.|0|||
142984864|NCT03375203|515481677|FG001|Overall Study|Randomized, not treated.|1|||
142984865|NCT03375203|515481678|FG002|Overall Study|Randomized, not treated.|0|||
142984866|NCT03375203|515481679|FG003|Overall Study|Randomized, not treated.|0|||
142984867|NCT03375203|515481680|FG004|Overall Study|Randomized, not treated.|0|||
142984868|NCT03107793|515481681|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
142984869|NCT03107793|515481682|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
142984870|NCT03107793|515481683|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
142984871|NCT03107793|515481684|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
142984872|NCT03107793|515481685|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
142984873|NCT03107793|515481681|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
142984874|NCT03107793|515481682|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
142984875|NCT03107793|515481683|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
142984876|NCT03107793|515481684|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
142984877|NCT03107793|515481685|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
142984878|NCT03107793|515481681|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
142984879|NCT03107793|515481682|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
142984880|NCT03107793|515481683|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
142984881|NCT03107793|515481684|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
142984882|NCT03107793|515481685|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
142984883|NCT03107793|515481681|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
142984884|NCT03107793|515481682|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
142984885|NCT03107793|515481683|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
142984886|NCT03107793|515481684|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
142984887|NCT03107793|515481685|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
142984888|NCT03107793|515481681|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
142984889|NCT03107793|515481682|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
142984890|NCT03107793|515481683|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
142984891|NCT03107793|515481684|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
142984892|NCT03107793|515481685|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
142984893|NCT03107793|515481681|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
142984894|NCT03107793|515481682|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
142984895|NCT03107793|515481683|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
142984896|NCT03107793|515481684|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
142984897|NCT03107793|515481685|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
142984898|NCT03107793|515481681|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
142984899|NCT03107793|515481682|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
142984900|NCT03107793|515481683|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
142984901|NCT03107793|515481684|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
142984902|NCT03107793|515481685|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
142984903|NCT03107793|515481681|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
142984904|NCT03107793|515481682|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
142984905|NCT03107793|515481683|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
142984906|NCT03107793|515481684|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
142984907|NCT03107793|515481685|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
142984908|NCT03107793|515481681|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
142984909|NCT03107793|515481682|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
142984910|NCT03107793|515481683|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
142984911|NCT03107793|515481684|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
142984912|NCT03107793|515481685|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
142984913|NCT03107793|515481681|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
142984914|NCT03107793|515481682|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
142984915|NCT03107793|515481683|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
142984916|NCT03107793|515481684|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
142984917|NCT03107793|515481685|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
142984918|NCT03107793|515481681|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
142984919|NCT03107793|515481682|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
142984920|NCT03107793|515481683|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
142984921|NCT03107793|515481684|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
142984922|NCT03107793|515481685|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
142984923|NCT03107793|515481681|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
142984924|NCT03107793|515481682|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
142984925|NCT03107793|515481683|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
142984926|NCT03107793|515481684|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
142984927|NCT03107793|515481685|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
142984928|NCT03107793|515481681|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
142984929|NCT03107793|515481682|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
142984930|NCT03107793|515481683|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
142984931|NCT03107793|515481684|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
142984932|NCT03107793|515481685|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
142984933|NCT03107793|515481681|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
142984934|NCT03107793|515481682|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
142984935|NCT03107793|515481683|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
142984936|NCT03107793|515481684|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
142984937|NCT03107793|515481685|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
142984938|NCT03107793|515481681|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
142984939|NCT03107793|515481682|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
142984940|NCT03107793|515481683|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
142984941|NCT03107793|515481684|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
142984942|NCT03107793|515481685|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
143003174|NCT01049360|515548746|FG002|Period 2|Lack of Efficacy|0|||
142984943|NCT03107793|515481681|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
142984944|NCT03107793|515481682|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
142984945|NCT03107793|515481683|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
142984946|NCT03107793|515481684|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
142984947|NCT03107793|515481685|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
142984948|NCT03107793|515481681|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
142984949|NCT03107793|515481682|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
142984950|NCT03107793|515481683|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
142984951|NCT03107793|515481684|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
142984952|NCT03107793|515481685|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
142984953|NCT03107793|515481681|FG000|Extension Period (Week 48- Week 104)|Death|0|||
142984954|NCT03107793|515481682|FG001|Extension Period (Week 48- Week 104)|Death|0|||
142984955|NCT03107793|515481683|FG002|Extension Period (Week 48- Week 104)|Death|0|||
142984956|NCT03107793|515481684|FG003|Extension Period (Week 48- Week 104)|Death|0|||
142984957|NCT03107793|515481685|FG004|Extension Period (Week 48- Week 104)|Death|1|||
142984958|NCT03107793|515481681|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
142984959|NCT03107793|515481682|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
142984960|NCT03107793|515481683|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
142984961|NCT03107793|515481684|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
142984962|NCT03107793|515481685|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
142984963|NCT03107793|515481681|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
142984964|NCT03107793|515481682|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
142984965|NCT03107793|515481683|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
142984966|NCT03107793|515481684|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
142984967|NCT03107793|515481685|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
142984968|NCT03107793|515481681|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
142984969|NCT03107793|515481682|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
142984970|NCT03107793|515481683|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
142984971|NCT03107793|515481684|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
142984972|NCT03107793|515481685|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
142984973|NCT03107793|515481681|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
142984974|NCT03107793|515481682|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
142984975|NCT03107793|515481683|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
142984976|NCT03107793|515481684|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
142984977|NCT03107793|515481685|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
142984978|NCT03107793|515481681|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
142984979|NCT03107793|515481682|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
142984980|NCT03107793|515481683|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
142984981|NCT03107793|515481684|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
142984982|NCT03107793|515481685|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
142984983|NCT03107793|515481681|FG000|Extension Period (Week 48- Week 104)|Other|0|||
142984984|NCT03107793|515481682|FG001|Extension Period (Week 48- Week 104)|Other|0|||
142984985|NCT03107793|515481683|FG002|Extension Period (Week 48- Week 104)|Other|0|||
142984986|NCT03107793|515481684|FG003|Extension Period (Week 48- Week 104)|Other|1|||
142984987|NCT03107793|515481685|FG004|Extension Period (Week 48- Week 104)|Other|3|||
142984988|NCT03107793|515481681|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
142984989|NCT03107793|515481682|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
142984990|NCT03107793|515481683|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
142984991|NCT03107793|515481684|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
142984992|NCT03107793|515481685|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
142984993|NCT01872897|515481692|FG000|Overall Study|Withdrawal by Subject|1|||
142984994|NCT01872897|515481693|FG001|Overall Study|Withdrawal by Subject|0|||
142984995|NCT02418585|515481698|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
142984996|NCT02418585|515481699|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
142984997|NCT02418585|515481698|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
142984998|NCT02418585|515481699|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
142984999|NCT02418585|515481698|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
142985000|NCT02418585|515481699|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
142985001|NCT02418585|515481698|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
142985002|NCT02418585|515481699|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
142985003|NCT02418585|515481698|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
142985004|NCT02418585|515481699|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
142985005|NCT02418585|515481698|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
142985006|NCT02418585|515481699|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
142985007|NCT02418585|515481698|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
142985008|NCT02418585|515481699|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
142985009|NCT02418585|515481698|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
142985010|NCT02418585|515481699|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
142985011|NCT02418585|515481698|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
142985012|NCT02418585|515481699|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
142985013|NCT02418585|515481698|FG000|Follow-up Phase (24 Weeks)|Other|3|||
142985014|NCT02418585|515481699|FG001|Follow-up Phase (24 Weeks)|Other|2|||
142985015|NCT02040857|515481700|FG000|Overall Study|Adverse Event|14|||
142985016|NCT02040857|515481700|FG000|Overall Study|Physician Decision|5|||
142985017|NCT02040857|515481700|FG000|Overall Study|Withdrawal by Subject|31|||
142985018|NCT02040857|515481700|FG000|Overall Study|patient non-compliance|3|||
142985019|NCT02040857|515481700|FG000|Overall Study|Lost to Follow-up|2|||
142985020|NCT02040857|515481700|FG000|Overall Study|recurrence|4|||
142985021|NCT02040857|515481700|FG000|Overall Study|ineligible|1|||
142985022|NCT01849562|515481701|FG000|Overall Study|Lost to Follow-up|1|||
142985023|NCT01849562|515481702|FG001|Overall Study|Lost to Follow-up|0|||
142985024|NCT01849562|515481703|FG002|Overall Study|Lost to Follow-up|0|||
142985025|NCT01849562|515481701|FG000|Overall Study|Non-compliance with Study Drug|1|||
142985026|NCT01849562|515481702|FG001|Overall Study|Non-compliance with Study Drug|0|||
142985027|NCT01849562|515481703|FG002|Overall Study|Non-compliance with Study Drug|0|||
142985028|NCT01024920|515481706|FG000|Overall Study|Progressive disease|47|||
142985029|NCT01024920|515481707|FG001|Overall Study|Progressive disease|25|||
142985030|NCT01024920|515481706|FG000|Overall Study|Adverse Event|8|||
142985031|NCT01024920|515481707|FG001|Overall Study|Adverse Event|4|||
142985032|NCT01024920|515481706|FG000|Overall Study|Lost to Follow-up|0|||
142985033|NCT01024920|515481707|FG001|Overall Study|Lost to Follow-up|1|||
142985034|NCT01024920|515481706|FG000|Overall Study|Patient refusal to continue|4|||
142985035|NCT01024920|515481707|FG001|Overall Study|Patient refusal to continue|0|||
142985036|NCT01024920|515481706|FG000|Overall Study|Other than listed|5|||
142985037|NCT01024920|515481707|FG001|Overall Study|Other than listed|1|||
142985038|NCT01024920|515481706|FG000|Overall Study|Not treated|3|||
142985039|NCT01024920|515481707|FG001|Overall Study|Not treated|0|||
142985040|NCT01024920|515481706|FG000|Overall Study|Protocol Violation|0|||
142985041|NCT01024920|515481707|FG001|Overall Study|Protocol Violation|1|||
142985042|NCT00481988|515481708|FG000|Overall Study|Withdrawal by Subject|1|||
142985043|NCT00481988|515481709|FG001|Overall Study|Withdrawal by Subject|1|||
142985044|NCT00610207|515481710|FG000|Overall Study|Lost to Follow-up|3|||
142985045|NCT03236506|515481718|FG000|Overall Study|Death|1|||
142985046|NCT03236506|515481719|FG001|Overall Study|Death|1|||
142985047|NCT03236506|515481720|FG002|Overall Study|Death|1|||
142985048|NCT03236506|515481718|FG000|Overall Study|Withdrawal by Subject|3|||
142985049|NCT03236506|515481719|FG001|Overall Study|Withdrawal by Subject|3|||
142985050|NCT03236506|515481720|FG002|Overall Study|Withdrawal by Subject|4|||
142985051|NCT03236506|515481718|FG000|Overall Study|Did not initiate treatment|2|||
142985052|NCT03236506|515481719|FG001|Overall Study|Did not initiate treatment|1|||
142985053|NCT03236506|515481720|FG002|Overall Study|Did not initiate treatment|2|||
142985054|NCT00910728|515481733|FG000|Overall Study|Lack of Efficacy|2|||
142985055|NCT00910728|515481734|FG001|Overall Study|Lack of Efficacy|3|||
142985056|NCT00910728|515481735|FG002|Overall Study|Lack of Efficacy|1|||
142985057|NCT00910728|515481736|FG003|Overall Study|Lack of Efficacy|2|||
142985058|NCT00910728|515481737|FG004|Overall Study|Lack of Efficacy|1|||
142985059|NCT00910728|515481738|FG005|Overall Study|Lack of Efficacy|0|||
142985060|NCT00910728|515481739|FG006|Overall Study|Lack of Efficacy|2|||
142985061|NCT00910728|515481740|FG007|Overall Study|Lack of Efficacy|2|||
142985062|NCT00910728|515481741|FG008|Overall Study|Lack of Efficacy|2|||
142985063|NCT00910728|515481733|FG000|Overall Study|Withdrawal by Subject|0|||
142985064|NCT00910728|515481734|FG001|Overall Study|Withdrawal by Subject|0|||
142985065|NCT00910728|515481735|FG002|Overall Study|Withdrawal by Subject|0|||
142985066|NCT00910728|515481736|FG003|Overall Study|Withdrawal by Subject|0|||
142985067|NCT00910728|515481737|FG004|Overall Study|Withdrawal by Subject|3|||
142985068|NCT00910728|515481738|FG005|Overall Study|Withdrawal by Subject|1|||
142985069|NCT00910728|515481739|FG006|Overall Study|Withdrawal by Subject|2|||
142985070|NCT00910728|515481740|FG007|Overall Study|Withdrawal by Subject|0|||
142985071|NCT00910728|515481741|FG008|Overall Study|Withdrawal by Subject|0|||
142985072|NCT00910728|515481733|FG000|Overall Study|(not specified)|2|||
142985073|NCT00910728|515481734|FG001|Overall Study|(not specified)|0|||
142985074|NCT00910728|515481735|FG002|Overall Study|(not specified)|1|||
142985075|NCT00910728|515481736|FG003|Overall Study|(not specified)|0|||
142985076|NCT00910728|515481737|FG004|Overall Study|(not specified)|1|||
142985077|NCT00910728|515481738|FG005|Overall Study|(not specified)|0|||
142985078|NCT00910728|515481739|FG006|Overall Study|(not specified)|0|||
142985079|NCT00910728|515481740|FG007|Overall Study|(not specified)|0|||
142985080|NCT00910728|515481741|FG008|Overall Study|(not specified)|0|||
142985081|NCT00910728|515481733|FG000|Overall Study|Adverse Event|2|||
142985082|NCT00910728|515481734|FG001|Overall Study|Adverse Event|0|||
142985083|NCT00910728|515481735|FG002|Overall Study|Adverse Event|1|||
142985084|NCT00910728|515481736|FG003|Overall Study|Adverse Event|1|||
142985085|NCT00910728|515481737|FG004|Overall Study|Adverse Event|0|||
142985086|NCT00910728|515481738|FG005|Overall Study|Adverse Event|0|||
142985087|NCT00910728|515481739|FG006|Overall Study|Adverse Event|2|||
142985088|NCT00910728|515481740|FG007|Overall Study|Adverse Event|1|||
142985089|NCT00910728|515481741|FG008|Overall Study|Adverse Event|1|||
142985090|NCT00437203|515481742|FG000|Overall Study|Death|0|||
142985091|NCT00437203|515481743|FG001|Overall Study|Death|0|||
142985092|NCT00437203|515481744|FG002|Overall Study|Death|1|||
142985093|NCT00437203|515481745|FG003|Overall Study|Death|0|||
142985094|NCT00437203|515481746|FG004|Overall Study|Death|0|||
142985095|NCT00437203|515481747|FG005|Overall Study|Death|0|||
142985096|NCT00437203|515481748|FG006|Overall Study|Death|0|||
142985097|NCT00437203|515481749|FG007|Overall Study|Death|1|||
142985098|NCT00437203|515481750|FG008|Overall Study|Death|0|||
142985099|NCT00437203|515481751|FG009|Overall Study|Death|1|||
142985100|NCT00437203|515481742|FG000|Overall Study|Adverse Event|1|||
142985101|NCT00437203|515481743|FG001|Overall Study|Adverse Event|1|||
142985102|NCT00437203|515481744|FG002|Overall Study|Adverse Event|0|||
142985103|NCT00437203|515481745|FG003|Overall Study|Adverse Event|0|||
142985104|NCT00437203|515481746|FG004|Overall Study|Adverse Event|0|||
142985105|NCT00437203|515481747|FG005|Overall Study|Adverse Event|0|||
142985106|NCT00437203|515481748|FG006|Overall Study|Adverse Event|0|||
142985107|NCT00437203|515481749|FG007|Overall Study|Adverse Event|1|||
142985108|NCT00437203|515481750|FG008|Overall Study|Adverse Event|0|||
142985109|NCT00437203|515481751|FG009|Overall Study|Adverse Event|1|||
142985110|NCT00437203|515481742|FG000|Overall Study|Study terminated by sponsor|0|||
142985111|NCT00437203|515481743|FG001|Overall Study|Study terminated by sponsor|0|||
142985112|NCT00437203|515481744|FG002|Overall Study|Study terminated by sponsor|0|||
142985113|NCT00437203|515481745|FG003|Overall Study|Study terminated by sponsor|0|||
142985114|NCT00437203|515481746|FG004|Overall Study|Study terminated by sponsor|0|||
142985115|NCT00437203|515481747|FG005|Overall Study|Study terminated by sponsor|0|||
142985116|NCT00437203|515481748|FG006|Overall Study|Study terminated by sponsor|0|||
142985117|NCT00437203|515481749|FG007|Overall Study|Study terminated by sponsor|0|||
142985118|NCT00437203|515481750|FG008|Overall Study|Study terminated by sponsor|1|||
142985119|NCT00437203|515481751|FG009|Overall Study|Study terminated by sponsor|0|||
142985120|NCT00437203|515481742|FG000|Overall Study|Objective progression or relapse|5|||
142985121|NCT00437203|515481743|FG001|Overall Study|Objective progression or relapse|6|||
142985122|NCT00437203|515481744|FG002|Overall Study|Objective progression or relapse|2|||
142985123|NCT00437203|515481745|FG003|Overall Study|Objective progression or relapse|3|||
142985124|NCT00437203|515481746|FG004|Overall Study|Objective progression or relapse|3|||
142985125|NCT00437203|515481747|FG005|Overall Study|Objective progression or relapse|3|||
142985126|NCT00437203|515481748|FG006|Overall Study|Objective progression or relapse|6|||
142985127|NCT00437203|515481749|FG007|Overall Study|Objective progression or relapse|1|||
142985128|NCT00437203|515481750|FG008|Overall Study|Objective progression or relapse|2|||
142985129|NCT00437203|515481751|FG009|Overall Study|Objective progression or relapse|2|||
142985130|NCT00437203|515481742|FG000|Overall Study|Other|0|||
142985131|NCT00437203|515481743|FG001|Overall Study|Other|1|||
142985132|NCT00437203|515481744|FG002|Overall Study|Other|0|||
142985133|NCT00437203|515481745|FG003|Overall Study|Other|0|||
142985134|NCT00437203|515481746|FG004|Overall Study|Other|0|||
142985135|NCT00437203|515481747|FG005|Overall Study|Other|0|||
142985136|NCT00437203|515481748|FG006|Overall Study|Other|1|||
142985137|NCT00437203|515481749|FG007|Overall Study|Other|0|||
142985138|NCT00437203|515481750|FG008|Overall Study|Other|0|||
142985139|NCT00437203|515481751|FG009|Overall Study|Other|0|||
142985140|NCT00431496|515481758|FG000|Overall Study|Adverse Event|3|||
142985141|NCT00431496|515481758|FG000|Overall Study|Lost to Follow-up|1|||
142985142|NCT00431496|515481758|FG000|Overall Study|Withdrawal by Subject|2|||
142985143|NCT00431496|515481758|FG000|Overall Study|Protocol-specified criteria|5|||
142985144|NCT04095793|515481759|FG000|Overall Study|Adverse Event|3|||
142985145|NCT04095793|515481759|FG000|Overall Study|Study Terminated by Sponsor|103|||
142985146|NCT04095793|515481759|FG000|Overall Study|Withdrawal by Subject|4|||
142985147|NCT02384993|515481760|FG000|Overall Study|Adverse Event|0|||
142985148|NCT02384993|515481761|FG001|Overall Study|Adverse Event|1|||
142985149|NCT00044213|515481762|FG000|Overall Study|Withdrawal by Subject|50|||
142985150|NCT00044213|515481763|FG001|Overall Study|Withdrawal by Subject|65|||
142985151|NCT00044213|515481764|FG002|Overall Study|Withdrawal by Subject|91|||
142985152|NCT00044213|515481765|FG003|Overall Study|Withdrawal by Subject|83|||
142985153|NCT00044213|515481762|FG000|Overall Study|Death|42|||
142985154|NCT00044213|515481763|FG001|Overall Study|Death|42|||
142985155|NCT00044213|515481764|FG002|Overall Study|Death|42|||
142985156|NCT00044213|515481765|FG003|Overall Study|Death|49|||
142985157|NCT00044213|515481762|FG000|Overall Study|Lost to Follow-up|8|||
142985158|NCT00044213|515481763|FG001|Overall Study|Lost to Follow-up|5|||
142985159|NCT00044213|515481764|FG002|Overall Study|Lost to Follow-up|5|||
142985160|NCT00044213|515481765|FG003|Overall Study|Lost to Follow-up|4|||
142985161|NCT00499460|515481770|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
142985162|NCT00499460|515481771|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
142985163|NCT00499460|515481770|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
142985164|NCT00499460|515481771|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
142985165|NCT00499460|515481770|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
142985166|NCT00499460|515481771|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
142985167|NCT03209362|515481774|FG000|Overall Study|Adverse Event|0|||
142985168|NCT03209362|515481775|FG001|Overall Study|Adverse Event|1|||
142985169|NCT03209362|515481774|FG000|Overall Study|Lost to Follow-up|0|||
142985170|NCT03209362|515481775|FG001|Overall Study|Lost to Follow-up|1|||
142985171|NCT03209362|515481774|FG000|Overall Study|Withdrawal by Subject|2|||
142985172|NCT03209362|515481775|FG001|Overall Study|Withdrawal by Subject|0|||
142985173|NCT03209362|515481774|FG000|Overall Study|Other|0|||
142985174|NCT03209362|515481775|FG001|Overall Study|Other|1|||
142985175|NCT00251589|515481776|FG000|Overall Study|Adverse Event|5|||
142985176|NCT00251589|515481777|FG001|Overall Study|Adverse Event|1|||
142985177|NCT00251589|515481778|FG002|Overall Study|Adverse Event|2|||
142985178|NCT00251589|515481779|FG003|Overall Study|Adverse Event|1|||
142985179|NCT00251589|515481776|FG000|Overall Study|Withdrawal by Subject|1|||
142985180|NCT00251589|515481777|FG001|Overall Study|Withdrawal by Subject|1|||
142985181|NCT00251589|515481778|FG002|Overall Study|Withdrawal by Subject|0|||
142985182|NCT00251589|515481779|FG003|Overall Study|Withdrawal by Subject|0|||
142985183|NCT00251589|515481776|FG000|Overall Study|Discontinued due to progressive disease|9|||
142985184|NCT00251589|515481777|FG001|Overall Study|Discontinued due to progressive disease|1|||
142985185|NCT00251589|515481778|FG002|Overall Study|Discontinued due to progressive disease|0|||
142985186|NCT00251589|515481779|FG003|Overall Study|Discontinued due to progressive disease|1|||
142985187|NCT02493868|515481782|FG000|Induction Phase: DE Participants|Adverse Event|22|||
142985188|NCT02493868|515481783|FG001|Induction Phase: DE Participants|Adverse Event|0|||
142985189|NCT02493868|515481782|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
142985190|NCT02493868|515481783|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
142985191|NCT02493868|515481782|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
142985192|NCT02493868|515481783|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
142985193|NCT02493868|515481782|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
142985194|NCT02493868|515481783|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
142985195|NCT02493868|515481782|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
142985196|NCT02493868|515481783|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
142985197|NCT02493868|515481782|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
142985198|NCT02493868|515481783|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
142985199|NCT02493868|515481782|FG000|Induction Phase: DE Participants|Other|8|||
142985200|NCT02493868|515481783|FG001|Induction Phase: DE Participants|Other|0|||
142985201|NCT02493868|515481782|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
142985202|NCT02493868|515481783|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
142985203|NCT02493868|515481782|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
142985204|NCT02493868|515481783|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
142985205|NCT02493868|515481782|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
142985206|NCT02493868|515481783|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
142985207|NCT02493868|515481782|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
142985208|NCT02493868|515481783|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
142985209|NCT02493868|515481782|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
142985210|NCT02493868|515481783|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
142985211|NCT02493868|515481782|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
142985212|NCT02493868|515481783|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
142985213|NCT02493868|515481782|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
142985214|NCT02493868|515481783|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
142985215|NCT02493868|515481782|FG000|Optimization Phase: DE+TE Participants|Other|10|||
142985216|NCT02493868|515481783|FG001|Optimization Phase: DE+TE Participants|Other|2|||
142985217|NCT02493868|515481782|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
142985218|NCT02493868|515481783|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
142985219|NCT02493868|515481782|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
142985220|NCT02493868|515481783|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
142985221|NCT02493868|515481782|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
142985222|NCT02493868|515481783|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
142985223|NCT02493868|515481782|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
142985224|NCT02493868|515481783|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
142985225|NCT02493868|515481782|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
142985226|NCT02493868|515481783|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
142985227|NCT02493868|515481782|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
142985228|NCT02493868|515481783|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
142985229|NCT02493868|515481782|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
142985230|NCT02493868|515481783|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
142985231|NCT02493868|515481782|FG000|Follow-up Phase|Lost to Follow-up|1|||
142985232|NCT02493868|515481783|FG001|Follow-up Phase|Lost to Follow-up|0|||
142985233|NCT02493868|515481782|FG000|Follow-up Phase|Withdrawal by Subject|3|||
142985234|NCT02493868|515481783|FG001|Follow-up Phase|Withdrawal by Subject|0|||
142985235|NCT02493868|515481782|FG000|Follow-up Phase|Investigator Decision|5|||
142985236|NCT02493868|515481783|FG001|Follow-up Phase|Investigator Decision|1|||
142985237|NCT02493868|515481782|FG000|Follow-up Phase|Other|2|||
142985238|NCT02493868|515481783|FG001|Follow-up Phase|Other|1|||
142985239|NCT01627782|515481784|FG000|Overall Study|Adverse Event|1|||
142985240|NCT01627782|515481785|FG001|Overall Study|Adverse Event|2|||
142985241|NCT01627782|515481786|FG002|Overall Study|Adverse Event|0|||
142985242|NCT01627782|515481787|FG003|Overall Study|Adverse Event|1|||
142985243|NCT01627782|515481784|FG000|Overall Study|Lack of Efficacy|11|||
142985244|NCT01627782|515481785|FG001|Overall Study|Lack of Efficacy|1|||
142985245|NCT01627782|515481786|FG002|Overall Study|Lack of Efficacy|15|||
142985246|NCT01627782|515481787|FG003|Overall Study|Lack of Efficacy|2|||
142985247|NCT01627782|515481784|FG000|Overall Study|Protocol Violation|1|||
142985248|NCT01627782|515481785|FG001|Overall Study|Protocol Violation|0|||
142985249|NCT01627782|515481786|FG002|Overall Study|Protocol Violation|0|||
142985250|NCT01627782|515481787|FG003|Overall Study|Protocol Violation|0|||
142985251|NCT01627782|515481784|FG000|Overall Study|Withdrawal by Subject|2|||
142985252|NCT01627782|515481785|FG001|Overall Study|Withdrawal by Subject|1|||
142985253|NCT01627782|515481786|FG002|Overall Study|Withdrawal by Subject|0|||
142985254|NCT01627782|515481787|FG003|Overall Study|Withdrawal by Subject|0|||
142985255|NCT01627782|515481784|FG000|Overall Study|Other|0|||
142985256|NCT01627782|515481785|FG001|Overall Study|Other|2|||
142985257|NCT01627782|515481786|FG002|Overall Study|Other|0|||
142985258|NCT01627782|515481787|FG003|Overall Study|Other|3|||
142985259|NCT01627782|515481784|FG000|Overall Study|Randomized But Not Treated|1|||
142985260|NCT01627782|515481785|FG001|Overall Study|Randomized But Not Treated|0|||
142985261|NCT01627782|515481786|FG002|Overall Study|Randomized But Not Treated|0|||
142985262|NCT01627782|515481787|FG003|Overall Study|Randomized But Not Treated|0|||
142985263|NCT04507360|515483636|FG000|Week 1|Lost to Follow-up|0|||
142985264|NCT04507360|515483637|FG001|Week 1|Lost to Follow-up|0|||
142985265|NCT04507360|515483638|FG002|Week 1|Lost to Follow-up|0|||
142985266|NCT04507360|515483639|FG003|Week 1|Lost to Follow-up|0|||
142985267|NCT04507360|515483640|FG004|Week 1|Lost to Follow-up|0|||
142985268|NCT04507360|515483641|FG005|Week 1|Lost to Follow-up|0|||
142985269|NCT04507360|515483642|FG006|Week 1|Lost to Follow-up|0|||
142985270|NCT04507360|515483643|FG007|Week 1|Lost to Follow-up|0|||
142985271|NCT04507360|515483644|FG008|Week 1|Lost to Follow-up|72|||
142985272|NCT04507360|515483645|FG009|Week 1|Lost to Follow-up|22|||
142985273|NCT04507360|515483646|FG010|Week 1|Lost to Follow-up|10|||
142985274|NCT04507360|515483636|FG000|Week 2|Lost to Follow-up|0|||
142985275|NCT04507360|515483637|FG001|Week 2|Lost to Follow-up|0|||
142985276|NCT04507360|515483638|FG002|Week 2|Lost to Follow-up|0|||
142985277|NCT04507360|515483639|FG003|Week 2|Lost to Follow-up|0|||
142985278|NCT04507360|515483640|FG004|Week 2|Lost to Follow-up|0|||
142985279|NCT04507360|515483641|FG005|Week 2|Lost to Follow-up|0|||
142985280|NCT04507360|515483642|FG006|Week 2|Lost to Follow-up|0|||
142985281|NCT04507360|515483643|FG007|Week 2|Lost to Follow-up|0|||
142985282|NCT04507360|515483644|FG008|Week 2|Lost to Follow-up|121|||
142985283|NCT04507360|515483645|FG009|Week 2|Lost to Follow-up|85|||
142985284|NCT04507360|515483646|FG010|Week 2|Lost to Follow-up|82|||
142985285|NCT04507360|515483636|FG000|Week 3|Lost to Follow-up|0|||
142985286|NCT04507360|515483637|FG001|Week 3|Lost to Follow-up|0|||
142985287|NCT04507360|515483638|FG002|Week 3|Lost to Follow-up|0|||
142985288|NCT04507360|515483639|FG003|Week 3|Lost to Follow-up|0|||
142985289|NCT04507360|515483640|FG004|Week 3|Lost to Follow-up|0|||
142985290|NCT04507360|515483641|FG005|Week 3|Lost to Follow-up|0|||
142985291|NCT04507360|515483642|FG006|Week 3|Lost to Follow-up|0|||
142985292|NCT04507360|515483643|FG007|Week 3|Lost to Follow-up|0|||
142985293|NCT04507360|515483644|FG008|Week 3|Lost to Follow-up|123|||
142985294|NCT04507360|515483645|FG009|Week 3|Lost to Follow-up|92|||
142985295|NCT04507360|515483646|FG010|Week 3|Lost to Follow-up|84|||
142985296|NCT04507360|515483636|FG000|Week 4|Lost to Follow-up|0|||
142985297|NCT04507360|515483637|FG001|Week 4|Lost to Follow-up|0|||
142985298|NCT04507360|515483638|FG002|Week 4|Lost to Follow-up|0|||
142985299|NCT04507360|515483639|FG003|Week 4|Lost to Follow-up|0|||
142985300|NCT04507360|515483640|FG004|Week 4|Lost to Follow-up|0|||
142985301|NCT04507360|515483641|FG005|Week 4|Lost to Follow-up|0|||
142985302|NCT04507360|515483642|FG006|Week 4|Lost to Follow-up|0|||
142985303|NCT04507360|515483643|FG007|Week 4|Lost to Follow-up|0|||
142985304|NCT04507360|515483644|FG008|Week 4|Lost to Follow-up|131|||
142985305|NCT04507360|515483645|FG009|Week 4|Lost to Follow-up|115|||
142985306|NCT04507360|515483646|FG010|Week 4|Lost to Follow-up|102|||
142985307|NCT04507360|515483636|FG000|Week 5|Lost to Follow-up|0|||
142985308|NCT04507360|515483637|FG001|Week 5|Lost to Follow-up|0|||
142985309|NCT04507360|515483638|FG002|Week 5|Lost to Follow-up|0|||
142985310|NCT04507360|515483639|FG003|Week 5|Lost to Follow-up|0|||
142985311|NCT04507360|515483640|FG004|Week 5|Lost to Follow-up|0|||
142985312|NCT04507360|515483641|FG005|Week 5|Lost to Follow-up|0|||
142985313|NCT04507360|515483642|FG006|Week 5|Lost to Follow-up|0|||
142985314|NCT04507360|515483643|FG007|Week 5|Lost to Follow-up|0|||
142985315|NCT04507360|515483644|FG008|Week 5|Lost to Follow-up|103|||
142985316|NCT04507360|515483645|FG009|Week 5|Lost to Follow-up|135|||
142985317|NCT04507360|515483646|FG010|Week 5|Lost to Follow-up|143|||
142985318|NCT04507360|515483636|FG000|Week 8|Lost to Follow-up|0|||
142985319|NCT04507360|515483637|FG001|Week 8|Lost to Follow-up|0|||
142985320|NCT04507360|515483638|FG002|Week 8|Lost to Follow-up|0|||
142985321|NCT04507360|515483639|FG003|Week 8|Lost to Follow-up|0|||
142985322|NCT04507360|515483640|FG004|Week 8|Lost to Follow-up|0|||
142985323|NCT04507360|515483641|FG005|Week 8|Lost to Follow-up|0|||
142985324|NCT04507360|515483642|FG006|Week 8|Lost to Follow-up|0|||
142985325|NCT04507360|515483643|FG007|Week 8|Lost to Follow-up|0|||
142985326|NCT04507360|515483644|FG008|Week 8|Lost to Follow-up|139|||
142985327|NCT04507360|515483645|FG009|Week 8|Lost to Follow-up|145|||
142985328|NCT04507360|515483646|FG010|Week 8|Lost to Follow-up|152|||
142985329|NCT01004159|515483647|FG000|Overall Study|Adverse Event|2|||
142985330|NCT01004159|515483647|FG000|Overall Study|Disease Progression|18|||
142985331|NCT00439309|515483649|FG000|Follow-Up|Death|1|||
142985332|NCT00439309|515483650|FG001|Follow-Up|Death|0|||
142985333|NCT00439309|515483649|FG000|Follow-Up|Lost to Follow-up|2|||
142985334|NCT00439309|515483650|FG001|Follow-Up|Lost to Follow-up|0|||
142985335|NCT00439309|515483649|FG000|Follow-Up|Withdrawal by Subject|0|||
142985336|NCT00439309|515483650|FG001|Follow-Up|Withdrawal by Subject|1|||
142985337|NCT00439309|515483649|FG000|Follow-Up|Late response by subject|0|||
142985338|NCT00439309|515483650|FG001|Follow-Up|Late response by subject|1|||
142985339|NCT01462045|515483652|FG000|Overall Study|Family matter|0|||
142985340|NCT01462045|515483653|FG001|Overall Study|Family matter|1|||
142985341|NCT01462045|515483654|FG002|Overall Study|Family matter|0|||
142985342|NCT00524043|515483655|FG000|Overall Study|Lack of Efficacy|15|||
142985343|NCT00524043|515483656|FG001|Overall Study|Lack of Efficacy|13|||
142985344|NCT00524043|515483657|FG002|Overall Study|Lack of Efficacy|14|||
142985345|NCT00524043|515483655|FG000|Overall Study|Withdrawal by Subject|5|||
142985346|NCT00524043|515483656|FG001|Overall Study|Withdrawal by Subject|7|||
142985347|NCT00524043|515483657|FG002|Overall Study|Withdrawal by Subject|7|||
142985348|NCT00524043|515483655|FG000|Overall Study|Adverse Event|5|||
142985349|NCT00524043|515483656|FG001|Overall Study|Adverse Event|2|||
142985350|NCT00524043|515483657|FG002|Overall Study|Adverse Event|7|||
142985351|NCT00524043|515483655|FG000|Overall Study|Lost to Follow-up|3|||
142985352|NCT00524043|515483656|FG001|Overall Study|Lost to Follow-up|5|||
142985353|NCT00524043|515483657|FG002|Overall Study|Lost to Follow-up|3|||
142985354|NCT00524043|515483655|FG000|Overall Study|Various (eg, incarceration)|2|||
142985355|NCT00524043|515483656|FG001|Overall Study|Various (eg, incarceration)|1|||
142985356|NCT00524043|515483657|FG002|Overall Study|Various (eg, incarceration)|0|||
142985357|NCT01536418|515483664|FG000|Overall Study|Protocol Violation|2|||
142985358|NCT01536418|515483665|FG001|Overall Study|Protocol Violation|3|||
142985359|NCT01536418|515483664|FG000|Overall Study|Physician Decision|1|||
142985360|NCT01536418|515483665|FG001|Overall Study|Physician Decision|3|||
142985361|NCT01536418|515483664|FG000|Overall Study|Study closed/terminated|41|||
142985362|NCT01536418|515483665|FG001|Overall Study|Study closed/terminated|37|||
142985363|NCT01536418|515483664|FG000|Overall Study|Lack of Efficacy|10|||
142985364|NCT01536418|515483665|FG001|Overall Study|Lack of Efficacy|16|||
142985365|NCT01536418|515483664|FG000|Overall Study|Adverse Event|9|||
142985366|NCT01536418|515483665|FG001|Overall Study|Adverse Event|4|||
142985367|NCT01536418|515483664|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
142985368|NCT01536418|515483665|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
142985369|NCT01536418|515483664|FG000|Overall Study|Withdrawal by Subject|5|||
142985370|NCT01536418|515483665|FG001|Overall Study|Withdrawal by Subject|3|||
142985371|NCT02658149|515483670|FG000|Overall Study|Physician Decision|1|||
142985372|NCT02658149|515483671|FG001|Overall Study|Physician Decision|0|||
142985373|NCT00711412|515483674|FG000|Induction Treatment|Death|2|||
142985374|NCT00711412|515483674|FG000|Induction Treatment|Adverse Event|1|||
142985375|NCT00711412|515483674|FG000|Induction Treatment|Other|1|||
142985376|NCT00711412|515483674|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
142985377|NCT00711412|515483674|FG000|Evaluated for Combination Treatment|Death|1|||
142985378|NCT00711412|515483674|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
142985379|NCT00711412|515483674|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
142985380|NCT00711412|515483674|FG000|Combination Treatment|Progressive Disease|1|||
142985381|NCT00711412|515483674|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
142985382|NCT00711412|515483674|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
142985383|NCT00711412|515483674|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
142985384|NCT00711412|515483674|FG000|Evaluation for Response and Surgery|Death|1|||
142985385|NCT00711412|515483674|FG000|Survival Follow up Until Death|Other|12|||
142985386|NCT00911144|515483677|FG000|Overall Study|Withdrawal by Subject|16|||
142985387|NCT00911144|515483678|FG001|Overall Study|Withdrawal by Subject|5|||
142985388|NCT01291511|515483679|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
142985389|NCT01291511|515483680|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
142985390|NCT01291511|515483679|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
142985391|NCT01291511|515483680|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
142985392|NCT01291511|515483679|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
142985393|NCT01291511|515483680|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
142985394|NCT01291511|515483679|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
142985395|NCT01291511|515483680|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
142985396|NCT01291511|515483679|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
142985397|NCT01291511|515483680|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
142985398|NCT01291511|515483679|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
142985399|NCT01291511|515483680|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
142985400|NCT01291511|515483679|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
142985401|NCT01291511|515483680|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
142985402|NCT01291511|515483679|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
142985403|NCT01291511|515483680|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
142985404|NCT01291511|515483679|FG000|Cross-Titration and Stabilization Phase|Death|1|||
142985405|NCT01291511|515483680|FG001|Cross-Titration and Stabilization Phase|Death|0|||
142985406|NCT01291511|515483679|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
142985407|NCT01291511|515483680|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
142985408|NCT01291511|515483679|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
142985409|NCT01291511|515483680|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
142985410|NCT01291511|515483679|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
142985411|NCT01291511|515483680|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
142985412|NCT01291511|515483679|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
142985413|NCT01291511|515483680|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
142985414|NCT01291511|515483679|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
142985415|NCT01291511|515483680|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
142985416|NCT01291511|515483679|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
142985417|NCT01291511|515483680|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
142985418|NCT01291511|515483679|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
142985419|NCT01291511|515483680|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
142985420|NCT01291511|515483679|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
142985421|NCT01291511|515483680|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
142985422|NCT01291511|515483679|FG000|Double-blind Relapse Prevention Phase|Death|1|||
142985423|NCT01291511|515483680|FG001|Double-blind Relapse Prevention Phase|Death|0|||
142985424|NCT00047008|515483681|FG000|Overall Study|Withdrawn consent|2|||
142985425|NCT00047008|515483682|FG001|Overall Study|Withdrawn consent|3|||
142985426|NCT00047008|515483681|FG000|Overall Study|Ineligible|9|||
142985427|NCT00047008|515483682|FG001|Overall Study|Ineligible|8|||
142985428|NCT03412565|515483683|FG000|Overall Study|Lost to Follow-up|0|||
142985429|NCT03412565|515483684|FG001|Overall Study|Lost to Follow-up|0|||
142985430|NCT03412565|515483685|FG002|Overall Study|Lost to Follow-up|1|||
142985431|NCT03412565|515483686|FG003|Overall Study|Lost to Follow-up|0|||
142985432|NCT03412565|515483683|FG000|Overall Study|Physician Decision|0|||
142985433|NCT03412565|515483684|FG001|Overall Study|Physician Decision|0|||
142985434|NCT03412565|515483685|FG002|Overall Study|Physician Decision|0|||
142985435|NCT03412565|515483686|FG003|Overall Study|Physician Decision|1|||
142985436|NCT03412565|515483683|FG000|Overall Study|Withdrawal by Subject|0|||
142985437|NCT03412565|515483684|FG001|Overall Study|Withdrawal by Subject|4|||
142985438|NCT03412565|515483685|FG002|Overall Study|Withdrawal by Subject|5|||
142985439|NCT03412565|515483686|FG003|Overall Study|Withdrawal by Subject|5|||
142985440|NCT03412565|515483683|FG000|Overall Study|Death|1|||
142985441|NCT03412565|515483684|FG001|Overall Study|Death|3|||
142985442|NCT03412565|515483685|FG002|Overall Study|Death|4|||
142985443|NCT03412565|515483686|FG003|Overall Study|Death|5|||
142985444|NCT03412565|515483683|FG000|Overall Study|Data collection ended|0|||
142985445|NCT03412565|515483684|FG001|Overall Study|Data collection ended|41|||
142985446|NCT03412565|515483685|FG002|Overall Study|Data collection ended|41|||
142985447|NCT03412565|515483686|FG003|Overall Study|Data collection ended|40|||
142985448|NCT03321526|515483687|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
142985449|NCT03321526|515483688|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
142985450|NCT03321526|515483687|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
142985451|NCT03321526|515483688|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
142985452|NCT03321526|515483687|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
142985453|NCT03321526|515483688|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
142985454|NCT03321526|515483687|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
142985455|NCT03321526|515483688|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
142985456|NCT03321526|515483687|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
142985457|NCT03321526|515483688|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
142985458|NCT03321526|515483687|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
142985459|NCT03321526|515483688|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
142985460|NCT03321526|515483687|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
142985461|NCT03321526|515483688|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
142985462|NCT03321526|515483687|FG000|Follow-up Phase (2 Weeks)|Other|24|||
142985463|NCT03321526|515483688|FG001|Follow-up Phase (2 Weeks)|Other|24|||
142985464|NCT03152110|515483712|FG000|Overall Study|Withdrawal by Subject|3|||
142985465|NCT01634100|515483715|FG000|Overall Study|Withdrawal by Subject|1|||
142985466|NCT01634100|515483716|FG001|Overall Study|Withdrawal by Subject|0|||
142985467|NCT01634100|515483717|FG002|Overall Study|Withdrawal by Subject|1|||
142985468|NCT01634100|515483718|FG003|Overall Study|Withdrawal by Subject|0|||
142985469|NCT01634100|515483719|FG004|Overall Study|Withdrawal by Subject|0|||
142985470|NCT01634100|515483720|FG005|Overall Study|Withdrawal by Subject|0|||
142985471|NCT00552344|515483721|FG000|Overall Study|Lack of Efficacy|55|||
142985472|NCT00552344|515483721|FG000|Overall Study|Loss of efficacy|75|||
142985473|NCT00552344|515483721|FG000|Overall Study|Lost to Follow-up|8|||
142985474|NCT00552344|515483721|FG000|Overall Study|Withdrawal by Subject|48|||
142985475|NCT00552344|515483721|FG000|Overall Study|SAE, non-fatal|6|||
142985476|NCT00552344|515483721|FG000|Overall Study|AE, non-serious non-fatal|38|||
142985477|NCT00552344|515483721|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
142985478|NCT00552344|515483721|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
142985479|NCT00552344|515483721|FG000|Overall Study|Other Reason|22|||
142985480|NCT00471276|515483722|FG000|Overall Study|Death|2|||
142985481|NCT00471276|515483722|FG000|Overall Study|Adverse Event|16|||
142985482|NCT00471276|515483722|FG000|Overall Study|Protocol Violation|1|||
142985483|NCT00471276|515483722|FG000|Overall Study|Objective progression or relapse|54|||
142985484|NCT00471276|515483722|FG000|Overall Study|Global deterioration of health status|1|||
142985485|NCT00471276|515483722|FG000|Overall Study|Other|3|||
142985486|NCT00471276|515483722|FG000|Overall Study|Refused treatment|6|||
142985487|NCT00744991|515483725|FG000|Overall Study|Progressive Disease|11|||
142985488|NCT00744991|515483725|FG000|Overall Study|Withdrawal by Subject|8|||
142985489|NCT00744991|515483725|FG000|Overall Study|Physician Decision|3|||
142985490|NCT00744991|515483725|FG000|Overall Study|Adverse Event|2|||
142985491|NCT00744991|515483725|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
142985492|NCT01662986|515483726|FG000|Overall Study|Adverse Event|5|||
142985493|NCT01662986|515483727|FG001|Overall Study|Adverse Event|4|||
142985494|NCT01662986|515483726|FG000|Overall Study|Protocol Violation|2|||
142985495|NCT01662986|515483727|FG001|Overall Study|Protocol Violation|3|||
142985496|NCT01662986|515483726|FG000|Overall Study|Lost to Follow-up|5|||
142985497|NCT01662986|515483727|FG001|Overall Study|Lost to Follow-up|4|||
142985498|NCT01662986|515483726|FG000|Overall Study|Withdrawal by Subject|2|||
142985499|NCT01662986|515483727|FG001|Overall Study|Withdrawal by Subject|2|||
142985500|NCT01662986|515483726|FG000|Overall Study|Not Treated|1|||
142985501|NCT01662986|515483727|FG001|Overall Study|Not Treated|0|||
142985502|NCT01662986|515483726|FG000|Overall Study|Other than stated above|3|||
142985503|NCT01662986|515483727|FG001|Overall Study|Other than stated above|0|||
142985504|NCT01487863|515483728|FG000|Overall Study|Death|19|||
142985505|NCT01487863|515483729|FG001|Overall Study|Death|19|||
142985506|NCT01975376|515483730|FG000|Overall Study|Adverse Event|5|||
142985507|NCT01975376|515483731|FG001|Overall Study|Adverse Event|5|||
142985508|NCT01975376|515483730|FG000|Overall Study|Death|65|||
142985509|NCT01975376|515483731|FG001|Overall Study|Death|72|||
142985510|NCT01975376|515483730|FG000|Overall Study|Lost to Follow-up|70|||
142985511|NCT01975376|515483731|FG001|Overall Study|Lost to Follow-up|66|||
142985512|NCT01975376|515483730|FG000|Overall Study|Withdrew consent|68|||
142985513|NCT01975376|515483731|FG001|Overall Study|Withdrew consent|62|||
142985514|NCT01975376|515483730|FG000|Overall Study|Other|2|||
142985515|NCT01975376|515483731|FG001|Overall Study|Other|4|||
142985516|NCT01975376|515483730|FG000|Overall Study|Randomized, Not Treated|16|||
142985517|NCT01975376|515483731|FG001|Overall Study|Randomized, Not Treated|8|||
142985518|NCT04449276|515483732|FG000|Overall Study|Adverse Event|1|||
142985519|NCT04449276|515483733|FG001|Overall Study|Adverse Event|2|||
142985520|NCT04449276|515483734|FG002|Overall Study|Adverse Event|0|||
142985521|NCT04449276|515483735|FG003|Overall Study|Adverse Event|0|||
142985522|NCT04449276|515483736|FG004|Overall Study|Adverse Event|2|||
142985523|NCT04449276|515483737|FG005|Overall Study|Adverse Event|0|||
142985524|NCT04449276|515483738|FG006|Overall Study|Adverse Event|0|||
142985525|NCT04449276|515483739|FG007|Overall Study|Adverse Event|1|||
142985526|NCT04449276|515483732|FG000|Overall Study|Withdrawal by Subject|2|||
142985527|NCT04449276|515483733|FG001|Overall Study|Withdrawal by Subject|0|||
142985528|NCT04449276|515483734|FG002|Overall Study|Withdrawal by Subject|0|||
142985529|NCT04449276|515483735|FG003|Overall Study|Withdrawal by Subject|1|||
142985530|NCT04449276|515483736|FG004|Overall Study|Withdrawal by Subject|0|||
142985531|NCT04449276|515483737|FG005|Overall Study|Withdrawal by Subject|0|||
142985532|NCT04449276|515483738|FG006|Overall Study|Withdrawal by Subject|0|||
142985533|NCT04449276|515483739|FG007|Overall Study|Withdrawal by Subject|0|||
142985534|NCT04449276|515483732|FG000|Overall Study|Other|0|||
142985535|NCT04449276|515483733|FG001|Overall Study|Other|2|||
142985536|NCT04449276|515483734|FG002|Overall Study|Other|3|||
142985537|NCT04449276|515483735|FG003|Overall Study|Other|2|||
142985538|NCT04449276|515483736|FG004|Overall Study|Other|0|||
142985539|NCT04449276|515483737|FG005|Overall Study|Other|0|||
142985540|NCT04449276|515483738|FG006|Overall Study|Other|0|||
142985541|NCT04449276|515483739|FG007|Overall Study|Other|1|||
142985542|NCT01614795|515483742|FG000|Overall Study|Adverse Event|0|||
142985543|NCT01614795|515483743|FG001|Overall Study|Adverse Event|0|||
142985544|NCT01614795|515483744|FG002|Overall Study|Adverse Event|1|||
142985545|NCT01614795|515483745|FG003|Overall Study|Adverse Event|1|||
142985546|NCT01614795|515483742|FG000|Overall Study|Lack of Efficacy|10|||
142985547|NCT01614795|515483743|FG001|Overall Study|Lack of Efficacy|10|||
142985548|NCT01614795|515483744|FG002|Overall Study|Lack of Efficacy|9|||
142985549|NCT01614795|515483745|FG003|Overall Study|Lack of Efficacy|8|||
142985550|NCT01614795|515483742|FG000|Overall Study|Physician Decision|1|||
142985551|NCT01614795|515483743|FG001|Overall Study|Physician Decision|0|||
142985552|NCT01614795|515483744|FG002|Overall Study|Physician Decision|1|||
142985553|NCT01614795|515483745|FG003|Overall Study|Physician Decision|1|||
142985554|NCT01614795|515483742|FG000|Overall Study|Withdrawal by Subject|0|||
142985555|NCT01614795|515483743|FG001|Overall Study|Withdrawal by Subject|1|||
142985556|NCT01614795|515483744|FG002|Overall Study|Withdrawal by Subject|0|||
142985557|NCT01614795|515483745|FG003|Overall Study|Withdrawal by Subject|2|||
142985558|NCT01614795|515483742|FG000|Overall Study|Ineligible|0|||
142985559|NCT01614795|515483743|FG001|Overall Study|Ineligible|1|||
142985560|NCT01614795|515483744|FG002|Overall Study|Ineligible|0|||
142985561|NCT01614795|515483745|FG003|Overall Study|Ineligible|0|||
142985562|NCT00179517|515483751|FG000|Overall Study|Withdrawal by Subject|2|||
142985563|NCT00179517|515483752|FG001|Overall Study|Withdrawal by Subject|1|||
142985564|NCT00023712|515483753|FG000|Overall Study|Not platinum sensitive|1|||
142985565|NCT00023712|515483754|FG001|Overall Study|Not platinum sensitive|0|||
142985566|NCT00023712|515483753|FG000|Overall Study|Never treated|1|||
142985567|NCT00023712|515483754|FG001|Overall Study|Never treated|1|||
142985568|NCT01390038|515483763|FG000|Overall Study|Death|1|||
142985569|NCT01390038|515483763|FG000|Overall Study|Lost to Follow-up|1|||
142985570|NCT01390038|515483763|FG000|Overall Study|Withdrawal by Subject|4|||
142985571|NCT01390038|515483763|FG000|Overall Study|Simpliciti System Removal|2|||
142985572|NCT01927068|515483764|FG000|Overall Study|Death|37|||
142985573|NCT01927068|515483765|FG001|Overall Study|Death|3|||
142985574|NCT01927068|515483764|FG000|Overall Study|Withdrawal by Subject|50|||
142985575|NCT01927068|515483765|FG001|Overall Study|Withdrawal by Subject|3|||
142985576|NCT01927068|515483764|FG000|Overall Study|Lost to Follow-up|10|||
142985577|NCT01927068|515483765|FG001|Overall Study|Lost to Follow-up|2|||
142985578|NCT01927068|515483764|FG000|Overall Study|Physician Decision|9|||
142985579|NCT01927068|515483765|FG001|Overall Study|Physician Decision|0|||
142985580|NCT01927068|515483764|FG000|Overall Study|Missed last follow-up visit|2|||
142985581|NCT01927068|515483765|FG001|Overall Study|Missed last follow-up visit|0|||
142985582|NCT02963766|515483767|FG000|Double-Blind Period|Adverse Event|1|||
142985583|NCT02963766|515483768|FG001|Double-Blind Period|Adverse Event|0|||
142985584|NCT02963766|515483769|FG002|Double-Blind Period|Adverse Event|1|||
142985585|NCT02963766|515483767|FG000|Double-Blind Period|Physician Decision|1|||
142985586|NCT02963766|515483768|FG001|Double-Blind Period|Physician Decision|0|||
142985587|NCT02963766|515483769|FG002|Double-Blind Period|Physician Decision|0|||
142985588|NCT02963766|515483767|FG000|Double-Blind Period|Withdrawal by Subject|1|||
142985589|NCT02963766|515483768|FG001|Double-Blind Period|Withdrawal by Subject|1|||
142985590|NCT02963766|515483769|FG002|Double-Blind Period|Withdrawal by Subject|0|||
142985591|NCT02963766|515483767|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
142985592|NCT02963766|515483768|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
142985593|NCT02963766|515483769|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
142985594|NCT02963766|515483767|FG000|Double-Blind Period|Protocol Violation|1|||
142985595|NCT02963766|515483768|FG001|Double-Blind Period|Protocol Violation|0|||
142985596|NCT02963766|515483769|FG002|Double-Blind Period|Protocol Violation|0|||
142985597|NCT02963766|515483767|FG000|Double-Blind Period|Lost to Follow-up|0|||
142985598|NCT02963766|515483768|FG001|Double-Blind Period|Lost to Follow-up|1|||
142985599|NCT02963766|515483769|FG002|Double-Blind Period|Lost to Follow-up|0|||
142985600|NCT02963766|515483767|FG000|Open Label Extension (OLE)|Physician Decision|1|||
142985601|NCT02963766|515483768|FG001|Open Label Extension (OLE)|Physician Decision|2|||
142985602|NCT02963766|515483769|FG002|Open Label Extension (OLE)|Physician Decision|2|||
142985603|NCT02963766|515483767|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
142985604|NCT02963766|515483768|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
142985605|NCT02963766|515483769|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
142985606|NCT02224274|515483773|FG000|Overall Study|Death|1|||
142985607|NCT02224274|515483774|FG001|Overall Study|Death|0|||
142985608|NCT00814307|515483775|FG000|Overall Study|Randomized but not treated|1|||
142985609|NCT00814307|515483776|FG001|Overall Study|Randomized but not treated|0|||
142985610|NCT00814307|515483777|FG002|Overall Study|Randomized but not treated|0|||
142985611|NCT00814307|515483778|FG003|Overall Study|Randomized but not treated|0|||
142985612|NCT00814307|515483775|FG000|Overall Study|Adverse Event|3|||
142985613|NCT00814307|515483776|FG001|Overall Study|Adverse Event|9|||
142985614|NCT00814307|515483777|FG002|Overall Study|Adverse Event|3|||
142985615|NCT00814307|515483778|FG003|Overall Study|Adverse Event|2|||
142985616|NCT00814307|515483775|FG000|Overall Study|Lack of Efficacy|1|||
142985617|NCT00814307|515483776|FG001|Overall Study|Lack of Efficacy|1|||
142985618|NCT00814307|515483777|FG002|Overall Study|Lack of Efficacy|3|||
142985619|NCT00814307|515483778|FG003|Overall Study|Lack of Efficacy|4|||
142985620|NCT00814307|515483775|FG000|Overall Study|Other|1|||
142985621|NCT00814307|515483776|FG001|Overall Study|Other|2|||
142985622|NCT00814307|515483777|FG002|Overall Study|Other|0|||
142985623|NCT00814307|515483778|FG003|Overall Study|Other|1|||
142985624|NCT00814307|515483775|FG000|Overall Study|Protocol Violation|2|||
142985625|NCT00814307|515483776|FG001|Overall Study|Protocol Violation|8|||
142985626|NCT00814307|515483777|FG002|Overall Study|Protocol Violation|1|||
142985627|NCT00814307|515483778|FG003|Overall Study|Protocol Violation|1|||
142985628|NCT00814307|515483775|FG000|Overall Study|Withdrawal by Subject|4|||
142985629|NCT00814307|515483776|FG001|Overall Study|Withdrawal by Subject|6|||
142985630|NCT00814307|515483777|FG002|Overall Study|Withdrawal by Subject|0|||
142985631|NCT00814307|515483778|FG003|Overall Study|Withdrawal by Subject|2|||
142985632|NCT00814307|515483775|FG000|Overall Study|Death|0|||
142985633|NCT00814307|515483776|FG001|Overall Study|Death|1|||
142985634|NCT00814307|515483777|FG002|Overall Study|Death|0|||
142985635|NCT00814307|515483778|FG003|Overall Study|Death|0|||
142985636|NCT02571972|515483783|FG000|Overall Study|Protocol Violation|2|||
142985637|NCT02571972|515483783|FG000|Overall Study|Withdrawal by Subject|2|||
142985638|NCT03039192|515483786|FG000|Overall Study|Lost to Follow-up|4|||
142985639|NCT03039192|515483787|FG001|Overall Study|Lost to Follow-up|4|||
142985640|NCT03039192|515483786|FG000|Overall Study|Adverse event, serious fatal|0|||
142985641|NCT03039192|515483787|FG001|Overall Study|Adverse event, serious fatal|1|||
142985642|NCT03039192|515483786|FG000|Overall Study|Adverse event, non-fatal|0|||
142985643|NCT03039192|515483787|FG001|Overall Study|Adverse event, non-fatal|2|||
142985644|NCT03039192|515483786|FG000|Overall Study|Withdrawal by Subject|6|||
142985645|NCT03039192|515483787|FG001|Overall Study|Withdrawal by Subject|9|||
142985646|NCT03039192|515483786|FG000|Overall Study|Discontinued from treatment phase|19|||
142985647|NCT03039192|515483787|FG001|Overall Study|Discontinued from treatment phase|12|||
142985648|NCT03039192|515483786|FG000|Overall Study|Other|3|||
142985649|NCT03039192|515483787|FG001|Overall Study|Other|2|||
142985650|NCT02177812|515483788|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
142985651|NCT02177812|515483789|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
142985652|NCT02177812|515483790|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
142985653|NCT02177812|515483791|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
142985654|NCT02177812|515483792|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
142985655|NCT02177812|515483793|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
142985656|NCT02177812|515483794|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
142985657|NCT02177812|515483795|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
142985658|NCT02177812|515483796|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
142985659|NCT02177812|515483788|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
142985660|NCT02177812|515483789|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
142985661|NCT02177812|515483790|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
142985662|NCT02177812|515483791|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
142985663|NCT02177812|515483792|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
142985664|NCT02177812|515483793|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
142985665|NCT02177812|515483794|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
142985666|NCT02177812|515483795|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
142985667|NCT02177812|515483796|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
142985668|NCT02177812|515483788|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
142985669|NCT02177812|515483789|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
142985670|NCT02177812|515483790|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
142985671|NCT02177812|515483791|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
142985672|NCT02177812|515483792|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
142985673|NCT02177812|515483793|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
142985674|NCT02177812|515483794|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
142985675|NCT02177812|515483795|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
142985676|NCT02177812|515483796|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
142985677|NCT00089999|515483797|FG000|Overall Study|Adverse Event|4|||
142985678|NCT00089999|515483798|FG001|Overall Study|Adverse Event|7|||
142985679|NCT00089999|515483797|FG000|Overall Study|Withdrawal by Subject|0|||
142985680|NCT00089999|515483798|FG001|Overall Study|Withdrawal by Subject|4|||
142985681|NCT00089999|515483797|FG000|Overall Study|Lost to Follow-up|2|||
142985682|NCT00089999|515483798|FG001|Overall Study|Lost to Follow-up|1|||
142985683|NCT00089999|515483797|FG000|Overall Study|Radiological Progression of Cancer|52|||
142985684|NCT00089999|515483798|FG001|Overall Study|Radiological Progression of Cancer|44|||
142985685|NCT00089999|515483797|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
142985686|NCT00089999|515483798|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
142985687|NCT00089999|515483797|FG000|Overall Study|Death|3|||
142985688|NCT00089999|515483798|FG001|Overall Study|Death|3|||
142985689|NCT00089999|515483797|FG000|Overall Study|Poor General Condition|1|||
142985690|NCT00089999|515483798|FG001|Overall Study|Poor General Condition|0|||
142985691|NCT00089999|515483797|FG000|Overall Study|Clinical Progression|1|||
142985692|NCT00089999|515483798|FG001|Overall Study|Clinical Progression|2|||
142985693|NCT00089999|515483797|FG000|Overall Study|Physician Decision|2|||
142985694|NCT00089999|515483798|FG001|Overall Study|Physician Decision|2|||
142985695|NCT00089999|515483797|FG000|Overall Study|Patient Underwent Surgery|2|||
142985696|NCT00089999|515483798|FG001|Overall Study|Patient Underwent Surgery|0|||
142985697|NCT00089999|515483797|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
142985698|NCT00089999|515483798|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
142985699|NCT03039569|515483799|FG000|Overall Study|Lost to Follow-up|5|||
142985700|NCT03039569|515483800|FG001|Overall Study|Lost to Follow-up|4|||
142985701|NCT00098865|515485859|FG000|Overall Study|Progressive Disease|6|||
142985702|NCT00098865|515485859|FG000|Overall Study|Adverse Event|2|||
142985703|NCT00098865|515485859|FG000|Overall Study|Alternative Therapy|1|||
142985704|NCT03050307|515485860|FG000|Overall Study|Adverse Event|4|||
142985705|NCT03050307|515485861|FG001|Overall Study|Adverse Event|2|||
142985706|NCT03050307|515485860|FG000|Overall Study|Significant Protocol Deviation|0|||
142985707|NCT03050307|515485861|FG001|Overall Study|Significant Protocol Deviation|1|||
142985708|NCT03050307|515485860|FG000|Overall Study|Lost to Follow-up|0|||
142985709|NCT03050307|515485861|FG001|Overall Study|Lost to Follow-up|1|||
142985710|NCT03050307|515485860|FG000|Overall Study|Voluntary Withdrawal|3|||
142985711|NCT03050307|515485861|FG001|Overall Study|Voluntary Withdrawal|4|||
142985712|NCT03050307|515485860|FG000|Overall Study|Reason not Specified|1|||
142985713|NCT03050307|515485861|FG001|Overall Study|Reason not Specified|1|||
142985714|NCT00430027|515485862|FG000|Overall Study|Study terminated|8|||
142985715|NCT00464620|515485863|FG000|Overall Study|Physician Decision|1|||
142985716|NCT00464620|515485864|FG001|Overall Study|Physician Decision|0|||
142985717|NCT00464620|515485865|FG002|Overall Study|Physician Decision|0|||
142985718|NCT00464620|515485863|FG000|Overall Study|Withdrawal by Subject|1|||
142985719|NCT00464620|515485864|FG001|Overall Study|Withdrawal by Subject|0|||
142985720|NCT00464620|515485865|FG002|Overall Study|Withdrawal by Subject|3|||
142985721|NCT00464620|515485863|FG000|Overall Study|Ineligible sarcoma subtype|0|||
142985722|NCT00464620|515485864|FG001|Overall Study|Ineligible sarcoma subtype|2|||
142985723|NCT00464620|515485865|FG002|Overall Study|Ineligible sarcoma subtype|2|||
142985724|NCT00464620|515485863|FG000|Overall Study|Use of prohibited concomitant medication|0|||
142985725|NCT00464620|515485864|FG001|Overall Study|Use of prohibited concomitant medication|0|||
142985726|NCT00464620|515485865|FG002|Overall Study|Use of prohibited concomitant medication|2|||
142985727|NCT04984876|515485870|FG000|Overall Study|Subject decision|2|||
142985728|NCT04984876|515485871|FG001|Overall Study|Subject decision|10|||
142985729|NCT04984876|515485872|FG002|Overall Study|Subject decision|3|||
142985730|NCT04984876|515485873|FG003|Overall Study|Subject decision|3|||
142985731|NCT04984876|515485874|FG004|Overall Study|Subject decision|3|||
142985732|NCT04984876|515485875|FG005|Overall Study|Subject decision|0|||
142985733|NCT04984876|515485870|FG000|Overall Study|Guardian decision|0|||
142985734|NCT04984876|515485871|FG001|Overall Study|Guardian decision|1|||
142985735|NCT04984876|515485872|FG002|Overall Study|Guardian decision|0|||
142985736|NCT04984876|515485873|FG003|Overall Study|Guardian decision|2|||
142985737|NCT04984876|515485874|FG004|Overall Study|Guardian decision|0|||
142985738|NCT04984876|515485875|FG005|Overall Study|Guardian decision|1|||
142985739|NCT04984876|515485870|FG000|Overall Study|Lost to Follow-up|0|||
142985740|NCT04984876|515485871|FG001|Overall Study|Lost to Follow-up|0|||
142985741|NCT04984876|515485872|FG002|Overall Study|Lost to Follow-up|1|||
142985742|NCT04984876|515485873|FG003|Overall Study|Lost to Follow-up|1|||
142985743|NCT04984876|515485874|FG004|Overall Study|Lost to Follow-up|0|||
142985744|NCT04984876|515485875|FG005|Overall Study|Lost to Follow-up|0|||
142985745|NCT04984876|515485870|FG000|Overall Study|Physician Decision|1|||
142985746|NCT04984876|515485871|FG001|Overall Study|Physician Decision|0|||
142985747|NCT04984876|515485872|FG002|Overall Study|Physician Decision|0|||
142985748|NCT04984876|515485873|FG003|Overall Study|Physician Decision|1|||
142985749|NCT04984876|515485874|FG004|Overall Study|Physician Decision|0|||
142985750|NCT04984876|515485875|FG005|Overall Study|Physician Decision|0|||
142985751|NCT04984876|515485870|FG000|Overall Study|Adverse Event|0|||
142985752|NCT04984876|515485871|FG001|Overall Study|Adverse Event|0|||
142985753|NCT04984876|515485872|FG002|Overall Study|Adverse Event|1|||
142985754|NCT04984876|515485873|FG003|Overall Study|Adverse Event|0|||
142985755|NCT04984876|515485874|FG004|Overall Study|Adverse Event|0|||
142985756|NCT04984876|515485875|FG005|Overall Study|Adverse Event|0|||
142985757|NCT02204410|515485876|FG000|Overall Study|Lost to Follow-up|5|||
142985758|NCT02204410|515485876|FG000|Overall Study|Physician Decision|2|||
142985759|NCT02204410|515485876|FG000|Overall Study|Protocol Violation|1|||
142985760|NCT02204410|515485876|FG000|Overall Study|Withdrawal by Subject|3|||
142985761|NCT00209092|515485883|FG000|Overall Study|Progression of disease|7|||
142985762|NCT00209092|515485884|FG001|Overall Study|Progression of disease|1|||
142985763|NCT00209092|515485883|FG000|Overall Study|Adverse Event|0|||
142985764|NCT00209092|515485884|FG001|Overall Study|Adverse Event|1|||
142985765|NCT00209092|515485883|FG000|Overall Study|Withdrawal by Subject|1|||
142985766|NCT00209092|515485884|FG001|Overall Study|Withdrawal by Subject|0|||
142985767|NCT02828644|515485887|FG000|Overall Study|Lost to Follow-up|23|||
142985768|NCT02828644|515485888|FG001|Overall Study|Lost to Follow-up|22|||
142985769|NCT02996110|515485889|FG000|Pre-Treatment|Other Reasons|0|||
142985770|NCT02996110|515485890|FG001|Pre-Treatment|Other Reasons|1|||
142985771|NCT02996110|515485891|FG002|Pre-Treatment|Other Reasons|0|||
142985772|NCT02996110|515485892|FG003|Pre-Treatment|Other Reasons|0|||
142985773|NCT02996110|515485893|FG004|Pre-Treatment|Other Reasons|1|||
142985774|NCT02996110|515485889|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
142985775|NCT02996110|515485890|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
142985776|NCT02996110|515485891|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
142985777|NCT02996110|515485892|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
142985778|NCT02996110|515485893|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
142985779|NCT02996110|515485889|FG000|Track 1|Disease Progression|15|||
142985780|NCT02996110|515485890|FG001|Track 1|Disease Progression|17|||
142985781|NCT02996110|515485891|FG002|Track 1|Disease Progression|0|||
142985782|NCT02996110|515485892|FG003|Track 1|Disease Progression|0|||
142985783|NCT02996110|515485893|FG004|Track 1|Disease Progression|0|||
142985784|NCT02996110|515485889|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
142985785|NCT02996110|515485890|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
142985786|NCT02996110|515485891|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
142985787|NCT02996110|515485892|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
142985788|NCT02996110|515485893|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
142985789|NCT02996110|515485889|FG000|Track 1|Study Drug Toxicity|5|||
142985790|NCT02996110|515485890|FG001|Track 1|Study Drug Toxicity|3|||
142985791|NCT02996110|515485891|FG002|Track 1|Study Drug Toxicity|0|||
142985792|NCT02996110|515485892|FG003|Track 1|Study Drug Toxicity|0|||
142985793|NCT02996110|515485893|FG004|Track 1|Study Drug Toxicity|0|||
142985794|NCT02996110|515485889|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
142985795|NCT02996110|515485890|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
142985796|NCT02996110|515485891|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
142985797|NCT02996110|515485892|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
142985798|NCT02996110|515485893|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
142985799|NCT02996110|515485889|FG000|Track 1|Administrative Reason by Sponsor|0|||
142985800|NCT02996110|515485890|FG001|Track 1|Administrative Reason by Sponsor|1|||
142985801|NCT02996110|515485891|FG002|Track 1|Administrative Reason by Sponsor|0|||
142985802|NCT02996110|515485892|FG003|Track 1|Administrative Reason by Sponsor|0|||
142985803|NCT02996110|515485893|FG004|Track 1|Administrative Reason by Sponsor|0|||
142985804|NCT02996110|515485889|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
142985805|NCT02996110|515485890|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
142985806|NCT02996110|515485891|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
142985807|NCT02996110|515485892|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
142985808|NCT02996110|515485893|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
142985809|NCT02996110|515485889|FG000|Track 2|Disease Progression|33|||
142985810|NCT02996110|515485890|FG001|Track 2|Disease Progression|26|||
142985811|NCT02996110|515485891|FG002|Track 2|Disease Progression|19|||
142985812|NCT02996110|515485892|FG003|Track 2|Disease Progression|16|||
142985813|NCT02996110|515485893|FG004|Track 2|Disease Progression|15|||
142985814|NCT02996110|515485889|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
142985815|NCT02996110|515485890|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
142985816|NCT02996110|515485891|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
142985817|NCT02996110|515485892|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
142985818|NCT02996110|515485893|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
142985819|NCT02996110|515485889|FG000|Track 2|Death|0|||
142985820|NCT02996110|515485890|FG001|Track 2|Death|0|||
142985821|NCT02996110|515485891|FG002|Track 2|Death|1|||
142985822|NCT02996110|515485892|FG003|Track 2|Death|0|||
142985823|NCT02996110|515485893|FG004|Track 2|Death|1|||
142985824|NCT02996110|515485889|FG000|Track 2|Study Drug Toxicity|4|||
142985825|NCT02996110|515485890|FG001|Track 2|Study Drug Toxicity|1|||
142985826|NCT02996110|515485891|FG002|Track 2|Study Drug Toxicity|4|||
142985827|NCT02996110|515485892|FG003|Track 2|Study Drug Toxicity|1|||
142985828|NCT02996110|515485893|FG004|Track 2|Study Drug Toxicity|0|||
142985829|NCT02996110|515485889|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
142985830|NCT02996110|515485890|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
142985831|NCT02996110|515485891|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
142985832|NCT02996110|515485892|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
142985833|NCT02996110|515485893|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
142985834|NCT02996110|515485889|FG000|Track 2|Participant Withdrew Consent|1|||
142985835|NCT02996110|515485890|FG001|Track 2|Participant Withdrew Consent|2|||
142985836|NCT02996110|515485891|FG002|Track 2|Participant Withdrew Consent|3|||
142985837|NCT02996110|515485892|FG003|Track 2|Participant Withdrew Consent|1|||
142985838|NCT02996110|515485893|FG004|Track 2|Participant Withdrew Consent|1|||
142985839|NCT02996110|515485889|FG000|Track 2|Other Reasons|0|||
142985840|NCT02996110|515485890|FG001|Track 2|Other Reasons|0|||
142985841|NCT02996110|515485891|FG002|Track 2|Other Reasons|1|||
142985842|NCT02996110|515485892|FG003|Track 2|Other Reasons|0|||
142985843|NCT02996110|515485893|FG004|Track 2|Other Reasons|1|||
142985844|NCT01938391|515485894|FG000|6 Month Follow up|Withdrawal by Subject|1|||
142985845|NCT01938391|515485894|FG000|12 Month Follow up|Physician Decision|1|||
142985846|NCT01938391|515485894|FG000|12 Month Follow up|Withdrawal by Subject|1|||
142985847|NCT01077193|515485895|FG000|Overall Study|Lost to Follow-up|1|||
142985848|NCT01077193|515485895|FG000|Overall Study|Withdrawal by Subject|2|||
142985849|NCT01077193|515485895|FG000|Overall Study|Lack of Efficacy|1|||
142985850|NCT01077193|515485895|FG000|Overall Study|Study Terminated by Sponsor|40|||
142985851|NCT02234050|515485908|FG000|Overall Study|Lack of Efficacy|38|||
142985852|NCT02234050|515485909|FG001|Overall Study|Lack of Efficacy|22|||
142985853|NCT02234050|515485908|FG000|Overall Study|Adverse Event|13|||
142985854|NCT02234050|515485909|FG001|Overall Study|Adverse Event|1|||
142985855|NCT02234050|515485908|FG000|Overall Study|Withdrawal by Subject|4|||
142985856|NCT02234050|515485909|FG001|Overall Study|Withdrawal by Subject|2|||
142985857|NCT02234050|515485908|FG000|Overall Study|Sponsor's decision|6|||
142985858|NCT02234050|515485909|FG001|Overall Study|Sponsor's decision|0|||
142985859|NCT01680991|515485913|FG000|Overall Study|Adverse Event|1|||
142985860|NCT01680991|515485914|FG001|Overall Study|Adverse Event|0|||
142985861|NCT01680991|515485915|FG002|Overall Study|Adverse Event|0|||
142985862|NCT01680991|515485913|FG000|Overall Study|Death|1|||
142985863|NCT01680991|515485914|FG001|Overall Study|Death|0|||
142985864|NCT01680991|515485915|FG002|Overall Study|Death|1|||
142985865|NCT01680991|515485913|FG000|Overall Study|Protocol Violation|0|||
142985866|NCT01680991|515485914|FG001|Overall Study|Protocol Violation|1|||
142985867|NCT01680991|515485915|FG002|Overall Study|Protocol Violation|0|||
142985868|NCT01680991|515485913|FG000|Overall Study|Withdrawal by Subject|5|||
142985869|NCT01680991|515485914|FG001|Overall Study|Withdrawal by Subject|1|||
142985870|NCT01680991|515485915|FG002|Overall Study|Withdrawal by Subject|0|||
142985871|NCT01680991|515485913|FG000|Overall Study|Progressive disease (PD)|0|||
142985872|NCT01680991|515485914|FG001|Overall Study|Progressive disease (PD)|10|||
142985873|NCT01680991|515485915|FG002|Overall Study|Progressive disease (PD)|0|||
142985874|NCT01680991|515485913|FG000|Overall Study|Physician Decision|0|||
142985875|NCT01680991|515485914|FG001|Overall Study|Physician Decision|7|||
142985876|NCT01680991|515485915|FG002|Overall Study|Physician Decision|2|||
142985877|NCT01680991|515485913|FG000|Overall Study|Bad physical condition|0|||
142985878|NCT01680991|515485914|FG001|Overall Study|Bad physical condition|0|||
142985879|NCT01680991|515485915|FG002|Overall Study|Bad physical condition|1|||
142985880|NCT01680991|515485913|FG000|Overall Study|PD confirmed in other hospital|1|||
142985881|NCT01680991|515485914|FG001|Overall Study|PD confirmed in other hospital|0|||
142985882|NCT01680991|515485915|FG002|Overall Study|PD confirmed in other hospital|0|||
142985883|NCT04097028|515485916|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
142985884|NCT04097028|515485916|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
142985885|NCT04097028|515485916|FG000|Overall Study|Disease Progression prior to Surgery|2|||
142985886|NCT04097028|515485916|FG000|Overall Study|Adverse Event prior to Surgery|1|||
142985887|NCT06073054|515485917|FG000|Overall Study|Withdrawal by Subject|2|||
142985888|NCT03149029|515485918|FG000|Overall Study|Adverse Event|2|||
142985889|NCT03149029|515485919|FG001|Overall Study|Adverse Event|0|||
142985890|NCT03687827|515485920|FG000|Treatment Period 1|Death|0|||
142985891|NCT03687827|515485921|FG001|Treatment Period 1|Death|1|||
142985892|NCT03687827|515485920|FG000|Treatment Period 1|Lost to Follow-up|2|||
142985893|NCT03687827|515485921|FG001|Treatment Period 1|Lost to Follow-up|2|||
142985894|NCT03687827|515485920|FG000|Treatment Period 1|Physician Decision|5|||
142985895|NCT03687827|515485921|FG001|Treatment Period 1|Physician Decision|2|||
142985896|NCT03687827|515485920|FG000|Treatment Period 1|Withdrawal by Subject|7|||
142985897|NCT03687827|515485921|FG001|Treatment Period 1|Withdrawal by Subject|3|||
142985898|NCT03687827|515485920|FG000|Treatment Period 2|Physician Decision|4|||
142985899|NCT03687827|515485921|FG001|Treatment Period 2|Physician Decision|1|||
142985900|NCT03687827|515485920|FG000|Treatment Period 2|Withdrawal by Subject|1|||
142985901|NCT03687827|515485921|FG001|Treatment Period 2|Withdrawal by Subject|2|||
142985902|NCT00068822|515485922|FG000|First Randomized Intervention|Lost to Follow-up|1|||
142985903|NCT00068822|515485923|FG001|First Randomized Intervention|Lost to Follow-up|2|||
142985904|NCT00981292|515485928|FG000|Day 1|Protocol Violation|1|||
142985905|NCT00981292|515485929|FG001|Day 1|Protocol Violation|0|||
142985906|NCT00981292|515485930|FG002|Day 1|Protocol Violation|0|||
142985907|NCT00981292|515485931|FG003|Day 1|Protocol Violation|0|||
142985908|NCT00981292|515485932|FG004|Day 1|Protocol Violation|0|||
142985909|NCT00981292|515485933|FG005|Day 1|Protocol Violation|2|||
142985910|NCT00981292|515485928|FG000|Day 2|Protocol Violation|2|||
142985911|NCT00981292|515485929|FG001|Day 2|Protocol Violation|0|||
142985912|NCT00981292|515485930|FG002|Day 2|Protocol Violation|0|||
142985913|NCT00981292|515485931|FG003|Day 2|Protocol Violation|0|||
142985914|NCT00981292|515485932|FG004|Day 2|Protocol Violation|0|||
142985915|NCT00981292|515485933|FG005|Day 2|Protocol Violation|0|||
142985916|NCT00981292|515485928|FG000|Day 3|Protocol Violation|0|||
142985917|NCT00981292|515485929|FG001|Day 3|Protocol Violation|0|||
142985918|NCT00981292|515485930|FG002|Day 3|Protocol Violation|0|||
143117229|NCT00787917|515970070|FG001|Open Label|Administrative problems|0|||
142985919|NCT00981292|515485931|FG003|Day 3|Protocol Violation|0|||
142985920|NCT00981292|515485932|FG004|Day 3|Protocol Violation|0|||
142985921|NCT00981292|515485933|FG005|Day 3|Protocol Violation|1|||
142985922|NCT02565576|515485934|FG000|Overall Study|abnormal lab value|2|||
142985923|NCT02565576|515485935|FG001|Overall Study|abnormal lab value|0|||
142985924|NCT02565576|515485934|FG000|Overall Study|subject / guardian decision|1|||
142985925|NCT02565576|515485935|FG001|Overall Study|subject / guardian decision|3|||
142985926|NCT02565576|515485934|FG000|Overall Study|Lost to Follow-up|1|||
142985927|NCT02565576|515485935|FG001|Overall Study|Lost to Follow-up|0|||
142985928|NCT02565576|515485934|FG000|Overall Study|Death|0|||
142985929|NCT02565576|515485935|FG001|Overall Study|Death|2|||
142985930|NCT02565576|515485934|FG000|Overall Study|Adverse Event|1|||
142985931|NCT02565576|515485935|FG001|Overall Study|Adverse Event|0|||
142985932|NCT00939341|515485936|FG000|Overall Study|Adverse Event|15|||
142985933|NCT00939341|515485936|FG000|Overall Study|Pregnancy|1|||
142985934|NCT00939341|515485936|FG000|Overall Study|Lost to Follow-up|23|||
142985935|NCT00939341|515485936|FG000|Overall Study|Withdrawal by Subject|13|||
142985936|NCT00939341|515485936|FG000|Overall Study|Protocol Violation|6|||
142985937|NCT00939341|515485936|FG000|Overall Study|Incorrect enrolment|8|||
142985938|NCT01408732|515485937|FG000|Overall Study|Withdrawal by Subject|2|||
142985939|NCT01408732|515485938|FG001|Overall Study|Withdrawal by Subject|2|||
142985940|NCT00424099|515485939|FG000|Overall Study|Adverse Event|0|||
142985941|NCT00424099|515485940|FG001|Overall Study|Adverse Event|1|||
142985942|NCT00424099|515485941|FG002|Overall Study|Adverse Event|1|||
142985943|NCT00424099|515485942|FG003|Overall Study|Adverse Event|0|||
142985944|NCT00424099|515485939|FG000|Overall Study|Death|0|||
142985945|NCT00424099|515485940|FG001|Overall Study|Death|1|||
142985946|NCT00424099|515485941|FG002|Overall Study|Death|0|||
142985947|NCT00424099|515485942|FG003|Overall Study|Death|0|||
142985948|NCT00424099|515485939|FG000|Overall Study|Illness|2|||
142985949|NCT00424099|515485940|FG001|Overall Study|Illness|0|||
142985950|NCT00424099|515485941|FG002|Overall Study|Illness|1|||
142985951|NCT00424099|515485942|FG003|Overall Study|Illness|4|||
142985952|NCT00424099|515485939|FG000|Overall Study|Lost to Follow-up|0|||
142985953|NCT00424099|515485940|FG001|Overall Study|Lost to Follow-up|0|||
142985954|NCT00424099|515485941|FG002|Overall Study|Lost to Follow-up|3|||
142985955|NCT00424099|515485942|FG003|Overall Study|Lost to Follow-up|0|||
142985956|NCT00424099|515485939|FG000|Overall Study|Hospitalized|1|||
142985957|NCT00424099|515485940|FG001|Overall Study|Hospitalized|2|||
142985958|NCT00424099|515485941|FG002|Overall Study|Hospitalized|1|||
142985959|NCT00424099|515485942|FG003|Overall Study|Hospitalized|3|||
142985960|NCT00424099|515485939|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
142985961|NCT00424099|515485940|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
142985962|NCT00424099|515485941|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
142985963|NCT00424099|515485942|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
142985964|NCT00424099|515485939|FG000|Overall Study|Withdrawal by Subject|1|||
142985965|NCT00424099|515485940|FG001|Overall Study|Withdrawal by Subject|9|||
142985966|NCT00424099|515485941|FG002|Overall Study|Withdrawal by Subject|4|||
142985967|NCT00424099|515485942|FG003|Overall Study|Withdrawal by Subject|6|||
142985968|NCT00424099|515485939|FG000|Overall Study|Physician Decision|0|||
142985969|NCT00424099|515485940|FG001|Overall Study|Physician Decision|0|||
142985970|NCT00424099|515485941|FG002|Overall Study|Physician Decision|1|||
142985971|NCT00424099|515485942|FG003|Overall Study|Physician Decision|0|||
142985972|NCT00424099|515485939|FG000|Overall Study|Missing|0|||
142985973|NCT00424099|515485940|FG001|Overall Study|Missing|0|||
142985974|NCT00424099|515485941|FG002|Overall Study|Missing|1|||
142985975|NCT00424099|515485942|FG003|Overall Study|Missing|0|||
142985976|NCT03377452|515485943|FG000|Overall Study|Refused assessment|0|||
142985977|NCT03377452|515485944|FG001|Overall Study|Refused assessment|2|||
142985978|NCT03377452|515485943|FG000|Overall Study|Lost to Follow-up|5|||
142985979|NCT03377452|515485944|FG001|Overall Study|Lost to Follow-up|4|||
142985980|NCT00764322|515485945|FG000|Overall Study|Withdrawal by Subject|11|||
142985981|NCT00764322|515485945|FG000|Overall Study|No CYP2D6 genotyping|9|||
142985982|NCT00796003|515485946|FG000|Overall Study|Disease Progression|2|||
142985983|NCT00796003|515485947|FG001|Overall Study|Disease Progression|13|||
142985984|NCT00796003|515485946|FG000|Overall Study|Adverse Event|1|||
142985985|NCT00796003|515485947|FG001|Overall Study|Adverse Event|7|||
142985986|NCT00796003|515485946|FG000|Overall Study|Specified organ function not met|0|||
142985987|NCT00796003|515485947|FG001|Overall Study|Specified organ function not met|1|||
142985988|NCT00796003|515485946|FG000|Overall Study|Physician Decision|0|||
142985989|NCT00796003|515485947|FG001|Overall Study|Physician Decision|4|||
142985990|NCT00796003|515485946|FG000|Overall Study|Withdrawal by Subject|0|||
142985991|NCT00796003|515485947|FG001|Overall Study|Withdrawal by Subject|1|||
142985992|NCT00796003|515485946|FG000|Overall Study|Other|0|||
142985993|NCT00796003|515485947|FG001|Overall Study|Other|1|||
142985994|NCT00796003|515485946|FG000|Overall Study|Participants Not treated|0|||
142985995|NCT00796003|515485947|FG001|Overall Study|Participants Not treated|2|||
142985996|NCT00246376|515485949|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
142985997|NCT00246376|515485950|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
142985998|NCT00246376|515485951|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
142985999|NCT00246376|515485952|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
142986000|NCT00246376|515485953|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
142986001|NCT00246376|515485949|FG000|Overall Study|Adverse Event|2|||
142986002|NCT00246376|515485950|FG001|Overall Study|Adverse Event|3|||
142986003|NCT00246376|515485951|FG002|Overall Study|Adverse Event|1|||
142986004|NCT00246376|515485952|FG003|Overall Study|Adverse Event|3|||
142986005|NCT00246376|515485953|FG004|Overall Study|Adverse Event|1|||
142986006|NCT00246376|515485949|FG000|Overall Study|Lost to Follow-up|2|||
142986007|NCT00246376|515485950|FG001|Overall Study|Lost to Follow-up|11|||
142986008|NCT00246376|515485951|FG002|Overall Study|Lost to Follow-up|11|||
142986009|NCT00246376|515485952|FG003|Overall Study|Lost to Follow-up|16|||
142986010|NCT00246376|515485953|FG004|Overall Study|Lost to Follow-up|13|||
142986011|NCT02465489|515485954|FG000|Overall Study|Adverse Event|5|||
142986012|NCT04599972|515485955|FG000|Overall Study|Withdrawal by Subject|6|||
142986013|NCT04599972|515485956|FG001|Overall Study|Withdrawal by Subject|1|||
142986014|NCT04599972|515485955|FG000|Overall Study|Adverse Event|1|||
142986015|NCT04599972|515485956|FG001|Overall Study|Adverse Event|1|||
142986016|NCT04599972|515485955|FG000|Overall Study|Lost to Follow-up|1|||
142986017|NCT04599972|515485956|FG001|Overall Study|Lost to Follow-up|6|||
142986018|NCT04599972|515485955|FG000|Overall Study|Protocol Violation|1|||
142986019|NCT04599972|515485956|FG001|Overall Study|Protocol Violation|0|||
142986020|NCT04599972|515485955|FG000|Overall Study|Other reason|1|||
142986021|NCT04599972|515485956|FG001|Overall Study|Other reason|0|||
142986022|NCT00638690|515485957|FG000|Overall Study|Death|655|||
142986023|NCT00638690|515485958|FG001|Overall Study|Death|335|||
142986024|NCT00638690|515485957|FG000|Overall Study|Withdrawal by Subject|22|||
142986025|NCT00638690|515485958|FG001|Overall Study|Withdrawal by Subject|5|||
142986026|NCT00638690|515485957|FG000|Overall Study|Lost to Follow-up|4|||
142986027|NCT00638690|515485958|FG001|Overall Study|Lost to Follow-up|2|||
142986028|NCT02348840|515485959|FG000|Overall Study|Withdrawal by Subject|2|||
142986029|NCT02348840|515485960|FG001|Overall Study|Withdrawal by Subject|1|||
142986030|NCT02348840|515485961|FG002|Overall Study|Withdrawal by Subject|0|||
142986031|NCT02348840|515485962|FG003|Overall Study|Withdrawal by Subject|0|||
142986032|NCT00373880|515485963|FG000|Overall Study|Physician Decision|3|||
142986033|NCT00373880|515485963|FG000|Overall Study|Arrested|1|||
142986034|NCT00373880|515485963|FG000|Overall Study|Protocol Violation|14|||
142986035|NCT01347073|515485964|FG000|Overall Study|Adverse Event|1|||
142986036|NCT01347073|515485964|FG000|Overall Study|Liver Transplant|1|||
142986037|NCT00621244|515485965|FG000|Overall Study|Withdrawal by Subject|7|||
142986038|NCT00621244|515485966|FG001|Overall Study|Withdrawal by Subject|3|||
142986039|NCT00621244|515485967|FG002|Overall Study|Withdrawal by Subject|3|||
142986040|NCT00621244|515485968|FG003|Overall Study|Withdrawal by Subject|3|||
142986041|NCT00621244|515485965|FG000|Overall Study|Disease progression|44|||
142986042|NCT00621244|515485966|FG001|Overall Study|Disease progression|20|||
142986043|NCT00621244|515485967|FG002|Overall Study|Disease progression|20|||
142986044|NCT00621244|515485968|FG003|Overall Study|Disease progression|15|||
142986045|NCT00621244|515485965|FG000|Overall Study|Death|3|||
142986046|NCT00621244|515485966|FG001|Overall Study|Death|3|||
142986047|NCT00621244|515485967|FG002|Overall Study|Death|1|||
142986048|NCT00621244|515485968|FG003|Overall Study|Death|1|||
142986049|NCT00621244|515485965|FG000|Overall Study|Adverse Event|27|||
142986050|NCT00621244|515485966|FG001|Overall Study|Adverse Event|7|||
142986051|NCT00621244|515485967|FG002|Overall Study|Adverse Event|9|||
142986052|NCT00621244|515485968|FG003|Overall Study|Adverse Event|2|||
142986053|NCT00621244|515485965|FG000|Overall Study|Administrative problems|5|||
142986054|NCT00621244|515485966|FG001|Overall Study|Administrative problems|1|||
142986055|NCT00621244|515485967|FG002|Overall Study|Administrative problems|0|||
142986056|NCT00621244|515485968|FG003|Overall Study|Administrative problems|2|||
142986057|NCT01690988|515485969|FG000|Overall Study|Withdrawal by Subject|2|||
142986058|NCT01690988|515485970|FG001|Overall Study|Withdrawal by Subject|2|||
142986059|NCT01690988|515485971|FG002|Overall Study|Withdrawal by Subject|3|||
142986060|NCT01690988|515485969|FG000|Overall Study|Physician Decision|0|||
142986061|NCT01690988|515485970|FG001|Overall Study|Physician Decision|0|||
142986062|NCT01690988|515485971|FG002|Overall Study|Physician Decision|1|||
142986063|NCT01690988|515485969|FG000|Overall Study|Operation Cancelled|1|||
142986064|NCT01690988|515485970|FG001|Overall Study|Operation Cancelled|1|||
142986065|NCT01690988|515485971|FG002|Overall Study|Operation Cancelled|0|||
142986066|NCT01690988|515485969|FG000|Overall Study|Determined ineligible|1|||
142986067|NCT01690988|515485970|FG001|Overall Study|Determined ineligible|0|||
142986068|NCT01690988|515485971|FG002|Overall Study|Determined ineligible|0|||
142986069|NCT01690988|515485969|FG000|Overall Study|Death|1|||
142986070|NCT01690988|515485970|FG001|Overall Study|Death|1|||
142986071|NCT01690988|515485971|FG002|Overall Study|Death|1|||
142986072|NCT01690988|515485969|FG000|Overall Study|Sedated|1|||
142986073|NCT01690988|515485970|FG001|Overall Study|Sedated|1|||
142986074|NCT01690988|515485971|FG002|Overall Study|Sedated|2|||
142986075|NCT03696576|515485974|FG000|Overall Study|Soreness of throat after therapy|1|||
142986076|NCT03696576|515485975|FG001|Overall Study|Soreness of throat after therapy|1|||
142986077|NCT03696576|515485974|FG000|Overall Study|Lost to Follow-up|2|||
142986078|NCT03696576|515485975|FG001|Overall Study|Lost to Follow-up|4|||
142986079|NCT00312728|515485976|FG000|Overall Study|Progressive disease|53|||
142986080|NCT00312728|515485976|FG000|Overall Study|Adverse Event|32|||
142986081|NCT00312728|515485976|FG000|Overall Study|Withdrawal by Subject|10|||
142986082|NCT00312728|515485976|FG000|Overall Study|Required non-protocol cancer treatment|2|||
142986083|NCT00312728|515485976|FG000|Overall Study|Protocol Violation|2|||
142986084|NCT00312728|515485976|FG000|Overall Study|Other|10|||
142986085|NCT00312728|515485976|FG000|Overall Study|Other|1|||
142986086|NCT01512693|515485985|FG000|Overall Study|Withdrawal by Subject|0|||
142986087|NCT01512693|515485986|FG001|Overall Study|Withdrawal by Subject|1|||
142986088|NCT00045630|515486001|FG000|Overall Study|Adverse Event|1|||
142986089|NCT00045630|515486001|FG000|Overall Study|Refusal unrelated to adverse event|1|||
142986090|NCT00045630|515486001|FG000|Overall Study|Progression/relapse|1|||
142986091|NCT00045630|515486001|FG000|Overall Study|Death|1|||
142986092|NCT00045630|515486001|FG000|Overall Study|Ineligible|2|||
142986093|NCT00981747|515486002|FG000|Losartan|Withdrawal by Subject|1|||
142986094|NCT00981747|515486002|FG000|Losartan|Death|1|||
142986095|NCT00981747|515486002|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
142986096|NCT00701103|515486003|FG000|Overall Study|Adverse Event|0|||
142986097|NCT00701103|515486004|FG001|Overall Study|Adverse Event|0|||
142986098|NCT00701103|515486005|FG002|Overall Study|Adverse Event|1|||
142986099|NCT00701103|515486006|FG003|Overall Study|Adverse Event|1|||
142986100|NCT00701103|515486007|FG004|Overall Study|Adverse Event|0|||
142986101|NCT00701103|515486008|FG005|Overall Study|Adverse Event|1|||
142986102|NCT00701103|515486009|FG006|Overall Study|Adverse Event|1|||
142986103|NCT00701103|515486010|FG007|Overall Study|Adverse Event|0|||
142986104|NCT00701103|515486011|FG008|Overall Study|Adverse Event|0|||
142986105|NCT00701103|515486012|FG009|Overall Study|Adverse Event|2|||
142986106|NCT00701103|515486013|FG010|Overall Study|Adverse Event|0|||
142986107|NCT00701103|515486003|FG000|Overall Study|Progressive Disease|5|||
142986108|NCT00701103|515486004|FG001|Overall Study|Progressive Disease|2|||
142986109|NCT00701103|515486005|FG002|Overall Study|Progressive Disease|6|||
142986110|NCT00701103|515486006|FG003|Overall Study|Progressive Disease|5|||
142986111|NCT00701103|515486007|FG004|Overall Study|Progressive Disease|6|||
142986112|NCT00701103|515486008|FG005|Overall Study|Progressive Disease|5|||
142986113|NCT00701103|515486009|FG006|Overall Study|Progressive Disease|7|||
142986114|NCT00701103|515486010|FG007|Overall Study|Progressive Disease|7|||
142986115|NCT00701103|515486011|FG008|Overall Study|Progressive Disease|8|||
142986116|NCT00701103|515486012|FG009|Overall Study|Progressive Disease|8|||
142986117|NCT00701103|515486013|FG010|Overall Study|Progressive Disease|11|||
142986118|NCT00701103|515486003|FG000|Overall Study|Withdrawal by Subject|0|||
142986119|NCT00701103|515486004|FG001|Overall Study|Withdrawal by Subject|1|||
142986120|NCT00701103|515486005|FG002|Overall Study|Withdrawal by Subject|1|||
142986121|NCT00701103|515486006|FG003|Overall Study|Withdrawal by Subject|0|||
142986122|NCT00701103|515486007|FG004|Overall Study|Withdrawal by Subject|0|||
142986123|NCT00701103|515486008|FG005|Overall Study|Withdrawal by Subject|0|||
142986124|NCT00701103|515486009|FG006|Overall Study|Withdrawal by Subject|0|||
142986125|NCT00701103|515486010|FG007|Overall Study|Withdrawal by Subject|0|||
142986126|NCT00701103|515486011|FG008|Overall Study|Withdrawal by Subject|0|||
142986127|NCT00701103|515486012|FG009|Overall Study|Withdrawal by Subject|0|||
142986128|NCT00701103|515486013|FG010|Overall Study|Withdrawal by Subject|0|||
142986129|NCT00701103|515486003|FG000|Overall Study|Other|0|||
142986130|NCT00701103|515486004|FG001|Overall Study|Other|0|||
142986131|NCT00701103|515486005|FG002|Overall Study|Other|0|||
142986132|NCT00701103|515486006|FG003|Overall Study|Other|0|||
142986133|NCT00701103|515486007|FG004|Overall Study|Other|0|||
142986134|NCT00701103|515486008|FG005|Overall Study|Other|0|||
142986135|NCT00701103|515486009|FG006|Overall Study|Other|0|||
142986136|NCT00701103|515486010|FG007|Overall Study|Other|0|||
142986137|NCT00701103|515486011|FG008|Overall Study|Other|1|||
142986138|NCT00701103|515486012|FG009|Overall Study|Other|1|||
142986139|NCT00701103|515486013|FG010|Overall Study|Other|0|||
142986140|NCT01448707|515486019|FG000|Overall Study|Adverse Event|3|||
142986141|NCT01448707|515486020|FG001|Overall Study|Adverse Event|1|||
142986142|NCT01448707|515486019|FG000|Overall Study|Lost to Follow-up|2|||
142986143|NCT01448707|515486020|FG001|Overall Study|Lost to Follow-up|6|||
142986144|NCT01448707|515486019|FG000|Overall Study|Withdrawal by Subject|6|||
142986145|NCT01448707|515486020|FG001|Overall Study|Withdrawal by Subject|7|||
142986146|NCT01448707|515486019|FG000|Overall Study|Other|7|||
142986147|NCT01448707|515486020|FG001|Overall Study|Other|4|||
142986148|NCT02033850|515486025|FG000|Overall Study|Death|1|||
142986149|NCT02033850|515486026|FG001|Overall Study|Death|0|||
142986150|NCT02033850|515486025|FG000|Overall Study|unrelated medical reason|1|||
142986151|NCT02033850|515486026|FG001|Overall Study|unrelated medical reason|1|||
142986152|NCT03215667|515486027|FG000|Overall Study|Physician Decision|4|||
142986153|NCT01810380|515486028|FG000|Overall Study|Randomised not treated|2|||
142986154|NCT01810380|515486029|FG001|Overall Study|Randomised not treated|1|||
142986155|NCT01810380|515486030|FG002|Overall Study|Randomised not treated|1|||
142986156|NCT01810380|515486028|FG000|Overall Study|Adverse Event|11|||
142986157|NCT01810380|515486029|FG001|Overall Study|Adverse Event|14|||
142986158|NCT01810380|515486030|FG002|Overall Study|Adverse Event|4|||
142986159|NCT01810380|515486028|FG000|Overall Study|Lack of Efficacy|24|||
142986160|NCT01810380|515486029|FG001|Overall Study|Lack of Efficacy|10|||
142986161|NCT01810380|515486030|FG002|Overall Study|Lack of Efficacy|11|||
142986162|NCT01810380|515486028|FG000|Overall Study|Protocol Violation|1|||
142986163|NCT01810380|515486029|FG001|Overall Study|Protocol Violation|0|||
142986164|NCT01810380|515486030|FG002|Overall Study|Protocol Violation|1|||
142986165|NCT01810380|515486028|FG000|Overall Study|Withdrawal by Subject|6|||
142986166|NCT01810380|515486029|FG001|Overall Study|Withdrawal by Subject|0|||
142986167|NCT01810380|515486030|FG002|Overall Study|Withdrawal by Subject|6|||
142986168|NCT01810380|515486028|FG000|Overall Study|Administrative or other reasons|11|||
143003175|NCT01049360|515548747|FG003|Period 2|Lack of Efficacy|0|||
142986169|NCT01810380|515486029|FG001|Overall Study|Administrative or other reasons|13|||
142986170|NCT01810380|515486030|FG002|Overall Study|Administrative or other reasons|9|||
142986171|NCT00441480|515486031|FG000|Overall Study|Protocol Violation|1|||
142986172|NCT00441480|515486032|FG001|Overall Study|Protocol Violation|1|||
142986173|NCT00441480|515486031|FG000|Overall Study|Withdrawal by Subject|2|||
142986174|NCT00441480|515486032|FG001|Overall Study|Withdrawal by Subject|3|||
142986175|NCT02623699|515486033|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
142986176|NCT02623699|515486034|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
142986177|NCT02623699|515486035|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
142986178|NCT02623699|515486036|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
142986179|NCT02623699|515486037|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
142986180|NCT02623699|515486038|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
142986181|NCT02623699|515486039|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
142986182|NCT02623699|515486040|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
142986183|NCT02623699|515486041|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
142986184|NCT02623699|515486042|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
142986185|NCT02623699|515486043|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
142986186|NCT02623699|515486044|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
142986187|NCT02623699|515486033|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
142986188|NCT02623699|515486034|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
142986189|NCT02623699|515486035|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
142986190|NCT02623699|515486036|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
142986191|NCT02623699|515486037|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
142986192|NCT02623699|515486038|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
142986193|NCT02623699|515486039|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
142986194|NCT02623699|515486040|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
142986195|NCT02623699|515486041|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
142986196|NCT02623699|515486042|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
142986197|NCT02623699|515486043|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
142986198|NCT02623699|515486044|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
142986199|NCT02623699|515486033|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
142986200|NCT02623699|515486034|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
142986201|NCT02623699|515486035|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
142986202|NCT02623699|515486036|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
142986203|NCT02623699|515486037|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
142986204|NCT02623699|515486038|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
142986205|NCT02623699|515486039|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
142986206|NCT02623699|515486040|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
142986207|NCT02623699|515486041|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
142986208|NCT02623699|515486042|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
142986209|NCT02623699|515486043|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
142986210|NCT02623699|515486044|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
142986211|NCT02623699|515486033|FG000|Part B (Up to 289 Days)|Death|0|||
142986212|NCT02623699|515486034|FG001|Part B (Up to 289 Days)|Death|0|||
142986213|NCT02623699|515486035|FG002|Part B (Up to 289 Days)|Death|0|||
142986214|NCT02623699|515486036|FG003|Part B (Up to 289 Days)|Death|0|||
142986215|NCT02623699|515486037|FG004|Part B (Up to 289 Days)|Death|0|||
142986216|NCT02623699|515486038|FG005|Part B (Up to 289 Days)|Death|1|||
142986217|NCT02623699|515486039|FG006|Part B (Up to 289 Days)|Death|1|||
142986218|NCT02623699|515486040|FG007|Part B (Up to 289 Days)|Death|0|||
142986219|NCT02623699|515486041|FG008|Part B (Up to 289 Days)|Death|1|||
142986220|NCT02623699|515486042|FG009|Part B (Up to 289 Days)|Death|0|||
142986221|NCT02623699|515486043|FG010|Part B (Up to 289 Days)|Death|0|||
142986222|NCT02623699|515486044|FG011|Part B (Up to 289 Days)|Death|0|||
142986223|NCT02623699|515486033|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
142986224|NCT02623699|515486034|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
142986225|NCT02623699|515486035|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
142986226|NCT02623699|515486036|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
142986227|NCT02623699|515486037|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
142986228|NCT02623699|515486038|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
142986229|NCT02623699|515486039|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
142986230|NCT02623699|515486040|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
142986231|NCT02623699|515486041|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
142986232|NCT02623699|515486042|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
142986233|NCT02623699|515486043|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
142986234|NCT02623699|515486044|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
142986235|NCT02623699|515486033|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
142986236|NCT02623699|515486034|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
142986237|NCT02623699|515486035|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
142986238|NCT02623699|515486036|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
142986239|NCT02623699|515486037|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
142986240|NCT02623699|515486038|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
142986241|NCT02623699|515486039|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
142986242|NCT02623699|515486040|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
142986243|NCT02623699|515486041|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
142986244|NCT02623699|515486042|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
142986245|NCT02623699|515486043|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
142986246|NCT02623699|515486044|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
142986247|NCT02623699|515486033|FG000|Part C (Up to 236 Days)|Death|0|||
142986248|NCT02623699|515486034|FG001|Part C (Up to 236 Days)|Death|0|||
142986249|NCT02623699|515486035|FG002|Part C (Up to 236 Days)|Death|0|||
142986250|NCT02623699|515486036|FG003|Part C (Up to 236 Days)|Death|0|||
142986251|NCT02623699|515486037|FG004|Part C (Up to 236 Days)|Death|0|||
142986252|NCT02623699|515486038|FG005|Part C (Up to 236 Days)|Death|0|||
142986253|NCT02623699|515486039|FG006|Part C (Up to 236 Days)|Death|0|||
142986254|NCT02623699|515486040|FG007|Part C (Up to 236 Days)|Death|0|||
142986255|NCT02623699|515486041|FG008|Part C (Up to 236 Days)|Death|0|||
142986256|NCT02623699|515486042|FG009|Part C (Up to 236 Days)|Death|0|||
142986257|NCT02623699|515486043|FG010|Part C (Up to 236 Days)|Death|0|||
142986258|NCT02623699|515486044|FG011|Part C (Up to 236 Days)|Death|1|||
142986259|NCT02623699|515486033|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
142986260|NCT02623699|515486034|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
142986261|NCT02623699|515486035|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
142986262|NCT02623699|515486036|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
142986263|NCT02623699|515486037|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
142986264|NCT02623699|515486038|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
142986265|NCT02623699|515486039|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
142986266|NCT02623699|515486040|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
142986267|NCT02623699|515486041|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
142986268|NCT02623699|515486042|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
142986269|NCT02623699|515486043|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
142986270|NCT02623699|515486044|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
142986271|NCT00033371|515486045|FG000|Overall Study|Adverse Event|1|||
142986272|NCT00033371|515486046|FG001|Overall Study|Adverse Event|5|||
142986273|NCT00033371|515486045|FG000|Overall Study|Lost to Follow-up|2|||
142986274|NCT00033371|515486046|FG001|Overall Study|Lost to Follow-up|1|||
142986275|NCT00033371|515486045|FG000|Overall Study|Withdrawal by Subject|3|||
142986276|NCT00033371|515486046|FG001|Overall Study|Withdrawal by Subject|3|||
142986277|NCT00033371|515486045|FG000|Overall Study|Disease Progression|0|||
142986278|NCT00033371|515486046|FG001|Overall Study|Disease Progression|1|||
142986279|NCT04489940|515486047|FG000|Overall Study|Other|2|||
142986280|NCT04489940|515486047|FG000|Overall Study|Withdrawal by Subject|2|||
142986281|NCT04489940|515486047|FG000|Overall Study|Death|5|||
142986282|NCT04489940|515486047|FG000|Overall Study|Lost to Follow-up|1|||
142986283|NCT02725268|515486048|FG000|Overall Study|Death|58|||
142986284|NCT02725268|515486049|FG001|Overall Study|Death|59|||
142986285|NCT02725268|515486050|FG002|Overall Study|Death|30|||
142986286|NCT02725268|515486051|FG003|Overall Study|Death|16|||
142986287|NCT02725268|515486048|FG000|Overall Study|Lost to Follow-up|4|||
142986288|NCT02725268|515486049|FG001|Overall Study|Lost to Follow-up|3|||
142986289|NCT02725268|515486050|FG002|Overall Study|Lost to Follow-up|0|||
142986290|NCT02725268|515486051|FG003|Overall Study|Lost to Follow-up|1|||
142986291|NCT02725268|515486048|FG000|Overall Study|Site Terminated by Sponsor|0|||
142986292|NCT02725268|515486049|FG001|Overall Study|Site Terminated by Sponsor|1|||
142986293|NCT02725268|515486050|FG002|Overall Study|Site Terminated by Sponsor|0|||
142986294|NCT02725268|515486051|FG003|Overall Study|Site Terminated by Sponsor|0|||
142986295|NCT02725268|515486048|FG000|Overall Study|Withdrawal by Subject|8|||
142986296|NCT02725268|515486049|FG001|Overall Study|Withdrawal by Subject|6|||
142986297|NCT02725268|515486050|FG002|Overall Study|Withdrawal by Subject|8|||
142986298|NCT02725268|515486051|FG003|Overall Study|Withdrawal by Subject|1|||
142986299|NCT02725268|515486048|FG000|Overall Study|Reason not Specified|2|||
142986300|NCT02725268|515486049|FG001|Overall Study|Reason not Specified|1|||
142986301|NCT02725268|515486050|FG002|Overall Study|Reason not Specified|0|||
142986302|NCT02725268|515486051|FG003|Overall Study|Reason not Specified|0|||
142986303|NCT04498468|515486052|FG000|Overall Study|Lost to Follow-up|3|||
142986304|NCT02290340|515486053|FG000|Overall Study|Lost to Follow-up|0|||
142986305|NCT02290340|515486054|FG001|Overall Study|Lost to Follow-up|0|||
142986306|NCT02290340|515486055|FG002|Overall Study|Lost to Follow-up|0|||
142986307|NCT02290340|515486056|FG003|Overall Study|Lost to Follow-up|1|||
142986308|NCT02290340|515486053|FG000|Overall Study|Withdrawal by Subject|1|||
142986309|NCT02290340|515486054|FG001|Overall Study|Withdrawal by Subject|0|||
142986310|NCT02290340|515486055|FG002|Overall Study|Withdrawal by Subject|0|||
142986311|NCT02290340|515486056|FG003|Overall Study|Withdrawal by Subject|0|||
142986312|NCT02290340|515486053|FG000|Overall Study|Other|1|||
142986313|NCT02290340|515486054|FG001|Overall Study|Other|0|||
142986314|NCT02290340|515486055|FG002|Overall Study|Other|0|||
142986315|NCT02290340|515486056|FG003|Overall Study|Other|1|||
142986316|NCT02407236|515486057|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
142986317|NCT02407236|515486058|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
142986318|NCT02407236|515486059|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
142986319|NCT02407236|515486060|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
142986320|NCT02407236|515486061|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
142986321|NCT02407236|515486062|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
142986322|NCT02407236|515486063|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
142986323|NCT02407236|515486064|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
142986324|NCT02407236|515486065|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
142986325|NCT02407236|515486066|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
142986326|NCT02407236|515486067|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
142986327|NCT02407236|515486068|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
142986328|NCT02407236|515486069|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
142986329|NCT02407236|515486057|FG000|Induction Study (8 Weeks)|Death|0|||
142986330|NCT02407236|515486058|FG001|Induction Study (8 Weeks)|Death|0|||
142986331|NCT02407236|515486059|FG002|Induction Study (8 Weeks)|Death|1|||
142986332|NCT02407236|515486060|FG003|Induction Study (8 Weeks)|Death|0|||
142986333|NCT02407236|515486061|FG004|Induction Study (8 Weeks)|Death|0|||
142986334|NCT02407236|515486062|FG005|Induction Study (8 Weeks)|Death|0|||
142986335|NCT02407236|515486063|FG006|Induction Study (8 Weeks)|Death|0|||
142986336|NCT02407236|515486064|FG007|Induction Study (8 Weeks)|Death|0|||
142986337|NCT02407236|515486065|FG008|Induction Study (8 Weeks)|Death|0|||
142986338|NCT02407236|515486066|FG009|Induction Study (8 Weeks)|Death|0|||
142986339|NCT02407236|515486067|FG010|Induction Study (8 Weeks)|Death|0|||
142986340|NCT02407236|515486068|FG011|Induction Study (8 Weeks)|Death|0|||
142986341|NCT02407236|515486069|FG012|Induction Study (8 Weeks)|Death|0|||
142986342|NCT02407236|515486057|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
142986343|NCT02407236|515486058|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
142986344|NCT02407236|515486059|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
142986345|NCT02407236|515486060|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
142986346|NCT02407236|515486061|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
142986347|NCT02407236|515486062|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
142986348|NCT02407236|515486063|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
142986349|NCT02407236|515486064|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
142986350|NCT02407236|515486065|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
142986351|NCT02407236|515486066|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
142986352|NCT02407236|515486067|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
142986353|NCT02407236|515486068|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
142986354|NCT02407236|515486069|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
142986355|NCT02407236|515486057|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
142986356|NCT02407236|515486058|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
142986357|NCT02407236|515486059|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
142986358|NCT02407236|515486060|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
142986359|NCT02407236|515486061|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
142986360|NCT02407236|515486062|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
142986361|NCT02407236|515486063|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
142986362|NCT02407236|515486064|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
142986363|NCT02407236|515486065|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
142986364|NCT02407236|515486066|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
142986365|NCT02407236|515486067|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
142986366|NCT02407236|515486068|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
142986367|NCT02407236|515486069|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
142986368|NCT02407236|515486057|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
142986369|NCT02407236|515486058|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
142986370|NCT02407236|515486059|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
142986371|NCT02407236|515486060|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
142986372|NCT02407236|515486061|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
142986373|NCT02407236|515486062|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
142986374|NCT02407236|515486063|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
142986375|NCT02407236|515486064|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
142986376|NCT02407236|515486065|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
142986377|NCT02407236|515486066|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
142986378|NCT02407236|515486067|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
142986379|NCT02407236|515486068|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
142986380|NCT02407236|515486069|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
142986381|NCT02407236|515486057|FG000|Induction Study (8 Weeks)|Other|2|||
142986382|NCT02407236|515486058|FG001|Induction Study (8 Weeks)|Other|1|||
142986383|NCT02407236|515486059|FG002|Induction Study (8 Weeks)|Other|5|||
142986384|NCT02407236|515486060|FG003|Induction Study (8 Weeks)|Other|0|||
142986385|NCT02407236|515486061|FG004|Induction Study (8 Weeks)|Other|0|||
142986386|NCT02407236|515486062|FG005|Induction Study (8 Weeks)|Other|0|||
142986387|NCT02407236|515486063|FG006|Induction Study (8 Weeks)|Other|0|||
142986388|NCT02407236|515486064|FG007|Induction Study (8 Weeks)|Other|0|||
142986389|NCT02407236|515486065|FG008|Induction Study (8 Weeks)|Other|0|||
142986390|NCT02407236|515486066|FG009|Induction Study (8 Weeks)|Other|0|||
142986391|NCT02407236|515486067|FG010|Induction Study (8 Weeks)|Other|0|||
142986392|NCT02407236|515486068|FG011|Induction Study (8 Weeks)|Other|0|||
142986393|NCT02407236|515486069|FG012|Induction Study (8 Weeks)|Other|0|||
142986394|NCT02407236|515486057|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
142986395|NCT02407236|515486058|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
142986396|NCT02407236|515486059|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
142986397|NCT02407236|515486060|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
142986398|NCT02407236|515486061|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
142986399|NCT02407236|515486062|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
142986400|NCT02407236|515486063|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
142986401|NCT02407236|515486064|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
142986402|NCT02407236|515486065|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
142986403|NCT02407236|515486066|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
142986404|NCT02407236|515486067|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
142986405|NCT02407236|515486068|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
142986406|NCT02407236|515486069|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
142986407|NCT02407236|515486057|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
142986408|NCT02407236|515486058|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
142986409|NCT02407236|515486059|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
142986410|NCT02407236|515486060|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
142986411|NCT02407236|515486061|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
142986412|NCT02407236|515486062|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
142986413|NCT02407236|515486063|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
142986414|NCT02407236|515486064|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
142986415|NCT02407236|515486065|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
142986416|NCT02407236|515486066|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
142986417|NCT02407236|515486067|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
142986418|NCT02407236|515486068|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
142986419|NCT02407236|515486069|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
142986420|NCT02407236|515486057|FG000|Maintenance Study (44 Weeks)|Other|0|||
142986421|NCT02407236|515486058|FG001|Maintenance Study (44 Weeks)|Other|0|||
142986422|NCT02407236|515486059|FG002|Maintenance Study (44 Weeks)|Other|0|||
142986423|NCT02407236|515486060|FG003|Maintenance Study (44 Weeks)|Other|5|||
142986424|NCT02407236|515486061|FG004|Maintenance Study (44 Weeks)|Other|7|||
142986425|NCT02407236|515486062|FG005|Maintenance Study (44 Weeks)|Other|8|||
142986426|NCT02407236|515486063|FG006|Maintenance Study (44 Weeks)|Other|4|||
142986427|NCT02407236|515486064|FG007|Maintenance Study (44 Weeks)|Other|6|||
142986428|NCT02407236|515486065|FG008|Maintenance Study (44 Weeks)|Other|0|||
142986429|NCT02407236|515486066|FG009|Maintenance Study (44 Weeks)|Other|0|||
142986430|NCT02407236|515486067|FG010|Maintenance Study (44 Weeks)|Other|0|||
142986431|NCT02407236|515486068|FG011|Maintenance Study (44 Weeks)|Other|0|||
142986432|NCT02407236|515486069|FG012|Maintenance Study (44 Weeks)|Other|0|||
142986433|NCT02407236|515486057|FG000|Maintenance Study (44 Weeks)|Death|0|||
142986434|NCT02407236|515486058|FG001|Maintenance Study (44 Weeks)|Death|0|||
142986435|NCT02407236|515486059|FG002|Maintenance Study (44 Weeks)|Death|0|||
142986436|NCT02407236|515486060|FG003|Maintenance Study (44 Weeks)|Death|0|||
142986437|NCT02407236|515486061|FG004|Maintenance Study (44 Weeks)|Death|0|||
142986438|NCT02407236|515486062|FG005|Maintenance Study (44 Weeks)|Death|0|||
142986439|NCT02407236|515486063|FG006|Maintenance Study (44 Weeks)|Death|0|||
142986440|NCT02407236|515486064|FG007|Maintenance Study (44 Weeks)|Death|1|||
142986441|NCT02407236|515486065|FG008|Maintenance Study (44 Weeks)|Death|0|||
142986442|NCT02407236|515486066|FG009|Maintenance Study (44 Weeks)|Death|0|||
142986443|NCT02407236|515486067|FG010|Maintenance Study (44 Weeks)|Death|0|||
142986444|NCT02407236|515486068|FG011|Maintenance Study (44 Weeks)|Death|0|||
142986445|NCT02407236|515486069|FG012|Maintenance Study (44 Weeks)|Death|0|||
142986446|NCT02407236|515486057|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
142986447|NCT02407236|515486058|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
142986448|NCT02407236|515486059|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
142986449|NCT02407236|515486060|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
142986450|NCT02407236|515486061|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
142986451|NCT02407236|515486062|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
142986452|NCT02407236|515486063|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
142986453|NCT02407236|515486064|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
142986454|NCT02407236|515486065|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
142986455|NCT02407236|515486066|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
142986456|NCT02407236|515486067|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
142986457|NCT02407236|515486068|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
142986458|NCT02407236|515486069|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
142986459|NCT02407236|515486057|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
142986460|NCT02407236|515486058|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
142986461|NCT02407236|515486059|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
142986462|NCT02407236|515486060|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
142986463|NCT02407236|515486061|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
142986464|NCT02407236|515486062|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
142986465|NCT02407236|515486063|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
143003176|NCT01049360|515548748|FG004|Period 2|Lack of Efficacy|0|||
142986466|NCT02407236|515486064|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
142986467|NCT02407236|515486065|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
142986468|NCT02407236|515486066|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
142986469|NCT02407236|515486067|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
142986470|NCT02407236|515486068|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
142986471|NCT02407236|515486069|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
142986472|NCT02407236|515486057|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
142986473|NCT02407236|515486058|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
142986474|NCT02407236|515486059|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
142986475|NCT02407236|515486060|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
142986476|NCT02407236|515486061|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
142986477|NCT02407236|515486062|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
142986478|NCT02407236|515486063|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
142986479|NCT02407236|515486064|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
142986480|NCT02407236|515486065|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
142986481|NCT02407236|515486066|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
142986482|NCT02407236|515486067|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
142986483|NCT02407236|515486068|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
142986484|NCT02407236|515486069|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
142986485|NCT02407236|515486057|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
142986486|NCT02407236|515486058|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
142986487|NCT02407236|515486059|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
142986488|NCT02407236|515486060|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
142986489|NCT02407236|515486061|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
142986490|NCT02407236|515486062|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
142986491|NCT02407236|515486063|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
142986492|NCT02407236|515486064|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
142986493|NCT02407236|515486065|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
142986494|NCT02407236|515486066|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
142986495|NCT02407236|515486067|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
142986496|NCT02407236|515486068|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
142986497|NCT02407236|515486069|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
142986498|NCT00643448|515486074|FG000|Overall Study|Lack of Efficacy|2|||
142986499|NCT00643448|515486075|FG001|Overall Study|Lack of Efficacy|0|||
142986500|NCT00643448|515486076|FG002|Overall Study|Lack of Efficacy|4|||
142986501|NCT00643448|515486074|FG000|Overall Study|Adverse Event|2|||
142986502|NCT00643448|515486075|FG001|Overall Study|Adverse Event|2|||
142986503|NCT00643448|515486076|FG002|Overall Study|Adverse Event|2|||
142986504|NCT00643448|515486074|FG000|Overall Study|QTcF>550 ms|0|||
142986505|NCT00643448|515486075|FG001|Overall Study|QTcF>550 ms|3|||
142986506|NCT00643448|515486076|FG002|Overall Study|QTcF>550 ms|0|||
142986507|NCT01167153|515486080|FG000|Overall Study|Non-effective therapy|1|||
142986508|NCT01167153|515486081|FG001|Overall Study|Non-effective therapy|4|||
142986509|NCT01167153|515486080|FG000|Overall Study|AE including clinical laboratory AE|2|||
142986510|NCT01167153|515486081|FG001|Overall Study|AE including clinical laboratory AE|8|||
142986511|NCT01167153|515486080|FG000|Overall Study|Hypotension|1|||
142986512|NCT01167153|515486081|FG001|Overall Study|Hypotension|0|||
142986513|NCT01167153|515486080|FG000|Overall Study|Lost to Follow-up|7|||
142986514|NCT01167153|515486081|FG001|Overall Study|Lost to Follow-up|9|||
142986515|NCT01167153|515486080|FG000|Overall Study|Non-compliance to concomitant medication|0|||
142986516|NCT01167153|515486081|FG001|Overall Study|Non-compliance to concomitant medication|2|||
142986517|NCT01167153|515486080|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
142986518|NCT01167153|515486081|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
142986519|NCT01167153|515486080|FG000|Overall Study|Withdrawal consent|1|||
142986520|NCT01167153|515486081|FG001|Overall Study|Withdrawal consent|1|||
142986521|NCT01167153|515486080|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
142986522|NCT01167153|515486081|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
142986523|NCT03695471|515487885|FG000|Overall Study|Cancellation|1|||
142986524|NCT02859558|515487886|FG000|Step 1|Not Eligible|0|||
142986525|NCT02859558|515487887|FG001|Step 1|Not Eligible|0|||
142986526|NCT02859558|515487888|FG002|Step 1|Not Eligible|0|||
142986527|NCT02859558|515487889|FG003|Step 1|Not Eligible|0|||
142986528|NCT02859558|515487890|FG004|Step 1|Not Eligible|3|||
142986529|NCT02859558|515487886|FG000|Step 1|Lost to Follow-up|1|||
142986530|NCT02859558|515487887|FG001|Step 1|Lost to Follow-up|3|||
142986531|NCT02859558|515487888|FG002|Step 1|Lost to Follow-up|3|||
142986532|NCT02859558|515487889|FG003|Step 1|Lost to Follow-up|0|||
142986533|NCT02859558|515487890|FG004|Step 1|Lost to Follow-up|0|||
142986534|NCT02859558|515487886|FG000|Step 1|Did Not Return to Clinic|2|||
142986535|NCT02859558|515487887|FG001|Step 1|Did Not Return to Clinic|3|||
142986536|NCT02859558|515487888|FG002|Step 1|Did Not Return to Clinic|4|||
142986537|NCT02859558|515487889|FG003|Step 1|Did Not Return to Clinic|0|||
142986538|NCT02859558|515487890|FG004|Step 1|Did Not Return to Clinic|0|||
142986539|NCT02859558|515487886|FG000|Step 1|Moved|0|||
142986540|NCT02859558|515487887|FG001|Step 1|Moved|1|||
142986541|NCT02859558|515487888|FG002|Step 1|Moved|1|||
142986542|NCT02859558|515487889|FG003|Step 1|Moved|0|||
142986543|NCT02859558|515487890|FG004|Step 1|Moved|0|||
142986544|NCT02859558|515487886|FG000|Step 1|Withdrawal By Participant|1|||
142986545|NCT02859558|515487887|FG001|Step 1|Withdrawal By Participant|2|||
142986546|NCT02859558|515487888|FG002|Step 1|Withdrawal By Participant|1|||
142986547|NCT02859558|515487889|FG003|Step 1|Withdrawal By Participant|0|||
142986548|NCT02859558|515487890|FG004|Step 1|Withdrawal By Participant|0|||
142986549|NCT02859558|515487886|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
142986550|NCT02859558|515487887|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
142986551|NCT02859558|515487888|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
142986552|NCT02859558|515487889|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
142986553|NCT02859558|515487890|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
142986554|NCT02859558|515487886|FG000|Step 1|Incarceration|0|||
142986555|NCT02859558|515487887|FG001|Step 1|Incarceration|1|||
142986556|NCT02859558|515487888|FG002|Step 1|Incarceration|0|||
142986557|NCT02859558|515487889|FG003|Step 1|Incarceration|0|||
142986558|NCT02859558|515487890|FG004|Step 1|Incarceration|0|||
142986559|NCT02859558|515487886|FG000|Step 1|Non-Adherence to Study Drug|2|||
142986560|NCT02859558|515487887|FG001|Step 1|Non-Adherence to Study Drug|0|||
142986561|NCT02859558|515487888|FG002|Step 1|Non-Adherence to Study Drug|1|||
142986562|NCT02859558|515487889|FG003|Step 1|Non-Adherence to Study Drug|0|||
142986563|NCT02859558|515487890|FG004|Step 1|Non-Adherence to Study Drug|0|||
142986564|NCT02859558|515487886|FG000|Step 1|Non-Adherence to Study Requirements|3|||
142986565|NCT02859558|515487887|FG001|Step 1|Non-Adherence to Study Requirements|1|||
142986566|NCT02859558|515487888|FG002|Step 1|Non-Adherence to Study Requirements|0|||
142986567|NCT02859558|515487889|FG003|Step 1|Non-Adherence to Study Requirements|0|||
142986568|NCT02859558|515487890|FG004|Step 1|Non-Adherence to Study Requirements|0|||
142986569|NCT02859558|515487886|FG000|Step 1|Virologic Failure|2|||
142986570|NCT02859558|515487887|FG001|Step 1|Virologic Failure|1|||
143455672|NCT03208036|517212505|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
142986571|NCT02859558|515487888|FG002|Step 1|Virologic Failure|1|||
142986572|NCT02859558|515487889|FG003|Step 1|Virologic Failure|0|||
142986573|NCT02859558|515487890|FG004|Step 1|Virologic Failure|0|||
142986574|NCT02859558|515487886|FG000|Step 2|Lost to Follow-up|3|||
142986575|NCT02859558|515487887|FG001|Step 2|Lost to Follow-up|3|||
142986576|NCT02859558|515487888|FG002|Step 2|Lost to Follow-up|1|||
142986577|NCT02859558|515487889|FG003|Step 2|Lost to Follow-up|0|||
142986578|NCT02859558|515487890|FG004|Step 2|Lost to Follow-up|0|||
142986579|NCT02859558|515487886|FG000|Step 2|Withdrawal by Subject|0|||
142986580|NCT02859558|515487887|FG001|Step 2|Withdrawal by Subject|1|||
142986581|NCT02859558|515487888|FG002|Step 2|Withdrawal by Subject|1|||
142986582|NCT02859558|515487889|FG003|Step 2|Withdrawal by Subject|0|||
142986583|NCT02859558|515487890|FG004|Step 2|Withdrawal by Subject|0|||
142986584|NCT02859558|515487886|FG000|Step 2|Unexpected Closure of Site|0|||
142986585|NCT02859558|515487887|FG001|Step 2|Unexpected Closure of Site|1|||
142986586|NCT02859558|515487888|FG002|Step 2|Unexpected Closure of Site|1|||
142986587|NCT02859558|515487889|FG003|Step 2|Unexpected Closure of Site|0|||
142986588|NCT02859558|515487890|FG004|Step 2|Unexpected Closure of Site|0|||
142986589|NCT02859558|515487886|FG000|Step 2|Death|1|||
142986590|NCT02859558|515487887|FG001|Step 2|Death|0|||
142986591|NCT02859558|515487888|FG002|Step 2|Death|0|||
142986592|NCT02859558|515487889|FG003|Step 2|Death|0|||
142986593|NCT02859558|515487890|FG004|Step 2|Death|0|||
142986594|NCT02859558|515487886|FG000|Step 2|Incarceration|0|||
142986595|NCT02859558|515487887|FG001|Step 2|Incarceration|0|||
142986596|NCT02859558|515487888|FG002|Step 2|Incarceration|1|||
142986597|NCT02859558|515487889|FG003|Step 2|Incarceration|0|||
142986598|NCT02859558|515487890|FG004|Step 2|Incarceration|0|||
142986599|NCT04888507|515487891|FG000|Open-Label Treatment (OLTP) (32 Weeks)|Adverse Event|1|||
142986600|NCT00636155|515487892|FG000|Overall Study|Adverse Event|8|||
142986601|NCT00636155|515487892|FG000|Overall Study|Lack of Efficacy|1|||
142986602|NCT00636155|515487892|FG000|Overall Study|Withdrawal by Subject|3|||
142986603|NCT00636155|515487892|FG000|Overall Study|Stem cell transplant|1|||
142986604|NCT00636155|515487892|FG000|Overall Study|Physician Decision|5|||
142986605|NCT00766142|515487893|FG000|Overall Study|Protocol Violation|4|||
142986606|NCT00400946|515487894|FG000|Overall Study|Ineligible|0|||
142986607|NCT00400946|515487895|FG001|Overall Study|Ineligible|0|||
142986608|NCT00400946|515487896|FG002|Overall Study|Ineligible|0|||
142986609|NCT00400946|515487897|FG003|Overall Study|Ineligible|5|||
142986610|NCT00400946|515487898|FG004|Overall Study|Ineligible|1|||
142986611|NCT00400946|515487894|FG000|Overall Study|Induction Failure|0|||
142986612|NCT00400946|515487895|FG001|Overall Study|Induction Failure|0|||
142986613|NCT00400946|515487896|FG002|Overall Study|Induction Failure|0|||
142986614|NCT00400946|515487897|FG003|Overall Study|Induction Failure|11|||
142986615|NCT00400946|515487898|FG004|Overall Study|Induction Failure|8|||
142986616|NCT00400946|515487894|FG000|Overall Study|Induction Death|0|||
142986617|NCT00400946|515487895|FG001|Overall Study|Induction Death|0|||
142986618|NCT00400946|515487896|FG002|Overall Study|Induction Death|0|||
142986619|NCT00400946|515487897|FG003|Overall Study|Induction Death|13|||
142986620|NCT00400946|515487898|FG004|Overall Study|Induction Death|3|||
142986621|NCT00400946|515487894|FG000|Overall Study|Lost to Follow-up|1|||
142986622|NCT00400946|515487895|FG001|Overall Study|Lost to Follow-up|1|||
142986623|NCT00400946|515487896|FG002|Overall Study|Lost to Follow-up|0|||
142986624|NCT00400946|515487897|FG003|Overall Study|Lost to Follow-up|0|||
142986625|NCT00400946|515487898|FG004|Overall Study|Lost to Follow-up|1|||
142986626|NCT00400946|515487894|FG000|Overall Study|Remission Death|1|||
142986627|NCT00400946|515487895|FG001|Overall Study|Remission Death|1|||
142986628|NCT00400946|515487896|FG002|Overall Study|Remission Death|0|||
142986629|NCT00400946|515487897|FG003|Overall Study|Remission Death|0|||
142986630|NCT00400946|515487898|FG004|Overall Study|Remission Death|1|||
142986631|NCT00400946|515487894|FG000|Overall Study|Relapse|9|||
142986632|NCT00400946|515487895|FG001|Overall Study|Relapse|2|||
142986633|NCT00400946|515487896|FG002|Overall Study|Relapse|1|||
142986634|NCT00400946|515487897|FG003|Overall Study|Relapse|1|||
142986635|NCT00400946|515487898|FG004|Overall Study|Relapse|5|||
142986636|NCT00400946|515487894|FG000|Overall Study|Transplant in CR1|0|||
142986637|NCT00400946|515487895|FG001|Overall Study|Transplant in CR1|0|||
142986638|NCT00400946|515487896|FG002|Overall Study|Transplant in CR1|0|||
142986639|NCT00400946|515487897|FG003|Overall Study|Transplant in CR1|10|||
142986640|NCT00400946|515487898|FG004|Overall Study|Transplant in CR1|1|||
142986641|NCT00400946|515487894|FG000|Overall Study|Withdrawal by Subject|2|||
142986642|NCT00400946|515487895|FG001|Overall Study|Withdrawal by Subject|5|||
142986643|NCT00400946|515487896|FG002|Overall Study|Withdrawal by Subject|1|||
142986644|NCT00400946|515487897|FG003|Overall Study|Withdrawal by Subject|5|||
142986645|NCT00400946|515487898|FG004|Overall Study|Withdrawal by Subject|8|||
142986646|NCT00400946|515487894|FG000|Overall Study|Clinical|1|||
142986647|NCT00400946|515487895|FG001|Overall Study|Clinical|2|||
142986648|NCT00400946|515487896|FG002|Overall Study|Clinical|0|||
142986649|NCT00400946|515487897|FG003|Overall Study|Clinical|2|||
142986650|NCT00400946|515487898|FG004|Overall Study|Clinical|9|||
142986651|NCT00400946|515487894|FG000|Overall Study|Other|0|||
142986652|NCT00400946|515487895|FG001|Overall Study|Other|0|||
142986653|NCT00400946|515487896|FG002|Overall Study|Other|0|||
142986654|NCT00400946|515487897|FG003|Overall Study|Other|0|||
142986655|NCT00400946|515487898|FG004|Overall Study|Other|1|||
142986656|NCT05643170|515487899|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
142986657|NCT05643170|515487899|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
142986658|NCT01432756|515487900|FG000|Overall Study|Lost to Follow-up|1|||
142986659|NCT01432756|515487901|FG001|Overall Study|Lost to Follow-up|0|||
142986660|NCT01432756|515487902|FG002|Overall Study|Lost to Follow-up|2|||
142986661|NCT01432756|515487903|FG003|Overall Study|Lost to Follow-up|1|||
142986662|NCT00777257|515487914|FG000|Overall Study|Adverse Event|3|||
142986663|NCT00777257|515487915|FG001|Overall Study|Adverse Event|1|||
142986664|NCT00777257|515487916|FG002|Overall Study|Adverse Event|0|||
142986665|NCT00777257|515487914|FG000|Overall Study|Lost to Follow-up|3|||
142986666|NCT00777257|515487915|FG001|Overall Study|Lost to Follow-up|3|||
142986667|NCT00777257|515487916|FG002|Overall Study|Lost to Follow-up|2|||
142986668|NCT00777257|515487914|FG000|Overall Study|Protocol Violation|2|||
142986669|NCT00777257|515487915|FG001|Overall Study|Protocol Violation|2|||
142986670|NCT00777257|515487916|FG002|Overall Study|Protocol Violation|2|||
142986671|NCT00777257|515487914|FG000|Overall Study|Withdrawal by Subject|3|||
142986672|NCT00777257|515487915|FG001|Overall Study|Withdrawal by Subject|6|||
142986673|NCT00777257|515487916|FG002|Overall Study|Withdrawal by Subject|5|||
142986674|NCT01431521|515487917|FG000|Overall Study|Withdrawal by Subject|0|||
142986675|NCT01431521|515487918|FG001|Overall Study|Withdrawal by Subject|0|||
142986676|NCT01431521|515487919|FG002|Overall Study|Withdrawal by Subject|1|||
142986677|NCT01431521|515487920|FG003|Overall Study|Withdrawal by Subject|0|||
142986678|NCT01998906|515487921|FG000|Overall Study|Participants ongoing in follow-up|77|||
142986679|NCT01998906|515487922|FG001|Overall Study|Participants ongoing in follow-up|60|||
142986680|NCT01998906|515487923|FG002|Overall Study|Participants ongoing in follow-up|58|||
142986681|NCT01998906|515487921|FG000|Overall Study|Death|21|||
142986682|NCT01998906|515487922|FG001|Overall Study|Death|30|||
142986683|NCT01998906|515487923|FG002|Overall Study|Death|17|||
142986684|NCT01998906|515487921|FG000|Overall Study|Lack of Efficacy|10|||
142986685|NCT01998906|515487922|FG001|Overall Study|Lack of Efficacy|9|||
142986686|NCT01998906|515487923|FG002|Overall Study|Lack of Efficacy|8|||
142986687|NCT01998906|515487921|FG000|Overall Study|Failure to return|0|||
142986688|NCT01998906|515487922|FG001|Overall Study|Failure to return|2|||
142986689|NCT01998906|515487923|FG002|Overall Study|Failure to return|4|||
142986690|NCT01998906|515487921|FG000|Overall Study|Violation of Selection Criteria|0|||
142986691|NCT01998906|515487922|FG001|Overall Study|Violation of Selection Criteria|0|||
142986692|NCT01998906|515487923|FG002|Overall Study|Violation of Selection Criteria|1|||
142986693|NCT01998906|515487921|FG000|Overall Study|Withdrawal by Subject|1|||
142986694|NCT01998906|515487922|FG001|Overall Study|Withdrawal by Subject|4|||
142986695|NCT01998906|515487923|FG002|Overall Study|Withdrawal by Subject|3|||
142986696|NCT01998906|515487921|FG000|Overall Study|Administrative/Other|2|||
142986697|NCT01998906|515487922|FG001|Overall Study|Administrative/Other|1|||
142986698|NCT01998906|515487923|FG002|Overall Study|Administrative/Other|3|||
142986699|NCT01998906|515487921|FG000|Overall Study|Other|3|||
142986700|NCT01998906|515487922|FG001|Overall Study|Other|8|||
142986701|NCT01998906|515487923|FG002|Overall Study|Other|4|||
142986702|NCT01572844|515487924|FG000|Overall Study|Physician Decision|1|||
142986703|NCT01572844|515487925|FG001|Overall Study|Physician Decision|1|||
142986704|NCT00366444|515487927|FG000|Overall Study|Withdrawal by Subject|1|||
142986705|NCT00366444|515487928|FG001|Overall Study|Withdrawal by Subject|1|||
142986706|NCT00366444|515487927|FG000|Overall Study|Lack of Efficacy|0|||
142986707|NCT00366444|515487928|FG001|Overall Study|Lack of Efficacy|1|||
142986708|NCT04667949|515487929|FG000|Overall Study|Adverse Event|0|||
142986709|NCT04667949|515487930|FG001|Overall Study|Adverse Event|2|||
142986710|NCT04667949|515487929|FG000|Overall Study|Lost to Follow-up|0|||
142986711|NCT04667949|515487930|FG001|Overall Study|Lost to Follow-up|1|||
142986712|NCT04667949|515487929|FG000|Overall Study|Physician Decision|0|||
142986713|NCT04667949|515487930|FG001|Overall Study|Physician Decision|2|||
142986714|NCT04667949|515487929|FG000|Overall Study|Subject decision|1|||
142986715|NCT04667949|515487930|FG001|Overall Study|Subject decision|7|||
142986716|NCT01804842|515487941|FG000|Overall Study|Adverse Event|1|||
142986717|NCT01804842|515487942|FG001|Overall Study|Adverse Event|1|||
142986718|NCT01804842|515487943|FG002|Overall Study|Adverse Event|0|||
142986719|NCT01804842|515487941|FG000|Overall Study|Lost to Follow-up|1|||
142986720|NCT01804842|515487942|FG001|Overall Study|Lost to Follow-up|0|||
142986721|NCT01804842|515487943|FG002|Overall Study|Lost to Follow-up|0|||
142986722|NCT01804842|515487941|FG000|Overall Study|Non-Compliance|1|||
142986723|NCT01804842|515487942|FG001|Overall Study|Non-Compliance|1|||
142986724|NCT01804842|515487943|FG002|Overall Study|Non-Compliance|0|||
142986725|NCT01804842|515487941|FG000|Overall Study|Personal Reason|0|||
142986726|NCT01804842|515487942|FG001|Overall Study|Personal Reason|0|||
142986727|NCT01804842|515487943|FG002|Overall Study|Personal Reason|1|||
142986728|NCT03887052|515487944|FG000|Overall Study|Adverse Event|2|||
142986729|NCT03887052|515487944|FG000|Overall Study|Physician Decision|2|||
142986730|NCT03887052|515487944|FG000|Overall Study|Withdrawal by Subject|3|||
142986731|NCT03887052|515487944|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
142986732|NCT03887052|515487944|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
142986733|NCT02365506|515487945|FG000|Overall Study|Investigator's Discretion|0|||
142986734|NCT02365506|515487946|FG001|Overall Study|Investigator's Discretion|0|||
142986735|NCT02365506|515487947|FG002|Overall Study|Investigator's Discretion|1|||
142986736|NCT02352090|515487948|FG000|Overall Study|general malaise|1|||
142986737|NCT02352090|515487949|FG001|Overall Study|general malaise|0|||
142986738|NCT02352090|515487950|FG002|Overall Study|general malaise|0|||
142986739|NCT02352090|515487948|FG000|Overall Study|non-specified mild side-effects|0|||
142986740|NCT02352090|515487949|FG001|Overall Study|non-specified mild side-effects|0|||
142986741|NCT02352090|515487950|FG002|Overall Study|non-specified mild side-effects|2|||
142986742|NCT05179057|515487951|FG000|Overall Study|Adverse Event|3|||
142986743|NCT05179057|515487952|FG001|Overall Study|Adverse Event|2|||
142986744|NCT05179057|515487951|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
142986745|NCT05179057|515487952|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
142986746|NCT05179057|515487951|FG000|Overall Study|Study terminated|13|||
142986747|NCT05179057|515487952|FG001|Overall Study|Study terminated|7|||
142986748|NCT05179057|515487951|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
142986749|NCT05179057|515487952|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
142986750|NCT05179057|515487951|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
142986751|NCT05179057|515487952|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
142986752|NCT03345342|515487953|FG000|Open-Label Phase|Adverse Event|30|||
142986753|NCT03345342|515487954|FG001|Open-Label Phase|Adverse Event|0|||
142986754|NCT03345342|515487955|FG002|Open-Label Phase|Adverse Event|0|||
142986755|NCT03345342|515487956|FG003|Open-Label Phase|Adverse Event|0|||
142986756|NCT03345342|515487957|FG004|Open-Label Phase|Adverse Event|0|||
142986757|NCT03345342|515487953|FG000|Open-Label Phase|Death|1|||
142986758|NCT03345342|515487954|FG001|Open-Label Phase|Death|0|||
142986759|NCT03345342|515487955|FG002|Open-Label Phase|Death|0|||
142986760|NCT03345342|515487956|FG003|Open-Label Phase|Death|0|||
142986761|NCT03345342|515487957|FG004|Open-Label Phase|Death|0|||
142986762|NCT03345342|515487953|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
142986763|NCT03345342|515487954|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
142986764|NCT03345342|515487955|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
142986765|NCT03345342|515487956|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
142986766|NCT03345342|515487957|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
142986767|NCT03345342|515487953|FG000|Open-Label Phase|Lack of Efficacy|6|||
142986768|NCT03345342|515487954|FG001|Open-Label Phase|Lack of Efficacy|0|||
142986769|NCT03345342|515487955|FG002|Open-Label Phase|Lack of Efficacy|0|||
142986770|NCT03345342|515487956|FG003|Open-Label Phase|Lack of Efficacy|0|||
142986771|NCT03345342|515487957|FG004|Open-Label Phase|Lack of Efficacy|0|||
142986772|NCT03345342|515487953|FG000|Open-Label Phase|Lost to Follow-up|9|||
142986773|NCT03345342|515487954|FG001|Open-Label Phase|Lost to Follow-up|0|||
142986774|NCT03345342|515487955|FG002|Open-Label Phase|Lost to Follow-up|0|||
142986775|NCT03345342|515487956|FG003|Open-Label Phase|Lost to Follow-up|0|||
142986776|NCT03345342|515487957|FG004|Open-Label Phase|Lost to Follow-up|0|||
142986777|NCT03345342|515487953|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
142986778|NCT03345342|515487954|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
142986779|NCT03345342|515487955|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
142986780|NCT03345342|515487956|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
142986781|NCT03345342|515487957|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
142986782|NCT03345342|515487953|FG000|Open-Label Phase|Physician Decision|4|||
142986783|NCT03345342|515487954|FG001|Open-Label Phase|Physician Decision|0|||
142986784|NCT03345342|515487955|FG002|Open-Label Phase|Physician Decision|0|||
142986785|NCT03345342|515487956|FG003|Open-Label Phase|Physician Decision|0|||
142986786|NCT03345342|515487957|FG004|Open-Label Phase|Physician Decision|0|||
142986787|NCT03345342|515487953|FG000|Open-Label Phase|Protocol Violation|8|||
142986788|NCT03345342|515487954|FG001|Open-Label Phase|Protocol Violation|0|||
142986789|NCT03345342|515487955|FG002|Open-Label Phase|Protocol Violation|0|||
142986790|NCT03345342|515487956|FG003|Open-Label Phase|Protocol Violation|0|||
142986791|NCT03345342|515487957|FG004|Open-Label Phase|Protocol Violation|0|||
142986792|NCT03345342|515487953|FG000|Open-Label Phase|Withdrawal by Subject|57|||
142986793|NCT03345342|515487954|FG001|Open-Label Phase|Withdrawal by Subject|0|||
142986794|NCT03345342|515487955|FG002|Open-Label Phase|Withdrawal by Subject|0|||
142986795|NCT03345342|515487956|FG003|Open-Label Phase|Withdrawal by Subject|0|||
142986796|NCT03345342|515487957|FG004|Open-Label Phase|Withdrawal by Subject|0|||
142986797|NCT03345342|515487953|FG000|Open-Label Phase|Other|15|||
142986798|NCT03345342|515487954|FG001|Open-Label Phase|Other|0|||
142986799|NCT03345342|515487955|FG002|Open-Label Phase|Other|0|||
142986800|NCT03345342|515487956|FG003|Open-Label Phase|Other|0|||
142986801|NCT03345342|515487957|FG004|Open-Label Phase|Other|0|||
142986802|NCT03345342|515487953|FG000|Double-Blind Phase|Adverse Event|0|||
142986803|NCT03345342|515487954|FG001|Double-Blind Phase|Adverse Event|1|||
142986804|NCT03345342|515487955|FG002|Double-Blind Phase|Adverse Event|6|||
142986805|NCT03345342|515487956|FG003|Double-Blind Phase|Adverse Event|0|||
142986806|NCT03345342|515487957|FG004|Double-Blind Phase|Adverse Event|0|||
142986807|NCT03345342|515487953|FG000|Double-Blind Phase|Death|0|||
142986808|NCT03345342|515487954|FG001|Double-Blind Phase|Death|2|||
142986809|NCT03345342|515487955|FG002|Double-Blind Phase|Death|1|||
142986810|NCT03345342|515487956|FG003|Double-Blind Phase|Death|0|||
142986811|NCT03345342|515487957|FG004|Double-Blind Phase|Death|0|||
142986812|NCT03345342|515487953|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
142986813|NCT03345342|515487954|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
142986814|NCT03345342|515487955|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
142986815|NCT03345342|515487956|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
142986816|NCT03345342|515487957|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
142986817|NCT03345342|515487953|FG000|Double-Blind Phase|Lost to Follow-up|0|||
142986818|NCT03345342|515487954|FG001|Double-Blind Phase|Lost to Follow-up|1|||
142986819|NCT03345342|515487955|FG002|Double-Blind Phase|Lost to Follow-up|7|||
142986820|NCT03345342|515487956|FG003|Double-Blind Phase|Lost to Follow-up|0|||
142986821|NCT03345342|515487957|FG004|Double-Blind Phase|Lost to Follow-up|0|||
142986822|NCT03345342|515487953|FG000|Double-Blind Phase|Physician Decision|0|||
142986823|NCT03345342|515487954|FG001|Double-Blind Phase|Physician Decision|1|||
142986824|NCT03345342|515487955|FG002|Double-Blind Phase|Physician Decision|4|||
142986825|NCT03345342|515487956|FG003|Double-Blind Phase|Physician Decision|0|||
142986826|NCT03345342|515487957|FG004|Double-Blind Phase|Physician Decision|0|||
142986827|NCT03345342|515487953|FG000|Double-Blind Phase|Protocol Violation|0|||
142986828|NCT03345342|515487954|FG001|Double-Blind Phase|Protocol Violation|0|||
142986829|NCT03345342|515487955|FG002|Double-Blind Phase|Protocol Violation|1|||
142986830|NCT03345342|515487956|FG003|Double-Blind Phase|Protocol Violation|0|||
142986831|NCT03345342|515487957|FG004|Double-Blind Phase|Protocol Violation|0|||
142986832|NCT03345342|515487953|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
142986833|NCT03345342|515487954|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
142986834|NCT03345342|515487955|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
142986835|NCT03345342|515487956|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
142986836|NCT03345342|515487957|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
142986837|NCT03345342|515487953|FG000|Double-Blind Phase|Other|0|||
142986838|NCT03345342|515487954|FG001|Double-Blind Phase|Other|1|||
142986839|NCT03345342|515487955|FG002|Double-Blind Phase|Other|3|||
142986840|NCT03345342|515487956|FG003|Double-Blind Phase|Other|0|||
142986841|NCT03345342|515487957|FG004|Double-Blind Phase|Other|0|||
142986842|NCT03345342|515487953|FG000|Follow-Up Phase|Adverse Event|0|||
142986843|NCT03345342|515487954|FG001|Follow-Up Phase|Adverse Event|0|||
142986844|NCT03345342|515487955|FG002|Follow-Up Phase|Adverse Event|0|||
142986845|NCT03345342|515487956|FG003|Follow-Up Phase|Adverse Event|0|||
142986846|NCT03345342|515487957|FG004|Follow-Up Phase|Adverse Event|4|||
142986847|NCT03345342|515487953|FG000|Follow-Up Phase|Lost to Follow-up|0|||
142986848|NCT03345342|515487954|FG001|Follow-Up Phase|Lost to Follow-up|0|||
142986849|NCT03345342|515487955|FG002|Follow-Up Phase|Lost to Follow-up|0|||
142986850|NCT03345342|515487956|FG003|Follow-Up Phase|Lost to Follow-up|0|||
142986851|NCT03345342|515487957|FG004|Follow-Up Phase|Lost to Follow-up|6|||
142986852|NCT03345342|515487953|FG000|Follow-Up Phase|Physician Decision|0|||
142986853|NCT03345342|515487954|FG001|Follow-Up Phase|Physician Decision|0|||
142986854|NCT03345342|515487955|FG002|Follow-Up Phase|Physician Decision|0|||
142986855|NCT03345342|515487956|FG003|Follow-Up Phase|Physician Decision|0|||
142986856|NCT03345342|515487957|FG004|Follow-Up Phase|Physician Decision|5|||
142986857|NCT03345342|515487953|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
142986858|NCT03345342|515487954|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
142986859|NCT03345342|515487955|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
142986860|NCT03345342|515487956|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
142986861|NCT03345342|515487957|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
142986862|NCT03345342|515487953|FG000|Follow-Up Phase|Other|0|||
142986863|NCT03345342|515487954|FG001|Follow-Up Phase|Other|0|||
142986864|NCT03345342|515487955|FG002|Follow-Up Phase|Other|0|||
142986865|NCT03345342|515487956|FG003|Follow-Up Phase|Other|3|||
142986866|NCT03345342|515487957|FG004|Follow-Up Phase|Other|1|||
142986867|NCT02437162|515487962|FG000|Overall Study|Protocol Violation|0|||
142986868|NCT02437162|515487963|FG001|Overall Study|Protocol Violation|1|||
142986869|NCT02437162|515487964|FG002|Overall Study|Protocol Violation|0|||
142986870|NCT02437162|515487962|FG000|Overall Study|Randomized but not treated|0|||
142986871|NCT02437162|515487963|FG001|Overall Study|Randomized but not treated|0|||
142986872|NCT02437162|515487964|FG002|Overall Study|Randomized but not treated|1|||
142986873|NCT02437162|515487962|FG000|Overall Study|Study discontinued by Sponsor|93|||
142986874|NCT02437162|515487963|FG001|Overall Study|Study discontinued by Sponsor|98|||
142986875|NCT02437162|515487964|FG002|Overall Study|Study discontinued by Sponsor|97|||
142986876|NCT02437162|515487962|FG000|Overall Study|Withdrawal by Subject|13|||
142986877|NCT02437162|515487963|FG001|Overall Study|Withdrawal by Subject|7|||
142986878|NCT02437162|515487964|FG002|Overall Study|Withdrawal by Subject|9|||
142986879|NCT02437162|515487962|FG000|Overall Study|Adverse Event|0|||
142986880|NCT02437162|515487963|FG001|Overall Study|Adverse Event|1|||
142986881|NCT02437162|515487964|FG002|Overall Study|Adverse Event|0|||
142986882|NCT02437162|515487962|FG000|Overall Study|Lost to Follow-up|1|||
142986883|NCT02437162|515487963|FG001|Overall Study|Lost to Follow-up|0|||
142986884|NCT02437162|515487964|FG002|Overall Study|Lost to Follow-up|1|||
142986885|NCT02437162|515487962|FG000|Overall Study|Death|0|||
142986886|NCT02437162|515487963|FG001|Overall Study|Death|1|||
142986887|NCT02437162|515487964|FG002|Overall Study|Death|0|||
142986888|NCT02437162|515487962|FG000|Overall Study|Other|0|||
142986889|NCT02437162|515487963|FG001|Overall Study|Other|0|||
142986890|NCT02437162|515487964|FG002|Overall Study|Other|1|||
142986891|NCT03277105|515487965|FG000|Overall Study|Death|129|||
142986892|NCT03277105|515487966|FG001|Overall Study|Death|124|||
142986893|NCT03277105|515487965|FG000|Overall Study|Lost to Follow-up|2|||
142986894|NCT03277105|515487966|FG001|Overall Study|Lost to Follow-up|4|||
142986895|NCT03277105|515487965|FG000|Overall Study|Withdrawal by Subject|10|||
142986896|NCT03277105|515487966|FG001|Overall Study|Withdrawal by Subject|10|||
142986897|NCT03277105|515487965|FG000|Overall Study|Other|118|||
142986898|NCT03277105|515487966|FG001|Overall Study|Other|125|||
142986899|NCT01989572|515487967|FG000|Overall Study|Lack of Efficacy|35|||
142986900|NCT01989572|515487968|FG001|Overall Study|Lack of Efficacy|48|||
142986901|NCT01989572|515487969|FG002|Overall Study|Lack of Efficacy|48|||
142986902|NCT01989572|515487970|FG003|Overall Study|Lack of Efficacy|43|||
142986903|NCT01989572|515487971|FG004|Overall Study|Lack of Efficacy|71|||
142986904|NCT01989572|515487972|FG005|Overall Study|Lack of Efficacy|79|||
142986905|NCT01989572|515487967|FG000|Overall Study|Adverse Event|2|||
142986906|NCT01989572|515487968|FG001|Overall Study|Adverse Event|1|||
142986907|NCT01989572|515487969|FG002|Overall Study|Adverse Event|3|||
142986908|NCT01989572|515487970|FG003|Overall Study|Adverse Event|0|||
142986909|NCT01989572|515487971|FG004|Overall Study|Adverse Event|3|||
142986910|NCT01989572|515487972|FG005|Overall Study|Adverse Event|0|||
142986911|NCT01989572|515487967|FG000|Overall Study|Death|0|||
142986912|NCT01989572|515487968|FG001|Overall Study|Death|0|||
142986913|NCT01989572|515487969|FG002|Overall Study|Death|0|||
142986914|NCT01989572|515487970|FG003|Overall Study|Death|0|||
142986915|NCT01989572|515487971|FG004|Overall Study|Death|1|||
142986916|NCT01989572|515487972|FG005|Overall Study|Death|0|||
142986917|NCT01989572|515487967|FG000|Overall Study|Withdrawal by Subject|4|||
142986918|NCT01989572|515487968|FG001|Overall Study|Withdrawal by Subject|1|||
142986919|NCT01989572|515487969|FG002|Overall Study|Withdrawal by Subject|5|||
142986920|NCT01989572|515487970|FG003|Overall Study|Withdrawal by Subject|1|||
142986921|NCT01989572|515487971|FG004|Overall Study|Withdrawal by Subject|12|||
142986922|NCT01989572|515487972|FG005|Overall Study|Withdrawal by Subject|4|||
142986923|NCT01989572|515487967|FG000|Overall Study|complicating disease|1|||
142986924|NCT01989572|515487968|FG001|Overall Study|complicating disease|1|||
142986925|NCT01989572|515487969|FG002|Overall Study|complicating disease|2|||
142986926|NCT01989572|515487970|FG003|Overall Study|complicating disease|0|||
142986927|NCT01989572|515487971|FG004|Overall Study|complicating disease|1|||
142986928|NCT01989572|515487972|FG005|Overall Study|complicating disease|0|||
142986929|NCT01989572|515487967|FG000|Overall Study|error|2|||
142986930|NCT01989572|515487968|FG001|Overall Study|error|1|||
142986931|NCT01989572|515487969|FG002|Overall Study|error|1|||
142986932|NCT01989572|515487970|FG003|Overall Study|error|1|||
142986933|NCT01989572|515487971|FG004|Overall Study|error|1|||
142986934|NCT01989572|515487972|FG005|Overall Study|error|1|||
142986935|NCT01989572|515487967|FG000|Overall Study|maximum dose reached|0|||
142986936|NCT01989572|515487968|FG001|Overall Study|maximum dose reached|1|||
142986937|NCT01989572|515487969|FG002|Overall Study|maximum dose reached|0|||
142986938|NCT01989572|515487970|FG003|Overall Study|maximum dose reached|0|||
142986939|NCT01989572|515487971|FG004|Overall Study|maximum dose reached|1|||
142986940|NCT01989572|515487972|FG005|Overall Study|maximum dose reached|0|||
142986941|NCT01989572|515487967|FG000|Overall Study|unknown/not specify|3|||
142986942|NCT01989572|515487968|FG001|Overall Study|unknown/not specify|4|||
142986943|NCT01989572|515487969|FG002|Overall Study|unknown/not specify|1|||
142986944|NCT01989572|515487970|FG003|Overall Study|unknown/not specify|3|||
142986945|NCT01989572|515487971|FG004|Overall Study|unknown/not specify|3|||
142986946|NCT01989572|515487972|FG005|Overall Study|unknown/not specify|5|||
142986947|NCT01989572|515487967|FG000|Overall Study|not start protocol therapy|5|||
142986948|NCT01989572|515487968|FG001|Overall Study|not start protocol therapy|1|||
142986949|NCT01989572|515487969|FG002|Overall Study|not start protocol therapy|2|||
142986950|NCT01989572|515487970|FG003|Overall Study|not start protocol therapy|3|||
142986951|NCT01989572|515487971|FG004|Overall Study|not start protocol therapy|4|||
142986952|NCT01989572|515487972|FG005|Overall Study|not start protocol therapy|18|||
142986953|NCT01989572|515487967|FG000|Overall Study|alternative therapy|3|||
142986954|NCT01989572|515487968|FG001|Overall Study|alternative therapy|0|||
142986955|NCT01989572|515487969|FG002|Overall Study|alternative therapy|0|||
142986956|NCT01989572|515487970|FG003|Overall Study|alternative therapy|0|||
142986957|NCT01989572|515487971|FG004|Overall Study|alternative therapy|1|||
142986958|NCT01989572|515487972|FG005|Overall Study|alternative therapy|3|||
142986959|NCT02280096|515487973|FG000|Overall Study|Pregnancy|1|||
142986960|NCT02280096|515487974|FG001|Overall Study|Pregnancy|0|||
142986961|NCT02280096|515487973|FG000|Overall Study|Functional neurological disorder|1|||
142986962|NCT02280096|515487974|FG001|Overall Study|Functional neurological disorder|0|||
142986963|NCT02280096|515487973|FG000|Overall Study|Lack of attachment|0|||
142986964|NCT02280096|515487974|FG001|Overall Study|Lack of attachment|1|||
142986965|NCT03146403|515487980|FG000|Overall Study|Withdrawal by Subject|0|||
142986966|NCT03146403|515487981|FG001|Overall Study|Withdrawal by Subject|3|||
142986967|NCT03146403|515487980|FG000|Overall Study|Lost to Follow-up|2|||
142986968|NCT03146403|515487981|FG001|Overall Study|Lost to Follow-up|0|||
142986969|NCT02182999|515487983|FG000|Overall Study|Adverse Event|4|||
142986970|NCT02182999|515487984|FG001|Overall Study|Adverse Event|3|||
142986971|NCT02182999|515487983|FG000|Overall Study|Physician Decision|1|||
142986972|NCT02182999|515487984|FG001|Overall Study|Physician Decision|0|||
142986973|NCT02252588|515487985|FG000|Overall Study|Withdrawal by Subject|4|||
142986974|NCT02252588|515487986|FG001|Overall Study|Withdrawal by Subject|0|||
142986975|NCT03039790|515487989|FG000|Overall Study|Lost to Follow-up|2|||
142986976|NCT03039790|515487990|FG001|Overall Study|Lost to Follow-up|0|||
142986977|NCT03039790|515487991|FG002|Overall Study|Lost to Follow-up|1|||
142986978|NCT03039790|515487992|FG003|Overall Study|Lost to Follow-up|1|||
142986979|NCT03039790|515487993|FG004|Overall Study|Lost to Follow-up|0|||
142986980|NCT03039790|515487994|FG005|Overall Study|Lost to Follow-up|1|||
142986981|NCT03039790|515487995|FG006|Overall Study|Lost to Follow-up|1|||
142986982|NCT03039790|515487996|FG007|Overall Study|Lost to Follow-up|1|||
142986983|NCT03039790|515487997|FG008|Overall Study|Lost to Follow-up|0|||
142986984|NCT03039790|515487998|FG009|Overall Study|Lost to Follow-up|1|||
142986985|NCT03039790|515487999|FG010|Overall Study|Lost to Follow-up|1|||
142986986|NCT03039790|515488000|FG011|Overall Study|Lost to Follow-up|0|||
142986987|NCT03039790|515488001|FG012|Overall Study|Lost to Follow-up|1|||
142986988|NCT03039790|515488002|FG013|Overall Study|Lost to Follow-up|0|||
142986989|NCT03039790|515488003|FG014|Overall Study|Lost to Follow-up|3|||
142986990|NCT03039790|515488004|FG015|Overall Study|Lost to Follow-up|1|||
142986991|NCT03039790|515488005|FG016|Overall Study|Lost to Follow-up|2|||
142986992|NCT03039790|515488006|FG017|Overall Study|Lost to Follow-up|2|||
142986993|NCT03039790|515488007|FG018|Overall Study|Lost to Follow-up|1|||
142986994|NCT03039790|515488008|FG019|Overall Study|Lost to Follow-up|3|||
142986995|NCT03039790|515487989|FG000|Overall Study|Withdrawal of Consent|1|||
142986996|NCT03039790|515487990|FG001|Overall Study|Withdrawal of Consent|0|||
142986997|NCT03039790|515487991|FG002|Overall Study|Withdrawal of Consent|0|||
142986998|NCT03039790|515487992|FG003|Overall Study|Withdrawal of Consent|1|||
142986999|NCT03039790|515487993|FG004|Overall Study|Withdrawal of Consent|0|||
142987000|NCT03039790|515487994|FG005|Overall Study|Withdrawal of Consent|0|||
142987001|NCT03039790|515487995|FG006|Overall Study|Withdrawal of Consent|0|||
142987002|NCT03039790|515487996|FG007|Overall Study|Withdrawal of Consent|0|||
142987003|NCT03039790|515487997|FG008|Overall Study|Withdrawal of Consent|0|||
142987004|NCT03039790|515487998|FG009|Overall Study|Withdrawal of Consent|1|||
142987005|NCT03039790|515487999|FG010|Overall Study|Withdrawal of Consent|0|||
142987006|NCT03039790|515488000|FG011|Overall Study|Withdrawal of Consent|0|||
142987007|NCT03039790|515488001|FG012|Overall Study|Withdrawal of Consent|2|||
142987008|NCT03039790|515488002|FG013|Overall Study|Withdrawal of Consent|0|||
142987009|NCT03039790|515488003|FG014|Overall Study|Withdrawal of Consent|1|||
142987010|NCT03039790|515488004|FG015|Overall Study|Withdrawal of Consent|5|||
142987011|NCT03039790|515488005|FG016|Overall Study|Withdrawal of Consent|3|||
142987012|NCT03039790|515488006|FG017|Overall Study|Withdrawal of Consent|0|||
142987013|NCT03039790|515488007|FG018|Overall Study|Withdrawal of Consent|2|||
142987014|NCT03039790|515488008|FG019|Overall Study|Withdrawal of Consent|5|||
142987015|NCT03039790|515487989|FG000|Overall Study|Death|0|||
142987016|NCT03039790|515487990|FG001|Overall Study|Death|0|||
142987017|NCT03039790|515487991|FG002|Overall Study|Death|0|||
142987018|NCT03039790|515487992|FG003|Overall Study|Death|0|||
142987019|NCT03039790|515487993|FG004|Overall Study|Death|0|||
142987020|NCT03039790|515487994|FG005|Overall Study|Death|0|||
142987021|NCT03039790|515487995|FG006|Overall Study|Death|0|||
142987022|NCT03039790|515487996|FG007|Overall Study|Death|0|||
142987023|NCT03039790|515487997|FG008|Overall Study|Death|0|||
142987024|NCT03039790|515487998|FG009|Overall Study|Death|0|||
142987025|NCT03039790|515487999|FG010|Overall Study|Death|0|||
142987026|NCT03039790|515488000|FG011|Overall Study|Death|0|||
142987027|NCT03039790|515488001|FG012|Overall Study|Death|0|||
142987028|NCT03039790|515488002|FG013|Overall Study|Death|0|||
142987029|NCT03039790|515488003|FG014|Overall Study|Death|0|||
142987030|NCT03039790|515488004|FG015|Overall Study|Death|1|||
142987031|NCT03039790|515488005|FG016|Overall Study|Death|3|||
142987032|NCT03039790|515488006|FG017|Overall Study|Death|0|||
142987033|NCT03039790|515488007|FG018|Overall Study|Death|2|||
142987034|NCT03039790|515488008|FG019|Overall Study|Death|0|||
142987035|NCT03039790|515487989|FG000|Overall Study|Reason, not Specified|1|||
142987036|NCT03039790|515487990|FG001|Overall Study|Reason, not Specified|0|||
142987037|NCT03039790|515487991|FG002|Overall Study|Reason, not Specified|0|||
142987038|NCT03039790|515487992|FG003|Overall Study|Reason, not Specified|0|||
142987039|NCT03039790|515487993|FG004|Overall Study|Reason, not Specified|0|||
142987040|NCT03039790|515487994|FG005|Overall Study|Reason, not Specified|0|||
142987041|NCT03039790|515487995|FG006|Overall Study|Reason, not Specified|0|||
142987042|NCT03039790|515487996|FG007|Overall Study|Reason, not Specified|0|||
142987043|NCT03039790|515487997|FG008|Overall Study|Reason, not Specified|0|||
142987044|NCT03039790|515487998|FG009|Overall Study|Reason, not Specified|0|||
142987045|NCT03039790|515487999|FG010|Overall Study|Reason, not Specified|0|||
142987046|NCT03039790|515488000|FG011|Overall Study|Reason, not Specified|0|||
142987047|NCT03039790|515488001|FG012|Overall Study|Reason, not Specified|0|||
142987048|NCT03039790|515488002|FG013|Overall Study|Reason, not Specified|0|||
142987049|NCT03039790|515488003|FG014|Overall Study|Reason, not Specified|0|||
142987050|NCT03039790|515488004|FG015|Overall Study|Reason, not Specified|0|||
142987051|NCT03039790|515488005|FG016|Overall Study|Reason, not Specified|2|||
142987052|NCT03039790|515488006|FG017|Overall Study|Reason, not Specified|0|||
142987053|NCT03039790|515488007|FG018|Overall Study|Reason, not Specified|1|||
142987054|NCT03039790|515488008|FG019|Overall Study|Reason, not Specified|0|||
142987055|NCT00498368|515488018|FG000|Overall Study|Withdrawal by Subject|3|||
142987056|NCT00498368|515488019|FG001|Overall Study|Withdrawal by Subject|2|||
142987057|NCT02266004|515488020|FG000|Overall Study|unrelated adverse event|1|||
142987058|NCT02266004|515488020|FG000|Overall Study|Physician Decision|1|||
142987059|NCT00537771|515488025|FG000|Overall Study|Withdrawal by Subject|6|||
142987060|NCT00537771|515488026|FG001|Overall Study|Withdrawal by Subject|23|||
142987061|NCT00537771|515488025|FG000|Overall Study|Adverse Event|8|||
142987062|NCT00537771|515488026|FG001|Overall Study|Adverse Event|15|||
142987063|NCT00537771|515488025|FG000|Overall Study|Lost to Follow-up|9|||
142987064|NCT00537771|515488026|FG001|Overall Study|Lost to Follow-up|15|||
142987065|NCT00537771|515488025|FG000|Overall Study|Protocol Violation|2|||
142987066|NCT00537771|515488026|FG001|Overall Study|Protocol Violation|6|||
142987067|NCT00537771|515488025|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
142987068|NCT00537771|515488026|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
142987069|NCT02736929|515488030|FG000|Main Study|Lost to Follow-up|7|||
142987070|NCT02736929|515488031|FG001|Main Study|Lost to Follow-up|1|||
142987071|NCT02736929|515488032|FG002|Main Study|Lost to Follow-up|0|||
142987072|NCT02736929|515488030|FG000|Main Study|Withdrawal by Subject|1|||
142987073|NCT02736929|515488031|FG001|Main Study|Withdrawal by Subject|1|||
142987074|NCT02736929|515488032|FG002|Main Study|Withdrawal by Subject|0|||
142987075|NCT02736929|515488030|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
142987076|NCT02736929|515488031|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
142987077|NCT02736929|515488032|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
142987078|NCT02972593|515488035|FG000|Overall Study|Lost to Follow-up|19|||
142987079|NCT02972593|515488036|FG001|Overall Study|Lost to Follow-up|15|||
142987080|NCT02972593|515488035|FG000|Overall Study|Protocol Violation|1|||
142987081|NCT02972593|515488036|FG001|Overall Study|Protocol Violation|0|||
142987082|NCT00693693|515488037|FG000|Overall Study|Lost to Follow-up|1|||
142987083|NCT00693693|515488038|FG001|Overall Study|Lost to Follow-up|1|||
142987084|NCT00693693|515488039|FG002|Overall Study|Lost to Follow-up|2|||
142987085|NCT00285649|515488040|FG000|Overall Study|Lost to Follow-up|6|||
142987086|NCT00285649|515488041|FG001|Overall Study|Lost to Follow-up|4|||
142987087|NCT00285649|515488042|FG002|Overall Study|Lost to Follow-up|4|||
142987088|NCT00285649|515488040|FG000|Overall Study|Withdrawal by Subject|3|||
142987089|NCT00285649|515488041|FG001|Overall Study|Withdrawal by Subject|2|||
142987090|NCT00285649|515488042|FG002|Overall Study|Withdrawal by Subject|2|||
142987091|NCT02203916|515488052|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
142987092|NCT02203916|515488053|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
142987093|NCT02203916|515488054|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
142987094|NCT02203916|515488052|FG000|Overall Study|Major Protocol Deviation|1|||
142987095|NCT02203916|515488053|FG001|Overall Study|Major Protocol Deviation|1|||
142987096|NCT02203916|515488054|FG002|Overall Study|Major Protocol Deviation|0|||
142987097|NCT02203916|515488052|FG000|Overall Study|Lost to Follow-up|0|||
142987098|NCT02203916|515488053|FG001|Overall Study|Lost to Follow-up|1|||
142987099|NCT02203916|515488054|FG002|Overall Study|Lost to Follow-up|0|||
142987100|NCT02203916|515488052|FG000|Overall Study|Voluntary Withdrawal|3|||
142987101|NCT02203916|515488053|FG001|Overall Study|Voluntary Withdrawal|3|||
142987102|NCT02203916|515488054|FG002|Overall Study|Voluntary Withdrawal|8|||
142987103|NCT02203916|515488052|FG000|Overall Study|Lack of Efficacy|3|||
142987104|NCT02203916|515488053|FG001|Overall Study|Lack of Efficacy|0|||
142987105|NCT02203916|515488054|FG002|Overall Study|Lack of Efficacy|0|||
142987106|NCT02203916|515488052|FG000|Overall Study|Reason Not Specified|0|||
142987107|NCT02203916|515488053|FG001|Overall Study|Reason Not Specified|2|||
142987108|NCT02203916|515488054|FG002|Overall Study|Reason Not Specified|1|||
142987109|NCT00414973|515488055|FG000|Overall Study|Withdrawal by Subject|14|||
142987110|NCT00414973|515488056|FG001|Overall Study|Withdrawal by Subject|4|||
142987111|NCT00414973|515488057|FG002|Overall Study|Withdrawal by Subject|1|||
142987112|NCT00414973|515488058|FG003|Overall Study|Withdrawal by Subject|0|||
142987113|NCT00414973|515488055|FG000|Overall Study|Adverse Event|10|||
142987114|NCT00414973|515488056|FG001|Overall Study|Adverse Event|0|||
142987115|NCT00414973|515488057|FG002|Overall Study|Adverse Event|1|||
142987116|NCT00414973|515488058|FG003|Overall Study|Adverse Event|0|||
142987117|NCT00414973|515488055|FG000|Overall Study|Protocol Violation|3|||
142987118|NCT00414973|515488056|FG001|Overall Study|Protocol Violation|4|||
142987119|NCT00414973|515488057|FG002|Overall Study|Protocol Violation|0|||
142987120|NCT00414973|515488058|FG003|Overall Study|Protocol Violation|0|||
142987121|NCT00414973|515488055|FG000|Overall Study|Lost to Follow-up|0|||
142987122|NCT00414973|515488056|FG001|Overall Study|Lost to Follow-up|2|||
142987123|NCT00414973|515488057|FG002|Overall Study|Lost to Follow-up|0|||
142987124|NCT00414973|515488058|FG003|Overall Study|Lost to Follow-up|0|||
142987125|NCT00414973|515488055|FG000|Overall Study|Sponsor Decision|1|||
142987126|NCT00414973|515488056|FG001|Overall Study|Sponsor Decision|0|||
142987127|NCT00414973|515488057|FG002|Overall Study|Sponsor Decision|0|||
142987128|NCT00414973|515488058|FG003|Overall Study|Sponsor Decision|0|||
142987129|NCT00414973|515488055|FG000|Overall Study|Death|0|||
142987130|NCT00414973|515488056|FG001|Overall Study|Death|0|||
142987131|NCT00414973|515488057|FG002|Overall Study|Death|1|||
142987132|NCT00414973|515488058|FG003|Overall Study|Death|0|||
142987133|NCT01466062|515488059|FG000|Overall Study|Adverse Event|1|||
142987134|NCT01466062|515488059|FG000|Overall Study|Withdrawal by Subject|1|||
142987135|NCT02865928|515488060|FG000|Overall Study|Withdrawal by Subject|1|||
142987136|NCT02865928|515488061|FG001|Overall Study|Withdrawal by Subject|0|||
142987137|NCT02865928|515488060|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
142987138|NCT02865928|515488061|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
142987139|NCT02865928|515488060|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
142987140|NCT02865928|515488061|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
142987141|NCT01925014|515488062|FG000|Overall Study|Inappropriate enrollment|4|||
142987142|NCT01925014|515488063|FG001|Overall Study|Inappropriate enrollment|6|||
142987143|NCT01925014|515488062|FG000|Overall Study|Withdrawal by Subject|5|||
142987144|NCT01925014|515488063|FG001|Overall Study|Withdrawal by Subject|13|||
142987145|NCT00338806|515488071|FG000|Acute Phase|Withdrawal by Subject|0|||
142987146|NCT00338806|515488072|FG001|Acute Phase|Withdrawal by Subject|1|||
142987147|NCT00338806|515488071|FG000|Follow-up|Lost to Follow-up|1|||
142987148|NCT00338806|515488072|FG001|Follow-up|Lost to Follow-up|3|||
142987149|NCT04731922|515488073|FG000|Overall Study|Adverse Event|0|||
142987150|NCT04731922|515488074|FG001|Overall Study|Adverse Event|0|||
142987151|NCT04731922|515488075|FG002|Overall Study|Adverse Event|0|||
142987152|NCT04731922|515488076|FG003|Overall Study|Adverse Event|0|||
142987153|NCT04731922|515488077|FG004|Overall Study|Adverse Event|0|||
142987154|NCT04731922|515488078|FG005|Overall Study|Adverse Event|0|||
142987155|NCT04731922|515488079|FG006|Overall Study|Adverse Event|0|||
142987156|NCT04731922|515488080|FG007|Overall Study|Adverse Event|0|||
142987157|NCT04731922|515488081|FG008|Overall Study|Adverse Event|0|||
142987158|NCT04731922|515488082|FG009|Overall Study|Adverse Event|0|||
142987159|NCT04731922|515488083|FG010|Overall Study|Adverse Event|1|||
142987160|NCT04731922|515488084|FG011|Overall Study|Adverse Event|0|||
142987161|NCT04731922|515488085|FG012|Overall Study|Adverse Event|0|||
142987162|NCT04731922|515488086|FG013|Overall Study|Adverse Event|0|||
142987163|NCT04731922|515488087|FG014|Overall Study|Adverse Event|0|||
142987164|NCT04731922|515488088|FG015|Overall Study|Adverse Event|0|||
142987165|NCT04731922|515488089|FG016|Overall Study|Adverse Event|0|||
142987166|NCT04731922|515488073|FG000|Overall Study|Lost to Follow-up|0|||
142987167|NCT04731922|515488074|FG001|Overall Study|Lost to Follow-up|0|||
142987168|NCT04731922|515488075|FG002|Overall Study|Lost to Follow-up|0|||
142987169|NCT04731922|515488076|FG003|Overall Study|Lost to Follow-up|1|||
142987170|NCT04731922|515488077|FG004|Overall Study|Lost to Follow-up|0|||
142987171|NCT04731922|515488078|FG005|Overall Study|Lost to Follow-up|1|||
142987172|NCT04731922|515488079|FG006|Overall Study|Lost to Follow-up|0|||
142987173|NCT04731922|515488080|FG007|Overall Study|Lost to Follow-up|0|||
142987174|NCT04731922|515488081|FG008|Overall Study|Lost to Follow-up|0|||
142987175|NCT04731922|515488082|FG009|Overall Study|Lost to Follow-up|0|||
142987176|NCT04731922|515488083|FG010|Overall Study|Lost to Follow-up|0|||
142987177|NCT04731922|515488084|FG011|Overall Study|Lost to Follow-up|0|||
142987178|NCT04731922|515488085|FG012|Overall Study|Lost to Follow-up|0|||
142987179|NCT04731922|515488086|FG013|Overall Study|Lost to Follow-up|0|||
142987180|NCT04731922|515488087|FG014|Overall Study|Lost to Follow-up|0|||
142987181|NCT04731922|515488088|FG015|Overall Study|Lost to Follow-up|0|||
142987182|NCT04731922|515488089|FG016|Overall Study|Lost to Follow-up|0|||
142987183|NCT04731922|515488073|FG000|Overall Study|Withdrawal by Subject|1|||
142987184|NCT04731922|515488074|FG001|Overall Study|Withdrawal by Subject|0|||
142987185|NCT04731922|515488075|FG002|Overall Study|Withdrawal by Subject|0|||
142987186|NCT04731922|515488076|FG003|Overall Study|Withdrawal by Subject|0|||
142987187|NCT04731922|515488077|FG004|Overall Study|Withdrawal by Subject|1|||
142987188|NCT04731922|515488078|FG005|Overall Study|Withdrawal by Subject|0|||
142987189|NCT04731922|515488079|FG006|Overall Study|Withdrawal by Subject|1|||
142987190|NCT04731922|515488080|FG007|Overall Study|Withdrawal by Subject|0|||
142987191|NCT04731922|515488081|FG008|Overall Study|Withdrawal by Subject|0|||
142987192|NCT04731922|515488082|FG009|Overall Study|Withdrawal by Subject|0|||
142987193|NCT04731922|515488083|FG010|Overall Study|Withdrawal by Subject|0|||
142987194|NCT04731922|515488084|FG011|Overall Study|Withdrawal by Subject|0|||
142987195|NCT04731922|515488085|FG012|Overall Study|Withdrawal by Subject|0|||
142987196|NCT04731922|515488086|FG013|Overall Study|Withdrawal by Subject|1|||
142987197|NCT04731922|515488087|FG014|Overall Study|Withdrawal by Subject|0|||
142987198|NCT04731922|515488088|FG015|Overall Study|Withdrawal by Subject|0|||
142987199|NCT04731922|515488089|FG016|Overall Study|Withdrawal by Subject|0|||
142987200|NCT04731922|515488073|FG000|Overall Study|Other|0|||
142987201|NCT04731922|515488074|FG001|Overall Study|Other|0|||
142987202|NCT04731922|515488075|FG002|Overall Study|Other|0|||
142987203|NCT04731922|515488076|FG003|Overall Study|Other|0|||
142987204|NCT04731922|515488077|FG004|Overall Study|Other|0|||
142987205|NCT04731922|515488078|FG005|Overall Study|Other|0|||
142987206|NCT04731922|515488079|FG006|Overall Study|Other|1|||
142987207|NCT04731922|515488080|FG007|Overall Study|Other|0|||
142987208|NCT04731922|515488081|FG008|Overall Study|Other|0|||
142987209|NCT04731922|515488082|FG009|Overall Study|Other|0|||
142987210|NCT04731922|515488083|FG010|Overall Study|Other|0|||
142987211|NCT04731922|515488084|FG011|Overall Study|Other|0|||
142987212|NCT04731922|515488085|FG012|Overall Study|Other|0|||
142987213|NCT04731922|515488086|FG013|Overall Study|Other|0|||
142987214|NCT04731922|515488087|FG014|Overall Study|Other|0|||
142987215|NCT04731922|515488088|FG015|Overall Study|Other|0|||
142987216|NCT04731922|515488089|FG016|Overall Study|Other|0|||
142987217|NCT01819194|515488091|FG000|Overall Study|Loss of study articles|2|||
142987218|NCT02820038|515488092|FG000|Overall Study|Lost to Follow-up|7|||
142987219|NCT02820038|515488093|FG001|Overall Study|Lost to Follow-up|11|||
142987220|NCT02820038|515488094|FG002|Overall Study|Lost to Follow-up|2|||
142987221|NCT02820038|515488095|FG003|Overall Study|Lost to Follow-up|9|||
142987222|NCT02820038|515488092|FG000|Overall Study|Withdrawal by Subject|3|||
142987223|NCT02820038|515488093|FG001|Overall Study|Withdrawal by Subject|14|||
142987224|NCT02820038|515488094|FG002|Overall Study|Withdrawal by Subject|3|||
142987225|NCT02820038|515488095|FG003|Overall Study|Withdrawal by Subject|13|||
142987226|NCT00614991|515488097|FG000|Overall Study|Adverse Event|3|||
142987227|NCT00614991|515488098|FG001|Overall Study|Adverse Event|3|||
142987228|NCT00614991|515488099|FG002|Overall Study|Adverse Event|0|||
142987229|NCT00614991|515488100|FG003|Overall Study|Adverse Event|0|||
142987230|NCT00614991|515488101|FG004|Overall Study|Adverse Event|1|||
142987231|NCT00614991|515488102|FG005|Overall Study|Adverse Event|0|||
142987232|NCT02358863|515489901|FG000|Overall Study|Physician Decision|3|||
142987233|NCT01673373|515489908|FG000|Overall Study|Death|2|||
142987234|NCT05426460|515489911|FG000|Overall Study|Protocol Violation|1|||
142987235|NCT05426460|515489912|FG001|Overall Study|Protocol Violation|1|||
142987236|NCT05426460|515489913|FG002|Overall Study|Protocol Violation|1|||
142987237|NCT05426460|515489914|FG003|Overall Study|Protocol Violation|0|||
142987238|NCT02973997|515489918|FG000|Overall Study|Withdrawal by Subject|4|||
142987239|NCT02973997|515489919|FG001|Overall Study|Withdrawal by Subject|0|||
142987240|NCT02973997|515489918|FG000|Overall Study|Adverse Event|4|||
142987241|NCT02973997|515489919|FG001|Overall Study|Adverse Event|1|||
142987242|NCT02973997|515489918|FG000|Overall Study|Disease Progression|11|||
142987243|NCT02973997|515489919|FG001|Overall Study|Disease Progression|20|||
142987244|NCT02973997|515489918|FG000|Overall Study|Alternative Therapy|3|||
142987245|NCT02973997|515489919|FG001|Overall Study|Alternative Therapy|0|||
142987246|NCT02973997|515489918|FG000|Overall Study|Other complicating disease|0|||
142987247|NCT02973997|515489919|FG001|Overall Study|Other complicating disease|1|||
142987248|NCT02973997|515489918|FG000|Overall Study|Death|0|||
142987249|NCT02973997|515489919|FG001|Overall Study|Death|1|||
142987250|NCT00444951|515489920|FG000|Overall Study|Lost to Follow-up|1|||
142987251|NCT00444951|515489921|FG001|Overall Study|Lost to Follow-up|1|||
142987252|NCT00444951|515489922|FG002|Overall Study|Lost to Follow-up|0|||
142987253|NCT00444951|515489920|FG000|Overall Study|Withdrawal by Subject|4|||
142987254|NCT00444951|515489921|FG001|Overall Study|Withdrawal by Subject|5|||
142987255|NCT00444951|515489922|FG002|Overall Study|Withdrawal by Subject|3|||
142987256|NCT02158728|515489927|FG000|Overall Study|no procedure according to CIP done|3|||
142987257|NCT02158728|515489927|FG000|Overall Study|no qualified dataset|24|||
142987258|NCT00673816|515489935|FG000|Overall Study|Adverse Event|1|||
142987259|NCT00673816|515489935|FG000|Overall Study|Withdrawal by Subject|1|||
142987260|NCT03774875|515489936|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
142987261|NCT03774875|515489937|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
142987262|NCT03774875|515489936|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
142987263|NCT03774875|515489937|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
142987264|NCT03774875|515489936|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
142987265|NCT03774875|515489937|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
142987266|NCT03774875|515489936|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
142987267|NCT03774875|515489937|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
142987268|NCT03774875|515489936|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
142987269|NCT03774875|515489937|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
142987270|NCT03774875|515489936|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
142987271|NCT03774875|515489937|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
142987272|NCT03774875|515489936|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
142987273|NCT03774875|515489937|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
142987274|NCT03774875|515489936|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
142987275|NCT03774875|515489937|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
142987276|NCT03774875|515489936|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
142987277|NCT03774875|515489937|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
142987278|NCT03774875|515489936|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
142987279|NCT03774875|515489937|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
142987280|NCT03774875|515489936|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
142987281|NCT03774875|515489937|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
142987282|NCT03774875|515489936|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
142987283|NCT03774875|515489937|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
142987284|NCT03774875|515489936|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
142987285|NCT03774875|515489937|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
142987286|NCT01764022|515489938|FG000|Overall Study|Death|3|||
142987287|NCT01764022|515489939|FG001|Overall Study|Death|5|||
142987288|NCT01764022|515489938|FG000|Overall Study|Withdrawal by Subject|2|||
142987289|NCT01764022|515489939|FG001|Overall Study|Withdrawal by Subject|6|||
142987290|NCT01764022|515489938|FG000|Overall Study|Lack of Efficacy|0|||
142987291|NCT01764022|515489939|FG001|Overall Study|Lack of Efficacy|1|||
142987292|NCT01764022|515489938|FG000|Overall Study|Physician Decision|0|||
142987293|NCT01764022|515489939|FG001|Overall Study|Physician Decision|2|||
142987294|NCT01764022|515489938|FG000|Overall Study|Lost to Follow-up|2|||
142987295|NCT01764022|515489939|FG001|Overall Study|Lost to Follow-up|0|||
142987296|NCT01764022|515489938|FG000|Overall Study|Protocol Violation|1|||
142987297|NCT01764022|515489939|FG001|Overall Study|Protocol Violation|0|||
142987298|NCT04043416|515489941|FG000|Washout|Change in health condition|0|||
142987299|NCT04043416|515489942|FG001|Washout|Change in health condition|1|||
142987300|NCT00372489|515489946|FG000|Overall Study|Adverse Event|18|||
142987301|NCT00372489|515489946|FG000|Overall Study|Lack of Efficacy|1|||
142987302|NCT00372489|515489946|FG000|Overall Study|Lost to Follow-up|3|||
142987303|NCT00372489|515489946|FG000|Overall Study|Physician Decision|3|||
142987304|NCT00372489|515489946|FG000|Overall Study|Withdrawal by Subject|5|||
142987305|NCT00372489|515489946|FG000|Overall Study|Patient Relocation|2|||
142987306|NCT00372489|515489946|FG000|Overall Study|Renal transplant|6|||
142987307|NCT00372489|515489946|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
142987308|NCT00893763|515489947|FG000|Overall Study|extubated|110|||
142987309|NCT00893763|515489948|FG001|Overall Study|extubated|110|||
142987310|NCT01437267|515489952|FG000|Overall Study|Withdrawal by Subject|0|||
142987311|NCT01437267|515489953|FG001|Overall Study|Withdrawal by Subject|0|||
142987312|NCT01437267|515489954|FG002|Overall Study|Withdrawal by Subject|0|||
142987313|NCT01437267|515489955|FG003|Overall Study|Withdrawal by Subject|1|||
142987314|NCT01437267|515489956|FG004|Overall Study|Withdrawal by Subject|0|||
142987315|NCT01437267|515489957|FG005|Overall Study|Withdrawal by Subject|0|||
142987316|NCT01437267|515489952|FG000|Overall Study|Protocol Violation|0|||
142987317|NCT01437267|515489953|FG001|Overall Study|Protocol Violation|1|||
142987318|NCT01437267|515489954|FG002|Overall Study|Protocol Violation|0|||
142987319|NCT01437267|515489955|FG003|Overall Study|Protocol Violation|0|||
142987320|NCT01437267|515489956|FG004|Overall Study|Protocol Violation|0|||
142987321|NCT01437267|515489957|FG005|Overall Study|Protocol Violation|0|||
142987322|NCT03934203|515489958|FG000|Overall Study|Adverse Event|0|||
143117230|NCT02093390|515970074|FG000|Overall Study|Withdrawal by Subject|0|||
142987323|NCT03934203|515489959|FG001|Overall Study|Adverse Event|0|||
142987324|NCT03934203|515489960|FG002|Overall Study|Adverse Event|1|||
142987325|NCT03934203|515489961|FG003|Overall Study|Adverse Event|0|||
142987326|NCT03934203|515489962|FG004|Overall Study|Adverse Event|1|||
142987327|NCT03934203|515489963|FG005|Overall Study|Adverse Event|0|||
142987328|NCT03934203|515489964|FG006|Overall Study|Adverse Event|2|||
142987329|NCT03934203|515489965|FG007|Overall Study|Adverse Event|0|||
142987330|NCT03934203|515489966|FG008|Overall Study|Adverse Event|0|||
142987331|NCT03934203|515489967|FG009|Overall Study|Adverse Event|0|||
142987332|NCT03934203|515489968|FG010|Overall Study|Adverse Event|0|||
142987333|NCT03934203|515489969|FG011|Overall Study|Adverse Event|0|||
142987334|NCT03934203|515489970|FG012|Overall Study|Adverse Event|0|||
142987335|NCT03934203|515489971|FG013|Overall Study|Adverse Event|1|||
142987336|NCT03934203|515489972|FG014|Overall Study|Adverse Event|0|||
142987337|NCT00608842|515489975|FG000|Overall Study|Participant's Request|0|||
142987338|NCT00608842|515489976|FG001|Overall Study|Participant's Request|1|||
142987339|NCT00608842|515489977|FG002|Overall Study|Participant's Request|2|||
142987340|NCT00608842|515489978|FG003|Overall Study|Participant's Request|1|||
142987341|NCT00608842|515489975|FG000|Overall Study|Lost to Follow-up|1|||
142987342|NCT00608842|515489976|FG001|Overall Study|Lost to Follow-up|0|||
142987343|NCT00608842|515489977|FG002|Overall Study|Lost to Follow-up|0|||
142987344|NCT00608842|515489978|FG003|Overall Study|Lost to Follow-up|0|||
142987345|NCT00899678|515489979|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
142987346|NCT00899678|515489980|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
142987347|NCT00899678|515489981|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
142987348|NCT00899678|515489979|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
142987349|NCT00899678|515489980|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
142987350|NCT00899678|515489981|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
142987351|NCT00899678|515489979|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
142987352|NCT00899678|515489980|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
142987353|NCT00899678|515489981|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
142987354|NCT00899678|515489979|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
142987355|NCT00899678|515489980|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
142987356|NCT00899678|515489981|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
142987357|NCT00899678|515489979|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
142987358|NCT00899678|515489980|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
142987359|NCT00899678|515489981|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
142987360|NCT00899678|515489979|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
142987361|NCT00899678|515489980|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
142987362|NCT00899678|515489981|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
142987363|NCT00899678|515489979|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
142987364|NCT00899678|515489980|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
142987365|NCT00899678|515489981|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
142987366|NCT00899678|515489979|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
142987367|NCT00899678|515489980|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
142987368|NCT00899678|515489981|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
142987369|NCT00899678|515489979|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
142987370|NCT00899678|515489980|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
142987371|NCT00899678|515489981|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
142987372|NCT02699125|515489984|FG000|Placebo|Lost to Follow-up|2|||
142987373|NCT02699125|515489985|FG001|Placebo|Lost to Follow-up|0|||
142987374|NCT02699125|515489984|FG000|Placebo|Protocol Violation|1|||
142987375|NCT02699125|515489985|FG001|Placebo|Protocol Violation|0|||
142987376|NCT02699125|515489984|FG000|Placebo|Withdrawal by Subject|0|||
142987377|NCT02699125|515489985|FG001|Placebo|Withdrawal by Subject|4|||
142987378|NCT02699125|515489984|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
142987379|NCT02699125|515489985|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
142987380|NCT04445051|515489989|FG000|Overall Study|Adverse Event|0|||
142987381|NCT04445051|515489990|FG001|Overall Study|Adverse Event|0|||
142987382|NCT04445051|515489991|FG002|Overall Study|Adverse Event|1|||
142987383|NCT04445051|515489992|FG003|Overall Study|Adverse Event|0|||
142987384|NCT04445051|515489993|FG004|Overall Study|Adverse Event|0|||
142987385|NCT04445051|515489994|FG005|Overall Study|Adverse Event|0|||
142987386|NCT03799627|515489999|FG000|Overall Study|Adverse Event|1|||
142987387|NCT03799627|515490000|FG001|Overall Study|Adverse Event|2|||
142987388|NCT03799627|515490001|FG002|Overall Study|Adverse Event|0|||
142987389|NCT03799627|515490002|FG003|Overall Study|Adverse Event|0|||
142987390|NCT03799627|515490003|FG004|Overall Study|Adverse Event|2|||
142987391|NCT03799627|515490004|FG005|Overall Study|Adverse Event|5|||
142987392|NCT03799627|515490005|FG006|Overall Study|Adverse Event|0|||
142987393|NCT03799627|515490006|FG007|Overall Study|Adverse Event|2|||
142987394|NCT03799627|515490007|FG008|Overall Study|Adverse Event|0|||
142987395|NCT03799627|515489999|FG000|Overall Study|Physician Decision|2|||
142987396|NCT03799627|515490000|FG001|Overall Study|Physician Decision|2|||
142987397|NCT03799627|515490001|FG002|Overall Study|Physician Decision|0|||
142987398|NCT03799627|515490002|FG003|Overall Study|Physician Decision|0|||
142987399|NCT03799627|515490003|FG004|Overall Study|Physician Decision|2|||
142987400|NCT03799627|515490004|FG005|Overall Study|Physician Decision|2|||
142987401|NCT03799627|515490005|FG006|Overall Study|Physician Decision|0|||
142987402|NCT03799627|515490006|FG007|Overall Study|Physician Decision|0|||
142987403|NCT03799627|515490007|FG008|Overall Study|Physician Decision|0|||
142987404|NCT03799627|515489999|FG000|Overall Study|Withdrawal by Subject|1|||
142987405|NCT03799627|515490000|FG001|Overall Study|Withdrawal by Subject|1|||
142987406|NCT03799627|515490001|FG002|Overall Study|Withdrawal by Subject|0|||
142987407|NCT03799627|515490002|FG003|Overall Study|Withdrawal by Subject|2|||
142987408|NCT03799627|515490003|FG004|Overall Study|Withdrawal by Subject|0|||
142987409|NCT03799627|515490004|FG005|Overall Study|Withdrawal by Subject|3|||
142987410|NCT03799627|515490005|FG006|Overall Study|Withdrawal by Subject|0|||
142987411|NCT03799627|515490006|FG007|Overall Study|Withdrawal by Subject|0|||
142987412|NCT03799627|515490007|FG008|Overall Study|Withdrawal by Subject|0|||
142987413|NCT03799627|515489999|FG000|Overall Study|Lack of Efficacy|0|||
142987414|NCT03799627|515490000|FG001|Overall Study|Lack of Efficacy|0|||
142987415|NCT03799627|515490001|FG002|Overall Study|Lack of Efficacy|0|||
142987416|NCT03799627|515490002|FG003|Overall Study|Lack of Efficacy|1|||
142987417|NCT03799627|515490003|FG004|Overall Study|Lack of Efficacy|0|||
142987418|NCT03799627|515490004|FG005|Overall Study|Lack of Efficacy|0|||
142987419|NCT03799627|515490005|FG006|Overall Study|Lack of Efficacy|0|||
142987420|NCT03799627|515490006|FG007|Overall Study|Lack of Efficacy|0|||
142987421|NCT03799627|515490007|FG008|Overall Study|Lack of Efficacy|0|||
142987422|NCT03799627|515489999|FG000|Overall Study|Lost to Follow-up|0|||
142987423|NCT03799627|515490000|FG001|Overall Study|Lost to Follow-up|0|||
142987424|NCT03799627|515490001|FG002|Overall Study|Lost to Follow-up|0|||
142987425|NCT03799627|515490002|FG003|Overall Study|Lost to Follow-up|0|||
142987426|NCT03799627|515490003|FG004|Overall Study|Lost to Follow-up|0|||
142987427|NCT03799627|515490004|FG005|Overall Study|Lost to Follow-up|0|||
142987428|NCT03799627|515490005|FG006|Overall Study|Lost to Follow-up|1|||
142987429|NCT03799627|515490006|FG007|Overall Study|Lost to Follow-up|0|||
142987430|NCT03799627|515490007|FG008|Overall Study|Lost to Follow-up|1|||
142987431|NCT03799627|515489999|FG000|Overall Study|Death|0|||
142987432|NCT03799627|515490000|FG001|Overall Study|Death|0|||
142987433|NCT03799627|515490001|FG002|Overall Study|Death|0|||
142987434|NCT03799627|515490002|FG003|Overall Study|Death|1|||
142987435|NCT03799627|515490003|FG004|Overall Study|Death|0|||
142987436|NCT03799627|515490004|FG005|Overall Study|Death|0|||
142987437|NCT03799627|515490005|FG006|Overall Study|Death|0|||
142987438|NCT03799627|515490006|FG007|Overall Study|Death|0|||
142987439|NCT03799627|515490007|FG008|Overall Study|Death|0|||
142987440|NCT03799627|515489999|FG000|Overall Study|Study Drug Put on Hold|1|||
142987441|NCT03799627|515490000|FG001|Overall Study|Study Drug Put on Hold|0|||
142987442|NCT03799627|515490001|FG002|Overall Study|Study Drug Put on Hold|0|||
142987443|NCT03799627|515490002|FG003|Overall Study|Study Drug Put on Hold|0|||
142987444|NCT03799627|515490003|FG004|Overall Study|Study Drug Put on Hold|0|||
142987445|NCT03799627|515490004|FG005|Overall Study|Study Drug Put on Hold|0|||
142987446|NCT03799627|515490005|FG006|Overall Study|Study Drug Put on Hold|0|||
142987447|NCT03799627|515490006|FG007|Overall Study|Study Drug Put on Hold|0|||
142987448|NCT03799627|515490007|FG008|Overall Study|Study Drug Put on Hold|0|||
142987449|NCT03799627|515489999|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
142987450|NCT03799627|515490000|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
142987451|NCT03799627|515490001|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
142987452|NCT03799627|515490002|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
142987453|NCT03799627|515490003|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
142987454|NCT03799627|515490004|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
142987455|NCT03799627|515490005|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
142987456|NCT03799627|515490006|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
142987457|NCT03799627|515490007|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
142987458|NCT03799627|515489999|FG000|Overall Study|Kidney Transplantation|1|||
142987459|NCT03799627|515490000|FG001|Overall Study|Kidney Transplantation|0|||
142987460|NCT03799627|515490001|FG002|Overall Study|Kidney Transplantation|0|||
142987461|NCT03799627|515490002|FG003|Overall Study|Kidney Transplantation|1|||
142987462|NCT03799627|515490003|FG004|Overall Study|Kidney Transplantation|1|||
142987463|NCT03799627|515490004|FG005|Overall Study|Kidney Transplantation|0|||
142987464|NCT03799627|515490005|FG006|Overall Study|Kidney Transplantation|0|||
142987465|NCT03799627|515490006|FG007|Overall Study|Kidney Transplantation|0|||
142987466|NCT03799627|515490007|FG008|Overall Study|Kidney Transplantation|0|||
142987467|NCT03799627|515489999|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
142987468|NCT03799627|515490000|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
142987469|NCT03799627|515490001|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
142987470|NCT03799627|515490002|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
142987471|NCT03799627|515490003|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
142987472|NCT03799627|515490004|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
142987473|NCT03799627|515490005|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
142987474|NCT03799627|515490006|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
142987475|NCT03799627|515490007|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
142987476|NCT03799627|515489999|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
142987477|NCT03799627|515490000|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
142987478|NCT03799627|515490001|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
142987479|NCT03799627|515490002|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
142987480|NCT03799627|515490003|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
142987481|NCT03799627|515490004|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
142987482|NCT03799627|515490005|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
142987483|NCT03799627|515490006|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
142987484|NCT03799627|515490007|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
142987485|NCT03799627|515489999|FG000|Overall Study|Met Exclusion Criteria|0|||
142987486|NCT03799627|515490000|FG001|Overall Study|Met Exclusion Criteria|0|||
142987487|NCT03799627|515490001|FG002|Overall Study|Met Exclusion Criteria|0|||
142987488|NCT03799627|515490002|FG003|Overall Study|Met Exclusion Criteria|1|||
142987489|NCT03799627|515490003|FG004|Overall Study|Met Exclusion Criteria|0|||
142987490|NCT03799627|515490004|FG005|Overall Study|Met Exclusion Criteria|0|||
142987491|NCT03799627|515490005|FG006|Overall Study|Met Exclusion Criteria|0|||
142987492|NCT03799627|515490006|FG007|Overall Study|Met Exclusion Criteria|0|||
142987493|NCT03799627|515490007|FG008|Overall Study|Met Exclusion Criteria|0|||
142987494|NCT03799627|515489999|FG000|Overall Study|Investigational Product Noncompliance|0|||
142987495|NCT03799627|515490000|FG001|Overall Study|Investigational Product Noncompliance|0|||
142987496|NCT03799627|515490001|FG002|Overall Study|Investigational Product Noncompliance|0|||
142987497|NCT03799627|515490002|FG003|Overall Study|Investigational Product Noncompliance|1|||
142987498|NCT03799627|515490003|FG004|Overall Study|Investigational Product Noncompliance|0|||
142987499|NCT03799627|515490004|FG005|Overall Study|Investigational Product Noncompliance|0|||
142987500|NCT03799627|515490005|FG006|Overall Study|Investigational Product Noncompliance|0|||
142987501|NCT03799627|515490006|FG007|Overall Study|Investigational Product Noncompliance|0|||
142987502|NCT03799627|515490007|FG008|Overall Study|Investigational Product Noncompliance|0|||
142987503|NCT03799627|515489999|FG000|Overall Study|Participant Relocation|0|||
142987504|NCT03799627|515490000|FG001|Overall Study|Participant Relocation|0|||
142987505|NCT03799627|515490001|FG002|Overall Study|Participant Relocation|0|||
142987506|NCT03799627|515490002|FG003|Overall Study|Participant Relocation|1|||
142987507|NCT03799627|515490003|FG004|Overall Study|Participant Relocation|0|||
142987508|NCT03799627|515490004|FG005|Overall Study|Participant Relocation|1|||
142987509|NCT03799627|515490005|FG006|Overall Study|Participant Relocation|0|||
142987510|NCT03799627|515490006|FG007|Overall Study|Participant Relocation|0|||
142987511|NCT03799627|515490007|FG008|Overall Study|Participant Relocation|0|||
142987512|NCT03799627|515489999|FG000|Overall Study|Eurofin Issue|0|||
142987513|NCT03799627|515490000|FG001|Overall Study|Eurofin Issue|0|||
142987514|NCT03799627|515490001|FG002|Overall Study|Eurofin Issue|0|||
142987515|NCT03799627|515490002|FG003|Overall Study|Eurofin Issue|0|||
142987516|NCT03799627|515490003|FG004|Overall Study|Eurofin Issue|1|||
142987517|NCT03799627|515490004|FG005|Overall Study|Eurofin Issue|0|||
142987518|NCT03799627|515490005|FG006|Overall Study|Eurofin Issue|0|||
142987519|NCT03799627|515490006|FG007|Overall Study|Eurofin Issue|0|||
142987520|NCT03799627|515490007|FG008|Overall Study|Eurofin Issue|0|||
142987521|NCT03799627|515489999|FG000|Overall Study|Noncompliance with Site Instructions|0|||
142987522|NCT03799627|515490000|FG001|Overall Study|Noncompliance with Site Instructions|0|||
142987523|NCT03799627|515490001|FG002|Overall Study|Noncompliance with Site Instructions|0|||
142987524|NCT03799627|515490002|FG003|Overall Study|Noncompliance with Site Instructions|0|||
142987525|NCT03799627|515490003|FG004|Overall Study|Noncompliance with Site Instructions|1|||
142987526|NCT03799627|515490004|FG005|Overall Study|Noncompliance with Site Instructions|0|||
142987527|NCT03799627|515490005|FG006|Overall Study|Noncompliance with Site Instructions|0|||
142987528|NCT03799627|515490006|FG007|Overall Study|Noncompliance with Site Instructions|0|||
142987529|NCT03799627|515490007|FG008|Overall Study|Noncompliance with Site Instructions|0|||
142987530|NCT03799627|515489999|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
142987531|NCT03799627|515490000|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
142987532|NCT03799627|515490001|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
142987533|NCT03799627|515490002|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
142987534|NCT03799627|515490003|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
142987535|NCT03799627|515490004|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
142987536|NCT03799627|515490005|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
142987537|NCT03799627|515490006|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
142987538|NCT03799627|515490007|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
142987539|NCT03799627|515489999|FG000|Overall Study|Changes In Hemoglobin Values|1|||
142987540|NCT03799627|515490000|FG001|Overall Study|Changes In Hemoglobin Values|2|||
142987541|NCT03799627|515490001|FG002|Overall Study|Changes In Hemoglobin Values|1|||
142987542|NCT03799627|515490002|FG003|Overall Study|Changes In Hemoglobin Values|0|||
142987543|NCT03799627|515490003|FG004|Overall Study|Changes In Hemoglobin Values|0|||
142987544|NCT03799627|515490004|FG005|Overall Study|Changes In Hemoglobin Values|2|||
142987545|NCT03799627|515490005|FG006|Overall Study|Changes In Hemoglobin Values|1|||
142987546|NCT03799627|515490006|FG007|Overall Study|Changes In Hemoglobin Values|0|||
142987547|NCT03799627|515490007|FG008|Overall Study|Changes In Hemoglobin Values|1|||
142987548|NCT02092324|515490010|FG000|Overall Study|Adverse Event|1|||
142987549|NCT02092324|515490010|FG000|Overall Study|Lack of Efficacy|6|||
142987550|NCT02092324|515490010|FG000|Overall Study|Proceed to Transplant|3|||
142987551|NCT02092324|515490010|FG000|Overall Study|Physician Decision|7|||
142987552|NCT02092324|515490010|FG000|Overall Study|Misdiagnosis|2|||
142987553|NCT01922739|515490017|FG000|Titration/Adjustment Period|Adverse Event|3|||
142987554|NCT01922739|515490017|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
142987555|NCT01922739|515490017|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
142987556|NCT01922739|515490017|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
142987557|NCT01922739|515490017|FG000|Open-label Treatment Period|Adverse Event|6|||
142987558|NCT01922739|515490017|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
142987559|NCT01922739|515490017|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
142987560|NCT01922739|515490017|FG000|Open-label Treatment Period|Protocol Violation|5|||
142987561|NCT01922739|515490017|FG000|Open-label Treatment Period|Pregnancy|1|||
142987562|NCT01922739|515490017|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
142987563|NCT01922739|515490017|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
142987564|NCT01922739|515490017|FG000|Open-label Treatment Period|Physician Decision|1|||
142987565|NCT01922739|515490017|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
142987566|NCT03148795|515490020|FG000|Overall Study|Progressive Disease|1|||
142987567|NCT00422240|515490021|FG000|Overall Study|Lack of Efficacy|1|||
142987568|NCT00422240|515490022|FG001|Overall Study|Lack of Efficacy|2|||
142987569|NCT00422240|515490023|FG002|Overall Study|Lack of Efficacy|0|||
142987570|NCT00422240|515490024|FG003|Overall Study|Lack of Efficacy|1|||
142987571|NCT00422240|515490021|FG000|Overall Study|Adverse Event|11|||
142987572|NCT00422240|515490022|FG001|Overall Study|Adverse Event|4|||
142987573|NCT00422240|515490023|FG002|Overall Study|Adverse Event|5|||
142987574|NCT00422240|515490024|FG003|Overall Study|Adverse Event|2|||
142987575|NCT00422240|515490021|FG000|Overall Study|Subject request|21|||
142987576|NCT00422240|515490022|FG001|Overall Study|Subject request|17|||
142987577|NCT00422240|515490023|FG002|Overall Study|Subject request|18|||
142987578|NCT00422240|515490024|FG003|Overall Study|Subject request|30|||
142987579|NCT00422240|515490021|FG000|Overall Study|Protocol Violation|0|||
142987580|NCT00422240|515490022|FG001|Overall Study|Protocol Violation|1|||
142987581|NCT00422240|515490023|FG002|Overall Study|Protocol Violation|0|||
142987582|NCT00422240|515490024|FG003|Overall Study|Protocol Violation|1|||
142987583|NCT00422240|515490021|FG000|Overall Study|Lost to Follow-up|31|||
142987584|NCT00422240|515490022|FG001|Overall Study|Lost to Follow-up|32|||
142987585|NCT00422240|515490023|FG002|Overall Study|Lost to Follow-up|19|||
142987586|NCT00422240|515490024|FG003|Overall Study|Lost to Follow-up|34|||
142987587|NCT00422240|515490021|FG000|Overall Study|Other|1|||
142987588|NCT00422240|515490022|FG001|Overall Study|Other|0|||
142987589|NCT00422240|515490023|FG002|Overall Study|Other|0|||
142987590|NCT00422240|515490024|FG003|Overall Study|Other|1|||
142987591|NCT00422240|515490021|FG000|Overall Study|Pregnancy|3|||
142987592|NCT00422240|515490022|FG001|Overall Study|Pregnancy|1|||
142987593|NCT00422240|515490023|FG002|Overall Study|Pregnancy|1|||
142987594|NCT00422240|515490024|FG003|Overall Study|Pregnancy|2|||
142987595|NCT00441012|515490025|FG000|Overall Study|Adverse Event|0|||
142987596|NCT00441012|515490026|FG001|Overall Study|Adverse Event|1|||
142987597|NCT00441012|515490025|FG000|Overall Study|Lost to Follow-up|3|||
142987598|NCT00441012|515490026|FG001|Overall Study|Lost to Follow-up|3|||
142987599|NCT00441012|515490025|FG000|Overall Study|Protocol Violation|10|||
142987600|NCT00441012|515490026|FG001|Overall Study|Protocol Violation|9|||
142987601|NCT00441012|515490025|FG000|Overall Study|Withdrawal by Subject|4|||
142987602|NCT00441012|515490026|FG001|Overall Study|Withdrawal by Subject|0|||
142987603|NCT00441012|515490025|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
142987604|NCT00441012|515490026|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
142987605|NCT01624467|515490027|FG000|Overall Study|Withdrawal by Subject|2|||
142987606|NCT01624467|515490027|FG000|Overall Study|Lost to Follow-up|1|||
142987607|NCT01624467|515490027|FG000|Overall Study|Adverse Event|7|||
142987608|NCT01624467|515490027|FG000|Overall Study|Progressive Disease|19|||
142987609|NCT01624467|515490027|FG000|Overall Study|Per Sponsor Requirement|1|||
142987610|NCT01624467|515490027|FG000|Overall Study|Subject Withdrew from Treatment|1|||
142987611|NCT00262314|515490032|FG000|Overall Study|Changing physicians|38|||
142987612|NCT00262314|515490032|FG000|Overall Study|Death|12|||
142987613|NCT00262314|515490032|FG000|Overall Study|Patient's decision|92|||
142987614|NCT00262314|515490032|FG000|Overall Study|Other|95|||
142987615|NCT00262314|515490032|FG000|Overall Study|Lost to Follow-up|70|||
142987616|NCT00262314|515490032|FG000|Overall Study|Administrative withdrawal|30|||
142987617|NCT05104749|515490033|FG000|Overall Study|Lost to Follow-up|2|||
142987618|NCT05104749|515490034|FG001|Overall Study|Lost to Follow-up|3|||
142987619|NCT03964493|515490035|FG000|Overall Study|Withdrawal by Subject|4|||
142987620|NCT03964493|515490036|FG001|Overall Study|Withdrawal by Subject|1|||
142987621|NCT03964493|515490035|FG000|Overall Study|Lost to Follow-up|13|||
142987622|NCT03964493|515490036|FG001|Overall Study|Lost to Follow-up|4|||
142987623|NCT00398138|515490037|FG000|Overall Study|Adverse Event|2|||
142987624|NCT04973085|515490042|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
142987625|NCT04973085|515490043|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
142987626|NCT00887068|515490044|FG000|Overall Study|Withdrawal by Subject|2|||
142987627|NCT00887068|515490045|FG001|Overall Study|Withdrawal by Subject|0|||
142987628|NCT00887068|515490044|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
142987629|NCT00887068|515490045|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
142987630|NCT03924427|515490046|FG000|Overall Study|Adverse Event|4|||
142987631|NCT03924427|515490046|FG000|Overall Study|Lack of Efficacy|1|||
142987632|NCT03924427|515490046|FG000|Overall Study|Withdrawal by Subject|1|||
142987633|NCT01316380|515490051|FG000|Overall Study|Adverse Event|0|||
142987634|NCT01316380|515490052|FG001|Overall Study|Adverse Event|2|||
142987635|NCT01316380|515490053|FG002|Overall Study|Adverse Event|1|||
142987636|NCT01316380|515490051|FG000|Overall Study|Protocol Violation|0|||
142987637|NCT01316380|515490052|FG001|Overall Study|Protocol Violation|0|||
142987638|NCT01316380|515490053|FG002|Overall Study|Protocol Violation|1|||
142987639|NCT01316380|515490051|FG000|Overall Study|Withdrawal by Subject|1|||
142987640|NCT01316380|515490052|FG001|Overall Study|Withdrawal by Subject|2|||
142987641|NCT01316380|515490053|FG002|Overall Study|Withdrawal by Subject|0|||
142987642|NCT01316380|515490051|FG000|Overall Study|Other|0|||
142987643|NCT01316380|515490052|FG001|Overall Study|Other|1|||
142987644|NCT01316380|515490053|FG002|Overall Study|Other|1|||
142987645|NCT01316380|515490051|FG000|Overall Study|Not treated|1|||
142987646|NCT01316380|515490052|FG001|Overall Study|Not treated|0|||
142987647|NCT01316380|515490053|FG002|Overall Study|Not treated|0|||
142987648|NCT00149890|515490057|FG000|Overall Study|Adverse Event|1|||
142987649|NCT00149890|515490058|FG001|Overall Study|Adverse Event|8|||
142987650|NCT00149890|515490057|FG000|Overall Study|Lack of Efficacy|8|||
142987651|NCT00149890|515490058|FG001|Overall Study|Lack of Efficacy|9|||
142987652|NCT00149890|515490057|FG000|Overall Study|Protocol Violation|1|||
142987653|NCT00149890|515490058|FG001|Overall Study|Protocol Violation|0|||
142987654|NCT00149890|515490057|FG000|Overall Study|Lost to Follow-up|1|||
142987655|NCT00149890|515490058|FG001|Overall Study|Lost to Follow-up|0|||
142987656|NCT00149890|515490057|FG000|Overall Study|Graft Loss|2|||
142987657|NCT00149890|515490058|FG001|Overall Study|Graft Loss|1|||
142987658|NCT01387594|515490059|FG000|Overall Study|Withdrawal by Subject|0|||
142987659|NCT01387594|515490060|FG001|Overall Study|Withdrawal by Subject|2|||
142987660|NCT01387594|515490059|FG000|Overall Study|Lost to Follow-up|0|||
142987661|NCT01387594|515490060|FG001|Overall Study|Lost to Follow-up|1|||
142987662|NCT03073200|515490068|FG000|Double Blind Treatment Period|Protocol Violation|1|||
142987663|NCT03073200|515490069|FG001|Double Blind Treatment Period|Protocol Violation|0|||
142987664|NCT03073200|515490070|FG002|Double Blind Treatment Period|Protocol Violation|0|||
142987665|NCT03073200|515490071|FG003|Double Blind Treatment Period|Protocol Violation|0|||
142987666|NCT03073200|515490072|FG004|Double Blind Treatment Period|Protocol Violation|0|||
142987667|NCT03073200|515490073|FG005|Double Blind Treatment Period|Protocol Violation|0|||
142987668|NCT03073200|515490074|FG006|Double Blind Treatment Period|Protocol Violation|0|||
142987669|NCT03073200|515490075|FG007|Double Blind Treatment Period|Protocol Violation|0|||
142987670|NCT03073200|515490076|FG008|Double Blind Treatment Period|Protocol Violation|0|||
142987671|NCT03073200|515490077|FG009|Double Blind Treatment Period|Protocol Violation|0|||
142987672|NCT03073200|515490078|FG010|Double Blind Treatment Period|Protocol Violation|0|||
142987673|NCT03073200|515490079|FG011|Double Blind Treatment Period|Protocol Violation|0|||
142987674|NCT03073200|515490080|FG012|Double Blind Treatment Period|Protocol Violation|0|||
142987675|NCT03073200|515490081|FG013|Double Blind Treatment Period|Protocol Violation|0|||
142987676|NCT03073200|515490082|FG014|Double Blind Treatment Period|Protocol Violation|0|||
142987677|NCT03073200|515490068|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
142987678|NCT03073200|515490069|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
142987679|NCT03073200|515490070|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
142987680|NCT03073200|515490071|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
142987681|NCT03073200|515490072|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
142987682|NCT03073200|515490073|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
142987683|NCT03073200|515490074|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
142987684|NCT03073200|515490075|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
142987685|NCT03073200|515490076|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
142987686|NCT03073200|515490077|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
142987687|NCT03073200|515490078|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
142987688|NCT03073200|515490079|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
142987689|NCT03073200|515490080|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
142987690|NCT03073200|515490081|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
142987691|NCT03073200|515490082|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
142987692|NCT03073200|515490068|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
142987693|NCT03073200|515490069|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
142987694|NCT03073200|515490070|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
142987695|NCT03073200|515490071|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
142987696|NCT03073200|515490072|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
142987697|NCT03073200|515490073|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
142987698|NCT03073200|515490074|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
142987699|NCT03073200|515490075|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
142987700|NCT03073200|515490076|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
142987701|NCT03073200|515490077|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
142987702|NCT03073200|515490078|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
142987703|NCT03073200|515490079|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
142987704|NCT03073200|515490080|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
142987705|NCT03073200|515490081|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
142987706|NCT03073200|515490082|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
142987707|NCT03073200|515490068|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
142987708|NCT03073200|515490069|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
142987709|NCT03073200|515490070|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
142987710|NCT03073200|515490071|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
142987711|NCT03073200|515490072|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
142987712|NCT03073200|515490073|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
142987713|NCT03073200|515490074|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
142987714|NCT03073200|515490075|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
142987715|NCT03073200|515490076|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
142987716|NCT03073200|515490077|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
142987717|NCT03073200|515490078|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
142987718|NCT03073200|515490079|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
142987719|NCT03073200|515490080|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
142987720|NCT03073200|515490081|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
142987721|NCT03073200|515490082|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
142987722|NCT03073200|515490068|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
142987723|NCT03073200|515490069|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
142987724|NCT03073200|515490070|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
142987725|NCT03073200|515490071|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
142987726|NCT03073200|515490072|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
142987727|NCT03073200|515490073|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
142987728|NCT03073200|515490074|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
142987729|NCT03073200|515490075|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
142987730|NCT03073200|515490076|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
142987731|NCT03073200|515490077|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
142987732|NCT03073200|515490078|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
142987733|NCT03073200|515490079|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
142987734|NCT03073200|515490080|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
142987735|NCT03073200|515490081|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
142987736|NCT03073200|515490082|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
142987737|NCT03073200|515490068|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
142987738|NCT03073200|515490069|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
142987739|NCT03073200|515490070|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
142987740|NCT03073200|515490071|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
142987741|NCT03073200|515490072|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
142987742|NCT03073200|515490073|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
142987743|NCT03073200|515490074|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
142987744|NCT03073200|515490075|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
142987745|NCT03073200|515490076|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
142987746|NCT03073200|515490077|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
142987747|NCT03073200|515490078|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
142987748|NCT03073200|515490079|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
142987749|NCT03073200|515490080|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
142987750|NCT03073200|515490081|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
142987751|NCT03073200|515490082|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
142987752|NCT03073200|515490068|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
142987753|NCT03073200|515490069|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
142987754|NCT03073200|515490070|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
142987755|NCT03073200|515490071|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
142987756|NCT03073200|515490072|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
142987757|NCT03073200|515490073|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
142987758|NCT03073200|515490074|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
142987759|NCT03073200|515490075|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
143003177|NCT01049360|515548749|FG005|Period 2|Lack of Efficacy|1|||
142987760|NCT03073200|515490076|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
142987761|NCT03073200|515490077|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
142987762|NCT03073200|515490078|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
142987763|NCT03073200|515490079|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
142987764|NCT03073200|515490080|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
142987765|NCT03073200|515490081|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
142987766|NCT03073200|515490082|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
142987767|NCT03073200|515490068|FG000|Extension Period|Lost to Follow-up|0|||
142987768|NCT03073200|515490069|FG001|Extension Period|Lost to Follow-up|0|||
142987769|NCT03073200|515490070|FG002|Extension Period|Lost to Follow-up|0|||
142987770|NCT03073200|515490071|FG003|Extension Period|Lost to Follow-up|0|||
142987771|NCT03073200|515490072|FG004|Extension Period|Lost to Follow-up|0|||
142987772|NCT03073200|515490073|FG005|Extension Period|Lost to Follow-up|0|||
142987773|NCT03073200|515490074|FG006|Extension Period|Lost to Follow-up|1|||
142987774|NCT03073200|515490075|FG007|Extension Period|Lost to Follow-up|1|||
142987775|NCT03073200|515490076|FG008|Extension Period|Lost to Follow-up|0|||
142987776|NCT03073200|515490077|FG009|Extension Period|Lost to Follow-up|0|||
142987777|NCT03073200|515490078|FG010|Extension Period|Lost to Follow-up|0|||
142987778|NCT03073200|515490079|FG011|Extension Period|Lost to Follow-up|0|||
142987779|NCT03073200|515490080|FG012|Extension Period|Lost to Follow-up|0|||
142987780|NCT03073200|515490081|FG013|Extension Period|Lost to Follow-up|0|||
142987781|NCT03073200|515490082|FG014|Extension Period|Lost to Follow-up|0|||
142987782|NCT03073200|515490068|FG000|Extension Period|Sponsor Decision|0|||
142987783|NCT03073200|515490069|FG001|Extension Period|Sponsor Decision|0|||
142987784|NCT03073200|515490070|FG002|Extension Period|Sponsor Decision|0|||
142987785|NCT03073200|515490071|FG003|Extension Period|Sponsor Decision|0|||
142987786|NCT03073200|515490072|FG004|Extension Period|Sponsor Decision|0|||
142987787|NCT03073200|515490073|FG005|Extension Period|Sponsor Decision|0|||
142987788|NCT03073200|515490074|FG006|Extension Period|Sponsor Decision|0|||
142987789|NCT03073200|515490075|FG007|Extension Period|Sponsor Decision|0|||
142987790|NCT03073200|515490076|FG008|Extension Period|Sponsor Decision|1|||
142987791|NCT03073200|515490077|FG009|Extension Period|Sponsor Decision|0|||
142987792|NCT03073200|515490078|FG010|Extension Period|Sponsor Decision|0|||
142987793|NCT03073200|515490079|FG011|Extension Period|Sponsor Decision|0|||
142987794|NCT03073200|515490080|FG012|Extension Period|Sponsor Decision|0|||
142987795|NCT03073200|515490081|FG013|Extension Period|Sponsor Decision|0|||
142987796|NCT03073200|515490082|FG014|Extension Period|Sponsor Decision|0|||
142987797|NCT03073200|515490068|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
142987798|NCT03073200|515490069|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
142987799|NCT03073200|515490070|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
142987800|NCT03073200|515490071|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
142987801|NCT03073200|515490072|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
142987802|NCT03073200|515490073|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
142987803|NCT03073200|515490074|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
142987804|NCT03073200|515490075|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
142987805|NCT03073200|515490076|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
142987806|NCT03073200|515490077|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
142987807|NCT03073200|515490078|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
142987808|NCT03073200|515490079|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
142987809|NCT03073200|515490080|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
142987810|NCT03073200|515490081|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
142987811|NCT03073200|515490082|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
142987812|NCT03073200|515490068|FG000|Extension Period|Withdrawal by Subject|0|||
142987813|NCT03073200|515490069|FG001|Extension Period|Withdrawal by Subject|0|||
142987814|NCT03073200|515490070|FG002|Extension Period|Withdrawal by Subject|0|||
142987815|NCT03073200|515490071|FG003|Extension Period|Withdrawal by Subject|0|||
142987816|NCT03073200|515490072|FG004|Extension Period|Withdrawal by Subject|0|||
142987817|NCT03073200|515490073|FG005|Extension Period|Withdrawal by Subject|0|||
142987818|NCT03073200|515490074|FG006|Extension Period|Withdrawal by Subject|1|||
142987819|NCT03073200|515490075|FG007|Extension Period|Withdrawal by Subject|2|||
142987820|NCT03073200|515490076|FG008|Extension Period|Withdrawal by Subject|0|||
142987821|NCT03073200|515490077|FG009|Extension Period|Withdrawal by Subject|0|||
142987822|NCT03073200|515490078|FG010|Extension Period|Withdrawal by Subject|0|||
142987823|NCT03073200|515490079|FG011|Extension Period|Withdrawal by Subject|0|||
142987824|NCT03073200|515490080|FG012|Extension Period|Withdrawal by Subject|0|||
142987825|NCT03073200|515490081|FG013|Extension Period|Withdrawal by Subject|0|||
142987826|NCT03073200|515490082|FG014|Extension Period|Withdrawal by Subject|0|||
142987827|NCT03073200|515490068|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
142987828|NCT03073200|515490069|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
142987829|NCT03073200|515490070|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
142987830|NCT03073200|515490071|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
142987831|NCT03073200|515490072|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
142987832|NCT03073200|515490073|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
142987833|NCT03073200|515490074|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
142987834|NCT03073200|515490075|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
142987835|NCT03073200|515490076|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
142987836|NCT03073200|515490077|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
142987837|NCT03073200|515490078|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
142987838|NCT03073200|515490079|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
142987839|NCT03073200|515490080|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
142987840|NCT03073200|515490081|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
142987841|NCT03073200|515490082|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
142987842|NCT03073200|515490068|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
142987843|NCT03073200|515490069|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
142987844|NCT03073200|515490070|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
142987845|NCT03073200|515490071|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
142987846|NCT03073200|515490072|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
142987847|NCT03073200|515490073|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
142987848|NCT03073200|515490074|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
142987849|NCT03073200|515490075|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
142987850|NCT03073200|515490076|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
142987851|NCT03073200|515490077|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
142987852|NCT03073200|515490078|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
142987853|NCT03073200|515490079|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
142987854|NCT03073200|515490080|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
142987855|NCT03073200|515490081|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
142987856|NCT03073200|515490082|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
142987857|NCT03073200|515490068|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
142987858|NCT03073200|515490069|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
142987859|NCT03073200|515490070|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
142987860|NCT03073200|515490071|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
142987861|NCT03073200|515490072|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
142987862|NCT03073200|515490073|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
142987863|NCT03073200|515490074|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
142987864|NCT03073200|515490075|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
142987865|NCT03073200|515490076|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
142987866|NCT03073200|515490077|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
142987867|NCT03073200|515490078|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
142987868|NCT03073200|515490079|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
142987869|NCT03073200|515490080|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
142987870|NCT03073200|515490081|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
142987871|NCT03073200|515490082|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
142987872|NCT03073200|515490068|FG000|Randomized Withdrawal Period|Adverse Event|0|||
142987873|NCT03073200|515490069|FG001|Randomized Withdrawal Period|Adverse Event|0|||
142987874|NCT03073200|515490070|FG002|Randomized Withdrawal Period|Adverse Event|0|||
142987875|NCT03073200|515490071|FG003|Randomized Withdrawal Period|Adverse Event|0|||
142987876|NCT03073200|515490072|FG004|Randomized Withdrawal Period|Adverse Event|0|||
142987877|NCT03073200|515490073|FG005|Randomized Withdrawal Period|Adverse Event|0|||
142987878|NCT03073200|515490074|FG006|Randomized Withdrawal Period|Adverse Event|0|||
142987879|NCT03073200|515490075|FG007|Randomized Withdrawal Period|Adverse Event|0|||
142987880|NCT03073200|515490076|FG008|Randomized Withdrawal Period|Adverse Event|0|||
142987881|NCT03073200|515490077|FG009|Randomized Withdrawal Period|Adverse Event|0|||
142987882|NCT03073200|515490078|FG010|Randomized Withdrawal Period|Adverse Event|1|||
142987883|NCT03073200|515490079|FG011|Randomized Withdrawal Period|Adverse Event|0|||
142987884|NCT03073200|515490080|FG012|Randomized Withdrawal Period|Adverse Event|0|||
142987885|NCT03073200|515490081|FG013|Randomized Withdrawal Period|Adverse Event|0|||
142987886|NCT03073200|515490082|FG014|Randomized Withdrawal Period|Adverse Event|0|||
142987887|NCT03073200|515490068|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
142987888|NCT03073200|515490069|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
142987889|NCT03073200|515490070|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
142987890|NCT03073200|515490071|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
142987891|NCT03073200|515490072|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
142987892|NCT03073200|515490073|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
142987893|NCT03073200|515490074|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
142987894|NCT03073200|515490075|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
142987895|NCT03073200|515490076|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
142987896|NCT03073200|515490077|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
142987897|NCT03073200|515490078|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
142987898|NCT03073200|515490079|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
142987899|NCT03073200|515490080|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
142987900|NCT03073200|515490081|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
142987901|NCT03073200|515490082|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
142987902|NCT03073200|515490068|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
142987903|NCT03073200|515490069|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
142987904|NCT03073200|515490070|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
142987905|NCT03073200|515490071|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
142987906|NCT03073200|515490072|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
142987907|NCT03073200|515490073|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
142987908|NCT03073200|515490074|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
142987909|NCT03073200|515490075|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
142987910|NCT03073200|515490076|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
142987911|NCT03073200|515490077|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
142987912|NCT03073200|515490078|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
142987913|NCT03073200|515490079|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
142987914|NCT03073200|515490080|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
142987915|NCT03073200|515490081|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
142987916|NCT03073200|515490082|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
142987917|NCT03073200|515490068|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
142987918|NCT03073200|515490069|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
142987919|NCT03073200|515490070|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
142987920|NCT03073200|515490071|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
142987921|NCT03073200|515490072|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
142987922|NCT03073200|515490073|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
142987923|NCT03073200|515490074|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
142987924|NCT03073200|515490075|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
142987925|NCT03073200|515490076|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
142987926|NCT03073200|515490077|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
142987927|NCT03073200|515490078|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
142987928|NCT03073200|515490079|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
142987929|NCT03073200|515490080|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
142987930|NCT03073200|515490081|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
142987931|NCT03073200|515490082|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
142987932|NCT03073200|515490068|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
142987933|NCT03073200|515490069|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
142987934|NCT03073200|515490070|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
142987935|NCT03073200|515490071|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
142987936|NCT03073200|515490072|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
142987937|NCT03073200|515490073|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
142987938|NCT03073200|515490074|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
142987939|NCT03073200|515490075|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
142987940|NCT03073200|515490076|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
142987941|NCT03073200|515490077|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
142987942|NCT03073200|515490078|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
142987943|NCT03073200|515490079|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
142987944|NCT03073200|515490080|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
142987945|NCT03073200|515490081|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
142987946|NCT03073200|515490082|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
142987947|NCT03073200|515490068|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
142987948|NCT03073200|515490069|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
142987949|NCT03073200|515490070|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
142987950|NCT03073200|515490071|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
142987951|NCT03073200|515490072|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
142987952|NCT03073200|515490073|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
142987953|NCT03073200|515490074|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
142987954|NCT03073200|515490075|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
142987955|NCT03073200|515490076|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
142987956|NCT03073200|515490077|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
142987957|NCT03073200|515490078|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
142987958|NCT03073200|515490079|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
142987959|NCT03073200|515490080|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
142987960|NCT03073200|515490081|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
142987961|NCT03073200|515490082|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
142987962|NCT03073200|515490068|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
142987963|NCT03073200|515490069|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
143117231|NCT02093390|515970075|FG001|Overall Study|Withdrawal by Subject|1|||
143117232|NCT01709864|515971808|FG000|Overall Study|Physician Decision|0|||
142987964|NCT03073200|515490070|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
142987965|NCT03073200|515490071|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
142987966|NCT03073200|515490072|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
142987967|NCT03073200|515490073|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
142987968|NCT03073200|515490074|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
142987969|NCT03073200|515490075|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
142987970|NCT03073200|515490076|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
142987971|NCT03073200|515490077|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
142987972|NCT03073200|515490078|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
142987973|NCT03073200|515490079|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
142987974|NCT03073200|515490080|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
142987975|NCT03073200|515490081|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
142987976|NCT03073200|515490082|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
142987977|NCT03073200|515490068|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
142987978|NCT03073200|515490069|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
142987979|NCT03073200|515490070|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
142987980|NCT03073200|515490071|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
142987981|NCT03073200|515490072|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
142987982|NCT03073200|515490073|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
142987983|NCT03073200|515490074|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
142987984|NCT03073200|515490075|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
142987985|NCT03073200|515490076|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
142987986|NCT03073200|515490077|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
142987987|NCT03073200|515490078|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
142987988|NCT03073200|515490079|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
142987989|NCT03073200|515490080|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
142987990|NCT03073200|515490081|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
142987991|NCT03073200|515490082|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
142987992|NCT03073200|515490068|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
142987993|NCT03073200|515490069|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
142987994|NCT03073200|515490070|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
142987995|NCT03073200|515490071|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
142987996|NCT03073200|515490072|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
142987997|NCT03073200|515490073|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
142987998|NCT03073200|515490074|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
142987999|NCT03073200|515490075|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
142988000|NCT03073200|515490076|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
142988001|NCT03073200|515490077|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
142988002|NCT03073200|515490078|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
142988003|NCT03073200|515490079|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
142988004|NCT03073200|515490080|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
142988005|NCT03073200|515490081|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
142988006|NCT03073200|515490082|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
142988007|NCT02632344|515491919|FG000|Overall Study|Adverse Event|3|||
142988008|NCT02632344|515491919|FG000|Overall Study|Lack of Efficacy|3|||
142988009|NCT02632344|515491919|FG000|Overall Study|Withdrawal by Subject|2|||
142988010|NCT02000622|515491924|FG000|Overall Study|Withdrawal by Subject|5|||
142988011|NCT02000622|515491925|FG001|Overall Study|Withdrawal by Subject|7|||
142988012|NCT02000622|515491924|FG000|Overall Study|Lost to Follow-up|4|||
142988013|NCT02000622|515491925|FG001|Overall Study|Lost to Follow-up|0|||
142988014|NCT02000622|515491924|FG000|Overall Study|Death|159|||
142988015|NCT02000622|515491925|FG001|Overall Study|Death|73|||
142988016|NCT02000622|515491924|FG000|Overall Study|Withdrawn due to site closure|1|||
142988017|NCT02000622|515491925|FG001|Overall Study|Withdrawn due to site closure|0|||
142988018|NCT01405027|515491926|FG000|Overall Study|Withdrawn consent|3|||
142988019|NCT01405027|515491927|FG001|Overall Study|Withdrawn consent|0|||
142988020|NCT01405027|515491926|FG000|Overall Study|Lost to Follow-up|16|||
142988021|NCT01405027|515491927|FG001|Overall Study|Lost to Follow-up|24|||
142988022|NCT01405027|515491926|FG000|Overall Study|Investigator judgement|0|||
142988023|NCT01405027|515491927|FG001|Overall Study|Investigator judgement|2|||
142988024|NCT01405027|515491926|FG000|Overall Study|Death|1|||
142988025|NCT01405027|515491927|FG001|Overall Study|Death|0|||
142988026|NCT01405027|515491926|FG000|Overall Study|Other or Unknown|12|||
142988027|NCT01405027|515491927|FG001|Overall Study|Other or Unknown|25|||
142988028|NCT06048809|515491941|FG000|Overall Study|Adverse Event|2|||
142988029|NCT06048809|515491942|FG001|Overall Study|Adverse Event|0|||
142988030|NCT06048809|515491941|FG000|Overall Study|Withdrawal by Subject|1|||
142988031|NCT06048809|515491942|FG001|Overall Study|Withdrawal by Subject|1|||
142988032|NCT04924114|515491945|FG000|Overall Study|Withdrawal by Subject|0|||
142988033|NCT04924114|515491946|FG001|Overall Study|Withdrawal by Subject|2|||
142988034|NCT04924114|515491947|FG002|Overall Study|Withdrawal by Subject|2|||
142988035|NCT04924114|515491948|FG003|Overall Study|Withdrawal by Subject|0|||
142988036|NCT04924114|515491949|FG004|Overall Study|Withdrawal by Subject|2|||
142988037|NCT04960202|515491950|FG000|Overall Study|Other|5|||
142988038|NCT04960202|515491951|FG001|Overall Study|Other|0|||
142988039|NCT04960202|515491950|FG000|Overall Study|Withdrawal by Subject|37|||
142988040|NCT04960202|515491951|FG001|Overall Study|Withdrawal by Subject|43|||
142988041|NCT04960202|515491950|FG000|Overall Study|Lost to Follow-up|20|||
142988042|NCT04960202|515491951|FG001|Overall Study|Lost to Follow-up|16|||
142988043|NCT04960202|515491950|FG000|Overall Study|Death|0|||
142988044|NCT04960202|515491951|FG001|Overall Study|Death|15|||
142988045|NCT03558828|515491953|FG000|Overall Study|Lost to Follow-up|4|||
142988046|NCT03558828|515491954|FG001|Overall Study|Lost to Follow-up|3|||
142988047|NCT03558828|515491955|FG002|Overall Study|Lost to Follow-up|3|||
142988048|NCT03558828|515491956|FG003|Overall Study|Lost to Follow-up|5|||
142988049|NCT03558828|515491957|FG004|Overall Study|Lost to Follow-up|2|||
142988050|NCT03558828|515491958|FG005|Overall Study|Lost to Follow-up|3|||
142988051|NCT03558828|515491953|FG000|Overall Study|dropped before the intervention|1|||
142988052|NCT03558828|515491954|FG001|Overall Study|dropped before the intervention|1|||
142988053|NCT03558828|515491955|FG002|Overall Study|dropped before the intervention|0|||
142988054|NCT03558828|515491956|FG003|Overall Study|dropped before the intervention|0|||
142988055|NCT03558828|515491957|FG004|Overall Study|dropped before the intervention|0|||
142988056|NCT03558828|515491958|FG005|Overall Study|dropped before the intervention|0|||
142988057|NCT03671148|515491959|FG000|Overall Study|Adverse Event|3|||
142988058|NCT03671148|515491960|FG001|Overall Study|Adverse Event|2|||
142988059|NCT03671148|515491959|FG000|Overall Study|Withdrawal by Subject|8|||
142988060|NCT03671148|515491960|FG001|Overall Study|Withdrawal by Subject|2|||
142988061|NCT03671148|515491959|FG000|Overall Study|Lost to Follow-up|1|||
142988062|NCT03671148|515491960|FG001|Overall Study|Lost to Follow-up|2|||
142988063|NCT03671148|515491959|FG000|Overall Study|Lack of Efficacy|7|||
142988064|NCT03671148|515491960|FG001|Overall Study|Lack of Efficacy|2|||
142988065|NCT03671148|515491959|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
142988066|NCT03671148|515491960|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
142988067|NCT03671148|515491959|FG000|Overall Study|Other|1|||
142988068|NCT03671148|515491960|FG001|Overall Study|Other|0|||
142988069|NCT03671148|515491959|FG000|Overall Study|Incomplete Randomization Visit|1|||
142988070|NCT03671148|515491960|FG001|Overall Study|Incomplete Randomization Visit|0|||
142988071|NCT03878160|515491961|FG000|Overall Study|Lost to Follow-up|1|||
142988072|NCT03878160|515491962|FG001|Overall Study|Lost to Follow-up|1|||
142988073|NCT03878160|515491963|FG002|Overall Study|Lost to Follow-up|1|||
142988074|NCT03878160|515491961|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
142988075|NCT03878160|515491962|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
142988076|NCT03878160|515491963|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
142988077|NCT00589602|515491964|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
142988078|NCT00413777|515491970|FG000|Fixed-dose Period|Lost to Follow-up|1|||
142988079|NCT00413777|515491971|FG001|Fixed-dose Period|Lost to Follow-up|1|||
142988080|NCT00413777|515491970|FG000|Fixed-dose Period|Adverse Event|2|||
142988081|NCT00413777|515491971|FG001|Fixed-dose Period|Adverse Event|1|||
142988082|NCT00413777|515491970|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
142988083|NCT00413777|515491971|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
142988084|NCT00413777|515491970|FG000|Fixed-dose Period|Withdrew Consent|0|||
142988085|NCT00413777|515491971|FG001|Fixed-dose Period|Withdrew Consent|1|||
142988086|NCT05505734|515491972|FG000|Overall Study|Withdrawal by Subject|51|||
142988087|NCT05505734|515491973|FG001|Overall Study|Withdrawal by Subject|64|||
142988088|NCT05505734|515491972|FG000|Overall Study|Adverse Event|6|||
142988089|NCT05505734|515491973|FG001|Overall Study|Adverse Event|20|||
142988090|NCT05505734|515491972|FG000|Overall Study|Protocol Violation|8|||
142988091|NCT05505734|515491973|FG001|Overall Study|Protocol Violation|15|||
142988092|NCT05505734|515491972|FG000|Overall Study|Lack of therapeutic response|0|||
142988093|NCT05505734|515491973|FG001|Overall Study|Lack of therapeutic response|1|||
142988094|NCT05505734|515491972|FG000|Overall Study|Lost to Follow-up|247|||
142988095|NCT05505734|515491973|FG001|Overall Study|Lost to Follow-up|237|||
142988096|NCT05505734|515491972|FG000|Overall Study|Physician Decision|22|||
142988097|NCT05505734|515491973|FG001|Overall Study|Physician Decision|13|||
142988098|NCT05505734|515491972|FG000|Overall Study|Death|2|||
142988099|NCT05505734|515491973|FG001|Overall Study|Death|1|||
142988100|NCT05505734|515491972|FG000|Overall Study|Withdrawal by parent/guardian|0|||
142988101|NCT05505734|515491973|FG001|Overall Study|Withdrawal by parent/guardian|1|||
142988102|NCT05505734|515491972|FG000|Overall Study|Pregnancy|1|||
142988103|NCT05505734|515491973|FG001|Overall Study|Pregnancy|0|||
142988104|NCT05505734|515491972|FG000|Overall Study|Other|17|||
142988105|NCT05505734|515491973|FG001|Overall Study|Other|13|||
142988106|NCT04288089|515491980|FG000|Overall Study|Ongoing Treatment|2|||
143117233|NCT01709864|515971809|FG001|Overall Study|Physician Decision|1|||
142988107|NCT04288089|515491981|FG001|Overall Study|Ongoing Treatment|1|||
142988108|NCT04288089|515491982|FG002|Overall Study|Ongoing Treatment|1|||
142988109|NCT04288089|515491983|FG003|Overall Study|Ongoing Treatment|4|||
142988110|NCT00976963|515491988|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
142988111|NCT00976963|515491989|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
142988112|NCT00976963|515491988|FG000|Overall Study|administrative error|1|||
142988113|NCT00976963|515491989|FG001|Overall Study|administrative error|0|||
142988114|NCT00976963|515491988|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
142988115|NCT00976963|515491989|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
142988116|NCT01688999|515491992|FG000|Overall Study|Withdrawal by Subject|5|||
142988117|NCT01688999|515491993|FG001|Overall Study|Withdrawal by Subject|1|||
142988118|NCT01688999|515491994|FG002|Overall Study|Withdrawal by Subject|1|||
142988119|NCT01688999|515491992|FG000|Overall Study|Adverse Event|2|||
142988120|NCT01688999|515491993|FG001|Overall Study|Adverse Event|0|||
142988121|NCT01688999|515491994|FG002|Overall Study|Adverse Event|2|||
142988122|NCT01688999|515491992|FG000|Overall Study|Ineligible/Not treated|1|||
142988123|NCT01688999|515491993|FG001|Overall Study|Ineligible/Not treated|0|||
142988124|NCT01688999|515491994|FG002|Overall Study|Ineligible/Not treated|0|||
142988125|NCT02768103|515491995|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
142988126|NCT00557323|515492012|FG000|Overall Study|Death|3|||
142988127|NCT00557323|515492012|FG000|Overall Study|Withdrawal by Subject|2|||
142988128|NCT00557323|515492012|FG000|Overall Study|Administrative change|2|||
142988129|NCT02148952|515492016|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
142988130|NCT02148952|515492017|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
142988131|NCT02148952|515492016|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
142988132|NCT02148952|515492017|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
142988133|NCT02148952|515492016|FG000|Follow-Up|Lost to Follow-up|219|||
142988134|NCT02148952|515492017|FG001|Follow-Up|Lost to Follow-up|231|||
142988135|NCT02148952|515492016|FG000|Follow-Up|Withdrawal by Subject|46|||
142988136|NCT02148952|515492017|FG001|Follow-Up|Withdrawal by Subject|48|||
142988137|NCT01025232|515492018|FG000|Overall Study|Study drug no longer available|3|||
142988138|NCT01025232|515492019|FG001|Overall Study|Study drug no longer available|6|||
142988139|NCT01600105|515492020|FG000|Total Participants|Withdrawal by Subject|1|||
142988140|NCT01600105|515492021|FG001|Total Participants|Withdrawal by Subject|0|||
142988141|NCT01600105|515492020|FG000|Total Participants|No images in PACS|10|||
142988142|NCT01600105|515492021|FG001|Total Participants|No images in PACS|0|||
142988143|NCT01600105|515492020|FG000|Total Participants|Insufficient image quality|30|||
142988144|NCT01600105|515492021|FG001|Total Participants|Insufficient image quality|10|||
142988145|NCT01600105|515492020|FG000|Sub Study I|Insufficient image quality|0|||
142988146|NCT01600105|515492021|FG001|Sub Study I|Insufficient image quality|10|||
142988147|NCT01600105|515492020|FG000|Sub Study II|Withdrawal by Subject|1|||
142988148|NCT01600105|515492021|FG001|Sub Study II|Withdrawal by Subject|0|||
142988149|NCT01600105|515492020|FG000|Sub Study II|No images in PACS|1|||
142988150|NCT01600105|515492021|FG001|Sub Study II|No images in PACS|0|||
142988151|NCT01600105|515492020|FG000|Sub Study II|Insufficient image quality|3|||
142988152|NCT01600105|515492021|FG001|Sub Study II|Insufficient image quality|0|||
142988153|NCT01600105|515492020|FG000|Sub Study III|Insufficient image quality|5|||
142988154|NCT01600105|515492021|FG001|Sub Study III|Insufficient image quality|0|||
142988155|NCT01600105|515492020|FG000|Sub Study V|Poor Image Quality|2|||
142988156|NCT01600105|515492021|FG001|Sub Study V|Poor Image Quality|0|||
142988157|NCT03748420|515492022|FG000|Overall Study|No 12 month medication adherence data available|0|||
142988158|NCT03748420|515492023|FG001|Overall Study|No 12 month medication adherence data available|1|||
142988159|NCT03748420|515492022|FG000|Overall Study|Death|24|||
142988160|NCT03748420|515492023|FG001|Overall Study|Death|28|||
142988161|NCT03748420|515492022|FG000|Overall Study|Lost to Follow-up|231|||
142988162|NCT03748420|515492023|FG001|Overall Study|Lost to Follow-up|230|||
142988163|NCT01263444|515492024|FG000|Overall Study|Adverse Event|8|||
142988164|NCT01263444|515492024|FG000|Overall Study|Withdrawal by Subject|1|||
142988165|NCT01263444|515492024|FG000|Overall Study|Protocol Violation|1|||
142988166|NCT04007367|515492025|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
142988167|NCT04007367|515492026|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
142988168|NCT04007367|515492027|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
142988169|NCT04007367|515492025|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
142988170|NCT04007367|515492026|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
142988171|NCT04007367|515492027|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
142988172|NCT04007367|515492025|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
142988173|NCT04007367|515492026|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
142988174|NCT04007367|515492027|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
142988175|NCT04007367|515492025|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
142988176|NCT04007367|515492026|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
142988177|NCT04007367|515492027|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
142988178|NCT04007367|515492025|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
142988179|NCT04007367|515492026|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
142988180|NCT04007367|515492027|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
142988181|NCT00117572|515492033|FG000|Overall Study|Site withdrew before starting treatment|2|||
142988182|NCT00117572|515492034|FG001|Overall Study|Site withdrew before starting treatment|3|||
142988183|NCT00117572|515492033|FG000|Overall Study|Withdrawal by Subject|3|||
142988184|NCT00117572|515492034|FG001|Overall Study|Withdrawal by Subject|3|||
142988185|NCT00117572|515492033|FG000|Overall Study|Protocol Violation|1|||
142988186|NCT00117572|515492034|FG001|Overall Study|Protocol Violation|0|||
142988187|NCT04228445|515492044|FG000|Overall Study|Lost to Follow-up|1|||
142988188|NCT04228445|515492045|FG001|Overall Study|Lost to Follow-up|1|||
142988189|NCT04228445|515492044|FG000|Overall Study|Physician Decision|1|||
142988190|NCT04228445|515492045|FG001|Overall Study|Physician Decision|2|||
142988191|NCT04228445|515492044|FG000|Overall Study|Withdrawal by Subject|0|||
142988192|NCT04228445|515492045|FG001|Overall Study|Withdrawal by Subject|1|||
142988193|NCT04228445|515492044|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
142988194|NCT04228445|515492045|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
142988195|NCT03418376|515492046|FG000|Overall Study|Musculoskeletal injury|1|||
142988196|NCT03418376|515492047|FG001|Overall Study|Musculoskeletal injury|2|||
142988197|NCT03418376|515492048|FG002|Overall Study|Musculoskeletal injury|1|||
142988198|NCT03418376|515492049|FG003|Overall Study|Musculoskeletal injury|0|||
142988199|NCT03418376|515492046|FG000|Overall Study|Personal reasons|0|||
142988200|NCT03418376|515492047|FG001|Overall Study|Personal reasons|2|||
142988201|NCT03418376|515492048|FG002|Overall Study|Personal reasons|2|||
142988202|NCT03418376|515492049|FG003|Overall Study|Personal reasons|1|||
142988203|NCT03418376|515492046|FG000|Overall Study|Exacerbation|0|||
142988204|NCT03418376|515492047|FG001|Overall Study|Exacerbation|1|||
142988205|NCT03418376|515492048|FG002|Overall Study|Exacerbation|0|||
142988206|NCT03418376|515492049|FG003|Overall Study|Exacerbation|0|||
142988207|NCT04757376|515492050|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
142988208|NCT04757376|515492051|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
142988209|NCT04757376|515492052|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
142988210|NCT04757376|515492053|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
142988211|NCT04757376|515492054|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
142988212|NCT04757376|515492050|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
142988213|NCT04757376|515492051|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
142988214|NCT04757376|515492052|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
142988215|NCT04757376|515492053|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
142988216|NCT04757376|515492054|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
142988217|NCT04757376|515492050|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
142988218|NCT04757376|515492051|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
142988219|NCT04757376|515492052|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
142988220|NCT04757376|515492053|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
142988221|NCT04757376|515492054|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
142988222|NCT04757376|515492050|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
142988223|NCT04757376|515492051|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
142988224|NCT04757376|515492052|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
142988225|NCT04757376|515492053|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
142988226|NCT04757376|515492054|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
142988227|NCT04757376|515492050|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
142988228|NCT04757376|515492051|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
142988229|NCT04757376|515492052|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
142988230|NCT04757376|515492053|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
142988231|NCT04757376|515492054|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
142988232|NCT04757376|515492050|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
142988233|NCT04757376|515492051|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
142988234|NCT04757376|515492052|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
142988235|NCT04757376|515492053|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
142988236|NCT04757376|515492054|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
142988237|NCT04757376|515492050|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
142988238|NCT04757376|515492051|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
142988239|NCT04757376|515492052|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
142988240|NCT04757376|515492053|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
142988241|NCT04757376|515492054|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
142988242|NCT04757376|515492050|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
142988243|NCT04757376|515492051|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
142988244|NCT04757376|515492052|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
142988245|NCT04757376|515492053|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
142988246|NCT04757376|515492054|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
142988247|NCT01365091|515492055|FG000|Period 1|Adverse Event|1|||
142988248|NCT01365091|515492056|FG001|Period 1|Adverse Event|0|||
142988249|NCT01365091|515492057|FG002|Period 1|Adverse Event|2|||
142988250|NCT01365091|515492058|FG003|Period 1|Adverse Event|3|||
142988251|NCT01365091|515492055|FG000|Period 1|Positive test result for drugs of abuse|1|||
142988252|NCT01365091|515492056|FG001|Period 1|Positive test result for drugs of abuse|0|||
142988253|NCT01365091|515492057|FG002|Period 1|Positive test result for drugs of abuse|0|||
142988254|NCT01365091|515492058|FG003|Period 1|Positive test result for drugs of abuse|0|||
142988255|NCT01365091|515492055|FG000|Period 1|No longer met study criteria|0|||
142988256|NCT01365091|515492056|FG001|Period 1|No longer met study criteria|1|||
142988257|NCT01365091|515492057|FG002|Period 1|No longer met study criteria|0|||
142988258|NCT01365091|515492058|FG003|Period 1|No longer met study criteria|0|||
142988259|NCT01365091|515492055|FG000|Period 1|Withdrawal by Subject|0|||
142988260|NCT01365091|515492056|FG001|Period 1|Withdrawal by Subject|1|||
142988261|NCT01365091|515492057|FG002|Period 1|Withdrawal by Subject|0|||
142988262|NCT01365091|515492058|FG003|Period 1|Withdrawal by Subject|0|||
142988263|NCT01365091|515492055|FG000|Period 1|Personal reasons|0|||
142988264|NCT01365091|515492056|FG001|Period 1|Personal reasons|0|||
142988265|NCT01365091|515492057|FG002|Period 1|Personal reasons|1|||
142988266|NCT01365091|515492058|FG003|Period 1|Personal reasons|0|||
142988267|NCT01365091|515492055|FG000|Period 2|Withdrawal by Subject|1|||
142988268|NCT01365091|515492056|FG001|Period 2|Withdrawal by Subject|0|||
142988269|NCT01365091|515492057|FG002|Period 2|Withdrawal by Subject|0|||
142988270|NCT01365091|515492058|FG003|Period 2|Withdrawal by Subject|0|||
142988271|NCT01365091|515492055|FG000|Period 2|Adverse Event|0|||
142988272|NCT01365091|515492056|FG001|Period 2|Adverse Event|0|||
142988273|NCT01365091|515492057|FG002|Period 2|Adverse Event|1|||
142988274|NCT01365091|515492058|FG003|Period 2|Adverse Event|0|||
142988275|NCT00901394|515492059|FG000|Overall Study|Physician Decision|1|||
142988276|NCT00901394|515492060|FG001|Overall Study|Physician Decision|1|||
142988277|NCT00901394|515492061|FG002|Overall Study|Physician Decision|2|||
142988278|NCT01388491|515492063|FG000|Overall Study|Adverse Event|10|||
142988279|NCT01388491|515492064|FG001|Overall Study|Adverse Event|9|||
142988280|NCT01388491|515492063|FG000|Overall Study|Sponsor Request|9|||
142988281|NCT01388491|515492064|FG001|Overall Study|Sponsor Request|7|||
142988282|NCT01388491|515492063|FG000|Overall Study|Withdrawal by Subject|6|||
142988283|NCT01388491|515492064|FG001|Overall Study|Withdrawal by Subject|10|||
142988284|NCT01388491|515492063|FG000|Overall Study|Lost to Follow-up|4|||
142988285|NCT01388491|515492064|FG001|Overall Study|Lost to Follow-up|3|||
142988286|NCT01388491|515492063|FG000|Overall Study|Protocol Violation|2|||
142988287|NCT01388491|515492064|FG001|Overall Study|Protocol Violation|0|||
142988288|NCT01388491|515492063|FG000|Overall Study|Noncompliance|2|||
142988289|NCT01388491|515492064|FG001|Overall Study|Noncompliance|0|||
142988290|NCT01388491|515492063|FG000|Overall Study|Pregnancy|1|||
142988291|NCT01388491|515492064|FG001|Overall Study|Pregnancy|0|||
142988292|NCT04964557|515492068|FG000|Overall Study|Withdrawal by Subject|3|||
142988293|NCT04964557|515492069|FG001|Overall Study|Withdrawal by Subject|2|||
142988294|NCT04964557|515492068|FG000|Overall Study|Lost to Follow-up|1|||
142988295|NCT04964557|515492069|FG001|Overall Study|Lost to Follow-up|2|||
142988296|NCT04964557|515492068|FG000|Overall Study|Physician Decision|2|||
142988297|NCT04964557|515492069|FG001|Overall Study|Physician Decision|0|||
142988298|NCT04964557|515492068|FG000|Overall Study|Death|3|||
142988299|NCT04964557|515492069|FG001|Overall Study|Death|0|||
142988300|NCT04964557|515492068|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
142988301|NCT04964557|515492069|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
142988302|NCT01190020|515492070|FG000|Overall Study|Adverse Event|2|||
142988303|NCT01190020|515492071|FG001|Overall Study|Adverse Event|0|||
142988304|NCT01190020|515492070|FG000|Overall Study|Lost to Follow-up|2|||
142988305|NCT01190020|515492071|FG001|Overall Study|Lost to Follow-up|0|||
142988306|NCT01190020|515492070|FG000|Overall Study|Withdrawal by Subject|3|||
142988307|NCT01190020|515492071|FG001|Overall Study|Withdrawal by Subject|0|||
142988308|NCT00796224|515492072|FG000|Overall Study|Adverse Event|1|||
142988309|NCT00796224|515492073|FG001|Overall Study|Adverse Event|0|||
142988310|NCT00796224|515492072|FG000|Overall Study|Protocol Violation|0|||
142988311|NCT00796224|515492073|FG001|Overall Study|Protocol Violation|1|||
142988312|NCT02569398|515492074|FG000|Overall Study|Adverse Event|0|||
142988313|NCT02569398|515492075|FG001|Overall Study|Adverse Event|1|||
142988314|NCT02569398|515492076|FG002|Overall Study|Adverse Event|6|||
142988315|NCT02569398|515492074|FG000|Overall Study|Withdrawal by Subject|43|||
142988316|NCT02569398|515492075|FG001|Overall Study|Withdrawal by Subject|43|||
142988317|NCT02569398|515492076|FG002|Overall Study|Withdrawal by Subject|30|||
142988318|NCT02569398|515492074|FG000|Overall Study|Study terminated by sponsor|130|||
142988319|NCT02569398|515492075|FG001|Overall Study|Study terminated by sponsor|131|||
142988320|NCT02569398|515492076|FG002|Overall Study|Study terminated by sponsor|134|||
142988321|NCT02569398|515492074|FG000|Overall Study|Other|12|||
142988322|NCT02569398|515492075|FG001|Overall Study|Other|14|||
142988323|NCT02569398|515492076|FG002|Overall Study|Other|13|||
142988324|NCT03227224|515492077|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
142988325|NCT03227224|515492078|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
142988326|NCT03227224|515492079|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
142988327|NCT03227224|515492080|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
142988328|NCT03227224|515492077|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
142988329|NCT03227224|515492078|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
142988330|NCT03227224|515492079|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
142988331|NCT03227224|515492080|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
142988332|NCT03227224|515492077|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
142988333|NCT03227224|515492078|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
142988334|NCT03227224|515492079|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
142988335|NCT03227224|515492080|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
142988336|NCT03227224|515492077|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
142988337|NCT03227224|515492078|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
142988338|NCT03227224|515492079|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
142988339|NCT03227224|515492080|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
142988340|NCT03227224|515492077|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
142988341|NCT03227224|515492078|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
142988342|NCT03227224|515492079|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
142988343|NCT03227224|515492080|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
142988344|NCT03227224|515492077|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
142988345|NCT03227224|515492078|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
142988346|NCT03227224|515492079|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
142988347|NCT03227224|515492080|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
142988348|NCT03227224|515492077|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
142988349|NCT03227224|515492078|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
142988350|NCT03227224|515492079|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
142988351|NCT03227224|515492080|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
142988352|NCT03227224|515492077|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
142988353|NCT03227224|515492078|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
142988354|NCT03227224|515492079|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
142988355|NCT03227224|515492080|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
142988356|NCT03227224|515492077|FG000|Follow-up Phase (2 Weeks)|Other|4|||
142988357|NCT03227224|515492078|FG001|Follow-up Phase (2 Weeks)|Other|4|||
142988358|NCT03227224|515492079|FG002|Follow-up Phase (2 Weeks)|Other|6|||
142988359|NCT03227224|515492080|FG003|Follow-up Phase (2 Weeks)|Other|3|||
142988360|NCT02406027|515492081|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
142988361|NCT02406027|515492082|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
142988362|NCT02406027|515492083|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
142988363|NCT02406027|515492084|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
142988364|NCT02406027|515492085|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
142988365|NCT02406027|515492086|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
142988366|NCT02406027|515492087|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
142988367|NCT02406027|515492081|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
142988368|NCT02406027|515492082|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
142988369|NCT02406027|515492083|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
142988370|NCT02406027|515492084|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
142988371|NCT02406027|515492085|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
142988372|NCT02406027|515492086|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
142988373|NCT02406027|515492087|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
142988374|NCT02406027|515492081|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
142988375|NCT02406027|515492082|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
142988376|NCT02406027|515492083|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
142988377|NCT02406027|515492084|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
142988378|NCT02406027|515492085|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
142988379|NCT02406027|515492086|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
142988380|NCT02406027|515492087|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
142988381|NCT02406027|515492081|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
142988382|NCT02406027|515492082|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
142988383|NCT02406027|515492083|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
142988384|NCT02406027|515492084|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
142988385|NCT02406027|515492085|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
142988386|NCT02406027|515492086|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
142988387|NCT02406027|515492087|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
142988388|NCT02406027|515492081|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
142988389|NCT02406027|515492082|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
142988390|NCT02406027|515492083|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
142988391|NCT02406027|515492084|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
142988392|NCT02406027|515492085|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
142988393|NCT02406027|515492086|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
142988394|NCT02406027|515492087|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
142988395|NCT02406027|515492081|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
142988396|NCT02406027|515492082|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
142988397|NCT02406027|515492083|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
142988398|NCT02406027|515492084|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
142988399|NCT02406027|515492085|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
142988400|NCT02406027|515492086|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
142988401|NCT02406027|515492087|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
142988402|NCT02406027|515492081|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
142988403|NCT02406027|515492082|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
142988404|NCT02406027|515492083|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
142988405|NCT02406027|515492084|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
142988406|NCT02406027|515492085|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
142988407|NCT02406027|515492086|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
142988408|NCT02406027|515492087|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
142988409|NCT02406027|515492081|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
142988410|NCT02406027|515492082|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
142988411|NCT02406027|515492083|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
142988412|NCT02406027|515492084|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
142988413|NCT02406027|515492085|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
142988414|NCT02406027|515492086|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
142988415|NCT02406027|515492087|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
142988416|NCT02406027|515492081|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
142988417|NCT02406027|515492082|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
142988418|NCT02406027|515492083|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
142988419|NCT02406027|515492084|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
142988420|NCT02406027|515492085|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
142988421|NCT02406027|515492086|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
142988422|NCT02406027|515492087|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
142988423|NCT02406027|515492081|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
142988424|NCT02406027|515492082|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
142988425|NCT02406027|515492083|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
142988426|NCT02406027|515492084|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
142988427|NCT02406027|515492085|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
142988428|NCT02406027|515492086|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
142988429|NCT02406027|515492087|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
142988430|NCT03782376|515492088|FG000|Overall Study|Lost to Follow-up|2|||
142988431|NCT03782376|515492089|FG001|Overall Study|Lost to Follow-up|2|||
142988432|NCT03782376|515492088|FG000|Overall Study|Withdrawal by Subject|7|||
142988433|NCT03782376|515492089|FG001|Overall Study|Withdrawal by Subject|11|||
142988434|NCT03782376|515492088|FG000|Overall Study|Death|1|||
142988435|NCT03782376|515492089|FG001|Overall Study|Death|0|||
142988436|NCT03782376|515492088|FG000|Overall Study|Other|16|||
142988437|NCT03782376|515492089|FG001|Overall Study|Other|17|||
142988438|NCT03559192|515492090|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
142988439|NCT03559192|515492091|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
142988440|NCT03559192|515492092|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
142988441|NCT03559192|515492090|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
142988442|NCT03559192|515492091|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
142988443|NCT03559192|515492092|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
142988444|NCT03559192|515492090|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
142988445|NCT03559192|515492091|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
142988446|NCT03559192|515492092|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
142988447|NCT03559192|515492090|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
142988448|NCT03559192|515492091|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
142988449|NCT03559192|515492092|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
142988450|NCT03559192|515492090|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
142988451|NCT03559192|515492091|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
142988452|NCT03559192|515492092|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
142988453|NCT03559192|515492090|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
142988454|NCT03559192|515492091|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
142988455|NCT03559192|515492092|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
142988456|NCT03559192|515492090|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
142988457|NCT03559192|515492091|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
142988458|NCT03559192|515492092|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
142988459|NCT03559192|515492090|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
142988460|NCT03559192|515492091|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
142988461|NCT03559192|515492092|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
142988462|NCT03559192|515492090|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
142988463|NCT03559192|515492091|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
142988464|NCT03559192|515492092|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
142988465|NCT03277794|515492095|FG000|Overall Study|Lost to Follow-up|2|||
142988466|NCT03277794|515492096|FG001|Overall Study|Lost to Follow-up|4|||
142988467|NCT03277794|515492095|FG000|Overall Study|Withdrew due to high acuity|1|||
142988468|NCT03277794|515492096|FG001|Overall Study|Withdrew due to high acuity|0|||
142988469|NCT05166603|515492098|FG000|Overall Study|Withdrawal by Subject|68|||
142988470|NCT05166603|515492099|FG001|Overall Study|Withdrawal by Subject|0|||
142988471|NCT01899768|515494129|FG000|Part A|Adverse Event|2|||
142988472|NCT01899768|515494129|FG000|Part A|Withdrawal by Subject|1|||
142988473|NCT01899768|515494129|FG000|Part B|Adverse Event|1|||
142988474|NCT01899768|515494129|FG000|Part B|Withdrawal by Subject|1|||
142988475|NCT01196091|515494130|FG000|Overall Study|Adverse Event|22|||
142988476|NCT01196091|515494131|FG001|Overall Study|Adverse Event|27|||
142988477|NCT01196091|515494132|FG002|Overall Study|Adverse Event|26|||
142988478|NCT01196091|515494130|FG000|Overall Study|Death|3|||
142988479|NCT01196091|515494131|FG001|Overall Study|Death|2|||
142988480|NCT01196091|515494132|FG002|Overall Study|Death|2|||
142988481|NCT01196091|515494130|FG000|Overall Study|Entry Criteria Not Met|11|||
142988482|NCT01196091|515494131|FG001|Overall Study|Entry Criteria Not Met|11|||
142988483|NCT01196091|515494132|FG002|Overall Study|Entry Criteria Not Met|10|||
142988484|NCT01196091|515494130|FG000|Overall Study|Lack of Efficacy|15|||
142988485|NCT01196091|515494131|FG001|Overall Study|Lack of Efficacy|12|||
142988486|NCT01196091|515494132|FG002|Overall Study|Lack of Efficacy|17|||
142988487|NCT01196091|515494130|FG000|Overall Study|Lost to Follow-up|5|||
142988488|NCT01196091|515494131|FG001|Overall Study|Lost to Follow-up|5|||
142988489|NCT01196091|515494132|FG002|Overall Study|Lost to Follow-up|6|||
142988490|NCT01196091|515494130|FG000|Overall Study|Parent/Caregiver Decision|0|||
142988491|NCT01196091|515494131|FG001|Overall Study|Parent/Caregiver Decision|0|||
142988492|NCT01196091|515494132|FG002|Overall Study|Parent/Caregiver Decision|1|||
142988493|NCT01196091|515494130|FG000|Overall Study|Withdrawal by Subject|16|||
142988494|NCT01196091|515494131|FG001|Overall Study|Withdrawal by Subject|19|||
142988495|NCT01196091|515494132|FG002|Overall Study|Withdrawal by Subject|22|||
142988496|NCT01196091|515494130|FG000|Overall Study|Physician Decision|3|||
142988497|NCT01196091|515494131|FG001|Overall Study|Physician Decision|3|||
142988498|NCT01196091|515494132|FG002|Overall Study|Physician Decision|4|||
142988499|NCT01196091|515494130|FG000|Overall Study|Protocol Violation|1|||
142988500|NCT01196091|515494131|FG001|Overall Study|Protocol Violation|3|||
142988501|NCT01196091|515494132|FG002|Overall Study|Protocol Violation|3|||
142988502|NCT01196091|515494130|FG000|Overall Study|Sponsor Decision|6|||
142988503|NCT01196091|515494131|FG001|Overall Study|Sponsor Decision|5|||
142988504|NCT01196091|515494132|FG002|Overall Study|Sponsor Decision|4|||
142988505|NCT01196091|515494130|FG000|Overall Study|Excluded Site|5|||
142988506|NCT01196091|515494131|FG001|Overall Study|Excluded Site|11|||
142988507|NCT01196091|515494132|FG002|Overall Study|Excluded Site|8|||
142988508|NCT01196091|515494130|FG000|Overall Study|Randomized, No Study Drug Received|1|||
142988509|NCT01196091|515494131|FG001|Overall Study|Randomized, No Study Drug Received|0|||
142988510|NCT01196091|515494132|FG002|Overall Study|Randomized, No Study Drug Received|1|||
142988511|NCT04476108|515494133|FG000|Overall Study|Adverse Event|4|||
142988512|NCT04476108|515494134|FG001|Overall Study|Adverse Event|1|||
142988513|NCT04476108|515494133|FG000|Overall Study|Lost to Follow-up|1|||
142988514|NCT04476108|515494134|FG001|Overall Study|Lost to Follow-up|0|||
142988515|NCT04476108|515494133|FG000|Overall Study|Inadvertent Enrollment|1|||
142988516|NCT04476108|515494134|FG001|Overall Study|Inadvertent Enrollment|0|||
142988517|NCT04476108|515494133|FG000|Overall Study|Protocol Violation|1|||
142988518|NCT04476108|515494134|FG001|Overall Study|Protocol Violation|1|||
142988519|NCT04476108|515494133|FG000|Overall Study|Withdrawal by Subject|1|||
142988520|NCT04476108|515494134|FG001|Overall Study|Withdrawal by Subject|1|||
142988521|NCT00355615|515494136|FG000|Randomized Double Blind Period|Adverse Event|1|||
142988522|NCT00355615|515494137|FG001|Randomized Double Blind Period|Adverse Event|0|||
142988523|NCT00355615|515494138|FG002|Randomized Double Blind Period|Adverse Event|0|||
142988524|NCT00355615|515494139|FG003|Randomized Double Blind Period|Adverse Event|0|||
142988525|NCT00355615|515494140|FG004|Randomized Double Blind Period|Adverse Event|0|||
142988526|NCT00355615|515494136|FG000|Randomized Double Blind Period|Protocol Violation|0|||
142988527|NCT00355615|515494137|FG001|Randomized Double Blind Period|Protocol Violation|0|||
142988528|NCT00355615|515494138|FG002|Randomized Double Blind Period|Protocol Violation|1|||
142988529|NCT00355615|515494139|FG003|Randomized Double Blind Period|Protocol Violation|1|||
142988530|NCT00355615|515494140|FG004|Randomized Double Blind Period|Protocol Violation|0|||
142988531|NCT00355615|515494136|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
142988532|NCT00355615|515494137|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
142988533|NCT00355615|515494138|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
142988534|NCT00355615|515494139|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
142988535|NCT00355615|515494140|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
142988536|NCT00355615|515494136|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
142988537|NCT00355615|515494137|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
143455673|NCT03406078|517212506|FG000|Overall Study|Death|1|||
143455674|NCT03406078|517212507|FG001|Overall Study|Death|0|||
142988538|NCT00355615|515494138|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
142988539|NCT00355615|515494139|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
142988540|NCT00355615|515494140|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
142988541|NCT00355615|515494136|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
142988542|NCT00355615|515494137|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
142988543|NCT00355615|515494138|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
142988544|NCT00355615|515494139|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
142988545|NCT00355615|515494140|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
142988546|NCT00355615|515494136|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
142988547|NCT00355615|515494137|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
142988548|NCT00355615|515494138|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
142988549|NCT00355615|515494139|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
142988550|NCT00355615|515494140|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
142988551|NCT00085644|515494141|FG000|Double-Blind Period|Adverse Event|5|||
142988552|NCT00085644|515494142|FG001|Double-Blind Period|Adverse Event|2|||
142988553|NCT00085644|515494143|FG002|Double-Blind Period|Adverse Event|0|||
142988554|NCT00085644|515494141|FG000|Double-Blind Period|Withdrawal by Subject|3|||
142988555|NCT00085644|515494142|FG001|Double-Blind Period|Withdrawal by Subject|0|||
142988556|NCT00085644|515494143|FG002|Double-Blind Period|Withdrawal by Subject|0|||
142988557|NCT00085644|515494141|FG000|Double-Blind Period|Lost to Follow-up|2|||
142988558|NCT00085644|515494142|FG001|Double-Blind Period|Lost to Follow-up|1|||
142988559|NCT00085644|515494143|FG002|Double-Blind Period|Lost to Follow-up|0|||
142988560|NCT00085644|515494141|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
142988561|NCT00085644|515494142|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
142988562|NCT00085644|515494143|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
142988563|NCT00085644|515494141|FG000|Double-Blind Period|Contemplating pregnancy|1|||
142988564|NCT00085644|515494142|FG001|Double-Blind Period|Contemplating pregnancy|0|||
142988565|NCT00085644|515494143|FG002|Double-Blind Period|Contemplating pregnancy|0|||
142988566|NCT00085644|515494141|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
142988567|NCT00085644|515494142|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
142988568|NCT00085644|515494143|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
142988569|NCT00085644|515494141|FG000|Open-Label Period|Adverse Event|0|||
142988570|NCT00085644|515494142|FG001|Open-Label Period|Adverse Event|0|||
142988571|NCT00085644|515494143|FG002|Open-Label Period|Adverse Event|38|||
142988572|NCT00085644|515494141|FG000|Open-Label Period|Withdrawal by Subject|0|||
142988573|NCT00085644|515494142|FG001|Open-Label Period|Withdrawal by Subject|0|||
142988574|NCT00085644|515494143|FG002|Open-Label Period|Withdrawal by Subject|29|||
142988575|NCT00085644|515494141|FG000|Open-Label Period|Lost to Follow-up|0|||
142988576|NCT00085644|515494142|FG001|Open-Label Period|Lost to Follow-up|0|||
142988577|NCT00085644|515494143|FG002|Open-Label Period|Lost to Follow-up|13|||
142988578|NCT00085644|515494141|FG000|Open-Label Period|Lack of Efficacy|0|||
142988579|NCT00085644|515494142|FG001|Open-Label Period|Lack of Efficacy|0|||
142988580|NCT00085644|515494143|FG002|Open-Label Period|Lack of Efficacy|15|||
142988581|NCT00085644|515494141|FG000|Open-Label Period|Pregnancy|0|||
142988582|NCT00085644|515494142|FG001|Open-Label Period|Pregnancy|0|||
142988583|NCT00085644|515494143|FG002|Open-Label Period|Pregnancy|3|||
142988584|NCT00085644|515494141|FG000|Open-Label Period|Contemplating pregnancy|0|||
142988585|NCT00085644|515494142|FG001|Open-Label Period|Contemplating pregnancy|0|||
142988586|NCT00085644|515494143|FG002|Open-Label Period|Contemplating pregnancy|3|||
142988587|NCT00085644|515494141|FG000|Open-Label Period|Protocol Violation|0|||
142988588|NCT00085644|515494142|FG001|Open-Label Period|Protocol Violation|0|||
142988589|NCT00085644|515494143|FG002|Open-Label Period|Protocol Violation|4|||
142988590|NCT00085644|515494141|FG000|Open-Label Period|Personal reason|0|||
142988591|NCT00085644|515494142|FG001|Open-Label Period|Personal reason|0|||
142988592|NCT00085644|515494143|FG002|Open-Label Period|Personal reason|4|||
142988593|NCT04259346|515494144|FG000|Overall Study|Lost to Follow-up|1|||
142988594|NCT04259346|515494145|FG001|Overall Study|Lost to Follow-up|3|||
142988595|NCT04259346|515494144|FG000|Overall Study|Protocol Violation|1|||
142988596|NCT04259346|515494145|FG001|Overall Study|Protocol Violation|0|||
142988597|NCT04259346|515494144|FG000|Overall Study|Withdrawal by Subject|1|||
142988598|NCT04259346|515494145|FG001|Overall Study|Withdrawal by Subject|0|||
142988599|NCT04259346|515494144|FG000|Overall Study|Adverse Event|1|||
142988600|NCT04259346|515494145|FG001|Overall Study|Adverse Event|1|||
142988601|NCT03330106|515494153|FG000|Part A|Withdrawal by Subject|1|||
142988602|NCT03330106|515494154|FG001|Part A|Withdrawal by Subject|1|||
142988603|NCT03330106|515494155|FG002|Part A|Withdrawal by Subject|0|||
142988604|NCT03330106|515494156|FG003|Part A|Withdrawal by Subject|0|||
142988605|NCT03330106|515494153|FG000|Part A|Death|2|||
142988606|NCT03330106|515494154|FG001|Part A|Death|1|||
142988607|NCT03330106|515494155|FG002|Part A|Death|0|||
142988608|NCT03330106|515494156|FG003|Part A|Death|0|||
142988609|NCT03330106|515494153|FG000|Part A|Adverse Event|0|||
142988610|NCT03330106|515494154|FG001|Part A|Adverse Event|1|||
142988611|NCT03330106|515494155|FG002|Part A|Adverse Event|0|||
142988612|NCT03330106|515494156|FG003|Part A|Adverse Event|0|||
142988613|NCT03330106|515494153|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
142988614|NCT03330106|515494154|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
142988615|NCT03330106|515494155|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
142988616|NCT03330106|515494156|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
142988617|NCT03330106|515494153|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
142988618|NCT03330106|515494154|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
142988619|NCT03330106|515494155|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
142988620|NCT03330106|515494156|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
142988621|NCT03330106|515494153|FG000|Part A|Progressive Disease|0|||
142988622|NCT03330106|515494154|FG001|Part A|Progressive Disease|1|||
142988623|NCT03330106|515494155|FG002|Part A|Progressive Disease|0|||
142988624|NCT03330106|515494156|FG003|Part A|Progressive Disease|0|||
142988625|NCT03330106|515494153|FG000|Part B|Lost to Follow-up|0|||
142988626|NCT03330106|515494154|FG001|Part B|Lost to Follow-up|0|||
142988627|NCT03330106|515494155|FG002|Part B|Lost to Follow-up|0|||
142988628|NCT03330106|515494156|FG003|Part B|Lost to Follow-up|1|||
142988629|NCT03330106|515494153|FG000|Part B|Withdrawal by Subject|0|||
142988630|NCT03330106|515494154|FG001|Part B|Withdrawal by Subject|0|||
142988631|NCT03330106|515494155|FG002|Part B|Withdrawal by Subject|4|||
142988632|NCT03330106|515494156|FG003|Part B|Withdrawal by Subject|0|||
142988633|NCT03330106|515494153|FG000|Part B|Death|0|||
142988634|NCT03330106|515494154|FG001|Part B|Death|0|||
142988635|NCT03330106|515494155|FG002|Part B|Death|2|||
142988636|NCT03330106|515494156|FG003|Part B|Death|0|||
142988637|NCT03330106|515494153|FG000|Part B|Clinical Progression|0|||
142988638|NCT03330106|515494154|FG001|Part B|Clinical Progression|0|||
142988639|NCT03330106|515494155|FG002|Part B|Clinical Progression|1|||
142988640|NCT03330106|515494156|FG003|Part B|Clinical Progression|1|||
142988641|NCT03330106|515494153|FG000|Part B|Symptomatic Deterioration|0|||
142988642|NCT03330106|515494154|FG001|Part B|Symptomatic Deterioration|0|||
142988643|NCT03330106|515494155|FG002|Part B|Symptomatic Deterioration|0|||
142988644|NCT03330106|515494156|FG003|Part B|Symptomatic Deterioration|1|||
142988645|NCT03330106|515494153|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
142988646|NCT03330106|515494154|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
142988647|NCT03330106|515494155|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
142988648|NCT03330106|515494156|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
142988649|NCT03330106|515494153|FG000|Part B|Progressive Disease|0|||
142988650|NCT03330106|515494154|FG001|Part B|Progressive Disease|0|||
142988651|NCT03330106|515494155|FG002|Part B|Progressive Disease|11|||
142988652|NCT03330106|515494156|FG003|Part B|Progressive Disease|4|||
142988653|NCT00623766|515494157|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
142988654|NCT00623766|515494158|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
142988655|NCT00623766|515494157|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
142988656|NCT00623766|515494158|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
142988657|NCT00623766|515494157|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
142988658|NCT00623766|515494158|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
142988659|NCT00623766|515494157|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
142988660|NCT00623766|515494158|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
142988661|NCT00623766|515494157|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
142988662|NCT00623766|515494158|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
142988663|NCT04247828|515494163|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
142988664|NCT00486889|515494164|FG000|Overall Study|Death|3|||
142988665|NCT00486889|515494164|FG000|Overall Study|Non-compliant|2|||
142988666|NCT00486889|515494164|FG000|Overall Study|Withdrawal by Subject|6|||
142988667|NCT03198728|515494165|FG000|Overall Study|Adverse Event|10|||
142988668|NCT03198728|515494166|FG001|Overall Study|Adverse Event|5|||
142988669|NCT03198728|515494165|FG000|Overall Study|Lost to Follow-up|21|||
142988670|NCT03198728|515494166|FG001|Overall Study|Lost to Follow-up|7|||
142988671|NCT03198728|515494165|FG000|Overall Study|Physician Decision|7|||
142988672|NCT03198728|515494166|FG001|Overall Study|Physician Decision|2|||
142988673|NCT03198728|515494165|FG000|Overall Study|Withdrawal by Subject|14|||
142988674|NCT03198728|515494166|FG001|Overall Study|Withdrawal by Subject|10|||
142988675|NCT00796549|515494167|FG000|Overall Study|Adverse Event|11|||
142988676|NCT00796549|515494167|FG000|Overall Study|not entered|149|||
142988677|NCT00796549|515494167|FG000|Overall Study|Other|2|||
142988678|NCT00796549|515494167|FG000|Overall Study|Progressive disease|56|||
142988679|NCT04051944|515494171|FG000|Overall Study|Study ending|1|||
142988680|NCT04051944|515494172|FG001|Overall Study|Study ending|1|||
142988681|NCT04051944|515494171|FG000|Overall Study|Early study termination by participant|1|||
142988682|NCT04051944|515494172|FG001|Overall Study|Early study termination by participant|0|||
142988683|NCT04051944|515494171|FG000|Overall Study|Withdrawal by Subject|2|||
142988684|NCT04051944|515494172|FG001|Overall Study|Withdrawal by Subject|2|||
142988685|NCT04051944|515494171|FG000|Overall Study|Lack of Efficacy|3|||
142988686|NCT04051944|515494172|FG001|Overall Study|Lack of Efficacy|0|||
142988687|NCT04051944|515494171|FG000|Overall Study|Adverse event, non- fatal|1|||
142988688|NCT04051944|515494172|FG001|Overall Study|Adverse event, non- fatal|1|||
142988689|NCT03077711|515494173|FG000|Overall Study|Lost to Follow-up|2|||
142988690|NCT03077711|515494174|FG001|Overall Study|Lost to Follow-up|2|||
142988691|NCT03077711|515494173|FG000|Overall Study|noncompliant taking medication|2|||
142988692|NCT03077711|515494174|FG001|Overall Study|noncompliant taking medication|0|||
142988693|NCT01526928|515494175|FG000|Overall Study|Progressive Disease|35|||
142988694|NCT01526928|515494176|FG001|Overall Study|Progressive Disease|17|||
142988695|NCT01526928|515494177|FG002|Overall Study|Progressive Disease|150|||
142988696|NCT01526928|515494178|FG003|Overall Study|Progressive Disease|182|||
142988697|NCT01526928|515494179|FG004|Overall Study|Progressive Disease|76|||
142988698|NCT01526928|515494180|FG005|Overall Study|Progressive Disease|4|||
142988699|NCT01526928|515494175|FG000|Overall Study|Adverse Event|2|||
142988700|NCT01526928|515494176|FG001|Overall Study|Adverse Event|1|||
142988701|NCT01526928|515494177|FG002|Overall Study|Adverse Event|29|||
142988702|NCT01526928|515494178|FG003|Overall Study|Adverse Event|40|||
142988703|NCT01526928|515494179|FG004|Overall Study|Adverse Event|13|||
142988704|NCT01526928|515494180|FG005|Overall Study|Adverse Event|2|||
142988705|NCT01526928|515494175|FG000|Overall Study|Death|0|||
142988706|NCT01526928|515494176|FG001|Overall Study|Death|0|||
142988707|NCT01526928|515494177|FG002|Overall Study|Death|3|||
142988708|NCT01526928|515494178|FG003|Overall Study|Death|0|||
142988709|NCT01526928|515494179|FG004|Overall Study|Death|0|||
142988710|NCT01526928|515494180|FG005|Overall Study|Death|0|||
142988711|NCT01526928|515494175|FG000|Overall Study|Withdrawal by Subject|1|||
142988712|NCT01526928|515494176|FG001|Overall Study|Withdrawal by Subject|0|||
142988713|NCT01526928|515494177|FG002|Overall Study|Withdrawal by Subject|13|||
142988714|NCT01526928|515494178|FG003|Overall Study|Withdrawal by Subject|11|||
142988715|NCT01526928|515494179|FG004|Overall Study|Withdrawal by Subject|3|||
142988716|NCT01526928|515494180|FG005|Overall Study|Withdrawal by Subject|0|||
142988717|NCT01526928|515494175|FG000|Overall Study|Physician Decision|0|||
142988718|NCT01526928|515494176|FG001|Overall Study|Physician Decision|0|||
142988719|NCT01526928|515494177|FG002|Overall Study|Physician Decision|2|||
142988720|NCT01526928|515494178|FG003|Overall Study|Physician Decision|5|||
142988721|NCT01526928|515494179|FG004|Overall Study|Physician Decision|0|||
142988722|NCT01526928|515494180|FG005|Overall Study|Physician Decision|0|||
142988723|NCT01526928|515494175|FG000|Overall Study|Other Reason|0|||
142988724|NCT01526928|515494176|FG001|Overall Study|Other Reason|1|||
142988725|NCT01526928|515494177|FG002|Overall Study|Other Reason|11|||
142988726|NCT01526928|515494178|FG003|Overall Study|Other Reason|4|||
142988727|NCT01526928|515494179|FG004|Overall Study|Other Reason|1|||
142988728|NCT01526928|515494180|FG005|Overall Study|Other Reason|0|||
142988729|NCT01526928|515494175|FG000|Overall Study|Lost to Follow-up|0|||
142988730|NCT01526928|515494176|FG001|Overall Study|Lost to Follow-up|0|||
142988731|NCT01526928|515494177|FG002|Overall Study|Lost to Follow-up|0|||
142988732|NCT01526928|515494178|FG003|Overall Study|Lost to Follow-up|1|||
142988733|NCT01526928|515494179|FG004|Overall Study|Lost to Follow-up|0|||
142988734|NCT01526928|515494180|FG005|Overall Study|Lost to Follow-up|0|||
142988735|NCT01526928|515494175|FG000|Overall Study|Protocol Deviation|0|||
142988736|NCT01526928|515494176|FG001|Overall Study|Protocol Deviation|0|||
142988737|NCT01526928|515494177|FG002|Overall Study|Protocol Deviation|0|||
142988738|NCT01526928|515494178|FG003|Overall Study|Protocol Deviation|2|||
143455675|NCT03406078|517212506|FG000|Overall Study|Lost to Follow-up|0|||
142988739|NCT01526928|515494179|FG004|Overall Study|Protocol Deviation|0|||
142988740|NCT01526928|515494180|FG005|Overall Study|Protocol Deviation|0|||
142988741|NCT01526928|515494175|FG000|Overall Study|Missing|0|||
142988742|NCT01526928|515494176|FG001|Overall Study|Missing|0|||
142988743|NCT01526928|515494177|FG002|Overall Study|Missing|1|||
142988744|NCT01526928|515494178|FG003|Overall Study|Missing|0|||
142988745|NCT01526928|515494179|FG004|Overall Study|Missing|2|||
142988746|NCT01526928|515494180|FG005|Overall Study|Missing|0|||
142988747|NCT02139280|515494181|FG000|Overall Study|No longer eligible|2|||
142988748|NCT02139280|515494182|FG001|Overall Study|No longer eligible|0|||
143003178|NCT01049360|515548750|FG006|Period 2|Lack of Efficacy|0|||
142988749|NCT04157751|515494183|FG000|Overall Study|Withdrawal by Subject|12|||
142988750|NCT04157751|515494184|FG001|Overall Study|Withdrawal by Subject|17|||
142988751|NCT04157751|515494183|FG000|Overall Study|Lost to Follow-up|6|||
142988752|NCT04157751|515494184|FG001|Overall Study|Lost to Follow-up|2|||
142988753|NCT04157751|515494183|FG000|Overall Study|Adverse Event|34|||
142988754|NCT04157751|515494184|FG001|Overall Study|Adverse Event|23|||
142988755|NCT04157751|515494183|FG000|Overall Study|Not treated|1|||
142988756|NCT04157751|515494184|FG001|Overall Study|Not treated|5|||
142988757|NCT04157751|515494183|FG000|Overall Study|Other reason not stated above|10|||
142988758|NCT04157751|515494184|FG001|Overall Study|Other reason not stated above|10|||
142988759|NCT00422903|515494188|FG000|Overall Study|Disease Progression|3|||
142988760|NCT00422903|515494189|FG001|Overall Study|Disease Progression|1|||
142988761|NCT00422903|515494188|FG000|Overall Study|Adverse Event|0|||
142988762|NCT00422903|515494189|FG001|Overall Study|Adverse Event|2|||
142988763|NCT00422903|515494188|FG000|Overall Study|Informed Consent Withdrawn|1|||
142988764|NCT00422903|515494189|FG001|Overall Study|Informed Consent Withdrawn|2|||
142988765|NCT01947894|515494194|FG000|Overall Study|Other|3|||
142988766|NCT01947894|515494195|FG001|Overall Study|Other|4|||
142988767|NCT01947894|515494196|FG002|Overall Study|Other|3|||
142988768|NCT01947894|515494194|FG000|Overall Study|Withdrawal by Subject|12|||
142988769|NCT01947894|515494195|FG001|Overall Study|Withdrawal by Subject|4|||
142988770|NCT01947894|515494196|FG002|Overall Study|Withdrawal by Subject|1|||
142988771|NCT01947894|515494194|FG000|Overall Study|Death|12|||
142988772|NCT01947894|515494195|FG001|Overall Study|Death|1|||
142988773|NCT01947894|515494196|FG002|Overall Study|Death|0|||
142988774|NCT01947894|515494194|FG000|Overall Study|Physician Decision|2|||
142988775|NCT01947894|515494195|FG001|Overall Study|Physician Decision|0|||
142988776|NCT01947894|515494196|FG002|Overall Study|Physician Decision|0|||
142988777|NCT01947894|515494194|FG000|Overall Study|Adverse Event|5|||
142988778|NCT01947894|515494195|FG001|Overall Study|Adverse Event|1|||
142988779|NCT01947894|515494196|FG002|Overall Study|Adverse Event|0|||
142988780|NCT01947894|515494194|FG000|Overall Study|Switched to other growth hormone brand|53|||
142988781|NCT01947894|515494195|FG001|Overall Study|Switched to other growth hormone brand|8|||
142988782|NCT01947894|515494196|FG002|Overall Study|Switched to other growth hormone brand|23|||
142988783|NCT01302691|515494197|FG000|Overall Study|Adverse Event|2|||
142988784|NCT01302691|515494198|FG001|Overall Study|Adverse Event|0|||
142988785|NCT01302691|515494197|FG000|Overall Study|Death|0|||
142988786|NCT01302691|515494198|FG001|Overall Study|Death|1|||
142988787|NCT01302691|515494197|FG000|Overall Study|Lost to Follow-up|1|||
142988788|NCT01302691|515494198|FG001|Overall Study|Lost to Follow-up|0|||
142988789|NCT01302691|515494197|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
142988790|NCT01302691|515494198|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
142988791|NCT01302691|515494197|FG000|Overall Study|Physician Decision|0|||
142988792|NCT01302691|515494198|FG001|Overall Study|Physician Decision|1|||
142988793|NCT01302691|515494197|FG000|Overall Study|Protocol Violation|1|||
142988794|NCT01302691|515494198|FG001|Overall Study|Protocol Violation|0|||
142988795|NCT03446612|515494199|FG000|Overall Study|Protocol defined stopping criteria|0|||
142988796|NCT03446612|515494200|FG001|Overall Study|Protocol defined stopping criteria|1|||
142988797|NCT00333970|515494203|FG000|Overall Study|Withdrawal by Subject|13|||
142988798|NCT00333970|515494204|FG001|Overall Study|Withdrawal by Subject|7|||
142988799|NCT03796195|515494205|FG000|Overall Study|Study closed early|1|||
142988800|NCT00062647|515494206|FG000|Overall Study|Death|2|||
142988801|NCT00062647|515494207|FG001|Overall Study|Death|2|||
142988802|NCT00062647|515494206|FG000|Overall Study|Adverse Event|1|||
142988803|NCT00062647|515494207|FG001|Overall Study|Adverse Event|1|||
142988804|NCT00062647|515494206|FG000|Overall Study|Withdrawal by Subject|2|||
142988805|NCT00062647|515494207|FG001|Overall Study|Withdrawal by Subject|1|||
142988806|NCT00062647|515494206|FG000|Overall Study|Protocol Violation|1|||
142988807|NCT00062647|515494207|FG001|Overall Study|Protocol Violation|0|||
142988808|NCT00062647|515494206|FG000|Overall Study|Lost to Follow-up|1|||
142988809|NCT00062647|515494207|FG001|Overall Study|Lost to Follow-up|2|||
142988810|NCT00062647|515494206|FG000|Overall Study|Failed continuation criteria|4|||
142988811|NCT00062647|515494207|FG001|Overall Study|Failed continuation criteria|2|||
142988812|NCT00062647|515494206|FG000|Overall Study|Other|4|||
142988813|NCT00062647|515494207|FG001|Overall Study|Other|4|||
142988814|NCT00062647|515494206|FG000|Overall Study|Never received study treatment|1|||
142988815|NCT00062647|515494207|FG001|Overall Study|Never received study treatment|1|||
142988816|NCT02392468|515494213|FG000|Overall Study|Adverse Event|0|||
142988817|NCT02392468|515494214|FG001|Overall Study|Adverse Event|1|||
142988818|NCT02392468|515494215|FG002|Overall Study|Adverse Event|0|||
142988819|NCT02392468|515494216|FG003|Overall Study|Adverse Event|0|||
142988820|NCT02392468|515494217|FG004|Overall Study|Adverse Event|0|||
142988821|NCT02392468|515494218|FG005|Overall Study|Adverse Event|1|||
142988822|NCT01039428|515494219|FG000|Overall Study|Protocol Violation|1|||
142988823|NCT01039428|515494220|FG001|Overall Study|Protocol Violation|0|||
142988824|NCT01039428|515494219|FG000|Overall Study|Withdrawal by Subject|1|||
142988825|NCT01039428|515494220|FG001|Overall Study|Withdrawal by Subject|0|||
142988826|NCT01313039|515494221|FG000|Overall Study|Physician Decision|1|||
142988827|NCT01313039|515494221|FG000|Overall Study|Adverse Event|1|||
142988828|NCT01678560|515494224|FG000|Overall Study|Physician Decision|4|||
142988829|NCT01678560|515494225|FG001|Overall Study|Physician Decision|4|||
142988830|NCT01678560|515494224|FG000|Overall Study|Death|0|||
142988831|NCT01678560|515494225|FG001|Overall Study|Death|1|||
142988832|NCT01678560|515494224|FG000|Overall Study|Withdrawal by Subject|0|||
142988833|NCT01678560|515494225|FG001|Overall Study|Withdrawal by Subject|1|||
142988834|NCT02201472|515494226|FG000|Overall Study|Lack of Efficacy|2|||
142988835|NCT02470429|515494227|FG000|Overall Study|Adverse Event|1|||
142988836|NCT02470429|515494228|FG001|Overall Study|Adverse Event|0|||
142988837|NCT02470429|515494227|FG000|Overall Study|Withdrawal by Subject|1|||
142988838|NCT02470429|515494228|FG001|Overall Study|Withdrawal by Subject|0|||
142988839|NCT01300767|515494229|FG000|Overall Study|Discomfort|2|||
142988840|NCT01300767|515494229|FG000|Overall Study|Biomicroscopy|1|||
142988841|NCT01300767|515494229|FG000|Overall Study|Unacceptable fit|1|||
142988842|NCT01188811|515494232|FG000|Overall Study|Withdrawal by Subject|0|||
142988843|NCT01188811|515494233|FG001|Overall Study|Withdrawal by Subject|2|||
142988844|NCT01188811|515494232|FG000|Overall Study|Adverse Event|6|||
142988845|NCT01188811|515494233|FG001|Overall Study|Adverse Event|0|||
142988846|NCT00654368|515494234|FG000|Overall Study|Ineligibility determined|6|||
142988847|NCT00654368|515494235|FG001|Overall Study|Ineligibility determined|0|||
142988848|NCT00654368|515494236|FG002|Overall Study|Ineligibility determined|0|||
142988849|NCT00654368|515494234|FG000|Overall Study|Protocol deviation|3|||
142988850|NCT00654368|515494235|FG001|Overall Study|Protocol deviation|2|||
142988851|NCT00654368|515494236|FG002|Overall Study|Protocol deviation|1|||
142988852|NCT00654368|515494234|FG000|Overall Study|Non-compliance|2|||
142988853|NCT00654368|515494235|FG001|Overall Study|Non-compliance|1|||
142988854|NCT00654368|515494236|FG002|Overall Study|Non-compliance|2|||
142988855|NCT00654368|515494234|FG000|Overall Study|Withdrawal by Subject|5|||
142988856|NCT00654368|515494235|FG001|Overall Study|Withdrawal by Subject|2|||
142988857|NCT00654368|515494236|FG002|Overall Study|Withdrawal by Subject|2|||
142988858|NCT00654368|515494234|FG000|Overall Study|Disease progression|21|||
142988859|NCT00654368|515494235|FG001|Overall Study|Disease progression|31|||
142988860|NCT00654368|515494236|FG002|Overall Study|Disease progression|13|||
142988861|NCT00654368|515494234|FG000|Overall Study|Requirement for alternative therapy|1|||
142988862|NCT00654368|515494235|FG001|Overall Study|Requirement for alternative therapy|1|||
142988863|NCT00654368|515494236|FG002|Overall Study|Requirement for alternative therapy|1|||
142988864|NCT00654368|515494234|FG000|Overall Study|Physician Decision|0|||
142988865|NCT00654368|515494235|FG001|Overall Study|Physician Decision|0|||
142988866|NCT00654368|515494236|FG002|Overall Study|Physician Decision|2|||
142988867|NCT00654368|515494234|FG000|Overall Study|Death|1|||
142988868|NCT00654368|515494235|FG001|Overall Study|Death|0|||
142988869|NCT00654368|515494236|FG002|Overall Study|Death|0|||
142988870|NCT00654368|515494234|FG000|Overall Study|Pregnancy|0|||
142988871|NCT00654368|515494235|FG001|Overall Study|Pregnancy|0|||
142988872|NCT00654368|515494236|FG002|Overall Study|Pregnancy|2|||
142988873|NCT00654368|515494234|FG000|Overall Study|Other|0|||
142988874|NCT00654368|515494235|FG001|Overall Study|Other|2|||
142988875|NCT00654368|515494236|FG002|Overall Study|Other|3|||
142988876|NCT00654368|515494234|FG000|Overall Study|Adverse Event|14|||
142988877|NCT00654368|515494235|FG001|Overall Study|Adverse Event|9|||
142988878|NCT00654368|515494236|FG002|Overall Study|Adverse Event|6|||
142988879|NCT00804986|515494237|FG000|Overall Study|Adverse Event|0|||
142988880|NCT00804986|515494238|FG001|Overall Study|Adverse Event|1|||
142988881|NCT00804986|515494239|FG002|Overall Study|Adverse Event|2|||
142988882|NCT00804986|515494240|FG003|Overall Study|Adverse Event|1|||
142988883|NCT00804986|515494241|FG004|Overall Study|Adverse Event|3|||
142988884|NCT00804986|515494242|FG005|Overall Study|Adverse Event|0|||
142988885|NCT00804986|515494237|FG000|Overall Study|Lack of Efficacy|0|||
142988886|NCT00804986|515494238|FG001|Overall Study|Lack of Efficacy|0|||
142988887|NCT00804986|515494239|FG002|Overall Study|Lack of Efficacy|0|||
142988888|NCT00804986|515494240|FG003|Overall Study|Lack of Efficacy|1|||
142988889|NCT00804986|515494241|FG004|Overall Study|Lack of Efficacy|0|||
142988890|NCT00804986|515494242|FG005|Overall Study|Lack of Efficacy|3|||
142988891|NCT00804986|515494237|FG000|Overall Study|Lost to Follow-up|0|||
142988892|NCT00804986|515494238|FG001|Overall Study|Lost to Follow-up|0|||
142988893|NCT00804986|515494239|FG002|Overall Study|Lost to Follow-up|0|||
142988894|NCT00804986|515494240|FG003|Overall Study|Lost to Follow-up|1|||
142988895|NCT00804986|515494241|FG004|Overall Study|Lost to Follow-up|1|||
142988896|NCT00804986|515494242|FG005|Overall Study|Lost to Follow-up|3|||
142988897|NCT00804986|515494237|FG000|Overall Study|Protocol Violation|0|||
142988898|NCT00804986|515494238|FG001|Overall Study|Protocol Violation|1|||
142988899|NCT00804986|515494239|FG002|Overall Study|Protocol Violation|0|||
142988900|NCT00804986|515494240|FG003|Overall Study|Protocol Violation|1|||
142988901|NCT00804986|515494241|FG004|Overall Study|Protocol Violation|0|||
142988902|NCT00804986|515494242|FG005|Overall Study|Protocol Violation|0|||
142988903|NCT00804986|515494237|FG000|Overall Study|Withdrawal by Subject|0|||
143117234|NCT01709864|515971808|FG000|Overall Study|subject/guardian decision|5|||
142988904|NCT00804986|515494238|FG001|Overall Study|Withdrawal by Subject|3|||
142988905|NCT00804986|515494239|FG002|Overall Study|Withdrawal by Subject|0|||
142988906|NCT00804986|515494240|FG003|Overall Study|Withdrawal by Subject|3|||
142988907|NCT00804986|515494241|FG004|Overall Study|Withdrawal by Subject|5|||
142988908|NCT00804986|515494242|FG005|Overall Study|Withdrawal by Subject|3|||
142988909|NCT00804986|515494237|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
142988910|NCT00804986|515494238|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
142988911|NCT00804986|515494239|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
142988912|NCT00804986|515494240|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
142988913|NCT00804986|515494241|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
142988914|NCT00804986|515494242|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
142988915|NCT00804986|515494237|FG000|Overall Study|Sponsor Decision|0|||
142988916|NCT00804986|515494238|FG001|Overall Study|Sponsor Decision|1|||
142988917|NCT00804986|515494239|FG002|Overall Study|Sponsor Decision|0|||
142988918|NCT00804986|515494240|FG003|Overall Study|Sponsor Decision|0|||
142988919|NCT00804986|515494241|FG004|Overall Study|Sponsor Decision|0|||
142988920|NCT00804986|515494242|FG005|Overall Study|Sponsor Decision|0|||
142988921|NCT00804986|515494237|FG000|Overall Study|Physician Decision|1|||
142988922|NCT00804986|515494238|FG001|Overall Study|Physician Decision|0|||
142988923|NCT00804986|515494239|FG002|Overall Study|Physician Decision|0|||
142988924|NCT00804986|515494240|FG003|Overall Study|Physician Decision|0|||
142988925|NCT00804986|515494241|FG004|Overall Study|Physician Decision|0|||
142988926|NCT00804986|515494242|FG005|Overall Study|Physician Decision|0|||
142988927|NCT01602744|515494243|FG000|Overall Study|Death|17|||
142988928|NCT01602744|515494244|FG001|Overall Study|Death|15|||
142988929|NCT01602744|515494243|FG000|Overall Study|Lost to Follow-up|13|||
142988930|NCT01602744|515494244|FG001|Overall Study|Lost to Follow-up|8|||
142988931|NCT00959699|515494245|FG000|Treatment Period|Adverse Event|3|||
142988932|NCT00959699|515494246|FG001|Treatment Period|Adverse Event|13|||
142988933|NCT00959699|515494245|FG000|Treatment Period|Lack of Efficacy|15|||
142988934|NCT00959699|515494246|FG001|Treatment Period|Lack of Efficacy|6|||
142988935|NCT00959699|515494245|FG000|Treatment Period|Lost to Follow-up|0|||
142988936|NCT00959699|515494246|FG001|Treatment Period|Lost to Follow-up|1|||
142988937|NCT00959699|515494245|FG000|Treatment Period|Withdrawal by Subject|1|||
142988938|NCT00959699|515494246|FG001|Treatment Period|Withdrawal by Subject|3|||
142988939|NCT00959699|515494245|FG000|Treatment Period|Non-Compliance with Protocol|0|||
142988940|NCT00959699|515494246|FG001|Treatment Period|Non-Compliance with Protocol|1|||
142988941|NCT00959699|515494245|FG000|Treatment Period|Did not receive treatment|0|||
142988942|NCT00959699|515494246|FG001|Treatment Period|Did not receive treatment|1|||
142988943|NCT00959699|515494245|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
142988944|NCT00959699|515494246|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
142988945|NCT00959699|515494245|FG000|Follow-up Period|Lost to Follow-up|3|||
142988946|NCT00959699|515494246|FG001|Follow-up Period|Lost to Follow-up|2|||
142988947|NCT00959699|515494245|FG000|Follow-up Period|Withdrawal by Subject|3|||
142988948|NCT00959699|515494246|FG001|Follow-up Period|Withdrawal by Subject|4|||
142988949|NCT00606294|515494249|FG000|Overall Study|Withdrawal by Subject|36|||
142988950|NCT00606294|515494250|FG001|Overall Study|Withdrawal by Subject|0|||
142988951|NCT01976624|515494251|FG000|Overall Study|Participants contraindicated|2|||
142988952|NCT01976624|515494251|FG000|Overall Study|Participants age less than 19 years|12|||
142988953|NCT01307046|515494256|FG000|Overall Study|Adverse Event|3|||
142988954|NCT01307046|515494257|FG001|Overall Study|Adverse Event|3|||
142988955|NCT01307046|515494256|FG000|Overall Study|Lack of Efficacy|0|||
142988956|NCT01307046|515494257|FG001|Overall Study|Lack of Efficacy|2|||
142988957|NCT01307046|515494256|FG000|Overall Study|Physician Decision|2|||
142988958|NCT01307046|515494257|FG001|Overall Study|Physician Decision|0|||
142988959|NCT01307046|515494256|FG000|Overall Study|Withdrawal by Subject|1|||
142988960|NCT01307046|515494257|FG001|Overall Study|Withdrawal by Subject|1|||
142988961|NCT01307046|515494256|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
142988962|NCT01307046|515494257|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
142988963|NCT01307046|515494256|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
142988964|NCT01307046|515494257|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
142988965|NCT02574520|515494258|FG000|Overall Study|Not dosed|2|||
142988966|NCT02574520|515494259|FG001|Overall Study|Not dosed|0|||
142988967|NCT02574520|515494260|FG002|Overall Study|Not dosed|5|||
142988968|NCT02574520|515494261|FG003|Overall Study|Not dosed|4|||
142988969|NCT02574520|515494258|FG000|Overall Study|Adverse Event|0|||
142988970|NCT02574520|515494259|FG001|Overall Study|Adverse Event|0|||
142988971|NCT02574520|515494260|FG002|Overall Study|Adverse Event|0|||
142988972|NCT02574520|515494261|FG003|Overall Study|Adverse Event|1|||
142988973|NCT02574520|515494258|FG000|Overall Study|Withdrawal by Subject|0|||
142988974|NCT02574520|515494259|FG001|Overall Study|Withdrawal by Subject|0|||
142988975|NCT02574520|515494260|FG002|Overall Study|Withdrawal by Subject|0|||
142988976|NCT02574520|515494261|FG003|Overall Study|Withdrawal by Subject|1|||
142988977|NCT02574520|515494258|FG000|Overall Study|Other|0|||
142988978|NCT02574520|515494259|FG001|Overall Study|Other|0|||
142988979|NCT02574520|515494260|FG002|Overall Study|Other|0|||
142988980|NCT02574520|515494261|FG003|Overall Study|Other|2|||
142988981|NCT05116683|515494270|FG000|Overall Study|Physician Decision|4|||
142988982|NCT01474889|515494272|FG000|Overall Study|Physician Decision|1|||
142988983|NCT01474889|515494273|FG001|Overall Study|Physician Decision|0|||
142988984|NCT01474889|515494274|FG002|Overall Study|Physician Decision|0|||
142988985|NCT01474889|515494272|FG000|Overall Study|Did not meet inclusion|1|||
142988986|NCT01474889|515494273|FG001|Overall Study|Did not meet inclusion|0|||
142988987|NCT01474889|515494274|FG002|Overall Study|Did not meet inclusion|0|||
142988988|NCT01474889|515494272|FG000|Overall Study|Withdrawal by Subject|0|||
142988989|NCT01474889|515494273|FG001|Overall Study|Withdrawal by Subject|1|||
142988990|NCT01474889|515494274|FG002|Overall Study|Withdrawal by Subject|0|||
142988991|NCT03935594|515494278|FG000|Overall Study|Physician Decision|3|||
142988992|NCT01435122|515494279|FG000|Overall Study|Early withdrawal due to toxicity|8|||
142988993|NCT03954704|515494280|FG000|Overall Study|Death|1|||
142988994|NCT03954704|515494281|FG001|Overall Study|Death|1|||
142988995|NCT03954704|515494282|FG002|Overall Study|Death|1|||
142988996|NCT03954704|515494283|FG003|Overall Study|Death|3|||
142988997|NCT03954704|515494284|FG004|Overall Study|Death|2|||
142988998|NCT03954704|515494285|FG005|Overall Study|Death|2|||
142988999|NCT03954704|515494286|FG006|Overall Study|Death|0|||
142989000|NCT03954704|515494280|FG000|Overall Study|Withdrew Consent|0|||
142989001|NCT03954704|515494281|FG001|Overall Study|Withdrew Consent|0|||
142989002|NCT03954704|515494282|FG002|Overall Study|Withdrew Consent|1|||
142989003|NCT03954704|515494283|FG003|Overall Study|Withdrew Consent|0|||
142989004|NCT03954704|515494284|FG004|Overall Study|Withdrew Consent|0|||
142989005|NCT03954704|515494285|FG005|Overall Study|Withdrew Consent|1|||
142989006|NCT03954704|515494286|FG006|Overall Study|Withdrew Consent|0|||
142989007|NCT03954704|515494280|FG000|Overall Study|Lost to Follow-up|0|||
142989008|NCT03954704|515494281|FG001|Overall Study|Lost to Follow-up|0|||
142989009|NCT03954704|515494282|FG002|Overall Study|Lost to Follow-up|0|||
142989010|NCT03954704|515494283|FG003|Overall Study|Lost to Follow-up|0|||
142989011|NCT03954704|515494284|FG004|Overall Study|Lost to Follow-up|0|||
142989012|NCT03954704|515494285|FG005|Overall Study|Lost to Follow-up|0|||
142989013|NCT03954704|515494286|FG006|Overall Study|Lost to Follow-up|1|||
142989014|NCT03954704|515494280|FG000|Overall Study|Study Terminated by Sponsor|0|||
142989015|NCT03954704|515494281|FG001|Overall Study|Study Terminated by Sponsor|0|||
142989016|NCT03954704|515494282|FG002|Overall Study|Study Terminated by Sponsor|1|||
142989017|NCT03954704|515494283|FG003|Overall Study|Study Terminated by Sponsor|0|||
142989018|NCT03954704|515494284|FG004|Overall Study|Study Terminated by Sponsor|1|||
142989019|NCT03954704|515494285|FG005|Overall Study|Study Terminated by Sponsor|4|||
142989020|NCT03954704|515494286|FG006|Overall Study|Study Terminated by Sponsor|2|||
142989021|NCT03954704|515494280|FG000|Overall Study|Enrolled but not Treated|0|||
142989022|NCT03954704|515494281|FG001|Overall Study|Enrolled but not Treated|0|||
142989023|NCT03954704|515494282|FG002|Overall Study|Enrolled but not Treated|0|||
142989024|NCT03954704|515494283|FG003|Overall Study|Enrolled but not Treated|0|||
142989025|NCT03954704|515494284|FG004|Overall Study|Enrolled but not Treated|0|||
142989026|NCT03954704|515494285|FG005|Overall Study|Enrolled but not Treated|1|||
142989027|NCT03954704|515494286|FG006|Overall Study|Enrolled but not Treated|0|||
142989028|NCT04035473|515494287|FG000|Screening/Baseline|Death|0|||
142989029|NCT04035473|515494288|FG001|Screening/Baseline|Death|1|||
142989030|NCT04035473|515494287|FG000|Screening/Baseline|Adverse Event|0|||
142989031|NCT04035473|515494288|FG001|Screening/Baseline|Adverse Event|1|||
142989032|NCT04035473|515494287|FG000|Follow-up Period|Adverse Event|2|||
142989033|NCT04035473|515494288|FG001|Follow-up Period|Adverse Event|0|||
142989034|NCT00112840|515494289|FG000|Overall Study|Physician Decision|1|||
142989035|NCT00112840|515494290|FG001|Overall Study|Physician Decision|0|||
142989036|NCT00112840|515494291|FG002|Overall Study|Physician Decision|0|||
142989037|NCT00112840|515494289|FG000|Overall Study|Withdrawal by Subject|1|||
142989038|NCT00112840|515494290|FG001|Overall Study|Withdrawal by Subject|0|||
142989039|NCT00112840|515494291|FG002|Overall Study|Withdrawal by Subject|1|||
142989040|NCT00112840|515494289|FG000|Overall Study|Protocol Violation|0|||
142989041|NCT00112840|515494290|FG001|Overall Study|Protocol Violation|0|||
142989042|NCT00112840|515494291|FG002|Overall Study|Protocol Violation|5|||
142989043|NCT03595176|515494292|FG000|Overall Study|Death|0|||
142989044|NCT03595176|515494293|FG001|Overall Study|Death|2|||
142989045|NCT03595176|515494292|FG000|Overall Study|Lost to Follow-up|0|||
142989046|NCT03595176|515494293|FG001|Overall Study|Lost to Follow-up|1|||
142989047|NCT00397891|515494295|FG000|Overall Study|Withdrawal by Subject|1|||
142989048|NCT00397891|515494296|FG001|Overall Study|Withdrawal by Subject|0|||
142989049|NCT00397891|515494297|FG002|Overall Study|Withdrawal by Subject|0|||
142989050|NCT00397891|515494298|FG003|Overall Study|Withdrawal by Subject|0|||
142989051|NCT00397891|515494299|FG004|Overall Study|Withdrawal by Subject|1|||
142989052|NCT00412113|515494300|FG000|Overall Study|Adverse Event|11|||
142989053|NCT00412113|515494301|FG001|Overall Study|Adverse Event|15|||
142989054|NCT00412113|515494300|FG000|Overall Study|did not receive treatment|1|||
142989055|NCT00412113|515494301|FG001|Overall Study|did not receive treatment|0|||
142989056|NCT04195750|515494306|FG000|Overall Study|Death|245|||
142989057|NCT04195750|515494307|FG001|Overall Study|Death|253|||
142989058|NCT04195750|515494308|FG002|Overall Study|Death|5|||
142989059|NCT04195750|515494306|FG000|Overall Study|Physician Decision|0|||
142989060|NCT04195750|515494307|FG001|Overall Study|Physician Decision|1|||
142989061|NCT04195750|515494308|FG002|Overall Study|Physician Decision|0|||
142989062|NCT04195750|515494306|FG000|Overall Study|Withdrawal by Subject|9|||
142989063|NCT04195750|515494307|FG001|Overall Study|Withdrawal by Subject|8|||
142989064|NCT04195750|515494308|FG002|Overall Study|Withdrawal by Subject|0|||
142989065|NCT04195750|515494306|FG000|Overall Study|Ongoing|120|||
142989066|NCT04195750|515494307|FG001|Overall Study|Ongoing|110|||
142989067|NCT04195750|515494308|FG002|Overall Study|Ongoing|4|||
142989068|NCT02254304|515494309|FG000|Overall Study|Adverse Event|2|||
142989069|NCT02254304|515494310|FG001|Overall Study|Adverse Event|1|||
142989070|NCT02254304|515494309|FG000|Overall Study|Lost to Follow-up|2|||
142989071|NCT02254304|515494310|FG001|Overall Study|Lost to Follow-up|2|||
142989072|NCT02254304|515494309|FG000|Overall Study|Protocol Violation|1|||
142989073|NCT02254304|515494310|FG001|Overall Study|Protocol Violation|0|||
142989074|NCT02254304|515494309|FG000|Overall Study|Withdrawal by Subject|3|||
142989075|NCT02254304|515494310|FG001|Overall Study|Withdrawal by Subject|0|||
142989076|NCT02254304|515494309|FG000|Overall Study|Injection site pain and Injection fear|1|||
142989077|NCT02254304|515494310|FG001|Overall Study|Injection site pain and Injection fear|0|||
142989078|NCT02254304|515494309|FG000|Overall Study|Personal causes|4|||
142989079|NCT02254304|515494310|FG001|Overall Study|Personal causes|1|||
142989080|NCT02254304|515494309|FG000|Overall Study|Personal decision|1|||
142989081|NCT02254304|515494310|FG001|Overall Study|Personal decision|0|||
142989082|NCT02531633|515496667|FG000|Part A (52 Weeks)|Sponsor request|24|||
142989083|NCT02531633|515496668|FG001|Part A (52 Weeks)|Sponsor request|24|||
142989084|NCT02531633|515496669|FG002|Part A (52 Weeks)|Sponsor request|18|||
142989085|NCT02531633|515496670|FG003|Part A (52 Weeks)|Sponsor request|18|||
142989086|NCT02531633|515496671|FG004|Part A (52 Weeks)|Sponsor request|19|||
142989087|NCT02531633|515496672|FG005|Part A (52 Weeks)|Sponsor request|0|||
142989088|NCT02531633|515496673|FG006|Part A (52 Weeks)|Sponsor request|0|||
142989089|NCT02531633|515496674|FG007|Part A (52 Weeks)|Sponsor request|0|||
142989090|NCT02531633|515496675|FG008|Part A (52 Weeks)|Sponsor request|0|||
142989091|NCT02531633|515496676|FG009|Part A (52 Weeks)|Sponsor request|0|||
142989092|NCT02531633|515496667|FG000|Part A (52 Weeks)|Protocol Violation|1|||
142989093|NCT02531633|515496668|FG001|Part A (52 Weeks)|Protocol Violation|0|||
142989094|NCT02531633|515496669|FG002|Part A (52 Weeks)|Protocol Violation|0|||
142989095|NCT02531633|515496670|FG003|Part A (52 Weeks)|Protocol Violation|0|||
142989096|NCT02531633|515496671|FG004|Part A (52 Weeks)|Protocol Violation|0|||
142989097|NCT02531633|515496672|FG005|Part A (52 Weeks)|Protocol Violation|0|||
142989098|NCT02531633|515496673|FG006|Part A (52 Weeks)|Protocol Violation|0|||
142989099|NCT02531633|515496674|FG007|Part A (52 Weeks)|Protocol Violation|0|||
142989100|NCT02531633|515496675|FG008|Part A (52 Weeks)|Protocol Violation|0|||
142989101|NCT02531633|515496676|FG009|Part A (52 Weeks)|Protocol Violation|0|||
142989102|NCT02531633|515496667|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
142989103|NCT02531633|515496668|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
142989104|NCT02531633|515496669|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
142989105|NCT02531633|515496670|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
142989106|NCT02531633|515496671|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
142989107|NCT02531633|515496672|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
142989108|NCT02531633|515496673|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
142989109|NCT02531633|515496674|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
142989110|NCT02531633|515496675|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
142989111|NCT02531633|515496676|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
142989112|NCT02531633|515496667|FG000|Part A (52 Weeks)|Physician Decision|1|||
142989113|NCT02531633|515496668|FG001|Part A (52 Weeks)|Physician Decision|4|||
142989114|NCT02531633|515496669|FG002|Part A (52 Weeks)|Physician Decision|3|||
142989115|NCT02531633|515496670|FG003|Part A (52 Weeks)|Physician Decision|1|||
142989116|NCT02531633|515496671|FG004|Part A (52 Weeks)|Physician Decision|0|||
142989117|NCT02531633|515496672|FG005|Part A (52 Weeks)|Physician Decision|0|||
142989118|NCT02531633|515496673|FG006|Part A (52 Weeks)|Physician Decision|0|||
142989119|NCT02531633|515496674|FG007|Part A (52 Weeks)|Physician Decision|0|||
142989120|NCT02531633|515496675|FG008|Part A (52 Weeks)|Physician Decision|0|||
142989121|NCT02531633|515496676|FG009|Part A (52 Weeks)|Physician Decision|0|||
142989122|NCT02531633|515496667|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
142989123|NCT02531633|515496668|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
142989124|NCT02531633|515496669|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
142989125|NCT02531633|515496670|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
142989126|NCT02531633|515496671|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
142989127|NCT02531633|515496672|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
142989128|NCT02531633|515496673|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
142989129|NCT02531633|515496674|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
142989130|NCT02531633|515496675|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
142989131|NCT02531633|515496676|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
142989132|NCT02531633|515496667|FG000|Part A (52 Weeks)|Other|2|||
142989133|NCT02531633|515496668|FG001|Part A (52 Weeks)|Other|0|||
142989134|NCT02531633|515496669|FG002|Part A (52 Weeks)|Other|0|||
142989135|NCT02531633|515496670|FG003|Part A (52 Weeks)|Other|0|||
142989136|NCT02531633|515496671|FG004|Part A (52 Weeks)|Other|0|||
142989137|NCT02531633|515496672|FG005|Part A (52 Weeks)|Other|0|||
142989138|NCT02531633|515496673|FG006|Part A (52 Weeks)|Other|0|||
142989139|NCT02531633|515496674|FG007|Part A (52 Weeks)|Other|0|||
142989140|NCT02531633|515496675|FG008|Part A (52 Weeks)|Other|0|||
142989141|NCT02531633|515496676|FG009|Part A (52 Weeks)|Other|0|||
142989142|NCT02531633|515496667|FG000|Part B (104 Weeks)|Sponsor request|0|||
142989143|NCT02531633|515496668|FG001|Part B (104 Weeks)|Sponsor request|0|||
142989144|NCT02531633|515496669|FG002|Part B (104 Weeks)|Sponsor request|0|||
142989145|NCT02531633|515496670|FG003|Part B (104 Weeks)|Sponsor request|0|||
142989146|NCT02531633|515496671|FG004|Part B (104 Weeks)|Sponsor request|0|||
142989147|NCT02531633|515496672|FG005|Part B (104 Weeks)|Sponsor request|8|||
142989148|NCT02531633|515496673|FG006|Part B (104 Weeks)|Sponsor request|5|||
142989149|NCT02531633|515496674|FG007|Part B (104 Weeks)|Sponsor request|3|||
142989150|NCT02531633|515496675|FG008|Part B (104 Weeks)|Sponsor request|5|||
142989151|NCT02531633|515496676|FG009|Part B (104 Weeks)|Sponsor request|4|||
142989152|NCT02531633|515496667|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
142989153|NCT02531633|515496668|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
142989154|NCT02531633|515496669|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
142989155|NCT02531633|515496670|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
142989156|NCT02531633|515496671|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
142989157|NCT02531633|515496672|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
142989158|NCT02531633|515496673|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
142989159|NCT02531633|515496674|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
142989160|NCT02531633|515496675|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
142989161|NCT02531633|515496676|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
142989162|NCT02903966|515496677|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
142989163|NCT02903966|515496678|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
142989164|NCT02903966|515496677|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
142989165|NCT02903966|515496678|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
142989166|NCT02903966|515496677|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
142989167|NCT02903966|515496678|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
142989168|NCT01320033|515496679|FG000|Overall Study|Lack of Efficacy|0|||
142989169|NCT01320033|515496680|FG001|Overall Study|Lack of Efficacy|0|||
142989170|NCT01320033|515496681|FG002|Overall Study|Lack of Efficacy|1|||
142989171|NCT01320033|515496679|FG000|Overall Study|Adverse Event|9|||
142989172|NCT01320033|515496680|FG001|Overall Study|Adverse Event|7|||
142989173|NCT01320033|515496681|FG002|Overall Study|Adverse Event|8|||
142989174|NCT01320033|515496679|FG000|Overall Study|Withdrawal by Subject|22|||
142989175|NCT01320033|515496680|FG001|Overall Study|Withdrawal by Subject|23|||
142989176|NCT01320033|515496681|FG002|Overall Study|Withdrawal by Subject|23|||
142989177|NCT01320033|515496679|FG000|Overall Study|Protocol Violation|3|||
142989178|NCT01320033|515496680|FG001|Overall Study|Protocol Violation|5|||
142989179|NCT01320033|515496681|FG002|Overall Study|Protocol Violation|3|||
142989180|NCT01320033|515496679|FG000|Overall Study|Lost to Follow-up|22|||
142989181|NCT01320033|515496680|FG001|Overall Study|Lost to Follow-up|26|||
142989182|NCT01320033|515496681|FG002|Overall Study|Lost to Follow-up|17|||
142989183|NCT01320033|515496679|FG000|Overall Study|Other|2|||
142989184|NCT01320033|515496680|FG001|Overall Study|Other|3|||
142989185|NCT01320033|515496681|FG002|Overall Study|Other|1|||
142989186|NCT00963469|515496682|FG000|Overall Study|Adverse Event|15|||
142989187|NCT00963469|515496683|FG001|Overall Study|Adverse Event|11|||
142989188|NCT00963469|515496684|FG002|Overall Study|Adverse Event|1|||
142989189|NCT00963469|515496682|FG000|Overall Study|Lack of Efficacy|10|||
142989190|NCT00963469|515496683|FG001|Overall Study|Lack of Efficacy|7|||
142989191|NCT00963469|515496684|FG002|Overall Study|Lack of Efficacy|2|||
142989192|NCT00963469|515496682|FG000|Overall Study|Lost to Follow-up|1|||
142989193|NCT00963469|515496683|FG001|Overall Study|Lost to Follow-up|1|||
142989194|NCT00963469|515496684|FG002|Overall Study|Lost to Follow-up|0|||
142989195|NCT00963469|515496682|FG000|Overall Study|Protocol Violation|5|||
142989196|NCT00963469|515496683|FG001|Overall Study|Protocol Violation|5|||
142989197|NCT00963469|515496684|FG002|Overall Study|Protocol Violation|3|||
142989198|NCT00963469|515496682|FG000|Overall Study|Withdrawal by Subject|4|||
142989199|NCT00963469|515496683|FG001|Overall Study|Withdrawal by Subject|1|||
142989200|NCT00963469|515496684|FG002|Overall Study|Withdrawal by Subject|1|||
142989201|NCT00963469|515496682|FG000|Overall Study|Pre-randomization Adverse Event|1|||
142989202|NCT00963469|515496683|FG001|Overall Study|Pre-randomization Adverse Event|2|||
142989203|NCT00963469|515496684|FG002|Overall Study|Pre-randomization Adverse Event|0|||
142989204|NCT00963469|515496682|FG000|Overall Study|Moved|1|||
142989205|NCT00963469|515496683|FG001|Overall Study|Moved|0|||
142989206|NCT00963469|515496684|FG002|Overall Study|Moved|0|||
142989207|NCT00963469|515496682|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
142989208|NCT00963469|515496683|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
142989209|NCT00963469|515496684|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
142989210|NCT00378534|515496693|FG000|Overall Study|Participants did not receive transplant|3|||
142989211|NCT00378534|515496694|FG001|Overall Study|Participants did not receive transplant|0|||
142989212|NCT04969900|515496695|FG000|Overall Study|Physician Decision|1|||
142989213|NCT04969900|515496696|FG001|Overall Study|Physician Decision|1|||
142989214|NCT04969900|515496695|FG000|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
142989215|NCT04969900|515496696|FG001|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
142989216|NCT04423718|515496700|FG000|Main Study|Adverse Event|9|||
142989217|NCT04423718|515496701|FG001|Main Study|Adverse Event|5|||
142989218|NCT04423718|515496702|FG002|Main Study|Adverse Event|8|||
142989219|NCT04423718|515496700|FG000|Main Study|Physician Decision|3|||
142989220|NCT04423718|515496701|FG001|Main Study|Physician Decision|3|||
142989221|NCT04423718|515496702|FG002|Main Study|Physician Decision|2|||
142989222|NCT04423718|515496700|FG000|Main Study|Protocol Violation|0|||
142989223|NCT04423718|515496701|FG001|Main Study|Protocol Violation|0|||
142989224|NCT04423718|515496702|FG002|Main Study|Protocol Violation|1|||
142989225|NCT04423718|515496700|FG000|Main Study|Lost to Follow-up|3|||
142989226|NCT04423718|515496701|FG001|Main Study|Lost to Follow-up|3|||
142989227|NCT04423718|515496702|FG002|Main Study|Lost to Follow-up|4|||
142989228|NCT04423718|515496700|FG000|Main Study|Lack of Efficacy|2|||
142989229|NCT04423718|515496701|FG001|Main Study|Lack of Efficacy|1|||
142989230|NCT04423718|515496702|FG002|Main Study|Lack of Efficacy|0|||
142989231|NCT04423718|515496700|FG000|Main Study|Withdrawal by Subject|14|||
142989232|NCT04423718|515496701|FG001|Main Study|Withdrawal by Subject|20|||
142989233|NCT04423718|515496702|FG002|Main Study|Withdrawal by Subject|20|||
142989234|NCT04423718|515496700|FG000|Main Study|Death|10|||
142989235|NCT04423718|515496701|FG001|Main Study|Death|7|||
142989236|NCT04423718|515496702|FG002|Main Study|Death|7|||
142989237|NCT04423718|515496700|FG000|Main Study|COVID-19 pandemic|2|||
142989238|NCT04423718|515496701|FG001|Main Study|COVID-19 pandemic|2|||
142989239|NCT04423718|515496702|FG002|Main Study|COVID-19 pandemic|2|||
142989240|NCT04423718|515496700|FG000|Main Study|Other|7|||
142989241|NCT04423718|515496701|FG001|Main Study|Other|3|||
142989242|NCT04423718|515496702|FG002|Main Study|Other|2|||
142989243|NCT04423718|515496700|FG000|Extension Phase|Other|1|||
142989244|NCT04423718|515496701|FG001|Extension Phase|Other|0|||
142989245|NCT04423718|515496702|FG002|Extension Phase|Other|0|||
142989246|NCT04423718|515496700|FG000|Extension Phase|Logistical problems|0|||
142989247|NCT04423718|515496701|FG001|Extension Phase|Logistical problems|1|||
142989248|NCT04423718|515496702|FG002|Extension Phase|Logistical problems|1|||
142989249|NCT04423718|515496700|FG000|Extension Phase|Physician Decision|1|||
142989250|NCT04423718|515496701|FG001|Extension Phase|Physician Decision|0|||
142989251|NCT04423718|515496702|FG002|Extension Phase|Physician Decision|1|||
142989252|NCT04423718|515496700|FG000|Extension Phase|Lack of Efficacy|2|||
142989253|NCT04423718|515496701|FG001|Extension Phase|Lack of Efficacy|0|||
142989254|NCT04423718|515496702|FG002|Extension Phase|Lack of Efficacy|1|||
142989255|NCT04423718|515496700|FG000|Extension Phase|Lost to Follow-up|0|||
142989256|NCT04423718|515496701|FG001|Extension Phase|Lost to Follow-up|2|||
142989257|NCT04423718|515496702|FG002|Extension Phase|Lost to Follow-up|3|||
142989258|NCT04423718|515496700|FG000|Extension Phase|Adverse Event|2|||
142989259|NCT04423718|515496701|FG001|Extension Phase|Adverse Event|3|||
142989260|NCT04423718|515496702|FG002|Extension Phase|Adverse Event|1|||
142989261|NCT04423718|515496700|FG000|Extension Phase|Death|4|||
142989262|NCT04423718|515496701|FG001|Extension Phase|Death|7|||
142989263|NCT04423718|515496702|FG002|Extension Phase|Death|2|||
142989264|NCT04423718|515496700|FG000|Extension Phase|Withdrawal by Subject|11|||
142989265|NCT04423718|515496701|FG001|Extension Phase|Withdrawal by Subject|11|||
142989266|NCT04423718|515496702|FG002|Extension Phase|Withdrawal by Subject|7|||
142989267|NCT00425945|515496703|FG000|Overall Study|Concern about Supplement|2|||
142989268|NCT00425945|515496704|FG001|Overall Study|Concern about Supplement|0|||
142989269|NCT00425945|515496703|FG000|Overall Study|Inconvenience|0|||
142989270|NCT00425945|515496704|FG001|Overall Study|Inconvenience|2|||
142989271|NCT00425945|515496703|FG000|Overall Study|Lost to Follow-up|0|||
142989272|NCT00425945|515496704|FG001|Overall Study|Lost to Follow-up|2|||
142989273|NCT00425945|515496703|FG000|Overall Study|Began hypertension medication|1|||
142989274|NCT00425945|515496704|FG001|Overall Study|Began hypertension medication|0|||
142989275|NCT00425945|515496703|FG000|Overall Study|Began cancer treatments|1|||
142989276|NCT00425945|515496704|FG001|Overall Study|Began cancer treatments|0|||
142989277|NCT00425945|515496703|FG000|Overall Study|Moved from area|0|||
142989278|NCT00425945|515496704|FG001|Overall Study|Moved from area|1|||
142989279|NCT02881151|515496705|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
142989280|NCT03381274|515496706|FG000|Overall Study|Death|2|||
142989281|NCT03381274|515496707|FG001|Overall Study|Death|9|||
143117235|NCT01709864|515971809|FG001|Overall Study|subject/guardian decision|6|||
142989282|NCT03381274|515496708|FG002|Overall Study|Death|3|||
142989283|NCT03381274|515496709|FG003|Overall Study|Death|2|||
142989284|NCT03381274|515496710|FG004|Overall Study|Death|3|||
142989285|NCT03381274|515496706|FG000|Overall Study|Lost to Follow-up|0|||
142989286|NCT03381274|515496707|FG001|Overall Study|Lost to Follow-up|0|||
142989287|NCT03381274|515496708|FG002|Overall Study|Lost to Follow-up|0|||
142989288|NCT03381274|515496709|FG003|Overall Study|Lost to Follow-up|1|||
142989289|NCT03381274|515496710|FG004|Overall Study|Lost to Follow-up|0|||
142989290|NCT03381274|515496706|FG000|Overall Study|Withdrawal by Subject|2|||
142989291|NCT03381274|515496707|FG001|Overall Study|Withdrawal by Subject|1|||
142989292|NCT03381274|515496708|FG002|Overall Study|Withdrawal by Subject|3|||
142989293|NCT03381274|515496709|FG003|Overall Study|Withdrawal by Subject|1|||
142989294|NCT03381274|515496710|FG004|Overall Study|Withdrawal by Subject|0|||
142989295|NCT03381274|515496706|FG000|Overall Study|Other|1|||
142989296|NCT03381274|515496707|FG001|Overall Study|Other|11|||
142989297|NCT03381274|515496708|FG002|Overall Study|Other|0|||
142989298|NCT03381274|515496709|FG003|Overall Study|Other|2|||
142989299|NCT03381274|515496710|FG004|Overall Study|Other|2|||
142989300|NCT04992507|515496713|FG000|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|5|||
142989301|NCT04992507|515496714|FG001|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|2|||
142989302|NCT04992507|515496713|FG000|Overall Study|Death|0|||
142989303|NCT04992507|515496714|FG001|Overall Study|Death|1|||
142989304|NCT03728881|515496717|FG000|Enrolled and Received 1st Vaccination|Adverse Event|0|||
142989305|NCT03728881|515496718|FG001|Enrolled and Received 1st Vaccination|Adverse Event|1|||
142989306|NCT03728881|515496717|FG000|Enrolled and Received 1st Vaccination|Death|1|||
142989307|NCT03728881|515496718|FG001|Enrolled and Received 1st Vaccination|Death|1|||
142989308|NCT03728881|515496717|FG000|Enrolled and Received 1st Vaccination|Withdrawal by Subject|5|||
142989309|NCT03728881|515496718|FG001|Enrolled and Received 1st Vaccination|Withdrawal by Subject|8|||
142989310|NCT03728881|515496717|FG000|Enrolled and Received 1st Vaccination|Out of Country|1|||
142989311|NCT03728881|515496718|FG001|Enrolled and Received 1st Vaccination|Out of Country|3|||
142989312|NCT03728881|515496717|FG000|Enrolled and Received 1st Vaccination|No Show|0|||
142989313|NCT03728881|515496718|FG001|Enrolled and Received 1st Vaccination|No Show|1|||
142989314|NCT03728881|515496717|FG000|Enrolled and Received 1st Vaccination|Unable to appoint|3|||
142989315|NCT03728881|515496718|FG001|Enrolled and Received 1st Vaccination|Unable to appoint|12|||
142989316|NCT03728881|515496717|FG000|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|0|||
142989317|NCT03728881|515496718|FG001|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|49|||
142989318|NCT03728881|515496717|FG000|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|25|||
142989319|NCT03728881|515496718|FG001|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|0|||
142989320|NCT03728881|515496717|FG000|Enrolled and Received 1st Vaccination|HPV6/11 positive|10|||
142989321|NCT03728881|515496718|FG001|Enrolled and Received 1st Vaccination|HPV6/11 positive|0|||
142989322|NCT03728881|515496717|FG000|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|36|||
142989323|NCT03728881|515496718|FG001|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|179|||
142989324|NCT03728881|515496717|FG000|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|52|||
142989325|NCT03728881|515496718|FG001|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|172|||
142989326|NCT04517253|515496719|FG000|Primary Treatment Period|Adverse Event|1|||
142989327|NCT04517253|515496720|FG001|Primary Treatment Period|Adverse Event|0|||
142989328|NCT04517253|515496721|FG002|Primary Treatment Period|Adverse Event|0|||
142989329|NCT04517253|515496719|FG000|Primary Treatment Period|Death|0|||
142989330|NCT04517253|515496720|FG001|Primary Treatment Period|Death|1|||
142989331|NCT04517253|515496721|FG002|Primary Treatment Period|Death|0|||
142989332|NCT04517253|515496719|FG000|Maintenance Period|Withdrawal by Subject|1|||
142989333|NCT04517253|515496720|FG001|Maintenance Period|Withdrawal by Subject|0|||
142989334|NCT04517253|515496721|FG002|Maintenance Period|Withdrawal by Subject|0|||
142989335|NCT04517253|515496719|FG000|Maintenance Period|Study Terminated by Sponsor|3|||
142989336|NCT04517253|515496720|FG001|Maintenance Period|Study Terminated by Sponsor|2|||
142989337|NCT04517253|515496721|FG002|Maintenance Period|Study Terminated by Sponsor|2|||
142989338|NCT03233308|515496726|FG000|Overall Study|Adverse Event|1|||
142989339|NCT03233308|515496726|FG000|Overall Study|Protocol Violation|1|||
142989340|NCT03287830|515496727|FG000|Overall Study|Withdrawal by Subject|1|||
142989341|NCT03287830|515496728|FG001|Overall Study|Withdrawal by Subject|1|||
142989342|NCT03287830|515496727|FG000|Overall Study|not meeting inclusion criteria|5|||
142989343|NCT03287830|515496728|FG001|Overall Study|not meeting inclusion criteria|12|||
142989344|NCT02136134|515496734|FG000|Overall Study|Death|170|||
142989345|NCT02136134|515496735|FG001|Overall Study|Death|148|||
142989346|NCT02136134|515496734|FG000|Overall Study|Withdrawal by Subject|19|||
142989347|NCT02136134|515496735|FG001|Overall Study|Withdrawal by Subject|10|||
142989348|NCT02136134|515496734|FG000|Overall Study|Lost to Follow-up|3|||
142989349|NCT02136134|515496735|FG001|Overall Study|Lost to Follow-up|3|||
142989350|NCT02136134|515496734|FG000|Overall Study|Uspecified|55|||
142989351|NCT02136134|515496735|FG001|Overall Study|Uspecified|90|||
142989352|NCT03070119|515496738|FG000|Overall Study|Adverse Event|0|||
142989353|NCT03070119|515496739|FG001|Overall Study|Adverse Event|0|||
142989354|NCT03070119|515496740|FG002|Overall Study|Adverse Event|1|||
142989355|NCT03070119|515496738|FG000|Overall Study|Lost to Follow-up|0|||
142989356|NCT03070119|515496739|FG001|Overall Study|Lost to Follow-up|1|||
142989357|NCT03070119|515496740|FG002|Overall Study|Lost to Follow-up|0|||
142989358|NCT03070119|515496738|FG000|Overall Study|Consent Withdrawn|6|||
142989359|NCT03070119|515496739|FG001|Overall Study|Consent Withdrawn|5|||
142989360|NCT03070119|515496740|FG002|Overall Study|Consent Withdrawn|3|||
142989361|NCT03070119|515496738|FG000|Overall Study|Investigator Decision|0|||
142989362|NCT03070119|515496739|FG001|Overall Study|Investigator Decision|0|||
142989363|NCT03070119|515496740|FG002|Overall Study|Investigator Decision|1|||
142989364|NCT03070119|515496738|FG000|Overall Study|Death|7|||
142989365|NCT03070119|515496739|FG001|Overall Study|Death|14|||
142989366|NCT03070119|515496740|FG002|Overall Study|Death|5|||
142989367|NCT03070119|515496738|FG000|Overall Study|Disease Progression|5|||
142989368|NCT03070119|515496739|FG001|Overall Study|Disease Progression|7|||
142989369|NCT03070119|515496740|FG002|Overall Study|Disease Progression|7|||
142989370|NCT03070119|515496738|FG000|Overall Study|Reason not Specified|2|||
142989371|NCT03070119|515496739|FG001|Overall Study|Reason not Specified|2|||
142989372|NCT03070119|515496740|FG002|Overall Study|Reason not Specified|1|||
142989373|NCT02974621|515496741|FG000|Overall Study|Didn't receive study treatment|1|||
142989374|NCT02974621|515496742|FG001|Overall Study|Didn't receive study treatment|10|||
142989375|NCT00732472|515496743|FG000|Overall Study|Adverse Event|0|||
142989376|NCT00732472|515496744|FG001|Overall Study|Adverse Event|1|||
142989377|NCT00732472|515496745|FG002|Overall Study|Adverse Event|1|||
142989378|NCT00732472|515496746|FG003|Overall Study|Adverse Event|1|||
142989379|NCT00732472|515496743|FG000|Overall Study|Protocol Violation|0|||
142989380|NCT00732472|515496744|FG001|Overall Study|Protocol Violation|0|||
142989381|NCT00732472|515496745|FG002|Overall Study|Protocol Violation|0|||
142989382|NCT00732472|515496746|FG003|Overall Study|Protocol Violation|1|||
142989383|NCT00732472|515496743|FG000|Overall Study|Withdrawal by Subject|0|||
142989384|NCT00732472|515496744|FG001|Overall Study|Withdrawal by Subject|2|||
142989385|NCT00732472|515496745|FG002|Overall Study|Withdrawal by Subject|0|||
142989386|NCT00732472|515496746|FG003|Overall Study|Withdrawal by Subject|1|||
142989387|NCT02155712|515496748|FG000|Overall Study|Death|12|||
142989388|NCT02155712|515496749|FG001|Overall Study|Death|0|||
142989389|NCT02155712|515496748|FG000|Overall Study|Lost to Follow-up|37|||
142989390|NCT02155712|515496749|FG001|Overall Study|Lost to Follow-up|22|||
142989391|NCT02155712|515496748|FG000|Overall Study|Revision of device|4|||
142989392|NCT02155712|515496749|FG001|Overall Study|Revision of device|3|||
142989393|NCT02155712|515496748|FG000|Overall Study|Withdrawal by Subject|39|||
142989394|NCT02155712|515496749|FG001|Overall Study|Withdrawal by Subject|21|||
142989395|NCT02155712|515496748|FG000|Overall Study|Site termination|77|||
142989396|NCT02155712|515496749|FG001|Overall Study|Site termination|19|||
142989397|NCT02155712|515496748|FG000|Overall Study|Sponsor terminated study early|150|||
142989398|NCT02155712|515496749|FG001|Overall Study|Sponsor terminated study early|0|||
142989399|NCT02155712|515496748|FG000|Overall Study|Missed final 5-year protocol visit|0|||
142989400|NCT02155712|515496749|FG001|Overall Study|Missed final 5-year protocol visit|32|||
142989401|NCT02155712|515496748|FG000|Overall Study|Censored because surgery cancelled|6|||
142989402|NCT02155712|515496749|FG001|Overall Study|Censored because surgery cancelled|10|||
142989403|NCT02155712|515496748|FG000|Overall Study|Censored because study device was not implanted|61|||
142989404|NCT02155712|515496749|FG001|Overall Study|Censored because study device was not implanted|66|||
142989405|NCT02155712|515496748|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
142989406|NCT02155712|515496749|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
142989407|NCT01266876|515496750|FG000|Overall Study|Adverse Event|0|||
142989408|NCT01266876|515496751|FG001|Overall Study|Adverse Event|0|||
142989409|NCT01266876|515496752|FG002|Overall Study|Adverse Event|0|||
142989410|NCT01266876|515496753|FG003|Overall Study|Adverse Event|1|||
142989411|NCT01266876|515496754|FG004|Overall Study|Adverse Event|0|||
142989412|NCT01058395|515496755|FG000|Overall Study|Death|2|||
142989413|NCT01058395|515496756|FG001|Overall Study|Death|1|||
142989414|NCT01058395|515496755|FG000|Overall Study|Lost to Follow-up|1|||
142989415|NCT01058395|515496756|FG001|Overall Study|Lost to Follow-up|0|||
142989416|NCT05180721|515496757|FG000|Overall Study|Lost to Follow-up|4|||
142989417|NCT05016037|515496758|FG000|Overall Study|Lost to Follow-up|2|||
142989418|NCT03575351|515496759|FG000|Overall Study|Adverse Event|1|||
142989419|NCT03575351|515496760|FG001|Overall Study|Adverse Event|0|||
142989420|NCT03575351|515496759|FG000|Overall Study|Death|2|||
142989421|NCT03575351|515496760|FG001|Overall Study|Death|2|||
142989422|NCT03575351|515496759|FG000|Overall Study|Death due to the COVID-19 pandemic|0|||
142989423|NCT03575351|515496760|FG001|Overall Study|Death due to the COVID-19 pandemic|1|||
142989424|NCT03575351|515496759|FG000|Overall Study|Lack of Efficacy|28|||
142989425|NCT03575351|515496760|FG001|Overall Study|Lack of Efficacy|0|||
142989426|NCT03575351|515496759|FG000|Overall Study|Withdrawal by Subject|1|||
142989427|NCT03575351|515496760|FG001|Overall Study|Withdrawal by Subject|1|||
142989428|NCT03575351|515496759|FG000|Overall Study|Physician Decision|3|||
142989429|NCT03575351|515496760|FG001|Overall Study|Physician Decision|0|||
142989430|NCT03575351|515496759|FG000|Overall Study|Disease relapse|15|||
142989431|NCT03575351|515496760|FG001|Overall Study|Disease relapse|6|||
142989432|NCT03575351|515496759|FG000|Overall Study|Study drug manufacturing failure|0|||
142989433|NCT03575351|515496760|FG001|Overall Study|Study drug manufacturing failure|1|||
142989434|NCT03575351|515496759|FG000|Overall Study|other reasons|5|||
142989435|NCT03575351|515496760|FG001|Overall Study|other reasons|0|||
142989436|NCT03715205|515496761|FG000|Overall Study|Death|13|||
142989437|NCT03715205|515496761|FG000|Overall Study|Lost to Follow-up|2|||
142989438|NCT03715205|515496761|FG000|Overall Study|Physician Decision|93|||
142989439|NCT03715205|515496761|FG000|Overall Study|Withdrawal by Subject|26|||
142989440|NCT02756845|515496762|FG000|Overall Study|Death|12|||
142989441|NCT02756845|515496763|FG001|Overall Study|Death|2|||
142989442|NCT02756845|515496762|FG000|Overall Study|Withdrawal by Subject|1|||
142989443|NCT02756845|515496763|FG001|Overall Study|Withdrawal by Subject|0|||
142989444|NCT03342404|515496766|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
142989445|NCT03342404|515496767|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
142989446|NCT03342404|515496766|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
142989447|NCT03342404|515496767|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
142989448|NCT03342404|515496766|FG000|Blinded Treatment Phase|Adverse Event|5|||
142989449|NCT03342404|515496767|FG001|Blinded Treatment Phase|Adverse Event|4|||
142989450|NCT03342404|515496766|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
142989451|NCT03342404|515496767|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
142989452|NCT03342404|515496766|FG000|Blinded Treatment Phase|Other reasons|1|||
142989453|NCT03342404|515496767|FG001|Blinded Treatment Phase|Other reasons|0|||
142989454|NCT03342404|515496766|FG000|Blinded Treatment Phase|Physician Decision|1|||
142989455|NCT03342404|515496767|FG001|Blinded Treatment Phase|Physician Decision|0|||
142989456|NCT03342404|515496766|FG000|Blinded Treatment Phase|Death|1|||
142989457|NCT03342404|515496767|FG001|Blinded Treatment Phase|Death|0|||
142989458|NCT03342404|515496766|FG000|Open-Label Phase|Lost to Follow-up|0|||
142989459|NCT03342404|515496767|FG001|Open-Label Phase|Lost to Follow-up|1|||
142989460|NCT03342404|515496766|FG000|Open-Label Phase|Other reasons|0|||
142989461|NCT03342404|515496767|FG001|Open-Label Phase|Other reasons|1|||
142989462|NCT03342404|515496766|FG000|Open-Label Phase|Adverse Event|0|||
142989463|NCT03342404|515496767|FG001|Open-Label Phase|Adverse Event|3|||
142989464|NCT03342404|515496766|FG000|Open-Label Phase|Withdrawal by Subject|0|||
142989465|NCT03342404|515496767|FG001|Open-Label Phase|Withdrawal by Subject|6|||
142989466|NCT01855425|515496768|FG000|Overall Study|Physician Decision|20|||
142989467|NCT00850135|515496773|FG000|Overall Study|Physician Decision|1|||
142989468|NCT02253992|515496774|FG000|Overall Study|Study drug toxicity|1|||
142989469|NCT02253992|515496775|FG001|Overall Study|Study drug toxicity|0|||
142989470|NCT02253992|515496776|FG002|Overall Study|Study drug toxicity|10|||
142989471|NCT02253992|515496774|FG000|Overall Study|Disease progression|4|||
142989472|NCT02253992|515496775|FG001|Overall Study|Disease progression|3|||
142989473|NCT02253992|515496776|FG002|Overall Study|Disease progression|98|||
142989474|NCT02253992|515496774|FG000|Overall Study|Withdrawal by Subject|0|||
142989475|NCT02253992|515496775|FG001|Overall Study|Withdrawal by Subject|0|||
142989476|NCT02253992|515496776|FG002|Overall Study|Withdrawal by Subject|3|||
142989477|NCT02253992|515496774|FG000|Overall Study|Adverse Event|0|||
142989478|NCT02253992|515496775|FG001|Overall Study|Adverse Event|0|||
142989479|NCT02253992|515496776|FG002|Overall Study|Adverse Event|8|||
142989480|NCT02253992|515496774|FG000|Overall Study|Death|0|||
142989481|NCT02253992|515496775|FG001|Overall Study|Death|0|||
142989482|NCT02253992|515496776|FG002|Overall Study|Death|1|||
142989483|NCT02253992|515496774|FG000|Overall Study|Subject discontinued study drug|1|||
142989484|NCT02253992|515496775|FG001|Overall Study|Subject discontinued study drug|0|||
142989485|NCT02253992|515496776|FG002|Overall Study|Subject discontinued study drug|1|||
142989486|NCT02253992|515496774|FG000|Overall Study|Completed treatment as per protocol|0|||
142989487|NCT02253992|515496775|FG001|Overall Study|Completed treatment as per protocol|1|||
142989488|NCT02253992|515496776|FG002|Overall Study|Completed treatment as per protocol|22|||
142989489|NCT02253992|515496774|FG000|Overall Study|Other|0|||
142989490|NCT02253992|515496775|FG001|Overall Study|Other|0|||
142989491|NCT02253992|515496776|FG002|Overall Study|Other|1|||
142989492|NCT00772889|515496777|FG000|Overall Study|Adverse Event|7|||
142989493|NCT00772889|515496778|FG001|Overall Study|Adverse Event|4|||
142989494|NCT00772889|515496779|FG002|Overall Study|Adverse Event|0|||
142989495|NCT00772889|515496777|FG000|Overall Study|Withdrawal by Subject|9|||
142989496|NCT00772889|515496778|FG001|Overall Study|Withdrawal by Subject|8|||
142989497|NCT00772889|515496779|FG002|Overall Study|Withdrawal by Subject|9|||
142989498|NCT00772889|515496777|FG000|Overall Study|Lost to Follow-up|6|||
142989499|NCT00772889|515496778|FG001|Overall Study|Lost to Follow-up|6|||
142989500|NCT00772889|515496779|FG002|Overall Study|Lost to Follow-up|7|||
142989501|NCT03323086|515496780|FG000|Overall Study|Lost to Follow-up|3|||
142989502|NCT03323086|515496781|FG001|Overall Study|Lost to Follow-up|2|||
142989503|NCT02324049|515496785|FG000|Part C|Study terminated|11|||
142989504|NCT02159365|515496787|FG000|Overall Study|Disease Progression|23|||
142989505|NCT02159365|515496787|FG000|Overall Study|Other reasons|11|||
142989506|NCT02159365|515496787|FG000|Overall Study|Administrative reason by Sponsor|9|||
142989507|NCT02159365|515496787|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
142989508|NCT02159365|515496787|FG000|Overall Study|Study drug toxicity|7|||
142989509|NCT02159365|515496787|FG000|Overall Study|Maximum clinical benefit|3|||
142989510|NCT02159365|515496787|FG000|Overall Study|Subject request to discontinue treatment|3|||
142989511|NCT02159365|515496787|FG000|Overall Study|Subject withdrew consent|3|||
142989512|NCT02159365|515496787|FG000|Overall Study|Death|1|||
142989513|NCT02159365|515496787|FG000|Overall Study|Lost to Follow-up|1|||
142989514|NCT03083470|515496788|FG000|Overall Study|Lost to Follow-up|0|||
142989515|NCT03083470|515496789|FG001|Overall Study|Lost to Follow-up|0|||
142989516|NCT03083470|515496790|FG002|Overall Study|Lost to Follow-up|0|||
142989517|NCT03083470|515496791|FG003|Overall Study|Lost to Follow-up|0|||
142989518|NCT03083470|515496792|FG004|Overall Study|Lost to Follow-up|1|||
142989519|NCT03083470|515496788|FG000|Overall Study|Withdrawal by Subject|0|||
142989520|NCT03083470|515496789|FG001|Overall Study|Withdrawal by Subject|0|||
142989521|NCT03083470|515496790|FG002|Overall Study|Withdrawal by Subject|0|||
142989522|NCT03083470|515496791|FG003|Overall Study|Withdrawal by Subject|0|||
142989523|NCT03083470|515496792|FG004|Overall Study|Withdrawal by Subject|1|||
142989524|NCT00606229|515496793|FG000|Overall Study|Adverse Event|11|||
142989525|NCT00606229|515496793|FG000|Overall Study|Lack of Efficacy|1|||
142989526|NCT00606229|515496793|FG000|Overall Study|Withdrawal by Subject|4|||
142989527|NCT00606229|515496793|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
142989528|NCT00606229|515496793|FG000|Overall Study|change of residence or other commitments|2|||
142989529|NCT03523715|515496794|FG000|Overall Study|Lost to Follow-up|11|||
142989530|NCT03523715|515496795|FG001|Overall Study|Lost to Follow-up|14|||
142989531|NCT03523715|515496794|FG000|Overall Study|Did not meet inclusion criteria|1|||
142989532|NCT03523715|515496795|FG001|Overall Study|Did not meet inclusion criteria|0|||
142989533|NCT03523715|515496794|FG000|Overall Study|Internally inconsistent reporting|0|||
142989534|NCT03523715|515496795|FG001|Overall Study|Internally inconsistent reporting|2|||
142989535|NCT00736450|515496796|FG000|Overall Study|Not ABC gene eligible|19|||
142989536|NCT00736450|515496796|FG000|Overall Study|Withdrawal by Subject|5|||
142989537|NCT00736450|515496796|FG000|Overall Study|Physician Decision|1|||
142989538|NCT01332851|515496797|FG000|Overall Study|Withdrawal by Subject|4|||
142989539|NCT01332851|515496798|FG001|Overall Study|Withdrawal by Subject|2|||
142989540|NCT01332851|515496797|FG000|Overall Study|Lost to Follow-up|7|||
142989541|NCT01332851|515496798|FG001|Overall Study|Lost to Follow-up|11|||
142989542|NCT05559203|515496799|FG000|Overall Study|Intervention not implemented at their care home due to insufficient staff|14|||
142989543|NCT03299166|515496800|FG000|Overall Study|Adverse Event|9|||
142989544|NCT03299166|515496801|FG001|Overall Study|Adverse Event|4|||
142989545|NCT03299166|515496800|FG000|Overall Study|Withdrawal by Subject|6|||
142989546|NCT03299166|515496801|FG001|Overall Study|Withdrawal by Subject|5|||
142989547|NCT03299166|515496800|FG000|Overall Study|Physician Decision|1|||
142989548|NCT03299166|515496801|FG001|Overall Study|Physician Decision|1|||
142989549|NCT03299166|515496800|FG000|Overall Study|Sponsor Decision|3|||
142989550|NCT03299166|515496801|FG001|Overall Study|Sponsor Decision|0|||
142989551|NCT03299166|515496800|FG000|Overall Study|Lost to Follow-up|2|||
142989552|NCT03299166|515496801|FG001|Overall Study|Lost to Follow-up|4|||
142989553|NCT03299166|515496800|FG000|Overall Study|Randomization Error|0|||
142989554|NCT03299166|515496801|FG001|Overall Study|Randomization Error|1|||
142989555|NCT03299166|515496800|FG000|Overall Study|Subject unable to return due to COVID|1|||
142989556|NCT03299166|515496801|FG001|Overall Study|Subject unable to return due to COVID|0|||
142989557|NCT03299166|515496800|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
142989558|NCT03299166|515496801|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
142989559|NCT02829775|515496805|FG000|Overall Study|Death|1|||
142989560|NCT02829775|515496805|FG000|Overall Study|Withdrawal by Subject|3|||
142989561|NCT02829775|515496805|FG000|Overall Study|Disease remission|1|||
142989562|NCT01249157|515496806|FG000|Overall Study|Withdrawal by Subject|1|||
142989563|NCT03630016|515496809|FG000|Overall Study|Poor Sensor Placement|1|||
142989564|NCT02422186|515496810|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
142989565|NCT02422186|515496811|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
142989566|NCT02422186|515496810|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
142989567|NCT02422186|515496811|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
142989568|NCT02422186|515496810|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
142989569|NCT02422186|515496811|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
142989570|NCT02422186|515496810|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
142989571|NCT02422186|515496811|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
142989572|NCT02422186|515496810|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
142989573|NCT02422186|515496811|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
142989574|NCT02422186|515496810|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
142989575|NCT02422186|515496811|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
142989576|NCT02422186|515496810|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
142989577|NCT02422186|515496811|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
142989578|NCT02422186|515496810|FG000|Follow-up Phase (2 Weeks)|Other|3|||
142989579|NCT02422186|515496811|FG001|Follow-up Phase (2 Weeks)|Other|0|||
142989580|NCT03074318|515496812|FG000|Overall Study|Adverse Event|0|||
142989581|NCT03074318|515496813|FG001|Overall Study|Adverse Event|1|||
142989582|NCT03074318|515496814|FG002|Overall Study|Adverse Event|1|||
142989583|NCT03074318|515496815|FG003|Overall Study|Adverse Event|1|||
142989584|NCT03074318|515496812|FG000|Overall Study|Death|1|||
142989585|NCT03074318|515496813|FG001|Overall Study|Death|0|||
142989586|NCT03074318|515496814|FG002|Overall Study|Death|0|||
142989587|NCT03074318|515496815|FG003|Overall Study|Death|0|||
142989588|NCT03074318|515496812|FG000|Overall Study|Withdrawal by Subject|1|||
142989589|NCT03074318|515496813|FG001|Overall Study|Withdrawal by Subject|2|||
142989590|NCT03074318|515496814|FG002|Overall Study|Withdrawal by Subject|2|||
142989591|NCT03074318|515496815|FG003|Overall Study|Withdrawal by Subject|4|||
142989592|NCT03074318|515496812|FG000|Overall Study|Trial Closure|2|||
142989593|NCT03074318|515496813|FG001|Overall Study|Trial Closure|2|||
142989594|NCT03074318|515496814|FG002|Overall Study|Trial Closure|3|||
142989595|NCT03074318|515496815|FG003|Overall Study|Trial Closure|11|||
142989596|NCT01226472|515496816|FG000|Overall Study|Progressive Disease|1|||
142989597|NCT03573804|515496817|FG000|Overall Study|claustrophobia or MRI table problems|10|||
142989598|NCT00952419|515496820|FG000|Overall Study|Adverse Event|2|||
142989599|NCT00952419|515496821|FG001|Overall Study|Adverse Event|0|||
142989600|NCT00952419|515496822|FG002|Overall Study|Adverse Event|0|||
142989601|NCT00952419|515496820|FG000|Overall Study|Protocol Violation|3|||
142989602|NCT00952419|515496821|FG001|Overall Study|Protocol Violation|7|||
142989603|NCT00952419|515496822|FG002|Overall Study|Protocol Violation|0|||
142989604|NCT00952419|515496820|FG000|Overall Study|Withdrawal by Subject|1|||
142989605|NCT00952419|515496821|FG001|Overall Study|Withdrawal by Subject|3|||
142989606|NCT00952419|515496822|FG002|Overall Study|Withdrawal by Subject|0|||
142989607|NCT01592773|515498175|FG000|Overall Study|Study Terminated by Sponsor|582|||
142989608|NCT01592773|515498175|FG000|Overall Study|Withdrawal by Subject|35|||
142989609|NCT01592773|515498175|FG000|Overall Study|Lost to Follow-up|19|||
142989610|NCT01592773|515498175|FG000|Overall Study|Adverse Event|17|||
142989611|NCT01592773|515498175|FG000|Overall Study|Lack of Efficacy|9|||
142989612|NCT01592773|515498175|FG000|Overall Study|Protocol Violation|2|||
142989613|NCT01592773|515498175|FG000|Overall Study|Inclusion/exclusion not meet|1|||
142989614|NCT01592773|515498175|FG000|Overall Study|Other Reason|1|||
142989615|NCT04418427|515498176|FG000|Overall Study|Death|0|||
142989616|NCT04418427|515498177|FG001|Overall Study|Death|1|||
142989617|NCT04418427|515498178|FG002|Overall Study|Death|0|||
142989618|NCT04418427|515498176|FG000|Overall Study|Lost to Follow-up|0|||
142989619|NCT04418427|515498177|FG001|Overall Study|Lost to Follow-up|2|||
142989620|NCT04418427|515498178|FG002|Overall Study|Lost to Follow-up|2|||
142989621|NCT04418427|515498176|FG000|Overall Study|Subject Discontinued by the Sponsor|1|||
142989622|NCT04418427|515498177|FG001|Overall Study|Subject Discontinued by the Sponsor|0|||
142989623|NCT04418427|515498178|FG002|Overall Study|Subject Discontinued by the Sponsor|1|||
142989624|NCT04418427|515498176|FG000|Overall Study|Pre-existing medical condition|0|||
142989625|NCT04418427|515498177|FG001|Overall Study|Pre-existing medical condition|1|||
142989626|NCT04418427|515498178|FG002|Overall Study|Pre-existing medical condition|0|||
142989627|NCT04076579|515498183|FG000|Overall Study|Adverse Event|2|||
142989628|NCT04076579|515498184|FG001|Overall Study|Adverse Event|0|||
142989629|NCT04076579|515498183|FG000|Overall Study|discontinued due to toxicity|1|||
142989630|NCT04076579|515498184|FG001|Overall Study|discontinued due to toxicity|0|||
142989631|NCT04076579|515498183|FG000|Overall Study|Physician Decision|1|||
142989632|NCT04076579|515498184|FG001|Overall Study|Physician Decision|0|||
142989633|NCT04076579|515498183|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
142989634|NCT04076579|515498184|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
142989635|NCT04076579|515498183|FG000|Overall Study|Noncompliance|0|||
142989636|NCT04076579|515498184|FG001|Overall Study|Noncompliance|1|||
142989637|NCT04076579|515498183|FG000|Overall Study|Withdrawal by Subject|0|||
142989638|NCT04076579|515498184|FG001|Overall Study|Withdrawal by Subject|2|||
142989639|NCT03793010|515498185|FG000|Overall Study|Withdrawal by Subject|5|||
142989640|NCT03793010|515498186|FG001|Overall Study|Withdrawal by Subject|7|||
142989641|NCT03793010|515498185|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
142989642|NCT03793010|515498186|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
142989643|NCT03793010|515498185|FG000|Overall Study|Lost to Follow-up|1|||
142989644|NCT03793010|515498186|FG001|Overall Study|Lost to Follow-up|2|||
142989645|NCT03793010|515498185|FG000|Overall Study|Patient couldn't sit still for injection|1|||
142989646|NCT03793010|515498186|FG001|Overall Study|Patient couldn't sit still for injection|0|||
142989647|NCT03793010|515498185|FG000|Overall Study|Withdrew to pursue other treatment|1|||
142989648|NCT03793010|515498186|FG001|Overall Study|Withdrew to pursue other treatment|0|||
142989649|NCT03793010|515498185|FG000|Overall Study|Did not meet eligibility criteria|1|||
142989650|NCT03793010|515498186|FG001|Overall Study|Did not meet eligibility criteria|0|||
142989651|NCT03258593|515498190|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
142989652|NCT03258593|515498191|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
142989653|NCT03258593|515498192|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
142989654|NCT03258593|515498193|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
142989655|NCT03258593|515498190|FG000|Run-In Maintenance Phase|Disease progression|3|||
142989656|NCT03258593|515498191|FG001|Run-In Maintenance Phase|Disease progression|0|||
142989657|NCT03258593|515498192|FG002|Run-In Maintenance Phase|Disease progression|0|||
142989658|NCT03258593|515498193|FG003|Run-In Maintenance Phase|Disease progression|0|||
142989659|NCT03258593|515498190|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
142989660|NCT03258593|515498191|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
142989661|NCT03258593|515498192|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
142989662|NCT03258593|515498193|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
142989663|NCT03258593|515498190|FG000|Expansion Maintenance Phase|Physician Decision|0|||
142989664|NCT03258593|515498191|FG001|Expansion Maintenance Phase|Physician Decision|1|||
142989665|NCT03258593|515498192|FG002|Expansion Maintenance Phase|Physician Decision|0|||
142989666|NCT03258593|515498193|FG003|Expansion Maintenance Phase|Physician Decision|0|||
142989667|NCT04284787|515498197|FG000|Overall Study|Disease Progression|9|||
142989668|NCT04284787|515498198|FG001|Overall Study|Disease Progression|12|||
142989669|NCT04284787|515498197|FG000|Overall Study|Physician Decision|12|||
142989670|NCT04284787|515498198|FG001|Overall Study|Physician Decision|7|||
143117236|NCT01709864|515971808|FG000|Overall Study|Lost to Follow-up|1|||
142989671|NCT04284787|515498197|FG000|Overall Study|Transplant|5|||
142989672|NCT04284787|515498198|FG001|Overall Study|Transplant|4|||
142989673|NCT04284787|515498197|FG000|Overall Study|Death|1|||
142989674|NCT04284787|515498198|FG001|Overall Study|Death|2|||
142989675|NCT04284787|515498197|FG000|Overall Study|Adverse Event|0|||
142989676|NCT04284787|515498198|FG001|Overall Study|Adverse Event|4|||
142989677|NCT04284787|515498197|FG000|Overall Study|Non-adherence|2|||
142989678|NCT04284787|515498198|FG001|Overall Study|Non-adherence|0|||
142989679|NCT04284787|515498197|FG000|Overall Study|Lack of Efficacy|2|||
142989680|NCT04284787|515498198|FG001|Overall Study|Lack of Efficacy|0|||
142989681|NCT01874353|515498199|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
142989682|NCT01874353|515498200|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
142989683|NCT01874353|515498201|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
142989684|NCT01874353|515498202|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
142989685|NCT01874353|515498199|FG000|Overall Study|Lost to Follow-up|2|||
142989686|NCT01874353|515498200|FG001|Overall Study|Lost to Follow-up|2|||
142989687|NCT01874353|515498201|FG002|Overall Study|Lost to Follow-up|2|||
142989688|NCT01874353|515498202|FG003|Overall Study|Lost to Follow-up|0|||
142989689|NCT01874353|515498199|FG000|Overall Study|Death|110|||
142989690|NCT01874353|515498200|FG001|Overall Study|Death|60|||
142989691|NCT01874353|515498201|FG002|Overall Study|Death|13|||
142989692|NCT01874353|515498202|FG003|Overall Study|Death|7|||
142989693|NCT01874353|515498199|FG000|Overall Study|Withdrawal by Subject|13|||
142989694|NCT01874353|515498200|FG001|Overall Study|Withdrawal by Subject|11|||
142989695|NCT01874353|515498201|FG002|Overall Study|Withdrawal by Subject|0|||
142989696|NCT01874353|515498202|FG003|Overall Study|Withdrawal by Subject|0|||
142989697|NCT01852591|515498203|FG000|Overall Study|Withdrawal by Subject|2|||
142989698|NCT01852591|515498203|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
142989699|NCT04651777|515498206|FG000|Overall Study|Adverse Event|1|||
142989700|NCT04651777|515498206|FG000|Overall Study|Withdrawal by Subject|2|||
142989701|NCT06048367|515498207|FG000|Overall Study|Withdrawal by Subject|0|||
142989702|NCT06048367|515498208|FG001|Overall Study|Withdrawal by Subject|1|||
142989703|NCT06048367|515498209|FG002|Overall Study|Withdrawal by Subject|0|||
142989704|NCT06048367|515498210|FG003|Overall Study|Withdrawal by Subject|0|||
142989705|NCT06048367|515498211|FG004|Overall Study|Withdrawal by Subject|0|||
142989706|NCT06048367|515498207|FG000|Overall Study|Withdrawal by Subject|0|||
142989707|NCT06048367|515498208|FG001|Overall Study|Withdrawal by Subject|0|||
142989708|NCT06048367|515498209|FG002|Overall Study|Withdrawal by Subject|1|||
142989709|NCT06048367|515498210|FG003|Overall Study|Withdrawal by Subject|0|||
142989710|NCT06048367|515498211|FG004|Overall Study|Withdrawal by Subject|0|||
142989711|NCT06048367|515498207|FG000|Overall Study|Withdrawal by Subject|0|||
142989712|NCT06048367|515498208|FG001|Overall Study|Withdrawal by Subject|0|||
142989713|NCT06048367|515498209|FG002|Overall Study|Withdrawal by Subject|0|||
142989714|NCT06048367|515498210|FG003|Overall Study|Withdrawal by Subject|1|||
142989715|NCT06048367|515498211|FG004|Overall Study|Withdrawal by Subject|0|||
142989716|NCT06048367|515498207|FG000|Overall Study|Withdrawal by Subject|0|||
142989717|NCT06048367|515498208|FG001|Overall Study|Withdrawal by Subject|0|||
142989718|NCT06048367|515498209|FG002|Overall Study|Withdrawal by Subject|0|||
142989719|NCT06048367|515498210|FG003|Overall Study|Withdrawal by Subject|1|||
142989720|NCT06048367|515498211|FG004|Overall Study|Withdrawal by Subject|0|||
142989721|NCT04088331|515498212|FG000|Overall Study|Lost to Follow-up|3|||
142989722|NCT04088331|515498212|FG000|Overall Study|Withdrawal by Subject|7|||
142989723|NCT04088331|515498212|FG000|Overall Study|Adverse Event|4|||
142989724|NCT00423592|515498217|FG000|Overall Study|Adverse Event (through Week 12)|2|||
142989725|NCT00423592|515498217|FG000|Overall Study|Adverse Event (post Week 12)|5|||
142989726|NCT00002981|515498218|FG000|Overall Study|Inevaluable|6|||
142989727|NCT00255008|515498221|FG000|Overall Study|Adverse Event|1|||
142989728|NCT00255008|515498222|FG001|Overall Study|Adverse Event|1|||
142989729|NCT00255008|515498223|FG002|Overall Study|Adverse Event|2|||
142989730|NCT00255008|515498224|FG003|Overall Study|Adverse Event|0|||
142989731|NCT00255008|515498221|FG000|Overall Study|Lost to Follow-up|1|||
142989732|NCT00255008|515498222|FG001|Overall Study|Lost to Follow-up|0|||
142989733|NCT00255008|515498223|FG002|Overall Study|Lost to Follow-up|1|||
142989734|NCT00255008|515498224|FG003|Overall Study|Lost to Follow-up|2|||
142989735|NCT00255008|515498221|FG000|Overall Study|Did not meet viral reduction criteria|4|||
142989736|NCT00255008|515498222|FG001|Overall Study|Did not meet viral reduction criteria|5|||
142989737|NCT00255008|515498223|FG002|Overall Study|Did not meet viral reduction criteria|0|||
142989738|NCT00255008|515498224|FG003|Overall Study|Did not meet viral reduction criteria|1|||
142989739|NCT00255008|515498221|FG000|Overall Study|Withdrew consent|0|||
142989740|NCT00255008|515498222|FG001|Overall Study|Withdrew consent|0|||
142989741|NCT00255008|515498223|FG002|Overall Study|Withdrew consent|2|||
142989742|NCT00255008|515498224|FG003|Overall Study|Withdrew consent|0|||
142989743|NCT00255008|515498221|FG000|Overall Study|Sponsor request|18|||
142989744|NCT00255008|515498222|FG001|Overall Study|Sponsor request|3|||
142989745|NCT00255008|515498223|FG002|Overall Study|Sponsor request|8|||
142989746|NCT00255008|515498224|FG003|Overall Study|Sponsor request|17|||
142989747|NCT00255008|515498221|FG000|Overall Study|Adverse lab experience|1|||
142989748|NCT00255008|515498222|FG001|Overall Study|Adverse lab experience|0|||
142989749|NCT00255008|515498223|FG002|Overall Study|Adverse lab experience|0|||
142989750|NCT00255008|515498224|FG003|Overall Study|Adverse lab experience|0|||
142989751|NCT00255008|515498221|FG000|Overall Study|Other|7|||
142989752|NCT00255008|515498222|FG001|Overall Study|Other|0|||
142989753|NCT00255008|515498223|FG002|Overall Study|Other|3|||
142989754|NCT00255008|515498224|FG003|Overall Study|Other|2|||
142989755|NCT05083949|515498225|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
142989756|NCT05083949|515498226|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
142989757|NCT05083949|515498225|FG000|Period 1|Adverse Event|1|||
142989758|NCT05083949|515498226|FG001|Period 1|Adverse Event|1|||
142989759|NCT05083949|515498225|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
142989760|NCT05083949|515498226|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
142989761|NCT05083949|515498225|FG000|Period 2|Adverse Event|0|||
142989762|NCT05083949|515498226|FG001|Period 2|Adverse Event|2|||
142989763|NCT03457636|515498230|FG000|Overall Study|Lost to Follow-up|2|||
142989764|NCT01833806|515498231|FG000|Overall Study|Alternative treatment|2|||
142989765|NCT01833806|515498231|FG000|Overall Study|Death|5|||
142989766|NCT01833806|515498231|FG000|Overall Study|Physician Decision|1|||
142989767|NCT01833806|515498231|FG000|Overall Study|Lost to Follow-up|1|||
142989768|NCT00090766|515498235|FG000|Overall Study|Nephrectomy Planned|0|||
142989769|NCT00090766|515498236|FG001|Overall Study|Nephrectomy Planned|0|||
142989770|NCT00090766|515498237|FG002|Overall Study|Nephrectomy Planned|1|||
142989771|NCT00090766|515498235|FG000|Overall Study|Death|1|||
142989772|NCT00090766|515498236|FG001|Overall Study|Death|0|||
142989773|NCT00090766|515498237|FG002|Overall Study|Death|0|||
142989774|NCT00090766|515498235|FG000|Overall Study|Admin|0|||
142989775|NCT00090766|515498236|FG001|Overall Study|Admin|2|||
142989776|NCT00090766|515498237|FG002|Overall Study|Admin|0|||
142989777|NCT00090766|515498235|FG000|Overall Study|Lost to Follow-up|2|||
142989778|NCT00090766|515498236|FG001|Overall Study|Lost to Follow-up|0|||
142989779|NCT00090766|515498237|FG002|Overall Study|Lost to Follow-up|2|||
142989780|NCT02774291|515498244|FG000|Overall Study|Lost to Follow-up|1|||
142989781|NCT01894776|515498245|FG000|Overall Study|Withdrawal by Subject|1|||
142989782|NCT02485860|515498246|FG000|Overall Study|Lost to Follow-up|4|||
142989783|NCT02485860|515498247|FG001|Overall Study|Lost to Follow-up|1|||
142989784|NCT02485860|515498246|FG000|Overall Study|Physician Decision|1|||
142989785|NCT02485860|515498247|FG001|Overall Study|Physician Decision|2|||
142989786|NCT02485860|515498246|FG000|Overall Study|Health context (COVID-19)|1|||
142989787|NCT02485860|515498247|FG001|Overall Study|Health context (COVID-19)|0|||
142989788|NCT03325010|515498249|FG000|Overall Study|Adverse Event|3|||
142989789|NCT03325010|515498250|FG001|Overall Study|Adverse Event|8|||
142989790|NCT03325010|515498249|FG000|Overall Study|Protocol Violation|1|||
142989791|NCT03325010|515498250|FG001|Overall Study|Protocol Violation|8|||
142989792|NCT03325010|515498249|FG000|Overall Study|Withdrawal by Subject|1|||
142989793|NCT03325010|515498250|FG001|Overall Study|Withdrawal by Subject|3|||
142989794|NCT03325010|515498249|FG000|Overall Study|Lost to Follow-up|1|||
142989795|NCT03325010|515498250|FG001|Overall Study|Lost to Follow-up|0|||
142989796|NCT03325010|515498249|FG000|Overall Study|Physician Decision|1|||
142989797|NCT03325010|515498250|FG001|Overall Study|Physician Decision|1|||
142989798|NCT03325010|515498249|FG000|Overall Study|Lack of Efficacy|2|||
142989799|NCT03325010|515498250|FG001|Overall Study|Lack of Efficacy|0|||
142989800|NCT00471315|515498253|FG000|Overall Study|Adverse Event|7|||
142989801|NCT00471315|515498253|FG000|Overall Study|Withdrawal by Subject|1|||
142989802|NCT04350372|515498257|FG000|Overall Study|Death|1|||
142989803|NCT00113555|515498259|FG000|Overall Study|Baseline Failure|59|||
142989804|NCT00113555|515498259|FG000|Overall Study|Permanently Explanted|7|||
142989805|NCT00113555|515498259|FG000|Overall Study|Death|1|||
142989806|NCT00113555|515498259|FG000|Overall Study|Missed Followup|4|||
142989807|NCT00113555|515498259|FG000|Overall Study|Lost to Follow-up|8|||
142989808|NCT04474366|515498260|FG000|Overall Study|Lost to Follow-up|2|||
142989809|NCT04474366|515498261|FG001|Overall Study|Lost to Follow-up|5|||
142989810|NCT00609167|515498262|FG000|Overall Study|Withdrawal by Subject|1|||
142989811|NCT00609167|515498263|FG001|Overall Study|Withdrawal by Subject|0|||
142989812|NCT00609167|515498262|FG000|Overall Study|Lack of Efficacy|1|||
142989813|NCT00609167|515498263|FG001|Overall Study|Lack of Efficacy|0|||
142989814|NCT00609167|515498262|FG000|Overall Study|Adverse Event|5|||
142989815|NCT00609167|515498263|FG001|Overall Study|Adverse Event|1|||
142989816|NCT00609167|515498262|FG000|Overall Study|Disease Progression|1|||
142989817|NCT00609167|515498263|FG001|Overall Study|Disease Progression|0|||
142989818|NCT00609167|515498262|FG000|Overall Study|Stem Cell Transplant|0|||
142989819|NCT00609167|515498263|FG001|Overall Study|Stem Cell Transplant|6|||
142989820|NCT03898323|515498264|FG000|Overall Study|Physician Decision|1|||
142989821|NCT00320190|515498266|FG000|First 12 Months|Completed but did not enter extension|5|||
142989822|NCT00320190|515498267|FG001|First 12 Months|Completed but did not enter extension|3|||
142989823|NCT00320190|515498266|FG000|First 12 Months|Sponsor terminated study|2|||
142989824|NCT00320190|515498267|FG001|First 12 Months|Sponsor terminated study|2|||
142989825|NCT00320190|515498266|FG000|First 12 Months|Lost to Follow-up|0|||
142989826|NCT00320190|515498267|FG001|First 12 Months|Lost to Follow-up|1|||
142989827|NCT00320190|515498266|FG000|First 12 Months|Enrollment failure|0|||
142989828|NCT00320190|515498267|FG001|First 12 Months|Enrollment failure|1|||
142989829|NCT00320190|515498266|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
142989830|NCT00320190|515498267|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
142989831|NCT00320190|515498266|FG000|First 12 Months|Investigator request|0|||
142989832|NCT00320190|515498267|FG001|First 12 Months|Investigator request|1|||
142989833|NCT00320190|515498266|FG000|First 12 Months|Study drug toxicity|0|||
142989834|NCT00320190|515498267|FG001|First 12 Months|Study drug toxicity|1|||
142989835|NCT00320190|515498266|FG000|First 12 Months|Withdrawal by Subject|0|||
142989836|NCT00320190|515498267|FG001|First 12 Months|Withdrawal by Subject|1|||
142989837|NCT00320190|515498266|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
142989838|NCT00320190|515498267|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
142989839|NCT00320190|515498266|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
142989840|NCT00320190|515498267|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
142989841|NCT00320190|515498266|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
142989842|NCT00320190|515498267|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
142989843|NCT00712270|515498268|FG000|Overall Study|Withdrawal by Subject|11|||
142989844|NCT00712270|515498268|FG000|Overall Study|Screen Failure|3|||
142989845|NCT04412668|515498279|FG000|Overall Study|Death - multiple comorbidities|2|||
142989846|NCT04412668|515498280|FG001|Overall Study|Death - multiple comorbidities|0|||
142989847|NCT04412668|515498281|FG002|Overall Study|Death - multiple comorbidities|0|||
142989848|NCT04412668|515498279|FG000|Overall Study|Withdrawal by Subject|3|||
142989849|NCT04412668|515498280|FG001|Overall Study|Withdrawal by Subject|0|||
142989850|NCT04412668|515498281|FG002|Overall Study|Withdrawal by Subject|0|||
142989851|NCT04412668|515498279|FG000|Overall Study|Other than Specified|2|||
142989852|NCT04412668|515498280|FG001|Overall Study|Other than Specified|0|||
142989853|NCT04412668|515498281|FG002|Overall Study|Other than Specified|0|||
142989854|NCT00102804|515498282|FG000|Overall Study|Progressive Disease (PD)|307|||
142989855|NCT00102804|515498283|FG001|Overall Study|Progressive Disease (PD)|196|||
142989856|NCT00102804|515498282|FG000|Overall Study|Withdrawal by Subject|46|||
142989857|NCT00102804|515498283|FG001|Overall Study|Withdrawal by Subject|7|||
142989858|NCT00102804|515498282|FG000|Overall Study|Adverse Event|37|||
142989859|NCT00102804|515498283|FG001|Overall Study|Adverse Event|3|||
142989860|NCT00102804|515498282|FG000|Overall Study|Physician Decision|24|||
142989861|NCT00102804|515498283|FG001|Overall Study|Physician Decision|6|||
142989862|NCT00102804|515498282|FG000|Overall Study|Death|5|||
142989863|NCT00102804|515498283|FG001|Overall Study|Death|6|||
142989864|NCT00102804|515498282|FG000|Overall Study|Enrollment Criteria Not Met|6|||
142989865|NCT00102804|515498283|FG001|Overall Study|Enrollment Criteria Not Met|0|||
142989866|NCT00102804|515498282|FG000|Overall Study|Lost to Follow-up|4|||
142989867|NCT00102804|515498283|FG001|Overall Study|Lost to Follow-up|1|||
142989868|NCT00102804|515498282|FG000|Overall Study|Protocol Violation|2|||
142989869|NCT00102804|515498283|FG001|Overall Study|Protocol Violation|1|||
142989870|NCT00102804|515498282|FG000|Overall Study|Satisfactory Response|2|||
142989871|NCT00102804|515498283|FG001|Overall Study|Satisfactory Response|0|||
142989872|NCT00102804|515498282|FG000|Overall Study|Sponsor Decision|1|||
142989873|NCT00102804|515498283|FG001|Overall Study|Sponsor Decision|0|||
142989874|NCT00102804|515498282|FG000|Overall Study|Alive, Receiving Treatment|7|||
142989875|NCT00102804|515498283|FG001|Overall Study|Alive, Receiving Treatment|2|||
142989876|NCT03858686|515498284|FG000|Period 1|Adverse Event|1|||
142989877|NCT03858686|515498285|FG001|Period 1|Adverse Event|1|||
142989878|NCT03858686|515498284|FG000|Period 1|Lack of compliance|0|||
142989879|NCT03858686|515498285|FG001|Period 1|Lack of compliance|1|||
142989880|NCT03858686|515498284|FG000|Period 1|Adverse Event|0|||
142989881|NCT03858686|515498285|FG001|Period 1|Adverse Event|1|||
142989882|NCT03858686|515498284|FG000|Period 2|Adverse Event|0|||
142989883|NCT03858686|515498285|FG001|Period 2|Adverse Event|1|||
142989884|NCT03864627|515498291|FG000|Overall Study|Adverse Event|0|||
142989885|NCT03864627|515498292|FG001|Overall Study|Adverse Event|1|||
142989886|NCT03864627|515498291|FG000|Overall Study|Lack of Efficacy|0|||
142989887|NCT03864627|515498292|FG001|Overall Study|Lack of Efficacy|1|||
142989888|NCT03864627|515498291|FG000|Overall Study|Lost to Follow-up|0|||
142989889|NCT03864627|515498292|FG001|Overall Study|Lost to Follow-up|1|||
142989890|NCT03864627|515498291|FG000|Overall Study|Withdrawal by Subject|4|||
142989891|NCT03864627|515498292|FG001|Overall Study|Withdrawal by Subject|8|||
142989892|NCT03864627|515498291|FG000|Overall Study|Study terminated by sponsor|0|||
142989893|NCT03864627|515498292|FG001|Overall Study|Study terminated by sponsor|1|||
142989894|NCT02299206|515498297|FG000|Overall Study|Lost to Follow-up|1|||
142989895|NCT02299206|515498297|FG000|Overall Study|Withdrawal by Subject|1|||
142989896|NCT02875366|515498298|FG000|Overall Study|Adverse Event|0|||
142989897|NCT02875366|515498299|FG001|Overall Study|Adverse Event|2|||
142989898|NCT02875366|515498298|FG000|Overall Study|Noncompliance|0|||
142989899|NCT02875366|515498299|FG001|Overall Study|Noncompliance|1|||
142989900|NCT00683774|515498300|FG000|Overall Study|Withdrawal by Subject|0|||
142989901|NCT00683774|515498301|FG001|Overall Study|Withdrawal by Subject|1|||
142989902|NCT00683774|515498300|FG000|Overall Study|Physician Decision|3|||
142989903|NCT00683774|515498301|FG001|Overall Study|Physician Decision|0|||
142989904|NCT00691054|515498302|FG000|Overall Study|Withdrawal by Subject|1|||
142989905|NCT02735044|515498304|FG000|Overall Study|Adverse Event|3|||
142989906|NCT02735044|515498305|FG001|Overall Study|Adverse Event|3|||
142989907|NCT02735044|515498304|FG000|Overall Study|Lack of Efficacy|1|||
142989908|NCT02735044|515498305|FG001|Overall Study|Lack of Efficacy|0|||
142989909|NCT02735044|515498304|FG000|Overall Study|Poor compliance to protocol|7|||
142989910|NCT02735044|515498305|FG001|Overall Study|Poor compliance to protocol|7|||
142989911|NCT02735044|515498304|FG000|Overall Study|Randomized and not treated|0|||
142989912|NCT02735044|515498305|FG001|Overall Study|Randomized and not treated|2|||
142989913|NCT02735044|515498304|FG000|Overall Study|Other, not specified above|5|||
142989914|NCT02735044|515498305|FG001|Overall Study|Other, not specified above|11|||
142989915|NCT01682759|515498306|FG000|Overall Study|Death|2|||
142989916|NCT01682759|515498307|FG001|Overall Study|Death|1|||
142989917|NCT01682759|515498306|FG000|Overall Study|Lost to Follow-up|10|||
142989918|NCT01682759|515498307|FG001|Overall Study|Lost to Follow-up|13|||
142989919|NCT01682759|515498306|FG000|Overall Study|Physician Decision|1|||
142989920|NCT01682759|515498307|FG001|Overall Study|Physician Decision|1|||
142989921|NCT01682759|515498306|FG000|Overall Study|Withdrawal by Subject|56|||
142989922|NCT01682759|515498307|FG001|Overall Study|Withdrawal by Subject|55|||
142989923|NCT02141854|515498308|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
142989924|NCT02141854|515498309|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
142989925|NCT02141854|515498310|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
142989926|NCT02141854|515498311|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
142989927|NCT02141854|515498312|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
142989928|NCT02141854|515498313|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
142989929|NCT02141854|515498308|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
142989930|NCT02141854|515498309|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
142989931|NCT02141854|515498310|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
142989932|NCT02141854|515498311|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
142989933|NCT02141854|515498312|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
142989934|NCT02141854|515498313|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
142989935|NCT02141854|515498308|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
142989936|NCT02141854|515498309|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
142989937|NCT02141854|515498310|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
142989938|NCT02141854|515498311|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
142989939|NCT02141854|515498312|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
142989940|NCT02141854|515498313|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
142989941|NCT02141854|515498308|FG000|Run-In Period (Pre-assignment)|Other|14|||
142989942|NCT02141854|515498309|FG001|Run-In Period (Pre-assignment)|Other|0|||
142989943|NCT02141854|515498310|FG002|Run-In Period (Pre-assignment)|Other|0|||
142989944|NCT02141854|515498311|FG003|Run-In Period (Pre-assignment)|Other|0|||
142989945|NCT02141854|515498312|FG004|Run-In Period (Pre-assignment)|Other|0|||
142989946|NCT02141854|515498313|FG005|Run-In Period (Pre-assignment)|Other|0|||
142989947|NCT02141854|515498308|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
142989948|NCT02141854|515498309|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
142989949|NCT02141854|515498310|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
142989950|NCT02141854|515498311|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
142989951|NCT02141854|515498312|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
142989952|NCT02141854|515498313|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
142989953|NCT02141854|515498308|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
142989954|NCT02141854|515498309|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
142989955|NCT02141854|515498310|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
142989956|NCT02141854|515498311|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
142989957|NCT02141854|515498312|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
142989958|NCT02141854|515498313|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
142989959|NCT02141854|515498308|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
142989960|NCT02141854|515498309|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
142989961|NCT02141854|515498310|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
142989962|NCT02141854|515498311|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
142989963|NCT02141854|515498312|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
142989964|NCT02141854|515498313|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
142989965|NCT02141854|515498308|FG000|Treatment Period|Protocol Violation|0|||
142989966|NCT02141854|515498309|FG001|Treatment Period|Protocol Violation|1|||
142989967|NCT02141854|515498310|FG002|Treatment Period|Protocol Violation|0|||
142989968|NCT02141854|515498311|FG003|Treatment Period|Protocol Violation|2|||
142989969|NCT02141854|515498312|FG004|Treatment Period|Protocol Violation|2|||
142989970|NCT02141854|515498313|FG005|Treatment Period|Protocol Violation|1|||
142989971|NCT02141854|515498308|FG000|Treatment Period|Noncompliance|0|||
142989972|NCT02141854|515498309|FG001|Treatment Period|Noncompliance|0|||
142989973|NCT02141854|515498310|FG002|Treatment Period|Noncompliance|0|||
143455676|NCT03406078|517212507|FG001|Overall Study|Lost to Follow-up|1|||
142989974|NCT02141854|515498311|FG003|Treatment Period|Noncompliance|1|||
142989975|NCT02141854|515498312|FG004|Treatment Period|Noncompliance|0|||
142989976|NCT02141854|515498313|FG005|Treatment Period|Noncompliance|0|||
142989977|NCT02141854|515498308|FG000|Treatment Period|Lack of Efficacy|0|||
142989978|NCT02141854|515498309|FG001|Treatment Period|Lack of Efficacy|0|||
142989979|NCT02141854|515498310|FG002|Treatment Period|Lack of Efficacy|0|||
142989980|NCT02141854|515498311|FG003|Treatment Period|Lack of Efficacy|1|||
142989981|NCT02141854|515498312|FG004|Treatment Period|Lack of Efficacy|1|||
142989982|NCT02141854|515498313|FG005|Treatment Period|Lack of Efficacy|7|||
142989983|NCT02141854|515498308|FG000|Treatment Period|Pregnancy|0|||
142989984|NCT02141854|515498309|FG001|Treatment Period|Pregnancy|1|||
142989985|NCT02141854|515498310|FG002|Treatment Period|Pregnancy|0|||
142989986|NCT02141854|515498311|FG003|Treatment Period|Pregnancy|0|||
142989987|NCT02141854|515498312|FG004|Treatment Period|Pregnancy|0|||
142989988|NCT02141854|515498313|FG005|Treatment Period|Pregnancy|0|||
142989989|NCT02141854|515498308|FG000|Treatment Period|Other|0|||
142989990|NCT02141854|515498309|FG001|Treatment Period|Other|1|||
142989991|NCT02141854|515498310|FG002|Treatment Period|Other|2|||
142989992|NCT02141854|515498311|FG003|Treatment Period|Other|0|||
142989993|NCT02141854|515498312|FG004|Treatment Period|Other|1|||
142989994|NCT02141854|515498313|FG005|Treatment Period|Other|2|||
142989995|NCT02141854|515498308|FG000|Treatment Period|Adverse Event|0|||
142989996|NCT02141854|515498309|FG001|Treatment Period|Adverse Event|2|||
142989997|NCT02141854|515498310|FG002|Treatment Period|Adverse Event|2|||
142989998|NCT02141854|515498311|FG003|Treatment Period|Adverse Event|0|||
142989999|NCT02141854|515498312|FG004|Treatment Period|Adverse Event|2|||
142990000|NCT02141854|515498313|FG005|Treatment Period|Adverse Event|2|||
142990001|NCT02141854|515498308|FG000|Treatment Period|Withdrawal by Subject|0|||
142990002|NCT02141854|515498309|FG001|Treatment Period|Withdrawal by Subject|2|||
142990003|NCT02141854|515498310|FG002|Treatment Period|Withdrawal by Subject|3|||
142990004|NCT02141854|515498311|FG003|Treatment Period|Withdrawal by Subject|3|||
142990005|NCT02141854|515498312|FG004|Treatment Period|Withdrawal by Subject|4|||
142990006|NCT02141854|515498313|FG005|Treatment Period|Withdrawal by Subject|7|||
142990007|NCT02141854|515498308|FG000|Treatment Period|Disease progression|0|||
142990008|NCT02141854|515498309|FG001|Treatment Period|Disease progression|2|||
142990009|NCT02141854|515498310|FG002|Treatment Period|Disease progression|1|||
142990010|NCT02141854|515498311|FG003|Treatment Period|Disease progression|3|||
142990011|NCT02141854|515498312|FG004|Treatment Period|Disease progression|0|||
142990012|NCT02141854|515498313|FG005|Treatment Period|Disease progression|18|||
142990013|NCT02141854|515498308|FG000|Treatment Period|Lost to Follow-up|0|||
142990014|NCT02141854|515498309|FG001|Treatment Period|Lost to Follow-up|1|||
142990015|NCT02141854|515498310|FG002|Treatment Period|Lost to Follow-up|1|||
142990016|NCT02141854|515498311|FG003|Treatment Period|Lost to Follow-up|1|||
142990017|NCT02141854|515498312|FG004|Treatment Period|Lost to Follow-up|0|||
142990018|NCT02141854|515498313|FG005|Treatment Period|Lost to Follow-up|1|||
142990019|NCT01868594|515498316|FG000|Overall Study|Do not meet inclusion criteria|4|||
142990020|NCT01868594|515498317|FG001|Overall Study|Do not meet inclusion criteria|3|||
142990021|NCT01201967|515498320|FG000|Overall Study|Lost to Follow-up|6|||
142990022|NCT01201967|515498321|FG001|Overall Study|Lost to Follow-up|5|||
142990023|NCT03517722|515498322|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
142990024|NCT03517722|515498323|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
142990025|NCT03517722|515498322|FG000|Double Blind Period: Week 0-52|Death|0|||
142990026|NCT03517722|515498323|FG001|Double Blind Period: Week 0-52|Death|4|||
142990027|NCT03517722|515498322|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
142990028|NCT03517722|515498323|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
142990029|NCT03517722|515498322|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
142990030|NCT03517722|515498323|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
142990031|NCT03517722|515498322|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
142990032|NCT03517722|515498323|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
142990033|NCT03517722|515498322|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
142990034|NCT03517722|515498323|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
142990035|NCT03517722|515498322|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
142990036|NCT03517722|515498323|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
142990037|NCT03517722|515498322|FG000|Double Blind Period: Week 0-52|Other|4|||
142990038|NCT03517722|515498323|FG001|Double Blind Period: Week 0-52|Other|3|||
142990039|NCT03517722|515498322|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
142990040|NCT03517722|515498323|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
142990041|NCT03517722|515498322|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
142990042|NCT03517722|515498323|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
142990043|NCT03517722|515498322|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
142990044|NCT03517722|515498323|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
142990045|NCT03517722|515498322|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
142990046|NCT03517722|515498323|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
142990047|NCT03517722|515498322|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
143003179|NCT01049360|515548751|FG007|Period 2|Lack of Efficacy|0|||
142990048|NCT03517722|515498323|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
142990049|NCT00186121|515499755|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
142990050|NCT00186121|515499755|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
142990051|NCT00186121|515499755|FG000|Overall Study|Not eligible (no treatment)|1|||
142990052|NCT00887822|515499756|FG000|Overall Study|Insufficient therapeutic response|53|||
142990053|NCT00887822|515499757|FG001|Overall Study|Insufficient therapeutic response|55|||
142990054|NCT00887822|515499756|FG000|Overall Study|Adverse Event|14|||
142990055|NCT00887822|515499757|FG001|Overall Study|Adverse Event|17|||
142990056|NCT00887822|515499756|FG000|Overall Study|Failure to return|11|||
142990057|NCT00887822|515499757|FG001|Overall Study|Failure to return|11|||
142990058|NCT00887822|515499756|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
142990059|NCT00887822|515499757|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
142990060|NCT00887822|515499756|FG000|Overall Study|Administrative/Other than specified|5|||
142990061|NCT00887822|515499757|FG001|Overall Study|Administrative/Other than specified|4|||
142990062|NCT00887822|515499756|FG000|Overall Study|Death|2|||
142990063|NCT00887822|515499757|FG001|Overall Study|Death|3|||
142990064|NCT00887822|515499756|FG000|Overall Study|Protocol Violation|0|||
142990065|NCT00887822|515499757|FG001|Overall Study|Protocol Violation|1|||
142990066|NCT00887822|515499756|FG000|Overall Study|Randomized but not treated|0|||
142990067|NCT00887822|515499757|FG001|Overall Study|Randomized but not treated|1|||
142990068|NCT03661983|515499758|FG000|Open Label Stabilization Phase|Adverse Event|5|||
142990069|NCT03661983|515499759|FG001|Open Label Stabilization Phase|Adverse Event|0|||
142990070|NCT03661983|515499760|FG002|Open Label Stabilization Phase|Adverse Event|0|||
142990071|NCT03661983|515499761|FG003|Open Label Stabilization Phase|Adverse Event|0|||
142990072|NCT03661983|515499758|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
142990073|NCT03661983|515499759|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
142990074|NCT03661983|515499760|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
142990075|NCT03661983|515499761|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
142990076|NCT03661983|515499758|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
142990077|NCT03661983|515499759|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
142990078|NCT03661983|515499760|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
142990079|NCT03661983|515499761|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
142990080|NCT03661983|515499758|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
142990081|NCT03661983|515499759|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
142990082|NCT03661983|515499760|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
142990083|NCT03661983|515499761|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
142990084|NCT03661983|515499758|FG000|Double-blind Randomized Phase|Adverse Event|0|||
142990085|NCT03661983|515499759|FG001|Double-blind Randomized Phase|Adverse Event|1|||
142990086|NCT03661983|515499760|FG002|Double-blind Randomized Phase|Adverse Event|0|||
142990087|NCT03661983|515499761|FG003|Double-blind Randomized Phase|Adverse Event|0|||
142990088|NCT03661983|515499758|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
142990089|NCT03661983|515499759|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
142990090|NCT03661983|515499760|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
142990091|NCT03661983|515499761|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
142990092|NCT03661983|515499758|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
142990093|NCT03661983|515499759|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
142990094|NCT03661983|515499760|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
142990095|NCT03661983|515499761|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
142990096|NCT03661983|515499758|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
142990097|NCT03661983|515499759|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
142990098|NCT03661983|515499760|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
142990099|NCT03661983|515499761|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
142990100|NCT02045979|515499762|FG000|Overall Study|Informed Consent Withdrawn|2|||
142990101|NCT02045979|515499763|FG001|Overall Study|Informed Consent Withdrawn|0|||
142990102|NCT02045979|515499764|FG002|Overall Study|Informed Consent Withdrawn|1|||
142990103|NCT02045979|515499762|FG000|Overall Study|not specified above|0|||
142990104|NCT02045979|515499763|FG001|Overall Study|not specified above|1|||
142990105|NCT02045979|515499764|FG002|Overall Study|not specified above|0|||
142990106|NCT03657576|515499766|FG000|Overall Study|Death|0|||
142990107|NCT03657576|515499767|FG001|Overall Study|Death|1|||
142990108|NCT03657576|515499768|FG002|Overall Study|Death|1|||
142990109|NCT03657576|515499769|FG003|Overall Study|Death|0|||
142990110|NCT03657576|515499770|FG004|Overall Study|Death|0|||
142990111|NCT03657576|515499771|FG005|Overall Study|Death|0|||
142990112|NCT03657576|515499766|FG000|Overall Study|Withdrawal by Subject|0|||
142990113|NCT03657576|515499767|FG001|Overall Study|Withdrawal by Subject|0|||
142990114|NCT03657576|515499768|FG002|Overall Study|Withdrawal by Subject|0|||
142990115|NCT03657576|515499769|FG003|Overall Study|Withdrawal by Subject|1|||
142990116|NCT03657576|515499770|FG004|Overall Study|Withdrawal by Subject|0|||
142990117|NCT03657576|515499771|FG005|Overall Study|Withdrawal by Subject|0|||
142990118|NCT03657576|515499766|FG000|Overall Study|Screen Fail|0|||
142990119|NCT03657576|515499767|FG001|Overall Study|Screen Fail|0|||
142990120|NCT03657576|515499768|FG002|Overall Study|Screen Fail|0|||
142990121|NCT03657576|515499769|FG003|Overall Study|Screen Fail|0|||
142990122|NCT03657576|515499770|FG004|Overall Study|Screen Fail|0|||
142990123|NCT03657576|515499771|FG005|Overall Study|Screen Fail|5|||
142990124|NCT03657576|515499766|FG000|Overall Study|Disease Progression|1|||
142990125|NCT03657576|515499767|FG001|Overall Study|Disease Progression|1|||
142990126|NCT03657576|515499768|FG002|Overall Study|Disease Progression|0|||
142990127|NCT03657576|515499769|FG003|Overall Study|Disease Progression|5|||
142990128|NCT03657576|515499770|FG004|Overall Study|Disease Progression|0|||
142990129|NCT03657576|515499771|FG005|Overall Study|Disease Progression|0|||
142990130|NCT03657576|515499766|FG000|Overall Study|Insurance Coverage|0|||
142990131|NCT03657576|515499767|FG001|Overall Study|Insurance Coverage|0|||
142990132|NCT03657576|515499768|FG002|Overall Study|Insurance Coverage|0|||
142990133|NCT03657576|515499769|FG003|Overall Study|Insurance Coverage|1|||
142990134|NCT03657576|515499770|FG004|Overall Study|Insurance Coverage|0|||
142990135|NCT03657576|515499771|FG005|Overall Study|Insurance Coverage|0|||
142990136|NCT04437511|515499772|FG000|Overall Study|Adverse Event|50|||
142990137|NCT04437511|515499773|FG001|Overall Study|Adverse Event|21|||
142990138|NCT04437511|515499772|FG000|Overall Study|Death|15|||
142990139|NCT04437511|515499773|FG001|Overall Study|Death|10|||
142990140|NCT04437511|515499772|FG000|Overall Study|Lost to Follow-up|11|||
142990141|NCT04437511|515499773|FG001|Overall Study|Lost to Follow-up|11|||
142990142|NCT04437511|515499772|FG000|Overall Study|Physician Decision|19|||
142990143|NCT04437511|515499773|FG001|Overall Study|Physician Decision|10|||
142990144|NCT04437511|515499772|FG000|Overall Study|Progressive Disease|4|||
142990145|NCT04437511|515499773|FG001|Overall Study|Progressive Disease|7|||
142990146|NCT04437511|515499772|FG000|Overall Study|Withdrawal by Subject|111|||
142990147|NCT04437511|515499773|FG001|Overall Study|Withdrawal by Subject|94|||
142990148|NCT04437511|515499772|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
142990149|NCT04437511|515499773|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
142990150|NCT04437511|515499772|FG000|Overall Study|Continuing Study|7|||
142990151|NCT04437511|515499773|FG001|Overall Study|Continuing Study|5|||
142990152|NCT05618808|515499776|FG000|Overall Study|Withdrawal by Subject|3|||
142990153|NCT05618808|515499777|FG001|Overall Study|Withdrawal by Subject|1|||
142990154|NCT05618808|515499778|FG002|Overall Study|Withdrawal by Subject|3|||
142990155|NCT01996865|515499788|FG000|Induction Period|Protocol Violation|1|||
142990156|NCT01996865|515499789|FG001|Induction Period|Protocol Violation|0|||
142990157|NCT01996865|515499790|FG002|Induction Period|Protocol Violation|0|||
142990158|NCT01996865|515499788|FG000|Induction Period|Progressive Disease|4|||
142990159|NCT01996865|515499789|FG001|Induction Period|Progressive Disease|0|||
142990160|NCT01996865|515499790|FG002|Induction Period|Progressive Disease|0|||
142990161|NCT01996865|515499788|FG000|Induction Period|Lost to Follow-up|10|||
142990162|NCT01996865|515499789|FG001|Induction Period|Lost to Follow-up|0|||
142990163|NCT01996865|515499790|FG002|Induction Period|Lost to Follow-up|0|||
142990164|NCT01996865|515499788|FG000|Induction Period|Other Reasons|13|||
142990165|NCT01996865|515499789|FG001|Induction Period|Other Reasons|0|||
142990166|NCT01996865|515499790|FG002|Induction Period|Other Reasons|0|||
142990167|NCT01996865|515499788|FG000|Induction Period|Adverse Event|20|||
142990168|NCT01996865|515499789|FG001|Induction Period|Adverse Event|0|||
142990169|NCT01996865|515499790|FG002|Induction Period|Adverse Event|0|||
142990170|NCT01996865|515499788|FG000|Induction Period|Withdrawal by Subject|60|||
142990171|NCT01996865|515499789|FG001|Induction Period|Withdrawal by Subject|0|||
142990172|NCT01996865|515499790|FG002|Induction Period|Withdrawal by Subject|0|||
142990173|NCT01996865|515499788|FG000|Induction Period|Death|111|||
142990174|NCT01996865|515499789|FG001|Induction Period|Death|0|||
142990175|NCT01996865|515499790|FG002|Induction Period|Death|0|||
142990176|NCT01996865|515499788|FG000|Maintenance Period|Protocol Violation|0|||
142990177|NCT01996865|515499789|FG001|Maintenance Period|Protocol Violation|1|||
142990178|NCT01996865|515499790|FG002|Maintenance Period|Protocol Violation|1|||
142990179|NCT01996865|515499788|FG000|Maintenance Period|Other reasons|0|||
142990180|NCT01996865|515499789|FG001|Maintenance Period|Other reasons|8|||
142990181|NCT01996865|515499790|FG002|Maintenance Period|Other reasons|5|||
142990182|NCT01996865|515499788|FG000|Maintenance Period|Progressive Disease|0|||
142990183|NCT01996865|515499789|FG001|Maintenance Period|Progressive Disease|6|||
142990184|NCT01996865|515499790|FG002|Maintenance Period|Progressive Disease|23|||
142990185|NCT01996865|515499788|FG000|Maintenance Period|Withdrawal by Subject|0|||
142990186|NCT01996865|515499789|FG001|Maintenance Period|Withdrawal by Subject|18|||
142990187|NCT01996865|515499790|FG002|Maintenance Period|Withdrawal by Subject|4|||
142990188|NCT01996865|515499788|FG000|Maintenance Period|Adverse Event|0|||
142990189|NCT01996865|515499789|FG001|Maintenance Period|Adverse Event|7|||
142990190|NCT01996865|515499790|FG002|Maintenance Period|Adverse Event|7|||
142990191|NCT01996865|515499788|FG000|Maintenance Period|Death|0|||
142990192|NCT01996865|515499789|FG001|Maintenance Period|Death|15|||
142990193|NCT01996865|515499790|FG002|Maintenance Period|Death|3|||
142990194|NCT01996865|515499788|FG000|Maintenance Period|Lost to Follow-up|0|||
142990195|NCT01996865|515499789|FG001|Maintenance Period|Lost to Follow-up|2|||
142990196|NCT01996865|515499790|FG002|Maintenance Period|Lost to Follow-up|0|||
142990197|NCT00515099|515499791|FG000|Overall Study|Lost to Follow-up|0|||
142990198|NCT00515099|515499792|FG001|Overall Study|Lost to Follow-up|4|||
142990199|NCT00515099|515499791|FG000|Overall Study|Withdrawal by Subject|2|||
142990200|NCT00515099|515499792|FG001|Overall Study|Withdrawal by Subject|0|||
142990201|NCT00515099|515499791|FG000|Overall Study|IRB Recommendation|1|||
142990202|NCT00515099|515499792|FG001|Overall Study|IRB Recommendation|0|||
142990203|NCT00592072|515499793|FG000|Wash Out Period|Lost to Follow-up|1|||
142990204|NCT00592072|515499794|FG001|Wash Out Period|Lost to Follow-up|1|||
142990205|NCT03369704|515499795|FG000|Treatment Epoch|technical problems|1|||
142990206|NCT03369704|515499796|FG001|Treatment Epoch|technical problems|0|||
142990207|NCT03369704|515499795|FG000|Treatment Epoch|Protocol Violation|1|||
142990208|NCT03369704|515499796|FG001|Treatment Epoch|Protocol Violation|0|||
142990209|NCT03369704|515499795|FG000|Treatment Epoch|Lost to Follow-up|0|||
142990210|NCT03369704|515499796|FG001|Treatment Epoch|Lost to Follow-up|1|||
142990211|NCT03369704|515499795|FG000|Treatment Epoch|Lack of Efficacy|0|||
142990212|NCT03369704|515499796|FG001|Treatment Epoch|Lack of Efficacy|2|||
142990213|NCT03369704|515499795|FG000|Treatment Epoch|Adverse Event|2|||
142990214|NCT03369704|515499796|FG001|Treatment Epoch|Adverse Event|0|||
142990215|NCT03369704|515499795|FG000|Follow-up Epoch|Lost to Follow-up|1|||
142990216|NCT03369704|515499796|FG001|Follow-up Epoch|Lost to Follow-up|0|||
142990217|NCT05333289|515499798|FG000|Overall Study|Other|1|||
142990218|NCT05333289|515499799|FG001|Overall Study|Other|0|||
142990219|NCT05333289|515499800|FG002|Overall Study|Other|0|||
142990220|NCT05333289|515499801|FG003|Overall Study|Other|1|||
142990221|NCT05333289|515499802|FG004|Overall Study|Other|1|||
142990222|NCT05333289|515499803|FG005|Overall Study|Other|2|||
142990223|NCT05333289|515499804|FG006|Overall Study|Other|2|||
142990224|NCT05333289|515499805|FG007|Overall Study|Other|0|||
142990225|NCT05333289|515499798|FG000|Overall Study|Withdrawal by Subject|1|||
142990226|NCT05333289|515499799|FG001|Overall Study|Withdrawal by Subject|2|||
142990227|NCT05333289|515499800|FG002|Overall Study|Withdrawal by Subject|2|||
142990228|NCT05333289|515499801|FG003|Overall Study|Withdrawal by Subject|1|||
142990229|NCT05333289|515499802|FG004|Overall Study|Withdrawal by Subject|1|||
142990230|NCT05333289|515499803|FG005|Overall Study|Withdrawal by Subject|2|||
142990231|NCT05333289|515499804|FG006|Overall Study|Withdrawal by Subject|1|||
142990232|NCT05333289|515499805|FG007|Overall Study|Withdrawal by Subject|3|||
142990233|NCT05333289|515499798|FG000|Overall Study|Protocol Violation|1|||
142990234|NCT05333289|515499799|FG001|Overall Study|Protocol Violation|0|||
142990235|NCT05333289|515499800|FG002|Overall Study|Protocol Violation|0|||
142990236|NCT05333289|515499801|FG003|Overall Study|Protocol Violation|0|||
142990237|NCT05333289|515499802|FG004|Overall Study|Protocol Violation|0|||
142990238|NCT05333289|515499803|FG005|Overall Study|Protocol Violation|0|||
142990239|NCT05333289|515499804|FG006|Overall Study|Protocol Violation|0|||
142990240|NCT05333289|515499805|FG007|Overall Study|Protocol Violation|0|||
142990241|NCT05333289|515499798|FG000|Overall Study|Physician Decision|0|||
142990242|NCT05333289|515499799|FG001|Overall Study|Physician Decision|0|||
142990243|NCT05333289|515499800|FG002|Overall Study|Physician Decision|1|||
142990244|NCT05333289|515499801|FG003|Overall Study|Physician Decision|0|||
142990245|NCT05333289|515499802|FG004|Overall Study|Physician Decision|0|||
142990246|NCT05333289|515499803|FG005|Overall Study|Physician Decision|2|||
142990247|NCT05333289|515499804|FG006|Overall Study|Physician Decision|0|||
142990248|NCT05333289|515499805|FG007|Overall Study|Physician Decision|0|||
142990249|NCT05333289|515499798|FG000|Overall Study|Lost to Follow-up|6|||
142990250|NCT05333289|515499799|FG001|Overall Study|Lost to Follow-up|0|||
142990251|NCT05333289|515499800|FG002|Overall Study|Lost to Follow-up|1|||
142990252|NCT05333289|515499801|FG003|Overall Study|Lost to Follow-up|6|||
142990253|NCT05333289|515499802|FG004|Overall Study|Lost to Follow-up|3|||
142990254|NCT05333289|515499803|FG005|Overall Study|Lost to Follow-up|3|||
142990255|NCT05333289|515499804|FG006|Overall Study|Lost to Follow-up|2|||
142990256|NCT05333289|515499805|FG007|Overall Study|Lost to Follow-up|1|||
142990257|NCT05333289|515499798|FG000|Overall Study|Death|1|||
142990258|NCT05333289|515499799|FG001|Overall Study|Death|0|||
142990259|NCT05333289|515499800|FG002|Overall Study|Death|0|||
142990260|NCT05333289|515499801|FG003|Overall Study|Death|0|||
142990261|NCT05333289|515499802|FG004|Overall Study|Death|0|||
142990262|NCT05333289|515499803|FG005|Overall Study|Death|0|||
142990263|NCT05333289|515499804|FG006|Overall Study|Death|0|||
142990264|NCT05333289|515499805|FG007|Overall Study|Death|0|||
142990265|NCT03733249|515499806|FG000|Overall Study|Death|7|||
142990266|NCT03733249|515499806|FG000|Overall Study|Disease relapse|16|||
142990267|NCT03733249|515499806|FG000|Overall Study|Lost to Follow-up|4|||
142990268|NCT03733249|515499806|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
142990269|NCT03733249|515499806|FG000|Overall Study|Withdrawal by Subject|1|||
142990270|NCT03685643|515499809|FG000|Overall Study|Lost to Follow-up|14|||
142990271|NCT03685643|515499810|FG001|Overall Study|Lost to Follow-up|22|||
142990272|NCT02750501|515499811|FG000|Overall Study|Adverse Event|4|||
142990273|NCT02750501|515499811|FG000|Overall Study|Physician Decision|1|||
142990274|NCT02750501|515499811|FG000|Overall Study|Protocol Violation|1|||
142990275|NCT02750501|515499811|FG000|Overall Study|G-tube came out|1|||
142990276|NCT02750501|515499811|FG000|Overall Study|Non-compliant use of PERT|1|||
142990277|NCT03797144|515499812|FG000|Enrollment|Protocol Violation|4|||
142990278|NCT03797144|515499813|FG001|Enrollment|Protocol Violation|1|||
142990279|NCT03797144|515499812|FG000|Surgery|Protocol Violation|1|||
142990280|NCT03797144|515499813|FG001|Surgery|Protocol Violation|0|||
142990281|NCT03797144|515499812|FG000|3 Month|Early termination cut-off date|2|||
142990282|NCT03797144|515499813|FG001|3 Month|Early termination cut-off date|0|||
142990283|NCT03797144|515499812|FG000|12 Month|Early termination cut-off date|8|||
142990284|NCT03797144|515499813|FG001|12 Month|Early termination cut-off date|9|||
142990285|NCT03797144|515499812|FG000|24 Month|Early termination cut-off date|1|||
142990286|NCT03797144|515499813|FG001|24 Month|Early termination cut-off date|1|||
142990287|NCT00403390|515499815|FG000|Overall Study|Withdrawal by Subject|1|||
142990288|NCT00403390|515499816|FG001|Overall Study|Withdrawal by Subject|0|||
142990289|NCT00403390|515499815|FG000|Overall Study|samples lost|1|||
142990290|NCT00403390|515499816|FG001|Overall Study|samples lost|0|||
142990291|NCT00403390|515499815|FG000|Overall Study|non-compliant|1|||
142990292|NCT00403390|515499816|FG001|Overall Study|non-compliant|0|||
142990293|NCT01878175|515499817|FG000|Overall Study|Developed contraindicated health problem|2|||
142990294|NCT04430036|515499818|FG000|Safety Run in Phase|Progression of disease|2|||
142990295|NCT01108068|515499819|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
142990296|NCT01108068|515499820|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
142990297|NCT00836953|515499821|FG000|Overall Study|Withdrawal by Subject|1|||
142990298|NCT00836953|515499821|FG000|Overall Study|Lost to Follow-up|1|||
142990299|NCT01842334|515499822|FG000|Overall Study|Withdrawal by Subject|3|||
142990300|NCT01842334|515499823|FG001|Overall Study|Withdrawal by Subject|3|||
142990301|NCT01842334|515499822|FG000|Overall Study|Moved away mid-study|0|||
142990302|NCT01842334|515499823|FG001|Overall Study|Moved away mid-study|1|||
142990303|NCT00376675|515499824|FG000|Overall Study|Withdrawal by Subject|9|||
142990304|NCT00376675|515499825|FG001|Overall Study|Withdrawal by Subject|2|||
142990305|NCT00376675|515499824|FG000|Overall Study|Adverse Event|10|||
142990306|NCT00376675|515499825|FG001|Overall Study|Adverse Event|5|||
142990307|NCT00376675|515499824|FG000|Overall Study|Other Reason|1|||
142990308|NCT00376675|515499825|FG001|Overall Study|Other Reason|7|||
142990309|NCT00942422|515499829|FG000|Overall Study|Withdrawal by Subject|1|||
142990310|NCT00942422|515499829|FG000|Overall Study|Death|1|||
142990311|NCT00942422|515499829|FG000|Overall Study|Progressive diease|1|||
142990312|NCT02943668|515499830|FG000|Overall Study|Disease Progression|1|||
142990313|NCT02724111|515499835|FG000|Overall Study|Protocol Violation|2|||
142990314|NCT02724111|515499836|FG001|Overall Study|Protocol Violation|5|||
142990315|NCT02996500|515499837|FG000|Overall Study|Adverse Event|1|||
142990316|NCT02996500|515499838|FG001|Overall Study|Adverse Event|1|||
142990317|NCT02996500|515499839|FG002|Overall Study|Adverse Event|4|||
142990318|NCT02996500|515499840|FG003|Overall Study|Adverse Event|3|||
142990319|NCT02996500|515499841|FG004|Overall Study|Adverse Event|1|||
142990320|NCT02996500|515499842|FG005|Overall Study|Adverse Event|2|||
142990321|NCT02996500|515499837|FG000|Overall Study|Lack of Efficacy|0|||
142990322|NCT02996500|515499838|FG001|Overall Study|Lack of Efficacy|0|||
142990323|NCT02996500|515499839|FG002|Overall Study|Lack of Efficacy|0|||
142990324|NCT02996500|515499840|FG003|Overall Study|Lack of Efficacy|0|||
142990325|NCT02996500|515499841|FG004|Overall Study|Lack of Efficacy|2|||
142990326|NCT02996500|515499842|FG005|Overall Study|Lack of Efficacy|0|||
142990327|NCT02996500|515499837|FG000|Overall Study|Lost to Follow-up|1|||
142990328|NCT02996500|515499838|FG001|Overall Study|Lost to Follow-up|0|||
142990329|NCT02996500|515499839|FG002|Overall Study|Lost to Follow-up|0|||
142990330|NCT02996500|515499840|FG003|Overall Study|Lost to Follow-up|0|||
142990331|NCT02996500|515499841|FG004|Overall Study|Lost to Follow-up|0|||
142990332|NCT02996500|515499842|FG005|Overall Study|Lost to Follow-up|1|||
142990333|NCT02996500|515499837|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
142990334|NCT02996500|515499838|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
142990335|NCT02996500|515499839|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
142990336|NCT02996500|515499840|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
142990337|NCT02996500|515499841|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
142990338|NCT02996500|515499842|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
142990339|NCT02996500|515499837|FG000|Overall Study|Non-Compliance With Study Drug|0|||
142990340|NCT02996500|515499838|FG001|Overall Study|Non-Compliance With Study Drug|0|||
142990341|NCT02996500|515499839|FG002|Overall Study|Non-Compliance With Study Drug|0|||
142990342|NCT02996500|515499840|FG003|Overall Study|Non-Compliance With Study Drug|0|||
142990343|NCT02996500|515499841|FG004|Overall Study|Non-Compliance With Study Drug|0|||
142990344|NCT02996500|515499842|FG005|Overall Study|Non-Compliance With Study Drug|1|||
142990345|NCT02996500|515499837|FG000|Overall Study|Progressive Disease|1|||
142990346|NCT02996500|515499838|FG001|Overall Study|Progressive Disease|0|||
142990347|NCT02996500|515499839|FG002|Overall Study|Progressive Disease|0|||
142990348|NCT02996500|515499840|FG003|Overall Study|Progressive Disease|0|||
142990349|NCT02996500|515499841|FG004|Overall Study|Progressive Disease|0|||
142990350|NCT02996500|515499842|FG005|Overall Study|Progressive Disease|0|||
142990351|NCT02996500|515499837|FG000|Overall Study|Other|2|||
142990352|NCT02996500|515499838|FG001|Overall Study|Other|0|||
142990353|NCT02996500|515499839|FG002|Overall Study|Other|2|||
142990354|NCT02996500|515499840|FG003|Overall Study|Other|0|||
142990355|NCT02996500|515499841|FG004|Overall Study|Other|0|||
142990356|NCT02996500|515499842|FG005|Overall Study|Other|0|||
142990357|NCT02996500|515499837|FG000|Overall Study|Protocol Violation|0|||
142990358|NCT02996500|515499838|FG001|Overall Study|Protocol Violation|0|||
142990359|NCT02996500|515499839|FG002|Overall Study|Protocol Violation|0|||
142990360|NCT02996500|515499840|FG003|Overall Study|Protocol Violation|1|||
142990361|NCT02996500|515499841|FG004|Overall Study|Protocol Violation|0|||
142990362|NCT02996500|515499842|FG005|Overall Study|Protocol Violation|0|||
142990363|NCT02996500|515499837|FG000|Overall Study|Withdrawal by Subject|3|||
142990364|NCT02996500|515499838|FG001|Overall Study|Withdrawal by Subject|0|||
142990365|NCT02996500|515499839|FG002|Overall Study|Withdrawal by Subject|3|||
142990366|NCT02996500|515499840|FG003|Overall Study|Withdrawal by Subject|0|||
142990367|NCT02996500|515499841|FG004|Overall Study|Withdrawal by Subject|2|||
142990368|NCT02996500|515499842|FG005|Overall Study|Withdrawal by Subject|0|||
142990369|NCT00322387|515499843|FG000|Treatment Period|Adverse Event|0|||
142990370|NCT00322387|515499844|FG001|Treatment Period|Adverse Event|1|||
142990371|NCT00322387|515499843|FG000|Follow-up Period|Final assessment not done|1|||
142990372|NCT00322387|515499844|FG001|Follow-up Period|Final assessment not done|3|||
142990373|NCT00322387|515499843|FG000|Follow-up Period|Death|1|||
142990374|NCT00322387|515499844|FG001|Follow-up Period|Death|0|||
142990375|NCT00707486|515499847|FG000|Overall Study|Withdrawal by Subject|1|||
142990376|NCT01885104|515499852|FG000|Overall Study|Withdrawal of Consent|1|||
142990377|NCT01885104|515499853|FG001|Overall Study|Withdrawal of Consent|0|||
142990378|NCT01885104|515499852|FG000|Overall Study|Lost to Follow-up|0|||
142990379|NCT01885104|515499853|FG001|Overall Study|Lost to Follow-up|1|||
142990380|NCT01885104|515499852|FG000|Overall Study|Physician Decision|1|||
142990381|NCT01885104|515499853|FG001|Overall Study|Physician Decision|0|||
142990382|NCT05307523|515499857|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
142990383|NCT05307523|515499858|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
142990384|NCT05307523|515499857|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
142990385|NCT05307523|515499858|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
142990386|NCT02116361|515499861|FG000|Overall Study|Pregnancy|0|||
142990387|NCT02116361|515499862|FG001|Overall Study|Pregnancy|0|||
142990388|NCT02116361|515499863|FG002|Overall Study|Pregnancy|0|||
142990389|NCT02116361|515499864|FG003|Overall Study|Pregnancy|1|||
142990390|NCT02116361|515499861|FG000|Overall Study|Protocol Violation|1|||
142990391|NCT02116361|515499862|FG001|Overall Study|Protocol Violation|0|||
142990392|NCT02116361|515499863|FG002|Overall Study|Protocol Violation|0|||
142990393|NCT02116361|515499864|FG003|Overall Study|Protocol Violation|2|||
142990394|NCT02116361|515499861|FG000|Overall Study|Physician Decision|2|||
142990395|NCT02116361|515499862|FG001|Overall Study|Physician Decision|3|||
142990396|NCT02116361|515499863|FG002|Overall Study|Physician Decision|0|||
142990397|NCT02116361|515499864|FG003|Overall Study|Physician Decision|0|||
142990398|NCT02116361|515499861|FG000|Overall Study|Adverse Event|1|||
142990399|NCT02116361|515499862|FG001|Overall Study|Adverse Event|0|||
142990400|NCT02116361|515499863|FG002|Overall Study|Adverse Event|0|||
142990401|NCT02116361|515499864|FG003|Overall Study|Adverse Event|3|||
142990402|NCT02116361|515499861|FG000|Overall Study|Other Reasons|3|||
142990403|NCT02116361|515499862|FG001|Overall Study|Other Reasons|3|||
142990404|NCT02116361|515499863|FG002|Overall Study|Other Reasons|3|||
142990405|NCT02116361|515499864|FG003|Overall Study|Other Reasons|3|||
142990406|NCT02116361|515499861|FG000|Overall Study|Lack of Efficacy|5|||
142990407|NCT02116361|515499862|FG001|Overall Study|Lack of Efficacy|7|||
142990408|NCT02116361|515499863|FG002|Overall Study|Lack of Efficacy|4|||
142990409|NCT02116361|515499864|FG003|Overall Study|Lack of Efficacy|3|||
142990410|NCT02116361|515499861|FG000|Overall Study|Lost to Follow-up|4|||
142990411|NCT02116361|515499862|FG001|Overall Study|Lost to Follow-up|5|||
142990412|NCT02116361|515499863|FG002|Overall Study|Lost to Follow-up|7|||
142990413|NCT02116361|515499864|FG003|Overall Study|Lost to Follow-up|5|||
142990414|NCT02116361|515499861|FG000|Overall Study|Personal Reasons|6|||
142990415|NCT02116361|515499862|FG001|Overall Study|Personal Reasons|6|||
142990416|NCT02116361|515499863|FG002|Overall Study|Personal Reasons|4|||
142990417|NCT02116361|515499864|FG003|Overall Study|Personal Reasons|9|||
142990418|NCT02116361|515499861|FG000|Overall Study|Investigator Decision - Relapse|9|||
142990419|NCT02116361|515499862|FG001|Overall Study|Investigator Decision - Relapse|7|||
142990420|NCT02116361|515499863|FG002|Overall Study|Investigator Decision - Relapse|8|||
142990421|NCT02116361|515499864|FG003|Overall Study|Investigator Decision - Relapse|5|||
142990422|NCT02497287|515499865|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
142990423|NCT02497287|515499865|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
142990424|NCT02497287|515499865|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
142990425|NCT02497287|515499865|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
142990426|NCT02497287|515499865|FG000|Induction Phase (4 Weeks)|Other|13|||
142990427|NCT02497287|515499865|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
142990428|NCT02497287|515499865|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
142990429|NCT02497287|515499865|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
142990430|NCT02497287|515499865|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
142990431|NCT02497287|515499865|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
142990432|NCT02497287|515499865|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
142990433|NCT02497287|515499865|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
142990434|NCT02497287|515499865|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
142990435|NCT02497287|515499865|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
142990436|NCT02497287|515499865|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
142990437|NCT02497287|515499865|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
142990438|NCT02497287|515499865|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
142990439|NCT02497287|515499865|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
142990440|NCT02497287|515499865|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
142990441|NCT02497287|515499865|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
142990442|NCT02497287|515499865|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
142990443|NCT02497287|515499865|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
142990444|NCT02497287|515499865|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
142990445|NCT02497287|515499865|FG000|Follow-up Phase (4 Week)|Other|1|||
142990446|NCT02659098|515499866|FG000|Overall Study|Withdrawal by Subject|7|||
142990447|NCT04363944|515499867|FG000|Overall Study|Withdrawal by Subject|2|||
142990448|NCT04363944|515499868|FG001|Overall Study|Withdrawal by Subject|0|||
142990449|NCT03399786|515499869|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
142990450|NCT03399786|515499870|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
142990451|NCT03399786|515499871|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
142990452|NCT03399786|515499872|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
142990453|NCT03399786|515499869|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
142990454|NCT03399786|515499870|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
142990455|NCT03399786|515499871|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
142990456|NCT03399786|515499872|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
142990457|NCT03399786|515499869|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
142990458|NCT03399786|515499870|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
142990459|NCT03399786|515499871|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
142990460|NCT03399786|515499872|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
142990461|NCT01855919|515501382|FG000|Overall Study|Adverse Event|16|||
142990462|NCT01855919|515501383|FG001|Overall Study|Adverse Event|8|||
142990463|NCT01855919|515501382|FG000|Overall Study|Lack of Efficacy|1|||
142990464|NCT01855919|515501383|FG001|Overall Study|Lack of Efficacy|3|||
142990465|NCT01855919|515501382|FG000|Overall Study|Withdrawal by Subject|4|||
142990466|NCT01855919|515501383|FG001|Overall Study|Withdrawal by Subject|10|||
142990467|NCT01855919|515501382|FG000|Overall Study|Entry Criteria Not Met|1|||
142990468|NCT01855919|515501383|FG001|Overall Study|Entry Criteria Not Met|1|||
142990469|NCT01855919|515501382|FG000|Overall Study|Protocol Violation|1|||
142990470|NCT01855919|515501383|FG001|Overall Study|Protocol Violation|4|||
142990471|NCT03455530|515501384|FG000|Overall Study|Withdrawal by Subject|9|||
142990472|NCT03455530|515501385|FG001|Overall Study|Withdrawal by Subject|1|||
142990473|NCT03455530|515501386|FG002|Overall Study|Withdrawal by Subject|3|||
142990474|NCT03455530|515501387|FG003|Overall Study|Withdrawal by Subject|3|||
142990475|NCT00740116|515501392|FG000|Overall Study|Withdrawal by Subject|1|||
142990476|NCT00740116|515501393|FG001|Overall Study|Withdrawal by Subject|1|||
142990477|NCT00740116|515501392|FG000|Overall Study|Protocol Violation|1|||
142990478|NCT00740116|515501393|FG001|Overall Study|Protocol Violation|4|||
142990479|NCT01888965|515501394|FG000|Overall Study|Adverse Event|5|||
142990480|NCT01888965|515501394|FG000|Overall Study|Lack of Efficacy|4|||
142990481|NCT01569568|515501395|FG000|Overall Study|Physician Decision|0|||
142990482|NCT01569568|515501396|FG001|Overall Study|Physician Decision|2|||
142990483|NCT01370499|515501397|FG000|Overall Study|Adverse Event|38|||
142990484|NCT01370499|515501398|FG001|Overall Study|Adverse Event|12|||
142990485|NCT01370499|515501397|FG000|Overall Study|Lack of Efficacy|4|||
142990486|NCT01370499|515501398|FG001|Overall Study|Lack of Efficacy|2|||
142990487|NCT01370499|515501397|FG000|Overall Study|Lost to Follow-up|2|||
142990488|NCT01370499|515501398|FG001|Overall Study|Lost to Follow-up|1|||
142990489|NCT01370499|515501397|FG000|Overall Study|Physician Decision|3|||
142990490|NCT01370499|515501398|FG001|Overall Study|Physician Decision|3|||
142990491|NCT01370499|515501397|FG000|Overall Study|Protocol Violation|5|||
142990492|NCT01370499|515501398|FG001|Overall Study|Protocol Violation|4|||
142990493|NCT01370499|515501397|FG000|Overall Study|Withdrawal by Subject|18|||
142990494|NCT01370499|515501398|FG001|Overall Study|Withdrawal by Subject|7|||
142990495|NCT01370499|515501397|FG000|Overall Study|Sponsor Decision|41|||
142990496|NCT01370499|515501398|FG001|Overall Study|Sponsor Decision|15|||
142990497|NCT05815758|515501399|FG000|Overall Study|Adverse Event|6|||
142990498|NCT05815758|515501400|FG001|Overall Study|Adverse Event|2|||
142990499|NCT05815758|515501399|FG000|Overall Study|Lost to Follow-up|14|||
142990500|NCT05815758|515501400|FG001|Overall Study|Lost to Follow-up|1|||
142990501|NCT05815758|515501399|FG000|Overall Study|Withdrawal by Subject|6|||
142990502|NCT05815758|515501400|FG001|Overall Study|Withdrawal by Subject|6|||
142990503|NCT05815758|515501399|FG000|Overall Study|Protocol Violation|1|||
142990504|NCT05815758|515501400|FG001|Overall Study|Protocol Violation|1|||
142990505|NCT05815758|515501399|FG000|Overall Study|Discontinued|4|||
142990506|NCT05815758|515501400|FG001|Overall Study|Discontinued|4|||
142990507|NCT00934791|515501401|FG000|Overall Study|Withdrawal by Subject|1|||
142990508|NCT00934791|515501402|FG001|Overall Study|Withdrawal by Subject|0|||
142990509|NCT04124952|515501403|FG000|Overall Study|Lost to Follow-up|1|||
142990510|NCT03345849|515501407|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
142990511|NCT03345849|515501408|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
142990512|NCT03345849|515501409|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
142990513|NCT03345849|515501410|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
142990514|NCT03345849|515501407|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
142990515|NCT03345849|515501408|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
142990516|NCT03345849|515501409|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
142990517|NCT03345849|515501410|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
142990518|NCT03345849|515501407|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
142990519|NCT03345849|515501408|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
142990520|NCT03345849|515501409|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
142990521|NCT03345849|515501410|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
142990522|NCT03345849|515501407|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
142990523|NCT03345849|515501408|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
142990524|NCT03345849|515501409|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
142990525|NCT03345849|515501410|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
142990526|NCT03345849|515501407|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
142990527|NCT03345849|515501408|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
142990528|NCT03345849|515501409|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
142990529|NCT03345849|515501410|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
142990530|NCT03345849|515501407|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
142990531|NCT03345849|515501408|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
142990532|NCT03345849|515501409|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
142990533|NCT03345849|515501410|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
142990534|NCT03345849|515501407|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
142990535|NCT03345849|515501408|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
142990536|NCT03345849|515501409|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
142990537|NCT03345849|515501410|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
142990538|NCT03345849|515501407|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
142990539|NCT03345849|515501408|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
142990540|NCT03345849|515501409|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
142990541|NCT03345849|515501410|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
142990542|NCT03345849|515501407|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
142990543|NCT03345849|515501408|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
142990544|NCT03345849|515501409|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
142990545|NCT03345849|515501410|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
142990546|NCT03345849|515501407|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
142990547|NCT03345849|515501408|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
142990548|NCT03345849|515501409|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
142990549|NCT03345849|515501410|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
142990550|NCT03345849|515501407|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
142990551|NCT03345849|515501408|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
142990552|NCT03345849|515501409|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
142990553|NCT03345849|515501410|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
142990554|NCT03261037|515501411|FG000|Overall Study|Withdrawal by Subject|2|||
142990555|NCT03261037|515501412|FG001|Overall Study|Withdrawal by Subject|13|||
142990556|NCT03261037|515501413|FG002|Overall Study|Withdrawal by Subject|0|||
142990557|NCT03261037|515501414|FG003|Overall Study|Withdrawal by Subject|18|||
142990558|NCT03261037|515501411|FG000|Overall Study|Non-compliance with study procedures|0|||
142990559|NCT03261037|515501412|FG001|Overall Study|Non-compliance with study procedures|2|||
142990560|NCT03261037|515501413|FG002|Overall Study|Non-compliance with study procedures|0|||
142990561|NCT03261037|515501414|FG003|Overall Study|Non-compliance with study procedures|6|||
142990562|NCT03261037|515501411|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
142990563|NCT03261037|515501412|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
142990564|NCT03261037|515501413|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
142990565|NCT03261037|515501414|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
142990566|NCT03261037|515501411|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
142990567|NCT03261037|515501412|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
142990568|NCT03261037|515501413|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
142990569|NCT03261037|515501414|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
143003180|NCT01049360|515548752|FG008|Period 2|Lack of Efficacy|0|||
143117237|NCT01709864|515971809|FG001|Overall Study|Lost to Follow-up|0|||
142990570|NCT03261037|515501411|FG000|Overall Study|Diagnosed but protocol deviation|1|||
142990571|NCT03261037|515501412|FG001|Overall Study|Diagnosed but protocol deviation|0|||
142990572|NCT03261037|515501413|FG002|Overall Study|Diagnosed but protocol deviation|0|||
142990573|NCT03261037|515501414|FG003|Overall Study|Diagnosed but protocol deviation|0|||
142990574|NCT03261037|515501411|FG000|Overall Study|Participant did not want to continue the study|0|||
142990575|NCT03261037|515501412|FG001|Overall Study|Participant did not want to continue the study|1|||
142990576|NCT03261037|515501413|FG002|Overall Study|Participant did not want to continue the study|0|||
142990577|NCT03261037|515501414|FG003|Overall Study|Participant did not want to continue the study|0|||
142990578|NCT03261037|515501411|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
142990579|NCT03261037|515501412|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
142990580|NCT03261037|515501413|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
142990581|NCT03261037|515501414|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
142990582|NCT03261037|515501411|FG000|Overall Study|Participant presented clinical improvement|0|||
142990583|NCT03261037|515501412|FG001|Overall Study|Participant presented clinical improvement|2|||
142990584|NCT03261037|515501413|FG002|Overall Study|Participant presented clinical improvement|0|||
142990585|NCT03261037|515501414|FG003|Overall Study|Participant presented clinical improvement|0|||
142990586|NCT03261037|515501411|FG000|Overall Study|Technical difficulties|0|||
142990587|NCT03261037|515501412|FG001|Overall Study|Technical difficulties|0|||
142990588|NCT03261037|515501413|FG002|Overall Study|Technical difficulties|0|||
142990589|NCT03261037|515501414|FG003|Overall Study|Technical difficulties|1|||
142990590|NCT03261037|515501411|FG000|Overall Study|Equipment failed to work|0|||
142990591|NCT03261037|515501412|FG001|Overall Study|Equipment failed to work|0|||
142990592|NCT03261037|515501413|FG002|Overall Study|Equipment failed to work|0|||
142990593|NCT03261037|515501414|FG003|Overall Study|Equipment failed to work|1|||
142990594|NCT03261037|515501411|FG000|Overall Study|End of study for participant and no follow up|0|||
142990595|NCT03261037|515501412|FG001|Overall Study|End of study for participant and no follow up|0|||
142990596|NCT03261037|515501413|FG002|Overall Study|End of study for participant and no follow up|0|||
142990597|NCT03261037|515501414|FG003|Overall Study|End of study for participant and no follow up|1|||
142990598|NCT03261037|515501411|FG000|Overall Study|Participant was too weak to continue in study|1|||
142990599|NCT03261037|515501412|FG001|Overall Study|Participant was too weak to continue in study|0|||
142990600|NCT03261037|515501413|FG002|Overall Study|Participant was too weak to continue in study|0|||
142990601|NCT03261037|515501414|FG003|Overall Study|Participant was too weak to continue in study|0|||
142990602|NCT02943577|515501415|FG000|Overall Study|Protocol Violation|0|||
142990603|NCT02943577|515501416|FG001|Overall Study|Protocol Violation|1|||
142990604|NCT02943577|515501415|FG000|Overall Study|Adverse Event|3|||
142990605|NCT02943577|515501416|FG001|Overall Study|Adverse Event|2|||
142990606|NCT02943577|515501415|FG000|Overall Study|Lost to Follow-up|0|||
142990607|NCT02943577|515501416|FG001|Overall Study|Lost to Follow-up|1|||
142990608|NCT02943577|515501415|FG000|Overall Study|Withdrawal by Subject|1|||
142990609|NCT02943577|515501416|FG001|Overall Study|Withdrawal by Subject|1|||
142990610|NCT02943577|515501415|FG000|Overall Study|Pregnancy|1|||
142990611|NCT02943577|515501416|FG001|Overall Study|Pregnancy|0|||
142990612|NCT01944462|515501425|FG000|PPPP Educational Program|Lost to Follow-up|60|||
142990613|NCT01222767|515501426|FG000|Overall Study|Progressive disease|13|||
142990614|NCT01222767|515501426|FG000|Overall Study|Adverse Event|2|||
142990615|NCT01222767|515501426|FG000|Overall Study|Surgical resection|1|||
142990616|NCT01222767|515501426|FG000|Overall Study|Never treated|1|||
142990617|NCT00723489|515501427|FG000|Overall Study|Physician Decision|0|||
142990618|NCT00723489|515501428|FG001|Overall Study|Physician Decision|1|||
142990619|NCT00723489|515501429|FG002|Overall Study|Physician Decision|0|||
142990620|NCT00723489|515501430|FG003|Overall Study|Physician Decision|0|||
142990621|NCT00723489|515501427|FG000|Overall Study|Pregnancy|0|||
142990622|NCT00723489|515501428|FG001|Overall Study|Pregnancy|0|||
142990623|NCT00723489|515501429|FG002|Overall Study|Pregnancy|0|||
142990624|NCT00723489|515501430|FG003|Overall Study|Pregnancy|1|||
142990625|NCT00723489|515501427|FG000|Overall Study|Withdrawal by Subject|0|||
142990626|NCT00723489|515501428|FG001|Overall Study|Withdrawal by Subject|0|||
142990627|NCT00723489|515501429|FG002|Overall Study|Withdrawal by Subject|0|||
142990628|NCT00723489|515501430|FG003|Overall Study|Withdrawal by Subject|1|||
142990629|NCT00723489|515501427|FG000|Overall Study|Seropositive at baseline|1|||
142990630|NCT00723489|515501428|FG001|Overall Study|Seropositive at baseline|0|||
142990631|NCT00723489|515501429|FG002|Overall Study|Seropositive at baseline|0|||
142990632|NCT00723489|515501430|FG003|Overall Study|Seropositive at baseline|0|||
142990633|NCT00723489|515501427|FG000|Overall Study|Prohibited Medication|0|||
142990634|NCT00723489|515501428|FG001|Overall Study|Prohibited Medication|0|||
142990635|NCT00723489|515501429|FG002|Overall Study|Prohibited Medication|0|||
142990636|NCT00723489|515501430|FG003|Overall Study|Prohibited Medication|1|||
142990637|NCT00723489|515501427|FG000|Overall Study|Samples Collected Out of Window|0|||
142990638|NCT00723489|515501428|FG001|Overall Study|Samples Collected Out of Window|3|||
142990639|NCT00723489|515501429|FG002|Overall Study|Samples Collected Out of Window|0|||
142990640|NCT00723489|515501430|FG003|Overall Study|Samples Collected Out of Window|0|||
142990641|NCT05298774|515501433|FG000|Overall Study|Physician Decision|3|||
142990642|NCT05298774|515501433|FG000|Overall Study|Withdrawal by Subject|2|||
142990643|NCT05298774|515501433|FG000|Overall Study|Lost to Follow-up|3|||
142990644|NCT05298774|515501433|FG000|Overall Study|Screen failure|1|||
142990645|NCT04564027|515501435|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
142990646|NCT04564027|515501436|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
142990647|NCT04564027|515501437|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
142990648|NCT04564027|515501438|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
142990649|NCT01267955|515501441|FG000|Stage 1 (6 Months)|Death|3|||
142990650|NCT01267955|515501441|FG000|Stage 2 (6 Months)|Death|5|||
142990651|NCT01267955|515501441|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
142990652|NCT05564039|515501442|FG000|Overall Study|Adverse Event|1|||
142990653|NCT05564039|515501443|FG001|Overall Study|Adverse Event|0|||
142990654|NCT05564039|515501442|FG000|Overall Study|Death|1|||
142990655|NCT05564039|515501443|FG001|Overall Study|Death|1|||
142990656|NCT05564039|515501442|FG000|Overall Study|Lost to Follow-up|3|||
142990657|NCT05564039|515501443|FG001|Overall Study|Lost to Follow-up|2|||
142990658|NCT05564039|515501442|FG000|Overall Study|Withdrawal by Subject|2|||
142990659|NCT05564039|515501443|FG001|Overall Study|Withdrawal by Subject|0|||
142990660|NCT05564039|515501442|FG000|Overall Study|Inadvertent enrollment|3|||
142990661|NCT05564039|515501443|FG001|Overall Study|Inadvertent enrollment|6|||
142990662|NCT04785144|515501444|FG000|Overall Study|Withdrawal by Subject|4|||
142990663|NCT04785144|515501445|FG001|Overall Study|Withdrawal by Subject|1|||
142990664|NCT04785144|515501446|FG002|Overall Study|Withdrawal by Subject|0|||
142990665|NCT04785144|515501447|FG003|Overall Study|Withdrawal by Subject|0|||
142990666|NCT04785144|515501448|FG004|Overall Study|Withdrawal by Subject|0|||
142990667|NCT04785144|515501449|FG005|Overall Study|Withdrawal by Subject|2|||
142990668|NCT04785144|515501450|FG006|Overall Study|Withdrawal by Subject|2|||
142990669|NCT04785144|515501451|FG007|Overall Study|Withdrawal by Subject|0|||
142990670|NCT04785144|515501452|FG008|Overall Study|Withdrawal by Subject|1|||
142990671|NCT04785144|515501453|FG009|Overall Study|Withdrawal by Subject|0|||
142990672|NCT04785144|515501444|FG000|Overall Study|Lost to Follow-up|1|||
142990673|NCT04785144|515501445|FG001|Overall Study|Lost to Follow-up|0|||
142990674|NCT04785144|515501446|FG002|Overall Study|Lost to Follow-up|0|||
142990675|NCT04785144|515501447|FG003|Overall Study|Lost to Follow-up|0|||
142990676|NCT04785144|515501448|FG004|Overall Study|Lost to Follow-up|1|||
142990677|NCT04785144|515501449|FG005|Overall Study|Lost to Follow-up|2|||
142990678|NCT04785144|515501450|FG006|Overall Study|Lost to Follow-up|1|||
142990679|NCT04785144|515501451|FG007|Overall Study|Lost to Follow-up|2|||
142990680|NCT04785144|515501452|FG008|Overall Study|Lost to Follow-up|4|||
142990681|NCT04785144|515501453|FG009|Overall Study|Lost to Follow-up|1|||
142990682|NCT04785144|515501444|FG000|Overall Study|Protocol Violation|0|||
142990683|NCT04785144|515501445|FG001|Overall Study|Protocol Violation|0|||
142990684|NCT04785144|515501446|FG002|Overall Study|Protocol Violation|0|||
142990685|NCT04785144|515501447|FG003|Overall Study|Protocol Violation|0|||
142990686|NCT04785144|515501448|FG004|Overall Study|Protocol Violation|0|||
142990687|NCT04785144|515501449|FG005|Overall Study|Protocol Violation|0|||
142990688|NCT04785144|515501450|FG006|Overall Study|Protocol Violation|1|||
142990689|NCT04785144|515501451|FG007|Overall Study|Protocol Violation|0|||
142990690|NCT04785144|515501452|FG008|Overall Study|Protocol Violation|0|||
142990691|NCT04785144|515501453|FG009|Overall Study|Protocol Violation|0|||
142990692|NCT04785144|515501444|FG000|Overall Study|Physician Decision|0|||
142990693|NCT04785144|515501445|FG001|Overall Study|Physician Decision|0|||
142990694|NCT04785144|515501446|FG002|Overall Study|Physician Decision|0|||
142990695|NCT04785144|515501447|FG003|Overall Study|Physician Decision|0|||
142990696|NCT04785144|515501448|FG004|Overall Study|Physician Decision|0|||
142990697|NCT04785144|515501449|FG005|Overall Study|Physician Decision|0|||
142990698|NCT04785144|515501450|FG006|Overall Study|Physician Decision|0|||
142990699|NCT04785144|515501451|FG007|Overall Study|Physician Decision|0|||
142990700|NCT04785144|515501452|FG008|Overall Study|Physician Decision|0|||
142990701|NCT04785144|515501453|FG009|Overall Study|Physician Decision|1|||
142990702|NCT04785144|515501444|FG000|Overall Study|Unable to continue due to work schedule|0|||
142990703|NCT04785144|515501445|FG001|Overall Study|Unable to continue due to work schedule|0|||
142990704|NCT04785144|515501446|FG002|Overall Study|Unable to continue due to work schedule|0|||
142990705|NCT04785144|515501447|FG003|Overall Study|Unable to continue due to work schedule|0|||
142990706|NCT04785144|515501448|FG004|Overall Study|Unable to continue due to work schedule|0|||
142990707|NCT04785144|515501449|FG005|Overall Study|Unable to continue due to work schedule|0|||
142990708|NCT04785144|515501450|FG006|Overall Study|Unable to continue due to work schedule|0|||
142990709|NCT04785144|515501451|FG007|Overall Study|Unable to continue due to work schedule|0|||
142990710|NCT04785144|515501452|FG008|Overall Study|Unable to continue due to work schedule|0|||
142990711|NCT04785144|515501453|FG009|Overall Study|Unable to continue due to work schedule|1|||
142990712|NCT01327573|515501454|FG000|Overall Study|Physician Decision|3|||
142990713|NCT01327573|515501455|FG001|Overall Study|Physician Decision|1|||
142990714|NCT00712712|515501456|FG000|Overall Study|Protocol Violation|11|||
142990715|NCT00712712|515501456|FG000|Overall Study|Radiofrequency not done|3|||
142990716|NCT00712712|515501456|FG000|Overall Study|Death|8|||
142990717|NCT00712712|515501456|FG000|Overall Study|Withdrawal by Subject|1|||
142990718|NCT03662789|515501457|FG000|Overall Study|Lost to Follow-up|1|||
142990719|NCT03662789|515501458|FG001|Overall Study|Lost to Follow-up|2|||
142990720|NCT03662789|515501457|FG000|Overall Study|Could not perform treadmill test|4|||
142990721|NCT03662789|515501458|FG001|Overall Study|Could not perform treadmill test|4|||
142990722|NCT03662789|515501457|FG000|Overall Study|Death|0|||
142990723|NCT03662789|515501458|FG001|Overall Study|Death|1|||
142990724|NCT05245071|515501461|FG000|Overall Study|Progressive disease|18|||
142990725|NCT05245071|515501461|FG000|Overall Study|Adverse event not related to Coronavirus Disease 2019|2|||
142990726|NCT05245071|515501461|FG000|Overall Study|Not related to Coronavirus Disease 2019|2|||
142990727|NCT02354690|515501462|FG000|Overall Study|Physician Decision|1|||
142990728|NCT00963820|515501463|FG000|Dose Escalation Phase|Progressive Disease|3|||
142990729|NCT00963820|515501464|FG001|Dose Escalation Phase|Progressive Disease|3|||
142990730|NCT00963820|515501465|FG002|Dose Escalation Phase|Progressive Disease|3|||
142990731|NCT00963820|515501466|FG003|Dose Escalation Phase|Progressive Disease|3|||
142990732|NCT00963820|515501467|FG004|Dose Escalation Phase|Progressive Disease|4|||
142990733|NCT00963820|515501468|FG005|Dose Escalation Phase|Progressive Disease|3|||
142990734|NCT00963820|515501469|FG006|Dose Escalation Phase|Progressive Disease|3|||
142990735|NCT00963820|515501470|FG007|Dose Escalation Phase|Progressive Disease|2|||
142990736|NCT00963820|515501471|FG008|Dose Escalation Phase|Progressive Disease|0|||
142990737|NCT00963820|515501472|FG009|Dose Escalation Phase|Progressive Disease|0|||
142990738|NCT00963820|515501473|FG010|Dose Escalation Phase|Progressive Disease|0|||
142990739|NCT00963820|515501474|FG011|Dose Escalation Phase|Progressive Disease|0|||
142990740|NCT00963820|515501463|FG000|Dose Escalation Phase|Adverse Event|0|||
142990741|NCT00963820|515501464|FG001|Dose Escalation Phase|Adverse Event|0|||
142990742|NCT00963820|515501465|FG002|Dose Escalation Phase|Adverse Event|0|||
142990743|NCT00963820|515501466|FG003|Dose Escalation Phase|Adverse Event|0|||
142990744|NCT00963820|515501467|FG004|Dose Escalation Phase|Adverse Event|0|||
142990745|NCT00963820|515501468|FG005|Dose Escalation Phase|Adverse Event|0|||
142990746|NCT00963820|515501469|FG006|Dose Escalation Phase|Adverse Event|3|||
142990747|NCT00963820|515501470|FG007|Dose Escalation Phase|Adverse Event|1|||
142990748|NCT00963820|515501471|FG008|Dose Escalation Phase|Adverse Event|0|||
142990749|NCT00963820|515501472|FG009|Dose Escalation Phase|Adverse Event|0|||
142990750|NCT00963820|515501473|FG010|Dose Escalation Phase|Adverse Event|0|||
142990751|NCT00963820|515501474|FG011|Dose Escalation Phase|Adverse Event|0|||
142990752|NCT00963820|515501463|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
142990753|NCT00963820|515501464|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
142990754|NCT00963820|515501465|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
142990755|NCT00963820|515501466|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
142990756|NCT00963820|515501467|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
142990757|NCT00963820|515501468|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
142990758|NCT00963820|515501469|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
142990759|NCT00963820|515501470|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
142990760|NCT00963820|515501471|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
142990761|NCT00963820|515501472|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
142990762|NCT00963820|515501473|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
142990763|NCT00963820|515501474|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
142990764|NCT00963820|515501463|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
142990765|NCT00963820|515501464|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
142990766|NCT00963820|515501465|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
142990767|NCT00963820|515501466|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
142990768|NCT00963820|515501467|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
142990769|NCT00963820|515501468|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
142990770|NCT00963820|515501469|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
142990771|NCT00963820|515501470|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
142990772|NCT00963820|515501471|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
142990773|NCT00963820|515501472|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
142990774|NCT00963820|515501473|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
142990775|NCT00963820|515501474|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
142990776|NCT00963820|515501463|FG000|Expansion Phase|Progressive Disease|0|||
142990777|NCT00963820|515501464|FG001|Expansion Phase|Progressive Disease|0|||
142990778|NCT00963820|515501465|FG002|Expansion Phase|Progressive Disease|0|||
142990779|NCT00963820|515501466|FG003|Expansion Phase|Progressive Disease|0|||
142990780|NCT00963820|515501467|FG004|Expansion Phase|Progressive Disease|0|||
142990781|NCT00963820|515501468|FG005|Expansion Phase|Progressive Disease|0|||
142990782|NCT00963820|515501469|FG006|Expansion Phase|Progressive Disease|0|||
142990783|NCT00963820|515501470|FG007|Expansion Phase|Progressive Disease|0|||
142990784|NCT00963820|515501471|FG008|Expansion Phase|Progressive Disease|8|||
142990785|NCT00963820|515501472|FG009|Expansion Phase|Progressive Disease|6|||
142990786|NCT00963820|515501473|FG010|Expansion Phase|Progressive Disease|4|||
142990787|NCT00963820|515501474|FG011|Expansion Phase|Progressive Disease|2|||
142990788|NCT00963820|515501463|FG000|Expansion Phase|Adverse Event|0|||
142990789|NCT00963820|515501464|FG001|Expansion Phase|Adverse Event|0|||
142990790|NCT00963820|515501465|FG002|Expansion Phase|Adverse Event|0|||
142990791|NCT00963820|515501466|FG003|Expansion Phase|Adverse Event|0|||
142990792|NCT00963820|515501467|FG004|Expansion Phase|Adverse Event|0|||
142990793|NCT00963820|515501468|FG005|Expansion Phase|Adverse Event|0|||
142990794|NCT00963820|515501469|FG006|Expansion Phase|Adverse Event|0|||
142990795|NCT00963820|515501470|FG007|Expansion Phase|Adverse Event|0|||
142990796|NCT00963820|515501471|FG008|Expansion Phase|Adverse Event|1|||
142990797|NCT00963820|515501472|FG009|Expansion Phase|Adverse Event|3|||
142990798|NCT00963820|515501473|FG010|Expansion Phase|Adverse Event|0|||
142990799|NCT00963820|515501474|FG011|Expansion Phase|Adverse Event|0|||
142990800|NCT00963820|515501463|FG000|Expansion Phase|Withdrawal by Subject|0|||
142990801|NCT00963820|515501464|FG001|Expansion Phase|Withdrawal by Subject|0|||
142990802|NCT00963820|515501465|FG002|Expansion Phase|Withdrawal by Subject|0|||
142990803|NCT00963820|515501466|FG003|Expansion Phase|Withdrawal by Subject|0|||
142990804|NCT00963820|515501467|FG004|Expansion Phase|Withdrawal by Subject|0|||
142990805|NCT00963820|515501468|FG005|Expansion Phase|Withdrawal by Subject|0|||
142990806|NCT00963820|515501469|FG006|Expansion Phase|Withdrawal by Subject|0|||
142990807|NCT00963820|515501470|FG007|Expansion Phase|Withdrawal by Subject|0|||
142990808|NCT00963820|515501471|FG008|Expansion Phase|Withdrawal by Subject|1|||
142990809|NCT00963820|515501472|FG009|Expansion Phase|Withdrawal by Subject|0|||
142990810|NCT00963820|515501473|FG010|Expansion Phase|Withdrawal by Subject|1|||
142990811|NCT00963820|515501474|FG011|Expansion Phase|Withdrawal by Subject|1|||
142990812|NCT00963820|515501463|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
142990813|NCT00963820|515501464|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
142990814|NCT00963820|515501465|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
142990815|NCT00963820|515501466|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
142990816|NCT00963820|515501467|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
142990817|NCT00963820|515501468|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
142990818|NCT00963820|515501469|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
142990819|NCT00963820|515501470|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
142990820|NCT00963820|515501471|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
142990821|NCT00963820|515501472|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
142990822|NCT00963820|515501473|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
142990823|NCT00963820|515501474|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
142990824|NCT04556175|515501482|FG000|Overall Study|Study terminated due to COVID-19|8|||
142990825|NCT04556175|515501483|FG001|Overall Study|Study terminated due to COVID-19|8|||
142990826|NCT05549505|515501485|FG000|Overall Study|Lost to Follow-up|2|||
142990827|NCT05549505|515501486|FG001|Overall Study|Lost to Follow-up|0|||
142990828|NCT05549505|515501485|FG000|Overall Study|Withdrawal by Subject|3|||
142990829|NCT05549505|515501486|FG001|Overall Study|Withdrawal by Subject|3|||
142990830|NCT05549505|515501485|FG000|Overall Study|Other: Miscellaneous|3|||
142990831|NCT05549505|515501486|FG001|Overall Study|Other: Miscellaneous|6|||
142990832|NCT05492877|515501487|FG000|Overall Study|Adverse Event|11|||
142990833|NCT05492877|515501488|FG001|Overall Study|Adverse Event|7|||
142990834|NCT05492877|515501487|FG000|Overall Study|Death|1|||
142990835|NCT05492877|515501488|FG001|Overall Study|Death|0|||
142990836|NCT05492877|515501487|FG000|Overall Study|Lost to Follow-up|1|||
142990837|NCT05492877|515501488|FG001|Overall Study|Lost to Follow-up|1|||
142990838|NCT05492877|515501487|FG000|Overall Study|Physician Decision|1|||
142990839|NCT05492877|515501488|FG001|Overall Study|Physician Decision|2|||
142990840|NCT05492877|515501487|FG000|Overall Study|Protocol Violation|1|||
142990841|NCT05492877|515501488|FG001|Overall Study|Protocol Violation|1|||
142990842|NCT05492877|515501487|FG000|Overall Study|Withdrawal by Subject|3|||
142990843|NCT05492877|515501488|FG001|Overall Study|Withdrawal by Subject|7|||
142990844|NCT05492877|515501487|FG000|Overall Study|Reason not specified|6|||
142990845|NCT05492877|515501488|FG001|Overall Study|Reason not specified|4|||
142990846|NCT01426009|515501490|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
142990847|NCT01426009|515501490|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
142990848|NCT01426009|515501490|FG000|Washout 1|Withdrawal by Subject|1|||
142990849|NCT01426009|515501490|FG000|Washout 1|Personal Reasons|1|||
142990850|NCT01426009|515501490|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
142990851|NCT01426009|515501490|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
142990852|NCT01426009|515501490|FG000|Washout 2|electrive surgery|1|||
142990853|NCT01426009|515501490|FG000|Washout 3|personal reasons|1|||
142990854|NCT01426009|515501490|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
142990855|NCT01426009|515501490|FG000|Washout 4|Lost to Follow-up|1|||
142990856|NCT00572728|515501499|FG000|Overall Study|Withdrawal by Subject|10|||
142990857|NCT00572728|515501499|FG000|Overall Study|Ineligible|3|||
142990858|NCT00572728|515501499|FG000|Overall Study|Enrolled under Amendment 4|5|||
142990859|NCT00572728|515501499|FG000|Overall Study|Offstudy due to complicating disease|1|||
142990860|NCT00572728|515501499|FG000|Overall Study|FLT1 not completed|4|||
142990861|NCT00572728|515501499|FG000|Overall Study|First Chemotherapy not initiated|2|||
142990862|NCT00572728|515501499|FG000|Overall Study|FLT2 not completed|5|||
142990863|NCT00572728|515501499|FG000|Overall Study|Second chemotherapy not initiated|1|||
142990864|NCT00572728|515501499|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
142990865|NCT00572728|515501499|FG000|Overall Study|Pathology missing|1|||
142990866|NCT00126425|515501503|FG000|Overall Study|Withdrawal by Subject|17|||
142990867|NCT00126425|515501504|FG001|Overall Study|Withdrawal by Subject|1|||
142990868|NCT00126425|515501503|FG000|Overall Study|Lost to Follow-up|8|||
142990869|NCT00126425|515501504|FG001|Overall Study|Lost to Follow-up|4|||
142990870|NCT00126425|515501503|FG000|Overall Study|Protocol Violation|9|||
142990871|NCT00126425|515501504|FG001|Overall Study|Protocol Violation|6|||
142990872|NCT00126425|515501503|FG000|Overall Study|Adverse Event|1|||
142990873|NCT00126425|515501504|FG001|Overall Study|Adverse Event|0|||
142990874|NCT00126425|515501503|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
142990875|NCT00126425|515501504|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
142990876|NCT00126425|515501503|FG000|Overall Study|Other|5|||
142990877|NCT00126425|515501504|FG001|Overall Study|Other|0|||
142990878|NCT02332876|515501505|FG000|Overall Study|Lost to Follow-up|1|||
142990879|NCT02332876|515501506|FG001|Overall Study|Lost to Follow-up|1|||
142990880|NCT02614261|515501507|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
142990881|NCT02614261|515501508|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
142990882|NCT02614261|515501509|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
142990883|NCT02614261|515501510|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
142990884|NCT02614261|515501507|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
142990885|NCT02614261|515501508|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
142990886|NCT02614261|515501509|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
142990887|NCT02614261|515501510|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
142990888|NCT02614261|515501507|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
142990889|NCT02614261|515501508|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
142990890|NCT02614261|515501509|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
142990891|NCT02614261|515501510|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
142990892|NCT02614261|515501507|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
142990893|NCT02614261|515501508|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
142990894|NCT02614261|515501509|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
142990895|NCT02614261|515501510|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
142990896|NCT02614261|515501507|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
142990897|NCT02614261|515501508|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
142990898|NCT02614261|515501509|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
142990899|NCT02614261|515501510|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
142990900|NCT02614261|515501507|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
142990901|NCT02614261|515501508|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
142990902|NCT02614261|515501509|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
142990903|NCT02614261|515501510|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
142990904|NCT02614261|515501507|FG000|Double-Blind Treatment Phase|Screen failure|0|||
142990905|NCT02614261|515501508|FG001|Double-Blind Treatment Phase|Screen failure|1|||
142990906|NCT02614261|515501509|FG002|Double-Blind Treatment Phase|Screen failure|2|||
142990907|NCT02614261|515501510|FG003|Double-Blind Treatment Phase|Screen failure|0|||
142990908|NCT02614261|515501507|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
142990909|NCT02614261|515501508|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
142990910|NCT02614261|515501509|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
142990911|NCT02614261|515501510|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
142990912|NCT02614261|515501507|FG000|Open-Label Extension Phase|Adverse Event|23|||
142990913|NCT02614261|515501508|FG001|Open-Label Extension Phase|Adverse Event|12|||
142990914|NCT02614261|515501509|FG002|Open-Label Extension Phase|Adverse Event|11|||
142990915|NCT02614261|515501510|FG003|Open-Label Extension Phase|Adverse Event|0|||
142990916|NCT02614261|515501507|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
142990917|NCT02614261|515501508|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
142990918|NCT02614261|515501509|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
142990919|NCT02614261|515501510|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
142990920|NCT02614261|515501507|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
142990921|NCT02614261|515501508|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
142990922|NCT02614261|515501509|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
142990923|NCT02614261|515501510|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
142990924|NCT02614261|515501507|FG000|Open-Label Extension Phase|Physician Decision|2|||
142990925|NCT02614261|515501508|FG001|Open-Label Extension Phase|Physician Decision|0|||
142990926|NCT02614261|515501509|FG002|Open-Label Extension Phase|Physician Decision|0|||
142990927|NCT02614261|515501510|FG003|Open-Label Extension Phase|Physician Decision|0|||
142990928|NCT02614261|515501507|FG000|Open-Label Extension Phase|Pregnancy|1|||
142990929|NCT02614261|515501508|FG001|Open-Label Extension Phase|Pregnancy|2|||
142990930|NCT02614261|515501509|FG002|Open-Label Extension Phase|Pregnancy|1|||
142990931|NCT02614261|515501510|FG003|Open-Label Extension Phase|Pregnancy|0|||
142990932|NCT02614261|515501507|FG000|Open-Label Extension Phase|Protocol Violation|3|||
142990933|NCT02614261|515501508|FG001|Open-Label Extension Phase|Protocol Violation|4|||
142990934|NCT02614261|515501509|FG002|Open-Label Extension Phase|Protocol Violation|1|||
142990935|NCT02614261|515501510|FG003|Open-Label Extension Phase|Protocol Violation|0|||
142990936|NCT02614261|515501507|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
142990937|NCT02614261|515501508|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
142990938|NCT02614261|515501509|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
142990939|NCT02614261|515501510|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
142990940|NCT02614261|515501507|FG000|Follow-up Phase|Adverse Event|2|||
142990941|NCT02614261|515501508|FG001|Follow-up Phase|Adverse Event|0|||
142990942|NCT02614261|515501509|FG002|Follow-up Phase|Adverse Event|1|||
142990943|NCT02614261|515501510|FG003|Follow-up Phase|Adverse Event|0|||
142990944|NCT02614261|515501507|FG000|Follow-up Phase|Lost to Follow-up|12|||
142990945|NCT02614261|515501508|FG001|Follow-up Phase|Lost to Follow-up|5|||
142990946|NCT02614261|515501509|FG002|Follow-up Phase|Lost to Follow-up|2|||
142990947|NCT02614261|515501510|FG003|Follow-up Phase|Lost to Follow-up|0|||
142990948|NCT02614261|515501507|FG000|Follow-up Phase|Physician Decision|5|||
142990949|NCT02614261|515501508|FG001|Follow-up Phase|Physician Decision|1|||
142990950|NCT02614261|515501509|FG002|Follow-up Phase|Physician Decision|0|||
142990951|NCT02614261|515501510|FG003|Follow-up Phase|Physician Decision|0|||
142990952|NCT02614261|515501507|FG000|Follow-up Phase|Pregnancy|0|||
142990953|NCT02614261|515501508|FG001|Follow-up Phase|Pregnancy|1|||
142990954|NCT02614261|515501509|FG002|Follow-up Phase|Pregnancy|0|||
142990955|NCT02614261|515501510|FG003|Follow-up Phase|Pregnancy|0|||
142990956|NCT02614261|515501507|FG000|Follow-up Phase|Protocol Violation|1|||
142990957|NCT02614261|515501508|FG001|Follow-up Phase|Protocol Violation|0|||
142990958|NCT02614261|515501509|FG002|Follow-up Phase|Protocol Violation|0|||
142990959|NCT02614261|515501510|FG003|Follow-up Phase|Protocol Violation|0|||
142990960|NCT02614261|515501507|FG000|Follow-up Phase|Withdrawal by Subject|12|||
142990961|NCT02614261|515501508|FG001|Follow-up Phase|Withdrawal by Subject|4|||
142990962|NCT02614261|515501509|FG002|Follow-up Phase|Withdrawal by Subject|11|||
142990963|NCT02614261|515501510|FG003|Follow-up Phase|Withdrawal by Subject|0|||
142990964|NCT02614261|515501507|FG000|Israel Addendum|Withdrawal by Subject|0|||
142990965|NCT02614261|515501508|FG001|Israel Addendum|Withdrawal by Subject|0|||
142990966|NCT02614261|515501509|FG002|Israel Addendum|Withdrawal by Subject|0|||
142990967|NCT02614261|515501510|FG003|Israel Addendum|Withdrawal by Subject|4|||
142990968|NCT03128307|515501516|FG000|Overall Study|Lost to Follow-up|29|||
142990969|NCT03128307|515501516|FG000|Overall Study|Withdrawal by Subject|5|||
142990970|NCT02499172|515503697|FG000|Overall Study|Financial reason|0|||
142990971|NCT02499172|515503698|FG001|Overall Study|Financial reason|0|||
142990972|NCT02499172|515503699|FG002|Overall Study|Financial reason|523|||
142990973|NCT02499172|515503700|FG003|Overall Study|Financial reason|436|||
142990974|NCT02499172|515503697|FG000|Overall Study|Lost to Follow-up|65|||
142990975|NCT02499172|515503698|FG001|Overall Study|Lost to Follow-up|64|||
142990976|NCT02499172|515503699|FG002|Overall Study|Lost to Follow-up|0|||
142990977|NCT02499172|515503700|FG003|Overall Study|Lost to Follow-up|0|||
142990978|NCT01293123|515503701|FG000|Overall Study|Lost to Follow-up|0|||
142990979|NCT01293123|515503702|FG001|Overall Study|Lost to Follow-up|1|||
142990980|NCT00121485|515503703|FG000|Overall Study|Not implanted|1|||
142990981|NCT00121485|515503704|FG001|Overall Study|Not implanted|5|||
142990982|NCT00121485|515503703|FG000|Overall Study|Crossover|0|||
142990983|NCT00121485|515503704|FG001|Overall Study|Crossover|2|||
142990984|NCT02608099|515503710|FG000|Overall Study|Ablation procedure not initiated|3|||
142990985|NCT02608099|515503711|FG001|Overall Study|Ablation procedure not initiated|2|||
142990986|NCT01952041|515503712|FG000|Overall Study|Lost to Follow-up|9|||
142990987|NCT01952041|515503713|FG001|Overall Study|Lost to Follow-up|16|||
142990988|NCT01952041|515503712|FG000|Overall Study|Withdrawal by Subject|7|||
142990989|NCT01952041|515503713|FG001|Overall Study|Withdrawal by Subject|5|||
142990990|NCT01952041|515503712|FG000|Overall Study|Death|1|||
142990991|NCT01952041|515503713|FG001|Overall Study|Death|0|||
142990992|NCT03650387|515503714|FG000|Overall Study|Withdrawal by Subject|13|||
142990993|NCT03650387|515503714|FG000|Overall Study|Lost to Follow-up|12|||
142990994|NCT03650387|515503714|FG000|Overall Study|Adverse Event (Not related)|1|||
142990995|NCT03650387|515503714|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
142990996|NCT00417248|515503715|FG000|Overall Study|Study Terminated|6|||
142990997|NCT00417248|515503715|FG000|Overall Study|Death|1|||
142990998|NCT00417248|515503715|FG000|Overall Study|Lack of Efficacy|1|||
142990999|NCT02425891|515503717|FG000|Overall Study|Death|333|||
142991000|NCT02425891|515503718|FG001|Overall Study|Death|314|||
142991001|NCT02425891|515503717|FG000|Overall Study|Lost to Follow-up|4|||
142991002|NCT02425891|515503718|FG001|Overall Study|Lost to Follow-up|6|||
142991003|NCT02425891|515503717|FG000|Overall Study|Non-Compliance|1|||
142991004|NCT02425891|515503718|FG001|Overall Study|Non-Compliance|1|||
142991005|NCT02425891|515503717|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
142991006|NCT02425891|515503718|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
142991007|NCT02425891|515503717|FG000|Overall Study|Physician Decision|0|||
142991008|NCT02425891|515503718|FG001|Overall Study|Physician Decision|1|||
142991009|NCT02425891|515503717|FG000|Overall Study|Protocol Violation|1|||
142991010|NCT02425891|515503718|FG001|Overall Study|Protocol Violation|1|||
142991011|NCT02425891|515503717|FG000|Overall Study|Study Terminated By Sponsor|85|||
142991012|NCT02425891|515503718|FG001|Overall Study|Study Terminated By Sponsor|95|||
142991013|NCT02425891|515503717|FG000|Overall Study|Withdrawal by Subject|27|||
142991014|NCT02425891|515503718|FG001|Overall Study|Withdrawal by Subject|32|||
142991015|NCT01654224|515503722|FG000|Overall Study|Lost to Follow-up|2|||
142991016|NCT01654224|515503723|FG001|Overall Study|Lost to Follow-up|2|||
142991017|NCT01654224|515503722|FG000|Overall Study|Did not receive allocation|1|||
142991018|NCT01654224|515503723|FG001|Overall Study|Did not receive allocation|8|||
142991019|NCT01654224|515503722|FG000|Overall Study|Insufficient blood sample|3|||
142991020|NCT01654224|515503723|FG001|Overall Study|Insufficient blood sample|2|||
142991021|NCT03763942|515503724|FG000|Overall Study|Lost to Follow-up|114|||
142991022|NCT03763942|515503725|FG001|Overall Study|Lost to Follow-up|54|||
142991023|NCT03763942|515503724|FG000|Overall Study|Protocol Violation|1|||
142991024|NCT03763942|515503725|FG001|Overall Study|Protocol Violation|0|||
142991025|NCT03763942|515503724|FG000|Overall Study|Withdrawal by Subject|2|||
142991026|NCT03763942|515503725|FG001|Overall Study|Withdrawal by Subject|0|||
142991027|NCT03763942|515503724|FG000|Overall Study|Other|2|||
142991028|NCT03763942|515503725|FG001|Overall Study|Other|3|||
142991029|NCT00166504|515503726|FG000|Overall Study|Adverse Event|3|||
142991030|NCT00166504|515503727|FG001|Overall Study|Adverse Event|3|||
142991031|NCT00166504|515503726|FG000|Overall Study|Lost to Follow-up|1|||
142991032|NCT00166504|515503727|FG001|Overall Study|Lost to Follow-up|1|||
142991033|NCT00166504|515503726|FG000|Overall Study|Withdrawal by Subject|1|||
142991034|NCT00166504|515503727|FG001|Overall Study|Withdrawal by Subject|0|||
142991035|NCT02274311|515503728|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
142991036|NCT00081263|515503729|FG000|Overall Study|clerical error|1|||
142991037|NCT00081263|515503730|FG001|Overall Study|clerical error|0|||
142991038|NCT00081263|515503729|FG000|Overall Study|wrong cell type|7|||
142991039|NCT00081263|515503730|FG001|Overall Study|wrong cell type|5|||
142991040|NCT00081263|515503729|FG000|Overall Study|improper pre-protocol therapy|0|||
142991041|NCT00081263|515503730|FG001|Overall Study|improper pre-protocol therapy|1|||
142991042|NCT00081263|515503729|FG000|Overall Study|Inadequate pathology|0|||
142991043|NCT00081263|515503730|FG001|Overall Study|Inadequate pathology|1|||
142991044|NCT00081263|515503729|FG000|Overall Study|Never treated|4|||
142991045|NCT00081263|515503730|FG001|Overall Study|Never treated|5|||
142991046|NCT00081263|515503729|FG000|Overall Study|Inadequate data|5|||
142991047|NCT00081263|515503730|FG001|Overall Study|Inadequate data|10|||
142991048|NCT00777036|515503739|FG000|On Treatment|Reached 18 years of age and transitioned to commercial drug|13|||
142991049|NCT00777036|515503740|FG001|On Treatment|Reached 18 years of age and transitioned to commercial drug|7|||
142991050|NCT00777036|515503741|FG002|On Treatment|Reached 18 years of age and transitioned to commercial drug|42|||
142991051|NCT00777036|515503742|FG003|On Treatment|Reached 18 years of age and transitioned to commercial drug|0|||
142991052|NCT00777036|515503739|FG000|On Treatment|Administrative Reason By Sponsor|1|||
142991053|NCT00777036|515503740|FG001|On Treatment|Administrative Reason By Sponsor|0|||
142991054|NCT00777036|515503741|FG002|On Treatment|Administrative Reason By Sponsor|9|||
142991055|NCT00777036|515503742|FG003|On Treatment|Administrative Reason By Sponsor|0|||
142991056|NCT00777036|515503739|FG000|On Treatment|Failure to Meet Study Criteria|0|||
142991057|NCT00777036|515503740|FG001|On Treatment|Failure to Meet Study Criteria|1|||
142991058|NCT00777036|515503741|FG002|On Treatment|Failure to Meet Study Criteria|4|||
142991059|NCT00777036|515503742|FG003|On Treatment|Failure to Meet Study Criteria|0|||
142991060|NCT00777036|515503739|FG000|On Treatment|Pregnancy|1|||
142991061|NCT00777036|515503740|FG001|On Treatment|Pregnancy|0|||
142991062|NCT00777036|515503741|FG002|On Treatment|Pregnancy|1|||
142991063|NCT00777036|515503742|FG003|On Treatment|Pregnancy|0|||
142991064|NCT00777036|515503739|FG000|On Treatment|Non-compliance with Study Drug|1|||
142991065|NCT00777036|515503740|FG001|On Treatment|Non-compliance with Study Drug|0|||
142991066|NCT00777036|515503741|FG002|On Treatment|Non-compliance with Study Drug|1|||
142991067|NCT00777036|515503742|FG003|On Treatment|Non-compliance with Study Drug|0|||
142991068|NCT00777036|515503739|FG000|On Treatment|Maximum Clinical Benefit|2|||
142991069|NCT00777036|515503740|FG001|On Treatment|Maximum Clinical Benefit|0|||
142991070|NCT00777036|515503741|FG002|On Treatment|Maximum Clinical Benefit|5|||
142991071|NCT00777036|515503742|FG003|On Treatment|Maximum Clinical Benefit|0|||
142991072|NCT00777036|515503739|FG000|On Treatment|Withdrawal by Subject|0|||
142991073|NCT00777036|515503740|FG001|On Treatment|Withdrawal by Subject|2|||
142991074|NCT00777036|515503741|FG002|On Treatment|Withdrawal by Subject|2|||
142991075|NCT00777036|515503742|FG003|On Treatment|Withdrawal by Subject|0|||
142991076|NCT00777036|515503739|FG000|On Treatment|Participant Request to Discontinue Study Treatment|4|||
142991077|NCT00777036|515503740|FG001|On Treatment|Participant Request to Discontinue Study Treatment|0|||
142991078|NCT00777036|515503741|FG002|On Treatment|Participant Request to Discontinue Study Treatment|6|||
142991079|NCT00777036|515503742|FG003|On Treatment|Participant Request to Discontinue Study Treatment|0|||
142991080|NCT00777036|515503739|FG000|On Treatment|Death|0|||
142991081|NCT00777036|515503740|FG001|On Treatment|Death|2|||
142991082|NCT00777036|515503741|FG002|On Treatment|Death|0|||
142991083|NCT00777036|515503742|FG003|On Treatment|Death|0|||
142991084|NCT00777036|515503739|FG000|On Treatment|Study Drug Toxicity|1|||
142991085|NCT00777036|515503740|FG001|On Treatment|Study Drug Toxicity|0|||
142991086|NCT00777036|515503741|FG002|On Treatment|Study Drug Toxicity|4|||
142991087|NCT00777036|515503742|FG003|On Treatment|Study Drug Toxicity|0|||
142991088|NCT00777036|515503739|FG000|On Treatment|Progressive Disease|6|||
142991089|NCT00777036|515503740|FG001|On Treatment|Progressive Disease|4|||
142991090|NCT00777036|515503741|FG002|On Treatment|Progressive Disease|7|||
142991091|NCT00777036|515503742|FG003|On Treatment|Progressive Disease|0|||
142991092|NCT00777036|515503739|FG000|On Treatment|Not Reported|0|||
142991093|NCT00777036|515503740|FG001|On Treatment|Not Reported|0|||
142991094|NCT00777036|515503741|FG002|On Treatment|Not Reported|2|||
142991095|NCT00777036|515503742|FG003|On Treatment|Not Reported|0|||
142991096|NCT00777036|515503739|FG000|On Treatment|Site Closed|0|||
142991097|NCT00777036|515503740|FG001|On Treatment|Site Closed|1|||
142991098|NCT00777036|515503741|FG002|On Treatment|Site Closed|1|||
142991099|NCT00777036|515503742|FG003|On Treatment|Site Closed|0|||
142991100|NCT00777036|515503739|FG000|Follow-Up|Withdrawal by Subject|0|||
142991101|NCT00777036|515503740|FG001|Follow-Up|Withdrawal by Subject|0|||
142991102|NCT00777036|515503741|FG002|Follow-Up|Withdrawal by Subject|5|||
142991103|NCT00777036|515503742|FG003|Follow-Up|Withdrawal by Subject|0|||
142991104|NCT00777036|515503739|FG000|Follow-Up|Death|1|||
142991105|NCT00777036|515503740|FG001|Follow-Up|Death|9|||
142991106|NCT00777036|515503741|FG002|Follow-Up|Death|0|||
142991107|NCT00777036|515503742|FG003|Follow-Up|Death|0|||
142991108|NCT00777036|515503739|FG000|Follow-Up|Lost to Follow-up|3|||
142991109|NCT00777036|515503740|FG001|Follow-Up|Lost to Follow-up|0|||
142991110|NCT00777036|515503741|FG002|Follow-Up|Lost to Follow-up|0|||
142991111|NCT00777036|515503742|FG003|Follow-Up|Lost to Follow-up|0|||
142991112|NCT00777036|515503739|FG000|Follow-Up|Reason Not Specified|4|||
142991113|NCT00777036|515503740|FG001|Follow-Up|Reason Not Specified|0|||
142991114|NCT00777036|515503741|FG002|Follow-Up|Reason Not Specified|13|||
142991115|NCT00777036|515503742|FG003|Follow-Up|Reason Not Specified|0|||
142991116|NCT00777036|515503739|FG000|Follow-Up|Missing - Administrative Reasons in Russia|1|||
142991117|NCT00777036|515503740|FG001|Follow-Up|Missing - Administrative Reasons in Russia|0|||
142991118|NCT00777036|515503741|FG002|Follow-Up|Missing - Administrative Reasons in Russia|4|||
142991119|NCT00777036|515503742|FG003|Follow-Up|Missing - Administrative Reasons in Russia|0|||
142991120|NCT05827978|515503743|FG000|Overall Study|Adverse Event|1|||
142991121|NCT05827978|515503744|FG001|Overall Study|Adverse Event|0|||
142991122|NCT05827978|515503745|FG002|Overall Study|Adverse Event|0|||
142991123|NCT05827978|515503746|FG003|Overall Study|Adverse Event|1|||
142991124|NCT05827978|515503747|FG004|Overall Study|Adverse Event|0|||
142991125|NCT05827978|515503748|FG005|Overall Study|Adverse Event|0|||
142991126|NCT05827978|515503743|FG000|Overall Study|Death|1|||
142991127|NCT05827978|515503744|FG001|Overall Study|Death|5|||
142991128|NCT05827978|515503745|FG002|Overall Study|Death|2|||
142991129|NCT05827978|515503746|FG003|Overall Study|Death|3|||
142991130|NCT05827978|515503747|FG004|Overall Study|Death|1|||
142991131|NCT05827978|515503748|FG005|Overall Study|Death|3|||
142991132|NCT05827978|515503743|FG000|Overall Study|Lost to Follow-up|57|||
142991133|NCT05827978|515503744|FG001|Overall Study|Lost to Follow-up|88|||
142991134|NCT05827978|515503745|FG002|Overall Study|Lost to Follow-up|54|||
142991135|NCT05827978|515503746|FG003|Overall Study|Lost to Follow-up|47|||
142991136|NCT05827978|515503747|FG004|Overall Study|Lost to Follow-up|25|||
142991137|NCT05827978|515503748|FG005|Overall Study|Lost to Follow-up|10|||
142991138|NCT05827978|515503743|FG000|Overall Study|Noncompliance with Study Procedures|0|||
142991139|NCT05827978|515503744|FG001|Overall Study|Noncompliance with Study Procedures|1|||
142991140|NCT05827978|515503745|FG002|Overall Study|Noncompliance with Study Procedures|1|||
142991141|NCT05827978|515503746|FG003|Overall Study|Noncompliance with Study Procedures|1|||
142991142|NCT05827978|515503747|FG004|Overall Study|Noncompliance with Study Procedures|1|||
142991143|NCT05827978|515503748|FG005|Overall Study|Noncompliance with Study Procedures|0|||
142991144|NCT05827978|515503743|FG000|Overall Study|Physician Decision|2|||
142991145|NCT05827978|515503744|FG001|Overall Study|Physician Decision|0|||
142991146|NCT05827978|515503745|FG002|Overall Study|Physician Decision|1|||
142991147|NCT05827978|515503746|FG003|Overall Study|Physician Decision|2|||
142991148|NCT05827978|515503747|FG004|Overall Study|Physician Decision|1|||
142991149|NCT05827978|515503748|FG005|Overall Study|Physician Decision|1|||
142991150|NCT05827978|515503743|FG000|Overall Study|Protocol Violation|5|||
142991151|NCT05827978|515503744|FG001|Overall Study|Protocol Violation|2|||
142991152|NCT05827978|515503745|FG002|Overall Study|Protocol Violation|0|||
142991153|NCT05827978|515503746|FG003|Overall Study|Protocol Violation|0|||
142991154|NCT05827978|515503747|FG004|Overall Study|Protocol Violation|0|||
142991155|NCT05827978|515503748|FG005|Overall Study|Protocol Violation|0|||
142991156|NCT05827978|515503743|FG000|Overall Study|Withdrawal by Subject|17|||
142991157|NCT05827978|515503744|FG001|Overall Study|Withdrawal by Subject|16|||
142991158|NCT05827978|515503745|FG002|Overall Study|Withdrawal by Subject|10|||
142991159|NCT05827978|515503746|FG003|Overall Study|Withdrawal by Subject|12|||
142991160|NCT05827978|515503747|FG004|Overall Study|Withdrawal by Subject|10|||
142991161|NCT05827978|515503748|FG005|Overall Study|Withdrawal by Subject|9|||
142991162|NCT05827978|515503743|FG000|Overall Study|Other Than Specified|0|||
142991163|NCT05827978|515503744|FG001|Overall Study|Other Than Specified|0|||
142991164|NCT05827978|515503745|FG002|Overall Study|Other Than Specified|1|||
142991165|NCT05827978|515503746|FG003|Overall Study|Other Than Specified|0|||
142991166|NCT05827978|515503747|FG004|Overall Study|Other Than Specified|2|||
142991167|NCT05827978|515503748|FG005|Overall Study|Other Than Specified|0|||
142991168|NCT04566445|515503749|FG000|Overall Study|Death|4|||
142991169|NCT04566445|515503750|FG001|Overall Study|Death|1|||
142991170|NCT04566445|515503751|FG002|Overall Study|Death|1|||
142991171|NCT04566445|515503749|FG000|Overall Study|Lost to Follow-up|3|||
142991172|NCT04566445|515503750|FG001|Overall Study|Lost to Follow-up|1|||
142991173|NCT04566445|515503751|FG002|Overall Study|Lost to Follow-up|1|||
142991174|NCT04566445|515503749|FG000|Overall Study|Study terminated by sponsor|11|||
142991175|NCT04566445|515503750|FG001|Overall Study|Study terminated by sponsor|17|||
142991176|NCT04566445|515503751|FG002|Overall Study|Study terminated by sponsor|32|||
142991177|NCT04566445|515503749|FG000|Overall Study|Withdrawal by Subject|12|||
142991178|NCT04566445|515503750|FG001|Overall Study|Withdrawal by Subject|14|||
142991179|NCT04566445|515503751|FG002|Overall Study|Withdrawal by Subject|13|||
142991180|NCT04566445|515503749|FG000|Overall Study|Randomized but not treated due to AE|2|||
142991181|NCT04566445|515503750|FG001|Overall Study|Randomized but not treated due to AE|1|||
142991182|NCT04566445|515503751|FG002|Overall Study|Randomized but not treated due to AE|0|||
142991183|NCT04566445|515503749|FG000|Overall Study|Adverse Event|1|||
142991184|NCT04566445|515503750|FG001|Overall Study|Adverse Event|1|||
142991185|NCT04566445|515503751|FG002|Overall Study|Adverse Event|0|||
142991186|NCT01263470|515503752|FG000|Overall Study|Adverse Event|2|||
142991187|NCT01263470|515503753|FG001|Overall Study|Adverse Event|2|||
142991188|NCT01263470|515503754|FG002|Overall Study|Adverse Event|1|||
142991189|NCT01263470|515503755|FG003|Overall Study|Adverse Event|1|||
142991190|NCT01263470|515503756|FG004|Overall Study|Adverse Event|2|||
142991191|NCT01263470|515503757|FG005|Overall Study|Adverse Event|2|||
142991192|NCT01263470|515503752|FG000|Overall Study|Protocol Violation|0|||
142991193|NCT01263470|515503753|FG001|Overall Study|Protocol Violation|1|||
142991194|NCT01263470|515503754|FG002|Overall Study|Protocol Violation|0|||
142991195|NCT01263470|515503755|FG003|Overall Study|Protocol Violation|0|||
142991196|NCT01263470|515503756|FG004|Overall Study|Protocol Violation|0|||
142991197|NCT01263470|515503757|FG005|Overall Study|Protocol Violation|1|||
142991198|NCT01263470|515503752|FG000|Overall Study|Withdrawal by Subject|0|||
142991199|NCT01263470|515503753|FG001|Overall Study|Withdrawal by Subject|1|||
142991200|NCT01263470|515503754|FG002|Overall Study|Withdrawal by Subject|1|||
142991201|NCT01263470|515503755|FG003|Overall Study|Withdrawal by Subject|2|||
142991202|NCT01263470|515503756|FG004|Overall Study|Withdrawal by Subject|0|||
142991203|NCT01263470|515503757|FG005|Overall Study|Withdrawal by Subject|2|||
142991204|NCT01263470|515503752|FG000|Overall Study|Lack of Efficacy|0|||
142991205|NCT01263470|515503753|FG001|Overall Study|Lack of Efficacy|0|||
142991206|NCT01263470|515503754|FG002|Overall Study|Lack of Efficacy|2|||
142991207|NCT01263470|515503755|FG003|Overall Study|Lack of Efficacy|0|||
142991208|NCT01263470|515503756|FG004|Overall Study|Lack of Efficacy|0|||
142991209|NCT01263470|515503757|FG005|Overall Study|Lack of Efficacy|0|||
142991210|NCT01263470|515503752|FG000|Overall Study|Participant Unavailability|0|||
142991211|NCT01263470|515503753|FG001|Overall Study|Participant Unavailability|1|||
142991212|NCT01263470|515503754|FG002|Overall Study|Participant Unavailability|0|||
142991213|NCT01263470|515503755|FG003|Overall Study|Participant Unavailability|0|||
142991214|NCT01263470|515503756|FG004|Overall Study|Participant Unavailability|0|||
142991215|NCT01263470|515503757|FG005|Overall Study|Participant Unavailability|0|||
142991216|NCT01263470|515503752|FG000|Overall Study|Study Drug Non-compliance|0|||
142991217|NCT01263470|515503753|FG001|Overall Study|Study Drug Non-compliance|0|||
142991218|NCT01263470|515503754|FG002|Overall Study|Study Drug Non-compliance|0|||
142991219|NCT01263470|515503755|FG003|Overall Study|Study Drug Non-compliance|0|||
142991220|NCT01263470|515503756|FG004|Overall Study|Study Drug Non-compliance|1|||
142991221|NCT01263470|515503757|FG005|Overall Study|Study Drug Non-compliance|0|||
142991222|NCT00610714|515503758|FG000|Overall Study|Adverse Event|3|||
142991223|NCT00610714|515503759|FG001|Overall Study|Adverse Event|1|||
142991224|NCT00610714|515503758|FG000|Overall Study|Death|12|||
142991225|NCT00610714|515503759|FG001|Overall Study|Death|18|||
142991226|NCT00610714|515503758|FG000|Overall Study|Withdrawal by Subject|9|||
142991227|NCT00610714|515503759|FG001|Overall Study|Withdrawal by Subject|3|||
142991228|NCT00610714|515503758|FG000|Overall Study|Study completion at 120 PFS events|2|||
142991229|NCT00610714|515503759|FG001|Overall Study|Study completion at 120 PFS events|2|||
142991230|NCT01108263|515503760|FG000|Overall Study|Adverse Event|0|||
142991231|NCT01108263|515503761|FG001|Overall Study|Adverse Event|1|||
142991232|NCT00729560|515503762|FG000|Overall Study|Withdrawal by Subject|3|||
142991233|NCT00829010|515503765|FG000|Overall Study|Adverse Event|1|||
142991234|NCT00829010|515503766|FG001|Overall Study|Adverse Event|0|||
142991235|NCT00829010|515503767|FG002|Overall Study|Adverse Event|0|||
142991236|NCT00829010|515503768|FG003|Overall Study|Adverse Event|0|||
142991237|NCT00829010|515503769|FG004|Overall Study|Adverse Event|0|||
142991238|NCT00829010|515503765|FG000|Overall Study|Withdrawal by Subject|0|||
142991239|NCT00829010|515503766|FG001|Overall Study|Withdrawal by Subject|1|||
142991240|NCT00829010|515503767|FG002|Overall Study|Withdrawal by Subject|1|||
142991241|NCT00829010|515503768|FG003|Overall Study|Withdrawal by Subject|0|||
142991242|NCT00829010|515503769|FG004|Overall Study|Withdrawal by Subject|2|||
142991243|NCT00829010|515503765|FG000|Overall Study|Lost to Follow-up|1|||
142991244|NCT00829010|515503766|FG001|Overall Study|Lost to Follow-up|0|||
142991245|NCT00829010|515503767|FG002|Overall Study|Lost to Follow-up|2|||
142991246|NCT00829010|515503768|FG003|Overall Study|Lost to Follow-up|0|||
142991247|NCT00829010|515503769|FG004|Overall Study|Lost to Follow-up|0|||
142991248|NCT00829010|515503765|FG000|Overall Study|Fatality|5|||
142991249|NCT00829010|515503766|FG001|Overall Study|Fatality|4|||
142991250|NCT00829010|515503767|FG002|Overall Study|Fatality|0|||
142991251|NCT00829010|515503768|FG003|Overall Study|Fatality|3|||
142991252|NCT00829010|515503769|FG004|Overall Study|Fatality|0|||
142991253|NCT00829010|515503765|FG000|Overall Study|Migrated/Moved from study area|3|||
142991254|NCT00829010|515503766|FG001|Overall Study|Migrated/Moved from study area|4|||
142991255|NCT00829010|515503767|FG002|Overall Study|Migrated/Moved from study area|0|||
142991256|NCT00829010|515503768|FG003|Overall Study|Migrated/Moved from study area|5|||
142991257|NCT00829010|515503769|FG004|Overall Study|Migrated/Moved from study area|0|||
142991258|NCT03598140|515503770|FG000|Overall Study|enrolled but didn't start|1|||
142991259|NCT03598140|515503771|FG001|Overall Study|enrolled but didn't start|0|||
142991260|NCT01029691|515503772|FG000|Continued APAP to Delivery|Death|0|||
142991261|NCT01029691|515503773|FG001|Continued APAP to Delivery|Death|0|||
142991262|NCT01029691|515503774|FG002|Continued APAP to Delivery|Death|1|||
142991263|NCT01023516|515503776|FG000|Overall Study|Voluntary discontinuation|7|||
142991264|NCT01023516|515503777|FG001|Overall Study|Voluntary discontinuation|5|||
142991265|NCT01023516|515503776|FG000|Overall Study|Adverse Event|9|||
142991266|NCT01023516|515503777|FG001|Overall Study|Adverse Event|6|||
142991267|NCT01023516|515503776|FG000|Overall Study|Safety reason|0|||
142991268|NCT01023516|515503777|FG001|Overall Study|Safety reason|3|||
142991269|NCT01023516|515503776|FG000|Overall Study|Study-specific criteria|4|||
142991270|NCT01023516|515503777|FG001|Overall Study|Study-specific criteria|2|||
142991271|NCT01023516|515503776|FG000|Overall Study|Incorrect enrolment|4|||
142991272|NCT01023516|515503777|FG001|Overall Study|Incorrect enrolment|2|||
142991273|NCT02559115|515503778|FG000|Overall Study|Withdrawal by Subject|3|||
142991274|NCT00137267|515503781|FG000|Overall Study|Lost to Follow-up|15|||
142991275|NCT00137267|515503782|FG001|Overall Study|Lost to Follow-up|21|||
142991276|NCT05304611|515503784|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
142991277|NCT05304611|515503785|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
142991278|NCT05304611|515503786|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
142991279|NCT05304611|515503787|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
142991280|NCT05304611|515503788|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
142991281|NCT05304611|515503789|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
142991282|NCT05304611|515503790|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
142991283|NCT05304611|515503791|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
142991284|NCT05304611|515503792|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
142991285|NCT05304611|515503793|FG009|Pediatric Efficacy Study|Lost to Follow-up|0|||
142991286|NCT05304611|515503794|FG010|Pediatric Efficacy Study|Lost to Follow-up|0|||
142991287|NCT05304611|515503795|FG011|Pediatric Efficacy Study|Lost to Follow-up|0|||
142991288|NCT05304611|515503784|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
142991289|NCT05304611|515503785|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
142991290|NCT05304611|515503786|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
142991291|NCT05304611|515503787|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
142991292|NCT05304611|515503788|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
142991293|NCT05304611|515503789|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
142991294|NCT05304611|515503790|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
142991295|NCT05304611|515503791|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
142991296|NCT05304611|515503792|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
142991297|NCT05304611|515503793|FG009|Pediatric Efficacy Study|Withdrew consent|0|||
142991298|NCT05304611|515503794|FG010|Pediatric Efficacy Study|Withdrew consent|0|||
142991299|NCT05304611|515503795|FG011|Pediatric Efficacy Study|Withdrew consent|0|||
142991300|NCT05304611|515503784|FG000|Pediatric Extension Study|Withdrawal by Subject|0|||
142991301|NCT05304611|515503785|FG001|Pediatric Extension Study|Withdrawal by Subject|0|||
142991302|NCT05304611|515503786|FG002|Pediatric Extension Study|Withdrawal by Subject|0|||
142991303|NCT05304611|515503787|FG003|Pediatric Extension Study|Withdrawal by Subject|0|||
142991304|NCT05304611|515503788|FG004|Pediatric Extension Study|Withdrawal by Subject|0|||
142991305|NCT05304611|515503789|FG005|Pediatric Extension Study|Withdrawal by Subject|0|||
142991306|NCT05304611|515503790|FG006|Pediatric Extension Study|Withdrawal by Subject|0|||
142991307|NCT05304611|515503791|FG007|Pediatric Extension Study|Withdrawal by Subject|0|||
142991308|NCT05304611|515503792|FG008|Pediatric Extension Study|Withdrawal by Subject|0|||
142991309|NCT05304611|515503793|FG009|Pediatric Extension Study|Withdrawal by Subject|0|||
142991310|NCT05304611|515503794|FG010|Pediatric Extension Study|Withdrawal by Subject|1|||
142991311|NCT05304611|515503795|FG011|Pediatric Extension Study|Withdrawal by Subject|2|||
142991312|NCT01602822|515503802|FG000|Overall Study|Adverse Event|11|||
142991313|NCT02871791|515503806|FG000|Phase 1b|Death|0|||
142991314|NCT02871791|515503807|FG001|Phase 1b|Death|1|||
142991315|NCT02871791|515503806|FG000|Phase 1b|progressive disease|6|||
142991316|NCT02871791|515503807|FG001|Phase 1b|progressive disease|2|||
142991317|NCT02871791|515503806|FG000|Phase 2|Death|1|||
142991318|NCT02871791|515503807|FG001|Phase 2|Death|0|||
142991319|NCT02871791|515503806|FG000|Phase 2|Lost to Follow-up|2|||
142991320|NCT02871791|515503807|FG001|Phase 2|Lost to Follow-up|0|||
142991321|NCT02010567|515503811|FG000|Overall Study|Adverse Event|0|||
142991322|NCT02010567|515503812|FG001|Overall Study|Adverse Event|0|||
142991323|NCT02010567|515503813|FG002|Overall Study|Adverse Event|1|||
142991324|NCT02010567|515503814|FG003|Overall Study|Adverse Event|0|||
142991325|NCT02010567|515503815|FG004|Overall Study|Adverse Event|1|||
142991326|NCT00118040|515503820|FG000|Overall Study|Adverse Event|0|||
142991327|NCT00118040|515503821|FG001|Overall Study|Adverse Event|1|||
142991328|NCT00118040|515503822|FG002|Overall Study|Adverse Event|0|||
142991329|NCT00118040|515503820|FG000|Overall Study|Withdrawal by Subject|0|||
142991330|NCT00118040|515503821|FG001|Overall Study|Withdrawal by Subject|0|||
142991331|NCT00118040|515503822|FG002|Overall Study|Withdrawal by Subject|2|||
142991332|NCT00118040|515503820|FG000|Overall Study|Medical Contraindication|0|||
142991333|NCT00118040|515503821|FG001|Overall Study|Medical Contraindication|0|||
142991334|NCT00118040|515503822|FG002|Overall Study|Medical Contraindication|1|||
142991335|NCT00118040|515503820|FG000|Overall Study|Non-Compliant Participant|1|||
142991336|NCT00118040|515503821|FG001|Overall Study|Non-Compliant Participant|1|||
142991337|NCT00118040|515503822|FG002|Overall Study|Non-Compliant Participant|2|||
142991338|NCT00118040|515503820|FG000|Overall Study|Other|0|||
142991339|NCT00118040|515503821|FG001|Overall Study|Other|0|||
142991340|NCT00118040|515503822|FG002|Overall Study|Other|1|||
142991341|NCT00397631|515503825|FG000|Overall Study|Adverse Event|5|||
142991342|NCT00397631|515503826|FG001|Overall Study|Adverse Event|6|||
142991343|NCT00397631|515503825|FG000|Overall Study|Lack of Efficacy|7|||
142991344|NCT00397631|515503826|FG001|Overall Study|Lack of Efficacy|10|||
142991345|NCT00397631|515503825|FG000|Overall Study|Lost to Follow-up|8|||
142991346|NCT00397631|515503826|FG001|Overall Study|Lost to Follow-up|9|||
142991347|NCT00397631|515503825|FG000|Overall Study|Physician Decision|2|||
142991348|NCT00397631|515503826|FG001|Overall Study|Physician Decision|0|||
142991349|NCT00397631|515503825|FG000|Overall Study|Protocol Violation|0|||
142991350|NCT00397631|515503826|FG001|Overall Study|Protocol Violation|1|||
142991351|NCT00397631|515503825|FG000|Overall Study|Withdrawal by Subject|7|||
142991352|NCT00397631|515503826|FG001|Overall Study|Withdrawal by Subject|14|||
142991353|NCT00397631|515503825|FG000|Overall Study|protocol discontinuation criteria|1|||
142991354|NCT00397631|515503826|FG001|Overall Study|protocol discontinuation criteria|4|||
142991355|NCT02202161|515503827|FG000|Overall Study|Adverse Event|1|||
142991356|NCT02202161|515503828|FG001|Overall Study|Adverse Event|1|||
142991357|NCT02202161|515503829|FG002|Overall Study|Adverse Event|0|||
142991358|NCT02202161|515503830|FG003|Overall Study|Adverse Event|0|||
142991359|NCT02202161|515503831|FG004|Overall Study|Adverse Event|0|||
142991360|NCT02202161|515503832|FG005|Overall Study|Adverse Event|1|||
142991361|NCT02202161|515503833|FG006|Overall Study|Adverse Event|0|||
142991362|NCT02202161|515503834|FG007|Overall Study|Adverse Event|0|||
142991363|NCT02202161|515503827|FG000|Overall Study|Did not meet continuation criteria|0|||
142991364|NCT02202161|515503828|FG001|Overall Study|Did not meet continuation criteria|0|||
142991365|NCT02202161|515503829|FG002|Overall Study|Did not meet continuation criteria|0|||
142991366|NCT02202161|515503830|FG003|Overall Study|Did not meet continuation criteria|0|||
142991367|NCT02202161|515503831|FG004|Overall Study|Did not meet continuation criteria|0|||
142991368|NCT02202161|515503832|FG005|Overall Study|Did not meet continuation criteria|0|||
142991369|NCT02202161|515503833|FG006|Overall Study|Did not meet continuation criteria|0|||
142991370|NCT02202161|515503834|FG007|Overall Study|Did not meet continuation criteria|3|||
142991371|NCT02202161|515503827|FG000|Overall Study|Physician Decision|0|||
142991372|NCT02202161|515503828|FG001|Overall Study|Physician Decision|0|||
142991373|NCT02202161|515503829|FG002|Overall Study|Physician Decision|0|||
142991374|NCT02202161|515503830|FG003|Overall Study|Physician Decision|0|||
142991375|NCT02202161|515503831|FG004|Overall Study|Physician Decision|0|||
142991376|NCT02202161|515503832|FG005|Overall Study|Physician Decision|0|||
142991377|NCT02202161|515503833|FG006|Overall Study|Physician Decision|0|||
142991378|NCT02202161|515503834|FG007|Overall Study|Physician Decision|3|||
142991379|NCT02202161|515503827|FG000|Overall Study|Withdrawal by Subject|0|||
142991380|NCT02202161|515503828|FG001|Overall Study|Withdrawal by Subject|0|||
142991381|NCT02202161|515503829|FG002|Overall Study|Withdrawal by Subject|0|||
142991382|NCT02202161|515503830|FG003|Overall Study|Withdrawal by Subject|0|||
142991383|NCT02202161|515503831|FG004|Overall Study|Withdrawal by Subject|1|||
142991384|NCT02202161|515503832|FG005|Overall Study|Withdrawal by Subject|0|||
142991385|NCT02202161|515503833|FG006|Overall Study|Withdrawal by Subject|0|||
142991386|NCT02202161|515503834|FG007|Overall Study|Withdrawal by Subject|0|||
142991387|NCT00832091|515503835|FG000|Overall Study|Adverse Event|1|||
142991388|NCT00832091|515503836|FG001|Overall Study|Adverse Event|1|||
142991389|NCT00832091|515503835|FG000|Overall Study|Protocol Violation|1|||
142991390|NCT00832091|515503836|FG001|Overall Study|Protocol Violation|0|||
142991391|NCT00832091|515503835|FG000|Overall Study|Withdrawal by Subject|2|||
142991392|NCT00832091|515503836|FG001|Overall Study|Withdrawal by Subject|1|||
142991393|NCT00832091|515503835|FG000|Overall Study|Prohibited Medication|1|||
142991394|NCT00832091|515503836|FG001|Overall Study|Prohibited Medication|0|||
142991395|NCT01738594|515503837|FG000|Registration and Treatment Start|Adverse Event|0|||
142991396|NCT01738594|515503838|FG001|Registration and Treatment Start|Adverse Event|1|||
142991397|NCT01738594|515503839|FG002|Registration and Treatment Start|Adverse Event|0|||
142991398|NCT01738594|515503840|FG003|Registration and Treatment Start|Adverse Event|0|||
142991399|NCT01738594|515503841|FG004|Registration and Treatment Start|Adverse Event|0|||
142991400|NCT01738594|515503842|FG005|Registration and Treatment Start|Adverse Event|0|||
142991401|NCT01738594|515503843|FG006|Registration and Treatment Start|Adverse Event|0|||
142991402|NCT01738594|515503844|FG007|Registration and Treatment Start|Adverse Event|0|||
142991403|NCT01738594|515503837|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
142991404|NCT01738594|515503838|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
142991405|NCT01738594|515503839|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
142991406|NCT01738594|515503840|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
142991407|NCT01738594|515503841|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
142991408|NCT01738594|515503842|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
142991409|NCT01738594|515503843|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
142991410|NCT01738594|515503844|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
142991411|NCT01738594|515503837|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
142991412|NCT01738594|515503838|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
142991413|NCT01738594|515503839|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
142991414|NCT01738594|515503840|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
142991415|NCT01738594|515503841|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
142991416|NCT01738594|515503842|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
142991417|NCT01738594|515503843|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
142991418|NCT01738594|515503844|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
142991419|NCT01738594|515503837|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
142991420|NCT01738594|515503838|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
142991421|NCT01738594|515503839|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
142991422|NCT01738594|515503840|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
142991423|NCT01738594|515503841|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
142991424|NCT01738594|515503842|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
142991425|NCT01738594|515503843|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
142991426|NCT01738594|515503844|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
142991427|NCT01738594|515503837|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
142991428|NCT01738594|515503838|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
142991429|NCT01738594|515503839|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
142991430|NCT01738594|515503840|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
142991431|NCT01738594|515503841|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
142991432|NCT01738594|515503842|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
142991433|NCT01738594|515503843|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
142991434|NCT01738594|515503844|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
142991435|NCT01738594|515503837|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
142991436|NCT01738594|515503838|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
142991437|NCT01738594|515503839|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
142991438|NCT01738594|515503840|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
142991439|NCT01738594|515503841|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
142991440|NCT01738594|515503842|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
142991441|NCT01738594|515503843|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
142991442|NCT01738594|515503844|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
142991443|NCT01738594|515503837|FG000|Follow up for 1 Year|Death|0|||
142991444|NCT01738594|515503838|FG001|Follow up for 1 Year|Death|0|||
142991445|NCT01738594|515503839|FG002|Follow up for 1 Year|Death|0|||
142991446|NCT01738594|515503840|FG003|Follow up for 1 Year|Death|0|||
142991447|NCT01738594|515503841|FG004|Follow up for 1 Year|Death|0|||
142991448|NCT01738594|515503842|FG005|Follow up for 1 Year|Death|1|||
142991449|NCT01738594|515503843|FG006|Follow up for 1 Year|Death|0|||
142991450|NCT01738594|515503844|FG007|Follow up for 1 Year|Death|0|||
142991451|NCT01738594|515503837|FG000|Follow up for 1 Year|Other|0|||
142991452|NCT01738594|515503838|FG001|Follow up for 1 Year|Other|0|||
142991453|NCT01738594|515503839|FG002|Follow up for 1 Year|Other|0|||
142991454|NCT01738594|515503840|FG003|Follow up for 1 Year|Other|0|||
142991455|NCT01738594|515503841|FG004|Follow up for 1 Year|Other|0|||
142991456|NCT01738594|515503842|FG005|Follow up for 1 Year|Other|2|||
142991457|NCT01738594|515503843|FG006|Follow up for 1 Year|Other|0|||
142991458|NCT01738594|515503844|FG007|Follow up for 1 Year|Other|0|||
142991459|NCT01796106|515503845|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
142991460|NCT01796106|515503846|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
142991461|NCT04107935|515503847|FG000|Overall Study|Death|1|||
142991462|NCT04107935|515503848|FG001|Overall Study|Death|0|||
142991463|NCT00935701|515503850|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
142991464|NCT02201251|515503851|FG000|Overall Study|Adverse Event|1|||
142991465|NCT02201251|515503852|FG001|Overall Study|Adverse Event|1|||
142991466|NCT02201251|515503851|FG000|Overall Study|Protocol Violation|1|||
142991467|NCT02201251|515503852|FG001|Overall Study|Protocol Violation|0|||
142991468|NCT02201251|515503851|FG000|Overall Study|Noncompliance with Study Drug|0|||
142991469|NCT02201251|515503852|FG001|Overall Study|Noncompliance with Study Drug|1|||
142991470|NCT02201251|515503851|FG000|Overall Study|Withdrawal by Subject|2|||
142991471|NCT02201251|515503852|FG001|Overall Study|Withdrawal by Subject|1|||
142991472|NCT02711553|515503855|FG000|Overall Study|Withdrawal by Subject|2|||
142991473|NCT02711553|515503856|FG001|Overall Study|Withdrawal by Subject|1|||
142991474|NCT02711553|515503857|FG002|Overall Study|Withdrawal by Subject|1|||
142991475|NCT02711553|515503858|FG003|Overall Study|Withdrawal by Subject|0|||
142991476|NCT02711553|515503855|FG000|Overall Study|Lost to Follow-up|3|||
142991477|NCT02711553|515503856|FG001|Overall Study|Lost to Follow-up|3|||
142991478|NCT02711553|515503857|FG002|Overall Study|Lost to Follow-up|6|||
142991479|NCT02711553|515503858|FG003|Overall Study|Lost to Follow-up|3|||
142991480|NCT02711553|515503855|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
142991481|NCT02711553|515503856|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
142991482|NCT02711553|515503857|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
142991483|NCT02711553|515503858|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
142991484|NCT02877134|515503859|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
142991485|NCT02877134|515503860|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
142991486|NCT02877134|515503861|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
142991487|NCT02877134|515503862|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
142991488|NCT02877134|515503863|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
142991489|NCT02877134|515503864|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
142991490|NCT02877134|515503865|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
142991491|NCT02877134|515503866|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
142991492|NCT02877134|515503867|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
142991493|NCT02877134|515503868|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
142991494|NCT02877134|515503869|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
142991495|NCT02877134|515503870|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
142991496|NCT02877134|515503859|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
142991497|NCT02877134|515503860|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
142991498|NCT02877134|515503861|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
142991499|NCT02877134|515503862|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
142991500|NCT02877134|515503863|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
142991501|NCT02877134|515503864|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
142991502|NCT02877134|515503865|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
142991503|NCT02877134|515503866|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
142991504|NCT02877134|515503867|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
142991505|NCT02877134|515503868|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
142991506|NCT02877134|515503869|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
142991507|NCT02877134|515503870|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
142991508|NCT02877134|515503859|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
142991509|NCT02877134|515503860|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
142991510|NCT02877134|515503861|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
142991511|NCT02877134|515503862|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
142991512|NCT02877134|515503863|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
142991513|NCT02877134|515503864|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
142991514|NCT02877134|515503865|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
142991515|NCT02877134|515503866|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
142991516|NCT02877134|515503867|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
142991517|NCT02877134|515503868|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
142991518|NCT02877134|515503869|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
142991519|NCT02877134|515503870|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
142991520|NCT02877134|515503859|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
142991521|NCT02877134|515503860|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
142991522|NCT02877134|515503861|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
142991523|NCT02877134|515503862|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
142991524|NCT02877134|515503863|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
142991525|NCT02877134|515503864|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
142991526|NCT02877134|515503865|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
142991527|NCT02877134|515503866|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
142991528|NCT02877134|515503867|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
142991529|NCT02877134|515503868|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
142991530|NCT02877134|515503869|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
142991531|NCT02877134|515503870|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
142991532|NCT02877134|515503859|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
142991533|NCT02877134|515503860|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
142991534|NCT02877134|515503861|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
142991535|NCT02877134|515503862|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
142991536|NCT02877134|515503863|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
142991537|NCT02877134|515503864|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
142991538|NCT02877134|515503865|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
142991539|NCT02877134|515503866|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
142991540|NCT02877134|515503867|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
142991541|NCT02877134|515503868|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
142991542|NCT02877134|515503869|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
142991543|NCT02877134|515503870|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
142991544|NCT02877134|515503859|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
142991545|NCT02877134|515503860|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
142991546|NCT02877134|515503861|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
142991547|NCT02877134|515503862|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
142991548|NCT02877134|515503863|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
142991549|NCT02877134|515503864|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
142991550|NCT02877134|515503865|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
142991551|NCT02877134|515503866|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
142991552|NCT02877134|515503867|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
142991553|NCT02877134|515503868|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
142991554|NCT02877134|515503869|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
142991555|NCT02877134|515503870|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
142991556|NCT02877134|515503859|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
142991557|NCT02877134|515503860|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
142991558|NCT02877134|515503861|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
142991559|NCT02877134|515503862|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
142991560|NCT02877134|515503863|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
142991561|NCT02877134|515503864|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
142991562|NCT02877134|515503865|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
142991563|NCT02877134|515503866|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
142991564|NCT02877134|515503867|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
142991565|NCT02877134|515503868|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
142991566|NCT02877134|515503869|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
142991567|NCT02877134|515503870|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
142991568|NCT02877134|515503859|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
142991569|NCT02877134|515503860|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
142991570|NCT02877134|515503861|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
142991571|NCT02877134|515503862|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
142991572|NCT02877134|515503863|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
142991573|NCT02877134|515503864|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
142991574|NCT02877134|515503865|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
142991575|NCT02877134|515503866|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
142991576|NCT02877134|515503867|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
142991577|NCT02877134|515503868|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
142991578|NCT02877134|515503869|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
142991579|NCT02877134|515503870|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
142991580|NCT04048876|515503873|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
142991581|NCT04048876|515503874|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
142991582|NCT04048876|515503875|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
142991583|NCT04048876|515503876|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
142991584|NCT04048876|515503873|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
142991585|NCT04048876|515503874|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
142991586|NCT04048876|515503875|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
142991587|NCT04048876|515503876|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
142991588|NCT04048876|515503873|FG000|Placebo Controlled Phase|Adverse Event|0|||
142991589|NCT04048876|515503874|FG001|Placebo Controlled Phase|Adverse Event|1|||
142991590|NCT04048876|515503875|FG002|Placebo Controlled Phase|Adverse Event|0|||
142991591|NCT04048876|515503876|FG003|Placebo Controlled Phase|Adverse Event|0|||
142991592|NCT04048876|515503873|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
142991593|NCT04048876|515503874|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
142991594|NCT04048876|515503875|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
142991595|NCT04048876|515503876|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
142991596|NCT01828567|515503879|FG000|Overall Study|Lost to Follow-up|27|||
142991597|NCT01828567|515503880|FG001|Overall Study|Lost to Follow-up|9|||
142991598|NCT01828567|515503879|FG000|Overall Study|Excluded - did not meet criteria|4|||
142991599|NCT01828567|515503880|FG001|Overall Study|Excluded - did not meet criteria|1|||
142991600|NCT03512275|515503882|FG000|Overall Study|Withdrawal by Subject|1|||
142991601|NCT03512275|515503883|FG001|Overall Study|Withdrawal by Subject|3|||
142991602|NCT03512275|515503882|FG000|Overall Study|Physician Decision|0|||
142991603|NCT03512275|515503883|FG001|Overall Study|Physician Decision|1|||
142991604|NCT03512275|515503882|FG000|Overall Study|Lost to Follow-up|0|||
142991605|NCT03512275|515503883|FG001|Overall Study|Lost to Follow-up|3|||
142991606|NCT03512275|515503882|FG000|Overall Study|Other|1|||
142991607|NCT03512275|515503883|FG001|Overall Study|Other|0|||
142991608|NCT04063865|515503884|FG000|Overall Study|Physician Decision|1|||
142991609|NCT04063865|515503885|FG001|Overall Study|Physician Decision|3|||
142991610|NCT04063865|515503884|FG000|Overall Study|Study Closed Prior to Completion|4|||
142991611|NCT04063865|515503885|FG001|Overall Study|Study Closed Prior to Completion|4|||
142991612|NCT04063865|515503884|FG000|Overall Study|Withdrawal by Subject|1|||
142991613|NCT04063865|515503885|FG001|Overall Study|Withdrawal by Subject|1|||
142991614|NCT01708915|515503889|FG000|Overall Study|Adverse Event|1|||
142991615|NCT01708915|515503890|FG001|Overall Study|Adverse Event|0|||
142991616|NCT01708915|515503891|FG002|Overall Study|Adverse Event|9|||
142991617|NCT01708915|515503892|FG003|Overall Study|Adverse Event|13|||
142991618|NCT01708915|515503889|FG000|Overall Study|Lack of Efficacy|84|||
142991619|NCT01708915|515503890|FG001|Overall Study|Lack of Efficacy|60|||
142991620|NCT01708915|515503891|FG002|Overall Study|Lack of Efficacy|35|||
142991621|NCT01708915|515503892|FG003|Overall Study|Lack of Efficacy|15|||
142991622|NCT01708915|515503889|FG000|Overall Study|Protocol Violation|0|||
142991623|NCT01708915|515503890|FG001|Overall Study|Protocol Violation|0|||
142991624|NCT01708915|515503891|FG002|Overall Study|Protocol Violation|0|||
142991625|NCT01708915|515503892|FG003|Overall Study|Protocol Violation|1|||
142991626|NCT01708915|515503889|FG000|Overall Study|Withdrawal by Subject|0|||
142991627|NCT01708915|515503890|FG001|Overall Study|Withdrawal by Subject|1|||
142991628|NCT01708915|515503891|FG002|Overall Study|Withdrawal by Subject|2|||
142991629|NCT01708915|515503892|FG003|Overall Study|Withdrawal by Subject|2|||
142991630|NCT01708915|515503889|FG000|Overall Study|Other reasons than stated above|1|||
142991631|NCT01708915|515503890|FG001|Overall Study|Other reasons than stated above|1|||
142991632|NCT01708915|515503891|FG002|Overall Study|Other reasons than stated above|0|||
142991633|NCT01708915|515503892|FG003|Overall Study|Other reasons than stated above|2|||
142991634|NCT03231228|515503896|FG000|Overall Study|Lost to Follow-up|2|||
142991635|NCT03231228|515503897|FG001|Overall Study|Lost to Follow-up|0|||
142991636|NCT03231228|515503896|FG000|Overall Study|Physician Decision|1|||
142991637|NCT03231228|515503897|FG001|Overall Study|Physician Decision|0|||
142991638|NCT00374127|515503898|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
142991639|NCT00374127|515503898|FG000|Overall Study|Blood could not be drawn.|2|||
142991640|NCT00374127|515503898|FG000|Overall Study|Protocol Violation|5|||
142991641|NCT00374127|515503898|FG000|Overall Study|Pregnancy|1|||
142991642|NCT00908895|515505904|FG000|Overall Study|Lost to Follow-up|1|||
142991643|NCT00908895|515505905|FG001|Overall Study|Lost to Follow-up|3|||
142991644|NCT00908895|515505904|FG000|Overall Study|algodystrophy|2|||
142991645|NCT00908895|515505905|FG001|Overall Study|algodystrophy|2|||
142991646|NCT00908895|515505904|FG000|Overall Study|Adverse Event|1|||
142991647|NCT00908895|515505905|FG001|Overall Study|Adverse Event|1|||
142991648|NCT01736176|515505911|FG000|Overall Study|Adverse Event|3|||
142991649|NCT01736176|515505911|FG000|Overall Study|Withdrawal by Subject|4|||
142991650|NCT01736176|515505911|FG000|Overall Study|Lack of Efficacy|3|||
142991651|NCT01736176|515505911|FG000|Overall Study|Unable to Complete PEG Placement|1|||
142991652|NCT02145429|515505912|FG000|Overall Study|Death|4|||
142991653|NCT02145429|515505913|FG001|Overall Study|Death|5|||
142991654|NCT02145429|515505912|FG000|Overall Study|Lost to Follow-up|4|||
142991655|NCT02145429|515505913|FG001|Overall Study|Lost to Follow-up|3|||
142991656|NCT02145429|515505912|FG000|Overall Study|Withdrawal by Subject|8|||
142991657|NCT02145429|515505913|FG001|Overall Study|Withdrawal by Subject|3|||
142991658|NCT02200510|515505914|FG000|Overall Study|Death|1|||
142991659|NCT02200510|515505915|FG001|Overall Study|Death|1|||
142991660|NCT02200510|515505914|FG000|Overall Study|Protocol Violation|0|||
142991661|NCT02200510|515505915|FG001|Overall Study|Protocol Violation|1|||
142991662|NCT02200510|515505914|FG000|Overall Study|Lost to Follow-up|7|||
142991663|NCT02200510|515505915|FG001|Overall Study|Lost to Follow-up|1|||
142991664|NCT02200510|515505914|FG000|Overall Study|potential COI - joined study team|1|||
142991665|NCT02200510|515505915|FG001|Overall Study|potential COI - joined study team|0|||
142991666|NCT04167514|515505916|FG000|Overall Study|Adverse event, not serious|0|||
142991667|NCT04167514|515505917|FG001|Overall Study|Adverse event, not serious|1|||
142991668|NCT04167514|515505916|FG000|Overall Study|Lost to Follow-up|1|||
142991669|NCT04167514|515505917|FG001|Overall Study|Lost to Follow-up|0|||
142991670|NCT04167514|515505916|FG000|Overall Study|Participant Decision|2|||
142991671|NCT04167514|515505917|FG001|Overall Study|Participant Decision|4|||
142991672|NCT04167514|515505916|FG000|Overall Study|Physician Decision|3|||
142991673|NCT04167514|515505917|FG001|Overall Study|Physician Decision|2|||
142991674|NCT04167514|515505916|FG000|Overall Study|Death|14|||
142991675|NCT04167514|515505917|FG001|Overall Study|Death|18|||
142991676|NCT04167514|515505916|FG000|Overall Study|Enrolled but treatment not administered|2|||
142991677|NCT04167514|515505917|FG001|Overall Study|Enrolled but treatment not administered|0|||
142991678|NCT04167514|515505916|FG000|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|3|||
142991679|NCT04167514|515505917|FG001|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|1|||
142991680|NCT04167514|515505916|FG000|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|2|||
142991681|NCT04167514|515505917|FG001|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|4|||
142991682|NCT00290355|515505918|FG000|Overall Study|Serious adverse event|7|||
142991683|NCT00290355|515505919|FG001|Overall Study|Serious adverse event|4|||
142991684|NCT00290355|515505918|FG000|Overall Study|Study product reactogenicity|1|||
142991685|NCT00290355|515505919|FG001|Overall Study|Study product reactogenicity|0|||
142991686|NCT00290355|515505918|FG000|Overall Study|Protocol Violation|1|||
142991687|NCT00290355|515505919|FG001|Overall Study|Protocol Violation|0|||
142991688|NCT00290355|515505918|FG000|Overall Study|Withdrawal by Subject|2|||
142991689|NCT00290355|515505919|FG001|Overall Study|Withdrawal by Subject|0|||
142991690|NCT00290355|515505918|FG000|Overall Study|Migrated / moved from the study area|1|||
142991691|NCT00290355|515505919|FG001|Overall Study|Migrated / moved from the study area|0|||
142991692|NCT00290355|515505918|FG000|Overall Study|Lost to Follow-up|3|||
142991693|NCT00290355|515505919|FG001|Overall Study|Lost to Follow-up|1|||
142991694|NCT00290355|515505918|FG000|Overall Study|Other|2|||
142991695|NCT00290355|515505919|FG001|Overall Study|Other|0|||
142991696|NCT00033514|515505920|FG000|Overall Study|Lost to Follow-up|1|||
142991697|NCT00033514|515505921|FG001|Overall Study|Lost to Follow-up|1|||
142991698|NCT00033514|515505920|FG000|Overall Study|Withdrawal by Subject|0|||
142991699|NCT00033514|515505921|FG001|Overall Study|Withdrawal by Subject|3|||
142991700|NCT00939055|515505922|FG000|Overall Study|Discontinuation prior to procedure|4|||
142991701|NCT00939055|515505923|FG001|Overall Study|Discontinuation prior to procedure|0|||
142991702|NCT00584987|515505924|FG000|Overall Study|Protocol Violation|1|||
142991703|NCT00584987|515505925|FG001|Overall Study|Protocol Violation|1|||
142991704|NCT00584987|515505926|FG002|Overall Study|Protocol Violation|1|||
142991705|NCT00584987|515505927|FG003|Overall Study|Protocol Violation|0|||
142991706|NCT00584987|515505924|FG000|Overall Study|Adverse Event|0|||
142991707|NCT00584987|515505925|FG001|Overall Study|Adverse Event|0|||
142991708|NCT00584987|515505926|FG002|Overall Study|Adverse Event|0|||
142991709|NCT00584987|515505927|FG003|Overall Study|Adverse Event|1|||
142991710|NCT03225833|515505931|FG000|Overall Study|Adverse Event|0|||
142991711|NCT03225833|515505932|FG001|Overall Study|Adverse Event|1|||
142991712|NCT03225833|515505933|FG002|Overall Study|Adverse Event|2|||
142991713|NCT03225833|515505934|FG003|Overall Study|Adverse Event|0|||
142991714|NCT03225833|515505935|FG004|Overall Study|Adverse Event|0|||
142991715|NCT03225833|515505936|FG005|Overall Study|Adverse Event|2|||
142991716|NCT03225833|515505931|FG000|Overall Study|Withdrawal by Subject|1|||
142991717|NCT03225833|515505932|FG001|Overall Study|Withdrawal by Subject|0|||
142991718|NCT03225833|515505933|FG002|Overall Study|Withdrawal by Subject|0|||
142991719|NCT03225833|515505934|FG003|Overall Study|Withdrawal by Subject|0|||
142991720|NCT03225833|515505935|FG004|Overall Study|Withdrawal by Subject|1|||
142991721|NCT03225833|515505936|FG005|Overall Study|Withdrawal by Subject|0|||
142991722|NCT03225833|515505931|FG000|Overall Study|Termination of Study by Sponsor|4|||
142991723|NCT03225833|515505932|FG001|Overall Study|Termination of Study by Sponsor|0|||
142991724|NCT03225833|515505933|FG002|Overall Study|Termination of Study by Sponsor|0|||
142991725|NCT03225833|515505934|FG003|Overall Study|Termination of Study by Sponsor|0|||
142991726|NCT03225833|515505935|FG004|Overall Study|Termination of Study by Sponsor|0|||
142991727|NCT03225833|515505936|FG005|Overall Study|Termination of Study by Sponsor|7|||
142991728|NCT03225833|515505931|FG000|Overall Study|Sponsor Decision|0|||
142991729|NCT03225833|515505932|FG001|Overall Study|Sponsor Decision|0|||
142991730|NCT03225833|515505933|FG002|Overall Study|Sponsor Decision|0|||
142991731|NCT03225833|515505934|FG003|Overall Study|Sponsor Decision|0|||
142991732|NCT03225833|515505935|FG004|Overall Study|Sponsor Decision|0|||
142991733|NCT03225833|515505936|FG005|Overall Study|Sponsor Decision|1|||
142991734|NCT00808028|515505937|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
142991735|NCT00808028|515505938|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
142991736|NCT00808028|515505939|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
142991737|NCT00808028|515505940|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
142991738|NCT00808028|515505937|FG000|Stage 1 (6 Months)|Other|1|||
142991739|NCT00808028|515505938|FG001|Stage 1 (6 Months)|Other|0|||
142991740|NCT00808028|515505939|FG002|Stage 1 (6 Months)|Other|2|||
142991741|NCT00808028|515505940|FG003|Stage 1 (6 Months)|Other|4|||
142991742|NCT00808028|515505937|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
142991743|NCT00808028|515505938|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
142991744|NCT00808028|515505939|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
142991745|NCT00808028|515505940|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
142991746|NCT00808028|515505937|FG000|Stage 1 (6 Months)|Adverse Event|0|||
142991747|NCT00808028|515505938|FG001|Stage 1 (6 Months)|Adverse Event|0|||
142991748|NCT00808028|515505939|FG002|Stage 1 (6 Months)|Adverse Event|1|||
142991749|NCT00808028|515505940|FG003|Stage 1 (6 Months)|Adverse Event|2|||
142991750|NCT00808028|515505937|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
142991751|NCT00808028|515505938|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
142991752|NCT00808028|515505939|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
142991753|NCT00808028|515505940|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
142991754|NCT00808028|515505937|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
142991755|NCT00808028|515505938|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
142991756|NCT00808028|515505939|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
142991757|NCT00808028|515505940|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
142991758|NCT00808028|515505937|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
142991759|NCT00808028|515505938|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
142991760|NCT00808028|515505939|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
142991761|NCT00808028|515505940|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
142991762|NCT00808028|515505937|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
142991763|NCT00808028|515505938|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
142991764|NCT00808028|515505939|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
142991765|NCT00808028|515505940|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
142991766|NCT00808028|515505937|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
142991767|NCT00808028|515505938|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
142991768|NCT00808028|515505939|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
142991769|NCT00808028|515505940|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
142991770|NCT00808028|515505937|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
142991771|NCT00808028|515505938|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
142991772|NCT00808028|515505939|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
142991773|NCT00808028|515505940|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
142991774|NCT00808028|515505937|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
142991775|NCT00808028|515505938|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
142991776|NCT00808028|515505939|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
142991777|NCT00808028|515505940|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
142991778|NCT00808028|515505937|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
142991779|NCT00808028|515505938|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
142991780|NCT00808028|515505939|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
142991781|NCT00808028|515505940|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
142991782|NCT00808028|515505937|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
142991783|NCT00808028|515505938|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
142991784|NCT00808028|515505939|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
142991785|NCT00808028|515505940|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
142991786|NCT00808028|515505937|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
142991787|NCT00808028|515505938|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
142991788|NCT00808028|515505939|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
142991789|NCT00808028|515505940|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
142991790|NCT00808028|515505937|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
142991791|NCT00808028|515505938|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
142991792|NCT00808028|515505939|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
142991793|NCT00808028|515505940|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
142991794|NCT03093350|515505942|FG000|Overall Study|Death|1|||
142991795|NCT03093350|515505942|FG000|Overall Study|Signed consent, never began treartment|1|||
142991796|NCT02060903|515505949|FG000|Overall Study|Lost to Follow-up|4|||
142991797|NCT02060903|515505950|FG001|Overall Study|Lost to Follow-up|0|||
142991798|NCT02060903|515505949|FG000|Overall Study|Withdrawal by Subject|0|||
142991799|NCT02060903|515505950|FG001|Overall Study|Withdrawal by Subject|7|||
142991800|NCT00638989|515505951|FG000|Overall Study|Lost to Follow-up|0|||
142991801|NCT00638989|515505952|FG001|Overall Study|Lost to Follow-up|0|||
142991802|NCT00638989|515505953|FG002|Overall Study|Lost to Follow-up|1|||
142991803|NCT00853112|515505955|FG000|Overall Study|Randomized but not treated|0|||
142991804|NCT00853112|515505956|FG001|Overall Study|Randomized but not treated|1|||
142991805|NCT00853112|515505957|FG002|Overall Study|Randomized but not treated|0|||
142991806|NCT00853112|515505958|FG003|Overall Study|Randomized but not treated|2|||
142991807|NCT00853112|515505959|FG004|Overall Study|Randomized but not treated|0|||
142991808|NCT00853112|515505960|FG005|Overall Study|Randomized but not treated|0|||
142991809|NCT00853112|515505961|FG006|Overall Study|Randomized but not treated|1|||
142991810|NCT01553591|515505962|FG000|Overall Study|Voluntarily withdrew|94|||
142991811|NCT01553591|515505963|FG001|Overall Study|Voluntarily withdrew|79|||
142991812|NCT01553591|515505964|FG002|Overall Study|Voluntarily withdrew|96|||
142991813|NCT01553591|515505962|FG000|Overall Study|Adverse Event|36|||
142991814|NCT01553591|515505963|FG001|Overall Study|Adverse Event|45|||
142991815|NCT01553591|515505964|FG002|Overall Study|Adverse Event|16|||
142991816|NCT01553591|515505962|FG000|Overall Study|Lost to Follow-up|25|||
142991817|NCT01553591|515505963|FG001|Overall Study|Lost to Follow-up|23|||
142991818|NCT01553591|515505964|FG002|Overall Study|Lost to Follow-up|16|||
142991819|NCT01553591|515505962|FG000|Overall Study|Physician decision: other|11|||
142991820|NCT01553591|515505963|FG001|Overall Study|Physician decision: other|14|||
142991821|NCT01553591|515505964|FG002|Overall Study|Physician decision: other|16|||
142991822|NCT01553591|515505962|FG000|Overall Study|Physician decision: lack of efficacy|2|||
142991823|NCT01553591|515505963|FG001|Overall Study|Physician decision: lack of efficacy|3|||
142991824|NCT01553591|515505964|FG002|Overall Study|Physician decision: lack of efficacy|7|||
142991825|NCT01553591|515505962|FG000|Overall Study|Protocol Violation|3|||
142991826|NCT01553591|515505963|FG001|Overall Study|Protocol Violation|4|||
142991827|NCT01553591|515505964|FG002|Overall Study|Protocol Violation|4|||
142991828|NCT01553591|515505962|FG000|Overall Study|Sponsor decision|1|||
142991829|NCT01553591|515505963|FG001|Overall Study|Sponsor decision|0|||
142991830|NCT01553591|515505964|FG002|Overall Study|Sponsor decision|3|||
142991831|NCT01553591|515505962|FG000|Overall Study|Randomized and never dispensed drug|0|||
142991832|NCT01553591|515505963|FG001|Overall Study|Randomized and never dispensed drug|1|||
142991833|NCT01553591|515505964|FG002|Overall Study|Randomized and never dispensed drug|0|||
142991834|NCT02477800|515505967|FG000|Placebo-Controlled Period|Adverse Event|16|||
142991835|NCT02477800|515505968|FG001|Placebo-Controlled Period|Adverse Event|25|||
142991836|NCT02477800|515505969|FG002|Placebo-Controlled Period|Adverse Event|28|||
142991837|NCT02477800|515505970|FG003|Placebo-Controlled Period|Adverse Event|0|||
142991838|NCT02477800|515505971|FG004|Placebo-Controlled Period|Adverse Event|0|||
142991839|NCT02477800|515505972|FG005|Placebo-Controlled Period|Adverse Event|0|||
142991840|NCT02477800|515505973|FG006|Placebo-Controlled Period|Adverse Event|0|||
142991841|NCT02477800|515505967|FG000|Placebo-Controlled Period|Change of Treatment|1|||
142991842|NCT02477800|515505968|FG001|Placebo-Controlled Period|Change of Treatment|2|||
142991843|NCT02477800|515505969|FG002|Placebo-Controlled Period|Change of Treatment|1|||
142991844|NCT02477800|515505970|FG003|Placebo-Controlled Period|Change of Treatment|0|||
142991845|NCT02477800|515505971|FG004|Placebo-Controlled Period|Change of Treatment|0|||
142991846|NCT02477800|515505972|FG005|Placebo-Controlled Period|Change of Treatment|0|||
142991847|NCT02477800|515505973|FG006|Placebo-Controlled Period|Change of Treatment|0|||
142991848|NCT02477800|515505967|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
142991849|NCT02477800|515505968|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
142991850|NCT02477800|515505969|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
142991851|NCT02477800|515505970|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
142991852|NCT02477800|515505971|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
142991853|NCT02477800|515505972|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
142991854|NCT02477800|515505973|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
142991855|NCT02477800|515505967|FG000|Placebo-Controlled Period|Death|0|||
142991856|NCT02477800|515505968|FG001|Placebo-Controlled Period|Death|3|||
142991857|NCT02477800|515505969|FG002|Placebo-Controlled Period|Death|2|||
142991858|NCT02477800|515505970|FG003|Placebo-Controlled Period|Death|0|||
142991859|NCT02477800|515505971|FG004|Placebo-Controlled Period|Death|0|||
142991860|NCT02477800|515505972|FG005|Placebo-Controlled Period|Death|0|||
142991861|NCT02477800|515505973|FG006|Placebo-Controlled Period|Death|0|||
142991862|NCT02477800|515505967|FG000|Placebo-Controlled Period|Disease Progression|1|||
142991863|NCT02477800|515505968|FG001|Placebo-Controlled Period|Disease Progression|0|||
142991864|NCT02477800|515505969|FG002|Placebo-Controlled Period|Disease Progression|1|||
142991865|NCT02477800|515505970|FG003|Placebo-Controlled Period|Disease Progression|0|||
142991866|NCT02477800|515505971|FG004|Placebo-Controlled Period|Disease Progression|0|||
142991867|NCT02477800|515505972|FG005|Placebo-Controlled Period|Disease Progression|0|||
142991868|NCT02477800|515505973|FG006|Placebo-Controlled Period|Disease Progression|0|||
142991869|NCT02477800|515505967|FG000|Placebo-Controlled Period|Investigator Decision|3|||
142991870|NCT02477800|515505968|FG001|Placebo-Controlled Period|Investigator Decision|2|||
142991871|NCT02477800|515505969|FG002|Placebo-Controlled Period|Investigator Decision|1|||
142991872|NCT02477800|515505970|FG003|Placebo-Controlled Period|Investigator Decision|0|||
142991873|NCT02477800|515505971|FG004|Placebo-Controlled Period|Investigator Decision|0|||
142991874|NCT02477800|515505972|FG005|Placebo-Controlled Period|Investigator Decision|0|||
142991875|NCT02477800|515505973|FG006|Placebo-Controlled Period|Investigator Decision|0|||
142991876|NCT02477800|515505967|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
142991877|NCT02477800|515505968|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
142991878|NCT02477800|515505969|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
142991879|NCT02477800|515505970|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
142991880|NCT02477800|515505971|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
142991881|NCT02477800|515505972|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
142991882|NCT02477800|515505973|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
142991883|NCT02477800|515505967|FG000|Placebo-Controlled Period|Relocation|2|||
142991884|NCT02477800|515505968|FG001|Placebo-Controlled Period|Relocation|0|||
142991885|NCT02477800|515505969|FG002|Placebo-Controlled Period|Relocation|0|||
142991886|NCT02477800|515505970|FG003|Placebo-Controlled Period|Relocation|0|||
142991887|NCT02477800|515505971|FG004|Placebo-Controlled Period|Relocation|0|||
142991888|NCT02477800|515505972|FG005|Placebo-Controlled Period|Relocation|0|||
142991889|NCT02477800|515505973|FG006|Placebo-Controlled Period|Relocation|0|||
142991890|NCT02477800|515505967|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
142991891|NCT02477800|515505968|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
142991892|NCT02477800|515505969|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
142991893|NCT02477800|515505970|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
142991894|NCT02477800|515505971|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
142991895|NCT02477800|515505972|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
142991896|NCT02477800|515505973|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
142991897|NCT02477800|515505967|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
142991898|NCT02477800|515505968|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
142991899|NCT02477800|515505969|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
142991900|NCT02477800|515505970|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
142991901|NCT02477800|515505971|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
143117238|NCT01709864|515971808|FG000|Overall Study|non-compliance with study treatment|1|||
142991902|NCT02477800|515505972|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
142991903|NCT02477800|515505973|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
142991904|NCT02477800|515505967|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
142991905|NCT02477800|515505968|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
142991906|NCT02477800|515505969|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
142991907|NCT02477800|515505970|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
142991908|NCT02477800|515505971|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
142991909|NCT02477800|515505972|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
142991910|NCT02477800|515505973|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
142991911|NCT02477800|515505967|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
142991912|NCT02477800|515505968|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
142991913|NCT02477800|515505969|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
142991914|NCT02477800|515505970|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
142991915|NCT02477800|515505971|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
142991916|NCT02477800|515505972|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
142991917|NCT02477800|515505973|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
142991918|NCT02477800|515505967|FG000|Placebo-Controlled Period|Reason not Specified|161|||
142991919|NCT02477800|515505968|FG001|Placebo-Controlled Period|Reason not Specified|161|||
142991920|NCT02477800|515505969|FG002|Placebo-Controlled Period|Reason not Specified|189|||
142991921|NCT02477800|515505970|FG003|Placebo-Controlled Period|Reason not Specified|0|||
142991922|NCT02477800|515505971|FG004|Placebo-Controlled Period|Reason not Specified|0|||
142991923|NCT02477800|515505972|FG005|Placebo-Controlled Period|Reason not Specified|0|||
142991924|NCT02477800|515505973|FG006|Placebo-Controlled Period|Reason not Specified|0|||
142991925|NCT02477800|515505967|FG000|Long Term Extension Period|Adverse Event|0|||
142991926|NCT02477800|515505968|FG001|Long Term Extension Period|Adverse Event|0|||
142991927|NCT02477800|515505969|FG002|Long Term Extension Period|Adverse Event|0|||
142991928|NCT02477800|515505970|FG003|Long Term Extension Period|Adverse Event|6|||
142991929|NCT02477800|515505971|FG004|Long Term Extension Period|Adverse Event|2|||
142991930|NCT02477800|515505972|FG005|Long Term Extension Period|Adverse Event|4|||
142991931|NCT02477800|515505973|FG006|Long Term Extension Period|Adverse Event|3|||
142991932|NCT02477800|515505967|FG000|Long Term Extension Period|Death|0|||
142991933|NCT02477800|515505968|FG001|Long Term Extension Period|Death|0|||
142991934|NCT02477800|515505969|FG002|Long Term Extension Period|Death|0|||
142991935|NCT02477800|515505970|FG003|Long Term Extension Period|Death|1|||
142991936|NCT02477800|515505971|FG004|Long Term Extension Period|Death|1|||
142991937|NCT02477800|515505972|FG005|Long Term Extension Period|Death|1|||
142991938|NCT02477800|515505973|FG006|Long Term Extension Period|Death|2|||
142991939|NCT02477800|515505967|FG000|Long Term Extension Period|Consent Withdrawn|0|||
142991940|NCT02477800|515505968|FG001|Long Term Extension Period|Consent Withdrawn|0|||
142991941|NCT02477800|515505969|FG002|Long Term Extension Period|Consent Withdrawn|0|||
142991942|NCT02477800|515505970|FG003|Long Term Extension Period|Consent Withdrawn|10|||
142991943|NCT02477800|515505971|FG004|Long Term Extension Period|Consent Withdrawn|4|||
142991944|NCT02477800|515505972|FG005|Long Term Extension Period|Consent Withdrawn|13|||
142991945|NCT02477800|515505973|FG006|Long Term Extension Period|Consent Withdrawn|16|||
142991946|NCT02477800|515505967|FG000|Long Term Extension Period|Disease Progression|0|||
142991947|NCT02477800|515505968|FG001|Long Term Extension Period|Disease Progression|0|||
142991948|NCT02477800|515505969|FG002|Long Term Extension Period|Disease Progression|0|||
142991949|NCT02477800|515505970|FG003|Long Term Extension Period|Disease Progression|3|||
142991950|NCT02477800|515505971|FG004|Long Term Extension Period|Disease Progression|1|||
142991951|NCT02477800|515505972|FG005|Long Term Extension Period|Disease Progression|1|||
142991952|NCT02477800|515505973|FG006|Long Term Extension Period|Disease Progression|0|||
142991953|NCT02477800|515505967|FG000|Long Term Extension Period|Investigator Decision|0|||
142991954|NCT02477800|515505968|FG001|Long Term Extension Period|Investigator Decision|0|||
142991955|NCT02477800|515505969|FG002|Long Term Extension Period|Investigator Decision|0|||
142991956|NCT02477800|515505970|FG003|Long Term Extension Period|Investigator Decision|0|||
142991957|NCT02477800|515505971|FG004|Long Term Extension Period|Investigator Decision|0|||
142991958|NCT02477800|515505972|FG005|Long Term Extension Period|Investigator Decision|0|||
142991959|NCT02477800|515505973|FG006|Long Term Extension Period|Investigator Decision|2|||
142991960|NCT02477800|515505967|FG000|Long Term Extension Period|Lost to Follow-up|0|||
142991961|NCT02477800|515505968|FG001|Long Term Extension Period|Lost to Follow-up|0|||
142991962|NCT02477800|515505969|FG002|Long Term Extension Period|Lost to Follow-up|0|||
142991963|NCT02477800|515505970|FG003|Long Term Extension Period|Lost to Follow-up|0|||
142991964|NCT02477800|515505971|FG004|Long Term Extension Period|Lost to Follow-up|1|||
142991965|NCT02477800|515505972|FG005|Long Term Extension Period|Lost to Follow-up|3|||
142991966|NCT02477800|515505973|FG006|Long Term Extension Period|Lost to Follow-up|0|||
142991967|NCT02477800|515505967|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
142991968|NCT02477800|515505968|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
142991969|NCT02477800|515505969|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
142991970|NCT02477800|515505970|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
142991971|NCT02477800|515505971|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
143003181|NCT01049360|515548753|FG009|Period 2|Lack of Efficacy|0|||
142991972|NCT02477800|515505972|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
142991973|NCT02477800|515505973|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
142991974|NCT02477800|515505967|FG000|Long Term Extension Period|Study Visit Burden|0|||
142991975|NCT02477800|515505968|FG001|Long Term Extension Period|Study Visit Burden|0|||
142991976|NCT02477800|515505969|FG002|Long Term Extension Period|Study Visit Burden|0|||
142991977|NCT02477800|515505970|FG003|Long Term Extension Period|Study Visit Burden|3|||
142991978|NCT02477800|515505971|FG004|Long Term Extension Period|Study Visit Burden|0|||
142991979|NCT02477800|515505972|FG005|Long Term Extension Period|Study Visit Burden|2|||
142991980|NCT02477800|515505973|FG006|Long Term Extension Period|Study Visit Burden|2|||
142991981|NCT02477800|515505967|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
142991982|NCT02477800|515505968|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
142991983|NCT02477800|515505969|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
142991984|NCT02477800|515505970|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
142991985|NCT02477800|515505971|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
142991986|NCT02477800|515505972|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
142991987|NCT02477800|515505973|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
142991988|NCT02477800|515505967|FG000|Long Term Extension Period|Reason not Specified|0|||
142991989|NCT02477800|515505968|FG001|Long Term Extension Period|Reason not Specified|0|||
142991990|NCT02477800|515505969|FG002|Long Term Extension Period|Reason not Specified|0|||
142991991|NCT02477800|515505970|FG003|Long Term Extension Period|Reason not Specified|126|||
142991992|NCT02477800|515505971|FG004|Long Term Extension Period|Reason not Specified|140|||
142991993|NCT02477800|515505972|FG005|Long Term Extension Period|Reason not Specified|270|||
142991994|NCT02477800|515505973|FG006|Long Term Extension Period|Reason not Specified|224|||
142991995|NCT04005755|515505983|FG000|Overall Study|Adverse Event|6|||
142991996|NCT04005755|515505983|FG000|Overall Study|Physician Decision|3|||
142991997|NCT04005755|515505983|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
142991998|NCT04005755|515505983|FG000|Overall Study|Withdrawal by Subject|3|||
142991999|NCT04005755|515505983|FG000|Overall Study|Lost to Follow-up|1|||
142992000|NCT02723019|515505984|FG000|Overall Study|Death|17|||
142992001|NCT02723019|515505985|FG001|Overall Study|Death|13|||
142992002|NCT02723019|515505984|FG000|Overall Study|Withdrawal by Subject|11|||
142992003|NCT02723019|515505985|FG001|Overall Study|Withdrawal by Subject|7|||
142992004|NCT02723019|515505984|FG000|Overall Study|Lost to Follow-up|57|||
142992005|NCT02723019|515505985|FG001|Overall Study|Lost to Follow-up|70|||
142992006|NCT00958191|515505986|FG000|Overall Study|Death|4|||
142992007|NCT00958191|515505986|FG000|Overall Study|Lost to Follow-up|5|||
142992008|NCT00958191|515505986|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
142992009|NCT00958191|515505986|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
142992010|NCT00958191|515505986|FG000|Overall Study|Revision of study device|4|||
142992011|NCT00958191|515505986|FG000|Overall Study|Site termination|11|||
142992012|NCT00958191|515505986|FG000|Overall Study|No 5 yr x-rays|56|||
142992013|NCT00611767|515505987|FG000|Overall Study|Withdrawal by Subject|4|||
142992014|NCT00611767|515505988|FG001|Overall Study|Withdrawal by Subject|1|||
142992015|NCT00611767|515505987|FG000|Overall Study|Thiopental not available|3|||
142992016|NCT00611767|515505988|FG001|Overall Study|Thiopental not available|0|||
142992017|NCT00611767|515505987|FG000|Overall Study|didn't like the medication|1|||
142992018|NCT00611767|515505988|FG001|Overall Study|didn't like the medication|1|||
142992019|NCT00611767|515505987|FG000|Overall Study|Physician Decision|1|||
142992020|NCT00611767|515505988|FG001|Overall Study|Physician Decision|0|||
142992021|NCT03442595|515505989|FG000|Overall Study|Lost to Follow-up|94|||
142992022|NCT03442595|515505990|FG001|Overall Study|Lost to Follow-up|0|||
142992023|NCT01642004|515505991|FG000|Randomization|Adverse Event unrelated to study drug|1|||
142992024|NCT01642004|515505992|FG001|Randomization|Adverse Event unrelated to study drug|0|||
142992025|NCT01642004|515505991|FG000|Randomization|Participant withdrew consent|1|||
142992026|NCT01642004|515505992|FG001|Randomization|Participant withdrew consent|6|||
142992027|NCT01642004|515505991|FG000|Randomization|No longer meets study criteria|2|||
142992028|NCT01642004|515505992|FG001|Randomization|No longer meets study criteria|2|||
142992029|NCT01642004|515505991|FG000|Treatment|Disease progression|95|||
142992030|NCT01642004|515505992|FG001|Treatment|Disease progression|79|||
142992031|NCT01642004|515505991|FG000|Treatment|Study drug toxicity|10|||
142992032|NCT01642004|515505992|FG001|Treatment|Study drug toxicity|13|||
142992033|NCT01642004|515505991|FG000|Treatment|Death|1|||
142992034|NCT01642004|515505992|FG001|Treatment|Death|1|||
142992035|NCT01642004|515505991|FG000|Treatment|Adverse event unrelated to study drug|9|||
142992036|NCT01642004|515505992|FG001|Treatment|Adverse event unrelated to study drug|13|||
142992037|NCT01642004|515505991|FG000|Treatment|Maximum clinical benefit|1|||
142992038|NCT01642004|515505992|FG001|Treatment|Maximum clinical benefit|9|||
142992039|NCT01642004|515505991|FG000|Treatment|Poor/non-compliance|1|||
142992040|NCT01642004|515505992|FG001|Treatment|Poor/non-compliance|0|||
142992041|NCT01642004|515505991|FG000|Treatment|No longer meets study criteria|1|||
142992042|NCT01642004|515505992|FG001|Treatment|No longer meets study criteria|2|||
142992043|NCT01642004|515505991|FG000|Treatment|Other reasons|2|||
142992044|NCT01642004|515505992|FG001|Treatment|Other reasons|0|||
142992045|NCT01642004|515505991|FG000|Treatment|Not reported|0|||
142992046|NCT01642004|515505992|FG001|Treatment|Not reported|3|||
142992047|NCT01642004|515505991|FG000|Treatment|Participant request to discontinue study treatment|6|||
142992048|NCT01642004|515505992|FG001|Treatment|Participant request to discontinue study treatment|4|||
142992049|NCT01642004|515505991|FG000|Treatment|Participant withdrew consent|5|||
142992050|NCT01642004|515505992|FG001|Treatment|Participant withdrew consent|5|||
142992051|NCT01818765|515505993|FG000|Overall Study|Death|2|||
142992052|NCT02005211|515505996|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
142992053|NCT02005211|515505997|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
142992054|NCT02005211|515505998|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
142992055|NCT02005211|515505999|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
142992056|NCT02005211|515506000|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
142992057|NCT02005211|515506001|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
142992058|NCT02005211|515506002|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
142992059|NCT00952588|515506003|FG000|Overall Study|Death|28|||
142992060|NCT00952588|515506004|FG001|Overall Study|Death|13|||
142992061|NCT00952588|515506003|FG000|Overall Study|Withdrawal by Subject|2|||
142992062|NCT00952588|515506004|FG001|Overall Study|Withdrawal by Subject|5|||
142992063|NCT00952588|515506003|FG000|Overall Study|Adverse Event|2|||
142992064|NCT00952588|515506004|FG001|Overall Study|Adverse Event|3|||
142992065|NCT00952588|515506003|FG000|Overall Study|Lost to Follow-up|2|||
142992066|NCT00952588|515506004|FG001|Overall Study|Lost to Follow-up|0|||
142992067|NCT00952588|515506003|FG000|Overall Study|Physician Decision|0|||
142992068|NCT00952588|515506004|FG001|Overall Study|Physician Decision|1|||
142992069|NCT00952588|515506003|FG000|Overall Study|Lack of Efficacy|2|||
142992070|NCT00952588|515506004|FG001|Overall Study|Lack of Efficacy|2|||
142992071|NCT04554394|515506005|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
142992072|NCT04554394|515506006|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
142992073|NCT04554394|515506005|FG000|Overall Study|Withdrawal by Subject|2|||
142992074|NCT04554394|515506006|FG001|Overall Study|Withdrawal by Subject|2|||
142992075|NCT04554394|515506005|FG000|Overall Study|Lost to Follow-up|2|||
142992076|NCT04554394|515506006|FG001|Overall Study|Lost to Follow-up|2|||
142992077|NCT04554394|515506005|FG000|Overall Study|Physician Decision|1|||
142992078|NCT04554394|515506006|FG001|Overall Study|Physician Decision|1|||
142992079|NCT01021553|515506007|FG000|Overall Study|Adverse Event|1|||
142992080|NCT01021553|515506008|FG001|Overall Study|Adverse Event|0|||
142992081|NCT01021553|515506009|FG002|Overall Study|Adverse Event|0|||
142992082|NCT01021553|515506007|FG000|Overall Study|Lack of Efficacy|2|||
142992083|NCT01021553|515506008|FG001|Overall Study|Lack of Efficacy|2|||
142992084|NCT01021553|515506009|FG002|Overall Study|Lack of Efficacy|0|||
142992085|NCT01021553|515506007|FG000|Overall Study|Protocol Violation|0|||
142992086|NCT01021553|515506008|FG001|Overall Study|Protocol Violation|2|||
142992087|NCT01021553|515506009|FG002|Overall Study|Protocol Violation|2|||
142992088|NCT01021553|515506007|FG000|Overall Study|Lost to Follow-up|0|||
142992089|NCT01021553|515506008|FG001|Overall Study|Lost to Follow-up|0|||
142992090|NCT01021553|515506009|FG002|Overall Study|Lost to Follow-up|1|||
142992091|NCT01021553|515506007|FG000|Overall Study|Withdrawal by Subject|1|||
142992092|NCT01021553|515506008|FG001|Overall Study|Withdrawal by Subject|1|||
142992093|NCT01021553|515506009|FG002|Overall Study|Withdrawal by Subject|0|||
142992094|NCT01950364|515506010|FG000|Overall Study|Adverse Event|3|||
142992095|NCT01950364|515506011|FG001|Overall Study|Adverse Event|0|||
142992096|NCT01950364|515506010|FG000|Overall Study|Stem Cell Transplant|2|||
142992097|NCT01950364|515506011|FG001|Overall Study|Stem Cell Transplant|6|||
142992098|NCT01950364|515506010|FG000|Overall Study|Disease Progression|5|||
142992099|NCT01950364|515506011|FG001|Overall Study|Disease Progression|2|||
142992100|NCT01950364|515506010|FG000|Overall Study|Withdrawal by Subject|0|||
142992101|NCT01950364|515506011|FG001|Overall Study|Withdrawal by Subject|1|||
142992102|NCT01950364|515506010|FG000|Overall Study|Protocol Violation|0|||
142992103|NCT01950364|515506011|FG001|Overall Study|Protocol Violation|1|||
142992104|NCT01055457|515506013|FG000|Overall Study|Lost to Follow-up|0|||
142992105|NCT01055457|515506014|FG001|Overall Study|Lost to Follow-up|1|||
142992106|NCT01055457|515506015|FG002|Overall Study|Lost to Follow-up|0|||
142992107|NCT01055457|515506016|FG003|Overall Study|Lost to Follow-up|0|||
142992108|NCT01055457|515506017|FG004|Overall Study|Lost to Follow-up|0|||
142992109|NCT01055457|515506018|FG005|Overall Study|Lost to Follow-up|1|||
142992110|NCT01055457|515506019|FG006|Overall Study|Lost to Follow-up|0|||
142992111|NCT01055457|515506020|FG007|Overall Study|Lost to Follow-up|0|||
142992112|NCT01055457|515506021|FG008|Overall Study|Lost to Follow-up|0|||
142992113|NCT01055457|515506022|FG009|Overall Study|Lost to Follow-up|0|||
142992114|NCT01055457|515506013|FG000|Overall Study|Protocol Violation|0|||
142992115|NCT01055457|515506014|FG001|Overall Study|Protocol Violation|0|||
142992116|NCT01055457|515506015|FG002|Overall Study|Protocol Violation|1|||
142992117|NCT01055457|515506016|FG003|Overall Study|Protocol Violation|1|||
142992118|NCT01055457|515506017|FG004|Overall Study|Protocol Violation|1|||
142992119|NCT01055457|515506018|FG005|Overall Study|Protocol Violation|2|||
142992120|NCT01055457|515506019|FG006|Overall Study|Protocol Violation|1|||
142992121|NCT01055457|515506020|FG007|Overall Study|Protocol Violation|0|||
143455677|NCT03406078|517212506|FG000|Overall Study|Withdrawal by Subject|5|||
142992122|NCT01055457|515506021|FG008|Overall Study|Protocol Violation|0|||
142992123|NCT01055457|515506022|FG009|Overall Study|Protocol Violation|1|||
142992124|NCT01055457|515506013|FG000|Overall Study|Subject Disinterest|0|||
142992125|NCT01055457|515506014|FG001|Overall Study|Subject Disinterest|0|||
142992126|NCT01055457|515506015|FG002|Overall Study|Subject Disinterest|0|||
142992127|NCT01055457|515506016|FG003|Overall Study|Subject Disinterest|0|||
142992128|NCT01055457|515506017|FG004|Overall Study|Subject Disinterest|0|||
142992129|NCT01055457|515506018|FG005|Overall Study|Subject Disinterest|0|||
142992130|NCT01055457|515506019|FG006|Overall Study|Subject Disinterest|0|||
142992131|NCT01055457|515506020|FG007|Overall Study|Subject Disinterest|1|||
142992132|NCT01055457|515506021|FG008|Overall Study|Subject Disinterest|0|||
142992133|NCT01055457|515506022|FG009|Overall Study|Subject Disinterest|0|||
142992134|NCT01055457|515506013|FG000|Overall Study|Subject Ineligible|1|||
142992135|NCT01055457|515506014|FG001|Overall Study|Subject Ineligible|0|||
142992136|NCT01055457|515506015|FG002|Overall Study|Subject Ineligible|1|||
142992137|NCT01055457|515506016|FG003|Overall Study|Subject Ineligible|0|||
142992138|NCT01055457|515506017|FG004|Overall Study|Subject Ineligible|1|||
142992139|NCT01055457|515506018|FG005|Overall Study|Subject Ineligible|0|||
142992140|NCT01055457|515506019|FG006|Overall Study|Subject Ineligible|0|||
142992141|NCT01055457|515506020|FG007|Overall Study|Subject Ineligible|0|||
142992142|NCT01055457|515506021|FG008|Overall Study|Subject Ineligible|0|||
142992143|NCT01055457|515506022|FG009|Overall Study|Subject Ineligible|0|||
142992144|NCT01055457|515506013|FG000|Overall Study|Discomfort|0|||
142992145|NCT01055457|515506014|FG001|Overall Study|Discomfort|0|||
142992146|NCT01055457|515506015|FG002|Overall Study|Discomfort|0|||
142992147|NCT01055457|515506016|FG003|Overall Study|Discomfort|0|||
142992148|NCT01055457|515506017|FG004|Overall Study|Discomfort|1|||
142992149|NCT01055457|515506018|FG005|Overall Study|Discomfort|0|||
142992150|NCT01055457|515506019|FG006|Overall Study|Discomfort|0|||
142992151|NCT01055457|515506020|FG007|Overall Study|Discomfort|0|||
142992152|NCT01055457|515506021|FG008|Overall Study|Discomfort|0|||
142992153|NCT01055457|515506022|FG009|Overall Study|Discomfort|0|||
142992154|NCT01055457|515506013|FG000|Overall Study|Pregnancy|0|||
142992155|NCT01055457|515506014|FG001|Overall Study|Pregnancy|0|||
142992156|NCT01055457|515506015|FG002|Overall Study|Pregnancy|0|||
142992157|NCT01055457|515506016|FG003|Overall Study|Pregnancy|1|||
142992158|NCT01055457|515506017|FG004|Overall Study|Pregnancy|0|||
142992159|NCT01055457|515506018|FG005|Overall Study|Pregnancy|0|||
142992160|NCT01055457|515506019|FG006|Overall Study|Pregnancy|0|||
142992161|NCT01055457|515506020|FG007|Overall Study|Pregnancy|0|||
142992162|NCT01055457|515506021|FG008|Overall Study|Pregnancy|0|||
142992163|NCT01055457|515506022|FG009|Overall Study|Pregnancy|0|||
142992164|NCT01055457|515506013|FG000|Overall Study|Adverse Event|0|||
142992165|NCT01055457|515506014|FG001|Overall Study|Adverse Event|0|||
142992166|NCT01055457|515506015|FG002|Overall Study|Adverse Event|0|||
142992167|NCT01055457|515506016|FG003|Overall Study|Adverse Event|1|||
142992168|NCT01055457|515506017|FG004|Overall Study|Adverse Event|0|||
142992169|NCT01055457|515506018|FG005|Overall Study|Adverse Event|0|||
142992170|NCT01055457|515506019|FG006|Overall Study|Adverse Event|0|||
142992171|NCT01055457|515506020|FG007|Overall Study|Adverse Event|0|||
142992172|NCT01055457|515506021|FG008|Overall Study|Adverse Event|0|||
142992173|NCT01055457|515506022|FG009|Overall Study|Adverse Event|0|||
142992174|NCT04055844|515506023|FG000|Overall Study|Adverse Event|12|||
142992175|NCT04055844|515506023|FG000|Overall Study|Poor Performance|1|||
142992176|NCT04055844|515506023|FG000|Overall Study|Death|1|||
142992177|NCT02187224|515506032|FG000|Overall Study|Did not show up for test day|1|||
142992178|NCT02187224|515506033|FG001|Overall Study|Did not show up for test day|0|||
142992179|NCT01347840|515506041|FG000|Overall Study|Withdrawal by Subject|1|||
142992180|NCT02415595|515506044|FG000|Overall Study|Administrative reason by sponsor|39|||
142992181|NCT02415595|515506045|FG001|Overall Study|Administrative reason by sponsor|40|||
142992182|NCT02415595|515506046|FG002|Overall Study|Administrative reason by sponsor|41|||
142992183|NCT02415595|515506047|FG003|Overall Study|Administrative reason by sponsor|39|||
142992184|NCT02415595|515506044|FG000|Overall Study|Adverse Event|1|||
142992185|NCT02415595|515506045|FG001|Overall Study|Adverse Event|3|||
142992186|NCT02415595|515506046|FG002|Overall Study|Adverse Event|5|||
142992187|NCT02415595|515506047|FG003|Overall Study|Adverse Event|10|||
142992188|NCT02415595|515506044|FG000|Overall Study|Lack of Efficacy|4|||
142992189|NCT02415595|515506045|FG001|Overall Study|Lack of Efficacy|4|||
142992190|NCT02415595|515506046|FG002|Overall Study|Lack of Efficacy|0|||
142992191|NCT02415595|515506047|FG003|Overall Study|Lack of Efficacy|0|||
142992192|NCT02415595|515506044|FG000|Overall Study|Lost to Follow-up|1|||
142992193|NCT02415595|515506045|FG001|Overall Study|Lost to Follow-up|3|||
142992194|NCT02415595|515506046|FG002|Overall Study|Lost to Follow-up|1|||
142992195|NCT02415595|515506047|FG003|Overall Study|Lost to Follow-up|1|||
142992196|NCT02415595|515506044|FG000|Overall Study|Poor/Non-compliance|1|||
142992197|NCT02415595|515506045|FG001|Overall Study|Poor/Non-compliance|0|||
142992198|NCT02415595|515506046|FG002|Overall Study|Poor/Non-compliance|1|||
142992199|NCT02415595|515506047|FG003|Overall Study|Poor/Non-compliance|0|||
142992200|NCT02415595|515506044|FG000|Overall Study|Reached stopping criteria|0|||
142992201|NCT02415595|515506045|FG001|Overall Study|Reached stopping criteria|1|||
142992202|NCT02415595|515506046|FG002|Overall Study|Reached stopping criteria|1|||
142992203|NCT02415595|515506047|FG003|Overall Study|Reached stopping criteria|0|||
142992204|NCT02415595|515506044|FG000|Overall Study|Withdrawal by Subject|4|||
142992205|NCT02415595|515506045|FG001|Overall Study|Withdrawal by Subject|0|||
142992206|NCT02415595|515506046|FG002|Overall Study|Withdrawal by Subject|1|||
142992207|NCT02415595|515506047|FG003|Overall Study|Withdrawal by Subject|3|||
142992208|NCT02415595|515506044|FG000|Overall Study|Other|0|||
142992209|NCT02415595|515506045|FG001|Overall Study|Other|1|||
142992210|NCT02415595|515506046|FG002|Overall Study|Other|1|||
142992211|NCT02415595|515506047|FG003|Overall Study|Other|0|||
142992212|NCT01700140|515506048|FG000|Overall Study|Use of rescue drugs|3|||
142992213|NCT01700140|515506049|FG001|Overall Study|Use of rescue drugs|3|||
142992214|NCT01700140|515506050|FG002|Overall Study|Use of rescue drugs|1|||
142992215|NCT01700140|515506048|FG000|Overall Study|Discontinuation of radiotherapy|1|||
142992216|NCT01700140|515506049|FG001|Overall Study|Discontinuation of radiotherapy|0|||
142992217|NCT01700140|515506050|FG002|Overall Study|Discontinuation of radiotherapy|0|||
142992218|NCT01700140|515506048|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
142992219|NCT01700140|515506049|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
142992220|NCT01700140|515506050|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
142992221|NCT01700140|515506048|FG000|Overall Study|Aggravation of symptoms|1|||
142992222|NCT01700140|515506049|FG001|Overall Study|Aggravation of symptoms|0|||
142992223|NCT01700140|515506050|FG002|Overall Study|Aggravation of symptoms|0|||
142992224|NCT01700140|515506048|FG000|Overall Study|Adverse Event|0|||
142992225|NCT01700140|515506049|FG001|Overall Study|Adverse Event|1|||
142992226|NCT01700140|515506050|FG002|Overall Study|Adverse Event|0|||
142992227|NCT01700140|515506048|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
142992228|NCT01700140|515506049|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
142992229|NCT01700140|515506050|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
142992230|NCT01060124|515506051|FG000|Overall Study|Other|16|||
142992231|NCT01060124|515506051|FG000|Overall Study|Adverse Event|14|||
142992232|NCT01060124|515506051|FG000|Overall Study|Withdrawal by Subject|7|||
142992233|NCT00518336|515506053|FG000|Year 7|Lost to Follow-up|2|||
142992234|NCT00518336|515506054|FG001|Year 7|Lost to Follow-up|0|||
142992235|NCT00518336|515506053|FG000|Year 7|Could not attend in time|0|||
142992236|NCT00518336|515506054|FG001|Year 7|Could not attend in time|3|||
142992237|NCT00518336|515506053|FG000|Year 8|Lost to Follow-up|1|||
142992238|NCT00518336|515506054|FG001|Year 8|Lost to Follow-up|1|||
142992239|NCT00518336|515506053|FG000|Year 8|Could not attend in time|0|||
142992240|NCT00518336|515506054|FG001|Year 8|Could not attend in time|1|||
142992241|NCT00518336|515506053|FG000|Year 9|Migrated/moved from study area|1|||
142992242|NCT00518336|515506054|FG001|Year 9|Migrated/moved from study area|1|||
142992243|NCT00518336|515506053|FG000|Year 9|Lost to Follow-up|3|||
142992244|NCT00518336|515506054|FG001|Year 9|Lost to Follow-up|0|||
142992245|NCT00518336|515506053|FG000|Year 9|Personal reasons|1|||
142992246|NCT00518336|515506054|FG001|Year 9|Personal reasons|0|||
142992247|NCT03037489|515507608|FG000|Overall Study|Adverse Event|4|||
142992248|NCT03037489|515507609|FG001|Overall Study|Adverse Event|0|||
142992249|NCT03037489|515507608|FG000|Overall Study|Withdrawal by Subject|3|||
142992250|NCT03037489|515507609|FG001|Overall Study|Withdrawal by Subject|0|||
142992251|NCT00621764|515507610|FG000|Overall Study|Protocol Violation|0|||
142992252|NCT00621764|515507611|FG001|Overall Study|Protocol Violation|0|||
142992253|NCT00621764|515507612|FG002|Overall Study|Protocol Violation|0|||
142992254|NCT00621764|515507613|FG003|Overall Study|Protocol Violation|1|||
142992255|NCT00724243|515507616|FG000|Overall Study|Lack of Efficacy|10|||
142992256|NCT00724243|515507616|FG000|Overall Study|Adverse Event|5|||
142992257|NCT03031327|515507617|FG000|Overall Study|Withdrawal by Subject|0|||
142992258|NCT03031327|515507618|FG001|Overall Study|Withdrawal by Subject|1|||
142992259|NCT03031327|515507619|FG002|Overall Study|Withdrawal by Subject|1|||
142992260|NCT01004861|515507620|FG000|Overall Study|Disease progression|3|||
142992261|NCT01004861|515507621|FG001|Overall Study|Disease progression|4|||
142992262|NCT01004861|515507622|FG002|Overall Study|Disease progression|5|||
142992263|NCT01004861|515507623|FG003|Overall Study|Disease progression|4|||
142992264|NCT01004861|515507624|FG004|Overall Study|Disease progression|4|||
142992265|NCT01004861|515507625|FG005|Overall Study|Disease progression|4|||
142992266|NCT01004861|515507626|FG006|Overall Study|Disease progression|5|||
142992267|NCT01004861|515507627|FG007|Overall Study|Disease progression|1|||
142992268|NCT01004861|515507628|FG008|Overall Study|Disease progression|4|||
142992269|NCT01004861|515507629|FG009|Overall Study|Disease progression|7|||
142992270|NCT01004861|515507630|FG010|Overall Study|Disease progression|6|||
142992271|NCT01004861|515507631|FG011|Overall Study|Disease progression|3|||
142992272|NCT01004861|515507632|FG012|Overall Study|Disease progression|8|||
142992273|NCT01004861|515507620|FG000|Overall Study|Physician Decision|0|||
142992274|NCT01004861|515507621|FG001|Overall Study|Physician Decision|2|||
142992275|NCT01004861|515507622|FG002|Overall Study|Physician Decision|1|||
142992276|NCT01004861|515507623|FG003|Overall Study|Physician Decision|1|||
142992277|NCT01004861|515507624|FG004|Overall Study|Physician Decision|1|||
143117239|NCT01709864|515971809|FG001|Overall Study|non-compliance with study treatment|1|||
142992278|NCT01004861|515507625|FG005|Overall Study|Physician Decision|0|||
142992279|NCT01004861|515507626|FG006|Overall Study|Physician Decision|0|||
142992280|NCT01004861|515507627|FG007|Overall Study|Physician Decision|1|||
142992281|NCT01004861|515507628|FG008|Overall Study|Physician Decision|0|||
142992282|NCT01004861|515507629|FG009|Overall Study|Physician Decision|0|||
142992283|NCT01004861|515507630|FG010|Overall Study|Physician Decision|0|||
142992284|NCT01004861|515507631|FG011|Overall Study|Physician Decision|0|||
142992285|NCT01004861|515507632|FG012|Overall Study|Physician Decision|3|||
142992286|NCT01004861|515507620|FG000|Overall Study|Adverse Event|0|||
142992287|NCT01004861|515507621|FG001|Overall Study|Adverse Event|0|||
142992288|NCT01004861|515507622|FG002|Overall Study|Adverse Event|0|||
142992289|NCT01004861|515507623|FG003|Overall Study|Adverse Event|1|||
142992290|NCT01004861|515507624|FG004|Overall Study|Adverse Event|0|||
142992291|NCT01004861|515507625|FG005|Overall Study|Adverse Event|2|||
142992292|NCT01004861|515507626|FG006|Overall Study|Adverse Event|1|||
142992293|NCT01004861|515507627|FG007|Overall Study|Adverse Event|1|||
142992294|NCT01004861|515507628|FG008|Overall Study|Adverse Event|13|||
142992295|NCT01004861|515507629|FG009|Overall Study|Adverse Event|1|||
142992296|NCT01004861|515507630|FG010|Overall Study|Adverse Event|1|||
142992297|NCT01004861|515507631|FG011|Overall Study|Adverse Event|0|||
142992298|NCT01004861|515507632|FG012|Overall Study|Adverse Event|2|||
142992299|NCT01004861|515507620|FG000|Overall Study|Protocol Violation|0|||
142992300|NCT01004861|515507621|FG001|Overall Study|Protocol Violation|0|||
142992301|NCT01004861|515507622|FG002|Overall Study|Protocol Violation|0|||
142992302|NCT01004861|515507623|FG003|Overall Study|Protocol Violation|0|||
142992303|NCT01004861|515507624|FG004|Overall Study|Protocol Violation|1|||
142992304|NCT01004861|515507625|FG005|Overall Study|Protocol Violation|0|||
142992305|NCT01004861|515507626|FG006|Overall Study|Protocol Violation|0|||
142992306|NCT01004861|515507627|FG007|Overall Study|Protocol Violation|0|||
142992307|NCT01004861|515507628|FG008|Overall Study|Protocol Violation|0|||
142992308|NCT01004861|515507629|FG009|Overall Study|Protocol Violation|0|||
142992309|NCT01004861|515507630|FG010|Overall Study|Protocol Violation|0|||
142992310|NCT01004861|515507631|FG011|Overall Study|Protocol Violation|0|||
142992311|NCT01004861|515507632|FG012|Overall Study|Protocol Violation|0|||
142992312|NCT01004861|515507620|FG000|Overall Study|Lost to Follow-up|0|||
142992313|NCT01004861|515507621|FG001|Overall Study|Lost to Follow-up|0|||
142992314|NCT01004861|515507622|FG002|Overall Study|Lost to Follow-up|0|||
142992315|NCT01004861|515507623|FG003|Overall Study|Lost to Follow-up|0|||
142992316|NCT01004861|515507624|FG004|Overall Study|Lost to Follow-up|0|||
142992317|NCT01004861|515507625|FG005|Overall Study|Lost to Follow-up|0|||
142992318|NCT01004861|515507626|FG006|Overall Study|Lost to Follow-up|0|||
142992319|NCT01004861|515507627|FG007|Overall Study|Lost to Follow-up|1|||
142992320|NCT01004861|515507628|FG008|Overall Study|Lost to Follow-up|3|||
142992321|NCT01004861|515507629|FG009|Overall Study|Lost to Follow-up|0|||
142992322|NCT01004861|515507630|FG010|Overall Study|Lost to Follow-up|0|||
142992323|NCT01004861|515507631|FG011|Overall Study|Lost to Follow-up|1|||
142992324|NCT01004861|515507632|FG012|Overall Study|Lost to Follow-up|0|||
142992325|NCT01004861|515507620|FG000|Overall Study|Non-compliance|0|||
142992326|NCT01004861|515507621|FG001|Overall Study|Non-compliance|0|||
142992327|NCT01004861|515507622|FG002|Overall Study|Non-compliance|0|||
142992328|NCT01004861|515507623|FG003|Overall Study|Non-compliance|0|||
142992329|NCT01004861|515507624|FG004|Overall Study|Non-compliance|0|||
142992330|NCT01004861|515507625|FG005|Overall Study|Non-compliance|0|||
142992331|NCT01004861|515507626|FG006|Overall Study|Non-compliance|0|||
142992332|NCT01004861|515507627|FG007|Overall Study|Non-compliance|0|||
142992333|NCT01004861|515507628|FG008|Overall Study|Non-compliance|5|||
142992334|NCT01004861|515507629|FG009|Overall Study|Non-compliance|0|||
142992335|NCT01004861|515507630|FG010|Overall Study|Non-compliance|0|||
142992336|NCT01004861|515507631|FG011|Overall Study|Non-compliance|0|||
142992337|NCT01004861|515507632|FG012|Overall Study|Non-compliance|1|||
142992338|NCT01004861|515507620|FG000|Overall Study|Other|0|||
142992339|NCT01004861|515507621|FG001|Overall Study|Other|0|||
142992340|NCT01004861|515507622|FG002|Overall Study|Other|0|||
142992341|NCT01004861|515507623|FG003|Overall Study|Other|0|||
142992342|NCT01004861|515507624|FG004|Overall Study|Other|0|||
142992343|NCT01004861|515507625|FG005|Overall Study|Other|0|||
142992344|NCT01004861|515507626|FG006|Overall Study|Other|0|||
142992345|NCT01004861|515507627|FG007|Overall Study|Other|0|||
142992346|NCT01004861|515507628|FG008|Overall Study|Other|0|||
142992347|NCT01004861|515507629|FG009|Overall Study|Other|2|||
142992348|NCT01004861|515507630|FG010|Overall Study|Other|1|||
142992349|NCT01004861|515507631|FG011|Overall Study|Other|2|||
142992350|NCT01004861|515507632|FG012|Overall Study|Other|3|||
142992351|NCT01004861|515507620|FG000|Overall Study|Patient decision|0|||
142992352|NCT01004861|515507621|FG001|Overall Study|Patient decision|0|||
142992353|NCT01004861|515507622|FG002|Overall Study|Patient decision|0|||
142992354|NCT01004861|515507623|FG003|Overall Study|Patient decision|0|||
142992355|NCT01004861|515507624|FG004|Overall Study|Patient decision|1|||
142992356|NCT01004861|515507625|FG005|Overall Study|Patient decision|0|||
142992357|NCT01004861|515507626|FG006|Overall Study|Patient decision|1|||
142992358|NCT01004861|515507627|FG007|Overall Study|Patient decision|0|||
142992359|NCT01004861|515507628|FG008|Overall Study|Patient decision|7|||
142992360|NCT01004861|515507629|FG009|Overall Study|Patient decision|1|||
142992361|NCT01004861|515507630|FG010|Overall Study|Patient decision|1|||
142992362|NCT01004861|515507631|FG011|Overall Study|Patient decision|2|||
142992363|NCT01004861|515507632|FG012|Overall Study|Patient decision|3|||
142992364|NCT01004861|515507620|FG000|Overall Study|Transitioned to Phase 4 study|0|||
142992365|NCT01004861|515507621|FG001|Overall Study|Transitioned to Phase 4 study|0|||
142992366|NCT01004861|515507622|FG002|Overall Study|Transitioned to Phase 4 study|0|||
142992367|NCT01004861|515507623|FG003|Overall Study|Transitioned to Phase 4 study|0|||
142992368|NCT01004861|515507624|FG004|Overall Study|Transitioned to Phase 4 study|0|||
142992369|NCT01004861|515507625|FG005|Overall Study|Transitioned to Phase 4 study|0|||
142992370|NCT01004861|515507626|FG006|Overall Study|Transitioned to Phase 4 study|0|||
142992371|NCT01004861|515507627|FG007|Overall Study|Transitioned to Phase 4 study|0|||
142992372|NCT01004861|515507628|FG008|Overall Study|Transitioned to Phase 4 study|2|||
142992373|NCT01004861|515507629|FG009|Overall Study|Transitioned to Phase 4 study|0|||
142992374|NCT01004861|515507630|FG010|Overall Study|Transitioned to Phase 4 study|0|||
142992375|NCT01004861|515507631|FG011|Overall Study|Transitioned to Phase 4 study|0|||
142992376|NCT01004861|515507632|FG012|Overall Study|Transitioned to Phase 4 study|0|||
142992377|NCT01004861|515507620|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
142992378|NCT01004861|515507621|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
142992379|NCT01004861|515507622|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
142992380|NCT01004861|515507623|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
142992381|NCT01004861|515507624|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
142992382|NCT01004861|515507625|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
142992383|NCT01004861|515507626|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
142992384|NCT01004861|515507627|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
142992385|NCT01004861|515507628|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
142992386|NCT01004861|515507629|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
142992387|NCT01004861|515507630|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
142992388|NCT01004861|515507631|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
142992389|NCT01004861|515507632|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
142992390|NCT01004861|515507620|FG000|Overall Study|Patient withdrew|0|||
142992391|NCT01004861|515507621|FG001|Overall Study|Patient withdrew|0|||
142992392|NCT01004861|515507622|FG002|Overall Study|Patient withdrew|0|||
142992393|NCT01004861|515507623|FG003|Overall Study|Patient withdrew|0|||
142992394|NCT01004861|515507624|FG004|Overall Study|Patient withdrew|0|||
142992395|NCT01004861|515507625|FG005|Overall Study|Patient withdrew|0|||
142992396|NCT01004861|515507626|FG006|Overall Study|Patient withdrew|0|||
142992397|NCT01004861|515507627|FG007|Overall Study|Patient withdrew|0|||
142992398|NCT01004861|515507628|FG008|Overall Study|Patient withdrew|1|||
142992399|NCT01004861|515507629|FG009|Overall Study|Patient withdrew|0|||
142992400|NCT01004861|515507630|FG010|Overall Study|Patient withdrew|0|||
142992401|NCT01004861|515507631|FG011|Overall Study|Patient withdrew|0|||
142992402|NCT01004861|515507632|FG012|Overall Study|Patient withdrew|0|||
142992403|NCT01004861|515507620|FG000|Overall Study|Surgical resection|0|||
142992404|NCT01004861|515507621|FG001|Overall Study|Surgical resection|0|||
142992405|NCT01004861|515507622|FG002|Overall Study|Surgical resection|0|||
142992406|NCT01004861|515507623|FG003|Overall Study|Surgical resection|0|||
142992407|NCT01004861|515507624|FG004|Overall Study|Surgical resection|0|||
142992408|NCT01004861|515507625|FG005|Overall Study|Surgical resection|0|||
142992409|NCT01004861|515507626|FG006|Overall Study|Surgical resection|0|||
142992410|NCT01004861|515507627|FG007|Overall Study|Surgical resection|0|||
142992411|NCT01004861|515507628|FG008|Overall Study|Surgical resection|1|||
142992412|NCT01004861|515507629|FG009|Overall Study|Surgical resection|0|||
142992413|NCT01004861|515507630|FG010|Overall Study|Surgical resection|0|||
142992414|NCT01004861|515507631|FG011|Overall Study|Surgical resection|0|||
142992415|NCT01004861|515507632|FG012|Overall Study|Surgical resection|0|||
142992416|NCT01004861|515507620|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
142992417|NCT01004861|515507621|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
142992418|NCT01004861|515507622|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
142992419|NCT01004861|515507623|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
142992420|NCT01004861|515507624|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
142992421|NCT01004861|515507625|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
142992422|NCT01004861|515507626|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
142992423|NCT01004861|515507627|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
142992424|NCT01004861|515507628|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
142992425|NCT01004861|515507629|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
142992426|NCT01004861|515507630|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
142992427|NCT01004861|515507631|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
142992428|NCT01004861|515507632|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
142992429|NCT01004861|515507620|FG000|Overall Study|Study termination by Sponsor|0|||
142992430|NCT01004861|515507621|FG001|Overall Study|Study termination by Sponsor|0|||
142992431|NCT01004861|515507622|FG002|Overall Study|Study termination by Sponsor|0|||
142992432|NCT01004861|515507623|FG003|Overall Study|Study termination by Sponsor|0|||
142992433|NCT01004861|515507624|FG004|Overall Study|Study termination by Sponsor|0|||
142992434|NCT01004861|515507625|FG005|Overall Study|Study termination by Sponsor|0|||
142992435|NCT01004861|515507626|FG006|Overall Study|Study termination by Sponsor|0|||
142992436|NCT01004861|515507627|FG007|Overall Study|Study termination by Sponsor|0|||
142992437|NCT01004861|515507628|FG008|Overall Study|Study termination by Sponsor|1|||
142992438|NCT01004861|515507629|FG009|Overall Study|Study termination by Sponsor|0|||
142992439|NCT01004861|515507630|FG010|Overall Study|Study termination by Sponsor|0|||
142992440|NCT01004861|515507631|FG011|Overall Study|Study termination by Sponsor|0|||
142992441|NCT01004861|515507632|FG012|Overall Study|Study termination by Sponsor|0|||
142992442|NCT00003389|515507633|FG000|Overall Study|Disease progression|6|||
142992443|NCT00003389|515507634|FG001|Overall Study|Disease progression|1|||
142992444|NCT00003389|515507633|FG000|Overall Study|Adverse Event|13|||
142992445|NCT00003389|515507634|FG001|Overall Study|Adverse Event|2|||
142992446|NCT00003389|515507633|FG000|Overall Study|Death|0|||
142992447|NCT00003389|515507634|FG001|Overall Study|Death|3|||
142992448|NCT00003389|515507633|FG000|Overall Study|Withdrawal by Subject|12|||
142992449|NCT00003389|515507634|FG001|Overall Study|Withdrawal by Subject|5|||
142992450|NCT00003389|515507633|FG000|Overall Study|Alternative therapy|2|||
142992451|NCT00003389|515507634|FG001|Overall Study|Alternative therapy|1|||
142992452|NCT00003389|515507633|FG000|Overall Study|Complicating disease|1|||
142992453|NCT00003389|515507634|FG001|Overall Study|Complicating disease|0|||
142992454|NCT00003389|515507633|FG000|Overall Study|Off-treatment reason missing|31|||
142992455|NCT00003389|515507634|FG001|Overall Study|Off-treatment reason missing|21|||
142992456|NCT00003389|515507633|FG000|Overall Study|Ineligible|33|||
142992457|NCT00003389|515507634|FG001|Overall Study|Ineligible|27|||
142992458|NCT02554721|515507635|FG000|Overall Study|Adverse Event|1|||
142992459|NCT02554721|515507636|FG001|Overall Study|Adverse Event|0|||
142992460|NCT02554721|515507637|FG002|Overall Study|Adverse Event|0|||
142992461|NCT02554721|515507638|FG003|Overall Study|Adverse Event|0|||
142992462|NCT02554721|515507639|FG004|Overall Study|Adverse Event|1|||
142992463|NCT02554721|515507635|FG000|Overall Study|Noncompliance|0|||
142992464|NCT02554721|515507636|FG001|Overall Study|Noncompliance|0|||
142992465|NCT02554721|515507637|FG002|Overall Study|Noncompliance|0|||
142992466|NCT02554721|515507638|FG003|Overall Study|Noncompliance|0|||
142992467|NCT02554721|515507639|FG004|Overall Study|Noncompliance|1|||
142992468|NCT00686699|515507640|FG000|Treatment Period 1|Adverse Event|0|||
142992469|NCT00686699|515507641|FG001|Treatment Period 1|Adverse Event|2|||
142992470|NCT04610827|515507643|FG000|Overall Study|Withdrawal by Subject|1|||
142992471|NCT04610827|515507644|FG001|Overall Study|Withdrawal by Subject|1|||
142992472|NCT04610827|515507645|FG002|Overall Study|Withdrawal by Subject|0|||
142992473|NCT01997892|515507647|FG000|Overall Study|Physician Decision|2|||
142992474|NCT01997892|515507647|FG000|Overall Study|Lost to Follow-up|6|||
142992475|NCT01997892|515507647|FG000|Overall Study|Death|14|||
142992476|NCT01997892|515507647|FG000|Overall Study|Renal transplant|8|||
142992477|NCT01997892|515507647|FG000|Overall Study|Other|3|||
142992478|NCT01997892|515507647|FG000|Overall Study|Study completion data not recorded|35|||
142992479|NCT00364611|515507648|FG000|Overall Study|Did not receive study medication|0|||
142992480|NCT00364611|515507649|FG001|Overall Study|Did not receive study medication|1|||
142992481|NCT00364611|515507648|FG000|Overall Study|Adverse Event|7|||
142992482|NCT00364611|515507649|FG001|Overall Study|Adverse Event|4|||
142992483|NCT00364611|515507648|FG000|Overall Study|Participant's Request|3|||
142992484|NCT00364611|515507649|FG001|Overall Study|Participant's Request|4|||
142992485|NCT00364611|515507648|FG000|Overall Study|Disease Progression|38|||
142992486|NCT00364611|515507649|FG001|Overall Study|Disease Progression|8|||
142992487|NCT00364611|515507648|FG000|Overall Study|Investigator decision|2|||
142992488|NCT00364611|515507649|FG001|Overall Study|Investigator decision|2|||
142992489|NCT00364611|515507648|FG000|Overall Study|Found Ineligible|1|||
142992490|NCT00364611|515507649|FG001|Overall Study|Found Ineligible|0|||
142992491|NCT00364611|515507648|FG000|Overall Study|Presumed CR on Study|0|||
142992492|NCT00364611|515507649|FG001|Overall Study|Presumed CR on Study|1|||
142992493|NCT00364611|515507648|FG000|Overall Study|Receiving Liver Ablation|0|||
142992494|NCT00364611|515507649|FG001|Overall Study|Receiving Liver Ablation|1|||
142992495|NCT01693562|515507650|FG000|Escalation Phase|Withdrawal by Subject|0|||
142992496|NCT01693562|515507651|FG001|Escalation Phase|Withdrawal by Subject|1|||
142992497|NCT01693562|515507652|FG002|Escalation Phase|Withdrawal by Subject|0|||
142992498|NCT01693562|515507653|FG003|Escalation Phase|Withdrawal by Subject|0|||
142992499|NCT01693562|515507654|FG004|Escalation Phase|Withdrawal by Subject|0|||
142992500|NCT01693562|515507655|FG005|Escalation Phase|Withdrawal by Subject|2|||
142992501|NCT01693562|515507656|FG006|Escalation Phase|Withdrawal by Subject|0|||
142992502|NCT01693562|515507657|FG007|Escalation Phase|Withdrawal by Subject|0|||
142992503|NCT01693562|515507658|FG008|Escalation Phase|Withdrawal by Subject|0|||
142992504|NCT01693562|515507659|FG009|Escalation Phase|Withdrawal by Subject|0|||
142992505|NCT01693562|515507660|FG010|Escalation Phase|Withdrawal by Subject|0|||
142992506|NCT01693562|515507661|FG011|Escalation Phase|Withdrawal by Subject|0|||
142992507|NCT01693562|515507662|FG012|Escalation Phase|Withdrawal by Subject|0|||
142992508|NCT01693562|515507663|FG013|Escalation Phase|Withdrawal by Subject|0|||
142992509|NCT01693562|515507664|FG014|Escalation Phase|Withdrawal by Subject|0|||
142992510|NCT01693562|515507665|FG015|Escalation Phase|Withdrawal by Subject|0|||
142992511|NCT01693562|515507666|FG016|Escalation Phase|Withdrawal by Subject|0|||
142992512|NCT01693562|515507667|FG017|Escalation Phase|Withdrawal by Subject|0|||
142992513|NCT01693562|515507668|FG018|Escalation Phase|Withdrawal by Subject|0|||
142992514|NCT01693562|515507669|FG019|Escalation Phase|Withdrawal by Subject|0|||
142992515|NCT01693562|515507670|FG020|Escalation Phase|Withdrawal by Subject|0|||
142992516|NCT01693562|515507671|FG021|Escalation Phase|Withdrawal by Subject|0|||
142992517|NCT01693562|515507672|FG022|Escalation Phase|Withdrawal by Subject|0|||
142992518|NCT01693562|515507650|FG000|Escalation Phase|Death|4|||
142992519|NCT01693562|515507651|FG001|Escalation Phase|Death|2|||
142992520|NCT01693562|515507652|FG002|Escalation Phase|Death|0|||
142992521|NCT01693562|515507653|FG003|Escalation Phase|Death|3|||
142992522|NCT01693562|515507654|FG004|Escalation Phase|Death|6|||
142992523|NCT01693562|515507655|FG005|Escalation Phase|Death|4|||
142992524|NCT01693562|515507656|FG006|Escalation Phase|Death|0|||
142992525|NCT01693562|515507657|FG007|Escalation Phase|Death|0|||
142992526|NCT01693562|515507658|FG008|Escalation Phase|Death|0|||
142992527|NCT01693562|515507659|FG009|Escalation Phase|Death|0|||
142992528|NCT01693562|515507660|FG010|Escalation Phase|Death|0|||
142992529|NCT01693562|515507661|FG011|Escalation Phase|Death|0|||
142992530|NCT01693562|515507662|FG012|Escalation Phase|Death|0|||
142992531|NCT01693562|515507663|FG013|Escalation Phase|Death|0|||
142992532|NCT01693562|515507664|FG014|Escalation Phase|Death|0|||
142992533|NCT01693562|515507665|FG015|Escalation Phase|Death|0|||
142992534|NCT01693562|515507666|FG016|Escalation Phase|Death|0|||
142992535|NCT01693562|515507667|FG017|Escalation Phase|Death|0|||
142992536|NCT01693562|515507668|FG018|Escalation Phase|Death|0|||
142992537|NCT01693562|515507669|FG019|Escalation Phase|Death|0|||
142992538|NCT01693562|515507670|FG020|Escalation Phase|Death|0|||
142992539|NCT01693562|515507671|FG021|Escalation Phase|Death|0|||
142992540|NCT01693562|515507672|FG022|Escalation Phase|Death|0|||
142992541|NCT01693562|515507650|FG000|Escalation Phase|Lost to Follow-up|0|||
142992542|NCT01693562|515507651|FG001|Escalation Phase|Lost to Follow-up|1|||
142992543|NCT01693562|515507652|FG002|Escalation Phase|Lost to Follow-up|1|||
142992544|NCT01693562|515507653|FG003|Escalation Phase|Lost to Follow-up|0|||
142992545|NCT01693562|515507654|FG004|Escalation Phase|Lost to Follow-up|0|||
142992546|NCT01693562|515507655|FG005|Escalation Phase|Lost to Follow-up|0|||
142992547|NCT01693562|515507656|FG006|Escalation Phase|Lost to Follow-up|0|||
142992548|NCT01693562|515507657|FG007|Escalation Phase|Lost to Follow-up|0|||
142992549|NCT01693562|515507658|FG008|Escalation Phase|Lost to Follow-up|0|||
142992550|NCT01693562|515507659|FG009|Escalation Phase|Lost to Follow-up|0|||
142992551|NCT01693562|515507660|FG010|Escalation Phase|Lost to Follow-up|0|||
142992552|NCT01693562|515507661|FG011|Escalation Phase|Lost to Follow-up|0|||
142992553|NCT01693562|515507662|FG012|Escalation Phase|Lost to Follow-up|0|||
142992554|NCT01693562|515507663|FG013|Escalation Phase|Lost to Follow-up|0|||
142992555|NCT01693562|515507664|FG014|Escalation Phase|Lost to Follow-up|0|||
142992556|NCT01693562|515507665|FG015|Escalation Phase|Lost to Follow-up|0|||
142992557|NCT01693562|515507666|FG016|Escalation Phase|Lost to Follow-up|0|||
142992558|NCT01693562|515507667|FG017|Escalation Phase|Lost to Follow-up|0|||
142992559|NCT01693562|515507668|FG018|Escalation Phase|Lost to Follow-up|0|||
142992560|NCT01693562|515507669|FG019|Escalation Phase|Lost to Follow-up|0|||
142992561|NCT01693562|515507670|FG020|Escalation Phase|Lost to Follow-up|0|||
142992562|NCT01693562|515507671|FG021|Escalation Phase|Lost to Follow-up|0|||
142992563|NCT01693562|515507672|FG022|Escalation Phase|Lost to Follow-up|0|||
142992564|NCT01693562|515507650|FG000|Escalation Phase|Other|0|||
142992565|NCT01693562|515507651|FG001|Escalation Phase|Other|0|||
142992566|NCT01693562|515507652|FG002|Escalation Phase|Other|2|||
142992567|NCT01693562|515507653|FG003|Escalation Phase|Other|0|||
142992568|NCT01693562|515507654|FG004|Escalation Phase|Other|0|||
142992569|NCT01693562|515507655|FG005|Escalation Phase|Other|1|||
142992570|NCT01693562|515507656|FG006|Escalation Phase|Other|0|||
142992571|NCT01693562|515507657|FG007|Escalation Phase|Other|0|||
142992572|NCT01693562|515507658|FG008|Escalation Phase|Other|0|||
142992573|NCT01693562|515507659|FG009|Escalation Phase|Other|0|||
142992574|NCT01693562|515507660|FG010|Escalation Phase|Other|0|||
142992575|NCT01693562|515507661|FG011|Escalation Phase|Other|0|||
142992576|NCT01693562|515507662|FG012|Escalation Phase|Other|0|||
142992577|NCT01693562|515507663|FG013|Escalation Phase|Other|0|||
142992578|NCT01693562|515507664|FG014|Escalation Phase|Other|0|||
142992579|NCT01693562|515507665|FG015|Escalation Phase|Other|0|||
142992580|NCT01693562|515507666|FG016|Escalation Phase|Other|0|||
142992581|NCT01693562|515507667|FG017|Escalation Phase|Other|0|||
142992582|NCT01693562|515507668|FG018|Escalation Phase|Other|0|||
142992583|NCT01693562|515507669|FG019|Escalation Phase|Other|0|||
142992584|NCT01693562|515507670|FG020|Escalation Phase|Other|0|||
142992585|NCT01693562|515507671|FG021|Escalation Phase|Other|0|||
142992586|NCT01693562|515507672|FG022|Escalation Phase|Other|0|||
142992587|NCT01693562|515507650|FG000|Exploration Phase|Withdrawal by Subject|0|||
142992588|NCT01693562|515507651|FG001|Exploration Phase|Withdrawal by Subject|0|||
142992589|NCT01693562|515507652|FG002|Exploration Phase|Withdrawal by Subject|0|||
142992590|NCT01693562|515507653|FG003|Exploration Phase|Withdrawal by Subject|0|||
142992591|NCT01693562|515507654|FG004|Exploration Phase|Withdrawal by Subject|0|||
142992592|NCT01693562|515507655|FG005|Exploration Phase|Withdrawal by Subject|0|||
142992593|NCT01693562|515507656|FG006|Exploration Phase|Withdrawal by Subject|2|||
142992594|NCT01693562|515507657|FG007|Exploration Phase|Withdrawal by Subject|0|||
142992595|NCT01693562|515507658|FG008|Exploration Phase|Withdrawal by Subject|0|||
142992596|NCT01693562|515507659|FG009|Exploration Phase|Withdrawal by Subject|0|||
142992597|NCT01693562|515507660|FG010|Exploration Phase|Withdrawal by Subject|0|||
142992598|NCT01693562|515507661|FG011|Exploration Phase|Withdrawal by Subject|0|||
142992599|NCT01693562|515507662|FG012|Exploration Phase|Withdrawal by Subject|0|||
142992600|NCT01693562|515507663|FG013|Exploration Phase|Withdrawal by Subject|0|||
142992601|NCT01693562|515507664|FG014|Exploration Phase|Withdrawal by Subject|0|||
142992602|NCT01693562|515507665|FG015|Exploration Phase|Withdrawal by Subject|0|||
142992603|NCT01693562|515507666|FG016|Exploration Phase|Withdrawal by Subject|0|||
142992604|NCT01693562|515507667|FG017|Exploration Phase|Withdrawal by Subject|0|||
142992605|NCT01693562|515507668|FG018|Exploration Phase|Withdrawal by Subject|0|||
142992606|NCT01693562|515507669|FG019|Exploration Phase|Withdrawal by Subject|0|||
142992607|NCT01693562|515507670|FG020|Exploration Phase|Withdrawal by Subject|0|||
142992608|NCT01693562|515507671|FG021|Exploration Phase|Withdrawal by Subject|0|||
142992609|NCT01693562|515507672|FG022|Exploration Phase|Withdrawal by Subject|0|||
142992610|NCT01693562|515507650|FG000|Exploration Phase|Death|0|||
142992611|NCT01693562|515507651|FG001|Exploration Phase|Death|0|||
142992612|NCT01693562|515507652|FG002|Exploration Phase|Death|0|||
142992613|NCT01693562|515507653|FG003|Exploration Phase|Death|0|||
142992614|NCT01693562|515507654|FG004|Exploration Phase|Death|0|||
142992615|NCT01693562|515507655|FG005|Exploration Phase|Death|0|||
142992616|NCT01693562|515507656|FG006|Exploration Phase|Death|17|||
142992617|NCT01693562|515507657|FG007|Exploration Phase|Death|0|||
142992618|NCT01693562|515507658|FG008|Exploration Phase|Death|0|||
142992619|NCT01693562|515507659|FG009|Exploration Phase|Death|0|||
142992620|NCT01693562|515507660|FG010|Exploration Phase|Death|0|||
142992621|NCT01693562|515507661|FG011|Exploration Phase|Death|0|||
142992622|NCT01693562|515507662|FG012|Exploration Phase|Death|0|||
142992623|NCT01693562|515507663|FG013|Exploration Phase|Death|0|||
142992624|NCT01693562|515507664|FG014|Exploration Phase|Death|0|||
142992625|NCT01693562|515507665|FG015|Exploration Phase|Death|0|||
142992626|NCT01693562|515507666|FG016|Exploration Phase|Death|0|||
142992627|NCT01693562|515507667|FG017|Exploration Phase|Death|0|||
142992628|NCT01693562|515507668|FG018|Exploration Phase|Death|0|||
142992629|NCT01693562|515507669|FG019|Exploration Phase|Death|0|||
142992630|NCT01693562|515507670|FG020|Exploration Phase|Death|0|||
142992631|NCT01693562|515507671|FG021|Exploration Phase|Death|0|||
142992632|NCT01693562|515507672|FG022|Exploration Phase|Death|0|||
142992633|NCT01693562|515507650|FG000|Exploration Phase|Other|0|||
142992634|NCT01693562|515507651|FG001|Exploration Phase|Other|0|||
142992635|NCT01693562|515507652|FG002|Exploration Phase|Other|0|||
142992636|NCT01693562|515507653|FG003|Exploration Phase|Other|0|||
142992637|NCT01693562|515507654|FG004|Exploration Phase|Other|0|||
142992638|NCT01693562|515507655|FG005|Exploration Phase|Other|0|||
142992639|NCT01693562|515507656|FG006|Exploration Phase|Other|2|||
142992640|NCT01693562|515507657|FG007|Exploration Phase|Other|0|||
142992641|NCT01693562|515507658|FG008|Exploration Phase|Other|0|||
142992642|NCT01693562|515507659|FG009|Exploration Phase|Other|0|||
142992643|NCT01693562|515507660|FG010|Exploration Phase|Other|0|||
142992644|NCT01693562|515507661|FG011|Exploration Phase|Other|0|||
142992645|NCT01693562|515507662|FG012|Exploration Phase|Other|0|||
142992646|NCT01693562|515507663|FG013|Exploration Phase|Other|0|||
142992647|NCT01693562|515507664|FG014|Exploration Phase|Other|0|||
142992648|NCT01693562|515507665|FG015|Exploration Phase|Other|0|||
142992649|NCT01693562|515507666|FG016|Exploration Phase|Other|0|||
142992650|NCT01693562|515507667|FG017|Exploration Phase|Other|0|||
142992651|NCT01693562|515507668|FG018|Exploration Phase|Other|0|||
142992652|NCT01693562|515507669|FG019|Exploration Phase|Other|0|||
142992653|NCT01693562|515507670|FG020|Exploration Phase|Other|0|||
142992654|NCT01693562|515507671|FG021|Exploration Phase|Other|0|||
142992655|NCT01693562|515507672|FG022|Exploration Phase|Other|0|||
142992656|NCT01693562|515507650|FG000|Expansion Phase|Withdrawal by Subject|0|||
142992657|NCT01693562|515507651|FG001|Expansion Phase|Withdrawal by Subject|0|||
142992658|NCT01693562|515507652|FG002|Expansion Phase|Withdrawal by Subject|0|||
142992659|NCT01693562|515507653|FG003|Expansion Phase|Withdrawal by Subject|0|||
142992660|NCT01693562|515507654|FG004|Expansion Phase|Withdrawal by Subject|0|||
142992661|NCT01693562|515507655|FG005|Expansion Phase|Withdrawal by Subject|0|||
142992662|NCT01693562|515507656|FG006|Expansion Phase|Withdrawal by Subject|0|||
142992663|NCT01693562|515507657|FG007|Expansion Phase|Withdrawal by Subject|16|||
142992664|NCT01693562|515507658|FG008|Expansion Phase|Withdrawal by Subject|2|||
142992665|NCT01693562|515507659|FG009|Expansion Phase|Withdrawal by Subject|54|||
142992666|NCT01693562|515507660|FG010|Expansion Phase|Withdrawal by Subject|2|||
142992667|NCT01693562|515507661|FG011|Expansion Phase|Withdrawal by Subject|2|||
142992668|NCT01693562|515507662|FG012|Expansion Phase|Withdrawal by Subject|3|||
142992669|NCT01693562|515507663|FG013|Expansion Phase|Withdrawal by Subject|5|||
142992670|NCT01693562|515507664|FG014|Expansion Phase|Withdrawal by Subject|16|||
142992671|NCT01693562|515507665|FG015|Expansion Phase|Withdrawal by Subject|7|||
142992672|NCT01693562|515507666|FG016|Expansion Phase|Withdrawal by Subject|40|||
142992673|NCT01693562|515507667|FG017|Expansion Phase|Withdrawal by Subject|4|||
142992674|NCT01693562|515507668|FG018|Expansion Phase|Withdrawal by Subject|8|||
142992675|NCT01693562|515507669|FG019|Expansion Phase|Withdrawal by Subject|3|||
142992676|NCT01693562|515507670|FG020|Expansion Phase|Withdrawal by Subject|1|||
142992677|NCT01693562|515507671|FG021|Expansion Phase|Withdrawal by Subject|8|||
142992678|NCT01693562|515507672|FG022|Expansion Phase|Withdrawal by Subject|1|||
142992679|NCT01693562|515507650|FG000|Expansion Phase|Death|0|||
142992680|NCT01693562|515507651|FG001|Expansion Phase|Death|0|||
142992681|NCT01693562|515507652|FG002|Expansion Phase|Death|0|||
142992682|NCT01693562|515507653|FG003|Expansion Phase|Death|0|||
142992683|NCT01693562|515507654|FG004|Expansion Phase|Death|0|||
142992684|NCT01693562|515507655|FG005|Expansion Phase|Death|0|||
142992685|NCT01693562|515507656|FG006|Expansion Phase|Death|0|||
142992686|NCT01693562|515507657|FG007|Expansion Phase|Death|42|||
142992687|NCT01693562|515507658|FG008|Expansion Phase|Death|17|||
142992688|NCT01693562|515507659|FG009|Expansion Phase|Death|208|||
142992689|NCT01693562|515507660|FG010|Expansion Phase|Death|30|||
142992690|NCT01693562|515507661|FG011|Expansion Phase|Death|8|||
142992691|NCT01693562|515507662|FG012|Expansion Phase|Death|19|||
142992692|NCT01693562|515507663|FG013|Expansion Phase|Death|42|||
142992693|NCT01693562|515507664|FG014|Expansion Phase|Death|23|||
142992694|NCT01693562|515507665|FG015|Expansion Phase|Death|23|||
142992695|NCT01693562|515507666|FG016|Expansion Phase|Death|128|||
142992696|NCT01693562|515507667|FG017|Expansion Phase|Death|16|||
142992697|NCT01693562|515507668|FG018|Expansion Phase|Death|36|||
142992698|NCT01693562|515507669|FG019|Expansion Phase|Death|16|||
142992699|NCT01693562|515507670|FG020|Expansion Phase|Death|17|||
142992700|NCT01693562|515507671|FG021|Expansion Phase|Death|35|||
142992701|NCT01693562|515507672|FG022|Expansion Phase|Death|7|||
142992702|NCT01693562|515507650|FG000|Expansion Phase|Lost to Follow-up|0|||
142992703|NCT01693562|515507651|FG001|Expansion Phase|Lost to Follow-up|0|||
142992704|NCT01693562|515507652|FG002|Expansion Phase|Lost to Follow-up|0|||
142992705|NCT01693562|515507653|FG003|Expansion Phase|Lost to Follow-up|0|||
142992706|NCT01693562|515507654|FG004|Expansion Phase|Lost to Follow-up|0|||
142992707|NCT01693562|515507655|FG005|Expansion Phase|Lost to Follow-up|0|||
142992708|NCT01693562|515507656|FG006|Expansion Phase|Lost to Follow-up|0|||
142992709|NCT01693562|515507657|FG007|Expansion Phase|Lost to Follow-up|1|||
142992710|NCT01693562|515507658|FG008|Expansion Phase|Lost to Follow-up|2|||
142992711|NCT01693562|515507659|FG009|Expansion Phase|Lost to Follow-up|10|||
142992712|NCT01693562|515507660|FG010|Expansion Phase|Lost to Follow-up|4|||
142992713|NCT01693562|515507661|FG011|Expansion Phase|Lost to Follow-up|4|||
142992714|NCT01693562|515507662|FG012|Expansion Phase|Lost to Follow-up|1|||
142992715|NCT01693562|515507663|FG013|Expansion Phase|Lost to Follow-up|3|||
142992716|NCT01693562|515507664|FG014|Expansion Phase|Lost to Follow-up|0|||
142992717|NCT01693562|515507665|FG015|Expansion Phase|Lost to Follow-up|1|||
142992718|NCT01693562|515507666|FG016|Expansion Phase|Lost to Follow-up|1|||
142992719|NCT01693562|515507667|FG017|Expansion Phase|Lost to Follow-up|0|||
142992720|NCT01693562|515507668|FG018|Expansion Phase|Lost to Follow-up|2|||
142992721|NCT01693562|515507669|FG019|Expansion Phase|Lost to Follow-up|1|||
142992722|NCT01693562|515507670|FG020|Expansion Phase|Lost to Follow-up|2|||
142992723|NCT01693562|515507671|FG021|Expansion Phase|Lost to Follow-up|2|||
142992724|NCT01693562|515507672|FG022|Expansion Phase|Lost to Follow-up|1|||
142992725|NCT01693562|515507650|FG000|Expansion Phase|Other|0|||
142992726|NCT01693562|515507651|FG001|Expansion Phase|Other|0|||
142992727|NCT01693562|515507652|FG002|Expansion Phase|Other|0|||
142992728|NCT01693562|515507653|FG003|Expansion Phase|Other|0|||
142992729|NCT01693562|515507654|FG004|Expansion Phase|Other|0|||
142992730|NCT01693562|515507655|FG005|Expansion Phase|Other|0|||
142992731|NCT01693562|515507656|FG006|Expansion Phase|Other|0|||
142992732|NCT01693562|515507657|FG007|Expansion Phase|Other|3|||
142992733|NCT01693562|515507658|FG008|Expansion Phase|Other|1|||
142992734|NCT01693562|515507659|FG009|Expansion Phase|Other|28|||
142992735|NCT01693562|515507660|FG010|Expansion Phase|Other|4|||
142992736|NCT01693562|515507661|FG011|Expansion Phase|Other|7|||
142992737|NCT01693562|515507662|FG012|Expansion Phase|Other|0|||
142992738|NCT01693562|515507663|FG013|Expansion Phase|Other|1|||
142992739|NCT01693562|515507664|FG014|Expansion Phase|Other|1|||
142992740|NCT01693562|515507665|FG015|Expansion Phase|Other|0|||
142992741|NCT01693562|515507666|FG016|Expansion Phase|Other|28|||
142992742|NCT01693562|515507667|FG017|Expansion Phase|Other|0|||
142992743|NCT01693562|515507668|FG018|Expansion Phase|Other|1|||
142992744|NCT01693562|515507669|FG019|Expansion Phase|Other|0|||
142992745|NCT01693562|515507670|FG020|Expansion Phase|Other|1|||
142992746|NCT01693562|515507671|FG021|Expansion Phase|Other|17|||
142992747|NCT01693562|515507672|FG022|Expansion Phase|Other|1|||
142992748|NCT02710422|515507673|FG000|Overall Study|Termination of study|9|||
142992749|NCT02710422|515507674|FG001|Overall Study|Termination of study|9|||
142992750|NCT02059174|515507696|FG000|Period 1|Withdrawal by Subject|0|||
142992751|NCT02059174|515507697|FG001|Period 1|Withdrawal by Subject|2|||
142992752|NCT02059174|515507696|FG000|Period 2|Withdrawal by Subject|0|||
142992753|NCT02059174|515507697|FG001|Period 2|Withdrawal by Subject|2|||
142992754|NCT02059174|515507696|FG000|Period 2|Protocol Violation|1|||
142992755|NCT02059174|515507697|FG001|Period 2|Protocol Violation|0|||
142992756|NCT02059174|515507696|FG000|Period 3|Physician Decision|1|||
142992757|NCT02059174|515507697|FG001|Period 3|Physician Decision|0|||
142992758|NCT02306148|515507698|FG000|Overall Study|Adverse Event|12|||
142992759|NCT02306148|515507699|FG001|Overall Study|Adverse Event|6|||
142992760|NCT02306148|515507698|FG000|Overall Study|Lost to Follow-up|1|||
142992761|NCT02306148|515507699|FG001|Overall Study|Lost to Follow-up|4|||
142992762|NCT00087594|515507704|FG000|Overall Study|Adverse Event|2|||
142992763|NCT00087594|515507705|FG001|Overall Study|Adverse Event|3|||
142992764|NCT00087594|515507704|FG000|Overall Study|Lost to Follow-up|0|||
142992765|NCT00087594|515507705|FG001|Overall Study|Lost to Follow-up|2|||
142992766|NCT00087594|515507704|FG000|Overall Study|Withdrawal by Subject|4|||
142992767|NCT00087594|515507705|FG001|Overall Study|Withdrawal by Subject|2|||
142992768|NCT00087594|515507704|FG000|Overall Study|Lack of Efficacy|2|||
142992769|NCT00087594|515507705|FG001|Overall Study|Lack of Efficacy|5|||
142992770|NCT04657003|515507708|FG000|Overall Study|Adverse Event|5|||
142992771|NCT04657003|515507709|FG001|Overall Study|Adverse Event|1|||
142992772|NCT04657003|515507710|FG002|Overall Study|Adverse Event|5|||
142992773|NCT04657003|515507708|FG000|Overall Study|Death|0|||
142992774|NCT04657003|515507709|FG001|Overall Study|Death|2|||
142992775|NCT04657003|515507710|FG002|Overall Study|Death|0|||
142992776|NCT04657003|515507708|FG000|Overall Study|Lost to Follow-up|8|||
142992777|NCT04657003|515507709|FG001|Overall Study|Lost to Follow-up|4|||
142992778|NCT04657003|515507710|FG002|Overall Study|Lost to Follow-up|10|||
142992779|NCT04657003|515507708|FG000|Overall Study|Other - As Reported by Investigator|3|||
142992780|NCT04657003|515507709|FG001|Overall Study|Other - As Reported by Investigator|2|||
142992781|NCT04657003|515507710|FG002|Overall Study|Other - As Reported by Investigator|2|||
142992782|NCT04657003|515507708|FG000|Overall Study|Pregnancy|2|||
142992783|NCT04657003|515507709|FG001|Overall Study|Pregnancy|0|||
142992784|NCT04657003|515507710|FG002|Overall Study|Pregnancy|2|||
142992785|NCT04657003|515507708|FG000|Overall Study|Withdrawal by Subject|16|||
142992786|NCT04657003|515507709|FG001|Overall Study|Withdrawal by Subject|7|||
142992787|NCT04657003|515507710|FG002|Overall Study|Withdrawal by Subject|10|||
142992788|NCT00768040|515507713|FG000|Overall Study|Adverse Event|3|||
142992789|NCT00768040|515507714|FG001|Overall Study|Adverse Event|2|||
142992790|NCT00768040|515507713|FG000|Overall Study|Abnormal laboratory value|1|||
142992791|NCT00768040|515507714|FG001|Overall Study|Abnormal laboratory value|1|||
142992792|NCT02987205|515507717|FG000|Overall Study|Adverse Event|1|||
142992793|NCT02987205|515507717|FG000|Overall Study|Withdrawal by Subject|3|||
142992794|NCT03558503|515507718|FG000|Overall Study|Adverse Event|1|||
142992795|NCT03558503|515507718|FG000|Overall Study|Death|1|||
142992796|NCT03558503|515507718|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
142992797|NCT02094612|515507719|FG000|Overall Study|Lost to Follow-up|47|||
142992798|NCT02094612|515507720|FG001|Overall Study|Lost to Follow-up|47|||
142992799|NCT02094612|515507719|FG000|Overall Study|Never started ADHD medication|32|||
142992800|NCT02094612|515507720|FG001|Overall Study|Never started ADHD medication|23|||
142992801|NCT02646891|515507721|FG000|Overall Study|Adverse Event|0|||
142992802|NCT02646891|515507722|FG001|Overall Study|Adverse Event|1|||
142992803|NCT02646891|515507723|FG002|Overall Study|Adverse Event|0|||
142992804|NCT02646891|515507724|FG003|Overall Study|Adverse Event|0|||
142992805|NCT02646891|515507725|FG004|Overall Study|Adverse Event|0|||
142992806|NCT02646891|515507726|FG005|Overall Study|Adverse Event|0|||
142992807|NCT02646891|515507727|FG006|Overall Study|Adverse Event|0|||
142992808|NCT02646891|515507728|FG007|Overall Study|Adverse Event|0|||
142992809|NCT02646891|515507729|FG008|Overall Study|Adverse Event|0|||
142992810|NCT02646891|515507730|FG009|Overall Study|Adverse Event|0|||
142992811|NCT02646891|515507721|FG000|Overall Study|Lost to Follow-up|0|||
142992812|NCT02646891|515507722|FG001|Overall Study|Lost to Follow-up|0|||
142992813|NCT02646891|515507723|FG002|Overall Study|Lost to Follow-up|0|||
142992814|NCT02646891|515507724|FG003|Overall Study|Lost to Follow-up|0|||
142992815|NCT02646891|515507725|FG004|Overall Study|Lost to Follow-up|0|||
142992816|NCT02646891|515507726|FG005|Overall Study|Lost to Follow-up|0|||
142992817|NCT02646891|515507727|FG006|Overall Study|Lost to Follow-up|2|||
142992818|NCT02646891|515507728|FG007|Overall Study|Lost to Follow-up|2|||
142992819|NCT02646891|515507729|FG008|Overall Study|Lost to Follow-up|2|||
142992820|NCT02646891|515507730|FG009|Overall Study|Lost to Follow-up|2|||
142992821|NCT02646891|515507721|FG000|Overall Study|Protocol Violation|0|||
142992822|NCT02646891|515507722|FG001|Overall Study|Protocol Violation|0|||
142992823|NCT02646891|515507723|FG002|Overall Study|Protocol Violation|0|||
142992824|NCT02646891|515507724|FG003|Overall Study|Protocol Violation|0|||
142992825|NCT02646891|515507725|FG004|Overall Study|Protocol Violation|0|||
142992826|NCT02646891|515507726|FG005|Overall Study|Protocol Violation|0|||
142992827|NCT02646891|515507727|FG006|Overall Study|Protocol Violation|1|||
142992828|NCT02646891|515507728|FG007|Overall Study|Protocol Violation|1|||
142992829|NCT02646891|515507729|FG008|Overall Study|Protocol Violation|0|||
142992830|NCT02646891|515507730|FG009|Overall Study|Protocol Violation|0|||
142992831|NCT02646891|515507721|FG000|Overall Study|Withdrawal by Subject|2|||
142992832|NCT02646891|515507722|FG001|Overall Study|Withdrawal by Subject|0|||
142992833|NCT02646891|515507723|FG002|Overall Study|Withdrawal by Subject|1|||
142992834|NCT02646891|515507724|FG003|Overall Study|Withdrawal by Subject|0|||
142992835|NCT02646891|515507725|FG004|Overall Study|Withdrawal by Subject|0|||
142992836|NCT02646891|515507726|FG005|Overall Study|Withdrawal by Subject|0|||
142992837|NCT02646891|515507727|FG006|Overall Study|Withdrawal by Subject|5|||
142992838|NCT02646891|515507728|FG007|Overall Study|Withdrawal by Subject|9|||
142992839|NCT02646891|515507729|FG008|Overall Study|Withdrawal by Subject|7|||
142992840|NCT02646891|515507730|FG009|Overall Study|Withdrawal by Subject|3|||
142992841|NCT02646891|515507721|FG000|Overall Study|Death|0|||
142992842|NCT02646891|515507722|FG001|Overall Study|Death|0|||
142992843|NCT02646891|515507723|FG002|Overall Study|Death|0|||
142992844|NCT02646891|515507724|FG003|Overall Study|Death|0|||
142992845|NCT02646891|515507725|FG004|Overall Study|Death|0|||
142992846|NCT02646891|515507726|FG005|Overall Study|Death|0|||
142992847|NCT02646891|515507727|FG006|Overall Study|Death|1|||
142992848|NCT02646891|515507728|FG007|Overall Study|Death|1|||
142992849|NCT02646891|515507729|FG008|Overall Study|Death|1|||
142992850|NCT02646891|515507730|FG009|Overall Study|Death|0|||
142992851|NCT01542632|515507731|FG000|Overall Study|Withdrawal of Consent|0|||
142992852|NCT01542632|515507732|FG001|Overall Study|Withdrawal of Consent|0|||
142992853|NCT01542632|515507733|FG002|Overall Study|Withdrawal of Consent|0|||
142992854|NCT01542632|515507734|FG003|Overall Study|Withdrawal of Consent|2|||
142992855|NCT01542632|515507735|FG004|Overall Study|Withdrawal of Consent|3|||
142992856|NCT01542632|515507736|FG005|Overall Study|Withdrawal of Consent|0|||
142992857|NCT01542632|515507731|FG000|Overall Study|Adverse Event|0|||
142992858|NCT01542632|515507732|FG001|Overall Study|Adverse Event|0|||
142992859|NCT01542632|515507733|FG002|Overall Study|Adverse Event|1|||
142992860|NCT01542632|515507734|FG003|Overall Study|Adverse Event|0|||
142992861|NCT01542632|515507735|FG004|Overall Study|Adverse Event|0|||
142992862|NCT01542632|515507736|FG005|Overall Study|Adverse Event|0|||
142992863|NCT01542632|515507731|FG000|Overall Study|Lost to Follow-up|0|||
142992864|NCT01542632|515507732|FG001|Overall Study|Lost to Follow-up|1|||
142992865|NCT01542632|515507733|FG002|Overall Study|Lost to Follow-up|0|||
142992866|NCT01542632|515507734|FG003|Overall Study|Lost to Follow-up|0|||
142992867|NCT01542632|515507735|FG004|Overall Study|Lost to Follow-up|0|||
142992868|NCT01542632|515507736|FG005|Overall Study|Lost to Follow-up|0|||
142992869|NCT01542632|515507731|FG000|Overall Study|Sponsor/Investigator Decision|0|||
142992870|NCT01542632|515507732|FG001|Overall Study|Sponsor/Investigator Decision|0|||
142992871|NCT01542632|515507733|FG002|Overall Study|Sponsor/Investigator Decision|0|||
142992872|NCT01542632|515507734|FG003|Overall Study|Sponsor/Investigator Decision|0|||
142992873|NCT01542632|515507735|FG004|Overall Study|Sponsor/Investigator Decision|1|||
142992874|NCT01542632|515507736|FG005|Overall Study|Sponsor/Investigator Decision|0|||
142992875|NCT03991936|515507737|FG000|Overall Study|Lost to Follow-up|1|||
142992876|NCT03991936|515507738|FG001|Overall Study|Lost to Follow-up|1|||
142992877|NCT03991936|515507739|FG002|Overall Study|Lost to Follow-up|1|||
142992878|NCT03991936|515507740|FG003|Overall Study|Lost to Follow-up|1|||
142992879|NCT03991936|515507741|FG004|Overall Study|Lost to Follow-up|1|||
142992880|NCT01599585|515507744|FG000|Overall Study|Withdrawal by Subject|16|||
142992881|NCT01599585|515507745|FG001|Overall Study|Withdrawal by Subject|9|||
142992882|NCT01599585|515507744|FG000|Overall Study|Lost to Follow-up|3|||
142992883|NCT01599585|515507745|FG001|Overall Study|Lost to Follow-up|5|||
142992884|NCT01599585|515507744|FG000|Overall Study|randomized did not start treatment|3|||
142992885|NCT01599585|515507745|FG001|Overall Study|randomized did not start treatment|3|||
142992886|NCT02421939|515507756|FG000|Randomization Period: Up to 3 Years|Progressive disease|76|||
142992887|NCT02421939|515507757|FG001|Randomization Period: Up to 3 Years|Progressive disease|16|||
142992888|NCT02421939|515507756|FG000|Randomization Period: Up to 3 Years|Lack of Efficacy|21|||
142992889|NCT02421939|515507757|FG001|Randomization Period: Up to 3 Years|Lack of Efficacy|31|||
142992890|NCT02421939|515507756|FG000|Randomization Period: Up to 3 Years|Death|38|||
142992891|NCT02421939|515507757|FG001|Randomization Period: Up to 3 Years|Death|10|||
142992892|NCT02421939|515507756|FG000|Randomization Period: Up to 3 Years|Disease relapse|37|||
142992893|NCT02421939|515507757|FG001|Randomization Period: Up to 3 Years|Disease relapse|2|||
142992894|NCT02421939|515507756|FG000|Randomization Period: Up to 3 Years|Adverse Event|32|||
142992895|NCT02421939|515507757|FG001|Randomization Period: Up to 3 Years|Adverse Event|5|||
142992896|NCT02421939|515507756|FG000|Randomization Period: Up to 3 Years|Withdrawal by Subject|9|||
142992897|NCT02421939|515507757|FG001|Randomization Period: Up to 3 Years|Withdrawal by Subject|24|||
142992898|NCT02421939|515507756|FG000|Randomization Period: Up to 3 Years|Physician Decision|13|||
142992899|NCT02421939|515507757|FG001|Randomization Period: Up to 3 Years|Physician Decision|11|||
142992900|NCT02421939|515507756|FG000|Randomization Period: Up to 3 Years|Protocol deviation|1|||
142992901|NCT02421939|515507757|FG001|Randomization Period: Up to 3 Years|Protocol deviation|1|||
142992902|NCT02421939|515507756|FG000|Randomization Period: Up to 3 Years|Miscellaneous|20|||
142992903|NCT02421939|515507757|FG001|Randomization Period: Up to 3 Years|Miscellaneous|5|||
142992904|NCT02421939|515507756|FG000|Long Term Follow up: up to 3 Years|Withdrawal by Subject|4|||
142992905|NCT02421939|515507757|FG001|Long Term Follow up: up to 3 Years|Withdrawal by Subject|5|||
142992906|NCT02421939|515507756|FG000|Long Term Follow up: up to 3 Years|Lost to Follow-up|1|||
142992907|NCT02421939|515507757|FG001|Long Term Follow up: up to 3 Years|Lost to Follow-up|2|||
142992908|NCT02421939|515507756|FG000|Long Term Follow up: up to 3 Years|Death|118|||
142992909|NCT02421939|515507757|FG001|Long Term Follow up: up to 3 Years|Death|65|||
142992910|NCT02421939|515507756|FG000|Long Term Follow up: up to 3 Years|Miscellaneous|10|||
142992911|NCT02421939|515507757|FG001|Long Term Follow up: up to 3 Years|Miscellaneous|1|||
142992912|NCT00129376|515507758|FG000|Overall Study|Adverse Event|1|||
142992913|NCT00129376|515507758|FG000|Overall Study|Lack of Efficacy|1|||
142992914|NCT02289833|515507761|FG000|Overall Study|Study discontinuation|0|||
142992915|NCT02289833|515507762|FG001|Overall Study|Study discontinuation|1|||
142992916|NCT02289833|515507761|FG000|Overall Study|Lost to Follow-up|4|||
142992917|NCT02289833|515507762|FG001|Overall Study|Lost to Follow-up|0|||
142992918|NCT02289833|515507761|FG000|Overall Study|Death|23|||
142992919|NCT02289833|515507762|FG001|Overall Study|Death|16|||
142992920|NCT01766401|515507765|FG000|Overall Study|Adverse Event|7|||
142992921|NCT01766401|515507766|FG001|Overall Study|Adverse Event|22|||
142992922|NCT01766401|515507765|FG000|Overall Study|Lack of Efficacy|1|||
142992923|NCT01766401|515507766|FG001|Overall Study|Lack of Efficacy|2|||
142992924|NCT01766401|515507765|FG000|Overall Study|Protocol Violation|3|||
142992925|NCT01766401|515507766|FG001|Overall Study|Protocol Violation|8|||
142992926|NCT01766401|515507765|FG000|Overall Study|Withdrawal by Subject|15|||
142992927|NCT01766401|515507766|FG001|Overall Study|Withdrawal by Subject|12|||
142992928|NCT01766401|515507765|FG000|Overall Study|Lost to Follow-up|10|||
142992929|NCT01766401|515507766|FG001|Overall Study|Lost to Follow-up|11|||
142992930|NCT01766401|515507765|FG000|Overall Study|Pregnancy|1|||
142992931|NCT01766401|515507766|FG001|Overall Study|Pregnancy|1|||
142992932|NCT01197794|515507767|FG000|Overall Study|Adverse Event|3|||
142992933|NCT01197794|515507768|FG001|Overall Study|Adverse Event|2|||
142992934|NCT01197794|515507769|FG002|Overall Study|Adverse Event|4|||
142992935|NCT01197794|515507770|FG003|Overall Study|Adverse Event|4|||
142992936|NCT01197794|515507771|FG004|Overall Study|Adverse Event|4|||
142992937|NCT01197794|515507772|FG005|Overall Study|Adverse Event|2|||
142992938|NCT01197794|515507773|FG006|Overall Study|Adverse Event|3|||
142992939|NCT01197794|515507767|FG000|Overall Study|Protocol Violation|0|||
142992940|NCT01197794|515507768|FG001|Overall Study|Protocol Violation|0|||
142992941|NCT01197794|515507769|FG002|Overall Study|Protocol Violation|0|||
142992942|NCT01197794|515507770|FG003|Overall Study|Protocol Violation|0|||
142992943|NCT01197794|515507771|FG004|Overall Study|Protocol Violation|2|||
142992944|NCT01197794|515507772|FG005|Overall Study|Protocol Violation|0|||
142992945|NCT01197794|515507773|FG006|Overall Study|Protocol Violation|1|||
142992946|NCT01197794|515507767|FG000|Overall Study|Development of study withdrawal criteria|3|||
142992947|NCT01197794|515507768|FG001|Overall Study|Development of study withdrawal criteria|0|||
142992948|NCT01197794|515507769|FG002|Overall Study|Development of study withdrawal criteria|0|||
142992949|NCT01197794|515507770|FG003|Overall Study|Development of study withdrawal criteria|1|||
142992950|NCT01197794|515507771|FG004|Overall Study|Development of study withdrawal criteria|0|||
142992951|NCT01197794|515507772|FG005|Overall Study|Development of study withdrawal criteria|0|||
142992952|NCT01197794|515507773|FG006|Overall Study|Development of study withdrawal criteria|1|||
142992953|NCT01197794|515507767|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
142992954|NCT01197794|515507768|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
142992955|NCT01197794|515507769|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
142992956|NCT01197794|515507770|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
142992957|NCT01197794|515507771|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
142992958|NCT01197794|515507772|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
142992959|NCT01197794|515507773|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
142992960|NCT01197794|515507767|FG000|Overall Study|Withdrawal by Subject|3|||
142992961|NCT01197794|515507768|FG001|Overall Study|Withdrawal by Subject|3|||
142992962|NCT01197794|515507769|FG002|Overall Study|Withdrawal by Subject|4|||
142992963|NCT01197794|515507770|FG003|Overall Study|Withdrawal by Subject|1|||
142992964|NCT01197794|515507771|FG004|Overall Study|Withdrawal by Subject|1|||
142992965|NCT01197794|515507772|FG005|Overall Study|Withdrawal by Subject|5|||
142992966|NCT01197794|515507773|FG006|Overall Study|Withdrawal by Subject|6|||
142992967|NCT01197794|515507767|FG000|Overall Study|Lost to Follow-up|1|||
142992968|NCT01197794|515507768|FG001|Overall Study|Lost to Follow-up|1|||
142992969|NCT01197794|515507769|FG002|Overall Study|Lost to Follow-up|0|||
142992970|NCT01197794|515507770|FG003|Overall Study|Lost to Follow-up|1|||
142992971|NCT01197794|515507771|FG004|Overall Study|Lost to Follow-up|0|||
142992972|NCT01197794|515507772|FG005|Overall Study|Lost to Follow-up|1|||
142992973|NCT01197794|515507773|FG006|Overall Study|Lost to Follow-up|0|||
142992974|NCT01197794|515507767|FG000|Overall Study|Other|1|||
142992975|NCT01197794|515507768|FG001|Overall Study|Other|1|||
142992976|NCT01197794|515507769|FG002|Overall Study|Other|3|||
143455678|NCT03406078|517212507|FG001|Overall Study|Withdrawal by Subject|2|||
142992977|NCT01197794|515507770|FG003|Overall Study|Other|0|||
142992978|NCT01197794|515507771|FG004|Overall Study|Other|2|||
142992979|NCT01197794|515507772|FG005|Overall Study|Other|2|||
142992980|NCT01197794|515507773|FG006|Overall Study|Other|4|||
142992981|NCT01010776|515507774|FG000|Main Phase|Withdrawal by Subject|14|||
142992982|NCT01010776|515507774|FG000|Main Phase|Lack of Efficacy|8|||
142992983|NCT01010776|515507774|FG000|Main Phase|Adverse Event|7|||
142992984|NCT01010776|515507774|FG000|Main Phase|Lost to Follow-up|6|||
142992985|NCT01010776|515507774|FG000|Main Phase|Non-compliance to study medication|5|||
142992986|NCT01010776|515507774|FG000|Main Phase|Selection failure|2|||
142992987|NCT01010776|515507774|FG000|Main Phase|Inform consent withdrawal|1|||
142992988|NCT01010776|515507774|FG000|Main Phase|Other|1|||
142992989|NCT01010776|515507774|FG000|Main Phase|Did not received study medication|5|||
142992990|NCT01010776|515507774|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
142992991|NCT01010776|515507774|FG000|Extension Phase|Other|3|||
142992992|NCT04191096|515507777|FG000|Overall Study|Death|102|||
142992993|NCT04191096|515507778|FG001|Overall Study|Death|89|||
142992994|NCT04191096|515507777|FG000|Overall Study|Lost to Follow-up|1|||
142992995|NCT04191096|515507778|FG001|Overall Study|Lost to Follow-up|1|||
142992996|NCT04191096|515507777|FG000|Overall Study|Withdrawal by Subject|5|||
142992997|NCT04191096|515507778|FG001|Overall Study|Withdrawal by Subject|5|||
142992998|NCT04191096|515507777|FG000|Overall Study|Participants Ongoing|518|||
142992999|NCT04191096|515507778|FG001|Overall Study|Participants Ongoing|530|||
142993000|NCT02683668|515507780|FG000|Period 2|Withdrawal by Subject|0|||
142993001|NCT02683668|515507781|FG001|Period 2|Withdrawal by Subject|1|||
142993002|NCT02683668|515507782|FG002|Period 2|Withdrawal by Subject|0|||
142993003|NCT04223778|515507783|FG000|Overall Study|Death|1|||
142993004|NCT04223778|515507784|FG001|Overall Study|Death|1|||
142993005|NCT04223778|515507783|FG000|Overall Study|Lost to Follow-up|4|||
142993006|NCT04223778|515507784|FG001|Overall Study|Lost to Follow-up|5|||
142993007|NCT04223778|515507783|FG000|Overall Study|Physician Decision|10|||
142993008|NCT04223778|515507784|FG001|Overall Study|Physician Decision|6|||
142993009|NCT04223778|515507783|FG000|Overall Study|Withdrawal by Subject|35|||
142993010|NCT04223778|515507784|FG001|Overall Study|Withdrawal by Subject|17|||
142993011|NCT04223778|515507783|FG000|Overall Study|Not Reported|7|||
142993012|NCT04223778|515507784|FG001|Overall Study|Not Reported|8|||
142993013|NCT03893630|515507787|FG000|Overall Study|Lost to Follow-up|5|||
142993014|NCT03893630|515507788|FG001|Overall Study|Lost to Follow-up|4|||
142993015|NCT03893630|515507789|FG002|Overall Study|Lost to Follow-up|2|||
142993016|NCT03893630|515507787|FG000|Overall Study|Withdrawal by Subject|3|||
142993017|NCT03893630|515507788|FG001|Overall Study|Withdrawal by Subject|6|||
142993018|NCT03893630|515507789|FG002|Overall Study|Withdrawal by Subject|3|||
142993019|NCT03893630|515507787|FG000|Overall Study|Discontinued Intervention|0|||
142993020|NCT03893630|515507788|FG001|Overall Study|Discontinued Intervention|4|||
142993021|NCT03893630|515507789|FG002|Overall Study|Discontinued Intervention|2|||
142993022|NCT03053180|515509060|FG000|Overall Study|Failure to Return|1|||
142993023|NCT03958149|515509062|FG000|Overall Study|Withdrawal by Subject|0|||
142993024|NCT03958149|515509063|FG001|Overall Study|Withdrawal by Subject|1|||
142993025|NCT02785588|515509064|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
142993026|NCT02785588|515509064|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
142993027|NCT00211536|515509070|FG000|Overall Study|Withdrawal by Subject|2|||
142993028|NCT00211536|515509071|FG001|Overall Study|Withdrawal by Subject|2|||
142993029|NCT00211536|515509070|FG000|Overall Study|Physician Decision|0|||
142993030|NCT00211536|515509071|FG001|Overall Study|Physician Decision|5|||
142993031|NCT00211536|515509070|FG000|Overall Study|Adverse Event|2|||
142993032|NCT00211536|515509071|FG001|Overall Study|Adverse Event|0|||
142993033|NCT00669240|515509072|FG000|Overall Study|Lack of Efficacy|33|||
142993034|NCT00669240|515509072|FG000|Overall Study|Withdrawal by Subject|42|||
142993035|NCT00669240|515509072|FG000|Overall Study|Lost to Follow-up|34|||
142993036|NCT00669240|515509072|FG000|Overall Study|Adverse Event|21|||
142993037|NCT00669240|515509072|FG000|Overall Study|Other|19|||
142993038|NCT00669240|515509072|FG000|Overall Study|Enrolled but not treated|15|||
142993039|NCT00669240|515509072|FG000|Overall Study|Enrolled but no dosing record|1|||
142993040|NCT02583399|515509073|FG000|Overall Study|Able to be discharged|3|||
142993041|NCT02583399|515509073|FG000|Overall Study|Wanted to use a restricted medication|3|||
142993042|NCT02759939|515509078|FG000|Overall Study|Missing data on first outcome assessed|11|||
142993043|NCT02759939|515509079|FG001|Overall Study|Missing data on first outcome assessed|2|||
142993044|NCT02759939|515509080|FG002|Overall Study|Missing data on first outcome assessed|5|||
142993045|NCT02759939|515509081|FG003|Overall Study|Missing data on first outcome assessed|2|||
142993046|NCT02759939|515509078|FG000|Overall Study|Ineligible for T2 and T3|310|||
142993047|NCT02759939|515509079|FG001|Overall Study|Ineligible for T2 and T3|179|||
142993048|NCT02759939|515509080|FG002|Overall Study|Ineligible for T2 and T3|366|||
142993049|NCT02759939|515509081|FG003|Overall Study|Ineligible for T2 and T3|391|||
142993050|NCT02759939|515509078|FG000|Overall Study|Lost to Follow-up|735|||
142993051|NCT02759939|515509079|FG001|Overall Study|Lost to Follow-up|791|||
142993052|NCT02759939|515509080|FG002|Overall Study|Lost to Follow-up|783|||
142993053|NCT02759939|515509081|FG003|Overall Study|Lost to Follow-up|650|||
142993054|NCT04397757|515509083|FG000|Overall Study|Death|3|||
142993055|NCT04397757|515509084|FG001|Overall Study|Death|11|||
142993056|NCT04397757|515509083|FG000|Overall Study|Withdrawal by Subject|2|||
142993057|NCT04397757|515509084|FG001|Overall Study|Withdrawal by Subject|0|||
142993058|NCT04397757|515509083|FG000|Overall Study|Lost to Follow-up|4|||
142993059|NCT04397757|515509084|FG001|Overall Study|Lost to Follow-up|3|||
142993060|NCT00508001|515509096|FG000|Overall Study|Adverse Event|2|||
142993061|NCT00508001|515509097|FG001|Overall Study|Adverse Event|0|||
142993062|NCT00508001|515509098|FG002|Overall Study|Adverse Event|4|||
142993063|NCT00508001|515509096|FG000|Overall Study|condition under investigation worsened|13|||
142993064|NCT00508001|515509097|FG001|Overall Study|condition under investigation worsened|7|||
142993065|NCT00508001|515509098|FG002|Overall Study|condition under investigation worsened|1|||
142993066|NCT00508001|515509096|FG000|Overall Study|Death|0|||
142993067|NCT00508001|515509097|FG001|Overall Study|Death|1|||
142993068|NCT00508001|515509098|FG002|Overall Study|Death|1|||
142993069|NCT00508001|515509096|FG000|Overall Study|Withdrawal by Subject|4|||
142993070|NCT00508001|515509097|FG001|Overall Study|Withdrawal by Subject|4|||
142993071|NCT00508001|515509098|FG002|Overall Study|Withdrawal by Subject|1|||
142993072|NCT01685372|515509101|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
142993073|NCT01685372|515509102|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
142993074|NCT00103207|515509103|FG000|Overall Study|Adverse Event|3|||
142993075|NCT00103207|515509103|FG000|Overall Study|Death|1|||
142993076|NCT00103207|515509103|FG000|Overall Study|Withdrawal by Subject|2|||
142993077|NCT00103207|515509103|FG000|Overall Study|Other complicating disease|1|||
142993078|NCT00103207|515509103|FG000|Overall Study|Ineligible|4|||
142993079|NCT00103207|515509103|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
142993080|NCT00811395|515509110|FG000|Extension Treatment|Adverse Event|1|||
142993081|NCT00811395|515509111|FG001|Extension Treatment|Adverse Event|2|||
142993082|NCT00811395|515509112|FG002|Extension Treatment|Adverse Event|2|||
142993083|NCT00811395|515509113|FG003|Extension Treatment|Adverse Event|2|||
142993084|NCT00811395|515509114|FG004|Extension Treatment|Adverse Event|0|||
142993085|NCT00811395|515509115|FG005|Extension Treatment|Adverse Event|1|||
142993086|NCT00811395|515509110|FG000|Extension Treatment|Progressive disease|1|||
142993087|NCT00811395|515509111|FG001|Extension Treatment|Progressive disease|1|||
142993088|NCT00811395|515509112|FG002|Extension Treatment|Progressive disease|0|||
142993089|NCT00811395|515509113|FG003|Extension Treatment|Progressive disease|0|||
142993090|NCT00811395|515509114|FG004|Extension Treatment|Progressive disease|0|||
142993091|NCT00811395|515509115|FG005|Extension Treatment|Progressive disease|0|||
142993092|NCT00811395|515509110|FG000|Extension Treatment|Participant did not wish to continue|0|||
142993093|NCT00811395|515509111|FG001|Extension Treatment|Participant did not wish to continue|3|||
142993094|NCT00811395|515509112|FG002|Extension Treatment|Participant did not wish to continue|0|||
142993095|NCT00811395|515509113|FG003|Extension Treatment|Participant did not wish to continue|1|||
142993096|NCT00811395|515509114|FG004|Extension Treatment|Participant did not wish to continue|0|||
142993097|NCT00811395|515509115|FG005|Extension Treatment|Participant did not wish to continue|1|||
142993098|NCT00811395|515509110|FG000|Extension Treatment|Other than above|0|||
142993099|NCT00811395|515509111|FG001|Extension Treatment|Other than above|0|||
142993100|NCT00811395|515509112|FG002|Extension Treatment|Other than above|1|||
142993101|NCT00811395|515509113|FG003|Extension Treatment|Other than above|0|||
142993102|NCT00811395|515509114|FG004|Extension Treatment|Other than above|0|||
142993103|NCT00811395|515509115|FG005|Extension Treatment|Other than above|0|||
142993104|NCT00170846|515509120|FG000|Overall Study|Subject withdrew Informed Consent|5|||
142993105|NCT00170846|515509121|FG001|Overall Study|Subject withdrew Informed Consent|12|||
142993106|NCT00170846|515509122|FG002|Overall Study|Subject withdrew Informed Consent|8|||
142993107|NCT00170846|515509120|FG000|Overall Study|Lost to Follow-up|6|||
142993108|NCT00170846|515509121|FG001|Overall Study|Lost to Follow-up|3|||
142993109|NCT00170846|515509122|FG002|Overall Study|Lost to Follow-up|2|||
142993110|NCT00170846|515509120|FG000|Overall Study|Death|0|||
142993111|NCT00170846|515509121|FG001|Overall Study|Death|3|||
142993112|NCT00170846|515509122|FG002|Overall Study|Death|3|||
142993113|NCT00170846|515509120|FG000|Overall Study|Reason Missing|0|||
142993114|NCT00170846|515509121|FG001|Overall Study|Reason Missing|1|||
142993115|NCT00170846|515509122|FG002|Overall Study|Reason Missing|0|||
142993116|NCT00528840|515509125|FG000|Overall Study|Lost to Follow-up|10|||
142993117|NCT00528840|515509125|FG000|Overall Study|Adverse Event|1|||
142993118|NCT00528840|515509125|FG000|Overall Study|Withdrawal by Subject|17|||
142993119|NCT00528840|515509125|FG000|Overall Study|Death|2|||
142993120|NCT00528840|515509125|FG000|Overall Study|Administrative Reasons|1|||
142993121|NCT00528840|515509125|FG000|Overall Study|Other|2|||
142993122|NCT02447952|515509126|FG000|Overall Study|Adverse Event|2|||
142993123|NCT02447952|515509126|FG000|Overall Study|Physician Decision|1|||
142993124|NCT02447952|515509126|FG000|Overall Study|Withdrawal by Subject|4|||
142993125|NCT01603628|515509133|FG000|Overall Study|Personal Reasons|1|||
142993126|NCT01603628|515509134|FG001|Overall Study|Personal Reasons|1|||
142993127|NCT01603628|515509135|FG002|Overall Study|Personal Reasons|2|||
142993128|NCT01603628|515509133|FG000|Overall Study|Protocol Violation|1|||
142993129|NCT01603628|515509134|FG001|Overall Study|Protocol Violation|1|||
142993130|NCT01603628|515509135|FG002|Overall Study|Protocol Violation|0|||
142993131|NCT01603628|515509133|FG000|Overall Study|Lost to Follow-up|0|||
142993132|NCT01603628|515509134|FG001|Overall Study|Lost to Follow-up|1|||
142993133|NCT01603628|515509135|FG002|Overall Study|Lost to Follow-up|0|||
142993134|NCT01603628|515509133|FG000|Overall Study|Other Miscellaneous Reason|1|||
142993135|NCT01603628|515509134|FG001|Overall Study|Other Miscellaneous Reason|0|||
142993136|NCT01603628|515509135|FG002|Overall Study|Other Miscellaneous Reason|0|||
142993137|NCT01969565|515509136|FG000|Overall Study|Withdrawal by Subject|1|||
142993138|NCT01756833|515509142|FG000|Overall Study|Withdrawal by Subject|4|||
142993139|NCT01756833|515509143|FG001|Overall Study|Withdrawal by Subject|3|||
142993140|NCT02795182|515509147|FG000|Overall Study|Death|5|||
142993141|NCT02795182|515509148|FG001|Overall Study|Death|4|||
142993142|NCT02795182|515509149|FG002|Overall Study|Death|4|||
142993143|NCT02795182|515509150|FG003|Overall Study|Death|18|||
142993144|NCT02795182|515509147|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
142993145|NCT02795182|515509148|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
142993146|NCT02795182|515509149|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
142993147|NCT02795182|515509150|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
142993148|NCT02795182|515509147|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
142993149|NCT02795182|515509148|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
142993150|NCT02795182|515509149|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
142993151|NCT02795182|515509150|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
142993152|NCT02795182|515509147|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
142993153|NCT02795182|515509148|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
142993154|NCT02795182|515509149|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
142993155|NCT02795182|515509150|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
142993156|NCT02795182|515509147|FG000|Overall Study|Withdrawal by Subject|4|||
142993157|NCT02795182|515509148|FG001|Overall Study|Withdrawal by Subject|0|||
142993158|NCT02795182|515509149|FG002|Overall Study|Withdrawal by Subject|0|||
142993159|NCT02795182|515509150|FG003|Overall Study|Withdrawal by Subject|3|||
142993160|NCT02795182|515509147|FG000|Overall Study|Lost to Follow-up|0|||
142993161|NCT02795182|515509148|FG001|Overall Study|Lost to Follow-up|0|||
142993162|NCT02795182|515509149|FG002|Overall Study|Lost to Follow-up|1|||
142993163|NCT02795182|515509150|FG003|Overall Study|Lost to Follow-up|1|||
142993164|NCT02795182|515509147|FG000|Overall Study|Roll Over to Long Term Extension|3|||
142993165|NCT02795182|515509148|FG001|Overall Study|Roll Over to Long Term Extension|3|||
142993166|NCT02795182|515509149|FG002|Overall Study|Roll Over to Long Term Extension|2|||
142993167|NCT02795182|515509150|FG003|Overall Study|Roll Over to Long Term Extension|5|||
142993168|NCT02795182|515509147|FG000|Overall Study|Progressive Disease|0|||
142993169|NCT02795182|515509148|FG001|Overall Study|Progressive Disease|1|||
142993170|NCT02795182|515509149|FG002|Overall Study|Progressive Disease|0|||
142993171|NCT02795182|515509150|FG003|Overall Study|Progressive Disease|4|||
142993172|NCT02795182|515509147|FG000|Overall Study|Physician Decision|0|||
142993173|NCT02795182|515509148|FG001|Overall Study|Physician Decision|0|||
142993174|NCT02795182|515509149|FG002|Overall Study|Physician Decision|0|||
142993175|NCT02795182|515509150|FG003|Overall Study|Physician Decision|1|||
142993176|NCT02087241|515509151|FG000|Overall Study|Death|2|||
142993177|NCT02087241|515509152|FG001|Overall Study|Death|1|||
142993178|NCT02087241|515509153|FG002|Overall Study|Death|1|||
142993179|NCT02087241|515509154|FG003|Overall Study|Death|1|||
142993180|NCT02087241|515509151|FG000|Overall Study|Withdrawal by Subject|1|||
142993181|NCT02087241|515509152|FG001|Overall Study|Withdrawal by Subject|0|||
142993182|NCT02087241|515509153|FG002|Overall Study|Withdrawal by Subject|0|||
142993183|NCT02087241|515509154|FG003|Overall Study|Withdrawal by Subject|1|||
142993184|NCT02087241|515509151|FG000|Overall Study|Progressive Disease|0|||
142993185|NCT02087241|515509152|FG001|Overall Study|Progressive Disease|0|||
142993186|NCT02087241|515509153|FG002|Overall Study|Progressive Disease|0|||
142993187|NCT02087241|515509154|FG003|Overall Study|Progressive Disease|1|||
142993188|NCT02087241|515509151|FG000|Overall Study|Study Terminated by Sponsor|0|||
142993189|NCT02087241|515509152|FG001|Overall Study|Study Terminated by Sponsor|2|||
142993190|NCT02087241|515509153|FG002|Overall Study|Study Terminated by Sponsor|0|||
142993191|NCT02087241|515509154|FG003|Overall Study|Study Terminated by Sponsor|4|||
142993192|NCT02181504|515509155|FG000|Overall Study|Adverse Event|1|||
142993193|NCT02181504|515509156|FG001|Overall Study|Adverse Event|1|||
142993194|NCT02181504|515509157|FG002|Overall Study|Adverse Event|1|||
142993195|NCT01289028|515509158|FG000|Overall Study|Progressive Disease|49|||
142993196|NCT01289028|515509158|FG000|Overall Study|Adverse Event|14|||
142993197|NCT01289028|515509158|FG000|Overall Study|Withdrawal by Subject|6|||
142993198|NCT01289028|515509158|FG000|Overall Study|Death|4|||
142993199|NCT01289028|515509158|FG000|Overall Study|Lack of Efficacy|2|||
142993200|NCT01289028|515509158|FG000|Overall Study|No longer required|2|||
142993201|NCT01289028|515509158|FG000|Overall Study|Lost to Follow-up|2|||
142993202|NCT01289028|515509158|FG000|Overall Study|New Cancer Therapy|2|||
142993203|NCT01289028|515509158|FG000|Overall Study|Abnormal Lab Value|1|||
142993204|NCT01289028|515509158|FG000|Overall Study|Missing reason for discon|1|||
142993205|NCT03117309|515509159|FG000|Overall Study|Not meeting inclusion criteria|0|||
142993206|NCT03117309|515509160|FG001|Overall Study|Not meeting inclusion criteria|1|||
142993207|NCT02120469|515509163|FG000|Overall Study|HER-2/neu-amplified|1|||
142993208|NCT02120469|515509164|FG001|Overall Study|HER-2/neu-amplified|0|||
142993209|NCT02120469|515509165|FG002|Overall Study|HER-2/neu-amplified|1|||
142993210|NCT00998985|515509170|FG000|Overall Study|Withdrawal by Subject|0|||
142993211|NCT00998985|515509171|FG001|Overall Study|Withdrawal by Subject|0|||
142993212|NCT00998985|515509172|FG002|Overall Study|Withdrawal by Subject|0|||
143003182|NCT01049360|515548754|FG010|Period 2|Lack of Efficacy|0|||
142993213|NCT00998985|515509173|FG003|Overall Study|Withdrawal by Subject|0|||
142993214|NCT00998985|515509174|FG004|Overall Study|Withdrawal by Subject|0|||
142993215|NCT00998985|515509175|FG005|Overall Study|Withdrawal by Subject|0|||
142993216|NCT00998985|515509176|FG006|Overall Study|Withdrawal by Subject|0|||
142993217|NCT00998985|515509177|FG007|Overall Study|Withdrawal by Subject|0|||
142993218|NCT00998985|515509178|FG008|Overall Study|Withdrawal by Subject|1|||
142993219|NCT00998985|515509179|FG009|Overall Study|Withdrawal by Subject|0|||
142993220|NCT00998985|515509180|FG010|Overall Study|Withdrawal by Subject|0|||
142993221|NCT00998985|515509181|FG011|Overall Study|Withdrawal by Subject|0|||
142993222|NCT00998985|515509182|FG012|Overall Study|Withdrawal by Subject|0|||
142993223|NCT00998985|515509183|FG013|Overall Study|Withdrawal by Subject|0|||
142993224|NCT00998985|515509170|FG000|Overall Study|Protocol Violation|0|||
142993225|NCT00998985|515509171|FG001|Overall Study|Protocol Violation|0|||
142993226|NCT00998985|515509172|FG002|Overall Study|Protocol Violation|0|||
142993227|NCT00998985|515509173|FG003|Overall Study|Protocol Violation|0|||
142993228|NCT00998985|515509174|FG004|Overall Study|Protocol Violation|0|||
142993229|NCT00998985|515509175|FG005|Overall Study|Protocol Violation|1|||
142993230|NCT00998985|515509176|FG006|Overall Study|Protocol Violation|0|||
142993231|NCT00998985|515509177|FG007|Overall Study|Protocol Violation|0|||
142993232|NCT00998985|515509178|FG008|Overall Study|Protocol Violation|0|||
142993233|NCT00998985|515509179|FG009|Overall Study|Protocol Violation|0|||
142993234|NCT00998985|515509180|FG010|Overall Study|Protocol Violation|0|||
142993235|NCT00998985|515509181|FG011|Overall Study|Protocol Violation|0|||
142993236|NCT00998985|515509182|FG012|Overall Study|Protocol Violation|0|||
142993237|NCT00998985|515509183|FG013|Overall Study|Protocol Violation|0|||
142993238|NCT02583711|515509184|FG000|Overall Study|Withdrawal by Subject|0|||
142993239|NCT02583711|515509185|FG001|Overall Study|Withdrawal by Subject|10|||
142993240|NCT02583711|515509186|FG002|Overall Study|Withdrawal by Subject|0|||
142993241|NCT01432938|515509190|FG000|First Intervention|Protocol Violation|1|||
142993242|NCT01432938|515509191|FG001|First Intervention|Protocol Violation|0|||
142993243|NCT01432938|515509190|FG000|First Intervention|Physician Decision|1|||
142993244|NCT01432938|515509191|FG001|First Intervention|Physician Decision|0|||
142993245|NCT01432938|515509190|FG000|Second Intervention|Adverse Event|1|||
142993246|NCT01432938|515509191|FG001|Second Intervention|Adverse Event|0|||
142993247|NCT02736474|515509192|FG000|Overall Study|Lost to Follow-up|0|||
142993248|NCT02736474|515509193|FG001|Overall Study|Lost to Follow-up|1|||
142993249|NCT02463331|515509194|FG000|Overall Study|Adverse Event|4|||
142993250|NCT02463331|515509195|FG001|Overall Study|Adverse Event|2|||
142993251|NCT02463331|515509194|FG000|Overall Study|Lost to Follow-up|1|||
142993252|NCT02463331|515509195|FG001|Overall Study|Lost to Follow-up|1|||
142993253|NCT02463331|515509194|FG000|Overall Study|Pregnancy|2|||
142993254|NCT02463331|515509195|FG001|Overall Study|Pregnancy|3|||
142993255|NCT02463331|515509194|FG000|Overall Study|Lack of Efficacy|6|||
142993256|NCT02463331|515509195|FG001|Overall Study|Lack of Efficacy|0|||
142993257|NCT02463331|515509194|FG000|Overall Study|Physician Decision|3|||
142993258|NCT02463331|515509195|FG001|Overall Study|Physician Decision|0|||
142993259|NCT02382276|515509196|FG000|Overall Study|Withdrawal by Subject|4|||
142993260|NCT02382276|515509197|FG001|Overall Study|Withdrawal by Subject|8|||
142993261|NCT02382276|515509198|FG002|Overall Study|Withdrawal by Subject|5|||
142993262|NCT02382276|515509196|FG000|Overall Study|Adverse Event|7|||
142993263|NCT02382276|515509197|FG001|Overall Study|Adverse Event|2|||
142993264|NCT02382276|515509198|FG002|Overall Study|Adverse Event|32|||
142993265|NCT02382276|515509196|FG000|Overall Study|Physician Decision|0|||
142993266|NCT02382276|515509197|FG001|Overall Study|Physician Decision|0|||
142993267|NCT02382276|515509198|FG002|Overall Study|Physician Decision|2|||
142993268|NCT01222416|515509199|FG000|Overall Study|ineligible;metastasis|3|||
142993269|NCT01222416|515509200|FG001|Overall Study|ineligible;metastasis|0|||
142993270|NCT01222416|515509199|FG000|Overall Study|Adverse Event|4|||
142993271|NCT01222416|515509200|FG001|Overall Study|Adverse Event|0|||
142993272|NCT01222416|515509199|FG000|Overall Study|Withdrawal by Subject|5|||
142993273|NCT01222416|515509200|FG001|Overall Study|Withdrawal by Subject|0|||
142993274|NCT01222416|515509199|FG000|Overall Study|scheduling|6|||
142993275|NCT01222416|515509200|FG001|Overall Study|scheduling|0|||
142993276|NCT01222416|515509199|FG000|Overall Study|missed view/scan|1|||
142993277|NCT01222416|515509200|FG001|Overall Study|missed view/scan|0|||
142993278|NCT01222416|515509199|FG000|Overall Study|Death|1|||
142993279|NCT01222416|515509200|FG001|Overall Study|Death|0|||
142993280|NCT00703781|515509203|FG000|Overall Study|Withdrawal by Subject|1|||
142993281|NCT00703781|515509204|FG001|Overall Study|Withdrawal by Subject|2|||
142993282|NCT00703781|515509203|FG000|Overall Study|Cancelled surgery|1|||
142993283|NCT00703781|515509204|FG001|Overall Study|Cancelled surgery|0|||
142993284|NCT02185040|515510950|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
142993285|NCT02185040|515510951|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
142993286|NCT02185040|515510952|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
142993287|NCT02185040|515510953|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
142993288|NCT02185040|515510954|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
142993289|NCT02185040|515510955|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
142993290|NCT02185040|515510956|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
142993291|NCT02185040|515510950|FG000|Part 1 Treatment Phase|Adverse Event|1|||
142993292|NCT02185040|515510951|FG001|Part 1 Treatment Phase|Adverse Event|0|||
142993293|NCT02185040|515510952|FG002|Part 1 Treatment Phase|Adverse Event|0|||
142993294|NCT02185040|515510953|FG003|Part 1 Treatment Phase|Adverse Event|2|||
142993295|NCT02185040|515510954|FG004|Part 1 Treatment Phase|Adverse Event|3|||
142993296|NCT02185040|515510955|FG005|Part 1 Treatment Phase|Adverse Event|0|||
142993297|NCT02185040|515510956|FG006|Part 1 Treatment Phase|Adverse Event|0|||
142993298|NCT02185040|515510950|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
142993299|NCT02185040|515510951|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
142993300|NCT02185040|515510952|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
142993301|NCT02185040|515510953|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
142993302|NCT02185040|515510954|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
142993303|NCT02185040|515510955|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
142993304|NCT02185040|515510956|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
142993305|NCT02185040|515510950|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
142993306|NCT02185040|515510951|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
142993307|NCT02185040|515510952|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
142993308|NCT02185040|515510953|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
142993309|NCT02185040|515510954|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
142993310|NCT02185040|515510955|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
142993311|NCT02185040|515510956|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
142993312|NCT02185040|515510950|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
142993313|NCT02185040|515510951|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
142993314|NCT02185040|515510952|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
142993315|NCT02185040|515510953|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
142993316|NCT02185040|515510954|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
142993317|NCT02185040|515510955|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
142993318|NCT02185040|515510956|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
142993319|NCT02185040|515510950|FG000|Active Treatment Extension Phase|Adverse Event|0|||
142993320|NCT02185040|515510951|FG001|Active Treatment Extension Phase|Adverse Event|0|||
142993321|NCT02185040|515510952|FG002|Active Treatment Extension Phase|Adverse Event|0|||
142993322|NCT02185040|515510953|FG003|Active Treatment Extension Phase|Adverse Event|0|||
142993323|NCT02185040|515510954|FG004|Active Treatment Extension Phase|Adverse Event|0|||
142993324|NCT02185040|515510955|FG005|Active Treatment Extension Phase|Adverse Event|1|||
142993325|NCT02185040|515510956|FG006|Active Treatment Extension Phase|Adverse Event|4|||
142993326|NCT02185040|515510950|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
142993327|NCT02185040|515510951|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
142993328|NCT02185040|515510952|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
142993329|NCT02185040|515510953|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
142993330|NCT02185040|515510954|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
142993331|NCT02185040|515510955|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
142993332|NCT02185040|515510956|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
142993333|NCT02185040|515510950|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
142993334|NCT02185040|515510951|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
142993335|NCT02185040|515510952|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
142993336|NCT02185040|515510953|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
142993337|NCT02185040|515510954|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
142993338|NCT02185040|515510955|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
142993339|NCT02185040|515510956|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
142993340|NCT03347279|515510957|FG000|Overall Study|Withdrawal by Subject|8|||
142993341|NCT03347279|515510958|FG001|Overall Study|Withdrawal by Subject|15|||
142993342|NCT03347279|515510957|FG000|Overall Study|Death|0|||
142993343|NCT03347279|515510958|FG001|Overall Study|Death|2|||
142993344|NCT03347279|515510957|FG000|Overall Study|Lost to Follow-up|5|||
142993345|NCT03347279|515510958|FG001|Overall Study|Lost to Follow-up|2|||
142993346|NCT03347279|515510957|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
142993347|NCT03347279|515510958|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
142993348|NCT00141297|515510963|FG000|Overall Study|Adverse Event|0|||
142993349|NCT00141297|515510964|FG001|Overall Study|Adverse Event|0|||
142993350|NCT00141297|515510965|FG002|Overall Study|Adverse Event|1|||
142993351|NCT00141297|515510966|FG003|Overall Study|Adverse Event|0|||
142993352|NCT00141297|515510967|FG004|Overall Study|Adverse Event|1|||
142993353|NCT00141297|515510968|FG005|Overall Study|Adverse Event|1|||
142993354|NCT00141297|515510969|FG006|Overall Study|Adverse Event|0|||
142993355|NCT00141297|515510970|FG007|Overall Study|Adverse Event|1|||
142993356|NCT00141297|515510971|FG008|Overall Study|Adverse Event|1|||
142993357|NCT00141297|515510972|FG009|Overall Study|Adverse Event|0|||
142993358|NCT00141297|515510963|FG000|Overall Study|Death|1|||
142993359|NCT00141297|515510964|FG001|Overall Study|Death|0|||
142993360|NCT00141297|515510965|FG002|Overall Study|Death|0|||
142993361|NCT00141297|515510966|FG003|Overall Study|Death|0|||
142993362|NCT00141297|515510967|FG004|Overall Study|Death|0|||
142993363|NCT00141297|515510968|FG005|Overall Study|Death|0|||
142993364|NCT00141297|515510969|FG006|Overall Study|Death|0|||
142993365|NCT00141297|515510970|FG007|Overall Study|Death|0|||
142993366|NCT00141297|515510971|FG008|Overall Study|Death|1|||
142993367|NCT00141297|515510972|FG009|Overall Study|Death|0|||
142993368|NCT00141297|515510963|FG000|Overall Study|Withdrawal by Subject|0|||
142993369|NCT00141297|515510964|FG001|Overall Study|Withdrawal by Subject|0|||
142993370|NCT00141297|515510965|FG002|Overall Study|Withdrawal by Subject|0|||
142993371|NCT00141297|515510966|FG003|Overall Study|Withdrawal by Subject|0|||
142993372|NCT00141297|515510967|FG004|Overall Study|Withdrawal by Subject|0|||
142993373|NCT00141297|515510968|FG005|Overall Study|Withdrawal by Subject|0|||
142993374|NCT00141297|515510969|FG006|Overall Study|Withdrawal by Subject|0|||
142993375|NCT00141297|515510970|FG007|Overall Study|Withdrawal by Subject|0|||
142993376|NCT00141297|515510971|FG008|Overall Study|Withdrawal by Subject|1|||
142993377|NCT00141297|515510972|FG009|Overall Study|Withdrawal by Subject|0|||
142993378|NCT00141297|515510963|FG000|Overall Study|Other|0|||
142993379|NCT00141297|515510964|FG001|Overall Study|Other|0|||
142993380|NCT00141297|515510965|FG002|Overall Study|Other|0|||
142993381|NCT00141297|515510966|FG003|Overall Study|Other|1|||
142993382|NCT00141297|515510967|FG004|Overall Study|Other|5|||
142993383|NCT00141297|515510968|FG005|Overall Study|Other|0|||
142993384|NCT00141297|515510969|FG006|Overall Study|Other|0|||
142993385|NCT00141297|515510970|FG007|Overall Study|Other|0|||
142993386|NCT00141297|515510971|FG008|Overall Study|Other|2|||
142993387|NCT00141297|515510972|FG009|Overall Study|Other|0|||
142993388|NCT00141297|515510963|FG000|Overall Study|Progressive Disease|2|||
142993389|NCT00141297|515510964|FG001|Overall Study|Progressive Disease|3|||
142993390|NCT00141297|515510965|FG002|Overall Study|Progressive Disease|6|||
142993391|NCT00141297|515510966|FG003|Overall Study|Progressive Disease|2|||
142993392|NCT00141297|515510967|FG004|Overall Study|Progressive Disease|15|||
142993393|NCT00141297|515510968|FG005|Overall Study|Progressive Disease|2|||
142993394|NCT00141297|515510969|FG006|Overall Study|Progressive Disease|3|||
142993395|NCT00141297|515510970|FG007|Overall Study|Progressive Disease|3|||
142993396|NCT00141297|515510971|FG008|Overall Study|Progressive Disease|15|||
142993397|NCT00141297|515510972|FG009|Overall Study|Progressive Disease|6|||
142993398|NCT00141297|515510963|FG000|Overall Study|Transitioned|0|||
142993399|NCT00141297|515510964|FG001|Overall Study|Transitioned|0|||
142993400|NCT00141297|515510965|FG002|Overall Study|Transitioned|0|||
142993401|NCT00141297|515510966|FG003|Overall Study|Transitioned|0|||
142993402|NCT00141297|515510967|FG004|Overall Study|Transitioned|1|||
142993403|NCT00141297|515510968|FG005|Overall Study|Transitioned|0|||
142993404|NCT00141297|515510969|FG006|Overall Study|Transitioned|0|||
142993405|NCT00141297|515510970|FG007|Overall Study|Transitioned|0|||
142993406|NCT00141297|515510971|FG008|Overall Study|Transitioned|0|||
142993407|NCT00141297|515510972|FG009|Overall Study|Transitioned|0|||
142993408|NCT02061540|515510973|FG000|Overall Study|Adverse Event|2|||
142993409|NCT02061540|515510973|FG000|Overall Study|Withdrawal by Subject|2|||
142993410|NCT02561273|515510974|FG000|Overall Study|Protocol Violation|1|||
142993411|NCT02561273|515510975|FG001|Overall Study|Protocol Violation|0|||
142993412|NCT02718625|515510977|FG000|Overall Study|Adverse Event|0|||
142993413|NCT02718625|515510978|FG001|Overall Study|Adverse Event|1|||
142993414|NCT02718625|515510977|FG000|Overall Study|Termination of Study by Sponsor|0|||
142993415|NCT02718625|515510978|FG001|Overall Study|Termination of Study by Sponsor|1|||
142993416|NCT01947127|515510979|FG000|Overall Study|Protocol Violation|18|||
142993417|NCT01947127|515510980|FG001|Overall Study|Protocol Violation|38|||
142993418|NCT01947127|515510979|FG000|Overall Study|Withdrawal by Subject|1|||
142993419|NCT01947127|515510980|FG001|Overall Study|Withdrawal by Subject|1|||
142993420|NCT01947127|515510979|FG000|Overall Study|Data loss|4|||
142993421|NCT01947127|515510980|FG001|Overall Study|Data loss|4|||
142993422|NCT01562327|515510981|FG000|Overall Study|Adverse Event|2|||
142993423|NCT01562327|515510981|FG000|Overall Study|Lack of Efficacy|1|||
142993424|NCT01562327|515510981|FG000|Overall Study|Participant drop-out|1|||
142993425|NCT01562327|515510981|FG000|Overall Study|Infusion not received at 6 month window|4|||
142993426|NCT00398086|515510984|FG000|Overall Study|Unacceptable Toxicity|2|||
142993427|NCT00398086|515510985|FG001|Overall Study|Unacceptable Toxicity|8|||
142993428|NCT00398086|515510986|FG002|Overall Study|Unacceptable Toxicity|2|||
142993429|NCT00398086|515510984|FG000|Overall Study|Adverse Event|1|||
142993430|NCT00398086|515510985|FG001|Overall Study|Adverse Event|4|||
142993431|NCT00398086|515510986|FG002|Overall Study|Adverse Event|0|||
142993432|NCT00398086|515510984|FG000|Overall Study|Physician Decision|1|||
142993433|NCT00398086|515510985|FG001|Overall Study|Physician Decision|4|||
142993434|NCT00398086|515510986|FG002|Overall Study|Physician Decision|0|||
142993435|NCT00398086|515510984|FG000|Overall Study|Withdrawal by Subject|5|||
142993436|NCT00398086|515510985|FG001|Overall Study|Withdrawal by Subject|7|||
142993437|NCT00398086|515510986|FG002|Overall Study|Withdrawal by Subject|0|||
142993438|NCT00696774|515510987|FG000|Period II|Adverse Event|0|||
142993439|NCT00696774|515510988|FG001|Period II|Adverse Event|0|||
142993440|NCT00696774|515510989|FG002|Period II|Adverse Event|15|||
142993441|NCT00696774|515510987|FG000|Period II|Lost to Follow-up|0|||
142993442|NCT00696774|515510988|FG001|Period II|Lost to Follow-up|0|||
142993443|NCT00696774|515510989|FG002|Period II|Lost to Follow-up|4|||
142993444|NCT00696774|515510987|FG000|Period II|Protocol Violation|0|||
142993445|NCT00696774|515510988|FG001|Period II|Protocol Violation|0|||
142993446|NCT00696774|515510989|FG002|Period II|Protocol Violation|11|||
142993447|NCT00696774|515510987|FG000|Period II|Withdrawal by Subject|0|||
142993448|NCT00696774|515510988|FG001|Period II|Withdrawal by Subject|0|||
142993449|NCT00696774|515510989|FG002|Period II|Withdrawal by Subject|4|||
142993450|NCT00696774|515510987|FG000|Period II|Sponsor Decision|0|||
142993451|NCT00696774|515510988|FG001|Period II|Sponsor Decision|0|||
142993452|NCT00696774|515510989|FG002|Period II|Sponsor Decision|0|||
142993453|NCT00696774|515510987|FG000|Period II|Lack of Efficacy|0|||
142993454|NCT00696774|515510988|FG001|Period II|Lack of Efficacy|0|||
142993455|NCT00696774|515510989|FG002|Period II|Lack of Efficacy|2|||
142993456|NCT00696774|515510987|FG000|Period III|Adverse Event|1|||
142993457|NCT00696774|515510988|FG001|Period III|Adverse Event|1|||
142993458|NCT00696774|515510989|FG002|Period III|Adverse Event|0|||
142993459|NCT00696774|515510987|FG000|Period III|Lost to Follow-up|2|||
142993460|NCT00696774|515510988|FG001|Period III|Lost to Follow-up|1|||
142993461|NCT00696774|515510989|FG002|Period III|Lost to Follow-up|0|||
142993462|NCT00696774|515510987|FG000|Period III|Protocol Violation|1|||
142993463|NCT00696774|515510988|FG001|Period III|Protocol Violation|1|||
142993464|NCT00696774|515510989|FG002|Period III|Protocol Violation|0|||
142993465|NCT00696774|515510987|FG000|Period III|Withdrawal by Subject|1|||
142993466|NCT00696774|515510988|FG001|Period III|Withdrawal by Subject|2|||
142993467|NCT00696774|515510989|FG002|Period III|Withdrawal by Subject|0|||
142993468|NCT00696774|515510987|FG000|Period III|Sponsor Decision|2|||
142993469|NCT00696774|515510988|FG001|Period III|Sponsor Decision|0|||
142993470|NCT00696774|515510989|FG002|Period III|Sponsor Decision|0|||
142993471|NCT00696774|515510987|FG000|Period III|Lack of Efficacy|0|||
142993472|NCT00696774|515510988|FG001|Period III|Lack of Efficacy|2|||
142993473|NCT00696774|515510989|FG002|Period III|Lack of Efficacy|0|||
142993474|NCT00890201|515510990|FG000|Overall Study|Protocol Violation|5|||
142993475|NCT00890201|515510991|FG001|Overall Study|Protocol Violation|56|||
142993476|NCT00033293|515510992|FG000|Overall Study|Death|0|||
142993477|NCT00033293|515510993|FG001|Overall Study|Death|1|||
142993478|NCT00033293|515510992|FG000|Overall Study|Lack of Efficacy|5|||
142993479|NCT00033293|515510993|FG001|Overall Study|Lack of Efficacy|8|||
142993480|NCT00033293|515510992|FG000|Overall Study|Lost to Follow-up|0|||
142993481|NCT00033293|515510993|FG001|Overall Study|Lost to Follow-up|1|||
142993482|NCT00033293|515510992|FG000|Overall Study|Physician Decision|3|||
142993483|NCT00033293|515510993|FG001|Overall Study|Physician Decision|1|||
142993484|NCT00033293|515510992|FG000|Overall Study|Withdrawal by Subject|1|||
142993485|NCT00033293|515510993|FG001|Overall Study|Withdrawal by Subject|0|||
142993486|NCT00033293|515510992|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
142993487|NCT00033293|515510993|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
142993488|NCT00033293|515510992|FG000|Overall Study|Treatment refused|0|||
142993489|NCT00033293|515510993|FG001|Overall Study|Treatment refused|6|||
142993490|NCT02442765|515510994|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
142993491|NCT02442765|515510995|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
142993492|NCT02442765|515510996|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
142993493|NCT02442765|515510997|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
142993494|NCT02442765|515510998|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
142993495|NCT02442765|515510999|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
142993496|NCT02442765|515511000|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
142993497|NCT02442765|515511001|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
142993498|NCT02442765|515510994|FG000|Stage 2- (Days 43 to 85)|Death|0|||
142993499|NCT02442765|515510995|FG001|Stage 2- (Days 43 to 85)|Death|0|||
142993500|NCT02442765|515510996|FG002|Stage 2- (Days 43 to 85)|Death|0|||
142993501|NCT02442765|515510997|FG003|Stage 2- (Days 43 to 85)|Death|1|||
142993502|NCT02442765|515510998|FG004|Stage 2- (Days 43 to 85)|Death|1|||
142993503|NCT02442765|515510999|FG005|Stage 2- (Days 43 to 85)|Death|0|||
142993504|NCT02442765|515511000|FG006|Stage 2- (Days 43 to 85)|Death|2|||
142993505|NCT02442765|515511001|FG007|Stage 2- (Days 43 to 85)|Death|0|||
142993506|NCT02442765|515510994|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
142993507|NCT02442765|515510995|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
142993508|NCT02442765|515510996|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
142993509|NCT02442765|515510997|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
142993510|NCT02442765|515510998|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
142993511|NCT02442765|515510999|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
142993512|NCT02442765|515511000|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
142993513|NCT02442765|515511001|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
142993514|NCT02442765|515510994|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
142993515|NCT02442765|515510995|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
142993516|NCT02442765|515510996|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
142993517|NCT02442765|515510997|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
142993518|NCT02442765|515510998|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
142993519|NCT02442765|515510999|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
142993520|NCT02442765|515511000|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
142993521|NCT02442765|515511001|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
142993522|NCT02442765|515510994|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
142993523|NCT02442765|515510995|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
142993524|NCT02442765|515510996|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
142993525|NCT02442765|515510997|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
142993526|NCT02442765|515510998|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
142993527|NCT02442765|515510999|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
142993528|NCT02442765|515511000|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
142993529|NCT02442765|515511001|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
142993530|NCT02442765|515510994|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
142993531|NCT02442765|515510995|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
142993532|NCT02442765|515510996|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
142993533|NCT02442765|515510997|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
142993534|NCT02442765|515510998|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
142993535|NCT02442765|515510999|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
142993536|NCT02442765|515511000|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
142993537|NCT02442765|515511001|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
142993538|NCT02442765|515510994|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
142993539|NCT02442765|515510995|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
142993540|NCT02442765|515510996|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
142993541|NCT02442765|515510997|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
142993542|NCT02442765|515510998|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
142993543|NCT02442765|515510999|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
142993544|NCT02442765|515511000|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
142993545|NCT02442765|515511001|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
142993546|NCT02442765|515510994|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
142993547|NCT02442765|515510995|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
142993548|NCT02442765|515510996|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
142993549|NCT02442765|515510997|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
142993550|NCT02442765|515510998|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
142993551|NCT02442765|515510999|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
142993552|NCT02442765|515511000|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
142993553|NCT02442765|515511001|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
142993554|NCT00545584|515511004|FG000|Overall Study|Only one reason for discontinuation|62|||
142993555|NCT00545584|515511005|FG001|Overall Study|Only one reason for discontinuation|61|||
142993556|NCT00545584|515511006|FG002|Overall Study|Only one reason for discontinuation|48|||
142993557|NCT00545584|515511004|FG000|Overall Study|Two or more reasons for discontinuation|17|||
142993558|NCT00545584|515511005|FG001|Overall Study|Two or more reasons for discontinuation|19|||
142993559|NCT00545584|515511006|FG002|Overall Study|Two or more reasons for discontinuation|8|||
142993560|NCT00461552|515511012|FG000|Overall Study|Drug Dispensing error|0|||
142993561|NCT00461552|515511013|FG001|Overall Study|Drug Dispensing error|2|||
142993562|NCT00374452|515511014|FG000|Overall Study|Left clinic before intervention started|4|||
142993563|NCT00374452|515511015|FG001|Overall Study|Left clinic before intervention started|1|||
142993564|NCT00374452|515511014|FG000|Overall Study|Change in job role before intervention|0|||
142993565|NCT00374452|515511015|FG001|Overall Study|Change in job role before intervention|1|||
142993566|NCT00374452|515511014|FG000|Overall Study|Left clinic after intervention started|1|||
142993567|NCT00374452|515511015|FG001|Overall Study|Left clinic after intervention started|1|||
142993568|NCT00374452|515511014|FG000|Overall Study|Withdrawal by Subject|0|||
142993569|NCT00374452|515511015|FG001|Overall Study|Withdrawal by Subject|2|||
142993570|NCT01040728|515511020|FG000|Overall Study|Adverse Event|4|||
142993571|NCT01040728|515511021|FG001|Overall Study|Adverse Event|8|||
142993572|NCT01040728|515511022|FG002|Overall Study|Adverse Event|0|||
142993573|NCT01040728|515511023|FG003|Overall Study|Adverse Event|4|||
142993574|NCT01040728|515511020|FG000|Overall Study|Withdrawal by Subject|0|||
142993575|NCT01040728|515511021|FG001|Overall Study|Withdrawal by Subject|1|||
142993576|NCT01040728|515511022|FG002|Overall Study|Withdrawal by Subject|1|||
142993577|NCT01040728|515511023|FG003|Overall Study|Withdrawal by Subject|0|||
142993578|NCT01040728|515511020|FG000|Overall Study|Protocol Violation|0|||
142993579|NCT01040728|515511021|FG001|Overall Study|Protocol Violation|0|||
142993580|NCT01040728|515511022|FG002|Overall Study|Protocol Violation|0|||
142993581|NCT01040728|515511023|FG003|Overall Study|Protocol Violation|1|||
142993582|NCT01040728|515511020|FG000|Overall Study|Lack of Efficacy|0|||
142993583|NCT01040728|515511021|FG001|Overall Study|Lack of Efficacy|1|||
142993584|NCT01040728|515511022|FG002|Overall Study|Lack of Efficacy|0|||
142993585|NCT01040728|515511023|FG003|Overall Study|Lack of Efficacy|1|||
142993586|NCT01040728|515511020|FG000|Overall Study|Other reasons not listed above|0|||
142993587|NCT01040728|515511021|FG001|Overall Study|Other reasons not listed above|1|||
142993588|NCT01040728|515511022|FG002|Overall Study|Other reasons not listed above|0|||
142993589|NCT01040728|515511023|FG003|Overall Study|Other reasons not listed above|0|||
142993590|NCT01012037|515511026|FG000|Overall Study|Adverse Event|0|||
142993591|NCT01012037|515511027|FG001|Overall Study|Adverse Event|8|||
142993592|NCT01012037|515511028|FG002|Overall Study|Adverse Event|3|||
142993593|NCT01012037|515511026|FG000|Overall Study|Protocol Violation|0|||
142993594|NCT01012037|515511027|FG001|Overall Study|Protocol Violation|3|||
142993595|NCT01012037|515511028|FG002|Overall Study|Protocol Violation|5|||
142993596|NCT01012037|515511026|FG000|Overall Study|Withdrawal by Subject|0|||
142993597|NCT01012037|515511027|FG001|Overall Study|Withdrawal by Subject|4|||
142993598|NCT01012037|515511028|FG002|Overall Study|Withdrawal by Subject|1|||
142993599|NCT01012037|515511026|FG000|Overall Study|Other reason (not specified)|1|||
142993600|NCT01012037|515511027|FG001|Overall Study|Other reason (not specified)|1|||
142993601|NCT01012037|515511028|FG002|Overall Study|Other reason (not specified)|1|||
142993602|NCT00415623|515511032|FG000|Overall Study|Adverse Event|3|||
142993603|NCT00415623|515511033|FG001|Overall Study|Adverse Event|4|||
142993604|NCT00415623|515511032|FG000|Overall Study|Death|1|||
142993605|NCT00415623|515511033|FG001|Overall Study|Death|0|||
142993606|NCT00415623|515511032|FG000|Overall Study|Withdrawal by Subject|1|||
142993607|NCT00415623|515511033|FG001|Overall Study|Withdrawal by Subject|1|||
142993608|NCT03267576|515511036|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
142993609|NCT03267576|515511037|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
142993610|NCT03267576|515511036|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
142993611|NCT03267576|515511037|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
142993612|NCT01369069|515511038|FG000|Overall Study|Lost to Follow-up|8|||
142993613|NCT01369069|515511039|FG001|Overall Study|Lost to Follow-up|9|||
142993614|NCT01369069|515511038|FG000|Overall Study|Withdrawal by Subject|9|||
142993615|NCT01369069|515511039|FG001|Overall Study|Withdrawal by Subject|7|||
142993616|NCT02573012|515511040|FG000|Overall Study|Adverse Event|5|||
142993617|NCT02573012|515511041|FG001|Overall Study|Adverse Event|5|||
142993618|NCT02573012|515511040|FG000|Overall Study|Lack of Efficacy|5|||
142993619|NCT02573012|515511041|FG001|Overall Study|Lack of Efficacy|4|||
142993620|NCT02573012|515511040|FG000|Overall Study|Non-compliance|1|||
142993621|NCT02573012|515511041|FG001|Overall Study|Non-compliance|2|||
142993622|NCT02573012|515511040|FG000|Overall Study|Withdrawal by Subject|2|||
142993623|NCT02573012|515511041|FG001|Overall Study|Withdrawal by Subject|2|||
142993624|NCT02573012|515511040|FG000|Overall Study|Study Ended per Protocol|1|||
142993625|NCT02573012|515511041|FG001|Overall Study|Study Ended per Protocol|0|||
142993626|NCT02573012|515511040|FG000|Overall Study|Physician Decision|1|||
142993627|NCT02573012|515511041|FG001|Overall Study|Physician Decision|2|||
142993628|NCT00882362|515511042|FG000|Overall Study|Adverse Event|13|||
142993629|NCT00882362|515511043|FG001|Overall Study|Adverse Event|10|||
142993630|NCT00882362|515511042|FG000|Overall Study|Withdrawal by Subject|13|||
142993631|NCT00882362|515511043|FG001|Overall Study|Withdrawal by Subject|10|||
142993632|NCT00882362|515511042|FG000|Overall Study|Lack of Efficacy|3|||
142993633|NCT00882362|515511043|FG001|Overall Study|Lack of Efficacy|0|||
142993634|NCT00882362|515511042|FG000|Overall Study|Protocol Violation|7|||
142993635|NCT00882362|515511043|FG001|Overall Study|Protocol Violation|2|||
142993636|NCT00882362|515511042|FG000|Overall Study|Pregnancy|1|||
142993637|NCT00882362|515511043|FG001|Overall Study|Pregnancy|0|||
142993638|NCT00882362|515511042|FG000|Overall Study|Physician Decision|5|||
142993639|NCT00882362|515511043|FG001|Overall Study|Physician Decision|1|||
142993640|NCT00882362|515511042|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
142993641|NCT00882362|515511043|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
142993642|NCT00882362|515511042|FG000|Overall Study|change of residence or other commitments|5|||
142993643|NCT00882362|515511043|FG001|Overall Study|change of residence or other commitments|0|||
142993644|NCT01268514|515511044|FG000|Overall Study|Adverse Event|20|||
142993645|NCT01268514|515511044|FG000|Overall Study|Death|8|||
142993646|NCT01268514|515511044|FG000|Overall Study|Lost to Follow-up|5|||
142993647|NCT01268514|515511044|FG000|Overall Study|Withdrawal by Subject|3|||
142993648|NCT01268514|515511044|FG000|Overall Study|Withdrawal by Surgeon|5|||
142993649|NCT01846208|515511045|FG000|Overall Study|Withdrew prior to treatment|1|||
142993650|NCT01846208|515511046|FG001|Overall Study|Withdrew prior to treatment|1|||
142993651|NCT01846208|515511047|FG002|Overall Study|Withdrew prior to treatment|1|||
142993652|NCT01846208|515511045|FG000|Overall Study|Dosing Symptoms|1|||
142993653|NCT01846208|515511046|FG001|Overall Study|Dosing Symptoms|2|||
142993654|NCT01846208|515511047|FG002|Overall Study|Dosing Symptoms|6|||
142993655|NCT01846208|515511045|FG000|Overall Study|Withdrawal by Subject|5|||
142993656|NCT01846208|515511046|FG001|Overall Study|Withdrawal by Subject|0|||
142993657|NCT01846208|515511047|FG002|Overall Study|Withdrawal by Subject|0|||
142993658|NCT01846208|515511045|FG000|Overall Study|Non-compliance|1|||
142993659|NCT01846208|515511046|FG001|Overall Study|Non-compliance|1|||
142993660|NCT01846208|515511047|FG002|Overall Study|Non-compliance|0|||
142993661|NCT01846208|515511045|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
142993662|NCT01846208|515511046|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
142993663|NCT01846208|515511047|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
142993664|NCT01846208|515511045|FG000|Overall Study|Refused SU OFC|0|||
142993665|NCT01846208|515511046|FG001|Overall Study|Refused SU OFC|0|||
142993666|NCT01846208|515511047|FG002|Overall Study|Refused SU OFC|1|||
142993667|NCT01424306|515511048|FG000|Overall Study|Protocol Violation|0|||
142993668|NCT01424306|515511049|FG001|Overall Study|Protocol Violation|0|||
142993669|NCT01424306|515511050|FG002|Overall Study|Protocol Violation|0|||
142993670|NCT01424306|515511051|FG003|Overall Study|Protocol Violation|0|||
142993671|NCT01424306|515511052|FG004|Overall Study|Protocol Violation|1|||
142993672|NCT01424306|515511053|FG005|Overall Study|Protocol Violation|0|||
142993673|NCT01875874|515511057|FG000|Overall Study|Death|3|||
142993674|NCT02096471|515511060|FG000|Overall Study|Adverse Event|1|||
142993675|NCT02096471|515511060|FG000|Overall Study|Lack of Efficacy|7|||
142993676|NCT02096471|515511060|FG000|Overall Study|Withdrawal by Subject|3|||
142993677|NCT02096471|515511060|FG000|Overall Study|Non-Compliant|2|||
142993678|NCT01809327|515511061|FG000|Overall Study|Lost to Follow-up|5|||
142993679|NCT01809327|515511062|FG001|Overall Study|Lost to Follow-up|2|||
142993680|NCT01809327|515511063|FG002|Overall Study|Lost to Follow-up|4|||
142993681|NCT01809327|515511064|FG003|Overall Study|Lost to Follow-up|2|||
142993682|NCT01809327|515511065|FG004|Overall Study|Lost to Follow-up|3|||
142993683|NCT01809327|515511061|FG000|Overall Study|Withdrawal by Subject|6|||
142993684|NCT01809327|515511062|FG001|Overall Study|Withdrawal by Subject|4|||
142993685|NCT01809327|515511063|FG002|Overall Study|Withdrawal by Subject|4|||
142993686|NCT01809327|515511064|FG003|Overall Study|Withdrawal by Subject|2|||
142993687|NCT01809327|515511065|FG004|Overall Study|Withdrawal by Subject|5|||
142993688|NCT01809327|515511061|FG000|Overall Study|Adverse Event|4|||
142993689|NCT01809327|515511062|FG001|Overall Study|Adverse Event|3|||
142993690|NCT01809327|515511063|FG002|Overall Study|Adverse Event|7|||
142993691|NCT01809327|515511064|FG003|Overall Study|Adverse Event|4|||
142993692|NCT01809327|515511065|FG004|Overall Study|Adverse Event|8|||
142993693|NCT01809327|515511061|FG000|Overall Study|Death|1|||
142993694|NCT01809327|515511062|FG001|Overall Study|Death|0|||
142993695|NCT01809327|515511063|FG002|Overall Study|Death|0|||
142993696|NCT01809327|515511064|FG003|Overall Study|Death|0|||
142993697|NCT01809327|515511065|FG004|Overall Study|Death|0|||
142993698|NCT01809327|515511061|FG000|Overall Study|Protocol Violation|0|||
142993699|NCT01809327|515511062|FG001|Overall Study|Protocol Violation|1|||
142993700|NCT01809327|515511063|FG002|Overall Study|Protocol Violation|0|||
142993701|NCT01809327|515511064|FG003|Overall Study|Protocol Violation|0|||
142993702|NCT01809327|515511065|FG004|Overall Study|Protocol Violation|0|||
142993703|NCT01809327|515511061|FG000|Overall Study|Physician Decision|1|||
142993704|NCT01809327|515511062|FG001|Overall Study|Physician Decision|1|||
142993705|NCT01809327|515511063|FG002|Overall Study|Physician Decision|0|||
142993706|NCT01809327|515511064|FG003|Overall Study|Physician Decision|0|||
142993707|NCT01809327|515511065|FG004|Overall Study|Physician Decision|0|||
142993708|NCT01809327|515511061|FG000|Overall Study|Pregnancy|1|||
142993709|NCT01809327|515511062|FG001|Overall Study|Pregnancy|0|||
142993710|NCT01809327|515511063|FG002|Overall Study|Pregnancy|0|||
142993711|NCT01809327|515511064|FG003|Overall Study|Pregnancy|0|||
142993712|NCT01809327|515511065|FG004|Overall Study|Pregnancy|0|||
142993713|NCT01809327|515511061|FG000|Overall Study|Other|14|||
142993714|NCT01809327|515511062|FG001|Overall Study|Other|15|||
142993715|NCT01809327|515511063|FG002|Overall Study|Other|7|||
142993716|NCT01809327|515511064|FG003|Overall Study|Other|4|||
142993717|NCT01809327|515511065|FG004|Overall Study|Other|9|||
142993718|NCT03344562|515511066|FG000|Overall Study|Withdrawal by Subject|2|||
142993719|NCT03344562|515511067|FG001|Overall Study|Withdrawal by Subject|0|||
142993720|NCT01610414|515511070|FG000|Study Start - Month 13|Serious Adverse Event|65|||
142993721|NCT01610414|515511071|FG001|Study Start - Month 13|Serious Adverse Event|67|||
142993722|NCT01610414|515511070|FG000|Study Start - Month 13|Adverse Event|14|||
142993723|NCT01610414|515511071|FG001|Study Start - Month 13|Adverse Event|14|||
142993724|NCT01610414|515511070|FG000|Study Start - Month 13|Protocol Violation|3|||
142993725|NCT01610414|515511071|FG001|Study Start - Month 13|Protocol Violation|1|||
142993726|NCT01610414|515511070|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
142993727|NCT01610414|515511071|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
142993728|NCT01610414|515511070|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
142993729|NCT01610414|515511071|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
142993730|NCT01610414|515511070|FG000|Study Start - Month 13|Lost to Follow-up|4|||
142993731|NCT01610414|515511071|FG001|Study Start - Month 13|Lost to Follow-up|6|||
142993732|NCT01610414|515511070|FG000|Study Start - Month 13|Suspected HZ episode|1|||
142993733|NCT01610414|515511071|FG001|Study Start - Month 13|Suspected HZ episode|3|||
142993734|NCT01610414|515511070|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
142993735|NCT01610414|515511071|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
142993736|NCT01610414|515511070|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
142993737|NCT01610414|515511071|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
142993738|NCT01610414|515511070|FG000|Month 13 - Month 25|Adverse Event|8|||
142993739|NCT01610414|515511071|FG001|Month 13 - Month 25|Adverse Event|4|||
142993740|NCT01610414|515511070|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
142993741|NCT01610414|515511071|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
142993742|NCT01610414|515511070|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
142993743|NCT01610414|515511071|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
142993744|NCT01610414|515511070|FG000|Month 13 - Month 25|Protocol Violation|0|||
142993745|NCT01610414|515511071|FG001|Month 13 - Month 25|Protocol Violation|2|||
142993746|NCT01610414|515511070|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
142993747|NCT01610414|515511071|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
142993748|NCT01610414|515511070|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
142993749|NCT01610414|515511071|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
142993750|NCT01610414|515511070|FG000|After Month 25|Study end not reached|48|||
142993751|NCT01610414|515511071|FG001|After Month 25|Study end not reached|53|||
142993752|NCT02483611|515511072|FG000|Overall Study|Protocol Violation|0|||
142993753|NCT02483611|515511073|FG001|Overall Study|Protocol Violation|0|||
142993754|NCT02483611|515511074|FG002|Overall Study|Protocol Violation|1|||
142993755|NCT04144140|515512142|FG000|Overall Study|Other|0|||
142993756|NCT04144140|515512143|FG001|Overall Study|Other|0|||
142993757|NCT04144140|515512144|FG002|Overall Study|Other|0|||
142993758|NCT04144140|515512145|FG003|Overall Study|Other|0|||
142993759|NCT04144140|515512146|FG004|Overall Study|Other|0|||
142993760|NCT04144140|515512147|FG005|Overall Study|Other|1|||
142993761|NCT04144140|515512148|FG006|Overall Study|Other|0|||
142993762|NCT01465958|515512149|FG000|Run-in Phase|Protocol Violation|1|||
142993763|NCT01465958|515512150|FG001|Run-in Phase|Protocol Violation|0|||
142993764|NCT01465958|515512149|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
142993765|NCT01465958|515512150|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
142993766|NCT02972658|515512155|FG000|Overall Study|Adverse Event|0|||
142993767|NCT02972658|515512156|FG001|Overall Study|Adverse Event|3|||
142993768|NCT02972658|515512157|FG002|Overall Study|Adverse Event|0|||
142993769|NCT02972658|515512158|FG003|Overall Study|Adverse Event|2|||
142993770|NCT02972658|515512155|FG000|Overall Study|Other-determined by Investigator|1|||
142993771|NCT02972658|515512156|FG001|Overall Study|Other-determined by Investigator|1|||
142993772|NCT02972658|515512157|FG002|Overall Study|Other-determined by Investigator|0|||
142993773|NCT02972658|515512158|FG003|Overall Study|Other-determined by Investigator|0|||
142993774|NCT02972658|515512155|FG000|Overall Study|Death|0|||
142993775|NCT02972658|515512156|FG001|Overall Study|Death|0|||
142993776|NCT02972658|515512157|FG002|Overall Study|Death|0|||
142993777|NCT02972658|515512158|FG003|Overall Study|Death|1|||
142993778|NCT02972658|515512155|FG000|Overall Study|Lost to Follow-up|0|||
142993779|NCT02972658|515512156|FG001|Overall Study|Lost to Follow-up|1|||
142993780|NCT02972658|515512157|FG002|Overall Study|Lost to Follow-up|1|||
142993781|NCT02972658|515512158|FG003|Overall Study|Lost to Follow-up|2|||
142993782|NCT02972658|515512155|FG000|Overall Study|Progressive Disease|0|||
142993783|NCT02972658|515512156|FG001|Overall Study|Progressive Disease|1|||
142993784|NCT02972658|515512157|FG002|Overall Study|Progressive Disease|0|||
142993785|NCT02972658|515512158|FG003|Overall Study|Progressive Disease|1|||
142993786|NCT02972658|515512155|FG000|Overall Study|Withdrawal by Subject|4|||
142993787|NCT02972658|515512156|FG001|Overall Study|Withdrawal by Subject|4|||
142993788|NCT02972658|515512157|FG002|Overall Study|Withdrawal by Subject|1|||
142993789|NCT02972658|515512158|FG003|Overall Study|Withdrawal by Subject|6|||
142993790|NCT02972658|515512155|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
142993791|NCT02972658|515512156|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
142993792|NCT02972658|515512157|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
142993793|NCT02972658|515512158|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
142993794|NCT02972658|515512155|FG000|Overall Study|Sponsor Decision|70|||
142993795|NCT02972658|515512156|FG001|Overall Study|Sponsor Decision|127|||
142993796|NCT02972658|515512157|FG002|Overall Study|Sponsor Decision|72|||
142993797|NCT02972658|515512158|FG003|Overall Study|Sponsor Decision|119|||
142993798|NCT04097925|515512159|FG000|Overall Study|Withdrawal by Subject|1|||
142993799|NCT01823991|515512160|FG000|Overall Study|Withdrawal by Subject|8|||
142993800|NCT01823991|515512161|FG001|Overall Study|Withdrawal by Subject|5|||
142993801|NCT05158244|515512162|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
142993802|NCT05158244|515512163|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
142993803|NCT05158244|515512164|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
142993804|NCT05158244|515512165|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
142993805|NCT05158244|515512166|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
142993806|NCT05158244|515512162|FG000|Overall Study|Withdrawal by Subject|0|||
142993807|NCT05158244|515512163|FG001|Overall Study|Withdrawal by Subject|0|||
142993808|NCT05158244|515512164|FG002|Overall Study|Withdrawal by Subject|1|||
142993809|NCT05158244|515512165|FG003|Overall Study|Withdrawal by Subject|0|||
142993810|NCT05158244|515512166|FG004|Overall Study|Withdrawal by Subject|0|||
142993811|NCT02408016|515512168|FG000|Overall Study|Death|6|||
142993812|NCT02408016|515512169|FG001|Overall Study|Death|1|||
142993813|NCT02408016|515512170|FG002|Overall Study|Death|0|||
142993814|NCT02408016|515512168|FG000|Overall Study|Physician Decision|0|||
142993815|NCT02408016|515512169|FG001|Overall Study|Physician Decision|2|||
142993816|NCT02408016|515512170|FG002|Overall Study|Physician Decision|0|||
142993817|NCT03818399|515512171|FG000|Overall Study|Lost to Follow-up|11|||
142993818|NCT03818399|515512171|FG000|Overall Study|Withdrawal by Subject|1|||
142993819|NCT03818399|515512171|FG000|Overall Study|Protocol Violation|2|||
142993820|NCT03557801|515512172|FG000|Overall Study|Protocol Violation|1|||
142993821|NCT03557801|515512173|FG001|Overall Study|Protocol Violation|0|||
142993822|NCT03557801|515512174|FG002|Overall Study|Protocol Violation|0|||
142993823|NCT03557801|515512172|FG000|Overall Study|Withdrawal by Subject|1|||
143003183|NCT01049360|515548755|FG011|Period 2|Lack of Efficacy|0|||
142993824|NCT03557801|515512173|FG001|Overall Study|Withdrawal by Subject|0|||
142993825|NCT03557801|515512174|FG002|Overall Study|Withdrawal by Subject|3|||
142993826|NCT03557801|515512172|FG000|Overall Study|Lost to Follow-up|0|||
142993827|NCT03557801|515512173|FG001|Overall Study|Lost to Follow-up|1|||
142993828|NCT03557801|515512174|FG002|Overall Study|Lost to Follow-up|0|||
142993829|NCT02773849|515512178|FG000|Overall Study|Lost to Follow-up|11|||
142993830|NCT02773849|515512178|FG000|Overall Study|Death|26|||
142993831|NCT02773849|515512178|FG000|Overall Study|Withdrawal by Subject|5|||
142993832|NCT02773849|515512178|FG000|Overall Study|Withdrawal of Consent|9|||
142993833|NCT02773849|515512178|FG000|Overall Study|Other: not due to lack of tolerability|11|||
142993834|NCT04005885|515512181|FG000|First Intervention|Withdrawal by Subject|1|||
142993835|NCT04005885|515512182|FG001|First Intervention|Withdrawal by Subject|1|||
142993836|NCT04005885|515512181|FG000|Second Intervention|Withdrawal by Subject|0|||
142993837|NCT04005885|515512182|FG001|Second Intervention|Withdrawal by Subject|2|||
142993838|NCT00750867|515512183|FG000|Overall Study|Adverse Event|2|||
142993839|NCT00474539|515512184|FG000|Infant Series|Withdrawal by Subject|3|||
142993840|NCT00474539|515512185|FG001|Infant Series|Withdrawal by Subject|4|||
142993841|NCT00474539|515512184|FG000|Infant Series|Randomization error|5|||
142993842|NCT00474539|515512185|FG001|Infant Series|Randomization error|0|||
142993843|NCT00474539|515512184|FG000|Infant Series|Lost to Follow-up|2|||
142993844|NCT00474539|515512185|FG001|Infant Series|Lost to Follow-up|1|||
142993845|NCT00474539|515512184|FG000|Infant Series|Protocol Violation|0|||
142993846|NCT00474539|515512185|FG001|Infant Series|Protocol Violation|1|||
142993847|NCT00474539|515512184|FG000|After Infant Series|Lost to Follow-up|3|||
142993848|NCT00474539|515512185|FG001|After Infant Series|Lost to Follow-up|0|||
142993849|NCT00474539|515512184|FG000|After Infant Series|Withdrawal by Subject|1|||
142993850|NCT00474539|515512185|FG001|After Infant Series|Withdrawal by Subject|0|||
142993851|NCT00474539|515512184|FG000|Toddler Dose|Protocol Violation|1|||
142993852|NCT00474539|515512185|FG001|Toddler Dose|Protocol Violation|0|||
142993853|NCT03018340|515512186|FG000|Overall Study|Adverse Event|1|||
142993854|NCT03018340|515512187|FG001|Overall Study|Adverse Event|2|||
142993855|NCT03018340|515512186|FG000|Overall Study|Withdrawal by Subject|0|||
142993856|NCT03018340|515512187|FG001|Overall Study|Withdrawal by Subject|8|||
142993857|NCT03018340|515512186|FG000|Overall Study|Lack of Efficacy|0|||
142993858|NCT03018340|515512187|FG001|Overall Study|Lack of Efficacy|1|||
142993859|NCT03018340|515512186|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
142993860|NCT03018340|515512187|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
142993861|NCT03018340|515512186|FG000|Overall Study|Lost to Follow-up|1|||
142993862|NCT03018340|515512187|FG001|Overall Study|Lost to Follow-up|7|||
142993863|NCT03018340|515512186|FG000|Overall Study|Protocol Violation|3|||
142993864|NCT03018340|515512187|FG001|Overall Study|Protocol Violation|7|||
142993865|NCT03018340|515512186|FG000|Overall Study|Not further specified|0|||
142993866|NCT03018340|515512187|FG001|Overall Study|Not further specified|1|||
142993867|NCT02520141|515512196|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
142993868|NCT02036476|515512201|FG000|Overall Study|Withdrawal by Subject|2|||
142993869|NCT02036476|515512201|FG000|Overall Study|Progressive Disease|4|||
142993870|NCT02036476|515512201|FG000|Overall Study|Unacceptable Toxicity|2|||
142993871|NCT02168816|515512202|FG000|Overall Study|Lost to Follow-up|2|||
142993872|NCT02168816|515512203|FG001|Overall Study|Lost to Follow-up|2|||
142993873|NCT01066546|515512206|FG000|Overall Study|Study terminated by sponsor|5|||
142993874|NCT03452397|515512207|FG000|Overall Study|Adverse Event|1|||
142993875|NCT03452397|515512208|FG001|Overall Study|Adverse Event|0|||
142993876|NCT03452397|515512209|FG002|Overall Study|Adverse Event|0|||
142993877|NCT03452397|515512210|FG003|Overall Study|Adverse Event|0|||
142993878|NCT03452397|515512207|FG000|Overall Study|Administrative reason|0|||
142993879|NCT03452397|515512208|FG001|Overall Study|Administrative reason|0|||
142993880|NCT03452397|515512209|FG002|Overall Study|Administrative reason|1|||
142993881|NCT03452397|515512210|FG003|Overall Study|Administrative reason|1|||
142993882|NCT03452397|515512207|FG000|Overall Study|Withdrawal by Subject|0|||
142993883|NCT03452397|515512208|FG001|Overall Study|Withdrawal by Subject|0|||
142993884|NCT03452397|515512209|FG002|Overall Study|Withdrawal by Subject|1|||
142993885|NCT03452397|515512210|FG003|Overall Study|Withdrawal by Subject|0|||
142993886|NCT00125268|515512211|FG000|Overall Study|Withdrawal by Subject|1|||
142993887|NCT00125268|515512212|FG001|Overall Study|Withdrawal by Subject|1|||
142993888|NCT00805142|515512214|FG000|Titration Period|Adverse Event|3|||
142993889|NCT00805142|515512215|FG001|Titration Period|Adverse Event|3|||
142993890|NCT00805142|515512214|FG000|Titration Period|Lack of Efficacy|1|||
142993891|NCT00805142|515512215|FG001|Titration Period|Lack of Efficacy|1|||
142993892|NCT00805142|515512214|FG000|Titration Period|Lost to Follow-up|0|||
142993893|NCT00805142|515512215|FG001|Titration Period|Lost to Follow-up|1|||
142993894|NCT00805142|515512214|FG000|Titration Period|Disease Progression|2|||
142993895|NCT00805142|515512215|FG001|Titration Period|Disease Progression|1|||
142993896|NCT00805142|515512214|FG000|Titration Period|Withdrawal of consent|0|||
142993897|NCT00805142|515512215|FG001|Titration Period|Withdrawal of consent|1|||
142993898|NCT00805142|515512214|FG000|Titration Period|Other|0|||
142993899|NCT00805142|515512215|FG001|Titration Period|Other|3|||
142993900|NCT00805142|515512214|FG000|Maintenance Period|Adverse Event|0|||
142993901|NCT00805142|515512215|FG001|Maintenance Period|Adverse Event|1|||
142993902|NCT00805142|515512214|FG000|Maintenance Period|Other|0|||
142993903|NCT00805142|515512215|FG001|Maintenance Period|Other|1|||
142993904|NCT01021423|515512217|FG000|Overall Study|Study terminated|4|||
142993905|NCT01021423|515512218|FG001|Overall Study|Study terminated|5|||
142993906|NCT03756285|515512219|FG000|Overall Study|Lost to Follow-up|0|||
142993907|NCT03756285|515512220|FG001|Overall Study|Lost to Follow-up|1|||
142993908|NCT03756285|515512219|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
142993909|NCT03756285|515512220|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
142993910|NCT03756285|515512219|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
142993911|NCT03756285|515512220|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
142993912|NCT00286156|515512222|FG000|Overall Study|Missed 12 month visit|0|||
142993913|NCT00286156|515512223|FG001|Overall Study|Missed 12 month visit|0|||
142993914|NCT00286156|515512224|FG002|Overall Study|Missed 12 month visit|1|||
142993915|NCT00286156|515512222|FG000|Overall Study|AE: pulmonary embolus|0|||
142993916|NCT00286156|515512223|FG001|Overall Study|AE: pulmonary embolus|1|||
142993917|NCT00286156|515512224|FG002|Overall Study|AE: pulmonary embolus|0|||
142993918|NCT00286156|515512222|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
142993919|NCT00286156|515512223|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
142993920|NCT00286156|515512224|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
142993921|NCT00286156|515512222|FG000|Overall Study|AE: pneumonia|1|||
142993922|NCT00286156|515512223|FG001|Overall Study|AE: pneumonia|0|||
142993923|NCT00286156|515512224|FG002|Overall Study|AE: pneumonia|0|||
142993924|NCT06334055|515512226|FG000|Overall Study|Adverse Event|4|||
142993925|NCT06334055|515512226|FG000|Overall Study|Disqualified|72|||
142993926|NCT02545049|515512227|FG000|Overall Study|Withdrawal by Subject|1|||
142993927|NCT02545049|515512228|FG001|Overall Study|Withdrawal by Subject|7|||
142993928|NCT02545049|515512227|FG000|Overall Study|Lost to Follow-up|4|||
142993929|NCT02545049|515512228|FG001|Overall Study|Lost to Follow-up|6|||
142993930|NCT02545049|515512227|FG000|Overall Study|GCP violations|37|||
142993931|NCT02545049|515512228|FG001|Overall Study|GCP violations|48|||
142993932|NCT02985684|515512229|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
142993933|NCT02985684|515512229|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
142993934|NCT02985684|515512229|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
142993935|NCT00424463|515512231|FG000|Overall Study|Adverse Event|2|||
142993936|NCT00424463|515512232|FG001|Overall Study|Adverse Event|3|||
142993937|NCT00424463|515512233|FG002|Overall Study|Adverse Event|2|||
142993938|NCT00424463|515512231|FG000|Overall Study|Physician Decision|0|||
142993939|NCT00424463|515512232|FG001|Overall Study|Physician Decision|2|||
142993940|NCT00424463|515512233|FG002|Overall Study|Physician Decision|2|||
142993941|NCT00424463|515512231|FG000|Overall Study|Withdrawal by Subject|4|||
142993942|NCT00424463|515512232|FG001|Overall Study|Withdrawal by Subject|2|||
142993943|NCT00424463|515512233|FG002|Overall Study|Withdrawal by Subject|5|||
142993944|NCT00424463|515512231|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
142993945|NCT00424463|515512232|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
142993946|NCT00424463|515512233|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
142993947|NCT00424463|515512231|FG000|Overall Study|Patient's convenience|0|||
142993948|NCT00424463|515512232|FG001|Overall Study|Patient's convenience|0|||
142993949|NCT00424463|515512233|FG002|Overall Study|Patient's convenience|1|||
142993950|NCT02449915|515512234|FG000|Overall Study|Exclusion criteria - drug use|1|||
142993951|NCT02449915|515512235|FG001|Overall Study|Exclusion criteria - drug use|0|||
142993952|NCT02449915|515512234|FG000|Overall Study|Withdrawal by Subject|0|||
142993953|NCT02449915|515512235|FG001|Overall Study|Withdrawal by Subject|2|||
142993954|NCT02449915|515512234|FG000|Overall Study|Intraoperative surgical findings|1|||
142993955|NCT02449915|515512235|FG001|Overall Study|Intraoperative surgical findings|1|||
142993956|NCT02449915|515512234|FG000|Overall Study|Abnormal preop lab|0|||
142993957|NCT02449915|515512235|FG001|Overall Study|Abnormal preop lab|1|||
142993958|NCT01436357|515512236|FG000|Overall Study|Death|5|||
142993959|NCT01436357|515512237|FG001|Overall Study|Death|1|||
142993960|NCT01436357|515512236|FG000|Overall Study|Enrolled but not vaccinated|1|||
142993961|NCT01436357|515512237|FG001|Overall Study|Enrolled but not vaccinated|1|||
142993962|NCT01436357|515512236|FG000|Overall Study|Incarceration|18|||
142993963|NCT01436357|515512237|FG001|Overall Study|Incarceration|20|||
142993964|NCT01436357|515512236|FG000|Overall Study|Lost to Follow-up|67|||
142993965|NCT01436357|515512237|FG001|Overall Study|Lost to Follow-up|61|||
142993966|NCT01436357|515512236|FG000|Overall Study|Protocol Violation|1|||
142993967|NCT01436357|515512237|FG001|Overall Study|Protocol Violation|0|||
142993968|NCT01436357|515512236|FG000|Overall Study|Withdrawal by Subject|26|||
142993969|NCT01436357|515512237|FG001|Overall Study|Withdrawal by Subject|38|||
142993970|NCT01436357|515512236|FG000|Overall Study|Physician Decision|3|||
142993971|NCT01436357|515512237|FG001|Overall Study|Physician Decision|4|||
142993972|NCT01436357|515512236|FG000|Overall Study|Moved out of area|1|||
142993973|NCT01436357|515512237|FG001|Overall Study|Moved out of area|2|||
142993974|NCT01436357|515512236|FG000|Overall Study|Subject in rehab|0|||
142993975|NCT01436357|515512237|FG001|Overall Study|Subject in rehab|1|||
142993976|NCT00656799|515512239|FG000|Overall Study|Death|2|||
142993977|NCT05281094|515512240|FG000|Overall Study|Adverse Event|1|||
142993978|NCT05281094|515512241|FG001|Overall Study|Adverse Event|0|||
142993979|NCT05281094|515512240|FG000|Overall Study|Lost to Follow-up|29|||
142993980|NCT05281094|515512241|FG001|Overall Study|Lost to Follow-up|22|||
142993981|NCT05281094|515512240|FG000|Overall Study|Withdrawal by Legally Authorized Representative|122|||
142993982|NCT05281094|515512241|FG001|Overall Study|Withdrawal by Legally Authorized Representative|103|||
142993983|NCT05281094|515512240|FG000|Overall Study|Death|1|||
142993984|NCT05281094|515512241|FG001|Overall Study|Death|2|||
142993985|NCT05281094|515512240|FG000|Overall Study|Not pre-specified reason|8|||
142993986|NCT05281094|515512241|FG001|Overall Study|Not pre-specified reason|5|||
142993987|NCT05466240|515514119|FG000|Overall Study|Adverse Event|1|||
142993988|NCT05466240|515514120|FG001|Overall Study|Adverse Event|0|||
142993989|NCT05466240|515514119|FG000|Overall Study|Withdrawal by Subject|1|||
142993990|NCT05466240|515514120|FG001|Overall Study|Withdrawal by Subject|0|||
142993991|NCT02679222|515514121|FG000|Overall Study|No time for project|1|||
142993992|NCT00945945|515514126|FG000|Overall Study|Adverse Event|15|||
142993993|NCT00945945|515514127|FG001|Overall Study|Adverse Event|35|||
142993994|NCT00945945|515514126|FG000|Overall Study|Withdrawal by Subject|7|||
142993995|NCT00945945|515514127|FG001|Overall Study|Withdrawal by Subject|10|||
142993996|NCT00945945|515514126|FG000|Overall Study|Lost to Follow-up|4|||
142993997|NCT00945945|515514127|FG001|Overall Study|Lost to Follow-up|5|||
142993998|NCT00945945|515514126|FG000|Overall Study|Lack of Efficacy|6|||
142993999|NCT00945945|515514127|FG001|Overall Study|Lack of Efficacy|2|||
142994000|NCT00945945|515514126|FG000|Overall Study|Protocol Violation|4|||
142994001|NCT00945945|515514127|FG001|Overall Study|Protocol Violation|2|||
142994002|NCT00945945|515514126|FG000|Overall Study|Entry Criteria Not Met|0|||
142994003|NCT00945945|515514127|FG001|Overall Study|Entry Criteria Not Met|1|||
142994004|NCT00626327|515514128|FG000|Overall Study|Withdrawal by Subject|21|||
142994005|NCT00626327|515514129|FG001|Overall Study|Withdrawal by Subject|29|||
142994006|NCT00626327|515514130|FG002|Overall Study|Withdrawal by Subject|30|||
142994007|NCT00626327|515514128|FG000|Overall Study|Adverse Event|1|||
142994008|NCT00626327|515514129|FG001|Overall Study|Adverse Event|0|||
142994009|NCT00626327|515514130|FG002|Overall Study|Adverse Event|0|||
142994010|NCT00626327|515514128|FG000|Overall Study|Lost to Follow-up|24|||
142994011|NCT00626327|515514129|FG001|Overall Study|Lost to Follow-up|21|||
142994012|NCT00626327|515514130|FG002|Overall Study|Lost to Follow-up|23|||
142994013|NCT00626327|515514128|FG000|Overall Study|Inappropriate enrollment|4|||
142994014|NCT00626327|515514129|FG001|Overall Study|Inappropriate enrollment|5|||
142994015|NCT00626327|515514130|FG002|Overall Study|Inappropriate enrollment|3|||
142994016|NCT00626327|515514128|FG000|Overall Study|Administrative Reason|2|||
142994017|NCT00626327|515514129|FG001|Overall Study|Administrative Reason|0|||
142994018|NCT00626327|515514130|FG002|Overall Study|Administrative Reason|6|||
142994019|NCT00626327|515514128|FG000|Overall Study|Protocol Violation|26|||
142994020|NCT00626327|515514129|FG001|Overall Study|Protocol Violation|4|||
142994021|NCT00626327|515514130|FG002|Overall Study|Protocol Violation|26|||
142994022|NCT01066819|515514131|FG000|Overall Study|Adverse Event|18|||
142994023|NCT01066819|515514132|FG001|Overall Study|Adverse Event|1|||
142994024|NCT01066819|515514133|FG002|Overall Study|Adverse Event|6|||
142994025|NCT01066819|515514134|FG003|Overall Study|Adverse Event|0|||
142994026|NCT01066819|515514135|FG004|Overall Study|Adverse Event|0|||
142994027|NCT01066819|515514136|FG005|Overall Study|Adverse Event|0|||
142994028|NCT01066819|515514131|FG000|Overall Study|Death|5|||
142994029|NCT01066819|515514132|FG001|Overall Study|Death|0|||
142994030|NCT01066819|515514133|FG002|Overall Study|Death|1|||
142994031|NCT01066819|515514134|FG003|Overall Study|Death|0|||
142994032|NCT01066819|515514135|FG004|Overall Study|Death|0|||
142994033|NCT01066819|515514136|FG005|Overall Study|Death|0|||
142994034|NCT01066819|515514131|FG000|Overall Study|Lack of Efficacy|22|||
142994035|NCT01066819|515514132|FG001|Overall Study|Lack of Efficacy|1|||
142994036|NCT01066819|515514133|FG002|Overall Study|Lack of Efficacy|2|||
142994037|NCT01066819|515514134|FG003|Overall Study|Lack of Efficacy|1|||
142994038|NCT01066819|515514135|FG004|Overall Study|Lack of Efficacy|0|||
142994039|NCT01066819|515514136|FG005|Overall Study|Lack of Efficacy|0|||
142994040|NCT01066819|515514131|FG000|Overall Study|Physician Decision|6|||
142994041|NCT01066819|515514132|FG001|Overall Study|Physician Decision|2|||
142994042|NCT01066819|515514133|FG002|Overall Study|Physician Decision|3|||
142994043|NCT01066819|515514134|FG003|Overall Study|Physician Decision|0|||
142994044|NCT01066819|515514135|FG004|Overall Study|Physician Decision|0|||
142994045|NCT01066819|515514136|FG005|Overall Study|Physician Decision|0|||
142994046|NCT01066819|515514131|FG000|Overall Study|Protocol Violation|12|||
142994047|NCT01066819|515514132|FG001|Overall Study|Protocol Violation|6|||
142994048|NCT01066819|515514133|FG002|Overall Study|Protocol Violation|0|||
142994049|NCT01066819|515514134|FG003|Overall Study|Protocol Violation|0|||
142994050|NCT01066819|515514135|FG004|Overall Study|Protocol Violation|0|||
142994051|NCT01066819|515514136|FG005|Overall Study|Protocol Violation|0|||
142994052|NCT01066819|515514131|FG000|Overall Study|Withdrawal by Subject|29|||
142994053|NCT01066819|515514132|FG001|Overall Study|Withdrawal by Subject|11|||
142994054|NCT01066819|515514133|FG002|Overall Study|Withdrawal by Subject|6|||
142994055|NCT01066819|515514134|FG003|Overall Study|Withdrawal by Subject|0|||
142994056|NCT01066819|515514135|FG004|Overall Study|Withdrawal by Subject|0|||
142994057|NCT01066819|515514136|FG005|Overall Study|Withdrawal by Subject|0|||
142994058|NCT01066819|515514131|FG000|Overall Study|Administrative|6|||
142994059|NCT01066819|515514132|FG001|Overall Study|Administrative|4|||
142994060|NCT01066819|515514133|FG002|Overall Study|Administrative|2|||
142994061|NCT01066819|515514134|FG003|Overall Study|Administrative|0|||
142994062|NCT01066819|515514135|FG004|Overall Study|Administrative|0|||
142994063|NCT01066819|515514136|FG005|Overall Study|Administrative|0|||
142994064|NCT01066819|515514131|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
142994065|NCT01066819|515514132|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
142994066|NCT01066819|515514133|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
142994067|NCT01066819|515514134|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
142994068|NCT01066819|515514135|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
142994069|NCT01066819|515514136|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
142994070|NCT01066819|515514131|FG000|Overall Study|Early termination|2|||
142994071|NCT01066819|515514132|FG001|Overall Study|Early termination|0|||
142994072|NCT01066819|515514133|FG002|Overall Study|Early termination|0|||
142994073|NCT01066819|515514134|FG003|Overall Study|Early termination|0|||
142994074|NCT01066819|515514135|FG004|Overall Study|Early termination|0|||
142994075|NCT01066819|515514136|FG005|Overall Study|Early termination|0|||
142994076|NCT01066819|515514131|FG000|Overall Study|Failed to return|298|||
142994077|NCT01066819|515514132|FG001|Overall Study|Failed to return|107|||
142994078|NCT01066819|515514133|FG002|Overall Study|Failed to return|68|||
142994079|NCT01066819|515514134|FG003|Overall Study|Failed to return|7|||
142994080|NCT01066819|515514135|FG004|Overall Study|Failed to return|2|||
142994081|NCT01066819|515514136|FG005|Overall Study|Failed to return|3|||
142994082|NCT01066819|515514131|FG000|Overall Study|Lab test not done|9|||
142994083|NCT01066819|515514132|FG001|Overall Study|Lab test not done|0|||
142994084|NCT01066819|515514133|FG002|Overall Study|Lab test not done|2|||
142994085|NCT01066819|515514134|FG003|Overall Study|Lab test not done|1|||
142994086|NCT01066819|515514135|FG004|Overall Study|Lab test not done|0|||
142994087|NCT01066819|515514136|FG005|Overall Study|Lab test not done|0|||
142994088|NCT01066819|515514131|FG000|Overall Study|Miscellaneous|28|||
142994089|NCT01066819|515514132|FG001|Overall Study|Miscellaneous|10|||
142994090|NCT01066819|515514133|FG002|Overall Study|Miscellaneous|18|||
142994091|NCT01066819|515514134|FG003|Overall Study|Miscellaneous|1|||
142994092|NCT01066819|515514135|FG004|Overall Study|Miscellaneous|0|||
142994093|NCT01066819|515514136|FG005|Overall Study|Miscellaneous|0|||
142994094|NCT01066819|515514131|FG000|Overall Study|Non responders|123|||
142994095|NCT01066819|515514132|FG001|Overall Study|Non responders|2|||
142994096|NCT01066819|515514133|FG002|Overall Study|Non responders|7|||
142994097|NCT01066819|515514134|FG003|Overall Study|Non responders|2|||
142994098|NCT01066819|515514135|FG004|Overall Study|Non responders|0|||
142994099|NCT01066819|515514136|FG005|Overall Study|Non responders|1|||
142994100|NCT01066819|515514131|FG000|Overall Study|Not categorised|9|||
142994101|NCT01066819|515514132|FG001|Overall Study|Not categorised|2|||
142994102|NCT01066819|515514133|FG002|Overall Study|Not categorised|6|||
142994103|NCT01066819|515514134|FG003|Overall Study|Not categorised|1|||
142994104|NCT01066819|515514135|FG004|Overall Study|Not categorised|0|||
142994105|NCT01066819|515514136|FG005|Overall Study|Not categorised|0|||
142994106|NCT01066819|515514131|FG000|Overall Study|Relapse|16|||
142994107|NCT01066819|515514132|FG001|Overall Study|Relapse|4|||
142994108|NCT01066819|515514133|FG002|Overall Study|Relapse|3|||
142994109|NCT01066819|515514134|FG003|Overall Study|Relapse|0|||
142994110|NCT01066819|515514135|FG004|Overall Study|Relapse|0|||
142994111|NCT01066819|515514136|FG005|Overall Study|Relapse|0|||
142994112|NCT01066819|515514131|FG000|Overall Study|Results not available|1|||
142994113|NCT01066819|515514132|FG001|Overall Study|Results not available|0|||
142994114|NCT01066819|515514133|FG002|Overall Study|Results not available|0|||
142994115|NCT01066819|515514134|FG003|Overall Study|Results not available|0|||
142994116|NCT01066819|515514135|FG004|Overall Study|Results not available|0|||
142994117|NCT01066819|515514136|FG005|Overall Study|Results not available|0|||
142994118|NCT01066819|515514131|FG000|Overall Study|Screen failure|1|||
142994119|NCT01066819|515514132|FG001|Overall Study|Screen failure|0|||
142994120|NCT01066819|515514133|FG002|Overall Study|Screen failure|0|||
142994121|NCT01066819|515514134|FG003|Overall Study|Screen failure|0|||
142994122|NCT01066819|515514135|FG004|Overall Study|Screen failure|0|||
142994123|NCT01066819|515514136|FG005|Overall Study|Screen failure|0|||
142994124|NCT01066819|515514131|FG000|Overall Study|Spontaneous cure|1|||
142994125|NCT01066819|515514132|FG001|Overall Study|Spontaneous cure|0|||
142994126|NCT01066819|515514133|FG002|Overall Study|Spontaneous cure|0|||
142994127|NCT01066819|515514134|FG003|Overall Study|Spontaneous cure|0|||
142994128|NCT01066819|515514135|FG004|Overall Study|Spontaneous cure|0|||
142994129|NCT01066819|515514136|FG005|Overall Study|Spontaneous cure|0|||
142994130|NCT01066819|515514131|FG000|Overall Study|Treatment never started|85|||
142994131|NCT01066819|515514132|FG001|Overall Study|Treatment never started|19|||
142994132|NCT01066819|515514133|FG002|Overall Study|Treatment never started|19|||
142994133|NCT01066819|515514134|FG003|Overall Study|Treatment never started|3|||
142994134|NCT01066819|515514135|FG004|Overall Study|Treatment never started|2|||
142994135|NCT01066819|515514136|FG005|Overall Study|Treatment never started|2|||
142994136|NCT01066819|515514131|FG000|Overall Study|Treatment stopped|12|||
142994137|NCT01066819|515514132|FG001|Overall Study|Treatment stopped|1|||
142994138|NCT01066819|515514133|FG002|Overall Study|Treatment stopped|2|||
142994139|NCT01066819|515514134|FG003|Overall Study|Treatment stopped|1|||
142994140|NCT01066819|515514135|FG004|Overall Study|Treatment stopped|0|||
142994141|NCT01066819|515514136|FG005|Overall Study|Treatment stopped|0|||
142994142|NCT01066819|515514131|FG000|Overall Study|Other|5|||
142994143|NCT01066819|515514132|FG001|Overall Study|Other|1|||
142994144|NCT01066819|515514133|FG002|Overall Study|Other|1|||
142994145|NCT01066819|515514134|FG003|Overall Study|Other|0|||
142994146|NCT01066819|515514135|FG004|Overall Study|Other|0|||
142994147|NCT01066819|515514136|FG005|Overall Study|Other|0|||
142994148|NCT00805194|515514137|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
142994149|NCT00805194|515514138|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
142994150|NCT00805194|515514137|FG000|Overall Study|Worsening or AE of underlying disease|64|||
142994151|NCT00805194|515514138|FG001|Overall Study|Worsening or AE of underlying disease|70|||
142994152|NCT00805194|515514137|FG000|Overall Study|Other AE|84|||
142994153|NCT00805194|515514138|FG001|Overall Study|Other AE|73|||
142994154|NCT00805194|515514137|FG000|Overall Study|Protocol Violation|9|||
142994155|NCT00805194|515514138|FG001|Overall Study|Protocol Violation|9|||
142994156|NCT00805194|515514137|FG000|Overall Study|Lost to Follow-up|5|||
142994157|NCT00805194|515514138|FG001|Overall Study|Lost to Follow-up|5|||
142994158|NCT00805194|515514137|FG000|Overall Study|Withdrawal by Subject|60|||
142994159|NCT00805194|515514138|FG001|Overall Study|Withdrawal by Subject|42|||
142994160|NCT00805194|515514137|FG000|Overall Study|Not treated|3|||
142994161|NCT00805194|515514138|FG001|Overall Study|Not treated|4|||
142994162|NCT00805194|515514137|FG000|Overall Study|Reasons other than stated above|20|||
142994163|NCT00805194|515514138|FG001|Overall Study|Reasons other than stated above|16|||
142994164|NCT00718887|515514142|FG000|Overall Study|Withdrawal by Subject|3|||
142994165|NCT00718887|515514143|FG001|Overall Study|Withdrawal by Subject|2|||
142994166|NCT00718887|515514142|FG000|Overall Study|Not identified|2|||
142994167|NCT00718887|515514143|FG001|Overall Study|Not identified|7|||
142994168|NCT00535236|515514144|FG000|Overall Study|Adverse Event|1|||
142994169|NCT00535236|515514145|FG001|Overall Study|Adverse Event|0|||
142994170|NCT00535236|515514146|FG002|Overall Study|Adverse Event|9|||
142994171|NCT00535236|515514147|FG003|Overall Study|Adverse Event|3|||
142994172|NCT00535236|515514148|FG004|Overall Study|Adverse Event|3|||
142994173|NCT00535236|515514149|FG005|Overall Study|Adverse Event|0|||
142994174|NCT00535236|515514150|FG006|Overall Study|Adverse Event|5|||
142994175|NCT00535236|515514151|FG007|Overall Study|Adverse Event|1|||
142994176|NCT00535236|515514152|FG008|Overall Study|Adverse Event|2|||
142994177|NCT00535236|515514153|FG009|Overall Study|Adverse Event|1|||
142994178|NCT00535236|515514144|FG000|Overall Study|Lost to Follow-up|1|||
142994179|NCT00535236|515514145|FG001|Overall Study|Lost to Follow-up|2|||
142994180|NCT00535236|515514146|FG002|Overall Study|Lost to Follow-up|0|||
142994181|NCT00535236|515514147|FG003|Overall Study|Lost to Follow-up|0|||
142994182|NCT00535236|515514148|FG004|Overall Study|Lost to Follow-up|2|||
142994183|NCT00535236|515514149|FG005|Overall Study|Lost to Follow-up|0|||
142994184|NCT00535236|515514150|FG006|Overall Study|Lost to Follow-up|0|||
142994185|NCT00535236|515514151|FG007|Overall Study|Lost to Follow-up|0|||
142994186|NCT00535236|515514152|FG008|Overall Study|Lost to Follow-up|6|||
142994187|NCT00535236|515514153|FG009|Overall Study|Lost to Follow-up|1|||
142994188|NCT00535236|515514144|FG000|Overall Study|Physician Decision|0|||
142994189|NCT00535236|515514145|FG001|Overall Study|Physician Decision|0|||
142994190|NCT00535236|515514146|FG002|Overall Study|Physician Decision|0|||
142994191|NCT00535236|515514147|FG003|Overall Study|Physician Decision|0|||
142994192|NCT00535236|515514148|FG004|Overall Study|Physician Decision|1|||
142994193|NCT00535236|515514149|FG005|Overall Study|Physician Decision|0|||
142994194|NCT00535236|515514150|FG006|Overall Study|Physician Decision|1|||
142994195|NCT00535236|515514151|FG007|Overall Study|Physician Decision|0|||
142994196|NCT00535236|515514152|FG008|Overall Study|Physician Decision|0|||
142994197|NCT00535236|515514153|FG009|Overall Study|Physician Decision|0|||
142994198|NCT00535236|515514144|FG000|Overall Study|Protocol Violation|2|||
142994199|NCT00535236|515514145|FG001|Overall Study|Protocol Violation|0|||
142994200|NCT00535236|515514146|FG002|Overall Study|Protocol Violation|1|||
142994201|NCT00535236|515514147|FG003|Overall Study|Protocol Violation|0|||
142994202|NCT00535236|515514148|FG004|Overall Study|Protocol Violation|0|||
142994203|NCT00535236|515514149|FG005|Overall Study|Protocol Violation|0|||
142994204|NCT00535236|515514150|FG006|Overall Study|Protocol Violation|0|||
142994205|NCT00535236|515514151|FG007|Overall Study|Protocol Violation|0|||
142994206|NCT00535236|515514152|FG008|Overall Study|Protocol Violation|1|||
142994207|NCT00535236|515514153|FG009|Overall Study|Protocol Violation|0|||
142994208|NCT00535236|515514144|FG000|Overall Study|Withdrawal by Subject|3|||
142994209|NCT00535236|515514145|FG001|Overall Study|Withdrawal by Subject|0|||
142994210|NCT00535236|515514146|FG002|Overall Study|Withdrawal by Subject|2|||
142994211|NCT00535236|515514147|FG003|Overall Study|Withdrawal by Subject|1|||
142994212|NCT00535236|515514148|FG004|Overall Study|Withdrawal by Subject|6|||
142994213|NCT00535236|515514149|FG005|Overall Study|Withdrawal by Subject|1|||
142994214|NCT00535236|515514150|FG006|Overall Study|Withdrawal by Subject|5|||
142994215|NCT00535236|515514151|FG007|Overall Study|Withdrawal by Subject|0|||
142994216|NCT00535236|515514152|FG008|Overall Study|Withdrawal by Subject|4|||
142994217|NCT00535236|515514153|FG009|Overall Study|Withdrawal by Subject|2|||
142994218|NCT02275052|515514154|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
142994219|NCT02275052|515514155|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
142994220|NCT02275052|515514156|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
142994221|NCT02275052|515514157|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
142994222|NCT02275052|515514154|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
142994223|NCT02275052|515514155|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
142994224|NCT02275052|515514156|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
142994225|NCT02275052|515514157|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
142994226|NCT02275052|515514154|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
142994227|NCT02275052|515514155|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
142994228|NCT02275052|515514156|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
142994229|NCT02275052|515514157|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
142994230|NCT02275052|515514154|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
142994231|NCT02275052|515514155|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
142994232|NCT02275052|515514156|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
142994233|NCT02275052|515514157|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
142994234|NCT02275052|515514154|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
142994235|NCT02275052|515514155|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
142994236|NCT02275052|515514156|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
142994237|NCT02275052|515514157|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
142994238|NCT02275052|515514154|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
142994239|NCT02275052|515514155|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
142994240|NCT02275052|515514156|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
142994241|NCT02275052|515514157|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
142994242|NCT02275052|515514154|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
142994243|NCT02275052|515514155|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
142994244|NCT02275052|515514156|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
142994245|NCT02275052|515514157|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
142994246|NCT02275052|515514154|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
142994247|NCT02275052|515514155|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
142994248|NCT02275052|515514156|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
142994249|NCT02275052|515514157|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
142994250|NCT02275052|515514154|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
142994251|NCT02275052|515514155|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
142994252|NCT02275052|515514156|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
142994253|NCT02275052|515514157|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
142994254|NCT02275052|515514154|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
142994255|NCT02275052|515514155|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
142994256|NCT02275052|515514156|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
142994257|NCT02275052|515514157|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
142994258|NCT02275052|515514154|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
142994259|NCT02275052|515514155|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
142994260|NCT02275052|515514156|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
142994261|NCT02275052|515514157|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
142994262|NCT03288987|515514158|FG000|Overall Study|Protocol Violation|10|||
142994263|NCT03288987|515514159|FG001|Overall Study|Protocol Violation|4|||
142994264|NCT02807376|515514162|FG000|Overall Study|Intra-operative exclusion criteria|3|||
142994265|NCT02807376|515514163|FG001|Overall Study|Intra-operative exclusion criteria|0|||
142994266|NCT02807376|515514162|FG000|Overall Study|Lost to Follow-up|0|||
142994267|NCT02807376|515514163|FG001|Overall Study|Lost to Follow-up|1|||
142994268|NCT00846027|515514164|FG000|Overall Study|Death|3|||
142994269|NCT00846027|515514164|FG000|Overall Study|Disease Progression|30|||
142994270|NCT00846027|515514164|FG000|Overall Study|Toxicity|12|||
142994271|NCT00846027|515514164|FG000|Overall Study|Patient Decision|7|||
142994272|NCT00846027|515514164|FG000|Overall Study|Investigator Discretion|29|||
142994273|NCT00846027|515514164|FG000|Overall Study|Protocol Violation|2|||
142994274|NCT00846027|515514164|FG000|Overall Study|Subject Not Treated|7|||
142994275|NCT04905563|515514171|FG000|Overall Study|Withdrawal by Subject|1|||
142994276|NCT04905563|515514172|FG001|Overall Study|Withdrawal by Subject|0|||
142994277|NCT04905563|515514171|FG000|Overall Study|Standard of care orders entered by resident|1|||
142994278|NCT04905563|515514172|FG001|Overall Study|Standard of care orders entered by resident|0|||
142994279|NCT04905563|515514171|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
142994280|NCT04905563|515514172|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
142994281|NCT04905563|515514171|FG000|Overall Study|Withdrawal by Subject|0|||
142994282|NCT04905563|515514172|FG001|Overall Study|Withdrawal by Subject|1|||
142994283|NCT03228836|515514173|FG000|Overall Study|Adverse Event|3|||
142994284|NCT03228836|515514173|FG000|Overall Study|Withdrawal by Subject|1|||
142994285|NCT03228836|515514173|FG000|Overall Study|Death|1|||
142994286|NCT03228836|515514173|FG000|Overall Study|Physician Decision|1|||
142994287|NCT03228836|515514173|FG000|Overall Study|Disease Progression|7|||
142994288|NCT03228836|515514173|FG000|Overall Study|Other|4|||
142994289|NCT00948389|515514174|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
142994290|NCT00948389|515514175|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
142994291|NCT00948389|515514176|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
142994292|NCT00948389|515514177|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
142994293|NCT00948389|515514178|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
142994294|NCT00948389|515514174|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
142994295|NCT00948389|515514175|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
142994296|NCT00948389|515514176|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
142994297|NCT00948389|515514177|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
142994298|NCT00948389|515514178|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
142994299|NCT00948389|515514174|FG000|Overall Study|Both Progression and Toxicity|1|||
142994300|NCT00948389|515514175|FG001|Overall Study|Both Progression and Toxicity|0|||
142994301|NCT00948389|515514176|FG002|Overall Study|Both Progression and Toxicity|0|||
142994302|NCT00948389|515514177|FG003|Overall Study|Both Progression and Toxicity|0|||
142994303|NCT00948389|515514178|FG004|Overall Study|Both Progression and Toxicity|0|||
142994304|NCT00568399|515514180|FG000|Overall Study|Death|2|||
142994305|NCT00568399|515514180|FG000|Overall Study|Adverse Event|5|||
142994306|NCT00568399|515514180|FG000|Overall Study|Withdrawal by Subject|8|||
142994307|NCT02967562|515514181|FG000|Overall Study|Consent not obtained|1|||
142994308|NCT02967562|515514182|FG001|Overall Study|Consent not obtained|0|||
142994309|NCT02967562|515514181|FG000|Overall Study|High leak precluding analysis|1|||
142994310|NCT02967562|515514182|FG001|Overall Study|High leak precluding analysis|1|||
142994311|NCT00242710|515514183|FG000|Core Study (up to Year 1)|Adverse Event|30|||
142994312|NCT00242710|515514184|FG001|Core Study (up to Year 1)|Adverse Event|25|||
142994313|NCT00242710|515514185|FG002|Core Study (up to Year 1)|Adverse Event|23|||
142994314|NCT00242710|515514186|FG003|Core Study (up to Year 1)|Adverse Event|14|||
142994315|NCT00242710|515514183|FG000|Core Study (up to Year 1)|Death|0|||
142994316|NCT00242710|515514184|FG001|Core Study (up to Year 1)|Death|0|||
142994317|NCT00242710|515514185|FG002|Core Study (up to Year 1)|Death|1|||
142994318|NCT00242710|515514186|FG003|Core Study (up to Year 1)|Death|0|||
142994319|NCT00242710|515514183|FG000|Core Study (up to Year 1)|Physician Decision|0|||
142994320|NCT00242710|515514184|FG001|Core Study (up to Year 1)|Physician Decision|1|||
142994321|NCT00242710|515514185|FG002|Core Study (up to Year 1)|Physician Decision|0|||
142994322|NCT00242710|515514186|FG003|Core Study (up to Year 1)|Physician Decision|1|||
142994323|NCT00242710|515514183|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
142994324|NCT00242710|515514184|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
142994325|NCT00242710|515514185|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
142994326|NCT00242710|515514186|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
142994327|NCT00242710|515514183|FG000|Core Study (up to Year 1)|Other|6|||
142994328|NCT00242710|515514184|FG001|Core Study (up to Year 1)|Other|1|||
142994329|NCT00242710|515514185|FG002|Core Study (up to Year 1)|Other|0|||
142994330|NCT00242710|515514186|FG003|Core Study (up to Year 1)|Other|2|||
142994331|NCT00242710|515514183|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
142994332|NCT00242710|515514184|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
142994333|NCT00242710|515514185|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
142994334|NCT00242710|515514186|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
142994335|NCT00242710|515514183|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
142994336|NCT00242710|515514184|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
142994337|NCT00242710|515514185|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
142994338|NCT00242710|515514186|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
142994339|NCT00242710|515514183|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
142994340|NCT00242710|515514184|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
142994341|NCT00242710|515514185|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
142994342|NCT00242710|515514186|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
142994343|NCT00242710|515514183|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
142994344|NCT00242710|515514184|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
142994345|NCT00242710|515514185|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
142994346|NCT00242710|515514186|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
142994347|NCT00242710|515514183|FG000|Period Between Core Study and Extension|Adverse Event|2|||
142994348|NCT00242710|515514184|FG001|Period Between Core Study and Extension|Adverse Event|3|||
142994349|NCT00242710|515514185|FG002|Period Between Core Study and Extension|Adverse Event|5|||
142994350|NCT00242710|515514186|FG003|Period Between Core Study and Extension|Adverse Event|2|||
142994351|NCT00242710|515514183|FG000|Period Between Core Study and Extension|Physician Decision|1|||
142994352|NCT00242710|515514184|FG001|Period Between Core Study and Extension|Physician Decision|1|||
143003184|NCT01049360|515548756|FG012|Period 2|Lack of Efficacy|0|||
142994353|NCT00242710|515514185|FG002|Period Between Core Study and Extension|Physician Decision|0|||
142994354|NCT00242710|515514186|FG003|Period Between Core Study and Extension|Physician Decision|0|||
142994355|NCT00242710|515514183|FG000|Period Between Core Study and Extension|Other|24|||
142994356|NCT00242710|515514184|FG001|Period Between Core Study and Extension|Other|24|||
142994357|NCT00242710|515514185|FG002|Period Between Core Study and Extension|Other|9|||
142994358|NCT00242710|515514186|FG003|Period Between Core Study and Extension|Other|11|||
142994359|NCT00242710|515514183|FG000|Period Between Core Study and Extension|Extension not Available|17|||
142994360|NCT00242710|515514184|FG001|Period Between Core Study and Extension|Extension not Available|21|||
142994361|NCT00242710|515514185|FG002|Period Between Core Study and Extension|Extension not Available|8|||
142994362|NCT00242710|515514186|FG003|Period Between Core Study and Extension|Extension not Available|7|||
142994363|NCT00242710|515514183|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
142994364|NCT00242710|515514184|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
142994365|NCT00242710|515514185|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
142994366|NCT00242710|515514186|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
142994367|NCT00242710|515514183|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
142994368|NCT00242710|515514184|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
142994369|NCT00242710|515514185|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
142994370|NCT00242710|515514186|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
142994371|NCT00242710|515514183|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
142994372|NCT00242710|515514184|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
142994373|NCT00242710|515514185|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
142994374|NCT00242710|515514186|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
142994375|NCT00242710|515514183|FG000|Study Extension (up to Year 2)|Death|0|||
142994376|NCT00242710|515514184|FG001|Study Extension (up to Year 2)|Death|0|||
142994377|NCT00242710|515514185|FG002|Study Extension (up to Year 2)|Death|0|||
142994378|NCT00242710|515514186|FG003|Study Extension (up to Year 2)|Death|1|||
142994379|NCT00242710|515514183|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
142994380|NCT00242710|515514184|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
142994381|NCT00242710|515514185|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
142994382|NCT00242710|515514186|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
142994383|NCT00242710|515514183|FG000|Study Extension (up to Year 2)|Other|3|||
142994384|NCT00242710|515514184|FG001|Study Extension (up to Year 2)|Other|5|||
142994385|NCT00242710|515514185|FG002|Study Extension (up to Year 2)|Other|4|||
142994386|NCT00242710|515514186|FG003|Study Extension (up to Year 2)|Other|3|||
142994387|NCT00242710|515514183|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
142994388|NCT00242710|515514184|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
142994389|NCT00242710|515514185|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
142994390|NCT00242710|515514186|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
142994391|NCT00242710|515514183|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
142994392|NCT00242710|515514184|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
142994393|NCT00242710|515514185|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
142994394|NCT00242710|515514186|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
142994395|NCT00579527|515514187|FG000|Overall Study|Death|4|||
142994396|NCT00203294|515514188|FG000|Overall Study|Withdrawal by Subject|8|||
142994397|NCT00203294|515514189|FG001|Overall Study|Withdrawal by Subject|13|||
142994398|NCT00886587|515514190|FG000|Overall Study|Adverse Event|2|||
142994399|NCT00886587|515514191|FG001|Overall Study|Adverse Event|1|||
142994400|NCT00886587|515514190|FG000|Overall Study|Protocol Violation|2|||
142994401|NCT00886587|515514191|FG001|Overall Study|Protocol Violation|0|||
142994402|NCT00886587|515514190|FG000|Overall Study|Withdrawal by Subject|0|||
142994403|NCT00886587|515514191|FG001|Overall Study|Withdrawal by Subject|1|||
142994404|NCT00808132|515514194|FG000|Overall Study|Adverse Event|34|||
142994405|NCT00808132|515514195|FG001|Overall Study|Adverse Event|33|||
142994406|NCT00808132|515514196|FG002|Overall Study|Adverse Event|16|||
142994407|NCT00808132|515514197|FG003|Overall Study|Adverse Event|31|||
142994408|NCT00808132|515514198|FG004|Overall Study|Adverse Event|33|||
142994409|NCT00808132|515514194|FG000|Overall Study|Death|0|||
142994410|NCT00808132|515514195|FG001|Overall Study|Death|0|||
142994411|NCT00808132|515514196|FG002|Overall Study|Death|0|||
142994412|NCT00808132|515514197|FG003|Overall Study|Death|0|||
142994413|NCT00808132|515514198|FG004|Overall Study|Death|1|||
142994414|NCT00808132|515514194|FG000|Overall Study|Physician Decision|0|||
142994415|NCT00808132|515514195|FG001|Overall Study|Physician Decision|1|||
142994416|NCT00808132|515514196|FG002|Overall Study|Physician Decision|0|||
142994417|NCT00808132|515514197|FG003|Overall Study|Physician Decision|0|||
142994418|NCT00808132|515514198|FG004|Overall Study|Physician Decision|0|||
142994419|NCT00808132|515514194|FG000|Overall Study|Lost to Follow-up|8|||
142994420|NCT00808132|515514195|FG001|Overall Study|Lost to Follow-up|10|||
142994421|NCT00808132|515514196|FG002|Overall Study|Lost to Follow-up|11|||
142994422|NCT00808132|515514197|FG003|Overall Study|Lost to Follow-up|8|||
142994423|NCT00808132|515514198|FG004|Overall Study|Lost to Follow-up|9|||
142994424|NCT00808132|515514194|FG000|Overall Study|Protocol Violation|8|||
142994425|NCT00808132|515514195|FG001|Overall Study|Protocol Violation|9|||
142994426|NCT00808132|515514196|FG002|Overall Study|Protocol Violation|4|||
142994427|NCT00808132|515514197|FG003|Overall Study|Protocol Violation|9|||
142994428|NCT00808132|515514198|FG004|Overall Study|Protocol Violation|5|||
142994429|NCT00808132|515514194|FG000|Overall Study|Withdrawal by Subject|27|||
142994430|NCT00808132|515514195|FG001|Overall Study|Withdrawal by Subject|18|||
142994431|NCT00808132|515514196|FG002|Overall Study|Withdrawal by Subject|2|||
142994432|NCT00808132|515514197|FG003|Overall Study|Withdrawal by Subject|7|||
142994433|NCT00808132|515514198|FG004|Overall Study|Withdrawal by Subject|16|||
142994434|NCT00808132|515514194|FG000|Overall Study|Other|6|||
142994435|NCT00808132|515514195|FG001|Overall Study|Other|4|||
142994436|NCT00808132|515514196|FG002|Overall Study|Other|6|||
142994437|NCT00808132|515514197|FG003|Overall Study|Other|2|||
142994438|NCT00808132|515514198|FG004|Overall Study|Other|15|||
142994439|NCT00808132|515514194|FG000|Overall Study|Randomized, but not treated|10|||
142994440|NCT00808132|515514195|FG001|Overall Study|Randomized, but not treated|7|||
142994441|NCT00808132|515514196|FG002|Overall Study|Randomized, but not treated|9|||
142994442|NCT00808132|515514197|FG003|Overall Study|Randomized, but not treated|8|||
142994443|NCT00808132|515514198|FG004|Overall Study|Randomized, but not treated|9|||
142994444|NCT00808132|515514194|FG000|Overall Study|Unsatisfactory response|5|||
142994445|NCT00808132|515514195|FG001|Overall Study|Unsatisfactory response|6|||
142994446|NCT00808132|515514196|FG002|Overall Study|Unsatisfactory response|6|||
142994447|NCT00808132|515514197|FG003|Overall Study|Unsatisfactory response|4|||
142994448|NCT00808132|515514198|FG004|Overall Study|Unsatisfactory response|12|||
142994449|NCT00550615|515514199|FG000|Overall Study|Withdrawal by Subject|0|||
142994450|NCT00550615|515514200|FG001|Overall Study|Withdrawal by Subject|0|||
142994451|NCT00550615|515514201|FG002|Overall Study|Withdrawal by Subject|2|||
142994452|NCT00550615|515514202|FG003|Overall Study|Withdrawal by Subject|3|||
142994453|NCT00550615|515514199|FG000|Overall Study|Not evaluable|0|||
142994454|NCT00550615|515514200|FG001|Overall Study|Not evaluable|0|||
142994455|NCT00550615|515514201|FG002|Overall Study|Not evaluable|2|||
142994456|NCT00550615|515514202|FG003|Overall Study|Not evaluable|7|||
142994457|NCT02405091|515514205|FG000|Overall Study|Adverse Event|16|||
142994458|NCT02405091|515514206|FG001|Overall Study|Adverse Event|10|||
142994459|NCT02405091|515514207|FG002|Overall Study|Adverse Event|0|||
142994460|NCT02405091|515514205|FG000|Overall Study|Protocol Violation|1|||
142994461|NCT02405091|515514206|FG001|Overall Study|Protocol Violation|0|||
142994462|NCT02405091|515514207|FG002|Overall Study|Protocol Violation|0|||
142994463|NCT02405091|515514205|FG000|Overall Study|Noncompliance|1|||
142994464|NCT02405091|515514206|FG001|Overall Study|Noncompliance|6|||
142994465|NCT02405091|515514207|FG002|Overall Study|Noncompliance|2|||
142994466|NCT02405091|515514205|FG000|Overall Study|Withdrawal by Subject|4|||
142994467|NCT02405091|515514206|FG001|Overall Study|Withdrawal by Subject|8|||
142994468|NCT02405091|515514207|FG002|Overall Study|Withdrawal by Subject|0|||
142994469|NCT02405091|515514205|FG000|Overall Study|Death|0|||
142994470|NCT02405091|515514206|FG001|Overall Study|Death|1|||
142994471|NCT02405091|515514207|FG002|Overall Study|Death|0|||
142994472|NCT02405091|515514205|FG000|Overall Study|Lost to Follow-up|5|||
142994473|NCT02405091|515514206|FG001|Overall Study|Lost to Follow-up|6|||
142994474|NCT02405091|515514207|FG002|Overall Study|Lost to Follow-up|0|||
142994475|NCT02405091|515514205|FG000|Overall Study|Physician Decision|2|||
142994476|NCT02405091|515514206|FG001|Overall Study|Physician Decision|2|||
142994477|NCT02405091|515514207|FG002|Overall Study|Physician Decision|0|||
142994478|NCT01601873|515514217|FG000|Overall Study|Lost to Follow-up|2|||
142994479|NCT01601873|515514218|FG001|Overall Study|Lost to Follow-up|3|||
142994480|NCT03196973|515514219|FG000|Overall Study|Adverse Event|1|||
142994481|NCT03196973|515514220|FG001|Overall Study|Adverse Event|1|||
142994482|NCT03196973|515514221|FG002|Overall Study|Adverse Event|2|||
142994483|NCT03196973|515514219|FG000|Overall Study|Lack of Efficacy|2|||
142994484|NCT03196973|515514220|FG001|Overall Study|Lack of Efficacy|6|||
142994485|NCT03196973|515514221|FG002|Overall Study|Lack of Efficacy|1|||
142994486|NCT03196973|515514219|FG000|Overall Study|Lost to Follow-up|4|||
142994487|NCT03196973|515514220|FG001|Overall Study|Lost to Follow-up|3|||
142994488|NCT03196973|515514221|FG002|Overall Study|Lost to Follow-up|2|||
142994489|NCT03196973|515514219|FG000|Overall Study|Consent withdrawn|2|||
142994490|NCT03196973|515514220|FG001|Overall Study|Consent withdrawn|1|||
142994491|NCT03196973|515514221|FG002|Overall Study|Consent withdrawn|0|||
142994492|NCT03196973|515514219|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
142994493|NCT03196973|515514220|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
142994494|NCT03196973|515514221|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
142994495|NCT00826540|515514238|FG000|Overall Study|ineligible|3|||
142994496|NCT00826540|515514238|FG000|Overall Study|Withdrawal by Subject|1|||
142994497|NCT01166386|515514239|FG000|Overall Study|Withdrawal by Subject|3|||
142994498|NCT01166386|515514240|FG001|Overall Study|Withdrawal by Subject|5|||
142994499|NCT02390362|515514241|FG000|Overall Study|Withdrawal by Subject|0|||
142994500|NCT02390362|515514242|FG001|Overall Study|Withdrawal by Subject|1|||
142994501|NCT01024946|515514243|FG000|Overall Study|Screen Failure|3|||
142994502|NCT01024946|515514243|FG000|Overall Study|Withdrawal by Subject|1|||
142994503|NCT01024946|515514243|FG000|Overall Study|Adverse Event|1|||
142994504|NCT00957723|515514246|FG000|Overall Study|Death|3|||
142994505|NCT00957723|515514246|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
142994506|NCT00957723|515514246|FG000|Overall Study|Lost to Follow-up|8|||
142994507|NCT00957723|515514246|FG000|Overall Study|Withdrawal by Subject|24|||
142994508|NCT00957723|515514246|FG000|Overall Study|Investigative Site Terminated|61|||
142994509|NCT00957723|515514246|FG000|Overall Study|Intercurrent Illness|2|||
142994510|NCT00957723|515514246|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
142994511|NCT00984009|515514247|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
142994512|NCT00281528|515514248|FG000|Overall Study|Progressive Disease|28|||
142994513|NCT00281528|515514249|FG001|Overall Study|Progressive Disease|18|||
142994514|NCT00281528|515514250|FG002|Overall Study|Progressive Disease|27|||
142994515|NCT00281528|515514248|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
142994516|NCT00281528|515514249|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
142994517|NCT00281528|515514250|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
142994518|NCT00281528|515514248|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
142994519|NCT00281528|515514249|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
142994520|NCT00281528|515514250|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
142994521|NCT00281528|515514248|FG000|Overall Study|Physician Decision|11|||
142994522|NCT00281528|515514249|FG001|Overall Study|Physician Decision|4|||
142994523|NCT00281528|515514250|FG002|Overall Study|Physician Decision|5|||
142994524|NCT00281528|515514248|FG000|Overall Study|Protocol Violation|1|||
142994525|NCT00281528|515514249|FG001|Overall Study|Protocol Violation|0|||
142994526|NCT00281528|515514250|FG002|Overall Study|Protocol Violation|1|||
142994527|NCT00281528|515514248|FG000|Overall Study|Withdrawal by Subject|5|||
142994528|NCT00281528|515514249|FG001|Overall Study|Withdrawal by Subject|5|||
142994529|NCT00281528|515514250|FG002|Overall Study|Withdrawal by Subject|7|||
142994530|NCT00281528|515514248|FG000|Overall Study|Other|6|||
142994531|NCT00281528|515514249|FG001|Overall Study|Other|3|||
142994532|NCT00281528|515514250|FG002|Overall Study|Other|5|||
142994533|NCT02178592|515514251|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
142994534|NCT02178592|515514252|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
142994535|NCT02178592|515514251|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
142994536|NCT02178592|515514252|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
142994537|NCT02178592|515514251|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
142994538|NCT02178592|515514252|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
142994539|NCT02178592|515514251|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
142994540|NCT02178592|515514252|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
142994541|NCT02178592|515514251|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
142994542|NCT02178592|515514252|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
142994543|NCT02178592|515514251|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
142994544|NCT02178592|515514252|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
142994545|NCT02178592|515514251|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
142994546|NCT02178592|515514252|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
142994547|NCT02178592|515514251|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
142994548|NCT02178592|515514252|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
142994549|NCT02178592|515514251|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
142994550|NCT02178592|515514252|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
142994551|NCT02178592|515514251|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
142994552|NCT02178592|515514252|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
142994553|NCT02178592|515514251|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
142994554|NCT02178592|515514252|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
142994555|NCT02178592|515514251|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
142994556|NCT02178592|515514252|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
142994557|NCT01984294|515514256|FG000|Overall Study|Randomized but Never Treated|0|||
142994558|NCT01984294|515514257|FG001|Overall Study|Randomized but Never Treated|0|||
142994559|NCT01984294|515514258|FG002|Overall Study|Randomized but Never Treated|1|||
142994560|NCT01984294|515514256|FG000|Overall Study|Lack of Efficacy|4|||
142994561|NCT01984294|515514257|FG001|Overall Study|Lack of Efficacy|2|||
142994562|NCT01984294|515514258|FG002|Overall Study|Lack of Efficacy|6|||
142994563|NCT01984294|515514256|FG000|Overall Study|Adverse Event|0|||
142994564|NCT01984294|515514257|FG001|Overall Study|Adverse Event|1|||
142994565|NCT01984294|515514258|FG002|Overall Study|Adverse Event|0|||
142994566|NCT00537810|515514265|FG000|Overall Study|Withdrawal by Subject|4|||
142994567|NCT00537810|515514266|FG001|Overall Study|Withdrawal by Subject|11|||
142994568|NCT00537810|515514267|FG002|Overall Study|Withdrawal by Subject|4|||
142994569|NCT00537810|515514268|FG003|Overall Study|Withdrawal by Subject|3|||
142994570|NCT00537810|515514265|FG000|Overall Study|Medically withdrawn|2|||
142994571|NCT00537810|515514266|FG001|Overall Study|Medically withdrawn|2|||
142994572|NCT00537810|515514267|FG002|Overall Study|Medically withdrawn|0|||
142994573|NCT00537810|515514268|FG003|Overall Study|Medically withdrawn|1|||
142994574|NCT03258762|515514277|FG000|Overall Study|Lost to Follow-up|0|||
142994575|NCT03258762|515514278|FG001|Overall Study|Lost to Follow-up|1|||
142994576|NCT01711359|515514279|FG000|Treatment Period|Withdrawal by Subject|18|||
142994577|NCT01711359|515514280|FG001|Treatment Period|Withdrawal by Subject|7|||
142994578|NCT01711359|515514281|FG002|Treatment Period|Withdrawal by Subject|13|||
142994579|NCT01711359|515514279|FG000|Treatment Period|Lack of Efficacy|13|||
142994580|NCT01711359|515514280|FG001|Treatment Period|Lack of Efficacy|2|||
142994581|NCT01711359|515514281|FG002|Treatment Period|Lack of Efficacy|2|||
142994582|NCT01711359|515514279|FG000|Treatment Period|Adverse Event|8|||
142994583|NCT01711359|515514280|FG001|Treatment Period|Adverse Event|10|||
142994584|NCT01711359|515514281|FG002|Treatment Period|Adverse Event|24|||
142994585|NCT01711359|515514279|FG000|Treatment Period|Physician Decision|4|||
142994586|NCT01711359|515514280|FG001|Treatment Period|Physician Decision|3|||
142994587|NCT01711359|515514281|FG002|Treatment Period|Physician Decision|2|||
142994588|NCT01711359|515514279|FG000|Treatment Period|Death|3|||
142994589|NCT01711359|515514280|FG001|Treatment Period|Death|0|||
142994590|NCT01711359|515514281|FG002|Treatment Period|Death|0|||
142994591|NCT01711359|515514279|FG000|Treatment Period|Entry Criteria Not Met|1|||
142994592|NCT01711359|515514280|FG001|Treatment Period|Entry Criteria Not Met|0|||
142994593|NCT01711359|515514281|FG002|Treatment Period|Entry Criteria Not Met|0|||
142994594|NCT01711359|515514279|FG000|Treatment Period|Sponsor Decision|1|||
142994595|NCT01711359|515514280|FG001|Treatment Period|Sponsor Decision|0|||
142994596|NCT01711359|515514281|FG002|Treatment Period|Sponsor Decision|0|||
142994597|NCT01711359|515514279|FG000|Treatment Period|Lost to Follow-up|1|||
142994598|NCT01711359|515514280|FG001|Treatment Period|Lost to Follow-up|1|||
142994599|NCT01711359|515514281|FG002|Treatment Period|Lost to Follow-up|1|||
142994600|NCT01711359|515514279|FG000|Treatment Period|Randomized, Not Treated|3|||
142994601|NCT01711359|515514280|FG001|Treatment Period|Randomized, Not Treated|1|||
142994602|NCT01711359|515514281|FG002|Treatment Period|Randomized, Not Treated|0|||
142994603|NCT00554840|515514282|FG000|Overall Study|Physician Decision|0|||
142994604|NCT00554840|515514283|FG001|Overall Study|Physician Decision|1|||
142994605|NCT02698176|515514284|FG000|Overall Study|Progressive disease|4|||
142994606|NCT02698176|515514285|FG001|Overall Study|Progressive disease|3|||
142994607|NCT02698176|515514286|FG002|Overall Study|Progressive disease|1|||
142994608|NCT02698176|515514287|FG003|Overall Study|Progressive disease|0|||
142994609|NCT02698176|515514284|FG000|Overall Study|Adverse Event|2|||
142994610|NCT02698176|515514285|FG001|Overall Study|Adverse Event|0|||
142994611|NCT02698176|515514286|FG002|Overall Study|Adverse Event|0|||
142994612|NCT02698176|515514287|FG003|Overall Study|Adverse Event|0|||
142994613|NCT02698176|515514284|FG000|Overall Study|Clinical progression|3|||
142994614|NCT02698176|515514285|FG001|Overall Study|Clinical progression|0|||
142994615|NCT02698176|515514286|FG002|Overall Study|Clinical progression|0|||
142994616|NCT02698176|515514287|FG003|Overall Study|Clinical progression|0|||
142994617|NCT00925522|515514288|FG000|Overall Study|study closed -- business decision|20|||
142994618|NCT02561572|515514293|FG000|Overall Study|Inadequate time before surgery|2|||
142994619|NCT02561572|515514294|FG001|Overall Study|Inadequate time before surgery|1|||
142994620|NCT02561572|515514293|FG000|Overall Study|Protocol Violation|0|||
142994621|NCT02561572|515514294|FG001|Overall Study|Protocol Violation|1|||
142994622|NCT00795717|515514295|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
142994623|NCT00795717|515514296|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
142994624|NCT00795717|515514295|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
142994625|NCT00795717|515514296|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
142994626|NCT00795717|515514295|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
142994627|NCT00795717|515514296|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
142994628|NCT00795717|515514295|FG000|Phase II|too busy|0|||
142994629|NCT00795717|515514296|FG001|Phase II|too busy|1|||
142994630|NCT00410514|515514297|FG000|Overall Study|Adverse Event|2|||
142994631|NCT00410514|515514298|FG001|Overall Study|Adverse Event|2|||
142994632|NCT00410514|515514299|FG002|Overall Study|Adverse Event|2|||
142994633|NCT00410514|515514297|FG000|Overall Study|Protocol Violation|0|||
142994634|NCT00410514|515514298|FG001|Overall Study|Protocol Violation|1|||
142994635|NCT00410514|515514299|FG002|Overall Study|Protocol Violation|1|||
142994636|NCT00410514|515514297|FG000|Overall Study|Lost to Follow-up|0|||
142994637|NCT00410514|515514298|FG001|Overall Study|Lost to Follow-up|0|||
142994638|NCT00410514|515514299|FG002|Overall Study|Lost to Follow-up|2|||
142994639|NCT00410514|515514297|FG000|Overall Study|Non-compliant with study procedures|0|||
142994640|NCT00410514|515514298|FG001|Overall Study|Non-compliant with study procedures|0|||
142994641|NCT00410514|515514299|FG002|Overall Study|Non-compliant with study procedures|2|||
142994642|NCT02691468|515514302|FG000|Overall Study|Bronchial blocker use|2|||
142994643|NCT02691468|515514303|FG001|Overall Study|Bronchial blocker use|1|||
142994644|NCT02691468|515514302|FG000|Overall Study|Lost to Follow-up|2|||
142994645|NCT02691468|515514303|FG001|Overall Study|Lost to Follow-up|1|||
142994646|NCT02691468|515514302|FG000|Overall Study|Failure to advance FOB|2|||
142994647|NCT02691468|515514303|FG001|Overall Study|Failure to advance FOB|0|||
142994648|NCT02886338|515514304|FG000|Overall Study|Withdrawal by Subject|1|||
142994649|NCT00394654|515514305|FG000|Overall Study|Lost to Follow-up|1|||
142994650|NCT00394654|515514306|FG001|Overall Study|Lost to Follow-up|0|||
142994651|NCT00394654|515514305|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
142994652|NCT00394654|515514306|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
142994653|NCT00957034|515514311|FG000|Overall Study|Adverse Event|0|||
142994654|NCT00957034|515514312|FG001|Overall Study|Adverse Event|1|||
142994655|NCT00957034|515514313|FG002|Overall Study|Adverse Event|1|||
142994656|NCT00957034|515514311|FG000|Overall Study|Sponsor Terminated Study|6|||
142994657|NCT00957034|515514312|FG001|Overall Study|Sponsor Terminated Study|1|||
142994658|NCT00957034|515514313|FG002|Overall Study|Sponsor Terminated Study|5|||
142994659|NCT00957034|515514311|FG000|Overall Study|Withdrawal by Subject|0|||
142994660|NCT00957034|515514312|FG001|Overall Study|Withdrawal by Subject|2|||
142994661|NCT00957034|515514313|FG002|Overall Study|Withdrawal by Subject|0|||
142994662|NCT02390167|515516669|FG000|Overall Study|Lost to Follow-up|1|||
142994663|NCT01265719|515516670|FG000|Overall Study|Does not meet entrance criteria|0|||
142994664|NCT01265719|515516671|FG001|Overall Study|Does not meet entrance criteria|3|||
142994665|NCT01265719|515516670|FG000|Overall Study|Other reasons|2|||
142994666|NCT01265719|515516671|FG001|Overall Study|Other reasons|0|||
142994667|NCT01265719|515516670|FG000|Overall Study|Withdrawal by Subject|8|||
142994668|NCT01265719|515516671|FG001|Overall Study|Withdrawal by Subject|3|||
142994669|NCT01265719|515516670|FG000|Overall Study|Lost to Follow-up|2|||
142994670|NCT01265719|515516671|FG001|Overall Study|Lost to Follow-up|7|||
142994671|NCT01265719|515516670|FG000|Overall Study|Adverse Event|2|||
142994672|NCT01265719|515516671|FG001|Overall Study|Adverse Event|0|||
142994673|NCT02039687|515516675|FG000|Overall Study|Adverse Event|0|||
142994674|NCT02039687|515516676|FG001|Overall Study|Adverse Event|0|||
142994675|NCT02039687|515516677|FG002|Overall Study|Adverse Event|1|||
142994676|NCT02039687|515516678|FG003|Overall Study|Adverse Event|0|||
142994677|NCT02039687|515516675|FG000|Overall Study|Withdrawal by Subject|0|||
142994678|NCT02039687|515516676|FG001|Overall Study|Withdrawal by Subject|1|||
142994679|NCT02039687|515516677|FG002|Overall Study|Withdrawal by Subject|0|||
142994680|NCT02039687|515516678|FG003|Overall Study|Withdrawal by Subject|0|||
142994681|NCT02039687|515516675|FG000|Overall Study|treatment assignment could not be confir|0|||
142994682|NCT02039687|515516676|FG001|Overall Study|treatment assignment could not be confir|0|||
142994683|NCT02039687|515516677|FG002|Overall Study|treatment assignment could not be confir|2|||
142994684|NCT02039687|515516678|FG003|Overall Study|treatment assignment could not be confir|0|||
142994685|NCT00959192|515516681|FG000|Overall Study|Adverse Event|1|||
142994686|NCT00959192|515516682|FG001|Overall Study|Adverse Event|1|||
142994687|NCT00959192|515516683|FG002|Overall Study|Adverse Event|1|||
142994688|NCT00959192|515516684|FG003|Overall Study|Adverse Event|0|||
142994689|NCT00959192|515516681|FG000|Overall Study|Investigator Request|1|||
142994690|NCT00959192|515516682|FG001|Overall Study|Investigator Request|0|||
142994691|NCT00959192|515516683|FG002|Overall Study|Investigator Request|0|||
142994692|NCT00959192|515516684|FG003|Overall Study|Investigator Request|0|||
142994693|NCT00959192|515516681|FG000|Overall Study|Caregiver Request|0|||
142994694|NCT00959192|515516682|FG001|Overall Study|Caregiver Request|0|||
142994695|NCT00959192|515516683|FG002|Overall Study|Caregiver Request|2|||
142994696|NCT00959192|515516684|FG003|Overall Study|Caregiver Request|1|||
142994697|NCT00532441|515516685|FG000|Overall Study|Death|1|||
142994698|NCT00532441|515516686|FG001|Overall Study|Death|0|||
142994699|NCT01967134|515516687|FG000|Overall Study|Lost to Follow-up|0|||
142994700|NCT01967134|515516688|FG001|Overall Study|Lost to Follow-up|1|||
142994701|NCT01967134|515516689|FG002|Overall Study|Lost to Follow-up|0|||
142994702|NCT00305773|515516691|FG000|Overall Study|Death|3|||
142994703|NCT00305773|515516692|FG001|Overall Study|Death|2|||
142994704|NCT00305773|515516691|FG000|Overall Study|Adverse Event|1|||
142994705|NCT00305773|515516692|FG001|Overall Study|Adverse Event|2|||
142994706|NCT00305773|515516691|FG000|Overall Study|Alternative Treatment|4|||
142994707|NCT00305773|515516692|FG001|Overall Study|Alternative Treatment|4|||
142994708|NCT00305773|515516691|FG000|Overall Study|Physician Decision|1|||
142994709|NCT00305773|515516692|FG001|Overall Study|Physician Decision|1|||
142994710|NCT00305773|515516691|FG000|Overall Study|Withdrawal by Subject|1|||
142994711|NCT00305773|515516692|FG001|Overall Study|Withdrawal by Subject|4|||
142994712|NCT00305773|515516691|FG000|Overall Study|Disease Progression|1|||
142994713|NCT00305773|515516692|FG001|Overall Study|Disease Progression|3|||
142994714|NCT00305773|515516691|FG000|Overall Study|All other reasons|3|||
142994715|NCT00305773|515516692|FG001|Overall Study|All other reasons|2|||
142994716|NCT00303329|515516693|FG000|Overall Study|Adverse Event|7|||
142994717|NCT00303329|515516694|FG001|Overall Study|Adverse Event|14|||
142994718|NCT00303329|515516693|FG000|Overall Study|Abnormal Laboratory Values|0|||
142994719|NCT00303329|515516694|FG001|Overall Study|Abnormal Laboratory Values|1|||
142994720|NCT00303329|515516693|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
142994721|NCT00303329|515516694|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
142994722|NCT00303329|515516693|FG000|Overall Study|Condition no longer requires study drug|0|||
142994723|NCT00303329|515516694|FG001|Overall Study|Condition no longer requires study drug|8|||
142994724|NCT00303329|515516693|FG000|Overall Study|Protocol Violation|3|||
142994725|NCT00303329|515516694|FG001|Overall Study|Protocol Violation|0|||
142994726|NCT00303329|515516693|FG000|Overall Study|Withdrawal by Subject|9|||
142994727|NCT00303329|515516694|FG001|Overall Study|Withdrawal by Subject|15|||
142994728|NCT00303329|515516693|FG000|Overall Study|Lost to Follow-up|0|||
142994729|NCT00303329|515516694|FG001|Overall Study|Lost to Follow-up|1|||
142994730|NCT00303329|515516693|FG000|Overall Study|Administrative problems|1|||
143455679|NCT00700778|517212508|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
142994731|NCT00303329|515516694|FG001|Overall Study|Administrative problems|0|||
142994732|NCT00303329|515516693|FG000|Overall Study|Death|2|||
142994733|NCT00303329|515516694|FG001|Overall Study|Death|12|||
142994734|NCT00303329|515516693|FG000|Overall Study|Stopped at end of core|3|||
142994735|NCT00303329|515516694|FG001|Overall Study|Stopped at end of core|9|||
142994736|NCT00303329|515516693|FG000|Overall Study|Stopped at end of extension 1|1|||
142994737|NCT00303329|515516694|FG001|Overall Study|Stopped at end of extension 1|0|||
142994738|NCT04735432|515516695|FG000|Overall Study|Other - due to personal reason|1|||
142994739|NCT04735432|515516696|FG001|Overall Study|Other - due to personal reason|0|||
142994740|NCT04735432|515516695|FG000|Overall Study|Adverse Event|2|||
142994741|NCT04735432|515516696|FG001|Overall Study|Adverse Event|0|||
142994742|NCT00775138|515516697|FG000|Overall Study|Withdrawal by Subject|0|||
142994743|NCT00775138|515516698|FG001|Overall Study|Withdrawal by Subject|0|||
142994744|NCT00775138|515516699|FG002|Overall Study|Withdrawal by Subject|2|||
142994745|NCT00775138|515516700|FG003|Overall Study|Withdrawal by Subject|2|||
142994746|NCT00775138|515516697|FG000|Overall Study|Adverse Event|0|||
142994747|NCT00775138|515516698|FG001|Overall Study|Adverse Event|0|||
142994748|NCT00775138|515516699|FG002|Overall Study|Adverse Event|1|||
142994749|NCT00775138|515516700|FG003|Overall Study|Adverse Event|0|||
142994750|NCT04880642|515516701|FG000|Randomization|Withdrawal by Subject|2|||
142994751|NCT04880642|515516702|FG001|Randomization|Withdrawal by Subject|3|||
142994752|NCT04880642|515516701|FG000|Treatment Period|Adverse Event|0|||
142994753|NCT04880642|515516702|FG001|Treatment Period|Adverse Event|1|||
142994754|NCT04880642|515516701|FG000|Treatment Period|Death|6|||
142994755|NCT04880642|515516702|FG001|Treatment Period|Death|6|||
142994756|NCT04880642|515516701|FG000|Treatment Period|Lost to Follow-up|1|||
142994757|NCT04880642|515516702|FG001|Treatment Period|Lost to Follow-up|0|||
142994758|NCT04880642|515516701|FG000|Treatment Period|Protocol Violation|0|||
142994759|NCT04880642|515516702|FG001|Treatment Period|Protocol Violation|1|||
142994760|NCT04880642|515516701|FG000|Treatment Period|Withdrawal by Subject|5|||
142994761|NCT04880642|515516702|FG001|Treatment Period|Withdrawal by Subject|3|||
142994762|NCT04880642|515516701|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
143455680|NCT00350103|517212511|FG000|Overall Study|Adverse Event|12|||
143455681|NCT00350103|517212512|FG001|Overall Study|Adverse Event|29|||
143455682|NCT00350103|517212513|FG002|Overall Study|Adverse Event|17|||
143455683|NCT00350103|517212511|FG000|Overall Study|Lack of Efficacy|5|||
143455684|NCT00350103|517212512|FG001|Overall Study|Lack of Efficacy|1|||
143455685|NCT00350103|517212513|FG002|Overall Study|Lack of Efficacy|3|||
143455686|NCT00350103|517212511|FG000|Overall Study|Withdrawal by Subject|6|||
143455687|NCT00350103|517212512|FG001|Overall Study|Withdrawal by Subject|6|||
143455688|NCT00350103|517212513|FG002|Overall Study|Withdrawal by Subject|8|||
143455689|NCT00350103|517212511|FG000|Overall Study|Protocol Violation|0|||
143455690|NCT00350103|517212512|FG001|Overall Study|Protocol Violation|0|||
143455691|NCT00350103|517212513|FG002|Overall Study|Protocol Violation|1|||
143455692|NCT00350103|517212511|FG000|Overall Study|Unsatisfactory Compliance|2|||
143455693|NCT00350103|517212512|FG001|Overall Study|Unsatisfactory Compliance|2|||
143455694|NCT00350103|517212513|FG002|Overall Study|Unsatisfactory Compliance|1|||
143455695|NCT00350103|517212511|FG000|Overall Study|Investigator´s decision|1|||
143455696|NCT00350103|517212512|FG001|Overall Study|Investigator´s decision|1|||
143455697|NCT00350103|517212513|FG002|Overall Study|Investigator´s decision|0|||
143455698|NCT00350103|517212511|FG000|Overall Study|Exclusion criteria met|0|||
143455699|NCT00350103|517212512|FG001|Overall Study|Exclusion criteria met|0|||
143455700|NCT00350103|517212513|FG002|Overall Study|Exclusion criteria met|1|||
143455701|NCT00350103|517212511|FG000|Overall Study|Patient relocated|0|||
143455702|NCT00350103|517212512|FG001|Overall Study|Patient relocated|0|||
143455703|NCT00350103|517212513|FG002|Overall Study|Patient relocated|1|||
143455704|NCT00350103|517212511|FG000|Overall Study|Need for prohibited medication|1|||
143455705|NCT00350103|517212512|FG001|Overall Study|Need for prohibited medication|0|||
143455706|NCT00350103|517212513|FG002|Overall Study|Need for prohibited medication|0|||
143455707|NCT00350103|517212511|FG000|Overall Study|Personal reasons|0|||
143455708|NCT00350103|517212512|FG001|Overall Study|Personal reasons|0|||
143455709|NCT00350103|517212513|FG002|Overall Study|Personal reasons|1|||
143455710|NCT00350103|517212511|FG000|Overall Study|Patient stopped feeling pain|1|||
143455711|NCT00350103|517212512|FG001|Overall Study|Patient stopped feeling pain|0|||
143455712|NCT00350103|517212513|FG002|Overall Study|Patient stopped feeling pain|0|||
143455713|NCT00350103|517212511|FG000|Overall Study|PR greater than 250ms|0|||
143455714|NCT00350103|517212512|FG001|Overall Study|PR greater than 250ms|0|||
143455715|NCT00350103|517212513|FG002|Overall Study|PR greater than 250ms|1|||
143455716|NCT00350103|517212511|FG000|Overall Study|Wrong calculation of QT interval|0|||
143455717|NCT00350103|517212512|FG001|Overall Study|Wrong calculation of QT interval|0|||
143455718|NCT00350103|517212513|FG002|Overall Study|Wrong calculation of QT interval|1|||
143455719|NCT00350103|517212511|FG000|Overall Study|Sponsor mistake|1|||
143455720|NCT00350103|517212512|FG001|Overall Study|Sponsor mistake|0|||
142994763|NCT04880642|515516702|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
142994764|NCT04880642|515516701|FG000|Follow-up|Death|4|||
142994765|NCT04880642|515516702|FG001|Follow-up|Death|3|||
142994766|NCT04880642|515516701|FG000|Follow-up|Withdrawal by Subject|1|||
142994767|NCT04880642|515516702|FG001|Follow-up|Withdrawal by Subject|0|||
142994768|NCT05102734|515516704|FG000|Overall Study|Did not require vasopressors|1|||
142994769|NCT05102734|515516705|FG001|Overall Study|Did not require vasopressors|0|||
142994770|NCT05102734|515516704|FG000|Overall Study|Did not have functioning PA catheter|1|||
142994771|NCT05102734|515516705|FG001|Overall Study|Did not have functioning PA catheter|0|||
142994772|NCT05102734|515516704|FG000|Overall Study|Inadequate video quality|2|||
142994773|NCT05102734|515516705|FG001|Overall Study|Inadequate video quality|0|||
142994774|NCT01797302|515516706|FG000|Overall Study|Lost to Follow-up|16|||
142994775|NCT01797302|515516707|FG001|Overall Study|Lost to Follow-up|23|||
142994776|NCT01797302|515516708|FG002|Overall Study|Lost to Follow-up|22|||
142994777|NCT01797302|515516706|FG000|Overall Study|Withdrawal by Subject|1|||
142994778|NCT01797302|515516707|FG001|Overall Study|Withdrawal by Subject|3|||
142994779|NCT01797302|515516708|FG002|Overall Study|Withdrawal by Subject|4|||
142994780|NCT02418000|515516711|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
142994781|NCT02418000|515516712|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
142994782|NCT02418000|515516713|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
142994783|NCT02418000|515516714|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
142994784|NCT02418000|515516715|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
142994785|NCT02418000|515516711|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
142994786|NCT02418000|515516712|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
142994787|NCT02418000|515516713|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
142994788|NCT02418000|515516714|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
142994789|NCT02418000|515516715|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
142994790|NCT02418000|515516711|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
142994791|NCT02418000|515516712|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
142994792|NCT02418000|515516713|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
142994793|NCT02418000|515516714|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
142994794|NCT02418000|515516715|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
142994795|NCT02418000|515516711|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
142994796|NCT02418000|515516712|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
142994797|NCT02418000|515516713|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
142994798|NCT02418000|515516714|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
142994799|NCT02418000|515516715|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
142994800|NCT02418000|515516711|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
142994801|NCT02418000|515516712|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
142994802|NCT02418000|515516713|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
142994803|NCT02418000|515516714|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
142994804|NCT02418000|515516715|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
142994805|NCT02418000|515516711|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
142994806|NCT02418000|515516712|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
142994807|NCT02418000|515516713|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
142994808|NCT02418000|515516714|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
142994809|NCT02418000|515516715|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
142994810|NCT02418000|515516711|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
142994811|NCT02418000|515516712|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
142994812|NCT02418000|515516713|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
142994813|NCT02418000|515516714|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
142994814|NCT02418000|515516715|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
142994815|NCT02418000|515516711|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
142994816|NCT02418000|515516712|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
142994817|NCT02418000|515516713|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
142994818|NCT02418000|515516714|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
142994819|NCT02418000|515516715|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
142994820|NCT02418000|515516711|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
142994821|NCT02418000|515516712|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
142994822|NCT02418000|515516713|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
142994823|NCT02418000|515516714|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
142994824|NCT02418000|515516715|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
142994825|NCT00732199|515516716|FG000|Overall Study|Withdrawal by Subject|25|||
142994826|NCT00732199|515516717|FG001|Overall Study|Withdrawal by Subject|18|||
142994827|NCT00732199|515516716|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
142994828|NCT00732199|515516717|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
142994829|NCT00672139|515516730|FG000|Overall Study|Death|14|||
142994830|NCT00672139|515516731|FG001|Overall Study|Death|23|||
142994831|NCT00672139|515516730|FG000|Overall Study|Withdrawal by Subject|2|||
142994832|NCT00672139|515516731|FG001|Overall Study|Withdrawal by Subject|11|||
142994833|NCT00672139|515516730|FG000|Overall Study|Adverse Event|4|||
142994834|NCT00672139|515516731|FG001|Overall Study|Adverse Event|7|||
142994835|NCT00672139|515516730|FG000|Overall Study|Physician Decision|2|||
142994836|NCT00672139|515516731|FG001|Overall Study|Physician Decision|0|||
142994837|NCT00672139|515516730|FG000|Overall Study|Lack of Efficacy|4|||
142994838|NCT00672139|515516731|FG001|Overall Study|Lack of Efficacy|1|||
142994839|NCT00672139|515516730|FG000|Overall Study|Protocol Violation|1|||
142994840|NCT00672139|515516731|FG001|Overall Study|Protocol Violation|1|||
142994841|NCT00672139|515516730|FG000|Overall Study|hospice discharge, caregiver requests|3|||
142994842|NCT00672139|515516731|FG001|Overall Study|hospice discharge, caregiver requests|2|||
142994843|NCT01051856|515516732|FG000|Overall Study|Withdrawal by Subject|1|||
142994844|NCT01051856|515516733|FG001|Overall Study|Withdrawal by Subject|0|||
142994845|NCT02381795|515516734|FG000|Overall Study|Withdrawal by Subject|1|||
142994846|NCT02381795|515516734|FG000|Overall Study|Study Terminated|2|||
142994847|NCT02176226|515516735|FG000|Overall Study|Lost to Follow-up|3|||
142994848|NCT02176226|515516735|FG000|Overall Study|Withdrew prior to treatment|6|||
142994849|NCT01488994|515516740|FG000|Overall Study|Withdrawal by Subject|0|||
142994850|NCT01488994|515516741|FG001|Overall Study|Withdrawal by Subject|1|||
142994851|NCT01072500|515516742|FG000|Overall Study|Death|2|||
142994852|NCT01072500|515516743|FG001|Overall Study|Death|2|||
142994853|NCT01072500|515516742|FG000|Overall Study|Lost to Follow-up|5|||
142994854|NCT01072500|515516743|FG001|Overall Study|Lost to Follow-up|2|||
142994855|NCT01072500|515516742|FG000|Overall Study|Withdrawal by Subject|17|||
142994856|NCT01072500|515516743|FG001|Overall Study|Withdrawal by Subject|10|||
142994857|NCT01611558|515516744|FG000|Induction Phase|Study drug toxicity|15|||
142994858|NCT01611558|515516744|FG000|Induction Phase|Disease progression|18|||
142994859|NCT01611558|515516744|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
142994860|NCT01611558|515516744|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
142994861|NCT01611558|515516744|FG000|Induction Phase|Death|1|||
142994862|NCT01611558|515516744|FG000|Maintenance Phase|Withdrawal by Subject|1|||
142994863|NCT01611558|515516744|FG000|Maintenance Phase|Elevated Uric acid|1|||
142994864|NCT03798366|515516756|FG000|Overall Study|Lost to Follow-up|0|||
142994865|NCT03798366|515516757|FG001|Overall Study|Lost to Follow-up|1|||
142994866|NCT01412333|515516761|FG000|Overall Study|Adverse Event|40|||
142994867|NCT01412333|515516762|FG001|Overall Study|Adverse Event|42|||
142994868|NCT01412333|515516761|FG000|Overall Study|Death|5|||
142994869|NCT01412333|515516762|FG001|Overall Study|Death|6|||
142994870|NCT01412333|515516761|FG000|Overall Study|Lack of Efficacy|22|||
142994871|NCT01412333|515516762|FG001|Overall Study|Lack of Efficacy|10|||
142994872|NCT01412333|515516761|FG000|Overall Study|Lost to Follow-up|15|||
142994873|NCT01412333|515516762|FG001|Overall Study|Lost to Follow-up|12|||
142994874|NCT01412333|515516761|FG000|Overall Study|Non-Compliance|3|||
142994875|NCT01412333|515516762|FG001|Overall Study|Non-Compliance|7|||
142994876|NCT01412333|515516761|FG000|Overall Study|Non-Compliance With Study Drug|1|||
142994877|NCT01412333|515516762|FG001|Overall Study|Non-Compliance With Study Drug|1|||
142994878|NCT01412333|515516761|FG000|Overall Study|Other|30|||
142994879|NCT01412333|515516762|FG001|Overall Study|Other|33|||
142994880|NCT01412333|515516761|FG000|Overall Study|Physician Decision|11|||
142994881|NCT01412333|515516762|FG001|Overall Study|Physician Decision|16|||
142994882|NCT01412333|515516761|FG000|Overall Study|Pregnancy|6|||
142994883|NCT01412333|515516762|FG001|Overall Study|Pregnancy|4|||
142994884|NCT01412333|515516761|FG000|Overall Study|Protocol Violation|1|||
142994885|NCT01412333|515516762|FG001|Overall Study|Protocol Violation|2|||
142994886|NCT01412333|515516761|FG000|Overall Study|Study Terminated By Sponsor|3|||
142994887|NCT01412333|515516762|FG001|Overall Study|Study Terminated By Sponsor|2|||
142994888|NCT01412333|515516761|FG000|Overall Study|Withdrawal by Subject|51|||
142994889|NCT01412333|515516762|FG001|Overall Study|Withdrawal by Subject|54|||
142994890|NCT01412333|515516761|FG000|Overall Study|Missing|1|||
142994891|NCT01412333|515516762|FG001|Overall Study|Missing|3|||
142994892|NCT01227252|515516766|FG000|Overall Study|Sponsor Decision|0|||
142994893|NCT01227252|515516767|FG001|Overall Study|Sponsor Decision|1|||
142994894|NCT01227252|515516768|FG002|Overall Study|Sponsor Decision|0|||
142994895|NCT01227252|515516769|FG003|Overall Study|Sponsor Decision|0|||
142994896|NCT01227252|515516766|FG000|Overall Study|Lost to Follow-up|0|||
142994897|NCT01227252|515516767|FG001|Overall Study|Lost to Follow-up|1|||
142994898|NCT01227252|515516768|FG002|Overall Study|Lost to Follow-up|0|||
142994899|NCT01227252|515516769|FG003|Overall Study|Lost to Follow-up|0|||
142994900|NCT01227252|515516766|FG000|Overall Study|Withdrawal by Subject|0|||
142994901|NCT01227252|515516767|FG001|Overall Study|Withdrawal by Subject|1|||
142994902|NCT01227252|515516768|FG002|Overall Study|Withdrawal by Subject|0|||
142994903|NCT01227252|515516769|FG003|Overall Study|Withdrawal by Subject|0|||
142994904|NCT01836549|515516772|FG000|Overall Study|Did not receive study drug|0|||
142994905|NCT01836549|515516773|FG001|Overall Study|Did not receive study drug|0|||
142994906|NCT01836549|515516774|FG002|Overall Study|Did not receive study drug|1|||
142994907|NCT01836549|515516775|FG003|Overall Study|Did not receive study drug|0|||
142994908|NCT01836549|515516776|FG004|Overall Study|Did not receive study drug|0|||
142994909|NCT01836549|515516777|FG005|Overall Study|Did not receive study drug|0|||
142994910|NCT01836549|515516778|FG006|Overall Study|Did not receive study drug|0|||
142994911|NCT01836549|515516772|FG000|Overall Study|Patient declared ineligible|0|||
143003185|NCT01049360|515548757|FG013|Period 2|Lack of Efficacy|0|||
142994912|NCT01836549|515516773|FG001|Overall Study|Patient declared ineligible|0|||
142994913|NCT01836549|515516774|FG002|Overall Study|Patient declared ineligible|0|||
142994914|NCT01836549|515516775|FG003|Overall Study|Patient declared ineligible|1|||
142994915|NCT01836549|515516776|FG004|Overall Study|Patient declared ineligible|0|||
142994916|NCT01836549|515516777|FG005|Overall Study|Patient declared ineligible|0|||
142994917|NCT01836549|515516778|FG006|Overall Study|Patient declared ineligible|0|||
142994918|NCT01836549|515516772|FG000|Overall Study|Patient inevaluable to start therapy|0|||
142994919|NCT01836549|515516773|FG001|Overall Study|Patient inevaluable to start therapy|0|||
142994920|NCT01836549|515516774|FG002|Overall Study|Patient inevaluable to start therapy|0|||
142994921|NCT01836549|515516775|FG003|Overall Study|Patient inevaluable to start therapy|0|||
142994922|NCT01836549|515516776|FG004|Overall Study|Patient inevaluable to start therapy|0|||
142994923|NCT01836549|515516777|FG005|Overall Study|Patient inevaluable to start therapy|0|||
142994924|NCT01836549|515516778|FG006|Overall Study|Patient inevaluable to start therapy|1|||
142994925|NCT04652102|515516779|FG000|Overall Study|Adverse Event|14|||
142994926|NCT04652102|515516780|FG001|Overall Study|Adverse Event|13|||
142994927|NCT04652102|515516779|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
142994928|NCT04652102|515516780|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
142994929|NCT04652102|515516779|FG000|Overall Study|Physician Decision|78|||
142994930|NCT04652102|515516780|FG001|Overall Study|Physician Decision|40|||
142994931|NCT04652102|515516779|FG000|Overall Study|Study Ended by Sponsor|64|||
142994932|NCT04652102|515516780|FG001|Overall Study|Study Ended by Sponsor|17|||
142994933|NCT04652102|515516779|FG000|Overall Study|Withdrawal by Subject|4625|||
142994934|NCT04652102|515516780|FG001|Overall Study|Withdrawal by Subject|5594|||
142994935|NCT04652102|515516779|FG000|Overall Study|Lost to Follow-up|2019|||
142994936|NCT04652102|515516780|FG001|Overall Study|Lost to Follow-up|1082|||
142994937|NCT04652102|515516779|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
142994938|NCT04652102|515516780|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
142994939|NCT04652102|515516779|FG000|Overall Study|Miscellaneous|80|||
142994940|NCT04652102|515516780|FG001|Overall Study|Miscellaneous|64|||
142994941|NCT02516306|515516781|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
142994942|NCT02516306|515516782|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
142994943|NCT02192190|515516785|FG000|Overall Study|Adverse Event|1|||
142994944|NCT02192190|515516786|FG001|Overall Study|Adverse Event|1|||
142994945|NCT02192190|515516787|FG002|Overall Study|Adverse Event|0|||
142994946|NCT02192190|515516788|FG003|Overall Study|Adverse Event|0|||
142994947|NCT02192190|515516789|FG004|Overall Study|Adverse Event|0|||
142994948|NCT02192190|515516790|FG005|Overall Study|Adverse Event|0|||
142994949|NCT02192190|515516785|FG000|Overall Study|Lost to Follow-up|3|||
142994950|NCT02192190|515516786|FG001|Overall Study|Lost to Follow-up|3|||
142994951|NCT02192190|515516787|FG002|Overall Study|Lost to Follow-up|2|||
142994952|NCT02192190|515516788|FG003|Overall Study|Lost to Follow-up|1|||
142994953|NCT02192190|515516789|FG004|Overall Study|Lost to Follow-up|4|||
142994954|NCT02192190|515516790|FG005|Overall Study|Lost to Follow-up|3|||
142994955|NCT02192190|515516785|FG000|Overall Study|Physician Decision|2|||
142994956|NCT02192190|515516786|FG001|Overall Study|Physician Decision|0|||
142994957|NCT02192190|515516787|FG002|Overall Study|Physician Decision|0|||
142994958|NCT02192190|515516788|FG003|Overall Study|Physician Decision|0|||
142994959|NCT02192190|515516789|FG004|Overall Study|Physician Decision|0|||
142994960|NCT02192190|515516790|FG005|Overall Study|Physician Decision|0|||
142994961|NCT02192190|515516785|FG000|Overall Study|Terminated by Sponsor|43|||
142994962|NCT02192190|515516786|FG001|Overall Study|Terminated by Sponsor|23|||
142994963|NCT02192190|515516787|FG002|Overall Study|Terminated by Sponsor|20|||
142994964|NCT02192190|515516788|FG003|Overall Study|Terminated by Sponsor|23|||
142994965|NCT02192190|515516789|FG004|Overall Study|Terminated by Sponsor|21|||
142994966|NCT02192190|515516790|FG005|Overall Study|Terminated by Sponsor|23|||
142994967|NCT02192190|515516785|FG000|Overall Study|Withdrawal by Subject|4|||
142994968|NCT02192190|515516786|FG001|Overall Study|Withdrawal by Subject|1|||
142994969|NCT02192190|515516787|FG002|Overall Study|Withdrawal by Subject|2|||
142994970|NCT02192190|515516788|FG003|Overall Study|Withdrawal by Subject|1|||
142994971|NCT02192190|515516789|FG004|Overall Study|Withdrawal by Subject|5|||
142994972|NCT02192190|515516790|FG005|Overall Study|Withdrawal by Subject|3|||
142994973|NCT02192190|515516785|FG000|Overall Study|Could not Keep Visit Schedule|1|||
142994974|NCT02192190|515516786|FG001|Overall Study|Could not Keep Visit Schedule|0|||
142994975|NCT02192190|515516787|FG002|Overall Study|Could not Keep Visit Schedule|0|||
142994976|NCT02192190|515516788|FG003|Overall Study|Could not Keep Visit Schedule|0|||
142994977|NCT02192190|515516789|FG004|Overall Study|Could not Keep Visit Schedule|0|||
142994978|NCT02192190|515516790|FG005|Overall Study|Could not Keep Visit Schedule|0|||
142994979|NCT02192190|515516785|FG000|Overall Study|Positive Drug Screen|0|||
142994980|NCT02192190|515516786|FG001|Overall Study|Positive Drug Screen|0|||
142994981|NCT02192190|515516787|FG002|Overall Study|Positive Drug Screen|0|||
142994982|NCT02192190|515516788|FG003|Overall Study|Positive Drug Screen|1|||
142994983|NCT02192190|515516789|FG004|Overall Study|Positive Drug Screen|0|||
142994984|NCT02192190|515516790|FG005|Overall Study|Positive Drug Screen|0|||
142994985|NCT02192190|515516785|FG000|Overall Study|Inadequate Pain Relief|0|||
142994986|NCT02192190|515516786|FG001|Overall Study|Inadequate Pain Relief|1|||
142994987|NCT02192190|515516787|FG002|Overall Study|Inadequate Pain Relief|1|||
142994988|NCT02192190|515516788|FG003|Overall Study|Inadequate Pain Relief|0|||
142994989|NCT02192190|515516789|FG004|Overall Study|Inadequate Pain Relief|0|||
142994990|NCT02192190|515516790|FG005|Overall Study|Inadequate Pain Relief|0|||
142994991|NCT02607865|515516793|FG000|Overall Study|Lost to Follow-up|9|||
142994992|NCT02607865|515516794|FG001|Overall Study|Lost to Follow-up|7|||
142994993|NCT02607865|515516795|FG002|Overall Study|Lost to Follow-up|7|||
142994994|NCT02607865|515516796|FG003|Overall Study|Lost to Follow-up|5|||
142994995|NCT02607865|515516793|FG000|Overall Study|Withdrawal by Subject|18|||
142994996|NCT02607865|515516794|FG001|Overall Study|Withdrawal by Subject|18|||
142994997|NCT02607865|515516795|FG002|Overall Study|Withdrawal by Subject|17|||
142994998|NCT02607865|515516796|FG003|Overall Study|Withdrawal by Subject|8|||
142994999|NCT02607865|515516793|FG000|Overall Study|Death|5|||
142995000|NCT02607865|515516794|FG001|Overall Study|Death|4|||
142995001|NCT02607865|515516795|FG002|Overall Study|Death|1|||
142995002|NCT02607865|515516796|FG003|Overall Study|Death|3|||
142995003|NCT02607865|515516793|FG000|Overall Study|Unclassified|1|||
142995004|NCT02607865|515516794|FG001|Overall Study|Unclassified|1|||
142995005|NCT02607865|515516795|FG002|Overall Study|Unclassified|2|||
142995006|NCT02607865|515516796|FG003|Overall Study|Unclassified|0|||
142995007|NCT03227692|515516797|FG000|Overall Study|Protocol Violation|1|||
142995008|NCT03227692|515516798|FG001|Overall Study|Protocol Violation|1|||
142995009|NCT03227692|515516797|FG000|Overall Study|Lost to Follow-up|4|||
142995010|NCT03227692|515516798|FG001|Overall Study|Lost to Follow-up|2|||
142995011|NCT03227692|515516797|FG000|Overall Study|Adverse Event|0|||
142995012|NCT03227692|515516798|FG001|Overall Study|Adverse Event|2|||
142995013|NCT01657253|515516799|FG000|Overall Study|Lost to Follow-up|6|||
142995014|NCT01657253|515516800|FG001|Overall Study|Lost to Follow-up|5|||
142995015|NCT01657253|515516799|FG000|Overall Study|Withdrawal by Subject|11|||
142995016|NCT01657253|515516800|FG001|Overall Study|Withdrawal by Subject|12|||
142995017|NCT01657253|515516799|FG000|Overall Study|Adverse Event|0|||
142995018|NCT01657253|515516800|FG001|Overall Study|Adverse Event|1|||
142995019|NCT01970540|515516801|FG000|Overall Study|Non-treatment-related AE|0|||
142995020|NCT01970540|515516802|FG001|Overall Study|Non-treatment-related AE|0|||
142995021|NCT01970540|515516803|FG002|Overall Study|Non-treatment-related AE|1|||
142995022|NCT01970540|515516801|FG000|Overall Study|Progressive disease|55|||
142995023|NCT01970540|515516802|FG001|Overall Study|Progressive disease|23|||
142995024|NCT01970540|515516803|FG002|Overall Study|Progressive disease|10|||
142995025|NCT01970540|515516801|FG000|Overall Study|Treatment delay over protocol|0|||
142995026|NCT01970540|515516802|FG001|Overall Study|Treatment delay over protocol|0|||
142995027|NCT01970540|515516803|FG002|Overall Study|Treatment delay over protocol|1|||
142995028|NCT01970540|515516801|FG000|Overall Study|Physician Decision|7|||
142995029|NCT01970540|515516802|FG001|Overall Study|Physician Decision|2|||
142995030|NCT01970540|515516803|FG002|Overall Study|Physician Decision|0|||
142995031|NCT01970540|515516801|FG000|Overall Study|Clinical progression|0|||
142995032|NCT01970540|515516802|FG001|Overall Study|Clinical progression|1|||
142995033|NCT01970540|515516803|FG002|Overall Study|Clinical progression|1|||
142995034|NCT01970540|515516801|FG000|Overall Study|End of study|2|||
142995035|NCT01970540|515516802|FG001|Overall Study|End of study|0|||
142995036|NCT01970540|515516803|FG002|Overall Study|End of study|2|||
142995037|NCT01970540|515516801|FG000|Overall Study|Adverse Event|0|||
142995038|NCT01970540|515516802|FG001|Overall Study|Adverse Event|2|||
142995039|NCT01970540|515516803|FG002|Overall Study|Adverse Event|1|||
142995040|NCT01970540|515516801|FG000|Overall Study|Treatment-related AE|4|||
142995041|NCT01970540|515516802|FG001|Overall Study|Treatment-related AE|0|||
142995042|NCT01970540|515516803|FG002|Overall Study|Treatment-related AE|2|||
142995043|NCT01970540|515516801|FG000|Overall Study|Withdrawal by Subject|4|||
142995044|NCT01970540|515516802|FG001|Overall Study|Withdrawal by Subject|0|||
142995045|NCT01970540|515516803|FG002|Overall Study|Withdrawal by Subject|1|||
142995046|NCT01970540|515516801|FG000|Overall Study|Clinical deterioration|1|||
142995047|NCT01970540|515516802|FG001|Overall Study|Clinical deterioration|0|||
142995048|NCT01970540|515516803|FG002|Overall Study|Clinical deterioration|0|||
142995049|NCT00381706|515516804|FG000|Overall Study|Never treated|7|||
142995050|NCT00381706|515516805|FG001|Overall Study|Never treated|2|||
142995051|NCT00381706|515516806|FG002|Overall Study|Never treated|1|||
143455721|NCT00350103|517212513|FG002|Overall Study|Sponsor mistake|0|||
143455722|NCT00350103|517212511|FG000|Overall Study|Randomization mistake|0|||
143455723|NCT00350103|517212512|FG001|Overall Study|Randomization mistake|1|||
143455724|NCT00350103|517212513|FG002|Overall Study|Randomization mistake|1|||
143455725|NCT00350103|517212511|FG000|Overall Study|Sponsor´s decision|0|||
143455726|NCT00350103|517212512|FG001|Overall Study|Sponsor´s decision|1|||
142995052|NCT01948791|515516808|FG000|Overall Study|Adverse Event|12|||
142995053|NCT01948791|515516808|FG000|Overall Study|Lack of Efficacy|3|||
142995054|NCT01948791|515516808|FG000|Overall Study|Protocol Violation|2|||
142995055|NCT01948791|515516808|FG000|Overall Study|Withdrawal by Subject|5|||
142995056|NCT01948791|515516808|FG000|Overall Study|Lost to Follow-up|6|||
142995057|NCT01948791|515516808|FG000|Overall Study|Management issues|1|||
142995058|NCT01948791|515516808|FG000|Overall Study|Others|7|||
143455727|NCT00350103|517212513|FG002|Overall Study|Sponsor´s decision|0|||
143455728|NCT00350103|517212511|FG000|Overall Study|Lost, Reason unknown|1|||
143455729|NCT00350103|517212512|FG001|Overall Study|Lost, Reason unknown|1|||
143455730|NCT00350103|517212513|FG002|Overall Study|Lost, Reason unknown|0|||
143455731|NCT02842151|517212514|FG000|Overall Study|Adverse Event|1|||
143455732|NCT02842151|517212514|FG000|Overall Study|Subject moved too far away|1|||
143455733|NCT01879553|517212515|FG000|Overall Study|Withdrawal by Subject|1|||
142995059|NCT01948791|515516808|FG000|Overall Study|Screening failure|35|||
142995060|NCT00247962|515516820|FG000|Overall Study|Adverse Event|15|||
142995061|NCT00247962|515516821|FG001|Overall Study|Adverse Event|12|||
142995062|NCT00247962|515516820|FG000|Overall Study|Lost to Follow-up|3|||
142995063|NCT00247962|515516821|FG001|Overall Study|Lost to Follow-up|1|||
142995064|NCT00247962|515516820|FG000|Overall Study|Physician Decision|0|||
142995065|NCT00247962|515516821|FG001|Overall Study|Physician Decision|1|||
142995066|NCT00247962|515516820|FG000|Overall Study|Protocol Violation|1|||
142995067|NCT00247962|515516821|FG001|Overall Study|Protocol Violation|1|||
142995068|NCT00247962|515516820|FG000|Overall Study|Withdrawal by Subject|3|||
142995069|NCT00247962|515516821|FG001|Overall Study|Withdrawal by Subject|2|||
142995070|NCT00247962|515516820|FG000|Overall Study|Lack of Efficacy|4|||
142995071|NCT00247962|515516821|FG001|Overall Study|Lack of Efficacy|2|||
142995072|NCT01955005|515516822|FG000|Overall Study|Withdrawal by Subject|3|||
142995073|NCT01955005|515516823|FG001|Overall Study|Withdrawal by Subject|5|||
142995074|NCT02555722|515516824|FG000|Week 2|Adverse Event|0|||
142995075|NCT02555722|515516825|FG001|Week 2|Adverse Event|1|||
142995076|NCT02555722|515516824|FG000|Week 2|Withdrawal by Subject|1|||
142995077|NCT02555722|515516825|FG001|Week 2|Withdrawal by Subject|0|||
142995078|NCT02555722|515516824|FG000|Month 1|Lens Discomfort|1|||
142995079|NCT02555722|515516825|FG001|Month 1|Lens Discomfort|0|||
142995080|NCT02555722|515516824|FG000|Month 2|Withdrawal by Subject|3|||
142995081|NCT02555722|515516825|FG001|Month 2|Withdrawal by Subject|0|||
142995082|NCT02555722|515516824|FG000|Month 2|Lost to Follow-up|1|||
142995083|NCT02555722|515516825|FG001|Month 2|Lost to Follow-up|0|||
142995084|NCT00702949|515516830|FG000|Overall Study|Refusal|3|||
142995085|NCT00702949|515516831|FG001|Overall Study|Refusal|2|||
142995086|NCT00702949|515516832|FG002|Overall Study|Refusal|2|||
142995087|NCT00702949|515516830|FG000|Overall Study|Adverse Event|1|||
142995088|NCT00702949|515516831|FG001|Overall Study|Adverse Event|6|||
142995089|NCT00702949|515516832|FG002|Overall Study|Adverse Event|3|||
142995090|NCT00702949|515516830|FG000|Overall Study|Other Medical Reason/unknown|1|||
142995091|NCT00702949|515516831|FG001|Overall Study|Other Medical Reason/unknown|1|||
142995092|NCT00702949|515516832|FG002|Overall Study|Other Medical Reason/unknown|3|||
142995093|NCT01469637|515516833|FG000|First Intervention|Unacceptable behavior|0|||
142995094|NCT01469637|515516834|FG001|First Intervention|Unacceptable behavior|1|||
142995095|NCT01469637|515516833|FG000|Second Intervention|Incarcerated|1|||
142995096|NCT01469637|515516834|FG001|Second Intervention|Incarcerated|0|||
142995097|NCT00887913|515516835|FG000|Overall Study|Withdrawal by Subject|6|||
142995098|NCT00598585|515516836|FG000|Overall Study|Lost to Follow-up|1|||
142995099|NCT00598585|515516837|FG001|Overall Study|Lost to Follow-up|0|||
142995100|NCT01371721|515516838|FG000|Overall Study|Adverse Event|5|||
142995101|NCT01371721|515516839|FG001|Overall Study|Adverse Event|4|||
142995102|NCT01371721|515516840|FG002|Overall Study|Adverse Event|5|||
142995103|NCT01371721|515516838|FG000|Overall Study|Protocol Violation|6|||
142995104|NCT01371721|515516839|FG001|Overall Study|Protocol Violation|4|||
142995105|NCT01371721|515516840|FG002|Overall Study|Protocol Violation|5|||
142995106|NCT01371721|515516838|FG000|Overall Study|Lost to Follow-up|8|||
142995107|NCT01371721|515516839|FG001|Overall Study|Lost to Follow-up|2|||
142995108|NCT01371721|515516840|FG002|Overall Study|Lost to Follow-up|6|||
142995109|NCT01371721|515516838|FG000|Overall Study|Withdrawal by Subject|5|||
142995110|NCT01371721|515516839|FG001|Overall Study|Withdrawal by Subject|7|||
142995111|NCT01371721|515516840|FG002|Overall Study|Withdrawal by Subject|11|||
142995112|NCT01371721|515516838|FG000|Overall Study|Other|2|||
142995113|NCT01371721|515516839|FG001|Overall Study|Other|3|||
142995114|NCT01371721|515516840|FG002|Overall Study|Other|0|||
142995115|NCT01371721|515516838|FG000|Overall Study|Lack of Efficacy|2|||
142995116|NCT01371721|515516839|FG001|Overall Study|Lack of Efficacy|4|||
142995117|NCT01371721|515516840|FG002|Overall Study|Lack of Efficacy|3|||
142995118|NCT01371721|515516838|FG000|Overall Study|Randomized but not treated|1|||
142995119|NCT01371721|515516839|FG001|Overall Study|Randomized but not treated|0|||
142995120|NCT01371721|515516840|FG002|Overall Study|Randomized but not treated|0|||
142995121|NCT01200758|515516841|FG000|Stage I|Death|0|||
142995122|NCT01200758|515516842|FG001|Stage I|Death|1|||
142995123|NCT01200758|515516843|FG002|Stage I|Death|0|||
142995124|NCT01200758|515516844|FG003|Stage I|Death|0|||
142995125|NCT01200758|515516841|FG000|Stage I|Physician Decision|1|||
142995126|NCT01200758|515516842|FG001|Stage I|Physician Decision|1|||
142995127|NCT01200758|515516843|FG002|Stage I|Physician Decision|0|||
142995128|NCT01200758|515516844|FG003|Stage I|Physician Decision|0|||
142995129|NCT01200758|515516841|FG000|Stage I|Lack of Efficacy|2|||
142995130|NCT01200758|515516842|FG001|Stage I|Lack of Efficacy|1|||
142995131|NCT01200758|515516843|FG002|Stage I|Lack of Efficacy|0|||
142995132|NCT01200758|515516844|FG003|Stage I|Lack of Efficacy|0|||
143455734|NCT01879553|517212516|FG001|Overall Study|Withdrawal by Subject|0|||
142995133|NCT01200758|515516841|FG000|Stage I|Adverse Event|5|||
142995134|NCT01200758|515516842|FG001|Stage I|Adverse Event|5|||
142995135|NCT01200758|515516843|FG002|Stage I|Adverse Event|0|||
142995136|NCT01200758|515516844|FG003|Stage I|Adverse Event|0|||
142995137|NCT01200758|515516841|FG000|Stage I|Withdrawal by Subject|1|||
142995138|NCT01200758|515516842|FG001|Stage I|Withdrawal by Subject|2|||
142995139|NCT01200758|515516843|FG002|Stage I|Withdrawal by Subject|0|||
142995140|NCT01200758|515516844|FG003|Stage I|Withdrawal by Subject|0|||
142995141|NCT01200758|515516841|FG000|Stage I|Disease Progression|9|||
142995142|NCT01200758|515516842|FG001|Stage I|Disease Progression|7|||
142995143|NCT01200758|515516843|FG002|Stage I|Disease Progression|0|||
142995144|NCT01200758|515516844|FG003|Stage I|Disease Progression|0|||
142995145|NCT01200758|515516841|FG000|Stage 2|Disease Progression|0|||
142995146|NCT01200758|515516842|FG001|Stage 2|Disease Progression|0|||
142995147|NCT01200758|515516843|FG002|Stage 2|Disease Progression|16|||
142995148|NCT01200758|515516844|FG003|Stage 2|Disease Progression|21|||
142995149|NCT01200758|515516841|FG000|Stage 2|Lack of Efficacy|0|||
142995150|NCT01200758|515516842|FG001|Stage 2|Lack of Efficacy|0|||
142995151|NCT01200758|515516843|FG002|Stage 2|Lack of Efficacy|4|||
142995152|NCT01200758|515516844|FG003|Stage 2|Lack of Efficacy|2|||
142995153|NCT01200758|515516841|FG000|Stage 2|Physician Decision|0|||
142995154|NCT01200758|515516842|FG001|Stage 2|Physician Decision|0|||
142995155|NCT01200758|515516843|FG002|Stage 2|Physician Decision|5|||
142995156|NCT01200758|515516844|FG003|Stage 2|Physician Decision|7|||
142995157|NCT01200758|515516841|FG000|Stage 2|Adverse Event|0|||
142995158|NCT01200758|515516842|FG001|Stage 2|Adverse Event|0|||
142995159|NCT01200758|515516843|FG002|Stage 2|Adverse Event|5|||
142995160|NCT01200758|515516844|FG003|Stage 2|Adverse Event|9|||
142995161|NCT01200758|515516841|FG000|Stage 2|Withdrawal by Subject|0|||
142995162|NCT01200758|515516842|FG001|Stage 2|Withdrawal by Subject|0|||
142995163|NCT01200758|515516843|FG002|Stage 2|Withdrawal by Subject|4|||
142995164|NCT01200758|515516844|FG003|Stage 2|Withdrawal by Subject|1|||
142995165|NCT01200758|515516841|FG000|Stage 2|Lost to Follow-up|0|||
142995166|NCT01200758|515516842|FG001|Stage 2|Lost to Follow-up|0|||
142995167|NCT01200758|515516843|FG002|Stage 2|Lost to Follow-up|3|||
142995168|NCT01200758|515516844|FG003|Stage 2|Lost to Follow-up|1|||
142995169|NCT01200758|515516841|FG000|Stage 2|Protocol Violation|0|||
142995170|NCT01200758|515516842|FG001|Stage 2|Protocol Violation|0|||
142995171|NCT01200758|515516843|FG002|Stage 2|Protocol Violation|1|||
142995172|NCT01200758|515516844|FG003|Stage 2|Protocol Violation|4|||
142995173|NCT01200758|515516841|FG000|Stage 2|Death|0|||
142995174|NCT01200758|515516842|FG001|Stage 2|Death|0|||
142995175|NCT01200758|515516843|FG002|Stage 2|Death|3|||
142995176|NCT01200758|515516844|FG003|Stage 2|Death|5|||
142995177|NCT03525613|515516850|FG000|Overall Study|Adverse Event|11|||
142995178|NCT03525613|515516851|FG001|Overall Study|Adverse Event|8|||
142995179|NCT03525613|515516852|FG002|Overall Study|Adverse Event|3|||
142995180|NCT03525613|515516853|FG003|Overall Study|Adverse Event|3|||
142995181|NCT03525613|515516850|FG000|Overall Study|Lost to Follow-up|4|||
142995182|NCT03525613|515516851|FG001|Overall Study|Lost to Follow-up|5|||
142995183|NCT03525613|515516852|FG002|Overall Study|Lost to Follow-up|3|||
142995184|NCT03525613|515516853|FG003|Overall Study|Lost to Follow-up|2|||
142995185|NCT03525613|515516850|FG000|Overall Study|Physician Decision|0|||
142995186|NCT03525613|515516851|FG001|Overall Study|Physician Decision|1|||
142995187|NCT03525613|515516852|FG002|Overall Study|Physician Decision|0|||
142995188|NCT03525613|515516853|FG003|Overall Study|Physician Decision|1|||
142995189|NCT03525613|515516850|FG000|Overall Study|Consent Withdrawal|25|||
142995190|NCT03525613|515516851|FG001|Overall Study|Consent Withdrawal|16|||
142995191|NCT03525613|515516852|FG002|Overall Study|Consent Withdrawal|12|||
142995192|NCT03525613|515516853|FG003|Overall Study|Consent Withdrawal|9|||
142995193|NCT03525613|515516850|FG000|Overall Study|Death|20|||
142995194|NCT03525613|515516851|FG001|Overall Study|Death|9|||
142995195|NCT03525613|515516852|FG002|Overall Study|Death|7|||
142995196|NCT03525613|515516853|FG003|Overall Study|Death|1|||
142995197|NCT03525613|515516850|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
142995198|NCT03525613|515516851|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
142995199|NCT03525613|515516852|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
142995200|NCT03525613|515516853|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
142995201|NCT00135694|515516854|FG000|Overall Study|Adverse Event|17|||
142995202|NCT00135694|515516855|FG001|Overall Study|Adverse Event|4|||
142995203|NCT00135694|515516856|FG002|Overall Study|Adverse Event|0|||
142995204|NCT00135694|515516854|FG000|Overall Study|Death|14|||
142995205|NCT00135694|515516855|FG001|Overall Study|Death|1|||
142995206|NCT00135694|515516856|FG002|Overall Study|Death|2|||
142995207|NCT00135694|515516854|FG000|Overall Study|Lost to Follow-up|8|||
142995208|NCT00135694|515516855|FG001|Overall Study|Lost to Follow-up|7|||
142995209|NCT00135694|515516856|FG002|Overall Study|Lost to Follow-up|1|||
142995210|NCT00135694|515516854|FG000|Overall Study|Withdrawal by Subject|41|||
142995211|NCT00135694|515516855|FG001|Overall Study|Withdrawal by Subject|7|||
142995212|NCT00135694|515516856|FG002|Overall Study|Withdrawal by Subject|4|||
142995213|NCT00135694|515516854|FG000|Overall Study|Protocol Violation|19|||
142995214|NCT00135694|515516855|FG001|Overall Study|Protocol Violation|1|||
142995215|NCT00135694|515516856|FG002|Overall Study|Protocol Violation|0|||
142995216|NCT00135694|515516854|FG000|Overall Study|Hepatitis C related reasons|39|||
142995217|NCT00135694|515516855|FG001|Overall Study|Hepatitis C related reasons|1|||
142995218|NCT00135694|515516856|FG002|Overall Study|Hepatitis C related reasons|0|||
142995219|NCT00135694|515516854|FG000|Overall Study|Ineligible for Random assignment|42|||
142995220|NCT00135694|515516855|FG001|Overall Study|Ineligible for Random assignment|0|||
142995221|NCT00135694|515516856|FG002|Overall Study|Ineligible for Random assignment|0|||
142995222|NCT02584660|515516857|FG000|Overall Study|Adverse Event|4|||
142995223|NCT02584660|515516858|FG001|Overall Study|Adverse Event|0|||
142995224|NCT02584660|515516857|FG000|Overall Study|Lost to Follow-up|3|||
142995225|NCT02584660|515516858|FG001|Overall Study|Lost to Follow-up|4|||
142995226|NCT02584660|515516857|FG000|Overall Study|Protocol Violation|0|||
142995227|NCT02584660|515516858|FG001|Overall Study|Protocol Violation|1|||
142995228|NCT02584660|515516857|FG000|Overall Study|Withdrawal by Subject|0|||
142995229|NCT02584660|515516858|FG001|Overall Study|Withdrawal by Subject|2|||
142995230|NCT02584660|515516857|FG000|Overall Study|Other|0|||
142995231|NCT02584660|515516858|FG001|Overall Study|Other|1|||
142995232|NCT00523744|515516859|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
142995233|NCT00523744|515516859|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
142995234|NCT00523744|515516859|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
142995235|NCT00523744|515516859|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
142995236|NCT00523744|515516859|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
142995237|NCT00523744|515516859|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
142995238|NCT00542425|515516863|FG000|Initial 24 Weeks|Administrative reasons|0|||
142995239|NCT00542425|515516864|FG001|Initial 24 Weeks|Administrative reasons|0|||
142995240|NCT00542425|515516865|FG002|Initial 24 Weeks|Administrative reasons|1|||
142995241|NCT00542425|515516866|FG003|Initial 24 Weeks|Administrative reasons|1|||
142995242|NCT00542425|515516867|FG004|Initial 24 Weeks|Administrative reasons|0|||
142995243|NCT00542425|515516863|FG000|Initial 24 Weeks|Adverse Event|0|||
142995244|NCT00542425|515516864|FG001|Initial 24 Weeks|Adverse Event|1|||
142995245|NCT00542425|515516865|FG002|Initial 24 Weeks|Adverse Event|1|||
142995246|NCT00542425|515516866|FG003|Initial 24 Weeks|Adverse Event|3|||
142995247|NCT00542425|515516867|FG004|Initial 24 Weeks|Adverse Event|2|||
142995248|NCT00542425|515516863|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
142995249|NCT00542425|515516864|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
142995250|NCT00542425|515516865|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
142995251|NCT00542425|515516866|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
142995252|NCT00542425|515516867|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
142995253|NCT00542425|515516863|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
142995254|NCT00542425|515516864|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
142995255|NCT00542425|515516865|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
142995256|NCT00542425|515516866|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
142995257|NCT00542425|515516867|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
142995258|NCT00542425|515516863|FG000|Initial 24 Weeks|Non-compliance|0|||
142995259|NCT00542425|515516864|FG001|Initial 24 Weeks|Non-compliance|0|||
142995260|NCT00542425|515516865|FG002|Initial 24 Weeks|Non-compliance|0|||
142995261|NCT00542425|515516866|FG003|Initial 24 Weeks|Non-compliance|1|||
142995262|NCT00542425|515516867|FG004|Initial 24 Weeks|Non-compliance|1|||
142995263|NCT00542425|515516863|FG000|Initial 24 Weeks|Protocol Violation|0|||
142995264|NCT00542425|515516864|FG001|Initial 24 Weeks|Protocol Violation|0|||
142995265|NCT00542425|515516865|FG002|Initial 24 Weeks|Protocol Violation|0|||
142995266|NCT00542425|515516866|FG003|Initial 24 Weeks|Protocol Violation|1|||
142995267|NCT00542425|515516867|FG004|Initial 24 Weeks|Protocol Violation|0|||
142995268|NCT00542425|515516863|FG000|Initial 24 Weeks|Refusal of treatment|2|||
142995269|NCT00542425|515516864|FG001|Initial 24 Weeks|Refusal of treatment|2|||
142995270|NCT00542425|515516865|FG002|Initial 24 Weeks|Refusal of treatment|1|||
142995271|NCT00542425|515516866|FG003|Initial 24 Weeks|Refusal of treatment|4|||
142995272|NCT00542425|515516867|FG004|Initial 24 Weeks|Refusal of treatment|1|||
142995273|NCT00542425|515516863|FG000|Initial 24 Weeks|Other|0|||
142995274|NCT00542425|515516864|FG001|Initial 24 Weeks|Other|2|||
142995275|NCT00542425|515516865|FG002|Initial 24 Weeks|Other|1|||
142995276|NCT00542425|515516866|FG003|Initial 24 Weeks|Other|0|||
142995277|NCT00542425|515516867|FG004|Initial 24 Weeks|Other|0|||
142995278|NCT00542425|515516863|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
142995279|NCT00542425|515516864|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
142995280|NCT00542425|515516865|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
142995281|NCT00542425|515516866|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
142995282|NCT00542425|515516867|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
142995283|NCT00542425|515516863|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
142995284|NCT00542425|515516864|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
142995285|NCT00542425|515516865|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
142995286|NCT00542425|515516866|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
142995287|NCT00542425|515516867|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
142995288|NCT00542425|515516863|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
142995289|NCT00542425|515516864|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
142995290|NCT00542425|515516865|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
142995291|NCT00542425|515516866|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
142995292|NCT00542425|515516867|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
142995293|NCT00542425|515516863|FG000|Extended 24 Weeks of Treatment|Other|1|||
142995294|NCT00542425|515516864|FG001|Extended 24 Weeks of Treatment|Other|1|||
142995295|NCT00542425|515516865|FG002|Extended 24 Weeks of Treatment|Other|0|||
142995296|NCT00542425|515516866|FG003|Extended 24 Weeks of Treatment|Other|0|||
142995297|NCT00542425|515516867|FG004|Extended 24 Weeks of Treatment|Other|1|||
142995298|NCT00590031|515516870|FG000|Overall Study|Adverse Event|3|||
142995299|NCT00590031|515516870|FG000|Overall Study|Withdrawal by Subject|1|||
142995300|NCT00590031|515516870|FG000|Overall Study|Metastatic Disease|1|||
142995301|NCT00590031|515516870|FG000|Overall Study|Admin Hold|1|||
142995302|NCT00472043|515516871|FG000|Overall Study|Withdrawal by Subject|1|||
142995303|NCT00472043|515516872|FG001|Overall Study|Withdrawal by Subject|0|||
142995304|NCT00472043|515516871|FG000|Overall Study|Death|1|||
142995305|NCT00472043|515516872|FG001|Overall Study|Death|0|||
142995306|NCT02802735|515516874|FG000|Overall Study|Withdrawal by Subject|0|||
142995307|NCT02802735|515516875|FG001|Overall Study|Withdrawal by Subject|1|||
142995308|NCT02802735|515516876|FG002|Overall Study|Withdrawal by Subject|0|||
142995309|NCT02802735|515516877|FG003|Overall Study|Withdrawal by Subject|0|||
142995310|NCT02802735|515516878|FG004|Overall Study|Withdrawal by Subject|0|||
142995311|NCT03922711|515516883|FG000|Overall Study|Adverse Event|3|||
142995312|NCT03922711|515516884|FG001|Overall Study|Adverse Event|2|||
142995313|NCT03922711|515516885|FG002|Overall Study|Adverse Event|2|||
142995314|NCT03922711|515516883|FG000|Overall Study|Protocol Violation|1|||
142995315|NCT03922711|515516884|FG001|Overall Study|Protocol Violation|0|||
142995316|NCT03922711|515516885|FG002|Overall Study|Protocol Violation|0|||
142995317|NCT03922711|515516883|FG000|Overall Study|Withdrawal by Subject|0|||
142995318|NCT03922711|515516884|FG001|Overall Study|Withdrawal by Subject|3|||
142995319|NCT03922711|515516885|FG002|Overall Study|Withdrawal by Subject|1|||
142995320|NCT03922711|515516883|FG000|Overall Study|Not further specified|0|||
142995321|NCT03922711|515516884|FG001|Overall Study|Not further specified|0|||
142995322|NCT03922711|515516885|FG002|Overall Study|Not further specified|1|||
142995323|NCT04009824|515516886|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
142995324|NCT04009824|515516887|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
142995325|NCT04009824|515516888|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
142995326|NCT04009824|515516889|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
142995327|NCT04009824|515516890|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
142995328|NCT00631969|515516894|FG000|Overall Study|Adverse Event|3|||
142995329|NCT00631969|515516895|FG001|Overall Study|Adverse Event|1|||
142995330|NCT00631969|515516894|FG000|Overall Study|Lack of Efficacy|2|||
142995331|NCT00631969|515516895|FG001|Overall Study|Lack of Efficacy|8|||
142995332|NCT00631969|515516894|FG000|Overall Study|Lost to Follow-up|2|||
142995333|NCT00631969|515516895|FG001|Overall Study|Lost to Follow-up|1|||
142995334|NCT00631969|515516894|FG000|Overall Study|Protocol Violation|1|||
142995335|NCT00631969|515516895|FG001|Overall Study|Protocol Violation|1|||
142995336|NCT00631969|515516894|FG000|Overall Study|Consent Withdrawn|5|||
142995337|NCT00631969|515516895|FG001|Overall Study|Consent Withdrawn|7|||
142995338|NCT00631969|515516894|FG000|Overall Study|Noncompliant With Study Medication|0|||
142995339|NCT00631969|515516895|FG001|Overall Study|Noncompliant With Study Medication|1|||
142995340|NCT00631969|515516894|FG000|Overall Study|No Drug Exposure|2|||
142995341|NCT00631969|515516895|FG001|Overall Study|No Drug Exposure|2|||
142995342|NCT01716585|515518734|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
142995343|NCT01716585|515518735|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
142995344|NCT01716585|515518734|FG000|Double-blind Treatment|Adverse Event|2|||
142995345|NCT01716585|515518735|FG001|Double-blind Treatment|Adverse Event|1|||
142995346|NCT01716585|515518734|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
142995347|NCT01716585|515518735|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
142995348|NCT01716585|515518734|FG000|Double-blind Treatment|Lost to Follow-up|2|||
142995349|NCT01716585|515518735|FG001|Double-blind Treatment|Lost to Follow-up|0|||
142995350|NCT01716585|515518734|FG000|Double-blind Treatment|Subject Noncompliant|1|||
142995351|NCT01716585|515518735|FG001|Double-blind Treatment|Subject Noncompliant|0|||
142995352|NCT01716585|515518734|FG000|Double-blind Treatment|Other|1|||
142995353|NCT01716585|515518735|FG001|Double-blind Treatment|Other|0|||
142995354|NCT01716585|515518734|FG000|Open-label Treatment|Adverse Event|0|||
142995355|NCT01716585|515518735|FG001|Open-label Treatment|Adverse Event|2|||
142995356|NCT01716585|515518734|FG000|Open-label Treatment|Virologic Failure|0|||
142995357|NCT01716585|515518735|FG001|Open-label Treatment|Virologic Failure|2|||
142995358|NCT01716585|515518734|FG000|Open-label Treatment|Withdrawal by Subject|0|||
142995359|NCT01716585|515518735|FG001|Open-label Treatment|Withdrawal by Subject|3|||
142995360|NCT00561795|515518736|FG000|Overall Study|Adverse Event|3|||
142995361|NCT00561795|515518737|FG001|Overall Study|Adverse Event|3|||
142995362|NCT00561795|515518738|FG002|Overall Study|Adverse Event|0|||
142995363|NCT00561795|515518739|FG003|Overall Study|Adverse Event|0|||
142995364|NCT00561795|515518736|FG000|Overall Study|Study Closed/Terminated|0|||
142995365|NCT00561795|515518737|FG001|Overall Study|Study Closed/Terminated|3|||
142995366|NCT00561795|515518738|FG002|Overall Study|Study Closed/Terminated|0|||
142995367|NCT00561795|515518739|FG003|Overall Study|Study Closed/Terminated|0|||
142995368|NCT00561795|515518736|FG000|Overall Study|Physician Decision|1|||
142995369|NCT00561795|515518737|FG001|Overall Study|Physician Decision|0|||
142995370|NCT00561795|515518738|FG002|Overall Study|Physician Decision|0|||
142995371|NCT00561795|515518739|FG003|Overall Study|Physician Decision|0|||
142995372|NCT04235959|515518741|FG000|Overall Study|Protocol Violation|0|||
142995373|NCT04235959|515518742|FG001|Overall Study|Protocol Violation|1|||
142995374|NCT04235959|515518743|FG002|Overall Study|Protocol Violation|0|||
142995375|NCT04235959|515518741|FG000|Overall Study|Adverse Event|1|||
142995376|NCT04235959|515518742|FG001|Overall Study|Adverse Event|0|||
142995377|NCT04235959|515518743|FG002|Overall Study|Adverse Event|0|||
142995378|NCT03055806|515518744|FG000|Overall Study|Adverse Event|0|||
142995379|NCT03055806|515518745|FG001|Overall Study|Adverse Event|0|||
142995380|NCT03055806|515518746|FG002|Overall Study|Adverse Event|1|||
142995381|NCT03055806|515518747|FG003|Overall Study|Adverse Event|1|||
142995382|NCT03055806|515518744|FG000|Overall Study|Lost to Follow-up|0|||
142995383|NCT03055806|515518745|FG001|Overall Study|Lost to Follow-up|3|||
142995384|NCT03055806|515518746|FG002|Overall Study|Lost to Follow-up|6|||
142995385|NCT03055806|515518747|FG003|Overall Study|Lost to Follow-up|7|||
142995386|NCT03055806|515518744|FG000|Overall Study|Physician Decision|1|||
142995387|NCT03055806|515518745|FG001|Overall Study|Physician Decision|0|||
142995388|NCT03055806|515518746|FG002|Overall Study|Physician Decision|0|||
142995389|NCT03055806|515518747|FG003|Overall Study|Physician Decision|1|||
142995390|NCT03055806|515518744|FG000|Overall Study|Protocol Violation|1|||
142995391|NCT03055806|515518745|FG001|Overall Study|Protocol Violation|0|||
142995392|NCT03055806|515518746|FG002|Overall Study|Protocol Violation|0|||
142995393|NCT03055806|515518747|FG003|Overall Study|Protocol Violation|0|||
142995394|NCT03055806|515518744|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
142995395|NCT03055806|515518745|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
142995396|NCT03055806|515518746|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
142995397|NCT03055806|515518747|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
142995398|NCT03055806|515518744|FG000|Overall Study|Withdrawal of consent to continue study|2|||
142995399|NCT03055806|515518745|FG001|Overall Study|Withdrawal of consent to continue study|3|||
142995400|NCT03055806|515518746|FG002|Overall Study|Withdrawal of consent to continue study|4|||
142995401|NCT03055806|515518747|FG003|Overall Study|Withdrawal of consent to continue study|6|||
142995402|NCT03055806|515518744|FG000|Overall Study|Partner not willing to try intercourse|1|||
142995403|NCT03055806|515518745|FG001|Overall Study|Partner not willing to try intercourse|0|||
142995404|NCT03055806|515518746|FG002|Overall Study|Partner not willing to try intercourse|0|||
142995405|NCT03055806|515518747|FG003|Overall Study|Partner not willing to try intercourse|0|||
142995406|NCT04601194|515518748|FG000|Overall Study|Lost to Follow-up|7|||
142995407|NCT02630459|515518749|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
142995408|NCT02630459|515518750|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
142995409|NCT02630459|515518751|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
142995410|NCT02630459|515518752|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
142995411|NCT02630459|515518753|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
142995412|NCT02630459|515518754|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
142995413|NCT02630459|515518755|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
142995414|NCT02630459|515518756|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
142995415|NCT02630459|515518749|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
142995416|NCT02630459|515518750|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
142995417|NCT02630459|515518751|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
142995418|NCT02630459|515518752|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
142995419|NCT02630459|515518753|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
142995420|NCT02630459|515518754|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
142995421|NCT02630459|515518755|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
142995422|NCT02630459|515518756|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
142995423|NCT02630459|515518749|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
142995424|NCT02630459|515518750|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
142995425|NCT02630459|515518751|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
142995426|NCT02630459|515518752|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
142995427|NCT02630459|515518753|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
142995428|NCT02630459|515518754|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
142995429|NCT02630459|515518755|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
142995430|NCT02630459|515518756|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
142995431|NCT02630459|515518749|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
142995432|NCT02630459|515518750|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
142995433|NCT02630459|515518751|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
142995434|NCT02630459|515518752|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
142995435|NCT02630459|515518753|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
142995436|NCT02630459|515518754|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
142995437|NCT02630459|515518755|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
142995438|NCT02630459|515518756|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
142995439|NCT02630459|515518749|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
142995440|NCT02630459|515518750|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
142995441|NCT02630459|515518751|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
142995442|NCT02630459|515518752|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
142995443|NCT02630459|515518753|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
142995444|NCT02630459|515518754|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
142995445|NCT02630459|515518755|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
142995446|NCT02630459|515518756|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
142995447|NCT02630459|515518749|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
142995448|NCT02630459|515518750|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
142995449|NCT02630459|515518751|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
142995450|NCT02630459|515518752|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
142995451|NCT02630459|515518753|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
142995452|NCT02630459|515518754|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
142995453|NCT02630459|515518755|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
142995454|NCT02630459|515518756|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
142995455|NCT02630459|515518749|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
142995456|NCT02630459|515518750|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
142995457|NCT02630459|515518751|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
142995458|NCT02630459|515518752|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
142995459|NCT02630459|515518753|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
142995460|NCT02630459|515518754|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
142995461|NCT02630459|515518755|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
142995462|NCT02630459|515518756|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
142995463|NCT00348686|515518759|FG000|Overall Study|Withdrawal by Subject|45|||
142995464|NCT00348686|515518759|FG000|Overall Study|Adverse Event|5|||
142995465|NCT00348686|515518759|FG000|Overall Study|Protocol Violation|6|||
142995466|NCT00348686|515518759|FG000|Overall Study|Lost to Follow-up|2|||
142995467|NCT00348686|515518759|FG000|Overall Study|Multiple Reasons|8|||
142995468|NCT01258738|515518760|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
142995469|NCT01258738|515518761|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
142995470|NCT01258738|515518760|FG000|Double-blind Period|Withdrawal by Subject|2|||
142995471|NCT01258738|515518761|FG001|Double-blind Period|Withdrawal by Subject|2|||
142995472|NCT01258738|515518760|FG000|Double-blind Period|Protocol Violation|1|||
142995473|NCT01258738|515518761|FG001|Double-blind Period|Protocol Violation|1|||
142995474|NCT01258738|515518760|FG000|Double-blind Period|Adverse Event|3|||
142995475|NCT01258738|515518761|FG001|Double-blind Period|Adverse Event|1|||
142995476|NCT01258738|515518760|FG000|Open-label Period|Did not meet inclusion criteria|0|||
142995477|NCT01258738|515518761|FG001|Open-label Period|Did not meet inclusion criteria|1|||
142995478|NCT01258738|515518760|FG000|Open-label Period|Insufficient clinical response|5|||
142995479|NCT01258738|515518761|FG001|Open-label Period|Insufficient clinical response|3|||
142995480|NCT01258738|515518760|FG000|Open-label Period|Lost to Follow-up|0|||
142995481|NCT01258738|515518761|FG001|Open-label Period|Lost to Follow-up|2|||
142995482|NCT01258738|515518760|FG000|Open-label Period|Withdrawal by Subject|5|||
142995483|NCT01258738|515518761|FG001|Open-label Period|Withdrawal by Subject|6|||
142995484|NCT01258738|515518760|FG000|Open-label Period|Protocol Violation|2|||
142995485|NCT01258738|515518761|FG001|Open-label Period|Protocol Violation|2|||
142995486|NCT01258738|515518760|FG000|Open-label Period|Adverse Event|4|||
142995487|NCT01258738|515518761|FG001|Open-label Period|Adverse Event|5|||
142995488|NCT01258738|515518760|FG000|Open-label Period|Other Reasons|0|||
142995489|NCT01258738|515518761|FG001|Open-label Period|Other Reasons|1|||
142995490|NCT01258738|515518760|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
142995491|NCT01258738|515518761|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
142995492|NCT00689611|515518762|FG000|Overall Study|Death|6|||
142995493|NCT00689611|515518763|FG001|Overall Study|Death|9|||
142995494|NCT00689611|515518762|FG000|Overall Study|Withdrawal by Subject|8|||
142995495|NCT00689611|515518763|FG001|Overall Study|Withdrawal by Subject|9|||
142995496|NCT00689611|515518762|FG000|Overall Study|Lost to Follow-up|27|||
142995497|NCT00689611|515518763|FG001|Overall Study|Lost to Follow-up|28|||
142995498|NCT00490815|515518768|FG000|Overall Study|Adverse Event|2|||
142995499|NCT00490815|515518769|FG001|Overall Study|Adverse Event|3|||
142995500|NCT00490815|515518768|FG000|Overall Study|Withdrawal by Subject|4|||
142995501|NCT00490815|515518769|FG001|Overall Study|Withdrawal by Subject|0|||
142995502|NCT00490815|515518768|FG000|Overall Study|Lost to Follow-up|1|||
142995503|NCT00490815|515518769|FG001|Overall Study|Lost to Follow-up|3|||
142995504|NCT00490815|515518768|FG000|Overall Study|Death|1|||
142995505|NCT00490815|515518769|FG001|Overall Study|Death|3|||
142995506|NCT02870348|515518784|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
142995507|NCT02908841|515518787|FG000|Overall Study|Physician Decision|4|||
142995508|NCT02908841|515518788|FG001|Overall Study|Physician Decision|0|||
142995509|NCT01038635|515518789|FG000|Overall Study|Disease Progression|2|||
142995510|NCT01038635|515518790|FG001|Overall Study|Disease Progression|0|||
142995511|NCT01038635|515518791|FG002|Overall Study|Disease Progression|0|||
142995512|NCT01038635|515518792|FG003|Overall Study|Disease Progression|0|||
142995513|NCT01038635|515518793|FG004|Overall Study|Disease Progression|0|||
142995514|NCT01038635|515518794|FG005|Overall Study|Disease Progression|0|||
142995515|NCT01038635|515518795|FG006|Overall Study|Disease Progression|1|||
142995516|NCT01038635|515518796|FG007|Overall Study|Disease Progression|4|||
142995517|NCT01038635|515518797|FG008|Overall Study|Disease Progression|0|||
142995518|NCT01038635|515518789|FG000|Overall Study|Death|0|||
142995519|NCT01038635|515518790|FG001|Overall Study|Death|0|||
142995520|NCT01038635|515518791|FG002|Overall Study|Death|0|||
142995521|NCT01038635|515518792|FG003|Overall Study|Death|0|||
142995522|NCT01038635|515518793|FG004|Overall Study|Death|1|||
142995523|NCT01038635|515518794|FG005|Overall Study|Death|0|||
142995524|NCT01038635|515518795|FG006|Overall Study|Death|1|||
142995525|NCT01038635|515518796|FG007|Overall Study|Death|1|||
142995526|NCT01038635|515518797|FG008|Overall Study|Death|2|||
142995527|NCT01034709|515518799|FG000|Overall Study|Protocol Violation|9|||
142995528|NCT01034709|515518800|FG001|Overall Study|Protocol Violation|16|||
142995529|NCT01060150|515518801|FG000|Overall Study|Adverse Event|6|||
142995530|NCT01060150|515518801|FG000|Overall Study|Lost to Follow-up|1|||
142995531|NCT01060150|515518801|FG000|Overall Study|Protocol Violation|6|||
142995532|NCT01060150|515518801|FG000|Overall Study|Withdrawal by Subject|8|||
142995533|NCT01060150|515518801|FG000|Overall Study|Enrolled, but not treated|2|||
142995534|NCT03480360|515518803|FG000|Overall Study|Death|2|||
142995535|NCT01142791|515518813|FG000|Overall Study|Alternative Treatment|1|||
142995536|NCT01142791|515518814|FG001|Overall Study|Alternative Treatment|0|||
142995537|NCT01142791|515518813|FG000|Overall Study|Lost to Follow-up|1|||
142995538|NCT01142791|515518814|FG001|Overall Study|Lost to Follow-up|0|||
142995539|NCT01142791|515518813|FG000|Overall Study|Withdrawal by Subject|5|||
142995540|NCT01142791|515518814|FG001|Overall Study|Withdrawal by Subject|0|||
142995541|NCT01142791|515518813|FG000|Overall Study|Received only 1 sonication|0|||
142995542|NCT01142791|515518814|FG001|Overall Study|Received only 1 sonication|6|||
142995543|NCT02608892|515518815|FG000|Overall Study|Lost to Follow-up|1|||
142995544|NCT02608892|515518816|FG001|Overall Study|Lost to Follow-up|0|||
142995545|NCT02590406|515518817|FG000|Overall Study|Adverse Event|1|||
142995546|NCT02590406|515518818|FG001|Overall Study|Adverse Event|0|||
142995547|NCT02590406|515518817|FG000|Overall Study|Saturometer malfunction|0|||
142995548|NCT02590406|515518818|FG001|Overall Study|Saturometer malfunction|1|||
142995549|NCT03032523|515518819|FG000|Overall Study|Withdrawal by Subject|2|||
142995550|NCT03032523|515518820|FG001|Overall Study|Withdrawal by Subject|2|||
142995551|NCT03032523|515518819|FG000|Overall Study|Physician Decision|1|||
142995552|NCT03032523|515518820|FG001|Overall Study|Physician Decision|0|||
142995553|NCT05375838|515518823|FG000|Overall Study|Other|0|||
142995554|NCT05375838|515518824|FG001|Overall Study|Other|0|||
142995555|NCT05375838|515518825|FG002|Overall Study|Other|0|||
142995556|NCT05375838|515518826|FG003|Overall Study|Other|1|||
142995557|NCT05375838|515518827|FG004|Overall Study|Other|1|||
142995558|NCT05375838|515518828|FG005|Overall Study|Other|0|||
142995559|NCT05375838|515518823|FG000|Overall Study|Withdrawal by Subject|2|||
142995560|NCT05375838|515518824|FG001|Overall Study|Withdrawal by Subject|1|||
142995561|NCT05375838|515518825|FG002|Overall Study|Withdrawal by Subject|3|||
142995562|NCT05375838|515518826|FG003|Overall Study|Withdrawal by Subject|2|||
142995563|NCT05375838|515518827|FG004|Overall Study|Withdrawal by Subject|2|||
142995564|NCT05375838|515518828|FG005|Overall Study|Withdrawal by Subject|0|||
142995565|NCT05375838|515518823|FG000|Overall Study|Protocol Violation|0|||
142995566|NCT05375838|515518824|FG001|Overall Study|Protocol Violation|0|||
142995567|NCT05375838|515518825|FG002|Overall Study|Protocol Violation|0|||
142995568|NCT05375838|515518826|FG003|Overall Study|Protocol Violation|0|||
142995569|NCT05375838|515518827|FG004|Overall Study|Protocol Violation|1|||
142995570|NCT05375838|515518828|FG005|Overall Study|Protocol Violation|0|||
142995571|NCT05375838|515518823|FG000|Overall Study|Physician Decision|0|||
142995572|NCT05375838|515518824|FG001|Overall Study|Physician Decision|1|||
142995573|NCT05375838|515518825|FG002|Overall Study|Physician Decision|0|||
142995574|NCT05375838|515518826|FG003|Overall Study|Physician Decision|0|||
142995575|NCT05375838|515518827|FG004|Overall Study|Physician Decision|0|||
142995576|NCT05375838|515518828|FG005|Overall Study|Physician Decision|1|||
142995577|NCT05375838|515518823|FG000|Overall Study|Lost to Follow-up|2|||
142995578|NCT05375838|515518824|FG001|Overall Study|Lost to Follow-up|7|||
142995579|NCT05375838|515518825|FG002|Overall Study|Lost to Follow-up|0|||
142995580|NCT05375838|515518826|FG003|Overall Study|Lost to Follow-up|4|||
142995581|NCT05375838|515518827|FG004|Overall Study|Lost to Follow-up|2|||
142995582|NCT05375838|515518828|FG005|Overall Study|Lost to Follow-up|3|||
142995583|NCT00877890|515518829|FG000|Overall Study|Adverse Event|6|||
142995584|NCT00877890|515518830|FG001|Overall Study|Adverse Event|6|||
142995585|NCT00877890|515518829|FG000|Overall Study|Lost to Follow-up|5|||
142995586|NCT00877890|515518830|FG001|Overall Study|Lost to Follow-up|5|||
142995587|NCT00877890|515518829|FG000|Overall Study|Protocol Violation|0|||
142995588|NCT00877890|515518830|FG001|Overall Study|Protocol Violation|1|||
142995589|NCT00877890|515518829|FG000|Overall Study|Withdrawal of Consent|6|||
142995590|NCT00877890|515518830|FG001|Overall Study|Withdrawal of Consent|12|||
142995591|NCT00877890|515518829|FG000|Overall Study|Investigator Decision|0|||
142995592|NCT00877890|515518830|FG001|Overall Study|Investigator Decision|2|||
142995593|NCT00877890|515518829|FG000|Overall Study|Loss of Glucose Control|3|||
142995594|NCT00877890|515518830|FG001|Overall Study|Loss of Glucose Control|4|||
142995595|NCT02975206|515518831|FG000|Overall Study|Withdrawal by Subject|14|||
142995596|NCT02975206|515518832|FG001|Overall Study|Withdrawal by Subject|11|||
142995597|NCT02975206|515518833|FG002|Overall Study|Withdrawal by Subject|11|||
142995598|NCT02975206|515518831|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
142995599|NCT02975206|515518832|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
142995600|NCT02975206|515518833|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
142995601|NCT01981096|515518835|FG000|Overall Study|Parent illness|1|||
142995602|NCT01981096|515518836|FG001|Overall Study|Parent illness|0|||
142995603|NCT01981096|515518835|FG000|Overall Study|Withdrawal by Subject|0|||
142995604|NCT01981096|515518836|FG001|Overall Study|Withdrawal by Subject|1|||
142995605|NCT01981096|515518835|FG000|Overall Study|Lost to Follow-up|2|||
142995606|NCT01981096|515518836|FG001|Overall Study|Lost to Follow-up|0|||
142995607|NCT00866606|515518837|FG000|Overall Study|Lost to Follow-up|3|||
142995608|NCT00866606|515518837|FG000|Overall Study|Adverse Event|1|||
142995609|NCT01225211|515518838|FG000|Overall Study|Adverse Event|0|||
142995610|NCT01225211|515518839|FG001|Overall Study|Adverse Event|0|||
142995611|NCT01225211|515518840|FG002|Overall Study|Adverse Event|1|||
142995612|NCT01225211|515518841|FG003|Overall Study|Adverse Event|0|||
142995613|NCT01225211|515518842|FG004|Overall Study|Adverse Event|0|||
142995614|NCT01225211|515518843|FG005|Overall Study|Adverse Event|0|||
142995615|NCT01225211|515518844|FG006|Overall Study|Adverse Event|0|||
142995616|NCT01225211|515518845|FG007|Overall Study|Adverse Event|0|||
142995617|NCT01225211|515518846|FG008|Overall Study|Adverse Event|0|||
142995618|NCT01225211|515518847|FG009|Overall Study|Adverse Event|1|||
142995619|NCT01225211|515518838|FG000|Overall Study|Withdrawal by Subject|0|||
142995620|NCT01225211|515518839|FG001|Overall Study|Withdrawal by Subject|0|||
142995621|NCT01225211|515518840|FG002|Overall Study|Withdrawal by Subject|0|||
142995622|NCT01225211|515518841|FG003|Overall Study|Withdrawal by Subject|0|||
142995623|NCT01225211|515518842|FG004|Overall Study|Withdrawal by Subject|0|||
142995624|NCT01225211|515518843|FG005|Overall Study|Withdrawal by Subject|0|||
142995625|NCT01225211|515518844|FG006|Overall Study|Withdrawal by Subject|1|||
142995626|NCT01225211|515518845|FG007|Overall Study|Withdrawal by Subject|0|||
142995627|NCT01225211|515518846|FG008|Overall Study|Withdrawal by Subject|1|||
142995628|NCT01225211|515518847|FG009|Overall Study|Withdrawal by Subject|3|||
142995629|NCT01225211|515518838|FG000|Overall Study|Other|0|||
142995630|NCT01225211|515518839|FG001|Overall Study|Other|0|||
142995631|NCT01225211|515518840|FG002|Overall Study|Other|0|||
142995632|NCT01225211|515518841|FG003|Overall Study|Other|0|||
142995633|NCT01225211|515518842|FG004|Overall Study|Other|0|||
142995634|NCT01225211|515518843|FG005|Overall Study|Other|0|||
142995635|NCT01225211|515518844|FG006|Overall Study|Other|0|||
142995636|NCT01225211|515518845|FG007|Overall Study|Other|0|||
142995637|NCT01225211|515518846|FG008|Overall Study|Other|0|||
142995638|NCT01225211|515518847|FG009|Overall Study|Other|1|||
142995639|NCT02993783|515518871|FG000|Overall Study|Reason not Specified|6|||
142995640|NCT02993783|515518872|FG001|Overall Study|Reason not Specified|9|||
142995641|NCT00606021|515518873|FG000|Induction Phase|Death|73|||
142995642|NCT00606021|515518874|FG001|Induction Phase|Death|0|||
142995643|NCT00606021|515518875|FG002|Induction Phase|Death|0|||
142995644|NCT00606021|515518873|FG000|Induction Phase|Physician Decision|2|||
142995645|NCT00606021|515518874|FG001|Induction Phase|Physician Decision|0|||
142995646|NCT00606021|515518875|FG002|Induction Phase|Physician Decision|0|||
142995647|NCT00606021|515518873|FG000|Induction Phase|Withdrawal by Subject|2|||
142995648|NCT00606021|515518874|FG001|Induction Phase|Withdrawal by Subject|0|||
142995649|NCT00606021|515518875|FG002|Induction Phase|Withdrawal by Subject|0|||
142995650|NCT00606021|515518873|FG000|Induction Phase|Lost to Follow-up|10|||
142995651|NCT00606021|515518874|FG001|Induction Phase|Lost to Follow-up|0|||
142995652|NCT00606021|515518875|FG002|Induction Phase|Lost to Follow-up|0|||
142995653|NCT00606021|515518873|FG000|Maintenance Phase|Death|0|||
142995654|NCT00606021|515518874|FG001|Maintenance Phase|Death|17|||
142995655|NCT00606021|515518875|FG002|Maintenance Phase|Death|15|||
142995656|NCT00606021|515518873|FG000|Maintenance Phase|Physician Decision|0|||
142995657|NCT00606021|515518874|FG001|Maintenance Phase|Physician Decision|1|||
142995658|NCT00606021|515518875|FG002|Maintenance Phase|Physician Decision|0|||
142995659|NCT00606021|515518873|FG000|Maintenance Phase|Lost to Follow-up|0|||
142995660|NCT00606021|515518874|FG001|Maintenance Phase|Lost to Follow-up|5|||
142995661|NCT00606021|515518875|FG002|Maintenance Phase|Lost to Follow-up|2|||
142995662|NCT00392210|515518878|FG000|First Voiding Trial|Physician Decision|2|||
142995663|NCT00392210|515518879|FG001|First Voiding Trial|Physician Decision|2|||
142995664|NCT03049852|515518883|FG000|Overall Study|Lost to Follow-up|0|||
142995665|NCT03049852|515518884|FG001|Overall Study|Lost to Follow-up|1|||
142995666|NCT03049852|515518885|FG002|Overall Study|Lost to Follow-up|0|||
142995667|NCT02067104|515518886|FG000|Overall Study|Study termination due to low accrual|4|||
142995668|NCT02067104|515518887|FG001|Overall Study|Study termination due to low accrual|5|||
142995669|NCT01987609|515518888|FG000|Overall Study|Adverse Event|1|||
142995670|NCT02610231|515518894|FG000|Overall Study|Withdrawal by Subject|27|||
142995671|NCT02610231|515518894|FG000|Overall Study|Adverse Event|20|||
142995672|NCT02610231|515518894|FG000|Overall Study|Death|5|||
142995673|NCT02610231|515518894|FG000|Overall Study|Surgery|2|||
142995674|NCT02610231|515518894|FG000|Overall Study|Physician Decision|1|||
142995675|NCT02610231|515518894|FG000|Overall Study|Non Compliance|2|||
142995676|NCT02610231|515518894|FG000|Overall Study|Other|3|||
142995677|NCT00806494|515518895|FG000|Overall Study|Adverse Event|29|||
142995678|NCT00806494|515518895|FG000|Overall Study|Lack of Efficacy|6|||
142995679|NCT00806494|515518895|FG000|Overall Study|Lost to Follow-up|10|||
142995680|NCT00806494|515518895|FG000|Overall Study|Other|30|||
142995681|NCT00806494|515518895|FG000|Overall Study|Withdrawal by Subject|5|||
142995682|NCT01279954|515518898|FG000|Overall Study|Lack of Efficacy|3|||
142995683|NCT01279954|515518899|FG001|Overall Study|Lack of Efficacy|4|||
142995684|NCT02140762|515518900|FG000|Overall Study|Adverse Event|1|||
142995685|NCT02140762|515518901|FG001|Overall Study|Adverse Event|1|||
142995686|NCT02140762|515518900|FG000|Overall Study|Lost to Follow-up|9|||
142995687|NCT02140762|515518901|FG001|Overall Study|Lost to Follow-up|5|||
142995688|NCT02140762|515518900|FG000|Overall Study|Protocol Violation|1|||
142995689|NCT02140762|515518901|FG001|Overall Study|Protocol Violation|1|||
142995690|NCT02140762|515518900|FG000|Overall Study|Withdrawal by Subject|6|||
142995691|NCT02140762|515518901|FG001|Overall Study|Withdrawal by Subject|4|||
142995692|NCT02140762|515518900|FG000|Overall Study|Other|0|||
142995693|NCT02140762|515518901|FG001|Overall Study|Other|1|||
142995694|NCT02709889|515518902|FG000|Overall Study|Withdrawal by Subject|11|||
142995695|NCT02709889|515518903|FG001|Overall Study|Withdrawal by Subject|10|||
142995696|NCT02709889|515518904|FG002|Overall Study|Withdrawal by Subject|2|||
142995697|NCT02709889|515518905|FG003|Overall Study|Withdrawal by Subject|12|||
142995698|NCT02709889|515518902|FG000|Overall Study|Death|25|||
142995699|NCT02709889|515518903|FG001|Overall Study|Death|38|||
142995700|NCT02709889|515518904|FG002|Overall Study|Death|4|||
142995701|NCT02709889|515518905|FG003|Overall Study|Death|44|||
142995702|NCT02709889|515518902|FG000|Overall Study|Physician Decision|1|||
142995703|NCT02709889|515518903|FG001|Overall Study|Physician Decision|2|||
142995704|NCT02709889|515518904|FG002|Overall Study|Physician Decision|3|||
142995705|NCT02709889|515518905|FG003|Overall Study|Physician Decision|5|||
142995706|NCT02709889|515518902|FG000|Overall Study|Lost to Follow-up|2|||
142995707|NCT02709889|515518903|FG001|Overall Study|Lost to Follow-up|0|||
142995708|NCT02709889|515518904|FG002|Overall Study|Lost to Follow-up|0|||
142995709|NCT02709889|515518905|FG003|Overall Study|Lost to Follow-up|4|||
142995710|NCT02709889|515518902|FG000|Overall Study|Study Terminated by Sponsor|4|||
142995711|NCT02709889|515518903|FG001|Overall Study|Study Terminated by Sponsor|6|||
142995712|NCT02709889|515518904|FG002|Overall Study|Study Terminated by Sponsor|2|||
142995713|NCT02709889|515518905|FG003|Overall Study|Study Terminated by Sponsor|17|||
142995714|NCT02709889|515518902|FG000|Overall Study|Other, Not Specified|0|||
142995715|NCT02709889|515518903|FG001|Overall Study|Other, Not Specified|1|||
142995716|NCT02709889|515518904|FG002|Overall Study|Other, Not Specified|1|||
142995717|NCT02709889|515518905|FG003|Overall Study|Other, Not Specified|6|||
142995718|NCT01385098|515518907|FG000|Overall Study|Adverse Event|10|||
142995719|NCT01385098|515518907|FG000|Overall Study|Lost to Follow-up|4|||
142995720|NCT01230827|515518908|FG000|Overall Study|Lost to Follow-up|0|||
142995721|NCT01230827|515518909|FG001|Overall Study|Lost to Follow-up|0|||
142995722|NCT01230827|515518910|FG002|Overall Study|Lost to Follow-up|1|||
142995723|NCT01230827|515518911|FG003|Overall Study|Lost to Follow-up|3|||
142995724|NCT01230827|515518908|FG000|Overall Study|Withdrawal by Subject|1|||
142995725|NCT01230827|515518909|FG001|Overall Study|Withdrawal by Subject|0|||
142995726|NCT01230827|515518910|FG002|Overall Study|Withdrawal by Subject|3|||
142995727|NCT01230827|515518911|FG003|Overall Study|Withdrawal by Subject|2|||
142995728|NCT01230827|515518908|FG000|Overall Study|Lack of Efficacy|14|||
142995729|NCT01230827|515518909|FG001|Overall Study|Lack of Efficacy|1|||
142995730|NCT01230827|515518910|FG002|Overall Study|Lack of Efficacy|2|||
142995731|NCT01230827|515518911|FG003|Overall Study|Lack of Efficacy|3|||
142995732|NCT01230827|515518908|FG000|Overall Study|Adverse Event|4|||
142995733|NCT01230827|515518909|FG001|Overall Study|Adverse Event|2|||
142995734|NCT01230827|515518910|FG002|Overall Study|Adverse Event|3|||
142995735|NCT01230827|515518911|FG003|Overall Study|Adverse Event|7|||
142995736|NCT01230827|515518908|FG000|Overall Study|Recovery|0|||
142995737|NCT01230827|515518909|FG001|Overall Study|Recovery|6|||
142995738|NCT01230827|515518910|FG002|Overall Study|Recovery|0|||
142995739|NCT01230827|515518911|FG003|Overall Study|Recovery|0|||
142995740|NCT01230827|515518908|FG000|Overall Study|Study terminated by Sponsor|0|||
142995741|NCT01230827|515518909|FG001|Overall Study|Study terminated by Sponsor|2|||
142995742|NCT01230827|515518910|FG002|Overall Study|Study terminated by Sponsor|56|||
142995743|NCT01230827|515518911|FG003|Overall Study|Study terminated by Sponsor|63|||
142995744|NCT00122317|515518914|FG000|Overall Study|Death|3|||
142995745|NCT00122317|515518914|FG000|Overall Study|Adverse Event|4|||
142995746|NCT00122317|515518914|FG000|Overall Study|Physician Decision|2|||
142995747|NCT00122317|515518914|FG000|Overall Study|patient non-compliance|1|||
142995748|NCT00122317|515518914|FG000|Overall Study|Withdrawal by Subject|1|||
142995749|NCT03458234|515518915|FG000|Overall Study|Withdrawal by Subject|1|||
142995750|NCT04728815|515518916|FG000|Overall Study|Lost to Follow-up|3|||
142995751|NCT04728815|515518917|FG001|Overall Study|Lost to Follow-up|0|||
142995752|NCT04728815|515518918|FG002|Overall Study|Lost to Follow-up|0|||
142995753|NCT04728815|515518919|FG003|Overall Study|Lost to Follow-up|1|||
142995754|NCT04728815|515518920|FG004|Overall Study|Lost to Follow-up|1|||
142995755|NCT04728815|515518921|FG005|Overall Study|Lost to Follow-up|0|||
142995756|NCT04728815|515518922|FG006|Overall Study|Lost to Follow-up|2|||
142995757|NCT04728815|515518923|FG007|Overall Study|Lost to Follow-up|0|||
142995758|NCT04728815|515518916|FG000|Overall Study|Physician Decision|0|||
142995759|NCT04728815|515518917|FG001|Overall Study|Physician Decision|0|||
142995760|NCT04728815|515518918|FG002|Overall Study|Physician Decision|1|||
142995761|NCT04728815|515518919|FG003|Overall Study|Physician Decision|0|||
142995762|NCT04728815|515518920|FG004|Overall Study|Physician Decision|0|||
142995763|NCT04728815|515518921|FG005|Overall Study|Physician Decision|0|||
142995764|NCT04728815|515518922|FG006|Overall Study|Physician Decision|0|||
142995765|NCT04728815|515518923|FG007|Overall Study|Physician Decision|0|||
142995766|NCT04728815|515518916|FG000|Overall Study|Treatment drop|0|||
142995767|NCT04728815|515518917|FG001|Overall Study|Treatment drop|2|||
142995768|NCT04728815|515518918|FG002|Overall Study|Treatment drop|1|||
142995769|NCT04728815|515518919|FG003|Overall Study|Treatment drop|0|||
142995770|NCT04728815|515518920|FG004|Overall Study|Treatment drop|3|||
142995771|NCT04728815|515518921|FG005|Overall Study|Treatment drop|1|||
142995772|NCT04728815|515518922|FG006|Overall Study|Treatment drop|3|||
142995773|NCT04728815|515518923|FG007|Overall Study|Treatment drop|0|||
142995774|NCT04728815|515518916|FG000|Overall Study|Study drop|0|||
142995775|NCT04728815|515518917|FG001|Overall Study|Study drop|3|||
142995776|NCT04728815|515518918|FG002|Overall Study|Study drop|3|||
142995777|NCT04728815|515518919|FG003|Overall Study|Study drop|0|||
142995778|NCT04728815|515518920|FG004|Overall Study|Study drop|0|||
142995779|NCT04728815|515518921|FG005|Overall Study|Study drop|0|||
142995780|NCT04728815|515518922|FG006|Overall Study|Study drop|7|||
142995781|NCT04728815|515518923|FG007|Overall Study|Study drop|0|||
142995782|NCT05315297|515518926|FG000|Overall Study|Lost to Follow-up|6|||
142995783|NCT05315297|515518927|FG001|Overall Study|Lost to Follow-up|4|||
142995784|NCT05315297|515518926|FG000|Overall Study|Withdrawal by Subject|0|||
142995785|NCT05315297|515518927|FG001|Overall Study|Withdrawal by Subject|1|||
142995786|NCT00027846|515520989|FG000|Overall Study|Lost to Follow-up|0|||
142995787|NCT00027846|515520990|FG001|Overall Study|Lost to Follow-up|41|||
142995788|NCT00027846|515520991|FG002|Overall Study|Lost to Follow-up|9|||
142995789|NCT00027846|515520989|FG000|Overall Study|Withdrawal by Subject|0|||
142995790|NCT00027846|515520990|FG001|Overall Study|Withdrawal by Subject|14|||
142995791|NCT00027846|515520991|FG002|Overall Study|Withdrawal by Subject|7|||
142995792|NCT00027846|515520989|FG000|Overall Study|Ineligible for study|2|||
142995793|NCT00027846|515520990|FG001|Overall Study|Ineligible for study|6|||
142995794|NCT00027846|515520991|FG002|Overall Study|Ineligible for study|14|||
142995795|NCT00027846|515520989|FG000|Overall Study|Entry into another COG therapeutic study|0|||
142995796|NCT00027846|515520990|FG001|Overall Study|Entry into another COG therapeutic study|5|||
142995797|NCT00027846|515520991|FG002|Overall Study|Entry into another COG therapeutic study|2|||
142995798|NCT00027846|515520989|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
142995799|NCT00027846|515520990|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
142995800|NCT00027846|515520991|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
142995801|NCT04335929|515520992|FG000|Overall Study|Lost to Follow-up|10|||
142995802|NCT02889861|515521010|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
142995803|NCT01864746|515521011|FG000|Overall Study|Disease recurrence|25|||
142995804|NCT01864746|515521012|FG001|Overall Study|Disease recurrence|40|||
142995805|NCT01864746|515521011|FG000|Overall Study|Second primary invasive nonbreast|2|||
142995806|NCT01864746|515521012|FG001|Overall Study|Second primary invasive nonbreast|3|||
142995807|NCT01864746|515521011|FG000|Overall Study|Death|2|||
142995808|NCT01864746|515521012|FG001|Overall Study|Death|1|||
142995809|NCT01864746|515521011|FG000|Overall Study|Adverse Event|33|||
142995810|NCT01864746|515521012|FG001|Overall Study|Adverse Event|5|||
142995811|NCT01864746|515521011|FG000|Overall Study|Withdrawal by Subject|56|||
142995812|NCT01864746|515521012|FG001|Overall Study|Withdrawal by Subject|41|||
142995813|NCT01864746|515521011|FG000|Overall Study|Physician Decision|5|||
142995814|NCT01864746|515521012|FG001|Overall Study|Physician Decision|6|||
142995815|NCT01005966|515521013|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
142995816|NCT01005966|515521014|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
142995817|NCT01005966|515521015|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
142995818|NCT01005966|515521016|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
142995819|NCT01005966|515521017|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
142995820|NCT01005966|515521013|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
142995821|NCT01005966|515521014|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
142995822|NCT01005966|515521015|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
142995823|NCT01005966|515521016|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
143003186|NCT01049360|515548758|FG014|Period 2|Lack of Efficacy|0|||
142995824|NCT01005966|515521017|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
142995825|NCT01005966|515521013|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
142995826|NCT01005966|515521014|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
142995827|NCT01005966|515521015|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
142995828|NCT01005966|515521016|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
142995829|NCT01005966|515521017|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
142995830|NCT01005966|515521013|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
142995831|NCT01005966|515521014|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
142995832|NCT01005966|515521015|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
142995833|NCT01005966|515521016|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
142995834|NCT01005966|515521017|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
142995835|NCT01005966|515521013|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
142995836|NCT01005966|515521014|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
142995837|NCT01005966|515521015|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
142995838|NCT01005966|515521016|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
142995839|NCT01005966|515521017|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
142995840|NCT01005966|515521013|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
142995841|NCT01005966|515521014|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
142995842|NCT01005966|515521015|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
142995843|NCT01005966|515521016|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
142995844|NCT01005966|515521017|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
142995845|NCT01005966|515521013|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
142995846|NCT01005966|515521014|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
142995847|NCT01005966|515521015|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
142995848|NCT01005966|515521016|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
142995849|NCT01005966|515521017|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
142995850|NCT01005966|515521013|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
142995851|NCT01005966|515521014|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
142995852|NCT01005966|515521015|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
142995853|NCT01005966|515521016|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
142995854|NCT01005966|515521017|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
142995855|NCT01005966|515521013|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
142995856|NCT01005966|515521014|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
142995857|NCT01005966|515521015|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
142995858|NCT01005966|515521016|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
142995859|NCT01005966|515521017|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
142995860|NCT01451203|515521018|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
142995861|NCT01451203|515521019|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
142995862|NCT01451203|515521018|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
142995863|NCT01451203|515521019|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
142995864|NCT01451203|515521018|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
142995865|NCT01451203|515521019|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
142995866|NCT01451203|515521018|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
142995867|NCT01451203|515521019|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
142995868|NCT01451203|515521018|FG000|Double-blind Treatment Period|Adverse Event|6|||
142995869|NCT01451203|515521019|FG001|Double-blind Treatment Period|Adverse Event|9|||
142995870|NCT01451203|515521018|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
142995871|NCT01451203|515521019|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
142995872|NCT01451203|515521018|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
142995873|NCT01451203|515521019|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
142995874|NCT01451203|515521018|FG000|Double-blind Treatment Period|Investigator decision|2|||
142995875|NCT01451203|515521019|FG001|Double-blind Treatment Period|Investigator decision|0|||
142995876|NCT01451203|515521018|FG000|Post-treatment Period|Consent withdrawn|2|||
142995877|NCT01451203|515521019|FG001|Post-treatment Period|Consent withdrawn|4|||
142995878|NCT01451203|515521018|FG000|Post-treatment Period|Lack of Efficacy|12|||
142995879|NCT01451203|515521019|FG001|Post-treatment Period|Lack of Efficacy|28|||
142995880|NCT01451203|515521018|FG000|Post-treatment Period|Adverse Event|0|||
142995881|NCT01451203|515521019|FG001|Post-treatment Period|Adverse Event|1|||
142995882|NCT01451203|515521018|FG000|Post-treatment Period|Investigator decision|0|||
142995883|NCT01451203|515521019|FG001|Post-treatment Period|Investigator decision|1|||
142995884|NCT02146274|515521020|FG000|Overall Study|Protocol Violation|73|||
142995885|NCT00027027|515521021|FG000|Overall Study|Adverse Event|0|||
142995886|NCT00027027|515521022|FG001|Overall Study|Adverse Event|0|||
142995887|NCT00027027|515521023|FG002|Overall Study|Adverse Event|1|||
142995888|NCT00027027|515521024|FG003|Overall Study|Adverse Event|0|||
142995889|NCT00027027|515521025|FG004|Overall Study|Adverse Event|1|||
142995890|NCT00027027|515521021|FG000|Overall Study|Admitted for Signs of PD|0|||
142995891|NCT00027027|515521022|FG001|Overall Study|Admitted for Signs of PD|0|||
142995892|NCT00027027|515521023|FG002|Overall Study|Admitted for Signs of PD|0|||
142995893|NCT00027027|515521024|FG003|Overall Study|Admitted for Signs of PD|0|||
142995894|NCT00027027|515521025|FG004|Overall Study|Admitted for Signs of PD|1|||
142995895|NCT00027027|515521021|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
142995896|NCT00027027|515521022|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
142995897|NCT00027027|515521023|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
142995898|NCT00027027|515521024|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
142995899|NCT00027027|515521025|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
142995900|NCT00027027|515521021|FG000|Overall Study|PD Requiring Surgery|0|||
142995901|NCT00027027|515521022|FG001|Overall Study|PD Requiring Surgery|0|||
142995902|NCT00027027|515521023|FG002|Overall Study|PD Requiring Surgery|1|||
142995903|NCT00027027|515521024|FG003|Overall Study|PD Requiring Surgery|0|||
142995904|NCT00027027|515521025|FG004|Overall Study|PD Requiring Surgery|0|||
142995905|NCT00027027|515521021|FG000|Overall Study|Physician Decision Due To PD|2|||
142995906|NCT00027027|515521022|FG001|Overall Study|Physician Decision Due To PD|3|||
142995907|NCT00027027|515521023|FG002|Overall Study|Physician Decision Due To PD|2|||
142995908|NCT00027027|515521024|FG003|Overall Study|Physician Decision Due To PD|3|||
142995909|NCT00027027|515521025|FG004|Overall Study|Physician Decision Due To PD|5|||
142995910|NCT00027027|515521021|FG000|Overall Study|Withdrawal by Subject|0|||
142995911|NCT00027027|515521022|FG001|Overall Study|Withdrawal by Subject|0|||
142995912|NCT00027027|515521023|FG002|Overall Study|Withdrawal by Subject|0|||
142995913|NCT00027027|515521024|FG003|Overall Study|Withdrawal by Subject|0|||
142995914|NCT00027027|515521025|FG004|Overall Study|Withdrawal by Subject|1|||
142995915|NCT00443534|515521028|FG000|Overall Study|Lack of Efficacy|67|||
142995916|NCT00443534|515521028|FG000|Overall Study|Adverse Event|16|||
142995917|NCT00443534|515521028|FG000|Overall Study|Death|9|||
142995918|NCT00443534|515521028|FG000|Overall Study|Withdrawal by Subject|8|||
142995919|NCT00443534|515521028|FG000|Overall Study|Study Terminated by Sponsor|12|||
142995920|NCT00443534|515521028|FG000|Overall Study|Other|10|||
142995921|NCT00443534|515521028|FG000|Overall Study|Enrolled, Not Treated|1|||
142995922|NCT00413231|515521029|FG000|0 to 30-day Post Treatment|Death|5|||
142995923|NCT00413231|515521029|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
142995924|NCT00413231|515521029|FG000|30-day to 365-day Post Treatment|Death|13|||
142995925|NCT00413231|515521029|FG000|365-day to 60-month Post Treatment|Death|36|||
142995926|NCT00413231|515521029|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
142995927|NCT00413231|515521029|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
142995928|NCT00413231|515521029|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
142995929|NCT02516605|515521030|FG000|Overall Study|Protocol Violation|0|||
142995930|NCT02516605|515521031|FG001|Overall Study|Protocol Violation|0|||
142995931|NCT02516605|515521032|FG002|Overall Study|Protocol Violation|0|||
142995932|NCT02516605|515521033|FG003|Overall Study|Protocol Violation|0|||
142995933|NCT02516605|515521034|FG004|Overall Study|Protocol Violation|1|||
142995934|NCT02516605|515521030|FG000|Overall Study|Withdrawal by Subject|0|||
142995935|NCT02516605|515521031|FG001|Overall Study|Withdrawal by Subject|0|||
142995936|NCT02516605|515521032|FG002|Overall Study|Withdrawal by Subject|0|||
142995937|NCT02516605|515521033|FG003|Overall Study|Withdrawal by Subject|1|||
142995938|NCT02516605|515521034|FG004|Overall Study|Withdrawal by Subject|0|||
142995939|NCT01731951|515521037|FG000|Overall Study|Documented Disease Progression|1|||
142995940|NCT01731951|515521038|FG001|Overall Study|Documented Disease Progression|0|||
142995941|NCT01731951|515521039|FG002|Overall Study|Documented Disease Progression|0|||
142995942|NCT01731951|515521040|FG003|Overall Study|Documented Disease Progression|0|||
142995943|NCT01731951|515521041|FG004|Overall Study|Documented Disease Progression|0|||
142995944|NCT01731951|515521042|FG005|Overall Study|Documented Disease Progression|0|||
142995945|NCT01731951|515521037|FG000|Overall Study|Lost to Follow-up|2|||
142995946|NCT01731951|515521038|FG001|Overall Study|Lost to Follow-up|0|||
142995947|NCT01731951|515521039|FG002|Overall Study|Lost to Follow-up|0|||
142995948|NCT01731951|515521040|FG003|Overall Study|Lost to Follow-up|1|||
142995949|NCT01731951|515521041|FG004|Overall Study|Lost to Follow-up|3|||
142995950|NCT01731951|515521042|FG005|Overall Study|Lost to Follow-up|1|||
142995951|NCT01731951|515521037|FG000|Overall Study|Withdrawal of Consent|1|||
142995952|NCT01731951|515521038|FG001|Overall Study|Withdrawal of Consent|0|||
142995953|NCT01731951|515521039|FG002|Overall Study|Withdrawal of Consent|0|||
142995954|NCT01731951|515521040|FG003|Overall Study|Withdrawal of Consent|0|||
142995955|NCT01731951|515521041|FG004|Overall Study|Withdrawal of Consent|0|||
142995956|NCT01731951|515521042|FG005|Overall Study|Withdrawal of Consent|2|||
142995957|NCT01731951|515521037|FG000|Overall Study|Death|13|||
142995958|NCT01731951|515521038|FG001|Overall Study|Death|15|||
142995959|NCT01731951|515521039|FG002|Overall Study|Death|9|||
142995960|NCT01731951|515521040|FG003|Overall Study|Death|8|||
142995961|NCT01731951|515521041|FG004|Overall Study|Death|9|||
142995962|NCT01731951|515521042|FG005|Overall Study|Death|6|||
142995963|NCT00253747|515521043|FG000|Overall Study|Lost to Follow-up|13|||
142995964|NCT00253747|515521044|FG001|Overall Study|Lost to Follow-up|14|||
142995965|NCT00253747|515521043|FG000|Overall Study|Withdrawal by Subject|10|||
142995966|NCT00253747|515521044|FG001|Overall Study|Withdrawal by Subject|11|||
142995967|NCT00253747|515521043|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
142995968|NCT00253747|515521044|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
142995969|NCT00104299|515521045|FG000|Overall Study|Adverse Event|3|||
142995970|NCT00104299|515521046|FG001|Overall Study|Adverse Event|1|||
142995971|NCT00104299|515521045|FG000|Overall Study|Death|2|||
142995972|NCT00104299|515521046|FG001|Overall Study|Death|2|||
142995973|NCT00104299|515521045|FG000|Overall Study|Withdrawal by Subject|2|||
142995974|NCT00104299|515521046|FG001|Overall Study|Withdrawal by Subject|6|||
142995975|NCT00104299|515521045|FG000|Overall Study|Physician Decision|1|||
142995976|NCT00104299|515521046|FG001|Overall Study|Physician Decision|1|||
142995977|NCT00104299|515521045|FG000|Overall Study|To have renal transplant|1|||
142995978|NCT00104299|515521046|FG001|Overall Study|To have renal transplant|0|||
142995979|NCT02452034|515521047|FG000|Overall Study|Adverse Event|0|||
142995980|NCT02452034|515521048|FG001|Overall Study|Adverse Event|0|||
142995981|NCT02452034|515521049|FG002|Overall Study|Adverse Event|0|||
142995982|NCT02452034|515521050|FG003|Overall Study|Adverse Event|0|||
142995983|NCT02452034|515521051|FG004|Overall Study|Adverse Event|0|||
142995984|NCT02452034|515521052|FG005|Overall Study|Adverse Event|1|||
142995985|NCT02452034|515521047|FG000|Overall Study|Death|0|||
142995986|NCT02452034|515521048|FG001|Overall Study|Death|0|||
142995987|NCT02452034|515521049|FG002|Overall Study|Death|0|||
142995988|NCT02452034|515521050|FG003|Overall Study|Death|0|||
142995989|NCT02452034|515521051|FG004|Overall Study|Death|1|||
142995990|NCT02452034|515521052|FG005|Overall Study|Death|1|||
142995991|NCT02452034|515521047|FG000|Overall Study|Physician Decision|0|||
142995992|NCT02452034|515521048|FG001|Overall Study|Physician Decision|1|||
142995993|NCT02452034|515521049|FG002|Overall Study|Physician Decision|1|||
142995994|NCT02452034|515521050|FG003|Overall Study|Physician Decision|0|||
142995995|NCT02452034|515521051|FG004|Overall Study|Physician Decision|0|||
142995996|NCT02452034|515521052|FG005|Overall Study|Physician Decision|0|||
142995997|NCT02452034|515521047|FG000|Overall Study|Protocol Violation|0|||
142995998|NCT02452034|515521048|FG001|Overall Study|Protocol Violation|0|||
142995999|NCT02452034|515521049|FG002|Overall Study|Protocol Violation|0|||
142996000|NCT02452034|515521050|FG003|Overall Study|Protocol Violation|0|||
142996001|NCT02452034|515521051|FG004|Overall Study|Protocol Violation|0|||
142996002|NCT02452034|515521052|FG005|Overall Study|Protocol Violation|1|||
142996003|NCT02452034|515521047|FG000|Overall Study|Screen Failure|1|||
142996004|NCT02452034|515521048|FG001|Overall Study|Screen Failure|0|||
142996005|NCT02452034|515521049|FG002|Overall Study|Screen Failure|0|||
142996006|NCT02452034|515521050|FG003|Overall Study|Screen Failure|1|||
142996007|NCT02452034|515521051|FG004|Overall Study|Screen Failure|0|||
142996008|NCT02452034|515521052|FG005|Overall Study|Screen Failure|0|||
142996009|NCT02452034|515521047|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
142996010|NCT02452034|515521048|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
142996011|NCT02452034|515521049|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
142996012|NCT02452034|515521050|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
142996013|NCT02452034|515521051|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
142996014|NCT02452034|515521052|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
142996015|NCT01904760|515521056|FG000|Overall Study|Protocol Violation|1|||
142996016|NCT01904760|515521057|FG001|Overall Study|Protocol Violation|0|||
142996017|NCT00783263|515521058|FG000|Overall Study|Adverse Event|3|||
142996018|NCT00783263|515521059|FG001|Overall Study|Adverse Event|0|||
142996019|NCT00783263|515521060|FG002|Overall Study|Adverse Event|2|||
142996020|NCT00783263|515521061|FG003|Overall Study|Adverse Event|1|||
142996021|NCT00783263|515521058|FG000|Overall Study|Lost to Follow-up|1|||
142996022|NCT00783263|515521059|FG001|Overall Study|Lost to Follow-up|1|||
142996023|NCT00783263|515521060|FG002|Overall Study|Lost to Follow-up|0|||
142996024|NCT00783263|515521061|FG003|Overall Study|Lost to Follow-up|0|||
142996025|NCT00783263|515521058|FG000|Overall Study|Withdrawal by Subject|0|||
142996026|NCT00783263|515521059|FG001|Overall Study|Withdrawal by Subject|1|||
142996027|NCT00783263|515521060|FG002|Overall Study|Withdrawal by Subject|1|||
142996028|NCT00783263|515521061|FG003|Overall Study|Withdrawal by Subject|2|||
142996029|NCT02519777|515521066|FG000|Overall Study|Death|1|||
142996030|NCT02519777|515521067|FG001|Overall Study|Death|0|||
142996031|NCT02519777|515521068|FG002|Overall Study|Death|0|||
142996032|NCT02519777|515521066|FG000|Overall Study|Lost to Follow-up|0|||
142996033|NCT02519777|515521067|FG001|Overall Study|Lost to Follow-up|4|||
142996034|NCT02519777|515521068|FG002|Overall Study|Lost to Follow-up|2|||
142996035|NCT02519777|515521066|FG000|Overall Study|Withdrawal by Subject|3|||
142996036|NCT02519777|515521067|FG001|Overall Study|Withdrawal by Subject|1|||
142996037|NCT02519777|515521068|FG002|Overall Study|Withdrawal by Subject|0|||
142996038|NCT02519777|515521066|FG000|Overall Study|Severe Debilitation|1|||
142996039|NCT02519777|515521067|FG001|Overall Study|Severe Debilitation|1|||
142996040|NCT02519777|515521068|FG002|Overall Study|Severe Debilitation|1|||
142996041|NCT02519777|515521066|FG000|Overall Study|Not able to get to clinic|1|||
142996042|NCT02519777|515521067|FG001|Overall Study|Not able to get to clinic|2|||
142996043|NCT02519777|515521068|FG002|Overall Study|Not able to get to clinic|1|||
142996044|NCT02195531|515521069|FG000|Overall Study|Withdrawal by Subject|1|||
142996045|NCT02195531|515521070|FG001|Overall Study|Withdrawal by Subject|1|||
142996046|NCT02195531|515521071|FG002|Overall Study|Withdrawal by Subject|1|||
142996047|NCT01284127|515521075|FG000|Overall Study|Adverse Event|2|||
142996048|NCT01284127|515521075|FG000|Overall Study|Withdrawal by Subject|4|||
142996049|NCT01284127|515521075|FG000|Overall Study|Physician Decision|1|||
142996050|NCT01683058|515521077|FG000|Overall Study|Lost to Follow-up|9|||
142996051|NCT01683058|515521077|FG000|Overall Study|Adverse Event|6|||
142996052|NCT01683058|515521077|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
142996053|NCT01683058|515521077|FG000|Overall Study|Withdrawal by Subject|7|||
142996054|NCT01683058|515521077|FG000|Overall Study|Lack of Efficacy|2|||
142996055|NCT04062240|515521081|FG000|Overall Study|equipment malfunction|1|||
142996056|NCT01057394|515521082|FG000|Overall Study|Not eligible|0|||
142996057|NCT01057394|515521083|FG001|Overall Study|Not eligible|2|||
142996058|NCT01195636|515521084|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
142996059|NCT01195636|515521085|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
142996060|NCT01195636|515521084|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
142996061|NCT01195636|515521085|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
142996062|NCT01195636|515521084|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
142996063|NCT01195636|515521085|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
142996064|NCT01195636|515521084|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
142996065|NCT01195636|515521085|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
142996066|NCT01195636|515521084|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
142996067|NCT01195636|515521085|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
142996068|NCT01195636|515521084|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
142996069|NCT01195636|515521085|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
142996070|NCT01195636|515521084|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
142996071|NCT01195636|515521085|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
142996072|NCT01195636|515521084|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
142996073|NCT01195636|515521085|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
142996074|NCT03961529|515521086|FG000|Overall Study|Adverse Event|13|||
142996075|NCT03961529|515521087|FG001|Overall Study|Adverse Event|5|||
142996076|NCT03961529|515521088|FG002|Overall Study|Adverse Event|2|||
142996077|NCT03961529|515521086|FG000|Overall Study|Withdrawal by Subject|17|||
142996078|NCT03961529|515521087|FG001|Overall Study|Withdrawal by Subject|2|||
142996079|NCT03961529|515521088|FG002|Overall Study|Withdrawal by Subject|1|||
142996080|NCT03961529|515521086|FG000|Overall Study|Withdrawal by parent/guardian|0|||
142996081|NCT03961529|515521087|FG001|Overall Study|Withdrawal by parent/guardian|7|||
142996082|NCT03961529|515521088|FG002|Overall Study|Withdrawal by parent/guardian|0|||
142996083|NCT03961529|515521086|FG000|Overall Study|Physician Decision|2|||
142996084|NCT03961529|515521087|FG001|Overall Study|Physician Decision|1|||
142996085|NCT03961529|515521088|FG002|Overall Study|Physician Decision|1|||
142996086|NCT03961529|515521086|FG000|Overall Study|Lost to Follow-up|2|||
142996087|NCT03961529|515521087|FG001|Overall Study|Lost to Follow-up|1|||
142996088|NCT03961529|515521088|FG002|Overall Study|Lost to Follow-up|0|||
142996089|NCT03961529|515521086|FG000|Overall Study|Lack of Efficacy|2|||
142996090|NCT03961529|515521087|FG001|Overall Study|Lack of Efficacy|0|||
142996091|NCT03961529|515521088|FG002|Overall Study|Lack of Efficacy|1|||
142996092|NCT03961529|515521086|FG000|Overall Study|Other|6|||
142996093|NCT03961529|515521087|FG001|Overall Study|Other|1|||
142996094|NCT03961529|515521088|FG002|Overall Study|Other|0|||
142996095|NCT03644173|515521089|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
142996096|NCT03644173|515521089|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
142996097|NCT03644173|515521089|FG000|Participants at the 1-month Follow up|Death|2|||
142996098|NCT03644173|515521089|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
142996099|NCT03500419|515521092|FG000|Overall Study|Withdrawal by Subject|2|||
142996100|NCT03500419|515521093|FG001|Overall Study|Withdrawal by Subject|25|||
142996101|NCT00256204|515521107|FG000|Overall Study|Adverse Event|10|||
142996102|NCT00256204|515521108|FG001|Overall Study|Adverse Event|14|||
142996103|NCT00256204|515521109|FG002|Overall Study|Adverse Event|16|||
142996104|NCT00256204|515521110|FG003|Overall Study|Adverse Event|14|||
142996105|NCT00256204|515521107|FG000|Overall Study|Death|0|||
142996106|NCT00256204|515521108|FG001|Overall Study|Death|1|||
142996107|NCT00256204|515521109|FG002|Overall Study|Death|0|||
142996108|NCT00256204|515521110|FG003|Overall Study|Death|0|||
142996109|NCT00256204|515521107|FG000|Overall Study|Lost to Follow-up|1|||
142996110|NCT00256204|515521108|FG001|Overall Study|Lost to Follow-up|1|||
142996111|NCT00256204|515521109|FG002|Overall Study|Lost to Follow-up|1|||
142996112|NCT00256204|515521110|FG003|Overall Study|Lost to Follow-up|2|||
142996113|NCT00256204|515521107|FG000|Overall Study|Protocol Violation|1|||
142996114|NCT00256204|515521108|FG001|Overall Study|Protocol Violation|0|||
142996115|NCT00256204|515521109|FG002|Overall Study|Protocol Violation|2|||
142996116|NCT00256204|515521110|FG003|Overall Study|Protocol Violation|1|||
142996117|NCT00256204|515521107|FG000|Overall Study|Physician Decision|0|||
142996118|NCT00256204|515521108|FG001|Overall Study|Physician Decision|0|||
142996119|NCT00256204|515521109|FG002|Overall Study|Physician Decision|1|||
142996120|NCT00256204|515521110|FG003|Overall Study|Physician Decision|2|||
142996121|NCT00256204|515521107|FG000|Overall Study|Withdrawal by Subject|17|||
142996122|NCT00256204|515521108|FG001|Overall Study|Withdrawal by Subject|6|||
143455735|NCT00591851|517212517|FG000|Overall Study|Withdrawal by Subject|3|||
143455736|NCT00591851|517212517|FG000|Overall Study|Adverse Event|2|||
143455737|NCT00591851|517212517|FG000|Overall Study|Progressive Disease|1|||
142996123|NCT00256204|515521109|FG002|Overall Study|Withdrawal by Subject|7|||
142996124|NCT00256204|515521110|FG003|Overall Study|Withdrawal by Subject|5|||
142996125|NCT00256204|515521107|FG000|Overall Study|Need for additional prohibited treatment|38|||
142996126|NCT00256204|515521108|FG001|Overall Study|Need for additional prohibited treatment|28|||
142996127|NCT00256204|515521109|FG002|Overall Study|Need for additional prohibited treatment|27|||
142996128|NCT00256204|515521110|FG003|Overall Study|Need for additional prohibited treatment|25|||
142996129|NCT00082628|515521111|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
142996130|NCT00082628|515521112|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
142996131|NCT00082628|515521113|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
142996132|NCT00082628|515521114|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
142996133|NCT00082628|515521115|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
142996134|NCT00082628|515521111|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
142996135|NCT00082628|515521112|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
142996136|NCT00082628|515521113|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
142996137|NCT00082628|515521114|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
142996138|NCT00082628|515521115|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
142996139|NCT00082628|515521111|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
142996140|NCT00082628|515521112|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
142996141|NCT00082628|515521113|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
142996142|NCT00082628|515521114|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
142996143|NCT00082628|515521115|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
142996144|NCT00082628|515521111|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
142996145|NCT00082628|515521112|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
142996146|NCT00082628|515521113|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
142996147|NCT00082628|515521114|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
142996148|NCT00082628|515521115|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
142996149|NCT00082628|515521111|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
142996150|NCT00082628|515521112|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
142996151|NCT00082628|515521113|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
142996152|NCT00082628|515521114|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
142996153|NCT00082628|515521115|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
142996154|NCT00082628|515521111|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
142996155|NCT00082628|515521112|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
142996156|NCT00082628|515521113|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
142996157|NCT00082628|515521114|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
142996158|NCT00082628|515521115|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
142996159|NCT00082628|515521111|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
142996160|NCT00082628|515521112|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
142996161|NCT00082628|515521113|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
142996162|NCT00082628|515521114|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
142996163|NCT00082628|515521115|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
142996164|NCT02364999|515521120|FG000|Overall Study|Death|136|||
142996165|NCT02364999|515521121|FG001|Overall Study|Death|138|||
142996166|NCT02364999|515521120|FG000|Overall Study|Lost to Follow-up|10|||
142996167|NCT02364999|515521121|FG001|Overall Study|Lost to Follow-up|15|||
142996168|NCT02364999|515521120|FG000|Overall Study|Protocol Violation|3|||
142996169|NCT02364999|515521121|FG001|Overall Study|Protocol Violation|2|||
142996170|NCT02364999|515521120|FG000|Overall Study|Withdrawal by Subject|14|||
142996171|NCT02364999|515521121|FG001|Overall Study|Withdrawal by Subject|14|||
142996172|NCT02364999|515521120|FG000|Overall Study|Other|0|||
142996173|NCT02364999|515521121|FG001|Overall Study|Other|1|||
142996174|NCT02364999|515521120|FG000|Overall Study|Randomized but did not receive treatment|2|||
142996175|NCT02364999|515521121|FG001|Overall Study|Randomized but did not receive treatment|3|||
142996176|NCT02177942|515521122|FG000|Overall Study|Adverse Event|1|||
142996177|NCT02177942|515521123|FG001|Overall Study|Adverse Event|0|||
142996178|NCT02177942|515521122|FG000|Overall Study|Lost to Follow-up|1|||
142996179|NCT02177942|515521123|FG001|Overall Study|Lost to Follow-up|1|||
142996180|NCT02177942|515521122|FG000|Overall Study|Protocol Violation|4|||
142996181|NCT02177942|515521123|FG001|Overall Study|Protocol Violation|6|||
142996182|NCT02177942|515521122|FG000|Overall Study|Withdrawal by Subject|71|||
142996183|NCT02177942|515521123|FG001|Overall Study|Withdrawal by Subject|81|||
142996184|NCT01566981|515521124|FG000|Overall Study|Lost to Follow-up|5|||
142996185|NCT01566981|515521125|FG001|Overall Study|Lost to Follow-up|8|||
142996186|NCT01351415|515521126|FG000|Overall Study|Withdrawal by Subject|15|||
142996187|NCT01351415|515521127|FG001|Overall Study|Withdrawal by Subject|17|||
142996188|NCT01351415|515521126|FG000|Overall Study|Trial termination by the Sponsor|28|||
142996189|NCT01351415|515521127|FG001|Overall Study|Trial termination by the Sponsor|19|||
142996190|NCT01351415|515521126|FG000|Overall Study|Lost to Follow-up|5|||
142996191|NCT01351415|515521127|FG001|Overall Study|Lost to Follow-up|7|||
142996192|NCT01351415|515521126|FG000|Overall Study|Death|190|||
142996193|NCT01351415|515521127|FG001|Overall Study|Death|187|||
142996194|NCT01351415|515521126|FG000|Overall Study|Physician Decision|2|||
142996195|NCT01351415|515521127|FG001|Overall Study|Physician Decision|3|||
142996196|NCT01351415|515521126|FG000|Overall Study|Reason unknown|0|||
142996197|NCT01351415|515521127|FG001|Overall Study|Reason unknown|2|||
142996198|NCT01351415|515521126|FG000|Overall Study|Never Started|5|||
142996199|NCT01351415|515521127|FG001|Overall Study|Never Started|5|||
142996200|NCT01234337|515521131|FG000|Overall Study|Adverse Event|58|||
142996201|NCT01234337|515521132|FG001|Overall Study|Adverse Event|21|||
142996202|NCT01234337|515521131|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
142996203|NCT01234337|515521132|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
142996204|NCT01234337|515521131|FG000|Overall Study|Investi. decision not protocol driven|5|||
142996205|NCT01234337|515521132|FG001|Overall Study|Investi. decision not protocol driven|6|||
142996206|NCT01234337|515521131|FG000|Overall Study|Non-compliant with study medication|3|||
142996207|NCT01234337|515521132|FG001|Overall Study|Non-compliant with study medication|2|||
142996208|NCT01234337|515521131|FG000|Overall Study|Randomized but not treated|6|||
142996209|NCT01234337|515521132|FG001|Overall Study|Randomized but not treated|4|||
142996210|NCT01234337|515521131|FG000|Overall Study|Lost to Follow-up|0|||
142996211|NCT01234337|515521132|FG001|Overall Study|Lost to Follow-up|1|||
142996212|NCT01234337|515521131|FG000|Overall Study|Protocol Violation|2|||
142996213|NCT01234337|515521132|FG001|Overall Study|Protocol Violation|3|||
142996214|NCT01234337|515521131|FG000|Overall Study|Withdrawal by Subject|11|||
142996215|NCT01234337|515521132|FG001|Overall Study|Withdrawal by Subject|9|||
142996216|NCT01234337|515521131|FG000|Overall Study|Death|0|||
142996217|NCT01234337|515521132|FG001|Overall Study|Death|1|||
142996218|NCT01234337|515521131|FG000|Overall Study|Switch to commercial drug|0|||
142996219|NCT01234337|515521132|FG001|Overall Study|Switch to commercial drug|1|||
142996220|NCT03481634|515521133|FG000|Overall Study|Withdrawal by Subject|16|||
142996221|NCT03481634|515521134|FG001|Overall Study|Withdrawal by Subject|19|||
142996222|NCT03481634|515521135|FG002|Overall Study|Withdrawal by Subject|14|||
142996223|NCT03481634|515521133|FG000|Overall Study|Protocol Violation|1|||
142996224|NCT03481634|515521134|FG001|Overall Study|Protocol Violation|0|||
142996225|NCT03481634|515521135|FG002|Overall Study|Protocol Violation|1|||
142996226|NCT03481634|515521133|FG000|Overall Study|Progressive disease|0|||
142996227|NCT03481634|515521134|FG001|Overall Study|Progressive disease|1|||
142996228|NCT03481634|515521135|FG002|Overall Study|Progressive disease|0|||
142996229|NCT03481634|515521133|FG000|Overall Study|Physician Decision|3|||
142996230|NCT03481634|515521134|FG001|Overall Study|Physician Decision|0|||
142996231|NCT03481634|515521135|FG002|Overall Study|Physician Decision|1|||
142996232|NCT03481634|515521133|FG000|Overall Study|Lost to Follow-up|3|||
142996233|NCT03481634|515521134|FG001|Overall Study|Lost to Follow-up|4|||
142996234|NCT03481634|515521135|FG002|Overall Study|Lost to Follow-up|4|||
142996235|NCT03481634|515521133|FG000|Overall Study|Death|4|||
142996236|NCT03481634|515521134|FG001|Overall Study|Death|8|||
142996237|NCT03481634|515521135|FG002|Overall Study|Death|7|||
142996238|NCT03481634|515521133|FG000|Overall Study|Adverse Event|6|||
142996239|NCT03481634|515521134|FG001|Overall Study|Adverse Event|3|||
142996240|NCT03481634|515521135|FG002|Overall Study|Adverse Event|7|||
142996241|NCT03490734|515521140|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
142996242|NCT03490734|515521141|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
142996243|NCT03490734|515521142|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
142996244|NCT03490734|515521143|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
142996245|NCT03490734|515521140|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
142996246|NCT03490734|515521141|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
142996247|NCT03490734|515521142|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
142996248|NCT03490734|515521143|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
142996249|NCT03490734|515521140|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
142996250|NCT03490734|515521141|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
142996251|NCT03490734|515521142|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
142996252|NCT03490734|515521143|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
142996253|NCT03490734|515521140|FG000|Post-intervention Scan Visit|Adverse Event|2|||
142996254|NCT03490734|515521141|FG001|Post-intervention Scan Visit|Adverse Event|0|||
142996255|NCT03490734|515521142|FG002|Post-intervention Scan Visit|Adverse Event|0|||
142996256|NCT03490734|515521143|FG003|Post-intervention Scan Visit|Adverse Event|0|||
142996257|NCT03490734|515521140|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
142996258|NCT03490734|515521141|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
142996259|NCT03490734|515521142|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
142996260|NCT03490734|515521143|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
142996261|NCT03490734|515521140|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
142996262|NCT03490734|515521141|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
142996263|NCT03490734|515521142|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
142996264|NCT03490734|515521143|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
142996265|NCT00994890|515521149|FG000|Overall Study|Adverse Event|13|||
142996266|NCT00994890|515521150|FG001|Overall Study|Adverse Event|9|||
142996267|NCT00994890|515521151|FG002|Overall Study|Adverse Event|11|||
142996268|NCT00994890|515521149|FG000|Overall Study|Lack of Efficacy|0|||
142996269|NCT00994890|515521150|FG001|Overall Study|Lack of Efficacy|0|||
142996270|NCT00994890|515521151|FG002|Overall Study|Lack of Efficacy|1|||
142996271|NCT00994890|515521149|FG000|Overall Study|Lost to Follow-up|6|||
142996272|NCT00994890|515521150|FG001|Overall Study|Lost to Follow-up|1|||
142996273|NCT00994890|515521151|FG002|Overall Study|Lost to Follow-up|3|||
142996274|NCT00994890|515521149|FG000|Overall Study|No longer willing to participate|8|||
142996275|NCT00994890|515521150|FG001|Overall Study|No longer willing to participate|5|||
142996276|NCT00994890|515521151|FG002|Overall Study|No longer willing to participate|13|||
142996277|NCT00994890|515521149|FG000|Overall Study|Protocol Violation|2|||
142996278|NCT00994890|515521150|FG001|Overall Study|Protocol Violation|4|||
142996279|NCT00994890|515521151|FG002|Overall Study|Protocol Violation|0|||
142996280|NCT00994890|515521149|FG000|Overall Study|Study terminated by sponsor|199|||
142996281|NCT00994890|515521150|FG001|Overall Study|Study terminated by sponsor|201|||
142996282|NCT00994890|515521151|FG002|Overall Study|Study terminated by sponsor|197|||
142996283|NCT00994890|515521149|FG000|Overall Study|Randomized, but not treated|1|||
142996284|NCT00994890|515521150|FG001|Overall Study|Randomized, but not treated|0|||
142996285|NCT00994890|515521151|FG002|Overall Study|Randomized, but not treated|0|||
142996286|NCT00994890|515521149|FG000|Overall Study|Other|2|||
142996287|NCT00994890|515521150|FG001|Overall Study|Other|2|||
142996288|NCT00994890|515521151|FG002|Overall Study|Other|1|||
142996289|NCT03323385|515521156|FG000|Overall Study|Withdrawal by Subject|1|||
142996290|NCT03323385|515521157|FG001|Overall Study|Withdrawal by Subject|2|||
142996291|NCT03323385|515521156|FG000|Overall Study|Noncompliance|0|||
142996292|NCT03323385|515521157|FG001|Overall Study|Noncompliance|1|||
142996293|NCT01849289|515521158|FG000|Overall Study|Adverse Event|3|||
142996294|NCT01849289|515521159|FG001|Overall Study|Adverse Event|3|||
142996295|NCT01849289|515521158|FG000|Overall Study|Protocol Violation|3|||
142996296|NCT01849289|515521159|FG001|Overall Study|Protocol Violation|3|||
142996297|NCT01849289|515521158|FG000|Overall Study|Withdrawal criteria|1|||
142996298|NCT01849289|515521159|FG001|Overall Study|Withdrawal criteria|0|||
142996299|NCT01849289|515521158|FG000|Overall Study|Unclassified|25|||
142996300|NCT01849289|515521159|FG001|Overall Study|Unclassified|18|||
142996301|NCT00352027|515521160|FG000|Overall Study|Progressive disease|3|||
142996302|NCT04491591|515521162|FG000|Overall Study|Accidently randomized|3|||
142996303|NCT04491591|515521163|FG001|Overall Study|Accidently randomized|1|||
142996304|NCT04491591|515521164|FG002|Overall Study|Accidently randomized|0|||
142996305|NCT04491591|515521162|FG000|Overall Study|Did not complete survey|28|||
142996306|NCT04491591|515521163|FG001|Overall Study|Did not complete survey|20|||
142996307|NCT04491591|515521164|FG002|Overall Study|Did not complete survey|3|||
142996308|NCT00660816|515521167|FG000|Overall Study|Adverse Event|1|||
142996309|NCT00660816|515521168|FG001|Overall Study|Adverse Event|2|||
142996310|NCT00660816|515521167|FG000|Overall Study|Withdrawal by Subject|1|||
142996311|NCT00660816|515521168|FG001|Overall Study|Withdrawal by Subject|0|||
142996312|NCT00660816|515521167|FG000|Overall Study|Death|0|||
142996313|NCT00660816|515521168|FG001|Overall Study|Death|2|||
142996314|NCT00660816|515521167|FG000|Overall Study|Lack of Efficacy|1|||
142996315|NCT00660816|515521168|FG001|Overall Study|Lack of Efficacy|0|||
142996316|NCT00660816|515521167|FG000|Overall Study|Physician Decision|0|||
142996317|NCT00660816|515521168|FG001|Overall Study|Physician Decision|2|||
142996318|NCT00660816|515521167|FG000|Overall Study|Protocol Violation|1|||
142996319|NCT00660816|515521168|FG001|Overall Study|Protocol Violation|0|||
142996320|NCT00660816|515521167|FG000|Overall Study|Disease Progression|16|||
142996321|NCT00660816|515521168|FG001|Overall Study|Disease Progression|12|||
142996322|NCT00660816|515521167|FG000|Overall Study|Complicating Disease|0|||
142996323|NCT00660816|515521168|FG001|Overall Study|Complicating Disease|1|||
142996324|NCT00715949|515521172|FG000|Overall Study|could not finish first test|4|||
142996325|NCT00420212|515521173|FG000|Overall Study|Adverse Event|22|||
142996326|NCT00420212|515521174|FG001|Overall Study|Adverse Event|40|||
142996327|NCT00420212|515521175|FG002|Overall Study|Adverse Event|36|||
142996328|NCT00420212|515521173|FG000|Overall Study|Lost to Follow-up|9|||
142996329|NCT00420212|515521174|FG001|Overall Study|Lost to Follow-up|11|||
142996330|NCT00420212|515521175|FG002|Overall Study|Lost to Follow-up|11|||
142996331|NCT00420212|515521173|FG000|Overall Study|Withdrawal by Subject|31|||
142996332|NCT00420212|515521174|FG001|Overall Study|Withdrawal by Subject|22|||
142996333|NCT00420212|515521175|FG002|Overall Study|Withdrawal by Subject|19|||
142996334|NCT00420212|515521173|FG000|Overall Study|Physician Decision|4|||
142996335|NCT00420212|515521174|FG001|Overall Study|Physician Decision|4|||
142996336|NCT00420212|515521175|FG002|Overall Study|Physician Decision|3|||
142996337|NCT00420212|515521173|FG000|Overall Study|Protocol Violation|4|||
142996338|NCT00420212|515521174|FG001|Overall Study|Protocol Violation|4|||
142996339|NCT00420212|515521175|FG002|Overall Study|Protocol Violation|8|||
142996340|NCT00420212|515521173|FG000|Overall Study|Death|0|||
142996341|NCT00420212|515521174|FG001|Overall Study|Death|0|||
142996342|NCT00420212|515521175|FG002|Overall Study|Death|1|||
142996343|NCT00420212|515521173|FG000|Overall Study|Other-Unspecified|21|||
142996344|NCT00420212|515521174|FG001|Overall Study|Other-Unspecified|14|||
142996345|NCT00420212|515521175|FG002|Overall Study|Other-Unspecified|18|||
142996346|NCT02274766|515521178|FG000|Overall Study|Withdrawal by Subject|3|||
142996347|NCT02274766|515521179|FG001|Overall Study|Withdrawal by Subject|6|||
142996348|NCT02274766|515521178|FG000|Overall Study|Did Not Receive Study Drug|1|||
142996349|NCT02274766|515521179|FG001|Overall Study|Did Not Receive Study Drug|1|||
142996350|NCT02274766|515521178|FG000|Overall Study|Subject Unwilling to Proceed|0|||
142996351|NCT02274766|515521179|FG001|Overall Study|Subject Unwilling to Proceed|1|||
142996352|NCT02274766|515521178|FG000|Overall Study|Adverse Event|0|||
142996353|NCT02274766|515521179|FG001|Overall Study|Adverse Event|1|||
142996354|NCT00742391|515521184|FG000|Overall Study|Adverse Event|2|||
142996355|NCT00742391|515521185|FG001|Overall Study|Adverse Event|1|||
142996356|NCT00742391|515521184|FG000|Overall Study|Lost to Follow-up|1|||
142996357|NCT00742391|515521185|FG001|Overall Study|Lost to Follow-up|0|||
142996358|NCT00742391|515521184|FG000|Overall Study|Protocol Violation|1|||
142996359|NCT00742391|515521185|FG001|Overall Study|Protocol Violation|0|||
142996360|NCT01058356|515521191|FG000|Overall Study|Adverse Event|5|||
142996361|NCT01058356|515521191|FG000|Overall Study|Administration of contraindicated drugs|12|||
142996362|NCT01058356|515521191|FG000|Overall Study|Withdrawal by Subject|21|||
142996363|NCT01058356|515521191|FG000|Overall Study|Lost to Follow-up|4|||
142996364|NCT01084096|515523250|FG000|Overall Study|Lost to Follow-up|1501|||
142996365|NCT01084096|515523251|FG001|Overall Study|Lost to Follow-up|1833|||
142996366|NCT01084096|515523250|FG000|Overall Study|Withdrawal by Subject|3|||
142996367|NCT01084096|515523251|FG001|Overall Study|Withdrawal by Subject|0|||
142996368|NCT01084096|515523250|FG000|Overall Study|Woman had a miscarriage|21|||
142996369|NCT01084096|515523251|FG001|Overall Study|Woman had a miscarriage|17|||
142996370|NCT02033369|515523252|FG000|Overall Study|Physician Decision|1|||
142996371|NCT02033369|515523253|FG001|Overall Study|Physician Decision|2|||
142996372|NCT02033369|515523252|FG000|Overall Study|Not a good demographic match|0|||
142996373|NCT02033369|515523253|FG001|Overall Study|Not a good demographic match|2|||
142996374|NCT02033369|515523252|FG000|Overall Study|Withdrawal by Subject|1|||
142996375|NCT02033369|515523253|FG001|Overall Study|Withdrawal by Subject|1|||
142996376|NCT02033369|515523252|FG000|Overall Study|Lost to Follow-up|1|||
142996377|NCT02033369|515523253|FG001|Overall Study|Lost to Follow-up|0|||
142996378|NCT02033369|515523252|FG000|Overall Study|Protocol Violation|2|||
142996379|NCT02033369|515523253|FG001|Overall Study|Protocol Violation|0|||
142996380|NCT01503229|515523254|FG000|Overall Study|Withdrew consent|1|||
142996381|NCT01354964|515523255|FG000|Overall Study|Lost to Follow-up|2|||
142996382|NCT01354964|515523256|FG001|Overall Study|Lost to Follow-up|0|||
142996383|NCT01354964|515523255|FG000|Overall Study|IV access issues|1|||
142996384|NCT01354964|515523256|FG001|Overall Study|IV access issues|1|||
142996385|NCT01354964|515523255|FG000|Overall Study|Physician Decision|1|||
142996386|NCT01354964|515523256|FG001|Overall Study|Physician Decision|0|||
142996387|NCT02534324|515523257|FG000|Overall Study|Protocol Violation|4|||
142996388|NCT02534324|515523258|FG001|Overall Study|Protocol Violation|1|||
142996389|NCT02534324|515523257|FG000|Overall Study|Lost to Follow-up|20|||
142996390|NCT02534324|515523258|FG001|Overall Study|Lost to Follow-up|7|||
142996391|NCT02534324|515523257|FG000|Overall Study|Adverse Event|1|||
142996392|NCT02534324|515523258|FG001|Overall Study|Adverse Event|0|||
142996393|NCT05604781|515523259|FG000|Overall Study|Lost to Follow-up|3|||
142996394|NCT05604781|515523259|FG000|Overall Study|Adverse Event|1|||
142996395|NCT03890731|515523260|FG000|Overall Study|Progressive disease|1|||
142996396|NCT03890731|515523260|FG000|Overall Study|Patient's decision|1|||
142996397|NCT03890731|515523260|FG000|Overall Study|Adverse Event|4|||
142996398|NCT02643420|515523272|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
142996399|NCT02643420|515523273|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
142996400|NCT02643420|515523272|FG000|Overall Study|Withdrawal by Subject|25|||
142996401|NCT02643420|515523273|FG001|Overall Study|Withdrawal by Subject|19|||
142996402|NCT02643420|515523272|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
142996403|NCT02643420|515523273|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
142996404|NCT02643420|515523272|FG000|Overall Study|Lost to Follow-up|6|||
142996405|NCT02643420|515523273|FG001|Overall Study|Lost to Follow-up|10|||
142996406|NCT02643420|515523272|FG000|Overall Study|Investigator Decision|2|||
142996407|NCT02643420|515523273|FG001|Overall Study|Investigator Decision|4|||
142996408|NCT02643420|515523272|FG000|Overall Study|Sponsor decision|1|||
142996409|NCT02643420|515523273|FG001|Overall Study|Sponsor decision|1|||
142996410|NCT02643420|515523272|FG000|Overall Study|Death|0|||
142996411|NCT02643420|515523273|FG001|Overall Study|Death|2|||
142996412|NCT02643420|515523272|FG000|Overall Study|Reason not Specified|8|||
142996413|NCT02643420|515523273|FG001|Overall Study|Reason not Specified|7|||
142996414|NCT02127970|515523274|FG000|Overall Study|Adverse Event|2|||
142996415|NCT02127970|515523275|FG001|Overall Study|Adverse Event|1|||
142996416|NCT02127970|515523274|FG000|Overall Study|Death|1|||
142996417|NCT02127970|515523275|FG001|Overall Study|Death|1|||
142996418|NCT02127970|515523274|FG000|Overall Study|Lost to Follow-up|14|||
142996419|NCT02127970|515523275|FG001|Overall Study|Lost to Follow-up|14|||
143003187|NCT01049360|515548759|FG015|Period 2|Lack of Efficacy|0|||
142996420|NCT02127970|515523274|FG000|Overall Study|Reason not Specified|4|||
142996421|NCT02127970|515523275|FG001|Overall Study|Reason not Specified|7|||
142996422|NCT02127970|515523274|FG000|Overall Study|Pregnancy|0|||
142996423|NCT02127970|515523275|FG001|Overall Study|Pregnancy|1|||
142996424|NCT02127970|515523274|FG000|Overall Study|Subject Withdrew Consent|5|||
142996425|NCT02127970|515523275|FG001|Overall Study|Subject Withdrew Consent|3|||
142996426|NCT01710709|515523276|FG000|Overall Study|Lost to Follow-up|29|||
142996427|NCT01710709|515523276|FG000|Overall Study|Adverse Event|48|||
142996428|NCT01710709|515523276|FG000|Overall Study|Participant met withdrawal criteria|33|||
142996429|NCT01710709|515523276|FG000|Overall Study|Participant withdrawn by investigator|2|||
142996430|NCT01710709|515523276|FG000|Overall Study|Withdrawal by Subject|53|||
142996431|NCT01710709|515523276|FG000|Overall Study|Protocol Violation|5|||
142996432|NCT01710709|515523276|FG000|Overall Study|Lack of Efficacy|3|||
142996433|NCT00542321|515523278|FG000|Overall Study|Death|0|||
142996434|NCT00542321|515523279|FG001|Overall Study|Death|1|||
142996435|NCT02988115|515523284|FG000|Overall Study|Adverse Event|6|||
142996436|NCT02988115|515523285|FG001|Overall Study|Adverse Event|1|||
142996437|NCT02988115|515523284|FG000|Overall Study|Sponsor Decision|5|||
142996438|NCT02988115|515523285|FG001|Overall Study|Sponsor Decision|2|||
142996439|NCT02988115|515523284|FG000|Overall Study|Withdrawal by Subject|1|||
142996440|NCT02988115|515523285|FG001|Overall Study|Withdrawal by Subject|1|||
142996441|NCT02988115|515523284|FG000|Overall Study|Withdrawn by Mistake|1|||
142996442|NCT02988115|515523285|FG001|Overall Study|Withdrawn by Mistake|0|||
142996443|NCT02988115|515523284|FG000|Overall Study|Lost to Follow-up|1|||
142996444|NCT02988115|515523285|FG001|Overall Study|Lost to Follow-up|0|||
142996445|NCT00125138|515523286|FG000|Overall Study|Adverse Event|1|||
142996446|NCT00125138|515523287|FG001|Overall Study|Adverse Event|0|||
142996447|NCT00125138|515523288|FG002|Overall Study|Adverse Event|3|||
142996448|NCT00125138|515523289|FG003|Overall Study|Adverse Event|2|||
142996449|NCT00125138|515523286|FG000|Overall Study|Withdrawal by Subject|2|||
142996450|NCT00125138|515523287|FG001|Overall Study|Withdrawal by Subject|3|||
142996451|NCT00125138|515523288|FG002|Overall Study|Withdrawal by Subject|1|||
142996452|NCT00125138|515523289|FG003|Overall Study|Withdrawal by Subject|1|||
142996453|NCT00125138|515523286|FG000|Overall Study|Lack of Efficacy|0|||
142996454|NCT00125138|515523287|FG001|Overall Study|Lack of Efficacy|0|||
142996455|NCT00125138|515523288|FG002|Overall Study|Lack of Efficacy|0|||
142996456|NCT00125138|515523289|FG003|Overall Study|Lack of Efficacy|1|||
142996457|NCT00125138|515523286|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
142996458|NCT00125138|515523287|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
142996459|NCT00125138|515523288|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
142996460|NCT00125138|515523289|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
142996461|NCT00405756|515523290|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
142996462|NCT00405756|515523291|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
142996463|NCT00405756|515523292|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
142996464|NCT00405756|515523290|FG000|Double-blind Treatment|Adverse Event|31|||
142996465|NCT00405756|515523291|FG001|Double-blind Treatment|Adverse Event|27|||
142996466|NCT00405756|515523292|FG002|Double-blind Treatment|Adverse Event|12|||
142996467|NCT00405756|515523290|FG000|Double-blind Treatment|Disease Progression|47|||
142996468|NCT00405756|515523291|FG001|Double-blind Treatment|Disease Progression|81|||
142996469|NCT00405756|515523292|FG002|Double-blind Treatment|Disease Progression|102|||
142996470|NCT00405756|515523290|FG000|Double-blind Treatment|Lack of Efficacy|1|||
142996471|NCT00405756|515523291|FG001|Double-blind Treatment|Lack of Efficacy|4|||
142996472|NCT00405756|515523292|FG002|Double-blind Treatment|Lack of Efficacy|2|||
142996473|NCT00405756|515523290|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
142996474|NCT00405756|515523291|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
142996475|NCT00405756|515523292|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
142996476|NCT00405756|515523290|FG000|Double-blind Treatment|Lost to Follow-up|1|||
142996477|NCT00405756|515523291|FG001|Double-blind Treatment|Lost to Follow-up|0|||
142996478|NCT00405756|515523292|FG002|Double-blind Treatment|Lost to Follow-up|0|||
142996479|NCT00405756|515523290|FG000|Double-blind Treatment|Death|4|||
142996480|NCT00405756|515523291|FG001|Double-blind Treatment|Death|4|||
142996481|NCT00405756|515523292|FG002|Double-blind Treatment|Death|4|||
142996482|NCT00405756|515523290|FG000|Double-blind Treatment|Protocol Violation|1|||
142996483|NCT00405756|515523291|FG001|Double-blind Treatment|Protocol Violation|0|||
142996484|NCT00405756|515523292|FG002|Double-blind Treatment|Protocol Violation|2|||
142996485|NCT00405756|515523290|FG000|Double-blind Treatment|Other|7|||
142996486|NCT00405756|515523291|FG001|Double-blind Treatment|Other|4|||
142996487|NCT00405756|515523292|FG002|Double-blind Treatment|Other|4|||
142996488|NCT00405756|515523290|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
142996489|NCT00405756|515523291|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
142996490|NCT00405756|515523292|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
142996491|NCT00405756|515523290|FG000|Open-label Extension|Adverse Event|1|||
142996492|NCT00405756|515523291|FG001|Open-label Extension|Adverse Event|3|||
142996493|NCT00405756|515523292|FG002|Open-label Extension|Adverse Event|7|||
142996494|NCT00405756|515523290|FG000|Open-label Extension|Disease Progression|8|||
142996495|NCT00405756|515523291|FG001|Open-label Extension|Disease Progression|23|||
142996496|NCT00405756|515523292|FG002|Open-label Extension|Disease Progression|26|||
142996497|NCT00405756|515523290|FG000|Open-label Extension|Withdrawal by Subject|2|||
142996498|NCT00405756|515523291|FG001|Open-label Extension|Withdrawal by Subject|3|||
142996499|NCT00405756|515523292|FG002|Open-label Extension|Withdrawal by Subject|3|||
142996500|NCT00405756|515523290|FG000|Open-label Extension|Death|1|||
142996501|NCT00405756|515523291|FG001|Open-label Extension|Death|2|||
142996502|NCT00405756|515523292|FG002|Open-label Extension|Death|4|||
142996503|NCT00405756|515523290|FG000|Open-label Extension|Other|0|||
142996504|NCT00405756|515523291|FG001|Open-label Extension|Other|1|||
142996505|NCT00405756|515523292|FG002|Open-label Extension|Other|7|||
142996506|NCT00405756|515523290|FG000|Follow-up|Ongoing in Follow-up Period|52|||
142996507|NCT00405756|515523291|FG001|Follow-up|Ongoing in Follow-up Period|51|||
142996508|NCT00405756|515523292|FG002|Follow-up|Ongoing in Follow-up Period|60|||
142996509|NCT00405756|515523290|FG000|Follow-up|Death|21|||
142996510|NCT00405756|515523291|FG001|Follow-up|Death|31|||
142996511|NCT00405756|515523292|FG002|Follow-up|Death|24|||
142996512|NCT00405756|515523290|FG000|Follow-up|Lost to Follow-up|2|||
142996513|NCT00405756|515523291|FG001|Follow-up|Lost to Follow-up|8|||
142996514|NCT00405756|515523292|FG002|Follow-up|Lost to Follow-up|4|||
142996515|NCT01957111|515523295|FG000|Overall Study|Withdrawal by Subject|1|||
142996516|NCT01957111|515523296|FG001|Overall Study|Withdrawal by Subject|1|||
142996517|NCT00699582|515523301|FG000|Overall Study|Adverse Event|4|||
142996518|NCT00699582|515523302|FG001|Overall Study|Adverse Event|11|||
142996519|NCT00699582|515523303|FG002|Overall Study|Adverse Event|23|||
142996520|NCT00699582|515523301|FG000|Overall Study|Withdrawal by Subject|6|||
142996521|NCT00699582|515523302|FG001|Overall Study|Withdrawal by Subject|7|||
142996522|NCT00699582|515523303|FG002|Overall Study|Withdrawal by Subject|4|||
142996523|NCT00699582|515523301|FG000|Overall Study|Lack of Efficacy|1|||
142996524|NCT00699582|515523302|FG001|Overall Study|Lack of Efficacy|0|||
142996525|NCT00699582|515523303|FG002|Overall Study|Lack of Efficacy|1|||
142996526|NCT00699582|515523301|FG000|Overall Study|Progressive Disease|1|||
142996527|NCT00699582|515523302|FG001|Overall Study|Progressive Disease|0|||
142996528|NCT00699582|515523303|FG002|Overall Study|Progressive Disease|0|||
142996529|NCT00699582|515523301|FG000|Overall Study|Administrative/Other|4|||
142996530|NCT00699582|515523302|FG001|Overall Study|Administrative/Other|3|||
142996531|NCT00699582|515523303|FG002|Overall Study|Administrative/Other|0|||
142996532|NCT00699582|515523301|FG000|Overall Study|Randomized, Not Treated|2|||
142996533|NCT00699582|515523302|FG001|Overall Study|Randomized, Not Treated|1|||
142996534|NCT00699582|515523303|FG002|Overall Study|Randomized, Not Treated|0|||
142996535|NCT03099304|515523309|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
142996536|NCT03099304|515523310|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
142996537|NCT03099304|515523311|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
142996538|NCT03099304|515523312|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
142996539|NCT03099304|515523313|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
142996540|NCT03099304|515523314|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
142996541|NCT03099304|515523309|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
142996542|NCT03099304|515523310|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
142996543|NCT03099304|515523311|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
142996544|NCT03099304|515523312|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
142996545|NCT03099304|515523313|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
142996546|NCT03099304|515523314|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
142996547|NCT03099304|515523309|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
142996548|NCT03099304|515523310|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
142996549|NCT03099304|515523311|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
142996550|NCT03099304|515523312|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
142996551|NCT03099304|515523313|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
142996552|NCT03099304|515523314|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
142996553|NCT03099304|515523309|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
142996554|NCT03099304|515523310|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
142996555|NCT03099304|515523311|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
142996556|NCT03099304|515523312|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
142996557|NCT03099304|515523313|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
142996558|NCT03099304|515523314|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
142996559|NCT03099304|515523309|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
142996560|NCT03099304|515523310|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
142996561|NCT03099304|515523311|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
142996562|NCT03099304|515523312|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
142996563|NCT03099304|515523313|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
142996564|NCT03099304|515523314|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
142996565|NCT03099304|515523309|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
142996566|NCT03099304|515523310|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
142996567|NCT03099304|515523311|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
142996568|NCT03099304|515523312|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
142996569|NCT03099304|515523313|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
142996570|NCT03099304|515523314|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
142996571|NCT03099304|515523309|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
142996572|NCT03099304|515523310|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
142996573|NCT03099304|515523311|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
142996574|NCT03099304|515523312|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
142996575|NCT03099304|515523313|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
142996576|NCT03099304|515523314|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
142996577|NCT03099304|515523309|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
142996578|NCT03099304|515523310|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
142996579|NCT03099304|515523311|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
142996580|NCT03099304|515523312|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
142996581|NCT03099304|515523313|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
142996582|NCT03099304|515523314|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
142996583|NCT03099304|515523309|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
142996584|NCT03099304|515523310|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
142996585|NCT03099304|515523311|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
142996586|NCT03099304|515523312|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
142996587|NCT03099304|515523313|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
142996588|NCT03099304|515523314|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
142996589|NCT03099304|515523309|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
142996590|NCT03099304|515523310|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
142996591|NCT03099304|515523311|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
142996592|NCT03099304|515523312|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
142996593|NCT03099304|515523313|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
142996594|NCT03099304|515523314|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
142996595|NCT03099304|515523309|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
142996596|NCT03099304|515523310|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
142996597|NCT03099304|515523311|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
142996598|NCT03099304|515523312|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
142996599|NCT03099304|515523313|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
142996600|NCT03099304|515523314|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
142996601|NCT03099304|515523309|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
142996602|NCT03099304|515523310|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
142996603|NCT03099304|515523311|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
142996604|NCT03099304|515523312|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
142996605|NCT03099304|515523313|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
142996606|NCT03099304|515523314|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
142996607|NCT03099304|515523309|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
142996608|NCT03099304|515523310|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
142996609|NCT03099304|515523311|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
142996610|NCT03099304|515523312|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
142996611|NCT03099304|515523313|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
142996612|NCT03099304|515523314|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
142996613|NCT03099304|515523309|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
142996614|NCT03099304|515523310|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
142996615|NCT03099304|515523311|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
142996616|NCT03099304|515523312|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
142996617|NCT03099304|515523313|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
142996618|NCT03099304|515523314|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
142996619|NCT03099304|515523309|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
142996620|NCT03099304|515523310|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
142996621|NCT03099304|515523311|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
142996622|NCT03099304|515523312|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
142996623|NCT03099304|515523313|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
142996624|NCT03099304|515523314|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
142996625|NCT03099304|515523309|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
142996626|NCT03099304|515523310|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
142996627|NCT03099304|515523311|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
142996628|NCT03099304|515523312|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
142996629|NCT03099304|515523313|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
142996630|NCT03099304|515523314|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
142996631|NCT03099304|515523309|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
142996632|NCT03099304|515523310|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
142996633|NCT03099304|515523311|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
142996634|NCT03099304|515523312|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
142996635|NCT03099304|515523313|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
142996636|NCT03099304|515523314|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
143455738|NCT00438672|517212518|FG000|Overall Study|Lost to Follow-up|7|||
142996637|NCT02692560|515523315|FG000|Overall Study|Withdrawal by Subject|0|||
142996638|NCT02692560|515523316|FG001|Overall Study|Withdrawal by Subject|6|||
142996639|NCT01326910|515523319|FG000|Overall Study|Withdrawal by Subject|3|||
142996640|NCT01326910|515523320|FG001|Overall Study|Withdrawal by Subject|2|||
142996641|NCT01326910|515523319|FG000|Overall Study|Protocol Violation|1|||
142996642|NCT01326910|515523320|FG001|Overall Study|Protocol Violation|1|||
142996643|NCT03147495|515523321|FG000|Overall Study|Physician Decision|0|||
142996644|NCT03147495|515523322|FG001|Overall Study|Physician Decision|6|||
142996645|NCT02607735|515523323|FG000|Primary Study|Randomized but Never Treated|1|||
142996646|NCT02607735|515523324|FG001|Primary Study|Randomized but Never Treated|0|||
142996647|NCT02607735|515523325|FG002|Primary Study|Randomized but Never Treated|0|||
142996648|NCT02607735|515523323|FG000|Primary Study|Lost to Follow-up|4|||
142996649|NCT02607735|515523324|FG001|Primary Study|Lost to Follow-up|0|||
142996650|NCT02607735|515523325|FG002|Primary Study|Lost to Follow-up|0|||
142996651|NCT02607735|515523323|FG000|Primary Study|Withdrew Consent|2|||
142996652|NCT02607735|515523324|FG001|Primary Study|Withdrew Consent|0|||
142996653|NCT02607735|515523325|FG002|Primary Study|Withdrew Consent|0|||
142996654|NCT02607735|515523323|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
142996655|NCT02607735|515523324|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
142996656|NCT02607735|515523325|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
142996657|NCT02607735|515523323|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
142996658|NCT02607735|515523324|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
142996659|NCT02607735|515523325|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
142996660|NCT01681836|515523328|FG000|Second Intervention|Withdrawal by Subject|0|||
142996661|NCT01681836|515523329|FG001|Second Intervention|Withdrawal by Subject|1|||
142996662|NCT02394028|515523330|FG000|Induction Phase|Adverse Event|2|||
142996663|NCT02394028|515523331|FG001|Induction Phase|Adverse Event|4|||
142996664|NCT02394028|515523332|FG002|Induction Phase|Adverse Event|1|||
142996665|NCT02394028|515523333|FG003|Induction Phase|Adverse Event|2|||
142996666|NCT02394028|515523334|FG004|Induction Phase|Adverse Event|5|||
142996667|NCT02394028|515523335|FG005|Induction Phase|Adverse Event|2|||
142996668|NCT02394028|515523336|FG006|Induction Phase|Adverse Event|0|||
142996669|NCT02394028|515523337|FG007|Induction Phase|Adverse Event|0|||
142996670|NCT02394028|515523338|FG008|Induction Phase|Adverse Event|0|||
142996671|NCT02394028|515523339|FG009|Induction Phase|Adverse Event|0|||
142996672|NCT02394028|515523340|FG010|Induction Phase|Adverse Event|0|||
142996673|NCT02394028|515523330|FG000|Induction Phase|Lack of Efficacy|3|||
142996674|NCT02394028|515523331|FG001|Induction Phase|Lack of Efficacy|6|||
142996675|NCT02394028|515523332|FG002|Induction Phase|Lack of Efficacy|2|||
142996676|NCT02394028|515523333|FG003|Induction Phase|Lack of Efficacy|17|||
142996677|NCT02394028|515523334|FG004|Induction Phase|Lack of Efficacy|14|||
142996678|NCT02394028|515523335|FG005|Induction Phase|Lack of Efficacy|8|||
142996679|NCT02394028|515523336|FG006|Induction Phase|Lack of Efficacy|17|||
142996680|NCT02394028|515523337|FG007|Induction Phase|Lack of Efficacy|23|||
142996681|NCT02394028|515523338|FG008|Induction Phase|Lack of Efficacy|0|||
142996682|NCT02394028|515523339|FG009|Induction Phase|Lack of Efficacy|0|||
142996683|NCT02394028|515523340|FG010|Induction Phase|Lack of Efficacy|0|||
142996684|NCT02394028|515523330|FG000|Induction Phase|Lost to Follow-up|1|||
142996685|NCT02394028|515523331|FG001|Induction Phase|Lost to Follow-up|0|||
142996686|NCT02394028|515523332|FG002|Induction Phase|Lost to Follow-up|0|||
142996687|NCT02394028|515523333|FG003|Induction Phase|Lost to Follow-up|1|||
142996688|NCT02394028|515523334|FG004|Induction Phase|Lost to Follow-up|0|||
142996689|NCT02394028|515523335|FG005|Induction Phase|Lost to Follow-up|0|||
142996690|NCT02394028|515523336|FG006|Induction Phase|Lost to Follow-up|1|||
142996691|NCT02394028|515523337|FG007|Induction Phase|Lost to Follow-up|0|||
142996692|NCT02394028|515523338|FG008|Induction Phase|Lost to Follow-up|0|||
142996693|NCT02394028|515523339|FG009|Induction Phase|Lost to Follow-up|0|||
142996694|NCT02394028|515523340|FG010|Induction Phase|Lost to Follow-up|0|||
142996695|NCT02394028|515523330|FG000|Induction Phase|Non-compliance|0|||
142996696|NCT02394028|515523331|FG001|Induction Phase|Non-compliance|1|||
142996697|NCT02394028|515523332|FG002|Induction Phase|Non-compliance|3|||
142996698|NCT02394028|515523333|FG003|Induction Phase|Non-compliance|1|||
142996699|NCT02394028|515523334|FG004|Induction Phase|Non-compliance|3|||
142996700|NCT02394028|515523335|FG005|Induction Phase|Non-compliance|0|||
142996701|NCT02394028|515523336|FG006|Induction Phase|Non-compliance|1|||
142996702|NCT02394028|515523337|FG007|Induction Phase|Non-compliance|1|||
142996703|NCT02394028|515523338|FG008|Induction Phase|Non-compliance|0|||
142996704|NCT02394028|515523339|FG009|Induction Phase|Non-compliance|0|||
142996705|NCT02394028|515523340|FG010|Induction Phase|Non-compliance|0|||
142996706|NCT02394028|515523330|FG000|Induction Phase|Physician Decision|0|||
142996707|NCT02394028|515523331|FG001|Induction Phase|Physician Decision|0|||
142996708|NCT02394028|515523332|FG002|Induction Phase|Physician Decision|1|||
142996709|NCT02394028|515523333|FG003|Induction Phase|Physician Decision|4|||
142996710|NCT02394028|515523334|FG004|Induction Phase|Physician Decision|0|||
142996711|NCT02394028|515523335|FG005|Induction Phase|Physician Decision|2|||
142996712|NCT02394028|515523336|FG006|Induction Phase|Physician Decision|1|||
142996713|NCT02394028|515523337|FG007|Induction Phase|Physician Decision|0|||
142996714|NCT02394028|515523338|FG008|Induction Phase|Physician Decision|0|||
143003188|NCT01049360|515548760|FG016|Period 2|Lack of Efficacy|0|||
142996715|NCT02394028|515523339|FG009|Induction Phase|Physician Decision|0|||
142996716|NCT02394028|515523340|FG010|Induction Phase|Physician Decision|0|||
142996717|NCT02394028|515523330|FG000|Induction Phase|Protocol Violation|0|||
142996718|NCT02394028|515523331|FG001|Induction Phase|Protocol Violation|2|||
142996719|NCT02394028|515523332|FG002|Induction Phase|Protocol Violation|0|||
142996720|NCT02394028|515523333|FG003|Induction Phase|Protocol Violation|3|||
142996721|NCT02394028|515523334|FG004|Induction Phase|Protocol Violation|0|||
142996722|NCT02394028|515523335|FG005|Induction Phase|Protocol Violation|1|||
142996723|NCT02394028|515523336|FG006|Induction Phase|Protocol Violation|1|||
142996724|NCT02394028|515523337|FG007|Induction Phase|Protocol Violation|0|||
142996725|NCT02394028|515523338|FG008|Induction Phase|Protocol Violation|0|||
142996726|NCT02394028|515523339|FG009|Induction Phase|Protocol Violation|0|||
142996727|NCT02394028|515523340|FG010|Induction Phase|Protocol Violation|0|||
142996728|NCT02394028|515523330|FG000|Induction Phase|Withdrawal by Subject|1|||
142996729|NCT02394028|515523331|FG001|Induction Phase|Withdrawal by Subject|2|||
142996730|NCT02394028|515523332|FG002|Induction Phase|Withdrawal by Subject|4|||
142996731|NCT02394028|515523333|FG003|Induction Phase|Withdrawal by Subject|6|||
142996732|NCT02394028|515523334|FG004|Induction Phase|Withdrawal by Subject|7|||
142996733|NCT02394028|515523335|FG005|Induction Phase|Withdrawal by Subject|4|||
142996734|NCT02394028|515523336|FG006|Induction Phase|Withdrawal by Subject|3|||
142996735|NCT02394028|515523337|FG007|Induction Phase|Withdrawal by Subject|6|||
142996736|NCT02394028|515523338|FG008|Induction Phase|Withdrawal by Subject|0|||
142996737|NCT02394028|515523339|FG009|Induction Phase|Withdrawal by Subject|0|||
142996738|NCT02394028|515523340|FG010|Induction Phase|Withdrawal by Subject|0|||
142996739|NCT02394028|515523330|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
142996740|NCT02394028|515523331|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
142996741|NCT02394028|515523332|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
142996742|NCT02394028|515523333|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
142996743|NCT02394028|515523334|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
142996744|NCT02394028|515523335|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
142996745|NCT02394028|515523336|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
142996746|NCT02394028|515523337|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
142996747|NCT02394028|515523338|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
142996748|NCT02394028|515523339|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
142996749|NCT02394028|515523340|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
142996750|NCT02394028|515523330|FG000|Induction Phase|Sponsor decision|0|||
142996751|NCT02394028|515523331|FG001|Induction Phase|Sponsor decision|1|||
142996752|NCT02394028|515523332|FG002|Induction Phase|Sponsor decision|2|||
142996753|NCT02394028|515523333|FG003|Induction Phase|Sponsor decision|0|||
142996754|NCT02394028|515523334|FG004|Induction Phase|Sponsor decision|0|||
142996755|NCT02394028|515523335|FG005|Induction Phase|Sponsor decision|0|||
142996756|NCT02394028|515523336|FG006|Induction Phase|Sponsor decision|0|||
142996757|NCT02394028|515523337|FG007|Induction Phase|Sponsor decision|0|||
142996758|NCT02394028|515523338|FG008|Induction Phase|Sponsor decision|0|||
142996759|NCT02394028|515523339|FG009|Induction Phase|Sponsor decision|0|||
142996760|NCT02394028|515523340|FG010|Induction Phase|Sponsor decision|0|||
142996761|NCT02394028|515523330|FG000|Induction Phase|Technical reason|0|||
142996762|NCT02394028|515523331|FG001|Induction Phase|Technical reason|0|||
142996763|NCT02394028|515523332|FG002|Induction Phase|Technical reason|0|||
142996764|NCT02394028|515523333|FG003|Induction Phase|Technical reason|1|||
142996765|NCT02394028|515523334|FG004|Induction Phase|Technical reason|0|||
142996766|NCT02394028|515523335|FG005|Induction Phase|Technical reason|0|||
142996767|NCT02394028|515523336|FG006|Induction Phase|Technical reason|0|||
142996768|NCT02394028|515523337|FG007|Induction Phase|Technical reason|0|||
142996769|NCT02394028|515523338|FG008|Induction Phase|Technical reason|0|||
142996770|NCT02394028|515523339|FG009|Induction Phase|Technical reason|0|||
142996771|NCT02394028|515523340|FG010|Induction Phase|Technical reason|0|||
142996772|NCT02394028|515523330|FG000|Induction Phase|:ack of calculation|0|||
142996773|NCT02394028|515523331|FG001|Induction Phase|:ack of calculation|0|||
142996774|NCT02394028|515523332|FG002|Induction Phase|:ack of calculation|0|||
142996775|NCT02394028|515523333|FG003|Induction Phase|:ack of calculation|0|||
142996776|NCT02394028|515523334|FG004|Induction Phase|:ack of calculation|0|||
142996777|NCT02394028|515523335|FG005|Induction Phase|:ack of calculation|0|||
142996778|NCT02394028|515523336|FG006|Induction Phase|:ack of calculation|0|||
142996779|NCT02394028|515523337|FG007|Induction Phase|:ack of calculation|1|||
142996780|NCT02394028|515523338|FG008|Induction Phase|:ack of calculation|0|||
142996781|NCT02394028|515523339|FG009|Induction Phase|:ack of calculation|0|||
142996782|NCT02394028|515523340|FG010|Induction Phase|:ack of calculation|0|||
142996783|NCT02394028|515523330|FG000|Maintenance Phase|Protocol Violation|0|||
142996784|NCT02394028|515523331|FG001|Maintenance Phase|Protocol Violation|0|||
142996785|NCT02394028|515523332|FG002|Maintenance Phase|Protocol Violation|0|||
142996786|NCT02394028|515523333|FG003|Maintenance Phase|Protocol Violation|0|||
142996787|NCT02394028|515523334|FG004|Maintenance Phase|Protocol Violation|0|||
142996788|NCT02394028|515523335|FG005|Maintenance Phase|Protocol Violation|0|||
142996789|NCT02394028|515523336|FG006|Maintenance Phase|Protocol Violation|0|||
142996790|NCT02394028|515523337|FG007|Maintenance Phase|Protocol Violation|0|||
142996791|NCT02394028|515523338|FG008|Maintenance Phase|Protocol Violation|0|||
142996792|NCT02394028|515523339|FG009|Maintenance Phase|Protocol Violation|0|||
142996793|NCT02394028|515523340|FG010|Maintenance Phase|Protocol Violation|1|||
142996794|NCT02394028|515523330|FG000|Maintenance Phase|Physician Decision|0|||
142996795|NCT02394028|515523331|FG001|Maintenance Phase|Physician Decision|0|||
142996796|NCT02394028|515523332|FG002|Maintenance Phase|Physician Decision|0|||
142996797|NCT02394028|515523333|FG003|Maintenance Phase|Physician Decision|0|||
142996798|NCT02394028|515523334|FG004|Maintenance Phase|Physician Decision|0|||
142996799|NCT02394028|515523335|FG005|Maintenance Phase|Physician Decision|0|||
142996800|NCT02394028|515523336|FG006|Maintenance Phase|Physician Decision|0|||
142996801|NCT02394028|515523337|FG007|Maintenance Phase|Physician Decision|0|||
142996802|NCT02394028|515523338|FG008|Maintenance Phase|Physician Decision|1|||
142996803|NCT02394028|515523339|FG009|Maintenance Phase|Physician Decision|3|||
142996804|NCT02394028|515523340|FG010|Maintenance Phase|Physician Decision|2|||
142996805|NCT02394028|515523330|FG000|Maintenance Phase|Lack of Efficacy|0|||
142996806|NCT02394028|515523331|FG001|Maintenance Phase|Lack of Efficacy|0|||
142996807|NCT02394028|515523332|FG002|Maintenance Phase|Lack of Efficacy|0|||
142996808|NCT02394028|515523333|FG003|Maintenance Phase|Lack of Efficacy|0|||
142996809|NCT02394028|515523334|FG004|Maintenance Phase|Lack of Efficacy|0|||
142996810|NCT02394028|515523335|FG005|Maintenance Phase|Lack of Efficacy|0|||
142996811|NCT02394028|515523336|FG006|Maintenance Phase|Lack of Efficacy|0|||
142996812|NCT02394028|515523337|FG007|Maintenance Phase|Lack of Efficacy|0|||
142996813|NCT02394028|515523338|FG008|Maintenance Phase|Lack of Efficacy|7|||
142996814|NCT02394028|515523339|FG009|Maintenance Phase|Lack of Efficacy|25|||
142996815|NCT02394028|515523340|FG010|Maintenance Phase|Lack of Efficacy|33|||
142996816|NCT02394028|515523330|FG000|Maintenance Phase|Death|0|||
142996817|NCT02394028|515523331|FG001|Maintenance Phase|Death|0|||
142996818|NCT02394028|515523332|FG002|Maintenance Phase|Death|0|||
142996819|NCT02394028|515523333|FG003|Maintenance Phase|Death|0|||
142996820|NCT02394028|515523334|FG004|Maintenance Phase|Death|0|||
142996821|NCT02394028|515523335|FG005|Maintenance Phase|Death|0|||
142996822|NCT02394028|515523336|FG006|Maintenance Phase|Death|0|||
142996823|NCT02394028|515523337|FG007|Maintenance Phase|Death|0|||
142996824|NCT02394028|515523338|FG008|Maintenance Phase|Death|0|||
142996825|NCT02394028|515523339|FG009|Maintenance Phase|Death|0|||
142996826|NCT02394028|515523340|FG010|Maintenance Phase|Death|1|||
142996827|NCT02394028|515523330|FG000|Maintenance Phase|Adverse Event|0|||
142996828|NCT02394028|515523331|FG001|Maintenance Phase|Adverse Event|0|||
142996829|NCT02394028|515523332|FG002|Maintenance Phase|Adverse Event|0|||
142996830|NCT02394028|515523333|FG003|Maintenance Phase|Adverse Event|0|||
142996831|NCT02394028|515523334|FG004|Maintenance Phase|Adverse Event|0|||
142996832|NCT02394028|515523335|FG005|Maintenance Phase|Adverse Event|0|||
142996833|NCT02394028|515523336|FG006|Maintenance Phase|Adverse Event|0|||
142996834|NCT02394028|515523337|FG007|Maintenance Phase|Adverse Event|0|||
142996835|NCT02394028|515523338|FG008|Maintenance Phase|Adverse Event|1|||
142996836|NCT02394028|515523339|FG009|Maintenance Phase|Adverse Event|1|||
142996837|NCT02394028|515523340|FG010|Maintenance Phase|Adverse Event|3|||
142996838|NCT02394028|515523330|FG000|Maintenance Phase|Site closure|0|||
142996839|NCT02394028|515523331|FG001|Maintenance Phase|Site closure|0|||
142996840|NCT02394028|515523332|FG002|Maintenance Phase|Site closure|0|||
142996841|NCT02394028|515523333|FG003|Maintenance Phase|Site closure|0|||
142996842|NCT02394028|515523334|FG004|Maintenance Phase|Site closure|0|||
142996843|NCT02394028|515523335|FG005|Maintenance Phase|Site closure|0|||
142996844|NCT02394028|515523336|FG006|Maintenance Phase|Site closure|0|||
142996845|NCT02394028|515523337|FG007|Maintenance Phase|Site closure|0|||
142996846|NCT02394028|515523338|FG008|Maintenance Phase|Site closure|0|||
142996847|NCT02394028|515523339|FG009|Maintenance Phase|Site closure|1|||
142996848|NCT02394028|515523340|FG010|Maintenance Phase|Site closure|0|||
142996849|NCT02394028|515523330|FG000|Maintenance Phase|Withdrawal by Subject|0|||
142996850|NCT02394028|515523331|FG001|Maintenance Phase|Withdrawal by Subject|0|||
142996851|NCT02394028|515523332|FG002|Maintenance Phase|Withdrawal by Subject|0|||
142996852|NCT02394028|515523333|FG003|Maintenance Phase|Withdrawal by Subject|0|||
142996853|NCT02394028|515523334|FG004|Maintenance Phase|Withdrawal by Subject|0|||
142996854|NCT02394028|515523335|FG005|Maintenance Phase|Withdrawal by Subject|0|||
142996855|NCT02394028|515523336|FG006|Maintenance Phase|Withdrawal by Subject|0|||
142996856|NCT02394028|515523337|FG007|Maintenance Phase|Withdrawal by Subject|0|||
142996857|NCT02394028|515523338|FG008|Maintenance Phase|Withdrawal by Subject|3|||
142996858|NCT02394028|515523339|FG009|Maintenance Phase|Withdrawal by Subject|12|||
142996859|NCT02394028|515523340|FG010|Maintenance Phase|Withdrawal by Subject|12|||
142996860|NCT01241318|515523347|FG000|Overall Study|Woman: false pregnancies|27|||
142996861|NCT01241318|515523348|FG001|Overall Study|Woman: false pregnancies|15|||
142996862|NCT01241318|515523347|FG000|Overall Study|Woman: miscarriage/abortion|46|||
142996863|NCT01241318|515523348|FG001|Overall Study|Woman: miscarriage/abortion|38|||
142996864|NCT01241318|515523347|FG000|Overall Study|Withdrawal by Subject|175|||
142996865|NCT01241318|515523348|FG001|Overall Study|Withdrawal by Subject|46|||
142996866|NCT01241318|515523347|FG000|Overall Study|Lost to Follow-up|740|||
142996867|NCT01241318|515523348|FG001|Overall Study|Lost to Follow-up|455|||
142996868|NCT01241318|515523347|FG000|Overall Study|Death|2|||
142996869|NCT01241318|515523348|FG001|Overall Study|Death|4|||
142996870|NCT01241318|515523347|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
142996871|NCT01241318|515523348|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
142996872|NCT01241318|515523347|FG000|Overall Study|Woman: Stillborn infant|129|||
142996873|NCT01241318|515523348|FG001|Overall Study|Woman: Stillborn infant|146|||
142996874|NCT02355665|515523349|FG000|Overall Study|Adverse Event|16|||
142996875|NCT02355665|515523350|FG001|Overall Study|Adverse Event|24|||
142996876|NCT02355665|515523349|FG000|Overall Study|Protocol Violation|2|||
142996877|NCT02355665|515523350|FG001|Overall Study|Protocol Violation|0|||
142996878|NCT02355665|515523349|FG000|Overall Study|Withdrawal by Subject|90|||
142996879|NCT02355665|515523350|FG001|Overall Study|Withdrawal by Subject|100|||
142996880|NCT02355665|515523349|FG000|Overall Study|Lost to Follow-up|131|||
142996881|NCT02355665|515523350|FG001|Overall Study|Lost to Follow-up|103|||
142996882|NCT02355665|515523349|FG000|Overall Study|Death|4|||
142996883|NCT02355665|515523350|FG001|Overall Study|Death|2|||
142996884|NCT02355665|515523349|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
142996885|NCT02355665|515523350|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
142996886|NCT04129242|515523351|FG000|Overall Study|Physician Decision|1|||
142996887|NCT04129242|515523352|FG001|Overall Study|Physician Decision|1|||
142996888|NCT04129242|515523351|FG000|Overall Study|Protocol Violation|0|||
142996889|NCT04129242|515523352|FG001|Overall Study|Protocol Violation|1|||
142996890|NCT01362049|515523353|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
142996891|NCT01362049|515523354|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
142996892|NCT01362049|515523355|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
142996893|NCT01362049|515523356|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
142996894|NCT01362049|515523353|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
142996895|NCT01362049|515523354|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
142996896|NCT01362049|515523355|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
142996897|NCT01362049|515523356|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
142996898|NCT02850276|515523359|FG000|Overall Study|screen failure|43|||
142996899|NCT02850276|515523359|FG000|Overall Study|Withdrawal by Subject|14|||
142996900|NCT02850276|515523359|FG000|Overall Study|Physician Decision|2|||
142996901|NCT02850276|515523359|FG000|Overall Study|Lost to Follow-up|2|||
142996902|NCT04815291|515523360|FG000|Overall Study|Lost to Follow-up|1|||
142996903|NCT04815291|515523360|FG000|Overall Study|Physician Decision|4|||
142996904|NCT04815291|515523360|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
142996905|NCT01899729|515523361|FG000|Overall Study|Adverse Event|1|||
142996906|NCT01899729|515523362|FG001|Overall Study|Adverse Event|0|||
142996907|NCT01899729|515523363|FG002|Overall Study|Adverse Event|0|||
142996908|NCT01899729|515523364|FG003|Overall Study|Adverse Event|0|||
142996909|NCT01899729|515523365|FG004|Overall Study|Adverse Event|1|||
142996910|NCT01899729|515523361|FG000|Overall Study|Withdrawal by Subject|1|||
142996911|NCT01899729|515523362|FG001|Overall Study|Withdrawal by Subject|2|||
142996912|NCT01899729|515523363|FG002|Overall Study|Withdrawal by Subject|0|||
142996913|NCT01899729|515523364|FG003|Overall Study|Withdrawal by Subject|0|||
142996914|NCT01899729|515523365|FG004|Overall Study|Withdrawal by Subject|0|||
142996915|NCT01899729|515523361|FG000|Overall Study|Lack of Efficacy|0|||
142996916|NCT01899729|515523362|FG001|Overall Study|Lack of Efficacy|0|||
142996917|NCT01899729|515523363|FG002|Overall Study|Lack of Efficacy|2|||
142996918|NCT01899729|515523364|FG003|Overall Study|Lack of Efficacy|0|||
142996919|NCT01899729|515523365|FG004|Overall Study|Lack of Efficacy|1|||
142996920|NCT01454531|515523368|FG000|Overall Study|Adverse Event|14|||
142996921|NCT01454531|515523368|FG000|Overall Study|Withdrawal by Subject|5|||
142996922|NCT01454531|515523368|FG000|Overall Study|Lost to Follow-up|1|||
142996923|NCT01454531|515523368|FG000|Overall Study|Physician Decision|1|||
142996924|NCT01454531|515523368|FG000|Overall Study|Delay in IMP administration|1|||
142996925|NCT01454531|515523368|FG000|Overall Study|Other|1|||
142996926|NCT00989664|515523371|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
142996927|NCT00989664|515523371|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
142996928|NCT00989664|515523371|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
142996929|NCT00989664|515523371|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
142996930|NCT00989664|515523371|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
142996931|NCT00989664|515523371|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
142996932|NCT00989664|515523371|FG000|Long-Term Follow-Up|Death|3|||
142996933|NCT00095836|515523372|FG000|Overall Study|Lost to Follow-up|1|||
142996934|NCT00095836|515523372|FG000|Overall Study|Adverse Event|1|||
142996935|NCT00095836|515523372|FG000|Overall Study|Death|2|||
142996936|NCT02363322|515523376|FG000|Overall Study|Lost to Follow-up|1|||
142996937|NCT02363322|515523377|FG001|Overall Study|Lost to Follow-up|0|||
142996938|NCT02269709|515523378|FG000|Time of Enrollment|Withdrawal by Subject|3|||
142996939|NCT02269709|515523378|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
142996940|NCT02269709|515523378|FG000|Six Month Follow-up|Lost to Follow-up|12|||
142996941|NCT01277666|515523379|FG000|Overall Study|Adverse Event|26|||
142996942|NCT01277666|515523380|FG001|Overall Study|Adverse Event|25|||
142996943|NCT01277666|515523381|FG002|Overall Study|Adverse Event|20|||
142996944|NCT01277666|515523379|FG000|Overall Study|Lack of Efficacy|8|||
142996945|NCT01277666|515523380|FG001|Overall Study|Lack of Efficacy|20|||
142996946|NCT01277666|515523381|FG002|Overall Study|Lack of Efficacy|12|||
142996947|NCT01277666|515523379|FG000|Overall Study|Protocol Violation|2|||
142996948|NCT01277666|515523380|FG001|Overall Study|Protocol Violation|3|||
142996949|NCT01277666|515523381|FG002|Overall Study|Protocol Violation|2|||
142996950|NCT01277666|515523379|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
142996951|NCT01277666|515523380|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
142996952|NCT01277666|515523381|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
142996953|NCT01277666|515523379|FG000|Overall Study|Lost to Follow-up|1|||
142996954|NCT01277666|515523380|FG001|Overall Study|Lost to Follow-up|1|||
142996955|NCT01277666|515523381|FG002|Overall Study|Lost to Follow-up|2|||
142996956|NCT01277666|515523379|FG000|Overall Study|Withdrawal by Subject|7|||
142996957|NCT01277666|515523380|FG001|Overall Study|Withdrawal by Subject|8|||
142996958|NCT01277666|515523381|FG002|Overall Study|Withdrawal by Subject|6|||
142996959|NCT01277666|515523379|FG000|Overall Study|Death|0|||
142996960|NCT01277666|515523380|FG001|Overall Study|Death|0|||
142996961|NCT01277666|515523381|FG002|Overall Study|Death|1|||
142996962|NCT03769753|515523382|FG000|Overall Study|Not Treated|6|||
142996963|NCT03769753|515523382|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
142996964|NCT00983827|515523387|FG000|Overall Study|Withdrawal by Subject|1|||
142996965|NCT01021293|515523389|FG000|Overall Study|Serious Adverse Event|2|||
142996966|NCT01021293|515523390|FG001|Overall Study|Serious Adverse Event|1|||
142996967|NCT01021293|515523389|FG000|Overall Study|Adverse Event|2|||
142996968|NCT01021293|515523390|FG001|Overall Study|Adverse Event|1|||
142996969|NCT01021293|515523389|FG000|Overall Study|Withdrawal by Subject|1|||
142996970|NCT01021293|515523390|FG001|Overall Study|Withdrawal by Subject|3|||
142996971|NCT01021293|515523389|FG000|Overall Study|Migrated/moved from study area|6|||
142996972|NCT01021293|515523390|FG001|Overall Study|Migrated/moved from study area|18|||
142996973|NCT01021293|515523389|FG000|Overall Study|Lost to Follow-up|1|||
142996974|NCT01021293|515523390|FG001|Overall Study|Lost to Follow-up|1|||
142996975|NCT01524900|515525476|FG000|Overall Study|Lost to Follow-up|3|||
142996976|NCT01524900|515525477|FG001|Overall Study|Lost to Follow-up|12|||
142996977|NCT01524900|515525478|FG002|Overall Study|Lost to Follow-up|1|||
142996978|NCT01524900|515525479|FG003|Overall Study|Lost to Follow-up|0|||
142996979|NCT01524900|515525480|FG004|Overall Study|Lost to Follow-up|0|||
142996980|NCT01524900|515525476|FG000|Overall Study|Other reason than stated above|1|||
142996981|NCT01524900|515525477|FG001|Overall Study|Other reason than stated above|1|||
142996982|NCT01524900|515525478|FG002|Overall Study|Other reason than stated above|0|||
142996983|NCT01524900|515525479|FG003|Overall Study|Other reason than stated above|0|||
142996984|NCT01524900|515525480|FG004|Overall Study|Other reason than stated above|0|||
142996985|NCT01524900|515525476|FG000|Overall Study|No reason documented|2|||
142996986|NCT01524900|515525477|FG001|Overall Study|No reason documented|1|||
142996987|NCT01524900|515525478|FG002|Overall Study|No reason documented|0|||
142996988|NCT01524900|515525479|FG003|Overall Study|No reason documented|1|||
142996989|NCT01524900|515525480|FG004|Overall Study|No reason documented|0|||
142996990|NCT04450394|515525481|FG000|Overall Study|Adverse Event|2|||
142996991|NCT04450394|515525482|FG001|Overall Study|Adverse Event|0|||
142996992|NCT04450394|515525483|FG002|Overall Study|Adverse Event|0|||
142996993|NCT04450394|515525481|FG000|Overall Study|Death|0|||
142996994|NCT04450394|515525482|FG001|Overall Study|Death|1|||
142996995|NCT04450394|515525483|FG002|Overall Study|Death|0|||
142996996|NCT04450394|515525481|FG000|Overall Study|Lost to Follow-up|0|||
142996997|NCT04450394|515525482|FG001|Overall Study|Lost to Follow-up|3|||
142996998|NCT04450394|515525483|FG002|Overall Study|Lost to Follow-up|0|||
142996999|NCT04450394|515525481|FG000|Overall Study|Physician Decision|0|||
142997000|NCT04450394|515525482|FG001|Overall Study|Physician Decision|1|||
142997001|NCT04450394|515525483|FG002|Overall Study|Physician Decision|0|||
142997002|NCT04450394|515525481|FG000|Overall Study|Protocol Violation|2|||
142997003|NCT04450394|515525482|FG001|Overall Study|Protocol Violation|0|||
142997004|NCT04450394|515525483|FG002|Overall Study|Protocol Violation|0|||
142997005|NCT04450394|515525481|FG000|Overall Study|Withdrawal by Subject|6|||
142997006|NCT04450394|515525482|FG001|Overall Study|Withdrawal by Subject|9|||
142997007|NCT04450394|515525483|FG002|Overall Study|Withdrawal by Subject|0|||
142997008|NCT03812224|515525491|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
142997009|NCT03812224|515525492|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
142997010|NCT03812224|515525491|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
142997011|NCT03812224|515525492|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
142997012|NCT03812224|515525491|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
142997013|NCT03812224|515525492|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
142997014|NCT03812224|515525491|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
143455739|NCT00438672|517212519|FG001|Overall Study|Lost to Follow-up|9|||
142997015|NCT03812224|515525492|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
142997016|NCT00303719|515525493|FG000|Overall Study|Not evaluable, prior therapies|0|||
142997017|NCT00303719|515525494|FG001|Overall Study|Not evaluable, prior therapies|30|||
142997018|NCT00303719|515525493|FG000|Overall Study|Lost to Follow-up|0|||
142997019|NCT00303719|515525494|FG001|Overall Study|Lost to Follow-up|7|||
142997020|NCT01641952|515525495|FG000|Overall Study|Lost to Follow-up|28|||
142997021|NCT01641952|515525495|FG000|Overall Study|Adverse Event|6|||
142997022|NCT02500901|515525496|FG000|Overall Study|Disease ProgressionDD|2|||
142997023|NCT03633461|515525510|FG000|Overall Study|Lost to Follow-up|0|||
142997024|NCT03633461|515525511|FG001|Overall Study|Lost to Follow-up|1|||
142997025|NCT03938857|515525517|FG000|Overall Study|Physician Decision|1|||
142997026|NCT03938857|515525518|FG001|Overall Study|Physician Decision|0|||
142997027|NCT03938857|515525519|FG002|Overall Study|Physician Decision|0|||
142997028|NCT03938857|515525520|FG003|Overall Study|Physician Decision|0|||
142997029|NCT01345162|515525521|FG000|Overall Study|Protocol Violation|2|||
142997030|NCT01345162|515525522|FG001|Overall Study|Protocol Violation|4|||
142997031|NCT01398176|515525523|FG000|Overall Study|Lost to Follow-up|1|||
142997032|NCT01398176|515525524|FG001|Overall Study|Lost to Follow-up|3|||
142997033|NCT01398176|515525523|FG000|Overall Study|Physician Decision|2|||
142997034|NCT01398176|515525524|FG001|Overall Study|Physician Decision|3|||
142997035|NCT01871870|515525525|FG000|Overall Study|Hardware issues|7|||
142997036|NCT01871870|515525525|FG000|Overall Study|hyperglycemia|2|||
142997037|NCT01977651|515525529|FG000|4 Month Treatment Period|Adverse Event|34|||
142997038|NCT01977651|515525529|FG000|4 Month Treatment Period|Death|3|||
142997039|NCT01977651|515525529|FG000|4 Month Treatment Period|Progressive Disease|43|||
142997040|NCT01977651|515525529|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
142997041|NCT01977651|515525529|FG000|4 Month Treatment Period|Physician Decision|4|||
142997042|NCT01977651|515525529|FG000|1 Year Extension Period|Adverse Event|14|||
142997043|NCT01977651|515525529|FG000|1 Year Extension Period|Death|10|||
142997044|NCT01977651|515525529|FG000|1 Year Extension Period|Lost to Follow-up|2|||
142997045|NCT01977651|515525529|FG000|1 Year Extension Period|Progressive Disease|86|||
142997046|NCT01977651|515525529|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
142997047|NCT01977651|515525529|FG000|1 Year Extension Period|Physician Decision|6|||
142997048|NCT01977651|515525529|FG000|1 Year Extension Period|Miscellaneous|1|||
142997049|NCT01977651|515525529|FG000|Post 1 Year Extension Period|Adverse Event|5|||
142997050|NCT01977651|515525529|FG000|Post 1 Year Extension Period|Death|13|||
142997051|NCT01977651|515525529|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
142997052|NCT01977651|515525529|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
142997053|NCT01977651|515525529|FG000|Post 1 Year Extension Period|Physician Decision|4|||
142997054|NCT01977651|515525529|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
142997055|NCT03287089|515525530|FG000|Overall Study|Lost to Follow-up|0|||
142997056|NCT03287089|515525531|FG001|Overall Study|Lost to Follow-up|2|||
142997057|NCT03287089|515525530|FG000|Overall Study|Physician Decision|0|||
142997058|NCT03287089|515525531|FG001|Overall Study|Physician Decision|2|||
142997059|NCT03287089|515525530|FG000|Overall Study|Withdrawal by Subject|0|||
142997060|NCT03287089|515525531|FG001|Overall Study|Withdrawal by Subject|2|||
142997061|NCT00608426|515525532|FG000|Overall Study|Death|32|||
142997062|NCT00608426|515525533|FG001|Overall Study|Death|36|||
142997063|NCT00608426|515525532|FG000|Overall Study|Lost to Follow-up|485|||
142997064|NCT00608426|515525533|FG001|Overall Study|Lost to Follow-up|521|||
142997065|NCT00608426|515525532|FG000|Overall Study|refused, health issues, wrong address|319|||
142997066|NCT00608426|515525533|FG001|Overall Study|refused, health issues, wrong address|348|||
142997067|NCT04249076|515525548|FG000|Overall Study|Adverse Event|1|||
142997068|NCT04249076|515525549|FG001|Overall Study|Adverse Event|1|||
142997069|NCT04249076|515525548|FG000|Overall Study|Protocol Violation|1|||
142997070|NCT04249076|515525549|FG001|Overall Study|Protocol Violation|2|||
142997071|NCT04249076|515525548|FG000|Overall Study|Lack of Efficacy|0|||
142997072|NCT04249076|515525549|FG001|Overall Study|Lack of Efficacy|1|||
142997073|NCT04249076|515525548|FG000|Overall Study|Withdrawal by Subject|0|||
142997074|NCT04249076|515525549|FG001|Overall Study|Withdrawal by Subject|1|||
142997075|NCT00106626|515525550|FG000|Overall Study|Adverse Event|5|||
142997076|NCT00106626|515525551|FG001|Overall Study|Adverse Event|4|||
142997077|NCT00106626|515525552|FG002|Overall Study|Adverse Event|3|||
142997078|NCT00106626|515525553|FG003|Overall Study|Adverse Event|3|||
142997079|NCT00106626|515525550|FG000|Overall Study|Progressive Disease|4|||
142997080|NCT00106626|515525551|FG001|Overall Study|Progressive Disease|1|||
142997081|NCT00106626|515525552|FG002|Overall Study|Progressive Disease|9|||
142997082|NCT00106626|515525553|FG003|Overall Study|Progressive Disease|10|||
142997083|NCT00106626|515525550|FG000|Overall Study|Received radiation on new therapy|1|||
142997084|NCT00106626|515525551|FG001|Overall Study|Received radiation on new therapy|0|||
142997085|NCT00106626|515525552|FG002|Overall Study|Received radiation on new therapy|0|||
142997086|NCT00106626|515525553|FG003|Overall Study|Received radiation on new therapy|0|||
142997087|NCT00106626|515525550|FG000|Overall Study|> 14 day delay in therapy start|0|||
142997088|NCT00106626|515525551|FG001|Overall Study|> 14 day delay in therapy start|1|||
142997089|NCT00106626|515525552|FG002|Overall Study|> 14 day delay in therapy start|0|||
142997090|NCT00106626|515525553|FG003|Overall Study|> 14 day delay in therapy start|0|||
142997091|NCT02135848|515525554|FG000|Overall Study|Adverse Event|2|||
142997092|NCT02135848|515525555|FG001|Overall Study|Adverse Event|0|||
142997093|NCT02135848|515525554|FG000|Overall Study|Withdrawal by Subject|1|||
142997094|NCT02135848|515525555|FG001|Overall Study|Withdrawal by Subject|1|||
142997095|NCT02242305|515525559|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
143003189|NCT01049360|515548761|FG017|Period 2|Lack of Efficacy|0|||
142997096|NCT02242305|515525560|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
142997097|NCT02242305|515525559|FG000|Overall Study|Adverse Event|1|||
142997098|NCT02242305|515525560|FG001|Overall Study|Adverse Event|0|||
142997099|NCT02242305|515525559|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
142997100|NCT02242305|515525560|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
142997101|NCT02242305|515525559|FG000|Overall Study|Subject withdraws inform consent|0|||
142997102|NCT02242305|515525560|FG001|Overall Study|Subject withdraws inform consent|4|||
142997103|NCT02242305|515525559|FG000|Overall Study|Lost to Follow-up|2|||
142997104|NCT02242305|515525560|FG001|Overall Study|Lost to Follow-up|0|||
142997105|NCT03018028|515525564|FG000|Overall Study|Withdrawal by Subject|3|||
142997106|NCT03018028|515525565|FG001|Overall Study|Withdrawal by Subject|0|||
142997107|NCT03018028|515525566|FG002|Overall Study|Withdrawal by Subject|1|||
142997108|NCT03018028|515525567|FG003|Overall Study|Withdrawal by Subject|2|||
142997109|NCT03018028|515525568|FG004|Overall Study|Withdrawal by Subject|0|||
142997110|NCT01117428|515525570|FG000|Overall Study|Lack of Efficacy|1|||
142997111|NCT01117428|515525571|FG001|Overall Study|Lack of Efficacy|0|||
142997112|NCT01117428|515525572|FG002|Overall Study|Lack of Efficacy|0|||
142997113|NCT01117428|515525573|FG003|Overall Study|Lack of Efficacy|0|||
142997114|NCT01117428|515525574|FG004|Overall Study|Lack of Efficacy|0|||
142997115|NCT01117428|515525575|FG005|Overall Study|Lack of Efficacy|0|||
142997116|NCT01117428|515525570|FG000|Overall Study|Adverse Event|4|||
142997117|NCT01117428|515525571|FG001|Overall Study|Adverse Event|0|||
142997118|NCT01117428|515525572|FG002|Overall Study|Adverse Event|0|||
142997119|NCT01117428|515525573|FG003|Overall Study|Adverse Event|0|||
142997120|NCT01117428|515525574|FG004|Overall Study|Adverse Event|1|||
142997121|NCT01117428|515525575|FG005|Overall Study|Adverse Event|2|||
142997122|NCT01117428|515525570|FG000|Overall Study|Death|0|||
142997123|NCT01117428|515525571|FG001|Overall Study|Death|1|||
142997124|NCT01117428|515525572|FG002|Overall Study|Death|2|||
142997125|NCT01117428|515525573|FG003|Overall Study|Death|0|||
142997126|NCT01117428|515525574|FG004|Overall Study|Death|0|||
142997127|NCT01117428|515525575|FG005|Overall Study|Death|1|||
142997128|NCT01117428|515525570|FG000|Overall Study|Physician Decision|0|||
142997129|NCT01117428|515525571|FG001|Overall Study|Physician Decision|1|||
142997130|NCT01117428|515525572|FG002|Overall Study|Physician Decision|0|||
142997131|NCT01117428|515525573|FG003|Overall Study|Physician Decision|0|||
142997132|NCT01117428|515525574|FG004|Overall Study|Physician Decision|0|||
142997133|NCT01117428|515525575|FG005|Overall Study|Physician Decision|0|||
142997134|NCT01117428|515525570|FG000|Overall Study|Withdrawal by Subject|0|||
142997135|NCT01117428|515525571|FG001|Overall Study|Withdrawal by Subject|0|||
142997136|NCT01117428|515525572|FG002|Overall Study|Withdrawal by Subject|1|||
142997137|NCT01117428|515525573|FG003|Overall Study|Withdrawal by Subject|0|||
142997138|NCT01117428|515525574|FG004|Overall Study|Withdrawal by Subject|0|||
142997139|NCT01117428|515525575|FG005|Overall Study|Withdrawal by Subject|0|||
142997140|NCT01117428|515525570|FG000|Overall Study|Progressive disease|15|||
142997141|NCT01117428|515525571|FG001|Overall Study|Progressive disease|27|||
142997142|NCT01117428|515525572|FG002|Overall Study|Progressive disease|10|||
142997143|NCT01117428|515525573|FG003|Overall Study|Progressive disease|12|||
142997144|NCT01117428|515525574|FG004|Overall Study|Progressive disease|16|||
142997145|NCT01117428|515525575|FG005|Overall Study|Progressive disease|17|||
142997146|NCT02543801|515525577|FG000|Overall Study|Protocol Violation|1|||
142997147|NCT02543801|515525578|FG001|Overall Study|Protocol Violation|2|||
142997148|NCT02543801|515525579|FG002|Overall Study|Protocol Violation|0|||
142997149|NCT02543801|515525580|FG003|Overall Study|Protocol Violation|0|||
142997150|NCT04118127|515525583|FG000|Overall Study|Trial terminated by sponsor|0|||
142997151|NCT04118127|515525584|FG001|Overall Study|Trial terminated by sponsor|12|||
142997152|NCT04118127|515525583|FG000|Overall Study|Adverse Event|1|||
142997153|NCT04118127|515525584|FG001|Overall Study|Adverse Event|2|||
142997154|NCT04118127|515525583|FG000|Overall Study|Physician Decision|0|||
142997155|NCT04118127|515525584|FG001|Overall Study|Physician Decision|1|||
142997156|NCT04118127|515525583|FG000|Overall Study|Withdrawal by Subject|2|||
142997157|NCT04118127|515525584|FG001|Overall Study|Withdrawal by Subject|1|||
142997158|NCT02417935|515525585|FG000|Treatment Period|Adverse Event|12|||
142997159|NCT02417935|515525586|FG001|Treatment Period|Adverse Event|10|||
142997160|NCT02417935|515525585|FG000|Treatment Period|Lost to Follow-up|1|||
142997161|NCT02417935|515525586|FG001|Treatment Period|Lost to Follow-up|0|||
142997162|NCT02417935|515525585|FG000|Treatment Period|Entry Criteria not met|0|||
142997163|NCT02417935|515525586|FG001|Treatment Period|Entry Criteria not met|1|||
142997164|NCT02417935|515525585|FG000|Treatment Period|Protocol Violation|2|||
142997165|NCT02417935|515525586|FG001|Treatment Period|Protocol Violation|1|||
142997166|NCT02417935|515525585|FG000|Treatment Period|Withdrawal by Subject|3|||
142997167|NCT02417935|515525586|FG001|Treatment Period|Withdrawal by Subject|3|||
142997168|NCT02417935|515525585|FG000|Treatment Period|Physician Decision|3|||
142997169|NCT02417935|515525586|FG001|Treatment Period|Physician Decision|1|||
142997170|NCT00962780|515525587|FG000|Overall Study|Death|0|||
142997171|NCT00962780|515525588|FG001|Overall Study|Death|1|||
142997172|NCT00962780|515525587|FG000|Overall Study|Protocol Violation|9|||
142997173|NCT00962780|515525588|FG001|Overall Study|Protocol Violation|4|||
142997174|NCT00962780|515525587|FG000|Overall Study|Withdrawal by Subject|1|||
142997175|NCT00962780|515525588|FG001|Overall Study|Withdrawal by Subject|8|||
142997176|NCT00962780|515525587|FG000|Overall Study|Other|0|||
142997177|NCT00962780|515525588|FG001|Overall Study|Other|1|||
142997178|NCT02055976|515525589|FG000|Overall Study|Other|0|||
142997179|NCT02055976|515525590|FG001|Overall Study|Other|0|||
142997180|NCT02055976|515525591|FG002|Overall Study|Other|1|||
142997181|NCT02055976|515525592|FG003|Overall Study|Other|0|||
142997182|NCT02055976|515525593|FG004|Overall Study|Other|0|||
142997183|NCT02055976|515525594|FG005|Overall Study|Other|0|||
142997184|NCT02055976|515525595|FG006|Overall Study|Other|0|||
142997185|NCT02055976|515525596|FG007|Overall Study|Other|0|||
142997186|NCT02055976|515525597|FG008|Overall Study|Other|0|||
142997187|NCT02055976|515525589|FG000|Overall Study|Adverse Event|0|||
142997188|NCT02055976|515525590|FG001|Overall Study|Adverse Event|0|||
142997189|NCT02055976|515525591|FG002|Overall Study|Adverse Event|0|||
142997190|NCT02055976|515525592|FG003|Overall Study|Adverse Event|0|||
142997191|NCT02055976|515525593|FG004|Overall Study|Adverse Event|0|||
142997192|NCT02055976|515525594|FG005|Overall Study|Adverse Event|1|||
142997193|NCT02055976|515525595|FG006|Overall Study|Adverse Event|1|||
142997194|NCT02055976|515525596|FG007|Overall Study|Adverse Event|0|||
142997195|NCT02055976|515525597|FG008|Overall Study|Adverse Event|0|||
142997196|NCT02055976|515525589|FG000|Overall Study|Does not meet entrance criteria|0|||
142997197|NCT02055976|515525590|FG001|Overall Study|Does not meet entrance criteria|0|||
142997198|NCT02055976|515525591|FG002|Overall Study|Does not meet entrance criteria|0|||
142997199|NCT02055976|515525592|FG003|Overall Study|Does not meet entrance criteria|0|||
142997200|NCT02055976|515525593|FG004|Overall Study|Does not meet entrance criteria|0|||
142997201|NCT02055976|515525594|FG005|Overall Study|Does not meet entrance criteria|0|||
142997202|NCT02055976|515525595|FG006|Overall Study|Does not meet entrance criteria|1|||
142997203|NCT02055976|515525596|FG007|Overall Study|Does not meet entrance criteria|0|||
142997204|NCT02055976|515525597|FG008|Overall Study|Does not meet entrance criteria|0|||
142997205|NCT02055976|515525589|FG000|Overall Study|Lost to Follow-up|0|||
142997206|NCT02055976|515525590|FG001|Overall Study|Lost to Follow-up|0|||
142997207|NCT02055976|515525591|FG002|Overall Study|Lost to Follow-up|0|||
142997208|NCT02055976|515525592|FG003|Overall Study|Lost to Follow-up|1|||
142997209|NCT02055976|515525593|FG004|Overall Study|Lost to Follow-up|0|||
142997210|NCT02055976|515525594|FG005|Overall Study|Lost to Follow-up|0|||
142997211|NCT02055976|515525595|FG006|Overall Study|Lost to Follow-up|0|||
142997212|NCT02055976|515525596|FG007|Overall Study|Lost to Follow-up|0|||
142997213|NCT02055976|515525597|FG008|Overall Study|Lost to Follow-up|0|||
142997214|NCT04411472|515525598|FG000|Overall Study|Adverse Event|5|||
142997215|NCT04411472|515525599|FG001|Overall Study|Adverse Event|10|||
142997216|NCT04411472|515525600|FG002|Overall Study|Adverse Event|1|||
142997217|NCT04411472|515525601|FG003|Overall Study|Adverse Event|0|||
142997218|NCT04411472|515525602|FG004|Overall Study|Adverse Event|0|||
142997219|NCT04411472|515525603|FG005|Overall Study|Adverse Event|0|||
142997220|NCT04411472|515525598|FG000|Overall Study|Protocol Violation|1|||
142997221|NCT04411472|515525599|FG001|Overall Study|Protocol Violation|0|||
142997222|NCT04411472|515525600|FG002|Overall Study|Protocol Violation|0|||
142997223|NCT04411472|515525601|FG003|Overall Study|Protocol Violation|0|||
142997224|NCT04411472|515525602|FG004|Overall Study|Protocol Violation|0|||
142997225|NCT04411472|515525603|FG005|Overall Study|Protocol Violation|0|||
142997226|NCT04411472|515525598|FG000|Overall Study|Withdrawal by Subject|0|||
142997227|NCT04411472|515525599|FG001|Overall Study|Withdrawal by Subject|1|||
142997228|NCT04411472|515525600|FG002|Overall Study|Withdrawal by Subject|0|||
142997229|NCT04411472|515525601|FG003|Overall Study|Withdrawal by Subject|1|||
142997230|NCT04411472|515525602|FG004|Overall Study|Withdrawal by Subject|0|||
142997231|NCT04411472|515525603|FG005|Overall Study|Withdrawal by Subject|0|||
142997232|NCT04411472|515525598|FG000|Overall Study|Physician Decision|1|||
142997233|NCT04411472|515525599|FG001|Overall Study|Physician Decision|0|||
142997234|NCT04411472|515525600|FG002|Overall Study|Physician Decision|0|||
142997235|NCT04411472|515525601|FG003|Overall Study|Physician Decision|0|||
142997236|NCT04411472|515525602|FG004|Overall Study|Physician Decision|0|||
142997237|NCT04411472|515525603|FG005|Overall Study|Physician Decision|0|||
142997238|NCT04411472|515525598|FG000|Overall Study|Study terminated by sponsor|17|||
142997239|NCT04411472|515525599|FG001|Overall Study|Study terminated by sponsor|20|||
142997240|NCT04411472|515525600|FG002|Overall Study|Study terminated by sponsor|3|||
142997241|NCT04411472|515525601|FG003|Overall Study|Study terminated by sponsor|0|||
142997242|NCT04411472|515525602|FG004|Overall Study|Study terminated by sponsor|0|||
142997243|NCT04411472|515525603|FG005|Overall Study|Study terminated by sponsor|0|||
142997244|NCT00426842|515525604|FG000|Overall Study|Lost to Follow-up|1|||
142997245|NCT00684073|515525607|FG000|Selection|Selection/non-selection criteria|3|||
142997246|NCT00684073|515525607|FG000|Selection|Death|1|||
142997247|NCT00684073|515525607|FG000|Selection|noncompliance|1|||
142997248|NCT00684073|515525607|FG000|Selection|Lost to Follow-up|1|||
142997249|NCT00684073|515525607|FG000|Selection|request of the sponsor|1|||
142997250|NCT00684073|515525607|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
142997251|NCT03529162|515525608|FG000|Overall Study|Lost to Follow-up|2|||
142997252|NCT03529162|515525609|FG001|Overall Study|Lost to Follow-up|2|||
142997253|NCT02728804|515525615|FG000|Overall Study|Ineligible|3|||
142997254|NCT02728804|515525615|FG000|Overall Study|Did not complete baseline questionnaire|9|||
142997255|NCT02728804|515525615|FG000|Overall Study|Death|99|||
142997256|NCT01854918|515525616|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
142997257|NCT01854918|515525617|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
142997258|NCT01854918|515525616|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
142997259|NCT01854918|515525617|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
142997260|NCT01854918|515525616|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
142997261|NCT01854918|515525617|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
142997262|NCT01854918|515525616|FG000|SOC-controlled Period (Year 1)|Death|5|||
142997263|NCT01854918|515525617|FG001|SOC-controlled Period (Year 1)|Death|5|||
142997264|NCT01854918|515525616|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
142997265|NCT01854918|515525617|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
142997266|NCT01854918|515525616|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
142997267|NCT01854918|515525617|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
142997268|NCT01854918|515525616|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
142997269|NCT01854918|515525617|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
142997270|NCT01854918|515525616|FG000|All-IP Period (Years 2 and 3)|Death|5|||
142997271|NCT01854918|515525617|FG001|All-IP Period (Years 2 and 3)|Death|16|||
142997272|NCT02146352|515525623|FG000|Overall Study|Death|1|||
142997273|NCT02146352|515525623|FG000|Overall Study|Patient entered hospice care|1|||
142997274|NCT02918006|515525624|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
142997275|NCT02918006|515525625|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
142997276|NCT02918006|515525626|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
142997277|NCT02918006|515525624|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
142997278|NCT02918006|515525625|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
142997279|NCT02918006|515525626|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
142997280|NCT02918006|515525624|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
142997281|NCT02918006|515525625|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
142997282|NCT02918006|515525626|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
142997283|NCT02918006|515525624|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
142997284|NCT02918006|515525625|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
142997285|NCT02918006|515525626|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
142997286|NCT02918006|515525624|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
142997287|NCT02918006|515525625|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
142997288|NCT02918006|515525626|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
142997289|NCT02918006|515525624|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
142997290|NCT02918006|515525625|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
142997291|NCT02918006|515525626|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
142997292|NCT02918006|515525624|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
142997293|NCT02918006|515525625|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
142997294|NCT02918006|515525626|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
142997295|NCT02918006|515525624|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
142997296|NCT02918006|515525625|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
142997297|NCT02918006|515525626|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
142997298|NCT02918006|515525624|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
142997299|NCT02918006|515525625|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
142997300|NCT02918006|515525626|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
142997301|NCT03091920|515525630|FG000|Overall Study|Adverse Event|0|||
142997302|NCT03091920|515525631|FG001|Overall Study|Adverse Event|1|||
142997303|NCT03091920|515525632|FG002|Overall Study|Adverse Event|0|||
142997304|NCT01459016|515527775|FG000|Overall Study|Withdrawal by Subject|11|||
142997305|NCT01459016|515527775|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
142997306|NCT00303602|515527779|FG000|Overall Study|Adverse Event|2|||
142997307|NCT00303602|515527780|FG001|Overall Study|Adverse Event|2|||
142997308|NCT00303602|515527779|FG000|Overall Study|Withdrawal by Subject|5|||
142997309|NCT00303602|515527780|FG001|Overall Study|Withdrawal by Subject|6|||
142997310|NCT00303602|515527779|FG000|Overall Study|Lost to Follow-up|5|||
142997311|NCT00303602|515527780|FG001|Overall Study|Lost to Follow-up|2|||
142997312|NCT00303602|515527779|FG000|Overall Study|Protocol entry criteria not met|2|||
142997313|NCT00303602|515527780|FG001|Overall Study|Protocol entry criteria not met|2|||
142997314|NCT00303602|515527779|FG000|Overall Study|Physician Decision|2|||
142997315|NCT00303602|515527780|FG001|Overall Study|Physician Decision|1|||
142997316|NCT00303602|515527779|FG000|Overall Study|Noncompliance|2|||
142997317|NCT00303602|515527780|FG001|Overall Study|Noncompliance|2|||
142997318|NCT00303602|515527779|FG000|Overall Study|Protocol Violation|1|||
142997319|NCT00303602|515527780|FG001|Overall Study|Protocol Violation|0|||
142997320|NCT03922945|515527781|FG000|Overall Study|Adverse Event|1|||
142997321|NCT03922945|515527782|FG001|Overall Study|Adverse Event|1|||
142997322|NCT03922945|515527783|FG002|Overall Study|Adverse Event|2|||
142997323|NCT03922945|515527781|FG000|Overall Study|Lost to Follow-up|13|||
142997324|NCT03922945|515527782|FG001|Overall Study|Lost to Follow-up|9|||
143117240|NCT01709864|515971808|FG000|Overall Study|Adverse Event|0|||
142997325|NCT03922945|515527783|FG002|Overall Study|Lost to Follow-up|20|||
142997326|NCT03922945|515527781|FG000|Overall Study|Lack of Efficacy|2|||
142997327|NCT03922945|515527782|FG001|Overall Study|Lack of Efficacy|0|||
142997328|NCT03922945|515527783|FG002|Overall Study|Lack of Efficacy|1|||
142997329|NCT03922945|515527781|FG000|Overall Study|Protocol Non-Compliance|0|||
142997330|NCT03922945|515527782|FG001|Overall Study|Protocol Non-Compliance|0|||
142997331|NCT03922945|515527783|FG002|Overall Study|Protocol Non-Compliance|1|||
142997332|NCT03922945|515527781|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
142997333|NCT03922945|515527782|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
142997334|NCT03922945|515527783|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
142997335|NCT03922945|515527781|FG000|Overall Study|All Other Personal Reasons|1|||
142997336|NCT03922945|515527782|FG001|Overall Study|All Other Personal Reasons|1|||
142997337|NCT03922945|515527783|FG002|Overall Study|All Other Personal Reasons|2|||
142997338|NCT00313716|515527786|FG000|Overall Study|Death|3|||
142997339|NCT00313716|515527787|FG001|Overall Study|Death|2|||
142997340|NCT00313716|515527788|FG002|Overall Study|Death|9|||
142997341|NCT00313716|515527789|FG003|Overall Study|Death|3|||
142997342|NCT00313716|515527790|FG004|Overall Study|Death|5|||
142997343|NCT00313716|515527791|FG005|Overall Study|Death|9|||
142997344|NCT00313716|515527786|FG000|Overall Study|Lost to Follow-up|2|||
142997345|NCT00313716|515527787|FG001|Overall Study|Lost to Follow-up|5|||
142997346|NCT00313716|515527788|FG002|Overall Study|Lost to Follow-up|2|||
142997347|NCT00313716|515527789|FG003|Overall Study|Lost to Follow-up|1|||
142997348|NCT00313716|515527790|FG004|Overall Study|Lost to Follow-up|0|||
142997349|NCT00313716|515527791|FG005|Overall Study|Lost to Follow-up|4|||
142997350|NCT00313716|515527786|FG000|Overall Study|Withdrawal by Subject|0|||
142997351|NCT00313716|515527787|FG001|Overall Study|Withdrawal by Subject|1|||
142997352|NCT00313716|515527788|FG002|Overall Study|Withdrawal by Subject|1|||
142997353|NCT00313716|515527789|FG003|Overall Study|Withdrawal by Subject|0|||
142997354|NCT00313716|515527790|FG004|Overall Study|Withdrawal by Subject|1|||
142997355|NCT00313716|515527791|FG005|Overall Study|Withdrawal by Subject|0|||
142997356|NCT02491463|515527792|FG000|Overall Study|Withdrawal by Subject|1|||
142997357|NCT02491463|515527793|FG001|Overall Study|Withdrawal by Subject|2|||
142997358|NCT02491463|515527794|FG002|Overall Study|Withdrawal by Subject|0|||
142997359|NCT02491463|515527795|FG003|Overall Study|Withdrawal by Subject|0|||
142997360|NCT02491463|515527792|FG000|Overall Study|Migrated/moved from study area|1|||
142997361|NCT02491463|515527793|FG001|Overall Study|Migrated/moved from study area|5|||
142997362|NCT02491463|515527794|FG002|Overall Study|Migrated/moved from study area|1|||
142997363|NCT02491463|515527795|FG003|Overall Study|Migrated/moved from study area|1|||
142997364|NCT02491463|515527792|FG000|Overall Study|Lost to Follow-up|0|||
142997365|NCT02491463|515527793|FG001|Overall Study|Lost to Follow-up|3|||
142997366|NCT02491463|515527794|FG002|Overall Study|Lost to Follow-up|3|||
142997367|NCT02491463|515527795|FG003|Overall Study|Lost to Follow-up|0|||
142997368|NCT01491802|515527796|FG000|Overall Study|Adverse Event|1|||
142997369|NCT01491802|515527797|FG001|Overall Study|Adverse Event|1|||
142997370|NCT01491802|515527796|FG000|Overall Study|Withdrawal by Subject|0|||
142997371|NCT01491802|515527797|FG001|Overall Study|Withdrawal by Subject|1|||
142997372|NCT00663208|515527800|FG000|Treatment Period|Lost to Follow-up|0|||
142997373|NCT00663208|515527801|FG001|Treatment Period|Lost to Follow-up|1|||
143455740|NCT02559895|517212520|FG000|Overall Study|Adverse Event|3|||
142997374|NCT00663208|515527802|FG002|Treatment Period|Lost to Follow-up|0|||
142997375|NCT00663208|515527803|FG003|Treatment Period|Lost to Follow-up|0|||
142997376|NCT00663208|515527804|FG004|Treatment Period|Lost to Follow-up|0|||
142997377|NCT00663208|515527805|FG005|Treatment Period|Lost to Follow-up|0|||
142997378|NCT00663208|515527806|FG006|Treatment Period|Lost to Follow-up|0|||
142997379|NCT00663208|515527800|FG000|Follow-up Period|Lost to Follow-up|2|||
142997380|NCT00663208|515527801|FG001|Follow-up Period|Lost to Follow-up|0|||
142997381|NCT00663208|515527802|FG002|Follow-up Period|Lost to Follow-up|3|||
142997382|NCT00663208|515527803|FG003|Follow-up Period|Lost to Follow-up|2|||
142997383|NCT00663208|515527804|FG004|Follow-up Period|Lost to Follow-up|0|||
142997384|NCT00663208|515527805|FG005|Follow-up Period|Lost to Follow-up|0|||
142997385|NCT00663208|515527806|FG006|Follow-up Period|Lost to Follow-up|0|||
142997386|NCT00663208|515527800|FG000|Follow-up Period|Other reason|1|||
142997387|NCT00663208|515527801|FG001|Follow-up Period|Other reason|0|||
142997388|NCT00663208|515527802|FG002|Follow-up Period|Other reason|0|||
142997389|NCT00663208|515527803|FG003|Follow-up Period|Other reason|0|||
142997390|NCT00663208|515527804|FG004|Follow-up Period|Other reason|0|||
142997391|NCT00663208|515527805|FG005|Follow-up Period|Other reason|0|||
142997392|NCT00663208|515527806|FG006|Follow-up Period|Other reason|1|||
142997393|NCT00039377|515527808|FG000|Initial Registration|Adverse Event|2|||
142997394|NCT00039377|515527809|FG001|Initial Registration|Adverse Event|0|||
142997395|NCT00039377|515527810|FG002|Initial Registration|Adverse Event|0|||
142997396|NCT00039377|515527811|FG003|Initial Registration|Adverse Event|0|||
142997397|NCT00039377|515527808|FG000|Initial Registration|Relapsed|6|||
142997398|NCT00039377|515527809|FG001|Initial Registration|Relapsed|0|||
142997399|NCT00039377|515527810|FG002|Initial Registration|Relapsed|0|||
142997400|NCT00039377|515527811|FG003|Initial Registration|Relapsed|0|||
142997401|NCT00039377|515527808|FG000|Initial Registration|Received non-protocol therapy|11|||
142997402|NCT00039377|515527809|FG001|Initial Registration|Received non-protocol therapy|0|||
142997403|NCT00039377|515527810|FG002|Initial Registration|Received non-protocol therapy|0|||
142997404|NCT00039377|515527811|FG003|Initial Registration|Received non-protocol therapy|0|||
142997405|NCT00039377|515527808|FG000|Initial Registration|Withdrawal by Subject|3|||
142997406|NCT00039377|515527809|FG001|Initial Registration|Withdrawal by Subject|0|||
142997407|NCT00039377|515527810|FG002|Initial Registration|Withdrawal by Subject|0|||
142997408|NCT00039377|515527811|FG003|Initial Registration|Withdrawal by Subject|0|||
142997409|NCT04067310|515527815|FG000|Overall Study|Physician Decision|2|||
142997410|NCT04067310|515527816|FG001|Overall Study|Physician Decision|6|||
142997411|NCT04067310|515527815|FG000|Overall Study|Lost to Follow-up|0|||
142997412|NCT04067310|515527816|FG001|Overall Study|Lost to Follow-up|1|||
142997413|NCT04067310|515527815|FG000|Overall Study|Withdrawal by Subject|3|||
142997414|NCT04067310|515527816|FG001|Overall Study|Withdrawal by Subject|0|||
142997415|NCT01041027|515527817|FG000|Overall Study|Withdrawal by Subject|2|||
142997416|NCT01041027|515527817|FG000|Overall Study|Protocol Violation|1|||
142997417|NCT01041027|515527817|FG000|Overall Study|Delayed Radiation Therapy|1|||
142997418|NCT01041027|515527817|FG000|Overall Study|Adverse Event|4|||
142997419|NCT01347931|515527818|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
142997420|NCT01249404|515527819|FG000|Overall Study|Study treatment not received|0|||
142997421|NCT01249404|515527820|FG001|Overall Study|Study treatment not received|1|||
142997422|NCT01249404|515527821|FG002|Overall Study|Study treatment not received|2|||
142997423|NCT01249404|515527819|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
142997424|NCT01249404|515527820|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
142997425|NCT01249404|515527821|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
142997426|NCT01249404|515527819|FG000|Overall Study|Adverse Event|2|||
142997427|NCT01249404|515527820|FG001|Overall Study|Adverse Event|2|||
142997428|NCT01249404|515527821|FG002|Overall Study|Adverse Event|2|||
142997429|NCT01249404|515527819|FG000|Overall Study|Withdrawal by Subject|2|||
142997430|NCT01249404|515527820|FG001|Overall Study|Withdrawal by Subject|2|||
142997431|NCT01249404|515527821|FG002|Overall Study|Withdrawal by Subject|0|||
142997432|NCT01249404|515527819|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
142997433|NCT01249404|515527820|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
142997434|NCT01249404|515527821|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
142997435|NCT01249404|515527819|FG000|Overall Study|Non compliance to visit schedule|0|||
142997436|NCT01249404|515527820|FG001|Overall Study|Non compliance to visit schedule|1|||
142997437|NCT01249404|515527821|FG002|Overall Study|Non compliance to visit schedule|0|||
142997438|NCT02493712|515527822|FG000|Overall Study|Withdrawal by Subject|1|||
142997439|NCT02493712|515527823|FG001|Overall Study|Withdrawal by Subject|0|||
142997440|NCT02493712|515527824|FG002|Overall Study|Withdrawal by Subject|2|||
142997441|NCT02493712|515527822|FG000|Overall Study|Protocol Violation|0|||
142997442|NCT02493712|515527823|FG001|Overall Study|Protocol Violation|0|||
142997443|NCT02493712|515527824|FG002|Overall Study|Protocol Violation|1|||
142997444|NCT02493712|515527822|FG000|Overall Study|Lost to Follow-up|1|||
142997445|NCT02493712|515527823|FG001|Overall Study|Lost to Follow-up|0|||
142997446|NCT02493712|515527824|FG002|Overall Study|Lost to Follow-up|0|||
142997447|NCT02493712|515527822|FG000|Overall Study|Physician Decision|0|||
142997448|NCT02493712|515527823|FG001|Overall Study|Physician Decision|1|||
142997449|NCT02493712|515527824|FG002|Overall Study|Physician Decision|0|||
142997450|NCT02493712|515527822|FG000|Overall Study|Lack of Efficacy|0|||
142997451|NCT02493712|515527823|FG001|Overall Study|Lack of Efficacy|5|||
142997452|NCT02493712|515527824|FG002|Overall Study|Lack of Efficacy|3|||
142997453|NCT02528643|515527825|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
142997454|NCT02528643|515527826|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
142997455|NCT02528643|515527825|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
142997456|NCT02528643|515527826|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
142997457|NCT02528643|515527825|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
142997458|NCT02528643|515527826|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
142997459|NCT02528643|515527825|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
142997460|NCT02528643|515527826|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
142997461|NCT02528643|515527825|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
142997462|NCT02528643|515527826|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
142997463|NCT02528643|515527825|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
142997464|NCT02528643|515527826|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
142997465|NCT02528643|515527825|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
143455741|NCT02559895|517212521|FG001|Overall Study|Adverse Event|3|||
142997466|NCT02528643|515527826|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
142997467|NCT02058940|515527827|FG000|Overall Study|Discharged from Critical Care Unit|1|||
142997468|NCT01640353|515527845|FG000|Overall Study|Withdrew prior to treatment|10|||
142997469|NCT01640353|515527845|FG000|Overall Study|Withdrawn from analysis at term site|12|||
142997470|NCT01640353|515527845|FG000|Overall Study|Withdrawal by Subject|5|||
142997471|NCT01640353|515527845|FG000|Overall Study|Death|2|||
142997472|NCT01640353|515527845|FG000|Overall Study|Early site termination|3|||
142997473|NCT01640353|515527845|FG000|Overall Study|Lost to Follow-up|12|||
142997474|NCT01640353|515527845|FG000|Overall Study|Physician Decision|1|||
142997475|NCT03758612|515527846|FG000|Washout Period|Withdrawal by Subject|0|||
142997476|NCT03758612|515527847|FG001|Washout Period|Withdrawal by Subject|0|||
142997477|NCT03758612|515527848|FG002|Washout Period|Withdrawal by Subject|2|||
142997478|NCT03758612|515527849|FG003|Washout Period|Withdrawal by Subject|0|||
142997479|NCT03758612|515527850|FG004|Washout Period|Withdrawal by Subject|0|||
142997480|NCT03758612|515527851|FG005|Washout Period|Withdrawal by Subject|0|||
142997481|NCT03758612|515527852|FG006|Washout Period|Withdrawal by Subject|0|||
142997482|NCT03758612|515527853|FG007|Washout Period|Withdrawal by Subject|0|||
142997483|NCT03758612|515527854|FG008|Washout Period|Withdrawal by Subject|0|||
142997484|NCT03758612|515527855|FG009|Washout Period|Withdrawal by Subject|0|||
142997485|NCT03758612|515527856|FG010|Washout Period|Withdrawal by Subject|0|||
142997486|NCT03758612|515527857|FG011|Washout Period|Withdrawal by Subject|0|||
142997487|NCT03758612|515527846|FG000|Period 2|Protocol Violation|0|||
142997488|NCT03758612|515527847|FG001|Period 2|Protocol Violation|0|||
142997489|NCT03758612|515527848|FG002|Period 2|Protocol Violation|0|||
142997490|NCT03758612|515527849|FG003|Period 2|Protocol Violation|0|||
142997491|NCT03758612|515527850|FG004|Period 2|Protocol Violation|1|||
142997492|NCT03758612|515527851|FG005|Period 2|Protocol Violation|0|||
142997493|NCT03758612|515527852|FG006|Period 2|Protocol Violation|0|||
142997494|NCT03758612|515527853|FG007|Period 2|Protocol Violation|0|||
142997495|NCT03758612|515527854|FG008|Period 2|Protocol Violation|0|||
142997496|NCT03758612|515527855|FG009|Period 2|Protocol Violation|0|||
142997497|NCT03758612|515527856|FG010|Period 2|Protocol Violation|0|||
142997498|NCT03758612|515527857|FG011|Period 2|Protocol Violation|0|||
142997499|NCT01603615|515527859|FG000|Overall Study|Did not Receive Treatment|7|||
142997500|NCT01603615|515527859|FG000|Overall Study|Lost to Follow-up|9|||
142997501|NCT01603615|515527859|FG000|Overall Study|Personal Reasons|17|||
142997502|NCT01603615|515527859|FG000|Overall Study|Other Miscellaneous|1|||
142997503|NCT02719028|515527860|FG000|Overall Study|Adverse Event|2|||
142997504|NCT02719028|515527861|FG001|Overall Study|Adverse Event|1|||
142997505|NCT02719028|515527862|FG002|Overall Study|Adverse Event|4|||
142997506|NCT02719028|515527863|FG003|Overall Study|Adverse Event|8|||
142997507|NCT02719028|515527860|FG000|Overall Study|Physician Decision|0|||
142997508|NCT02719028|515527861|FG001|Overall Study|Physician Decision|1|||
142997509|NCT02719028|515527862|FG002|Overall Study|Physician Decision|1|||
142997510|NCT02719028|515527863|FG003|Overall Study|Physician Decision|1|||
142997511|NCT02719028|515527860|FG000|Overall Study|Use of prohibited medication|0|||
142997512|NCT02719028|515527861|FG001|Overall Study|Use of prohibited medication|0|||
142997513|NCT02719028|515527862|FG002|Overall Study|Use of prohibited medication|1|||
142997514|NCT02719028|515527863|FG003|Overall Study|Use of prohibited medication|0|||
142997515|NCT02719028|515527860|FG000|Overall Study|Protocol Violation|0|||
142997516|NCT02719028|515527861|FG001|Overall Study|Protocol Violation|0|||
142997517|NCT02719028|515527862|FG002|Overall Study|Protocol Violation|0|||
142997518|NCT02719028|515527863|FG003|Overall Study|Protocol Violation|1|||
142997519|NCT00561912|515527870|FG000|Overall Study|ineligible|1|||
142997520|NCT02577107|515527872|FG000|Overall Study|Protocol deviation|0|||
142997521|NCT02577107|515527873|FG001|Overall Study|Protocol deviation|1|||
142997522|NCT00577382|515527874|FG000|Overall Study|Adverse Event|0|||
142997523|NCT00577382|515527875|FG001|Overall Study|Adverse Event|6|||
142997524|NCT00577382|515527874|FG000|Overall Study|Withdrawal by Subject|0|||
142997525|NCT00577382|515527875|FG001|Overall Study|Withdrawal by Subject|1|||
142997526|NCT00577382|515527874|FG000|Overall Study|Progressive Disease|17|||
142997527|NCT00577382|515527875|FG001|Overall Study|Progressive Disease|19|||
142997528|NCT00577382|515527874|FG000|Overall Study|Intercurrent Illness|1|||
142997529|NCT00577382|515527875|FG001|Overall Study|Intercurrent Illness|2|||
142997530|NCT00577382|515527874|FG000|Overall Study|Death|1|||
142997531|NCT00577382|515527875|FG001|Overall Study|Death|1|||
142997532|NCT00577382|515527874|FG000|Overall Study|Lost to Follow-up|2|||
142997533|NCT00577382|515527875|FG001|Overall Study|Lost to Follow-up|2|||
142997534|NCT03007472|515527876|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
142997535|NCT03007472|515527876|FG000|Overall Study|Death|2|||
142997536|NCT03007472|515527876|FG000|Overall Study|Loss to Follow Up|1|||
142997537|NCT02906644|515527877|FG000|First 2 Weeks|Withdrawal by Subject|0|||
142997538|NCT02906644|515527878|FG001|First 2 Weeks|Withdrawal by Subject|2|||
142997539|NCT02906644|515527877|FG000|First 2 Weeks|Physician Decision|1|||
142997540|NCT02906644|515527878|FG001|First 2 Weeks|Physician Decision|1|||
142997541|NCT02906644|515527877|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
142997542|NCT02906644|515527878|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
142997543|NCT02906644|515527877|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
142997544|NCT02906644|515527878|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
142997545|NCT01014442|515527881|FG000|Overall Study|Adverse Event|0|||
142997546|NCT01014442|515527882|FG001|Overall Study|Adverse Event|8|||
142997547|NCT01014442|515527881|FG000|Overall Study|Withdrawal by Subject|4|||
142997548|NCT01014442|515527882|FG001|Overall Study|Withdrawal by Subject|4|||
142997549|NCT01014442|515527881|FG000|Overall Study|Protocol Violation|2|||
142997550|NCT01014442|515527882|FG001|Overall Study|Protocol Violation|5|||
142997551|NCT01014442|515527881|FG000|Overall Study|Lack of Compliance|0|||
142997552|NCT01014442|515527882|FG001|Overall Study|Lack of Compliance|1|||
142997553|NCT01014442|515527881|FG000|Overall Study|Unspecified Reason|1|||
142997554|NCT01014442|515527882|FG001|Overall Study|Unspecified Reason|1|||
142997555|NCT02764229|515527883|FG000|Overall Study|Withdrawal by Subject|15|||
142997556|NCT02764229|515527883|FG000|Overall Study|Adverse Event|9|||
142997557|NCT02764229|515527883|FG000|Overall Study|Physician Decision|5|||
142997558|NCT02764229|515527883|FG000|Overall Study|Lost to Follow-up|3|||
142997559|NCT02764229|515527883|FG000|Overall Study|Lack of Efficacy|1|||
142997560|NCT02764229|515527883|FG000|Overall Study|Study Stopped by Sponsor|69|||
142997561|NCT02030067|515527885|FG000|Overall Study|Disease Progression|1|||
142997562|NCT02030067|515527886|FG001|Overall Study|Disease Progression|1|||
142997563|NCT02030067|515527887|FG002|Overall Study|Disease Progression|2|||
142997564|NCT02030067|515527888|FG003|Overall Study|Disease Progression|2|||
142997565|NCT02030067|515527889|FG004|Overall Study|Disease Progression|3|||
142997566|NCT02030067|515527890|FG005|Overall Study|Disease Progression|2|||
142997567|NCT02030067|515527891|FG006|Overall Study|Disease Progression|3|||
142997568|NCT02030067|515527892|FG007|Overall Study|Disease Progression|3|||
142997569|NCT02030067|515527893|FG008|Overall Study|Disease Progression|4|||
142997570|NCT02030067|515527894|FG009|Overall Study|Disease Progression|3|||
142997571|NCT02030067|515527895|FG010|Overall Study|Disease Progression|7|||
142997572|NCT02030067|515527896|FG011|Overall Study|Disease Progression|2|||
142997573|NCT02030067|515527897|FG012|Overall Study|Disease Progression|59|||
142997574|NCT02030067|515527885|FG000|Overall Study|Withdrawal by Subject|0|||
142997575|NCT02030067|515527886|FG001|Overall Study|Withdrawal by Subject|0|||
142997576|NCT02030067|515527887|FG002|Overall Study|Withdrawal by Subject|0|||
142997577|NCT02030067|515527888|FG003|Overall Study|Withdrawal by Subject|1|||
142997578|NCT02030067|515527889|FG004|Overall Study|Withdrawal by Subject|0|||
142997579|NCT02030067|515527890|FG005|Overall Study|Withdrawal by Subject|0|||
142997580|NCT02030067|515527891|FG006|Overall Study|Withdrawal by Subject|0|||
142997581|NCT02030067|515527892|FG007|Overall Study|Withdrawal by Subject|1|||
142997582|NCT02030067|515527893|FG008|Overall Study|Withdrawal by Subject|0|||
142997583|NCT02030067|515527894|FG009|Overall Study|Withdrawal by Subject|0|||
142997584|NCT02030067|515527895|FG010|Overall Study|Withdrawal by Subject|3|||
142997585|NCT02030067|515527896|FG011|Overall Study|Withdrawal by Subject|0|||
142997586|NCT02030067|515527897|FG012|Overall Study|Withdrawal by Subject|6|||
142997587|NCT02030067|515527885|FG000|Overall Study|Physician Decision|0|||
142997588|NCT02030067|515527886|FG001|Overall Study|Physician Decision|0|||
142997589|NCT02030067|515527887|FG002|Overall Study|Physician Decision|0|||
142997590|NCT02030067|515527888|FG003|Overall Study|Physician Decision|0|||
142997591|NCT02030067|515527889|FG004|Overall Study|Physician Decision|0|||
142997592|NCT02030067|515527890|FG005|Overall Study|Physician Decision|0|||
142997593|NCT02030067|515527891|FG006|Overall Study|Physician Decision|0|||
142997594|NCT02030067|515527892|FG007|Overall Study|Physician Decision|0|||
142997595|NCT02030067|515527893|FG008|Overall Study|Physician Decision|0|||
142997596|NCT02030067|515527894|FG009|Overall Study|Physician Decision|0|||
142997597|NCT02030067|515527895|FG010|Overall Study|Physician Decision|1|||
142997598|NCT02030067|515527896|FG011|Overall Study|Physician Decision|0|||
142997599|NCT02030067|515527897|FG012|Overall Study|Physician Decision|3|||
142997600|NCT02030067|515527885|FG000|Overall Study|other reasons|0|||
142997601|NCT02030067|515527886|FG001|Overall Study|other reasons|0|||
142997602|NCT02030067|515527887|FG002|Overall Study|other reasons|0|||
142997603|NCT02030067|515527888|FG003|Overall Study|other reasons|0|||
142997604|NCT02030067|515527889|FG004|Overall Study|other reasons|0|||
142997605|NCT02030067|515527890|FG005|Overall Study|other reasons|1|||
142997606|NCT02030067|515527891|FG006|Overall Study|other reasons|0|||
142997607|NCT02030067|515527892|FG007|Overall Study|other reasons|0|||
142997608|NCT02030067|515527893|FG008|Overall Study|other reasons|2|||
142997609|NCT02030067|515527894|FG009|Overall Study|other reasons|0|||
142997610|NCT02030067|515527895|FG010|Overall Study|other reasons|0|||
142997611|NCT02030067|515527896|FG011|Overall Study|other reasons|0|||
142997612|NCT02030067|515527897|FG012|Overall Study|other reasons|4|||
142997613|NCT02030067|515527885|FG000|Overall Study|Adverse Event|0|||
142997614|NCT02030067|515527886|FG001|Overall Study|Adverse Event|0|||
142997615|NCT02030067|515527887|FG002|Overall Study|Adverse Event|0|||
142997616|NCT02030067|515527888|FG003|Overall Study|Adverse Event|0|||
142997617|NCT02030067|515527889|FG004|Overall Study|Adverse Event|0|||
142997618|NCT02030067|515527890|FG005|Overall Study|Adverse Event|0|||
142997619|NCT02030067|515527891|FG006|Overall Study|Adverse Event|0|||
142997620|NCT02030067|515527892|FG007|Overall Study|Adverse Event|0|||
142997621|NCT02030067|515527893|FG008|Overall Study|Adverse Event|0|||
142997622|NCT02030067|515527894|FG009|Overall Study|Adverse Event|0|||
142997623|NCT02030067|515527895|FG010|Overall Study|Adverse Event|0|||
142997624|NCT02030067|515527896|FG011|Overall Study|Adverse Event|1|||
142997625|NCT02030067|515527897|FG012|Overall Study|Adverse Event|8|||
142997626|NCT03451630|515527900|FG000|Overall Study|Death|15|||
142997627|NCT03451630|515527901|FG001|Overall Study|Death|16|||
142997628|NCT03451630|515527902|FG002|Overall Study|Death|11|||
142997629|NCT03451630|515527900|FG000|Overall Study|Lost to Follow-up|9|||
142997630|NCT03451630|515527901|FG001|Overall Study|Lost to Follow-up|0|||
142997631|NCT03451630|515527902|FG002|Overall Study|Lost to Follow-up|4|||
142997632|NCT03451630|515527900|FG000|Overall Study|Withdrawal by Subject|0|||
142997633|NCT03451630|515527901|FG001|Overall Study|Withdrawal by Subject|3|||
142997634|NCT03451630|515527902|FG002|Overall Study|Withdrawal by Subject|0|||
142997635|NCT03451630|515527900|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
142997636|NCT03451630|515527901|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
142997637|NCT03451630|515527902|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
142997638|NCT00089505|515527903|FG000|Overall Study|Death|4|||
142997639|NCT00089505|515527904|FG001|Overall Study|Death|1|||
142997640|NCT00089505|515527905|FG002|Overall Study|Death|5|||
142997641|NCT00089505|515527906|FG003|Overall Study|Death|8|||
142997642|NCT00089505|515527903|FG000|Overall Study|Withdrawal by Subject|3|||
142997643|NCT00089505|515527904|FG001|Overall Study|Withdrawal by Subject|0|||
142997644|NCT00089505|515527905|FG002|Overall Study|Withdrawal by Subject|6|||
142997645|NCT00089505|515527906|FG003|Overall Study|Withdrawal by Subject|6|||
142997646|NCT00089505|515527903|FG000|Overall Study|Lost to Follow-up|1|||
142997647|NCT00089505|515527904|FG001|Overall Study|Lost to Follow-up|1|||
142997648|NCT00089505|515527905|FG002|Overall Study|Lost to Follow-up|9|||
142997649|NCT00089505|515527906|FG003|Overall Study|Lost to Follow-up|7|||
142997650|NCT00089505|515527903|FG000|Overall Study|Physician Decision|1|||
142997651|NCT00089505|515527904|FG001|Overall Study|Physician Decision|0|||
142997652|NCT00089505|515527905|FG002|Overall Study|Physician Decision|0|||
142997653|NCT00089505|515527906|FG003|Overall Study|Physician Decision|0|||
142997654|NCT00089505|515527903|FG000|Overall Study|Protocol Violation|0|||
142997655|NCT00089505|515527904|FG001|Overall Study|Protocol Violation|0|||
142997656|NCT00089505|515527905|FG002|Overall Study|Protocol Violation|1|||
142997657|NCT00089505|515527906|FG003|Overall Study|Protocol Violation|0|||
142997658|NCT01646255|515527911|FG000|Overall Study|Adverse Event|7|||
142997659|NCT01646255|515527912|FG001|Overall Study|Adverse Event|8|||
142997660|NCT01646255|515527911|FG000|Overall Study|Lack of Efficacy|2|||
142997661|NCT01646255|515527912|FG001|Overall Study|Lack of Efficacy|0|||
142997662|NCT01646255|515527911|FG000|Overall Study|Withdrawal by Subject|10|||
142997663|NCT01646255|515527912|FG001|Overall Study|Withdrawal by Subject|6|||
142997664|NCT01646255|515527911|FG000|Overall Study|Compliance is not well|1|||
142997665|NCT01646255|515527912|FG001|Overall Study|Compliance is not well|0|||
142997666|NCT01646255|515527911|FG000|Overall Study|Inclusion Criteria Deviation|1|||
142997667|NCT01646255|515527912|FG001|Overall Study|Inclusion Criteria Deviation|0|||
142997668|NCT01376908|515527913|FG000|Overall Study|Protocol Violation|1|||
142997669|NCT01376908|515527914|FG001|Overall Study|Protocol Violation|1|||
142997670|NCT01376908|515527913|FG000|Overall Study|Withdrawal by Subject|1|||
142997671|NCT01376908|515527914|FG001|Overall Study|Withdrawal by Subject|2|||
142997672|NCT02142712|515527915|FG000|Overall Study|Lost to Follow-up|1|||
142997673|NCT02142712|515527916|FG001|Overall Study|Lost to Follow-up|1|||
142997674|NCT02142712|515527917|FG002|Overall Study|Lost to Follow-up|1|||
142997675|NCT02142712|515527918|FG003|Overall Study|Lost to Follow-up|0|||
142997676|NCT03480841|515527919|FG000|Overall Study|Lost to Follow-up|2|||
142997677|NCT02853318|515527922|FG000|Overall Study|Withdrawal by Subject|1|||
142997678|NCT02646332|515527925|FG000|Overall Study|Lost to Follow-up|0|||
142997679|NCT02646332|515527926|FG001|Overall Study|Lost to Follow-up|3|||
142997680|NCT01882439|515527927|FG000|Overall Study|Adverse event related to study drug|3|||
142997681|NCT01882439|515527928|FG001|Overall Study|Adverse event related to study drug|8|||
142997682|NCT01882439|515527929|FG002|Overall Study|Adverse event related to study drug|1|||
142997683|NCT01882439|515527930|FG003|Overall Study|Adverse event related to study drug|2|||
142997684|NCT01882439|515527927|FG000|Overall Study|Pregnancy|0|||
142997685|NCT01882439|515527928|FG001|Overall Study|Pregnancy|1|||
142997686|NCT01882439|515527929|FG002|Overall Study|Pregnancy|0|||
142997687|NCT01882439|515527930|FG003|Overall Study|Pregnancy|0|||
142997688|NCT01882439|515527927|FG000|Overall Study|Protocol Violation|2|||
142997689|NCT01882439|515527928|FG001|Overall Study|Protocol Violation|2|||
142997690|NCT01882439|515527929|FG002|Overall Study|Protocol Violation|0|||
142997691|NCT01882439|515527930|FG003|Overall Study|Protocol Violation|1|||
142997692|NCT01882439|515527927|FG000|Overall Study|No longer willing to participate|1|||
142997693|NCT01882439|515527928|FG001|Overall Study|No longer willing to participate|4|||
142997694|NCT01882439|515527929|FG002|Overall Study|No longer willing to participate|2|||
142997695|NCT01882439|515527930|FG003|Overall Study|No longer willing to participate|3|||
142997696|NCT01882439|515527927|FG000|Overall Study|Medication error with no associated AE|0|||
142997697|NCT01882439|515527928|FG001|Overall Study|Medication error with no associated AE|0|||
142997698|NCT01882439|515527929|FG002|Overall Study|Medication error with no associated AE|2|||
142997699|NCT01882439|515527930|FG003|Overall Study|Medication error with no associated AE|0|||
142997700|NCT01882439|515527927|FG000|Overall Study|Insufficient clinical response|1|||
142997701|NCT01882439|515527928|FG001|Overall Study|Insufficient clinical response|4|||
142997702|NCT01882439|515527929|FG002|Overall Study|Insufficient clinical response|4|||
142997703|NCT01882439|515527930|FG003|Overall Study|Insufficient clinical response|2|||
142997704|NCT01882439|515527927|FG000|Overall Study|Adverse event unrelated to study drug|2|||
142997705|NCT01882439|515527928|FG001|Overall Study|Adverse event unrelated to study drug|2|||
142997706|NCT01882439|515527929|FG002|Overall Study|Adverse event unrelated to study drug|1|||
142997707|NCT01882439|515527930|FG003|Overall Study|Adverse event unrelated to study drug|1|||
142997708|NCT03125902|515527933|FG000|Overall Study|Adverse Event|0|||
142997709|NCT03125902|515527934|FG001|Overall Study|Adverse Event|1|||
142997710|NCT03125902|515527933|FG000|Overall Study|Death|119|||
142997711|NCT03125902|515527934|FG001|Overall Study|Death|229|||
142997712|NCT03125902|515527933|FG000|Overall Study|Lost to Follow-up|4|||
142997713|NCT03125902|515527934|FG001|Overall Study|Lost to Follow-up|13|||
142997714|NCT03125902|515527933|FG000|Overall Study|Other|0|||
142997715|NCT03125902|515527934|FG001|Overall Study|Other|4|||
142997716|NCT03125902|515527933|FG000|Overall Study|Physician Decision|2|||
142997717|NCT03125902|515527934|FG001|Overall Study|Physician Decision|1|||
142997718|NCT03125902|515527933|FG000|Overall Study|Progressive Disease|0|||
142997719|NCT03125902|515527934|FG001|Overall Study|Progressive Disease|3|||
142997720|NCT03125902|515527933|FG000|Overall Study|Study Terminated By Sponsor|74|||
142997721|NCT03125902|515527934|FG001|Overall Study|Study Terminated By Sponsor|143|||
142997722|NCT03125902|515527933|FG000|Overall Study|Withdrawal by Subject|21|||
142997723|NCT03125902|515527934|FG001|Overall Study|Withdrawal by Subject|37|||
142997724|NCT01775995|515527935|FG000|Overall Study|Lost to Follow-up|1|||
142997725|NCT01775995|515527936|FG001|Overall Study|Lost to Follow-up|1|||
142997726|NCT01997333|515527937|FG000|Randomization and Treatment|Disease Progression|70|||
142997727|NCT01997333|515527938|FG001|Randomization and Treatment|Disease Progression|159|||
142997728|NCT01997333|515527937|FG000|Randomization and Treatment|Adverse Event|10|||
142997729|NCT01997333|515527938|FG001|Randomization and Treatment|Adverse Event|32|||
142997730|NCT01997333|515527937|FG000|Randomization and Treatment|Physician Decision|0|||
142997731|NCT01997333|515527938|FG001|Randomization and Treatment|Physician Decision|4|||
142997732|NCT01997333|515527937|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
142997733|NCT01997333|515527938|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
142997734|NCT01997333|515527937|FG000|Randomization and Treatment|Did not receive treatment|17|||
142997735|NCT01997333|515527938|FG001|Randomization and Treatment|Did not receive treatment|5|||
142997736|NCT01997333|515527937|FG000|Survival Follow up|Withdrawal by Subject|15|||
142997737|NCT01997333|515527938|FG001|Survival Follow up|Withdrawal by Subject|6|||
142997738|NCT01997333|515527937|FG000|Survival Follow up|Lost to Follow-up|0|||
142997739|NCT01997333|515527938|FG001|Survival Follow up|Lost to Follow-up|6|||
142997740|NCT01997333|515527937|FG000|Survival Follow up|Various|1|||
142997741|NCT01997333|515527938|FG001|Survival Follow up|Various|2|||
142997742|NCT02909504|515527939|FG000|Overall Study|Adverse Event|2|||
142997743|NCT02909504|515527939|FG000|Overall Study|Lack of Efficacy|3|||
142997744|NCT02909504|515527939|FG000|Overall Study|Withdrawal by Subject|4|||
142997745|NCT02909504|515527939|FG000|Overall Study|Pregnancy|1|||
142997746|NCT02909504|515527939|FG000|Overall Study|Subject moved|1|||
142997747|NCT02909504|515527939|FG000|Overall Study|Lost to Follow-up|1|||
142997748|NCT02504424|515527942|FG000|Overall Study|Withdrawal by Subject|2|||
142997749|NCT00440232|515527946|FG000|Overall Study|Lost to Follow-up|1|||
142997750|NCT00440232|515527947|FG001|Overall Study|Lost to Follow-up|1|||
142997751|NCT00440232|515527946|FG000|Overall Study|Unable to treat within allowed time|0|||
142997752|NCT00440232|515527947|FG001|Overall Study|Unable to treat within allowed time|1|||
142997753|NCT00440232|515527946|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
142997754|NCT00440232|515527947|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
142997755|NCT00362297|515527948|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
142997756|NCT00362297|515527949|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
142997757|NCT01747655|515527954|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
142997758|NCT01747655|515527955|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
142997759|NCT01747655|515527954|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
142997760|NCT01747655|515527955|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
142997761|NCT01747655|515527954|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
142997762|NCT01747655|515527955|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
142997763|NCT00982111|515527956|FG000|Overall Study|Adverse Event|1|||
142997764|NCT00982111|515527957|FG001|Overall Study|Adverse Event|1|||
142997765|NCT00982111|515527956|FG000|Overall Study|Progressive Disease|46|||
142997766|NCT00982111|515527957|FG001|Overall Study|Progressive Disease|39|||
142997767|NCT00982111|515527956|FG000|Overall Study|Lost to Follow-up|9|||
142997768|NCT00982111|515527957|FG001|Overall Study|Lost to Follow-up|6|||
143455742|NCT02559895|517212522|FG002|Overall Study|Adverse Event|2|||
143455743|NCT02559895|517212523|FG003|Overall Study|Adverse Event|1|||
142997769|NCT00982111|515527956|FG000|Overall Study|New Anti-Cancer Therapy|5|||
142997770|NCT00982111|515527957|FG001|Overall Study|New Anti-Cancer Therapy|5|||
142997771|NCT00982111|515527956|FG000|Overall Study|Medical Decision|1|||
142997772|NCT00982111|515527957|FG001|Overall Study|Medical Decision|0|||
142997773|NCT00982111|515527956|FG000|Overall Study|Withdrawal by Subject|17|||
142997774|NCT00982111|515527957|FG001|Overall Study|Withdrawal by Subject|19|||
142997775|NCT00982111|515527956|FG000|Overall Study|Global Study End|0|||
142997776|NCT00982111|515527957|FG001|Overall Study|Global Study End|1|||
142997777|NCT00982111|515527956|FG000|Overall Study|Sponsor's Decision|0|||
142997778|NCT00982111|515527957|FG001|Overall Study|Sponsor's Decision|1|||
143455744|NCT02559895|517212520|FG000|Overall Study|Lack of Efficacy|2|||
142997779|NCT01070381|515527958|FG000|Period 2, 1 Week of Wear|Handling|0|||
142997780|NCT01070381|515527959|FG001|Period 2, 1 Week of Wear|Handling|1|||
142997781|NCT01070381|515527958|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
142997782|NCT01070381|515527959|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
142997783|NCT01657903|515527960|FG000|Overall Study|Lost to Follow-up|1|||
142997784|NCT01657903|515527960|FG000|Overall Study|Withdrawal by Subject|1|||
142997785|NCT01259388|515527961|FG000|Overall Study|Adverse Event|3|||
142997786|NCT01259388|515527962|FG001|Overall Study|Adverse Event|0|||
142997787|NCT01259388|515527961|FG000|Overall Study|Withdrawal by Subject|1|||
142997788|NCT01259388|515527962|FG001|Overall Study|Withdrawal by Subject|1|||
142997789|NCT01259388|515527961|FG000|Overall Study|Physician Decision|1|||
142997790|NCT01259388|515527962|FG001|Overall Study|Physician Decision|0|||
142997791|NCT03512028|515527963|FG000|Overall Study|Withdrawal by Subject|2|||
142997792|NCT03512028|515527964|FG001|Overall Study|Withdrawal by Subject|0|||
142997793|NCT03512028|515527963|FG000|Overall Study|Protocol Violation|2|||
142997794|NCT03512028|515527964|FG001|Overall Study|Protocol Violation|0|||
142997795|NCT00453349|515527965|FG000|Randomized|Adverse Event|12|||
142997796|NCT00453349|515527966|FG001|Randomized|Adverse Event|11|||
142997797|NCT00453349|515527965|FG000|Randomized|Lack of Efficacy|2|||
142997798|NCT00453349|515527966|FG001|Randomized|Lack of Efficacy|1|||
142997799|NCT00453349|515527965|FG000|Randomized|Lost to Follow-up|7|||
142997800|NCT00453349|515527966|FG001|Randomized|Lost to Follow-up|5|||
142997801|NCT00453349|515527965|FG000|Randomized|Protocol Violation|1|||
142997802|NCT00453349|515527966|FG001|Randomized|Protocol Violation|1|||
142997803|NCT00453349|515527965|FG000|Randomized|Withdrawal by Subject|3|||
142997804|NCT00453349|515527966|FG001|Randomized|Withdrawal by Subject|5|||
142997805|NCT00453349|515527965|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
142997806|NCT00453349|515527966|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
142997807|NCT00453349|515527965|FG000|Completed Study|Adverse Event|12|||
142997808|NCT00453349|515527966|FG001|Completed Study|Adverse Event|11|||
142997809|NCT00453349|515527965|FG000|Completed Study|Lack of Efficacy|2|||
142997810|NCT00453349|515527966|FG001|Completed Study|Lack of Efficacy|1|||
142997811|NCT00453349|515527965|FG000|Completed Study|Lost to Follow-up|7|||
142997812|NCT00453349|515527966|FG001|Completed Study|Lost to Follow-up|5|||
142997813|NCT00453349|515527965|FG000|Completed Study|Protocol Violation|1|||
142997814|NCT00453349|515527966|FG001|Completed Study|Protocol Violation|1|||
142997815|NCT00453349|515527965|FG000|Completed Study|Withdrawal by Subject|3|||
142997816|NCT00453349|515527966|FG001|Completed Study|Withdrawal by Subject|5|||
142997817|NCT00453349|515527965|FG000|Completed Study|Lost to follow up after study treatment|2|||
142997818|NCT00453349|515527966|FG001|Completed Study|Lost to follow up after study treatment|11|||
142997819|NCT01513460|515527971|FG000|Overall Study|Death|0|||
142997820|NCT01513460|515527972|FG001|Overall Study|Death|0|||
142997821|NCT01513460|515527973|FG002|Overall Study|Death|1|||
142997822|NCT01513460|515527971|FG000|Overall Study|Lost to Follow-up|0|||
142997823|NCT01513460|515527972|FG001|Overall Study|Lost to Follow-up|0|||
142997824|NCT01513460|515527973|FG002|Overall Study|Lost to Follow-up|2|||
142997825|NCT01513460|515527971|FG000|Overall Study|Abnormal laboratory value|1|||
142997826|NCT01513460|515527972|FG001|Overall Study|Abnormal laboratory value|0|||
142997827|NCT01513460|515527973|FG002|Overall Study|Abnormal laboratory value|1|||
142997828|NCT01513460|515527971|FG000|Overall Study|Lack of Efficacy|1|||
142997829|NCT01513460|515527972|FG001|Overall Study|Lack of Efficacy|2|||
142997830|NCT01513460|515527973|FG002|Overall Study|Lack of Efficacy|5|||
142997831|NCT01513460|515527971|FG000|Overall Study|Protocol deviations|3|||
142997832|NCT01513460|515527972|FG001|Overall Study|Protocol deviations|4|||
142997833|NCT01513460|515527973|FG002|Overall Study|Protocol deviations|3|||
142997834|NCT01513460|515527971|FG000|Overall Study|Withdrawal by Subject|7|||
142997835|NCT01513460|515527972|FG001|Overall Study|Withdrawal by Subject|8|||
142997836|NCT01513460|515527973|FG002|Overall Study|Withdrawal by Subject|21|||
142997837|NCT01513460|515527971|FG000|Overall Study|Adverse Event|16|||
142997838|NCT01513460|515527972|FG001|Overall Study|Adverse Event|18|||
142997839|NCT01513460|515527973|FG002|Overall Study|Adverse Event|23|||
142997840|NCT01513460|515527971|FG000|Overall Study|Abnormal test procedure|1|||
142997841|NCT01513460|515527972|FG001|Overall Study|Abnormal test procedure|0|||
142997842|NCT01513460|515527973|FG002|Overall Study|Abnormal test procedure|0|||
142997843|NCT00701064|515527974|FG000|Overall Study|Protocol Violation|1|||
142997844|NCT00701064|515527975|FG001|Overall Study|Protocol Violation|1|||
142997845|NCT00701064|515527974|FG000|Overall Study|Withdrawal by Subject|1|||
142997846|NCT00701064|515527975|FG001|Overall Study|Withdrawal by Subject|1|||
142997847|NCT00701064|515527974|FG000|Overall Study|initiated other PTSD treatment|2|||
142997848|NCT00701064|515527975|FG001|Overall Study|initiated other PTSD treatment|2|||
142997849|NCT01884675|515529818|FG000|Overall Study|Study closed/terminated|3|||
142997850|NCT01884675|515529819|FG001|Overall Study|Study closed/terminated|2|||
142997851|NCT02361307|515529820|FG000|Overall Study|Unstable medical condition.|0|||
142997852|NCT02361307|515529821|FG001|Overall Study|Unstable medical condition.|1|||
142997853|NCT00711009|515529822|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
142997854|NCT00711009|515529823|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
142997855|NCT00711009|515529822|FG000|Overall Study|Withdrawal by Subject|4|||
142997856|NCT00711009|515529823|FG001|Overall Study|Withdrawal by Subject|2|||
142997857|NCT00711009|515529822|FG000|Overall Study|Lost to Follow-up|3|||
142997858|NCT00711009|515529823|FG001|Overall Study|Lost to Follow-up|9|||
142997859|NCT00711009|515529822|FG000|Overall Study|Participant Noncompliant|0|||
142997860|NCT00711009|515529823|FG001|Overall Study|Participant Noncompliant|1|||
142997861|NCT00711009|515529822|FG000|Overall Study|Virologic Failure|2|||
142997862|NCT00711009|515529823|FG001|Overall Study|Virologic Failure|1|||
142997863|NCT00711009|515529822|FG000|Overall Study|Pregnancy|1|||
142997864|NCT00711009|515529823|FG001|Overall Study|Pregnancy|0|||
142997865|NCT00711009|515529822|FG000|Overall Study|Site closing|0|||
142997866|NCT00711009|515529823|FG001|Overall Study|Site closing|1|||
142997867|NCT00711009|515529822|FG000|Overall Study|Dose adjustment|1|||
142997868|NCT00711009|515529823|FG001|Overall Study|Dose adjustment|0|||
142997869|NCT03359811|515529824|FG000|Overall Study|Protocol Violation|2|||
142997870|NCT03359811|515529825|FG001|Overall Study|Protocol Violation|0|||
142997871|NCT01682876|515529827|FG000|Overall Study|Administrative reason|4|||
142997872|NCT01682876|515529828|FG001|Overall Study|Administrative reason|4|||
142997873|NCT01682876|515529829|FG002|Overall Study|Administrative reason|0|||
142997874|NCT01682876|515529830|FG003|Overall Study|Administrative reason|3|||
142997875|NCT01682876|515529827|FG000|Overall Study|Adverse Event|0|||
142997876|NCT01682876|515529828|FG001|Overall Study|Adverse Event|0|||
142997877|NCT01682876|515529829|FG002|Overall Study|Adverse Event|0|||
142997878|NCT01682876|515529830|FG003|Overall Study|Adverse Event|1|||
142997879|NCT01682876|515529827|FG000|Overall Study|Lost to Follow-up|11|||
142997880|NCT01682876|515529828|FG001|Overall Study|Lost to Follow-up|15|||
142997881|NCT01682876|515529829|FG002|Overall Study|Lost to Follow-up|9|||
142997882|NCT01682876|515529830|FG003|Overall Study|Lost to Follow-up|11|||
142997883|NCT01682876|515529827|FG000|Overall Study|Protocol Violation|1|||
142997884|NCT01682876|515529828|FG001|Overall Study|Protocol Violation|1|||
142997885|NCT01682876|515529829|FG002|Overall Study|Protocol Violation|1|||
142997886|NCT01682876|515529830|FG003|Overall Study|Protocol Violation|1|||
142997887|NCT01682876|515529827|FG000|Overall Study|Withdrawal by Subject|4|||
142997888|NCT01682876|515529828|FG001|Overall Study|Withdrawal by Subject|0|||
142997889|NCT01682876|515529829|FG002|Overall Study|Withdrawal by Subject|0|||
142997890|NCT01682876|515529830|FG003|Overall Study|Withdrawal by Subject|2|||
142997891|NCT01682876|515529827|FG000|Overall Study|Other|1|||
142997892|NCT01682876|515529828|FG001|Overall Study|Other|0|||
142997893|NCT01682876|515529829|FG002|Overall Study|Other|1|||
142997894|NCT01682876|515529830|FG003|Overall Study|Other|1|||
142997895|NCT00240331|515529836|FG000|Overall Study|Withdrawal by Subject|125|||
142997896|NCT00240331|515529837|FG001|Overall Study|Withdrawal by Subject|132|||
142997897|NCT00240331|515529836|FG000|Overall Study|Option selected by investigator|1|||
142997898|NCT00240331|515529837|FG001|Overall Study|Option selected by investigator|2|||
142997899|NCT02551874|515529842|FG000|Overall Study|Lost to Follow-up|0|||
142997900|NCT02551874|515529843|FG001|Overall Study|Lost to Follow-up|2|||
142997901|NCT02551874|515529842|FG000|Overall Study|Pregnancy|0|||
142997902|NCT02551874|515529843|FG001|Overall Study|Pregnancy|1|||
142997903|NCT02551874|515529842|FG000|Overall Study|Reason not reported|10|||
142997904|NCT02551874|515529843|FG001|Overall Study|Reason not reported|4|||
142997905|NCT02551874|515529842|FG000|Overall Study|Did not receive randomized treatment|0|||
142997906|NCT02551874|515529843|FG001|Overall Study|Did not receive randomized treatment|7|||
142997907|NCT02551874|515529842|FG000|Overall Study|Did not enter long-term study|18|||
142997908|NCT02551874|515529843|FG001|Overall Study|Did not enter long-term study|25|||
142997909|NCT04563845|515529845|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
142997910|NCT04563845|515529846|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
142997911|NCT04563845|515529847|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
142997912|NCT04563845|515529848|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
142997913|NCT04563845|515529849|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
142997914|NCT04563845|515529850|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
142997915|NCT04563845|515529851|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
142997916|NCT04563845|515529852|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
142997917|NCT04563845|515529853|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
142997918|NCT04563845|515529854|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
142997919|NCT04563845|515529855|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
142997920|NCT04563845|515529856|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
142997921|NCT04563845|515529857|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
142997922|NCT04563845|515529858|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
142997923|NCT04563845|515529845|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
142997924|NCT04563845|515529846|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
142997925|NCT04563845|515529847|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
142997926|NCT04563845|515529848|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
142997927|NCT04563845|515529849|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
142997928|NCT04563845|515529850|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
142997929|NCT04563845|515529851|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
142997930|NCT04563845|515529852|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
142997931|NCT04563845|515529853|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
142997932|NCT04563845|515529854|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
142997933|NCT04563845|515529855|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
142997934|NCT04563845|515529856|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
142997935|NCT04563845|515529857|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
142997936|NCT04563845|515529858|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
142997937|NCT01020812|515529859|FG000|Overall Study|Physician Decision|1|||
142997938|NCT01020812|515529859|FG000|Overall Study|Withdrawal by Subject|1|||
142997939|NCT01020812|515529859|FG000|Overall Study|Protocol Violation|1|||
142997940|NCT02927990|515529860|FG000|Overall Study|Protocol Violation|4|||
142997941|NCT02927990|515529860|FG000|Overall Study|Physician Decision|9|||
142997942|NCT02927990|515529860|FG000|Overall Study|Room switched and therefore no study device available|15|||
142997943|NCT02927990|515529860|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
142997944|NCT00960323|515529861|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
142997945|NCT03419741|515529866|FG000|Overall Study|Adverse Event|1|||
142997946|NCT03419741|515529867|FG001|Overall Study|Adverse Event|0|||
142997947|NCT03419741|515529866|FG000|Overall Study|Withdrawal by Subject|1|||
142997948|NCT03419741|515529867|FG001|Overall Study|Withdrawal by Subject|2|||
142997949|NCT04354870|515529868|FG000|Overall Study|Lost to Follow-up|32|||
142997950|NCT04354870|515529869|FG001|Overall Study|Lost to Follow-up|12|||
142997951|NCT04354870|515529868|FG000|Overall Study|Withdrawal by Subject|10|||
142997952|NCT04354870|515529869|FG001|Overall Study|Withdrawal by Subject|16|||
142997953|NCT04354870|515529868|FG000|Overall Study|Did not complete all study visits|6|||
142997954|NCT04354870|515529869|FG001|Overall Study|Did not complete all study visits|5|||
142997955|NCT03384316|515529870|FG000|Overall Study|Screen failure|0|||
142997956|NCT03384316|515529871|FG001|Overall Study|Screen failure|1|||
142997957|NCT02194699|515529879|FG000|Randomised|Did not receive treatment|1|||
142997958|NCT02194699|515529880|FG001|Randomised|Did not receive treatment|5|||
142997959|NCT02194699|515529879|FG000|Randomised|Without potential for 52 weeks of IP|5|||
142997960|NCT02194699|515529880|FG001|Randomised|Without potential for 52 weeks of IP|5|||
142997961|NCT02194699|515529879|FG000|Randomised|Duplicate patient|2|||
142997962|NCT02194699|515529880|FG001|Randomised|Duplicate patient|1|||
142997963|NCT02194699|515529879|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
142997964|NCT02194699|515529880|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
142997965|NCT02194699|515529879|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
142997966|NCT02194699|515529880|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
142997967|NCT02194699|515529879|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
142997968|NCT02194699|515529880|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
142997969|NCT02194699|515529879|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
142997970|NCT02194699|515529880|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
142997971|NCT02194699|515529879|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
142997972|NCT02194699|515529880|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
142997973|NCT02194699|515529879|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
142997974|NCT02194699|515529880|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
142997975|NCT01539720|515529881|FG000|Overall Study|Screen Fail|15|||
142997976|NCT01539720|515529882|FG001|Overall Study|Screen Fail|3|||
142997977|NCT01539720|515529881|FG000|Overall Study|Lost to Follow-up|14|||
142997978|NCT01539720|515529882|FG001|Overall Study|Lost to Follow-up|7|||
142997979|NCT00298766|515529883|FG000|Overall Study|Adverse Event|18|||
142997980|NCT00298766|515529883|FG000|Overall Study|Death|2|||
142997981|NCT00298766|515529883|FG000|Overall Study|Withdrawal by Subject|9|||
142997982|NCT00298766|515529883|FG000|Overall Study|Treatment ongoing|4|||
142997983|NCT00298766|515529883|FG000|Overall Study|Progression of amyloid markers|4|||
142997984|NCT00298766|515529883|FG000|Overall Study|Deterioration in KPS and organ function|1|||
142997985|NCT00298766|515529883|FG000|Overall Study|Subjects overall condition deterioration|4|||
142997986|NCT00298766|515529883|FG000|Overall Study|Other|4|||
142997987|NCT03287960|515529884|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
142997988|NCT03287960|515529884|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
142997989|NCT00656136|515529887|FG000|Overall Study|Progressive disease|177|||
142997990|NCT00656136|515529888|FG001|Overall Study|Progressive disease|322|||
142997991|NCT00656136|515529887|FG000|Overall Study|Other Adverse Event|5|||
142997992|NCT00656136|515529888|FG001|Overall Study|Other Adverse Event|51|||
142997993|NCT00656136|515529887|FG000|Overall Study|Protocol Violation|2|||
142997994|NCT00656136|515529888|FG001|Overall Study|Protocol Violation|3|||
142997995|NCT00656136|515529887|FG000|Overall Study|Patient refused to take study medication|7|||
142997996|NCT00656136|515529888|FG001|Overall Study|Patient refused to take study medication|10|||
142997997|NCT00656136|515529887|FG000|Overall Study|Unknown and others|4|||
142997998|NCT00656136|515529888|FG001|Overall Study|Unknown and others|4|||
142997999|NCT01191190|515529890|FG000|Overall Study|Withdrawal by Subject|1|||
142998000|NCT00386152|515529891|FG000|Overall Study|Adverse Event|6|||
142998001|NCT00386152|515529892|FG001|Overall Study|Adverse Event|5|||
142998002|NCT00386152|515529893|FG002|Overall Study|Adverse Event|4|||
142998003|NCT00386152|515529891|FG000|Overall Study|Chang from original chemo stratification|4|||
142998004|NCT00386152|515529892|FG001|Overall Study|Chang from original chemo stratification|5|||
142998005|NCT00386152|515529893|FG002|Overall Study|Chang from original chemo stratification|6|||
142998006|NCT00386152|515529891|FG000|Overall Study|Death|3|||
142998007|NCT00386152|515529892|FG001|Overall Study|Death|0|||
142998008|NCT00386152|515529893|FG002|Overall Study|Death|1|||
142998009|NCT00386152|515529891|FG000|Overall Study|Disease progression|7|||
142998010|NCT00386152|515529892|FG001|Overall Study|Disease progression|4|||
142998011|NCT00386152|515529893|FG002|Overall Study|Disease progression|5|||
142998012|NCT00386152|515529891|FG000|Overall Study|Physician Decision|13|||
142998013|NCT00386152|515529892|FG001|Overall Study|Physician Decision|10|||
142998014|NCT00386152|515529893|FG002|Overall Study|Physician Decision|4|||
142998015|NCT00386152|515529891|FG000|Overall Study|Lost to Follow-up|1|||
142998016|NCT00386152|515529892|FG001|Overall Study|Lost to Follow-up|0|||
142998017|NCT00386152|515529893|FG002|Overall Study|Lost to Follow-up|0|||
142998018|NCT00386152|515529891|FG000|Overall Study|Completed chemotherapy|4|||
142998019|NCT00386152|515529892|FG001|Overall Study|Completed chemotherapy|5|||
142998020|NCT00386152|515529893|FG002|Overall Study|Completed chemotherapy|1|||
142998021|NCT00386152|515529891|FG000|Overall Study|Protocol Violation|3|||
142998022|NCT00386152|515529892|FG001|Overall Study|Protocol Violation|5|||
142998023|NCT00386152|515529893|FG002|Overall Study|Protocol Violation|2|||
142998024|NCT00386152|515529891|FG000|Overall Study|Withdrawal by Subject|3|||
142998025|NCT00386152|515529892|FG001|Overall Study|Withdrawal by Subject|6|||
142998026|NCT00386152|515529893|FG002|Overall Study|Withdrawal by Subject|10|||
142998027|NCT01729559|515529897|FG000|Overall Study|Protocol Violation|31|||
142998028|NCT01729559|515529898|FG001|Overall Study|Protocol Violation|28|||
142998029|NCT00661362|515529899|FG000|Overall Study|Adverse Event|5|||
142998030|NCT00661362|515529900|FG001|Overall Study|Adverse Event|4|||
142998031|NCT00661362|515529899|FG000|Overall Study|Incorrect enrollment|2|||
142998032|NCT00661362|515529900|FG001|Overall Study|Incorrect enrollment|0|||
142998033|NCT00661362|515529899|FG000|Overall Study|Study specific discontinuation criteria|4|||
142998034|NCT00661362|515529900|FG001|Overall Study|Study specific discontinuation criteria|11|||
142998035|NCT00661362|515529899|FG000|Overall Study|Withdrawal by Subject|13|||
142998036|NCT00661362|515529900|FG001|Overall Study|Withdrawal by Subject|23|||
142998037|NCT00661362|515529899|FG000|Overall Study|Lost to Follow-up|3|||
142998038|NCT00661362|515529900|FG001|Overall Study|Lost to Follow-up|1|||
142998039|NCT00661362|515529899|FG000|Overall Study|Severe non-compliance to protocol|0|||
142998040|NCT00661362|515529900|FG001|Overall Study|Severe non-compliance to protocol|1|||
142998041|NCT00661362|515529899|FG000|Overall Study|Safety reasons|1|||
142998042|NCT00661362|515529900|FG001|Overall Study|Safety reasons|0|||
142998043|NCT00661362|515529899|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
142998044|NCT00661362|515529900|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
142998045|NCT03672006|515529907|FG000|Overall Study|exclusion criteria met|0|||
142998046|NCT03672006|515529908|FG001|Overall Study|exclusion criteria met|1|||
142998047|NCT00761891|515529909|FG000|Overall Study|Withdrawal by Subject|10|||
142998048|NCT01453439|515529913|FG000|Treatment Phase|Withdrawal by Subject|13|||
142998049|NCT01453439|515529914|FG001|Treatment Phase|Withdrawal by Subject|10|||
142998050|NCT01453439|515529913|FG000|Treatment Phase|Suicidal Ideation|2|||
142998051|NCT01453439|515529914|FG001|Treatment Phase|Suicidal Ideation|0|||
142998052|NCT01453439|515529913|FG000|Treatment Phase|Need for higher level of care|1|||
142998053|NCT01453439|515529914|FG001|Treatment Phase|Need for higher level of care|1|||
142998054|NCT01453439|515529913|FG000|Treatment Phase|Therapist conflict of interest|1|||
142998055|NCT01453439|515529914|FG001|Treatment Phase|Therapist conflict of interest|0|||
142998056|NCT01453439|515529913|FG000|Follow-up|Withdrawal by Subject|0|||
142998057|NCT01453439|515529914|FG001|Follow-up|Withdrawal by Subject|1|||
142998058|NCT01453439|515529913|FG000|Follow-up|Lost to Follow-up|5|||
142998059|NCT01453439|515529914|FG001|Follow-up|Lost to Follow-up|10|||
142998060|NCT03258710|515529915|FG000|Overall Study|Adverse Event|1|||
142998061|NCT03258710|515529915|FG000|Overall Study|Protocol-defined stopping criteria|1|||
142998062|NCT03258710|515529915|FG000|Overall Study|Physician Decision|1|||
142998063|NCT02041533|515529918|FG000|Pre-Treatment Period|Disease Progression|1|||
142998064|NCT02041533|515529919|FG001|Pre-Treatment Period|Disease Progression|1|||
142998065|NCT02041533|515529918|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
142998066|NCT02041533|515529919|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
142998067|NCT02041533|515529918|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
142998068|NCT02041533|515529919|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
142998069|NCT02041533|515529918|FG000|Treatment Period|Disease progression|189|||
142998070|NCT02041533|515529919|FG001|Treatment Period|Disease progression|146|||
142998071|NCT02041533|515529918|FG000|Treatment Period|Study drug toxicity|30|||
142998072|NCT02041533|515529919|FG001|Treatment Period|Study drug toxicity|34|||
142998073|NCT02041533|515529918|FG000|Treatment Period|Death|1|||
142998074|NCT02041533|515529919|FG001|Treatment Period|Death|0|||
142998075|NCT02041533|515529918|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
142998076|NCT02041533|515529919|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
142998077|NCT02041533|515529918|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
142998078|NCT02041533|515529919|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
142998079|NCT02041533|515529918|FG000|Treatment Period|Participant withdrew consent|2|||
142998080|NCT02041533|515529919|FG001|Treatment Period|Participant withdrew consent|2|||
142998081|NCT02041533|515529918|FG000|Treatment Period|Maximum clinical benefit|0|||
142998082|NCT02041533|515529919|FG001|Treatment Period|Maximum clinical benefit|18|||
142998083|NCT02041533|515529918|FG000|Treatment Period|Poor/Non-compliance|1|||
142998084|NCT02041533|515529919|FG001|Treatment Period|Poor/Non-compliance|0|||
142998085|NCT02041533|515529918|FG000|Treatment Period|Administrative reason by sponsor|1|||
142998086|NCT02041533|515529919|FG001|Treatment Period|Administrative reason by sponsor|0|||
142998087|NCT02041533|515529918|FG000|Treatment Period|Other reasons|9|||
142998088|NCT02041533|515529919|FG001|Treatment Period|Other reasons|2|||
142998089|NCT02041533|515529918|FG000|Treatment Period|Not Reported|0|||
142998090|NCT02041533|515529919|FG001|Treatment Period|Not Reported|1|||
142998091|NCT01756846|515529920|FG000|Overall Study|Lost to Follow-up|5|||
142998092|NCT01756846|515529921|FG001|Overall Study|Lost to Follow-up|10|||
142998093|NCT01756846|515529920|FG000|Overall Study|Withdrawal by Subject|1|||
142998094|NCT01756846|515529921|FG001|Overall Study|Withdrawal by Subject|2|||
142998095|NCT00565721|515529926|FG000|Overall Study|Screen Failure|2|||
142998096|NCT00565721|515529926|FG000|Overall Study|Lost to Follow-up|6|||
142998097|NCT00565721|515529926|FG000|Overall Study|Technical Problems|1|||
142998098|NCT00565721|515529926|FG000|Overall Study|Physician Decision|2|||
142998099|NCT00565721|515529926|FG000|Overall Study|Other reasons|6|||
142998100|NCT00529152|515529927|FG000|Overall Study|Adverse Event|2|||
142998101|NCT00529152|515529927|FG000|Overall Study|Withdrawal by Subject|2|||
142998102|NCT00529152|515529927|FG000|Overall Study|Lost to Follow-up|1|||
142998103|NCT01497899|515529928|FG000|Double-Blind Phase|Randomized but not Treated|1|||
142998104|NCT01497899|515529929|FG001|Double-Blind Phase|Randomized but not Treated|0|||
142998105|NCT01497899|515529930|FG002|Double-Blind Phase|Randomized but not Treated|0|||
142998106|NCT01497899|515529931|FG003|Double-Blind Phase|Randomized but not Treated|0|||
142998107|NCT01497899|515529928|FG000|Double-Blind Phase|Adverse Event|1|||
142998108|NCT01497899|515529929|FG001|Double-Blind Phase|Adverse Event|0|||
142998109|NCT01497899|515529930|FG002|Double-Blind Phase|Adverse Event|0|||
142998110|NCT01497899|515529931|FG003|Double-Blind Phase|Adverse Event|0|||
142998111|NCT01497899|515529928|FG000|Double-Blind Phase|Lack of Efficacy|0|||
142998112|NCT01497899|515529929|FG001|Double-Blind Phase|Lack of Efficacy|1|||
142998113|NCT01497899|515529930|FG002|Double-Blind Phase|Lack of Efficacy|0|||
142998114|NCT01497899|515529931|FG003|Double-Blind Phase|Lack of Efficacy|0|||
142998115|NCT01497899|515529928|FG000|Double-Blind Phase|Investigator's Discretion|1|||
142998116|NCT01497899|515529929|FG001|Double-Blind Phase|Investigator's Discretion|0|||
142998117|NCT01497899|515529930|FG002|Double-Blind Phase|Investigator's Discretion|0|||
142998118|NCT01497899|515529931|FG003|Double-Blind Phase|Investigator's Discretion|0|||
142998119|NCT01497899|515529928|FG000|Double-Blind Phase|Withdrew Consent|0|||
142998120|NCT01497899|515529929|FG001|Double-Blind Phase|Withdrew Consent|1|||
142998121|NCT01497899|515529930|FG002|Double-Blind Phase|Withdrew Consent|0|||
142998122|NCT01497899|515529931|FG003|Double-Blind Phase|Withdrew Consent|0|||
142998123|NCT01497899|515529928|FG000|Double-Blind Phase|Lost to Follow-up|3|||
142998124|NCT01497899|515529929|FG001|Double-Blind Phase|Lost to Follow-up|2|||
142998125|NCT01497899|515529930|FG002|Double-Blind Phase|Lost to Follow-up|0|||
142998126|NCT01497899|515529931|FG003|Double-Blind Phase|Lost to Follow-up|0|||
142998127|NCT01497899|515529928|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
142998128|NCT01497899|515529929|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
142998129|NCT01497899|515529930|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
142998130|NCT01497899|515529931|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
142998131|NCT01497899|515529928|FG000|Open-Label Extension Phase|Adverse Event|1|||
142998132|NCT01497899|515529929|FG001|Open-Label Extension Phase|Adverse Event|0|||
142998133|NCT01497899|515529930|FG002|Open-Label Extension Phase|Adverse Event|0|||
142998134|NCT01497899|515529931|FG003|Open-Label Extension Phase|Adverse Event|0|||
142998135|NCT01497899|515529928|FG000|Open-Label Extension Phase|Death|1|||
142998136|NCT01497899|515529929|FG001|Open-Label Extension Phase|Death|0|||
142998137|NCT01497899|515529930|FG002|Open-Label Extension Phase|Death|0|||
142998138|NCT01497899|515529931|FG003|Open-Label Extension Phase|Death|0|||
142998139|NCT01497899|515529928|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
142998140|NCT01497899|515529929|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
142998141|NCT01497899|515529930|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
142998142|NCT01497899|515529931|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
142998143|NCT01497899|515529928|FG000|Open-Label Extension Phase|Pregnancy|0|||
142998144|NCT01497899|515529929|FG001|Open-Label Extension Phase|Pregnancy|1|||
142998145|NCT01497899|515529930|FG002|Open-Label Extension Phase|Pregnancy|1|||
142998146|NCT01497899|515529931|FG003|Open-Label Extension Phase|Pregnancy|0|||
142998147|NCT01497899|515529928|FG000|Open-Label Extension Phase|Protocol Violation|0|||
142998148|NCT01497899|515529929|FG001|Open-Label Extension Phase|Protocol Violation|0|||
142998149|NCT01497899|515529930|FG002|Open-Label Extension Phase|Protocol Violation|1|||
142998150|NCT01497899|515529931|FG003|Open-Label Extension Phase|Protocol Violation|0|||
142998151|NCT01497899|515529928|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
142998152|NCT01497899|515529929|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
142998153|NCT01497899|515529930|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
142998154|NCT01497899|515529931|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
142998155|NCT04212221|515529932|FG000|Overall Study|Remained on Treatment|0|||
142998156|NCT04212221|515529933|FG001|Overall Study|Remained on Treatment|0|||
142998157|NCT04212221|515529934|FG002|Overall Study|Remained on Treatment|0|||
142998158|NCT04212221|515529935|FG003|Overall Study|Remained on Treatment|1|||
142998159|NCT04212221|515529936|FG004|Overall Study|Remained on Treatment|0|||
142998160|NCT04212221|515529937|FG005|Overall Study|Remained on Treatment|0|||
142998161|NCT04212221|515529938|FG006|Overall Study|Remained on Treatment|3|||
142998162|NCT04212221|515529939|FG007|Overall Study|Remained on Treatment|9|||
142998163|NCT04212221|515529932|FG000|Overall Study|Adverse Event|0|||
142998164|NCT04212221|515529933|FG001|Overall Study|Adverse Event|0|||
142998165|NCT04212221|515529934|FG002|Overall Study|Adverse Event|0|||
142998166|NCT04212221|515529935|FG003|Overall Study|Adverse Event|0|||
142998167|NCT04212221|515529936|FG004|Overall Study|Adverse Event|0|||
142998168|NCT04212221|515529937|FG005|Overall Study|Adverse Event|0|||
142998169|NCT04212221|515529938|FG006|Overall Study|Adverse Event|2|||
142998170|NCT04212221|515529939|FG007|Overall Study|Adverse Event|3|||
142998171|NCT04212221|515529932|FG000|Overall Study|Death|0|||
142998172|NCT04212221|515529933|FG001|Overall Study|Death|0|||
142998173|NCT04212221|515529934|FG002|Overall Study|Death|0|||
142998174|NCT04212221|515529935|FG003|Overall Study|Death|0|||
142998175|NCT04212221|515529936|FG004|Overall Study|Death|0|||
142998176|NCT04212221|515529937|FG005|Overall Study|Death|0|||
142998177|NCT04212221|515529938|FG006|Overall Study|Death|0|||
142998178|NCT04212221|515529939|FG007|Overall Study|Death|2|||
142998179|NCT04212221|515529932|FG000|Overall Study|Disease progression according to irRECIST|1|||
142998180|NCT04212221|515529933|FG001|Overall Study|Disease progression according to irRECIST|2|||
142998181|NCT04212221|515529934|FG002|Overall Study|Disease progression according to irRECIST|3|||
142998182|NCT04212221|515529935|FG003|Overall Study|Disease progression according to irRECIST|3|||
142998183|NCT04212221|515529936|FG004|Overall Study|Disease progression according to irRECIST|2|||
142998184|NCT04212221|515529937|FG005|Overall Study|Disease progression according to irRECIST|2|||
142998185|NCT04212221|515529938|FG006|Overall Study|Disease progression according to irRECIST|21|||
142998186|NCT04212221|515529939|FG007|Overall Study|Disease progression according to irRECIST|17|||
142998187|NCT04212221|515529932|FG000|Overall Study|Global Deterioration of Health Status|0|||
142998188|NCT04212221|515529933|FG001|Overall Study|Global Deterioration of Health Status|0|||
142998189|NCT04212221|515529934|FG002|Overall Study|Global Deterioration of Health Status|0|||
142998190|NCT04212221|515529935|FG003|Overall Study|Global Deterioration of Health Status|0|||
142998191|NCT04212221|515529936|FG004|Overall Study|Global Deterioration of Health Status|0|||
142998192|NCT04212221|515529937|FG005|Overall Study|Global Deterioration of Health Status|0|||
142998193|NCT04212221|515529938|FG006|Overall Study|Global Deterioration of Health Status|0|||
142998194|NCT04212221|515529939|FG007|Overall Study|Global Deterioration of Health Status|2|||
142998195|NCT04212221|515529932|FG000|Overall Study|Investigator's Decision|0|||
142998196|NCT04212221|515529933|FG001|Overall Study|Investigator's Decision|0|||
142998197|NCT04212221|515529934|FG002|Overall Study|Investigator's Decision|0|||
142998198|NCT04212221|515529935|FG003|Overall Study|Investigator's Decision|1|||
142998199|NCT04212221|515529936|FG004|Overall Study|Investigator's Decision|0|||
142998200|NCT04212221|515529937|FG005|Overall Study|Investigator's Decision|0|||
142998201|NCT04212221|515529938|FG006|Overall Study|Investigator's Decision|3|||
142998202|NCT04212221|515529939|FG007|Overall Study|Investigator's Decision|0|||
142998203|NCT04212221|515529932|FG000|Overall Study|Participant refused to continue treatment|0|||
142998204|NCT04212221|515529933|FG001|Overall Study|Participant refused to continue treatment|1|||
142998205|NCT04212221|515529934|FG002|Overall Study|Participant refused to continue treatment|0|||
142998206|NCT04212221|515529935|FG003|Overall Study|Participant refused to continue treatment|1|||
142998207|NCT04212221|515529936|FG004|Overall Study|Participant refused to continue treatment|1|||
142998208|NCT04212221|515529937|FG005|Overall Study|Participant refused to continue treatment|2|||
142998209|NCT04212221|515529938|FG006|Overall Study|Participant refused to continue treatment|4|||
142998210|NCT04212221|515529939|FG007|Overall Study|Participant refused to continue treatment|2|||
142998211|NCT04212221|515529932|FG000|Overall Study|Protocol Violation|0|||
142998212|NCT04212221|515529933|FG001|Overall Study|Protocol Violation|0|||
142998213|NCT04212221|515529934|FG002|Overall Study|Protocol Violation|0|||
142998214|NCT04212221|515529935|FG003|Overall Study|Protocol Violation|0|||
142998215|NCT04212221|515529936|FG004|Overall Study|Protocol Violation|0|||
142998216|NCT04212221|515529937|FG005|Overall Study|Protocol Violation|0|||
142998217|NCT04212221|515529938|FG006|Overall Study|Protocol Violation|0|||
142998218|NCT04212221|515529939|FG007|Overall Study|Protocol Violation|1|||
142998219|NCT00636506|515529947|FG000|Overall Study|Lost to Follow-up|8|||
142998220|NCT00636506|515529947|FG000|Overall Study|Explanted|1|||
142998221|NCT00636506|515529947|FG000|Overall Study|Withdrawal by Subject|6|||
142998222|NCT00636506|515529947|FG000|Overall Study|Procedure aborted|1|||
142998223|NCT01624974|515529948|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
142998224|NCT01624974|515529949|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
142998225|NCT01624974|515529948|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
142998226|NCT01624974|515529949|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
143003190|NCT01049360|515548762|FG018|Period 2|Lack of Efficacy|0|||
142998227|NCT01624974|515529948|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
142998228|NCT01624974|515529949|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
142998229|NCT01624974|515529948|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
142998230|NCT01624974|515529949|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
142998231|NCT01624974|515529948|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
142998232|NCT01624974|515529949|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
142998233|NCT01624974|515529948|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
142998234|NCT01624974|515529949|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
142998235|NCT01624974|515529948|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
142998236|NCT01624974|515529949|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
142998237|NCT01624974|515529948|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
142998238|NCT01624974|515529949|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
142998239|NCT01624974|515529948|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
142998240|NCT01624974|515529949|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
142998241|NCT01624974|515529948|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
142998242|NCT01624974|515529949|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
142998243|NCT01624974|515529948|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
142998244|NCT01624974|515529949|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
142998245|NCT01624974|515529948|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
142998246|NCT01624974|515529949|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
142998247|NCT02380703|515529950|FG000|Overall Study|Withdrawal by Subject|12|||
142998248|NCT02380703|515529951|FG001|Overall Study|Withdrawal by Subject|9|||
142998249|NCT02380703|515529950|FG000|Overall Study|Lost to Follow-up|12|||
142998250|NCT02380703|515529951|FG001|Overall Study|Lost to Follow-up|12|||
142998251|NCT02380703|515529950|FG000|Overall Study|Caregiver death|1|||
142998252|NCT02380703|515529951|FG001|Overall Study|Caregiver death|0|||
142998253|NCT02380703|515529950|FG000|Overall Study|Person with dementia (PWD) death|7|||
142998254|NCT02380703|515529951|FG001|Overall Study|Person with dementia (PWD) death|8|||
142998255|NCT02380703|515529950|FG000|Overall Study|Entered Long-term Care|4|||
142998256|NCT02380703|515529951|FG001|Overall Study|Entered Long-term Care|7|||
142998257|NCT00266695|515529952|FG000|Overall Study|Adverse Event|1|||
142998258|NCT00266695|515529952|FG000|Overall Study|Death|9|||
142998259|NCT00266695|515529952|FG000|Overall Study|Physician Decision|1|||
142998260|NCT00266695|515529952|FG000|Overall Study|Lost to Follow-up|3|||
142998261|NCT00266695|515529952|FG000|Overall Study|Withdrawal by Subject|15|||
142998262|NCT03607994|515529953|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
142998263|NCT03607994|515529954|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
142998264|NCT05060003|515529961|FG000|Overall Study|ctDNA negative|7|||
142998265|NCT00489216|515529963|FG000|Overall Study|Adverse Event|1|||
142998266|NCT02828982|515529966|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
142998267|NCT02828982|515529967|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
142998268|NCT02312934|515529968|FG000|Overall Study|Lost to Follow-up|1|||
142998269|NCT02312934|515529969|FG001|Overall Study|Lost to Follow-up|0|||
142998270|NCT02312934|515529968|FG000|Overall Study|Physician Decision|1|||
142998271|NCT02312934|515529969|FG001|Overall Study|Physician Decision|0|||
142998272|NCT02098733|515529970|FG000|Overall Study|Data Not Available|5|||
142998273|NCT02098733|515529970|FG000|Overall Study|Lost to Follow-up|5|||
142998274|NCT01156012|515529971|FG000|Overall Study|Adverse Event|3|||
142998275|NCT01156012|515529972|FG001|Overall Study|Adverse Event|1|||
142998276|NCT01156012|515529971|FG000|Overall Study|Lost to Follow-up|1|||
142998277|NCT01156012|515529972|FG001|Overall Study|Lost to Follow-up|0|||
142998278|NCT01156012|515529971|FG000|Overall Study|Withdrawal by Subject|1|||
142998279|NCT01156012|515529972|FG001|Overall Study|Withdrawal by Subject|0|||
142998280|NCT01156012|515529971|FG000|Overall Study|use of commercial drug instead of study|0|||
142998281|NCT01156012|515529972|FG001|Overall Study|use of commercial drug instead of study|1|||
142998282|NCT01156012|515529971|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
142998283|NCT01156012|515529972|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
142998284|NCT03395704|515529973|FG000|Overall Study|Adverse Event|2|||
142998285|NCT03395704|515529974|FG001|Overall Study|Adverse Event|1|||
142998286|NCT03395704|515529973|FG000|Overall Study|Withdrawal by Subject|2|||
142998287|NCT03395704|515529974|FG001|Overall Study|Withdrawal by Subject|1|||
142998288|NCT03395704|515529973|FG000|Overall Study|Physician Decision|0|||
142998289|NCT03395704|515529974|FG001|Overall Study|Physician Decision|1|||
142998290|NCT02475564|515529975|FG000|Overall Study|Withdrawal by Subject|1|||
142998291|NCT02475564|515529976|FG001|Overall Study|Withdrawal by Subject|0|||
142998292|NCT02475564|515529975|FG000|Overall Study|Lost to Follow-up|2|||
142998293|NCT02475564|515529976|FG001|Overall Study|Lost to Follow-up|1|||
142998294|NCT02475564|515529975|FG000|Overall Study|Intense Menstrual bleeding|1|||
143455745|NCT02559895|517212521|FG001|Overall Study|Lack of Efficacy|3|||
142998295|NCT02475564|515529976|FG001|Overall Study|Intense Menstrual bleeding|0|||
142998296|NCT01906489|515529977|FG000|Overall Study|Adverse Event|10|||
142998297|NCT01906489|515529978|FG001|Overall Study|Adverse Event|3|||
142998298|NCT01906489|515529977|FG000|Overall Study|Worsening of CKD|6|||
142998299|NCT01906489|515529978|FG001|Overall Study|Worsening of CKD|4|||
142998300|NCT01906489|515529977|FG000|Overall Study|Withdrawal by Subject|5|||
142998301|NCT01906489|515529978|FG001|Overall Study|Withdrawal by Subject|0|||
142998302|NCT01906489|515529977|FG000|Overall Study|Worsening of Anemia|1|||
142998303|NCT01906489|515529978|FG001|Overall Study|Worsening of Anemia|0|||
142998304|NCT01906489|515529977|FG000|Overall Study|Protocol Violation|0|||
142998305|NCT01906489|515529978|FG001|Overall Study|Protocol Violation|1|||
142998306|NCT01906489|515529977|FG000|Overall Study|Non- Compliance|1|||
142998307|NCT01906489|515529978|FG001|Overall Study|Non- Compliance|0|||
142998308|NCT01906489|515529977|FG000|Overall Study|Sponsor Decision|1|||
142998309|NCT01906489|515529978|FG001|Overall Study|Sponsor Decision|0|||
142998310|NCT01906489|515529977|FG000|Overall Study|Lost to Follow-up|1|||
142998311|NCT01906489|515529978|FG001|Overall Study|Lost to Follow-up|1|||
142998312|NCT01906489|515529977|FG000|Overall Study|Other|1|||
142998313|NCT01906489|515529978|FG001|Overall Study|Other|0|||
142998314|NCT01078389|515531796|FG000|Overall Study|Adverse Event|10|||
142998315|NCT01078389|515531797|FG001|Overall Study|Adverse Event|6|||
142998316|NCT01078389|515531796|FG000|Overall Study|Major Protocol Deviation|2|||
142998317|NCT01078389|515531797|FG001|Overall Study|Major Protocol Deviation|0|||
142998318|NCT01078389|515531796|FG000|Overall Study|Lost to Follow-up|23|||
142998319|NCT01078389|515531797|FG001|Overall Study|Lost to Follow-up|23|||
142998320|NCT01078389|515531796|FG000|Overall Study|Voluntary Withdrawal|20|||
142998321|NCT01078389|515531797|FG001|Overall Study|Voluntary Withdrawal|36|||
142998322|NCT01078389|515531796|FG000|Overall Study|Other|9|||
142998323|NCT01078389|515531797|FG001|Overall Study|Other|2|||
142998324|NCT02198040|515531798|FG000|Overall Study|Work reasons|0|||
142998325|NCT02198040|515531799|FG001|Overall Study|Work reasons|1|||
142998326|NCT02198040|515531800|FG002|Overall Study|Work reasons|0|||
142998327|NCT02198040|515531798|FG000|Overall Study|Withdrawal by Subject|0|||
142998328|NCT02198040|515531799|FG001|Overall Study|Withdrawal by Subject|0|||
142998329|NCT02198040|515531800|FG002|Overall Study|Withdrawal by Subject|1|||
142998330|NCT01189201|515531805|FG000|Overall Study|Adverse Event|1|||
142998331|NCT00911508|515531806|FG000|Overall Study|Lost to Follow-up|27|||
142998332|NCT00911508|515531807|FG001|Overall Study|Lost to Follow-up|18|||
142998333|NCT00911508|515531806|FG000|Overall Study|Withdrawal by Subject|79|||
142998334|NCT00911508|515531807|FG001|Overall Study|Withdrawal by Subject|112|||
142998335|NCT01409382|515531808|FG000|Overall Study|Lost to Follow-up|1|||
142998336|NCT01409382|515531809|FG001|Overall Study|Lost to Follow-up|1|||
142998337|NCT01409382|515531808|FG000|Overall Study|Protocol Violation|0|||
142998338|NCT01409382|515531809|FG001|Overall Study|Protocol Violation|3|||
142998339|NCT01409382|515531808|FG000|Overall Study|Multiple pregnancy|2|||
142998340|NCT01409382|515531809|FG001|Overall Study|Multiple pregnancy|4|||
142998341|NCT01409382|515531808|FG000|Overall Study|Still pregnant when study ended|13|||
142998342|NCT01409382|515531809|FG001|Overall Study|Still pregnant when study ended|2|||
142998343|NCT01409382|515531808|FG000|Overall Study|Did not manage to get pregnant|64|||
142998344|NCT01409382|515531809|FG001|Overall Study|Did not manage to get pregnant|70|||
142998345|NCT01409382|515531808|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
142998346|NCT01409382|515531809|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
142998347|NCT01233076|515531810|FG000|Period 2, One Week|Lost to Follow-up|1|||
142998348|NCT01233076|515531811|FG001|Period 2, One Week|Lost to Follow-up|0|||
142998349|NCT04308668|515531812|FG000|Overall Study|Lost to Follow-up|32|||
142998350|NCT04308668|515531813|FG001|Overall Study|Lost to Follow-up|38|||
142998351|NCT04308668|515531812|FG000|Overall Study|Withdrawal by Subject|4|||
142998352|NCT04308668|515531813|FG001|Overall Study|Withdrawal by Subject|4|||
142998353|NCT01266967|515531814|FG000|Overall Study|Death|69|||
142998354|NCT01266967|515531815|FG001|Overall Study|Death|61|||
142998355|NCT01266967|515531814|FG000|Overall Study|Study Closed/Terminated|15|||
142998356|NCT01266967|515531815|FG001|Overall Study|Study Closed/Terminated|17|||
142998357|NCT01266967|515531814|FG000|Overall Study|Lost to Follow-up|2|||
142998358|NCT01266967|515531815|FG001|Overall Study|Lost to Follow-up|1|||
142998359|NCT01266967|515531814|FG000|Overall Study|Physician Decision|0|||
142998360|NCT01266967|515531815|FG001|Overall Study|Physician Decision|1|||
142998361|NCT01266967|515531814|FG000|Overall Study|Withdrawal by Subject|3|||
142998362|NCT01266967|515531815|FG001|Overall Study|Withdrawal by Subject|3|||
142998363|NCT01519700|515531816|FG000|Overall Study|Death|1|||
142998364|NCT01519700|515531817|FG001|Overall Study|Death|0|||
142998365|NCT01519700|515531818|FG002|Overall Study|Death|0|||
142998366|NCT01519700|515531819|FG003|Overall Study|Death|0|||
142998367|NCT01519700|515531816|FG000|Overall Study|Lost to Follow-up|0|||
142998368|NCT01519700|515531817|FG001|Overall Study|Lost to Follow-up|0|||
142998369|NCT01519700|515531818|FG002|Overall Study|Lost to Follow-up|1|||
142998370|NCT01519700|515531819|FG003|Overall Study|Lost to Follow-up|1|||
142998371|NCT01519700|515531816|FG000|Overall Study|Physician Decision|1|||
142998372|NCT01519700|515531817|FG001|Overall Study|Physician Decision|1|||
142998373|NCT01519700|515531818|FG002|Overall Study|Physician Decision|3|||
142998374|NCT01519700|515531819|FG003|Overall Study|Physician Decision|0|||
142998375|NCT01519700|515531816|FG000|Overall Study|Withdrawal by Subject|5|||
142998376|NCT01519700|515531817|FG001|Overall Study|Withdrawal by Subject|3|||
142998377|NCT01519700|515531818|FG002|Overall Study|Withdrawal by Subject|3|||
142998378|NCT01519700|515531819|FG003|Overall Study|Withdrawal by Subject|2|||
142998379|NCT01519700|515531816|FG000|Overall Study|Other Reason|2|||
142998380|NCT01519700|515531817|FG001|Overall Study|Other Reason|2|||
142998381|NCT01519700|515531818|FG002|Overall Study|Other Reason|0|||
142998382|NCT01519700|515531819|FG003|Overall Study|Other Reason|4|||
142998383|NCT00772031|515531820|FG000|Overall Study|Early termination of trial|12|||
142998384|NCT00772031|515531821|FG001|Overall Study|Early termination of trial|10|||
142998385|NCT00772031|515531820|FG000|Overall Study|Lost to Follow-up|20|||
142998386|NCT00772031|515531821|FG001|Overall Study|Lost to Follow-up|33|||
142998387|NCT03824704|515531827|FG000|Overall Study|Study Terminated by Sponsor|1|||
142998388|NCT02155660|515531830|FG000|Overall Study|Other Reason|8|||
142998389|NCT02155660|515531831|FG001|Overall Study|Other Reason|6|||
142998390|NCT02155660|515531832|FG002|Overall Study|Other Reason|10|||
142998391|NCT02155660|515531833|FG003|Overall Study|Other Reason|10|||
142998392|NCT02155660|515531830|FG000|Overall Study|Study-specific withdrawal criteria|0|||
142998393|NCT02155660|515531831|FG001|Overall Study|Study-specific withdrawal criteria|1|||
142998394|NCT02155660|515531832|FG002|Overall Study|Study-specific withdrawal criteria|1|||
142998395|NCT02155660|515531833|FG003|Overall Study|Study-specific withdrawal criteria|1|||
142998396|NCT02155660|515531830|FG000|Overall Study|Severe non-compliance|0|||
142998397|NCT02155660|515531831|FG001|Overall Study|Severe non-compliance|4|||
142998398|NCT02155660|515531832|FG002|Overall Study|Severe non-compliance|0|||
142998399|NCT02155660|515531833|FG003|Overall Study|Severe non-compliance|1|||
142998400|NCT02155660|515531830|FG000|Overall Study|Adverse Event|2|||
142998401|NCT02155660|515531831|FG001|Overall Study|Adverse Event|6|||
142998402|NCT02155660|515531832|FG002|Overall Study|Adverse Event|3|||
142998403|NCT02155660|515531833|FG003|Overall Study|Adverse Event|1|||
142998404|NCT02155660|515531830|FG000|Overall Study|Lost to Follow-up|3|||
142998405|NCT02155660|515531831|FG001|Overall Study|Lost to Follow-up|6|||
142998406|NCT02155660|515531832|FG002|Overall Study|Lost to Follow-up|5|||
142998407|NCT02155660|515531833|FG003|Overall Study|Lost to Follow-up|8|||
142998408|NCT02155660|515531830|FG000|Overall Study|Death|17|||
142998409|NCT02155660|515531831|FG001|Overall Study|Death|19|||
142998410|NCT02155660|515531832|FG002|Overall Study|Death|17|||
142998411|NCT02155660|515531833|FG003|Overall Study|Death|19|||
142998412|NCT02155660|515531830|FG000|Overall Study|Withdrawal by Subject|28|||
142998413|NCT02155660|515531831|FG001|Overall Study|Withdrawal by Subject|31|||
142998414|NCT02155660|515531832|FG002|Overall Study|Withdrawal by Subject|24|||
142998415|NCT02155660|515531833|FG003|Overall Study|Withdrawal by Subject|21|||
142998416|NCT03730987|515531834|FG000|Overall Study|Lost to Follow-up|2|||
142998417|NCT03730987|515531835|FG001|Overall Study|Lost to Follow-up|0|||
142998418|NCT03730987|515531836|FG002|Overall Study|Lost to Follow-up|2|||
142998419|NCT03730987|515531837|FG003|Overall Study|Lost to Follow-up|0|||
142998420|NCT02505945|515531838|FG000|Overall Study|Withdrawal by Subject|13|||
142998421|NCT02505945|515531839|FG001|Overall Study|Withdrawal by Subject|2|||
142998422|NCT02505945|515531838|FG000|Overall Study|Adverse Event|1|||
142998423|NCT02505945|515531839|FG001|Overall Study|Adverse Event|0|||
142998424|NCT02505945|515531838|FG000|Overall Study|Physician Decision|2|||
142998425|NCT02505945|515531839|FG001|Overall Study|Physician Decision|1|||
142998426|NCT02505945|515531838|FG000|Overall Study|Lost to Follow-up|6|||
142998427|NCT02505945|515531839|FG001|Overall Study|Lost to Follow-up|1|||
142998428|NCT01667731|515531841|FG000|Overall Study|Enrolled but not treated|0|||
142998429|NCT01667731|515531842|FG001|Overall Study|Enrolled but not treated|0|||
142998430|NCT01667731|515531843|FG002|Overall Study|Enrolled but not treated|0|||
142998431|NCT01667731|515531844|FG003|Overall Study|Enrolled but not treated|0|||
142998432|NCT01667731|515531845|FG004|Overall Study|Enrolled but not treated|1|||
142998433|NCT01667731|515531841|FG000|Overall Study|Efficacy Failure|1|||
142998434|NCT01667731|515531842|FG001|Overall Study|Efficacy Failure|12|||
142998435|NCT01667731|515531843|FG002|Overall Study|Efficacy Failure|0|||
142998436|NCT01667731|515531844|FG003|Overall Study|Efficacy Failure|1|||
142998437|NCT01667731|515531845|FG004|Overall Study|Efficacy Failure|24|||
142998438|NCT01667731|515531841|FG000|Overall Study|Lost to Follow-up|2|||
142998439|NCT01667731|515531842|FG001|Overall Study|Lost to Follow-up|3|||
142998440|NCT01667731|515531843|FG002|Overall Study|Lost to Follow-up|1|||
142998441|NCT01667731|515531844|FG003|Overall Study|Lost to Follow-up|1|||
142998442|NCT01667731|515531845|FG004|Overall Study|Lost to Follow-up|2|||
142998443|NCT01667731|515531841|FG000|Overall Study|Subject Withdrew Consent|2|||
142998444|NCT01667731|515531842|FG001|Overall Study|Subject Withdrew Consent|0|||
142998445|NCT01667731|515531843|FG002|Overall Study|Subject Withdrew Consent|1|||
142998446|NCT01667731|515531844|FG003|Overall Study|Subject Withdrew Consent|0|||
142998447|NCT01667731|515531845|FG004|Overall Study|Subject Withdrew Consent|1|||
142998448|NCT01667731|515531841|FG000|Overall Study|Death|0|||
142998449|NCT01667731|515531842|FG001|Overall Study|Death|1|||
142998450|NCT01667731|515531843|FG002|Overall Study|Death|0|||
142998451|NCT01667731|515531844|FG003|Overall Study|Death|0|||
142998452|NCT01667731|515531845|FG004|Overall Study|Death|0|||
142998453|NCT00649220|515531855|FG000|Overall Study|Adverse Event|2|||
142998454|NCT00649220|515531855|FG000|Overall Study|Withdrawal by Subject|1|||
142998455|NCT00525499|515531856|FG000|Overall Study|Lost to Follow-up|2|||
142998456|NCT00525499|515531857|FG001|Overall Study|Lost to Follow-up|4|||
142998457|NCT00525499|515531858|FG002|Overall Study|Lost to Follow-up|1|||
142998458|NCT00525499|515531859|FG003|Overall Study|Lost to Follow-up|4|||
142998459|NCT00525499|515531856|FG000|Overall Study|Adverse Event|0|||
142998460|NCT00525499|515531857|FG001|Overall Study|Adverse Event|1|||
142998461|NCT00525499|515531858|FG002|Overall Study|Adverse Event|0|||
142998462|NCT00525499|515531859|FG003|Overall Study|Adverse Event|1|||
142998463|NCT00525499|515531856|FG000|Overall Study|Withdrawal by Subject|5|||
142998464|NCT00525499|515531857|FG001|Overall Study|Withdrawal by Subject|1|||
142998465|NCT00525499|515531858|FG002|Overall Study|Withdrawal by Subject|5|||
142998466|NCT00525499|515531859|FG003|Overall Study|Withdrawal by Subject|2|||
142998467|NCT00525499|515531856|FG000|Overall Study|Protocol Violation|0|||
142998468|NCT00525499|515531857|FG001|Overall Study|Protocol Violation|1|||
142998469|NCT00525499|515531858|FG002|Overall Study|Protocol Violation|1|||
142998470|NCT00525499|515531859|FG003|Overall Study|Protocol Violation|0|||
142998471|NCT03380091|515531866|FG000|Overall Study|Withdrawal by Subject|2|||
142998472|NCT03380091|515531867|FG001|Overall Study|Withdrawal by Subject|1|||
142998473|NCT01707667|515531868|FG000|Period 1|expulsion of colonic sensor catheter|1|||
142998474|NCT01707667|515531869|FG001|Period 1|expulsion of colonic sensor catheter|0|||
142998475|NCT02074059|515531872|FG000|Overall Study|Death|0|||
142998476|NCT02074059|515531873|FG001|Overall Study|Death|0|||
142998477|NCT02074059|515531874|FG002|Overall Study|Death|0|||
142998478|NCT02074059|515531875|FG003|Overall Study|Death|0|||
142998479|NCT02074059|515531876|FG004|Overall Study|Death|1|||
142998480|NCT02074059|515531877|FG005|Overall Study|Death|1|||
142998481|NCT01220024|515531885|FG000|Overall Study|Lost to Follow-up|1|||
142998482|NCT01220024|515531886|FG001|Overall Study|Lost to Follow-up|1|||
142998483|NCT00174460|515531889|FG000|Overall Study|Withdrawal by Subject|0|||
142998484|NCT00174460|515531890|FG001|Overall Study|Withdrawal by Subject|1|||
142998485|NCT00579059|515531891|FG000|Overall Study|Study Canceled at 1 Year|21|||
142998486|NCT00579059|515531892|FG001|Overall Study|Study Canceled at 1 Year|10|||
142998487|NCT02500706|515531893|FG000|Overall Study|Adverse Event|0|||
142998488|NCT02500706|515531894|FG001|Overall Study|Adverse Event|0|||
142998489|NCT02500706|515531895|FG002|Overall Study|Adverse Event|1|||
142998490|NCT02500706|515531893|FG000|Overall Study|Lost to Follow-up|0|||
142998491|NCT02500706|515531894|FG001|Overall Study|Lost to Follow-up|1|||
142998492|NCT02500706|515531895|FG002|Overall Study|Lost to Follow-up|1|||
142998493|NCT02500706|515531893|FG000|Overall Study|Withdrawal by Subject|4|||
142998494|NCT02500706|515531894|FG001|Overall Study|Withdrawal by Subject|6|||
142998495|NCT02500706|515531895|FG002|Overall Study|Withdrawal by Subject|4|||
142998496|NCT02500706|515531893|FG000|Overall Study|Unclassified|0|||
142998497|NCT02500706|515531894|FG001|Overall Study|Unclassified|0|||
142998498|NCT02500706|515531895|FG002|Overall Study|Unclassified|1|||
142998499|NCT03370133|515531902|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
142998500|NCT03370133|515531903|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
142998501|NCT03370133|515531904|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
142998502|NCT03370133|515531905|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
142998503|NCT03370133|515531906|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
142998504|NCT03370133|515531907|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
142998505|NCT03370133|515531902|FG000|Initial Treatment Period (WK 16)|Death|1|||
142998506|NCT03370133|515531903|FG001|Initial Treatment Period (WK 16)|Death|1|||
142998507|NCT03370133|515531904|FG002|Initial Treatment Period (WK 16)|Death|1|||
142998508|NCT03370133|515531905|FG003|Initial Treatment Period (WK 16)|Death|0|||
142998509|NCT03370133|515531906|FG004|Initial Treatment Period (WK 16)|Death|0|||
142998510|NCT03370133|515531907|FG005|Initial Treatment Period (WK 16)|Death|0|||
142998511|NCT03370133|515531902|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
142998512|NCT03370133|515531903|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
142998513|NCT03370133|515531904|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
142998514|NCT03370133|515531905|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
142998515|NCT03370133|515531906|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
142998516|NCT03370133|515531907|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
142998517|NCT03370133|515531902|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
142998518|NCT03370133|515531903|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
142998519|NCT03370133|515531904|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
142998520|NCT03370133|515531905|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
142998521|NCT03370133|515531906|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
142998522|NCT03370133|515531907|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
142998523|NCT03370133|515531902|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
142998524|NCT03370133|515531903|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
142998525|NCT03370133|515531904|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
142998526|NCT03370133|515531905|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
142998527|NCT03370133|515531906|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
142998528|NCT03370133|515531907|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
142998529|NCT03370133|515531902|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
142998530|NCT03370133|515531903|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
143003191|NCT01049360|515548763|FG019|Period 2|Lack of Efficacy|0|||
142998531|NCT03370133|515531904|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
142998532|NCT03370133|515531905|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
142998533|NCT03370133|515531906|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
142998534|NCT03370133|515531907|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
142998535|NCT03370133|515531902|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
142998536|NCT03370133|515531903|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
142998537|NCT03370133|515531904|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
142998538|NCT03370133|515531905|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
142998539|NCT03370133|515531906|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
142998540|NCT03370133|515531907|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
142998541|NCT03370133|515531902|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
142998542|NCT03370133|515531903|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
142998543|NCT03370133|515531904|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
142998544|NCT03370133|515531905|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
142998545|NCT03370133|515531906|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
142998546|NCT03370133|515531907|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
142998547|NCT03370133|515531902|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
142998548|NCT03370133|515531903|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
142998549|NCT03370133|515531904|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
142998550|NCT03370133|515531905|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
142998551|NCT03370133|515531906|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
142998552|NCT03370133|515531907|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
142998553|NCT03370133|515531902|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
142998554|NCT03370133|515531903|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
142998555|NCT03370133|515531904|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
142998556|NCT03370133|515531905|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
142998557|NCT03370133|515531906|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
142998558|NCT03370133|515531907|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
142998559|NCT03370133|515531902|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
142998560|NCT03370133|515531903|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
142998561|NCT03370133|515531904|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
142998562|NCT03370133|515531905|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
142998563|NCT03370133|515531906|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
142998564|NCT03370133|515531907|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
142998565|NCT03370133|515531902|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
142998566|NCT03370133|515531903|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
142998567|NCT03370133|515531904|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
142998568|NCT03370133|515531905|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
142998569|NCT03370133|515531906|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
142998570|NCT03370133|515531907|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
142998571|NCT03370133|515531902|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
142998572|NCT03370133|515531903|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
142998573|NCT03370133|515531904|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
142998574|NCT03370133|515531905|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
142998575|NCT03370133|515531906|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
142998576|NCT03370133|515531907|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
142998577|NCT03370133|515531902|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
142998578|NCT03370133|515531903|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
142998579|NCT03370133|515531904|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
142998580|NCT03370133|515531905|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
142998581|NCT03370133|515531906|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
142998582|NCT03370133|515531907|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
142998583|NCT03370133|515531902|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
142998584|NCT03370133|515531903|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
142998585|NCT03370133|515531904|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
142998586|NCT03370133|515531905|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
142998587|NCT03370133|515531906|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
142998588|NCT03370133|515531907|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
142998589|NCT03742271|515531908|FG000|Overall Study|Unsatisfactory Visual Response|1|||
142998590|NCT03742271|515531908|FG000|Overall Study|Withdrawal by Subject|3|||
142998591|NCT03742271|515531908|FG000|Overall Study|Lost to Follow-up|4|||
142998592|NCT03742271|515531908|FG000|Overall Study|Failed Insertion & removal|3|||
142998593|NCT03742271|515531908|FG000|Overall Study|Protocol Violation|1|||
142998594|NCT04490499|515531912|FG000|Overall Study|Withdrawal by Subject|2|||
142998595|NCT00819052|515531915|FG000|Overall Study|Adverse Event|0|||
142998596|NCT00819052|515531916|FG001|Overall Study|Adverse Event|5|||
142998597|NCT00819052|515531915|FG000|Overall Study|Protocol Violation|1|||
142998598|NCT00819052|515531916|FG001|Overall Study|Protocol Violation|2|||
142998599|NCT00819052|515531915|FG000|Overall Study|Lost to Follow-up|1|||
142998600|NCT00819052|515531916|FG001|Overall Study|Lost to Follow-up|2|||
142998601|NCT00819052|515531915|FG000|Overall Study|Withdrawal by Subject|1|||
142998602|NCT00819052|515531916|FG001|Overall Study|Withdrawal by Subject|2|||
142998603|NCT00819052|515531915|FG000|Overall Study|Lack of Efficacy|1|||
142998604|NCT00819052|515531916|FG001|Overall Study|Lack of Efficacy|1|||
142998605|NCT00819052|515531915|FG000|Overall Study|Pregnancy|1|||
142998606|NCT00819052|515531916|FG001|Overall Study|Pregnancy|2|||
142998607|NCT00819052|515531915|FG000|Overall Study|Death or events leading to death|1|||
142998608|NCT00819052|515531916|FG001|Overall Study|Death or events leading to death|0|||
142998609|NCT01373294|515531917|FG000|Overall Study|Adverse Event|1|||
142998610|NCT01373294|515531918|FG001|Overall Study|Adverse Event|0|||
142998611|NCT02694562|515531919|FG000|Overall Study|Death|8|||
142998612|NCT02694562|515531919|FG000|Overall Study|Protocol Violation|4|||
142998613|NCT02694562|515531919|FG000|Overall Study|Lost to Follow-up|3|||
142998614|NCT02694562|515531919|FG000|Overall Study|Screen Failure|2|||
142998615|NCT02694562|515531919|FG000|Overall Study|Physician Decision|1|||
142998616|NCT03702166|515531920|FG000|Overall Study|Lost to Follow-up|1|||
142998617|NCT03702166|515531920|FG000|Overall Study|Withdrawal by Subject|1|||
142998618|NCT01888367|515531923|FG000|Overall Study|Physician Decision|3|||
142998619|NCT01888367|515531924|FG001|Overall Study|Physician Decision|4|||
142998620|NCT01888367|515531925|FG002|Overall Study|Physician Decision|2|||
142998621|NCT01888367|515531923|FG000|Overall Study|Death|2|||
142998622|NCT01888367|515531924|FG001|Overall Study|Death|0|||
142998623|NCT01888367|515531925|FG002|Overall Study|Death|1|||
142998624|NCT01888367|515531923|FG000|Overall Study|Withdrawal by Subject|1|||
142998625|NCT01888367|515531924|FG001|Overall Study|Withdrawal by Subject|0|||
142998626|NCT01888367|515531925|FG002|Overall Study|Withdrawal by Subject|1|||
142998627|NCT01888367|515531923|FG000|Overall Study|Lost to Follow-up|1|||
142998628|NCT01888367|515531924|FG001|Overall Study|Lost to Follow-up|1|||
142998629|NCT01888367|515531925|FG002|Overall Study|Lost to Follow-up|0|||
142998630|NCT01888367|515531923|FG000|Overall Study|Protocol Violation|0|||
142998631|NCT01888367|515531924|FG001|Overall Study|Protocol Violation|0|||
142998632|NCT01888367|515531925|FG002|Overall Study|Protocol Violation|1|||
142998633|NCT01888367|515531923|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
142998634|NCT01888367|515531924|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
142998635|NCT01888367|515531925|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
142998636|NCT03969589|515531926|FG000|Overall Study|Lost to Follow-up|3|||
142998637|NCT03969589|515531927|FG001|Overall Study|Lost to Follow-up|2|||
142998638|NCT03969589|515531926|FG000|Overall Study|Declined Follow-Up|0|||
142998639|NCT03969589|515531927|FG001|Overall Study|Declined Follow-Up|1|||
142998640|NCT00517634|515531928|FG000|Second Treatment Period|Withdrawal by Subject|0|||
142998641|NCT00517634|515531929|FG001|Second Treatment Period|Withdrawal by Subject|0|||
142998642|NCT00517634|515531930|FG002|Second Treatment Period|Withdrawal by Subject|0|||
142998643|NCT00517634|515531931|FG003|Second Treatment Period|Withdrawal by Subject|0|||
142998644|NCT00517634|515531932|FG004|Second Treatment Period|Withdrawal by Subject|1|||
142998645|NCT00517634|515531933|FG005|Second Treatment Period|Withdrawal by Subject|0|||
142998646|NCT03417999|515531934|FG000|Overall Study|Withdrawal by Subject|1|||
142998647|NCT03417999|515531935|FG001|Overall Study|Withdrawal by Subject|0|||
142998648|NCT03417999|515531936|FG002|Overall Study|Withdrawal by Subject|0|||
142998649|NCT03417999|515531934|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
142998650|NCT03417999|515531935|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
142998651|NCT03417999|515531936|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
142998652|NCT03417999|515531934|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
142998653|NCT03417999|515531935|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
142998654|NCT03417999|515531936|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
142998655|NCT03417999|515531934|FG000|Overall Study|Inadequate study staff available to process samples|0|||
142998656|NCT03417999|515531935|FG001|Overall Study|Inadequate study staff available to process samples|0|||
142998657|NCT03417999|515531936|FG002|Overall Study|Inadequate study staff available to process samples|1|||
142998658|NCT00422942|515531941|FG000|Overall Study|Study terminated by Sponsor|3|||
142998659|NCT02539160|515531942|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
142998660|NCT02539160|515531943|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
142998661|NCT02539160|515531944|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
142998662|NCT02539160|515531945|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
142998663|NCT02539160|515531942|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
142998664|NCT02539160|515531943|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
142998665|NCT02539160|515531944|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
142998666|NCT02539160|515531945|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
142998667|NCT02539160|515531942|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
142998668|NCT02539160|515531943|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
142998669|NCT02539160|515531944|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
142998670|NCT02539160|515531945|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
142998671|NCT01681004|515531946|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
142998672|NCT01681004|515531947|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
142998673|NCT01681004|515531946|FG000|Study Completion|Lost to Follow-up|8|||
142998674|NCT01681004|515531947|FG001|Study Completion|Lost to Follow-up|3|||
142998675|NCT01681004|515531946|FG000|Study Completion|Physician Decision|1|||
142998676|NCT01681004|515531947|FG001|Study Completion|Physician Decision|3|||
142998677|NCT01681004|515531946|FG000|Study Completion|Site Termination|2|||
142998678|NCT01681004|515531947|FG001|Study Completion|Site Termination|1|||
142998679|NCT01681004|515531946|FG000|Study Completion|Death|1|||
142998680|NCT01681004|515531947|FG001|Study Completion|Death|1|||
142998681|NCT00372905|515531948|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
142998682|NCT00372905|515531949|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
142998683|NCT00372905|515531950|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
142998684|NCT00372905|515531951|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
142998685|NCT00372905|515531948|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
142998686|NCT00372905|515531949|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
142998687|NCT00372905|515531950|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
142998688|NCT00372905|515531951|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
142998689|NCT00372905|515531948|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
142998690|NCT00372905|515531949|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
142998691|NCT00372905|515531950|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
142998692|NCT00372905|515531951|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
142998693|NCT00372905|515531948|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
142998694|NCT00372905|515531949|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
142998695|NCT00372905|515531950|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
142998696|NCT00372905|515531951|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
142998697|NCT00372905|515531948|FG000|Follow up Until Relapse or Progression|Study closed|0|||
142998698|NCT00372905|515531949|FG001|Follow up Until Relapse or Progression|Study closed|0|||
142998699|NCT00372905|515531950|FG002|Follow up Until Relapse or Progression|Study closed|0|||
142998700|NCT00372905|515531951|FG003|Follow up Until Relapse or Progression|Study closed|3|||
142998701|NCT00372905|515531948|FG000|Follow up Until Relapse or Progression|Other|0|||
142998702|NCT00372905|515531949|FG001|Follow up Until Relapse or Progression|Other|1|||
142998703|NCT00372905|515531950|FG002|Follow up Until Relapse or Progression|Other|0|||
142998704|NCT00372905|515531951|FG003|Follow up Until Relapse or Progression|Other|0|||
142998705|NCT00695318|515531953|FG000|Overall Study|Lost to Follow-up|1|||
142998706|NCT00695318|515531954|FG001|Overall Study|Lost to Follow-up|0|||
142998707|NCT00695318|515531953|FG000|Overall Study|Withdrawal by Subject|2|||
142998708|NCT00695318|515531954|FG001|Overall Study|Withdrawal by Subject|0|||
142998709|NCT00695318|515531953|FG000|Overall Study|Death|1|||
142998710|NCT00695318|515531954|FG001|Overall Study|Death|1|||
142998711|NCT00695318|515531953|FG000|Overall Study|Study Terminated|1|||
142998712|NCT00695318|515531954|FG001|Overall Study|Study Terminated|0|||
142998713|NCT02705755|515531955|FG000|Part A (6 Days)|Adverse Event|1|||
142998714|NCT02705755|515531956|FG001|Part A (6 Days)|Adverse Event|0|||
142998715|NCT02705755|515531957|FG002|Part A (6 Days)|Adverse Event|0|||
142998716|NCT02705755|515531958|FG003|Part A (6 Days)|Adverse Event|0|||
142998717|NCT02705755|515531955|FG000|Part A (6 Days)|Physician Decision|3|||
142998718|NCT02705755|515531956|FG001|Part A (6 Days)|Physician Decision|0|||
142998719|NCT02705755|515531957|FG002|Part A (6 Days)|Physician Decision|0|||
142998720|NCT02705755|515531958|FG003|Part A (6 Days)|Physician Decision|0|||
142998721|NCT02705755|515531955|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
142998722|NCT02705755|515531956|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
142998723|NCT02705755|515531957|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
142998724|NCT02705755|515531958|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
142998725|NCT02705755|515531955|FG000|Part C (20 Weeks)|Physician Decision|0|||
142998726|NCT02705755|515531956|FG001|Part C (20 Weeks)|Physician Decision|0|||
142998727|NCT02705755|515531957|FG002|Part C (20 Weeks)|Physician Decision|0|||
142998728|NCT02705755|515531958|FG003|Part C (20 Weeks)|Physician Decision|2|||
142998729|NCT02705755|515531955|FG000|Part C (20 Weeks)|Adverse Event|0|||
142998730|NCT02705755|515531956|FG001|Part C (20 Weeks)|Adverse Event|0|||
142998731|NCT02705755|515531957|FG002|Part C (20 Weeks)|Adverse Event|0|||
142998732|NCT02705755|515531958|FG003|Part C (20 Weeks)|Adverse Event|6|||
142998733|NCT02705755|515531955|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
142998734|NCT02705755|515531956|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
142998735|NCT02705755|515531957|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
142998736|NCT02705755|515531958|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
142998737|NCT00939094|515531959|FG000|Overall Study|Adverse Event|9|||
142998738|NCT00939094|515531960|FG001|Overall Study|Adverse Event|0|||
142998739|NCT00939094|515531959|FG000|Overall Study|Withdrawal by Subject|1|||
142998740|NCT00939094|515531960|FG001|Overall Study|Withdrawal by Subject|6|||
142998741|NCT00939094|515531959|FG000|Overall Study|Lost to Follow-up|1|||
142998742|NCT00939094|515531960|FG001|Overall Study|Lost to Follow-up|1|||
142998743|NCT00939094|515531959|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
142998744|NCT00939094|515531960|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
142998745|NCT00939094|515531959|FG000|Overall Study|Severe non-compliance to protocol|0|||
142998746|NCT00939094|515531960|FG001|Overall Study|Severe non-compliance to protocol|1|||
142998747|NCT00939094|515531959|FG000|Overall Study|Study stopped by sponsor|0|||
142998748|NCT00939094|515531960|FG001|Overall Study|Study stopped by sponsor|2|||
142998749|NCT00939094|515531959|FG000|Overall Study|Abnormal ECG findings|1|||
142998750|NCT00939094|515531960|FG001|Overall Study|Abnormal ECG findings|0|||
142998751|NCT04823494|515534019|FG000|Overall Study|Programming software malfunction.|1|||
142998752|NCT04823494|515534020|FG001|Overall Study|Programming software malfunction.|0|||
142998753|NCT04823494|515534019|FG000|Overall Study|Withdrawal by Subject|1|||
142998754|NCT04823494|515534020|FG001|Overall Study|Withdrawal by Subject|0|||
142998755|NCT04823494|515534019|FG000|Overall Study|Devices lost|0|||
142998756|NCT04823494|515534020|FG001|Overall Study|Devices lost|1|||
142998757|NCT03726320|515534021|FG000|Overall Study|Lost to Follow-up|2|||
142998758|NCT03726320|515534022|FG001|Overall Study|Lost to Follow-up|4|||
142998759|NCT03726320|515534023|FG002|Overall Study|Lost to Follow-up|0|||
142998760|NCT03726320|515534021|FG000|Overall Study|Time Constraints|4|||
142998761|NCT03726320|515534022|FG001|Overall Study|Time Constraints|1|||
142998762|NCT03726320|515534023|FG002|Overall Study|Time Constraints|0|||
142998763|NCT03726320|515534021|FG000|Overall Study|Ineligible after enrollment|3|||
142998764|NCT03726320|515534022|FG001|Overall Study|Ineligible after enrollment|3|||
142998765|NCT03726320|515534023|FG002|Overall Study|Ineligible after enrollment|0|||
142998766|NCT03726320|515534021|FG000|Overall Study|Clinic / insurance issue|2|||
142998767|NCT03726320|515534022|FG001|Overall Study|Clinic / insurance issue|0|||
142998768|NCT03726320|515534023|FG002|Overall Study|Clinic / insurance issue|0|||
142998769|NCT03726320|515534021|FG000|Overall Study|Language barrier|1|||
142998770|NCT03726320|515534022|FG001|Overall Study|Language barrier|0|||
142998771|NCT03726320|515534023|FG002|Overall Study|Language barrier|0|||
142998772|NCT03726320|515534021|FG000|Overall Study|Provider left the clinic|0|||
142998773|NCT03726320|515534022|FG001|Overall Study|Provider left the clinic|0|||
142998774|NCT03726320|515534023|FG002|Overall Study|Provider left the clinic|1|||
142998775|NCT03691831|515534026|FG000|Overall Study|Lost to Follow-up|16|||
142998776|NCT03691831|515534027|FG001|Overall Study|Lost to Follow-up|12|||
142998777|NCT03691831|515534026|FG000|Overall Study|Withdrawal by Subject|9|||
142998778|NCT03691831|515534027|FG001|Overall Study|Withdrawal by Subject|17|||
142998779|NCT03691831|515534026|FG000|Overall Study|Investigator Decision|2|||
142998780|NCT03691831|515534027|FG001|Overall Study|Investigator Decision|2|||
142998781|NCT02028182|515534028|FG000|Overall Study|Protocol Violation|2|||
142998782|NCT01684930|515534031|FG000|Overall Study|Withdrawal by Subject|3|||
142998783|NCT01684930|515534032|FG001|Overall Study|Withdrawal by Subject|1|||
142998784|NCT04524663|515534033|FG000|Overall Study|Withdrawal by Subject|0|||
142998785|NCT04524663|515534034|FG001|Overall Study|Withdrawal by Subject|2|||
142998786|NCT00337935|515534035|FG000|Overall Study|Adverse Event|2|||
142998787|NCT00337935|515534036|FG001|Overall Study|Adverse Event|5|||
142998788|NCT00337935|515534035|FG000|Overall Study|Death|2|||
142998789|NCT00337935|515534036|FG001|Overall Study|Death|8|||
142998790|NCT00337935|515534035|FG000|Overall Study|Physician Decision|1|||
142998791|NCT00337935|515534036|FG001|Overall Study|Physician Decision|1|||
142998792|NCT00337935|515534035|FG000|Overall Study|Lost to Follow-up|0|||
142998793|NCT00337935|515534036|FG001|Overall Study|Lost to Follow-up|1|||
142998794|NCT00337935|515534035|FG000|Overall Study|Protocol Violation|4|||
142998795|NCT00337935|515534036|FG001|Overall Study|Protocol Violation|3|||
142998796|NCT00337935|515534035|FG000|Overall Study|Withdrawal by Subject|1|||
142998797|NCT00337935|515534036|FG001|Overall Study|Withdrawal by Subject|7|||
142998798|NCT00337935|515534035|FG000|Overall Study|Other|0|||
142998799|NCT00337935|515534036|FG001|Overall Study|Other|1|||
142998800|NCT00337935|515534035|FG000|Overall Study|Lack of Efficacy|0|||
142998801|NCT00337935|515534036|FG001|Overall Study|Lack of Efficacy|1|||
142998802|NCT01786707|515534039|FG000|Overall Study|Lost to Follow-up|1|||
142998803|NCT01786707|515534040|FG001|Overall Study|Lost to Follow-up|1|||
142998804|NCT01425268|515534046|FG000|Overall Study|Withdrawal by Subject|2|||
142998805|NCT01425268|515534047|FG001|Overall Study|Withdrawal by Subject|0|||
142998806|NCT01425268|515534046|FG000|Overall Study|Sponsor Decision|5|||
142998807|NCT01425268|515534047|FG001|Overall Study|Sponsor Decision|0|||
142998808|NCT01425268|515534046|FG000|Overall Study|Physician Decision|1|||
142998809|NCT01425268|515534047|FG001|Overall Study|Physician Decision|0|||
142998810|NCT02406586|515534048|FG000|Overall Study|Lost to Follow-up|0|||
142998811|NCT02406586|515534049|FG001|Overall Study|Lost to Follow-up|4|||
142998812|NCT02406586|515534050|FG002|Overall Study|Lost to Follow-up|2|||
142998813|NCT02406586|515534048|FG000|Overall Study|Withdrawal by Subject|1|||
142998814|NCT02406586|515534049|FG001|Overall Study|Withdrawal by Subject|0|||
142998815|NCT02406586|515534050|FG002|Overall Study|Withdrawal by Subject|0|||
142998816|NCT00883896|515534053|FG000|Overall Study|Lost to Follow-up|0|||
142998817|NCT00883896|515534054|FG001|Overall Study|Lost to Follow-up|0|||
142998818|NCT00883896|515534055|FG002|Overall Study|Lost to Follow-up|0|||
142998819|NCT00883896|515534056|FG003|Overall Study|Lost to Follow-up|2|||
142998820|NCT00883896|515534053|FG000|Overall Study|Withdrawal by Subject|5|||
142998821|NCT00883896|515534054|FG001|Overall Study|Withdrawal by Subject|0|||
142998822|NCT00883896|515534055|FG002|Overall Study|Withdrawal by Subject|1|||
142998823|NCT00883896|515534056|FG003|Overall Study|Withdrawal by Subject|3|||
142998824|NCT00883896|515534053|FG000|Overall Study|Lack of Efficacy|0|||
142998825|NCT00883896|515534054|FG001|Overall Study|Lack of Efficacy|0|||
142998826|NCT00883896|515534055|FG002|Overall Study|Lack of Efficacy|0|||
142998827|NCT00883896|515534056|FG003|Overall Study|Lack of Efficacy|2|||
142998828|NCT00883896|515534053|FG000|Overall Study|Other|1|||
142998829|NCT00883896|515534054|FG001|Overall Study|Other|0|||
142998830|NCT00883896|515534055|FG002|Overall Study|Other|0|||
142998831|NCT00883896|515534056|FG003|Overall Study|Other|0|||
142998832|NCT03764813|515534061|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
142998833|NCT03764813|515534062|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
142998834|NCT03764813|515534063|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
142998835|NCT03764813|515534064|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
142998836|NCT01654666|515534067|FG000|Overall Study|Protocol Violation|7|||
142998837|NCT01654666|515534068|FG001|Overall Study|Protocol Violation|4|||
142998838|NCT01654666|515534069|FG002|Overall Study|Protocol Violation|8|||
142998839|NCT01654666|515534067|FG000|Overall Study|Lost to Follow-up|4|||
142998840|NCT01654666|515534068|FG001|Overall Study|Lost to Follow-up|5|||
142998841|NCT01654666|515534069|FG002|Overall Study|Lost to Follow-up|5|||
142998842|NCT01654666|515534067|FG000|Overall Study|Withdrawal by Subject|4|||
142998843|NCT01654666|515534068|FG001|Overall Study|Withdrawal by Subject|4|||
142998844|NCT01654666|515534069|FG002|Overall Study|Withdrawal by Subject|1|||
142998845|NCT00779506|515534070|FG000|Overall Study|Screening Failed|2|||
142998846|NCT00779506|515534070|FG000|Overall Study|Adverse Event|4|||
142998847|NCT00779506|515534070|FG000|Overall Study|Lack of Efficacy|11|||
142998848|NCT00779506|515534070|FG000|Overall Study|Protocol Violation|5|||
142998849|NCT00779506|515534070|FG000|Overall Study|Withdrawal by Subject|6|||
142998850|NCT00779506|515534070|FG000|Overall Study|Lost to Follow-up|1|||
142998851|NCT04047472|515534071|FG000|Overall Study|Adverse Event|3|||
142998852|NCT04047472|515534072|FG001|Overall Study|Adverse Event|3|||
142998853|NCT04047472|515534071|FG000|Overall Study|Death|0|||
142998854|NCT04047472|515534072|FG001|Overall Study|Death|1|||
142998855|NCT04047472|515534071|FG000|Overall Study|Lost to Follow-up|1|||
142998856|NCT04047472|515534072|FG001|Overall Study|Lost to Follow-up|0|||
142998857|NCT04047472|515534071|FG000|Overall Study|Physician Decision|1|||
142998858|NCT04047472|515534072|FG001|Overall Study|Physician Decision|2|||
142998859|NCT04047472|515534071|FG000|Overall Study|Protocol Violation|1|||
142998860|NCT04047472|515534072|FG001|Overall Study|Protocol Violation|0|||
142998861|NCT04047472|515534071|FG000|Overall Study|Withdrawal by Subject|10|||
142998862|NCT04047472|515534072|FG001|Overall Study|Withdrawal by Subject|10|||
142998863|NCT03982069|515534073|FG000|Overall Study|Lost to Follow-up|5|||
142998864|NCT03982069|515534074|FG001|Overall Study|Lost to Follow-up|5|||
142998865|NCT03982069|515534075|FG002|Overall Study|Lost to Follow-up|3|||
142998866|NCT03982069|515534076|FG003|Overall Study|Lost to Follow-up|5|||
142998867|NCT03982069|515534073|FG000|Overall Study|Physician Decision|0|||
142998868|NCT03982069|515534074|FG001|Overall Study|Physician Decision|1|||
142998869|NCT03982069|515534075|FG002|Overall Study|Physician Decision|0|||
142998870|NCT03982069|515534076|FG003|Overall Study|Physician Decision|0|||
142998871|NCT03982069|515534073|FG000|Overall Study|Withdrawal by Subject|2|||
142998872|NCT03982069|515534074|FG001|Overall Study|Withdrawal by Subject|1|||
142998873|NCT03982069|515534075|FG002|Overall Study|Withdrawal by Subject|5|||
142998874|NCT03982069|515534076|FG003|Overall Study|Withdrawal by Subject|2|||
142998875|NCT03982069|515534073|FG000|Overall Study|Specimen loss|3|||
142998876|NCT03982069|515534074|FG001|Overall Study|Specimen loss|3|||
142998877|NCT03982069|515534075|FG002|Overall Study|Specimen loss|1|||
142998878|NCT03982069|515534076|FG003|Overall Study|Specimen loss|1|||
142998879|NCT01218477|515534077|FG000|Overall Study|Disease progression|2|||
142998880|NCT01218477|515534078|FG001|Overall Study|Disease progression|3|||
142998881|NCT01218477|515534079|FG002|Overall Study|Disease progression|6|||
142998882|NCT01218477|515534080|FG003|Overall Study|Disease progression|2|||
142998883|NCT01218477|515534077|FG000|Overall Study|Study drug toxicity|0|||
142998884|NCT01218477|515534078|FG001|Overall Study|Study drug toxicity|2|||
142998885|NCT01218477|515534079|FG002|Overall Study|Study drug toxicity|5|||
142998886|NCT01218477|515534080|FG003|Overall Study|Study drug toxicity|0|||
142998887|NCT01218477|515534077|FG000|Overall Study|No longer meets study criteria|1|||
142998888|NCT01218477|515534078|FG001|Overall Study|No longer meets study criteria|0|||
142998889|NCT01218477|515534079|FG002|Overall Study|No longer meets study criteria|0|||
142998890|NCT01218477|515534080|FG003|Overall Study|No longer meets study criteria|0|||
142998891|NCT01218477|515534077|FG000|Overall Study|Withdrawal by Subject|0|||
142998892|NCT01218477|515534078|FG001|Overall Study|Withdrawal by Subject|0|||
142998893|NCT01218477|515534079|FG002|Overall Study|Withdrawal by Subject|1|||
142998894|NCT01218477|515534080|FG003|Overall Study|Withdrawal by Subject|0|||
142998895|NCT01218477|515534077|FG000|Overall Study|Prepared for cell transplantation|0|||
142998896|NCT01218477|515534078|FG001|Overall Study|Prepared for cell transplantation|1|||
142998897|NCT01218477|515534079|FG002|Overall Study|Prepared for cell transplantation|1|||
142998898|NCT01218477|515534080|FG003|Overall Study|Prepared for cell transplantation|0|||
142998899|NCT01218477|515534077|FG000|Overall Study|Administrative reason by sponsor|0|||
142998900|NCT01218477|515534078|FG001|Overall Study|Administrative reason by sponsor|0|||
142998901|NCT01218477|515534079|FG002|Overall Study|Administrative reason by sponsor|1|||
142998902|NCT01218477|515534080|FG003|Overall Study|Administrative reason by sponsor|0|||
142998903|NCT01218477|515534077|FG000|Overall Study|Maximum clinical benefit|0|||
142998904|NCT01218477|515534078|FG001|Overall Study|Maximum clinical benefit|2|||
142998905|NCT01218477|515534079|FG002|Overall Study|Maximum clinical benefit|0|||
142998906|NCT01218477|515534080|FG003|Overall Study|Maximum clinical benefit|0|||
142998907|NCT00787527|515534083|FG000|Overall Study|Toxicity|3|||
142998908|NCT03137433|515534084|FG000|Overall Study|Withdrawal by Subject|11|||
142998909|NCT03137433|515534085|FG001|Overall Study|Withdrawal by Subject|11|||
142998910|NCT03137433|515534084|FG000|Overall Study|Lost to Follow-up|5|||
142998911|NCT03137433|515534085|FG001|Overall Study|Lost to Follow-up|6|||
142998912|NCT03137433|515534084|FG000|Overall Study|Physician Decision|2|||
142998913|NCT03137433|515534085|FG001|Overall Study|Physician Decision|0|||
142998914|NCT03137433|515534084|FG000|Overall Study|Moved out of study area|1|||
142998915|NCT03137433|515534085|FG001|Overall Study|Moved out of study area|0|||
142998916|NCT03137433|515534084|FG000|Overall Study|Too far out of window due to COVID|0|||
142998917|NCT03137433|515534085|FG001|Overall Study|Too far out of window due to COVID|1|||
142998918|NCT00083616|515534086|FG000|Overall Study|Disease Progression|16|||
142998919|NCT00083616|515534086|FG000|Overall Study|Lost to Follow-up|1|||
142998920|NCT00083616|515534086|FG000|Overall Study|Physician Decision|2|||
142998921|NCT00083616|515534086|FG000|Overall Study|Withdrawal by Subject|3|||
142998922|NCT00083616|515534086|FG000|Overall Study|Ineligibility determined|2|||
142998923|NCT00083616|515534086|FG000|Overall Study|Non-compliance|1|||
142998924|NCT00083616|515534086|FG000|Overall Study|Other|6|||
142998925|NCT00265382|515534090|FG000|Overall Study|Adverse Event|21|||
142998926|NCT00265382|515534090|FG000|Overall Study|Laboratory Abnormality|1|||
142998927|NCT00265382|515534090|FG000|Overall Study|Lost to Follow-up|3|||
142998928|NCT00265382|515534090|FG000|Overall Study|Lack of Efficacy|6|||
142998929|NCT00265382|515534090|FG000|Overall Study|Miscellaneous|6|||
142998930|NCT00265382|515534090|FG000|Overall Study|Withdrawal by Subject|13|||
142998931|NCT00265382|515534090|FG000|Overall Study|Study terminated by sponsor|94|||
142998932|NCT00265382|515534090|FG000|Overall Study|Death|1|||
142998933|NCT01474993|515534093|FG000|Overall Study|Lost to Follow-up|1|||
142998934|NCT01474993|515534094|FG001|Overall Study|Lost to Follow-up|2|||
142998935|NCT01474993|515534093|FG000|Overall Study|Adverse Event|0|||
142998936|NCT01474993|515534094|FG001|Overall Study|Adverse Event|1|||
142998937|NCT01853397|515534095|FG000|Overall Study|Withdrawal by Subject|0|||
142998938|NCT01853397|515534096|FG001|Overall Study|Withdrawal by Subject|0|||
142998939|NCT01853397|515534097|FG002|Overall Study|Withdrawal by Subject|0|||
142998940|NCT01853397|515534098|FG003|Overall Study|Withdrawal by Subject|1|||
142998941|NCT01853397|515534095|FG000|Overall Study|Subject Noncompliance|0|||
142998942|NCT01853397|515534096|FG001|Overall Study|Subject Noncompliance|0|||
142998943|NCT01853397|515534097|FG002|Overall Study|Subject Noncompliance|0|||
142998944|NCT01853397|515534098|FG003|Overall Study|Subject Noncompliance|1|||
142998945|NCT02132312|515534099|FG000|Overall Study|Adverse Event|2|||
142998946|NCT02132312|515534100|FG001|Overall Study|Adverse Event|0|||
142998947|NCT02132312|515534099|FG000|Overall Study|Physician Decision|1|||
142998948|NCT02132312|515534100|FG001|Overall Study|Physician Decision|1|||
142998949|NCT02132312|515534099|FG000|Overall Study|Protocol Violation|0|||
142998950|NCT02132312|515534100|FG001|Overall Study|Protocol Violation|1|||
142998951|NCT02132312|515534099|FG000|Overall Study|Withdrawal by Subject|1|||
142998952|NCT02132312|515534100|FG001|Overall Study|Withdrawal by Subject|0|||
142998953|NCT02132312|515534099|FG000|Overall Study|Lost to Follow-up|2|||
142998954|NCT02132312|515534100|FG001|Overall Study|Lost to Follow-up|1|||
142998955|NCT01632345|515534101|FG000|Treatment: Part I|Adverse Event|1|||
142998956|NCT01632345|515534102|FG001|Treatment: Part I|Adverse Event|4|||
142998957|NCT01632345|515534103|FG002|Treatment: Part I|Adverse Event|2|||
142998958|NCT01632345|515534104|FG003|Treatment: Part I|Adverse Event|1|||
142998959|NCT01632345|515534105|FG004|Treatment: Part I|Adverse Event|3|||
142998960|NCT01632345|515534106|FG005|Treatment: Part I|Adverse Event|0|||
142998961|NCT01632345|515534107|FG006|Treatment: Part I|Adverse Event|0|||
142998962|NCT01632345|515534101|FG000|Treatment: Part I|Lack of Efficacy|0|||
142998963|NCT01632345|515534102|FG001|Treatment: Part I|Lack of Efficacy|1|||
142998964|NCT01632345|515534103|FG002|Treatment: Part I|Lack of Efficacy|0|||
142998965|NCT01632345|515534104|FG003|Treatment: Part I|Lack of Efficacy|1|||
142998966|NCT01632345|515534105|FG004|Treatment: Part I|Lack of Efficacy|1|||
142998967|NCT01632345|515534106|FG005|Treatment: Part I|Lack of Efficacy|0|||
142998968|NCT01632345|515534107|FG006|Treatment: Part I|Lack of Efficacy|0|||
142998969|NCT01632345|515534101|FG000|Treatment: Part I|Lost to Follow-up|3|||
142998970|NCT01632345|515534102|FG001|Treatment: Part I|Lost to Follow-up|2|||
142998971|NCT01632345|515534103|FG002|Treatment: Part I|Lost to Follow-up|1|||
142998972|NCT01632345|515534104|FG003|Treatment: Part I|Lost to Follow-up|3|||
142998973|NCT01632345|515534105|FG004|Treatment: Part I|Lost to Follow-up|4|||
142998974|NCT01632345|515534106|FG005|Treatment: Part I|Lost to Follow-up|0|||
142998975|NCT01632345|515534107|FG006|Treatment: Part I|Lost to Follow-up|0|||
142998976|NCT01632345|515534101|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
142998977|NCT01632345|515534102|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
143003192|NCT01049360|515548744|FG000|Period 4|Protocol Violation|0|||
142998978|NCT01632345|515534103|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
142998979|NCT01632345|515534104|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
142998980|NCT01632345|515534105|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
142998981|NCT01632345|515534106|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
142998982|NCT01632345|515534107|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
142998983|NCT01632345|515534101|FG000|Treatment: Part I|Physician Decision|2|||
142998984|NCT01632345|515534102|FG001|Treatment: Part I|Physician Decision|1|||
142998985|NCT01632345|515534103|FG002|Treatment: Part I|Physician Decision|0|||
142998986|NCT01632345|515534104|FG003|Treatment: Part I|Physician Decision|0|||
142998987|NCT01632345|515534105|FG004|Treatment: Part I|Physician Decision|1|||
142998988|NCT01632345|515534106|FG005|Treatment: Part I|Physician Decision|0|||
142998989|NCT01632345|515534107|FG006|Treatment: Part I|Physician Decision|0|||
142998990|NCT01632345|515534101|FG000|Treatment: Part I|Pregnancy|0|||
142998991|NCT01632345|515534102|FG001|Treatment: Part I|Pregnancy|1|||
142998992|NCT01632345|515534103|FG002|Treatment: Part I|Pregnancy|0|||
142998993|NCT01632345|515534104|FG003|Treatment: Part I|Pregnancy|0|||
142998994|NCT01632345|515534105|FG004|Treatment: Part I|Pregnancy|0|||
142998995|NCT01632345|515534106|FG005|Treatment: Part I|Pregnancy|0|||
142998996|NCT01632345|515534107|FG006|Treatment: Part I|Pregnancy|0|||
142998997|NCT01632345|515534101|FG000|Treatment: Part I|Protocol Deviation|0|||
142998998|NCT01632345|515534102|FG001|Treatment: Part I|Protocol Deviation|0|||
142998999|NCT01632345|515534103|FG002|Treatment: Part I|Protocol Deviation|1|||
142999000|NCT01632345|515534104|FG003|Treatment: Part I|Protocol Deviation|1|||
142999001|NCT01632345|515534105|FG004|Treatment: Part I|Protocol Deviation|0|||
142999002|NCT01632345|515534106|FG005|Treatment: Part I|Protocol Deviation|0|||
142999003|NCT01632345|515534107|FG006|Treatment: Part I|Protocol Deviation|0|||
142999004|NCT01632345|515534101|FG000|Treatment: Part I|Withdrawal by Subject|3|||
142999005|NCT01632345|515534102|FG001|Treatment: Part I|Withdrawal by Subject|4|||
142999006|NCT01632345|515534103|FG002|Treatment: Part I|Withdrawal by Subject|4|||
142999007|NCT01632345|515534104|FG003|Treatment: Part I|Withdrawal by Subject|1|||
142999008|NCT01632345|515534105|FG004|Treatment: Part I|Withdrawal by Subject|4|||
142999009|NCT01632345|515534106|FG005|Treatment: Part I|Withdrawal by Subject|0|||
142999010|NCT01632345|515534107|FG006|Treatment: Part I|Withdrawal by Subject|0|||
142999011|NCT01632345|515534101|FG000|Treatment: Part II|Adverse Event|0|||
142999012|NCT01632345|515534102|FG001|Treatment: Part II|Adverse Event|0|||
142999013|NCT01632345|515534103|FG002|Treatment: Part II|Adverse Event|0|||
142999014|NCT01632345|515534104|FG003|Treatment: Part II|Adverse Event|0|||
142999015|NCT01632345|515534105|FG004|Treatment: Part II|Adverse Event|0|||
142999016|NCT01632345|515534106|FG005|Treatment: Part II|Adverse Event|3|||
142999017|NCT01632345|515534107|FG006|Treatment: Part II|Adverse Event|8|||
142999018|NCT01632345|515534101|FG000|Treatment: Part II|Lost to Follow-up|0|||
142999019|NCT01632345|515534102|FG001|Treatment: Part II|Lost to Follow-up|0|||
142999020|NCT01632345|515534103|FG002|Treatment: Part II|Lost to Follow-up|0|||
142999021|NCT01632345|515534104|FG003|Treatment: Part II|Lost to Follow-up|0|||
142999022|NCT01632345|515534105|FG004|Treatment: Part II|Lost to Follow-up|0|||
142999023|NCT01632345|515534106|FG005|Treatment: Part II|Lost to Follow-up|3|||
142999024|NCT01632345|515534107|FG006|Treatment: Part II|Lost to Follow-up|1|||
142999025|NCT01632345|515534101|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
142999026|NCT01632345|515534102|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
142999027|NCT01632345|515534103|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
142999028|NCT01632345|515534104|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
142999029|NCT01632345|515534105|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
142999030|NCT01632345|515534106|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
142999031|NCT01632345|515534107|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
142999032|NCT01632345|515534101|FG000|Treatment: Part II|Withdrawal by Subject|0|||
142999033|NCT01632345|515534102|FG001|Treatment: Part II|Withdrawal by Subject|0|||
142999034|NCT01632345|515534103|FG002|Treatment: Part II|Withdrawal by Subject|0|||
142999035|NCT01632345|515534104|FG003|Treatment: Part II|Withdrawal by Subject|0|||
142999036|NCT01632345|515534105|FG004|Treatment: Part II|Withdrawal by Subject|0|||
142999037|NCT01632345|515534106|FG005|Treatment: Part II|Withdrawal by Subject|2|||
142999038|NCT01632345|515534107|FG006|Treatment: Part II|Withdrawal by Subject|2|||
142999039|NCT01724021|515534108|FG000|Overall Study|Adverse Event|11|||
142999040|NCT01724021|515534109|FG001|Overall Study|Adverse Event|6|||
142999041|NCT01724021|515534108|FG000|Overall Study|Death|46|||
142999042|NCT01724021|515534109|FG001|Overall Study|Death|58|||
142999043|NCT01724021|515534108|FG000|Overall Study|Participant request/ Withdrew consent|18|||
142999044|NCT01724021|515534109|FG001|Overall Study|Participant request/ Withdrew consent|14|||
142999045|NCT01724021|515534108|FG000|Overall Study|Lost to Follow-up|15|||
142999046|NCT01724021|515534109|FG001|Overall Study|Lost to Follow-up|15|||
142999047|NCT01724021|515534108|FG000|Overall Study|Reason Not Specified|36|||
142999048|NCT01724021|515534109|FG001|Overall Study|Reason Not Specified|39|||
142999049|NCT01724021|515534108|FG000|Overall Study|Missing|1|||
142999050|NCT01724021|515534109|FG001|Overall Study|Missing|1|||
142999051|NCT02543918|515534110|FG000|Overall Study|Never treated|0|||
142999052|NCT02543918|515534111|FG001|Overall Study|Never treated|1|||
142999053|NCT02543918|515534110|FG000|Overall Study|Lost to Follow-up|1|||
142999054|NCT02543918|515534111|FG001|Overall Study|Lost to Follow-up|1|||
142999055|NCT02543918|515534110|FG000|Overall Study|Withdrawal by Subject|1|||
142999056|NCT02543918|515534111|FG001|Overall Study|Withdrawal by Subject|1|||
142999057|NCT02543918|515534110|FG000|Overall Study|Adverse Event|1|||
142999058|NCT02543918|515534111|FG001|Overall Study|Adverse Event|1|||
142999059|NCT02452892|515534112|FG000|Week 1 Initial Randommization|Adverse Event|1|||
142999060|NCT02452892|515534113|FG001|Week 1 Initial Randommization|Adverse Event|0|||
142999061|NCT02452892|515534114|FG002|Week 1 Initial Randommization|Adverse Event|0|||
142999062|NCT02452892|515534115|FG003|Week 1 Initial Randommization|Adverse Event|0|||
142999063|NCT02452892|515534112|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
142999064|NCT02452892|515534113|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
142999065|NCT02452892|515534114|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
142999066|NCT02452892|515534115|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
142999067|NCT02452892|515534112|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
142999068|NCT02452892|515534113|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
142999069|NCT02452892|515534114|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
142999070|NCT02452892|515534115|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
142999071|NCT02452892|515534112|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
142999072|NCT02452892|515534113|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
142999073|NCT02452892|515534114|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
142999074|NCT02452892|515534115|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
142999075|NCT02452892|515534112|FG000|Follow-up|Withdrawal by Subject|0|||
142999076|NCT02452892|515534113|FG001|Follow-up|Withdrawal by Subject|0|||
142999077|NCT02452892|515534114|FG002|Follow-up|Withdrawal by Subject|0|||
142999078|NCT02452892|515534115|FG003|Follow-up|Withdrawal by Subject|1|||
142999079|NCT02452892|515534112|FG000|Follow-up|Subject left town on Day 42|1|||
142999080|NCT02452892|515534113|FG001|Follow-up|Subject left town on Day 42|0|||
142999081|NCT02452892|515534114|FG002|Follow-up|Subject left town on Day 42|0|||
142999082|NCT02452892|515534115|FG003|Follow-up|Subject left town on Day 42|0|||
142999083|NCT00545740|515534117|FG000|Overall Study|Lack of Efficacy|34|||
142999084|NCT00545740|515534118|FG001|Overall Study|Lack of Efficacy|35|||
142999085|NCT00545740|515534119|FG002|Overall Study|Lack of Efficacy|47|||
142999086|NCT00545740|515534120|FG003|Overall Study|Lack of Efficacy|36|||
142999087|NCT00545740|515534117|FG000|Overall Study|Withdrawal by Subject|17|||
142999088|NCT00545740|515534118|FG001|Overall Study|Withdrawal by Subject|15|||
142999089|NCT00545740|515534119|FG002|Overall Study|Withdrawal by Subject|16|||
142999090|NCT00545740|515534120|FG003|Overall Study|Withdrawal by Subject|18|||
142999091|NCT00545740|515534117|FG000|Overall Study|Adverse Event|10|||
142999092|NCT00545740|515534118|FG001|Overall Study|Adverse Event|18|||
142999093|NCT00545740|515534119|FG002|Overall Study|Adverse Event|19|||
142999094|NCT00545740|515534120|FG003|Overall Study|Adverse Event|9|||
142999095|NCT00545740|515534117|FG000|Overall Study|Lost to Follow-up|7|||
142999096|NCT00545740|515534118|FG001|Overall Study|Lost to Follow-up|5|||
142999097|NCT00545740|515534119|FG002|Overall Study|Lost to Follow-up|5|||
142999098|NCT00545740|515534120|FG003|Overall Study|Lost to Follow-up|6|||
142999099|NCT00545740|515534117|FG000|Overall Study|Protocol Violation|1|||
142999100|NCT00545740|515534118|FG001|Overall Study|Protocol Violation|3|||
142999101|NCT00545740|515534119|FG002|Overall Study|Protocol Violation|1|||
142999102|NCT00545740|515534120|FG003|Overall Study|Protocol Violation|0|||
142999103|NCT00545740|515534117|FG000|Overall Study|Non-compliance|0|||
142999104|NCT00545740|515534118|FG001|Overall Study|Non-compliance|2|||
142999105|NCT00545740|515534119|FG002|Overall Study|Non-compliance|1|||
142999106|NCT00545740|515534120|FG003|Overall Study|Non-compliance|0|||
142999107|NCT00545740|515534117|FG000|Overall Study|Moved|2|||
142999108|NCT00545740|515534118|FG001|Overall Study|Moved|0|||
142999109|NCT00545740|515534119|FG002|Overall Study|Moved|1|||
142999110|NCT00545740|515534120|FG003|Overall Study|Moved|0|||
142999111|NCT00545740|515534117|FG000|Overall Study|Diverticulitis attack|0|||
142999112|NCT00545740|515534118|FG001|Overall Study|Diverticulitis attack|0|||
142999113|NCT00545740|515534119|FG002|Overall Study|Diverticulitis attack|1|||
142999114|NCT00545740|515534120|FG003|Overall Study|Diverticulitis attack|1|||
142999115|NCT00545740|515534117|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
142999116|NCT00545740|515534118|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
142999117|NCT00545740|515534119|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
142999118|NCT00545740|515534120|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
142999119|NCT00545740|515534117|FG000|Overall Study|Site closure|1|||
142999120|NCT00545740|515534118|FG001|Overall Study|Site closure|0|||
142999121|NCT00545740|515534119|FG002|Overall Study|Site closure|0|||
142999122|NCT00545740|515534120|FG003|Overall Study|Site closure|0|||
142999123|NCT00545740|515534117|FG000|Overall Study|Missed visit|1|||
142999124|NCT00545740|515534118|FG001|Overall Study|Missed visit|0|||
142999125|NCT00545740|515534119|FG002|Overall Study|Missed visit|0|||
142999126|NCT00545740|515534120|FG003|Overall Study|Missed visit|0|||
142999127|NCT00545740|515534117|FG000|Overall Study|Physician Decision|0|||
142999128|NCT00545740|515534118|FG001|Overall Study|Physician Decision|0|||
142999129|NCT00545740|515534119|FG002|Overall Study|Physician Decision|3|||
142999130|NCT00545740|515534120|FG003|Overall Study|Physician Decision|0|||
142999131|NCT00545740|515534117|FG000|Overall Study|Accepted only monthly telephone calls|1|||
142999132|NCT00545740|515534118|FG001|Overall Study|Accepted only monthly telephone calls|0|||
142999133|NCT00545740|515534119|FG002|Overall Study|Accepted only monthly telephone calls|0|||
142999134|NCT00545740|515534120|FG003|Overall Study|Accepted only monthly telephone calls|0|||
142999135|NCT00545740|515534117|FG000|Overall Study|Sponsor decision|0|||
142999136|NCT00545740|515534118|FG001|Overall Study|Sponsor decision|1|||
142999137|NCT00545740|515534119|FG002|Overall Study|Sponsor decision|0|||
142999138|NCT00545740|515534120|FG003|Overall Study|Sponsor decision|0|||
142999139|NCT00545740|515534117|FG000|Overall Study|Lack of time|0|||
142999140|NCT00545740|515534118|FG001|Overall Study|Lack of time|1|||
142999141|NCT00545740|515534119|FG002|Overall Study|Lack of time|0|||
142999142|NCT00545740|515534120|FG003|Overall Study|Lack of time|0|||
142999143|NCT00545740|515534117|FG000|Overall Study|Non-adherence to visits|0|||
142999144|NCT00545740|515534118|FG001|Overall Study|Non-adherence to visits|1|||
142999145|NCT00545740|515534119|FG002|Overall Study|Non-adherence to visits|0|||
142999146|NCT00545740|515534120|FG003|Overall Study|Non-adherence to visits|0|||
142999147|NCT00545740|515534117|FG000|Overall Study|Patient difficulties|0|||
142999148|NCT00545740|515534118|FG001|Overall Study|Patient difficulties|1|||
142999149|NCT00545740|515534119|FG002|Overall Study|Patient difficulties|0|||
142999150|NCT00545740|515534120|FG003|Overall Study|Patient difficulties|0|||
142999151|NCT00545740|515534117|FG000|Overall Study|Husband against study|0|||
142999152|NCT00545740|515534118|FG001|Overall Study|Husband against study|0|||
142999153|NCT00545740|515534119|FG002|Overall Study|Husband against study|1|||
142999154|NCT00545740|515534120|FG003|Overall Study|Husband against study|0|||
142999155|NCT02117024|515534121|FG000|Overall Study|Progressive Disease|26|||
142999156|NCT02117024|515534122|FG001|Overall Study|Progressive Disease|9|||
142999157|NCT02117024|515534121|FG000|Overall Study|Significant Clinical Progression|7|||
142999158|NCT02117024|515534122|FG001|Overall Study|Significant Clinical Progression|4|||
142999159|NCT02117024|515534121|FG000|Overall Study|Death|5|||
142999160|NCT02117024|515534122|FG001|Overall Study|Death|0|||
142999161|NCT02117024|515534121|FG000|Overall Study|Withdrawal by Subject|3|||
142999162|NCT02117024|515534122|FG001|Overall Study|Withdrawal by Subject|1|||
142999163|NCT02117024|515534121|FG000|Overall Study|Protocol Violation|1|||
142999164|NCT02117024|515534122|FG001|Overall Study|Protocol Violation|0|||
142999165|NCT02117024|515534121|FG000|Overall Study|Adverse Event|1|||
142999166|NCT02117024|515534122|FG001|Overall Study|Adverse Event|2|||
142999167|NCT02117024|515534121|FG000|Overall Study|Randomized in Error|1|||
142999168|NCT02117024|515534122|FG001|Overall Study|Randomized in Error|0|||
142999169|NCT02117024|515534121|FG000|Overall Study|Patient returned to primary oncologist|0|||
142999170|NCT02117024|515534122|FG001|Overall Study|Patient returned to primary oncologist|1|||
142999171|NCT02117024|515534121|FG000|Overall Study|Patient took treatment break|0|||
142999172|NCT02117024|515534122|FG001|Overall Study|Patient took treatment break|1|||
142999173|NCT02117024|515534121|FG000|Overall Study|Physician Decision|0|||
142999174|NCT02117024|515534122|FG001|Overall Study|Physician Decision|2|||
142999175|NCT01874288|515534125|FG000|Overall Study|Withdrawal by Subject|1|||
142999176|NCT01874288|515534126|FG001|Overall Study|Withdrawal by Subject|0|||
142999177|NCT01874288|515534127|FG002|Overall Study|Withdrawal by Subject|2|||
142999178|NCT01874288|515534128|FG003|Overall Study|Withdrawal by Subject|1|||
142999179|NCT01874288|515534129|FG004|Overall Study|Withdrawal by Subject|1|||
142999180|NCT01874288|515534125|FG000|Overall Study|Physician Decision|0|||
142999181|NCT01874288|515534126|FG001|Overall Study|Physician Decision|0|||
142999182|NCT01874288|515534127|FG002|Overall Study|Physician Decision|0|||
142999183|NCT01874288|515534128|FG003|Overall Study|Physician Decision|1|||
142999184|NCT01874288|515534129|FG004|Overall Study|Physician Decision|0|||
142999185|NCT01874288|515534125|FG000|Overall Study|Progressive disease|2|||
142999186|NCT01874288|515534126|FG001|Overall Study|Progressive disease|0|||
142999187|NCT01874288|515534127|FG002|Overall Study|Progressive disease|3|||
142999188|NCT01874288|515534128|FG003|Overall Study|Progressive disease|5|||
142999189|NCT01874288|515534129|FG004|Overall Study|Progressive disease|1|||
142999190|NCT01333865|515534130|FG000|Overall Study|Adverse Event|2|||
142999191|NCT00620815|515534133|FG000|Overall Study|Adverse Event|1|||
142999192|NCT00620815|515534134|FG001|Overall Study|Adverse Event|1|||
142999193|NCT00620815|515534135|FG002|Overall Study|Adverse Event|2|||
142999194|NCT00620815|515534133|FG000|Overall Study|Withdrawal by Subject|1|||
142999195|NCT00620815|515534134|FG001|Overall Study|Withdrawal by Subject|2|||
142999196|NCT00620815|515534135|FG002|Overall Study|Withdrawal by Subject|0|||
142999197|NCT00620815|515534133|FG000|Overall Study|Lost to Follow-up|1|||
142999198|NCT00620815|515534134|FG001|Overall Study|Lost to Follow-up|6|||
142999199|NCT00620815|515534135|FG002|Overall Study|Lost to Follow-up|3|||
142999200|NCT00620815|515534133|FG000|Overall Study|Inappropriate enrolment|0|||
142999201|NCT00620815|515534134|FG001|Overall Study|Inappropriate enrolment|0|||
142999202|NCT00620815|515534135|FG002|Overall Study|Inappropriate enrolment|1|||
142999203|NCT00620815|515534133|FG000|Overall Study|Protocol Violation|1|||
142999204|NCT00620815|515534134|FG001|Overall Study|Protocol Violation|2|||
142999205|NCT00620815|515534135|FG002|Overall Study|Protocol Violation|1|||
142999206|NCT00591786|515534138|FG000|Overall Study|Withdrawal of Informed Consent|0|||
142999207|NCT00591786|515534139|FG001|Overall Study|Withdrawal of Informed Consent|0|||
142999208|NCT00591786|515534140|FG002|Overall Study|Withdrawal of Informed Consent|1|||
142999209|NCT00591786|515534141|FG003|Overall Study|Withdrawal of Informed Consent|0|||
142999210|NCT00591786|515534142|FG004|Overall Study|Withdrawal of Informed Consent|0|||
142999211|NCT00591786|515534143|FG005|Overall Study|Withdrawal of Informed Consent|0|||
142999212|NCT00591786|515534144|FG006|Overall Study|Withdrawal of Informed Consent|0|||
142999213|NCT00591786|515534145|FG007|Overall Study|Withdrawal of Informed Consent|0|||
142999214|NCT00591786|515534146|FG008|Overall Study|Withdrawal of Informed Consent|0|||
142999215|NCT00591786|515534147|FG009|Overall Study|Withdrawal of Informed Consent|0|||
142999216|NCT01920061|515534149|FG000|Overall Study|Death|1|||
142999217|NCT01920061|515534150|FG001|Overall Study|Death|1|||
142999218|NCT01920061|515534151|FG002|Overall Study|Death|0|||
142999219|NCT01920061|515534152|FG003|Overall Study|Death|1|||
142999220|NCT01920061|515534153|FG004|Overall Study|Death|1|||
142999221|NCT01920061|515534154|FG005|Overall Study|Death|0|||
142999222|NCT01920061|515534155|FG006|Overall Study|Death|0|||
142999223|NCT01920061|515534156|FG007|Overall Study|Death|1|||
142999224|NCT01920061|515534157|FG008|Overall Study|Death|0|||
142999225|NCT01920061|515534158|FG009|Overall Study|Death|1|||
142999226|NCT01920061|515534159|FG010|Overall Study|Death|0|||
142999227|NCT01920061|515534160|FG011|Overall Study|Death|1|||
142999228|NCT01920061|515534161|FG012|Overall Study|Death|0|||
142999229|NCT01920061|515534162|FG013|Overall Study|Death|2|||
142999230|NCT01920061|515534163|FG014|Overall Study|Death|0|||
142999231|NCT01920061|515534164|FG015|Overall Study|Death|0|||
142999232|NCT01920061|515534165|FG016|Overall Study|Death|0|||
142999233|NCT01920061|515534166|FG017|Overall Study|Death|0|||
142999234|NCT01920061|515534167|FG018|Overall Study|Death|1|||
142999235|NCT01920061|515534168|FG019|Overall Study|Death|0|||
142999236|NCT01920061|515534149|FG000|Overall Study|Lost to Follow-up|0|||
142999237|NCT01920061|515534150|FG001|Overall Study|Lost to Follow-up|2|||
142999238|NCT01920061|515534151|FG002|Overall Study|Lost to Follow-up|0|||
142999239|NCT01920061|515534152|FG003|Overall Study|Lost to Follow-up|0|||
142999240|NCT01920061|515534153|FG004|Overall Study|Lost to Follow-up|0|||
142999241|NCT01920061|515534154|FG005|Overall Study|Lost to Follow-up|0|||
142999242|NCT01920061|515534155|FG006|Overall Study|Lost to Follow-up|1|||
142999243|NCT01920061|515534156|FG007|Overall Study|Lost to Follow-up|0|||
142999244|NCT01920061|515534157|FG008|Overall Study|Lost to Follow-up|0|||
142999245|NCT01920061|515534158|FG009|Overall Study|Lost to Follow-up|0|||
142999246|NCT01920061|515534159|FG010|Overall Study|Lost to Follow-up|3|||
142999247|NCT01920061|515534160|FG011|Overall Study|Lost to Follow-up|0|||
142999248|NCT01920061|515534161|FG012|Overall Study|Lost to Follow-up|0|||
142999249|NCT01920061|515534162|FG013|Overall Study|Lost to Follow-up|0|||
142999250|NCT01920061|515534163|FG014|Overall Study|Lost to Follow-up|0|||
142999251|NCT01920061|515534164|FG015|Overall Study|Lost to Follow-up|0|||
142999252|NCT01920061|515534165|FG016|Overall Study|Lost to Follow-up|0|||
142999253|NCT01920061|515534166|FG017|Overall Study|Lost to Follow-up|1|||
142999254|NCT01920061|515534167|FG018|Overall Study|Lost to Follow-up|4|||
142999255|NCT01920061|515534168|FG019|Overall Study|Lost to Follow-up|3|||
142999256|NCT01920061|515534149|FG000|Overall Study|Other|1|||
142999257|NCT01920061|515534150|FG001|Overall Study|Other|1|||
142999258|NCT01920061|515534151|FG002|Overall Study|Other|2|||
142999259|NCT01920061|515534152|FG003|Overall Study|Other|1|||
142999260|NCT01920061|515534153|FG004|Overall Study|Other|0|||
142999261|NCT01920061|515534154|FG005|Overall Study|Other|1|||
142999262|NCT01920061|515534155|FG006|Overall Study|Other|0|||
142999263|NCT01920061|515534156|FG007|Overall Study|Other|0|||
142999264|NCT01920061|515534157|FG008|Overall Study|Other|0|||
142999265|NCT01920061|515534158|FG009|Overall Study|Other|1|||
142999266|NCT01920061|515534159|FG010|Overall Study|Other|1|||
142999267|NCT01920061|515534160|FG011|Overall Study|Other|2|||
142999268|NCT01920061|515534161|FG012|Overall Study|Other|1|||
142999269|NCT01920061|515534162|FG013|Overall Study|Other|4|||
142999270|NCT01920061|515534163|FG014|Overall Study|Other|0|||
142999271|NCT01920061|515534164|FG015|Overall Study|Other|1|||
142999272|NCT01920061|515534165|FG016|Overall Study|Other|1|||
142999273|NCT01920061|515534166|FG017|Overall Study|Other|0|||
142999274|NCT01920061|515534167|FG018|Overall Study|Other|1|||
142999275|NCT01920061|515534168|FG019|Overall Study|Other|1|||
142999276|NCT01920061|515534149|FG000|Overall Study|Participant refused further follow-up|0|||
142999277|NCT01920061|515534150|FG001|Overall Study|Participant refused further follow-up|0|||
142999278|NCT01920061|515534151|FG002|Overall Study|Participant refused further follow-up|0|||
142999279|NCT01920061|515534152|FG003|Overall Study|Participant refused further follow-up|0|||
142999280|NCT01920061|515534153|FG004|Overall Study|Participant refused further follow-up|1|||
142999281|NCT01920061|515534154|FG005|Overall Study|Participant refused further follow-up|1|||
142999282|NCT01920061|515534155|FG006|Overall Study|Participant refused further follow-up|0|||
142999283|NCT01920061|515534156|FG007|Overall Study|Participant refused further follow-up|0|||
142999284|NCT01920061|515534157|FG008|Overall Study|Participant refused further follow-up|1|||
142999285|NCT01920061|515534158|FG009|Overall Study|Participant refused further follow-up|0|||
142999286|NCT01920061|515534159|FG010|Overall Study|Participant refused further follow-up|1|||
142999287|NCT01920061|515534160|FG011|Overall Study|Participant refused further follow-up|0|||
142999288|NCT01920061|515534161|FG012|Overall Study|Participant refused further follow-up|1|||
142999289|NCT01920061|515534162|FG013|Overall Study|Participant refused further follow-up|0|||
142999290|NCT01920061|515534163|FG014|Overall Study|Participant refused further follow-up|1|||
142999291|NCT01920061|515534164|FG015|Overall Study|Participant refused further follow-up|2|||
142999292|NCT01920061|515534165|FG016|Overall Study|Participant refused further follow-up|1|||
142999293|NCT01920061|515534166|FG017|Overall Study|Participant refused further follow-up|1|||
142999294|NCT01920061|515534167|FG018|Overall Study|Participant refused further follow-up|0|||
142999295|NCT01920061|515534168|FG019|Overall Study|Participant refused further follow-up|0|||
142999296|NCT00877929|515534169|FG000|Overall Study|Adverse Event|11|||
142999297|NCT00877929|515534170|FG001|Overall Study|Adverse Event|20|||
142999298|NCT00877929|515534169|FG000|Overall Study|Protocol Violation|3|||
142999299|NCT00877929|515534170|FG001|Overall Study|Protocol Violation|3|||
142999300|NCT00877929|515534169|FG000|Overall Study|Lost to Follow-up|0|||
142999301|NCT00877929|515534170|FG001|Overall Study|Lost to Follow-up|1|||
142999302|NCT00877929|515534169|FG000|Overall Study|Withdrawal by Subject|4|||
142999303|NCT00877929|515534170|FG001|Overall Study|Withdrawal by Subject|4|||
142999304|NCT00877929|515534169|FG000|Overall Study|Lack of Efficacy|0|||
142999305|NCT00877929|515534170|FG001|Overall Study|Lack of Efficacy|1|||
142999306|NCT00877929|515534169|FG000|Overall Study|Other reason (not specified)|2|||
142999307|NCT00877929|515534170|FG001|Overall Study|Other reason (not specified)|6|||
142999308|NCT00554229|515534171|FG000|Overall Study|Lost to Follow-up|3|||
142999309|NCT00554229|515534172|FG001|Overall Study|Lost to Follow-up|6|||
142999310|NCT00554229|515534171|FG000|Overall Study|Withdrawal by Subject|29|||
142999311|NCT00554229|515534172|FG001|Overall Study|Withdrawal by Subject|37|||
142999312|NCT00554229|515534171|FG000|Overall Study|Adverse Event|71|||
142999313|NCT00554229|515534172|FG001|Overall Study|Adverse Event|39|||
142999314|NCT00554229|515534171|FG000|Overall Study|Protocol Violation|3|||
142999315|NCT00554229|515534172|FG001|Overall Study|Protocol Violation|3|||
142999316|NCT00554229|515534171|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
142999317|NCT00554229|515534172|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
142999318|NCT00554229|515534171|FG000|Overall Study|Randomised but no treatment received|1|||
142999319|NCT00554229|515534172|FG001|Overall Study|Randomised but no treatment received|0|||
142999320|NCT01140646|515534173|FG000|Overall Study|Adverse Event|4|||
142999321|NCT01140646|515534173|FG000|Overall Study|Refused Further Treatment|5|||
142999322|NCT00784836|515534179|FG000|Overall Study|Early Study Termination|3|||
142999323|NCT03143855|515534180|FG000|Overall Study|Withdrawal by Subject|4|||
142999324|NCT03143855|515534181|FG001|Overall Study|Withdrawal by Subject|3|||
142999325|NCT03143855|515534180|FG000|Overall Study|Protocol Violation|1|||
142999326|NCT03143855|515534181|FG001|Overall Study|Protocol Violation|0|||
142999327|NCT03143855|515534180|FG000|Overall Study|Participant experienced withdrawal|0|||
142999328|NCT03143855|515534181|FG001|Overall Study|Participant experienced withdrawal|1|||
142999329|NCT02612194|515534182|FG000|Overall Study|Death|5|||
142999330|NCT02612194|515534183|FG001|Overall Study|Death|0|||
142999331|NCT02612194|515534184|FG002|Overall Study|Death|2|||
142999332|NCT02612194|515534182|FG000|Overall Study|Early Study Termination|1|||
142999333|NCT02612194|515534183|FG001|Overall Study|Early Study Termination|0|||
142999334|NCT02612194|515534184|FG002|Overall Study|Early Study Termination|0|||
142999335|NCT00689299|515534185|FG000|Overall Study|Adverse Event|2|||
142999336|NCT00689299|515534186|FG001|Overall Study|Adverse Event|1|||
142999337|NCT00689299|515534187|FG002|Overall Study|Adverse Event|1|||
142999338|NCT00689299|515534185|FG000|Overall Study|Lost to Follow-up|0|||
142999339|NCT00689299|515534186|FG001|Overall Study|Lost to Follow-up|1|||
142999340|NCT00689299|515534187|FG002|Overall Study|Lost to Follow-up|1|||
142999341|NCT00689299|515534185|FG000|Overall Study|Withdrawal by Subject|4|||
142999342|NCT00689299|515534186|FG001|Overall Study|Withdrawal by Subject|1|||
142999343|NCT00689299|515534187|FG002|Overall Study|Withdrawal by Subject|3|||
142999344|NCT00689299|515534185|FG000|Overall Study|Protocol Violation|1|||
142999345|NCT00689299|515534186|FG001|Overall Study|Protocol Violation|0|||
142999346|NCT00689299|515534187|FG002|Overall Study|Protocol Violation|0|||
142999347|NCT02613910|515534190|FG000|Overall Study|Termination of study|1|||
142999348|NCT00434876|515534193|FG000|Overall Study|Lost to Follow-up|1|||
142999349|NCT00434876|515534194|FG001|Overall Study|Lost to Follow-up|1|||
142999350|NCT00758394|515534195|FG000|2nd Intervention Order|Lost to Follow-up|0|||
142999351|NCT00758394|515534196|FG001|2nd Intervention Order|Lost to Follow-up|1|||
142999352|NCT00758394|515534197|FG002|2nd Intervention Order|Lost to Follow-up|0|||
142999353|NCT00758394|515534198|FG003|2nd Intervention Order|Lost to Follow-up|0|||
142999354|NCT00758394|515534195|FG000|3rd Intervention|Lost to Follow-up|1|||
142999355|NCT00758394|515534196|FG001|3rd Intervention|Lost to Follow-up|0|||
142999356|NCT00758394|515534197|FG002|3rd Intervention|Lost to Follow-up|0|||
142999357|NCT00758394|515534198|FG003|3rd Intervention|Lost to Follow-up|1|||
142999358|NCT00965458|515535681|FG000|Overall Study|Adverse Event|1|||
142999359|NCT00965458|515535682|FG001|Overall Study|Adverse Event|0|||
142999360|NCT00965458|515535681|FG000|Overall Study|Lost to Follow-up|1|||
142999361|NCT00965458|515535682|FG001|Overall Study|Lost to Follow-up|3|||
142999362|NCT00965458|515535681|FG000|Overall Study|Withdrawal by Subject|0|||
142999363|NCT00965458|515535682|FG001|Overall Study|Withdrawal by Subject|1|||
142999364|NCT05111548|515535686|FG000|Overall Study|Withdrawal by Subject|2|||
142999365|NCT05111548|515535687|FG001|Overall Study|Withdrawal by Subject|1|||
142999366|NCT05111548|515535686|FG000|Overall Study|Adverse Event|1|||
142999367|NCT05111548|515535687|FG001|Overall Study|Adverse Event|0|||
142999368|NCT00594958|515535688|FG000|Overall Study|Withdrawal by Subject|1|||
142999369|NCT00594958|515535689|FG001|Overall Study|Withdrawal by Subject|0|||
142999370|NCT00594958|515535690|FG002|Overall Study|Withdrawal by Subject|1|||
142999371|NCT00594958|515535688|FG000|Overall Study|Adverse Event|4|||
142999372|NCT00594958|515535689|FG001|Overall Study|Adverse Event|1|||
142999373|NCT00594958|515535690|FG002|Overall Study|Adverse Event|2|||
142999374|NCT00594958|515535688|FG000|Overall Study|Pregnancy|0|||
142999375|NCT00594958|515535689|FG001|Overall Study|Pregnancy|2|||
142999376|NCT00594958|515535690|FG002|Overall Study|Pregnancy|0|||
142999377|NCT00594958|515535688|FG000|Overall Study|Protocol Violation|1|||
142999378|NCT00594958|515535689|FG001|Overall Study|Protocol Violation|0|||
142999379|NCT00594958|515535690|FG002|Overall Study|Protocol Violation|2|||
142999380|NCT00594958|515535688|FG000|Overall Study|Lost to Follow-up|5|||
142999381|NCT00594958|515535689|FG001|Overall Study|Lost to Follow-up|0|||
142999382|NCT00594958|515535690|FG002|Overall Study|Lost to Follow-up|3|||
142999383|NCT00594958|515535688|FG000|Overall Study|administrative|3|||
142999384|NCT00594958|515535689|FG001|Overall Study|administrative|0|||
142999385|NCT00594958|515535690|FG002|Overall Study|administrative|2|||
142999386|NCT03233009|515535691|FG000|Overall Study|Lost to Follow-up|1|||
142999387|NCT02079077|515535692|FG000|Overall Study|Lost to Follow-up|5|||
142999388|NCT02079077|515535693|FG001|Overall Study|Lost to Follow-up|7|||
142999389|NCT02079077|515535692|FG000|Overall Study|Became STIs Positive|1|||
142999390|NCT02079077|515535693|FG001|Overall Study|Became STIs Positive|2|||
142999391|NCT02087085|515535694|FG000|Overall Study|Adverse Event|10|||
142999392|NCT02087085|515535695|FG001|Overall Study|Adverse Event|14|||
142999393|NCT02087085|515535694|FG000|Overall Study|Lack of Efficacy|4|||
142999394|NCT02087085|515535695|FG001|Overall Study|Lack of Efficacy|3|||
142999395|NCT02087085|515535694|FG000|Overall Study|Lost to Follow-up|6|||
142999396|NCT02087085|515535695|FG001|Overall Study|Lost to Follow-up|4|||
142999397|NCT02087085|515535694|FG000|Overall Study|Withdrawal by Subject|9|||
142999398|NCT02087085|515535695|FG001|Overall Study|Withdrawal by Subject|11|||
142999399|NCT02087085|515535694|FG000|Overall Study|Protocol Violation|1|||
142999400|NCT02087085|515535695|FG001|Overall Study|Protocol Violation|0|||
142999401|NCT02087085|515535694|FG000|Overall Study|Study Terminated by Sponsor|87|||
142999402|NCT02087085|515535695|FG001|Overall Study|Study Terminated by Sponsor|80|||
142999403|NCT02087085|515535694|FG000|Overall Study|Other Miscellaneous Reasons|3|||
142999404|NCT02087085|515535695|FG001|Overall Study|Other Miscellaneous Reasons|4|||
142999405|NCT01101321|515535696|FG000|Period 1|Withdrawal by Subject|1|||
142999406|NCT01101321|515535697|FG001|Period 1|Withdrawal by Subject|1|||
142999407|NCT01101321|515535696|FG000|Period 1|Adverse Event|3|||
142999408|NCT01101321|515535697|FG001|Period 1|Adverse Event|3|||
142999409|NCT00719706|515535698|FG000|Overall Study|Adverse Event|5|||
142999410|NCT00719706|515535699|FG001|Overall Study|Adverse Event|4|||
142999411|NCT00719706|515535698|FG000|Overall Study|Withdrawal by Subject|1|||
142999412|NCT00719706|515535699|FG001|Overall Study|Withdrawal by Subject|2|||
142999413|NCT00719706|515535698|FG000|Overall Study|Protocol Violation|3|||
142999414|NCT00719706|515535699|FG001|Overall Study|Protocol Violation|0|||
142999415|NCT01270139|515535700|FG000|Overall Study|Adverse Event|8|||
142999416|NCT01270139|515535701|FG001|Overall Study|Adverse Event|17|||
142999417|NCT01270139|515535702|FG002|Overall Study|Adverse Event|18|||
142999418|NCT01270139|515535700|FG000|Overall Study|Lost to Follow-up|10|||
142999419|NCT01270139|515535701|FG001|Overall Study|Lost to Follow-up|9|||
142999420|NCT01270139|515535702|FG002|Overall Study|Lost to Follow-up|2|||
142999421|NCT02839330|515535703|FG000|Overall Study|Adverse Event|0|||
142999422|NCT02839330|515535704|FG001|Overall Study|Adverse Event|1|||
142999423|NCT02839330|515535705|FG002|Overall Study|Adverse Event|2|||
142999424|NCT02839330|515535706|FG003|Overall Study|Adverse Event|2|||
142999425|NCT02839330|515535703|FG000|Overall Study|Death|4|||
142999426|NCT02839330|515535704|FG001|Overall Study|Death|6|||
142999427|NCT02839330|515535705|FG002|Overall Study|Death|1|||
142999428|NCT02839330|515535706|FG003|Overall Study|Death|1|||
142999429|NCT02839330|515535703|FG000|Overall Study|Withdrawal by Subject|27|||
142999430|NCT02839330|515535704|FG001|Overall Study|Withdrawal by Subject|19|||
142999431|NCT02839330|515535705|FG002|Overall Study|Withdrawal by Subject|11|||
142999432|NCT02839330|515535706|FG003|Overall Study|Withdrawal by Subject|13|||
142999433|NCT02839330|515535703|FG000|Overall Study|Lost to Follow-up|22|||
142999434|NCT02839330|515535704|FG001|Overall Study|Lost to Follow-up|27|||
142999435|NCT02839330|515535705|FG002|Overall Study|Lost to Follow-up|29|||
142999436|NCT02839330|515535706|FG003|Overall Study|Lost to Follow-up|25|||
142999437|NCT02839330|515535703|FG000|Overall Study|Administrative Reason|0|||
142999438|NCT02839330|515535704|FG001|Overall Study|Administrative Reason|0|||
142999439|NCT02839330|515535705|FG002|Overall Study|Administrative Reason|0|||
142999440|NCT02839330|515535706|FG003|Overall Study|Administrative Reason|1|||
142999441|NCT02839330|515535703|FG000|Overall Study|Protocol Violation|1|||
142999442|NCT02839330|515535704|FG001|Overall Study|Protocol Violation|2|||
142999443|NCT02839330|515535705|FG002|Overall Study|Protocol Violation|2|||
142999444|NCT02839330|515535706|FG003|Overall Study|Protocol Violation|3|||
142999445|NCT02839330|515535703|FG000|Overall Study|Other reason, not specified|4|||
142999446|NCT02839330|515535704|FG001|Overall Study|Other reason, not specified|3|||
142999447|NCT02839330|515535705|FG002|Overall Study|Other reason, not specified|3|||
142999448|NCT02839330|515535706|FG003|Overall Study|Other reason, not specified|6|||
142999449|NCT00682539|515535707|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
142999450|NCT00682539|515535708|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
142999451|NCT00682539|515535709|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
142999452|NCT00682539|515535707|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
142999453|NCT00682539|515535708|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
142999454|NCT00682539|515535709|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
142999455|NCT00508872|515535717|FG000|Overall Study|Lost to Follow-up|1|||
142999456|NCT00508872|515535717|FG000|Overall Study|Physician Decision|1|||
142999457|NCT03339999|515535723|FG000|Overall Study|Adverse Event|1|||
142999458|NCT03339999|515535724|FG001|Overall Study|Adverse Event|2|||
142999459|NCT03339999|515535725|FG002|Overall Study|Adverse Event|2|||
142999460|NCT03339999|515535726|FG003|Overall Study|Adverse Event|1|||
142999461|NCT03339999|515535723|FG000|Overall Study|Lack of Efficacy|0|||
142999462|NCT03339999|515535724|FG001|Overall Study|Lack of Efficacy|1|||
142999463|NCT03339999|515535725|FG002|Overall Study|Lack of Efficacy|0|||
142999464|NCT03339999|515535726|FG003|Overall Study|Lack of Efficacy|0|||
142999465|NCT03339999|515535723|FG000|Overall Study|Lost to Follow-up|0|||
142999466|NCT03339999|515535724|FG001|Overall Study|Lost to Follow-up|0|||
142999467|NCT03339999|515535725|FG002|Overall Study|Lost to Follow-up|0|||
142999468|NCT03339999|515535726|FG003|Overall Study|Lost to Follow-up|1|||
142999469|NCT03339999|515535723|FG000|Overall Study|Study Terminated by Sponsor|6|||
142999470|NCT03339999|515535724|FG001|Overall Study|Study Terminated by Sponsor|3|||
142999471|NCT03339999|515535725|FG002|Overall Study|Study Terminated by Sponsor|4|||
142999472|NCT03339999|515535726|FG003|Overall Study|Study Terminated by Sponsor|3|||
142999473|NCT01856920|515535727|FG000|Overall Study|Disease Progression On Study|3|||
142999474|NCT01856920|515535728|FG001|Overall Study|Disease Progression On Study|4|||
142999475|NCT01856920|515535727|FG000|Overall Study|Disease Progression before Treatment|1|||
142999476|NCT01856920|515535728|FG001|Overall Study|Disease Progression before Treatment|0|||
142999477|NCT01856920|515535727|FG000|Overall Study|Ineligible|0|||
142999478|NCT01856920|515535728|FG001|Overall Study|Ineligible|1|||
142999479|NCT01856920|515535727|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
142999480|NCT01856920|515535728|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
142999481|NCT01856920|515535727|FG000|Overall Study|Refused further Treatment|5|||
142999482|NCT01856920|515535728|FG001|Overall Study|Refused further Treatment|1|||
142999483|NCT01856920|515535727|FG000|Overall Study|Other Reasons|0|||
142999484|NCT01856920|515535728|FG001|Overall Study|Other Reasons|1|||
142999485|NCT01856920|515535727|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
142999486|NCT01856920|515535728|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
142999487|NCT04594213|515535734|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
142999488|NCT04594213|515535735|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
142999489|NCT04594213|515535736|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
142999490|NCT04594213|515535737|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
142999491|NCT04594213|515535738|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
142999492|NCT04594213|515535739|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
142999493|NCT04594213|515535734|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
142999494|NCT04594213|515535735|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
142999495|NCT04594213|515535736|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
142999496|NCT04594213|515535737|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
142999497|NCT04594213|515535738|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
142999498|NCT04594213|515535739|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
142999499|NCT04594213|515535734|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
142999500|NCT04594213|515535735|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
142999501|NCT04594213|515535736|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
142999502|NCT04594213|515535737|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
142999503|NCT04594213|515535738|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
142999504|NCT04594213|515535739|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
142999505|NCT04594213|515535734|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
142999506|NCT04594213|515535735|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
142999507|NCT04594213|515535736|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
142999508|NCT04594213|515535737|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
142999509|NCT04594213|515535738|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
142999510|NCT04594213|515535739|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
142999511|NCT04594213|515535734|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
142999512|NCT04594213|515535735|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
142999513|NCT04594213|515535736|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
142999514|NCT04594213|515535737|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
142999515|NCT04594213|515535738|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
142999516|NCT04594213|515535739|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
142999517|NCT04594213|515535734|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
142999518|NCT04594213|515535735|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
142999519|NCT04594213|515535736|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
142999520|NCT04594213|515535737|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
142999521|NCT04594213|515535738|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
142999522|NCT04594213|515535739|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
142999523|NCT04594213|515535734|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
142999524|NCT04594213|515535735|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
142999525|NCT04594213|515535736|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
142999526|NCT04594213|515535737|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
142999527|NCT04594213|515535738|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
142999528|NCT04594213|515535739|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
142999529|NCT04594213|515535734|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
142999530|NCT04594213|515535735|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
142999531|NCT04594213|515535736|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
142999532|NCT04594213|515535737|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
142999533|NCT04594213|515535738|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
142999534|NCT04594213|515535739|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
142999535|NCT04594213|515535734|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
142999536|NCT04594213|515535735|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
142999537|NCT04594213|515535736|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
142999538|NCT04594213|515535737|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
142999539|NCT04594213|515535738|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
142999540|NCT04594213|515535739|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
142999541|NCT04594213|515535734|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
142999542|NCT04594213|515535735|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
142999543|NCT04594213|515535736|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
142999544|NCT04594213|515535737|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
142999545|NCT04594213|515535738|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
142999546|NCT04594213|515535739|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
142999547|NCT04594213|515535734|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
142999548|NCT04594213|515535735|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
142999549|NCT04594213|515535736|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
142999550|NCT04594213|515535737|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
142999551|NCT04594213|515535738|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
142999552|NCT04594213|515535739|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
142999553|NCT01980056|515535741|FG000|Overall Study|Death|1|||
142999554|NCT01980056|515535742|FG001|Overall Study|Death|1|||
142999555|NCT01980056|515535743|FG002|Overall Study|Death|0|||
142999556|NCT00535262|515535744|FG000|Overall Study|No funding|3|||
142999557|NCT03802331|515535745|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
142999558|NCT03802331|515535746|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
142999559|NCT00368069|515535747|FG000|Overall Study|Adverse Event|5|||
142999560|NCT00368069|515535748|FG001|Overall Study|Adverse Event|2|||
142999561|NCT00368069|515535747|FG000|Overall Study|Lack of Efficacy|0|||
142999562|NCT00368069|515535748|FG001|Overall Study|Lack of Efficacy|1|||
142999563|NCT00368069|515535747|FG000|Overall Study|Lost to Follow-up|1|||
142999564|NCT00368069|515535748|FG001|Overall Study|Lost to Follow-up|0|||
142999565|NCT00368069|515535747|FG000|Overall Study|Protocol Violation|0|||
142999566|NCT00368069|515535748|FG001|Overall Study|Protocol Violation|2|||
142999567|NCT00368069|515535747|FG000|Overall Study|Withdrawal of Consent|2|||
142999568|NCT00368069|515535748|FG001|Overall Study|Withdrawal of Consent|1|||
142999569|NCT00368069|515535747|FG000|Overall Study|no blood sampling possible|0|||
142999570|NCT00368069|515535748|FG001|Overall Study|no blood sampling possible|1|||
142999571|NCT00917553|515535749|FG000|Overall Study|Lost to Follow-up|2|||
142999572|NCT00917553|515535750|FG001|Overall Study|Lost to Follow-up|1|||
142999573|NCT01616173|515535751|FG000|Overall Study|Lost to Follow-up|0|||
142999574|NCT01616173|515535752|FG001|Overall Study|Lost to Follow-up|2|||
142999575|NCT01616173|515535753|FG002|Overall Study|Lost to Follow-up|0|||
142999576|NCT03432819|515535756|FG000|Overall Study|Lost to Follow-up|2|||
142999577|NCT03432819|515535757|FG001|Overall Study|Lost to Follow-up|2|||
142999578|NCT03432819|515535756|FG000|Overall Study|Withdrawal by Subject|5|||
142999579|NCT03432819|515535757|FG001|Overall Study|Withdrawal by Subject|3|||
142999580|NCT04382066|515535759|FG000|Overall Study|Adverse Event|1|||
142999581|NCT04382066|515535760|FG001|Overall Study|Adverse Event|0|||
142999582|NCT04382066|515535761|FG002|Overall Study|Adverse Event|0|||
142999583|NCT04382066|515535759|FG000|Overall Study|Death|1|||
142999584|NCT04382066|515535760|FG001|Overall Study|Death|0|||
142999585|NCT04382066|515535761|FG002|Overall Study|Death|1|||
142999586|NCT00779142|515535762|FG000|Overall Study|Screen Failures|3|||
142999587|NCT00486720|515535763|FG000|Overall Study|Adverse Event|1|||
142999588|NCT00486720|515535764|FG001|Overall Study|Adverse Event|2|||
142999589|NCT00486720|515535763|FG000|Overall Study|Lack of Efficacy|4|||
142999590|NCT00486720|515535764|FG001|Overall Study|Lack of Efficacy|6|||
142999591|NCT00486720|515535763|FG000|Overall Study|Physician Decision|1|||
142999592|NCT00486720|515535764|FG001|Overall Study|Physician Decision|2|||
142999593|NCT00486720|515535763|FG000|Overall Study|Protocol Violation|1|||
142999594|NCT00486720|515535764|FG001|Overall Study|Protocol Violation|0|||
142999595|NCT00486720|515535763|FG000|Overall Study|Withdrawal by Subject|3|||
142999596|NCT00486720|515535764|FG001|Overall Study|Withdrawal by Subject|1|||
142999597|NCT00486720|515535763|FG000|Overall Study|Progressive Disease|0|||
142999598|NCT00486720|515535764|FG001|Overall Study|Progressive Disease|1|||
142999599|NCT02813681|515535765|FG000|Overall Study|Physician Decision|5|||
142999600|NCT02813681|515535766|FG001|Overall Study|Physician Decision|5|||
142999601|NCT02813681|515535767|FG002|Overall Study|Physician Decision|0|||
142999602|NCT02813681|515535765|FG000|Overall Study|Lost to Follow-up|0|||
142999603|NCT02813681|515535766|FG001|Overall Study|Lost to Follow-up|1|||
142999604|NCT02813681|515535767|FG002|Overall Study|Lost to Follow-up|0|||
142999605|NCT00606931|515535770|FG000|Overall Study|Withdrawal by Subject|3|||
142999606|NCT00302731|515535782|FG000|Overall Study|Lost to Follow-up|1|||
142999607|NCT00302731|515535783|FG001|Overall Study|Lost to Follow-up|2|||
142999608|NCT00302731|515535784|FG002|Overall Study|Lost to Follow-up|0|||
142999609|NCT00302731|515535785|FG003|Overall Study|Lost to Follow-up|0|||
142999610|NCT00302731|515535782|FG000|Overall Study|Adverse Event|0|||
142999611|NCT00302731|515535783|FG001|Overall Study|Adverse Event|2|||
142999612|NCT00302731|515535784|FG002|Overall Study|Adverse Event|2|||
142999613|NCT00302731|515535785|FG003|Overall Study|Adverse Event|0|||
142999614|NCT00302731|515535782|FG000|Overall Study|Withdrawal by Subject|1|||
142999615|NCT00302731|515535783|FG001|Overall Study|Withdrawal by Subject|1|||
142999616|NCT00302731|515535784|FG002|Overall Study|Withdrawal by Subject|0|||
142999617|NCT00302731|515535785|FG003|Overall Study|Withdrawal by Subject|0|||
142999618|NCT00302731|515535782|FG000|Overall Study|Protocol Violation|1|||
142999619|NCT00302731|515535783|FG001|Overall Study|Protocol Violation|0|||
142999620|NCT00302731|515535784|FG002|Overall Study|Protocol Violation|0|||
142999621|NCT00302731|515535785|FG003|Overall Study|Protocol Violation|0|||
142999622|NCT00302731|515535782|FG000|Overall Study|cancer unrelated to study discovered|1|||
142999623|NCT00302731|515535783|FG001|Overall Study|cancer unrelated to study discovered|0|||
142999624|NCT00302731|515535784|FG002|Overall Study|cancer unrelated to study discovered|1|||
142999625|NCT00302731|515535785|FG003|Overall Study|cancer unrelated to study discovered|0|||
142999626|NCT01000311|515535786|FG000|Overall Study|Adverse Event|2|||
142999627|NCT01000311|515535787|FG001|Overall Study|Adverse Event|5|||
142999628|NCT01000311|515535786|FG000|Overall Study|Withdrawal by Subject|16|||
142999629|NCT01000311|515535787|FG001|Overall Study|Withdrawal by Subject|24|||
142999630|NCT01000311|515535786|FG000|Overall Study|Lost to Follow-up|15|||
142999631|NCT01000311|515535787|FG001|Overall Study|Lost to Follow-up|24|||
142999632|NCT01000311|515535786|FG000|Overall Study|Protocol Violation|1|||
142999633|NCT01000311|515535787|FG001|Overall Study|Protocol Violation|2|||
142999634|NCT01000311|515535786|FG000|Overall Study|Inappropriate enrollment|2|||
142999635|NCT01000311|515535787|FG001|Overall Study|Inappropriate enrollment|0|||
142999636|NCT01000311|515535786|FG000|Overall Study|Administrative reason|9|||
142999637|NCT01000311|515535787|FG001|Overall Study|Administrative reason|15|||
142999638|NCT00283062|515535790|FG000|Overall Study|Did not receive any study medication|5|||
142999639|NCT00283062|515535791|FG001|Overall Study|Did not receive any study medication|4|||
142999640|NCT00283062|515535792|FG002|Overall Study|Did not receive any study medication|36|||
142999641|NCT00283062|515535793|FG003|Overall Study|Did not receive any study medication|45|||
142999642|NCT00283062|515535790|FG000|Overall Study|Adverse Event|2|||
142999643|NCT00283062|515535791|FG001|Overall Study|Adverse Event|0|||
142999644|NCT00283062|515535792|FG002|Overall Study|Adverse Event|1|||
142999645|NCT00283062|515535793|FG003|Overall Study|Adverse Event|0|||
142999646|NCT00283062|515535790|FG000|Overall Study|Lost to Follow-up|1|||
142999647|NCT00283062|515535791|FG001|Overall Study|Lost to Follow-up|0|||
142999648|NCT00283062|515535792|FG002|Overall Study|Lost to Follow-up|1|||
142999649|NCT00283062|515535793|FG003|Overall Study|Lost to Follow-up|0|||
142999650|NCT00283062|515535790|FG000|Overall Study|Progressive disease|0|||
142999651|NCT00283062|515535791|FG001|Overall Study|Progressive disease|0|||
142999652|NCT00283062|515535792|FG002|Overall Study|Progressive disease|1|||
142999653|NCT00283062|515535793|FG003|Overall Study|Progressive disease|0|||
142999654|NCT00283062|515535790|FG000|Overall Study|Participant did not wish to continue|3|||
142999655|NCT00283062|515535791|FG001|Overall Study|Participant did not wish to continue|2|||
142999656|NCT00283062|515535792|FG002|Overall Study|Participant did not wish to continue|1|||
142999657|NCT00283062|515535793|FG003|Overall Study|Participant did not wish to continue|0|||
142999658|NCT00283062|515535790|FG000|Overall Study|Undefined|0|||
142999659|NCT00283062|515535791|FG001|Overall Study|Undefined|1|||
142999660|NCT00283062|515535792|FG002|Overall Study|Undefined|1|||
142999661|NCT00283062|515535793|FG003|Overall Study|Undefined|4|||
142999662|NCT00283062|515535790|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
142999663|NCT00283062|515535791|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
142999664|NCT00283062|515535792|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
142999665|NCT00283062|515535793|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
142999666|NCT01468844|515535794|FG000|Overall Study|Adverse Event|1|||
142999667|NCT01468844|515535795|FG001|Overall Study|Adverse Event|0|||
142999668|NCT01468844|515535794|FG000|Overall Study|Withdrawal by Subject|1|||
142999669|NCT01468844|515535795|FG001|Overall Study|Withdrawal by Subject|0|||
142999670|NCT00252499|515535796|FG000|Overall Study|Lost to Follow-up|1|||
142999671|NCT00252499|515535797|FG001|Overall Study|Lost to Follow-up|0|||
142999672|NCT00252499|515535798|FG002|Overall Study|Lost to Follow-up|0|||
142999673|NCT01843933|515535799|FG000|Overall Study|Data lost|6|||
142999674|NCT01843933|515535800|FG001|Overall Study|Data lost|4|||
142999675|NCT03137173|515535801|FG000|Overall Study|Withdrawal by Subject|8|||
142999676|NCT03137173|515535802|FG001|Overall Study|Withdrawal by Subject|13|||
142999677|NCT03137173|515535801|FG000|Overall Study|Death|1|||
142999678|NCT03137173|515535802|FG001|Overall Study|Death|3|||
142999679|NCT03137173|515535801|FG000|Overall Study|Physician Decision|1|||
142999680|NCT03137173|515535802|FG001|Overall Study|Physician Decision|0|||
142999681|NCT03137173|515535801|FG000|Overall Study|Lost to Follow-up|13|||
142999682|NCT03137173|515535802|FG001|Overall Study|Lost to Follow-up|18|||
142999683|NCT03137173|515535801|FG000|Overall Study|Other reasons|3|||
142999684|NCT03137173|515535802|FG001|Overall Study|Other reasons|2|||
142999685|NCT01535638|515535803|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
142999686|NCT01535638|515535804|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
142999687|NCT01535638|515535805|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
142999688|NCT01535638|515535806|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
142999689|NCT01535638|515535807|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
142999690|NCT01535638|515535808|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
142999691|NCT01535638|515535803|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
142999692|NCT01535638|515535804|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
142999693|NCT01535638|515535805|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
142999694|NCT01535638|515535806|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
142999695|NCT01535638|515535807|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
142999696|NCT01535638|515535808|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
142999697|NCT01365468|515535809|FG000|Overall Study|Physician Decision|1|||
142999698|NCT01365468|515535810|FG001|Overall Study|Physician Decision|0|||
142999699|NCT01365468|515535809|FG000|Overall Study|Disease progression|1|||
142999700|NCT01365468|515535810|FG001|Overall Study|Disease progression|0|||
142999701|NCT01365468|515535809|FG000|Overall Study|Lost to Follow-up|2|||
142999702|NCT01365468|515535810|FG001|Overall Study|Lost to Follow-up|0|||
142999703|NCT03524664|515535811|FG000|Overall Study|Withdrawal by Subject|1|||
142999704|NCT03524664|515535812|FG001|Overall Study|Withdrawal by Subject|2|||
142999705|NCT03524664|515535811|FG000|Overall Study|Lost to Follow-up|4|||
142999706|NCT03524664|515535812|FG001|Overall Study|Lost to Follow-up|13|||
142999707|NCT01482598|515535813|FG000|Overall Study|Death|7|||
142999708|NCT01482598|515535814|FG001|Overall Study|Death|10|||
142999709|NCT01482598|515535813|FG000|Overall Study|Physician Decision|0|||
142999710|NCT01482598|515535814|FG001|Overall Study|Physician Decision|3|||
142999711|NCT01482598|515535813|FG000|Overall Study|Withdrawal by Subject|4|||
142999712|NCT01482598|515535814|FG001|Overall Study|Withdrawal by Subject|5|||
142999713|NCT01482598|515535813|FG000|Overall Study|Lost to Follow-up|5|||
142999714|NCT01482598|515535814|FG001|Overall Study|Lost to Follow-up|4|||
142999715|NCT00423267|515535815|FG000|Period A|Withdrawal by Subject|0|||
142999716|NCT00423267|515535816|FG001|Period A|Withdrawal by Subject|1|||
142999717|NCT00423267|515535815|FG000|Period A|Non-compliance with protocol|1|||
142999718|NCT00423267|515535816|FG001|Period A|Non-compliance with protocol|0|||
142999719|NCT00423267|515535815|FG000|Period A|Administrative|1|||
142999720|NCT00423267|515535816|FG001|Period A|Administrative|0|||
142999721|NCT00827112|515535817|FG000|Overall Study|Adverse Event|2|||
142999722|NCT00827112|515535818|FG001|Overall Study|Adverse Event|0|||
142999723|NCT00827112|515535817|FG000|Overall Study|Lack of Efficacy|2|||
142999724|NCT00827112|515535818|FG001|Overall Study|Lack of Efficacy|0|||
142999725|NCT00827112|515535817|FG000|Overall Study|Lost to Follow-up|3|||
142999726|NCT00827112|515535818|FG001|Overall Study|Lost to Follow-up|2|||
142999727|NCT00827112|515535817|FG000|Overall Study|Pregnancy|0|||
142999728|NCT00827112|515535818|FG001|Overall Study|Pregnancy|1|||
142999729|NCT00827112|515535817|FG000|Overall Study|Protocol Violation|0|||
142999730|NCT00827112|515535818|FG001|Overall Study|Protocol Violation|2|||
142999731|NCT00827112|515535817|FG000|Overall Study|Withdrawal by Subject|2|||
142999732|NCT00827112|515535818|FG001|Overall Study|Withdrawal by Subject|1|||
142999733|NCT00827112|515535817|FG000|Overall Study|Randomized but not treated|5|||
142999734|NCT00827112|515535818|FG001|Overall Study|Randomized but not treated|3|||
142999735|NCT00827112|515535817|FG000|Overall Study|Other|1|||
142999736|NCT00827112|515535818|FG001|Overall Study|Other|3|||
142999737|NCT01521494|515535819|FG000|Overall Study|Adverse Event|1|||
142999738|NCT01521494|515535820|FG001|Overall Study|Adverse Event|2|||
142999739|NCT01521494|515535821|FG002|Overall Study|Adverse Event|9|||
142999740|NCT01521494|515535822|FG003|Overall Study|Adverse Event|6|||
143455746|NCT02559895|517212522|FG002|Overall Study|Lack of Efficacy|2|||
142999741|NCT01521494|515535823|FG004|Overall Study|Adverse Event|2|||
142999742|NCT01521494|515535819|FG000|Overall Study|Lack of Efficacy|0|||
142999743|NCT01521494|515535820|FG001|Overall Study|Lack of Efficacy|0|||
142999744|NCT01521494|515535821|FG002|Overall Study|Lack of Efficacy|0|||
142999745|NCT01521494|515535822|FG003|Overall Study|Lack of Efficacy|0|||
142999746|NCT01521494|515535823|FG004|Overall Study|Lack of Efficacy|2|||
142999747|NCT01521494|515535819|FG000|Overall Study|Withdrawal by Subject|1|||
142999748|NCT01521494|515535820|FG001|Overall Study|Withdrawal by Subject|1|||
142999749|NCT01521494|515535821|FG002|Overall Study|Withdrawal by Subject|0|||
142999750|NCT01521494|515535822|FG003|Overall Study|Withdrawal by Subject|2|||
142999751|NCT01521494|515535823|FG004|Overall Study|Withdrawal by Subject|0|||
142999752|NCT01521494|515535819|FG000|Overall Study|Decrease in serum phosphate|0|||
142999753|NCT01521494|515535820|FG001|Overall Study|Decrease in serum phosphate|2|||
142999754|NCT01521494|515535821|FG002|Overall Study|Decrease in serum phosphate|3|||
142999755|NCT01521494|515535822|FG003|Overall Study|Decrease in serum phosphate|12|||
142999756|NCT01521494|515535823|FG004|Overall Study|Decrease in serum phosphate|0|||
142999757|NCT01521494|515535819|FG000|Overall Study|Decrease in serum calcium|0|||
142999758|NCT01521494|515535820|FG001|Overall Study|Decrease in serum calcium|0|||
142999759|NCT01521494|515535821|FG002|Overall Study|Decrease in serum calcium|0|||
142999760|NCT01521494|515535822|FG003|Overall Study|Decrease in serum calcium|1|||
142999761|NCT01521494|515535823|FG004|Overall Study|Decrease in serum calcium|1|||
142999762|NCT01521494|515535819|FG000|Overall Study|Physician Decision|0|||
142999763|NCT01521494|515535820|FG001|Overall Study|Physician Decision|0|||
142999764|NCT01521494|515535821|FG002|Overall Study|Physician Decision|0|||
142999765|NCT01521494|515535822|FG003|Overall Study|Physician Decision|0|||
142999766|NCT01521494|515535823|FG004|Overall Study|Physician Decision|2|||
142999767|NCT01336647|515537596|FG000|Overall Study|Lost to Follow-up|4|||
142999768|NCT01336647|515537597|FG001|Overall Study|Lost to Follow-up|1|||
142999769|NCT01336647|515537598|FG002|Overall Study|Lost to Follow-up|3|||
142999770|NCT03808298|515537599|FG000|Overall Study|Adverse Event|3|||
142999771|NCT03808298|515537599|FG000|Overall Study|Physician Decision|1|||
142999772|NCT03808298|515537599|FG000|Overall Study|Withdrawal by Subject|1|||
142999773|NCT03808298|515537599|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
142999774|NCT01004822|515537600|FG000|Overall Study|Objective progression or relapse|3|||
142999775|NCT01004822|515537601|FG001|Overall Study|Objective progression or relapse|3|||
142999776|NCT01004822|515537602|FG002|Overall Study|Objective progression or relapse|0|||
142999777|NCT01004822|515537603|FG003|Overall Study|Objective progression or relapse|1|||
142999778|NCT01004822|515537604|FG004|Overall Study|Objective progression or relapse|2|||
142999779|NCT01004822|515537605|FG005|Overall Study|Objective progression or relapse|2|||
142999780|NCT01004822|515537606|FG006|Overall Study|Objective progression or relapse|1|||
142999781|NCT01004822|515537607|FG007|Overall Study|Objective progression or relapse|4|||
142999782|NCT01004822|515537600|FG000|Overall Study|Global deterioration of health status|0|||
142999783|NCT01004822|515537601|FG001|Overall Study|Global deterioration of health status|0|||
142999784|NCT01004822|515537602|FG002|Overall Study|Global deterioration of health status|0|||
142999785|NCT01004822|515537603|FG003|Overall Study|Global deterioration of health status|1|||
142999786|NCT01004822|515537604|FG004|Overall Study|Global deterioration of health status|0|||
142999787|NCT01004822|515537605|FG005|Overall Study|Global deterioration of health status|0|||
142999788|NCT01004822|515537606|FG006|Overall Study|Global deterioration of health status|1|||
142999789|NCT01004822|515537607|FG007|Overall Study|Global deterioration of health status|0|||
142999790|NCT01004822|515537600|FG000|Overall Study|No longer willing to continue|0|||
142999791|NCT01004822|515537601|FG001|Overall Study|No longer willing to continue|0|||
142999792|NCT01004822|515537602|FG002|Overall Study|No longer willing to continue|0|||
142999793|NCT01004822|515537603|FG003|Overall Study|No longer willing to continue|1|||
142999794|NCT01004822|515537604|FG004|Overall Study|No longer willing to continue|2|||
142999795|NCT01004822|515537605|FG005|Overall Study|No longer willing to continue|1|||
142999796|NCT01004822|515537606|FG006|Overall Study|No longer willing to continue|1|||
142999797|NCT01004822|515537607|FG007|Overall Study|No longer willing to continue|0|||
142999798|NCT01004822|515537600|FG000|Overall Study|Adverse Event|0|||
142999799|NCT01004822|515537601|FG001|Overall Study|Adverse Event|0|||
142999800|NCT01004822|515537602|FG002|Overall Study|Adverse Event|0|||
142999801|NCT01004822|515537603|FG003|Overall Study|Adverse Event|0|||
142999802|NCT01004822|515537604|FG004|Overall Study|Adverse Event|0|||
142999803|NCT01004822|515537605|FG005|Overall Study|Adverse Event|0|||
142999804|NCT01004822|515537606|FG006|Overall Study|Adverse Event|1|||
142999805|NCT01004822|515537607|FG007|Overall Study|Adverse Event|1|||
142999806|NCT01004822|515537600|FG000|Overall Study|Other|0|||
142999807|NCT01004822|515537601|FG001|Overall Study|Other|0|||
142999808|NCT01004822|515537602|FG002|Overall Study|Other|4|||
142999809|NCT01004822|515537603|FG003|Overall Study|Other|1|||
142999810|NCT01004822|515537604|FG004|Overall Study|Other|0|||
142999811|NCT01004822|515537605|FG005|Overall Study|Other|1|||
142999812|NCT01004822|515537606|FG006|Overall Study|Other|0|||
142999813|NCT01004822|515537607|FG007|Overall Study|Other|0|||
142999814|NCT01858701|515537608|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
142999815|NCT01858701|515537609|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
142999816|NCT01858701|515537608|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
142999817|NCT01858701|515537609|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
142999818|NCT01858701|515537608|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
142999819|NCT01858701|515537609|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
142999820|NCT01858701|515537608|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
142999821|NCT01858701|515537609|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
142999822|NCT01801475|515537612|FG000|Overall Study|Withdrawal by Subject|0|||
142999823|NCT01801475|515537613|FG001|Overall Study|Withdrawal by Subject|0|||
142999824|NCT01801475|515537614|FG002|Overall Study|Withdrawal by Subject|0|||
142999825|NCT01801475|515537615|FG003|Overall Study|Withdrawal by Subject|0|||
142999826|NCT01801475|515537616|FG004|Overall Study|Withdrawal by Subject|1|||
142999827|NCT00421928|515537617|FG000|Overall Study|Adverse Event|61|||
142999828|NCT00421928|515537618|FG001|Overall Study|Adverse Event|140|||
142999829|NCT00421928|515537619|FG002|Overall Study|Adverse Event|22|||
142999830|NCT00421928|515537617|FG000|Overall Study|Lost to Follow-up|5|||
142999831|NCT00421928|515537618|FG001|Overall Study|Lost to Follow-up|0|||
142999832|NCT00421928|515537619|FG002|Overall Study|Lost to Follow-up|3|||
142999833|NCT00421928|515537617|FG000|Overall Study|Withdrawal by Subject|50|||
142999834|NCT00421928|515537618|FG001|Overall Study|Withdrawal by Subject|48|||
142999835|NCT00421928|515537619|FG002|Overall Study|Withdrawal by Subject|43|||
142999836|NCT00421928|515537617|FG000|Overall Study|Lack of Efficacy|15|||
142999837|NCT00421928|515537618|FG001|Overall Study|Lack of Efficacy|7|||
142999838|NCT00421928|515537619|FG002|Overall Study|Lack of Efficacy|35|||
142999839|NCT00421928|515537617|FG000|Overall Study|Study drug non-compliant|6|||
142999840|NCT00421928|515537618|FG001|Overall Study|Study drug non-compliant|7|||
142999841|NCT00421928|515537619|FG002|Overall Study|Study drug non-compliant|4|||
142999842|NCT00421928|515537617|FG000|Overall Study|All other|26|||
142999843|NCT00421928|515537618|FG001|Overall Study|All other|21|||
142999844|NCT00421928|515537619|FG002|Overall Study|All other|27|||
142999845|NCT00421928|515537617|FG000|Overall Study|Death|0|||
142999846|NCT00421928|515537618|FG001|Overall Study|Death|1|||
142999847|NCT00421928|515537619|FG002|Overall Study|Death|0|||
142999848|NCT00635804|515537635|FG000|Overall Study|Adverse Event|0|||
142999849|NCT00635804|515537636|FG001|Overall Study|Adverse Event|0|||
142999850|NCT00635804|515537637|FG002|Overall Study|Adverse Event|0|||
142999851|NCT00635804|515537638|FG003|Overall Study|Adverse Event|0|||
142999852|NCT00635804|515537639|FG004|Overall Study|Adverse Event|0|||
142999853|NCT00635804|515537640|FG005|Overall Study|Adverse Event|1|||
142999854|NCT00635804|515537641|FG006|Overall Study|Adverse Event|0|||
142999855|NCT00635804|515537642|FG007|Overall Study|Adverse Event|0|||
142999856|NCT00635804|515537635|FG000|Overall Study|Withdrawal by Subject|1|||
142999857|NCT00635804|515537636|FG001|Overall Study|Withdrawal by Subject|0|||
142999858|NCT00635804|515537637|FG002|Overall Study|Withdrawal by Subject|0|||
142999859|NCT00635804|515537638|FG003|Overall Study|Withdrawal by Subject|0|||
142999860|NCT00635804|515537639|FG004|Overall Study|Withdrawal by Subject|0|||
142999861|NCT00635804|515537640|FG005|Overall Study|Withdrawal by Subject|0|||
142999862|NCT00635804|515537641|FG006|Overall Study|Withdrawal by Subject|0|||
142999863|NCT00635804|515537642|FG007|Overall Study|Withdrawal by Subject|0|||
142999864|NCT02681094|515537649|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
142999865|NCT02681094|515537650|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
142999866|NCT02681094|515537651|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
142999867|NCT02681094|515537649|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
142999868|NCT02681094|515537650|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
142999869|NCT02681094|515537651|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
142999870|NCT02681094|515537649|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
142999871|NCT02681094|515537650|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
142999872|NCT02681094|515537651|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
142999873|NCT02681094|515537649|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
142999874|NCT02681094|515537650|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
142999875|NCT02681094|515537651|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
142999876|NCT02681094|515537649|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
142999877|NCT02681094|515537650|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
142999878|NCT02681094|515537651|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
142999879|NCT02681094|515537649|FG000|1 -Modified Enrolled Participants Set|Other|6|||
142999880|NCT02681094|515537650|FG001|1 -Modified Enrolled Participants Set|Other|6|||
142999881|NCT02681094|515537651|FG002|1 -Modified Enrolled Participants Set|Other|7|||
142999882|NCT02681094|515537649|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
142999883|NCT02681094|515537650|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
142999884|NCT02681094|515537651|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
142999885|NCT02681094|515537649|FG000|2 - Enrolled Participants Set|Participant decision|7|||
142999886|NCT02681094|515537650|FG001|2 - Enrolled Participants Set|Participant decision|10|||
142999887|NCT02681094|515537651|FG002|2 - Enrolled Participants Set|Participant decision|9|||
142999888|NCT02681094|515537649|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
142999889|NCT02681094|515537650|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
142999890|NCT02681094|515537651|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
142999891|NCT02681094|515537649|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
142999892|NCT02681094|515537650|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
142999893|NCT02681094|515537651|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
142999894|NCT02681094|515537649|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
142999895|NCT02681094|515537650|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
142999896|NCT02681094|515537651|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
142999897|NCT02681094|515537649|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
142999898|NCT02681094|515537650|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
142999899|NCT02681094|515537651|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
142999900|NCT02681094|515537649|FG000|2 - Enrolled Participants Set|Other|6|||
142999901|NCT02681094|515537650|FG001|2 - Enrolled Participants Set|Other|6|||
142999902|NCT02681094|515537651|FG002|2 - Enrolled Participants Set|Other|7|||
142999903|NCT02681094|515537649|FG000|2 - Enrolled Participants Set|No treatment given|0|||
142999904|NCT02681094|515537650|FG001|2 - Enrolled Participants Set|No treatment given|1|||
142999905|NCT02681094|515537651|FG002|2 - Enrolled Participants Set|No treatment given|1|||
142999906|NCT00134563|515537654|FG000|Overall Study|Not treated due to protocol violation|0|||
142999907|NCT00134563|515537655|FG001|Overall Study|Not treated due to protocol violation|1|||
142999908|NCT00134563|515537656|FG002|Overall Study|Not treated due to protocol violation|1|||
142999909|NCT00134563|515537654|FG000|Overall Study|Adverse Event|29|||
142999910|NCT00134563|515537655|FG001|Overall Study|Adverse Event|37|||
142999911|NCT00134563|515537656|FG002|Overall Study|Adverse Event|38|||
142999912|NCT00134563|515537654|FG000|Overall Study|Lack of Efficacy|24|||
142999913|NCT00134563|515537655|FG001|Overall Study|Lack of Efficacy|14|||
142999914|NCT00134563|515537656|FG002|Overall Study|Lack of Efficacy|17|||
142999915|NCT00134563|515537654|FG000|Overall Study|Protocol Violation|3|||
142999916|NCT00134563|515537655|FG001|Overall Study|Protocol Violation|2|||
142999917|NCT00134563|515537656|FG002|Overall Study|Protocol Violation|5|||
142999918|NCT00134563|515537654|FG000|Overall Study|Lost to Follow-up|4|||
142999919|NCT00134563|515537655|FG001|Overall Study|Lost to Follow-up|0|||
142999920|NCT00134563|515537656|FG002|Overall Study|Lost to Follow-up|2|||
142999921|NCT00134563|515537654|FG000|Overall Study|progressive disease|11|||
142999922|NCT00134563|515537655|FG001|Overall Study|progressive disease|4|||
142999923|NCT00134563|515537656|FG002|Overall Study|progressive disease|2|||
142999924|NCT00134563|515537654|FG000|Overall Study|did not wish to continue|33|||
142999925|NCT00134563|515537655|FG001|Overall Study|did not wish to continue|32|||
142999926|NCT00134563|515537656|FG002|Overall Study|did not wish to continue|26|||
142999927|NCT00134563|515537654|FG000|Overall Study|Reason other than above|0|||
142999928|NCT00134563|515537655|FG001|Overall Study|Reason other than above|2|||
142999929|NCT00134563|515537656|FG002|Overall Study|Reason other than above|5|||
142999930|NCT02546193|515537659|FG000|Overall Study|Withdrawal by Subject|2|||
142999931|NCT02546193|515537660|FG001|Overall Study|Withdrawal by Subject|0|||
142999932|NCT02546193|515537661|FG002|Overall Study|Withdrawal by Subject|1|||
142999933|NCT02546193|515537662|FG003|Overall Study|Withdrawal by Subject|0|||
142999934|NCT02546193|515537659|FG000|Overall Study|Not eligible at time of induction|4|||
142999935|NCT02546193|515537660|FG001|Overall Study|Not eligible at time of induction|6|||
142999936|NCT02546193|515537661|FG002|Overall Study|Not eligible at time of induction|1|||
142999937|NCT02546193|515537662|FG003|Overall Study|Not eligible at time of induction|0|||
142999938|NCT00148109|515537663|FG000|Overall Study|Lack of Efficacy|10|||
142999939|NCT00148109|515537664|FG001|Overall Study|Lack of Efficacy|18|||
142999940|NCT00148109|515537663|FG000|Overall Study|Adverse Event|0|||
142999941|NCT00148109|515537664|FG001|Overall Study|Adverse Event|2|||
142999942|NCT00148109|515537663|FG000|Overall Study|Withdrawal by Subject|2|||
142999943|NCT00148109|515537664|FG001|Overall Study|Withdrawal by Subject|0|||
142999944|NCT01098266|515537665|FG000|Overall Study|Physician Decision|1|||
142999945|NCT01098266|515537666|FG001|Overall Study|Physician Decision|0|||
142999946|NCT01098266|515537665|FG000|Overall Study|Death|3|||
142999947|NCT01098266|515537666|FG001|Overall Study|Death|2|||
142999948|NCT01098266|515537665|FG000|Overall Study|Withdrawal by Subject|3|||
142999949|NCT01098266|515537666|FG001|Overall Study|Withdrawal by Subject|5|||
142999950|NCT00438815|515537667|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
142999951|NCT00438815|515537667|FG000|Overall Study|3-month follow-up no longer required|12|||
142999952|NCT00438815|515537667|FG000|Overall Study|Noncompliance with protocol requirements|9|||
142999953|NCT00438815|515537667|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
142999954|NCT00438815|515537667|FG000|Overall Study|Lost to Follow-up|6|||
142999955|NCT00438815|515537667|FG000|Overall Study|Withdrawal by Subject|6|||
142999956|NCT00438815|515537667|FG000|Overall Study|Death|1|||
142999957|NCT01733758|515537668|FG000|Overall Study|Adverse Event|5|||
142999958|NCT01733758|515537669|FG001|Overall Study|Adverse Event|7|||
142999959|NCT01733758|515537670|FG002|Overall Study|Adverse Event|8|||
142999960|NCT01733758|515537671|FG003|Overall Study|Adverse Event|1|||
142999961|NCT01733758|515537668|FG000|Overall Study|Withdrawal by Subject|1|||
142999962|NCT01733758|515537669|FG001|Overall Study|Withdrawal by Subject|1|||
142999963|NCT01733758|515537670|FG002|Overall Study|Withdrawal by Subject|5|||
142999964|NCT01733758|515537671|FG003|Overall Study|Withdrawal by Subject|3|||
142999965|NCT01733758|515537668|FG000|Overall Study|Persistent Hyperglycemia|3|||
142999966|NCT01733758|515537669|FG001|Overall Study|Persistent Hyperglycemia|2|||
142999967|NCT01733758|515537670|FG002|Overall Study|Persistent Hyperglycemia|0|||
142999968|NCT01733758|515537671|FG003|Overall Study|Persistent Hyperglycemia|0|||
142999969|NCT01733758|515537668|FG000|Overall Study|Protocol Violation|0|||
142999970|NCT01733758|515537669|FG001|Overall Study|Protocol Violation|1|||
142999971|NCT01733758|515537670|FG002|Overall Study|Protocol Violation|2|||
142999972|NCT01733758|515537671|FG003|Overall Study|Protocol Violation|2|||
142999973|NCT01733758|515537668|FG000|Overall Study|Non-compliance|1|||
142999974|NCT01733758|515537669|FG001|Overall Study|Non-compliance|0|||
142999975|NCT01733758|515537670|FG002|Overall Study|Non-compliance|0|||
142999976|NCT01733758|515537671|FG003|Overall Study|Non-compliance|0|||
142999977|NCT01733758|515537668|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
142999978|NCT01733758|515537669|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
142999979|NCT01733758|515537670|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
142999980|NCT01733758|515537671|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
142999981|NCT01733758|515537668|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
142999982|NCT01733758|515537669|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
142999983|NCT01733758|515537670|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
142999984|NCT01733758|515537671|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
142999985|NCT02557308|515537674|FG000|Overall Study|Withdrawal by Subject|11|||
142999986|NCT02557308|515537675|FG001|Overall Study|Withdrawal by Subject|3|||
142999987|NCT02557308|515537676|FG002|Overall Study|Withdrawal by Subject|2|||
142999988|NCT02557308|515537677|FG003|Overall Study|Withdrawal by Subject|0|||
142999989|NCT02557308|515537678|FG004|Overall Study|Withdrawal by Subject|1|||
142999990|NCT02557308|515537679|FG005|Overall Study|Withdrawal by Subject|0|||
142999991|NCT02557308|515537680|FG006|Overall Study|Withdrawal by Subject|10|||
142999992|NCT02557308|515537681|FG007|Overall Study|Withdrawal by Subject|1|||
142999993|NCT02557308|515537674|FG000|Overall Study|Disease Progression|0|||
142999994|NCT02557308|515537675|FG001|Overall Study|Disease Progression|1|||
142999995|NCT02557308|515537676|FG002|Overall Study|Disease Progression|0|||
142999996|NCT02557308|515537677|FG003|Overall Study|Disease Progression|0|||
142999997|NCT02557308|515537678|FG004|Overall Study|Disease Progression|0|||
142999998|NCT02557308|515537679|FG005|Overall Study|Disease Progression|0|||
142999999|NCT02557308|515537680|FG006|Overall Study|Disease Progression|0|||
143000000|NCT02557308|515537681|FG007|Overall Study|Disease Progression|0|||
143000001|NCT02557308|515537674|FG000|Overall Study|Lack of Efficacy|3|||
143000002|NCT02557308|515537675|FG001|Overall Study|Lack of Efficacy|0|||
143000003|NCT02557308|515537676|FG002|Overall Study|Lack of Efficacy|0|||
143000004|NCT02557308|515537677|FG003|Overall Study|Lack of Efficacy|0|||
143000005|NCT02557308|515537678|FG004|Overall Study|Lack of Efficacy|0|||
143000006|NCT02557308|515537679|FG005|Overall Study|Lack of Efficacy|0|||
143000007|NCT02557308|515537680|FG006|Overall Study|Lack of Efficacy|1|||
143000008|NCT02557308|515537681|FG007|Overall Study|Lack of Efficacy|0|||
143000009|NCT02557308|515537674|FG000|Overall Study|Adverse Event|4|||
143000010|NCT02557308|515537675|FG001|Overall Study|Adverse Event|1|||
143000011|NCT02557308|515537676|FG002|Overall Study|Adverse Event|2|||
143000012|NCT02557308|515537677|FG003|Overall Study|Adverse Event|0|||
143000013|NCT02557308|515537678|FG004|Overall Study|Adverse Event|0|||
143000014|NCT02557308|515537679|FG005|Overall Study|Adverse Event|0|||
143000015|NCT02557308|515537680|FG006|Overall Study|Adverse Event|4|||
143000016|NCT02557308|515537681|FG007|Overall Study|Adverse Event|1|||
143000017|NCT02557308|515537674|FG000|Overall Study|Lost to Follow-up|2|||
143000018|NCT02557308|515537675|FG001|Overall Study|Lost to Follow-up|0|||
143000019|NCT02557308|515537676|FG002|Overall Study|Lost to Follow-up|1|||
143000020|NCT02557308|515537677|FG003|Overall Study|Lost to Follow-up|0|||
143000021|NCT02557308|515537678|FG004|Overall Study|Lost to Follow-up|0|||
143000022|NCT02557308|515537679|FG005|Overall Study|Lost to Follow-up|0|||
143000023|NCT02557308|515537680|FG006|Overall Study|Lost to Follow-up|2|||
143000024|NCT02557308|515537681|FG007|Overall Study|Lost to Follow-up|0|||
143000025|NCT02557308|515537674|FG000|Overall Study|Death|1|||
143000026|NCT02557308|515537675|FG001|Overall Study|Death|0|||
143000027|NCT02557308|515537676|FG002|Overall Study|Death|0|||
143000028|NCT02557308|515537677|FG003|Overall Study|Death|0|||
143000029|NCT02557308|515537678|FG004|Overall Study|Death|0|||
143000030|NCT02557308|515537679|FG005|Overall Study|Death|0|||
143000031|NCT02557308|515537680|FG006|Overall Study|Death|0|||
143000032|NCT02557308|515537681|FG007|Overall Study|Death|0|||
143000033|NCT02557308|515537674|FG000|Overall Study|Study Close|98|||
143000034|NCT02557308|515537675|FG001|Overall Study|Study Close|18|||
143000035|NCT02557308|515537676|FG002|Overall Study|Study Close|5|||
143000036|NCT02557308|515537677|FG003|Overall Study|Study Close|3|||
143000037|NCT02557308|515537678|FG004|Overall Study|Study Close|1|||
143000038|NCT02557308|515537679|FG005|Overall Study|Study Close|0|||
143455747|NCT02559895|517212523|FG003|Overall Study|Lack of Efficacy|8|||
143000039|NCT02557308|515537680|FG006|Overall Study|Study Close|123|||
143000040|NCT02557308|515537681|FG007|Overall Study|Study Close|5|||
143000041|NCT02557308|515537674|FG000|Overall Study|Except for study close|5|||
143000042|NCT02557308|515537675|FG001|Overall Study|Except for study close|0|||
143000043|NCT02557308|515537676|FG002|Overall Study|Except for study close|0|||
143000044|NCT02557308|515537677|FG003|Overall Study|Except for study close|0|||
143000045|NCT02557308|515537678|FG004|Overall Study|Except for study close|3|||
143000046|NCT02557308|515537679|FG005|Overall Study|Except for study close|0|||
143000047|NCT02557308|515537680|FG006|Overall Study|Except for study close|6|||
143000048|NCT02557308|515537681|FG007|Overall Study|Except for study close|10|||
143000049|NCT02545270|515537685|FG000|Overall Study|technical difficulties|0|||
143000050|NCT02545270|515537686|FG001|Overall Study|technical difficulties|1|||
143000051|NCT02545270|515537687|FG002|Overall Study|technical difficulties|0|||
143000052|NCT02545270|515537685|FG000|Overall Study|Videos being too similar to other|0|||
143000053|NCT02545270|515537686|FG001|Overall Study|Videos being too similar to other|0|||
143000054|NCT02545270|515537687|FG002|Overall Study|Videos being too similar to other|2|||
143000055|NCT02898662|515537690|FG000|Overall Study|Adverse Event|1|||
143000056|NCT02898662|515537691|FG001|Overall Study|Adverse Event|0|||
143000057|NCT02898662|515537690|FG000|Overall Study|Loss of asthma control|23|||
143000058|NCT02898662|515537691|FG001|Overall Study|Loss of asthma control|24|||
143000059|NCT02898662|515537690|FG000|Overall Study|Withdrawal by Subject|4|||
143000060|NCT02898662|515537691|FG001|Overall Study|Withdrawal by Subject|1|||
143000061|NCT02898662|515537690|FG000|Overall Study|Technical issue|0|||
143000062|NCT02898662|515537691|FG001|Overall Study|Technical issue|1|||
143000063|NCT02898662|515537690|FG000|Overall Study|Randomized in error|0|||
143000064|NCT02898662|515537691|FG001|Overall Study|Randomized in error|1|||
143000065|NCT02898662|515537690|FG000|Overall Study|Subject decision|1|||
143000066|NCT02898662|515537691|FG001|Overall Study|Subject decision|0|||
143000067|NCT02898662|515537690|FG000|Overall Study|Other|0|||
143000068|NCT02898662|515537691|FG001|Overall Study|Other|1|||
143000069|NCT01430559|515537696|FG000|Overall Study|Adverse Event|7|||
143000070|NCT01430559|515537697|FG001|Overall Study|Adverse Event|3|||
143000071|NCT01430559|515537696|FG000|Overall Study|Entry criteria not met|1|||
143000072|NCT01430559|515537697|FG001|Overall Study|Entry criteria not met|1|||
143000073|NCT01430559|515537696|FG000|Overall Study|Lost to Follow-up|1|||
143000074|NCT01430559|515537697|FG001|Overall Study|Lost to Follow-up|0|||
143000075|NCT01430559|515537696|FG000|Overall Study|Medication error|1|||
143000076|NCT01430559|515537697|FG001|Overall Study|Medication error|0|||
143000077|NCT01430559|515537696|FG000|Overall Study|Withdrawal by Subject|3|||
143000078|NCT01430559|515537697|FG001|Overall Study|Withdrawal by Subject|2|||
143000079|NCT01430559|515537696|FG000|Overall Study|Protocol Violation|1|||
143000080|NCT01430559|515537697|FG001|Overall Study|Protocol Violation|0|||
143000081|NCT01430559|515537696|FG000|Overall Study|Other|3|||
143000082|NCT01430559|515537697|FG001|Overall Study|Other|3|||
143000083|NCT01430559|515537696|FG000|Overall Study|Randomized, Not Treated|3|||
143000084|NCT01430559|515537697|FG001|Overall Study|Randomized, Not Treated|3|||
143000085|NCT01177943|515537698|FG000|First Intervention|Withdrawal by Subject|2|||
143000086|NCT01177943|515537699|FG001|First Intervention|Withdrawal by Subject|0|||
143000087|NCT04225026|515537701|FG000|Overall Study|Withdrawal by Subject|4|||
143000088|NCT04225026|515537701|FG000|Overall Study|Adverse Event|1|||
143000089|NCT04225026|515537701|FG000|Overall Study|Other|1|||
143000090|NCT04225026|515537701|FG000|Overall Study|Death|11|||
143000091|NCT04225026|515537701|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
143000092|NCT00672490|515537704|FG000|Overall Study|Withdrawal by Subject|8|||
143000093|NCT00672490|515537705|FG001|Overall Study|Withdrawal by Subject|8|||
143000094|NCT00672490|515537704|FG000|Overall Study|Lack of Compliance|2|||
143000095|NCT00672490|515537705|FG001|Overall Study|Lack of Compliance|7|||
143000096|NCT00672490|515537704|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
143000097|NCT00672490|515537705|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
143000098|NCT00672490|515537704|FG000|Overall Study|Adverse Event|5|||
143000099|NCT00672490|515537705|FG001|Overall Study|Adverse Event|8|||
143000100|NCT00672490|515537704|FG000|Overall Study|Violation of Concomitant Medicine|1|||
143000101|NCT00672490|515537705|FG001|Overall Study|Violation of Concomitant Medicine|0|||
143000102|NCT00672490|515537704|FG000|Overall Study|Intolerance|0|||
143000103|NCT00672490|515537705|FG001|Overall Study|Intolerance|2|||
143000104|NCT00672490|515537704|FG000|Overall Study|Lost to Follow-up|1|||
143000105|NCT00672490|515537705|FG001|Overall Study|Lost to Follow-up|5|||
143000106|NCT00672490|515537704|FG000|Overall Study|No reason was provided|6|||
143000107|NCT00672490|515537705|FG001|Overall Study|No reason was provided|2|||
143000108|NCT04738123|515537709|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
143000109|NCT04738123|515537710|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
143000110|NCT04738123|515537709|FG000|Overall Study|Progressive Disease|0|||
143000111|NCT04738123|515537710|FG001|Overall Study|Progressive Disease|4|||
143000112|NCT04738123|515537709|FG000|Overall Study|Adverse Event|8|||
143000113|NCT04738123|515537710|FG001|Overall Study|Adverse Event|7|||
143000114|NCT04738123|515537709|FG000|Overall Study|Other Reasons|0|||
143000115|NCT04738123|515537710|FG001|Overall Study|Other Reasons|1|||
143000116|NCT04738123|515537709|FG000|Overall Study|Suicidal or assaultive behavior|0|||
143000117|NCT04738123|515537710|FG001|Overall Study|Suicidal or assaultive behavior|2|||
143000118|NCT04738123|515537709|FG000|Overall Study|Protocol Violation|2|||
143000119|NCT04738123|515537710|FG001|Overall Study|Protocol Violation|2|||
143000120|NCT04738123|515537709|FG000|Overall Study|Consent Withdrawn|35|||
143000121|NCT04738123|515537710|FG001|Overall Study|Consent Withdrawn|22|||
143000122|NCT00496782|515537716|FG000|Overall Study|Protocol Violation|1|||
143000123|NCT00496782|515537717|FG001|Overall Study|Protocol Violation|2|||
143000124|NCT00760994|515537718|FG000|Overall Study|Lost to Follow-up|4|||
143000125|NCT00760994|515537719|FG001|Overall Study|Lost to Follow-up|4|||
143000126|NCT00760994|515537720|FG002|Overall Study|Lost to Follow-up|3|||
143000127|NCT01288911|515537721|FG000|Double-blind Period|Death|11|||
143000128|NCT01288911|515537722|FG001|Double-blind Period|Death|7|||
143000129|NCT01288911|515537721|FG000|Double-blind Period|Lost to Follow-up|0|||
143000130|NCT01288911|515537722|FG001|Double-blind Period|Lost to Follow-up|2|||
143000131|NCT01288911|515537721|FG000|Double-blind Period|Progressive Disease|75|||
143000132|NCT01288911|515537722|FG001|Double-blind Period|Progressive Disease|103|||
143000133|NCT01288911|515537721|FG000|Double-blind Period|Protocol Violation|1|||
143000134|NCT01288911|515537722|FG001|Double-blind Period|Protocol Violation|0|||
143000135|NCT01288911|515537721|FG000|Double-blind Period|Withdrawal by Subject|25|||
143000136|NCT01288911|515537722|FG001|Double-blind Period|Withdrawal by Subject|26|||
143000137|NCT01288911|515537721|FG000|Double-blind Period|Miscellaneous Reason|29|||
143000138|NCT01288911|515537722|FG001|Double-blind Period|Miscellaneous Reason|42|||
143000139|NCT01288911|515537721|FG000|Double-blind Period|Randomized but never received study drug|1|||
143000140|NCT01288911|515537722|FG001|Double-blind Period|Randomized but never received study drug|2|||
143000141|NCT01288911|515537721|FG000|Open-label Period (All Enzalutamide)|Death|0|||
143000142|NCT01288911|515537722|FG001|Open-label Period (All Enzalutamide)|Death|1|||
143000143|NCT01288911|515537721|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
143000144|NCT01288911|515537722|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
143000145|NCT01288911|515537721|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
143000146|NCT01288911|515537722|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
143000147|NCT01288911|515537721|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
143000148|NCT01288911|515537722|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
143000149|NCT01288911|515537721|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
143000150|NCT01288911|515537722|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
143000151|NCT01288911|515537721|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
143000152|NCT01288911|515537722|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
143000153|NCT02431559|515537723|FG000|Overall Study|Adverse Event|0|||
143000154|NCT02431559|515537724|FG001|Overall Study|Adverse Event|1|||
143000155|NCT02431559|515537725|FG002|Overall Study|Adverse Event|0|||
143000156|NCT02431559|515537726|FG003|Overall Study|Adverse Event|4|||
143000157|NCT02431559|515537723|FG000|Overall Study|Progressive disease|2|||
143000158|NCT02431559|515537724|FG001|Overall Study|Progressive disease|1|||
143000159|NCT02431559|515537725|FG002|Overall Study|Progressive disease|4|||
143000160|NCT02431559|515537726|FG003|Overall Study|Progressive disease|22|||
143000161|NCT02431559|515537723|FG000|Overall Study|Withdrawal by Subject|0|||
143000162|NCT02431559|515537724|FG001|Overall Study|Withdrawal by Subject|1|||
143000163|NCT02431559|515537725|FG002|Overall Study|Withdrawal by Subject|0|||
143000164|NCT02431559|515537726|FG003|Overall Study|Withdrawal by Subject|4|||
143000165|NCT02431559|515537723|FG000|Overall Study|Physician Decision|0|||
143000166|NCT02431559|515537724|FG001|Overall Study|Physician Decision|0|||
143000167|NCT02431559|515537725|FG002|Overall Study|Physician Decision|0|||
143000168|NCT02431559|515537726|FG003|Overall Study|Physician Decision|1|||
143000169|NCT00955682|515537729|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
143000170|NCT00955682|515537730|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
143000171|NCT05047601|515537732|FG000|Overall Study|Lost to Follow-up|9|||
143000172|NCT05047601|515537733|FG001|Overall Study|Lost to Follow-up|11|||
143000173|NCT05047601|515537734|FG002|Overall Study|Lost to Follow-up|7|||
143000174|NCT05047601|515537732|FG000|Overall Study|Withdrawal by Subject|25|||
143000175|NCT05047601|515537733|FG001|Overall Study|Withdrawal by Subject|36|||
143000176|NCT05047601|515537734|FG002|Overall Study|Withdrawal by Subject|23|||
143000177|NCT05047601|515537732|FG000|Overall Study|Other|10|||
143000178|NCT05047601|515537733|FG001|Overall Study|Other|6|||
143000179|NCT05047601|515537734|FG002|Overall Study|Other|5|||
143000180|NCT00286234|515537735|FG000|Overall Study|Protocol Violation|1|||
143000181|NCT00286234|515537736|FG001|Overall Study|Protocol Violation|2|||
143000182|NCT00286234|515537737|FG002|Overall Study|Protocol Violation|0|||
143000183|NCT00286234|515537738|FG003|Overall Study|Protocol Violation|1|||
143000184|NCT00286234|515537735|FG000|Overall Study|Physician Decision|1|||
143000185|NCT00286234|515537736|FG001|Overall Study|Physician Decision|0|||
143000186|NCT00286234|515537737|FG002|Overall Study|Physician Decision|0|||
143000187|NCT00286234|515537738|FG003|Overall Study|Physician Decision|1|||
143000188|NCT00286234|515537735|FG000|Overall Study|Adverse Event|0|||
143000189|NCT00286234|515537736|FG001|Overall Study|Adverse Event|0|||
143000190|NCT00286234|515537737|FG002|Overall Study|Adverse Event|0|||
143000191|NCT00286234|515537738|FG003|Overall Study|Adverse Event|1|||
143000192|NCT00286234|515537735|FG000|Overall Study|Adverse Event|0|||
143455748|NCT02559895|517212520|FG000|Overall Study|Lost to Follow-up|22|||
143000193|NCT00286234|515537736|FG001|Overall Study|Adverse Event|0|||
143000194|NCT00286234|515537737|FG002|Overall Study|Adverse Event|0|||
143000195|NCT00286234|515537738|FG003|Overall Study|Adverse Event|1|||
143000196|NCT02924129|515537742|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
143000197|NCT02924129|515537743|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
143000198|NCT02924129|515537742|FG000|Overall Study|Withdrawal by Subject|2|||
143000199|NCT02924129|515537743|FG001|Overall Study|Withdrawal by Subject|2|||
143000200|NCT02924129|515537742|FG000|Overall Study|Physician Decision|1|||
143000201|NCT02924129|515537743|FG001|Overall Study|Physician Decision|0|||
143000202|NCT02924129|515537742|FG000|Overall Study|Missed Visit|0|||
143000203|NCT02924129|515537743|FG001|Overall Study|Missed Visit|1|||
143000204|NCT01610752|515537746|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
143000205|NCT01610752|515537747|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
143000206|NCT01610752|515537748|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
143000207|NCT00689728|515537751|FG000|Double-Blind Treatment|Adverse Event|1|||
143000208|NCT00689728|515537752|FG001|Double-Blind Treatment|Adverse Event|0|||
143000209|NCT00689728|515537753|FG002|Double-Blind Treatment|Adverse Event|0|||
143000210|NCT00689728|515537751|FG000|Double-Blind Treatment|Protocol Violation|0|||
143000211|NCT00689728|515537752|FG001|Double-Blind Treatment|Protocol Violation|0|||
143000212|NCT00689728|515537753|FG002|Double-Blind Treatment|Protocol Violation|1|||
143000213|NCT00689728|515537751|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
143000214|NCT00689728|515537752|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
143000215|NCT00689728|515537753|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
143000216|NCT00689728|515537751|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
143000217|NCT00689728|515537752|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
143000218|NCT00689728|515537753|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
143000219|NCT00689728|515537751|FG000|Rescue|Adverse Event|0|||
143000220|NCT00689728|515537752|FG001|Rescue|Adverse Event|1|||
143000221|NCT00689728|515537753|FG002|Rescue|Adverse Event|0|||
143000222|NCT00689728|515537751|FG000|Rescue|Withdrawal by Subject|1|||
143000223|NCT00689728|515537752|FG001|Rescue|Withdrawal by Subject|1|||
143000224|NCT00689728|515537753|FG002|Rescue|Withdrawal by Subject|1|||
143000225|NCT00689728|515537751|FG000|Optional Follow-Up|Adverse Event|1|||
143000226|NCT00689728|515537752|FG001|Optional Follow-Up|Adverse Event|0|||
143000227|NCT00689728|515537753|FG002|Optional Follow-Up|Adverse Event|0|||
143000228|NCT00689728|515537751|FG000|Optional Follow-Up|Lack of Efficacy|0|||
143000229|NCT00689728|515537752|FG001|Optional Follow-Up|Lack of Efficacy|1|||
143000230|NCT00689728|515537753|FG002|Optional Follow-Up|Lack of Efficacy|1|||
143000231|NCT00689728|515537751|FG000|Optional Follow-Up|Lost to Follow-up|0|||
143000232|NCT00689728|515537752|FG001|Optional Follow-Up|Lost to Follow-up|1|||
143000233|NCT00689728|515537753|FG002|Optional Follow-Up|Lost to Follow-up|1|||
143000234|NCT00689728|515537751|FG000|Optional Follow-Up|Protocol Violation|0|||
143000235|NCT00689728|515537752|FG001|Optional Follow-Up|Protocol Violation|0|||
143000236|NCT00689728|515537753|FG002|Optional Follow-Up|Protocol Violation|1|||
143000237|NCT00689728|515537751|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
143000238|NCT00689728|515537752|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
143000239|NCT00689728|515537753|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
143000240|NCT01277757|515539832|FG000|Overall Study|Disease Progression|1|||
143000241|NCT01277757|515539832|FG000|Overall Study|Withdrawal by Subject|1|||
143000242|NCT04120116|515539833|FG000|Overall Study|Lost to Follow-up|0|||
143000243|NCT04120116|515539834|FG001|Overall Study|Lost to Follow-up|1|||
143000244|NCT04120116|515539835|FG002|Overall Study|Lost to Follow-up|0|||
143000245|NCT04120116|515539836|FG003|Overall Study|Lost to Follow-up|2|||
143000246|NCT04120116|515539833|FG000|Overall Study|Withdrawal by Subject|1|||
143000247|NCT04120116|515539834|FG001|Overall Study|Withdrawal by Subject|0|||
143000248|NCT04120116|515539835|FG002|Overall Study|Withdrawal by Subject|1|||
143000249|NCT04120116|515539836|FG003|Overall Study|Withdrawal by Subject|1|||
143000250|NCT04120116|515539833|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
143000251|NCT04120116|515539834|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
143000252|NCT04120116|515539835|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
143000253|NCT04120116|515539836|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
143000254|NCT03410693|515539837|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
143000255|NCT03410693|515539838|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
143000256|NCT03410693|515539837|FG000|Overall Study|Disc trt: Lost to follow up|0|||
143000257|NCT03410693|515539838|FG001|Overall Study|Disc trt: Lost to follow up|1|||
143000258|NCT03410693|515539837|FG000|Overall Study|Disc trt: radiological progression|58|||
143000259|NCT03410693|515539838|FG001|Overall Study|Disc trt: radiological progression|50|||
143000260|NCT03410693|515539837|FG000|Overall Study|Disc trt: Other|1|||
143000261|NCT03410693|515539838|FG001|Overall Study|Disc trt: Other|0|||
143000262|NCT03410693|515539837|FG000|Overall Study|Study drug never administered|1|||
143000263|NCT03410693|515539838|FG001|Overall Study|Study drug never administered|6|||
143000264|NCT03410693|515539837|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
143000265|NCT03410693|515539838|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
143000266|NCT03410693|515539837|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
143000267|NCT03410693|515539838|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
143000268|NCT03410693|515539837|FG000|Overall Study|Disc trt: Physician decision|0|||
143000269|NCT03410693|515539838|FG001|Overall Study|Disc trt: Physician decision|5|||
143000270|NCT03410693|515539837|FG000|Overall Study|Disc trt: clinical progression|1|||
143000271|NCT03410693|515539838|FG001|Overall Study|Disc trt: clinical progression|5|||
143000272|NCT03410693|515539837|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
143000273|NCT03410693|515539838|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
143000274|NCT00501969|515539839|FG000|Overall Study|Major Protocol Violation|4|||
143000275|NCT00501969|515539839|FG000|Overall Study|Lack of Efficacy|29|||
143000276|NCT00501969|515539839|FG000|Overall Study|Adverse Event|76|||
143000277|NCT00501969|515539839|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
143000278|NCT00501969|515539839|FG000|Overall Study|Subject withdrew consent|51|||
143000279|NCT00501969|515539839|FG000|Overall Study|Lost to Follow-up|4|||
143000280|NCT00501969|515539839|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
143000281|NCT00501969|515539839|FG000|Overall Study|Other: Sponsors Request|10|||
143000282|NCT00501969|515539839|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
143000283|NCT00501969|515539839|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
143000284|NCT00501969|515539839|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
143000285|NCT00501969|515539839|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
143000286|NCT00501969|515539839|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
143000287|NCT00501969|515539839|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
143000288|NCT00501969|515539839|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
143000289|NCT00501969|515539839|FG000|Overall Study|Other: As Required by Local EC|2|||
143000290|NCT00501969|515539839|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
143000291|NCT00501969|515539839|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
143000292|NCT05637515|515539850|FG000|Overall Study|Withdrawal by Subject|17|||
143000293|NCT05637515|515539851|FG001|Overall Study|Withdrawal by Subject|17|||
143000294|NCT00151775|515539852|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
143000295|NCT00151775|515539853|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
143000296|NCT00151775|515539854|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
143000297|NCT00151775|515539855|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
143000298|NCT00151775|515539856|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
143000299|NCT00151775|515539857|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
143000300|NCT00151775|515539858|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
143000301|NCT00151775|515539859|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
143000302|NCT00151775|515539860|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
143000303|NCT00151775|515539861|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
143000304|NCT00151775|515539862|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
143000305|NCT00151775|515539863|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
143000306|NCT00151775|515539852|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
143000307|NCT00151775|515539853|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
143000308|NCT00151775|515539854|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
143000309|NCT00151775|515539855|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
143000310|NCT00151775|515539856|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
143000311|NCT00151775|515539857|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
143000312|NCT00151775|515539858|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
143000313|NCT00151775|515539859|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
143000314|NCT00151775|515539860|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
143000315|NCT00151775|515539861|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
143000316|NCT00151775|515539862|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
143000317|NCT00151775|515539863|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
143000318|NCT00151775|515539852|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
143000319|NCT00151775|515539853|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
143000320|NCT00151775|515539854|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
143000321|NCT00151775|515539855|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
143000322|NCT00151775|515539856|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
143000323|NCT00151775|515539857|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
143000324|NCT00151775|515539858|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
143000325|NCT00151775|515539859|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
143000326|NCT00151775|515539860|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
143000327|NCT00151775|515539861|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
143000328|NCT00151775|515539862|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
143000329|NCT00151775|515539863|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
143000330|NCT00151775|515539852|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
143000331|NCT00151775|515539853|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
143000332|NCT00151775|515539854|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
143000333|NCT00151775|515539855|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
143000334|NCT00151775|515539856|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
143003193|NCT01049360|515548745|FG001|Period 4|Protocol Violation|0|||
143000335|NCT00151775|515539857|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
143000336|NCT00151775|515539858|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
143000337|NCT00151775|515539859|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
143000338|NCT00151775|515539860|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
143000339|NCT00151775|515539861|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
143000340|NCT00151775|515539862|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
143000341|NCT00151775|515539863|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
143000342|NCT00151775|515539852|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
143000343|NCT00151775|515539853|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
143000344|NCT00151775|515539854|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
143000345|NCT00151775|515539855|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
143000346|NCT00151775|515539856|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
143000347|NCT00151775|515539857|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
143000348|NCT00151775|515539858|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
143000349|NCT00151775|515539859|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
143000350|NCT00151775|515539860|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
143000351|NCT00151775|515539861|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
143000352|NCT00151775|515539862|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
143000353|NCT00151775|515539863|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
143000354|NCT00151775|515539852|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
143000355|NCT00151775|515539853|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
143000356|NCT00151775|515539854|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
143000357|NCT00151775|515539855|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
143000358|NCT00151775|515539856|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
143000359|NCT00151775|515539857|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
143000360|NCT00151775|515539858|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
143000361|NCT00151775|515539859|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
143000362|NCT00151775|515539860|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
143000363|NCT00151775|515539861|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
143000364|NCT00151775|515539862|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
143000365|NCT00151775|515539863|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
143000366|NCT00151775|515539852|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
143000367|NCT00151775|515539853|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
143000368|NCT00151775|515539854|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
143000369|NCT00151775|515539855|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
143000370|NCT00151775|515539856|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
143000371|NCT00151775|515539857|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
143000372|NCT00151775|515539858|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
143000373|NCT00151775|515539859|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
143000374|NCT00151775|515539860|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
143000375|NCT00151775|515539861|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
143000376|NCT00151775|515539862|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
143000377|NCT00151775|515539863|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
143000378|NCT00151775|515539852|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
143000379|NCT00151775|515539853|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
143000380|NCT00151775|515539854|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
143000381|NCT00151775|515539855|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
143000382|NCT00151775|515539856|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
143000383|NCT00151775|515539857|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
143000384|NCT00151775|515539858|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
143000385|NCT00151775|515539859|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
143000386|NCT00151775|515539860|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
143000387|NCT00151775|515539861|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
143000388|NCT00151775|515539862|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
143000389|NCT00151775|515539863|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
143000390|NCT00151775|515539852|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
143000391|NCT00151775|515539853|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
143000392|NCT00151775|515539854|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
143000393|NCT00151775|515539855|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
143000394|NCT00151775|515539856|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
143000395|NCT00151775|515539857|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
143000396|NCT00151775|515539858|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
143000397|NCT00151775|515539859|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
143000398|NCT00151775|515539860|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
143000399|NCT00151775|515539861|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
143000400|NCT00151775|515539862|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
143000401|NCT00151775|515539863|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
143000402|NCT00151775|515539852|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
143000403|NCT00151775|515539853|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
143000404|NCT00151775|515539854|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
143000405|NCT00151775|515539855|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
143000406|NCT00151775|515539856|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
143000407|NCT00151775|515539857|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
143000408|NCT00151775|515539858|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
143000409|NCT00151775|515539859|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
143000410|NCT00151775|515539860|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
143000411|NCT00151775|515539861|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
143000412|NCT00151775|515539862|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
143000413|NCT00151775|515539863|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
143000414|NCT00151775|515539852|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
143000415|NCT00151775|515539853|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
143000416|NCT00151775|515539854|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
143000417|NCT00151775|515539855|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
143000418|NCT00151775|515539856|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
143000419|NCT00151775|515539857|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
143000420|NCT00151775|515539858|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
143000421|NCT00151775|515539859|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
143000422|NCT00151775|515539860|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
143000423|NCT00151775|515539861|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
143000424|NCT00151775|515539862|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
143000425|NCT00151775|515539863|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
143000426|NCT00151775|515539852|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
143000427|NCT00151775|515539853|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
143000428|NCT00151775|515539854|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
143000429|NCT00151775|515539855|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
143000430|NCT00151775|515539856|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
143000431|NCT00151775|515539857|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
143000432|NCT00151775|515539858|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
143000433|NCT00151775|515539859|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
143000434|NCT00151775|515539860|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
143000435|NCT00151775|515539861|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
143000436|NCT00151775|515539862|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
143000437|NCT00151775|515539863|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
143000438|NCT00151775|515539852|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
143000439|NCT00151775|515539853|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
143000440|NCT00151775|515539854|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
143000441|NCT00151775|515539855|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
143000442|NCT00151775|515539856|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
143000443|NCT00151775|515539857|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
143000444|NCT00151775|515539858|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
143000445|NCT00151775|515539859|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
143000446|NCT00151775|515539860|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
143000447|NCT00151775|515539861|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
143000448|NCT00151775|515539862|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
143000449|NCT00151775|515539863|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
143000450|NCT00151775|515539852|FG000|Period 4: Open Label|Increased blood pressure|0|||
143000451|NCT00151775|515539853|FG001|Period 4: Open Label|Increased blood pressure|0|||
143000452|NCT00151775|515539854|FG002|Period 4: Open Label|Increased blood pressure|0|||
143000453|NCT00151775|515539855|FG003|Period 4: Open Label|Increased blood pressure|0|||
143000454|NCT00151775|515539856|FG004|Period 4: Open Label|Increased blood pressure|1|||
143000455|NCT00151775|515539857|FG005|Period 4: Open Label|Increased blood pressure|0|||
143000456|NCT00151775|515539858|FG006|Period 4: Open Label|Increased blood pressure|0|||
143000457|NCT00151775|515539859|FG007|Period 4: Open Label|Increased blood pressure|0|||
143000458|NCT00151775|515539860|FG008|Period 4: Open Label|Increased blood pressure|0|||
143000459|NCT00151775|515539861|FG009|Period 4: Open Label|Increased blood pressure|1|||
143000460|NCT00151775|515539862|FG010|Period 4: Open Label|Increased blood pressure|0|||
143000461|NCT00151775|515539863|FG011|Period 4: Open Label|Increased blood pressure|0|||
143000462|NCT00151775|515539852|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
143000463|NCT00151775|515539853|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
143000464|NCT00151775|515539854|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
143000465|NCT00151775|515539855|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
143000466|NCT00151775|515539856|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
143000467|NCT00151775|515539857|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
143000468|NCT00151775|515539858|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
143000469|NCT00151775|515539859|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
143000470|NCT00151775|515539860|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
143000471|NCT00151775|515539861|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
143000472|NCT00151775|515539862|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
143000473|NCT00151775|515539863|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
143000474|NCT00151775|515539852|FG000|Period 4: Open Label|Adverse Event|0|||
143000475|NCT00151775|515539853|FG001|Period 4: Open Label|Adverse Event|0|||
143000476|NCT00151775|515539854|FG002|Period 4: Open Label|Adverse Event|0|||
143000477|NCT00151775|515539855|FG003|Period 4: Open Label|Adverse Event|0|||
143000478|NCT00151775|515539856|FG004|Period 4: Open Label|Adverse Event|1|||
143000479|NCT00151775|515539857|FG005|Period 4: Open Label|Adverse Event|0|||
143000480|NCT00151775|515539858|FG006|Period 4: Open Label|Adverse Event|0|||
143000481|NCT00151775|515539859|FG007|Period 4: Open Label|Adverse Event|0|||
143000482|NCT00151775|515539860|FG008|Period 4: Open Label|Adverse Event|0|||
143000483|NCT00151775|515539861|FG009|Period 4: Open Label|Adverse Event|2|||
143000484|NCT00151775|515539862|FG010|Period 4: Open Label|Adverse Event|0|||
143000485|NCT00151775|515539863|FG011|Period 4: Open Label|Adverse Event|0|||
143000486|NCT00151775|515539852|FG000|Period 4: Open Label|Lost to Follow-up|0|||
143000487|NCT00151775|515539853|FG001|Period 4: Open Label|Lost to Follow-up|0|||
143000488|NCT00151775|515539854|FG002|Period 4: Open Label|Lost to Follow-up|0|||
143000489|NCT00151775|515539855|FG003|Period 4: Open Label|Lost to Follow-up|0|||
143000490|NCT00151775|515539856|FG004|Period 4: Open Label|Lost to Follow-up|17|||
143000491|NCT00151775|515539857|FG005|Period 4: Open Label|Lost to Follow-up|0|||
143000492|NCT00151775|515539858|FG006|Period 4: Open Label|Lost to Follow-up|0|||
143000493|NCT00151775|515539859|FG007|Period 4: Open Label|Lost to Follow-up|0|||
143000494|NCT00151775|515539860|FG008|Period 4: Open Label|Lost to Follow-up|0|||
143000495|NCT00151775|515539861|FG009|Period 4: Open Label|Lost to Follow-up|7|||
143000496|NCT00151775|515539862|FG010|Period 4: Open Label|Lost to Follow-up|0|||
143000497|NCT00151775|515539863|FG011|Period 4: Open Label|Lost to Follow-up|0|||
143000498|NCT00151775|515539852|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
143000499|NCT00151775|515539853|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
143000500|NCT00151775|515539854|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
143000501|NCT00151775|515539855|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
143000502|NCT00151775|515539856|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
143000503|NCT00151775|515539857|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
143000504|NCT00151775|515539858|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
143000505|NCT00151775|515539859|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
143000506|NCT00151775|515539860|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
143000507|NCT00151775|515539861|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
143000508|NCT00151775|515539862|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
143000509|NCT00151775|515539863|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
143000510|NCT00151775|515539852|FG000|Period 4: Open Label|Other|0|||
143000511|NCT00151775|515539853|FG001|Period 4: Open Label|Other|0|||
143000512|NCT00151775|515539854|FG002|Period 4: Open Label|Other|0|||
143000513|NCT00151775|515539855|FG003|Period 4: Open Label|Other|0|||
143000514|NCT00151775|515539856|FG004|Period 4: Open Label|Other|1|||
143000515|NCT00151775|515539857|FG005|Period 4: Open Label|Other|0|||
143000516|NCT00151775|515539858|FG006|Period 4: Open Label|Other|0|||
143000517|NCT00151775|515539859|FG007|Period 4: Open Label|Other|0|||
143000518|NCT00151775|515539860|FG008|Period 4: Open Label|Other|0|||
143000519|NCT00151775|515539861|FG009|Period 4: Open Label|Other|3|||
143000520|NCT00151775|515539862|FG010|Period 4: Open Label|Other|0|||
143000521|NCT00151775|515539863|FG011|Period 4: Open Label|Other|0|||
143000522|NCT00151775|515539852|FG000|Period 4: Open Label|Physician Decision|0|||
143000523|NCT00151775|515539853|FG001|Period 4: Open Label|Physician Decision|0|||
143000524|NCT00151775|515539854|FG002|Period 4: Open Label|Physician Decision|0|||
143000525|NCT00151775|515539855|FG003|Period 4: Open Label|Physician Decision|0|||
143000526|NCT00151775|515539856|FG004|Period 4: Open Label|Physician Decision|0|||
143000527|NCT00151775|515539857|FG005|Period 4: Open Label|Physician Decision|0|||
143000528|NCT00151775|515539858|FG006|Period 4: Open Label|Physician Decision|0|||
143000529|NCT00151775|515539859|FG007|Period 4: Open Label|Physician Decision|0|||
143000530|NCT00151775|515539860|FG008|Period 4: Open Label|Physician Decision|0|||
143000531|NCT00151775|515539861|FG009|Period 4: Open Label|Physician Decision|2|||
143000532|NCT00151775|515539862|FG010|Period 4: Open Label|Physician Decision|0|||
143000533|NCT00151775|515539863|FG011|Period 4: Open Label|Physician Decision|0|||
143000534|NCT00151775|515539852|FG000|Period 4: Open Label|Protocol Violation|0|||
143000535|NCT00151775|515539853|FG001|Period 4: Open Label|Protocol Violation|0|||
143000536|NCT00151775|515539854|FG002|Period 4: Open Label|Protocol Violation|0|||
143000537|NCT00151775|515539855|FG003|Period 4: Open Label|Protocol Violation|0|||
143000538|NCT00151775|515539856|FG004|Period 4: Open Label|Protocol Violation|1|||
143000539|NCT00151775|515539857|FG005|Period 4: Open Label|Protocol Violation|0|||
143000540|NCT00151775|515539858|FG006|Period 4: Open Label|Protocol Violation|0|||
143000541|NCT00151775|515539859|FG007|Period 4: Open Label|Protocol Violation|0|||
143000542|NCT00151775|515539860|FG008|Period 4: Open Label|Protocol Violation|0|||
143000543|NCT00151775|515539861|FG009|Period 4: Open Label|Protocol Violation|0|||
143000544|NCT00151775|515539862|FG010|Period 4: Open Label|Protocol Violation|0|||
143000545|NCT00151775|515539863|FG011|Period 4: Open Label|Protocol Violation|0|||
143000546|NCT04516291|515539864|FG000|Treatment Period (24 Weeks)|Other|1|||
143000547|NCT04516291|515539865|FG001|Treatment Period (24 Weeks)|Other|0|||
143000548|NCT04516291|515539866|FG002|Treatment Period (24 Weeks)|Other|0|||
143000549|NCT04516291|515539867|FG003|Treatment Period (24 Weeks)|Other|2|||
143000550|NCT04516291|515539868|FG004|Treatment Period (24 Weeks)|Other|2|||
143000551|NCT04516291|515539869|FG005|Treatment Period (24 Weeks)|Other|4|||
143000552|NCT04516291|515539870|FG006|Treatment Period (24 Weeks)|Other|2|||
143000553|NCT04516291|515539871|FG007|Treatment Period (24 Weeks)|Other|0|||
143000554|NCT04516291|515539864|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
143000555|NCT04516291|515539865|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
143000556|NCT04516291|515539866|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
143000557|NCT04516291|515539867|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
143000558|NCT04516291|515539868|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
143000559|NCT04516291|515539869|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
143000560|NCT04516291|515539870|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
143000561|NCT04516291|515539871|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
143000562|NCT04516291|515539864|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
143000563|NCT04516291|515539865|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
143000564|NCT04516291|515539866|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
143000565|NCT04516291|515539867|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
143000566|NCT04516291|515539868|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
143000567|NCT04516291|515539869|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
143000568|NCT04516291|515539870|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
143000569|NCT04516291|515539871|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
143000570|NCT04516291|515539864|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
143000571|NCT04516291|515539865|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
143000572|NCT04516291|515539866|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
143000573|NCT04516291|515539867|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
143000574|NCT04516291|515539868|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
143000575|NCT04516291|515539869|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
143000576|NCT04516291|515539870|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
143000577|NCT04516291|515539871|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
143000578|NCT04516291|515539864|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
143000579|NCT04516291|515539865|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
143000580|NCT04516291|515539866|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
143000581|NCT04516291|515539867|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
143000582|NCT04516291|515539868|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
143000583|NCT04516291|515539869|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
143000584|NCT04516291|515539870|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
143000585|NCT04516291|515539871|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
143000586|NCT04516291|515539864|FG000|Follow-up Period (12 Weeks)|Other|0|||
143000587|NCT04516291|515539865|FG001|Follow-up Period (12 Weeks)|Other|1|||
143000588|NCT04516291|515539866|FG002|Follow-up Period (12 Weeks)|Other|0|||
143000589|NCT04516291|515539867|FG003|Follow-up Period (12 Weeks)|Other|2|||
143000590|NCT04516291|515539868|FG004|Follow-up Period (12 Weeks)|Other|0|||
143000591|NCT04516291|515539869|FG005|Follow-up Period (12 Weeks)|Other|0|||
143000592|NCT04516291|515539870|FG006|Follow-up Period (12 Weeks)|Other|0|||
143000593|NCT04516291|515539871|FG007|Follow-up Period (12 Weeks)|Other|0|||
143000594|NCT04516291|515539864|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
143000595|NCT04516291|515539865|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
143000596|NCT04516291|515539866|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
143000597|NCT04516291|515539867|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
143000598|NCT04516291|515539868|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
143000599|NCT04516291|515539869|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
143000600|NCT04516291|515539870|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
143000601|NCT04516291|515539871|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
143000602|NCT04516291|515539864|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
143000603|NCT04516291|515539865|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
143000604|NCT04516291|515539866|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
143000605|NCT04516291|515539867|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
143000606|NCT04516291|515539868|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
143000607|NCT04516291|515539869|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
143000608|NCT04516291|515539870|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
143000609|NCT04516291|515539871|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
143000610|NCT03039686|515539872|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
143000611|NCT03039686|515539873|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
143000612|NCT03039686|515539874|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
143000613|NCT03039686|515539872|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
143000614|NCT03039686|515539873|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
143000615|NCT03039686|515539874|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
143000616|NCT03039686|515539872|FG000|Double-blind Period|Withdrawal by Subject|2|||
143000617|NCT03039686|515539873|FG001|Double-blind Period|Withdrawal by Subject|2|||
143000618|NCT03039686|515539874|FG002|Double-blind Period|Withdrawal by Subject|1|||
143000619|NCT03039686|515539872|FG000|Double-blind Period|Death|0|||
143000620|NCT03039686|515539873|FG001|Double-blind Period|Death|0|||
143000621|NCT03039686|515539874|FG002|Double-blind Period|Death|1|||
143000622|NCT03039686|515539872|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
143000623|NCT03039686|515539873|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
143000624|NCT03039686|515539874|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
143000625|NCT03039686|515539872|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
143000626|NCT03039686|515539873|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
143000627|NCT03039686|515539874|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
143000628|NCT03039686|515539872|FG000|Open Label Period|Withdrawal by Subject|0|||
143000629|NCT03039686|515539873|FG001|Open Label Period|Withdrawal by Subject|3|||
143000630|NCT03039686|515539874|FG002|Open Label Period|Withdrawal by Subject|1|||
143000631|NCT02158949|515539875|FG000|Overall Study|Withdrawal by Subject|1|||
143000632|NCT02158949|515539876|FG001|Overall Study|Withdrawal by Subject|0|||
143000633|NCT02158949|515539875|FG000|Overall Study|Lost to Follow-up|5|||
143000634|NCT02158949|515539876|FG001|Overall Study|Lost to Follow-up|11|||
143000635|NCT02181634|515539877|FG000|Overall Study|Lack of Efficacy|33|||
143000636|NCT02181634|515539877|FG000|Overall Study|Adverse Event|17|||
143000637|NCT02181634|515539877|FG000|Overall Study|Physician Decision|8|||
143000638|NCT02181634|515539877|FG000|Overall Study|Withdrawal by Subject|5|||
143000639|NCT02181634|515539877|FG000|Overall Study|Death|2|||
143000640|NCT02181634|515539877|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
143000641|NCT02181634|515539877|FG000|Overall Study|Ineligible|1|||
143000642|NCT02181634|515539877|FG000|Overall Study|Max number of dose reduction|1|||
143000643|NCT02181634|515539877|FG000|Overall Study|Symptomatic progression|1|||
143000644|NCT02181634|515539877|FG000|Overall Study|Patient opted to proceed to surgery|1|||
143000645|NCT02528331|515539884|FG000|Overall Study|Withdrawal by Subject|2|||
143000646|NCT02452320|515539888|FG000|Overall Study|Adverse Event|0|||
143000647|NCT02452320|515539889|FG001|Overall Study|Adverse Event|1|||
143000648|NCT03382639|515539890|FG000|Overall Study|Adverse Event|2|||
143000649|NCT03382639|515539891|FG001|Overall Study|Adverse Event|0|||
143000650|NCT03382639|515539892|FG002|Overall Study|Adverse Event|1|||
143000651|NCT03382639|515539893|FG003|Overall Study|Adverse Event|1|||
143000652|NCT03382639|515539890|FG000|Overall Study|Lost to Follow-up|1|||
143000653|NCT03382639|515539891|FG001|Overall Study|Lost to Follow-up|0|||
143000654|NCT03382639|515539892|FG002|Overall Study|Lost to Follow-up|0|||
143000655|NCT03382639|515539893|FG003|Overall Study|Lost to Follow-up|0|||
143000656|NCT03382639|515539890|FG000|Overall Study|Withdrawal by Subject|4|||
143000657|NCT03382639|515539891|FG001|Overall Study|Withdrawal by Subject|3|||
143000658|NCT03382639|515539892|FG002|Overall Study|Withdrawal by Subject|2|||
143000659|NCT03382639|515539893|FG003|Overall Study|Withdrawal by Subject|3|||
143000660|NCT03382639|515539890|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
143000661|NCT03382639|515539891|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
143000662|NCT03382639|515539892|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
143000663|NCT03382639|515539893|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
143000664|NCT03382639|515539890|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
143000665|NCT03382639|515539891|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
143000666|NCT03382639|515539892|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
143000667|NCT03382639|515539893|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
143000668|NCT03382639|515539890|FG000|Overall Study|Other|2|||
143000669|NCT03382639|515539891|FG001|Overall Study|Other|0|||
143000670|NCT03382639|515539892|FG002|Overall Study|Other|0|||
143000671|NCT03382639|515539893|FG003|Overall Study|Other|3|||
143000672|NCT01072175|515539894|FG000|Part A (Drug-Drug Interaction)|Death|1|||
143000673|NCT01072175|515539895|FG001|Part A (Drug-Drug Interaction)|Death|0|||
143000674|NCT01072175|515539896|FG002|Part A (Drug-Drug Interaction)|Death|0|||
143000675|NCT01072175|515539897|FG003|Part A (Drug-Drug Interaction)|Death|0|||
143000676|NCT01072175|515539898|FG004|Part A (Drug-Drug Interaction)|Death|0|||
143000677|NCT01072175|515539899|FG005|Part A (Drug-Drug Interaction)|Death|0|||
143000678|NCT01072175|515539900|FG006|Part A (Drug-Drug Interaction)|Death|0|||
143000679|NCT01072175|515539901|FG007|Part A (Drug-Drug Interaction)|Death|0|||
143000680|NCT01072175|515539902|FG008|Part A (Drug-Drug Interaction)|Death|0|||
143000681|NCT01072175|515539903|FG009|Part A (Drug-Drug Interaction)|Death|0|||
143000682|NCT01072175|515539904|FG010|Part A (Drug-Drug Interaction)|Death|0|||
143000683|NCT01072175|515539905|FG011|Part A (Drug-Drug Interaction)|Death|0|||
143000684|NCT01072175|515539906|FG012|Part A (Drug-Drug Interaction)|Death|0|||
143000685|NCT01072175|515539894|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
143000686|NCT01072175|515539895|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
143000687|NCT01072175|515539896|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
143000688|NCT01072175|515539897|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
143000689|NCT01072175|515539898|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
143000690|NCT01072175|515539899|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
143000691|NCT01072175|515539900|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
143000692|NCT01072175|515539901|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
143000693|NCT01072175|515539902|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
143000694|NCT01072175|515539903|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
143000695|NCT01072175|515539904|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
143000696|NCT01072175|515539905|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
143000697|NCT01072175|515539906|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
143000698|NCT01072175|515539894|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
143000699|NCT01072175|515539895|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
143000700|NCT01072175|515539896|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
143000701|NCT01072175|515539897|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
143000702|NCT01072175|515539898|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
143000703|NCT01072175|515539899|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
143000704|NCT01072175|515539900|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
143000705|NCT01072175|515539901|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
143000706|NCT01072175|515539902|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
143000707|NCT01072175|515539903|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
143000708|NCT01072175|515539904|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
143000709|NCT01072175|515539905|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
143000710|NCT01072175|515539906|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
143000711|NCT01072175|515539894|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
143000712|NCT01072175|515539895|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
143000713|NCT01072175|515539896|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
143000714|NCT01072175|515539897|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
143000715|NCT01072175|515539898|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
143000716|NCT01072175|515539899|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
143000717|NCT01072175|515539900|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
143000718|NCT01072175|515539901|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
143000719|NCT01072175|515539902|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
143000720|NCT01072175|515539903|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
143000721|NCT01072175|515539904|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
143000722|NCT01072175|515539905|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
143000723|NCT01072175|515539906|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
143000724|NCT01072175|515539894|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
143000725|NCT01072175|515539895|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
143000726|NCT01072175|515539896|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
143000727|NCT01072175|515539897|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
143000728|NCT01072175|515539898|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
143000729|NCT01072175|515539899|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
143000730|NCT01072175|515539900|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
143000731|NCT01072175|515539901|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
143000732|NCT01072175|515539902|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
143000733|NCT01072175|515539903|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
143000734|NCT01072175|515539904|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
143000735|NCT01072175|515539905|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
143000736|NCT01072175|515539906|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
143000737|NCT01072175|515539894|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
143000738|NCT01072175|515539895|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
143000739|NCT01072175|515539896|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
143000740|NCT01072175|515539897|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
143000741|NCT01072175|515539898|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
143000742|NCT01072175|515539899|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
143000743|NCT01072175|515539900|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
143000744|NCT01072175|515539901|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
143000745|NCT01072175|515539902|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
143000746|NCT01072175|515539903|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
143000747|NCT01072175|515539904|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
143000748|NCT01072175|515539905|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
143000749|NCT01072175|515539906|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
143000750|NCT01072175|515539894|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
143000751|NCT01072175|515539895|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
143000752|NCT01072175|515539896|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
143000753|NCT01072175|515539897|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
143000754|NCT01072175|515539898|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
143000755|NCT01072175|515539899|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
143000756|NCT01072175|515539900|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
143000757|NCT01072175|515539901|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
143000758|NCT01072175|515539902|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
143000759|NCT01072175|515539903|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
143000760|NCT01072175|515539904|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
143000761|NCT01072175|515539905|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
143000762|NCT01072175|515539906|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
143000763|NCT01072175|515539894|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
143000764|NCT01072175|515539895|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
143000765|NCT01072175|515539896|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
143000766|NCT01072175|515539897|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
143000767|NCT01072175|515539898|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
143000768|NCT01072175|515539899|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
143000769|NCT01072175|515539900|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
143000770|NCT01072175|515539901|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
143000771|NCT01072175|515539902|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
143000772|NCT01072175|515539903|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
143000773|NCT01072175|515539904|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
143000774|NCT01072175|515539905|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
143000775|NCT01072175|515539906|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
143000776|NCT01072175|515539894|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
143000777|NCT01072175|515539895|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
143000778|NCT01072175|515539896|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
143000779|NCT01072175|515539897|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
143000780|NCT01072175|515539898|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
143000781|NCT01072175|515539899|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
143000782|NCT01072175|515539900|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
143000783|NCT01072175|515539901|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
143000784|NCT01072175|515539902|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
143000785|NCT01072175|515539903|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
143000786|NCT01072175|515539904|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
143000787|NCT01072175|515539905|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
143000788|NCT01072175|515539906|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
143000789|NCT01072175|515539894|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
143000790|NCT01072175|515539895|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
143000791|NCT01072175|515539896|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
143000792|NCT01072175|515539897|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
143000793|NCT01072175|515539898|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
143000794|NCT01072175|515539899|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
143000795|NCT01072175|515539900|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
143000796|NCT01072175|515539901|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
143000797|NCT01072175|515539902|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
143000798|NCT01072175|515539903|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
143000799|NCT01072175|515539904|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
143000800|NCT01072175|515539905|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
143000801|NCT01072175|515539906|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
143000802|NCT01072175|515539894|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
143000803|NCT01072175|515539895|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
143000804|NCT01072175|515539896|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
143000805|NCT01072175|515539897|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
143000806|NCT01072175|515539898|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
143000807|NCT01072175|515539899|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
143000808|NCT01072175|515539900|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
143000809|NCT01072175|515539901|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
143000810|NCT01072175|515539902|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
143000811|NCT01072175|515539903|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
143000812|NCT01072175|515539904|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
143000813|NCT01072175|515539905|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
143000814|NCT01072175|515539906|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
143000815|NCT01072175|515539894|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
143000816|NCT01072175|515539895|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
143000817|NCT01072175|515539896|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
143000818|NCT01072175|515539897|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
143000819|NCT01072175|515539898|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
143000820|NCT01072175|515539899|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
143000821|NCT01072175|515539900|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
143003194|NCT01049360|515548746|FG002|Period 4|Protocol Violation|0|||
143000822|NCT01072175|515539901|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
143000823|NCT01072175|515539902|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
143000824|NCT01072175|515539903|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
143000825|NCT01072175|515539904|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
143000826|NCT01072175|515539905|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
143000827|NCT01072175|515539906|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
143000828|NCT01072175|515539894|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
143000829|NCT01072175|515539895|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
143000830|NCT01072175|515539896|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
143000831|NCT01072175|515539897|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
143000832|NCT01072175|515539898|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
143000833|NCT01072175|515539899|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
143000834|NCT01072175|515539900|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
143000835|NCT01072175|515539901|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
143000836|NCT01072175|515539902|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
143000837|NCT01072175|515539903|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
143000838|NCT01072175|515539904|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
143000839|NCT01072175|515539905|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
143000840|NCT01072175|515539906|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
143000841|NCT01072175|515539894|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
143000842|NCT01072175|515539895|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
143000843|NCT01072175|515539896|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
143000844|NCT01072175|515539897|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
143000845|NCT01072175|515539898|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
143000846|NCT01072175|515539899|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
143000847|NCT01072175|515539900|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
143000848|NCT01072175|515539901|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
143000849|NCT01072175|515539902|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
143000850|NCT01072175|515539903|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
143000851|NCT01072175|515539904|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
143000852|NCT01072175|515539905|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
143000853|NCT01072175|515539906|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
143000854|NCT01072175|515539894|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
143000855|NCT01072175|515539895|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
143000856|NCT01072175|515539896|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
143000857|NCT01072175|515539897|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
143000858|NCT01072175|515539898|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
143000859|NCT01072175|515539899|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
143000860|NCT01072175|515539900|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
143000861|NCT01072175|515539901|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
143000862|NCT01072175|515539902|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
143000863|NCT01072175|515539903|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
143000864|NCT01072175|515539904|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
143000865|NCT01072175|515539905|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
143000866|NCT01072175|515539906|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
143000867|NCT01072175|515539894|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
143000868|NCT01072175|515539895|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
143000869|NCT01072175|515539896|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
143000870|NCT01072175|515539897|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
143000871|NCT01072175|515539898|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
143000872|NCT01072175|515539899|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
143000873|NCT01072175|515539900|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
143000874|NCT01072175|515539901|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
143000875|NCT01072175|515539902|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
143000876|NCT01072175|515539903|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
143000877|NCT01072175|515539904|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
143000878|NCT01072175|515539905|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
143000879|NCT01072175|515539906|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
143000880|NCT01072175|515539894|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
143000881|NCT01072175|515539895|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
143000882|NCT01072175|515539896|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
143000883|NCT01072175|515539897|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
143000884|NCT01072175|515539898|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
143000885|NCT01072175|515539899|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
143000886|NCT01072175|515539900|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
143000887|NCT01072175|515539901|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
143000888|NCT01072175|515539902|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
143000889|NCT01072175|515539903|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
143000890|NCT01072175|515539904|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
143000891|NCT01072175|515539905|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
143000892|NCT01072175|515539906|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
143000893|NCT01072175|515539894|FG000|Part D (HPMC Capsules)|Death|0|||
143000894|NCT01072175|515539895|FG001|Part D (HPMC Capsules)|Death|0|||
143000895|NCT01072175|515539896|FG002|Part D (HPMC Capsules)|Death|0|||
143000896|NCT01072175|515539897|FG003|Part D (HPMC Capsules)|Death|0|||
143000897|NCT01072175|515539898|FG004|Part D (HPMC Capsules)|Death|0|||
143000898|NCT01072175|515539899|FG005|Part D (HPMC Capsules)|Death|0|||
143000899|NCT01072175|515539900|FG006|Part D (HPMC Capsules)|Death|0|||
143000900|NCT01072175|515539901|FG007|Part D (HPMC Capsules)|Death|0|||
143000901|NCT01072175|515539902|FG008|Part D (HPMC Capsules)|Death|0|||
143000902|NCT01072175|515539903|FG009|Part D (HPMC Capsules)|Death|10|||
143000903|NCT01072175|515539904|FG010|Part D (HPMC Capsules)|Death|12|||
143000904|NCT01072175|515539905|FG011|Part D (HPMC Capsules)|Death|28|||
143000905|NCT01072175|515539906|FG012|Part D (HPMC Capsules)|Death|26|||
143000906|NCT01072175|515539894|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
143000907|NCT01072175|515539895|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
143000908|NCT01072175|515539896|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
143000909|NCT01072175|515539897|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
143000910|NCT01072175|515539898|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
143000911|NCT01072175|515539899|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
143000912|NCT01072175|515539900|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
143000913|NCT01072175|515539901|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
143000914|NCT01072175|515539902|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
143000915|NCT01072175|515539903|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
143000916|NCT01072175|515539904|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
143000917|NCT01072175|515539905|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
143000918|NCT01072175|515539906|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
143000919|NCT01072175|515539894|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
143000920|NCT01072175|515539895|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
143000921|NCT01072175|515539896|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
143000922|NCT01072175|515539897|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
143000923|NCT01072175|515539898|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
143000924|NCT01072175|515539899|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
143000925|NCT01072175|515539900|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
143000926|NCT01072175|515539901|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
143000927|NCT01072175|515539902|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
143000928|NCT01072175|515539903|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
143000929|NCT01072175|515539904|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
143000930|NCT01072175|515539905|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
143000931|NCT01072175|515539906|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
143000932|NCT01072175|515539894|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
143000933|NCT01072175|515539895|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
143000934|NCT01072175|515539896|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
143000935|NCT01072175|515539897|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
143000936|NCT01072175|515539898|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
143000937|NCT01072175|515539899|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
143000938|NCT01072175|515539900|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
143000939|NCT01072175|515539901|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
143000940|NCT01072175|515539902|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
143000941|NCT01072175|515539903|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
143000942|NCT01072175|515539904|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
143000943|NCT01072175|515539905|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
143000944|NCT01072175|515539906|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
143000945|NCT01072175|515539894|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
143000946|NCT01072175|515539895|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
143000947|NCT01072175|515539896|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
143000948|NCT01072175|515539897|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
143000949|NCT01072175|515539898|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
143000950|NCT01072175|515539899|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
143000951|NCT01072175|515539900|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
143000952|NCT01072175|515539901|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
143000953|NCT01072175|515539902|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
143000954|NCT01072175|515539903|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
143000955|NCT01072175|515539904|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
143000956|NCT01072175|515539905|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
143000957|NCT01072175|515539906|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
143000958|NCT02477215|515539907|FG000|Dose Escalation Phase|Physician Decision|1|||
143000959|NCT02477215|515539908|FG001|Dose Escalation Phase|Physician Decision|2|||
143000960|NCT02477215|515539909|FG002|Dose Escalation Phase|Physician Decision|0|||
143000961|NCT02477215|515539907|FG000|Fixed Dose Phase|Physician Decision|0|||
143000962|NCT02477215|515539908|FG001|Fixed Dose Phase|Physician Decision|7|||
143000963|NCT02477215|515539909|FG002|Fixed Dose Phase|Physician Decision|0|||
143000964|NCT02210559|515539910|FG000|Overall Study|Progressive Disease|3|||
143000965|NCT02210559|515539911|FG001|Overall Study|Progressive Disease|2|||
143000966|NCT02210559|515539910|FG000|Overall Study|Adverse Event|2|||
143000967|NCT02210559|515539911|FG001|Overall Study|Adverse Event|2|||
143000968|NCT02210559|515539910|FG000|Overall Study|Physician Decision|1|||
143000969|NCT02210559|515539911|FG001|Overall Study|Physician Decision|0|||
143000970|NCT02210559|515539910|FG000|Overall Study|Withdrawal by Subject|0|||
143000971|NCT02210559|515539911|FG001|Overall Study|Withdrawal by Subject|1|||
143000972|NCT02210559|515539910|FG000|Overall Study|Other than specified|0|||
143000973|NCT02210559|515539911|FG001|Overall Study|Other than specified|1|||
143000974|NCT00310440|515539912|FG000|Overall Study|Lost to Follow-up|17|||
143000975|NCT00310440|515539913|FG001|Overall Study|Lost to Follow-up|8|||
143000976|NCT00310440|515539912|FG000|Overall Study|Withdrawal by Subject|2|||
143000977|NCT00310440|515539913|FG001|Overall Study|Withdrawal by Subject|1|||
143000978|NCT00310440|515539912|FG000|Overall Study|Missed 12 Month Visit|7|||
143000979|NCT00310440|515539913|FG001|Overall Study|Missed 12 Month Visit|4|||
143000980|NCT01287403|515539914|FG000|1st Intervention (1 Day)|Adverse Event|1|||
143000981|NCT03911401|515539917|FG000|Overall Study|Adverse Event|1|||
143000982|NCT03911401|515539918|FG001|Overall Study|Adverse Event|2|||
143000983|NCT03911401|515539919|FG002|Overall Study|Adverse Event|5|||
143000984|NCT03911401|515539917|FG000|Overall Study|Lack of Efficacy|1|||
143000985|NCT03911401|515539918|FG001|Overall Study|Lack of Efficacy|1|||
143000986|NCT03911401|515539919|FG002|Overall Study|Lack of Efficacy|8|||
143000987|NCT03911401|515539917|FG000|Overall Study|Physician Decision|0|||
143000988|NCT03911401|515539918|FG001|Overall Study|Physician Decision|0|||
143000989|NCT03911401|515539919|FG002|Overall Study|Physician Decision|1|||
143000990|NCT03911401|515539917|FG000|Overall Study|Withdrawal by Subject|1|||
143000991|NCT03911401|515539918|FG001|Overall Study|Withdrawal by Subject|2|||
143000992|NCT03911401|515539919|FG002|Overall Study|Withdrawal by Subject|0|||
143000993|NCT03911401|515539917|FG000|Overall Study|Withdrawal by parent/guardian|4|||
143000994|NCT03911401|515539918|FG001|Overall Study|Withdrawal by parent/guardian|4|||
143000995|NCT03911401|515539919|FG002|Overall Study|Withdrawal by parent/guardian|11|||
143000996|NCT06104423|515539920|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|3|||
143000997|NCT06104423|515539921|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|6|||
143000998|NCT06104423|515539922|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|0|||
143000999|NCT06104423|515539920|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
143001000|NCT06104423|515539921|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
143001001|NCT06104423|515539922|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|0|||
143001002|NCT02918968|515539923|FG000|1st Line AAT|Progressive disease|9|||
143001003|NCT02918968|515539924|FG001|1st Line AAT|Progressive disease|4|||
143001004|NCT02918968|515539923|FG000|1st Line AAT|Adverse Event|12|||
143001005|NCT02918968|515539924|FG001|1st Line AAT|Adverse Event|3|||
143001006|NCT02918968|515539923|FG000|1st Line AAT|Physician Decision|4|||
143001007|NCT02918968|515539924|FG001|1st Line AAT|Physician Decision|2|||
143001008|NCT02918968|515539923|FG000|1st Line AAT|Withdrawal by Subject|2|||
143001009|NCT02918968|515539924|FG001|1st Line AAT|Withdrawal by Subject|1|||
143001010|NCT02918968|515539923|FG000|1st Line AAT|Lost to Follow-up|0|||
143001011|NCT02918968|515539924|FG001|1st Line AAT|Lost to Follow-up|1|||
143001012|NCT02918968|515539923|FG000|1st Line AAT|Death|1|||
143001013|NCT02918968|515539924|FG001|1st Line AAT|Death|0|||
143001014|NCT02918968|515539923|FG000|1st Line AAT|Miscellaneous|1|||
143001015|NCT02918968|515539924|FG001|1st Line AAT|Miscellaneous|0|||
143001016|NCT02918968|515539923|FG000|2nd Line AAT|Progressive disease|21|||
143001017|NCT02918968|515539924|FG001|2nd Line AAT|Progressive disease|3|||
143001018|NCT02918968|515539923|FG000|2nd Line AAT|Adverse Event|2|||
143001019|NCT02918968|515539924|FG001|2nd Line AAT|Adverse Event|5|||
143001020|NCT02918968|515539923|FG000|2nd Line AAT|Physician Decision|0|||
143001021|NCT02918968|515539924|FG001|2nd Line AAT|Physician Decision|1|||
143001022|NCT02918968|515539923|FG000|2nd Line AAT|Withdrawal by Subject|2|||
143001023|NCT02918968|515539924|FG001|2nd Line AAT|Withdrawal by Subject|2|||
143001024|NCT02918968|515539923|FG000|2nd Line AAT|Death|0|||
143001025|NCT02918968|515539924|FG001|2nd Line AAT|Death|1|||
143001026|NCT02046993|515539925|FG000|Overall Study|Withdrawal by Subject|2|||
143001027|NCT02046993|515539926|FG001|Overall Study|Withdrawal by Subject|10|||
143001028|NCT02046993|515539925|FG000|Overall Study|Lost to Follow-up|1|||
143001029|NCT02046993|515539926|FG001|Overall Study|Lost to Follow-up|1|||
143001030|NCT00851721|515539929|FG000|Overall Study|planned surgery|1|||
143001031|NCT00851721|515539930|FG001|Overall Study|planned surgery|0|||
143001032|NCT00851721|515539929|FG000|Overall Study|Death|1|||
143001033|NCT00851721|515539930|FG001|Overall Study|Death|0|||
143001034|NCT00851721|515539929|FG000|Overall Study|Adverse Event|0|||
143001035|NCT00851721|515539930|FG001|Overall Study|Adverse Event|1|||
143001036|NCT03604159|515539931|FG000|Overall Study|Lost to Follow-up|6|||
143001037|NCT03604159|515539932|FG001|Overall Study|Lost to Follow-up|7|||
143001038|NCT01005875|515539935|FG000|Overall Study|Death|3|||
143001039|NCT01348828|515539945|FG000|Overall Study|Death|20|||
143001040|NCT01348828|515539945|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
143001041|NCT01348828|515539945|FG000|Overall Study|Conversion|2|||
143001042|NCT01348828|515539945|FG000|Overall Study|missed visit|1|||
143001043|NCT02815670|515539946|FG000|Overall Study|Prematurely discontinued of the trial|1|||
143001044|NCT00842829|515539950|FG000|Dose Titration Period|Adverse Event|11|||
143001045|NCT00842829|515539951|FG001|Dose Titration Period|Adverse Event|10|||
143001046|NCT00842829|515539952|FG002|Dose Titration Period|Adverse Event|0|||
143001047|NCT00842829|515539950|FG000|Dose Titration Period|Lack of Efficacy|4|||
143001048|NCT00842829|515539951|FG001|Dose Titration Period|Lack of Efficacy|1|||
143001049|NCT00842829|515539952|FG002|Dose Titration Period|Lack of Efficacy|0|||
143001050|NCT00842829|515539950|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
143001051|NCT00842829|515539951|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
143001052|NCT00842829|515539952|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
143001053|NCT00842829|515539950|FG000|Dose Titration Period|Withdrawal by Subject|2|||
143001054|NCT00842829|515539951|FG001|Dose Titration Period|Withdrawal by Subject|6|||
143001055|NCT00842829|515539952|FG002|Dose Titration Period|Withdrawal by Subject|0|||
143001056|NCT00842829|515539950|FG000|Dose Titration Period|Other|5|||
143001057|NCT00842829|515539951|FG001|Dose Titration Period|Other|4|||
143001058|NCT00842829|515539952|FG002|Dose Titration Period|Other|0|||
143001059|NCT00842829|515539950|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
143001060|NCT00842829|515539951|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
143001061|NCT00842829|515539952|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
143001062|NCT00842829|515539950|FG000|Dose Titration Period|Non-compliance to study drug|2|||
143001063|NCT00842829|515539951|FG001|Dose Titration Period|Non-compliance to study drug|1|||
143001064|NCT00842829|515539952|FG002|Dose Titration Period|Non-compliance to study drug|0|||
143001065|NCT00842829|515539950|FG000|Treatment Period|Adverse Event|0|||
143001066|NCT00842829|515539951|FG001|Treatment Period|Adverse Event|0|||
143001067|NCT00842829|515539952|FG002|Treatment Period|Adverse Event|15|||
143001068|NCT00842829|515539950|FG000|Treatment Period|Lack of Efficacy|0|||
143001069|NCT00842829|515539951|FG001|Treatment Period|Lack of Efficacy|0|||
143001070|NCT00842829|515539952|FG002|Treatment Period|Lack of Efficacy|6|||
143001071|NCT00842829|515539950|FG000|Treatment Period|Unstable persistent cancer pain|0|||
143001072|NCT00842829|515539951|FG001|Treatment Period|Unstable persistent cancer pain|0|||
143001073|NCT00842829|515539952|FG002|Treatment Period|Unstable persistent cancer pain|5|||
143001074|NCT00842829|515539950|FG000|Treatment Period|Withdrawal by Subject|0|||
143001075|NCT00842829|515539951|FG001|Treatment Period|Withdrawal by Subject|0|||
143001076|NCT00842829|515539952|FG002|Treatment Period|Withdrawal by Subject|11|||
143001077|NCT00842829|515539950|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
143001078|NCT00842829|515539951|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
143001079|NCT00842829|515539952|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
143001080|NCT00842829|515539950|FG000|Treatment Period|Protocol Violation|0|||
143001081|NCT00842829|515539951|FG001|Treatment Period|Protocol Violation|0|||
143001082|NCT00842829|515539952|FG002|Treatment Period|Protocol Violation|2|||
143001083|NCT00842829|515539950|FG000|Treatment Period|Other|0|||
143001084|NCT00842829|515539951|FG001|Treatment Period|Other|0|||
143001085|NCT00842829|515539952|FG002|Treatment Period|Other|18|||
143001086|NCT00842829|515539950|FG000|Treatment Period|Non-compliance to study procedures|0|||
143001087|NCT00842829|515539951|FG001|Treatment Period|Non-compliance to study procedures|0|||
143001088|NCT00842829|515539952|FG002|Treatment Period|Non-compliance to study procedures|4|||
143001089|NCT00842829|515539950|FG000|Treatment Period|Unclear completion status|0|||
143001090|NCT00842829|515539951|FG001|Treatment Period|Unclear completion status|0|||
143001091|NCT00842829|515539952|FG002|Treatment Period|Unclear completion status|1|||
143001092|NCT00842829|515539950|FG000|Continuation Period|Adverse Event|0|||
143001093|NCT00842829|515539951|FG001|Continuation Period|Adverse Event|0|||
143001094|NCT00842829|515539952|FG002|Continuation Period|Adverse Event|32|||
143001095|NCT00842829|515539950|FG000|Continuation Period|Lack of Efficacy|0|||
143001096|NCT00842829|515539951|FG001|Continuation Period|Lack of Efficacy|0|||
143001097|NCT00842829|515539952|FG002|Continuation Period|Lack of Efficacy|6|||
143001098|NCT00842829|515539950|FG000|Continuation Period|Unstable persistent cancer pain|0|||
143001099|NCT00842829|515539951|FG001|Continuation Period|Unstable persistent cancer pain|0|||
143001100|NCT00842829|515539952|FG002|Continuation Period|Unstable persistent cancer pain|3|||
143001101|NCT00842829|515539950|FG000|Continuation Period|Withdrawal by Subject|0|||
143001102|NCT00842829|515539951|FG001|Continuation Period|Withdrawal by Subject|0|||
143001103|NCT00842829|515539952|FG002|Continuation Period|Withdrawal by Subject|10|||
143001104|NCT00842829|515539950|FG000|Continuation Period|Other|0|||
143001105|NCT00842829|515539951|FG001|Continuation Period|Other|0|||
143001106|NCT00842829|515539952|FG002|Continuation Period|Other|7|||
143001107|NCT00842829|515539950|FG000|Continuation Period|Non-compliance to study procedures|0|||
143001108|NCT00842829|515539951|FG001|Continuation Period|Non-compliance to study procedures|0|||
143001109|NCT00842829|515539952|FG002|Continuation Period|Non-compliance to study procedures|2|||
143001110|NCT00842829|515539950|FG000|Continuation Period|Non-compliance to study drug|0|||
143001111|NCT00842829|515539951|FG001|Continuation Period|Non-compliance to study drug|0|||
143001112|NCT00842829|515539952|FG002|Continuation Period|Non-compliance to study drug|1|||
143001113|NCT00660829|515539955|FG000|Overall Study|Adverse Event|3|||
143001114|NCT00660829|515539956|FG001|Overall Study|Adverse Event|4|||
143001115|NCT00660829|515539955|FG000|Overall Study|Lack of Efficacy|2|||
143001116|NCT00660829|515539956|FG001|Overall Study|Lack of Efficacy|3|||
143001117|NCT00660829|515539955|FG000|Overall Study|Non-Compliance|0|||
143001118|NCT00660829|515539956|FG001|Overall Study|Non-Compliance|4|||
143001119|NCT00660829|515539955|FG000|Overall Study|Withdrawal by Subject|1|||
143001120|NCT00660829|515539956|FG001|Overall Study|Withdrawal by Subject|2|||
143001121|NCT00660829|515539955|FG000|Overall Study|Lost to Follow-up|3|||
143001122|NCT00660829|515539956|FG001|Overall Study|Lost to Follow-up|2|||
143001123|NCT00660829|515539955|FG000|Overall Study|Other|9|||
143001124|NCT00660829|515539956|FG001|Overall Study|Other|4|||
143001125|NCT03590613|515539957|FG000|Period 2, 4 Days|Physician Decision|0|||
143001126|NCT03590613|515539958|FG001|Period 2, 4 Days|Physician Decision|0|||
143001127|NCT03590613|515539959|FG002|Period 2, 4 Days|Physician Decision|0|||
143001128|NCT03590613|515539960|FG003|Period 2, 4 Days|Physician Decision|1|||
143001129|NCT04369742|515539961|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
143001130|NCT04369742|515539962|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
143001131|NCT04369742|515539961|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
143001132|NCT04369742|515539962|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
143001133|NCT00280059|515539963|FG000|Efficacy Assessment Phase|Death|2|||
143001134|NCT00280059|515539964|FG001|Efficacy Assessment Phase|Death|0|||
143001135|NCT00280059|515539963|FG000|Efficacy Assessment Phase|Adverse Event|33|||
143001136|NCT00280059|515539964|FG001|Efficacy Assessment Phase|Adverse Event|31|||
143001137|NCT00280059|515539963|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
143001138|NCT00280059|515539964|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
143001139|NCT00280059|515539963|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
143001140|NCT00280059|515539964|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
143001141|NCT00280059|515539963|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
143001142|NCT00280059|515539964|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
143001143|NCT00280059|515539963|FG000|Efficacy Assessment Phase|Other|7|||
143001144|NCT00280059|515539964|FG001|Efficacy Assessment Phase|Other|8|||
143001145|NCT00280059|515539963|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
143001146|NCT00280059|515539964|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
143455749|NCT02559895|517212521|FG001|Overall Study|Lost to Follow-up|16|||
143455750|NCT02559895|517212522|FG002|Overall Study|Lost to Follow-up|12|||
143455751|NCT02559895|517212523|FG003|Overall Study|Lost to Follow-up|17|||
143455752|NCT02559895|517212520|FG000|Overall Study|Physician Decision|1|||
143455753|NCT02559895|517212521|FG001|Overall Study|Physician Decision|1|||
143455754|NCT02559895|517212522|FG002|Overall Study|Physician Decision|3|||
143455755|NCT02559895|517212523|FG003|Overall Study|Physician Decision|0|||
143455756|NCT02559895|517212520|FG000|Overall Study|Withdrawal by Subject|16|||
143001147|NCT02127931|515539967|FG000|Overall Study|Glitch in Game|1|||
143001148|NCT01130831|515539968|FG000|Overall Study|Withdrawal by Subject|7|||
143001149|NCT01130831|515539968|FG000|Overall Study|Death|4|||
143001150|NCT01130831|515539968|FG000|Overall Study|Information was missing|3|||
143001151|NCT00951912|515539969|FG000|Overall Study|Lack of Efficacy|1|||
143001152|NCT00951912|515539970|FG001|Overall Study|Lack of Efficacy|0|||
143001153|NCT00951912|515539971|FG002|Overall Study|Lack of Efficacy|0|||
143001154|NCT00951912|515539969|FG000|Overall Study|Adverse Event|0|||
143001155|NCT00951912|515539970|FG001|Overall Study|Adverse Event|1|||
143001156|NCT00951912|515539971|FG002|Overall Study|Adverse Event|1|||
143001157|NCT00951912|515539969|FG000|Overall Study|Lost to Follow-up|2|||
143001158|NCT00951912|515539970|FG001|Overall Study|Lost to Follow-up|2|||
143001159|NCT00951912|515539971|FG002|Overall Study|Lost to Follow-up|0|||
143001160|NCT00951912|515539969|FG000|Overall Study|Physician Decision|1|||
143001161|NCT00951912|515539970|FG001|Overall Study|Physician Decision|0|||
143001162|NCT00951912|515539971|FG002|Overall Study|Physician Decision|1|||
143001163|NCT00951912|515539969|FG000|Overall Study|Withdrawal by Subject|1|||
143001164|NCT00951912|515539970|FG001|Overall Study|Withdrawal by Subject|1|||
143001165|NCT00951912|515539971|FG002|Overall Study|Withdrawal by Subject|0|||
143001166|NCT00951912|515539969|FG000|Overall Study|Other:Depression|1|||
143455757|NCT02559895|517212521|FG001|Overall Study|Withdrawal by Subject|9|||
143001167|NCT00951912|515539970|FG001|Overall Study|Other:Depression|0|||
143001168|NCT00951912|515539971|FG002|Overall Study|Other:Depression|0|||
143001169|NCT00951912|515539969|FG000|Overall Study|Other: Colon cancer|1|||
143001170|NCT00951912|515539970|FG001|Overall Study|Other: Colon cancer|0|||
143001171|NCT00951912|515539971|FG002|Overall Study|Other: Colon cancer|0|||
143001172|NCT00951912|515539969|FG000|Overall Study|Other: Stroke|0|||
143001173|NCT00951912|515539970|FG001|Overall Study|Other: Stroke|1|||
143001174|NCT00951912|515539971|FG002|Overall Study|Other: Stroke|0|||
143001175|NCT01377194|515539972|FG000|Overall Study|Adverse Event|3|||
143001176|NCT01377194|515539973|FG001|Overall Study|Adverse Event|12|||
143001177|NCT01377194|515539974|FG002|Overall Study|Adverse Event|19|||
143455758|NCT02559895|517212522|FG002|Overall Study|Withdrawal by Subject|20|||
143001178|NCT01377194|515539972|FG000|Overall Study|Lack of Efficacy|3|||
143001179|NCT01377194|515539973|FG001|Overall Study|Lack of Efficacy|3|||
143001180|NCT01377194|515539974|FG002|Overall Study|Lack of Efficacy|3|||
143001181|NCT01377194|515539972|FG000|Overall Study|Protocol Violation|4|||
143001182|NCT01377194|515539973|FG001|Overall Study|Protocol Violation|10|||
143001183|NCT01377194|515539974|FG002|Overall Study|Protocol Violation|6|||
143001184|NCT01377194|515539972|FG000|Overall Study|Withdrawal by Subject|8|||
143001185|NCT01377194|515539973|FG001|Overall Study|Withdrawal by Subject|10|||
143001186|NCT01377194|515539974|FG002|Overall Study|Withdrawal by Subject|7|||
143001187|NCT01377194|515539972|FG000|Overall Study|Lost to Follow-up|14|||
143001188|NCT01377194|515539973|FG001|Overall Study|Lost to Follow-up|8|||
143001189|NCT01377194|515539974|FG002|Overall Study|Lost to Follow-up|11|||
143001190|NCT01728454|515539975|FG000|Stage 1 and 2|Pregnancy|1|||
143001191|NCT01728454|515539976|FG001|Stage 1 and 2|Pregnancy|0|||
143001192|NCT01728454|515539977|FG002|Stage 1 and 2|Pregnancy|0|||
143001193|NCT01728454|515539975|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
143001194|NCT01728454|515539976|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
143001195|NCT01728454|515539977|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
143001196|NCT01728454|515539975|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
143001197|NCT01728454|515539976|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
143001198|NCT01728454|515539977|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
143001199|NCT01728454|515539975|FG000|Stage 1 and 2|Lost to Follow-up|1|||
143001200|NCT01728454|515539976|FG001|Stage 1 and 2|Lost to Follow-up|1|||
143001201|NCT01728454|515539977|FG002|Stage 1 and 2|Lost to Follow-up|0|||
143001202|NCT01728454|515539975|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
143001203|NCT01728454|515539976|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
143001204|NCT01728454|515539977|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
143001205|NCT01728454|515539975|FG000|Stage 3|Reason Missing|0|||
143001206|NCT01728454|515539976|FG001|Stage 3|Reason Missing|0|||
143001207|NCT01728454|515539977|FG002|Stage 3|Reason Missing|1|||
143001208|NCT01728454|515539975|FG000|Stage 3|Subject Required Other Treatment|0|||
143001209|NCT01728454|515539976|FG001|Stage 3|Subject Required Other Treatment|1|||
143455759|NCT02559895|517212523|FG003|Overall Study|Withdrawal by Subject|9|||
143455760|NCT02559895|517212520|FG000|Overall Study|Study Burden|10|||
143455761|NCT02559895|517212521|FG001|Overall Study|Study Burden|16|||
143455762|NCT02559895|517212522|FG002|Overall Study|Study Burden|12|||
143455763|NCT02559895|517212523|FG003|Overall Study|Study Burden|22|||
143455764|NCT02559895|517212520|FG000|Overall Study|Other|1|||
143455765|NCT02559895|517212521|FG001|Overall Study|Other|5|||
143455766|NCT02559895|517212522|FG002|Overall Study|Other|3|||
143455767|NCT02559895|517212523|FG003|Overall Study|Other|3|||
143455768|NCT00320528|517212527|FG000|Study Period II|Adverse Event|3|||
143455769|NCT00320528|517212528|FG001|Study Period II|Adverse Event|4|||
143455770|NCT00320528|517212529|FG002|Study Period II|Adverse Event|8|||
143455771|NCT00320528|517212527|FG000|Study Period II|Parent/Caregiver Decision|8|||
143455772|NCT00320528|517212528|FG001|Study Period II|Parent/Caregiver Decision|3|||
143455773|NCT00320528|517212529|FG002|Study Period II|Parent/Caregiver Decision|11|||
143455774|NCT00320528|517212527|FG000|Study Period II|Withdrawal by Subject|0|||
143455775|NCT00320528|517212528|FG001|Study Period II|Withdrawal by Subject|1|||
143455776|NCT00320528|517212529|FG002|Study Period II|Withdrawal by Subject|1|||
143455777|NCT00320528|517212527|FG000|Study Period II|Entry Criteria Exclusion|0|||
143455778|NCT00320528|517212528|FG001|Study Period II|Entry Criteria Exclusion|2|||
143455779|NCT00320528|517212529|FG002|Study Period II|Entry Criteria Exclusion|2|||
143455780|NCT00320528|517212527|FG000|Study Period III|Adverse Event|1|||
143455781|NCT00320528|517212528|FG001|Study Period III|Adverse Event|0|||
143455782|NCT00320528|517212529|FG002|Study Period III|Adverse Event|0|||
143455783|NCT00320528|517212527|FG000|Study Period III|Lost to Follow-up|1|||
143455784|NCT00320528|517212528|FG001|Study Period III|Lost to Follow-up|0|||
143455785|NCT00320528|517212529|FG002|Study Period III|Lost to Follow-up|0|||
143455786|NCT00320528|517212527|FG000|Study Period III|Withdrawal by Subject|1|||
143455787|NCT00320528|517212528|FG001|Study Period III|Withdrawal by Subject|1|||
143455788|NCT00320528|517212529|FG002|Study Period III|Withdrawal by Subject|2|||
143455789|NCT00320528|517212527|FG000|Study Period III|Lack of Efficacy|2|||
143455790|NCT00320528|517212528|FG001|Study Period III|Lack of Efficacy|0|||
143455791|NCT00320528|517212529|FG002|Study Period III|Lack of Efficacy|0|||
143455792|NCT00320528|517212527|FG000|Study Period III|Parent/Caregiver Decision|14|||
143455793|NCT00320528|517212528|FG001|Study Period III|Parent/Caregiver Decision|3|||
143455794|NCT00320528|517212529|FG002|Study Period III|Parent/Caregiver Decision|11|||
143455795|NCT00320528|517212527|FG000|Study Period III|Protocol Violation|0|||
143455796|NCT00320528|517212528|FG001|Study Period III|Protocol Violation|1|||
143455797|NCT00320528|517212529|FG002|Study Period III|Protocol Violation|0|||
143001210|NCT01728454|515539977|FG002|Stage 3|Subject Required Other Treatment|0|||
143001211|NCT01728454|515539975|FG000|Stage 3|Pregnancy|1|||
143001212|NCT01728454|515539976|FG001|Stage 3|Pregnancy|0|||
143001213|NCT01728454|515539977|FG002|Stage 3|Pregnancy|0|||
143001214|NCT01728454|515539975|FG000|Stage 3|Withdrew Consent|1|||
143001215|NCT01728454|515539976|FG001|Stage 3|Withdrew Consent|0|||
143455798|NCT00320528|517212527|FG000|Study Period III|Physician Decision|0|||
143455799|NCT00320528|517212528|FG001|Study Period III|Physician Decision|1|||
143455800|NCT00320528|517212529|FG002|Study Period III|Physician Decision|2|||
143455801|NCT00320528|517212527|FG000|Study Period III|Sponsor Decision|0|||
143001216|NCT01728454|515539977|FG002|Stage 3|Withdrew Consent|1|||
143001217|NCT01728454|515539975|FG000|Stage 3|Non-compliance with Protocol|0|||
143001218|NCT01728454|515539976|FG001|Stage 3|Non-compliance with Protocol|0|||
143001219|NCT01728454|515539977|FG002|Stage 3|Non-compliance with Protocol|1|||
143001220|NCT01728454|515539975|FG000|Stage 3|Lost to Follow-up|0|||
143001221|NCT01728454|515539976|FG001|Stage 3|Lost to Follow-up|3|||
143001222|NCT01728454|515539977|FG002|Stage 3|Lost to Follow-up|1|||
143001223|NCT01728454|515539975|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
143001224|NCT01728454|515539976|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
143001225|NCT01728454|515539977|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
143001226|NCT01190839|515539980|FG000|Overall Study|Adverse Event|32|||
143001227|NCT01190839|515539981|FG001|Overall Study|Adverse Event|41|||
143001228|NCT01190839|515539980|FG000|Overall Study|Protocol Violation|2|||
143001229|NCT01190839|515539981|FG001|Overall Study|Protocol Violation|2|||
143001230|NCT01190839|515539980|FG000|Overall Study|Lost to Follow-up|7|||
143001231|NCT01190839|515539981|FG001|Overall Study|Lost to Follow-up|1|||
143001232|NCT01190839|515539980|FG000|Overall Study|Death|1|||
143001233|NCT01190839|515539981|FG001|Overall Study|Death|0|||
143001234|NCT01190839|515539980|FG000|Overall Study|Trial stopped by Sponsor|71|||
143001235|NCT01190839|515539981|FG001|Overall Study|Trial stopped by Sponsor|68|||
143001236|NCT01190839|515539980|FG000|Overall Study|Undefined|35|||
143001237|NCT01190839|515539981|FG001|Overall Study|Undefined|31|||
143001238|NCT01190839|515539980|FG000|Overall Study|Randomized but not treated|2|||
143001239|NCT01190839|515539981|FG001|Overall Study|Randomized but not treated|4|||
143001240|NCT01265511|515539986|FG000|Overall Study|Lack of Efficacy|2|||
143001241|NCT01265511|515539987|FG001|Overall Study|Lack of Efficacy|1|||
143001242|NCT01265511|515539986|FG000|Overall Study|Met stopping rules|0|||
143001243|NCT01265511|515539987|FG001|Overall Study|Met stopping rules|2|||
143001244|NCT00323479|515539990|FG000|Overall Study|Adverse Event|2|||
143001245|NCT00323479|515539990|FG000|Overall Study|Withdrawal by Subject|2|||
143001246|NCT00323479|515539990|FG000|Overall Study|Protocol Violation|3|||
143001247|NCT00323479|515539990|FG000|Overall Study|house moving|1|||
143001248|NCT01362062|515539991|FG000|Overall Study|Adverse Event|1|||
143001249|NCT01362062|515539992|FG001|Overall Study|Adverse Event|0|||
143001250|NCT01362062|515539991|FG000|Overall Study|Lost to Follow-up|11|||
143001251|NCT01362062|515539992|FG001|Overall Study|Lost to Follow-up|0|||
143001252|NCT01362062|515539991|FG000|Overall Study|Withdrawal by Subject|2|||
143001253|NCT01362062|515539992|FG001|Overall Study|Withdrawal by Subject|0|||
143001254|NCT01362062|515539991|FG000|Overall Study|Non-compliant participant|2|||
143001255|NCT01362062|515539992|FG001|Overall Study|Non-compliant participant|0|||
143001256|NCT01362062|515539991|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
143001257|NCT01362062|515539992|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
143001258|NCT01362062|515539991|FG000|Overall Study|Had significant improvement|9|||
143001259|NCT01362062|515539992|FG001|Overall Study|Had significant improvement|0|||
143001260|NCT02545504|515539993|FG000|Overall Study|Death|174|||
143001261|NCT02545504|515539994|FG001|Overall Study|Death|168|||
143001262|NCT02545504|515539993|FG000|Overall Study|Unknown reason|30|||
143001263|NCT02545504|515539994|FG001|Overall Study|Unknown reason|32|||
143001264|NCT02545504|515539993|FG000|Overall Study|Withdrew consent|9|||
143001265|NCT02545504|515539994|FG001|Overall Study|Withdrew consent|11|||
143001266|NCT02545504|515539993|FG000|Overall Study|Investigator's discretion|3|||
143001267|NCT02545504|515539994|FG001|Overall Study|Investigator's discretion|1|||
143001268|NCT02545504|515539993|FG000|Overall Study|Lost to Follow-up|2|||
143001269|NCT02545504|515539994|FG001|Overall Study|Lost to Follow-up|2|||
143001270|NCT00967343|515539996|FG000|Overall Study|Study termination by sponsor|12|||
143001271|NCT00967343|515539996|FG000|Overall Study|Death|24|||
143001272|NCT00967343|515539996|FG000|Overall Study|Relapse|1|||
143001273|NCT00967343|515539996|FG000|Overall Study|Lost to Follow-up|1|||
143001274|NCT03044730|515539998|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
143001275|NCT03044730|515539998|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
143001276|NCT03044730|515539998|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
143001277|NCT03044730|515539998|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
143001278|NCT03044730|515539998|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
143001279|NCT03044730|515539998|FG000|Cycles 4 and Beyond|Adverse Event|1|||
143001280|NCT03044730|515539998|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
143001281|NCT03044730|515539998|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
143001282|NCT03044730|515539998|FG000|On Follow-up for 2 Years|Death|17|||
143001283|NCT00950755|515539999|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
143001284|NCT00950755|515539999|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
143001285|NCT00950755|515539999|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
143001286|NCT00950755|515539999|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
143001287|NCT00950755|515539999|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
143003195|NCT01049360|515548747|FG003|Period 4|Protocol Violation|0|||
143455802|NCT00320528|517212528|FG001|Study Period III|Sponsor Decision|0|||
143001288|NCT00950755|515539999|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
143001289|NCT00950755|515539999|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
143001290|NCT00950755|515539999|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
143001291|NCT00950755|515539999|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
143001292|NCT00950755|515539999|FG000|Long-Term Follow-Up|Death|8|||
143001293|NCT00508820|515540001|FG000|Overall Study|Adverse Event|6|||
143001294|NCT00508820|515540002|FG001|Overall Study|Adverse Event|10|||
143001295|NCT00508820|515540001|FG000|Overall Study|Death|6|||
143001296|NCT00508820|515540002|FG001|Overall Study|Death|8|||
143001297|NCT00508820|515540001|FG000|Overall Study|Lost to Follow-up|1|||
143001298|NCT00508820|515540002|FG001|Overall Study|Lost to Follow-up|1|||
143001299|NCT00508820|515540001|FG000|Overall Study|Physician Decision|8|||
143001300|NCT00508820|515540002|FG001|Overall Study|Physician Decision|2|||
143001301|NCT00508820|515540001|FG000|Overall Study|Pregnancy|0|||
143001302|NCT00508820|515540002|FG001|Overall Study|Pregnancy|2|||
143001303|NCT00508820|515540001|FG000|Overall Study|Protocol Violation|2|||
143001304|NCT00508820|515540002|FG001|Overall Study|Protocol Violation|0|||
143001305|NCT00508820|515540001|FG000|Overall Study|Withdrawal by Subject|10|||
143001306|NCT00508820|515540002|FG001|Overall Study|Withdrawal by Subject|12|||
143001307|NCT00508820|515540001|FG000|Overall Study|Other|11|||
143001308|NCT00508820|515540002|FG001|Overall Study|Other|2|||
143001309|NCT00508820|515540001|FG000|Overall Study|Noncompliance|1|||
143001310|NCT00508820|515540002|FG001|Overall Study|Noncompliance|0|||
143001311|NCT00508820|515540001|FG000|Overall Study|Requirement for alternative therapy|7|||
143001312|NCT00508820|515540002|FG001|Overall Study|Requirement for alternative therapy|15|||
143001313|NCT00508820|515540001|FG000|Overall Study|Protocol-specified Criteria|3|||
143001314|NCT00508820|515540002|FG001|Overall Study|Protocol-specified Criteria|12|||
143001315|NCT01002573|515542074|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
143001316|NCT01002573|515542075|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
143001317|NCT00690612|515542081|FG000|Overall Study|Adverse Event|1|||
143001318|NCT00690612|515542081|FG000|Overall Study|Withdrawal by Subject|2|||
143001319|NCT02926833|515542082|FG000|Overall Study|Death|1|||
143001320|NCT02926833|515542083|FG001|Overall Study|Death|1|||
143001321|NCT02926833|515542084|FG002|Overall Study|Death|2|||
143001322|NCT02926833|515542085|FG003|Overall Study|Death|13|||
143001323|NCT02926833|515542082|FG000|Overall Study|Lost to Follow-up|1|||
143001324|NCT02926833|515542083|FG001|Overall Study|Lost to Follow-up|2|||
143001325|NCT02926833|515542084|FG002|Overall Study|Lost to Follow-up|0|||
143001326|NCT02926833|515542085|FG003|Overall Study|Lost to Follow-up|3|||
143001327|NCT02926833|515542082|FG000|Overall Study|Full Consent Withdrawal|0|||
143001328|NCT02926833|515542083|FG001|Overall Study|Full Consent Withdrawal|0|||
143001329|NCT02926833|515542084|FG002|Overall Study|Full Consent Withdrawal|0|||
143001330|NCT02926833|515542085|FG003|Overall Study|Full Consent Withdrawal|2|||
143001331|NCT02926833|515542082|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
143001332|NCT02926833|515542083|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
143001333|NCT02926833|515542084|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
143001334|NCT02926833|515542085|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
143001335|NCT02926833|515542082|FG000|Overall Study|Investigator Decision|0|||
143001336|NCT02926833|515542083|FG001|Overall Study|Investigator Decision|1|||
143001337|NCT02926833|515542084|FG002|Overall Study|Investigator Decision|0|||
143001338|NCT02926833|515542085|FG003|Overall Study|Investigator Decision|0|||
143001339|NCT02926833|515542082|FG000|Overall Study|Adverse Event|0|||
143001340|NCT02926833|515542083|FG001|Overall Study|Adverse Event|0|||
143001341|NCT02926833|515542084|FG002|Overall Study|Adverse Event|1|||
143001342|NCT02926833|515542085|FG003|Overall Study|Adverse Event|0|||
143001343|NCT02926833|515542082|FG000|Overall Study|Partial Withdrawal of Consent|0|||
143001344|NCT02926833|515542083|FG001|Overall Study|Partial Withdrawal of Consent|0|||
143001345|NCT02926833|515542084|FG002|Overall Study|Partial Withdrawal of Consent|0|||
143001346|NCT02926833|515542085|FG003|Overall Study|Partial Withdrawal of Consent|1|||
143001347|NCT01945866|515542086|FG000|Overall Study|Eyes did not complete or were dropped|2|||
143001348|NCT01945866|515542087|FG001|Overall Study|Eyes did not complete or were dropped|0|||
143001349|NCT02946515|515542090|FG000|Overall Study|Lost to Follow-up|2|||
143001350|NCT02946515|515542091|FG001|Overall Study|Lost to Follow-up|1|||
143001351|NCT02600559|515542094|FG000|Overall Study|Withdrawal by Subject|3|||
143001352|NCT02600559|515542094|FG000|Overall Study|Lost to Follow-up|20|||
143001353|NCT00379639|515542103|FG000|Overall Study|Disease Progression|3|||
143001354|NCT00379639|515542104|FG001|Overall Study|Disease Progression|3|||
143001355|NCT00379639|515542105|FG002|Overall Study|Disease Progression|3|||
143001356|NCT00379639|515542106|FG003|Overall Study|Disease Progression|4|||
143001357|NCT00379639|515542107|FG004|Overall Study|Disease Progression|4|||
143001358|NCT00379639|515542103|FG000|Overall Study|Physician Decision|0|||
143001359|NCT00379639|515542104|FG001|Overall Study|Physician Decision|2|||
143001360|NCT00379639|515542105|FG002|Overall Study|Physician Decision|1|||
143001361|NCT00379639|515542106|FG003|Overall Study|Physician Decision|1|||
143001362|NCT00379639|515542107|FG004|Overall Study|Physician Decision|0|||
143001363|NCT00379639|515542103|FG000|Overall Study|Symptomatic Deterioration|0|||
143001364|NCT00379639|515542104|FG001|Overall Study|Symptomatic Deterioration|0|||
143001365|NCT00379639|515542105|FG002|Overall Study|Symptomatic Deterioration|1|||
143001366|NCT00379639|515542106|FG003|Overall Study|Symptomatic Deterioration|0|||
143001367|NCT00379639|515542107|FG004|Overall Study|Symptomatic Deterioration|1|||
143001368|NCT00379639|515542103|FG000|Overall Study|Adverse Event|0|||
143001369|NCT00379639|515542104|FG001|Overall Study|Adverse Event|0|||
143001370|NCT00379639|515542105|FG002|Overall Study|Adverse Event|1|||
143001371|NCT00379639|515542106|FG003|Overall Study|Adverse Event|0|||
143001372|NCT00379639|515542107|FG004|Overall Study|Adverse Event|1|||
143001373|NCT00379639|515542103|FG000|Overall Study|Lost to Follow-up|0|||
143001374|NCT00379639|515542104|FG001|Overall Study|Lost to Follow-up|0|||
143001375|NCT00379639|515542105|FG002|Overall Study|Lost to Follow-up|0|||
143001376|NCT00379639|515542106|FG003|Overall Study|Lost to Follow-up|1|||
143001377|NCT00379639|515542107|FG004|Overall Study|Lost to Follow-up|0|||
143001378|NCT00379639|515542103|FG000|Overall Study|Other|0|||
143001379|NCT00379639|515542104|FG001|Overall Study|Other|0|||
143001380|NCT00379639|515542105|FG002|Overall Study|Other|3|||
143001381|NCT00379639|515542106|FG003|Overall Study|Other|0|||
143001382|NCT00379639|515542107|FG004|Overall Study|Other|0|||
143001383|NCT01928758|515542122|FG000|Overall Study|Lost to Follow-up|14|||
143001384|NCT01928758|515542123|FG001|Overall Study|Lost to Follow-up|9|||
143001385|NCT01928758|515542122|FG000|Overall Study|Withdrawal by Subject|5|||
143001386|NCT01928758|515542123|FG001|Overall Study|Withdrawal by Subject|2|||
143001387|NCT01928758|515542122|FG000|Overall Study|Adverse Event|3|||
143001388|NCT01928758|515542123|FG001|Overall Study|Adverse Event|5|||
143001389|NCT01928758|515542122|FG000|Overall Study|Protocol Violation|3|||
143001390|NCT01928758|515542123|FG001|Overall Study|Protocol Violation|4|||
143001391|NCT02718131|515542124|FG000|Overall Study|Withdrawal by Subject|1|||
143001392|NCT02718131|515542125|FG001|Overall Study|Withdrawal by Subject|0|||
143001393|NCT02718131|515542124|FG000|Overall Study|Adverse Event|1|||
143001394|NCT02718131|515542125|FG001|Overall Study|Adverse Event|0|||
143001395|NCT02718131|515542124|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
143001396|NCT02718131|515542125|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
143001397|NCT01097057|515542127|FG000|Overall Study|Physician Decision|3|||
143001398|NCT05602818|515542128|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
143001399|NCT05602818|515542129|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
143001400|NCT05602818|515542130|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
143001401|NCT05602818|515542131|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
143001402|NCT05602818|515542132|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
143001403|NCT05602818|515542133|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
143001404|NCT05602818|515542134|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
143001405|NCT05602818|515542135|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
143455803|NCT00320528|517212529|FG002|Study Period III|Sponsor Decision|1|||
143455804|NCT00320528|517212527|FG000|Study Period III|Atomoxetine Commercially Available|68|||
143455805|NCT00320528|517212528|FG001|Study Period III|Atomoxetine Commercially Available|25|||
143455806|NCT00320528|517212529|FG002|Study Period III|Atomoxetine Commercially Available|90|||
143455807|NCT00760474|517212537|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
143455808|NCT00760474|517212538|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
143455809|NCT00760474|517212537|FG000|Placebo Washout Period|Other|0|||
143455810|NCT00760474|517212538|FG001|Placebo Washout Period|Other|1|||
143455811|NCT00760474|517212537|FG000|Period 2 (P2)|Lost to Follow-up|1|||
143455812|NCT00760474|517212538|FG001|Period 2 (P2)|Lost to Follow-up|0|||
143455813|NCT00760474|517212537|FG000|Period 2 (P2)|Adverse Event|0|||
143455814|NCT00760474|517212538|FG001|Period 2 (P2)|Adverse Event|1|||
143001406|NCT05602818|515542136|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
143001407|NCT05602818|515542137|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
143001408|NCT05602818|515542138|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
143001409|NCT05602818|515542139|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
143001410|NCT05602818|515542128|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
143001411|NCT05602818|515542129|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
143001412|NCT05602818|515542130|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
143001413|NCT05602818|515542131|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
143001414|NCT05602818|515542132|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
143001415|NCT05602818|515542133|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
143001416|NCT05602818|515542134|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
143001417|NCT05602818|515542135|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
143001418|NCT05602818|515542136|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
143001419|NCT05602818|515542137|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
143001420|NCT05602818|515542138|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
143001421|NCT05602818|515542139|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
143001422|NCT05602818|515542128|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
143001423|NCT05602818|515542129|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
143001424|NCT05602818|515542130|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
143001425|NCT05602818|515542131|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
143001426|NCT05602818|515542132|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
143001427|NCT05602818|515542133|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
143001428|NCT05602818|515542134|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
143001429|NCT05602818|515542135|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
143001430|NCT05602818|515542136|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
143001431|NCT05602818|515542137|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
143001432|NCT05602818|515542138|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
143001433|NCT05602818|515542139|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
143001434|NCT05602818|515542128|FG000|Qualification Phase (3 Days)|Other|1|||
143001435|NCT05602818|515542129|FG001|Qualification Phase (3 Days)|Other|0|||
143001436|NCT05602818|515542130|FG002|Qualification Phase (3 Days)|Other|0|||
143001437|NCT05602818|515542131|FG003|Qualification Phase (3 Days)|Other|0|||
143001438|NCT05602818|515542132|FG004|Qualification Phase (3 Days)|Other|0|||
143001439|NCT05602818|515542133|FG005|Qualification Phase (3 Days)|Other|0|||
143001440|NCT05602818|515542134|FG006|Qualification Phase (3 Days)|Other|0|||
143001441|NCT05602818|515542135|FG007|Qualification Phase (3 Days)|Other|0|||
143001442|NCT05602818|515542136|FG008|Qualification Phase (3 Days)|Other|0|||
143001443|NCT05602818|515542137|FG009|Qualification Phase (3 Days)|Other|0|||
143001444|NCT05602818|515542138|FG010|Qualification Phase (3 Days)|Other|0|||
143001445|NCT05602818|515542139|FG011|Qualification Phase (3 Days)|Other|0|||
143001446|NCT05602818|515542128|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
143001447|NCT05602818|515542129|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
143001448|NCT05602818|515542130|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
143001449|NCT05602818|515542131|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
143455815|NCT04540887|517212539|FG000|Overall Study|Withdrawal by Subject|2|||
143455816|NCT00513305|517212540|FG000|Overall Study|Adverse Event|6|||
143455817|NCT00513305|517212541|FG001|Overall Study|Adverse Event|2|||
143455818|NCT00513305|517212540|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
143455819|NCT00513305|517212541|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
143455820|NCT00513305|517212540|FG000|Overall Study|Lack of Efficacy|8|||
143455821|NCT00513305|517212541|FG001|Overall Study|Lack of Efficacy|13|||
143455822|NCT00513305|517212540|FG000|Overall Study|Withdrawal by Subject|1|||
143455823|NCT00513305|517212541|FG001|Overall Study|Withdrawal by Subject|2|||
143455824|NCT00513305|517212540|FG000|Overall Study|Disease progression|8|||
143455825|NCT00513305|517212541|FG001|Overall Study|Disease progression|5|||
143455826|NCT00513305|517212540|FG000|Overall Study|Eligible for stem cell transplant|1|||
143455827|NCT00513305|517212541|FG001|Overall Study|Eligible for stem cell transplant|0|||
143455828|NCT00513305|517212540|FG000|Overall Study|Hematologic counts did not recover|1|||
143455829|NCT00513305|517212541|FG001|Overall Study|Hematologic counts did not recover|0|||
143455830|NCT00513305|517212540|FG000|Overall Study|Physician Decision|1|||
143455831|NCT00513305|517212541|FG001|Overall Study|Physician Decision|0|||
143455832|NCT00513305|517212540|FG000|Overall Study|Persistent hypocellularity|0|||
143455833|NCT00513305|517212541|FG001|Overall Study|Persistent hypocellularity|1|||
143455834|NCT00513305|517212540|FG000|Overall Study|Sponsor Decision|0|||
143455835|NCT00513305|517212541|FG001|Overall Study|Sponsor Decision|2|||
143455836|NCT01262027|517212542|FG000|Overall Study|Adverse Event|1|||
143455837|NCT01262027|517212542|FG000|Overall Study|Withdrawal by Subject|3|||
143455838|NCT01262027|517212542|FG000|Overall Study|Protocol Violation|1|||
143455839|NCT03014479|517212543|FG000|Overall Study|Adverse Event|0|||
143455840|NCT03014479|517212544|FG001|Overall Study|Adverse Event|1|||
143455841|NCT03014479|517212543|FG000|Overall Study|Voluntary Withdrawal|0|||
143455842|NCT03014479|517212544|FG001|Overall Study|Voluntary Withdrawal|2|||
143455843|NCT03014479|517212543|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
143455844|NCT03014479|517212544|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
143455845|NCT01394978|517212550|FG000|Overall Study|Withdrawal by Subject|2|||
143455846|NCT01394978|517212551|FG001|Overall Study|Withdrawal by Subject|4|||
143455847|NCT01394978|517212550|FG000|Overall Study|Lost to Follow-up|13|||
143455848|NCT01394978|517212551|FG001|Overall Study|Lost to Follow-up|20|||
143455849|NCT01394978|517212550|FG000|Overall Study|Death|6|||
143455850|NCT01394978|517212551|FG001|Overall Study|Death|7|||
143455851|NCT02217501|517212552|FG000|Overall Study|Death|3|||
143455852|NCT02217501|517212553|FG001|Overall Study|Death|4|||
143455853|NCT02019667|517212554|FG000|First Intervention (6 Months)|Adverse Event|0|||
143455854|NCT02019667|517212555|FG001|First Intervention (6 Months)|Adverse Event|1|||
143455855|NCT02019667|517212554|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
143455856|NCT02019667|517212555|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
143455857|NCT02019667|517212554|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
143455858|NCT02019667|517212555|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
143455859|NCT01942785|517212556|FG000|Overall Study|Adverse Event|2|||
143455860|NCT01942785|517212556|FG000|Overall Study|Withdrawal by Subject|1|||
143455861|NCT01942785|517212556|FG000|Overall Study|Protocol Violation|1|||
143001450|NCT05602818|515542132|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
143455862|NCT05038163|517212560|FG000|Stage 1|Did not complete survey|374|||
143455863|NCT05038163|517212561|FG001|Stage 1|Did not complete survey|0|||
143455864|NCT05038163|517212562|FG002|Stage 1|Did not complete survey|0|||
143455865|NCT05038163|517212563|FG003|Stage 1|Did not complete survey|0|||
143455866|NCT05038163|517212564|FG004|Stage 1|Did not complete survey|0|||
143455867|NCT05038163|517212565|FG005|Stage 1|Did not complete survey|0|||
143455868|NCT05038163|517212560|FG000|Stage 2|Did not complete Stage 2 survey|0|||
143455869|NCT05038163|517212561|FG001|Stage 2|Did not complete Stage 2 survey|29|||
143455870|NCT05038163|517212562|FG002|Stage 2|Did not complete Stage 2 survey|30|||
143455871|NCT05038163|517212563|FG003|Stage 2|Did not complete Stage 2 survey|24|||
143455872|NCT05038163|517212564|FG004|Stage 2|Did not complete Stage 2 survey|21|||
143455873|NCT05038163|517212565|FG005|Stage 2|Did not complete Stage 2 survey|100|||
143455874|NCT05453201|517212566|FG000|Overall Study|Withdrawal by Subject|1|||
143455875|NCT03798691|517212569|FG000|Overall Study|Lost to Follow-up|2|||
143455876|NCT03798691|517212570|FG001|Overall Study|Lost to Follow-up|2|||
143455877|NCT00552929|517212571|FG000|Overall Study|Lost to Follow-up|0|||
143455878|NCT00552929|517212572|FG001|Overall Study|Lost to Follow-up|0|||
143455879|NCT00552929|517212573|FG002|Overall Study|Lost to Follow-up|0|||
143455880|NCT00552929|517212574|FG003|Overall Study|Lost to Follow-up|0|||
143455881|NCT00552929|517212575|FG004|Overall Study|Lost to Follow-up|0|||
143455882|NCT00552929|517212576|FG005|Overall Study|Lost to Follow-up|0|||
143455883|NCT00552929|517212577|FG006|Overall Study|Lost to Follow-up|0|||
143455884|NCT00552929|517212578|FG007|Overall Study|Lost to Follow-up|0|||
143455885|NCT00552929|517212579|FG008|Overall Study|Lost to Follow-up|1|||
143455886|NCT00552929|517212580|FG009|Overall Study|Lost to Follow-up|0|||
143455887|NCT00552929|517212571|FG000|Overall Study|Not Eligible|0|||
143455888|NCT00552929|517212572|FG001|Overall Study|Not Eligible|0|||
143455889|NCT00552929|517212573|FG002|Overall Study|Not Eligible|0|||
143455890|NCT00552929|517212574|FG003|Overall Study|Not Eligible|0|||
143455891|NCT00552929|517212575|FG004|Overall Study|Not Eligible|0|||
143455892|NCT00552929|517212576|FG005|Overall Study|Not Eligible|1|||
143455893|NCT00552929|517212577|FG006|Overall Study|Not Eligible|0|||
143455894|NCT00552929|517212578|FG007|Overall Study|Not Eligible|0|||
143455895|NCT00552929|517212579|FG008|Overall Study|Not Eligible|0|||
143455896|NCT00552929|517212580|FG009|Overall Study|Not Eligible|0|||
143455897|NCT01147536|517212584|FG000|Overall Study|Administrative study close|2|||
143455898|NCT01147536|517212584|FG000|Overall Study|Death|1|||
143455899|NCT03762200|517212585|FG000|Overall Study|Death|2|||
143455900|NCT05110690|517212590|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
143455901|NCT05110690|517212590|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
143455902|NCT05110690|517212590|FG000|Completion of Intervention|Lost to Follow-up|1|||
143455903|NCT05110690|517212590|FG000|Completion of Intervention|Death|1|||
143455904|NCT05110690|517212590|FG000|Completion of Intervention|Withdrawal by Subject|2|||
143455905|NCT00759915|517213915|FG000|Overall Study|Withdrawal by Subject|1|||
143455906|NCT00759915|517213916|FG001|Overall Study|Withdrawal by Subject|0|||
143455907|NCT00759915|517213915|FG000|Overall Study|Adverse Event|0|||
143455908|NCT00759915|517213916|FG001|Overall Study|Adverse Event|1|||
143455909|NCT03527173|517213917|FG000|Overall Study|Lost to Follow-up|4|||
143455910|NCT03527173|517213918|FG001|Overall Study|Lost to Follow-up|2|||
143455911|NCT03527173|517213917|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
143455912|NCT03527173|517213918|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
143455913|NCT03527173|517213917|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
143455914|NCT03527173|517213918|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
143455915|NCT03527173|517213917|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
143455916|NCT03527173|517213918|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
143455917|NCT01664598|517213919|FG000|Overall Study|Sponsor Decision|1|||
143455918|NCT01664598|517213919|FG000|Overall Study|Withdrawal of Informed Consent|4|||
143455919|NCT01664598|517213919|FG000|Overall Study|Adverse Event|1|||
143455920|NCT01658150|517213920|FG000|Overall Study|Withdrawal by Subject|1|||
143455921|NCT03602066|517213921|FG000|Overall Study|Withdrawal by Subject|2|||
143455922|NCT03602066|517213922|FG001|Overall Study|Withdrawal by Subject|0|||
143455923|NCT03602066|517213921|FG000|Overall Study|Physician Decision|1|||
143455924|NCT03602066|517213922|FG001|Overall Study|Physician Decision|0|||
143455925|NCT03245151|517213923|FG000|Overall Study|Withdrawal by Subject|2|||
143455926|NCT03245151|517213924|FG001|Overall Study|Withdrawal by Subject|0|||
143455927|NCT03245151|517213925|FG002|Overall Study|Withdrawal by Subject|0|||
143455928|NCT03245151|517213926|FG003|Overall Study|Withdrawal by Subject|2|||
143455929|NCT03245151|517213927|FG004|Overall Study|Withdrawal by Subject|1|||
143455930|NCT03245151|517213923|FG000|Overall Study|Death|3|||
143455931|NCT03245151|517213924|FG001|Overall Study|Death|14|||
143455932|NCT03245151|517213925|FG002|Overall Study|Death|9|||
143455933|NCT03245151|517213926|FG003|Overall Study|Death|16|||
143455934|NCT03245151|517213927|FG004|Overall Study|Death|7|||
143455935|NCT03245151|517213923|FG000|Overall Study|Sponsor's decision|0|||
143455936|NCT03245151|517213924|FG001|Overall Study|Sponsor's decision|1|||
143455937|NCT03245151|517213925|FG002|Overall Study|Sponsor's decision|0|||
143455938|NCT03245151|517213926|FG003|Overall Study|Sponsor's decision|0|||
143455939|NCT03245151|517213927|FG004|Overall Study|Sponsor's decision|0|||
143455940|NCT04772898|517213934|FG000|Overall Study|Withdrawal by Subject|0|||
143455941|NCT04772898|517213935|FG001|Overall Study|Withdrawal by Subject|1|||
143455942|NCT00434213|517213940|FG000|Overall Study|Adverse Event|12|||
143455943|NCT00434213|517213940|FG000|Overall Study|Lack of Efficacy|9|||
143455944|NCT00434213|517213940|FG000|Overall Study|Lost to Follow-up|14|||
143455945|NCT00434213|517213940|FG000|Overall Study|Withdrawal by Subject|7|||
143455946|NCT00434213|517213940|FG000|Overall Study|Protocol Violation|3|||
143455947|NCT00434213|517213940|FG000|Overall Study|Unable to comply with study visit window|2|||
143455948|NCT00434213|517213940|FG000|Overall Study|Application site reaction|1|||
143455949|NCT00434213|517213940|FG000|Overall Study|Non-compliant to study schedule|1|||
143455950|NCT01004848|517213941|FG000|Overall Study|Lost to Follow-up|55|||
143455951|NCT01004848|517213942|FG001|Overall Study|Lost to Follow-up|45|||
143455952|NCT01631227|517213944|FG000|Overall Study|withdrawn consent|27|||
143455953|NCT01631227|517213945|FG001|Overall Study|withdrawn consent|21|||
143455954|NCT01631227|517213944|FG000|Overall Study|Adverse Event|1|||
143455955|NCT01631227|517213945|FG001|Overall Study|Adverse Event|0|||
143455956|NCT01631227|517213944|FG000|Overall Study|administrative|2|||
143455957|NCT01631227|517213945|FG001|Overall Study|administrative|1|||
143455958|NCT00766363|517213946|FG000|Overall Study|Withdrawal by Subject|1|||
143455959|NCT00766363|517213947|FG001|Overall Study|Withdrawal by Subject|0|||
143455960|NCT00766363|517213948|FG002|Overall Study|Withdrawal by Subject|0|||
143455961|NCT00766363|517213949|FG003|Overall Study|Withdrawal by Subject|0|||
143455962|NCT00766363|517213946|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
143455963|NCT00766363|517213947|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
143455964|NCT00766363|517213948|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
143455965|NCT00766363|517213949|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
143455966|NCT03292432|517213950|FG000|Overall Study|Lost to Follow-up|11|||
143455967|NCT03292432|517213951|FG001|Overall Study|Lost to Follow-up|8|||
143455968|NCT03292432|517213950|FG000|Overall Study|Death|2|||
143455969|NCT03292432|517213951|FG001|Overall Study|Death|1|||
143455970|NCT03292432|517213950|FG000|Overall Study|Withdrawal by Subject|1|||
143455971|NCT03292432|517213951|FG001|Overall Study|Withdrawal by Subject|2|||
143455972|NCT03292432|517213950|FG000|Overall Study|Site closed before any data collected|1|||
143455973|NCT03292432|517213951|FG001|Overall Study|Site closed before any data collected|0|||
143455974|NCT01498679|517213955|FG000|Overall Study|Adverse Event|1|||
143455975|NCT01498679|517213956|FG001|Overall Study|Adverse Event|4|||
143455976|NCT01498679|517213955|FG000|Overall Study|Lack of Efficacy|72|||
143455977|NCT01498679|517213956|FG001|Overall Study|Lack of Efficacy|12|||
143455978|NCT01498679|517213955|FG000|Overall Study|Protocol Violation|4|||
143455979|NCT01498679|517213956|FG001|Overall Study|Protocol Violation|0|||
143455980|NCT01498679|517213955|FG000|Overall Study|Physician Decision|0|||
143455981|NCT01498679|517213956|FG001|Overall Study|Physician Decision|2|||
143455982|NCT01498679|517213955|FG000|Overall Study|Withdrawal by Subject|12|||
143455983|NCT01498679|517213956|FG001|Overall Study|Withdrawal by Subject|4|||
143455984|NCT00158860|517213959|FG000|Overall Study|Adverse Event|3|||
143455985|NCT00158860|517213960|FG001|Overall Study|Adverse Event|6|||
143455986|NCT00158860|517213959|FG000|Overall Study|Lost to Follow-up|11|||
143455987|NCT00158860|517213960|FG001|Overall Study|Lost to Follow-up|17|||
143455988|NCT00158860|517213959|FG000|Overall Study|Protocol Violation|8|||
143455989|NCT00158860|517213960|FG001|Overall Study|Protocol Violation|23|||
143455990|NCT00158860|517213959|FG000|Overall Study|Withdrawal by Subject|7|||
143455991|NCT00158860|517213960|FG001|Overall Study|Withdrawal by Subject|17|||
143455992|NCT00158860|517213959|FG000|Overall Study|MOVING OUT OF STATE|1|||
143455993|NCT00158860|517213960|FG001|Overall Study|MOVING OUT OF STATE|0|||
143455994|NCT00158860|517213959|FG000|Overall Study|Pregnancy|3|||
143455995|NCT00158860|517213960|FG001|Overall Study|Pregnancy|3|||
143455996|NCT00158860|517213959|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
143455997|NCT00158860|517213960|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
143455998|NCT00158860|517213959|FG000|Overall Study|SPONSOR REQUEST|0|||
143455999|NCT00158860|517213960|FG001|Overall Study|SPONSOR REQUEST|1|||
143456000|NCT00158860|517213959|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
143456001|NCT00158860|517213960|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
143456002|NCT00158860|517213959|FG000|Overall Study|Closed per sponsor|0|||
143456003|NCT00158860|517213960|FG001|Overall Study|Closed per sponsor|1|||
143456004|NCT00964886|517213961|FG000|Overall Study|Lost to Follow-up|2|||
143456005|NCT00964886|517213962|FG001|Overall Study|Lost to Follow-up|2|||
143456006|NCT00964886|517213963|FG002|Overall Study|Lost to Follow-up|6|||
143456007|NCT00964886|517213964|FG003|Overall Study|Lost to Follow-up|4|||
143456008|NCT00964886|517213961|FG000|Overall Study|Withdrawal by Subject|6|||
143456009|NCT00964886|517213962|FG001|Overall Study|Withdrawal by Subject|2|||
143456010|NCT00964886|517213963|FG002|Overall Study|Withdrawal by Subject|5|||
143456011|NCT00964886|517213964|FG003|Overall Study|Withdrawal by Subject|3|||
143456012|NCT00964886|517213961|FG000|Overall Study|Adverse Event|3|||
143456013|NCT00964886|517213962|FG001|Overall Study|Adverse Event|1|||
143456014|NCT00964886|517213963|FG002|Overall Study|Adverse Event|5|||
143456015|NCT00964886|517213964|FG003|Overall Study|Adverse Event|2|||
143456016|NCT00964886|517213961|FG000|Overall Study|Protocol Violation|0|||
143456017|NCT00964886|517213962|FG001|Overall Study|Protocol Violation|2|||
143456018|NCT00964886|517213963|FG002|Overall Study|Protocol Violation|0|||
143456019|NCT00964886|517213964|FG003|Overall Study|Protocol Violation|0|||
143456020|NCT03047395|517213966|FG000|Overall Study|Adverse Event|142|||
143456021|NCT03047395|517213966|FG000|Overall Study|Withdrawal by Subject|155|||
143456022|NCT03047395|517213966|FG000|Overall Study|Lost to Follow-up|144|||
143456023|NCT03047395|517213966|FG000|Overall Study|COVID-19 Infection|2|||
143456024|NCT03047395|517213966|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
143456025|NCT03047395|517213966|FG000|Overall Study|Other, Not Specified|117|||
143456026|NCT00468104|517213972|FG000|First Intervention|Protocol Violation|2|||
143456027|NCT00468104|517213973|FG001|First Intervention|Protocol Violation|1|||
143456028|NCT00468104|517213972|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
143456029|NCT00468104|517213973|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
143456030|NCT00468104|517213972|FG000|First Intervention|died within 3 weeks|1|||
143456031|NCT00468104|517213973|FG001|First Intervention|died within 3 weeks|0|||
143456032|NCT00468104|517213972|FG000|First Intervention|malposition/blocked chest tube tube|2|||
143456033|NCT00468104|517213973|FG001|First Intervention|malposition/blocked chest tube tube|0|||
143456034|NCT00468104|517213972|FG000|First Intervention|large lung mass with minimal effusion|1|||
143456035|NCT00468104|517213973|FG001|First Intervention|large lung mass with minimal effusion|0|||
143456036|NCT00468104|517213972|FG000|First Intervention|associated prolonged pneumothorax|1|||
143456037|NCT00468104|517213973|FG001|First Intervention|associated prolonged pneumothorax|0|||
143456038|NCT00468104|517213972|FG000|First Intervention|trapped lung|1|||
143456039|NCT00468104|517213973|FG001|First Intervention|trapped lung|0|||
143456040|NCT00468104|517213972|FG000|Second Intervention|Withdrawal by Subject|5|||
143456041|NCT00468104|517213973|FG001|Second Intervention|Withdrawal by Subject|2|||
143456042|NCT00468104|517213972|FG000|Second Intervention|discarded for malposition of chest tube|0|||
143456043|NCT00468104|517213973|FG001|Second Intervention|discarded for malposition of chest tube|2|||
143456044|NCT02706899|517213974|FG000|Overall Study|Withdrawal by Subject|1|||
143456045|NCT02706899|517213975|FG001|Overall Study|Withdrawal by Subject|0|||
143456046|NCT02706899|517213974|FG000|Overall Study|Death|8|||
143456047|NCT02706899|517213975|FG001|Overall Study|Death|0|||
143456048|NCT02706899|517213974|FG000|Overall Study|Study Termination by Sponsor|4|||
143456049|NCT02706899|517213975|FG001|Overall Study|Study Termination by Sponsor|6|||
143456050|NCT00324675|517213976|FG000|Overall Study|Adverse Event|1|||
143456051|NCT00324675|517213977|FG001|Overall Study|Adverse Event|0|||
143456052|NCT00381615|517213978|FG000|Overall Study|Withdrawal by Subject|1|||
143456053|NCT00381615|517213979|FG001|Overall Study|Withdrawal by Subject|3|||
143456054|NCT00381615|517213980|FG002|Overall Study|Withdrawal by Subject|0|||
143456055|NCT00381615|517213981|FG003|Overall Study|Withdrawal by Subject|1|||
143456056|NCT00381615|517213978|FG000|Overall Study|Lost to Follow-up|3|||
143456057|NCT00381615|517213979|FG001|Overall Study|Lost to Follow-up|2|||
143456058|NCT00381615|517213980|FG002|Overall Study|Lost to Follow-up|0|||
143456059|NCT00381615|517213981|FG003|Overall Study|Lost to Follow-up|1|||
143456060|NCT00381615|517213978|FG000|Overall Study|Protocol Violation|0|||
143456061|NCT00381615|517213979|FG001|Overall Study|Protocol Violation|0|||
143456062|NCT00381615|517213980|FG002|Overall Study|Protocol Violation|1|||
143456063|NCT00381615|517213981|FG003|Overall Study|Protocol Violation|0|||
143456064|NCT04860297|517213983|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
143456065|NCT04860297|517213984|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
143456066|NCT04860297|517213985|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
143456067|NCT04860297|517213986|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
143456068|NCT04860297|517213987|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
143456069|NCT04860297|517213988|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
143456070|NCT04860297|517213989|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
143456071|NCT04860297|517213990|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
143456072|NCT04860297|517213983|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
143456073|NCT04860297|517213984|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
143456074|NCT04860297|517213985|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
143456075|NCT04860297|517213986|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
143456076|NCT04860297|517213987|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
143456077|NCT04860297|517213988|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
143456078|NCT04860297|517213989|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
143456079|NCT04860297|517213990|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
143456080|NCT04860297|517213983|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
143456081|NCT04860297|517213984|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
143456082|NCT04860297|517213985|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
143456083|NCT04860297|517213986|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
143456084|NCT04860297|517213987|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
143456085|NCT04860297|517213988|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
143456086|NCT04860297|517213989|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
143456087|NCT04860297|517213990|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
143456088|NCT04860297|517213983|FG000|Part B (Booster Dose)|Other Than Specified|0|||
143456089|NCT04860297|517213984|FG001|Part B (Booster Dose)|Other Than Specified|0|||
143456090|NCT04860297|517213985|FG002|Part B (Booster Dose)|Other Than Specified|0|||
143456091|NCT04860297|517213986|FG003|Part B (Booster Dose)|Other Than Specified|0|||
143456092|NCT04860297|517213987|FG004|Part B (Booster Dose)|Other Than Specified|0|||
143456093|NCT04860297|517213988|FG005|Part B (Booster Dose)|Other Than Specified|1|||
143456094|NCT04860297|517213989|FG006|Part B (Booster Dose)|Other Than Specified|1|||
143456095|NCT04860297|517213990|FG007|Part B (Booster Dose)|Other Than Specified|0|||
143456096|NCT04860297|517213983|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
143456097|NCT04860297|517213984|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
143456098|NCT04860297|517213985|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
143456099|NCT04860297|517213986|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
143456100|NCT04860297|517213987|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
143456101|NCT04860297|517213988|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
143456102|NCT04860297|517213989|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
143456103|NCT04860297|517213990|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
143456104|NCT04860297|517213983|FG000|Part B (Booster Dose)|Death|0|||
143456105|NCT04860297|517213984|FG001|Part B (Booster Dose)|Death|0|||
143456106|NCT04860297|517213985|FG002|Part B (Booster Dose)|Death|0|||
143456107|NCT04860297|517213986|FG003|Part B (Booster Dose)|Death|0|||
143456108|NCT04860297|517213987|FG004|Part B (Booster Dose)|Death|1|||
143456109|NCT04860297|517213988|FG005|Part B (Booster Dose)|Death|2|||
143456110|NCT04860297|517213989|FG006|Part B (Booster Dose)|Death|1|||
143456111|NCT04860297|517213990|FG007|Part B (Booster Dose)|Death|0|||
143456112|NCT04860297|517213983|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
143456113|NCT04860297|517213984|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
143456114|NCT04860297|517213985|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
143456115|NCT04860297|517213986|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
143456116|NCT04860297|517213987|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
143456117|NCT04860297|517213988|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
143456118|NCT04860297|517213989|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
143456119|NCT04860297|517213990|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
143456120|NCT04811131|517213991|FG000|Overall Study|Adverse Event|0|||
143456121|NCT04811131|517213992|FG001|Overall Study|Adverse Event|0|||
143456122|NCT04811131|517213993|FG002|Overall Study|Adverse Event|1|||
143456123|NCT04811131|517213994|FG003|Overall Study|Adverse Event|0|||
143456124|NCT04811131|517213991|FG000|Overall Study|Lack of Efficacy|0|||
143456125|NCT04811131|517213992|FG001|Overall Study|Lack of Efficacy|0|||
143456126|NCT04811131|517213993|FG002|Overall Study|Lack of Efficacy|0|||
143456127|NCT04811131|517213994|FG003|Overall Study|Lack of Efficacy|1|||
143456128|NCT04811131|517213991|FG000|Overall Study|Lost to Follow-up|0|||
143456129|NCT04811131|517213992|FG001|Overall Study|Lost to Follow-up|1|||
143456130|NCT04811131|517213993|FG002|Overall Study|Lost to Follow-up|0|||
143456131|NCT04811131|517213994|FG003|Overall Study|Lost to Follow-up|0|||
143456132|NCT04811131|517213991|FG000|Overall Study|Sponsor request|31|||
143456133|NCT04811131|517213992|FG001|Overall Study|Sponsor request|35|||
143456134|NCT04811131|517213993|FG002|Overall Study|Sponsor request|27|||
143456135|NCT04811131|517213994|FG003|Overall Study|Sponsor request|10|||
143456136|NCT04811131|517213991|FG000|Overall Study|Withdrawal by Subject|3|||
143456137|NCT04811131|517213992|FG001|Overall Study|Withdrawal by Subject|1|||
143456138|NCT04811131|517213993|FG002|Overall Study|Withdrawal by Subject|3|||
143456139|NCT04811131|517213994|FG003|Overall Study|Withdrawal by Subject|1|||
143456140|NCT00620282|517213999|FG000|Overall Study|Adverse Event|0|||
143456141|NCT00620282|517214000|FG001|Overall Study|Adverse Event|1|||
143456142|NCT00620282|517214001|FG002|Overall Study|Adverse Event|0|||
143456143|NCT00620282|517213999|FG000|Overall Study|Arterial line unable to be placed|0|||
143456144|NCT00620282|517214000|FG001|Overall Study|Arterial line unable to be placed|0|||
143456145|NCT00620282|517214001|FG002|Overall Study|Arterial line unable to be placed|1|||
143456146|NCT00620282|517213999|FG000|Overall Study|Withdrawal by Subject|0|||
143456147|NCT00620282|517214000|FG001|Overall Study|Withdrawal by Subject|1|||
143456148|NCT00620282|517214001|FG002|Overall Study|Withdrawal by Subject|0|||
143456149|NCT02703259|517214002|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
143456150|NCT02703259|517214003|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
143456151|NCT02703259|517214002|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
143456152|NCT02703259|517214003|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
143456153|NCT02703259|517214002|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
143456154|NCT02703259|517214003|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
143456155|NCT00371683|517214004|FG000|DB Treatment Period-Randomized Patients|Death|1|||
143456156|NCT00371683|517214005|FG001|DB Treatment Period-Randomized Patients|Death|1|||
143456157|NCT00371683|517214004|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
143456158|NCT00371683|517214005|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
143456159|NCT00371683|517214004|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
143456160|NCT00371683|517214005|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
143456161|NCT00371683|517214004|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
143456162|NCT00371683|517214005|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
143456163|NCT00371683|517214004|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
143456164|NCT00371683|517214005|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
143456165|NCT00371683|517214004|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
143456166|NCT00371683|517214005|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
143456167|NCT00371683|517214004|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
143456168|NCT00371683|517214005|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
143456169|NCT00371683|517214004|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
143456170|NCT00371683|517214005|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
143456171|NCT00371683|517214004|FG000|Follow-Up Period - Randomized Patients|Death|0|||
143456172|NCT00371683|517214005|FG001|Follow-Up Period - Randomized Patients|Death|2|||
143456173|NCT00371683|517214004|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
143456174|NCT00371683|517214005|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
143456175|NCT00371683|517214004|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
143456176|NCT00371683|517214005|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
143456177|NCT03181789|517214006|FG000|Overall Study|Withdrawal by Subject|0|||
143456178|NCT03181789|517214007|FG001|Overall Study|Withdrawal by Subject|1|||
143456179|NCT03181789|517214008|FG002|Overall Study|Withdrawal by Subject|1|||
143456180|NCT03181789|517214009|FG003|Overall Study|Withdrawal by Subject|0|||
143456181|NCT03181789|517214006|FG000|Overall Study|Lost to Follow-up|7|||
143456182|NCT03181789|517214007|FG001|Overall Study|Lost to Follow-up|1|||
143456183|NCT03181789|517214008|FG002|Overall Study|Lost to Follow-up|0|||
143456184|NCT03181789|517214009|FG003|Overall Study|Lost to Follow-up|0|||
143456185|NCT03181789|517214006|FG000|Overall Study|Participant unable to adhere to visit|0|||
143456186|NCT03181789|517214007|FG001|Overall Study|Participant unable to adhere to visit|1|||
143456187|NCT03181789|517214008|FG002|Overall Study|Participant unable to adhere to visit|0|||
143456188|NCT03181789|517214009|FG003|Overall Study|Participant unable to adhere to visit|0|||
143456189|NCT01131182|517214010|FG000|Overall Study|Withdrawal by Subject|1|||
143456190|NCT01131182|517214011|FG001|Overall Study|Withdrawal by Subject|1|||
143456191|NCT01131182|517214010|FG000|Overall Study|Lost to Follow-up|14|||
143456192|NCT01131182|517214011|FG001|Overall Study|Lost to Follow-up|15|||
143456193|NCT01131182|517214010|FG000|Overall Study|Other Reason|1|||
143456194|NCT01131182|517214011|FG001|Overall Study|Other Reason|0|||
143456195|NCT00998790|517214014|FG000|Overall Study|Withdrawal by Subject|21|||
143456196|NCT01080716|517214015|FG000|Part 1|Physician Decision|1|||
143456197|NCT01080716|517214016|FG001|Part 1|Physician Decision|0|||
143456198|NCT01080716|517214017|FG002|Part 1|Physician Decision|0|||
143456199|NCT01080716|517214018|FG003|Part 1|Physician Decision|0|||
143001451|NCT05602818|515542133|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
143001452|NCT05602818|515542134|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
143001453|NCT05602818|515542135|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
143001454|NCT05602818|515542136|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
143001455|NCT05602818|515542137|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
143001456|NCT05602818|515542138|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
143001457|NCT05602818|515542139|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
143001458|NCT05602818|515542128|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
143001459|NCT05602818|515542129|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
143001460|NCT05602818|515542130|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
143001461|NCT05602818|515542131|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
143001462|NCT05602818|515542132|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
143001463|NCT05602818|515542133|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
143001464|NCT05602818|515542134|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
143001465|NCT05602818|515542135|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
143001466|NCT05602818|515542136|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
143001467|NCT05602818|515542137|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
143001468|NCT05602818|515542138|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
143001469|NCT05602818|515542139|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
143001470|NCT05602818|515542128|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
143001471|NCT05602818|515542129|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
143001472|NCT05602818|515542130|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
143001473|NCT05602818|515542131|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
143001474|NCT05602818|515542132|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
143001475|NCT05602818|515542133|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
143001476|NCT05602818|515542134|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
143001477|NCT05602818|515542135|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
143001478|NCT05602818|515542136|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
143001479|NCT05602818|515542137|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
143001480|NCT05602818|515542138|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
143001481|NCT05602818|515542139|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
143001482|NCT05602818|515542128|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
143001483|NCT05602818|515542129|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
143001484|NCT05602818|515542130|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
143001485|NCT05602818|515542131|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
143001486|NCT05602818|515542132|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
143001487|NCT05602818|515542133|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
143001488|NCT05602818|515542134|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
143001489|NCT05602818|515542135|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
143001490|NCT05602818|515542136|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
143001491|NCT05602818|515542137|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
143001492|NCT05602818|515542138|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
143001493|NCT05602818|515542139|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
143001494|NCT00727246|515542140|FG000|Overall Study|could not complete MRI|0|||
143001495|NCT00727246|515542141|FG001|Overall Study|could not complete MRI|1|||
143001496|NCT00727246|515542142|FG002|Overall Study|could not complete MRI|0|||
143001497|NCT00727246|515542143|FG003|Overall Study|could not complete MRI|1|||
143001498|NCT00727246|515542140|FG000|Overall Study|incidental finding|0|||
143001499|NCT00727246|515542141|FG001|Overall Study|incidental finding|0|||
143001500|NCT00727246|515542142|FG002|Overall Study|incidental finding|0|||
143001501|NCT00727246|515542143|FG003|Overall Study|incidental finding|1|||
143001502|NCT00727246|515542140|FG000|Overall Study|withdrawn|0|||
143001503|NCT00727246|515542141|FG001|Overall Study|withdrawn|0|||
143001504|NCT00727246|515542142|FG002|Overall Study|withdrawn|1|||
143001505|NCT00727246|515542143|FG003|Overall Study|withdrawn|0|||
143001506|NCT03814499|515542144|FG000|Overall Study|Lost to Follow-up|3|||
143001507|NCT00351611|515542145|FG000|Overall Study|Adverse Event|11|||
143001508|NCT00351611|515542146|FG001|Overall Study|Adverse Event|3|||
143001509|NCT00351611|515542145|FG000|Overall Study|Death|1|||
143001510|NCT00351611|515542146|FG001|Overall Study|Death|0|||
143001511|NCT00351611|515542145|FG000|Overall Study|Lost to Follow-up|1|||
143001512|NCT00351611|515542146|FG001|Overall Study|Lost to Follow-up|0|||
143001513|NCT00351611|515542145|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
143001514|NCT00351611|515542146|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
143001515|NCT00351611|515542145|FG000|Overall Study|Other|1|||
143001516|NCT00351611|515542146|FG001|Overall Study|Other|0|||
143001517|NCT00351611|515542145|FG000|Overall Study|Protocol Violation|0|||
143001518|NCT00351611|515542146|FG001|Overall Study|Protocol Violation|2|||
143001519|NCT01589185|515542147|FG000|Overall Study|Death|1|||
143001520|NCT01589185|515542148|FG001|Overall Study|Death|2|||
143001521|NCT01589185|515542149|FG002|Overall Study|Death|2|||
143001522|NCT01589185|515542150|FG003|Overall Study|Death|0|||
143001523|NCT01589185|515542151|FG004|Overall Study|Death|1|||
143001524|NCT01589185|515542147|FG000|Overall Study|Lost to Follow-up|1|||
143001525|NCT01589185|515542148|FG001|Overall Study|Lost to Follow-up|0|||
143001526|NCT01589185|515542149|FG002|Overall Study|Lost to Follow-up|2|||
143001527|NCT01589185|515542150|FG003|Overall Study|Lost to Follow-up|3|||
143001528|NCT01589185|515542151|FG004|Overall Study|Lost to Follow-up|0|||
143001529|NCT00598442|515542153|FG000|Overall Study|Adverse Event|3|||
143001530|NCT00598442|515542154|FG001|Overall Study|Adverse Event|0|||
143001531|NCT00598442|515542155|FG002|Overall Study|Adverse Event|0|||
143001532|NCT00598442|515542153|FG000|Overall Study|Death|19|||
143001533|NCT00598442|515542154|FG001|Overall Study|Death|11|||
143001534|NCT00598442|515542155|FG002|Overall Study|Death|11|||
143001535|NCT00598442|515542153|FG000|Overall Study|Lost to Follow-up|4|||
143001536|NCT00598442|515542154|FG001|Overall Study|Lost to Follow-up|3|||
143001537|NCT00598442|515542155|FG002|Overall Study|Lost to Follow-up|3|||
143001538|NCT00598442|515542153|FG000|Overall Study|Physician Decision|2|||
143001539|NCT00598442|515542154|FG001|Overall Study|Physician Decision|1|||
143001540|NCT00598442|515542155|FG002|Overall Study|Physician Decision|1|||
143001541|NCT00598442|515542153|FG000|Overall Study|Withdrawal by Subject|8|||
143001542|NCT00598442|515542154|FG001|Overall Study|Withdrawal by Subject|16|||
143001543|NCT00598442|515542155|FG002|Overall Study|Withdrawal by Subject|6|||
143001544|NCT00598442|515542153|FG000|Overall Study|Noncompliance|0|||
143001545|NCT00598442|515542154|FG001|Overall Study|Noncompliance|2|||
143001546|NCT00598442|515542155|FG002|Overall Study|Noncompliance|1|||
143001547|NCT00598442|515542153|FG000|Overall Study|Relocation|1|||
143001548|NCT00598442|515542154|FG001|Overall Study|Relocation|4|||
143001549|NCT00598442|515542155|FG002|Overall Study|Relocation|0|||
143001550|NCT00598442|515542153|FG000|Overall Study|Renal transplant|0|||
143001551|NCT00598442|515542154|FG001|Overall Study|Renal transplant|0|||
143001552|NCT00598442|515542155|FG002|Overall Study|Renal transplant|1|||
143001553|NCT00598442|515542153|FG000|Overall Study|Site closed by sponsor|5|||
143001554|NCT00598442|515542154|FG001|Overall Study|Site closed by sponsor|2|||
143001555|NCT00598442|515542155|FG002|Overall Study|Site closed by sponsor|1|||
143001556|NCT00598442|515542153|FG000|Overall Study|Started dialysis|1|||
143001557|NCT00598442|515542154|FG001|Overall Study|Started dialysis|0|||
143001558|NCT00598442|515542155|FG002|Overall Study|Started dialysis|0|||
143001559|NCT00462501|515542164|FG000|Overall Study|Not treated|3|||
143001560|NCT00462501|515542164|FG000|Overall Study|Adverse Event|2|||
143001561|NCT00679354|515542166|FG000|Overall Study|Death|3|||
143001562|NCT00679354|515542166|FG000|Overall Study|Lack of Efficacy|22|||
143001563|NCT00679354|515542166|FG000|Overall Study|Physician Decision|4|||
143001564|NCT00679354|515542166|FG000|Overall Study|Ineligible|1|||
143001565|NCT00408408|515542167|FG000|Overall Study|No follow up data|2|||
143001566|NCT00408408|515542168|FG001|Overall Study|No follow up data|3|||
143001567|NCT00408408|515542169|FG002|Overall Study|No follow up data|0|||
143001568|NCT00408408|515542170|FG003|Overall Study|No follow up data|7|||
143001569|NCT00408408|515542171|FG004|Overall Study|No follow up data|5|||
143001570|NCT00408408|515542172|FG005|Overall Study|No follow up data|3|||
143001571|NCT00267202|515542181|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
143001572|NCT00267202|515542182|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
143001573|NCT00267202|515542181|FG000|Overall Study|Withdrawal by Subject|12|||
143001574|NCT00267202|515542182|FG001|Overall Study|Withdrawal by Subject|15|||
143001575|NCT00267202|515542181|FG000|Overall Study|Adverse Event|13|||
143001576|NCT00267202|515542182|FG001|Overall Study|Adverse Event|7|||
143001577|NCT00267202|515542181|FG000|Overall Study|Protocol Violation|2|||
143001578|NCT00267202|515542182|FG001|Overall Study|Protocol Violation|3|||
143001579|NCT00267202|515542181|FG000|Overall Study|Administrative problems|2|||
143001580|NCT00267202|515542182|FG001|Overall Study|Administrative problems|1|||
143001581|NCT00267202|515542181|FG000|Overall Study|Lost to Follow-up|3|||
143001582|NCT00267202|515542182|FG001|Overall Study|Lost to Follow-up|0|||
143001583|NCT00399542|515542183|FG000|Overall Study|Adverse Event|18|||
143001584|NCT00399542|515542184|FG001|Overall Study|Adverse Event|15|||
143001585|NCT00399542|515542183|FG000|Overall Study|Protocol Violation|13|||
143001586|NCT00399542|515542184|FG001|Overall Study|Protocol Violation|3|||
143001587|NCT00399542|515542183|FG000|Overall Study|Withdrawal by Subject|28|||
143001588|NCT00399542|515542184|FG001|Overall Study|Withdrawal by Subject|10|||
143001589|NCT00399542|515542183|FG000|Overall Study|Lack of Efficacy|18|||
143001590|NCT00399542|515542184|FG001|Overall Study|Lack of Efficacy|8|||
143001591|NCT00399542|515542183|FG000|Overall Study|Lost to Follow-up|6|||
143001592|NCT00399542|515542184|FG001|Overall Study|Lost to Follow-up|6|||
143001593|NCT00399542|515542183|FG000|Overall Study|Other|1|||
143001594|NCT00399542|515542184|FG001|Overall Study|Other|0|||
143001595|NCT00399542|515542183|FG000|Overall Study|Physician Decision|0|||
143001596|NCT00399542|515542184|FG001|Overall Study|Physician Decision|1|||
143001597|NCT03172026|515542185|FG000|Overall Study|Withdrawal by Subject|1|||
143001598|NCT03172026|515542186|FG001|Overall Study|Withdrawal by Subject|0|||
143001599|NCT03172026|515542185|FG000|Overall Study|COVID restrictions|1|||
143001600|NCT03172026|515542186|FG001|Overall Study|COVID restrictions|0|||
143001601|NCT00612456|515542187|FG000|Overall Study|Adverse Event|1|||
143001602|NCT00612456|515542188|FG001|Overall Study|Adverse Event|0|||
143001603|NCT00612456|515542189|FG002|Overall Study|Adverse Event|0|||
143001604|NCT00612456|515542187|FG000|Overall Study|Lack of Efficacy|1|||
143001605|NCT00612456|515542188|FG001|Overall Study|Lack of Efficacy|1|||
143001606|NCT00612456|515542189|FG002|Overall Study|Lack of Efficacy|0|||
143001607|NCT00612456|515542187|FG000|Overall Study|Withdrawal by Subject|0|||
143001608|NCT00612456|515542188|FG001|Overall Study|Withdrawal by Subject|1|||
143001609|NCT00612456|515542189|FG002|Overall Study|Withdrawal by Subject|0|||
143001610|NCT03907072|515542190|FG000|Overall Study|Study Terminated by Sponsor|2|||
143001611|NCT03907072|515542191|FG001|Overall Study|Study Terminated by Sponsor|2|||
143001612|NCT03907072|515542192|FG002|Overall Study|Study Terminated by Sponsor|2|||
143001613|NCT02463097|515542195|FG000|Overall Study|Withdrawal by Subject|1|||
143001614|NCT00504595|515542196|FG000|Overall Study|Lack of Efficacy|1|||
143001615|NCT00504595|515542197|FG001|Overall Study|Lack of Efficacy|0|||
143001616|NCT00504595|515542198|FG002|Overall Study|Lack of Efficacy|0|||
143001617|NCT00504595|515542199|FG003|Overall Study|Lack of Efficacy|0|||
143001618|NCT00504595|515542196|FG000|Overall Study|Other|0|||
143001619|NCT00504595|515542197|FG001|Overall Study|Other|0|||
143001620|NCT00504595|515542198|FG002|Overall Study|Other|2|||
143001621|NCT00504595|515542199|FG003|Overall Study|Other|0|||
143001622|NCT00808665|515542200|FG000|Overall Study|Withdrawal by Subject|1|||
143001623|NCT00808665|515542201|FG001|Overall Study|Withdrawal by Subject|0|||
143001624|NCT00808665|515542200|FG000|Overall Study|only required minimally invasive surgery|1|||
143001625|NCT00808665|515542201|FG001|Overall Study|only required minimally invasive surgery|0|||
143001626|NCT00808665|515542200|FG000|Overall Study|surgery cancelled|1|||
143001627|NCT00808665|515542201|FG001|Overall Study|surgery cancelled|0|||
143001628|NCT00808665|515542200|FG000|Overall Study|required an additional procedure|0|||
143001629|NCT00808665|515542201|FG001|Overall Study|required an additional procedure|1|||
143001630|NCT00808665|515542200|FG000|Overall Study|Physician Decision|3|||
143001631|NCT00808665|515542201|FG001|Overall Study|Physician Decision|1|||
143001632|NCT00808665|515542200|FG000|Overall Study|Medication stopped by resident|0|||
143001633|NCT00808665|515542201|FG001|Overall Study|Medication stopped by resident|1|||
143001634|NCT03326323|515542202|FG000|Overall Study|Unable to receive ANH protocol|3|||
143001635|NCT01757821|515542203|FG000|Overall Study|Adverse Event|1|||
143001636|NCT03831282|515542204|FG000|Overall Study|Could not place sensor|1|||
143001637|NCT00334893|515542205|FG000|Overall Study|Not Treated|1|||
143001638|NCT00334893|515542206|FG001|Overall Study|Not Treated|0|||
143001639|NCT01258803|515542207|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
143001640|NCT01258803|515542208|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
143001641|NCT01258803|515542209|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
143001642|NCT01258803|515542210|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
143001643|NCT01258803|515542211|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
143001644|NCT01258803|515542212|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
143001645|NCT01258803|515542207|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
143001646|NCT01258803|515542208|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
143001647|NCT01258803|515542209|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
143001648|NCT01258803|515542210|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
143001649|NCT01258803|515542211|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
143001650|NCT01258803|515542212|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
143001651|NCT01258803|515542207|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
143001652|NCT01258803|515542208|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
143001653|NCT01258803|515542209|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
143001654|NCT01258803|515542210|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
143001655|NCT01258803|515542211|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
143001656|NCT01258803|515542212|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
143001657|NCT00920582|515542213|FG000|Overall Study|Lost to Follow-up|5|||
143001658|NCT00920582|515542214|FG001|Overall Study|Lost to Follow-up|1|||
143001659|NCT00920582|515542215|FG002|Overall Study|Lost to Follow-up|2|||
143001660|NCT00920582|515542216|FG003|Overall Study|Lost to Follow-up|0|||
143001661|NCT00920582|515542213|FG000|Overall Study|Withdrawal by Subject|5|||
143001662|NCT00920582|515542214|FG001|Overall Study|Withdrawal by Subject|4|||
143001663|NCT00920582|515542215|FG002|Overall Study|Withdrawal by Subject|6|||
143001664|NCT00920582|515542216|FG003|Overall Study|Withdrawal by Subject|3|||
143001665|NCT00920582|515542213|FG000|Overall Study|Protocol Violation|1|||
143001666|NCT00920582|515542214|FG001|Overall Study|Protocol Violation|0|||
143001667|NCT00920582|515542215|FG002|Overall Study|Protocol Violation|0|||
143001668|NCT00920582|515542216|FG003|Overall Study|Protocol Violation|0|||
143001669|NCT00920582|515542213|FG000|Overall Study|Other|2|||
143001670|NCT00920582|515542214|FG001|Overall Study|Other|1|||
143001671|NCT00920582|515542215|FG002|Overall Study|Other|3|||
143001672|NCT00920582|515542216|FG003|Overall Study|Other|2|||
143001673|NCT04652245|515542223|FG000|Wash-Out Period|Adverse Event|0|||
143001674|NCT04652245|515542224|FG001|Wash-Out Period|Adverse Event|2|||
143001675|NCT04652245|515542223|FG000|Wash-Out Period|Withdrawal by Subject|0|||
143001676|NCT04652245|515542224|FG001|Wash-Out Period|Withdrawal by Subject|2|||
143001677|NCT01552408|515542225|FG000|Overall Study|Lost to Follow-up|2|||
143001678|NCT01552408|515542226|FG001|Overall Study|Lost to Follow-up|0|||
143001679|NCT01552408|515542225|FG000|Overall Study|Relocation|0|||
143001680|NCT01552408|515542226|FG001|Overall Study|Relocation|1|||
143001681|NCT01552408|515542225|FG000|Overall Study|Withdrawal by Subject|2|||
143001682|NCT01552408|515542226|FG001|Overall Study|Withdrawal by Subject|1|||
143001683|NCT03319160|515542227|FG000|Overall Study|Data not available.|7|||
143001684|NCT00665002|515542228|FG000|Overall Study|Progression/relapse during treatment|11|||
143001685|NCT00665002|515542228|FG000|Overall Study|Cytogenetic resistance|1|||
143001686|NCT00383292|515542229|FG000|Overall Study|Adverse Event|4|||
143001687|NCT00383292|515542230|FG001|Overall Study|Adverse Event|1|||
143001688|NCT00383292|515542231|FG002|Overall Study|Adverse Event|2|||
143001689|NCT00383292|515542229|FG000|Overall Study|Death|3|||
143001690|NCT00383292|515542230|FG001|Overall Study|Death|3|||
143001691|NCT00383292|515542231|FG002|Overall Study|Death|3|||
143001692|NCT00383292|515542229|FG000|Overall Study|Physician Decision|4|||
143001693|NCT00383292|515542230|FG001|Overall Study|Physician Decision|0|||
143001694|NCT00383292|515542231|FG002|Overall Study|Physician Decision|1|||
143001695|NCT00383292|515542229|FG000|Overall Study|Withdrawal by Subject|3|||
143001696|NCT00383292|515542230|FG001|Overall Study|Withdrawal by Subject|2|||
143001697|NCT00383292|515542231|FG002|Overall Study|Withdrawal by Subject|2|||
143001698|NCT00383292|515542229|FG000|Overall Study|Other|1|||
143001699|NCT00383292|515542230|FG001|Overall Study|Other|0|||
143001700|NCT00383292|515542231|FG002|Overall Study|Other|0|||
143001701|NCT04533204|515542232|FG000|Overall Study|Unable to understand training instructions|1|||
143001702|NCT04533204|515542233|FG001|Overall Study|Unable to understand training instructions|1|||
143001703|NCT01303159|515542240|FG000|Overall Study|Death|16|||
143001704|NCT01303159|515542240|FG000|Overall Study|Study Termination|7|||
143001705|NCT02442284|515542252|FG000|Overall Study|Adverse Event|1|||
143001706|NCT02442284|515542252|FG000|Overall Study|Withdrew Consent|2|||
143001707|NCT02442284|515542252|FG000|Overall Study|Lost to Follow-up|3|||
143001708|NCT02442284|515542252|FG000|Overall Study|Other|1|||
143001709|NCT02173158|515542254|FG000|Efficacy Phase|Adverse Event|1|||
143001710|NCT03077646|515542255|FG000|Overall Study|Lost to Follow-up|29|||
143001711|NCT03077646|515542256|FG001|Overall Study|Lost to Follow-up|30|||
143001712|NCT03077646|515542257|FG002|Overall Study|Lost to Follow-up|31|||
143001713|NCT02058966|515542258|FG000|Open-Label Methamphetamine|Adverse Event|1|||
143001714|NCT02058966|515542258|FG000|First Intervention|Withdrawal by Subject|1|||
143001715|NCT02993731|515542259|FG000|Overall Study|Study Termination|101|||
143001716|NCT02993731|515542260|FG001|Overall Study|Study Termination|105|||
143001717|NCT04398030|515543805|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
143001718|NCT04398030|515543806|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
143001719|NCT04398030|515543805|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
143001720|NCT04398030|515543806|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
143001721|NCT02713490|515543810|FG000|Overall Study|Withdrawal by Subject|2|||
143001722|NCT02713490|515543811|FG001|Overall Study|Withdrawal by Subject|1|||
143001723|NCT02713490|515543810|FG000|Overall Study|Did not receive study drug|1|||
143001724|NCT02713490|515543811|FG001|Overall Study|Did not receive study drug|0|||
143001725|NCT02713490|515543810|FG000|Overall Study|Met exclusion criteria|0|||
143001726|NCT02713490|515543811|FG001|Overall Study|Met exclusion criteria|1|||
143001727|NCT00346775|515543812|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
143001728|NCT00346775|515543813|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
143001729|NCT00346775|515543812|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
143001730|NCT00346775|515543813|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
143001731|NCT00346775|515543812|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
143001732|NCT00346775|515543813|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
143001733|NCT03799198|515543814|FG000|Overall Study|Lost to Follow-up|4|||
143001734|NCT03799198|515543815|FG001|Overall Study|Lost to Follow-up|8|||
143001735|NCT03799198|515543814|FG000|Overall Study|Death|0|||
143001736|NCT03799198|515543815|FG001|Overall Study|Death|1|||
143001737|NCT00960869|515543816|FG000|Overall Study|Adverse Event|17|||
143001738|NCT00960869|515543817|FG001|Overall Study|Adverse Event|26|||
143001739|NCT00960869|515543816|FG000|Overall Study|Withdrawal by Subject|16|||
143001740|NCT00960869|515543817|FG001|Overall Study|Withdrawal by Subject|14|||
143001741|NCT00960869|515543816|FG000|Overall Study|Lost to Follow-up|1|||
143001742|NCT00960869|515543817|FG001|Overall Study|Lost to Follow-up|4|||
143001743|NCT00960869|515543816|FG000|Overall Study|Misc|19|||
143001744|NCT00960869|515543817|FG001|Overall Study|Misc|18|||
143001745|NCT00548340|515543820|FG000|Overall Study|Protocol Violation|2|||
143001746|NCT00548340|515543821|FG001|Overall Study|Protocol Violation|3|||
143001747|NCT00548340|515543822|FG002|Overall Study|Protocol Violation|3|||
143001748|NCT00548340|515543820|FG000|Overall Study|Adverse Event|2|||
143001749|NCT00548340|515543821|FG001|Overall Study|Adverse Event|2|||
143001750|NCT00548340|515543822|FG002|Overall Study|Adverse Event|2|||
143001751|NCT00548340|515543820|FG000|Overall Study|Lost to Follow-up|1|||
143001752|NCT00548340|515543821|FG001|Overall Study|Lost to Follow-up|1|||
143001753|NCT00548340|515543822|FG002|Overall Study|Lost to Follow-up|0|||
143001754|NCT00548340|515543820|FG000|Overall Study|Withdrawal by Subject|2|||
143001755|NCT00548340|515543821|FG001|Overall Study|Withdrawal by Subject|4|||
143001756|NCT00548340|515543822|FG002|Overall Study|Withdrawal by Subject|3|||
143001757|NCT00548340|515543820|FG000|Overall Study|Other|1|||
143001758|NCT00548340|515543821|FG001|Overall Study|Other|1|||
143001759|NCT00548340|515543822|FG002|Overall Study|Other|1|||
143001760|NCT01096017|515543823|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
143001761|NCT01096017|515543824|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
143001762|NCT01846442|515543828|FG000|Overall Study|Adverse Event|2|||
143001763|NCT01846442|515543829|FG001|Overall Study|Adverse Event|4|||
143001764|NCT01846442|515543830|FG002|Overall Study|Adverse Event|2|||
143001765|NCT01846442|515543831|FG003|Overall Study|Adverse Event|1|||
143001766|NCT01846442|515543828|FG000|Overall Study|Lost to Follow-up|0|||
143001767|NCT01846442|515543829|FG001|Overall Study|Lost to Follow-up|0|||
143001768|NCT01846442|515543830|FG002|Overall Study|Lost to Follow-up|1|||
143001769|NCT01846442|515543831|FG003|Overall Study|Lost to Follow-up|0|||
143001770|NCT01846442|515543828|FG000|Overall Study|Withdrawal by Subject|3|||
143001771|NCT01846442|515543829|FG001|Overall Study|Withdrawal by Subject|2|||
143001772|NCT01846442|515543830|FG002|Overall Study|Withdrawal by Subject|0|||
143001773|NCT01846442|515543831|FG003|Overall Study|Withdrawal by Subject|1|||
143001774|NCT01846442|515543828|FG000|Overall Study|Left the city/Lost medication|1|||
143001775|NCT01846442|515543829|FG001|Overall Study|Left the city/Lost medication|0|||
143001776|NCT01846442|515543830|FG002|Overall Study|Left the city/Lost medication|1|||
143001777|NCT01846442|515543831|FG003|Overall Study|Left the city/Lost medication|1|||
143001778|NCT01153971|515543838|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
143001779|NCT01153971|515543838|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
143001780|NCT01153971|515543838|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
143001781|NCT01153971|515543838|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
143001782|NCT01153971|515543838|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
143001783|NCT01153971|515543838|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
143001784|NCT01153971|515543838|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
143001785|NCT01789476|515543839|FG000|Overall Study|Lack of Efficacy|6|||
143001786|NCT01789476|515543840|FG001|Overall Study|Lack of Efficacy|2|||
143001787|NCT01789476|515543839|FG000|Overall Study|Adverse Event|1|||
143001788|NCT01789476|515543840|FG001|Overall Study|Adverse Event|0|||
143001789|NCT01789476|515543839|FG000|Overall Study|Unable to get IV access|1|||
143001790|NCT01789476|515543840|FG001|Overall Study|Unable to get IV access|0|||
143001791|NCT00953576|515543841|FG000|Overall Study|Adverse Event|0|||
143001792|NCT00953576|515543842|FG001|Overall Study|Adverse Event|1|||
143001793|NCT00953576|515543841|FG000|Overall Study|Ineligible after Consent|2|||
143001794|NCT00953576|515543842|FG001|Overall Study|Ineligible after Consent|0|||
143001795|NCT00665366|515543843|FG000|Overall Study|Lack of Efficacy|11|||
143001796|NCT00665366|515543844|FG001|Overall Study|Lack of Efficacy|10|||
143001797|NCT00665366|515543843|FG000|Overall Study|Adverse Event|25|||
143001798|NCT00665366|515543844|FG001|Overall Study|Adverse Event|23|||
143001799|NCT00665366|515543843|FG000|Overall Study|Withdrawal by Subject|11|||
143001800|NCT00665366|515543844|FG001|Overall Study|Withdrawal by Subject|14|||
143001801|NCT00665366|515543843|FG000|Overall Study|Lost to Follow-up|3|||
143001802|NCT00665366|515543844|FG001|Overall Study|Lost to Follow-up|5|||
143001803|NCT00665366|515543843|FG000|Overall Study|Poor compliance/noncompliance|3|||
143001804|NCT00665366|515543844|FG001|Overall Study|Poor compliance/noncompliance|5|||
143001805|NCT00665366|515543843|FG000|Overall Study|Pregnancy|1|||
143001806|NCT00665366|515543844|FG001|Overall Study|Pregnancy|0|||
143001807|NCT00665366|515543843|FG000|Overall Study|No longer meets study criteria|0|||
143001808|NCT00665366|515543844|FG001|Overall Study|No longer meets study criteria|1|||
143001809|NCT00665366|515543843|FG000|Overall Study|Other reasons|4|||
143001810|NCT00665366|515543844|FG001|Overall Study|Other reasons|1|||
143001811|NCT03778021|515543846|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
143001812|NCT03778021|515543847|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
143001813|NCT01545375|515543848|FG000|Overall Study|Adverse Event|2|||
143001814|NCT01545375|515543849|FG001|Overall Study|Adverse Event|1|||
143001815|NCT01545375|515543848|FG000|Overall Study|Lost to Follow-up|34|||
143001816|NCT01545375|515543849|FG001|Overall Study|Lost to Follow-up|31|||
143001817|NCT01545375|515543848|FG000|Overall Study|Protocol Violation|3|||
143001818|NCT01545375|515543849|FG001|Overall Study|Protocol Violation|3|||
143001819|NCT01545375|515543848|FG000|Overall Study|Withdrawal by Subject|58|||
143001820|NCT01545375|515543849|FG001|Overall Study|Withdrawal by Subject|55|||
143001821|NCT00679042|515543850|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
143001822|NCT00679042|515543850|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
143001823|NCT00679042|515543850|FG000|5-Year Follow Up|Death|1|||
143001824|NCT00679042|515543850|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
143001825|NCT00679042|515543850|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
143001826|NCT02687815|515543851|FG000|Overall Study|Lost to Follow-up|2|||
143001827|NCT02687815|515543852|FG001|Overall Study|Lost to Follow-up|4|||
143001828|NCT02687815|515543851|FG000|Overall Study|Withdrawal by Subject|2|||
143001829|NCT02687815|515543852|FG001|Overall Study|Withdrawal by Subject|4|||
143001830|NCT04177862|515543853|FG000|Overall Study|Protocol Violation|2|||
143001831|NCT04177862|515543854|FG001|Overall Study|Protocol Violation|7|||
143001832|NCT01846039|515543855|FG000|Overall Study|Protocol Violation|1|||
143001833|NCT01846039|515543855|FG000|Overall Study|Subject Withdrew Consent|1|||
143001834|NCT01855607|515543857|FG000|Overall Study|Withdrawal by Subject|1|||
143001835|NCT01855607|515543857|FG000|Overall Study|Study was terminated|11|||
143001836|NCT02392078|515543858|FG000|Overall Study|Did not have procedure|32|||
143001837|NCT02392078|515543859|FG001|Overall Study|Did not have procedure|43|||
143001838|NCT02392078|515543860|FG002|Overall Study|Did not have procedure|20|||
143001839|NCT02392078|515543861|FG003|Overall Study|Did not have procedure|1|||
143001840|NCT04963231|515543863|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
143001841|NCT04963231|515543864|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
143001842|NCT04963231|515543865|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
143001843|NCT04963231|515543863|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
143001844|NCT04963231|515543864|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
143001845|NCT04963231|515543865|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
143001846|NCT04963231|515543863|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
143001847|NCT04963231|515543864|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
143001848|NCT04963231|515543865|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
143001849|NCT04963231|515543863|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
143001850|NCT04963231|515543864|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
143001851|NCT04963231|515543865|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
143001852|NCT04963231|515543863|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
143001853|NCT04963231|515543864|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
143001854|NCT04963231|515543865|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
143001855|NCT04963231|515543863|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
143001856|NCT04963231|515543864|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
143001857|NCT04963231|515543865|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
143001858|NCT04963231|515543863|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
143001859|NCT04963231|515543864|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
143001860|NCT04963231|515543865|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
143001861|NCT06045026|515543866|FG000|Overall Study|Lost to Follow-up|60|||
143001862|NCT06045026|515543866|FG000|Overall Study|Adverse Event|12|||
143001863|NCT06045026|515543866|FG000|Overall Study|Withdrawal by Subject|3|||
143001864|NCT06045026|515543866|FG000|Overall Study|Enrollment closed|1|||
143001865|NCT04511533|515543867|FG000|Treatment|Other|2|||
143001866|NCT04511533|515543867|FG000|Treatment|Withdrawal by Subject|11|||
143001867|NCT04511533|515543867|FG000|Treatment|Death|5|||
143001868|NCT04511533|515543867|FG000|Treatment|Physician Decision|1|||
143001869|NCT04511533|515543867|FG000|Treatment|Progressive Disease|61|||
143001870|NCT04511533|515543867|FG000|Follow-Up|Other|7|||
143001871|NCT04511533|515543867|FG000|Follow-Up|Withdrawal by Subject|5|||
143001872|NCT04511533|515543867|FG000|Follow-Up|Lost to Follow-up|2|||
143001873|NCT04511533|515543867|FG000|Follow-Up|Death|4|||
143001874|NCT01224171|515543868|FG000|Overall Study|Adverse Event|8|||
143001875|NCT01224171|515543869|FG001|Overall Study|Adverse Event|4|||
143001876|NCT01224171|515543868|FG000|Overall Study|Protocol Violation|0|||
143001877|NCT01224171|515543869|FG001|Overall Study|Protocol Violation|1|||
143001878|NCT01224171|515543868|FG000|Overall Study|Lack of Efficacy|5|||
143001879|NCT01224171|515543869|FG001|Overall Study|Lack of Efficacy|1|||
143001880|NCT01224171|515543868|FG000|Overall Study|Withdrawal of Consent|2|||
143001881|NCT01224171|515543869|FG001|Overall Study|Withdrawal of Consent|4|||
143001882|NCT01224171|515543868|FG000|Overall Study|Lost to Follow-up|0|||
143001883|NCT01224171|515543869|FG001|Overall Study|Lost to Follow-up|3|||
143001884|NCT03198559|515543873|FG000|Overall Study|Adverse Event|2|||
143001885|NCT03737812|515543874|FG000|Overall Study|Withdrawal by Subject|1|||
143001886|NCT03737812|515543875|FG001|Overall Study|Withdrawal by Subject|2|||
143001887|NCT03737812|515543876|FG002|Overall Study|Withdrawal by Subject|1|||
143001888|NCT03737812|515543874|FG000|Overall Study|Sponsor Discontinued the Study|4|||
143001889|NCT03737812|515543875|FG001|Overall Study|Sponsor Discontinued the Study|3|||
143001890|NCT03737812|515543876|FG002|Overall Study|Sponsor Discontinued the Study|2|||
143001891|NCT03737812|515543874|FG000|Overall Study|Adverse Event|0|||
143001892|NCT03737812|515543875|FG001|Overall Study|Adverse Event|1|||
143001893|NCT03737812|515543876|FG002|Overall Study|Adverse Event|0|||
143001894|NCT03737812|515543874|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
143001895|NCT03737812|515543875|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
143001896|NCT03737812|515543876|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
143001897|NCT02624713|515543877|FG000|Overall Study|Lost to Follow-up|14|||
143001898|NCT02624713|515543878|FG001|Overall Study|Lost to Follow-up|0|||
143001899|NCT00285857|515543882|FG000|Overall Study|Withdrawal by Subject|2|||
143001900|NCT00285857|515543882|FG000|Overall Study|Inadequate initial breast cytology|1|||
143001901|NCT00285857|515543882|FG000|Overall Study|Adverse Event|1|||
143001902|NCT01161173|515543888|FG000|Overall Study|Protocol Violation|13|||
143001903|NCT01161173|515543888|FG000|Overall Study|Lost to Follow-up|7|||
143001904|NCT01161173|515543888|FG000|Overall Study|Progressive Disease|82|||
143001905|NCT01161173|515543888|FG000|Overall Study|Withdrawal of Consent|5|||
143001906|NCT01161173|515543888|FG000|Overall Study|Unacceptable Toxicity|21|||
143001907|NCT01161173|515543888|FG000|Overall Study|Death|194|||
143001908|NCT01161173|515543888|FG000|Overall Study|End of Study|2|||
143001909|NCT01161173|515543888|FG000|Overall Study|Reasons Not Specified|23|||
143001910|NCT01911546|515543889|FG000|Overall Study|Lost to Follow-up|1|||
143001911|NCT01911546|515543889|FG000|Overall Study|Everolimus was discontinued|5|||
143001912|NCT01474291|515543891|FG000|Overall Study|Not Evaluable for Efficacy|26|||
143001913|NCT01474291|515543891|FG000|Overall Study|Lack of Treatment Efficacy|88|||
143001914|NCT01474291|515543891|FG000|Overall Study|Adverse Event|53|||
143001915|NCT01474291|515543891|FG000|Overall Study|Lost to Follow-up|29|||
143001916|NCT01474291|515543891|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
143001917|NCT01474291|515543891|FG000|Overall Study|No Reason Reported|10|||
143001918|NCT01474291|515543891|FG000|Overall Study|Death|2|||
143001919|NCT00792467|515543892|FG000|Overall Study|progression of disease|17|||
143001920|NCT00792467|515543892|FG000|Overall Study|Adverse Event|1|||
143001921|NCT00792467|515543892|FG000|Overall Study|patient request|1|||
143001922|NCT00792467|515543892|FG000|Overall Study|Lost to Follow-up|1|||
143001923|NCT00792467|515543892|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
143001924|NCT00792467|515543892|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
143001925|NCT02213666|515543893|FG000|Overall Study|Withdrawal by Subject|1|||
143001926|NCT01399619|515543894|FG000|Overall Study|Adverse Event|10|||
143001927|NCT01399619|515543895|FG001|Overall Study|Adverse Event|0|||
143001928|NCT01399619|515543896|FG002|Overall Study|Adverse Event|4|||
143001929|NCT01399619|515543897|FG003|Overall Study|Adverse Event|10|||
143001930|NCT01399619|515543894|FG000|Overall Study|Lack of Efficacy|9|||
143001931|NCT01399619|515543895|FG001|Overall Study|Lack of Efficacy|0|||
143001932|NCT01399619|515543896|FG002|Overall Study|Lack of Efficacy|5|||
143001933|NCT01399619|515543897|FG003|Overall Study|Lack of Efficacy|0|||
143001934|NCT01399619|515543894|FG000|Overall Study|Withdrawal by Subject|6|||
143001935|NCT01399619|515543895|FG001|Overall Study|Withdrawal by Subject|0|||
143001936|NCT01399619|515543896|FG002|Overall Study|Withdrawal by Subject|3|||
143001937|NCT01399619|515543897|FG003|Overall Study|Withdrawal by Subject|4|||
143001938|NCT01399619|515543894|FG000|Overall Study|Protocol Violation|0|||
143001939|NCT01399619|515543895|FG001|Overall Study|Protocol Violation|0|||
143001940|NCT01399619|515543896|FG002|Overall Study|Protocol Violation|0|||
143001941|NCT01399619|515543897|FG003|Overall Study|Protocol Violation|1|||
143001942|NCT01399619|515543894|FG000|Overall Study|Not treated|0|||
143001943|NCT01399619|515543895|FG001|Overall Study|Not treated|0|||
143001944|NCT01399619|515543896|FG002|Overall Study|Not treated|0|||
143001945|NCT01399619|515543897|FG003|Overall Study|Not treated|2|||
143001946|NCT03781167|515543909|FG000|Overall Study|Adverse Event|23|||
143001947|NCT03781167|515543910|FG001|Overall Study|Adverse Event|25|||
143001948|NCT03781167|515543909|FG000|Overall Study|Withdrew consent|16|||
143001949|NCT03781167|515543910|FG001|Overall Study|Withdrew consent|12|||
143001950|NCT03781167|515543909|FG000|Overall Study|Lost to Follow-up|0|||
143001951|NCT03781167|515543910|FG001|Overall Study|Lost to Follow-up|1|||
143001952|NCT03781167|515543909|FG000|Overall Study|Lack of Efficacy|4|||
143001953|NCT03781167|515543910|FG001|Overall Study|Lack of Efficacy|5|||
143001954|NCT03781167|515543909|FG000|Overall Study|Difficulty with drug delivery system|2|||
143001955|NCT03781167|515543910|FG001|Overall Study|Difficulty with drug delivery system|3|||
143001956|NCT03781167|515543909|FG000|Overall Study|Other, not specified|2|||
143001957|NCT03781167|515543910|FG001|Overall Study|Other, not specified|2|||
143001958|NCT01590628|515543918|FG000|Overall Study|Death|2|||
143001959|NCT01590628|515543919|FG001|Overall Study|Death|0|||
143001960|NCT00229931|515543920|FG000|Overall Study|Death|1|||
143001961|NCT00229931|515543921|FG001|Overall Study|Death|0|||
143001962|NCT00229931|515543920|FG000|Overall Study|Lost to Follow-up|3|||
143001963|NCT00229931|515543921|FG001|Overall Study|Lost to Follow-up|2|||
143001964|NCT00475657|515543922|FG000|Overall Study|Death|1|||
143001965|NCT00475657|515543922|FG000|Overall Study|Sponsor's Decision|3|||
143001966|NCT02992743|515543923|FG000|Overall Study|Withdrawal by Subject|1|||
143001967|NCT02992743|515543924|FG001|Overall Study|Withdrawal by Subject|1|||
143001968|NCT02992743|515543923|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
143001969|NCT02992743|515543924|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
143001970|NCT02992743|515543923|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
143001971|NCT02992743|515543924|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
143001972|NCT02992743|515543923|FG000|Overall Study|No measurable disease|1|||
143001973|NCT02992743|515543924|FG001|Overall Study|No measurable disease|0|||
143001974|NCT02992743|515543923|FG000|Overall Study|Lost to Follow-up|0|||
143001975|NCT02992743|515543924|FG001|Overall Study|Lost to Follow-up|1|||
143001976|NCT00998166|515543925|FG000|Overall Study|Early Study Termination|8|||
143001977|NCT00697255|515543935|FG000|Stage 1a|Insufficient ovarian response|1|||
143001978|NCT00697255|515543936|FG001|Stage 1a|Insufficient ovarian response|0|||
143001979|NCT00697255|515543935|FG000|Stage 1a|Multifollicular growth|1|||
143001980|NCT00697255|515543936|FG001|Stage 1a|Multifollicular growth|0|||
143001981|NCT00697255|515543935|FG000|Stage 1a|Not growing of dominant follicle|1|||
143001982|NCT00697255|515543936|FG001|Stage 1a|Not growing of dominant follicle|0|||
143001983|NCT00697255|515543935|FG000|Stage 1b|Not growing of dominant follicle|0|||
143001984|NCT00697255|515543936|FG001|Stage 1b|Not growing of dominant follicle|1|||
143001985|NCT00697255|515543935|FG000|Stage 1b|Insufficient ovarian response|0|||
143001986|NCT00697255|515543936|FG001|Stage 1b|Insufficient ovarian response|1|||
143001987|NCT02243306|515543941|FG000|Overall Study|Adverse Event|0|||
143001988|NCT02243306|515543942|FG001|Overall Study|Adverse Event|1|||
143001989|NCT02243306|515543941|FG000|Overall Study|Other: Reached stopping criteria|0|||
143001990|NCT02243306|515543942|FG001|Overall Study|Other: Reached stopping criteria|1|||
143001991|NCT02243306|515543941|FG000|Overall Study|Physician Decision|0|||
143001992|NCT02243306|515543942|FG001|Overall Study|Physician Decision|1|||
143001993|NCT01016912|515543943|FG000|End of Treatment Period|Lack of Efficacy|0|||
143001994|NCT01016912|515543944|FG001|End of Treatment Period|Lack of Efficacy|1|||
143001995|NCT01016912|515543945|FG002|End of Treatment Period|Lack of Efficacy|0|||
143001996|NCT01016912|515543946|FG003|End of Treatment Period|Lack of Efficacy|4|||
143001997|NCT01016912|515543947|FG004|End of Treatment Period|Lack of Efficacy|4|||
143001998|NCT01016912|515543943|FG000|End of Treatment Period|Adverse Event|0|||
143001999|NCT01016912|515543944|FG001|End of Treatment Period|Adverse Event|1|||
143002000|NCT01016912|515543945|FG002|End of Treatment Period|Adverse Event|1|||
143002001|NCT01016912|515543946|FG003|End of Treatment Period|Adverse Event|0|||
143002002|NCT01016912|515543947|FG004|End of Treatment Period|Adverse Event|0|||
143002003|NCT01016912|515543943|FG000|End of Treatment Period|Completed double-blind period only|0|||
143002004|NCT01016912|515543944|FG001|End of Treatment Period|Completed double-blind period only|1|||
143002005|NCT01016912|515543945|FG002|End of Treatment Period|Completed double-blind period only|0|||
143002006|NCT01016912|515543946|FG003|End of Treatment Period|Completed double-blind period only|0|||
143002007|NCT01016912|515543947|FG004|End of Treatment Period|Completed double-blind period only|0|||
143002008|NCT01016912|515543943|FG000|Follow-up Period|Other reason|0|||
143002009|NCT01016912|515543944|FG001|Follow-up Period|Other reason|0|||
143002010|NCT01016912|515543945|FG002|Follow-up Period|Other reason|1|||
143002011|NCT01016912|515543946|FG003|Follow-up Period|Other reason|1|||
143002012|NCT01016912|515543947|FG004|Follow-up Period|Other reason|0|||
143002013|NCT01018680|515545678|FG000|Overall Study|Adverse Event|23|||
143002014|NCT01018680|515545679|FG001|Overall Study|Adverse Event|40|||
143002015|NCT01018680|515545678|FG000|Overall Study|Withdrawal by Subject|10|||
143002016|NCT01018680|515545679|FG001|Overall Study|Withdrawal by Subject|10|||
143002017|NCT01018680|515545678|FG000|Overall Study|Protocol Violation|5|||
143002018|NCT01018680|515545679|FG001|Overall Study|Protocol Violation|8|||
143002019|NCT01018680|515545678|FG000|Overall Study|Sponsor Decision|6|||
143002020|NCT01018680|515545679|FG001|Overall Study|Sponsor Decision|7|||
143002021|NCT01018680|515545678|FG000|Overall Study|Lack of Efficacy|8|||
143002022|NCT01018680|515545679|FG001|Overall Study|Lack of Efficacy|2|||
143002023|NCT01018680|515545678|FG000|Overall Study|Lost to Follow-up|5|||
143002024|NCT01018680|515545679|FG001|Overall Study|Lost to Follow-up|3|||
143002025|NCT01018680|515545678|FG000|Overall Study|Entry Criteria Not Met|1|||
143002026|NCT01018680|515545679|FG001|Overall Study|Entry Criteria Not Met|4|||
143002027|NCT01018680|515545678|FG000|Overall Study|Physician Decision|3|||
143002028|NCT01018680|515545679|FG001|Overall Study|Physician Decision|1|||
143002029|NCT02930889|515545680|FG000|Overall Study|Lost to Follow-up|2|||
143002030|NCT02930889|515545680|FG000|Overall Study|Withdrawal by Subject|6|||
143002031|NCT02930889|515545680|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
143002032|NCT03159455|515545683|FG000|Overall Study|Adverse Event|0|||
143002033|NCT03159455|515545684|FG001|Overall Study|Adverse Event|0|||
143002034|NCT03159455|515545685|FG002|Overall Study|Adverse Event|0|||
143002035|NCT03159455|515545686|FG003|Overall Study|Adverse Event|0|||
143002036|NCT03159455|515545687|FG004|Overall Study|Adverse Event|0|||
143002037|NCT03159455|515545688|FG005|Overall Study|Adverse Event|1|||
143002038|NCT05056311|515545689|FG000|Overall Study|Lost to Follow-up|14|||
143002039|NCT05056311|515545689|FG000|Overall Study|Withdrawal by Subject|1|||
143002040|NCT05056311|515545689|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
143002041|NCT01714726|515545692|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
143002042|NCT01714726|515545693|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
143002043|NCT01714726|515545694|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
143002044|NCT01714726|515545695|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
143002045|NCT01714726|515545692|FG000|Double-Blinded Induction Period|Adverse Event|0|||
143002046|NCT01714726|515545693|FG001|Double-Blinded Induction Period|Adverse Event|1|||
143002047|NCT01714726|515545694|FG002|Double-Blinded Induction Period|Adverse Event|0|||
143002048|NCT01714726|515545695|FG003|Double-Blinded Induction Period|Adverse Event|0|||
143002049|NCT01714726|515545692|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
143002050|NCT01714726|515545693|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
143002051|NCT01714726|515545694|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
143002052|NCT01714726|515545695|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
143002053|NCT01714726|515545692|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
143002054|NCT01714726|515545693|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
143002055|NCT01714726|515545694|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
143002056|NCT01714726|515545695|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
143002057|NCT01714726|515545692|FG000|Open-Label Period|Other|0|||
143002058|NCT01714726|515545693|FG001|Open-Label Period|Other|0|||
143002059|NCT01714726|515545694|FG002|Open-Label Period|Other|1|||
143002060|NCT01714726|515545695|FG003|Open-Label Period|Other|3|||
143002061|NCT01714726|515545692|FG000|Open-Label Period|Adverse Event|0|||
143002062|NCT01714726|515545693|FG001|Open-Label Period|Adverse Event|0|||
143002063|NCT01714726|515545694|FG002|Open-Label Period|Adverse Event|1|||
143002064|NCT01714726|515545695|FG003|Open-Label Period|Adverse Event|0|||
143002065|NCT01714726|515545692|FG000|Open-Label Period|Withdrawal by Subject|0|||
143002066|NCT01714726|515545693|FG001|Open-Label Period|Withdrawal by Subject|0|||
143002067|NCT01714726|515545694|FG002|Open-Label Period|Withdrawal by Subject|9|||
143002068|NCT01714726|515545695|FG003|Open-Label Period|Withdrawal by Subject|19|||
143002069|NCT01714726|515545692|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
143002070|NCT01714726|515545693|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
143002071|NCT01714726|515545694|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
143002072|NCT01714726|515545695|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
143002073|NCT01714726|515545692|FG000|Open-Label Period|Lost to Follow-up|0|||
143002074|NCT01714726|515545693|FG001|Open-Label Period|Lost to Follow-up|0|||
143002075|NCT01714726|515545694|FG002|Open-Label Period|Lost to Follow-up|3|||
143002076|NCT01714726|515545695|FG003|Open-Label Period|Lost to Follow-up|4|||
143002077|NCT02501642|515545696|FG000|Overall Study|Lost to Follow-up|7|||
143002078|NCT02501642|515545697|FG001|Overall Study|Lost to Follow-up|11|||
143002079|NCT00474994|515545700|FG000|Overall Study|Patient Not treated|1|||
143002080|NCT00474994|515545700|FG000|Overall Study|Patient evaluable for toxicity only|3|||
143002081|NCT00474994|515545700|FG000|Overall Study|Patient found to be ineligible|1|||
143002082|NCT03472586|515545702|FG000|Overall Study|Physician Decision|6|||
143002083|NCT03472586|515545702|FG000|Overall Study|Death|6|||
143002084|NCT03472586|515545702|FG000|Overall Study|Adverse Event|1|||
143002085|NCT00750061|515545704|FG000|Overall Study|Adverse Event|2|||
143002086|NCT00750061|515545705|FG001|Overall Study|Adverse Event|0|||
143002087|NCT00750061|515545704|FG000|Overall Study|Withdrawal by Subject|0|||
143002088|NCT00750061|515545705|FG001|Overall Study|Withdrawal by Subject|1|||
143002089|NCT00750061|515545704|FG000|Overall Study|Physician Decision|0|||
143002090|NCT00750061|515545705|FG001|Overall Study|Physician Decision|1|||
143002091|NCT03417245|515545708|FG000|Overall Study|Adverse Event|1|||
143002092|NCT03417245|515545709|FG001|Overall Study|Adverse Event|0|||
143002093|NCT03417245|515545708|FG000|Overall Study|Protocol Violation|1|||
143002094|NCT03417245|515545709|FG001|Overall Study|Protocol Violation|0|||
143002095|NCT03417245|515545708|FG000|Overall Study|Withdrawal by Subject|1|||
143002096|NCT03417245|515545709|FG001|Overall Study|Withdrawal by Subject|1|||
143002097|NCT02708524|515545713|FG000|Overall Study|Adverse Event|0|||
143002098|NCT02708524|515545714|FG001|Overall Study|Adverse Event|1|||
143002099|NCT02708524|515545715|FG002|Overall Study|Adverse Event|0|||
143002100|NCT02708524|515545716|FG003|Overall Study|Adverse Event|0|||
143002101|NCT02708524|515545713|FG000|Overall Study|Lens Discomfort|1|||
143002102|NCT02708524|515545714|FG001|Overall Study|Lens Discomfort|0|||
143002103|NCT02708524|515545715|FG002|Overall Study|Lens Discomfort|1|||
143002104|NCT02708524|515545716|FG003|Overall Study|Lens Discomfort|0|||
143002105|NCT02708524|515545713|FG000|Overall Study|Lost to Follow-up|1|||
143002106|NCT02708524|515545714|FG001|Overall Study|Lost to Follow-up|1|||
143002107|NCT02708524|515545715|FG002|Overall Study|Lost to Follow-up|1|||
143002108|NCT02708524|515545716|FG003|Overall Study|Lost to Follow-up|0|||
143002109|NCT02708524|515545713|FG000|Overall Study|Protocol Violation|0|||
143002110|NCT02708524|515545714|FG001|Overall Study|Protocol Violation|1|||
143002111|NCT02708524|515545715|FG002|Overall Study|Protocol Violation|0|||
143002112|NCT02708524|515545716|FG003|Overall Study|Protocol Violation|0|||
143002113|NCT02708524|515545713|FG000|Overall Study|Withdrawal by Subject|1|||
143002114|NCT02708524|515545714|FG001|Overall Study|Withdrawal by Subject|1|||
143002115|NCT02708524|515545715|FG002|Overall Study|Withdrawal by Subject|0|||
143002116|NCT02708524|515545716|FG003|Overall Study|Withdrawal by Subject|0|||
143002117|NCT02708524|515545713|FG000|Overall Study|Dispensed incorrect study lens|0|||
143002118|NCT02708524|515545714|FG001|Overall Study|Dispensed incorrect study lens|1|||
143002119|NCT02708524|515545715|FG002|Overall Study|Dispensed incorrect study lens|1|||
143002120|NCT02708524|515545716|FG003|Overall Study|Dispensed incorrect study lens|0|||
143002121|NCT02708524|515545713|FG000|Overall Study|Did not wear lens at final visit|0|||
143002122|NCT02708524|515545714|FG001|Overall Study|Did not wear lens at final visit|1|||
143002123|NCT02708524|515545715|FG002|Overall Study|Did not wear lens at final visit|0|||
143002124|NCT02708524|515545716|FG003|Overall Study|Did not wear lens at final visit|0|||
143002125|NCT02708524|515545713|FG000|Overall Study|Subject lost study lens|1|||
143002126|NCT02708524|515545714|FG001|Overall Study|Subject lost study lens|0|||
143002127|NCT02708524|515545715|FG002|Overall Study|Subject lost study lens|0|||
143002128|NCT02708524|515545716|FG003|Overall Study|Subject lost study lens|0|||
143002129|NCT00381680|515545717|FG000|Overall Study|Adverse Event|9|||
143002130|NCT00381680|515545718|FG001|Overall Study|Adverse Event|3|||
143002131|NCT00381680|515545717|FG000|Overall Study|Death|10|||
143002132|NCT00381680|515545718|FG001|Overall Study|Death|7|||
143002133|NCT00381680|515545717|FG000|Overall Study|Lost to Follow-up|3|||
143002134|NCT00381680|515545718|FG001|Overall Study|Lost to Follow-up|2|||
143002135|NCT00381680|515545717|FG000|Overall Study|Physician Decision|25|||
143002136|NCT00381680|515545718|FG001|Overall Study|Physician Decision|6|||
143002137|NCT00381680|515545717|FG000|Overall Study|Withdrawal by Subject|3|||
143002138|NCT00381680|515545718|FG001|Overall Study|Withdrawal by Subject|1|||
143002139|NCT00381680|515545717|FG000|Overall Study|Entry onto another COG Trial|1|||
143002140|NCT00381680|515545718|FG001|Overall Study|Entry onto another COG Trial|2|||
143002141|NCT00381680|515545717|FG000|Overall Study|Alternative Therapy|11|||
143002142|NCT00381680|515545718|FG001|Overall Study|Alternative Therapy|5|||
143002143|NCT00381680|515545717|FG000|Overall Study|Secondary Malignancy|3|||
143002144|NCT00381680|515545718|FG001|Overall Study|Secondary Malignancy|0|||
143002145|NCT00381680|515545717|FG000|Overall Study|Delay initiation|1|||
143002146|NCT00381680|515545718|FG001|Overall Study|Delay initiation|0|||
143002147|NCT00381680|515545717|FG000|Overall Study|Stem Cell Transplant|26|||
143002148|NCT00381680|515545718|FG001|Overall Study|Stem Cell Transplant|10|||
143002149|NCT00381680|515545717|FG000|Overall Study|Relapse|18|||
143002150|NCT00381680|515545718|FG001|Overall Study|Relapse|9|||
143002151|NCT00381680|515545717|FG000|Overall Study|Induction Failure|4|||
143002152|NCT00381680|515545718|FG001|Overall Study|Induction Failure|1|||
143002153|NCT00381680|515545717|FG000|Overall Study|Progression|1|||
143002154|NCT00381680|515545718|FG001|Overall Study|Progression|1|||
143002155|NCT00381680|515545717|FG000|Overall Study|Other not otherwise specified|7|||
143002156|NCT00381680|515545718|FG001|Overall Study|Other not otherwise specified|2|||
143002157|NCT00381680|515545717|FG000|Overall Study|Ineligible|3|||
143002158|NCT00381680|515545718|FG001|Overall Study|Ineligible|1|||
143002159|NCT00361504|515545721|FG000|Overall Study|Withdrawal by Subject|94|||
143002160|NCT00361504|515545722|FG001|Overall Study|Withdrawal by Subject|31|||
143002161|NCT00361504|515545721|FG000|Overall Study|Lost to Follow-up|40|||
143002162|NCT00361504|515545722|FG001|Overall Study|Lost to Follow-up|7|||
143002163|NCT00361504|515545721|FG000|Overall Study|Adverse Event|203|||
143002164|NCT00361504|515545722|FG001|Overall Study|Adverse Event|82|||
143002165|NCT00361504|515545721|FG000|Overall Study|Lack of Efficacy|72|||
143002166|NCT00361504|515545722|FG001|Overall Study|Lack of Efficacy|7|||
143002167|NCT00361504|515545721|FG000|Overall Study|Resolution of Pain|2|||
143002168|NCT00361504|515545722|FG001|Overall Study|Resolution of Pain|0|||
143002169|NCT00361504|515545721|FG000|Overall Study|Study medication non compliant|42|||
143002170|NCT00361504|515545722|FG001|Overall Study|Study medication non compliant|15|||
143002171|NCT00361504|515545721|FG000|Overall Study|All other|28|||
143002172|NCT00361504|515545722|FG001|Overall Study|All other|3|||
143002173|NCT01374516|515545724|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
143002174|NCT01374516|515545725|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
143002175|NCT01374516|515545724|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
143002176|NCT01374516|515545725|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
143002177|NCT01374516|515545724|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
143002178|NCT01374516|515545725|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
143002179|NCT01374516|515545724|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
143002180|NCT01374516|515545725|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
143002181|NCT01374516|515545724|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
143002182|NCT01374516|515545725|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
143002183|NCT01374516|515545724|FG000|Surveillance Expansion Period|Protocol Violation|386|||
143002184|NCT01374516|515545725|FG001|Surveillance Expansion Period|Protocol Violation|217|||
143002185|NCT01374516|515545724|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
143002186|NCT01374516|515545725|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
143002187|NCT01374516|515545724|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
143002188|NCT01374516|515545725|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
143002189|NCT01374516|515545724|FG000|Surveillance Expansion Period|Serious adverse event|20|||
143002190|NCT01374516|515545725|FG001|Surveillance Expansion Period|Serious adverse event|5|||
143002191|NCT03732534|515545730|FG000|Overall Study|Study terminated by Sponsor|6|||
143002192|NCT02190604|515545731|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
143002193|NCT02190604|515545732|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
143002194|NCT02190604|515545733|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
143002195|NCT02190604|515545734|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
143002196|NCT02190604|515545735|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
143002197|NCT02190604|515545736|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
143002198|NCT02190604|515545737|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
143002199|NCT02190604|515545738|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
143002200|NCT02190604|515545739|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
143002201|NCT02190604|515545740|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
143002202|NCT02190604|515545741|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
143002203|NCT02190604|515545742|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
143002204|NCT02190604|515545743|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
143002205|NCT02190604|515545744|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
143002206|NCT02190604|515545745|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
143002207|NCT02190604|515545746|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
143002208|NCT02190604|515545747|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
143002209|NCT02190604|515545748|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
143002210|NCT02190604|515545749|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
143002211|NCT02190604|515545731|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
143002212|NCT02190604|515545732|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
143002213|NCT02190604|515545733|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
143002214|NCT02190604|515545734|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
143002215|NCT02190604|515545735|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
143002216|NCT02190604|515545736|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
143002217|NCT02190604|515545737|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
143002218|NCT02190604|515545738|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
143002219|NCT02190604|515545739|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
143002220|NCT02190604|515545740|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
143002221|NCT02190604|515545741|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
143002222|NCT02190604|515545742|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
143002223|NCT02190604|515545743|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
143002224|NCT02190604|515545744|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
143002225|NCT02190604|515545745|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
143002226|NCT02190604|515545746|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
143002227|NCT02190604|515545747|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
143002228|NCT02190604|515545748|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
143002229|NCT02190604|515545749|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
143002230|NCT03735849|515545750|FG000|Overall Study|Lost to Follow-up|1|||
143002231|NCT03735849|515545751|FG001|Overall Study|Lost to Follow-up|0|||
143002232|NCT03735849|515545752|FG002|Overall Study|Lost to Follow-up|0|||
143002233|NCT03735849|515545750|FG000|Overall Study|Participant unable to adhere to visit|1|||
143002234|NCT03735849|515545751|FG001|Overall Study|Participant unable to adhere to visit|0|||
143002235|NCT03735849|515545752|FG002|Overall Study|Participant unable to adhere to visit|0|||
143002236|NCT03735849|515545750|FG000|Overall Study|Not Randomized|0|||
143002237|NCT03735849|515545751|FG001|Overall Study|Not Randomized|0|||
143002238|NCT03735849|515545752|FG002|Overall Study|Not Randomized|4|||
143002239|NCT04585906|515545755|FG000|Overall Study|Lost to Follow-up|8|||
143002240|NCT04585906|515545756|FG001|Overall Study|Lost to Follow-up|5|||
143002241|NCT01333501|515545760|FG000|Overall Study|Adverse Event|3|||
143002242|NCT01333501|515545761|FG001|Overall Study|Adverse Event|1|||
143002243|NCT01333501|515545760|FG000|Overall Study|Abnormal laboratory value|2|||
143002244|NCT01333501|515545761|FG001|Overall Study|Abnormal laboratory value|1|||
143002245|NCT01333501|515545760|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
143002246|NCT01333501|515545761|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
143002247|NCT01333501|515545760|FG000|Overall Study|Withdrawn consent|3|||
143002248|NCT01333501|515545761|FG001|Overall Study|Withdrawn consent|12|||
143002249|NCT00914940|515545762|FG000|D0 to D100 Post-transplant|Death|2|||
143002250|NCT00914940|515545762|FG000|D101 to 2 Years Post-transplant|Death|8|||
143002251|NCT00914940|515545762|FG000|2 Years to 5 Years Post-transplant|Death|3|||
143002252|NCT02221882|515545763|FG000|Overall Study|Withdrawal by Subject|0|||
143002253|NCT02221882|515545764|FG001|Overall Study|Withdrawal by Subject|0|||
143002254|NCT02221882|515545765|FG002|Overall Study|Withdrawal by Subject|4|||
143002255|NCT02221882|515545766|FG003|Overall Study|Withdrawal by Subject|2|||
143002256|NCT02221882|515545767|FG004|Overall Study|Withdrawal by Subject|2|||
143002257|NCT02221882|515545768|FG005|Overall Study|Withdrawal by Subject|2|||
143002258|NCT02221882|515545763|FG000|Overall Study|Death|0|||
143002259|NCT02221882|515545764|FG001|Overall Study|Death|1|||
143002260|NCT02221882|515545765|FG002|Overall Study|Death|0|||
143002261|NCT02221882|515545766|FG003|Overall Study|Death|0|||
143002262|NCT02221882|515545767|FG004|Overall Study|Death|0|||
143002263|NCT02221882|515545768|FG005|Overall Study|Death|0|||
143002264|NCT00796367|515545769|FG000|Overall Study|Adverse Event|6|||
143002265|NCT00796367|515545770|FG001|Overall Study|Adverse Event|4|||
143002266|NCT00796367|515545771|FG002|Overall Study|Adverse Event|7|||
143002267|NCT00796367|515545769|FG000|Overall Study|Lost to Follow-up|5|||
143002268|NCT00796367|515545770|FG001|Overall Study|Lost to Follow-up|4|||
143002269|NCT00796367|515545771|FG002|Overall Study|Lost to Follow-up|21|||
143002270|NCT00796367|515545769|FG000|Overall Study|Withdrawal by Subject|9|||
143002271|NCT00796367|515545770|FG001|Overall Study|Withdrawal by Subject|11|||
143002272|NCT00796367|515545771|FG002|Overall Study|Withdrawal by Subject|12|||
143002273|NCT00796367|515545769|FG000|Overall Study|Lack of Efficacy|2|||
143002274|NCT00796367|515545770|FG001|Overall Study|Lack of Efficacy|1|||
143002275|NCT00796367|515545771|FG002|Overall Study|Lack of Efficacy|0|||
143002276|NCT00796367|515545769|FG000|Overall Study|non compliance|3|||
143002277|NCT00796367|515545770|FG001|Overall Study|non compliance|1|||
143002278|NCT00796367|515545771|FG002|Overall Study|non compliance|1|||
143002279|NCT00796367|515545769|FG000|Overall Study|Pregnancy|1|||
143002280|NCT00796367|515545770|FG001|Overall Study|Pregnancy|0|||
143002281|NCT00796367|515545771|FG002|Overall Study|Pregnancy|1|||
143002282|NCT00796367|515545769|FG000|Overall Study|Requirement for restricted medication|2|||
143002283|NCT00796367|515545770|FG001|Overall Study|Requirement for restricted medication|0|||
143002284|NCT00796367|515545771|FG002|Overall Study|Requirement for restricted medication|2|||
143002285|NCT00796367|515545769|FG000|Overall Study|other|2|||
143002286|NCT00796367|515545770|FG001|Overall Study|other|4|||
143002287|NCT00796367|515545771|FG002|Overall Study|other|3|||
143002288|NCT02260791|515545775|FG000|Overall Study|Lost to Follow-up|4|||
143002289|NCT02260791|515545776|FG001|Overall Study|Lost to Follow-up|4|||
143002290|NCT02260791|515545775|FG000|Overall Study|Lack of Efficacy|2|||
143002291|NCT02260791|515545776|FG001|Overall Study|Lack of Efficacy|1|||
143002292|NCT02260791|515545775|FG000|Overall Study|Adverse Event|13|||
143002293|NCT02260791|515545776|FG001|Overall Study|Adverse Event|9|||
143002294|NCT02260791|515545775|FG000|Overall Study|Death|1|||
143002295|NCT02260791|515545776|FG001|Overall Study|Death|0|||
143002296|NCT02260791|515545775|FG000|Overall Study|Withdrawal by Subject|11|||
143002297|NCT02260791|515545776|FG001|Overall Study|Withdrawal by Subject|16|||
143002298|NCT02260791|515545775|FG000|Overall Study|Screen failure|0|||
143002299|NCT02260791|515545776|FG001|Overall Study|Screen failure|1|||
143002300|NCT02260791|515545775|FG000|Overall Study|Protocol deviation|2|||
143002301|NCT02260791|515545776|FG001|Overall Study|Protocol deviation|3|||
143002302|NCT04246996|515545777|FG000|Overall Study|Physician Decision|1|||
143002303|NCT04246996|515545778|FG001|Overall Study|Physician Decision|1|||
143002304|NCT04246996|515545777|FG000|Overall Study|Did not meet eligibility criteria|1|||
143002305|NCT04246996|515545778|FG001|Overall Study|Did not meet eligibility criteria|4|||
143002306|NCT01411917|515545779|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
143002307|NCT01411917|515545780|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
143002308|NCT00242658|515545783|FG000|Overall Study|Lost to Follow-up|22|||
143002309|NCT00242658|515545784|FG001|Overall Study|Lost to Follow-up|19|||
143002310|NCT01815099|515545785|FG000|Overall Study|Lack of Efficacy|1|||
143002311|NCT01815099|515545785|FG000|Overall Study|unable to attend study visits|1|||
143002312|NCT01475214|515545788|FG000|Overall Study|Lost to Follow-up|1|||
143002313|NCT01475214|515545789|FG001|Overall Study|Lost to Follow-up|0|||
143002314|NCT01475214|515545790|FG002|Overall Study|Lost to Follow-up|1|||
143002315|NCT01475214|515545788|FG000|Overall Study|Physician Decision|2|||
143002316|NCT01475214|515545789|FG001|Overall Study|Physician Decision|0|||
143002317|NCT01475214|515545790|FG002|Overall Study|Physician Decision|0|||
143002318|NCT01475214|515545788|FG000|Overall Study|Withdrawal by Subject|2|||
143002319|NCT01475214|515545789|FG001|Overall Study|Withdrawal by Subject|4|||
143002320|NCT01475214|515545790|FG002|Overall Study|Withdrawal by Subject|1|||
143002321|NCT00643851|515545791|FG000|Overall Study|Death|0|||
143002322|NCT00643851|515545792|FG001|Overall Study|Death|1|||
143002323|NCT00643851|515545793|FG002|Overall Study|Death|0|||
143002324|NCT00643851|515545791|FG000|Overall Study|Lack of Efficacy|0|||
143002325|NCT00643851|515545792|FG001|Overall Study|Lack of Efficacy|1|||
143002326|NCT00643851|515545793|FG002|Overall Study|Lack of Efficacy|0|||
143002327|NCT00643851|515545791|FG000|Overall Study|Adverse Event|2|||
143002328|NCT00643851|515545792|FG001|Overall Study|Adverse Event|6|||
143002329|NCT00643851|515545793|FG002|Overall Study|Adverse Event|6|||
143002330|NCT00643851|515545791|FG000|Overall Study|Lost to Follow-up|4|||
143002331|NCT00643851|515545792|FG001|Overall Study|Lost to Follow-up|6|||
143002332|NCT00643851|515545793|FG002|Overall Study|Lost to Follow-up|9|||
143002333|NCT00643851|515545791|FG000|Overall Study|Withdrawal by Subject|8|||
143002334|NCT00643851|515545792|FG001|Overall Study|Withdrawal by Subject|15|||
143002335|NCT00643851|515545793|FG002|Overall Study|Withdrawal by Subject|9|||
143002336|NCT00643851|515545791|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
143002337|NCT00643851|515545792|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
143002338|NCT00643851|515545793|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
143002339|NCT02354599|515545796|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
143002340|NCT02354599|515545797|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
143002341|NCT02354599|515545798|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
143002342|NCT02354599|515545799|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
143002343|NCT02354599|515545800|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
143002344|NCT02354599|515545801|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
143002345|NCT02354599|515545796|FG000|Overall Study|Withdrawal by Subject|1|||
143002346|NCT02354599|515545797|FG001|Overall Study|Withdrawal by Subject|1|||
143002347|NCT02354599|515545798|FG002|Overall Study|Withdrawal by Subject|0|||
143002348|NCT02354599|515545799|FG003|Overall Study|Withdrawal by Subject|0|||
143002349|NCT02354599|515545800|FG004|Overall Study|Withdrawal by Subject|0|||
143002350|NCT02354599|515545801|FG005|Overall Study|Withdrawal by Subject|0|||
143002351|NCT04806334|515545802|FG000|Overall Study|Withdrawal by Subject|1|||
143002352|NCT04557189|515545807|FG000|Overall Study|Adverse Event|0|||
143002353|NCT04557189|515545808|FG001|Overall Study|Adverse Event|1|||
143002354|NCT04557189|515545807|FG000|Overall Study|Lost to Follow-up|1|||
143002355|NCT04557189|515545808|FG001|Overall Study|Lost to Follow-up|1|||
143002356|NCT04557189|515545807|FG000|Overall Study|Withdrawal by Subject|2|||
143002357|NCT04557189|515545808|FG001|Overall Study|Withdrawal by Subject|1|||
143002358|NCT04557189|515545807|FG000|Overall Study|Reason not Specified|3|||
143002359|NCT04557189|515545808|FG001|Overall Study|Reason not Specified|6|||
143002360|NCT00553319|515545824|FG000|Overall Study|Lost to Follow-up|10|||
143002361|NCT00553319|515545825|FG001|Overall Study|Lost to Follow-up|9|||
143002362|NCT00553319|515545826|FG002|Overall Study|Lost to Follow-up|5|||
143002363|NCT00553319|515545824|FG000|Overall Study|wanted treatment elsewhere|2|||
143002364|NCT00553319|515545825|FG001|Overall Study|wanted treatment elsewhere|1|||
143002365|NCT00553319|515545826|FG002|Overall Study|wanted treatment elsewhere|1|||
143002366|NCT00553319|515545824|FG000|Overall Study|non-compliance|0|||
143002367|NCT00553319|515545825|FG001|Overall Study|non-compliance|0|||
143002368|NCT00553319|515545826|FG002|Overall Study|non-compliance|2|||
143002369|NCT00553319|515545824|FG000|Overall Study|incarceration|1|||
143002370|NCT00553319|515545825|FG001|Overall Study|incarceration|0|||
143002371|NCT00553319|515545826|FG002|Overall Study|incarceration|0|||
143002372|NCT00553319|515545824|FG000|Overall Study|moved|1|||
143002373|NCT00553319|515545825|FG001|Overall Study|moved|0|||
143002374|NCT00553319|515545826|FG002|Overall Study|moved|1|||
143002375|NCT01087944|515545827|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
143002376|NCT01087944|515545828|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
143002377|NCT01087944|515545827|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
143002378|NCT01087944|515545828|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
143002379|NCT01731600|515545834|FG000|Overall Study|Adverse Event|2|||
143002380|NCT01731600|515545835|FG001|Overall Study|Adverse Event|0|||
143002381|NCT01731600|515545834|FG000|Overall Study|Withdrawal criteria|1|||
143002382|NCT01731600|515545835|FG001|Overall Study|Withdrawal criteria|0|||
143002383|NCT01731600|515545834|FG000|Overall Study|Other reasons|3|||
143002384|NCT01731600|515545835|FG001|Overall Study|Other reasons|0|||
143002385|NCT03575975|515545836|FG000|Overall Study|Lost to Follow-up|1|||
143002386|NCT03575975|515545837|FG001|Overall Study|Lost to Follow-up|0|||
143002387|NCT03575975|515545838|FG002|Overall Study|Lost to Follow-up|0|||
143002388|NCT00465894|515545839|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
143002389|NCT00465894|515545840|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
143002390|NCT00465894|515545839|FG000|Treatment For 12 Weeks|Family Issues|1|||
143002391|NCT00465894|515545840|FG001|Treatment For 12 Weeks|Family Issues|1|||
143002392|NCT00465894|515545839|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
143002393|NCT00465894|515545840|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
143002394|NCT00495794|515545841|FG000|Overall Study|Pharmacist did not activate patient|522|||
143002395|NCT00495794|515545842|FG001|Overall Study|Pharmacist did not activate patient|0|||
143002396|NCT01636076|515545843|FG000|Overall Study|Terminated by sponsor|1|||
143002397|NCT01636076|515545844|FG001|Overall Study|Terminated by sponsor|1|||
143002398|NCT01636076|515545843|FG000|Overall Study|Lack of Efficacy|0|||
143002399|NCT01636076|515545844|FG001|Overall Study|Lack of Efficacy|1|||
143002400|NCT01636076|515545843|FG000|Overall Study|Lost to Follow-up|1|||
143002401|NCT01636076|515545844|FG001|Overall Study|Lost to Follow-up|0|||
143002402|NCT01636076|515545843|FG000|Overall Study|Physician Decision|1|||
143002403|NCT01636076|515545844|FG001|Overall Study|Physician Decision|1|||
143002404|NCT01636076|515545843|FG000|Overall Study|Non-compliance with study treatment|1|||
143002405|NCT01636076|515545844|FG001|Overall Study|Non-compliance with study treatment|1|||
143002406|NCT01636076|515545843|FG000|Overall Study|Adverse Event|6|||
143002407|NCT01636076|515545844|FG001|Overall Study|Adverse Event|11|||
143002408|NCT01636076|515545843|FG000|Overall Study|Withdrawal by Subject|7|||
143002409|NCT01636076|515545844|FG001|Overall Study|Withdrawal by Subject|10|||
143002410|NCT01159665|515545845|FG000|Overall Study|Withdrawal by Subject|0|||
143002411|NCT01159665|515545846|FG001|Overall Study|Withdrawal by Subject|1|||
143002412|NCT01159665|515545847|FG002|Overall Study|Withdrawal by Subject|0|||
143002413|NCT01159665|515545848|FG003|Overall Study|Withdrawal by Subject|0|||
143002414|NCT01159665|515545849|FG004|Overall Study|Withdrawal by Subject|0|||
143002415|NCT01159665|515545850|FG005|Overall Study|Withdrawal by Subject|0|||
143002416|NCT00540228|515545851|FG000|Overall Study|Adverse Event|2|||
143002417|NCT00540228|515545852|FG001|Overall Study|Adverse Event|0|||
143002418|NCT00540228|515545853|FG002|Overall Study|Adverse Event|0|||
143002419|NCT00540228|515545854|FG003|Overall Study|Adverse Event|0|||
143002420|NCT00540228|515545855|FG004|Overall Study|Adverse Event|0|||
143002421|NCT00540228|515545851|FG000|Overall Study|Lost to Follow-up|1|||
143002422|NCT00540228|515545852|FG001|Overall Study|Lost to Follow-up|1|||
143002423|NCT00540228|515545853|FG002|Overall Study|Lost to Follow-up|0|||
143002424|NCT00540228|515545854|FG003|Overall Study|Lost to Follow-up|0|||
143002425|NCT00540228|515545855|FG004|Overall Study|Lost to Follow-up|0|||
143002426|NCT02451137|515545856|FG000|Overall Study|Randomized but not treated|19|||
143002427|NCT02451137|515545857|FG001|Overall Study|Randomized but not treated|27|||
143002428|NCT02451137|515545856|FG000|Overall Study|Adverse Event|43|||
143002429|NCT02451137|515545857|FG001|Overall Study|Adverse Event|42|||
143002430|NCT02451137|515545856|FG000|Overall Study|Lack of Efficacy|4|||
143002431|NCT02451137|515545857|FG001|Overall Study|Lack of Efficacy|9|||
143002432|NCT02451137|515545856|FG000|Overall Study|Participant decision:discontinue insulin|41|||
143002433|NCT02451137|515545857|FG001|Overall Study|Participant decision:discontinue insulin|43|||
143002434|NCT02451137|515545856|FG000|Overall Study|Hypoglycemia|2|||
143002435|NCT02451137|515545857|FG001|Overall Study|Hypoglycemia|1|||
143002436|NCT02451137|515545856|FG000|Overall Study|Investigator's decision|23|||
143002437|NCT02451137|515545857|FG001|Overall Study|Investigator's decision|19|||
143002438|NCT02451137|515545856|FG000|Overall Study|Lost to Follow-up|53|||
143002439|NCT02451137|515545857|FG001|Overall Study|Lost to Follow-up|61|||
143002440|NCT02451137|515545856|FG000|Overall Study|Physician Decision|6|||
143002441|NCT02451137|515545857|FG001|Overall Study|Physician Decision|5|||
143002442|NCT02451137|515545856|FG000|Overall Study|Sponsor decision|13|||
143002443|NCT02451137|515545857|FG001|Overall Study|Sponsor decision|25|||
143002444|NCT02451137|515545856|FG000|Overall Study|Withdrawal by Subject|40|||
143002445|NCT02451137|515545857|FG001|Overall Study|Withdrawal by Subject|63|||
143002446|NCT02451137|515545856|FG000|Overall Study|Other than specified above|2|||
143002447|NCT02451137|515545857|FG001|Overall Study|Other than specified above|3|||
143002448|NCT00765726|515545858|FG000|Overall Study|Withdrawal by Subject|1|||
143002449|NCT00765726|515545858|FG000|Overall Study|Discontinuation of study by sponsor|8|||
143002450|NCT01674010|515547060|FG000|Open Treatment Phase 1|Adverse Event|10|||
143002451|NCT01674010|515547061|FG001|Open Treatment Phase 1|Adverse Event|0|||
143002452|NCT01674010|515547062|FG002|Open Treatment Phase 1|Adverse Event|0|||
143002453|NCT01674010|515547060|FG000|Open Treatment Phase 1|Death|1|||
143002454|NCT01674010|515547061|FG001|Open Treatment Phase 1|Death|0|||
143002455|NCT01674010|515547062|FG002|Open Treatment Phase 1|Death|0|||
143002456|NCT01674010|515547060|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
143002457|NCT01674010|515547061|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
143002458|NCT01674010|515547062|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
143002459|NCT01674010|515547060|FG000|Open Treatment Phase 1|Physician Decision|9|||
143002460|NCT01674010|515547061|FG001|Open Treatment Phase 1|Physician Decision|0|||
143002461|NCT01674010|515547062|FG002|Open Treatment Phase 1|Physician Decision|0|||
143002462|NCT01674010|515547060|FG000|Open Treatment Phase 1|Protocol Violation|7|||
143002463|NCT01674010|515547061|FG001|Open Treatment Phase 1|Protocol Violation|0|||
143002464|NCT01674010|515547062|FG002|Open Treatment Phase 1|Protocol Violation|0|||
143002465|NCT01674010|515547060|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
143002466|NCT01674010|515547061|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
143002467|NCT01674010|515547062|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
143002468|NCT01674010|515547060|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
143002469|NCT01674010|515547061|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
143002470|NCT01674010|515547062|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
143002471|NCT01674010|515547060|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
143002472|NCT01674010|515547061|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
143117241|NCT01709864|515971809|FG001|Overall Study|Adverse Event|2|||
143117242|NCT01709864|515971808|FG000|Overall Study|Death|0|||
143117243|NCT01709864|515971809|FG001|Overall Study|Death|1|||
143117244|NCT01066793|515971816|FG000|Overall Study|Death|4|||
143117245|NCT01066793|515971817|FG001|Overall Study|Death|1|||
143002473|NCT01674010|515547062|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
143002474|NCT01674010|515547060|FG000|Randomization Phase 2|Adverse Event|0|||
143117246|NCT01066793|515971818|FG002|Overall Study|Death|1|||
143117247|NCT01066793|515971819|FG003|Overall Study|Death|0|||
143117248|NCT01066793|515971820|FG004|Overall Study|Death|0|||
143117249|NCT01066793|515971821|FG005|Overall Study|Death|0|||
143117250|NCT01066793|515971816|FG000|Overall Study|Lack of Efficacy|2|||
143117251|NCT01066793|515971817|FG001|Overall Study|Lack of Efficacy|1|||
143117252|NCT01066793|515971818|FG002|Overall Study|Lack of Efficacy|0|||
143117253|NCT01066793|515971819|FG003|Overall Study|Lack of Efficacy|0|||
143456200|NCT01993927|517214019|FG000|Overall Study|Case Report Forms Uncollected|18|||
143456201|NCT01993927|517214019|FG000|Overall Study|Protocol Violation|11|||
143456202|NCT00895154|517214020|FG000|Overall Study|Lost to Follow-up|1|||
143456203|NCT00895154|517214021|FG001|Overall Study|Lost to Follow-up|1|||
143456204|NCT00895154|517214020|FG000|Overall Study|Withdrawal by Subject|0|||
143456205|NCT00895154|517214021|FG001|Overall Study|Withdrawal by Subject|1|||
143117254|NCT01066793|515971820|FG004|Overall Study|Lack of Efficacy|0|||
143117255|NCT01066793|515971821|FG005|Overall Study|Lack of Efficacy|0|||
143117256|NCT01066793|515971816|FG000|Overall Study|Lost to Follow-up|180|||
143117257|NCT01066793|515971817|FG001|Overall Study|Lost to Follow-up|39|||
143117258|NCT01066793|515971818|FG002|Overall Study|Lost to Follow-up|82|||
143117259|NCT01066793|515971819|FG003|Overall Study|Lost to Follow-up|16|||
143117260|NCT01066793|515971820|FG004|Overall Study|Lost to Follow-up|0|||
143117261|NCT01066793|515971821|FG005|Overall Study|Lost to Follow-up|1|||
143117262|NCT01066793|515971816|FG000|Overall Study|Physician Decision|3|||
143117263|NCT01066793|515971817|FG001|Overall Study|Physician Decision|0|||
143117264|NCT01066793|515971818|FG002|Overall Study|Physician Decision|0|||
143117265|NCT01066793|515971819|FG003|Overall Study|Physician Decision|0|||
143117266|NCT01066793|515971820|FG004|Overall Study|Physician Decision|0|||
143117267|NCT01066793|515971821|FG005|Overall Study|Physician Decision|0|||
143117268|NCT01066793|515971816|FG000|Overall Study|Protocol Violation|3|||
143117269|NCT01066793|515971817|FG001|Overall Study|Protocol Violation|2|||
143117270|NCT01066793|515971818|FG002|Overall Study|Protocol Violation|2|||
143117271|NCT01066793|515971819|FG003|Overall Study|Protocol Violation|0|||
143117272|NCT01066793|515971820|FG004|Overall Study|Protocol Violation|0|||
143117273|NCT01066793|515971821|FG005|Overall Study|Protocol Violation|0|||
143117274|NCT01066793|515971816|FG000|Overall Study|Withdrawal by Subject|7|||
143117275|NCT01066793|515971817|FG001|Overall Study|Withdrawal by Subject|4|||
143117276|NCT01066793|515971818|FG002|Overall Study|Withdrawal by Subject|1|||
143117277|NCT01066793|515971819|FG003|Overall Study|Withdrawal by Subject|0|||
143117278|NCT01066793|515971820|FG004|Overall Study|Withdrawal by Subject|0|||
143117279|NCT01066793|515971821|FG005|Overall Study|Withdrawal by Subject|0|||
143117280|NCT01066793|515971816|FG000|Overall Study|Early Termination|3|||
143117281|NCT01066793|515971817|FG001|Overall Study|Early Termination|0|||
143117282|NCT01066793|515971818|FG002|Overall Study|Early Termination|0|||
143117283|NCT01066793|515971819|FG003|Overall Study|Early Termination|0|||
143117284|NCT01066793|515971820|FG004|Overall Study|Early Termination|0|||
143117285|NCT01066793|515971821|FG005|Overall Study|Early Termination|0|||
143117286|NCT01066793|515971816|FG000|Overall Study|Lab test not done|7|||
143117287|NCT01066793|515971817|FG001|Overall Study|Lab test not done|0|||
143117288|NCT01066793|515971818|FG002|Overall Study|Lab test not done|0|||
143117289|NCT01066793|515971819|FG003|Overall Study|Lab test not done|1|||
143117290|NCT01066793|515971820|FG004|Overall Study|Lab test not done|0|||
143117291|NCT01066793|515971821|FG005|Overall Study|Lab test not done|0|||
143117292|NCT01066793|515971816|FG000|Overall Study|Miscellaneous|4|||
143117293|NCT01066793|515971817|FG001|Overall Study|Miscellaneous|5|||
143117294|NCT01066793|515971818|FG002|Overall Study|Miscellaneous|6|||
143117295|NCT01066793|515971819|FG003|Overall Study|Miscellaneous|0|||
143117296|NCT01066793|515971820|FG004|Overall Study|Miscellaneous|0|||
143117297|NCT01066793|515971821|FG005|Overall Study|Miscellaneous|0|||
143117298|NCT01066793|515971816|FG000|Overall Study|Non-responders|104|||
143117299|NCT01066793|515971817|FG001|Overall Study|Non-responders|5|||
143117300|NCT01066793|515971818|FG002|Overall Study|Non-responders|11|||
143117301|NCT01066793|515971819|FG003|Overall Study|Non-responders|25|||
143117302|NCT01066793|515971820|FG004|Overall Study|Non-responders|0|||
143456206|NCT00287690|517214022|FG000|Overall Study|Protocol Violation|20|||
143456207|NCT00287690|517214023|FG001|Overall Study|Protocol Violation|26|||
143456208|NCT01146782|517214024|FG000|Screening Cohort|Screen Failure|187|||
143456209|NCT01146782|517214024|FG000|Screening Cohort|Lost to Follow-up|4|||
143456210|NCT01146782|517214024|FG000|Screening Cohort|Physician Decision|1|||
143456211|NCT01146782|517214024|FG000|Screening Cohort|Withdrawal by Subject|29|||
143456212|NCT01146782|517214024|FG000|Safety Cohort|Screen Failure|61|||
143456213|NCT01146782|517214024|FG000|Safety Cohort|Withdrawal by Subject|4|||
143456214|NCT01146782|517214024|FG000|Safety Cohort|Control AHI <5|4|||
143456215|NCT01146782|517214024|FG000|Safety Cohort|TST <4 hrs|14|||
143456216|NCT01146782|517214024|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
143456217|NCT01146782|517214024|FG000|Primary Endpoint Cohort|Physician Decision|1|||
143456218|NCT00470366|517214025|FG000|Overall Study|Adverse Event|3|||
143117303|NCT01066793|515971821|FG005|Overall Study|Non-responders|0|||
143456219|NCT00470366|517214025|FG000|Overall Study|Poor compliance|1|||
143456220|NCT03562975|517214035|FG000|Overall Study|Death|1|||
143456221|NCT03562975|517214035|FG000|Overall Study|Lost to Follow-up|1|||
143456222|NCT03562975|517214035|FG000|Overall Study|Withdrawal by Subject|1|||
143456223|NCT01758900|517214040|FG000|Overall Study|difficulty for further intubation|7|||
143117304|NCT01066793|515971816|FG000|Overall Study|Other|15|||
143456224|NCT01758900|517214041|FG001|Overall Study|difficulty for further intubation|8|||
143456225|NCT00935818|517214043|FG000|Overall Study|Withdrawal by Subject|45|||
143456226|NCT00935818|517214044|FG001|Overall Study|Withdrawal by Subject|50|||
143456227|NCT00935818|517214043|FG000|Overall Study|Lost to Follow-up|40|||
143456228|NCT00935818|517214044|FG001|Overall Study|Lost to Follow-up|42|||
143456229|NCT00935818|517214043|FG000|Overall Study|Adverse Event|6|||
143456230|NCT00935818|517214044|FG001|Overall Study|Adverse Event|7|||
143456231|NCT00935818|517214043|FG000|Overall Study|Physician Decision|0|||
143456232|NCT00935818|517214044|FG001|Overall Study|Physician Decision|1|||
143456233|NCT05559476|517214047|FG000|Overall Study|Adverse Event|2|||
143456234|NCT05559476|517214048|FG001|Overall Study|Adverse Event|0|||
143456235|NCT05559476|517214047|FG000|Overall Study|Lost to Follow-up|13|||
143456236|NCT05559476|517214048|FG001|Overall Study|Lost to Follow-up|12|||
143456237|NCT05559476|517214047|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
143456238|NCT05559476|517214048|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
143456239|NCT05559476|517214047|FG000|Overall Study|Other|0|||
143456240|NCT05559476|517214048|FG001|Overall Study|Other|2|||
143003196|NCT01049360|515548748|FG004|Period 4|Protocol Violation|0|||
143002475|NCT01674010|515547061|FG001|Randomization Phase 2|Adverse Event|1|||
143002476|NCT01674010|515547062|FG002|Randomization Phase 2|Adverse Event|1|||
143002477|NCT01674010|515547060|FG000|Randomization Phase 2|Lost to Follow-up|0|||
143002478|NCT01674010|515547061|FG001|Randomization Phase 2|Lost to Follow-up|1|||
143002479|NCT01674010|515547062|FG002|Randomization Phase 2|Lost to Follow-up|2|||
143002480|NCT01674010|515547060|FG000|Randomization Phase 2|Mood episode recurrence|0|||
143002481|NCT01674010|515547061|FG001|Randomization Phase 2|Mood episode recurrence|8|||
143002482|NCT01674010|515547062|FG002|Randomization Phase 2|Mood episode recurrence|2|||
143002483|NCT01674010|515547060|FG000|Randomization Phase 2|Physician Decision|0|||
143002484|NCT01674010|515547061|FG001|Randomization Phase 2|Physician Decision|0|||
143002485|NCT01674010|515547062|FG002|Randomization Phase 2|Physician Decision|2|||
143002486|NCT01674010|515547060|FG000|Randomization Phase 2|Pregnancy|0|||
143002487|NCT01674010|515547061|FG001|Randomization Phase 2|Pregnancy|1|||
143002488|NCT01674010|515547062|FG002|Randomization Phase 2|Pregnancy|1|||
143002489|NCT01674010|515547060|FG000|Randomization Phase 2|Protocol Violation|0|||
143002490|NCT01674010|515547061|FG001|Randomization Phase 2|Protocol Violation|1|||
143002491|NCT01674010|515547062|FG002|Randomization Phase 2|Protocol Violation|1|||
143002492|NCT01674010|515547060|FG000|Randomization Phase 2|Sponsor Decision|0|||
143002493|NCT01674010|515547061|FG001|Randomization Phase 2|Sponsor Decision|42|||
143002494|NCT01674010|515547062|FG002|Randomization Phase 2|Sponsor Decision|45|||
143002495|NCT01674010|515547060|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
143002496|NCT01674010|515547061|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
143002497|NCT01674010|515547062|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
143002498|NCT03628781|515547072|FG000|Overall Study|Lost to Follow-up|16|||
143002499|NCT03628781|515547073|FG001|Overall Study|Lost to Follow-up|8|||
143002500|NCT03628781|515547072|FG000|Overall Study|Withdrawal by Subject|16|||
143002501|NCT03628781|515547073|FG001|Overall Study|Withdrawal by Subject|1|||
143002502|NCT03053102|515547076|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
143002503|NCT03053102|515547076|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
143002504|NCT01238861|515547077|FG000|Overall Study|Lost to Follow-up|4|||
143002505|NCT01238861|515547078|FG001|Overall Study|Lost to Follow-up|2|||
143002506|NCT01238861|515547079|FG002|Overall Study|Lost to Follow-up|3|||
143002507|NCT01238861|515547080|FG003|Overall Study|Lost to Follow-up|1|||
143002508|NCT01238861|515547081|FG004|Overall Study|Lost to Follow-up|1|||
143002509|NCT01238861|515547082|FG005|Overall Study|Lost to Follow-up|2|||
143002510|NCT01238861|515547077|FG000|Overall Study|Unplanned surgery|1|||
143002511|NCT01238861|515547078|FG001|Overall Study|Unplanned surgery|0|||
143002512|NCT01238861|515547079|FG002|Overall Study|Unplanned surgery|0|||
143002513|NCT01238861|515547080|FG003|Overall Study|Unplanned surgery|0|||
143002514|NCT01238861|515547081|FG004|Overall Study|Unplanned surgery|0|||
143002515|NCT01238861|515547082|FG005|Overall Study|Unplanned surgery|0|||
143002516|NCT01238861|515547077|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
143002517|NCT01238861|515547078|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
143002518|NCT01238861|515547079|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
143002519|NCT01238861|515547080|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
143002520|NCT01238861|515547081|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
143002521|NCT01238861|515547082|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
143002522|NCT01238861|515547077|FG000|Overall Study|Incorrect enrollment/randomization|0|||
143002523|NCT01238861|515547078|FG001|Overall Study|Incorrect enrollment/randomization|0|||
143002524|NCT01238861|515547079|FG002|Overall Study|Incorrect enrollment/randomization|1|||
143002525|NCT01238861|515547080|FG003|Overall Study|Incorrect enrollment/randomization|0|||
143002526|NCT01238861|515547081|FG004|Overall Study|Incorrect enrollment/randomization|1|||
143002527|NCT01238861|515547082|FG005|Overall Study|Incorrect enrollment/randomization|0|||
143002528|NCT01238861|515547077|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
143002529|NCT01238861|515547078|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
143002530|NCT01238861|515547079|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
143002531|NCT01238861|515547080|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
143002532|NCT01238861|515547081|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
143002533|NCT01238861|515547082|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
143002534|NCT01238861|515547077|FG000|Overall Study|Subject moved out of state/area|0|||
143002535|NCT01238861|515547078|FG001|Overall Study|Subject moved out of state/area|0|||
143002536|NCT01238861|515547079|FG002|Overall Study|Subject moved out of state/area|1|||
143002537|NCT01238861|515547080|FG003|Overall Study|Subject moved out of state/area|1|||
143002538|NCT01238861|515547081|FG004|Overall Study|Subject moved out of state/area|0|||
143002539|NCT01238861|515547082|FG005|Overall Study|Subject moved out of state/area|0|||
143002540|NCT01238861|515547077|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
143002541|NCT01238861|515547078|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
143002542|NCT01238861|515547079|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
143002543|NCT01238861|515547080|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
143002544|NCT01238861|515547081|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
143002545|NCT01238861|515547082|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
143002546|NCT01238861|515547077|FG000|Overall Study|Personal problems|0|||
143002547|NCT01238861|515547078|FG001|Overall Study|Personal problems|0|||
143002548|NCT01238861|515547079|FG002|Overall Study|Personal problems|0|||
143002549|NCT01238861|515547080|FG003|Overall Study|Personal problems|1|||
143002550|NCT01238861|515547081|FG004|Overall Study|Personal problems|0|||
143002551|NCT01238861|515547082|FG005|Overall Study|Personal problems|0|||
143002552|NCT01238861|515547077|FG000|Overall Study|Unable to continue visits|0|||
143002553|NCT01238861|515547078|FG001|Overall Study|Unable to continue visits|0|||
143002554|NCT01238861|515547079|FG002|Overall Study|Unable to continue visits|0|||
143002555|NCT01238861|515547080|FG003|Overall Study|Unable to continue visits|1|||
143002556|NCT01238861|515547081|FG004|Overall Study|Unable to continue visits|0|||
143002557|NCT01238861|515547082|FG005|Overall Study|Unable to continue visits|1|||
143002558|NCT01238861|515547077|FG000|Overall Study|Serious adverse event|0|||
143002559|NCT01238861|515547078|FG001|Overall Study|Serious adverse event|0|||
143002560|NCT01238861|515547079|FG002|Overall Study|Serious adverse event|0|||
143002561|NCT01238861|515547080|FG003|Overall Study|Serious adverse event|0|||
143002562|NCT01238861|515547081|FG004|Overall Study|Serious adverse event|0|||
143002563|NCT01238861|515547082|FG005|Overall Study|Serious adverse event|1|||
143002564|NCT01238861|515547077|FG000|Overall Study|Lack of compliance|0|||
143002565|NCT01238861|515547078|FG001|Overall Study|Lack of compliance|0|||
143002566|NCT01238861|515547079|FG002|Overall Study|Lack of compliance|0|||
143002567|NCT01238861|515547080|FG003|Overall Study|Lack of compliance|0|||
143002568|NCT01238861|515547081|FG004|Overall Study|Lack of compliance|0|||
143002569|NCT01238861|515547082|FG005|Overall Study|Lack of compliance|1|||
143002570|NCT01238861|515547077|FG000|Overall Study|Adverse Event|0|||
143002571|NCT01238861|515547078|FG001|Overall Study|Adverse Event|1|||
143002572|NCT01238861|515547079|FG002|Overall Study|Adverse Event|0|||
143002573|NCT01238861|515547080|FG003|Overall Study|Adverse Event|0|||
143002574|NCT01238861|515547081|FG004|Overall Study|Adverse Event|0|||
143002575|NCT01238861|515547082|FG005|Overall Study|Adverse Event|0|||
143002576|NCT01238861|515547077|FG000|Overall Study|Withdrawal by Subject|6|||
143002577|NCT01238861|515547078|FG001|Overall Study|Withdrawal by Subject|5|||
143002578|NCT01238861|515547079|FG002|Overall Study|Withdrawal by Subject|4|||
143002579|NCT01238861|515547080|FG003|Overall Study|Withdrawal by Subject|8|||
143002580|NCT01238861|515547081|FG004|Overall Study|Withdrawal by Subject|10|||
143002581|NCT01238861|515547082|FG005|Overall Study|Withdrawal by Subject|9|||
143002582|NCT01269346|515547083|FG000|Treatment Phase|Disease progression|3|||
143002583|NCT01269346|515547083|FG000|Treatment Phase|Adverse Event|3|||
143002584|NCT01269346|515547083|FG000|Treatment Phase|Withdrawal by Subject|1|||
143002585|NCT01269346|515547083|FG000|Treatment Phase|Other|2|||
143002586|NCT01269346|515547083|FG000|Extension Phase|Adverse Event|6|||
143002587|NCT01269346|515547083|FG000|Extension Phase|Withdrawal by Subject|4|||
143002588|NCT01269346|515547083|FG000|Extension Phase|Disease progression|22|||
143002589|NCT01269346|515547083|FG000|Extension Phase|Physician decision or participant choice|9|||
143002590|NCT01269346|515547083|FG000|Extension Phase|Clinical progression|1|||
143002591|NCT01269346|515547083|FG000|Extension Phase|Started a prohibited con med|1|||
143002592|NCT00247416|515547084|FG000|Overall Study|3 patients were found to be ineligible|1|||
143002593|NCT00247416|515547085|FG001|Overall Study|3 patients were found to be ineligible|2|||
143002594|NCT00278473|515547094|FG000|Overall Study|drop out|4|||
143002595|NCT00278473|515547095|FG001|Overall Study|drop out|3|||
143002596|NCT00761761|515547099|FG000|Overall Study|Lost to Follow-up|3|||
143002597|NCT00761761|515547100|FG001|Overall Study|Lost to Follow-up|1|||
143002598|NCT00761761|515547099|FG000|Overall Study|Withdrawal by Subject|3|||
143002599|NCT00761761|515547100|FG001|Overall Study|Withdrawal by Subject|0|||
143002600|NCT02706327|515547107|FG000|Overall Study|Lost to Follow-up|1|||
143002601|NCT02706327|515547108|FG001|Overall Study|Lost to Follow-up|1|||
143002602|NCT02706327|515547109|FG002|Overall Study|Lost to Follow-up|2|||
143002603|NCT00450814|515547118|FG000|Overall Study|Failed to complete the initial therapy|0|||
143002604|NCT00450814|515547119|FG001|Overall Study|Failed to complete the initial therapy|0|||
143002605|NCT00450814|515547120|FG002|Overall Study|Failed to complete the initial therapy|0|||
143002606|NCT00450814|515547121|FG003|Overall Study|Failed to complete the initial therapy|1|||
143002607|NCT00450814|515547122|FG004|Overall Study|Failed to complete the initial therapy|1|||
143002608|NCT00450814|515547123|FG005|Overall Study|Failed to complete the initial therapy|1|||
143002609|NCT00450814|515547124|FG006|Overall Study|Failed to complete the initial therapy|0|||
143002610|NCT00450814|515547125|FG007|Overall Study|Failed to complete the initial therapy|0|||
143002611|NCT00450814|515547126|FG008|Overall Study|Failed to complete the initial therapy|0|||
143002612|NCT00450814|515547127|FG009|Overall Study|Failed to complete the initial therapy|0|||
143002613|NCT00450814|515547128|FG010|Overall Study|Failed to complete the initial therapy|0|||
143002614|NCT00450814|515547118|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
143002615|NCT00450814|515547119|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
143002616|NCT00450814|515547120|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
143002617|NCT00450814|515547121|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
143002618|NCT00450814|515547122|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
143002619|NCT00450814|515547123|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
143002620|NCT00450814|515547124|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
143002621|NCT00450814|515547125|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
143002622|NCT00450814|515547126|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
143002623|NCT00450814|515547127|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
143002624|NCT00450814|515547128|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
143002625|NCT04145531|515547129|FG000|Part A|Adverse Event|2|||
143002626|NCT04145531|515547130|FG001|Part A|Adverse Event|12|||
143002627|NCT04145531|515547131|FG002|Part A|Adverse Event|6|||
143002628|NCT04145531|515547132|FG003|Part A|Adverse Event|0|||
143002629|NCT04145531|515547129|FG000|Part A|Death|1|||
143002630|NCT04145531|515547130|FG001|Part A|Death|2|||
143002631|NCT04145531|515547131|FG002|Part A|Death|0|||
143002632|NCT04145531|515547132|FG003|Part A|Death|0|||
143002633|NCT04145531|515547129|FG000|Part A|Physician Decision|2|||
143002634|NCT04145531|515547130|FG001|Part A|Physician Decision|5|||
143002635|NCT04145531|515547131|FG002|Part A|Physician Decision|2|||
143002636|NCT04145531|515547132|FG003|Part A|Physician Decision|0|||
143002637|NCT04145531|515547129|FG000|Part A|Progressive disease|0|||
143002638|NCT04145531|515547130|FG001|Part A|Progressive disease|2|||
143002639|NCT04145531|515547131|FG002|Part A|Progressive disease|1|||
143002640|NCT04145531|515547132|FG003|Part A|Progressive disease|0|||
143002641|NCT04145531|515547129|FG000|Part A|Protocol deviation|0|||
143002642|NCT04145531|515547130|FG001|Part A|Protocol deviation|0|||
143002643|NCT04145531|515547131|FG002|Part A|Protocol deviation|1|||
143002644|NCT04145531|515547132|FG003|Part A|Protocol deviation|0|||
143002645|NCT04145531|515547129|FG000|Part A|Withdrawal by parent or guardian|1|||
143002646|NCT04145531|515547130|FG001|Part A|Withdrawal by parent or guardian|0|||
143002647|NCT04145531|515547131|FG002|Part A|Withdrawal by parent or guardian|0|||
143002648|NCT04145531|515547132|FG003|Part A|Withdrawal by parent or guardian|0|||
143002649|NCT04145531|515547129|FG000|Part A|Withdrawal by participant|0|||
143002650|NCT04145531|515547130|FG001|Part A|Withdrawal by participant|0|||
143002651|NCT04145531|515547131|FG002|Part A|Withdrawal by participant|1|||
143002652|NCT04145531|515547132|FG003|Part A|Withdrawal by participant|0|||
143002653|NCT04145531|515547129|FG000|Part A|Other|0|||
143002654|NCT04145531|515547130|FG001|Part A|Other|0|||
143002655|NCT04145531|515547131|FG002|Part A|Other|1|||
143002656|NCT04145531|515547132|FG003|Part A|Other|0|||
143002657|NCT04145531|515547129|FG000|Part B|Adverse Event|0|||
143002658|NCT04145531|515547130|FG001|Part B|Adverse Event|0|||
143002659|NCT04145531|515547131|FG002|Part B|Adverse Event|0|||
143002660|NCT04145531|515547132|FG003|Part B|Adverse Event|21|||
143002661|NCT04145531|515547129|FG000|Part B|Physician Decision|0|||
143002662|NCT04145531|515547130|FG001|Part B|Physician Decision|0|||
143002663|NCT04145531|515547131|FG002|Part B|Physician Decision|0|||
143002664|NCT04145531|515547132|FG003|Part B|Physician Decision|7|||
143002665|NCT04145531|515547129|FG000|Part B|Progressive disease|0|||
143002666|NCT04145531|515547130|FG001|Part B|Progressive disease|0|||
143002667|NCT04145531|515547131|FG002|Part B|Progressive disease|0|||
143002668|NCT04145531|515547132|FG003|Part B|Progressive disease|1|||
143002669|NCT04145531|515547129|FG000|Part B|Recurrent disease|0|||
143002670|NCT04145531|515547130|FG001|Part B|Recurrent disease|0|||
143002671|NCT04145531|515547131|FG002|Part B|Recurrent disease|0|||
143002672|NCT04145531|515547132|FG003|Part B|Recurrent disease|1|||
143002673|NCT04145531|515547129|FG000|Part B|Withdrawal by parent or guardian|0|||
143002674|NCT04145531|515547130|FG001|Part B|Withdrawal by parent or guardian|0|||
143002675|NCT04145531|515547131|FG002|Part B|Withdrawal by parent or guardian|0|||
143002676|NCT04145531|515547132|FG003|Part B|Withdrawal by parent or guardian|3|||
143002677|NCT04145531|515547129|FG000|Part B|Withdrawal by participant|0|||
143002678|NCT04145531|515547130|FG001|Part B|Withdrawal by participant|0|||
143002679|NCT04145531|515547131|FG002|Part B|Withdrawal by participant|0|||
143002680|NCT04145531|515547132|FG003|Part B|Withdrawal by participant|1|||
143002681|NCT04145531|515547129|FG000|Part B|Other|0|||
143002682|NCT04145531|515547130|FG001|Part B|Other|0|||
143002683|NCT04145531|515547131|FG002|Part B|Other|0|||
143002684|NCT04145531|515547132|FG003|Part B|Other|1|||
143002685|NCT00933543|515547133|FG000|Overall Study|Adverse Event|2|||
143002686|NCT00933543|515547134|FG001|Overall Study|Adverse Event|1|||
143002687|NCT00933543|515547133|FG000|Overall Study|Lost to Follow-up|0|||
143002688|NCT00933543|515547134|FG001|Overall Study|Lost to Follow-up|1|||
143002689|NCT00933543|515547133|FG000|Overall Study|Withdrawal by Subject|0|||
143002690|NCT00933543|515547134|FG001|Overall Study|Withdrawal by Subject|1|||
143002691|NCT00933543|515547133|FG000|Overall Study|Lack of Efficacy|0|||
143002692|NCT00933543|515547134|FG001|Overall Study|Lack of Efficacy|3|||
143002693|NCT00933543|515547133|FG000|Overall Study|Other|1|||
143002694|NCT00933543|515547134|FG001|Overall Study|Other|1|||
143002695|NCT04988035|515547135|FG000|Overall Study|Death|19|||
143002696|NCT04988035|515547136|FG001|Overall Study|Death|13|||
143002697|NCT04988035|515547135|FG000|Overall Study|Lost to Follow-up|12|||
143002698|NCT04988035|515547136|FG001|Overall Study|Lost to Follow-up|6|||
143002699|NCT04988035|515547135|FG000|Overall Study|Protocol Violation|0|||
143002700|NCT04988035|515547136|FG001|Overall Study|Protocol Violation|1|||
143002701|NCT04988035|515547135|FG000|Overall Study|Withdrawal by Subject|2|||
143002702|NCT04988035|515547136|FG001|Overall Study|Withdrawal by Subject|4|||
143002703|NCT04988035|515547135|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
143002704|NCT04988035|515547136|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
143002705|NCT03602976|515547139|FG000|Overall Study|Withdrawal by Subject|1|||
143002706|NCT02797951|515547140|FG000|Overall Study|Adverse Event|4|||
143002707|NCT02797951|515547140|FG000|Overall Study|Death|1|||
143002708|NCT02797951|515547140|FG000|Overall Study|Lack of Efficacy|19|||
143002709|NCT02797951|515547140|FG000|Overall Study|Lost to Follow-up|4|||
143002710|NCT02797951|515547140|FG000|Overall Study|Physician Decision|6|||
143002711|NCT02797951|515547140|FG000|Overall Study|Withdrawal by Subject|15|||
143002712|NCT04626947|515547141|FG000|Overall Study|Study terminated|14|||
143002713|NCT00265109|515547146|FG000|Overall Study|Withdrawal by Subject|5|||
143002714|NCT00265109|515547146|FG000|Overall Study|Adverse Event|1|||
143002715|NCT03556202|515547149|FG000|Extension Treatment Period|Adverse Event|18|||
143002716|NCT03556202|515547150|FG001|Extension Treatment Period|Adverse Event|14|||
143002717|NCT03556202|515547151|FG002|Extension Treatment Period|Adverse Event|9|||
143002718|NCT03556202|515547149|FG000|Extension Treatment Period|Death|2|||
143002719|NCT03556202|515547150|FG001|Extension Treatment Period|Death|6|||
143002720|NCT03556202|515547151|FG002|Extension Treatment Period|Death|0|||
143002721|NCT03556202|515547149|FG000|Extension Treatment Period|Lack of Efficacy|5|||
143002722|NCT03556202|515547150|FG001|Extension Treatment Period|Lack of Efficacy|12|||
143002723|NCT03556202|515547151|FG002|Extension Treatment Period|Lack of Efficacy|18|||
143003197|NCT01049360|515548749|FG005|Period 4|Protocol Violation|0|||
143002724|NCT03556202|515547149|FG000|Extension Treatment Period|Lost to Follow-up|9|||
143002725|NCT03556202|515547150|FG001|Extension Treatment Period|Lost to Follow-up|20|||
143002726|NCT03556202|515547151|FG002|Extension Treatment Period|Lost to Follow-up|2|||
143002727|NCT03556202|515547149|FG000|Extension Treatment Period|Pregnancy|2|||
143002728|NCT03556202|515547150|FG001|Extension Treatment Period|Pregnancy|4|||
143002729|NCT03556202|515547151|FG002|Extension Treatment Period|Pregnancy|3|||
143002730|NCT03556202|515547149|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
143002731|NCT03556202|515547150|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
143002732|NCT03556202|515547151|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
143002733|NCT03556202|515547149|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
143002734|NCT03556202|515547150|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
143002735|NCT03556202|515547151|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
143002736|NCT03556202|515547149|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
143002737|NCT03556202|515547150|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
143002738|NCT03556202|515547151|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
143002739|NCT03556202|515547149|FG000|Extension Treatment Period|Physician Decision|0|||
143002740|NCT03556202|515547150|FG001|Extension Treatment Period|Physician Decision|8|||
143002741|NCT03556202|515547151|FG002|Extension Treatment Period|Physician Decision|2|||
143002742|NCT03556202|515547149|FG000|Extension Treatment Period|Protocol Violation|0|||
143002743|NCT03556202|515547150|FG001|Extension Treatment Period|Protocol Violation|1|||
143002744|NCT03556202|515547151|FG002|Extension Treatment Period|Protocol Violation|1|||
143002745|NCT03556202|515547149|FG000|Extension Treatment Period|Sponsor Decision|0|||
143002746|NCT03556202|515547150|FG001|Extension Treatment Period|Sponsor Decision|1|||
143002747|NCT03556202|515547151|FG002|Extension Treatment Period|Sponsor Decision|0|||
143002748|NCT03556202|515547149|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
143002749|NCT03556202|515547150|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
143002750|NCT03556202|515547151|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
143002751|NCT03556202|515547149|FG000|Follow-Up Period (12 Weeks)|Death|1|||
143002752|NCT03556202|515547150|FG001|Follow-Up Period (12 Weeks)|Death|0|||
143002753|NCT03556202|515547151|FG002|Follow-Up Period (12 Weeks)|Death|0|||
143002754|NCT03556202|515547149|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
143002755|NCT03556202|515547150|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
143002756|NCT03556202|515547151|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
143002757|NCT03556202|515547149|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
143002758|NCT03556202|515547150|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
143002759|NCT03556202|515547151|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
143002760|NCT03556202|515547149|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
143002761|NCT03556202|515547150|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
143002762|NCT03556202|515547151|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
143002763|NCT03556202|515547149|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
143002764|NCT03556202|515547150|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
143002765|NCT03556202|515547151|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
143002766|NCT03556202|515547149|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
143002767|NCT03556202|515547150|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
143002768|NCT03556202|515547151|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
143002769|NCT03556202|515547149|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
143002770|NCT03556202|515547150|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
143002771|NCT03556202|515547151|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
143002772|NCT03556202|515547149|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
143002773|NCT03556202|515547150|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
143002774|NCT03556202|515547151|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
143002775|NCT03556202|515547149|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
143002776|NCT03556202|515547150|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
143002777|NCT03556202|515547151|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
143002778|NCT03556202|515547149|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
143002779|NCT03556202|515547150|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
143002780|NCT03556202|515547151|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
143002781|NCT03556202|515547149|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
143002782|NCT03556202|515547150|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
143002783|NCT03556202|515547151|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
143002784|NCT03556202|515547149|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
143002785|NCT03556202|515547150|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
143002786|NCT03556202|515547151|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
143002787|NCT03556202|515547149|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
143002788|NCT03556202|515547150|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
143002789|NCT03556202|515547151|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
143002790|NCT05146999|515547152|FG000|Overall Study|Withdrew consent|6|||
143002791|NCT05146999|515547153|FG001|Overall Study|Withdrew consent|1|||
143002792|NCT05146999|515547152|FG000|Overall Study|Lost to Follow-up|3|||
143002793|NCT05146999|515547153|FG001|Overall Study|Lost to Follow-up|2|||
143002794|NCT05146999|515547152|FG000|Overall Study|Other|1|||
143002795|NCT05146999|515547153|FG001|Overall Study|Other|3|||
143002796|NCT02370173|515547162|FG000|Overall Study|Protocol Violation|1|||
143002797|NCT02370173|515547163|FG001|Overall Study|Protocol Violation|1|||
143002798|NCT02370173|515547162|FG000|Overall Study|Withdrawal by Subject|2|||
143002799|NCT02370173|515547163|FG001|Overall Study|Withdrawal by Subject|2|||
143002800|NCT01365182|515547168|FG000|Overall Study|Withdrawal by Subject|10|||
143002801|NCT01365182|515547169|FG001|Overall Study|Withdrawal by Subject|13|||
143002802|NCT01365182|515547170|FG002|Overall Study|Withdrawal by Subject|12|||
143002803|NCT00736840|515547171|FG000|Overall Study|Lost to Follow-up|13|||
143002804|NCT01728194|515547176|FG000|Overall Study|Lost to Follow-up|4|||
143002805|NCT01728194|515547177|FG001|Overall Study|Lost to Follow-up|3|||
143002806|NCT01728194|515547176|FG000|Overall Study|Physician Decision|4|||
143002807|NCT01728194|515547177|FG001|Overall Study|Physician Decision|0|||
143002808|NCT01728194|515547176|FG000|Overall Study|Withdrawal by Subject|7|||
143002809|NCT01728194|515547177|FG001|Overall Study|Withdrawal by Subject|3|||
143002810|NCT01728194|515547176|FG000|Overall Study|Perceived Medication Side Effects|4|||
143002811|NCT01728194|515547177|FG001|Overall Study|Perceived Medication Side Effects|0|||
143002812|NCT01728194|515547176|FG000|Overall Study|Family Member Request|1|||
143002813|NCT01728194|515547177|FG001|Overall Study|Family Member Request|0|||
143002814|NCT02309372|515547178|FG000|Overall Study|Lost to Follow-up|3|||
143002815|NCT02309372|515547179|FG001|Overall Study|Lost to Follow-up|2|||
143002816|NCT04604015|515547182|FG000|Overall Study|Incomplete Data Collection|33|||
143002817|NCT03289676|515547183|FG000|Overall Study|Withdrawal by Subject|2|||
143002818|NCT03289676|515547184|FG001|Overall Study|Withdrawal by Subject|0|||
143002819|NCT03289676|515547183|FG000|Overall Study|Protocol Violation|2|||
143002820|NCT03289676|515547184|FG001|Overall Study|Protocol Violation|0|||
143002821|NCT03289676|515547183|FG000|Overall Study|Lost to Follow-up|0|||
143002822|NCT03289676|515547184|FG001|Overall Study|Lost to Follow-up|1|||
143002823|NCT02576652|515547185|FG000|Overall Study|Withdrawal by Subject|2|||
143002824|NCT02811640|515547190|FG000|Overall Study|Technology malfunction|2|||
143002825|NCT01230489|515547194|FG000|Overall Study|Death|2|||
143002826|NCT01230489|515547194|FG000|Overall Study|Adverse Event|2|||
143002827|NCT01230489|515547194|FG000|Overall Study|Treatment modality changed|1|||
143002828|NCT01977573|515547197|FG000|Overall Study|Adverse Event|7|||
143002829|NCT01977573|515547198|FG001|Overall Study|Adverse Event|0|||
143002830|NCT01977573|515547199|FG002|Overall Study|Adverse Event|2|||
143002831|NCT01977573|515547200|FG003|Overall Study|Adverse Event|1|||
143002832|NCT01977573|515547197|FG000|Overall Study|Lost to Follow-up|1|||
143002833|NCT01977573|515547198|FG001|Overall Study|Lost to Follow-up|0|||
143002834|NCT01977573|515547199|FG002|Overall Study|Lost to Follow-up|0|||
143002835|NCT01977573|515547200|FG003|Overall Study|Lost to Follow-up|1|||
143002836|NCT01977573|515547197|FG000|Overall Study|Physician Decision|1|||
143002837|NCT01977573|515547198|FG001|Overall Study|Physician Decision|0|||
143002838|NCT01977573|515547199|FG002|Overall Study|Physician Decision|0|||
143002839|NCT01977573|515547200|FG003|Overall Study|Physician Decision|0|||
143002840|NCT01977573|515547197|FG000|Overall Study|Protocol Violation|3|||
143002841|NCT01977573|515547198|FG001|Overall Study|Protocol Violation|1|||
143002842|NCT01977573|515547199|FG002|Overall Study|Protocol Violation|0|||
143002843|NCT01977573|515547200|FG003|Overall Study|Protocol Violation|0|||
143002844|NCT01977573|515547197|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
143002845|NCT01977573|515547198|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
143002846|NCT01977573|515547199|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
143002847|NCT01977573|515547200|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
143002848|NCT01977573|515547197|FG000|Overall Study|Withdrawal by Subject|6|||
143002849|NCT01977573|515547198|FG001|Overall Study|Withdrawal by Subject|1|||
143002850|NCT01977573|515547199|FG002|Overall Study|Withdrawal by Subject|1|||
143002851|NCT01977573|515547200|FG003|Overall Study|Withdrawal by Subject|1|||
143002852|NCT03996694|515548639|FG000|First Washout (7 Days)|positive urine drug screen|0|||
143002853|NCT03996694|515548640|FG001|First Washout (7 Days)|positive urine drug screen|0|||
143002854|NCT03996694|515548641|FG002|First Washout (7 Days)|positive urine drug screen|1|||
143002855|NCT03996694|515548642|FG003|First Washout (7 Days)|positive urine drug screen|0|||
143002856|NCT03996694|515548643|FG004|First Washout (7 Days)|positive urine drug screen|0|||
143002857|NCT03996694|515548644|FG005|First Washout (7 Days)|positive urine drug screen|0|||
143002858|NCT03996694|515548639|FG000|First Washout (7 Days)|Adverse Event|0|||
143002859|NCT03996694|515548640|FG001|First Washout (7 Days)|Adverse Event|1|||
143002860|NCT03996694|515548641|FG002|First Washout (7 Days)|Adverse Event|0|||
143002861|NCT03996694|515548642|FG003|First Washout (7 Days)|Adverse Event|0|||
143002862|NCT03996694|515548643|FG004|First Washout (7 Days)|Adverse Event|0|||
143002863|NCT03996694|515548644|FG005|First Washout (7 Days)|Adverse Event|0|||
143002864|NCT03996694|515548639|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
143002865|NCT03996694|515548640|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
143002866|NCT03996694|515548641|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
143002867|NCT03996694|515548642|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
143002868|NCT03996694|515548643|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
143002869|NCT03996694|515548644|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
143002870|NCT03996694|515548639|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
143002871|NCT03996694|515548640|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
143002872|NCT03996694|515548641|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
143002873|NCT03996694|515548642|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
143002874|NCT03996694|515548643|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
143002875|NCT03996694|515548644|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
143002876|NCT00656669|515548645|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
143002877|NCT00656669|515548645|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
143002878|NCT00656669|515548645|FG000|AC (Cycles 6-9)|Adverse Event|1|||
143002879|NCT00656669|515548645|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
143002880|NCT02777554|515548648|FG000|Overall Study|Adverse Event|4|||
143002881|NCT02777554|515548649|FG001|Overall Study|Adverse Event|4|||
143002882|NCT02777554|515548650|FG002|Overall Study|Adverse Event|0|||
143002883|NCT02777554|515548651|FG003|Overall Study|Adverse Event|1|||
143002884|NCT02777554|515548652|FG004|Overall Study|Adverse Event|0|||
143002885|NCT02777554|515548653|FG005|Overall Study|Adverse Event|0|||
143002886|NCT02777554|515548648|FG000|Overall Study|Withdrawal by Subject|3|||
143002887|NCT02777554|515548649|FG001|Overall Study|Withdrawal by Subject|1|||
143002888|NCT02777554|515548650|FG002|Overall Study|Withdrawal by Subject|1|||
143002889|NCT02777554|515548651|FG003|Overall Study|Withdrawal by Subject|0|||
143002890|NCT02777554|515548652|FG004|Overall Study|Withdrawal by Subject|0|||
143002891|NCT02777554|515548653|FG005|Overall Study|Withdrawal by Subject|0|||
143002892|NCT02777554|515548648|FG000|Overall Study|Discharged early due to hurricane|22|||
143002893|NCT02777554|515548649|FG001|Overall Study|Discharged early due to hurricane|20|||
143002894|NCT02777554|515548650|FG002|Overall Study|Discharged early due to hurricane|0|||
143002895|NCT02777554|515548651|FG003|Overall Study|Discharged early due to hurricane|0|||
143002896|NCT02777554|515548652|FG004|Overall Study|Discharged early due to hurricane|0|||
143002897|NCT02777554|515548653|FG005|Overall Study|Discharged early due to hurricane|0|||
143002898|NCT02777554|515548648|FG000|Overall Study|Other - Miscellaneous|1|||
143002899|NCT02777554|515548649|FG001|Overall Study|Other - Miscellaneous|0|||
143002900|NCT02777554|515548650|FG002|Overall Study|Other - Miscellaneous|0|||
143002901|NCT02777554|515548651|FG003|Overall Study|Other - Miscellaneous|0|||
143002902|NCT02777554|515548652|FG004|Overall Study|Other - Miscellaneous|0|||
143002903|NCT02777554|515548653|FG005|Overall Study|Other - Miscellaneous|0|||
143002904|NCT00066573|515548654|FG000|Overall Study|Did not received protocol treatment|28|||
143002905|NCT00066573|515548655|FG001|Overall Study|Did not received protocol treatment|28|||
143002906|NCT01798056|515548656|FG000|Overall Study|Serious Adverse Event|13|||
143002907|NCT01798056|515548657|FG001|Overall Study|Serious Adverse Event|12|||
143002908|NCT01798056|515548656|FG000|Overall Study|Withdrawal by Subject|12|||
143002909|NCT01798056|515548657|FG001|Overall Study|Withdrawal by Subject|9|||
143002910|NCT01798056|515548656|FG000|Overall Study|Migrated/moved from study area|1|||
143002911|NCT01798056|515548657|FG001|Overall Study|Migrated/moved from study area|1|||
143002912|NCT01798056|515548656|FG000|Overall Study|Lost to Follow-up|1|||
143002913|NCT01798056|515548657|FG001|Overall Study|Lost to Follow-up|1|||
143002914|NCT01798056|515548656|FG000|Overall Study|Other|0|||
143002915|NCT01798056|515548657|FG001|Overall Study|Other|2|||
143002916|NCT01013207|515548658|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
143002917|NCT01541644|515548665|FG000|Overall Study|Withdrawal by Subject|3|||
143002918|NCT01458535|515548668|FG000|Overall Study|Other|0|||
143002919|NCT01458535|515548669|FG001|Overall Study|Other|0|||
143002920|NCT01458535|515548670|FG002|Overall Study|Other|0|||
143002921|NCT01458535|515548671|FG003|Overall Study|Other|0|||
143002922|NCT01458535|515548672|FG004|Overall Study|Other|1|||
143002923|NCT01458535|515548673|FG005|Overall Study|Other|1|||
143002924|NCT01458535|515548668|FG000|Overall Study|Withdrawal by Subject|0|||
143002925|NCT01458535|515548669|FG001|Overall Study|Withdrawal by Subject|0|||
143002926|NCT01458535|515548670|FG002|Overall Study|Withdrawal by Subject|2|||
143002927|NCT01458535|515548671|FG003|Overall Study|Withdrawal by Subject|0|||
143002928|NCT01458535|515548672|FG004|Overall Study|Withdrawal by Subject|1|||
143002929|NCT01458535|515548673|FG005|Overall Study|Withdrawal by Subject|1|||
143002930|NCT01458535|515548668|FG000|Overall Study|Lost to Follow-up|0|||
143002931|NCT01458535|515548669|FG001|Overall Study|Lost to Follow-up|2|||
143002932|NCT01458535|515548670|FG002|Overall Study|Lost to Follow-up|0|||
143002933|NCT01458535|515548671|FG003|Overall Study|Lost to Follow-up|3|||
143002934|NCT01458535|515548672|FG004|Overall Study|Lost to Follow-up|2|||
143002935|NCT01458535|515548673|FG005|Overall Study|Lost to Follow-up|2|||
143002936|NCT01458535|515548668|FG000|Overall Study|Adverse Event|0|||
143002937|NCT01458535|515548669|FG001|Overall Study|Adverse Event|0|||
143002938|NCT01458535|515548670|FG002|Overall Study|Adverse Event|0|||
143002939|NCT01458535|515548671|FG003|Overall Study|Adverse Event|1|||
143002940|NCT01458535|515548672|FG004|Overall Study|Adverse Event|0|||
143002941|NCT01458535|515548673|FG005|Overall Study|Adverse Event|0|||
143002942|NCT02842736|515548674|FG000|Overall Study|Lost to Follow-up|13|||
143002943|NCT02842736|515548674|FG000|Overall Study|Intervention for menstrual bleeding|17|||
143003198|NCT01049360|515548750|FG006|Period 4|Protocol Violation|0|||
143002944|NCT02842736|515548674|FG000|Overall Study|Withdrawal by Subject|4|||
143002945|NCT02842736|515548674|FG000|Overall Study|Pregnancy|3|||
143002946|NCT02842736|515548674|FG000|Overall Study|Hysterectomy for fibroids|2|||
143002947|NCT02842736|515548674|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
143002948|NCT02842736|515548674|FG000|Overall Study|IUD: Mirena|1|||
143002949|NCT02660489|515548678|FG000|Overall Study|Lost to Follow-up|1|||
143002950|NCT02660489|515548679|FG001|Overall Study|Lost to Follow-up|1|||
143002951|NCT02660489|515548678|FG000|Overall Study|Adverse Event|1|||
143002952|NCT02660489|515548679|FG001|Overall Study|Adverse Event|3|||
143002953|NCT02660489|515548678|FG000|Overall Study|no rhinovirus infection|4|||
143002954|NCT02660489|515548679|FG001|Overall Study|no rhinovirus infection|4|||
143002955|NCT04854421|515548680|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
143002956|NCT04854421|515548681|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
143002957|NCT02322866|515548682|FG000|Overall Study|Adverse Event|6|||
143002958|NCT02322866|515548683|FG001|Overall Study|Adverse Event|11|||
143002959|NCT02322866|515548682|FG000|Overall Study|Withdrawal of Consent|16|||
143002960|NCT02322866|515548683|FG001|Overall Study|Withdrawal of Consent|25|||
143002961|NCT02322866|515548682|FG000|Overall Study|Lost to Follow-up|36|||
143002962|NCT02322866|515548683|FG001|Overall Study|Lost to Follow-up|39|||
143002963|NCT02322866|515548682|FG000|Overall Study|Protocol Violation|1|||
143002964|NCT02322866|515548683|FG001|Overall Study|Protocol Violation|0|||
143002965|NCT02322866|515548682|FG000|Overall Study|Noncompliance with Treatment|3|||
143002966|NCT02322866|515548683|FG001|Overall Study|Noncompliance with Treatment|4|||
143002967|NCT02322866|515548682|FG000|Overall Study|Lack of Efficacy|3|||
143002968|NCT02322866|515548683|FG001|Overall Study|Lack of Efficacy|1|||
143002969|NCT02322866|515548682|FG000|Overall Study|Other Miscellaneous Reasons|6|||
143002970|NCT02322866|515548683|FG001|Overall Study|Other Miscellaneous Reasons|6|||
143002971|NCT00798161|515548684|FG000|Overall Study|Adverse Event|3|||
143002972|NCT00798161|515548685|FG001|Overall Study|Adverse Event|4|||
143002973|NCT00798161|515548686|FG002|Overall Study|Adverse Event|6|||
143002974|NCT00798161|515548687|FG003|Overall Study|Adverse Event|6|||
143002975|NCT00798161|515548688|FG004|Overall Study|Adverse Event|5|||
143002976|NCT00798161|515548689|FG005|Overall Study|Adverse Event|2|||
143002977|NCT00798161|515548690|FG006|Overall Study|Adverse Event|4|||
143002978|NCT00798161|515548684|FG000|Overall Study|Protocol Violation|2|||
143002979|NCT00798161|515548685|FG001|Overall Study|Protocol Violation|1|||
143002980|NCT00798161|515548686|FG002|Overall Study|Protocol Violation|3|||
143002981|NCT00798161|515548687|FG003|Overall Study|Protocol Violation|3|||
143002982|NCT00798161|515548688|FG004|Overall Study|Protocol Violation|3|||
143002983|NCT00798161|515548689|FG005|Overall Study|Protocol Violation|2|||
143002984|NCT00798161|515548690|FG006|Overall Study|Protocol Violation|0|||
143002985|NCT00798161|515548684|FG000|Overall Study|Lost to Follow-up|1|||
143002986|NCT00798161|515548685|FG001|Overall Study|Lost to Follow-up|3|||
143002987|NCT00798161|515548686|FG002|Overall Study|Lost to Follow-up|4|||
143002988|NCT00798161|515548687|FG003|Overall Study|Lost to Follow-up|3|||
143002989|NCT00798161|515548688|FG004|Overall Study|Lost to Follow-up|4|||
143002990|NCT00798161|515548689|FG005|Overall Study|Lost to Follow-up|0|||
143002991|NCT00798161|515548690|FG006|Overall Study|Lost to Follow-up|0|||
143117305|NCT01066793|515971817|FG001|Overall Study|Other|5|||
143117306|NCT01066793|515971818|FG002|Overall Study|Other|6|||
143117307|NCT01066793|515971819|FG003|Overall Study|Other|2|||
143117308|NCT01066793|515971820|FG004|Overall Study|Other|0|||
143117309|NCT01066793|515971821|FG005|Overall Study|Other|0|||
143117310|NCT01066793|515971816|FG000|Overall Study|Relapse|20|||
143117311|NCT01066793|515971817|FG001|Overall Study|Relapse|8|||
143117312|NCT01066793|515971818|FG002|Overall Study|Relapse|2|||
143117313|NCT01066793|515971819|FG003|Overall Study|Relapse|3|||
143117314|NCT01066793|515971820|FG004|Overall Study|Relapse|0|||
143117315|NCT01066793|515971821|FG005|Overall Study|Relapse|0|||
143117316|NCT01066793|515971816|FG000|Overall Study|Result Not Available|1|||
143117317|NCT01066793|515971817|FG001|Overall Study|Result Not Available|0|||
143117318|NCT01066793|515971818|FG002|Overall Study|Result Not Available|0|||
143117319|NCT01066793|515971819|FG003|Overall Study|Result Not Available|0|||
143117320|NCT01066793|515971820|FG004|Overall Study|Result Not Available|0|||
143117321|NCT01066793|515971821|FG005|Overall Study|Result Not Available|0|||
143117322|NCT01066793|515971816|FG000|Overall Study|Treatment Interrupted|1|||
143002992|NCT00798161|515548684|FG000|Overall Study|Withdrawal by Subject|5|||
143002993|NCT00798161|515548685|FG001|Overall Study|Withdrawal by Subject|4|||
143002994|NCT00798161|515548686|FG002|Overall Study|Withdrawal by Subject|5|||
143002995|NCT00798161|515548687|FG003|Overall Study|Withdrawal by Subject|4|||
143002996|NCT00798161|515548688|FG004|Overall Study|Withdrawal by Subject|2|||
143002997|NCT00798161|515548689|FG005|Overall Study|Withdrawal by Subject|3|||
143002998|NCT00798161|515548690|FG006|Overall Study|Withdrawal by Subject|1|||
143002999|NCT00798161|515548684|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
143003000|NCT00798161|515548685|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
143003001|NCT00798161|515548686|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
143003199|NCT01049360|515548751|FG007|Period 4|Protocol Violation|0|||
143117323|NCT01066793|515971817|FG001|Overall Study|Treatment Interrupted|1|||
143117324|NCT01066793|515971818|FG002|Overall Study|Treatment Interrupted|0|||
143117325|NCT01066793|515971819|FG003|Overall Study|Treatment Interrupted|0|||
143117326|NCT01066793|515971820|FG004|Overall Study|Treatment Interrupted|0|||
143117327|NCT01066793|515971821|FG005|Overall Study|Treatment Interrupted|0|||
143117328|NCT01066793|515971816|FG000|Overall Study|Treatment Never Started|18|||
143117329|NCT01066793|515971817|FG001|Overall Study|Treatment Never Started|5|||
143117330|NCT01066793|515971818|FG002|Overall Study|Treatment Never Started|4|||
143117331|NCT01066793|515971819|FG003|Overall Study|Treatment Never Started|1|||
143117332|NCT01066793|515971820|FG004|Overall Study|Treatment Never Started|0|||
143117333|NCT01066793|515971821|FG005|Overall Study|Treatment Never Started|0|||
143117334|NCT01066793|515971816|FG000|Overall Study|Treatment Stopped|2|||
143117335|NCT01066793|515971817|FG001|Overall Study|Treatment Stopped|1|||
143117336|NCT01066793|515971818|FG002|Overall Study|Treatment Stopped|0|||
143117337|NCT01066793|515971819|FG003|Overall Study|Treatment Stopped|1|||
143117338|NCT01066793|515971820|FG004|Overall Study|Treatment Stopped|0|||
143117339|NCT01066793|515971821|FG005|Overall Study|Treatment Stopped|0|||
143117340|NCT03334422|515971822|FG000|Overall Study|Adverse Event|1|||
143117341|NCT03334422|515971823|FG001|Overall Study|Adverse Event|3|||
143117342|NCT03334422|515971824|FG002|Overall Study|Adverse Event|2|||
143117343|NCT03334422|515971825|FG003|Overall Study|Adverse Event|2|||
143117344|NCT03334422|515971822|FG000|Overall Study|Lack of Efficacy|10|||
143117345|NCT03334422|515971823|FG001|Overall Study|Lack of Efficacy|2|||
143117346|NCT03334422|515971824|FG002|Overall Study|Lack of Efficacy|7|||
143117347|NCT03334422|515971825|FG003|Overall Study|Lack of Efficacy|3|||
143117348|NCT03334422|515971822|FG000|Overall Study|Withdrawal by Subject|8|||
143117349|NCT03334422|515971823|FG001|Overall Study|Withdrawal by Subject|3|||
143117350|NCT03334422|515971824|FG002|Overall Study|Withdrawal by Subject|1|||
143117351|NCT03334422|515971825|FG003|Overall Study|Withdrawal by Subject|0|||
143003002|NCT00798161|515548687|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
143003003|NCT00798161|515548688|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
143003004|NCT00798161|515548689|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
143003005|NCT00798161|515548690|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
143003006|NCT04001790|515548700|FG000|Overall Study|Withdrawal by Subject|1|||
143003007|NCT04001790|515548701|FG001|Overall Study|Withdrawal by Subject|2|||
143003008|NCT02652793|515548703|FG000|Overall Study|Adverse Event|1|||
143003009|NCT02652793|515548703|FG000|Overall Study|Lost to Follow-up|2|||
143003010|NCT02652793|515548703|FG000|Overall Study|Withdrawal by Subject|1|||
143003011|NCT03868410|515548706|FG000|Overall Study|Physician Decision|0|||
143003012|NCT03868410|515548707|FG001|Overall Study|Physician Decision|1|||
143003013|NCT01059175|515548708|FG000|Overall Study|Death|17|||
143003014|NCT01059175|515548709|FG001|Overall Study|Death|17|||
143003015|NCT01059175|515548708|FG000|Overall Study|Adverse Event|4|||
143003016|NCT01059175|515548709|FG001|Overall Study|Adverse Event|2|||
143003017|NCT01059175|515548708|FG000|Overall Study|Lost to Follow-up|0|||
143003018|NCT01059175|515548709|FG001|Overall Study|Lost to Follow-up|1|||
143003019|NCT02957149|515548710|FG000|Overall Study|Withdrawal by Subject|5|||
143003020|NCT03471507|515548713|FG000|Overall Study|Lost to Follow-up|1|||
143003021|NCT03471507|515548714|FG001|Overall Study|Lost to Follow-up|3|||
143003022|NCT03471507|515548713|FG000|Overall Study|Physician Decision|0|||
143003023|NCT03471507|515548714|FG001|Overall Study|Physician Decision|1|||
143003024|NCT03471507|515548713|FG000|Overall Study|Withdrawal by Subject|2|||
143003025|NCT03471507|515548714|FG001|Overall Study|Withdrawal by Subject|1|||
143003026|NCT00761735|515548720|FG000|Overall Study|Lost to Follow-up|6|||
143003027|NCT00761735|515548720|FG000|Overall Study|Withdrawal by Subject|6|||
143003028|NCT00761735|515548720|FG000|Overall Study|Non-compliance with protocol|1|||
143003029|NCT00761735|515548720|FG000|Overall Study|Administrative|1|||
143003030|NCT03290131|515548721|FG000|Overall Study|Adverse Event|22|||
143003031|NCT03290131|515548722|FG001|Overall Study|Adverse Event|57|||
143003032|NCT03290131|515548723|FG002|Overall Study|Adverse Event|11|||
143003033|NCT03290131|515548721|FG000|Overall Study|Withdrawal by Subject|18|||
143003034|NCT03290131|515548722|FG001|Overall Study|Withdrawal by Subject|13|||
143003035|NCT03290131|515548723|FG002|Overall Study|Withdrawal by Subject|8|||
143003036|NCT03290131|515548721|FG000|Overall Study|MS Relapse|2|||
143003037|NCT03290131|515548722|FG001|Overall Study|MS Relapse|1|||
143003038|NCT03290131|515548723|FG002|Overall Study|MS Relapse|0|||
143003039|NCT03290131|515548721|FG000|Overall Study|Unknown reason|0|||
143003040|NCT03290131|515548722|FG001|Overall Study|Unknown reason|1|||
143003041|NCT03290131|515548723|FG002|Overall Study|Unknown reason|0|||
143003042|NCT04837807|515548725|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
143003043|NCT04837807|515548726|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
143003044|NCT04629534|515548727|FG000|Overall Study|Physician Decision|1|||
143003045|NCT04629534|515548728|FG001|Overall Study|Physician Decision|0|||
143003046|NCT04629534|515548727|FG000|Overall Study|Protocol Violation|0|||
143003047|NCT04629534|515548728|FG001|Overall Study|Protocol Violation|2|||
143003048|NCT00814502|515548729|FG000|Overall Study|Adverse Event|1|||
143003049|NCT00814502|515548730|FG001|Overall Study|Adverse Event|0|||
143003050|NCT00814502|515548729|FG000|Overall Study|Withdrawal by Subject|0|||
143003051|NCT00814502|515548730|FG001|Overall Study|Withdrawal by Subject|2|||
143003256|NCT01012765|515548770|FG005|Treatment Period 1|Protocol Violation|0|||
143003257|NCT01012765|515548765|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
143003258|NCT01012765|515548766|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
143003259|NCT01012765|515548767|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
143003260|NCT01012765|515548768|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
143003261|NCT01012765|515548769|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
143003262|NCT01012765|515548770|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
143003263|NCT01012765|515548765|FG000|Treatment Period 2|Withdrawal by Subject|1|||
143003264|NCT01012765|515548766|FG001|Treatment Period 2|Withdrawal by Subject|0|||
143003265|NCT01012765|515548767|FG002|Treatment Period 2|Withdrawal by Subject|1|||
143003266|NCT01012765|515548768|FG003|Treatment Period 2|Withdrawal by Subject|0|||
143003267|NCT01012765|515548769|FG004|Treatment Period 2|Withdrawal by Subject|1|||
143003268|NCT01012765|515548770|FG005|Treatment Period 2|Withdrawal by Subject|0|||
143003269|NCT01012765|515548765|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
143003270|NCT01012765|515548766|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
143003271|NCT01012765|515548767|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
143003272|NCT01012765|515548768|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
143003273|NCT01012765|515548769|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
143003274|NCT01012765|515548770|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
143003275|NCT01012765|515548765|FG000|Treatment Period 2|Adverse Event|0|||
143003276|NCT01012765|515548766|FG001|Treatment Period 2|Adverse Event|1|||
143003277|NCT01012765|515548767|FG002|Treatment Period 2|Adverse Event|1|||
143003278|NCT01012765|515548768|FG003|Treatment Period 2|Adverse Event|0|||
143003279|NCT01012765|515548769|FG004|Treatment Period 2|Adverse Event|0|||
143003280|NCT01012765|515548770|FG005|Treatment Period 2|Adverse Event|0|||
143003281|NCT01012765|515548765|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
143003282|NCT01012765|515548766|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
143003283|NCT01012765|515548767|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
143003284|NCT01012765|515548768|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
143003285|NCT01012765|515548769|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
143003286|NCT01012765|515548770|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
143003287|NCT01326312|515548771|FG000|Overall Study|Adverse Event|11|||
143003288|NCT01326312|515548772|FG001|Overall Study|Adverse Event|11|||
143003289|NCT01326312|515548773|FG002|Overall Study|Adverse Event|1|||
143003290|NCT01326312|515548771|FG000|Overall Study|Withdrawal by Subject|1|||
143003291|NCT01326312|515548772|FG001|Overall Study|Withdrawal by Subject|2|||
143003292|NCT01326312|515548773|FG002|Overall Study|Withdrawal by Subject|1|||
143003293|NCT01326312|515548771|FG000|Overall Study|Protocol Violation|0|||
143003294|NCT01326312|515548772|FG001|Overall Study|Protocol Violation|1|||
143003295|NCT01326312|515548773|FG002|Overall Study|Protocol Violation|0|||
143003296|NCT01326312|515548771|FG000|Overall Study|Lack of Efficacy|13|||
143003297|NCT01326312|515548772|FG001|Overall Study|Lack of Efficacy|7|||
143003298|NCT01326312|515548773|FG002|Overall Study|Lack of Efficacy|1|||
143003299|NCT01326312|515548771|FG000|Overall Study|Death|1|||
143003300|NCT01326312|515548772|FG001|Overall Study|Death|0|||
143003301|NCT01326312|515548773|FG002|Overall Study|Death|1|||
143003302|NCT01326312|515548771|FG000|Overall Study|progressive disease|0|||
143003303|NCT01326312|515548772|FG001|Overall Study|progressive disease|1|||
143003304|NCT01326312|515548773|FG002|Overall Study|progressive disease|1|||
143003305|NCT01326312|515548771|FG000|Overall Study|Study terminated by Sponsor|8|||
143003306|NCT01326312|515548772|FG001|Overall Study|Study terminated by Sponsor|32|||
143003307|NCT01326312|515548773|FG002|Overall Study|Study terminated by Sponsor|46|||
143003308|NCT01326312|515548771|FG000|Overall Study|Treatment arm terminated|19|||
143003309|NCT01326312|515548772|FG001|Overall Study|Treatment arm terminated|0|||
143003310|NCT01326312|515548773|FG002|Overall Study|Treatment arm terminated|0|||
143003311|NCT01326312|515548771|FG000|Overall Study|QTc > 500|0|||
143003312|NCT01326312|515548772|FG001|Overall Study|QTc > 500|1|||
143003313|NCT01326312|515548773|FG002|Overall Study|QTc > 500|0|||
143003314|NCT00499694|515548788|FG000|Overall Study|Patient never received treatment.|1|||
143003315|NCT00674440|515548789|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
143003316|NCT00674440|515548789|FG000|Overall Study|did not have surgery, so unevaluable|7|||
143003317|NCT00674440|515548789|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
143003318|NCT03457701|515548790|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
143003319|NCT03457701|515548791|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
143003320|NCT03457701|515548790|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
143003321|NCT03457701|515548791|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
143003322|NCT03329404|515548792|FG000|Overall Study|The study was suspended.|1|||
143003323|NCT03329404|515548793|FG001|Overall Study|The study was suspended.|4|||
143003324|NCT05664672|515548796|FG000|Overall Study|Adverse Event|0|||
143003325|NCT05664672|515548797|FG001|Overall Study|Adverse Event|0|||
143003326|NCT05664672|515548798|FG002|Overall Study|Adverse Event|0|||
143003327|NCT05664672|515548799|FG003|Overall Study|Adverse Event|0|||
143003328|NCT05664672|515548800|FG004|Overall Study|Adverse Event|0|||
143003386|NCT00129220|515548822|FG001|Study Period II|Protocol Violation|2|||
143003387|NCT00129220|515548823|FG002|Study Period II|Protocol Violation|1|||
143003388|NCT00129220|515548821|FG000|Study Period II|Physician Decision|0|||
143003389|NCT00129220|515548822|FG001|Study Period II|Physician Decision|1|||
143003390|NCT00129220|515548823|FG002|Study Period II|Physician Decision|0|||
143003391|NCT00129220|515548821|FG000|Study Period II|Withdrawal by Subject|1|||
143003392|NCT00129220|515548822|FG001|Study Period II|Withdrawal by Subject|3|||
143003393|NCT00129220|515548823|FG002|Study Period II|Withdrawal by Subject|4|||
143003394|NCT00129220|515548821|FG000|Study Period II|Reason Not Specified|2|||
143003395|NCT00129220|515548822|FG001|Study Period II|Reason Not Specified|0|||
143003396|NCT00129220|515548823|FG002|Study Period II|Reason Not Specified|5|||
143003397|NCT00129220|515548821|FG000|Study Period III|Adverse Event|1|||
143003398|NCT00129220|515548822|FG001|Study Period III|Adverse Event|0|||
143003399|NCT00129220|515548823|FG002|Study Period III|Adverse Event|3|||
143003400|NCT00129220|515548821|FG000|Study Period III|Protocol Violation|1|||
143003401|NCT00129220|515548822|FG001|Study Period III|Protocol Violation|1|||
143003402|NCT00129220|515548823|FG002|Study Period III|Protocol Violation|2|||
143003403|NCT00129220|515548821|FG000|Study Period III|Withdrawal by Subject|1|||
143003404|NCT00129220|515548822|FG001|Study Period III|Withdrawal by Subject|0|||
143003405|NCT00129220|515548823|FG002|Study Period III|Withdrawal by Subject|3|||
143003406|NCT00129220|515548821|FG000|Study Period III|Sponsor Decision|1|||
143003407|NCT00129220|515548822|FG001|Study Period III|Sponsor Decision|0|||
143003408|NCT00129220|515548823|FG002|Study Period III|Sponsor Decision|0|||
143003409|NCT00129220|515548821|FG000|Study Period III|Reason Not Specified|9|||
143003410|NCT00129220|515548822|FG001|Study Period III|Reason Not Specified|0|||
143003411|NCT00129220|515548823|FG002|Study Period III|Reason Not Specified|2|||
143003412|NCT01883362|515548824|FG000|Treatment|Adverse Event|1|||
143003413|NCT01883362|515548825|FG001|Treatment|Adverse Event|8|||
143003414|NCT01883362|515548824|FG000|Treatment|Withdrawal by Subject|6|||
143003415|NCT01883362|515548825|FG001|Treatment|Withdrawal by Subject|2|||
143003416|NCT01883362|515548824|FG000|Treatment|Administrative problems|4|||
143003417|NCT01883362|515548825|FG001|Treatment|Administrative problems|1|||
143003418|NCT01883362|515548824|FG000|Treatment|Relapse|4|||
143003419|NCT01883362|515548825|FG001|Treatment|Relapse|2|||
143003420|NCT01883362|515548824|FG000|Treatment|Randomized, not treated|1|||
143003421|NCT01883362|515548825|FG001|Treatment|Randomized, not treated|1|||
143003422|NCT01883362|515548824|FG000|Post Treatment Follow-up|Protocol Violation|0|||
143003423|NCT01883362|515548825|FG001|Post Treatment Follow-up|Protocol Violation|1|||
143003424|NCT01883362|515548824|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
143003425|NCT01883362|515548825|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
143003426|NCT01883362|515548824|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
143003427|NCT01883362|515548825|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
143003428|NCT01883362|515548824|FG000|Post Treatment Follow-up|Administrative problems|2|||
143003429|NCT01883362|515548825|FG001|Post Treatment Follow-up|Administrative problems|0|||
143003430|NCT01883362|515548824|FG000|Post Treatment Follow-up|Death|8|||
143003431|NCT01883362|515548825|FG001|Post Treatment Follow-up|Death|4|||
143003432|NCT01883362|515548824|FG000|Post Treatment Follow-up|Relapse|1|||
143003433|NCT01883362|515548825|FG001|Post Treatment Follow-up|Relapse|2|||
143003434|NCT00198107|515550623|FG000|Double-Blind Period|Adverse Event|1|||
143003435|NCT00198107|515550624|FG001|Double-Blind Period|Adverse Event|1|||
143003436|NCT00198107|515550625|FG002|Double-Blind Period|Adverse Event|0|||
143003437|NCT00198107|515550623|FG000|Double-Blind Period|Lack of Efficacy|2|||
143003438|NCT00198107|515550624|FG001|Double-Blind Period|Lack of Efficacy|0|||
143003439|NCT00198107|515550625|FG002|Double-Blind Period|Lack of Efficacy|0|||
143003440|NCT00198107|515550623|FG000|Double-Blind Period|Lost to Follow-up|2|||
143003441|NCT00198107|515550624|FG001|Double-Blind Period|Lost to Follow-up|1|||
143003442|NCT00198107|515550625|FG002|Double-Blind Period|Lost to Follow-up|0|||
143003443|NCT00198107|515550623|FG000|Double-Blind Period|Physician Decision|1|||
143003444|NCT00198107|515550624|FG001|Double-Blind Period|Physician Decision|0|||
143003445|NCT00198107|515550625|FG002|Double-Blind Period|Physician Decision|0|||
143003446|NCT00198107|515550623|FG000|Double-Blind Period|Withdrawal by Subject|0|||
143003447|NCT00198107|515550624|FG001|Double-Blind Period|Withdrawal by Subject|1|||
143003448|NCT00198107|515550625|FG002|Double-Blind Period|Withdrawal by Subject|0|||
143003449|NCT00198107|515550623|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
143003450|NCT00198107|515550624|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
143003451|NCT00198107|515550625|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
143003452|NCT02513732|515550626|FG000|Overall Study|Lost to Follow-up|11|||
143003453|NCT02513732|515550626|FG000|Overall Study|Death|9|||
143003454|NCT02513732|515550626|FG000|Overall Study|Changing hospital|2|||
143003455|NCT00934661|515550627|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
143003456|NCT00934661|515550628|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
143003457|NCT02147132|515550635|FG000|Overall Study|Lost to Follow-up|1|||
143003458|NCT02147132|515550636|FG001|Overall Study|Lost to Follow-up|0|||
143003459|NCT02147132|515550637|FG002|Overall Study|Lost to Follow-up|0|||
143003460|NCT02147132|515550638|FG003|Overall Study|Lost to Follow-up|0|||
143003461|NCT02646566|515550639|FG000|Overall Study|Lost to Follow-up|5|||
143003462|NCT02646566|515550640|FG001|Overall Study|Lost to Follow-up|4|||
143003564|NCT05028816|515550672|FG001|Overall Study|Withdrawal by Subject|1|||
143003565|NCT05028816|515550671|FG000|Overall Study|Physician Decision|1|||
143003566|NCT05028816|515550672|FG001|Overall Study|Physician Decision|0|||
143003567|NCT05064436|515550673|FG000|Overall Study|Other Reasons|1|||
143003568|NCT05064436|515550674|FG001|Overall Study|Other Reasons|0|||
143003569|NCT01711736|515550675|FG000|Overall Study|Lost to Follow-up|4|||
143003570|NCT01711736|515550676|FG001|Overall Study|Lost to Follow-up|1|||
143003571|NCT01711736|515550675|FG000|Overall Study|Withdrawal by Subject|6|||
143003572|NCT01711736|515550676|FG001|Overall Study|Withdrawal by Subject|6|||
143003573|NCT01711736|515550675|FG000|Overall Study|Migrated/moved from study area|2|||
143003574|NCT01711736|515550676|FG001|Overall Study|Migrated/moved from study area|1|||
143003575|NCT01342445|515550677|FG000|Overall Study|Experienced side effects|0|||
143003576|NCT01342445|515550678|FG001|Overall Study|Experienced side effects|2|||
143003577|NCT04579666|515550684|FG000|RTP (Up to Week 52)|Adverse Event|4|||
143003578|NCT04579666|515550685|FG001|RTP (Up to Week 52)|Adverse Event|3|||
143003579|NCT04579666|515550686|FG002|RTP (Up to Week 52)|Adverse Event|0|||
143003580|NCT04579666|515550687|FG003|RTP (Up to Week 52)|Adverse Event|0|||
143003581|NCT04579666|515550684|FG000|RTP (Up to Week 52)|Death|24|||
143003582|NCT04579666|515550685|FG001|RTP (Up to Week 52)|Death|9|||
143003583|NCT04579666|515550686|FG002|RTP (Up to Week 52)|Death|0|||
143003584|NCT04579666|515550687|FG003|RTP (Up to Week 52)|Death|0|||
143003585|NCT04579666|515550684|FG000|RTP (Up to Week 52)|Lost to Follow-up|1|||
143003586|NCT04579666|515550685|FG001|RTP (Up to Week 52)|Lost to Follow-up|0|||
143003587|NCT04579666|515550686|FG002|RTP (Up to Week 52)|Lost to Follow-up|0|||
143003588|NCT04579666|515550687|FG003|RTP (Up to Week 52)|Lost to Follow-up|0|||
143003589|NCT04579666|515550684|FG000|RTP (Up to Week 52)|Physician Decision|4|||
143003590|NCT04579666|515550685|FG001|RTP (Up to Week 52)|Physician Decision|1|||
143003591|NCT04579666|515550686|FG002|RTP (Up to Week 52)|Physician Decision|0|||
143003592|NCT04579666|515550687|FG003|RTP (Up to Week 52)|Physician Decision|0|||
143003593|NCT04579666|515550684|FG000|RTP (Up to Week 52)|Progressive disease|1|||
143003594|NCT04579666|515550685|FG001|RTP (Up to Week 52)|Progressive disease|0|||
143003595|NCT04579666|515550686|FG002|RTP (Up to Week 52)|Progressive disease|0|||
143003596|NCT04579666|515550687|FG003|RTP (Up to Week 52)|Progressive disease|0|||
143003597|NCT04579666|515550684|FG000|RTP (Up to Week 52)|Site terminated by sponsor|7|||
143003598|NCT04579666|515550685|FG001|RTP (Up to Week 52)|Site terminated by sponsor|5|||
143003599|NCT04579666|515550686|FG002|RTP (Up to Week 52)|Site terminated by sponsor|0|||
143003600|NCT04579666|515550687|FG003|RTP (Up to Week 52)|Site terminated by sponsor|0|||
143003601|NCT04579666|515550684|FG000|RTP (Up to Week 52)|Study terminated by sponsor|2|||
143003602|NCT04579666|515550685|FG001|RTP (Up to Week 52)|Study terminated by sponsor|0|||
143003603|NCT04579666|515550686|FG002|RTP (Up to Week 52)|Study terminated by sponsor|0|||
143003604|NCT04579666|515550687|FG003|RTP (Up to Week 52)|Study terminated by sponsor|0|||
143003605|NCT04579666|515550684|FG000|RTP (Up to Week 52)|Withdrawal by Subject|25|||
143003606|NCT04579666|515550685|FG001|RTP (Up to Week 52)|Withdrawal by Subject|11|||
143003607|NCT04579666|515550686|FG002|RTP (Up to Week 52)|Withdrawal by Subject|0|||
143003608|NCT04579666|515550687|FG003|RTP (Up to Week 52)|Withdrawal by Subject|0|||
143003609|NCT04579666|515550684|FG000|RTP (Up to Week 52)|Other|2|||
143003610|NCT04579666|515550685|FG001|RTP (Up to Week 52)|Other|0|||
143003611|NCT04579666|515550686|FG002|RTP (Up to Week 52)|Other|0|||
143003612|NCT04579666|515550687|FG003|RTP (Up to Week 52)|Other|0|||
143003613|NCT04579666|515550684|FG000|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
143003614|NCT04579666|515550685|FG001|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
143003615|NCT04579666|515550686|FG002|OLP (From Week 52 up to Week 104)|Adverse Event|2|||
143003616|NCT04579666|515550687|FG003|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
143003617|NCT04579666|515550684|FG000|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
143003618|NCT04579666|515550685|FG001|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
143003619|NCT04579666|515550686|FG002|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|19|||
143003620|NCT04579666|515550687|FG003|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|12|||
143003621|NCT04579666|515550684|FG000|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
143003622|NCT04579666|515550685|FG001|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
143003623|NCT04579666|515550686|FG002|OLP (From Week 52 up to Week 104)|Sponsor request|63|||
143003624|NCT04579666|515550687|FG003|OLP (From Week 52 up to Week 104)|Sponsor request|31|||
143003625|NCT04579666|515550684|FG000|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
143003626|NCT04579666|515550685|FG001|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
143003627|NCT04579666|515550686|FG002|OLP (From Week 52 up to Week 104)|Physician Decision|3|||
143003628|NCT04579666|515550687|FG003|OLP (From Week 52 up to Week 104)|Physician Decision|1|||
143003629|NCT04579666|515550684|FG000|OLP (From Week 52 up to Week 104)|Death|0|||
143003630|NCT04579666|515550685|FG001|OLP (From Week 52 up to Week 104)|Death|0|||
143003631|NCT04579666|515550686|FG002|OLP (From Week 52 up to Week 104)|Death|10|||
143003632|NCT04579666|515550687|FG003|OLP (From Week 52 up to Week 104)|Death|6|||
143003633|NCT05450198|515550688|FG000|Overall Study|Withdrawal by Subject|1|||
143003634|NCT05450198|515550689|FG001|Overall Study|Withdrawal by Subject|1|||
143003635|NCT05450198|515550690|FG002|Overall Study|Withdrawal by Subject|2|||
143003636|NCT05450198|515550691|FG003|Overall Study|Withdrawal by Subject|0|||
143003637|NCT05450198|515550688|FG000|Overall Study|Lost to Follow-up|1|||
143003638|NCT05450198|515550689|FG001|Overall Study|Lost to Follow-up|0|||
143003720|NCT04338685|515550713|FG006|Overall Study|Withdrawal by Subject|1|||
143003721|NCT04338685|515550714|FG007|Overall Study|Withdrawal by Subject|1|||
143003722|NCT04338685|515550715|FG008|Overall Study|Withdrawal by Subject|0|||
143003723|NCT00234533|515550716|FG000|Overall Study|Withdrawal by Subject|6|||
143003724|NCT00234533|515550716|FG000|Overall Study|Adverse Event|2|||
143003725|NCT00234533|515550716|FG000|Overall Study|Enrolled but not treated|3|||
143003726|NCT02967055|515550717|FG000|Overall Study|Excluded|40|||
143003727|NCT02967055|515550717|FG000|Overall Study|Screen fail|3|||
143003728|NCT02967055|515550717|FG000|Overall Study|Lost to Follow-up|2|||
143003729|NCT02967055|515550717|FG000|Overall Study|Stopped due to side effects|3|||
143003730|NCT02967055|515550717|FG000|Overall Study|Stopped due to drug cost|1|||
143003731|NCT00570492|515550718|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
143003732|NCT00570492|515550719|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
143003733|NCT00570492|515550720|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
143003734|NCT00570492|515550718|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
143003735|NCT00570492|515550719|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
143003736|NCT00570492|515550720|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
143003737|NCT00570492|515550718|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
143003738|NCT00570492|515550719|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
143003739|NCT00570492|515550720|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
143003740|NCT00570492|515550718|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
143003741|NCT00570492|515550719|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
143003742|NCT00570492|515550720|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
143003743|NCT00570492|515550718|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
143003744|NCT00570492|515550719|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
143003745|NCT00570492|515550720|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
143003746|NCT00570492|515550718|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
143003747|NCT00570492|515550719|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
143003748|NCT00570492|515550720|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
143003749|NCT00570492|515550718|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
143003750|NCT00570492|515550719|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
143003751|NCT00570492|515550720|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
143003752|NCT00570492|515550718|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
143003753|NCT00570492|515550719|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
143003754|NCT00570492|515550720|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
143003755|NCT00570492|515550718|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
143003756|NCT00570492|515550719|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
143003757|NCT00570492|515550720|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
143003758|NCT00570492|515550718|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
143003759|NCT00570492|515550719|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
143003760|NCT00570492|515550720|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
143003761|NCT00570492|515550718|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
143003762|NCT00570492|515550719|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
143003763|NCT00570492|515550720|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
143003764|NCT00570492|515550718|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
143003765|NCT00570492|515550719|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
143003766|NCT00570492|515550720|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
143003767|NCT00570492|515550718|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
143003768|NCT00570492|515550719|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
143003769|NCT00570492|515550720|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
143003770|NCT00570492|515550718|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
143003771|NCT00570492|515550719|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
143003772|NCT00570492|515550720|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
143003773|NCT00976989|515550721|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
143003774|NCT00976989|515550722|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
143003775|NCT00976989|515550723|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
143003776|NCT00976989|515550721|FG000|Overall Study|Death|5|||
143003777|NCT00976989|515550722|FG001|Overall Study|Death|7|||
143003778|NCT00976989|515550723|FG002|Overall Study|Death|10|||
143003779|NCT00976989|515550721|FG000|Overall Study|Refused Treatment|4|||
143003780|NCT00976989|515550722|FG001|Overall Study|Refused Treatment|3|||
143003781|NCT00976989|515550723|FG002|Overall Study|Refused Treatment|5|||
143003782|NCT00976989|515550721|FG000|Overall Study|Failure to Return|2|||
143003783|NCT00976989|515550722|FG001|Overall Study|Failure to Return|1|||
143003784|NCT00976989|515550723|FG002|Overall Study|Failure to Return|0|||
143003785|NCT00976989|515550721|FG000|Overall Study|Recurrence of Disease|0|||
143003786|NCT00976989|515550722|FG001|Overall Study|Recurrence of Disease|1|||
143003787|NCT00976989|515550723|FG002|Overall Study|Recurrence of Disease|0|||
143003788|NCT00976989|515550721|FG000|Overall Study|Other|1|||
143003789|NCT00976989|515550722|FG001|Overall Study|Other|0|||
143003790|NCT00976989|515550723|FG002|Overall Study|Other|1|||
143003791|NCT00908375|515550724|FG000|Overall Study|Withdrawal by Subject|2|||
143003792|NCT00908375|515550725|FG001|Overall Study|Withdrawal by Subject|4|||
143003793|NCT00908375|515550724|FG000|Overall Study|Lost to Follow-up|8|||
143003794|NCT00908375|515550725|FG001|Overall Study|Lost to Follow-up|6|||
143003795|NCT04419558|515550726|FG000|DB Period (48 Weeks)|Adverse Event|6|||
143003796|NCT04419558|515550727|FG001|DB Period (48 Weeks)|Adverse Event|6|||
143003797|NCT04419558|515550726|FG000|DB Period (48 Weeks)|Death|14|||
143003798|NCT04419558|515550727|FG001|DB Period (48 Weeks)|Death|11|||
143003799|NCT04419558|515550726|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
143003800|NCT04419558|515550727|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
143003801|NCT04419558|515550726|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
143003802|NCT04419558|515550727|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
143003803|NCT04419558|515550726|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
143003804|NCT04419558|515550727|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
143003805|NCT04419558|515550726|FG000|DB Period (48 Weeks)|Disease Progression|1|||
143003806|NCT04419558|515550727|FG001|DB Period (48 Weeks)|Disease Progression|0|||
143003807|NCT04419558|515550726|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
143003808|NCT04419558|515550727|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
143003809|NCT04419558|515550726|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
143003810|NCT04419558|515550727|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
143003811|NCT04419558|515550726|FG000|DB Period (48 Weeks)|Participant Decision|4|||
143003812|NCT04419558|515550727|FG001|DB Period (48 Weeks)|Participant Decision|3|||
143003813|NCT04419558|515550726|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
143003814|NCT04419558|515550727|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
143003815|NCT04419558|515550726|FG000|OLE Period (48 Weeks)|Death|4|||
143003816|NCT04419558|515550727|FG001|OLE Period (48 Weeks)|Death|6|||
143003817|NCT04419558|515550726|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
143003818|NCT04419558|515550727|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
143003819|NCT04419558|515550726|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
143003820|NCT04419558|515550727|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
143003821|NCT00903357|515550728|FG000|First Intervention|Withdrawal by Subject|5|||
143003822|NCT00903357|515550729|FG001|First Intervention|Withdrawal by Subject|3|||
143003823|NCT00903357|515550728|FG000|First Intervention|Flu|0|||
143003824|NCT00903357|515550729|FG001|First Intervention|Flu|1|||
143003825|NCT00903357|515550728|FG000|Wash Out Period of 2 Weeks|Flu|0|||
143003826|NCT00903357|515550729|FG001|Wash Out Period of 2 Weeks|Flu|1|||
143003827|NCT00903357|515550728|FG000|Second Intervention|Lost to Follow-up|1|||
143003828|NCT00903357|515550729|FG001|Second Intervention|Lost to Follow-up|0|||
143003829|NCT00678652|515550731|FG000|Overall Study|Protocol Violation|2|||
143003830|NCT00678652|515550732|FG001|Overall Study|Protocol Violation|0|||
143003831|NCT00678652|515550733|FG002|Overall Study|Protocol Violation|0|||
143003832|NCT00678652|515550734|FG003|Overall Study|Protocol Violation|0|||
143003833|NCT00678652|515550731|FG000|Overall Study|Pregnancy|0|||
143003834|NCT00678652|515550732|FG001|Overall Study|Pregnancy|0|||
143003835|NCT00678652|515550733|FG002|Overall Study|Pregnancy|1|||
143003836|NCT00678652|515550734|FG003|Overall Study|Pregnancy|0|||
143003837|NCT00678652|515550731|FG000|Overall Study|Relocation|1|||
143003838|NCT00678652|515550732|FG001|Overall Study|Relocation|0|||
143003839|NCT00678652|515550733|FG002|Overall Study|Relocation|0|||
143003840|NCT00678652|515550734|FG003|Overall Study|Relocation|0|||
143003841|NCT01484691|515550735|FG000|Overall Study|Withdrawal by Subject|1|||
143003842|NCT01484691|515550736|FG001|Overall Study|Withdrawal by Subject|1|||
143003843|NCT01484691|515550737|FG002|Overall Study|Withdrawal by Subject|1|||
143003844|NCT01484691|515550735|FG000|Overall Study|Physician Decision|0|||
143003845|NCT01484691|515550736|FG001|Overall Study|Physician Decision|2|||
143003846|NCT01484691|515550737|FG002|Overall Study|Physician Decision|1|||
143003847|NCT03958045|515550742|FG000|Overall Study|Withdrawal by Subject|1|||
143003848|NCT04236986|515550748|FG000|Overall Study|Withdrawal by Subject|3|||
143003849|NCT04236986|515550749|FG001|Overall Study|Withdrawal by Subject|1|||
143003850|NCT01590810|515550754|FG000|Overall Study|Physician Decision|0|||
143003851|NCT01590810|515550755|FG001|Overall Study|Physician Decision|1|||
143003852|NCT01590810|515550756|FG002|Overall Study|Physician Decision|1|||
143003853|NCT01590810|515550757|FG003|Overall Study|Physician Decision|0|||
143003854|NCT01590810|515550758|FG004|Overall Study|Physician Decision|0|||
143003855|NCT02441517|515550766|FG000|Overall Study|Lost to Follow-up|1|||
143003856|NCT02441517|515550766|FG000|Overall Study|Withdrawal by Subject|2|||
143003857|NCT02441517|515550766|FG000|Overall Study|Study Terminated by Sponsor|1|||
143003858|NCT01393444|515550767|FG000|Overall Study|Withdrawal by Subject|1|||
143003859|NCT01393444|515550767|FG000|Overall Study|Determined ineligible during screening.|2|||
143003860|NCT03039699|515550768|FG000|Overall Study|Incorrect inclusion|5|||
143003861|NCT03039699|515550769|FG001|Overall Study|Incorrect inclusion|4|||
143003862|NCT03039699|515550768|FG000|Overall Study|Lack of data to assess study endpoint|5|||
143003863|NCT03039699|515550769|FG001|Overall Study|Lack of data to assess study endpoint|3|||
143003864|NCT03039699|515550768|FG000|Overall Study|Bacterial infection|12|||
143003933|NCT02911285|515550784|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
143003934|NCT02911285|515550785|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
143003935|NCT01207427|515550786|FG000|Double-blind Treatment Period|Adverse Event|0|||
143003936|NCT01207427|515550787|FG001|Double-blind Treatment Period|Adverse Event|1|||
143003937|NCT01207427|515550788|FG002|Double-blind Treatment Period|Adverse Event|0|||
143003938|NCT01207427|515550786|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
143003939|NCT01207427|515550787|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
143003940|NCT01207427|515550788|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
143003941|NCT01207427|515550786|FG000|Double-blind Treatment Period|Protocol Violation|2|||
143003942|NCT01207427|515550787|FG001|Double-blind Treatment Period|Protocol Violation|1|||
143003943|NCT01207427|515550788|FG002|Double-blind Treatment Period|Protocol Violation|1|||
143003944|NCT01207427|515550786|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
143003945|NCT01207427|515550787|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
143003946|NCT01207427|515550788|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
143003947|NCT01791543|515550789|FG000|Overall Study|Lost to Follow-up|1|||
143003948|NCT01791543|515550789|FG000|Overall Study|Adverse Event|1|||
143003949|NCT00761462|515553002|FG000|Treatment|Subjects never received study medication|23|||
143003950|NCT00761462|515553003|FG001|Treatment|Subjects never received study medication|12|||
143003951|NCT00761462|515553002|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
143003952|NCT00761462|515553003|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
143003953|NCT00761462|515553002|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
143003954|NCT00761462|515553003|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
143003955|NCT00761462|515553002|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
143003956|NCT00761462|515553003|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
143003957|NCT02985541|515553007|FG000|Overall Study|Withdrawal by Subject|33|||
143003958|NCT02985541|515553007|FG000|Overall Study|Lost to Follow-up|26|||
143003959|NCT02985541|515553007|FG000|Overall Study|Adverse Event|27|||
143003960|NCT02985541|515553007|FG000|Overall Study|Physician Decision|2|||
143003961|NCT02985541|515553007|FG000|Overall Study|Pregnancy|2|||
143003962|NCT02985541|515553007|FG000|Overall Study|Wish for pregnancy|44|||
143003963|NCT02985541|515553007|FG000|Overall Study|Other reason|5|||
143003964|NCT02985541|515553007|FG000|Overall Study|Not valid for analysis|2|||
143003965|NCT02383966|515553008|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
143003966|NCT02383966|515553009|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
143003967|NCT02383966|515553008|FG000|Overall Study|Randomized, but not treated|1|||
143003968|NCT02383966|515553009|FG001|Overall Study|Randomized, but not treated|3|||
143003969|NCT02163759|515553010|FG000|Overall Study|Withdrawal by Subject|1|||
143003970|NCT02163759|515553011|FG001|Overall Study|Withdrawal by Subject|5|||
143003971|NCT02163759|515553012|FG002|Overall Study|Withdrawal by Subject|1|||
143003972|NCT02163759|515553010|FG000|Overall Study|Adverse Event|0|||
143003973|NCT02163759|515553011|FG001|Overall Study|Adverse Event|0|||
143003974|NCT02163759|515553012|FG002|Overall Study|Adverse Event|1|||
143003975|NCT02163759|515553010|FG000|Overall Study|Death|0|||
143003976|NCT02163759|515553011|FG001|Overall Study|Death|0|||
143003977|NCT02163759|515553012|FG002|Overall Study|Death|1|||
143003978|NCT01479777|515553021|FG000|Overall Study|Physician Decision|2|||
143003979|NCT00451191|515553025|FG000|Overall Study|withdrawal or received alternate tx|15|||
143003980|NCT00451191|515553026|FG001|Overall Study|withdrawal or received alternate tx|11|||
143003981|NCT03575806|515553038|FG000|Overall Study|Withdrawal by Subject|0|||
143003982|NCT03575806|515553039|FG001|Overall Study|Withdrawal by Subject|2|||
143003983|NCT03575806|515553038|FG000|Overall Study|Protocol Violation|0|||
143003984|NCT03575806|515553039|FG001|Overall Study|Protocol Violation|2|||
143003985|NCT00219349|515553040|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
143003986|NCT00219349|515553040|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
143003987|NCT00219349|515553040|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
143003988|NCT00219349|515553040|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
143003989|NCT00270205|515553042|FG000|Overall Study|Lost to Follow-up|1|||
143003990|NCT00270205|515553043|FG001|Overall Study|Lost to Follow-up|0|||
143003991|NCT00270205|515553044|FG002|Overall Study|Lost to Follow-up|0|||
143003992|NCT00270205|515553045|FG003|Overall Study|Lost to Follow-up|1|||
143003993|NCT00869362|515553049|FG000|Overall Study|Death|0|||
143003994|NCT00869362|515553050|FG001|Overall Study|Death|2|||
143003995|NCT00869362|515553049|FG000|Overall Study|Lost to Follow-up|1|||
143003996|NCT00869362|515553050|FG001|Overall Study|Lost to Follow-up|3|||
143003997|NCT01241591|515553051|FG000|Overall Study|Lack of Efficacy|5|||
143003998|NCT01241591|515553052|FG001|Overall Study|Lack of Efficacy|2|||
143003999|NCT01241591|515553053|FG002|Overall Study|Lack of Efficacy|2|||
143004000|NCT01241591|515553054|FG003|Overall Study|Lack of Efficacy|3|||
143004001|NCT01241591|515553051|FG000|Overall Study|Protocol Violation|5|||
143004002|NCT01241591|515553052|FG001|Overall Study|Protocol Violation|2|||
143004003|NCT01241591|515553053|FG002|Overall Study|Protocol Violation|3|||
143004004|NCT01241591|515553054|FG003|Overall Study|Protocol Violation|0|||
143004005|NCT01241591|515553051|FG000|Overall Study|Lost to Follow-up|1|||
143004006|NCT01241591|515553052|FG001|Overall Study|Lost to Follow-up|2|||
143004055|NCT00489411|515553066|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
143004056|NCT00489411|515553067|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
143004057|NCT00489411|515553066|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
143004058|NCT00489411|515553067|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
143004059|NCT00489411|515553066|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
143004060|NCT00489411|515553067|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
143004061|NCT00489411|515553066|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
143004062|NCT00489411|515553067|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
143004063|NCT03219372|515553069|FG000|Overall Study|Withdrawal by Subject|1|||
143004064|NCT03219372|515553070|FG001|Overall Study|Withdrawal by Subject|0|||
143004065|NCT02985996|515553074|FG000|Overall Study|Withdrawal by Subject|0|||
143004066|NCT02985996|515553075|FG001|Overall Study|Withdrawal by Subject|0|||
143004067|NCT02985996|515553076|FG002|Overall Study|Withdrawal by Subject|1|||
143004068|NCT02985996|515553077|FG003|Overall Study|Withdrawal by Subject|0|||
143004069|NCT02985996|515553078|FG004|Overall Study|Withdrawal by Subject|0|||
143004070|NCT02985996|515553074|FG000|Overall Study|Protocol Violation|0|||
143004071|NCT02985996|515553075|FG001|Overall Study|Protocol Violation|1|||
143004072|NCT02985996|515553076|FG002|Overall Study|Protocol Violation|0|||
143004073|NCT02985996|515553077|FG003|Overall Study|Protocol Violation|0|||
143004074|NCT02985996|515553078|FG004|Overall Study|Protocol Violation|0|||
143004075|NCT00401726|515553079|FG000|Overall Study|Adverse Event|34|||
143004076|NCT00401726|515553080|FG001|Overall Study|Adverse Event|45|||
143004077|NCT00401726|515553079|FG000|Overall Study|Death|0|||
143004078|NCT00401726|515553080|FG001|Overall Study|Death|3|||
143004079|NCT00401726|515553079|FG000|Overall Study|Sponsor Request|0|||
143004080|NCT00401726|515553080|FG001|Overall Study|Sponsor Request|1|||
143004081|NCT00401726|515553079|FG000|Overall Study|Physician Decision|3|||
143004082|NCT00401726|515553080|FG001|Overall Study|Physician Decision|6|||
143004083|NCT00401726|515553079|FG000|Overall Study|Lost to Follow-up|23|||
143004084|NCT00401726|515553080|FG001|Overall Study|Lost to Follow-up|20|||
143004085|NCT00401726|515553079|FG000|Overall Study|Protocol Violation|6|||
143004086|NCT00401726|515553080|FG001|Overall Study|Protocol Violation|3|||
143004087|NCT00401726|515553079|FG000|Overall Study|Withdrawal by Subject|18|||
143004088|NCT00401726|515553080|FG001|Overall Study|Withdrawal by Subject|24|||
143004089|NCT00401726|515553079|FG000|Overall Study|Lack of Efficacy|4|||
143004090|NCT00401726|515553080|FG001|Overall Study|Lack of Efficacy|6|||
143004091|NCT00401726|515553079|FG000|Overall Study|Protocol Deviation|9|||
143004092|NCT00401726|515553080|FG001|Overall Study|Protocol Deviation|4|||
143004093|NCT03532048|515553082|FG000|Overall Study|Lost to Follow-up|12|||
143004094|NCT03532048|515553083|FG001|Overall Study|Lost to Follow-up|17|||
143004095|NCT03532048|515553082|FG000|Overall Study|Withdrawal by Subject|7|||
143004096|NCT03532048|515553083|FG001|Overall Study|Withdrawal by Subject|0|||
143004097|NCT00308555|515553084|FG000|Overall Study|Withdrawal by Subject|1|||
143004098|NCT00308555|515553085|FG001|Overall Study|Withdrawal by Subject|0|||
143004099|NCT00308555|515553084|FG000|Overall Study|Physician Decision|2|||
143004100|NCT00308555|515553085|FG001|Overall Study|Physician Decision|0|||
143004101|NCT01901393|515553086|FG000|Overall Study|Adverse Event|1|||
143004102|NCT01901393|515553087|FG001|Overall Study|Adverse Event|0|||
143004103|NCT04113746|515553090|FG000|Overall Study|Lost to Follow-up|4|||
143004104|NCT04113746|515553091|FG001|Overall Study|Lost to Follow-up|4|||
143004105|NCT03125382|515553092|FG000|Randomization|screening failure|1|||
143004106|NCT03125382|515553093|FG001|Randomization|screening failure|4|||
143004107|NCT03125382|515553094|FG002|Randomization|screening failure|2|||
143004108|NCT03125382|515553095|FG003|Randomization|screening failure|0|||
143004109|NCT03125382|515553092|FG000|Follow-up|Death|1|||
143004110|NCT03125382|515553093|FG001|Follow-up|Death|2|||
143004111|NCT03125382|515553094|FG002|Follow-up|Death|1|||
143004112|NCT03125382|515553095|FG003|Follow-up|Death|2|||
143004113|NCT03125382|515553092|FG000|Follow-up|Lost to Follow-up|1|||
143004114|NCT03125382|515553093|FG001|Follow-up|Lost to Follow-up|4|||
143004115|NCT03125382|515553094|FG002|Follow-up|Lost to Follow-up|3|||
143004116|NCT03125382|515553095|FG003|Follow-up|Lost to Follow-up|1|||
143004117|NCT01050998|515553096|FG000|Overall Study|Adverse Event|1|||
143004118|NCT01050998|515553097|FG001|Overall Study|Adverse Event|0|||
143004119|NCT01050998|515553098|FG002|Overall Study|Adverse Event|1|||
143004120|NCT01050998|515553099|FG003|Overall Study|Adverse Event|0|||
143004121|NCT01050998|515553100|FG004|Overall Study|Adverse Event|2|||
143004122|NCT01050998|515553096|FG000|Overall Study|Withdrawal by Subject|0|||
143004123|NCT01050998|515553097|FG001|Overall Study|Withdrawal by Subject|0|||
143004124|NCT01050998|515553098|FG002|Overall Study|Withdrawal by Subject|0|||
143004125|NCT01050998|515553099|FG003|Overall Study|Withdrawal by Subject|1|||
143004126|NCT01050998|515553100|FG004|Overall Study|Withdrawal by Subject|3|||
143004127|NCT01050998|515553096|FG000|Overall Study|Other|3|||
143004128|NCT01050998|515553097|FG001|Overall Study|Other|2|||
143004129|NCT01050998|515553098|FG002|Overall Study|Other|1|||
143004130|NCT01050998|515553099|FG003|Overall Study|Other|1|||
143004131|NCT01050998|515553100|FG004|Overall Study|Other|5|||
143004132|NCT01050998|515553096|FG000|Overall Study|Data integrity issues|0|||
143004133|NCT01050998|515553097|FG001|Overall Study|Data integrity issues|0|||
143004134|NCT01050998|515553098|FG002|Overall Study|Data integrity issues|1|||
143004135|NCT01050998|515553099|FG003|Overall Study|Data integrity issues|1|||
143004136|NCT01050998|515553100|FG004|Overall Study|Data integrity issues|4|||
143004137|NCT04246593|515553101|FG000|Overall Study|Withdrawal by Subject|14|||
143004138|NCT04246593|515553102|FG001|Overall Study|Withdrawal by Subject|13|||
143004139|NCT04246593|515553101|FG000|Overall Study|Lost to Follow-up|124|||
143004140|NCT04246593|515553102|FG001|Overall Study|Lost to Follow-up|71|||
143004141|NCT04246593|515553101|FG000|Overall Study|Moved out of area/became ineligible|3|||
143004142|NCT04246593|515553102|FG001|Overall Study|Moved out of area/became ineligible|1|||
143004143|NCT04246593|515553101|FG000|Overall Study|Reason unknown|4|||
143004144|NCT04246593|515553102|FG001|Overall Study|Reason unknown|2|||
143004145|NCT04668157|515553106|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
143004146|NCT04668157|515553107|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
143004147|NCT04668157|515553106|FG000|Treatment Period (52 Weeks)|Other|0|||
143004148|NCT04668157|515553107|FG001|Treatment Period (52 Weeks)|Other|2|||
143004149|NCT04479358|515553108|FG000|Overall Study|Withdrawal by Subject|0|||
143004150|NCT04479358|515553109|FG001|Overall Study|Withdrawal by Subject|0|||
143004151|NCT04479358|515553110|FG002|Overall Study|Withdrawal by Subject|1|||
143004152|NCT04479358|515553111|FG003|Overall Study|Withdrawal by Subject|0|||
143004153|NCT04479358|515553112|FG004|Overall Study|Withdrawal by Subject|0|||
143004154|NCT04479358|515553113|FG005|Overall Study|Withdrawal by Subject|1|||
143004155|NCT03282123|515553114|FG000|Overall Study|Withdrawal by Subject|5|||
143004156|NCT00764465|515553115|FG000|Overall Study|Adverse Event|2|||
143004157|NCT00764465|515553116|FG001|Overall Study|Adverse Event|0|||
143004158|NCT00764465|515553117|FG002|Overall Study|Adverse Event|0|||
143004159|NCT00764465|515553118|FG003|Overall Study|Adverse Event|1|||
143004160|NCT00764465|515553119|FG004|Overall Study|Adverse Event|1|||
143004161|NCT00764465|515553120|FG005|Overall Study|Adverse Event|1|||
143004162|NCT00764465|515553115|FG000|Overall Study|Withdrawal by Subject|0|||
143004163|NCT00764465|515553116|FG001|Overall Study|Withdrawal by Subject|1|||
143004164|NCT00764465|515553117|FG002|Overall Study|Withdrawal by Subject|1|||
143004165|NCT00764465|515553118|FG003|Overall Study|Withdrawal by Subject|0|||
143004166|NCT00764465|515553119|FG004|Overall Study|Withdrawal by Subject|0|||
143004167|NCT00764465|515553120|FG005|Overall Study|Withdrawal by Subject|0|||
143004168|NCT01463631|515553122|FG000|Overall Study|Withdrawal by Subject|0|||
143004169|NCT01463631|515553123|FG001|Overall Study|Withdrawal by Subject|0|||
143004170|NCT01463631|515553124|FG002|Overall Study|Withdrawal by Subject|0|||
143004171|NCT01463631|515553125|FG003|Overall Study|Withdrawal by Subject|1|||
143004172|NCT01463631|515553122|FG000|Overall Study|Death|0|||
143004173|NCT01463631|515553123|FG001|Overall Study|Death|0|||
143004174|NCT01463631|515553124|FG002|Overall Study|Death|1|||
143004175|NCT01463631|515553125|FG003|Overall Study|Death|0|||
143004176|NCT01463631|515553122|FG000|Overall Study|Progressive Disease|0|||
143004177|NCT01463631|515553123|FG001|Overall Study|Progressive Disease|0|||
143004178|NCT01463631|515553124|FG002|Overall Study|Progressive Disease|0|||
143004179|NCT01463631|515553125|FG003|Overall Study|Progressive Disease|5|||
143004180|NCT01298323|515553126|FG000|Overall Study|Adverse Event|2|||
143004181|NCT01298323|515553127|FG001|Overall Study|Adverse Event|4|||
143004182|NCT01298323|515553126|FG000|Overall Study|Death|11|||
143004183|NCT01298323|515553127|FG001|Overall Study|Death|16|||
143004184|NCT01298323|515553126|FG000|Overall Study|Lost to Follow-up|1|||
143004185|NCT01298323|515553127|FG001|Overall Study|Lost to Follow-up|0|||
143004186|NCT01298323|515553126|FG000|Overall Study|Withdrawal by Subject|6|||
143004187|NCT01298323|515553127|FG001|Overall Study|Withdrawal by Subject|3|||
143004188|NCT01298323|515553126|FG000|Overall Study|Protocol Violation|1|||
143004189|NCT01298323|515553127|FG001|Overall Study|Protocol Violation|0|||
143004190|NCT01298323|515553126|FG000|Overall Study|Other|10|||
143004191|NCT01298323|515553127|FG001|Overall Study|Other|9|||
143004192|NCT01298323|515553126|FG000|Overall Study|Ongoing|55|||
143004193|NCT01298323|515553127|FG001|Overall Study|Ongoing|55|||
143004194|NCT01298323|515553126|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
143004195|NCT01298323|515553127|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
143004196|NCT02500732|515553128|FG000|Overall Study|Physician Decision|0|||
143004197|NCT02500732|515553129|FG001|Overall Study|Physician Decision|1|||
143004198|NCT01990339|515553130|FG000|Overall Study|Data Not Available|49|||
143004199|NCT01990339|515553130|FG000|Overall Study|Voluntary Withdrawal|1402|||
143004200|NCT01990339|515553130|FG000|Overall Study|Lost to Follow-up|861|||
143004201|NCT01038609|515553131|FG000|Overall Study|Adverse Event|0|||
143004202|NCT01038609|515553132|FG001|Overall Study|Adverse Event|0|||
143004203|NCT01038609|515553133|FG002|Overall Study|Adverse Event|1|||
143004204|NCT01038609|515553134|FG003|Overall Study|Adverse Event|0|||
143004205|NCT01038609|515553135|FG004|Overall Study|Adverse Event|0|||
143004206|NCT01038609|515553131|FG000|Overall Study|Dosing Error|0|||
143004207|NCT01038609|515553132|FG001|Overall Study|Dosing Error|0|||
143004208|NCT01038609|515553133|FG002|Overall Study|Dosing Error|0|||
143004209|NCT01038609|515553134|FG003|Overall Study|Dosing Error|1|||
143004210|NCT01038609|515553135|FG004|Overall Study|Dosing Error|1|||
143004211|NCT01038609|515553131|FG000|Overall Study|Death in the Family|1|||
143004227|NCT01314261|515553138|FG002|Overall Study|Withdrawal by Subject|1|||
143004228|NCT01314261|515553139|FG003|Overall Study|Withdrawal by Subject|0|||
143004229|NCT01314261|515553136|FG000|Overall Study|Lost to Follow-up|1|||
143004230|NCT01314261|515553137|FG001|Overall Study|Lost to Follow-up|0|||
143004231|NCT01314261|515553138|FG002|Overall Study|Lost to Follow-up|2|||
143004232|NCT01314261|515553139|FG003|Overall Study|Lost to Follow-up|2|||
143004233|NCT01314261|515553136|FG000|Overall Study|Virologic Failure|0|||
143004234|NCT01314261|515553137|FG001|Overall Study|Virologic Failure|1|||
143004235|NCT01314261|515553138|FG002|Overall Study|Virologic Failure|0|||
143004236|NCT01314261|515553139|FG003|Overall Study|Virologic Failure|1|||
143004237|NCT02129192|515553140|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
143004238|NCT02129192|515553141|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
143004239|NCT01231620|515553143|FG000|Overall Study|Physician Decision|3|||
143004240|NCT01231620|515553144|FG001|Overall Study|Physician Decision|5|||
143004241|NCT01231620|515553145|FG002|Overall Study|Physician Decision|10|||
143004242|NCT01231620|515553143|FG000|Overall Study|Death|12|||
143004243|NCT01231620|515553144|FG001|Overall Study|Death|14|||
143004244|NCT01231620|515553145|FG002|Overall Study|Death|11|||
143004245|NCT01231620|515553143|FG000|Overall Study|Adverse Event|2|||
143004246|NCT01231620|515553144|FG001|Overall Study|Adverse Event|2|||
143004247|NCT01231620|515553145|FG002|Overall Study|Adverse Event|1|||
143004248|NCT01231620|515553143|FG000|Overall Study|Withdrawal by Subject|6|||
143004249|NCT01231620|515553144|FG001|Overall Study|Withdrawal by Subject|6|||
143004250|NCT01231620|515553145|FG002|Overall Study|Withdrawal by Subject|8|||
143004251|NCT01231620|515553143|FG000|Overall Study|Lost to Follow-up|3|||
143004252|NCT01231620|515553144|FG001|Overall Study|Lost to Follow-up|4|||
143004253|NCT01231620|515553145|FG002|Overall Study|Lost to Follow-up|9|||
143004254|NCT02400281|515553146|FG000|Overall Study|Adverse Event|0|||
143004255|NCT02400281|515553147|FG001|Overall Study|Adverse Event|0|||
143004256|NCT02400281|515553148|FG002|Overall Study|Adverse Event|1|||
143004257|NCT02400281|515553149|FG003|Overall Study|Adverse Event|0|||
143004258|NCT02400281|515553150|FG004|Overall Study|Adverse Event|1|||
143004259|NCT02400281|515553151|FG005|Overall Study|Adverse Event|0|||
143004260|NCT02400281|515553146|FG000|Overall Study|Physician Decision|0|||
143004261|NCT02400281|515553147|FG001|Overall Study|Physician Decision|0|||
143004262|NCT02400281|515553148|FG002|Overall Study|Physician Decision|1|||
143004263|NCT02400281|515553149|FG003|Overall Study|Physician Decision|0|||
143004264|NCT02400281|515553150|FG004|Overall Study|Physician Decision|0|||
143004265|NCT02400281|515553151|FG005|Overall Study|Physician Decision|0|||
143004266|NCT04524507|515553152|FG000|Overall Study|Lost to Follow-up|2|||
143004267|NCT04524507|515553153|FG001|Overall Study|Lost to Follow-up|4|||
143004268|NCT04524507|515553152|FG000|Overall Study|Withdrawal by Subject|2|||
143004269|NCT04524507|515553153|FG001|Overall Study|Withdrawal by Subject|9|||
143004270|NCT04524507|515553152|FG000|Overall Study|Death|2|||
143004271|NCT04524507|515553153|FG001|Overall Study|Death|10|||
143004272|NCT00412360|515553154|FG000|Overall Study|Lost to Follow-up|0|||
143004273|NCT00412360|515553155|FG001|Overall Study|Lost to Follow-up|1|||
143004274|NCT00412360|515553154|FG000|Overall Study|Not Transplanted|1|||
143004275|NCT00412360|515553155|FG001|Overall Study|Not Transplanted|2|||
143004276|NCT03655951|515553156|FG000|Overall Study|Lost to Follow-up|39|||
143004277|NCT03655951|515553157|FG001|Overall Study|Lost to Follow-up|20|||
143004278|NCT03655951|515553156|FG000|Overall Study|Withdrawal by Subject|0|||
143004279|NCT03655951|515553157|FG001|Overall Study|Withdrawal by Subject|1|||
143004280|NCT01383317|515553158|FG000|Overall Study|Lost to Follow-up|2|||
143004281|NCT01383317|515553159|FG001|Overall Study|Lost to Follow-up|1|||
143004282|NCT01383317|515553158|FG000|Overall Study|Death|1|||
143004283|NCT01383317|515553159|FG001|Overall Study|Death|0|||
143004284|NCT01383317|515553158|FG000|Overall Study|Adverse Event|0|||
143004285|NCT01383317|515553159|FG001|Overall Study|Adverse Event|1|||
143004286|NCT03418727|515553161|FG000|Overall Study|Adverse Event|1|||
143004287|NCT03418727|515553162|FG001|Overall Study|Adverse Event|2|||
143004288|NCT03418727|515553163|FG002|Overall Study|Adverse Event|0|||
143004289|NCT03418727|515553161|FG000|Overall Study|Withdrawal by Subject|0|||
143004290|NCT03418727|515553162|FG001|Overall Study|Withdrawal by Subject|0|||
143004291|NCT03418727|515553163|FG002|Overall Study|Withdrawal by Subject|2|||
143117352|NCT03334422|515971822|FG000|Overall Study|Lost to Follow-up|0|||
143117353|NCT03334422|515971823|FG001|Overall Study|Lost to Follow-up|0|||
143117354|NCT03334422|515971824|FG002|Overall Study|Lost to Follow-up|0|||
143117355|NCT03334422|515971825|FG003|Overall Study|Lost to Follow-up|1|||
143117356|NCT03334422|515971822|FG000|Overall Study|Inability to obtain laboratory samples|0|||
143117357|NCT03334422|515971823|FG001|Overall Study|Inability to obtain laboratory samples|1|||
143117358|NCT03334422|515971824|FG002|Overall Study|Inability to obtain laboratory samples|0|||
143117359|NCT03334422|515971825|FG003|Overall Study|Inability to obtain laboratory samples|0|||
143117360|NCT03334422|515971822|FG000|Overall Study|Pregnancy|0|||
143117361|NCT03334422|515971823|FG001|Overall Study|Pregnancy|1|||
143117362|NCT03334422|515971824|FG002|Overall Study|Pregnancy|0|||
143117363|NCT03334422|515971825|FG003|Overall Study|Pregnancy|0|||
143117364|NCT01313221|515971826|FG000|Overall Study|Protocol Violation|0|||
143117365|NCT01313221|515971827|FG001|Overall Study|Protocol Violation|1|||
143117366|NCT01313221|515971828|FG002|Overall Study|Protocol Violation|1|||
143117413|NCT01777139|515971842|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
143117414|NCT01777139|515971843|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
143117415|NCT01777139|515971842|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
143117416|NCT01777139|515971843|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
143117417|NCT01777139|515971842|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
143117418|NCT01777139|515971843|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
143117419|NCT01777139|515971842|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
143117420|NCT01777139|515971843|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
143117421|NCT01777139|515971842|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
143117422|NCT01777139|515971843|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
143117423|NCT01887288|515971844|FG000|Overall Study|The study was terminated and the PI has|16|||
143117424|NCT01092637|515971845|FG000|Overall Study|Death|47|||
143117425|NCT01092637|515971846|FG001|Overall Study|Death|49|||
143117426|NCT02921750|515971847|FG000|Overall Study|Adverse Event|1|||
143117427|NCT02921750|515971848|FG001|Overall Study|Adverse Event|2|||
143117428|NCT02921750|515971847|FG000|Overall Study|Withdrawal by Subject|1|||
143117429|NCT02921750|515971848|FG001|Overall Study|Withdrawal by Subject|1|||
143117430|NCT02921750|515971847|FG000|Overall Study|Lost to Follow-up|3|||
143117431|NCT02921750|515971848|FG001|Overall Study|Lost to Follow-up|3|||
143117432|NCT02921750|515971847|FG000|Overall Study|Wound healed|3|||
143117433|NCT02921750|515971848|FG001|Overall Study|Wound healed|3|||
143117434|NCT02921750|515971847|FG000|Overall Study|Serious Adverse Event|1|||
143117435|NCT02921750|515971848|FG001|Overall Study|Serious Adverse Event|2|||
143117436|NCT00593606|515971849|FG000|Overall Study|Adverse Event|13|||
143117437|NCT00593606|515971849|FG000|Overall Study|Withdrawal by Subject|1|||
143117438|NCT00593606|515971849|FG000|Overall Study|Protocol Violation|3|||
143117439|NCT00593606|515971849|FG000|Overall Study|Lost to Follow-up|2|||
143117440|NCT00593606|515971849|FG000|Overall Study|Run-In Failure|5|||
143117441|NCT00593606|515971849|FG000|Overall Study|Screen Failure|3|||
143117442|NCT03309696|515971850|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
143117443|NCT03309696|515971851|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
143117444|NCT03309696|515971852|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
143117445|NCT03309696|515971853|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
143117446|NCT02278367|515971854|FG000|Overall Study|Physician Decision|5|||
143117447|NCT02278367|515971855|FG001|Overall Study|Physician Decision|0|||
143117448|NCT02278367|515971854|FG000|Overall Study|Withdrawal by Subject|5|||
143117449|NCT02278367|515971855|FG001|Overall Study|Withdrawal by Subject|0|||
143117450|NCT02638129|515971857|FG000|Overall Study|Study terminated|28|||
143117451|NCT02638129|515971858|FG001|Overall Study|Study terminated|30|||
143117452|NCT00869557|515971859|FG000|Randomized Phase|Lost to Follow-up|2|||
143117453|NCT00869557|515971860|FG001|Randomized Phase|Lost to Follow-up|1|||
143117454|NCT00869557|515971859|FG000|Randomized Phase|Investigator's Discretion|1|||
143117455|NCT00869557|515971860|FG001|Randomized Phase|Investigator's Discretion|0|||
143117456|NCT00869557|515971859|FG000|Randomized Phase|Withdrew Consent|0|||
143117457|NCT00869557|515971860|FG001|Randomized Phase|Withdrew Consent|1|||
143117458|NCT00869557|515971859|FG000|Extension Phase|Adverse Event|2|||
143117459|NCT00869557|515971860|FG001|Extension Phase|Adverse Event|2|||
143117460|NCT00869557|515971859|FG000|Extension Phase|Lack of Efficacy|1|||
143117461|NCT00869557|515971860|FG001|Extension Phase|Lack of Efficacy|0|||
143117462|NCT00869557|515971859|FG000|Extension Phase|Lost to Follow-up|3|||
143117463|NCT00869557|515971860|FG001|Extension Phase|Lost to Follow-up|1|||
143117464|NCT00869557|515971859|FG000|Extension Phase|Investigator's Discretion|2|||
143117465|NCT00869557|515971860|FG001|Extension Phase|Investigator's Discretion|0|||
143117466|NCT00869557|515971859|FG000|Extension Phase|Withdrew Consent|2|||
143117467|NCT00869557|515971860|FG001|Extension Phase|Withdrew Consent|0|||
143117468|NCT01472939|515971861|FG000|Overall Study|Adverse Event|3|||
143117469|NCT01472939|515971862|FG001|Overall Study|Adverse Event|7|||
143117470|NCT01472939|515971863|FG002|Overall Study|Adverse Event|7|||
143117471|NCT01472939|515971864|FG003|Overall Study|Adverse Event|14|||
143117472|NCT01472939|515971861|FG000|Overall Study|Lack of Efficacy|1|||
143117473|NCT01472939|515971862|FG001|Overall Study|Lack of Efficacy|0|||
143117474|NCT01472939|515971863|FG002|Overall Study|Lack of Efficacy|0|||
143117475|NCT01472939|515971864|FG003|Overall Study|Lack of Efficacy|1|||
143117476|NCT01472939|515971861|FG000|Overall Study|Lost to Follow-up|3|||
143117477|NCT01472939|515971862|FG001|Overall Study|Lost to Follow-up|0|||
143117478|NCT01472939|515971863|FG002|Overall Study|Lost to Follow-up|2|||
143117479|NCT01472939|515971864|FG003|Overall Study|Lost to Follow-up|0|||
143117480|NCT01472939|515971861|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
143117481|NCT01472939|515971862|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
143117482|NCT01472939|515971863|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
143117483|NCT01472939|515971864|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
143117484|NCT01472939|515971861|FG000|Overall Study|Prohibited Medication|0|||
143117485|NCT01472939|515971862|FG001|Overall Study|Prohibited Medication|1|||
143117486|NCT01472939|515971863|FG002|Overall Study|Prohibited Medication|0|||
143117487|NCT01472939|515971864|FG003|Overall Study|Prohibited Medication|0|||
143117496|NCT01472939|515971861|FG000|Overall Study|Withdrawal by Subject|9|||
143117497|NCT01472939|515971862|FG001|Overall Study|Withdrawal by Subject|3|||
143117498|NCT01472939|515971863|FG002|Overall Study|Withdrawal by Subject|1|||
143117499|NCT01472939|515971864|FG003|Overall Study|Withdrawal by Subject|4|||
143117500|NCT00114738|515971865|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
143117501|NCT00114738|515971866|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
143117502|NCT00114738|515971867|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
143117503|NCT00114738|515971865|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
143117504|NCT00114738|515971866|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
143117505|NCT00114738|515971867|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
143117506|NCT00114738|515971865|FG000|Screening for Randomization|Neuropathy|17|||
143117507|NCT00114738|515971866|FG001|Screening for Randomization|Neuropathy|0|||
143117508|NCT00114738|515971867|FG002|Screening for Randomization|Neuropathy|0|||
143117509|NCT00114738|515971865|FG000|Screening for Randomization|Progressive disease|2|||
143117510|NCT00114738|515971866|FG001|Screening for Randomization|Progressive disease|0|||
143117511|NCT00114738|515971867|FG002|Screening for Randomization|Progressive disease|0|||
143117512|NCT00114738|515971865|FG000|Screening for Randomization|CNS Hemorrhage|1|||
143117513|NCT00114738|515971866|FG001|Screening for Randomization|CNS Hemorrhage|0|||
143117514|NCT00114738|515971867|FG002|Screening for Randomization|CNS Hemorrhage|0|||
143117515|NCT00114738|515971865|FG000|Screening for Randomization|Other|1|||
143117516|NCT00114738|515971866|FG001|Screening for Randomization|Other|0|||
143117517|NCT00114738|515971867|FG002|Screening for Randomization|Other|0|||
143117518|NCT02223819|515971873|FG000|Overall Study|Lost to Follow-up|2|||
143117519|NCT03435224|515971874|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
143117520|NCT02945254|515971875|FG000|Overall Study|Lost to Follow-up|1|||
143117521|NCT02945254|515971876|FG001|Overall Study|Lost to Follow-up|0|||
143117522|NCT02945254|515971875|FG000|Overall Study|Withdrawal by Subject|1|||
143117523|NCT02945254|515971876|FG001|Overall Study|Withdrawal by Subject|0|||
143117524|NCT03436199|515971877|FG000|Overall Study|Adverse Event|15|||
143117525|NCT03436199|515971878|FG001|Overall Study|Adverse Event|40|||
143117526|NCT03436199|515971879|FG002|Overall Study|Adverse Event|7|||
143117527|NCT03436199|515971877|FG000|Overall Study|Withdrawal by Subject|4|||
143117528|NCT03436199|515971878|FG001|Overall Study|Withdrawal by Subject|10|||
143117529|NCT03436199|515971879|FG002|Overall Study|Withdrawal by Subject|3|||
143117530|NCT03436199|515971877|FG000|Overall Study|Lost to Follow-up|1|||
143117531|NCT03436199|515971878|FG001|Overall Study|Lost to Follow-up|0|||
143117532|NCT03436199|515971879|FG002|Overall Study|Lost to Follow-up|2|||
143117533|NCT03436199|515971877|FG000|Overall Study|Protocol Violation|1|||
143117534|NCT03436199|515971878|FG001|Overall Study|Protocol Violation|1|||
143117535|NCT03436199|515971879|FG002|Overall Study|Protocol Violation|0|||
143117536|NCT03436199|515971877|FG000|Overall Study|Physician Decision|0|||
143117537|NCT03436199|515971878|FG001|Overall Study|Physician Decision|1|||
143117538|NCT03436199|515971879|FG002|Overall Study|Physician Decision|0|||
143117539|NCT03436199|515971877|FG000|Overall Study|Could not return to clinic|1|||
143117540|NCT03436199|515971878|FG001|Overall Study|Could not return to clinic|0|||
143117541|NCT03436199|515971879|FG002|Overall Study|Could not return to clinic|0|||
143117542|NCT03436199|515971877|FG000|Overall Study|Withdrawn per physician|0|||
143117543|NCT03436199|515971878|FG001|Overall Study|Withdrawn per physician|1|||
143117544|NCT03436199|515971879|FG002|Overall Study|Withdrawn per physician|0|||
143117545|NCT00085098|515971882|FG000|Overall Study|Withdrawal by Subject|0|||
143117546|NCT00085098|515971883|FG001|Overall Study|Withdrawal by Subject|1|||
143117547|NCT00085098|515971882|FG000|Overall Study|Ineligible|1|||
143117548|NCT00085098|515971883|FG001|Overall Study|Ineligible|1|||
143117549|NCT03329248|515971884|FG000|Overall Study|Progressive Disease|6|||
143117550|NCT01886781|515971885|FG000|Overall Study|Protocol Violation|5|||
143117551|NCT01886781|515971886|FG001|Overall Study|Protocol Violation|0|||
143117552|NCT01886781|515971885|FG000|Overall Study|Adverse Event|1|||
143117553|NCT01886781|515971886|FG001|Overall Study|Adverse Event|0|||
143117554|NCT01886781|515971885|FG000|Overall Study|Lost to Follow-up|5|||
143117555|NCT01886781|515971886|FG001|Overall Study|Lost to Follow-up|0|||
143117556|NCT01886781|515971885|FG000|Overall Study|Withdrawal by Subject|2|||
143117557|NCT01886781|515971886|FG001|Overall Study|Withdrawal by Subject|1|||
143117558|NCT01886781|515971885|FG000|Overall Study|Worsening of symptoms|1|||
143117559|NCT01886781|515971886|FG001|Overall Study|Worsening of symptoms|1|||
143117560|NCT03000530|515971887|FG000|Overall Study|Adverse Event|0|||
143117561|NCT03000530|515971888|FG001|Overall Study|Adverse Event|0|||
143117562|NCT03000530|515971889|FG002|Overall Study|Adverse Event|2|||
143117563|NCT03000530|515971887|FG000|Overall Study|Lost to Follow-up|0|||
143117564|NCT03000530|515971888|FG001|Overall Study|Lost to Follow-up|3|||
143117565|NCT03000530|515971889|FG002|Overall Study|Lost to Follow-up|1|||
143117566|NCT03000530|515971887|FG000|Overall Study|Withdrawal by Subject|0|||
143117567|NCT03000530|515971888|FG001|Overall Study|Withdrawal by Subject|2|||
143117568|NCT03000530|515971889|FG002|Overall Study|Withdrawal by Subject|1|||
143117569|NCT01430624|515971890|FG000|Overall Study|Lost to Follow-up|23|||
143117570|NCT01430624|515971891|FG001|Overall Study|Lost to Follow-up|29|||
143117571|NCT01430624|515971892|FG002|Overall Study|Lost to Follow-up|27|||
143117572|NCT01430624|515971890|FG000|Overall Study|technical or eligibility|5|||
143117573|NCT01430624|515971891|FG001|Overall Study|technical or eligibility|5|||
143117574|NCT01430624|515971892|FG002|Overall Study|technical or eligibility|2|||
143117575|NCT01362517|515971894|FG000|Overall Study|Protocol Violation|1|||
143117576|NCT01362517|515971894|FG000|Overall Study|Lost to Follow-up|1|||
143117577|NCT01672294|515971895|FG000|Overall Study|Withdrawal by Subject|4|||
143117578|NCT01672294|515971896|FG001|Overall Study|Withdrawal by Subject|4|||
143117579|NCT01672294|515971897|FG002|Overall Study|Withdrawal by Subject|4|||
143117580|NCT01672294|515971898|FG003|Overall Study|Withdrawal by Subject|4|||
143117581|NCT01672294|515971895|FG000|Overall Study|Excluded by study|1|||
143117582|NCT01672294|515971896|FG001|Overall Study|Excluded by study|1|||
143117583|NCT01672294|515971897|FG002|Overall Study|Excluded by study|0|||
143117584|NCT01672294|515971898|FG003|Overall Study|Excluded by study|0|||
143117585|NCT01672294|515971895|FG000|Overall Study|Lost to Follow-up|1|||
143117586|NCT01672294|515971896|FG001|Overall Study|Lost to Follow-up|16|||
143117587|NCT01672294|515971897|FG002|Overall Study|Lost to Follow-up|7|||
143117588|NCT01672294|515971898|FG003|Overall Study|Lost to Follow-up|9|||
143117589|NCT02649426|515971899|FG000|Overall Study|Follow-up on going|1|||
143117590|NCT02649426|515971900|FG001|Overall Study|Follow-up on going|26|||
143117591|NCT02649426|515971901|FG002|Overall Study|Follow-up on going|28|||
143117592|NCT02649426|515971902|FG003|Overall Study|Follow-up on going|31|||
143117593|NCT01606202|515971903|FG000|Overall Study|Adverse Event|5|||
143117594|NCT01606202|515971904|FG001|Overall Study|Adverse Event|0|||
143117595|NCT01606202|515971903|FG000|Overall Study|Withdrawal by Subject|2|||
143117596|NCT01606202|515971904|FG001|Overall Study|Withdrawal by Subject|1|||
143117597|NCT01606202|515971903|FG000|Overall Study|Personal problems|0|||
143117598|NCT01606202|515971904|FG001|Overall Study|Personal problems|1|||
143117599|NCT01606202|515971903|FG000|Overall Study|Problems with administration|0|||
143117600|NCT01606202|515971904|FG001|Overall Study|Problems with administration|1|||
143117601|NCT03887117|515971910|FG000|Overall Study|Discontinued prematurely|0|||
143117602|NCT03887117|515971911|FG001|Overall Study|Discontinued prematurely|1|||
143117603|NCT03887117|515971912|FG002|Overall Study|Discontinued prematurely|1|||
143117604|NCT03887117|515971913|FG003|Overall Study|Discontinued prematurely|2|||
143117605|NCT03008278|515971914|FG000|Overall Study|Progressive Disease|0|||
143117606|NCT03008278|515971915|FG001|Overall Study|Progressive Disease|0|||
143117607|NCT03008278|515971916|FG002|Overall Study|Progressive Disease|32|||
143117608|NCT03008278|515971914|FG000|Overall Study|Adverse Event|0|||
143117609|NCT03008278|515971915|FG001|Overall Study|Adverse Event|0|||
143117610|NCT03008278|515971916|FG002|Overall Study|Adverse Event|4|||
143117611|NCT03008278|515971914|FG000|Overall Study|Withdrawal by Subject|0|||
143117612|NCT03008278|515971915|FG001|Overall Study|Withdrawal by Subject|0|||
143117613|NCT03008278|515971916|FG002|Overall Study|Withdrawal by Subject|3|||
143117614|NCT03008278|515971914|FG000|Overall Study|Physician Decision|0|||
143117615|NCT03008278|515971915|FG001|Overall Study|Physician Decision|2|||
143117616|NCT03008278|515971916|FG002|Overall Study|Physician Decision|0|||
143117617|NCT01389258|515971917|FG000|Overall Study|Lost to Follow-up|5|||
143117618|NCT04249622|515971918|FG000|Overall Study|Withdrawal by Subject|1|||
143117619|NCT04249622|515971919|FG001|Overall Study|Withdrawal by Subject|1|||
143117620|NCT04249622|515971918|FG000|Overall Study|Alternative therapy|1|||
143117621|NCT04249622|515971919|FG001|Overall Study|Alternative therapy|0|||
143117622|NCT04249622|515971918|FG000|Overall Study|Discontinuation of pertuzumab|1|||
143117623|NCT04249622|515971919|FG001|Overall Study|Discontinuation of pertuzumab|0|||
143117624|NCT03482167|515971920|FG000|Allocated to Intervention|Physician Decision|1|||
143117625|NCT03482167|515971921|FG001|Allocated to Intervention|Physician Decision|2|||
143117626|NCT03482167|515971920|FG000|Received Intervention|Adverse Event|3|||
143117627|NCT03482167|515971921|FG001|Received Intervention|Adverse Event|1|||
143117628|NCT03482167|515971920|FG000|Received Intervention|Physician Decision|1|||
143117629|NCT03482167|515971921|FG001|Received Intervention|Physician Decision|1|||
143117630|NCT03482167|515971920|FG000|Received Intervention|Withdrawal by Subject|1|||
143117631|NCT03482167|515971921|FG001|Received Intervention|Withdrawal by Subject|0|||
143117632|NCT04148287|515971925|FG000|Overall Study|Death|2|||
143117633|NCT03164265|515971926|FG000|Overall Study|Physician Decision|3|||
143117634|NCT02680834|515971928|FG000|Overall Study|Physician Decision|5|||
143117635|NCT02680834|515971929|FG001|Overall Study|Physician Decision|2|||
143117636|NCT02680834|515971928|FG000|Overall Study|Withdrawal by Subject|6|||
143117637|NCT02680834|515971929|FG001|Overall Study|Withdrawal by Subject|0|||
143117638|NCT02680834|515971928|FG000|Overall Study|Lost to Follow-up|0|||
143117639|NCT02680834|515971929|FG001|Overall Study|Lost to Follow-up|1|||
143117640|NCT02407054|515971932|FG000|Overall Study|Adverse Event|1|||
143117641|NCT02407054|515971933|FG001|Overall Study|Adverse Event|4|||
143117642|NCT02407054|515971934|FG002|Overall Study|Adverse Event|1|||
143117643|NCT02407054|515971932|FG000|Overall Study|Non-compliance with Study|0|||
143117644|NCT02407054|515971933|FG001|Overall Study|Non-compliance with Study|2|||
143117645|NCT02407054|515971934|FG002|Overall Study|Non-compliance with Study|1|||
143117646|NCT02407054|515971932|FG000|Overall Study|Physician Decision|1|||
143117647|NCT02407054|515971933|FG001|Overall Study|Physician Decision|3|||
143117648|NCT02407054|515971934|FG002|Overall Study|Physician Decision|3|||
143117649|NCT02407054|515971932|FG000|Overall Study|Withdrawal by Subject|5|||
143117650|NCT02407054|515971933|FG001|Overall Study|Withdrawal by Subject|9|||
143117651|NCT02407054|515971934|FG002|Overall Study|Withdrawal by Subject|2|||
143117652|NCT00415597|515971935|FG000|Enrollment|Withdrawal by Subject|1|||
143117653|NCT00415597|515971935|FG000|Enrollment|Protocol Violation|1|||
143117654|NCT00415597|515971935|FG000|Treatment|Adverse Event|110|||
143117655|NCT00415597|515971935|FG000|Treatment|Lack of Efficacy|39|||
143117656|NCT00415597|515971935|FG000|Treatment|Protocol Violation|67|||
143117657|NCT00415597|515971935|FG000|Treatment|Physician Decision|3|||
143117658|NCT00415597|515971935|FG000|Treatment|Withdrawal by Subject|51|||
143117659|NCT00415597|515971935|FG000|Treatment|Lost to Follow-up|28|||
143117660|NCT00415597|515971935|FG000|Treatment|Drug Screen|2|||
143117661|NCT00415597|515971935|FG000|Treatment|Administrative|3|||
143117662|NCT00415597|515971935|FG000|Treatment|Sponsor Decision|1|||
143117663|NCT00415597|515971935|FG000|Treatment|Multiple Reasons|1|||
143117664|NCT01764997|515971937|FG000|Run-in Period|Adverse Event|15|||
143117665|NCT01764997|515971938|FG001|Run-in Period|Adverse Event|0|||
143117666|NCT01764997|515971939|FG002|Run-in Period|Adverse Event|0|||
143117667|NCT01764997|515971940|FG003|Run-in Period|Adverse Event|0|||
143117668|NCT01764997|515971941|FG004|Run-in Period|Adverse Event|0|||
143117669|NCT01764997|515971937|FG000|Run-in Period|Lack of Efficacy|5|||
143117670|NCT01764997|515971938|FG001|Run-in Period|Lack of Efficacy|0|||
143117671|NCT01764997|515971939|FG002|Run-in Period|Lack of Efficacy|0|||
143117672|NCT01764997|515971940|FG003|Run-in Period|Lack of Efficacy|0|||
143117673|NCT01764997|515971941|FG004|Run-in Period|Lack of Efficacy|0|||
143117674|NCT01764997|515971937|FG000|Run-in Period|Poor compliance to protocol|1|||
143117675|NCT01764997|515971938|FG001|Run-in Period|Poor compliance to protocol|0|||
143117676|NCT01764997|515971939|FG002|Run-in Period|Poor compliance to protocol|0|||
143117677|NCT01764997|515971940|FG003|Run-in Period|Poor compliance to protocol|0|||
143117678|NCT01764997|515971941|FG004|Run-in Period|Poor compliance to protocol|0|||
143117679|NCT01764997|515971937|FG000|Run-in Period|Other than specified above|17|||
143117680|NCT01764997|515971938|FG001|Run-in Period|Other than specified above|0|||
143117681|NCT01764997|515971939|FG002|Run-in Period|Other than specified above|0|||
143117682|NCT01764997|515971940|FG003|Run-in Period|Other than specified above|0|||
143117683|NCT01764997|515971941|FG004|Run-in Period|Other than specified above|0|||
143117684|NCT01764997|515971937|FG000|Study Drug Treatment Period|Adverse Event|0|||
143117685|NCT01764997|515971938|FG001|Study Drug Treatment Period|Adverse Event|1|||
143117686|NCT01764997|515971939|FG002|Study Drug Treatment Period|Adverse Event|0|||
143117687|NCT01764997|515971940|FG003|Study Drug Treatment Period|Adverse Event|0|||
143117688|NCT01764997|515971941|FG004|Study Drug Treatment Period|Adverse Event|24|||
143117689|NCT01764997|515971937|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
143117690|NCT01764997|515971938|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
143117691|NCT01764997|515971939|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
143117692|NCT01764997|515971940|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
143117693|NCT01764997|515971941|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
143117694|NCT01764997|515971937|FG000|Study Drug Treatment Period|Other than specified above|0|||
143117695|NCT01764997|515971938|FG001|Study Drug Treatment Period|Other than specified above|0|||
143117696|NCT01764997|515971939|FG002|Study Drug Treatment Period|Other than specified above|0|||
143117697|NCT01764997|515971940|FG003|Study Drug Treatment Period|Other than specified above|0|||
143117698|NCT01764997|515971941|FG004|Study Drug Treatment Period|Other than specified above|10|||
143117699|NCT04438499|515971948|FG000|Overall Study|Lack of Efficacy|3|||
